>fig|195.2024.peg.575 Putative periplasmic protein
MKIIRFFFILIIVFILVCLVMNQSIFSYIEQKYHFAFYPKNDILQEANSFKNKLEQIRAI
LSNEPLPQNIEENIMVQEDMDELNASNDFIDKNTTIEDIQQTEDENVSFIDNTKLEVHKG
DEFLFIGDSLMQGVAIALNRDLIDLGLKANDLSKQNTGLSYKSYFDWAKATKEAFAKNPN
IKYLVVLLGANDPWDIKKGGIYHRFGSDSWIDIYTYRVNEIINIAKQHHAKILWFEIPPV
KKNELNEKIQILNKIYSEEILKNKQIFINTKLFFSVNDEFSTYIKNENNKSIKMRTDDGI
HFTSNGAKEMSKLLLQHITIKEENAN
>fig|195.2024.peg.1455 Fe2+ ABC transporter, permease protein 2
MVDKFFLNELFKSIAFSYQRLFIIVLSVFIGALTCSAFLNIYFDIDTKLSKELKAYGANV
IIEPKNDKELILNQDYEEGKKNLKARALTPFLYTFLNLGSTSGVVLGTDFRALKITKPFI
EVKEGSFSLSDFDENSAFLGINLSKQLGLKVGNELQIYNPENGKTTKLTIKGILLSNDEL
DSIVLAPLSVVQNLSDTFGIQYANAVVYGNFDEINTKTKNISNESINAKPISSVSLSEGL
VLDKIKALMFLIILVVLIIVTTSVNTTLSSIIFSRKKEIALRLALGAKKSEIFKLFACEY
FIISLFASIIGAFCGIFLANIFGYLIFNASIDFRFKAIFMALIVSLFFAFLAAFFPIKKA
LKINVCENLKGE
>fig|195.2024.peg.1693 4-hydroxybenzoyl-CoA thioesterase family active site
MKIRIYYEDTDAGGVVYHSNYLKFCERARSEIFFAKNAPIFDANKGHFLLTKANCFFIKS
AKLGDIIEVKTKLLKIKNASVDIAQEIYRDEILLFKVELTLAYIQNEKPAKIDAGIKKLF
EELF
>fig|195.2024.peg.935 Cinnamyl alcohol dehydrogenase/reductase (EC 1.1.1.195) @ Alcohol dehydrogenase (EC 1.1.1.1)
MDSKIFLENGRIQSKGYAMLSKDAKFTPFEFTRHAVGDNDILIKILYAGICHSDIHTARS
EWGEAVYPCVPGHEIAGEVIAVGKNVSKFKVGDYAGVGCMVNSCGECEACKKSQEQFCEK
GQTIYTYNSCDIFHDNENTYGGYSNNIVVSEKFAVCVPKDAPMEKVAPLLCAGITTYSPL
KFSNIKAGSSVAVAGFGGLGMMAVKYAVKMGAKVSVFARNENKKADALAMGVSSFYTSTD
KNAVKERFDLIISTIPTPYDPSAYMDLLKFGGEMAIVGLPPHEVAPSISVITFVHKAGKK
VYGSLIGGIAETQEMLDFSLKHKIYPETELITSKDIDKAYENLTSGKAKFRYVIDMRDE
>fig|195.2024.peg.24 Two-component transcriptional response regulator, LuxR family
MYNMSKSKILIIEDDIDLNDLLSLRLKACDYQIFSLLDFKGVEDLLDSEQIDLLIVDRNL
PSGDSLDRIKELRKQGYKEAVIFLTAKTLHQDLLEGFESGCDDYMCKPFDFNELLLRIKA
ILKRHKREEEKLVFKDFSLDLINYEFFYKNEKLDVSNLEYELLKCFFENPNTLLTRQFLS
ENVWKDDTTSDKTINIALTRLRNKFPKLKEHIISVRGIGYKIC
>fig|195.2024.peg.1184 Positive regulator of CheA protein activity (CheW)
MSNEKLEQILQKQQTQIAGPVGDQKEDDIIQLVGFVVGDEEYAIPILNIQEIIKPIEYTR
VPSVPDYVLGVFNMRGNVMPLIDLAQRFNLGSSKMTPQTRYIVLRGESNGSGVGGNAGFV
IDRLTEAIKIHRNRIDPPPETLVKDKGMIYGIGKRDENILTILKVEALLKREF
>fig|195.2024.peg.961 ATP-dependent Clp protease proteolytic subunit ClpP (EC 3.4.21.92)
MYIPYVIEKTSRGERSYDIYSRLLKDRIIMLSGEIHDELAASIVAQLLFLEAEDPQKDIY
LYINSPGGVITSGFSIYDTMNYIKPDVCTICIGQAASMGAFLLSCGTEGKRFALPNSRIM
IHQPLGGARGQATDIEIQAKEILRLKAILNDILAKNTKQKVAKIVKDTERDFFMSAQEAK
EYGLIDKVLEKSFK
>fig|195.2024.peg.1317 Fumarate reductase flavoprotein subunit (EC 1.3.5.4)
MNIQYSDALVIGGGLAGLRAAIEVAKSGQSVTLLSICPVKRSHSAAVQGGMQASLGNGAK
GEGDNEDLHFADTVKGSDWGCDQEVARMFAQTAPKAVRELASWGVPWTRVTKGPRTVVIN
AQKTVIEEREEAHGLINARDFGGTKKWRTCYIADATGHCMLYGVANEAIKHQVKIIDRME
AVRVIHDGKKCLGVIARDLTNGQLIAYIARGTMIATGGYGRIYKQTTNAVICEGTGAAIA
LETGLCRLSNMEAVQFHPTPIVPSGILLTEGCRGDGGILRDVDGYRFMPDYEPEKKELAS
RDVVSRRMMEHIRKGKGVKSPYGDHLWLDISILGRAHVEKNLRDVQDICKTFNGIDPADE
GPKGWAPVLPMQHYSMGGIRTKPTGESQWLDGLFACGEAACWDMHGFNRLGGNSCAETVV
AGMIIGDYFADYCKNNGEVIDTNIVKDFLTKEYQYLKSLVDKEGKYSVFEIKNRMKEIMW
DKVAIFRTGEGLKEAVDELEKLYKESQNVKVHCKELDCANPELEEAYRVPRMLKVALCVA
YGALLRTESRGAHYREDYPKRDDLNWMKRTLTYWVEGESLPRVEYDELDIMKMEMPPAFR
GYGAKGNIIENPLSEKRQAEVDAIREKMEAEGKNRHEIQHALMPYELQPKYKALNQRIGV
DYE
>fig|195.2024.peg.704 Transcription termination protein NusA
MERIADIIESIANEKNLDIESVKEKVIIALINTAKRIYGQEYDFFVDRKNLNLYQKITVV
ADNDERLNENKESYIEFSKAKKEAPDVEIGDELTYECSLENLGRTAVNILHKELEYHIQK
LLEQTIFEKYKNKVGQMVFGNVVRIDNEENTYIEIDELRAFLPRKNRIKGEKFKVGDVVK
AVIRRVYTDKGIKMELSRTSPKFLECLLEAEVPEIKDGYVSVVKCARIPGERAKIILQAN
GANIDPVGATVGVKGVRINAVSKELHNENIDCIEFSNEPEILIARALAPAIVSSVKIENE
KAIVTLNSEQKSKAIGKSGINIRLAGMLSGYEIELNEVNARTTSNTLSNEEALKNLQDLF
KI
>fig|195.2024.peg.949 hypothetical protein
MKYQILNNGLKIPIVGFGTARLQGRECFKVLNNALECGYRLIDTAQMYKNHKDIAKVLKE
SQIPRKELFIESKISQNLSYLQAKDMIYKILDELDLEYLDLLLIHEPYENSLQIYDAMQE
AFENKLIKSLGVSNFNENLLFDFIQKVTIKPVINQCETHLLYQQKSLHKALQKHDIFLQS
WGPFIANKNKIFNHPLLLCMAKKYSKTPAQIILNFLYKLGILLIPKSSNLQRMKQNLQIF
DFELEDEDTQKLIYLDQNKSFFGWYD
>fig|195.2024.peg.360 hypothetical protein
MVVKDIQTTSSSMFSATTKVKEKSTSADEFQATLNEVKNKEEKEDKKTSSSEFTNEDLDL
SAVKEDFKSYAWQKMREDQYKKNEEDLLNKLFATIDAGNTAKI
>fig|195.2024.peg.952 Arsenical resistance operon repressor
MQKFLTIISAINDESRVLILYHLLKYQELCVCDLQKLLNMGQSRLSRHLKILKDAGFLYV
KRKGTWAYYGINNELLKLHSDLFENIKNLDIDNIVLEQNTCENDK
>fig|195.2024.peg.491 GTP cyclohydrolase 1 type 2 homolog YbgI
MKLIEIYNFLDKLSPFETQEIWDNSGLLLGNFNDEIHNVYLSLDIDEQLIQNAEENSLFI
THHPLIFKGLKDLANSAYPRAFVKEMLRKNLSLISMHTNFDLSHLNTYFIEEILGFEISS
KNKFLAYIDVDMSFEELCIVVKKRLNLEILRTSFCGKEYLKRLAVCTGSGGDLLNEVKAD
CYLSGDFKYHQALEAISNHLNLIDLGHFESERYFAQCLAKHLKNLPLKVIITVSKNPFQY
F
>fig|195.2024.peg.1659 Flagellar synthesis regulator FleN
MNNQANKLRSLMNQNGGKKSQNTHFIAITSGKGGVGKSTISANLANVLANNGYKVGLFDA
DIGLANLDVILNVRIQKNLLHVLRGECSLEDILIEVKPNLWLIPGESGDEILKYNDKNIY
ERFLNQASILDELDFLIIDTGAGIGGNILNFLEMSDEVVVVTVPDPAAITDAYATIKTTS
KTKENLLMLFNVVKNENEALKVFENIKKVADANIKNRLNLEFLGHLSASKDVSGSIKKRT
LFTDENSASSDELKALASKLLYRLERKVLDNVTSRSFSNFFRKIIERF
>fig|195.2024.peg.1000 LSU ribosomal protein L31p @ LSU ribosomal protein L31p, zinc-dependent
MKKEIHPEYVECKVSCACGNTFVTKSNKSELRVDICSSCHPFFTGSEKIVDAAGRVEKFK
KKYAMQ
>fig|195.2024.peg.139 Transcriptional regulator, AraC family
MEQILSLPQDLKQLKGVDYKNFKSCTFAKYTQVSASHSSFVNVGSHLLTFVRKGYKILHT
ASKDYKIDSYETLFLKAGNYTLSNVGLSSGVYEAYLFFFDNAFLIELIYKYKDLFKLEQA
SEESEIFWVKNDKILQGILESFTPHFDENTQILDPIVSLKFEEIFLHLLLNKNTYFIGFL
AGILKEFRLDLSQLFEYCGREFVSVSEMADFAKLDFATFSREFKKCFGQSPKKWLDEKRL
QKAKVLLEFSKKNVNEIANECAFSSVAWFIERFKEKYNQTPKQYQKSKNLYFLSKN
>fig|195.2024.peg.746 Iron compound ABC uptake transporter permease protein
MLFKHLFSLNILLILLVVFGIISLFIGVIRINLDDIFSLSTTQLEIILLTRIPRLIAILL
TGMSLSICGLIMQQLTQNKFVSPTTAGTMDCAKFGILISLIFFTGASFFTQALIASIFAL
LGSFIFIQILRKIKLKDVIFVPLIGLMFGGIINAITTFFAYALNYIQNIQGWLQGSMANV
MQGNYELLYISLPLFILAYFLAHKITIAGMGEDLALNLGVSYNTILFLGLIIVSIITSVV
IVSIGVIPFLGLIIPNLVAIYRGDNLKKNLIYIALCGALFLLICDIISRLVIFPFEMPLS
ITTGVLGSLIFIFLLLKRKTYA
>fig|195.2024.peg.83 Putative oxidoreductase ferredoxin-type protein, clusters with CPO
MNFSQISDACVKCGKCIPVCTIHEVNRDETTSPRGFLDLLAAYKEEKLELDKEAKKIFES
CFLCTNCVEVCPSKLRVDNVIEEVRYDIAKKFGIAWYKKIIFFFLRRRKILDLVAKLGYV
FQSCAFKIQSQDQNVGMKAKFSMPFVKKGRLLTSFNKKSFLNSNPDFIDNGGEKTVGFFV
GCLANYFYIDTANAVLKIAKEVKINVDLMKEQVCCGAPQFFTGDFKSVEILAKKNIEYFE
KKLEKLDAIIIPEATCSAMLKIDLEHFFNMQNEPEWAKRAQKISSRIYMASEYFYKFTNL
KELLESKKKLNYSITYHDPCHARKMQGVFKEPRELLKANYHFVEMSNPNACCGFGGVSMQ
TDYYDRALSVGLKKASMIDESKACVVSAECSACRMQISNALEQNSSKAIFASPLELIAKA
L
>fig|195.2024.peg.542 Septum-associated rare lipoprotein A
MKPYTINGKTYYPTVVSVGETADGIASWYGPGFHGKKTSNGETYNQNGLTAAHKTLPMNT
ILKVTNLNNNRQVTVRVNDRGPFVNNRIIDLSKGAASQIDMIAAGTAPVRLEVIGFGSAN
SGNNVVHSNINYGASGGIANNGQIYEGGNFMVQIGAFKNPSGAQTIASRYKTYRTYSSTI
RKSSVDGLSRVFLTGFRSEEEARDFAASGAFAGAFVVRE
>fig|195.2024.peg.50 Carbon starvation protein A
MARFGTKILWLFVAALGAICFAHLALQNGESVSAIYLVVAAVCIYMIGYRFYGRFVAYKV
LELDKNRATPAVLENDGRDFVPTNRTVLFGHHFAAIAGAGPLVGPILAAQMGYLPSMLWI
LVGGVLAGAVHDFVVLFISTRRRGRSLGEIIKDEMGKFTGGVAMVAIFGIMLIIIAILAM
VVVKALAESPWGLFTIAMTIPIAIFMGVYMRFIRPGRVGEASVIGFILLILAIHYGSVIA
ADPYWAKIFTLEAPTLAIIMMAYGFIAAVLPVWFLLAPRDYLSTFLKIGVIVVMAVAIII
VAPDLQMPKTNAQYFDGTGPVFAGAIFPFLFITIACGAISGFHALISSGTTPKMLENETH
ALPVGYGSMLAESAVAIMALICACILHPGLYFAINSSSALIGSDVASAAQAISSWGFSIT
PEEISTLTANIGEYTILSRTGGAPTFAIGVALILHELFGGIDLMAFWYHFAILFEALFIL
TAVDAGTRACRFMVQDILGNVYKPLGNIHNYPAGLLATALSVAGWGYFLYQGAIDPKGGI
YTLWPLFGVSNQMLAGMALLLATAILVKMGKAKYTWVTLIPATFVLVATLYGGIQKVMPY
EERNKVGNAVSHVAAVTIQSQKIQDLELKLNHAKDENEIAAIEKEISVATQSKIGNLINA
ILCVFFMLATLLVILSCIGICLGKIKIPLKETKYIKLDEFQKV
>fig|195.2024.peg.153 hypothetical protein
MVYSFFTFLLGIYAFARAIYKMANIKRIYVTKEKLVIKYHIKNDLVFPLGTFFIYYRKIS
YSPSPGHIVIHTFGDKAKEYLEPGLFSDGDDPTKGCFERINAIIKPYVMPYLLGLSDEEF
EKIFFHINATSEIDTTFLKEAMELRKEKKDE
>fig|195.2024.peg.1377 DNA-directed RNA polymerase alpha subunit (EC 2.7.7.6)
MRNITTSAYTPTEFTIENISDTVAKISAWPFEIGYGITLAHPLRRLLYTSTIGYAPTAIH
IDGVAHEFDSMRGMLEDVALFIINLKKLRFKLKSDSNKEIVEFSFKGPKEIYGKDLNNDQ
VEVVNTDAYLATINEDAELKFTLIIEKGIGYVPSEEIKELLNDPKFIALDAFFTPVREAT
YDIEKVLFEDNPDYEKVVLTVTTDGQITPNEAFQNALEAMYKQLSVFDKITNVRSIIKSQ
ATSNELENTKLLQNITDLNLSARSYNCLEKAGIVYIGELALMSVNELAGLKNLGKKSLDE
IKSIMESIGFPVGTSKLSDNKDLLKKKIDELKAQNEG
>fig|195.2024.peg.1243 Flagellar biosynthesis protein FlhB
MAGEDQEKTEEPTSKKIEDARKEGNVPKSQDAAAIVTLIVGFVITLFMMGFIGERITNLY
RYYQSFIGVEFDLRIIQAIMIKSIFEVLILLAPIVLSIMIAGILGNVMQFGFIFTTKPIM
PNLGKINPLKGLKNLFSLKKLVESVKIVLKVGVVFTVAFIVLLKFMQELPLVERYNIIGQ
LIWLRDRAIILAAIVIIAFLVIAVLDIFLVRFQYFKGLRMSKQEIKDEYKQMEGDPQVKG
RIRRLQMEAARRRMVQDVAGADVVITNPTHYAVAIRYDTTKEQAPRVVAKGVDFLALRIK
QVAYDNNVVVYENPPLARELYKACDINDLIPREMFKAVAEVLGFVYNTNNKSRLAGQVKK
NN
>fig|195.2024.peg.1298 Uncharacterized membrane anchored protein HP_1479
MADKEDIVLEKPEDTLNEPRLDESLGEFKGQEGQAPEDEEFASLPEELPRENSDGGFKFT
RESAPEESSTFEEVKEDEPTPWYKDRKFMSLVGLSLGIICILVFTLFYLTFNEGKVKPDI
IASKPIEQPVVMPDESYNYNDMTRVDGMIQKANALYLKGEVEQALKVYEQIAVYNESLSN
YNLGVSQMNEGKFDEAFDSFKKAIANGENQSVAAINAAVCALKLNDKEKFKYYIDLAQVY
LPKEGKSKLYDYYLALINYYKGYYPEALQMLQRVNSEPYTDVAKYLSAKIYAKMDFDAKS
VQQLNTQGSFEPSLSLGLLYARMGEYDKAKIALNTAMKIERDFNQSLSALTLVDIKTGDF
QDMLLRLQDTYRNDEDKYKILDRYKIKVRLNKELFNIAIAQRNFSNDILKKQKDQFDLLF
YFAPYQVFDSKQASLYIKKANITNFVDDSSDGQSYLARSQALSSTNVKISNIINDALNQK
LRLANKEFQALLEDYPEHSILQYNLALTYAQMQNYELAYKHFSSSYHLNPKNYLAGAFAM
FCGKLSDNDTTKLYHEILDNIAADSNFKANMQKNMLFLANGDYISMLPYLDENGQKTPLN
LIFETIIAKNNNLNNQVDVRIAKLRSELPQDIVANILYFNSLNSNLNIKEYAQNAQIHFK
NLQVDYRSVFGGSNIARELYVNLMHIAGLLNLERQKFKTLINTSKVKDEGMIQTLAYLDI
FAQQYEESYALYNTLIDEYGAKDSRTLFLASVAAVGANNPNSAIALLQLSKLTDKNNKES
KVALGLLYQEVGNYEAAMTQYRTLPNDFKSEFFTFDIKNQ
>fig|195.2024.peg.701 FIG015287: Zinc protease
MQNLEVSRVKIPFIFEENNDFPIVILKLVFRNCGRSYDEIAGLAKMFARILNEGVDDSFF
KELEFKAVNLEASSGFESLEINLSCLKENFEFALKHLENLLLNPRFEEKILEKLKINALG
ELASKNSDFDYLAKNLLNSEIFECKEFQSPNDGDEKSIKQISLSDLESFYKKNINLSNLV
VILGGNLAQEKAKGLLNKLLAKLQKGSQNSQKTYEINSKNKDIIQIRKESEQAYIYFAAP
FFTKFNDKDFYLAKIALFILGQGGFGSRIMEEIRVKRGLAYSAYAMLDMNASFTRVFGYL
QTKNESAKEAKKIVKEVFRDFVKEGVSQNELVQAKNFLIGSTPLRYESLSRRLSISFNEY
YQGLPKGYYKEELKLIEKVELQELNAYIQKHNEILDLNFASIANEN
>fig|195.2024.peg.1077 Citrate synthase (si) (EC 2.3.3.1)
MSNSVTVTDNRNGKSYEFPIYDGTTGPSVVDMGSFYKQTGMFAYDEGLTSTATCKSKITY
IDGEEGVLMHRGYPIEWLAENKLFLDVVHLLLYKELPSNERLEAFRYELKKRSYIHEGMH
RLFDSFPDNAHPMAVLQGAVSSLSAFYPDHLNMNVREEYMEMAARVVAKIPTIVAAAYRY
KNGFPMAYPNLDRGFTENFLYMLRTYPYDHVELKPIEVKALDTVFMLHADHEQNASTSTV
RAVGSTHAHPYACISAGIGALWGHAHGGANEGVIRMLEEIATVDRVDEFIKRAKDKNDPF
RLMGFGHRVYKNFDPRAKVLKKLRDQLIDELGIDTNLIKVATRIEEIALQDDYFVQRNLY
PNVDFHSGLILKALGIPNEMFATLFVIGRTPGWIAQWIEQKEQETLKIVRPRQLYLGETS
KI
>fig|195.2024.peg.703 Integral membrane protein
MNYIDLLKNNKNIRILTLVQFIVYFGAWFSQTGVFTLLVSLNAPTWATATSAMLAFLPGV
LLAPINGVIVEKNKPKKLLLSMISIELVSIFCLIFVTSLSMLWLLFILIFVRLCVASIYF
QAEMSLLAKILNPKELKLANEMHSVIWAVSYTASMASAGIFINFFGIKAAFLFDCCLIII
GILFLTKLHIPHFKQKIQNKFFILIKEGFLYVLQNKIILHLIILHAFIGLTAYETLVTLL
AQHEYKEVLSAALVIGFLNAIRALALAFGPIFLSKITNNKNVFFLYLGQGLGIILWALTQ
FNFYISFIGLIAAGFCTSSLWAYTYTMIQKNCDKTYYGRVIAYTDMVYLSFSALISQLMG
LLFEQGFKLAIITALLGVVFIFAAFYWRWFDKKYL
>fig|195.2024.peg.738 N(6)-L-threonylcarbamoyladenine synthase (EC 2.3.1.234)
MKNLILAIESSCDDSSIAVIDKDTLECKFHKKISQEMEHNVYGGVVPELAARLHSEALPK
ILEQCKGYFDKLCAIAVTNEPGLSVSLLSGISMAKTLALSLNLPLMAINHLKGHIYSLFL
EEPICLDMGILLVSGGHTKVLYLKEDGKIEILARTNDDSFGESFDKVAKMMNLGYPGGVL
IENLAQKAKSKNIHFNIPLKHSKELAYSFSGLKNAVRLEILKHENLDEDIKAEIAYAFEN
VACEHIMDKLEKIFNLYKFKTFGVVGGASANLNLRSRLQNLCEKYQSKLKLAPLKYCSDN
ALMIARAGVDTYKRKEFVELEEEILSPKNKNFLRM
>fig|195.2024.peg.18 Para-aminobenzoate synthase, amidotransferase component (EC 2.6.1.85)
MKKILLIDNYDSFSYTIVFYLKELGYQCKIIKNDEFEKAKDLARFDFSHLIISPGPNSPT
ESKLSLKAIQYFKKDKKILGICLGHQCIGEIFGGKITPMPYPMQGKISRLHLKKNAKKSL
LFKGIKNKSKICLYHSLHISKMPKSCEILALNDKNIIMAIKHKKYEIYGVQFHPEAILSQ
NGKKLLKNFMKI
>fig|195.2024.peg.740 1-deoxy-D-xylulose 5-phosphate reductoisomerase (EC 1.1.1.267)
MIVFGSTGSIGLNALKLATLKNIKISALACGENISLLNEQIEQFKPQFVAIKNSKDKHLV
KHDKVFVGQEGLEEILSLCEDDLLLNAIVGFAGLKSTLKAKELGKKIALANKESLVVAGK
FLKGAKFLPVDSEHSALKFLLEGKKDIAKLYVTASGGAFYKHKIKDLSHVSVKDALKHPN
WNMGSKITIDSATMANKLFEIIEAYHLYNFKNIDALIEPKSLVHAMCEFKNGASTAYFSR
ADMKLSISEAIFSKHDSKILEPVDFVKLSGLKFYKISTKKYPIFKLKDELLNNPDLGVII
NAANEIGVQNFLDHKIQFLDIAHVVFKALDHFGVPKISSIDEVFEYDYKTREYLRGMK
>fig|195.2024.peg.285 SSU ribosomal protein S2p (SAe)
MVSMRDLLECGVHFGHQTRRWNPKMKKFIFGERKGIYVIDLQKTLRYFRYTYNIVRDAAA
EGKTILFVGTKKQAGGAIKEYAEKCGMPYVNHRWLGGMMTNFGTIRQSIRKLEVIEKMEE
DGSIKLLTKKEALMLTRKKEKLLAYLGGIRYMKTQPDMIFVIDTVKEKIAVQEANRLRIP
VVAPLDTNCDPDLVTYPIPGNDDAIRSVQLFCQEMAEAINEGKALREQDGEALPSEEKEI
TDEEKKEVLDEAMSEEDFNGEQE
>fig|195.2024.peg.1309 Lysyl-tRNA synthetase (class II) (EC 6.1.1.6)
MFDNILEQQRIQKANELKNAGVNPYPHFLVKELSLADFKKKFSYIFDTENKRDESISSVI
SGRLKLLRIAGKSIFANIEDENENLQIYFSKDSLGEEKFNLFKKNLEVGDIILAKGFPFV
TKTGEFSLHASEITLATKSIVPLPEKYHGLTDIEQRYRKRYVDMIMNAEVRKDFLTRSKV
VSLIRHFFEEKGFLEVETPMMHPIAGGANAKPFVTFHNSLGVERFLRIAPELYLKRLVVG
GFEAVFEINRCFRNEGMDLTHNPEFTTIEFYWAYHNYKDLMDLTEELFALLLEKLQLGKI
IEFDGQKIDFSKPFERITYKDALKKYGALSDEIIENKDKILEKLKKDGFEANDKLDLGHL
QAELFDNYVESKLIDPTFITDFPISISPLSRRSDKNSEIAERFELFVCGRELANGFNELN
DPLDQYERFLKQIEAKNAGDEEACEMDEDFVNALGYGMPPTAGQGIGIDRLVMLLTNKKS
IRDVILFPAMRPLKSELKEDKE
>fig|195.2024.peg.62 Cytosol aminopeptidase PepA (EC 3.4.11.1)
MIFELSDKKIHGIKADFELVFIQDKNLKPFTNEKDFFKLNNYTGEGILLDLNNKRLFIEL
KSLNYEDIRLALYTAYKNLEKLNIKSVKLPSILGDCVVRSFTSLVEGVLFGAYNFDKYKS
EKKESTLEKFIISAEELNAKKFNLDEAKIGLLRGEILANATNFAKDIVNEIPEIYTPLKM
AEDAQNLAKKNKNITCKICDEKFLAKEKMNAFLAVNRASAHPPRLIHLSYKAKNAKKRIV
FVGKGLTYDSGGLSLKPADYMLTMKADKSGAAAAMGIIKAVAELALELEVHCILGATENM
IGGNAYKPDDVLISREGVSIEVRNTDAEGRLVLADCLSYAQDLKPDLLIDMATLTGACVV
GLGEFTSGIMGNNEELQNEFYLSSKKSGEYTTILHFNPHLKELIKSNIADVSNSASSRYG
GAITAGLFLDKFIRKEYKDKWLHLDIAGPAYIEKSWGYNSFGAGGTGVRMCVNFLIHLLR
KNK
>fig|195.2024.peg.1198 Phosphoglycerate transporter protein PgtP
MFDFFKPKVKAIKFPKEEILPRYYKMRAWSLSGVFIGYMGYYLVRNNTTLSTPFIQNQLE
LSKSDIGTITGSMLIAYGISKGAMSVLSDKADPKNTWL
>fig|195.2024.peg.596 UFA synthesis enzyme FabX, enoyl-[ACP] 2,3-dehydrogenase/trans-2-decenoyl-[ACP] isomerase
MSLKSLQIGKHTIKYPIFQGGMGLGISWDKLASAVSLNGGLGIISSVGTGYYENRTHISK
ELNAKPYGSENFYSREGLQTLINNARKVCGDAPLGCNILCASNDYARIARDACEVGFNII
VSGAGLPTNLPEFTADFPDVALVPIISSPKALKIICKRWQSRYNRLPDAVVLEGPKSGGH
QGFTYEQCLDPNYQLENLIAPVVEEAKNWGSFPVIAAGGIWDKKDIENAISLGASGVQMG
TRFIGTFECDASDEFKNVLLACKKEDIELIKSPVGYPARGVRTNLLDLVDKRMGPKINCI
SNCVAPCGRGKEATKVGYCIADRLFDAWSGKKETGLFFTGANGYRLEKLISVKELMDKLV
NGE
>fig|195.2024.peg.237 UDP-glucose 4-epimerase (EC 5.1.3.2)
MKILISGGAGYIGSHTLRQFLKTNHEICVLDNLSKGSKIAIDDLQNIREFKFFEQDLSDF
EGVKALFEREKFDAVVHFAASIEVFESMQNPLKYYMNNTINTTNLIQTCIQTGVGKFIFS
STAATYGEPTTPVVSENSPLAPINPYGRSKLMSEEVLRDANMAHPEFKYCILRYFNVAGA
CMDYKLGQRYPKATLLIKVAAECAAGKRDKLFIFGDDYDTKDGTCIRDFIHVDDISSAHL
AALDYLENNESNIFNVGYGHGFSVKEVIDAMKRVSGVDFKVELAPRRAGDPSVLISDASK
IRNLTSWQPKFDDLDLICKSAFDWEKQC
>fig|195.2024.peg.1429 Ribonuclease III (EC 3.1.26.3)
MKNIELLEQKLAYKFKDKDLLIHALTHKSFKKPYNNERLEFLGDAVLDLVVGEYLFHKFA
KDAEGDLSKLRAALVNEKSFAKIANSLNLGDFIFMSAAEENNGGKEKPSILSDALEAIMG
AIHLEAGFDFARNIALKLIEKNFPQIDAKNLIKDYKTKLQEITQAKLGQTPQYETVRAFG
PDHLKQFEIALFLNGQELARAIAGNKKEAQQMAAKITLEKLGAL
>fig|195.2024.peg.69 ATP synthase F0 sector subunit c (EC 3.6.3.14)
MKKIFFLFLALAATAFAAEANAPVEQEAINVWIKAFSVLAAGLGLGVAALGGAIGMGNTA
AATIAGTARNPGLGPKLMTTMFIALAMIEAQVIYALVIALIALYANPFIVFA
>fig|195.2024.peg.1387 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (EC 2.3.1.117)
MIINTKEDFLLLIKQIEQKNEYRKPKAFGIARLDRGQLNKNKILQASFALVNYEQNFGSA
AIMLEAFMQRGVEIDFEASEFVQILKLEDIDYALACFKPFLEEEGHKNIDILKIIKDKFK
DDEFAFVCLFEDKEPLSVESVYLKLYLLSTKKVPLRSLNLNGAFGLLSNVAWSDDKPIEL
EYLRENEMRLKMSNQYPKIDFVDKFPRFLAHIIPEDNTRILESSKVRMGASLAAGTTIMP
GASYVNFNAGTTGACMVEGRISSSAIVGEGSDVGGGASILGVLSGTSGNAISVGKACLLG
ANSVTGIPLGDNCIVDAGIAVLEGTKFLLKDREELAKLNPYFDFSKEIYKGIELKGLNGL
HFRQDSISGAMIVSLNKKAIKLNEALH
>fig|195.2024.peg.494 N5-carboxyaminoimidazole ribonucleotide mutase (EC 5.4.99.18)
MKFVSIMMGSKSDYEIMSECAKTLEKFGVKYELIISSAHRSPKRTQEYIKEAEEKGAKVF
IAAAGMAAHLAGAVAAYTTKPVLGVPMPGSALASMDSLFSTVQMPGGIPVGTLAVGKAGA
KNAAYLAMQILALNDETLAKALKQDRKNQEENLISDSKSVEVLL
>fig|195.2024.peg.982 Ferric iron ABC transporter, iron-binding protein
MKKIFSLCLLGFSLLGAAELNIYSARHYDADFQIIKKFEEKTGIKVNHTQAKASELIKRL
SLEGSNSPADIFITADISNLTEAKNSGLLSPVKSKYLEDTIPAHLRDKDGEWFAITKRAR
IIAYNKNANTDISKMKNYEDLAKPEFKGQIVMRSATAPYSKTLLASIIANDGDENAKVWA
KGVLDNLATKPKGGDRDQARQVFAGEAKFAVMNTYYIGLLKNSKNPKDVEVGNSLGIIFP
NQDNRGTHINISGIAMTKSSKNQEAAKKFMEFMLTPEIQKILTDSNYEFPIRNDVELSQT
VKDFGTFKEDQIPVSQIAEKVKEAVKIYDQVGFR
>fig|195.2024.peg.1473 Cytochrome d ubiquinol oxidase subunit II (EC 1.10.3.-)
MFFGLELEGLQIYWWLILSLLGGLLVFMFFVQGGQTLIDELSSDELEKTMLVNSLGRKWE
LGFTTLVLFGGAAFAAFPLFYSTSFGGAYWAWLCILFCFILQAVAYEYRKKENNVYGSKT
YEIFLKINGYLGVFLIGVAVSSFFSGSEFILNEHNFVSWQNPLHGLELLLNPFNYLLGLA
LVFLARLLGAAYFMNNINDENIKIRVMKKLMINSILFLPFFLGFLAWIFLKDGFSVDTNG
VVSMSANLYLYNFLNQMIFAILLAIGVILVLLGMVQGTKGCSKAIFTLGLGTVLTVFALL
SSIGLGQSAFYPSLSDLQSSLTLKNASSSYYTLSVMAYVSLLVPFVLAYIIYVWNAMDKV
KITREEIANDDHAY
>fig|195.2024.peg.792 Phosphoglycerate kinase (EC 2.7.2.3)
MSDIISIKDIDLAKKKVFIRCDFNVPQDDFLNITDDRRIRSAIPTIRYCLDNGCSVILAS
HLGRPKEISSKYSLEPVAKRLARLLDKEIVMAKDVIGEDAKSKAANLKASEILMLENLRF
EKGETKNDENLAKELASMAEVYINDAFGVCHRAHASVEAITKFFDENHKGAGFLLQKEIE
FAENLIKRPARPFVAVVGGSKVSGKLQALTNLLPKVDKLIIGGGMAFTFLKAQGFDIGNS
LLEEELLEEANKILTKGKNLGVKIYLPVDVVAAPACSQESPMKFVPSQEIPSGWMGLDIG
PASVRLFKEVISDAQTIWWNGPMGVFEIDKFSKGSIKMSHAISDGHATTVVGGGDTADVV
ARAGDADEMTFISTGGGASLELIEGKELPGVKVLRSGGVQ
>fig|195.2024.peg.135 Peptidoglycan glycosyltransferase FtsW (EC 2.4.1.129)
MIADKKLFYLSCILISIGIVFSYSLTVFTVLFFDYNEFHFFIRQLFFGLSGILIMFFISR
LDPDKILAKRIILAILIGSFICIIILPFLPSALATASGGAKRWIRLGPLSISPVEFFKIG
LIYFLAWSYTRRIDDSKKAIKHEALILLPYCILASIVIGYIYITQNDLGQSVISFFLILA
LAFFAGASKRLFAFGILIIMMIGIMVIFSNQRRIQRIASWWGNIQDAFLPMLPDWMADAL
RVSGNSEPYQISHSLNAIAHGGLFGEGLGLGTFKLGFLSEVHTDFVLSGITEEIGLFGLG
LICFIYLWMILRIFRIAGRCEEKQDFIFCSGIALLLLFSFFMNAFGIISLTPLKGVAVPL
LSYGGSSMWAICIGIGYVLMISKKVKL
>fig|195.2024.peg.407 3,4-dihydroxy-2-butanone 4-phosphate synthase (EC 4.1.99.12) / GTP cyclohydrolase II (EC 3.5.4.25)
MKFVSIEQAIKDLQEGKMLVMVDAEDRENEGDLIFPAQFSTKEKVNFMIKEARGVVCVAL
AEELARKFELPLMVPKNTSNHETAFTITVDAKDATTGVSAYERDMTIKIFADDNAKASDF
VRPGHINPLIAKKGGVLERTGHTEGTVDLCHLAGLKQACVICEIVKDDGDMARRSDLEEF
CTKHNLNMIAVSDIIEYRLKNESLIKLQEKSDAILAGFKAQKFIFTDHNNAQHIAFAFKE
IQKCENVKFHISGSDFELLTSDKFSKLLDQIRFLSENGGVIVFMQGEKSSVTQFKNYGIG
AQILRYFGIEEIKLMSQSCDKDYIGLKGFGLNLKICNFN
>fig|195.2024.peg.1619 Predicted amino-acid acetyltransferase (EC 2.3.1.1) complementing ArgA function in Arginine Biosynthesis pathway
MQVRAMQKSDYEGVYKLWCDIKGFGIRSIDDSKENIEKFLDRNPNLSAVAVIDQEIVGSI
LCGHDGRTGGFYHVCVHKDHRKKGIAHEMTKFCLEALKSEKINKIALIAFKSNDLGNEFW
KHYGFTLREDANYYDLSLNSHNQTSFNV
>fig|195.2024.peg.264 Transcription termination factor Rho
MEKEKKQHQRTHIPVEGYKIEDLKLLDLENLVKIANECEIENPREFRRQELIFEILKAQT
KKGGFILFTGILEISSEGYGFLRGMDSNLSDSVNDAYVSNSQIRKFALRVGDIVTGQVRE
PKDQEKYYALLKIEAINYLPLQEAKERPLFDNLTPIFPTEKIKLEYDAMKLTGRILDLFT
PIGKGQRGLIVAPPRTGKTELMKELASAIAKNHPEMHLIVLLVDERPEEVTDMQRCVKGE
VFSSTFDLPAYNHVRVAELVIEKAKRMVETGKDVIILLDSITRLARAYNTATPSSGKVLS
GGVDANALHKPKRFFGAARNIENGGSLTIVATALIDTGSRMDDVIFEEFKGTGNSEIVLD
RNISDRRIYPAINIIKSGTRKEELLQGVAELQKIWAIRSAISQMDDIEALKFLYSKMLKT
KDNVELLSIMNE
>fig|195.2024.peg.1582 Histidyl-tRNA synthetase (EC 6.1.1.21)
MINALKGMKDLSDKDALYYEKIIKTCEEVAKNYGFNFINTPHLEQSILFKRSVGESSDIV
GKEMYEFTDKGGNEVCMRPEGTAGVVRAYIEKKLDKNISVKRWFYHGSMFRYERPQKGRL
REFHQFGVESFGIPSVYEDASIILMLVEIFSRLSIDFKLQLNSLGCSQCLPKYRDELVEF
LDSKEGFCEDCLRRKNLNPIRVLDCKNEYCQNLLENAPLLINNLCTSCQKDFETLQQILK
DNGVKFELDSKLVRGLDYYSKTAFEFISDEIGAKAAIAGGGRYDRLIEYLGGKSGYGIGF
AMGIERIIAILEQKEELEKREGIYLCAMDEIYIPKLLQIATKLRKKHKVILSYEARKLAK
HLENGDKINSKHFLCMGENEAKSESLFYKNLENKDEKVIQISDLENAL
>fig|195.2024.peg.979 Putative outer membrane siderophore receptor
MKKLSLFCVMGLCFANFAFSEELEFDSLEISGSKIKNDEKPFVTPGATSTRDNLNSNTQS
IDSIVRSVPGAYTQVDQAQGGVSVNIRGMTGLGRVNTQIDGVTQTFFGSASDDSFHGQIG
TSSFTAPIDKNFLVALDINRGTFSGANGVNALMGSANFRTIGVDDIVQEGRVFGFLGKYS
YGSNAIGPNFMGAIAGKTMLENNANLGILFAYSGQNVSQNYKIGGGGYIGDQKPPFDTDD
DGIPDDNLAAPINPNNLYNQPRSQLFKVEYKSDISEAILNYRAYNNNLAGRKIANDTYQI
DYRLNPDSNLLDLKFLFAYNDGKQKYNQDKTWGYHNMSGIKTKNRAVTFDLSNTMNKEFS
QDSNLYFTYGVNILNNHYSNDFPQDRVLLPYILTSFYPKGKQDIKTFYLDTSFTKGIFTL
NSNVNWINAQLSGYKGVCSMANPYCQPKNATNLEKDYNNFNYSLMLSADIHPLFNPFISY
SKSHRIPNVQEYFFTHDASGEHNMNTFLRAESANTYQIGFNSFAHEILNNNDTLGFKVLY
YDTKVKNYIYNRRYWQKADNAIFIMQLNDDEKAKFHGVELEFKYDTGFFYSILSYTYQKS
KHKFSDTESLETGGAQSGQSQFAQLPEHYANLDMGVRLFEEKLTLGALAKYTGKAKRVAP
VGSLEDDPSNPDAIAPLKTTDELPKIPTIVDLYANYKILKNFTIKAEIQNLFDKNYMDAL
YTYNTGDSQNAGGLFNPIYIYNNSARGRTFIVSFEYKY
>fig|195.2024.peg.1433 NifU protein homolog
MMPFSDEELINPVKASLDKSMPMLERDGGGLEFLGIKNGVVYVHLIGACKGCASSGTTLK
YGLERQLKIDIHPEITIVNLNGGAEDFAKL
>fig|195.2024.peg.1080 DNA topoisomerase I (EC 5.99.1.2)
MKKNLIIVESPAKAKTIGNFLGKEYEVIASKGHIRDLPKSSFGIKIENDEFIPEYRITSD
HSALVKELKSKAKDAKEVYLATDEDREGEAIAYHIAKAIGKDENTLPRIVFHEITKSAIE
NALKNPRKLNMHSVNAQQTRRLLDRIVGYKLSPLLGQKIQRGLSAGRVQSAALKIIVDRE
KEIRAFVPLEYFSIDMIFQKDLNTELVEFDKAKIEKLTLTNKDRAKLVFEACKNENYAIS
DIESKERKIAPPPPFMTSTLQQSASNRLGFNPKKTMMIAQKLYEGVNTHEGVMGVITYMR
TDSLNLAKEAVENARKFIQANFGKDYLPSKANVYTTKTKGAQEAHEAIRPTNLSFTPEIA
AKFLDKDELKLYTLIYNRFLACQMSPAISQTQNVFVKNDRAVFKISGRKILFDGYYKVYG
DMDKDKILPNFKIGENLKIQNLEMNSHFTEPPSRYSEAGLVKKLESLGIGRPSTYAPTIS
ILTSRDYVKIDKKQLIPSEVAFSVTEVLEKNFSDIVDSKFTSNLENTLDEIAEDKANWQE
TLKEFYYPFMRKVEEGKTKIASQKTVTKLGENCPDCGGELAIRKGRFGEFVACLNFPKCK
YSRNLKNESKNEAEVSASKAKAKGIGITCPSCKEGEIVERLSKRGKFYGCSAYPKCNFIS
KYKPSDEKCEECGENLVIKELKKGTFLECLKCKIKKEIKD
>fig|195.2024.peg.609 hypothetical protein
MAFLAGCGDEAKTSDYYKAHLDEAKARVAECKKNGENE
>fig|195.2024.peg.229 UDP-N-acetylbacillosamine N-acetyltransferase (EC 2.3.1.203)
MARTEKIYIYGASGHGLVCADVATNLGYKECIFLDDFKGKKFESSLPKYDIFIAIGNNEI
RKKLFNQISDSGFKIVNLIHKSAIISQSADIAEDAGILIMPYVVVNAKAKIKKGVILNTS
SVIEHECEVGEFSHISVGAKCAGNVKIGKNCFLGINSCVLPNLSLADDSILGGGATLVKS
QSEKGVFVGVPAKRM
>fig|195.2024.peg.615 Gamma-glutamyl phosphate reductase (EC 1.2.1.41)
MRNLLENIKKNSQKLLNLTPKDKENIILKLACALRENFKIILEANEKDMTNFTKSGAMRD
RLLLDEKRIFSLCDALEKIAYLEDPIGKISKGWVNYAGLKIEKISIPIGLISVIYEARPS
LSAEIIALMIKSSNACVLKGGSEAKFTNSAIFDLVYKVLEEFNLQDCFAMFYERNEIMQI
LAFDDLVDVIIPRGSSNMIQEIASHTKIPLIKQDKGLCHAFVDESANLNMALEIILNAKC
QRVSVCNALETLLIHEKIAKDFIKLLIPEFEKFKVKIHAHENILEHFKNSKLEISKADES
TFDTEWLDYAISIKSVKDCDEAIEHINQHSSLHSETIISNNALNIGKFQRLLRSSCIYVN
ASTRFSDGGEFGFGGEVGISTSKLHARGPMGVEDICTYKYLISGEGQIRK
>fig|195.2024.peg.692 Protein translocase subunit SecE
MEKLITYFKLSKVELRKVIFPLKEQVRNAYITVFVVVAVISLFLALVDWIMSSIVSAIV
>fig|195.2024.peg.1395 Putative heme oxygenase
MSFESIISHMNDHHQSNLIDLCKKFGAVKDPKGVRLVGVDFEGLDIAYNDKENLRIEFPK
KANEETLKDAIIELCMSAKTKKDLSGVAREAKEFMLSFNSVSLATLSADKEVVCSYAPFV
NTPWGNYIYISEVSEHFNNIKENPNNIEIMFLEDESKAASVILRKRLRYKVKASFIERGE
VFDKIYDEFEKQTGGEGGIKTIRNMLDFHLVKLEFQKGRFVKGFGQAYDIENENVTHVGA
NSSPHKFPHKH
>fig|195.2024.peg.1048 TolA protein
MKEYGLGKINSFLLAVAVYVFIIILIFFRLVTHIQPAIQYTDIQDSFIDIELMEPSKKVV
NEQSAPKDIQKPAQELDIEKLFAQTTNKAVKTEDVDQKASNFNELFGSIKEIQEEKTTKI
QSSAKSETTSSSKTQASELVKQLNDSLLEEESINQGESIKNQKTGIYDEFLGKVVRTITQ
RWRQYHPNSENISVKVKIFIDENGNFGYTSVEKSGNSLYDAKVAEFLENQKGKFIAYPPQ
NKSISITMNLKDEAQIQK
>fig|195.2024.peg.1704 DnaJ-like protein DjlA
MIFVLIILTILVFYWYYKTWGKQDFLNSATRGAKGFAKGFARGVMEERIDEFKRRMNYYV
IALLAKIAKSDGRVSENEAEMISQILDANAKDERERAFLKASFNEHKENIHDAFYVAKDF
LKEVPLPKNERFNVLRVLVFMALVDADFSAKKREILEQIAKAFDIAKSELDNFIASISNL
KSTKKELSLDEAYRILELSNNADLNAVKKQYRALAKKYHPDILNANNVSEEELKKGVEKF
QKINEAYEKIKKHLEK
>fig|195.2024.peg.986 Superoxide dismutase [Fe] (EC 1.15.1.1)
MFELRKLPYDTNAFGDFLSAETFSYHHGKHHNTYVTNLNNLIKDTEFASKDLVSIIKSSS
GGVFNNAAQVYNHDFYFDCIKPITGCGCGGSCQSMDANLQAALEKEFGSLENFKAEFIKG
ATGVFGSGWFWLVYNTKNQKLEFVGTSNAATPITEDKVPLLVVDVWEHAYYVDHRNARPA
YLEKFYAHINWEFVAKAYEWALKEGMGSVSFYANELHPVK
>fig|195.2024.peg.98 tRNA t(6)A37-methylthiotransferase (EC 2.8.4.5)
MKEKVFFKTFGCRTNIYDTELLKSYVKDYEIVNDEEKAQIIVVNSCTVTNGADSGIKSYI
NSMQKKGVRVILTGCGAVSKGKELLDKKQVFGVLGASNKDKINEFLGLKTSFYELGNLNF
IDKDIVCEYENHTKAFVKIQEGCDFACSYCIIPSVRGKSRSVDEQALLRQVEILGANGYS
EVVLTGTNIGSYGLKNGTTLGKLLQKMGQISGIKRIRLGSLEPAQIDESFLEILDERWME
RHLHIALQHTSEKMLRIMRRRSHTDNDLKLFNTIASKGYALGTDFIVGHPGETEELWHEA
LKHFQEFPLTHIHAFIFSPRNNTHSATMKDTINGAVAKERLNTLKVIIENNNYEFRKRVK
TPLEILVENQKDGFFEGYDQFFNKIKIKSSKDIAKEWLKLERYEVQEKHNFADLEGKK
>fig|195.2024.peg.1319 ATP/GTP-binding protein
MKELLQKLWQNELQLLDFNASFKDKNILDVSELAIILSVNKDNYERYFLLKEFSNICKKI
DLRVDIFSIQKAQICVLNMFREGFIPKQDLLKALRILQKISNNAEILEYIQNIQVQSIDK
KALFQSGFNELNHINMELSQLSFDENSKIRLQKTLEKFQKLEFNIAITGVMNSGKSSLLN
ALLKEDFLGVSNIPETANLTLLSYGNTQEAVIYFWDTQEWDNILKSSKFSKELKEFIDEL
ALKIDIKEYVQDKALTQKINLKELKEFSSAKNQISALIKKIEIKSNLEFLKNNISIVDTP
GLDDIVVQREILTNEYLKESDFLIHLMNASQALTQKDAEFLIHCLLNSRLSKFLIVLTKA
DLLSQKDLDEVINYTKESLKARLENFDTHLIEKIDFLCVSAKMASDFYKGLSSEESFKKS
GMKEFEEYLFNELYSGEKSKIILQAYKKELLLELRNILNEYEMQNKLIKEDGQGLSEEND
KLLLEFKAKEEALKEAKEEISNSILNLENFENGVDNLVLLLAKKLKERLIDEIKYLKDKA
QKININRILNMIDITVKDGINDILREVKFENIKKIEELKTSLALKYDFLKDDFDNGFEGF
KDEISKKIENIFSDEKFALLRLQIEQIISTKVDLFELETKLTEVIFSTFESFNIGAILKD
LDINGAFFAFLNERMKNYEVLQKEKLASIEHLINNLKNQNADILFSYEGNLEKIAKLQQL
EVELMNAN
>fig|195.2024.peg.1407 hypothetical protein
MKKFILISSILSSFFIFAEANELPSDKIQPEVKVIKEHFKNKVEKIEFEAWAKGMGLNFS
TQKYLNNQNYKKYAKTMAKLIRKTRGVKGKVEICYEGTPQKRVHKCNKF
>fig|195.2024.peg.577 Efflux transport system, outer membrane factor (OMF) lipoprotein
MKNLLSILLAFFLSACGVKLSLPKEPTMSEESFKDLNITYDWYKAYDNAKLNEFLNFVLL
NNSDINIARSTLLTALARADLIDYDFYPTLSANLGLSGEKNLNSGVQSKKFSNSLNLSYE
LDIYGRIRDSSSASDFSAKASAYDLENLKISMINTALNGIFELAYFNDVDNLLKEYLANL
EQMRELYAYKFELGKIEELDLLNIEQNLLKARQDLLRNEQNRNLLIKNLQDLIGKQEGFA
YIDYFKALTLSDFKNLNPNFNIPLEALVYRPDVRSKLNTLKSAFKDYTSVQKSIFPSISL
GGALNGSDKQFDDSFKFEVLSGNIKISLPFLDYGRVKQNIKISQFDYESALVNYEQSLQS
AMNEFALNYKDYQSNTMLLQILKDTSFKQELITQAYWEKYNLGKSELKDYLDASNTLNSA
KQSLLGARFNLLKTINSYYQITALNYDERNLEMP
>fig|195.2024.peg.1586 hypothetical protein
MKITQWNKADFSPKEVKINVLIDDEHSKEIQILLAKDSVMKEHKAPFAIRVQVLSGKIWF
EVENEKFEFNTLDMISLEANVPHSLGGLEDSVIRLSLNKLDKVQRVNAVLKKP
>fig|195.2024.peg.608 hypothetical protein
MQVVLKKLEVNQTQTLLNRNKIMLKYFVSISNQGEEQ
>fig|195.2024.peg.215 Possible periplasmic thioredoxin
MKKKTILSFFIIIGFFISACSHQEDIQNDFMFEEYSKGDKIVLNSVNGGAKTLIRTDKGF
IVEGEEDKVLMIDFFGTFCAPCKEEALELSKLWKNNSNKFIIMGLTHFEDVSDETVKKFA
DDYGAYYFLSNDSQNDRIIAQILKDIDYQSMEQLPFKVVMKNGIYQNLSNYWDSNTSTNF
YLGKIPTDFIQDDLDKIYKEK
>fig|195.2024.peg.755 hypothetical protein
MGILTKLELDYEIDDIEKFLQFFRTMCDRFEPLIIQLGSDSVRYKEAIKELETLAHNTAW
AARRLNLDEVTDFCVFCEEMMAQANRFDGPASDEFTDWMLLMSDQFEKYCRSYENDDSVL
AVFNPLIVNVPNIISK
>fig|195.2024.peg.836 Capsular polysaccharide ABC transporter, permease protein KpsM
MLNVIHALFFRELKTRFGKNKYLGYFWVIGEPMSVILILTTIVTILREYHHQLMPEGISI
FMFLISGIVPYFMFRSIVTQLMNGIGANLALFAYKPVKPIHVFIARTLLEFCIYFVIFVA
VLFIVGWFFRLEVIPRHFLSVMVCIFLLMCSGFALGMVFAIIGYFLEPLKTLLNYFSIVF
YWGSGVIFPTWLMPKPILDILYYNPLLHVMELLRFNFFENYPLQDDYTYTYPVFCIICTS
FVGLFLYYYNRQALTAVRRT
>fig|195.2024.peg.684 Transcriptional regulator, IclR family
MHQPTLRVLNILELLAKEKLTLSAIAKKLNIPAGTLWPILQTLQEKKYIKCDLKNKSYYL
DFKIIELGCNIKNENNIFEIIKKHMKNIRNLTNQTCQMGILKDGNVLYLEKIDANNTVQL
KSFIGTSYPAYATSLGKALLSNKNKKELEKLYPKNFDKITENTLNNINELYQQIKQIKKE
KIAIEIGEMNPQIECMAIGIEHKNKIIAAISISYLIYCSNKAFREKNKKILLEEKNKIEK
VLKIYFNDLDTLY
>fig|195.2024.peg.1069 Enolase (EC 4.2.1.11)
MLVIEDVRAYEVLDSRGNPTVKAEVTLSDGSVGAAIVPSGASTGSKEALELRDNDERFGG
KGVLKAVANINESIADEILGLDAFNQIQLDDTLRELDGTNNYSNLGANATLGVSMATARA
AAAALGMPLYRYLGGANASILPVPMCNIINGGAHANNNVDFQEFMIMPFGFTSFKEALRS
VCEIYAILKKELANLGHSTALGDEGGFAPNLANNTEPIDLLMTCIKKAGYENRVKIALDV
ASTEFFKEGKYHMEGKAFSSEDLIERYVELCAKYPICSIEDGLAENDFEGWIKLTEKLGN
KIQLVGDDLFVTNEDILREGIIKKMANAVLIKPNQIGTITQTMRTVRLAQRNNYKCVMSH
RSGESEDVFIADFAVALNTGQIKTGALARGERTAKYNRLLEIELESDEYLGEKL
>fig|195.2024.peg.319 (S)-2-hydroxy-acid oxidase (EC 1.1.3.15)
MKKEFEQYFIKLLGSENAYFDDIHKRAYSYDATKKHYLPDGVLFPRNEEDISKILKFCNE
NNIIIIPRGAGSGFTGGALAVNGGLILSFEKHMNKILEIDLENLVAVVQPGVINIHLQRE
VAKHGLFYPPDPASMEYSSLGGNVSENAGGMRAAKYGITKDYVMALRAVLPNGEIIRAGK
RTIKDVAGYNLAGILIASEGSLAVLSELTLKLIALPKFKKTAFGIFPSVKSAMNAVYKSL
ASGVNPVSMEFLDNLSIRAVESKFNKGLPVDAGAILIADVDGNVKEAIDEDLKILGEHFL
DTGASQFKIAKDEQEAADIWFARRNCSQSIAMYGTLKLNEDITVPRSKLPALLEGIDEIS
KKYGFKIPCFGHTGDGNVHTNVMVPDKNDEEQVKKGYEAVEEVFRLTVELGGTLSGEHGI
GLSKAPFMKLAFSDAEMNLMRNIKKAFDPNNILNPFKMGL
>fig|195.2024.peg.347 DnaJ-class molecular chaperone CbpA
MNSLYETLGVSKNASADEIKKAYRRLARQYHPDINKEKGAEEKFKEINAAYEILSDEKKR
AQYDQYGDSMFGGQSFHDFSKNTGGVNLDDILKDLFGGGFGGGSSRGSRFNGFSSKGFNT
GFGGFGGFEEEDLDSTIELSIPFEKAVVGGEYSFNLQGETIKFKIPHGIKQGEKLRIRNK
GKNGRNGTRGDLIVKVKLGESEIYQREDDDLYQKVDISLKTALFGGKVTVNTLKENKKEA
TITIPANSKNGQKIRLKGYGVQNRKSDIYGDMYLVLNVVLPNTETLDEKLIEMLKEKLS
>fig|195.2024.peg.97 ATP-dependent zinc metalloprotease HP0286
MKNKKIILISFLILCLLFGILYFKNEPKYIDENLYQSLLSQNLIEKAVIDKDEIWLKAKG
ESYVIVKDGVDIKTLLSKVPVEIKKDSTLWVFFVIFVFLIALLLSFVYFARKKELAKYPI
SSKTQTQTSTTNLESSNIKPVISNITFNDVAGVSEVKMELSELVDFLQNPKKYKEFGVKM
PKGVLMVGPPGVGKTLIAKAVAGEAGVPFFYQSGSSFVEIYVGMGAKRVRELFSRAKMMA
PSIIFIDEIDAVGKARGEMSNVERDSTLNQLLTQMDGFEDNSGVIVIAATNKIELMDPAL
LRSGRFDRRIFLSLPDFKDRLKILEIYMKGKNNNIDLNKIAKASVGFSGAGLETLVNEAA
INALRRNSSLVEESDFYAVLNKVLLGKKKILSFNDEEKGIQATYQAAKALSAYYFDIGFE
KITLIEDRFKEYEHAIRSKSELINRIKVYLAGSRAMSLIYNESYTNSQNDFLKVKELLDY
MISFGMLEEPNLNEIKRELDEFLFPLKEKISTLAKILLEKEKIEYNDVKEVVQV
>fig|195.2024.peg.1695 DNA polymerase, bacteriophage-type (EC 2.7.7.7)
MIRTLHYLKAMGYDFTDENLKLHSKIENFKDLRKNIQECTLCHFSKSRCFTLMENEIKNA
SLMIVDTLAHKNENEKGVLLNSKKGERLKFYLKEILGLCEKEFYFSYLFKCFSNGKFDDF
SLQSCLPFFWNELELVQPKMILCLGEYPFKSLGFSDFNALRGEIFAYKNFFIMASFELEF
IEKNPSCEKIFIQDLKKIKGFL
>fig|195.2024.peg.13 hypothetical protein
MKNLSVQEKKDLDNCVFKTLGKKEPSALVLLFKKILLKLKTFFYSK
>fig|195.2024.peg.799 Holo-[acyl-carrier-protein] synthase (EC 2.7.8.7)
MRIGCDIVAISRIDTIYQKHGNAFLDKFLNQNEQKLIKSSSTLAGFWAAKEAASKALGVG
ISKECGFLDIEISKDSKNAPHLKLASHVLEKFKINSTSLSISHDNGFAIAVVALD
>fig|195.2024.peg.129 Multidrug efflux system, membrane fusion component => CmeE
MKKILFLLLAFNYAFGEEIYASFNVEASKQSKLALESIGLVQKIPVEIGQKVSKGELLLA
LDQESEKIALQNAQNSYQLALVEYENTKSRMQKIKAVENVIDKQSYEDMKAKFDAANLNL
IKAKINIAYYKNIMAKKELRAPYDAIIANKFIQVGEGVGGVAQPLIEIFSYPQSKLILSF
DEKYKDKVRLGDDFFYKIDQNGTELKGKISLIYPSIEVKTRKIYAEVQTTNLTPGLFGEG
RIITKD
>fig|195.2024.peg.195 Leucyl-tRNA synthetase (EC 6.1.1.4)
MAYDANLIEKRWQEIWDKNEYFEPKDDLTLPKKYILSMFPYPSGRIHMGHVRNYSIGDAI
ARYYRKIGYNVLHPIGFDSFGMPAENAAIKHKIHPKSWTYENIAYMKNELFSLGFSFSKK
RMLATSDPLYTKFEQEFFIKMYEKGLIYTKEANVNWCEQDQTVLANEQVEDGKCWRCGHE
VVQKKMPGYYVKITAYAEELLSELENLKDKWPSQVLTMQENWIGKSEGLEFSLNLDKESL
EKTKTQSFEVFTTRADTIYGISYVALAPEHKIVQNLIQANCLDDEKVEQIKNMQKQSARE
RQIADKEGCFLGIYAIHPLTQEKLPVWVANFVLADYGSGAVMAVPAHDERDFEFANKYKL
KIKQVIECEDAQLPHVQKTGKLIQSGEFNGFDCNEVRARIISKFEDEKLGKRVINFKIRD
WGVSRQRYWGAPIPMVKCKNCGIVPQKIENLPITLPEDIQITGEGNPLEKHPIWKNCTCP
KCGQEAQKESDTLDTFFESSWYFARFASDEKTWQEKALDKESVKYWMNVDQYIGGIEHAI
LHLLYARFFQKVLKDLGYLEDNEPFARLLTQGMVLKDGAKMSKSKGNVVDPDDIINKYGA
DTARLFILFAAPPAKELEWNDDAVEGAYRFICRLYDRAQNVRAGELLEFKHDDLNKEEKY
ARLKVYEALKKSFEVYTQSFAFNTLIAACMEALNALAPCKNEALEQEAFYIILNILEPII
PHVCFELSDKLFKCENFKVLNLKEEVFVKDSLNLGISVNGKKRGEIEVSSSASQDEILEL
AKQKVSKWLEGKNIVKEIYVEGKLVNLVIK
>fig|195.2024.peg.148 NAD-dependent protein deacetylase of SIR2 family
MKNIMILSGAGLSAPSGLKTFRDNDGLWEEYDVMEVCSATGFRKNPKKVLDFYDARRAQL
QNVKPNHAHEKIAQLKEKWGKNLFVITQNVDDLLERAGCKDVVHLHGFLPELRCLKCEGI
FNIGYEKFTDKQCPKCKSKDLRHNIVMFEEQAPAYATLYSLLNQTSLFISVGTSGAVLPV
GRYASMCEKSILNIYEKDANLERYFDKIYTEDIISAIDKIALDIENFMKDGNV
>fig|195.2024.peg.832 D-arabinose-5-phosphate isomerase (EC 5.3.1.13)
MKIDTLKIAKEVFATEAKAIEDLALNLDENFSKAIELMLHTKGRCIVSGMGKSGHIGAKI
AATLASTGTPSFFIHPGEALHGDLGMLTPDDVLIAISNSGETEEILKIIPAIKKRKIPLI
AMCGKKNSTLVKQGDIFLNISVKEEACPLQLAPMSSTTATLVMGDALAAALMKARNFRPD
DFALFHPGGSLGRKLLTRVSDLMVSKNLPIVHPDTEFNDLVDVMTSGKLGLCLVVENEKL
VGIITDGDLRRALKANDKPRFDFKAKEIMSINPKVVDADAMASEAEEIMLKYKIKEIVVS
KEDKVVGIIQLYAIGNV
>fig|195.2024.peg.295 Signal transduction protein CetB, mediates an energy taxis response
MEEIFLAKDALITSKTDLKGNIIYANNDFLKYAGYKVDELLYKSHNIVRHEDMPRTVFKC
LWDYIQKGDEIFAFVKNKAKDGNFYWVFANVSASFDANGNIINYYSVRRAPNRKSIFYN
>fig|195.2024.peg.525 Lipopolysaccharide ABC transporter, ATP-binding protein LptB
MSKLEIVNLEKIIKKTKIIQGISLELNSGEVVGLLGPNGAGKTTTFYMICGLISPSSGKV
LLDGLDITKEPLNKRARLGIGYLPQESSIFKDLSVEDNLLLAAQIFYKDKKILHEKVEQM
LELLSIEPIRLRKGLSLSGGERRRCEIARSLMCEPKFLLLDEPFAGVDPIAVAEIQSLIN
ELKKLDIGILITDHNVRETLAICDRAYVIRSGSLLASGNAEEIANNKDVKKYYLGAEFKL
LD
>fig|195.2024.peg.1374 SSU ribosomal protein S13p (S18e)
MARIAGVDLPKKKRIEYGLTYIYGIGLFTSRKILDKTGISYDKRVHELSEDEAAAIRKEI
QENYMVEGDLRKQVAMDIKALMDLGSFRGLRHRKGLPVRGQKTKTNARTRKGKRKTVGAK
S
>fig|195.2024.peg.1210 Malonyl-[acyl-carrier protein] O-methyltransferase (EC 2.1.1.197)
MNFLKAKDYQKHAKVQDLMGLKLCEILKNLEISHFKKVFEFGCGRGEFSDKLSKIITFDE
YLKNDILDYPDNLNVEIFDMNTLATQNLSKQKFDLITSNASLQWLDLKQVLPTLANMLNK
KGILLLSTFGEMNLKEIKQSTSLGLKYFSTKELEQIFKPYFSDIKITEEIVNLEFQNALE
VFRHLKLSGVNSLGFYRLNKQFLKEFEEKFQNKLTYHPIFILCKKDTK
>fig|195.2024.peg.545 Two-component system response regulator protein
MNKKILLIDDNKMLGKLLAKKIQTTLNHEVDIVFSLAEVKALPNDEYFLTFADLCLPDAP
NGEVVDYVLAKNWPVIVLTASNDKATRDKFMDKDILDYIFKESDTCIDQIIDSIVKLERY
AKTKVILALSKLPERNEIKKILTQRKFNVLAAAHGEEAMSYLNDNSDVKLIIADANMPVI
SGSELLSEVRARFSDDELGVIILGDKDDALEASLLVSGANEYLVKPLSKESLNCRLDKCL
HYMANMQFLSIYNNLDPISGIKNSNALLSCVEDYLNEIVSKEEEFAFAFLDIDNLRNLNE
EYGYEVGDKIIKICADEIVNETKGRDIVGRYSAEKICIVLKNISQERAIKILSRIRVNIK
KVGILVNLDEVFFTASIGVVFAKSGDKFEILVDKASKALSQAKANGKDRVEVCS
>fig|195.2024.peg.682 Altronate dehydratase (EC 4.2.1.7)
MKGYIIVNEKDNVATALRDFKKGEKVANIELLNDIASGHKFALKDIKKDEIIIKYAEAIA
SASCDISTGEWVHIHNTAGIRGRGDKE
>fig|195.2024.peg.1351 NADH-ubiquinone oxidoreductase chain B (EC 1.6.5.3)
MAEHQVNYASGLPVVLTSVDKLVQWGRSNSLWALSYGLACCAIEMMAAGGSRYDFDRFGT
IFRASPRHSEVMIIAGTLCKKHAEFTRRLYDQMPDPKWVISMGSCANTGGMFNTYSTVQG
VDRIIPVDIYVPGCAPRPESFQFALMILQKKIRKEKASRKIAPKRLV
>fig|195.2024.peg.599 DNA-directed RNA polymerase omega subunit (EC 2.7.7.6)
MENRIEEIAAKALERMGDDRYRLSLVVAKRAEQLADGAAPLVDIDKSKLKFADIALYEIA
ENKITLEGLVETSR
>fig|195.2024.peg.631 2-oxoglutarate/2-oxoacid ferredoxin oxidoreductase, beta subunit (EC 1.2.7.-)
MAFNYDEYLRTDKLPTQWCWGCGDGVVLKCIIRAIEKLGWNMDDVCLVSGIGCSGRMSSY
VNCNTVHTTHGRAIAYATGIKLANPSKHVIVVSGDGDTLAIGGNHTIHGCRRNIDLTHIV
INNFIYGLTNSQTSPTTPKGFYTVTAQFGNIDPNFDACELTKAAGASFVARGNVIEANKL
ENLIYKALAHKGYSFVDVFSNCHINLGRKNKMGEAVAMLDWIKNRVVDKSKFESMDFEER
KDKFPTGVLYEDSTQPEYCHAYEEVRRAAKEKRMVDLGALK
>fig|195.2024.peg.41 Putative periplasmic protein
MVSAYPKPIKIFKNTAIKVSNFPFDPNLKIKIYSLNSYIGNIIPQFTNTKDSIIINFTGK
SVTDDSRFRVEFLNNDKPIGFFFDFDVTLQKIYNSAILPQN
>fig|195.2024.peg.388 putative lipoprotein
MNKAILLTLICLFFTACEQTKSVEYYKAHPEEAKKRSDECRLKSIISQDCVNAHSVAIPK
EDWDEGNDTQTR
>fig|195.2024.peg.853 hypothetical protein
MLKQRLDEVNAILAKLIALTEEDIENIKVAKHESVTPSVEEKNKLIAEFITAKKQLDVAL
VELNNSSTKGLSELLDDEDKQKLDLLKKNLQNLHSKNKEYAKFVLIVKDFLDGLVNKMFD
INDGTNNAYGDKKTNPESIFKINV
>fig|195.2024.peg.921 UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9)
MLQTCIFPAAGYGTRFLPATKALPKEMLPILTKPLIHYGVDEALEAGMDNMGFVTGRGKR
ALEDYFDISYELEHQISGTNKEYLLKDIRSLIHRCTFTFTRQNEMRGLGDAVLKGRPLAG
DEAFGVILADDLCINEEGVNVMAQMVKIYEKYRCTIIAVMEVPKEQVSSYGVIAGNFVEE
DLIMVNSMIEKPSPQEAPSNLAIIGRYILTPDIFGILENTKAGKNGEIQLTDALLTQATN
GMVLAYKFKGKRFDCGSVEGFVEATNYFYEKSKC
>fig|195.2024.peg.458 Glutamine--fructose-6-phosphate transaminase (isomerizing), isomerase subunit (EC 2.6.1.16)
MKVLIIGFGSIGKKHFLALKNLNHEVSLLSLSAKKEEFKNTPIYRSLKECDLNEFDLFII
ANITTEHFNTLKTLDGLVKDKTILVEKPLFEKSQNFTSLKNHIYVAYLLRFHPVIVALKR
LLKGEKIYFASLICNSYLPHWRALDYRQNYSAKKELGGGVLLDLSHEIDLAFFLFGDLKL
IYSQNAKISELDITSDDFAFLALKNSQKAKIHIELDYFSKFNKREITIHTLEKSFKADLI
NNKIEIYHKDQSQKILNFENDTIKTLQNLHHAVFEKDKELCDLKQALKVLEICDEVRKKN
G
>fig|195.2024.peg.207 Aspartate carbamoyltransferase (EC 2.1.3.2)
MRHLITTKDFTNDEIMELFEEARNFLDEKPRTLLEGKSVTTIFFENSTRTLSSFESAARR
LGARILRLDVSRSSSSKGETLYDTATNLDAMSPNAIIVRHANSGVPHILASHMHCPVVNG
GDGKHAHPTQALLDLFTIYEHFKGDIKGRKILIVGDIKNSRVASSNAELLTRFGLDITFV
APPHFMPHSPLKKSYSLNEDLISKTDIIMSLRTQTERHNKIIYGSLKDYANDFCIKLDLI
KDKKLILLHPGPVHRNIDISDEVMDDERALVLKQVKNGVAIRMAVLKKLILES
>fig|195.2024.peg.526 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MKEFILAKNELNTMLQTLPKQGVVLLQGELASGKTSLVQAWVSFLNLDEKVDSPTFSIMQ
KYENQDICIYHYDIYQEGLEGLLKNGLFENFFEEGLHLVEWGDENLKKALLKLGIPSLEI
KISVEDDKRKYVIHE
>fig|195.2024.peg.156 Phosphoglycerol transferase-like protein
MLLLAVIFSIFCIWINIKILNLKLKEIQIKPIFFIFLNILLIYAYVVALRGHFTYNALRV
SSYEFSTIKAFNEISTNPLMAFSWAYKEYKNQQEFKSVDTKQLNQLEEKLFPMFDTTLPH
QNHAKNHIYVNIMESFGLNLAEFSTKKIDLFGNLKKHFEQDIVFTRFLSSANNTIESLNR
LIFLSPNTISNGLYQKEELAFTPLQIYKNAGYRIIFVYSGNASWYNLGNYFKNQGADQII
DENTLMQDFPQAKETKHKYGIADEFMYKKIYSIFENAKSPTLVISLSISTHRPYIHKSKK
QLIDTENLDEKILNQFIIDNSTEALNTYAYANDEFGMFLDRIKESKFKENIIIAATGDHR
FRDIKMDINSQKAFAYSVPFYLYLPKYLKNDIYYDKNRVGSHKDIFPTLYNLTLNNTKYL
SLGGRNMLAPIKNQKLEFGFNEVVWIDQDGVYDGNKGYYFENNASIKDTNKAFELDLYHK
NFSKIYKELFQKQLSYRLVNLKTKNNE
>fig|195.2024.peg.616 Membrane protein
MSKRKILKQQCKEIIQLNPTERVWQMPFFFALAVGFVLSIAAYYDRMDLGLIAIIGIMAF
VYTTNTPMYHRMAVTMCCSFGLCLSFLIGLCTHFFPAFSPLVVGLVAMASSILIRYYNIG
APGYFFFVFSCLLASFFPFPPKDYIFLVGLICIGGIIANITAFLYSVSVIYIFKNSPPKP
VLKNGNLGFDVIFVDSIIIAFFVGFAVFLGTFLELDRSYWVAVSTTVILQGTNLNSVWIK
QLQRILGTTVGILFAWWLLRIKFTPLEFIFLMMFLAFIIEFLVVRNYALAVIFLTPYVTY
LAEAASFGNLSVDMLIHARLQDIIIGSLLGLLGGFVIHRAYLRKYFKYIAKYIFRVKLTS
K
>fig|195.2024.peg.1285 Membrane protein
MRTKYFKFLAYFAFLASLIYGFYHILKAFDFVKEAYIYTGVFALFFLNLSLLFSLCKFKK
TKSYPKLLGIFAAFWAFLHFLNYFIFDRNANFLRLFDDISHRLLEASGFFAFIIIFFMFL
SSFRFFKRIEKIRKLGYVCLVLASYHYFLSPKVPMFWEWSALMLSLVYFMIRYLKFFKFK
KA
>fig|195.2024.peg.739 Putative periplasmic protein
MKFFISIIFFISGLFALDLEFSVGENGKSLDDNNTVLIFGGIQGDEPGGFHAASLLLSDY
NITKGKIIVAPNLAFDSIIKRSRGKNGDLNRKFASISPKDPDYQTVKRIKELILLPEVSM
VINLHDGWGFYKPTYIDAMQNPKRWGNSSVIDTNEINASKYPDLESIATQTVNSVNASLV
DPKHAYHLKNTKTQELGDAEMLKALTYFVISNRKAAFANEASKNLPVNLRAYYHLLAIEN
YLKTAGIEFTRTFELTPQGVDKAINQELEVKLFDDKILLSLKNPRQVINYVPFPVNKELN
YNTSNELTAVIAENNSFYIQYGNRFQTRLYPEYLEFSNPFNEVTFQVDGNETTVPFGTKV
KVKENFLIPKIANVRVNIIGFDHSKDESNILVSKKNMQKPYSLDMAGKIYRVEFYELRGA
NLQQFLENSVESKLIKNAKMLDLATLRTARAKDKFIGSILVEFE
>fig|195.2024.peg.57 Chemotaxis response regulator protein-glutamate methylesterase CheB (EC 3.1.1.61)
MKLLLIGSSTGGPNQLKFLLKDVDIKNTCVVIAQHMSASFIPSFVNQFNKEALSEVSLLN
DKEVLANKIYICQKNTILSGNLNLMANWKEVVTSFKPNVDLLFHSAVPLVKTNKILAVIL
TGMGDDGAKGLFELYKVGVKCLCENEADSIVYGMPKKAKDINPKLRPMSLKEIKQEILNF
INEE
>fig|195.2024.peg.424 hypothetical protein
MKENIEKLFQAIAQKNPIHSKYLKKIEFSQEDEEEFDKLISYYIQDGISIKEQCDCYLLI
LNDTLEETKFFIENGAYRYSSFDEVKDKVYFNESYMKQYMIGLALSSFVWIAHIKVRKYF
SQYLQNFTPKTTYFEIGPGHGEYFARAVKSGKFSAFYGLDISPTSCELTQKMVKQQVGGL
ITKCDFLCQDFFTYDFDKKADLIVIGEVLEHVEKPLEFLKRSKELLSDGGEIFATIPINA
PAIDHIYLFSHPDEVKDLIEKSGLKLKTYECFMANDYSLEKALKFKNAITMAVVLNA
>fig|195.2024.peg.1376 SSU ribosomal protein S4p (S9e) @ SSU ribosomal protein S4p (S9e), zinc-independent
MARYRGPVEKLERRFGVSLALKGERRLAGKSALDKRPYAPGQHGARKGKISEYGLQLREK
QKAKFMYGVSEKQFRRLFAEAARRDGNTGVLLIQLLEQRLDNVVYRMGFATTRRFARQLV
THGHILVNGKRVDIPSFRVEAGAKIEVIEKSKNNPQITRAIELTAQTGIVAWVDVEKDKR
FGIFTRKPEREEVIIPVEERFIVELYSK
>fig|195.2024.peg.1574 Methionine ABC transporter permease protein
MNEVSIFDAFLGRISQFFTEFSWQGIKEVSLNSISTFAQNYENILKPALNETIYMSLMAV
FFGFILAIIPGILLAIWDKNGIKHNKIAYAVLDFITNLLRAFPFLILIVVLLPLSKIIVG
TSIGTNAAIVPLAIGIAPYLAKMLESAFKEVDHGIIEAAKSYGASNTQIIFKVIFNESLP
NIISGITLTLIFTIGFSALAGTVGGGGLGDVAIRYGYERFNKEIMIQTVVILLVLVQLVQ
ILGNLFYTWAKNSKTLYILATLIALFVISIIININNDESFVWQAIILIVLALCFIYKFLK
K
>fig|195.2024.peg.1359 Putative bacterial haemoglobin
MTQEQIQIIKDCVPILQKNGEDLTKEFYKIMFNDYPEVKPMFNMEKQASGEQPKALAMAI
LMAAKNIENLENMRSFVDKVAITHTKLNVKEEHYPIVGACLLKAIKVVLNADETTLKAWE
EAYKAIAQFYIDIEKEIYAKAK
>fig|195.2024.peg.1216 Broad-specificity multidrug efflux pump YkkC
MNEKFNINIAWFLIILGGIIECFWVSGLKYSTEIWQYILTAIGVCISFTCFLKACERLEV
SITYSVFVGIGTIGVVLNEMFIFNEAVSIIKLVLIAILLLSIIALKWVSKEA
>fig|195.2024.peg.948 Dienelactone hydrolase and related enzymes
MKNNFFKLLLMVLLIGGANMLYATTWDKVFTRSDKVKIQKVTFKNRYGITLVGDLYIPKN
AKSKKLSAIAISGLFGAVKEQASGFYAQTLAELGFVVLAFDPSFTGESGGSPRNVASPDI
NTEDFSAAVDFLSNLANVDPSKIGILGICGFGGFALNAGSMDTRIKAIVTSTMYDMSRVN
AYGYNDSLDKQARYELKKKLNEARTKDFKNGTFELASTLPQKLSGNEPQFIKEYWEYYKT
KRGFHKRSINSNGAWNATSSLGFINAPILKFSDEINASVLMIHGENAHSRYFSEDAFKNL
KGDNKELFIVKNANHVDLYDNADKIPFSKIAEFFKANLK
>fig|195.2024.peg.1494 Probable integral membrane protein Cj0851c
MENKKAFFIILCLIHVLFYCILVIFKWINLNIILSYEFAFFSILLIVFTSYSNYKKFILA
QAKNHQKDFIYPSLFYIKKIEKLPRIVKFISIKDDLSLNFKDRLRFFTLFFALFKLIAYG
VLVAGFLFLHRQDKLDILSYICGISSLLVCVFIFMLYIRRYESKKNH
>fig|195.2024.peg.140 Thiazole tautomerase TenI (EC 5.3.99.10)
MWDKKIIAISDRKCVEIDFLKQVEKLAKSGIDAFVLREKDLSEFEYYDLAKEVLAICAKH
KTTCFLHFFDRECLKLGHRYFHMPLALLRQEPKMSKYFHMIGTSVHSKEELLEAMNYGVN
YAFVGHIFESSCKKDLEPRGLEFLNSLLSFSQIPLYAIGGINVQNIASFKDINVAGVCMR
EVLMREKDVKKYLVECKRNLL
>fig|195.2024.peg.259 ADP-L-glycero-D-manno-heptose-6-epimerase (EC 5.1.3.20)
MKIAITGGAGFIGSQLALNLQDEHEILIIDKMRSYATFENGNLQSFGHFKNLLDFNGELF
VGDINDEKVLKKIEDFKPEVIFHQAAISDTTVFDQTKVLQTNLNTFKDFIELSIKLHAKL
VYASSASVYGDAKSPQTVGKDEEPKNPYAFSKFMMDKLAKKYYDKAHLVGLRYFNVYGKG
EFYKNKTASMVVQFAHQILAGKNPRLFEGSDQIFRDFTYIKDVISANLIALESKCGVYNV
GSGVARSFQDIVDILQKELHTNLTCEYIPNPYAKSYQFHTQAKLDETWGYKPKFSLEEGI
RDYLEEIKRLFEKEVNA
>fig|195.2024.peg.254 Glucose-1-phosphate thymidylyltransferase (EC 2.7.7.24)
MKGIILAGGSGTRLYPITLTLCKQLLPIYDKPMIYYPLSVLMLAKIREVLIISTPKDTSK
FQELFGDGSWLGMEISYCVQEQPKGLAEGLILADNFIKNDDIALILGDNIFYGQGFSDLL
QNAKNDSKNGYASIFSYHVKDPERFGVAEISKNGEVLSLEEKPQYPKSNYAVTGLYFYDN
SAIEIAKSVKPSSRGELEITDVNIEYLKQNRLKSQILGRGFAWIDTGTHDSLIEASEFVQ
TIELRQGYKIACLEEIAFRNNWIDERRLLDRAKLLDKSGYGVYLRKLLEQGI
>fig|195.2024.peg.1227 1-deoxy-D-xylulose 5-phosphate synthase (EC 2.2.1.7)
MNEIIKKDYQFAYTKEELEKLNLTQLEDLAARIREKIIDVVSKNGGHLSSNLGAVELTIA
MHTVFDNGIDPLIFDVSHQSYTHKLLSGKENVFESLRQFGGLSGYTKPNDGDYFVAGHSS
TSISLAVGACKAIALKGEKRTPVALIGDGALSAGMAYEALNELGDSKFPCVVILNDNEMS
ISKPIGAISKYLSQAMATQFYQNFKKRVAKMLDALPDSATYMAKRFEESFKLITPGLLFE
ELGLEYIGPIDGHNLSEVISALKQAKAMQKPCIVHAQTLKGKGYSLAEGKNAKWHGVSAF
DVDSGESIKKPDAKNSATEIFSKALFDLATKYKNIVGITAAMPSGTGLEKLIEHYPNRFW
DVGIAEQHAVTSMAAMAKEGFKPFIAIYSTFLQRAYDQVIHDCAIMNLNVVFAMDRAGIV
GEDGETHQGAFDVSFLAPLPNLTLIAPRDELMMKNIMEYAYTHEGCLAFRYPRGSFILDE
EFNPTKIELGKAQWLVKNQSNIAFLGYGQGVGKAWKVLRKLQDEGQNANLIDLIFAKPLD
KLLLKELAKQSQIWFVFSENARIGGVASLLESFVQENDLKIKIVSFEYEDSFIEHGKTNE
VEKALKLDIDGLVQRVKINWVDNIL
>fig|195.2024.peg.1593 Ferric receptor CfrA
MKKLCLSVCAIGLLASNAISQNVELDSSIISASGFAQDIKEAPATINVISKKELQSKPYR
DVAEAIADIPGVDLYASKGKTGSYNITMRGITGYTLVLIDGRRQGIGGEVGPNGFNEISN
SFLPPISSIERIEVIKGPMSTLYGSEALGGVVNIITKKVSDKWETSVSLDALLNENKDWG
NTYGTSIYSSGPLMNDKLGLTLRFREFYRQQSNVEFTNGSGQRVQGDQAQSPTKANNFNI
GTRISYLANDYNTFIFDIDFSRNHYDNKQGQLGTITSPGRTPGSLTGGYADIMEVDKFVT
YLSHEGVYENFSITSGLQYNRVSNDGREVVGQSTQPFLGENRDIVAEDIILDTKSVIPLG
QSHILSVGGEYRLEKMQDKIASPTNFDQYLLAIFAEDEYSIKDDLRLTFGARYNHHEIFG
NNVSPRAYVVYNPTNELTLKGGVSTGFRTPYANRLINGTYSYSGQGRFPTYGNPDLKEET
SLNYEIAAIYNNDLFYVSATGFLTNFKDKISSQSYNNSEPIPGIGTCDADRCSRAINHGK
VEYKGVELGAGISPLDNLNVNFAYTYLDTEVKEAQDRSVIGKPEQDSLKHNIMLKTEYSF
YNKFTPWIKGEWQIDRYMGDTNINREYYKDIFLASMGVRYDINKQWSINAAIYNLFDKSF
TNGWESYASGSGSTWVNTYNRIEEGRRMYISINGNF
>fig|195.2024.peg.1009 Thioredoxin reductase (EC 1.8.1.9)
MLDVAIIGGGPAGLSAGLYTTRGGLKNVVMFEKGMPGGQITSSSEIENYPGVAQVMDGIS
FMAPWSEQCMRFGLKHEMVGVEQISKNEDGSFTIRLEGGKTELAKAVIVCTGSAPKRAGF
KGEDEFFGKGVSTCATCDGFFYKNKEVAVLGGGDTALEEALYLANICSKVYLIHRRDEFR
AAPSTVEKVKKNEKIELITSASIDEVYGDKMGVTGVKVKLKDGSIRDLNVPGIFTFVGLN
VRNEILKQDDGKFLCNMEEGGQVSVNLKMQTNVPGLFAAGDLRKDAPKQVICAAGDGAVA
ALSAMAYIESLH
>fig|195.2024.peg.40 Putative periplasmic protein
MLKKILAFYFICISALGASDLVKIYLNQGLDAVGVAIEKELTNKDFWLDEIGDRNISLGY
YNDDVAIVLTNKTDKILRVYSYSDGKIKQDFEQKAIITGLMGDKQVEGDLKTPVGFYELG
RKFNPGDPYYGPFAFATTYPNLLDKVQGKTGGGIWIHGYPLDGTRLDEFKTRGCIALFNE
NLEEFAKVVQDKKVFAMTEEKEKVRAKKEDIAALLADLFAWKLAWTDSDINTYLNFYDEK
QFKRFDKMKFEQFASMKKSIFSRKEDKKIKFSDINISPYPNVENETMYRISFYEDYYTKN
YQFKGDKILYVKIDSKGKMKILAEQ
>fig|195.2024.peg.1463 hypothetical protein
MKKIFLFLTILSFMWAQDDVIIYDYVPLEDVNLSSLDPVQSLKTLPHQRNKFQKVVQGNG
TGESKEEALNNALIDALSQFKGVSNVNLRQELQSIDLSFSHLGQISQKSKSVLQNVSKGY
IDTYKVDKIDQNGTLWQVEISAFKSLYQNDNKPKLVILNDKNKEESYLKRALYDAFSQDE
NFTLLEREHDFKDENKIIKSEDGSREESYKLGNVLGADYILEFEILDITQAKQSKISYQN
NTKVSINIAYKLIFYPTRELVFSKTFNTTFTLSGDSKKEQKNWENIALFMQREMEKSLFF
DTLEEDNKQEGKENTYKLHENGGVNLGF
>fig|195.2024.peg.1611 hypothetical protein
MLKNILISLILSFLLIACGGEKNKNSSELIRAQSQGLLKNHEAIFVEFKEAIVDFDEMSI
DAKINSKNSKILLTKASDSRFLLDLTYLEANQNYKIEFIYKNIPIVLEFQTGWIENFTYK
AQLEQDEEKAYLHLNYSFGSTYNWQFEDKTQEGLKITLDGKDLAFSLGEFSLDTDDIKLL
DRPQELVLTYDEKIMGFKEAKVLQFQIPSKSKNNDFRLISAEEKDQIATLKFSKELAENQ
AFQDFIQISPELNFRAWSIGKELKISANFEPGEKYKVKIAKGLKSNQGLINQGEEANITL
QKDLDPSLVFANDGVFLPSGAEYQVYIKSRNVKKIHLKVSQIFANNISEYLRYKNLVGKK
DDSTQEAFYSSDGFNYVAKNVIDKKIELKNQKNTWINTALDLSDLKGKSGIFSVSLSVDA
NDLDYKGENVYRIINKASVSKNLIFSNIALSAQNLNKQLVVHARDFSKNEALENVKIELV
SKQNQILQSQNTNSNGDVKFQIQEDDEILYILASKENQISVLRFSNPLSTDGYDVEGDQN
HEMIKAFIYTDRGVYRAGDSVHLSVVARENTNPLKHPISFTLINPKNQKIIENQILKSQN
DIYYTQIHLDKNAINGLYRAIFNIAGVEFSKDILVQSVVPNRIKVELNADENRSLDDGNL
NYELSSKYLFGALASNLKYQSFVYFSPKNYHNSKYKDYIFINPSSLIIRASADDKGNLDE
KGRVQSSVEIPENILNSQGYNFNARIVSEVFEKGGRSVKAVRDVNLNRYDYFVGMKALTN
SYVSEGETIDFYAIVSDLKENLVSGKTLEYRIYQNDYYWWWDYDSYDEFLRSIKQDHNTK
LIEKGELTSSSEPMKFSFNTSNYYGQMFIELIDKESGISAGQSFYVSSWGEPSYADVVSS
LKIKSDKNKYKIGQSAKIEFESVAGAKALITLSSNSKIIDRFVMDTQGESTSIELAMKKE
YAPNIYVSVSLFQDYNKIDNDRALRLFGIIPLYVEDENTKLNLELKTPDKILPNSDFEIE
IQSKDKRAFNYTVAIVDEGLLDLTDFKTPDIWEGFYAKTGFTLKTYDTYSQIIPKFTGGD
SVSKIGNLRADKNRDDSAQRFKPVVLFNAPARSDEAGFAKLKFKMPSYMGLVRVMVVANE
NDAYGSISKDMQVSAPLVLLETLPRTLKIGDNFTLLTQIFKTENRIKNATLSVRSKNSLI
KISPDTQAIDFKNATNLEVMMDANVSDNRIGKELLEFELKSENYTYKNEIEIDIKPINAY
TYENNTSLIKAGESKEFIIKDYILGTTNATLKLSPTPILDMDKRIKYLLNYPYGCIEQTT
SAVLPQLFLDKFSTEFDKQKAINNINAAIERYANFQTADGGFAYWQGGDESNAWGSNYAG
MFLILAKQNGYFVPDSMYERWLKYEQNFVQKSIYHDYMMDIKANSLYLLAMAKKPNISEM
NLLYDSLNTLSTEAKWQLAAAYKLAGVEDTAKQIASKISIEPDSKYSSYTYGSLIRDEAI
IANAYKQIYGTNNEELLQKISDTLLSKDYLSTQSTGYALYALAMGANLENMNENFMDATL
KIGDQVHTIDQNQMQIFSFNNEKAIINANKDIFVSFGVEGVKAGENSAFSNKISLDRAFY
DEKGNKISPSEIGSGQTFYMRISASLNEGANYVSNIALTQILPSGWEVSNTLLDDNTPSF
IKNSSYDFIDVRDDKIMWFFSLNKNRTHHFYIKLNAITPGSYTLSGAYVEAMYDDTYRAL
SESEKVVVKR
>fig|195.2024.peg.954 Arsenical-resistance protein ACR3
MLGFIDRFLTLWIFLAIFLGLILGIIFPNIALLWNLFEYKSVNVVLTLCLILMMYPPLAK
VDYAKLSKVFDSKKVILLSMILNWFIGPLLMFILAFIFLKDEPLYMQGVIIIGLARCIAM
VVVWSDLAKGDREYTSALVAMNSIFQILFFSTLAYIYLDFLPKLLGQSTLATSLDIDFSA
LSKNVLIYLGIPFLMGFITRTLLLKYKSKRWYENTFLPKISPITLITLLATIIIMCSYKA
NEVFHLPLEALKIAFVLTLYFIFMFFLTWFISKKNHLSYPKTCSLCFSASGNNFELAIII
CIATFGLHSEQAFASIIGPLVEVSVLILLVKWALGKSLNSKK
>fig|195.2024.peg.528 Argininosuccinate synthase (EC 6.3.4.5)
MKNEVKKVVLAYSGGLDTSIILKWLQDEYKCEVVTFTADIGQGEELEPARKKALSLGIKE
ENVFIKDLREEFVKDYVFPMFRANTIYEGEYLLGTSIARPLIAKTQAQIALQTRADAVSH
GATGKGNDQVRFELGYLAFNPDLKIIAPWREWDLNSREKLLAYAQKHGIDISKKKGKSPY
SMDANLLHISYEGLVLEDPAHAPEEDMWRWSKSPKEAPNESEIIELDFQKGDLVAINGEH
LSPAGLLSKLNELGAKHGIGRLDIVENRYVGMKSRGCYETPGGTILLKAHRAIESITLDR
EAAHLKDELMPKYASLIYNGYWFSPERMMLQALIDESQKHANGRVKLELYKGNVMVIGRE
SANDSLFNAAYCTFEEDEVYNQKDAAGFIKLNALRFIIAGKNGRKF
>fig|195.2024.peg.1447 Probable lipoprotein nlpC precursor
MRFVIFFLVVIAFYIGGCSLAQNASHTPTNYNVDKETRLRMIANEWKKTPYVLGGTTKKG
ADCSGFAQSTLAQFNTRIPRTTTKQLRSGIKVSKSKLKTGDLVFFKTGRGPNGMHVGIYM
SKGKFIHLSTKGGVREVDLNSSYWKNRYIGARRY
>fig|195.2024.peg.130 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MFKLAINRPITVLMFFLALMIFGLISAFSMSVNLFPNVSIPLIKITSKINGDLNFVESKV
TKEIENALSEIDGVKTITSTAYDNFSVSVVEFKLGKNLEVAANDVRDKIGTLSLPSKPEI
EKISSDSGSAISLFLYSKDKLQLMREINDKIKPFLQRIDGVGKIEAKGFLEPQIRIELKP
NELRKYNLNALDVANIIKSQNFKQALGELNNNQDNYIIKGYFEATNLEELSNLRIKTGIF
LSDIANISSLYEDEKQSALYEGKEGVLLELGKITNYNTLEMIKNVKNALPILEKQIPKDI
SINMLYDKSLNIHKHLSQVIFDMVLGIFLTLVIVFLFLRNLSATLIACIAIPTSIISTFF
IIDLLGYDLNRLTFIALTLSIGIFIDDAIVVIENIAKKLKTYPPLQAAFLGINEIGFSVL
SISIVLLCVFIPISYMNSISGLFFNALGISVASGIVISFLVSVFLIPSIGARFLNPKENK
FYEKTEAFFEKIEQKYENLLYKILQNKVKFILATLVFIGFSFALATRIGLDFLPMEDDSE
IQVLLESKKDLSLEAMKEKSLNLLEKIKNDSNVKYAFLLVGYDDAKDATKAKIYVKLKNL
DERNLRQSAIVSLYRQKFQDESLKIKILELPKIEGAGIDDPVQFLILGDDLNTLKEAASQ
AKEILGTNARIVDISDNANATKDEVALHINKEKAKLLDVNPQYIAGVLGYSFSQLSVGSM
DRGNSKDDIILSFAPEFKKDIEALKRISIKNNQGINLELSSVVDFIYSKDLKTINRYNKN
RSVKITAGVNDLSLGAVQKLLLDNMDKILNNNPSLSYAFSGFINLLGETVQGFAMAVALA
FVLIYLVLAALYESFILPLIIMITMPLAFGGASIGLFITGHNFSLFVLIAIILLFGMVGK
NAILLVDVANKKCHEGLDPDKALLIAGKSRLRAILMTTFAMIFAMLPLALSRGAGYEANS
PMAIAIIFGLISSTLLTLLVVPALFKFCFKLDSKLRKIYEREKLN
>fig|195.2024.peg.720 Citrate lyase beta chain (EC 4.1.3.6)
MKAKSFLFVSSIFPERFTKALQSGASQIIIDLEDSVEVAKKKLEEKIL
>fig|195.2024.peg.1391 Sulfate adenylyltransferase (EC 2.7.7.4)
MKSAKKNKSIIIDKNELGILSLIKEGLLGSCTHLMDEHETKQIFKTGKSNNESFPYPLSF
APKVSEEFIKDIRIGSKIDLILDDEIVGNITLKSKFKNDKNFSNIFSPHTCSLDDMGEIC
IGGEIEIYSSTIQKIKEEFHKTKENLNAHKITAIVSSFDPLHRAHERMFRWTIDKADLVV
VFLVESFDANGFDFDLKQNYLKKFIQNYLPPDRIFIFPLKDINLFHAHLNPSLESILAKS
LGCTKLVVGQNHTGLGMFYDDNQPKTILDDFSKDYDIEVIVLPEFVFCDACRMIVSTRSC
PHGCHHHLHYNSQSLKELLRAGIVPPAVFMRKEVSSIILSSIFPNRFKNLQKIYNDLFAT
DGILEYKSDEEFYQKLLETHQMSYMV
>fig|195.2024.peg.48 Putative acyl-CoA thioester hydrolase (EC 3.1.2.-)
MRDMGEPKLKIVAMPSDTNPAGNIFGGWILSQIDLAGAIAARELSPERVVTISMDKVVFK
EPVFIGDIISCYSKIVSVGKTSIGVEVEVSAQRVDSQGCTSCINVTSALVTYVSVTREGK
KKPISEELKKIHGFTNT
>fig|195.2024.peg.149 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNENNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLHEMLSKSSKVLRVIDYACGAGHFLNTYANELKRYLTEDELKEYYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINMETNNSIECFFCERANQILNDNAKAAIIL
PSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLRKKETFKQENHLI
SQDYSLIKERIEAENLKDNESFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLAELEAFK
DYRNAFRQTSDYKRLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLI
IKSPSDIKEQKKFLGYEWSNRKGDEGLKELYNPYLSPLFERDNPQNETKLNTLIYKSFLN
TLDVIPQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSMQSEMSNPFINSKFELVRLK
DFVLDIQTAKRPSGGVGKYENGALSLGGEHIDNKSGYIKLDNPKYVPIKFYESFALQDKG
IVKQFDILICKDGALTGKIAMVRNEFIRKSAMINEHIFLLRCDNIAKQKYLFYILHSYSG
QQALKSKITGSAQGGINKTNLESILIPNADFEIQKQIVAECEKVEEQYNTIRMSIEEYQN
LIKAILQKCGIIDDGGGYELNSILENLQKLEFKLDFNLLLSLIEEQISHSEVLVEETQSK
ERKQDFNAFKNFSKTIQELLQTLSTPPKDGWKRISLKNEQYIELNPSKKEISKLDENMLV
SFIEMASVSDKGYIQSKIDRSLNEVRKGYTYFIENDILIAKITPCMENGKCAIAKNLTNN
IGFGSTEFHIFRAKTGLDSSFLFYNLNQQNIREKAALAMTGASGHKRVPISFYENLTIPL
PPLEIQEKIVQNIELVEQQIDFLNLKLELLEKEKEKILQKYLFS
>fig|195.2024.peg.589 Recombination protein RecR
MTHKGIEKFNELVESFAKLPTIGKKTAIRLAYHICTGNQLEGMKLAHNIENAIRFIKPCQ
QCGSLSENELCEICTDDERDKNCLCIVQSPKDVLVIEESKSYGGLYFVLDELNDEKLAQL
RQMILKLQSKELIFAFTHNLNSDTMIFYIEDRLKDLNLQFSKIAQGIPSGVNLENVDFIS
LNKAINFRTKV
>fig|195.2024.peg.21 Molybdopterin molybdenumtransferase (EC 2.10.1.1)
MKNIFQTLAHLQDQIKALNEFELISLEEAKDRVLAKDLYAVKNLPSFDNAALDGYAFNYA
DVNQALDIKGTILAGDKNTYEIYKNECFKIMTGAKMPKNADTILMIEDECIEEGKLVIKK
PPKQYNAYRYKGEELKKDELLLKKGTRLNARHIALLSSQGLYKIEVVRKIRIGIFSSGDE
LKEPWQDCDEENIYNANALPLLALFKDCATSYLGIIKDDFNATKKALENANFDLLITSGG
ASVGEADFMEKALNELGFTPLFKGLKARPARPTKLYQKDKTLVLILPGNPMAAYLSAFIF
ARKIIALLYGNLENPLQIQAFMGSDLKVKSGRNNLILGNLEKGIFYPFNDNKFGSGMILP
LIQSEFLLISEEEKVDFQKDERIMLFKL
>fig|195.2024.peg.1047 Tol-Pal system beta propeller repeat protein TolB
MKKIVTVFLIFLGILWAEDPVIDVVNSGVVLPKIIVKDNSNLSDINLKRSFYNIIVNDLK
VSSNFEVVSDASSEAANYTFEYDLSKNGNALNLHVKIKAGGLEKSSQTYALNGVEQYPFL
AHKSVKASVNALGLAPVEWMDHKILIARNSSSKKSQIIMADYTLTYQKVIIDGGLNLFPK
WGNKEQSIFYYTAYDHDRPTLYRYDLRANKASKILASGGMVVASDVSLDGSKLLVTMAPK
DQPDVYLYDLNSKNLTQLTNYSGIDVNGNFIGVDDSKFVFVSDRLGYPNIFIQNLNNGSA
EQAVFHGKNNSAVSTYKDFLVYSSREPNQVGVFNIYLMSINSTGIRQFTANGKNLFPRFS
SDGGSIVFIKYLGAQSALGVIRVNANKTFYFPLKVGKIQSIDW
>fig|195.2024.peg.1119 NADPH-dependent 7-cyano-7-deazaguanine reductase (EC 1.7.1.13)
MRYGEKEIKEFDVENMEIWPNDAKNDYIIKITLPEFMCCCPRSGYPDFATIYLEYIPDQF
VVELKAIKLYINTFMHRNVSHEASINEIYNTLKDKLKPKWIKVVGDFNPRGNVHTVIECR
SDMVVPK
>fig|195.2024.peg.1090 LSU ribosomal protein L24p (L26e)
MAVKLKIKKGDSVKVITGDDKGKTGKVLAVYPKTLKVVVEGCKIAKKAIKPSEKNPNGGF
INKEMPMDISNVAKVQE
>fig|195.2024.peg.1398 Haemin uptake system ATP-binding protein
MILKIQNLSFSYHKKELLKNINLELQNKAFIGILGPNGSGKSTLLKLILKNLNISKGEIS
LFNTNIKNFALKEFAQLCGFVPQNSGLNTPLKVIDVLLMSKFTNLKHAFCDYSKEDILEV
EKFAKTLKLENFLERNILSLSGGEFQRVLLARALLKKPKILFLDEPTSALDLNHAIELLS
LCERLIKQNNIAVVAILHDLNLASMFCDKVLFLKEGEIKYFGSTKELFTKEILKEIYNLN
CEIVYKDLKPYILALKEKI
>fig|195.2024.peg.878 Cytochrome c oxidase (cbb3-type) subunit CcoO (EC 1.9.3.1)
MFSWLEKNPFFFAVAVFIVIAYAGIIEVLPNFAENARPIEGKKPYTVLQLAGRQIYIKDS
CNACHSQLIRPFKSETDRYGMYSVSGEFAYDRPFLWGSKRTGPDLMRVGNYRTTDWHENH
MWDPVSVVPNSIMPAYKHMFKNNADMETAYAEALTVKKVFNVPYDTENGTKLGTWEEAQA
EIKAEAQAIVDQMKNQEVKDAFARGEIKEIVALIAYLNSLK
>fig|195.2024.peg.709 putative membrane protein
MKSYSFIQPRKKPIFTLFDKIWFGLFSFGIVFIFAVYFLYLTQIALTHNFIEEQKEQVLQ
FQNKTQENGKLYDILLEQSKIANTFHTQNQAFKNSLKNLFDIIVKTDGITLESIEQEENS
LKLIGVTPTKEMFALLLETPLKSIFDQSFTTYYRLNNGWYRFISISKQNSGVLQ
>fig|195.2024.peg.1002 23S rRNA (guanosine(2251)-2'-O)-methyltransferase (EC 2.1.1.185)
MIVYGKQIFFYILERHKELINELYLAKECDKETFKKIASLGFKIKKLDFKTAQAYAKGGN
HQGFLLDIKEYEFKDLHTLKKGEFITILYGISDVGNIGAIVRTAYALGVDGLIFIGERLA
MEGVIRTSSGAALDLEIALNNDIFTVLNELKQVGFKLFASASGGKQIHHYKVDKGKKALI
LGSEGLGLSAKIIKKCDECVGIEMKNNFDSLNVSVAFAILCDRMINA
>fig|195.2024.peg.527 Ribosome-associated heat shock protein implicated in the recycling of the 50S subunit (S4 paralog)
MRVDKFLNAVNITKRRAISEDMCRSGVVGINGVIVKASKEVKVGDIISLHFTDYTQEYKV
LALPTTKNIPKNAQSEYVVKL
>fig|195.2024.peg.352 Glycyl-tRNA synthetase beta chain (EC 6.1.1.14)
MSELLIEIGTEELPAIPLLKELANIEKKWKDVLEDYRLVSDFKFYYTPRRLVIFHKNFAS
KQEDSFAEFIGAPKNVAYKDGQLSAAGQSFLQKAGISENELSFKEIKGKEVLYHQKAIKG
LQSQEVLGEMIHQFLKSLNFGKSMRWGTNSFEFIRAIRSIVCILDDNLVEFESYGVKSAK
KTFIHRSVSYDLQEFNNAKEYFSLLEKNYIILDPLQRKERILKQFKLLESQNNIQIGEDE
ELLAEVIAITEYPNALLGSFEEEYLQIPSEVIITSMRENQRYFAVFNEKGLSNHFIVVSN
AVCEDYSKIIHGNERVLRARLSDAMFFYQNDLQSGLNPEKLAKMTYLEGLGTMQDKSLRE
IKIAEVLCQMLNNDKIANISTAIKYAKADLATQMVYEFTDLQGIMGSYYAQKMGLDYEIC
LAIKEQYLPNSEQAPLPSTEFSSIVALANKLDTLIGLFSIGKIPSGTKDPYALRRAANGI
IKIALNLNKEFDIQALLEKLASHYKNFDMQILKDFIFERLYTFYSVNASFIKAVLSSKST
DLIHINQSVKALIELSKKANFQENFTTFKRLANIANKTSHKVDESLFVEEAENKLYKAFK
EKIQAHSLQEKLENLFSLKPFIDEFFDKVMINAKDEKLKNNRQALIYEIYEEFLKIADLK
ELSL
>fig|195.2024.peg.1558 hypothetical protein
MDYTLFILTFVSVSLLPGLCMSLAFSLGLSLGYKNTLWMIFGELVGLALVVLCCALGIEF
ILRYENLFKFFQIAGALYLLYIAFILFKSKSQITQEKIIHKKKFSLIIQGFIASSSNPKA
WIFMFSILPSFLKFQVNVNILLLIILLIEFCSLSLYALGGSIFKIFMNKHLDKINKISAL
FIFAMALSVLYKV
>fig|195.2024.peg.939 Type I restriction-modification system, specificity subunit S
MTNLPQGWKWKSLGEICFITDGTHKTPNYIETGIPFLSVKNISKGFFDLSDVKYISLEEH
NKLIKRAKPEFGDILICRIGTLGKAIKISLEFEFSIFVSLGLLKPKVKIISDYLVYFLNS
CFIEEWINDNKVGGGTHTAKLNLNILEKCPIALPPLKEQERIVGILDESFAKIDESIKIL
EQNLLNLDELMQSTLQKAFNPLKDNAKENYKLPQSWEWKSLEEISENISAGGDKPKNCTE
SKTAKNQIPVYANGVNNNGLVGYTDKATIIKPSLTISARGTIGFVCIRKEPYFPIVRLIS
LIPCENILCLHYLYFCLNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKEQEQIAKHLDFV
FEKTKALKELYTKELKDYEELKQSLLNKAFKGEL
>fig|195.2024.peg.1152 Ribonucleotide reductase of class Ia (aerobic), alpha subunit (EC 1.17.4.1)
MKVIKRNGRTEELDVSKIKKCTFDAIKDLEGVNLSELELDAKIQFRDGISTEEIQKTLIK
TAVDKIDIDCPNWTFVAARLFLFDLYKKVNGMNRYNHLREYFEKGEKEGRILLGLKEKYD
LDDLNDYIKPERDMQFTYLGIKTLYDRYLIKDSKGMPIELPQQMFMAIAMFLAQNEFNPQ
EWAKKFYDLISKFELMLATPTLSNARTTRHQLSSCYIGSTPDNIEGIFDSYQEMALLSKF
GGGIGWDWSKVRAMGGSIDGHKNAAGGIIPFLKITNDIAVAVDQLGTRKGAIAVYIEPWH
MDVSDFIDLRKNSGEERRRAHELFPALWINDLFMKRVRANDKWTLFDPADTQDLCDLYGE
AFEKRYEEYEKDESIAKEIVEAKELWKKILLNYFETGLPFLCFKDNANKANPNAHVGIIR
SSNLCTEIFQNTEPNYYKIKVVFENGDEKHFDEEERVIIDGGYEKPAKKISTLDSFNGNK
VYIVEKYKSDGKTAVCNLASINLSKVYTKEDIERVVPTAIRMLDNVIDLNFYPHRKVKDT
NLKSRAIGLGVMGEAQMLAEARIHWGSDEHLNKIDEIMEKISYEAINASSNLAIEKGSYP
DFEGSNWSKGIFPIDVASEKAKALTLREGLFNQSECDWDKLREKVKEDGMRNGYLMAIAP
TSSISILVGTTQTIEPVYKRKWFEQNLSGMIPVVVPNLSLETWQYYTPAYELDQRILVKA
AAVRGKWIDQGQSLNIFLSLDKASGGYLNDIYQLAWELGVKSTYYLRSESPDSEKINIAD
RSIECEGCQ
>fig|195.2024.peg.1219 Lipopolysaccharide export system permease protein LptG
MWIFFRFISGIYLKNFFIIFLSLLGFYCGIDLLLNFNDLPDAANLSLLYVIFLAFSAVTY
VLPVSLIFALVLSLVSMIRANEFVSLYALGLSKNLVIIFPFLWALFFCFVYVGLNFTPFA
YANDYKRNILKNGTMLKQSGEVFLKFNNEFIYISKVNNGQSTAQNIKIFNIKDLNLSSFI
EAKSGIFEKKNWILKEGNLTLLPKEYELGNKGLNISEFKELNTLEGFKPKIIEGVASDSD
YSILDILESLELFKTQNISIESLKISLYKLVFMPFFAPFLMLIMYYFFPVIARFFNLAFV
AFVAFVVTLLTWGMLFLLSRLSENGVILSELGIVMPIVLLIFLGGFMFYKHR
>fig|195.2024.peg.1140 Glutamate synthase [NADPH] large chain (EC 1.4.1.13)
MDLENILENNQSVGLYHPKNEHDACGIAAVANIRGIASYKVICDALEILMNLEHRGGAGA
EENSGDGAGILIQIPHDFFMTQELGFELPQKGDYAVAQMFLSPNADAKEEAKAIFLQGLK
DKNLEFLGFREVPFNPSDIGASALKAMPYFLQAFVKKPSTVNAGLEFERVLYACRRLIEK
RALHVPKFYFSSFSSRTIVYKGMLLSTQLSDFYLDFKDVNMKSAIALVHSRFSTNTFPSW
ERAHPNRYMVHNGEINTIRGNVDSIRAREGLMESEYFENLDEIFPIIAKPSSDSAMFDNT
LEFLALNGRTLEEAFMMMVPEPWHKNENMGSKKRAFYEYHSLLMEPWDGPAAIVFTDGVI
MGASLDRNGFRPSRYYLTKDDMLILSSETGALKLDENNIKAKKRLEPGKLLLVDTARGRV
IADNEIKEHYANAKPYKQWLKNLVELEKQHSGVYKHKFLKEDEVLKLQKAFGWSYDELKM
SVASMAQNGKEALAAMGVDTPLAILSKTYQPLYNYFKQLFAQVTNPPLDAIREEIVTSTR
IYLGSEGNLLKPDENNAKRVKISLPIISNEELFEVKALNNFQVKEFSILYDYSKKTLEKA
LDELCVKIEDEVKKGVSIIILSDKGVDEKNAYIPALLAVSGVHNHLVRKNLRTHTSLIIE
SGEPREIHHFACLLGYGATVINPYLVYESIQKLIANKDLNLSYEKAVENFIKASSSGIVK
IASKMGVSTLQSYNGSALFECLGLSSKVIDKYFTSTTSRIEGMDLEDFEKELIALHKHAF
NDTHKALDSKGIHGFRSAKEEHLIDPLVIFNLQQACRNKDYKSFKKYSALVDEKQVNLRS
LMEFDFSEAISIDKVESVESIVKRFRTGAMSYGSISKEAHECLAQAMNKIGAKSNSGEGG
EDEERYEIKDGVNKNSAIKQVASGRFGVDLNYLSHAKELQIKVAQGAKPGEGGQLMGFKV
YPWIAKARHSTAGVTLISPPPHHDIYSIEDLAQLIYDLKNANKDAKISVKLVSENGIGTV
AAGVAKAGANLILVSGYDGGTGASPRTSIPHAGIPWELGLAETHQTLILNKLRDRVRLET
DGKLMNGRDLAIAALLGAEEFGFATAPLIVMGCTMMRVCHLNTCPFGIATQDKELRDRFK
GKVDDVVNFMYFIAEELREYMARLGFERLDDMIGRVDKLRQKPMQGKAGKVNLDKILKSL
PTYNRTAVHFKDYKDNKLEKTIDYRILLPLCKNAVEKKEPIKLSLEVGNQSRTFATMLSS
EILKTYGKDALSEDSIQIKAIGNAGNSFGAFLLKGIKLEIIGDSNDYLGKGLSGGKIIAK
ISNEATFSPEENIIAGNACLYGATEGEVYLDGIAGERFCVRNSGAKAVVLGTGVHGCEYM
TGGLVVVLGDVGANFAAGMSGGVVYIFGRHNEAHVNTELVDIKDLSTKDEKELKTMIENH
IAYTNSKKAKDILEKFDKKDFFKVMPRDYEKMLEMIELCKDEEDPSLAAFLKITQK
>fig|195.2024.peg.828 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGDEIPFGVLIYKYKLKINTINKVNTLPNNSKDSILIHAGTDM
KFWSSFISYISFQEWHVNNKVWSNNYDKMININFRQHNLPIKDQSDLYQFLFSYNLFYSI
YPMLNVLINYKLKEYKLYIDFLISNSRRSFNIFSSFLGSKNFYYQIEFEYGYGEWGTKIY
FNLVLKDFYKEKLKFILLEMVDFKPSTIKKLEEVIIRIQVDINQSFLYILEKIIITTFKY
SSFKMEYNQLDIFGYSAKTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSYIKDKHKQE
QKNYQEKIKKDPSLKLPPLENYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMWF
EIGKLKREFKEKVNHA
>fig|195.2024.peg.276 Spermidine export protein MdtJ
MNIAKKELFIAWFFLIAAIVFEVLGTSFLKMENQILGYIFMALFIAFSYFFMGKAIKKIQ
VGIAYAVWELLGIILILLVSFIVFKESLTLTQFLGIVLSIVGIIMINIGEVKE
>fig|195.2024.peg.465 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MNENLSLKAKIYHYAVLFLVFLFLALPLMATFLYSISTSWGVSVLPDDLTLKWYQELFHD
ERFLLALWHSLLVCVGSILLSVILVFPLVFVLNYYFLKLKAFVNILIIMPFAVPPIVSCV
GLLQLYADNIGGTAWILIFTYFTIALPFIYRALDNAMSNVNLNELIASNAMLGGSLMGAI
FKLVLPNLRNGILVAVFLSFSFLIGEFLYANILVGSAYETLQVYLYNIKNQSGHYSSALV
IVYFVLIFITTFIASLIKE
>fig|195.2024.peg.27 SSU ribosomal protein S1p
MSEVNKKVQNNLEDYLEDEDFGQLLEAFDKSREETITEGVIVEIKNDEVYVDIGRKSEGI
LALNEIQDENANLLFKVGDSIKVAVVGSRGGRSLLSHKKALRKEKVIDFIQNYKEDDEYI
FEVKVVGKNKGGLVVVNDDDVEFFLPKSQYGFKENNNLIGKTFKVKIIKVDKEEQSIIVS
RKKTLDDERKKRKELINNIAQQEGLIEGVVKKITTYGMFVDVGGVDGLVHYSEISYKGPV
NPSILYKEGDKVPVKVVKYDKDRKHLSLSIKAALPDPWGEIKDSLEVGDTIKVIVSNIEP
YGAFVDLGNDIEGFLHISEISWDKNIKNPKDYISKGQEIDVEVIEINSDERRLRVSLRNL
LSKPFDEFMKNHKIGDVIEGEVTSTTSFGAFVKIGSVEGLLHNEDASWDRNEKCKDKFNN
GDIIKVKIIKIDEEGQKISLSIKELSESPVQEYAKNHKVGDIVKGKIRDIKDFGVFVELN
KNVDALIHKEDISASTLENLKIGDEIEAAIAFIDEKKNRIRLSVKNLVRIKEREVLNEIN
SDDKVTLGDIIKDQLA
>fig|195.2024.peg.1005 Aspartate aminotransferase (EC 2.6.1.1)
MFDEIRFNTIERLPNYVFAEVNAIKMAARRAGKDIIDFSMGNPDGKTPQHIIDKLCESAN
KDKTSGYSTSMGIYKLRLAICNWYKRKYGVNLDPESEVVATMGSKEGFVNLARAIINPGD
VAIVPAPAYPIHTQAFIIAGGNVAKMPLKYNEKFELDENKFFEDLDKTLHESIPRPKYVV
VNFPHNPTTVTCEKSFYERLVATAKKERFYIISDIAYADLTYDDYKTPSILEVEGAKDVA
VETYTLSKSYNMAGWRVGFTVGNKRLVAALKKIKSWFDYGMYTPIQVAATIALDGDQSCV
DEIRATYDKRMHILLEAFENAGWKLHKPRASMFVWAKLPESKMYLKSLEFSKQLLQHAEV
AVSPGIGFGEAGDEYVRIALIENENRIRQAARNIKKYLKEE
>fig|195.2024.peg.459 CMP-N,N'-diacetyllegionaminic acid synthase (EC 2.7.7.82)
MAEILCTICARGGSKGVKNKNIRKINELEMIAYSIIQAQNSKLFKHIVISTDSDKIASVA
QKYGAEVFFKREAHLANDRAAKLPVMRDALLRSEEHFKTRFETLIDLDASAPLRSSLDIK
KAYESFVENDNSNLITAVPARRNPYFNLVEIQNNKVVKSKEGNFTTRQSAPKCYDMNASI
YIFKRDYLLENDSVFGEKTGLFVMDESTAFDIDSELDFKIVEFLISLKNLSPKDF
>fig|195.2024.peg.1615 Threonyl-tRNA synthetase (EC 6.1.1.3)
MEKEVIAYLDDEKIVDSQSKNSIDLKEIYFDNSKESLEVIRHSCAHLMAQAIKSLYPEAK
FFVGPVIEDGFYYDFRVESKIGEEDLVKIEKKMKELVEAKQEIEKYEITKNEAIAKFKDD
DLKQEVLLRIPDGKVSIYKQGEFEDLCRGPHVPNTKFLRFFKLTRVAGAYLGGDEKREML
TRIYGTAFADKESLKEYLTIIEEAKKRDHRKLGTELKLFTFDDEIGGGLPIWLSNGARLR
SKLEHMLYKIHRLRGYEPVRGPELLKADAWKISGHYANYKENMYFTQIDEQEYGIKPMNC
VGHIKIYQSDVRSYRDLPLKFFEYGVVHRHEKSGVLHGLFRVREFTQDDAHIFCMPSQIK
EQVLEILAFVDNLMKLFDFSYEMEISTKPAKAIGDDEIWDTATKALKEALDEQGLKYGID
EGGGAFYGPKIDIKITDALKRKWQCGTIQVDFNLPERFKLEYTDSNNEKKQPVMLHRAIL
GSFERFIGILTEHCAGEFPFFIAPTAVGIVPISDSHIAYAKEIQRALLELNIDSEVYEKN
ESLSKKIRTAEKQKLPMILVLGDEEVAKRSVALRDRRAKEQKNLSLDEFIKLVKEKMSEV
HF
>fig|195.2024.peg.1697 LSU ribosomal protein L34p
MKRTYQPHGTPRKRTHGFRVRMKTKNGRKVINARRAKGRKRLAV
>fig|195.2024.peg.1373 Translation initiation factor 1
MAKDDVIEIDGTVLEALPNANFKVELDNKHVILCHIAGKMRMHYIRIMPGDKVKVELTPY
SLDKGRITFRYK
>fig|195.2024.peg.1548 D-alanine--D-alanine ligase (EC 6.3.2.4)
MKLAILFGGNSYEHEISIVSAVVLKKVINTDLTFIFCDEKRRFYLIPSEKMNSKTFSGGA
YQKEKELFLRQKAFYHKSLWSEKNLDLDCVINLIHGRDGEDGKIASLLEFFDIKFIGPRV
EASVLSFNKEFTKLYAQSVGVKTLDYQMLRKSQKQDFTAHFPCILKPARLGSSIGISIAK
NEKELDYAKDVGFEFDTDILVEDFKSNIKEYNLAGCMIKDEFIFSIIEEPKKKEFLDFEQ
KYLSFSGHNELIEADLSEELKQKLKDNFAKIYNPLFKGALIRCDFFILDNEVYLNEINPN
PGSLANYLFKDFNKIIEQLALSIESEKKIKITYEFLHSINGQKGKL
>fig|195.2024.peg.1083 LSU ribosomal protein L15p (L27Ae)
MNLTKAAGSTHKTKRIGRGQGSGMGKTATKGGKGQTARKGYNEKRGFEGGQQPLQRRLPK
VGFTSKIAKPYVINVEKITAVKELNEITIESIKSVHKISKSVTKIKLIGASAKDLASKIK
DENISVTGSK
>fig|195.2024.peg.813 NAD-dependent epimerase/dehydratase
MNKNVLVFGGSGFIGSYVIEELLANNYNVLYADLNPSSSIPMQYFRQCDIMQKEEVQNLC
QDMDIVFNFAGFAHLDDAIANPLKTLELNVIGNMHILEGCKNYKVKRYIYASSAYAMSDK
GSFYGISKLTSEKIIEEYFKKFGLKFTIIRYGSVYGEREYYNNYIYNLVKEAMLTGKISH
SGDGEEIREYIHVYDVAKLALQVIENSEFENEHLILTGMEKMQRKELFEIINEMLGGHIE
ISLKSSGYHNHYKTTPYSFHPTRSKKLVANPHIDMGQGILECMKNIEKKYL
>fig|195.2024.peg.1196 Phosphoglycerate transporter protein PgtP
MFYAVKGSPKNEGLVDITEINEMRGIKTEEIKAIETPNLSSFEIFYHYVLKNKNA
>fig|195.2024.peg.876 Cytochrome c oxidase (cbb3-type) subunit CcoP (EC 1.9.3.1)
MQWLNLQDNVNLLSFIGAILIILITLVVVGRMFKYMKEKKGEAELSEHSWDGIGEYKNAI
PIGWAVIFFLTIVWAVWYFLWGYPLNSYSSIGEYNEEVKAYNTKFEEKFQNLSTEDKVAM
GQNIFLVQCSACHGITGDGINGKAQNLNIWGSEEGLIDAIKHGAKGMNFPGGEMPAAADL
GIAEEDIPAIAAYVAKELSAIKKTSNENLIAKGKEAYATCAACHGEDGKGQDGIFPDLTK
YGSAAFVVDVLHSGKTGFIGAMPAFSILNDTQKEAVGEYVISLSRGE
>fig|195.2024.peg.571 Phosphate ABC transporter, permease protein PstC (TC 3.A.1.7.1)
MLKEKIIKFALFLCAFVSVIVSFAIMLTILIEALKFFQKESVVTFLFSSQWAADAAFMNA
DGTSKQGVFGALSLFWGTFYISLIAMLTALPLGVMCAIYLGVFAGKKSKNYLKPILEIIA
GIPTVVFGFFAAIVVAPFIVWFFSLFGIQASFQSALGAGFIMGIMIVPIVASLSQDCIEA
VSEKRINGAYALGMTKKEVVFAVILPEAIPGIVAACLLGLSRALGETMIVVMAASLRPNL
TMNFLEDMTTVTVKIVEALSGDQAFDSSLALSAFSLGLVLFIITLIINMFSVYLINRFHK
RKNL
>fig|195.2024.peg.788 Ferrous iron transporter FeoB
MKKIKIALVGQPNVGKSLLINALCKANMKVGNFSGVTIEKASAKTFYKNYEFEVIDLPGT
YSLDGYSEEEKITRHFLNQNDYDVIVNVLDATNLERNLILSAELLSLNKKMLLALNMCDE
AKKEGIELDTSVLSQEFQSQVVEISAKTKKNLELLLQKIIILFESKFIPRSQFYTPLCEK
SPEKEDLLYFINELSKKIITHKKEERNLTKKIDALLIHKFFGLPIFLFLMWLLFQLTFSL
GQIPMDYIESGFNALGELVKNNISNTFIASALADGIIAGVGAVILFLPNIIILFLGIALL
ETTGYMSRVAFLLDGILHKFGLHGKSFIPLITGFGCSVPAFMATRTLKNKRDRLLTLFVI
NFMSCGARLPVYVLFIGAFFPSEEAGNCLFGIYLLGAILGLIAAKFLRSTAFRGIDEPFV
MEMPKYRMPNWHLVWFMVYNKAKMYLKKAGTFILLASLLIWFASNFPKNEENLNDFNAQE
RAIEQSYLGQFGKGIEPIFKPLELDWKLSVSLISGLAAKEVMISTMGVLYSLGKDVDETN
NDLKGIIAKNIPLPSAVAYILFVMIYNPCFAATIVFSKESGKIKYTFFLFLFTCISAYIV
AFIGLNITKFVIN
>fig|195.2024.peg.1188 Transcription elongation factor GreA
MQKEPMSQFGYDKLSAELKDLKDNQRPAVVIEIDTARSHGDLKENAEYHAAREKQALIES
RIAELSDLIARAQIIDPSSYEHDSVKFGSSVVIMDLDTEKESKYTLVGICEGNLDKGYIS
IASPIAKAMLGKKEGDEFKVRLPKGESEFEIISINYEPLKF
>fig|195.2024.peg.496 hypothetical protein
MTQEELDALMNGDVNFDEDAESNIKSETESHNIESEEGLMLEDVKVSDYKPDPSVVWPPP
PPNQEHKVVHQLDDVTKDSELKATEMMDKLESINNFFADSENLFSEIDKVLAKNIEIFSK
LNEKFPNVVSFNEALQLNSKVKKTSQEIIDKLQCGQDEVMMAMDAMQYQDIHRQKIERVI
NVMRALSRYMSSLFEGRIDDKKRVSSAVHIEGDSTTDIVSNDDIEALIASLGQK
>fig|195.2024.peg.763 Xanthine-guanine phosphoribosyltransferase (EC 2.4.2.22)
MIFYSYEEFKEDVKILAKEIKEDFNPDALLAIARGGMSLGHSLAVALQTRKLFALNSIHY
DDTKKLDTIEIFNIPDLSKYKKILLIDDIVDSGESLAEIKKVLLEKFPHIELKVATIFYK
KTALLEPEFKVKEAKEWVEFYWDIHID
>fig|195.2024.peg.920 Glucose-6-phosphate isomerase (EC 5.3.1.9)
MLNNTLFFKESEIRTISSYANRINDEVESGDIGYYHLIDTSLTLIDESLNFIQDKEHVKN
IVLVGMGGSSCGVKALRDMLFDEKNNQRELFILDNTSSHSFSRTLEKIKLEESLFLIISK
TGSTIEVVSLFKLLIEHFKLDIQELKKYFIFITDKDSKLHKEGENLGIKCFFIPENVGGR
FSILSAVGIVPLCFCGYNAKALLEGAKACFEDFFIHKKDEILQKAYHYCTHKSASINVLF
SYSDAFKGFNEWYIQLIAESLGKKQGYKRIGLTPIALIGARDQHSFLQLIMDGPKNKTIT
FLKIKDSQKAPVIPDIHFKFLDDLSNKVNLHDLLNAQCDATMHALIAENLSVDIIELEKL
DAWHAGYLMYYYELFTSACGVMLGINTYDQPGVEVGKLILKNILKS
>fig|195.2024.peg.648 Fluoride ion transporter CrcB
MLNTILVVGLGGFIGAVLRMLSINLINKILPHSISFGTLFVNVLGSFMMGLLFSYAHHKG
LSPALKSFISTGFLGAFTTFSTFSYENLLLLQSGNYFNFSLNILLNIILCLIAVWLGFII
FK
>fig|195.2024.peg.314 Signal recognition particle receptor FtsY
MFDFFKKGLAKTLESIVGVKGENKKITKDLLEEILLEADVAYEIVEEIIYYLPPSDEVKK
EDLKRVMGSYFLYENKEFLDEKPFVELILGVNGAGKTTSIAKLANLYKSQGQKVILGACD
TFRAGAIEQLRLWSEKVGVDIVLTQQGHDPSAVAFDTISKARAKGFDKVIIDTAGRLQNQ
KNLANELEKIVRISAKAMPHAPHRKILVLDGTQGNAGILQAKAFNELVQLDGVIITKLDG
TAKGGALFSIARELELPILYIGVGEKMQDLIEFNAQNFLDTLLEGVFD
>fig|195.2024.peg.1559 Branched-chain amino acid transport protein, putative
MLDKNILYAILAASLATYLTRVLAFILFKNKKENYHLLFVQYNMPLVIIIILFFYTFYEV
DFYSYPYGLDFIVSCILVFLIHLLFKNALLSIILGTIFYMFVLRLF
>fig|195.2024.peg.106 hypothetical protein
MQGESIDTIRQELIGVSEDFFTKASVEYLGHINIGKLDWYIAFSSYYPT
>fig|195.2024.peg.103 Magnesium and cobalt transport protein CorA
MVCDENLSKFLANKNLNTLYMDFLGQKILILNSYSSKTKKANFSVFGFEDDTIFKLENAQ
FKPFSLNDFLSTIRAILEDCKNENAYFERILERKENILLKGNLIKNFFKKSFILKQKINK
NLKNLSLLDEALNLLAGTSPHKKALKPIIFAVGVTLKNNKEIITRLNELHLLMSAIKNEK
MNQSLYFLSILSAIFLPLNLIVGFFGMNTNDLFLSNVKHATWYVFALICFILLSGLIVYR
KKRKKELEFEDKILNK
>fig|195.2024.peg.865 Outer membrane fibronectin-binding protein
MRKLLLCLGLSSVLFGADNNVKFEITPTLNYNYFEGNLDMDNRYAPGIRLGYHFDDFWLD
QLELGLEHYSDVKYTNSTLTTDITRTYLSAIKGIDLGEKFYFYGLAGGGYEDFSKGAFDN
KSGGFGHYGAGLKFRLSDSLALRLETRDQISFHDADHSWVSTLGISFGFGAKQEKVVVEQ
TKEVVNKPQVVTPAPAPVVSQSKCPEEPREGALLDENGCEKTIYLEGHFDFDKVNINPAF
EEQIKEIAQILDENVRYDTILEGHTDNIGSRSYNQKLSERRANSVAKELEKFGVDKSRIQ
TVGYGQDKPRSSNDTKEGRADNRRVEAKFILN
>fig|195.2024.peg.368 SAM-dependent methyltransferase
MENSIKDSYNKICKKWSEFCKNTSINQCIVDFANNLSPNSRVLDIGCGTGYPIALYLSKQ
GFQVTGIDISEEMIKQAQKLNLHNATFLVEDILNFKTDKKYDAIIAFDSIWHIRYDKQEC
IYQIISSLLTSGGLFLFTHGKNDGEIISTMWKESFYHSALDLEKVHKLLKQNGFDILSSI
EDYIEETTGDRELLIIAKKKEL
>fig|195.2024.peg.925 Tungstate ABC transporter, substrate-binding protein
MKKIISLALALTLSASAAELKMATTTSTDNTGLLDALKPLYEQESGNTLKWVAVGTGAAL
KMGEDCNADVLFVHSPKAEKEFIKKGFGVDRTPVMYNDFIIIADKSLASKFKGKNLKESL
ELIKNEKLTFISRGDKSGTDNKEKSLWKNLGGVPEKQSWYQQSGQGMLASIKIAEEKKGV
ILTDRGTYIKYEANEKGKPNLVIVNEGDDSLKNFYSVIATNPKHCKNVNYTEAKKFINWL
TSDDTLSFISGFKLLYKPLFVVDAKTRKD
>fig|195.2024.peg.521 hypothetical protein
MFDEKIINTMSDKVNELIEKYNEVCEANENLRNELVSVKAQNEAKSNQIMRLEEELKSRN
IESEDIFKKIEAVLGK
>fig|195.2024.peg.1042 Aminodeoxyfutalosine nucleosidase (EC 3.2.2.30)
MKIAILGAMSEEITPLLETLKNYTKIEHANNTYYFANYKNHELILAYSKIGKVNSTLSAS
VMIEKFGAQVLLFTGVAGAFNPELEIGDLLYATKLAQYDLDITAFGHPLGFVPGNEIFIK
TDDKLNNLALEVAKELNIKLRAGIIATGDEFICDEAKKAKIREIFNADACEMEGASVALV
CDALKVPCFILRAMSDKAGEKAEFDFDEFVINSAKISANFVLKMCEKL
>fig|195.2024.peg.681 Altronate dehydratase (EC 4.2.1.7)
MKKIMGYRREDGKFGLRNKVIIIPSVHCANKVCENIARKCNGAVYINHQHGCSQLEFDAL
QTRDVLIGHGSNANVFGVLIVGLGCEVIQAKVVAEKIKEATPYKKVEYLVIQECGGSKNT
IEKGIKIVNEMLESAAKLQKSEGDFSDLILGTECGGSDSYSGLSANPALGSLSDFVIDEG
GAVILAETTELIGCEAILAKRAKNDEIAKKVYDKILGYENLVKSFRADIRGANPSPGNIA
GGLSTIEEKSLGCVYKAGTRTLMDVIDYAKPIVSKGLTFMNTPGNDIEQLSAMVAGGANI
CVFTTGRGTPTGSAIVPTIKMSSNTFCYENMNDAIDINAGSIIDGVKTKEEVRDELIELI
VRISDGELVKAEINEQNDFSVWRLATTC
>fig|195.2024.peg.292 Signal transduction protein CetB, mediates an energy taxis response
MSREIFLQEDSLITSKTDLKGKIVYANDDFLKYAGYTMGEVLNKPHNIVRHEEMPKTVFK
YLWDYMREGKEIFAYVKNKTKDNNYYWVFANVTPSIDINNNIIGYYSVRRMPNKSAISTI
ESLYSDLLRAEQQQDLNKGVEMLKNFCKDADKTYNELIFSLQETR
>fig|195.2024.peg.189 Transcription-repair coupling factor
MQANFFEYLQDSNIAQLVLCEDDKESFLLSQVALFKDLKTFVLPDFRAEFGDDLRAFSKE
LFELCKVLNAYHKEKDTKILISPLSTILKKLPGQKHLKNYKLSKKNVFNLSEFKNELNKL
GYEFVDMVQDKGEVSIRGEIIDIFCINEELPTRVLLFGDELESIRKFDPMNQKSFPKEYE
ELEICPFLTYFSEENYENFKDKLENFNSDVLINDINSLGFWCINDFCDYLELDFISIKKF
NQEEWDKDLSKINAKIIPQASVYKDLKSSYNKDFFSLQQNKKITILAKNEALFKALELEN
TQNISFQKSDLILNLISNQELIISLNHKEKQKYKRKANLIIDELKIGDFIVHEDYGVGKF
LGLEMISISGAKKEFVAIEYQNSDKLLLPVENLYMIDKYLGASGGIPLLDRLGKMTFIRL
KERLKTKLLAIASEIVIMAAKRALIKPKEIKIDYADQAYFVSKAGFSYTQDQNKACEEIL
NDFENGKVMDRLLSGDVGFGKTEVAMNAIYPVVKSGFCAFFFAPTTLLSHQHYKSLKKRF
EPFGIEVFKLDRFTSTKEKKTLMLNLEQNKACVVIGTHALLNVECENLALVIIDEEHKFG
VKQKEKLKELTQNSHLLSMSATPIPRSLNQALSSIKSYSVLQTPPEDRLDVRTFVKENDD
ALLKEAITRELRRGGQIFYIHNHIASIEQCKKHLLDLFKNLRILILHSKIDAKIQEEEML
KFENKEYDLLLSTSIVESGIDLPNANTMIVERSDRFGMADLHQLRGRVGRSDRQGYCYFL
VENKEELTQDALKRLVSLESNSYLGAGSVLAYHDLEIRGGGNLLGIDQSGHIEQIGLSLY
LKMLEDELNALTKKESFEEKKIDLKLTINAFLNSELINEDRLRLELYRRLSKCKNIDEVY
EIEGEIEDRFGKLDLYTKQFLMLIIIKILALGKFKTISNFEQNIQFVKINDEKEFIKARS
KDDDDIIEAVLTHLRKDK
>fig|195.2024.peg.324 Riboflavin synthase eubacterial/eukaryotic (EC 2.5.1.9)
MFNGLIREIAKVKSYQNNVLNLKANYRPNLGDSVAVNGACLSVTKLHNDGFELELSHESR
KHIAVQNLKDKVHIEPALRYGDRIDGHLMQGHIDFIGRLEKIEKDENGVDFYIALPKEAM
KFMARKGSIGIDGVSLTINEIIENGVRLTIIPITFKETLFKEYEIGREINIESDLLARYI
YAQMQDKDKGLSWEEVERIAYLY
>fig|195.2024.peg.346 HtrA protease/chaperone protein / Serine protease (Protease DO) (EC 3.4.21.-)
MKKLILSLSLASALFAANINFNETSITSNRVNPAAGDVVLSYHNSIRDAKKSVVNISTSK
TITRANRPSPLDDFFNDPYFKQFFDFDFPQRRGGNDKEVVSSLGSGVIISQDGYIVTNNH
VVDDADTISVSLPGSDTEYKAKLIGKDPKTDLAVIKIEANNLWAITFTNSDDLMEGDVVF
ALGNPFGVGFSVTSGIISALNKDNIGLNQYENFIQTDASINPGNSGGALVDSRGFLVGIN
SAILSRGGGNNGIGFAIPSNMVKDIAKKLIEKGRIDRGFLGVTISALQGDTKKAYKNQDG
ALITDIQKGSSADEAGLKRGDLVTKVNDKVIKSPSDLKNYIGTLEIGQKISLDFERDGEN
KRVDFILKGEKENPKAVQNDLIEGMTLRNLDPRFKERLQIPKDVNGVFVESVKDKSRAKD
SGFKEGDIIIGVGQSEIKNLKDLEQALRQVKKKEFTKIWVYRNGFATLLILK
>fig|195.2024.peg.234 GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase (EC 2.4.1.293)
MPKLSVIVPTFNRSSLLQKAVQSILNQDFKDLEIIISDDNSSDDTKSVVENLQKSDKRIK
YFLNQNYKQGPNGNKNNGLDKASGEFITFLDDDDELLPYALGVLMQKVDEGYSHVFGNCL
IEKEGILSDEFSGRGLQKEDEISKKDFLMQRFSGEFFSVFKASLLKNKRFNEEFYGNEAT
LWVNLYEEKSFYIHKAFRIYRVFRKDSVTLGASKNAHRVHLGYLELAKILENELKASGDD
DYRKTCASYYKMAAYYAKLSANYKALYHCLFKSLSIKINAPALILLTLSIIPSKMIEKLS
KIRVALCKN
>fig|195.2024.peg.1326 Putative H-T-H containing protein
MTKKSKRDMAYELDIDVSTLYNWRKYKPNLYRIVMLGFKFDELLENSKKTHEELLHIEQT
IQDEIAKFK
>fig|195.2024.peg.514 Methyltransferase (EC 2.1.1.-), possibly involved in O-methyl phosphoramidate capsule modification
MQKLVEQVWDYTKHAKFYSYRPNYAPKTIDMLISLVGKNDIKVADIGAGTGNLSIMLLER
GCKVVSVEPNDAMREIGIERTKGEKIEWVRATGLNSTLQNSEFDWVTFGSSFNVMDRNEA
LKETHRLLKSEGYFSCMWNHRDLNDPIQKIAEDTIIEFVPNYTRGTRREDQRPIIESRKD
LFDNIVYIEEDFYFHQSIENYINAWKSVKNPYWDLETEEGNELFNKISDKISQRLPKEFS
IKYTTRCWSAKKI
>fig|195.2024.peg.1234 Exodeoxyribonuclease VII large subunit (EC 3.1.11.6)
MKVSELNLKAKALLETHLNDIVLSGELSKITMHGSGHWYFDLKDEKSSIACAMFKGANLK
VDFQPKVGDFLELVGSVSLYAESGRYQFIASSMKKAGMGDLEAQFLALKERLQKEGLFNS
EYKKTLPQFPKKIGIITSKTSAALQDMLKLINQKEYFLAKIYVFNALTQGSGAVYSLIQA
LKKADEIGLDVIIIARGGGSREDLFCFNDEGLAREIFKAKTPIISAIGHEIDYVISDFVA
DFRAPTPSAAIDTLLYSRLDLEQGLDLLEEKLTKLWESKLEYCENLLSNLHKFFKAKSLE
TMIEAKEKQLAFLLKQAKIIIESKIQKAELELQKLQNAFFQHENFFKKSKNLISIKKNGK
IANLEELKSEDIITLSSQTLQKEAKIL
>fig|195.2024.peg.1661 RNA polymerase sigma factor for flagellar operon
MQKEPPKAYAQMIKDEQDQLVLSYMPALRAMAFRLKERLPSSIDVNDLISIGVEEMIKLS
RRYDKEQNDSFWGFARKRVNGAMLDFLRSLDVMSRNNRKIIKDIDILIDEYFREHEEEPD
DEYLAKKLDLDVEKIKEVRTAHAISYTLPIDDQLELYNEDDTLEKLEKEQLLEKIHEVLE
DLKERDQLIIQLYYYEELSLKEISEILEISESRISQIHKKLLKKLRERLV
>fig|195.2024.peg.305 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (EC 2.1.1.14)
MKNSIISYPRIGANRELKFAIEKYFKAQSSKEELLETAKNLRARHWKDIQNAGIDFIPSN
DFSLYDNVLDVAVLFNITPKRYKDLNLDPLDEYFAQSRGYQGKNGDTIALAMKKWFNTNY
HYLVPECDDASIIALSGDKIFKEYLEAKELGIETKPVLVGIFTLFKLIAFKDENTKQLAK
DKLLQAYIELLKKLNSLGVAWLELDEPYLVYDLNQEDIALFEEFYKELLKHKGEVKILLQ
SYFGDLRDIYTKLLESDFDALGLDFVEGKESLNLIQKHGFANDKILFAGIVNGKNIYAND
YAKSLKLIKELQKYTQNIVINTSCSLLHVPYSTEFETKLDSSYLKLFSFAKEKLKELQDL
KAIINSNEENPLFKANQELFKNIPNRLDEKVKARLQTLKKEDFVRKPEFKERIQIQKEFL
ELPVLPTTTIGSFPQSADVRSNRLAFKQEKISAQNYTEFNQQKIKECIQIQEEIGLDVLV
HGEFERNDMVEYFGENLKGFLFTQNGWVQSYGTRCVKPPVIWGDVSRTKPITLAWSKFAQ
SLSKKIVKGMLTGPVTILNWSFPREDISLKESTEQIALALRDEVLDLENAGIKIIQIDEA
ALREKLPLRKSDWHSEYLDWAIPAFNLVHSGVKTKTQIHTHMCYSEFSDILKEIDAMDAD
VISFEASRSNLNLLDTLKAVNFQTEVGPGVYDIHSPRVPSVEEISSTIEKILNKLPKEQI
WINPDCGLKTRGYEEVVAALKNLVIATQKIREKL
>fig|195.2024.peg.1579 Flavin prenyltransferase UbiX
MKILLGISGSSSTHLGLKLLKNLENKCELYCIITEGAKISFEAENKKNLEKICQEQFQNI
CFLNDNNLSASVASGSFSIEKTIIAPCSISSLAKIHAGLADTLLMRAAAVALKERKSLIL
GVREMPFSTLILEHMHKLSQLGVIIAPPIIASYSHASNLEQMENFIIGKWLDLLGISHNL
YERWQNF
>fig|195.2024.peg.919 DNA protection during starvation protein
MSVTKQLLQMQADAHHLWVKFHNYHWNVKGLQFYSIHEHTEKAYEEMAELFDDCAERALQ
LGEKAITCQKTLMENAKSPKVEKDCFTPVEVMELIKKDYEYLLAEFKKLNEEAEKASDTT
TAAFAQENIAKYEKSLWMLSSALQNTCKM
>fig|195.2024.peg.802 Probable integral membrane protein Cj1412c
MDREVFYIAGYDPKSYRFYYDLFKKNLKDYSHRFDFKAEISGIEKNENFPSFKIDCKDVQ
TRYHFLTWNDIVKKNWSQSYKDALMDCYSFFRIYTITGLFLKFGKESIYQLVTGYYPFFY
VIFSLLLSLGLALGSFVFLQNHIPSFLAIVIGIVLGFLLNRFLFKLGRKLAVFWIARICA
FCATWKEKRLGAMEQRIKLFADEILKSLKQNENRQDYELILVAHSVGTIVCIEVLEHILK
QNLDKRVLDKLKILTLGECIPLTSYQKNSDDFRKKLEFVSAFDLKWYDYTSIIDGACFPQ
VDFFRTSGVQANFTPPFLSAKFHTLYEKNEYKKIKRDKNKAHFLYLYSPHIKGSYDFFAF
VVAPKFLEEKVKI
>fig|195.2024.peg.850 Flagellar P-ring protein FlgI
MRVLIFFLLLMTSVFATQIKDIANTVGVRDNQLIGYGLVVGLNGSGDGTSSKFTLQSISN
LLQGMNIKVDPNDIKSKNTAAVMVTAKLPAFAKSGDKLDITVSSMGDAKSLQGGTLLLTA
LRGIDGEIYAIAQGSISTGGLTARPGGAGSHSTAATVMGGANVEREIPQNFSQDSDLTLS
LKVADFKTASDIERILNTIFEEDVARAIDSRTVKLKKPEDLSNVDFMARVLEQDIAYTPQ
SKVIIDERTGTVIAGVDIEVEPVLITHKDITIKIDPNNNAAAAQNEIDMKDGGFVDPNSN
TLRINNAKSTVANIARMLNKLGATPNDIIAIMENLKRAGAINADLEII
>fig|195.2024.peg.996 6-carboxy-5,6,7,8-tetrahydropterin synthase (EC 4.1.2.50)
MIIRKLFEFENAHIVRFCSSSRCKSSIHGHSYKVEVLLESKYLDNAGMVYDFGLLKTHMR
QIIDSFDHAITLFNQDDESYLNEMKKYSQRWISLPVNVSAENFCRVFFILIDALLKQTKM
INGEQGVNLQSIIVHETRTGYAQGFKEDAYSPTMPKITLEDIEFSPAIKAEWNDIEFYDK
LKNLHIFTNPKEV
>fig|195.2024.peg.539 Lipopolysaccharide export system protein LptA
MVRKIILFLMSISISLASQIEVKALNFYSDENKGESILSGNVEIIRGDDILTAEKVIIYT
DKNRKPMRYEAVQNANFKIVLKGKTYKGSGDKFIYNVAKDIYEIDGNAFINELESNQKLY
GDRIIVDKRNNVYRVESKDKKPARFIFDLEQK
>fig|195.2024.peg.1551 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (EC 6.3.2.10)
MLTNTLYFINSLFFNFCVAFYLMSALQWYSYKFKRVFFHYHRPLWHLYFLFLPYFFFLTF
PLYSLAYFALIHTPILYFWNKSIDKKLVFTSKIKWFFVFVFIYNTLFAILALRFSFLFNL
FALPFALISLKIFELFSNLYFKNKAKAKLQNNPQLKIILITASFGKTSIKNFFYELLKDD
FKTYKTPRSVNTLLGIIADINTNLSDDTQIYIAEAGARVKGDIDVITRFLEPQICIVGEI
GNAHLEYFKNIENTRKTKLEALNSKRLEKAFLHTSTQKSEDELILLYDDKLQDIQASLQG
LEFKINLENKTYEFKSQILGDFNAQNLCACVLCANYLGVKIEKIQKQVLKINSVEHRLQI
ISKEPKFIIDDGFNGNYKGMSASYKLCKNYKGRKVLVSPGIVEVDKDENVKLAKIINECF
DLAIITAQVNADIFKKELKIKTIILKEKADLVKVLAKETQQGDLILFSNDAPSFM
>fig|195.2024.peg.403 UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase (EC 2.3.1.191)
MRLKEIAEFLSLEYEGEDIEITALNSLLRANFTELTYCDGERNIKDIPNTGAAAILVAKE
YENLVPKDTKALITQSPHLCFAFLSKIFAKPLFSNAKEKVQNIAKSAKIMPNVYIGNNVN
IGENVVIMAGAYIGDNVSIGEESIIHPNVVIYNDSKIGKKCHLLANCVIGSDGFGYAHNK
NGEHYKIYHNGNVILEDFVEIGACTTIDRAVFDSTIIKAGTKVDNLVQIGHNCDIGQNCI
IVAQTGISGSSELGRNVVMGGQSATSGHLRIGDFSTIAARGGVSKNLEGGRVYGGFPIML
QKDWLKLQAKIAMKFKE
>fig|195.2024.peg.1073 UDP-N-acetylenolpyruvoylglucosamine reductase (EC 1.3.1.98)
MIIDFKKYSSVKIGGEFEVEVLEQIREFDGFLIGGANNLLISPKPKNIGILSDNFNFIEI
LEQNKDFLHLRIGCKTKASQMYRFSKENNLYGFEYLSKIPGTLGGLLKMNAGLKDECISQ
NLVKIATSKGEILRENIDFSYRFCPLNMPFFWAEFKLGFGFDKIKDENLKNARNNQPSGA
SFGSIFKNPKGDFAGRLIEAVGLKGFSKGDAMLSDKHANFLINKKNASFDDAIFLIELAK
KKVFEEFGIKLEEEVIII
>fig|195.2024.peg.230 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase (EC 2.7.8.36)
MYEKVFKRIFDFILALVLLVLFSPVILITALLLKITQGSVIFTQNRPGLNEKIFKIYKFK
TMSDERDEKGELLSDELRLKAFGKIVRSLSLDELLQLFNVLKGDMSFVGPRPLLVEYLPL
YNEEQKLRHKVRPGITGWAQVNGRNAISWQKKFELDVYYVKNISFLLDLKIMFLTALKVL
KRSGVSKEGHVTTEKFNGKN
>fig|195.2024.peg.1291 6,7-dimethyl-8-ribityllumazine synthase (EC 2.5.1.78)
MTIIEGKLNLDSNTKIAIINARFNHIITDRLVEGARDAFLRHGGKEENLSLILVPGAFEL
PFALKKAIESKKFDAICCVGAVIRGSTPHFDYVSAETTKGIANVSLNHNIPVSFGVLTTD
TIEQAIERAGSKAGNKGFEAMTTVIEMLNLSKEF
>fig|195.2024.peg.1092 SSU ribosomal protein S17p (S11e)
MAFKREIQGVVVKIAGEKTASILVERKVVHPRYRKIVKRFKKYLIHDERNEVKVGDTVVA
VECRPLSKRKSFRLKSVLATGVE
>fig|195.2024.peg.274 Peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8)
MIKTIDTSKVNEYKFALIETEKGTMKLKLFGDEAPQTVCNFATLANEGFYKDLNFHRVIP
NFVIQGGCPHGNGIGGPGYEIICECDDQEHKHERGTLSMAHAGRDTGGSQFFICHSPQAH
LDGVHTVFGQIDPKDEESLEVLDSIRQGDKIIDIKICDKI
>fig|195.2024.peg.1296 Tryptophanyl-tRNA synthetase (EC 6.1.1.2)
MRVLTGLQPSGDLHIGNYFGAIRQMVEVQEKSEMFMFIANYHAMTSSQDGKKLEQNSLKA
AAAFLSLGIDPQKSVFWLQSDVKEVMELYWILSQFTPMGLLERAHSYKDKVAKGLSASHG
LFSYPVLMAADILLFDTQLVPVGKDQIQHVEIARDIALKVNNEWGEIFTLPEAKINEEVA
VVVGTDGAKMSKSYQNTIDIFASQKALKKQISSIVTDSTALEDPKDYQNCNVFKIAKLFL
NEVEQKELQARYEKGGEGYGHFKMYLNDLVNEYFKEARMKYDELLEKPSHLKEILELGAS
KARKIAQEKMQKIYEKIGL
>fig|195.2024.peg.382 Membrane protein
MDIRSDEISELILPESKEKKGYLVYLKIIFIPALLYVFILLGYYDIINFKVELHTVVMIG
FIFFTALVFARHSSEYAYSIFEQQKDEFKQALKRHIMKHFLTIGKDTKSNANFDDFAYAY
VRGARNENFASIGAAIFPMMGILGTFISIALSMPNFSSSDTAALEQEIALLLSGVGTAFY
VSIYGIFLALWWMFFEKFGKSKIERLLNRQKNSTSGFFWTKEELDQRYLSESLQHFEKIS
AIFKQVSNQDFFAELDHTIDRKFGIFQDMLNVEEKAIRLSGEHIKQTMGELSRAQRDQRD
LGKMYGEMLNGIGMLNQNLKEINMRMSEQYNRLLDISSEKIQHFDKTLLAFDEKVDRFGK
NFELYEKAILESQEKVFEGFKASLFEGMHKFKEVYEEEKSIDAKIKMMDKLKQEIKNLNE
ETNEVMAKIGKIPNPAQEEQDNIENEILSSEKITENTEQTKENQNDSDTLDSNKNFNKEE
KEDK
>fig|195.2024.peg.1680 Integral membrane protein
MEELTKEQRQIIEEEIKKEIKKADTFLKPESINKIIQDIIGDIKGKINNKFKCPKNLEEI
LSSIPQKVYVSLGKEEIKQILKLDFCCFVDNVFYIDSAPKIEPYEHNQNKTAIEEQRIIQ
CSYDDLLYLFKTYPLIFNHCIFDYKIDKKTPIEQIKKLSFLNCNFKKEVYLNFQECLDSF
QMDNCVFEDRVTIKGKFNDNVYFNNSIFKNYADFHECEFEKTANFYGVRFNKTPNFSQAI
FRGNLNAVNANLNFTFDDLQERIKQEYEDFNKNIENKKSLDKFANDFRDSFRTFKNALIK
DNNLLDASNFHKYELYCKEIELKQNWDKRGENVKNTTDLEKNVSRIRDFMDFLLLGFYRK
LCDHHTDFLKVFNNLILLIALYALFVFGFTWLHDDKLEDTRAILTLFGFFDKFRLYFDII
STIFVVFGCGFFVCKLDSYEKKNNVSKKQNINFIYIIGDFLNLIKSLLFASFIPCVFYVL
FLLFGFFLNLGKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFSYIVFIIMLIKQP
NVIHPLIGKIANESDKFFNYPSLIVLNILYTILLALVLFSLQKTARKNSIVPS
>fig|195.2024.peg.576 Putative periplasmic protein
MQIKQFKAILLILIFSINLYANNTNHTIDEILSQTKNKSALSNYASKKDLKLLEQKLKEH
KNVGIRIYGDSHTAADFFPRVIRGYLIKSNSIGFAYPLQPKYQQNLNLDYSYKDYEILNS
RNTDTAGIDFPLGGIIAKAKEKGAKITLDTNLDKKNFKVGFVFKAPNNTNAFSIKDAQNK
SYELRSVANKWSYKEYELVFPLQISALQKNAQLGGYFITSKEDNVYLDTIAINGAKSDLW
MSWNKKVSEQELKLLSNDLILLAYGSNDALFKGFEKNKFKKNLKDWIHTLKTYNKNALIM
LVSPPTVVKKQGKKYTLAPDFFAIRQALYEVAKEEKTLLFDMHQFMQDSGGKNKWIEQKL
SLQDVHLTIKGYELMAKKLLDDLKKYVHY
>fig|195.2024.peg.592 Quinone-reactive Ni/Fe-hydrogenase large chain (EC 1.12.5.1)
MSQKIIVDPITRIEGHLRVEVVVDDNNVVKEAYAGSTLWRGIETIVKGRDPRDAGFMTQR
ICGVCTFSHYKAGIVAVENALGITPPLNALLTRTLMNAALFLHDHIVHFYQLHGLDWADV
VSALSADVKKASDEAFKYTSNPYATGADKLLEVQQRLKTFVDKGNLGPFANAYYGHPTYR
LTPEQNLIVLSHYLECLRIQRIIAQCMAIFGAKNPHPQSLTVGGVTCVMDLLDPARMGEY
MVKFQEVQDFVNRAYYPDLVMAGKAYADEPSVLNDIGVNNLYTFQEFQLGRDEWLFESGI
IKNGDLSKVYEVEEDKITEEATHSWYADNEPLHPYEGKTNPNYTGLVEGESVDHHGNTVH
SKVFDTKGKYSWIKAPRYEGNPMQVGPLANIVVNYAKGNQNVVPVVDEFLKETGLPLNAV
FSTLGRTAARCLEAKIVANNALKAFRNLVENLKVDESTCAPYVIDNSKEYKGRYMGHVPR
GTLSHWCRIKNGVIENWQAVVPSTWNASPKDANGVGGSYEQCLIGLKIADVKQPLEIIRK
IHSYDPCIACAVHVMDTKGNNLSEYKVNASL
>fig|195.2024.peg.654 Putative carboxyl-terminal protease (EC 3.4.21.-)
MSSKRFLAAITGFTGSLALCVFLASNLQAKPKNPSDLMQQRLESLDKLTKTLAIVEQYYV
DDENITDLIDKSLSGLLSNLDAHSSFLNEKDFNDMKIQTSGEFGGLGITVGMKDGALTVI
SPIEGTPADKAGIKSGDIILKINDEATLGINLNDAVDKMRGKPKTQITLTIFRKGATKPF
DVTLTRDIIKVESVYAKLIEDENILYLRVTNFDKNVVDMTSKELKKHPNVKGVILDLRNN
PGGLLNQATGLVNLFVDKGVIVSQKGRVTSENQEYTANPKNKISNSSLVVLVNGGSASAS
EIVSGALQDLKRAIIVGENTFGKGSVQQIIPINETEALRLTIARYYLPSGRTIQAVGVKP
DIEVFPGKVNTQEDGFNIKESDLKQHLESELEKLDKNEKKEDKKEQKNDKNIITQKQIND
DAQLKSAIDTIKILNIKQGQ
>fig|195.2024.peg.1084 SSU ribosomal protein S5p (S2e)
MEKYNREEFEEVIVDIGRVTKVVKGGRRFRFTALVIVGNRKGLVGVGYGKAKEVPDAIRK
AVDDAFKNIVEVKTKGSTIAHDVEVKYNASRILLKPASEGTGVIAGGSTRPIVELAGIKD
ILTKSLGSNNSANVVRATIKALTMLKG
>fig|195.2024.peg.1600 hypothetical protein
MQLSIRKKMLMLGAICFISMLATFAIFYYNNLQGSQKIAQTTKI
>fig|195.2024.peg.485 KH domain RNA binding protein YlqC
MVENFLREYAKLIADYPDKIATEKIKLDENFAEIILYADKIDTGKLIGKNGKMINAIKTV
VSACKSKDSMSYRVTVKALE
>fig|195.2024.peg.859 Transformation system protein
MNIEERVRELEDKYKRYLLKKYFKFLFIFAILIVCMLISFFMVQDFYKQKALALEALEYK
KTLNWQITQAQIANEKNKILQERLSKDESKDELEEELKTQIDIYSKILNISDLKRSFYQN
PSYQKAMNLATQYYENKDYEKSIFWSLKANDIDRKNSDSWVLFAKAKQALGKDEEAKQAL
DTYVSYYGLIEFDKEIDD
>fig|195.2024.peg.475 Membrane protein
MKAINLFLLAAMIGIELILGIVVAPVIFYPANLIGEGVLSHFQSGLMMTQIFIKMGYLLI
FVSIINLLFEIYSFAKEDMKFQIKFSKLMLTILILILSLVFVLYFTNTIIELQNLGEQAT
KSQEFLSIHNASEVVIKIILLMQVFLYFLSFKIAKKC
>fig|195.2024.peg.1587 Membrane protein
MNLSFKTFDLSSKERQKAKKVQGKKYEIFLNENPQTHNAFKVSFREVLRYYYLYPKNAKA
TFKLPFFKPNLKYVRTPHITWLGHSSLFVSYKNYKILIDPIFNTHASPFSFINKAFKNAP
VYNANDFDEIFAVIITHSHFDHLDEKSVKTLKDRAKFFIAPLKVGNYLKSYGVSEKKIIE
LDWWSGVEFDDLRIVATPAQHSSSRGDGLNKTLWASFVMEFLSADKRVFFSGDGGYFTHF
KKIGAYFGGFDLVCLESGQFNAAWPFSHSFPDQILKEAKDLNAKALMPIHWGRFLAGTHA
WNGVVEYLYENSNLPLITPKMGEAYEVGSEFEQDFWWKEG
>fig|195.2024.peg.1696 Acetyltransferase, GNAT family
MPKFEITTLKREELDILLEMIKEFAQYEEMEDSLQCSKEKLETSLFDNQFARAFLLKEDE
NIIGYMIYFYTFSSFLGNGGIYLEDIYIRKNFRKKGYGRAVFKFLGQICKKENLKRLDWV
CLNENILGINFYEGLKAQHLKQWRNYRLSGENLEKLCEL
>fig|195.2024.peg.1650 integral membrane protein
MDINTVLMMISDKIPSNSLPLVQDKLKNASEDKINSLAILPFKSHIIGLILGLFLGAFGI
DRFYKGDIGLGIAKLITWLVGVVTIWIYIGGLILFVLWIWCIVDWFLVWKGIKKDNLNKI
LAVL
>fig|195.2024.peg.765 Phospholipid ABC transporter shuttle protein MlaC
MKKIFLILALSLNIFALQLDEISNTMQKNINKSLQLLQNNKEDKKQAADGIFLIFDHIID
YKLMAQLSLSKDYAKLNPKEQEKFASAFEASLKKSFTDKLDLYKDQVLMVKNGELKNAKR
YFLTSSMILDGEEKNIIFKFYNNNNDWLIYDIDVLGVSIVQTYRSQFGDILANQDFDTLL
QKLENITIE
>fig|195.2024.peg.1118 FIG00638667: hypothetical protein
MKTKIIPAILACSAILASANMVPASTQTPAVAPAPLHPYPAYPQQAMPPQDYFNGLPKNI
NSQIQNLHPGAFIVDVDWEEYGYEVKLNNFMELYFDRNGNFLGQKFDD
>fig|195.2024.peg.847 hypothetical protein
MKNLELRIFRFDKQKDYEAYYKPYVYNNYENFATLYDLLLQVQNDDIYFDFEKNDKSYIV
VNKEFLPLNTPLDILVKKYDFNLIIEPLSTKRSVKDLIINKDDFLEKFKYLAPFANEEDK
KLYEKYDYLYYSSEILDFLPEYMGDAVFYLTSKMIEKYPDKKIKILKTICDTQKGIFYHL
TSKNEDLENTIKNLQKEIIDLKLINEAALEFDLPKINAFDNEIKELGEVKYDFDNFNIAC
YGFKIKDDIKSKIKAHFISYENSDKNNGFSLLQLNPELSYKMAANIILDAYDSGADFMVV
NQAKDFYMFDTCSKKLMQSSGREFKDFYVLSYFEFLSLIQGIKNPSLQNHDLKVSLI
>fig|195.2024.peg.671 FIG00469900: hypothetical protein
MLKFFFTISLSSLLFAQNFIDFASQNNALKQEQNTSKENTPLKRIKIPTH
>fig|195.2024.peg.1249 Membrane protein
MSNLNFHQMFEIQRQNDFKSIKKLAWVVFISFLLCVCFQFLPIILDFAYDLKLLKFNSNT
NILAMVFNAIFLISYLIMILKLYFVSQSKVLLISFFIAAFTQFIALLSLNYLIASPVVDK
ILRIFLYGFSFLCLAIAIFCTFIFFKTLKTLCENKIYFKLCFIFKSAILIIIYILMFVLI
YSEHSLALIIAYFMIFFFAGLLFTIYYALFAFALSKNQNIKLSQT
>fig|195.2024.peg.981 Putative lipoprotein of ferric iron transporter system
MKKLVLFLFCLGFAFACSEHSNADFKDHDKTKYNSQYKDK
>fig|195.2024.peg.349 Inner membrane protein, KefB/KefC family
MDNFLEIFLITAALAIVLNVIFKKFEIPTIIGYIAAGEIISKIYHLSGKGEITHIAEFGI
VFLMFTIGLEFSFKHLIAMKQEVFLNGSLQMLTCGFVFMLLAIGILGLGDKSATIVGFAL
ALSSTAVVLKILNDNGDINEQYGRKALGILLFQDIAVIPLLLLVDIFSSNNQNIGQLLLT
TLLSAVILIALLFFIGKYLVDRIFRLIIRASSQEIFISTILFMVIGASFLANYFGFSYSL
GAFIAGALIAETKYKHKIEADLIPFRDLLLGLFFITVGMQIQLHIVAQNWFIICVLTLLI
MGLKFGIVCGFLFLYTKKRVALKTAFSIAQVGEFALAIFSLLQAKSMLDVETAQILIVVS
IVTMIITPFVLNNIRKIANVVEDMTLNTNVVQQSTHSTLKNHLVIFGYGRLGQEIVQKIK
NTGVPYLVLESDLNLVELGISRGENVVFANAAQEETLKIANITECAVAIVTITNEAKLEM
ICQVLASYPKPIDTIIHVNGSLEKMLFSSIDENIRIVRSEKVIARNLVQEALECRIHKNT
>fig|195.2024.peg.1705 IMP cyclohydrolase (EC 3.5.4.10) / Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3)
MRALLSVSDKEGIVEFGKELENLGFELLSTGGTFKLLKENGVKVVEVSEFTKSPELFEGR
VKTLHPKIHGGILHKRSNESHIKQAKENGILGIDLVCVNLYPFKKTTIMSDDFDEIIENI
DIGGPAMIRSAAKNYKDVMVLCDPLDYEKTIEALKKGENDEKFRLNLMIKAYEHTANYDA
YIANYMNERFNRGFGASKFIIGQKVFDTKYGENPHQKGALYEFDAFFSTNFKALKGEASF
NNLTDINAALNLASSFDKAPAIAIVKHGNPCGFAIKENLVQSYIHALKCDSISAYGGVVA
VNGTLDEALANKINEIYVEVIIAANVDEKALAVFEGKKRIKIFTQESPYLIRSFDSYDFK
HIDGGFVYQNSDEVGEDELKNAKLVSQREASQVEIQDLEIAMKVAALTKSNNVVYVKNGA
MVAIGMGMTSRIDAAKAAIAKAKEMGLDLQGCVLASEAFFPFRDSIDEASKVGVKAIVEP
GGSIRDDEVIQAANEYGIALYFTGVRHFLH
>fig|195.2024.peg.186 Hydroxymethylpyrimidine kinase (EC 2.7.1.49) @ Hydroxymethylpyrimidine phosphate kinase ThiD (EC 2.7.4.7)
MKAKGSDLIPVLSIAGSDCSGGAGIQADLKTFSAHNLFGMSVVLSVVAENTARVISVHDI
PVQSVDEQMLAVFEDIVPKATKIGMIGTCELMECVARNLEKFKPQNIVIDPVMFAKNGFA
LMPQENCDFFKKTIVKFADILTPNIPEAEFLCDFKIKNEEDMIKAAKYLCTQGAKAVLLK
GGHSEENANDVLFDGNEIFILKGERIETKNTHGTGCTLSSAIASNLALGKDLYNAVSEAK
EYVRNAIYYSLNLGKGCGPTNHFFRFLNEK
>fig|195.2024.peg.1560 AzlC family protein
MKQRELFLLTIPVLMGYIPLGAAFGILAASKDFSLFEILLSSIFIYAGAGQFLLVALVAQ
NVSFLMIFFTLFLLNFRHFFYTLSLLKELKSINFLRHYIIFALTDESFALLSSIKEKIKN
LSRAQRSLIMFEVCLLNQIYWVIGSVLGYYFKQGLNIDYSGVEFSLNALFIVLAYELYKQ
NPNLKILLYSSFVALFALFCIDKPYMLAFCIFIALMILIFGKKYVR
>fig|195.2024.peg.146 N-succinyl-L,L-diaminopimelate desuccinylase (EC 3.5.1.18)
MNAKEFLIELLKFKSVTPNDDGALNFIAMELSDFEAFFIEKKGIKNLLLTKKFKDEGEHL
AFGGHVDVVPAGEGWKNDPFEPLEEEGFIYARGAQDMKSGVAAFVDAVKNADFKGARLSL
ILTSDEEGEAIYGTKAVLEWMQERDMLPDYAVVAEPTCVKKIGDSIKIGRRGSINGKLLI
RGKQGHAAYPEKCINPVHDFAPVLKLLAGFDLDPGSAEFSPSKIVITDIRGGMGVCNVTP
NDLKLMFNVRNSPDTSLEDVKSYVEKICHGLNYELELKQSSEPFLTSIDNKIVQKMNESV
QKITHEVPELNTKGGTSDARYFAKYGVKVVEFGVCNDRIHAIDERVSIEEFEKLCLVFKD
LVENFN
>fig|195.2024.peg.261 Cytochrome C553 (soluble cytochrome f)
MKKLLVVSALACLGVSAFAADGATLFKKCAVCHGAKADKVYLNKVPALKSISSAERLQYM
KEYSEGKRNAYGQGAIMKINLKGLTEEDFKAIEAYIETL
>fig|195.2024.peg.144 Sulfur carrier protein ThiS
MIINGEKFELKELKFMDFIKEKGFKIELIALELNGEIVPKSEFENLILKENDKAEIVSFV
GGG
>fig|195.2024.peg.778 hypothetical protein
MSVLVIGADEITPIKAVLYDLGAKKIEHWDARNENRVNRKPIPCDTECIVMLTSFLNHNT
MKKIKNEAKKRKIPLVCAKRSVSCVYCEYCKIFNLDKEFSCSKVE
>fig|195.2024.peg.1040 Nicotinamidase (EC 3.5.1.19)
MKKAFVLVDYQNDFIDGSLGFDKALKIKENILKALNQIDFNNTHLLLTYDTHDEDYLKSK
EGLNLPIEHCIKDSSGWQMPKDFTPFLQKAHKVFHKNTFGSLEFANFIAKSEYEEIHFAG
LVSHICVFCNIILAFSAKPNSRLILHQNLSASFDENLEKSAFDLLRAYGIEIL
>fig|195.2024.peg.965 NAD(P)H-hydrate epimerase (EC 5.1.99.6) / ADP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.136)
MKTITDDIKTLEQNAINKGLDELILMENAGLNLAKLIKKEAKKIRKQYKIKKVKILFLLG
GGNNAADGLVALRNLKHAKAYKLGFKENEIFKKQEQILKNFGFKFAKKEPKFKKFHIIVD
CILGTGTNREVDEKTKEILEKVNQSKALKIACDIPTNLGFTPCFKADITQCMGALKEILL
EDFAKEFVGKIKLANLGINAKKFSLDSKAFLLEEKDLKTIERNTSSNKGNFGHIYIIASA
SAGTLAGLGALNFGSGLVSLVAKKSFSPLLMLKEKIENNASAIALGMGLENLDILKDEIL
QNIPLVLDANCFLSEAMLWYLSRKDVVITPHPKEFIRLYKMCFDEDLSIEDLQRNRFFYA
KKFAQNYDCVLVLKGANPIIIQKEKIFVVNLGNEALAKGGSGDVLSGMIATLLGVKFSAL
EAAKNACLAHALVAKKYKFNKNSFDAIKLIKGLKCL
>fig|195.2024.peg.678 Fucose permease
MTDSKNIKIAIVLVTSLFFLWGVSYGLIDVMNKNFQNHLHISQHESGFLQFAYFGAYFII
ALPAGYIANKYSYKMGIIFGLALYAVGALLIIPATNLASFHLFLFAFFVLACGIGSLETS
ANPYMVKLGDEKNASFRINAAQSFNGLGQFVGPIIGGALFLSITKQEEGASAEQIEAALL
ANMGNVQLVYVGIAAIVILILIAFVLNKLPEGSAVSDDYKQKDDSKPIHVFKHRHFNLGL
LAQFSYIANQVAAGAFFINYVVDHNEGLKDAQAAYYFSIALVAFMLGRIVSTPLMKVIKG
EKILGLYSLINVLICFGLYFTSGFLSTILLIALFFFMSISFPTIFAVATKNLPLNQVKLG
GSLLVMSIVGGAIMPLIIGFINDHYGTGMGYLAMAPLFLYVAWYGFVGSKIKA
>fig|195.2024.peg.275 Probable transcriptional regulatory protein YebC
MGRAFEYRRASKEARWDKMSKLFPKLAKAIQVAAKEGGTDPDMNPKLRSAIATAKANNMP
KDNIDAAIKRASGKDSADIKNIHYEGKAAHGALVIVECMSDNPTRTVANVKAIFSKNGGE
VLQNGSLGFMFTRKAVFHLEKFAGDLEELELDLIDAGLEELEQNEEELVISGDYTAFGEL
SSAIEAKGLVLKKAGLEYIPNNPVSFSEEQLSDIEKLLDKLEDDDDVQAVYTNID
>fig|195.2024.peg.842 Ribosomal protein S12p Asp88 (E. coli) methylthiotransferase (EC 2.8.4.4)
MSKLYLMSLGCNKNLVDSEIMLGRLSAYELCDEPSKADVLIVNTCGFIDSAKKESINAIL
DLHEQRKKDSLLVVTGCLMQRYREELMKELPEVDLFTGVGDYERIDEMILKKTNLFSNST
YLQGENSKRIITGSNSHAFIKIAEGCNQKCSFCAIPSFKGKLKSREISSIIAELKDLVAR
GYKDFSFIAQDTSSYLFDKGEKDGLIRLIDEVEKIEGIKAARILYLYPTSASEALIKRII
ASKIFVNYFDMPLQHISDNMLKIMKRGANSTRLKEMLNLMKSAPDSFLRTGFIVGHPGES
DADFGELCEFIKDFGFDRVSVFAYSKEEDTAAFDMEQVPFKVINKRLKIIEKIVDETIEK
SFEKEVGQKRLVVCTGESSEGEFFIAAKDLRWDREIDGEILINESECGNLEMGQIYECEI
IQNVDKKLIAKALRKIDAN
>fig|195.2024.peg.1231 Tripartite tricarboxylate transporter TctA family
MDTWMYLMQGFSIALDPYNILIALIGCFIGTIVGMLPGLGPINGVAILLPLAFAMNLPAE
SAIILLATVYMGCEYGGRISSILLGIPGDAAAIMTTLDGHPLAKKGQAGKALSISALSSF
IGSFIAICGIILFAPLIAQWSLKFGPAEYFALIVFGLATLGSMLAQKPIRSFLSALIGLF
LTTIGIDGNTGVYRFTFDSPHLYDGISFVVLVMGLFSVSEIFLMLEHTQTSQNIINKTGK
ILVNIKEFFFCFWTIIRSSIIGFFVGVLPGAGATIASAITYMSEKKIAGEKGKFGQGDLK
GVAAPEAANNASACGSFIPMLTLGLPGSGTTAVMMGALTLYNITPGPTMFTDQVNIVWGL
IASLLFANVILLLMNLPLVGIFVKILSIPMWSLAPIIAIVSIIGVYSINSTDFDIILILI
IGILGYFLRKLEFPMAPLILGFVLGEQLETNLRRALSISNGDFSILWSGIIAQSLLIGAV
LIILIPLLIKKIRKSKF
>fig|195.2024.peg.478 DNA polymerase III alpha subunit (EC 2.7.7.7)
MSQFTHLHLHTEYSLLDGANKLKELAKTLKEQGATSVAMTDHGNMFGAIDFYQTMRSEGL
KPIIGLEAYLHNHEDISDKSSRQRFHLCLYAKNEVGYQNLMYLSSQSYIKGLYYYPRINK
KLLEEHSEGLICSSACLQGEVNWHLNIHSERNVRFGAKGYEAAKEAALWYKKVFGDDFYF
EIMRHGIGDQRAIDDDIIRLSKELNIKIIATNDTHYTFKERAAAHEVFMCIAMGKKLNDP
DRLRHSVHEFYVKSPAQMSELFADIPEAIENTQEIANKCNLELNLGNPTPPNFKFTREYA
KEYNISLPEEGKEFSFDNDDVVFDELCKKGLEERLKFVDISKHEEYKTRLEVEINIIKKM
KFSGYMLIVHDFIKVAKDKGIPVGPGRGSAAGSLVAYSLKITDLDPIPYSLLFERFLNPE
RVSMPDIDVDFCQDRRAEVIDYVIDKYGADKVAQVITFGKLLARGVIRDVARVCDMSIPD
ADELAKLIPEELKITLDAAYEKEPKIKEFIERHPKGPEVWEYAKALEGLNRNAGMHAAGV
VISNESLWKKTPLFRQSKNDERHLVTQYSKDHLEDVDLIKFDFLGLKTLTLINNAIKLIK
KRYNKDIIWEAIDVNDAKVYKTIQSGNTLGIFQIESGGMQNLNARLKPERFEDIIAVLAL
YRPGPMESGMLDDFIDRKHGLKKIEYPFDTLESVLEPTYGIIVYQEQVMQIVQIIGGFSL
GGADVVRRAMGKKDPEKMKKLKSEFADGAEKQGYDRVKAEELWELIVKFAGYGFNKSHSA
AYALITFQTAYLKTYYPSEFMAALLTSEENNVDKIAVYIDEMKKMNIKLLPPSVNKAIRE
FSAVEQEDGKDAIVYGLGAIKSVGIPAVENLLEARERGEFKNIDDFLSRIEPTKINKRTL
ESLIKAGAFDEFGYTRKCLFDNMDNLTEGSKKMADARKNAASSLFGEDELTVGLQVNIVA
KNEEFEVMEKLEFEKEILGIYVSGHPLDRFYDKFKEIDYVKSIDFSTLKGSGEILSIGKI
ESFKSMMSKNNKRYGRLEILDFYSTFEVTVFESNIEEIENILKNEASKNEAYGFLLSYKA
EEGKLDSLALRSIKTLEGLQEGEIKAVKKFNAKKNTQENKDFIAEPKEFENNIIELDLSR
LNRELVYEIHEIARSAHNPNEKGNKKLVLKIVSTGSCLLYHTDFVISDSVSEKIINKYAG
>fig|195.2024.peg.1509 Aconitate hydratase 2 (EC 4.2.1.3)
MSFMQDYNKLVEERAALGIPPLPLNAEQTKELCELLKTQNDEKLVSLLQNRVNPGVDDAA
LIKCEFLDGILKNKFQAPAIDKKLALKMLETMLGGYNVKVLIDALKDESIASDAAEVLKN
IIFVHDNFHTVAELSKSNNHAKAVLESWANADWFNKKEKLPQVIQCVVFKVAGETNTDDL
SPAGDAFTRSDIPLHANAMLKVRQTGSLEKIKELKKSGREVVYVGDVVGTGSSRKSAINS
IQWHLGKEIDGVPNKHSGGIVMGSTIAPIFFNTAQDSGALPIICDVSNLEMGDEFEIHPY
EGKIVKNGSVVAEFKLSPNTILDEVRAGGRIPLIIGRGLCAKAREFLGMENENIFTKPEQ
PEASSGGYTLAQKMLGRACGVEGVRPGMYIEPRTLTVGSQDTTGPMTRDEIKELASLGFN
ADFVMQSFCHTAAYPKVSDSNLHKTLPNFMTSRGGVSLKPGDGVIHSWLNRFVLPDTVGT
GGDSHTRFPIGISFPAGSGLVAFAAVTGSMPLNVPESVLVRFSGELQAGVTLRDLVNAIP
YYAIKQGQLTVEKKNKKNIFAGKILEIEGLPNLKVEQAFELSDASAERSAAACSVDLSIE
SVSEYIKSNISLIEAMIEAGYEDKATLARRADKMREWLKNPTLLRADKDAKYAYIIDINL
NDIKEPILACPNDPDDVATLSEILADDKRPKNIDEVFVGSCMTNIGHYRALGEILKDKGI
LKTRLWVVPPTKMDKAQLTKEGYYSIFGAAGARIEVPGCSLCMGNQARVNDGAVVFSTST
RNFDNRMGMGAKVYLGSAELAAVCAILGKIPSKEEYLQIVSDKLSDAHKANIYKYLNFNE
IDNFKLDN
>fig|195.2024.peg.1362 L-Proline/Glycine betaine transporter ProP
MKKSKLGTKEFKILGLSSLGGTLEFYDFIIFVFFAEYIAKVFFPKDMSEFWTLLNTYGAF
AAGYLARPLGGIVMAHFGDKFGRKNMFMLSILLMVLPTFTLAFIPGYETLGFLAPFLLIL
IRIFQGIAIGGELPGAWVFVREHCKEDQKAFSLSCLNSAMALGILLGSMVFLLINAFFST
EEIAAYAWRIAFFVGGIFGIISIYLRRFLQETPIFKQMQKERSLSAFPLKDLFKEKNIFK
NMLASIFITWVLTGCVVVLILLMPKFMPSILGLSAIEGSYLQVLGILGITLGGVFMGYLV
DKLGLFKICIFFSLVFAFFSCLYFYALYDLKNLVLTCILYTSVCFLGGINVFAPILMSEV
FRAKIRFSGISFSYNIAYAIAGGVTPQLIFWLNTLATRGENPFLYGMSIYMIFLALLAIC
AVFLVKDKINFDNRS
>fig|195.2024.peg.1178 probable periplasmic protein Cj0413 , putative
MRLLGREFAANTRLPLDLNKALLLFQKACKLGRLDSCVRINNIKFKLLKKLDEETYQSNL
KYFLDQNSSFALLEHITTLSKQDIKSAIILAKKSCEQGMMLFVRDFLICMHADKG
>fig|195.2024.peg.714 LSU ribosomal protein L28p @ LSU ribosomal protein L28p, zinc-independent
MARICQITGKGPMVGNNVSHANNKTKRRFLPNLRTVRVTLEDGTTRKMRIAASTLRTLKK
QNSK
>fig|195.2024.peg.487 Signal recognition particle protein Ffh
MFELVSESFKSAINKLRFVDDEKALKNALDTLKKALLKADVHHKVVKDLLLLIEEDVKKN
GIGQKQFLEAIKTNLENILNADGKNQGFVFATKPPTVVLMVGLQGGGKTTSTVKLANYLK
LRNKKVLIAACDLQRLAAVEQLKQLCEANELDLFYIENEKDPIKVAQQALEKAKNSMADV
LLVDTAGRLAIDEALMNELKAVKNVLNPDEIFYVADAMSGQDGVKTASSFNELLGITGVI
LSKFDADTKGGIALGITKQIGIPLRFVGVGEKIADLEIFIPERIVNRIIGEGDLATLAEK
TAAIIDEKEAKKLNQKIKKGEFNFNDFLTQMESVKKLGSMKSIIGMIPGLSNVASSVKDL
DLDNSKEIIHIKAMISSMTPKERENPDLLNNARKRRIAEGAGLSQVEVNRFLKQFANAAK
LAKRFSGKKGMDSLMQMMNQARRQF
>fig|195.2024.peg.784 Cystathionine beta-lyase (EC 4.4.1.8)
MNSKTKLIHCGRGDQNVEVRSVNPTLMRASTILFKDHATWQKYRELRKTDRVLSYGARGT
TTNFELEKLICSLEGGYRAQLFPTGLAALAMVLLNYASKDAHFLITDAIYGPVRTICELF
LEKMGVEIDFLKADASDVEEKIKPNTKLILCESPGSILYEIIDLPKLCKIAHSHNIPVAI
DNTYSSGYFLNPLELGVDISVIAATKYLSGHSDVTMGVVVINEKEWKNFDKLPEALGFTT
SPDDAYLVLRGMRTLDVRMKAHEKSADEIVEFLQTRKEIKTIFYPKLKTHPNHEIFMRDH
KGANGMVTIEFAEGYSKEDAIKFVDELEYFSIGASWGGYESLATVTTPPRTATDWSKRGP
FVRFHIGLEDTKDLIADLAKAFDSIKK
>fig|195.2024.peg.1625 Ribonucleotide reductase of class Ia (aerobic), beta subunit (EC 1.17.4.1)
MQRKRIYNPGSNETLTDRKVFSGNPHGILNFTKAKYTWALKLWDLMEANTWFPKEVDTTK
DALDYRCNLTAGEKRMYDLVWSQLISMDSFQTNNLADNINPYITAPEINAVLARQAYEEA
NHSKSYAVMVEAICDNTDLIYEMEKHDETLREKNDFISSIYEELAGDVDDNKLLLAMVAN
QILEGVYFYSGFTAIYALARAGKMLGSAQMIRFIQRDEITHLLLFQNMINSVRKERPDLF
NENNINKIYDMFKKAGDLEIKWGKYITQNQIMGFTDDIIEEYIHYLVDQRLVAINLDKIY
NAKHPIKWVDDFSKFNDQKSNFFESKVTNYSKGSISFDDF
>fig|195.2024.peg.1289 Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23)
MKLCVALDLATKEECLRLAKELKGLDLWLKVGLRAYLRDGFKFIEELKKIDEYKIFLDLK
IHDIPNTMADACEEISKLGVDMINIHASAGKVAMQEVMSRLNRFNKRPLVLAVSALTSFD
EENFYSIYKQNIDEAVIHFSKMSYQNGLDGMVCSVFESKKIKEHTNSNFLTLTPGIRPFG
EASDDQKRVANLTMARENLSDYIVVGRPIYKNENPRAVCEKILDKIHRKNISENDIEQNY
EAMQQKEWDMCNHFEEWIKTQPDKEQALKEFYTKCGIKY
>fig|195.2024.peg.166 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKISEEDLHFILESGILAPSSHGFEPWKFIILDKKEDNQKLA
KLCFDQASVASASHNIILLARKDLQSKDEFAQKQVRRFSGSSEENFQKILEIYTHKTNAM
NDNELYHYAQLQCYLAMMQMSLAAMSLGIDSCMIGGYEKDKVDDFLKLEYPFETAVILSL
GYQAHEPKYPTQRLKFDEVVEFYKEK
>fig|195.2024.peg.127 Translation elongation factor LepA
MSVKNIRNFSIIAHIDHGKSTLADRIISECGAISDRQMSSQVMDTMDIEKERGITIKAQS
VRLNYKFNNENFVLNLIDTPGHVDFSYEVSRSLASCEGALLVVDASQGVEAQTIANVYIA
LENNLEIIPVINKIDLPNADVEKVKHEIEHIIGIDCKDAICVSAKTGVGIKELIETIITK
IPAPKTDDEAPTKALIYDSWFDNYLGALALVRIYEGSIAKNDEVLVMSTEKKHIVQDLFY
PHPLSPIKTQSLQSGEVGVVVLGLKTVGDVQVGDTITLVKNKAKEAIGGFEKAKAFVFAG
LYPIETDKFEDLRDALDKLKLNDSSITYEPETSLALGFGFRVGFLGLLHMEVIKERLERE
FNLDLIATAPTVTYEIYQTDGELIKIQNPSELPPVNKIDHIKEPYVKATIITPSEFLGNL
ITLLNRKRGVQVKMDYITPERVLLEYDVPLNEIVMDFYDKLKSLTKGYASFDYEPIEFRV
GDLVKLDIKVAGENVDALSIIVPNEKAQSKGRELVSAMKEIVPRQLFEVAIQASIGNKII
ARETVKSMGKNVTAKCYGGDITRKRKLLEKQKEGKKRMKAIGKVNLPQEAFLSVLKID
>fig|195.2024.peg.102 Queuine tRNA-ribosyltransferase (EC 2.4.2.29)
MEFKLKHKDNLARVCEITTAHSTFETPMFMPVGTVGAVKSLDAIDLKEQLNAKIILANTY
HMYLRPGSKIVKHFGGLHGFTKFDRSFLTDSGGFQAFSLSANSKHFQEGIEFKSHIDGSK
HLFTPKSVLDTQYDLNSDIMMILDDLIALPATKERIKVSVDRTIKWAKEAIDYHKQMQIQ
GLGLKQNIFGIIQGGTDYEERKRCALALNEMDFDGLAIGGLSVGEENALMYETVENLNPF
LDENRPRYLMGVGTPEDLVENIERGVDMFDCVMPTRNARNGTFFTNFGKFNIKRAEFIND
HESIDNECSCYTCRNFSRGYLNHLFKAKELTFFRLASLHNLHYYLTLVAQAREAIKKSEF
KKFKYEFYAKRLTNGMR
>fig|195.2024.peg.904 Laccase (EC 1.10.3.2)
MNRRNFLKFNTLTLASISMAYASPMHDMHSMHKNHSINHHLDASFINFAPKNLKLLDPKQ
FPQGEILKALPLLKNESKEKNIFRATLEIKENHIELIKGKKTLFYTYNGLIPAPKIEVFE
GDKLEILVKNKLKEATTIHWHGVPVPPDQDGSPHDPILAGEERIYRFEIPQDSAGTYWYH
PHPHFTTSKQVFMGLAGAFVIKAKKDALSHLKERDLMISDLRLDENAQIPNNNLNDWLNG
REGEFVLINGQFKPKIKLATNERIRIYNATAARYLNLRIQGAKFILVGTDGGLIEKPIFK
EELFLSPASRVEILIDAPKDGEFVLESTYYDRDKMMVKEEPNTLFLANISLKKENVELPK
NLKNFKPSEEPKEFKEIIMSEDHMQMHGMMGKSESELKIALASMFLINGKSYDLKRIDLS
SKLGVVEDWIVINKSHMDHPFHIHGTQFELISSKLNGKVQKAEFRALRDTINVRPNEELR
LRMKQDFKGLRMYHCHILEHEDLGMMGNLEVKE
>fig|195.2024.peg.1316 Fumarate reductase cytochrome b subunit
MSELIEGYLGKSIDGKKSKMPAKLDFIQSASGLFLGLFMWVHMVFVSTILVSKDFFNSVV
HFLELKFIYNDPMMSYITSFLAACVLVVFFVHALLAMRKFPINFRQYQILRTHAKKMNHG
DTSLWLVQAFTGFVMFFLGSAHLIFVITNGDKISADMSGDRVINHFMWLFYIALLICVEL
HGSIGLYRLCVKWGWFEAKDVKDIRKSRKKLKMAKWIISIFFLVLGVLSLAAFAKIGFEN
YQSQTTAMVKTYNGANYEYSI
>fig|195.2024.peg.573 Bacterial non-heme ferritin (EC 1.16.3.2)
MLSKKVVDLLNEQINKEMYAANLYLSMSSWCYENSLDGAGLFLFQHASEESEHARKLITY
LNETDSHVELKEVKQPEQNFKSLLDVFEKTYEHEQSITKSINDLVEHMLGNKDYSTFNFL
QWYVSEQHEEEALFRGIVDKIKLISDNGNGLYLADQYIKNLALSKK
>fig|195.2024.peg.416 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MTKEEIKELVNLFAEANISKIKIKEQDGFEIELERDMCCDVPAPLACPPVPAPQPINVNV
VNEAQPSSAKSNKPSINSPMVGTFYQAPSPGAAPFVKVGSSVKKGDTIAIIEAMKIMNEI
EAEFDCRIVEILVADGQPVEFGMPLFTVEKL
>fig|195.2024.peg.1585 Aspartate aminotransferase (EC 2.6.1.1)
MLTQRSQVLEESITLAITALANELKAKGEDVISFSAGEPDFDTPQTIKNAAIAAIEKGCG
KYTAVAGIADVLKAIQNKLKKDNNLSYETSEIITNVGAKHSLFECIECLVEEGDEVIIPS
PYWVSYPEMVKFAGGKPVFIEGLEENGFKINAEQLKKAITPKTKILMLNSPSNPVGSIYN
KEELLSIAKVLEGTKIIVLSDEMYEKLRYDGFEFVAFASVSEDALNRTVTINGLSKCGAM
PGWRFGYMASKNKALISAVKRLQGQSTSNICSITQHAAIPALNGECDEDIEKMRQAFEKR
RDLALNMLHQIPNISVYKPEGAFYLFVNTQKIEKDSMKFCQKLLEQEKVAVVPGIGFGMD
GYFRLSYATSDELIKKGIERIANFIKNYK
>fig|195.2024.peg.503 16S rRNA (cytosine(1402)-N(4))-methyltransferase (EC 2.1.1.199)
MKIPHIPVLLNEVNQAFEKLNSGYFLDCTLGFGGHSESLLKDHPNLKLIACDQDKEALEF
SKKRLHDFKDRTEFVLSNFSQILDQISHDKLNDLKGILADIGVSSYQLDNNKRGFNLHSD
FLDMRMNQDAKISAFEIINNYTQEQLSDIFKKYGELNDGYFIAQKICQERQKNKIKSAKE
LYEIIGKTKQNHRSVSKATLVFQAIRIEVNQELEVLKNFLEKLEKIKLKNCILAIICFHS
LEDRIVKNYFKKWAKNCICDERAFRCECGNNHSLGEIISKKAITPSKEEIMINSRSSCAK
MRLFHFKNMEK
>fig|195.2024.peg.409 KtrAB potassium uptake system, peripheral membrane component KtrA
MKKLSYGVIGLGKFGSVVADELLAGGHTVIIADKDEEALKSIQNSPSYAYILDSTNISAL
KEAGFHDVEVVIVSIGENVEKSILTLMALKDIGVNNIIAKATSNIHGQILSKLGATKVIY
PEKESAKKLVKDFLTKDADYEVFDLSANTIRAIKITIDDKLAGNSLKHIAQNMRVISYKK
LNTDWEILPDLETTTVYGGDVVILLGTVKELREFEH
>fig|195.2024.peg.779 Catalase KatE (EC 1.11.1.6)
MKKLTNDFGNIIADNQNSLSAGAKGPLLMQDYLLLEKLAHQNRERIPERTVHAKGSAAYG
EIKITADLSAYTKAKIFQKGEVTPLFLRFSTVAGEAGAADAERDVRGFAIKFYTKEGNWD
LVGNNTPTFFIRDAYKFPDFIHTQKRDPRTHLRSNNAAWDFWSLCPESLHQVTILMSDRG
IPASYRHMHGFGSHTYSFINDKNERFWVKFHFKTLQGIKNLSNKEAAELIAKDRESHQRD
LYNAIENKDFPKWKVQVQILAEKDADKLGFNPFDLTKIWPHSVVPLMDIGEMILNQNPQN
YFNEVEQAAFSPSNIVPGIGFSPDKMLQARIFSYPDAQRYRIGTNYHLLPVNRARSEVNT
YNVAGAMNFDSYRNGAAYYEPNSYEESPKEDKSYLEPDLVLEGNAQRYAPLDDDFYTQPR
ALFNIMNQNQKEQLFENIAASMEGVEEKIITRALGHFEKISPDYAQGIKKALGK
>fig|195.2024.peg.1059 Chromosome (plasmid) partitioning protein ParA
MSEIITIANQKGGVGKTTTAVNLAASLAVAEKKVLLIDVDPQANATTGLGFNRNNYEYNI
YHVFIGRKKLSDIILKTELPQLHLAPSNIGLVGIEQELAKGENNEKKMILKNQIQEVLDE
YDFIIIDSPPALGSITINAFVASDSVIIPIQCEFYALEGVAMVLNTIKIIKKTINPKLKV
RGFLPTMYSSQNNLSKDVVEDLKQNFKKQLFTINGNEDDFIVIPRNVKLAESPSFGKPII
LYDIKSPGSLAYQNLAYSILG
>fig|195.2024.peg.315 Putative lipoprotein thiredoxin
MKIKKVFTLAILLSFFVACSNDKEKDQSDMNASVQSSLSQSENLRFNLNLIDGNSIFIKK
DNENLNFADGDKATLFVFFTTWCSPCIAEIPHLNKLQEKYEEQFNIVGVLLEDKSDEELR
AFAQKNQILYKIANGENNYLLVKILGGVNGIPTMFLYDKNSQLINQYLGLIPEEMLEIDI
QKAIL
>fig|195.2024.peg.1385 Phosphoribosyl-AMP cyclohydrolase (EC 3.5.4.19) / Phosphoribosyl-ATP pyrophosphatase (EC 3.6.1.31)
MQNFQNLNEKINWQKVNGLIPVIIQDAKSCEVLMLGFMDEKALEKSLESKKVVFFSRTKN
RLWMKGEESGNFLNIVDLSLDCDNDTLLILVDPIGATCHIGNISCFENVSKNADFVFLAR
LEKLINSRKNADENTSYTAKLFKKGTKRIAQKVGEEGVETALAATVKDKDELICEAADLM
YHLSVLLTDANLSFSDVIAKLKERHKE
>fig|195.2024.peg.733 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MYYLSYFSDYAFFTYISVRAGFAFFIALCLSLFIMPKFIAWAKNKNANQPIYELAPQTHK
VKSQTPTMGGLIFIGCAVFTSLLCAKLDNVFTITALLCLVLFCLIGLVDDLGKILKKDNH
SGLSPKMKLLAQISVGLICILPLYFSPEFNTEFYLPFYKYPLFDMKIFALAFWILVLISS
SNAVNLTDGLDGLATVPSIFSLSTLGIFLYLSGNLNYSEYLLLPKIQGLGEVVIICAALI
GALMGFLWYNCYPAQVFMGDSGSLALGGFIGFLAIISKNEILLLLVGFVFALETISVILQ
VGSFKIFNKRVFKMAPIHHHFEKIGWVENKIIVRFWMIALLSNLLALASIKLR
>fig|195.2024.peg.1209 Molybdenum ABC transporter, substrate-binding protein ModA
MKKLVLCFIVLFLSLNLNAQNLSVFVASSASKAMEEVKNEFLKSHPNDNIDLVFGASGKY
YQLLKQGREFDLFFSADTKYAQAIYEDQNALDKPKVYVLGILALYSLDESLLEGGIEKLK
DKANKIHHLSLANPKVAPYGVAAKEVLENLNLDKLFEDKIVLGENISVPVLHVDSNNADL
GIVAYSLVSSINHPKGKAILIDQKYFTPLKQSYVITKYAKDKKLAFEFSDFISSQKAKEI
FKKYGFDTP
>fig|195.2024.peg.1153 Putative transmembrane symporter
MDKQFFQMFLMFSQIQTVAIIAVLFVIFYILKKMRDKKVNFSLRMLFALFIGLGFGFALQ
YLAQFPDSKEASAIIWYNEAKHWFGFVSSVFVAFIKMLVIPLVGICIIKVIIEIDKNIKI
SSLLSISLFWILFSTAIAASLGILLAYNFQLGDNFTAYEGTRQIREIQTFSSIILGLIPS
NIISVMNKENIIAIVIFAFFVGICAKKVSKKEEYAQAFQTFENFVLVFYNIMMNMTAAVI
RFMPYAVVCMMANVLLSNGFEAIKTAGLFIILTYIAMFIIFGVHFLLLASQGLNPIKYAK
KAFPVWLFAFSSRSSLGTLPMTTSTLQNKFGVNPAVANFVASIGTTTGLNGCAGYFPAMA
AIFVAFATHTPIDFTFALMIVLVAVIGSLGIAGVPGSATMAASIMLAGIGFGDNFVMLSL
ILAIDPIIDMARTASNVSGAMTSALCTAKNLKAIDKEIYNS
>fig|195.2024.peg.341 hypothetical protein
MINGGKIGNEKSKITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDF
EDEILKTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFY
TEFNKGGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLKPELESIKNNLN
RLEFLKAEIKRLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNK
PFLDV
>fig|195.2024.peg.975 Transmembrane transport protein
MFSSFFASKKWALWAYLGLFLLLFFLYMQTSLNVAINSWYSDFYNVLQKPKIELLDSNTT
QKAEEKFENNASLIQEANQKAQENFQKANIINKGALYYYQSLLEYFFNSRAMIEKESYSA
SDFYALILVFLAIAIPYVLIATINIYFASVYAFKWREAMTFSYLKFWKNKDDNIEGSSQR
IQEDTYNFSKIVESLGLSFIRALMTLVAFIPILWTLSDVVSKALFANLSENSSFYFLKNI
DGLLVYVALLISLGGLIVSWFVGIKLPGLEYNNQKAEAAFRKELVYAEDNRKEYAKNETM
IELFTGLKFNYKRLFLHYGYFNIWLILFEQMIVIVPFLIMAPGLFAGAIGLGIVMQINNA
FDQVRSSFSVFITNWTTITQLRSIHKRLKEFEKNIEYAKNKNKNHL
>fig|195.2024.peg.1495 Uncharacterized MFS-type transporter
MTALFASMTFLFAGNALIVSSIGVILKENKESSLAVGVLSSCFFIGALIGTIGAHKIISR
IGHIRSFGLFGAVFGISAMLHTLSENLVFWAILRFFIGICYYGLLMVIESWLNEKSKNAV
RSRILGFYEIVFYLAFGIGILIIALDLNKHNIFILSAALILLSSLPLNLIKIKEPVLPAP
SPISIPKIFDIAPLAIVTSFIAGMLINGFFSMASLFILLQGFGAQEVSYFMFCGVLGGFL
AQIVVGSISDKMGRKFAIITCSSIGFFTMLIFAFFKLHLYMQYFLGILLGIGVFCLYALA
LARANDMLTNKNQGVEVGRGVLFCYSLGSLFGPLILGFLIQYFNTDGFVWFYIASLGFLI
LFAVNKPNILNKKFKKKPGNMVMLDD
>fig|195.2024.peg.226 Chemotaxis regulator - transmits chemoreceptor signals to flagellar motor components CheY
MKLLVVDDSSTMRRIIKNTLTRLGHNDVLEAEHGVEAWDLLEKNEDIKILITDWNMPEMN
GLELVKKVRAEKKYEDMPIIMVTTEGGKAEVITALKAGVNNYIVKPFTPQVLKEKLEDVL
GTGNGDSEAE
>fig|195.2024.peg.603 Cell-division-associated, ABC-transporter-like signaling protein FtsE
MSNLIQAHKLSLGYDELVIKEASFTFKDDDFVFITGKSGSGKSTLLKSFYGDLELLSGQL
EVCGSSMRKIGNSELLKLRQQIGIIFQDYRLIQEYSVEKNVMLPLMIKGYSKKVCHDQAS
KLLKHVNLTFKADKLPNQLSGGEQQRVAMARALAHNPKLLLCDEPTGNLDEYSSDIIWTL
LKSARELLGTCVVVVTHRIPSNLRLNYRRFNIENGNMNEIF
>fig|195.2024.peg.95 Integral membrane protein
MVVILLILLNILFYFTIPYGYYNLLGLNILFFKGAYWQILSSMFMHGNLTHLILNMIVLF
QFGRILESYLGALRFFLLYIIGGLMCSLLSAFYVYFSFYYFGGMINLVGASGAICVLMGY
YAFLDKSSTKGLIVAILLMSFAPLLMGVNVAWYGHIFGFICGYFLGKLRRKI
>fig|195.2024.peg.888 UPF0394 inner membrane protein YedE
MNSFKQKYLINFWDNSRAMITLGILSAVYFGIFGGVWAVTGEMTRWGGEFLELLGMDLNG
YSYYQKQNLNGTPLTRTDGIMLIGMFIGCLVAALLANKVKFRLPASNIRIFQAIVGGILS
GYGARLAFGCNLANFFTGLPYFSLHTWFFGVFMVLGIYLGVKLCNTSFFKPKAKLQCANK
ENIPLLKQNSRAKFHFVLGSILFVAFLIWVFYLVLVNGNISTQSKQSLLALALIFGFAFG
FIISRGQICFTACFRDLFLFGRENAIKGALIGMIIASLIAFAFILHGHNSKLIELSPAVA
IGAFLFGFGIVFAGGCECGWTYRACEGQSHFMIVGIANIIGTMILALTYDFLPSAFKEGV
KINLLNEFGNLGGFFINLALFILMFACVLFYKKHFFQKLNQKG
>fig|195.2024.peg.562 [NiFe] hydrogenase metallocenter assembly protein HypC
MCLSIPSEILEIDELNNALVQTLGVKRKVNLDLIDEPLKQGDYVLIHVGVAMEKIDKEAA
LESIKTYQEIVEKMNSGEIKSDEGDLGLNEFYR
>fig|195.2024.peg.1229 hypothetical protein
MVHEIQKTFLLPDATLLEKLQKDGIVFEIYEIETFYTKITYFYDVKFQNLNGNFYKITRL
NNPILEQNQEEKISKKDYEKARKKLIEKSIKKKRYEFKLCSFKSLIDVYEDFNLYVLKVF
FPTLEMANLFTPPKEFRIQRELCGVLDSKNIILYGFNNLEIDIEKCFKIIEKNQNFTLDF
PSSILAFDGYRIFLFYLFRKLKLYWNLALENRQREVFCEFFSYARKIYIILMSTEEIFDE
ELNKNLALRFEDLVKQSYCILANNELDENLLLFLGSEDLQNLLSDFDFFIKEDSFYKSEQ
EKYFFKQMIAMQLRKRLVLFKKNLLKNFEIETFEENFLGLSVFLEYFHNLYNLKILSKLY
NKYFICDLEKKTLLKLTKKKEKLGKLIHKASKKLKIYKGY
>fig|195.2024.peg.1497 Uncharacterized homolog of the cytoplasmic domain of flagellar protein FhlB
MSKIKKSIKKAVALGYQKEKNSAPKVLASGKGESAAKIISLAKEHGVPIKEDEDLIEILS
KLDLGDEIPPNMYKAVAEVFAFIYQMANKTPKN
>fig|195.2024.peg.600 Uridylate kinase (EC 2.7.4.22)
MQERKRVLVKFSGEALAGENGFGIENSILKFIANEIKELVKNNIEVGIVIGGGNIIRGVS
AAKGGLIKRTSGDHMGMLATVINAIAIQEALESCGLDVRVQSAIQMEAFCETYIMRRAQR
HLEKGRVVIFAAGTGNPYFTTDTTAILRAVEIDAQMVIKATKVNGVYDKDPNKFDDAVFL
QTLSYDEAMQDNIKVMDDTAIALAKDNSLPIVVCNMFEEGNLLKIIQGDNSLCSIVKN
>fig|195.2024.peg.1401 Alpha-ketoglutarate permease
MQELTRAKKIRSIVAASSGNLVEWFDFYIYAFTATYFAHTFSTSDNPIVQQINAFGVFAA
GFFMRPIGSWLFGSLADKVGRKKSMVVSVVLMALGSFMIAALPSKDVVGDFAIILLLLAR
LIQGLSVGGEYGIAATYLSELATEGKRGFYSSFQYVTLIGGQLLAVASISIMLFFFSIDE
MKDYAWRILFVVGGILALGSLLVRKVMNESATQIHKHEDRGTLKALFTSSWKQFLMVLGI
TAGGSLAFYTITTYTKTFMENSGMDKTLVNNLFLGALFILMIIQPLFGYIGDKIGHKRSL
IIFCILAFVGIYPIFNLISSNAQSNASLVFILVVLLFIILSFYTSVAGIFKAKLFPEHVR
ALGTGLGYAISNAIFGGSAPWVALQFKNAGMENGFFVYIAVLTLLMFIATLCLPKKSELN
>fig|195.2024.peg.1573 Methionine ABC transporter ATP-binding protein
MIKIQNLKKYYGKELVINDVSLEIKKGEIYAIVGHSGAGKSTLLRCINGLESYQEGSLKV
LDAEIKDLSQNNPKKLRMLRKDIGMIFQNFALMERKNVFENVAMPLRMHYSQCKIYSKLF
GKEYMSEKDLNQKVNSLLDVVGLDHKNKAYPRELSGGQKQRVAIARALTLNPKILLSDEA
TSALDPNTTKNILELIAKINAEFGITVVLVTHEMDVVKDVAQKALLLEHGQIIGSGAIDE
LFLKPNEKMKEFLGESDFLPSTGLNIKLYFPKEVAQNSIITHMARTLNIDFNIVWGKIEK
LNGNALGNLVINIDEKDKSKVLNYIEQSGVLWEVVS
>fig|195.2024.peg.381 Putative periplasmic protein
MKNEQEEGNFWIAYADLMAGLLFVFILLIGAIVVKYVLTQSDLREIKDNLNKQEARLEES
KEELRNKEAIVFKLSSDLNNASSALNLINSQKAELEANITNYEQLSKELNSSIDNKDKQI
LILLGQLEKKDEEIRNLQESFDKAKEKVQNLSLIRENLSKELQAKLDSNITIDQKTGSIS
LPSEVLFDKDSYTLKNEAKASLRKILSEYFNAIINDPKILSNIENIIIEGHTDSDGSYIY
NLDLSQKRAYEVMNFIYTFYKDIRLQKLLMASGRSFSDPVLVNGVEDKDKSRRIEIKFSI
KNDNALKDVEKFFEFH
>fig|195.2024.peg.811 conserved hypothetical protein 22
MAIFCKLRDIGRYNIKDLDLIFNYLSNCTNPRSKEFARLLAYQEGVFEKIRLTEDIFALE
QTYFTKNESQAFFESHRDYMDIQLIVSGEEKIEFGNKELFEIEKEYDETKDLIVYKKPKF
SVSSLVLNTNDIAIFYPEDVHMPGLSIEHSSYVIKTVIKCKI
>fig|195.2024.peg.871 Helicase / RecB family exonuclease
MILRIFSSSRKIKEYQEKAKAKNALLDSAFLVSDFLDRVCVVNSFKASSYESLLLMQEAC
LKSKDLEKKLGISAEFFAFLKNNEYLFSFFKELSLEKKSIQDLKNNDYYATYNEHLEILD
EVYTNYLLLLKQHNLYDDLSLAQEYKLNLDFLNEYEGIYYDLQGFLSKFEEDLLCEISKI
KSTIISFKTSKFNLEYLLELDFLKDIHLELDMFYEVNLSQKKILKQEKLSNPNTLVKLKA
FELRSLQCAFVMDEISNFVRAGIDPEKIAVITPDESFCELLKLFDKNNMLNFASGVSIKE
SLFYQKIKALYNGANSDAFIYKIDENYFEQEKMIFDYHNTLLHYLELQFEDFRTRFDQIC
DLQYFENLIHSFLKDESQELMNLVQKELYFIKDLLKNKSLKFKELMQLFFMQLDQIKLSY
VGGGKVTVMGLLESRGLSFDGVVILDFNEDFVPKRSINELFLNNEVRKKAGLISYERREN
LQRLYYENLMKNAKKLSISFVENEEQTRSRFLDELDFNFFEEKTTPSKAYLNALKLDYQG
VELNLNPIKVPVLKHDIFEKELSFSRLNLFLYQKRTYFYRYILELPEARALSDESKAKNQ
GNFIHKMLELYYKNYSKNNFNLKIFNDLLEQEYQKYSISELELEIFKLKFIQFAENEKEH
FKLGYKVIEQEEEHHKALNIQNHTIRLKGIVDRIDKLEDKHFIIDYKSGKVPEKSFQLAF
YKALCDENAEAKFYDLNQMQFVEEKAKSLDELKECLKDLLEQREEEIEFENDKDEYCPYK
IIYKKDFR
>fig|195.2024.peg.1357 ABC transporter, substrate-binding protein (cluster 5, nickel/peptides/opines)
MLRWFILLFLLFFNLEAKIPKDTLIVAVENEISRINPAYSEDHDAVINLVFSGLTRFDEH
MSLKPDLAASWNVSKDGLSYDIFLREDVLWHDGVKFSADDVKFSLEAFKNPKNNSSVYVN
FEDIKSIEILNPYHLKITLSKPFPAFLDALSIGMLPKHLLSDKDLNTASFNQNPIGTGPY
KFVKWKKGEYVEFKANENFYLTKVKTPRLIIKHIFDPSVASVELKNGKIDAALIDVSLLN
IFKKDENFKILRERSADYRALMFNLENEFLKDIQIRKALNYAVNKQSIVKNLLHDYGFVA
NHPLERSWADSKAFKTYEYNPKKAQDLILALGFKKNDEGIFEKDGKILDFEIWTMSNDPL
RVSLAGILQSEFKKIGVIAKVVAKPAGSFDYSKVDSFLVGWGSPLDPDFHTFRVFESSQD
SALNNEGWNFGHYHDKKVDIALQKARNTLNLEERKKYYKEFIDALYENPPFIFLTYLDFA
LVYNAKLEGVKARNLGHHGVGFTWNIYEWSKK
>fig|195.2024.peg.37 Putative amino-acid transport protein
MGEQNLTLNPSVPFDEKILKILEYVLPYTDTIMVVLLIICGIYYSFLTRFVQFRMLKSVF
KILTERNENHTKEHISPFQALMISTASRVGIGNIAGISIAIAAGGAGALFWMWFMAFFGG
ASAFAESTLAQIYKSKDNTGGFKGGPAYYIKKALGSHFFGAFFAFILIITYAYGFNGLQS
QTMTSAFKVYYDMFNPNTTTDFASSSWPMIIGIILTLFGIWMFFSHHTKIGKVSSLIVPF
MALAYILLAFIAVLINFEKIPSVIVLIFESAFDFKAILGGFAGSALVIGIKRGLFSNEAG
MGSAPNAAAAALTSHPAKQGIIQAFSVLIDVIVCTSSGFLVLFSMAYFNVGADGKPLLTA
MPLVQEAMREYYGGFGVHFITIAIVLFAITSLIGNYYYAQANVKYLTNSKLVMNLFRITA
VAMIFIGSQMNLKLAWSLADLTMAFMAVTNIVSLLLLGGIVNKVLKDFNTQQDSKINPKF
SASKLGIKNAECWD
>fig|195.2024.peg.1563 Periplasmic nitrate reductase component NapL
MKKILFILSFLYILSPAYELKLNSNITALKLDQQELYIGTDKGEIYEYNLKDKSLKELLS
LPKIKNYYEGDFARIYNIDVYQNSLLILSEGDFGAKNLSLYNNNLQIQTLQESSVKEAFF
IDENTYLLVLLGSKIELVDKDLKRINEFKFSHSSLNDAALNEEKTKFIAGFESGEVELFD
LKSWKILKNYDKMHKDNIYQVDFKNDTLISCGTDRRIGLVKNEEQTFLQKDFLIYTCALS
PSGKLAAYSDNEEGFNEVFDTNTLKTVRIFKDENLMSEIIIFINERELIISGFGDKIVFR
SLDESF
>fig|195.2024.peg.286 Putative cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79)
MLEKQMIKFILSKWNYGNFRIVFWDQEEFYVGNQPAKFSLIFKEKIPLLKLFSDTSLVFA
KHYMESKLEIEGDYDEIAKVLYYFSNKRFLKNKEDILSKIAQKEESKNIKSHYDIGNDFY
RLWLDDTMSYSCAYFKTSSDTLYEAQINKIEHTLKKLDLKPNEKLLDIGCGWGWLSIMAA
QKYGVKVVGVTISEEQCKKAQERVRELKLEDRVEIRLQNYQDLEFEDYFDKVVSVGMFEH
VGKENLGLYFMKAKQVLKPGGSMLLHSILAMFEGKTNAWIDKYIFPGGYLPSLREVVSAM
SEWDFHLLLAESLRIHYAKTLDIWSENFNQVLPQVREKYDEEFVRMWDLYLRSCASAFRV
GSVDLFQFLITKEINNNLSLTKEYIYK
>fig|195.2024.peg.967 hypothetical protein
MSVDEWVTDQVSDIRDFVYALKNFKSKYR
>fig|195.2024.peg.990 tRNA dimethylallyltransferase (EC 2.5.1.75)
MFFQIALIGTTASGKTYIANALAKEFNAVVLSLDSLCVYKEINIANAKPSKDELANLNYF
GVNLLSVDEHFNVELFIREYQKAKEFALINDLPLIIVGGTGFYLKTMIDGLSQKIQDTTS
TLSNDEIYALLLKIDPAYKIEKNDTYRLKKWLSIYESTNEIPSDFLKKTQKDGVLKDIEI
YELVWDREILRKRIEARTKEMIDNGLIEEARMLFSNFDNNLKALNSIGLKECKEYLENQI
SLKELESLISIHTSQLAKRQRTFNKKFQSTPLEFSKALELLRNKFLAKE
>fig|195.2024.peg.1486 hypothetical protein
MRAIFVLIFLALSNLYSCALCATYTPNVDVNLDFNMSNEKIKQVDISWEFSEEFFNVLLE
NYDFNYNDKFDPDELEIVKYTLLDYIKPKHFLTQFSFNGLEENINIKQFKNPKLQIKSPR
LFFSYQVVLDMPIKDYNTFSIKIHDDGGFFNFNIKNQNSISLNSQNYIISSIDSSTASFE
VYQGQLPQDVYIDNAPSPSPSKNFLEKLIEFNNTLFAHIKDILRKEFDFKSFLILLVISF
AYGVFHASAPGHAKMLTSSYFLTHKSTPLKILYFVSRIGVIHILSAFLLVSVGVVLLEHL
LKDVNNEAGFVLTKITSLFIIFIALFMISKKILSDKKQCCCAHHKSNEWGIILSAALVPC
PGVVLLIVFAYEFSFWYALSSAIFITLGMCLVLFAFALGANQFYKSISHTKIRIFLEYFG
LIVMFLFGLFLFINIKTNAL
>fig|195.2024.peg.1212 8-amino-7-oxononanoate synthase (EC 2.3.1.47)
MSLKNILETLEKNHNLRKLTSLKHEGNFVFKEGKKLLNLAGNDYLNLSFCKSLKDEFLDN
IKEQDLFFSSSSSRSLSGNFTIYEELESFLKSKFKEKEILHFNSGYHLNISCIAALASIP
NTLFLADKFIHASMIDGLKLGGAKFFRFYHNDMNHLENLIQKHYDHYENIIILSEALFSM
DGDFSDFNTLIAFKEKYPKIKLYIDEAHSVGCFDEEGLGLVKALNLEEKVDFIVFTFGKA
LASMGACMICNNLYKSFFINKARAFIYSTALPPINIAWTKFIFEKMSELKEKREKLQIIG
NFFKNQLIEKSHQILGDAYIISLVLGENQKAIELAKKLEVNGIFAPAIKEPTVPKNTARI
RFSLHAGLSKEDLKKVVELL
>fig|195.2024.peg.593 Quinone-reactive Ni/Fe-hydrogenase small chain (EC 1.12.5.1)
MIDYNQIESRLSALEKLPSLNPENSIPKALERSGFTRRDFMKWAGAMTAFLALPASFTPM
VAKAAELADRLPVIWLHMAECTGCSESLLRSDTPTIDSLIFDYISLEYHETVMAAAGWQA
EENLESAIEKYKNKYILMVEGGIPMGDTENFLTIGPHGKSGYELSKVASENALAIFAIGT
CSSFGGIQAARPNPSNAQPLSKVTSKTVINVPGCPPSEKNIVGNVLHYLLFGELPALDVY
NRPKWAYGLRIHDLCERRGHFDAGEFVQNFGDEGAKNGYCLYKVGCKGPYTFNNCSRERF
NQHTSWPIQAGHGCIGCSEPNFWDTMGPFEEPMASRKFDTVFGLGADNVSDKIGIGVLTL
TGVAIAAHAVIASMKKNEE
>fig|195.2024.peg.65 Phosphoenolpyruvate carboxykinase [ATP] (EC 4.1.1.49)
MKKFENLGLENIKKVYHNLSFDELYEHEKKNEEGQCTDNGTFTVDTGIFTGRSPKDKYFV
KQDPSSKYIAWGKVNQAITKELFDELLMKARKELSNKEIYVQDVFCGASLKSRKAIRFVT
EIAWQAHFVKNMFIRPNDKELDEFKADFIVYNACKCVNKDYEKNGLNSEVFVIFNIEENI
AVIGGTWYGGEMKKGIFSMMNYWLPLENKLSMHCSANVGEKGDVALFFGLSGTGKTTLST
DPKRKLIGDDEHGWDDEGVFNFEGGCYAKTINLDPESEPEIYGAIKRNALLENVVLRSDK
SVDYSDASKTENTRVSYPIEHIENHEPSLKAGHPKNIIFLSADAFGILPPVSKLSKEQAM
YYFLSGYTAKVAGTERGITEPQATFSACFGEPFMPLHPTVYARLLGEKIDKHEVNVYLVN
TGWSGGSYGVGKRMSIKATRACINAILDGSITQCEFENFDVFNLAIPKTLAGVESSLLNP
INTWKDKDEFIATRNKLAKMFSDNFKRYEDVKEGVEYSQFGPKI
>fig|195.2024.peg.1477 Predicted L-lactate dehydrogenase, Fe-S oxidoreductase subunit YkgE
MKKVYFYATCLGTAAMQESVLNGIKLLRREGVEVIFKKNQTCCAQPSFNSGYFNESREIA
LYNVDLFDKDYPIVVPSGSCAGMMSHDYKELFKDRPEFSRVKDFSSRVIELSQYLDEVLN
VNYEDKGEPIKVTWHSNCHALRVQKSIQASKNLIRKLKNVELVELQYEEECCGFGGTFSV
KEPEISNAMVRNKIKDIQNTGVKYLISGDGGCLLNIDGTMRRMGLDVKGIHLYEFLFKRL
EGERL
>fig|195.2024.peg.313 Metal chaperone, involved in Zn homeostasis
MAKIPVHVVTGFLGSGKTTFLKEILTNQALNDIALVINELGEVSLDHKLVQTDFIEEQTL
FLNAGCACCNKREDLQKKFKELLDNFENKGKKPQRVILETSGLANPAPIIFTFQSDVFLA
NHFELANIITCIDAFEGLNHLQNEEACNQILSSDFLILTKKDLNPHTQSLEEKINTLYPN
IQIISKENFNFDMLSSHHKIQREIKNIEIKSHKDDISSITLIFDKAINWNIFSIWLSMLL
HEHGSKILRVKGLINTEESYLTNINGVGHLIYHPTHTKISSLNHPSQLVFIAKNLKLDKI
KESLENFLRLEQLN
>fig|195.2024.peg.1310 Serine hydroxymethyltransferase (EC 2.1.2.1)
MSLEQFDKEIFDLTNQELVRQCEGLEMIASENFTLPEVMEVMGSVLTNKYAEGYPGKRYY
GGCEFVDEIENLAIERCKKLFNCSFANVQPNSGSQANQGVYAALLNPGDKILGMDLSHGG
HLTHGAKVSSSGKMYESFFYGVELDGRINYEKVREIAHIVKPKLIVCGASAYARIIDFSK
FREIADEVGAYLFADIAHIAGLVVAGEHPSPFPHAHVVSSTTHKTLRGPRGGIIMTNDEE
LAKKINSAIFPGIQGGPLMHVIAAKAVGFKFNLSEEWKIYAKQVRSNAQALAKVLMDRKY
KLVSDGTDNHLVLMSFLEREFSGKDADLVLGNAGITANKNTVPGETRSPFVTSGLRLGTP
ALTARGFKENEIQIVANYIADILDDIQNTHLQKEIKEQLKTLASNFIIYEKAMF
>fig|195.2024.peg.1626 Integral membrane protein
MKTKAKIASRWLRFRALLIDIFLIYVPILYLFYFLLGSKEAFLNNSYITALCTFLFGFIQ
ALFLASKAQSPGLKAYDLYLIDLKTGKKITFFRILLRYIIFIISFGLIFGLFISFLRKDK
LNLHDILTQTCIVTKI
>fig|195.2024.peg.35 ABC transporter, permease protein (cluster 3, basic aa/glutamine/opines)
MNQKNIRIFVFFAIILFWGYFSFPIEILQIKEADGAINYRYTPNAQAYIKSYFITLLLTA
CSAIIGVVVGFSLAILRFSKIKVLNFIIDEYIDIIRGTPVILQLMIFAFVIFTFIDNLYA
AIFALGLNSSAYIAEIVRSGINSVDKGQMEAARAMGLDYKTSMKEIILPQATKNILPALA
NEFISLFKETSVVGFISVIDITMQSQSLQAVLYNPKPLIFTGLVYYVSVKIFSYFAKKLE
LRMSKND
>fig|195.2024.peg.668 Uncharacterized protein HP0275
MYRNLLFVLIGFFLTACGASKTIIAYPDYKQQKSNEFDLRIMKAYNYEYFNQYEEARDEF
LALFRDYNITNFLENAFLLTLANNLDKKEEINNIAKPYLDKSDNLKRLSALYALNSYNLK
EAQELIQGLLKKKSDDPRNLELYGDVLIRQNNLKDAIKYYQLAYNQVQNEEILFKLVGVY
AILNDTSSIKNILENSKNINGCTLKTCILLAKIYNDKGNSKALQEIYIELYNITKNKSFI
LALIELLSSQNKDKEALHFALKYNADDDMKLYLYQRLKLYNKAKDLSMQIYKRTQEKEYL
LRAAVFEFEEANLNKKITPQVVALVSEKFSNAIDENSDALYLNYYGYLLIDYDLDLKKGM
KLVELALKKEPQNLYYLDSLAWGYYKQGDCKKAWEILKQTLEDKEFANSDESKAHAKAIK
ACIKP
>fig|195.2024.peg.697 ABC transporter, permease protein (cluster 3, basic aa/glutamine/opines)
MDFDFILANSNAFIAAAWLTLKLSFFGIIFSIIIGFFCILMSYFKITIMEAFCKVYIEFS
RNTPLLIQLFFLYYALPKFDIHLEQIPPLNLICLSVDEALRPAFACAIVGLSFLGGSYMA
ESFRAGFEAIKKQQFEAGLSLGFTKLNNLRYVIMPQALGVCLPGISANIVFLIKETSVVS
IIALPDLVTVMKGLNSLTYKTDELLLLLFLGYLCIILPISLFLFFLEKRFSNV
>fig|195.2024.peg.212 Carbon storage regulator
MLILSRKENESIVIGEGIEIKIVQTGKGYAKIGIDAPKSLMILRKELLTQIKDENLHSVV
KNDVKLDDLSKKLIP
>fig|195.2024.peg.482 LSU ribosomal protein L19p
MKNKYIEQFEAKQIEGKNVPEFRAGDTLRLAIRIKEGDKTRIQNFEGICIARRGNGVDET
FIVRKMGANNVGVERIFPIYSESLESITVVRKGRVRRARLFYLRDRRGKAARIKELKK
>fig|195.2024.peg.307 Membrane protein
MIYILEFFKGASLALMLFGALFFFFKFHSFLYFFLGLLPGLLLSLVFVCLIENYELKLKI
NQDKSK
>fig|195.2024.peg.1235 Phosphoserine aminotransferase (EC 2.6.1.52)
MRKINFSAGPSTLPLELLEYAKNELCDYQGKGYSIMEISHRSKVFEEVHFGAMQKAKELY
GLNDDYEVLFLQGGASLQFAMIPMNLSLGGVCEYANTGVWTQKAIKEAQILGVNVKVVAS
SEESKFDHIPQVEFSDNADYAYICSNNTIYGTQFKNYPKTKAPLIVDASSDFFSRKVDFS
NIALFYGGVQKNAGISGISCLFIRKDMLERSQNKNLPSMLKYSIHAQNQSLFNTPPTFAI
YMFNLEMKWLLDQGGLDAIDAKNSQKAAMLYECIDSSEGFYKGHADKKDRSLMNVSFNIA
KNSELEPIFVKEAEEVGMLGLKGHRILGGIRASIYNAVTLDQVKTLCEFMKEFAKKYN
>fig|195.2024.peg.168 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (EC 2.7.8.5)
MNIPNTLAVLRMILAPLLFFLLSYKFDNIHQSWINYFAALTFALAALSDFFDGFIARTLQ
QTTKLGGILDPLADKMLTLAAFLGLLLSGKANEWIVYLILVREFFITGFRVVMVSENLNV
NASFTGKLKTTFQMIAIGFLTMEWIGGDILLYIALFLTLYSGFEYIFSYVKQSKGKLQ
>fig|195.2024.peg.1533 3-deoxy-manno-octulosonate cytidylyltransferase (EC 2.7.7.38)
MIIIPTRLASTRFPEKILCDIGGVPMFIATAKQVSSVDEVCIAVDDEKVLEIAKQYGFKA
VLTSKNHESGTDRINEACKKLGLKDDEIIINVQADEPFIECENLAKFKEFANSCLKQEAF
MASCYKDISKDDASDPNLVKVVCDKNDFALYFSRAKIPYERADYEESFKGHLGIYAYSVK
ALCEFCTLENSALEKAEKLEQLRAIENGKKIKMLQINTSSMGIDTKEDYERALRIYLGK
>fig|195.2024.peg.764 Outer-membrane-phospholipid-binding lipoprotein MlaA
MKLKLISCILLFSTIFAFANELDLNDFEEEYQSYKVNDPLYGYNKAMTSFNVALYDYSLR
PILKGYNAITPEFIRTGVRNFFDNLFAPLRFVGNVLQFKFEEAGEEFKRFSANTIMGFGG
IMDPASKMGLKKHPADLGTVLAHWGVGSGFHIVLPILGPSNLRDTLTLPATWYASPTAYI
DPTWASIAISAYGFGNELSFRLDEIDEIYYNTPNLYPFIRDAYEQRRNELSK
>fig|195.2024.peg.602 Cell-division-associated, ABC-transporter-like signaling protein FtsX
MKFFKTHLSLILPLLFMMFAFEFILLTNATLRHYEELVNKDYNIIVASSAELDKNVIKTK
LSSFSSLEPLDPKDLIDRLKNDISDKNLKVLRDSLPKFYSIKLDYLPTQNELNTIKNQLL
SIPSISKVETFAKTHDKVYSLLVLMKFVFWLFLFIIILLSFVLFLKQMRIWLFEHTERVE
IMYLFGAPFWFRSFMLYKIVVLDCFIAFIILFVFFTQIYNLSIVQDSLKAVDIILPPINF
IVHLGVIYLVTLFICLFCVNSVMFRVKK
>fig|195.2024.peg.80 UPF0246 protein YaaA
MKILFSPSESKNDTCKEKPIDKSSFIFENLFDFRMQAVKKYEEYINNADLKALQELFGIK
NENEISNFQRDLKNSPAQQAITLYSGVSYEYLNFDILDKESQKYILENTLIFSNLFGVVK
ASDHLPFYKFKQGAKINNFALEKFYKEHFSKALDEYLKNEELLDLRAGFYDKFYTPKRKF
STYKFIKKGKVVSHFAKAYRGILLALCARIKAKNNAEILNHLPSNLSLKEIQNKGLKEEI
VLEILD
>fig|195.2024.peg.1467 Aspartate ammonia-lyase (EC 4.3.1.1)
MGTRKEHDFIGELEISDEVYYGVQTFRAVENFNISHERLKDFPRFVRALARVKKAAAMAN
YELGLLDKDIQDAIIKACDKILEGGYYDQFVVDMIQGGAGTSTNMNANEVIANIALELMG
HKKGEYQYLHPNDHVNLSQSTNDAYPTALHLALHDYLSDLAKAMEHLKKAYERKAEEFKD
VLKMGRTQLQDAVPMTLGREFKTFAVMMGEDIQRVLEARKLILEINLGGTAIGTGINSHP
NYPKVVERKIREVTGFEYTVAEDLIEATQDTGAYVQISGVLKRVATKLSKVCNDLRLLSS
GPKCGLNEINLPKMQPGSSIMPGKVNPVIPEVVNQVCYAVIGADVTVTFASEGGQLQLNV
FEPVIAYSLFNSIVMLEKAMHTLADKCIDGISANEKICSDFVYNSVGIVTALNPYIGYEN
SASIAKEAMSTGKRVADIALERGLLSKEQIDEILTPANMLNPHMEAKK
>fig|195.2024.peg.900 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
MSSMNETIKLNRRSFLKMAALSSLATPLLARSETLREANADELKEAYEGSQKIKSVCTAC
SVGCGIIAEVQNGVWVRQEIAQDHPVSSGGHCCKGSDMIDMVRSHVRLKYPMKKENGEWK
RISYEQALSEIGEKLAAYRKENPESVMFLGSAKLNNEQAYYIRKFAAFFGTNNVDHQARI
UHSATVAGVANTFGYGAMTNHLGDIQRSKCIIIIGANPAVNHPVGFRHFLKAKEKGAKLI
VVDPRFTKSAAKADIYARIRPGTDIAFMYGMLKIIFDEGLEDTKYLDERVFGIDKIREEA
AKWTAEEVENVTGISKELLIQITHEVAKNKPTTLIWAMGLTQHTVGTSNTRLAPIVQMVL
GNIGKFGGGVNILRGHDNVQGASDMACLSENLPGYYPLNEVTWRYYAKIWGVDYEWLLGN
FVSKDWMHKTGLSLARWWAAALNGKDGNDKVDNAGTSLKALVVMGNGITSTAQQAKVKEG
LEALELLVLADPFVNEAGIIAERKDGIYLLPAATQFETSGSVTATNRSGQWRFKVIDPLY
ESKEDQEILFELAKKLGFYEDFTKTLRDENGKIVWPENATREIASAVRSIGLNGWSPERL
KKHTLNWDKFDEVTLEGKDELVGEYYGLPWPCWSDKHPGSPVLYNTDIEVAKGGMGFRNN
FGLEYEGENLLAKNAPINSPIDTGYPQITKDNIEKVLGITLSAQEKEKMGAIWSYDDSNI
IATKCIEKGIVPYGNAKARAVVWTFKDQIPLHREPLHSPRNDLVQKYPSFEDQKALYRVD
TKFVSVQKAKDYSKEFPLNLVTARLVNLNGAGMENRASMYLTRLTPEMFCEINPELASEQ
KIKAGDMIWVHSPEGTKIHVRVKFNPGVAKDMIFLPFHFTGVMQGVDLTHNFPKGTKPYA
SGESANTVTNYGYDIMCQIPETKGGLCRISKDGV
>fig|195.2024.peg.1448 Na+/H+ antiporter NhaA type
MNNIVHKLRTLVLNEAFGGVLLIVCTLLALLVQNGSFSEHYREFLNLKVGFSVGEFELNK
PFLLWINDGLISIFFFAIGLELKKEFLHGDFKNPKNIVLPFMGALGGILIPALIFAIVNI
GDAYTLKGWAIPTATDTAFALAILMMCGKHIPSSLKIFLLSLAIFDDVGAILIIAIFYTT
KLSVAAFVVVGIAIFMMLILNILGITRKSFYFICSVILWISVLKSGVHATLAGIITAFFI
PMQTKNGEAFLEEIYESLKFWLAFVILPLFAFANAGVNLSNIDIGAIFSGVSIGIFLGLF
VGKQVGVFLFSYLAIRFKFAALPQGSNLKQLYGVCILTGIGFTMSLFIDGLAYEVSDIFN
YADNLAILIASFFSGIWGFIYLKFFTTRP
>fig|195.2024.peg.1445 Methionine aminopeptidase (EC 3.4.11.18)
MIELKKPAEIEKLRVANQIVAKTLDFLENEIKAGMSLKQIDKMAEDFILSLGAKPSFKGL
YGFPGAICTSLNQVCIHGIPDEKIIKEGDILGLDVGSLIDGYYGDAARTIAIGKISSTDE
ALISCAKDALYHAIDIIREGMRFKELSAALGEFIDLRGFVPLRGYCGHGIGRKPHGEPEI
LNYLEKGASAKSGPKIKNGMVFCIEPMICQKDGTPKHFNGKWGAGSVDELNSAHYEHCVA
IINGRAEILSSL
>fig|195.2024.peg.1093 LSU ribosomal protein L29p (L35e)
MKYTEIKDKTAAELATMLKEKKVLLFTLKQKLKTMQLTNPKEISEVRKDIARINTAINAL
K
>fig|195.2024.peg.557 3'-to-5' exoribonuclease RNase R
MKEFLNNLNYGISAHEVSNEFKQILRELLANNIIKEHKNRYYLNNGYVFGTLDISSKGTG
FLQCFDESFKKDLLIENKNLKGANYKDIVAAKLLPLKKKRPSAKVVLVLKRANETSLVIT
KRYGEAVLGMNIKTGLSTTLKASQKSLKALPLGTILKIENENNNIIEVLGHIDDESVDEK
ISLALFNKNNEFSDACIKEALANGDSVDASMYENRMDLRALPFCTIDPIHAKDFDDAIYF
DTQKREIYVAIADVSEYVHAYSAIDKEARNRGFSIYFPHIAIPMLPRPLSENICSLKPHL
DRLAYCFKITLDHENKVIKEELFEGIINSKRRFNYDEVDEILIQKPDLKELSWLYELFEI
TKNLRKMRLKNAFEFRTEELRMNLDENLSLKSTVFEKDTPSHNLIEDCMLLANKAAAKLI
DVGVFRNHSSADMKKIDRLLNELLELGIDVKLKPNLPELIRDIQALADELGLRAEVDKLI
IKAQKKAEYSSENGGHFGLGFDKYSHFTSPIRRYSDLILHRLLKAKQKKDEKLFNYLLLN
IQSTCENLSVLEREADKVAYDFMDRKFARWAAKNIGKKFKALVVQNDGICIAKLDDEIKG
ADIILYDTRVNLLESVEVQILEADIIMAKIYAKITQRLGKESNV
>fig|195.2024.peg.581 Polyphosphate kinase 2 (EC 2.7.4.1)
MQEKVPAKIQEETKKDEIYVSVKKKKSTIEYEKDLKNLQIELLKFQNYVKAKGLKVLILI
EGRDAAGKGGAIKRLIEYLNPRGCRVVALEKPSDVEKTQWYFQRYVTYLPSAGEIVIFDR
SWYNRAGVEPVMGFCTPQQHKDFLREVPLFENMISNSNLMFFKFYFSVSKEEQKKRFEKR
RIDPLKQYKLSPVDQKSQELWDKYTLAKYSMLLASNTPTCPWTIISSDDKKKARLNLLRF
ILSKVDYADKKIGDFSKIDQDLVRSGEEEIRKMEANLEKIDNKKADEKIKDLD
>fig|195.2024.peg.1709 Ferrous-iron efflux pump FieF
MNLQKKATLIASLCAIVLALIKFVVGITSGSVAVLSSAIDSLMDFAISAFNFLALKKSSQ
KANENYNFGFSKIEALMGLLEGVFIVSVGIFIFYESILKIYYKEEIINLNASIYVMIFAL
ILTFLLVLFLNYVVKKTKSLIIESDALHYKTDCLTNAFTLAALVLIYFTNLHIIDAIFGI
VVSLYTAFSAFKIIKKALAFLMDEALPKEQVNQICALISSNPEVISYHELKTRKTPNCNY
LSVHLVFCPIISLLSAHKVSDEIENGVREMFNGEKWDIQIHLDPYDDEEQERQRQ
>fig|195.2024.peg.1325 Membrane protein
MFLLDFLISLSFIFEISALVLSFYFKNSKIFFLTLVLLGAKLPYFYTSFFQANLFVALFL
PMIFTLFCLGKHHVLILNKKNIASITTLIFIGVLSIILPRNTTFNSAGLEFHFITLNFFK
PVSELGFLFFLVGLILIFIKTFKTKEYYLLIAFFAAYFQFLFQEGTGIRYFEFASLVFCF
YLLNYAYRLAFFDTLTKLPNEKSLTRFTKGKNNYIIALLHFNELKDTKESYTKLILKQIA
KILKRFRAKIFIVENDFILIFNDKNQALNHLAFLESTLKNTEFNLENENFKPDFKLIWQE
SEENLDKNLQSLRARLLD
>fig|195.2024.peg.197 Protein translocase subunit SecD
MRNSKITYRLVVFIAVFIFGVVFSLPSFLQSERGVKINLGLDLQGGLYMLLGVDNQEAVK
SKIKSVASSLSYSFNKENILNDGLNIHDDSLDFTLLDNADIVKTENLLKEINGLNVQRED
MHYTISFTSEEVKSIENFALLQAVETIRNRLDQFGLAEPTVAKQGEDKILVELAGIKTKE
DELRAKERITKAAHLQLMEVDDSKMSQASNMSDAEAASYGLVLVPDSRNPNLKYPLKSIP
ILDGSMLTDARVGLSDTSNYPVINFTLNAEGSKKFADYTGANVGKRLAIVLDNKVYSAPS
INERIGGGSGQISGAFTQEEARDVAVALRSGALLAPVKLLEQRSIGPSLGADSIKMSMIA
LIGASIFIVVFMVLYYGMAGIFANIAMLVNVLVVVAVMAMFGATLTLPGMAGLVLTVGMA
VDANVIINERIRELLREGANIKASIEQGYKNAMSAIIDSNITSLVTSIALYAYGTGAVKG
FAVTLGIGIVVSMITAIWGTHGMFDYFMRRIEKSNNTRFWFGYRRK
>fig|195.2024.peg.1390 Possible two-component regulator
MKVLIIENEIYLAQSISIKLSDVGYSCEIINSFDERNPEKYYDIVLLSTNTSNFLKAVTE
FKHSIIILLISYISTDTVSNPLKLGACDYIQKPFMIEELIRKIKHYQDFKKLSILNKAYK
SYIKSRLQTVKIPEYNYKKLKLPVVLKSNKQSSADAFVFNYINEYDNTLSYVDLSVSNSV
EKAMKLPTENNLLFLSNFQVLKPLEREKLLEFIKNKSVILHTNSNIEDLELPCINLSDNE
KNIDSNQILTIDEYVKYIILNYQNVFPDTDLSKKLGISRKSLWEKRKKYEISKKK
>fig|195.2024.peg.1666 Predicted Rossmann fold nucleotide-binding protein, possible lysine decarboxylase
MDTKISQDLEKFVNIPNLKNAITFFGSARLKEDSFYYQEAKKLASLCVENGFCVVSGGGG
GIMRAANAGAAKCKNDANFIKSVGFNILLPFEQKLNDFVEYNITFESLAIRKMALIEKSL
AFVIFPGGFGTLDELCEVLTLKQLGFKNNVPIILFGSEFWQGFDEFVRNSLLKLEVISKG
DELKYEITDDLDYIINTLKEL
>fig|195.2024.peg.677 L-fuconolactone hydrolase
MQKIFDAHLHLWDLDKMPISWLKGNEKLEQNYDFFRAKEEYEGFEFLGAMYVETNSDDLE
KEALFALEQKKLHNLLLCLADLKYKEELSSFREVMHTSKKEAKRLFEADFEEKIEILKTF
NIPFEACMKNEEFSFLEKFLNKNPNLKVVLNHLGSPKIDRLNEYKKDLNLLKKFPNLYIK
LSVPDDFSEQTSKEFIYELFAFFKENFSEDKFIFGSNYPVAKIAPAKWAKLIIESKIFKN
LNKIFYQNALSIYKEDRCKDMAKS
>fig|195.2024.peg.1648 Putative helix-turn-helix motif protein
MAVKIENLMREILGKKRFELLQFLCENADENGFVMIKISELEARLNQSKPTIIATFKFLE
EKKLFKKLKNGFYQLCIPCD
>fig|195.2024.peg.1660 Motility integral membrane protein
MRPENYVAFFTVCGFFIGLAFSIISIEEAFDILIFTCFITFMFYVFIHIAIMNFIDIKKI
SGRIFNKHDYEKTSNNIINDLVIREKKMDIILEKLNEEREELKKNESKERRKNAKRAA
>fig|195.2024.peg.183 Probable periplasmic protein Cj1079
MKRAYILLSLVFLISALGIWLSLNITTSSYIPRFVKDAYYYLQAQILADEKLVKYLLYQA
KLDGKECLDSITLHYPNLNDKIKIQYHYPIAQCKNFKFQAINKDANLSQDGIIIAHMSIA
LNTQKNVNDEILINKTFILHTKESFWNQTK
>fig|195.2024.peg.629 hypothetical protein
MDIFDEMFNKTPKEKFIEIIQNGNLGALEKVFENFFADHIAMIELLEKQGFNEMDMKSFI
LENGDFIQERQNDLFIELGAKILGHEG
>fig|195.2024.peg.711 Phosphomethylpyrimidine synthase ThiC (EC 4.1.99.17)
MKTQMLYAKEGIFTKEMEIVAQKEEVSKDFLLENIACGKIIIPANINHKSLDPNGIGLGL
RTKVNVNLGVSNDCVDYSEEMKKVELAHKFGIEAIMDLSNYGKTSRFRDELIAVSKAMIG
TVPVYDAVGFLEKDLKQISARDFLDVVYHHAKSGVDFMTIHAGINSRAARVFKESKRLTN
IVSRGGSVLYAWMAMKEAENPFFEYYDDLLEICLKYDVTLSLGDALRPGSTHDASDAAQI
SELIELSLLTQRAWEAGVQVMIEGPGHMAINEIEANMQIEKRICKGAPFYVLGPLVTDIG
AGYDHISGAIGGAVAAAAGADILCYVTPAEHLRLPNLNDVRDGIVATKIAAHAGDLAKLP
KERKRDDEMSKARQDIDWEKMFKLAIDGEKAKKMFNERRPDDLNSCSMCGKMCAMNTMNQ
VLKGENVSLV
>fig|195.2024.peg.1087 SSU ribosomal protein S8p (S15Ae)
MINDIISDSLTRIRNAGMRKLETTKLLHSKVVEALVGIFQAKGYIESFNVIEEDKKKFIN
VVLKYDEKGKSVINELKRVSKPGRRVYKGKEEIKRFKNGYGTIVVSTSRGVLANDEAYKA
GVGGEILCTIW
>fig|195.2024.peg.402 S-adenosylmethionine:tRNA ribosyltransferase-isomerase (EC 2.4.99.17)
MKDLLLSSYDYTLPNELIATYPVHPKEDAKLLVFERKNNQISHTTFKNLQDFLPDCALFF
NDTKVIKARIYGNKSSGGKIELFLHQPCLDSQDSLFLAQIKGRVKKDEILSFEQNLKAKV
IELLDDGLRKVQFFQNDEVLNTFKLYELLDTIGHVPLPPYIKRSDEKSDLEDYQSIFAKN
LGAVAAPTASLHFSENMLENLKKRHEIYHLTLHVGAGTFKSVECENLENHKIHSEFFDIP
KKACEVIDSQKKILGVGTTVTRTIEYYARTKQNQGFCDLFLHPHNPPLRQDYLLTNFHLP
KSTLIMLVSAFIGRQNCLKLYDIAIKEKYRFYSYGDAMLIL
>fig|195.2024.peg.61 Membrane protein
MRKWFKFFIFIVLIALIIYVIHGLVKNDFSLEEFIIRIWNEHVETWGYLILFCWSILEGE
LGLIFAGLAAHDGKMHVVLAIFIAGLGGFVGDQIYFYIGRYNKRYIQKKLRSQRRKFAVA
HLLLQRFGWPIIFIQRYMYGFRTVIPMSIGITRYSAKKFAIINLLSAWVWAAITILLAWH
FGNLIQNFLTWAKNHWYLAAIMIICFLSLLVFTFKQIEKAILKEKRKKNDI
>fig|195.2024.peg.1294 GTP-binding protein EngA
MQSIILIGKPNVGKSSLFNRMARQRIAITSEISGTTRDTNKTEVFINSKKALLIDSGGLD
ESNELFKNVKKNTLKIAKQSDIILYLVDGKLSPDDEDRQFFHSLKKLGKPIALVINKVDN
KKDEERSWEFANFGVKEVFNLSVTHNIGLDELYNWLENFLDEQFLIPDEEENLEDFLEHY
EEGKEFQFKELDQNYIRVGIVGRVNVGKSSLLNALVKQERSVVSSIAGTTIDPVNESIVY
KDKVIEFVDTAGIRKRGKIQGLERFALNRTEKILSNSQIALLVLDANEGFNELDERIAGL
AAKHYLGVIIVLNKWDKTEFEFDKVVKELKLDRFKFLAYAPVVSVSALSGKRVHVLLEKI
LEVFTNFTQKIPTSKLNDLIASATKAHPLPHDYGKLVKIYYAVQYDLAPPKIALIMNRPK
ALHFSYKRYLQNQIRKEFNFEGVPLVIASRKKGSKENDES
>fig|195.2024.peg.835 Capsular polysaccharide ABC transporter, ATP-binding protein KpsT
MIKVLNLTKSYPLFNGGRHYVFKDFTFEFPENCSIGLMGRNGAGKSTLMKLLSGSELPDK
GKIITNKKFSWPLGLSGAFQGSLTARDNAKFVARVYGYKGEKLHEKVKFVEDFAELGKFF
DEPMNTYSSGMSARIAFGLSMAFDFDYYLIDEAGAVGDPKFREKSRKLYKERLSQSKVIM
VSHNVAEIKEWCDKIIFMENGKATVYDDIDEGIAVYQGKK
>fig|195.2024.peg.1492 Glutamate-1-semialdehyde 2,1-aminomutase (EC 5.4.3.8)
MTNKKAFKIACSLIAGGVNSPVRAFANVQSEPRFISHGKGAHIFDIEGNSYIDYVQSWGP
LLFGHCDKDILKACNEALKKGSSFGAPTLLETQLAELVLEDFPHLDKIRFVSSGTEATMS
AIRLARGFTKKDKILKFEGCYHGHSDSLLVSAGSGAATFNSPSSLGVLADVAKHTLVATY
NDIESVKELFEKNKDIACVIIEPIAGNMGLVPGKQDFLEELVKICKENDTLLIFDEVMSG
YRASYLGSYGINHIQADIVTFGKVIGGGVPAAAFAARAEIMDILSPLGGVYQAGTLSGNP
LAMAAGIASLSKAKKKKDLYTKLGKLAKRLTKGMKELANERGIALQTCYVGSMFGYFFTQ
DPVYNYKNALKSDLKLFSKFHQNMLKNGIYLAPSQFETGFICAKMNKEHIDKTLQSTHES
FKKL
>fig|195.2024.peg.613 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSNIFSTLSPFRLFVKCAVPNVISMAFISFYYIVDGIFVGKYLGNDALAALALIIPFIMI
SFALADMIAIGSAVQISMHLGLGKKHLARKIFSSSMLIIFLISCLVGILEYLLSPVLIDF
LDVNEDIKSMAKECMLVFALFAPFTMCSFALDNYLRICGKTTYSMTMNVIIALSNIVLDY
IFIVVLGWGLFSAALATCLGLMLGGIFGIFPFLFQNLELKFSSLYMNMKIFKNIVYNGSS
EFFGNISGSLYGIFANLVLLKISGTQAVAAFSIVSYIDNFIIMLIIAMGDAMQPALSYNY
AKKDFSRIKDILKVMFFAGAILSLLSVAMIFVLGKDLVGLFTQENDQEFIIFAYMALMLF
SFNYLFAWFNVLSGSFLTASNKASFSLILSLSQNLFIPLCFLLILSSIMGLKGVWLSPFF
AEFCVLVLACIFVRKVFKKLSFL
>fig|195.2024.peg.1116 hypothetical protein
MLKELLEIKKEMEPVIHEANVKLNVLAREVIVRRKEYEIYGPMVDRVYLDNAIYVKVMAS
GRDVKTDNVPIKTGFYMVFVAPEKESTKDIKNKLKVAYEGLDNKFIATLIRSCQRFKEII
NKTQATLSKASKMNVLVKTNLGEASAALKFNITIEYTKENQKLTRENTKSAGSFRDTRTY
INLVVDKNTDSQICEKLLDDVERYFIGGG
>fig|195.2024.peg.1668 C4-dicarboxylate transporter
MEKKKIPMLILCVLIALAFWIIPTPIGLEENSWHFLGLFIAVIMAVILQVMPLGAVCMIA
IAIVALSGITTTQSSVRATHIKTLEAIVLKDNSNIYKVTMDQKSQASILENLIKANVAKN
LEPKVNEILKSNSNIEYQIDSLNKLYAKATSKVAAQKLIDESKIAALNSLALEFMSQKDI
DEKVNTAISSLKSKTGIKDALSGFSNSLIWLIVVSIIVARGVIKTGLGERLAYYFISIFG
KKTLGIAYSIAFCETILAPVTPSNTARAGAIINPIVQAISRSFKSTPEDGTQNKIGTYLS
LVNFQANPISSAMFITATAPNPLVVDLVAQATNLEVHLTWGQWALGMFLPGIAAMLLMPL
VIYFLSPPEIKSTPNAKIFAKGKLEELGAMKGGEKITLGVFVLLLLLWAGALGFLFGISL
DATSVALLGLSLVLVSGVLTFGEVLAEKAAWNTLVWFSALVMMATLLGKLGVTQFLAEAL
GEFASAMGLGEISIMIFLSLAFLYTHYFFASTTAHISAMFFVFYSAGLALGAPPLLYAFI
MIASGNVMMALTHYATGTAPVIFGTGYVSLKKWWSVGFVISVIDITVMILVGLVWWKFLG
FY
>fig|195.2024.peg.856 Transmembrane protein YfcA
MGFEHLDTIYYFVLFFVALFAGFIDSIVGGGGLITLPALIACGIPAHLSLATNKLQSVFG
SFTATLTYFKSTTLPHLAYGIFFTALGAAIGSYSVLFVKDEHLKLIILIFLTLTFLYTAL
RPSLGKHESEAKIKNIKFFHLICGLTLGFYDGFLGPGTGSFWIFACVMLLGFNMKKASIN
TKILNFTSNVVALFIFLWRYELLWIVGLLMGVGQILGAYLGSKLVLKTNGKFIKTLFLIV
VGATIIKVAWDYFS
>fig|195.2024.peg.743 Fibronectin/fibrinogen-binding protein
MKYTELMQLQNFFSQFKKIDFIKRVNDNILELSFNRERFIFDLTRGMSAIYTAKLMSKNY
NAPFDFMLKKYFNNAFIKEVKLLQDNRILCFSVKVDKAYKSYESKIYFEFTGKNTNVIIT
DEKDLIIEALRHIDKSYRVVKPNVILEALKPYKMDEKFEEIKNFKDYFTQKFEILHANKI
KQIQTLKLAQIDKKIENLKELYLALDKEEVLLDQALNLRKQADILFANLSILKEYEREFE
LDDFEGKKVKFKLDLSPKESANLFYKNAKKLEQKARNLNLQRENLKEKLDFAYGLKEMLS
KAKNEFELEILLPKKSTKKNQENKQDNGIANFYFNEFKICVGKNEKGNENLLKSAKKDDL
WLHVRDIPSSHVLIISNKQKISEEVIEFSARLCVNFSGLKKGSYWVDYALKNFVKVQQKA
FVKYTNFKSINITKD
>fig|195.2024.peg.1263 Two-component regulator
MRILVIEDEISLNKTIIDNLNEFGYQTDSSENFKDGEYFIGIRHYDLVLASWNLPDGDGA
ELVNTIKHKSPRTSVMIMSAKADKDTEIEALKAGADDFVKKPLDFDILLARIEARLRLGG
TNVIKIEDLVIDPDEEKITYKGQDIELKGKPFEVLTHLARHSDQIVSKEQLLDAIWEEPE
LVTPNVIEVAINQIRQKMDKPLNISTIETVRRRGYRFCFPKKS
>fig|195.2024.peg.1284 Probable AAA family ATPase
MVRLKEFLSLKNIEESQIYKELKCSKNEALILRELCKNYVISISSINAFTLLTGIFGSEK
YSYLDTLEDLKRLIERGFVNQNSGFFKNIESNKSQNLILSLLQSELSLSEYFLEFLEAKP
RLNLDKKEAYGEYLEYLKDEFMRVELYERLSFIRSSTYSDELKAQIKLYEKHIKERLKKS
KFYNILADIFKEYSLEYKEQIIFLALLKEEYTLSNENSVSREMNSLLSLVSENDLEKHKN
KSLLQENAPLLNLIEYDEYLNVFGDISKSFFITDEILQRIINFEPKQNKKIKIENVLKEQ
DIFELIEPSIDINDIIMPQNTKELLENILKQQDKKVLERLNSWGIKSNKNIEAKIIFYGP
AGTGKTMSALAMAKSMKKTVLSFDCSKILSKWVGESEQNVRKIFDTYKNIVQTCKQSPIL
LLNEADQFLSTRVESSSGSDKMHNQMQNIFLEQIERFNGVIIATTNFLESLDSAFSRRFD
YKIEFKKPDFKDRLKMWEKFLPRKASFEKAFDVNLLANYELSGAQILMVVKNTALKVAVT
EDGVFKMQDFIESIQKELNSSFDKSKIVGF
>fig|195.2024.peg.1328 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MKCFNAKFMFVGILAVFLSACSSGIPKCSDQDVQNVLTEIILEHNFGRFSEVDRKKLKFT
YSGFMSDLTDKESKTQYCKAQVKANGSIDSCPYKWDAWIEYFARYTDDGMVYVEITR
>fig|195.2024.peg.872 putative lipoprotein
MLESKKTFWPYGILISIFAIVVACVATIIVASNYPVYEDDFYFDSYQNVENNYNIIQKQQ
EQFDALFKVEFQNDKIDLIGKRKIASYTISADSYLAQFKITALNDQANIQNLKSEILLTR
PHTREFDQKLLGQIQDGVLSVSLSQLEKGRWQLKIKLSTDDEITGFFSYELNVQ
>fig|195.2024.peg.1700 Inner membrane protein translocase and chaperone YidC, long form
MNNSNNIFQQKRILLAVVISFLFFVVYDYFFIPKQQIKLEQNITTTQADSQNATNINAPQ
QNPQANLNVAATSNTIPQDKIIADIKSEHFEAQIDSLGRIVNFYLQDKKYQNEKGEAINL
ISKGNLPYPLEMRFSDPAINTQAFSVPYAADMSEVFIDENGSKTLKLTQQLSDLIVEKKI
TFYSKGNYDIEVKLSKNINYFISPGYRPSIAVDSYTVHGALVMDDQETIHTYEDGDMDKD
ENIKNAWMTSAFDRYYAAFFYNFEKPLNVTISKDAQNNPLVFAMSDNEFKAGGYMGPKEH
VILRSIDPRLEAVVEYGWFTFIAKPMFEFLNFLHNHIGNWGWAIVIMVLIIRIILFPLTY
KSMISMNKLKDLAPKMKELRERYKGDPQKMNMHMMELYKKHGANPMSGCLPILLQIPIFF
AIYRVLLNAIELKAAPWAFWIHDLSVMDPYFILPILMGVTMFIQQLITPMTIQDPMQAKI
MKFLPIIFTFFFITFPAGLTLYWFVNNLCSLVQQWVINKMFAKEHHKKQAE
>fig|195.2024.peg.700 ATP-dependent DNA helicase RecG (EC 3.6.4.12)
MKIKENDFDFFKKLKIKSAIDLALILPKKIENLSPSKTPKENELCTQKIIIKSIHSKKGQ
LFGLGFCKEWSQDISFVFFHPRAWHFGICKIGKELILNGKLTRFGHVWQFNNPKILTSFA
GFAPKYQIQGLQDKKISEFIHKYLNYENLKESGIEDKYIHFLLNLHTYDEKSFLMFENLE
RFEKDLKYIEIYNFLKRLKAKKSHFKAYEIEIFNIANWLKNLPFSPTRDQLNALKDIEQD
LGSKEAKRRVIMGDVGCGKTLVLLGAALMVYPKQAILMAPTSILANQLYEEAKKLLPEFV
DILFIKGGKKEKDLEEKIKKANLIIGTHALIHLQSHNAVLVMIDEQHRFGSAQRQQIYSL
NENELAPHFIQFSATPIPRTLSMIQSELLNFSFIKEMPFKKDITTLCIQNEGFAKLSEKI
KEEIAQNHQIIIIYPLVNPSDKIPYLSLEQARRYWEDNYEKVFVTHGKDKQKDEILERFR
DEGNILLSTTVVEVGISLPRLSTIVIVGAERLGLATLHQLRGRVGRVGLKSTCYLYTKLK
EIPSRLKEFASTLDGFKIAELDLKNRLSGDLLDGFIQHGNEFKYFDFSKDEYILEKAKKD
LMEI
>fig|195.2024.peg.1364 probable integral membrane protein Cj0564 - related protein
MMIIVGILGLIISTAVLLTCGVFWVLFGIVFWGVILAFMLLDLSGSYGMVALYILFIVLN
LVLIYKIIRRKK
>fig|195.2024.peg.861 Type II secretion outermembrane pore forming protein (PulD)
MECQKRLFDININEDLSIEESLKELASYCSFSVVIKDTIAKEKLKAIQSSINIHQMSLDE
IFKLFIEEQDLAYKFDGKILKISALQTRIFKINYITSVREGQSITKASVDSKPRQSEYYS
AFEDNEDNMIKSMEKFDFWQNIEKEIMILLSSSHENYDIKAPIVNPNAGLVIVTGTHSQL
QRVKAYLQKLESRLKKQVIIDVSILAVNLNKNHSSGINWQNFNIGLNSQTSDNTNSFMQI
QNGQGFVKNLGLRANLNFDSIVNFLSQSGKTSVLSNPKLMVLNNQQAIISIGDTVNYQVK
ESSKGTENGTTVSESYSNYSIFIGILLNILPEISDDGKIMLRINPSLSDFKYPEDNKRQK
EPRTIAPDTIQKKLSSVVQVENNQTLILGGLISHNRSQNDNSVNFLSKIPILGSLFRSED
ENSNITEIVFIITPSIVDNTHIPSLRELGFKYNE
>fig|195.2024.peg.1493 ATP synthase protein I-like membrane protein
MSENSNKRQKIIRKTIEAADGLSLGISMVVAILIGIGVGYLLKKFTPYPWLFWLGVFWGV
AAAILNVYKAYKSQVKSYGEFQQRDEFIKEKIRQKEQDNGK
>fig|195.2024.peg.472 hypothetical protein
MFFKKKISQKQKEKPKIPINDVILDDRLCKFKNKVQKISKDEASASLLARQLSRLVRANK
F
>fig|195.2024.peg.1020 Bacterial ribosome SSU maturation protein RimP
MNLEALCKEVNLELYDSELTSENGKKIYRVYVMKPLDEKGERTGVNLDDCARLSEILSPI
FDVEPPVSGEYFLEVSSAGLERKLSKIEHFAKSINELVKITTNEKEKIEAKIISVENENI
TLEKLENQEKTTLKFSDIKKARTFIQW
>fig|195.2024.peg.1671 Flagellar hook protein FlgE
MMNSFYNGISGVKSNSFGIDITANNIANVNTTGFKYSDAQFKDIFYTTITTQSTNPAQGG
YGSGAASSQVVFEQGSPVASDGEFDVALQGKGFFGVLGADGNAYYTRNGSFRRDANGYLV
DSYGNFVLGTMNPAFTGINYSDRVAGLMGDYLNTGTPVNNGFTVNSNNSFSIGTTASQGA
IKVPVNMYLPPQVTQNVKWSGSLNTNTTTEVVKVDLDPSKFNITKTEDGKYVVSGSVSKE
DVFSAKAGDRIILNFTDDNGVKTSFEATLDENLNFKSNELDLKGLDENSIKLDTAQISTE
QQKANKDILESPIYNADGSKSTLRVTLERVLPQEGDNIQYKAIAQIYDSNGNAVGNPTEG
NMVFDKNGALLQNNITSIANPNGGTINIDLGSPYDANKPGSGYSGIYIKQGVEKNVVTQQ
DGVAEGFFEQYNISDDGSIVAQFSNGKNAIVGKLALYNFINEQGLVAMGDNIFAATANSG
DASFIMKDGQVVNTAKFKGGFLEQSNVDLSAELSNLIVTQKAFDASSKSITTSDQMIQKA
INMKR
>fig|195.2024.peg.408 KtrAB potassium uptake system, integral membrane component KtrB
MKQFGLDRRTFKILLAGYIVIALLGAILLHSSWAHTSPISFIDAFFTSTSAVSMTGLIVK
NTAVDFTLAGQIIILILVQIGGLGYMSIGLFVYLIIRKKVGFNGRNLLKESLFYPSMEGL
FKFFKKVLLFIFTIELIGTILLTMRFALEMNFGKALWFGFFHSISAFNNSGFTIFENGLL
AYKHDVAINLIFTSLIIIGGLGYFVLVELYFFQRKRLQNLSLHTKVVIMATLFLIISSTL
IIFLLEYANPKSIGSFSLFDKILSSYFIAINYRTAGFNTLDMSGLHDASLFFGSLFMVIG
GAPGGTAGGMKITTVVVLLFYAYWSIRNGRVRIFNHEIPQEIISRAFIIAVGSAVYIVIA
VIFLSLLESEFNFIHLLFETSSAFATVGISVGDGGDLSLCALFSNPSKIIIIIMMLSGRI
GVFAFLLSVFQQDKAIHIKFPKGKIYL
>fig|195.2024.peg.559 [NiFe] hydrogenase nickel incorporation protein HypA
MHELSIVESLIELCEENALNNKACNVQEIYVKIGRLSGIEVDLFKRCFETFKENSNICKN
AKLFIELAPLEILCLKCDQTSILEENVFKCPKCQSIEYKITQGEDLHLMRLVME
>fig|195.2024.peg.469 ABC transporter, substrate-binding protein (cluster 1, maltose/g3p/polyamine/iron)
MSKKFFLSLGLVALLFSNSQAIDENLIKAAQAEGRVNSLAMPDTWANWKDTWADLKNLYG
IEHSDTDMSSAQEIAKFKAEKKNASGDIGDVGASFGEIAVKQGVAQPFKTSYWDQIPTWA
KDKDGNWLLAYTGTIAFIVNKDVVKDIPKTWQDLLKGNYKITVGDVSVAAQAVSAVLAAN
YALGGDEKDLSPALAFFNTLAKQGRLVNNDVSIANLEKGEVEVGLVWDFNGLGYRDKVGK
DRYEVLIPADGSVISGYTTIINKYAKHPNAAKLAREFILSDKGQINLAKGYARPIRIDHI
TLPDDIKAKLLPSEQYKNARAIKDQKAWEKSAKELPQLWQEKVIVDMK
>fig|195.2024.peg.14 Periplasmic thiol:disulfide interchange protein, DsbA-like
MFKKMTKILTSLSLVCTFAMADDFITLSETLPDSKNSVVEAFSYKCIHCYNHHKFGTLEK
LREAFPNLHFKLYPVSLMNGEYANELNELFAFAQFKDEQNGKDASYSDSLSHKLADVYFV
VYFINKQDNFSSSDEFYDIGLKAMNVDKNEVLNFLSTPKAKEILNEFKRANDIARTYGTP
AFVVNGKYQINPSAISSMQALEDIVKKLSNMP
>fig|195.2024.peg.419 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine transaminase (EC 2.6.1.92)
MLTYSHQNIDQSDIDTLTKALKDEILTGGKKVDEFEEALCEYVGVKHACVLNSATSALHL
AYTALGVQEKIVLTTPLTFAATANAALIAGAKVEFIDIKNDGNIDEKKLEARLLKDSKNI
GAISVVDFGGNSVEIDEISSLAKKYNIPLIDDASHALGALYKSEKVGKKADLSIFSFHPV
KPITTFEGGAVVSDNEELITKIKLLRSHGIIKKRLWDSDMIELGYNYRLSDVACALGINQ
LKKLDHNLEKREEIASFYDKEFEKNPYFSTIKIKDYKKSSRHLYPILLFPEFYCQKEELF
ESLLHTGIGVQVHYKPTYEFSFYKKLLGEIRLQNADNFYKAELSIPCHQEMNLKDAKFVK
DTLFSILEKVKKGYCG
>fig|195.2024.peg.1712 Putative helicase
MLDKLEKFLVYDNVFLSGGAGVGKSFLTNELIRSYKRQGKVVIALGSSALSAFNIAGVTL
HSFFCLGYCQDMDTLSVFDRNQKQREKILKLKENLKKIDLIIIDEISMVSADIFEMIGFR
LKNSQFDGKILVVGDFFQLPPVIKEKKENLFLNSTYAFSSFFWKELKFKNIKLTQPKRTH
NLEFYGNLSLIRQGFLDDKILNFFENLCINTKELEELDDDYTLLCSINKKVNAVNDDRLS
KLESPLVCFKAEICKESKDIDEHKIQTWIKSLNILDELKLKIGARVIFCVNNWDKGYYNG
EQGIIESITYEEDKTYIGIMKNNGIKIMLEPYVFFMEELEQNNNEMFINVLASVSQFPIK
LAYAITIHKSQGMSIEKLVCDIDHIFENGQLYVALSRAINPATLKIYFTKRINFKAYFAS
ILKFDISVREFYQNNDFLDLELENNII
>fig|195.2024.peg.1223 Biosynthetic Aromatic amino acid aminotransferase beta (EC 2.6.1.57) @ Histidinol-phosphate aminotransferase (EC 2.6.1.9)
MKFNDFLNHLSNYEPGKDIEVIAREYGVKEAIKLASNENPFGAPPKAVKVLQENAFKANL
YPDDSMVELKGELAQKYNVKNENIIIGAGSDQVIEFAIHSKLNPQNAFLQAGVSFAMYEI
YAKQCGAKCYKTQSITHDLSEFKTLYEAHKDEIEIIFLCLPNNPLGECLDTNEVFEFIRG
IDENCLVIIDAAYNEFASFKDQNKYLKPCDLVQEFKNVLYLGTFSKLYGLGGLRIGYGIA
NAEIISAFYKLRAPFNVSNLALKAAVAALHDEEFAKKTLENNFSQMELYKEFAKKHHIKF
IESYTNFITYFFEEKNSTDLSEKLLKKGIIVRNLKSYGLNAMRITIGTPYENERFFTEFE
GILK
>fig|195.2024.peg.1616 Translation initiation factor 3
MSKEKEVLLNEEIRADEIRCIGDDGKAYGIISSDEALEIANRLGLDLVMIAADAKPPVCK
IMDYGKFRYQQEKKQKEAKKKQKVIDIKEIKLSVKIAQNDINYKVKHALEFLEQGKHVRF
RVFLKGREMATPEAGVALLEKIWTMIENDANRDKEPNFEGRYVNMLVTPKKA
>fig|195.2024.peg.674 SSU ribosomal protein S12p (S23e)
MPTINQLVRKERKKVLEKSKSPALKNCPQRRGVCTRVYTTTPKKPNSALRKVAKVRLTSG
FEVISYIGGEGHNLQEHSIVLVRGGRVKDLPGVKYHIVRGALDTAGVAKRTVSRSKYGAK
RPKAGAAK
>fig|195.2024.peg.204 hypothetical protein
MFKYLIRDFKDLKALQKAKDKAEELFYLDSEMVENSKKMQGILKGLIDKNNS
>fig|195.2024.peg.1471 transcriptional regulator, Crp/Fnr family
MDKEKILKEYFKNYNLENKDFEAMVEKSYFKEFDKNTILDDCLGFVIVLKGGFRAFILGQ
NAKEITVFKLKQNEECVICSHCIFETISYNLTLESFEDTQILIVPVKIYSQLKDKYPLIA
NYTLNLIAKRFNSLINILEQALFTPLHHRVKMFLKENAKEGKITFTHEEIALHLGSTREV
ISRILKTMQKEGFIQQNRKEITLLKDL
>fig|195.2024.peg.176 SSU ribosomal protein S18p @ SSU ribosomal protein S18p, zinc-independent
MAEKRKYSRKYCKYTEAKVEFIDYKDTAMLKHALSERFKIMPRRLTGTSKKYQEMVEVAI
KRARHVALIPYIVDRKEVVNNPFEGL
>fig|195.2024.peg.178 putative lipoprotein
MKKNFFLCILLGILFSACSTKNDEGLYNLSASEWYKQIIKDLQDKDLEKADDHYNGMASE
HIADPLLETTQIILAQAHMDEEEYQLAEFYLDEYNKKFGNSRNADYIRYLKIKAKFDAFA
VPNRNQALMLESQKEIDSFLNDYPYTEYEPLVQTMLTKFNLAVFYLNDTIQDLYERTGHT
QSAEIYQERLQESEFYQQSIIKPELPWYRSIFEKF
>fig|195.2024.peg.1713 Putative periplasmic protein
MKKIFLLAFLSLSLNAQSLELDKIRTDLYSKSGANVLKKIEISLEFEGEKLKENENKLTD
AVNTVISGFFYEDIFTELGKNNFKKTLEKFIDKKYKIKINEIYILSLSGVEKFDLEEFKR
FLASTEAKEKNVGSEVKKALDNLELPQTPAVPNISNIETPQIDQLFQDDNTQNQYDNGEI
DINTLNIPKMTSDIEEKIKRDLIANPPQIFKENNSSEEKGFELNLDTNSTMP
>fig|195.2024.peg.1137 Acetate permease ActP (cation/acetate symporter)
MKVFIFLSLIFNLALSAGFDLGEVHQKPINITAVSMFLVFVLATLFITYYSNKKSKSKSG
FYTAGGNITGMQNGVAIAGDYMSAASFLGITALVFTNGFDGLIYSIGFLVGWPIILFLIA
EKFRNLGKFTFADITAYRLEAKPIRVISAISALSVIIFYLIAQMVGAGQLIQLLFGLPYT
FAVVLVGILMICYVTFGGMHATTWVQIIKAILLLAGATFMAVMILYLTKFDLKYYFDLAI
SHHPKGENIMKPGTFLPDTVSALSLGLALMFGTAGLPHILIRFFTVKDAKEARKSVFYAT
GFIGYFYILTFIIGFGAIALLLGNPQFTNADGSFNGASNMIAVTLADVLGGDVFLGFISA
VAFATILAVVAGLAISGAGAISHDLYVNVIKKGDVKHEDEMRVTKIATIAIGIFAILLGI
VFEKQNVAFTVGLAFAIAASVNFPILLLCIYWKNLTTKGAFWGGLIGLIVVLALVILSPS
IWVKSFGFSEAIFPYDHPALFSMPLSFILIYIISKLDNSKRAKKDKEGFEAQDFRAQSGV
GVSEAVAH
>fig|195.2024.peg.474 Peptide chain release factor N(5)-glutamine methyltransferase (EC 2.1.1.297)
MTIKNALIEAKTRLEKHENEALFILCEYLKKDRTWIFLNQDLEFDSKPYFELIKRFQSGE
PFEYIFEKADFWGLEFKVKKGVLIPRYDSEILLSQVLKICKNNNFQNILEIGFGSGILSI
VLAKELGIKITACDINPKALQLALENAKLHKVEHLIDFKLCDFKQIKENYDFIFSNPPYI
QNSYPIDLWVQNEPKEALFGGEKGYEILEEIITFSFERKVKFLACEFGYDQKVILKQILY
QKNFQAEFFQDEQGYDRAFVAQFAKK
>fig|195.2024.peg.830 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTIGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTARNVGIEYFSGEYKLKNKTQTIKENSLIEFNIEGNNPYEIYTVYKS
YKAFNNEQDLTSFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVLWFDYRPLYDKVK
RKHISQMTYFDYKNEIIITPKEWLEKARERRLFYFWFTWQGMINFDFFKNIKLKFINGIF
AEDCHFGVLLFALSKNIYVLSKQIYIYRLRELSSMNFTNKKWIIHPNSHLKKIDVFENSS
ITRLYYESASWMQIALDFIKFIDSNHYLSEGIKTHFLPVVCNKALTLQRFDKDPLCLKKH
TKNLKIYIQNQPLGAVDRVKKYLSYKLTKELSRKKGILRLTLPFSVIRVSLQHQKGFIEY
KKNIKRDVLNKRLPLEFYRDYQQALTLKNQKLIQSLHDIGLKIMSLKG
>fig|195.2024.peg.251 unknown
MITKKINCKLINLKYFDDKNSTLIAIEKQVNCPFEIKRIFYIFDVPKNTIRGEHANLNSE
FFFIVLKGECKIKIDNGKEQKNFILNNPKQGLYIDKMLWKQMYDFSKDCILLVLSNTLYD
ANEYIRDYNEFLKAVDDT
>fig|195.2024.peg.1129 DNA polymerase III beta subunit (EC 2.7.7.7)
MKLSINKNTLESAVLLCNAYVEKKDSSTITSHLLFEADEDKLIIRASDFEIGINYKIRKI
RVESGGFATANAKSIADVIKSLNNEEVVLETIDNFLFIRQKSTKYKLPMFNHEDFPNFPK
TEGKNQFDIDSSDLSRSLKKILPSIDTNNPKYSLNGAFLDIKTDRINFVGTDTRRLAVYT
LEKTNNQEFHISIPKKAIMEMQKLFYEKIEIYYDENMLIAKNDNFEFFTKLINDKFPDYE
KVIPKTFKQELKFSTEDFIDSLKKISVVTEKMKLHFNKDKIIFEGISLDNMEAKTELEIE
TGVSEEFNLNIKIKYLLDFLTSIEEEQFTLSVNEPNLAFVVNSQGLSMVIMPMIL
>fig|195.2024.peg.1238 LSU ribosomal protein L32p @ LSU ribosomal protein L32p, zinc-independent
MAVPKRRVSKTRAAKRRTHYKVSLPMPIKDKDGSYKMPHRANPNTKEY
>fig|195.2024.peg.845 tRNA pseudouridine(13) synthase (EC 5.4.99.27)
MNLEEENTIFKPLYSLKHSSINAYFSKNSDDFVVRERPLYEFSGKGEHLILHINKKDLST
NEALRILSELSGVKMRDFGYAGLKDKQGSTFQYLSMPKKFESFLANFSHPKLKILETFIH
ENKLRIGHLKGNSFFIRLKKVLPSDALKLEQALINLDKQGFANYFGYQRFGKFGDNYKEG
LEILRGKKMKNVKMKEFLISAFQSELFNRYLSKRVELSYFANDFTEKELAQIYSISKEEA
KELKKQEQFFKLLKGEVLGHYPFGKCFLCEDLSAELERFKARDISAMGLLIGAKAYEASQ
GLALNLENEIFKDALEFKAKMQGSRRFMWSYLEDVKWRYDEQKAHFCMEFFLQKGSYATV
VLEEILHKNLFE
>fig|195.2024.peg.1192 Cytolethal distending toxin subunit B, DNase I-like
MKKIVFLILSFNVLFAALENYNTGTWNLQGSSAATESKWNVSIRQLITGANPMDVLAVQE
AGVLPSTAMMTPRQVQPVGVGIPIHEYIWNLGSVSRPSSVYIYYSRVDVGANRVNLAIVS
RVQADEVFVLPPPTVASRPIIGIRIGNDAFFNIHTLASGGNDAGAIVAAVDMFFRNRPDI
NWMILGDFNRESGALVTLLDPDLRARTRVVVPPSSTQTSGRTIDYAITGNSNTAALYNPP
PIVAILALAGLRTFLASDHFPVNFRRP
>fig|195.2024.peg.839 Dimeric dUTPase (EC 3.6.1.23)
MKNVEILENMLKLQQKLNDETNGLNWEEGYTKEGKLISWRRCIYMECAELIDSFAWKHWK
NISSPTNWENVRMEIVDIWHFILSLLLEEYTNKKDKNFQAIANEIISVSVFQDFCKEEGN
PSENDLYSILNDIELIIHKCSGFGFSLGELLSNYFILAIKCGLNLEILYKTYIGKNILNI
FRQNNGYKQGTYKKDWNGKEDNEVLAEILEQELDFDTIYKKLEEYYKKV
>fig|195.2024.peg.1211 Pimeloyl-[acyl-carrier protein] methyl ester esterase BioG (EC 3.1.1.85)
MKISNLIQNENSQELILVFGGFASHPSHFAHLKSDKNVVLVYDYENLDFKFDLNSFSKIT
LIAFSMGVCVASRVLKNIEFSQKIAINGTPFGIDKLKGIHPAIFAKQIKKFDLTAFKKSL
FKERENEAKDFIFKDEKDLKTELEKLFEFALKERNESFIWDKIYSSNHDEIFPQNALKNT
FSKLIFLDEPHFAFFHFKTWDEI
>fig|195.2024.peg.1224 Flagellar M-ring protein FliF
MDFKNMLHQIGQLYQNLTRKQRIVIAASIVVVVGFLVFLALFRGSGSGANNGYAVLVDNV
DPSSSAAIVAKLEQNNVPYILESESKILVPQDQVYRQRMFIASEGLIKDSRVGFEAFDTQ
SFGATNEEQRVKYQRAIEGELARTIETLEPIRSAVVHIAFPKDSVFTERQIPPTASVVVN
VREGLKLTRKQIDGIKNIVSAAIPKLTKENVRISDQSGVPLDEQEAYEDDLVRAQIKYKS
DQERALEDKIIETLAPYAGGTDKVRVSVNIDFDFSKQESQSEIYDPNPIVRSEQTLNEER
TGRKEPEIQGVPGAVSNIGPVEGLDNKGQIDTYKKNQVTTNNELSKTITNTKKQFATVVR
TSAAVTIDGKYQDVVDENGDVKSEYVPLSKEELASVESIVKNTINYSANRGDSVVVQNLP
FHRESIRVESKVKTFYGRFIEPFIPPVKYIIAAILLFIFYKKVIAPFTQKMLEDVAAQEE
VQQGPNAVLDDAEDALEKFNAARKKVEEQLGFGENFNEDSIQYEVLLEKLRGLVSDKSEE
IAALLQNLIQNDTEFGEKDM
>fig|195.2024.peg.1001 16S rRNA (cytidine(1402)-2'-O)-methyltransferase (EC 2.1.1.198)
MLYFIPTPIGNLSDISFRALELLKTCDIFFCEDTRVSKSLLSLLSSKFEIDFGDKKFISF
HTHNEKKVLENLDLEFFNQDIAFLSDAGMPGISDPGQFLIDFALENDIQFEVLPGANAAL
VALVSSALCEKEFIFMGFLANKGKERQKDIQKILNHPYPSVIYESPKRILSLIEQIAILD
SQREVFVIKEISKKFEAKFKGKAIDLFNELKQVNLKGEWVVVLAKNDKDNISHSLCENDI
LELEIPLKTKSKLLAKMNGKNPKEIYQKLLLSQS
>fig|195.2024.peg.1393 SSU ribosomal protein S20p
MANHKSAEKRARQTIKKTERNRFYRTRLKNITKAVREAAAKNDKNAANEALKIANKSIHA
MVSRGFLKKQTASRRVSRLALLVNKIA
>fig|195.2024.peg.142 Thiazole synthase (EC 2.8.1.10)
MQENLKNDSLKIGKYEFKSRFILGSGKYSLELIKSAIEEAKAEIITLALRRANTGEIANI
LDYIPKNITLLPNTSGARNADEALRIARLSRELGCGELIKIEVIGDSKYLLPDNYETIKA
CELLAKEGFTPLPYMHADLYVARAMRDAGAAAIMPLAAPIGSNKGLCAKEFIQILLNEID
LPIIVDAGIGTPAQACEAMQMGVSAVMANTAIAEAKDIALMAKAFSLAIQAGRAGYLAGL
ASVSEAKASSPLTGFLRD
>fig|195.2024.peg.1340 NADH-ubiquinone oxidoreductase chain M (EC 1.6.5.3)
MLNYLIFFPLIAAFVTLVLNRGGIKVFSVIASLMVLGLNIKIWQDYLNGINLEYQLPFKV
VNFMSYHIGADSIALILMLLSSLMIFLSFLFLKIEQKAMVSCIFFLEFAIMGLFSSLDGL
LFYVFWEFSLLPLLYIMGVYGKDYRAGIKFFIYAFAGSILMLLALIYQAYATYKLLNIFT
FDIEIWKNNASAMSFNEQILLFGAFFIAFAIKAPLFPFHTWAPKVYANSPILVSMMLVVF
KMAPFGFLRFCLPLFPDASVYFMPLVVALCIVSIVYNALIAYRASNLKELIAYSSISHLG
VMILGIFSFNALGLSGAVFYMFAHGIVTGALFLMAELLYKKYGTLEISYYHSLANKAPLF
TIFFTLILLASISLPLTISFVGEFLILLGVAKLNLLYALLAGLVIILGAIYMLHVFRKMF
FMQKESQLETCSLHAREILSLIPIVVLIFYLGIAPKIFLDPLNKDADFIVEKMKERAIDD
QTIRFLNHLEGENNVR
>fig|195.2024.peg.1126 hypothetical protein
MRLCEVYKQVLFQLLKFFMNFLKIYRKNLKVFWEFMKLWAFV
>fig|195.2024.peg.267 Hypothetical protein Cj1162c
MKFKVANINCQNCANLIKNSLEDIFGEIKIDLDVNPRTLSLNLDSSREEEFKKELSELGF
EVLEKIE
>fig|195.2024.peg.1690 hypothetical protein
MKYNYIKWNKEEKCAIFFPDIDYSLWKKTQLKENAYNNPSLIISSCLITKMDILELFEYY
ILFICGKSMGVSRWECNNLILLGTCNIDNLSNPFSLNTPKPTYISEYINILGQLFLAGYI
DFGSYCDEEDRNKIDYPSNLSYYKEDKYQAWIYFRDNFFYQDKFIRDLDDPETLDEGGYS
LILNDVSWDTPQYWSQYNIWVATTPKGTKYFNEILAPKFYNKYKDLEVEIDDKGNIIRWI
GKINR
>fig|195.2024.peg.511 Possible sugar transferase
MEQILKILKQMLSPDQAQILLKALKNSNNENFYNFALENIEIICEWLNSKEFQENYTNHP
YPPLLNPNYIDTDASRHCAELAWDLNLPLPKHYKFIYISPHGVGAAAFLRYLNEACNVFC
LASWMLPYDAKERYCINYMCLNDKNISDQAINISELNIINLEKYLALLDPHSKVICGIRD
PIGILKHNWGRDWSKVQRNFQNEFDLTYDYRNYINFLNHKKPEIKINLEELNYSVFIINY
LSKYFNQEYIYYLDMEKIKTKNAFQTMEDLAFRFGFTPPCLKESENLFKIQEFRGYIRYL
FPITLYANQKDLSNIFSIKSPNNNPNASIDTSTSIAIILDRPHKNSQKINIINEILNNDL
SNDMSVYIDKSDLEKLEKNTLFFKQIKNYLYEFLQAIHKTIEHTEDSMMKEEDVLLYFSK
NKTLALEFKEIFNKELNNVKQSHPNIIASWKYYQEFEKICKKLDEKE
>fig|195.2024.peg.365 hypothetical protein
MEKFQSPKIIKNTSAILNDLMSKSHYRPLKTLFFCKDFLNSFPPAKQRLIARIYIKNHIL
NIVTLNSAAYQELNHDNSKIYIKVLIKKYGKMYPLSGFSDIKDLKIFTQKYNNTIKNNEN
FTAKKPYIELSLGKFENKFENKILAKKFEEIRQMIRNG
>fig|195.2024.peg.912 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLMESDFLEKIPFIDEVLIYKD
DFLEKIQSKNPVIFITTRRQGLYFKKLKFLNVQKCIVFPHLISIISKNLTTPLPFFRAKK
HMSEIVLKLVRMINTRHFDKNFNQIDFSKIKNLLPYDARLSDNFFKQIDTKYEKIIGINA
FSNNSEYRGFNFFIKDWIGLARQLSLKYPKFLFILLNFSTNSIQYNIDQNANLKVFCNNK
NIASLVSISQKLDFLITVDTGNLHLCDILQIPTLAFTSSLAAYRFGGGSYGGRFDKLIVK
PAWQKEYRKIYEIFTKKAENNLENL
>fig|195.2024.peg.1159 Membrane protein
MQFTIFHILAFVILLLCFILVCILIFLKVKQKEFALISYTIATIFTALLIYSVFLTINQF
TTQASLSKLTFSRDLRHESIIITGRVQNLTKFNIRKCYLMLSILNKKRVGGEIFNDKNIR
NAKMQNTSVSYTIEIIDTLPGNTYKEFRVSVPFPPSFNNPEFYHTLKCI
>fig|195.2024.peg.1136 hypothetical protein
MKKIALFFVLFVCLLNLNAKDKEWLPKGESISVYEYIPNNPRSPAAFSSVDSKKLNANQR
KGQQVYSKWCIACHGEGMPGTNALSALYKDQGIPALLEDRTDLSPDLVTIFVRYGKHSMP
FFRKTEISDKELQYLGEYLGRNYK
>fig|195.2024.peg.881 Two-component system sensor histidine kinase
MANSVAEQVLKVIEKKTIFFKINLQGIIIDASEKFYKISGYSKKELIGKHHFILKHPDVK
ESYINQLLGKLWQKEAYWVVFKNVDKLGKTFYLDAFLIPIVDNKGDLNEIIALSYDISNS
FKLNEELVLNHAKLREISVNLEKTAKERKEEFAKLSKDFEYKLKVALEKNEKDTKKIYKE
ILNSSIEQMISDIAHQWRQPLNELGIAMFQMKQNVQDEKGFTEIYLQSKSTIKNMSETID
IFRTLFKNNENEKNHVSLREILNKVIGIAFETIEKHQVNTRIISKTDYRVIAHENGLMRV
FLNLIINSIEAFKTQKVKNIIFSFSKFGKNYIKVKVKDNAGGVDEDILDKIFQPYITTKH
PSQGIGAGLYISKQIVESFGGKIQVKNIKDGACFEIYLKLQEGN
>fig|195.2024.peg.216 ATP-dependent Clp protease adaptor protein ClpS
MPKLKVLEKSKLKEPKMFKVILLNDDVTTMDFVIEVLINIFYHDFETANKIMLEVHLNGS
GICGIYTQEIALSKQKKVSDAAKLANFPLQTRVEEE
>fig|195.2024.peg.1527 ABC transporter, substrate-binding protein (cluster 3, basic aa/glutamine/opines)
MKKIILIFISFFALNLSAKDLVVGMELGYPPFEMSDKTGKASGISVDFLEAFAKKNGYKL
VVKNIAWDGLIPALKTAKIDLIMSSMTITDERKKVVDFSIPYAKANLAILTPLNSDITNI
KDLDKKGKVLALKRGSTGHLYAVKNLKNATINLFDKENAAILEVIQGKADGFFYDQLTIY
RTWQKHQDTTRAILAPFQENPEFWGIAVRKGDEALKDKLDNFIDESRKNGFLDFLGNKYL
KDIKEVFKQNNITFFL
>fig|195.2024.peg.1562 Periplasmic nitrate reductase component NapD
MNLSSVLIVAKVQHIDELKKEILKIPSCSIELCENEKIIVVIESESLEKELESYKMLEKL
PHIISINMVFSYQDLDKDIQKAINSGAIQTIEKNENAENIRYYGSIYNQMS
>fig|195.2024.peg.1595 putative TonB-dependent receptor
MKTFISNHKNQSSFITLFVFTPLFFVFLYSKDFLHIQPNETIKENKFNMAIKHFVQNSSD
MKPTQPTQTIQEPSNVQPKEPVQEIKKIKPRKEKPIAKPKKIIPPANAKAISQPKKDTNM
QQPIMQQQTPQASSYQSVSLTSNSEFLKEIKSAIDEALIYPRQARKMRMSGEVLVEFTWT
KEKKLENLKILKPSKYDFLNKSALETIRIASKKFPQYEKTFHIKIPLVYKLS
>fig|195.2024.peg.1457 Possible periplasmic thiredoxin
MKKVFLFFISLFLLNACSFDTNQDQGKIGQIGAEISAKDTLGKAVKLADDKSNIKVLVFF
QNGCPSCLQELPSLDKFMREHPNKISVYAINSVDKVEVVQVLAEQLNFKNIKVLTDDLKI
TNDRYAVFATPTTIILKDGIIKERILGEKPWQTFESKLISLL
>fig|195.2024.peg.101 TrkA domain protein HP0282
MNHILIIIDGILAKHFLERLCFEKGLGYFFTIVCQNEENINLGANSEYIEFHHFDPTSTA
RLETLMNKSFKQAFIYMQDEFETKKTYEALRSLDANLEIEIMDFWGLNINDVHTNLADAR
MTLSRRFMDFLPDIALTAYCVGLGVGEVMEVKIPAGSIFAYRHISSIQQKRWRIVLIYRN
SKIYFVKPSFVLQPNDSILIVGDPAVLQSIFHNIRGKAGQFPLPFGSNIFTLIDMKKMSE
DTQERLLDTTLQLVKKSNAKKFFIRVLNPKLGALYDKMKQLSDEQESIFFDFFNTDFANL
NSFLENNDIGIILTDFKHFEQEKKTFFELKIPILKIGEGKFENIQNAVILSTNETELENN
ANVITDLSKQLDFDITLYYYNPNLQNTTDMEEYFGSLSKLYDKNIQIISKNDENPILSLS
YRADLLQFVSFEKELLEGEFSKSLSTNLNRHYSKMRQNYQLFIPVE
>fig|195.2024.peg.401 Twin-arginine translocation protein TatC
MFEELRPHLIELRKRLFISVACVIVMFIVCFAFRSYILDVLKAPLIQALPEVAKHVNVIE
VQEALFTAIKVSFFAAFIFSLPVIFWQFWKFVAPGLYDNEKRLVVPFVSFASIMFALGAC
FCYFIVVPLAFKFLINFGLSEDFNPVITIGTYVDFFTKVVVAFGLAFEMPVIAFFFAKIG
LIDDSFLKRHFRIAVLAIFVFSAFMTPPDVLSQFLMAGPLCGLYGLSILIVQKVNPAPKD
EEKEESDK
>fig|195.2024.peg.1432 DNA primase DnaG
MITKESIENLSQRLNIVDIIENYIEVKKQGSSFVCVCPFHADKNPSMHINPTKGFYHCFA
CKAGGDAFKFVMDYEKLSFTNAVEKIANLCNFTLSYTKEKNENKKELRTILPSLNAYFKS
NLKHHKEALDYLYKRTLNDQDIAKFELGFAGSSEDSIRLFHNEKIPLEDAMSVGALKKDE
NNEFYASFIWRITFPIYDHKDLLVGFGGRTLNPNVAAKYVNSPQNILFDKSRIFYAFNIA
KENIAKKKEMIVCEGYMDAIAFHKAGFNNAVAVLGTALTENHLPLIRRYEAKVILCFDND
EAGLNAATRSAFLLSTHKIDGKVALLEGGKDPAELVANNQSAKLHTLLEKGMDLGEFYIR
RILSSFSLNSALDKQKALENIQKYTFSLEPLVASSYVGLVSKLLGVDEKLIVLTSNRKPS
KTINFNTSFQQTQNHNPKSHITELELLNYLKNNPNMHELFIKITDIRCFKHKVLLEKILE
HKSYEDSDIREFESKNFSKDLSQIEFLWGICKVNLAFLNHINITNSYLALKKQIFTLIEK
NFVLLSKNLNDHELVEFLKENLFLLKNEKDEEKLEALFKNLHRFFSAKNLDIKILKNNSE
NDYNEEPF
>fig|195.2024.peg.767 Nucleoside 5-triphosphatase RdgB (dHAPTP, dITP, XTP-specific) (EC 3.6.1.66)
MKILLATSNKHKVIELKELLKEFEIYAFDEILTTFEIEENGNSFKENALIKARAVFNALD
ENQKNEFIVLSDDSGICVDVLGGKPGIYSARFSGKGDDKSNRDELVKQMRVLGFEKSKVH
YVAAIALVSLEGEWTMHGTMHGHVINTERGENGFGYDSLFIPKGFDKTLAELSHNEKNQL
SHRFKALELTRIVLKVLNKGKG
>fig|195.2024.peg.5 Flagellar hook-associated protein FlgL
MRITNKLNFTNSISTSMGAQSSLYQISQQLSSGIKIQNSYEDASVYIDNTRLEYELKTLE
QVKQATNSAKEMTQNSMKALQDMVKLLEDFKVKVTQAASDSNSQTSREAIAKELERIKES
IVQLANTSVNGQYLFAGSQVANKPFDSNGNYYGDKNNINVVTGAGTESPYNIPGWDLFFK
ADGDYKKQISTNVSFTDNRWDLNKDPDKTKYLTGDSKWQQLIGQSYVKDNSLDADKDFEY
DDSKLDFPPTTLYVQGTRPDGTSFKSAVLVKPEDTLEDVMENIGALYGNTPNNKVVEVSM
NDSGQIQITDLKQGNNKLDFHAVAFTPQADDKTELNNIIQAAQDEGITMEDVTNRVMTAA
LGNPNNGDITNLNNPVTIQINGQNFEIDLKQTDFIKSKMTDTDGNAANGADYDNVYFEKN
GNTVYGNVSQVIKGSNAYATDSTKLSEVMAGDSLNGTTLNLKVNSKGGNSYDVTINLQTS
TVSYPDPNNPGQTISFPIMHTNPATGNSGVVTGSNDITYGQINDIIGMFAADKIPTTTIQ
ANNGQINNADYTQIQQLMKDSQATVDVSMDYKGRISVTDKLSSGTNIEISLSDSQSGQFP
APPFTTTSTVQNGPNFSFSANNSLTIDEPNVDIIKDLDSMIDAVLKGNMRADSESENPRN
TGMQGALERLDHLADHVSKLNTTMGAYHNTIEGVNTRTSFLSVNVQSIKSNVIDVDYGEA
MMNLMQTQLAYQASLKASTTISQLSLLNYM
>fig|195.2024.peg.378 Putative efflux pump
MENFNRTLWVCWFGVFTTSMGLSQIAPILPLYIKELGHTDTSEIAFYSGLAFGITPLGMA
IFSPLWAYLGAKYGYKNMLLRASLGMSALTLWLSFAHDAMEVVLIRGLTGIVSGFTAAAV
VFIAVIAPKEKVAYALGTLSTASISGSLLGPLFGGVVAGIFSISAVFDLVAFLLACSFVT
IFLFIHERKIQKEAKKNTQEFKENKKLIVIIFITTFIIQFGTFGVMPILSLYVEQIYQGE
NLALWAGIVVAASGISNLFFAPKLGKIADKIGPSKVIFSALIFCGICFYLQSLATNVYAL
IFVRLLIGIGLGGLLPCVNALLKKGVSAKNLSLVFGFNQTCQFLGNFCGAFGGGLITAHF
SVELVFAFICCIFILNAIIFLIFERNYIFSNQGL
>fig|195.2024.peg.1314 putative lipoprotein
MKKYFLFIIALFLAACSGASNNFVHVSMPNFKPQTPTKVEPIDSGVSIMLEPINIEQNNN
YSDYFENSVLKIRIDKEVALLKENLEEQFKTIAQLKGYKIVTSNPDYTLKSLINVLIEEK
NIQKSNNFMSGESVKSNLGIKFQGKIDFIDQHNPQNSTNLTSHTKLDSLVDLNYPIKTKD
GINMFKTTISTVPTQLNKGLEKPAFEIDKSFLHFYKNTLNTLYNNLPKATDIGKTVPNSN
TDSSGFNHFDTNTIFEENLPQEQNLDNSSQDISFQEQTSSNSNIQYENNTNKNQDGVIIF
E
>fig|195.2024.peg.1345 NADH-ubiquinone oxidoreductase chain H (EC 1.6.5.3)
MSDFAFFALEALIKCIIVIAIFATLAGLATYAERKVLAYFQRRIGPDMVGPFGLIQLVAD
MIKLFTKEDIIPSNSQKLIFAIAPLIAAICAFVSLAAIPMLPEFTLFGRTIQPLIADINV
ALLFVIGTSGLCFYAIFLGGLASNNKWSIIGAARGLVAIISYESVGALALIAIVMLVGSF
SLIDINNYQSDGFFSWLIFKQPLAFALFVIALFIETNRTPLCLTENEADIVAGYGTEYSG
LRWGMFFIGEYASMIAGAILITLLFLGGFNDFYFIPGWIMMIVKSSFIFFWYFWARAAFP
QLRPDQVMRMCYLILIPLAVLNLLITAFAVLI
>fig|195.2024.peg.672 Translation elongation factor G
MSRSTPLKRVRNIGIAAHIDAGKTTTSERILFFTGMSHKIGEVHDGAATMDWMEQEKERG
ITITSAATTCFWKDHQINLIDTPGHVDFTIEVERSMRVLDGAVAVFCSVGGVQPQSETVW
RQANKYGVPRIVFVNKMDRIGANFYNVEDQIRNRLKANPVPLQIPIGAEDNFKGVIDLVT
MKALVWEDDTKPTDYVEKEIPAELKEKAEEYRTKMIEAVSETSDELMEKYLGGEELSLEE
IKTGIKAGCLSLSIVPMLCGTAFKNKGVQPLLDAVVAYLPAPDEVANIKGEYEDGTEVSV
KSTDDGEFAGLAFKIMTDPFVGQLTFVRVYRGCLESGSYAYNSTKDKKERIGRLLKMHSN
KREEIKVLYAGEIGAVVGLKDTLTGDTLASEKDKVILERMDFPDPVISVAVEPKTKADQE
KMSIALNKLAQEDPSFRVSTDEESGQTIISGMGELHLEIIVDRMLREFKVEAEVGQPQVA
YRETIRKTVEQEYKYAKQSGGRGQYGHVFLRLEPLEPGSGYEFVNDIKGGVIPKEYIPAV
DKGVQEALQNGVLAGYPVEDVKVTVYDGSYHEVDSSEMAFKLAASMGFKEGARKAGAVIL
EPMMKVEVETPEDYMGDVIGDLNKRRGQVNSMDERGGNKIITAFCPLAEMFGYSTDLRSQ
TQGRATYSMEFDHYDEVPKNVADEIIKKRNG
>fig|195.2024.peg.544 Uncharacterized metal-dependent hydrolase YcfH
MFLNLEFKDGLKIIDTHCHLDSEVFKEDLDELLKHSFDNGIEKIIIPGADIKDLPYAAEL
ASKYENVFFAAGVHPYELEGFDEKILRAYLQDEKCVAVGECGLDYFRFKSEDLKEREKEK
EEQKRLFVAQLELAKEFKKPVIIHSREANNDTYEILHEHSKDLVGGVLHCFNASEHLLRL
SDDGFYFGIGGVLTFKNAKNLVNILPQIPKDRLLLETDAPYLTPEPYRGKRNEPLLTQFV
ANKMSEILDLPKQELLRICLENSYRLFFKG
>fig|195.2024.peg.638 Uncharacterized membrane-anchored protein HP0586
MKKKIVYALLVLIVFISVVFLVLKNGILISHIQFSFLNLEQLYIKLDKKLIVRAKNITFN
EDNNASIQDDKNVNSDFASKELLNITKNLKYLYTFVEEIDIQNFNIKDNHMRILFKNDEF
FVDNDLLFLKLALHREGKEINADIKNLLLKDYNLSIDGNLSINAKSEFYNFKGQANSDLA
DFKINISYKNQNLAYKFEDINIRDITTIFNQAKKRIALPEPLVLWVAHRAKGDFYHFDFI
QGFIDFSKNNYYFDDISAWGYANNVKVRLDNQMNAINFPKLDLNLSNQKLNFTFNKASYN
ESDLSESKVFLYDLFDNKKHGIYLRIKSKNLKFDEKLAKALKNYDLNLPFYQKNGKLGSD
LELIIDFNEKGDVKYNGTLSLENAELSLANFSVARAFVKLNQNDLSIENASVKNEFLEAD
FNAKIDLATHKGIFDTQISRLYFDNGELFDMRNQKTKINLDYTDDLQLSVPEWDLTLNFK
EGFEAYANNPNILIPHSPLLKKFGFMSAKSIYYKSVDFNDFNAQIQDAHFKNNLLVNNKP
YENDSFGIVRKSGVLNINTQSGLANVKVIDNNKTIHLKNLTYIYQKDENVSTSSFDIAKN
TQNIILNGENLTLILADFNKTLNFDKMEANLKSDILDARATRKNANFDLHYSPNDLKLFI
KNINDEHLNEFLQKRAVQEGVFNFSVIGSGLDYFEGEFNFKDTFIRDLKGVNQLISFIDT
VPSLLMFKTPTFNEKGLSLHDGRVVFNRKKDLLSFEAINLNGNSMDLYGLGSANLRLNTI
DIDLELKTLKSASETISKVPILNYVILGKNQEISANIKVDGALDDPKFHTQILSDTLKTP
FNLIKNIIQLPSNLFN
>fig|195.2024.peg.1183 Phosphoserine phosphatase (EC 3.1.3.3)
MIKLCVFDFDSTLMDGETIDILAKAYDKEKEVVDITHRAMAGELDFFESLQERVSFLKGM
PYDLVLKIGQDLPLMNGAYELIEFLNSKNIFVVIFSGGFHEGIDPAMKKLKVNLGFANYL
HHKNNTLSGLVGGEMMFSNSKGLMLQRLKNFLNLQTHEVMCVGDGANDIAMFNESGLKVA
FCAKEILRSKADICVDNKDLKEIIKVI
>fig|195.2024.peg.1007 UPF0102 protein YraN
MGFASYLSGILGEDKACEFLKKQKFEILKRNFRSKFGEIDVIAKKDGILHFIEVKFTQNN
YEVSERLNVKKYEKILKTIEFYELKHGILDDFQIDLICISDDMIQFFENISF
>fig|195.2024.peg.1252 Membrane protein
MNFTDLPYIFIGIFSGITSGLFGIGGGMIIVPSMFALGASAHHAIGISVLQMIFAAIFGS
YINYKKKNLNLKDGIVIGLGGLLGASFSGILLQALSDVALTAIFLGVSCVFFIKYAFGIK
ESVVKSHKSVWVKNGILFIAGAFTGIFAISLGIGGGLLIAPILAYFLGYDSKKVVSLSLF
FVIFASISGIISFANSGVIDAEVIHKGVLVGFASMIGVFIGIKIIEKMHISAHRKILLCV
YALSILATTLSLLRKLGILAF
>fig|195.2024.peg.927 Uncharacterized metal ion transporter YcsG, Mn(2+)/Fe(2+) NRAMP family
MINKTALLGAAFLMATSAIGPGFLTQTATFTGSLLASFGFVILVSIILDIGAQLNIWRII
GISGKRGTEVANMVLPNLGYFVAFLIALGGFFFNIGNIAGAGLGLNIVLGISVENAAVIS
AIIAIGIFIFKKAGELMDKFIVLAGFVMIVLTAYVAFASKPPIGEALFRTFIPTQIDVIS
IVTLVGGTVGGYIVFSGAHRLIDAKLYGKENLNYINKAAVSGIIITGIMRVILFLAVLGV
VSSGFILDKENPAGSVFHHALGDLGLKIFGVVLFLAAISSVIGAAYTSVSFIRSFHPWIE
KYNRFVVIFFIIVSTLVFYILGKSPASILIIVGTINGWILPVTLFIMIIAAHKKSVVGDY
KHPKWMSAFGLLIVALMSYLSVLSMIKLM
>fig|195.2024.peg.1242 Alkyl hydroperoxide reductase subunit C-like protein
MIVTKKALDFTAPAVLGNNEIVEDFNLYKNIGPKGAVVFFYPKDFTFVCPSEIIAFDKRY
QEFKNRGIEVIGISGDNEFSHFAWKNTPVNQGGIGQVKFPLVADLTKQIARNFDVLYAEA
VALRGSFLLDADGTVRHAVVNDLPLGRNIDEMIRMVDTMLFTNEHGEVCPAGWNKGDAGM
KANPKGVAEYLDKNEDKL
>fig|195.2024.peg.657 Multimodular transpeptidase-transglycosylase (EC 2.4.1.129) (EC 3.4.-.-)
MKILKYIFSFFVVCLIAVFIYVAYLFANADTQGYTFKEYKPPLTTQIYDRNGKLVANIFE
QHRFYASYEELPLRLIEALVAIEDTSFFEHDGVNIDAIFRAIVKIIRSGGKTMEGASTLT
QQFIKNTELTPERTITRKIREALLAYKMETILSKEQILERYLNYIFFGHGYYGVKTAAQG
YFHKNLNELSLKEIAMLVGMPKAPSSYDPTKHLDLSIARANNVVARMYTLGWISKAEYDE
AMKEIPQVYDDTLTQNAAPYVVDEVIKQLSPSIKDLKTGGYKITLNIDLDVQEMAQNALK
FGYDEIVKRDKDANLSTLNGAMVVVNHQSGDVLALVGGVDYEKSNYNRATQSTRQPGSSF
KPFVYQAAINLGYSPMSEIADISRIFEGGAGDNKDWKPKNDGGKFLGLITLKEALTRSRN
LATINLALGMGLDVLHSKLVEFGFRDIPANLSIVLGSFGISPLEYSKFYTMFGNYGVIKE
PQIIKQVQDRNDQIIMEFNSNEYRVSDEAQSFLVLDMMRNVVEHGTGRNARVEGIEIAGK
TGTTNKNIDAWFCGLTPEIEALIWYGNDNNKPMRYTEGGARTSAPVFKEFLNKYLEKFPD
TTRKFSIPNGVYRGSYKGQNAYYTIKSPLPRANMKFNESEILF
>fig|195.2024.peg.651 Phosphoribosylformylglycinamidine synthase, glutamine amidotransferase subunit (EC 6.3.5.3)
MKVAIIRFPGTNCEFDTQYAFEKLGVKAQIIWHEEKEIDADLVVLPGGFSYGDYLRCAAI
AKIAPAMQGVIAHAKRGGYILGICNGFQILLESGLLEGAMKHNNNLSFISKNQNLRVVSN
DNVFLKNFQKDEIINLPVAHGEGNYYADEATLKKMQDKDLILLKYEPNPNGSVLDIAGIC
DENKKIFGLMPHPERACDKILGNDIGLRMLEGFM
>fig|195.2024.peg.586 Chaperone protein DnaJ
MELSYYEILEITQSADKDTIKKAYRKMALKYHPDRNQGDKEAEDKFKLVNEAYEVLSNEE
KRAIYDRYGKDALKSGGFGSGGAGFGGFEDLGDIFSSFFGGGFGGSSQRRKKSSDEKFQA
ELVVNLKLSFKEAVFGCKKNIDFTYKSSCKTCSGTGAKDGKLQTCPKCKGRGQVGISQGF
ITFAQTCPDCKGSGESASEKCKDCKGKGYEELKDSVEVNIPEGIDNGMNLRVAAKGNLSK
SGDRGDLYVKVIVEEDDTFIRDDEDIYIEFPVFFTQAILGQSIKVPTIRGEATLNLPKGA
KDGQRFVLEREGVKDVHSSRIGNQIVQIAIKFPNSLNDEQKELLEKLSESFGIKDGMHHE
QKGLFEKITHWFKS
>fig|195.2024.peg.1259 Flagellar motor switch protein FliN
MGSDIDFGDRHGLLQSYEDILDITVDFVSELGTTNMSVAELLKLEVGSVIDLEKPAGESV
ELYINKRIFGKGEVMVYEKNLAIRINEILDSKTVLQYFKKEI
>fig|195.2024.peg.483 tRNA (guanine(37)-N(1))-methyltransferase (EC 2.1.1.228)
MKFSFVSLFPNLLEFYFKDSILARAIQKELFQLDFLNPRNFTDNIYHKVDDYKIGGGAGL
LMQIKPLYNTLKFIKDSEKDPYFIFLNPSGKTFNQKDAKRLSKKENIVFVCGRYEGIDER
VIEIFANEVFSIGDFILTGGELPALTLCDAIARNINGVLGNACSLEEESFENDLLEAPSF
AKPFIFEQNFKKFYTPSEFLKGNHAKIATLKTTLASCKTKFFRPDLFLEHERKK
>fig|195.2024.peg.321 Putative membrane protein related to metalloendopeptidases
MKKLLFLFAFVIQSFAALSVEELTWDNGDTLLKFLQRNSIPISLYYGLDREDQELASDIA
YKVKYQVLKDENNNIEQVLIPISDDLQIHIYKDKNNQYTLAFSPISYQKEDRILHLTIKS
SAYQDVYEESGSSTLARAMVRSFRGSVNFRNIQKGDKVTLYYEQKRRMGKLWGDIAIKMA
VVEINKNAQEVFAFNDIFYNRDGKEVEAFLLTKPVNYTRISSTFSTARYHPILKRYRAHL
GIDYAAPTGTPVKSAGKGTITFVGTKGGYGNVIQVKHDSGYMTLYAHLSRFAKIKKGQKV
NQGQLIGYVGSTGMSTGPHLHFGVYLNNKAINPASVVKIAKSELSGKAKEEFKSTIVKYE
GIINEALAANKPNPPKEEDFENYIEF
>fig|195.2024.peg.902 Putative formate dehydrogenase-specific chaperone
MDLEKLRLARSLYYQCLGELFVFSFSENRLCNLKAYLEAMQEGLFDESLRTSFEILLRNL
QDVQDLQAFYKEYDELFLALKNTIPMTFSYIEEGFENSKALLNVRQILAKSTIRRNEKIF
KEAEDSVGFCFVLMSEFLKNKEDELAKALFEKVINQSIDEFLMLIFSNSKAKLYKEIANI
AAQFIEFERYCFELEKPTIKPSKKVQNDLSRSEFLRREANKQRRSREKSQGIS
>fig|195.2024.peg.63 GTP-binding and nucleic acid-binding protein YchF
MSLSVGIVGLPNVGKSTTFNALTKAQNAQSANYPFCTIEPNKAMVEVPDLRLNELAKIVK
PERIMHSLIEFVDIAGLVKGASKGEGLGNKFLSNIRETEVILHIVRCFDEENITHVEGGV
DPLRDVEIINTELILADIEQLGKKIEKLNKEARANTKGAKESLEMANSLLEHLNKGLPAS
TYLQKEDEIFQALNKELRLLSAKEVIYGANVDENGISEDNEYVKILKDYANKNNHEVIKL
CAKIEEELVGLSNEESAEFLSSLGVNESGLDQIIRTAFSKLGLISYFTAGVLEVRSWTIK
KGWKAPKAASVIHNDFEKGFIKAEVISYEDFITYKGENGAKEAGKLRLEGKDYIVLDGDV
MHFRFNV
>fig|195.2024.peg.538 GTP-binding protein EngB
MIISAKFITSLDKFNKNFASHFSEVAFLGRSNVGKSSLINSLCKQKKLAKSSATPGKTQL
INIFEVLCKKDEDKFSIHFIDLPGFGYAKVSKNLKEIWNKNLDEFLKLRSSIKLFVHLID
SRHTNLDIDLNLDKYLKSFLKPDQRILKVFTKCDKLNQSEKAKLKNSFKDAILISNLNKM
GLDDLEHEVIKQTLGL
>fig|195.2024.peg.742 Putative coiled-coil protein
MPVSPIGNMNFVNQNMAYPATQASNELAKEGFAATLNMAEFNEKEKTLNKLEKVNETHEI
KEEIKEKAEQEEKKKKHNQEAKTSDDEKNEEDESKDPNFKDAQSIHRLDISI
>fig|195.2024.peg.371 Phosphoribosylamine--glycine ligase (EC 6.3.4.13)
MKIMILGSGAREYSIALALKRVDENLEFYFAPGNGATESLGTNLNFKDPVVLATYAKEKE
FDLCIVGSESFLAEGVVDIFKQHNIPIFGPTKAAAMLETSKSFMKSFLKKYRIKTAKFLN
TNDIEKAKNFILSLTPPIVVKADGLCAGKGVIIAKTHEEAIEEASKMLSGESFGEAGKLI
VVEEFLDGFELSIFAVCDGNDFVLLPAAQDHKKLLDGDKGPNTGGMGAYAPSSLANESLL
RKIQKDIIIPTLAGMKKEGSEFCGVLFIGIMVVGNKPYVLEFNVRFGDPECEVLMPLIEN
PLELILATTQKRLRHTKIKIKKDYAVGVVCASENYPYKSSPKSEISITNIPENTHISYAG
VSLEDGKLMADGGRVLVCVGTGSSIEEAQKKAYELCENVHFKGKQFRKDIAHQVIQ
>fig|195.2024.peg.1281 UPF0234 protein Yitk
MASEHSFDISAALDKQELKNAFEQAKKELDSRYDLKGIKCEIEFSEKDGVFKLHSSSEAK
LDVLKDIVISKLIKRGINSSAIKELSRESGAMFRLNLKANDSIDSENAKKINKAIKDSKL
KVSSSIRGDEIRVVAKQIDDLQAVMKMVKELNLELNLSFKNLK
>fig|195.2024.peg.1541 FIG015547: peptidase, M16 family
MIDYSKITLKNKLDVYTFPVNKNSDVISVDIFYKVGSRNEIMGKSGIAHMLEHLNFKSTK
NLKAGEFDEIVKGFGGVDNASTGFDYTHYYIKCSKKNLDKTLELFAELMENLSLKDEEFQ
PERSVVLEERRWRTDNNPLGYLYFRLFNHAFMYHPYHWTPIGFFKDIENWSIEDIKEFHS
TYYQPKNAILIVSGDIDSEEVFSGAKKHFEKIKNTKPIPKIHTKEPKQDGAKRIEIKKPT
QTELLAIGFKIPNFKHKDIPALNALAELLGNGKSSMMNEILVDELNLVNEFYSFANDCID
ENLFIFICNCNVGVKAEKVEQELWKIIDRLKKGDFSSKDLQKVKNNVKSDFIFSLDTASA
VSNTYGSYLARGDLKPLLEYESNIAHLCEQDLVKSAKKYFDRSNSTTLILRKD
>fig|195.2024.peg.242 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGIVIPIYNVEKYLRECLESVINQTYVNLEIILVNDGSTDENSLNIAKEYALKDKRI
TLFDKENGGLSSARNTGIEFFYKEYETHFSNEIDGFYTFTVANENPQNVYKIYKNKNTFI
EKNLEAPDIDYLIFLDSDNSWELNCIEECVKRMQDIDILWFDHLCVYEKGIEDKGQKTRM
QIFSYKEECIINPKDYAKRALEVGSRDISFSWGGMIDFNFLKKIKLKFVNHIINEDIHFG
MILFASANKIYVLPKRLYKCLLRSNSISNHDKKVTKANISHYFKNIYEAFDEDAKSAKEY
LRLASRVITVLKLIDFFQGKKENENSKAIKEIFLPFYAKKALKFKKVNKDPLNLKNELDK
IKPFVKNILPYDAWKILQKIKNIFS
>fig|195.2024.peg.1244 Flagellar motor rotation protein MotB
MAKKHKCPECPAGEKWAVPYADFLSLLLALFIALWAISKTNPAKVEALKTEFVKIFDYTA
TQTVQQETQDTYKYKGSQEEKEDELSKLKQMAVNQQEVIKKLQAALDQSENQEILNLPSK
VEFERGSAQIVSADIQDYLKRIAQLISYLPPQIEIEIRGYTDNSDSALRSYDLGYTRAEN
VLKYLIEGGVSTKNINLKSYGLNSPINGNPQALENNRVQIYFKVDIKDNDAKQSVLDLIE
KSK
>fig|195.2024.peg.1270 Oxygen-independent coproporphyrinogen III oxidase, putative
MNLFQNLALKYSHAMMEKSLHKSFNVELLKNPQEKQAKKDKTYMLYAHIPFCHTFCPYCS
FHKYYYDEELAKIYFENLRKELMLIKDKGFDFSSMYVGGGTTLINENELLKTLELCKKLF
NIKEISCESDPNHIIPEKLSMFKGIIDRLSCGIQSFDDEILKKIARYNKFGSSKQLQEKI
SKALGILPIFSLDLIFNFPSQTEEQLLNDLKIAKNLAPQQITTYPLMKSNLTKDNIAKSL
GVETKDNEFKYYQMIRNFFKDYQQNNGWSFSLEKNQLNDEYVSSHHEYLGVGSGAFSFLD
GELLINAFDLNDYAKMIQEKQNANIAKASFTRKEIIKYIFLTEMFAGKIQIDKFNQTLNC
DLEKELFKELLGLKISNAIKKENGALITSEFGQYLFVVLMKDFYTGMDLVRAVFRDSKRL
KNKDFINIMKENISSI
>fig|195.2024.peg.122 Flagellar-associated protein FlgQ
MERIVCLLIFFSFKLIAQDEFIFWAELSNKNLILFHQSQNLSPAMTRSENTISEFACEIS
YTDDDLKKLPRTELGMIDDDMSKAIKFDFLNAHKDELSDCFMGARISVKDIVKTDLLKAQ
NETYVKILPLRFSVEFGERNALIYYLKKK
>fig|195.2024.peg.634 Succinyl-CoA ligase [ADP-forming] alpha chain (EC 6.2.1.5)
MSILVNKNTKVIVQGFTGKEATFHAEQCMAYGTNIVGGVTPHKGGQTHLGKPVFDTVADA
VKATGADVSLIFVPAFAVGDSVIEAADAGIKLAVVITEHTPVKDMMFAKQYANKKGMKII
GPNCPGIITSEECKLGIMPGFIFKKGCVGLISKSGTLTYEAANQVVQGGYGISTAVGIGG
DPIIGLAYKELLSEFEKDNETKAIVMIGEIGGSLEVEAAKFIKENISKPVVAFIAGATAP
KGKRMGHAGAIVGSADESAAAKKEALKSYGIHVVDSPALIGEEIQKILG
>fig|195.2024.peg.694 Translation elongation factor Tu
MAKEKFSRNKPHVNIGTIGHVDHGKTTLTAAISAVLSRRGLAELKDYDNIDNAPEEKERG
ITIATSHIEYETDNRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIVVFMNKADMVDDAELLELVEMEIRELLSSYDFPGDDTPIISGSALKALE
EAKAGQDGEWSAKIMDLMAAVDSYIPTPTRDTEKDFLMPIEDVFSISGRGTVVTGRIEKG
IVKVGDTIEIVGIKDTQTTTVTGVEMFRKEMDQGEAGDNVGVLLRGTKKEEVIRGMVLAK
PKSITPHTDFEAEVYILNKDEGGRHTPFFNNYRPQFYVRTTDVTGSIKLADGVEMVMPGE
NVRITVSLIAPVALEEGTRFAIREGGKTVGSGVVSKIIK
>fig|195.2024.peg.1236 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.180)
MPKASLKSIASYIPEQILSNHDLEKIIDTTDEWITRRTGIKERRIASKDESTSDLGTKAA
IKAIERANLKPQDIDAILVATLSPDYFTMPSTACKIAANLGLNGISAFDISAACSGFIYL
LEQAKALVESGLKKNVLIIGAEKASSIMDYTDRSICILFGDGAGAGVVSLDENNPIIDVH
TASNGNYGDLLMTERSQESKEASSLAMKMKGNEVFKIAVQTLSNDVVEILSKNQILPEQI
DLFIPHQANLRIIKAVQERLNLSDEKCVVTVHKYGNTSAASIPMAMNDAYEEGRLKKGNL
ILLDAFGGGFTWGSALLKFGGENFS
>fig|195.2024.peg.1411 L-serine dehydratase, beta subunit (EC 4.3.1.17) / L-serine dehydratase, alpha subunit (EC 4.3.1.17)
MSNLNIFKIGVGPSSSHTLGPMLAGNLFCKKIAKKLEKIERIQIILYGSLSLTGRGHLSD
KAVIWGLNALEAKNLSAAIQDEVNKNAIENAQIDFCGEKKLCFNYEKDLIFSKDFLPLHE
NGMKIKAYDCKGGLVDEETYYSVGGGFVLTAAQLEKKGKNSNQNKKKKLDIELNNAKEAL
ELCDKRDWDLAELSYRYELQFHTKEEIRAYCLEIWEVMQEVYYNGTHPNEDYLPGKLHLK
RRAKGLKERVTMTADPMGIIDFISLYAIAIAEENASGAKVVTAPTNGACAVIPAVMLYLK
NHTIGFNDEKAIEFLLVAMLIGSFYKKNASISGAEAGCQAEIGSASSMAAAAMATVLGAN
AFKACNAAEMAMEHHLGLTCDPVGGLVQIPCIERNAFGAIKAISAARMAMTRKSIPIVSL
DEVIETMYETGKDMNYKYKETSLGGLATNLKTVC
>fig|195.2024.peg.85 hypothetical protein
MKELEKYSNCLKRIDEFSQNLGMKKEDRAIFEMKQSENENEKCLILKNGSFDSPEPWFIM
DENDQIHTLISLNSLKNILENLKQTQKENFELRLEKAIYQQIPIDFSDVWIVAMDEIKRK
AQEGVMEISIDLEKLLADIKKEHPNLFVDMQAMVERVKNNERL
>fig|195.2024.peg.1097 SSU ribosomal protein S19p (S15e)
MARSLKKGPFVDDHVMKKVIAAKKANDNKPIKTWSRRSTIIPDMIGLTFNVHNGKSFIPV
YITENHIGYKLGEFAPTRTFKGHKGSVQKKIGK
>fig|195.2024.peg.218 Leucyl/phenylalanyl-tRNA--protein transferase (EC 2.3.2.6)
MESSILYSKLMDAPKDAPVFLSQKLEPDFILKAYRFGLFPWTNKPVTWWCPDPRCVLNPS
EIHIQKNMKKFINLYQIKLDYDFLSLIHLCRNTRPQSWIDDEFIENYYELFKQGYVHTLE
LYEDKELIGGIYGLIIGKVFFGESMVSLRKNASKIALIKLCKLLKPYDFVIDCQVYNKHL
EFMGAKNIERKIFLNILKEKCDQESGFTNFSTLINQI
>fig|195.2024.peg.866 SSU ribosomal protein S9p (S16e)
MATTYATGKRKTAIAKVWVKPGSGKISVNGIDLNTWLGGHEAIKLKVVQPLLVTKQETSM
DIKATTLGGGYSAQAEALRHGISRALAAMDTDFRALLKPKGLLTRDSRTVERKKYGRRKA
RRSPQFSKR
>fig|195.2024.peg.1539 Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.-), 7-alpha-HSDH-like => refractory to triclosan
MNTEFQGKTLVISGGTRGIGKAIVYEFAKVGANIAFTYNSNAQIADEMVQDLEKNYKIKA
RAYEFNILEPETYKELFEKIDVDFDRVDYFISNAIISGRAVVGGYTKFMKLKPKGINNIF
TATVNAFVVGAQEAAKRMEKVGGGSIISISSTGNLVYIENYSGHGTAKAAVEAMARYAAT
ELGEKNIRVNVVSGGPIETDALRAFTNYEEVKQATINLSPLNRMGQPEDLAGACLFLCSN
KASWVTGHTFIVDGGTTFK
>fig|195.2024.peg.753 Polyphosphate kinase (EC 2.7.4.1)
MQTNPNMFLNRELSWLRFNSRVLDQCSRPLPLLERLKFVAIYCTNLDEFYMIRVAGLKQL
FSAGVNISSSDEMSPLQQLKAIRKYLHKEKDLLEHYFNEIISDLEKENLFIKNYENLDNN
LKQKCDEYFFSTIFPVIVPIAVDATHPFPHLNNLSFSLAVKICDKTHPELIKFGMIRIPR
VLPRFYEVSANVYVPIESIVEKHTEEIFPGYKLLASAAFRVTRNADMVIEEEEADDFMMI
LEQGLKLRRKGAFVRLQIQKGADEQIVEFLNTHMKIFHKDVYEYSILLNLPSLWQIAGNK
TFTHLLSPLYTPKTLPPFDENLSIFDAIDKEDILIIQPFESFDPVYKFIKEASKDPEVIS
IRMTLYRVEKNSNIVQALIDAASDGIQVTVMVELKARFDEENNLHWAKALENAGAHVIYG
ITGFKVHAKVSQVIRKKGDKLKFYMHLSTGNYNASSAKIYTDVSYFTSKVEFARDTTSFF
HILSGFSKNRRLQTLSMSPNQIKEKILEMIALEASKGSEGVIIAKMNSLVDSDIIKALYE
ASIKGTQIDLIVRGICCLKPNEEFSKNIRVRSIIGKYLEHARVFYFKHSEPNYFISSADW
MPRNLERRLELMTPIYDERSKAKLAQFLRLQLSDNLLAYELQNDGEYAKVASNEKVIDSQ
QILEEYVSKIYKTLKKDTDQSRATHLASKLFKEN
>fig|195.2024.peg.1720 Cell wall-associated hydrolase
MLSAFILSKLSYAAMLLAEQQLHQWFVQPGPLVLGSNLFNLLTPTADRDRTVSRRSEPSS
RTALNGEQPYPWDLLQPQDAMSRHRGAKPPRRCELLGEISLLSPGYLLSFERWPFHTEPP
DH
>fig|195.2024.peg.1280 Putative D-2-hydroxyacid dehydrogenase
MKIVCLDAATLGDYDLSIFKNFGEFQSYALTDRKETIERLKDTDVVMTNKVVIDKEVMDA
CPNLKLILETATGVNNIDVEYAKEKGIIVKNAAGYSTMSVVQHTFAFIFAFLNHIPYYDK
WSKEGKWCDSPIFTDFGRILNSMEGKKHGIIGLGSIGKEVAKISSAFGAKICYYSTSGLN
QNAEFECLNLEELLRTCDIVSIHAPLNEKTKNLLTYEKLKLLKDNAILVNVGRGGIINEN
DLAKIMDEKNIRVGLDVLESEPMIKNHPLLNIKNKENLIITPHVAWASKEAVEKLMSMVY
DNLKEWIENGK
>fig|195.2024.peg.522 Excinuclease ABC subunit B
MLELTSDFKPSPDQEQAIQGIVKSIKKGNKYQTLLGVTGSGKTFTMANVIKELNMPTLIM
SHNKSLCAQLYSEFKGFFSKNHVEYFISYYDYYQPEAYIPRTDVFIEKDSSTNEDLERLR
LSATASLLSYEDVVCIASVSANYGLGNPNEYIGMVLIFELDMQISQKELLKKLVDMGYKR
NDNFFDRADFRVQGDIIDIYPAYYEDEVVRLEFFGDELDAMYHYNVLENKKGKDLKRFIL
YPTSQFSVGETRLKQAIKDIKAELNERLAYFEHENKLVEYQRLKQRVEFDLEMLTSTGMC
KGVENYARHLTGLKEGDTPYTLFDYFAIKNRKFLVIVDESHVSLPQFRGMFAGDRSRKQT
LVDYGFRLPSALDNRPLMFDEFIHKDCQFLFISATPAPLELELSKENIFHQIMRPTGLLD
PLIELKDSDNQVEILFDEAKKVIQRNERVLVTVLTKKLAEELTRYYLELGIKVKYMHSDI
DAIERNEIIRGLRSGAFDMLIGINLLREGLDLPEVSLIAIMDADKEGFLRSTTSLIQTMG
RAARNVNGKVLLFCKKITKSMQEAMDTTNERRKLQEAYNQKHNITPTSVKRHIEESLKNE
ENLGEIYRKGKKFEKMPANERAKIVKELRKQMLEAAKALEFEKAATLRDEINKLKDL
>fig|195.2024.peg.258 D-glycero-beta-D-manno-heptose 1-phosphate adenylyltransferase (EC 2.7.7.70) / D-glycero-beta-D-manno-heptose-7-phosphate kinase (EC 2.7.1.167)
MLEFLSDQNPKILIIGDFMVDNYTWCDCSRISPEAPVLVAKTLKEDKRLGGAANVYANLK
SLGADVFALGVVGDDESGKFLKENLKGEFLIQKGRKTPFKNRIMAHNQQVLRLDEEDTSV
ILLEDELVELFNKRIENFKAVVLSDYAKGVLTPKVCKAFIQKANELNIPILIDPKGNDFG
KYSGATLLTPNKKEALEVLKFENLEGENLEKGIKKLKEDFSLRYSIITLSEAGIAFFDEN
LRIAPAKALEVYDVTGAGDSVIAVLAFCLASGVEIFKACEIANEAAAIVVSKIGSVSVSF
DEMKSFKRVGFEKKIKTKEELLKILEQSDKRIVFTNGCFDIVHFGHIKYLEKAKRLGDIL
IVGLNSDKSVKRLKGEDRPVNSEFQRACMLAAFYFVDFVVIFDEDTPLELISFLKPDVLV
KGADYKDKLVVGSNLVSRVELIDFEEGFSTSKIIEKIKDKK
>fig|195.2024.peg.100 3-dehydroquinate synthase (EC 4.2.3.4)
MQINVDLKENAYKVYIDELDNLELDTKVFILSNPKISGLHLKTLLSKIKAKELFIATIED
GEEYKNLLTLEKILNQMFNSKLNRKSILISFGGGVISDMGGFAASIYQRGIDFINIPTTL
LACVDAAVGGKTGVNNAFGKNLIGTFYQPKAVYCESEFLRTLGRRELAAGMAEFIKMAAM
FDRDLLEFVEAIDKESFLNATCENEIFTQIISKSVELKARVVECDEKESGLRMLLNYGHT
FAHVIENFTDYKQYLHGEAVAIGMNMANRLALKLGLLSKEECERIEKILLQFNLPTHYKI
ENINEFYEAFFMDKKSANQKLNFILANSLGKGLIKGDIAKEMILETLEEFQ
>fig|195.2024.peg.745 Phospholipase A1 (EC 3.1.1.32) (EC 3.1.1.4) @ Outer membrane phospholipase A
MKKILFLIFFYSLVFCDDFEQALEFEKKGQYKKAMQIYKKLALQNSPKQDLKENNASLLS
SIKHETQNTQKTPSTKEDFSRIALANYLGENSSFNPLGISSYKMNYFLPFAYSFGSLGGE
NRKTEMKFQLSIKKRLFEDLLGLGEKYYVGYTQTSWWQNYKHSSPFRETNYQPEFFVDIP
LHFEDYKFLNNLRVGILHESNGKGDENLESRSWNRIYASSVFLYQRFLFVPRIWYRIPEN
SEDDDNPEITHYMGNFDINIGYLGNDYFINLMLRNNLDFHDNKGAVQVDIGYDIFDNGIY
WYLQYFNGYGESLIDYNKRLQRLSTGFLISY
>fig|195.2024.peg.1530 FIG00973752: TolA-like membrane protein
MKKFIFILAVLSSCLFASDELNIDSLFKKQIGLRSITSLSLLSTGNPHSYYIYPNIGVNG
DLNVWNDTKQLYLNQTFIYTLTPNFDLLISGGGNYARQEYNNIISGAFTSKNTLNFDSLW
IGFIYTGESIADFVPQIKFQTAIIQREKTVLQTKNFYFQSQNLEASLRGYSDPVVYSIYT
GFGYNAQRKFKIAKIDYGNSIYFGGNLSIILSPKITLDLGAEQRFQTEQKSMV
>fig|195.2024.peg.1702 tRNA-5-carboxymethylaminomethyl-2-thiouridine(34) synthesis protein MnmE
MNDTIVAIATAHGVGSISIIRLSGERALEIALKLSKKNELCPRYATFTKLFNQKNEFLDE
AIVIYFKAPFSFTGEDIVEFQVHGGFSVSEILLEELISLGARLAEPGEFSKRACLRGKMS
PLKALNIQDLILAKSANAAKIIARNMQGSLGELLDKIRTDLVKTLAFVETSIDYADDDLP
SDLLEQISTMCEENSKILKEIYTLSESKKGLIEGFKIAIVGKPNVGKSSLLNALLSYKRA
IVSDIAGTTRDTIEESFKLGTHLLRIIDTAGIRESKDEIEQIGIELSKKSIEDADIILAI
FDNSRKKDEEDENIFKLLSQSDKKIFYLLNKSDLKTQFDKPCDIDFIELSVQNDIQILKE
KLEKYLNSLDSDGFLVSSIALINACKISSEAILRAKELLSENSLELFAFELNLAIGELAK
FTKDFDRNEILDEMFGNFCLGK
>fig|195.2024.peg.530 ATP-dependent protease subunit HslV (EC 3.4.25.2)
MFHATTILAYKGKNKSVIGGDGQVSFGNTVLKGNAVKIRKLNNGKVLAGFAGSTADAFNL
FDMFENLLQSSKGDLLKAAIDFSKEWRKDKYLRKLEAMMLVLDRNHIFLLSGTGDVVEPE
DGQIAAIGSGGNYALSAARALAKHANLDEEELVKSSLQIAGEICIYTNTNIKTYVIEDEK
>fig|195.2024.peg.1139 Histidine permease YuiF
MTLLTNPIIISVVLMTLLCLFRFNVLLSLLISALVAGIFSHIEIMEIMSILIDGMKGNLK
TALSYILLGAIAAAISRTNLTAYLIKVVSRFISHKKYLLLLSIALISCFSQNLIPIHVAF
IPLLIPPLLSLFNKLKIDRRAVACALTFGLTTPYMVLPIGFGLNFQDLLRENLEKNGVNV
NLADVTNAMYYAAICMVLGLFLALFVFYRKPREYQEIEIQKMDFDNIKMGRKEWGVLVGL
ILTLVLQIFTMNLPLSGLLGFISMVILGGVEYKSVNDIFDDGLKLMGFIAFVMLVAAGYG
EVLKQSGAVNELVNSVVPWMQENKFLAVFLMLLIGLIITMGIGTSFGTIPIIATLFCPIC
LELGFSAALIIFILGVAGALGDAGSPASETTMGTSVGLSVDKQHDHIKDTCIPTFIFYNG
PLLILGSIIAMFL
>fig|195.2024.peg.509 (E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (EC 1.17.7.3)
MEYKRFKTRQIKVGDVLIGGDAPISVQSMLFTKTRDIEGSLEQLNRLYFAGANIVRLACL
DMADARALKEIKAKSPLPLIVDIHFNHNLAVFCAEFIDGVRINPGNIGSKENVKEVVKAC
KERGIPIRIGVNHGSIEKEFSDKYGYGVDAMLESALYNIKLLEDLDFFDIKISMKTSDTQ
KTIEAYERLRPLCDYPFHLGVTEAGTKFHSTIKSSIALGNLLLKGIGDTMRVSMTGELEE
EIKVARAILQDSGVQKSGVNIISCPTCGRIQSDLISAIKIVEEKTKHIKEPLNISVMGCV
VNALGEAKGADVAIAFGKNQGLVIRHGEVVAKLKENELVDRFLAEVEDEVKSREIKE
>fig|195.2024.peg.29 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19)
MKINALESFNTEISDIAADKSISHRFAIFSLLTQSENRAKNYLLAEDTLNTLKIIENLGA
KVKREGSSVSIMPPSEILSPNCVLECGNSGTAMRLMIGFLAGVSGFFVLSGDKYLNNRPM
KRICKPLSEIGAKIYGREQANLAPLCIEGQKLKAFDYKSEISSAQVKTAMILSAFRADKT
SKFSEISLSRNHSENMLKAMNAPLKISDDYLSLEISPLNQALKAQDILIPNDPSSAFYFA
LAAIILPNSKVVLKNILLNPTRIEAYKILQKMGAKLEIKITQNDFETIGEIHASSSELKA
VEVKENIAWLIDEAPALAIAFALAKGKSKLINAKELRVKESDRIAATVENLKLCGVNAKE
LEDGFEIEGSQIKKAKIKSYGDHRIAMSFAILGLLCGMEIDESECIKTSFPNFMDILTKI
GARIDY
>fig|195.2024.peg.1305 hypothetical protein
MGLKDNLKAVKAEINTEEQFIENFIKGERFIKKYKLYIFALIAILIIWFTISFISGKIEQ
YNIEESNKIYTSLLNNPNDQALLEQLKNKNANLYAIFLMKELAKDINNTEIKSQLQSLSS
NSDANHLLKNIISLPLGEKSIFLKNYDKILQAYRLLGEGKIEQANILLSQIKDDSALSQI
AKNLKHYQGISR
>fig|195.2024.peg.1369 hypothetical protein
MDNKRLVINPKKNLQNLKEIGEIQGQIKNYTPEELQILAKDQVKQIDMKIQEASRKIVRA
KELAYKAKNIENSFFETLNPFAKSETDKKLEALSEADIANAEAIGAQNELIQETIKLICV
IWFLRI
>fig|195.2024.peg.1388 putative ATP/GTP-binding protein (mrp protein homolog)
MKEQILEKLKSVKYPGFDKDIVSFNFVKDIKTENENVIVELEIVSSNPQVSEELRKNIDE
ALASLNLKNLQIHIITPKIPEEKSNSRSGKNIAPQVKNFIMVSSGKGGVGKSTTTVNLAI
SMAKMGKRVGILDADIYGPNIPRMLGETKTQPEVVGQRLKPILSHGVYMMSMGVLIEEGQ
GLMWRGAMIMKAIEQLLADVIWPELDVLFLDMPPGTGDAQITSAQSIPITAGVCVSTPQT
VSLDDSKRALDMFNKLHIPIAGVIENMSGFLCPDNGKEYDIFGKGTAEDMAKAYKSEVLA
QIPIEMIVREGGDEGKPVSFYHPESVSAKRYLMAAEKIWQFIEKINNEGGADNSAIQPVM
NGKSACSH
>fig|195.2024.peg.702 Cyclic dehypoxanthine futalosine synthase (EC 1.21.98.1)
MKRLDKEEALYLLRNANLAELGEIAYQRKLELHPEKITTFVVDRNINYTNVCCIDCSFCA
FYRHHKEDDAYILSFEEIGKKIEELEAIGGTQILFQGGVHPKLKIEWYEELVSWIKEHYP
NITVHGFSAVEIAYIAKASKISISEVLQRLQAKGLFSIPGAGAEVLSDRVRDIIAPNKCD
TATWLEVHRRAHEIGMKSTATMMFGTVESDEEIIDHFEHLRKLQDETGGFRAFILWSFQS
ENTALIQKHPEIMKQSSNKYLRLLALARLYLDNFKNLQSSWVTQGSLIGQLALKFGANDL
GSTMMEENVVSAAGASYRMNQDEMIRLIKSLGENPAKRNTAYEILERF
>fig|195.2024.peg.1175 2-methylcitrate dehydratase (EC 4.2.1.79)
MSDMGILEAKRPEFDELLTKIAKYADEFEITSDLALETARYCLMDTIGCGLLALKYPACT
KLLGPSVEGAEFRPLGAKVFGTSYQLEPIRGAFNVGAMVRWLDFNDTWLAAEWGHPSDNL
GAIWAVADYVSRKNISEGKEPLKVKCVLKAMIKAHEIQGVLALENCFNKVGMDHVLLVRI
ASTAVAAKLLGCDFEEIRNAISHAFIDGGALRTYRHAPNTGSRKSWAAGDASSRGVDLAL
KAKTGEMGYPSALSAKFWGYEDVKMKGQKLTIPQEFGSYVMENVLFKISFPAEFHAQTAV
EAALALHDEVKDRLEQIEKIIITTQESGHRIINKVGELANPADRDHCIQYMVAVPLIFGR
LNADDYEDSVASDERIDALRAKMQVEVDDRYTKEYLESDKRSIANAVQVFFKDGTSTKKV
EVEYPIGHKRRRSEGIPLLIAKFKANLAARLSPKQCEKIMQICEDQKSLEQMNFNEFSDL
FWLG
>fig|195.2024.peg.630 2-oxoglutarate/2-oxoacid ferredoxin oxidoreductase, gamma subunit (EC 1.2.7.-)
MKYQLRFGGEGGQGVITAGEILAEAAIKEGRQAFKASTYTSQVRGGPTKVDIIIDDKEIL
FPYAVEGEVDFMLSTADKGYKGFRGGVKEGGIIVVEPNLVHPESEDYKKWQIFEIPIITI
AKDEVGNVATQSVVALAIAAYMSKCIDLDILKETMLHMVPAKTRDANSKAFDLGVKYAQE
TKAHS
>fig|195.2024.peg.1612 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKNALKIFSFLLLFFLAYVFYVYFSFDKNTLLDDFKSRYSKILYDKNGEILSVFLNDEEQ
WHIKSTDIPKRLKVSVINYEDRKFYSHFGVDFLALMRAFVNNFNSTQRSGASTISMQTIK
LWDKKDRTYFNKFNEIIQSLALENAFSKDEILKLYLSNAPYGGNLIGYEAAILFYFDKNP
KDLTWAQAALLAILPNQPGLINLEKNKTKLLDKRNKLLAKLYERKLINKDIYELSLKEPL
PNFKPRKNIAPHLALRLLSDDNKEIFSSIDKKIQLKIEKKAKEFSYTLQQKGIQNLAIIL
ADTKTRKVLAYVGSQDFYDMANLGQINGNIAKRSVGSTLKPFLYALSIDEGIIAPDSILL
DVPTFFSNFNPQNANKKYYGIISAKEALQRSLNVPFVSLLQDYGYEKFFYKLKAFLNFED
ENYKRYGLSLILGTKELSLEDLIKLYLGLANYGELANLSFIRDENLSGVARMFSKGSAYL
TLEAMKELQRVGLENYNKEKIISWKTGTSYGRKDAWAMGATPKYTLGVWVGNFSGEANAN
LYGVSIAGDLLFEILGLLDEVDLEFAPPDDLMTIKLDSISKYRYDEDLNTSYINVLYPKG
ANILRTSPFLKKVYEYQGRELDSKDIHFKDAKALIKLDFPAYALHFFQQRNFKFSNKKGV
KIIYPKDNLKLILAKDLNGMKGLVAKVANLNNEKLFWYLNQKLIYEGDENTQNLNLKEGK
YQLFIISQSGEQDTVWFEIK
>fig|195.2024.peg.588 Two-component system histidine kinase RacS
MTRNYSIYTKLVILFVVTFFLVCVLFIVLLKIESNTYSEEEGFKQESFIKNIINSYGNAS
GVDIGAHLNNSGFVAIQNDYFVKIARLEGQSLFRAGNGENACTLTSLKYQNKLYLDVQCK
DFSALFEEDTNNRVYNLLLIGFFFFSFLVVFMYFSVLKSLEPLKKLRKQVAEVANGGKAD
FENYQEDEVGKIALEFQKAFKKNQELIQSRQLFLRTIMHELKTPIGKGRIISEMLQEEKQ
KERLIDIFLRMDSLINEFAKIENLFSKNYNLQFKPVHFSTILNEAKDYLMRDDFNRVVKL
NLKHDALINVDMEIFPLILKNLIDNALKYSSNGTCELYCCKECFVIKNPGNPLREPIEHY
FEAFTREPYQKVKGMGLGLYIVFEVCKLHNFDIIYFYEEGKHCFKIFFGVKTNNDA
>fig|195.2024.peg.1682 hypothetical protein
METQDSIKNFQESLYEGLEEQDDKENEIYPIKDIKIEKKSFSVYEANRRIIKNDFILTPE
FQRDQRWNNKQKSELIESILMGIPIPVIYAYQTGDGRLEIADGKQRLGCLNEFLEGKLIL
KGLKILTDCNGKKFEQLQAQEKTRIEDYQIDMYIISPQTPEKIKYDIFDRVNRGGTKINN
QEMRNALYNGTCTKIINKMSDYEAFKEATGNPNSKNMKDRYLNLRFLSLYLCITKKIDIE
LFTPMDDFLAKAMRTINKKAEQDFESFLQNYEEIMKFIAINYKDNLFRFKTKDIHKTNKR
QLSMALFEALTSAFMYAKENNKPYPLKEQIDIFKQELDKPEKITYGIDSKENIEFRINKA
LELIK
>fig|195.2024.peg.317 Membrane protein
MQDMIDTLLKYGYIVLFFYSLGGGMVGILAAGVLSSQGKMDLALCISIAFVANTLGSTLL
FILGKYYKKDIMPYFKNHRRKLALAMMKTKQHGVVLLITQKFVYGLKTFIPIAAGIAKYK
FINFFIINTFASLLWAVLLGYSAYAFGFAIEAIFNKLSSYPYIAPLFLIVLVGIIWFYLA
KFSKK
>fig|195.2024.peg.1023 Hypothetical protein Cj0135
MLKEEKKRYNFVKDKHEPIRMCIVCKNRYLQKNMHRFKHFQGELYKDFAFGRSVYLCETC
ILSEGKVLQKAFFKSCKNLNTKITQQNLKEIVLNGKN
>fig|195.2024.peg.1370 hypothetical protein
MINELSLMIYEKYEINEEAILSLSNDTKKISKEITTTILHQAKQRITEMQKAKQEIQETK
EDIRDMEDDIKELEERLNKKRQIDDKQHKLIETHYQEFINFKMQMENDTKEKENKISDLK
FKISKKNTAFSIIISSLALIVSIVAIILQFIK
>fig|195.2024.peg.266 Lead, cadmium, zinc and mercury transporting ATPase (EC 3.6.3.3) (EC 3.6.3.5); Copper-translocating P-type ATPase (EC 3.6.3.4)
MQEFRVKIGKMTCVNCSNAIERACKKIQGVSDASVSYVNSSGVFLLEDEARSQDVIEKIQ
NLGFEILENEQNLEEYRKKELIALRKNLLLSIVLSALIMYFEMFDTSFLSQNMQMLLSFF
AIFYCGRTFFSHAIKGLKNWNLDMNTLIALGCISAFAYSFCIYLNLFEDEKHLYFSGAAM
IISFVLLGKFLETNAKFKALNYQKRLNEIDIKKAKILNEAGELSEIPSAFVKNGDIIVVR
EGESVAVDGVVIQGKAEIDTSFLSGEFLPSSVRVDDEIKAGSILLNGNLHIKASKKAMDS
TLEQIKDLVFKAGNIKTPLENSVDRISRYFVITIIAFALAVFVFWSFKAGVSGAFLHACA
VLLISCPCALGLATPIALITAQGAAMKNFILIKNPAALENLNKIKTAFFDKTGTLTQNNL
ELFRHNLNAKDFQMLALIESSSSHPIAKAIFEASKIKAQILKGSSEIFIGKGVKYIEENE
EYLLGNLKFMQESGVKNLEKADEFLQSLKEEALICVYFAKNGECLGVLTLKNTLKEGAKE
LIEDFKKQKIQSIILSGDNEKSVQSVANLLGIADFKAGLLPEEKLQIIKEHKQNSLFVGD
GINDAAALNLASVSMSFKEGSDLAKNAGDFILMKDDLRLISWCFKLAKKTKNIIKLNLFW
AFFYNILCIPIAAGFVPFITLSPHLAALAMCFSSLCVVLNSLRLRKV
>fig|195.2024.peg.1575 Methionine ABC transporter substrate-binding protein
MNIKNLIVASFLGLAVNLTAAETISIAATPVPHVEILEQVKPELEKQGYKLEIKEFTDYV
LPNLAVDSGEVDANFFQHTPYLEEFNKNKGTKLTKVANVHIEPMAVYSKKYKSLDDIKEG
ATIAIPNDPTNESRALDIIAKKGLVEFKEKALKTPLDITTNPKKIKFVELKAAQLPRALN
DVDFAVINSNYALSANLNPAQDGVFIEDKESPYANILVVKTGNENDPKIQALAKALQSEK
VKQFIIEKYKGSILPAF
>fig|195.2024.peg.357 Pyridoxine 5'-phosphate synthase (EC 2.6.99.2)
MLLGVNIDHIAVLRQARMVNDPDLLEAAFIAAKFGDQITLHVREDRRHAQDFDLENIIRF
CKSPINLECALNDEILNLALKLKPHRITLVPEKREELTTEGGLNLNHNKIKKSIEKLQNA
QIEVSLFINPSLEDIQKSYELKADFIELHTGHYANLHNALFSNISHTAFALKEFDLSKKT
LQSKFEEELNNIEICAKKGVELGLKVAAGHGLNYKNVSQIANIKEICELNIGQSIVARSV
FVGLQNAILEMKALL
>fig|195.2024.peg.1095 SSU ribosomal protein S3p (S3e)
MGQKVNPIGLRLGINRNWESRWFPTKANLVENIGEDYKIRAFLKRKLYYAGISQILVERT
AKKLRVTVVAARPGIIIGKKGSDVDNLRKELQDLIGKDVNINIKEERKAGASAQLAAESV
ATQLEKRIAFRRAMKKVIQGAQKAGAKGIKVSVSGRLGGAEMARTEWYLEGRVPLHTLRA
KIDYGFAEARTTYGNIGVKVWIFKGEVLQKGLQTEKTEESAPAKKQRRTRRSK
>fig|195.2024.peg.1088 SSU ribosomal protein S14p (S29e) @ SSU ribosomal protein S14p (S29e), zinc-dependent
MAKKSMIAKAARKPKFKVRGYTRCQICGRPHSVYRDFGICRVCLRKMGNEGLIPGLKKAS
W
>fig|195.2024.peg.1049 Tol biopolymer transport system, TolR protein
MPFDDEKPELNITPLVDIMLVLLAILMVTAPSITYEEKINLPQGSQKSTSAPSVKSLIVS
INAKKEIFLNQEKYSFVSFADNLAQKKAQLNTDEPVFIRADKSLKYDDVIFVLKSIKNLG
FNKVALQTE
>fig|195.2024.peg.1203 Pantoate--beta-alanine ligase (EC 6.3.2.1)
MQVITSVKEAKQIVKDWKSHQLSIGYVPTMGFLHDGHLSLVKHAKTQDKVIVSIFVNPMQ
FGPNEDFSSYPRDLERDIKMCQDNGVDMVFIPDATQMYLKNFSTYVDMNTITDKLCGAKR
PGHFRGVCTVLTKFFNILNPDIVYMGQKDAQQCVVVRHMVDDLNFDLKIQICPIIREEDG
LAKSSRNVYLSKEERKASLAISQSIFLAEKLVREGEKNTSKIIQAMKDILEKEKLIKIDY
IELVDFNTMENIENITDNVLGAVAAFVGKTRLIDNFLVQGLK
>fig|195.2024.peg.931 Membrane protein
MDRSKYLFILLVIAMFLWGSSWPTSKILANYTDTSIITFWRFFFVVLGSFFVLSFLKIPL
RLEKNALKWVLIAGVLNGLYAFVFFIAIKHGLAGKGGVLVTTMIPIFSYLIFVIAIFFQK
DKKSTHKITKSEILGLFLGLISGLCLLNLGSMEELLGKFNALFLSCAFIWALMAVFTHKA
KGTHPLAINFYINLMSLLMFSWVLFDLKSYEIFQFDFKFWINLFVVAFLSTVVGTSIYYY
GIHILGSVKANSFVLITPASALICSFFILDEVPTILTLIGCVLAIFAIYFINIYGKKKS
>fig|195.2024.peg.580 Acetylornithine deacetylase type II (EC 3.5.1.16)
MLERVKNLSDKYYEKIVNLRHQIHMHPELEFEEENTARLVCEILDEYGIKYEKNIAKTGI
LASIEGKKPSTKKAQCVLLRADMDALPVQEETNLSYASKINGKMHACGHDGHTAGLLGAV
LILNELRDEFSGTIKFMFQPAEEGSGGAKPMIEAGILENPHVDAVFGCHLWGPLLENTAQ
IVSGEMMAGVDVFDLEFIGKGGHGAHPHTTIDPIVMASKFVSDVQCIISRRLRPVDAGVI
TIGKFHAGTTFNVIPQNAILQGTVRFLSDENQKLLQSSIENTAKAVALEFGGDFKLDYKR
EYPPLINDENAAKIARKAFGKVLGEQNIISVAKPDMGAEDFAFLTRERMGAYVFVGISKD
LKNPTLHHSSTFCWEDENLKVLMQGDSMMALEFLNS
>fig|195.2024.peg.277 Spermidine export protein MdtI
MYIFIIVLSALLDIVANLLLKKSDGFKHKIWGLAAIVNAILAFFLLSFSLKYVPLSIAYS
TWGAIGIIGTCLGGWILYKEKLNKIGILGIIIVIIAVFLLNY
>fig|195.2024.peg.1627 Orotate phosphoribosyltransferase (EC 2.4.2.10)
MDLEQIYKDCGAYLQGHFLLSSGKHSEFYLQSAKVLENPKLAARLCDELTKIIAEFNIEF
DSICSPALGGILAGYELARACDKRFIFTERVNGEMTLRRGFEVKEGERFIICEDIITTGG
SALESAKIIESLGGKVLGFAALANRGFCAVENLKNPRKPSAKLPDNLPLFTLGNFDFQIY
DENDCPFCKEGSKAIKPGSRGN
>fig|195.2024.peg.689 LSU ribosomal protein L1p (L10Ae)
MAKITKRLKELSQKIDVSKEYALNEAIETVRNLKSAKFDETVEIALKLNVDPRHADQMVR
GSVVLPAGTGKKVRVAVIAKDAKADEAKNAGADIVGSDDLIEEIQKGNMNFDVLIATPNL
MGLVGKVGRILGPKGLMPNPKTGTVTMDVAQAVNNAKSGQVNFRVDKQGNIHAGLGKVSF
SKEQLWDNISTFIKAINKHKPAAAKGRYIKSAALSLTMSPSVKLETQELLDMK
>fig|195.2024.peg.1206 Molybdenum ABC transporter ATP-binding protein ModC
MIKIDIKLPINTAKGKKQLELNTCLKANEITAIFGESGAGKTTLLKIIAGLIKPEFGRIE
VGDELWFDTQKNVNLAIQKRKIGFVFQDYALFPNMSVKENISYAATSKQKAEELLSLMNL
ENLAKIYPKNLSGGQAQRVALARALAREPQILLLDEPLSALDFKMRSFLQDELVKILQHF
KITTLLVSHDLAEIYKLSHRILELSDGKIIKDARTNEFFTSSNLSAKLRLSATLLEMKKS
DILVIFTLLLNQDIVKITLSEEEFLKSYKDVKIGDTLLLSIKAFNPIIVGKLDK
>fig|195.2024.peg.499 Flagellar basal-body rod protein FlgF
MQNGYYQATGGMVTQFNKLDVITNNLANINTSGYKRDDVVIADFKRIFKETQDELPIENH
TRDASRFVNTTIDGVPQVSQGYTDFSLGSLKTTNNPLDLAITREDAFYLVQTKDGEIRLS
KDGNFQLNEEGYLVNKQGYRILSSDYFNNPQNAGIRLPNGAVYINVDKNGSIEVDGVQNA
RLFIAQVDDIRALQKDGDNVYRIDDLTRIRDLDNSNAVRQGFSQGSNVNPVTEMVGLIEA
NRMVEMYQKVMTAHMDDLNQEAINKLAAVK
>fig|195.2024.peg.1024 Homoserine kinase (EC 2.7.1.39)
MKILVPATSANLGPGFDCLGLSLTLFNHTIIEKSNFFSISVNGEGSENLSLKKNNIFVSI
FNEIYQRLSGRKDHFRFIFDNAIPLSRGLGSSSAVIIGAIASAYEMAGFKAEKEKILNEA
LKYENHPDNIAPAALGGFVVSMVENEKVFSIKKDLDENLNAVVVIPNVAMSTEQSRNALP
SNLSLKDCVFNLCHSSFLTACFLEKKYDLLALASKDLLHQTRRMQNLPELFEVQKFALEN
KALMSTLSGSGSSFFNLAYKDDAKHLAQKMEQKFRNFKILCLEFDNKGFKIC
>fig|195.2024.peg.25 D-3-phosphoglycerate dehydrogenase (EC 1.1.1.95)
MKKKIIVCDAILDKGVELLRKAEDIELIEAAKVPKNELMDMLADVEVAITRSSTDVDVNF
LNHAKKLKALIRAGVGVDNVDIPECSKRGVIVMNVPTANTIAAVELTMAHLLSSARSFVN
AHNFLKNERKWEREKWYGVELMGKTLGVIGFGNIGSRVAIRAKAFGMKILAYDPYISASK
ITDLDMEQAKSLDEILIQSDFITIHTPKTKETDGMIGANEIAKMKDGIRLINCARGGLYT
EEALCEGLKSGKIAWLGIDVFKKEPATNHPLLDFENVSVTSHLGANTLESQDNIAREACE
QALNAARGVAYPNALNLPIKTEDLPPFVAPYIELVSKMAFLAVQIDKNPIKSIKLEAEGV
IGEYATSMLTFAAVGALSGILGEKINYVNAEFVAKEKGVDLSCETLPNSGYNNKLSVKII
TENSNINVSGTVFNENEQRIVGLNGFQTDFKPKGKMIIFKNKDIPGVIAKISSVLASKNI
NIADFRLGRDGFGYALAVVLIDEKVQKEVLEELRQLEACIFVQYVEI
>fig|195.2024.peg.994 GTP 3',8-cyclase (EC 4.1.99.22)
MLIDQFGRKINYLRISVTQRCNFRCLYCMPKIPFNHQPKENLLSFEELFLFVKVAIDEGI
EKIRITGGEPLLRKDLSVFIKMINDYKKDLDLAITTNGFLLKDFAKDLKDAGLKRLNISL
DTLESKKAKILAQKDVLDSVLAGIDEALSVGLKVKLNTVVLKGLNDDELIPLLEFAKSKN
IQIRFIEFMENIHAYGKLQGLKRDEIIQILSQKYQVKLIKKAEKAPVSIYSADGYEFGII
DPHSHEFCDSCNRIRLSAEGLLIPCLYFDEALSIKEAVRKGDINAAANILQEVLRNKPEK
NRWSVVDNETSSRAFYQTGG
>fig|195.2024.peg.669 hypothetical protein
MIFNKDFSYGFNENACQECGGKCCTGESGNIFANKEELKALREHLQLDEKEFALKYLKKV
GFRMSFKEVEFEDGFACIFFDKEKRNCSIYDFRPKQCRTFPFWEYFKTHQEELKKECIGI
CYLS
>fig|195.2024.peg.898 Putative formate dehydrogenase, cytochrome B subunit (EC 1.2.1.2)
MKKILITLLSTFVSLFAYGSERMGQDTQIWDFHRIINIPNYDTFGKLWTTLQGEYIATIA
LIAMIAVFSAFALHYMVIGPKQFSHAGKKIYAFSLFERIFHFIAAISWVILVPTGFVMMF
GATFGGGVFVRVCKNLHAFATILFIISIIPMFLWWIKRMLPASYDIRWMMIVGGYLSKVK
RPVPAGKFNFGQKSWYYIAVFGGFLMIITGGFMYFLDFNSTAIQGLFGLTQIELLRLSAI
IHNFLGIICAVFFGIHIYMAVFAIKGSIHSMVSGYKEEEEVYILHSYWYKELSNKKQIEP
SFSYDPNVKI
>fig|195.2024.peg.858 Type II secretion cytoplasmic ATP binding protein (PulE, ATPase)
MIERFLFEDYINGKITLEQIDREHKIDSEIFLKALASDKNISYSTLEELDLSLGEKFPCS
FLFKFKILPILSKENTLHIASSKPCSLELLDEIRIFYEVKNIEVLIASEFKIMKFLYKLQ
VREKLKNLSTNLRLEWKENRSQDEQSCISQIFDFILDEILEFNPSDIHIEARENDTLIRF
RVDGILREFACLEKDIYEALVFHIKFLSQLNVAESRKAQDGNFELKIKENRYDFRISSLP
LQNGESIVIRILKHNEEILDLENLNLGEKNLTILKKALYNPYGMILLTGPTGSGKSTSLY
ACLNELKSIEKKIISVEDPIEYKMPLIQQILLNPKAGLEFNNALRAILRQDPDIIMVGEI
RDEESLDIAIKASLTGHLLLSTLHTNNAISTIDRLIDMSAKPYLIASALRLVIAQRLVRK
LCPKCKQKSTKVYEIKGDFFEAKGCEYCHHSGYQGRELISECLYIDEEIAQVIREGGYKN
KILELAKVKGFQSMFEQGLQKAKEGITSIDELLRVLNEAL
>fig|195.2024.peg.1320 ATP/GTP-binding protein
MQINILNHFIKAYEDAYNIDFDKSFEGQIKMLCKKLNEPFMHPSYNLIQELEELSFSLDK
NINIAIIGQFSSGKSTLLNLILKKECLPTGVVPVTFKPTFLRYADEYFLRVEFQDGSDEI
THIEELAKYTDQRNNVKETKSLHIFAPIPLLKKITLVDTPGLNANEDDTLTTLKELQNIH
AAIWLSLIDNAGKKSEEDAIKANLELLGENSICVLNQKDKLSAQELENVLNYAKTVFSKY
FKELIAISCKEAKDETKYEESNFNLLLDFLDNLDEKALKQKFTKRKMLHLCQVLEDENRL
FVDIFDKLANQFQIYQEKLNSSFDDFIKEVQILNHQILNKLKSIGERIASEIFNCIKEKE
AHFYKEAKGFLKKDLYVKYDYKAPFISSDDAFLAMFYNSDIMNKEFKKIKNEIYESFEKI
KQKLKDFIDNLEKDILLFKAEFSNIQKDNILQSDKNFSELRAFCNASDEYFLKDFKELLF
KSLLELDLFFEKLNLKAFANYANATKLSLAFFSRKINESRVLYELDSSEFTLFYPKKSEI
YERVLTELNAYEFEALLINKPILVKISNHFLEQNTNIIQEKNKILDLKKVELQKRKEQIL
EVRSVLKENL
>fig|195.2024.peg.1366 hypothetical protein
MQENLKEIYKEFEFLNTQFSSYFNDEEFVNFKKGFEAKNALNYRDFKEFRLEETDKERLK
DIQICLLAYINFCSSKDIKEKRVEMISKTFMPMFLISRLYFTLKEEKLDIQIRKILKEKD
ELAEEKSLWISKVLPF
>fig|195.2024.peg.489 3-deoxy-D-manno-octulosonic acid transferase (EC 2.4.99.12)(EC 2.4.99.13)
MIFLYYILVWIAFLLCAIPLFLLSLFKPKYKYSLKARFFLFRNISQKRSDVHFHVCSYGE
ARSVKELVLRFDSRITTITQTGYDYAKEICNKVNYLAFENWIPFWLKPSKVLVIFEAEYW
LMLVFIAKLQKSKVILLNARISDNSYASYKKFRFFYKKIFCYIDEVFAQSEVDKIRLEDL
GAKNVKIFSNIKSKLQIFPTQKYLKPKQKLIIFASTHKGEEELLLKHYKMDKQEKLIIAP
RHPERFLEVEQLLHDKGLKFDKFSLLQNEDKKFNQDILLLDCLGELVNFYAISDVVVLGG
SFFEGIGGHNPIEVAHFNNVLISGIYIHNQKSLFQEVDNVYFCEDLKELDGIIHNYNLKA
KIAQNNDLSTIIQAIQEGIDARKSI
>fig|195.2024.peg.1293 Integral membrane protein
MLKVIKHNLGIYFMILACLDFALMGACAKILSKEMSSIEIMFFRNIIGVLFIVYLLKRSK
VHKEGGHFWLLVFRGVTGTLSLYMFFYNVSNITLGGAFAFQKTAPIFITLIAFIIFKENI
GAKGWLGILIAFSGVLLIAQPWADSSTHSGFDLKNSIIGVMSGFLAALALTSVRELRKFY
TTEQIAFSFILLGALMPLISMIGAEFFEPQHLDSLHLDFILAPFVMPSLTAWLIIAVMGA
LGTIYQIHVTKAYGIAKQAGVVAGVSYLDVVFSMVVGIILGDDLPSAMVFLGIIGIIFGG
IILVKNKGKK
>fig|195.2024.peg.679 L-fuco-beta-pyranose dehydrogenase, type 2 (EC 1.1.1.122)
MDLKIKNKVCIITGGAKGIGYGIAKLWAMEGGIPVVFSRSMPKEHDEELKNLCKSYEFYE
IDLKNYEQIEELIKKVVTKHGGIYALVNNAGANDNLHIENTSTKDLIKSYENNLFHYYAM
AKECLPYIKKEQGSILNIVSKTGITGQGRTSAYASAKAAQIGFTREWACAFAKDSVRVNA
IAPAEVMTPLYEKWLQNFPNPKEQYEKIAKTIPLGHRFTTIEEIANTAVFTLSPLASHTT
GQILMPDGGYVHLDRALNWDEI
>fig|195.2024.peg.1617 DNA modification methylase (Adenine-specific methyltransferase) (EC 2.1.1.72)
MKENPSFLKEQIITYLGNKRALLGFLNKGFKVAKKELGKDKFSFCDIFSGSGVVSRFAKA
HSNYILANDLENYSKLINKCYLSNKDKNLTELLKHYHKILTQNLEFQAGFISELYAPKNE
ACIQKDERVFYTLKNALYLDTLRQKIEKEIPEELKHFFIAPLIYEASVHSNTSGVFKGFY
KGRDGVGKFGGEAQNALKRIKGDIELKMPIFSNFSCEFEVVQKDANLLAKELENIDVAYL
DPPYNQHPYSSNYFMLNLIANYQRPDEISKISGIPRDWNRSIFNKEKQAEDALFELINDL
KAKIILLSYNCEGFVKKEKFLKRLQSLGKCQILEQKYPTFRASRNLKNRSIHIHEQLYIL
KKKYLIY
>fig|195.2024.peg.332 Hemerythrin domain protein
MLPKWDSSFSVHNAKIDDQHKKLFELAAKVEIVSDRSVSKNEVKELLAEFFNYMKDHFND
EEKYMQLIAYPAFEEHKKIHKEIIQTMINLIKDIKSTNDLKEKLYIIAKKWLLEHILYED
MKVEKWRSSSLATDEGKDVSFEAADDSDDDKPQFYLYKCNCPGKVHDVPYGIHQKIELQG
HKFTCKICKQAITFFQKHS
>fig|195.2024.peg.1162 Branched-chain amino acid aminotransferase (EC 2.6.1.42)
MISADKIWMDGKLVDFKDATLHFLTHSLHYGNAVFEGTRAYKTDKGLAIFRLEDHTKRLL
ESAKITLLNCPFSQKELEKAQIELLKVNDFKNNVYIRPVIFLGDGVMGLYHVKAPVRVGI
AAWEWGAYLGEEGLEKGIKVKISSFVRNSVKSCMGKAKASANYLNSQIAKFEAIEAGYEE
ALMLDEEGFIAEGTGECFFIVKDGVLITPPNDFSLKSITQDTVLKIAHDLGLTVLRQRIS
RDEVYTADEAFFTGTAAEITPINNVDARIIGSGIRGSITKKLQDAYFDVVYGRNEKYASM
LTYI
>fig|195.2024.peg.691 Transcription antitermination protein NusG
MSTHKWYAIQTYAGSEMAVKRAIENLVKDNGIEEQLKEIVVPTEDVIEFKNGKEKISERS
LYSGYVFAHLDLNTELWHRIQSLPKVGRFIGESKKPTPLTEKDINLILEKVHNRAAPKPK
ISFEEGENVRITEGPFANFTAIVEEYDMVRGLLKLNVSIFGRSTPVEILYSQVEKII
>fig|195.2024.peg.120 Aspartate-semialdehyde dehydrogenase (EC 1.2.1.11)
MSKKQKIAIVGATGAVGEELLNVLDELDFPVESILPLASAKSAGNQIEFRGKSYTIKELT
EDVFRENPVDIAFFSAGGSVSEKYAKFAVEAGAVVIDNTSHFRMEEDVPLVVPECNPEDI
KEWKKTGIIANPNCSTIQMVHILKPLNDAFDLKRVDVSTYQAASGAGKEGMEELVRAMQS
FFAFKLDEFEAQTFPHTLALNLIPQIDVFMDNGYTKEELKMINETQKILHKNLEISATCV
RVPVLRSHSEAITMHFAKEVDVNKARDILQNAPSVVVIDEPKDKKYPMPLMTSDTNETYV
GRIRLDVTHKNILHLWCVADQIRVGAATNAVRIAQKWLELENK
>fig|195.2024.peg.1082 Protein translocase subunit SecY
MNKALTNKILITLAFLFAYRVLAYVPVPGVNADVIAEFFNNNQNNALGLFNVFSGGAAER
FSIISLGIMPYITASIIMELLAATFPNIGKMKKERDGMQKYMQIIRYATIVITLVQSIGV
AIGLQSLHGRGGAGAIMIENLNMFIALCAISMLAGTMLLMWIGEQITQRGIGNGISLIIF
AGIVSGIPRAISGTVGQINSGEMNFLTAFVILALILITIGVIIYVELGERRIPISYSRKV
VMQNQNKRIMNYIPIKINLSGVIPPIFASAILMFPTTILQTSTNPYLQAINDFLNPNGYL
FHVLTFLFVIFFAYFYASIVFNAKDIAENLKKQGGFIPGIRPGEGTANYLNEVASRLTLS
GSIYLGLVATLPWVLVKFMGVPFNFGGTSVLIVVQVALDTMRKIEAQIYMNKYQTLNAIG
L
>fig|195.2024.peg.486 SSU ribosomal protein S16p
MTVIRLTRMGRTKRPFYRIVVTDSRKRRDGGWIESIGYYNPMVEPEVVKFDSERLAYWKS
VGAKLSDKVASITSK
>fig|195.2024.peg.636 Malate dehydrogenase (EC 1.1.1.37)
MKITIIGAGNVGSSVAYALILRELANEIVLVDINEDLLIARELELSQSIAALNLDIELTC
TKDYAYTKNSDIVLFSAGFARKDGQSREELLQLNTNIMLDCAKKIKEFNPDPLFIILTNP
VDFLLNTLYESGIFSSKKIVAMAGVLDNARFKYEVAKKLKARISSVDTRLIGFHNDDMVL
VKSYASVKNQKLGELLSEEEFEDLENEVKTGGAKVIKHLKTSAYLAPASACVRMLESIRS
GEFLPMSVILHGEFGVQNKALGTMARLGLEGVVEIMKLELSDEEKDKVKKSLIKYQYIKE
DK
>fig|195.2024.peg.1437 Putative periplasmic protein
MKFLFFLVTFLISLSAIERPKFEDFAAGYERNKASMLNYEGMPAFALSENLLAVLKQPNV
KLNKYVKYDPFLNLYLVRTDFSLIPTPMGDEEKLTRNDWIGIWDPNRAYIGHIKYLAQNI
DEKDQLDFSTKVGLLGTPCCEMMGIALNNSSFIGNRYLKHFMKYNDVYWGDIGVDFAVRE
NKIYVNNVRKSGQFLINDEIISVDGTLVKDIRKLNEKILFADRGSTLYFQVLRDNVDLNI
STEVFAKDLSKFNLPSNKPKPKPTNFRSNIGLSVNSSLIVTKVDAGSKAALAGFMVGDKI
LRANNVTLKDFKELQTLLGTGNDFNILIERKSDKLPLLGLNNDLGGVHSGGDGKFQFFIR
LVK
>fig|195.2024.peg.414 Putative periplasmic protein
MKKILLSFVFFISLTHANTINAIAVVVDKEPITTYDIEQTMKTLNIPKNQALGILINEKM
ELSQIKQFGIYTSELELDNAIGKMLAQNKISLEDFKRDLQAKGQNYEQFRSNFKKDFEKR
KLYEKIASTAKTDFSDEGAKKFFEQNKNKFTLFTEINVNIYRSNNAQDLENIKATTKTAL
KAEKATLTPNNSDPRLLGLLSSIPIGSFSPVLNSQKGYEIYQVKDKNGGQTPEYYQIKNE
ILNAYVSEQRQNYIQDYFDKLRSKINIEYLR
>fig|195.2024.peg.1465 putative lipoprotein
MKYKTIVFSILAIIFSACSTHQEQNVFYQQNLFSQTCNKQFFQEQQEKISQNKDVIFTGL
NTGYIARDCKDFNLSNSIFDKVEDSYKYDVDLQSLSKKSTRALASTLINEGVNDYQGAWY
ERTMLNVYKGLNFMSLGDFVNARVEFNRALMRQEKAKEYFASEIKKAYQEASKEEKLRQN
IDNNIKIVSKQYENLFKDFNAQKDYTNPYVTYISSIFFFMDYDYKKAADLLKEVYVLNLN
KEIEKEFKIFDQYSSSLNPKKLKKYIFIIYENGLSPALDEFNLTLPFIFDDYITTASVAL
PILKKRNASYENLNIANNHQKFTTSNAFDFDQIVASEFKANLTSIIIKSLISSTLKTSLN
MAVAKNDESGILSLATNIFSIATTRSDLRFWNFLPKNIQIMMIENDGSVQIYDDKNQKIY
SSEVDIDKNVLIVVRSFASQFPARVYKIEN
>fig|195.2024.peg.1338 Paralysed flagella protein PflA
MKIIFLVLLSICTLFSFELALNTGRENNQAFAVLHASNDLDFTCQKIVIEDKIHFECEIM
GVVDNKLSDQSFTAFDLKFIKEPQKIKMIILPKMSARMFDLSQNIYADKELNSSSMHKSK
SFTFIFTPELEHVKDYDGLDFNINFPYESLPYVGALDLNSDPVIIPQSADINTYLRIKNE
YDKANYTQVVIDAQNAINRYRGSIFMNEFILYKLRAQSQIYTQDPSMRDQQVLEKMIDEA
KNWNRTFTSDKNFPEVLHIMLRTYIALSQRADIEYTMSILNNEQPNSYFTQLARLDYADY
IYPLNEKERAIDIYEDIYFNTKNLDLAARAAMSLIKDYLANNQIDKAVQYVNTILKANPE
YFPKDMFRSLELAKLFNQHKQYDISASIYEDVFVKMPKIDDRYEQVLKDLALTLAMTSRS
SDANKYLDLYMDNYLDGKYLDEIRKANDEVFFALADNNATFLHQRYANLMKEYAQKDENI
VNKALSEDVALYYKEGNLSAVLTYKDQIENKKLTNSAKLLEQAAIQLLNNDLKADNCINA
VNIFTQFNAYEIGQKIENKKQMLACLMRTSNMQQAMDYIDKNHNEDSIFYGLQKASILYD
NKQYPLALNIAREIANSRILKSDEENFKAYYLQFLSYLKMDDYNMAIKILQILESFPMNF
TMVEAYDNLLIYANDHNMQTTILTYAPKAIDYQNLKGINLFSPNLEFIYLDTLAKTNQNQ
EALAVLIDLLKLKLSDEDRARALYIQSMTYERMQNTQAQKESLKQCLELKTTSNWQNLCR
DKNQILAQ
>fig|195.2024.peg.541 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase (EC 3.1.3.45)
MIELIFLDVDGCLTDGKIIYTSNGSVIKEFDVKDGAAVEAWIKLGKKIAIITGRNCPCVS
ARAKDLKIEIVHQGVKDKLTCAKKILEELNLDFSQCAAIGDYFNDKNLLENVGLSFKPKD
AHRDLKVDITLDKKGGKAAVAQMIEYIIKKNDMQEEWDKLWL
>fig|195.2024.peg.932 Modulator of drug activity B
MKNILLLNGAKSFGHSGGKLNDTLHEVAKESLLNLGLKVDETYIDKGYDIENEVAKILNA
DAIIYQMPGWWMGEPWIVKKYIDEVFTAGHGKFYANDGRSREDASKKYGSGGLVNNKKYM
FSLTWNAPLEAFNDKDQFFEGVGVDGVYLHLHKANQFLGMKPLPTFICNDVMKNPQVEKY
IEDYKAHLQKVFS
>fig|195.2024.peg.427 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.180)
MKTRFDKAKISGICVSVPEHKICIDDELESVFSNDIKTLKRMKKVIGLNTRYICDENTCV
SDLGKHAANTLLQGLNIDKNSLDALIVVTQSPDFFMPSTACYLHQLLNLSSKTIAFDLGQ
ACAGYLYGLFVAHSLIQSGLGKILLVCGDTLSKFIHPKNMNLAPIFGDGVSATLIEKTDF
NEAFFELGSDGRHFDKLIIPKGAMRIPKADIFNDDSLMQTEEFRQLENLYMDGANIFNMA
LECEPKSFKEILEFSKVDEKDIAFHLFHQSNAYLVDCIKEELKLNDDKVPNFIMEKYANL
SACSLPALLCELDTPKEFKASLSAFGAGLSWGSAVLNFKDLYTKDILIYIKEK
>fig|195.2024.peg.77 Transmembrane transport protein
MQKKYKNIIYASLGGILEFYDFVLFAFFLDIFAKVFFPQNDTFWMQINAYIAFGAAYLAR
PFGSIVMAHFGDRYGRKNIFYISMLFMVLPSFALVFLPSYESIGILATLILFLIRILQGL
AVGTEVSGAWVYVSEFVKGRQVPLALGFISATLTIGLLLGNLATLGIRSYFSAQEVEEYA
WRIPFIVGGFFGFFALFLRTKLSETPEFERIKKENRLLNFPLKDALKTYKTSMLVCFLMT
VVLTSGVATLMILPKYLEELLSINKTSALWIQNFAILAVILGALIQGILASKWGSYRICS
IFSITFMFFGMLFSFYDANFLFYFLLACFAQGIITFAPVFMTQIFKSELKFSGLSFAYNI
SYALLGFLTPFIVNAFYKEYMGVYLMVVGCCSLFSVFLLKRIFARSEAKELSVVF
>fig|195.2024.peg.1276 Ferredoxin domain-containing integral membrane protein
MENHITNYTKKRYFVYLIATIVIFCLPFITINGNHFFLLSFDHSKLNLFFISFSTQELYL
MPFLLIFLFLFIFFITTLGGRVWCAWSCPQTIFRVIYRDIIQTKLLKIRKNINNKQKEYE
GYYFKKIIGVILFYFISLVAVSNLLWYFVPPEDFFAYIQNPGEHLLLLGVLFCASLFLTL
DITYLAEKFCIYVCPYARVQSVMFDRDTMQVIYDEKRGGVIYDGHTKLYKKPPEGECIGC
EACVSICPTHIDIRKGMQLECINCLECADACSKVQSKFNRPSLINWTSVKAIETRKKVNY
LRFRTIAYFIVLVIALIALMIMGSKKEDMLLNINRSSELYQISHTNNGLEISNAYTFLFQ
NTDSKAHEYYFEASLEGIDNGIEIIRPSKAFTLKAGEQAKKIVVIKATKKLADNDQKDVI
FPLHIKAYAKDNDEIVIFRESIFVYPKSTILKGYNESK
>fig|195.2024.peg.8 Rrf2 family transcriptional regulator
MLFTKASEYALLSLIYIAHKENPQDVDSLALELNIPKSFLAKILQTLAKDNLLKSFKGAK
GGFALIKEPSQYSIKEIVNSAEKKEVSVFECSGGVCPNNKEENCTLMPMLVNLQNKVDEF
LDSLTLADIMNHNGKK
>fig|195.2024.peg.1262 4Fe-4S ferredoxin, iron-sulfur binding
MALLITKDCVCCDACREECPDEAIYEHSPIYVIDADLCSECVNDFSEPACIVACPYECII
PDPDNVESIEELKLKNRNREF
>fig|195.2024.peg.1365 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MKKLALALGGIALGACGEKIYKGIKNTWDKLIFKDLITLRKVIKQYEEIEQIYPSYLNDP
KFLEFRKTHKYDAEAIHNIKDHLFSDLKKEKLIQIGTTMEAFMEYSDKYLQDDITALKIS
WRFCAIRLKFDSALLQLQDINKIV
>fig|195.2024.peg.933 Putative transporter
MQQSSITINNTYQIKILITLCLGVFGLISMELGVMGIIPLISEKFGVSVSDAGWSVSIFA
LIVMCCAPIAPMLCANFNPKKLMLFCLAIFSLSSLASMFVNDFWLHLILRAIPAFFHPIY
LALAFSTAANLADDKSKVPHIVAKIFMAISAGLVLGVPLSSYFGGNFSFEMAMAFYVVIN
SLAFFITLFFMPEFKKTSRIKVGKQLLSLRYALLWISMLAVFCISTGYLGFYSYYSEFLF
SVSKMSFTNISLALFIYGFASIIGNNIAGKTLVNHSNQTLIFASMAMILIYALIFVNAAQ
FAIMLTLSLILGIVNGAMNNAMHYIITFPFPRAKDFTNGLFISVSNISISVGATLCGLVI
SIKETKYIAISSIIMVGLGLILVLVRMRLEDKKLKI
>fig|195.2024.peg.1030 Putative fructose-1,6-bisphosphatase or related enzymes of inositol monophosphatase family
MKQFLDACLKANLQISEYLNNICESDLSFCPELGFDNNQSYKLDLKCEKIFIEHLCNLGQ
IFSEESGLIGENSPYKIILDPLDGSSNFVSKIPFYGTSAALFKDEEAQSAFICNLANHEI
LIFDDNKNLKSNLFNPNYSPFLPNHFSQIGIVEKITLCPSLINHLAQNKLKFRSLGATAL
SIAYAPYFSFVLVLGKTRIFDTAGALMLCKNLYIENNENFLLISKDKKIFDIILEFLK
>fig|195.2024.peg.915 Diaminopimelate epimerase (EC 5.1.1.7)
MKFYKYCASGNDFVIINASEKKDRSALAKELCNRYEGIGADGFIVILPHEKYDFEWEFYN
NDGSRAAMCGNGSRAAAHFAHHINGIKPHMAFLTGAGVIKANVDNNSVEVSLGKIKNIQD
AFSECEKNWQLCDTGVPHLVHFCENLDEFDLKLCKQMREKYNANVNFVKVENDNTLRVRT
FERGVEDETQACGTGMGACFYLAFLNKKIHNQARVIPKSGEELSFKFENEELFFKGKVRY
CFEANYNFS
>fig|195.2024.peg.447 Similar to imidazole glycerol phosphate synthase cyclase subunit (LPS cluster)
MLKTRIIPCVLLKNSQLVKSIEFKDFRTIGHLTSTMRIYNARNVDELIILDIDASKSGEI
DFESIEDLAKECFMPLTIGGGIKTLEDIQKILNLGADKISINSKALEDMDFISKAANRFG
SQCIVCSIDVKRKGEQFCVYDRGNLLEKSPLELALEYEKKGAGELLLTSVDFEGRAKGYD
LELLKIFQNKLKIPLIINGGLSNPSDGVEALNLGADALAGAYIFHFSKYTPKDVKEELAR
QGFAVRLL
>fig|195.2024.peg.914 Dephospho-CoA kinase (EC 2.7.1.24)
MKNAFFVTASIACGKSTFIEIANSLGFKSISADKIAHKILDENALELEKIFSPFSLKNLL
TKEKKIDRKILGEIVFNNKEAKKILENFTHPKIRAKILEQMQILDKENKAFFVEIPLFFE
SGAYENLGKVIVIYTPKELSLKRIMQRDKLSLEAAKARLDSQIDIEEKLKKADFIIKNIG
SYADFRQECVKVIQEISKGKM
>fig|195.2024.peg.194 Probable lipoprotein Cj1090c
MKGILFFIVALFLGACGYVPTSKVADNIFDDKVYVNVELSLQDPRNSIFVADTLKEMVIS
KLGRRLALKHEADDVINVRMNNLEFIPLIYDQNGYVVSYKAKLNLEFKVVFKDGSVEHFN
TSGSYNFDISPNSIISDTARYEAIRSASSEAFDEFISVIAIKGQKRAAQY
>fig|195.2024.peg.75 Thermonuclease family protein
MRINYKKLFNLRKIASDPKKLLAFLIFALMIAFVQNYIVQNPSFKAQVIRVIDGDTIEIS
TNNKTSKIRFFGIDAPELKQNFGKQSKAALEKILKDKEVYIFSKNKDNYGRIVAIVKLKD
VDINQFLVSQGYAWADTYYTNAYIKEQEKAQKNKLGLWKDDNPIEPYKWRKQNRF
>fig|195.2024.peg.284 Translation elongation factor Ts
MAEITAAMVKELRESTGAGMMDCKNALSETNGDFDKAVQLLREKGLGKAAKKADRLAAEG
LVSVKVSDDFTSATVSEINSETDFVAKNDQFIALTKDTTAHIQNNSLQSVEELHSSTING
VKFEEYLKSQIATIGENLVVRRFASLKASANGVVNGYIHTNGRVGVIIAAACDNAEVANK
SRDFLKQLCMHIAAMKPSYLSYEDLDIEFVENEYKALVAELEKENEERRRLKDPNKPEHK
IPKFASRKQLSDAILKEAEENIKEELKAQGKPEKIWDNIIPGKMNSFIADNSQLDSKLTL
MGQFYVMDDKKTIEQVIAEKEKELGGKIKIVEFIRFEVGEGLEKKTEDFAAEVAAQL
>fig|195.2024.peg.989 Putative manganese efflux pump MntP
MDFYSLILLSCALAMDAFAVSLCKGFSVKKLNLKHYIITGVYFGGFQALMPAIGYAIGIT
FASFIASIDHWIAFVLLSLIGLKMIKESFENENCDTNSNQFGFKIMFALAVATSVDALAI
GVSFAFLDVDLFLALFLIGSITFILCAIALELGNKFGTRFRNKAEFLGGAVLIILGIKIL
VEHLFFS
>fig|195.2024.peg.1029 Outer membrane protein assembly factor YaeT
MKKIISICALVALSNAAVIKEIKFSGLNHLSNASALNLTGLKIGETINLDKINTAILNLY
KQNYFENIAVEENNGILNIIVTEKPSIAKISITGIASNDRKQVESILGIKRGTLFDEASA
KEASERIKAYYEAKSYFDTIVEYRKKTLENTEGLELEFIVNRGENIIINNVNLSGAEKFS
YSDIEPAIVNKEKEFMGWMWGRNDGKLKIFELSNDSARISDEYMKKGYLDVQVSSPYLKT
YTDTYQANLTYFIKEGKPYKIENISIENPLFSEEENIQNVKNLRSTQGKLINIEDIRKDV
KTIETQSADLGYAFAEVYPDIQKNDQTQEASVVFKVIPHDKVYIRNVIISGNSRTVDRVV
RRELYITEGNLYNRTDLSESTNALRRTSYFDDVEIKEEKVDDTHIDLIVNVKEASTGAIS
GGIGYGSSDGLLLNASLSDTNIFGSGIKSSVSVDKSDDTLSGRISLINPRILDSQYSLGG
TLYSNDYEWDNYSEKNYGFDITLGRQFARYYNVSLTYNLEQSDIYHLSPTLLRTGYELGK
TIKSSITPAITFNNTDDYYLPRKGIIASTSLEYAGLGGDQEFLSSSSKFNFYQGLQDYIG
YDLIYRYKASFYKVWDEGYLPINQRIYLGGIRSLRGFESRTVSPKNEWGDEVGGTIAFAN
SVELSFPLIDRIKLRGSVFFDYGMIGNKNLDEIQRMSTGLGIEWITPIGPLQLVFAKPLN
DKKGDDTNTFEFNLGTRF
>fig|195.2024.peg.1520 Undecaprenyl diphosphate synthase (EC 2.5.1.31)
MNELKHLAVVMDGNRRWAKAKGFLAKLGYSQGVKTMQKLMEACVEEGISNLSLFAFSTEN
WNRPQDEIEFIFELLDRCLDEALKEFEKNNVRLRAIGDLSRLDTHLQEKIALVEEKTKHC
DLLCVNLAISYGAKDEIVRSVKRLIEKGLEINEKNISDNLDLPLDVDLMLRVGNAKRLSN
FLLWQCAYAEIYFSETLFPSLTKREFKKIIKEFRKRERTFGK
>fig|195.2024.peg.54 ABC transporter, substrate-binding protein PebA (cluster 3, basic aa/glutamine/opines)
MVFRNSLLKLAALALGACMAFTSANAAEGKLEAIKAKGELVIGVKNDVPHYALLDQATGE
IKGFEVDVAKMLAKSILGDENKVKLIAVNAKTRGPLLDNGSVDAVIATFTITPERKRVYN
FSEPYYQDAVGLLVLKEKNYKSLADMNGATIGVAQAATTKKVINTAAKKIGVKVKFSEFP
DYPSIKAALDAKRIDAFSVDKSILLGYKDENNEILPDSFDPQSYGIVTKKDDANFSNYVN
DFVKQNKTEIDALAKKWGL
>fig|195.2024.peg.38 tRNA (cytidine(34)-2'-O)-methyltransferase (EC 2.1.1.207)
MFNIVLIHPRIPQNTGSIGRMCFNAGFKLHIVKPIVFDISQKAVRRAGLDYWEKLEPVIW
ESLDIFLEHNLIYKDRFFFATTKSNKFYFQAKFQENDFLFFGSESYGLPMELMQLNWDNA
ITIPMKACGRSLNLATSVGIVSYEALRQNFDRFSL
>fig|195.2024.peg.893 Hypothetical protein Cj1505c
MRIDCRNLECPKPIVETKKALQNLQNNEILEIVLNSVISKNNVLKFLTSLNLHADIEENN
NEFYIRVKKQELDFSKASTDEYNVLFLKTDKVGDGKLGENLLVGFLSTLKNVENIPSKIL
CVNESVFINVDENHRAHLAMKELEKLGVEIISCGACLEFFGKSKELKIGSIGNAYEILNE
LCGKAKIITL
>fig|195.2024.peg.715 Hypothetical protein Cj0449c
MLHEYRELMSELKGKDAHFDKLFERHNELDDQIKDAEEGRNLLSDIEISNLKKEKLHIKD
QLNQYLANYKK
>fig|195.2024.peg.758 Fumarate hydratase class II (EC 4.2.1.2)
MEYRIEHDTMGEIKVPNDKYWGAQTERSFENFKIGCEKMPKVLIYAFANLKKSLALVNNK
LGKLDDAKKSAIVQACDEIIAGKFDDNFPLAIWQTGSGTQSNMNMNEVIANRATEIMGGD
FRKEKLVHPNDHVNMSQSSNDTFPTAMSIVAVEQVEKKLIPALDELIATFEKKVKEFEGI
IKIGRTHLQDATPLTLAQEFSGYLSMLLHSKEQIIASLPTLRELAIGGTAVGTGLNAHPE
LSEKVSEELSKLIGTKFVSSPNKFHALTSHDAINFTHGAMKGLAANLMKIANDIRWLASG
PRCGLGELNIPENEPGSSIMPGKVNPTQCEAITMVAVQVMGNDAAIGFAASQGNFELNVF
KPVIIYNFLQSLDLLADSMHSFNIHCAVGIEPNREKIEYNLHNSLMLVTALNPHIGYENA
AKVAKNAHKKGISLKESAMELGLVSEEDFAKFVDPAKMIGPKA
>fig|195.2024.peg.529 LSU ribosomal protein L9p
MKVLLIKDVKALGKAGEIKEVKDGYGQNFLIAKGFAKAATNEVLRKYESDKKKEAENLRF
ELANLEKLKEELSKVTLEISKPVGANGSLFGGVTKDEIAHALKEQSHIEIDKKSLECDTL
KSLGTHEVSVKLGHAIHAKFNINIKAE
>fig|195.2024.peg.548 Aspartyl-tRNA synthetase (EC 6.1.1.12) @ Aspartyl-tRNA(Asn) synthetase (EC 6.1.1.23)
MRSHYNTDLNSTHIGEVVKLCGWVNSYRDHGGVIFIDLRDRSGIIQLVCDPNDSKEAHEI
ASRTRNEFVLIAEGKIRPRGEGLTNPKLKTGEIEVVVSKLIIENESAVPPFGIGDESVNE
ELRLKYRFLDLRNPKLYENFALRSKACIAARNSLANMGFLEVETPILTKATPEGARDYLV
PSRVHQGEFYALPQSPQLFKQLLMCSGFDRYFQIAKCFRDEDLRADRQPEFTQIDVEMSF
CEQKDVIATAETFLKDIFKACGKEIQIPFRQMPYKEAMENYGSDKPDLRFDLKLIDVIDI
FAKSNNEIFANIAKDSKKNRVKALRVPKGDTIFSKRQMQRFEEFVRKFGAQGLAFIQVKE
DGLKGPLCKFFNEEDLNELIKRCELEVGDVVFFGAGVKKTVLDYMGRFRIFLAGELNLIN
PDALEFLWVVDFPMFEQNDDGSYSAMHHPFTMPKNIDEADLEEISSIAYDVVLNGVELGG
GSIRIHKNDIQQKVFKLLNIDEEQQKEKFGFLLDALSFGAPPHGGIAIGLDRLIMLVTGA
NSIREVIAFPKTQRAQCLMTDAPSAASNETMRELGIKLRENIK
>fig|195.2024.peg.910 hypothetical protein
MQNLHEILLQKKIKEIRFKAIASIVCGFLGIIPYLGFLFALASWILFFILLYDLKIYGGA
KNLFKNLFIAAGIGFFGILISTSSLFVILEPRTQLQPDLF
>fig|195.2024.peg.1469 Uncharacterized protein YgeA of aspartate/glutamate/hydantoin racemase family
MKTIGIIGGMSFESTITYYKTINETINNQLGNLNSAKILLYSVNFEEIANLQKNGEWEKA
AQILGECAKKLELGGADFILIATNTMHKIFDQIQKNIKIPLIHIAQSTAKILKQQNIHTI
GLLGTQYTMMEDFYKNALKKENINTITPNQSDMQELSDIIFNELCKGQMKENSKEKYLKI
IQKLKDEGAQGIVLGCTEIGLLISQEDTNIPIFDTALIHALDAVNLALKD
>fig|195.2024.peg.751 Cytochrome c552 precursor (EC 1.7.2.2)
MKKNFLRLAIVVLVLLIVGVLWLNNDINQKKEDEANKNAIAANADFSLLSDDNPNFERWG
KVFPEQLKMYLTVEEEEPKATEFGGNLSYSKLIRFPQLTILWAGYPFSLDFNEERGHFWV
QVDQMKTARNNKDFLNAHGLKAFKGQPAACMNCHSGWTPWLINNIAKGDFVAFNSTNYWT
MIKNVPAVDGIVENSPEHAGPHGGKRMGVTCADCHNPNDMSLRLTRPAAINALVARGYEK
DPVQGVKATREEMRTLVCSQCHVEYYFKPTGEKVKVMGETIADDSSKKWWDGTQKNYDEY
EFWRDGNQPKEIEANGIMLTFPWNEWKKDQPFRIEMLDDYYDKVRNVFGADFTHKLTGAQ
IIKIQHPESELYSGGVHAANGVSCADCHMPYVREGAKKISQHNITSPLRDINSACKTCHK
QSEDYLRAQVRDIQNSVAHDQRTAEYAIVSLIMDTKKLRDELGNMEKFQTDGKADASKIS
EELKEVLELHRKSQMRADFVNAENSTGFHNPREASRMLLQAVDMAKTGQIKLIEIANANG
INDFKTSNLGFEDMQKFNPGELYYKVDVNGHKAGERYYGDEIEVNGNPPKELLEHDKNLA
PYNYQVIDKK
>fig|195.2024.peg.728 Acyl carrier protein
MATFDDVKAVVVEQLSIDADAVKMESKIIEDLGADSLDVVELIMALEEKFEVEIPDSDAE
KLIKIEDVVNYIENLKK
>fig|195.2024.peg.690 LSU ribosomal protein L11p (L12e)
MAKKVVGEIKLQIAATKANPSPPVGPALGQQGVNIMEFCKAFNERTKDMAGFNIPVVITV
YADKSFTFITKQPPATDLIKKAAGISKGTDNPLKNKVGKLTRAQVLEIVDKKIADLNTKD
RDQAAKIIAGSARSMGVEIVD
>fig|195.2024.peg.873 Membrane protein
MRKILQDGLLAIFLFFIPVQILALEPVVFNENVLNQKVVDEINLIGKELQEKSGIFAGVA
IGDKSDFQTLLDLHKQLPQSYVLLVLSKNSHKVDIIGSKGALTLIDKEAVLSPYPGTGSI
LPILATNKGDIYNAAILNGYGDMVDRLAQARGIELQHSIGNANRDTINILRILIYGFICF
ALLYYAQRRMKRKKNA
>fig|195.2024.peg.761 Aminodeoxyfutalosine synthase (EC 2.5.1.120)
MKNLLEKLENEERLNENEANALWDLDLFTLAKFAHKKRTKLHGKKVYFNINRHINPTNIC
ADTCKFCAFSAHRKNPNPYLMSHEEIMKIVDDTITRGTKEVHIVSAHNKDTSWQWYLEIF
KMIKEKYPQMHIKAMTAAEIDFLHRRFKMSYEEVIEKMLEYGVDSMPGGGAEIFDEEIRK
KICHGKVSSENWLKIHKLWHDKGRQSNATMLFGHIEERHHRIDHMLRLRALQDESGGFNA
FIPLVWQRDNSYIQTDKIMDSEEILKTIAISRLVLDNIKNIKAYWATMTLNLAMVAQEFG
ANDLDGTIEKESIQSAGGAKSAKGTNLKTFIEMIKTANLTPVERDSLYNELKTY
>fig|195.2024.peg.744 Molybdenum cofactor guanylyltransferase (EC 2.7.7.77)
MKLENLNCVILCGGKSSRMGEDKSKLIFKNQTLTQFQVEKFSKIFKNVYVSAKEDKFGAK
FKLIKDCPEFEIYSPMLALYSILSNFKDEFVFILSVDSPNLSDKELLKFLPSLKQDYQII
IAKTPSHKHPLCGFYHSSVAHFCKELLEKNEQKIALLFSKAKTHFVDFEDESPFLNLNFY
QEYEQFKSEYE
>fig|195.2024.peg.1508 Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63)
MFKVYYKIPFCYLSLHSNGDFLTKIDFCDRLDIENTCPLLEFAKEELRLYFAKKLQKFQT
PLWIQGGDFEQKVYKELINIPYAKLVTYKEIAININHPKAFRAVGNANSKNLIPIFIPCH
RVIASNGLGGYNGGLAIKRFLLECEGVDLSQFKNKLGD
>fig|195.2024.peg.1341 NADH-ubiquinone oxidoreductase chain L (EC 1.6.5.3)
MQNLALISLFSPFVAFLFASCFALSERKIFVAYVCSLLIGISAFCSLYLLFNNQAFNVSL
FEWFIGLSFGFNIDAISLTMMSVVGVVATCVHFYSIFYMAHDKDFNKFFAYLGLFVFSML
FLVMSDNFLGLFVGWEGVGLCSWLLIGFWYKNNTYSFAANEAFIMNRIADLGMLLGIFWL
YIQAGTLKYNEVFAIAQNLDHNALVLIASCLFIGAMGKSAQFPLHTWLADAMAGPTPVSA
LIHAATMVTAGVYLVIRAGEIYSLVPEVSYFIALLGAFVAIFAASMALVARDLKRIIAYS
TLSQLGYMFVAAGLGAYGIALFHLVTHAFFKSLLFLGAGNVMHAMDDQLDIKKMGGLFKS
LKITAIFMTIGSLALAGIYPLAGFFSKDLILGYSFIAHYHGIFLILLISAFLTAFYSFRL
LMLVFFTPSRHDKHPHEASKIALLAMSPLVVLAIIAGLFEHSFFEYLSTQLIFIDAQNKL
VMICASVAAVLGVVLAIIAYKASWFKDSIEQNKIHKLLSNDYFIPKFYHEFIVSKYESLC
AVLKHCDTYIFDAIVDKIAYYCNLISQKIIMSNSLNLMLRFLVAGFVILLILVWVV
>fig|195.2024.peg.727 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
MKRVVVTGIGMINALGLDKESSFKAICEGKSGVKKITLFDTTDFPVQIAAEIENFDPLEV
VDGKEVKKIDRFIQLGIKAAREAMQDANFDQNLDKEEFGVVSAAGIGGLPNIEKNSVICS
ERGPRKISPFFIPSALVNMLGGLISIEHGLKGPNISCVTACAAGTHAIGEAYKSIALGNA
NKMLVIGAEAAICPVGIGGFASMKALSTRNDDPAHASRPFDKERDGFVMGEGAGALVFEE
YEEAKKRGAKIYAELVGFGESADAHHITSPTLDGPLRAMKKALKMAGNPKVDYINAHGTS
TPVNDKNETAAIKELFGSEIPAVSSTKGQTGHCLGAAGAIEAVISIMALDNGIMPPTINQ
FVSDEECDLDYIPNEARKADLRVVMSNSFGFGGTNGCVVFKKVD
>fig|195.2024.peg.950 Putative transporter
MQALNQEKFNSLSDIKIILVLCLGVFGILSTELGMMGIIPIVSQNFSVSISDAGWSVSIF
ALVITFCAPIVPLLCANFNPKKLMLICLAVFILSSLIAAFVSEFWQLLVFRAIPAFFHPI
YIALALSMAANLASDKKDIPKNVGKIFAAVSVGMVLGVPLTSYLGGNFGFEISMLLFVFL
NLLSFVATLFFVPNFKKENKVKIGKQLLILRYPLLWISILCVVCINAGIWGFYSYFSDFL
LSISKINFDLISIILALYGFANIIGNNLAPKLLIKNVNLNLIFTLLLMIGIYVLIFNFYY
QNMILMILAFILGILGGVMNNGTHFLISHPFPRAKDFTNGLFISVANIGLSVGTAICGLV
ISLSNTRFIAISSVVLLSFGIVIILLRDKIQSMKLRF
>fig|195.2024.peg.512 Methyltransferase (EC 2.1.1.-), possibly involved in O-methyl phosphoramidate capsule modification
MKQGDFTEVAKHYHNRPAYSPFLLEKLIACINDKNKNIKNLNIVEVGAGTGKLTKMLGEM
FECQIDAIEPNDNMREEGRKFTQNLSNISWHQGSGEETRMKDNQADWVIMASSFHWTDPK
KSLPEFNRILTGGGISLRFGILATL
>fig|195.2024.peg.771 Putative periplasmic protein
MKKISLILACSMSLFAASNSEISDFYSKSIKAQFPNATVSVGNRQKVGNTGFESVIVTIT
LEGQKQEQILFTKDNLIVPDIIDLKTKTSYAQEYEMKKFQEARANFTKNVKPVVQKETML
IALGDKSKPAIYVFSDPECPYCRDHLAQIKDELKNYQVNYILTPVHGKSAFEKSALIYKE
SKKAKSDDEKIAILNKYYDANIKSYPKVSDSELKEVFSLYEKYRSLGLSATPTIIK
>fig|195.2024.peg.1632 Membrane protein
MKKIIILFLLGISCLWGDEFRLIDTNASAQDKSVYSLVQKYIDLNRQIKEFKKNNDENSS
SYDGILSEFEKDKKSILSKMPDMIVKQQINEKAVESFLKTRQNLLDLQKKSINKPYVYVD
TTLNIMYLDVVKSFYSSLFELERLFKNAANSESIISTVDKAMENLQNSTNIDLSIYKAKI
NNPSELEKISNKEEMIFNAVDAYVEILKYLRANADLLESNYIFSLLELQVWIDRINEMAN
IDFINTGKIVISILVLVFFMSLRRFFSNIVYFILVRLVYRNKSDADDIKVIFIDNIKKPV
GFLLICYAISLCLTIATYPAPLSINLSNLFHIVYAVLIAWLILRILDGYGVVLVSKLAQK
SGKKEVVNLVIKILYFVIFVIALLYILAQLGFNISAIIASLGIGGLAVALAAKDIIANFF
ASILLLFDNSFNQGDWVEVSGVEGTVVETGLRKTTIRTFDNCLVFLPNSTIMGANIKNWS
KRRMGRHVRMYLGVGYDATPEKLENCVKDLKELLYTSPLVAHEDDGALKYGDHTTKYRQN
LVSINDLEGYKNACYVALSEFADSSINIELYFYIKEIGGKDFREARQSLMLEFMRIIEKN
GLTFAFPSRSIYIENLPPLDLQAKAIK
>fig|195.2024.peg.1181 Threonylcarbamoyl-AMP synthase (EC 2.7.7.87)
MIYLAQTDTTAGFLSKNLEEINALKGRAKDQPCLITSAKFDELKKIVRVPNQFKNWVRRA
KKTTFIYPNNQAIRIVKDCKHAQFLEKMGCFYSSSANKHGQKFDELWARSVADVVVDEIF
VENTPSKIIKLHRKKLKKIR
>fig|195.2024.peg.1655 Adenosine deaminase (EC 3.5.4.4), alternative form
MYIISAKYIFLCDEQFSILENKAFVFENEILELGELEELKKRYPKAKLIKTSPHCVILPA
FINPHTHLEFSANSTTLHFGEFLIWLKSVINSRSMLNEQAKEELILKNIQKMQKSGIGTI
GEISSFGSDLNPCVRASQNGMRVVFFNEILGINEAQIQDKKQEFLTRFEKSLKFKDEFFI
PAISVHSAYSTHPELAKFAINLAKKQKLLISTHFLESKAENAWLKEVKGGFKEWFKNFTP
DPKPLYKASEFIQLFKGVRTLFTHCVYLKEMDLLDKNLHSITHCAFSNRLLSQKTFDLKK
ALKSGLNIHLGTDGLSSNISLSILDEMRANLLVHTDFDLLKLAPKLLQMATLYPAKALNL
NLGEIKQGKMADFSVFELGECNKEQAPLQFILNAKEVQKIFIKGKECKF
>fig|195.2024.peg.1130 DNA gyrase subunit B (EC 5.99.1.3)
MQENYGASNIKVLKGLEAVRKRPGMYIGDTNIGGLHHMIYEVVDNSIDEAMAGHCDTIDI
EITTEGSCIVSDNGRGIPVDMHPTENMPTLTVVLTVLHAGGKFDKDTYKVSGGLHGVGVS
VVNALSKKLVATVERNGEIYRQEFSEGKVISEFDIIGKSKKTGTTIEFWPDDTIFEVTEF
DYDILAKRFRELAYLNPKITINFKDNRVGKSESFHFEGGISQFVSDLNKKEALTKPIFFS
VDEEDVNVEVALLYNDTYSENLLSFVNNIKTPDGGTHEAGFRMGLTRVISNYIEANASAR
EKDSKITGDDVREGLIAVVSVKVPEPQFEGQTKGKLGSSYVRPIVSKASFEYLSKYFEEN
PIEAKAIMNKALMAARGREAAKKARELTRKKESLSVGTLPGKLADCQSKDPSESEIYLVE
GDSAGGSAKQGRERSFQAILPLRGKILNVEKARLDKILKSEQIQNMITAFGCGIGEDFDL
SKLRYHKIIIMTDADVDGSHIQTLLLTFFFRFMNELVANGHIYLAQPPLYRYKKGQKKEI
YLKDEKALNDYLIETGIESSNYEGIGLNDLKDFLKIVAAYRSVLNELKKRFNVISVIRYL
IENPDFIKENNEELFKIVKAFLEKEGHNILNHYINENEIRIYVQTENGLEELIINDDLFS
HPLYEEANYIFNKIKDRDLSFEKDILDILDEVEKNAKKGAYIQRYKGLGEMNPEQLWETT
MDPSVRRLLKITIEDAQSANDTFNLFMGDEVEPRRDYIQTHAKDVKHLDV
>fig|195.2024.peg.1313 Shikimate 5-dehydrogenase I alpha (EC 1.1.1.25)
MKFLAVIGDPISHSKSPRIHNNAIQVLKLDGIYTRYHLQDYHQLRQDFFKLKLQGANITL
PFKEAALEMADVKDELASNIGSANTLCLKDGKIYAYNTDALGFLEAIKEFESINKALILG
AGGTALALAFALKQKGVEVCVANRSEKRFKDFTLYKTSLYNALDDFDFDLVVNSTSAGLK
DDDLPCDKILLDKILNRAKFAFDVIYGKETSFLKLCKEHNLKVKDGFDMLLWQAVFAFEL
FFDVKDKREKIKNAMQEVLKLEF
>fig|195.2024.peg.1258 Putative uncharacterized protein FIG019238
MLKVLEYSITHFFEHILRLHIEKAEDIVGELYGASIPVMEKSGREYHFYLFFPKEFLQTI
ANVLVRDEKFKEDDWCDLSKECANQIIGYAKNLLNDAKGDDEYKLGIPEYLGRVDFSSII
LDESLTYSFENHYFRIGYCK
>fig|195.2024.peg.1435 UDP-N-acetylmuramoyl-dipeptide--2,6-diaminopimelate ligase (EC 6.3.2.13)
MKLKLDQSFITDNTLECEKDCYFLKTAQNMNFASDALEKGAKIIDVEECKKLLKIDENIK
IIGITGTNGKTTTAAAIYSILLDLGFKCGLCGTRGAFINDEQIDEKSLTTSPILKTLEYL
QLATQKKCDFFIMEVSSHALVQNRIEGLKFAAKIFTNITQDHLDFHGNFENYKAAKELFF
TDESLKFINKDTLMIKFNVRNAFTYGIENPSLYQVKAYSLEDGISAIVALKDQSFHIDSP
LLGLFNLYNLLAASACVNELVKPNLKDLEKAISGFGGVCGRVEQVANGVIVDFAHTPDGI
EKVLDTLKNKKLIVVFGAGGDRDKTKRPLMGKIVEHFAKIAIITSDNPRSEEPKDIMNEI
LSGFQNPDKALMIEDRKEAINKALKLKEKDDLVVILGKGDENTQEIKGIKHPFSDKAIVN
EILKNQG
>fig|195.2024.peg.477 Pyridoxal phosphate-containing protein YggS
MTLEQILEKTKNIRLVAASKYVDANIIEKLFTQGITEFGENQVQALVQKKEILDKKDLNI
KWHFIGTLQSNKINLLIKQKPILWHSCNGLKIAKAMDKRLNYKLDTLLEINSANELSKSG
LNPDQAIEEYLQIQEECPNLNLCGVMSIGSHSEDQREIEKSFETTYKIYEKLQKHGAKIC
SMGMSNDFEIAIKCGSNMVRLGSILFKNLK
>fig|195.2024.peg.1089 LSU ribosomal protein L5p (L11e)
MRLKEKYDQSIKPALVKEFDIKNPMLIPAIEKIVISVGAGELAKDQKVLQNVADTISLIA
GQKAVITKAKKSVAGFKVREGFPVGVMVTLRKENMFAFLDKLISIALPRVKDFRGLSRDG
FDGRGNYNFGLDEQLMFPEVEYDKILRTHGMNISIVTTAQNDKEAQKLLELIGVPFTKGK
>fig|195.2024.peg.1318 Fumarate reductase iron-sulfur protein (EC 1.3.5.4)
MSRKLTIKAFKYNPLSKISKPHFVTYELEETPFMTVFVCLTLIREKMDADLSFDFVCRAG
ICGSCAMMINGVPKLACKTLTKDYSDGVIELMPMPAFRHIKDLSVNTGEWFEDMCKRVES
WVHNEKETDISKIEERIEPEVAEETFELDRCIECGICVASCATKLMRPNFIAATGLLRTA
RYLQDPHDHRTVEDFYELVGDDDGVFGCMSLLACEDNCPKNLPLQSKIAYMRRQLVAQRN
K
>fig|195.2024.peg.164 ADP-ribose pyrophosphatase of COG1058 family (EC 3.6.1.13) / Nicotinamide-nucleotide amidase (EC 3.5.1.42)
MKHLLFLIGDELIMNENFKDYIYRSYENKFKEIHETRFQNKTDKELPFLLEKLLDNYDFI
TLFTTPNHYATIAKILATLSEDNLVLKEDNLVPDKAYFQKDSFICDFINSKINVIKTNPG
QKLPPLLGDIFPNFAYFCLLGIDDESAVLLLDTLTKSYEVSIKSSKILENLTLIKASCVN
FGKLDGFLTSVKNLFGQKVFLGKDPIQFIVSKLLEKKIKISFAESCTGGLCASTLTKFSG
VSEIFEGSIVSYSNKIKHEWLGISESILENQGEYSERCVYFMLKGIFKTAKPDFALAISG
VTGEQDEGLVKSGTVYIGAMFKDGTFVQETLYLSGDREFMQKQATLATFCLLLKLKPEIF
EF
>fig|195.2024.peg.995 7-carboxy-7-deazaguanine synthase (EC 4.3.99.3)
MQLVESFLSIQGEGKYSGKLSIFMRFAGCNFNCSGFGVKLIKNGKTLKGCDTIRAVFTKE
FNEEYEILNASELFKRVLDLKKDFNPIVVITGGEPLIHHENPEFIDFIQALLKNNFEVHF
ESNGSIELDFEKYPFYKECVFALSVKLQNSGMGKEKRLNFNALKGFKHYAKDSFYKFVLN
SSQLESLSLEILEILEKAPNEIFCMPMGENEQNLKQNALKIAEFCIKNGYNYSDRIHIRL
WNDKEGV
>fig|195.2024.peg.167 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MKTELEIFSTRYSCRNFKNEKLKKEDLDTILEIARLSPSSLGLEPWRFLVVQDDNKKEEL
AQICNQQQHVKDCGALIIIVSRLDFLDYFEDKLRKRDMSEAEIQKRLDTYMPFLQSLSQE
QKISYAREQAHIALASILYSANALNIASCTIGGFDKEKLDSYLLLDTKKEKSTLVIALGY
SNDEKIPQKNRFEFDKIVQFL
>fig|195.2024.peg.923 Tungstate ABC transporter, ATP-binding protein
MIELCNFKFNYGQKNILNIKHLCLDTDKISILMGSNGSGKSTLLRILKFLEGEFDNITYF
GNKHLNSDEKRQIYLLFPEPVFLNRSVEKNFYFLLKTYKLDSKEIKKRLNEVLNLLEIDR
SLLKKYPSELSSGQGQKIAFALALSVRAKYYLLDEPSAFLDKDTMILFKKAILYMQKTYK
SGFLIASHDKNFLDFLAQKKYYLHAGEILEFENTNIFELENKGVNFSNFIDFSMCKNYIC
KDEISNKIAIDPYKISFLYPDDFSKQTFDFILQKCIIIALRTRKEFVFIRVECGGKILEF
ALESERFKQEKLSLYQELCLVFNEEAICFLN
>fig|195.2024.peg.1331 hypothetical protein
MAKFRIQYSAGFGHFTQNHKGFGPTIYIEEVVEFDNGKDYFDYIDFYNTYSKSDDTYFHI
SFLEDRPLSDKEITIRNEYRKIRDENCKRAKEEFIRDNELDVEHLPTHGD
>fig|195.2024.peg.498 Flagellar basal-body rod protein FlgG
MMRSLHTAATGMVAQQTQIDVTSNNIANVNTAGFKKGRAEFADLMYQVMKYAGTSTSATT
LSPSGIEVGIGVRPTAVTKVFTEGNLKATSTDSLDMAIAGNGFFQIQLPDGTIAYTRNGQ
FTKDNEGNIVNADGYRLLPEMTIPEGATAINVATDGTVSVMLPGEQQETQIGQVELVQFI
NPAGLHSMGDNLYLETGASGAPVAGIATQDGLGTIRHGFIELSNVQLVEEMTDLITGQRA
YEAGSKAITTSDDMLGIVNQLKR
>fig|195.2024.peg.515 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAELNFKTKAQNLKNLQTKLKKAKILPLVLTSLEELILNEEKILSDIQALKANKLIIRSS
SLSEDSMKNSNAGAFLSLANIDANSKDELLKALYKVANSMPSKSDEILIQPMLENITLCG
VGFSVDKDNFSPYFCLQYDENGSNNSITDGSSKSAKTYYHYREHLDFKDIKLQKIIELIK
ELESLYDCCFLDVEFAFAFKDNKEELFCLQVRPLVMQEKENLFNALPKEALQRFYKRFIS
LQNLRPRVLGEKALFGVMPDWNPAEIIGLRPKRLAFSLYKEIITDNIWAYQRDNYGYKDL
RSHPLIHSFLGIPYVDVRLSFNSFIPKKLDENIAQKLVNFYLDKLNKNHELHDKIEFDIV
YSCYDFNSSKKLQELLNHGFNENELKRLEFSLLELTNKIINPQSGLYLKDIKKAYRLKER
YDGIIDSNFSLIDKIYWLIEECKRYGTLPFAGVARAAFVAMQLLNSLVEINFISKEEKND
FLNSLNTVSKNLSKQTNNLNSCTKNQFLIEFGHLRAGTYNILSPRYDENFELYFEINQKD
NNVYLEDKAFILPEEKMKALNTLLKEHGLEISACEFFDFLKQSIEGRELLKFEFTRLLSK
AIVYIEELGKYYDIKKEDLAHLDIKSILNLYSSLYSINPREQFLEEIARNKKEYKLTQAI
KLPSLLCNTEEIFSFYNHSIIPNFITQKSITAFTAKENDKDLEGKIVLIYAADPGYDYLF
TKNIAGLITCYGGANSHMAIRASELGMPAVIGVGEENFEKYLKAKKINIECESEQIFCL
>fig|195.2024.peg.706 tRNA-i(6)A37 methylthiotransferase (EC 2.8.4.3)
MSSKKLFIQTLGCAMNVRDSEHMIAELTQKDNYTLTEDIKEADLILINTCSVREKPVHKL
FSEVGGFEKVKKSGAKIGVCGCTASHLGSEIFRRAPYVDFVLGARNISKITQAVNTPKFM
SVDIDYDESEFAFGDFRNSIYKSYINISIGCDKHCTYCIVPHTRGDEISIPLNIIYKEAQ
KAVDKGAKEIFLLGQNVNNYGKRFRNEHKKMDFSDLLEELSTIEGLERIRFTSPHPLHMD
DKFLEVFAKNPKVCKSMHMPLQSGSSQILKAMKRGYTKEWYLDRALKLRELCPNVSISTD
IIVAFPGESDKDFEETMEVLEKVRFEQMFSFKYSKRPLTKAATMPNQIDEEIASNRLSTL
QARHNEILDDIVKKQENKTFKVLFEELRAGNAIVGRTDNNFLVQVEGSEELLGTFKEVKI
TNAKRMVLYGEII
>fig|195.2024.peg.1439 Transketolase (EC 2.2.1.1)
MDLSILQEQANTLRFLSADMVQKANSGHPGAPLGMADILTVLSYHLSHNPKNPTWLNRDR
LVFSGGHASALLYSFLHLSGYDLSLDDIKNFRQLHSKTPGHPEISTQGVEIATGPLGQGI
ANAVGFAMAAKKAQNLLGKELINHKVYCLCGDGDLQEGISYEACSLAGLHKLDNLIIIYD
SNEISIEGDVSLAFNEDVKMRFESQGFEVLSIDGHDYEAIDKALKQAKEANKPCLIIAKT
TIAKGAGELEGSHKSHGAPLGEEVIKKAKEKAGFDPNLNFYIPKAAKIRFESAVELGDLE
EAKWKDKLEKSEKKELLEKLLNPDFSKINYPDFKGKDLATRDSNGEILNALAKDLEGFLG
GSADLAPSNKTELYGMGDFAEGKNIHFGIREHAMAAINNAFARYGIFLPFSATFFIFSEY
LKPAARIAALMKVKHFFIFTHDSIGVGEDGPTHQPIEQLSTFRAMPNFLTFRPADGVENV
KAWQIALNADIPSAFVLSRQKLKALNEPVFGDVKNGAYLLKESKDAKFTLLASGSEVSLC
LESANELEKQGFACNIISMPCFELFEKQDKAYKDRLLQGEVIGVEAAHSNELYKFCDRVY
GIESFGESGKDKDVFEHFGFSVPQILNFILDK
>fig|195.2024.peg.90 Putative periplasmic protein
MKKMFYGIAVSLILATSLSAVSFNQDSLKVSFEGYKTEDMVGVGGEFKDVKYKFSKNTST
LASYLKGARAVVNPSSVFMGEGNEIITDNLAKVFFPSLLGNSDIKVVFKDVVTGENKGVI
SARVTIDKKSTLVPLSYTIENNKFVAKGQLDLHAFKNSSQALKALSDVAPGHGGISWPLV
DIVFSADVVQ
>fig|195.2024.peg.1261 Exopolyphosphatase (EC 3.6.1.11)
MAKKTAVVDLGSNSIRMVVFEKTSRYSFYTTCEYKRKVRLGENAYNNGKILQEDSMQRAE
NALAFFKQCALKHKCKKIFIIGTSALRDAPNSKDFIKRIKDKLNLNIRCIDGKNESYLGG
LATLNLLSPFKDGTTLDIGGGSSELCLIKNNKIISCISLDLGTVRLKELFYDKGKADALD
DFIKPILEQIPSEFCNQNLIAIGGSLRAISNSIMQKNSYPLKNIHDFRYMLEDEKEHILK
IFNSKADALINFGIKKDRFDTIKEGIFIFLKIAEKLKAKQIITSGVGIREGVYLQDLLRP
KHTFPVNFNPSLKSLQDRFLQGNINNKTPYFSIQIFKVLQGLHKIHEKYQQSLLNAAKLC
HLGEYLNFYFANEHSAYFILNGLNYGFSHQEKVLIATLIKLNGKKVNPYNLEPYRQLLPN
THIISWLNFILSLAKILSTNENKIEIAFANNTLYIYSESKILDLPKDELKKITKPATIAL
AINQKP
>fig|195.2024.peg.200 short chain dehydrogenase
MDKVVFITGGSTGIGNACVHKFHNEGYKVAFMDINQEEGQKIANNLKDVLFIAGDTKNKE
DIKNAVARAVEKFGNFDVISLNAGIHRCNTILDISDEELDLIIQTNIYGYVNTMRIAIPH
MKKEGGSIVINASD
>fig|195.2024.peg.1444 hypothetical protein
MKNELDVFKKHLGEIQGVSEFKATQICSQINDANDFIGALQILDLTLKKIEKSITERLDE
QNDDLQKRTLDATSSQLIQNCSFMGTALFGNIFNVYVGQKLFEFEISNPLLVLEKAGYEG
VLAYIQDKRDEIKDILCKLSSAITMGISMDNMNFSDSATNFKNLFR
>fig|195.2024.peg.1329 hypothetical protein
MDYNVFLLNIQDKINQEDFFNLKLKFEQLQNKKEALSNLVFLRLQDPIKPLIMSIICGFL
SLGWLAIDRFMIKDYALGILRIILSLFPCALFLILGISYENDSNSDISEIFFGLFGIFLL
LGIIWWGVDLFLVYKKIKKQNYNKIIEFIFNYQKI
>fig|195.2024.peg.134 Pyruvate carboxylase subunit A (EC 6.4.1.1)
MVQIHKILIANRAEIAVRVIRACRDLHIKSVAVFTEPDRECLHVKIADEAYRIGTDAIRG
YLDVGRIIEIAKACGADAIHPGYGFLSENYDFAKACEEAGIIFIGPKSEVIHKMGNKNIA
RKLMAQNGIPIVPGTEKLNAYSMDEIKVFAEKIGYPVILKASGGGGGRGIRVVHKEEELE
NAFDSCKREALTYFNNDEVFMEKYVVNPRHIEFQILGDNYGNIIHLCERDCSIQRRHQKV
IEIAPCPGISDNLRKTMGVTAVAAAKAVGYTNAGTIEFLLDDYNRFYFMEMNTRIQVEHP
VTEEITGVDLIVRQIRIAGGEILDLEQSDIKPRGFAIEARITAENVWKNFIPSPGKIGEY
YPALGPSVRVDSHIYKDYTVPPYYDSMLAKLIIKATSYDLAVNKLERALKEFTIDIRTTI
PFLIAITKTREFRRGYFDTSFIETHMQELLENTEDRHQDNKEEVIAAIAATLKKIRESRE
>fig|195.2024.peg.1034 Probable membrane protein Cj0124c
MRIRLFFIASFIYIALIFALAWYLELGNYTLNFNTYSFELPIMIWLILPLIPLVFFAIIH
MGFYYFLLTLKFKHFFKDSTKFENFTRDLLLEKESNISFQTKEFRQVAQLAKTLKTHEKI
PNANKINEILDLIDGIKKEEYFNLNKFKLENNNILFLENEKNHIKNDINYAYSKIKNLSQ
TQDEFQDLAFESLIKKGTYEQIKNIKITKKPCHILTLIKRFKEGNLELNAAEYEVLLSHN
ILSEKDYLDIAKLSIKLLNPDAVIGIFNKIKNEKSEALRAYLYLLAEFGLLDELREQIHN
DDKKFNDFKAFLILREKNIKIDLNQLIQ
>fig|195.2024.peg.1597 transposase
MFHLYQAYNICLNLQQEQWDKNKNLDKKDRSYLKASKIDNQ
>fig|195.2024.peg.56 Chemotaxis protein methyltransferase CheR (EC 2.1.1.80)
MEEKINPSELELNEFIKIINEISGIDLNEKRNILVLKLSKFVSSTGVKTFAEFLSKLQIN
RQLRQDTLDFVTIGETYFLRELSQLKEIIFYAKSLEKTVNILSAPCSSGEEVYSMAILGA
QNFLKDMMILGIDINSNVIEKAKVGKYQGRTLQRLSESEKRRFFTDIGEQTFSINKSELC
TCRFELCNVFEDKFLRLGKFDIIVSRNMMIYFDYDSRIKLMERFYQILADNGRLHVGNAD
LIPETTFFKKVFSPRGVYYEKI
>fig|195.2024.peg.1414 hypothetical protein
MQENHNFISFVLLDEAKFDFLKLKKILEDDFDIWIADENFTQDGVIFSFKNMIVTLNLIK
NPIPNNEAEYYANFNFVWKDALEQTQKHKAHLLVSVLSQSESKLDQAKLFTQISSACLQD
EHTLGFYTGGVVLEPKFYIENAKMLKENRLPIYNWIYVSVYPGDNGNNAYTYGLRNFDKL
ELEVCDANIEEKELFFTLYDIILHILTYDLSLKDGDTLKFEDGRILSFKKSQGIGVENES
LKIIF
>fig|195.2024.peg.1594 hypothetical protein
MFKKINFETNFTEKNNNQIIKLVSKRYLIFAIYFSKKTYIFKNYSKKK
>fig|195.2024.peg.471 Molybdopterin adenylyltransferase (EC 2.7.7.75)
MDIINIGILTLSDRASSGIYEDKATAEIERVLNSYIKNDIIYHKELIPDDYDLIIKKLLY
LADEKKCDLIVTSGGTGPALRDVTPEATEAVCDKMMPGFGELMRLESLKYVPTAILSRQS
AGIRNKSFIINLPGNPKAIAECLEPVFPAIPYCIDLIGGACIEGNDEVIQVFRPKKKCQN
>fig|195.2024.peg.1025 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MLNALSKPLMIGIYQDDKLVKSIESEEKASEFVPKILKILLKEFSFDELIYANGPGSYMG
IKISYVSLRTLSIVKNIPLFAISAFELNNNQPIAAHKNMCFVKKEDEIILEENTAGEFFL
PPNLSKLNKKDDNLPFYFLSAI
>fig|195.2024.peg.890 Proline/sodium symporter PutP (TC 2.A.21.2.1) @ Propionate/sodium symporter
METVQINTPIAIMFVAYAALMLYIGFYFYRQNKNTEDYFLGGRSLGPVVSALSAGASDMS
GWLLMGLPGALYASGLIESYIAIGLSIGALLNWSFVAKRLRIYTSVIANSITIPDYFETR
FDDDKHILRIVCAIVILIFFTFYVSSGLVGGAKLFEATFGIRYEYALTTGTLIIVAYTFL
GGYKAVCWTDLLQGLLMMGALIVVPAVMLYHLGGFGEAMAVIEEIKPNALSMGEGIGALS
IVSALAWGLGYFGQPHILVRFMSIRSTKDIPAATFVGISWMVISLIGACFIGLLGIAYVH
KFELTLQDPEKIFIVMSQLLFNPWIAGILLSAILAAIMSTASSQLLVSSSTIAEDFYKRI
FNKEASNKTVMNLGRIGVLLVALVAFVISTDKESSVLSIVAYAWAGFGASFGSVMLFSLF
WSRMTRIGAILGMITGAVMVVLWKNYLAELFNFPIYEIVPGFVAASAVIIIASLLTQVRP
GTKAAYERMLKEL
>fig|195.2024.peg.350 FIG00469465: hypothetical protein
MAKIDEKTLRVKYLRALEKFANAAISALKKENFDKEKFQERMEKNKKIVEKCEAVNLNSS
YNKSLENFVNHCLDFSKQKEELLSLANALDKLKKGEKKEKHKTYLKDYYD
>fig|195.2024.peg.1397 Haemin uptake system permease protein
MLNLNMRSKNLVIIGLFLAYIITCIIALCLGDENLSPKELLSYAFGENEILRQIIIDGRL
PRIIMAILIGMLLASSGAVTQNVFSNPIADPYIIGIASAATFGSVLAYLLKLPDYYYGIL
GFICSAIFSLAIFKVSSKASIATLLIIGIAASSFLGAFTSFFTYLIGEDSFKIVAWLMGN
IGSASWFRIGILILPLIFCLMYFYAHKNELNIILSGDDEARNLGVDAQKLKINLLIVSSL
AVSFAVAFTGLIAFVGLIIPHTVRLLLRNYDNALVIPFCTAFGGLFLLICDTLARTLIAP
VQIPIGVLTAFFGAPVFLYLALSARRFL
>fig|195.2024.peg.325 Putative periplasmic protein
MKKIFYGVAAFIVVLLIALYTLLFTSLGNNIVANFIQDKIKQSTGLDANITQFVLCFSSL
DIEANLANMADLKLEGNLSLFKLGFDLDYIISLDKNYAKNLGLNLNQNLAFLGKINGKSS
DFMIDGKGYLFGSNVLLDARVYNYSPIALNLSANDLQISELLALFGRGNLAKGTIDIASK
ISAKDLKPDGNAIIKLDNTYINYAEIKKEFNIDLPENSNLKAEILANIKDDTVYTVSKIY
NSYLTLQTQKTLYNLIQNTLNTDFDLSVPNLAKLEKLTKTKLNGSLGVKGDASVANNALT
GLNANVIGLGGEVKANLKNNQLNLNASNASLEKILALIGYGGIVSGNLNANLVSEGLDFA
NFNADVKINNAKLNSAEIKKIAKLDLPNTNFSLDAKAKAKNGNISYNALLASNLLNIKKL
DGTYNLKNAELNTDLNAFIDDLSQFNAIAGQKLQGKAELNAKAHIIGAQIQNLNANANIA
GGLIKANSNGKKLDLDINKLDLSKVFTIVGMPNYASGIVNASARLDDINFNNLNGKINAE
AKGILNAVVLSQIMDKKFPSNTNYDLNIKADLKNNIADFEGVLNSSLANLSNFKGKFDIN
KMVLNSDYVLDIADFSKLGFLLDRKLKGKASFNGKIGFDKTLNFTALSKNLFEGKLDSTL
KNNILNAKLEGVDLSTLASGLDFIDIYQGKANLDAKYNLISEQGEVNADMKEGKLKPNAI
TAALKLITLKNITTDVFHTANAKALINKENIKLDLNMQADRSYVLVSSGMLNSKSGSLNL
PFDIKIDRANFKGNITGTTQKPQVKLEAGSVVNSIKNIVGDKAQDGVQKAGEKVDEGINK
LLNKIF
>fig|195.2024.peg.942 hypothetical protein
MKKIIFLLCLCISFVFAKQIYIVHGYGSDENYGFLPSVAKNLKAKNHEVLLLSFPNAFSP
KLDEWMQTMSQNFTKLDENTFFITHSLGGVAVLDFLNSLDERTKIGGVIMVAPFDEPLAK
LPILNDFIKPKLNYKKLDNMIIHKIIISAKDDKVVPIWVSENLAKKLNAKFIQTPNGGHF
MESKGFKDLPLVIEELERIK
>fig|195.2024.peg.231 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase (ED 2.4.1.290)
MRVGFLTHAGASIYHFRLPIIKALIARGDEVFVIVPQDEYTEKLKALNLNIVVYELSRAS
LNPLIVFKNFLHLKNVLKNLNLDLLQSGAHKSNTFGLIAAKYAKIPYKIGLVEGLGSFYI
DKGFKANLVRFVINTLYKLSFKIADSFIFVNQANADFMRNLGLKENKICVIKSVGINLKK
FFPMRVEQEAKKAFWQNLKIDEKPIVLMIARALWHKGVKEFYESAEYLKDRANFVLVGGR
DDNPSCASLEFLNSGKVFYLGARSDIVELLQNCDIFVLPSYKEGFPVSVLEAKACGKVIV
VSDCEGCVEAISNAYDGLWAKTKDSKDLIEKIQVLLEDESLRINLGKNAAKDALQYDENV
IAQRYLELYDRVIKNV
>fig|195.2024.peg.11 hypothetical protein
MPQTHNKNLKNELEDLRYELSIVLEAMLLYAGVKREKLESAIEAYIDNIDSVLENSNKEG
VDEVLEVVEFLKNQHSELFQ
>fig|195.2024.peg.1019 McrBC restriction endonuclease system, McrB subunit, putative
MLEDKYDWKISNPDKNGNVYYHFPKDEDEFKEAVVKNGGMSVYIYQEGELIDEFHTKSQG
YRWTSPVFNYLKTMNKKGERFYRYYKNCKFFAIVD
>fig|195.2024.peg.937 hypothetical protein
MQDNEIENTTAINTYVKNKDNDNFIIILNETLCCQYHHFLLSISNQFESKKWKMKNFRNF
IITNLKECALTEQERQSLAGNEGEILDKAISKLRIDERSGEIGEIFLHGIMREYYNALPI
VPKIFYKQNRNMEAFGFDSVHLTIENQEYHLWLGESKLYKNLDDAIRKATKSLKDNLSDE
TILNEARIIANLHELDNLAKHHNIETSTLTNFKQIISGNINLDNLKGILHVPISIIYDCD
YTKNIEEITDDYKTTIKNFHKENGNKISEEIKNLLNEITYIDRIKFHIILFPVPDKEEII
SKINKIFESYRNAD
>fig|195.2024.peg.223 Phosphatidylserine decarboxylase-related protein
MGKYITKEGHWFIAIVFILFVICWIFYSFSVLLFLFLLVLLFIFRIPNRVRVCNDSKAIL
SPIDGRITRIENTFDKYLGESVEISIKNAFYDAGAFYTPFKMDINDIALKHGLFLCSELK
SARIMNENVSIFASSNGSNVVLRIYAGSFDRKLKLDNLSHSLTVGDKMGFLINGTISILL
PRDTRIHVGLGDELKSGSLLGYLA
>fig|195.2024.peg.278 Arginyl-tRNA synthetase (EC 6.1.1.19)
MKNIIFNEVKKILECDFALENPKDKNLAHFATPLAFSLAKELRKSPISIANELAAKFQEH
SYFDKVEALNGYLNFRLSKTFLNELANKALQNPNEFSKGEDKTESFLLEYVSANPTGPLH
IGHARGAVFGDTLARIAKHLGYKFDTEYYVNDAGNQIYLLGLSIFLSIKESILKEEVEYP
EQYYKGDYITDLAKEAYEHFSQDFFSEENIPALADWAKDKMLVLIKDNLNQANIQIDTYA
SERSYYGALEATLLALKEHGGVYEQEGKIWLASSLKGDEKDRVIIREDGRGTYLAADIVY
HKDKMSRGYDKCINIWGADHHGYISRMKAAMEFLGFKADDLEIILAQMVSLLKNGEPYKM
SKRAGNFILMSDVVEEIGSDALRYIFLSKKCDTHLEFDISDLQKEDNSNPVYYINYAHAR
IHQVFAKAGKKIDDVMKADLQSLNQDGVNLLFEALNLKAILNDAFEARALQKIPDYLKNL
AANFHKFYNENKVVGSANENDLLKLFSLVALSIKTAFSLMGIEAKNKMEH
>fig|195.2024.peg.1101 LSU ribosomal protein L3p (L3e)
MEYIVEKIGMSRTITNPSIAVTLLRVVNAKVCEVEGGKALVAYPKGKASNKCVAGQQKKY
NLSAEYNRFATLEVANTEAGDLDETPLNEAKILKVSFNTKGRGYSGVMKRHNFAGGPASH
GSRFHRRHGSIGNREWPGRVQPGMKMAGHYGNTKVTVKNEVVSYDAENKILVVKGAVPGY
NGAMGKIRIAK
>fig|195.2024.peg.1630 Membrane protein
MSLYDRDYSRSREFENTRSSELGIFIKQTYQLFAASLLAATVGAYVGIYALAAFFIQSQV
TFWILFAVEIGLLIALQFKKREAPLNLILLFGFTFCSGLTLTPLLISVLALPAGGVIIAQ
AFALTTVAFAALSIFAMNTKKDFTLMGKALFIVLIVVVAASLLNIFFQSSLLNLAISAVA
AILFSFYILYDTQNIIRGNYETPIEGAVALYLDFVNLFVSLLNILRSFNSR
>fig|195.2024.peg.688 LSU ribosomal protein L10p (P0)
MTRSEKVEIIAKLQEEFKISEAIVVCNYKGLSTKKLEELRNNARENNVKVQIIKNTLANI
ALNNSGKTGLVLKDTNVYLWGEDQLSVSKVAAKFEENNDKFEIKTAHIEGEVADVAKVRA
LAKMPSRNELLAMLLQVWNAPITNFTIGLNALKNKKESE
>fig|195.2024.peg.1412 Serine transporter
MNTPKWTRYDTRWVLSLFGTAVGAGILFLPIKAGVGGFWPVVVMALIIFPMVYLSHRALS
RFVSQANGNDKDITHAAEEYFGRKVSIFISVLYFFAIFPICLAYCVGITNTFESFIYHQF
LPLLNSEGVFADIIRAMYEVSTDDKEKVVASLFPFYRLLLAFILVSVFMLIMLFSEELIT
KVCEWLVYPLCAILFIFSLYLIPQWSFESFSAIPGVKEFITIVWLTLPVLVFSFNHSPAI
STFSLSVKRQYKEHAVEKADQILFRTSTMLLFFVMFFVISCVLSLSPEELNEARAQNIPV
LSYFANKLDNPFISYGGPLIAFLAISSSFFGHYFGAREGAYGIVRKCCKLAGSENPDLKK
IAIYSTLVMYIIMLITAYINPSILGFIESLGGPIIAAILFLMPIIAIYTVSKMKKFQNKA
LDAFVFITGVLTIITVIYTF
>fig|195.2024.peg.425 FIG00469638: hypothetical protein
MLNTTLNLPLHHIGVACKNLEKERECFFKLGFYKESEFIDEKQGVRGEFIIPCNEAFPQY
RFELLQNLNDKGPLDSYLKNNTKMYHLAYESKNIAQDLILLEQQGGICIVPIMQASYFAK
LCFIMMPNRLLIELVELK
>fig|195.2024.peg.209 hypothetical protein
MIEKILENENFIALMQKNCYDLLSILIQENIEFSIVANTNFIDFDPVLPENLDVKQNPFA
LFVLGGYTFESIQLEKDHIQFHAGFGPDDFASYVKVDLGAITQIQVENSVLFVNFSFYKR
KDNTKSQKSKNIFLNNPKNKDIFKK
>fig|195.2024.peg.565 Protein hydE
MTLDFDFIYNADNDIFEYLLRFYAKNYNYTLSKEENTYHFSIDADEENLKTFCDSLNLMS
HSVFLKKFDVKAGQDFNPCIPEDKEFSKFSYITHLNSNAYQEKKLLNKNEWGVFCECEFS
SNLSEFEKINEENFNTFLNLAFDLLSQEKKIYLKDKNGIYEFSLFKNEFIGDFLLPCDIK
AINSVFVCSNENLKLLASLEKPLMKLRLNAIFRKNHNLDFNDFKIRLARDLFCFALGLKL
FENEYKFLSVKKIEEYQKDFYISALDEQVVVLEGFEFINAKARELIFSKEDKNMARISYL
VSRYKEKAFILELSKDDEDILLINKELNLLKLCLPKHSKELYEEIKKDEIGARLLENFSK
EFPLLDENFELQNNFYSLFGLVGRVLNLGKNLQESVSELLKIADESKMPRGVKIDYRLKE
DKSFDYTRTLRSAMSFMLAGVDSANIAYGAVESLAYFLRDTYDELREKKQSDLALISGSL
FEHKSLLKNTLKHLKNCQLSDVPLRI
>fig|195.2024.peg.1540 4-hydroxy-tetrahydrodipicolinate synthase (EC 4.3.3.7)
MDKNIIIGAMTALITPFKNGKLDEQSYARLIQRQIDNGIDAVVPVGTTGESATLTHEEHR
TCIEIAVDICKGTKVKVLAGAGSNATHEAVDLAQFAKEHGADGILSVAPYYNKPTQQGLY
EHYKAIANSVDIPVLLYNVPGRTGCEICTETIIKLFRDCENIYGVKEASGNIDKCVDLLA
HEPRMILISGEDAINYPILSNGGKGVISVTSNLLPDMISKLTHLALEENYKEAKKINDEL
YNINKILFCESNPIPIKTAMYIAGLIESLEFRLPLCSPSKENFAKIEEVMKKYKIKGF
>fig|195.2024.peg.854 Flagellar hook-associated protein FlgK
MGIFGTLYTGVTGLKASEVQIATTGNNISNANATFYTRQRVVQTTNGYITTGGVQVGTGT
TVESIVRLHDEYSYYKLKGASTQLEYTKYMASTLQEIAQRFPDLQNTGILQDLENYNKAW
NDFASNPNENATKIALVKASQTLTESVNNTFATLDKIQKKVNDDIKNTVDEINRIGEEIA
TINKQIYGQEALPTEHANELRDRRDELELTLSKLVSAVASKNEINQDNRLDTTITDPGHQ
YNLSIEGFSIVDGVNFHPLKLDYDDKNKAYSIYYETPDEKVRDLTAKINGGQLGAQLDLR
GRNYSKSEGKYSDGIIQGYMDSLNTFAKTMINETNNLYASSAKSSVTSDYLPGLTEDIPL
VNYDRTIQPGSFDIVIYDDKGDKKLTKTITVDVNTTMEDIMRQITANTDDNGNNNANDDV
DDHINASFSYDAKTGDSLFQINAKSGFKVAIEDKGTNFAGAFSIGGFFSGTNASDIKVKD
SILNDPSTVRASLNGVDSGNDMANKIIQLQYDKVNFYNEDGTIDNLTMEEYYRKLTGKIG
SDGENNNVVNASNQTLYNSVYSEYQSKSGVNTNEELAALIQWQSSYGAAAKIVTTVDQML
DTLLGLKS
>fig|195.2024.peg.1239 FIG01269488: protein, clustered with ribosomal protein L32p
MKIAFSRINNTNYPFKLNLENVVFEGNLVKVNPKLVKINATMQGFVYRPCDSCGEELELE
IKENLDLFASDGIFKDNTNELSNTIEFFDGHIDLIEVAVSELEAYLSDYFYCNNCKNKS
>fig|195.2024.peg.377 Membrane protein
MELILLSLIVILLVFVIIKQFKNSSKIEEKDIHISNDITQLKSIGELSVFQVFSKEIVTK
KDSAFNGIWKSILGWSLSERQIALIFEFEITFLYDLRDKNFEIIVLDNDHYKIIMPECKY
KHSIIDMKFYDEKNAKFLPFLLPDSINSTGLSFSENDKNKLIREAKEEVKELSLNLIRNL
ESKIHKSARDTLEAIAKGFGAKKVEFEFKDNTQKLDIN
>fig|195.2024.peg.1422 hypothetical protein
MKFLKIIFLLMSFICLLQADDSAKTLNLLDKRQQQLHIQKNLMN
>fig|195.2024.peg.639 Murein endolytic transglycosylase MltG
MIFILGIFYYLTQPLKSNSVVFLPQGSIAQIITHLKQNKYEMSTIDKYILFFLGHPQSGW
INIGTKELNRIEFLHKLTIAKAALETLTLIPGETSVIFLEQAAKQLELDKNTLLAEFEKQ
ATYKEGVFLPETYKIPKGITEALLVQVLLKHAENSNRKTSEKIFGEYNAKKWHQYIITAS
VIQKEAANESEMPIVASVIYNRIKKGMKLQMDGTLNYGFYSHTKITPQRIREDNSSYNTY
KFEGLPKEAVCNVSLSAIRAAIFPAKTDYLYFVRDKTTGAHIFSTNLNDHNKAIQSQKNK
>fig|195.2024.peg.666 HIT family protein
MQYLYAPWRSEYFEKEKSECPFCDCANKIKSDEELGVIFRAKYCFGVMNRYPYSAGHFMI
IPYLHEEHIENLSDEAWQEISQFVRLGVRILKSELHAGGVNIGMNLSKDAGAGIAPHCHY
HLVPRWAGDTNFITTIGETRVCGTNIEQVYQKLVLAFKNVK
>fig|195.2024.peg.1204 3-methyl-2-oxobutanoate hydroxymethyltransferase (EC 2.1.2.11)
MRKSMISFLEKKAKNEKITMVSAYDYHSARILDNSDIDIILVGDSLAMTVLGMQDTLSVT
MDEMLIFTKAVSRGAKKSFVLADMPFMSYQSSDRDAILNASRFIKESHANGVKVEGGIEI
ASKIKLISQSGIPVVAHLGLTPQAVNMLGGYRVQGKDLQSAQKIIDDAKAVQDAGACMLV
LECVPVKLAQKISSILEIPTIGIGSGKYCDGQVLVYHDLLGLNKDFKAKFVKHFDKIDPQ
VGVEKYRDEVKSGIFPSQEHSFDYLDDELLDKLY
>fig|195.2024.peg.951 Uncharacterized membrane protein, YraQ family
MQVFFSTFKEFLYLFVELSVLFIGINILVAFLNAKYSNFFEKHLKQDNFQTRLKAIFFGS
LTPFCSCSSIPLLNAFLKAKVPLSVCMAYLITSPLINPIIIVVFIVSFGIKISFIYIGFL
YAIILFISFLLSKFDTSKFLNNDFLENEFNEKSSCCSTKKCCSSKTHINLKQICIDSLKE
YKKILPYALAGTFIGALIHGVFPSNFFEIYLKDYGILGVFIAAFIGVLLYMNCTAMIPVA
LVLTQTGIPLGIMMSFLIAGSGCSLPELILLKRNFKTSFLILFALLIILIAILFGILMFF
I
>fig|195.2024.peg.962 Peptide deformylase (EC 3.5.1.88)
MVRKIITYPNSRLFLNSEPVKQFDQELHTLLDDMYDTMIASQGVGLAAIQVDIPLRALIV
NILDENEEQKKEDLLEIINPQIIPLGEEKITCTEGCLSVPDFFEEVERYNHILLKYQDRF
GNFKELEAQGFLAVAIQHENDHLNGHLFIEKISFLKRQKFDKEFKKKLKNQKKSK
>fig|195.2024.peg.1100 LSU ribosomal protein L4p (L1e)
MSKVVVLNDKLEKAGELDLPSKYAEVNPHNLYLYVKSYLASLRANTAHTKGRSDVSGGGK
KPWRQKGRGGARAGSTRTNVWVGGAVAFGPTNERNYFQKVNKKQKRLALERALADKAAKG
VLFTADSLAIESGKTKDANAVIKKLGVKDALIVKDLLDEKTLLAYRNLANCYVVDISEVN
AYLISVFNAVIIEKSALESITKEG
>fig|195.2024.peg.1518 Lipopolysaccharide export system permease protein LptF
MKLALRYVLNQFLSTNLSIFFVLFTIVSMVFFIQLAKLTSSIEINFADLLKLYGFMLPRI
LIFTLPIAFFIALTLALFRLSRENESIVLFTLGFSPKILAKFFLKIAALVSALMLIIALV
MIPIVFELQDNFVNFKKTQVKFNYKTGEFGQRFLEWMIFIEKQESDRYENIIMYHPKRNI
EDKEQLIIAKEATAQRNEDSFAFKLSNGKMYNFENGQTLFIGNFDKLIVNTQFNDQNLQT
KKFYEYWNDLNTNPKRAKEFVIYVTIALFPLASTLFALSFGIVTYRYEKGFIYFGMFGVI
AVYFGLLSSFSQPPILACIGIFALSFIASIVCFKKMILSRY
>fig|195.2024.peg.426 HAD-superfamily phosphatase, subfamily IIIC
MNLFSPHLKRNELIKFAKELDFSKSQDLLINVHRNHAFEGVQSIIAPFLHFANLRAEFNF
SSYDDSLSFDNFKEASLELLWLDLTRYKNNVQNFIEERLLELRKISQNPILVLSLGEFKT
DKKILNCEIFNIEKLIKEYFDEEDILDLAKEELTGSKLNNKALIFLAQILGLSLIPALVK
PALKALVLDLDNTLYQGILGEEGIDNLNLSPLHKTLQEKIKTFKKQGFLLALASKNEEKD
AKKLFETRKDFILQWDDFDAKMINWEPKGENILKIAKKFNINTNAMLFIDDNIAELENTK
FTGVKTLLCDENILYKIKLFPNLLKLSNTKEDQIRAKDIAANALREELKSLSDEEYFQNL
EISLNFSKNDLQNIPRISELLGKTNQFIANYTRLNQEKVAQHMQKELIVSVSMSDKLSDS
GIIAIFVFSCKEGNLFIDDLCISCRALGRKLETRMFFKAFELALHFFDLKNNNARLYYQK
GERNMPFLSFLEQISKEFEKNSALVSFQNLNFKGLIIHEN
>fig|195.2024.peg.1476 L-lactate permease
MWQQIYDPFNSIWLSALFAFLPILCFLACLVFFKLKGYQAGFLTVVLASVIALFVYDMPW
NLVGASFVQGFTNGMWPIAWIIIAAIFLYKLSIKSGSFEIIKKSVMSITPDHRIQVILIG
FCFGSFLEGAIGFGGPVAITAALLVGLGLRPLQAAGLCLIANTAPVAFGAVGIPIIAMAN
LVGVEAHSVSAMVGRMLVPLSLTIPFFIVFLMDGLKGVKETFPAILVAALSFTATQFWSS
NHLGAELPDIISAIVSLAVTTIFLKFWKPKNIFRLDGETHFSEDNTLNFGDVLKAWTPFI
LLIVCIIIWTQPWFKAIFDKDGFLSYTSISLQFSNLTSGILSPSITGIGEAKPLSLGLGI
DLINGKSVAQAGTAILLAAFLTIAILRIKAEDAAECFWATLKEMAIPCLTIGLVVAFAFI
SKNSGMSTTLGLAFAHTGDAFAFFSPIIGWIGVFLTGSDTSANLLFGTLQQVSAQKLGVS
EALFLAANSVGGVVGKMISPQSIAIACAAVGLVGKESDLFKFTLKYSIAFIILIGIWTCI
IAFFLQGIIPEVVAK
>fig|195.2024.peg.1384 Imidazole glycerol phosphate synthase cyclase subunit
MLTKRIIACLDVKDGRVVKGTQFKNHKDMGDIVELAKRYSQSGIDELVFYDIAASARKER
ISREWVSEVAKNINIPFCVAGGIKSEEDAAELLANGADKISINSPALNDPNLITRLAKSF
GVQCVVVGIDSFKDENGNLKVFKYTGDENTSKHSGKNTIEWIKEVQDLGAGEIVLNMMNQ
DGVKNGYDLEQLSLVKKECKVPLIASGGAGKMEHFLEAFEIGVDGALAASVFHQQIIDIK
ELKNYLKTRGVSIRI
>fig|195.2024.peg.1269 Protoporphyrinogen IX oxidase, novel form, HemJ (EC 1.3.-.-)
MTEWINEYYFWIKWVHYLAFVSWMAGLFYLPRLFVYHAENKNNKGFVDVVKIQERRLYFG
IQNPAMIATVISGSLMLHAHKEVLMVGSGFMHAKLTCATLLIIFHIHNYFCLKALANDTS
TKSGRYFRIYNEFPTLMFIIIALMMVIRPF
>fig|195.2024.peg.558 DNA polymerase III delta subunit (EC 2.7.7.7)
MYRKELQNLLSKNQIDNFFFLYGADNFQSELYADFIKEKYQADEILKLFFEEYSFTRASD
FLSGGSLFSEKKLLEIKTSKKIPTKELKVLVELCKNNKDNFLLLELYDESSKQSDIEKIF
SPNFVRFFKANNAREGIELLSIKAKQLHIEITQNALFTLFTSFDENLYLAASELNKFSGL
RVDEKTIEQYCYSLNIGSFESFFEKILKRADFKNELEKILDNFNEIALINSLSSAFYRLF
KIALYAKIYGKVDFKELLGYTPPPQVAQNLNEQAFSLKIKHYKEIFNLLLKSEYELKTNS
KLAKKEFLIATLLKLARIIKS
>fig|195.2024.peg.364 Excinuclease ABC subunit C
MAEILLKNTLKEELQTLPANAGVYQYFNAEGKLLYVGKAKNLKNRVRSYFAFTPNLRANP
KNSLRIQKMIEEAVHLEFITTNSEADALILENSFIKQLHPKYNILLRDDKTYPYIYVDFN
EEFPRFEITRKLVKKSKIKYFGPFFKGARELLDALYLYYPLKQKASCKSPCIFYQISRCL
APCDKKITQEEYRLILDKAINALLSPSILVKNLEKQMFHLAQNENYEEAAKIRDQIATIR
DLEIKVEIDIAKLEDFEIFALACESSMLSTLRFVVQNGKIISANSKITPLKNNTDFDKNE
IYKQLILENFSVDIPLVANTVYVYEDFEDRELLEEILSQRFDKKISIKVPKIGEKRRICD
LAFQNACLNIQKEQKNSDFNIQKELKNYFELENLPNCIEVFDNSHLQGVANVGAMITYKM
GTWDKSNYRKFHLKYKNDYEQMREVLTRRALEFDKMPAPDLWLIDGGKALLDLAKEIILS
SGANVDILAISKEKIDAKAHRAKGGAKDKIHSLKGEFALSINDKKLQFLQKLRDEAHRFA
ISFHQNTKKKQDLSSSKLVKSGLSAGVIQKLLAYYGNFESIYKADFKDLTMLVGKKAARK
IREN
>fig|195.2024.peg.211 tRNA pseudouridine(55) synthase (EC 5.4.99.25)
MNKIFVAFKPAEMSSNAFLGQIKKRYKNKKAGYSGTLDPFAKGVLIVAFGQYTKLFRFLK
KTPKTYQATLWLGVKSLSLDNKNIQEIKLIKAFDIKLLEQIKMELLGKISYTPPQFSAKR
IEGKRAYEFAKRGENIELKSCIMEIFSCKIIHYTHPFLQLELSVSEGAYIRSYCELFAKK
LGINATLSSLERTREGEFFYNHEKSLNVLEYLNLKPNFIKDLTKLENGTKISLEELKFQD
EGFYYIENKKYFSIINIKENKVEYLLNKVEKC
>fig|195.2024.peg.1266 Cytochrome c551 peroxidase (EC 1.11.1.5)
MKVKSLLIASLVAFSSLNAQSLIEEAKNSGLVALPKDQKGVDEILKANGVKATEFTLDKV
ELGKKLYFEPRLSKSGIISCNTCHNLGLGGADGISAAVGHKWTANPHHLNSPTVYNAVLN
TTQFWDGRAGTLADQAKGPIESEAEMATPAKLAVEKIASLPEYVKEFKKIYGKSGVNFDN
IADAIANFERTLITPSRFDNFLNGDEKALTKEEQKGLKLFIDKGCVACHNGVNLGGNMQA
FEVAGKYKFANLGDFKGDENGMVKTPTLRNVVETAPYFHNGAIWKLTDAIKEMGSVQLGI
QISDKEAKSIETFLKSLTGTKPAVVYPQLPVSTEKTPKPEL
>fig|195.2024.peg.569 Phosphate ABC transporter, ATP-binding protein PstB (TC 3.A.1.7.1)
MIAKTTNLNLFYGKKQALFDINMQIEQNKITALIGASGCGKSTFLRCFNRMNDKIAKIDG
LVEIEGKDVKNQDVVALRKNVGMVFQQPNVFVKSIYENISYAPKLHGMIKNKDEEEALVA
DCLQKVGLFEEVKDKLKQNALALSGGQQQRLCIARALAIKPKLLLLDEPTSALDPISSGV
IEELLKELSHNLSMIMVTHNMQQGKRVADYTAFFHLGELIEFGESKEFFENPKQEKTKAY
LSGAFG
>fig|195.2024.peg.1552 Lysophospholipid transporter LplT / 2-acylglycerophosphoethanolamine acyltransferase (EC 2.3.1.40) / Acyl-[acyl-carrier-protein] synthetase (EC 6.2.1.20)
MQKNSFLKIYGLIPFLLVAFINAFVDLGHKIIIQNTIYKVYEGSTQLLLTAIVNALILLP
FILMLSPSGFLADKYPKNLIMKLSAVFSVILTIIICISYYNGAFWTAFTLTFIMGIQAAL
YSPSKYGFIKELVGKDLLAMGNGAVNAVSIVAILAGMSLFSLSFESLYDINHNSSEEVLK
QVAPLGFLLILFSLIELYLAWRLPKLKDEIKELKFDSKRYLSGKLLMSNLKLIFENKVIW
LCIVGISIFWAISQLYLVSFPVFSKNELFIENTFFVQVSLGFSGIGVVLGSLIAGRFSKN
YIELGLIPFGALGVFLMALIMPYFTSLITYSFIFFIFGFCGALFIIPLNSLIQFHAKENE
LGKILAGNNFIQNIAMLTFLVLATLFANLEINVIYLFYFITLVAFLGAIYVVFKLPFSLV
RMLLSIAFLGRYRLLVEGFKNIPEKGGALLLGNHISFIDWAIVQMAIPRKIYFVMERSIY
SKWYIKIFLDKFGVIPVSSAASKASLELIAERIKQGDLVCLFPEGVLSRHGQLNEFKGGF
EHVCSNLEEDDGVILPFYIRGLWGSTFSRSDEEFSARNRTLSKRNIAIAFGAPMSLHSKK
EEVKAKVLELSFMAWKSQCEAMHTIARAFITSAKRNLSNIAIIDSLAGAISYRKLLSLSF
ILSTLIKENSKKINSNFERGSYAPKEECVGILLPASFASSLLNLSVLLAQKVVVNLNFTA
GEKALQAAVKSAQISQIYTSKKFLEKLESKGVSLNFGEEVNLIYMEDVVEIFKKQKSKIL
AMMMAVSILPSFILKAIFAPSKNNLAIAAILFSSGSEGTPKGVMLNNRNILSNIAQISDV
LCTRNNDVILSSLPPFHAFGLTVTTFLPLLESIKSITFADPTDALGIAKAVAKNNVTIMC
GTSTFLGIYARNKKLDAIMFESLRVVVSGAEKLKSEVRSAFEMKFKKSIFEGYGATETTP
VASVNLPNRFDADYWIVHRASKEGSVGMPLPGTAVRIVDPNTYETLKTNEDGLILIGGHQ
VMVGYLNNKEKTDEVIKEIDGIRWYNTGDKGHLDEDGFLYIVDRYSRFAKIGGEMISLGA
LEEEIAKFIDTNIVKFCTVALEDEKKGEQVALLIECDEEFFEGVCEAIKSSSMPAIFKPS
RYLKVEKIPLLGSGKVDLKGAKELAKSLV
>fig|195.2024.peg.1167 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (EC 2.3.1.129)
MKKIHPSAVIEDGAILGDDVVIEAYAYVSKEAKIGNGVVIKQGARILSDTTIGDHSRVFS
YAIVGDIPQDISYKDEQKSGVIIGQNSTIREFATINSGTAKGDGFTRIGDNAFIMAYCHI
AHDCLLGDNIILANNATLAGHVELGDFTVVGGLTPIHQFVKVGEGCMIAGASALSQDIVP
FCLAEGNRASIRSLNLVGIRRRFDKDEVDRLSKAFKFLFRQGDLKENAQKLLENNESENV
NKMCKFILETKRGIPVYRGKNNA
>fig|195.2024.peg.1076 3'(2'),5'-bisphosphate nucleotidase (EC 3.1.3.7)
MFKLDNLLKTAIDASNEASKAILKERKNLQIWQKQDQSPLTSADLASNEILNDILGKTDI
KILSEEGLLSQEESKNLQSYWLIDPLDGTSGFLKGSDEFCIMISLIHEDRPILALIKNPS
KGDIFYAHQNTRVYKNDKILDISEQDFIDNQSKALLSVNHLSKEDENFAKKHNLTPINIG
SGLKFCAILEGRAGVYKRFEKLNSWDIAAGDFLVNQKGGFMGTFSKEMILYSPLNYKCEP
FICVSKKSFLNIYT
>fig|195.2024.peg.1257 Tryptophan synthase alpha chain (EC 4.2.1.20)
MVDFTKFYKDKANVAYMVLGYPNLKISEEFLKRLDESSIDVLELGIAYSDPIADGEIIAN
AAKIALEQGADIHKIFELLAKIKTKKALVFMVYYNLIFSYGLENFVKKAKALGISALIVP
ELSYEESKPLYKECQKYDIALITLVSITTPKERVKELVKNAKGFIYLLASVGITGGQSAD
NKLLQEKIQEIRSFTQLPIYVGFGVKNNTDVRNMRKLADGVIVGTNIVKLFASNDVNQIL
KGVEEIFEK
>fig|195.2024.peg.508 Flagellar L-ring protein FlgH
MKKVLFYVLPFAFFGCSATVDPQISMKPPAYVEELAPKQSNNVETSPGSLFGKGDNPLFS
DKKAMNVNDLVTVVIQESTTQSTQANKATSRTNTSNLGGGALTGGSGLLGTAIDKVNAYS
NIGFQTNSANNYQGTGTQSRNESFNTTISTRVIKILSNGNYFIEGSRELLINGEKQIIQL
SGVIRPYDIGQDNTIDSRYIADAKILYKTEGEVDRSTRKPWGSKVIEAIWPF
>fig|195.2024.peg.213 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (EC 2.7.1.148)
MKAYAKANIFLKLVGFDKRRYHLLESRFILLKNLFDEIHIVEKSSNSPKGFEIISNFNCE
DNIITKAYHLLCQNGYQNKLEEFFKTKSLKLIKNIPTCAGLGGGSSDCASFLMLINEELN
LKLSTQKLIELSTQLGSDIAFFLSGFESANVSGCGEIIEEFNDTIPSLEWVFPEVSCQTK
KVYDEFDKGEIDFEKNILEAKIYKDLNTKELLETFKNTQLNDLFTPCVTLYPKMFLFLEQ
GFFLSGSGSSVFKVHQ
>fig|195.2024.peg.31 Phenylalanyl-tRNA synthetase alpha chain (EC 6.1.1.20)
MQNFIEQIQECKNLNDLEALRVAVLGKKGILTESFAKLKDLAGEEKKEFAAKLNSQKDAF
NEAYLSKFKILENLALEEKMKQDALDFNYFDESPTNGALHPVMSTMDRIIEYFVNLNFSI
EKGPLIEDDFHNFEALNLPKSHPARDMQDTFYFDDKRLLRTQTSPVQIRTMLAQKPPIRM
IAPGAVFRRDFDITHTPMFHQVEGLVVEEGQRVSFANLKSILEDFLRYMFGDVKVRFRPS
FFPFTEPSAEVDISCVFCKGCGCRVCKQTGWLEVLGCGVVDPNVFNFVGYKDVSGYAFGL
GVERFAMLLHQIPDLRSLFEGDLRLLEQFR
>fig|195.2024.peg.429 hypothetical protein
MLINQTFEIDSCDDVELGIKRTSKLEYRISYDDEKDVKAIVFIVGGFGANANISFLDFDR
EYIAKNFDVAVVHVFYHCFCHRRSNVEKYSAYKFFQDEDIENIKNLLNRFHFSYGEINND
NALFLANSLVKHVENLKMQNKLDYNFKLNFTSTIIPPNGDYQNYGIMAALDHINALKDLV
KRFPKFADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSALPSPMFILERESGQYD
YFEEYPHNKIGFFIKTYWNADVSSKYFFHTENYLIRIIPNLAHLTIQANINKNIILVSYH
SLKDPFNTAKDKQTLFLAYKELGYDATLHLIKDESEIDGRFIKDLNHGMRISDKALFRKE
LPLMLEKLQKRKSLMQENSISYPCGNKVFIFKDVGDKFELTIKD
>fig|195.2024.peg.944 Uncharacterized NAD(P)H oxidoreductase, YdeQ/YrkL/YwrO family
MKTLIIFAHTFWEDSKVNKALFESIKNLKQVQIHNLSEIYKEGKIDVSKEMDLLKNADKI
IFQFPLFWFSTPALLKEWQDRVLTAILYGENKELLKDKKFQIVTTLGGAQESYDGHHGAT
LEELLKPICYAFEYLGCKSLKPFAIFSADANKLDLKAYQDAISQNSGCS
>fig|195.2024.peg.334 conserved hypothetical protein
MAGREGKNDIFVDAVGLELLYIKPNGFYIKLDLAKAAYKYEADGKRRDRLYTSMGFYF
>fig|195.2024.peg.1631 Carbonic anhydrase, beta class (EC 4.2.1.1)
MDNLISGAIKFMQEDFKEHEELFESLKNKQNPHTLFIGCSDSRVIPNLITNTGPGELFVI
RNIANIVPPYRVGQDYLATTSAIEYALNSLRIKNIVVCGHSNCGGCNALYYSDEELDKIP
NVKKWLTMLDPIKRDVTIFARDDIAMRSWLTEKLNLVNSLQNIFTYPGVQEALDEGRLEV
HAWYYIIETGEIYEYDFKAKIFKLIQNRKTQ
>fig|195.2024.peg.466 ABC transporter, permease protein 1 (cluster 1, maltose/g3p/polyamine/iron)
MKEKFLAFLSILPFFIVFTFFMIAPLIWIVFNAFYVEEDEIYSLANFIHIFESKFYLQSI
INSLQISFISSIFGLLIGLLASYSLFVLAPSKICKFLFSLNTMISNFSGVPLAFAFIIVL
GSNGVVNVFLKNLGIEPFVSVYANFGVNIVYVYFQIPLAILLLLPAFKSLENSHLNACKM
LGGGNFLYWLKIALPLLAPALFGVFVILFANAFGAYATIYALSSGNFNVAPVRIAALIAG
DINLDPYMASALSIIITIIMLVVTFIANFLSKKYHFKVL
>fig|195.2024.peg.1499 Predicted phosphohydrolase
MIFFIFSFVTLLIFGLANIYIYKRLIKKIFIFKYLYKIFAFVFTLLFLAQAIFLIFRRNE
YLSDTWYEFLAALYAPTYCLFFITLGLDFIRLILMLMGKMHKKYSLALRSVFDLTIISLA
VVLIYTSINNAIRVPEIQSTDIYLAKLDRDLKIAMLTDIHLGKNLHKDFLDRLIVEVNLQ
KPDMVVIVGDLVDTNPKELQNYISRLNDLKSTYGTFYALGNHEYYHGVDEVLNLLKEYTN
MKILLNQNLDLGFINIAGLGDLAGLSKGLYAPDLARVKVDLNTSKASILLAHQPKTALLY
NLSDFDLILSGHTHGGQIFPFMFLVKLHQGFIRGLYDLGENTKLFVSSGAGFWGPSLRVF
APNEIVILNLKGEK
>fig|195.2024.peg.1535 Tetraacyldisaccharide 4'-kinase (EC 2.7.1.130)
MNEEKKYQLWLDNYFFKPSFFQKCLAFIFLPLSLLYGLCAILNTCFRQKIDFKKPIISVG
NLSFGGNGKTPICKAIAREFEGVFIVLRGYRRKSKGLLVVKNENAILAQVSQSGDEAMEY
AFEECVKGVIVSEDRVAGIQKAFELGAKIVLLDDAFSKFHIQKFDILLESKIKPYFNFTL
PSGAYRLPKFYEKKADFIACEGRDFIRYSYVKENPKAVLVTAIAKPFRLYEHFIKARACY
FFKDHYEFKKEELQALLDKHHCDTLMLTFKDYVKVKDFGFKCQIIELNIELKENFKEKLY
QYIRSFNVAS
>fig|195.2024.peg.1177 hypothetical protein
MLKNPKFQAFFFAFLAAIFNAFVGIFSVFLFKKGFMSSEVAFYKCFVASVILFAILIYMR
KLGALLVFIKQKIFTLLLLAFFGFFMLYHFESAAYTSMGVANVVFVLFGVGMIITFICEA
LDAKRFFHLNELLAMVFALLGLWMIFLAEGGTLENFTHLKGLVNAILAGIGYALFLFFTR
KLKLGFGLIPLCALLFIGSLYLSIPLFGANLNLNFSLESLILILALAFLPTIGGFYCTTR
ALSLAKSNSVQLIELSEPLFAMLFGFLFLAQSVSFLQILGGVFILFAIFVHEFKLKL
>fig|195.2024.peg.1158 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVASYSEKEAKNAILLSSKRYVNYIQGI
LNEEVTLTKVVATSLNEMFQNNDHVDINLIESLIKNAFDSSHYAAYTFLYLKDTTVLSDM
QNVDKKYISPDGKTFSMIFFDQIAEKSGGITTISTPNNFSQLNLIQNIEQNAKYGDKDSV
FVGSPRKLNYDNNEFLGINFGMPIFNNKGKFIGVIGYTLDLLEISEIILDPKFDFFEGDL
RILMNDQGIIAVHKIKNGILKTLFDINKDQSAQLIVEAVKNHKDEILDNYIASTGDPSYA
SISSFSTLGNSSHWSVIVTAPKKSVLAPLYKLQYTIISVAIIALIAILTVVYFFIRKIIG
SRIPLILKSLENFFRFLNHEKIEIQTIEIKANDELGKMGKIINENILATKQGLEQDAKAV
KESVETVGVVESGNLTARITANP
>fig|195.2024.peg.844 FIG00638667: hypothetical protein
MKKILTSALALGAMTLIIGCGGDDHFVEFNKNELNSFVEKGFELIKAKNNNANMDFYSPE
TLKNFDEKRYKYLKSKDFRLYGSVKGYQYMIFSVNKDKSDKREFWALICEDSKVENCKIE
NATGRGV
>fig|195.2024.peg.1543 Efflux ABC transporter, permease/ATP-binding protein
MHKDMTLKDVLIRFKPFYKKYKKEFAIAIFGMILTSIGTAGSFASLKPILDYIFVEKNEA
LLYTLPFLLVIIYILKNLGFYLQTYYLSFIGMDTLRILRFKVLKNLLKLDMDFFKRNRSG
ELVSRCTNDINALQSIVSNIIPDFFRELLTIVGLLIVVFYQSPILAFFALVVLPCAILPL
VHFARKLKKYARSIQETNSDLLSRLSEIFSNIELIKASNTQNKESEKFAKQNNELCRLNL
KSTRIDALTSPLMEIIGSLGVAAVIIIGGREVIHGTMSVGSFFAFITALFAIYTPLKRLS
SLYGRLQGAIAASERTFYLLDLEPQILNGSKNLESIARIEFKQVDFAYENPYKSVLKDIN
FEFNKGEILALVGTSGGGKSSIINLLMRFYDKQKGEILLNDLDISEFSIESLHDRIGLVT
QNIYLFNDSFAENVAYSEEPNKEKIIKALKLANAYEFVQEMGGIYAEIKEHGKNLSGGQK
QRIAIARALYKNPDLLIFDEATSALDNESEKAIIETIENLKKDRLVLMIAHRLSTIENAD
KIAVIDQGQMIAIGSNEELLQSCELYQKFKNKEVDKV
>fig|195.2024.peg.1332 hypothetical protein
MQVSYKTISSYEYDAISGQYKQVDKQVEDYSSTSDSDFMDILSKLEENSGISSTEENLQN
NTQSSNSNSSQYAQMSSMYAYRFRQNEGELSLKAQSASVHNDLLNQNANGQNKDSSLLGD
LLNAI
>fig|195.2024.peg.664 Ammonium transporter
MNAINSSFIVLCTLLVLLMTPALAMFYSGMVRSKNTLNTIMNCFIVFGVITLQWVVLGFS
LSFGKDEGLGLVGNFENFLLEGISGYNASGVPNILFVIFQMMFALIASAIITGSLVGRIK
LGVLVIFLLFWSTLVYDVLAHMIWSSEGFLLKRGSLDFAGGGVVHISSGVAGLVGALMVG
ARKSDDEDKNAHSIPYAFLGAILLFIGWLGFNAGSAGEMNDIAINAFIVSIISAACGFLS
WVVLEWLIHKKPTILGGLSGLVAGLVGITPACGYVDIYASLVIGTLSSVFCYFGLSFIKY
KLKWDDSLDAFSLHGIGGIWGGIATGLFASAKVNPNVIAQNALGEGFFISGSLELLKEQI
FAIVICVVLSALISFVIFKIISCFTDLRVKEEVEQKGLDVSLHGEKAYTLA
>fig|195.2024.peg.363 Membrane protein
MILAGIIFIFNLILAYLSIDISKLDSVTEQLKIGMFSSIFVLSLTLFIFAFRQNRNINKI
YQKIFCMQNDFLNFQKKIDVDSALDLLKEKFETTGQNLTKISHEKDRYLHLLEENLYQLG
NISNAMRCLNEGYNKEINSLILNALNSQKDQIRLELNEALEHLKSIIGTSHGKVLQFEAS
VAIVNNDELENFLLANLLSYFGIESTCFKNLSFDVNDFHLIFIKDKILNENVKKNYDFIV
MGRHKNTHYEYFLTLPFEKKDLENILQNKLDKVCTLKFKTPYQNNVLLFKQNDFDATLFF
NIIEKQCSQNMRVNSFSELKKELKKEAYRLILLDYELIKFDLEQMRSILSAYKKQHPQSH
IIFFSRERVRDFDCVSEVLNDVSRNDLITLLRKYLPKA
>fig|195.2024.peg.667 Indole-3-glycerol phosphate synthase (EC 4.1.1.48)
MILDKIFEKTKEDLKERKAQLPYDMLGRSLASNPFFPKDVKAALKRIENEVRIIAEVKKA
SPSKGVIRENFDPLDIALKYEKNGAAAISVLTEPHFFQGSLEYLSMIRRYTHAPLLRKDF
IFDEYQILEALVYGADFVLLIARMLSMKELKRLLEFTRHLGLEALVEIHDKEDLSKAIFS
GADIIGINHRNLDDFSMDMNLCEKLIPQIPNSKIIIAESGLEDKDFLRHLQNLGVDAFLI
GEYFMRQNDEGEALKALL
>fig|195.2024.peg.647 Chaperone protein HtpG
MQFQTEVNQLLQLMIHSLYSNKEIFLRELVSNSSDALDKLNFLSVSDDKYKSLKFEPRID
IKIDKDKKTLTISDNGIGMDKDDLINNLGTIAKSGTKSFLENLSGDAKKDSQLIGQFGVG
FYSAFMVASKIEVLSKKALDDKAYLWISDANGYEIEDATKEEQGTSITLYLKDDEFANSY
KIESIIEKYSNHIQFPIFMEKEEFIPAKEGEEEGKTELKISQINKANALWRMQKSSLKTE
DYERFYEQNFHDSNKPLLYLHTKSEGKLEYNSLFFIPQNAPFDLYRVDYQSGLKLYVKRV
FISDDDKELLPTYLRFVRGIIDVEDLPLNVSREILQENQILKDVKEASVKKILSELEKFK
NKDKEKYLSFFKNFGKVLKEGLYGFGGEKDSLLKLMLYKSTKGESLRSLEEYKNDIQGEQ
KEIFYITGNNESLLRNSPLLEEYKQKNIEVLLMDDEIDSLVTPMLGEYEGLKFIAINQVE
DKNELSDEEKNEFAPLVAKFKELLKDQVEDVRLTSRLKDSPSCIVYDKNKPDFAMQQLLK
QMGQEQNFKPILEINPKHAIFTGLKNNETFSADIATLVLNMAKLSEGMGVDNPAEFNASL
TKIITKAFS
>fig|195.2024.peg.372 hypothetical protein
MKEDLLTRLERENLTIASFNKRILAYFIDNLVLSLIVFVIFYDKLLNAKDLFDTAQILGD
FYLGFLLLHITYQTIFTYLYGASLGKMVCKIIILDEDLLDKPNLNQSCIRSIVRQISDMA
FMLGFAWALSNDLRKTWEDYLARTIVVNVA
>fig|195.2024.peg.118 FIG00638667: hypothetical protein
MKKLFLILLAVINVLTFSYAAPLDEVFKDVEVSGVVRYRYETQRVKKTDNKNKKHNVTNR
TEITIK
>fig|195.2024.peg.137 Putative transmembrane transport protein
MLSFRKIFWLNVAIVIIVAFNLRAPITAIGPMIDIIQDEYNLNSTLAGVLTSLPLIAFGS
ISFIVGYFSPIRAIIVGIFLIFIAELIRSYLGVYGLFLGMLGIGCGIAIANVLLPSFIKE
KFPKKMASMMGIYSLVLSISSIAGIALSMPLLNIFDLAGAMVFWSVFSFIALMIYYPQAK
NGRFFRTKKKESKKINLLKNPTTWKITLFMGFQSFLAYSLFFWYVQIIVEKGYDKDFATN
MVLFSQLVAAPISLFGPLLLGKLKKSLHTPYIAILCAMYAVSFGILFAFDTRFMIMLAAF
IVGFPWGGVFGIALLFIAQKSSNAKIAARLSAFAQGFGYLIAAQGQWIIGFFHDMFGNFT
SSICILFIVGILVNIFGYLAYKSKVI
>fig|195.2024.peg.476 Flagellin C
MMISDASMMQQNYYLNNAQKASEKALENIAAVRAISGIDSANLAIADSLRSQSSTIDQGI
ANAYDAIGVLQIADASLTNISQSADRLNELSVKMNNAALSDSQKSMLRTEATRIQESIND
SFNNATYNGKNVFQTMNFVVGSGTETTNLNPLTTSGLSIDNQDSITNFMDQLGALRSEIG
SSINAITSNINASVQNSINTKAAENNLLNNDMAKNVNDFNSNYLKENAAAFVAAQSNMQL
QSKIASLLQ
>fig|195.2024.peg.179 Flagellar assembly factor FliW
MTLAVKCPILGFEETKNMEFSTIDEVFVRLKSLDGKDFSFVLINPYLIRPDYEFEIPTYY
QELLSLTPESNMKIFNIVAIAKSIEESTVNFLAPVVINLDNNSMVQVILDTVAYPNFFQA
DQIANYIKK
>fig|195.2024.peg.519 Putative periplasmic protein
MKKAFTLLELVFVILILGILASLSFSFANQNKNDAKLLKLKIDYEMLNSALSLMRTQTEL
KQISSFSPNLDEAKINTQKEKLFYCQTSQNCTYSLLHTPIYSSFNAWMKTAPNRYRFFLN
TKEWVDFFYNADFAILECLSEKYCKELL
>fig|195.2024.peg.1441 ABC transporter, ATP-binding protein (cluster 9, phospholipid)
MIIKAQNIITRFGNKVVHDGVSFEINKNEIFGILGGSGNGKSVLLKQMLMLEHFDEGEYE
ILGFKLKNISEEDALELRKKWGVVFQFSALFSFFSVYENIAIPLKEYTNLDSIAIKELVL
MKLKMVGLNEAVLKQLPSELSGGMQKRVAIARALALDSKLLFLDEPTSGLDPHSSREFDD
LILELKQSFDLNIVLVTHDKESMKNLLERFIILEDKKVAFCGNYEELRAQNERLFKRFME
>fig|195.2024.peg.554 SMF family protein, DNA processing chain A (DprA)
MQSELPSAYLELFKELKNPPKKLYYKGNLKLLEQRKIAIIGSRRMSTYTKNCVFELSNLL
KNSKISVVSGGALGVDISASMAAMPNTIGVFANGLDEIYPRSNEKIIKQIYENALALSEN
ESYYKPKPYDFLLRNRLIVALSEAVVVAQADLQSGSMQSARLALELNKPLYVLPQRKNES
DGTNLLLQEKNANLLLDFKEFASCFGVIEEEKDEFLDFCRQGVSVDEATQIYREKVYEYE
LEGKISIEGLFIRVLV
>fig|195.2024.peg.1371 hypothetical protein
MGFLDSLKEKALEASEAVKEKTTSATEAIVDTALKIKCATNWHTGEFNNEEGKPECFFSK
VCPDCGKYITKTKHFFNEPPVIEDPNRCYGYRVCELCGFKQSDYFHNYERADKNEQCVII
ERCSLCGHERFGKPEHEWIHNREGDAFFKICRDCHIKIRVYE
>fig|195.2024.peg.1145 Hydrolase, HAD superfamily
MINIKLIEHIFKAASISRWNDYPRMANLVELDKQAHKFIIAYFIAKMEKDVDMKIIIEGG
IFEFLSRVVVTDIRPDVYHEIVRQKKAEVNAWVLSKIEPMIEDIEDGEFLKRFEAYLNGN
AYAKERLILKAASYFATRWEFNIVYQTSAFLNDIDEIKNKVEEELEDYYELIGARKIALN
QKIAKIIDLSGRLRFQKRWAQTPRIPETAVLGHMLVVAILGYFYSLKIKACDKRLENNFY
CALFHDLPESLTRDIISPVKYGIDGLHTIINDYEMKLINDRILPFVPENLRAEFSYILGI
REGRSNEASFVKNEFENRTYKNAKIELCSGSLSSFNQNEFGAIDGKALKYCDKIAAFIEA
GLSISYGVKSKELENGFEDMFRFFNESPTIDGVNFLEICREFRDYFKI
>fig|195.2024.peg.718 Ferric receptor CfrA
MNAKKLKLSILCFCLMGLGEIKAEEQYQLDDVVVSASGFEQDLVDAPASISVITKEELSK
KPIKDIGEAISDIPGVDVTMNKTGTYDFSIRGFGSSYTLVLIDGKRQSVANGFYDNGFGG
SESGYLPPASMIERIEVIRGPASTLYGSDAVGGVINIITKKNPNKTEANIEFSTLLQQHS
SKYGNAGGFNAYVATPLIEDTLSISARIKYYDKAASDLKWPTPVWSNGTQRPENYQIASH
SPGYFTSLGFGSRLNWTVDDSNNVYLDVERYINEISVNSTSSSAIKSERQLFKDNVVLNH
DGNYEFGTTNSYLQYGSTKDKDLHSQIWVGEGKVVLPWNLDKYGNLVSTFGTRIDYETLK
NDQESAGSEIRGKNLDQTTVALYGEGEYFISDDLIFTTGLRYIYSDLFDSEVTPRVYLVY
HLNDNVAFKGGVAMGYKTPAAKQLTNGYYNYSNNGASFGNPDLKPEESTNYELGVDFRIF
DFAHYSITGFITDFKNQISSEELTGMYNGIDCANGVTCERSINLGKTQTRGIELAFNTKP
YKGFSVNSSYTFMDNRYKDGQTNWFGGDRIENLPRHIAMLKLNYEQGKFSSYVKARARLD
TIARSKGGGSGTLPWQKYKPFYIVDLGVNYKIDKQSSLSFTVQNLFDKDFFDPQVTRWDG
ANPGGYANRYQDYTEGRSFWLSYKYDF
>fig|195.2024.peg.327 Heat shock protein 60 kDa family chaperone GroEL
MAKEIIFSDEARNKLYEGVKKLNDAVKVTMGPRGRNVLIQKSFGAPSITKDGVSVAKEVE
LKDSLENMGASLVREVASKTADQAGDGTTTATVLAHAIFKEGLRNITAGANPIEVKRGMD
KACEAIVAELKKLSREVKDKKEIAQVATISANSDEKIGNLIADAMEKVGKDGVITVEEAK
SINDELNVVEGMQFDRGYLSPYFITNAEKMTVELSNPYILLFDKKIANLKDLLPVLEQIQ
KTGKPLLIIAEDIEGEALATLVVNKLRGVLNISAVKAPGFGDRRKAMLEDIAILTGGEVI
SEELGRTLESATIQDLGQASSVIIDKDNTTIVNGAGEKANIDARVNQIKAQIAETSSDYD
REKLQERLAKLSGGVAVIKVGAATETEMKEKKDRVDDALSATKAAVEEGIVIGGGAALIK
AKAKINLDLKGDEAIGAAIVERALRAPLRQIAENAGFDAGVVVNSVENAKDENTGFDAAK
GEYVNMLESGIIDPVKVERVALLNAVSVASMLLTTEATISEIKEDKPAMPDMSGMGGMGG
MGGMM
>fig|195.2024.peg.386 DNA/RNA non-specific endonuclease
MKLIIFLLAFTLHVFALEAYKPDKDFAPYFNPLNCSVVLDKFFYTNCYDYKLKGTKAVAY
KVEASNLKEKQIKKRARFEDDTNIPKKYRSTWSDYKNSGYTRGHIASNASFRFSKAAQTS
VFLMSNITPQNAQVNATVWNEIEQRERSLAFKFQSVEVLNLILYGKNPKFIKNGIAIPSS
YVKIIKTSRFEECYEVPNNNIQSEEINDYKISCNKF
>fig|195.2024.peg.1642 Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17)
MELTHLDENNRPKMVDVSQKDISKRVATASGMISMSEEAFKAIKNNTAKKGPVLQTAVIA
AIMGAKKTSEIIPMCHPLMISKVETDIVEFPKDYTFKLIVTVKCEGKTGVEMEALSGVSI
GLLTIYDMIKAIDKTMKISEIVLESKEGGKSGKFVRS
>fig|195.2024.peg.1295 Shikimate kinase I (EC 2.7.1.71)
MMKVKNIIFIGFMGSGKSTIARALAKDLDLVFLDSDGLIEMKFDQKISEIFKEKGEAFFR
QEEQKVANFLCSCNGASIASGGGFIHVLDFDKIGFCIYLKASFEYLKKRLSENEIAKRPL
FYDEVQAKRLYNERLNKYEQKANLILDVENKSIDELVIEIKKVIK
>fig|195.2024.peg.532 GTP-binding protein Era
MKSGFVSIIGRTNAGKSTLINSLLEEKIALVSHKQNATRRKIKAIVMNGEDQIIFIDTPG
LHESKATLNQFLIQSAIKSMGDCDVILFVASIFDSVKDYENFLSLNPKVPHIIVLNKVDL
ADNGTLLKKLNEYAKFSKYFKAILPYSCKKKNYQKPLLNELCKLLPEHEYFYDSEFLTPS
SQKDIFREFILESIYENLSEELPYSCEIMIKNTKETSNLFIIDAQIITDTNSHKAMLIGK
DGTTLKRIGKDARFKISKLIQNKVLLKLFVIVKKNWQKDEIFLKKILNYEE
>fig|195.2024.peg.708 hypothetical protein
MLFLLKKILPQLFTSIILEDKKNILKTSIYKNHKLISSNEKTFDKSEKLLEYVKTLNSKF
LFYHTALFLNVKEQGLIPSKNDKDFERFNVGKMSLKSIALNNALIYTATEHIEYFNELFE
DYGGLDFLYSPFAILYHNILKEKPNSDKITLYAYKHEHILTLIICRGIEILYGDIIFFEE
ELDLEFGHQEENLDNLGEDTLNDTEVTLDNFNETLEDKLNALDQFDNILGNNENDSEFLD
GKDKFDLEEMDQFGNDIELCRHIVTSIEKFYKDDKYPSAFIDKALILSTKELDQSAIEFL
EEETLLEIESKPINTLDSIIELMQKELQ
>fig|195.2024.peg.117 Putative cytochrome c
MFRYLTIFSIFVVALFGINLKSFFTYTFDANKQYDMVQAKDLYFKNKCNTCHGDNAEKSV
AGSRVLKDMSPEDIKAALVGYTLDGSTSANASQMAFYARNLSHDDMDNIIAYIKGGNFAV
DLQVKDLLEEEPPQKTKHNTFLK
>fig|195.2024.peg.928 Allophanate hydrolase 2 subunit 1 (EC 3.5.1.54)
MFSVHFSGSKAVLLRFKQEISPQINALVLSTEARIQKGINENEIYGIDELVSAYSSLLIY
FNPCVLSLNSLLDFLEKIKKDIKITEKKSNLCIKVPLCYDEEFGLDLEFVCKYHNLSKEE
LINLHTKPYYLVFMLGFMAGFPYLGGLDERLFTPRLASPRTKIEAGSVGIADKQTGVYPI
SSPGGWQIIARTPLEFFNKEDEKNPTLLKAGMLLKFKAISKDEFYDIKEQVLKKAYQKEI
YEYKSH
>fig|195.2024.peg.1656 3-dehydroquinate dehydratase II (EC 4.2.1.10)
MKIMVIQGPNINMLGVREVRIYGAMKMEDIHTQMKMAASQNNVELDFFQSNFEGEIVDKI
QECLGTVDGIIINAAGYTHTSVAIRDAISAVALPTIEVHISNVYRREEFRQKSLIAPVCS
GSIVGFGPFGYHLALMGIIQICEQVKNLHAAQAQQMQARAQN
>fig|195.2024.peg.1075 Putative periplasmic protein
MKIFLILFMSILLNSSLFANNFSQKKIIKLEQQESFEIIDLQQNVEKQNLDQQKGIFDSS
SLMSKKESIRKDNDVDFAIAMSFRQNFGYALDGFNISAKEFSTLFAKNLVDNLRLNFVNS
AANGVYQDLRTLARFSPKDSKLLNVSPFLKKEKDKSQIYAKFTDYLVVVNLDDFYVNITN
YFVAITKNAVANINFKVVSTSNGKILTSKNVRLNFALHAQDPRVNYQELVNQMPNMLAEV
INKELEKLNLTVQ
>fig|195.2024.peg.33 DJ-1/YajL/PfpI superfamily, includes chaperone protein YajL (former ThiJ), parkinsonism-associated protein DJ-1, peptidases PfpI, Hsp31
MSKKVLIPLAQGFEEAEFIGIADVLKRAAELSGNLEVIIASLDNELLVKGANGISIKADC
SLEAVDTKNLDAIALAGGFDGMNNLKNSNEILSIIKKLHSEGKIVSAICASPIVLNAAGV
LEGEFTCYPSCETGLQGNRVNKAVVVNKNVITSAGPATAILFGLELAKQLCGDEIYNSLY
EGLLIPLTK
>fig|195.2024.peg.972 Putative serine/threonine protein phosphatase (EC 3.1.3.16)
MRILLILRGNYYAGQEEFIKENRLKDYTLDLNSLRLLSGSVSKIVSKYKNLNLKNDEELY
KILLQFLEMRMQKGEFCIINAYNETLKVYKELAKQYRYDIYIIDFKSSLEECLRKNEQKA
KERGYIVSQSLLKKTHHLLERIPKKYTILNPNDWKKCLYQMPNLSKYRKIHHIGDIQGCF
SILKEYLQELEDDECYIFLGDYIDRGIENGKVLKFLLKICERENVYLLEGNHERHLIKWA
NGELSSSKEFNENTLKDFRKEKLTPRDARKFYPYLKECLYYKFHEKQVFCSHGGVNLLPS
KAYQISFMPSYDFIYGVGNYEESQKVASQFCEFTKDNVYQIFGHRNRTKLPVQIEKRVFL
CEGKVDDGGHLRIVTLDKKGFECIELKNKVYRKK
>fig|195.2024.peg.340 hypothetical protein
MADKPILSLPENENSGDSQTTNNTDSTDIVNTFSKQVKLTSTESILILPAEETQSHIKED
ERERGRVCITSDNAKTNNPCIAITF
>fig|195.2024.peg.1160 Membrane protein
MERLKEIVHFYTTHLYLVDYMLILFVFFLFTCVLLLCIFLRHKPVAALLIIALNIIICFL
IYTYGYKFIDSEVRSRKTTIVEQKFIQSSEALIIDFNITNTSKNDFKQCKVIARIFKDKL
PEDNLINEYKNQLIPFRQKSREIFNLKKNTTQFQRISFDNFNYDNNYTIRLNSECF
>fig|195.2024.peg.1590 Heat shock protein GrpE
MSEQKQEIENENAENSEHLQDENLQNIEDVEQNKLQKDYDELKDKYMRANAEFENIKKRM
EKEKLSAMAYANESFAKDLLDVLDALEAAINVECQDEISLKIKEGVQNTLDLFLKKLEKH
GVALIKDEKEFDPNLHEAMFHVDSENHQSGEVVQVLQKGYKIADRVIRPTKVSVAK
>fig|195.2024.peg.1286 Protein-methionine-sulfoxide reductase catalytic subunit MsrP
MIVTPEKLYKQRRDFFKLGAGALIGSSLIVSKLSALNFINDTNANKLEISNEELATNYIN
FYEFSTDKRKAVSLAQNFNTQNWKIDISGEIEKPFTLSMEDILKFPLEERIYRFRCVETW
SMVVPWVGFELRRLIDMAKPTSEAKFIKFTTLLDKNQFPDQDALFPTVEYPYVEGLRMDE
AMHPLTLLAVGMYKKALKPQNGAPIRLVIPWKYGFKSIKSIVKIKFVKEQPIGTWEKYAP
NEYGFYANVNPNVSHPRWSQANERALGDFFTKPTLMFNGYEKEVASLYAGMDLKANY
>fig|195.2024.peg.1010 PhoX, Predicted phosphatase
MGNPDNQKGLNKGSNNITSENKFNSPDGLKFDRDGRLWIQTDGSYSNKGEYAGMGNNCML
AANPKTGEIKRFLTGPIACEITGIAFDEDYTTMFVGIQHPGEGLKGSTFPYGKTPRSSIV
MIRKLDGGVIGA
>fig|195.2024.peg.1232 Tricarboxylate transport protein TctB
MSSIRIVAGILLVISLIGIYIGWNIHSDFNYEPLGPRPFPVGTLILIALCSIFLVFFSED
TKVKWGDFILWKKLIVLTLAFLIYALFFEFLGFIICTIFLIFTITLLFGATLIKAIVFSI
SSSIILYYLFNTLLQITLPFGFIFDNF
>fig|195.2024.peg.1483 hypothetical protein
MGNYDLPLIWTADFILDNDEKGNDKYVLGEINCSCVGFTSHLELADEVAQNIINIVSKAK
N
>fig|195.2024.peg.1155 CTP synthase (EC 6.3.4.2)
MNKQTKYIFVTGGVLSSLGKGIAAASIATLLKNSGLKVSILKADPYINVDPGTMSPFEHG
EVFVTDDGAETDLDLGHYERFLDESLSQDNNFTTGRVYQSVIEKERRGEYLGKTIQVIPH
IVGEIKDRIKKAGEGKDILIVEIGGTVGDIEGLPFLEAIRALRLEVGKNNAMNIHLTLVP
FIKAAGELKTKPTQHSVGELRRIGISPDMIICRSEKALDRDLKDKIAISCGVEKNCVIES
VDAASIYQIPLNFLKQDILNPIASILDLKNLKPNMENWDILVKRVIAPSNEVKIAFVGKY
VDLKESYKSLTEAIIHAGAALDTRVELQWVDSEKLENLESAEAFKNVSGILVAGGFGYRG
VEGKIKAINYARENKIPFLGICLGMQLALVEFARHVLKIEDANSSEFDDKCSNPIVYLID
EFMDASGKKQIRTAKTPLGGTMRLGSYECKVKPNSLLAKVYNNAKNIKERHRHRYEANPK
YRKEFEDKGLIVSGESEGLIEAVELNNHPFFLAVQFHPEFTSRLERVNPVICGFIKAAIS
YEDD
>fig|195.2024.peg.23 Two-component system sensor histidine kinase
MLKTKNIFITFFVLLILCFGVIFYTLTNSYLNFLLLKQYEQKIKSLDDVLKFSLLEDLNS
NNIKEFAQDTRADFIILKDDFEISSVLNADLFLNLEENKIYDLNSKRVLVKKFTYKDYKY
MIIVYPRFLNLQNFWLKISISFGIYFMLVFILVFFMGRKLAKSFKKILEFLNFINDSKPI
ILEKSIFKELNLLNKKLLKTKEKILKNTQKNKKQSDKISLKNTQLASVISAISHELKNPL
SVIDLSLEMLKDENLKDEKLKNELLEKISRQSLKLNALTHKLNFVFNLNHEALQMQEFDL
FTLCEKIVKNPGFERVILRGKSTRVKADEFLIEQVIINLLSNALKYSQKEVILIAQDQKI
SVLDFGKGIEKNQLKFITKKFYKIDTKSNNSFGLGLFLVKKILSIHKSYLEISSTVSQGS
KFSFKLH
>fig|195.2024.peg.774 Iron-sulfur cluster-binding protein
MKDFVFIQNENLIPLPDEINIWENCKDEEVLISNEKAQKAQIYAPEINFYLKSSQDEILE
KSKNILKLYEARANVYDLGLDLEQNKEVKNRIILVDSDDTMADFLKKQNFKIISLKNEEI
LAVFGSIGELCAVILNQGEEVEIDFDILLFNTNSNDIRKDFTRQSGCYNISNFKNQESLL
KFLQDKSPKYTYKTYITYDSSVCQYHERRSEHCAKCAEICPTIAILKDDENKHLEFSQVD
CLGCGGCISVCPSGSLDYAPMPRESFFELCEFYKEKKILIIPKKMSLENLNIKLPKDVLP
FMIEGEKWLSSMHFLTLLQSSGANLVFYTDFISRGSAEAIDLLNTFFERKFQKEAIFTAK
DEKELQNALGKQEFIENLSFDFHNNTLTTRENFAKRMQNLIQNDDFGVKESGEWLRYGKI
EINANTCTLCLSCVGACNVGALIADTKENALKFNASLCTTCGYCEVSCAEKDTLKLTRSG
MEFNPNYFEYQTMAKDELFACIECGKEFATKKAVEKIANLMKPKFGNDESKIKTLYCCAD
CKAKVMIEAMRKG
>fig|195.2024.peg.551 Peptide-methionine (S)-S-oxide reductase MsrA (EC 1.8.4.11)
MKNIILGGGCFWCVEAAFENFEGIIHTEVGYTGGNDNPSYESVCNGDGNIEVVKIIYNEA
KISLEQILSLFFKIHDPTSFDKQGADIGIQYRSAIFYENQSDKNTIEDFIKKEQVNFSLP
IVTQIYKLQKYYKAEDYHQHYFIHNPNQSYCRFVIAPKLEKIRNYE
>fig|195.2024.peg.1148 hypothetical protein
MEFLELLLVLIALILIIKKPEKENLAFGLVMVAWLLMVFFYVGHKTGALLTIMNL
>fig|195.2024.peg.283 ABC transporter, ATP-binding protein
MELLRAENLGHSFDYPLFENLNFSLNQKDCIAIQGSSGCGKSTLLHIISSLLKPNKGEVF
FKGQNLYKISENERLKIRRYDLGIIFQTHYLFKGFSALENIELASVLSNQDLDEKILKKL
GIHELLKQKIGKLSGGQQQRVSIARVLCKKPKIIFADEATGNLDFDNAKNVIELLVSYAK
ENDAALFFVTHDSKLAQFCDKTYILNTNGIC
>fig|195.2024.peg.227 UDP-N-acetylglucosamine 4,6-dehydratase (EC 4.2.1.135)
MDFYKSKRLIFFLCFDAFLFILSIFLAFSLRFSGEIPSIFYEGMIKAGLILLVLKIAFLF
IFRIYKVAWRFFSLSEARKIFFALVLAEICFLLIFYFYDDFFNPFPRSVIGIDLILSYMF
VGTLRISKRMLIDFKPSRAKEEETPCIVVGATSKALHLLKGAKEGSLGLFPVGVVDARRE
LIGTYCDKFIVEDKSKIKDYVNEGVKTAIIALKLDQAELKALFEELIAYGISDVKIFSFT
RNEARDISIEDLLARKPKDLDDSAVASFLKDKVVLVSGAGGTIGSELCKQCIKFGAKHLI
MLDHSEFNLYKINEDLSLYKEKITPVLLSILDEQSLDEIIKEYKPELILHAAAYKHVPLC
EQNPHSAVLNNIVGTKTLCDVAKKNKVKKFVMISTDKAVRPTNIMGCTKRVCELYTLNSS
DENFEVSCVRFGNVLGSSGSVIPKFKAQIANNEPLTLTHPDIVRYFMLVSEAVQLVLQAG
AIAKGGELFVLDMGEPVKIMDLAKKMLILSNREDLEIKITGLRRGEKLFEELLIDENDAK
TEYESIFVAKNEKMDIQILNDYIKKLQDCQNIAEILKEIVPEFNHNKDGN
>fig|195.2024.peg.1583 Arginine decarboxylase (EC 4.1.1.19)
MMNYGIDIWGNDNFIIKNGKVCINHEKKPAIIDIVKELRDDGYKGPLLLRFPHLIQKQIE
SIYGSFNKARKEFNYKGKFNAVYPLKVNQYPGFVKNLVRLGKDYNYGLEAGSKAELLLAM
AYNNEDAPITVNGFKDRELINIGFIAAEMGHNITLTIEGLNELEAIVDIAKERFKPKPNI
GLRVRLHSAGVGIWAKSGGINSKFGLTSTELIEAVNLLKENKLLEQFTMIHFHLGSQITE
IHPLKKALNEAGNIYTELRKMGAKNLKAINLGGGLAVEYSQFKNEKSRNYTLREYANDVV
FILKNIAEQKKDLEPDIFIESGRFVAANHAVLVAPVLELFSQEYTESKLILKKQNPKLID
ELYDLYKSIKPSNALEYLHDSIDHLESILTLFDLGYVDLQDRSNAEILTHLITKKAILLL
GDKQNPADLLAIQDEVQERYLVNFSLFQSIPDFWGLEQNFPIMPLDRLDEEPTRSASIWD
ITCDSDGEISYSKNNPLFLHDVDVEKENYFLGFFLVGAYQEVLGMKHNLFTHPTEATISV
NEKGYEIEGIIEAQSILDALEDLDYDIHTIMDILNERISNSKLVNEKQKKHILGELYLFL
NDNGYLKSIGV
>fig|195.2024.peg.1292 2-Keto-3-deoxy-D-manno-octulosonate-8-phosphate synthase (EC 2.5.1.55)
MKKMILIAGPCVIENKDLVFKVAQNLQEFNENENIEFYFKSSFDKANRTSINSFRGPGLE
EGLKVLQSVKNEFGMKILTDIHESTQAAPVSEVVDVLQIPAFLCRQTDLLVAAAKTKAKV
NIKKGQFLNPSDIKYSVKKVLQTRGIEEEGYEVADKNGIFVAERGASFGYGNLVVDMRSL
VIMREFAPVIFDATHSVQMPGAAGGSSGGKSEFVEPLARAAAAVGVDGFFFETHTNPCEA
LCDGPNMLDLNRLKACVKTLLEIQNIIEGK
>fig|195.2024.peg.513 Methyltransferase (EC 2.1.1.-), possibly involved in O-methyl phosphoramidate capsule modification
MECDYKELWDKDRYLGAWHSVNDIQAQAGKKRWKEILDMIESKISHMQSIEIPYKIRAWT
ARKA
>fig|195.2024.peg.36 ABC transporter, ATP-binding protein (cluster 3, basic aa/glutamine/opines)
MIEIKNLNKKYGNLEVIKNISTKISKGDIISIIGPSGGGKSTFLRCINRLELADSGEILI
KGRNILDEQTDINKIRQKVSMVFQHFNLFANKNVLQNLCLAPVKTGILSEDEAINKAEIL
LKKVGLSDKKEVIPHKLSGGQKQRIAIARSLMMNPDVILFDEPTSALDPEMIGEVLSIMK
DLAAEGLTMIVVTHEMGFARNVANRIFFMNKGELAVDASPKEVFENPKNERLKEFLNKVL
NH
>fig|195.2024.peg.1591 Heat-inducible transcription repressor HrcA
MKSRDKKDLILESIIQTYLLDNAPIGSNELNSNLCIPASTIRVYLKRLSDEGLITQLHIS
SGRIPTILTMQNYWQNFWEKEQDKNIHIKNESFLKELSKEFEIYCLVYGGRSLVLKEVLD
LNAKFIVLDFKEEELVLKYEKEAWNFLQSLIGLDLSSIEKIALRVHFIDLVEKIASLRQN
LICYRSNEERAYQIYQNDEFVKLLDCQIHRHFKESLEFEPLFKEGFMGLKVDAQFLGEDV
NIILAGSVYTDYKKILQYIKEAA
>fig|195.2024.peg.1512 NhaC, Na+/H+ antiporter
MRFLVFFLPPLLAFANTHQATANANLFGVFTLIPPLVAITLAFITKDVILSLFAGVLSGT
FLLSLASNIFQADSLSFIHFYNTAIDSFSKIISYILESTSDPVNAGIILQILCIGGLVAL
ITKMGGAKAVAIKFAKRAKSAVSAQVNTWFLGLLIFFDDYANLLIVGPIMRPLADKFKIS
REKFAFIIDSTAAPVAGIAVISTWIGLEVSLIKNAYEDIGISNISAFGVFVETIPYRFYN
IFMLFFVLMTALMGREFGPMLKAEIRARTTGQIAPLSKSSTLDTAELEDQFLAPKEDIKI
RALDATIPILTLIVLAILGFYFNGLSTLEGEELLKANANPLSFETLRLAFGSANSSVVLF
QAALFAAIVAIFIGVYRKIFNFKEAVETWIYGWKTMIFTIVLLLFAWSLSSIVKELGTPE
FISSLLADKLPEFILPATIFAFASLISFAIGTSYGTMGILMPLAVPLAYKVAQINAMDMD
AMHHYMVINISCVLTGAIFGNHCSPISDNVILSSMSAKCDHMEHVRTQIPYALFICVISL
FAGYIPVSLGLSVWLVLPLNLILIAFLLRIIGKKVS
>fig|195.2024.peg.773 L-seryl-tRNA(Sec) selenium transferase (EC 2.9.1.1)
MNKFRTFPQIGSLIDDESLKEYPFYLRSYFCKSVVAKLKANISEDLLDKNTILEKIQQEI
QKHLRKDLQSVINATGVVIHTNLGRSVIDESIFEKSKDVLCNYANIEFDLESGKRGSRYA
LVLEKLKMLFECEDALVVNNNAAAVFLVLHSLCFDKELVTSRGELIEIGGSFRVSEVIKA
AGVKLCEVGTSNKTHLKDYEKAINENTKMLLKTHKSNFALIGFHSEVGIKDLGNLAKEKG
LLSYYDLGSGWCENLNPKLIKNEPKIKDLIKHCDILSFSGDKLFGSVQAGIILGKKELID
KIKENQLLRMLRVDKITLALLNESLKIYLEKDYEKITSLKLLNDEIAHIKEKALRVQNEI
QIKSELKMSKSLVGGGSMPDKTLETYVLAFNGNALKLQEKFRAKNIIGRIENEAFVLDFR
TIREKDLSKLIQIINTMENL
>fig|195.2024.peg.400 Twin-arginine translocation protein TatB
MSFGEIIVILIVAILVLGPDKLPEAIVQIAKILKALKRNIDDAKSSIEKEVRINDLKEEA
KKYKDEFSSANENIRKKLSFEEFDDLKRDILDKTKVDLTFDSRENSTPSPNEQNPNENQK
PKLNPFENQEKVEK
>fig|195.2024.peg.480 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase II (EC 2.5.1.54)
MTWTKNSWKNFSIKQQPIYSNQEELNKVLNKLEKLPPLVFAGEVRELQSALARVCRKEAF
LLQGGDCAESFANFGAVNIRDMFKILLQMAIVLTFAGGCPVVKIGRMAGQFAKPRSSDYE
EINGVKLPSYRGDIINGFEFNEKARIPDPNRMLEAYYQSATTLNLLRGFAKGGLANLHEV
HRWNLGFLKKSELHQQYTDISEKISQALDFMEACGINTYNTPSLKEVDIYTSHEALLLPY
EEALTRVDSLSGEIYDCSAHMLWIGERTRGLDEAHVHFLSGVRNPLGVKIGPNASADDVI
ALANALNPNNEEGRLNIIIRMGAEKIATQLPKIFSKLKKEGLNLVYSIDPMHGNTVKAGD
FKTREFDKIMQEVRYFFEIAMSEGVYAGGVHLEMTGQDVTECTGGASNVTAQSLEKRYET
QCDPRLNADQALELAFLIADLVKKARK
>fig|195.2024.peg.1180 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
MPKRTDIKNILLIGSGPIVIGQACEFDYSGTQAAKTLKEQGYRVVLINSNPATIMTDPEF
ADATYIEPVTKESILSIIKKEKIDAILPTMGGQVALNVAMEVYESGLLGDVKFLGANPEA
IKKGEDRQVFKECMKKIGMDLSKSMYAYNYDEALKAVDEIGFPLMIRASYTLGGAGSGVV
YNMDEFKELANTALALSPIHEILIEESLLGWKEYEMEVIRDKNDNCIIVCSIENLDPMGV
HTGDSITVAPALTLTDKEYQVMRNASFAILREIGVDTGGSNVQFAVNPTNGRMIVIEMNP
RVSRSSALASKATGYPIAKVATLLAIGFSLDEIKNDITGTPASFEPVIDYIVTKIPRFTF
EKFPGANTTLGTAMKSVGEVMAIGRTFKESIQKALCSLERNLSGFDRVKFEDKNDLIFKI
RNANEKRLLYVAQAFREGFDVKELYELCKIDPWFLSQIKEIVDFEEQIDMDILHNKTLLR
KAKTMGFSDKMIALLVNLKDNLELSQNDIYYARMKQKIIAEFSEVDTCAGEFEALTPYLY
SSINVSELTQSKNEARDKKEKKVMIIGGGPNRIGQGIEFDYACVHASFALKDLGVKTIMY
NCNPETVSTDYDTSDILYFEPIDFEHLRGVIEREKPDGVIVHFGGQTPLKFAKRLSAFGA
KIIGTSARVIDMAEDRKKFAEFITKLGINQPKNSTATSVEEAVLKASEIGYPVLVRPSYV
LGGRAMRVVTDESELRLYMQEAVDVSDKSPVLIDQYLDNATEIDVDAISDGKDVYVAGIM
EHIEEAGIHSGDSACSLPPCNIDEKMQEQIVQKTADIALNLGVVGLLNIQFAIYNNELYM
IEVNPRASRTVPFVSKATGIPLAKVATRVMWQGNLKEALKFYDAFGVVNFDNAILRPKPS
KYISVKEAVFPFSKLSGSDLELGPEMRSTGEVMGISKDFANSYAKSQISSFNHLPESGVV
FISLKEKDKKYAKKLASEYSKLGFKLMATSGTCKEIVETGFECELVHKISEGRPNVEDKL
KNGEIQLVINTSDSHTFAGDTKKIRENIIRFKIPYFTNLRSALAGAKSIKAIQNQSYLEV
KSLQEYLKA
>fig|195.2024.peg.1342 NADH-ubiquinone oxidoreductase chain K (EC 1.6.5.3)
MVEKYFFIAIAMFIVGLIGILKRQNLIMLFISSEILLNAANLALVAASKMHQDLNGQVFA
LFVMGVAACEVAVGVAFCVLWYRRKGTLELKSLKEEV
>fig|195.2024.peg.1714 Outer membrane lipoprotein carrier protein LolA
MKKIFCLFFFFLSHILATDLNFNTYSSHFTQSVKSKNSALSYSGHFTLSQEQAYWSYDTP
SKKEIYINKNQIVLVEHDLEQVVFSHLDNIPNLNEIFKKAKHLNDNQLIAKYENINYTIT
LKDNEIQSIAYKDEFENDILITLNHQIKNPTINPEVFKPKFPNYYDMVR
>fig|195.2024.peg.852 hypothetical protein
MINPIQQSYVANTALNTNRIDKETKTNDTQKTENDKASKIAEQIKNGTYKIDTKATAAAI
ADSLI
>fig|195.2024.peg.238 Polysaccharide biosynthesis protein WlaX
MMKNEGYICIFDCESIPDTDLIRKTLAFEGEDLEVSLKALGWQKEQSGSEFLSLPYHKIV
SICAVISDHYGKFIKVNKIDGENEKEMIHNFFAFIEKYEPKLVSFNGKNYDMPLLVLRAL
KYNIKAANYLDTQSDKWNNYKTRFSELKHCDLFESFGSTRGLKLDTICAMADLPGKYDVH
GDEVMKLYYEDKIEKIHEYCESDVLNTYMLFLKYELIKGNVSDEDYAYFLNSMSEFLKAK
KANRAYVEIFCKACENEISKMKI
>fig|195.2024.peg.1684 hypothetical protein
MKFSLVLDDEVLIEFEKFKNSLECDKNIIENLFKYYKPTHLINLKQIQKLEESNLVIDSD
IKSAFLQSGYANLTLEKLSQKTTLKIILTNDKNKSFPYLYIKDEKIENNLCATFKQKESR
EKAFEYFKNLFLEANSIFIYDQYLTQENLNDFIEICSINKNIYLPKYIYSRINPHNEMIK
IDKQNNRYLGCHDRYILIYYPTYKIELILTSGIDYLLDTEKDFTYIVRVITSSTS
>fig|195.2024.peg.370 hypothetical protein
MHGKIAIYMDSTGRGTVTNSANTFFDFSRQIWNDKKSMPSVGMLVEFRTLSSDKKSENGA
PVPVSKTITGIKPSKFQEFKEGDFITEHDFWKTDSDDELEDLQNSRRSAYITELYRSIDF
DSIEKIPLSFTIPQAIQKYFAHEILSVEALQANLQDEKDIPCILDYLILKRFLFKAYDTL
IFMDNSIDQTQFSALKSIMMHLENSYKQMIADKKPNITKIFNETFLSLQCHYQALIATID
TRKNRLASLEAQMKALQSEIQLKSNAANADPEKLKARQEKLAKLQKEAEYYRTTLKRLGA
IQEDFYKKNYNIFENAFKLSREKLFKKIITGLNLCATIMDVKIWHLSLKSSGVKNSYFTM
SNIENSFCSLSFAEHYLSRLNKAALNPFDQKLLVYIQKITKEQRKKFLVVTSDLDLLCKL
KIETFAQNPYFIVKYAPKKVNYQSLMRDNSFDIVFIDEKHIWESVADIILEGKHFDKIGK
TKFKLI
>fig|195.2024.peg.1679 Putative periplasmic protein
MKTNNIFMALAIVLASLILAFGFNKALSDFKTLERSVSVKGLSQKEVEADTLILPIKFTR
SNNNLTNLYEELEQDKENIIKFLEKQGIKEDEISYNSPNIIDRLSDPYSNDTQAAYRYIG
TANLLIYTQNVKLGKSILENISSLAKFGIVTKIDDYDIEYLYTKLNDIKPQMIEEATLNA
RNAAIKFAQDSNSHLGKIKKASQGQFSISNRDKNTPYIKTIRVVSTIEYYLKD
>fig|195.2024.peg.1665 hypothetical protein
MDYEIDNEGYFTSEFNKAAGIPEDIKIHSSTMENFIKAQNNGILQSYTNIDIAKTVGNAY
KIVSQLIEKTPELKGKSSFSKEDLANYFPQNYLIDKNTLEVKQTFSYEEMKDIIAKGGFK
NINENEKLSPSFFNFDNTDEKSELLPFNPDILHSAKNTALSWDTSADKYTNNDGSITMGG
F
>fig|195.2024.peg.1322 SrpA-related protein
MQIGLNYNYASNSSYYDKTQKNNAEQENTENTNSQNKDSKQNNEQTQMINGVELTIQQAQ
QVRELQSIDRNVKAHEAAHQAAGGGLAGAASFSYTRGPDNQMYATAGEVPIRMQKGRTPE
ETIANARQVVAAAMAPADPSPQDYKVAANALKMEFEARAEATKLKAQEAQEKKEENEEKQ
ENLDINNQDSKDNFEETQANKDFKNFIGKIYQQNSQNNPINFSLVS
>fig|195.2024.peg.1421 hypothetical protein
MYLENQDSEDKIYIFKQIQFKKNDTLTMQANNILKNTLISL
>fig|195.2024.peg.523 Anaerobic C4-dicarboxylate transporter DcuB
MDFLTSLDESIQFLIQIIIVLICLFYGAKKGGIALGLLGGIGILMLVFAFHIKPGKPAID
VMLTILAVVVASATLQASGGLDVMLQIAERILRRNPKFLTILAPFVTCFLTILCGTGHVV
YTIMPIIYDIAIKNGIRPERPMAAASISSQMGIIASPVSVAVVSLTALLLNAEHKLAGFD
GYINLLQITIPSTLFGVLCVGIFSWFRGKDLDKDEVFQEKLKDPEFKKYVYGDSKTLLGV
QLPKSNWIAMWIFLGAIALVALLGIFDSLRPNWGQVVKNGIPQVDALGNPKMDILSMVSV
IQMFMLLAGSLIIIFTKTDVKKIGSNEIFKSGMIALVAVFGISWMADTMFAVHTPMMKKA
LGDVVVDYPWTYAIMLLLISKFVNSQAAAIAAFVPLALGIGVEPGVIVAFAAACYGYYIL
PTYPSDLATIQFDRSGTTHIGKFVINHSFILPGLIGVISSCVAGYFLALAAGYL
>fig|195.2024.peg.896 hypothetical protein
MKLSYHTSKVLMSVSISALLSSAALAQEITIADGDGSMENHFETNDGQHFTLKNDYTNGN
LTININNTDIPNSIAKEGYEDLATVNINLGSNDLAIKNISHGDISTYVTNYTINAKKTEA
IDVIFQSTNGRSIVNGDFNIKGSSAPTEGVLDDIKSSAILIGDGYGLQGSLEVNGNFTAD
QSTLFTVGGNKSQNHIQINGKANITNSNFSIGATSFGDLALNNYVFMSASEGFNEDITNS
NKASANISKNFESIVGMSNKDLGLDYEVVRAMDIKDFIEYKLSTKDNKLLISGGANKNVD
NNKMILENDKKYLELIKTDLEGAKNEEGTNKEKIDEAIAKIDEQIKQIQDMISNAGDQII
SNDDYIKNDSSVSASNKDFVSKILDGLTLGKDFNAIGSIKFDKAGEQIANDIKDSAKSIS
NINQASSGINSTINISNDVSIGSRVAMLNNPYGNYATKLSQMRFAVNDYRGNYVDNYENS
IWGNVIGGTNIIDGDSSALYGATIGMDRKINDDAIIGAYFTYVNAEIKDNLLTQKSDNFQ
FGAYSNIYISPKVEVNVKAYAQISTTDQDITNRGFNTTNSADFNRKFLGLSANMGYVFDF
SDNTLFVKPFAGANYYYAYTPSYKENGIAGKNVDSTSNNSLSLELGTEIRKYMSEESYLF
ITPKIEQYVMNNGDDFVASLNGVALPSVKSDDKKKTYGQIIIGGNIDISEQFSLNAGIGA
KQILAGKTDGKNETYVSGQLGFKYKF
>fig|195.2024.peg.344 Putative two-component sensor
MNRSSIFYTITFIFIFAGVSVILGFLWLIEYDQQNYTRELNTKYSLIANARLLNFAGIIS
EREFEEQTKNYNKMEPILEVRQIRRILFGGEVLARVEVNNGLIEIISYDRQVYLNIIFDG
KVNLYKDQDYQTYRYFIIKAIAVAVICILVLLYIYIFKKLKPLKALKKQIDKFAQGKLND
IEDVSTGVDEISQVSEAFYQAIVQIRKLNQSRQFFLRNMMHELKTPITKGLITLEMLEDN
KYKERLESIFNRLEILINEFAAIEQITSGAAFINRKKYNILDVLDEAKEIAMRDDNNIRI
FMDESFFVNVDFKLFTTAIKNMIDNGIKHSENGFIQIDIMDDYICFKNRGPELNNTLEYY
TQAFTQGGSKQKSSFGLGLYIVNTILESHGMKLDYDYEEGINLFYFRNLKSIIVKE
>fig|195.2024.peg.984 Putative iron-uptake ABC transport system ATP-binding protein
MLEIKNLSKNFGKIQALKNINLHVKEGEFLSILGGSGSGKSTLLRIIAQLEQASSCEFLK
CKGEVAMMFQNYALFPHLNVEKNILFALYDKKDKKQILEDLLKTFEIENLRYKKIDEISG
GQAQRVAFARAVARGCKLLLLDEPFSNLDQNLKQDLRRELKKLIQKQKITAIMVTHDIED
AYCMSDKIAFLDKGEILAHADPKELYFKPNHKSARILPDLNIIEEELDLEDEFFQWIASK
NYTFGYAELKIGNRFEATILQKEFLGAFYRLKVRYKNIDFFMLLSSNYTLKEKINFDIIN
F
>fig|195.2024.peg.193 hypothetical protein
MLPNINEIAKETLITLKDRKLRPTPENYTEIFEELSKKYGLISSNKAKLEKYKALLLPNY
QQELNSKSIRTLEELISFLISALNRQNGKQFSEFFDFLATLSKSLQVSKDKKIRDLAKIT
SIRISKTMDSESIYLLSKKWKEFEKNYNENDLEGGLRRYGIAKYDDFDTVVKKLLNKLEE
RSLEVFAELLASCLNPSLVEDLKIHGFAQNLLQKPFLLSESGFKNELLEFVNRRVMVDNM
YVQKNLNFFNDNLKKIYELFMLLNKSNEQNMDFINTLKPDKQGEIKLSFELLKQKFIQLN
ERINSLNAQIEFTQNLEERESWSVLKELERLDENYNKYKVNYSLALFSIKNYRFIMERYG
VGSLNEIFVRFKKILKDNCSEFDELWMIDEKSYLIISPGRNKEKVAQLVRENLKTIENFR
FIYKQDIITPKIITAYLDKQSKPHANILEELMNQISNLDERNNAKDQ
>fig|195.2024.peg.1150 Uncharacterized RNA pseudouridine synthase HP0347
MEFYLKKFRERLSLAYTKIKLSNNGKKAFQVLIDNLKININEAQKLIDKKRLFCDGILVE
EKNKILKGDVELIVYENNPKGVEIVFENEDFAVLEKESGILSHPNGRHCKYSLSDEIWHL
WGKKACVAHRLDKETSGLILVAKHKKAQIELKTMFEKKQIQKEYLALASGEIKVNFIVDQ
AMDLTKDYDDVKTRMQICENGKKAITEFEVLSFYPKLNATLLLCKPLTGRQHQIRVHLFY
KNHKILGDPLYGLEKKDIEKILDDKMDIEERIKLSGAKRLCLHSYRLKFNYNGENFDIFS
KKGMEKILAAF
>fig|195.2024.peg.886 hypothetical protein
MKSKYNSVAKVRKQQLDKAQSNLNAAKQRQIENERLYELSRKECESLSVLPSSGSIAELR
SNLTMAQVGRDALARAKERVELSKKEMNHYQFLYQKAHLDYEKIKVLEAEEIKQKQKELA
KIEEKILDEIAITRFLKGEKNV
>fig|195.2024.peg.162 Small hydrophobic protein
MLDNLIPNSIIIATIAITAIFCAVAVVFIKNLAKKQKEKE
>fig|195.2024.peg.255 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MPQLSIIIPLFNSCDFIARALQSCINQTLRDIEILVIDDKSEDESVKIALEFAKKDERVK
IFQNDENLGTFATRNLGVLKSRAEFIMFLDSDDFLALNACEVALTKIKQGFDLLCFDAFV
HRVKTKQFYRFKQDEAFNQKEFFEFLGKQRHFCWSVWAKLFRKDLILKSFERINLYERLS
YGEDVLFCYMNFLECDKMGVFKECIYHYEFNEKGRYENKNKEILWQNYKDKKRSNELIKK
LSLKSKGDEFCKRLFEVLEKEEKDLKARIAKIDTLDLA
>fig|195.2024.peg.1346 NADH-ubiquinone oxidoreductase chain G (EC 1.6.5.3)
MTIKINGIDCAFEEGEYILNIARRNDIFIPAICYLSGCSPTLACRMCMVEADGKKVYSCN
TKAKEGMVVESDLQNLWDERNEIMQAYCINHPLECGVCDKSGECELQNFTHKSRVNIQRH
WIKDTHKPHKHWGMINYDPALCIVCERCITVCKDKIGESALKTVPRGGDSVDNSFKESMG
KDAYAIWTKFQKSLIGPANGDMLDCSFCGECTSVCPTGALIGSKFQYTSNIWELKRIPAS
NPHSSDCELMYYDVKQSGISNQKAKIYRVSNDFAFASLNKAARFAFDTQNEASKDEKAFK
ELVELFEKNEIRNIKFNSFITNEEALILQNFKKKFGLNLINNEALKFKDFLEEFISNGGE
FYNATTQDITKSDFLVVAGTLLRYDAPTLSYKINNALVMNKGSGLYFHPIEDTGIAKYSK
NFISHTHKSGDEEQILYFLLQKFTQDENIKANLAEFFVNENKEIEESINEEVIEQVVEKD
EEGNEISKEVKKVVPKKVKKTIEVKRSVFAKNLGIDEDKLEDLLLKKANFTLIIGSDFYF
HKNAKKLAKLLALIQNTTPFKVFLNPTHTNTLGVAMICDLDKNTQEGKTLGYNEKGDFSF
SYEEHANLASASLNQQEGTFLNYDKKVVPTNAALEFDGYFLNDLANALGFDEEYTINYTK
RLPINKGFSPLEFDSLDNFYTNGGECKRGYDLNLECHKKSAKNEFIAPHLQNLTLQEDEI
LLYSANPSYQFGRFSNRASATNEAIFLGVSQNLAKEKNLQDKDLVKLKIKDKELSLSVRI
DKDIKNGAFLPYFDEKIDTLSFFDERFIVANLEKLGASHE
>fig|195.2024.peg.741 Phosphatidate cytidylyltransferase (EC 2.7.7.41)
MFNTTRIISALVMIGAIIIIALIDQFFINFIVFAVLLYLSFSEAKKLFALENISIIPLAI
AFILGSLSHKALLFGILALLLVVGYLVYKKDSLKPALIYIYPSLPVLALWQVYLDQGMFA
LFWLIIIVAACDSGAYFIGKLMGKTPFSPTSPNKTLEGVIGGLVCASILGTLIGIFVYSF
WLSLLCSFFVAFFAVIGDLLESYFKREAGVKDSGDLIPGHGGILDRIDAVIIATFVMVAL
L
>fig|195.2024.peg.1456 Fe2+ ABC transporter, ATP-binding subunit
MKELIQIKNLSKKFGKVKALDNINLNIYKGEWLAIMGPSGSGKSTLLNILSLMDDPSSGK
YILDNEDLEQINEEQKITLRREKIGLIFQQFHLIPYLSALENVMLSQYYHSSVDEEDAKA
ILEKVGLSHRLSHLPSQLSGGEQQRVCIARALINNPEILLADEPTGNLDEANEKIVLETL
QKLKNEGKTIVLITHNPELAKFADRTLILQHGILK
>fig|195.2024.peg.84 Coproporphyrinogen III oxidase, oxygen-independent (EC 1.3.99.22)
MRDYKAFVKYSKAGPRYTSYPTAVEFNTNFKYEEYIEILKKQNKALSLYFHLPFCRSACY
FCGCNVIYTAKEESKERYLKYLFQELDILSTIIDTKREVVQMHFGGGTPTFFSAKQLESL
ILKIKSVFGNFTKDAEISCEIDPRFLNEEQADVLTKNGFNRISFGVQDFDERVQKEIHRI
QPFELTQNALKLVRDRGIKSVNMDLIYGLPFQSLQSFAKTLEKAMLLNPDRLAIFNYAHV
PWLKKNMRKFDENTLPSPDVKLEILEFCEKFLTQNGYKMIGMDHFAKEEDELFKALENGT
LHRNFQGYTTKDGADLIGIGLTSIGEGQSHYAQNFKDMPSYEAAISEGRLPFERGIKLSY
DDELRKAVIMDLMANFRLDIKAIEKEFKINFKEYFKEDLKALEEYKEFIDLSENFILVNE
TGVLLIRNIAMCFDAYMKNISEDKKVFSKTV
>fig|195.2024.peg.1058 Chromosome (plasmid) partitioning protein ParB
MGLNKNRGLSTLMGDVGEVYSRELGLDKNQVSLVEISKITPNPFQPRKTFDEAALNELAN
SIKEHGLIQPIIVLKKNDSFILVAGERRLRATQILGKENILAFVSDSDESKLRELALIEN
IQRENLNPIELANSYKDLIEVYNITQENLAELIHKSRTQITNTLRLLNLDPKTQDLIASG
KISQGHAKVLVGLDKEDEKVLVDSILGQKLSVRDTERLVQKVKNKENTEDVEFENSMQSL
KQTLNKLGFASKNNKKELIIRLDNIEKIKKLTEILNKF
>fig|195.2024.peg.1122 UPF0033 protein YeeD
MVTLDTRGKVCPFPLVEAKNLVQTLKSGEELEILFDCTQATETIPQWAAEEGHEIVDFEL
LGDAEWRIKLIKK
>fig|195.2024.peg.843 Peptide chain release factor 2
MDNYEFSELLKTLKNKVGNIASIIKPENIQTRLKEIEELENSPSFWNDVKQAGIIGKEKT
KITNLLKNYENAFNALNDASELFDLANSENDAETLEALFNDAPKLEDTITSLEISMLLSG
ENDGKNAIVSIHPGAGGTESNDWASMLYRMYLRFCEREGFKVETLDFQEGEEAGLKDVSF
LVKGENAYGYLKAENGIHRLVRTSPFDSAGRRHTSFSSVMVSPELDDDIEIEIEEKDIRI
DYYRASGAGGQHVNKTESAVRITHFPTGIVVQCQNDRSQHKNKATAFKMLKSRLYELELM
KQQDSANAGEKSEIGWGHQIRSYVLFPYQQVKDNRSGEAFSQVDNILDGDIKKMIEGVLI
ALKSE
>fig|195.2024.peg.831 Predicted glycosyltransferase involved in capsule biosynthesis
MPLLSVIIPFGLSKERSYIQERVYEKAQCFKTDEKIEFIFVEGYSSQEHNLKTCILKNNH
IYLKDESQEEYFSQGKCRNFGASYANASVLLFLDLDCFISFDSLEKILKLIKIKNILNNP
SALLVLPVVYLTQEASEILREYPMDLWDVLIQEDLISGKNFLVKFFAPSSTSGLIINRHK
FLEIGGNDENFIGHGYEDFDLFARVLNSCLKFEKIPLNLNYDSRNWNFYNFKGFRSWFSL
LGYELCFYGIYMYHLWHIEPNQNGYMDKKHKNHKLFYKHLKKIKDYSIDPLQISSVKNTK
ILVIANKKYNFRALSVYLGKFVYKSLDELAYQSKKEIEIYLQEEKFDKILLDKNIYNEDL
HKIFKDYLCVYFESGILPDSWLFYKDANGLYDRKHWDIDLDKLQIKEMQAYIISLKFEEK
KKILTFIQKLGFDKDDDLYKIVFYLKNELYSFAKNDDFYQIIFNKKKMLMLGNYDKEYYS
LKSFVYKPYLYEIKRVRFFSKILEFLGLNFLLSLISQTKFYRLARKLFFNPRDFFKDSKF
YKRHNNAN
>fig|195.2024.peg.1434 hypothetical protein
MQNYKKLGIEHFLRKDFKTAKIYFSLAYEKRKNKRLFHFITLCDLASKSPKEALLLFEFY
LEHYQIKNIDKDLEEILSTIELKNEKNTDETENEIQEAHTLNYKDFLKSEEQIGFKKSFE
NIIHSTKLVIDNRDDFLDFLEKLLDNGYKDMTLNYIESVMPHFWANERFIKLQEKLIGFK
SEIKA
>fig|195.2024.peg.1637 LSU ribosomal protein L20p
MARVKTGVVRRRRHKKVLKLARGFYSGRRKHFRKAKEQLERSLVYAYRDRRRKKRDFRRL
WIVRINAACRLNDLSYSKFINGLKKAGIELDRKILADLAMNDAAAFAKIAEAAKKAL
>fig|195.2024.peg.111 Branched-chain amino acid ABC transporter, ATP-binding protein LivF (TC 3.A.1.4.1)
MLVVKNLHVYYGLIEAVKGIDFKVETGHIVSLIGSNGAGKTSTLNALLNAVKRTGEINFL
GYDTKRHLTHTLVQKGIALVPEGRRVFINLSVEENLKIGAYNNSENYEYLREQMYKLFPR
LASKKHAMAGNLSGGEAQMLAISRALMSEPKLLMLDEPSLGLAPKIVGEVFDIIVRLKEE
GITILLVEQNAYSALKISDYAYVLENGLIAMQGKAKKLIGDDNIRKKYLGL
>fig|195.2024.peg.1461 LSU ribosomal protein L21p
MYAIIKHSGKQYKVSVGDELKLDHFEAESKASIEVSEVLAINDKELKVGAPFVAGAKVVL
EVINHGKDKKVVIYKKRRRKDSKLKRGFRRQFTRVVVKDIKA
>fig|195.2024.peg.330 Two-component system histidine kinase DccS
MAKKVIRQILLIYLTTTGIFLAIFFTLWYQKLYEELVVVKGTSLRENHRNIIINILNSRF
VPMNESASNIAQSTGLKFAIFDKKQAIFDNLDFDFRKAKVELKGRGIYDGKVFFLDRMNT
DNYFLKHTNEDNANTESRLKILIQGEDVKKDLIWIRIKVFSFAIMAFCILGLIAYILVKI
ALKPLEDKIITLNRFIKDSTHELNTPLSVILMSIEQLENQKLEHNTKFTRIKLAAKSLSQ
VYSDLVFYNFPNTLELNKQELDLKALIEERLEYFKIFFEQKKISLKLNLHQASIFASKNQ
ISKLIDNLLSNAIKYNKKGGEISIELKTGFLSIADTGCGISKSNLKHIFDRYARFNTDQG
GFGIGLSLVKKICDDNDIKIICESVENQGSVFELSWSAKKI
>fig|195.2024.peg.1031 Acetyl-coenzyme A carboxyl transferase beta chain (EC 6.4.1.2)
MNFADIFSKIRRQQPSTKEAPNHWVKCQSCHALMYYKEIESCFNVCPKCSYHMRISPMDR
IKLLSDENTFVEYDANLEAIDPLKFVDSKSYKKRLSEGESKTGRKSAVISGECLIDGLKI
QLVVFDFSFMGGSLGSVEGEKIVRAIQRAITDKTPVVIVSASGGARMQESTYSLMQMSKT
SAALKLLSKEKLPYISVLTDPTMGGVSASFAWLGDLIIAEPGALVGFAGARVIKQTIGAD
LPEGFQKAEFLLEHGLIDAIVERSDMKKYLSDTLKFFCGK
>fig|195.2024.peg.1380 Histidinol dehydrogenase (EC 1.1.1.23)
MQIINFNELDEKQKQEVLKRPAIAAKDEISQIVSSIIKEVREKGDEALIEQALKFDKAQI
SSIKVSEEELENASLRLDKDLKEAILIAYENIKKFHEAQIPKEIAIETTKGVKCEVLTRP
IEKVGLYIPGGLAPLFSTVLMLAIPAKIAQCEKIVLASPAKINDATLFCAKLCGVDEIYQ
MGGAGAIAALAYGTKSVLKVDKIFGPGNAFVTEAKRQVSSDINGAAIDMQAGPSEVLVIA
DEKANVKFVASDLLSQAEHGADSQVILVCLSKEFAQGASDEVSRQLENLPRKELASKSIA
NSKIIIAKNLDEALLISNLYAPEHLIIQTQNPRELLDKVKHAGSVFLGELSPESMGDYAS
GTNHVLPTYGLTKTHSSLGLADFSKRMSVQELSKEGFLNLGKSVEILAANEHLDAHKNAV
TFRLESLK
>fig|195.2024.peg.1163 2-hydroxymuconate tautomerase-like protein
MPIVNIKLAKPALSKEQKAELIADITELLSTKYNKSKERVVVMLEDIESYDIGFGGESVE
AIKAKANK
>fig|195.2024.peg.228 UDP-N-acetylbacillosamine transaminase (EC 2.6.1.34)
MRFFLSPPHMGGNELKYIEEVFKSNYIAPLGEFVNRFEESVKDYAQCENALALNSATAAL
HLALRVAGVEQDDIVLASSFTFIASVAPICYLKAKPVFIDCDETFNIDIDLLKLAIKESE
KKPKALILTHLYGNAAKMDEIVQICEKENIILIEDAAEALGSFYKGRALGTFGEFGAYSY
NGNKIITTSGGGMLIGKDKQKIERARFYSTQARENCLHYEHLDYGYNYRLSNVLGAIGVA
QMEVLEQRVLKKREIYEWYKEFLGDSFVFLDELENSRSNRWLSTALIDFDKNEMNAYQKC
IEISQKDLILHPKISKLITDLQKEQIETRPLWKAMHTQEVFKGAKAYVNGNSELFFKKGI
CLPSGTAMSKDNVREISELIIKSVKA
>fig|195.2024.peg.323 FIG00003370: Multicopper polyphenol oxidase
MGRSGENCLSLLENQKVSVFCAYDKDYNIFRAKVHKENLFSHLGFKDIEKCVFMDQIHSN
KVEIYDEILKNLSCDGLISIEKNTALCVLSADCLPLILWHESGIIAALHSGRKGSFENIL
KECVDKIYTKNPNLDMQKFHLFILPSICAKNYEIDGEILEFARVEFKDFLDERKLDLKAL
VKFQAQNLGIKNIIDSNICSFDDKTFYSYRRDKTLKRFVSVVYLKG
>fig|195.2024.peg.987 integral membrane protein, putative
MVGLVLSITVGLFGVDRFYKGDILLACIKLAFFIILLFATFAAFIALLDESHSIFIDYFA
IFALMFVVASIWKLVDIYLVFVGIKKDNFHKILNFFS
>fig|195.2024.peg.318 Inner membrane protein YihY, formerly thought to be RNase BN
MKRIFAILSNLRDKEILNYAAALSFYTILSLIPILFVCFSVFTQISSFKAYYEKAKQIIF
AFLIPAQQDIVAAYLDTFLNNSVNLGIVGLIAMTFTSLAFFSGYDFVINRITKSEPKGLW
QSISSYWTLLTLVPLGLGLSFYISGLIQQALDDYKIGFNFFEILPFVIIWGLFFISYSSS
IQKGTLKSLIFVSFAAGAIWYIGKNLFVYYVVYNKTYASVYGSFSTILFFFIWIYISWIV
YLFGIKIYYFLNHNHDKGDKIRKNTKKS
>fig|195.2024.peg.51 Ribose-phosphate pyrophosphokinase (EC 2.7.6.1)
MRGYKIFSGSANVEFAKQISKYLSLPLSDAGVKRFSDGEISVQIDESVRGKDVFIIQSTC
VPTNDNLMELLILTDALRRSSANSITAIIPYFGYARQDRKANPRVPITAKLVANLIEAAG
IDRVATIDLHAGQIQGFFDIPVDNLYGSIVFNDYIKTKHFKNAIVGSPDIGGVARARSVA
KNLGLDIVIVDKRREKANESEVMNIIGDVKDKEVILVDDIIDTAGTIVKAAEALKNKGAK
SVMACCTHAVLSGKAYERIASGALDELVVTDTIPLREQLPNIKVLSVAPVFAEVIRRVYH
NESVNSLFI
>fig|195.2024.peg.362 Putative Fe-S oxidoreductase
MKILFGPVSSRRFGRSLGIDLSPSKKQCNFDCVYCELDPKKAQEKQDEIISIDKIISEVK
VVLEKNVEFDFLTLTANGEPSLYPHLNELILSLRSIAKDKKLLILSNGTAVLDGDKFNAL
LKLDVVKFSLDSAVAKTFYRIDRALKNIDLEKMIEKMADFRARFNGDLIMEILVVKDLND
NEEEFKALNQALKKIMPLRVDLSTIDRPPAYAVKKVSEEKLLELSKLIDSTPVLLAKRHY
EGEKLSFNEEELLKMLHLRSQSEIDIEVKFDEQSKTLLNQLIKEKKVKILDLAGVKFYKV
>fig|195.2024.peg.1054 ATP synthase alpha chain (EC 3.6.3.14)
MKFKADEISSIIKERIENFDLNLEIEETGKIISVADGVAKVYGLKNIMAGEMVEFDNGDK
GMALNLEESSVGIVILGKGEGLKEGTSVKRLKKLLKVPVGEALIGRVVNALGEPIDAKGV
INSNEFRFVEEKAKGIMARKSVHEPLHTGIKAIDALVPIGRGQRELIIGDRQTGKTTVAV
DTIISQKGQGVVCIYVAIGQKQSTVAQVVKRLEEHGAMDYTIVVNAGASDPAALQYLAPY
TGVTMGEFFRDNAKHALIVYDDLSKHAVAYREMSLILRRPPGREAYPGDVFYLHSRLLER
ASKLNDELGAGSLTALPIIETQAGDVSAYIPTNVISITDGQIFLETDLFNSGIRPAINVG
LSVSRVGGAAQIKATKQVSGTLRLDLAQYRELQAFAQFASDLDEASRKQLERGQRMVELL
KQPPYSPLSVEKQVVLIFAGTKGYLDDVAVSKIREFEDGIYPFIEAKYPDLFEQIRSKKA
LDAELEEKLAKAINEFKANHL
>fig|195.2024.peg.1164 Thiol peroxidase, Bcp-type (EC 1.11.1.15)
MSVLKVGDEAPQFELLNQDGVKIALKDFIGKKVILYFYPKDNTPGCTTEACDFSANYDKF
CDKNAVIIGVSPDGVTSHDKFIAKFNLKHILLSDSEKEVAKAYGAWGLKKNYGKEYEGII
RSTFVIDEAGKIAQIYSNVRVKDHALKVLESL
>fig|195.2024.peg.1522 Phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36) / Phosphopantothenoylcysteine synthetase (EC 6.3.2.5)
MKTILLAISGSIAFYKSYELISLFKKEGFRVKVLLSNGLLKFASKMSFEALADEVLCEEN
ESWQNSNNHIAFSKDADLVLFAPASVNSINKLAFGIADNLFIQTLIAANKPLIIAPAANT
NMFHHFSTQNSLKILKENKALIIEPICKVLACKDEGIGALAEVKDIFNISKRELFKQSFW
CDKEVVISGGGTKEKIDNVRCVSNFSSGKMAKAIADAFYFLGAKVTLLSSVYFDTPYSLK
SFESSRELKELLEQNSNKDYLIMAAAVSDFMPEFKKGKIKKNEHLKGLNLHLRLNEDLLK
NLNFKGKKIGFKMEFDAQNALENAKKSLNDKKLDMVCLNILEEENYFGSSKNEIHFITVN
KIEKSGLKSKEDLAFDLVSWCEKI
>fig|195.2024.peg.322 hypothetical protein
MYEKKDLRVLKIIQKAREFGDGDLLNEALVNQLVNAEFKEIESKEREELIALLNSLIEAK
DKALLSNP
>fig|195.2024.peg.705 hypothetical protein
MDLKLARNLINEEPKNISLAKIEEAVNQEGQKFFYFDKENSHKDLIALVEHFEKKGLSVY
HRTIRYGLDSNDFMYEVHIL
>fig|195.2024.peg.1608 Replication-associated recombination protein RarA
MSLALNFRPKTLDEILGQQELVEVFKKFISMQKLPHSLFFGPAGCGKTTFARVVAKDFGL
DFYEFDGGNFKLEDLRKIIENYKNSLYKPLIFIDEIHRLSKTQQEMLLIPMENYRCIVIG
ASTENPYFVLSSGIRSRSMLFEFKNLGQKDLELLLERVQQKIAFKIEDNAKEFLLKSFDA
RAMLNLLEFALVLNEKEITLENLKKLRNGVNSEGVSSKDTHYILASALIKSLRGSDVDAA
IYYLARLIDAGESADFIARRLIIFASEDISNADPNALNLAVSTLTAVKNIGYPEARIILS
QCAVYLASAPKSNSSYNAINKALDYVKNNPALEIPNYLNNNHPEKKNYLYPHNFGGWVKQ
NYLSANLKFYESKGIGEEARLLENLSKLKNIKS
>fig|195.2024.peg.1193 Cytolethal distending toxin subunit A
MVEGKKFPAIPLVPPVITPNTFKGDNAVKGPLPRLKSPNEFASNALYENTGMVSDFVTIM
NPNGASLTIWALNPGNWIWGYSLFASRPFGDARAWQLIEFPNNTVMIKNAKTFTCLNAYR
NGIVHYPCDQTNFAQFWRLYPMTNGAYQIQNFATQQCIQTPVSNVMEEFNLSFYNIYLTD
CLKEKEKNLDRQWYIGAPI
>fig|195.2024.peg.28 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (EC 1.17.7.4)
MIIELAKNYGFCFGVKRAIKKAEQIKDAATIGPLIHNNEEIARLQKNFNVKTLENIRALS
DEKKAIIRTHGITKQDLEELKKKDIEIFDATCPFVTKPQQICEQMSAEGYDVVIFGDENH
PEVKGVRSYVATKAYVVLDKKDLENIKLPNKIAVVSQTTKKPEHFMEIVNFLILRVKEVR
VFNTICDATFKNQDAIKELSVKSDVMVVVGGKNSANTKQLFLIAKANCEDSYLIETEEEL
QKEWFLNKTHCGISAGASTPDWIIKKVIAKIESFKC
>fig|195.2024.peg.659 Alanyl-tRNA synthetase (EC 6.1.1.7)
MDVRSEYLNFFKSKGHEITPSSPLVPDDATLLFTNAGMVPFKSIFIGEVPRPNPPRKTSC
QTCIRAGGKHNDLDNVGYTARHHTFFEMLGNFSFGDYFKEQAIAYAWEFVTEVLKLPKDR
LYVTVHESDDEAFELWQKHIQKERIYRFGDKDNFWQMGDTGPCGPCSEIFYDQGEEYFNG
EEDYMGGDGDRFLEIWNLVFMQYERSADGKLTPLPKPSIDTGMGLERVTAIKEGKFSNFD
SSLFMPIIDEIAKLCGKTYIYESGASFRVIADHIRSSVFLLAQGTSFDKEGRGYVLRRIL
RRALRHGYLLGLKKPFMYNLVDVVCKLMGEHYTYLNEKKDFIKEQICLEEERFLSTIENG
IEIFNKELKNTKEVFSGEVAFKLYDTYGFPLDLTQDMLREKNLVVDEAKFEELMNEQKNR
AKASWKGSGDKVASGDFKNLLEKFGENCFVGYEKTECQATVLALLDEDFKEVSSLKGLGW
VMLDNTPFYATSGGQIADTGYIGTSEVLDTQKFFNLNLSLVKANEEIKLNDKIIAKIDTD
KREQTARHHSATHLLHHALREILGSHISQAGSLVESNKLRFDFTHHKALSKEELESIEKR
VNEMIISSSEAILENMPLEDAKKSGAIALFNEKYQGNVRVLTLGESKELCGGTHVKNTAQ
IGSFYIVKESGVSAGVRRIEAVVSRAALEFCKTFMNENLNLKEELKSNDLSLGVKKLKNE
ILKLKNELKNSNKSQLNSSNINGVQICVECVESGDIKTMIDEFKNKFEKAAILLIQTKDD
KITLAAGVKNCPLKAGNLVKNIAQILGGNGGGRDDFATAGGKDISKIDEALKQALDLIQK
GL
>fig|195.2024.peg.1489 Signal peptidase I (EC 3.4.21.89)
MNFLKKLYKFSQSWTGTVIIVLLVIFFFIQAFVIPSGSMKNTLLVGDFLFVKKFSYGIPT
PHIPWLEIPVLPDFDKDGHLIKGQSPQRGDIVVFRNPKNEKEHFVKRCVGVGGDRIVYAN
KTLYVRMHEGDEFMKEHYPDDLATLGGQIYVKEPYRQKGIHYDLNKDIESDILRFLSVGK
FAMSPTYFKELGNNIGFSGGNAYVFDVAEEEYFMVGDNRDYSYDSRFWGSVPYRLIVGKP
WFVYFSWDQDKNVRWERIGRFVDTLENEEEYIHDHDDEDKLS
>fig|195.2024.peg.444 Pseudaminic acid cytidylyltransferase (EC 2.7.7.81)
MKNLCIIPARGGSKRIPRKNIIDFLGKPLISYSIENALNSGIFDEVVLSSDDEEIIKVAL
KYGVKVPFVRDKNLSDDYASSTAVVQNAIEILQSQNQIYDHVCCLYATAPLLNKDILKQA
YEKFIQNQSKFLFAAAEFEYPIQRAFYLNENNQVYMFDEKHYKSRSQDLTKAFHDAGAFY
FGTSKAWLEEDFMFKPHSSVFVLPRNLVCDIDTMQDLEFAKILYKANHESAF
>fig|195.2024.peg.892 Selenide,water dikinase (EC 2.7.9.3) @ selenocysteine-containing
MARQKSSLYKENMEYKNQNLTHFVKAAGUAAKLSPGGLKTILNFMQTSPALLSDIGNNED
ASVFQISPELALVQTLDFITPIVDSAYHFGAIAAANALSDVFAMGAEVINALNIVGFDTC
HHELNVLQELLQGANDKVQECGGIIVGGHTIESGELFFGLSVTGKVHPKKFIANNTAKEG
DLILLTKPLGTGILSTALKAQMLEEKHLDRMLESMMGLNYKSSQIALRFGVNAMSDVTGF
GFLGHLREMLNDSISFMIFKDKLPYLEGVKEYFDMGLIPGGAYKNLDFIQEFYPGLNEED
LLLCDPQTSGGLLISIEEKKALECLKALEDENIKAKIVAKAVAKQDDRFIFS
>fig|195.2024.peg.1506 Methionyl-tRNA synthetase (EC 6.1.1.10)
MRYLTTPIYYVNDVPHLGHAYTTIIADTLARFYRLQGHETRLLTGTDEHGQKIEQAAKIR
NSTPKEYADKISSEFKKLWDEFEITYDIYARTTDTRHVEFVKAMFLKMWQKGDIYKDEYE
GHYCISCESFFAKSQLINECGCPDCGKDTSLLKEESYFFKLSKYQDKILQWYDKEDPILP
KNKKNELINFVQSGLKDLSITRTSFDWGIEIPEEIKDDKHIIYVWLDALFIYISSLDYQS
QGENAKFWPAHIHLVGKDILRFHAIYWPAFLMSVDLPLPKFIGAHGWWTKEGEKMSKSKG
NVVKPKEVVDAYGLEAFRYFLLREVPFGNDGDFSESVLINRINTELGNEFGNLLNRIIGM
SIKYNQGNISQEGVLEFYKNELDTAKEHLDNAINFLENLQCNRYLEELFKALSVANLAIS
KYEPWNLIKANKIKEANALIGLCANILAKTSLLLSPTLPKSCQKVGLALNFEISPTNYQK
LILQNELLDFKASACEALFPKIEKPLLSQEEKQEVKKEEKPKIKIDDFAKIEIKVAKVID
CQNIEGSEKLLKFKLELDNKEIRQVLSGIAKYYKASDLIGKQVCVISNLKKAKIFGHESD
GMILSAKSGDKLVLISPEQLVENGSLVG
>fig|195.2024.peg.354 SAM-dependent methyltransferase, MidA
MKFSEFFHAWLHESYYKNAVSIGKNGDFFTAVSVGNLFGTLLAKHFLDLIDKKVLKLPLE
LVEIGANEGYLSRDFLAALLEFRPEIFSKLSFFIIEPHEKLRNLQKKTLEGVEFTHKRSL
KECHFENAFFFCNELFDSFTCELIDDDKMAFIKDFKLVFEPMEAKLKEKCEILNLKKGEL
SLELEEFFKDLDKASKKFIFASFDYGVFNPQQFSIRIYQKHEVFNPFEITLKDFFGKSDL
TYNVNFNQIQQLIKEHDFKLLALKKQNQALIDFGFEELLKYIKDKNLKTYENFLSQSKIL
FFNFDEKFHFFEFAKF
>fig|195.2024.peg.762 Putative transmembrane transport protein
MDFFKLKENGTNIRTEVVAGLTTFLAMVYIIPVNSSIVSNTGMPIEALITATALITIVAT
AFNAFFANTPVAMSVGMGLNAYFTFAVCLGQKIPWQSALGAVFISSIIFLILSFTPFRLW
VIRNIPKDLRLAICAGIGCFIAFLGLSQMGIITPNKDTLVSIGNFKNPHVLFGIFTLILI
VFFWAIKLRGAFILGVLISSIIAWIFGIDNASFPKQILSLPNFSSDNGLGAIFLELDIKS
ALNITMIPIILTFFITQLFDSIGTITGIGERGKIFDDAKDGEKKLGKTLMADATGSALGA
LGGTSTVTAFVESTTGVESGGRTGLTALVVAICFAFTLFLLPLFKAIPANAIYPVLVMVG
ILMFMEVKNIDFKDSAIAVASFFTIIMMPFTYSITTGFAFGFLSYLLVRIFKREWDKINL
GIIVLSLISLGNFLLIALQ
>fig|195.2024.peg.1347 FIG00010922: Possible NADH-ubiquinone oxidoreductase subunit
MSYERALCFVDMLSLKNKILCEKIQGENIYISCLEDKNLNAKFYKCEIASLSYVLALLCK
MSEMDNFQDLDEGYLSAESCLGEEEASEILDFLENAKYLIVDENINSYKDSENIKYFLNF
LSQKYKLKILDSNEKECDFKNAKLSTLKELDSYDGLVLFRANLKDDNLHCSKQFLQIAKC
KDKSEVEVLAKDFSLKTTLCLDENLQGTIAFLNYDQQGFDFTPIRIKEAK
>fig|195.2024.peg.1271 hypothetical protein
MDKTKVVENLNALFKQRAEFYSYFDKNISKVGNTEVFDFSNAKDLNAEEVYKQFYHLDYA
MRKLLPAIYKAYEVSDSDLNRDF
>fig|195.2024.peg.1004 Putative periplasmic protein
MVKKIFIFLFLANSVFAVSSLELAKNLVANPSKDSQLRLLFPSSSYMDNKGNPDIAKISR
ILKTNSLINLTLPEPRTLKLNFKAKADSVVFFKILTDALTNLGYIYFIPTDMILRDGNID
YTIQVESQYILDPGALYALLKDNSVYIDNIKRIGTYDYEYDLNFENAQLNTNIDLKLNST
QALERPLKDYVFTLQGASNLMIDAHDADFWFPKVLFLDKNLNLIKAVKSQAQNNHFSELI
PSGAVYAIVSDMYSLDNIRRGLKITLKK
>fig|195.2024.peg.897 hypothetical protein
MNSKNYFQIFLKQKAKQFIFCFAFQDFKSFLVKFSLAY
>fig|195.2024.peg.196 Protein translocase subunit SecF
MQFFSEKKIYDFMRMRFAAISLSIVLFFGSIYLLWDRGLQFGIDFSGGTLIQLKYDTAAP
IPQIREILEKQGSFQNLSVTEFGSKEEITIRFLGSNDSLGSDIGEHISTLLKDTGKFEVR
RADVVGPKVGDELRNKGIMAIIVSLVAILIYIAIRFEWRFALAAIISEIHDVVITLGAIS
LFKIDVNLDTLAAVLTVLGYSLNDTIIIFDRIREGIKTSKKSELAPIINESVSATLSRTV
LTSGLTLATVVILYFFGGEMIQGFSLALIVGIVVGTLSSIFVASPTLLWFKFSVIDFRNK
ELEKLKRKQEKERNRAMYEKGTV
>fig|195.2024.peg.1717 Inner membrane protein CreD-like protein
MEQKFDENKFMQEYARNQRLKSLTLKGVLIFIISIVLLIPLLMLKTLVEDRKYNAQNVIS
LMGKAWGSDEFYTPSLNEKILPNKLELWVDLKYQERIKGIYKIPLYTAFVDFNASFNMEN
LSNFDENSIQFSNGNLKDLQFNILKDVLWVSGTLQLKGYGSFDANMQAKENIIHINSNAT
NPSFEYALPNDYSIDKKGFSAFYEFQNSISNDRVEKRRLSVEFYQGVDEYRLIDRMIKYG
YLFIILTFLVLFLCELASKKNVILLQYAILGASLIVFYLMLLSFSERIGFNFAYLFSSLA
IIIPLSLYTLSIMGQKRFAIVMATILFILYLCLFIMLKQDEYALLIGTFIAMFGIYAAMY
FTRNLNKDYHQG
>fig|195.2024.peg.1605 CAAX amino terminal protease family protein
MILTFILLALALALLSFKKIKLSFVVLVISGFLAYYHNIIEISFIVFVGVFFLLSLYYKN
NKNVFLELLIVAFCLLLFLHFIPGVNNVKILDKVHASEHSSAFTLYFSFDKPLGVFLLFL
LMPSLFENLNRIKPKLFQAALLFASPFLLLSIPWYLGVIKMEIGFPSWIVYFLFSNLFLV
ALVEEAFFRGYLQQRLQGLIGGVGALLVASLAFGVAHYKAGILMIIFASLAGLIYGMAWR
YSKSLWLSVFFHYGLNLTHLFFFTYPSYVK
>fig|195.2024.peg.1107 23S rRNA (adenine(2503)-C(2))-methyltransferase @ tRNA (adenine(37)-C(2))-methyltransferase (EC 2.1.1.192)
MKELINILDFLPEELEEKIKPMFRVKQIYQWIYQKYANNFSDMSSLPKDLRLELAQTYHF
SPLKCVKNEQSKDGSIKYLFELIDGLRIESVLLPMKEEQFDEEGKRISHTRYTICVSSQV
GCKSGCSFCLTAKGGLKRNLSAGEIVGQILWIKKQNNIPYERRVNIVYMGMGEPLDNLKN
VSKAVKILSQNDGLAISPRRQTISTSGLAKQIKELGEMNLGVLLAISLHAVNDELRTELM
PINKAYNIAAIMDAVRAFPIDQRKRVMFEYLLIDGINDKLEHAKELVKLLNGIKAKVNLI
LFNPHEGSIYHRPKLENAIKFQDLLSAKGVTCTIRESKGLDISAACGQLKERAKEL
>fig|195.2024.peg.1032 23S rRNA (pseudouridine(1915)-N(3))-methyltransferase (EC 2.1.1.177)
MQVNIFHIQKNDEFKIWGEKYAKLISKFADLKEHNLFNKKIAAAQNLNAQAAKLSYEEAF
APYTKGFCIVLDERGKELTSVEFAKLIADKNNLNFFIGGAYGLRDEFSQSLDFRLSLSKL
TLAHQFVKILLLEQIYRAFCINSNHPYHK
>fig|195.2024.peg.578 Macrolide export ATP-binding/permease protein MacB
MLFLKNICKNIGENSILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDMPSSGSYIF
ENYEVTKLNSDEKARLRREKIGFVFQRYNLLSLLSADRNVSLPAVYAGKSIHERSQKAKE
LLENLELVYKLNSKPNELSGGQQQRVCIARALMNGGELILADEPTGALDSKSGIMVLEIL
QKLNAQGHTIILVTHDPKIAAQAKRIIEIKDGEILSDTKDGNFNPKIILKAMPKEKKTFN
LFKNQIFECFKIAYSSILAHKLRSILTMLGIIIGVASVVCVVALGLGSQAKVLETIAGLG
TNTIEIYPGRGFGDLRSGRTRLNFSDLQTLRTLEYLDAVDAHSSTSGIATYTNISLSARA
EGVGVNNFAIEGLKLQVGRILNNEDIETNANVAVLDFNAKKNLFPRQKSEDVLGRVVIFN
SQPFKIIGVLQKDTEKPIEDNVVRLYMPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AVIRILEIKRGQRDFFTFNSDTFKQAITANKRTTTILTASVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICSMGAILGVLLSVFVIFGFNTLSTDFPM
ILNAYSVLLGLLSSVLIGVIFGFFPARNAANLNPISALSKE
>fig|195.2024.peg.1018 hypothetical protein
MKIVEFNFSNGEKIQAQIEESNEENFRAFLEKN
>fig|195.2024.peg.583 hypothetical protein
MKLKSLQIGHIKDYKGFRSAFIKDLYLEEVDIDFLGILNDNIADTKHHGGKNKALFANSY
HNYGLWENFLGKKLACGMMGENLTLENLHEQNVCIGDIHRFENAILQVSEPRKPCVKISK
VHQNPNFTQEIFKTGLSGWYYRVLEGKKIHAHSKIELIEKNPINLSVLELNHLFYNPHQA
LKQNPSLLEKLSKLDTLISQNWHETIQKRLKNTYNLDYMQNL
>fig|195.2024.peg.495 Uncharacterized protease HP_0169
MIIPEIVAPAGNFAKLKIALAYGADAVYAGVNNFSLRSRTAREFNYESFEEAIEYTHQRG
KKVYVTLNGFHLGGQIESLKKHILKLKEMKPDAFIVASVGAMALVRELAPEIALHVSTQA
NVLNYLDARVYKNMGAKRVVIARELSLKDAKSLKENCDIELEAFVHGSMCFAYSGRCLIS
SVQSGRMSNRGSCANDCRFNYELYAKNPENGVLFRLEEDENGTHVFNSKDLNLCSYIEKI
MKEDCISAFKIEGRTKSEYYVALTTRTYKMAIQDVLEGKFEASKYEKEIATLKNRGFTDG
YLVSRPLEKADTQNHDTSIEEGTHQVHAIVEDGEYFKCKGKVVLNKAYEILMPLGDEIET
CDNKLGKIYKKEDKYFVEFKKLISKNNKEFNEIHSGNENEIKMPNKISSFSFLRKEIG
>fig|195.2024.peg.406 Transamidase GatB domain protein
MNLKEQILNDIKEAMKQKDDFKRDTLRTLNAAFKQVEVDERIELSDERILKIIASEIKKR
KDAIELYSKGGREDLAQKEQKEIALFESYLPQQLSDEELQAALKEMIANLGVSSLKDQGL
VMKEAKAKFGARVDGKRLNVTLRELLN
>fig|195.2024.peg.619 Flagellar biosynthesis protein FliS
MQNNLAYNAYSQNQVGIESPQKLIEMLYEGILRFCARAKVAIRNEDIEQRVYFVKRTTAI
FIELINTLNYEKGGEVAHYLSGLYTREIQLLSLANLENNEDRINEVINVTKGLLEAWREV
HNNETVAQ
>fig|195.2024.peg.428 hypothetical protein
MTKTEFLEELKEAMHRDEDLNEDMLLDDIDEWDSLAFVSVMVLYKNLFALKITAEDLKNC
QKVSDLINLAKLD
>fig|195.2024.peg.1635 hypothetical protein
MTINSANPYQNLALSNPLQNSQALNLIKDKKGSNLEENENNLENLNYIFNTTSYASEFSF
RIDEKGFFEKDLNKIANIPESYNINIKSVRNIAKELTRQDATLNYNKIDLPYLLNSYYSS
LKSVNLEFSENDNANLSRDMISKFATGFSTENGEFLGKISRIYNNQEELNSALNKTLSLN
TLMLDNKITNFHFDRALNNTSSNEILKPYLTKNAEVSKSGLLMNFIYHDIKTQNDNELNF
FMKPASLDLNAHTNFQKILRGEMDIKDYIKQQNEQKMSFDLYLYVNGVDKKTASQDKLSV
FFQQYVNYQKDMDLREFANSSSIFQIYIDENHSEFNSLKEEYQSQNKDLEKLDNANNMRS
SSIENFLDRRQKQANLNKILNSYLSVLL
>fig|195.2024.peg.643 Cell division protein FtsI [Peptidoglycan synthetase] (EC 2.4.1.129)
MQEHKKNRVSKVAFAYCMALFFMIIFLSSTFFLTSKRHIPNTEKDQYSLALRGNIITKDN
FTITSSRQIYRAEIDLRSINKDKFDLFLKLFQIYSGISDDEIADIKKRIQKQKKRSYHFI
LSQNLDSKQASYLRDLAKKLYIQGFFKAFTNNLGKVETRGLSIIEHEEDRIYMSKDALTP
AIGYTKMVLDPQSGILKNVGVKGLEKYYDDCLSPLQNEKIQGLKDIGGNIILNLNSLQQK
KIDGCLLYLNISLKLQKSIEKAIDGRNEDLKANEIIVGVMDSKTGQILALASSRRYDPQN
RGKDLSVLNASAIEYGYEAGSVIKPFIFTTALRLGKLKTDEVINTYGGAYKLGRFTIRDD
HKMDQMTMEEVIRYSSNIGMIQIAKRLSNLEIIAGLKIFKFGEKSGIDLPYEQKGEIPNS
KRLRDIEKSVLSYGYGLKTTFIQLLAAYNVFNNNGVYITPHLAEKFYQDGRFVSLEEDIK
KEVILTPQAAQTMQKILIDVIEKGTGKKAITQGIIVGGKTGTARIAERQGYTSNRYNASF
FGFANDTKHNYTIGVLVRNPTKPYSYYAAQSALPMFKDVIDILINEDFLTPIITENNQTL
N
>fig|195.2024.peg.366 FIG00470841: hypothetical protein
MILAFFFLIFLCACGYKGNPQYTSYEQNGSIKSIKKYEQLNRW
>fig|195.2024.peg.1409 Diaminohydroxyphosphoribosylaminopyrimidine deaminase (EC 3.5.4.26) / 5-amino-6-(5-phosphoribosylamino)uracil reductase (EC 1.1.1.193)
MKNFYMNLALNEAWKYQFLTYPNPAVGCVILDKNEKILAIKAHEKAGCAHAELNAIAHAF
TNLNPEISLPQEANAMHEFICKNHRGIFKDSIAFVTLEPCSHQGKTPPCAKLFSELGFKK
IFISVKDENEIASKGAEFLKKQGVEIEFGVLEDEGKKLLKPFLKWQKGQFKLFKLALSMN
GSPFGKIVSNELSRTYAHKIRSVIDLLVLGGETIRKDRPILDARLCKGKAPNLCILSHQN
LENFDKSIPLFSVPHRQIYTQIPNKAKFLMYEGGENFLKKFKDEMDMFLIFQSSSLNDEK
NVTMPLNFKPLYRNFLGSDTYGIYEL
>fig|195.2024.peg.1636 LSU ribosomal protein L35p
MPKMKSVKSAVKRFKVGKNKIKRGSAFRSHILTKKPAKRMRDLRTAKYVHSTNVKAVEKM
LGI
>fig|195.2024.peg.395 DNA poymerase III subunit delta' (EC 2.7.7.7)
MFVSKIIITDDFDGIRAELLKQFHPNSLRFIPKEVASEFLIDDAKAVEKESYIAETSEKI
IVLMANSFRIEAQNFLLKLLEEPPKNIKFLIVVPSKNLLLPTIKSRLICEKRNKIKAKNT
LNLELNKMDLKTLFEFLQENENLDKAELMEKIALIAEESVKFKDFNADELEFFYESYELA
KLNSKSSLILATLLLNYYTKNEK
>fig|195.2024.peg.294 Signal transduction protein CetB, mediates an energy taxis response
MHPIENLYSIIEEVYKILLEKEKKSGINAGVSALMDIVSSYKMTYNELIFNLQENN
>fig|195.2024.peg.1449 Na+/H+ antiporter NhaA type
MQAVKKIILSETFPGILLIFFTLLALLFKNSSLSVIYTDFFHANFTIGFDHFQIAKSLDL
WINDGLIAIFFLCIGLELKYEILRGQLKNIRSVSLPIFGALGGMIVPALIFSAINYSHEF
AMKGWAIPTATDIAFAVGILMLLGNRIPSSLKLFLLSLAIFDDLGAIVIIALFYTDQLSA
LAIIICLFCIFALLLLNYYHITHLSLYVLVGVVLWIAMLKSGVHATLAGVIIALFIPLDT
KNKKPYLHEVHKDLNPWVVYFILPLFAFANAGIDLRDMHLGSVFSPVSLGIILGLFLGKQ
LGVFGFCYLAIKLKLAKLPENIKYGKFYGICILTGIGFTMSLFIDGLAYKNSDIFEYADK
LAILVASFLSAIVGFIYLKIIK
>fig|195.2024.peg.655 hypothetical protein
MKHTHTHSPKHIKAISNRLSRTIGHLEAIKKMVERDEDCSDILIQLAAVKAAVNNTAKAI
LKEHLAHCMYHAVMEKDTQSIEDLNKAIDMFVK
>fig|195.2024.peg.1348 NADH-ubiquinone oxidoreductase chain E (EC 1.6.5.3)
MRRVDLRKSKELFEDLAQIIKEAKQGEVLVVLFEIGDFSPVEKSFSFVKEQGCELLNSLK
FNQVDWTIVIKKESV
>fig|195.2024.peg.383 Fructose-bisphosphate aldolase class II (EC 4.1.2.13)
MGLLDIVKAGVVSGDELNKVYEYAKAQGFAIPAVNVVGTDSINAVLEAAKKVNSPVIIQF
SNGGAKFYAGKNCPQGDVLGAISGAKHVHLLAKAYGIPVILHTDHAARKLLPWIDGLIEA
NAEYKKTHGQALFSSHMLDLSEEDLEDNLSTCETYLKKLDSLGISLELELGCTGGEEDGV
DNTGIDNSKLYTQPEDVALAYERLGKISDKFSIAASFGNVHGVYKPGNVSLQPEILKNSQ
KFVKEKFGLEVDKPINFVFHGGSGSELKDIKDAVSYGVVKMNIDTDTQWAFWDGVREYEA
KNREYLQGQIGNPEGEDKPNKKYYDPRVWLRSGEESMIKRLELAFEDLNCIGRN
>fig|195.2024.peg.296 Putative C4-dicarboxylate transport protein
METLSQTFAERKPPLYKRMFKSLGFWVIVGIVAGIVLGYVNKEMAIASKPGVDYFISALK
VLIGPIIFVTLVLGIISLESLKKVGGIGAKAVIYFEVVSTLALALGIFMANIMQPGHGMN
LDPKQLDTTSVQKYISQTTEVSASSEIMHILQDAMPRDIITPFTEGKTMQVLVIAIITAL
IISLMRIEDRQAIQRVLEVIQNFVFKILQVIMYFSPVAAFSAMAVLIAQYGLGSLINLAY
LLLVMLVSCLIFIFGILGLICYFAKVNIFKFMRFISREVLIVFATSSSESALAPLMRKLE
KAGLSKATVGLVLPTGYSFNLDCTNIYLAMSLIFLAQAFNVNLSLAHEISILIVLMIASK
GAVGVTGSGFIVLGSTLAALGNMEISEANATLAQVLPVAAIGVLLGVDKFMSEMRAVGNL
CGNSVAALIVAIWDKQIDWGKFRYALDNPEKFHNAGMH
>fig|195.2024.peg.524 RNA polymerase sigma-54 factor RpoN
MLRQKTTQAPKTKISQTLRSWLPILQANIEDLKENLDKFAEENPFLSVQEPIQTHEHNKN
YFDSFYKRNANSAFVDNKGLATKSVYELLNEQIIPPLFPTSKSQELAGKIVECLNHEGYF
EYDEEILKDYDINELERIRARFKFLDPVGVGAKDYKEAFLFALENIELDAELYDFCKMLI
QDFENIQNYTKEPLYKEALAIFKRFSIPPFLEYFEDSRVIIPDIFVYRENNEIKVKINDD
YYPEISIETDGLTHEYLNHYIKEAKNLVDALMMRKATLYKIGLMIVEYQYDFFMGKDIKP
MTFKDLALDLERNASTISRAVANKYLSCDRGLIPLRDFFAFALDEEGETSNVGVKDFVAN
LVKNENRSKPLSDSKILELIKKEFKVDIGRRTITKYRKHLNIPSSTDRKKLYELEG
>fig|195.2024.peg.750 Integral membrane protein
MINKNKLFRQIHIYVSLFFLPCAVLFALTGIAYILRADQDTGLKVETYKLVKNIEPGKEK
DALIQYLQENNLKVPSDAEATQGKGKGANMGGMHHNANAAPANVKAGKGKNNELTIGGAH
YSANITPVAQNEYVITLKTRSLLGDMIMLHKDKGAWYFSVLSIGFGIALFLLYISGLIIT
LFASKKDRQKQLATLGAGVVITILLAYLSL
>fig|195.2024.peg.1220 Diaminopimelate decarboxylase (EC 4.1.1.20)
MDYKKLKDEFQTPFYIYDFDFIKERFLKLKNAFKARKSQIFYAVKANSNLSLLQMLVKLD
SGFDCVSIGEVKRALKAGAKSYKIIFSGVGKTQEELRLALEYDILYINLESEAEMMLLES
VAKELNLKARISIRVNPNVNAKTHPYISTGLNENKFGVEIDLARKMYLYAKNSPHLEPIG
VHFHIGSQLLDISPIHEAAAIVAKLVRELKALQIELKFFDIGGGLGVRYEKEDVEPDLYD
YAQGILAQLHGLDVTIGMEPGRFLVANSGEFVCSVLYEKHNKTKRFVIVDGAMNDLIRPS
LYEAYHEILLPYNQGEESPCDVVGGICESGDFFAKARSLPSTQSGDIMVIKNTGAYGFSM
SSNYNTRNKVCELALEEGQVRLIRQRENFEDQIALEEKFLKA
>fig|195.2024.peg.817 hypothetical protein
MNISVLLPMKGHSERVKNKNMKDFNGFPLYHAIVRTLLKSSYVNKIFINTDSDIIASDAK
KSFGDGIVIIKRPLEIQGDFVSMNDIIAYDLTQCDGGIFFTNA
>fig|195.2024.peg.181 Transformation system protein
MKVAFSLLELILCIIILGLIFTSISKLFYQLNDNHDYLNYFERLYTLQDKLYTDPHQRDI
KLHIQNLKTFDFKENFINDNIFQFKKLHIQNQDYSLYFYDE
>fig|195.2024.peg.191 Peptidase, M23/M37 family
MIKNKFTITITDINGSRHFYLNQIIKKIVLYVVAFIFLFLIFSGFYIKYLDSKLSDISTK
REELLAKSKELEFANAQMQKNVEEKAKQYAAIEDKIASFEEALGLEAENNLTITDRLDNL
KLTNEQQIGILGQIPNGWPIENKGVTGNFGWREHPLLKRREFHPGIDLRAAIGTPIYAPA
SGVVEFSGYSDNGYGYNVILLHNFGFKTVFAHMVRKDVVKAGQFVNKGQLIGYAGNTGLS
TGPHLHYEVRFINKTLEPLYFLNLERKNMNEFFNQERRIPWQSLIKAVTAQHLAPVPKQQ
>fig|195.2024.peg.171 hypothetical protein
MKIGLETESMYLWFQNGRMDIFSYIDFAEELGCDGIIINIIKDFGLDEEWGCLGSNDESH
LKKIKEKLDTYGMYCEIDSKGFDKDKFEKIAKVSQLLGVKIIRSYVPLTDKNKKVKNASD
GAYDDSKITAKFDKSEFLSTADEIKALIPLLEEYDLKLAIENHEYQTSDDLLELLNLIHH
PRIGFLYDFGNSMMAYEEPIKACENMAKHTFSTHCKDHIVFIEDDTKYVCGVPLGEGNLD
IKTCVEILKQAGLDRINVEQCYPYCATFKREEGAGGIKELGKGAFKIEKPLFNDLKAMQY
YYPQEVSKEHLERLLILQKEGCERSVKYLKSII
>fig|195.2024.peg.1063 hypothetical protein
MSILVNAVDTFYSTKNEAVFSASKSENIKRNVADFNTDNNTKNSVYFFSDDKEISLNLSN
ESMELLTNHFSANDFLKLSNGNIGLSGKAAAFVEGWYKDIMINRNFLNADRDKNGRIENN
EHLSLKNSVEDVAKNQDLSKNFGAVVLRMTQSTTGYVENTISDKSLSIEALIDESIKSDR
NFDGIITRLEYSAKGGTDMQGYTNWAIDALNDILDDSDKAKNSFSCRSYKQNLAFVCRQN
IK
>fig|195.2024.peg.397 Aspartokinase (EC 2.7.2.4)
MLIVQKYGGTSVGTLERIDAVAERVIKSAKEGHQLVVVVSAMSGVTNTLIEQAEYFSKNP
NGKDMDMLLSSGERVTSALLSIALNERGYPSLAFSGRKAGIITDSVSTKARISYIDTQAI
TKALNEGKIVVVAGFQGVDKEGDVTTLGRGGSDLSAVAVAGALKADLCEIYTDVDGVYTT
DPRIEPKAKKLDKISYEEMLELASLGAKVLQNRSVELAKKLNVKLVTRSSFNDNEGTMIT
KEDGMEQALVSGIALDRNQARVTLRNIEDKPGIAAEIFSVLADENINVDMIIQNVGVDGA
TNLGFTVPQNELDLAKNAMQKILGSKTTIESDSAVVKVSIVGVGMKSHSGVASKAFKALA
DEGINIGMISTSEIKISMIVHEKYGELAVRALHECYGLDK
>fig|195.2024.peg.1091 LSU ribosomal protein L14p (L23e)
MIQSFTRLAVADNSGAKELMCIKVLGGSKRRYATVGDVIVASVKKALPNGKVKKGQVVKA
VIVRTKKEIHRDNGSLIRFDENAAVILDNKREPIGTRIFGPVGREVRYGGFMKIVSLAPE
VL
>fig|195.2024.peg.594 tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase (EC 2.1.1.61) / FAD-dependent cmnm(5)s(2)U34 oxidoreductase
MKKANLIFKDNTPFSLDFDDFYFNSKDGLNESKFVYSEAFEFEENDTFIIAESGFGIGLN
FFLTLKRFLQAKKRPKKLFYTSIEGFYIEKDKLREIYQKLGFYEEFKEILEAFLKFYPKA
KKGYYRFYFKDCFLDLIFDDIAILRELDFNADVWFLDGFSPSKNSAMFDENFIAQVARLS
KTNTQICTFSASSALQKNLIKYGFEIQKTKGFRKREMIKAFLRKEYPTLDKEAYFQRIPS
LYKNKKVAIIGSGICGATLAYELSLRDFEVSVFEKNDSLGCGASGNESGILSSLILKPDV
ALGEFSQLAFIEASRFYKQILDLNLKGVIEFAHTPLMQERFISQKDNILFKIDKNEAFLE
DGGYIKPKEILKSLFEKSQAKMYFNHEYDFFQYQEDKFILHFKNQKAMQDFDILIYAMGA
DTKDFLVYDGMLLSKVRGQVTHLKPFLDNAFALSSKAYICPSDGDLQVIGASYDRLNSNP
NPQKADDEENLQNIQEFLKGDEEIIIKGSRVGFRSYSSDRFAIVGAAYDEAFYKQEYKAL
LWTKNKAQVLPQNIPNLYLNLAHGSRAFSTSVLAARYLCALINEEPLGVFKNFIPCIHPA
RFLIRKLKKGI
>fig|195.2024.peg.22 Bis-ABC ATPase Uup
MALIDLIDASKKFGEKIVLNEANFSANEGEKIAIIGKNGEGKSSLLKALLGTLALDSGRA
VRQNGKSIAMLSQTVDFNANLSVKEAIKIELEEIYNTLKEYEASQSKLEKEPTNKEYLKQ
MDDLIALIDSKDAWNIEAKITRVLKEFSLLDYSDRLVCTLSGGEIRRVGLCILLLKNPDI
LLLDEPTNHLDVYMTSFLEDLLKNSKMCVIFISHDRYFIDAIAHKCVEVDQGKLSVFKGG
YTNYLEKKTQILESLAKSHETLLKHLKSEEEWLRRGVKARLKRNEGRKERIFKMREEAKK
NPGAIKRLKLEISRAALNFTGEKIPNRKKMLFELKNVSKNLGEKALFADFSSRILQGERI
AIVGKNGCGKSTFLKMLLGELKQDSGEIKRGEIKIGYFDQARSLVNSDKTLLEIFCPNGG
DRVEVRGKNMHVYGYLKNFLFPKEFLDKSVSILSGGEKNRVALALLFTEEYDVLILDEPT
NDLDIATINILEEYLLSFEGAILLVSHDRYFVDKIATKLYAFENGAKINILHTLYTEYLE
NEKEMQEFDDYVSSLDLQEQTRMQKEKSSKKLSYKENEILKNHPEKIEMLEKQISKLNSD
LSNPSVYQEIGINTLYEELEQAQKELEKLESEYFEVLEKSENL
>fig|195.2024.peg.448 Similar to imidazole glycerol phosphate synthase amidotransferase subunit (LPS cluster)
MIALIDYKAGNLNSVAKAFEKIGAINFIAKNPKDLQKADKLLLPGVGSFKEAMKNLKELG
FIEALKEQVLVQKKPILGICLGMQLFLERGYEGGVCEGLGFIEGEVVKFEEDLNLKIPHM
GWNELEILKQDPLYQGIDNKSDFYFVHSFYVKCKDEFVSAKAQYGHKFVASLQKDHIFAT
QFHPEKSQNLGLKLLENFIRL
>fig|195.2024.peg.680 Uncharacterized MFS-type transporter
MGHLKLTKLELVCKKISWRILPLIVLMFCLSMLDRTNISFVKSHIEMDAGISETAYALGA
GIFFVGYALFEVPSNLLLHKLGAKIWLSRIMITWGLVTMAMIFIQGETSFYILRFFLGLT
EAGFSPGIILYLSYFFPAIYRSKAYGIYQMGVPIAFVFGSLISGFILDYASNMYFKNWQW
MFLIEGGITVLVGVFCLFYLDSHPKDAKWLDIKEKDILLKHIEISNTKAKDYSIKDIFKS
ILVWKFVFVYFCIQLSVYGVLFYLPSKIAQILQINVGFEVGLLNAIPWIFVFIALPIFTS
LADKKRSWNLYAILFLLLASLSMIASTFVANLAPFLFFISLAVIGFIVIQPIFWNLPTQV
LKGKGGAAAIALIGSLGNLGGFVAPTLKTYIENHFGVEFGLITLALIAVLGVLILVHLKM
TLN
>fig|195.2024.peg.1536 NAD synthetase (EC 6.3.1.5)
MDCEKISQTLCEFIQYKVKDSGLNGVVLGLSGGIDSALVATLCKKALGENVFALLMPTKF
SNQENLNDALKLCQELNLKYKIIEIQDILEAFLKQSENTDELSRGNFAARIRMSLLYDYS
ALKKALVVGTSNKSELLLGYGTIYGDLAYAFNPIGELYKSEIYGLARYLNLNEKFIQKAP
SADLWIGQSDEKDLGFSYELIDKGLKALENQDMKALENLDKKLLDMLQSRIKNNAFKRNM
PEIASLNK
>fig|195.2024.peg.252 Galactoside O-acetyltransferase( EC:2.3.1.79 )
MKIIIKNLQKLRVLYYKKFLSNVSIKSKCKIRSATLFYSINGGKIDIHDTVSFGFFPSPY
FYTCYNHIDIREGGNIIIKENTIINNNFILCAFRNNINIGKNCLIGVNFSALNADYHGIE
INNRNKIEKISSADISIGDDCFLGNNVTILKGVKLGKGCVVANSSVVTKSFDDNSLIAGN
PARLIRVIEQK
>fig|195.2024.peg.1664 hypothetical protein
MINGINSYSSYNYTNTFSNNATNIKSSNAINETSNLVSDKSQAVNKVLGYGVDKDGFFTS
DFNEKAGIPKDYKIYVDDVENLVKHIINSNSKFFTSIDIAKSVGNAYKVFSQLVDEPNGN
FTTEDLSKIPLGFSYDKKSFQVTNIFQTQKEFESALSANNNLQIYQNSEQLALSFPSSHI
DIKEIYKNDNGSINKGGVLMAFFASMSGQNPLIEGKTTIAGKLNGYDKNMSQSQIEDLNE
FTYSNNRVFILKNNANSIDDLFKHLLDYVNLQYQHTDINDYQQAVQEWIKNNTQETQTTQ
IQNDNTNNSKEDKEKPFKPIQAQSSSETYKEDNTRNELLRKLLETKFGKSDELEILFGMK
FKGDIGEFNKILSQIGLNSSESKSIDIKA
>fig|195.2024.peg.109 Membrane protein
MSHIFWVIICTSGALLLFLSLIAYLILSDNKKKNKKQKNTKNTAKARKFDNDLNKMIAAA
SDLKYSDRDLKELVKLFVQTHKLGSKISKELDEKTKNKLEFVSALAANPKASPQTVSFLN
QELKKISASYKKEIDAYEQMGLAKRKIKEEK
>fig|195.2024.peg.463 Phosphoserine phosphatase (EC 3.1.3.3)
MKLVLFDLDDTLIQGDSAKLWLKFCVEKGFLPQEYLEKIVFYQKQYQEKKLDMDEFMTFF
LQSVKGKNEDRISSLVDEFIKIYIKPYEKAKELIIKYQDQRCIIISATAEFLVRKIASFL
GVRESIAIKCERVGDKFSGKAYGIYSFKEGKVLRLKEYLSKDYEKWMKDSYFFSDSINDL
PLLESVSKAFVCNGDEKILKIAKERKYEILTF
>fig|195.2024.peg.331 Two-component system response regulator DccR
MAARILLLEDDLSLSEIIEEFLIDEGYEVYLCTNAKEALELAYEKHFDLWILDVKVPLGD
GFSLLKELRACGKQTPAIFMTSLNTTEDLKEGYNAGCDDYIRKPFELAELSIRIQVLLKR
AFSHKNEDYEDLGNGFKFSFTSQILYHFDKALTLPSKEIKLLSLLLKNKNNFLSTERIFE
ELWEYDEEPSELSLRAYIKNLRKILGKEKIINQRGRGYCYG
>fig|195.2024.peg.309 DNA repair protein RadA
MAKNKILFECQACGNQQSKWLGKCPECGSWDSFIELKSEQIKVLKEIAQASTKASEAICI
EDVELEHFSRCSTDDDELDLVLGGGLVEGSLVLIGGSPGVGKSTLLLKIASNLAKKNKKV
LYVSGEESKAQIKLRADRLEANTPNLFLLTELCLENILEELHKKNYEILIIDSIQTLYSN
KIASAAGSITQVREITFELMRVSKTYNISTFIIGHITKEGAIAGPRVLEHMVDVVLYFEG
DATKEIRLLRGFKNRFGGTSEVGIFEMTPKGLISAKDLANRFFTRGKATSGSALGVVMEG
SRALVLEVQALVCESSYPKRSATGYEKNRLDMLLALLERKLEIPLGHYDVFVNISGGVRV
NETAADLAVVAAIISSFKNRPLSKDCVFIGELSLNGEIREVFSLDTRLKEAKMQKFKNAI
IPSKPLEDVGLKCFVAKELAQVLEWM
>fig|195.2024.peg.1378 LSU ribosomal protein L17p
MRHKHGYRKLGRTSSHRAALLKNLTIALVNSGKIETTLPKAKELRGYVERLITRARLGDF
NAHRAVFAALQDKNATNKLVTEIAPNFKERNGGYTRIIKTRIRRGDAAEMAFIEFVA
>fig|195.2024.peg.1538 Small hydrophobic protein
MNLDFVLLCFFVFLDAFALLGLLLGNKKKNQFNDKKFYKICPCKQMAENGSLSTICIYSA
VGGFFYSVLSIGYIGFGDLFLNLIFLFTLLSAYMGWKLKLD
>fig|195.2024.peg.1099 LSU ribosomal protein L23p (L23Ae)
MADITDIKTILYTEKSLNLQEQGVVVIQTSPKMTKTGLKAVLKEYFGVTPQSINSLRMDG
KVKRFRGRLGQRNDYKKFYVKLPEGVSLESMEA
>fig|195.2024.peg.1070 RecA protein
MDDNKKKSLDAALKSLDKAFGKGTILRLGDKEVEQIDSIGTGSVGLDLALGIGGIPKGRI
IEIYGPESSGKTTLTLHIIAECQKAGGVCAFIDAEHALDVKYAKNLGVNTDDLYVSQPDF
GEQALEIVETIARSGAVDLIVVDSVAALTPKAEIEGDMGDQHVGLQARLMSQALRKLTGI
VHKMNTTVIFINQIRMKIGAMGYGTPETTTGGNALKFYASVRLDVRKVATLKQNEEPIGN
RVKVKVVKNKVAPPFRQAEFDVMFGEGLSREGELIDYGVKLDIVDKSGAWFSYKDKKLGQ
GRENSKAFLKENPEIADEITKAIQNSMGIEGMISGSEDDEGEE
>fig|195.2024.peg.1339 NADH-ubiquinone oxidoreductase chain N (EC 1.6.5.3)
MLGNIDLSSLNIPLSYPFAFLIAVAIVLLLCSGFWKFHRTFYMATSSLSLIVSVFLILNN
IAAQGLEAKGFLGTLNNDIVSLYASLVILCFSFLYLLMQKEENQGEFYSLFLFMVAGLLL
MVSSSNLILIFIGLESSSLALYTLIAMRGSNNAISSAIKYFSVAAVGSGFFVMASALIYI
RTGTLDLGLKLALDKDPMLLGAGVMIFVLCAIKLSLAPFHFWLKDVYSSAHVNLVAFISV
VPKIAMFVVVIRLFSFLNHLGFENILNVLAVFSMLVAALAALSQKDVKKMFAHSSIVHSS
FVLAACIPLLNAADDVLNSIFVYWVLFGFANYGVFLILSTFKGSSFEEFNALLFKKPLIA
LSLSFCILSLAGIPPFGAFWGKVMVLKTLIVADYWYLALFMALASLIMLYAYLKLVIHAL
FVKTQAKVSEHLNFIQSFILALCTLISVFALFLLLKI
>fig|195.2024.peg.1503 Molybdopterin-guanine dinucleotide biosynthesis protein MobB
MKKSIIAFSGPSNSGKTTLITKIANEFIKQNLKVLIIKHDPADKAQFDVNGKDSFKFFQS
GAEVMVLSPTRTTFFSHEKRDILSALKIAPDFDLCLVEGLKTLDLPRISVFYKEIDESYF
AFSNAIASYEKIDSYPNLTWLDLNDVQRICNYILKNAKNLQGEL
>fig|195.2024.peg.301 Aspartyl-tRNA(Asn) amidotransferase subunit B (EC 6.3.5.6) @ Glutamyl-tRNA(Gln) amidotransferase subunit B (EC 6.3.5.7)
MFEVVIGLEVHTQLNTKTKIFCSCATSFGEAPNTNVCPTCLALPGALPVLNEEAVKKAIA
FGKAVNATINKKSVFNRKNYFYPDLPKAYQISQFDIPIVEKGELFININGENKRIGITRA
HLEEDAGKNIHENNYSKVDLNRAGTPLLEIVSEPELRSSDEAVAYLKKLHSIIRFLDISD
ANMQEGSFRCDANVSIRPKGDTKLYTRVEIKNLNSFRFIQKAIEYEVKRQSEAWEDGTYE
QEVVQETRLFDTTNLVTRSMRGKEEAAEYRYFPDPDLLPVLLKDEFLDTQIPELPDEKKM
RYINELGIKESDAEVLIGSLELSRFFESLIALNLNPKLCVNWLNTELMGLLKGELTIENS
PVDAIKLGTLIKRIEEGVISAKAAKDVLAHVFENPDMDIDETIEKLGLKQVSDDSAIEAV
IEQILNANADKVAEYKSGKDKLFGFFVGQTMKEGKGAFNPNKVNEILKAKLG
>fig|195.2024.peg.752 Cytochrome c nitrite reductase, small subunit NrfH
MKKSLNLFGIFLVLLFVFFAVGFYTFYNAKGTSYLSNASESCNNCHIMNEVYNEYMAGPH
AQKVKGEARATCVDCHLPHGFLAKWIAKAESGLNHAYAFTFKLDELPTNLSATEKSRNMI
QDNCVRCHADFAQTAINATTNPHADKSLKCASCHQDVGHKHGI
>fig|195.2024.peg.1485 hypothetical protein
MKITMIILSLFSLVFLSACAFKEKKASEIETLASNYGGIYIFDKKIREEILELEKKREEF
RSKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFA
YYEDQF
>fig|195.2024.peg.1282 putative lipoprotein
MLRKIFIFFLILFFSACALKNQDYSSQKMKVVFSTPTIKINDFGFLKKENKALNLEVYKL
GQAFFKLKIREDICLNSVCYSKMVFNQKFFKNAYYEDILKDILEAKPLWNGKNMQKTQCG
FNQNLNSANYEIFYEVCDNKISFVDRISRIKIVLMNFKDKI
>fig|195.2024.peg.1505 Uncharacterized protein HP1384
MSEIRDEFEQDLDKKKEILSSCQSSKGLKSCYNCDEIFNCSTRKDYVDAVYNSMSKGKTE
GGFDF
>fig|195.2024.peg.1442 ABC transporter, substrate-binding protein (cluster 9, phospholipid)
MENKANYFFVGLFVFGVFFASIGFMLWLGRYSKEESFEYYEIHTQESVAGLGIKAPVRLL
GVEIGNVENISIYDKENLGVNILIKIKKGTPIKEDTFATLQFQGITGLKFVQLQGGSKNS
PKLQVKGKEEFPVIQFKEGFFAAIDRQSEHIFSLIKRADDKSKELFSDKNIKNLEILLDN
LAQLSTTLNKDSKTLNHNIANTSLKLGEMAENVSLSAKGFNASLKDIQEGALALSSFAKK
ANVKLDSYDDLRLSLAENLELLKKVLIESNILIQNLQKSPSDLIFKETKPKLGPGEKQ
>fig|195.2024.peg.1078 NA+/H+ antiporter (napA), putative
MHPSVIDSQGLIDLQILIVIALCLLFSPHIAKILRLPISATEIILGAFMAYFGFIGKSEN
FTILANVGFYYLMFIAGMEVNLRAFFNMDKEIAKKSFFYIILLYSFSSAIVWVFELSFVF
VLIIPVMSVGLLSLLYKDFGKECYWLNTAMIVATLAEVVSIVLLTIAGAFLREGTNIIDV
VQSILYLNIFLGLCLLGFKVLGVLFWWYPQLKVVLMPWEDKNEKDIRFCMAIFILIIVAM
IITKLEIVLGSFIAGSFIATFFDHKKDLEHKLSSFGHGFLIPIFFIHIGTTFDLKMILEY
EIVFDAILLMFVMVGLRILCASVFWKKIGFQNMVLFGLSHSMPLTLLIATATLGYSGKVI
SEELYSALILTALFEAIVVMSAIKFISNIKK
>fig|195.2024.peg.1336 methyl-accepting chemotaxis protein, putative
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNF
>fig|195.2024.peg.1460 LSU ribosomal protein L27p
MAHKKGQGSTQNNRDSIGRRLGVKKFGGEFVRAGNIIIRQRGTATHAGNNVGIGKDHTIF
ALIDGFVKFERKDKDRKKVSVYPA
>fig|195.2024.peg.1214 Dethiobiotin synthase BioD (EC 6.3.3.3)
MQIYVSGIHTDVGKTHFSAAFCANFNYDYFKLIQAGTPTDSEFIAKFSPKTKIFKEGIFL
QTPASPHLGKIKEKLDYKSLDIILPKSKNLLIELAGGLFSPMDENYTMIDFVNIFKHPTI
LVAKYYLGSINHILLSIEALKQRNINLLALVMMGKKDILQDDFIKNYAKIPIINLDFFDE
NSILNKDFKEQIQEILQLKIP
>fig|195.2024.peg.924 Tungstate ABC transporter, permease protein
MDYILEGFTQALFLLFNADESVISAIKTTLFSSSISIVLSLIVGFPLGFALGFFEFKLKR
FIKLIVDTSLSFPTVAVGLILYALISSRGPLGDLGLLFTVKALILGQFVLALPIVIALFS
NLIENMNKKHFLLIKSLHLSTLKLVMTIIYELRFALVSVVALAYGRIVAEVGVAMIVGGN
IKYDTRTITTAISLETNKGEFASGIALALVLIFIAFILNFIIHKLKRY
>fig|195.2024.peg.729 Thiaminase II (EC 3.5.99.2) involved in salvage of thiamin pyrimidine moiety, TenA subgroup with Cys in active site
MLFSRLIETNSHIWDEYLHHEFVKKLENGSLKEENFLFYLKQDYIYLIHYAKCHARLALN
AKNAEELRFAMKFQNYIIEGEIELHKSILKLGINADKLNVKDESLTNIAYTRYMLSVGES
GDFLDMLVALSACAIGYGYIGAEIYKRLGKEKLQNHPYKEWILTYSSDEFQSEIKEFEDF
LNSYTQQISQEKFENLSEIFYNVVRLENAFWEHALQMKMDI
>fig|195.2024.peg.81 putative membrane protein
MQYFFVFLIIIFLFIVFMLIMRYEKKLELLNQSIQNIKEEVNELKNTTQNNRSLIEKNRS
DIESINK
>fig|195.2024.peg.396 hypothetical protein
MSDFLSFTLENIRNGGTFMAWMESRRLEWAPLMAARLRYLLEGRTFVLMCDEQRAWYEEY
FLANINSKTTRPMLPFVSLKSLCKKKIQNIEDIALLNDLLDISFPNGFIYFYIGSASDKK
SLIAKSRDDSLLWLFDEQLQDSFYLNSKDKDLDVKLITLYKLFDTSLDAILFSKVSL
>fig|195.2024.peg.772 Selenocysteine-specific translation elongation factor
MKSLLIGTAGHIDHGKTSLIKAINGFEGDSLKEEKERQITINLSFSNLNYKQKHLSFIDV
PGHKDLVKTMISGAFGFSACLFVVDINEGLKEQSIEHLEVLELLGVKDIILVLSKCDLCE
NPKEQEQKILNSLEFIPMKVFHTSIKDQESIERLKNYLLNLECKNANANLVFRYYIDRVF
SLKGIGTIVTGSLNEGKISLNEKIICLDNQKELVVKNIQNHESNFAEISAFNRVALSLNC
DYKELKKGYVLSKKGFFKGFKECDVLIKAKRLKNEKMLFCVGAKSIECKISILKELENNE
FFAHLEFEKNLFLCFNEKFILLQNNRVVGGGEVLNPVSEPLKKEQKNKFLMLLKNKELKK
AFEFLKNTHKYGFGLLSSYQRFKLSHEEALNLAKELNGVFIDEKNLNIYNLLALDELKKF
ISFILEKNPYAMLSASSLALRLPWASAEFCEFGLQNLSNLLEFEKGVYFKKGINYEKLRE
KNNDELYNILKKQGIKPQAPYNLYEFLELDRKSGDEILKKLTKQNRVIRLSHNLFVEKNA
LDKLMQECLEILKSQSLDIQSMKERFNLSRKYAIAYLEYLDKDERVQKKDEKRFLKTNI
>fig|195.2024.peg.1067 Putative periplasmic protein
MKTKILGIFLIFISLLNAEENPFKSEQNMSMIMPPDFQKEDIKFNSNARVLKSVSFNYIN
LDGSEEVLNVDINKSIDWHDTYTLVRTKSPDPSKVFDVSVTIPERNDSKKESNGTANIEI
PLQVDKIYDFISYAVYKNKIKLNTSDELISDFSIGNPSKIVVDFKSDLVNPTKNIRISNS
LFKRIDFGSHKGYYRLVIYLDGNYNYNIQKDATGYMINLL
>fig|195.2024.peg.1436 Nucleoid-associated protein YaaK
MFENMDFSKMGELLNQVQEKAKNIELELANREFSAKSGAGLVKVSANGKGEIIDVSIDGS
LLEDKESLQILLISAINDVLAMVAQNRSSLASDVLGGFGKL
>fig|195.2024.peg.786 MmgE/PrpD family protein, putative
MLYSEILADFIFNLKYENIPNTVVQRAKELMLDSLGTAIAASKEECVLNAFKAFENLSTE
KNTLIWVNDQKLDPIYAAMLDGIASHALDFDDTHTEAILHASAILTPLCLSYGFHVSKDA
KKIIKAFIVGWEIAARVGIASKGTFHKRGFHTTAIAGIFGSVSASAILLDLNKEQIINAL
GLAGSFASGINEFLSNGSNSKVLHIANAIKNGIIVAHFAKNHMSGPLSIFEGRDNIFKCF
GIEEECDKTELNKALGEIWQTMQVSIKPYPSCHFAHGLIDCAIALKNDGLKADEIKSIHC
FVDEVPISFICDPLEAKYTPNSAYEAKFSMPFLMALGFFDGKITLESYENLKREEVLEFA
KKIRYEKRKSQGFPKYFPGHLEASLQDGRTIQKDVFINKGNFDNPLSFEELKAKFLANAQ
IYLDNAKANKILDQIINLENLNHFSF
>fig|195.2024.peg.1113 3-isopropylmalate dehydratase large subunit (EC 4.2.1.33)
MAKTLYEKVFDSHVVYQKENELPILYIDRHLIHEVTSPQAFSGLKMANRKMARSDLTLAT
IDHDVSTKSTDLDACSGMAKEQITTLMQNTKEFGVRLLGLGDKNQGIVHIVSPELGFTLP
GVTLVCGDSHTATHGAFGALAFGIGTSEVEHVMATQTLKQAKLKTMKIECKGQFQKGVYA
KDLILYLISKYGTAKGTGYAIEFCGELIEGLSMEARMTLCNMAIEFGAKVGMIAPDEITF
EYIKGKEFAPKGEEFEKHCEYWRSLKSDEGAQYDESIVLDASQIQPQISYGTNPSQVIAI
NERIPKVSDFINPSDQKSLLDALDYVNLEQDQSLEGVKIDIVFIGSCTNGRLEDLKIAAD
ILKGRKIHKDVKALIVPGSMQVRKEAENLGLDKIFIEAGCEWRYAGCSMCLGMNDDKASA
GQRVASTSNRNFVGRQGKGSITHLMSPASAAACAIEGIICDNRKYLGV
>fig|195.2024.peg.235 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-undecaprenol alpha- 1,4-N-acetyl-D-galactosaminyltransferase (EC 2.4.1.292)
MKITFIIATLNSGGAERVLATLANALCTQHEVSIIKFHVGDSFYKLEENIKLITLEQFRF
DTLYHKIASRFKKYLALRKALKENESDVFISFLDTTNIACIFAKIGLKTPLIISEHSNEA
YLKSKIWRFLRRLSYPFCDALTVLGSSDKIYYEKFVKRVKLLPNPCHFSTEISLNEHFEK
ENLVLFIGRLDQNKNPQMFLKAIVHLDKKLQEDYEFVVAGDGELRQELEYKAKSLGIRVK
FLGRVENVKALYEKAKVLCLCSFVEGLPTVLIESLYFEVCRISTSYYNGAKDLINDNKDG
FLVGCDDEIALARKLELVLKDEQLRKNIVINAKKRCEDFEISHIKKQWLELIDEVKNA
>fig|195.2024.peg.1703 Phosphoribosylformylglycinamidine synthase, synthetase subunit (EC 6.3.5.3)
MDKETIKAHKISDEEYEQILEILGREPNLLELGVISAMWSEHCSYKSSKKYLNGFPTKAP
WVIQGPGENAGVIDIGQGMAAVFKVESHNHPSFIEPFAGAATGVGGILRDVFTMGARVVA
GLNSLKFGDIHDGKCGKHQKYLVKGVVSGISHYGNCMGVPTIGGECAFDECFNGNILVNA
FALGICKSEDIFYAKAEGIGNPVIYVGSKTGRDGLGGAVMASDSFNEESKSLRPTVQIGD
PFSEKLLMEACLELFKTDYIVGIQDMGAAGLTSSSFEMAGRSGSGMKLYLDQTPMRESGM
TPYELMLSESQERMLICAKKGYEDKVIEIFKKWNLDAVVMGEVTDTGKMELFWHDELVGL
IPIDPLSEKAPILDRPVSKPKYLNEIKDYNFTLKMSQQELFEKMLKNENINNKAFIYDQF
DSSVQTNTIKADGALGASVIRIKENGASVAMAIECNSRLNYVNPKIGAALAVASAGRKVA
CTGAKPLAISDCLNYGNPQNPEVMWQFAQGCEGIKEACKELNTPVVSGNVSLYNETEGVS
IFPSPTIVNVGVLEDANKTLKANFEKENTIVYLLGESFGEFAASMAMKIQDKKVAGSLKE
LDYKAELALWNLLYKANQNSLLECANSVGIGGIAMTLAKMFAISSMGANLNSGFSDEKMI
FDESASRAIVGLDKENEEAFLKLAHELGVKATKLGFSTKEQSFKLDSINLSKDELNKLYF
DSFKEQIQ
>fig|195.2024.peg.1035 tRNA-dihydrouridine synthase DusB
MIDFSKKPLFLAPMAGFSDLPFRNVVKKFGADITISEMISSNALVYESSKTLHMLERAEL
ENPYIVQIAGGDKEVLKKAVQMLNEMDFVDGIDFNCGCPVNKVVKQCAGSALLENLELFK
SLVGVIKENNKKSLTSVKFRLGFNEKYPEKMAKICESLGVDFVSIHGRTRKQLYSGKADY
ESIANAKASVKIPVIANGDINAQNAKEVYEITKCDGLMIGRASVGNPWIFYEIKSGKNVD
EKLKKEIILTHFDEMIKHYKDQGVSIFRKHLHEYSKGHKDASAFRDSVNRIDNVEEMRKK
IEEFFSLT
>fig|195.2024.peg.488 Uncharacterized RNA pseudouridine synthase HP0956
MQEKAYKLLALQENISNREAKDLIDKGCVFSHGKKVVVARALMSDKTKFSIVKTSKPKVI
FEDENIIAINKPYAYISEELEKKINAKLLNRLDKETSGVILLCKNEDFRKICIEEFKKQR
VYKSYIAVLDGILAEEIEIDEPILTIKTKNGALSKISKEGLSAVSIFTPIMMQAKKTLAK
IIIKTGRTHQIRVHAKFIKHGIIGDEKYAKISSDRMYLHSHEIRILNYQFKAELDSSFSK
LGFEIKNLDF
>fig|195.2024.peg.361 Uroporphyrinogen III decarboxylase (EC 4.1.1.37)
MIFIDACFKKPTPYTPVWMMRQAGRYLPEYMKVRQEAGDFLSLCKDYKRASEVSLQPVDI
LGVDAAIIFSDILVVPLEMGMNLRFEKGEGPVFQTPISTLEDLNKLDDQNAYKKLNYVYD
ALKLAREKLPLDKALIGFCGSPWTIATYMIEGSGSKNYAKCKKMLYQNPELLHEILNKLT
QVLKLYLEEQIKAGANAIQIFDSWASALEYDKFFEFSFNYMLEISNFIKGKYPNIPVILF
PKGISGYLDRIDGNFDVFGVDWSTPLDLARDKLSHKYTLQGNMEPCRLYDKNAIKEGVEK
ILKTMQNKAHIFNLGHGILPDIPVENAKYFIQLVQESSAK
>fig|195.2024.peg.133 hypothetical protein
MDFFDSLKSIKKEMQTHSKEQKSPKNSNKKDMNHFNKETKTQRQETILDKEMQEVFLKQE
KLQDEFLEFIKNADIKKI
>fig|195.2024.peg.879 Cytochrome c oxidase (cbb3-type) subunit CcoN (EC 1.9.3.1)
MHPGNALNYDYTVAKYFMFATILFGIVGMAIGTLIAFQMAYPNLNYLAGEYATFSRLRPL
HTSGVIFGFMLSGIWATWYYIGQRVLKVSMAESKFLMAIGKLHFWLYMITMIVAVISLFA
GVSTSKEYAELEWPLDILVVLIWVLWGVSIFGLIGIRREKTLYISLWYYIATFLGIAMLY
LFNNMAVPTYFVAEMGKWWHSVSMYAGTNDALVQWWYGHNAVAFVFTVGIIAQIYYFLPK
ESGQPIFSYKLSLFAFWGLMFVYLWAGGHHLIYSTVPDWMQTMGSVFSVVLILPSWGSAI
NILLTMKGEWSQLRESPLIKFMILASTFYMFSTLEGPILSIKSVNALAHFTDWIPGHVHD
GTLGWVGFMTMAALYHMTPRIFRRELYSKSLMEAQFWIQTTGIVLYFASMWIAGITQGMM
WRATDEYGNLLYSFIDTVVAIIPYYWIRAIGGLLYLIGFFMFTYNIYKSIACGKVLDKEP
KSASPMAA
>fig|195.2024.peg.1392 Phosphatidylglycerophosphatase A (EC 3.1.3.27)
MQKLFLTFFYSGCAKKAPGTFGTLAALIPAFFILKYLGITTLFLLSILIFIASIRVIDNY
ERKTGIHDDKHIVIDEVAGVFLACAIAASGANSLLNFFMAFVFFRIFDITKPSIIGKIDK
KTKGGLGVMLDDMLAGLFAGLLSAVIYGFLLKFDLVFWDKDLINLF
>fig|195.2024.peg.759 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16)
MCGIVGYIGKNEKKHTILSGLKELEYRGYDSAGLAVMKNGELDFFKAVGKLENLANKCAN
FTSEEFGFAIGHTRWATHGKPTEINAHPHLGQYSCVIHNGIIENYKEIKNKLEDQGVSFL
SQTDTEVIVQLFEFYAEKMEVFEAWKKTIEELRGAFATLLVSKKDPTRVFFAKNAAPLIV
GKSQNNEFYFASADTPLIGLCDEVIYLEDLSLGYANEKELIIYENNQLKQNSFTKLSGDK
AYAKKDGFRFFMEKEIYEQSRVMSEVLMGRINGDEVVFDELENEDLSTVDEITLCACGTS
YHAAMASAYLFERLARVKAKVEIASEFRYREAIIKPNSLFIVISQSGETADTLEALKIAK
EQGAKTFAICNVDNSNIVRLAHLSLLTRAGIEKGVASTKAFATQVLTLWMLAIFIAQKKK
IDMSAQIKALLHTPNCVVVSAKLHEKIHRLSKRYLDGHGFFFIGRDVFYPLALEGALKLK
ELSYLHAEGYPAGEMKHGPIALADSKLYTIALMPKTLLYEKTKSNVEELIARDSTVLCVS
PLDFDLSDDFIKTNEQDHYMCEFFEMMVITQLLAMEISIRLGNDVDMPRNLAKSVTVE
>fig|195.2024.peg.574 Probable poly(beta-D-mannuronate) O-acetylase (EC 2.3.1.-)
MTYFSLEFSILMIVFFAIYWAFKDNYKIQNILILAFSYLIYILINPYFALILFIYTFFIH
FFALLIFVRRKRYIFATCITFIILNLCFFKYFPNIKGSLDQVLSFLGLDFLNIELILPIG
ISFYTFASITYLVDVYKKHHLESFLNLATFLSFFPTLLAGPIMRSAFFFEQAYQKREFKH
ANLIIILLIFGIVKKVLIANYLGIYAKNILDFPQSYNFIQLLSAIYAYAVQIYCDFSGYV
DLVCAFALMLGFTLPPNFNMPYLAKNLKEFWARWHISLSTFIRDYIYIPLGGNRKGMPRT
VANILIAFILSGLWHGSTLAFGVWGLLHGLGIVFIHLLALSKFSLQKIPALGRFLTFQFV
CFTWIFFYYNKNLEDALEYFKACYNNFFQIPSYNDIYMLVSFAVLFMIYPLFVNFREYCV
RILNLTPFLLKPFVITFILLLVFAFMPNGIPDFIYSSF
>fig|195.2024.peg.1138 hypothetical protein
MNLNAEQKNAVLRFKKFVSFRNKISLNLSLIVLICYYIFVLGIGLMPEILGYKLGPSSIT
LGIMVGIGLILLCIISTGIYTFIANYFLDKEQEEVIKSLENEGLLDALKDGKINYKELV
>fig|195.2024.peg.108 hypothetical protein
MQDASRKYLVVLHTMINYSVESYGLFGDEREVSSFTSVGHKGVDGG
>fig|195.2024.peg.534 FIG00638667: hypothetical protein
MNQIEQFLENLSSREKILIYLTTILLAILLSFHFYHSYLKSFFNHEFFIQSNDMDKIITT
NQDLNQQIKQLEKELVFIQDKIKSYENYLNVFNKNHETYIKNLQNLALENNLWISNIEWL
QSEENSYRKISLNIFGDFSPILSFMKQLENSDLHYQIHKFEIDNTTSLNLHLKLALSFIS
LAKLK
>fig|195.2024.peg.1114 3-isopropylmalate dehydrogenase (EC 1.1.1.85)
MNTYKIAVLPGDGIGPSVMKEALKILNFVAQKHGFKLETKEAKIGGASIDAYGVALSDET
LKLCEQSDAILFGSVGGPKWDNLPIDQRPERASLLPLRKHFNLFANLRPCKIYESLRHAS
PLKDEIIQKGVDILCVRELTGGIYFGKQELGKESAYDTEIYTKAEIERITRLAFESARIR
NKKVHLIDKANVLASSILWRDVVGQIAKEYEDIKLEYMYVDNAAMQIIKNPSTFDVMLCS
NLFGDILSDELAAISGSLGLLCSASLNDKGFGLYEPAGGSAPDIAHLNIANPIAQILSAA
LMLKYSFKEEKAARDIENAIAIALEREKMTKDLNANSYLSTDEMGDCIVEILKENNNG
>fig|195.2024.peg.19 Permease of the drug/metabolite transporter (DMT) superfamily
MGVFLVLLGGIFWAISGVLAEYLFKNNYGVDWVSFYRLFCTGIVLILYSLKKIKIFQFKK
DELLSFLIFAFFGLLMTQYGYFKAIFYTDAGTATMIQYCAPLLIMIYVCLKDKKMPKIFE
SMALIFIILALFLLASGGDISNLNLNLWGIFWAILGAFGVAFYSLGARKIIAKYGIFFVM
GWSSLIASFILFGILEFKEGLVHYDFALNLYLAQAGIIFIGTIGAFCLYLKGVEYIGALR
ASMIACIEPVAAAFMSFLFLGTRYSFLDLFAFALIILSVILNAKKS
>fig|195.2024.peg.418 UDP-N-acetylglucosamine 4,6-dehydratase (inverting) (EC 4.2.1.115)
MFNGKNILITGGTGSFGKTYTKVLLENYKPNKIIIYSRDELKQFEMASVFNAPCMRYFIG
DVRDKERLSVAMRDVDFVIHAAAMKHVPIAEYNPMECIKTNIHGAQNVIDACFENGVKKC
IALSTDKACNPINLYGATKLASDKLFVAANNIAGNKQTRFGVTRYGNVVGSRGSVVPFFK
KLIEQGAKELPITDTRMTRFWISLEDGVKFVLSNFARMHGGEIFIPKIPSMKITDLAHAL
APHLSHKIIGIRAGEKLHEIMISSDDSHLTYEFENYYAISPSIKLVDKDNDFSINALGEK
GQKVKDGFSYSSDNNPLWASEKELLEIINHTEGF
>fig|195.2024.peg.1121 Homoserine O-succinyltransferase (EC 2.3.1.46)
MPLIIPENIPAYELLKEHAFIMGSRRAKHQDIRPQEILIINLMPKKIETENQILSLLANS
PLQVNITLLATTSYVGKNTPFTHLEKFYKGLDEVKKRKFDGAIVTGAPVEQMDFEKVAYW
KELLEIFDFLQQNVTSSMYICWGAMAALKHFHGVDKIALDKKIFGIYKHDKISPDLLLTN
LDEKVLMPHSRHSSMDEEQILALQKQGKLKVLLRNKKIGSALLRDEKNIFILGHLEYFKD
TLHQEYVRDNFIQKAKNYYDKKGNIKYNWRSNANTIFANWLNYDVYQSTPFVL
>fig|195.2024.peg.312 FIG00710175: hypothetical protein
MCILCGEMISTLHWSELNFKEEKHELSVGEEQKERLRIRLKKVKILNEILEFYGLKLKEW
QNSKYILSNKKGRDIIVNDLGDLWIKASELEKKSFDVLDENLLHFLRAKHG
>fig|195.2024.peg.641 Flagellar basal-body rod protein FlgC
MAYLSDFDISGYGLSAQRFRMNVISSNIANANTTRTAEGGPYRRREVIFKATDFDKLLNE
QINKDNNFLKYENPLNDPSSPEEAKPAIQSVVVDKVVRDDKDFRMKYDPSHPDANAQGYV
AYPNVNPVIEMADLIEATRAYQANVSAFTSAKTIAQSAIDLLRG
>fig|195.2024.peg.1490 Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9) / Methylenetetrahydrofolate dehydrogenase (NADP+) (EC 1.5.1.5)
MTLLDGKALSAKIKQELKEKNKMLKENGVETCLAVILVGNDPASQTYVNSKAKACEECDI
KSLVYRLDENTTQNELLALINTLNHDDSVHGILVQLPLPKHISKDLILESIISSKDVDGF
HPINVGYLNLGLESGFLPCTPLGVMKLLKAYDINLEGLDSVVIGASNIVGRPMATMLLNA
GCTVSICHIKTKDLSAYTQKADLIIVAVGCVNLLRADMVKEGAIIIDVGINRLENGKIVG
DVDFEEVSKKASFITPVPGGVGPMTIAMLLENTVKSAKNSLKSGI
>fig|195.2024.peg.1568 Thiol peroxidase, Tpx-type (EC 1.11.1.15)
MSSVNFKGNPVKLKGNSVEVGADAPKVGLKAKDLSTIEIGAAGKTQIVLSLPSLDTPVCA
TEAREFNKKVASYNGAEVVVVSMDLPFAMGRFCSTEGIENLSVASDFVAKEFGEKYGVLI
GEGPLEGLLARAVFVIKDGKIAYKELVSEVTEMPDIAKLDAFFGGSSCCGGCGCH
>fig|195.2024.peg.337 Putative periplasmic protein
MNKSQLNQLLGRISKNPKTLNYKKIPQLQQENLRVVPLTLSLDNKGKVIYGEIQSD
>fig|195.2024.peg.348 HspR, transcriptional repressor of DnaK operon
MEHHYNEPVYLISVVAKVLSIHPQTLRQYEREGLIEPSRTDGKIRLYSQRDIDRIKLILR
LTRDMGVNLAGVDVILKLKNQLHEFENLIDELRLELSKQQNPNASSKAVVKHKNSFDLIF
YEKK
>fig|195.2024.peg.1120 Putative periplasmic protein
MRKSIAIIGGSIAGLSAALFFASAKNEELDFDITVFDEGKADLKAAAIYNVPFFPKGAKA
DEIYTHIKEQIASMLEVKYIDSKVVSISGEKGDFTVNDEQGLGIKADYIIVATGASKSEI
KGLEDFVIPHELMPKPNKFCFKHHGRQIIKEGIYAAGLASGVTTMVACAMGSANEAACAI
LSDIKGAVSVYHDTPTTRN
>fig|195.2024.peg.1299 hypothetical protein
MQINTFSNVASMAQAQVSNKKADGNATENTKDTNVQSANSNQDILDKLNALGGKGISQIY
LVQFQQQTMSTVLNTSNAQAGINDLLGGNDLNSVKSMLSDIDFASLGYNGKNPLTMNTDE
LNQLISEEGFFGIDNTANRIADFVIKGAGNDVEKLKKGLEGIKQGFEQAEKIWGGELPQI
SQDTIEATIKKVSDRIDELGGKTLDLKA
>fig|195.2024.peg.297 Putative periplasmic protein
MKSILYMLILFFSLLNADELDNALKNNQNKWQKFNYQATQKAPTIKEENIDFKSALNGIL
SNVLENKNGIDKTDGNLDFQNENVQIKNLNSLYEGENNSLLFQKEFYATQDSYNYSGGLI
NRYEKDDFLLGINGFIDGQKEQKESKSFGAELGYYQFVKAYSNYYVPNEADENLQFGVSF
TIPSYSAFIFDISKDSEKINYQVSYSPYSVLSLKILRRDFSANEAIDDTVLQVGFSFNFN
ESFVKQLRKKDNALQEVNRYDFLQRVR
>fig|195.2024.peg.1045 Cell division coordinator CpoB
MKKIFSVALIGATLLYAESSAFGAGDLTSNSPYGLTSSEKLLKEKLDTLSNNNVQANSRI
NEIEQRVEGLQSTLEGINSQYAKSNSRLTQLETRFEAMENNLSTELQNLKAYVEESRKIQ
DTNNKQIKKILTELSSLVDSINANYVSKDDLNSTNLSIKNTVVVPLSIDDKNITSSDENN
ASVAPVQEKEVKQIDDSWKKKKNNEILDLAIKDLNNNSYENSKIKLNYLISKQYKPARAN
FWLGEIEYKQKKYNNAIAYYKKSSALSTKGDYFPKLLYHTAISLDKIGDPKTANGFYKAL
KTNYPNSPEAKASPNRK
>fig|195.2024.peg.1104 Ribonuclease J (endonuclease and 5' exonuclease)
MNENNKGNSENTNNPNSNSKNNKRYKYRNRRKKLADSISENSQNSTHEFSNNEKINTKKN
STNSQPLEGENVEKPSEKKKKRNRNLPSKLTGNEDWQIALAECIEANRVSHENRLHPLKY
NNSSEHKIRITPLGGLGEIGGNISVFETNKDAIIVDIGMSFPDGTMHGVDIIIPDFDYVR
KIKDKIRGIVITHAHEDHIGAVPYFFKEFQFPIYATPLALGMISNKFEEHGLKAERKWFR
PVEKRRVYEIGEFDIEWIHITHSIIDASALAIKTKAGTIIHTGDFKIDQTPIDGYPTDLG
RLAHYGEEGVLCLLSDSTNSYKEGYTKSESSVGPTFDQIFARTKGRVIMSTFSSNIHRVY
QAITYGLKYGRKVCVIGRSMERNLYTTMELGYIKLDRKIFIDADEVSKYKDNEVLIVTTG
SQGETMSALYRMATDEHKFIKIKPSDQIIISAKAIPGNEASVSAVLDYLLKAGAKVAYQE
FSEIHVSGHASIEEQKLMLTLVKPKFFLPVHGEYNHINKHKETAIKCGIPEKNIYLMSDG
DQVELCQKYVKRIKTVKTGKVFVDNQINKQIADDVVIDRQKLADSGIVVIIAQLDKASKT
LINKPRVFSYGLVADKQDHAFSKEMAEVLGQFFVNVKDEVLNDPRFLENQIRQVLRKHIF
RKIKKYPTIVPTIFVM
>fig|195.2024.peg.1255 Phosphoribosylanthranilate isomerase (EC 5.3.1.24)
MTKLKICGIKDENNAKEIAELNVDFMGLIFAKSPRQLSLEQAMNLSDIIHAGFKKSVGVF
VDENLEFILKAIKQAKLDGVQIHRKISEFEFKTLKESGVFVWQVLSVGDRLELEENIYAD
LILFDTKGKFHGGNGESFNWDLLKDFKKDFALAGGIGTHNINEALSLKPKIIDLNSKIEK
ENHLKDVEKIKYILKEMRK
>fig|195.2024.peg.849 16S rRNA (guanine(966)-N(2))-methyltransferase (EC 2.1.1.171)
MNNEFISVKDFLQGKKNIHFNDSTQPNKKEKTKKTLPKLYTSIESGIYKGKKLLLPSLQT
TRSTKSIVKKCVFDVLRSDLRNKIFIEAFGGSALMAAEALSNYALKAYAIELDLNAYKIA
LENAKNIDTNLKVIHANTFEILPKLIEDSKEDIILYLDPPFDIREGFSGIYEKIYNFLEK
LKLDALFCIVLEHNSKIKTPDNIANFTKIKEKKFGSTSLSFYQKNILEE
>fig|195.2024.peg.1304 putative lipoprotein
MRQFFLISFCLIFLCACGTKRQYFEPSQTDGKLSSNDSLKSSIVDWNTISAKLKNNQVIL
KNDAIIEDFKLDKGYILLAYQEGEFIEADDNGNLKIYNSSHDEVYSYKFDAAVLGVALHG
DDLALVLANNSIVLANRSLGIKFSQNLTPAPAQDSRVANPIFLDNIIIYPTLDGKITIVS
KNTFEVVKDVVISAESFFNNVIHLDINDDKMIAATAKKVIVVSPARTLYLDADIKDIALD
SNALFILEKNGNIIKTDYNLRKITEKKFDFAIFTKVSIHNDHLYAFEKTGYLIKCDLNLE
NIQIFELPNAVEKISFMGNGKFYYGDKILDLL
>fig|195.2024.peg.440 FIG00470572: hypothetical protein
MTAYLHIGTTNTGNQEKQGFLMQNEERLLKKGYIYPKSLRVANRH
>fig|195.2024.peg.1581 Thymidylate kinase (EC 2.7.4.9)
MYVVFEGVDCVGKSTQISLLKECFKEAVFTAEPGGTKLGNHLRELLLYKPYQLDKKTELL
LFLADRAQHCEEILKANQDKLIISDRSFISGMAYAKDFENEELFRLNAFALENFFPQKVI
FLKGDENLIKERLSQKEQDAIEKRGIDYFLSVQDKLENTLYFLKEKINLQVLTLNANDTK
ENLHQKIKDFLQ
>fig|195.2024.peg.1115 2-isopropylmalate synthase (EC 2.3.3.13)
MKNNKIIIFDTTLRDGEQALGSSLNINQKLQIALALENLGVDVIEAGFPVSSQGDFEAVK
NIASKVKNSTICALSRALDKDIDTAYEALKVADSFRIHTFIATSTLHIQDKLKKDFDEIL
AMAQRAIARARNYTDDVEFSCEDAGRTPIDNLCFMVENAIKAGARTINIPDTVGYTLPSE
FANIIKILFNKVPNIDKAVISVHCHNDLGMATGNSLSAILQGARQIECTMNGLGERAGNC
ALEEVVMAIKTRSDYLKGFYTDIKCENISKTSKLVSAITNESIPSHKAIVGSNAFSHSSG
IHQDGVLKNRQTYEIISPSSIGLHENRMLMTARSGRAMIKTCLDNLGYDEKTYNLDEVYE
SFLRLADKKGQVYDYDLEALMFLSYENDEENELVLEKLSVISGTIPTACVCVRIKEELKT
EACTGNGPIEAVFNCISRITGLNPVLKAYSINAKSSGVDAQGQVDVDLEFKGRKFHGKGL
STDVIEASAQAFISAYNAIYRSLKVEERKAV
>fig|195.2024.peg.887 Adenylosuccinate synthetase (EC 6.3.4.4)
MSKADIIVGIQWGDEGKGKVVDKLCENYDYVCRSAGGHNAGHTIWVNGVRYALHLMPSGV
LHSRCINVIGNGVVVSPEVLIAEMAQFENLKGRLYISDRAHLNLKHHSLIDIAKEKLKGK
DAIGTTGKGIGPSYADKINRTGHRVGELLDPQRLHNALMKDFEANKNYLEFLGIEIPDSD
ELLSDLKRFNEILTPFITDTTRMLWKALDEDKKVLLEGAQGSMLDIDHGTYPYVTSSSTI
SAGALTGLGLNPKEAGNIIGIVKAYTTRVGNGAFPTEDKGEDGEKIAQIGKEIGVSTGRK
RRCGWFDAVAVRYTARLNGLDALSLMKLDVLDGFEKIKICRAYEYKGMEIDYIPSDLENV
KPIYEEMDGWDKVFGIKDYDLLPENAKKYIARLEELCGVKIKYISTSPERDDTIIL
>fig|195.2024.peg.1722 hypothetical protein
MTLNNDNYKEHLGLKPKGSIWYIKYIYKYILALDFKA
>fig|195.2024.peg.184 Uroporphyrinogen-III synthase (EC 4.2.1.75)
MKIYLLNETVFEGVENLVLNEIVFYDFGVNLDEFDALLCTSKNALKALKKTKNSLNLDIN
VYAVGQNTAQFAKDMGFKKVQFAPKSYGSELFNHFKEELKNQKCLYLRAENIASTLNLDL
RTYGVDLQEIIVYKNVFKKSKQTILHPAIFIFTSPLSVENFFKQYDLKKEDKVIAIGQST
AKKLTHLDNLFISSKQDLKECVKLAKSLI
>fig|195.2024.peg.271 Membrane protein
MQKPDIQSLTNFLIDYTKTLLSAGTYTARVAKCVGRIAQVYGYEININFFFHHITLNIVD
IEDNSIQRTYVIPNHHAHINFKLIFELSALSWAIYDHKYELEKAKSAFNAISIQKKHSYV
LNLLFVSIANSGFCRLFGGDFGAGVLVFFATFLGLLLRFALTKIKIDLRIQYILCSFVSS
WFVFLGLDMGYTNTSDAALGSSILYLIPGVFFINSIIDILKDHILMGLSRIISVAILICC
IALGIYMTLSISKFGILQ
>fig|195.2024.peg.390 FMN adenylyltransferase (EC 2.7.7.2) / Riboflavin kinase (EC 2.7.1.26)
MNIFTTTLKNNIKTLAIGCFDGVHLGHRKLIECLDDSGALLIIDKFKGKKLCTNQDKAFL
AQKEIIELDFENIKALDGKDFLQALKEEFVNLERIVVGFDFSFGKNRSYKAKDIEALSGI
KTTIIDEFKLDGVGVHASLIKEYLTQGDIKKANSFLGRNYAIKGKLIKGQGLGSKELFAT
LNLECEEYFLPKNGVYASIVSFHDKRYKSVSFVGVRSSDMQFAIESHIIEKFDESLAIGE
VLELEFVEFLRENQKFNDLAQLKEQISKDINQAKECLG
>fig|195.2024.peg.1199 5'-nucleotidase SurE (EC 3.1.3.5)
MKEILITNDDGFESEGLKKLIKMLKKEFKAKITIVAPATEKSACSHSITLTKPLRFIKVG
KRFYKLDDGTPADCVYLALHALYKTRLPDLVISGINKGANVGEDITYSGTCAGAMEAVLQ
GIPAIALSQFYKKSEKELDFKNALKITKKIVQNIFDKGFPLGKKEFLNINFPAKSNIKGI
KICKAGKRVYNFEAHSNINPRGVEYYWLAAANLDFEDEKDSDIALLKKGYVTITPIMLDL
SAYDKMKKVKKWLKANDE
>fig|195.2024.peg.959 GTP cyclohydrolase I (EC 3.5.4.16) type 1
MSQEKNTENNLQEKFENCVKTMLEIMGENPTREGLVKTPNRVFKAYEFLTSGYKKNVKEI
LNNALFESSNNEMVLVRDIEFYSLCEHHLLPFFGRVHVAYIPDQKVVGLSKIPRLVEVYA
RRLQIQEQLTEQIAEALMENVGAKGVGVVIEARHMCVEMRGVQKANSTTTTSALRGLFLK
NEKTREEFFSLINSPKQVRF
>fig|195.2024.peg.225 Ribosomal protein L11 methyltransferase
MQKFYYELFLEIQEQYKNLFLDFVFDLGVDAIEEKDNGIYIRSEENLEELAWAIEIFAQK
LSQRFNLKENIILHKSIEKKENKDWVEEYKKGIKPILIDNIYIHTTWQEEKENYLNIKIN
PALAFGSGHHESTYGCVKFLQKFAKNNSRSLDIGCGSGILAIVMAKLGCKVEICDTDDLA
IESALDNAKLNNVNFAQAWHGSVDKAEGLYDLVVANIIADVILILEKDIKKHLEDNAILI
LSGILDKYKTRVKEKFQDLELIDEMQINEWCSLVYKNKTKEK
>fig|195.2024.peg.415 Biotin carboxylase of acetyl-CoA carboxylase (EC 6.3.4.14)
MEIKSILIANRGEIALRALRTIKEMGKKAICVYSEADKDALYLKYADASICIGKARSSES
YLNIPAIISAAEIAEADAIFPGYGFLSENQTFVEICAKHNIKFIGPSVEAMNLMSDKSKA
KQVMQRAGVPVIPGSDGALAGAEAAKKLAKEIGYPVILKAAAGGGGRGMRVVEHEKDLEK
AYWSAESEAMTAFGDGTMYMEKYIQNPRHIEVQIIGDSFGNVIHIGERDCSMQRRHQKLI
EESPAILLDEKTRARLHETAVKAAKAISYEGAGTFEFLVDKNLDFYFIEMNTRLQVEHCV
SEMVSGIDIIEQMIKVAEGYALPSQENVKLKGHSIECRITAEDPKTFLPSPGKIIKYVPP
AGRNVRMESHCYQDYSVPPYYDSMIGKLVVWAEDRNKAISKMKVALDELIIGGIKTTKDF
HLAMMDNPDFISNNYDTNYLARH
>fig|195.2024.peg.1686 hypothetical protein
MTYILLLIIISTILSYLILKFIYKIIFKSTKSVSRFLVFLGSIGLIIMP
>fig|195.2024.peg.389 Carboxy-S-adenosyl-L-methionine synthase
MKDELFKEKLTKQFEFDKSVASVFDDMINRSVPFYRENLELCANLIKKLTKEGAKVCDLG
CSSANFLIFLASLRKDLKLFGADNAPSMLEIAKSKAQAYGLNIEFFEVNLCDFVFFQSDV
FVANYTLQFIRPPKRQELVNEIYKNLNKGGIFIMSEKILYEDAFLSKNMIELYADYKERQ
GYSKIEIAAKREALENVLIPYSEKENLDMLKNAGFEKIESVFKWVNFETFIAFK
>fig|195.2024.peg.566 Predicted metal-dependent hydrolase
MARQSSSLKSFIYKDECYFYSKKRIKTLRLRINERGEFVLSIPYFCTFKSVYEFLDKSSS
WMNEAKKRFEKKVLKDDELIFLAKKYKIIFDENVKKTYFDKDKIICQNKAKLDLFLRQNA
KKIFTFYLKKWSQKTGLFYTHLSIKNMKTRWGSCNHNKAYINLNLKLIQKSLRAIEYVIL
HEICHLKFPNHSKEFYDFIEYFMSDFRQREKEFLS
>fig|195.2024.peg.712 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
MSLQQVDQIISILSKQSKPYEWVIKEFKKIEELKDYELDLETFELLGLGLTLDKNNIFTL
QTRTKKIKEEIFCIVDIESTGGIKNGQILEIGAVKIKNLQEIDRFSSLVQVKEIPENITE
LTGINLDMVKDAPSLTKVLNDFRLFLKDSIFVAHNVRFDYGFISKALNECGFGILLNRRI
CTIEFAQCCIESPRYKLDVLKELLGIKNAHHRALNDALAAAEIFKHCLGKLPYHIKTTEE
LINFTKTSRIKQK
>fig|195.2024.peg.929 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54)
MSIKVIEASINSTIQDLGRKNYAKLGIARSGVMDELSLRIANILLGNKQDEAGLELCLKG
GKYEFLDESYFVLSGAEFEAKLNNKKIQTCKVYQAKKGDILELGLAKIGFRGYLCVAGGF
KIKSFLNSKSSDVKMGVGVFNGRALQKDDVLELNNSFIPFNLSKRECENPVFQFAKEPTI
RVILGTNDDAFTQNGLNTFLNTSYKIGLKSDRMAIYAEAKTTIEHKNSADIISDPAVFGS
IQVPKNGLPIILMAGRQSTGGYTKIASVIENDLPLLAQAKLGTNFKFENISMQNALELYK
QREEKFKTLDKKINLDFENLI
>fig|195.2024.peg.1529 hypothetical protein
MFKKLLSVVALGTLLSSSAFAEDILAKVSNGTISDNSAGVKVLSLDEMKEVKGGYYFKRD
SAFDYGAGSLSSYGYVVMNDSFHQDSNAVTQSLGYSSGYIVAKYRYVNNQKDYYLQYFSS
KYGSGTNIWAYANSPAYKILNEFRSKY
>fig|195.2024.peg.891 Proline dehydrogenase (EC 1.5.5.2) / Delta-1-pyrroline-5-carboxylate dehydrogenase (EC 1.2.1.88)
MIQKSLALAEELQGKIEANISNSEKEFHAKMQKLLNNPENKVMLIELLDRSFRCKDKRAS
FELIEHTLNKYGIADFFSAFEKFLLFSFLNFGKFAPNLSVPFFVKHLREDTKAMVLDANP
SVLEPHMRKRKDQDNITLNVNLIGEEVLGEAESKYRIQKYEEALKSSYITYISIKITTIF
SQINIIDFEYSKDEVVKRLDHLYALALEEEKKQGVSKFINLDMEEFRDLELTVAAFMESV
SKFDIKAGIVLQAYIPDSYEYLKKLFAFSKERVLKGMKPIKIRFVKGANMESEETIASQR
GWELPTFYKKIDTDSNYNKMLDFVLEGDNYKYINVGIASHNIFEIAYAYTRISEAGALDS
FTFEMLEGMSLQCSYELSKMHDLILYAPVCDEAHFNNAIAYLVRRLDENTSEDNFMRYFF
NLKVGDNNWNVQKELFLKSLEGIKTLDNSTHRTQDRNKAPNIVSAYESGMFNNESDTDFI
LPQNRAWAKVIRAKYENLENYDVMPVIGDLEFDKNTLNILEVKDKIKDRMIGKAYLAGEN
EIKKALEVAKNSNFKNTSFDEIHAILAKAANLMRERRGDLIGLAALEVGKTFLEIDPEVS
EAIDFTEFYPHSLKVLREQNKNTQFSPKGIGVTIAPWNFPIGISVGTIAAPLAAGNVVIY
KPSSLSTLTGYMLCKCFWDAGISKDALIFLPSKGSDISKYLLVDEAVKFSILTGGEDTAY
AMLKANPTLLLSAETGGKNATIVSKFADRDSAIKNIIHSAFSNSGQKCSATSLLVLEEEV
YEDEEFKKTLVDAAASMAVGNPFEFKNKLGTLADKPSAKVEKALNELAPYEEWALKPQFL
ENNPYLMTPGIKYGTKKGDFTHMNELFVPILSVMKAKDLKEAIEIVNSTGYGLTAGFESL
DEREWEYFHTHIEAGNIYINKPTTGAIVLRQPFGGVKKSAIGFGRKVGIYNYITQFLDIS
TSEADENLLNNEFVKTLEKIDLGTNEENKKALNNAILMAKSYAYHYRNEFSVSKDYVNIR
GEDNLFSYTKIKNLAFRVCENDNLQDILGVIIAANILNIPLSVSYEENDKISLVKELCKA
INLNLEITNESKAQFVSRLKNFERIRYHGKVSVEDEIYQEAAKEAKIIIREKPLLNGRFE
LLFYHNEKALSVSFHRYGNLGIRALNH
>fig|195.2024.peg.1363 hypothetical protein
MHFFSLILISKKSIKYSYDSLCRFFEKLLKILLKLIFMIFIIKMS
>fig|195.2024.peg.342 hypothetical protein
MGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYK
YLGGLAGHIENGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNG
GGFVGYTTGNTTFDGISLKDIRFIKSGAFTGGFAGMTQGNVIFENIVLNDLEEISGSHAG
GFAGWINDGTFNNIILNNIEKSVLALHINISLQVALQDMQALELIKILF
>fig|195.2024.peg.1596 hypothetical protein
MNTFFKMRYHRDLPNTYKFNQITIIKNHNKYYLAFSIIYDESNISLISSKDFDIKKAVDI
DLNINEITLSSGELIATNSKLLSRAEYDLAFKRLQRKQSRRILKTKKEKTKLSHNFKKTQ
LKLNKIYEKSSNIKKDSYHRITSKLIQEFDLLAVEDLQIKNMSKRAKLKNIKAKSGLNKS
ILNISFYQFSQYLEYKAKHNGKFFIKVNPQYTSKTCSVCGNIKKNLMFKDRVYLCEKCGN
TLHRDINAANNILKRGLKSFGLGISLEDYKLKAFRIS
>fig|195.2024.peg.115 Leucine-specific ABC transporter, substrate-binding protein LivK (TC 3.A.1.4.1)
MKKKIILAAALALSLQAKEVNLGVVLPLSGATAAYGQSALEGIKLANEMQSTLANGDKIN
LVVLDTKGDKIESASAATRLVNQDKVLGLIGEMVTANTLQVMRIAEENKVPLIAPAATGD
KLLENKLYSSRVCFMDSFQGSSLAKYAFEKLNHKKAVIVVDQSTDYSLGLAKAFEKEFKA
KGGEILKTLRVNSGDKDFKAIATQIKILNPDFIFLPLYYSEASLFVRQAKLIGLNTPMGS
ADGVADATFIKLAGNASEGYIFTDSFDANNPTTQLSKDFIAKYAKENQSKEVPNFTAMGA
DAYFVMFNAMNACQNTLTSECINEKIHQTNNYEGVSGVISIDKSGNATRSVVVKEIKNQK
QTYKDTINP
>fig|195.2024.peg.1272 Multidrug efflux system, outer membrane factor lipoprotein => CmeC
MNKIISISVIASLSLFISACSLSPNLNIPEANYSLDNKLGALSWEKENNHTLSKEWWKEF
DDEKLNHVVDLALQNNNDLKLAFIHMEQAAAQLGIDFSDLLPKLDGSASANRAKTPTNAP
SNRTGGVSYGNDFKMGLDLSYEIDLWGRYRDTYRASRSGFKASQYDYEAARLSIVSSVVQ
TYFNFVNANENEKALKDAYESAQEIYQINYEKFQVGAVGEYEIAQSRANLESTALQYNEA
KLNKENYLKALKILTSNDLNDILYQDQAYQVFKLKDFDIPSGISSTILLQRPDIGSSLEK
LTQQNYLVGVARTAFLPNLSLTGLLGFESGDLNTLVEAGSRTWSIGGNFVMPIFHWGEIY
QNVNLAKLNKDEAFVNYQNTLVAAFGEIRYALIARKTIRLQYNNAQASELSYKRIYEISK
ERYDVGEMSLQDYLQARQDWLNATVAFNNTKYSYANSIVNVIKAFGGGFEQGENISKNIE
EESKTLDMSFRE
>fig|195.2024.peg.163 Isoleucyl-tRNA synthetase (EC 6.1.1.5)
MDYKDTLLLPNTTFAMRANLAEFEPKRFEKWFSKNYAYEKMKTKRKEAKKAFTLHDGPPY
ANGHIHIGHALNKILKETIIKMHYFNGESIRFTPGWDCHGLPIEQQVEIKLGDKKKSLSK
KEIRSFCREHANEFVNIQRDEFKSLGVIADWDKPYLTMKFEFEAAIYRTLCEIAKKGLLC
ERSKPVFWSWAAKSALAEAEVEYEDKEDYSIFVAFDLDEQSCQKLGISKASAVIWTTTPW
TLVANQAIALNPNENYVITKEGLIFASALLESMIAKGLTKGEIQKELNAKEFEKLEAINP
LNSRKSILIMGEHVLMEGGSGLVHTAPGHGEDDYYACLKYDIEVIMPVDDGGCYDETLRH
KGLLPSDLLDEFIGLHIFKANEKILELLGNHLLHSSKFIHSYPFCWRTHKPVIYRATKQW
FILMDEPKLKGKTLRECAKEQILKTKFYPQSGVKRIGSMVENRPDWCISRQRDWGTPIAF
FRDKNTKEVIFDAELFDFVANIFEKHGADAWWEFEIKDLIPQNSKYNADNLEKVYDILDV
WFDSGSTWNAVLNSGIYDAGEKRASMYLEGSDQHRGWFQSSLLVGTAINEFTPYESILTH
GFTTDEKGQKMSKSKGNVIAPEYVAKTYGVEILRLWILLSDYSTDLKISDNILKQVGEQY
RKIRNTIRFLLANTNDLENLEVEEFSFIDKWILTRATRVFKSAKENFLAYEFAKGFNVLL
NFLSADLSGIYLDISKDRLYCDAKNSKRRKSAQVAMALIARELLNLLAPNLTYSVDEALE
HANSLIKGDAKDVFDLSLEEKFEYDFNIDDEFLLSVREKFFENIDILKKDKVIKSTLELN
LDTNSKLLNSIPKDELNDWFMVSFDENLQGEVLCEFEVENESFRIMKATLCKCPRCWKVE
SAKEDEPCMRCAEVLKHA
>fig|195.2024.peg.1623 Protein YrdA
MLIRFKDKFPNLGQNVFVAEGAKIIGEVEIGDESSVWFNCVLRGDVNFIKIGKRTNIQDL
TTIHVWHREFNKDGSLKDAGFPTCIGDDVTIGHNCVIHACKIGSRVLVGMNAVIMDDAAI
GDDSIVGAGSVVTKGKKFPPKSLILGNPAKLIRELSDEEVAFLKQSALNYVEFKNDFLD
>fig|195.2024.peg.1074 hypothetical protein
MQININLEEMTKWQITYELKRILSSLDPITAHEIAKELRQEFLSIEELQDRIRQIND
>fig|195.2024.peg.1165 Epoxyqueuosine reductase (EC 1.17.99.6) QueH / hypothetical domain
MLVHICCSVDSHYFIEELRKEYPKEKIIGYFYDPNIHPLSEYELRFLDVKRSCDKLGIKL
YKGEYEYEKWLKAVKGYEDEPEKGARCEICFDLRMGSSVEFAAKIGEKKLTTTLLTSPKK
DLEQLKNALQKECEPYGVEFLAPDFRKNGGTQRQFALAKKEMLYHQNYCGCIYGLKKQKQ
DKNFIDELMSPINAQILPASIEARIALYKKVNLLEKKGIKFEIIRQKFLNYRLLSALIKL
DKKAVKSHILFYSHFKNHYTRFSLDEKNLNENLKNGIYKSTKDEISFIEFWRFNSDFKNK
WKSFEDFLKHPLKIEEEIKWRNKHFGAYDLSPVIVLEKILPTRYEIVAKSEIYYDVKEVI
KRT
>fig|195.2024.peg.289 Ubiquinol-cytochrome C reductase iron-sulfur subunit (EC 1.10.2.2)
MATSESRRSFMGFAFGTVAAVGGVFSLVAVKKTWDPLPSVKAAGFTTVDLSGMQDGELRT
IEWRKKPIFILKKDPNMEKDTKRDVVVDNAAYTVVIGLCTHLGCIPAYHASEQLFKCACH
GGEFDTSGKNTFGPPPRPLDIPPFKIDGTKLVLGEEGPEYKKMTEEA
>fig|195.2024.peg.999 16S rRNA (uracil(1498)-N(3))-methyltransferase (EC 2.1.1.193)
MQFLYHKQAGEEILKLKGEEFAHLKARRIKENEILSLRNLEDDFIYEYKISNLDRNSCLL
YFLHKHFKSHPQSELDLALAVIDTKILEKTLPFLNELGVKKLHLVFTEFSQRNFKLDFER
LEKIIISSCEQCGRSHKMQIQSYKNIQEFSKVFPDAVLVDFEGEVKEFDKTRLYFIGPEG
GFSPKEKQMFKEKICLKVPNILRSQSAAIAVAAKILL
>fig|195.2024.peg.1006 Homoserine dehydrogenase (EC 1.1.1.3)
MKVAILGYGVVGSAVARVLIQNKEIIRARCGQDIIPVVALAKSQKENALIPIVTNVDEIL
QRDDIDVFVELMGGVETPFKIISEILKKNKPVVTANKAMLAYHRYELEELAKNTTFGYEA
SVAGGIPIIKALKEGLSANNILSIEGILNGTSNYILSAMNSKGLNFDDVLKKAQELGYAE
ADPTFDIEGQDAAHKLLILASIAYGLRAKPEDILIEGISKISAEDMYFAKEFDFTIKLLG
IAKAQNSIVELRVHPTMISKDKMIAKVDGVMNAISIVSDILGESLYYGAGAGGNATASAV
IADLMDIARNEAKGPMMGFENNLNFKLLNRDEIYTKYYLRLKVEDKTGVLSKITQLMSEN
NISIDSFLQKPKQGEIYSTLFFTTHHTFEKSIQNLLSILEKQDFIKAKPFMMRIEE
>fig|195.2024.peg.1443 FIG00545237: hypothetical protein
MKKFIYITILAFIFNGCSIPTSTLDKTQSFILKNDELPLQANFIKSDKILKIQNASLPLY
LHSRSIIYVQKGISKAYAYHFWADLPNNLYQSLLLSKFEQSQIFKALLSQGSSVGSDYIL
ESRIDSFEQVVDENENYVSISISINFIDAKESKIIAHRLFSIKERVKKIDIFDVYQSFEK
ALNSLGNEIVLWINATLDEK
>fig|195.2024.peg.141 2-iminoacetate synthase (ThiH) (EC 4.1.99.19)
MQDYMQYLPHMQEIKSEILNKVLSQVQSYDESQFSAKDVKNALNQTHLSIEHLKALLSST
AEDFIEELAFKSAKTKQKYFGNSISLFTPLYLSNYCNSKCVYCGFQKGNKIARAKLSEDE
IHEEMQAIAKTGLQEILMLTGEGREFASVEYIAKACKIAREYFKVVGVEIYPMNEDEYKI
LHENGCDYVTIFQETYNPLKYSKIHLGGEKRIFPYRFNGQERALRAGMRGVAFAALLGID
DFRKDALATALHAYFLQKAYPHAEISISVPRLRPIINNAKIHPKDVSEKRLLQVLCAYRL
FLPFAGITISSRERVGFRDEVVKLGATKMSAGVSVGIGEHKGEKKGDGQFEISDERGVDE
ILAMLKRSNLQAVMSDSIYVG
>fig|195.2024.peg.411 Uracil phosphoribosyltransferase (EC 2.4.2.9)
MKNIHHICHPLIEHKLGFLRDKETKPFHFRMLIDEISTFLLFEATKDLCLKETQIQTPVA
NAKVKRLDEKIMICPILRAALGMLDSIFRLIPDASVGFLGFVRNEKTLKADFYFQKLPKD
AKKRTAIVIDPMFATGGTAIEACNFLKSQGVKKIKFISILAALQGLQKFSQMHDDVEVFV
ACIDEDLNEKGYIIPGLGDAGDRVFNTL
>fig|195.2024.peg.1544 Cysteinyl-tRNA synthetase (EC 6.1.1.16)
MKLMDSVLKEKIELDQDNVNIYLCGPTVYDDAHLGHARSSVCFDLLRRVLLSLGYRVQFA
RNYTDIDDKILKKMSESGKSLNELVEFYIANYERDMKALNVLEPDFKPRATYYIEPMLDL
IHKLSKNGFTYTLEDGVYFDTSKDEDYLSLSHRNTEENVSRLSNEVEKRNESDFVLWKFD
ENFYDSEFGKGRPGWHTECVAMIDSIFGDTLDIHAGGVDLLFPHHENEAAQCRCACKRTL
AKIWLHNGFVKINGEKMSKSLNNSFFLKDALKDFMGEALRFYLLSSHYRAHFNYSLDDLE
NVKKRLDKFYRLKKRLAVGKTPDFGILNDIEIHSNIAKQILEVLSDDLNISKALALLDEF
ITNANLELDQQSKNKELKQKIKEALSELAKIFGFGFMDENLYFQWGVAKELKEKIQDQIL
QRNEAKKNKDFAKADQIREDLLKLGIALQDTPQGTIWEKI
>fig|195.2024.peg.1050 Tol-Pal system protein TolQ
MNFEAIFQFFGSSSIITYIVLAWLSLYFILSFFILFSRVTYLAAWKNKEKESLEALLLGE
KDLSRTRSILRKCTDTSLSHLEIYKNLASRRASNGLTWLSIVASTSPFIGLFGTVISILE
TFGGLGTQNSLSIIAPKISEALVATGCGILVAIPAYTFHLIIKRKAFELLSIIDSEIKVI
SSNK
>fig|195.2024.peg.113 Branched-chain amino acid ABC transporter, permease protein LivM (TC 3.A.1.4.1)
MVKIKISALVYIVLAIAFIMLAPQFFDGYGIGILNQIAIYITLAVSYNLINGVTGQFSLE
PNGFIAVGAYAAALVLLSSEQKLDLFSLEDPNPIILALHTNSFILALLVAGFSACVLSLI
LAFAVFRVRGDYLAIVTLGFGIIIQKLAINFPSWTNGSMGLNGIPLLSNLYWTGGVAIIS
VILILNLVYSKFGRAMQAIRDDEDAASAMGVNTFWTKTLAFGTSAFLEGVGGGLLVCLLA
SVSPEQFGFEFTFMLLIIIVLGGLGSTTGAILGAILIIGGREWLRFLDEMQIKIDFLGID
MGSMPGLRMVVFSLILILVMLFARRGIFGDRELNSFFKRPSKKGLK
>fig|195.2024.peg.1459 GTP-binding protein Obg
MFIDSVKITLASGDGGKGAVSFRREKHVPLGGPDGGDGGNGGDIIFVCDNNTHTLVNFKG
KRELRAQNGAGGMGRNKNGKKGENLELIVPEGTQVIDAQTNEVLLDLTKEGQRELFLKGG
KGGLGNTHFKHATNQRPDYAQPGIKGESRLVRLELKLIADVGLVGFPNVGKSTLISVVSN
AKPEIANYEFTTLTPKLGLVDVDEYNSFVMADIPGIIEGASGGKGLGLAFLKHIERTSFL
LFVLDPMREMPLKEQFIVLRKELEKFSNELFGREFGIMISKSDSVNLGEDFAEQIAQNIA
NLEEYLKSIDNPQSFLIKVSSLEKTGLKELKFMLLEEIKKLREKREKKVIK
>fig|195.2024.peg.926 Lactam utilization protein LamB
MFKVDLNSDLGESFGAYKIGMDEEILKFVSSVNVACGFHAGDPCVMDKTLNLAKQNGVCI
GAHPSYPDLLGFGRRNMQISFEEAKNYALYQLGALFGFAKAKDMKIQHFKAHGALYNMAA
LDENLALALCEAVASFDENIIFLGLSNSAMNEAAKKKGLRYANEVFADRAYNDDGTLVSR
KLEGALIHDENLAIKRVIKMIKESKVTSINGKEIDLKADSICVHGDGIKALEFVKKIKEN
LTKEQIQIKALNDFIN
>fig|195.2024.peg.507 BioD-like N-terminal domain / Phosphate acetyltransferase (EC 2.3.1.8)
MANLYLMRSRSDELNTLVTTKLLKNYSKIYKNIAIYCPVIYVHRIPVLQGWLEEFDIKQT
LKNAYSFTFREAMEEFSKDPHSFFNTILEEYEELNRKYDFVLVNSFCEFGILDGFDLSIK
LAKNLNTPIAAIINNEDKLIAQKYFDEALDGRDYALINENFNFEEMHKLQAYDFMTPHRF
KYELIKKSVKNKKTVVLPESNDERILKAVEILLKSSVVDLILLGDEQDIKQKADELALDL
TAVKILNPLHSEYNEEFATLLYEARKSKGMSLEEAKELVKDRTYFGTLLIHSGKADAMVS
GASTTTAETIRPALQIIKTQEGVDSVSGIFFMGLDDKVLAFADCAVNPNPNAEQLAASAY
VSAMTAKSFGIEPRIALLSYSSGDSGKGESVDLVKEALRIAKEKYPELNIDGPMQFDCAY
DPKTAAKKMPNSKIAGNVNVYIFPDLDAANICYKAVQRTANALAIGPILQGLKKPVNDLS
RGCLVDDIVDTVILSAIQAQ
>fig|195.2024.peg.1166 3-hydroxyacyl-[acyl-carrier-protein] dehydratase, FabZ form (EC 4.2.1.59)
MIDVMKIQEILPHRYPFLLVDKITELKVGEVVRGYKNISISDHVFMGHFPGHPIYPGVLI
LEGMAQTGGVLAFESMDAKVDPKSKVVYFTGIDGAKFRNPVRPGDRLDYEMQVVKNRGNM
WIFKGQAFVDGNLVAEAELKAMIVDK
>fig|195.2024.peg.1302 Pantothenate kinase type III, CoaX-like (EC 2.7.1.33)
MLFCDIGNSNASFLDDNKFFTLNIEQFLEFKSEQKIFYINVNEHIKEHLKARKNFINLEP
YFVFDTIYQGLGVDRIAACYTIEDGVVVDAGSAITVDIVSNSIHLGGFILPGIANYRKIY
AHISPRLKHEFNTQISLDAFPQKTSDALSYGVFKSIYLLIKDAAQNKKLYFTGGDGQFLA
NYFDYAIYDKLLIFRGMKKIIQENPNLLF
>fig|195.2024.peg.112 Branched-chain amino acid ABC transporter, ATP-binding protein LivG (TC 3.A.1.4.1)
MILELKNITKKFGEVRAINETSFHIKEGEIFALIGPNGAGKTTLFNIITGNYKPTSGEVF
FQNKKINDLKPHKIVHLGIARTFQNIRLFSSMSVLENVMIGFDKQMKYSVLEAFLHLGRF
HRVEQEFKNKAYKLLEELGISEFADEKATSLSYGQQRKVEIARAMATNPKLLLLDEPAAG
MNSSESDELAELILKLRKDYKISVLLIEHDMKFVNRLCDKVLVLDYGKTIFEGKISDAVN
HKEVIAAYLGDFDASS
>fig|195.2024.peg.985 Carboxynorspermidine synthase (EC 1.5.1.43)
MKNLLIIGAGGVSRVATVKCAMNSDTFSKITLASRTKSKCDEIASFIKERLGVEIQTAQI
DADDSDAVVELIKKTGAQILLNVALPYQDLSLMDACIKAGIDYVDTANYEHPDLAKFEYK
EQWARNDKFKEAGILGLLGSGFDPGVTNVFCAYAQQNLFDEISYIDILDCNAGDHGYAFA
TNFNPEINLREVSAKGRYWEKGEWIETQPMEIKMEWDYPEVGVKDSYLLYHEELESLVKN
IKGLKRIRFFMTFGQSYLTHMKCLENVGMLGIKPVMHQGKEIIPIEFLKTLLPDPASLGP
RTKGYTNIGCVIRGIKDGKDRQVYIYNVCNHEECYKETGAQAVSYTTGVPAMIGTKLIAK
GIWQGKGVFNMEEFDAKPFMDELNSQGLPWKIIEMTPSLGE
>fig|195.2024.peg.88 GTP cyclohydrolase II (EC 3.5.4.25)
MDIKISEIANLPSKWGSFQIQSFKEGEKEHLCIFKNTPQDILNLRIHSECLTGDALGSLK
CDCGEQLEFSLKYIEKHGGMVIYLRQEGRGIGLFNKVNAYALQDKGFDTIKANHQLGFKA
DERTYEIVEFILKHYKISKVNLLTNNPQKIHSIQDKIMARVPILINPNRFNANYLEVKQN
QMGHLL
>fig|195.2024.peg.1300 Pyruvate kinase (EC 2.7.1.40)
MLKKTKIVATVGPASEKEDVLRQMIINGVNVFRLNFSHGTHEYHKNNLETIRKVSRELNT
RVGILQDISGPKIRTGELKTPFELKKGDRLDFYYEKIIGEQIAPNHYKLSINQSEILNML
KLDEYVYLYDGSIRAKVTAKDSEKIETLIENDGFLNSNKGINFPNTKINIDVITQKDKKD
LLWGIENEVDFLAISFVQNAHDIDEVREILAQNNAKISIFAKIEKFDAVENIDEIIASSD
GIMVARGDLGIEVPYYKVPNIQKAIIHKANNASKPVITATQMLFSLAKSKTATRAEISDV
ANAVLDGTDAVMLSEESAVGIDPANAVDVMCQTIIETEKRYPYNKFNEFENLDNTDKIMR
SSAHLATDLNADAIFSLTSSGKSAIKISRYRPDMEIIAVAHSEKTLNSLSIVWGVNPAIL
VNKSEDLTDLLRDSVKSSVEKGFMNKEKCYLLTAGFPTGVEGTSNLIRILAKEQIAYYLK
>fig|195.2024.peg.438 FIG00470572: hypothetical protein
MRELGFTQIYIIVYFRDTLGYLNSHCSQDHKNNMEYYSADFAPQDHPRKYIFDYEWICKT
HAEVFGEENLIVRLLREDYVGGTLLKDFVYHLRLE
>fig|195.2024.peg.1123 UPF0394 inner membrane protein YeeE
MLSGIIVGLLLGFVLQRGRFCVVGAYRDVFLSKKFTIFIALFIVVALQSIGVWALHSLGY
ISIKPQEFYWLSTIIGGIIFGFGMVIAGGCATGTWYRAGEGLIGSIAALLFYAFSASAVK
YGVLLPLQDNLNTFKISDGTFYQSLGISPWILVLALSLVVGFFVIRELRKPRLKVARLKP
RKQGISHILFEKSWHPFVTAVLVALIAILAWPLSSLSGRNYGLGITTPSANLVQYLSTGD
VQFVDWGVFLVLGIALGSFLGAKLSGEFRFRLPDKKTLAYASIGGILMGVGASLAGGCTI
GNGLVETSLFSYKGWVATVFFLIGAYIATFYTIILPTRKATQKI
>fig|195.2024.peg.1474 Cytochrome d ubiquinol oxidase subunit I (EC 1.10.3.-)
MNELSSVDWSRAQFALTALYHFLFVPLTLGLSFIIAIMETIYVKTGNERWKKITKFWLSL
FAINFAIGVATGIIMEFEFGTNWANYSWFVGDIFGAPLAVEGIMAFFLEATFFAVMFFGW
DKVSKGFHLLSTWCVAIGSNLSAFWILVANGWMQYPVGMSFNPDTARNEMQSFFEVALSP
VAISKFLHTIGSGYVISALFVMGISAWFILKGRHIIEAKKSLVVGASFGLVCSVFLFFSG
DESAYRVTQTQPMKLAAMEGVYQGEHRAGLVPFGILNPKKTIDNNESVFLFDITIPYALS
ILGNRDPNSFVPGIEDLIHGNEDRGIEPMQERIDKGKIAIQALKDYKLAKDNNDTAAMAT
HKSILEANFKDFGYGYLEKPTDAIPPVALTFYSFHIMVALGSLFFLLFIATLYLTMANDI
EKFRKILRLCLLCIPLGYIAAEAGWIVAEVGRQPWAIQDLMPVHIAATELGKVNVQISFW
IFAVLFTALLIAEVKIMLTQIKKGFDAHAGHTPLMGKGEK
>fig|195.2024.peg.180 Pyrroline-5-carboxylate reductase (EC 1.5.1.2)
MKADLYILANGAMAQALAYGLKDSYNIYIVGRNLEKLQILEKEGFKTLLYKDFNIENKNI
ILAFKPYALESVAANLKGKAKILISVLANTDFDKLKLIQAQNYARIMPNTAAKYKASTTP
YVLKNSNFKDEVIEILNTFGKAYELNEEKQMNAAMAISGCAPAFLALVAESIANAGVYEG
LSKELSLNLTRSLFKSAAALLENEHPAIIKENICSPAGVTIKGIKVLEQKGIRGTFFEAL
NASAT
>fig|195.2024.peg.815 2-dehydro-3-deoxyglucarate aldolase (EC 4.1.2.20)
MNLKEKLKNNQLTIGSWISIGHTSVVEVMASAGFEWLVIDFEHTSMNYETIQNLIIAIQS
KNIKALVRVSKNEEVVIKKVLDMGADGIIVPMIKNEIDAIKAVEFAKYPPIGKRGVGLFR
AQGYGSKFEEYKKWVDDNLIIIAQIEHYEAVENIEEIIKTEGINGVIIGPYDLSGSLGFP
GEYHRIEVKEAIARVLKCCKKYNIPSGFHVIETDPKKLQERIHEGCTFLAYSLDFLFLSD
SARKGMELIKKEIK
>fig|195.2024.peg.1343 NADH-ubiquinone oxidoreductase chain J (EC 1.6.5.3)
MIEILAFTFFSVVVLGFFLVAVLSKNMLYSLSALAGGMVFLSGFYFLLDAEFLGVIQIIV
YSGAVLGLYSFAMMFFDSSKEFKEKLRAKKSFFLLVILSAVLLLFMLLGFKHQNIAGDLA
LSDPNLFDYNKQLAFAIFSKYLLAFEFIAILLLIALICAIVLTHKELTKER
>fig|195.2024.peg.1561 Small hydrophobic protein
MVFLIPLLIIIAIIFGIDYLYFNDENVKVKEERQIHKSDPNLDKQREEYLKHLFKEKK
>fig|195.2024.peg.889 UPF0033 protein YedF
MKITYTLNLEGEACPYPAIATLDALPQLKSGEILEVLCDCPQSINSIPQDAKNRGFKILE
IDQNGPTLRFLIQKP
>fig|195.2024.peg.326 Heat shock protein 10 kDa family chaperone GroES
MNFQPLGKRVLVKRVEETKTTASGIIIPDNAKEKPLMGEVVAVSKEITDIANGDKIVFAK
YGGTEIKIDNSEYLVLNLDDILGILK
>fig|195.2024.peg.492 Glycyl-tRNA synthetase alpha chain (EC 6.1.1.14)
MTFSQMILNLQEFWQKQGCAIMQPYDMPAGAGTFHPATFLRSLGKKPWATAYVAPSRRPT
DGRYGENPNRLGAYYQFQVLMKPSPDNIQELYLKSLENLGFDLKSHDVRFVEDNWESPSL
GAWGLGWEVWLDGMEVTQFTYFQQVGGIAVDLVSAEITYGLERIAMYLQNVDNVYDIVWS
EFNGEKIKYADVHKRSEYEFSKYNFEISNVDFLNQQFENTYKECKSILEQGLALPAYDYC
MLAAHTFNLLDARGAISVAQRQDYMLKIRELSKTCAEIYKKNLDETD
>fig|195.2024.peg.794 Nicotinate-nucleotide adenylyltransferase (EC 2.7.7.18)
MKIALFGGSFDPPHKGHDAIVKEALAKLDIDKLIIMPTFINPFKKGFFADEKQRFAWVNK
LWGNLEKVEICDFEIKQKRPVPSIESVEYLYKIYHPSKFYLLIGADHLEKLHLWHDFERL
NSLVEFIIANRNDIEIPKNFKDLKTNIKIASSFIRSTLDTHEVCDEIKNEVKNYYEKLQK
N
>fig|195.2024.peg.119 Membrane protein
MLEKIFESLLVKSRIVTILPVIFGLVGAFVLFFIASYDVLKVILYTYQYFFSAGIKIDLH
EDVVALIIGAVDLYLMALVLFIFSFGVYELFISEIEEFKQTKQSKVLEVHSLDQLKDKLA
KVIIMVLVVNFFQRVLQMKFATPTDMAFLAGSILALCVGLYFLHKGGH
>fig|195.2024.peg.147 Membrane protein
MFDSFLSGVFLGFGVSVPFGPVNILILTYALKAFKNSIAVGLGAFSIDMLYLFLLQFGLL
NFLDNVIFMRFLAIFGFCFLTYMAYLMLKKKNEDLHLDQHKDFKESLLKSYVKGIILNGS
NPYVIGFWLSATGIVLSNQHAYSTILGLVVAILFWIGALAFVVAKYSYLFSAKVIRIINI
VSALIIEYFALSLLYKTFIG
>fig|195.2024.peg.880 Two-component system response regulator protein
MKELVILVVEDEVKIRESLVNVLSSRYSKVIGAQNGDEGLKKFKKFKPDLIITDIAMPIM
DGLDMAKEIKEIANDVPIVVLSAYSEKERLLRSIDIGIDKYLIKPVDVDELFKVLDYLVG
EKIETNALVDISKEYQFNKTKRILIHKGQEIVLTKKELAFISLLLKQPGVLVLHEDIKKN
VWIGEHVSDTAVRTFIKRVRDKVGEKFIKNVPGLGYKINIEN
>fig|195.2024.peg.604 tRNA (guanine(46)-N(7))-methyltransferase (EC 2.1.1.33)
MPNFKTRKLKEIILPFEKDGIEFVWMAHNDNVNLIYTRVEEESFFLQIKKGENEFVVKVD
KHTKPSKIAYLHKALYIFKQYFCEDVISEAFGIKNNALAEKTPLIANDFEEVLERLEGKI
YIEIGFGSGRHLLYQAKNNPQILILGIEIYNPAITQVAKLARAQGIDNILLVQSDARLLL
SVLRSDSIEKIFLHFPVPWDKKPHRRVVSKAFCKECARVLTTQGVFELRTDSYEYFDFTF
KEFLEFSSPQFSIRKNENLEISSKYEDRWKRQEKDIYDLWVWNLDKEEKNVLSEEFDFSD
IHLSKNDLMLLEKNFENFTLKKEDFFLHFENIYKQGESLLLKIAFGAFNKPEHCYLHIGE
AISFVFKEPFKIQENLKAIKELKKSVKFHFNMKHFLEN
>fig|195.2024.peg.611 Replicative DNA helicase (DnaB) (EC 3.6.4.12)
MQQEHFDLDLERAILSSCIMSEDAYSSIAGDIEPKDFSLKAHQDVFKAIIACVNAGEPIS
ISFLKKHKKIDEQILTEIIATPSIIDLPAYVNELREKSIKRQLLSFAHLLPTRINDNRAV
SEISDEIGKEIFNITNRVNTNDIKDIEIVLSELLEEFKKQKSLENKSVIGLDTGFEDLNT
MTKGFKGGELIIIAARPGMGKTTLCLNFIEKVLRQDKGVVMFSLEMPAAQIMQRMLSAKT
SIPLQKILTADLNDNEWERIGDACNYYSKKKLFIYDSGYATITDVRAILRRLKAQEESIG
LCVIDYIGLMMSNSNFNDRHLQVSEISRGLKLLARELDMPIIALSQLNRSLEQRANKRPM
MSDLRESGAIEQDADTILFVYRDEVYREQDEKERENKAKAEGKPYQRNFIPNPMQENAEI
LVGKNRNGPVGVVEVLFLKEKSCFVDKPRFESVEFQE
>fig|195.2024.peg.1056 ATP synthase F0 sector subunit b (EC 3.6.3.14)
MKKLFYFIFLLPLCAFGASNGSGEYDIVPRTINFLIFVAILYYFVANPFKAFYKNRILRI
SLKLDEIQKKLLESKAKKLDTMKKLEEAKANAAAALVVAKKEAEVLAQKIKEETQNELAL
LEKHFEEQKDYEFRKMEKEVVSLTLKEIFEDSNIALKQNEIIDIMMKKVS
>fig|195.2024.peg.1389 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (EC 2.7.7.60) / 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (EC 4.6.1.12)
MANLSLIMLAAGNSTRFDMGVKKQFLRLGDDPLWLYATRNLSTFYPFKKIVVTSSNTSYM
KKFARNYEFVEGGATRAESLKKALEIIDSEFVMVSDVARVLVSKSLFDRLIENLDKADCI
TPALKVADTTLFENEALQREKIKLIQTPQISRTRLLKQALNQNLDFTDDSTAISAVGGKI
WFVEGEENTRKITFKEDLKKLDLPRPSNEIFCGNGFDVHEFGEERPLLLGGVEIHPTMGL
KAHSDGDVLAHSLTDAILGAACLGDIGELFPDTDEKFKNANSMNLLKEAYKRVKEFGFEL
VNIDICVMAQTPKLKDFKEAIAQNIANTLNVDEFRVNIKATTTEKLGFIGRKEGMAVLAS
ANLKYFDWTKI
>fig|195.2024.peg.110 Putative cytochrome C-type biogenesis protein
MKNIIKSVGDLRISIVLFLLFALSCGLATFIESAYGTPTAWAMVYDSFWFEYIQLLLGIN
LLFGMFRYKMFALKKMPLMIFHFSFLFILLGSAMTRYGGFEGLLAIREHTQNALVESSKT
SLRISTIKDGERYTSVNDRYIGNLPFANSFKLNLNMGDEKAVLKYENLILDADYTYKEDN
VSSPLLVLTISEKNSQGANLEFRSGEVQNINGINFAFMNDDVAKPYIKIDKNLKLSSSEN
LSVFNMKKGENSTLKIGEKADAKDLRLYSLDNLNFVVKFASLHGAQEIQGVNRPQDESFW
LWFKSAWLEFARTIMISSFGEPQNWKASWLTNFKDFAMSKDYQALELKGAHALKLQLDYK
NESKEFYVFEYNKPTVVELAGQKFFISWALAYEQLPFEIYLRDFVIDRYPGSMSPASYAS
EITVKNNEDNFDYRIFMNNVLDYKGYRFYQSSYDQDEKGTILSVNKDPGKIPTYIGYFLL
CLGMFLNFLNPHSRFRTLARLINKDALKHTASVLALFVALFGADKMLAQDLNISLEQNIP
IVDKAHVKELKALIVQKSVDGRMIPFDTLAREILEKIHKSADYKGQEASAIMLSMLINVD
LWQNEAFILMPSNKNVREAIAEILEISPELKYVKYKDFFDANNRYKLQKYVENANRKNPN
ARGVFDKEIIYLDERANVVNLVFSGELFKFIPIQNHDNNAWLAPFSAITTLKDEEGQFVF
TLIKNYFSSVDSAFHDGNWTRANEALGFIKQYQEKIGHEVMPNKTKVEMEIFSNKAEIFV
KLAPVYLIAGFLLLIVLLIKMVAPKLKISLIFKVIYILNILAFIVHTVGLGLRAYLADHA
PWSNGYESMVYIAWALSLSGIFFSRKSPIALSLTSILAGIVLAVAHLSEMNPQITNLMPV
LNSYWLSIHVSVITASYGFLGLCSLLGIFTLLLMCFLKENNQYNQSILRNITEATRINEM
SMIFGLCLLTVGNFLGAIWANESWGRYWSWDPKETWALVSILVYAAILHIRMIPKYSNQF
TFALWSMFAYWVVIMTYFGVNYFLVGLHSYAAGEAAQIPSYVYWGVVIMIVLALLARRKR
EFVGKL
>fig|195.2024.peg.1692 hypothetical protein
MQFYFLRYLEAAIQNNIKEDKILFENLTLKALEKYIKDFE
>fig|195.2024.peg.1248 putative membrane protein
MKKKIFKFSILFTIFISLSQSTLVFIFNHYLIIDYSAYETLPQSFAMLNLADQKLYHLTQ
NLRFLHSILAFLLIISFFFVHLFFFYISRKEKFIPYSFFCFVLMVISAIANLLEGIEQKE
SIFWYYKAFLDVGVCLIYLLFLDKFFQSHLFKIFFVCACLCTILTEFKFMDFTTPFVLPI
YLFILLILMRKKSFNV
>fig|195.2024.peg.1315 Prolipoprotein diacylglyceryl transferase
MEFWQNIYSNFDVVAFSVLGFKVHWYGIMYVLALLLALLLAKFFVRKFKLDIDEKRLDSY
FIWVEIGVILGARLGYILIYDAHTMYYITHPWQIFNPYANGEFVGIRGMSYHGAIIGFLI
ATFLFCKKYKENPWKFLDLVALSVPLAYVFGRIGNFLNQELFGRITDVSWGIYVEGVLRH
PSQLYEAFLEGVVVFIVIYLVKMKQKFQGELILVYACVYSLARFVCEFYREPDFGLGFIF
WGMSMGQILSLLMFVAALLFYICIKFKKVNI
>fig|195.2024.peg.1237 Phosphate:acyl-ACP acyltransferase PlsX (EC 2.3.1.n2)
MIDIAIDAMGGDFGEKPIIEGVIEALKERPFNAILVGNPNILRPLIPKNLEQYIQYENAN
EVFSMNENATDALKRKETTIYKTIELVKNGKAKAAVSAGHSGASMSLATLRLGRLKGVLR
PAIATLMPNTTSKTLFLDVGANTDCKAENLFQFAIMGDAYAKEIMKISKPRLALLSNGEE
ECKGNELTKEAHQLMKQIPSFVGNAEGRDIFNGEVDVLVCDGFDGNVILKACEGVATAII
HILKNEIKQSLISKIGALLMKPSFKRLKKHIDWQEYGGAPLLGVNGCVIISHGKSDARAI
KNAIFQAINFSESNINQIIEKELEKYNA
>fig|195.2024.peg.997 Putative haem-binding lipoprotein
MGKNLSILISLFAVLFLNACSDDKEFNHKNQNTTEEIVQIEQNDEKTEFSDTNLPLPVDD
EASISEDYDVNPSVINSLYKQKCATCHGEKGEVKTKKGIAIKNLSSEKFIQRLQNLKDEA
HNFLTQEQRENLAKYISKEK
>fig|195.2024.peg.506 Acetate kinase (EC 2.7.2.1)
MKILVLNSGSSSIKFKFFDDKVVKASGLVEKIGEEKSKVILKNALNDETFERELPIKNHE
HGLQIVNELFKESGILEDLNALDGCGHRIVHGGRNLSEHCLVDDYVLKEIDRVSIFAPLH
NPAHLAGIKTMIKAAPSVANAAIFDTAFHRTMPDFAYMYALPYDFYDKHNIRRYGFHGTS
HAFVSARAAQLLGKNKEDLNAISAHLGNGASVCAIEGGKSIDTSMGFTPLEGLVMGTRCG
DLDPAILPFISHLKGLTIEEIDTLLNKKSGLYGICGSNDFRDIGAKIEQGDDRARLAFDM
FCYRLLKYIGAYFTVLPRTDAIIFTGGIGENAALVRQKVCERLSHLGVELDIELNNKKAS
CERMISTANSKVKIFIVPTDEELEIARITEELINKS
>fig|195.2024.peg.798 Flagellar basal body-associated protein FliL
MDEELENNEEKKKKGGSLVIIIVILLFVLLLSIMGVIAWLISSSSSDESEVKAAPKEEAK
TDKAKVTAPAQRGSDFANIGPMYPLDPFTLNLLSDSGSRYVKCTIELEQNTELLKPELDK
KVAVIRDIIIRTLTAKTFEEVSTQKGKERLKDELVEKINEILTDGFIKNVYFTDFVVS
>fig|195.2024.peg.1662 Flagellar motor switch protein FliM
MAEILSQEEIDALLEVVDDNTNTPTASEKDGKDERNIVVYDFKRPNRVSKEQLRTIKGIH
DKLARNLASQISSMMRSIVETKLHSVDQMTYGEFLMSLPSPTSFNVFSIKPLDGNCVLEI
NPSIAFPMIDRLLGGQGDSYEASRELTDIELNLLDSILRIIMQRLKESWATVTEIYPSIE
AKESSPNVVQIVSQNEIVIMVVMEIIIGNSSGMVNICYPVVHLESILSRLANRDIMMGET
SAKKSRNKELKTLIGRAEVVYEAILGKTLINVHEFLELKQGDILRLDREADDKAIVSIDK
KDVFLAQIGLHRFRKSIKILELIRTDKDEIKEILERYEEERKAKASVYDEPEEEEEEI
>fig|195.2024.peg.1715 Protein translocase subunit SecA
MFLNTLKAVFGTKNDREVKKYLKRVAQINALESKYQNLSDDELKAEFGKFKEQILSGEKK
ESDILNDVFAIVREVGKRTLNMRHFDVQLIGGMVLHDGKIAEMKTGEGKTLVATLPVVLN
AMSGKGVHVVTVNDYLAKRDAEQMSAIYNFLGFSVGVILSSQNSDLEHKKAYDCDITYGT
NNEFGFDYLRDNMKFSKAEKVQREHHFVIVDEVDSILIDEARTPLIISGPTNRTLDGYIK
ANEVAKQMQRGEAVLPPAKPEGDFIVDEKNRNILITEAGIAKAEKLFGVENLYSLDNAIL
AHQLDQALKAHNLFEKDVHYVLRNNEVIIVDEFTGRLSEGRRFSEGLHQALEAKENVKIQ
EESQTLADITFQNYFRMYEKLAGMTGTAQTEATEFSQIYSLDVVSIPTNIPIKRQDKDDL
IYKTQNEKFKAVIEEIKKANAKGQPVLVGTASIERSEVFHNMLVKEKIPHHVLNAKNHEQ
EALIIQDAGKKGAVTIATNMAGRGVDIKIDDEIRALGGLYIIGTERHESRRIDNQLRGRA
GRQGDPGISRFYLSLEDNLLRIFGGDRIKNIMERLGIQEGEHIESRIVTRAVENAQKKVE
SLHFESRKHLLEYDDVANEQRKTIYRYRNELLDEEYDIKTKISQNIAEYSAYVMNDFMIE
ESGTELNFENLKAKILDECSIELKQSDFENLSLIEMQKKLSEILEKSYDEKMSKLDSKQL
HHIERILYLQVLDNAWREHLYQMDILKTGIGLRGYNQKDPLVEYKKESYNLFLELVNRIK
FDSIKLLFSVKFNQEEAQNLEEKANQENEALFEKSVEMGASEDNLGEAEFKKVPRNAPCP
CGSGKKFKECHGKSGPKQGILA
>fig|195.2024.peg.1169 Rod shape-determining protein MreB
MILDQLIGFFSSDMGIDLGTANTLVLVKDKGIVINEPSVVAVERERYGSRAKILAVGKEA
KDMVGKTPGNIEAIRPMKDGVIADFDMTEKMIRYFIEKTHRRKSFLRPRIIISVPYGLTQ
VERKAVRESALSAGAREVFLIEEPMAAAIGANLPIQEPKGNLVVDIGGGTTEIGVISLGG
LVISKSIRTAGDKLDTSIVNYVKEKYNLIIGERTGEEIKIAIGSAIQLPKELSMVVKGRD
QVSGLLSRIELTSEDVREAMREYLKEIADALKMVLEMMPPDLASDIVENGVVLTGGGALI
RGLDKYLSEIVRLPVYIADEPLLAVAKGTGKALEEISLLQQLTNEE
>fig|195.2024.peg.695 ABC transporter, ATP-binding protein (cluster 3, basic aa/glutamine/opines)
MSILKIKNLQKYYGFHHALKNINLEVKQKEVVVILGPSGCGKSTLLRCINGLEEIADGVI
EIGQDKIDKNFKDWTRVRQKVGMVFQSYELFEHLSVKDNILLGPLKVQKRAKEEVLQEAK
IWLEKVGLAHKIDAYPKELSGGQKQRIAIVRSLCMNPELMLFDEVTAALDPEIVREVLEV
ILNLAKDGMTMLIVTHEMGFARAVADRIIFMDNGEIIEENTPDGFFENPKSERAKKFLNL
FDYHK
>fig|195.2024.peg.1117 Putative outer membrane protein
MNKKFLSVIVGIALFSSSALAAEESGFFIGADAAYVQTKVKGDLKHNKTGAVFNGDLSSS
IPILGLRMGYRFNDLHRLYAAYNYSDEFSDIIRTPNLRIEGDFNTHKFLLGYDFTPEIFK
RVRAVAGGYLGYAKTSIDLKTSLLSLSQDFDGFVYGAKIGAIFELGASNEIEVGFKAEQI
EYNTRNYYQEAIGSNFYDPRQTNYGLYLGYTYKF
>fig|195.2024.peg.1323 Diadenosine tetraphosphate (Ap4A) hydrolase and other HIT family hydrolases
MIYENDLIYIEKEEAQVPWIKIFTKQVYKEFSDCPYELQKEIFDKILRCEKAMIEFYKPE
KINIASFANYVPRVHFHIMARFKEDAFFPECMWGKQQRELKDLNLPSFDEFVIFLKNKMD
>fig|195.2024.peg.1721 hypothetical protein
MFSYIFTDFYRVKIEIKLSKISKNILRLKLSSLSCVQVVGERSICVEGIPVRSAGANRSE
HAGMSSDN
>fig|195.2024.peg.345 Putative two-component regulator
MTNILMIEDDLELAEITAEYLEKFDMKVDIAHEPYIGLSKLALKEYQLIILDLSLPGLDG
LEVCEEIRKKYDTPIIISSARHDITDKVNALELGADDYLPKPYNPKELQARIKSHLRRIS
NTKSAIAKSVKDLVYDQYKHIITMKGQELTLTNAEFDILSYLIKKEGGVVSREELVYNCS
SISEDSSNKSIDVIISRIRQKMGDDPKTPKYIHSIRGIGYKLTQ
>fig|195.2024.peg.855 hypothetical protein
MKNFTPLKNKLDSLVEEKNTNKALFESPDPLQVAKFHNDEFIALLCALFAYGNAKNIVNF
LKKLDFSLLDLSQKQIQKELKNLKYRFQNEKDIQEIFLTFARLKNEISLHELFSTAYQKR
ENTTDAILAFLQKIKTLNSYSSYGYDFFFGKIWQNTPTSPLKRYNMYLRWMVRKDELDLG
LFTKIHTKDLLIPLDTHTHKISLTLGLLKRKIYDYKSVLELTHNLKRLDANDPIKYDFAL
YRLGQNKELSKLKE
>fig|195.2024.peg.552 NOL1/NOP2/sun family protein
MEYNLASIYNDKELENLKNSFKLPKKICCFINRLKCDNLTLEREFQDLNLEYKKLNEYCY
LFKACDKSILSSMQAFNEFKFYIQNYASYLCALNLDVKAGQSVLDMCAAPGGKSINLANF
MQNEGYLACNEASKDRFFTLQKNLKNYGVKARVFMKDGKNIGNLCPLKFDKILLDAPCST
LAKMGLELEKSSKEIKNIAKLQKKLLHSALKALKVGGELVYSTCTFTKEENEEVIENALK
SDFDIELLDINLENALAKNGQSSEFEAISKCKRILPCEEYDGFFITKLRKN
>fig|195.2024.peg.114 Branched-chain amino acid ABC transporter, permease protein LivH (TC 3.A.1.4.1)
MDSTLFLQQLVNGLSLGSMYALIAVGYTMVYGVLRLINFAHGDIMMVGAYIALLLINFFS
PIINHLNQTFFGSDELGKYLVVIFAAALVASMIFSSIVGILIDKIAYKPLRKAPRISLLI
TAIGISFFLQNLFNVIFTSTEQQFPAPPIFETLVSIGGVSTTLGSLLVPLVTLVVMLGVL
FILYKSKYGIAIRALAFDIQTVNLMGINANKIIAIVFALGSALAALAGIFWSSNYYSAYP
TMGTLVGLKAFAAAVLGGIGSVVGAVLGGLIIGLTEVMAVAFFPELSGFKDAFAFIFLVF
ILLFRPTGILGINFEKSRF
>fig|195.2024.peg.452 GDP-N-acetylglucosamine 4,6-dehydratase [NAD+]
MDGKGEKVRNILVTGADGFIGSHLCESLVKKGFKVRALSQYNSFNFWGHLEKSPFLKDME
VISGDLRDSFFCEKITKNIDAIFHLGALIAIPYSYAAPQSYVDTNVNGTLNMLEAAKKNK
ISHFIHTSTSEVYGTAFYVPIDEKHPLQPQSPYSASKIAADMMALSYYNSFNLNVNIARP
FNTYGPRQSARAIIPTIITQILSGAKEIKLGDLSPKRDLNFVLDTCEGFISLLNLKHFGE
VYNIGSGVEYSMQEVLDLIQKILDSKVKIIQDEQRFRPKNSEVFRLCCDANKLKKATNWQ
SKISLEEGLRQSIEYFKENLENYKSELYNV
>fig|195.2024.peg.1352 NADH ubiquinone oxidoreductase chain A (EC 1.6.5.3)
MSHIDASHPYFGIFLMLVLASVIFFGLVFLASKIGNNFAAKNRKKLGLGIYECGPIPVKQ
ANKINSQFFIVALIFILLDIEVVFLFPWALIFKDLGWFGLLEVFVFILLLGVGFLYAYKK
GAFAWQSIK
>fig|195.2024.peg.1514 membrane protein
MVQAYPYILIIHLSCAIFFIGYLFVDIFILNIIKRKNPNFDKNLFSSVGVKIMPFIVLLL
FLSGGAMISFHLNPLNLIFLIKLILAFSILSLVVFSLFFHFVLKRKNPLTRFIHPFVFML
CIFIVVLAKLMNYYFL
>fig|195.2024.peg.520 hypothetical protein
MASDNLKQVIINVSAKDFIVKCSGEFANFLEDDIALISGGTKKIELKRFVDAFVKKSYEN
YILERELKKLIKAINEELPVK
>fig|195.2024.peg.185 Thiamin-phosphate pyrophosphorylase (EC 2.5.1.3)
MKNDLDLSLYLVASRGKKSDEFFLNTLEEAIKGGVSIIQLREKELSSREFYKLGLKVQKL
CKEYEIPFLINDRIDIALALDADGVHLGQEDLEVRFARKILGKEKIIGLSLKNLEQLKDI
DGADYLGCGAIKATPTKESSVISFETLSQICEKSPIGVVAIGGIDKELIKELKGIKISGI
AVVRAIMDAQNAYLATKELRQEMNENLSFK
>fig|195.2024.peg.1268 Lipoprotein signal peptidase (EC 3.4.23.36)
MVKRYKTILIFILVFIAVFAFDQWVKSLTLSGLRWQSEYLDLTYALNTGVAFSMFSFLEH
YLKYLHLALILALVIYLLWQKQFLREHLVAFGMMLGAGCSNLLDRFIHGGVVDMFFWHKW
FHFAIFNVADVMINISVALILIKEIFIKKEKNDRMD
>fig|195.2024.peg.870 Helicase
MKFKPFLALEASAGSGKTFALSVRFVALILQGAKINEILALTFTKKASNEMKKRIIETFL
NLEKESKKSECKELCELLGCEEDELIFLRDKKKQEFLRQELKISTFDSFFSRILRAFALN
LGLSSDFDTSEEKLDVRAVFLKLLNRQELKDLAYYKVSLEDNHDFFEELENFYENAYFKE
CVRIPNPSKASINQAYDDLRVYCLSLDHVKGYKYLCTHFKDEVLQLSQFAKSDLLNLTGA
PKYLQELEDSDVKFSQKRKAFIKALDAYAKELEEYKIANLMNLLSHFSKAKDIIQKDKNT
LSFSDISRRVLDLIRSDFKDMIYFRLDGYISHLLIDEFQDTSVVQYQILRPLIAELVSGE
GVKKNRTFFYVGDKKQSIYRFRKGKKELFDLLQTEFKQIQKDQLTINYRSKQILVDFVNK
TFQSKIKDYTPQLSLESKKGGFVRVIESQETKVDKDQAKEIQDKTLEALLEQLKFLKSKN
IIYDDICILCWKNNDADMILDFLHEQDIPAFTQSNILLENKACIRVLLEYAKYCIFGDKF
YLHFLKEMLGFEPLKLKLDLAKSAVQNVLYLIKELKLDLNDMALIQFIEYAKSKDDFLKL
LFEPCTLKIMSEQNRGINIMTVHKSKGLEFDHVILLDSLSKNNPNNKTIMLEYDIDQGWE
LHIKDSYRKATQESEYKAFIEKITKADYEDDINKLYVAFTRAKDNLIIIKRNASFQSGNY
PSYLNTMLDIEIQELGEIEIQTNDTHLPQKESFQALMEFEKIPLQDIERKENTSSDEIYF
GNAFHFFMQNLKLPQGENFDILCQKVSGKFRHFLNHDDFERLFKRIKNLLANAQFQKLIE
NKKLLKEQALSFQGEIKQLDLLALGEDEAIIIDYKTGLNFNKHKEQVLLYKEAIEKILAK
KSTQAFLVYVLEDKVEIIEI
>fig|195.2024.peg.1354 Putative peptide ABC-transport system ATP-binding protein
MKVRNLSLKLNQKKIFENISFDIKIAKSLMIVGESGVGKSLLGKSLIRLLDPKFEINADE
WSFNEVSVFNLNQNELRAFRSKVGLVLQDAELSLYPYLNIGNLFHLILKTHTKLNQKDRK
RYAFDLLEKLGFDDVDLLWHSYANELSLGMARRVSLALALLSKPQILICDEITASLDKEN
VQKIIQILKKLKNTLGLVCITHDLNLVNSLADEVLFLEKNQAQLFRVDEFLRIYHA
>fig|195.2024.peg.1215 Broad-specificity multidrug efflux pump YkkD
MEWFYLFLATACEIFGVVIMKELVSTKNKLYLLALIVCFGFSFTFLSLSMQNIAMSVAYA
IWTGAGTAGGVMIGVLFYKESKCFLKLFLIAVIITCTAGLKFLS
>fig|195.2024.peg.233 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase (EC 2.4.1.291)
MQKLAIFIYSLGSGGAERVVATLLPILSLKFEVHLILMNDKISYEISECKIHFLERSKPS
ENPILKFLKLPFLALKYKKLCQKLNIDTEFVFLNRPNYIALMAKIFGNKTRLVINECTTP
SVMYAKNNFNSLANKLLITLLYPRADLILPNSKGNLEDLLCNFKIDKAKCEILYNAIDLE
KIEQKALEDISLKDKFILSVGRLDEGKNHALLIRAYARLKTDLKLVILGEGVLKDELLAL
IKDLNLEDKVLLLGFDNNPYKYMSKCEFFAFASVFEGFSNVLIESLACGCAVVCTDHRSG
ARELFGDDEFGLLVEVNNENSMFMGLKTMLEDENLRKAYKKKAKDRALDFDKAKIARNAL
KYLLG
>fig|195.2024.peg.1572 Valyl-tRNA synthetase (EC 6.1.1.9)
MYDKSIEKTYYQICEERGYFEIDGNKAIQEKNKNFCIMMPPPNVTGVLHIGHALTFTLQD
IMTRYKRMDGYKVLYQPGLDHAGIATQNVVEKQLLAQGIKKEELGREKFIEKIWEWKEQS
GGKILDQMRTLGITPAWSRLRFTMDEGLANAVKKAFVELYDKKLIVRGNYMINWCTHDGA
LSDIEVEYKENKGKLYHIKYYLKDSDEYLVVATTRPETFFGDTAVMVHPDDERYKQFIGK
ELILPLSNKAIKIIADEHVEKEFGTGVVKVTPAHDMNDYEVGLRHNLEFISVFDEKGILN
EHCLEFKGLERLEARDKIVAKLDSLGFIDKIEEHNNQVGYCYRCNNIVEPYISKQWFVKQ
EIAKESIEKVALGESKFYPSHWVNSFNAWMKDLRAWCISRQLWWGHQIPVYYCECSHEWA
SQDTPKACPKCGGQNFKQDEDVLDTWFSSGLWAISTLGWGNDTWGKDKIWFEEDLKEFYP
NSLLITGFDILFFWVARMMFQSTNALGALPFKDIYLHALVKDEQGRKMSKSLGNVIDPNE
SIKEYSADILRFTLALLAIQGRDIKLSNDKLLQVRNFTNKIYNATNYLLLNEEQFEDLEK
IELKSALAQFVYSRFQDCVKNVRENLDNYRFNDAANTLYKFFWDDFCDWGIELSKAQKES
VKELGSIFKEALKLLNPFMPFISEYLYHKLSKSELKTSASIMISKYPQFHAKNSNIEEIF
SLIIESIVSIRRAKSLVDLGNSKIEKAYIKLNDKKMQDEIKSYMKFITMLAKCENIEFTE
NKLQKAICDVSENLEIFITLNNVDLSGILTRLENQKTKLEKESTKLNAMLSNEKFIANAP
KEVVEQNKEALANLKTQLEKISAELANLKG
>fig|195.2024.peg.151 Membrane protein
MSRFFLYLLIILILALITFALREKLGKKTKPFFGILLVIFIVLAVFFEFENTQKSHLRTD
IIVAFNQNKNILCKDINVSKAYFNYEFGTGSFISKDNNQSFNSLIIDIKDCRLNDE
>fig|195.2024.peg.280 Guanylate kinase (EC 2.7.4.8)
MSAFILLVSGPSGAGKSTLLKKLFDEFQEELYFSISSTTRLPREGEQHGVDYYFITHDEF
QQGIDKEQFLEWAKVHENFYGTSLEHIQNALNDGKIVVFDIDVQGFKIVKKKMAEKIISV
FITTKNKDELKKRLIKRNTDTILQLEKRLQNASDEMKELNEYDYFIINDKLEESYEALRA
ILIAHKFKTKGQNLEQIQNIWNKGE
>fig|195.2024.peg.1454 Fe2+ ABC transporter, permease protein 1
MLVKMITHSIFRNKIQKFLAFLTCFLATLLLCTMLNITLSIGDEVTKQLKSYGSNILVLP
KGSSLSIEIGNELYEPLKNKNYLEEKNLYMLKDIYWRNNITAFAPFLEGKIEIKSNNSSK
KILLYGTYFQKAIEIKDDDDFITGIKSLYPYLKVQGKWAKDDSNEIMLGEDFAKNNDLKI
NDTIQLIGENKISKEVKIVGILLHANPKMSNKIITPLNLAQELLEKKGLYASAEVRAFTI
PESALSEKVRRMGEEKLDQIEYDKWYCSAYVGSIASQISDGLPGADAKALNAISDAQSLV
VKKIQSLMAITCIICLIVASIAISSLMSSEIHRRKKEIGLLKVLGANTFQIYLLFAGENL
IIALVSAVFGFIFGIGLSELISLGIFGYFINIAFIALPLSLVFAGLIAILGCLLPIKNIA
NLSPAGVLYGR
>fig|195.2024.peg.516 gamma-Glutamyl-CDP-amidate hydrolase involved in O-methyl phosphoramidate capsule modification
MFIGITQRLICNESYYEERECLAKDWGELFNKDLFKNFIPLPLSYEIDFSRYKDLVKAVI
LSGGNDLNFLNPNAMSKKRDSYEIQVIEACLKEKIPLLGICRGAQIIAHYFNSCISPYVN
HVSKHEIFFLEEKFISNSFHNFAIARLGDELEPLCFAKDKTIEAFKHKYENIFGIMWHIE
REDGLNNVQILKEWLDLIKEEK
>fig|195.2024.peg.1335 Putative periplasmic ATP /GTP-binding protein
MKKFIKSKDTSDAFTLFELVLVVLILGLVISIAQINLKQDRLMQGAKQILNDIRYARTLA
MTQESFRDLELAVAKREWYKSRWQLYFINSAATNYEQTYTIFLDKNGDGNANLGKTEINI
DREIAVDIINPKKLINSGQSGVIDKSDSKTTQRFNIFKKFGIKKVEFKGSCRGSTRIVFD
ERGRLYSPLRTSQGVYDKNLAKTNQDCVIRLSSIQANQICIIVNPLSGFAYIPKFQDFNK
QMIMINGVLSQCSKI
>fig|195.2024.peg.1186 Chemotaxis protein CheV (EC 2.7.3.-)
MFDENIVKTGSNEMELVDFRIFKQGHDKVYEGIYGVNVSKVREIIKIPSLTELPGVPDYI
EGIFDLRGVVIPVVNLAKWMQITEPESTMLKPRVIITEFSNILIGFIVHEAKRIRRINWK
DIEPATFSTGSGALDKGKITGVTRIENDEVLLILDLESVVEDLGIYSPKTDIDFSKIEKF
SGSALILDDSMTARKRVKEMMQQMGFQVIEAKDGVEGLNKLEELSQVYGENLSSVLKIIV
SDVEMPQMDGFHFAARIKEDARFKDIPIVFNSSLSNEFMNEKGVHEAGGESYLVKFNASD
FFNEIAKVIKKHQSQEQG
>fig|195.2024.peg.725 Dicarboxylate carrier protein
MMDTINIIILFSLIISIALGYVLKANIGVFAILSAFIGAYLYGITPEKVINLWNGSLSLF
FILLSITYFYGFAIANGTLNNLR
>fig|195.2024.peg.423 hypothetical protein
MEKQFYEILENILETKVDENTNLSMENCKNWTSLAHIDIIMSLEEEFEIKFNKEDLSLLK
SQSALLEKIQTLKAEK
>fig|195.2024.peg.30 Phenylalanyl-tRNA synthetase beta chain (EC 6.1.1.20)
MIITKSWLSDWLDFEDKSLDDIAHTLNSIGIEVDKICTLKVPDKIVVGFVKEKVKHENSD
KLSICQVDVGNEILQIVCGAQNVAQGQFVAVALKGALMPNGMEIKEAKLRGVDSCGMLCS
STELGFEKINDGIMLLDDSIGKLELGKALNSYEIFNDGLIEVELTPNRGDCLSIYGIARD
LAVALNLNLKEKPPFKEGENILGIGRILRLSAEKELNSLYNYRAIELKEKIQTNLLISLR
LAQIENFGKNPIENLLNYATHSTGVLFNAYDLNSFYKENEEFTFSLVKETRGETKISYQD
ELLSVSGIYQEEKFKCKEDSKIIIIEANYTDPMIIADAKMAYKKQDEQTIYRSFRGSEPK
LNLGMDFLLSVLEKNPNLIIYSSSQQIITNKELSNIAISIESINKTIGQEIDKDEVLKIL
KKLGFELIISADGLVNVKAPMHRPDIKNLADICEEVVRIIGIDNIASKGLEFVEKNRLNS
TYKNYKELVELRKKAVANGYFESLHYVLDNEEELKSLGFNPIKLKLINPITAELNTLRTT
LLNHLLNAASLNAKNSKKIIKLFELGVVFGTNNEELNHIAFVHSGYQEEPKISNKAKPEL
VNFYDFLLDLKNIIGDFKLKASKHDILSPYEQADIYLKDLKIGFAGRLHLKIENERDLLK
TYICELDLNLIKHHFKLAKPYSKFPSISRDLSILIPKGFEYEKIKNCIEELDLENLENFR
LVDLYSDASLENSYSLTLKFVFRDMNKTLEEAQVAEHMDKILQSFKEMGLELR
>fig|195.2024.peg.540 Lipopolysaccharide export system protein LptC
MAIRIFGILIALFTITFTILSLQDPYSLNIKSYALNFKNIEASDLNAYELNASNVKSYYK
AQSWARYTDKDEFDNFVNFNLDFNLSANKLELKGKEMDKVLLEGNVTYIGLNNTKIFADK
VEYAPKNKILSTNTGFKALINGSIINGNTLNYDVEKKILQVQGVNAWLER
>fig|195.2024.peg.864 Haloacid dehalogenase-like hydrolase
MKKTILFDLDGTLIDSTDAILNSFQGAFKILGLTPKNNEEIKNLIGHPLEHMFKILYHEK
AHLSQEFVLAYREIYSQIYLEQTTLLPKAKEALELAFEIADLGIVTTKGGKFTPLLLEHL
GVKKFFKTLITLEDITNPKPHAEPILLALEKMQKTKENAYMIGDTILDIQAAMAANITPL
ALSCGYGDEDELKRYSMVFPSAYKSVLYIKND
>fig|195.2024.peg.1085 LSU ribosomal protein L18p (L5e)
MRANVLKRKLTLRIKRKKRIRAKISGCENFPRISVFKSNRTLYIQAIDDVKAVTLAAVDG
RKLGVKANKEGAKKIATEFAKVLKAKQIEQAVFDRNGYVYHGVIAALAESLRENGIRL
>fig|195.2024.peg.1098 LSU ribosomal protein L2p (L8e)
MAIKTYKPYTPSRRYITGLSSEDITAKPSVRSLLVKLPVHAGRNSYGRITSRHKEAGAKK
LYRIIDFKRRKFGIEGKVEAIEYDPYRNCRIALISYKDGEKRYILQPRGLSVGDIVAAAE
SGLDIKPGNAMKLKNIPVGTIVHNVELKPGKGGQMIRSAGAYAQLMGKEEKYVILRLASG
EMRQVLAECMASIGEVGNEEWANVTIGKAGRNRHRGIRPQTRGSAMNPVDHPHGGGEGKK
NSGRHPVTPWGKPTKGAKTRRKKASDKLIISRRKGK
>fig|195.2024.peg.561 [NiFe] hydrogenase metallocenter assembly protein HypD
MNFIDEFRDKESILALKKLIEQELKNPINIMEICGGHTHSIMKYALPSILPKEINFIHGP
GCPVCVMPRVRIDTAIKLASMKDTIFCTLGDLLRVPGSEISLLDLRAKGADVRALYSPLE
VLEIAKQNLNKNIIFFAIGFETTTPMSALLLQKVIEEKINNVFFHINHITVPAPVEAIMN
DENVKINAFLGPSHVSVITGYGIYEPLAAKFKTPIAVSGFEPVDILESVLNIIKQSNEGT
FKVYNQYKRAVSKEGNVKAQNLVKKYFRVCDFEFRGLGLIKDGGLELKEEFSAYDASKKF
DCTVQSKNESKACICGQILRGLAKPYDCKVFGKACTPRSPIGSCMVSGEGACAAYYKYSK
VNA
>fig|195.2024.peg.159 Exodeoxyribonuclease VII small subunit (EC 3.1.11.6)
MSFEENLKNANESLEKLNDKELSLDESVKIYKEGLKSIEKARLALEKARLEVEQIDE
>fig|195.2024.peg.1440 ABC transporter, permease protein (cluster 9, phospholipid)
MEANFKFQKEENKVFIFGIWDKTSVSKIKIKDLLSQISQTNCIFDFSQLNEIDMTGVRFF
LALEHDLKKNDILILKQGLNTRFKSLFELCEKNYQRINEKQEKKFNFTDFFISLGILSFD
LLKILQKFINFTGAFFTSLFLCIKNPKNFRFISFLYHIENSAFKALPIVILTALLVGVVL
AYQAAYQLAQFGANIFIVDLVGISATRELAPLIAAIVIAGRSASSYTAQIGVMKITDEIN
AMNTMGFRSFEFIIIPRVMALVIAMPLIVALSDAISILGGMVVAKINLDISFGEFLRRFR
EAVEMKHIIIGLAKAPIFGFLIGLIACFRGFEVKNTTQSIGIYTTKSVVNAIFWVIAFDA
LFSVVLTIMEV
>fig|195.2024.peg.356 Putative phosphatase
MLGIDLGSNTLRAVFINEKFEKLDEYEFIIGSAKNLDKTGKISDEAIEKLRNALQEIAKK
YDLSQARAVATAAFRKASNTNEIFTRLKQEFQIDFKVIDAKIEAKISVLGMKRGLLNLGL
NLDCGYCDLGGASCEFSFRDNFQSFDFGIISFYEKCKIKKIANSFSFKKILQKYPNFPYR
FKDKKLKIHFLIHDNFLKTMAFEAFGQSNGLKKALKQSKMKNIVLNSGVPTALAALKKGL
NYEKYEAKKINGARLNINDFLTFGQKLWYMDEKKASFWVGNTRKNYLVAGCFLLFSIFER
EKLIVIDEGLREGLCMADLNLKDYQ
>fig|195.2024.peg.823 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MKIIVALSILGLLVLLVSNKIKPFILFGSVAVLYYLLGYLNLNSWLGSYTSESLIVLILL
LLVSLAIEKSVVIAWCSKFIIGKNYHLSLLKLGVITASISAFLNNTAVVASFMSLIKNNK
FQAPSKLLIPLSYFSIVGGTMTLIGTSTNLIVNSFVVQNGLESLKIFDFFAVGFCISVSV
LIVLLIFSFLLPNYKEKDNEINEYLINAKVLKNSSLIGKTIQENGLRNLEFLFLFEIQRQ
DEIISPVSHDEIIKEGDVLIFSGDITHLETLKKFDGLQMGAQEIKLETLNLVDVVINSES
SLIGKSVKEANFRAKFDAGIVALKRGSQNISKIGKSILQAGDRLILSVGKDFHSRDNINK
NFYIISNIIQNQKLSNAQSFIVVFAFLAIIALSALEIVSLLKALLVFLAFLFVFKFISFD
EIKRRFPLEIFIIVGSSLAITKVLVDSGLAKDFADLIIGTFGAYGLYGSFVGIYLLTLLL
TEIITNNAAAALAFPIAYSTALALEVNPVPFILAVAYGASCGFMMPHGYQTHLMVGSICG
YKTTDFVKIGWIVSLTYSAMVLIMTPIFFKF
>fig|195.2024.peg.374 Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8)
MLNIFKSLTNLLYGKKGQMMQYSIEINGNLEVFDIEKVAKQAAGAVLMRQGKSVVLAAVA
REEKPVEEDFLPLTVQYIEKAYAAGKIPGGYVKRETKPSDAETLTARIIDRSLRPLFPKG
YAYPTQIVVMVLSADPQVDLQVMSLNAASVALYLSDIPMKAPVCGVRIGRIEEKFVLNPN
NEELKNSTLDLYVAGVKDELLMIEMRALPNQKEDEIFIEVPYADVLTQTTSQSMNELSED
EILEALSLAQKAILNGSNAYEEAFLKHKKSSDLNFKDEIENFELLAFIENNFHDQIVQAI
NQMAKSERASELNKIAEKILNFESATKWDEESILNALAKVKHKIVRSQILNTKKRADGRN
LNEVRPIAIETNILPNAHGSCLFTRGQTQALVVATLGSENDAQMVDVLTEKNPINERFMV
NYNFPGFSVGEASPIKAPGRRELGHGNLAKRALYPSIDENYPYIIRLVSEILESNGSSSM
ATVCGGSLALRAAGVPSLKLVAGVAMGLIFEGDQYAILTDIMGLEDHDGDMDFKVAGSKD
GITALQMDIKLGGIDQKILKEALYQAKEGRIHILNIMEEALKEIVVNEEVLPKLELFNVD
PSKIVDIIGQAGKTIKEIIEKFGVSIDLDREKGEVKIAGNENEQIKAAKDYIINITSSQK
NNKKGFKEKDLSNFEIGEEFEGKVKKITNFGAFIELKNGIDGLLHNSKSKNLNLSENQIL
KVKVSEIKNGKISVDLCE
>fig|195.2024.peg.1618 N-acetyl-gamma-glutamyl-phosphate reductase (EC 1.2.1.38)
MRLKVGILGASGYAGNELVRILLNHPKVEISYIGSSSSVGQSYTKLYPNTPLNLNFEDKN
LDELELDVLFTATPHEFSAKLFSESLLKKMKIIDLSADFRLKNPKDYELWYKFTHPNQEL
LKNAVYGLCELYQEEIKNANLIANPGCYTTCSILSLYPLFKEKMIDLNSVIIDAKSGVSG
AGRSAKVENLFCEVNENIKAYGLASHRHTPEIEEHLSYAAGEKITLQFTPHLVPMQRGIL
TTAYANLKHSVSEKEIREIYQKYYQDRKFIRLLPPQSFPQTRWVKSSNFADINFSIDERT
NRIIVLGAIDNLIKGAAGQAVQNMNLMFDFDEDEGLKFFANL
>fig|195.2024.peg.1589 Chaperone protein DnaK
MSKVIGIDLGTTNSCVAVYERGESKVIPNKEGKNTTPSVVAFTDKGEVLVGDSAKRQAVT
NPEKTIYSIKRIMGLMINEDAAKEAKNRLPYHITERNGACAIEIAGKIYTPQEISAKVLM
KLKEDAEAFLGESVTDAVITVPAYFNDAQRKATKEAGTIAGLNVLRIINEPTSAALAYGL
DKKDSEKIVVYDLGGGTFDVTVLETGDNVVEVLATGGNAFLGGDDFDNKLIDFLASEFKD
ETGIDLKNDVMALQRLKEAAENAKKELSSANETEINLPFITADASGPKHLVKKLTRAKFE
GMIDSLVAETITKINEVVKDAGLDKNEIKEIVMVGGSTRVPLVQEEVKKAFGKELNKSVN
PDEVVAIGAAIQGAVIKGDVKDVLLLDVTPLSLGIETLGGVMTKIIEKGTTIPTKKEQVF
STAEDNQSAVTINVLQGEREFSRDNKSLGNFNLEGIPPAPRGMPQIEVTFDIDANGILTV
SAKDKATGKAQEIKITGSSGLSEEEINNMVKDAELHKEEDKKRKEAVDARNAADSLAHQV
EKSLNELGEKVADSDKENIQKALDDLRETLKNQNASKEEIEAKMKALSEVSHKLAENMYK
KDEPNAANDKKKKDDDVIDAEVE
>fig|195.2024.peg.1265 Acyl-phosphate:glycerol-3-phosphate O-acyltransferase PlsY (EC 2.3.1.n3)
MENLIIYAIAYLLGSIPFGLILAKQFAQINIQNQGSKSIGATNVLRVVKEKDPALAKKLA
IATIVLDFAKATIPLLVLKFLNYDLNLLWTVAVLTVFGHCFSIYLLFEGGKGVATGAGAM
IVLLPLELITAFIVWFIVGKIFKISSLASLLALLVFIGSSFIFNYDMQTIKTHAPVFIIA
FIIIYKHLPNIKRLVFKEECKVI
>fig|195.2024.peg.9 Flagellar biosynthesis protein FlhA
MAKNKLVDLVFPFLGPLIGPVLRAKSLTIVGFIVCILAIIIVPLPSPILDFFLALSIALS
VLIILISIYIPKPTDLTTFPTLILIITLFRLSLNIATTRMILSEGQNGPAAVSEIIAAFG
EFVVGGNMVIGVIVFCILVLINFMVVTKGSTRVSEVQARFTLDAMPGKQMAIDADLNAGL
IDEQTARARRQEIIAEANFYGAMDGSSKFIKGDAVAGIIITIINIIGGFLIGAFQHDMAL
SDAASTYTILTIGDGLVSQIPGLITSTATAIIITRASKDEENFAEGTLTQLLSEYRTLLI
VGFVLFIFALVPGLPHLSLGFMALVFLGLGYLTKQVKEGKIEVNAPKKAKASAANAASGA
GGAGGVTAPAKKSEEEILKEEEHKINDILKVEILELELGYGLIKLAESELTERIRSMRRS
IAESLGFLMPKIRIRDNLRLKPNEYSFKLKGVSIASAEIYPDKYLAMDSGFITEEIEGIA
TKEPAFNSDALWIDANLKDEATLNGYIVIDPASVISTHMSELIKAHASELLTRQEVQNLL
DKVKNDYPIIVEGALGVAPVSLIQKILKDLLKHNIPIKDMLTILESISDIAEVSKSFDMI
IEHVRASLARMITNMYLDDKGNLDIFILDSASSAVLMENVQFRDGSYHLPLSVAQTGTLV
DTLRAEVAAVANGRIKPFILCVEPQLRKFIADICYNFNINIVVLSFAEIAENTNFNTEGI
IRIEL
>fig|195.2024.peg.632 2-oxoglutarate/2-oxoacid ferredoxin oxidoreductase, alpha subunit (EC 1.2.7.-)
MREVIATGNVLIAKAAIDCGCKFFGGYPITPSSEIAHELSHMLPANDGTFIQMEDEISGI
SVTIGAAMSGVKSMTASSGPGISLKAEQIGLAFIAEIPLVIVNVMRGGPSTGLPTRVAQG
DLFQAKAPTHGDFASVAIAPASLEEAYTETIRAFNLAEKYMTPVFLLMDETVGHMNGKAV
LPDLKDIEIINRKKFTGDKKDYKPYAAGENEPATLNPFFTGYRYHVTGLHHGDIGFPTED
GAIVKKNMERLIGKIKNNQDDICTYEEYMLDDAEFLIIAYGSVSRSAKEAINRLREEGIK
VGLFRPITLYPVAEKKIAEVASKFKKVMVSELNMGQYLEEIERVSSRRDFISLHRANGRP
ITPSEIIAKVKENI
>fig|195.2024.peg.627 All-trans-hexaprenyl-diphosphate synthase (EC 2.5.1.33)
MQPIDDLIKQYLQELDYEPILTMLANTKSGKKLRSKLLLAIAGENANSYKICAAIELIHL
ASLLHDDIIDESKLRRGAKSVNAEFGTKNALMLGDILYSKAFYELSQLDACFASIISDAV
VKLAVGELMDVELSKSFNADKDKYLKMIYNKTAVLIEASARCGAILANLDEKAFGEYGKN
LGLAFQMIDDILDIKGDEKTLGKPAMNDFKEGKTTLPYIYLYENLNNEDRAQLKNLFQKD
LNNDEKIWIQTKFEETKALNKAILEAKEYAHQAALAIKDFSNEKLQDIIQAMIDRDF
>fig|195.2024.peg.1710 N-carbamoylputrescine amidase (EC 3.5.1.53) @ Aliphatic amidase AmiE (EC 3.5.1.4)
MKIALIQQKFHFTKEKTIEKTCEFIEQAAKQGAELVCLGELHQSEYFCQSENVDFFDLAN
DYEKDVQFWSSIAKKHGVVLLTSLFEKRSAGLYHNTAVVFEKDGSIAGKYRKMHIPDDPC
FYEKFYFTPGDLGFEPINTSLGKLGVLVCWDQWYPEAARLMALKGAQILIYPTAIGWFDK
DEKEEKQRQLGAWLGVQKGHAIANGLYTIAVNRVGFEEDKSGVEEGIRFWGNSFVFGPQG
EEICILDSENECIKLVDIDLQRSENVRRWWPFLRDRRIEYFGDLSKRFID
>fig|195.2024.peg.1646 N-linked glycan phosphoethanolamine transferase EptC [Campylobacter]
MFKFKLSWFGFVLFNSILITLLNFNLHSFVYEKLSQNLLLTLVFIVAYFGLVHMIFSLIF
VKYLTKILSIFFILSSCTSLYFITFYGVLIDSDMIQNVMQTDIKEVKDLLSWRLVLLAIV
VLLFCVFILRIRIENNTEQGFFKKIRVRVLSALLGCSIFLIAFVPLSKTFIPFFRTYNEI
RMYNVPFYQIYAVYRYYVRFLKPKSEFKTIGDDAFRENNSSKKLLVLVVGETARAANYSL
GGYAKNDTNFYTKKDNVVFFDNFSSCGTATAVSLPCMFSLSKRQNYSSSEYQENVMDILQ
KTGVKASWIDNNSGECKGVCDRLSDKQQLSSDWDENLLPFLKERLDSLDTQNIIVLHLQG
SHGPAYYKRYPNEFKKFTPTCDTNELSKCDSEALINTYDNTLLYTDYLLSEIIKLLKEKK
DYESSLLYLSDHGESLGENGIYLHGMPYAIAPSYQTHIPVIFWSNDKKLMMTAQNHKGLK
LSQDNLFSTLLGYFDVKTMVYESDYDLLNQTLKAN
>fig|195.2024.peg.598 Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase (EC 3.1.7.2) / GTP pyrophosphokinase (EC 2.7.6.5), (p)ppGpp synthetase II
MKPVDEELLLEKLIEDIKNCRDLTRAKELLFSICQEDAIVEKAVDYCIKSHEGQVRKSGE
PYAVHPILVASLVAFLSENKATILAALLHDVIEDTQCTEEELRDQFGSEVLKLVLGLTKI
VEIREDNLIPSKSKKSLTKSALTFRNMLLASIEDVGVLVVKLCDRLHNMLTLDALREDKQ
KRISEETLVVYAPIAHRLGISSIKNYLEDLSFKYLMPDEYKLIDNYINSNDQQMQLGLNE
FISKIELLFLSNGFRQGSFQIQKRIKHSYSIYLKMQRKGVGIEEVLDLLGVRILVENVSD
CYLALGVLHTNFNPLVSRFKDYIALPKQNGYQTIHTTLFDTKNIIEAQIRTFDMHKIAEF
GIAAHWKYKEDGSVVAPRLDWLTDISMQSTNNLENAEDYNAIELYEYAKDSLYVEDVAVY
SPKGEIFTLPRGATVLDFAYEVHTKVGLHAKSAYVNRVKVPLLTELKNGDIVRVVTSNDR
FYRCSWVDSVKTGKAKASIREFCKQKMREINLLSAINMLSFIFSVDKNKIENWIERENLG
RRIRQVASDSAYLKDIVNGLKKYAKKSYWFDKYEIKEQKIGNFLLYSNHKIANVDFDYCC
HPKRGDAVLAFIENGNAIVHHKLCDRADKMIDNNKDMVLIKWDSNIPKSYKLIFSLENKK
GILAEFLAVLAKMQINLLTISLSSDINTVVDYFEITIEIPDNINPDNVRDRLKSYCKILD
FTSLNDAYKEA
>fig|195.2024.peg.1375 SSU ribosomal protein S11p (S14e)
MAKRKIVKKKVVKKNIAKGIVYISATFNNTMVTVTDEMGNAIAWSSAGGLGFKGSKKSTP
YAAQQAVEDALNKAKEHGIKEVGIKVQGPGSGRETAVKSVGAMEGIKVTFLKDITPLAHN
GCRPPKRRRV
>fig|195.2024.peg.1222 Chorismate mutase I (EC 5.4.99.5) / Prephenate dehydratase (EC 4.2.1.51)
MSNLNLEDFRNKIDMVDDKILELLNERMSYVKSIGEIKQTSGGAIYRPERERAIINRLKN
ANLGLLDQNAIEAIYQEIFAVSRNLEMPQIVAYLGPEGTYTHQAARSRFGAMSRYIALAT
IEDVFKELSNKEAKYGVVPIENNTEGAVGVTLDCLGKYNELKIFGEIYMDIHHSFVGINE
NLKEIKRIYSHPQGYNQCRKFLESHELSNIEFVPSKSTANAAYLASQDKYSAAICSKIAA
KLYNVPVLFDKIEDNAANRTRFLILSDIKNPKMPNCKTSILAHTAHKPGGLSSLLEQFKK
ENINLTKLESRPVKSKEFLHSFYIDFEGHIDDENVQRALKNADEVVWLGSYLSGEKNEIQ
>fig|195.2024.peg.375 G:T/U mismatch-specific uracil/thymine DNA-glycosylase (EC 3.2.2.27)
MSEFLTHPFKPFFDKDSKILILGSFPSVKSREDGFYYQHPRNRFWPILETLFDTRLENIT
KQQAFLKEKNIAIWDVLQSCKIKNSDDKTISYAKANDLNLILSQAQIQAIFTTGKSAYRF
FTKFHPHLKAIALPSSSPANLNFSFEQLLQSYKIIKNFIK
>fig|195.2024.peg.165 Acetyltransferase
MREINLKEDLEKIYPLIKQLRNNLSLEDFLEKFQLAKKTQHYKLFAYEDKGAFKAACGVM
PFNVLYHNHCLYICDFVVDETLRGKGIGQAFLKKIQIWANNQGYEELELSSSFFRTQAHE
FYIQKMGFEKSGFVFKKNIKL
>fig|195.2024.peg.1554 Formyltetrahydrofolate deformylase (EC 3.5.1.10)
MISVLKICTKDQKGLIYRISDVIFKYHINIVKNDEFVGEEMFFFRAILEGEFDKKAFVGT
LEAMLGEEAYIELCEKRKKDIIVFATKESHCLGDLLIKYYSNELEANIKAVISNHDTLKN
LVEKFEIPYHCISAENLKREEQEKQVLECLKEYQFDYLVLAKYMRILSPDFVKHFEGKIV
NIHHSFLPAFVGANPYKQAFERGVKIIGATAHFVNNNLDEGPIITQAVLPVSHEYTWQDM
QQAGRNVEKNVLSKALDLVFDDRIFIHKNKTIVF
>fig|195.2024.peg.1141 Glutamate synthase [NADPH] small chain (EC 1.4.1.13)
MGNARGFLDFKRVDFKKVAPKERVLNFKEFTTLLDKKEQEIQGGRCMDCGVAFCHTGVMS
EGKDVGCPLNNLIPEWNDLIYRSLWKEAYERLDLTNPFPEFTGRVCPAPCEDSCVCAING
KSVSIKNNELAIIENAFKENLVSPNKPKQYNGKKIAVIGSGPAGLACANTLNSLGYKVSV
FERSDKVGGLLMYGIPDMKLDKSIVQRRVDLLKESGIEFKVNENIDSKDKVSKLLKEFDA
LVLCTGASKPIDLDIEGRKLKGVEFALDFLTQNTKTLLKTGKGADTAKGKNVLVIGSGDT
SVDCIAVATRQGAKSIVRFERSPKRPLQRSQSNPWPLKADIFTTDYGLEEAIAVYEKDPR
EYQKMTKKFLGKDKVESVEACDLKREFKEGKAINVELPNSNQNYKADLVLLAMGFSGSED
AIASNFGVSLDEKNNVKTKNFQTTHEKIFACGDARKGQSLVVWAIKDGIECALNIHENLA
K
>fig|195.2024.peg.769 Uncharacterized MFS-type transporter
MLNNVLPLSFIVGTRFFGLFIVLPVLSFYALELQGANEFLVGLLVGVYALTQMALQMPFG
ILSDKIGRKKTMLIGLIIFIIGSLICSWADNIYTMLIGRMLQGAGAIGAVATAMISDFIT
EENRGKAMAIMGSFIGLSFAASMVISPLMSAKWGLSSLFDLSAVLSLLCIILLYTVVPKE
NKLTHENTKTPFFHLIKQKNLALMNFTNFMQKMLMSIAFLSISIILVKHLGFDEHKLWIV
YTASMIAGFIAMGFSGSLGEKRGLAKQILLLGIAFFILSYIFFVFSSTITFFIVAVVIFF
IGFNLHEPIMQSCASKFCKVHEKGAALGLFNAFGYGGSFIGGIIGGIFLHLNKLELLAII
LVILSIVWFIALLYLKNPSEFKNIYLPLETTLNLSEFGKNLGVVDIYKNSKNLVIKFDSK
LTNKEELESKI
>fig|195.2024.peg.570 Phosphate ABC transporter, permease protein PstA (TC 3.A.1.7.1)
MKKLFKKRQKASKSFKRLCKMGLYINLIFLCIFLGSVAYLGFPAFKQTYIFVEANRNSPA
YDLLSRAEQRKIRTGQITEKSWLLANSEVDQYMKQKYNRLSEKQRTLVDDLMQKGEIELK
FNSNFFLNGDSKSPENSGILSSVVGTLLVMLVCMVVSVPIGVAAAIYLEEFAPQNILTHF
IEVCINNLASIPSILFGLLGLGVFINLFGMPRSSALVGGLTLAIMSLPIIIVSTKAALKS
VDINMKNAAYALGMTKVQMVKGIMLPLAMPMILTGSILTLAGAIGETAPLMIIGMIAFIP
DVASSIFDPTSVLPAQIYSWSAMPERAFLERTAAGIIVLLGLLVVLNLSAILLRKYFQGK
LK
>fig|195.2024.peg.53 ABC transporter, permease protein PebE (cluster 3, basic aa/glutamine/opines)
MNESVGFVDKLRQLLSSWGLYDESSTNPFAIWKFLDALDNGDAFISGFIYTLEVSILALL
IAIVFGTIGGVMATSKIKILRAYTRVYVELFQNIPLVIQIFFLYFALPGLGIHLDIFTIG
VLGIGAYHGAYVSEVVRSGILSVPRGQFEASASQGFTYVQQMRYIIVPQTIKIILPPMTN
QMVNLIKNTSVLLIIGGAELMHSADSYAADYGNYAPAYIFAAILYFIICYPLAYFAKVYE
DKLKKAHLTR
>fig|195.2024.peg.899 Formate dehydrogenase-O, iron-sulfur subunit (EC 1.2.1.2); Putative formate dehydrogenase iron-sulfur subunit (EC 1.2.1.2)
MSKVNFANLEKERLKFFCDNERCIDCNGCSVACDEAHELPINIRRRRVITLNEGVQGKEV
STSISCMHCDDAPCAIVCPVDCFYIRADGIVLHDKEICIGCGYCLYACPFGAPQFPKDSV
FGNKGIMDKCTMCAGGPESTNSEKERELYGQNRIAEGKVPVCAAMCSTKALLVGESSKIE
EIYHSRLQSRGYGIANPSQSIEWKIAYIGKERL
>fig|195.2024.peg.1182 Transaldolase (EC 2.2.1.2)
MKKFSLWCDFIENSFLDDDFLNLLSRGVNGATSNPAIFKNAILNSPIYKEKIAKLKGKKA
KEIYEELAIADIQKAADKLAPLYHTGNDGFISLEIDPRFYDNTSLSLGEAKKLYSAIGKD
NVMIKVPATNASYEVMYELMKNGISVNATLIFSLEQSQKCFEALNAGLIEFRKNNIALQG
KNTHLRTPQAVISIFVSRFDRLLNSKAKEQNRIGILNANLAYNNIISKNEPNIRALFAST
GVKGDDLPKDYYIKELLFENSINTAPLDAINAFKTEIEFKKPLMNFEIYTQLNAIISQNE
REKACDELLKDGLEQFCIAFEEILQALN
>fig|195.2024.peg.518 Helicase PriA essential for oriC/DnaA-independent DNA replication
MRYYELAVFGFYLQNLTFHSKEEIPALREVIIDLKNKKNLRALVLKECQKPEFQTKEIKE
ITSFSLSCVQFELAKFISYYYSSKLGFVLGLFSTHQTYTCSATKIENKPELSQKQEEALK
FIETHPTSLLFADTGSGKTEIYICLIKQYLEQGKQVLLLMPEISLTPQMQKRLEVYFKDK
FFLWHSKISKKKKQENLERFCKGEALLVAGARSALFLPFVNLGLVIVDEEHDNSYKASNQ
PYINARDLTLFLSSKFDIKVLLGSATPSLTSFYKQKSFRLKGTFFESKKHFLYDENELGV
TPMLLGELQKSLENQKQAIIFLPTKANFRQIVCKDCGQTIKCPFCSIAMSLHKKRNVLKC
HYCNYTSLIEQNCPSCQGVMLEARKMGTAELQELLQEALPLARIAKFDSDEITSIRKLNA
ILKDFNENKIDILIGTSMLAKGHDYHSVDLSVILGLDEYLFRPNFKASEETLALAMQVAG
RAGRKGEGRVLLQTKNRNFFERYIEDYDSFLQDELENRKDLYPPFKRLLRIVIEDKEQKQ
AQNLCKKLVDQISHILKVEIIGYGACSIEMLKGQYRFYILLRSDFYKVLIKIQEYALNFK
NVSVDIDPIDFL
>fig|195.2024.peg.74 putative lipoprotein
MKKYILMLALLFGISGCFVNERGISNRFYDDCHEYYDASGTYHKDCPKNWVDIKMTP
>fig|195.2024.peg.1555 CCA tRNA nucleotidyltransferase (EC 2.7.7.72)
MVGGSVRDLFLGLEIYDYDIELYDITPSDFEKMMKKLGAQGFGKSFFVYKFKNYDFALAR
TENKTGYGHTGFEVQICNDEKLGAKRRDFTINSMMINLFNDEFLDFYGGLKDLEQGILRH
IDQTSFQEDSLRILRAVAFASRFDFKIADESLKLMQSMNIKDLSRDRINAELYKFFKSSK
LEVGYKYLQELNMEKEIFGFDSAFKSMEFQALLRKSREVVKDDALFLYLYLNFFNLNKEE
FFKKSKIKKEYFKKANQAFYLDEMSDFDLASIALDMPLKEWLGLWDKERIKWAKKFKLYE
NKFKTSILAKDFLDAGIYGKMLGLKLKEARENELYEYIKRLN
>fig|195.2024.peg.1504 Fructose-1,6-bisphosphatase, type I (EC 3.1.3.11)
MQELISYIQKAVIEISNALKFPDTSYSQNQNSTGDTQLKFDVLSDEIITNTLSQCPSIKA
IISEEKDEILNINENAKFIVAYDPLDGSSLMDVNFAIGSIFAIYEEKASAKNLKAALYSM
YGARLELVICEDKPKLYRLDKNNEFVFVKDLQMQEKGKINATGGTQKFWEEKHAKFIKKL
FDEGYRLRYSGAMVSDINQILLKGGGLFSYPATSDAPKGKLRAFFEVFPLAFIIEKAGGK
TTNGKNHSLLELDFDEIHATTPCFFGSKYEISELLKAYNE
>fig|195.2024.peg.1246 DNA polymerase I (EC 2.7.7.7)
MKTLTIIDTFGFFFRLYYALKGFKNSQGQASGMISGFANFIYSLKNEYKSDYIIFALDSK
GKTFRSDIDPNYKKNRTPPPPELLEQIPICIEMIEKMGFMSASYEGYEADDIIASVVKTC
KDKDIFVRIITQDKDLYQLIKDGKTSIYSPISKNDYDEEACFEKYGVKPYQIKDFLALCG
DSSDNIPGVKGIGAKGAKTLLDEFGSIEGIYENLTLVRNERSRKLLLEGKENAFLSKKLA
SLYEDLEVSNLLEKADFPQDEPLLKILEILEHYELNVLLKKLRQNPDNKDKNLGFKATLI
QDEDKLFEILNSLEQESIIAFDTETTSIDTKEAKIVGFSFCMSENEAFYVPLTHNYLGVG
KQVSLQSAKKAIELIFKHFIIGHNLKYDFKIIENNFKLSLPQKYADTMILAWLKNPSLRV
NMDDLALRLFNYETLHFESLVKKGENFASVELEKACKYATEDAYITLRFYLYFLKNLEPH
LLDLAKNYEFDFIKIIMMMEENGIKLDTHALEILMKKFESEIKILSEEIYALCEDRFNLN
SPKQVGDILFEKLKLPSGKKGKTGYSTDEKVLNELLDKHPVISKILDYRELAKLYSTYCE
PLLKLALKDENSRIYSSFLQTGTATGRLSSKDPNLQNIPAHGQYAKDYKSCFIAKEGFSF
ISLDYSQIELRMLAHFSEDEKLLNAFKNDEDIHARTAIMIFGESNYETRSIAKSINFGLI
YGMGYKTLSKNLKIEANLAKTYIEKYFENFTSIKSYFEKVKNEAKANGFISTLSGRKRYF
DFENAKPMQVAMYERESINSILQGSAADIIKFAMLEIAKILNQDKRLILQIHDELIFEVK
DELCENFVKKTSDIMENIVKLKVKLKTSSSIAKKWGDLK
>fig|195.2024.peg.94 phosphohistidine phosphatase SixA, putative
MKKIYILRHAKAVKDEEVQDFDRKLNKRGKEDLEKLFYNLKTHEIKFDFILSSPSKRTAK
TAKKIAEFYNFDKEKIQFIDELYLANLSKIYQILQTIDKKYNEVLLVGHNPTLMELGEFL
GSLCLTSFPTSSMLCLEFDIEDFKDLKAHSGKVIFFEHVRKLKEEKELD
>fig|195.2024.peg.445 UDP-6-deoxy-AltdiNAc hydrolase (PseG, third step of pseudaminic acid biosynthesis)
MKVLFRSDSSSQIGFGHIKRNLVLAKQYDDVSFACLPLEGSLIDEIPYPVYELSSESIYE
LINLIKEEKFELLIIDHYGISVDDEKLIKLETGVKILSFDDEIKPHHCDILLNVNAYAKA
SDYEGLVPFKCEVRCGFSYALIREEFYQEAKENREKKYDFFICMGGTDIKNLSLQIASEL
PKTKIISIATSSSNPNLKKLQKFAKLHNNIRLFIDHENIAKLMNESNKLIISASSLVNEA
LLLKANFKAICVAKNQEKLANWLAKKGYEVEYRY
>fig|195.2024.peg.1667 tRNA-specific 2-thiouridylase MnmA (EC 2.8.1.13)
MKILVAMSGGVDSTVTAYKLKNAGHEVIGCYMKLHGKPNYHEENIKKVEKVANFLQIPYH
VLDLQEDFKNKVYMPFVDTYKEGKTPNPCALCNRFIKLGKLLEFAKSLGCEKLATGHYAR
LENNLIRTAVDESKDQSYFLASADKEALKYLIFPLGEMKKEDVKKFASTIEVLKSFATQK
ESSEICFVEDTYVQVLDQFMDTKIPGEVLDSSGKVVGKHEGYMHYTIGKRRGFEVRGAHE
PHFVLKINPKQNQIIVGTKEELKINEFKLKNINLFIDAKELDCEVKIRYRSKSTPCKVII
NDDKSANISLKESVYGLASGQMAVFYDGDKVIASGFIE
>fig|195.2024.peg.1051 ATP synthase epsilon chain (EC 3.6.3.14)
MDNLISFEIVTPMGVIYQGEVKSVTLPGSEGEFGVLKGHAALVSSLKSGVIDIEKADLNH
ELIAIDAGHAKVDEDKISVLAKGAVWISGSSESEIEKNLESAKELIKSMSSDNTALAATF
SKLDNAKVR
>fig|195.2024.peg.1173 Methylisocitrate lyase (EC 4.1.3.30)
MSAGKKFKELVKTSKPLIIVGAVNAYSALQATKIGHKALYLSGSGVASASYGLPDLGIIA
LEEVCIDVRRICSRVDTPLLVDADTGFGGAFNIARTIKELIRAGAAATHIEDQVAQKRCG
HRPNKELVSTEEMCDRIKAAVDAKIDPDFVIMARTDAHAIEGQQKAIERALAYVEAGAEM
VFAEAITSLEEYEEFVKNVKVPILANITEFGKTPYFTKEELNRAGVSMVLYPLSANRAMN
KAAVQVYESILKNGHQKDVLEIMQTREELYEMLDYYSYEQKLDELFKRGAK
>fig|195.2024.peg.1654 protease IV (PspA)
MQILKSFFKGLGSVIKFINTYFKTFVLLLIVIWLLAPSSNSSSSYANLERIDLKGEILDS
SELLEKIISAKNNDNIKGVLFVIDSPGGAFAPSMELALAIKDLKTKKPVIAYASGTMASG
SYLAGVGANKILANPASFIGSIGVIMQGADLSELAKKIGIKEQTIQAGEFKSAGTFTRAW
SEEEREFLQNLIDESYDLFSEFVAKERDLELDKRKDWANARVFLAQNAKDLGLIDELSNY
ENAKKELQELAKVLNPVWKEEGRIDRFLNRLESQSSNFLGKVISDTVLRLNANFLELK
>fig|195.2024.peg.1379 ATP phosphoribosyltransferase (EC 2.4.2.17) => HisGl
MQENSRLRIAIQKSGRLSKESVELLNKCGIKMHIHEQSLIAFSTNLPIDILRVRDDDIPG
LIFDGVVDLGIIGENVLEENELERKSLGEEANYKLLTKLDFGYCRLSLALPQEKKFDNLK
DFENLRIATSYPQLLKRFMKENNIHYKNCMLTGSVEVAPRANLADAICDLVSSGATLQAN
NLKEVKVIYQSRACLIQKQNTLSDEKQALVDKIMLRVAGVMQARESKYIMLHAPKEKLDK
IQSLLPGVEKPTILPLAHDEKNVALHMVSKENLFWETMEALKEEGASSILVLPIEKMLK
>fig|195.2024.peg.412 NADP-dependent malic enzyme (EC 1.1.1.40)
MNLKEEALRYHLGGKIDIKPSKPMNSSHDLSLAYSPGVAEPCIEIASNNELAYTYTNKAN
LVAIVSDGSAVLGLGNIGAQASKPVMEGKACLFKKFADVNAYDLEIEAHSIEEIVAFCKA
IAPTFGGINLEDISAPKCFEIEAALQDLGIPVMHDDQHGTAIISTAGLMNAMEISGKKFE
EIKVVVSGAGAAGIASARMYRNLGVKNIILVDSKGVVNKKRTDLNQYKLEFVSDTQADTL
KEAMKDADVFLGLSAPKILDDEMILSMAKDPVIFALANPIPEVMPEDVARLRKDAIVGTG
RSDYPNQINNVLGFPFIFRGALDVRATKITENMKVAAAKALADLAKLPVSDAVKNAYKIS
HLEFGKDYVIPKPFDERVKAVVSTAVAAAAVKDGVALLKEFDEKTYFESLK
>fig|195.2024.peg.132 Arginyl-tRNA--protein transferase (EC 2.3.2.8)
MLEIGFCTLEDECPYLKDRRSRIEYKYIENCSKEINSELIRRGWRRFGRYFSRPICKDCK
ECLSLRILVDEYQFSRSERRVINKNTNTKIILRKPLLSNEHLFLYDKYHRFMEEKKTWKR
YDLNFRQYYNLYVDGFMNFGYELAFYVEDKLVCVDLIDWLEDGISSIYCFYDPDFSHLSL
GKFSLLSEIKIAKKEKLKYIYLGYFVKKCQSLSYKADYTPNEILKGTKELFENEILWER
>fig|195.2024.peg.1557 hypothetical protein
MKNTVTEASIYEAQGLKDEALEIYKNILKEDPNNQNAIDAVRRLSGFRSKHQDLNTQMLD
FFINMKSDEEINEFKRWLIKI
>fig|195.2024.peg.1588 hypothetical protein
MDLNIVTNLIRYDLARLKQSIVNFKNNPNNLHFIPKEENVKKKNTKTTRSINYFFICMHF
ILYYIYYLFLLNKPSKSIRQENFSYNTFIQIIFIH
>fig|195.2024.peg.1450 hypothetical protein
MISDATMSNANLLTAVNTSVLKKSMDTNEVLMNELIKGMESASGASALQTSSSSGLDIYA
>fig|195.2024.peg.1479 Predicted L-lactate dehydrogenase, hypothetical protein subunit YkgG
MSKINEISNKSKEKILLALNEAYEAKDFTYQASIDPVEHIQTKEDALAEMKQKMSDNKYI
VENATKETLEEKINEIITKYNYKKMIYGTDLGLDLNKIQAEEKICFDKEIENLRYEVFHS
DFSIVHARAGVSSHGVALIPSSKGQPRMLSLAPKLCIVLLKKEDIVKSLSEALNLVKKEN
EILPTNILFIAGPSRTADIELITVFGVHGPQIAHIVIY
>fig|195.2024.peg.882 Heavy-metal-associated domain (N-terminus) and membrane-bounded cytochrome biogenesis cycZ-like domain, possible membrane copper tolerance protein
MNFLPLNFDFLAIFSVAFLSSFGHCYSMCGGFILAFMNLNSTHKNLFLLTFIYQLFRIFS
YILLGIIFGIFGNLLAINAKIQSLSFFILGVFMVILGFSLIFRGKILAFIENRAFFEYFI
KKIIKKSMGFKGVKSAMILGFANGFVPCGLVYFFLANAMSRQNVTESILVMLVFGLSTLP
AMLFFVKISQYLGVFLKKVFNYLSYFIIVAYGIGLAYMGFKAF
>fig|195.2024.peg.449 Pseudaminic acid biosynthesis protein PseA, possible Pse5Ac7Ac acetamidino synthase
MRFCKKCVMPDTKPDLHFDEEGVCDACRSQEAKNQNINWQEREKEFFELIKKYKKHPVYD
CVIGVSGGKDSTFQVVKMLELGLNPLCVCFEPSVPTKIGRKNLDNLNHLGVDLIHIKRDP
KVYQKLAREAFIRTGDNEWQNHLGIFTSVPRIAVNFGVPLIIWGESPQIEYGGPASSKNK
NILGREWLEEFGGLLGNRASDMLGVNGIAEKDLFLYTYPSDEELQRVGVTGLFLGYYFKW
DYKKILEISKKYGFLTLDHPVETTYENFENLDCYSNHVHDYLKYCKYGFGRATDNACLDI
RLGYISREEGVRLVQKYDGKPPKKAIKKYLEFSGFSEEEFQKIVDSFTNKKIFKRDENGK
FIRDYDGSLVRKDECVLK
>fig|195.2024.peg.1171 hypothetical protein
MLNSKDRTQVILEKSGLSLSKFATILGKDRRTLAKFIENDTVKELDTKSKEKICEFFRYP
FKIWESNENEFYTLLNQIENNEIRIIDEGYIGGLKYIFENENEGSLILHPAFPNPAYRDF
IVPLVYQNNDSEEARIYRIKRGEKMRAYSFNASEWYSIKSLLEFCFSPIGNFYTKEQKIQ
ILELMINTFKDNLNKSLYFFDSYDKKIYGLDVFYLSINAKENTMFFKAPLEMLLVEIKNS
TLVHKIHEHYTHAKKCPAHILTQDACFIMEILLQCLKDNLDIKESCDILDKKSPYGNLFK
KSLSVDL
>fig|195.2024.peg.533 Putative transmembrane protein
MKNKAHFISFENLIYKQKNGNFEEDDLFKELTKECDLQNPFEYQLAFLKQDQIYHCFLAR
VAKLPKTQFCFPQPLVFQSLFLENKIKEENFCILEIKPQKVFLCFYEQGKFKTFKTLDFC
DNIEEFINKSRILELLQHYESKILLSTKAHEIFNLISAKAKLPFKMIQEDKIALSKHSIH
HLDKNANFIKHYKKYLPWYFKFIFLFALSFIISIVVLSLIDFAQYQNAKTTHIQNEISQN
KIYEIQEKQSQKLKANIEQLQLEIQTQNLLLEKYSEQLSKITQNFKADKNTILILTKAIA
WLNDHSLRISNLMIDKTLITIKFSNEEDFNKALQFTSPQFSLISQDKSLHEITLRAL
>fig|195.2024.peg.766 Exporter protein, RND family
MFAKFLKIFIYHPKSTFFATLFICLFLSFFASKLSVDASAESLLLEDDKDLKIFRELSKH
YKSDNFLLLAFKPEDENPFSGKNLNKLKELHQELEQVSLVERVFSIINAPLLQSSENTDL
KELLKNIPNIQSKDINLTKAQNEILNSPFYKNNIISKDGKTTGLIIYLKPDTIYNELIEK
RDLSTDENKKEQIRLAIKKHQEQQKIITKQGLDTIKNIIKKYEKNEDRFYLGGVSMIADD
MITYIKSDLMLYGISLVFLLACALYCFFRAWRFVFLPLFICFISLSAASGVFALLNFQIT
VISSNYVALVLIITLSVVIHLITHFIEISKLYPKAKIERLVLQTLLAKANPSFYAIITTM
IGFFSLMLSNIEPIIKLGIMMSIGIGLALIFSYLFLASILVLLKLKKYYKKEFKFNFLAF
CAKTSLDPKKRSIIYILSITTIILALIGISKLRVENSFVNYFKDGSEIKKGLLVIDKNLG
GTLPLDIIIRFPDNKNNPSLNDVFDSFESEFDALATKDTYWFNSQKTRIAKKVHEFLENK
EFIGSVLSLNSLLSLGKNINDGKDLDDFTLAFLNENLPPELKQELLSPFVNIEENELRFS
IRIIDSDPKLRRNEFLTNLKQELETLLKNDGVEIQITGIMLLYNNMLQSLFSSQFDTLVF
VILVIFVLFIIIFRSLKFSIIALLVNIIPLSMVFALMGILGIPLDMMSITIAAIAIGIGV
DDTIHYIYRFKEEIKTKSVEEAILASHLSIGSALYYTTIGIVLGFSVMMSSNFIPTIYFG
VLTVFVMILLLSGSLFLLPSLLVTIYTKKTKALNPHKAHK
>fig|195.2024.peg.391 RNA binding methyltransferase FtsJ like
MRYDIFVAKRLNLSRNKALELIENEEILLNSKPYKASFDVQNLLKNKIADQEELLNSKEL
NLELLGELYVSRAAFKLKYFLENHNINIANKTCLDIGSSTGGFVQILLERKALKVSALDV
GDNQLHPSLRDDKRIEIIENTDLRTFKSEQKFDFITCDVSFISLAYLLSYIDNLALKDIV
LLFKPQFEVGKQAKRDKKGVLKDEKAVFKAMREFENACARLGWILQCCEESKIKGKEGNI
EYFYYYTKK
>fig|195.2024.peg.1565 Polyferredoxin NapH (periplasmic nitrate reductase)
MRYLIARRIVQIGILALFSFKATDFILKGNLSSSRLFDTLPLSDPFAVIQIYLASFSIDL
MALMGALIVLILYGVFLGRAFCAWVCPVNLITDFAAFVRSKMAFKQSKVLILSKNLRYYI
LALSLILSFVLSLPVFESMSYIGIIHRGIIFGTTSWIFIAFILFCIDAFLSPRAICSHLC
PLGAFYALISRFALLKIKHNHQKCTKCYKCIGICPEKQVLWMIAKESASVNSGECIRCGR
CVEVCNDDALNFNIFDLRKK
>fig|195.2024.peg.198 Protein translocase subunit YajC
MAENSILTSLLPLVVLFAIFYFLVIRPQQKQAKAHKQMLESLQKGDKIITNGGLICEVVK
PEDDFIKVKLNEDNVTAKISREFIAKKIDA
>fig|195.2024.peg.1628 Ribosome recycling factor
MINEILNKQKTQSEKSLEALKKDFTTLRTGKVNTHILDHIQVDYYGSLTPLNQVATVLAS
DASTISITPWEKPMLKTIESAIAAANIGVNPNNDGESVKLFFPPMTREQREENVKQAKAM
GEKAKVSVRNIRKDANDAVKKLEKDKAISEDEAKKAYDEVQKLTDTYTAKIDESVKNKES
ELLKV
>fig|195.2024.peg.43 FIG00638667: hypothetical protein
MKKIFFILASGLSLLILYIIFDFYVLKDRTTLSQTEVLSPLSCDLNIENCTYSFKDREVL
ISMDPKPLQSLEITNLKIKNLGNYKNLKIKIYGLNMFMGDIMPRVTKINETDYESRLVLA
ACVLEVMRFRAEVFEDDKPIGFHFDFDLKR
>fig|195.2024.peg.1240 Nucleoside diphosphate kinase (EC 2.7.4.6)
MEKTLSIIKPDAVKKGVIGKILDRFESNGLRIAAMKKVQLSKEQAEAFYAVHKERPFFKD
LVEFMISGPVVVSVLEGEGAVLKNRDLMGATNPKEAQPGTIRADFAESIDANAVHGSDSL
ENAKIEIEFFFKSNEIC
>fig|195.2024.peg.1641 Highly acidic protein
MAYDDEDLEFDDYEGEEDEYAHNHHKSYNYDDDDYDFDDEVNDDDFYEMD
>fig|195.2024.peg.1657 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (EC 2.7.6.3)
MLKIKGARRLETSRFFPYFSQNKKEFKYLALVGLGSNIEPEKKRFNKLFRVMMEDRRFKI
LATSPFLINEAFGFKAQKDFTNAAMLIQTNLHARAFLKVLLFYELKFKRKRTFKNAPRTL
DLDLLYFSQKVKRDEGCMVPHIGANQRISVILPLGLTKGL
>fig|195.2024.peg.1062 hypothetical protein
MIEEPRILPSNDLENEKEQLLNEFPEFRALIQNNPNITKEKLLKLKNQQRITHNYQDHQK
QDLQKEFTQNFFKTDLKA
>fig|195.2024.peg.1226 Flagellar assembly protein FliH
MVNRSNVISGGTSDQHVVEGYRFKVISEFDNHAEEKQHSQISNEENITTSSKDESPVEES
QTPAPSQVVQEVQTPAFQPSFVEDLLKKTDEMSSNIIKLQMQIESQENEFNNRLNSELES
AKEKFSKEGYEQARAEFEKELNDLRDKYLKSVSKLEEACVNLNAFIEKNEKELADTAIDI
AKEVILKELENNSSKIAYALAKDLINELKGAGSIEIKVNSIDYNYLKEHFSENSHIKITL
DDAISKGSVIILSDSGNIESNLNARLIKIKKMVNNE
>fig|195.2024.peg.756 Holliday junction ATP-dependent DNA helicase RuvB (EC 3.6.4.12)
MDRIVEIEKYSFDETYETSLRPSNFDGYIGQENIKKNLNVFISAAKKRNECLDHILFSGP
AGLGKTTLANIISYEMGANIKTTAAPMIEKSGDLAAILTNLSEGDVLFIDEIHRLSPAIE
EVLYPAMEDYRLDIIIGSGPAAQTIKIDLPKFTLIGATTRAGMLSNPLRDRFGMQFRLEF
YKDEELAIILQKAALKLNKSCENEAALEIAKRSRSTPRIALRLLKRVRDFADVNDEETIT
KERAKEALNSLGVNELGFDAMDLRYLELLTEAKRKPIGLSSIAAALSEDENTIEDVIEPY
LLANGYIERTAKGRIASTKSFSVLKLNYEQTLFDEN
>fig|195.2024.peg.3 Flagellar sensory histidine kinase FlgS
MNENILKSLDSSEKETLQKGLQSLIEQTYIVENEYKILNENYNSLRAMVDEIIEVLPSAL
WILDKEKNIILQNQEALKKPKLLDIISLEKNRDELEFENRFYAVKIIAHNEKTIVSATDI
SDEKRNERLASMGSVAAHLAHEIRNPIGSISLLASTLFSRSELKNKHIVLEIQKAIARVE
RIVNSTLLFTKGVHINANEFNLLELTEECESAINSYNYSSQIDFEIKFLDMKIYGDKALL
SLVLQNLIYNAIDAIEESECENPKIKIQASCDEQNLYIRVYDNGCEIKDENAVFEAFKTT
KLKGNGLGLSLSKEIINAHKGELKFEIQPKNFYFVLPLH
>fig|195.2024.peg.535 Xaa-Pro aminopeptidase (EC 3.4.11.9)
MNIRKIRVEKIRQFMIKEKLDAYLILSADPHLNEYLPSFYQSRAFVSGFKGSAGSLIITS
QDAFLWTDGRYWIQAQKELEGSGILLQKQDANNTFLKWLKENLNEEQNLGIDFSVLSLSL
QKEIQKNCKAELKNIDLISLIWEDRPALPKNKVYEHELEYCSYSRKEKLLLVREKMNKLQ
AKNHLISSLDDIAWITNLRGNDVCYNPIFLSHLLILEGKALLFIDREKIDFELEKKLNLD
GICLKEYNKIQDELKKLQNTNLLIEPSKTTTLLIEILDKSVEILEEINPSTHLKAIKTDK
EIAHIQNAMIEDGVALCKFFTWLEENIKNNTQISELDIDTKITEFRSQSPYYISNSFSTI
AGFNANAALPHYKAEKESFSYIQKNGLLLIDSGGQYKNGTTDITRVVAIGELNEEQIHDY
TLVLKAHIAIASTIFPKDIAMPLLDAITRAPLWQEQLDYTHGTGHGVGYFLNVHEGPQTL
SYFSPVLEKTKAKEGMLTSIEPGIYRTGKWGIRLENLVVNAKIENPKNKDFGEFLYFKPL
TLCPFEISCIDKTLLDAKEKAWINTYHKEVYEKLSPKLHDNLKALKWLKERTKAV
>fig|195.2024.peg.236 Multi-drug resistance efflux ABC transporter, permease/ATP-binding protein HetA
MLKKIFFILSKEDKKFLFSLLLFSVFISFIESFAISLVMPFITLASDFSYFDRNKYLIQL
KDYLALPVFEIIVYFGVVLIVFYVLRALLNSYYFHLLARFSKGRYHAITYKVFAKFLNTD
YENFTQKNQSEILKSITGEVYNLSTMISSFLLMMSEIFVVLLLYTLMLLVNYKITLFLSL
FMIINAFILIKVLSPIVKKAGLKREEAMKNFFEILNTNLNNFKLIKLKTKEDGVLNLFKT
QSEIFAKANITNESVSAMPRIYLEGVGFCVLVFIVVFLVFKNQSDISGILATISIFVLAL
YRLMPSANRIITSYHDLLYYRSSLDIIYQILKQKEESLGEEKIDFDKELRLENLSFGYKD
KKNLFTCLNLSIKKGEKIAFIGESGCGKSTLVDIIIGLLSPREGRVLVDKNELNMKNVKN
YRQKIGYIPQNIYLFNDSIAKNISFGDEVDEEKLQRVIKQANLEHFVKNLPQGVQTKVGD
GGSNLSGGQKQRIAIARALYLDPEILVLDEATSALDTESEARIMDEIYKISKDKTMIIIA
HRLSTITRCDSIYRLEHGKLFKEDKK
>fig|195.2024.peg.1698 Ribonuclease P protein component (EC 3.1.26.5)
MKTFGKFSENEEFSAVYKTGKKWYCDGIIIFYLKNDEQKMAVVASKKVGKAVIRNRSKRI
LRALFTQFENKLQNGKYIFVAKSEITQFPFSRLEKNLKWGLKKLECLK
>fig|195.2024.peg.652 Phosphoribosylformylglycinamidine synthase, PurS subunit (EC 6.3.5.3)
MKILVNVFLKNGVLDPQGKAIEKALHSLNFNEIKEARVAKQIVLDLDESDEQKAKERVKS
MCEELLVNSVIEDYELIVSEK
>fig|195.2024.peg.270 Membrane protein
MIEFILKDMFFAAMAGFGFAYACNPPLKTLILSALLAAIAHGLRFTLIEYFHFETLAIAT
FVASFCVGCLGIALAKIIKTPAEVIAFPALIPMIPGIYAYKAILYLISFIRSDDLKAKSE
FLVQFFDYFFTTLSVTLALAIGVSVTLLIFFEQSFMMTRHAKKH
>fig|195.2024.peg.501 Cell division protein FtsA
MNILGIDLGSTQTCAIVAQKDEEGLKIIGFAKAKTNGVKKGAITNIELASKSIEEAVRNA
EMMSGVHYDKVVVSISGAYTKSVDSIGVVNIPNHEIGIKEIHRAVSTAKHTANLPSGYEI
IHVLPYNFKVNDLEHVDDPLGMSGNRLEVSTHIVISQESHIKNLKKAVELADLRVDNIVL
SGYASAIACLDDSEKELGAVLIDMGGAICDMVVHTGNSIRYNDCLQIGSINITQDLSMAL
HTPLKEAEKIKLNYAALSQQPNALIQIPSMGDERKVNEVSLDIISNVIYARAEETLMILA
KILSDNRYANSIGGGVVLTGGMTKLAGIDELAPATFDNRSVRLATARKDLITGFSEIFND
PENTCAIGLCLYGAGYFTPYELDSNEKLRYKGEIENYNRQIRQEIIPQKEVENETKSDFF
GENLQENDTIIIQEQLDFKEPKEKKPSVFSNIWHKIMNQF
>fig|195.2024.peg.1174 2-methylcitrate synthase (EC 2.3.3.5)
MSISEATKKTGGLAGVIAGQSAICTCGLGNGLNYYGYSIEELAQNAEFEEIAYLLQFGEL
PNAKELENYKEKIIAQRALSENLKNVLKAIPKEVHPMNLMQTAVAALGALEGENEDFSDQ
DEKIIRLLGILPSMLCYWHHYVNFGKEIDFDSNQTSIAGYFLEKLKLEAPKEDFIKAMQC
SLILYAEHEFNASTFTARICASTKSDIFSAVAAAIGALRGPLHGGANEAAMHLIESFKSV
EDAIEGVNKKLENKELLMGFGHRVYGLGGDPRNTLIKVWSKHLGGDDLLFKISEAIEALM
KEKRPSLPPNADFYSASAYHFMGIPTEYFTPIFIMSRVSGWCAHIKEQRANNKLIRPSSE
YIGVEPRKFVKIQDR
>fig|195.2024.peg.1061 Methionyl-tRNA formyltransferase (EC 2.1.2.9)
MMKKIIFMGTPSYATCILKALLEDENFELLALFTQPDKAVGRKQILTPSDTKAFLLQKAP
QIPIFTPNSLKDESVIEQICALKPDFIVVAAYGKILPKAILDIAPCINLHASLLPKYRGA
SPIQSAILNADEKSGVCTMLMEEGLDTGAVLESVECDIRDKNVNEVFEILANLAAKLTLS
TLLNYEKLLPKKQDESLATHCKKIKKEDGLVSLDNAREIYQKYLAFTPWPGVFLENGLKF
IELELVDELKQNAKMGEILELEKESFLLACKQGILRIKKLQESGKKALDGRTYLNGKRLK
SADSLC
>fig|195.2024.peg.1208 hypothetical protein
MNILNGKIIELLNEGEIVIVKISIKEQIFKVLMLDLHSLQDLKIGTKIQVLFKEHELGFT
LPHSILSVENSFLARIKSIKKGKILYHIFFDFEGDEISSIITKEKALELKLEEGQEWLCF
VKENDIILKAVYG
>fig|195.2024.peg.123 Flagellar protein FlgP
MKKFYFMLIIAGIFAGCTASTNSTTAKNPNSPSTSAQASDIVVQKVDKDDVRDIIREEKM
LAPDVSESELSFSAVGEGIAPLNTVSSAQALALAKRAAITDAYRQLASKLYGVKVNGKDT
VKDAMLRSSTITAQVNGLIKNASIIDENFNQGLYRVNVELKIDADKWKELFAY
>fig|195.2024.peg.55 ABC transporter, ATP-binding protein PebC (cluster 3, basic aa/glutamine/opines)
MIELRNVNKYYGTHHVLKNINLCVKEGEKLVIIGPSGSGKSTTIRCMNGLEEVSSGEVVV
NNLVLNHKNKIEICRKYCAMVFQHFNLYPHMTVLQNLTLAPMKLQKKLRQEAEETAYQYL
KVVGLVDKANVYPATLSGGQQQRVAIARALCTKKPYILFDEPTSALDPETIQEVLDVMKE
ISTQRNTTMVVVTHEMGFAKEVADRIIFMEDGAIVEENVPSEFFSNPKTERARLFLGKIL
KN
>fig|195.2024.peg.1349 NADH-ubiquinone oxidoreductase chain D (EC 1.6.5.3)
MQIPSKLKPYYENIAFEQEDSKMIINLGPQHPSAHGNLRLILELDGEQVVKARPTIGYMH
RGMEKMAENMIYQEFIPTTDRMDYIAASANNYAYCAAVEKLCGLEIPRRAAVIRMILLEL
NRIASHLLWLATHALDIGAMSVFLYCFREREYVLDLIEKYCGARLTHSSMRIGGVMLDLP
EGFLNELLAFCDKFPKDIADYEALLDDNRIWRLRTENVGVVSKEQAMNWGCTGVMLRGSG
VRYDIRKEEPYLLYNEIDFGVPYTTQGDSYARYKVYMQEFRESLKILRQCAALYKDTPPE
ILANHPEYVSASKEQILTQNYSLMQHFVLITQGLKPPKGEVYVPTESPKGELGFFIHSDG
TGRPYRLKARTPSYWHCAFFEEMLVGTYLADVVAIMGNVNIVLGEIDR
>fig|195.2024.peg.732 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.12)
MRQKCILVITDGIGFNKEKDFNAFEAAKKPNYERLFREVPNSLIKTSGLAVGLPEGQMGN
SEVGHMCIGSGQIIYQNLVRINKAIESCELEKNANLKKLLQKCKRVHVIGLYSDGGVHSM
DTHFNALLEICAKNGNEVFAHAITDGRDVSPTSGLEFIRKLKNHCEEIGVHFATLCGRFY
AMDRDKRWERVKEYYDCLLGKSKGVSNWVDYIEECYQNETTDEFIQAAKNENYKGMQEDD
GLIFVNFRNDRMKQLIEVLNSQNFKEFEREKVFENLLTMSVYDDKFNIPVLFEKEEIKNT
LSETISKAGLTQLHTAETEKYAHVTFFFNGGKEELLENETRVLIPSPKVKTYDEKPEMSA
FEVCDAVKKGIEKGEDFIVVNFANGDMVGHTGDFNAAIKAVEAVDVCLGEVVECARKHDY
AFIITSDHGNCEAMQDKKGNLLTNHTTFDVFVFVEAKGVDKLKENMGLSNIAASVLKILN
LEIPKEMNEALF
>fig|195.2024.peg.243 Capsular polysaccharide synthesis protein
MNLYNNTTYKLSNLIPIKPLRRKLRAHIAYKIEHPKVSKYLNENYIQPFLKGEIAPFIFK
KKQDFKDDKIIWQLWFQGEENASDMIRQCFKSVQRQMGDEYKIIILNEENIKDYLDFPDF
VLEKIKQKTFGEKTIVFFSDLLRVSLLATYGGIWCDASIFLSDKIPLNLRAREFFAFERA
RNRPSREKLKRIIKSPYFSYGYFNWNEDFMVKMLSSFIIAKSNSHFISALRDILINYWQK
EKNIINHYYFVLHVIFELLKKYGYSNNTYKNMSDIECHLLQFYAKNKFDSKLWQEIQQQS
FLHKLTHFRTIKKDSMIDKIIIQGIN
>fig|195.2024.peg.59 Membrane protein
MFANWFILTALICATIYLVVMLFYYKTLLNKEKTSKDFIKNNLDDTEIVIRKLQIQLQRS
LGNIDILTEELNKIKADLTSLRTRNSQYRLENDKLRQRIKELEAKIEALL
>fig|195.2024.peg.136 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (EC 2.4.1.227)
MTIVLTGGGTGGHLAIVRCLLESAIKKNIECVYIGSQNGQDRAWFESETRFKAKFFLSSR
GVVNQNKLGKINSLLHTFKLSKECKQIFKDYDIKAVFSVGGYSAAPASFAALFSHLPLFI
HEQNSKSGSLNKLLKPFAKQFYSAFEKEIVPYPVADKFFEKARIRKELKNIIFLGGSQGA
KFINDLALNLAPELQKKGINIIHQCGKNELEKYQQAYKDLNIQADVFDFSPHLEEKMQNA
DLAISRAGASTLFELCANTLPSIFIPYPHAAKNHQYFNAKFLQDKALCQIFMQNNTYPDE
ILKAIFKLNLEDISTRLKDMAQKNGADILLEKALKLIK
>fig|195.2024.peg.385 Endonuclease III (EC 4.2.99.18)
MKRNSEIKELFLKHFDKPTTELKFSNLYELLVCVMLSAQCTDKRVNLITPELFKAYPDIT
SLANANLSSLKTYIQSCSFYNNKAQNLIKMAQSVRENFNAEIPLDEEKLKSLAGVGQKTA
HVVLIEWCGANCMAVDTHVFRVSHRLGLSKAKTPEATEEDLTRIFKDNLNYLHQAMVLFG
RYTCKAKKPLCKECFLNHLCKSKDKELE
>fig|195.2024.peg.44 Cytochrome oxidase biogenesis protein Sco1/SenC/PrrC, thiol-disulfide reductase involved in Cu(I) insertion into CoxII Cu(A) center
MKKVFLFAVAFVAMGILAFCLINKNQYDFNLRSAFKEQTTLEDFKGKKLIVYFGYTFCPD
ICPSTLSLIGKNLKALKDPKAHVLFISLDISRDGNLTSTNEWLRYFYPNADALIAKNDSV
LKKVAKNYGVQYQKIDINDSVMKYSVAHSSEIFLIDENGKLQKIIRDLNPEEVAKELKNF
LSSK
>fig|195.2024.peg.676 L-fucose mutarotase (EC 5.1.3.29)
MQRYGQIIKIKKEKIEEYKNLHAKPYEGVCEMIKKCNMQNYSIYLFGEYLFAYFEYVGAD
FEADMAKMARDESTQKWWKVTDPCQISLGYAGQKWLNMEEVFHLD
>fig|195.2024.peg.1502 Soluble lytic murein transglycosylase (EC 4.2.2.n1)
MRKILILLSLSLVFLNASPYNLERLKQEENSIAKDYYIYRLLEKKTISKKEAEGLNSHIF
RYVGKIKSELEKIIPVKIFIDPKYAPCYNYTKANILDANQTCQSVRLNSIAFIASLDNAS
RSALAQKLSHQRDDLANLLLAFNTPEPMAYIIQKEDVNGFFRLRNYSKKYDFDLNASFAN
KLPTHVGFKNFAQNIIIKKENPKFRASMLKIDPTFVNEDSAFYLGINALAYNKEELAYNF
FAKAAQTFKMQSNKDNAIFWMWMIKKDDKDLQTLAKSSSLNIYSLYAKELTNSEFLKIEV
IDSTNKKKNNFNMQDPFAWQKLNKQIREANASELDRLAKEFDSKETLPIYAYILERKSKF
KNHYFIMPYYEYIKNYSAPRQALILAIARQESRFIPTAISVSYALGMMQFMPFLANHIGE
KELKIPNFDQDFMFEPKNAYYFGNHHLNYLEKHLKSPLFIAYAYNGGIGFTNRMLARDDM
FKQGKFEPFLSMEFVPYQESRIYGKKVLANYIVYRRLLNDSIKISDIFENLTQNKAGDLN
KS
>fig|195.2024.peg.1577 Methionine ABC transporter substrate-binding protein
MKFKKILLSVFCITSFLFGAEKSIIIGATPTPYAEILNFAKPIFKERGWNLEVKEFSDYN
IPNISLNEKDLDANLYQHKPFLEDFNAHKGTKLSSLGSIVLVPMAIYSNDIKDIKNIPNG
AKIAIPNDATNESRALDLLAKAGLIEFKTSSTLKTPINISKNPKNLKFIELKAAQLPRAL
NDVDLAVITTNYALGAGLNPLKDGIFIEDKDSLYAIVLAVRQGDEKNEKSLILKEILTSD
KIKNFINEQYKGSVIPTF
>fig|195.2024.peg.675 Aldehyde dehydrogenase A (EC 1.2.1.22) @ Glycolaldehyde dehydrogenase (EC 1.2.1.21)
MTTYLNYIDGKFIPHNGEFIEVLNPATKEVISRVASASLEDTKRAIEAAKKAQKVWEAKP
AIERANHLKEIASLIRKNANFLTEVLMQEQGKTRVLASIEINFTADYMDYTAEWARRYEG
EIIQSDRANEHIYLYKSAIGVIGGILPWNFPFFLIARKMAPALLTGNTIVIKPSSETPNN
AFEFAKLVSQSSLPKGVFNLVAGKGSVVGYELSSNENIGMVSLTGSVEAGTRVMEAAAKN
IIKVSLELGGKAPAIVCKDADIDLAVEAIKASRICNNGQVCNCAERAYVHTSIYDEFVDK
FVKAMSKVSVGNTLKGDFDMGPLVNQAGVDNALAMLQRATAKGAIVECGGKITDTSGYYF
PASVLTNVKHEDEIMQKEIFAPILPIAKFDTLDEAIDMANDCEYGLTSSIYTQNLDIAMR
ASREIKFGETYINRENFEAMQGFHAGFRKSGIGGADGKHGLEEYLATHVVYLQYNTNKQ
>fig|195.2024.peg.1707 putative lipoprotein
MKKTLQIVLAAAFFAGCASTSVNSKSTSKISNEFMQNQLFEIDKIVVNGKTFDPKNAEEN
PNISFENNKFYGYAGCNRFFGSYQSNENTLEIQGDRVASTQMLCHPLDVMEFENAFLSNF
KGSFTISNKNGKLILNNGEMEIFFK
>fig|195.2024.peg.1658 Flagellar biosynthesis protein FlhF
MGQLIHTFTVEDTEQIIPKVKEDYGDKALIITNKQIRPKTLNRAALYEVMVAIEESDYEE
HLKKMGKSLPPKKTIAKTLEKQNLEEKVNASIPQNNEDEDVILDFSNTRANLAKTKTSDT
NYQDFPQSKINPNPTMGFNDFKERLSEVSNEISKVTNTPLVDNYAPNPNYNKKIENFEKQ
INKLNDKIDLLADMMWDEKAEARNNLIIPPEFATIYKKAKETGMLEKHLEAIMKATIENM
PAAMKTNKDAVQRYFYSLLRNILPCRVESEIKKQKIMMLVGPTGVGKTTTLAKLAFRYAY
GDKRYKTGIITLDTYRIGAVEQLFQYAKMMKLPIIDSIEPKDLDEAIKSLNNCEVILVDT
IGNSQYDQNKLAKTKEFLMHSNAEIDVSLVVSANTKHEDLMEIYKNFSFLNIDTLIITKF
DETKVFGNIFSLIYETNIPLSFFSTGQEVPDDIEVANSDFLVRCILEGFNKGKDNE
>fig|195.2024.peg.1156 Single-stranded-DNA-specific exonuclease RecJ
MKTIDKNEIRKILASRFEKDLHTKLCDLPLPCCLKDIYKAANRIKEAIDKNEKIAIVGDY
DVDGIISCVIMAEFFDDIGFDYTVRIPNRFKDGYGLNAEIINELDVNLIITVDNGIAAFE
AAKLCKEKNIDLIITDHHMPQDTLPDAFAIINPKQKDCDFPDIEICGAQVAWYLIAALKE
VCKLKYDMGKFLELLAIAIVADMMELRDLNRALVRRGIECINKSKRVAFKAIKQYYQKDK
FALDNIGFLIAPLINSAGRMDDASISYEFLHTKDLDKASAYLEQIISFNESRKDEEKQLF
EDSLSQIDENDSCIVVSGLNWHEGVLGIVASRLAKHFNKPAFVFSQNDQRLKGSARSVGK
IDILALISKANFILSNYGGHKGAAGLSLDLDSFEKFKTIIKKECMEISQSEFLDTDEILG
ILDPNEIDFEMLEILESFEPFGHKNPRPFFILENLYVKNKKFLGKDEKHLKLILTKDNKT
IEALFFNFDKEPQLYENISLLGSISKNEFRGLATPQFIIKEIL
>fig|195.2024.peg.642 Flagellar hook-basal body complex protein FliE
MNNINDLRLNNNISNANKSQNSNDKIGDEFAKMLKNEIEDLDKTQKTAEAAMTDIATGQV
KDLHQAAIAITKAESSMKFMLEVRNKAISTYKEITRTQI
>fig|195.2024.peg.93 RNA polymerase sigma factor RpoD
MNAKTQDMELEELFKENEKDYITYEKLVKYFSKQPNSATAKKVQTLMKKYKVQLFSAAEI
AQMKNIEDAKRLQEEKQKLQDTSLENEFDLANENDLLEWSRSDSPVRMYLREMGQIALLN
KDEEIEISKKIELGEDIIIDAFCSVPYLIDFILDYREPLINRERRVKELFKSFDDEEKND
DKLDELEDEDEENDEELENEEETPKKTSKKEDERTLKVIEKFKALEKAKKDWLKVSKDKE
SGDEILDKLGIAFKKNILKEKLMDLGPTSKLISEIVKSMETALKSDEEFDKELKRLEYRL
PMFSEELKNRHANILKDITKLSKEEITERALETTMVSTYMEIKKLFQTKEASEKSFDLEK
ERLKEILEQIKRGKKISDEAKTRMAKSNLRLVVSIAKRYTNRGLPFLDLIQEGNIGLMKA
VDKFEYKRGYKFSTYATWWIRQAISRAIADQARTIRIPIHMIETINQINKIIREHLQKDG
KEPDVSVIAKEVGLSVDKVKQVIKITKEPISLEAPIGSEDDGKFGDFVEDRNSLSPMDHI
LKDDLKEQIDEVLDQLNDREKAVIRMRFGLMDDESDRTLEEIGKELNVTRERVRQIESSA
IKKLKHPKVGRKLKNYIEGWK
>fig|195.2024.peg.1256 Tryptophan synthase beta chain (EC 4.2.1.20)
MKKAYYGEFGGQFLPESAMFALNELEDAFLKFAQDKAFKKELQGLLATYVGRPTPLYFAR
NLSKKYGHEIYLKREDLNHTGAHKINNAIAQALLAKKMGKKKIIAETGAGQHGLATATAA
ALLGLECEIYMGATDVQRQALNVYKMELLGAKVNAIQSGLKTLKEATTAAIQAWVGDIKN
LFYVVGSAVGPYPYPKMVTHFQSVIGKECKSQLKKLGKKVDYIIAAVGGGSNAGGIFYEF
IKDESVNLIGIEAGGLGVDTLYHAATLTKGKTGIIHGMKTKVLQDELGNILPVHSVSAGL
DYPGIGPLHAFLSQSGRAKYYAITDEECMMALKMLCKEEGIIPAIESSHALAFLEKLCPK
LNKKSVIVVNLSGRGDKDMQTIREYKKGTIYG
>fig|195.2024.peg.913 Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1)
MKISYEDAGVSIDNGNAFVEAIKPLVKETFNDNVVGGIGSFAGAFRMPSGFKNPVILGAT
DGVGTKLRLAIDAKKYDTIGQDLVAMCVNDLICNFATPLFFLDYYATAKLEVEVAKSVVA
GIAEGCKMANCALIGGETAEMPGMYAKDDFDLAGFAVGMAEEDEIDRSKFVKNGDILLAL
PSSGLHSNGYSLARKVLFEGLKLKFDDKIEGKNLIDVLLEPTRIYVRDFLTLKPYISALA
HITGGGLVENLPRVLPRGMGATIRKHHLKTPEIFYTIGQAVEESEMYRSFNMGVGLVMVV
DPSNVSRVLENSDAFIIGEICINEGIVLE
>fig|195.2024.peg.1523 N-acetylglucosamine-1-phosphate uridyltransferase (EC 2.7.7.23) / Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)
MKTSILILAAGLGTRMKSEKPKVLQELCQKSMILHILEKAFAISEDVSVVLSHQKERVEK
EILKHFPKTQILEQDLINFPGTAGALKEFRPKNEKVLILCGDMPLVEQTSLEALLSNNAK
LNLAVFKARDPKSYGRVVIKNDSVEKIVEFKDANTQEKEINTCNAGVYVIDSRLLKELLP
LIDNNNAAKEYYLTDIVKLAKEKDVMIKAVFVDEDEFMGINDKFELSIAENFMQEKIKKY
WMQQGVIFHLPQSTFIGADVEFVGECEVYENVRIEGKSKIINSIIKSSSVIENSIVENSD
VGPLAHLRPNCELKNTHIGNFVECKNAKLNTVKAGHLSYLGDCEIDSGTNIGCGTITCNY
DGVKKHKTIIGKNVFVGSDTQFIAPVKIEDEVIIAAGSTVSVNVEKGALFINRAEHKMIK
DYYYKKFQK
>fig|195.2024.peg.623 Porphobilinogen deaminase (EC 2.5.1.61)
MKELVIATRKSQLALWQSEFIADFLNKTHGIAVRLEGFKTKGDVLLDSPLAKIGGKGLFT
KELEESMLRNEAHLAVHSLKDVPSFFPQGLVLAAVSKREQSNDAMLSQNYKDFLSLPKGA
KIGTTSLRRKMQLLLLRPDLEIISLRGNVNSRIEKLKNGDFDAIILAMAGIKRLDLDKQV
NFVYTFSKDELIPAASQGALGIESIDDEKFLKFLKCLNDDNALIETTIEREFISTLEGGC
QVPIGINAELLGDEICVRAVLGLPDGSEILKDKRMIKKNDFKGFGESLAKEFIAKGAKEL
LKKAESMI
>fig|195.2024.peg.308 ATP synthase F0 sector subunit a (EC 3.6.3.14)
MKDLFLFSSLLDSSHTFSYFFHLGLVALIAVICASMATRSMQLVPRGMQNLGEAFLEGVL
SMGRDTMGDEKGARKYLPLVATLGIIVFFSNIIGIIPGFHAPTASLNLTLSLAIIVFVYY
HFEGIRTQGFIKYFAHFMGPIKFLAPLMFPIEVVSHLSRVVSLSFRLFGNIKGDDLFLMV
ILALVPYIAPLPAYVLLTFMAFLQAFIFMILTYVYLAGATIVEEGH
>fig|195.2024.peg.1427 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MEFSKKKIVRLSLNLTFLGALFPCVLFSADLRQRNGNVIVSRTTDLTQSSNKTDVINIKN
PNQNGVSHNQFDEFSVQDGVIFNNSLKDGNSQIGGWVGKNPNLKQNANTIINEISSKQAS
NINGAVEVFGKSANLIFANENGFSVNGAAFLNTKGVTLSTGKFNGDFTEVTSNGRVAIGE
KG
>fig|195.2024.peg.1108 Alternative cytochrome c oxidase polypeptide CoxO (EC 1.9.3.1)
MTALDIFQIIFIFVVVLIGFVGMIWVISKDKSNR
>fig|195.2024.peg.150 Recombination inhibitory protein MutS2
MNDTKEELISKLDLNSYLEEFKALFARDKEIFLQGDSNLHFKRIHELCEVEFPTMPELSN
LDKALVHLSKQGILHLDEIFEFVKIFRYFEKLKKIKLGTNLGSWLQKIEFVSGALELCLN
FDEKGELKESLDERLVNLNAALRLKNESIIAEFKKFCYTKALMPYLIDTQIHLINNLEAL
LVRGGFNHAIKAKIIGRSSGGGFYIVPLSVENLQNDIEKIKNQKEEIYYEYAKNFSAFLA
KNLPFLKFINTAFDLFDHYSARVLLAKKRDFEFVLCDQSTDLVLKNFAHPALKNPKSVSL
EFKKQVLIITGVNAGGKSMLLKSMLSAAFLAKHLLPMHIKASESKIGTFKEFDAIIEDPQ
NVKNDISTFAGRMLHFSRLFSKKNLLLGIDEIELGTDFEEAACLYSVLISKLIANNLKII
ITTHHKRLAMLLAKNEQVELIAALYDEELSRPKYEFLKGTIGKSYAFETALRYQIPPNLV
SEAKKLYGEDKENLEELVGKNINLELELKAKLENVEKKEQKVDEILLSLKEQKEKNEQEF
RTSLRNLEFKFHKAIEEAKKTIQLKDMKDKQRSLNKANELKKEIILPSMEQNEELRVGDF
VKYEKIKGKIISISKNDAMVESDGIKLRVSLKLLKKSTPTPKISPKTSISVTKPSNLSVS
LDLHGLRSDEAISRLDKFISDALIAGFDEVLIYHGIGTGKLAFAVREFLKTHKSVKDFND
APINQGGFGAKVVRL
>fig|195.2024.peg.885 Putative periplasmic protein
MYKRLLFLAFFINLAWGAEQDCEQYFEARKAQLELQTREFDEARQALEAYKASFEALQKE
RLEVLNQREAEVNATLAQIESLKEQNTKLLEEQQKILNSINEKTEGRIKEIYSQMKDTAI
ADVLTQMDAEDASKIMLSLESRKISGVLSKMDPAKASELTLLLKNMDNNKSN
>fig|195.2024.peg.49 Uncharacterized proteins YbdD and YjiX
MGLSSYDKYLEHMKHKHPEKTPKTRGEFFKECLDKKYNSGGLNKC
>fig|195.2024.peg.387 UPF0126 inner membrane protein YicG
MEISALTITILYIIGISAEGMTGALAAGRHKMDLFGVIFIALVTAIGGGSIRDVLLGHYP
LTWVKHPEYIVLICLCALVATKIPRIVSRLESLFLTLDAIGLVVFSILGAQIAIEQNHGF
IIAISAAVITGVFGGILRDILCMRIPLVFQKEIYAGIAIIAGAIYYTLMVYLQLHALICT
LVTLFVGVTARLLAIKYQWSLPIFSYNEEK
>fig|195.2024.peg.1510 Ankyrin repeat-containing possible periplasmic protein
MRLLFILFCCFLGLKAENLITCDYIKNNKAQVFQDSPKQDYLDIASTCDFSLKNQAFTKR
LYQLANEIRGGNAACSGIEYFPKLQEFDFLLLKISIDPIEYQKGLDAPENLEKKYTLLRS
YFRYWAYQSIGNFRLYQEFWQEYNNAIEPLEQYFENNFKFDKGSNIYYTTNALNEFLNWA
VGETKIYKDISPLAKVLSNKKHSITYIQDFIYTNNLNRDELTIGLQAALLNQRNKDILNL
LIRLGARIDEGYENALFYALENYDNTKFLLELGLNVNSANTFGKTPLFYAIEFKRKDIVS
LLLEYGTDVNKKYINDNEKLALSANIGGNTPYFITFCALEHTSKNVLMHAAAYGDVEILK
MLVAKGADINEIDDLGFNALDFALAANQKDNANYLQSLGLKPNENLIYGGSLE
>fig|195.2024.peg.1711 putative lipoprotein
MKIWLYPCLTALFFTACSIKETKLSPALSQTILNFKDQQDSHYAKLEFDQNISILSKMNQ
NINFDSQKYKQLFFSPWHSSFKTLKNQNLFWSFSLYTNPKNTYYFFNKQVIPLSWFEKTI
DNANTKELGKFDKKALVIQNTLIKNIPTQRAILKNPFLENEGIPFDYASDSILNAGTPIL
VSHFSKDKRYAFVLSEAGVGFIESKDLEFFSNNRAQIYEKLNFLTPLKEKLAILDEDGNF
FFESRIGALYPYYKEDKNYFYGKIGPKKYKISKDNASNFPLNFNDENLKNQISEVLNLPY
GWGGYNFERDCSLLTRDVFSAFGLYLPRNSAAQKNSFTHFDINTLDNSQKKDFLDRFGKA
YLNLLYLPGHIMLYAGKISDKNVAVHNIWGLRKDETQRLLISSSVITSLEIGKDEISKEN
LLLSRLKEVSFIYLSKEEKEQITNYLEKLKNKAD
>fig|195.2024.peg.1511 Oxidoreductase
MKTAFITGASSGFGHACVEAFIQEGYKVIALARRKDRLDELKAKYKDQIHILCLDVRKQE
EIFKAVENLPNDFKEIDVLFNNAGLALGIDEFDKLSIEDIDTMVDTNIKGLLYVAKAIIP
ILRKQKSAYIFNLGSVAARNPYFGGNVYCGTKAFVGQFSRALRNDLRGENIKVTNIAPGL
CKTEFSEVRFKGDKAKADAVYEGTQYISAQDIAKVVMSIINLPSHINVNEIELMPVTQTW
NGFYIEQNQ
>fig|195.2024.peg.1545 Peptidoglycan lipid II flippase MurJ
MKSLVFKNFIINALGILFSRVLGLARDVLIALFLGAGIYSDIFFVALKMPAFFRRIFAEG
AFGQSFLPNFVKAKKKGAFCVSVMYQFSVIVFLFCLLVSFFSSFFTKLFAFGFSSDTIAL
ASPLVAINFWYLFFIFLVTFLGAILNYRQKFFITSFSAALFNLSIVIAAFFVDKDAPQDT
LYYFSYATVLSGVAQLILHLMVLRKNPVIRAMALSVKFRRAKAKLEGFYSNFFHGVLGSS
ATQISSLLDTTIASFLMTGSISYLYYANRVFQLPLALFAIALTQVSFPKILKHLKSDQEN
LALSFMQRALAVLSILLIVSSIVGSVFALEISKLLFERGNFTHEDSIITAYVLIAYLIGL
LPFGLQKLFSLWLYAKFKQKTAAFIAFKALLISALCSVLFIFLIKDESLKVIAVALSSSL
SAFYLLIANIKEFGFKNFFALISFKFCFLMITGLVVFTILLYEIKPYLIEALLWIVASVK
GVF
>fig|195.2024.peg.1003 Membrane protein
MLNWKKIEDLNLKEVAARTKIELEFLEALVKKDFATLNRFNVRGFVKILSREYELDFTDF
NEEFETYLNENNLNDTTTKPKMITPKLDAYSQKSTSFVSFIIIVIIIALIGFGIYYFDYI
KSFFQKDQNNSSAAVVDIIGKAQSNLKALENNVVVIDNQAEENETEANLTQIQNTELNNT
KEEIKQISTTPNNTNANEENLSTNDSLATTNQEVAEVSKALNKEAHFKASGKIWIGLIDL
SNYRKTGLVKENDFNLSLEVNRLVLTGAAALSVFDENGKEQKFPAGNSKRFLIKDGKITS
ISAAEFMKLNKGKEW
>fig|195.2024.peg.1564 Nitrate reductase cytochrome c550-type subunit
MKKKTILLGSVAIMFLAACALNSGVSSEQIGLRKASLENENKVALVDASFTALQPGESVL
FERSFENAPPLISHTIEDMLPITKDNNTCLSCHDKAIATDVGATPLPASHYYDFRTNKTT
GDAISDSRFNCTQCHVPQSDAKPLVGNSFKAEFKNEGLKNRSNLIDVINEGVE
>fig|195.2024.peg.1546 hypothetical protein
MALDEKIISYTENPSRELLSVASRTNIALNELDFHLLAFSTQYCLENTEWIKIAEKDLTL
FEKDEVFLKEDLQIKQEYKIEIFHQTRQDKTANAIKLIANKNLTKIVAQINFNELKYHEK
LAFELLQIIYKKMLKLKFLIGIRIFDFKKELIRICNEHKKNTLNKTLQINVAKGVEPIQS
QDEALVLLYKEKAKDYTIDEKRSGIIAVDENEVVLRYNKFKQGKEGKDLNLHTLKVIDAN
QNKIKFNCSSLAFKTVEYEDYTEYLALKKGYVVEDQDKFDIANLLEFNNKVDFKNIGIIR
AGLDKNVKINIKFISDMQDAVNSGVGIECEELNITGSVGSNTNLKATRMRVEGTTHTKSK
IYAKEAYIKTHRGFAQADKLNIDLLEGGNIKAKEVRIKKSLGGVIEADRIYIEQLESNNS
CVFYNNVVIERFEGENNKFHTKIKKMDKDYDQELLKIKNEISSLHHKISKLKQYILSNKN
NVLDIEKKVLELKNQGQNIPSQYEKFLKNFSIQNANLNKLQNQEKELLEYRKKIHDELLA
LEEDLFKAKFINKSGKWSDMNEIRFSLLEPKEDIFYSSSTKESAKFIALKKIIQNNQEYI
EIDKKLDYEEKDIEWLLPSKE
>fig|195.2024.peg.584 Sodium-dependent transporter, SNF family
MQRQTWSSTLTYILTVAGATIGFGATWRFPYLVGENGGGAYVLVFCVAMILIGIPVILAE
NVIGRKSMTNSVDAFKGKWKFVGYMGLLGSFGIMAYYMVLGGWVFVYIFELIIGNFDLSH
TVTKDFTEHFFNEKISFNPLGVGIFTTLFVLINYVILRRGIIDGIEKSVKFLMPLLFICL
ILVVGRNLSLEGAINGVKFYLTPDFNKILSPKLLIDVLGQVFFALSLGFGVMITLSSHLS
KNENMAKTAIYTGVLNTLIAVLAGFMIFPALFAAGLEPDKGPSLVFQTLPIAFSHIHFGT
IICILFFILLLIAALTTSLPIYQVIISVLEEKFKLSKKTAINLTLGSIFILGNIPCILTY
GPWRDITLVKGKNIFDSFDFISGNILFVLTAFFCCIYVGWILGKEQSIKELSNEGKLKSV
GFKIWFYYIKFIIPLIILTIFVYGVTN
>fig|195.2024.peg.1694 Uncharacterized periplasmic protein HP0781
MKKIFLILCLCFGFVFAKEQKLVDVKPAENFYPKISTQECDSNCLLELLEARLYLSFLSE
FVDQHDQFLSNIYAKLLNSITDFDKNLQKITSVKLAIIIPEKTIKSYSNTIINSSIAYLL
SQRAEIKVKVFLTGTEDNDKIRSTLEQVQAQGYQYAIAALTLKGVNQLKDYSGDMKIFIP
TLHKNNVSFSNLNKNIIFGSIDYDAQVLALLNKANSDIAAFSDGSMLSSNLNSRVLEQNA
NTRFYRVEGEKLDFYRLLRSQGSLNNASIFLNTPLIKTALISSQLRVYNIQPFVLLSTQI
NYNSTFLSLTQEGDRKNFILANSIDNHDDNLSYLNEIFNQSIDYNWIAYATSIGTDYFYT
QFLNTKSDSLFDEKIQNSQILYKVRLMKGSKASFEELK
>fig|195.2024.peg.182 FIG00638667: hypothetical protein
MWEFYYLNNQQLKMKDLILKTHLSVLRLEKLLQTCTNITFEPNHISCLLKDDLLYLDDNK
EKLLNSSLILENNTSLYSPNSNFKLQLQNRKELYNDEQNIIYALVNKEIKKIFIHSENNI
TASFKGKFIPIQARIKLFLKEDKIHYELYPYFNNQLEQYSIFMDNVSLFEIQKQKLKVCL
KEQEQEYCLTKRLFI
>fig|195.2024.peg.747 hypothetical protein
MRKKILILAFLTLIMALVFVFAGLKDFDEYALKNRFLQIAAIVIVAICIAISTVIFQTLC
NNKILTPAIIGLDSLYMLLQSALVFSLGSANLSVYRNDINFLITLACMVVFSLGLYKILF
SSDKSIYLIMLLGLIFGTLFSTLSSFFEILIDPDEFMIIQGRMFASFDNVAFDVLALAYI
VTLLSFIWIFRYMKFLDPLSLGKDLSINLGINYQKISKHLMIIIAILTSISTALVGPITF
LGLLVVNITYELFKTAKHSILLLACILISILALLGGVFFVSRIFDYNTTISVIINFLGGI
YFIYLVLKGNKL
>fig|195.2024.peg.1106 purine nucleoside phosphorylase (punB)
MIVCAGGNENFSFAKTIGIGLVESTFHLTQLCLKEKPSKLIFIGTCGLYDKGEILGIYKS
SHACNIEFSYISDQFYTPANIEIKLNNQNVSRETIKVNSSNYICQNSKAAKEFAKLGFFA
ENMEAFSILSVAKNLDIDAECILCATNFCNENAHEDFIKNHQKAKEKLEEYLKINHYI
>fig|195.2024.peg.287 Ubiquinol-cytochrome C reductase, cytochrome C1 subunit
MRELKIFLVVVVFTALVYWGVEPYAHSVMKPHVAPANFDYAAEDTAYAKGIIAEKEIALE
DAKKSNDAKRIESAQKDLDKAKENLAKVEELWADVAKIDFTKGNAAKGKEFFNNNCFACH
GVKEDDIAANITDSSLGVIPPDLSSAGVIFDEKFLAALIMNPALALKVDHKFGDAFIMTA
YNSEVSGDSEELVNANIADVIAYLKEVGLKFEAKENATIKQEAELKYSKIEDANEKSALV
EKEIAFAKDKSTFIEACGRCHDIKYDNFFTPSNHNDLANYLGSVPPDLSMIIRSRGEQYL
HDFINNTQKLLPGTAMPRVGLTEDAQVKVVSYLEKVGDSKKEERESTGIYIMIFFVILSI
FAIGWKRSVWSKLH
>fig|195.2024.peg.1264 Dihydroneopterin aldolase (EC 4.1.2.25)
MQSHINIKMQFKCIIGILKFERKKKQKVCIYLTAKANDFLDYAKVSKRIKKYYKKEQFLT
LEESLEFVCAKLHRKFPQIYYIKIKTYKPEIIKNARVGVKLKKFY
>fig|195.2024.peg.1251 Excinuclease ABC subunit A
MNDTIKIIGAKENNLKNIHLEIPKNKLIVFTGLSGSGKSTLAFGTLYAEGQRRYIESLSA
YARQFLDKVGKPDVDKIEGLTPAIAIDQKTTSKNPRSTVGTITEIYDYLRLLYARVGIQH
CHQCGQKISSMSASDIVGEILKFPKGAKIIIYAPLVREKKGTYADLLENLRNKGYIRAQI
DGVLVRLDEDIELSKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLEESFGEIEIEVLNP
DEVGLNKHYHFSEHSACFACKISFVPLEPLSFSFNSPKGACEACDGLGIRYTLDMKKIID
ESLSLENGAVKIMYGFNKSYYYKFLIAFCEQNEIPIKLPFAELSEEQKRLVLYGNAKTID
FFWKRNRLKRTFEGVVKMAYEMLKDEKDLAEYMSEKICKDCAGHRLKPESLAVKIASKGL
GEILDMSIEDSTSFFANKKNFSYLSEQERLISEPILKEINERLFFLYDVGLGYLSLGRDA
RTISGGEAQRIRIASQIGSGLSGVMYVLDEPSIGLHERDTAKLIKTLRNLQQKGNTLIVV
EHDKMTIEEADFIVDIGPKAGKFGGEVVFAGTYKELLKSKSETALYMNGKKQISQLQNRE
QKEWLELKNVNINNIKDLSVSFPLQNLVAITGVSGSGKSSLILQTLLPFAQEELNRAKKV
KKLGGVQIEGLEKLDKVIYLDQSPIGRTPRSNPATYTGAMDEIRNLFAATKEAKMRGYKA
GRFSFNVKGGRCEKCSGDGEIKIEMHFLPDVMVVCDTCHGKRYNDATLEIKYKGKNISEI
LNMSVLEASEFFAAVPKIKQKLDTLVKVGLDYLTLGQNATTLSGGEAQRIKLAKELSRSD
TGKTLYILDEPTTGLHFEDVNKLILVLQHLVDLKNSVFVIEHNLDVIKNADYIIDMGPEG
GVKGGKIISTGSVEKVAKDHKKTKSYTGYYLDLELKNAKS
>fig|195.2024.peg.713 Ribulose-phosphate 3-epimerase (EC 5.1.3.1)
MYVAPSLLSANFLKLEEEIKAIDEAGADLLHIDVMDGHFVPNLTFGPCVIEKISTITEIP
LDVHLMVKDVGKFVDLFIPIKPKFISFHIESEAHPIRLCEYIRSQGIHPAIVLNPHTPIN
SIKHMIDFADMVLLMSVNPGFGGQKFLPLVYDKIKELRRLIDEKNAKVFIEVDGGVNGLN
ASDLEAAGADILVAGSYIFSSNDYKTSISSLKLEF
>fig|195.2024.peg.768 integral membrane protein, putative
MNRFQTFSLAMEGKVNIELLAAYKDKIETLSDETLFRFCYLELKNPIIGLILGVVPAFIL
SGLTFDRFYKGDMGLGFAKMAMWAFIFIGLLIAGFFDSSSMLVVWIFNIVALFIWNILDF
FLVWQGIKNDNLAKIIQFLEQDNENFISNKQ
>fig|195.2024.peg.1102 SSU ribosomal protein S10p (S20e)
MERIRLKLKAYDHRVLDRTVAAIVEAVKRTGADIRGPIPMPTKIKRYTVLKSPHINKDSR
EQFEIRIHARMLDIVAATPDTVDSLTKLDLAPEVSVEVRAMGK
>fig|195.2024.peg.543 Membrane-bound lytic murein transglycosylase D
MKKIIFCFILFYNFLFAQTTTPEFYERQMSVLRNLDIDPSFISDLAFVQSQQDLRSKHAP
TLIDGIQNFSKVTPMIRKILAQQEVPEEILYLAMVESGLKTHSVSNAKAVGVWQFMQPTA
RNLGLRIDAYVDERRDPVKSTYAAVHYLKSLKEEFGKWYLALLAYNCGNGKLRQAIKQAG
SDDLRVLIDPDKKYLSLETRNFIRKILTLAFLANDRDFLLDKDGALVNYALNNDFAKVDA
PSSVALKDLAKNLNMDLATFKKYNPHFKHGFTPPGKGYYMYIPLNKVAFFDKNFKVEKLA
KVDTTIPMTKIYVVKSGDSLYKIAKKYNTSVEQIRELNKIAKNHLSINQKLIIPIKENKN
ANYKTKAKENFTQVVSR
>fig|195.2024.peg.1452 Periplasmic protein p19 involved in high-affinity Fe2+ transport
MIKKVLSVVAAAAVISTNLFAGEVPIGDPKELNGMEIAAVYLQPIEMEPRGIDLAASLAD
IHLEADIHALKNNPNGFPEGFWMPYLTIAYELKNTDTGAIKRGTLMPMVADDGPHYGANI
AMEKDKKGGFGVGNYELTFYISNPEKQGFGRHVDEETGVGKWFEPFKVDYKFKYTGTPK
>fig|195.2024.peg.973 Uncharacterized protein HP_1490
MDPSQVLDLNQTLPTASFDAGYSILMVVIALALVLLNGFFVLSEFSIVKVRRSKLEEMVK
EKKVGAKKALEVTSRLDTYLSACQLGITLSSLALGWIGEPAIAKMLEIPLANLGFNGVII
HTIAFIIAFSIITLLHVVLGELVPKSIAIAIADKAVLWVARPLHWFWILFLPCIKIFDFL
AAMTLKLFGIKPAKESELTHSEEEIKIIASESQKGGVLDEFETEIIRNAVDFSDTVAKEV
MTPRKDMICLNKQKTYAENMQIICDHKHTRFPYIDGSKDTILGMIHIRDIVQNELSDKSE
NLDTFVKPLILVPENISISKVLVMMNKERSHTALVIDEYGGTAGILTMEDIMEEIIGEIK
SENEEDSYKKLAENIYEFQGRCDIETVEEMLLISYDEDLEQVTIGGYVFNLLGRLPVAGD
RIEDELCYYEVKKMDGNSIERVKVVKKTNKDEE
>fig|195.2024.peg.572 Phosphate ABC transporter, substrate-binding protein PstS (TC 3.A.1.7.1)
MKKILALSVASFALAGALNAADLKIAGSSTVYPFTSFVAEEYAAIHNTKTPIVESLGTGG
GFKVFCEGITDISNASRAMKFSEFETCKKAGVTDIVGIMVGYDGIVLAQNKANAPLNITK
KELFLALAKEIPQNGKLIPNPYTNWNQINKNLPNRKISVYGPPSSSGTRDTVEELVMSDI
SKKIPEYKGEYKTIRQDGAYIPSGENDNLIVSKLTIDKDAFGLFGYGFLVSNVDKINAAD
IDGVKADEKNIADGKYDLARSLFIYINAKKNPKEAFEFAKIYMSDDLAKSGGELEKIGLV
PLSDDKLKASQKHVEDRKILNDELVKAGKVF
>fig|195.2024.peg.202 hypothetical protein
MINGINSYSSYNYTNTFSNNTPNTKSSNTVNETSNLVSDKSRTVSKMLGYGVDKDGFFTS
DFNEAADLPKDYKIYAKDIENFVNIQTKSLLSSYINIDIVKNIGNAYKVFSQLLNDELNN
KINFTKEDLVKIPQGFEFNQNTLEINKKYNLNDKEYKDFMSNYQNYSPTSHNIKIMTFFS
LDDKSDIFKYSLIDPTPYSNNDKTITKSGIL
>fig|195.2024.peg.206 Serine/threonine:Na+ symporter SstT
MFSKLVQSYAKGSLILQICAGIILGILVGISSKEIAEVVNLLGVLFTNALKAIAPILVFI
LILTSICTRDFSQSSSKIRNIVILYIVGTFLAAACAVIASFMFPVELVLEGVQKAENTSP
MHLNEIFKNLLLNIVDNPINALSSGNYLGILAWAIGGGIALKNCSQEAKQIFVDINEGVL
KIVKFIVKLAPFGIFGLVANSVAQTGAQGLLSYAKLLVLLVLTMLFVAFVINALIVFIYT
RKNPFPLIFICLRRSAFFAFFTRSSAANIPVNMALCAKLGINKEFYSISIPLGATINMAG
AAVTIAILSLSAAHSVGIQVSFLQAFLLSIIATFAACGASGVAGGSLLLIPLACSLFNID
YDIAMKVVAIGFIIGVVQDSVETALNSSTDVLFSAICSKDELNYDIR
>fig|195.2024.peg.1039 hypothetical protein
MQGFILHTQKVKDEDLIVYILSPKELIKAYRFYGLRHSSILNGYKIDFALDENPSFLPRL
KDVLHLGFVWIMDREKMLIWQEFIRLLYHHLKDAQVLESFYFELLDECVKRFEKQNPKRV
IVDAYLKILEFEGRLHQEFRCFACDESIENPITLIRAFLPSHHTCALGYAFEKQKLKNFY
ESKNCAIFGDEEIGNLYQLIKEGL
>fig|195.2024.peg.46 DNA-binding protein HU
MTKADFISQVAQTAGLTKKDATAATDAVISTITDVLAKGDSVSFIGFGTFSTAERAAREA
RVPSTGKTIKVPATRVAKFKVGKNLKDAVAKAKKKK
>fig|195.2024.peg.299 Amidohydrolase
MLIKNAKIYGENLQDLLIKDAKIVKIGANLDDNDEVLDAQGMTLLPSFVDLCVNLKNDKF
SLSNLELLEKECLRGGVGAIILRDCMDFDEESFSLFLQNLKTRKIQIFPSICALDKQGKL
KNLATLFNKGAHALELKSSSNANILRVGMQYALMKEKSIFVKCHDENFDDNGVMNDCETG
FELGLAGMSAVAESSEVAKIQEIAKFYGVKVIFDLLSLKRSIELLEDENLKLISIHHLIK
DDSACAGFNTAAKLNPPLRSKEDKESLKQALKQGKIDFLSSLHSAKSISLKDLAFDEAAF
GIHSVCEFMSLCYTFLIKEDLLTWQNLCKATSQNPSEFLGLNSGIIEVGKEANLVLFDQN
EEISAPKSSLYANDKLFGKVKLHLVKGEKIILN
>fig|195.2024.peg.1451 High-affinity Fe2+/Pb2+ permease precursor
MKFFKILFFFSMLFLANSVFARVDDYVAEANTIKNILEESIKSYEKGDNLKAKKLSEDAY
FQHFENMEGSIGRNIGKKAITMERKFTNLRRLYKDKAPIEQIDALIESLYYDLDEVAPIL
QNGYRLQAEASDINYDKAAAEKSSIQANAKREAEAEALIAQMMGIDKNDLAKTNSSSSTQ
NETINDSINNDLQAAAAMDARLQFVLDNISTKFSQAANAFKNKDYQTSKDFLNDALFNDY
RNTKVEVLINKFTKAGNDQKIQQAIRTLIRQINNANIDEKNLRNDLDSIEEQLFDIFLQI
PNSELSNLKIEGFDDETKGKDYTKVSNDIKLALDEILKNYDGFSASIVDDLQGIYLDIFE
ASGMENKIGAVDSGLKLKIESLFSKSVALIKASTDKKELEATFNDLEQLIASSVDKIQDS
TPYSLFIWALGIILREGLEALIIVVAIVSYLVQSGNKNRLNIAYSALFTGVILSFITAFG
VSWLFKENAGQSRELIEGITMLVAVLLLFYVGFWLLSNAQNKKWTSFIKQGAIDAISNNS
AKTLWITVFLAVYREGAETVLFYQALLFDAKTSTDFGAVFGGLGLGILILIVLYFLLKAG
AIRIPVKQFFYITSYIIFYMVFVFTGKGIAELIEGKVIIPSLIPMNFEPILWLGIYPYYE
TLIPQFIVLIMLIIGILITKQISKKGVKS
>fig|195.2024.peg.917 Putative helix-turn-helix containsing protein
MKVLNFFYENHPKFEISYERKVQIPLCNIIIKGPKFSGKKTLIFNYLSQFKPNEILFLNL
YDTRFENQSLGHLSNFLEKNVQIKFLCIYNVEFALNLQDIKIPIIISTDKKDLHIEGFQE
LELDYFDFEEFVSISRKNLPINNLVGLFLQSGRSKLGEKNILLRQNFNTLELEILKYLAL
NLGQQISISKLFLELKKKLKTSKDSVYHTIKELENTYIIHPISHDEKKLQKIYFRDFGLR
NNLCIQKDFAHLFENLILNELFKFKQEFFYNKFFTFYSKVSKIAYISSPTLDIDLIKLRA
KKILSKGLELGIFHVVFITLSSEDSFFEQGVKFEVLPFDKFSLGF
>fig|195.2024.peg.531 ATP-dependent hsl protease ATP-binding subunit HslU
MNLTPKEIVKFLDDYVIGQKKAKKIIAIALRNRYRRMQLSPELQDDIVPKNILMIGSTGV
GKTEIARRLAKMMGFPFIKIEASKYTEVGFVGRDVESMVRDLANAALNLVKNEQREKNKD
KIDEFIENKILEKLLPPLPKGISDEKQEEYKNSLEKMRTKLRNGDLDESVIEIEISQSMF
DTNPNLPPEMGAMQDIVKVIGVGSKKVKKEMKIKDAKNALKNEAAEKILDQESIKSEALK
RAENEGIIFIDEIDKIAVSSGNSNRQDPSKEGVQRDLLPIVEGSSVQTKIGTLKTDHILF
IAAGAFHLSKPSDLIPELQGRFPLRVELDSLDDKALYEILTRPKNSLLKQYEQLLKTENL
ELEFDDEAIKEIAKIASKANEEMQDIGARRLHTVIEKLLEDLSFEADEYAGKKFVVDKKM
VEEKLGDIIENKDLARYIL
>fig|195.2024.peg.1274 Multidrug efflux system, membrane fusion component => CmeA
MNLFQKNTLLLLSALFLFSACSKEEAPKIQMPPQPVTTMSAKSEDLPLSFTYPAKLVSDY
DVIIKPQVSGVIVEKLFKAGDLIKKGQTLFIIEQDKFKASVNSAYGKALMARANFDNASK
DYNRSKTLYNKGAISQKEYDSALANFNNTKANLTSARADLENARIDLAYTEIKAPFDGIV
GDALINIGDYVSSSSTELVRITNLNPIYADFYISDTDKLNIVRNTQDGKWDLSNIYADLN
LNGEVVKGKLYFIDSVIDANSGTVKAKAIFDNNDSTLLPGAFATITSNGFIQKNGFKIPQ
IAIKQDQNEVYVFLLKEGKVAKAPVHISYQDNEYAIIDKGLQNGDKIILDNFKKIRLGSE
VKEVGAQ
>fig|195.2024.peg.460 Glutamine--fructose-6-phosphate transaminase (isomerizing), glutaminase subunit (EC 2.6.1.16)
MLENKIIFVAGACGRIGKALCQKILLSKGIPILADINKERLNKLQENLETNFKTKLLSLE
LDITKQESLQTALQKSQERYGKIDAFVNSSYPFGKDWGKTPYYELKYEQICESLNLHLAG
FMLAAQEFVKFFKQQGYGNIINLSSIMGVYAPKFENYEGTSMQSSLEYSVIKAGINHMSS
WLAKELFNQNIRVNTLASGGILDNQNELFLKAYRKCCASKGMLDADDVCGTLVFLLSDES
RFITGQTLVVDDGWGL
>fig|195.2024.peg.553 Putative pre-16S rRNA nuclease YqgF
MRALALDVGLKRIGVALCIDKIAIPLEGIIRKNRNQAANEVKNLLQIHDISLLIVGIPKG
GSSEEEMTRRIKHFVSLLEFDKEIRFVDESGTSKEALGYGVANTRKKDAKLDSLAALIMI
KDYFGI
>fig|195.2024.peg.606 LSU rRNA pseudouridine(1911/1915/1917) synthase (EC 5.4.99.23)
MQTFLVDEPSRLDIFLAKNLQQSRNQIASMIEKNCVWVNDKIQNKNSFKLKVGDKLVLNL
PLVEEAKPKFDIDFDIEILYEDEDLLVLNKPSNLVVHGAKSVRSATLVDWLIEKQYTLST
LGGEVRAGLVHRLDKETSGAILIAKNNFTHQKLSEQLSDKTMGRIYLALIDLPLKEDKII
IDKALIRSSANAIKKIVTNSFVKGSKEAKSAFVNLAKSEEVSLIGAKLFTGRTHQIRAHL
ASINRHILGDELYGYRGKYECRIMLHAYFLYFIHPRNGEKIFIQAPLMDDFKQILEKKFI
LGELNEKISLESLLGCFDSFI
>fig|195.2024.peg.1640 L-Proline/Glycine betaine transporter ProP
MRKILSKKDIKTLGLSSLGGTLEFYDFIIFAFFSSYISKNFFPENLSPFWQLFNTYGIFA
AAYVVRPLGGIVMAHFGDKFGRKKMFMLSILLMVIPTFALAFIPSYESIGYLCVVFLMLI
RIAQGISIGGELPGAWIFVYEHSPQGQRRTYIGFLTASVVGGILLGSIVFLLMHKIYTQE
ELYEWAWRVPFFLGGIFGLISIYLRKFLSETPVFEQMRKENVLEKFPLKEVFKRAKAGVL
ISMLITWVLTGCIIVMILFIPKYMAEILQFDTNFQTYLQMGGIFFISLGCIISGILADKI
GIFKSSIIFSLFFGLACAFYFHFLYNTNADITLVSIFYLLACLFGGVMNFCPLIMNEAFE
AKIKFSGLSFSYNIAYAIAGGITPQLTLLLHKFAFANLDNAWRFSLGYYMFLIVLLALLS
AFIFRYLNNTQRTYSQ
>fig|195.2024.peg.607 Rod shape-determining protein RodA
MFIPDRRILTHFDYMQPILFVPIILISFFLIFEANAFLAEKQFVYACVGIAAFSVFFLLP
IRKLMWLIPIAYWVNIFLLLSTDIFGVEKLGAKRWLEIPFTHFTIQPSEIFKPSFILMLA
YLIYQDPPPKNGYKLKQFLKLSFFIILPFLLIAQEPDLGSAMVLLIVGFGVLFIMGVHYK
IWLSIIIAIGISSPIIYTHLLKPYQKQRIHDFISEKPSYQVAQSMIAIGNGGLIGKSQDE
ATQTHFNFLPISTSDFIFAYLIERFGFWGGFVLILLYTLLIFHLLSLNQKLKDDYFARVA
INCVALFIFIYAAVNISMTIGFAPVVGIPLPFFSYGGSSFTIFMIFFGILQHLITFRYFW
VDNKNK
>fig|195.2024.peg.161 Aspartyl-tRNA(Asn) amidotransferase subunit A (EC 6.3.5.6) @ Glutamyl-tRNA(Gln) amidotransferase subunit A (EC 6.3.5.7)
MITLKEALKYSKEELENLKKELNDKAKKENKIGAYIEQFLGKDLSDGGEGIPIAIKDNIS
VKDWELTCASKILQGYVAPYDATAIKNLRSKGFSPYGRTNMDEFAMGSSSATSFYGKTLN
PLNFARVPGGSSGGSAAAVAGGLALASLGSDTGGSVRQPAAFCGCVGFKPSYGRVSRYGL
ASYSSSLDQIGVLTQNVEDAAILYDAIAGYDKMDSTSAKVDFTPTAPNLNAEKKLRIAVI
ENYVNEASAEVKAALLKSIEMLKANGHEIVYKNMLDSKFDIAAYYIIATAEASANLSRYD
GVRYGKRSQNAENLKDMYINTRSEGFGEEVKRRILLGTFVLSSGYYDAYYIKAQKARAFI
KAKYEEILQDCDLIFMPVTPTTAFKFDTQKSPMQTYLEDVYTISVNLAGLGGISVPVGED
KEGLNISAQLICKAYDEQTLLDGALSLEKIIKENK
>fig|195.2024.peg.537 Membrane protein
MRKTISAYKVKLNGSYVFLGFLCILYQILGSVFLYMPLLYGVFFCYMYFLLEERQKTFNK
LDFRWYFSLFFLFFTDITYDFFLFSSWLAFVIFYYTCADWIKTNLKIGKIIPIILVLCVY
AFIFILDAIFSYVGDQEFKMPNFGYMISIMFECLFAYMLYRSKF
>fig|195.2024.peg.470 Magnesium and cobalt transport protein CorA
MLYIYIKTQNALVQRINFNLDSQELPQNILWIDLLHPSVAEIAFISSEFNLEFPTKEERE
EIELSAKYWEDNATITINAHFLVRDLKSDEEDRNLIKLRTEIVTFATAKNILFTIRYNEF
STFEEIQARILASPKNFEDGFDIIDKMFEVRVEKDADLLEWIDKEARRLRTSVLEKKDEY
SYDEMLKDISSLQELNMRVRDSLFDKRRAMTSLLKSDKIDKDIKQNLTIVLKDLNSLVEF
SVSQLNILDNIQTILASQINIEQNKIIKIFTVATVAMMPPTLIGTVYGMNFKFMPELELH
YAYPIVLGVMVISIILPLVVFKKKGWL
>fig|195.2024.peg.39 Alanine racemase (EC 5.1.1.1)
MSLIKINQKAYESNLKIIAEKIGSFSRLICVFKDNAYGHGAKILAPIASTLGVNFVAVKN
EKEAYELEDFFDNILILSHHPHGKENSKFIYALNDIDKINAYQNDTRIHLKIDTGMHRNG
VCVEDLNEALLKIKCSALKLEGIFAHFAGADEMDASFFIQREKFSKAKDIAKQIYKNLIF
HSHNSPALFRAVKIPEDELCRTGLAQFGYGDESLKKVLSLYAHRLSHRELQIGQSVGYGG
AFSATEKIKIATYDLGYADGLFRYDGKGDLLLANKQKILGKISMDSFSCQDFGKEICVFD
NADVWADFFNTINYEILVKLHPDIPRVLV
>fig|195.2024.peg.125 Uncharacterized protein HP_1473
MKCLNCGVFTLLCFCHHCAEELSEFSLGVRELKKDFKVYSFYKYHEIKHLLHAKHKFYGY
FVFHFLAKLSFFKFKNFFSVNEQINVIPLDDRVENLLYSHSAILAKYLKTEFIKPIFGAL
HAQNHLKYSGKSLKFRQDNKRKFKLLKKINNPVILVDDIVSSGSSLLEAKQFLEKNKISV
LFAVVLADAKV
>fig|195.2024.peg.1624 Nicotinate phosphoribosyltransferase (EC 6.3.4.21)
MKKDSYTKPNNTLLCDFYELTMMQGYFLNGFENKIAYFDIFFRKIPDHGSFAIFAGLEDI
LDFVSCLHFDEDDIAYLHSQGIFKEEFLRYLKNFKFKGEIYAMQEGEIIFPNEPLMIIKA
NAIEAQILESFLLLSINHQSLIATKANRIVRAAKNLSVLEFGTRRAHGSEAALKGARAAI
IGGCKASSCTLAGKNYSIMTSGTMAHSWVQMFDDELSAFCHYLELYPQNPTLLIDTYNYK
QGLENAVKAFKKFKIKQCGVRIDSGNLEILSKEIRTILDKNDLKECKIIVSNSLDEKSIN
KLLKNDAPIDAFGVGEKLITASSDPIFGCVYKLVAIEEDKLITPKIKISEDKQKITLPHF
KKLFRIYDKNTQKMLFDELYIYNEKLPKLDENLERKELLKCVFKEGKILNKQKNVEEIAL
YAKSQISKLDEKFLNFNNKEKYKIKLSKDLTKLRQNFTNTTL
>fig|195.2024.peg.1381 Histidinol-phosphatase (EC 3.1.3.15) / Imidazoleglycerol-phosphate dehydratase (EC 4.2.1.19)
MSEKILFIDRDGTIIEEPKSDFQIDSLEKLRFEKGAIPTLLKLKNFGFKFVLVSNQDGLG
TQSFPKEDFEIAHQKMLDILQSCGIEFKDIFICPHFENENCECRKPKTALLDEYIKHNLY
NKEQSFVIGDRDTDMILASNLGVRGLKYSENLTWKEIEEEILNSFRTASISRITKETNIH
VKVCLNGGKIAINTGVPFFDHMLEQIAVHGGIGLEISCKGDLEIDEHHSVEDVALALGSA
IKQALGDKIGITRYGFVLPMDECLASCAIDFCNRPHLVYKAKFKKEKLGELSTEMIEHFF
YSLSYSMGVSLHLKVKGKNDHHKAEGLFKAFAKALKMAVKIESENLASSKGVI
>fig|195.2024.peg.291 tRNA-5-carboxymethylaminomethyl-2-thiouridine(34) synthesis protein MnmG
MFDVIVIGGGHAGVEASAAAARMGKKTLLLTTLIEQIGAASCNPAIGGLAKGHLVKELDA
MGGLMGEITDEAGIQFRILNESKGVAVRGSRAQIDMDKYRIVARNKLLKLKNLEISQEQV
CELIYENGSVVGVKTNLQNTYEAKKVILTTGTFLNGLIHVGENKLTAGRVGELASVNLGQ
NLLSTSLKMGRLKTGTCPRVDAKSIDFDVLEIQYGDQNPKAFSFRTKNFNPIQLPCYIAR
TNTTTHEIIKNNFYRAPLFTGQIEGVGPRYCPSIEDKINRFSDKESHHLFIEPQTIDATE
YYINGFSTSLPYEVQTQMLRSVKGFEEAKITRFGYAIEYDYIEPTELYHTLETKKIKNLY
CAGQINGTTGYEEAAAQGFMAGVNAVLALDNKEPFILRRDEAYIGVLIDDLVIKGTKEPY
RMFTSRAEFRLLLREENAIVRLGKYGKGLGLLEDESYQFIENIRLNTQKGLELLLEKEFT
PNTENNAFLASIGEEKITSIVNLQKIVARSSFDIEKLKKLNTIFENMDEYSLREILNEAK
YYHYIAMQKSQVEKMKNLIDMKIPSDFDFTSVSGLSNEVVEKLQKHKPLTLFAASEISGI
TPAALDILQIYIKMQKKKS
>fig|195.2024.peg.1041 tRNA-(cytosine32)-2-thiocytidine synthetase TtcA
MINLSKKLIRQVAQANAKFGLIKDGDRVLLGLSGGKDSLALAHLLNRVQAHAPFKFELEA
ATLSYGMGEDYSGLHAHCEEHGIKHSVIDSNIYEVSGDTIRQNSSFCSYFSRMRRGALYT
YALEKGFNKLAIAHHLDDAAESFFMNFIHNGALRTLAPIYQSKRGITVIRPLIFVRERQL
RDNATQNELSVIGNEFCPGMKLSEKNVKFPHAREEAKQLLANLEKDHPKLFTSLKTAFAN
LHTESFWLERTKI
>fig|195.2024.peg.726 Acetyl-coenzyme A carboxyl transferase alpha chain (EC 6.4.1.2)
MASYLDFEKNIQQIDEDIINAQIKGDTEAVAILKKNLEKEIAKTYKNLSDFGRLQLARHP
DRPYALDYIDLILNDAYEIHGDRAFRDDPAIVCFMGYLGEKKLIVIGEQKGRGTKEKIAR
NFGMPHPEGYRKALRVARLAEKFQIPILFLIDTPGAYPGLGAEERGQSEAIATNLYELSD
LKTPTIAVVIGEGGSGGALAIGVADKLAMMKNSVFSVISPEGCAAILWNDPSKSEAATKA
MKVTADDLKSQGLIDDVIEEPINGAHRNKEAAAVAIADYVKKALDELEKIDPRELASNRM
QKILQLGAFSES
>fig|195.2024.peg.219 MarC family integral membrane protein
MFSNVGSELYLMFFAGITLLAVLNPFGNLTQFLAMSDGLPLALRKKLFRTILYTALAIVL
AFLFSGPLFMNYIFRVSLDDLRVSGGLVLIIMAIKNLLFSTKLATQSFDSYQEANEKEIL
RQSLIPMAFPMLVGPGTLASVIVISEDGGLDIAFGGVIIAFIFMFALFHFAATIEKIVGK
LILHVFSRIAQVFIVAMGCKMIIIGIKNIFNI
>fig|195.2024.peg.546 DNA repair protein RecN
MINRVLMKENLGFKEVELEISQGLTVFTGLSGAGKSVLFKGILSAFALSESEAKLVEIEL
DDKIDLEEYGIEGEEENVFKLLKDKNTKYFINNQSISKKSLIHLSKKFIKYLSAKEINEF
SNEKFLNLLDALECAKNPEFEDFLSHFKDDYKQWLQISEELTTILEEEKRIEELKELAST
QIERISKINPKVGEYEELLNLKKKLSKKDKIEAAWEKASAIFELEKVVIDALNLSEKDTS
FFSECLNELRIIAENEKIEDLDFDIEEVLNRIEDLSSLIKRYESIENALEVLENKKNELA
HYDNLSFEKKELEKKLEKIEKKINQSTQLLTQARMQNLKTLEDFLNDYLKNLYMKNVSLE
LVDTSKITSLGKDEIKLSINAANLKNLSSGELNRLRLAFIATECRILNSGTGIIFLDEID
ANLSGKEAMSIANVLNELSAFYQIFAISHLPQLSSKAHNHFLVEKNASCSTVKKLKDKER
IKELARMISGETITDEALEFAKTLFKA
>fig|195.2024.peg.824 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MKTNVEKYLKEHENKELCRFITCGSVDDGKSTLIGRMLYDSKMLFEDQILSLEKDSKKLG
NAGEKLDFALLVDGLASEREQGITIDVAYRFFTSEKRKFIIADTPGHEQYTRNMATGAST
ADIAIILIDAEKGVLTQTKRHSYIASLLGIKQFIIAVNKMDLIDYNQEIFNTICKNYQEI
LPCLKNHERIKTHFVPICALDGDNIASKSINMPWYDGKTLSELLDTLPIVTNLSDEFIMS
VQYVNRPHLNFRGFCGNIASGSINVKDEVVILPSLKTSKVKQIITPDIENLKVLDKNEKI
QSSKNASFPSAITLTLEDEIDISRGDVIVSKNHSLKISNSFKAMMIWMSEAKFSLSGNYL
IKMANLTTSITFEKIDFKKDINTFEESQSDELKLNDIAKCTLRLSKKTALAAYKDNKTLG
SFIIIDRYSNETLAAGMVEEILTHEDKARVYTQAEIELNTYIRKNYPEWECKKI
>fig|195.2024.peg.174 SSU ribosomal protein S6p
MKHYEVLFILKPTLTEEEVNAKLEFVKEVLVKNGAEIETVVPMGTRKLAYKIKKYERGTY
FVIYFKAPTNLIAELERILRITEEVIRFLIVKYENKKEIAAWEKLSHGIKQSKKEIKPLD
APEIQ
>fig|195.2024.peg.1267 Phosphoglucosamine mutase (EC 5.4.2.10)
MMKLFGTDGVRGKAGEFLDSFLAMRLAMAAGIYFKDKSVTNNILVGKDTRRSGYMIENAI
VSGLTSIGYNVIQIGPMPTPAIAFLTEDMRCDAGIMISASHNPYYDNGIKFFDAHGNKLS
EDIEKKIEEIYYDDKLIQSSKVDMEKIGQAKRIDDVIGRYIVSIKNSFPKDLTLKSLRVV
LDVAHGAAYKVAPTVFKELGAEVIVMSDKPNGLNINENCGALYPSNLAAEVKRLRADVGF
AFDGDADRLVVVDEKGEVANGDSLLGVLALFLKEQGKLKSSVVATIMSNGALKEFLNGHG
IELDTCNVGDKYVLEKLKVRGGNFGGEQSGHIIFSDYAKTGDGLIAALQFSALMLCKKKS
ASTILGQIKPYPQLLTNLKISEKKDLDKIKGLKELKQDLENKNINVLFRYSGTENLIRLL
LEAKDAKILEKEMKNVVEFFKKALNG
>fig|195.2024.peg.20 UDP-N-acetylglucosamine 1-carboxyvinyltransferase (EC 2.5.1.7)
MTYLEIQGSQKLQGEVIISGAKNAALPLIASSILAKNEVKINNVPNVADIKTLISLLENL
GAKTDFKENTAYLDTSTLDKTVAKYDIVRKMRASILTLGPLLARFNHCEVSLPGGCAIGQ
RPIDLHLSALEKMGANIEIKQGYVVASGNLKGAQILFDKITVTGSENIIMAAALAKGKTK
LVNVAKEPEVVQLCEVLAKAGLDIKGIGTDELEIYGTDKELLDFKEFSVIPDRIEAGTYL
CAGAITNSKITLKKVNAEHLGAVLAKLHQMGFETLVDNDNITLFPAKEIKATEIMTSEYP
GFPTDMQAQFMALALMAKGTSIIDERLFENRFMHVSELLRMGADIKLNGHIATIVGGKEL
NAADVMATDLRASSALILAALVAKGTSRIHRIYHLDRGYEKLEEKFKALGAKITRLEE
>fig|195.2024.peg.1458 Possible lipoprotein thiredoxin
MANFRIQTYLFALIVALFFIACDSGENFKALNSNKIYNFSYNGFEKSLKLDDQTQNFALV
FFTKDCGVCKEQIPILQDLAKNYDFNIFIVLGDAKDAKDAKAWADEKGLSHLALFYEKKA
AKYLSGAVGEIYGVPVLSFFKEGKIDEKFIGLTPYGVLENEIKKLKI
>fig|195.2024.peg.434 formyl transferase domain protein
MVKESIDTGDILVQKEIKLDNNCTALSLLNAQHKLALTLFREALEILKNKAFKMQISGGG
VSQKIIFTK
>fig|195.2024.peg.1200 MoeB/thiF family protein
MNDRFTRIKWLVSEENFNKISQTKVLVCGLGGVGGMCVDALYRSGFQNLTLIDADKFEIT
NQNRQIHSENLGEEKAKVFARIYNAKGIVSKIDNEFLANFDLSEFDLIIDAIDDIPAKVA
LANLIDFKRQIFISSTGGARKLDPTRIKTTSIFKTHGDALAKKFRYELRKSGFKGNFDVV
FSDEEAHCKDLGSFMGVTASFGLALASLALRKVLAKKN
>fig|195.2024.peg.1406 Putative periplasmic protein
MLAFFKGLGIGFLCLVLFVAGVIFNVEFLNKNKTTQTLNFSRSIETSMEAKPDIFHANIN
FWANENLSTQTFLSNEDKIQISNTFNQILERSKKENFCSGGSFSLEPNFSYKDGVQTPKG
QRLHANLECEFTADKLENFNKLLNDLNSIIAKSEFIGISTPALEPKFSKQTLKDNKEKLY
SELLKKAYSYEKIYSLDLNKTCILKNLNIESIPNFYPRALNSMKSADNMELSLPIVKDEE
QSISGTALFICK
>fig|195.2024.peg.683 Dihydrodipicolinate synthase family
MGILKGTLPALLTPYKDDGSINEKEFIHYCEFGISKGLNGLFCNGSAGDSQALSIEEQVK
LMRLTKEVAKNNVPIITGIASTIYQNTFTLAQKAYEIGLDALLLAMPYYYKLSEDALFEY
VKDLSSKVKLPLYVYNIPLFAPALSLKFIERVSKLDNVVGIKDSSGDALLLNHILDVVPS
NFDVFVGREEFYVGALLAGAKGSMTSIGGVFPELMSEIYKSINEKNIGRALLIQKSLLKA
IRFGMSIAFPMGFALLLKARGFEFVNASIHPLSPATKEELNTRFDEAKELIKTIEKETGI
KL
>fig|195.2024.peg.605 Putative fibronectin domain-containing lipoprotein
MSLCLGALTLLFSACSVSQLSNIGSNKELLVNESLPKINNLKSLSDISNIAFEWDPLYDD
NIKGFYLYRSNDANPEFKLVGTIKNKFQTHYVDAKLEPNTKYYYMMRSFNDQGHISEDGK
VIEVKTMPRLEAIPFAQAITNLPSRIKLIWRPHPDPRVASYIIERAKADGQEFKKIAEVK
NRLNAEFIDEDLKPEESFNYRIIAVGFDGVQSQPSSILNSTSKALPPQVEHLNASLDGAN
KVVLTWDAPKYKDFSYYKVYSTSSSFLPYTLLAKTEQNSYEDIVEGAAKSKYYKVTMVDI
DELESPMPKDGVEGKTLGIPSSPSIILAQSTSDGIDLEWVDNDSRAVEYEVRRYGGDQNA
IFKGVKEKRLKDIKALPGVEYSYEVIAIDSVGLRSEPSKKVKAKQ
>fig|195.2024.peg.1161 Membrane protease family protein HP0248
MPADLNDYFNKKNGNSNNNNNRQNFNFKAPEFNFKGFGKFSPFVYGVIIIVLFLIIAKPF
MVINSGEMGIKSTTGRYDPNPLEPGLHFFIPFIQKITTIDTRVRQINYASIEGSNENLTS
GSGVINKNSISVLDSRGLPVSIDVTVQYRLNPLQVPQTIATWSLNWENKIIDPVVRDVVR
SVVGKYTAEELPTNRNAIATQIEEGIRKTIEAQPNEPVELRAVQLREIILPLKVKEQIER
VQIAKQEAERTKYEVERANQEALKKAALAEGEANATIISAKGKAMAVKIEADAQAYSNKE
IANSLNTPLLNLKQIETQKEFNEALKVNQDAKIFLTPGGAVPNIWVDTKDAKKQSSTNMN
>fig|195.2024.peg.1111 Acetyltransferase
MQNFVIEKATQKDLNSILNITKDALNSMKAMNFNQWDEHYPNEEIFKEDIKAQELYLYKE
KDEILGFICINEKFEPEFYEQINFKKSYNNLAFYLHRLAVKENAKGKGVAQKLLNFCETY
AKNEGKYSLRADTHSKNIPMNSLFKKLNFEFCGAFHIPCYEDEFFAYEKILNQKAF
>fig|195.2024.peg.1706 methyl-accepting chemotaxis protein (tlpB), putative
MFRTIGFKVSAAIFVVLVLSFIAMQLILNLDFKNTADKMSKSNLNTVSSSVFQTMRMAMN
LGDPEKIQEAIEDAKTIEGISDIKIYPSKETIELFEIKNPKISQEKLIIDQFTQPNLISL
EQKLDNINHLRLIRPLIADESCIACHANANLGSVLGVMDVYHSLENIEKDIVKTSRSYIV
IFTIALIFTLVVVLFVLKMVVGNPIMELLSHAKELAQGSGNLRARIRVKGRDEIAKACEY
INQFIEKTQKTVSSASLNSKNVEKQSILLNSNAIELNEISTSSHQKIDSSFKLGVDIGAD
LDEISNLSSDANKANDKSYQLLDQMIHSLLEIDKKVSDLVQNENNLALKIENMVKYAQNI
QKATQMMGEIADKTNLLSLNAGIESARAGSYGKGFSVIAEDIRALANNSEEFLHNVELII
KELLESIQEVTKELKENSHSIFSLNENTHLLASSANEVKLCNQNSKNLVTQCTQRIKISQ
ENIQNLLIHMRENVEASGKNEEISKILLQVADELKIVCHNLESELSQFQI
>fig|195.2024.peg.1052 ATP synthase beta chain (EC 3.6.3.14)
MQGFISQVLGPVVDVDFNDYLPQINEAIVVNFESEGKKQKLVLEVAAHLGDNRVRTIAMD
MTDGLVRGLKAEALGAPISVPVGEKVLGRIFNVTGDLIDEGEEVAFDKKWAIHRDPPAFE
DQSTKSEIFETGIKVVDLLAPYAKGGKVGLFGGAGVGKTVIIMELIHNVAFKHSGYSVFA
GVGERTREGNDLYNEMKESNVLDKVALCYGQMNEPPGARNRIALTGLTMAEYFRDEMGLD
VLMFIDNIFRFSQSGSEMSALLGRIPSAVGYQPTLASEMGKFQERITSTKKGSITSVQAV
YVPADDLTDPAPATVFAHLDATTVLNRSIAEKGIYPAVDPLDSTSRMLDPQIIGEEHYKV
ARGVQSVLQKYKDLQDIIAILGMDELSEEDKLIVERARKIEKFLSQPFFVAEVFTGSPGK
YISLEETIAGFKGILEGKYDHLPENAFYMVGNIDEAIAKADKLKG
>fig|195.2024.peg.1021 Ribosome-binding factor A
MNPSEIKKLRTESILKELIPEALANLDDENLKNLCVVDVECKKGRYDAFVYLDKMFFNTH
EQEKILNSLKKASRALQNYCMSEQGWYRCPNFHFKFDDRLEYQNHMDALFEKIKKDKNES
>fig|195.2024.peg.1151 Adenylosuccinate lyase (EC 4.3.2.2) @ SAICAR lyase (EC 4.3.2.2)
MVERYSREIMAKKWDMQAKYDAWLKVELAAVKAWNKLGLINDTDCEKILKNAKFDIARID
EIEKTTKHDVIAFLTSVSESLGEESRFVHYAMTSSDCIDTAVALQMKESLDLILEDVSLL
LEVIKKRALEHKNTLMVGRSHGIHGEPITFGLVLAIWYDEILHAKELLEHAREVISYGKI
SGAMGNFAHAPLEFEEEVCKNLDLKPAPVSNQVIQRDRYAQVISAIAILASSCEQIAVAI
RHFQRTEVYEAEEYFSVGQKGSSAMPHKRNPVLSENITGLCRVLRSFVTPALENVALWHE
RDISHSSVERFILPDAFVTADFMLMRLTNLIDKLLVYPENMMKNLNLTGGLVFSQRVLLE
LPFKGISREEAYKIVQRNAMKVWADLQNGKAAINEKNESLFLLALLADEDLRKSLSEEDI
RKCFDYNYYTKNVDAIFARTFK
>fig|195.2024.peg.1015 Zinc ABC transporter, permease protein ZnuB
MFEILNFTFFQNALLAAVLVSIACGVVGTLVMINRLFSIAGGITHGAFGGIGIAFYFSLP
ILISTGIFTLFLAFLVAFLSKRYEHRSDSIVAVIWAFGMAFGIILIDLSPGYSTDLMAYL
FGNILAVGMQDLWLMAIVDGVVIVLMLLFYRQFEALSFDVEFAKVRGINTSFFHYLLIAL
MAFCIVISIRLVGIILIMALLSIPSFIAENFTKKLGLIMILASVLSMIFCVLGLIISYYF
NLSSGACIIAVACFGFLIHLLAKFLLKR
>fig|195.2024.peg.1478 Predicted L-lactate dehydrogenase, Iron-sulfur cluster-binding subunit YkgF
MSQKIPHEEIVHIKLNDIQMRENLMTAMHTLQKNRLGVIDARFRDWQGLRAKAKQAKNNA
LMSLKDRLLEFEKNATKNGIQVHWASSDKDACEIVYEIMREKNITKLLKGKSMASEEIGL
NHYLEKKGLKAIETDLGELILQLNEEPPLHIVVPAIHRNRHEIGQIFKDKLGAKLENDEP
ESLNAIARDHLRKDFEGLKLGLSGVNFAMSREGAFWLIENEGNGRMCTTAPDIHIALCGV
EKVMESFEDAATMVSLLTPSATGQFIPTYNNIITGPRKNGDLDGPKEVHVILFDHNRTKM
LAHKDYYEALRCIRCGACMNFCPVYDQIGGHAYQTTYPGPIGEVISPNIFGIDHTGDILN
FCSLCGRCSEVCPVQIPLADLIRKLRCDKIGQGENPPMGAKNIHHNAMEAFAFKQFKKAA
TKGERWRFALSKAHYFNWFVQNLSGALPVIKKWYAFKELPQIKKDLYKEIQAIEGVIYE
>fig|195.2024.peg.1033 RNA polymerase-binding transcription factor DksA
MKKNEIQVFKTTLENRKKTILENLQSNSKEIEALHNSVPSDSVDFSVIETGSQIDFAISA
NLKQELEEIEDSLEKIKDGTYGICESCDEEITIERLKIKPHAKYCIVCRENLEKGEL
>fig|195.2024.peg.803 Capsular polysaccharide export system protein KpsS
MKFSDKIKKEFSGKTVLLLQGPVGTFFHRLAIKMKKNKTKVFKLNFNGGDFLFYPSGKRC
KCDEKDLENFYESFFKEKKIDAIVMYNDCRLIHAKAIKVAKELGIGIWIFEEGYLRPYCI
TFEKDGVNANSSLPRDKNFYLSCNILTKESIKEIPGGFKFMAFSAFLYWLFSFLLAPFFN
NKLHHRTLYPFEFLFWFRSLYRKYLYKLTEKKLNQKIYSLEKKYFLAILQVYSDTQIKYH
YKKSIEDFIEELILSFANHARAKSYLVFKHHPMDRGYRNYSKLINELSQKYHVEGRILYV
HDTYLPTLLKKALGCITINSTVGLSAILEGCPTKVCGNAFYDFEGLAYPKKLQFFWREAH
AYKPNPNLVINFKNYLLNTNQFNGNFYKNSFLSR
>fig|195.2024.peg.1639 hypothetical protein
MKSIILPPNEFLDHYVLNAEFHRLAGISKNAYKFWKKVEIGRYQGTRIIFLHKNSILEKH
REVLKQCSDLSGFVLASAFCSFTGLAPSHLVKKNNSSIYKLLDLKEIHGIKFVNLKKFYD
FLGLNYYQHIYIEKCHFFSPTPFEKRIKITESMCVGYY
>fig|195.2024.peg.884 Hypothetical protein probably associated with Carbamoyl-phosphate synthase
MRIKLPHIPYITNKIMLDIAHSSFVEIKDNIEKLNPCIKQILEDDLMNERKLDERVKELL
EQQEDEMELMQVDRKNMFWLVKKKLAPEFGVILNSEDRHNHLAHRILEELIENDYINFVV
SENRVKNLIFSSIDDYLKIYEKLEDEVYEKISNYKTKPIPGSEEYELIFEKLYQEELRKK
GMF
>fig|195.2024.peg.696 ABC transporter, permease protein (cluster 3, basic aa/glutamine/opines)
MFDLLNPDTLSRLWKGLYITLEISIVSIIITSFGGLFLGILMSLKNRYIYILCRFALEFV
RVMPLLVWLFMVYFGLSRWLGINLSSVSSAIIVFSIWGSFEMMDLVRTSLKSIPKHQYES
AASLGLNKAQSYFYIIIPQAMRRLTPMSMNLLTRMIKSTTFAYLIGAVELVKVGQQIIEF
NNKNDLAPFIIYGLIFFIFFLICYPVTLYSKKLEKKWS
>fig|195.2024.peg.628 hypothetical protein
MSIRLLVFFTLMANCIVLNAAPVFDYTYKFTLKKDERASVEIKELGYDNGVQNFDFYWTL
FDNTNIVVHSKFRKYPRQFVMSLRRNLDWVTQTLIPDYKNPHIDRARLILEFSEYKKGEA
IFTVYIEDKDSRLEVKFLDPRKMQLTNPPQNNQVVPMIDFNEPQVEPLIQRENTTN
>fig|195.2024.peg.1464 putative lipoprotein
MKKNIFIIFSAFFAVFFAACGAPVYTDGYASQKKQGDALTLGLDREDFEKTAQIMIDSML
SDPAFANIQPGQRKVIAIGKIINDTPQRIDTDKLISKITIALRKSGKFVLTTAVAAGGAR
DEMSEAVRELRDNDEFNQNTISSKGTLVAPDFSISGKIRQDNVKLKNGDIQAEYFFYLSV
TDLNSGLAYWEDERTIDKTGSSKSVTW
>fig|195.2024.peg.993 Putative periplasmic protein
MSNDVLYLVFMIVLLVAILAYMNIKDKESSAKINKLQGVVEDITKELHYLRKELGVKDEG
DQEEEDYKITLLKEEIQITLEKQISAKITPVLRTLKTMEHIIEDFQNEQQNRILNLEQKA
QSMTKLTPNYDTEEQKIVDLFKEGKSIEQIAKDLRIGTGNVELVLKFKQLIK
>fig|195.2024.peg.1610 Putative periplasmic protein
MKKGILIASALLTGSMLLADSVKLQGTIAEVYDNNKTLLIDSIYGGQMAVRILPNTEIDM
DNCGIFGMDKHGKFKDLKVGDFLEVKLYYPGYSSNPTQAPAIPVAREIDIECYKKAY
>fig|195.2024.peg.860 Transformation system protein
MNNIIAFRQECFDQINALLKNKALILLWGKSGSGKSVLLQRLALYHNEDFTNEIFTDEKD
FHHFIQDKKRKIIILDEVGMYSPNVLELIRIYSDEMSFVLSSHKKINLFEEEYFKSRFSA
IFWLQKPDINELSNYIKMKFNQDFPQKSLKFLMKIYQGNLRYLDKILQSFCELNTYLNNK
KSQDYILRLSALEQGFLK
>fig|195.2024.peg.1416 Biopolymer transport protein ExbD/TolR
MLKLPKNEGLNIVPFIDIMLVLLAIILSISTFIAHGKIEINLPVSENALSLNNDEKKLSI
SIDENNIFYLDDKTTDLKGLSDAISSLHKKTIVELKSDKNAKFESFVQIIDLLKAKEHEN
FQIITEKNR
>fig|195.2024.peg.905 Molybdopterin synthase sulfur carrier subunit
MVKVEFLGPINKENLELEVKNLKELKEILQEDESLKEWLELCAISLNDEIVFDENTSLKD
GDKIALLPPVCGG
>fig|195.2024.peg.138 Putative periplasmic ATP/GTP-binding protein
MKKYVLSLALVGASLLGASELKYQEFDGFKSPESIFVDKNSVYVSNVGEKLEPLAKDNDG
FISKLDKNGKVLEHKFISNLNAPKGMMEVVNTLYVVDIDVVRGFDLKSKKEVFNLPIKGA
IFLNAIEKLNDDTLLVSDTGTGLVLKVDLKAKKYDELLKLDIAKFGGPNGLYLDRKNDKL
FIAGYHPDGASGGVVMSYDLNDKKLSVIKNEKEAYDGIVPYENALLVSSWGENLNGVIYR
LEDDKALKLDLPSIKGPADIFIEGDTLWIPKMVEGKILKVELKN
>fig|195.2024.peg.1225 Flagellar motor switch protein FliG
MIKLSEEQKMLYDDLSMPEKVAIFLIQLGEDATTSVFSHMEIDVITEISRYIAMAKNVDR
AVATAVLEEFYTLLQSNQYIKSGGLEYAKEILFRTFGPEIANKILEKLTKSMENNQNFAY
LAQIKPQQLADFITKEHPQTIALILAHMDSIHAAETLEYFSDELRAEVVIRMANLGDISP
SIIKRVSAVLESKLESLTSYKVEVGGPRAVAEVLNRLGQKASKSTITYIEQSDERLAETI
KELMFTFDDIQKLSTQAIREILKVADKRDLMIGLKGASEELKQKFLANMSTRASEAFLEE
MGFLGAVRVKDVEDAQRKVVEVVQKLAEQGLVQTGDADEMIE
>fig|195.2024.peg.1288 hypothetical protein
MNYQQLECDYFNLYNQFISVDFQISLFEKNHKSLIKDFIFFIIKF
>fig|195.2024.peg.1321 Putative periplasmic protein
MRIFFILSLFFRTLFAADDLDNALRLYEGNKFVKAYEIFERLCEKDNARACFSLAYMNEN
AQGVARDFDKAYKFYDKSCKLGLAKACSNMALTLQDLGYVNESLLAFNKACNLGESSSCN
HMGLVYEDEKDGQMATHFYKRSCDLKDARACYKLGFLYERGELVRQNLKSALAFYSKSCT
LGFAEACYLIGRYYDLEKKDLKKAKRYLGMACDKKHQEACAAYRKLNSQDIEIY
>fig|195.2024.peg.568 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIISGLGGDIDDNLYIEEY
CARNYNVAVLSVNYHCIGNRPQTGASFYINELDRLILKTSLEAIGIQLPVDMQNLKTYDE
FYCVVDFVNKFIEKLKKEKELSEDYCLYLSVGLEPTKNEYQNYGIMQAMDIINAILYINI
NLPFKVSNMSTVSRMGGGIKTILIGVSHGGYLANLCAKISPWNIDVVLDNSSNVTLDNDL
WRFIGFGREIDYVKYCSVGITYMFKNIKLAAFDKTYWTTNKQSPYYFSNARKIVREPLNK
EHLKIQSLYPKPKYIAYHSKFDQYVLLEKRENYFNILRELGFEVDFIKITDEKEIDGKFI
KNLEHGCGIPMKLLIKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2024.peg.1470 FIG00469923: hypothetical protein
MGKLERIIRIILALVIFSVGVYYASWWALIGFIPLLTGIFGVCPIRVWTGKQACPLGVCP
ISKKKD
>fig|195.2024.peg.87 Porphobilinogen synthase (EC 4.2.1.24)
MFKRFRRLRLNESLRAMVREHTLSINDFIYPLFVVNGKGIKKEISSMPDVFQMSLDEILK
ECKIISELGIKAIILFGVLENDKKDSCGSDAMDDEGLIARSIREIKKEFPNLFVISDLCF
CEYTDHGHCGIIDPKTKSVDNDATLEISAKQALVHARAGVDMIAPSGMMDGIIETLRKAL
DEEGFENLPIMAYSTKFASSYYGPFRDVADSTPSYGDRKSYQMDFANGKEALEESLEDEA
QGADILMVKPALAYLDVVKEISLHSNLPLCVYNVSGEYAMLKAAGRAGVIDYEKVLYETM
IAFKRAGAKLIITYHAKELAKMLKGEK
>fig|195.2024.peg.393 DNA ligase (NAD(+)) (EC 6.5.1.2)
MTKKEYLEKVALAASWMRAYYEKDEPLASDEEYDALIRELRVFEEQNKDEISKDSPTQKI
APTIQSEFKKIAHLKRMWSMEDVFDESELRAWAKRAKCEKNFFIEPKFDGASLNLLYENG
KLVSGATRGDGEVGEDITLNVLEIDNIPKTINYKEKIEIRGEVVILKDDFEKINEKRTRL
NQSLFANPRNAASGSLRQLDTSITKERNLKFYPWGVGENTLNFTKHSEVMQFIRELGFLK
DDFVKLCTNLDEVLKAYNELLSLRDQKPMMMDGMVVRVDDLALCKELGHTVKFPKFMAAF
KFPALEKTTRLIGVNLQVGRSGVITPVAVLEPVNLDGVIVKSATLHNFDEIARLDAKIND
FVSVIRSGDVIPKITKVFKERRDGLELDIARPRFCPTCKSELLDEGTLIKCQNIDCEDRL
VNSIIHFVSKKCLNIDGLGESIVELLFKEKKINTLESIFHLKFSDFEGLEGFKEKKINNI
LNAIEQARDCELFRFITALGIEHIGEVAAKKLALSFGKEWHKQSLEAYANLEGFGEQMAL
SLCEFSRVNSARIDEFYKLLNLKEQKVQIQEDSVIFGKTFVITGALSRPRDEFKNLIESL
GGKVSGSVSKKTDYVLFGQEAGSKLDKAQELGVKCIDENEFNELIEK
>fig|195.2024.peg.1170 Rod shape-determining protein MreC
MKNKLIFVLVLFFLVFISFYYGGLVKKNVLLVNDTVLEKFYGIKDAITEFFSKHFDQVDQ
IEQLKARNQELEYAAVLTTSFANQLNRILEDKNSTRYLPQVSLVRVISYVKLNDYKRFWL
DFAKVSPNKNKGLIHQGYTIGIAINKDGRAMALLQGDEQCVFSVYIGKNKIPGLIQGEDD
KLKVKFIPKWAKINIGDEILTSGLDNIFFSDVPVGIVSAIKDEDMYQSVEVKPYANINIP
AYLYIIDSL
>fig|195.2024.peg.1079 Biotin synthase (EC 2.8.1.6)
MQIMLCAISNIASGNCSEDCKYCTQSAYVKTNIQKYRQKEISQIVLEAKIAKKNEALGFC
LVTAGLGLDDEKLEYVCKAAHAVQKEVPNLLLIACNGMASVEQLKELKKAGIFSYNHNLE
ASKEFFPQICTTHTWESRFQTNLNAKEAGLMLCCGGIYGMGESEEDRLSFRKSLQELQPF
STPINFFIANENLKLQVPKLSADEALKIISDTKEALPNTVVMVAGGREVVLQERQYEIFK
AGAGAIVIGDYLTTKGEEPSRDIVKLKEMGFTFASECH
>fig|195.2024.peg.731 3-oxoacyl-[acyl-carrier protein] reductase (EC 1.1.1.100), FadG
MKFSGKNVLITGASKGIGASIAKTLASFGLKVWINYRSKPELADALKDEILAQGGNAAVI
KFDASKEDEFENGIKTIVESDGELSYLVNNAGVTNDKLALRMKLEDFTSVVDTNLSSAFL
GCREALKTMSKKRFGAVVNIASIVGEMGNAGQTNYSASKGGMIAMTKSFAKEGASRNLRF
NCVTPGFIKSDMTEILSDEIKQAYQDNIPLKRFAEPEEVANCVAFLLSDYASYVTGDVLK
INGGLYM
>fig|195.2024.peg.934 Homolog of BLC protein
MIELIGDVNLEKYMGTWLEMARKPAFFQKSCVQSKAEYQLEYEGSTPVVNIKNICVKKDG
EVSQVQGKAKVKSPRALSVKFSIFMNLFNKTNYEILFIDTNYEVAVVGSPDKEYLWILSR
KIIDKKEIDKLLDIAKQKGFDISDIVFDKY
>fig|195.2024.peg.1172 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
MGIVYEQTYRESLQNPEAFWAEAAKKVHWYNEWDRVLDDSDGHYRWFVGGCMNTCYNALD
LHVHNGRGDQLALIYDSPVTDTKKKYTYKQLRDRVAKVAGILANKGVVKGDRVVIYMPMI
PEALIAMLACARLGAIHSVVFGGFAAHELATRIEDAKPRMIISASCGIEVSSIIEYKPIL
DEAIKKCTHKPTTCLIWQRPQYRANMLPWRDIDWELEEEKTRGVDPVPVLATDPLYILYT
SGTTGSPKGVIRSNGGHSVAMKWSMDNIYNAKAGDVFFTASDVGWVVGHSYIVYAPLMNG
CTTIVYEGKPVRTPNPSAFWRIIEEYKVNVLFSAPTAFRAIKKEDPKGEWIKKFNLDSLR
SIFVAGERCDSDTLKWIEKLTKKPVIDNWWQTETGWAIAANPLGLEAQVVKAGSPTKPMP
GFNLKVLDEKGQELGAGKKGILCLKLPLPPACLMGIWENDERYRRGYLDQFPGYYLTGDT
GYIDKDGYVYVLGRMDGIINVAGHRLSTGEMEEIIAKHPDVAECAVIGVNDELKGEIPMG
FIVLKEGIERDHRGIVEGVVALVRQEIGAVASFKIATVVSALPKTRSGKILRKNLREIAD
GSTLNVPATIEDSNVLKACEKAINALGYPKNKGEK
>fig|195.2024.peg.1135 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRQMVQTAAEHGWGDYRAAPTFQDDVMGAYSYNNHILRRFNEQLKDCIDPNGILAPSRG
GIWPKNLRDERFVNNKRDALRMKEGKEK
>fig|195.2024.peg.1053 ATP synthase gamma chain (EC 3.6.3.14)
MSNLKEIKRKIKSVHNTQKTTNAMKLVSTAKLKKAEEAAKRSRVYAQKIDEILSEISFQV
NKIVHNEEDSRFVLFHKKNQIKNVDLIFITADKGLCGGFNIKTLKAVSELLKEYEEKNIN
VRLRAIGKTGIEYFNFQKIELLEKYLGLSSSPDYDKACSVIQAAVDDYLNGITDEVVLVH
NGYKNMITQELKISHLIPVEPKQIEGNSNSLLELEPEDTDLLGDLMKTYFEYNMYYALID
SLAAEHSARMQAMDNATNNAKARVKQLNLAYNKARQESITTELIEIISGVESMK
>fig|195.2024.peg.214 tmRNA-binding protein SmpB
MKVIARNKKALFDYSIIERFESGVVLKGSEVVALRAGRANLKDSFVHIIKGELFLLNAHI
SHLSTTHSYYKHEERAARKLLMHRKQIDKLLGKVSIEGYTLVVLELYFNHKNKVKATLAL
AKGKNLHDKRESLKKKQADMEARSAMKNYK
>fig|195.2024.peg.903 Carboxynorspermidine decarboxylase (EC 4.1.1.96)
MINTKFQTPAYILEEDKLRRNCEILANVGEKSGAKVLLALKGFAFSGAMKIVGEYLKGCT
CSGLWEAKFAKEYMDKEIHTYSPAFKEDEMSEIAHLSHHIVFNSLYQFDKFKSLCANNSL
GLRCNLEFSFAPKELYNPCGKYSRLGILSKDLENFDLSGVEGLHFHALCEESADALEAVL
KVFEEKFGKWIKQMKWVNFGGGHHITKQGYDIRKIITLCKNFSDKYGVQVYLEPGEAVGW
QSGVLVASIVDIVENEKRIAILDTSSEAHMPDTIIMPYTSEVLNARILATRENEKISDFK
ENEFAYLLTGNTCLAGDVMGEYAFKEELKRGDRVVFLDQIHYSIVKNTTFNGIRLPNLML
LNSKNELEMVREFSYKDYALRN
>fig|195.2024.peg.1279 Similarity with glutathionylspermidine synthase (EC 6.3.1.8), group 2
MQLLQVDKLQKDYLENIGFSWHTDEDGSDYISDKLVCVSENEANAYYEAVNELYDMFVAA
AQNVIDNNRFDELGIPFNLVDAIKMSWENEVHWHLYGRFDLAGGLDGKPIKLIEFNADTP
TALFESAILQWAILKQNGMDESKQFNSIYESLMDNFKRLITLDESVEGFEEHYQGWKILF
SSVAGSKEEEITTKLLSHIANEAGFQTNFSFVDEVEFSEEGIFKEGVNYEYWFKLVPWED
IAIEEGELAMLLTQIMRNQKAIILNPAYTLLFQSKGILKILWELFPNHPLLLETRDVPLE
GKDYVKKPVFGREGANISIIKEGKILHENVGPYGNNKAIYQEYVEFNSCENEYYQAGVFF
AYEGCGLGFRKGGLVLDNYSKFVGHIIKD
>fig|195.2024.peg.177 ATP-dependent protease La (EC 3.4.21.53) Type I
MQIEEMQNYPSNLPILVEDELFLYPFMITPIFISDSANMKALDLAIKNDSMLFVAPSKLE
NGRSFDEIYDCGVVGTIMRKVPLPDGRVKILFQGYAKARIIKPLSSKPLEAKIELIKEEF
LEGTKKEALLDILKEKVRALANISHYFSPDLLRTIDEGLDASRICDLILNTVRIKKQEAY
QFFILTDLEEKLLKLIDLIAQEIEANKIQKEIKNKVHSRIDKVNKEYFLKEQLRQIQKEL
GSDNQKEDEVRDYYKKLESKKKFMHEDAYKEIKKQIEKFERIHQDNSEASMIQTYIETAL
DVPFEKIAKKKLDIKEVAKQLNHDHYALNKPKERIEEYFAVRELLEKRGVADKDGAKVIL
CLYGPPGVGKTSLANSVAKALKRELIRIALGGLEDVNELRGHRRTYIGAMPGRITQGLIE
AKQINPVVVLDEIDKLNRSFRGDPSAVLLEILDPEQNSKFRDYYLNFNLDLSKVIFIATA
NDISNIPAPLRDRMEFIELSSYTPNEKFHITKKYLIPDELKKHGLKSSELDINDETIELI
ISEYTRESGVRNLRRKIAELCRKSAKKLLLENIKKVSINVKNLNEFLDKKVFEIEKHDGE
NRIGQVNGLAWTSVGGDVLKVEAIKIKGKGELTLTGSLGDVMKESARIAFSVIKVLIDEG
KIKIPKKMILDPKTNVYDSYNLHIHVPDGATPKDGPSAGITMSTAIASVFSDKKVRSDVA
MTGEIDLAGNVLPIGGLKEKLIAAYKADIKIALIPKKNYERDLKDIPDEVKDNMKIIGVK
DFDEVLKYALV
>fig|195.2024.peg.1273 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeB
MFSKFFIERPVFASVVAIIISLAGAIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIAS
TVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMP
DAVKKLGVTVRKTSSTTLAAISMYSSDGSMSAVDIYNYITLNVLDELKRVPGVGDANAIG
NRNYSLRIWLKPDLLNKFGATATDVIAAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQG
RLQSPSEFENIILRTNEDGSFLRLKDVADVEIGSQQYSSQGRLNGNDAVPIMINLQSGAN
ALNTAKLVEAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVVKTFVEALILVIIVMYMF
LKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDR
ILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAIS
VTISGFVALTLTPSLCALFLRRNEGEPFKFVKKFNDFFDWSTSVFSAGVAYILKRTIRFV
LIFCIMLGAIFYLYKAVPSSLVPEEDQGLMIGIINLPSASALHRTISEVDSMSQEILKTN
GVKDAMAMIGFDLFTSSLKENAAAMFIGLKDWKDRNVSADEIAMELNKKFAFDRNASSIF
IGLPPIPGLSITGGFEMYVQNKSGKSYDEIQKDVNKLVAVANQRKELSRVRTTLDTTFPQ
YKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDAL
KNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQ
VAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAV
PFAVFGSFLLVYLRGFTNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAV
AAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLF
FYLLENFNEWLDKKRGKVHE
>fig|195.2024.peg.1324 Putative periplasmic protein
MKKILLSSLVAASLLSAGLFAKEYTLDKTHTDVGFKIKHLQISNVKGNFQDYDAVIDFDP
ASFEFKKLEATIKVASVNTDNQTRDNHLQQNDFFKAKQFPNMTFVMKKYEKIDNEKGKMT
GTLTITGVSKDVVLDTEIGGKAKGKDGKEKVGFSLNGKIKRSDFNFAPGTSTITLSDDIN
LNIEVEANEK
>fig|195.2024.peg.413 Glutamyl-tRNA synthetase (EC 6.1.1.17)
MTGKLTTRFAPSPTGYLHIGGLRTALYSYLYARKNKGNFLLRIEDTDLKRNSKEATQAII
EAFKWCGLDYDGEVTYQSERFDLYKKYIQKLLDEGKAYYCYMSKEELDELRAKQEAAKER
PRYDGRYRDFTGTPPSNIEPVVRIKAPQKGEICFIDGVKGEVKFKVEDILDDFIIARSDG
SPTYNFTVVIDDALMGVSDVIRGDDHLSNTPKQIVLYEALGFEIPKFYHVAMIHGEDGKK
LSKRHGATDVMEYKAMGILPQALLNFLVRLGWSHGDDEVFSLEDLKRLFDPNHINKSASC
YNFKKLEWLNAHYIKTLPFEEINRQLKDLGFDLSVYTKAGFLLDLLRERAKTLLEIISGA
KSIVEAPQNYDENAINKFINENNLLLLQNYANELNEEKSAKDFEEFTNEFLQKNEVKLKD
LAQPIRIALTGSAVSPSIFEVLEFLGVNECKKRIKKFLDFKGK
>fig|195.2024.peg.32 HIT family protein
MKEKTVFELIVEGKIPCNKVLENNDFLAFHDIAPKAPIHILIIPKKHFKDFQEFDPKLME
KMTSFIQELAVLLGVDKSGYRLVTNCGKNSGQEVFHLHFHMLGGFRLPKEKDENENPQAL
F
>fig|195.2024.peg.1217 LSU ribosomal protein L25p
MLEGIVRESIGRKAAKALKRDGYLIANIYGKGLENINAAFKVNEFIKEVRKKTTLIFDVK
VGSQTLSVVVVDYQKDPVTAELKHVDLKVAQKGVISKYMVPVKITGTAIGLKNKGVLIQS
KRRLKVKCPAENLPNFFELDVSKLDVGDALLVRDIVVPEGVTMIDADRVAVVGVEKAR
>fig|195.2024.peg.1057 ATP synthase F0 sector subunit b' (EC 3.6.3.14)
MFEDMHPSIMLATMAIFLAMIVILNTMLYRPLLKFMDERNDSIKNDENKVKENSQEMLGA
NDEVEAIHVSTREEIHKIKQNAINAAKEEAQQAIKAKKEELERKMANFYTELVSQKKELQ
DHLSAHLPDLKQALQNNIKQH
>fig|195.2024.peg.874 Putative periplasmic protein
MSKVLEYLIVIGLVVTAAITAWSVLTANHLHIG
>fig|195.2024.peg.15 Inner membrane thiol:disulfide oxidoreductase, DsbB-like
MKNLYWFVYFSKWQDMRNPWFIMSIIMISLVLIAHFLFQEYLYMRPCEQCVYIRLDMLII
ALGGIIALINPKNTIIKILAYTLAFYGIWLGLEHSLNLNRIHEAISTENPFSGVNGCRDI
PLYPFNLPLHEWFPSWFKPVGQCGMDFPMVPKSAYLNAFQEFFVGKNGIYNNGWYLIPSL
KFMNMATCCFIAFLCSFILLFIMFVSYVFSQRKIVFTIITISLVVALKILG
>fig|195.2024.peg.205 S-adenosylmethionine synthetase (EC 2.5.1.6)
MYLFTSEVVSAGHPDKCADIIADTIVDILLKNDKNSRVASEVFVAGNKVVIGGEVKSNHK
LSKADYDNLVKDVLKNIGYDGAGYFSKEQCLHPDEVDVMVFLNEQSPDINQGVDQEDGET
GAGDQGIMFGFASCEAKEYMPAAISYARALCDKVYAYAKAHPQELGVDIKTQVTIDYGTK
ANFENCKPQSIHTIVVSVPCVESMKIEDLRALVNKLILESDLPKELFNPEKTRILINPTG
KYVNHSSLHDSGLTGRKLIVDSFGGYAPIGGGAQSSKDYTKVDRSGLYAGRWLAKNIVAA
GLAKKCIVQLSYAIGVAKPTSVSVDCLGTNTGVNDDVLSDFVMKNFSLTPNWIRDKFGLD
KPSKDTFLYADVAARGQVGQKDYPWEKLDAIDQFKTLIK
>fig|195.2024.peg.1245 Flagellar motor rotation protein MotA
MDLSTILGMVLAVTSISVGDILEGGNPLHVIHLSSFLIVMPTAAFCAMTSTHKKIVKAAY
KELKIVFKGSGVNLPERIAQLIEFAIIARRDGLLALESRTNEIENEFLRNAMMMLVDGKS
FEEIHESMEIQTEQLEEHYKECAEYWIIFGETCPTMGLVGAVFGLILALKLLDNPQAMAA
GISGAFTATVTGIFGAYALFAPWGRKMKANGMDLVKEQIVITEAIKGIAEGANPRDLEAK
LFNFLSHDDPRISQFDKG
>fig|195.2024.peg.1124 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-succinylhomoserine sulfhydrylase (EC 2.5.1.48)
MNFNKETLALHGAYNFDTQRSISVPIYQNTAYNFENLDQAAARFNLQELGNIYSRIGNPT
SDVLGQRLANVEDGAFGIPVSSGMAACFYALANLASSGDNVAYSNKIYGGTQTLISHTLK
NFGIEAREFDIDDLDSLEKVIDQNTKAIFFESLSNPQIAIADIEKITQIAKKHKIATICD
NTVATPFLLQPFKHGVDIIVHSLSKYVSGQGSALGGALIERKDLNDLLKNNDRYKTFNTP
DPSYHGLNLNTLDLPIFSIRIIITWLRDLGASLAPQNAWLLLQGLETLAVRIEKHSQNAE
KVANFLNSHPDIKGVNYPTLASNAYHNLFKKYFDKNFASGLLSFEARDYEHARRICDKTQ
LFLLAANLGDSKSLIIHPASTTHSQLSEEELQKAGIKKTTVRLSIGLENSDDLIADLKQA
IES
>fig|195.2024.peg.373 LPS-assembly protein LptD @ Organic solvent tolerance protein precursor
MWRKILFLSASLTLLNATQVDIYALDAKKQGDILTANDDVIIFSDFYFITANKAIYNEKT
GDLELFGDVNILRGQNERSHSNYAKINLNSNEANFNNFFFSNNNLEVWFQSKTSYLDENV
FKSEISAVSSCNVEDPDWEIRFSKGWLNRENNFVHLYNAKLYVKDFPIFYLPYFGFSADT
HRQSGLLIPKIVLKNSEGLYYEQPIYIAPYENWDLELNPQIRTDRGFGLYSTLRFIDSPY
SIGEVNLGAFRENSSYYHDENLKNQSHYGAELKYARNDLIKTLLGDNFQEGLWIDATYLN
DIDYLNLGSRDYRDLNSLVTSKINYFLADENNYYGAYAKYYIDTSALNNDNTLQEYPSFQ
YHRFLNNFFDERLRYSFDASFHNFYRPVGPYANQLNLNLPISYHNAFFDDFLHFTFTERF
YASFLNYSHYPQKDHEHYFRNTHDFNLYTDLSKAYDNFFHTLNFGLKYVLPGAKSGSISE
DYLEEIDKEEEHLGFYTTQYFYNNEGQKKIKHRINIDYLNKQGEFDEISNLLSYYYNNNI
SFNSEIIYSDLQDRFTNIISQMEINPNPKFNWSFSHAYQNDEYGKYSFIGTRANYLANAN
YHLFGGIWFDTQRAHANMWELGYTFQRKCWNYSLMYRERIDPQLTSAGITAKNQSGIYFI
FNFYPLGGVKYDFSLAETESKI
>fig|195.2024.peg.963 AAA+ ATPase superfamily protein YifB/ComM, associated with DNA recombination
MKKLKCVSFDENLDIIDVESTFTRGLPNLSIVGLANIAIKESIERIKATLLTCNFSFPAK
KITINLSPSGIPKKGSHFDLVIATLILLQNEDFDDFFVVGELGLDGSIKSTNELFSLLLF
LSTKVKSAKVVVPKNIALKASMIPNLEIYGLEHLNEVIEFFKEKNYEKFKFTQSHPLFAN
PLIIENEIFIKNHHFELDFKDIKGQEKAKRACLIAALGMHNILFEGSPGSGKSMCAKRLV
EIMPPQSLNEVLMQNAYMSLNSKDCEFTQKRALRHPHHTSTRASIFGGGAKNAKIGEIAL
ANGGVLFFDEFPHFNKQIIESLREPLEDHKIHISRVNSKTTYETKFSFVAAQNPCPCGNL
FSKNLSCVCSENEIKRYKNHISAPIMDRIDLYVAMDEISKDDKSSINSKEMSERILKAFI
FGKKRGQKEFNGKLNDTELQKFCILEKDAKDTLDLAISRYNLSQRALNKILKVSRSIADF
EEKELLSKNHILEALSFRMRS
>fig|195.2024.peg.800 Membrane protein
MKRVKARIRANFRNRIKRNLKGSLKEKLAGTILLCAIVPLAICGYLLIVIVGTFFNTARA
RQGVRALDHFVNASLFNGYAWESVSSHAWRERNRKKWARVVIKITDFFQKDHCKRANKRE
QPVVDFILSRNLDKQTIGKR
>fig|195.2024.peg.379 Low molecular weight protein tyrosine phosphatase (EC 3.1.3.48)
MKKIVFVCLGNICRSPMAEFVMKDLVKKANLEKEFFITSAGTSGEHDGENMHYGTQNKLK
SLNIKYQNFTSKKLTQALCDESDFLITMDNSNFKNVQKNYKNTQNKLLKITDFASHLGYD
EVPDPWYSGNFDETYQIISLACKNLLSHLQK
>fig|195.2024.peg.624 Putative integral memnbrane protein
MNYKLSLSPLFLLELVASILFIVFFGLGNFLIFILASMIFGVILLGIFWKNMLEFRISGF
KDMLTQFAFVMAAFLFIFPGIVTSIFGFFVLCFGLIFNFAKPRYKRNYRQNNTSDEEIID
VEIIEERK
>fig|195.2024.peg.644 Sodium-dependent phosphate transporter
MNLKSLEAKVQERKNFLKYLKMTFWGIFTLVLIFALIRFSELANLLAGVAVLLIGMTNLS
LGFKSFSGGLLEKILTHSTNTKLKSILFGAISTLIMQSSTLVSIISLSFLSAGLISLVAG
VGIIFGANLGNTASSWLIVWLTRVNISILAIPLLVIGVLFFFQKDNMIKSFGNIFIGIGF
FFLGVDYIKNGFNEFQDVIDLSYFDFTGFKGVLIFVGLGALLTGIIQSSTATIAIIVTAL
LTGQISFENSLAATLGTSVGGVVTAVLASLSTNVEGKKLAFANCIFNFTIAIIIILIFPY
FIDFLNGMAKILNIENLALKMALFHTLFNLLGIFIFVLFIPQLVNFLNKIVKAPKDKNKD
RPLYLEPSLLKFSDTAIEALRKESEHLYDNAYAIIAHAIGLSRKDIQSNKSFEEILQNKK
WFSKNVDLDYLYQTRIKVLFEAIIDFSTKAQIHIDDELKNHRIFTFKIAAKNLTEATKNL
KLVQENIKKYSNCGNKDLALEYNKIRSNLGELLRSIQELRSVDDEKVYLIIKNFQKGKEI
LKEIDGLTLNNVEHLILVRKITTAEGISIINDTSFIAKIAKDLIDAVEIIFAREKVLWDD
IN
>fig|195.2024.peg.776 Flavodoxin 1
MSVAVIYGSAMGNTEGAANTIASKLGISDVLNVADIDAAKINSYDKLICGTSTWGSGDLQ
DDWDGFDFSGLSLGGKTVAVFGMGDSESYSDTFCGGMGKLAENLKNAGANLVGEVSTDGY
TFESSDAVVDGKFVGLALDNDNQEDQTEARIDAWVEQIKAHFA
>fig|195.2024.peg.66 Oxaloacetate decarboxylase Na(+) pump, alpha chain (EC 4.1.1.3)
MAKKFIDVMDTSFRDGFQSVYGARVLMQDFFPAVEAAKEAGITHFEFGGGARFQSLYFYL
NEDAFEMMDKFRSIVGKDANLQTLARGVNTVTLDTGSKELIDLHAKLFAKHGTTTIRNFD
ALNDVNNLKFSGECIKKYGLKHEITITLMDLPPNCQGAHDVPFYERILKEILAAEIPFDS
ICFKDASGTSNPNKIYETIKMARKNLPQDVHIRLHTHETAGVSIACYLAALEAGVDGIDL
AAAPVSGGTSQPDILTMMHALKGKNYDLGGLEEEKILKYEAVLKDSLKEYFLPPEATMVS
PLIPFSPMPGGALTANTQMMRDNNILDKFPEVIHAMREVVEKGGFGTSVTPVSQFYFQQA
FNNVMFGPWEKIAEGYGKMVLGYFGKTPVEPDAEVKKLAAKQLNLEPTTELAIDIADKDE
TKSIAYVKSLLEKEGIAVSEENIFIAAACKEKGIAYLKGEAKVNVRKNVSAPKQNSTGID
ENKFTVSVNGNKYHVEISAGFDKDVNIKSIHKADTQEDIMQDADSSEGIQAGISGNVFKI
YINEGEEVKSGQVVMILEAMKMEIEVSAPKDGIIEKICVKTGDSVSENNLVAIYKNN
>fig|195.2024.peg.1708 Agmatine deiminase (EC 3.5.3.12)
MIKSIPEWSEQEYLMLSLPHEKSDWKPYLGEIIQAYKDFVKAASEFQKVLLIAPSKSDFA
PFENIANVEFFVCDTNDTWIRDFGAIDILEDNRLKALDFTFNAWGNKFQSELDNEVNSKL
FKEKFNEKLIKIDFILEGGSIDFNGEGVMLTSSNCLLNENRNSHLDKSQIEVKLKEIFGL
KQIIWLENGFIKGDDTDHHIDTLARFIDKNTIAHSICEDEKDEHYIPLQKMKKELEATGF
NLVELPLPKPLYYEERRLGATYANFVFVNDALIMPFYKDENDEIIRQRLAKALPKRKIIG
VDARVFLRQNGSLHCSCQNRFKGLR
>fig|195.2024.peg.734 UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (EC 6.3.2.9)
MRISLFGYGKTTQAIAKNLANQFGPFDIYDDHFQEKSKDKWGNHLLNPKEFDEKVSELEI
PSPGFPPNHNLIKKAKNLQSEYDFFYDAMPKSVWISGTNGKTTTTQMATHLLSHVGAVMG
ANVGFPLAELDLNAKIWILETSSFTLHYTHTAKPEIYALLPISADHLSWHGSFENYAKDK
LSVLERMNECDIAILPEIYAKTPTKAYIISYKDEFDLAQKMGIDIEKISFKSPFLLDAVM
ALSIEKILLDSLSYELLNQFIMEKNKLEELQDSQGRLWVNDTKATNENAVMAALNRYKNK
KIHLIVGGDDKGVDLSALFNFMKNFNIELYAIGLSTQKMLDYALKANLKARKCEFLENAV
QEISKTLKNNEVALLSPACASLDQFSSYAQRGEKFKECVGKI
>fig|195.2024.peg.827 3'(2'),5'-bisphosphate nucleotidase (EC 3.1.3.7)
MLRQINLKDITFIAIKAGKSVLEIYNQDFKISYKDDNSPLSEADIISNEIICNELAKFSL
PILSEENKTLPYEQRKNWEYFWCIDPIDGTKEFINKNGEFTINIALIYKDTPVLGVVYAP
ALDLLYSAKKGEGAFKNSIKLPLQRNENSR
>fig|195.2024.peg.1112 3-isopropylmalate dehydratase small subunit (EC 4.2.1.33)
MQKFTTHKGIACPLEYANIDTDQIIPKQFLLAVSKQGFGKHLFHDLRYLDDKESVLNMDF
NLNKKEYQNSSILVSFENFGSGSSREHAPWALVDYGIRAIIAPSFADIFKNNALGNGLLT
IELAKDEVVSIIKQLKESEDKNIEISLFEKKVFFKDQVFSFDLDEFRRTCLLEGLDNIAL
TLKYEEQIKAYEKNSKSFLV
>fig|195.2024.peg.10 3'-to-5' oligoribonuclease B, Bacillus type
MKIYHLSHTDLDGYACQYIVNFYFKNVNFYNSNYGKEINENFNAILADIEKDNSFGQAII
LITDLNLNLNQCEEFDKICKEKNIKIFLLDHHQSGEECAQKYAWYLLDNQRCATKITYDF
FSKICKPDLELLNFAQVVNAVDIWLSEDANFELGKVFLGLIANAKEINRVMFKKAQVFYM
FFLLERARKFINQPNSHILLDNAIHFIKKDFFAKNHDDTLSNLISYFVVEKLSELKEEFS
IEYEGHKGILTSNIGNTSIIGNEFLVKNPDYDFFIDVSSRKTLSFRANGKIDVSLMAKKL
VGGGGHKNASGGLFAAYKDGANYNYIKAQIVDLIKSKELKKGNSDATNTQ
>fig|195.2024.peg.1402 A/G-specific adenine glycosylase (EC 3.2.2.-)
MQKQMIQNLQDKLLLWYDKNGRKNLPWRNLESKDCDERLKDIDRAYGVYISEIMLQQTQV
KSVLEKFYFPFLQKFPTLQSLAKANEDELLKAWQGLGYYTRARNLKKAALECVDKFEGKL
PKKLDELKNLSGIGTYTAGAIACFAYDQKVSFVDGNIRRVLSRLFALENPKMSELERKAK
ELLNLADAFNHNQALLDIGALICVSKNAKCGICPLYDFCQGKFNTELYPGIKKTSYENAN
LSLFVFEWDKKFAIQKSQDKLYKGMYNFPFFKKEEGEIFKNMKLLGEFKHHYTKYKLNIK
VYHQILKEENKNYQFKSLKELESTALSILSLKALRLIKL
>fig|195.2024.peg.1297 Seryl-tRNA synthetase (EC 6.1.1.11)
MLDLKNLQNNFDEVAKKLQNKKVDENILKNLAELFTNLKKEKASLEEFQAFQNKFSKELA
TVEDKESLKAKLSENKIKINEQNAKVNALENELETIAHAIPNIPDECVPVGEDEEENVEI
KKVLTPPQFDFTPKEHHDLGESLNWLDFVRGVKISQSRFCVLKNEGALLSRALVNYMIDF
NRSRGFEFVNVPFLVNSPTMFGTGQLPKFKDDMYKIEDEDLYLISTSEIPVTNLYSGEIL
TSESLPIKMTCYSACFRKEAGSAGRDTRGIIRQHQFEKVELVSITKPEQSDSIFNEMVEC
ASDLLSSLGLAHRHLMLCTGDLGFSAAKTIDLEVWIPSQNKYREISSVSNCRDFQARRAK
IRYKNEKGKNELVHTLNGSSLAVGRTLVAIMENYQDKEGRIQIPDVLKKYF
>fig|195.2024.peg.1488 Peroxide stress regulator / Ferric uptake regulation protein
MEALELLKKHDIAITDLRVELLQILSLAKTPLSYDHFDIKANKTSFYRNMELFEKKGIVS
KSELNRKSFYELADHAKAHFVCDKCHKISDVQMPKVKGMIKSVLIKGICSDCEK
>fig|195.2024.peg.1386 FIG00470755: hypothetical protein
MMFFILMHRKYISEVPMLGFHTNMEIFKRAGIYYFYLLVIHIPLFLVWKKVISRIESLDF
INTFYFGIAFSLCVFFLLTLPLDGHLALVPLLCVLFSFVFVFKFIYFCFKKISYFTWKKL
IFIITTLLGICAGLAYIFFCLYYQLCIFDNYDFLGKFYNIPSYKRPLNFIF
>fig|195.2024.peg.875 Putative periplasmic protein
MENTNRCVFSLSGVTGMLIATVLLLAILVGLTIWGLKAQQEVMQQPYSLKDIQNVKMLGS
KEQDHKSIGGTAQ
>fig|195.2024.peg.1604 hypothetical protein
MKFKCILKIKLFIYDKFIFFMIDTSFAWVFLITYMSDFYRYLIF
>fig|195.2024.peg.1674 hypothetical protein
MSKPLNEEIFVEFKSDLAERKNEVLLQVLELLETFRSDENEKMARISSELTEILENEENL
EKILNAKNLEELLNILTALNEDKMIKVYEDSYLKEKFPNVMVDKFLK
>fig|195.2024.peg.1576 Methionine ABC transporter substrate-binding protein
MKLFKIILLFCLLNLSPIFAKTITIGATPNPFASLLEKVKDDFKDKGYELKIIEFSDYIL
PNRALEEKELDANLYQHKPFLEEYNAQKGTNLTPTTPVVIAPVGIYSKTIKDLKNLKKGA
RVAIPNDATNESRALELLEKAGLIELNQNTLKTPLDIKKNPKNLKFIELKAAQLPRALDD
VDIAVINSNFALGAGLNPIKDTIFREDKNSPYVNYVVVRFEDKDNEKTKIIDEILRSDKF
RNIIDEHYKDVLIPAF
>fig|195.2024.peg.969 hypothetical protein
MRAARTCGANNNDFSILDYLFDEYGLSLKDPKYNFRFADMKYIKEANDKYIVVRYMEDNP
SIYKEALIYRYILKVRNPNPQIIQYLANHGAKFEVYREDTGWSPIHFWASNNDYKFLELA
IKGGANVDMEEYEFESIYKYQDTPLFEAVKESGNYRTVQLLIELGANVNFVPYLTTPLDQ
AEGARNRKLLKAAGAMTSDQLEKKFNIFYKDYEDRNEYCDLLNEAIRKDKEKENLQKN
>fig|195.2024.peg.1419 Possible RNA methyltransferase aq_898
MKALALFSGGLDSMLAMKLITAQGIEVKALNINIGFGSTSDKSEIMKKRAAMVGADFEMI
DVRNSYLQEVLFNPQYGYGKHFNPCIDCHAFMFKTALAMLKEENASFIITGEVLGQRPMS
QRSDAMAKVKKLALDEEDLILRPMCAKNLPLTKPEREGWVDREKLEGISGRSRKRQLELA
VKFGLEDFESPGGGCLLTLDSFAKKIRDFIEFDKDMQVNDAQLLKYGRHLRLPNGAKMII
GRNELENTLLKGLKTPKYEVIELGDLIGAYSLLSANADEKDLELALKIALTYTKHEANKS
YELRFKDKSYKSIAFEDKKEINPFFIS
>fig|195.2024.peg.1247 Integral membrane protein
MFDFLYNDISYLGLFIVCFLSSTLLPLASEAFVVAFIKLDFNAHLVLFIATLGNTLGSLS
TYALAYLGKEKILEKYFSKSLKKLDKFNANFTKFGSLYAFLTFLPLIGDIFALGLGFAKY
PFIKACFFISLGKLSRYIFIIFIANSL
>fig|195.2024.peg.1356 Putative peptide ABC-transport system permease protein
MLKRLVFSIFIAFFSTFLCFVLLYFSKGSVAYANKVNSQSKELVQRIEANLGLDKPLLGQ
YQIWLFKALKGDLSVSFLSGESVLKLIKERMANTLILSLSALVLLFLLSVFLALLGHYYK
ESFIDKLITFLAFNFFALPPFVLALFFVLIFGIFWQVLPITGTSDIGFEDDFFNRLKHLI
LPVLVLVLSHLALFLRIARNFINETFSQIFIQNLYARALREKDIYFLVLKYSLSPIVAYF
GGSALSFMMGTYVVESVFAYEGLGSLLFESILFKDFPMALALIFFSVLLAAFFTFLSDVF
AWILNPRLKRLKFV
>fig|195.2024.peg.1517 tRNA pseudouridine(38-40) synthase (EC 5.4.99.12)
MKLKIIFSYDGSKFLGSATQPHKKSVQDALQDALSHLGIFSSVLMASRTDKGVHASYAVA
CVECGEHFRDLNYLKKQINKFSHPFIHVKNLKIMPSNFEVRYDVKSREYRYIFYHGVYNP
FLASYVHFYPFIDVLKADLVLQNFVGIKDFKFFCKSGGDNKTTIREIFLAKAYSYKDFTI
FRFKANGFLRAQIRLMVASVLKVLENKMSIEELKEQIEAKKQYNHFLAPPCGLYLSRISY
>fig|195.2024.peg.1303 FIG00469601: hypothetical protein
MNILNEAMKVLKLNLKPFDLTNLTKKKTYLCALNDENLLLIYTGKARFINKDAIFINNLA
NDFDLKYKYFFTKSPLCSKAKHYLEEKGFHIHAIL
>fig|195.2024.peg.710 Membrane protein
MKDKSLEELNILKIVIYVLSFITVCTALILFLLLPVLKDYKQTHLRKNSQAAIFNAAKAK
LDASENKISALRTENNKSLEQFEQQFNLTHFQNFLEKYFENIQITELKLDKKEKYLTHRI
NIRASINNPRRLYDFIDALAQYNNLVKIDYPMTLKASDHGIMINLNVQIYSN
>fig|195.2024.peg.68 Sodium-dependent transporter, SNF family
MNSKFSKIGFILAVAGSAVGLGNAWKFPTLVGQSGGSAFILLYIILTLGVGFVIFLAELS
IGKISEKDPVNAYEKLAPSNKKAWSYAGFTMIGAILIVSFYTLVIGWILKYAYLSISGNL
YPELNTSSAEFGKLISSDFVSQFVCFTLIFLIVFYTVSKGVKNGIEKLNVWMMPALFILL
VLMLIYAMTKDGFMMAVEFLFVPDFSKISTSNVLEALGLAFFSLSLGVGTIITYSASLPE
RTNFITSTLNIIFINLLIGLLMGLVVFTFIFEFGFDASKEGPGLIFVSLATLFQKLGAIG
HILGAAFFISLIFAGITSAVSMIEPFAFYLINSFGMSRKKALILIGIIVYTLGILCILSS
LDSTAFKIFGLSVFDLLDTLSSKIIMPLGGILAAIFVGFVIKKEALQILFGPYMKGIFFE
LWYIFLRFISPLAVIVVMISAFLK
>fig|195.2024.peg.658 Septum formation protein Maf
MLILASSSVSRSNLLKEAKIEFQQISFDYDENLDKNLKPSIYVQKIVLEKERQFCTTYEE
KFKDETLLFADSIVCIGDKILTKANTKEEACEMLDLQDGKCASILSAFLLKNLKKRVFSL
SKTTLYFSKFDPRDLKDYVENGFYKGKAGAIMCEGFHKNYIIKQEGNLNTALGLDTQNLK
AYL
>fig|195.2024.peg.1012 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVTNP
DSDEKGLNFGIYGKADNYDARTRDYFKGAVKANGLYVTPSYLDLTTNLPCFTYATPLYKE
GKFIGVLAIDILVKDLQREFENLPGRTFVFDSENSIFVSTDKELLKPGYDVSPVANIAKD
KKDYEPFRYVRPLDGTQRFGVCAKVLGEYTACVGESIDYIEEPVFKIAYIQIAIVIITSI
ISVLLLYFIVSRYLSPLASIQVGLNSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENI
LATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKV
GSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESS
KLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGD
IADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSIND
MAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2024.peg.64 Argininosuccinate lyase (EC 4.3.2.1)
MKNEMWSGRFSEASNELLKEFNASLNIDRALYVEDIQGSIAHATMLENCGILKKDELEAI
VKGLEQVRVEIEQNRFVFNIEDEDIHMAIEKRLSELIGSEIGGRLHTARSRNDQVATDFK
LFTKKSHLELIMLLKELIQTLLSHARAHKRTIMPSFTHLQHAQPISFSFYILSYAFMFMR
DIKRLQNSLELADFSPLGSCACAGTSYATNRNLSAQILGFKDIMPNAMDGVSDRDFALDL
LYDIAVIFTHTSRLCEEMILFSASEFGFLTISDSFSTGSSIMPQKKNPDVCELIRGKTGR
VYGNLISLLTIMKALPLAYNKDMQEDKEGLFDSVKTAKDSLIILNAMLKEVKINEENMLK
SCKKGHLLATDLADYLVREKNIPFRKAHFIVGNVVAQAEKQGIDISDIEDLSKIDPIFDE
KAMKLLDFENSLNSKQSEGSSSVASVEKQIQILEKFLECLG
>fig|195.2024.peg.417 Deoxycytidine triphosphate deaminase (EC 3.5.4.13)
MGLKADNWIRKMALEHQMIEPFCEANIGKGVVSYGLSSYGYDIRVGREFKIFTNVNSTVV
DPKNFLEENVVDFEGDVCIVPANSFALARTIEYFKMPDDVLAICLGKSTYARCGIIVNVT
PFEPGFEGHITIEISNTTPLPAKIYANEGIAQVLFLQGDEKCDTTYKDKKGKYQAQTGIT
LPRILK
>fig|195.2024.peg.1283 Putative periplasmic protein
MKIGLLLCFFVSLVCAQIYKGEIYFYDLKDKQVFAIVYDNAPFVPIFDRDVNQTSSSFLI
LSDLDTNIEIALFQTANSWEDGEKKYKISSSKELVFDNKKIQGNKLGTTTLELIKEQNNI
RIKRSLDFLAHQDEIRQFRPMYNDIVSFEQIRQKPIVLKDGKLSFEEWYYFYEEDNRAIL
ELNNFVFDMDKKVFLSLNELYDVDNLKFKELLHQKLNLVCDECFDDMEQVFFNNNFLITN
LGLRLCYLPYENHYLNENICVDFNENEIKEFRK
>fig|195.2024.peg.1081 Putative efflux protein
MKKKSYKFHPNDTKLDKKMVEITEKSGFKIAVFSMAAMTMLGSVVISSALPAINRHFEDI
LIQSGANMQTNFTLAHLDILVRLVLTLPAIFVVILSPFAGILMDKLGKLKFVFPAMIAWA
LAGVSGFFLNDIYAILTSRAIFGMATAFIMTGASALLGDYYSRGGFNRRENALSLQGFFC
AVGGAVFISIAGFVSSYSWRYPFLVYGLGILITLIAMIYLFEPRKFKFYNHTKIEEKTNY
WKFFPIYFIGFFIMVVYYISPTQLPYYIEEHLGLDPKFIGISMSISALCYGIFSLSYKYI
MRFLSIKMIYIATLFIVGCSFLILFLIDDFIAVLFALALLGMGGGIMLVNNTAYLFSICP
ENARARAYGILASCIFLGQFLSPIISQPIVRQLGLVDAFLIWAILNFIVCIVFLFLKQR
>fig|195.2024.peg.730 hypothetical protein
MDLKEIEQFLDENTPAFLATLGTCGNPRVRPMQSPLLVGDRIYFCTSNNKGLFKHIQNYN
GIEFCSCSREGVFLRLRANAVFEPNAKVKELMFEKYPYLVSLYENPQNSRFEVFYLDNLS
AKMQFPNGDFKLYKA
>fig|195.2024.peg.353 Membrane protein related to metalloendopeptidases
MKAFFLFLSLALWLFGAQNFELIKGQALFLELDKKDFISLKNEDKILATFPHPKNQEKIL
AIFSLPYKNPPQNTKLTALYKNKKEEIFIKTLEGNYKSEKLSVENKKVFPPKAVKERIAK
EFKEANAIYSSYTPKALFDGSFNTPLNSFITSDFGKARTFNEKVASYHSGTDFRAAVGTP
IYAANSGVVKIAKDRYFAGKSVVIDHGFGIYSQYYHLSKIEVKVGQKVKKGDFLGLSGAT
GRVSGPHLHFGILAGGKQVDPLDFISKFNTLFQ
>fig|195.2024.peg.777 hypothetical protein
MLFGFDDKREFIPRVYSSLCKQELVKTFLIQYNASIDSALRIPLSYAKSAKDLKMPFQNF
LQDVIHTPFGKIKNIDKNLTLNISYFQKRKSLIFKTKIFQNVDILRLLRAYFRGICFDAQ
VLFDFYVYDKISHQNQNRSIVQNDNLIIIDNKIAVLPLCKEVDLQNLNIDNEIQKISKFI
YQNQFEQIYIVCPRNKKFTHFIQIKHFLCDLNKTMLKLVPYSITNKLIRRK
>fig|195.2024.peg.232 Oligosaccharyltransferase PglB (EC 2.4.1.119)
MLKKEYFKNPTFILLAFIILAYVFSVLCRFYWIFWASEFNEYFFNNELMIISNDGYAFAE
GARDMIAGFHQPNDLSYYGSSLSTLTYWFYKITPFSLESIFIYISTFLSSLVVIPLILIA
NEYKRPLMGFVAALLASIANSYYNRTMSGYYDTDMLVIVLAMMIVFFMIRLILKKDLLSL
ITLPLFVGIYLWWYPSSYTLNVALLGLFFIYTLVFHIKEKTLYMAIILASITLSNIAWFY
QSAIIVILFSLFVLQNKRFSFALLGILGLATLVFLILSGGIDPILYQLKFYIFRSDESAN
LAQGFMYFNVNQTIQEVESIDLSIFMQRISGSELVFFVSLIGFIFLVRKHKSMILALPML
ALGFLALKSGLRFTIYAVPVLALGFGFLMSLLQERKQKNNNTYWWANIGVFIFTFLSLIP
MFYHINNYKAPTVFSQNEATKLDELKKIAQREDYVVTWWDYGYPIRYYSDVKTLADGGKH
LGKDNFFPSFVLSKDQVAAANMARLSVEYTEKSFYAPLNDILKNDLLQAMMKDYNQNNVD
LFLASLSKPDFKINMPKTRDVYIYMPARMSLIFSTVASFSFVDLETGEINKPFTFSAAYP
LDVKNGEIYLSNGIALSDDFRSFKINNSTISVNSIIEINSIKQGEYKITPIDDMAQFYIF
YLKDSTIPYAQFILMDKTMFNSAYVQMFFLGNYDKNLYDLVINARDAKVFKLKI
>fig|195.2024.peg.203 hypothetical protein
MTFFTGFQAKNYFIEGQTSILDKMQGFDKTMSQSEIDNLNKFISENSMNFKGDIFKLFDL
LNSDMSIDDFKQKILEQKENLNNPTKNTNNKETSEEDKKKPFKPMQAQSSSETYKDDNKM
NELLKKLLENKFGTSDELEILFGMKFSDDDTGEFNKILSLNSAPKSIDIKA
>fig|195.2024.peg.1133 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MEVVLANGEILRTGMGALPKAKTFADLWKTDECGVKRLSYK
>fig|195.2024.peg.1144 Dihydroxy-acid dehydratase (EC 4.2.1.9)
MRSDAIKKGHLKAPNRSLLRACGLKDEDFDKPFIGVANSYIDIIPGHYFLNEYAKIIKDE
IRKNGCIPFEFNTIGVDDGIAMGHEGMLYSLPSREIIANSVESVMNAHQLDALICIPNCD
KITPGMLMGALRVNVPTIFVSGGPMRSGVTKKGEKISLSSVFEAVGAYEANKISEEEFKD
IECSACPSGGSCSGMFTANSMNTLCEAMGIALEGNGTILALSKEREELLRKAARRICEIA
LDERFKIKNIITQKAIRNAMVVDMAMGGSTNTILHMLAISREAGVALDIKDLNFISSKVA
HIAKIAPSLNTVYMDDIHKAGGVSAVMAEISSREGHILELDALTITGESLQDRLKNAKIK
DETIIRKVDNAYSKVGGLAVLFGNLAEQGCVVKTAGITGERKFKGKAVCFNSQDEAIKGI
IKGKVQKGDVCVIRYEGPKGGPGMQEMLSPTSLIMGMGLGADVALITDGRFSGATRGLSI
GHVSPEAAEGGLIGLLKDGDEIEIDVDAYIINANLSDEEIAKRKNDFVMPQKEVKSRWLR
MYQKLVTNASKGAVLDME
>fig|195.2024.peg.320 hypothetical protein
MLKFLAFILSLSMSLFAIDLNLKPVKMELLKVEDIYGYVEDSPDIKLNSSGVVIQRFQTS
KSIIARASVIAKEKSLAKLKFSVFADLEQDALPLPNVVPQKGDEVVLNFLYDRGLVIAPD
EQTYNELVFSFPEIYFTHIDMLGAQLIRSSSLAPKRSDFRKFCADNAVGILIFALEDKAK
IVDCQDFSELYELTISKPSSIQVPFYSRIGGYKSNFFDFNSQEVGNYYRYYDALINIPKV
SQ
>fig|195.2024.peg.826 3'(2'),5'-bisphosphate nucleotidase (EC 3.1.3.7)
MKIVASKSHLNEQTKDFIDSIQTTKQKEFVSMGSSLKLCLVASNEADIYPRLAPTMEWDT
AAADAIVREVGKMTYNFDTQKPLVYNKENLLNPYFIVK
>fig|195.2024.peg.490 FIG137478: Hypothetical protein
MNKYLEQLVLLSKIDQEIDSFEPKMESISKTLKDAENKIAKFNVELNNLENEIQDVENQK
VQNNAHISEFSAKIKELSKKSGAVKTEKEANALKIEEDIAKEQLDAANDEIVRLDKILEN
KELFKKELLEERAKEEQNLDEIRVSISSQMDGLEKERMNVYTKKTKLVAEMNQKVLSFYE
KIRKWAKNTAVVPVKKQACYGCFMKIYDKTYLSVIKGEEIITCPHCGRILYKEQEDQN
>fig|195.2024.peg.1168 ATP-dependent Clp protease ATP-binding subunit ClpX
MPRKCSFCNEVENPQRRILANENDDAFICEYCVEGAYSIIYGEEKEFKEPKHEHGVDFKD
ITPKELKAYLDRYVIGQDRAKKVFSVGVYNHYKRLFKSELQDDDVELFKSNILLIGPTGS
GKTLLAQTLAKFLDVPIAICDATSLTEAGYVGEDVENILTRLLQAADGDVERAQKGIVFI
DEIDKIARMSENRSITRDVSGEGVQQALLKIIEGSLVNIPPKGGRKHPNQDFIQIDTSNI
LFVCGGAFDGLETILKRKLGDKVVGFFDNEKENSKALLEKIEPDDLVHFGLIPELIGRLH
VITSLNELNEDDMVRILTEPKNAIVKQYQKLFAIDGVNLKFEDDALREIAKLALERKTGA
RGLRSIIEEIMVDLMFELPEYKNYDIVITKEVVRDGAKALLIKKKIS
>fig|195.2024.peg.201 hypothetical protein
MAERLFQDFANITHGGNTDFYWQNEAEKYPLKKVEQANEVAELIYFLASPKASFITGGLY
LIDGGLTAGIPH
>fig|195.2024.peg.58 Ribose-5-phosphate isomerase B (EC 5.3.1.6)
MLRKKIYIASDHAGFMLKEKICTFLKEKQIPFDDLGTNDPTSCDYPDYAHLLASKIDEQS
FGILICGSGIGISIAANRHKNIRCALCNESLSAKLARKHNDANVLAFGGRLIGIDAAIDM
IENFIQTPFDQGRHVKRIQKIEVDC
>fig|195.2024.peg.1550 2-hydroxy-6-oxohepta-2,4-dienoate hydrolase
MALVNVIYNNDTYELSYEILNQDKKKSLLILHGWGANKELMKQAFSKNLNDFCQIYLDLP
GFGNSSAPKSLYSQDYVNIIKEFLKEKKLDIDIFLGHSFGGKIAALLVLDFQKAQLILLS
NSGILAKKSFKVRFKIMLFKFLKKLGLGRFYRYFASKDGANLNPLMYQTFKNVVDEDLSQ
TFAKIDNKSLIFWGIDDKATPLKSGEAMHKLIKNSEFYPLEGDHFFFLKHSLFIANKIKE
NQC
>fig|195.2024.peg.384 Cell binding factor 2 precursor
MRKVSLIAAALIAGVTLNLNAATIATVNGKNISDTEVSEFFAPMLRGEDFKSLPDHQKKA
LLQQYIMQDLILQDAKKQNLEKDPLYKKELERAKDSILVNVYQEKILNSIKVDSSKVKAF
YEQNKEKYIKPAAVQAKHILVSSEQEAKDIIKELKGLKGKALDDKFSQLAQEKSIDPGSK
NQGGELGWFDQSTMVKPFTDAAFALKNGTITTTPVKTNFGYHVILKENSRAKEQIKFDDV
KKGIENGLKFEEFKKVINQKGQDLLNNAKVEYK
>fig|195.2024.peg.1068 hypothetical protein
MVFWAFLVIIGAIYFGNMLFGQYSLDTLLSLEATKEELNKKISFLKEQNAKAQKDYFELQ
GLYPNEN
>fig|195.2024.peg.625 Prolyl-tRNA synthetase (EC 6.1.1.15), bacterial type
MKFSKLYAPSLKEAPKDATLPSHIFLTRAGFVEQIGSGLYNFLPLGKRVLDKIRTIVKEE
MDKAGAQEVNLSFVTPATLWQESGRYNVFGKELLRFKDRKENDFVLGPTHEEAMLSLVKN
KITSYKQLPLHLYQIGLKFRDEARPRFGLLRCREFLMKDGYSFHANEEDLTREFDLMYNT
YSQILQRMGLDFRAVEADSGAIGGSGSKEFMVLAKNGEDDILICENCDYAANVEAAVRAN
KTCDEERPEANYASKFHTPDIKTIEALAQFFKINAFYTIKAVVKKAIYENENKLVVFFIR
GCDDLQETKAQNACNALELVDASEEELEKAGLVAGFIGFVGLKNVDFYLDKELEGEKQMI
MGANEKDYHLIGIDVVNLNKDRFKDLAEVKENDCCAKCGAKLKLSKGIEVGHIFKLGQKY
SKAMNANFLDENGKSKPFYMGCYGIGVSRLLAVAIEANHDEKGCIWNKTLAPFTLEIIIS
NIKDEKSLEFATKLYEDLSNAGIEVLLDDRNERFGVKMNDFELMGFPYALVVGKGLEKDE
LEFIDRKTLEKKIISSKEVFDFIKKSVE
>fig|195.2024.peg.1368 hypothetical protein
MVFIINIFATTLKKIVQIIRAGFTSLWQAVKIITNPPKDIPKEDIYYEASKIMVTGLISA
TAMLGSETLNKLLTSVPILGPVMQFPIPFTGEKNDQGGLVNFQTIGDALSLCITSACGAV
LSTIAIFYMDKWRNDSKIGSLQIQLVAQNGVVMHYKIAQTWFVLGDAYNLFGQVMERGSQ
NLVILKNKVNQVQNKLKQAEGERQEAISDCIKQLENLRGE
>fig|195.2024.peg.556 Ketol-acid reductoisomerase (NADP(+)) (EC 1.1.1.86)
MAVTVYYDKDCDLSLIKSKKVAIIGFGSQGHAHAMNLRDNGVNVVIGLREDGASFSKAKS
AGFEVMSVSEASKVADVIMILAPDEIQADIFNAEIKPNLSEGKAIAFAHGFNIHYGQIVA
PRGIDVIMIAPKAPGHTVRNEFAIGGGTPCLIAIHQDESKNAKNLALSYASAIGGGRTGI
IETTFKAETETDLFGEQAVLCGGLSALIQAGFETLVEAGYEPEMAYFECLHEIKLIVDLI
YQGGIADMRYSISNTAEYGDYITGPKIITEETKKAMKGVLKDIQDGNFAKDFILERRAGF
ARMHAERKNMNNSLIEQTGRNLRAMMPWISAKKLIDKDKN
>fig|195.2024.peg.1453 Fe2+ ABC transporter, substrate binding protein
MSIYFVHFLSSILPLSILMAFITPDKRYIFKSFLALFLGFLFGYFAFFIAAQFLKTENLI
FNFNFIFIACLLLSFVFYFWQKIEILSFILLGNLSFCIALHYYNLTQDFPIFNGVLIDSE
AISSLGFIALALLICILIFFFLKWQKNINKKASFILFLILIFIEGDKVLANILLTLMRNS
FIETHTFLVSFVGKSNYFGVFGIYVYLFFIIFLAFLSLQIRKKNIVKKQILDIVYRKNEA
KNTLINRYFSSVFISCILSFCIILYFFMVSSKPLSIDEPTELLPDKNGKFIFDVALLRDN
KLHRFAYISEQGKVIRFFLINKREDRDSPVAVFDACAICGDMGYIKKEGELICISCNVRI
FLPSVGKTGGCNPIPLKYDYDGEKITIDVKDVVAGSNYFSQIKDIQVQDPVSKDKIINTQ
APFSYSYKGITYYFSNEKNYEEFKKDPMKYVEDTEALFLIQRRNNAS
>fig|195.2024.peg.1534 Threonine synthase (EC 4.2.3.1)
MLLVESRNINNKVDFKNALVNPNAPQGGLYSPLSLPQFDGEKYTNLSYKEFALKLIESFE
FGHEALFDKALKSYEKFDDKNSPIALKKIKDKTYINELWHGPTRAFKDMALQPFGVLLNE
FSQNEKILIICATSGDTGPATLKSFENLENIKVLCMYPKGGTSAIQELQMRALDKGNLKV
FAIRGDFDDAQRTLKNLLAKETFKDELSKVGYGLCAANSVNFGRILFQIIYHYYASLKLY
HEFKEEIEILIPSGNFGNALGAYYAKLMGAKISKIKIVSNANNILTDFFTKGEYDLRDRS
LKKTISPAMDILISSNIERLLFSKFSDLRTNELMNLLKTEKYFKLEKEELQSLQEDFEAD
FCTDEECMKFIKESKILIDPHTATCFKMLDTSKPSIITSTAEWTKFTPSMVKALFGRECK
DEKADFELLAKEFKVDIKKDLLELFDLKNADEKVYEIGDIEGEILEWIKK
>fig|195.2024.peg.614 Thioredoxin reductase (EC 1.8.1.9)
MKKVDLIVVGAGPTGIGCAVEAKLKNKEVLVLEKSNNICQTLMQFYKDGKRVDMAYKGCE
GTNHGHVPFQDGTKESTIETFQNALNEHKIEVEFGSEVESVKNENGVFLVSTGKGVYECK
NIIVAIGRMGKPNKPDYKLPITLTKIINFNANSVLGDEKILVVGGGNSAAEYAVDLANSN
KVSLCYRKKEFTRLNDINLKDIHEAGNSGKVELKLGIDIEELEDDNGKAKVKFNDGSNET
YDRIIYAIGGSTPLDFLQKCGINVDDKGVPLMDENKQSNVKGIFVAGDIATKNGASIVTG
LNDAVKILAVI
>fig|195.2024.peg.536 Peptidoglycan D,D-transpeptidase MrdA (EC 3.4.16.4)
MRMRLVVGFILLFFIFLLSRVYYLSIKSNVYYEELAKQNAIKTEFIVPTRGQILDRNGTP
LAINDLGFSISIKPYLTLKRANRGVLEKELNQLQGFFPDLNTTKLAEFYKRNDSYYNQDF
IKIIDFIPSQEMMKHYSELNLNQNIRIDPAVQRKYPFGKLASHIIGYVGKADLQDIKENE
ISKLTNFTGKSGIERYYNDVLQGEKGTKIYKVNALNQEVEQLSYTSALSNDIELTIDIEL
QSFLTQLFEGNAGAAIIMDISDGSILAAGSFPEYDLNPFVTGISYKEWDELSNNLDHPFT
NKLINGYYPPGSVVKMGVGLSFLNSKSINPSTQFFCNGSIELGGRFFRCWNRAGHGAVDL
KHAIKASCDVYFYDGSLQVGIDQISRTLSRIGFGAKTGVDLPNEFVGILPSREWKMQRYK
QAWFQGDTLNTSIGQGNFLATPMQIARYTAQIAKGAEVVPHFLKSVENNNTITEDKAQDS
NEIFTLFEKSQLPYIRDAMYAVANEQGGTSYHYLRNLEVKVAAKTGTAQVVGFSQADKNR
VDEKQLRYYTRSHAWVTSYAPYSKPRYVVTVLVEHGGRTISSGVATAKIYQKMIELGYFK
PENKANSLKKN
>fig|195.2024.peg.1524 Flagellar biosynthesis protein FliP
MKKILTLLFISGFFSVIFAAEATIPTVNLSLSAPDTPNQLVTTLNIVIVLTILALAPSII
FVMTSFLRLIVVFSFLRQAMGTQSMPPNTILVTLALILTFFIMEPVATKSYNEGIKPYLA
EQIGYEEAFARGVKPFKDFMLKNTREKDLALFYRIRNLPNPKTIDDVPLTVLVPAFMISE
LKTAFEIGFLIYLPFLVIDMVVSSVLMAMGMMMLPPVMISLPFKLLIFVLVDGWNLLVQR
LVESFVT
>fig|195.2024.peg.1647 Diacylglycerol kinase (EC 2.7.1.107)
MKPKYHLLNNARYALEGILALLKNEMAFRLELCVIIPAIVFSFFLDVSFLEHLFLITVLI
LILITEALNSAIEACVDLITNEWHEKAKVAKDCASAAVFFSVCLALFIWGFILGKLWL
>fig|195.2024.peg.549 Adenylate kinase (EC 2.7.4.3)
MKELFLIIGAPGSGKTTDASLIAQADADVTHYSTGDLLRAEVASGSELGKTIDGFISKGN
LVPLDVVINTIVSALKAAPTKTVIIDGYPRSVEQMVEFDKVLSEQNEICLKGVIEVRVSE
QVAKDRVLGRSRGADDNEEVFYNRMKVYTEPLEEIISFYQKKKLHFIIDGERTIEPIVAD
MKELIKKIQSI
>fig|195.2024.peg.1580 Phosphopantetheine adenylyltransferase (EC 2.7.7.3)
MTCLYPGTFDPITNGHLDVIKRALKIFDKVIVAIANSEHKKPCFSLEQRKELAKLATSHL
NNVEIITFDNLLVDLAKELKVNTIVRGLRAVSDFEYELQIGYANHALWEEIETIYLMPNL
KNAFISSSIVRSIASHGGDISTLVPKEILPFLKDLPCM
>fig|195.2024.peg.547 NAD kinase (EC 2.7.1.23)
MQNKIDYKNIKKIGLAARPNSNLDKEILILKEILEKKGVELLLYKESSEIVKLPKYDLDT
LFELSDFVISLGGDGTLISLCRKACEYNKAVLGIHAGHLGFLTDFKVDEAEVFFEAFFRG
EFRVENPFLLSIILESNDGQIMQKFAFNDVVISKDRKASMAHIEVFRKAKKFNEYFGDGL
IVATPAGSTAYNLSANGPIVYTLAQAFILTPVCSHSLTQRPIVLPKGFDLEIGAKDCIFS
IDGQENYKMNDFKSVKVGLSDKSVALIHPKNRDYFQILREKLNWGH
>fig|195.2024.peg.1028 Prephenate and/or arogenate dehydrogenase (unknown specificity) (EC 1.3.1.12)(EC 1.3.1.43)
MKVAIIGLGLIGGSLGLCLKENKLISCVYGLDSSKENEQDALNLGLVHELIEFENLHLCD
MIFIATPVNAIIEILQKLVNLPSNITIIELGSTKRKIIEKLPAKLTKQTLFAHPMAGTEN
SGPKAAFKELYKDAVCVLCDSEVADDLHQKRAVEIFSHLGMRIVFMDSTAHDHHAAIISH
LPHVISFSLANFVMKEEDKRNIVHLAGGSFKGMSRIAKSSPIMWGSIFEQNKDNVLSSIE
FFQKELEFCKKMIEEDKNEELKSWMQKANTLREIL
>fig|195.2024.peg.399 Oxygen-independent coproporphyrinogen-III oxidase-like protein YggW
MHLYIHIPFCESKCHYCAFTSLKKHDYENRYFEALYEDISFHLQKLNIKKNSIKTLFIGG
GTPSAVSAKNFEMILTLLEPFLSKNIEFSSEANPNSADIEWLKTMKNLGLNRISFGAQSF
HPKKLEFLGRIHDQKMIFKALENVNKLGFKKINLDLIYDTKLDDKKMLEFELEQLKQIKN
LITHLSAYNLTIEPLSAFAKKEYFKKNAPYLMKFFIQELQNLGFLQYEISNFAKNNAQIC
KHNLAYWKGLDYLGCGLSAVSCYKNERFYTAKNLKSYLQNPIFRDVEKLNQEDLNLEHLF
LGLRSIVGIKECKLSKIQKEKANLLVREKKLKFEKGRYYNLNFLISDELALYLSS
>fig|195.2024.peg.60 Adenine phosphoribosyltransferase (EC 2.4.2.7)
MTKLTQNEQQFLSESIRVIPNFPKEGIIFRDITTLLNNQKALSFLLDHLSKRYQTMNLDF
IAGTESRGFIFAAMICAKLNLPFVPIRKPNKLPSNTYSCEYELEYGTDRVEIHQDAFRNI
KNAKILLVDDLIATGGTALASFELIKKAGGECIEACFLMNLKNLGGEEKLQKHCSVYSVL
EF
>fig|195.2024.peg.1663 Flagellar motor switch protein FliN
MINEFLKLFTNECTSTIEGLTGKSAEFSEYKEFDVSSQDTLKPPLVYAVFNIKEGGKIGI
LAGAVLMSAIGEWMMGEEEISKNDQLGPDEMDAAKEAIQNIISAFSTTLGAQKDIPKMDF
EISSCEFVAENVDFKDFTKLYFFDVKIEDLEEQISLIVDQTLHNILSGKAADDGHAHSSS
NSENKGFEISEELKNINLIMDVRLPVRVRIGNKKMLLKDVLTMDIGSVVELNQLANDPLE
ILIGDKKIAYGEVVIVDGNFGVQITEIGSKKERLEQLR
>fig|195.2024.peg.1187 FIG022708: hypothetical protein
MGDIFDLLIGEISATHEFAKPYIKLLEELALKMEIIYLEGNHDFNLARFFQRVKIFNLQE
QPLKLNLHTSKGKNTDFKNSFITLAHGDIFLSPPLQFALKSLRNHYLLVFLNFLNQISFN
SISNKILKNQNKKNLFYKIENFKNLAKERYKKYENLGFWVCEGHYHQNLILDEKDVKYFN
LASFAYERSFFVVECCQEIKFREQKLRGQNV
>fig|195.2024.peg.1643 Proposed lipoate regulatory protein YbeD
MVNLCDLKQEPIVNYPTFWDYKVIFEAHVHAGALFEELLGQRDFKYKHSNASSSGKYQSF
LLSVYVDSKKDRLDIFEKLKAKAKFVL
>fig|195.2024.peg.587 Two-component system response regulator RacR
MINVLMIEDDPDFAQLLSEYLTQFNIKITNFENPKEALNVGIQGYDCLILDLTLPGIDGL
EVCREIRQKYNIPIIISSARGDLSDKVVGLQIGADDYLPKPYDPKEMHARIMSLIRRTKR
AENTNNENINSAFKIDERKHEITYQNKVLTLTPAEYEILEYLIQQHGYSVSREQLVSRCK
NLKDKDSKSLDVIIGRLRTKINDSSKAPKHIFSVRGIGYKLIG
>fig|195.2024.peg.279 Twin-arginine translocation protein TatA
MGGWSSPSHWLIILLIVVLLFGAKKIPELAKGLGKGIKTFKDEMSNEDEAAKNAHKIEEK
QNTTNHANTDANIDEVKKS
>fig|195.2024.peg.851 hypothetical protein
MKVDNFLNTYSMNSALLDRAAKARSLESSIKINDNDIVTKSKEDEALKEQTDAFEAFFLK
QVLDVSLKSQNSLFGKDASDEIYSSMYNDTMSKALSGGMGFSKLLYDFLKERG
>fig|195.2024.peg.1571 Probable periplasmic protein Cj0776c
MNFKFFSIIVGILVVVILILSGTYYYLFEYSKPSYTPITQTSTEQNQYSNNTHTTTQNSY
VSDITNTNNENINLIQDKQDEKDANNIINDDNKSDTKSSQITKQNNEEKLAAIEKEISKQ
QKILEQEKIFKPQNTNNNKTNYQAKKLSPAQEYLSLGKNSRLEPQLSTENMKVYVLDGKF
LSDYRIKLLKDMLAIIEDNSKDYFLSVFVKMLPKGEMSLTIYNKDIIFSDMKKSYKYISM
DKISPYIKTPEVLNQYVAREEIIERFKLQTKKEGKGSEFSKHINSLKTGLNKAQYFFPFC
EIIEITSVK
>fig|195.2024.peg.1014 Zinc ABC transporter, ATP-binding protein ZnuC
MLFFEISNINYAYNNETILKNINLSYDSKDFLSIIGPNGAGKSTLVKLILGLLKTKKTIS
FHGLKKNEIGYVPQHTLANPNFCPRVIEIVLMGLVNKKIFGFYSKKDKNKALEALASVGM
QDFWDRKINELSGGQKQRVFIARALVDECKMLILDEPTASVDSKSAIQIFELLSSLHEKG
IGILLICHDINLVLAYSDKIAYLNKELFLHTNTKEKDKSVFLKHLYENHSHFCDVEMSLN
SCFCDEENCEKKKICEQEFARRNLKKSNFKKENFCLKFSKESHV
>fig|195.2024.peg.699 hypothetical protein
MKYETINQESIAKLMELFYDKIRKDKDLGPIFNNAIGTSDEAWKEHKAKIGNFWAGMLLG
EGDYIGQPLKKHLDLPPFPQEFFGIWLGLFEESLDKIYNNEEMKNVILQRAQMIASHFQN
MLYRFGGH
>fig|195.2024.peg.1344 NADH-ubiquinone oxidoreductase chain I (EC 1.6.5.3)
MKNYYLIDEKRKTPTSTWQKISQALKRSVKLELFVGLWVVMREMLKRNNSATIKYPFEKV
KLDNRYRAVHRLMRFIESENERCIGCGLCEKICISNCIRMETSLDENARKKVGNYSINLG
RCIYCGFCAEVCPELAIVHGTEYENAAEQRSYFGYKQDFLTPIDKLKNQVEFEGAGSLRK
DADLLVKKTPNYYEVLQEREKNLCTDEECTLPNLAPQGEVK
>fig|195.2024.peg.1060 Biotin--protein ligase (EC 6.3.4.9)(EC 6.3.4.10)(EC 6.3.4.11)(EC 6.3.4.15)
MEKGLKVQIACVESIDSTHLFLCEQIRSGKINENFALYALNQTKGVGSRENSWQSSSGNL
HLSFCIKEGDLPSDLPLASVSIYFAYLLKEILQEKGSRIWLKWPNDLYLDDKKVGGVIST
KISDFIVGGMGLNLKFAPHDAALCDVEILLKDLIQEFLQRLEKKFLWKHIFSKYMLEFEK
SRQFSVHYEGKVFSLENAFLYEDGSILLGDKRVYSLR
>fig|195.2024.peg.922 Acetyl-CoA synthetase (EC 6.2.1.1)
MRYQNTQGLFKPNKQLSRNARIKNLCEYYDLCDEVREDFEGFWKRQALEKIDWFSPFSRV
LNDDKAPFYKWFEGGTLNVSYQCLDRHMKTRRNKAAIVFEGEMGDYEVYTYRRLLHEVCK
AANLLKRFGVKKGDRVIIYMPMIPETAIVMLACARIGAIHSVVFGGFSPEALRDRIIDAG
AKLVVTADGAFRRGKPYMLKPAVDKALSEGCESVEKVLIVIRNNEPIEYVKGRDYIYNEL
VKNESYKCEPEIMDSEDLLFLLYTSGSTGKPKGVMHASAGYILWAQMTMEWVFDIKDYDN
YWCSADVGWITGHTYVVYGPLACGATTIMHEGTPTYPNSGRWWRMIEEYQVSKFYTSPTA
IRMLHADAPDEPKKYDLNTLEVLGTVGEPINPSAWQWFYENIGNSKCSIVDTWWQTETGG
HMITPLPGATPLKPGCATLPLPGIFAEVIDEEGNVKDVAEDGLLCITKPWPSMIRGIWGD
ENRYIESYFSQAKKEGKPVYFSGDGAFYDDNGYITITGRTDDVVNVAGHRIGTAEIESAI
AKHPSVAESAVVSVLDAIKGESLFAFVVLNPTSSCDLGGAIETLKELNDILRAEIGPIAK
IEKILYTTGLPKTRSGKIMRRILRTIARGEELKQDISTLEDSGVVQSIIDAAKTGIQ
>fig|195.2024.peg.484 16S rRNA processing protein RimM
MSERNFIQVAKLGKTVGLKGYLKLYNLSDFIQQFKKGASFFTENGKSQLKIKHYNLANSS
VLFEGYENVEAAKQLINLILYQSIEATRQTCILKKDEFFYFDILKCEVFDDERRLGKVVD
ILEVGDSYLFEIQSDQELIDKAYAKTFFIPYIDKYVNKIDIEKYSIFCTKDVFLILENS
>fig|195.2024.peg.1071 1,4-dihydroxy-6-naphtoate synthase
MKKTITIAHSPDADDIFMYMAIKLGWIGNDFDYKNTALDIQTLNDLALKNEFDATAISFG
LYPLIAKEYALLRTAVSFGEGYGPKLIKKQNTHLKRNFKVALSGANTTNALIFRMKYPEA
RIIYKNFLEIENAVLSGEVDAGVLIHESILEFDSSLCVEAEIWDIWLELAQENLPLPLGG
MALRRSLPLSDAIKIERDLTNAVKIANSNRRILAPMLMERNLIRVNEEKLDTYLNLYANK
NSICMSETQFKAADVLFKLGYDYKFYDKIIHAKDYLIPSEYEEFRNS
>fig|195.2024.peg.797 Phosphoglucomutase (EC 5.4.2.2) @ Phosphomannomutase (EC 5.4.2.8)
MLDVIFREYDIRGLYGKELNEKSVKAIGFCLGQTMLAKGCKNVSVGYDARYSADELYRYL
VSGLNKAGIQVYNIGLVPTPLGYFSLYEGMKFDANIMITGSHNPKDYNGFKITIGKESFF
GAELKEFSKEVYKHLEDEIEENLEAQKYDILSLYVNFMCEQFNFLKDFNYKFAIDCSNGA
AGVVIEPLVKALNLKAHVMFSNPDGQFPNHEPDPTEEKNLHAIKNFLNENQEYPLAFAFD
GDADRMVALSKTHIFCGDELCYLFAKNIPNPRILGEVKCSKNLFDEVAKFGTIFMGKTGH
SNIKKMMKEKDIDLAAEVSGHIFFKHRYFGYDDGIYAFLRALELVYKGFDLESMIKALPK
LYTTPEIKIPVNEEEKFKLVEEFQKEIEKGALKGVKSLCEIDGARIDFGDGWALLRASNT
SPYLITRFEASSLEQAKELEAKVFKLFNDIKESV
>fig|195.2024.peg.1683 hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRN
LIQDTEKIQNNIKFGVSGEYIGNYFSTNSLKSIDEIFYENPDSNKILNYHVDKWIKEILD
LEISFTTNESIDIILNGFKDKNFSNYFLPSNISTGLNFATKIIIIGLSLKKGDIFIIENP
EIHLHPKAISKFADFFAFLVSKGIQVIIETHSNYLLSKLRYINFKKEFKDEDCIIYYKDQ
QTDFVPIFIHSGKFTNINREKINFPTGFFDTDLDKLMEIR
>fig|195.2024.peg.468 Putative periplasmic protein
MKKVILTSAMLCSVLFGVQEYEANLAGHIIIDSKSTVKPPKDAPDFFKTYGKFANITREE
KIGTFKSKGNRETDFYLPFKNQPIQGHSGIKYIPKKDVFWVISDNGLGKKYNSYDAMLYA
HEFKFDFKNSKYELLKTVFFKDSDKKYPYPITTETTKERYLSGVDFDTESIQVINDEFYI
GDEFGPYLLHFDKNGNLKEVFDVYVEGKKLISPDNPSLKFSDKPDGENEKFNIKRSKGFE
AMASSKDGSKLYLLLEGSIYNNNAYENEKGKEYLRIIEFDVKNKKFTGKTYKYFLEDKSH
SIGDFNMIDDKYGIIIERDQKEGTKDKVCKEGEDTKHCFNNVAQFKRIYKVKLDDKTHEA
QKISYIDLLNIKDRNKISKKPLVNDKFVFPFETIEGVDIVDDSHIVVENDNNFPYSSSRE
PNKTDDNEFILLEVKDFLKSK
>fig|195.2024.peg.351 Predicted phosphatase
MINVFFDMDGTLIDSANAISCAVNEIRNELNLSPLSREKIMQTINTPNVDWAKELYSIDN
FHHSSFKDGFEKYFIKHYEQSVVLFEGVKEILEFLKEQNCFLAIATNAPQSSLSSILKKH
EIIPYFDKILGVSLGIEPKPHPMMLDLLKSEAPHKISVFIGDSQKDRECAKNANVPYFHA
KWYQKDLQENEFSNANELKNFLEKYL
>fig|195.2024.peg.610 Conjugative transfer protein TrbL
MKITTKTLLNGNKLAIIFLIFLAPNLAFGVESAEGVLSIIHNGLLS
>fig|195.2024.peg.1260 Probable transmembrane protein Cj0352
MKVLLLSILALPLFAVELISYNIYDRNDRVDLMLSFDSAYGGKISQKKEKNLTLLTLSDL
KYSKEELKSLNSGLVDKISISSKDNNTYIMLQNKEPISLELSSINDKFGVRIRAVQQGKE
SINPEQSNLSTNEEPILNSKKTSLEGYDYTNYILVMLVLFVLLIVLWWLKRTLAFKNTGV
SRDFRMVFQRFLDKNNQLIVFEYASKRYTMIVGNSNIVLEEIEIPDYEPKVTEKSEKNFD
SFFEENKKRIQSLIEQRQKNKKS
>fig|195.2024.peg.45 Cysteine synthase (EC 2.5.1.47)
MRVYKKVNELIGNTPIIQLEKFGANLFAKCEFLNPSHSIKDRAAFAMIQSALNEGKIDSK
TVIVEATSGNTGIALAMICADLGLQFVATMPESMSIERRKMITLFGAQLELTPASLGMKG
AVDKANEILKNTPNSFMPSQFDNLANKNAHRKTTALEILKDLDNDLDIFVAGFGTGGTIS
GVGEILKEKLGKIHVVAVEPLASPLLSKGEAGSHKIQGIGANFIPAILNKDVIDEIITVS
NEDAINTAKELAKNGLMVGISSGANVFAASVLAKKFPDKKILTMLNDTAERYLSTDLFA
>fig|195.2024.peg.1676 Membrane protein
MDLKSLENKRLYILKRLGILKFLSVVEALLVGFLAFVFTKDILIALILAVFVGIFFFRLT
AKKLKLAKKELEIDALNLFLRRFGAKFRKESLSQKDFLKLELSENLKDFKSQNCFEFKEF
KIYDIQFLDENKRFFCGILLEILKPSKNPSFEDEEKIYVKLQDKNFTLNHIFSKDNHYLI
ATLTNPFFIDLKESLEKNFKNLENNLKLIEEKIIKI
>fig|195.2024.peg.1424 FIG00472317: hypothetical protein
MSSSQIQSDILNLNAQKNVSIKGSELNGGEIDIKADKVDFIAA
>fig|195.2024.peg.442 hypothetical protein
MDGVIDNSGVCLPFLAHILGRDMNQGEFVFEGDNNRIYCFVQKYWTRNINSSYYFGDENY
LIRAVLNSNHLKIQASMNNNTIFISYHSMQDMGAPVQNKIELYKCYQELGYDATLYLVKD
ENDIDGRFIKSLEHGLRMTDKALFRKELPLMLEKLQGRKFDMSKNSITYPCKDKQFIFKD
KDDKFELEIV
>fig|195.2024.peg.1603 putative cytochrome C-type haem-binding periplasmic protein
MKIFISFFVLATCLWAKEIAYTDEVVSLYLNKDDTKVTGRLLPTNAFEILKSDKDRVLIK
VDGYVNPKAPSVIYFNDSQRIIVAAFSKNTKLNFSQTSAGKNGKWDKVSLEIWADKKDFA
KDNKEMLSRAKNLFAENCGICHALHPEKEFTANAWPAVFRSMADRTGIDKKDRWLVIQYL
QKNAKDFKAK
>fig|195.2024.peg.1290 Transcription termination protein NusB
MATRHQVRQSVISLLYALEMNEKNENFIDEFLNEKKIRNEQKNFTLSLYEGIIKNLDDID
KNLNPYLNENEIEKLGHIERAILRLGAYELLFTDTPNAIVINEAIELAKELANDNSPKFI
NGVLDTLVKAKQ
>fig|195.2024.peg.288 Ubiquinol-cytochrome C reductase, cytochrome B subunit (EC 1.10.2.2)
MAHIRKANGLVDWLDQRLAVHKLLDVLMVKYWIPKQINFLWAMGVILTTLFTVLFITGLL
LVMYYKPDTTLAFDSVNKTIMQEVEYGWLWRHMHGVAASVIFLIIYIHMLTGIYYGSYKR
GREMIWVSGMLLFVVFSAEAFSGYMLPWGQMSYWAAQVITNLFGGIPLIGPELVIWIRGD
YAVSDPTLTRFFMLHVCLLPIVIIVIIAFHFYSLRIPHVNNEIAEELDFDLEAEKYMAGD
TKGSKVIPFWPGFLSKDFMYICLFMIFFFYLVSFKFGFAMDPINFDPANALKTPAHIYPE
WYFLWSYEVLRGFFFDIAGIKAFDIGLAAFGIAQIIFFLLPWLDRSNVVKPAHERPLFFI
WFWVLLIDLIVLTIYGKLPPTGVNAWVGFYASIIFLLLFIVVLPVITIMERKGAKQ
>fig|195.2024.peg.224 Cell division-associated, ATP-dependent zinc metalloprotease FtsH
MNNNNNAPNNKGNPQGNNFFNKNPIFIFAIFAIVMIIVFKGFFDGNGSLGGALNGTEVSK
NVPYSELKKLIESGQINQVSIGQTTIKAVSSAQNTVYTTKKVNDPEFVSLLDSKNIAYGA
YSETNWFTDILFSWVLPIFIFFGIWMFLASRMQKNMGSSILGIGSSKKLVNSEKPKVKFN
DVAGVEEAKEEVKEIVDFLKYPERYIKLGAKIPKGLLLVGPPGTGKTLLAKAVAGEADVP
FFSVSGSSFIEMFVGVGASRVRDLFENAKKEAPAIVFIDEIDAIGKSRAASGMMGGNDER
EQTLNQLLAEMDGFGTESSPVIVLAATNRPEVLDAALLRPGRFDRQVLVDKPDFKGRCDI
LKVHMKDVKISPKVKVEDIARLTAGLAGADLANIINEAALLAGRDSKKYVEQNDLVEAVE
RTIAGLEKKSRRINDKEKKIITYHECGHALIAETTKGAKRVSKVSVIPRGLAALGYTLNT
PEENKFLMQKHELIAEVDVLLGGRAAEEVFIGEISTGASNDLERATDIIKAMISMYGMSE
IAGLMVLEKQRNTFLTGGQTIKDYSEKMAESLDDYVKKTLDERYKDVKDTLNTYKGAIET
MVTALYEEETIEGAKVRDIIKSYENENNLPTRLQEINEEHKEESKQAE
>fig|195.2024.peg.646 hypothetical protein
MITNLPASVWMKQDLSEYQIFDVRTPAEWEEGVLPHAECVALYDNHGLLNANFLEEFQAR
RNENKKLAFICRGGYRSMMAANFIKNELGLESVNLDGGMLALKGLI
>fig|195.2024.peg.863 Pyruvate-flavodoxin oxidoreductase
MGKIMKTMDGNEAAAYAAYAFTEVAGIYPITPSSPMADYTDMWAAAGKKNLFGVPVKIVE
MQSEAGAAGTVHGSLQTGALTTTYTASQGLLLKIPNMYKIAGQLLPCVIHVAARSLAAQA
LSIFGDHQDIYAARQIGFAMLCSHSVQETMDLAGVAHLCAIKGRVPFLHFFDGFRTSHEI
QKVEVMDYEHFDRLLDRKALLEFRNSALNPENPKTRGTAQNDDIYFQTREVSNRFYDALP
DVVNEYMQEISKITGREYKPFTYYGHKEPERIVIAMGSVTQTLEEVVDHLNSKGEKVGIV
KVYLYRPFSLKYFFDVMPKSVKKIAVLDRTKEPGSLGEPLYLDIKSAFYGKENAPIIVGG
RYGLSSKDVDPAQMIAVFENLKLDNPKDGFTVGIIDDVTHTSLQTGEKISLGDESAIECL
FYGLGADGTVGANKNSIKIIGDKTDFYAQAYFAYDSKKSGGYTRSHLRFSKKPIRSTYLV
STPHFIACSVAAYLEIYDVLAGIRKGGTFLLNSIWNAEETIRQLPDAVKKTLAEKEVNFY
IINATKLARDIGLGNRTNTIMQSAFFKLAKIIPYEDAQKYMKELAYKSYSKKGDAIVEMN
YKAIDVGADGLVKVEVDPSWKNLEIKEKEQINAYKGTEFVEKIVKPMNAAKGDELPVSTF
LGYEDGSFEHGTTEYEKRGVGVMVPRWIEANCIQCNQCASVCPHAVIRPFLINDEEMAKA
PRGVKDHALEAKGTKGEKLSFKIQVSPLDCTGCELCVHECPTKEKSLVMVPLQEEMDFGE
QENADYLFKEITYKDDILNKESTKGAQFAQPLFEFHGACPGCGETPYITLITRLFGERMI
IANATGCSSIYGGSAPSTPYRKSVKNGHGPAWGNSLFEDNAEFGLGMKIATENTRYRIEN
IMNENMQKVPNALAALFKEWIANKDKGAESVEIKDKMIPILEQNTDIKAVQDILNLKHFL
SKKSHWIFGGDGWAYDIGYGGLDHVLASGENVNILVLDTEVYSNTGGQSSKSSRTGAVAQ
FAAAGKPIQKKDLGQIAMTYGYIFVAQVNSTANYSHLIKAIMAAEAYDGPSLIICYSPCI
AHGIKGGLGYSGEQGELATKCGYWPLYTFDPRLEEQGKNPLTMVGKEPDWDLYESFLMNE
VRYNSLKKSNPEHAKELFERNKKDAQRRYRQLKRIAMADFSDEVES
>fig|195.2024.peg.591 Quinone-reactive Ni/Fe hydrogenase, cytochrome b subunit
MQNKEEKLQRKAEYEFSIGLRLTHWVRAFAIVVLVITGYYLSYVFQNPISNGEPVNFMQA
KYRMVHQAVGFVLIACVIFKVYLFFFDRISRKERISIVDVLNPKLWIEQIKFYLFLGKHP
HLKGVYNPLQFVTYIFFYIVMVGIILTGLILYTHTYHEGLGGLLYEVLRPLEAALGGLAD
VRTYHRILMWVILIFVPVHIYMAFFNAIKGKDGAIDAIVSGYKFVKEEKN
>fig|195.2024.peg.737 Type II secretion envelope pseudopilin protein (PulG,guides folded protein to PulD in outer membrane)
MKRAFTILELVFVIVILGILAAIALPKFSSSRDEAEVSKSLNNLKTLINDISIYALKNSH
LNTMNFMSNVSGVENVDLNNFIGIKEVNFKVGEDKECIKLIFIDRNDFVLMGISSNEASK
NAIINIANNPKQEFQNLDFTSNSKNKACVALSKNENFKNLASKTYLLIGGM
>fig|195.2024.peg.787 Ferrous iron transporter-associated protein FeoA
MTLNELKDGQKAIIVNLNAHKELKNRLLSFGFIKNKNLKKIHSSLKNATIMVELDTSCVI
LRSDEAKTIEVNLI
>fig|195.2024.peg.497 Glutamine synthetase type I (EC 6.3.1.2)
MGKFVNNVNEFFDFCKQNEVLFVDFRFTDMIGTWHHITYNLHAISEETFEAGIPFDGSSI
HGWQPIEKSDMILKPDAQSAFLDPFTADPTIIVFCDVYDIYKGQMYEKCPRSIAKKAMEH
LKNSGIADTAYFGPENEFFVFDSVKIVDTTHCSKYEVDTEEGEWNDDKDFADSYNTGHRP
RNKGGYFPVQPIDSLVDIRSEMVQTLEKVGLKTFVHHHEVAQGQAEIGVNFGTLVEAADN
VQIYKYIVKMVAHLNGKTATFMPKPLYGDNGNGMHVHMSLWKDGVNLFYDKEGYGGLSQT
AINYIGGVLKNARSVAAFTNPSSNSYKRIVPGFEAPCILTYSCQNRSASCRVPYGIGKNS
ARVEIRFPDSTANPYLAFVSLLMAGLDGIKNKTIPVGPMDENLFDLTLDEIREKGIEQLP
HTLRGSLEALIRYNAFLKPVMSDIFIDDYQHLKFETQVWPVEARPTAYEFKTCYSC
>fig|195.2024.peg.1027 Putative periplasmic protein
MARKKGKIYLYLLVLVLIGVLAFFISKTNAFETTPPKILMPDIIYSDLKKPISVHVKDDE
GSIESVQIFLQKEGNETGMLIADEKIQNSNDITLQVALPKLAYKEKVKSFIMEIKAKDKS
FWNFFGGNEASKQVLIMIDDSAPKVNVLSNSYQIEQGGAASVVFSASDANLDKVYIETNT
GKIFQATPYLKEGYYAALIAWDARDEEFRAYIIATDKAGNITKERIRYYFVNRKYRVSNI
NLTDRFLDGKIEDLAQEYAPKDNNFTRFEKFKFVNETLRGNNEILIHKITSEVPESKIDD
FKIDLFLPLRNGMKVADFADHRYYSYNGQFVSDSYHMGIDLASVAEAPIISNNSGKVVFA
EENGIYGLNLIVYHGFGVYSLYGHCSSKSVELDDILSKKSVIGRTGVSGLALGDHLHFGV
LVQGVETRPEQWQDKKWIENNIYNVLNEGKKIILGKN
>fig|195.2024.peg.1128 Chromosomal replication initiator protein DnaA
MNPNQILENLKKELTENEYENYIAILKFNEKQSKADFLVFSAPNELLAKFIQTKYGKKIS
HFYEVQSGNKASVLIQAQSQKHSSKSTKIDIAHIKAQSTILNPSFTFESFVVGDSNKYAY
GACKAISQKDKLGKLYNPIFIYGPTGLGKTHLLQAVGNASLEMGKKVIYATSENFINDFT
SNLKNGSLDKFHEKYRNCDVLLIDDVQFLGKTDKIQEEFFFIFNEIKNNDGQIIMTSDNP
PNMLKGITERLKSRFAHGIIADITPPQLDTKIAIIRKKCEFNDINLSNDIINYIATSLGD
NIREIEGIIISLNAYANILGQEITLELAKSVMKDHIKEKKENISIEDILSLICKEFNIKP
SDVKSSKKTQNVVTARRIAIYLARELTSLTFSQLANFFVMKDHTAISHSVKKIKELMEDD
EQIKTKIEELKNKILTKSQS
>fig|195.2024.peg.188 ATP/GTP-binding protein
MIDWDKTYAAIYRSRKDYLKPIIDLDNISLNDLLGMEEQKNVLYQNTLNFIHNKGANHAL
LWGAKGTGKSSLIKAIFNEFKDKGLRLVELAKDDLFALVDIIDELREQPFKFILFCDDFS
FEKNDDSYKFLKPLLEGSIEAPPQNIIIYASSNRRHLLSESMSDNQGVQVAHTELHASDA
AEERLSLSDRFGLWLSFYQGNLNEYLKLVDFYFKDIKCDKELLHKKAKEFANLRASRSGR
TAKQFYLAFKESIE
>fig|195.2024.peg.907 Molybdopterin molybdenumtransferase (EC 2.10.1.1)
MLMSYEESLKILHSHIKPFARVEKIALTECLGRILAQDIKASKNQPEFPTSAMDGYAIKF
EDQDKPLKILGLTPAGTMPEFKVENNTCVKTFTGSLMSEGSDTLVPVENVRVEKDTLFIE
KKVSKGFAVREIGENYKKDEILLKKGTKLSYSEIALLAELGFFHISVFIKPIVGVLSSGS
EIKDLGEALENPAQIRSSNHIAIANLAKNLNCDTRVFPLLKDDEKATFSTLESALQSCDI
LITTGGVSMGDFDFLKKAVKEYEIIIDKADIKPGRHIKIAKANEKFIIALPGFPYSAMVM
FNLYAREILNSWLLQPKDYICKAFLQGSYKKKTPYLEFVACNVEFKNGRILANLEGKKEG
SSAIINNLNNKAALMVVPKECEMLENESLVDIIFMP
>fig|195.2024.peg.1607 4-hydroxy-tetrahydrodipicolinate reductase (EC 1.17.1.8)
MINIGIYGAKGRMGKQIEECLKSETKAKAAALFDKGDNLEEFFEKSDVIIDFSSPNGTHE
LLNYARTMPKPLVIGTTGLDEKTLHLMQNASEVMPVFYATNMSLGVAVLNHLASKASQML
RNFDIEILEMHHRHKKDAPSGTAMTLAQGVAKARNLDLEKVRISGRDGIIGERSKDEIAV
MSLRGGDIVGRHTVGFYEEGEFLELNHTATSRATFAKGAIKIAIWLNAQKPKMYSINDFL
GI
>fig|195.2024.peg.977 Ferric siderophore transport system, biopolymer transport protein ExbD
MIKTEMAHKEEELSEINITPFIDIMLVLLIVFMAVTPLITSSIKIELPKSSQQAEDKLKN
PIILYLNTDNTLAINDDKLSLENLSSALDIKTKGNKEEIIYFHIDKSVKYEDIMQVMQKL
KENGYGKIALSSKKVD
>fig|195.2024.peg.79 hypothetical protein
MKKSIALTLGAIFFFSACSNSLDKTTVAKYEERLNTQINETLKDFQQDMGVRIEISNFSC
KGDGMFLRCSSPNFNVFAKDNTQTEQKLIEAKNLEIYSNEIYTGEEQGLISLKDYYDNLL
NKNKNLKTSFTLEGFKLGEKVISDINASLSQSDPKIQDYLAKLSSGVFTLSFENSLFVKN
SDYNNNFNMKINNQDLNFDMNLNFDYKQSLLDFFEKAGIKYNTQTYAIDEKAVEELLDQQ
GFAQPIQESVILNNFKINSSLDTQGVFENYITIAKGGLEALKIQSQNEEQTLLIDKALLA
LNEITKDEVYKLDLEAKFKPIALSDYPKEGINAVEKLTVNNQDFTETLRILFGFMMIPIM
LGGATGF
>fig|195.2024.peg.1566 Ferredoxin-type protein NapG (periplasmic nitrate reductase)
MKDRREFFASAFKGLCLCTAGGFLANLSLKADDDYALRPPGAEDEARFLSKCIRCGLCVK
ACPYNTLKLATLLDSAKNGTPFFKAREIPCYLCKDIPCIKECPTDALDKKHLEQGIESLK
MGIAIVDSASCVAHWGIQCDACYRACPLIDRALKLELKRNERTAKHAFLLPSVDHEVCVG
CGLCELACITEKPAIRVLPREYVLGKAGSHYVKGWDQEDEDRIKDADTSKYFDAKKATNY
LNEGEF
>fig|195.2024.peg.693 LSU ribosomal protein L33p @ LSU ribosomal protein L33p, zinc-independent
MRIKVGLKCEECGDINYSTYKNGKNTTEKLELKKYCPRLKKHTLHKEVKLKS
>fig|195.2024.peg.72 tRNA ho5U(34) carboxymethyltransferase
MQENPLEKQFLNHPLFSKIQNLKEVELDSKLYLEDSVTLKTNSQAKKEILELTKELKPWR
KGPFKIDELFIDTEWQSFIKFNILKPFMSEISQKCVADIGCNNGYYMFKMLEFNPKKLIG
FDPSIKYRLQFELINTLAKTPIKYELLGVEDLPKYGLKFDVIFCLGVIYHRSNPIKMLKD
LKAGLNKNGTVFLDTMYIEDPREIALVPNKTYSKIPNIYFVPSISALKNWCERAGFKDFE
VLATKTTDENEQRKTEWIDSFSLENFLDPNDKNLTIEGYEAPKRVYVRIKV
>fig|195.2024.peg.517 Phosphoglutamine cytidylyltransferase (EC 2.7.7.-) in O-methyl phosphoramidate capsule modification
MKAIILAAGFGSRLMPLTKNQPKCMVEYKNKKIIDYEIQALKENNIDEICVVGGYLFDVL
RTYINQSYDLVTFYKNENYDKTNMVQTLFCARDFLQKCIEDKQDLIISYADIVYFKNSIE
KLKEAKEDFAVIVDKDWKELWEKRFENPLDDAETLKLKDGFIVELGKKAKTYDEIQGQYT
GLFKFSYLFLKEVIKTYDSLDKNLTYDGKDFKNMYMTSFLQILIDKYKNAKAVEIKGNWC
EIDFMSDLEINPIKNQ
>fig|195.2024.peg.964 hypothetical protein
MENKSIAIFIDAENIPAKYAKSIFDIASDYGEIIIKRIYGDWTQKNIQAWKEQIAEYSLI
AMQQFNFAANKNSSDMYLITEIMSIFYEKDIDIFVIVSSDSDYTSLIQKLRENKKQVIGM
GLEKSIKSYVNAFSEFFYLDQDENKKEDILSKDYLRALINITEQLIDEKGRAEYAQIRTN
MNRKYSDFNPQNYGFKNFRALIQKFLPKMKKFEEEREKNIYFLVKKDYENYY
>fig|195.2024.peg.1086 LSU ribosomal protein L6p (L9e)
MSRIGKQPIAIPSGVEVKLEGNLLKFKKGNLAKELDTKANVNVEIKDNNILFSPKGEDRQ
SRAYWGTYRALAYNIVVGLTQGFSKTLEINGVGYKAALKGKVLELSLGFSHPINYDIPEG
IEITVDKNNVIIKGSDKQVVGQVAAQIREFRPPEPYKGKGVKYSDERIIRKAGKTSKK
>fig|195.2024.peg.310 Aliphatic amidase AmiE (EC 3.5.1.4)
MQKLLKVALIQFAPKSYEVQNNLDKALKLAHLALEQGARLIVLPELYDSAYCVEDQDEKF
SLNLHQAHPNLDALQKLAKNYQAYIVACSIEKDTQLYDSAYIISHKGLLGVYRKIYLWGN
EKERFARGDKYPIFELEFENFKLKLGLQICYEIGFSEGSRFLALQGAEIICFPSAFGKAR
TYVWNLASRSRALENGVFVLAANRSGSEISKINNETLTFAGKSKIINPKGEIIKEILEEE
GFIIAELDLEEVQIQRKNLPYLKDLNLKLNQEILTNIHLNTKE
>fig|195.2024.peg.311 Putative polysaccharide deacetylase
MAKEILVAYGVDIDAVAGWLGSYGGEDSPDDISRGLFAGEVGIPRLLKLFKKYNIPATWF
APGHSIETFPEQMKMIVDAGHEIGAHGYSHENPIAMSAKQEEDVLLKSIELIEKISGKKP
SGYVAPWWEFSNITNELLLKHGIKYDHSLMHNDFTPYYVRVGDKWTKIDYSKDAKEWMKP
LVRGQETDLIEIPANWYLDDLPPMMFIKKSPNSFGFVSPRDIGQMWIDQFDWVYREMDYA
IFPMTIHPDVSARPQVLLMHERIIEHINKHEGVKWVNLNDMADDFSKRFPRKK
>fig|195.2024.peg.673 SSU ribosomal protein S7p (S5e)
MRRRKAPVREVLPDPIYGNKVITKFINSLMYDGKKSTATTIMYGALELIDKKGGEKKGID
IFNDAIENIKPLLEVKSRRVGGATYQVPVEVRPARQQALAIRWIISFARKRSERTMIDKL
AAELLDAANSKGASFKKKEDTYKMAEANKAFAHYRW
>fig|195.2024.peg.867 LSU ribosomal protein L13p (L13Ae)
MTKITKPNEVKREWIVLDAEGKRFGRLLTEVATILRGKNKPCFTPNVDCGDYVIIINASK
AVFTGANKAEDKLYHRHSGYFGSVKSEKFGDLLEKNPAKLYKLAVRGMLPKTNLGRAMLK
KLKIYAGSEHPHTAQIAKEGK
>fig|195.2024.peg.1498 Phosphatidylserine decarboxylase (EC 4.1.1.65)
MSFSNESSRIFGLIAGVEFPSFIQKIINEKYVNYFKIDMSEFKAPCEYESLNALFTRSLQ
IPREINEGFISPSDGKILECGSAFLADNALFAFSIKGHTYSIEELLKDSFKKEELENGLD
YVNIYLSPRDYHRYHSPCNMQILSATYTSGALYSVNEKHLERISNLYVKNERVSLKCQNE
KGIFWLVFVGAQNVGKMRFKFDTSIQTNAKFSHNFTRKYENLELKKGEELGNFELGSTIV
LIAQKGLLDIKLKAGQNVKFGEKIAD
>fig|195.2024.peg.302 S-ribosylhomocysteine lyase (EC 4.4.1.21) @ Autoinducer-2 production protein LuxS
MPLLDSFKVDHTKMPAPAVRLAKTMKTPKGDDISVFDLRFCIPNKDIMSEKGTHTLEHLF
AGFMRDHLNSDLVEIIDISPMGCRTGFYMSLIGIPDEKSVAKAWEAAMKDILNVSDQSQI
PELNIYQCGTCAMHSLDEAKEIAQKVLNSTIGVMNNEELKLENI
>fig|195.2024.peg.618 hypothetical protein
MKQWLSDFKLALIQEDVNKLENLLDELDMKAFIKNLAKESPSEDFLKENANDVFYQVQAL
LQEAVILIEQKKKTKAVEIQKFQKALTYFKS
>fig|195.2024.peg.841 tRNA(Ile)-lysidine synthetase (EC 6.3.4.19)
MQIKDEILSFLKKGQNLLAFSYGSDSSALFHFLVQKKINFDLVMINYKTRKNSDLEEQKA
KELALEFHKKIFIKIAPVIKGNFEKEARDFRYDFFEKICLEQNYSNLILAHHLNDQLEWF
LMQLSRGAGLAEILGMQECEKRSNYTLLRPLLFMSKDEILSYLKENDIFYFQDESNENEK
YFRNYIRKNFSNAFVSKFHQGLKRSFFYLDEDRKKLYDLESIKEIQGLMICPKNESLIAK
AVKMKGLLLSAAQRKEFLKGDCVLGGKIGIVYKDEKAIVFKYETCQKLPKEFKEACRIAK
IPRLLRAYLYNHKIDISSLNF
>fig|195.2024.peg.1638 Predicted signal transduction protein
MATDMNEILLRSVEVLPPLPDTINKLRKYINESGSNVKIDEIANIISSDPLMTAKLLRLA
NSPFYGFSREITSLAQVVSLLGIGNIVNTIMADSIRDSFKIDVSPYGLSTTEFVNKCSEE
TSFIMDWLGNEDKKLSHLLVPCSMLLRLGIVVFSNFLIQNKKDAEFLARLEKNNFSDLSM
VENEFLGVDHISFLGFLLYRWKFDDMLVETICFARSPHAARNEVKKSAYALSVVDHLFTP
HNNFSSFNIKASIALINEARSQGIDFNLDNFISKLPKEAKENLIKEG
>fig|195.2024.peg.660 Putative aminotransferase
MNFINLQAQYLKYKEEIDSEIASVLSSSSFIGGAKLNEFETNLAQYTHVQHAIGCSSGTS
ALYLALRALDIKQGDEVIVPSFTFIATAEMVALLGAKPVFVDINLDNFNIDFELLKNAIS
PKTKAIIAVSMFGQMSNLQELNTFCESKNISLIEDGAQSFGASFKSEKSCSIAKISCTSF
FPSKPLGAYGDGGAIFCNDESIAKKLRILLNHGQTDRYKHEFIGINARLDTLQAAILNVK
LKHLDEEINKRQEIAKFYNENLTNCQIPKIDENAISAYAQYSVLVEDRARVLKAFEKANI
PYAIHYPTPLHKQPCFSEFSHLKLEKSEFASKHILSLPFSAFLSQSEQESVIKVFKEGL
>fig|195.2024.peg.1350 NADH-ubiquinone oxidoreductase chain C (EC 1.6.5.3)
MRKYSDKKNAQLQNYYKDRFYHAPHTQKLDVNESAFKQDYEVLKTEVDIINSFIELDFWV
IEIKKEDNVKTLQMLHTLGYLNFTEASAIDFVADKNGFEVFYQLLNLEKRLRVRVRTFVG
VKERLQSVAHVFKGANWSEREIYDMFGIFIINHPNLKRILMPDDWYGHPLLKTYPLQGDE
FAQWYEIDKIFGKEYREVVGVEQRDPGFADDKDTLNFARLYHEVPKGGSRKEVSFKQEYQ
EDGGVAFVKKVKRDEAKILEKRR
>fig|195.2024.peg.510 Cytidine diphosphoramidate kinase Cj1415
MQFITKGGVIWLTGLAGSGKSCIAEALYQKLKEKYDNIIYLDGDEFRELLGYYKYDKQSR
IEVSIKRSKFAHFLSSQNMLVIVSAISMWDEIYRYNRKTLKNYYEIYIKCDIEELKKRDK
KRLYSKALSGKISNVVGIDINYDEPNADLILDNSKLDLLDEKVDRILQALNT
>fig|195.2024.peg.1230 Demethylmenaquinone methyltransferase (EC 2.1.1.163)
MQKQDKIIKMFNEIAPTYDKANRILSFGVDVSWRKFACKRVLKLYQKDNLNIVDVACGTG
DMIEIWQESAKKLNKNIAHIKGIDPSEGMLNIAKQKFPNIEFIEAGAQELPLQSESVDIV
SISYGIRNVVEREKALREFSRVLKQDGIFVVLEFTKREKGGFVASCRDFYLKNILPSLGG
MISKNKSAYEYLPNSIEGFLSKEEFIAELKQVGFEMLEFKSFSFGVSSMFIAKKV
>fig|195.2024.peg.670 tRNA(1)(Val) (adenine(37)-N(6))-methyltransferase (EC 2.1.1.223)
MQDSIKLAQLSDGYRYNSDSLLLADFVLEMGIKNQVLEVGSGCGIIGILLKKFVSNLDLS
LLDIQQENIELIHRNLKQNNIQAGVLHEDFRNFQNDKKFDFIVCNPPFYRDGAHEGKNTH
KNISKFQKYLTLNEFIVRSNALLKPMGVLYFCYEALALDKICLVLESKKLKLTKIRFVHT
HQNISARLVLVQARKSVKSPCEILPPFFIYKNENLSEQMQEIHSRFRLESYDI
>fig|195.2024.peg.1094 LSU ribosomal protein L16p (L10e)
MLMPKRTKYRKMMKGRNRGYANRGTEFTFGEFALKATEAGRINSRQIEAARIALTRFVKR
QGKTWIRVFPDKPLTKKPLETRMGKGKGAVEEWVMNIKPGRIIYEMAGVSEEMAREALTL
AMHKLPFKTKFVTRESQNEIY
>fig|195.2024.peg.1547 Holliday junction ATP-dependent DNA helicase RuvA (EC 3.6.4.12)
MVVAIEGIITKKEPTFAIIKCASGLSYGVFISLFCAAKLETHQKYELFITQIIKEDSNKF
YGFLDKDEQKMFEMLLKVNGVGASTAMAICSSLDVNSFYKALNLGDESVLKKVPGIGPKS
AKRIIVELGDAKVQLESVSDDKSEALAALLSLGFKQDKILSVLSTCNGKDTSELIKEALK
KLA
>fig|195.2024.peg.247 Aminotransferase
MINFLDLRKINTRFENEIKDKINEVINSGWYILGEQNKIFEENFSAYCGVKGCVGVANGL
DALRLIIKAYGFSNEDEIIVPANTYIASVLAITDNGCKPIFVEPDINTYNINPDLIEEKI
TSKTKAIMVVHLYGLATDMSKIQKIAKKYNLKIIEDCAQAHGAVYDKKRVGNLGDAAAFS
FYPGKNLGALGDGGCVVSNDEKLILKIRALANYGSHKKYENLYTGLNSRLDEIQAGILDI
KLKYLDEDNRKRRKIAKYYLENIKHKDIILPFYEEEENHVWHLFVIRTKNRNDLQEYLMK
NGVQTLIHYPIPPHKQECYKEYNHLNFPITEQIHVEVLSLPISPVMTQDEISETAKIINS
WKKL
>fig|195.2024.peg.398 Adenosine (5')-pentaphospho-(5'')-adenosine pyrophosphohydrolase
MEKEKKYRPNVAAIVLSSAYPFECKLFIAKRSDMDNIWQFPQGGIDEGEDPKSAVLRELK
EEIGTDEVEIIAEHPEWLSYDFPEKVAKKMYPYDGQSQKYFLVRLKHGAKININTKHPEF
DAYQFVGVKQVFEIINHFKRNIYVKVIKYFEEKGYI
>fig|195.2024.peg.1228 Peroxide stress regulator; Ferric uptake regulation protein; Fe2+/Zn2+ uptake regulation proteins
MELLQILKKHELKATPQRLCVLKILKRHEHPNIEELYEEIKKEYPSISLATVYKNLNTLQ
EQGLVVEINVANQKTCYDIYEERHIHIICNKCGNIEDMSFQDAELDEYQEKLEKKMGNII
DHLAVCAHVSTCKKCH
>fig|195.2024.peg.781 YheO-like PAS domain
MDEKQKEQFIKLTNFLGQVLGKQYEVVFHVLSKEGAYIAAIANSHVSGRTLESPLSAFAS
ELVQNKAYLKEDFLCDYKALIGKSKLVRGSTFFIKNSDELVGILCINHDTSMMRDLVCRI
IDIEKLGDMSEFLNQDKENNTSVDSLGNIETLSHSIEEILAQSIDMNYLNSDYQLSMAQK
EEITKTLYQKGIFNIKGSVPIVARLLKISEPSVYRYLKNFKS
>fig|195.2024.peg.1311 hypothetical protein
MISPMDLSLIKIISDHYYIRRDKIMKKITHRGRLFFDKFERIDAPLNLNIMREHAAKKIV
VAHDLITKDNKVENIVFDYNGFNAERFYHRAQLILREEGFINFTAYKTKTPGHLHLYIHK
GHTALNEGYSLASKLSMMFASKMPVEWKVFPSMDIPREFNILILPYEVYQKERGSSWSKH
M
>fig|195.2024.peg.685 DNA-directed RNA polymerase beta' subunit (EC 2.7.7.6)
MSKFKVIEIKEDARPRDFEAFQLRLASPEKIKSWSYGEVKKPETINYRTLKPERDGLFCA
KIFGPIRDYECLCGKYKKMRFKGVKCEKCGVEVANSKVRRSRMGHIELVTPVAHIWYVNS
LPSRIGTLLGVKMKDLERVLYYEAYIVENAGDAYYDNESTKKVEYCDVLNEEQYQNLMQR
YENSGFKARMGGEVVRDLLANLDLVALLNQLKEEMAATNSEAKKKTIIKRLKVVENFLNS
NLNANTNNEDAVPNRPEWMMITNLPVLPPDLRPLVALDGGKFAVSDVNDLYRRVINRNTR
LKKLMELDAPEIIIRNEKRMLQEAVDALFDNGRRANAVKGANKRPLKSLSEIIKGKQGRF
RQNLLGKRVDFSGRSVIVVGPKLRMDQCGLPKKMALELFKPHLLAKLEEKGYATTVKQAK
KMIENKTNEVWECLEEVVKGHPVMLNRAPTLHKLSIQAFHPVLVEGKAIQLHPLVCAAFN
ADFDGDQMAVHVPLSQEAIAECKVLMLSSMNILLPASGKSVTVPSQDMVLGIYYLSLEKM
GAKGSHKICTGIDEVMMALESKCLDIHASIQTMVDGRKITTTAGRLIIKSILPDFVTENM
WNKVLKKKDIAALVDHVYKQGGLQTTASFLDKLKNLGFEYATKAGISISIADIIVPNDKQ
KAIDEAKKQVREIQNSYNLGLITSGERYNKIIDIWKTTNNTLSRDMMKLVEKDKEGFNSI
YMMADSGARGSAAQISQLAAMRGLMTKPDGSIIETPIISNFREGLNVLEYFISTHGARKG
LADTALKTANAGYLTRKLIDVAQNVKITVEDCGTHEGVEINEITADSSIIETLEERILGR
VIAEDVIDPITNSVLFTEGTLIDEEKARILGESGVKSVNIRTPITCKAKKGICAKCYGIN
LGEGKLVKPGEAVGIISAQSIGEPGTQLTLRTFHSGGTASTDLQDRQVSAQKEGFIRFYN
LKTYKNKEGKDIVANRRNAAILLVEPKIKAPFKGIINIENIHEDVIVSIKDKKQEAKYIL
RKYDLAKPNELAGVSGSIDGKLYLPYQSGAEVEENESIVEMIKEGWNVPNRIPFASEILV
KDGDPVVQNIKAGEKGILKFYILKGDGLDRVRNIKKGDIVKEKGFFVVVADENDREAKRH
YIPRESRIEFNDSEEVNFDSIIASAPKQEKSVIAEWDAYNNTIIAEIDGVVSFEDIEAGY
SADEQIDEATGKRSLVINEYLPSGVRPTLIIAGKGDKAVRYQLEPKTVIFVHDGDKISQA
DILAKTPKAAAKSKDITGGLPRVSELFEARKPKNAAVIAEIDGVVRFDKPLRSKERLIIQ
AEDGTSAEYLIDKSKHIQVREGEFIHAGEKLTDGVVSSHDVLKILGEKALHYYLISEIQQ
VYRGQGVVISDKHIEVIVSQMLRQVKIINSGHTKFIEGDLVSRRKFREENERILRLGGEP
AIAEPVLLGVTRAAIGSDSVISAASFQETTKVLTEASIAGKFDYLEDLKENVILGRMIPV
GTGLYGEQNLKLKEQE
>fig|195.2024.peg.1602 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MLDRRRFLKIGAALSTLPLIPTLGAGKSAEATKVSLGLVKNGEVITAAHWGILKLTIKDG
KIIKSEPWEKITKMDNPLQHYTADMVYKSRVKYPYVRKSYLENPDNPKPELRGKDEFVRV
SYDEAIKLIAKELKKTREARVQVLFLVEVMVGNQVVICKMLEYYYIDF
>fig|195.2024.peg.367 GMP synthase [glutamine-hydrolyzing], amidotransferase subunit (EC 6.3.5.2) / GMP synthase [glutamine-hydrolyzing], ATP pyrophosphatase subunit (EC 6.3.5.2)
MKKADILVLDFGSQYTQLIARRLREQGVYAEILPFNVSLADIKAKEPKGIILSGGPASVY
ATDAYFCDKEVFNLGLPILGICYGMQLMAHHYKANVAPAGHKEYGKASIKIQKDSDLFKN
LPKKQIVWMSHSDKVENLPQGFEVLATSENSPYCVFANEEKKFFALQFHPEVQHSEFGKS
ILKNFAKYACNCESIWNMGSFAKTQAEKIREEVGKDKVLCAVSGGVDSSVVAALLANAIK
DQVIVVFVDNGLLRSDEKEQVEFMFKNTLGINLISIDASKIFLDRLAGVTDPEQKRKIIG
NTFIEVFEEEAKKHKDVKFLAQGTLYTDIIESSVIGASKTIKSHHNVGGLPEKMNLKLIE
PLKEIFKDEVRALGIELGLSKEIVYRHPFPGPGLAIRIMGEVNRPSLELLRKADVILLEE
LRSTGWYDKTWQAFCVLLNVKSVGVMGDNRTYDNTICVRVVDASDGMTATFSHIPYEILE
NISRRIINEVEGINRVVYDISSKPPATIEWE
>fig|195.2024.peg.473 Integral membrane zinc-metalloprotease HP0382, M48 family
MTLIAILCLYTALLSWISYAQIRFLEREKDKQAQILSEKDYQNAADIAIENEKFKLFSNF
YMLIVNIAWIGFGFLYLKELLISENSRLENTLFLLAFLIITSILNLPLSIYESFVKDKAH
GFSNMTLKLFIKDTIKSLILTLIFGFLILYALLFCYDFFGTFWWLAAFIFAFCVIVIINV
IYPTLIAPIFNKMEKLEDENLLSKINDLMKQCGFNANGVYVIDASKRDKRLNAYFGGLFK
SKRVVLFDTLLKALSERELLAVLGHELGHFVHKDIIKALINGAITMFLLFFIFAHLPDFV
YQESHLEGVNGGVFALLFIFANIFSFIISPLINALSRKNEFAADQHGAKVTSKEDMKNAL
LALARENKAFIKTSKIYTFFYLSHPSISDRIKALS
>fig|195.2024.peg.1701 RNA-binding protein Jag
MRIEAKDLQSALTEASKSLECSVIDLEYEIIQYSKNGFLGFWRKNAIIEARAKKQPYSKK
NSRKDFNASKNDVHRNYEKPYRKFDDRSKIDNKKEFEVEAREVKPKEKYVVKSDGIFDSF
HKESGGTRNKEDILDEIRIQLENLLKATCFNISLVELRMYDEESVFIRLDGDDAALLIGK
EAHRYKAISYLLHNWINLKYNLLVRLEIAQFLENQIQGMQIYLQGVIEKVKINGRGQTKP
LDGVLIKIALEKLRAEFPNKYVGIKQNNDQRYVVINDFFKKDE
>fig|195.2024.peg.883 Carbamoyl-phosphate synthase small chain (EC 6.3.5.5)
MKAYIYIENDIFLTAKAFGKGGTFFGELVFNTSLTGYQEIISDPSYAGQFIIFSMPEIGI
VGTNENDNESKEIFASGVLMRELSPTFSNFRAQKSLQEYLEEHGKIGVYGLDTRYLVKML
RDSGNLRAVISTEISSKEELKAALEKSAKIDEINFVKEVSTKKSYAHKHGVWNNATQSYN
KAKKNTKKVAVIDYGVKANILNELVEVGLEVEVFPYNTKAEELIKLYQKGQIQGVFLSNG
PGEPKILKQEIAEIKKLAEAKIPMLGICLGHQLLSNAFGYETYKMKFGQHGANHPVINLE
NKSVEITAQNHNYNVPEELCEVAIITHRNLFGDNVEGVRYKDYPIISVQHHPESSSGPHE
SKYIFKEFMNLM
>fig|195.2024.peg.1382 Imidazole glycerol phosphate synthase amidotransferase subunit HisH
MKLIIIDTACANLASLKFCLDRLGFNAKISRDLKDLENADKLFLPGVGTAAKAMSNLESF
NLTNFIKNTKKPLLGICLGMQILGDFSEELDQETLGIIPFKTQKFELPKEYSLPHMGWNE
VASSHPLFKGLNGAYFYFVHSYHVALNDYTIATSDYGVKFSASLAKDNFYGVQFHPERSG
EAGEILISNFIKDIA
>fig|195.2024.peg.455 N,N'-diacetyllegionaminic acid synthase (EC 2.5.1.101)
MKKTLIIAEAGVNHNGDLNLAKKLIEIAADSGADFVKFQSFKAKNCISTKAKKAPYQLKT
TANDESQLQMVQKLELDLKAHKELILHAKKCNIAFLSTPFDLESVDLLNELGLKIFKIPS
GEITNLPYLKKIAKLNKKIILSTGMANLGEIEEALNALCKNGTKRQNITLLHCTTEYPAP
FDEVNLKAMQSLKDAFKLDVGYSDHTRGIHISLAAVALGACVIEKHFTLDKNMSGPDHKA
SLEPHELKTLCTQIRQIQKAMGDGIKKASKSERKNINIVRKSLVAKKDIQKGEIFNEENL
TTKRPANGISAMRYEEFLGKIATKNYKEDELICE
>fig|195.2024.peg.1606 Amidophosphoribosyltransferase (EC 2.4.2.14)
MCAVVGVINSKNASTYAYYALFAMQHRGQEASGISVSNGKTIKTIKAKGEVNQIFNPENL
KTLEGEIAIGHNRYSTAGNSSLNDAQPVAATSVLGDIALAHNGNLVNKEKVRSKLIEDGA
IFQTNMDTENVVHLIARSKKESLKDRFIESLQECIGAYCFVLASKDKLYVARDPYGVRPL
SLGCLKDGGYIVASETCAFDLIEAEFIRDVKPGEMIIFTQGNDKFESIELFKQEPRICAF
EYIYFARPDSIIEGKSVYEIRKKMGEALAKKFTHSADFVVPVPDSGVSAAIGFSQYLKIP
LEMAIVRNHYVGRTFIEPTQELRNLKVKLKLNPMHKVLKDKEIVVVDDSLVRGTTSKKII
SLLRAAGASKIHLAIACPEIKFPDTYGIDTPTFEELISANKNLEEVREYVEADSLSFLSI
EELTQSIGDERRYSLISFDGDYFIK
>fig|195.2024.peg.380 pyridoxal phosphate-dependent deaminase, putative
MLISPIEKIQFQGFEFYIKRDDLLGEINGNKARKLAFYLSQNYNQSQRFISYGGIQSNAL
VALSIFASKRNLTLIYACEKIPTYLRNNPCGNYKLALENNVYFIENHSDKDLKTFALSLC
EKDDVFIEQGVANLNAESGYIQLAKEIESQSKNLGLDFDIFLPSGTGTSAAFLAKNSKFK
VFTCACVGDECYLKTQILNLIKNYDFSNLEILKSDKKYHFSKLYLEFYQLYKDLKQECQI
EFDLLYDMLGLSIALKREWKNPLLYIHQGGISGNSSMLERYIFKYCKDK
>fig|195.2024.peg.405 Acetolactate synthase large subunit (EC 2.2.1.6)
MRKISGSAMICEALKEENVKIVFGYPGGAALNIYDEIYLQKYFKHILVRHEQAAVHAADA
YARMSGEVGVAVVTSGPGFTNTITGLATAYSDSIPLVLISGQVANSLIGTDAFQEIDAVG
ISRPCVKHNYLVTCIEEFPRILKEAFYIAKSGRKGPVHIDVPKDVSAALGIWDYPKEISM
KTYKPIYKGNSKQIKKLAENLEEAKRPLFYLGGGCIASNAANEIRELVKITQIPAVETLM
ALGTLRSDDELNLKMAGMHGSYTANMALSECDLLVAIGARFDDRITGKTSEFAKHSKIVH
IDIDPSSISKIINAHFPIVGDIKEVVKELLEELKKNQFKSNIHEWRQTLKRYDELYPLAY
EDSDEVLKPQWVIQECAKLAPDARIITDVGQHQMWVAQFYPFNYPRQLATSGGQGTMGYS
LPAALGAKLAVGEEVVINFVGDGSVLMNIQELMTAYENGIKTINIILNNSFLGMVRQWQS
MFYEEHFSATDLSLQADFIKIAEGFGCEGYNIKTKDEFRTAFKQALESNKTSLLNVFIDR
FEDVLPMVPAGGAIYNMILPKLKDKQ
>fig|195.2024.peg.601 Murein hydrolase activator EnvC
MRKILIFLCFFLLSNEMHANAISEKTKNLEENKRIQEQVNKKLEDLANDILSGEKSLKEL
SAQIETLNSQTLKLEARAKAQNKDLNLLTSQNTDLLKNKANMEGKLIALMAKDFAYDLSI
PQGYVESKESFMAFEVLGGLDKILQDEIFKLSKDYEDISKLIDDKQEQIKKINEDLKDYN
TQLAKLQNLRQKQVSEIKKQKTDRAIYAKKLENLQDQQDELRKTLNQLKIIESKQEDKKQ
SQKTASDSKIVNNTQKIRQIGSSYQGSSTKRYTGKKTIAPLESFTVKQKFGNYIDPVYNI
KIFNENVVLRSNKADAVVKSVLDGKIVFAKDTSMLARVVIVEHDNGIHTIYAHLDKIAPN
IKVGKNVKKGAVVGRIKNDLTFEVTQKNFHINPLELISLN
>fig|195.2024.peg.1633 Iron-sulfur cluster assembly scaffold protein IscU/NifU-like
MGKNSLIGGSIWDEYSQKVQDRMNNPQHMGEFSEEDAKARNAKLIVADFGAESCGDAVRL
FWLVDEKTDKIIDAKFKSFGCGTAIASSDTMVDLCIGKTVDEAVKITNLDVEFAMRDNPE
IPAVPPQKMHCSVMAYDVIKQAAAHYKGISPEDFEDQIIVCECARVSLGTIKEVIKLNDL
HTVEEITQYTKAGAFCKSCIKPGGHEKRDYYLVDILAETRAEIDREKLKNTMKSDVAFDE
MTVVGQLKAVESVLDAEIRPMLHNDGGDLEVIDIQKAEGAAIDVYIRYLGACSGCSSGSG
ATLYAIETILQEELSPNIRVMPV
>fig|195.2024.peg.930 UPF0317 protein YcsI
MNPKELREKIAKGEIKEQTSGMALGYAQANLVILPKEYAKDFQTFCMLNPKPCPLLEIVH
GKFTQKIAKNANIYTDIPKYFIYENGIKTKEAYDISEYYNDDLIGFLLGCSFSFEEALLE
KGLEIRHISNKCNVPMYKTNIACKSVGVFSGEMVVSMRPFTPDNAKKAKEITANFPLVHG
APVQIGNAKEIGINNILKADFGDDPIIKEGEIPVFWACGVTPQNVIMKAKLPFVITHAPG
HMFISDILNSSLKS
>fig|195.2024.peg.158 Uncharacterized amidohydrolase HP_1481
MSKIAALQFPTLALSESRLDYYLKASKDSGANLVVLGEYVLNSFFTELLHMPKNMIKEQS
EAKKESLIKLAKKYELEIIAPYVSVEAKSYKKLCLKVTPNGVKSYEQQVLMPYNHWNEEK
FFSNKINKGNLKLFTFNHDKLKCALLFGFEVHFDIFWQQIMAKKIDLVIVPSACTFESKQ
RWEELLKTRAFLNSTNILRVNRIGTTKDEWSFYGDSMLINAFGEIESRLGSEEEMLIVEP
KKADEARKIWAFDKIVKNF
>fig|195.2024.peg.453 GDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hexos-4-ulose aminotransferase [PLP]
MFEKEISFIKSLFNKENIALHEPCFIGNEKKYLLECIDSGFVSSVGEFVTRFEEALKEKT
KARFVIATNTGTAALHIALLANGIDENCEVITQSISFVATANAIAYTGAKPVFLDIDENT
LSLSPKALEHFLENQTYQKDNLSYNKTTHKPIKACVIMHTFGLSAHIKAIKELCEKYHIL
LIEDAAEALGSTYENKDLGTFGKCGILSFNGNKIITGGCGGAILSDDENLAKLARHLSTT
AKIPHPYEYDHDRIAYNYRLCNINAAILLAGLENLELFLENKRELAKIYKDFFKNHDKCK
FIDEKSNEKSNFWLNTLLFKDENLRNIFLEECLKNNIFVRPVWKSLPSLKAFQNCQSNEL
INTKKLEKRLINLPSSVRIANKKE
>fig|195.2024.peg.187 Endonuclease III (EC 4.2.99.18)
MNGADIFKKLLACNLDFKEFDWLENQGLSDFELLISVILTQNTKWDNVLKALNNLKNARI
SSLEQLSNLSNLELATLIKPSGFYNTKAKRLKELANKILDTYSNIENFKKNVDREWLLNT
KGLGFESVDSILNYLCKREILVVDSYTQRLATHLGYEFENYEELREFFESGIENEQENLC
QILEKKYELFELYQIFHAAIIAFGKVAFEGVKLTLEGENLIQNLKEE
>fig|195.2024.peg.7 SSU ribosomal protein S15p (S13e)
MALDSAKKAEIVAKFARKAGDTGSTEVQVALLSARIAELTEHLKIYKKDFSSRLGLLKLV
GQRKRLLAYLKRKDYNSYSKLITELNLRDK
>fig|195.2024.peg.210 ATP-dependent DNA helicase UvrD/PcrA/Rep, epsilon proteobacterial type 2
MNLFTGLNESQKEAASHIDGPMLILAGAGSGKTKTITTRLAYMIGEVGIPAINTLTLTFT
NKAASVMKNRALSLLNSNENPLLCTFHKFGLLFLKLHIERLGRKNNFIIIDNDDSKKILK
ELINDDKTSPHQILQFISHFKNESKSVQDVFNDLELLKDNEIKHQALQKIAIYYQNYQEY
LLKHNFVDFDDLLLLTNILLENDQNFAKEQSSFYRYITVDEYQDTNALQYKILKNLCCIH
ENICVVGDDDQSIYSWRGAKIENILNFQSEFSNVKLVKLEQNYRSVGMILKAANNLISHN
KKRLGKTLLCTKDEGEDVQILSSDNEKIESVLVAKKIKELLNSGIYAGEIAVLFRINALS
RSIEEAFMKEKIPYKLLSGMRFYERLEIKDLICYFRILINPNDDLSFKRIINRPKRSIGE
KALQNLEDYAQKRKISLFEALCESDGSVGIFSLKKAQNEAKKFIQNIYKLREYSDLKKMI
EKFEELFALKEFYALQEDGDERVLNIDEFYASIKEKIKEEPQTTLEDILSEISLLSDQDG
IEGECVYLMSVHASKGLEFDHVFIVGLEEGFFPLNESDIEEERRLAYVAITRAKKCLSLS
IAKSRFYRGSRTELDSSRFLEESQLTKKISINKTEQGYHKGDLVKHKIFGIGRVISVNKS
AKEEKLTINFGGIERIIMASFVEKAV
>fig|195.2024.peg.306 5,10-methylenetetrahydrofolate reductase (EC 1.5.1.20)
MCSFSFEIFPPRRDENIKNLNAILDDLGQLSPNFISVTFGAGGSINSKNTLETASLIQEE
YKIPSIVHLPCIHSGKEKIISILQECKERQLDKILALRGDVCNDLEKSKDFSYASDLISF
IRKQGEIEIYAACYPEKHNESRNFIEDIHHLKNKVDAGTDKLITQLFYDNEDFYTFKQNC
ALAGINIPIYAGIMPITNKRQVLKISQLCGAKIPPKFAKILEKYENNTLALEDAGIAYAI
DQIVDLITSGVDGIHLYTMNKSKAAIKIYEAVKYLLKEELHA
>fig|195.2024.peg.1521 hypothetical protein
MNMINSTLPIQMKVLAKSGYAHYTLLLNHRKIQTKSMIELEIGAEYLAELYIEKGGAIAF
KHLSKRPDFHPFEEGLSLMVEILEGRIDYKKYIISNLLECKDKNKYHILKEMLFASFENI
YHIPFIFKGKACLFQMKKRVKFLEIYLYFSVFGALKILIDEGGISIFTPFFKVQKFLNEH
LQFNVLQDKNIQPLFVFKKLFDFKG
>fig|195.2024.peg.1190 Zinc transporter ZupT
MLFMEFTLEQILVAMALTILAGLSTAIGSVIAFFSRNDNLRILSFGLGFSAGVMIYISFM
EILPSAFTDFKKYYNSNYGELLALLCFFGGIFLSAIIDKFIPEDVNPHDPKEDLSELKIC
PLPQKNEKAPAFHAGEPLKKINVKALKRTGIFTALAIAIHNFPEGFATFISSLDNLSFGV
AIAVAVAIHNIPEGMAVSLPIYHATKDKKKAFIYSALSGVAEPMGAIVGAFLILPIMNEL
TLAITFAVVAGIMVFISFDELLPAAKTYDKAHDSLYGLVLGMAVMAVSLILLNP
>fig|195.2024.peg.810 hydrolase, haloacid dehalogenase-like family
MINIENIKNIIFDFDGVILDSVELKTQAFAELFKEFPKNKVQELVKYHIQNGGISRYHKI
QYFFENILCEEISDKEILNYAKLYSQLTKEKLCNPKYIIKETFEFIKKNQTHYNMHIASG
ADEQDLIEICKMLDLTQYFLSIHGSPTKKEILVKNLLINNNYKNKETILIGDSVNDYEAA
LKNNIYFYGLFRLGREE
>fig|195.2024.peg.1399 Haemin uptake system periplasmic haemin-binding protein
MKKILIIMSLFLTLLNAKERIVVLDPASIETLFMLNAQDQIVGIANLQHSNIYPEEKTSK
ITSVGTFSHPSLEKIVALKPSLVILSSYSLNLEEGLKNFGIKSINLKAQRLDEIKSNIQI
LAKLTDKEEQGKKLLEEFEQGLQELQKNPLNKSGIYLYSSNPLMAFNDNSLIADILRLIG
IKNLSPQSEIARPIISAEYILKQNPDLLILGINADGNILNANALLKNTKAAQMGQIYHNE
NTHILLRLSPKIIDRIKEFKTRLENQNF
>fig|195.2024.peg.1644 hypothetical protein
MKNTLIIFENSLSNLKKDEVKDLLEDLSFNLAYKQISQDPHSTKKILNSLLVEFLTILKK
LDLFDDENVAKVIKALVKASVGDAQNVLYEYISEAELLNKQIENQKNLIKNQISDNFLEF
ENILQECSFCDEFSSGLNDAILFDIEMLGILKETAESAFLTTLEKAEDIELTSSEIAKSL
VYNAICEAHFEKERILKISSIILNTAFEIANESIAYAKDLCLGAIKGTRDGISLAMEKFK
TTLAYAKFEEDVSLKSKELIGIEDDFIALLKREIKEQKNPSKDIVENLLEHELDNLFAKF
KRLAVESREQLLLVLNDIKKNPKINDFNRLTQRKLHRFKQEILELEKVAGEKYKELNSKK
AKKLGVRLWERAKKLIKK
>fig|195.2024.peg.1629 Protein translocase membrane subunit SecG
MITLLTILQFVIVVIICIAVLLQKSSSIGLGAYSGSNESLFGAKGPAGFLAKFTFIMGIL
LIANTIGLGYLYNSTSKDSLAEKIKIETNTSIPTAPNAINVPAIPSAPQIPNESNTSK
>fig|195.2024.peg.650 Putative periplasmic protein
MRIIFFLVFVCLSLFARSEISVFDGQDENMQRELQKLPKEEQQIYQNIAPSDENSDFDSN
IYDPFIPQSSLVLTTDDYVNKVYVGEVFPIVLHAKITEDTNFDFNITLQKSKDLIFLNPD
LKWEYIKGDYRAVLWFEAKTSNANLEQISVSLLRNGKIFQSASISIGAIHFENTPNNKNF
SHLVASSLEVKKIKTSYFDDSSIITMIELSATNANLKSFFVNGVEKQGIENLKGDFNSSN
AFYYAIFPSTKTDFEFSYFNKDTKKMENMSFKLKISDDEVSTQSDLNPTNRDFNIYKQYA
LWALTLILALWFVWKKNYFILAGALLCFILSFLVDTNTENAILKAGSRAKILPTESSTYF
YTANSNEKVEVLGKRLHYVKVLFRDGKIGWVESSDLQKN
>fig|195.2024.peg.217 ATP-dependent Clp protease ATP-binding subunit ClpA
MKYQENLQKYLDNAKHLSTINRHEFTTCEHVLFAILKLSSDFKSIFEELADAEFELLESE
LKNYIAEKNQSLDQEIEPVNSIVLDEILNHKNEIKIIDFLEKLIQDDRTYSSFLLQKHGM
NLEKIQDFKQNSEIENLNSYASDLTLLAQKGKIDPLIGRKFELERIIQILSRRKKNNPIL
IGEAGVGKTAIVEGLALAIAEKKVPKNLQNAKIFSLDIAGLLSGTKYRGDFEKRIKEVLE
GLQKLPNAILFIDEIHTIVGAGATGESHTDFSNLLKPALSNGTLKCIGATTFMEYKNTFD
KNKALSRRFAKINVDEPSQEEAFQILQGLKSKYEDFHKIKISDEVLQQAIVWGKKFFSDK
YLPDSAIDLIDELGASYVLKAKTKKNADIKDLEQVLAKMTHHHKMFEFDQNKALMNLSLN
LKAKIFGQDEVIDKLVATLKQSFAGFKNLNTPRGVFLFTGSSGVGKTELCKVLAEFLGLN
LERFDMSEYAEKHSISKLIGSPAGYVGYEDGGLLSNAVRKNPFSLILFDEIEKAHPDLSN
TFLQIFDNAELTDNSGLKADFKNTIIIMTSNLGLKESNELGFLSKNEEKSNRAIKDFFAP
EFINRIDKILHFNDLDDTVLVKIIQKELDEISKNLKNIQLVADEKAKLYLAKKAYNKEFG
VRLLKRIISEEIGEKISDEILFGKLKKGGIAKIKLNKNGKLDLIF
>fig|195.2024.peg.269 hypothetical protein
MLCPVCNVDLVMSDRSGVEIDYCPKCRGVWLDRGELDKIIERSTPNTASFNQAPRQEPRY
NDHSYSHQSHDHYYKKKKRESWLGELFDF
>fig|195.2024.peg.974 major facilitator family transporter, putative
MKMLKILIIFCATLTLSIVYAPQPIAPLLSNYFHVNLHQISWIISVTLIPLAIAPLVYGY
LLEIFSLKKILVVSLFLCSIFGIIGNLNDNFYFFLFLRFLQALCIPAILTALLTLLSRLE
SDNMQKNIAIYVGATTFGGFVGRVFGSFLSDLFSWHFALNFFSILMMVCAFLFLFFKEHP
ISLNTQTSLRDFLPFIKELRFMVILFCVFTIFFSFQSIVSFLPFHLKESIKDITQTQIGL
VYLGFLTGVISSLLIGKTIEILGSKIRTAIFGFLVFIAGCFCMIVGNFYFAFFAMFVFCS
GMFISHCIFSGILNSIADKKGLANGIYLTFYYSGGALGSVLPSFYYESFGWEFLCIFTAF
LLFIALIIFSKFRHFYK
>fig|195.2024.peg.190 Polymer-forming bactofilin
MLHVDGELNGIVHSESIVVIGKNGNLKGELKADKIVVNGCFEGDLEADSLEILAGGVVSG
NISIKDLAIENGGRFNGTSKIKQEEPVRLLENSSE
>fig|195.2024.peg.1202 Aspartate 1-decarboxylase (EC 4.1.1.11)
MNITLLKSKIHRASVTEARLDYVGSISIDEKLLQASGILEYEKVQVVNVNNGARFETYTI
ATQEEGVVCLNGAAARLAEVGDKVIIMSYADFNEEEVKTFKPKVVFVDENNTATKITNYE
KHGAIF
>fig|195.2024.peg.462 ABC transporter, substrate-binding protein (cluster 3, basic aa/glutamine/opines)
MKKFLTAFLVAFTGLFLVACQNTKTENNASNEANTTLTLKVGTAPNYKPFNFKQDSKLTG
FDTDLIEEIAKKNGIEIVWVETNFDGLIPALKSGKIDMIASAMSATDERRQSVDFTKPYY
MSKNLYLKLKNNDSLQTKNDLEGKKIGVQLGTLQENTAKAIKNAQVQSNKDLNIAVLALK
NNKIDAIVADQDTAKGFLAENPELVSFYQETDGGEGFSFAFDKNKQKDIIEIFNKGIDEA
KTDGFYDTLIKKYELE
>fig|195.2024.peg.837 Hypothetical UPF0306 protein Cj1449c
MDERILEFIKNEQLLSWAMSDEKGVYIANAFYVFDEKNLAFIIASHEDTKHIKLASKNPS
IALNIAKESKIAFLKGIQAKAKFKSASKEQIKIYFSKFPFAKLDKSAKIYALELDWLKFT
NNALGFGKKLEFYKDKIL
>fig|195.2024.peg.938 hypothetical protein
MPTNEQIGEKIFDKCVEIYEILNNDKEAEAKEKLFYLLDEIQDKALYPPILNHLIRQFGL
YPYMNQDTSILEDKFLLECFKTDIGEDEPKVLHREQSRVLKRLLSNESLILSAPTSFGKS
FIIDALIAMKKPKNILIIVPTISLLDEARRRLVRKFYNYNITTTTQQTNLENNNIFIFSP
ERAVEYFSFINKENIRLDFFIVDEFYKISKDYENERFAPLQNAILKYTSISDQRYYICPN
IDKIKNENSILCKGMKFECLDFNTVFIHINKCYKNKDFEKEEKILEIVKKDEKTLVYTQS
QSNIKKVCEILVENTIIENSNALLENFAKWLSKYYGEHYLNDTLKIGVGIHHGRLHRCLS
QLQVRLFEGKDLLKTIVSTSSLIEGVNIPAKNLILWDKKNGAKNINHFTYKNIIGRSGRM
FKYFIGEVYLFESPNEDDNQEKILDVEIKSESLSINDEINNEIPDNIQVEVENNQLEIIK
LIGRDKFNLLKKETLLKNDLGVIIKIIQILQSKDFNSEIFTYLFNDEPDKWYILSRIASI
REFHCKNIGDINTVELVKKLSQNWTKSLPELIKDMRIDLDDFFKFENHVAFKIASLFSDI
NTLQKILYPEKEIDISSFVTKLSNVFLPSVVYTLEEFGLPRIISKKLHECGFINFENKEL
TLEQALDKFKEHTADDIINILKEKNLYDDFEDYILNYFYEGLGQ
>fig|195.2024.peg.244 hypothetical protein
MIKIYVEGKSDKIFLDLLCKNLKIDEFETIPIGGNNLSSSDLKSIKEDISDMRIEKICII
FDADDDYQKTKENLQQQLKNLQNEKIKIFLFPNNKDNKEIEILLTKIAKYPHFITCFKEY
SKCLKDKGTILNEKELNKNLIYAYNQACGSGTKEICLDHYDLDHEYIKPLIDFLKA
>fig|195.2024.peg.820 hypothetical protein
MDGKKILIFGFISDNFLEISSFLEKNKIKKAEIEEKISYMLNTILSSKESTRSACDFKIQ
KMYHCLLQDFNNEASKKRCYIANQNLLYIAEEWLKLDENVLFVLLYENPIEILRQKIFSN
HKFCFKDILMDWLRYNNLMLEFYSKNNNKCILMNYSNYHNSLIKYLSKHNNPDMVYAEND
AYIFKNKELFDFLLESLINKDYQIINDSYEKLEKNSLSPICKRKFSSENVEKEIVDLFYF
IETNSILKSKNKSLLDFIFDIQEDLEKLHQENLSQINNLNQTIETKNKTIQNKDDLLNFQ
AQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRKIEKD
PSLKLPSLEQYPDYQEAIKFKNYLSYRLGQVIIKGFKNPLSIILLPYEIVKLIYKFRKR
>fig|195.2024.peg.1189 Lipid-A-disaccharide synthase (EC 2.4.1.182)
MKNLLVCALEPSANLHLKEVLKAYKEEFGEFKLDGIYDENLCKEFALNSTPLYSSHEFSA
MGFVEILPLIFKAKKAIKELVNLTLNQTIDAVLCIDSPAFNIPFAKALKKANSKTKRIYY
ILPQVWAWKKGRIPIIESHFDVLASILPFDEQFFSKSIYVGHPLLDEIKDFKNENDIKIL
LSKNESEKTIAFLPGSRRSEIKRLMPVFRELSRKFEGEKILCVPPFNLERLEIYGDVKDF
KIQSNTPQVLKKADFAFICSGTATLEAALVGTPFVLAYKAKTIDIFIARLFVKLKHIGLA
NIFCDFAGKEALNPEFLQDEVNVLNLYEAYNKYDYKAFFDKVHFLKEYLKFGSAKNLAKI
LNQ
>fig|195.2024.peg.121 Signal-transduction regulatory protein FlgR
MNLVIVEDDINMRKSLEIALGEYEEFQIKSYKSATEALKKIDSDTDLIITDINMPGIDGL
EFIKACENKYDFIIMTGNATLNRAIEAVRLGVKDFLTKPFDIETLVEAIKRAKVIREKTA
DKKIKKQEEKQENGFFSSSDKLEQVLSLSQKAAKTDASVMLFGESGVGKEVFSRFIHQNS
KRSQKPFVAINMAAIPSNLIESELFGFEKGAFTDANATKIGLFEMANNGTLFLDEIGEMP
YEIQAKLLRALQEKEITRLGSTKSIKIDVRIISATNANLQDKIDNGEFRSDLYYRLNTVP
INIPPLRERKEEILGIAQKVLENTCKEYELEMKKISQEAQKALLEYNFPGNIRELISIVQ
RACILSEGLEISEQDLFLEARSVKKDVKNLEKELLEQILEQCEFDKEKASNELGMSIENL
NNKIKQYKIKEK
>fig|195.2024.peg.998 Membrane protein
MDKSYEFFLALHLYSLYASGFLMFFYLVLTQGNFKTEFIFIRRIRLFLPIYYVFLALMLF
TGSLLLAIKQFQTHLNLWLMIFSWIFIFALAIFHFIQFKKARRLRRYITFRRISFMILFC
ELVLLILPFLTGKYL
>fig|195.2024.peg.1278 Putative flagellar motility protein
MKKIKKIIQIGMISGLAAVAGGALVGCGSSNDNSDTLNQAANTQGAFVIIEEIAPGQYKI
KDQFPSDETRVVLKDINGTERVLSKEEMDALIKEEAAKIDNGTSNLTKEGGQISSGGLSL
GETLLASAAGAILGSWIGSKLFNNQNFANQQRGAFSNQSAYQRSVNSFNKAGTAGSASSA
SKSGFFGGGSKATSSSSSFGS
>fig|195.2024.peg.911 hypothetical protein
MPIFMICSTLLAVIVVAYYILKKYNPIFVFFLSGIILLIFAFYITGAPIPKAPSREHASF
LNVLLDSYAFITATFKSQLSGVGLIIMSVAGFAAYMKHINASAKLAFLANKPLGKIKNKY
LILSGTFIVGMALKIVISSYAGLLLLLLACIYPVLISLKIRPITAVCVLSLIALDYGPKD
GNSINMADMVGQSDNVVGLFLNYQIYSVIAYVMVIAILIPFYFAWVDKRDKEKGVLNDEV
EIPPIIDPKCPTFYILFPWLPVVFLFIAYFFTIKLDVVTANFLSISLVFLVEFARHRNAR
KLGEDMMVILKAMAEIFISVVSIIIAAGVFAEGIKALGGVNILANAVSNLGTGNFAWFGI
LLSIAILSFLVYFATVIMGSGIAAFNAFGKLAPDIATKLGVAPITFVLPIEIASCLGRAA
SPIAGGIIALAGFAKVAPMDIIKRTTPLLLIAMLVNVLVAFYLAQTNPLPKEQNTTKIAV
SLNNKYLLFYKNYKFSKLFSAFLVKIS
>fig|195.2024.peg.265 DNA polymerase III subunits gamma and tau (EC 2.7.7.7)
MLQALAIKYRPKTFDELIGQKTVSTSLKYALNHNRLAHAYLFSGLRGSGKTSSARIFSRA
LVCDNGPSDTPCGTCKQCLAALEGKHIDIIEMDAASNRGLEDIQALIEQTKYTPSMARFK
IFIIDEVHMLTPQAANALLKTLEEPPSYVKFILATTDPLKLPATVLSRTQHFRFKQIPQN
EILNHLKEILNKENVKFEEEALKFVARSGNGSLRDTLTLLDQAIIFCQNDISTSKITDML
GFLDPAKIKEFYHAILTKNKDRVFDFLEELKDYEASSVIDEMLFYLKESFFAKSSEFSTL
IYERFFRILARAKNLICDDDGFTLCVMAFMMMEASHLKEIDTQINEIQKNLTNINSNPEK
QEIKTPIAVEIQKSSPIKNAYEILLEKIYDRDYELGECFKQSTQFISYENEILTISSNAQ
GSNRDKLNKGFKLIQELFKNHFGSDAKIAVQKAIIIDESKLQSLTQELPQQNNEAQSSKK
IDLHSSFNELKQGAKKFDPQEDTKEALREYFGEPKIEN
>fig|195.2024.peg.1277 SSU ribosomal protein S21p
MPGIKVHPNESFDEAYRKFKKQVDRNLVVTEVRARRFFEPMTEIRKKQKISARKKMLKRL
YMLRRYESRL
>fig|195.2024.peg.1046 Tol-Pal system peptidoglycan-associated lipoprotein PAL
MKKILFSSIAAFALVISGCSTKSTSVSGDTSVDSNRGTGGSDGWDIDSKISQLNDTLGKV
YFDFDKFNIRPDMQNVVNTNANIFNNEVSGVSITVEGNCDEWGTDEYNQALGLKRAKAVK
EALIAQGVNSDRIAVKSYGETNPVCTEKTKACDAQNRRAEFKLSR
>fig|195.2024.peg.404 Acetolactate synthase small subunit (EC 2.2.1.6)
MRRVLSVIVLNEHGVLSRIVGLFSGRGYNIDSLTVAPLLGGEFSRINIVTFGDERVFEQI
VKQLHKLIPTYKVIERDEFIEKEMALVKIPLSENLGGLDAVLKAYNGTIANSNENFLFLL
VADDTNRIENFLKTIKKYNPSDIVRSGSVLMELK
>fig|195.2024.peg.1645 Exodeoxyribonuclease III (EC 3.1.11.2)
MKLLSWNVNGLRAICDKNALDWIIKENIDFIGFQEIKAHEDKFPKKIYEYPFKHMYSNSA
KRAGYSGVMSLCNFDSEVKKCEFFDDEEGRVLEHRFKNIALFNIYFPNGQKDEERLSFKM
KFYAKFLVYLEKLLKDGFEIIICGDVNTAHKEIDLTHPKANANTSGFLPIERAWIDDLLK
LGFIDTFREINGDIKEKYSWWSYRMKARERNVGWRIDYFFISTGLKDKLKNAFIRDDIFG
SDHAPVGIEIDI
>fig|195.2024.peg.1149 2-keto-4-pentenoate hydratase/2-oxohepta-3-ene-1,7-dioic acid hydratase (catechol pathway)
MKFVNFKFNQKATLGVFNSSGKVVNLADLDINVRDMNELIINFDEFKHKFKDLDSKTAYE
IPKEDYLAPIIEPRQDIICLGINFLDHAKESAQFKGEKFEEREYPVYFGKRCNQATDPFG
SISLHADVTSQLDYECELAFILSKDAYKIKAEDAKDYIFGYTIINEISARDLQKRHKQFY
RAKSLEGSTIMGPYITSVDEIAYPPELHLKSYVNKELRQNSNTKFFIFDIGYVLEELSSG
MLLKAGTIISMGTPSGVGMGLNPPVFLKKGDEIRCVIENLGEICNIIS
>fig|195.2024.peg.991 Menaquinone via futalosine polyprenyltransferase (MenA homolog)
MNTIWNKFKDILELVVFKHSIFALPFLFSSMIVASKLVNDSAWFGFKALILGIICAVSAR
NFAMATNRLMDEDIDKDNPRCANRPNVSGKIGRKSVWIFIILNAIIFILCSYFINTLAFY
LSFPVLFVLAIYSAFKRFSSLAHLVLGFCLGLAPIAGSVIVMGEIHIYSVILCLGVTFWT
AGFDLLYSLQDMEYDKKVGLHSIPAKFGSKATLFISAFCHVLAVLFWLLFVWQVWGVALG
NIALFGVIISGIILAFEHKIVHKNFAHIDKAFFTLNGYLSIIFFIFIWVDLVWK
>fig|195.2024.peg.582 Cytochrome c-type biogenesis protein DsbD, protein-disulfide reductase (EC 1.8.1.8)
MRFIFTLLFTCYFLFASVLSLNEAFEVKSSSYDSAVSIDIKLGKDIYLYSNQLKLYLNQN
DISSLINLPPSTQRLNEKVYYQDLNLALPNLLLERFVQNQNNQIKLQFQGCSEQGLCYNP
QTWYFDLKHKDNKFEISAPYKEKQKTLSAKSEESMIANFLATDNLFWILLSFLGYGLLLS
LTPCILPMIPILSSLIVAKSETKFSKKHSFFLSFIYVFFMSLAYAIAGVIASFLGASVQG
LLQKPSVLIFFALIFVLLALAMFESFRFELPLKFQNFLHKKSEKGKGVLGIAIMGFLSAL
IVGPCVAAPLTGALIYIANTGDALLGASALFIMSFGMGIPLLFIGLGLGFLKAGAWMQKV
KIFFGFVMLAMAIWMLSRIIETRYILIAFGILGVFFSVFMGIFEQAFNAVAKIKKSLLIL
VLAYSLSIFLGGIFGAKNFLNPLNLNSNMPLNSSKLNYNFINDLNTLQKEIKTSTRPIMF
NFTASWCENCKLLDELTFSDERIQEKLKNFHLIKIDLTQNSDKDLEIIKEFGVFGPPVLI
FFEKGKENLRITGFISAHDLLQKLEK
>fig|195.2024.peg.560 [NiFe] hydrogenase metallocenter assembly protein HypE
MKNISLAHGGGGEEMNELLTKLFEIFDNEILNANNDAAILGNLALSTDSFVLSPIFLDDE
VNIGKLCVCGSINDVLMVGAKPKYLSLGLILEEGFELEKLERILKSIKEECEKCGVMLVC
GDTKVVPKGKADEIYINTTALGEIISKKESKNIKAGLSILLSGDIGRHGASVLIKRNELE
ADVKSDCKALDKEVLELLEKDIKVVAMRDATRGGLSAVLNEWAKQSGNDLLIFEEKIIVQ
DEVLGLCELFGYEAYELANEGTFILCVEKEDELKALEILKKYNVNASIIGEVLEEKKARV
ILQNAYGAKRFLESPKGELLPRIC
>fig|195.2024.peg.300 Glycerol-3-phosphate dehydrogenase [NAD(P)+] (EC 1.1.1.94)
MSKIAIIGAGKWGSALYSALSINNTCFMTSRTQRDLPYFVSLEQALNCEYLVFALSSQGI
YSWLKQNFVNKGQKILIASKGIDTSTCKFLDEIFSEFIDRDKLCVLSGPSFAAEVMQNLP
CALVVSGIKEELCKKFASFFPDFIKVYTDDDVRGAEICGAYKNVLAIASGISDGLGLGNN
ARASLISRGLIEMHRFGKFFGAKEETFLGLGGAGDLFLTATSVLSRNYRVGLALAKEKKL
DDILQELGEVAEGVKTAYAIAKISKDKAIYTPIVNEIVQILQGKNVKQAVQNLLKTKDN
>fig|195.2024.peg.1205 Class D beta-lactamase (EC 3.5.2.6) => OXA-61 family
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>fig|195.2024.peg.1066 DNA ligase (ATP) (EC 6.5.1.1)
MRIFVFLWCVSFAFASDILLLSKISEQEIQNKNFNGYLMSEKLDGVRGIWEVGKFKTRQD
NPIYTPSYFTYNFPSFKLDGELWIARAKFDEVSALIRGDNLDSSLWKSVTYNVFDVPNAC
EEFKLTSCTLSNRLKVLEQYLQQNPNPYIKIIKQIPIKDQEHLKEFYKDIVLNKGEGVVI
RKDLAPYEKGRSKNAFKLKPYEDAECKVIGYTEGKGKFQGKIGALLCQMPNDRVIRIGSG
LKDKDRENPPKIGSIVTYKFNGLTKNSLPRFPVFLRIRD
>fig|195.2024.peg.1142 Ribonuclease HII (EC 3.1.26.4)
MGDFSPFLRENLKTLFEENELLTPFDINLIGIDEAGRGALAGPMMMAACKLHKDLEGLCD
SKKLSEKRREELYEIILLHSDYLILAFSSEKIDEIGLSACLKMGLTLIKKHFKTENNFLY
DGNTNLGISGIKTQIKADANIKQVSAASILAKVSKDRVMNFLAKDFPCYEFEKNKAYGTK
AHKELIAKFGICKLHRKSFKLL
>fig|195.2024.peg.1481 Hemerythrin domain protein
MFPKWDDNYSVHNAKIDEQHKKLFELAGKVEFMFDRPVYKDDIKALLADFFNYMKDHFND
EEKYMKLIGYPGLEEHKKIHKEIIQSMIDLIKNIKSTNDLKEKLYTVSKKWLLEHILYED
MKVEQYRRSSLSSEDDSEVSFEEVKEEKDDETALYFYTCECVGQIHDVPFGIHQKIQLKG
AKFKCKKCKMAIQFYKKHSESFE
>fig|195.2024.peg.1567 Periplasmic nitrate reductase (EC 1.7.99.4)
MNRRDFIKNTAIASAASVAGLSVPRPVFGAQEEEWKWDKAVCRFCGTGCGIMIARKDGKI
VAIKGDPAAPVNRGLNCIKGYFNAKIMYGEDRLVMPLLRMNDKGEFDKKGKFKQVSWQRA
FDEMEKQFKKAYNELGVTGIGIFGSGQYTIQEGYAALKLAKAGFRTNNIDPNARHCMASA
VVGFMQTFGVDEPSGCYDDIELTDTIITWGANMAEMHPILWSRVSDRKLSNLDKVKIVNL
STFSNRTSNIADIEIIFKPNTDLAIWNYIAREIVYNHPEAMDKKFIKDHCVFATGYADIG
YGMRNNPNHPKFKESEKDTVAKENAITLDEEEATSLSYLGVKAGDKFEMKHQGVADKNWE
ISFEEFKKGLAPYTLEYTAKVAKGDDNESLEDFKKKLQELANLYIEKNRKVVSFWTMGFN
QHTRGSWVNEQAYMVHFLLGKQAKPGSGAFSLTGQPSACGTAREVGTFSHRLPADMVVAN
PKHREISEKIWKVPAKTINPKPGSPYLGIMRDLEDGKIKFAWVQVNNPWQNTANANHWIT
AARDMDNFIVVSDCYPGISAKVADLILPSAMIYEKWGAYGNAERRTQHWKQQVLPVGAAM
SDTWQILEFAKRFKLKEVWKEQKVDGKLTLPSVLEEAKAMGYSEDDTLFDVLFANKEAKN
FTSNDAVMKDYDNSEVKGDERKIQGSDGKEFKGYGFFVQKYLWEEYRKFGLGHGHDLADF
NTYHQVRGLRWPVVNGKETQWRFNTKFDYYAKKAAPNSDFAFYGEFNKMLTNGDLIAPKD
EKEHSIKNKAKIFFRPFMKAPERPNEEYPFWLSTGRVLEHWHSGTMTMRVPELYRAVPEA
LCYMSEKDGEKLGLNQGDLVWVESRRGKVKARVDMRGRNKPPVGLVYVPWFDENVYINKV
TLDATCPLSKQTDFKKCAVKIYKA
>fig|195.2024.peg.1241 4Fe-4S ferredoxin, iron-sulfur binding
MAVKITDSCIACGSCIDECPVSAIVDDANNPEGEDRYYVYADKCVECVGHNDQPACASAC
PTDGCIVWSEIASGQPSRDNIGSDMRDGTTPVFA
>fig|195.2024.peg.89 16S rRNA (guanine(527)-N(7))-methyltransferase (EC 2.1.1.170)
MNLDFLNLILSDFNEEDFRAKLKIYKEILNKFNRIHNLTQLKNIDENILDSIEILKYFDF
SKAKNIVDIGSGAGFPAIFLAFILPSNFHLFEPNPKKAAFLRSIKIECNLTNLTVYKEKV
ENYKSSFKADIITSRALMDVKPLIKLCLNISDQKTIFILWKGSEIFDEVEGLKDYDIFEN
GLRRYCVLKNTQSGMNTTL
>fig|195.2024.peg.1446 Glutamate racemase (EC 5.1.1.3)
MKIGVFDSGVGGLSVLKSLYEARLFDEIIYYGDTARVPYGVKDKDTIVKFCLEALDFFSK
FNIDMLIIACNTASAYALDALRLKADFPIYGVIDAGVEATKKALLDKNKKILVIATKATI
QSKEYQNRLQKQGFNNVDALATGLFVPMVEEGIFEGELLQSAMRYYFKGIETPDALILAC
THFPLLANSLSVYFGSKTKLIHSGDAIVEFLKQRQKLLLKEEKAKLHFYASSDVKSLENT
AKIWLNL
>fig|195.2024.peg.966 Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2)
MLVKLAVLFSGNGSNLQNILEKLHKKTIGKNTYEVVLCLCNKKDAYGIQRAKNFDLESVI
IEHKDYKNREEFDEILVKKIKESGADLTILAGFMRILSPVFTKNIKAINLHPSLLPLFKG
AHAIKESYESDMKVAGVSVHWVNEELDGGKIIAQKAFEKQNLTFEEFEAKIHGLEHEILP
LSVVEIFENCH
>fig|195.2024.peg.550 Inorganic pyrophosphatase (EC 3.6.1.1)
MDLSKIKIGNIPNKINAVIEIPYGSSIKYEIDKDSGAIMVDRVMASAMFYPANYGFIANT
LADDGDPVDILVLNEYPIQAGAVIPCRLIGVLIMEDESGMDEKLLAVPNSKIDARYDNIK
TYTDLPQATLNKIKNFFETYKILEPNKWVKVQDFKDEKAAVEILEKAIKNYK
>fig|195.2024.peg.597 Tyrosyl-tRNA synthetase (EC 6.1.1.1)
MDIKNILAEIKRGCAEIIDEERIENLIKNYYEKGENFFVKAGFDPTAPDLHLGHSVVLTK
MAYLQKHGAIVQFLIGDFTGQIGDPSGKSVTRKKLDKEQVLQNAKTYEEQVFKILDPQKT
QLKFNSQWLNELGATGIVELTSTFSVARMLERDDFTKRFKEQSPISICEFLYPLLQGYDS
VALKCDIEMGGTDQKFNLLMGRTLQRIYNIGKEQAVMMMPLLEGLDGVNKMSKSLGNYIG
VTEKANDMYAKILSISDELMWRYYELLSTKSLEEIENMKKEISSGNLHPKLAKENLALEI
TTRFHNEESAKAAKAEFDSVHSGNALPSDIKEFEIEGEIWLAKALVECGLENSTSAARRS
INANAVSVNSQKVSDEQMQLGTGEYILQVGKRKFAKLKVNI
>fig|195.2024.peg.1301 Malate:quinone oxidoreductase (EC 1.1.5.4)
MTQQEFDVIVIGAGISGAALFYELARYTDIKNIALIEKYHAPATLNSKGTSNSQTIHCGD
IETNYTLEKAKKVKRTADMIVKYGLLQNAQNQFMFSHQKMALAVGDSECEYMKKRHEEFG
ELYPYMKFFNKDKIKQIEPKVALGENGRDDRPENICAMGVEAGEVFTTVDFGKMSASLVE
QGQKQGKNTFVAFNQEIVHIEKKDDIFILKTNTYQEYRSKAVVVNAGAHSLYLAHKMNLG
MDKSCWPVAGSFYLTKQKLLNGKVYMVQNPKLPFAALHGDPDLLADMNTRFGPTALVIPK
LERYHGLKSVPEFFEALKLDKTVLKVTFSMFKDPTIRNYILYNYLFELPFIDKGLFVKDA
KKIVPSLKTSDIYYAKGFGGVRPQVIDKTRGELMLGEASITETPGIIFNMTPSPGATSCL
GNAERDAKLICEYLGAKFDEDKFASELL
>fig|195.2024.peg.906 Molybdopterin synthase catalytic subunit MoaE (EC 2.8.1.12)
MSEFVLTNNALDIPQIYAKWYEFAKDKNCGALLTFCGIVREEEGIEALSFDIYEPLLKKW
FDEWQKRVKEEGVILLFAHSIGDVKTHESSYLAGVLSKQRKLGLKLINEFVEDFKASAPI
WKYDVINKQRIYAKERSSKLCGAGLLKS
>fig|195.2024.peg.757 Acid membrane antigen A
MQTGKIFLICFILVVLSLLLYLFKGFLLVIIIASLMAVATSNANAKFLSLTNGRKFLASM
LTTACMVLLFFAPFVYAMIELAKALKNFDINLVTQTLNYVKNYQFTLPESLSFLEPKIKE
FLASIDLNSISKQILNYASSFTKSGAKFLIDMVLICIFYFFANLYGTELVIYIKSVIPID
KQELDDILSEVGNVMAVVLYSMIIIAILQGALFSIIAMFYGYDAILMGVIFAVSSLIPAL
GGALVYIPISLYEFASSGLGSALVIFIYSVVVISFIADTLVKPLIIKWINEKLVKTPAKI
NELLIFLAMIAGISTFGFWGIILGPAILTFFISTIRLYMILKDKNLI
>fig|195.2024.peg.303 2-Oxobutyrate oxidase, putative
MNLPVLDLKIYEKDKSAFLKNLREVTSNVGFFYLINHGIDKNLNEKLFKLSKDFFNLPRS
SKELISMVHSPQFRGYTSEGFEYTAGEKDYREQIDIGTERKALKWDLNSPLWQRLEGPNL
WPDEIPELKEIFLAWHEQTRNACLKILQAFAEALDLPSDAFGKLYGENSYEHCKIIHYPK
ISKDASQGVGPHKDGGLITFVFQEEQNGLEAFIDDQWISVPPLEGSVVVNIGEFLELATN
GYLKATIHRVNLSPKERFSIAYFLGVQLDKDIPIFPLNPELVQESKGVDTDPKNPLLRNV
ASNYFKRMIRSHPDVARIYHSDLIEKFSFA
>fig|195.2024.peg.1462 hypothetical protein
MVSTTKHRNSDLKALMARKVLILQKFSLIFDEFKKDFRV
>fig|195.2024.peg.1154 Thymidylate synthase ThyX (EC 2.1.1.148)
MQITLLFHTPLSVCSHATRTCWQSFDKGDCGGEKDKELIDRVGNKFKHASTLEHLNYTFY
IQGISRACLQEVARHRHTSPSVKSTRYTLKELRNEGEFKIGDFENASRYLVLCGNEEVDN
ASIQALENLRLILQKSISLDIAKYCLPESYKTELTLTINARSLQNFISLRSSKSALWEIR
NLANALFEALPQDHQFIFEHCLHKDIH
>fig|195.2024.peg.595 N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28)
MFRILVFCIALFSICFGAYENELANFDKNFIASKNDAQVKFHHQLKSLYIQSVINEDEKT
KIEILKRLIISSNALNLDDKSYANELEESGVSKASINALRKAVIKDKQKVQPDSKNVEVS
SFEPPKSTSKPPQTKQESTKTQNNKPQQTKKVDKVYVLKSSKTSQGVVLDLNTNLEQKDI
KSFALDEKGNYRYISDFEGILEGGRKEYKFDDYRIVISQYNPKMIRIVAYAKEKIPLNFD
FEDEKISISKKSQAIQKSTPSKQESKTAAKQESEKVVAKQESKPVKTQEAKTNTKKEQEN
DEPLYVLDVDKSSNSVVLNLSDELDEKDITSFSTKDQKFFRQVVSFQGILEGSRKNFTFG
QNAVTVTQYNPKTVRIVLSSTKEFKLFKDLDDKSLTLGFSGSTSKSTSTSSKSTSKTASK
NVLNSNFKSDKLIVLDAGHGGKDSGALSDKKGSLKEKDIVLSTTLKLGNELKKRGYKVLY
TRSSDKFINLRDRTKYANDKRADLFLSIHANAAPSASKAKSSEGVETFFLSPARSERSKK
AAEKENQGDFEEINYFSKQSILNFLNREKIVASNKLAIDVQKNILTQTRKKYKIVDGGVR
EAPFWVLVGAQMPAILIEIGYITHPSEGKRIANKSFQDTLVKGIADGVENYFYNNR
>fig|195.2024.peg.1622 Protein-L-isoaspartate O-methyltransferase (EC 2.1.1.77)
MNAFEQKRCQSMAEEIAQKIFINEELFNAFCQIPREIFSPLKAHAYRLDALPLANSQWIS
SPLTVAKMTMALNFKDADSVLEIGCGSGYQAAILSKVIRRVFTIERIENLAKKAAQTFRE
LELFNINVKFEDGQNGWKNYAPYDRILFSAYTTQLPEILLDQLSDGGILVAPILHNGKQF
ITRITKNGTHLQKEILEECLFVPIVDGKE
>fig|195.2024.peg.1221 NagD, Predicted sugar phosphatases of the HAD superfamily
MFFLDVQGTLISDHDKSLIHGAKELIDFLNAKNLPYLIITNNTKKLDFLEKLQQKGLAIK
ENAYIDPFSVLKHLLRPCKVAAFGADEFVKSLENLGFELDFVNPSAVLVASYDDFKFKDF
ATMIELARREVRFIAMHETSIYKKDGRPYPGVGSIMAMLKNAIDFEYEVVGKPSIAFYKE
ALNLIRRQNSKIDFEDIKIVSDDFRGDLLKAKELGMKTLLVLSGKISDTKGFDTDLLDGV
YPSVLEILKDLKCQI
>fig|195.2024.peg.567 Na+-driven multidrug efflux pump
MAKKQLSLTRLSFPIFWDLLSKYLTVIINTAMVSHYSNFLVGAMGAGNQILDLFITIFSF
LSVGCSVVIAQAIGAKDHVLARKVIHQSLFLNALLGFVCGVLILWHGEYLLYLLKIPQEL
LKDSEIYLHMLAICLFFDAIGIVLAAIVRVYNMAYWVMLIGFLMDIVVICGNYYVLHYTK
SELFGVGLSNIFARIVAIVALLVILFYKLKIHLKIKEMIKLEKEVLKKVLNIGGFSAGEN
LLWIVQYTIAFAFVASLGEASLSVQTIYFQISMLIMLIGQATSIANEIIVGKLVGARYEN
IAYKHAWRALYFSVIASALVALLNYLCQDFTMQILGLKEELKNLMIPLFALSIFLEISRT
FNIVMVNSLRASGDAKFPFFSGLVFMMGVSLPVGYVLCFHFNLGILGVWIGFCADEFLRG
MVNSYRWKSKKWQGKALV
>fig|195.2024.peg.1651 Hypothetical protein Cj0261c
MNLWDKKAKSYARYNQKLNSIQEQSFKELEKLNISFKDKNIIDIGCGTGVWTLYLAQNAK
ETTALDNAKAMLEILKEDANKLQLTNIKYENCTFTEWINKNQNAQFDIAFLSMSPALQDK
KDYLNFMRLAKIRIYLGWADYRKSDFLDPIFKHFNTEFKGIYKQDLESYLLENNVKFHKF
IFDETRIVKRKKDEAIENALWHLNMNGVKASKQDLETFVKGDIKETIQSKIKLLVF
>fig|195.2024.peg.1549 Hypothetical protein Cj0797c
MLSFKQDEIYTATEVVRNFSPLIEKLKKSESGKMVILKNNKFEAVLLSMKEFERLQNAMQ
LLENIYKNQKV
>fig|195.2024.peg.848 JHP0747 family
MKISLECKDLIIEKALELFLKEHLVMKKDCDFIISDEKISTQKPLFIIAKNSPFLSLPFS
KEALMNSLNEFDSALKATAQKLADERRRVLEARIDEIASEFKRDYQSKIDLAISELKDKL
VKALMYE
>fig|195.2024.peg.1330 Bis-ABC ATPase YbiT
MVEVKNLTMRFANQLLFENVNLKLVRGQRYGLIGANGAGKSTFLKILSGEIESSSGEIVF
DEGLKIAVLGQDQFAFENYTIKDAVMCANKRLYEALKEKEKLYMSEEFTDEINERLGELE
IITAEEDPNYDCETRCEKILSSLKIKDFDALMSTLQSADKFKVLLAQVLFLGADVLFLDE
PTNNLDLEAISWLENELLRHEGTLVVISHDRHFLNKICTRILDVDFKQIRDFAGNYDDWY
MASTLLAKQAELKRDKTLKEREELENFIRRFSANASKAKQATSRAKALEKLELEEIKISS
RRDPSIVFRTNREIGNEVLELKGISKAYDKELFSNLELKIEKNDKIALIGANGVGKSTLA
KIIANAIAPDSGSIHLGATIELGYFPQDTSNLICENLKLYEWLMSEKFKDLDEIRKCLGR
MLFSGSDQEKMAASLSGGEKHRLMLSRLMLERPNFLLLDEPDNHLDLESIIALGEALYNF
KGVALCISHDRELVSAFANRIWHLKDGELTDFRGTYQEFLGENDG
>fig|195.2024.peg.748 Enterochelin uptake ATP-binding protein
MIRLQNITKCYDQKAIISDLSIDFHKGKITSIIGANGAGKSTLLALASRLIKPDSGRIYI
DGMNLTLYKEQDLAQKISILKQQNHINLRLKVEELVAFGRFPHSQGRINLNDKMKIDEAL
EYMGLNTLRNEFLDSLSGGQKQRAFIAMIIAQDTEFIMFDEPLNNLDMKHSVQIMQLMKN
LVKDFNKSIAVVLHDINFASIYSDEIIALKNGKLLKQGLKDEIIQEDVLRQIYDMDIPVS
QIDGKKICIYF
>fig|195.2024.peg.1157 L-asparaginase (EC 3.5.1.1)
MAEAKPKIAILATGGTIAGSIDSAVATTGYTAGVVGVDVLIKAVPQIQDLANISGEQVAN
IDSSNMRDEIWLKLAKKINKLFDEGVDGVVITHGTDTMEETAYFLNLTIKSDKPVVLVGA
MRPSTAISADGPKNLYNAVALAADKEAKNKGVMVAMNDKILSARGVVKTHSLNVDAFSSP
DFGDLGYIVDGKVFFYNNISKAHTKNSPFDVSKLTSLPKVDILYTYSNDGSAIAAKALFD
NGTKGIVVAGSGAGSIHEDQKNTLKELIKQGLDVVVSSRVAAGRVAVSDADKKLGFISAE
DLNPQKARVLLMLALTKTNDPKKIQEYFLKY
>fig|195.2024.peg.26 Putative periplasmic protein
MMKKYATISILSILLLILLIVVFVLLWKFKANSNFIPEFAKDTNTHQIEERQTQELTWRE
ELAKWPSKDFTPAVEQFTLHFDADTSELKEKNKYYQLVVNKHDIYSMFCLRQTLNSFNVK
YFLLKSGESPEIFLDTGNKNLIDDIIKELKKYKINTEAKEIWL
>fig|195.2024.peg.801 Cytochrome P450 family protein
MSQCPFFPKPYKNKASTLLTFLLKRRSWLDGLYERSYKMQTGYVKMPNFDLYVINDTKEV
KRMMVDEVKEFPKSAFLHELLSPLLGESIFTTNGEVWKKQRELLRPSFEMTRISKVFNLM
SEAVSDMMKRFEKYPNASIIEVDEAMTFITADVIFRTIMSSKLDEEQGKKILDAFVTFQE
QSVHTAMRRMFRFPKWLSYVLGDRKRAKAGDVIRQALSDIIKPRYDAVSSGKAENFEDIL
GSLLLVVDAQTNQRFSFEEILDQVAMLFLAGHETTASSLTWTLYLLSLYPDEQEKAYKEI
IQVLQGENIQISHLKQFRYLTHIFKESLRLYPPVGFFAREAKKDTKVRDKMIKKGSGVVI
APWLIHRHEGFWANPHEFKPSRFEGEYKKDAYLPFGVGERICIGQGFAMQEAILILANIL
KKYKLELEEGFVPDVVGRLTIRSANGMRIKFSKRES
>fig|195.2024.peg.1592 hypothetical protein
MIEEPKSFQRLLWFFILISYTFKKLDNQFNLKFSSYFYHCIFNLKR
>fig|195.2024.peg.73 Hot dog fold protein HP0420
MAKKDTFEEYAQLEEYASAEDISRVRAELLTCPELNTSLAGTIIELDKNFAKSILITTSD
MVVDEQGLVFDAFIFAAANYVAQASINKEFSVVIGSKCFFYAPLKLGDVLELEAHALFDE
TSKKRDVKVVGHVKEIKMFEATIQVVSIDEHIFKLKRPPLNTAKAAENPDSPTSTVNPEA
IGSALSASLRK
>fig|195.2024.peg.971 Protein PhnA
MPKDANGTELNAGDSVSVIKDLKVKGASTTLKRGTTIKNIKLTSKENEIEAKVDKFGVIV
LKTEFLKKI
>fig|195.2024.peg.1038 Metal-dependent hydrolase YbeY, involved in rRNA and/or ribosome maturation and assembly
MILSDEKCEFLEPIASFLSSKDVELVFVESKEMQEINLEQRKQDKTTDVLSFPLENIDES
LPLGSVVINVDLAKQKAKELGHSFEEEVSLLFIHAMLHLLGFDHEVDNGEMREKEKELIE
HFNLPKSLIIRTLED
>fig|195.2024.peg.126 Outer membrane liproprotein mapA precursor
MNKKILFFIALALFLNACASKQNTFTQVNQLSKASQCVPCESSSGFEAKIKGLLYVSDIG
IQCCANKRTLDTGVALKKVYLHRFYDLKEEQKVLNANGQKLFVNLDFNAIFYVYLKQELE
ARGIIVLDDNKANSPYVTKIDLAFTGYSAKQDSLGLHSRLVGVLSLSDINKNKKFTLRTK
QDVQGFENLKDISFYTHLLIKQMANKAASIISEL
>fig|195.2024.peg.1716 Lipoprotein releasing system transmembrane protein LolC/LolE
MKKSVLKYLLFKYLRFDKEQPFINLSMLLAFLGVCVGLCVLLVAMAIMNGFDKEFEKRFF
VMNYPITIVPKFYSPMNDDLLTELKREFPHLLFSPYISTQVVAKADNRFEGGVLFGVNFN
DEVKINEVVAKALKDENLSGFDILVGSVLADELNLHKNDKLSLIFSNLSPSGFSLVPQAK
RFDVKARFTSGLIFYDKAYMYTDVNALRKVLGISNQQSYDGVHVYSENAFKDVEKLKSYL
KSDYAVVGWWEQNQNFFSALKLEKRALFIVLMLIILVASLNIVSSLLMIVMNRRTEIALL
LALGASKLEVKKSFFALGMLIGGGGMIIGIILAFFVLWLLGNFDIVTLPADVYGTSKLPL
DLSVMDFSLTLVGALIIIALSSYYPAKKATQINVLDTLRNE
>fig|195.2024.peg.1620 N-acetylglutamate kinase (EC 2.7.2.8)
MQKYLEKANVLIEALPYIRKFSSKIILIKYGGSAMENEELKHCVMQDIALLKLVGLKPII
VHGGGKDISKMCEKLGVKSEFNNGLRVSDQATTEVASMVLNYINKNLVHSLQNLGVKAIG
LCGKDGGLLECVQKDENLGFVGEIQKVNSSVLQDLLEKDFLPIIAPIGMDENFNTYNINA
DDAACAIAKALKAEKLAFLTDTAGLYENFEDKNSLISKISITQAKALVDKIQGGMHVKLK
SCIDACESGVKKVHILDGRVKHSLLLEFFTDEGIGTLVG
>fig|195.2024.peg.298 Probable low-affinity inorganic phosphate transporter
MQKDNLIAFIIFTISVIAFIIWGFGYISQHQLILFILASIFGIFMAFNIGGNDVANSFGT
SVGAKTVTIKQALIIAAVFELSGAIFAGAEVTKTIRSGIVIFPEQFDPMLFVAIMLAALL
SSGVWIFIATKKGLPVSTTHSIIGGIVGASIMMGLLKFDGSQTLSMVKWSEIVRIAVSWV
ISPLLGGLVAYIIYSYIDKKILKPSEKLGEELKNLKKERKKFKENYFLNLKTKSMEEQIK
ELSAIALEDEGQENSFYKNQIKEFKEKEKNIDIYSVLKTHMPIIACIGAAIIAAMFLFKG
LNNVSTLDILQNFWIIGIVGTISYVVTFAIVKIVKKTELNKTTDRLFAWFQIFTASSFAF
SHGANDIANAIGPFAAILDVLKNGTINANSPVPFAALAMFGVALVIGLWFLGKEVITTVG
SKLASIRPTTGFSAELGASIVILLATQFGIPVSSTHILIGAVLGIGVYNKNANWMMMKPI
GLAWIITLPAAGIMAALVFLGFKLSLGL
>fig|195.2024.peg.1430 Ribonuclease HI (EC 3.1.26.4)
MRHIEIYTDGSCLKNPGFGGWAYILRYNQHQKEGFGAEANTTNNRMELKAIIEALKALKE
PCEISLFTDSNLMVQSINEWLEAWIKKDFKGKKNVDLWKEYIDVAKPHKIKAYWIKAHNG
HLENERCDTLAREAALKIARENDEKY
>fig|195.2024.peg.846 Thiamine-monophosphate kinase (EC 2.7.4.16)
MNKEDFIIKAFLNEKNGDDGAIIDKWCLSKDLFFENVHFKREWFSLEQIATKAMLVNISD
AIVMNAKPKYALLGLALPNSLGEDEIKALQKGFLKTAKKFNIKIIGGDTISNDKIDISIT
IISKVRNKAIFRKGLKKGHLLAYTGVLGKSLRGLEILQNGGTLNSNHVFIKPKLRPDFFY
EIAPFISCAMDISDGLSKDLSRLLAQNKCGISWFKKLDDYTLYSGEEYEILFAFDEKERQ
NIKTIAKKHGVKLNIFGKAVKGKYEFRGREHHF
>fig|195.2024.peg.953 Arsenate reductase (EC 1.20.4.4) thioredoxin-coupled, LMWP family
MKLAFICIHNSCRSQMAEALARHKAEKMGVDIEVFSAGSDTSKGVNSQAIRLMHEIYQIN
MKKHYSKLIDSLPKDLDIVVSMGCGVACPSLKSRYYFDFGLKDPSGSCDDEFKKIIQILD
SKLTALLQAIKTNSLKDFRC
>fig|195.2024.peg.1008 Thioredoxin
MGKYIELTSDNFAQAKEGVALVDFWAPWCGPCRMLAPVIDELANDFDGKAKICKVNTDEQ
GDLAAEFGVRSIPTLIFFKNGEVVDQLVGAQSKQAISDKLNSLL
>fig|195.2024.peg.653 Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6)
MKKKELLYEGKGKKLYTTEDENFLISEFKDDLTAFNAEKKGSESGKGALNCKISTELFHL
LEKNGIKTHLVETISDNEQVVKKCKIVPIEVIVRNVATGSLTKRLGIKDGTVLPFALVEF
CLKNDELGDPFINDEHCLILNLVQNEAQIKEIKEMAKKINAILTPFFDAKNLRLIDFKIE
LGLTKDNELVLADEISPDSCRFWDKFSNEKLDKDRFRQDLGNVKMAYEEVLKRILN
>fig|195.2024.peg.78 ABC transporter, substrate-binding protein (cluster 3, basic aa/glutamine/opines)
MKKMLLSIFTTFVAVFLAACGGNSDSGASNSLERIKQDGVVRIGVFGDKPPFGYVDEKGI
NQGYDIVLAKRIAKELLGDENKVQFVLVEAANRVEFLKSNKVDIILANFTQTPERAEQVD
FCLPYMKVALGVAVPQDSNISSIEDLKDKTLLLNKGTTADAYFTKEYPDIKTLKYDQNTE
TFAALIDQRGDALSHDNTLLFAWVKEHPEFKMAIKELGNKDVIAPAVKKGDKELKEFIDN
LITKLGEEQFFHKAYDETLKSHFGDDVKADDVVIEGGKI
>fig|195.2024.peg.916 Putative periplasmic protein
MKRIIIFLSFYLLPLFGNSELKNGFGEEYYKLNVEQKRQIFFTKMNTMFDKSFEEIAKER
AFVEAFFYDAYKNGLRNSNQNNLEKLINLKNKYRVENLYDFTEYKKRIQKIPKSMGIAQA
LVESAMGTSRFAREANNLFGEWTWGEKGLIPDLRYPDKKHKIRIFDSLQDSVDSYVLNLN
RHFAYEEFRNERAKFESEGKEITGLEAIKTLDSYSERKSYYINIVTKIIQRYDLERYDTP
KSF
>fig|195.2024.peg.42 Copper metallochaperone PCu(A)C, inserts Cu(I) into cytochrome oxidase subunit II
MKKIITLSALLALSLYAKDIEIKDAFIKQTPPNAVNSAIFLTIVNNTDKDISLIDAKTDI
NQVSELHTHEHKHGMKAMIQIPEIPVKAHSSTELKPGSYHIMLFKLNQAIDENTKANLTL
TFDNNQSLEVRDIGSKKL
>fig|195.2024.peg.493 hypothetical protein
MQTYLELQEFCKLVHLNEDVVKGMMANGALNFKEEEGKIYIEANQGTFSVVPSASNSKPA
MVNSMTLAGESFVEKTIGTILNLHEKVLDAKDETLDALKNENKFLKDALYSMQELYDEDR
KTIETLNHELKHAREEIEFLKRKYKLMWSKTAEIFGARTEPDLEMKKDENSSTANEKLNE
NKEG
>fig|195.2024.peg.1501 Cell division integral membrane protein, YggT and half-length relatives
MVVDSLIISIFQVIQIIINIYTWIIIITALLSWVNPDPYNPIVQILYKLSSPAYALVRKI
PTRIGSIDLAPLIIVLALQFLSIFLGNILRSLL
>fig|195.2024.peg.1634 Cysteine desulfurase (EC 2.8.1.7)
MKVYLDNNATTMLDPSAYELMLPFLKDMYGNPNSLHQWGSATHPALREAMDKLYAGLGAN
DLDDIVITSCATESINWVLKGIYFDHILDKERNEVIISSVEHPAVAAAAYFLKSLGVKVI
ELPVNEEGVSTVEDLRKVISDKTALVSVMWANNETGMIFDIKAMAELAHEFGALFHTDAT
QAVGKIKVNLTQVGVDFASFSAHKFHGPKGVGGLFIKKGLKLTPLLHGGEHMGGRRSGTL
NVPYIVAMGEALRIANTMLDFEDSHIRRLRDKLEDQILALPDTTVVGKREHRVPNTILAS
IKGVEGEAMLWDLNKNGIAASTGSACASEALESNPIMEAIGAEHDLAHTALRLSLSRFNT
EEEIDYAAKQIKNATQRLRAISCTYAYNPNNYK
>fig|195.2024.peg.304 Methionine ABC transporter substrate-binding protein
MTIFAKAFCIATLFTGFAWANEELKVGSSVVPHADILKFIKPTLQKQGYDLKIYEFNDGV
IPNIMVENGELDANYFQHEPYLKEFNQRQGTHLVKVASIHIEPMAVYSKKHKEFQPKTGA
SISIPNNPTNESRALRIVASAGLIEIKDSELVTPLDIVKNPKNLKFVELKDAQLTRSLDD
VDYSLINSNFAILSGLNPIKDGLYTENKYSEYGNIIAVKAGNEELDKIKALVKALQSDEV
KNFIEEKYQGALIPTF
>fig|195.2024.peg.1072 Flagellar biosynthesis protein FliQ
MDESTLVALGVQTFKITLLLSLPMLLAGLIAGLIISIFQATTQINEMTLSFVPKIILVVI
VIIFLMPWMTTTMIDFTENILNQIPTFIK
>fig|195.2024.peg.1306 Aspartyl-tRNA(Asn) amidotransferase subunit C (EC 6.3.5.6) @ Glutamyl-tRNA(Gln) amidotransferase subunit C (EC 6.3.5.7)
MQIDEKLLSKLEKLSALQIEEEKRSEVICELSEIVNFVEKLNELDLSSSEVAISTIKGGA
PFRSDSVNSSNVVETVLNHAPKSNDHFFIVPKIIE
>fig|195.2024.peg.785 Formerly called adenylosuccinate lyase (similar to archaeal version), but most likely something else
MTGISVFDHKLLADSWSTQDMRAVFCEENRVQKWLDVEAALAKAQAKLNIIPQEAADEIA
KKAYYKFMDMDFIFNEFKKTKHPLVPTVRGLEKACDNNLGEYVHFGVTTQDIIDTGLVLQ
FKEAMTLVKSELKAIAKALVKLAKTHKNTAMMGRTLALQALPITFGHKVAIWLSELERHF
ERILELEKRLYVGSIVGAVGTKASLSDECNEVEKLTLENLGLDVPNISWQSARDRFIELG
FVLGNINATFNKIAHEILILSHNEIDEVAEPFGKGQVGSSTMPHKRNPAVSENAVTVSNA
FKANLAILSDIERHEHERDGQVWKMEWKLLPEMFLMLSVVLANMKFALSDLEVKKDKMLK
NLNTLNGFVLAERVMFALSDHYGKQHAHEIVYENAMLGIEKQKTFKEVLLADKRVSKVLK
EKEIDALLDATTYVGYAPKLVDEFLEKIKNSAILK
>fig|195.2024.peg.1438 (2E,6E)-farnesyl diphosphate synthase (EC 2.5.1.10)
MKELFIKHLENHLPKVQSFHPFFNEALAKMLKAGGKHFRAQLLLGVVQNKAPHLIPNALN
AALALEFIHTYSLIHDDLPAMDNADLRRGTPTLHKSYDETTAILVGDALNTEAFLLLSNL
NLKESIKINLIRTLAFNAGINGMILGQAIDCYFEDKKLNLEELEFLHTHKTAKLIAAALK
MGCEICELDEKESEKIYQIGLKLGLIFQINDDIIDETMSEEESGKPSKHDEHKNSFVNLL
GLEKAIQSKENLINECKNDLGDLDANLAHMIKSLMIKYL
>fig|195.2024.peg.1233 Tripartite tricarboxylate transporter TctC family
MKLKIFCSVLIFGFSLTFAKEPNRPECIAPAQPGGGFDLTCKLIQVGMLKANIISTPMRV
TYMPGGVGVVAYNTMVNNRSKDGNVVVAFSSGTLLNIATGKHGKYNENNVKWLASAGVDY
GMIAVKSDSPYKNLEDLINALHKDPNSISIGAGGSIGGQDWMQTALLAKTINIDVKKIRY
VAFEGGGDALTSLLGNHIDVISAGIAELVPQIETGTIRVLAIFSPKRLPGTLANIPTAKE
LGYEVEWPVIRAYYMGAKVSDEAYNWWLDAFDKFQQTQEYKDQLKQRSLFEFDKKGKELE
DFVKKQTDQYRILAKEFDLIK
>fig|195.2024.peg.1578 Flagellar basal-body P-ring formation protein FlgA
MRIISFIFFVFIGLSHGANLEEIKTALAKEFKNNFPSLIIKNIDLKITTLPKDFEQYQFI
RIANARFNQAQGFIRAEFKTPQNIQKNVFFRYFMQASLEVLKSERSIQRGDKLGAFDYKS
VLMDFDKVPSNALTLEDTHNLIAKSNISKNTILKENMFKTMALIRRNDPIIGVLSDGNVD
VLIELTALHSADMGERIRAKNKEGKVMQGIVTGKNRMIIQ
>fig|195.2024.peg.192 Dihydrofolate synthase (EC 6.3.2.12) @ Folylpolyglutamate synthase (EC 6.3.2.17)
MQKISKVDEFLVQKSTNYDKIDRFVMFRMYEKYKTNFSIKPIVHIIGTNGKGSTGRFLTQ
LLEGLGFKVGHYTSPHIFEFRERFYKNGDIISENDLELAHENLLDIFKDNLKKLSYFEYA
TFLAVELFKDCDYAIFEAGVGGEYDATSVFDKSLSIFTKVGFDHTQILGDSLEKITRTKF
KVMAKQALISSEQDERVLQMAQKIAFLKNTKLYFSWQLKDENLMQLNEYVQKYDLPEFLR
HNLILALNALEILLSKEKLSQALLKLGKLNLKGRCEQIAPHLYVDVGHNVMAASALCKKF
SGEKLVLIYNSYLDKDIFEILKTLKPIIDTIKIYKYVSLERRLANDKIYQVANALNLKCE
EFVSLDEKKKTLVFGSFALVESFLKEWSDKK
>fig|195.2024.peg.791 Triosephosphate isomerase (EC 5.3.1.1)
MIFAANLKCNHTRSSFKIYANILNQYLEAKNDDIIVFPPSIAFLENELNFIQGAQNFYPC
VNGAFTGELGKEHLDEFGIKCVLIGHSERRALGDENLIKAKFDFAKEHAYKIVFCIGEDL
KLKNSNQTLDFLKKQLEVIDLDYKNLIIAYEPIYSIGSGVSAKKEDIAKVLEFLSSLTQA
PLLYGGSVNEDNIKDILNIKHCSGVLIGSAALKAENFIKLIKG
>fig|195.2024.peg.814 D-3-phosphoglycerate dehydrogenase (EC 1.1.1.95)
MKVFISTHPFGETSKIPLELLDKNGFEVRINNRGRKITSKELSKDIGEAEVLIAGTEKIT
EDVLRNAPNLKLISRVGIGLDGIDFELCRKYNIKVVYTPDAPTMAVAELCVGLILDLSRK
ISFTDANLKQGIWNRHMGMLLYGKTIGIIGMGRIGKSLIKLLSSFNVSFKVCDPNPDFAF
LKMYNVELTNKTKLLKESDVVSLNLPLKKDTMNFLMLDDLKNMKKSSILINTARGGIINE
DDLYIALKENLIAGAAVDVFEEEPYKGKLRELNNVVLTCHMGASTIESRTDMETQAVEEV
VRYKNHIPLKNEVFKNE
>fig|195.2024.peg.1500 Glutamyl-tRNA(Gln) synthetase (EC 6.1.1.24)
MYRFAPSPTGDMHIGNLRAALFNYICARQKNMDFILRIEDTDKARNITGKEEEIKEILHL
FGISWQHYYVQSENLKFHRQMALKLVSEKKAFACFCTEEELEAKKELAKKQGKAYRYDGT
CQNLADIDVLKCEKPFVIRLKKPTHTMKFTDFIKGELSFEPENIDSFVIMRTDKTPTYNF
ACAVDDMLENVSCIIRGEDHVSNTPKQEHIRASLGYDKAMTYAHLPIILNEEGVKMSKRE
AHSSVKWLLESGILPSAIANYLIMLGNKTPCEIFTLEEAIEWFDISKISKAPARFDLKKL
LQINREHIKMMADNELNTALNLNKDLAQLAKFYTQEASTIKEIKEKLEAIFGAKDFNEFE
PECKILKDLLSQIEPFESYEEFKSYLLEKSQLKGKKFFMPLRIILTGNTHGPELNDLYPY
IKNYINELARI
>fig|195.2024.peg.640 Flagellar basal-body rod protein FlgB
MINPFKSKELITSALAGRNLRNQLINANLANVDTPFYKARDIEFETALVNRANEIFKKND
NKELQLAITEEGHQKPWKFPDPSKSTIYLRDGHLARNDANTVDLDVETTEMSKNTVMITA
LDGVLRRQSNIFSSILDASSKLS
>fig|195.2024.peg.1675 GTP-binding protein TypA/BipA
MENIRNIAVIAHVDHGKTTMVDELLKQSGTFSEREQISERVMDSNDIEKERGITILSKNT
AINYKGTKINIIDTPGHADFGGEVERVLKMIDGVLLLVDAQEGVMPQTKFVVKKALSLGL
KPIVVINKIDKPAADPERVINEIFDLFVALDANDEQLDFAIVYAAAKNGYAKLDLNDESD
NMEPLFKTILERVPAPSGTNDNPLQLQVFTLGYDNFVGKIGIARIFNGVVKKNQSVMLAK
ADGTKVNGRISKLIGFMGLEKMDIEEAGSGDIVAIAGFEALDVGDSVVDPNNPMPLDPLH
IEEPTLSIVFSVNDGPLAGTEGKHVTSNKIAERLEAEMKTNIAMKYESTGEGKFKVSGRG
ELQITILAENMRREGFEFCMGRPEVIVKVEDGVKTEPFEHLVIDVPEEFSGAVIEKLGKR
KAEMKTMAPTGDGQTRLEFEIPARGLIGFRSQFLTDTKGEGVMNHSFLEFRPFSGAVEKR
NNGALISMENGVALGYSLFNLQERGVLFIEPQTKVYTGMIIGEHSRPNDLDVNPIKGKNL
TNVRASGSDDAIKLVPPRKLSLERALEWIEEDELVEVTPVNVRVRKRYLDPTQRKRMEKA
KS
>fig|195.2024.peg.1360 glcG protein
MKKLLILCVFLGVSLMAKSFELVKEPVLTTQMVEGILELAKKEARKNGFYVSITIVDKSG
QILAVLRDDKAGVHTLNASYKKAYTATSQKRETAVIFKGVKDGKIPEDIRYLDDKFSIMP
GGVPIFIDGVVVGGIGVGGAHLDEDVKIAKAGIAFLK
>fig|195.2024.peg.1275 Transcriptional repressor of CmeABC operon, CmeR
MNPNKTPSKKVLARREKIKNVAFDLFLTKGFQETSLSDIIKLSGGSYSNIYDSFNSKEGL
FFEILDDVCKKHFDLIASQTQTIKDKNLKEFLTSFGLTFVDIFNQVQTVAFGKIIFSQVY
DKHKHVKNWIENNQKIFSYNILIELFKKQDSSYISNNAQKLAMLFCAMLREPYHSLNVLA
DTPLMNKQEQKEHVEFIVNIFLKGIENKTSI
>fig|195.2024.peg.983 Ferric iron ABC transporter, permease protein
MLKTLKYYKIGAILLALFLTLPIFGIFAELFYILFQNFNTSNLAEISSIKENLSHFFDYL
FLKFIKDTLIVSIGVLLLSLILGVSSAYLMANYNFYFCRILEKLLILPLAIPAYILAFVY
VGIMDFQGFFHEVFGFRIDFFNHYGVIFVLGISLYPYIYLFAKTAFKSEAIEAYEVAKIM
KYSEFRIFTRVALLSARPAIFSGALLVLMETLSDYGASAYLGVDTFSAGIFKLWYDLNDS
YSSSILSGILMIFVFLIMYIDYYYKNKHHYSFNQNLTLFIKKRKLSHIKQILACFYCFII
ALLGFILPFIWLVYWGLKDFKLFEAEFYIISFQTIILAFITALITTLLAYFLMFSSRIIK
NNFFSLCILKLSSLGYSIPAAALGISMIVLFVFLDKIFHLNLLGTSLIILVFAYIIRFLA
SAIYSLEGGYNKIHLNTDEASLNLRPSYLILFFKIHTPLMKHFLFLAFIIVFIDTIKELP
LSRILAPFGFETLSVKAFWFASDERIYDAALPSLLIVLLSLIVVIWMDKITRKDDVRN
>fig|195.2024.peg.1431 Putative periplasmic protein
MDFFFVEYRDPLVGLIILTVLIFVVAVANYIWKVFASKDEEQKLEKFIKKFEMDNIHKDL
LRNEGLSFGNLSFLAEIFTKSGEFEKATQIYLIALEKSKDKQEREFIFFALAKVYFKAGF
LERAKEVLLQALKLRPRNIQALKLLKIVYLKLRKYKENLELLGCLFELGENVKEEKEFLK
ALDFLASSLSDEEKKEHILKLQTDNNPMLGRFVFEKYHIFLNQDFSSICDLLYKENKAFN
LQNKEYFEFFYALGLIEDEESKDVNFKNSNFKMLKILKENSFKARLEFSYRCTECKSVMP
LFFYHCPVCYEFNTCQIIYEVKNNETY
>fig|195.2024.peg.1516 Threonine dehydratase, catabolic (EC 4.3.1.19) @ L-serine dehydratase, (PLP)-dependent (EC 4.3.1.17)
MLELNKIYQAKQKIADFVSKTPFIHSSFLSELCKSEVYLKNENLQITGAYKIRGAYNKIA
NLDPEAKKAGVIAASAGNHAQGVAISAKKFGTKAIIVMPESTPLLKVSATKSLGAEVILK
GDNFDEAYAFATNYAKENGLSFIHPFEDELVMAGQGTLMLEMLDDVSDLDTIIAPVGGGG
LISGIASAAKQINPNIKIIAVGAKGAPAMHDSFKAKEVKNSKSVRTIADGIAVRDANPIN
LGIILECVDEFVQVDDEEIANAVLFLLEKHKIIVEGAGAASVAALLHQKIDIKDSKKIGV
VLSGGNIDVQMLNIIIEKGLFKAYRKMQINVTLIDKPGALLNLTDSLKSANANIVKIDYD
RFSTKLDYGDAMISITLETKGKEHQEEVRNILKDKGFDFYETF
>fig|195.2024.peg.1026 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (EC 3.5.1.108)
MKQLTLAKTVKGVGIGLHKGEPIEITLEPLEANSGIVFFRSDLNATYKASPENVINTQMA
TVLGDERGFISTIEHLMSAINAYGIDNVRIVLNANEAPVMDGSSISFCMMLDEAGVKELD
APKKIMVIKKPIEVRDGDKYVRLTPTKEPRINYTIKFDNAVIGEQSYNFEFSKKNYIENI
ARARTFGFLKDVQALRDMNLALGGSLENTIVVDENRILNPEGLRFKDEFVRHKILDAIGD
LTLLGYRVFGDYISYAGSHHLNHLLTKEVLKDKDAYEIVTLEKANEKAYEKVFA
>fig|195.2024.peg.86 Ornithine carbamoyltransferase (EC 2.1.3.3)
MRHFLTLRDFSKYEILSLVEHASELKKNPKKLLQDKTLAMIFEKNSTRTRMAFELAITEL
GGKALFLSSNDLQLSRGESIKDTARVIGAMVDFVMMRVNKHESLVEFAKYSKAPVINALS
ELYHPTQVLGDLLTIKECGKMKDDIAKVAFVGDSNNMCNSWLIAAAILGFDFSVALPKNY
EINSEILEFAKEKAKISGAKIFLTHDKFEAIKGKDVVITDTWVSMGEESEKEKKIKDFDG
FIIDEEAMNAANQDAILLHCLPAYRGYEVSEESFEKHSKVIFEEAKNRLYVVKALLCFLN
KEK
>fig|195.2024.peg.1254 Anthranilate synthase, amidotransferase component (EC 4.1.3.27) / Anthranilate phosphoribosyltransferase (EC 2.4.2.18)
MILLIDNYDSFVFNIKSMLENVYKGEILVVRNDKITLDEIKALNPNYIILSPGPKHPKDS
GVCLEIFKSRLNIPTLGICLGHQALGFSFKAEIAKLQNPMHAKNSLIKIYNKDTIFKDFE
DEVSVMRYHSLEVKNLPDDFEILALSDDNVIMAIKHKTLPYFGVQFHPESYFSEYGIKIF
ANFLNQEKAVQDKKHTLGFYLQKMSENHYLESEDFSEICKIIMSRDYEPLQAAALLVLIS
EKSLNQKSLSSLVREILRYSKTFSDESDMIDICGTGGDNFKSINVSTASAFILAALGVKV
AKHGNRAISSSSGSTDVLDALDVKIPDNLECALNDLQNKNLAFFHAPYFHPLVGELRELR
AKLGIRTVFNVLGPLLHPNLKLKYQMMGNYHAPVHKLLAEVLRSLGRKRALVVRGNDGMD
EISICDETKIFEVREGEIYEYGVTPEQFGFKRAFHSEIMGGNAYENAKDLKDILSGKIQG
AKFDIVVLNSMFALYTANKVSTPLKAKDIILEAIYSGKVMEYFRSLNDKA
>fig|195.2024.peg.1542 Dihydroorotate dehydrogenase (quinone) (EC 1.3.5.2)
MLYNFIKPLLFKLDPENAHALVEGSLRSLNATLPGSLSFFAYNYIVNDDSLKQKLLGLDF
NNPVGLAGGFDKNATMIRPLAALGFGFLEFGTFTPKPQEGNEKPRLFRLVKQESIQNAMG
FNNQGAEKIAARLSKIYPFVLPLGANIGKNKITSNDKALEDYFTLFRNFKDLCDYFIVNI
SSPNTKNLRELQNDDFLSHLLEEARKITNKPILIKIAPDMPIDSALKLCENAILKGADGF
IIANTSVDYSLLDNNRTFGGISGRLITEKSGIFFKELAKVLFGKTLLIASGGIDSGELAY
ERIKNGANLIQVYTALIFKGPSLVRDINKTLIELLKQDGFMHISEAVGVNLK
>fig|195.2024.peg.1055 ATP synthase delta chain (EC 3.6.3.14)
MNDLIAKRYAKAIALRADISEFYDNLFVLSSAFASPKFKNIIESNQIQKEKKLEFVISLI
EKASPSFNNFLKLLAENSRLSCIPQIAKELERQKSFKENIFLGTVYSKEVLSEDNIKELE
NRLSTKFGVKIKLQNKVGLNEGVKISLEELGYEISFSMKALQNKMSEYILKII
>fig|195.2024.peg.437 FIG00470572: hypothetical protein
MSRLNQKDLKQDNLNSLLFMARRKFEGSKEKRLKFAVQKDIAKAYVDYFASSLEWVKNKY
FPHKNSLFTPVNWEEYEQNYTLTHMLSKDWDDVADFIAQIIVSKNEIISSLKEQLELARK
D
>fig|195.2024.peg.1103 LSU rRNA pseudouridine(2605) synthase (EC 5.4.99.22)
MRINKFISHNSPYSRREADELIKQGLVKINNKIALLSDEVKTNDKVFVKGKALRKKTQFS
VIIYHKQKGEIVSKKDDRGRKTIYDTLPRQFSTWLSVGRLDFASEGLLLLTDSPVIADAL
MHSDLEREYYLKVKGTVSKQVIEAMQNGLEIKNEKKGAHAKTKITSMSFAPFIDFEIFGS
SGGYTKLRVVINEGKNRELRRFFGHFDLEVMDLKRVAFGALDLGMLKAGKYRYLENGEYE
KLRDFLKFNEIRY
>fig|195.2024.peg.257 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28)
MINLVEKEWQEHQKVAKASEILKGQIAKVGELLCECLKKGGKILICGNGGSAADSQHFAA
ELSGRYKKERKALAGIALTTDTSALSAIGNDYGFEFVFSRQVEALGNENDILIGISTSGK
SPNVLEAFKKAKELNMLCLGLSGKGGGKMNELCDHNLVVPSDDTARIQEMHILIIHTLCQ
IVDESF
>fig|195.2024.peg.1022 Translation initiation factor 2
MAKIRIHEIAKELGYDSKEIIEKANELGLNIKTASNAVEPEVAAGIYEYIQTKIIPEAFK
KNLKQDPVKKAKAAPKEEKKEEKSPKEVETKAPAKVVEEVKPEPKTPEEPKENIQESLAS
ATLAKRRGLVIVKKKKDEEEAAKKEEPKASTPSNEERLSLKTMFSNADENLKKKKKEKKP
FVATKKESAEKMDFLEGHDFADISLEDEDVVVLPDFSVKEQEKPQNTMKKPPNFLRQAVG
NSANLGLEGGIQRRSRKKPPKKVEKKENEAVSSVEISKEIRVYEFADKIGKSVSEVISKL
FMLGMMTTKNDFLDEDAIEILAAEFGIEINIINEADEFDYVKDYEEEVDEKDLVSRAPVI
TIMGHVDHGKTSLLDYIRKSRVASGEAGGITQHVGAYMVEKNGRKITFIDTPGHEAFTAM
RARGASITDIVIIVVAADDGVKPQTKEAINHAKAAGVPIIIAINKMDKEAANPDMVKTQL
AEMEIMPVEWGGSYEFVGVSAKTGMGIEDLLEIVLLQADILELKANPKSFAKASVIESSI
QKGRGAVATIIVQNGTLKVGSTIVAGEAYGKVRAMSDDQGKALKEIKPGECGVIVGLSEV
ADAGEILIAVKSDKEAREYANKRHEYNRQKELSKSTKVSIDELGAKIKEGNLKALPVILK
ADVQGSLEALKASLEKLRNDEIKVNIIHSGVGGITQSDIELASASENSIVLGFNIRPTGE
IKERAKDKGVEIKTYNVIYNLLDDVKALLGGMMSPIISEEQLGQAEIRQVINVPKIGQIA
GCMVTEGVINRGAKIRLIRDGVVVYEGNVSSLKRFKDDAKEVAKGYECGVGIEGCDDMRV
GDYIESYKEVEEQASL
>fig|195.2024.peg.637 Isocitrate dehydrogenase [NADP] (EC 1.1.1.42); Monomeric isocitrate dehydrogenase [NADP] (EC 1.1.1.42)
MQVTYTLTDESPALATYSFLPIVKAFLSKAHIGVKTSDISLSGRILATFSEYLKEDQRCE
DALELLGELVKKSDANLIKTPNISASIPQLKAAIKELQEKGYMLPNYPDEPKNDEEFQIK
AKYQKVLGSAVNPVLRQGNSDRRSTKAVKDYAKNNPYRVVEFNPNSKTRVSYMKEGDFFS
NEKAVLIDEDCVASIEFVADSGKSEILKEGLKLEKNEILDATFMDVEKLQDFYAKEIKAS
KDNDLLFSLHLKATMMKVSDPILFGYAVKIFFKELFDEFKDEFETLGINPNNGLSELLSK
VQTSSKKDEILRRYNEILNSRADISMVNSDKGITNLHVPSDVIVDASMPAMLKNGARLWD
KEGKEKDTNAVIPDQTYATIYEAVIEDLHKNGTLNPAKLGSVSNVGLMAKKAQEYGSHDK
TFVAKEDGVFKIIAKGKVLLEHKVRKGDIYRANQAKFDAVLNWIDLGIERADLTGAEAIF
WLDSKRASNKIMIDLVQNRLKEKNKNIAILAPYEACLKSLELIRAGKDAISITGNVLRDY
LTDLFPILELGTSAKMLSVVPMLNGGAMFETGAGGSAPKQVEQLVEENHLRWDSLGEFLA
LQASLEFYANKCNNHKAKVLAECLDEAIGEWLENNKAPSRKVKEDDNRTSHFYLAMYFAN
HLARQANDMELQSFFKDIALELSSNEEKIRAEFNDAQGVKVDLGGYYKFDDEKANKIMRP
SATFNAIIEKIGQR
>fig|195.2024.peg.617 Translation elongation factor P
MASYSMGDLKKGLKIEIDGIPFKIVEYQHVKPGKGPAFVRIKIKSFIDGKVLEKTFHAGD
KCEAPNLEEKTMQYLYDDGENCQFMDTESYEQVAISDEDVGEAKKWMLDGMMVDVLFHNG
KAIGVEVPQVVELKIVETAPNFKGDTQGSNKKPATLETGAVVQIPFHVLEGEVIRVDTVR
GEYIERANK
>fig|195.2024.peg.450 Pseudaminic acid synthase (EC 2.5.1.97)
MQIGNFNTDKKVFIIAELSANHAGSLEMALQSIKAAKKAGADAIKIQTYTPDSLTLNSDK
EDFIIKGGLWDKRKLYELYESAKTPYEWHSQIFETAQNEGILCFSSPFAKEDLEFLKRFD
PIAYKIASFEANDENFVRLIAKEKKPTIVSTGIATEEELFKICEIFKEEKNPDLIFLKCT
SAYPTAIEDMNLKGIASLKEKFNVEVGLSDHSFGFLAPVMAVALGARVIEKHFMLDKNIE
SEDSKFSLDFDEFKAMVDAVRQAESAVGDGKLDLDEKALKNRVFARSLYASKDIKKGEMF
SEENVKSVRPSFGLHPKFYQELLGKKASKDIEFGDALKQGDFQ
>fig|195.2024.peg.282 Flagellar biosynthesis protein FliR
MEFVNYLGDKNVATFMLLFARMSGLIVFFPFFSHNSIPMIIKTTFALFLTMYLFPLAKLE
ILHLDSFFIIQLLSEIVFGMIAGLMLQIVFAIVMMAGEQIAFTMGFTMASVLDPSSGTNM
PITSQILHLIALLFFLAFDGHHLMLLFLSHSLGYINLGGFYPHENLMHYLNMGMLNIFII
GFTMSFPILGISLLADTIFGLLMKTMPQFNLLVIGYPIKIALGFVVLIAILLVMMQYFKD
LILEVFTHMQTLFFA
>fig|195.2024.peg.790 Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)
MIMKGKKGLIVGVANNKSIAYGIAKACYEQGASLAFTFLNDALKKRVEPIAEEFGSNFVY
ELDVNNNEHLDSIAEKIKKDLGEIDFIVHAVAYAPKEALENSFLETSKEAFDIAMGTSVY
SLLSLTRAVLPVLKEKGAILTLSYLGGVKYVPHYNVMGVAKAALESSVRYLARDLGVKGI
RVNAISAGPIKTLAASGIGDFRMILKYNEINAPLKRNVSIEDVGNSAMYLLSDLARGVTG
EVHYVDAGYNIMGMGDVTKDENGNTVLCWDNQKGQ
>fig|195.2024.peg.1 Cysteine desulfurase (EC 2.8.1.7)
MQISDLKKEIILKKGTLHFDFTASALALKCVEKEIAKILPSYANTHSDSSLNSFKTQQIY
EQARKDIKTSLDLSDEFALIACGSGSSSAIKKFQELLGIYIPPLIKEKYFDKVDKNTLPL
VIVGPYEHHSNELSFREGLCECIRIPLDKKGNIDFEILEKVLKENQYRKIIASFSLASNV
TGILSDYKRISKLVRKFKGIVAFDASSFIPYKNIACKYYDALFISSHKLIGGIGGSGLLA
IKKELCGSKPSFAAGGTVGYVSRTSQCYLCNEEALEEGGTPGILQLIRASLAFKIKDEIG
IEEIEKKEEILKEYFFEKLKIIPHLILYANNIKTRLPIFAFNIKNISPFDLAYELSKKYH
IETRAGCACAGPYGHDLLGLKDNEELKTKPGWLRISLHYTHEKEDIDYFFEALQKSIAKL
KF
>fig|195.2025.peg.728 SSU ribosomal protein S11p (S14e)
MAKRKIVKKKVVKKNIAKGIVYISATFNNTMVTVTDEMGNAIAWSSAGGLGFK
>fig|195.2025.peg.988 hypothetical protein
MQYSEFATFDFFHHIKTHCSTKTFWTSNSSSPCFFSPARRKIRNLLEEDHLLEQSKYLKT
CFISYHSLYDEYVSLKEKTMLYEELEKLGFDATLCSITKESQVDGKFIKNLNHGMGIPVK
LLIKKELPLMLEKIKQNLKKDYKEKCISYPCEDLLYQFSEKDDKILLKIDKI
>fig|195.2025.peg.1656 Multimodular transpeptidase-transglycosylase (EC 2.4.1.129) (EC 3.4.-.-)
MIIKKNRDIALEEYKFCCKILESEERIFDNLIKYMLTFGTIIISLLSGASEKIKAIFKDV
TENPNYIIWFIIALVLLFFIFMTKNFAEKQKSIIFAKRKIIILRRMLGMDYGTQEFLFKK
GMLEGANMPFSIKLRFNYLYHIIPILCVTALLIIIHMFLGYSLMYAIVFNSIIIIALYLF
YIYCILDINETILLVIIRILFSRLGINFVDNFEHVLYRAKLSAYECKRQKIDLDNLKKIL
VAIEDQKFYQHKGVDFKALCRALLSRGRKIPFFNKISFIKNIPFTGGSTITQQLFRTLFI
ENMNKKRYRRKIAEILLSYLWFNKILSKEEQLEIYLSAVRFDKKIFGIMQAIRHFYGGDK
YIKNLSKAQSFFLIERVSVTSGTMLPKVIDTIVRLEKEKILNKEDIEDIIKIYTKAQQDN
KITVFFKNRNILEELSKKYKHQN
>fig|195.2025.peg.1558 L-serine dehydratase, beta subunit (EC 4.3.1.17) / L-serine dehydratase, alpha subunit (EC 4.3.1.17)
MAELSYRYELQFHTKEEIRAYCLEIWEVMQEVYYNGTHPNEDYLPGKLHLKRRAKGLKER
VTMTADPMGIIDFISLYAIAIAEENASGAKVVTAPTNGACAVIPAVMLYLKNHTIGFNDE
KAIEFLLVAMLIGSFYKKNASISGAEAGCQAEIGSASSMAAAAMATVLGANAFKACNAAE
MAMEHHLGLTCDPVGGLVQIPCIERNAFGAIKAISAARMAMTRKSIPIVSLDEVIETMYE
TGKDMNYKYKETSLGGLATNLKTVC
>fig|195.2025.peg.826 hypothetical protein
MELGTEIRKYMSEESYLFITPKIEQYVMNNGDDFVASLNGVALPSVKSDDKKKTYGQIII
GGNIDISEQFSLNAGIGAKQILAGKTDGKNETYVSGQLGFKYKF
>fig|195.2025.peg.1727 hypothetical protein
MRIARGGGYCKIIEPNSSIKGLFDENMDIIFANQSLYYIPLKELKQNILEFYELLNTGGI
LFAAMMSKKNYYFSHSQKEEKNGLSKVEIKGRLNETSFIHFIDKVEDLENLFQPFETLFL
GDYDPINFYNFEGSAHHYIYIGIKK
>fig|195.2025.peg.198 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MFLDSDDFLALNACEVALTKIKQGFDLLCFDAFVHRVKTKQFYRFKQDEAFNQKEFFEFL
GKQRHFCWSVWAKLFRKDLILKSFERINLYERLSYGEDVLFCYMNFLECDKMGVFKECIY
HYEFNEKGRYENKNKEILWQNYKDKKRSNELIKKLSLKSKGDEFCKRLFEVLEKEEKDLK
ARIAKIDTLDLA
>fig|195.2025.peg.1663 hypothetical protein
MSKPLNTEFFIELDTPVINRKSEVLLQVLDLLETLKSNQNEKMARISSELTELLENEENL
EKITRAQNLEELLDILVALNEDKMIKVYENAYLKERFPHLASSQFLK
>fig|195.2025.peg.1044 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVASYSEKEAKNAILLSSKRYVNYIQGI
LNEEVTLTKVVATSLNEMFQNNDHVDINLIESLIKNAFDSSHYAAYTFLYLKDTTVLSDM
QNVDKKYISPDGKTFSMIFFDQIAEKSGGITTISTPNNFSQLNLIQNIEQNAKYGDKDSV
FVGSPRKLNYDNNEFLGINFGMPIFNNKGKFIGVIGYTLDLLEISEIILDPKFDFFEGDL
RILMNDQGIIAVHKIKNGILKTLFDINKDQSAQLIVEAVKNHKDEILDNYIASTGDPSYA
SISSFSTLGNSSHWSVIVTAPKKSVLAPLYKLQYTIISVAIIALIAILTVVYFFIRKIIG
SRIPLILKSLENFFRFLNHEKIEIQTIEIKANDELGKMGKIINENILATKQGLEQDAKAV
KESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEY
KSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSN
SQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAI
EAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQ
INESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2025.peg.1655 Multimodular transpeptidase-transglycosylase (EC 2.4.1.129) (EC 3.4.-.-)
MKNYNKVLKTKKTENFSNSKNYEEQVVNWQQYFPTYHFDYKKK
>fig|195.2025.peg.1255 Small hydrophobic protein
MFFAPFKGASLALQAYLGSLVILGLGLNCLQFIANSLLLGVSCNKILSNVI
>fig|195.2025.peg.561 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIISGLGGDIDDNLYIEEY
CARNYNVAVLSVNYHCIGNRPQTGASFYINELDRLILKTSLEAIGIQLPVDMQNLKTYDE
FYCVVDFVNKFIEKLKKEKELSEDYCLYLSVGLEPTKNEYQNYGIMQAMDIINAILYINI
NLPFKVSNMSTVSRMGGGYKDYINRCFAWRIFSQFMCKNLSLEY
>fig|195.2025.peg.1657 Integral membrane protein
MTNTQINDKILELANYLKIDNKCVAHNARLQSIQINGAVIKNFSFKLFNEYKLSFFNCKF
LCEINEAPGFFEIENPVYIYGCTFEENVISYNIKFKSNVVIAYCRFNKNFYFEANTFCNS
SNFERNFYNYASFKKSHFEKNVTFYNSTFKGLDFSQAIFNENLNIVNTKLNFTFSNLEEK
IEQEYEEFNKNKKEEDQKSLDKFANDFRDSFRTFKSALIKDNNALDASNFHKYELYCKEI
ELKQNWDKKGENVKNTTDLEKNVSRIRDFMDFLLLGFYRKLCDHHTDFLKVFNNLILLIA
LYALFVFGFTWLHDDKLEDTRAILTLFGFFDKFRLYFDIISTIFVVFGCGFFVCKLDSYE
KKNNVSKKQNINFIYIIGDFLNLIKSLLFASFIPCVFYGLFSLFGFFLNLGKDFGYSLLI
NTLFVSLYICLVYTKSLFFGRYVVLIFSYIVFIIMLIKQPNVIHPLIGKIANESDKFFNY
PSLIVLNILYTILLALVLFSLQKTARKNSIVPS
>fig|195.2025.peg.916 haloacid dehalogenase-like hydrolase domain/phosphoribulokinase domain protein
MSNAINEIYKSFIISTDGYHKYERHSKIWERVTHYNPKANNLIQLAIDIKHIYQDIGNKL
HIPIYDHKNGVIVKSDEIEIKDLDIVIIEGLHTLYQEVIGDFVKIKIYIDSDEADRQKID
RDSKERNYSHSKIIDTIQKREEDYKKYLEKQKDNANFLILVRDGIFKIYLKDILLNNYLQ
KEYTGRYEDLIQTVKDIFDLILKNRWVKENDA
>fig|195.2025.peg.296 hypothetical protein
MRKILLQIFSFSFIFMGIFALVRSLMVKNLTNESENSLMVYMYGLGHDMRTFSAIFLPLF
LCGLFSYIGLVFKNRKYNIMGGGNL
>fig|195.2025.peg.1557 L-serine dehydratase, beta subunit (EC 4.3.1.17) / L-serine dehydratase, alpha subunit (EC 4.3.1.17)
MSNLNIFKIGVGPSSSHTLGPMLAGNLFCKKIAKKLEKIERIQIILYGSLSLTGRGHLSD
KAVIWGLNALEAKNLSAAIQDEVNKNAIENAQIDFCGEKKLCFNYEKDLIFSKDFLPLHE
NGMKIKAYDCKGGLVDEETYYSVGGGFVLTAAQLEKKVKIPTKIKRKN
>fig|195.2025.peg.1747 Flagellin
GNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRISTSGEVQFTLKNYNGIDDF
QFQKVVISTSVGTGLGALAEEINKSADQTGVRATFTVETRGMAAVRAGTTSDDFAINGVK
IGKVEYKNGDS
>fig|195.2025.peg.781 hypothetical protein
MKKIIFLLCLCISFVFAKQIYIVHGYGSDENYGFLPSVAKNLKAKNHEVLLLSFPNAFSP
KLDEWMQTMSQNFTKLDENTFLSRIL
>fig|195.2025.peg.446 hypothetical protein
MVILKAKIISNKTKNKLNFIFLFQSSFFKPFSKVFLL
>fig|195.2025.peg.60 Alternative dihydrofolate reductase 2 / Dihydropteroate synthase (EC 2.5.1.15)
MKFFKINPNTDFNLLCSFINPHKMGQKIMSEKTQIHFILIKDIATPAANILKQDALRVGA
ELITHKEVITAKITYSNALLMATKEQIQKLINKEKLQDFGLKNLARFLENDFSKPKQAEL
MAVINVNEDSFNADSRVSYKDFEERLNEILALNPEYIDIGAVSSRPKSVYCGKEEEFRYC
GKEEEFRRLKNVLDLIYDKNYYEKAIFSLDSFDEYCLEYALNKGFKFINDISSLRNLNLA
KLASKYNAKYCLMHMQNDPLTMQDDPRYDDLLDEMSSFFKEKLEILDTLGVKESILDVGI
GFGKSAEHNMILIKHLEHFLQFKKPLLIGASRKSVINAYYESEVKDRLAGTLYLHLKAFE
NGASIIRVHDLYEHKQLFAMANAMQSIGV
>fig|195.2025.peg.24 hypothetical protein
MLINQTFEIDSCDDVELGIKRTSKLEYRISYDDEKDVKAIVFIVGGFGANANISFLDFDR
EYIAKNFDVAVVHVFYHCFCHRRSNVEKYSAYKFFQDEDIENIKNLLNRFHFSYGEINND
NALFLANSLVKHVENLKMQNKLDYNFKLNFTSTIIPPNGDYQNYGIMAALDHINALKDLV
KRFPKFADLPKIYGGGVLWRIPIFTHSKNSSLVCGWCD
>fig|195.2025.peg.1746 Motility accessory factor
ISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDIKPDYVCMLERDEIVA
ECFNNDFGEFDKDIVFIVKSVTHPHTIKYLQKNNRAFILVSTYASFIQYLKLDYFGYFNM
GFSVAHMNFLLTIHLKYKNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDKFST
>fig|195.2025.peg.948 Predicted hydrolase of the alpha/beta superfamily
MGRTNQSSFCLIFKNIGFLCRYCIVFLILTIPLFSKPDQKITPIIEKAKDYFFIEKDLKL
THYHTSYRIFVAKSKIKYKKYKVIYLLDGNAFFSRFLNLYNYLPKEDILIVGIGYDSPLA
FDTTHRTKDYTPKVQGLEFQNGGGSFEFRQFIKTELLPYINTHYETSEDFQILFGHSFGG
LFALDTLFNDTKLFSHYFIISPSLWWGGSEFIPKRISLSNCPQIYMALGSAESNSSIKKA
KAKISVKELGMQILNHSACEVEFKLFENETHGSVIEKAMIWAIENIKSEPID
>fig|195.2025.peg.560 hypothetical protein
MTLDNDLWRFIGFGREIDYVKYCSVGITYMFKNIKLAAFDKTYWTTNKQSPYYFSNARKI
VREPLNKEHLKIQSLYPKPKYIAYHSKFDQYVLLEKRENYFNILRELGFEVDFIKITDEK
EIDGKFIKNLEHGCGIPMKLLIKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENHQ
IILNITN
>fig|195.2025.peg.1543 Hemolysin, putative
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYATIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGGIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEIKANNVVNIDSVNDLNIKNSDIS
TSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQKSNTTTSIDGVLSTNIKGANVGI
VSNQDVNIIASNINADSKIDINANNVNIKDAHELSKTKTDGVY
>fig|195.2025.peg.784 Type I restriction-modification system, specificity subunit S
MSNLPQGWEVKTLSEIGEIVTGSTPSKSNLDFYGKDYPFFKPSDFEQGYFLENAGDNLSK
LGFDKARQLPPKTILVVCIGSLGKVALTKVIGSCNQQINAIIPHKNIISEYIYYYCISSK
FQSILFSKAPQTTLAILNKTEFSKLEIIYPKDIKEQERIVGILDFAFSKIDENIKKAKEN
LANIDELMQSALQKAFNPLNDNTKENYQLPQSWEWKSLGDTSNYGKTSQVKPSQLKGNDW
ILELEDIEKESGVLLQKVLFQDRQSKSNKIKFNKGDILFGTLRPYLKKVIIADDNGACSS
EIMPFSTGNSITNHFIYYYLFANFLHDRISSLTYGARMPRLGTKDGKSLQIPLPPLQEQE
QIAEHLDFVFEKAKALKELYTKELKDYEELKQSLLDKAFKGEL
>fig|195.2025.peg.783 Fic family protein MloA
MKEFIPQKLPLNIELNANIYSLIIKASRKLAELNGLSKSIPNPNILINALILQEAKDSSE
IENIITTHDELFLSQIDESKLTRAAKEVKDYENALKKGYELLKKERLLRNAHILEIQKRL
ERNNAGFRKQSGTMLKNPITGEIKHIPPQNHSDIQELMRNLEQYINDDTLDELDFLVKMA
IIHYQFESIHPFYDGNGRTGRIINILYLVYKGLLDLPILYLSAYIVKNKGEYYSLLQKVR
DEGAILEWIEYILKGVEQTAIKTIETIATIEKMMLNVSEILQNKTNFYSKDFVELLFSHP
YTKIDFLIEKLNISRQSASKYLKICENLGVLECIKIGRNHYYINIELLRLFKKGIFLNAK
>fig|195.2025.peg.1542 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MVDGDYFNVISRGIDLAGSIAHYQSGKNLSDINFIAGLNKVDLSTPNAPKIIASKQKDEK
NDYGIDGKYLGTMYANTVTLISTEEGVGVRHSGVIRGIEDVIVKVKDKAEFQAIGVNTNG
SVKIDAKDIKTSLINADTIDLKASGKVTNEGLYKGKQIQINANNFENAKQTNLSQETKDI
FKINQENSSIFADSLTLNTLDKTSNFGFINALNDIKVGTNSFDNQGEISANKDISLMLND
DAFINNGKILSQNDIQIQANKDLTLNHGNLYAQNLLHIKSLNDLNINSKFENTSSIELDA
KNIYVKNLVASGKELNLHADENLVNDAYLFSNGDLRAQATTLTNNSTFNSLNNLYLNAHT
IHNNALIFADKDINIEANILNNNANLTGMLETSTEYSQGFGQVGYGDTAFKRWNMEVGVT
GIVKYNNLLDSKQASIQAGKDININTQSQDNARQINNSGKILAQGNIVSFGNIDNKSLSK
EISVGEILEQIRVNGFFAKEYLGSWNTNSTYYFVDHESLLDALKYFSTTQAKNHQRESAW
NALKDAAAKNSALNQYFSLLFGSDYASKRFVPDQKEWNLDAKIVFKAKSEAVIASKGKLD
LNAKEYNQDLVSSLDKNFALLDSDLKKATNSQDLILNSIPDLINSGLFTLENKTNDNITY
EYTTNTSIIDESKYFGFLSILNQFKNKNFNEFIVIGDPFLKISLLTQCMQTHYNPILN
>fig|195.2025.peg.906 hypothetical protein
MNISVLLPMKGHSERVKNKNMKDFNGFPLYHAIVRTLLKSSYVNKIFINTDSDIIASDAK
KSFGDGIVIIKRPLEIQGDFVSMNDIIAYDLTQCDGEYFLQTHSTNPLLKTSTIDLAIKK
FFDNLDLYDSLFSVTKVQTRFYDKNAKAINHNPQKLLRTQDLEPMYEENSNFYIFSKKSF
ELAGKKRIGLKPQIFSMNKLEAVDIDNPEDFILAELLYKNRSII
>fig|195.2025.peg.197 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MGRWIKIFIDFLKFDKILFIILTKFRENMPQLSIIIPLFNSCDFIARALQSCIN
>fig|195.2025.peg.780 hypothetical protein
MLDFLNSLDERTKIGGVIMVAPFDEPLAKLPILNDFIKPKLDYKKLDNMIIHKIIISAKD
DKVVPTWMSENLAKKLNAKFIQTPNGGHFMESEGFKDLPLVIEELERIK
>fig|195.2025.peg.1371 hypothetical protein
MITHFKKCIHKSKYLKLSSITIFDFVGLIIPIKALLCKFRVFKFGKAFVFISNCLL
>fig|195.2025.peg.1654 hypothetical protein
MERKIYNIKRGWLFKTKRDFAKRWNIEIEDRFYERCITLIGDIINPKQLSELEQKIFLIV
GEIYKGEKKFSGVISIFNHFNGLHDSYFAFHETALYSLLMQLKDVKFLEALENIINFCKK
DKDDEFLLTFNDIVLMSNKPFRLYYNDKYEFHPSNIEIFDQVLINDVLEFLKDYPKAKKQ
LSEALKIFITKENYRDVVDKTRLSLELFLTQLLNNEKSLENQKDEILRYFGNLLDENFKK
MFLEILNYYQRLNNNRAKHCKSNGQEFKDYEVEFLIYLVGNFLQLFMTFNKFKK
>fig|195.2026.peg.1380 hypothetical protein
MAGEFLMIYDAIDVNKIKKLSNLSDEAIKSSLANEFLELVSGFNNISKKKFKREFAEFLF
EKGVNEKDILKITNLSKTTIWRIMNENKKN
>fig|195.2026.peg.1309 hypothetical protein
MKSKYNSVVKVRKQQLDKAESNLNQAKQRQLEHEKAYELSRQECESLGVLPKSGSIAELR
SNLSMAQVGREALARAREKVELSKKEMNHYQFLYQKAHLDYEKMKVLEAEEIKQKQKELA
KAEEKFLDEIAISRFFKGEKDD
>fig|195.2026.peg.1255 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MQNLYSEDDTRVKLIDAKLYASSWSEENIIRNYYFTDGRKLIGNKRAERKFADYLLKFQN
NNLAIIEAKKQNKDALDGLSQGIEYAKTLNVPFVYSTNGDKIYEYDLRVSRGEYIENFPS
PNELFQRVYGNLKEWQYKLLTQRELYIPQKTLRYYQKIAVDKVIEALINGKDRILLTLAT
GTGKTTIAFALCYRLLEARWNKENKDQKPKILFLCDRVSLRDQALGEFNAVESDCKVISA
EEIRKNDGKIITNANVFFGIYQSLAANSKDQENTQEEQESKFYLQYPKDFFDLIIIDECH
RGGANEEGNWACVLEHFSSATHLGLTATPKKSDNVDTYRYFGESAYEYSLKEGIEDGFLT
PYKVKRITTTLSEGYVYNPDDLIEGELEKGFYKMSEFERNIHLPQYNDFLAKEILKLIDP
MEKPSSFVPIKLTQAI
>fig|195.2026.peg.802 hypothetical protein
MCSANPTEDAQLARKWYVDYGGGIKNLGNQTAPKIDLRQAQHFILTMTARGAIGIANWGG
AGKSGTITVNNAQNITAFSAPFKFRVAQSGFSGTETFAYFCIASNNVLITRT
>fig|195.2026.peg.145 PhoX, Predicted phosphatase
MQRRVFLKGSALGSMVAFFGGSNLSAAVLKDKELLGFKAVSASTKDEVIVPEGYEAKVLI
SWGDPLFSKAKAYDESKNIDMNAVDNARFVFGDNNDGMSFFSLSKNRGILAINNEYINPE
IMFNHQGKNLSKEDVLYEQASVGVSVLEIQKKGNEWAVVLDSKYNRRIDANTKMEVSGAA
KKEVLKDKKFAYGTFANCANGQTPWGTYISCEENFDDYFGSSDENLKFDENFKRYGFKTK
SEYGWEKFDERFDLAKNLDEANRFGWIVEINPFDAKSTPIKRTALGRFKHENAEFIVEKD
GLVIVYMGDDEIDEFIYKFVSKHKYVKGGDTSKILDEGTLYVGQFNGNVGDFRGSGKWIA
LEYGKNGLDESKGFKSQADILINTRLAASVVGATPMDRCEWIASHKESGSREVFATLTNN
KNRTQANAANPRTKNLYGQILKWIPKNSHKDDEFTWEIFTLVGNPDNQKGLNKGSNNITS
ENKFNSPDGLKFDRDGRLWIQTDGSYSNKGEYAGMGNNCMLAANPKTGEIKRFLTGPIAC
EITGIAFDEDYTTMFVGIQHPGEGLKGSTFPYGKTPRSSIVMIRKLDGGVIGA
>fig|195.2026.peg.1559 Anaerobic C4-dicarboxylate transporter DcuC
MSNTLAGLGLTLMAIAGFSAYMDHVGASYALLKFLKNL
>fig|195.2026.peg.1523 GDP-L-fucose synthetase (EC 1.1.1.271)
MEKNSRIYIAGHRGSAGSAIMEKLQNLGFDNLIYATREELDLLDFDAVKNFFDDNQPEYV
FFAAAKMSALGVRAPADILYENLAIQNNIFHNSYLSNVKKLIFFGSSWMYPQYTQNPIKE
DSLLTGELEYNAEPYALAKIAGVRMCEFYNLQYNTNFISVALTNLYGKTADFNLKTARVL
PVMLRKFHLAKLLNEKKYGDILLDLNLQDENEAISYLKTNGIYEEYIELWGTGKTRREFI
HSDDLVDACMYIMKHVNFSDLSKNNIKNTHINIGTGSDLSIAELALLIKKITQYKGEIKF
DISKPDSPMNRLLDCSKIHSLGWKHKIELEEGVKIMYEDYLQNSKRVLRG
>fig|195.2026.peg.1400 hypothetical protein
MSNEVVLKEENKLEINFNPYELALVKGDLSKLSDVERASYVKNLCESLGLNMLTKPFEYI
VLNGKLTLYANKSATDQLRQIRKVSITKTEVAQVGDIYMVTAYAATPDGRTDCDTGALNI
KNLGGDNLANAIMKAITKAKRRVTLSICGLGMLDESELETIKEKRFLNPNEDLKVWGSDE
KAIENKAKEIKALGAELRKFMSDNGLNTGEQNNFIKKHSLFTSEKIREVLSNKDEFLTQL
KGEL
>fig|195.2026.peg.1355 Probable integral membrane protein Cj1452
MDILKLAIKDFLSLKFLKFALIPLIFSLVLMLFLGVLGFSALLDYFNSLFSVGEDSFWAW
FYALHFVQILITIISFLFSGFIVVFASVFLALFITSFLTPFIAKEINQKYYHYDNTNEVS
TLKTIFEIFKIFIKFIGIFLLCTLALFLPFINLFVYYLAFYYLFHKLLMLDITSSVLDKE
NFKIFNAQASTFEFKFSTLCFYLLSSIPLLGIFLQVFFVIFLTHLAYQRILKLEVKG
>fig|195.2026.peg.1557 Anaerobic C4-dicarboxylate transporter DcuC
MLDSILVLMGISSAEEVKAAASTAIKMNVPVAMVISTFVAIIFEMIRYKSIVETLNSIMI
FFKGMGHLFVITVSLIVCGQVFASGLLSVGFVDTLIEFCKNAGFGVLAIIIAVSILLVVC
AFLMGSGNAAFFSFAPLIPNIAKHFGVETITMIAPIQIMTGFGRCVSPIAPAILAISAIA
KVSPFAVVKRTAIPMLVAAIVNVIMTYIYL
>fig|195.2026.peg.1761 hypothetical protein
MEFHFTIINIGAVTGISSFLILLLKYILERYSFIKYIKYKPNLQLLSALYKAEIEGYKFI
KTGKDMALIGHTQDKWIKPYRCIISIFSKSQFLDESTNEIYIYKIDLFLLLMIKLLRKVK
NKNILELNNQLEIFNINNSRQKQYYKFEFFKNQKDFIENHR
>fig|195.2026.peg.498 Membrane protein
MLLVWIIFIFNIILAFLSIDFTRIHESLEQIKLTFFASIFILSLTLIFFLFRKKRALARK
DQKILLIKNEFIHAEEIDIETSLDLIREKIAHLNQDLFKISHEKETYAKLLEDSLYQIGN
IEGVVRCLDEEEASKEIKSLVLNALKHQKEQIRLGLNQALEYHKSIGVAQGNVLQFEASA
AIVSDDGLEAFLLANLLSYFGIENTIFKSLSFDINDFHVVFIKDKILEQSSKKADDFIVF
GRSKNLYYEYFLSLPFEKKELENILQRKLDKICALKFQTPYQNNVLLFKQNEFDATLFFN
IIEKQCSQNMRVNSFSELKKELKKEAYRLILLDYELIKFDLEQMRSILSAYKKQHPQSHI
IFFSRERVRDFDCVSEVLNDISRNDLIALIRKYLPKN
>fig|195.2026.peg.38 FIG00638667: hypothetical protein
MKTKIIPAILACSAILASANMVPASTQTPAVAPAPLHPYPAYPQQAMPPQDYFNGLPKNI
NSQFKIYIQVLLLLMWIGKSMVMRLSSIILWSFILIAMAIFWDKNLMINHF
>fig|195.2026.peg.795 hypothetical protein
MQTQQVVTKIEIQKVRIPQELLTLSPLEKPKAKNELDILNAYSMLFYKYKQCEIQISKIK
ELNNE
>fig|195.2026.peg.1677 Major antigenic peptide PEB2
MVVDGAGQVGLYEDMALKDGKRENLVKLRKNIKVYAKNSKIAIDEWNNNPNIDALIIWSH
WAKVLGDKALFIEDEKAAVYCTAEIIPTKKRTSK
>fig|195.2026.peg.1375 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANEFQQEQDLRKQQMEFNQ
AMQNNQLLQNERNFDYQKERANIADQQWQMNYNQRARQYAMQNALRQQAINARQQKDEIL
AGQAILNLPSYTKSNPEMRAIQERFNTIKKGGGDSYYDGQGLLGGTWQNIKGLFGGDNIN
DAQDSLFKLVSDSIYNEKVRRDTSYNRTRHDEIYKEPSAWKAQTINAKEYEKAIRDYIAT
SEANINAYYDKQMANISNLKNPYINNLYEEQRQEDLKHFREGLAKDLGSYYIKDEKYSKP
SKNAAIIDNSTTNQNIQNDLAKNTLAVQNQNTPKLHSVSFNGINAQISEPDANGNVILVN
QAGKKMQVSVEELKKQGLIQ
>fig|195.2026.peg.1202 hypothetical protein
MENDIIKKFINTDYKLLEKELEELSKKDELRLEVDQGLDQTLRDLEIISAKIPQEETQKL
FDQCANNAMDAVMGHFGFAAVILDAKDGGNVNTTHNVRNGFYASEKEKQRYANRGKYDSD
NYHQDDNYKRINKEQNVLKKQGKLEDYMTGKKINANADTDLDHIVAAKTIHDDPARVLAE
IDGAKLANTESNLKMTDSSLNRSKKDKSAEKFLADRDKRLKFLAEKEKNGALTPSQQKEK
EKLLKQKEIQDEKFKEQYEQNEKEINREVDKTYYTSSKPYKEALITGTQDAAKIAVYSAL
GVVLKDFIKAIIIELKVTFKEFGNESLKEILVRFKDRFCKVWEELKLKWKDILKNSLEGA
LQTFFSNLVVFIINIFATTLKKIVQIIRAGFTSLWQAVKIITNPPKDIPKEDIYYEASKI
MVTGLISVTAMLGSETLNKLLTSVPILGPVMQFPIPFTGEKNDQGELVNFQTIGDALSLC
ITSACGAVLSTIAIFYMDKWRNDSKIGSLQIQLVAQNGVVMHYKIAQTWFVLSDAYNLFG
QVMERGSQNLVILKNKVNQVQNKLKQAEGERQEAISDCIKQLENLRGE
>fig|195.2026.peg.713 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72)
MIEEILKDSDYKLDLFSKKAIAELETKIIAKTNKNNQIIYYTNCLIRDKEIKLTPEEIVR
QLYIDKLLNEYNYPKDMIKIEFGVHFGREVKRADIVIMDKIQITVPYIIIEVKKPKLKDG
KEQLKSYCNATGATMAVWCNGKEISYYHRKDLNYFESIPNIPASNQTLPDLLKVKFTFDD
LIKEDILKSQKRSLKNLVTEMEDEVLANAGVDVFEECFKLIFIKLFDELEGARDRTKSLE
FRNYGESDSELKQKIEKLFDKAKKKWEGVFNNDEKIKLSPSHLSVCVSSLQNVKLFNSNL
EVIDDAFEYLVNKSSKGEKGQYFTPRYVIDMCVKMLNPKKDESMIDTASGSCGFPIHTCF
YVWRSIYKERGIEASHLFTAQEKISECQDYVKEKVFGIDFDEKSVRVSKMLNLIAGDGHT
NVLYLNSIDFDRWDEWVKDDEDWQDVYFEGFKRLKNLRVTKNQNRDFNFDVLMANPPFAG
DIKESRILARYELGKKENGKPQSKVGRDILFIERNLDMLKPGGRMAIVLPQGRFNNSSDK
YIREFIAQKARILAVVGLHGNVFKPHTGTKTSVLFLQKWDDKLCPKCEDYNIFFATMNEP
SKDNSGEKIYYPLLDSHDHLVVKHDLFHPHLEGDEPIKQKDESQEEFDKRIQEYRLNVEK
YKDLQKDGVAEAFIEFAKAENLSFWKE
>fig|195.2026.peg.270 hypothetical protein
MITGGSGGSNTRTGLVFEGQVDLATFLSQQNGYTLNEKQEVFFNNEKVARIFKKYKLYEF
LEELKINWKECISKKLLPDDSIYVIINNTLHIIECKFQSVAGSVDEKLQTCDFKKKQYQK
LFSRANIEVEYIYLLNDWFRKPEYKDVLDYIISVRCQYYFEYIPLQKLGLPVP
>fig|195.2026.peg.1479 hypothetical protein
MLHLIKKQMLFFTELEDQFLKGEVGKSSIKLDFEYYILYSQFLQIDRESLISGRNYELVF
CFLLYYRALLNKNNTQKIVAKIINAIRCQERLPEKIHYKEKIICMDNHHRDLSQILSSCV
VEFYNSIDLYNTFRKNIGFENRKK
>fig|195.2026.peg.716 hypothetical protein
MNLNQTLQEKYPHLEVSVLKLSEVKKNIDFRIDDSFWTMKLIYNNKLNYKKIGECLLKSQ
YGISINMNEEGDGIPIYRMNDIDNMLCNFEVKKYALIDKNELQTFRLNYGDVLFNRANSY
EFVGRTGIFYNNRENFVFASYLVRLVCNKEILLPEYLTVFLNTHIGKKEIRRRARPSINQ
ANVNPEELKEIKIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDPKNP
LQSLLDSKTNNPTKSLNISIHTLKESFLKTGRLDSEYYQSKYEDIEKMIRSYKDGFCNLK
DLVNDISSGFAFSSDDYQDVGELVLIRINNIKNATLDLSNVIYLKNEAYNLSPKDKIKKG
DILISMSGSIGLSCVVRDDISAMVNQRILKISIKNFNSDVLVLLLNSFICKMQFERIGTT
GGVQTNLSSIDMQNILIPKIDSTTQEKIAKYIQESFNLRKKSKQLLDNAKIKVEEQIQGK
I
>fig|195.2026.peg.798 hypothetical protein
MKIAFYKVKENDKSTFLDKAIAFFTSSWKERLNGDFLNSYSHCEIILDNLMISSSPRDKG
VRIKEFKDSGRWDFIEINDINETKIKEFLYSQIGKKYDFLGILGFFTFTKDSEDKWFCSE
IIIRALQIGGLVKLGDMNAGSSSPNKLYKKLKDTNEN
>fig|195.2026.peg.1253 hypothetical protein
MQDKDNIKTYYECLKELSKEELYEGLLGYGMFADRIPNFLTSEYFFEFCKSNKPSFEQKE
YRYIKYESMRNINVPRVLSIPNPFAYYKQCKILKEYWKKLQRYFYKKTKSNKYKISRIHI
RKLYEKKLIDNKYYDVEIEKIFIMNFKNYKLDGTPEQEIFIGKGYKVNADISNCFPSIYT
HSIPWVLIGKIGAKKNKGFTKLYYNKIDNATQWLNYGETHGILIGPHSSNLISEIILVAV
DYKLSKKYKYIRNIDDYTCYVKSHEEAEQFLLDLSIELKKYGLSLNHKKTEIIKLPSSFE
KPWKNKLKLFKLDSYSGGIKYTGIMPFLDMALNLMKDNKNNAAILNYAFKILIKKKMTPS
AKKYFINIIHHLVLLYPYLIFLLDKIFNEKELITQENIEKISSDIFNLGKEKRNYEAMSY
ALYFALKYNFKLKEKINLLEEAKRKEDCILMLLCYLYDKKNNKDTEEYKIIANNFIINTT
SKNTNFKILDDEYWLFAYEVLSREDPSALNKCKDWKQIKNSNISFIRQEFQ
>fig|195.2026.peg.281 hypothetical protein
MKKFFILFFALLSFLKAEPSLDELADFTPMFAIRSLETGISLSPFRKTSKRLEDQNWFLK
EIVANDELKARDMHAKDLPFGYVQFISPRGDDICLAVLSEKSFGTKSCKQDLQDGTMQTI
FSIIPMTNGSIQIRSLTNGGNQCMSTFPDSSIAIENRFGLGEYLLDRSIVTVLSKLFFFS
PAIIEASAIY
>fig|195.2026.peg.1367 hypothetical protein
MGTSLNELKTGREKLEIINQVLARISNVATALDNTRIEEIVGLKEQVNNFYNQILELKNL
VVKNSELTQSNTDFTKNKRNEIEKISNEIKNTLNNIEEIYNNIIKSEKDISNGVNFVKDK
YPELNEFNKNFEIIKIKLEEYYNIAVDFNAGLKKIEENKNLTKSYLDLSIELKQQILQEL
EHAQSIKEDLHSNIELVNKLVSNIVATKNEIISITNNFKNVKSEVQNIVNDAEATIKLKI
NTILFENQRLNQNMIDLLKRCEKLEDEIVGKYEDILKIEDLINSSTGIINDLREAVKQSE
QISEDMRSFTAIINDFKTEISNLKADLESYGERLKGQLDLKLAQANSSVDAKISSIETLK
NQIEAYVEANKNTVDVALANFIERSKIANEDLGRLAEVARTELANDKTAIESYLLELKKS
IVDEMKEVSNSVTDETSGILAQKNQIELIMAQGKSDLDTLINNFNSNYQNKLNEFNSNTN
EKLASINSLSEESITNIQNKTDENISRLDTASEEKLAKFDEIIKDNLGEIYSHIFSIENV
LMDKKIIKLTYKE
>fig|195.2026.peg.1526 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28)
MENLNLYIKSHFSDSIDVKDKILNDDNIINLIKEVSLKVISAYKNGHKTLLAGNGGSAAD
AQHIAGEFVSRFYFDRPGIASIALTTDTSILTAIGNDYGYENLFARQVQAQGVSGDVFIG
ISTSGNSKNILKALDVCKEKGILSIGLTGASGGAMNELCDYCIKVPSSCTPRIQEAHILI
GHIICAIVEEELFGKGFDCKL
>fig|195.2026.peg.814 FIG00471048: hypothetical protein
MLKGYKVKITSQITKPKRLNAAQWKTIFIVCFVFAVIMISSFFLALNPHDETLKKVTSIF
NPVFVSFLGIVLAVIFGIGSEKEAFKNVPWDLIFMIGSLSMLIELSKTTGIMENITIFMS
AHGSSSSNWLYYLLGILSSCMSAFASSMGVVMPTFFSIVPSIKALEPSLAFSIIAVFATF
TGYSSFSTGGALVLAGAQNESEKRYLFIRLIILPLILVVFGFVLLFLGILN
>fig|195.2026.peg.1793 hypothetical protein
MISLNSHYPNINYPNNALSIKKDENNEYAYAKKDEPKSEEDAYWEDFVQKYFGEMLSKEY
ANKYGYNGSPDVKEVENSLYKRYMEDKLSKDEIKILNEFGTDYLVEGVDLTALIRRKVDL
LKTLTSMNEFEKIWGAERAQREKQFFNELGKPLTQEDIDRFLANKNNQKEDKKTFKPIQA
ESKNKETYKDDNTRNELLRKLLETKFGTSDELEILFGMNFSNDNAGEFNKILSLNSTPKS
IDIKA
>fig|195.2026.peg.1383 hypothetical protein
MEKYFLKIDLKSNPVPYKRTTQKSKFACKDYLKYLDFKKLLQMEFRRQNNISCFQAFDKQ
KKYEFSLKIGFNSKRHGDGDNIVKGVLDALFENDKNVLKGDYEIISFKKSFLDLEIKEFN
FKEGVA
>fig|195.2026.peg.1199 Transcriptional regulator, YafY family
MTHDKLAVRLAQILMRFNNGGRFSLEELASEFNVDIRTIQRDLNQRLSFMPIKKENGKYF
LESFALGKLSVKDIQNFAMLSGIQELYPKLDEDFITDLLNSKVNSIFMIKNNGFEKVDYE
NFEIISVAILKHNILNFNYKEKSREVKPYKLLNYQGIWYLIADEKDKLKHFTFSKIKNIR
KNNEIFTPKEEFLDQILNDKNIWLDDSKEAIVKLDKKAKEYFF
>fig|195.2026.peg.1406 hypothetical protein
MSEQTYELRFEYFNEENATVFFQKITDFLLSIDKLNNSLVSVFGIEIDINIQIKSIEKGS
IRIWIAEKLSKISDDDIKHYVSNPRELLANLLIKSKKMILEKIQDKKCQDIPKEYKNIIE
KSDLKDFGYNNNETNLLTCVSDLTHKAKEFKHKPMIIFEEKVYGISETFDYNPKTADGVK
EQISKMQGAFIIKKPDLTGESKWEIINDKVIKVKINDENFKNKLKDRSIKLSYGDKIKGV
LISKTYISKDLEVLENEYFLEDIKGIIEPSYTQEKNLFK
>fig|195.2026.peg.1150 Channel-forming transporter/cytolysins activator of TpsB family
MKFLKIIFLLMSFICLLQADDSAKTLNLLDKRQQQLHIQKEFDELEKKQQQEKDVYLENQ
DSEDKIYIFKQIQFKKNDTLTMQANNILKKYINQPLSVNDIYNMIKELTNFIVAKGYSTS
SVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPLKKGDKFNIYDLDTGIEN
LNNGARDVKIAVKASENYGYSDIFINLKSKPPDLILDFDNSGYKAKGEYKASAYLSLSNI
LNLNDSIRFGFIKGLLKDMSQERENVYVANYTLPIQSYQLSYSMQYSDNINMIEGYDNSF
IKNTDTSLRHKIMLKKILHRTSKDKFSIYANLGIKDDVNEIDNFRLESSSGRYSSIASGV
EYSTLAFGGFLFLNLEYEKGIPFLGSKKDSKDSLYKIEFNKVNFNLSYQKSFYANDGLAF
LYQNSLGASYSNEPLLYADKFLIGDEYTVRGFKESSAALDYGAYSNNTIYLQFLNAPKYL
RALEPFVGLDMGYGRDYLLPNKDFLAGVAFGFRYNLNHLSLNLTASKALHKSSNMPSETI
PIYLRASVFF
>fig|195.2026.peg.1161 hypothetical protein
MFKIILLISIIFGLNACKGEDMNNNEDTNKDIKMVYTPNGGGIKLNTKTNEFLFNQREKP
TGKYTKEYTKALLEAVNIVDNSPYKKFYEPKYLDPEFHTGEKSTLLEFKDWQKIYLKDPV
KGSLAPWTKAEKAYYNSLDGEGRYNYLVKRSGLVCTPIDLKDSALIRPKRPKEKRFINAY
KEGMKDYKEAKRLDYKGYDLFQKAIKNLSYAYEEGKDYKAGLALAELGYSKDYFRAIIGK
LDQDENNEALLDKLINEFLNANYRSIRIYEELIEKYDLGDAYWGLYVYSRKIEDTVFDDR
FYFAQLKDSSEELYKNAFEHGAYGAFGAKANTIYSDLIAGEYQLCLGILGNKKAFYEAAV
YLSDSGLKSRAFQALWLGVQLGDEKCLEGLYRPLYGIHENPLKRQLMKDFAKNPPYDKYG
MLPFLDELISTEWIIDPNEYDFIYDINNRVVTAMLNGIDKGKYKDPRDVDSTPESRWEFD
QEIDAYKEGSVRSYSYDLPNHWSEADVEIYLEELYLHAKLAALTPPQGYPNAPRYYSPER
LEFIYNKHKLDSKLDPRIPAIYRANFPEELRAKIRAFAKEHNIKE
>fig|195.2026.peg.22 hypothetical protein
MKKIALFFVLFVCLLNFNAKDKEWLPKGESISVYEYIPNNPRSPAAFSSVDSKKLNANQR
KGQQVYSKWCIACHGEGMPGTNALSVLYKDQGIPALLEDRTDLSPDLVTIFFALW
>fig|195.2026.peg.283 Cytolethal distending toxin subunit B, DNase I-like
MKKIVFLILSFNVLFAALENYNTGTWNLQGSSAATESKWNVSIRQLITGANPMDVLAVQE
AGVLPSTAMMTPRQVQPVGVGIPIHEYIWNLGSVSRPSSVYIYYSRVDVGANRVNLAIVS
RVQADEVFVLPLQQLLQDLL
>fig|195.2026.peg.138 McrBC restriction endonuclease system, McrB subunit, putative
MKIYLRKIDKQCIIKQISIKKYILRDFFNNAQDQEIVSMVGALSNQNGNVKILTATDPRL
GGEIKNIINAEVDKIIQTDPSYQLSIDDILLFAYIESKKYILEIITKKDARYQVLLDLIN
NPQFKTRNGWDNLHLLTYSDSEESNFINDASSNSVEINENLREKGGENIILYGVPGSGKS
HTIRIKYPQNEYIFEKLVFHPDYSYSDFVGQIMPIVKDEIVSYEFIPGPFTNILKKAYNN
PSRKYVLVIDEINRGNAPAIFGEVFQLLDRDKDGNSNYAINNDNIAKIVYEGDTQRHIKI
PSNLWIIATMNTSDQNVFTLDTAFQRRFSMQLIRNSFDKNKEEFESEEKYNEYKNFIDKK
ILNTDVTWQKFCKTINSIISKSNNDINSMEDKRLGVFFVKTDDLESKEKFAHKVLKYLWD
DVFKFDKDKLFNKNKYHTLEEVIKGFVDEDGKSQFDIFIDDIKDMLYV
>fig|195.2026.peg.140 DNA-cytosine methyltransferase (EC 2.1.1.37)
MKKYTCIDLFAGAGGLSLGFKQTDRFDILAHVEWEKPMVKTLRNDLVKRFKISQSEAEKR
VIKFDIQKVDELINGSWSDEILKDYGDDNNENIIKHGLNGLIKDKKIDVIIGGPPCQAYS
IAGRAQDKHSMKYDYRNYLFESFVKIVDYYKPRCFIFENVPGMLSAKPGDEFVTHRIYNA
FTKIGYDIKKPNQMKDIIYNSNDYEVPQSRNRVIIFGIRKINGKNKKLTDFYTILDSLKS
KNPPLILKDVLANLPKFKPLKTPIKINGKNISHELVGNFNLTQNFPRFNNQRDLKAMKFW
VENNMNNATTKEKLDFYTKITGKISKHNKYRNLEWDKPSPTLVSHLQKDGFMFIHPDSSQ
NRSITVREAGILQTFPNDFEFIGSQGACFKMIGNAVPVNFAKYIALAVAKALDEKN
>fig|195.2026.peg.714 Putative phage protein
MDNMKEFKIFCDESNHLFYKDNPTLCSRVMVLGALKVPSSEIIKINKTIKYLKHKYKYNK
EIKWTKLNLSQKGFYDELLEFFFSSVYMWFKAVLIPNKTILQHDIYNQGDHDLFYYKMYY
QALHNLIDIDTKIKIYLDYKDTKSGDKIKGLEKVLFNKFKQSVNIKIFTIQSHESNIVQL
VDLLIGAISYKARNDIEHVSEIKNYIINKIETLANIELDAGTPPWENKFNIFRIQLSKGE
Q
>fig|195.2026.peg.139 hypothetical protein
MKKINILVACEESQRVCIEFRKLGFNAYSCDILECSGGHPEWHFNHDIFKIIKSKGGITQ
SGENIKVEKWDMMIAHPPCTFLAVSGAKWYYHPDDKDLPTEKRRPHPKFPNRAKDREDGA
NFFMNLINSDIKYIAVENPIGIMNTRYRKADQIVQPYHFGDSASKTTCLWLKNLPPLKHT
NVVEPGEFIEFKSGKRIAKWYSDGLTKTKSAKERQIWRSKTFPGFAKAIAEQWGKFIKNE
LNKKDNK
>fig|195.2026.peg.1369 hypothetical protein
MLCIMAKKLIIAKVKNSYKMIEDDEVLKAYFMEAFYYILSKCVPSVLLKNVEQSEKVFRQ
VRNNHFLIIPDEPDFDNEKEHLMIDEALSFAVINYVCYLITRCEEKDFLALCDKIINEYI
ANDGKELDDERTWL
>fig|195.2026.peg.1786 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
NDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDYNKIYESGFLDQK
NDWTWFLGYNRNSGSKKISSKLWLERYKHIGHFAFVWQGVINFRFLKNIDLKFIDGIFHQ
DVHFGFLLFAQSSYIYLLSKKLLVYRIRNGATTVRNFKNNLKDEIPFYIQELLSYFEIKT
AKEYYSIYSWIQIILNVMHSHNIKNNLHSDLYYLFIGNLSEQILKLKFSYKQDPMHLSGF
INFIKTFVGLHRILQNNMQEKITQLSTKTQELTSKTTQIKELNQVVANQTTQIQNLNNTL
NTKTQELTSKTTQINSLQTTLKNKDSLLSFQSQHGTAKQRIQNQLSYKLGQTMIINSKNI
FGILFMPICIISTILSYRQEQKLYQEKIKKDPSLKLPPLENYPDYKEALKFKNHLSYKLG
QALIKANKTWYKGGYVRFLFELRKIYKQKTMKNSLILYKNRDSNKKDTTRSIKGGG
>fig|195.2026.peg.1399 hypothetical protein
MNCKIIDLEQGSVEWLNFRKGKIGASMVASCVGIKGAFNSKEEARDIILGLKEVYQNEAM
RRGNEYEPLIRARVEFLHSVSITPVVLQSLENEMFIASLDGIDENGIIYEFKYSQDEYDF
IKRNKKPSDKYYAQVQFGLYISGKEKCIFVAMNKEEEIVECEVSKDEAYQEWLVKNIKEF
ILDYIIDQKSEYKELEDTKAKNLTIEIIRLENTIKPIKEKLESLKKELIALANGEKARCL
DITIYPQSRTTVDYKGFLEQKNITVPKEFYKESTSMCLKIKKGA
>fig|195.2026.peg.1340 Transmembrane protein YfcA
MGFEHLDTIYYFVLFFVALFAGFIDSIVGGGGLITLPALIACGIPAHLSLATNKLQSVFG
SFTATLTYFKSTTLPHLAYGIFFHSLRRSHRKLQRAFCKR
>fig|195.2026.peg.1658 Membrane protein
MVEYLYENSNLPLITPKMGEAYEVGSEFEQDFWWKEG
>fig|195.2026.peg.980 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
MLFDKKALQNFELIGEIKNLQEYLKNNPNLLIKGNNLLVLHSLKKLYVNKIKLIYIDPPY
NTGNDSFGYNDKFKHSTWLTFMKNRLEIAREFLRDDGVIFVQCDDNEQAYLKVLMDEIFG
RDNFVNSIAVKLKNIAGASGGGEDKRFKKNIEYILIYGKSYEKLEQFKSVYDSRELYSHI
SFCKENNISWKYTSALLNGGEKKLIATTLDGDGNEIKIFERINYDIKSIGQMIKDFKMNE
KEIFYHYVNKIFRTTMPQSSIRVRVLEKLKELNLSPYLISIEYTPKSGRNKGVVYEQFYN
GEKLNLFAWLKDVVEIKDKQIFKKELAGTLWDFAFAMTNLTKEGDTQFSNAKKPEALLQR
IIEISTNENDIVMDFFAGSGTTLAVAHKMKRKWIGIEQMDYIESITKERLKKVIEGEQGG
ISKAINWQGGGNFVYAELMPLNAIYKEKIQNLNDEKELDNIYQELKTKAFLDYRVDINEI
LKDKEFENLDLESKKEILKLVLDSNMDYLLYGDIKDEDYALSKEIIKLNKIFYGDENV
>fig|195.2026.peg.1244 aminoglycoside 6-adenylyltransferase
MQNQDKFLKQFKKLALLDKNIRLVTLEGSRVNKKAKKDKYQDYDISFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKRYCKILGKL
>fig|195.2026.peg.522 putative periplasmic protein
MLSGSVIRIPNYTNNKADDNTLPAPSLAQLTKDNHLILEQALRARVVNNFEHYSLIYHSN
NQDKPFIESLETPINLSEES
>fig|195.2026.peg.1285 CRISPR-associated protein Cas1
MSYDEAFKTLLISSNAKLNLELNHLVIKQDENIAKLFLKDINIIVLESLQVSLSSALFNA
FARHKIILLTCDETHSINGVFTPFLGHFQSAKIAKEQMNVSAQKKAILWQKIIKNKILNQ
AFVLKKHNKIEQSNELINLAKKVSLNDSKNIEAVAAALYFKTLFGVSFSRDELCFENSAL
NYGYAIIRACIIRAVCISGLLPWLGIKHDNIYNSFALCDDLIEVFRASVDDCVLKLKGES
EFLSKDDKRALIGNLQSKINFDGQNYPLNRAINHYVANFKNALLYEDELKIVKFDD
>fig|195.2026.peg.1787 hypothetical protein
MEYDISNGQIYKLLSKNIDELSEELKNTNKCSYLPEIYGIYKHTDEIDFDFLPNSFVIKT
NHDWGGVVVVNNKAEFLADSSKKIESLTKLQKHLDRNYYDVSKEWHYKNITPRIFIEENL
SQKNNDLKDYRFHVFNHKTQFIQVANSAHTCNNLYYPDWKIFPIMYLNKRDSKEIQKPYK
LKKMLKLASLLSIDFDYIRVDMYLVDSKIYIGELTFTPNCGKAKIEPAEWDLKLGQMWRS
DVFKL
>fig|195.2026.peg.723 Transcriptional regulator, AraC family
MFFFDNAFLIELIYKYKDLFKLEQASEESEIFWVKNDKILQGILESFTPHFDENTQILDP
IVSLKFEEIFLHLLLNKNTYFIGFLAGILKEFRLDLSQLFEYCGREFVSVSEMADFAKLD
FATFSREFKKCFGQSPKKWLDEKRLQKAKVLLEFSKKNVNEIANECAFSSVAWFIERFKE
KYNQTPKQYQKSKNLYFLSKN
>fig|195.2026.peg.1266 hypothetical protein
MRKNNYKLHGYISTNRSKHNLKAHLILVCKYRKKLLVGLLNDEIKAIIDKIANTSDFNII
AMESDIDHLHLMVQYLPKVSITQIIRKIKQITTFRIWQDKRFYHLLCRNFWKEKTFWSDG
YFACSVGEATPETIKKYIENQG
>fig|195.2026.peg.1514 hypothetical protein
MLNYSIIENSLNIKLECLRKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNLE
CIHGGKVILKSNKGKSFKSDGIPIMLESDLLNSSIVACPHTIANVSYPCTKVVDIKGSLS
QKKVNGEYAILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEA
RLRMYYKEHKYQKDNLFTNLYLNDTLYQNEQGLDKLELSKNDLFNLNDINVLNTLKQDFS
KDYEFKECEIRLGMHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRE
NENIIHHRVFLAPAKMQKIGFEIAKGLDEWLDNENVCCFNVYTKDYFNANDKDMLISDNI
KDDTNITQAHTNENYNNTQEIIPDNVIRIQTQDGSGEFIEIIFDEFKEWEKSSSGAIKPL
FTPLEGIVEDISNSLENVSIIGDALAMLGAVKNPKNAKNIIKKKSKYATKQEVIEVLKNK
YNLKTSKELGLGRSKNVFWVKDNKQIKEIWEEITDGADILKDINQDKLGGTIKMRKLDDQ
TIIQYKKLLKVEVGP
>fig|195.2026.peg.1402 hypothetical protein
MKVCRSNYLEIVKIVPFSERRSCFCRFLRSNGIAIEKINYKNHISKKELRKAYKIYKSKP
SGRNYFHEEKLIVKAFEDVEKFLRSENETTRL
>fig|195.2026.peg.520 FIG00638667: hypothetical protein
MKVQGIYDFFSGYTLDGEANFNTLDIELKSPLQVSNSYLRHSGFGFYGAFASKGCKQ
>fig|195.2026.peg.467 Glycerate kinase (EC 2.7.1.31)
MADFNIFKNKYKQYEDTLKNTSYDKTNNEYLCLKENTVINFENLSLSLENNKGVKKVDAL
FCQADKIFLVEFKNQKQSNIEKQEIVQKFEDSVTLLKRLFQENNIAFKNYIINLYLVIKD
GNNYQTYKNRQKGSEIEHAIKARDSLKNFEIKCAPRKSFLPIYEKIFSARCEI
>fig|195.2026.peg.1201 hypothetical protein
MDNKRLVINPKKNLQNLKEIGEIQGQIKNYTPEELQILAKDQVKQIDMKIQEASRKIVRA
KELAYKAKNIENSFFETLNPFAKSETDKKLEALSEADIANAEAIGAQNELIQETIKLICC
DMVFADLMINELLLMIYEKYEINEEAILSLSNDTKKISKEITTTILHQAKQRITEMQKAK
QEIQETKEDIRDMEDDIKELEERLNKKRQIDDKQHKLIETHYQEFINFKMQMENDTKEKE
NKISDLKFKISKKNTAFSIIISSLALIVSIVAIILQFIK
>fig|195.2026.peg.1368 hypothetical protein
MKEHGCECNFTNKFNRALSYKDYAQSINSADFIAYLDDKKWLLAMDDLLFFCEKRIKDSD
YYEG
>fig|195.2026.peg.1529 3'(2'),5'-bisphosphate nucleotidase (EC 3.1.3.7)
MLSQIALQDINDIAIKASKNVLKIYNQDFKISYKDDNSPLSEADLISNEIICKELAKFSL
PILSEENKTLPYEQRKDWEYFWCVDPIDGTKEFINKNGEFTINIALVYKDTPVLGVVYAP
ALDLLYSAKKGEGAFKNGVKLPLQRNDNFLKIVASKSHLNEQTKDFIDSIQATKQKEFVS
MGSSLKLCLVASNEADIYPRLAPTMEWDTAAADAIVREVGKMTYDFDTQKPLVYNKENLL
NPYFIVK
>fig|195.2026.peg.532 sodium/pantothenate symporter , putative
MSLTHNDLSNLCILISLLFLEYILINAKTFRQMTRFANFYGVIMVLSFIVSWQIFNAYFN
FLVFLILFFVSYKIWQFKKK
>fig|195.2026.peg.1401 hypothetical protein
MLPAFKASFEVANYSPSVEYLSEGGLYSGVFRKAFLYDKLASDGSNNTFICFEFLTRKEQ
KLAIFNLFVAKNNDFSQINENGEKENYLGFRQLNAIMKFFGIDELDFSEKGNENVFGVQT
EVIYLNSLVNKLLVLGFGTKEYLNKNREIANTIFLDKIFNEKMQNIDEFENNKEPLSIKS
FKARHKSLNNDNNKSFIPKENQSYNPYGNEVKNNNNEKYIEIGDDDESLPF
>fig|195.2026.peg.1377 hypothetical protein
MENDALKDLINVITDDDKGDVANNGDEPTQVEDNESMQVANENEPDYKAMFEAYKSENDN
KLNALMSELEALKNPKKEPSEQELQREQYLKELGLDGLDEKLKRLEELDKKQKDKEEQDA
LIAKYAQVESELRKAYPDADLKAMAELATKLNGLGEGNIDSWKTLLNLVGKSNNAKKAED
LSSANNNVRTSDFNDKLKKGEVSEIDLGKELLSLV
>fig|195.2026.peg.1521 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MSNRKIGIIGAGISGMSIARLLKDDFEVEVLEKFNNVGGIARTKDVGGKPYHINGGHCFN
SKFDDVLDFVFNTVLDKDKWNYLPRKAEILFKNNWVTYPIEFSIKEIDSFDTSLAFQITK
EMFNASYEKGKNLEEWFINHFGLTLAKEYFIPYNTKIWGIAPKNMDNVWIEDEKQMKLPV
PTKESFYKSLVGKITDKMSHAAFYYPKTNNQNTFIEAIGEGVDILTNYDVKDITKENNQW
IVNGEKKYDILINTSPLDLIPQILKNIPIKALSCFNKLKYNKVTNIFWETDGSLDITWGY
IPDPSIGFHRISNTGSIVQPKGNFCTTEAIGEIPYDRLVEEGQKIPFLKKPLDYNVTEHA
YVFFDLNYTKAKTGAISYLDSLGIYSHGRFGEWEYYNMDVCIKRSIDLAKNIKEKYKG
>fig|195.2026.peg.1781 UDP-glucose 6-dehydrogenase (EC 1.1.1.22)
MKICVVGAGYVGLANALVLCKNNNVVILDVDANKIKQINRKQSPIKDKMIEEYLTNDNKI
YATLDKKNAYENCDYIIIATPTNYDENTQYFDTKSIESVMFDIVKFNKDAIVIIKSTIPI
GYTKYLKMTFAVKDIIFCPEFLREGNALYDNLYPSRIIIGSKGENAHNVAKIFSSSVLKE
NTPVLFMDSSEAESVKLFSNTYLAMRVGFFNELDTFAKSNKLNTEDIISGVCADPRIGNY
YNNPSFGYGGYCLPKDSKQLLSNFKDIPNALIQAIVQTNDLRKKFIIQEILSKEVDTVGF
YRLIMKHESDNFRNSVMLDLINEIQKYKQVVIYEPLIDSKQFNGCEIENDFEKFINRIEM
IVANRLDKQLTTYRDKVYTSDIYTSDI
>fig|195.2026.peg.797 hypothetical protein
MKIKIIRRYTGKTCVIGKFKVLDDDDKLLLECFSLEEDKEGLESGKDLRIPEGNYNLRRH
TPSRFENTLRSITKKDDDTMINVYNDEVPASRAILIHWGNTDKDTQGCILLGLSKDNNNE
SVGQSRQACKEFYDLVYGKNLEDIKLEITNELA
>fig|195.2026.peg.47 lipopolysaccharide core biosynthesis protein LpsA
MLQSRLFMNLKGIGISFTPRYFFQTKLHKIFNEILKYNAKELEEIRTRVKYYNQINDFFT
LTEREKIGKFPFKNTSYAFDAYEISKYFNDDFLWKKEFGDVKYF
>fig|195.2026.peg.1391 hypothetical protein
MLNIENLMNSYFSYIKSNFDISKIENNMYEITTPFLDKSNDNILFYIEKKDDLIELSDGG
ETLRNLSLSGFDFNSEKRLKELEIILNGFNIQKNNDILFTRANENNFAKKQHNLIQALIS
VNDMFVLAQGKIQSFFFDDVKNFFEENFIRYTENISLDGKSHLNHKFDFLITKSSQQKER
LIKIINNPKNDNLKATLFSFMDLPQERKANADNIIIFNNKEGKNMDALVNASNEHNVKAF
LWSKKEEYIDYLVA
>fig|195.2026.peg.758 hypothetical protein
MLNTNNIDIDDTLANTKTTGAYAGIFSKYDLEDFYLLGSFRMGYEHTKLNRNVNIGAFSA
NYNSKFNSYLISEMVGIGKSFNHYGVSYGPLAYIEHSFLYHFAINEENQNSTALNIDSKN
FHALNSFMGFNVNYEKGMSDKAIVNFYFLGGWNHYFLDSLKNNASFKDASLNKFYTKSKL
SNQDSLYLQGEIDFTHNQSFFTRLMLSSDIKDNIDFSTKLEVGAKF
>fig|195.2026.peg.981 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MFNKKLHELLQEEFGKRGIEQIEIPFYVKENLSKELRIYQEKALKYYYANSDSIKQRHLM
FNMATGSGKTLIMAALILDCYKKGYKDFIFFVNSTSILEKTKANFANKYSSKYLFKENIN
IDSKNIEINIINNLFESKDDCINIYFTTIQALFSLFKNERENSLSFEDLKDKKLVFLADE
AHHLNSNTKSKNENEIKEGWEAIIKRAYESNNENLLFEFSATIPQEFNVLEKYQDKIIYE
YTLREFCKEGYSKRIFLVKYDNDSLEHRFLGAVLCSLYRELLAQKYNIVLKPVVLFKSES
IKESMQNQEKFIDFIDNLESLHIEDFYKNINKESDLLNKSLEFFKKEYQNTYAKTIVNFL
KNNFKTLYMLNTNDDKELEKNQILLNSLEEKDNQIRVIFCVDKLNEGWDVLNLFDIVRLG
NKKASKTITTKEAQLIGRGARYYSFKSDLFDFDDEFRFKRKYDSDLENELNALEKLTYHT
RNDVEFIKQLNESMNKEGLLFEEEKTRIDLIVNEKIKEIIKNNKIYYANNKRIKKRDLKN
FYITRIEMEQKIKGLQIPYFSNSIKESEEKFEEIKEEYDLQKPSALNHIDNIYFLKAMNI
LGLDFNKINENFTFKSKKDFIENCLKNTVVCFSKRQEFNQINNLEIAKYILENFKSLKQN
IKQEYEVSEFITHEFNIGNKVVFKNKENFKEMNFEWLYHKTFCFDSNLEKEFLNFIEVKK
DEINKVFSKWFVIRNEGFEEFKIYDNRKDEVTYAMGFEPDFIFFGKKNKDDDNFLSIQCF
IETKGEHLAIAKDAWKEEFLETLKGKIITTKDDKKLTLQSLPFFINKNFNINDKFLSSFD
EFVSFQDER
>fig|195.2026.peg.979 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
MLKDKLLQDLEEHFETLGQVRNLAQNYDERLFNYLLEESKYKEEFKNRFFIFNKKVLIFK
INEFLTF
>fig|195.2026.peg.1027 Methyltransferase (EC 2.1.1.-), possibly involved in O-methyl phosphoramidate capsule modification
MKQGDFTEVAKHYHNRPAYSPFLLEKLIACINDKNKNIKNLNIVEVGAGTGKLTKMLGEM
FECQIDAIEPNDNMREEGRKFTQNLSNISWHQGSGEETRMKDNQADWVIMASSFHWTDPK
KSLPEFNRILTGGGYFTAIWNPRHIVEGSVFDEIEKEIKHIIPELARVSSGTQNVKKWEE
ILVSTGDFVDCFFMECDYKELWDKDRYLGAWHSVNDIQAQAGKKRWKEILDMIESKISHM
QSIEIPYKIRAWTARKA
>fig|195.2026.peg.1076 Ferric iron ABC transporter, ATP-binding protein
MAYLKIKNFKKAYGDKIIFEDINFSAKKGEFITLLGPSGCGKSTLLRCIAGLSQINGGKI
SLNDKDLTKLSPQKRNIGMVFQNYALFPNLNVFENVAFGLKIKKMDKKDIEKRVKKMLKL
VELEEYAKTYPHKLSGGQMQRVALARSLVTKPDLLLLDEPLSALDAKIRKHLRVQIKEIQ
KELELTTIFVTHDQEEALELSDRIILMNEGKIIQNSNANNLYLLPESHFVASFIGNYNIL
SPKELDSLGLKHDFKKDIALRPETIEISNEGLEAKIKEKSLLGNIIRYRVRVQEIEFKVD
TLNFSTHSTYEAGDKIALKFNLSLAKELK
>fig|195.2026.peg.688 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLRTFFQIDP
MLATMSQEDFAIKALALMSVLKL
>fig|195.2026.peg.1075 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MPFAVPPIVSCVGLLQLYADNIGGTAWILIFTYFTIALPFIYRALDNAMSNVNLNELIAS
NAMLGGSLMGAIFKLVLPNLRNGILVAVFLSFSFLIGEFLYANILVGSAYETLQVYLYNI
KNQSGHYSSALVIVYFVLIFITTFIASLIKE
>fig|195.2026.peg.1533 Adenylylsulfate kinase (EC 2.7.1.25)
MDNNLTWHTSSITKTQRAKLKNQKPCVLWFTGLSGSGKSTLANAVEKKLFEQGFHTYLLD
GDNVRHGLNGDLGFDEASRVENIRRIGELCKLFMDAGMIVLCAFISPFEKDRKLIKDLLN
DDEYIEIFVDTPLEICEKRDPKGLYKKARNGEIKNFTGIDSPYEKPKNPHIHIIKEDLNE
NVDMILRFLNGKYK
>fig|195.2026.peg.1394 hypothetical protein
MSFTDFYFDREEKRISNYARELVKDELESRENFADIFNSLQEFKNILEVSLEDDEDIAAS
LQAYGDEFINDTYDLLEKVRKFEKKYEKLY
>fig|195.2026.peg.973 Acylphosphate phosphohydrolase (EC 3.6.1.7) / [NiFe] hydrogenase metallocenter assembly protein HypF
MCHLGYKLQISGLVQGVGFRPLVFELASELGLHGEVKNDGFGVEIILACTKEECENFIYK
LKEKLPPLARIDSIDITEQTTTNYTHFSIGTSLQNAKTTPMLSDFALCKECKKEFFDEKN
PRFLYPFITCTHCGPRFSIIKNLPYDRCNTTMEALKMCEFCKSEYEDPKNRRFHAQPISC
PKCKINVFLKNPKGEILAKDQEAFIQSAKFLKEGKILAIKGMGGFHLMCDAFNEEALKTL
RLRKNRPKKPFALMCKDLQSAKELAFIDEKEEALLGGVLAPIVILKAKKAFSLIAPDVDK
IGIMLAYTPLHLLLFEYFKGSLVATSANLSGESIIKDEFNLCKKLDKVFDFYLDYDREII
NASDDSIAQVVNGKTMFLRTSRGLNPFYLERNFNKKGTFLALGAELKNEFVIFYENKLLI
SPYIGDLKSLDVHERFFKLLEFFKQNYDLKFDAILCDKHPHFSYAKEFEERIKISHHYAH
FCAAYFEYEENFAKDEKALAFICDGTGYGEDGKIWGGEVFVGNLKEYERIAHFENFTLIN
SDIKNIQNLALSLIFHYDLEDKAKDFLAKIPKIKLKNLKKIYSHSNLQTSSLGRIIDAFG
SIVFNLEKSSYEAQVGLMCEAFYDKNLDFSYKLFVEKGQVNFKNLILGALQDEKTKAITG
MFNALANFIIDFSKDYDLKVLLSGGVFQNKTLLEILKAKNFDFFIPLKYPCNDSSIALGQ
MVHFLNLEK
>fig|195.2026.peg.1381 terminase B protein, putative
MKLKLDFSYTPAQLKVFDDKNPRFITVAKGRRLGFTRGSAKFVIENLLLGQNVLWVDTIQ
ANLQNYYELYFTPELKNLPKDFYSWSVQDKKLIINGAVLHMRSAERSENIEGFGYDLVIL
NEAGIILKGSKGEYLWYNAIRPMLLDNPKSRAIIGGVPKGKNLFYELCRKELSDKNWKHF
QFSSYDNPFLKEDQIKELIEEVGGEDSEVVKQEIYGEFIDSGGAELFSLSEIENAMSKNS
FSIEKMQGENIWGLDVARYGDDKSVLAKRKGFVVDEIKKYSQLGTMELANKILAEYNQSE
DKPKGIFIDTCGLGVGVYDVLLNYGLPVFEANSANSATSNEYLNKRAQMYFTFAKNLKHM
ELVKDEELKKDMRMIEYEYSDKGLLKIVSKEQLKKNYGKSPDVSDAVALTFFEKLYSRNN
TNEDWSYDGW
>fig|195.2026.peg.746 Branched-chain amino acid ABC transporter, substrate-binding protein LivJ (TC 3.A.1.4.1)
MKKVTLVFSALALANCLYAKTINLGVVLPLTGPVAAYGQDVFNGIELANKLNAKLDNGDE
VKLIVIDTKGDKLETTSAVNRLIAQDKVIGIIGEATTPNTIQAISIVEDKKIPLIAPVAS
GDKLLEGKKYASRVCFSDSFQGDKFASYVTKELNLKNAVVIIDQSNVYSLGLAKAFEKSL
KENGGKVIKKLAISSGDKDFRAVVSQLKSLNPDFVYMPIYHPEAALIARQAKQIGFDKLL
AAGDGVNNQTFIDLGSTAVNGVVFTDSFDSSNPSTARGKTFINEYEKIKGNANLPAFSAM
GADAYYVMLNAMNACQNTLTSECINEKIHQTSNYEGVGGIISIDASGNAIRPVVIKEIQD
GKQVYKTLINPKEK
>fig|195.2026.peg.1384 hypothetical protein
MQEKIQILMDLLEINKAQATDIVGRYLKNAKDIHSFLDFYFETLERENIVGTTYEKLRMV
CKKAEIEFKKRFEDKEIFLEWLCNKYKNQACFRLHEGDFEYSYFANCGNGKKIKINQKSI
DILVCVNAFKQISYKNGEPLENNEFKEALLEFIFKNQDRIGKNLNIPLSVKKIEKVLSLE
EKREIEKIEETKLFNENKDRFEIFIKSKKAFKKIS
>fig|195.2026.peg.1388 hypothetical protein
MKKIDFFDFTKILSNHYTVISVKKIRTNKSRPSFKKQIEFKKLYGIPHEFWVDVRSNLTN
IPKRGRKRKDRE
>fig|195.2026.peg.1560 Anaerobic C4-dicarboxylate transporter DcuC
MLGLAFSLFSVFLLVFMLYKKINAHMALLLSGLLLLSITSLANFLIHTFPENYVLLNYPN
IYAFLNALDFYQLKHAILGKESLNLGFF
>fig|195.2026.peg.466 ABC transporter ATP-binding protein
MNKKLYLENIGIIKEASINLEGLSIIAGENDTGKSTVGKILMALIKTHNMSEWKTKKSNK
VWIKERAFDKLMDLIFNGELKNNGKIILSKGQNIIYEACIERNRCASFKSKGQDYVDCTF
IQSPLVWDLFDFFTKVRLANDNARVYGGGYELSYPYLLWDLYQKIGLQRPLKKFLDFKEL
KEEIVEIINGHFLQNNKEVYKFYRNNREISIENVATGIKQFGILQTLINNHRITPQGFLI
FDEPENHLHPTWQILFAQILIKLSTKNIPILINTHSPYVVEAIYKYGIHYKARVNFHVSL
ESKIEQVENNEKTMELIFEKLNKPFQTFDELDIKNG
>fig|195.2026.peg.1389 phage repressor protein, putative
MGRNGDIFDFHFDTEKFKFYLKNRDKKVTYQDLMEILYKNGIESSEATIKKWLMSKEDNK
TKPKPQYIKILCNALDIPFNEVILQDVFRNDNQINFRYFPDIYASAGLGTSSQSEEAKIV
SVDENFLKEILDIPIKKSYDIIKINGDSMEPILSNGDFIIIDRSKNSLGAISNADIVIFR
KNDDLFCKKIKKEPFADYIFLVSENKKYEDKKVDNSEFEQCEILGAVVSKMAVETFKNFI
EVVG
>fig|195.2026.peg.1791 hypothetical protein
MINTAYINNHHKGGYSTQKLKDISQATTQSLGISKNYKIDATQMQTLVKNLSQNKHFDTI
DFTKTLENAYKVFSNLMQFSKNELPLGFEMDKNSFEILKIYDKAQDLENNFLNENNSYKG
SKVVINLKDLNSKDKSFMNFANVVFNQFGGGYLIEGQSNISGKLMGFDKNMDKNQIQDLN
DFIKNNSFIANGSMEKLMEALDLFSSNLSIEEFKQKWLNLTINLEPSNKTIEQIVREDLK
AKEEQKPRTPIQSESQNKETYKDDSKMNELVKKLLENKFGKSEELELLFGVKFSDDDAGE
FNKFLSSNSAPKSIDIKA
>fig|195.2026.peg.1297 hypothetical protein
MDKNSNDEYIKKIKIKLKREETIILIFLIINTSFLSYRLCLLKRINCKILY
>fig|195.2026.peg.1372 hypothetical protein
MEYVKSYDFAYYTTRINHFLQRKDRQNIKVLQDFFCSFILYYWDGIVLLCKQENKESVEY
FLSEIFSLEMNDINLILSQLGQFKNSTNKRLECLDVKLTLN
>fig|195.2026.peg.1390 hypothetical protein
MINIKELLSIEKHPKVQQTYILPSFENSKSLKIELQCDDDKYHKENFILDISRSSVQFQR
KTNQYRYNAINIIARIDFYASHTNPEFNPNKIPSDKRLSELMEKYTEFRFRNENHIHIFT
EGYADKWAFPLSEFNIKTNDDFLNQSYDFCQFCNIINIKFAKGDLFC
>fig|195.2026.peg.506 hypothetical protein
MELEKKREEFRSKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYRNDYNYKIGESN
FNFKDKPEFAYYEDQFKAYMGEENYKKLRPYLGMTTYYVCEGKKYPVVFSTMIDYKVKNY
GLFGDEGRGFSFSSISRKSAGGGSFHYFTNGKFIKSDEKYTGQSY
>fig|195.2026.peg.23 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRQMVQTAAEHGWGDYRAAPTFQDDVMGAYSYNNHILRRFNE
>fig|195.2026.peg.756 hypothetical protein
MGQCFNGFLNSFSDHLYDLNGVKAQIGMRIVKTQAEVEEAKLKGETVFLVKDDGVYINGS
FSNASGNVYFKGENVAEVIKNAKLGYDGVNGIPINAWEGIILDMSHIELDNSLMSHQSWR
NYNFYMEAELALLQDIGYNFDRKLYYGDSIYESNLLNWQSDHGYYARKDGKWLIGEYNPT
EYGVSLHIYSKNNIATQSHDILSSGVAASGIRIDGSNNQLIIANDTKVYTLGDYSNALLI
AYGKDHVIEHNGELKATGKEGIAINIDFGDNTLGNAEEYRGSYIHQMSGNNQDDLAEYNL
DGVLVKSLNLNAASSTIGSLASIYIADNAYVNTINIAQWAKVEGDIISNWDPNNEKLANQ
YKDSFYTDLNFGSDSSLSRAAFNALDNTWSVKANVLGYDNFKMNVNENLNLQGSAFVYDL
NNKAHFSLLGADGINPSLLYIKNNFTQDSNAILTAGINANGQSLVYVGGNANLAGAFNFY
MLKDFYKDKVVLDPDLISANQIQGAFNSIVYDSSLDFSPTLNFIYDANTKELGVVRDYTP
YIKNSSDISLAYALNSLKI
>fig|195.2026.peg.266 probable periplasmic protein Cj0413 , putative
MCLLGREFAANTRLPLDLNKALLLFQKACKLGRLDSCVRINNIKFKLLKKLDEETYQSNL
KYFLDQNSSFALLEHIATLSKKDTKLYFAQGWVELFNQNDILAQKLFYKSCQAGYYTDCN
MAVDKNSKDQAMQLYLIKITQKNSQNQCQNSSNKQSFACHKASALSKEILKIQLKKISEK
LLFTILI
>fig|195.2026.peg.429 hypothetical protein
NANIYFLDSYRNYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTMFTKDDVSNLSQALLE
IGVNINVNLENAQQCYELLNQNITTLKSQRKLAQNYQAKFTSTFIPPNGDYQNYGIMAAL
DHINALKDLVKRFPKLADLPKIYGGGVLWRIPIFTHSKNSSLVCGWCD
>fig|195.2026.peg.1544 hypothetical protein
MILIPLRVVFIILMPFHLENSFLGKTFYFLENLFCLAFAILLIVAIIMPFLERISKIFF
>fig|195.2026.peg.1267 Mobile element protein
MLRAVKYRIYPNKAQQELILKHFGCARFVYNHFLNYRQERYALGIKETYFTMQSKLTELK
KEHTFLSECNSQSLQMALRQLVTAFDNFFSKRAKYPRYKSRKHSKQSFAIPQNIKLSKNR
VILPKFKEGIKAKIHKILSNDCVIKQAFISCVAGNYYVSLSYEDNKSIPKPVEIKSAVGL
DMGLENLLIRSDKIVYENKKFLQNKEAKLIKLQKAVSKKKKGSNNRAKAIKKLAIAHHRV
VLARDDYLHKITNEITNDYDFIAIENLNVKGLIRNKHLSKSIANVSWHKLISMLTYKAEL
KGKTLMQIDKFFPSSQICSNCGVNTGKKALNIRAFTCPNCNTYHNRDINASINIRNYALG
MLDDRSRVKIDKFRVGITRSYACGDSSCGTSKYGKIFAS
>fig|195.2026.peg.715 FIG00469921: hypothetical protein
MYHLLDFSTCKCENEKFDLAYKIFKQDFIEVPLYLAGCIYIDPQSHKKHKGKEKIFWHIT
TRENKQNKTREFDSQRACRINWIKQIIINHTHPEIKAFYYKEKRAIRFYLWLHNHNFIVI
LQKLGRSSSFLVTSFYIDKGYNKNIYEKRYRNYINGNDIELKNCEWF
>fig|195.2026.peg.1395 hypothetical protein
MPRLADLLGFIKNKNKFDKITLFKWLISLGGEGAVFDDREVFKNCFFIVRNSKKVD
>fig|195.2026.peg.267 hypothetical protein
MKKIKILVFLIFFCQFSVLANNLPQNIKENLGINQFLDESLKEILNQPLKEKFALTPKGN
IFSRVI
>fig|195.2026.peg.1397 hypothetical protein
MFLIFKKNEKIRNLEKEVQRLKGVIALKDTAINEMSLKFEEEIKINVKLSNFRIRILDAL
GLIGVKNNDEIAIKEVKRLKEKECQ
>fig|195.2026.peg.1254 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MLTTGVDARNVRNIVLLANIGSIIEFKQIIGRGTRVYEGKDFFTIIDFVGATKLFYDPKW
DGEQVKDEDKEDKSEIWGKQNKKESDKTKETESKKAITVHLKGTKLKVLDINTSYLGSNG
KPLSTKEFLEFLIGKLAEYYDDEVKLREIWSKQETRLNFLKTLEKDGVDENALKDLGEIF
DKKDCDIYDVLAHLSFNAEIKTRQERVLQVEKSEFLKRFQKEKALKFIEFLLGRYQQYGI
KDFDRSLAPLIELSSLGNVKEIVSEFGGVENLKQSVDDLQREIYAR
>fig|195.2026.peg.1196 LSU ribosomal protein L36p @ LSU ribosomal protein L36p, zinc-dependent
MKVRPSVKKMCDKCKVVRRKGVVRIICENPKHKQRQG
>fig|195.2026.peg.1386 hypothetical protein
MFNSFLSEMLKTATLENLVYFLIGVLFGLSIRPLFLYLTKKQKLKRVCIKDMKLENDLTK
RLYPNLGYKLVTKKTPFEMVFKKDKFKYIICPYYRDKKCVLDNDKCKILKSQPKYQPLET
V
>fig|195.2026.peg.1339 Transmembrane protein YfcA
MLFVKDEHLKLIILIFLTLTFLYTALRPSLGKHESEAKIKNIKFFHLICGLTLGFYDGFL
GPGTGSFWIFACVMLLGFNMKKASINTKILNFTSNVVALFIFLWQYELLWIVGLLMGVGQ
ILGAYLGSKLVLKTNGKFIKTLFLIVVGATIIKVAWDYFS
>fig|195.2026.peg.1283 hypothetical protein
MPIFMICSTLLAVIVVAYYILKKYNPIFVFFLSGIILLIFAFYITGTPIPKAPSREHASF
LNVLLDSYAFITATFKSQLSGVGLIIMSVAGFAAYMKHINASAKLAFLANKPLGKIKNKY
LI
>fig|195.2026.peg.1638 hypothetical protein
MANRHWALVDMVLELVQKEDILQKESILSHITNERLLRAIENFKSESALHKDKKFIFSAE
GIVWDFSTKKHVEILEKIMRELGFTQIYIIVYFRDILGYLNSHCSQDHKNNMEYYSADFA
PQDHPRKYIFDYEWICKTHAEVFGEENLIVRLLREDYVGGTLLKDFVYGKKKI
>fig|195.2026.peg.1396 hypothetical protein
MKAYHTKEQVIIKLSKDEYRKEMKLNKSLKDENKSLKTEISNLENEKIELLKELKDQIEA
NMKNIKEISSLQNKIYELLYAKERSKLCS
>fig|195.2026.peg.1252 RloE
MKMTGLENLYKDIKNKQMTYCIFNYTHNRIELEIMFDINPKPFKLLIIKKYSNKTLLLDI
LNGFKLDIFLSKEKYQILLDILDIKGGGATPFSTKKFFEELNSAIPSAIVQYDLNSNLRH
IISQIKNFEDADLIYVKHLIDWNKINSGKHVSQKNRDKTEYLYPDIFKIIKDKNISVVYT
NNKDSSKYTNIEDIEIING
>fig|195.2026.peg.1407 hypothetical protein
MQNIGGFKALSKELITKLLNEFPNKSILFYDDFIKECEIYKIDFVSCIYFLKECKVLKYE
KENKMGFMDTLLSPKAYLYFSKNDLKDIDDLIEFCIK
>fig|195.2026.peg.1410 hypothetical protein
MAEEKENIVKKVCKELNITQAELGRQLDVPASTINTWASGKIPKMAEVALTLMLENKQQK
EILEAIKKARDFIGRI
>fig|195.2026.peg.1378 hypothetical protein
MLNIEIKSDISKTKGGKKLIDFIKAKYSECFYIAKNNDEKELRLKALDTMAFLDIIINKI
KDEEDGK
>fig|195.2026.peg.1251 hypothetical protein
MNNILTYKIDTEQPIDIKELAESLIAIQNMYRKSIISNEASIKISEVRKGSYEFDIVVLG
LGLTLPYIENFNSAIDFIKNLKNCYSFFKDNKFDNNTNQINIDDAKNTSKIIQPIISIGN
NSTVIIQNGYSDSECFSVISKEAAEVQKKFIVILKIKKEKLKKNCKHINIFKIYLLNLHK
QEPMISVEINYYVKIFIIKN
>fig|195.2026.peg.718 Sulfur carrier protein ThiS / Sulfur carrier protein ThiS adenylyltransferase (EC 2.7.7.73)
MMRVKFNGKELDTKLSTSLDFFKSVSKNENDVWIINGFATKENIALNENDELFCIEKNTL
PPKDALDAMMRARHTPKLHDKLKNGRVAVCGLGGLGSHIAINLARSGVGYLKLIDFDVIE
PSNLNRQAYRVSDLGKFKTEALKEQISEINPYIKTEICTLKIDEENLPDLFKGIDIVCEA
FDGALAKAMIAQNFHRFYKDITLICASGLAGYGDSNSIQTRKIAKNFYVCGDLVNGAKVG
NGLMAPRVNICAGHQSNLVLELLANKE
>fig|195.2026.peg.1165 Hemerythrin-like iron-binding protein
MLPKWDKIYSVHNGRIDNQHKKLFELAAKVEHIFDKPVHRDEIKALLTDFFNYMKYHFDD
EEKYMQFIRYPDFERHRQIHKEIIQSMIKIIQNIKTTNDLREKLYIMVKNGF
>fig|195.2026.peg.1408 hypothetical protein
MQEETITYARGRLTELKDKKDELQRLIKDSKNLAIKNIQNDDLKGARLYIDKLELYFDEL
LKTNTDLNLLCNKWGFK
>fig|195.2026.peg.600 D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7-phosphatase (EC 3.1.3.82)
MFIFFNLNYIIIYSMKRKALFLDRDGIINIDKKYVYKIQDFEFCDGIFELCRYFLAQKYL
LFVATNQSGIARGYYTQEDFFKLCDFMLNEFLKENIKIDKIYHCPHLEGCECRKPKAGML
LKAREEFDIDMGNSIFIGDNLSDMQAGKNAQIGTLCLVNEEEKEGDFFRQFKNLNELLDF
FKKKEDR
>fig|195.2026.peg.1643 Acetyltransferase, GNAT family
MFKKAFYKGFKLSNYYDNFGTIEEKILKQEFILQKYKNNNFFFFNRVDNLLYYFINDLQN
FNLKANYIKILTKTDKQLLQHNDFLKLNHFKEILNYKQMILKKDEIKLKKFTFISKASHE
DSKEIYSFFRKYFDPYLFYFSQKNLEEKIPNILVYKENQKIRAALIYTQTLNANFLDFIA
VDRNLKHKNVAFALLNHYFAANTQNKFFKLFVEEKNQKAINFYKRAGFCFNHINLKFYRN
F
>fig|195.2026.peg.1598 Enterochelin uptake permease CeuB
MLFKHLFSLNILLILLVVFGIISLFIGVIRINLDDIFSLSTTQLEIILLTRIPRLIAILL
TGMSLSICGLIMQQLTQNKFVSPTTAGTMDCAKFGILISLIFFTGASFFTQTIIASVFAL
LGSFIFIQILRKIKLKDVIFVPLIGLMFGGIINAITTFFAYALNYIQNIQGWLQGSMANV
MQGNYELLCISLPLFILAYFLAHKITIAGMGEDLALNLGVSYNTILFLGLIIVSIITSVV
IVSIGVIPF
>fig|195.2026.peg.813 Dicarboxylate carrier protein
MMDTINIIILFSLIISIALGYVLKANIGVFAILSAFIGACLYGITPEKVINLWNGSLSLF
FILLSITYFYGFAIANGTLNNLALKAVYSVRNRPWSIPIALYITVMVFVGIGPGHYAGFA
FMSPLVLYIASKIKMNKILAAIIIYSGSCAGGFNPFTLGGRVTFDLIEKLGYSAEASAIM
QLNLGKNMFIAHTLIFYNRIFFAKRL
>fig|195.2026.peg.195 Cell division trigger factor (EC 5.2.1.8)
MEVKAKQLDSVNATASVKIPSGMIKSEVENLAKKASKSVKMDGFRPGKVPVSAVLKRYER
ELTQDAEQNLFKSAVNNALQELKKESKELVGEPYFEKFDRKDGEIIAELILSFKPEIKLE
GYEKLIPEYQTPKVSKKEIDEKKDELLKRFTTPEAIKTKRALKEGDFAKFDFEGFVDDKA
FDGGKAENYVLEIGSKQFIPGFEDGMVGMKIGEEKDIKVTFPKEYGAAHLAGKDAVFKVK
LHEIQELKLPELDDEMLKKLLPGEEKASVEVLDEKLKEQIKNEKLFKLVNDELKGKFADA
LIEKYNFDLPKGIVEQETDMQMRAAFNTFSEKEIEELKASKEKYQEKRDSFKEEAQKSVK
LTFIIDELAKLRKIEVNDQELIQAIYFEAYRYGMNPKEHLENYKKQGALPAVKMALIEEK
LFNDIFMPKTEKSEKVSKKEKEDK
>fig|195.2026.peg.1393 hypothetical protein
MMGIAVGIYAYVFALTVLLRLTFKGIEVNYPVSNSSVIRLLKVLHIACLVADLTIIGAFF
GIPIFLALWIFQYIFANEKNPFFVFKKYNPKPYQEEDIIDVEVEDEKPKKSLKTFLENWK
D
>fig|195.2026.peg.1799 hypothetical protein
MLINQTFEIDSCDDVELGIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYS
>fig|195.2026.peg.1282 C4-dicarboxylate anaerobic carrier, putative
MALKIVISSYAGLLLLLLACIYPVLISLKIRPITAVCVLSLIALDYGPKDGNSINMADMV
GQSDNVVGLFLNYQIYSVIAYVVVIAILIPFYFAWIDKRDKEKGVLNDEVEIPQIIDPKC
PTFYILFPWLPVVFLFTAYFFTIKLDVVTANFVSISLVFLVEFARHRNARKLGEDMMVIL
KAMAEIFISVVSIIIAAGVFAEGIKALGGVNILANAVSNLGTGNFAWFGILLSIAILSFL
VYFATVIMGSGIAAFNAFGKLAPDIATKLDVAPITLVLPIEIASCLGRAASPIAGGIIAL
AGFAKVAPMDIIKRTTPLLLIAMLVNVLVAFYLAQTNPLPKEQNTTKIAVSLNNKYLLFY
KNYKFSKLFSAFLVKIS
>fig|195.2026.peg.1376 hypothetical protein
MDFITALKGGTGLGSSFADTLMKTSNFTPNLASSSGGFLNGLKNSFSNFGDWLFKSSDTN
KITNFDRLGNVLGAGGALYGAYNQQKMAQKNYELQKDAYNFNKYLANEELNRRKNMENKL
QSVWSN
>fig|195.2026.peg.1714 hypothetical protein
MSIFSINDNSNYGSILSQAKANKESKENSKISFANAFLKQNASKLSDIESKNSQTLARSE
ILSNNNALSNNSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQADTSN
IVSLAYGYSVDKDGYMGSDFNKAAGLPNDFKIHKSTLDEIKKAAENEPYIADMKQYFGVS
EYYTNIDMAETIKQYYNLFSNALGQSFPNDKTSFSEADINSMPSGYGVSGTQWMDFNDPS
NRMNITGLKDFSNSLISNIYKTPEQAKEADDLWADSGYMIDGLLPKTLGLSLEEIKNVSK
GEDWQFNPDMSVYPKNEDGNYSKEALFMSFLKSYSPIPSSNQVVLSPEAKVLEAKFEQEM
KANPSFSVSLDDIMTGKVDFASLLKGYAQDGWLDAGIYAMEKGVAWQNTSIGYGGAWFER
ELNQAKANGWKASNQSIDSYVNSIMDRLNNLLGQTRV
>fig|195.2026.peg.1392 hypothetical protein
MAKSICFFNHKGGVSKTTTTYNIGWALSKLGKKVLMVDLDPQCNLTGLVLSSKALDDDFM
ASFYQNRQFITFEPIIEKIISGANSYGSANDGEIFPVNDNLFLLAGSLNLSQLDSQITTA
LKITAGIPILGNIITCFFEVLNKIAINNEIDYVLLDLSPSISGLNQIALMGSRYFIVPTS
PDYFCLQAIYSLSKTLKLWHKEIKDFKQATGVKGIPNNPLFIGAIQQRYRLRNEAPTKAF
EKWISAIRDAINTTLVTELSNINCVIEKEKFENGIKNEFPNLSPYDLAQIPDFNTLIAIS
QRSKKPVFLLDDKDLDEANQFGAAKQTSKEKIQDFHNTFMKLGRTIINITS
>fig|195.2026.peg.1449 Small hydrophobic protein
MIVLDFILVVAFVLFMIFLIVGFNRQMSEKAKIREEKFKNKERKNE
>fig|195.2026.peg.1275 hypothetical protein
MAFYFIKRFDLLAHTNEDYLDSRGGFRASLFQNKENKEFILAIAGSDLRPLKFDIGDLIS
DFILLNGKIPKKQFDSLLKFYTLIKKEFCFDKITLVGHSLGGHLAQLFVLDFALEVQNIY
TFQAPGIAKKILKDIKNEAYIQKISYHFHTCDDFKKNAWYKFNFVQNLHSKIGYPIWLNI
GNKFHHPKICPKILHKVLNML
>fig|195.2026.peg.1373 FIG00470767: hypothetical protein
MVWGEVIDKIKHKGYGLAHIIDKHPELDLKLISDIVDKGKLNNQNNIRYRIEYKNYIIGL
SSEYKGNKRTFIITAFERYKG
>fig|195.2026.peg.1597 Enterochelin uptake permease CeuB
MFLLICDIISRLVIFPFEMPLSITTGVLGSLIFIFLLLKRKTYA
>fig|195.2026.peg.1404 hypothetical protein
MKIIKYGNDEGIVFNNGNSLWDTYSQSCCEYNYAEWDQLEPSALNYDFDEESFQLMPNDY
GFRFGDKNRTFFIPCYSEQNGEYSYRITIIYEDKSGKTLKEINTECERAEE
>fig|195.2026.peg.1382 hypothetical protein
MARIMTNGKSMTKEELVSKIENYFSEKTVLKETKESVIFAPKTKVGLAVHLGISMQTLNE
WEKDKDFGEIVANAKQRCEMDILNHSLIGTYTPSVSMFLLKNQHGYVDKQEILSDNVQKI
EIIRSEIK
>fig|195.2026.peg.1286 CRISPR-associated protein Cas2
MIEDKFMRVLLMFDVPTKSKKEQKLASKFRNNLIKLGYFMLQFSVYMRICKGLSSAKSSI
ENVKKILPPYGNVRALIITEKQFDKMELLLGGIVFNEKVNNETNLTLFDIDSHGEFKYKN
SNNEEIQINKKQEKYHQQNLFEF
>fig|195.2026.peg.722 Transcriptional regulator, AraC family
MEQILSLPQDLKQLKGVDYKNFKSCTFAKYTQVSTSHSSFVNVGSHLLTFVRKGYKILHT
ASKDYKIDF
>fig|195.2026.peg.245 FIG00471707: hypothetical protein
MWHLNMNGVKASKQDLETFVKGDIKETIQSKIKLLVF
>fig|195.2026.peg.656 hypothetical protein
MINGINSYSSYNYTNTFSNNTPNTKSSNTVNETSNLVSDKSGAVNKVLGYGVDENGFFTS
DFNEAAGLPKDYKIYAKDIENFVNIQTKSLLSSYINIDIAKSIGNAYKVFSQLLNDELNN
KINFTKEDLVKIPQGFEFNQNTLEINKKYNLNDKEYKDFMSNYQNYSPTSHNIKIMTFFS
LDDKSDIFKYSLIDPTPYSNNDKTITKSGIFMTFFTGFQAKNYFIEGQTSILGKMQGFDK
TMSQSEIDNLNKFISENSMNFKGDIFKLFDLLNSDMSIDDFKQKILEQKENLNNPTKNTN
NKETLEEDKEKPFKPIQAQSSSETYKDDNKMNELLKKLLENKFGTSDELEILFGMKFSDD
DTGEFNKILSLNSAPKSIDIKA
>fig|195.2026.peg.1074 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MNENLSLKAKIYHYAVLFLVFLFLALPLMATFLYSISTSWGVSVLPDDLTLKWYQELFHD
ERFLLALWHSLLVCVGSILLSVILVFPLVFVLNYYFFKIKSLCKYTYYHAFCCTSYS
>fig|195.2026.peg.1398 hypothetical protein
MSVTTISQEKQVLNILLNKGKIDNFYCIDTRITTRLGAYIYNLRNKGYAIETVRNKETRN
TFYILKSTPKIKKAG
>fig|195.2026.peg.1646 hypothetical protein
MFTCIGLFIQSIFMCQLFFICLVYILLCSLGLFNNWVGFLITQVYFIVFIEVLWLGVVYD
EINIAVNTCKGLVLSKKRLFALNLSFLFNKTLTS
>fig|195.2026.peg.269 DNA modification methyltransferase (EC 2.1.1.-)
MNLKEKPIFISKDKNFTLYQNDCNKLLPKFEKQFDLIFADPPYFLSNDGLSIQNGKIVSV
NKGNWDKGDDIEKIDKFNLKWLSNAKIALKDTGSILISGTYHNVFSLGRILQKLDFKILN
IITWQKTNPPPNFSCRYLTHSTEQIIWARKSYKHKHIFNYEILKLLNSNKQMRDVWAFNA
IAPWEKTNGKHPTQKPLALLTRLILMASDESSLICDPFSGSSTTGIAANLLNRQFIGFEK
ENEFINISIARKKELENNFNTIKNKINDLKLLNKNSLFQGGYL
>fig|195.2026.peg.757 hypothetical protein
MLFKELDFATDAQTIAQGLNELNAKAYLDSAKISLDFQEELNKEALSEYANEWQSFVTPF
GTYQSSRANGDFDAYKGYGGGVKAKLLRDLIVSI
>fig|195.2026.peg.705 hypothetical protein
MIHTFGDKAKEYLEPGLFSDGDDPTKGCFERINAIIKPYVMPYLLGLSDEEFEKIFFHIN
ATSEIDTTFLKEAMELRKEKKDE
>fig|195.2026.peg.799 FIG00471942: hypothetical protein
MSTENIIKEGAILGSLSGSALLGLMVFVLAGIAWHLYKTLHKEAGEKTKELISETKNTNV
LIREQIAVSKASNDSLIKFIQTHCSKTNDKLEAIETDLMRMDERLVKLIQIRNDELRMIY
KRKENE
>fig|195.2026.peg.1480 hypothetical protein
MLNRASEHYGFFGLNRGGITYKEAKISCAPIPVLNEFHHAMSHLCEVFLKDDARYTNLER
AIPHFKRGMMDIYKTIIRDFLILNQDALGVKQEALKIRELEYQTIGKPKKVTKNPTSNLI
SKKEEKVIPGYKELCERIVRQSKNTN
>fig|195.2026.peg.1524 GDP-mannose 4,6-dehydratase (EC 4.2.1.47)
MKKIALITGFTGQVGSQMADFLLENTEYDVIGMMRWQESMDNIYHLSDRINKKDRISIFY
ADLNDYSSIQKLFETKRPDVIFHLAAQSYPKTSFDIPIETLQTNIIGTANILENIRLLKA
KDGYDPVVHVCSSSEVYGRAKVGVKLNEDTAFHGASPYSISKIGTDYLGRFYGEAYGIKT
YVTRMGTHSGPRRSDVFFESTVAKQIALIEAGYQEPVVKVGNLSSVRTFQDCRDAIRAYY
LLSLESEKGKVPCGEAFNIAGEEAFKLPEVIDILLGFSTRKDIKVEEDEERLRPIDADYQ
MFDNTKIKSYINWKPEIPARKMFEDLLNHWRKEISMGRIPLNR
>fig|195.2026.peg.304 hypothetical protein
MKKVLIILGFIFLNFACSQEDLIEKGENAYKNKDYTNAIKYFQQACDLNNGNGCNELGTM
YTLVKKNNFKAMESYQKACDLNYKQGCSNLGFMYMLGMRTKDDKFKAIELYEKACNLNEG
SSCGVVGAMYANGTYVEKNDFKAVKFLKIACDMDYANSCVNLGGMYENGYGVRKDISKAL
KFYGKACDLKYDTGCKNYARLKR
>fig|195.2026.peg.1788 Uncharacterized amino acid permease, GabP family
MFLNYNILFFCIGCIIGWGAFALPGLLFLDMGLINSIVGLLLGALFIIIIATNYFKLSQM
FPQTGGEFLYTLHFFGKKHGFVCGWFLILAYLCIIPLNLTAISLLFDHLQFNYLQNNILY
YINDKPIYLNNIILSLLILALVLYINLRGVKIALYIQNIFTIIIFISILFCVIGMMLSEF
SWKNLATYISNQDISLQNILRVVAIAPWLYVGFDCAVQVIQDTKNKNSWFFNQLVCASIL
IGCLIYILVLMIAAYSYPYTEFKKIIWIVGQGVENYFGFYGLFILSVGVFCAILSGVNGF
FIATSKVLYSLSENGIISKRFIQTNQYNSPFYICFFIAIVSAILPFFGREYLLYVVDMSS
IGIIVSFVYISLINFKFLCFSVMDKIRSLFSLILSCIFMLLLFFPNSPAALKYPSVIMLL
FWIILGILFFKIKKIEC
>fig|195.2026.peg.1379 hypothetical protein
MKTKRTNDERVSFLTQLISESKSGYVNYKPHFKELQDAYLLENKVMQKLRKRNKSSIYIP
KINSKVKYLITSLNEVYFNSERMADIETYINSDDTIIELWQNAIDFYSGKINMFKIFQPL
FLDVLLVGTSIAKLTWHKGMPRIERVDIDSIFFDPNALNSEDIGYIVNEIYLTYNQIHER
QKLGFYKKIEIEKLFDEDDEYKKVKLYDIYERKNDDEWVVSTLFENNLLRNEVTLQDGQP
FIWGSMLPQLKKIDNENYVSAYGEPIMASAMPLQDEINITRNLLIDAVRSHIMPKIMMPK
SMGVSREDIETLGKPIYTDDPKGIQILPPPNINSSGINLQLLESELTEVTGVSPQNNGAQ
TAQNETATEISIKAQEGGRRSADYIRQYNETFIEPLFDRFAMLVFKYGEDSFFNGFQRED
IPSFRFKIQTGTGAMNKEIRRAGIQASMQVFSQLYQMYMSIGDANSAYGIINASKELTKE
LLPILGVKNVNSLFAFENNEDINPQMQGETNA
>fig|195.2026.peg.1780 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MINDKTIWTFWEPKDKMPGYVKLCIETWKVFFSDYRVVILDYSNLHNFLPKDFYDESLYE
NFSLPKQADAIRAAVLYLYGGIWLDADTIITSSKIKYFFENPSNFSIFSSHIGVLKAKKG
SIICFNWFQECQKRILNYRKIKESNGDLRQFEAYYYLGNGPLNPNIETFKNNKNEVVIFN
RVKNKVIMEAFWRTKDENKEGNAIVNYQEFYFLNDYSDFVLENEAGLLMLHNSWTPYSYK
NLNIEDFLICKNTLSGIFLKILNLDFGKMYMDIRDRLYLRSLQANPLSFQSKYGTAKSRI
QNQLSYKLGQAMIVNSKSLLGYIRMPFVLSYTKDKHKQEQKIYQEKIKKDPSLKLPSLES
YPDYKEALKEKECFTYKLGESLIKANKTWYKGGYVKLWFEIRKLQGS
>fig|195.2026.peg.26 Tat (twin-arginine translocation) pathway signal sequence domain protein
MLEVSRRNFLKATALSAVCLSGLNASFLEFSQAKQVKYFIKDSEIPHQGNFINVDEILLI
EKDISNIYSQLKEAFENKALIGSVSSGTTFFVIRTMAADYGMRVAYEKNKVIFILGFWHQ
KELNYNFTKKCFAK
>fig|195.2026.peg.1520 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MIWKEEDLIDILKSDGSVYKNYENNSYFFDLQKEIKLEYIVLKLNNKTNIVNIKYSKDNL
NFYSFDSELCEIKDNAMIFILSEKISVRYLRICIKKEELNQINLYVRKFPLLFIAARGDA
FGSRIMALLNAIWLSKKFRCKFGFVWNALFHIKQDDNVQHKTVMPSLPLEEEVFESIFIK
KYSYTKLLKSHPGSIFQYKAANKMSIDRLLEKPYSHDFGWYVAGGFIDIYLDGLQDGEYL
TGLRNAWREIQFLPDFNDSIQKGIDEAGKLGEFVSIHIRCADMCYSDFRFIMLRNYKYRH
IVTVEMALAIIDYELNHQNVLICGDDLALLDSLKKHYSNQPRKFKLYSMNDFVNKYTFKT
NIEQILFELYFRSKSSLIYSTKSTFGILPYLVSESSRLNHIYDFCSKNDYYKYIKSNIGK
IVVHDYQLAASYFVLFILGIEIEVDINELYIYIRKSLSHDKLNITYQLFLFFTLLRKGKN
YQAEKYICFLFKKYPKSIFSFIQKEPLNIYKNIITEIMSLQEKKYNFSFLFASAVYSHHK
DYENSLLCYNKIIGNIELETFSYLVANLLENLHVIRNEDEKCKFLDRIYNSLSKANCATQ
FNQPQSKLSFQAHHGTAKSRIQNQLSYKLGQVMIVNSKSLLGYIRMPFVLSYIKDKHKQE
QKIYQEKIKKDPSLKLPPLESYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKLLF
KIRKLKIKKRKLNE
>fig|195.2026.peg.1776 hypothetical protein
MINSLNSNLNYDYNTSNFKQDKNIDFKINKHGVAVITGEGALPYRGKKFEYNPKIFGLDE
SISKKDMQEFNNFMKSNALKDPNKIEKSPLKDFNPAYTKWDPTTEKMMLGFFVSYSKMFH
LGYDIIKKADEFYKEFDALISKDLSLNEFKTKYIDFKQRHDEFVKEYEMAMGDKMLLSSD
DEIITQQSEKPFKAIQGESKNKETYKDDSTRNELVKKLLEGKFSTSDELELLFGMKFSDD
NTGEFNKILSLNSTPKSIDIKA
>fig|195.2026.peg.420 putative membrane protein
MDYNVFLLNIQDKINQEDFFNLKLKFEQLQNKKEALSNLVFLRLQDPIKPLIMSMICGFF
KFRLVGNR
>fig|195.2026.peg.1409 hypothetical protein
MSENIELFESYTAKTLGELYSTFPIPSDFNFFDFIPKLEYEEFLTHQLNAYHTINYLKNN
HFLDFESMDLESGKVKKAILKPKALELLKQDGLGVQLRKALSTGRDELIRSIVNRALEMS
LKFMF
>fig|195.2026.peg.1411 Phage antirepressor protein
MNDLIVKYNGALVTTQNKISKLTNNNEISIQKLIRTYKADLEEFGILEFENQLIVNSKNV
KNYKKIYYLNEQQATLLLTYMKNSESVRNAKKVLVFAFYQMKEKLRSLEQEQEKARFKTL
SDENLRLNSLNHHQKIGYKSQLAQQKEKYENKIKALQYDLEKKKELSFKRKLSKEELLEL
RKILAKDYNMLCFKEWEYMLFAESVSGKNYKLEKENDFCIYKSIKDSFNSKLDYYKNYEE
YEEKWRKILRR
>fig|195.2026.peg.1091 hypothetical protein
MKKNIVFFEVRGGSDKGEDGYRKDTMPMVNALKAKGWNAEVIFFEVGKKNEIYNYVKENF
DGYVSRINPGNLKEENEYFDMLRKLCQEGLVGMPHPDAMIGYGAKDALTKLADTDLVPSD
TYAYYDIKTFKENFPKSLAKGERVLKQNRGSTGEGIWRVSVEGEVKGDILPLDTKIKCTE
AKDNHVEHRELGEFMDFCEQYIIGDNGMLVDMTFLPRIKEGEIRLLMLYNTPVNVVHKKP
AEDADAFSATLFSGAQYRYDKPEDWQNLVDMFLGELPKVRAKLGNYDLPLIWTADFILDN
DEKGNDKYVLGEINCSCVGFTSHLELADEVAQNIINIVSKAKN
>fig|195.2026.peg.794 hypothetical protein
MSNTNVDYNKRLEVFKEIYPQILEMSLAEKSPFGEFKKLLEQFGNENVIRNDQQFQSLAQ
ALVSVGQTIVAQSQNTALSMILQGDENELNAEKALLLRAQTETEKAKPALIARQTSQIDD
NLRIEAAKVTQSVQFGYCTGGLDIPQEIMSLVKEKIENIEKSS
>fig|195.2026.peg.198 Methyl-accepting chemotaxis signal transduction protein
MKLSIRKKMLMLGGICLVSMLITFGIFYYNNLQGSEKIAQITKNLINKEINVKVELLTKS
MAIALGDLIKNVHSEEEKVKIIATAIENFRFEEDKSGYFFVYQKTTVKAHPVRKDLIGTD
LYNAKDENGVFYVRELYQRALEKGGFVTFYFTKPQPDGKNIIAEKTAYSYLIPDTNDLWI
STGVYKDTLEPYIDGNLEELLSFFSKNFFKTIIFFTLFILIIIPFIFIFYRNLITGVQGI
KTNITSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVET
VGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEYKSLDFR
NKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAASL
EETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAG
EHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVA
QIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2026.peg.1797 FIG00973752: TolA-like membrane protein
MKKIFLAFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNIT
>fig|195.2026.peg.687 hypothetical protein
MIYDVNKGLESFKFLPQDQIIFKFDEDFELYLGSNRHVSEEGFWALSLRYQNAPLNNAVF
VLP
>fig|195.2026.peg.1370 hypothetical protein
MALPSMGHTTPATENVKLKQSIYETIIKIGATETPILNKIGTSKVTNPLTHSWLTDTFEE
PKKNANLELSKFVGETKNTAQKTTNATQIFITEAMVSKALLKANQYGGNEMEYQIGKKTK
EHKMDMEYALFGLGRDSDVKKSVFKDYVQAQEATSGEMAGLFHYIAKGKDSFADGKRGNV
LAFDETGDWSGTATELTEDKLNQILQTIWNSGVTPKDVFLGADLKGAINKFATRILGNET
KLAGQVVSLETDFGTVNFHMHRLLSPKYGLGDVLIAGDFEYMKHGLYIPTMIEDVPTDIT
AKAKRFYTQSTLEVRNADAFAIGVGLTSGNNAKAKAVLKAARGA
>fig|195.2026.peg.137 hypothetical protein
MFNLREHCFTDNELGDNFVGIRSKNNNLQICFPLGFHLNTNNIRIDIRRLISVLSNFNET
HTNFLFTKNENKLIEQTFPLIAYKNVIEYFLSHDYYKERESIYQTTTKGKINFAKTIKRN
RPIIQNNNSLVYIEFQTKKNQINENELVTAINKYCVYEAFSKFGFAYNSYKPLKFNLPTS
KKECLYVLQNKLNNTFDDSKRILFNSMINILTQKDKELKEDEFKFGTTKFHTIWEKMIDI
AFGIKDKYRYFPQTKWELKYTNNKDNSLLQPDTIMIDNKQIYILDAKYYKYGINLKELPQ
SSDITKQVAYGEYSAYISKNKNIHNAFLMPYNKQNNKFNTKIDSDFKNIGKATIKWKNHE
NYATIQGILVDTRFLIYNYDKISIADKEKLAKAISDSKF
>fig|195.2026.peg.1198 Putative transcriptional regulator
MIKRLKSIFFRKNILNNFELIDEDEQSYTLKVYFSYDDELLNVVKQWILYMKIEKPFELK
EKLDSILKDYLEN
>fig|195.2026.peg.1403 hypothetical protein
MKLQDFDFRIWNGKKYLKQKIYNDNINNNEYIAVTGNIDDENYVFTIEHGCERDYYGGDY
DEYCKVKDFTTCNYEIELFTGFYDKKGNKIYENDIIKNESLEEIYYIRRDNTYKMFEIII
YDKDCNENLYRKKNPADINLLKMLVSDKNMSVIGNIHENKELLNVRL
>fig|195.2026.peg.1637 FIG00470572: hypothetical protein
MTAYLHIGTTNTGNQEKQGFLMQNEERLLKKRLYLSKKP
>fig|195.2027.peg.386 hypothetical protein
MDNKILIQKLRDNAELAWASYGYFHLLKDSKGISRKRYALDEQGNKITDNSYLRGYKEIE
ATFADILNLQLNRQEVLINQTTSNEFLSSILNKLDDTFNFDALKGEFSPLQAKQFFSRYD
LLKHCPNTGSGFSATLSYEKTERIKRN
>fig|195.2027.peg.1464 hypothetical protein
MSKKDKIIKDLKNNPNNVRFETLKILLESEGYECFNKGGSHYQFRKKECDLITIPFKRPI
KAIYVKMVLKAITGE
>fig|195.2027.peg.1205 hypothetical protein
MELYKLYFTIKKFKKGLKRVIICLINIIYFTIKKFKKGLKLQLLYHIARKYFTIKKFKKG
LKQLDYRYTLKAHFTIKKFKKGLKRKRNSTAKPRNFTIKKFKKGLKLNSSSFK
>fig|195.2027.peg.807 ABC-type siderophore export system, fused ATPase and permease components
MPFILELLKQNKFKFISFLIFSFITSAVGVLTLVFINDYLLKNTQNIPILYFIALLIVFF
LSSTIVELGLSVFGQNFIFKMQRRVVKQILDTPLLKVAKVGKARILASLGSDVRNISFGL
LRLPDFLQSSILILCTSVYLCYLSPQIFTLCAIWIIVVFTINNFLMMKVYAYFRKAREND
DALQNNYQNILDGHKELLINRYRAKLYYEDEFESNARSKKKNSTLGNLFNNLSSNFTNVA
LLALVGVEFYLALEFKWASVAEATTIALSILFLRTPLVSMIGSFPTLLLAKIALDKIAKL
ELDDYKEHFEKTNFIKDWRQISFKNTSFSYDDNFHLNPVNLDLKKGELIFLIGKNGSGKS
TFCMLLTGLFKPSEGEIFVDDMKIDDDNLDVYRSLVSAVFSDFHLFTKTLAKEKFADEEK
IASWLEFLELKGKTRVEDHELVLTKLSTGQKKRLAMLIALLEERDILVLDEWAADQDPVF
RRFFYKKLLPLLKEQGKTIFAITHDDAYFDSADRIFLAEGGNISELKGENIKELAKNLVE
KFD
>fig|195.2027.peg.372 hypothetical protein
MAIGKVIHKYGSFFPDFDEIFYKIKYEIYRGDWEMLFFLQIPNIKKTDILEYFEDHFLGS
TLQDGCEFNDTCFPLFFTEDENLKNSIKPNYNSEYVSIIGQLFLAGYIEFGMCGLQNKEE
NLLSNQR
>fig|195.2027.peg.966 hypothetical protein
MSSNIDILKYLLFVEYLTPQNIKKINNCCDTCETSYINQYIREKIEKICNALTLNNKNLD
DYSVEIIIQGAIYNNKTLFENIINKFNINKDLENFYDNLNTEYASFVLKFNGRLNFTNEN
EIIKFNEFNSNIHQNFNPIIDNDFVFNAKNFYLSTAPWAINNIENIKSSYIDFINLSQNI
AKELSSLKNICIDKFYNNAIKIIEHDVPLLGNKFRISVNLTKTMNENVFLNSFYIQELAN
ILNNYEENTFPMIDKYLSNKIKQRIDIKTNQLEILENYIDELAPSSFVSQFALMYSQQFA
VNKILKMNKDYNDIYSINGPPGTGKTTLVKDIIAGIITQRAIEISKLNYDEIIKKEDGIY
KLNEKLKGYEIILSSSNNNAVENISKEIPTNNGIDSSYIQDLDYFSEIATRFLNQNKKTE
VKAWGLICGILGNNSNKSSFIYNVLKDFKSKEYEFIGLINYIKSNKLTSKDFEQAKNDFN
QALRRVNNLLDKNKKEKHIIQKVKIYNKLKNDSSLINTITYLYKILSYRLMGKNYVKNIE
KHISFLNQKFYLHDEASMEKSSFFMVENGETTELSKARKDLFIKALNLHKVAILSNNLYF
AQNLEVLSDILENNNYRNLSENKIVEIWKSLFFIIPSISSTYASFGSCFKDIGHNQFGYL
ISDESGQSTITSAIGAIYRTKKAIIIGDPLQLEPIVNIPNNINNFFTQYFNIDKAFDVKN
TSLQSRCDFLQSYGRYIYQDSQKIWLGSPLRVHNRCDRPIFELSNKIAYGGMMIYGKKNE
NTLQLQNTWYNIKEEQWNGNCNEREIEYLHILLDEITQYDLEIGIITPFVDVKQKLKDIA
NKYNNLKDDKIGTIHTMQGKEADIIILILGGNNENARNWVASRPNLINVALTRAKNTIFI
IGNKEKYIKLNYFNHLESMHTITPSFSNL
>fig|195.2027.peg.135 hypothetical protein
MAFFTSDFNEAAELPKDYKIYAKSAESFVNFQENDNYLFSFFHKVDIAKTIGNSYKILSQ
IIPKTSNAYLSPEELKNIPYAINIDENSKVTKTYTYEEFKEYKNKEINSKNYPGLTFNTT
TGLIGINYEYLPIDTNNIFNSDNSKAQIDKTPYIDNNDNVSKGGVLMAFLNQFGTSKIEG
DTKLIGKLIGYDNNIDNSQINFFQKFMNANKIQSAFSYSSNPNEWNIIEEQLSMKLFIRR
SDNIGNAELSRLAMDLDKEYQEMINSNMSLEEFKTKYLDFKQRRDEFVKSLEEAEKAKGI
DYNNPAKSTNNKETLEEDKEKPFKPMQAESKSETYNDDNARNELLRKLLETKFGKSDELE
ILFGMKFSDDDTGEFNKILSLNSAPKSIDIKA
>fig|195.2027.peg.383 hypothetical protein
MSKNIKTQEAKLDLITKFLDYANIADASYAMLQYVFKGIIKYKNDNGNELEKSRYPKTR
>fig|195.2027.peg.1794 Motility accessory factor
FNIDENLNIYDKTHNVFMYENLEEELNFFYQSILEKTPRYPFVCIYGIGNALLIKNLAKH
YKHLFVFESEIELFILALSTIDLSEELKVYKVVLFDCVAKDLEIQIAMIFDQQSILEYLS
LYEMFISSHYYLKYYETSILSLNELCIKTASVAIRNADITCFLPLLTHGQFLQNIPSMLK
SIPFQRILNERKNKFENAIVVSAGPSLAKQLPLLKAYQDKAVIFCADGALSMLEKEGIVP
DYVLNIDFKDCHAMKFFQNKENLKQSIIALECATHPNVAHSLKAENCMIVLRNKALYQRF
NFNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFDFGEKFEEEH
KKYKLKIPAYAGKGEVLTHITWNDYRIKLEYLFACNDQKAKFYNATEGGARINFTEELSF
KECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRFLDDALALK
>fig|195.2027.peg.1181 Tetracycline resistance, ribosomal protection type => Tet(O)
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYPSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKPEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>fig|195.2027.peg.1619 Membrane protein
MKNNIQLFVLFGIFTFLFFWQKFAWVSLFLIPIFLAFFLEFFYFLRLRKNIIKEATMIKN
SLIYRVSAGDFYIYSLSFFMALFALASLFLNLISYEKQDGFFLFVLLPLFLFFFKQKLQL
QFLDNAYNDFRIIILSSLILALLYAIFNGVVNPIQSFNLEDFNQSIIHYKNSKFFVFDLI
SQILTLINALKEYFLYSLGLFWFRVLNFIFDFINFFIFCSFVAYLYNFAFKAKKKTYVFV
FSFFITLASFFIIEDKNQNPKAYQKELVLMMNNLSFLKEQNLSMLQNDKDRLVKNLKQVQ
ELLDKNAFEIGIWWFSKEKEELQKALNESLQ
>fig|195.2027.peg.1172 hypothetical protein
MAKNVVELHNKQLEKYSDSLNEFVQKLGIPIDVFQNCDDRIAVISNLESIVYKIEKHKLQ
HANYISKFIASISVGLFDSALNYLWNETILNIRNKIIQYDINYFLEQSSLSENSKLQIKS
DEDLSKLNDYELLKGARDIDLLSEVGYKQLEHIRYMRNEMSAAHPNNNGLKPFQMLSFLE
TCISEVICSQESEIALKVKKLLGNIKKQAMSKSEIENISAFIQAQPSRKVISLALGLFGI
YTDKNTPKFVVDNINILYPYVWNNLKDSAKYKIGIKIGEYTAHADSYRSSKGKELLEHVN
NGMSYLCEENKIVEFKRGLEELIVTHNSFNNFYTEPTYVNKIKQLVGDKFFIPKDIETEY
VFTIINVFLGNGCGISWEANEIYLFLIENFTENQIKLAIQSILEDEINRKLEFSQIAREQ
FLKMIGIFKKKLKNSNLIKICEDMEKSQNLYAFFGKDIDEESKKNILNTRFS
>fig|195.2027.peg.1547 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
AQKAYKLKIKKNPNLALPPLESYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKML
FEVRKLKREFKEK
>fig|195.2027.peg.1473 IncF plasmid conjugative transfer protein TraN
MKNYNLLRFFSKNTSVEQITPKTLRLAILLSASLSFSQAAIQCTDYNDFKQFNGHYYTAT
VQKMTFEDARKLAEDSGGYLAIPDSKAENDFLSSLFRGGQYAWIGVYDPSYISNYCVEGN
SGCIYDDSRFKTVKGNPLTYKNWAQTQPDNLLKKYDIVDGKERVSPLGEHWVAMASPSGQ
WSDQGNHFGDTNNPVRNYALLEFDKIPDCAGGGSDGGDNGHTATDAMQCNTNFSDDPNFK
PANGQGQSIACLQNSQQKYFCPAQLTQCVNSDDAVDGSSKKIEGGVLKTGKTKVRLTFSK
SIGYNAWQVVTNDIYITDIDAIDSFKLVYAGADDWVVPFAPNSTVAVVGNKPNNTKDALD
YIPYRPNNDNYGELSKFSGKNLNIELKQYLHTGINKSVAFFATVGSGGWQLTYEATGKDI
SCSNFGRNLNCTEESETIPFSAYKYTCPAGYQPKEQGGVCSPQSVDDLIDTNGDGIGDSC
NSSIAPAKNCLGVTRTCPFNSSRECVLIDNKYQCSPFPCFKGVSDVENTDTPVGVNDANN
NGWNDDGTCSGQIIIFNGQDNRCKNWDMFGGLLGGGCCDKDNVFLGLVACKEDEKKLAKL
NDAGKCHEVGTYCSKKVSLGFTKICVEKKKSFCCFNSKLGRIFNEQGRPQLGKGWGSAEG
PQCKGFTPEEFQKLDFSEIDLSEFIADIVGSFDTGKIQADSVKIQEKIQNNIENATKKPT
N
>fig|195.2027.peg.170 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFSNRP
DACYNVTRRFCDKSFSANERVKTLIYDVNKGLESFKFLPQDQIIFKFDEDFELYLGSNRH
VSEEGFWALSLRYQKRTIEQCCFCFTLDNKLLISCIQGYQYSDFNVLDINKIFTKKCYGL
RPIALLIECIKMLCVSLKLDATLGVHEKNQIRSQKGEDKGYFVDYQKIWLENRGKLVKIN
NHLYYELSHKRKNLEEIPSSKRSMYKKRFAILEEIKQALDQSLFI
>fig|195.2027.peg.1203 Bacillosamine/Legionaminic acid biosynthesis aminotransferase PglE; 4-keto-6-deoxy-N-Acetyl-D-hexosaminyl-(Lipid carrier) aminotransferase
MPPFTLKKIYFTIKKFKKGLKLKNGALIDLAYFTIKKFKKGLKLSSIIKLVISDFTIKKF
KKGLKR
>fig|195.2027.peg.1776 hypothetical protein
MENKNLLDEDMQQVFEYYLKNDSYLKGAIDGLKNMKQELL
>fig|195.2027.peg.1429 McrBC restriction endonuclease system, McrB subunit, putative
MSEAVKFNKDNWCKPDEYEEDWYVLSISKLKSIFQNKIIPLLQEYFYNDYALISAVLNDN
GMIEKCEKNDKYLQKIKNLDNVDSEKIIYNIASFDNKIWNDIKTYQAIYNDGENQSKNDK
Q
>fig|195.2027.peg.378 hypothetical protein
MDAFADIGLTFGKGDFQANALKQFLLDIAPILNNIDSSKITFVGHSLGGYLAVVAMQFCD
TIDRTLCTDFNQIKFSASKVCTFNSPTIDGIIIC
>fig|195.2027.peg.1311 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MKKREDLIPAVEILNYLEDSFIVGWPQYFSPLNPPYGKPMNAELKGYLTSKNGLPDMDKI
QNYALKNKIPYWNIDVSVYGCKEVCYANLEYIKQRFKIIEGVDISIVQEFSLPLNLEQKK
QLKHKVTLGIPNMEIFWLSTRGEVLEPSDGHVWFSPIIPRDGKELLKCQEVYMNLFREFG
EESPITPFSHPRSWMYRAFCFMLAFNNSRTDKAHN
>fig|195.2027.peg.335 hypothetical protein
MEAKGIAIFPANVAFNKKTNAFFTELEDQFLKGEVGKSSIKLDFEYYILYS
>fig|195.2027.peg.1156 Uncharacterized membrane protein, YraQ family
MQVFFNTFKEFLYLFVELSVLFIGISFLISIINQKYEGMFRKQLSGDKISSYFKAIFLGA
LTPFCSCSTIPLLKAFLEARVKLSVCLAYLFTSPLINPIIFTMLFVTFGLKLSLMYVLFL
VIFIFIISLIFSKFKEEYFLKHTPKNSAPSIFTQNAKNIGKIVFKPSSCCANTQNKTNDT
KINFKKLFKESIANYKKLLPYIVIAVLIGALIHDFIPQEILQKYLSGNEILSIILAAFFG
VLLYLRVETIIPIGLILLQMGISQGVIMSFLIAGAGCSLPELVLLKQMFKMKFLLLFIAI
ILSVAISFGMLINFI
>fig|195.2027.peg.89 putative butyryltransferase
MNEIYIAGKNIDLYLVETKDAEFILKLRSEKGKYLNQVEYNINKQKEWIKNYKEREAKGE
EFYFLIANKNKEKLGVVRLYDFCKNSFCWGSFIIKKNTPYYVAIEAVLQVYEFGFYKLGF
RKSHFDVRKDNERVVAFHKRFGARIYKENDKDLFFTLKLKEYAKIKPRYKKFIE
>fig|195.2027.peg.87 hypothetical protein
MRWEKKGLIFCPNKESEWISNSVLTPQPFLLNEEVIRVYASFRDEIGIGRIGYIDLEAKN
PKKIIKISKKPILNIGKNGMFDDNGVILGDVLRIENKIYMYYVAFQLVEKAKFLAFSGLA
ISSDNGENFQKVQEFPVLDRSSEGLFGRCIHSVIYEDGVFKVWYSVIHNWEIINNIPYPA
YFIKYIESKDGIHFPLYGEDCIKCNESEYRIGRPKVYKTNFGYEMYYTSDTFTKEYKPGY
AISKDGINWTRKDDFFSLQKSDKGFDSQMLCYPTILKTKYATYMFYDGNGMGRDGFGYAE
LIEE
>fig|195.2027.peg.847 Hemerythrin-like iron-binding protein
MDHHKLIPLWDERYNINHQKIDTQHQRLFEPAAQVENAVFKFVKRDELKEILTELFAYMK
EHFHDEEEFMQEIQYPRLYEHKQMHKISYMKCFN
>fig|195.2027.peg.387 hypothetical protein
MKKHIIFIIFVVYLIACFLFALLAGAIGHGATPYKIATFFITLVVAPLVPHVIVSLVIDT
YKQFQWWKILNLIFLIIPIYIFFTRLWR
>fig|195.2027.peg.1206 hypothetical protein
MVKYRIASYSVESSFSPFLNFFMVKSSAIVDNYGNSFSPFLNFFMVK
>fig|195.2027.peg.1430 hypothetical protein
MMGKINQKMINNNTFSIIEHQAFSKEDLQGIFKEKAKKFYQELEDFAKNNENFLGFKNKN
TLTAKNYVGIIQTKSGVLEILPKCTNLDSYKDKECKLSTISKEKLLKNYILNQISQAKTS
ENFYGEDFAFNPKTLLINMLKTLKNSPFKKSQISSLQISKMPLLEVFIAMFLDELDGVYK
KGLKKDYISIEENRNFLKGKLQFSQHLKQNLVHKERFFTQSDEFMLDIAPNRLIKSTLNL
LKSKTTHHKFKIIKALEMFDEVGFSTNYEKDFTYKISRHFDYYENLLSWCKIFLQNQTFA
PYKGKNEAFALLFPMEKLFEDYVAHMLKKANPTQNIKTQSSGKYLISKKGEKCFMLKPDL
YIENETILDTKWKIPDSNEDKKHGIAQSDLYQMFAYACKFKIHDIKLIYPLCERTMSLQN
TIKELEFNANEHLAFLNDNSPLKTNIKVQVIFAPLPF
>fig|195.2027.peg.1535 CDP-abequose synthase
MKILVTGATGFIGTNFILQMHDRYEIIALVRKSSNIDKIKDYCKICYYEDFAVLKENLQE
EQIDGVLHLATLYLKHHRPEDLKDLIDSNILFGIKLLEILYLIGFSGWFINIGTFWQFYQ
NLSNNPLNLYAATKTAFLNIANYYTQIAKYKFVTILLNDTYGLNDWRPKIINLWKKSLET
KEAIRMSGGEQIIDMLYIDDVINAFEKCIHNFENKKNTNNVIYALHSKERITLKQLSNIF
EECAQEKLNIIWGVLPYSNRENFIPFEGGEKLPNWEQKISLKEGFLKMINEK
>fig|195.2027.peg.1791 Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49)
MENFKFVLFGATGDLAMRKIFPSLYQAFIDGLLPSMGKIIATSRSALNTEQFIEELNNRL
KIHIKNYDDKKWEEFTHIITYLSINLNEVRDFDCLREEMGNESQNIVIYFSVAPEFFMKA
CKNLALVHLNQSNVKIILEKPLGMDLQSCQAINNEIAKYYAENQIYRIDHYLGKESIQNL
LILRSCNPIFTSLWGKEHIDCVEISVFETLGVESRGEFYDSTGALRDMVQNHILQILSLV
AMKIPQNFDAESIRRSKLELLKSLKPLSDEDIKNNVIRAQYIKSGEFKAYLAEDNVKSDS
QTETFVAIKAELLEENWKGVPFYIRTGKRMADSFAQIVVSFKNKELSNLNPNKLIIRLQP
DNHISLNLRVKKIGKTIEYEEKNLILNLNNASIMQPYERLILDAIEGNQASFNHKEELEA
AWTWVDSILENWKANKTPLYSYLAGSWGPREVFELVKKEGHEWHNF
>fig|195.2027.peg.872 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MVDRDYFNVISRGIDLAGSIAHYQSGKNLSDINFIAGLNKVDLSTPNAPKIIASKQKDEK
IDYGIDGKYLGSMYANTVTLISTEEGVGVRHSGVIRGIEDVIVKVKDKAEFQAIGVNTNG
SVKIDAKDIKTSLINADTIDLKASGKVTNEGLYKGKQIQINANNFENAKQTNLSQETKDI
FKINQENSSIFADSLTLNTLDKTSNFGFINALNDIKVGTNSFDNQGEISANKDISLMLND
DAFINNGKILSQNDIQIQANKDLTLNHGNLYAQNLLHIKSLNDLNINSKLENTSSIELDA
KNIYVKNLVASGKELNLHADENLVNDAYLFSNGDLRAQATTLTNNSTFNSLNNLYLNAHT
IHNNALIFADKVSISRQIF
>fig|195.2027.peg.1472 hypothetical protein
MKRFYFLFFSTLFFAPSFLFGANIENIKKYRNSIERREA
>fig|195.2027.peg.1536 UDP-glucose 6-dehydrogenase (EC 1.1.1.22)
MKSLKVTVFGLGFVGLTTAVGFAKKGFDVIGYEIDKNKALLLNDGKIPFHEEGLPEALND
VLGKKLKITNDATEALKEAKIIFYCIGTPMSEDGSADLSFLLDALRTTAKNLNKCQKEPI
LVIKSTVPPSSCKEVFIPHLESLGLSVGQKCHLVNNPEFLREGFAYSDFMNPDRVVIGSQ
DAQIFHELEELYKPFSSPVFFTSLNTGEFIKYLSNTTLSLSISYANEMSMIAQNIGDIDV
ISAFKILHSDKRFSGNPSGITSYLYPGMGFGGYCLPKDTLALYKKSKDKGYEAKILNDIL
KVNDEILDFYAYKIQKEISKDKKIAILGLSFKPGSDDVRDTKSATLISKLLNLGFENIYA
YDPIANDVFAKTYDYKLYYRNSLDEIISECDVLVIATAWMEFKPLIERQDKIVYNLRWIK
>fig|195.2027.peg.492 hypothetical protein
MQALKNEIKQKAIFMSLINIKETIKNIQDSADAEVMVIFCEEDMKRLSKSRNIAAHNSQA
MDLNIVTNLIRYDLARLKQSIVNFKNNPNNLHFIPKEENVKKKNTKTTRSINYFFICMHF
ILYYIYYLFLLNKPSKSIRQGNFSYNFHTSYFYSLDPFILNLPQAGRQKYIHCTIDLELI
KEISLEDFTKISPVIRDTIIQTILAKEIQEIEFSNFKLELQRELVKKINEKLGNKLIKEL
YFRDFIIS
>fig|195.2027.peg.1534 Putative O-antigen synthesis protein, WbyH
MKSESIVVLGAGIAGISAAYHLKQQNKQVKVYEKSSEYGGLCGGFFVDSTKGKFWFDNAV
HLSFTKDESVKKAFFASAKHYTHVPQLLNYYKGIWVKHPAQNNLYPLPLDIKLKAIKDML
QNTYENIKVENFEQWLKAQYGKFFSEEFAMKYTRKYWTLDAKYLSVNPMFVGPRFYKPSI
DEILP
>fig|195.2027.peg.90 Putative N-acetylgalactosaminyl-diphosphoundecaprenol glucuronosyltransferase
MIKISIFTCCYNHEKYLERCINSILKQTYQNWELVCVDDKSTDNSLKILQDFAKKDKRIR
IIEKEKNSGKAAPNCNIALNYLDGEFVLGVGPDDEISENCLQEFINVYSDLEDKEIDAII
IPTLFYFIENKEKNFIMSGVNGVKNSENRILTGREAFELSIDWKISGFAFFRTNMVKQFG
FYEEGMNRDEYSCREFFLNSRKVTFLKENFYFYHQINTSITRKLSPKLFTVYKTLWKTEE
LAKKHKLQASLIKFINQRRYTESYNLWEKYLKNKNNFCAAEQKKIEEYFEENYQLLKPYK
TTRDYFFRKEKDRIGKSIIFFDKIKFYYKRLKNA
>fig|195.2027.peg.166 Putative membrane protein
MNLSNTQIGLALSVYGIVQTVGNFASIYIADGFSKKFLFLFH
>fig|195.2027.peg.298 Putative periplasmic protein
MFKLNTCLPLKCDLNSQDCTFLFKGKQILVSAYPKPIKIFKNTAIKVSNFPFDPNLKIKI
YSLNSYIGNIIPQFTNTKDSIIINFYRKKCYR
>fig|195.2027.peg.1578 FIG00470572: hypothetical protein
MDYFASSLEWVKNKYFPHKNSLFTPVNWEEYEQNYTLTHMLSKDWDDVADFIAQIIVSKN
EIISSLKEQLELARKD
>fig|195.2027.peg.1170 Type I restriction-modification system, specificity subunit S
MSKFAKVKLKNCATFINGMAFKPIDWDVKGLPIVRIQNLTGTNKNFNYYSKEYNPKFEIN
NGDLLISWSASLGIFIWNNDKAILNQHIFKVVFYKIEINKKYFYFCILDVLEEMSEKTHG
SVMRHITKGDFDNIEIPLPSLKKQERIVGILDELIQSALQKAFNPLKDNTKKNYQLPQG
>fig|195.2027.peg.514 FIG00471048: hypothetical protein
MLGILSSCMSAFASSMGVVMPTFFSIVPSIKALEPSLAFSIIAVFATFTGYSSFSTGGAL
VLAGAQDESEKRYLFIRLIILPLILVVFGFVLLFLGILN
>fig|195.2027.peg.84 dTDP-glucose 4,6-dehydratase (EC 4.2.1.46)
MNNVLITGGAGFIGSNFIEFYCNKYPNDKVINLDLLTYAGNLENLKDISSNKNYIFYQGD
ICDIKLVEKIINTHKINIIIHFAAESHVDNSISSPDVFVKTNVNGTFNLLYSAYKTWFEE
PFKAKVGFENALFYHISTDEVFGSLGEEGYFSESTPYAPNSPYSASKASSDMLVRSFHHT
YGLNAVISNCSNNYGAKQHDEKLIPTIIRKALNGENIPIYGDGKNVRDWLYVNDHCEAID
KILHFALQSKGNFFDTFNIGGNEEWKNIDIATLICEILDKKFPKARSHKEQITFVKDRAG
HDKRYAIDSSKLQKELRWKPKESFESGILKTIEWYVEKYKDNL
>fig|195.2027.peg.1477 hypothetical protein
MKKNASSKILLSLGVATLLYSGAFAAEITFNSDSDLNTHFDINEKDNVATFKNENYKNQD
LTFKINTLAFDDAPEDAKINIDLGNNSLTLENTRNSGGETAALVRNFNVDAKDFKTTDIG
LSYFNAGIINANFTMVGSGEDFDLDNIDKNKASSLLIFNGSRENTNDTVNGSLTVNGDFS
ATNSAIVSMKSDTFKVNGTATIEKSGLGFLSQSYSNLDVNDFIALRAKDIKTDKLNDETN
AGALILKSASSYIDESLLNDDDYVASLDVTAEDNKYGGVFVDYKLSLKNCGGDKCLVING
GATAAAKKLTNQIAVDLEAITRIIDGLDNEQAKEALQEQKTELEQLKQEAEKNGGKIDDE
KYIDLVNKNSNLNLSANDKASILALRSITEQLGSIGADLASREGVKLALDIKKDTDNTGK
SVSNLNSASSAVNTTMNISNDVSIGSRVAMLNNPFGTYASKMNGLKFAALDSDMRPSYVN
EYTNSVWANAFGGANIIDGDSGAMYGATVGVDKQANDDVLWGAYFTYANAKIKDNNLEQK
SDNFQLGMYSTINVAPQWELNLKAYAQVSPTKQDNVQIDGAYNSDYTSKFLGLSANAGRV
FDFSDNTLFIKPFAGVNYYFSYTPSHTENGAIAKDIDSMKNNSVSVEVGAEFRKYMNENS
YIFVTPKIEQFVINSGDDYTANLAVNNAFFTSVEANNKKKTYGQIIVGGNVDFTNQLSMN
LGFGAKQILAGKVDNKNETYLSGQVGLKYKF
>fig|195.2027.peg.390 hypothetical protein
MGEENYKKLRPYLGMTTYYVCEGKKYPVVFATMIDYKVKNYGLFGDEGRGFSFSSISRKS
AGGGSFHYFTNGKFIKSDEKYTGQSY
>fig|195.2027.peg.781 Phosphoserine phosphatase (EC 3.1.3.3)
MKLVLFDLDDTLIQGDSAKLWLKFCVEKGFLPQEYLEKIVFYQKQYQEKKLDMDEFMTFF
FKVLRVKMKIEFHL
>fig|195.2027.peg.78 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28)
MINLVEKEWQEHQKVTKASEILKGQIAKVGELLCECLKKGGKILICGNGGSAADSQHFAA
ELSGRYKKERKALAGIALTTGHFST
>fig|195.2027.peg.776 hypothetical protein
MSKVILVVLDGLNCKSASINMGYLNALCKENLGKFYSLECELPSMSRPLYECLLTGVKPV
LSGIINNKLSFSKQTSIFDLCKEQGLKAGGAAYHWVFEFYNKKEFIPSLHRHIEDENLTL
PYGHFYYEDDYLDSHLFADGGSI
>fig|195.2027.peg.1468 hypothetical protein
MTLTINNADEKLLKAVQSIVSLSPKATLEIEQEIPSGETIEALNNPVSCGVFENYEDFKK
ALQD
>fig|195.2027.peg.388 hypothetical protein
MDNKGLITKLRDNSELAWAAYGYFHLANPRYDFNKDNIDKERLEYFRKLYKNNNLESSKT
DEQLQSIYPTPADILNIEYKYFKDNNGKPKDSWYHKYFLGGEFSPLQAKQFFSRYDLLKH
CPNTDSGFSATLF
>fig|195.2027.peg.1787 Homolog of fucose/glucose/galactose permeases
MQMKSNNFALATLTALFFVMGFITVLNDILIPHLKAIFELNYFEAALVQFCFFGAYFITG
GFFGKLLEKVGYPVGVVLGFVLTSIGCILFYPAASTASYPIFLGALFVLASGVVLLQTAG
NPFVTLLAPGKEATALTLVQAFNSLGTTLGPIFGATFILSGTAEYISKAQEAQSVQIPYL
IIAGVLILLAVVVYLLRLPDVRERAEKISEENHDGKISIFEYPHLVLGAAGIFFYVGAEV
SIGSFLILTMKKFADIEEITGAKYIAFYWGGAMVGRFIGSAVMSIIPPNRCLAFNAMMSI
CLILLAVLVGGKVAMVSLIAIGFFNSIMFPTIFSLATKNLGKFTSQASGLICMAIVGGAL
IPPVQGLVADYSNLLLSYMIPMLCYFYILFFALKGYKSR
>fig|195.2027.peg.624 Arginine/ornithine antiporter ArcD
MDSIIIAFFVGFAVFLGTFLEFDRSYWVAVSTTVILQGTNLNSVWIKQLQRILGTTVGIL
FA
>fig|195.2027.peg.1138 Integral membrane protein
MDFNSVLSNIGDKLPRDGLAAITLKEKFERLSEERKKMC
>fig|195.2027.peg.379 hypothetical protein
MKQQIKNLRDYAELAWASYFNLIYIDGQKTNDFTIGTERILKDKENIEKFEYYKALSKDH
RIEIILFMMIR
>fig|195.2027.peg.515 hypothetical protein
MSYENFIGKQEKFTENINEKQVQKIVATLQSKQLKNGDALPYLWQWCFFNEALTPDKLGR
DGHPKLGLDKNSFFPSFGEVNRMWAGGRFNFIAPLIIGEDAT
>fig|195.2027.peg.1537 UDP-glucuronate decarboxylase (EC 4.1.1.35)
MKSYSCLENPIVIEDLEYIYNSLTKVEKQKFNNSTILFTGCAGFLGFYFINFFIKYSKDL
NIKKIIALDNFMLRKPKWLEHLSNDYFDILELHKFDIINDKIDLLKDAHSADLIIHAASI
ASPMFYRTYPIETLDANIWGLRSLLDFYKNKNIKGFLFFSSSEIYGDPDISQIPTDEEYR
GNVACIGPRACYDESKRFGETMCSLFAQKFNMPITIARPFNNYGPGMSIGDKRVPADFAK
AVIEGKNIEILSDGSPKRTFCYIADAIVGYLKVLVHGKFDYFNIGIDKPEISVKELSYIY
AKYSKEIFNFEPQVNFAVSEDKNYLKDNPNRRCPIIDKARNKLQYNPTILVEDGVRRFLK
FLKFEKENGELL
>fig|195.2027.peg.1589 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MDIGIKAGDMICVHTEIFNLGIPLLTKNEYLKALIECFLEILTNNGTLVMPTFSYSFCKN
EIYDKNKSKCTVGLLNNFFRKLPEVTRSNDPIFSFAAYGLKANLFQVENNSCFGKNSGYD
ILTKNNAKIVYLGADWAHTFIHYIEEQIGVDYRYFKTFQGYIIDENNQKYEKKINYYVRC
LDKPSELNLSTIAKLLEESGSLKKKSFGGTSISAIDTNDFKKIIIQALNTDKYILVRKD
>fig|195.2027.peg.1588 hypothetical protein
MEKQFYEILKNILEIEVNEHTNLSMNNCPEWNSLAHIDIIMSLEEEFEIKFDKEKLTELN
SQNMLLKEIKKLKNE
>fig|195.2027.peg.512 Dicarboxylate carrier protein
MYSVRNRPWSIPIALYITVMVFVGIGPGHYAGFAFMSPLVLYIASKIKMNKILAAIIIYS
GSCAGGFNPFTLGGRVTFDLIEKLGYSAEASAIMQLNLGKNMFIAHTLIFYNRIFFAKRL
>fig|195.2027.peg.1465 hypothetical protein
MKDLDYYLNLPYEIIIKKLDEKDGGGYFARYKDFPYIMGDGENEIEALKDLKEAFKGALE
VMLEKGDYIKEPIDNEAKIRINITLPKSLVEAIDTISDNRSKFLADLANSAIKSYKIST
>fig|195.2027.peg.385 hypothetical protein
MDPQYYEFRSLCKDIDNKVIIYNKAYWEIFSNREKGNTMHDEKGEFFFNQKINKKIYFDF
KKSKKH
>fig|195.2027.peg.380 hypothetical protein
MNNKEQIKKLRDNAELAWASSGYFDFINKQYSFDEKDKDKFKTLYAKINDLKKSDEKVQN
AKATYTDILNMEYNSLFDGEFSPLQAKQFFERYDLLIHQPNTESSFSAALFYDTHKDGFV
VWFRGIECGF
>fig|195.2027.peg.382 hypothetical protein
MDNDISRVGLNDALSKRTIDFVNRFKLLKHQPNTTSGFSATLFGEKRKQINSKTKEESYT
SEYGYINYILAIRGTEMSSFKDLFVADASLAIGSIPKAQYDDMLNFYETCIKDYPQIKEK
DSLTITGHSLGGCLAQLFALSICDDKNRNNIKFIYL
>fig|195.2027.peg.961 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MPKFINWAKKKNASQPIYEHAPQNHQIKSHTPTMGGVIFVFCAIFASLLCIKFDNLFALM
GLLCLISFCFIGVIDDLGKILKKNNHSGLSPKAKMFGLIFASFLCLAPLYFSGILSADFY
IPFYKYPLFNMYIFALFFWILVLISSSNAVNLTDGLDGLATVPSIFSLATLGVFLYLSGN
LIYSEYLFLPKINGLGELVVICAALICALMGFLWFNCYPAQIFMGDSGSLALGGFIGFLT
VVSKNEILLLLVGFVFVLETISVILQVGSFKIWGKRVFKMAPIHHHFEKVGWVENKIIVR
FWMIALLSNLLALASLKLR
>fig|195.2027.peg.1540 hypothetical protein
MLHIAFSCSIEYIKYCAVVITSILMHGDHKEEYCFYIITSSSITKSMVDRIKAFEKKLNE
NYTVNISLFFINEDEYKNHPIYAGSTASFWRLKVAEALPVDVDKCIFLGVDVLVLGNIKK
LIEMDLQNKTVGMAPDCFNFKGFLRSMKSRDVEKLDFIFPYPEYYSNVDVMLIDLKQWRQ
KNISQQCELLFQQYIPKWVEQDLINAVLGDDIYELSPRWNFWIGGHYVISRLGKKITFKG
ESLKPYWKYTRSEFEQSERNIQIAHFTHCCRKPWVTPYSHLDQDFKFIKYPYYDTWWHIA
MQTPVFKKELIEIYRRIENNKVDVYQNTVVPQIKSLQTTIKNNEAKLVQMQTSNNTLNKT
IQEKDIIINSNTNQIDQLQNNIQEKSTQLNQLQSKLSFQTQYGTAKSRIQNQLSYKLGQA
MIINSKSLLGYLIMPMILLNIIISHKQAQKAYKLKIKKNPNLALPPLESYPDYKEALKEK
ECLTYKLGEALIKASNNWYGGGYIKLWFEIRKLKREGRKVRK
>fig|195.2027.peg.1171 Type I restriction-modification system, specificity subunit S
MMNYWEVKKLGDIAEISSGGTPSRNKKEYWENGIIPWVKIKDIKENFISTTKEFITENGL
KNSLVKLFKKGTLFYSILAICVLIIFVTFIMSKYYSQQAIESYKEIMMENDICQNLQK
>fig|195.2027.peg.669 FIG00469879: hypothetical protein
MGVPLEVSKGLSPLSQDGIYFRREVKNVSKMFPTFSKLPLLF
>fig|195.2027.peg.869 hypothetical protein
MYLKPVEISYESANLETSKSISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENIT
IENGENKISSSSHSSTSSIAGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELN
GGEIDIKVDKVDFIAAQNKTHTESDSIAIGVFANANLELTGNGVAVNYSFVQDKANARLL
>fig|195.2027.peg.1328 hypothetical protein
MLSLLSLKNKSLKIWKYDLKSQIYKRFKADSSRICKQSQTIEYLHILEKN
>fig|195.2027.peg.1167 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72)
MQNKIDKITDILRRDDGISGAMHYSEQISWILFLKFLDDYEEELKLEAILNDKAYKSILE
EKFSWRIWAAPKTSEGKLDVKNALSGDDLLSFVNNELFPYLKSFKDNENFKSIEYKIGGI
FEFIDNRIANGHTLREVINLVDELSFSKESDVFALGEVYEKLLKDMGSDGGNSGEFYTPR
PLIRAMVEVIDPKAKERIYDPACGSCGFLVESFLHILYEDRNKNKKANLSVEELEFLQND
ALFGKEKTPLSYAMGVMNMILHEVKSPNIIKTNTLNKKNHRHNPKRKI
>fig|195.2027.peg.962 Sodium-dependent anion transporter family
MSNSTKTFIIVADIILFIALLALLPFETKVNQGLTILAFIAVLWLSEALHVTITAILIPI
LAVIMGLMPTKSALHGFADPNIFLFFGGFALAAAMHFQELDKIIAQRILMLARGNFALAA
LYIFFTTAFLSMWMSNTATAAMMLPLAIGMLSQLDYEENKNTYVFVLLGIAFSASIGGIG
TLVGTPPNAIVATNLNITFAQWLQYGIPIVIIFMPLMILVLYVTFKPNLKFQINTNLEQK
IPMDTQKYITLIIFAIVAMCWIFSSYINPFVSNLLGFEKKIANFDSVIAILAAVLVCTFR
VVSWKKVQENTDWGVLMLFGGGITLSLVLKDSGASKIMADGIISLIAGGHLFLIGLLVSL
FIVFLTEFTSNTASAALLVPLFISMAESLGAPPLGLALIIGIGASCAFMLPVATPPNAIV
FGTGYIKQSQMVRVGIYLNVLCSIIIALMAYFFWL
>fig|195.2027.peg.377 hypothetical protein
MLMRFLANLLGNNIVEQILNPEKIVCVFDNGGVEIIASAQYDASNALGIYTGKNDHSIKP
LVNTLYFYSYLLELDANYNKVKDKSLSECIEYLNHFMKNIQIYTETFVLKNNATNKNSSF
GFNKNHPEKINHFEYSLSLIATIMQETNGILEELGDSYYTSYKVPIIS
>fig|195.2027.peg.940 Bacteriocin resistance protein; peptidase C39
MEKILKILLFLPILALSTKAEWVVKSYQEIKNERVIRQTYEQSCGASSLATLLNILDDQK
KFDELELLKIMSGQELYTDMVSFADLNDAVKKLGFQSNSYQINRENLDKLVNIPMLVKIE
DDPRFPHFVIIINHKGNYLQILDPSHGEYISSKSQFFSIWDRYNKGGYALIIAPKKELKP
FKLNTPKSLHFDFSPFSLF
>fig|195.2027.peg.684 Family of unknown function (DUF450) family
MDFENQLNAIVETIAERKTLVNTEEATKMTFIMPFLKTLGYDVFNPSIVVPEYTADIGTK
KGEKVDYAIFKDSKPFILIEAKNHTENLDNHNNQLVRYFNTNPSIKFAILTNGIEYRFFT
DIEQQNLMDKIPFLVVNLEKLKPRDIKDLKRFICTDLNLDEILSIAMEKKYYRSIQEIFK
SEIENPSDEFTSFFAKQMTEKRMTSAVLEEFKNYIKKSFKEIINDLAYEKITSIKNNLQN
INDDENDEQIDESKDIVTTEEELQGFYIVKSILASVSANLEDVSYKDTLSYFSILYQGKV
TKWICRLYFNTSKKSISFPDGASYNIEKLEDIYQYKADIIKAFESRK
>fig|195.2027.peg.1682 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MLDRRRFLKIGAALSTLPLIPTLGAGKSAEATKVSLGLVKNGEVITAAHWGILKLTIKDG
KIIKSEPWEKITKMDNPLQHYTADMVYKSRVKYPYVRKSYLENPDNPKPELRGKDEFVRV
SYDEAIKLIAKELKKTREAKGTSAIFGGSYGWKSSGNMQNARILLHRFLNVTGGFVGATG
DYSTGASQIIMPYVVGSIEVYEQQTSWENILEHSKYVVIWGADPISTLRIAWTASEQRGL
AYFEKLKEKKIKVICIDPVKTDTAKFLNAKWVAPRPNTDVALMMGMASHLIAQNKVNYEF
LENYTTGFDKFKDYLDGKEDGIKKDVKWASKICGIDEKMIKNLAEIFYDNPTMIMSGWGM
QRAHYGEQPHWMLVTLASMIGQIGTKGGGFGLSYHYSNGGVPTCKGGVIGGINAESLGIW
KNGKFQGLAKSNQASGGAEWPSKCCKLFFPCSKNSRCFT
>fig|195.2027.peg.615 UbiD family decarboxylase associated with menaquinone via futalosine
MKDFIKILKDNDLLKVYEEPVDVDLEIAHLAYIEAKKGEKGKALLFKNPIDKKLNKQYKF
PVLMNTFCNEKALNLAFGRDYKEVADEISKLTKLHIPTSFKAKIDFFMNLLSLKNVPPKR
LKADKALYDYELLNSLEELPILKTWEEDAGRFITMGQVYTQNLDKTQNNLGMYRLQVSDK
NELLMHWQIHKDGANFYHEYKNAGFKKMPVSIAIGGDPLYIWCSQAPLPKGIFELLLYGF
IKKTPAKLTPCENGIFVPYDSDIVIEGYVDLEEFKVEGPFGDHTGFYTPAELFPVMKVEK
IYAKKEAIYQATVVGKPPLEDKIMGLGTERIFLPLLQTSVPDLIDYKMPENGVFHNLILA
KIDAKYPAHAQQIMHAFWGVGQMSFVKHAIFVDKKAPNLDDYDALIPYILNRFNTNKILI
SEGICDQLDHASPNSCFGGKAGLDACEEAMVEELEILEDEKLLELFTTKIEPVNLKQFYK
ESKSPIVCILLDKKEKIEQSFEKLLEFKKHFRILVFLDSNNKLENPYMLVWRVVNNIDAK
RDIFIKADRVGVDASAKGLVEGYERVWPKQTDCTKSVIEDLILRNILENNSELFSKFEIL
G
>fig|195.2027.peg.1470 hypothetical protein
MDKAHLITYLVSLAFIVSGLIVCCILYLFKDKINKITPDNIENINSNIKDFIEKNIGILS
SNKSTTDYIMDPEYSCFTGNIYNDEIR
>fig|195.2027.peg.1533 Putative O-antigen synthesis protein, WbyH
MSEDTPVTYYAKEMYYPVKGGYKAFLENMVKEIDIVYRKEVVVIDNEEKIIYFSDGTKVK
YEKLISTLPLPLLVKMLKNTPQDILESSKHLYVTSVALVSLGFDKEIAERLWYYVYDEDI
LFARFYSPSVKSSYNAPKDCSSIQVEIYFSDFKSLEKMSNNCCNLADFFIKHVKEKLSQM
KFCNEADIICEDFRIIPYANVVFNHNMEKHRDRLLNYVRKCGILTCGRFGEWDYLWSDQS
FLSGKNIIDRM
>fig|195.2027.peg.777 hypothetical protein
MNIDDAGHKFGSHSIEYANKTKKVDILISEYLPTWLEQGINVIITSDHGMTEGKSHGGLS
EDEILVPFFTFGSAFSYENAKIKQDEICGSICEILGLKHDKRYNDEILKAKK
>fig|195.2027.peg.1790 6-phosphogluconolactonase (EC 3.1.1.31), eukaryotic type
MAFQLYRFENTQECELALAKAVASLLKKHLLHKNSINLAFSGGKSPIGFLELLNQEDCAW
DRCNISLVDERIVNLDDENSNTRLIATHFLKNLAKKSHFQAYFENPNIPLDELVDKANAY
YKQPDIAILGMGLDGHTASLFPEAEEFEWALKTKQNIVLISPKNAPYKRLSMSLSALEKC
EELFLSIATEEKLEILNQALKVINPKFPISYILHSRKVKCNVYFSK
>fig|195.2027.peg.616 Flagellar protein FlaG
MEISKANGQLDAAFANLGQRASGVHQTYSDIQAGENKSQGGDDGQKEQGLSEKLADITKK
LNEQMDSLDTNVRFGYSDKIGSMYISVTEKSTGREIRQIPSEEAMRLAEYFRDVIGMIFD
KES
>fig|195.2027.peg.1139 Integral membrane protein
MLNQLPMLKLKSPALMFWVGTFLFGPFGVGCFMIGDMVLGFVRLAFVIIPIIFNIVASES
LQNIAYILALMNWIVN
>fig|195.2027.peg.1141 putative lipoprotein
MFFLFTGCFNNKPKCDDEDVKFTLKSILDDEWVYIEYGLDEQSLRTLRINSNGMDIRDLE
AALSTDTLGV
>fig|195.2027.peg.1601 Chorismate dehydratase (EC 4.2.1.151)
MIFGKIDYINLLPLHIYLKKYPLPNGFKASMEHKKGVPSKLNKDLFYRRIDAAIISSIES
ARKKYKNLDLGICANKRVLSVLVEKNTPNAKDPSSATSNALAKVLKQEGRVIIGDKALKL
YLQDPSRYTDLCTKWHEKTGLPFVFARFSCVQKKALYKQILKKFPKTKIKIPYYILQNYA
KTRDLDIKDIRYYLDEIIYHKISTKEKAALKRFIKASKALNLTY
>fig|195.2027.peg.86 Putative transferase
MNNKLVIIGAGETANLAHEYFTHDSNYHIVAFAVHSEYRNEDKFKNLPLVDFENLSLLYP
KEEFHIFIALASERLNYNRAKIYQEVKQLGYKCASYVSSKAFVWHNVQIGENCFILENNT
LQPFVRIEDNVTLWSGNHIGHQSIVKNNVFISSHVVVSGFCEIGENTFIGVNSCIADGVK
IAKDNFIALGSVINKDTEENKIYRGNPAEASKISAKKFCKVKE
>fig|195.2027.peg.1576 hypothetical protein
MTAYLHIGTTNTGNQEKQGFLMQNEERLLKKGYIYPKSLRVANRHWALVDMVLELVQKED
ILQKESILSHITNERLLRAIENFKSESALHKDKNLFFQLRV
>fig|195.2027.peg.336 hypothetical protein
MFCFLLYYRALLNKNNTQKIVAKIINAIRCQERLPEKIHYKEKIICMDNHHRDLSQILSS
CVVEFYNSIDLYNTFRKNIGFENRKKIAIEMLNRASEHYGFFGLNRGGITYKEAKISCAP
IPVLNEFHHAMSHLCEVFLKDDARYTNLERAIPHFKRGMMDIYIKQSSEIFLY
>fig|195.2027.peg.1575 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
MNLKLNSHNIKAISIVLPKNPHTLEKELQECNLNQKKYELLKQNTGINHHFISPNNIYQV
I
>fig|195.2027.peg.1140 hypothetical protein
MSEKYVPFEVEPTLLYEKDTYKIVVGKAYTNKDEKFCIGLKSNGFPINSYLIFPPQLSSD
LLKSLLGQDGAKNDEIIEFIKIIMEK
>fig|195.2027.peg.1587 hypothetical protein
MNSISQKNLELFSKLSGDFNPLHLDQEFAKNSYYGDQVIYGIYQVFLTLENFFKKNQKNI
KIQKIKASFINPLFKNEDFKLKSIKSKNNFLKKYEITNKNKILSKIDFEFQEELKLHNPY
ESNFFNKYDAISNPLSKEKNAKEELKYNTILFKQLFPLCANYLNPQNIAILLASTRIVGM
KIPGLHSIYSSLNLNFSNDNIENKQLIYNYEKHHSIECYLIDFISPCKGSIKAFIRPQLV
KNLNYKSLVLKYPNISENKNFKEQKALVIGASSGLGNTCAKILALGGAKILATYHTKNIQ
EDIPNCDFLQYNVLKPSKISIEKIKKFNPTHIYYFATPKISTQNNKLDRKMLFDFLDYYI
FGLEKILSFTSPISSSSSSSSSIEDLPLDMKEYSIAKAAMEIYMKYLKKTKNIEIKIPRF
PRAKTNQTLSFIPQDLKETDELIVSMLLNKELK
>fig|195.2027.peg.1538 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MNSDMLKQDILNKVKEYYKLYHANKQTQFIEGKTKINYAGRIFDEKEMENLVDSSLDFWL
TAGKYTEQFEKNLANFLGVKWAFLVNSGSSANLLAFYALTSPLLKERQIKRGDEIITVAA
GFPTTIAPVVQYGAVPVFVDMELRFANVDVTQLEKALSSRTKAIMIAHSLGNPFNIKAIK
EFCDKNNLWLIEDNCDALGSKYDNKYTGTWGDIGTSSFYPAHHITMGEGGAVYTNNLLLK
KIILSMRDWGRDCWCKGGKDNTCGCRFTQQFGSLPKGYDHKYVYSHFGFNLKATDMQAAI
GCAQLKKLPEFIEKRQKNYQELYNGLKNLSEFHLVEAQPNSQPSWFGFMITLKDSVKFTR
NEITSFLEECNIQTRTLFAGNIIRHPAFDVLEKDKDYRVVGNLEVTEKIMNDSFWIGVYP
GMSEEMIEYMICRIQEFCAKQK
>fig|195.2027.peg.954 Flagellar hook-length control protein FliK
MSNLAPQNDVLNLTPNKTSNTSSSFSKTSKNKEHESSDSKNSTQDDTESFLNSLLNSIDE
TNEFLPDHMKISQKEVVNEAMSRLQKGAFDESDKISIFESASFMQILSLLDKLKTDTADV
KLANLSTQLSSLIKTEANFNALKGASNLSELLDIAKDLGLNVKNIKVDRLLDLKATFPNL
DKADFFKGAVDNVFKEIINNKISNVSKNLNHNLQNTTHTTSTHSTQKTNSKDSGSLLSQT
LKNLDSILSSKESKHEKNDKVKSKIEEDVTDAKNTLKNIKNDEFAKNLTEELNIKDKKNQ
DNLNKDNNLKDLIKDSTKQDKNSNKELKDNASTQELTNLKDLNKENKDLNKDFNKELNKN
QGDMQGQNKNLKNNNQNLNLDKNLNKEIVKDTQNLVSNLTHLTQKDFNLNKELKNNNKEN
KDIKQNFFDQKLNFENLNKTQVVQNKENNANFNNNTNKETFTQEQTKTHSENVDKNSLDE
LNSLVKDLNKATQNNARNITPKETLQYFSQDLKEAVDQYKAPITKLSITLNPNNLGEVEV
TLVQRGNNLHINFNSNTNAMNLFIQNQAEFKNSLVNMGFTGLEMNFSDQGKREQNQNQGK
NRSGYGFKDALDGKNESEKVNLELVLAKYF
>fig|195.2027.peg.1270 FIG00638667: hypothetical protein
MKKILTSALALGAMTLIIGCGGDDRFVENLIKTN
>fig|195.2027.peg.370 hypothetical protein
MKYKVLNKEHMNFYFYELGKKISKYYEMHLFLQIPNLKKQIF
>fig|195.2027.peg.1683 putative cytochrome C-type haem-binding periplasmic protein
MVNGIRRAFEIWADKKDFAKDNKEMLSRAKNLFAENCGICHALHPEKEFTANAWPAVFRS
MADRTGIDKKDRWLVIQYLQKNAKDFKAK
>fig|195.2027.peg.782 Phosphoserine phosphatase (EC 3.1.3.3)
MRESIAIKCERVGDKFSGKAYGIYSFKEGKVLRLKEYLGKDYEKWMKDSYFFSDSINDLP
LLESVSKAFVCNGDEKILKIAKERKYEILTF
>fig|195.2027.peg.1793 4-hydroxy-2-oxoglutarate aldolase (EC 4.1.3.16) @ 2-dehydro-3-deoxyphosphogluconate aldolase (EC 4.1.2.14)
MQAKEVLEISKIIPVITIYDLKTSVNLAKALLDGGIKILEITLRTNNAIEAIKLIANEVP
QVIVGAGTILNFKMLEEVKNAGAKFAISPGLNSIFAKEAQNIDITLIPGVATASEVMLAL
EFGYKNLKFFPAESAGGITMLKSLAAPFSGVKFCPTGGINLDNMQNYLNLNNVLCVGGSW
LSPKELILEKQWSKITQITKQSLEKIS
>fig|195.2027.peg.1442 hypothetical protein
MIVSKTYEIDSCDDVELDIKRESKLEFKLWYDDEKEIKALVFIIPGLGGDVDENYREHLA
EFVAGEFNVAVVSVNYHCIGNRPQTGSSFFMDDIDKLILKTSCEALNIQVNLDKLNSLEE
LSSTLKEVDHILEEQKNQKLINPNFKLSIHLSLQPTKNEYQNFGVMQAQDLLNAALYLKA
HAPFDTMGGGMPVIMIGSSHGGYLAHLAAKFAPWLINGVIDNSSYAKFLWRLIGFGKEID
FTKYYCFGTGIFFKHIHIYCSDKTFWTSNSSSNNFFSIPRRMIRYILELNHIENQANYPK
PYYVSYHSFYDKEIAPPDEKLELYKYLKQFDFDAELHMIKNPDQIDGKFIKSLDHGMGMS
IKTLISKELPCMLEKVLSESDSKKEWKNKSISYPCDGLVYRFSEKNNKINLDITKT
>fig|195.2027.peg.1656 hypothetical protein
MENERKKGEAKKKMSLGDDFWDQLKVIEKNSPKSFLMVVNIIVMIIIIK
>fig|195.2027.peg.963 Translation elongation factor LepA
MGKNVTVKCYGGDITRKRKLLEKQKEGKKRMKAIGKVHLPQEAFLSVLKID
>fig|195.2027.peg.625 membrane protein
MSKRKILKQQCKEIIQLNPTERVWQMPFFFALAVGFALSIAAYYDRMDLGLIAIIGIMAF
VYTTNTPMYHRMAVTMCCSFGLCLSFLIGLCTHFFSCILSACSWLSSYG
>fig|195.2027.peg.381 Tgh091
MDIEKNKTTNEILPLKKVFFYVEWHNRRKYLTTKSVASYELEWRENYENCAYFKKEIK
>fig|195.2027.peg.1271 hypothetical protein
MEKGFELIKAKNNNANMDFYSPETLKNFDEKRYKYLKSKDFRLYGSVKGYQYMIFSVNKD
KSDKREFWALICEDSKVENCKIENATGRGV
>fig|195.2027.peg.1457 hypothetical protein
MQITKGFKYRIYPNLEQQKLLNHQFFIYNQAYNIILDLQKKQMQINKNLDKSQRTYLTAV
QLDNKVKEILRQRELAFKSVVTQQARINLLRALKDKTKGFPKFKNSKFAKQSFNWNNQGY
QIKDSNNPKFKIFHLMKLPLKMRYHKDLPQNYKLNQITISKSHNKYFVSFSITYENPSVS
LISSQNLDIKKAVGIDLNINEIALSSGRLIKTNSKLISKAKYDNAFKRLQRKQSRRVLRA
KKEKVKLGANFFKTQIELNRIYEKASNIKKDLQHKITSQIVNDFDLIAVEALQTKNMTKR
AKLKNVKVKSGLNKSILDTSFYQFLSFLEYKTSHNGKIFTKIPPQYTSKTCSKCGSIKAD
LRLSDRIYICKECGNEMHRDINASINILNRALESFELGINSLDYKQQALCVS
>fig|195.2027.peg.1679 Ribbon-helix-helix protein, copG family domain protein
IDKVVENLQKESDDLGDFDFAIEALEELKDGDYSKASKKIDKIVKNLKKPE
>fig|195.2027.peg.1788 Glucose-6-phosphate isomerase (EC 5.3.1.9)
MKTLTHLNSYKALQNHFLDIKDVHMRTLFSEDLNRGFKYFLQSGDLKLDYSKNRINDETL
KLLFDLAKECSLKEKIDAMFEGEKINSTENRAVLHTALRNKSDYAVKIDDMDIMPNVREV
LAKMQKFSDSIRVGSWLGYTNQVITDIVNIGIGGSDLGALMVCKALKNYAHPRIHMHFVS
NVDGIQLQGVLEKVHPETTLFIVASKTFSTQETLTNAFTARRWFLNHALDEKYITKHFVA
VSTNKEAVKEFGIDLENMFEFWNWVGGRYSLWSAIGLAIMIYLGKENFSSLLEGAYLIDK
HFRNEPFEKNMPVLMALIGIWYINFFDAGSHIIAPYDSVLRYFPKFIQQLDMESNGKQIT
KSGKRVDYDTGPIIWGDVGINAQHAFFQLLHQGTHLSPIDLIASLVKRGNFPEHHEILLS
NVFAQAEAFMLGRTLEEVQEEMTKKGLTKEQIHKLAPHRVFSGNRPSNILLLDEIHPKSI
GSLVALYEHKIFVQGVIWDINSFDQWGVELGKELAKTILSELKGETTQEHDSSTKNLIQI
YRKLNSI
>fig|195.2027.peg.1792 Phosphogluconate dehydratase (EC 4.2.1.12)
MAQKKLEQITKNIIERSKKTREAYLERIETYQGKIQRKDLGCANLAHAYASIPSHIKDRI
KNNEGLNYAIISAYNDMLSAHQPFKNYPDIIKKEIFKHNAFAQFAGGTPAMCDGITQGYE
GMELSLFSRDVIAMSVAIALSHNVFDGAFYLGVCDKIVPGLLIGALSFGHLPSIFVPSGP
MTSGISNDEKSKIRQLFAEGKISRDKLLESEMKSYHDIGTCTFYGTANSNQMMMEFMGLH
LPNSAFINPNTTLREALVKEAASHMVKNKIKGIGELLSEKNIVNAIIGLMVTGGSTNHTI
HLSAIARTAGIIINWDDFDAISNITPLLARVYPNGKADVNQFEASGGIAFVIHQLLKEGL
LHEDADTIMGKGLEAYTKNPFLIDDKIIYKDGVRASKNENILRSIENPFSKDGGVRILRG
NIGRAVIKISAVKEEHQVIKAPALVFHSQQEFLQSFQNGELEKDFIAVLPYQGPRASGMP
ELHKLTPPLGILQDRGFKVALVTDGRMSGASGKVPAAIHMSPEALLGGSIAKIKNGDLLL
LDAKNGTLEVLIDEKEWQERTVNQFKSQELFGCGRELFAGFRTQSSSAETGAMSFGGYFS
>fig|195.2027.peg.867 hypothetical protein
MEVNSLADSLNSQKYSALLNASGTGGLSSNHLVTGSVSGTLGIGYAKTDKTTVTTQSGIS
AGNEINGHVNGNLNLQGGILNSDNQKGNLLVDGKVTNSEVSVYEKSDVAMIRLSGETNQS
FGGVVDIDDHIDKTGSVNSAANININNNKNHGISTDTQNTTDTQDHSWAGGTINLNSSIS
KIKNGISKVTGSDSTFNQPSNQPSKSDGPYINESTQTTRL
>fig|195.2027.peg.371 hypothetical protein
MEVKELYKDMSDDDYVYSSWNTPQYWDRYRFWVARTEKGTKYLREILEPRIYNKYKDLEV
EIDDKGSVLRWIGEINR
>fig|195.2027.peg.473 Major antigenic peptide PEB2
MKELALKFEEKTKEKVVVTAGPTPSWFKKARKDADLIFSGNTSMMDGFIKRIPSLNLEDL
VVLNARPSGIIVRPNNPKNIKSFEDILKDNVNVMVVDGAGQVGLYEDIFKRW
>fig|195.2027.peg.1577 hypothetical protein
MRELGFTQIYIIVYFRDTLGYLNSHCSQDHKNNMEYYSADFAPQDHPRKYIFDYEWIYKT
HAEVFGEENLIVRLLREDYVGGTLLKDFVYHLGLEWDESFVLKQTKNESFNLLGMELMSR
LNQKDLKQDNLNSLLFMARRKFEGSKEKRLKFAV
>fig|195.2027.peg.1193 hypothetical protein
MAFYFIKRFDLLAHINEDYLDSRGGFRASLFQNKENKEFILAIAGSDLRPLKFDIGDLIS
DFILLNGKIPKKQFDSLLKFYTLIKKEFCFGKITLVGHSLGGHLAQLFVLDFALEVQNIY
TFQAPGIAKKY
>fig|195.2027.peg.1169 Type I restriction-modification system, specificity subunit S
MYPLFKPSDLNGDMIIKYASDNLSKLGFDNARNLPKNTILIVCIGASIGKVGLSGANGSC
NQQINAIIPNSKFLPKFLFFLCSSNYFQEILKNNASQATLPIINKTEFSKLQIPLPPLKE
QKQIASHLLDELSLNIKDLKQNYQAQIKNLQELKKSLLDRAFKGRL
>fig|195.2027.peg.33 hypothetical protein
MLKPKDALDTTHLAHQFHSFSLEKLIFKNCKEKYIKKSLILENSRINS
>fig|195.2027.peg.269 hypothetical protein
MENNQNKQEKLESVNIDKPIEKKEEDLFGRNSVAEQLNTIIKNYKEEDSITFGIIGDWGS
GKTSFVNMTLEDFKDDENFIIVKFNPWNISTRKNLSAIFLQRLPKKFVKLHFQNLKLKI
>fig|195.2027.peg.1463 hypothetical protein
MALPSMGHTSPATKNVKLKQSIYETIIKIGATETPILNKIGTSKVTNPLTHSWITDTFEE
PKKNANLELSKFVGETKNTAQ
>fig|195.2027.peg.1681 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MHHQDTNTNVKAWRKPRTVVVNEIYWTPTAKMADIVMPATSSYERDDITMSGDYSNMHIV
PMKQAVEPVGESKDDYIIFADICKVYGQNVYNAYTEKGKKAKDFIKEYYDSALKQTQSFG
EAFATPMPNFEEFWAKNEPITFEATAESLEWTRFSEFIEDPILNALGTESGLIEIYSQTI
KNYNYDDCKAHPTWFEPIEWLGNATKEAPFHLLTNHPKDRLHSQLCHTSLRDTYAIKDRE
PILINTKDAKKLGVKNGDVVRVFNKRGEVLAGVIISDDIMQGVVRLCEGAWYDPDENGLC
KCGNANVLTIDIPSSKLANGNIAHTGLVNIEKFTGTLPALNAFSAPKGAI
>fig|195.2027.peg.1590 hypothetical protein
MKSNIQQIFDHIEKSNPIHAKYLKKVNLNEEEKVELENLIRFYLNQGFSINKQANAYLLF
LNDTLKEIYYFIEHGTYRYSTLKDVEDKIYFNHDYMENYMIGLAISNFIWDTHIAIRRYF
IDLMQNNNIFGKYLEIGPGHGNFFLQSLKFGQFSELLGVDISPTSCEMTKKIVSFNDHKA
KQKCQFICMDFLEYDFNEQFDFITIGEVLEHVENPKNFLNKARKILSDDGNIFITVPING
PAVDHIYLFSHPDEVKNMIKNCELEIVKEEYFMANNYSLKKALETRNAIIMVALLKKIIK
>fig|195.2027.peg.1 Ribbon-helix-helix protein, copG family domain protein
MKQETRNYSLRMPLELKERLDNLSKNLSKPKSSIVREALEAYLNEIEDFSFAVNALEELK
DGDYSKASKKIDKVVENLQKESDDLGDFDFAIEALEELKDGDYSKASKKIDKVVENLQKE
SDDLGDFDFAIEALEELKDGD
>fig|195.2027.peg.1460 hypothetical protein
MRKEYDFSKAMRNPYVDNELKGNQITSYYLDYLFLFKENQKKFQSLYNEHKKNNNKS
>fig|195.2027.peg.1286 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYTIISAVYNVEK
YLDDYFKSIINQRLDFKKNIFMILVDDGSIDNSANIIKKYQKKYPKNIVYLYKENGGQAS
ARNLGLKYIQENNYKTPWVTFTDPDDFLDRNYFYEVDKFLSTHQDDDICMVGCNIKIYRD
ETGVFQEHFTNFQFTSNLYEKISSMKWGITTSTRSFFSYNIILTNNILFEEGFSSFEDAQ
FVLMYLVLNNTKNIALLRDALYFARKRKGSTTNLQNKTTHYYIDSLTRTINVFCEISKLN
NIPLYVQNSILAHLVFNIKDLINSPEKLSFMSENEKQRYLELLDQNFSYIDTETILNFNL
AGLYFDKKVGILNCFKNEKPPFQIAYIEDYDPYKEQILITYYTGDDKDIESIRIDNEVIY
ADYEKIVKYDFLDRVFCYQKRLWVSIPIDIKGKLEFFIDGVKTRITFNKKQLQNVNIQDI
RKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEQEIVFALRKESSDWKRLEKE
RFNLIEFGSFEFERIIKKASKVISSHCDAYLGRYLKQFNKDFIFLQHGVTFASDVSAWFN
CNPWIKMITVANTLEWHNIADNYSRYKFGKKEVLLTGFARHDSLLKKSKKENKQILIMPT
WRKNIVGNVIPNTGIREINLEFLECEYFKKWKSVIQSSQLEQLVKKYDYKIYFFPHFQIR
PYLSYFQVPSYIQVDVRNNGMSLQNIFANVDLMITDYSTACSEMAIQNKPTIFYQFDEEE
NLQGIHHQRDYNFDYRKNGFGPVVNNESELMVKLDELLNNKCELDNFYSKNITQTFIHRD
IESCSRIYNSIIKMSKQEHNKAFATKEKALLAQNKQLYYEAFEKWLNIIKNDFISEDVVY
NFAFCAYNSSCYIFVKEFIEDQQSIEKYCIKTKIEILKNLVEIKDVKNVFILAEQLLEGE
AIIQFKLRYSLYIDNEELFYENYKILINDFAKSKESIFEKLLLFQSSLISRAFEQNNSKK
YNCFENFFKEII
>fig|195.2027.peg.942 hypothetical protein
MKKIFALLALTSLLTSSVFAEDFLAKLTKGALSDTSPGVKELSLEEMKEVRGGAFQSVGN
CLSGTNSCLSLAVSQTSL
>fig|195.2027.peg.1166 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72)
MILANPPFGGKEKEQIQNNFPVKSNATELLFLQHILKSLNNNGRCAIIVPEGVLFQNSNA
FVSVKKDLLENFNLECVLSLPSGVFLPYSAVKTNVLFFSKGKRSICGEDDKVYYYELIPP
FKLTKNKPLEYAHFEEFLKIYKERKITPHSYLVSIKELEERNYDLSAKNPNSKEEKTLRE
VEEILSTLKANQEKANELLQKIQNII
>fig|195.2027.peg.813 hypothetical protein
MENDIIKKFINTDYKLLEKELEELSKKDELRLEVDQGLDQALRDLEIISAKIPQEETQKL
FDQCANNAMDAVMGHFGFAAVILDAKDGGNVNTTHNVRNGFYASEKEKQRYANRGKYDSD
NYHQDDNYKRINKEQNVLKKQGKLEDYMTGKKINANADTDLDHIVAAKTIHDDPARVLAE
IDGAKLANTESNLKMTDSSLNRSKKDKSAEKFLADRDKRLKFLAEKEKNGALTPSQQKEK
EKLLKQKEIQDEKFKEQYEQNEKEINREVDKTYYTSSKPYKEALITGTQDAAKIAVYSAL
GVVLKDFIKAIIIELKVTFKEFGNESLKEILVRFKDRFCKVWEELKLKWKDILKNSLEGA
LQTFFSNPPKDIPKEDIYYEASKIMVTGLISATAMLGSETLNKLLTSVPILGPVMQFPIP
FTGEKNDQGELVNFQTIGDALSLCITSACGAVLSTIAIFYMDKWRNDSKIGSLQIQLVAQ
NGVVMHYKIAQTWFVLSDAYNLFGQVMERGSQNLVILKNKVNQVQNKLKQAEGERQEAIS
DCIKQLENLRGE
>fig|195.2027.peg.1010 Phosphoglycerate transporter protein PgtP
MFDFFKPKAKAIKFPKEEILPRYYKMRTWSLSGVFIGYMGYYLV
>fig|195.2027.peg.1466 hypothetical protein
MHTITITSDNIDFIKSLECLSKNAGAIFKISKNDLEATLDNYEDNRTLDEVKKEAEETLL
HYKQGKLSVTPLGSEWL
>fig|195.2027.peg.1204 hypothetical protein
MVKFCQVSSEEAKSFSPFLNFFMVKLALIVGLRILCFSPFLNFFMVKFKLSVDLVNNRFS
PFLNFFMVKY
>fig|195.2027.peg.1459 DNA repair protein RAD50, putative
MSDTIILDILLEKYNNAKYKKVGNCIKLHYQYHDVNVNLYFDGYDKNYPSTSIILAMDKS
YYITSFNVDNFDEKNQYLDKIPDPILNLIKDENNKLTSFYNEMRKRIKEDNFQNISYSSD
IVFNNTMQCNKNKENGNPFFHYIRATAMTPEHFKKLFHSMNISKEILTKIQQAGFTIVTT
SDPNKRKNFHEELKNKEILTD
>fig|195.2027.peg.621 membrane protein
MFLAFIIEFLVVRNYALAVIFLTPYVTYLAEAASFGNLSVDMLIHARLQDIIIGSLLGLL
GGFVIHRAYLRKYFEYIAKYIFRVKLTSK
>fig|195.2027.peg.1153 Arsenical-resistance protein ACR3
MLGFIDRFLTLWIFLAIFLGLILGIIFPNIALFWNLFEYKSVNVVLTLCLILMMYPPLAK
VDYAKLSKVFDSKKVILLSMILNWFIGPLLMFILAFIFLKDEPLYMQGVIIIGLARCIAM
VVV
>fig|195.2027.peg.1789 Glucokinase (EC 2.7.1.2)
MSISQNKKSYPRLLADIGGTNARFALEVAANTIENIEVLVCNDYNTVVDAVKVYLNKVGN
PIVKYSAFAIANPVVGDWVQMTNHHWTFSIETTRQALNLEVLILINDFTAQAYAISQMSS
TELIQVGGTSCEINAPKAVLGPGTGLGVSGLIPCSNGGYIALAGEGGHTSFSPFDDTEVM
IWQYAKKKYGHVSAERFLSGSGLVLIYEALADREGIKSSKIAPELISEQALSGRSPLCRL
TLDIFCAMLGTISANLALTLGARGGVYLCGGIIPRFIDYFKTSPFRMRFENKGRFNAYLA
AIPVYVVLAKYPGIYGVAVALENHLKDYFLKNRG
>fig|195.2027.peg.167 Inner membrane protein YihN
MICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVLLKAIRLLGDSTQQGRLFGFLE
AGRGVVDTIVAFSALGIFLLLGSGAGGLKAAILFYSACVIIAGILAYFLLEDDKISTKDD
EGHEISKNKF
>fig|195.2027.peg.1469 Domain of unknown function (DUF332) superfamily
MRKINLLRSFKKDYEKVKKQSWDLNTIDDVIQCLMNLDVLPTRLKDHALKGEFKDFRECH
IFGDLVIIYKRDDKILSLYRIGRHQDLFKKY
>fig|195.2027.peg.1467 Death on curing protein, Doc toxin
MKIVESDKFKKELNNILAFIAKDSVSAKNYFSKSLKDAILCIDNMPYKFRKSTLFNDENI
RDFIFKKYVIPYYIDSKNDKILLITIYKNNLVK
>fig|195.2027.peg.1005 Cytolethal distending toxin subunit A
MQKIKLSLMFLIVTIIFLACSSKEQQINPLGRSYGKFNDNDPLKLGSKPTPPVKQKTPSL
VEGKKFPAIPLVPPVITPNTFKGDNAVKGPLPRLKSPNEFASNALYENTGMVSDFVTIMN
PNGASLTIWALNPGNWIWGYSLFASRPFGDARAWQLIEFPNNTVMIKNAKTFTCLNAYRN
GIVHYPCDQTNFAQFWRLYPMTNGAYQIQNFATQQCIQTPVSNVMEEFNLSFYNIYLTDC
LKEKEKNLDRQWYIGAPI
>fig|195.2027.peg.389 predicted membrane-associated
MIYILLLIIISTILSYLILKFIYKIIFKSTKSVLRFLVFLGSIGLIIFYYTPYSYYLEPS
YWQFRNMCKLNELPNNEEKYNKILSYFGLSLDTLDWEELNRRAYKISKEQQFYLQNFRIC
NIYRRNKKD
>fig|195.2027.peg.79 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28)
MGNENDILIGISTSGKSPNVLEAFKKAKELNMLCLGLSGKGGGKMNELCDHNLVVPSDDT
ARIQEMHILIIHTLCQIVDENF
>fig|195.2027.peg.870 Hemolysin, putative
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGDIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEIKANNVVNIDSVNDLNIKNSDIS
TSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQNPILQRV
>fig|195.2027.peg.369 hypothetical protein
MTILTSFDNEAEMDETIFADYLFDFSNLYKLANHYADDYVAIVGQLFLDDYIDFWRCAYH
KMDNENTKTPNLSQYKKENKYETWKYFRDNYIYSYNDNLVNHVTKGDFWGNLDNWDVYNI
NCFRTQKGTKYFNEILAPKFYNKYKDLEVEIDDKGNIIRWIGKINR
>fig|195.2027.peg.1312 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRDHFGSHCGMEVVLANGEILRTGMGALPKAKTFAENKYGYGPYVDGLFSQSNFGIVTK
MGFWMMPKPEHYMLLIYKNEKTRGFDPSG
>fig|195.2027.peg.1777 hypothetical protein
MENGNLKVDEQYKVTLPPNLITVLEYDKKDFEGATLKNFIDDVECELSDWEIELYDDPHF
YGYDEDEEGYEDDEDDEKMSVDEWVTDQVSDIRDFLYALKNFKSKYR
>fig|195.2027.peg.967 hypothetical protein
EVLWLGGIHFLVGLGVNVGLGWIDYDCLFLLARMNVILEINFIIDSLAI
>fig|195.2028.peg.1309 hypothetical protein
MKDYGISYIPNANQSSKEPSEPIVSDKLNAQKVNELIDKKLNLFKEGLANQEELKSLIRE
ILKDQNFQNTNIKISKTPPNYNTQAKVGEIWAVLESKKQLFICIANDNDFTSWVDLLGDG
SNDIAPKEKIIITFDNTTTGGQYGGCMSDLRLGFENGFATPNKVQDEYENAKFTMTKDGN
GLNRSDFTIDSNPIAGENQILGTIKTSGIYQETYHKIAHVFKKYNGGSDECCLWSSSGTR
EVSIELENTPMPNKLFARGNGYYGQTEITNVRVKKSIFIGEQEIQSEDFNVEKLEASSDT
YGDYAFLFEISKQDQIVMKKELNLNPKKTKNTKNVKK
>fig|195.2028.peg.1301 hypothetical protein
MSKVIADIKKGFSKTFINAICNHNNELVLEYLKNGMSATKECMGEEPMFYAITHNNFGAI
LLLLKYGAILDKEYLEESNKDFSKEALKFLSSLLK
>fig|195.2028.peg.22 Phage tail protein GpX
MSKIYIAKNNERLDSIVYKHYGTLLYFNQVLLANPRLEPLLKTGDKVILPSIKIKESKEK
ALW
>fig|195.2028.peg.11 hypothetical protein
MKNNPYFKIDEFKCKCGKCKLPQDIPSDELVDILCEIRAHYNAPVIINSGYRCKEYNAKV
GGAAKSQHAIGSAADFVVKGVKTEDVHQYVLKRYGDKPFGIAIKHNFSNPYAGFVHLDTR
GKKARWTYA
>fig|195.2028.peg.538 hypothetical protein
MLIFAFYITGTPIPKAPSREHTSFLNVLLDSYLLSQRFLKVSFLE
>fig|195.2028.peg.1305 hypothetical protein
MKVLKFINDDIISHIALLLTTLIPAFYISYQSASDGFFNTMAIFIFSYFISIIITAILVM
IMPPIALLLILPTWLIVISLDFILFAILKIYFLKNKTIKNS
>fig|195.2028.peg.37 hypothetical protein
MALVYVASPYKALVVRESQRKAQAISIAQQECLKIMRECEGFVPVSPILQFSYLDENKHR
DKALQMGLELLKACDYIYMSAHKDAKNSTGMQEELALAKKLGIKELVLELPLQ
>fig|195.2028.peg.1793 Motility accessory factor
LIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2028.peg.527 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
MSSVGENIKLTRRSFLKMAALSSLATPLLARSETLREASADELKEAYEGSKKVKTVCTAC
SVGCGIIAEVQNGVWVRQEIAQDHPVSSGGHCCKGSDMIDMVRSHVRLKYPMKKENGEWK
RISYEQALSEIGEKLAAYRKENPESVMFLGSAKLNNEQAYYIRKFAAFFGTNNVDHQARI
>fig|195.2028.peg.32 hypothetical protein
MKSFNKAFNEKDEYYTPLILIEFLELILKDKNIKTIMCPFDDDSSNYVKFFKAKGFNVIN
GHINQGKDFFSKWWLDYDFDILISNPPFSKKNEIIGLLTTNYNVPFMLLMNLMAINYQDF
SETLRIANKQAPINFIIPNKKVSFDGNTSSFSSGYICNCIDKNIFIDLPHNNTGKIYKNP
>fig|195.2028.peg.539 C4-dicarboxylate anaerobic carrier, putative
MALKIVISSYAGLLLLACIYPVLISLKIRPITAVCVLSLIALDYGPKDGNSINMADMVGQ
SDNVVGLSLNYQIYSVITYVVVNCHLDSFLFYLD
>fig|195.2028.peg.14 FIG00469991: hypothetical protein
MDENLTQDQQNASNENDLKNKENEDQNPPVTENEDEGQTQDQNPPVTENEEGEKMAKEAL
IQLPRSLEQIISKDLLSINVKIDLESNANLALGMLLISEDFGETFKKCPDDLAGKSNFKL
GLLKDDVFANGNYGVLLMGEVNLLNVNASIKQAAFLQNLIINTKE
>fig|195.2028.peg.1758 Phosphoserine phosphatase (EC 3.1.3.3)
SLQERVSFLKGMPYDLVLKIGQDLPLMNGAYELIEFLNSKNIFVVIFSGGFHEGIDPAMK
KLKVNLGFANYLHHKNNTLSGLVGGEMMFSNSKGLMLQRLKNFLNLQTHEVMCVGDGAND
IAMFNESGLKVAFCAKEILRSKADICVDNKDLKEIIKVI
>fig|195.2028.peg.4 Phage baseplate assembly protein GpW
MSYMVSVEESIKDILITSLGSRVMRPEYGSLLYTLIDRKIDDDFKIKLTRYTAEAISKWE
KRVKLKGVRLNECKDNKLSITLLFENYGDLTMELGK
>fig|195.2028.peg.1434 Putative periplasmic protein
MKKWIFIVFCFILGFIIHIFYIGYTNELLFNKFIKNSNPDYTITDIYFKKGFLTSKGSFT
LNHSHTQLSTKINLKFNNYFFLNKIIKGNFTNPFDFLDEVLKNNKLGTFTLKLHDNNSKI
FLNIKDINLSNEGGDTIINGGYIEALINKNLEIKNMKIHFDMINFSQFYTKFVLQNLNYE
QFFNNPVQFYELNLFSDSQQQINFDYLVLDNNKINSFYSKNQVNFNEENSTINLNIQGES
NEIDIDLKSLLGQNLNFDKTKFNITINKFLNSNFNISHFIQKNLDLKIQNLILEKNKQNI
SLQGNLNINNSYQAKLQVISLDEPDEIFPWTKDYGGLNQYFLKENNNFFLNLSYDSLANP
QLKINGSEFSNMDLN
>fig|195.2028.peg.1533 Citrate/H+ symporter of CitMHS family
MVAFIKDGVKSVTDTAALFVFSILFFSVLNASGFFTKILNAFLSKMKANVYQVCILTVFI
AAAVHLDGSGASTFLIVIPALLPIYERLGIRKTSMLLIITSAMGVMNVIPWGGPTLRAAT
NIGMDANLLWHHIIPIQIVGLVLSLLLAIWIAKIEIKRGAGAGNLSGINLNIEKSEHHNE
KWFWLNLLVAIGVIGLLISGIIPSYIYFMIGLAIILPLNYPNLKTAKKVLDRASAGAMLM
YITLIGAGILIGVFDKSGIMEKMGVLILNFVPDYLGAYIPLMVGILAVPMAIIFCTDSYF
YGVMPIVLSVTKAFGAEPLTIAIIMVIARNCATFISPVVPATLLGCGLAEVNIKDHIKRS
FFYIWGISIICLIFAEVAGII
>fig|195.2028.peg.1534 hypothetical protein
MAKSLFEELGGKYERQGDYLIPCLTVPAEEEQAIGIWGQRHLDYLKQYRKVTYTNLLTSG
RLNAYLADINRQAQERFERLIEGMKQAQGITEQLKAENALEWTGCLNNIRACAREIVEKE
IIFA
>fig|195.2028.peg.1459 Ferric siderophore transport system, biopolymer transport protein ExbB
MLKKMFLFCFLLLNLNATDTNLSFDSSKIETKAPKIELSLSSLYQNADEVVKGVIYILVL
FSILAWAVFISKLMQFYFMKKI
>fig|195.2028.peg.5 hypothetical protein
MAISQDSLVYKMEEHLQAQGYLRVEDEDDGRGYRRYSMPFLRALAGAIVEEIKENAKAID
MTDGGKWSIE
>fig|195.2028.peg.43 Transcriptional regulator
MEVLDILQKMFEAVGVKNKNQLAKYLKIENSLIAGWEKRGKIPEKYVYKISQDSNLPYEY
FINNTNKNEYNNNNNKRDVNFYSIPKLNVSVSAGSGNELIGLEEYETGEMLELSKAFFKT
TPKNVKAIKVDGYSMVPMLLPDSWVVFEETHEYQGDGLYILNFDNQLMVKLLQLNPINKI
LDIISVNKDYKSYSIDLRDSQVEIIIQGKVLRSII
>fig|195.2028.peg.541 C4-dicarboxylate anaerobic carrier, putative
MVILKAMAEIFISVVSIIIAAGVFTEGIKALGGVNILANAVSNLGTGNFAWFGILLSIAI
LSFLVYFATVIMGSGIAAFNTFGKLAPDIATKLGVAPITLVLPIEIASCLGRAASPIAGG
IIALAGFAKVAPMDIIKRTTPLLLIAMLVNVLVAFYLAQTNPLPKEQNTTKIAVSLNNKY
LLFYKNYKFSKLFSAFLVKIS
>fig|195.2028.peg.1433 Putative periplasmic protein
MKKSILFASALLASSMLFADSLKLEGTIAQIYDNNKTLLIDSIYGGQMAIKVLPNTEIEM
DDCGIFGTDKDGTFKDLKVGNFLESKISYGTPATPNTQAIPVARKIEIQCYKKAY
>fig|195.2028.peg.503 Cytochrome c oxidase (cbb3-type) subunit CcoQ (EC 1.9.3.1)
MMEHLSIVFDVIKNLITFDLATVQKHEWEIFQGYGFFALVMFLSIVLYAYLYHLYRTEKK
GERNYENYANLALKDDIDDSVLESKRSA
>fig|195.2028.peg.1757 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVASYSEKEAKNAILLSSKRYVNYIQGI
LNEEVTLTKVVATSLNEMFQNNDHVDINLIESLIKNAFDSSHYAAYTFLYLKDTTVLSDM
QNVDKKYISPDGKTFSMIFFDQIAEKSGGITTISTPNNFSQLNLIQNIEQNAKYGDKDSV
FVGSPRKLNYDNNEFLGINFGMPIFNNKGKFIGVIGYTLDLLEISEIILDPKFDFFEGDL
RILMNDQGIIAVHKIKNGILKTLFDINKDQSAQLIVEAVK
>fig|195.2028.peg.6 Phage baseplate assembly protein GpV
MNELGIICDIKDNKAKVAIGEMVTDFLSVFQSLANSYAVSFSPLRIGEQVLVIPVRGDLN
SGVILRGLYQEKHKAKNTDENTFNIDFEDGTHLEYNSKTSTLKLDVTKDINIACINANIK
ADKVLVDSPSIDLGLGGKGVVTTECICAFTGSPHPHGSNNTRSKI
>fig|195.2028.peg.20 Phage virion morphogenesis protein Mup30, F
MFFGKPDKAIEYLQSKKPQTSFDYDEIMHETHNKVFTIAKLNDLNLLKDIQNSLIEALKN
GDKFETWKKQITPKLKAKGWFGDKVEVVNPKTGEVKNIKIGTSRLKKVFETNMRIAKAQA
VWENILQSNKEYVRWISLLHGNRRKEHLALHGMILRRDDPFWINNRPPCGYGCKCSIQGV
SESELKLYGWKLSKQTPADLADKNFNYNKNLGVEKLEKLYKEKISQISQNFIKLEALSLA
TKTKENAQSFQREKELYIWQKSLDDMVDEVIIKENQKYPINFIQVGKIDKTTKEFLEKLN
KKDLEDLYFTLSKNNLLHASPTRKASYNQALSADEIKQIVKVLDEAKEVYWDTKEESLVY
FFDDLKNSKKVNKIIIRPDYKLKKFGKTNALITLGKVDKDTKESSKEYEKIK
>fig|195.2028.peg.1705 Motility accessory factor
MMTFTPTQKELFNKNIEALSNILLKEGL
>fig|195.2028.peg.1311 hypothetical protein
MKYFIDKNNNNQIYAYEDNTKDEQIKEGLILLSEEEFNSLVNPPKTKEELLNEAKELKIN
EINTKKESVLNGGFLFQEKIYQSSNEDQLRINGAVTNALVNPNLVSHIEWIALDNTITNF
SVDEFKIFASSMAYFVQETIFKASALKEKARNAQSKEELDLIVWESEK
>fig|195.2028.peg.1307 Phage major tail tube protein GpFII
MKRMIGEVIQEGNIYIDGQGYLGVVRNLKLPDIEQEMIETKGVLGANYSSGVLKPLEISF
KLAVVDPVLYAAFFHTTFSEIKAPLLFRESVHKGGKNYGISAEFLGEFISISESDHESGK
EVEAEIKMAVHFYMQRRNNIPIITYDHKNTILMINGVDMMSDVRSNLTL
>fig|195.2028.peg.1306 Phage tail protein E
MKEKIIKLENGEELKMREPNVRVLKNATNKSEKEMEQTINMIATLTNKQESEIEDLNLKD
FKALQDALKDFLVEAGVIA
>fig|195.2028.peg.21 Phage tail protein GpU
MVLALGEFEFKALNFDNLERSLEYNIQSQNRLNNHNALFASSKESEKIKIQGKTLPLKGD
RNTYLDKLENMAKEQRSFILTGANGKYYGKFVILSLNENRSAFVDGSGFVAQSFSMDLER
DFDE
>fig|195.2028.peg.42 hypothetical protein
MIKAYFENNAINVKAFARAHNINYDILHRIIKGEITGERNTKGSTKAVFEKLLELGIINE
LPQGLK
>fig|195.2028.peg.34 hypothetical protein
MYVNVSIDASDLEDIDAHDLAELFEDLSTKEQEEFFGIIHKDNKPLERIRAILSNLSNDE
ALKLLKELNNEFKSDEEWQKTIKSINGGNK
>fig|195.2028.peg.27 hypothetical protein
MNTQNTLKKHLIKIIHTLRKDANLSDDESYRWVLNKRYGKASSKDLSIEELRDFAITLGY
DEKFFKKQNTKKARYFKKENARSGRATKKQLNMIQAIWSKNAKNPTQWALREFINNIIKK
RPLHLWYLSVEDANKIILGLKNLENNSTH
>fig|195.2028.peg.529 Putative formate dehydrogenase-specific chaperone
MGALMDLEKLRLARSLYYQCLGELFVFSFSEERLSKLQEYLKTMQECLFDENLKSNFDIL
LKHLDDENSIQAFFKEYDLLFLSLKNSIPTTFSYIEEGFENSNPLLCVRQILVKSKIRRN
EKFFKESEDSVGFCLLLMSEFLRQNEDDLAKELFEKVINKSIDEFLGDVFMNKNANLYKE
IASIASAFMEFERLCFEVEKPAKINSKKVQNDLSRSEFLRREANKQRRTREKSQGIS
>fig|195.2028.peg.15 Phage head, major capsid protein E
MDLEQLLELFSSTKVTEVINQTKASPHFVSDTFFKDRVPSLESTARVEIIKGAGIVLNSV
SENGEHSLEETRNSYILNIPLPRFALVKRISASEINSLRSLALREAQIKSLSGAMGVLIK
EMKESFTTTLEYMANGALFGKILDGKGNVLFDFGSASKKAISVKKDGSVTLASVCDAIDS
AIIDEFGTSADYEVLCGNELFAAISNLALSEDLYKNHLASRDEKDKSLILYGTKYRRYSA
KYKNTNGKSVEFLKGTEGMVVPKDNSNRIYYTRANHTDALGKAPSLMFVSKPEILPRGAG
IEIVGEMRAMPVCTRPNGLIKLVLE
>fig|195.2028.peg.528 Formate dehydrogenase subunit or accessory protein
MKNRREFLKKSAFALGAAGVLGSTTLALAKDEERKDLVKGKSKKKEVLFQRSANWENYYI
KAE
>fig|195.2028.peg.1302 Phage DNA adenine methylase (EC 2.1.1.72)
MKINTDKFLKTSPLIKPTQTKLKAPFAWVGGKNYLAKEIIALMPEHKSYIEVFGGALSVF
YQKSASKIEVINDINDELINLHLCIRNKPQSLTSILHSMLVSRKIFHMLKNKEIKPRNNI
ERAAFYFYLISTSFGSSMGQFAMSKQRAPKRLCRDFSLYTKRLKNASIENKSFEYILKEY
DYNEALFYLDPPYVGTENYYKNTGGFELKEHELLCNLLKNIKGKFMLSYNDCELIRELYK
DFNIKELKVRYSLNNNVLKRKESKELLIMNF
>fig|195.2028.peg.40 Replication initiation ATPase; bacteriophage DNA transposition B protein
MQLVELTKKFLSTQNISQNNLSDRLGINKSYMVGYMKEGSNYKYASKVEPLLEKYIKSFV
EEKSVKELQTPFIATKDAKAINVTIESAMSNREMGVIIGEAGTGKSRAIKEYATKNGTRV
VLFEATTETSKRMLLVGLENKLNVCFKGSLDDKIRGIASELARTSKVLIIDESEHLPFRA
LECLRRIYDFSNTALILVGTRKLKNNLTGIGRNDYNEYGQLSSRIGAKWELKGLCYQNKE
GLKDEDLKTLCKHFDVEDKKAIDLVFNLARGNFRKSEKLLKRACEFADGKAVELKHIEAA
ASFLMLG
>fig|195.2028.peg.1297 hypothetical protein
MEDSYIENLKSNEVIFYEILLESLKLDFSSSYIKNLSNQKFLIAF
>fig|195.2028.peg.79 Acyl-CoA:1-acyl-sn-glycerol-3-phosphate acyltransferase (EC 2.3.1.51)
MKVVIYKKIKALYFWFFFIISVAFVVLCFCFIKSQDTLWKLRKSWARFQKNILFCKYEVI
GEFDLKANMILMNHQSTLDIIALEDLYPKNLCWIAKKELGEIPLFKIAIKKPKLLCIDRK
NPRDLVRVLKEAKQRLSEDRVLAIFPEGTRSRNEKLLKFQSGAKILSEKLDLKVQPILIV
DSAKILDTKSFSASSGVLKIICMDLVDTSDKKWLENTRKKMQELLDQERAKLC
>fig|195.2028.peg.1813 Motility accessory factor
EFLEKVYQNIENFNHSLDEDEFIQDGILKAVMYERGLKISLVYKENIVDNASFITAYIKA
YDEWLLYFIEKLEQRINIIIDSFKELP
>fig|195.2028.peg.23 Phage tail formation protein GpD
MVRKPKFKLIAKGKDITEKLSKNLISISYEDKEKAESDEISLSIFGLYSKPLFGDSLELY
LGFEKLFKCGSFSVNVVSKNYTSNTTEVRASAINFSGKGSVNIKEKKTRSFENTTLFTIA
RKIANENNLKIKTSGEDQNIVSILQNNQSNLEFLYSICFDYGFICCVKENTLIITPKDGK
IGDNAANITSKNENLPLFEIALKECISLEISESVRNEYSAVIAEWQDINEAKIKSIKVGS
GENIYKMQISQPKNDNEAFKKAQAKLNELQKGGLNGRCELIGREIRAGGKLKIKDINMDH
YEFSIKSVSHSFNDQAYIISVEFES
>fig|195.2028.peg.947 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
QKIYKRKIEKDPSLKLPSLEQYPDYREAIKLKNHLSYKLGKELVKANKIWYKGGYFQFLY
FIKKLKV
>fig|195.2028.peg.1792 Mobile element protein
MSANNNELISISHKIELKPNNKAKTHFKKAFGCARLAYNWGLAKWQEYYKQGIKKSHLEL
KKEFNVIKKEQFPFVYEVSKYATQQPFLNLNLAFQKFFRDLKQGKVSYPKFKKKKDNFGS
YYIGGDQAIIKDEKYLKVPNLGLVKMKEKLRFNGKINSFTISQSADKFFVSFSMQISKDE
YLKTHNKAKNNNLALSIDVGLKSFLSLSNGLEIKAPKPLAKFNRLMIKRARQLSKKQHAK
TKQEALQGIKKSSNYLKASIKLNKLHRKIANIRSDFLHKLTSSLVANAKYFCLEDLNVKG
MMSNHRLAKSISDVSFYEFKRQLEYKSSYNDKEIYQVDRFYPSSKLCSNCGTIKENLALK
DRVYICDECGISIDRDYNASLNLLSQLKQKIGKVLAEFTPADLTALLNDLAINQIATSKV
ETGIQQKSYL
>fig|195.2028.peg.31 conserved hypothetical protein TIGR01671
MKLQDFDFRIWNTACKKYIDDVGLISNIMCDLIHSATDIIEDFEIELWTGIYDKNGKKIY
EGDIVKTKSPYDCFLAKVSIHKEGTFYLESKSRDYIGSLIYLVKDEGYDTEIIGNIHENP
ELLKC
>fig|195.2028.peg.1431 Diaminopimelate decarboxylase (EC 4.1.1.20)
EKEDVEPDLYDYAQGILAQLHGLDVTIGMEPGRFLVANSGEFVCSVLYEKHNKTKRFVIV
DGAMNDLIRPSLYEAYHEILLPYNQGEESPCDVVGGICESGDFFAKARSLPSTQSGDIMV
IKNTGAYGFSMSSNYNTRNKVCELALEEGQVRLIRQRENFEDQIALEEKFLKA
>fig|195.2028.peg.733 Methyl-accepting chemotaxis signal transduction protein
SAIISSTVSDIANNILEDVKKKRF
>fig|195.2028.peg.38 hypothetical protein
MIPMIKGEKADYSASLFEIKGVSIIYKESGVFVDVLKGIYPDYIAKKIIRFHLGKKLNKS
A
>fig|195.2028.peg.1308 Phage tail sheath monomer GpFI
MAANYGVNFNISNGAASPIKVQSDTPIGIAGAIKGASKEMIYTKAGYESVDNFPIFAFSN
VSKAKEFVNDLIKENNLQDFRLLDTLECINLQNVFNVIIISFFEESEESENTLTHIVNAI
EAFKKAKHKTGFSPDLIIAPYYSHEAGVKAKLESVASSMNITAIVDLYATNVGEAINTME
AFSSKRLIATWPQVQILNTQGKYAYVPQSPIIAGLIAHTDGDKEYGFSDSYSNRVMNGVT
GTEYFIEFINGFDCDAERLRNAHISTCILGEGYRSWGGETSHEDTIWQDLARVRTFDRIA
LAGQKAAFKAIDKKASELYFIKISIEELLRDLKGAKVLIGYEVSWDEERNTDANVSAGKF
YLNIKMMNNPIVKQITLEFIYSDKWASDLIKTISADS
>fig|195.2028.peg.7 Phage holin/antiholin component S
MKLEDVFVYIVLMIVSFIAGLVGIVTKNKLSQALNLKGKFALFLKGMLGSMFVAYLVFEI
VNYLNFGIKLSVAVGGFAAYMGTDALLKIEQLVEKLINKKMEKL
>fig|195.2028.peg.540 C4-dicarboxylate anaerobic carrier, putative
MIPFYSTWIDKRDKEKGVLNDEVEIPQIIDPKCPTFLHTLSLVTCCIFIYSVFFLLSSSM
L
>fig|195.2028.peg.216 Methyltransferase (EC 2.1.1.-), possibly involved in O-methyl phosphoramidate capsule modification
MKQGDFTEVAKHYHNRPAYSPFLLEKLIACINDKNKNIKNLNIVEVGAGTGKLTKMLGEM
FECQIDAIEPNDNMREEGRKFTQNLSNISWHQGSGEETRMKDNQADWVIMASSFHWTDPK
KSLPEFNRILTGGGVFHCDLESSPHCRGFGF
>fig|195.2028.peg.1303 phage virion morphogenesis protein, putative
MSEYIEIKGIENFFKACDKLIDMDKHGQSIMAGAGESIRNSIIDSFKNERSIFNGKWKSL
KPATIKQKIKDGKNKGILKRDGDLSNDLNWQSEPTKSGVKVFNNMQSKSGFKYGLVHQYG
SRKKNIPARSFLPIDNNNVLHQSIRSVIYKDTKDFIVKIAKK
>fig|195.2028.peg.28 hypothetical protein
MDNAKEALKELFGISEVQAVAIERLYFKAKTPKDILGFKKYYDLTMLKKQFIGTSYEKLS
LVCAFAELDLNLRYKNIESFLEWLFISFSNRFIFQTKKGDFSYSFVLKYYDGSIVYDELG
KPVLKHVDCGDNLYFINANKELCDEQRKPLNAGEFYNKLVEYMFKNQEKIIFDNKIEIIP
VIKTQIANQATINKDYEQNYLEYKKNQNKLYNANIDKFTSKLEQILKAKK
>fig|195.2028.peg.44 hypothetical protein
MNVVLLILTIIFIFLLCNYLYRKAKGVPDKPLKEIQDELKLEWIKYKQENKEIWNRCKQE
IQKINEKSKKEQKDLEEIESSYKEIYEEYKNLSMDKQGKFLYNLSLNNQDEYVEVIRFIQ
IAEESVNIALKSKNKDTAESRRKVALEMEQKIQERHPKAYGLIADIVQLLEDNYDVSLFE
NQCIKYYEEARKLKTIKSKQKRIDYIKDLIKEAEINPKIDKKFVDFWKNKVKEIQ
>fig|195.2028.peg.1298 phage repressor protein, putative
MQMQEVIEKLKDILASEGKRDLKTKDIAKELGINPDTFNSMKFRNSIPYPQILNFLNQRN
ISINYFFYGSSPKDQLECENKYKILKLYKTNASLGGGGINDLIDCSELIVDEKLLNFFGS
KECEFITCYGESMEPLIKDGSICVIDRNKTFKNKSICVINTRDGLFIKQVLKQDDGVILH
SLNPLYKDIFYKSGDFLLIGVVIGELSKM
>fig|195.2028.peg.16 hypothetical protein
MNYQDILEEKLITETKTHFFMIDEKDLIKELSVHAIAELSDLNADGVCDKEVIDDAINDA
QSYIASFIKIPKNPTPLLKDICVKLTIMELKRRNDFPKESLEEIKEWANDLLLKMANKKI
PTEIDEDNFIPQNKVRAFKIKRKRMDLRRING
>fig|195.2028.peg.26 hypothetical protein
MHDGITHQIKTDKDFGILLNVVCNIREKLDESFNEEDKSLVIDIDEIVAKVCKELE
>fig|195.2028.peg.1537 HIT family protein
MKEKTVFELIVEGKIPCNKVLENNDFLAFH
>fig|195.2028.peg.13 Phage protein Mup32, I
MLFINKESLIEISNDKPIKVAIKGEWKGHNNGRFKVDDEDLKSMIENFNQKKIDLVIDYE
HQSLKNEKAPAAGWIKELYLENEALMAKAEFNEEAKNFIDNKQYRYLSPVFEFNAKDNKS
GEFVRAKLHSVALTNTPFIDELGELIANKNNIHQNKGVKMDEKIKELESQIIALKNENSS
LAEQNEALKKQNEENAKNLASSLVDNALNTGKIANSQKEWAMSYACKDLEGFKSFLDTKD
TQAQTQVPKNNVFANKNNSASNSGLDVVKLMLGA
>fig|195.2028.peg.1811 hypothetical protein
KKFPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFAYYEDQFKAYMGEENYKKLRPYLGM
TTYYVCEGKKYPVVFSTMIDYKVKNYGLFGDEGRGFSFSSISRKSAGGGSFHYFTNGKFI
KSDEKYTGQSY
>fig|195.2028.peg.19 Phage protein Mup29, H
MKKEIKSKREVILKNNSLINTLINSSYLNVLKISENDQKMIFKDLSFTQAHQSRRSVILA
KELQIVCENEKIKESFEYLFNPDLLSQILETYLYGLNVFEVNYKLKDGFYYPILKQRDFR
NFGFNENDELVYNGNGCEEIVEDKKAIYGLFGSNFLFKNGDALLTKLYFPVKLKNASLKF
WMEFLERFGSPWAVAKTDSDPDALASEIHQMLNGDSAVIDKEEELDLIQPKTKANYNEII
DYLDNQIRSVVLGANLSSQVSGGSLAAAESHNQIRKDLAAQDGQIVLFILNRAIKFFKEI
NHFKDELYVQFFSEAEPKSELCERDLKLFNMGFCFDEEYIKSTYNVEGELIRETLEKKDF
KDLENDKKVFENKVKFIQKKPMDKIDAALESKEFKVIDEQIKEKLEQAFNQLLNDSNSYE
ELFENLQKEFSDISINILEEFMFQALANSSILGYGD
>fig|195.2028.peg.1536 hypothetical protein
MEQRHLPAFETGRAGKGQKLCAGYCRSYKPIKSYKKI
>fig|195.2028.peg.1300 hypothetical protein
MKYPNVYVKLVGEDGNAFSILARVSNALKKAGVSKEEISQFQKEAMSSDYNHLLNVVQDW
VNTN
>fig|195.2028.peg.1812 hypothetical protein
LGLFNNWVGFLITQVYFIVFIEVLWVGGGYTLLGWVRG
>fig|195.2028.peg.33 conserved domain protein
MKLQDFDFRIWNKDEKCFLDPYTKSRAVVKNLPNEKLLNLEIELFTGLCDKNGNKIYEGD
IAKIITFSYDFVGHVAYDKEETRFKLIDNKYMEDFANYEDWDSIEVIGNIHENKELLRI
>fig|195.2028.peg.1638 ATP synthase F0 sector subunit c (EC 3.6.3.14)
MKKIFFLFLALAATAFAAEANAPVEQEAINVWIKAFSVLAA
>fig|195.2028.peg.25 Endonuclease I precursor (EC 3.1.21.1)
MKKIISVLILALSLLNAKSFGESKKELVKLYNDLGSSYWYDFYCQAPFKVNKKGKYISFK
VIKSDLYTPRNEYTKKGKINQRAKHIEWEHIMPAQNFGKHLPCWKEGGRKACQNDPLFTK
MEADKQNLVPAIGEINGDRSNFRYAEAPTNLKYTQYGNCKVYTDFKAKRFYPANYSKGWI
ARSYLYMSKTYNIRLSDQERKLMEAWDKQYPIDEKEKRIRELL
>fig|195.2028.peg.1299 hypothetical protein
MKDIKNYTDKELKEKIMQDLEDEFRILYKKLLKEKDYLARDNILELMTIYNMGINSYSIA
KNLEMNEDKSLIQVPLFERYIIGRKFVVKYNNEKQRYELKSTFCEF
>fig|195.2028.peg.18 phage uncharacterized protein
MLFSKEELDEFLISNEQKHENTPNELKGAMQRKDFLEWMDELKNELKTQFLHESHLDPTL
KEERIKRASVDFDYFARTYFPHYFTIKGECGLHLHLNEIFTKIALKKESKGEKHAIAAPR
AHGKSTYTSQLFPLWCLVFNYKSFIVEISDAVELMEGMLEAIKAELEDNPHLKLDFPEVV
GIGKTWRVGEFVSNNGVKIKAFGSGKRLRGVRYGVKRPDLVILDDLENDTNVRSKDQRDK
LEDWVDEAVLNLGSADGSLDVLYIGTILHNDSVLSRKLKLGFWNPKVFRSIEEFPQRLDL
WDEYATLYRNTDFNTAHQFYLKNKALMDKGAKVLWKEAKSLEDLMKLRAENLKAFNKEQL
NNPRSENQIFSLDGINFYDDLPAINQYYMYIDPAGEKAKSDFTAITIIGKGAKGFYVAES
IVKILKAQSIIKTIFNLQKIYKCRLIEIETNGGQFFLKKWLQEKSLESGVFLPLRGKNNS
VSKFERIESLSLAFENEELFLHKNQTMLINQLLEFPEGKNDDAPDSLAGAFLLARTKSSI
KRRKHHFNSVSRIRRF
>fig|195.2028.peg.1799 protease IV (PspA)
KQEYNKNPIYRVLYLFIGFYRFVGTAWSEEEREFLQNLIDESYDLFSEFVAKERDLELDK
RKDWANARVFLAQNAKDLGLIDELSNYENAKKELQELAKVLNPVWKEEGRIDRFLNRLES
QSSNFLGKVISDTVLRLNANFLELK
>fig|195.2028.peg.1252 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeB
MFSKFFIERPVFASVVAIIISLAGAIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIAS
TVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMP
DAVKKLGVTVRKTSSTTLAAISMYSSDGSMSAVDIYNYITLNVLDELKRVPGVGDANAIG
NRNYSLRIWLKPDLLNKFGATATDVIAAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQG
RLQSPSEFENIILRTNEDGSFLRLKDVADVEIGSQQYSSQGRLNGNDAVPIMINLQSGAN
ALNTAKLVEAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVVKTFVEALILVIIVMYMF
LKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDR
ILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAIS
VTISGFVALTLTPSLCALFLRRNEGEPFKFVKKFNDFFDWSTSVFSAGVAYILKRTIRFV
LIFCIMLGAIFYLYKAVPSSLVPEEDQGLMIGIINLPSASALHRTISEVDSMSQEILKTN
GVKDAMAMIGFDLFTSSLKENAAAMFIGLKDWKDRNVSADEIAMELNKKFAFDRNASSIF
IGLPPIPGLSITGGFEMYVQNKSGKSYDEIQKDVNKLVAVANQRKELS
>fig|195.2028.peg.36 host-nuclease inhibitor protein Gam, putative
MQINNLEDVNLALKKVAELSVKIEKINGEVTLACNEIKEARAGEIKVLSDELKYIEQCIT
TFCENNKHEFAEKRSKEFTFGKIGYRLSKSVSLPRVKEKLENLIKALKSYGLNDCITYKE
ELNKDAITELEDSTLVKLGLKRVVKDNFRIEPKIESLEIEK
>fig|195.2028.peg.1432 Citrate/H+ symporter of CitMHS family
MEIFLALLGFFSLGLIVWLLLKDYATPALAFISVSISVACILLILEQLGFGVGAALRAYN
C
>fig|195.2028.peg.1253 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
TRNDDPAHASRPFDKERDGFVMGEGAGALVFEEYEEAKKRGAKIYAELVGFGESADAHHI
TSPTLDGPLRAMKKALKMAGNPKVDYINAHGTSTPVNDKNETAAIKELFGSEIPAVSSTK
GQTGHCLGAAGAIEAVISIMALDNGIMPPTINQFVSDEECDLDYIPNEARKADLRVVMSN
SFGFGGTNGCVVFKKVD
>fig|195.2028.peg.3 Phage baseplate assembly protein GpJ
MSELLSANDSYFKQSFLKDIPYPQIIEEQDYEKLLKAYEELFKSFLKDNVELLESDPFKA
ILEALAYREMIIRARINESIKATYLHYAKGSDLDNVVANGYLIQRLKGVKPTAKVEFELN
TLLTYDVIIPKGAIFSNEKADLATLKEEVIIKKGQNKAQGILELDEFIQSKESKTEFLQT
PLPFVAKIKQLEFFKGGASEESDEALRERAVMSVHRFSTAGSEKGYIYHALSASAKVASI
KALNNGAGKVRVIIKSEDELSVDVVKEYLSADERRPLTDEVSVELAKKREFIVDAKLLLL
ELSRANEISEKINALQKDFDLSVDLALGFIYKCLHQDGVYKSEILSIKEKIINEEEQELK
DLPLANIIIADDEFATLSFSLSYEKAVL
>fig|195.2028.peg.24 Putative DNA-binding protein
MLSNNDYFEYFIDFVKNNDKREILKEFGGANIYIPSYKTLLRDEELKEDFKTLIKQGLTT
KNASLECAKKYDLSLNAVYLITKELRENLEPSLF
>fig|195.2028.peg.10 hypothetical protein
MFDISKLFGFEKIAIFALIALSSFLFFKNHTLTLENENLKLKSLHLNSQIDAFSNKLIEQ
NKAIDKLKLDLKPKEVLKEVLKVDKVFIKDKSCESELKAYKELFNILGDKP
>fig|195.2028.peg.1600 protease IV (PspA)
MQILKSFFKGLGSVIKFINTYFKTFVLLLIVIWLLAPSSNSSSSYANLERIDLKGEILDS
SELLEKIISAKNNDNIKGVLFVIDSPGGAFAPSMELALAIKDLKTKKPVIAYASGTMASG
SYLAGVGANKILANPASFIGSIGVIMQGADLSELAKKIGIKEQTIQAGEFKSAGTFTRAY
NC
>fig|195.2028.peg.12 hypothetical protein
MLKIFENELLELLKDFKAKMYLGEFEDTQNIATCINSLDASLLLDFEGESYKDLENKVGT
WKLYILTHTKSKAPKHRIDAKHKLFDTIESVDKVLLNAELSNGFRIELKDLKKVYEGISD
HGYLSIYARTLQSSFLPKNDFLRI
>fig|195.2028.peg.30 hypothetical protein
MNLDFLNEFKLKNKDLNEKLEFLIPDFLVKKAITIIYANGGSGKSYLSAAISKTLCKDAR
VKSIVYVDMDNPLNVLNERGFGELILNESKFTYIHRSSLKTSAYELLEMIEGKGVAGSYE
GVLFVLDSLRNFADIDNDTKMMSLMSLLMNLRECGATIMALHHSTKDGRAFKGSNHIRNS
SDCMYFLQKVANLEQGFEVLLSVQKERAGIKDQAFFINIKTLNIKNTDLQNAKISDKEEA
FIEKVLKLLKEKNLSTSEILLALDVSRSDNFSRNTLEKFKGIFWESELGGENGRTFVWKS
LKADNKDSNDKELSLFGDEL
>fig|195.2029.peg.1576 hypothetical protein
MEEKEQLLQEMIEFYSVKDKFELAEYLGLSRESAHNWPNRISKKQILIYEKDKKIKISSK
NTEKIISDNEDIVLVPFYKDNSVSAGFGSKNYEGLVQHIPFNKQDLRLMFNIQGFLKIGI
IPVIGDSMAPTIKEGEMIVFQDDGSMIEGGIYVIEYQSEVFVKRLRKRPLSLISDNKDYP
PIVMDEDEEIKIIGRVVGTYDLNYRRL
>fig|195.2029.peg.1609 hypothetical protein
MFSFILSRFLSPSKIAFFVLIALCGFLYLKNNALALENENLKLKALHFSNEINVFKDKLA
QQNKAIDKLKLDLKPKETLKEVLKVDKVFIKDKSCESELKAYKELFNILGAKK
>fig|195.2029.peg.1808 hypothetical protein
MAYPLLGTRIVLDEEKILKEGKYNLEDMYKMIDEYAKESGMIKINKETYHCKGDKYDLGC
MALFIYKYLIDSEWFTKNAKEWIWISEKEGNSDLISASKAEGEGIWE
>fig|195.2029.peg.1575 hypothetical protein
MKKLKYILGLGLLLLTGCENGEYNTSTNVLDI
>fig|195.2029.peg.1101 hypothetical protein
MEHKEIYSRILDIHKHIFEQLKFVETKNNILLVFIVAFIAMIVRFLQSSNNDNIGIKVVM
ICILIILSCAAWELILSFKPILNNKEKKYNFLVRICNKYFNKTRNNSKICNIFFFKDLAK
INSKELMEIVIRDLEDNTEKEKIQNDKFINDLLNQICVLSLITLNKHKCFSNSLFYIALL
FICFFIIIIIEIFSIIKIF
>fig|195.2029.peg.1776 Ribbon-helix-helix protein, copG family domain protein
MNKNNNCVIKVSKDDKIILEYIKSETNASYSKIISILLKKFNSCDTDEKNKINDEISKNK
FYTSDENKIIKLKLTENEVNILKEISKNTGFSSITKQAKFLLLNSIKNEKLFTNIEIDEF
IKTRTEINAIGKNIYQLLKILRSGNSVKINENNLNKTMDNIRDKIDILSDQLGAIIEKNN
ERI
>fig|195.2029.peg.1791 IncQ plasmid conjugative transfer protein TraQ (RP4 TrbM homolog)
MKKITFATILFFGVVSSSNAIKLDILTGDTKLACEAMLCLASPVKPPECGAALARYFSID
ARKWADVIAKRRSFLNLCPVDASSDPEMYKYKNDILVHLDGECSVSALNNRVEDTLLRTE
TIQKCSHGDGCTTEIIKHYGYRINPQLTNSCRLLASSKYTDYHLKYTCNTKFYEKKDWER
GYELKEVSQEIFNALPISQREQGEKLVPVSYAEFVRLPADKRKQGGFGKYYRVDIAFYQK
IIIKKDCWINEK
>fig|195.2029.peg.1783 hypothetical protein
MLEMDNNKEFKILRLNKQEILKIGGYGICDSCNRRLSNDGYMICVLYSCYCEKCYKEWYK
VAINHKEDREIEKDVYENIKSKITNIYF
>fig|195.2029.peg.1778 hypothetical protein
MRQAFYTSKFYISKKSEKEVCFKLNFEIEISGGGEKIYKVEIRAFVDYQYLKNGNNITPN
IHKNQNDWWLSYECDRWSFHSSIAIRDEYQSLGIGTFLINKMLEIALKYVPTARLSGTLS
AVDEEILENHIRRDKLYKNLGFIFNEDNTGFSIEQIGDLKIRKDFDYIQEVHILNMCYQL
SNLQHEKEGCIRQLESHKDDMRKLNKENAALRTRNKFILCFCIALIFLIVCLIK
>fig|195.2029.peg.1214 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MKTNVEKYLKEHENKELCRFITCGSVDDGKSTLIGRMLYDSKMLFEDQILSLEKDSKKLG
NAGEKLDFALLVDGLASERARYNYRCGLSFFYK
>fig|195.2029.peg.1780 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRYGDTSRRANKSQSIHSDRTPNLFSFISRNDDERQGTDAARSYNQQSVLETAARND
GYERRSLKSGQKLDFVSDDEIYLGSLKDRFQKNLQAIKLSKTIEQENRYATKQEQEILNK
FSGWGGIPQAFDHQNKEWEKEFKELISTLDYAEYEKAKTSTLDAFYTPKIIIDTIYQGLN
QLGFNNDDHTKEIFEPSAGIGSFLSYAKNYSDKYHFTCVELDTISANILKHLHPNQTIYN
KAFQHHLFDKPYDAFIGNPPFGQKKILDLNDPTLNKTSVHNYFIGNAIKNLKEDGIAAFV
VSSYFLDSKNSTIRNFIAEQATFLGAVRLPNNAFKKRANTEVTTDIIFFKKGKDLNIDKS
WLESVEYYDDRFDEAEKRGMHPDVFNDFRINEYFKNNPQNILGKMNIKSSQYGYSLECLD
DGRDLKIALENFTKTLPKNIYKYQETKIKLSYYRIDRESPEYEKYSKTLSKLKDGNYFEY
NNEIYMKIGSDDELVFSKPVLNEHDTRRIKKLIALRDQFNTLIEYEKNESNDLLVENQRK
SLNKLYDEFVAKEGYLNRDANKKAFREDVEANKILALEKNYSSGISKSVALKEGIDPIAP
SATKADIFFKRTINAQKEIKISTPKEALIASINEYGRIDLKFLETNLNQPLEETLKSLEQ
DRLIFKDHKNPANYVLAEKYLSGNVKAKHKEVKKLVEDGFNEFVNNLESLEQVLPKDLKA
VDISISLGTTWIPIKYYKQFIEETLQITPKDYDLFLMEKTGEWSLKGFGYSLSSYIRSEY
ATERIGCFDLLEHGLLRKPIRIYDKKLDPSGKEIRELNPKETAIANSKLENLKNEFIEWI
YKDYDRRTDLENIYNERFNTNIEPRYNGEHLELPNFNANIKLKKHQKNAIYRAIQENSII
FDHQVGAGKTLVAICSVMEQKRMGLLNKPLIVVPNHLARQWNDEFYHAYTNANILVATND
DLKKDNREKFFSKITTNNFDAIIMTHSQFKLIPAPYEVIKKQYEEDINILEQTLEKKQND
DNVMRYSVKDLEKRIENFKVKLSDLQTTHKKSKAIDFSELGIDALIIDEAHEFKNLLITT
SMGDISGLGNLKGSQKAYDLYSKTQYIHEQNKKLYFLTGTPISNSITELYTLQRYIQPNI
LKEKGIQAFDSWASTFGEVTNAWELDSSGINYKIVARFNKFKNVPELSTMYKSVADIVTN
NDIMKYQKDFVPKLYNDKPINIVAPRSKEIAEFIGIQDENGRWNEGSIVWRMEHQQDDIT
RNNLLACTTDARKAGLDFRLINPHCDDYANSKINKLIENVFNEYNAWNDDKGTQLIFCDL
STPKQHSQKVALNGNIATPNLNKEEFVNINETIEQTEEENSKSLDELLAEQAKFDVYTDI
LKKLVAKGIPQNEIRFIHDAKTDLQKGQLFADMNSGKARILIGSTQKMGAGTNVQKRIVA
LHHLDCPWRPSDLEQRSGRVIRQGNELFMRDPQNFRVKEFRYATERTYDARMWQVIESKA
RSIEQFRKAGADVRTLEDVTSGAADAAEMKAEATGNPLILLQVQLNSDLRQEEMLYSGYK
RQIHNNEESLITNLSKIELLKKDIAKMEILNSIIKENNSEHFQGKYYINDDEKDFIVFKN
DTSDLNKSRQAELERNFEKIVKTIADDYQKEYKVLEFKGLLISGERTDLNTLNFYVSTTD
GKTIIEPENLIYKRDEKTFFKLESYVNFGGFVKRLNNFYNDLEKFTQLNKNKIENLEKEI
VELKSITGDNTPKYKRKDYLEALREDNRIIMDEIEKMSKQKNYKSDFVPKSAKILEDLNK
HNKILKDRELLI
>fig|195.2029.peg.1218 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILSLQDEEFKEEILSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQT
YKIIREIYRDDFEIFDYDLEDKKYFNIPQNIYLNNLESKILIKNINLDSLRLKKSFQIQN
LNQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVI
LLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYQEAIKFKNYLSYRLGQEIIKGFKN
PLSIILLPYEIVKLIYKFRKR
>fig|195.2029.peg.1804 hypothetical protein
MSDKELQKEILALENDVKQLEATIDVIKQRITHLKDIAWDRQSKKESSQMYKVLKEDKTH
TRVKSNVGDIKVDKDFMDKEIKKHLDNPNLRGMVTTQEMLSFPKVAKGVEANNEARGYTW
QVKANDGNTLVYGSRKYETNNEKIHRLATSHSKTEKNERQAEVGGRSHPHHPIFNDFNFR
KSAENIISQQNKSTNDFKAKLEEFSTKKTNAIESINKEFKR
>fig|195.2029.peg.1812 hypothetical protein
MPELPRMTAKEAEKLLLQNDFSIDRQKGSHRIYKKGLYRMVIPHHSGEILHPKIIKQLFE
IIEVAKD
>fig|195.2029.peg.1577 FIG00470129: hypothetical protein
MLKQYFEDNGINLKKFAQKHNLHYMSLFRVVNGLYSEKYKAKTNTKAVYEKLFELKIIDE
MPRACS
>fig|195.2029.peg.826 hypothetical protein
MLHKLKKNARNLDFLPSKCVKISLILRYQILRKMYEYS
>fig|195.2029.peg.1781 hypothetical protein
MEKKPFTIAEALNSETSSQKTYSKADKKSAGRKTIDQKLRRDNLVVCRLNEQEMEILKKL
MDLDLVSEYGTYIRKLILKEARALNINS
>fig|195.2029.peg.1809 hypothetical protein
MGINRKAINFDLSTKSLEKYFKDTREPYSLIKKFMLENGFEHRQYSGYTSKEPIDERRVA
RIVTKLAKKFTWFGECVKEFDITEIGEQYSLKDTIQNLCIKEINKQAGYNKDFHGKFKEF
TQKTPKNQKLKDLER
>fig|195.2029.peg.1605 hypothetical protein
MAKAKKETQNLENEDLETGDLPKALSLEDENLANEEAVSENETAKEFINEEGEEMPSKVT
PKSLSNDPLIAMPKSLESFINKDLFSINAKIDLETNESLALGTLLISEDFGESFKKCPNE
DISAKENVKLAMLKDHALRSGVYGVLLAGEINLKGVHVSAVKKAFMQNLIINTKE
>fig|195.2029.peg.1844 IncQ plasmid conjugative transfer protein TraG
MKNTIKLALLGAVITGVFSACSSEPKTVQYYEDPKNATELEAKIKECDKNANSAKTDTEC
ANA
>fig|195.2029.peg.1807 Major pilus subunit of type IV secretion complex, VirB2
MKIKLLSLILLSPIFVFAAGGIDKVNTFMENLSTALYALGAVLLTIAFMWGGSKIMFQGQ
TLREVAPIFIGGVIFGSASAIAGYIIT
>fig|195.2029.peg.1578 bacteriophage DNA transposition protein A, putative
MSYFLETKEAAQAFNVSTGALRLAASRNSNKYEWLKVDNEKGGRGGKKLLFKISKDKLLT
AFNQELISKNTLIYDEKMQKVKLSEIITTDNLKTINNSLKTSNLNLAEPKMNNDLAVLNL
KFENLSDELKEDAKSKVKLLKQVEKYIEGGLSIARTLKIEKINRRFYERIRKAYKENGIL
GLIDTRGLHRKDKTKLSAWMQEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDFIGF
DLGKVKPLFSVKTLQNFIKNYYKDKPLEHCIITQGLDRAKSKFLPAQGNQRELYDMKNMC
WQIDSSPADFIVRDDETLEPFRPHILSVVDVFSGMGVATLVGKSNSLSLTRLLWKAIDKF
GKPDMIKGDNGKDYLSKDFQSLLDSLNISYDAAIAYAGEQKALVERRFGTLQRARLSQMH
GHIGNSLAKREMIEQKTPKKERKAKDEYGFAKKTNQKLLHTFSEACELLEAEVIKWNMSK
VRRKKGVKTPLELWNSCDRSIVKISYEEFLFNAGNKELRVVGKKGINFESRVYKSALMPS
VGTRVKCVQNIDNIKELFIYDLSGNFLCLALDESIAKLSKESYKMLKKGYESEVKAIKEV
LKKDEIAAFTKLNIKQDLQDLQSAFENSLVEAKEVHQKSLAKEALKTQRELEEIKNNANA
DELILNAKKEINNNESEFDMEAFVEKKYFAG
>fig|195.2029.peg.1816 IncQ plasmid conjugative transfer protein TraG
SEPKTVQYYEDPKNATELEAKIKECDKNANSAKTDTECANAYKANYSKSLQKPRESAMEF
FKNNK
>fig|195.2029.peg.136 Ribonuclease Y
MILRVNFISTLIKNTTRKTTNMIESLIALITAIVGLGIGYLVAKKINDAKYEIFVEQAKA
KAKAIEYEAELILKDAKNSILNAELEVKKKYEDKTHKIQKEFNQKFDELSKKEQKLQLQE
ESLKENQEELLRSKKQMLDLQSDADKLKKQYQTKLNDVLNILEHSAGLTQDEAKNIILEK
VEENSRNEIAHIVRRYEEEARNEAKRKANYIIAQATSRFAGEFAAERLINVVNIKNDELK
GRIIGKEGRNVKTLEMVLGVDIIIDDTPGAIIVSCFNLYRRAIATKVIELLVEDGRIQPA
RIEEIHEKVCKEFDNAILEEGETILMDLGLSKVHPEITKLIGKLKYRASYGQNALAHSLE
VAHLAGIIAAECGGDENLARRAGILHDIGKALTHDFEGSHVDLGAELCKRYKEHPVVINA
IYAHHGHEEATSIESAAVCTADTLSAARPGARREVLEAFLRRVSELEEIAKSKEGIKNAY
AINAGREIRVIANAKLVNDDESVLLAKEIAAEIQEKMQYPGEIKVNVIRELRAIEYAK
>fig|195.2029.peg.1620 hypothetical protein
MIGKILTFVPNSYCNFACSYCYLGKLTERKEKTTDMAEQFKKIAKKLKDDGVIITEVILH
GAELSASPYEHVKELLKAIDEYKKENHFLIRVLSKDSKKGHHYIHLKTNLYFLDRFFELF
KKYEVGISASIDLPLRFHEKYRVLKSGKSTLEKTLKMIELLSAYPYFKQISTTMTKEHLN
VDEFIRDVYKLESLGFDMASDFYIMFTYQSANAQGDFQMPSDEDMLSFYKNLREKLKDTK
YSFALEHFWFKEFLGGYCTNCTNCGDNLLIQKNGDVYVCHRSQALNELRAGNIFNENYES
LKIRNITNIRILENSLKLHKDCLECDYFHLCKASCTIERNDTKLGKSYTCALQKAIYKNN
AEFFKADKTLAEISLDEFLRQNQTNNYKSFLIPNLSLEFRESKNSLENIINDDEILQKLY
LKDNFLISVNDELALLDFEKDALYKSFKISSKDNIKLLIKKEVFDYSTKETLSNFIYMSL
LGGEAKVYGDEKREKTLHIETKHLYLEKLLNESLELEGYLIYDISSFLKENSRLYSLNHK
NFIFFTTKALREYHYEKQAKNAFYHAQTINLPFLRFEFTWEDKND
>fig|195.2029.peg.1779 hypothetical protein
MNSSNPNMEFSIIQPKKTAVLVDLSFFLERYNTHKSIKTMEAKELAKRLKDYVWETLRRN
EDYLHRVYIYDCEPLDKNVPMPPIEKTDKSKNLSKTTTYKFRSELLNHLRKQPYFAVRLG
EIDENSFQWKFRDYDKFRKILRKEIDICELTSEDFVLDIKQKGVDMKIGLDIATLANKHH
AEKIILITADSDFIPAVKHARKEGIIVQLDPMRIPETQIKKGLLEHIDILSSVFINKNKN
GN
>fig|195.2029.peg.1787 DNA topoisomerase III, TraE-type (EC 5.99.1.2)
MKLFIAEKPELGRAIAEGLDGNYKSGEGYIQKGDNIVTWAFGHILELAKPEEYDEKYKLW
KLEDLPLPIKEFKYLPKKESKKQLKIICDLIHSDKITSIVNCGDADDEGQILVDEIIQYS
KTSKPVFRVLINDLTPKAVKEEIAKIKPNADFKGMSERGFARSQADWIVGINLTRAYTIM
ARKNGYEGILSVGRVQTPILALIVNRDKEFENFKSINYYSLLGDFNINNNTIKARLKTED
KILDENLAKEIKESCENQNAKINLKIENKKEYPPLPYNLLVLQAECAKLFGFSPDKTLEI
TQILREKHKAITYNRSDCQYLPETMFEQAPNILNIIKENLNSNDEIQALIASSDLTIKSK
AFNDANISAHYGIIPTQNKISSQLTQDELVVYNLIAKRFIIQFFHPREYQTTTINLEVNQ
RIFTATQNKTTKSGFRSLWQNIDSEEEQENNENDINDLSILKNGDIAKCSLIQIEKKQTK
PRPYYTMTTLLKDLNSVAKYVSDERIKKLLIEKDKDKKGESGGIGTPATRSNHIKTLIER
EYIEVSKDKKQIIKSTKKGRDLIKLSPKSLITPDMTALWFEQQKMIEISELRREQFLEEI
TKEVISEIQRIDKNQEFKILDNENKPKIQCPQCNKGFLTKRKGKYGNFWGCSEFKQGCKA
IYPDNKGTPNFETKQASNDTTHKCPQCNKGFLQRIKSKNGNSWWWGCSEFKQGCKAMYYD
DNGKPKIINV
>fig|195.2029.peg.1788 hypothetical protein
MKVNYIELEKKEGQIGNIPYIIIKVEYPNLKKLQENDLLMANDKGQWLCGFIGLKENQKV
DFKELDNGYIAPQYLYLNSKDQKEIDLFSNNLEITKVLQFDLNHSWNKTEKNTQLDEEEC
LKIIKNTIEYINNFNKNISKQEFEELSKEENTHKTHKLIERLMMQEEGTSGLIEKDLKEI
KKDKSYFFDKMSSFAKNQTIEKSRTKEDYSINN
>fig|195.2029.peg.1774 hypothetical protein
MEKYYKIKVTDVSELNEQYKEAIQEGTYEGEDVNKFFNTIKTFDVAESLLKKDFSNQYIK
FDIITDKEKIPLNIRLGDKNFEKGIEHLINIGSSKISKENINPEIKKDLNNQLGTYKPKV
YDEMLDGTFKALKNLSEVANKDIGVMISEFANSYSETREKFEKKQINKKSFFKEKMNEFF
KKKLNKILPDREISNEKTYSRSR
>fig|195.2029.peg.1562 putative lipoprotein
MQNPSKIQSTLKDELALRLKNLGLKEVSLNADYEILINLVDFKKHSYAQRITSSGRFFYD
FDPFENNGEWYIENYYTMQVNIQIGFKNTLQKTSLFTRTAYLSDKKRCQLSLENKIIDQI
SSFFYF
>fig|195.2029.peg.1574 hypothetical protein
MQKTINENISMGNTIIQASNIEPKFKIDPIQFKECVFYEIWTIKNPQNTSYTLSAERCQT
AFLSNKELIKYADPSFVMGNFTKDNQENILGIKAVKEELSKPSYVTDVKSYKFISDKYKI
LENGNYIYILQNFKAKSEILGEYTQNAHIIFDNKGNVIKIELNQNKEFGSY
>fig|195.2029.peg.1610 putative lipoprotein
MNDKMRIFLLIIPFVFLSACASKDILIKTEIKEVKVPIKCPLKLPLKPLDKKDLESAKEI
SKYYLEVENIAKLCTGEKDERK
>fig|195.2029.peg.1228 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKRLAVQLYGHLRTYEYTYISFIKNIIKPNLEDGWVIDIFMHTWDTLSSSEKSWHQNKFI
FNERKLLNSEIKIIKEIYNPKEILIEHLDKDEYGLHKTVNRVNKLREEYEKKHNIKYDFI
IYTRPDVFFYKELKLSFFLQLYAKHIHLSRLGLPDNFIFCASGILEKVPLFDPRWTPAND
LLWITKQSNGCVPNLCKNSFIIYLKYRLGIEFDIARPCDMISQYLLQGVAKQHVNNGYSA
KTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSYIKD
>fig|195.2029.peg.1813 hypothetical protein
MLLNIIIEKDQDGYFARILEFEGCVSQGNTYEEALVNIKEAGELYLESLANEEKRIIENK
TTSIIPMVLANA
>fig|195.2029.peg.1793 Coupling protein VirD4, ATPase required for T-DNA transfer
MQNNKSIQIIFLAISSVFLTYLLTPLVFFFLNKVKIMKAIEIYNINFTLQAIANGYPKIW
LSLSITFGICFVVFSVLVLSLKAKKSQFGEARFANFNEIKKMNLFGDKGIIIGKYKGKLL
RFGGQQFVALGAPTRSGKGVGIVIPNLLEWQESAVVQDIKQECFDYTSKYRKEILKQEVY
LFNPFSRQTHRYNPLTYIDMSDKEHCDSQLMDLANILYPLDGDSTSKFFNGLAQNLFIGL
CYLWRDLQLTDMGKEFQKSFNVDVGNFNFYNILQLSKGFSLKNEEKTLRGFDDTYNFLVY
CEILDEATIRRLETYFNINSDATKSGVMSSFNAPLVPFESETLRLSTETSDFDLRDLRKK
KMTIYIGITPDQLANAQFILNIFWSQLILLNTKELPQSNKELKYTCLMVMDEFTAPGRIP
IYQSAISFMAGYWLRSLMIYQSNSQLETQPPLGYGKEGAKTLLTNHACQIFYAPREQEDA
EAISRILGNTTFKTKSRSINTGNNGGGSHSISEASRALMLPQELREMPFENELITIDSGK
PILCNKAFYYSDSYFMDKFKAVSKSLSGIKKIPSRKQLEDAILKGECKIKIQIIGENNEK
NVA
>fig|195.2029.peg.1794 hypothetical protein
MSDKELEIFELCERLSKLLGDKEAIADLKKLYTNHPEMFKDMQEVSNTIKEVVKEPELII
KNPRPKNEKDFIAVKHLQDKKQKIGDIGIRNDSGTNTIFHANISSNRNFKRLAKKEQAVT
GEAVHSLHTSRPAELGGNNQELSGANAHSVTANSIIPQQNKSANDFKAKLKEFDAKGKNH
IQTKEKER
>fig|195.2029.peg.1810 Site-specific recombinase, resolvase family
MNIAYIRVSTNKQELDSQKLEIMEYCHKNNIILDEILEVKISSTKSQEKRKIKDLKQRLQ
SGDLLIATELSRLGRSMLEIINLVLEFNANNINFLFLRQRELSNFNNPSSKLILSIYAYL
AENERDLISQRTKAGLENAKASGKKLGRPKGSLNSIYDKDIDKIQTLLDKDLSIRSIWKL
FYKDSGKTYDGLLWFIKKRKLKQK
>fig|195.2029.peg.1523 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
DYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMWFEIGKLRKRYREREKK
>fig|195.2029.peg.727 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAIDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLSFQCEVKSIHKGNSGIDLALKKDGLTQVIIEAKLPNSREFFSPSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYSFFIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EIYKEFEKILNGDSTLKGLFVDLKPILEQDKLSFSKLKPLFKIFSKDCLLGEFNPNDANS
LNNAFYKELLYILGLYESKQNSKLIITKSEESKEEQGTFYTAINSKLKEENFETILKLLI
LWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEVLAKEKSTRKKSEFA
YLPYLNSSLFEKQSIENTLEISSLSNDLKLFYYKNTVLKDDKCKAKKGQVGLLEYLFEFL
DSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSFITSYMCKESITKVV
LDKFNAQFDLDAKDISELRRSLRKEDKKAQKELLNSIKICDPAVGSGHFLVSALNVMLSI
YDELNLFDEEFYLEVQNDEILITGRKGEFIEYKRPSTPKDKAHLIQQELFHTKKDIIENN
LFGVDINPNSCEITKLRLWIELLKHSFYQSFDDENYHDLKTLPNIDINIKCGNSLVSYFE
TGKSLNHYPNIKERINKYKRIVKDYKEGFYTDKSHINQEIKNLKISFKNFCFADKFKKEM
KGFNDKCEKYSKKYGNFLAINDENLKFFVSANLTLFDFDEKEATKEFANLKKEYDNIFNL
ESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIKENDNKDLFTNTKKLRTYQGKMDIW
YHFVGRGFDILKNNGYLAFIATNNWVTNSGAKKLRNIVLEESQILSLVDFSSFMVFDSAS
IQTMIMQFQKIKPPKNYEFHFAKITTQTPIYEDVINLLKNEKTQNNEILSINLTPKKFID
KTLNFTKSDYEELFNKIQKYGKFYLEESEVAQGIVYPQENINKKSLEILGNNFYLGQGIQ
KLTNEEVENLNLLKNEKILLKPIFESDNIQKYFVKRYNYFWVIYTNSSFKNPNSMDNYPN
LKKHLDKFQNVITSDNKPYGLHRARDEKFFTGSPRIVALRKCVGEPKFSYVDFDCYVSAT
FYVIKTQRINVKYLTAILNSKLIAFWLKHKGKMQGNNYQIDKEPLLNIPIVTINSKNQKI
ADELINLVDEILKVKEQDKNANTQELENKINSLVYKLYDLTEEEIKIIENKEQK
>fig|195.2029.peg.124 sodium/pantothenate symporter , putative
MTRFANFYGVIMVLSFIVSWQIFNAYFNFLVFLILFFVSYKIWQFKKK
>fig|195.2029.peg.1786 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYSIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEFEFNQNIFYALNFKNKEISFTELVFSFKI
NSLDRKSFDIINIYNKKHFIIQKDNSLITFKYRKIQSKGFNLVFLLENNILKNYYFNYLE
KINPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTKINFNLNKFDIH
LALSFAISLNFIAKNEQNKLYKFVLENNKLIYDYIDFINNNFANEHFIKIKYKRKKYKII
NIASFLLYHKLKPQKESYQNEFLEIYILINDYIKLSYETNNLINLNINSINRITNEHNVL
TIELEKKQIPKNKKLKIKEDFINLKLPEEFKLIETHKELYLHGMEQKNCVYTRRREIEDG
LSAIYSLNYEGGVYTLEIFKRKNKFAIKEIKAKYNEFANKEVINFVEKSLKAV
>fig|195.2029.peg.1777 IncQ plasmid conjugative transfer DNA nicking endonuclease TraR (pTi VirD2 homolog)
MSRSIRIFDDEIIAKKVFTKIENASKLPLNYINKNRDKYTKDIKTGKLISKNMFRKNTEV
VVKITSGSKNSQALSKHLDYISRDGNVELITNDFDRYAGEDEILEVKRIFKNEGSPIPLY
KEGAKEKRHTINMVFSMKEHSTTPKEKLQQAVITTLKRMYPNNFFVVAFHNDTDNPHCHV
CLKVADKNGKRINPKKADLANLRAEFAKALNELGVEAKATNKKQREVEINQEFSVKLNAN
NEINQAPKIKMHYYQVMDFGEANYQFSTDKNAKKSYYVSYKTKKGITTIWGQDLERVVRE
NKVLRGEYARFKIVGQEEYEIKRKAKINNKWQEVVKTLKKPIWEVSVIGREKDLKQINKA
KTTKKYKIIQDKGVNNERDYTKQYRQRILQELGNKSTIRRETAQERNSMRILSKQPVVHN
TKRTQMLLHINALNQLQQGERGRSDNILRWTSARNNEIKRDG
>fig|195.2029.peg.728 hypothetical protein
MKLKLNLENCYGIGKLQKEFDFSDKNVLLFYAQNGTFKTSFAKTFKNIKDDKQIKDEIFP
ERISKAYIEFNGEKINKEDIFVFDSYDREFDSSKSVTTFMASPKLKKEYDEIFSELDKQK
KSLLKSLKKYTGSSDCEKEILKIFSNKNLYQILSDNIDFIKEVKENYEFKYHDIFDDKNK
VKEFVDTNKELLQGYFDKYNEILLSSEIFKKTENGEFGTHKIKELQNTLSDDRFFLASHK
LLISNQEITTSENLNNLIQNEIDRILENDEIKNKFDDIEKKITKNQNLKDFKEVINANKG
ILLKLINYEEFRKEVIFSYLNKKINEIEDLVSLYENQKEKIQKIINNSKLEQESWKKIIE
IFNSRFIVPFEVGIENQDDILLKNEVAKFVFKFKDNANEKIVNKEKLEEILSNGEKRALY
ILQILFEIEAQKNTNKPILLIFDDIVDSFDYRNKHAVVEYLDDIRENINFKIIIMTHNFD
FYRAIARFGASKFMIHRNDEREIVFGRGEYTNEFIKSLKKNDENIKKNFITLIPFVRNIL
EYTKNEKDKEYLLLTSCLHMKDDTKNIKVEQALNVLKNYIQEYQANINKDDNLLDFIYGT
CDEIANTNNINPIELQNKIVLSIGIRLKAEEFMLSKVNLQNEITRNQTRNLYNLTKEQNA
INDKQDFIIRKVLAITSDNIHINSFMYEPILDTSIEHLVKLYRDIKKI
>fig|195.2029.peg.1658 hypothetical protein
MIGSSHGGYLAHLAAKIAPWLIDGVLDNSAYAKFLWRVVGFGKEIDFMQYSEFATFDFFH
HIKTHCSTKTFWTSNSSSPCFFSPARRKIRNLLEEDHLLEQSKYLKTCFISYHSLYDEYV
SLKEKTMLYEELEKLGFDATLCSITKESQVDGKFIKNLNHGMGIPVKLLIKKELPLMLEK
IKQNLKKDYKEKCISYPCEDLLYQFSEKDDKILLKIDKI
>fig|195.2029.peg.1099 Type I restriction-modification system, specificity subunit S
MKIKIWKINKLEKICEILDNKRVPISQKDRISGIYPYYGASGIVDYIDKYIFDEELVLIG
EDGAKWDAFENSAFIASGKYWVNNHAHILKPNNEILINKFLVYFLNYSNLEKYITGATVK
KLNQQKLKQIEIPLPPLKEQERIVGILDESIKILEQNLLNLDELMQSALRKAFNPLNDDT
KENYQLPQSWEWKSLEEISENISAGGDKPKNCTESKTAKNQIPVYANGVNNNGLVGYTDK
ATIIKPSLTISARGTIGFVCIRKEPYFPIVRLISLIPCENILCLHYLYFCLNFFIAKGEG
SSIPQLTIPKFKSLQIPLPPLKEQEQIAKHLDFVFEKTKALKELYTKELKDYEELKQSLL
NKAFKGEL
>fig|195.2029.peg.1263 hypothetical protein
MKITMIILSLFSLVFLSACAFKEKKASEIETLASNYGGIYIFDKKIREEILELEKKREEF
RSKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFA
YYEDQFKAYMGEENYKKLRPYLGMTTYYVCEGKKYPVVFSTMIDYKVKNYGLFGDEGRGF
SFSSISRKSAGGGSFHYFTNGKFIKSDEKYTGQSY
>fig|195.2029.peg.1789 hypothetical protein
MAFGKLVNDKIVIDTNNALNYRSREGDIQQRKVDTALIDIIKEAGQVAAMEHGAVLFSAK
VNEVWKNYFVNRDEKTHNIVLKPTNSQNRDDFIYINSNINEQGYFYYTINQKRESAKELI
EGVGIVEHQNQDGTKSHYLETNVRLYNEELKRELKEKGNEFIAVISNAGIKVVNEAEMKA
QKQEQQIQQTQEIKEPEKTQNQEFGR
>fig|195.2029.peg.1785 hypothetical protein
MNTNKITDLHIQISKEDLKILDLLLKANEYSNIVFYCENDEEHFIFTEVKLGNYFCINR
>fig|195.2029.peg.1795 ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB11
MSITLDKYTQKYFGEFLKDDNINEICYNGDNKIWVQNSKGLWESVQTELDFESAGHFATA
SASFKKDKIDVSRPILSCILVGGERMQIVIPPATKSEHISITIRKPSKTRFKMEDHVKSG
LFEDLNPDDKNIIKPSDEELIKLYKERDYQAFISKAVSYGKNIIIAGETGSGKTTFMKNL
IDFISLDDRIITIEDVEEIKFYEHKNFVQLFYPSEAKSTDFLNSATLLKSCLRMKPDRIL
LAELRGAETYDFINVLASGHGGSITSCHAGSPEETFTRLALMTLQNPQGQCVPFEIIQKT
LKDLIDIVVHIHAHHGKRRISGIYFKEIENIKKDSNE
>fig|195.2029.peg.169 Flagellar biosynthesis protein FliR
MEFVNYLGDKNVATFMLLFARMSGLIVFFPFFSHNSIPMIIKTTFALFLTMYLFPLAKLE
ILHLDSFFYYTAFK
>fig|195.2029.peg.1775 hypothetical protein
MLKESKLIEELKREYDEKLKKLRQKEKENKERIYKKLSSALFKDFEINEDFKNEFNLLVE
KFDCKNTKNILDKINNLYDFNHRNDKIDTAKKQ
>fig|195.2029.peg.1790 hypothetical protein
MMNEEINSNENSLYELVKEDNSTNMVIQNYNELLSKFENLIKTIIAKIDIGKQNSSSNTE
DGIFKDLEKNIIELDNTFLALISYFKNPPSDEEKEFINKTASIKKTMEDFAEFANEIQKL
SLDDKLKKYNEQINKFCEIVEYKLSHNAENYNSFLDHFVENGKLKLNIFSEIFTKMTKNT
KWYLIFFSFTSIGLGIALGILILLTYIKYSEYNNLKERVSTITQGLATISIDENSKGSFT
LSFAKNKKTIFNENKNSIQITLQGGE
>fig|195.2029.peg.170 Flagellar biosynthesis protein FliR
MIAGLMLQIVFAIVMMAGEQIAFTMGFTMASVLDPSSGTNMPITSQILHLIALLFFLAFD
GHHLMLLFLSHSLGYINLGGFYPHENLMHYLNMGMLNIFIIGFTMSFPILGISLLADTIF
GLLMKTMPQFNLLVIGYPIKIALGFVVLIAILLVMMQYFKDLILEVFTHMQTLFFA
>fig|195.2029.peg.1619 hypothetical protein
MFYNLSQEDFLKLEESIAKIIKKLEVLQGLEDIKSINKAKHLNECKESLNQCLEKKDKDK
YDFFIYEIYNLTWGTKPFDEIDESEKISANLKVDKYQENIPSLKEIAQSVLKEEVDDLIN
DHPLMLEKLKDYDEFGVPRKISIRQAKLALLEVGLLENVEIMMQSADKATQISWEYATEF
ERQNELILFFQQQTKLSDEFVDELFKKAKEY
>fig|195.2029.peg.1802 hypothetical protein
MSIKNLSVEELAQELETSNHEKLIKALFLFEKSSSMEDLNSDQIEIILDEVYEFYINHKS
ISSFLQEDINQALDEAIDKELCKKQEKSFER
>fig|195.2029.peg.1806 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MEKNPLFKGLTRPPMIFGVPMTPFVIAMGSIILVAFYSQNIFLVGFSIPVFFIMKAMTKR
DDFIFRLMFLKMRFFSNPASKNYHKVKTYSTNSYRQMPPNSNFPKISVFGLNAEPNFEKL
IPFSSLINDSVVITKDYLLMTTWEIGGISFEAEDDDELDIKNDLLNMLFKSFANEPVSFY
FHNCRYSIEDKLTSKFNNAFLEEIDRKYYESFKQGTLKKNSLYLTLIFNPLKVKIEKTTF
MKSSFENKRKTISVFLAKFSEFADRLEANIKDFNPKRLKTYSKDDKTYSKQLEFYNYLLG
GKFNPIRVLSSPIDQYLNGNLQNIQFGHDTIQFNQNDSTKKFARCIEIKDYTNETFAGIL
DILMYLDVEYTVTQSFSPIPRVDAKSAISKQKKQLIATEDDGFSQVEQIDEALDQLTNGE
ISFGKYHFSILVYGNTIKECKDNTNEVVTKMNELGFGVTLATIALPATFFSQLPSNFAIR
PRINLISSINYSSLIALHNFSMGKRDKNCWGDAVSILKTPNKQPYYFNFHQSSGANKNDF
GKFFLANTLILGQSSGGKTVFMNFIVDQMMKYASKDTFPDDIPEDKRKFTAIYLDKDKGA
LGNILCAGGRYISIENGKPTGFNPFMVESTQENIRQLQSLMKLLVTRNNEILTTREEEML
NNAVNSLMKGFEKEERKYPISLLLENLTENVDDDNSLKSRLALFKKGKQFGWVFDNEYDN
LDFPDDINLFGIDGTEFLDDKDVSGILSYYILWRVMSLADGRRLCIDIDEAWKWLENEIV
QEEVKNKFKTIRKQNGFLRLATQSLEDFLKLKNAATLIEQSSTMVFLSNPKAKEEEYVKG
VGLSYDEYMIIKGFNPVKRQFLIKRQDEKVICTLDLSPLGNENLKILSTETAYIDVIEKI
FSQENKSLDEKVLELKEIYKNS
>fig|195.2030.peg.707 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MDKIYFVAKQESTGIILDFESFAIDRIIFSFKKNIYLDKIRLLCLTNDKKWKEILNYNLL
ISSNNKIVIDFEKTIFNYLKIELSEQTYFQVEIDLFLRNRIIVAGLNSYIGDRFLSILNS
MYIADILNFNFAMVWNSRKVDTKDMKKYQNDKKLVSYIIDDEKEIFDDLFLQKNSYTSAL
PIRQTKWMSKMSFHDLKYGPFVEKQWGWYVGHSPLEHFIEGEIDKSYSIKLKEYFKKIIF
SKKVQEIIAKIDLLAKNFIKKNGNFHAIHVRTGDLVYCDENPFFAAVHWRKAMPPEIALE
LALKNLENNMNIVLFGDSLSVVEEIQMHCNTYYQGKARIYKAQELIDDLSCPTPFLQAFA
EIIFMSNADEIYSGDSSFARLASIIGHGKEPKYYFKFFSFVQQQDILMDNIGILNTDNIM
KAYTMCYYYLISRLYLKKNFNHLVKIVFKILSYNSNNEFYHVLFIDSLLNLEKYDTAERH
LDDFIFKLQREDRFLSCLKQSSFYNLFKNVYMSDKINEKYQKLMLIKSSII
>fig|195.2030.peg.718 Two-component system sensor histidine kinase/response regulator hybrid
MTAYVHIGIAKTGTTSIQDFLTQNYDLLINQGFLYPKSLHGIEEQYSREWSQHRELAFII
KATKARGFLEKESEKLNLFRKEICGFEKVIISSEMLHDSLIDKEHILHCKNILQDLGFKK
IKIIIYLREPAELFQSVCSQSIKNCYNQDVCFKLPEQSNILNHRCSHSKTLINWGQVFGK
ENLIIRLFDKSEFVEQNLLKDFVSCLNINWNEQFIIPNKANESLDVIGSEILLRVNKKLP
LVLSGKINFLRGNLLFYVEKYFSNPKLKITPPKDMYQFYIDYFEESNEWVRKEFFPHKER
LFPKKDLTDYKENYELKEMKPEYWDQIADFVVDVVETKNKTIQENLSQINNLNQTIETKN
KTIQENLSQINNLNQTIETKNKTIQENLSQINNLSQTIETKNKTIQENLSQINNLNQTIE
TKNKTIQENLSQINNLSQTIETKNKTIQENLSQINNLNQTIETKNKTIQNKDDLLNFQAQ
YGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKQKIEKDPS
LKLPSLEQYPDYREAIKLKNHLSYKLGKELVKANKIWYKGGYFYFLYFIKKIKI
>fig|195.2030.peg.371 Citrate lyase beta chain (EC 4.1.3.6)
MGGGSLCIHPNQVAPINEVFSPSAKQIAWAKEILSLRQNSNDIIFNYNGMMVDLPVIKKA
EQILLDSNSNLS
>fig|195.2030.peg.702 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13)
MAVEFDIQESKKIKGVYVVTPSISKDLRGNIWTSFLKDKIEELLPNGLYFKHDKFSKSCK
NVLRGIHGDYKSWKYVTCVYGDIFQVIVDCRKDSPTYLKWESFDINENNQKIILIPPNMG
NAYYVRSQEAIYHYKYAYDGEYVEVADQFTYAWDNCQINIKWPFNGKPILSSRDIKGKAL
DVERN
>fig|195.2030.peg.716 hypothetical protein
MQIGFYPEIKNKEELVDIISRAVWYLWPLEGFIEKFHLCTNLVFDNRLILSRFPKYLDPS
ILRYIGKISPKKVVLHKKIHNSYFENLQYIFLTSEEYREELLKIKTKLNLKFDIVRIDHN
NLSYADSFYLRFAEKIPALHSTYKKISKSRIFNLLERLKTKKIYLFGTGPNFSYSEKYDY
SDGCVIACNSMVINRDVIERLKPKIFVIADPIFHAGPSSYAGKFRQSLIDIFNLNPCPIV
VPLRDYHIYSTYLPDCMVDFLVPIFFKIPSEDDSPFYFDIFKSLEVKTTNNILTLFQLPL
ATSLGEEIYITGCDGRPIKNDSYFWSHNREVQINDKMQDIQIAHKGFFDIKYNDYYNRHI
GFLSQFINLAEKNNKKIYNLTPSYIQPLQNRIINNIIVNDRASKKEYDLSIIIPVYNAEK
FIEKCIASIENTCYLDYEILAVDDFSDDSSLKLLMKMAQLNKRIKIYQNFGKKGASGARN
TGIALSSGKAICFLDSDDTVLENSLNIRYNILMSDEGKKIVHGIIQFIDENDNFLGVEYG
KKSTVTIKDCIHGNPISFNTMMLKREIINLLYFDEQVTNGEDWLANFNLFKNNLSSNFVY
DSISTYRIHSESTVLKNFELHENNLLAIIDKIFSDDTVKHITNQYKKQDLKSKIIRMRSI
SNFFMLFFKSDFDVWKDFLDKTDFADIFYDNTINFIEKMRVSFIRTFKIHILKVSNILSE
DNLFLDKFALLKQKYPDSKIVLDINSIIGFYSSSMQEIKKGNLCFSQKDYIGALKYYEKV
DISLRKYIDINIALCQILKERR
>fig|195.2030.peg.699 Capsular polysaccharide export system protein KpsC
MFYLKYNISFYTNSKKLIKNVKDFYKIVLYKAYKSIGKEDVFVGWGRKNSGLKAIALAKK
HHAKFMLLEDGFLRSLNLGVENSPSFSIVKDDVGIYYDASTPSRLENILNTYEFSPKELA
WAKKAIELIKKEKLSKYNNNLCIPQELFSANEERVLIITQVANDASLRFGLASDFSTQDI
INDALEENPKAKIYIKIHPDVLSGKKQSDFSMQDLPSRCVILKENYNPIELLSHFKKVYT
KTSGMGFEALMLGCKCVCYGMPFYAGWGLTQDKLECKRRVKKRSLEEVFCAAYILYSEYF
NPYLNQKSDIFDTIFTLARYKKIEQANSHTLYFLGFTLWKRWFMKPFFKAKNNKIIFLNS
LNELYKANLNSEDKIFIWGKKYDKALLAKDFNNEIFLVEDGFLRSVFLGSDLTRPFSLIV
DSKGLYVDPNHPSDLEELLQNHEFDDTLRQRAKKLITTITQNKFSKYNGLKHEKLDFNTN
KKIILIPAQVEDDASMILGGADFDTLKLLQSVRKANENAFIVFKPHPDVLSGNRKGLKDK
DIILKYCDEIIENVSIDSAINACDEVHTITSTSGFDALLRGKKVVVYGKPFYAGWGLTQD
LHHISRRTRVLSLEELVAGVLILYPRYIHPKSKNLCEVELALDTMLALQKDYFSKRWLKI
LIDFRILMLRKIRRIGEVFIKR
>fig|195.2030.peg.704 Mannose-1-phosphate guanylyltransferase (EC 2.7.7.13) / Mannose-6-phosphate isomerase (EC 5.3.1.8)
MTNILLCGGSGTRLWPLSRILMPKQFLKLFDNISLFELALRRNSKICTNTLIVCNEEQYF
LALDQILSTNKTKFILEPLARNTAAAITLACLFLHKEEVVLITPSDHLIKNEKAYQEAIT
KALEFANDDHLVTFGIKPDNPHTGYGYIKSKNIYDVESFIEKPDLKKAKEFLEDGNYLWN
SGMFMFKVEFFLEEMQKHAKEIYDFCFKAYKNALKQDNFIKIKSLDMEKIPELSIDYALM
EKSSRVKVISSDISWSDVGSFESLAKEFNNNKNYTNTNAKFLDSNNIFCYASDKNKFIAT
IDLDDIFIIDTQDALLVSKKSSSQKVKQIYEFIKENENLSKNHLCTHRPWGSFTILEDEK
GYKIKRIEVKPGKRLSLQKHFHRNEHWIVLSGTASVEIDGIESLVRPNESIYIRMGQKHR
LSNYGKIPVVIIEVQVGEYTGEDDIVRLEDDYKRI
>fig|195.2030.peg.1416 hypothetical protein
MKKMSLGDDFWDQLKVIEKNSPKSFLMVVNIIVMIIIIK
>fig|195.2030.peg.710 conserved hypothetical protein 22
MAIFCKLRDINRYNIKDFDIVFNYLSRCVNPDSKEFARLHAYKEGTFKKIKLTEDIFALE
QAYFTKNESQAFFESHRDYMDIQFIVSGKEKIKFGDKDLFEVEKEYDKSKDLIIYKEPIF
LVSNLLLNKNEIAVFYPEDVHMPGLSIVNDSYVIKTVIKCKI
>fig|195.2030.peg.705 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MKVGVIGAGISGMSIARLIDSDFEVEILEKESVVGGIARTKDVNGIAYHIVGGHCFKSIY
PEVLNFIFDKVLSKDNWNLIERQARALFRDQWISYPVEFAISEIDKIDSFLGMKIVQEML
NASYEKGSNLEEWFINHFGPTLSREYFLPYNEKIWGINPKEMDNSWIRDEKQMKLPVPTK
MSFYKSLLNNSKNVFDNMPHAFYYYPKTNNQNTFIDALSVGLKIIYNYQVKHIEYFNKKW
CINGEKQYDILINTSPLDLIPNILQNIPSDIINSFKKLKYNKISNMLWETDGSFDSTWAY
VPKKDIGFHRLLNIGTYFRPIKNYCITESVGEKTYEHFVNEGKKINFLKRPVDFHVSDRA
YICFDLNYVLSKTTTLKYLESIGLISHGRFAEWEYYNMDVCIKRSIDLAKKIKSEYLL
>fig|195.2030.peg.1634 Membrane protein insertion efficiency factor YidD
MGIKKTRMFKIVCLKTLRFYQKFLSPLKPPVCRYYPTCSEYAFWQFQKRNCILAFFSSFF
RILKCNPFFKGGFDYPKITKNITSCNLCFKPIFLAQKQLYFLYIPHHQDKSFYLVKIIFQ
RTNK
>fig|195.2030.peg.761 Haloacid dehalogenase-like hydrolase
MPKAKEALELAFEIADLGIVTTKGGKFTPLLLEHLGVKKFFKTLITLEDITNPKPHAEPI
LLALEKMQKTKENAYMIGDTILDIQAAMAANITPLALSCGYGDEDELKRYSMVFPSAYKS
VLYIKND
>fig|195.2030.peg.701 GDP-L-fucose synthetase (EC 1.1.1.271)
MNKEAKIYVAGHTGTAGSAIVELLYKRGYCNLVFKGSSELDLRNQKSVEKFFQQEKPEYV
FMCAATPCGVANMQYRADFIYNNIMMQINVIHASFKHRVKKLICFGSGYMYPKEAQNPLK
EEYILSGKLDYSIEPYALSKIIALKASEAYNIQYNTEFICVAINNLYGGNAKFDLKQARL
MPALLQKFYLGKLLQKQEYVQLANELKVTGVKNIEEKLKEIGIFKDQIFLWGNGRTRREF
IHCEDLADACIYLMNYNFKTCDLHFNIGTNVDYSIADVASIVSNIVGFNGEIKFDITKPS
SDMNRLMDCSKIHSLGWKHKIELEQGIKMMYKWYLENKGAIE
>fig|195.2030.peg.1684 Multimodular transpeptidase-transglycosylase (EC 2.4.1.129) (EC 3.4.-.-)
MKNYNKVLKTKKTENFSNSKNYEEQVVNWQ
>fig|195.2030.peg.1732 Flagellin
GRITSGGEVQFTLKNYNGIDDFKFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVE
TRGMAAVRAGTTSNDFAINGVTIGKVDYTDGDGNGALVSAINSVKDTTGVEASIDANGQL
LLTSREGRGIK
>fig|195.2030.peg.703 GDP-mannose 4,6-dehydratase (EC 4.2.1.47)
MKKVALITGVTGQDGAYLSEFLLSKGYEVHGIKRRASLFNTDRIDHLFEGHHGKNNDFYL
HYGDMTDSMNLTRIIAEIKPDEIYNLAAMSHVHVSFETPEYTANADGIGTLRILDAVRFL
NLIQKTKIYQASTSELFGKVQEIPQSEKTPFYPRSPYAVAKMYAYWITVNYREAYNMFAC
NGILFNHESPVRGETFVTRKITRAVAKIALNLDDIFYLGNLDAKRDWGHAKDYVKMMWMI
LQYDKAEDWVIATGKTTTVRDFVKLAFEYCGIKLNFKGDGVDEEGFIEDFDQQRANELSL
NLNHLRKGQVVVKVNPRYFRPTEVDLLLGDPSKAEKELGWNREYDLKNLVNDMMESDLKL
MNKDVYLKKGGYKTMRYYE
>fig|195.2030.peg.903 hypothetical protein
MNYQQLECDYFNLYNQFISVDFQISLFEKNHKSLIKDFIFFYHQILKQKDLNFLLGVRNK
IALKVHNYMQEYSTSPKDLSLICLREHKHIEFFQRFYKALAYFVAFRKKLDEEQKIKNLI
SNINDCFGCHFINSDFNNLQNFQKMISLHCLKNVFNIFILL
>fig|195.2030.peg.708 hypothetical protein
MNMEDRINLAVDKRDILELNNIISLYEKEGKIIELSNIMQGSKNAILPFDYGNQEEQYGK
MIERYFLLLARNLKKENYCSLIEDLISKDFCINGETYWYYHHKAHLLDNLYYDKMQDEAD
ILFSMAAAKARSKDLFHITNGVFSTRSLKYFESMLSVDVKKRNIIEYYGNYIFSKQDSCF
LICADSKYFKNYSFAFLNSFRNSINKNSGFNIIPHIHIINPDQECKELILDKYKDEFTFN
YSFEYIDLDNISDHSKRAYYTTPRYTLVPDLLELYGVDIIVSEIDAVIGKNLYEFVRFCR
NYELALSQGVSSMNFYYHYGRISAILSYFGNNFLSKTFAKLNKKYIDLYFDFSKTSTNWL
IDQISLYKIFKFLKSDIYVKNNTIGKINANMLVELAQHFPGGKEAFIKHYKKN
>fig|195.2030.peg.762 Haloacid dehalogenase-like hydrolase
MKKTILFDLDGTLIDSTDAILNSFQGAFKILGLTPKNNEEIKNLIGHPLEHMFKILYHEK
AHLSQEFVLAYREFIHRFI
>fig|195.2030.peg.1734 SMF family protein, DNA processing chain A (DprA)
YTKNCVFELSNLLKNSKISVVSGGALGVDISASMAAMPNTIGGFANGLDEIYPRSNEKII
KQIYENALALSENESYYKPKPYDFL
>fig|195.2030.peg.706 alpha-2,3-sialyltransferase
MKKIVLLGGSNSILSDGIPKAMKANKDINFINLALGGSASLQNVYEIIRKKDEIEHADLL
ICESNLNDKREDFHQRNLKQIIRDIVILYEQLNMLNVKRILILLLPYDHVQCKNSKIIDN
VHRKLCQDYNFNVVDMASFFHVIGVHDFYMNLKDSAHQLPSILYQLGVSILNNLQLLSIH
KYNNATTGNVFTFYTPKEISDSKIEINNSLVQETAYKVSIKDIKENFSNQEDRYLIGAHY
LHVTASTKLSIYKSLKEIFLHSESDFSELSKWLDRFRYLTSLLFCDKSYLYGITEKVNKL
LSEDLMLDKSIYFRKFDCLIPDVLLFKSIIEDYNKVNLSQNPSDEIFYNVNNQIIFGAVN
RVKHHLAYKLGQVMVYYSKTIKGRLLMPIILSCVMVNHKFTRKFNDKLPPLSEYIDYEQG
MKIKQHLTYQLGEALIYAHKNWYKGGYVRLFFHIRKIKSRKGKLQ
>fig|195.2030.peg.579 Possible sugar transferase
MEQILKILKQMLSPDQAQILLKALKNSNNENFYNFALENIEIICEWLNSKEFQENYTNHP
YPPLLNPNYIDTDASRHCAELAWDLNLPLPKHYKFIYISPHGVGAAAFLRYLNEACNVFC
LASWMLPYDAKERYCINYMCLNDKNISDQAINISELNIINLEKYLALLDPHSKVICGIRD
PIGILKHNWGRDWSKVQRNFQNEFDLTYDYRNYINFLNHKKPEIKINLEELNYSVFIINY
LSKYFNQEYIYYLDMEKIKTKNAFQTMEDLAFRFGFTPPCLKESENLFKIQEFRGYIRYL
FPITLYANQKDLSNIFSIKSPNNNPNARALILLQALLLF
>fig|195.2030.peg.578 hypothetical protein
MSVYIDKSDLEKLEKNTLFFKQIKNYLYEFLQAIHKTIEHTEDSMMKEEDVLLYFSKNKT
LALEFKEIFNKELNNVKQSHPNIIASWKYYQEFEKICKKLDEKE
>fig|195.2030.peg.835 RloF
MSNSFLNTETLTLNDLFGKDRTYSVPKYQRNYSWSEDQWEDLWCDIEDLEKSNYPHFMGS
IVLQETKDAKNIDIIDGQQRLTTLSIFMSAIIFYIDNLVKKDKDKTDNEKRKEIFNKKYL
GYESSTTLKIVPKLTLNNTNNNFFTHYIINQNIPDKPTLADEDNSNYLLYKAFNFFQKKI
KEKFQEEDGKIIAEYVEMIGEQLKFIVIIVQNELDAYVLFQTLNARGVELTAADLLKNYF
LNLLKNEPEILNQANLMWENINNKISTEKIPDFLRSVINSQIDLVTKNRLFKEVKKNIKT
SEEAFNFISKLHKLSSLYLALQNSNHSSWNDFTAQDAKYYIDILELLRFKSSLPLLLIAK
EKIVDDQDFIKILKACAILSIRYSISKTRTNKLESSYNKIACNIFHSKYKNTKEIIDALK
SIDIDDNDFKKSFSIYSKKATSGNDAKIVKFLLVNIERHLSGGICDEQIATIEHILPSSL
NNEKVHKLGNYILLEKKYNQELKDKKFEEKISIYNKSSFKLPRYIADNFKTWDTKSIDQY
QNFLAKQALALWKIQ
>fig|195.2030.peg.904 hypothetical protein
MIHLCFMVLNPLNFKDSNRHLDKAINYLIDGAFEIYELIFKEYFLLFPKDEELKDELKKI
KNLEFKILMQEVSRVKLLNHYKEFCEEIFYNIELEKII
>fig|195.2030.peg.1733 Flagellin
VEASIDANGQLLLTSREGRGIKIDGNIGGGAFINANMKENYGRLSLVKNDGKDILVSGTG
LTAAGFGANSFISQASISLRESKGQLDANIADAMGFGSVNKGVAIGGFSTVTAYMSSEGS
GFSAGSG
>fig|195.2030.peg.851 Arsenical-resistance protein ACR3
MLGFIDRFLTLWIFLAIFLGLILGIIFPNIALFWNLFEYKSVNVVLTLCLILMMYPPLAK
VDYAKLSKVFDSKKVILLSMILNWFIGPLLMFILAFIFLKDEPLYMQGVIIIGLARCIAM
VVIWSDLAKGDREYTSALVAMNSIFQILFFFHFGLYLSRFFTKITRSKHFSYKFRYRFFS
SK
>fig|195.2030.peg.717 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MQKKILVSGFVLDNFLEISSFLEKNQIKRAKIEKKILHMLNTIVPSGELIHLAQGYKIQK
MYHCLLQDFDKEAKEKECFISDRNLIYIAEDWIQLDQNILFILFYESPVEVLKQKACLND
KFYINDILNSWLKYNTFLLDFYKKNRERSILINYKDFDVALCKYLNEKYYFNMVKIYKEN
SSIKSKNLFDFLLEYMLNSNEKCLNCYKGLEGYSLNPNFNSNDLPFKNLESEIINLFQIL
KISEILSIKNKSLLDFIFEMQEYIEKLYYQHGNCLKEITFKKSQTIETKNKTIQNKDDLL
NFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRKI
EKDPSLKLPSLEQYPDYREAIKLKNHLSYKLGQSAIKFCKNPLKLWSLPYEIFKIIKNK
>fig|195.2031.peg.1834 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSKSILGYLIMPMALLSIIISHKQE
QKIYQEKIKKDPSLKLPPL
>fig|195.2031.peg.1096 Auxin efflux carrier family protein
MKASIIVAIIESATPTMTLAGAMVMKAKLDSNLAVSTVAFGVLFAFISIPILVWALA
>fig|195.2031.peg.900 Channel-forming transporter/cytolysins activator of TpsB family
MGSKKDSKDSLYKIEFNKVNFNLSYQKSFYANDGLAFLYQNSLGASYSNEPLLYADKFLI
GDEYTVRGFKESSAALDYGAYSNNTIYLQFLNAPKYLRALEPFVGLDMGYGRDYLLPNKD
FLAGVAFGFRYNLNHLSLNLIASKALHKSSNMPSETIPIYLRASVFF
>fig|195.2031.peg.1794 hypothetical protein
MQRGKRGKRGVLRVNENSFFLLGFCEATARNFSCVREAKKIKRKKRYRTNKSLNLAFS
>fig|195.2031.peg.1546 hypothetical protein
MLFPVIVKKLKTMEVSILIIRQERPEDYDTVYHVVKEAFENAEYTDGNEQNLVAALRKSK
SFIPELSLVAVEDEKIVGHILFTKAVVQGVEVLALAPLSVLPDYQNRGIGLSLMKEGHSI
AHKLGYEYSVVLGHSKYYPKAGYIPASECGIKAPFEVDDESFMALNLNGSQNKLNGVIEY
DKAFGI
>fig|195.2031.peg.640 hypothetical protein
MFKAIFQFLSGIINDLNRDKIWDSKDGISKTKINGKYGFINDNGESIVKPYFDMVYDFND
DLALVELNGKYGFINKKGEVAIDLKFDFAYSFHRGYAIVKIKKKWGVINESGNMILQPIF
DDITGPDKHGEAFFATLKGKFGIVDKNSNFTQL
>fig|195.2031.peg.444 Filamentous haemagglutinin domain protein
MDILKNKNKPFLDDLITKEYSFEDKYTDIQGTFAIAGSSIDANAIENLADKPILSLPENE
NSGDSQTTNNTDSTDIVNTFSKQVKLTSTESILILPAEETQSHIKEDERERGRVCITSDN
AKTNNPCIAITF
>fig|195.2031.peg.1508 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MKTELGIFSTRYSCRNFKNEKLKKEDLDTILEIARLSPSSLGLEPWRFLVVQDDNKKEEL
AQICNQQQHVKDCGALIIIVSRLDFLDYFEDKLRKRDMSEAEIQKRLDTYMPFLQSLSQE
QKISYAREQAHIALASILYSANALNIASCTIGGFDKEK
>fig|195.2031.peg.1832 Motility accessory factor
IQLLILFDMKDMFEYLSLYEMFVNNVYYKKFYEDIWHKADELCEKNIEVIVRNLNSSLHI
AFECYSHLLQNIPSMLESIPFQRILNERKNKFE
>fig|195.2031.peg.949 FIG00469658: hypothetical protein
MIRPKPFLKKCPKCGKMFLCTPKSDCLNPSDFFCDKCSGKKDTSLISKIISVIKKV
>fig|195.2031.peg.899 Channel-forming transporter/cytolysins activator of TpsB family
MIKELTNFIVVKGYSTSSVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPL
KKGDKFNIYDLDTGIENLNNGARDVKIAVKASENYGYSDIFINLKSKPPDLILDFDNSGY
KAKGEYKASAYLSLSSILNLNDSIRFGFIKGLLKDMSQERENVYVANYTLPIQSYQLSYS
MQYSDNINMIEGYDNSFIKNTDTSLRHKIMLKKILHRTSKDKFSIYANLGIKDDVNEIDN
FRLESSSGRYSSIASGVEYSTLAFGGFLFLN
>fig|195.2031.peg.1244 hypothetical protein
MAGFQSPITINEAMQRIKNNEYLLPAFQREYVWKPEDIEKLFDSLMRGYPISSFLFWKVK
DESKTAWKFYRFLEYYREKYHMHNDYFNTSNHKDFYAILDGQQRLTSLYLALFGNYDIRK
PYERGNNDRYFEICHFYFNLTQSKQPENEDVEYEFLWLDKLETEEQNIYIDKHQQKWFKC
QYLYQYDSGRVRKIAKEFNLNENEEDRLDLLHQKIFDKTLINFYLEEEQNPDKAVNIFIR
INANGKPLDYSDILFSTAIANWNKVDARTEINNLVDKINENFKISKDLILKGFLYLFHNN
IKFQINSFDIYFIKSVEAKWEGIKNAFIETFRLLRSFGFEAKTFSLNNAILPILYFIYHK
DLTNNIVDSVKCNENRAIIKKWLLRVIILKPLDRRTDAVLSNMRKAFIKDFKQNQNSGFF
DREIELFPLEEIEKEAKYIQTIDEEYLENNIGEWRKNSSATFAVLSLLYPNLDYKNNNFH
KDHLHPESAYKEYKKLYKATDNCISFDIYDSLPNLQMLDANENKSKNNKPLEQWVNEKCN
GNRKEFLEKHLIPDVDLSLKNFNNFIEERKKIIIDKLKSILNKE
>fig|195.2031.peg.642 hypothetical protein
MIFFKKHKKTSDDDDFFIALSDIMTALMLLFLLISIVYMIKVEDSVKVPKIFKETTQGLS
ERLNKEFDKDLKGWGAVLDKDLTIRFYQPDILFKTGSWVLSPKFKEILNEFFPRYLKIMM
DEQFVNNIEEIRIEGHTSSFWGNIKGDVAYLNNMELSQARTREVIKYLLSLELDEKEKEW
LKKHFRAIGFSSAKPLNDKSQTLQKGEKENFINSQRVEFRVRTNIENKIAEVVSK
>fig|195.2031.peg.1550 Streptothricin acetyltransferase => sat-4
MITEMKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEE
ADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINI
SIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF
>fig|195.2031.peg.1837 Putative periplasmic protein
SLQKLKDNAEELFYLDKQRVLKAKEAQIYKNLFT
>fig|195.2031.peg.641 hypothetical protein
MNIESILKPIIDLRIKIGATLEHIDLSYIKNSISAEEIKLLETQGIDVEINDIKVVSDGT
FAYKNRRVLIYIRDVSPLYKENDINSTLPRYHLCHCNAYQTMLSNNRKHRYVVSSRDDGV
FWLNFFGFQGDTMVKTKSQERKLNVCMYCLRKLNWCNINQYSDKDRSIIRNNFDLKDFFK
KYPKNIIDPKNHFNDKIAPLNIYSNDWREISYNTRKKAQWKCQKCHKDFSQNKTQLDVHH
INGQKNDNNSNNLMVLCKECHSKEPMHEHYYK
>fig|195.2031.peg.1798 UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183)
MKKIVFVSGTRADFSKIKSLMMKVENSNEFELFIFVTGMHMSKKFGSTYMEIEKCGFKNI
YKYINHDKYYQMDKALSSTIDGFSKFIHEIEPDLIVVHGDRVEPLAAAIVGSLNNILVAH
IEGGELSGTIDESLRHAISKLAHIHLVNDEIAKKRLIQMGEDEKSIFIIGSPDLELLNNT
ISLDEAKKYYDIKFKNYAIAIFHPITTEINSLYKQSEEFVNALIKSEKNYIVIYPNNDLG
FELILQNYERLKNNERFKIFPSLRFEYFISLLKNANFIIGNSSCIIKEALYLNVNGILVG
SRQDGRTDINKTIRVNAEEKDILEAILNTSKCTNIINKRLEILNSSEQFYRLLKNNILFT
INKQKIFMDKK
>fig|195.2031.peg.1788 Motility accessory factor
LQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSLAKQLSLLKAYQDKAVIFCADGALS
MLEKEGIIPDYVTNLDCRDLAMKFFQNKENKTSLNVLSCATHPSLVHFLDNKSVVLRDDP
LYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFVLGEK
IDHTLNIPTLKTQAYGGKGEVLTHIAWNDYRIKLEYLFACNDQKAKFYNATEGGARINFT
EELSFKECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQDNAKRFLDDALALK
QILENILSKDFLLPLEFLEKVYQNIENFNHSLDTDEFIQDEVLRGAFAYRGKLISDVLKL
HIKDETHFITAYIKAYHEWLLYFMEKLEQKYKSLSKV
>fig|195.2031.peg.1753 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing) (EC 3.2.1.184)
MSKRKICIVSATRAEWYLLRNLCHEIQNDKDLSLQIIAIGAHLSHEFGLTYKEIEKEFKI
TKKVEMLLSSDSEIGICKSMGLTQISFAETLNELKPDIIVVLGDRYEIFSCVASAMICKI
PVAHLHGGEATWGLIDEAIRHSITKMSHLHFVATKEYQKRVIQLGESPLRVFNVGGFGLD
NIANLKLLSKDELQKALNFTFEKRNFLITFHPVTLEYQSSQKQFQDLLKVLDLEYKKENL
GLIFTKSNADTNGRIINEMIDDFCSCHKNCIAFVSMGALNYLSSMQFINAVVGNSSSALC
EAPSFKIASINIGDRQKGRIKAKSVIDCEANFKSIEEAFKKLNDKNFIKELKNTENPYGK
AGAAKKTKEILKKINLENILKKEFFDIDFSTEFEK
>fig|195.2031.peg.951 hypothetical protein
MFSKILSALSLANSFKAMIFKRLSSPVQSAYLGSLVWDIINILNGDQQDSEKICQILDLL
SDFKNKHPEDFDKIVDILKEILDEYEKNPSEVKKNLKELF
>fig|195.2031.peg.1196 FKBP-type peptidyl-prolyl cis-trans isomerase SlyD (EC 5.2.1.8)
MAIEKNSVVSMFYELKDANTNEVLESNLYAQPISFILGKGQILEALEEEVMKLDCPSNAD
VVIKKDKGLGEYDENAVQVLPKEQFAGIDLKIGMELFGEGENGETVRVTVKEISDNDVTI
DYNHPYAGRDLLFSLNIVDARAASEDELLTGIIAGSHSCGCGSGHGHGHDHHGHGGGGCC
GGGGGGGGCGCH
>fig|195.2031.peg.1761 Putative amino acid activating enzyme (EC 6.3.2.-)
MTTHIYNFLEKSLIKFSEKTAFVEPFAKERKEITYKDFDLFSKKLASEILKTLKNDNPTQ
VPVLIILPKGIDCLISFFGVALSGNFYTLLDEKSPKERVEKVIEVLKPKLFITSKDLNFN
LDLPTLYTQDFESFNIDESLIKHAKEKHIDTNLLYVFFTSGSTGIPKGVSIAHRSVIDYA
FHFCEAFEVDENEIIANQAPLYVDASLPDILATIKPSATLHLIPNHLFAFPNKILDYLEQ
EKITMIFWKPTVLIYFIKDQDNLKNYPLKNLNKILIGGEIMPIKQLNIWRKHLPNALFAN
CYGPTEITDVCCYYILDREFSENEILPIGKAYKNTELLVFDENMNFISPKQIGVKGELFV
RGTSLSLGYYNDKEKSKQAFIQNPLHDNYLDLLYKTGDIVSYNEFGELLCYGRNDNRIKF
MGHRIELGEIESVINSHSKIILCACIFKEKIICFYESDEELDFKAFLKDKLPSYMIPKNF
IKIEKFKLNQNSKIDRKALHELI
>fig|195.2031.peg.1789 hypothetical protein
MICDNGVRGREVSLELTNGQATALMYHQNFFCFFFSRAYAYANFFIFYIFFYIFRGLSKP
YKMGILEPIKSRN
>fig|195.2031.peg.1398 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MLDRRRFLKIGAALSTLPLIPTLGAGKSAEATKVSLGLVKNGEVITAAHWGILKLTIKDG
KIIKSEPWEKITKMDNPLQHYTADMVYKSRVKYPYVRKSYLENPDNPKPELRGKDEFVRV
SYDEAIKLIAKELKKTREAKGTSAIFGGSYGWKSSGNMQNARILLHRFLNVTGGFVGATG
DYSTGASQIIMPYVVGSIEVYEQQTSWENILEHSKYVVIWGADPISTLRIAWTASEQRGL
AYFEKLKEKKIKVICIDPVKTDTAQFLNAKWVAPRPNTDVALMMGMASHLIAQNKVNYEF
LENYTTGFDKFKDYLDGKEDGIKKDVKWASKICGIDEKMIKNLAEIFYDNPTMIMSGWGM
QRAHYGEQPHWMLVTLASMIGQIGTKRGGFGLSYHYSNGGVPTCKGGVIGGINAGSLGIW
KNGKFQGLAKSNQASGGAEWLQNAASYSFPVARIADALLNPGKTIDHNGSKITYPDIDFI
YWVGGNPLVHHQDTNTNVKAWRKPRTVVVNEIYWTPTAKMADIVMPATSSYERDDITMSG
DYSNMHIVPMKQAVEPVGESKDDYIIFADICKVYGQNVYNAYIEKGKKAKDFIKEYYDSA
LKQTQSFGEAFATPMPNFEEFWAKNEPITFEATAESLEWTRFSEFIEDPILNALGTESGL
IEIYSETIKNYNYDDCKAHPTWFEPIEWLGNATKEAPFHLLTNHPKDRLHSQLCHTSLRD
TYAIKDREPILINTKDAKKLGVKNGDVVRVFNKRGEVLAGVIISDDIMQGVVRLCEGAWY
DPDENGLCKCGNANVLTIDIPSSKLANGNIAHTGLVNIEKFTGTLPALNAFSAPKGAI
>fig|195.2031.peg.1839 Motility accessory factor
YERFHEDILGLNKKLAENFKNSIVSYGNDSTDTLQGIEQFVYNLPQMITHPSYKELLSKR
KGISDTAIIVSTGPSL
>fig|195.2031.peg.763 Beta-1,3-glucosyltransferase
MILNSKKLRKLRTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYTIISAVYNVEKY
LDDYFKSIINQRLDFKKSIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQASA
RNLGLKYIQENNYKTPWVTFTDPDDFLDRNYFYEVDKFLATHQDDDICMIGCNIIFYYEK
QKIHKDNHPLNFKFKSGVQVKENYNLDSFIQLSAASCFMNIGYLDKLLFDEKLKPNFEDA
KFINEYLLDNINLKSAFLPTVKYFYRKREDGSSTLDLKLKSKNYYLNVTRNGYLKILSDC
VKNKRDIPLFVQNLVLYDLCWQIKPLINSPEKLSILNESEQQEYLNLLDKIFSFIEIETV
VNFSLAGCWFFYKVGILNCFKNEKPAFQIAYIEDYDPYKEQILLTYYTGDDKDIESILID
REEVYVDYKKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEVLINNEQGMVGKYGEYFLDV
KNIRKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEREIVFALRKESLDWERL
EKEGFNLVEFGSFEFERIIKKASKVISSHADEYLMRYITSRQQFIFLQHGVTQNDISKWL
NNRKINLFFVSAQMEFDSIVKNYTRYKFGQKEVVLTGFARHDALLKNNKTNTKQILIMPT
WRHYLSGLMIGNSGIRELKDDFKESEYFQKWNLLLDSNTLQKLCEKYSYTIVFNPHPNII
PYLKDFNIPSYVKIANQSESLQKLFCNSSLMITDYSSVAFEMAYLNKPVLYYQFDQEDFF
SSHTLQKGYFDYRKNGFGPVVEKEENLLKELENLLQDNCRVFGVYKDNIDSTFVFRDGRC
CERIYKNILISTKNRNTVEIILELQEKRHFKEAYIEWKNFINKMQFDNSNYLYNFLYCAR
KSGYSDDALNHILLPDFRVLNPKIRIEIIKNLILNQNYEVIFNELLKFNLSDNDKECLFL
AKLRLYLYEKNKIKFDLLSTYLKQYNIIDDFKLKEEILLSQAFLVNIKHLKLKHLGVDLR
KYKRYLCVK
>fig|195.2031.peg.1756 Formyl transferase domain protein
MLVSMSFDQIFKEELLKLYPRKISIVMQVNYLFTGVEIY
>fig|195.2031.peg.1559 hypothetical protein
MDIISRKYINEGFNSKAYIINDDYILLDGVNQNSYKNYQKYVNVINQISNVKSLEIPRII
ELIEPCEEYPNGALIYKMIKGHTFRKEHIEIANLDNIAKKLAEFMNELYEIRVDFDKDKY
IKNELEITEQSVIELKEYLSESNYEKILSWFNEYKNYLLTFNDYHFIHGDLWYENYILND
NNELVGIVDFEGSGMGDPAYDIAALYYLGTDFINKVLSYYKYTDEDLIKRVSMLIKAREI
ADFDDMVKNYPEEVEEQVDKIKKVL
>fig|195.2031.peg.1057 hypothetical protein
MKELFLLLFSLVFFMLFCMGAFYAFLNLNFFIKSIFIGFFIAFMFLGFSQILENIFEFYK
GLK
>fig|195.2031.peg.443 FIG00638667: hypothetical protein
MQVKFFLKNRIFLSFASVALIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTF
KQINDTNYYGVFKQGLVSDITLEVFNPKQSL
>fig|195.2031.peg.447 Lincosamide nucleotidyltransferase => Lnu(C)
MVNITDVKQILQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMK
ANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETFSGKGRIEE
IEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETFHIEIPNEYR
>fig|195.2031.peg.748 Putative periplasmic protein
MKKILTSALALGAMTLIIGCGDGDLVELKNNGNDQAMFDLGNQEIMKKYPNYKLYDYTSV
RAISDFKDPEGKIKEMKRDLEIDKTPYSNYVFLLNPNDKKDYKVVSVYCDKDFKKRIYCS
VNDAFRFYAR
>fig|195.2031.peg.1706 Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63)
FIPCHRVIASNGLGGYNGGLAIKRFLLECEGVDLSQFKNKLGD
>fig|195.2031.peg.1793 hypothetical protein
MNFAYLRISTDGKKQKNSFEMQLKAIETKFTIDEIVKETISGSAEFSKRTALIKMLERLK
NGDNVIIFRLDRLSRDLLKSGWIKYEILRRGANLISLDNKCDDINENLKFQILSVFANYE
KELIRFRIKNTLNLKKERGEALGGKHPPFGYEFKFENGVKKLKELHHEQLLIKRIYKLRK
KPVKDIVKIVNLESDRKLSYKLVQSILKRY
>fig|195.2031.peg.1809 FIG00470567: hypothetical protein
MLENLIAQIIEGIVGCKARKMGFFCIIAVMALAFVLWLVFSHLYGYL
>fig|195.2031.peg.1221 McrBC restriction endonuclease system, McrB subunit, putative
MWNLDEKKLQEMLDGFLNFQEVWTLEKVKNMTLEEYTNIKKDNPNRDDFTFWIESKLDNL
GSIWGGSAFKFGIYRRNDESQKESSSGRLYSQNYAWIAKYGNNENEAFNNIKEKIIQIIQ
ASQDNNLKTIEKIDFGDAIKWKIAFHYQDVKNIKIVNIFSKNVLDLISLNEFKEKLKIYQ
IHKKLLENKNLSLVKMIENIAIPLWNKYGMDSQNYIDKMKNLFSEYLNKKKLDKNTINKY
IQVIENISKEFLKENLYSCDLFSFDQNINKLNKNEEFKLKNSNGHNMYSSALNYYRAFLI
DYYEQDIFITERVQSEESNMKIIPLNQILYGSPGTGKTYHTIDKALEIISKEEKIQIPSE
DDRINRKKIFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPIIDNDENSQEVKYDVKDGIFK
ELCDKSLKNYILSMQNENEIDLDKLIFEFANYINQDFLNKGNEFPLENKVSIKKILLNFK
DEYRSFSLGGSIKSPQSLTIDIIKRDYLNFKNKKILSFKDIKPKYDSQSDYHGNAIYYFM
FYNKLKEFENIQNEKFKIKKEILKSYIIIIDEINRGNVSKIFGELITLIEPSKRIGEKEE
LKVTLPYSGKEFGVPKNVYIIGTMNTADRSITSLDTALRRRFEFIEMMPDVSKLSMDCEG
INLQELLKAINTRIEYLLDREKTIGHAFFISVENLEDLKKVFKNKIIPLLQEYFYNDYAL
IYAVLNKNGMLEISVENKDYLKNMTEFIESDKIVYKFSDSNNWSKDTFIKIYE
>fig|195.2031.peg.448 Transposase
MIATNSIVSGTRKDLSVWEQYIDCMMNGLSIRKTAVACGIHRNTAFLWRHKILDALQNMA
DDVTLDGIIEADETFFAISYKGNHSKSKTFAMPRKAHKRGHSTHIRGLSQEKVCVPCAVN
RNGLSISKITNTGRVSTRDLHHIYDGRIKTNSTLVTDKMNSYVRFTNANGIDLVQLKTGK
AKKGIYNIQHINSYHSQLKRFMRGFNGVSTKYLNNYLVWNNLVNYAKESDMEKRNIFLTF
VLATLKTAKCRDLSNRPAVPLVA
>fig|195.2031.peg.1549 Aminoglycoside 3'-phosphotransferase (EC 2.7.1.95) => APH(3')-III/APH(3')-IV/APH(3')-VI/APH(3')-VII
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>fig|195.2031.peg.495 Cytolethal distending toxin subunit C
MKKFFILFFALLSFLKAEPSLDELADFTPMFAIRSLETGISLSPFRKTSKRLEDQNWFLK
EIVANDELKARDMHAKDLPFGYVQFISPRGDDICLAVLSEKSFGTKSCKQDLQDGTMQTI
FLSYQ
>fig|195.2031.peg.1547 hypothetical protein
MNQGRIIVITGSPGTGKTTTASAVAKESDLEKSVHMHTDDFYHYLSKGAIPPHLPESNEQ
NLIVIEAFLEAAKRYARGGYDVIVDGIIGPWFLKPWLNIVQEHYEVHYIVLRASKEETMK
RAIERSKLDRETNIELVETMWKQFSNLGIYELNVIDTTTHSIKDTVSAVQEKIASKRTTL
VEESELTHVAAPDNPTKEFENRQERFALYRAMQQLDAETREVIHLRLAGDFSFRDIGDIL
GHSEVWARVRFYRGKEKLVKIIGGDNNA
>fig|195.2031.peg.645 4-carboxymuconolactone decarboxylase (EC 4.1.1.44)
MSKPFCLAISKSLSISFFVNDFLSANCFGDYYTRNGLDLKTRELLTLVYLISLGGVDNQV
KAHISGNLNMGQSREDLLNIIAALIPYIGYPRALNAIAVLDGLTLKA
>fig|195.2031.peg.644 Alcohol dehydrogenase (EC 1.1.1.1)
MGDNDILLKFLYAGICYSDIHTRRNEWGEAVYPCASILCAGMTI
>fig|195.2031.peg.555 Membrane protein
MGSLHCEFLCISGRFLCFFSWIYIVLAFIFMVARIYFLFSSKKILIYFLLAIISLGSSFF
LLENKILFLGLLALFFVFYFLFSLTLASLFKEVKMSFYFVFLCMLLAFLFFEKLSFLFFF
LALHFLTFAYAFDRYETLKKLY
>fig|195.2031.peg.1582 hypothetical protein
MENERKKGEAKKKMSLGDDFWDQLKVIEKNSPKSFL
>fig|195.2031.peg.1558 hypothetical protein
MNQGRIIVITGAPGTGKTTTASAVAKESDLEKSVHMHTDDFYHYLSKGAIPPHLPESNEQ
NLIVIEAFLEAAKRYARGGYDVIVDGIVGPWFLEPWLNIVQEHYEVHYIVLRASKEETMK
RAIERSKLDRETNIELVETMWNQFSNLGIYELNVIDTTAHSIKDTVSAVKEKIVSGTALL
F
>fig|195.2031.peg.1791 hypothetical protein
MKLKILILVLWLMPLFGDYNASKITKEDLENLAKMDASIYEKSTARQRLSVEQIVNLIWV
NRAIKIEPLLERFNLSVSGFAGEKSKISYYESSDKYEKLRPYAYIGLQAEFKIIDAKEAR
MKKDEIRKQRELIAKFVRDFFAKKIEISHLKNEISILQEKENRLKIRVNEAVANFDERLK
NLETLHTKTAKLDLAELELSELKFNLLDFVKDDFKPNLERLLK
>fig|195.2031.peg.950 hypothetical protein
MQNLLILYNPYYQQDVIKLHLEILLDKGQVAFGKIKSKLKEPLSYERDENKISHNQKLSE
IYKNTSADNPLQLFLSDYANLFVAKVVKISKEVDKNIIPKYYQEKNLEVEDYFLITDLRE
LVRENFTLIRDKFLANFTTENNHTYAIYGNNYSYPLVVKQKEEINYFYDEINKYYLSVYK
NQEYLKMQENFIQFIFGKKFFYMLHPDSINNLILAELELQQNLENPLYDFTSIIVKYSKT
IEYEIYDFAKKIFTKLIKQNSHLSSISYSIQGKEFNFKQFFINKPNLGTIKFLLKNREIQ
ELLDRDVKGFINYEFNKTLDEFQTIRNHAVHAKSPTLEQTLKIRNLILGIENTSILKRVL
EYKFKQKG
>fig|195.2031.peg.1538 Putative periplasmic ATP/GTP-binding protein
MKKYVLSLALVGASLLGASELKYQEFDGFKSPESIFVDKNSVYVSNVGEKLEPLAKDNDG
FISKLDKNGKVLEHKFISNLNAPKGMMEVVNTLYVVDINVVRGFDLKSKKRSV
>fig|195.2031.peg.1732 hypothetical protein
MFCFLLYYRALLNKNNTQKIVAKIINAIRCQERLPEKIHYKEKIICMDNHHRDLSQILSS
CVVEFYNSIDLYNTFRKNIGFENRKKIAIEMLNRASEHYGFFELNRGGITYKEAKISCAP
IPVLNEFHHAMSHLCEVFLKDDARYTNLERAIPHFKRGMMDIYKTIIRDFLILNQDALGV
KQEALKIRELEYQTIGKPKKVTKNPTSNLISKKEEKVIPGYKELCERIVRQSKNTN
>fig|195.2031.peg.1557 hypothetical protein
MSLREMHEQQKQSSPREQLQELNRQSRTELENSLLKEALAMSSENCEELMKQSNQEQVRA
EQNRQRDAEQNRKLISELKQSVELLKNSNELLQDAISGEIGSLKDEVKENTVQEVRKALQ
ANIEAIQRATKLLEKQSDTLTSVMKQKIRELEESKNSFFRYEGLKLYLFWGGMVCNILVF
LMLLYGMISK
>fig|195.2031.peg.1751 FIG00469908: hypothetical protein
MYKKVLVIAVHPDDETLGAGGTLLKHKAKGDEIHCIFCTDIFEDEGFSKEQIDTREQELQ
EISKSYAFTSIHRLGLKTTKIDQYSQAHLVSLFSQIFEKIKPNILYLPFAYDVHSDHRIV
FQTAFSCTKSFRYPSIEKILMMETLSESEFAPALTHQSFIPNVFVDISDFFEKKCQIMKI
YKSELGKAPFPRSIENIKALATFRGCTMGGGF
>fig|195.2031.peg.1554 Aminoglycoside 3'-phosphotransferase (EC 2.7.1.95) => APH(3')-III/APH(3')-IV/APH(3')-VI/APH(3')-VII
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAGKKRDVK
>fig|195.2031.peg.952 hypothetical protein
MAYKVDNDLEFLRELNDESLDNLVSILIKDENGKTRTTESLTDKDLYKKHYPNHGQYLDL
ILEELQTFGGNTFANKIRGTGVVYKEILCDVADNLKVKYDKSASIENIEKAILLNSFNKS
LENLSESDLKEIAKDFSIDVNTYTIESISNAIAKTNNLKLLYQIAMLVVNAIASKVAINT
AIFTTSSLIAGSGLVGSAAISGVLGSTATFLGSRAVGTLAGPIGMIISSAWMINDIAGPA
FRVTVPAVIYVAFLRRQFLYEKEMIKQMEAEQKEKVSNLNKGKKYSATELFNQELNILIV
GGTGAGKSSTIKALFETEGYNLDIEINSGGKPVTQEIKEYKLGNLTIYDSPGLGDSGEND
NEHMKKIKNLLLEKDSKGNAKIDLVLVVVAATVGRDLESTYKTIKEAIMPYMEEKERILI
ALNKCDKAGADEDIEFDKENNQLTPELEEILEEQVKAIKERIKTDTGVDVDVIYYAAGST
SKKTKIKKPAYNLNKLLAYIVAKAPLKKRLVFLKHQSRNQDDFKYGDNKENYTEEMVKSF
IETIKEYAKNVSDFIIEVKNFFTSDKGKEVVGVVKDVFEGFVSIFGKRK
>fig|195.2031.peg.1653 GTP-binding protein Obg
MFIDSVKITLASGDGGKGAVSFRREKHVPLGGPDGGDGGNGGDIIFVCDNNTHTLVNFKG
KRELRAQN
>fig|195.2031.peg.1040 Enterochelin uptake permease CeuB
MIVSIGVIPFLGLIIPNLIAIYRGDNLKKNLIYIALCGALFLLICDIISRLVIFPFEMPL
SITTGVLGSLIFIFLLLKRKTYA
>fig|195.2031.peg.1673 predicted ATP-dependent endonuclease, OLD family
MKLVKCKIENFRSYENTEFNFSDLSVIIGKNDVGKSTLFDALDIFFENNKALEDDVNMNS
SENKFSITCFFRLNHRDRLILMLVKAKEHKHL
>fig|195.2031.peg.1551 Aminoglycoside 6-nucleotidyltransferase (EC 2.7.7.-) => ANT(6)-I
MNQGRIIVITGSPGTGKTTTASIVAKESNMDKSVHMHTDDFYHYHVRKPSAREYDDCCNE
FWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERY
ISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRD
MYKKYTGKTGCLDSTYAADIEERREQ
>fig|195.2031.peg.1548 hypothetical protein
MRETNLDCCVVRDLLPSYLEELTETETSAMVREHIEHCAACRQLEEDMRRQVPIEKAPQR
ALRFLKRVKRTRLIAAILSALVALFCIGWLYDLEFHYANTEAGRLEAVCDYIPSPEGNTI
SGVEAGTPVRAVSWQTIDNHLLIFFAADNEENVHGVMHLYSVNPVQILFLLCDFHKKYIL
CVLKLAAVSASHCTLVIKAILTNLFTKTLYISNIELYLANF
>fig|195.2031.peg.1835 FIG00470281: hypothetical protein
VLFTYGVAVYNVNNGQIYQYNSSPMLNNNRIIREIAHQYKSVIEDAMGGWNPRLF
>fig|195.2031.peg.358 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQKQIQKLFEKNPNLKNKLEFIFFKAVDAIKIKNI
>fig|195.2031.peg.1733 hypothetical protein
MLHLIKKQMLFFTELEDQFLKGEVGKSSIKLDFEYYILYSQFLQNR
>fig|195.2031.peg.1330 hypothetical protein
MKIVTWLRKHKNTLSKNVTILESKKHFWDIKFKIKTRIYIPFKQHLITFLG
>fig|195.2031.peg.1833 Motility accessory factor
QDLAYAENGNSHPDDYQNSATYESQMYEHILTTAYGGNGKVETHSIWLLFKNWFENEMIP
NTRKMDITTYNCTEGGARIEGTIEKPFLWAC
>fig|195.2031.peg.1553 Uridine phosphorylase (EC 2.4.2.3)
MAACAKFRKVTWAMLLFSADTLADPHKYQEREWGKTSISIALELALDAVLSVVEE
>fig|195.2031.peg.357 Beta-1,4-galactosyltransferase
MEFSDEFLNNGEEYIEELSKSEYEYVRLCYLTQGKMLKLNDNFLFTLDSIGGTQGYLIKP
ISALKFIDNLKFWIKPVDNVMDMYYYSKVFTITYTPLLLKTTDINSTIEERKKDKRPIFK
RIIKEICRLYFIYLKFTYKQKAIKFLRREV
>fig|195.2031.peg.1829 hypothetical protein
MGSIKSHRKKFPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFAYYEDQFKAYMGEENYK
KLRPYLGMTTYYVCEGKKYPVVFSTMIDYKVKNY
>fig|195.2031.peg.1522 hypothetical protein
MANIKRIYVTKEKLVIKYHIKNDLVFPLGTFLYIIVKFHIHLLQDI
>fig|195.2031.peg.1204 hypothetical protein
MIGINSTFNNSFVNLNIKNNNNSSLNSNTSNANVKNLQDTQDTTKTSNKVLGYEVNKDGF
FTSEFNKAAGIPKDYKIYAKGAENFVNYITNLNFKSFTNIDIAKSLGNAYKVFSQLIDEP
SGNFTTEDLSKIPLGFSYNKKSFQVTNIYYSEKDFESALSFEDDLKIYQNPKQLTLSFPS
WKEKAPADYIKKNSDIFDPSSHINIGASFYKNDNGTISKGGVLMAFFAGMSGQNPLIEGE
TTIEGKLLGYDKNMSQSQVEDLNEFINQNPIEWSITGDVFADSVYITKLRNTITDIDEFK
KQWLEMKAKSDEMGEIYKAEIAKQNREIALAQKNSNKEKDKPFEPMQAESKSETYKDDNK
MNELLKKLLETKFGTSDELEILFGMKFGDDNAGEFNKILSLNSTPKSIDIKA
>fig|195.2031.peg.1806 FIG00973752: TolA-like membrane protein
LRSITSFSLLSTGNANSYSLYPNITNGKIIGFRVRKFKDINSLQKLKDNAEELFYLDKQR
VLKAKEAQSYKNLFI
>fig|195.2031.peg.1560 Mobile element protein
MSANNNELISISHKVELKPNNKAKTHFKKALVVLDLLIIGDSLNGKNTISKALKNLI
>fig|195.2031.peg.1076 hypothetical protein
MSRIAQPFLHFDATKMHSLILFFQKTFAKSYEKQSKDQVSLTKEFEEKIINEILEQYIDY
AIAYELVVEDVCPYKILAWYGYLLADALYIEQKELAILSISTSIICMLKLLEIESVKLED
AFHKKALQMVVSELKGNHMKSEESNKKQHTKIGLGMNGLYMMFRTASICKKINSQTLA
>fig|195.2031.peg.1084 conserved hypothetical protein TIGR01671
MKLQDFDFRVWDKHHKGCGNKDCKCQTKYVYGEEAKTRLSEFKEDCEIELFTGLYDKKGK
KVYENDIVKVKSLYDYFLAKISIHKEGTFYFEGKNGDYIGSLIYLVEDEGYTIETIGNIH
ENPELLKC
>fig|195.2031.peg.1750 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing) (EC 3.2.1.184)
MLNTLKASCSLRKGVKKIMLISATRAEWYLLRNLCHEIQNDKDLSLQIIATGAHLSPEFG
LTYKEIEKEFKITKKIPILLANDDKISLCKSMSLAFSAFSQAFEDLKPDIVVILGDRYEM
LSVASVCLLMHIPLVHLCGGELTLGAIDDSIRHSISKMSHLHFVSHEIYKKRLLQLGEEE
KRVFNIGSLASTIIKNMNFLNKKDLEKALEMKLDKELYLITYHPLTLNVKNTQKEIKTLL
KKLDTLKNASLIFTKANADENGLLINEILQNYCQKNSHKAKLFDNLGSQKYLSLMKIAKA
MIGNSSSGISESPFFKTPCINIGDRQKGRLRTQNIIDCEINDLDQAFEKLESKEFKQNLK
NFKNPYDNDKNPNKFIKTCLKNANLDTILHKNFIDL
>fig|195.2031.peg.1795 hypothetical protein
MSDIVKYHNDFNKIQLPSFTEQEQNLLCGIISKIRENPINQSIKLTPQELIKFSTQNFTN
KALGDMLFILRNKFFKADFMILIEDKERDFIGKEIINLFESFKLWYDKKDTEFKHLLEIE
LKVNPRFEYIVNEVTKNFTGFKLEEFIALNGKYTKTLYRLLKQYRITGKAYFEWEEFKRI
MDIPEDYEIHNIDKWILKPALKELTKERNLFDQIRVPFKNLAYEKEKQKGTRGRGGKVIG
ITFTFKPENIQMQKLEHESQKIMSDEQKYLKILNNMKLNQVRFDYHDRFWQFNDFDFDEF
KIIAIELVRDEYENLNFANHMHFNAKNQEQFFNMVDTFRKRIR
>fig|195.2031.peg.1752 hypothetical protein
MRIFFIGCVQFSHFALKKLLSLQNENLQVVGIATKEKSNFNSDFYDLKQDIKNLPCLHVK
DINDTQSLKFIHSLKPDIIYCFGWSSLIKKELLNSYPIIGFHPSKLPCNRGRHPIIWALF
LNLKESGSSFFVMDKGADTGRILSQKSIKISSKDNAKSLYEKITQKALKQIEDFTLKIYK
KSLKNKDFKSILYTLSYKQTKGNAWRKRDFKDGKIDFRMNSLAIYNLIRALAPPYIGAEV
LYNNKIYKIYEAKIVKNSQNNLECGKILKVNQKGILVKSYDGAILLTKHNFDILPKNGEY
FKG
>fig|195.2031.peg.1775 Motility accessory factor
MTFTPTQKELFNKNIESLSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGV
>fig|195.2031.peg.1545 FIG00519111: hypothetical protein
MMCGVCGSGKTTYAKKKEQEGYIRLSVDEEMWKLYGRKGIDYPEEQYEKLSEQVEAALQK
KLLSLIQQGKDVVIDFSFWSKENRNFYKELIQKAGAETELVYMKASKELLQKRLYKRNQV
LNANSPFVITDEILEHHYHAFQEPCGEGEKVILQKEDIIQYSKEESKAIWNQNAEFWDCS
MGDESNDFHREVVRPKVTELLNPDPTDYILDIACGNGNYSAYLAEKAVSVLAFDYSEKMV
ELAKKRQKRYADHIEFCVADATNETSLMALKRNKPFTKAVSNMAVMDITDIKPLFTSVYK
LLEDNGVFVFATQHPCFVTLTEKYMTPHSYYDIAIEGQPQKQCYYHRSLQDIFNLCFDTG
FVIDGFYEECYFNKEIPDIIIVRAIKIER
>fig|195.2031.peg.1672 Translation elongation factor LepA
MLQIKKIWEKGKLSKIYLVCNYPTNWEKPLIVSKIQELKKLLPEDAKVRLDIKKEIRKFL
FSQEKLNFTEQEIDISTKDTDIVSIYNKLKEKIPKFLLFKADRTNTDKDNEITQITNITS
KELSSLFSYEFKSDNGISFNKRGSGVKRLFLLSFFLEDAERKHQSNMIYAIEEPETSQHP
NYQRIIIESLKKLAQNKGRQILLTTHTPEIARMVNKENIIFIQKDNKDKRIVYHGDEIDI
EILVDALSIIVPNSKALSKGRELVKAMKEIVPRQLFEVAIQASIGNKIIARENVKSMGKN
VTAKCYGGDITRKRKLLEKQKEGKKRMKAIGKVHLPQEAFLSVLKID
>fig|195.2031.peg.1811 hypothetical protein
MTINSLNFSTNTMQYDKEIINFKQKANEKHQAKFMDLSGLPNLGYAKNGETTILGKLWGY
DKNISKKEVEDLKKFIEVDHKIGGFDFGGKGLFMLYESEFNSLFNSTMSINEFKEKYLET
KKRYEIRHGYQTHNIVSINIRA
>fig|195.2031.peg.1830 Motility accessory factor
TAIIVSTGPSLTKQLPLLKKYASKATIFCADSAYPILAKHDIKPDYVCMLERTEITAEFF
NHDFGEFDKDIVFICAGVVHPKAIEYLKGRNLVITQKVLAFP
>fig|195.2031.peg.1313 Major antigenic peptide PEB2
MKKYLFLSLVAASFLNAEVLVYGPGGPAPVMKELALKFEEKTKEKVVVTAGPTSSWFKKA
RKDADLIFSGNTSMMDGFIKRIPSLNLEDLVVLNARPSGIIVRPNNPKNIKSFEDILKDN
VNVMVVDGAGQVGLYEDMALKDGKRENLVKLRKNIKVYAKNSKIAIDEWNNNPNIDALII
WSHWAKVLGDKALFIEDEKAAVYRTAEIIPTKKGLQNKQALEFVKFIQSKEAQKIWKKHA
WNEVE
>fig|195.2031.peg.1256 Crossover junction endodeoxyribonuclease RuvC (EC 3.1.22.4)
MYKFYLKFYKKRLKSAFVFYFSKGMNLKILGIDPGSRNCGYAIIEADKGKNILIEAGLIK
IKPSTLQYQITELCEGLDLIFKNHSFDEVAIEDIFFAYNPKTVLKLAQFRGALSLKILQI
HGDFAEYTPLQVKKAVTGKAKATKEQVAFMVKRLLGLSKDIKPLDITDAIAVALTHAANL
RVRV
>fig|195.2031.peg.502 hypothetical protein
MIDMLMCFIKSAKLTPKNAAKANPESDTIGAIIPPPKLCEIFQIAV
>fig|195.2031.peg.1250 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MDGEIIAQLKDCIDPNGILAPGRGGIWPKNLRDERFVNNKRDALRMKEGKEK
>fig|195.2031.peg.1058 Phage baseplate assembly protein GpV
MNELGIICNIKDNKAKVAIGEMVTDFLSVFQSLANSYAVSFSPLRIGEQVLVIPVRGDLN
SGVILRGLYQEKHRAKNTDENTFNIDFEDGTHLEYNSKSSTLKLDVVKDINITCVDKTTH
NQNNTLNTKNHITNANTITLNAPSINLNGNTQIAGAISTSGEGGASGTFNIKGNLNLIGN
LQVSGNISDSKGDLTNHTHSCTCGATASPR
>fig|195.2031.peg.1552 Aminoglycoside 9-nucleotidyltransferase (EC 2.7.7.-) => ANT(9)-I
MNINEFPQQVNQVISIAETILQGQILGIYLYGSATMNGLRPDSDIDILIITKQELSNSIR
ADLTKQLLKISGSVGCIEKRPLEVTIINQSDIVPLQFPPKCQYMYGEWLRGEMEAGEYPQ
ACNDPDIMILLWQARKNSITLKGAESKELIPAIPFHEIKKAIRFSLPGLISSFKGDERNV
LLTLSRMWFTLVTEEITTKDVAAKWVILKLPERFRPLLTTAKEAYLGNLSDEWETVEKEA
MALVEYMKKQIEELLRTE
>fig|195.2031.peg.1808 hypothetical protein
MGICDKVWHKICLYFTNYKKGEKMKKLFFIIANLFISYRYKNQFDSHLGGLSR
>fig|195.2031.peg.1826 hypothetical protein
LAKLTKGALSDTSPGVKELSLEEMKEVKGGYLVRFKFFKDRPNLISEVYAIAEITLEERK
NLDKGLCGAGEDKCQNPSRDRLFAWLQASANSPADYRPVYKVKRQIKYSNLGQ
>fig|195.2031.peg.494 Cytolethal distending toxin subunit C
MTNGSIQIRSLTNGGNQCMSTFPDSSIAIENRFGLGECLLDRSIVTVLSKLFFFSPAIIE
ASAIY
>fig|195.2031.peg.1799 N-acylneuraminate cytidylyltransferase (EC 2.7.7.43)
MTLAIIPARAGSKGIKNKNLALLHNKPLLYYTINAAKNSKYVDKIVLSSDGNDILEYGKT
QGVDVLKRPKELALDDTTSDKVVLHTLSFYKDYENIVLLQPTSPLRTNVHIDEAFLKFKN
ENSNALISVVECDNKILKAFTDDNGNLKGICNNKYPFMPRQKLPKTYMSNGAIYIVKSNL
FLNNPTFLQEKTSCYIMDEKASLDIDTTEDLKWIANIK
>fig|195.2031.peg.1336 hypothetical protein
MENKEINLTLSYNEMVIVKEVFQNFVRTNQNINFELGRIKEIENYLEILKKIENGLNQEL
KIRTERQED
>fig|195.2031.peg.156 hypothetical protein
MFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKEIDFTRYHGTYDDT
LFKNIFLYLSDKTYWNNNKFSKKYFSNARKIIREPLNKEHLIIQSLYPNPKYILYHSIFD
ERSPFENKENFVHILKELNFKVEFFAVSQVDNKFIKNLNHGMGLSTKLFFKKHLLQILKE
PLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2031.peg.1796 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
EALKLKNHLSYKLGEALIQANKTWYGGGYIKLLFDIRKIKREIKEKYANKNR
>fig|195.2031.peg.1094 Transcriptional regulator
MTANDFKQIREKLGLTQEQLGNKLNLTRQQIINIEKGKTPISKKYFDNISKLSKKFYIDK
EENALNKDRNKQEINFYSIPKLNISASAGGGNELIGLEEYETGEMLELSKAFFKTTPKNV
KAIKVDGYSMIPMLLPDSWVIFEEIHEYQGDGLYILNFDNQLMVKLLQLDPISKVLDIIS
VNKDYKSYSLDLKDSQVEIIIQGKVLRSII
>fig|195.2031.peg.1763 formyl transferase domain protein
MTYSHIYIIGTGKVTKECQKIASDFFKQEVIFAKNIENLDDFCKNLKNCLIISANNSYIF
KKE
>fig|195.2031.peg.1556 hypothetical protein
MQRAELGTGLACAGERKDICWRSPGRNGGMEQRHLPAFETGRAGKGQKLCAGYCPCGAGL
>fig|195.2031.peg.449 hypothetical protein
MPTIKDALDVIGKLTVAEQESLKTMLLSPAFVKSLNIEDFVAKERFANGRVALFVAVSMW
FAMVIVKMAHSDMYVRIVASPS
>fig|195.2032.peg.1354 hypothetical protein
MKNLFSNVLIAREKIERFFMRSSLEKVIKNYNENFSNKRDNDFAQGLIKYLYENAIIGEN
DKFFLEKNFQYIRIINEKEKRLINVYFCEKPIIDFFQNAEYEKELQYYGINEKDFIKTDI
>fig|195.2032.peg.1564 Membrane protein
MERLKEIVHFYTTHLYLVDYMLILFVFFLFTCVLLLCIFLRHKPVAALLIIALNIIICFL
IYTYGYKFIDSEVRSRKTTIVEQKFIQSSEALIIDFNITNT
>fig|195.2032.peg.1308 hypothetical protein
MKKITIVAYAICFLSGLWFLFSSVKDDFGILSFILGIALIYFGVINIKRILNDSNENKTE
LETLFATANIIFVSISSIFLLMLIAFFTFQNEINIKFFSDQGLVLKNDKKISIYLKGKEI
KSFDENKYGFVMAVYGDKHIEVVLQNKENDTFFELRCNEEGCKEILKEDK
>fig|195.2032.peg.1590 Signal transduction histidine kinase CheA
IKAQIESSAKKPKEKPSDYKVLIVDDSKMDRTLMQKALEPLGVSLIEATNGVEALNIIKS
GDHDIDAILIDIEMPRMDGYTLAGEIRKYSKYRNLPLIAVTSRTSKTDRLRGVEVGMTEY
ITKPYSPEYLENVVRKNLKLG
>fig|195.2032.peg.1251 Acetolactate synthase large subunit (EC 2.2.1.6)
WRQTLKRYDELYPLAYEDSDEVLKPQWVIQECAKLAPDARIITDVGQHQMWVAQFYPFNY
PRQLATSGGQGTMGYSLPAALGAKLAVGEEVVINFVGDGSVLMNIQELMTAYENGIKTIN
IILNNSFLGMVRQWQSMFYEEHFSATDLSLQADFIKIAEGFGCEGYNIKTKDEFRTAFKQ
ALESNKTSLLNVFIDRFEDVLPMVPAGGAIYNMILPKLKDKQ
>fig|195.2032.peg.1722 Acetolactate synthase large subunit (EC 2.2.1.6)
MRKISGSAMICEALKEENVKIVFGYPGGAALNIYDEIYLQKYFKHILVRHEQAAVHAADA
YARMSGEVGVAVVTSGPGFTNTITGLATAYSDSIPLVLISGQVANSLIGTDAFQEIDAVG
ISRPCVKHNYLVTCIEEFPRILKEAFYIAKSGRKGPVHIDVPKDVSAALGIWDYPKEISM
KTYKPIYKGNSKQIKKLAENLEEAKRPLFYLGGGCIASNAANEIRELVKITQIPAVETLM
ALGTLRSDDELNLKMAGMHGSYTANMALSECDLLVAIGARFDDRITGKTSEFAKHSKIVH
IDIDPSSISKIINAHFPIVGDIKEVVKELLEELKKNQFKSNIHEWRQTLKRYDELYPLAY
EDSDEVLKP
>fig|195.2032.peg.1703 8-amino-7-oxononanoate synthase (EC 2.3.1.47)
MKLEKILQDLEQNHNLRTLTPLKHENKFVYKQDHKLLNLVGNDYLYLASSKELKAEFLNT
LKEQDLFFSSSSSRSLSGNFEIYEKLESFLKTKFKDKEILHFNSGYHLNISCIAALSSVS
KTLFLTDKFIHASMIDGLRLGRADFFRFHHKDMNHLESLIQKHYENYENIIVLSEALFSM
DGDFSDFKTLCELKRRYDKIKLYIDEAHSVGCFDEEGLGLVKKLALENEVDFLVFTFGKA
LASMGACIICDEKYKKFFINKARAFIYSTALPPINVAWTQFIFKKMPYFKKEREKLELLS
TFFKSKLQEKNHIVLGDAYIICLLLGENKKALEISQKLQKAGFFAPAIKEPTVPKNTARI
RFSLHAGLNTEELERIIELL
>fig|195.2032.peg.1485 Phosphoribosylformylglycinamidine synthase, synthetase subunit (EC 6.3.5.3)
MDKETIKAHKISDEEYEQILEILGREPNLLELGVISAMWSEHCSYKSSKKYLNGFPTKAP
WVIQGPGENAGVIDIGQGMAAVFKVESHNHPSFIEPFAGAATGVGGILRDVFTMGARVVA
GLNSLKFGDIHDGKCGKHQKYLVKGVVSGISHYGNCMGVPTIGGECAFDECFNGNILVNA
FALGICKSEDIFYAKAEGIGNPVIYVGSKTGRDGLGGAVMASDSFNEESKSLRPTVQIGD
PFSEKLLMEACLELFKTDYIVGIQDMGAAGLTSSSFEMAGRSGSGMKLYLDQTPMRESGM
TPYELMLSESQERMLICAKKGYEDKVIEIFKKWNLDAVVMGEVTDTGKMELFWHDELVGL
IPIDPLSEKAPILDRPVSKPKYLNEIKDYNFTLKMSQQELFEKMLKNENINNKAFIYDQF
DSSVQTNTIKADGALGASVIRIKENGASVAMAIECNSRLNYVNPKIGAALAVASAGRKVA
CTGAKPLAISDCLNYGNPQNPEVMWQFAQGCEGIKEACKELNTPVVSGNVSLYNETEGVS
IFPSPTIVNVGVLEDANKTLKANFEKENTIVYLLGESFGEFAASMAMKIQDKKVAGSLKE
LDYKAELALWNLLYKANQNSLLECANSVGIGGIAMTLAKMFAISSMGANLNSGSKF
>fig|195.2032.peg.1223 Putative efflux pump
MREKFKKKQKKNTQEFKENKKLIVIIFITTFIIQFGTFGVMPILSLYVEQIYQGENLALW
AGIVVAASGISNLFFAPKLGKIADKIGPSKVIFSALIFCGICFYLQSLATNVYALIFVRL
LIGIGLGGLLPCVNALLKKGVSAKNLSLVFGFNQTCQFLGNFCGAFGGGLITAHFSVELV
FAFICCIFILNAIIFLIFERNYIFSNQGL
>fig|195.2032.peg.1352 hypothetical protein
MNYNLFDPHIMQTIWNGRIVFIFCPHETSPSNSNLSISFYLLIIPYNSIRNTKILQTIPP
QNRYNFKPSYLKKLFLLSSSSRIFCFITLVSVSDCFSRSFVALCIASIFACNAFLTSWTV
FSLTSSFRLPISPDIAS
>fig|195.2032.peg.1320 IncQ plasmid conjugative transfer protein TraG
MKNTIKLALLGAVITGVFSACSSEPKTVQYYEDPKNATELEAKIKECDKNANSAKTDTEC
ANAYEARYSKSFDYKPQVSTKELMQKAREQNKNMELK
>fig|195.2032.peg.1704 Pimeloyl-[acyl-carrier protein] methyl ester esterase BioG (EC 3.1.1.85)
MKYEFLCKNPDSKKLIVVFGGFASHSSHFSHLKSDKNVILFYDYENFDLNFDFKAFDELF
LIAFSMGVCVANRLLKELNFKQKIAINGTNLGIDKSKGIHPAIFRKTLQNFKLENFKEAL
FKERKNLTKDFIFKDEKALKIELEKLFDFALVKQEENLLWDKVYSSKKDEIFPPNALKNA
FSKLIFLNEPHFAFFHFKTWDEL
>fig|195.2032.peg.1322 hypothetical protein
MENRDFKKTIDLNVMISKFLNLLNSIILNKVNQKLKFLNFYFKKLQTESVADRNRNYDIM
F
>fig|195.2032.peg.1806 membrane protein
KTTIVEQKFIQSSEALIIDFNITNTSKNDFKQCKVIARIFKDKLPEDNLINEYKNQLIPF
RQKSREIFNLKKNTTQFQRISFDNFNYDNNYTIRLNSECF
>fig|195.2032.peg.840 DNA transfer protein
MSFWNSLYLNLKEFRYLFLFGFIVFVFNIFLEYNHFLNLKEKKHYLVENALLLQYYPKHN
KNNKKYWVLKLKTKDFILYTTSFKDLNLSKNQLLNLKIITNNISFKDYLGKSFYAPSYGF
EVLGYLKNNTLISYFLNQHTNEKIQEFYGALFFALPISSELRNDVNHYGVAHLIAISGYH
IGLLFTLVFFILAPLYSFFQKRYFPYRSLRFDLSIFIFILLFAYAYLIGFVPSYVRSLIM
ALWGFYLLCKNIKILSFFTLFISIYLCIVLYPRLLLSIGFFFSCLGVFYIFLYLHHFSKL
FNNFLNIILVNIWTFFCMITPVLYFFPLISYQQFLAIILSGIFIVFYPLVLCLHFIAHGN
LLDPVLIDFFNLKFYALNIKIPTWALISYLILSFIAMRYKILALFCIFANFIPFIMIMI
>fig|195.2032.peg.1338 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB8
MKNEFNTAIDYEASFRYLIEKSNKRAWLIAFISIFIAIISIIAVVLLTPLKTIEPYVIRV
DNTTGMVDILTMLDEKEIKANEALDKYFISTYVKAREGYYYDLLNQDYLLTQLMSSEKVA
NEYRALYEGDNARDQILKNSNEVSVQILSIVLGESNGVKTATVRAIITTKNLTSKGTTQA
TKVITLSYDYILAKASEENRFLNPLGFKVLTYRIDDEVAQ
>fig|195.2032.peg.1535 HtrA protease/chaperone protein / Serine protease (Protease DO) (EC 3.4.21.-)
GSGVIISQDGYIVTNNHVVDDADTISVSLPGSDTEYKAKLIGKDPKTDLAVIKIEANNLW
AITFTNSDDLMEGDVVFALGNPFGVGFSVTSGIISALNKDNIGLNQYENFIQTDASINPG
NSGGALVDSRGFLVGINSAILSRGGGNNGIGFAIPSNMVKDIAKKLIEKGRIDRGFLGVT
ISALQGDTKKAYKNQDGALITDIQKGSSADEAGLKRGDLVTKVNDKVIKSPSDLKNYIGT
LEIGQKISLDFERDGENKRVDFILKGEKENPKAVQNDLIEGMTLRNLDPRFKERLQIPKD
VNGVFVESVKDKSRAKDSGFKEGDIIIGVGQSEIKNLKDLEQALRQVKKKEFTKIWVYRN
GFATLLILK
>fig|195.2032.peg.1314 hypothetical protein
MFKEVCNTLGMSRTELAEKLGLSKTTIDSWSDSSRISKTAKVALELMLENYKLRSTIKNF
QDGFASLNSYNLGENMMNNVFSKDHNDLINRINHIFNELKLSEITCSRAMGESNYAKINQ
ILNFKMYPDFDFLEKFALRFKINHNWLLTGEGSPFASDLIKSNFNSQFIKEAEEFDRIYI
VTSKNNLDHTRIIVINRNNEFGLYQTYFCIGSNFIMEARECSDLCDLYEFYQKFKYKISC
LEFNEDDYRKLLSLKYYPKNILDRGQTSYMLFDLFDLREDDKERYGEFFEKCINIIKSTL
KDRENRRIERNGIN
>fig|195.2032.peg.1827 hypothetical protein
EIETLASNYGGIYIFDKKIREEILELEKKREEFRSKYLGSEIKVGNETHFVNFSYLKKKF
PQILSNGCKYYRNDYNYKIGES
>fig|195.2032.peg.1309 hypothetical protein
MRVVNLSKKIVDKILFLRINRVVNILMLIFALFSTIAIALFLSYFIEEENYYAYFVSSFF
LVNGFLLTIHLIGEKKCAKEVDYDDNFISKLNNSLRKELEDDLLKLQEYYDGINVLEYKT
FALLKCNSYYEKGRINEELIDKIKKYYINLFKKKIAKELEEMQKEKERRNILKTNQELIL
KKIGE
>fig|195.2032.peg.1623 Motility accessory factor
MGGGYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNH
>fig|195.2032.peg.1503 Excinuclease ABC subunit A
TYTGAMDEIRNLFAATKEAKMRGYKAGRFSFNVKGGRCEKCSGDGEIKIEMHFLPDVMVV
CDTCHGKRYNDATLEIKYKGKNISEILNMSVLEASEFFAAVPKIKQKLDTLVKVGLDYLT
LGQNATTLSGGEAQRIKLAKELSRSDTGKTLYILDEPTTGLHFEDVNKLILVLQHLVDLK
NSVFVIEHNLDVIKNADYIIDMGPEGGVKGGKIISTGSVEKVAKDHKKTKSYTGYYLDLE
LKNAKS
>fig|195.2032.peg.1705 Malonyl-[acyl-carrier protein] O-methyltransferase (EC 2.1.1.197)
MNFLKAKDYEKHAKVQDFMGLKLCEILKNLRISHFEKVFEFGCGRGELSKKLQNFITFDE
YLKNDILDFKENSSILIFDMNEIAKQDLSKEKFDLIVSNATLQWLDLKRIIPSLRDMLNQ
NGILLLSTFAEQNLKEIKQSTGFGLNYFSLNELEQIFKVYFNEVKITQELIKLSFDNALD
VFRHLKLSGVNSLGFYPLNKGFLKEFEEKFQNKLTYHPVFILCKNDIK
>fig|195.2032.peg.1486 Phosphoribosylformylglycinamidine synthase, synthetase subunit (EC 6.3.5.3)
MAANFEKENTIVYLLGESFGEFAASMAMKIQDKKVAGSLKELDYKAELALWNLLYKANQN
SLLECANSVGIGGIAMTLAKMFAISSMGANLNSGFSDEKMIFDESASRAIVGLDKENEEA
FLKLAHELGVKATKLGFSTKEQSFKLDSINLSKDELNKLYFDSFKEQIQ
>fig|195.2032.peg.1351 hypothetical protein
MHVPEKGKTFAGEVREETVAWSKDTYQLLKQAEQGKVKSYVQDIALAVLDCKETATSRET
FIRLMNERGYGVDWQDSHKYITYTDLAREQAGEKACKIRDNKLEKYYNMDFGKESMEHEF
ERNARTAEAEQSKRAASRVKPTEPDRAGKQSAQRSVGDVERELRGIDEAVKSRTSEGRAE
QAERRRAEQEAHQRAEAERRAAEEQQRIASRRYIGRDWEPER
>fig|195.2032.peg.1563 Inner membrane protein YihY, formerly thought to be RNase BN
MKRIFAILSNLRDKEILNYAAALSFYTILSLIPILFVCFSVFTQISSFKAYYEKAKQIIF
AFLIPAQQDIVAAYLDTFLNNSVNLGIVGLIAMTFTSLAFFSGYDFVINRITKSEPKGLW
QSISSYWTLLTLVPLGLGLSFYISGLIQQALDDYKIGFNFFEILPFVIIWGLFFISYSSS
IQ
>fig|195.2032.peg.1708 Molybdenum ABC transporter permease protein ModB
MLDPAFLQTLYLTFKLAFITTFILFFIGVFLAYLLSFVRFPFKTILQSFISLPLILPPSV
LGFYLLVTFSANSFLGQVLKEYFNLSLVFSFEGLVFASLIFSLPFMVNPLQSAFSSINPN
LLDASYSLGKSKIYTLFRVILPNSKAGIFSACAMSFAHTVGEFGVVMMIGGHKQGETLVA
SIAIYDELEILNYSLAHQYAFILFIFSFLVLFSLYFINKKMSFQ
>fig|195.2032.peg.554 Na+-driven multidrug efflux pump
IGIVLAAIVRVYNMAYWVMLIGFLMDIVVICGNYYVLHYTKSELFGVGLSNIFARIVAIV
ALLVILFYKLKIHLKIKEMIKLEKEVLKKVLNIGGFSAGENLLWIVQYTIAFAFVASLGE
ASLSVQTIYFQISMLIMLIGQATSIANEIIVGKLVGARYENIAYKHAWRALYFSVIASAL
VALLNYLCQDFTMQILGLKEELKNLMIPLFALSIFLEISRTFNIVMVNSLRASGDAKFPF
FSGLVFMMGVSLPVGYVLCFHFNLGILGVWIGFCADEFLRGMANSYRWKSKKWQGKALV
>fig|195.2032.peg.1707 FIG00469761: hypothetical protein
MNLIKGQICELLNQEDIVIVKILSKEVIFSVLMLELKSLENLKIGVSVELLFKEHELCFS
ASKTLLSVENSFLAKITKIKKGKLLYQVFFDFKGNELSSIITKEKALELEICENQEWLCF
VKANDIVLRSHSA
>fig|195.2032.peg.1343 cag pathogenicity island protein (cag12)
MIKKSLDNLVIMALVFIMVGCSTAPKPKELDDNSALSINNSILEKKYSFVPKDPYLSGFN
WTYHIVVEKKTIDDDFIKNDLITKTFLLAHNSTKIILVGRDDLIKQYKHYFEKNQVLAPI
ELQPVSPIERDFNKVNILFFNKTNLGE
>fig|195.2032.peg.1770 HtrA protease/chaperone protein / Serine protease (Protease DO) (EC 3.4.21.-)
MKKLILSLSLASALFAANINFNETSITSNRVNPAAGDVVLSYHNSIRDAKKSVVNISTSK
TITRANRPSPLDDFFNDPYFKQFFDFDFPQRRGGNDKEVVSSLGSGVIISQDGYIVTNNH
VVDDADTI
>fig|195.2032.peg.1737 Protein containing aminopeptidase domain
MDKLDFRSQDFNQTGKAMYELACELFPIPRSITGQGFRASLEILNKTLGGG
>fig|195.2032.peg.1749 Motility accessory factor
VSTGPSLIKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNNDF
GEFDKDIIFICAGVVHPKAIEYLKGRNLVITQKVLAFPYYINLKDFSYAAVGLSVAHTLS
YLATYLSHKNIIFIGQDLAYAENGNSHPDDYQNSANYESQMYEHILTTAYGGNGKVETHS
IWLLFKNWFENEMIPNTRKMGITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEK
LEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFEKIQSIYLSLNEKEEDINLAIE
KIDKFKNKLEDIKQMQDLYEILQPLRTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLK
FMELVYGHIKAQESALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2032.peg.1646 Excinuclease ABC subunit A
MNDTIKIIGAKENNLKNIHLEIPKNKLIVFTGLSGSGKSTLAFGTLYAEGQRRYIESLSA
YARQFLDKVGKPDVDKIEGLTPAIAIDQKTTSKNPRSTVGTITEIYDYLRLLYARVGIQH
CHQCGQKISSMSASDIVGEILKFPKGAKIIIYAPLVREKKGTYADLLENLRNKGYIRAQI
DGVLVRLDEDIELSKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLEESFGEIEIEVLNP
DEVGLNKHYHFSEHSACFACKISFVPLEPLSFSFNSPKGACEACDGLGIRYTLDMKKIID
ESLSLENGAVKIMYGFNKSYYYKFLIAFCEQNEIPIKLPFAELSEEQKRLVLYGNAKTID
FFWKRNRLKRTFEGVVKMAYEMLKDEKDLAEYMSEKICKDCAGHRLKPESLAVKIASKGL
GEILDMSIEDSTSFFANKKNFSYLSEQERLISEPILKEINERLFFLYDVGLGYLSLGRDA
RTISGGEAQRIRIASQIGSGLSGVMYVLDEPSIGLHERDTAKLIKTLRNLQQKGNTLIVV
EHDKMTIEEADFIVDIGPKAGKFGGEVVFAGTYKELLKSKSETALYMNGKKQISQLQNRE
QKEWLELKNVNINNIKDLSVSFPLQNLVAITGVSGSGKSSLILQTLLPFAQEELNRAKKV
KKLGGVQIEGLEKLDKVIYLDQSPIGRTPRSNPATYTGAMDEIRNLFAATKEAKMRGYK
>fig|195.2032.peg.1738 FIG00638667: hypothetical protein
MKIGLLLCFFVSLVCAQIYKGEIYFYDLKDKQVFAIVYDNAPFVPIFDRDVNQTSSSFLI
LSDLDT
>fig|195.2032.peg.913 DNA recombination and repair protein RecF
MIDNIKIQNYKLIKELEIDKFKNINIFTGENNCGKSSILEAIYLLLSQDYIKNFIYSYDV
FR
>fig|195.2032.peg.1020 N-linked glycan phosphoethanolamine transferase EptC [Campylobacter]
MLRLTWLQFTFFNSLMIVLLNFNLFYFVYEKNTQNWFITFVFIVAYFALVHVICSLLFIK
FFTKFFSILFIISSFLSVYFISFYGVLIDSDMIQNVVQTDIKEVKDLLNLKLILFVVLAL
LLVFYVVKVKIDYYGSFKSHLKIKIINIISGLIVVCAVLIPLSKTFLPFFRNYNEIRMYN
TPFYQIYAVYRYYVRFVKAKPEFKTIANDAYRENNHTKKLLVLVVGETARAANYSLGGYA
KNDTNFYTKKDNVVFFDNFSSCGTATAVSLPCMFSISKRENYSSSEFQENAMDVLYKTGV
DTAWFDNNSGGCKGVCDRLAYKQKLSSDLDENLLAPFKEKLNHLSDQNIIVLHLQGSHGP
TYYKRYPSEFKKFTPTCDTNELSKCDSEALINTYDNTLLYTDYLLSEIIKLLKEKKDYES
SLLYLSDHGESLGENGIYLHGMPYAIAPSYQTHIPVIFWSNDKKLMMTAQNHKGLKLSQD
NLFSTLLGYFDVKTMVYESDYDLLNQTLKAN
>fig|195.2032.peg.1337 Lipoprotein of type IV secretion complex that spans outer membrane and periplasm, VirB7
MQAKLIFILLLGVLFFSACSTKNQGKYDEFFNNQTGWIPVNTQNKDLNKGTMDEK
>fig|195.2032.peg.1355 UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9)
GLGDAVLKGRPLAGDEAFGVILADDLCINEEGVNVMAQMVKIYEKYRCTIIAVMEVPKEQ
VSSYGVIAGNFVEEDLIMVNSMIEKPSPQEAPSNLAIIGRYILTPDIFGILENTKAGKNG
EIQLTDALLTQATNGMVLAYKFKGKRFDCGSVEGFVEATNYFYEKSKC
>fig|195.2032.peg.1432 UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9)
MLQTCIFPAAGYGTRFLPATKALPKEMLPILTKPLIHYGVDEALEAGMDNMGFVTGRGKR
ALEDYFDISYELEHQISGTNKEYLLKDIRSLIHRCTFTFTRQNEMRGLGDAVLKGRPLAG
DEAFGVILADD
>fig|195.2032.peg.405 Na+-driven multidrug efflux pump
MAKKQLSLTRLSFPIFWDLLSKYLTVIINTAMVSHYSNFLVGAMGAGNQILDLFITIFSF
LSVGCSVVIAQAIGAKDHVLARKVIHQSLFLNALLGFVCGVLILWHGEYLLYLLKIPQEL
LKDSEIYLHMLAICLFFDAIGIVLAAIVRVYNMAYWVMLIGFLMP
>fig|195.2032.peg.1588 Phosphoserine phosphatase (EC 3.1.3.3)
MIKLCVFDFDSTLMDGETIDILAKAYDKEKEVVDITHRAMAGGLDFF
>fig|195.2032.peg.1333 Single-stranded DNA-binding protein
MNNVNLIGYLGKDFEVGTTNSGRVYAKNSLAITKRWKNERGNEESSTTWIPIVLFGKSAE
SASTHIKKGSQFACSGELSSNQYQDEDGNTRTMLTVIVSKFYWLGKKDKDDNGTQNPQVP
PKEPNIDYENTNIESEETQVF
>fig|195.2033.peg.186 Aminotransferase
MINFLDLQKINLRFKKEIENKFGEVLQSGWFLLGEQNKIFEENFSAYCGVKGCVGVANGL
DALRLIIKAYGFSNEDEIIVPANTYIASVLAITDNGCKPIFVEPDINTYNINPDLIEEKI
TSKTKAIMVVHLYGLATDMSKIQKIAKKYNLKIIEDCAQAHGAVYDKKRVGNLGDAAAFS
FYPGKNLGALGDGGCVVSNDEKLILKIRALANYGSHKKYENLYTGLNSRLDEIQAGILDI
KLKYLDEDNRKRRKIAKYYLENIKHKDIILPFYEEEENHVWHLFVIRTKNRNDLQEYLMK
NGVQTLIHYPIPPHKQECYKEYNHLNFPITEQIHVEVLSLPISPVMTQDEISETAKIINS
WKNNVPYNF
>fig|195.2033.peg.1981 hypothetical protein
MKDYGISFIPDINQGSKEPSEPIVSDKLNAQKVNELIDKKLKLFKEELVNKEELKSLIEE
ILQDQNFQNTNIKISKTPPNYNTQAKVGEIWAVVESKKQLFICIANDNDFTSWVDLLGDG
SNDIAPKEKIIITFD
>fig|195.2033.peg.1170 Channel-forming transporter/cytolysins activator of TpsB family
MKFLKIIFLLMSFICLLQADDSAKTLNLLDKRQQQLHIQKEFDELEKKQQQEKDVYLENQ
DSEDKIYIFKQIQFKKNDTLTMQANNILKNTLISL
>fig|195.2033.peg.2008 FIG00638667: hypothetical protein
RVRKFKDINSLQKLKDNAEELFYLDKQRVLKAKEAQSYKNLFT
>fig|195.2033.peg.117 Inner membrane protein YihN
MQNAKPIRWFTFIVLVIGGGTVFKLSSLKDAFYVPMQEFMNLSNTQIGLALSVYGIVQTV
GNFASIYIADRFSKKILIPFSLICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVL
LKAIRLLGDLLNKEDFLDF
>fig|195.2033.peg.851 hypothetical protein
MYLNLSFLKTISKGVFFVTNLYPKLGYSLFVKSFSSFISLIQTLFSFCFLVKYKNKGRIL
KPNKTPIKKYTKFSKVADFCISDKKKLKIKKLFNLNYNIKESW
>fig|195.2033.peg.1982 Glycerate kinase (EC 2.7.1.31)
EAIRKLKSPKNKDKWIAIFETINLIKKEKAKRENLIQGEKK
>fig|195.2033.peg.2022 Phage baseplate assembly protein GpJ
LSIKEKIINEEEQELKDLPLANIIIADDEFATLSFSLSYEKAAL
>fig|195.2033.peg.1748 hypothetical protein
MTINQKTAIRINQDFKEKYNQLWRKNCLLRENEKRLEKLKPLEEIFIKVCNTVHNLNWFF
YNDLKKQDAYYSYCLKIACKVYSDGFKSEYQLKKMIKQEIKKDIEIRRMKNITDI
>fig|195.2033.peg.865 Hypothetical protein pVir0042
MTKTQAFIDGFVGKPIKNECFNLWDLNAIIREKQAKLYKENIEFREKQIEKITKTKNT
>fig|195.2033.peg.1730 hypothetical protein
MEESIERRINEIYQETLKQNFDERYDTLKQFDFISKNCSDEYKLRKDIIKKNFFNFMGEV
LGDRVKRGFFIDFLISIFCLSFSAFAIILSAVSREELFLNYCLIAGFFGFIGIWGFDSNL
NALKYYANLYSKEFIRKRIFG
>fig|195.2033.peg.1716 mRNA interferase YafQ
MKYNIAYSPKFKKAYKKLNAKEELETDIIINRLANDETLEEKYKDHALKGNYIGFRECHI
KPDLLLVYRKRDDILELYLANLGNHNNIF
>fig|195.2033.peg.969 lipopolysaccharide core biosynthesis protein LpsA
MEKNFLSKKEQMKYKFIISLEGNDVASNLKWEMNSNSLVLAPKITCETWFMEGTLKPNYH
FALIDNDNLATVIEHFISHPKDALEIINNAHQYVKNS
>fig|195.2033.peg.1897 hypothetical protein
SKNKETYKDNNISSEFLKKLLENSFNKAKELELLFGVKFSDDNTGEFNKILSLNSTPKGI
DIKA
>fig|195.2033.peg.297 Methyl-accepting chemotaxis signal transduction protein
MQSINSGKSVGISAKLTLMVGILVVLIFTITSAVSYFDSRNNTYELLKDNQLKTMQDVGA
FFESYSMSKRHGIQILANELNKRPDMSDEELINLIKAFEKVNGYDLVYVGFDNTGKNYQS
DDQILDLSKGYDTKNRPWYKAAKEAKKLIVTEPYKSHNSGEVGLTYAAPFYDRNGNFRGV
VGGDYDLAKFSTDVLTVGKSYNTFTQVLDLEGTILFNDEVAKILTKTELSINIANAIKAD
PALIDPKNQDTLFTAKDHQGVDYAIMCNSAFNPLFKICTITENKVYTEAVNSILMKQVIV
SIIAIIIALILIRFSISRSLSPLAAIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISK
AINENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANP
>fig|195.2033.peg.2016 hypothetical protein
ANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLVDALRSELT
KEIESFIPELRVEKRIITANYDRKYKKM
>fig|195.2033.peg.1769 hypothetical protein
MKKSFSDYWEEIQKIKKASSVIKDNYKRNKVFNNFVNSYSIKHNINNINQTTYSKQAVVK
LCSNLSKDGAKRAMDYILNSADTPYLINEKGEEILTEDVIKDWKMDFSNQENAKDAWHLI
FSIKENPTEKNLEILKKSVKETMDNNFFGYKYVMAIHTHQNNPHIHIVLNKRNILTKKKI
HFNTKDDIKDFWNDVRSNFSMSLSSKGLHYHNQASYEKDLDRKYQKIKSTLYLDESDTKK
DLSDIILNIIRKESKKLENKKSKIDILNNESLELKKKRLDLINLFNQYKKKNNKKYFKLG
KELKKVSDDLNKIDLQILSEIKEIQKINEKISLLNKELDRYNYQNIVDVKNLRNFVDFMR
KNKLATKSDYDLLEKVKLSILKNDINLDKGLKNTMETNTILTKLFNGKKESIFKIEKKIN
NINDYIEILKQSNAEVKEYENYLKILEKNKEFLKDYAKNRLNNLKLSISKNMNKIPLNAY
IIQEYKKGCEYLNINDDLKLASVNFNKMDYGKFNKSKDNQKTL
>fig|195.2033.peg.822 hypothetical protein
MENFKAFKLISKRIIKTLLNDFPNQSILFSDDFNKDCKEYKIDFSSCIHFLKECKVLKYD
KENNGDFSGVLISPKAYLYFSKNDLNDIDDLIEFCIK
>fig|195.2033.peg.1933 hypothetical protein
MTKMIKGEKADYSRSLFKIKGVSIYYKENNAFVDVLKGVYPDYIVQKILNFHLKKKLNKS
A
>fig|195.2033.peg.187 hypothetical protein
MINVTMQKNVYFFYPSKILGGAELLFIRVANYLAQYSNDIEIGYIGLCDDIALLHLQQKI
RFVVVNDGIRLPDNTVIISHPAASLKIPRIIGNDICYIFWILHIKELESFLFSCKMNQNE
AYSEFCKMVDDKSVICMDNETYNVAKKFVRHDLEYPCIVPVMLDNVRYTVKKQLNEKNTL
NIAWIGRLSEDKIYALINLMERLEKIRLDDLKIKLHIVGEGPYGAKLFKDYKNFSILTYG
SIQPKELSIFLEKNIDLVFAMGTSMLEAEKLGIPSALVFYTEKITSDNCFLWSFKLKEYC
LGMEDKNNYKADIVDLESIIGYFLKNIQLCSIEARKHFEQFLIDKQIYSFVECVNNTEYT
NEALRQFYNRHKKLVLKNTKLKNKIYLRLFNHLKRKLTNKGLLFYD
>fig|195.2033.peg.1985 hypothetical protein
MLKKLASSLILGSLLASSAFAGDFLAKVSNGALSDNSQGVKALNLDEMKQVKGGYVFGDY
KIFKDRRNLTSEVYAIVDFTQYELENLN
>fig|195.2033.peg.1973 hypothetical protein
MLKIFENELLELLKDFKAKMYLGEFEDTQNIATCINNLDASLLLDFEGESYKDLENKVGT
WKLYILTHTKSKAPKHRIDAKHKL
>fig|195.2033.peg.1695 hypothetical protein
MINKFTRERKKVKDLNKKLENIIYKIQNDENINEIDLNRQLENIFKNIDNSLDNMQKILD
KNTND
>fig|195.2033.peg.2032 FIG00471796: hypothetical protein
FENLQKEFSDISINILEEFMFQALANSSILGYGD
>fig|195.2033.peg.2034 Phage tail sheath monomer GpFI
MAANYGVNFNISNGAASPIKVQSDTPIGIAGAIKGVSKEMIYTKAGYESVDSFPIFAFSN
VSKAKEFVNDLIKENNLQ
>fig|195.2033.peg.1 hypothetical protein
ATNPTANNQVANKSYVDTVVNTVGNSKVALSGNQTIAGVKTFNAAPVCSANPTEDAQLAR
KWYVDYGGGIKNLGNQTAPKIDLRQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQN
ITAFSAPFKFRVAQSGFSGTETFAYFCIASNNVRLVRT
>fig|195.2033.peg.817 Phage antirepressor protein
MQNITSNLIFTNEQIAINYGLTTGLTIAKHLRMHNDEFIENTHYFLVENSFKNKTIKWTL
EGVYKLFDKIKKLKERSKMTNIKDIKKIKITCKECKSEFSMFIGHSLYVCPICGNNFGIN
QLNDPFFRIKQAFECFTNPKNCDIELVCEIKE
>fig|195.2033.peg.816 hypothetical protein
MTAQEIKEFCKEQGLTYKQLGELIGMTEPSVKTALSVDKISNQIEASINLLKKIKEQEQE
LKEFRALKEILINLTKSDK
>fig|195.2033.peg.839 hypothetical protein
MEEKQKTNKSEIISIRLDTVTKNKLAYICELEYRPMALQIRKIIEDYINAYESENSLWQK
GDYPN
>fig|195.2033.peg.2048 hypothetical protein
TAASLDAQLRDELIALINKKENIGVAKQLVDALRSELTKEIESFIPELRVEKRIITANYD
RKYKKM
>fig|195.2033.peg.1965 Phage tail formation protein GpI
AMNTLILNHHPKQSKAIDLSAKARFEDLKIESITNLAMRCDERLLPVLANAYDVSIDGLE
EKEARKLISKALLLDRYNGTTWAIKEALSAVFPTAVVKEWFNYGGKPYFFKVKVSTTNVS
FDERTLNTLERLIKDFKNVRSVLEAIEIEIESKNDSFNASAELSGEAIEILPFQTTFLEN
EIKSTKNAFGVFICEISKTNIDFKGVY
>fig|195.2033.peg.98 VgrG protein
MKGENKLLIEKSLTQTIEKEFFLNVHQNLSAHIQDNTSLKSNSMQTKIEEQYSLESDNST
FDFQTDCEVKAGNQILHQVGDTQIVTKKDCVIIKAGGVEVIIDSNDLWLKVESLRQSKG
>fig|195.2033.peg.1722 Hypothetical protein pVir0042
MTKTQAFVDGFVGKPIKNECFNLWDLNAIIREKQAKLYLRIFLLFYDFHFFSKIFISKRG
ILK
>fig|195.2033.peg.834 hypothetical protein
MKSYKITCRNCDTQIIAKVEQSILFCPACHTNFFNSYDEAPFKTLRQSLKSFEDKSSVLK
FEFITDEKE
>fig|195.2033.peg.1968 hypothetical protein
EMKQVKGGYVFGDYKIFKDRRNLTSEVYAIVDFTQYELENLNKGLCGAGEDKCQNPSRDR
LFAWLQVSANSPADYRPVYKVKRQIKYSNLGQPYVLFTYGVAVYNVNNGQIYQYNSSPML
NNNRIIREFAHQYKSVIEDAMGGWNPRLF
>fig|195.2033.peg.819 hypothetical protein
MLELIFNTGRNIGLGVFVNGAFALQFSDVPQSQATYAIAEGILIMFLSGLGEIKSKRS
>fig|195.2033.peg.1135 GTP-binding protein Obg
MGRNKNGKKGGNLELIVPEGTQVIDAQTNEVLLDLTKEGQRELFLKGGKGGLGNTHFKHA
TNQRPDYAQPGIKGESRLVRLELKLIADVGLVGFPNVGKSTLISVVSNAKPEIANYEFTT
LTPKLGLVDVDEYNSFVMADIPGIIEGASGGKGLGLAFLKHIERTSFLLFVLDPMREMPL
KEQFIVLRKELEKFSNELFGREFGIMISKSDSVNLGEDFAEQIAQNIANLEEYLKSIDNP
QSFLIKVSSLEKTGLKELKFMLLEKIKKLREKREKKVIK
>fig|195.2033.peg.827 Phage antirepressor protein
MNDLVYSLNGGLVTDQNKISTISKVDINSIQRLIRNYKQDLECFGELGFELQKIAKTNKK
IYYLNEQQATLLLTYMKNSESVRNAKKVLVFAFYQMKEKLRSLEQEQEKARFKSLSDENL
RLNSLNHHQKIGYKSQLAQQKEHYENKIKALKYDLENKNELSFKRKLSQKELLELRKILA
RDYGMICIKEWEFEFLAEKIALESTRMTTWDAVVKKLKQSLDYWQNYEEYEEKWRKILRR
>fig|195.2033.peg.1761 hypothetical protein
MKTNYTELERKEGQINGIPYTVLKVEYPNLKELKDNDLLMKNDKGQWLCGYVGLEHEQKL
DFDKIGNEVCIAPVYLPKFDTDLFKNNPKVTKIVYFDQNHSWNRSRINTQLDEDLCLKDI
EKIINHIIEHNKIKNKNFTLNDELEKQINDNVSLLQKKGAIYTQIALKKLINTTKNKIKT
AKENNIKINDKTLNNFNQIVKKHNFQLEL
>fig|195.2033.peg.2030 Phage major tail tube protein GpFII
IETKGVLGANYSSGVLKPLEISFKLAVVDPVLYAAFFHTTFSKIKAPLLFRESVHKGGKN
YGISAEFLGEFISISESDHESGKE
>fig|195.2033.peg.1855 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKIIGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTARNVGIEYFSGEYKLKNKTQIIKENSLIEFNIEGNNPYEIYTIYKS
YKAFNDEQDLTSFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDFEMFIDKEH
KDINNPNWNRMRHFSLDGKISREEFEIEMIKKKLRVFAFVCDGLIDFIFFKKNKLKFFNY
GYAEDHYFGLSCFLSLNNIYILRKKFYNYRVRSDSSCDFSQTYIINPNNKILFYIYKNMN
YNAKEAMEYFRTYCYIETTLNIISFFETRSIKSVELFKNIIQFYYHRCRAIEQYNLDPMK
IKKRLNKIFYYYSLFYEYKQLFNDKMGVIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQL
SYKLGQAMIL
>fig|195.2033.peg.1739 hypothetical protein
METINKLIFFEKFFKEKGFKIIKISENKFFIKNF
>fig|195.2033.peg.1756 Coupling protein VirD4, ATPase required for T-DNA transfer
MKFNIDKLEYVNFAKEEEFEEMGIVKGKNKEGICFGETNRKIEIKANNPNSVLLMAEAGT
GSVSTFITPNLLKISNSSIVLDFEREIYDKTSEHRKKHLNNEILLFEPFSDDNTLFFNPF
DNSIIENMNLEELSDFAFKIAKAIFDGNEIGIEKDLFVLFILHNCKNIFLSNLSKISLNF
EQFLDFLEKIKNNNSDVVLIKHISKIQKKIKDEKEYVKNIQAYNSVMKIFDNSKIANFTS
KMNFRFEDFVEKKVTAYLSIPYETKNIELFAPVARVFIETLYIKLRQKSNSDFIYLYFNQ
FLTFGKNLTLLERLETAPSKIVPILITNKLYEKIQTHYSEIIDFIENRVKYFVVYDHREN
DKVYIFVNNFLNKPIKVYKNPKS
>fig|195.2033.peg.1694 plasmid replication protein, putative
MITKKSLNKTFKISKVAGYHRYFREEIDKETGEVNLIEVDKSFYQDLYNKDFNFMKMFTN
NMLNVIKDFFGGAKADIFNILIKNADKENCIFATQSEIAEACNTSREEVNKNLKSLEKCG
FIKKIKNGVYQINVDYLFKGSHTQRMNAKEKFTKPLKK
>fig|195.2033.peg.34 Transcriptional regulator, LysR family
MKIKDMEIFLDLLNTQSPTNTPIIFPSHNLMFPSLLKI
>fig|195.2033.peg.1987 Bacteriocin resistance protein; peptidase C39
MEKILKILLFLPILALSTKAEWVVKSYQEIKNERVIRQTYEQSCGASSLATLLNILDDQK
KFDELELLKIMSGQELYTDMVSF
>fig|195.2033.peg.1751 DNA topoisomerase I (EC 5.99.1.2)
MENTIIIIESPNKREKIEKITGAKVYATKGHFKSLSKNFLKEYENYEPIFDFSSDETKKR
MNAIFADCKNKDVIIATDPDREGYGIAYLFYEVIKNIAKSIKRAEFHEITESGINKGLKN
AVEFSKSNFNDFEAFKARIVGDKMVGFIMSPKYINKMNDKNISVGRVQTPALSLIVEREK
AIQNFLNDDNNKKLDYKIKAKLEKDGIVFFANNPNIYPNKEEALEKIESLRGKNAKLYTI
ETKKSEIKPAHPFRTSQFQEKANKVFGFAPDKSMALAQKLFEKGLITYHRTDSNALSVEF
LNEVEDFFKEKQWYQKREYKAGEQSQAEAHEAIRISHLHSFEDIEKIAKEENLSDDEKNT
YTLIYLNSIQSQAKNAINEITSYDFNIGILSFKTNISKCIDKGFKGAFDFKEEEEKDEKD
DTQELEINIKEGEEAKVLDFELVEVKKQAPRRYKESNFISLLEKEGIGRPSTYASFLKTL
LDREYVELATKGKNKEIVATKKGISLIDFLNENNDEWITKSEFTKQMEEILDTISKGNLQ
YIDFIKPLHQKMEFIHIDDSDQIRKPSEKQIAFAEKLAKENNLELPKDYKENIKVCMNFL
EKAKENVKPLPASAKQIAFAEKLAKENNLELPKDYKENIKVCSSFIDEAIKKNKK
>fig|195.2033.peg.2006 hypothetical protein
GQTEITNVRVKKSIFIGEQEIQSEDFNVEKLEASSDTYGDYAFLFEISKQDQIVMKKELN
LNPKKTKNTKNVKK
>fig|195.2033.peg.302 putative cytochrome C-type haem-binding periplasmic protein
MKIFISFFVLATCLWAKEIAYTDEVVSLYLNKDDTKVTGRLLPTNAFEILKSDKDRVLIK
VDGYVNPKAPSVIYFNDSQRIIVAAFSKNTKLNFSQTSAGKNGKWDKVSLEFGQIKKILL
KTIKKC
>fig|195.2033.peg.2037 hypothetical protein
VFDYSTKETLSNFIYMSLLGGEAKVYGDEKREKTLHIETKHLYLEKLLNESLELEGYLIY
DISSFLKENSRLYSLNHKNFIFFT
>fig|195.2033.peg.1763 Outer membrane and periplasm component of type IV secretion of T-DNA complex, has secretin-like domain, VirB9
MRKYSKIAFLALFVNLTAFADNIQIQDVPNPNVNTGESILQTKDQALNNYTQTNIKIDPL
GNQMQKIDNSSYANPQYQVQAFDTYSQSNGEQLSEEQIALMKSAIRNQNLNALQRRFFQK
KYSGYENTLNLNYKENKTQKIRTRFAMATTLIFETDITNYILGDTTGFKVEEIPSMPNAI
AIKPMLIGIDTSLTIFTKDNKLHTFYIFSTDYKNSKDPSLVIYIHDENSKEMIKEKQEKL
AKDYLIIKEGIAEVRVKKSEIYNHYSQKAKKGNEWLISEEIFNDKKFTYFKYDKDKMPQV
PAIFAVIDKQDSPVETRIIGNYVIAETTARKFTIKSGDSYVCVERLEKSNQNKKAKK
>fig|195.2033.peg.1732 hypothetical protein
MEDNFKKFLEEEIKRQKQEKENDNANNTRSNSTGIVRENDKTEPREISQSSSHSDPERDG
GYSTMATLGLSDNLQTIRFKRELSESLSRNTDEPRNTAQSRLSGAESRESRAESRESGAI
ISANKEFQNINDEKIPSKLSKEENKEFKDYIKDLRKQTLLSYTKDENVAENILNLQNDLK
YYTKKSEILTPNAKKDLEEKIKTSFSKLNNFENANIIPKGTLKEVLNQKELDLCQKISNQ
NKTKER
>fig|195.2033.peg.831 RloG protein, putative
MSGEYIISGFLTICLVIASYQVYKVYKKEIEYQKIHENALITMYKTTNKIDNKTKHKAKC
DALSPYAVDVSFSDEKIAEEVLKNPYGFNFLVDLEYYKNDKNKIILYRIFNIKDKISLE
>fig|195.2033.peg.838 hypothetical protein
MSQEEKFLECLAKATKGKKDLSNFEVLEFAFSIFCCLDNYIQNNKARDKKILKLLKGDEK
>fig|195.2033.peg.1967 Phage major tail tube protein GpFII
MKRMIGEVIQEGNIYIDGQGYLGVVRNLKLPDIEQEMIETKGVLGANYSSGVLKPLEISF
KLAVVDPVLYAAFFHTTFS
>fig|195.2033.peg.711 hypothetical protein
MKTSSIIEFFLAPAKMQKIGFEIAKGLDEWLDNENVCCFNVYTKDYFNANDKDMLISDNI
KDDTNTTQAHTNENYNNTQEIIPDNVIRIQTQDGSGEFIEIIFDEFKEWEKSSSGAIKPL
FTPLEGIVEDISNSLENVSIIGDALAMLGAVKNPKNAKNIIKKKSKYATKQEVIEVLKNK
YNLKTSKELGLGRSKNVFWVKDNKQIKEIWEEITDGADILKDINQDKLGGTIKMRKLDDQ
TIIQYKKLLKVEVGP
>fig|195.2033.peg.300 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MLDRRRFLKIGAALSTLPLIPTLGAGKSAEATKVSLGLVKNGEVITAAHWGILKLTIKDG
KIIKSEPWEKITKMDNPLQHYTADMVYKSRVKYPYVRKSYLENPDNPKPELRGKDEFVRV
SYDEAIKLIAKELKKTREAKGTSAIFGGSYGWKSSGNMQNARILLHRFLNVTGGFVGATG
DYSTGASQIIMPYVVGSIEVYEQQTSWENILEHSKYVVIWGADPISTLRIAWTASEQRGL
AYFEKLKEKKIKVICIDPVKTDTAQFLNAKWVAPRPNTDVALMMGMASHLIAQNKVNYEF
LENYTTGFDKFKDYLDGKEDGIKKDVKWASKICGIDEKMIKNLAEIFYDNPTMIMSGWGM
QRAHYGEQPHWMLVTLASMIGQIGTKRGGFGLSYHYSNGGVPTCKGGVIGGINAGSLGIW
KNGKFQGLAKSNQASGSAEWLQNAASYSFPVARIADALLNPGKTIDHNGSKITYPDIDFI
YWVGGNPLVHHQDTNTNVKAWRKPRTVVVNEIYWTPTAKMADIVMPATSSYERDDITMSG
DYSNMHIVPMKQAVEPVGESKDDYIIFADICKVYGQNVYNAYTEKGKKAKDFIKEYYDSA
LKQTRSFGEAFATPMPNFEEFWAKNEPITFEATAESLEWTRFSEFIEDPILNALGTESGL
IEIYSETIKNYNYDDCKALPTWFEPIEWLGNATKEAPFHLLTNHPKDRLHSQLCHTSLRD
TYAIKDREPILINTKDAKKLGVKNGDVVRVFNKRGEVLAGAVVSDEIMQGVVRLCEGAWY
DPNENGLCKCGNANVLTMDIPTSKLANGNISHTGLVNIEKFKGELPKLTAFSAPKGAN
>fig|195.2033.peg.1867 Probable integral membrane protein Cj1452
MKILRLAIKDFFTLQFLKFALIPLTFSFILMIFLAIFGFSFLLDYFNSLFSVGEDSFWAW
FYALHFVQILITLISVLFSGFVIIFASVFLALFITSFLTPLIVKQINNKYYHHEVQNISN
MYIIFEIFKIFLKFIGIFLLCTLALFLPFINLFVYYLAFYYLFHKLLMLDITSSVLDKEN
FKIFNTVGGKIKCNHRKIK
>fig|195.2033.peg.1759 ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB11
MSNNTIVLNNILNVLKPYLEMEANELIFNKPCEIKVDKGDIWETIYDERLNYNFLETFLI
ELAIKRNQRFDEKHCHLSCELPYPFLRYRVQAQHKTSLFNSEICICIRIPSKNRFALENF
VLSDKCLEKGWSYEKIKELIRNKKNVLVSGGTGSGKTSFLNSLMGEIDPNERIVTIEDAQ
ELYIENENKTQLAVPKEESEIYSYQTAINNAMRLRPDRLFLGEIDIRNTFTFLRVNNTGH
AGNLSTLHANNPEDAIKAIITNIILGGGLQNPDNKMLTELIITAIDFIIQITRNKKTGKR
DITDILDLKNDYAKLLI
>fig|195.2033.peg.276 Cytochrome C553 (soluble cytochrome f)
MTVLIIYGIDNKVRVYMPLVYMRGYQNFMPFPCLCMLCQLDSVLVSLLRGLKLCVGVCIA
NDILIKKGENLYKKCIACHGANGDKIAPGSKGNIKIGGLNKAYLIKQLQGYAAGKADNGG
AKVIMYANMKNWKFTTSDIEAVSAYIAQLPKAK
>fig|195.2033.peg.1883 hypothetical protein
TKHAVLLRYGVILWDYQINKFNLKGE
>fig|195.2033.peg.1729 hypothetical protein
MFFICYFKLILHQTQNIFPLFFTYLKSFLALEKDLKINDTDKMKLRFKYGV
>fig|195.2033.peg.2039 phage virion morphogenesis protein, putative
IKDGKNKGILKRDGDLSNDLNWQSEPTKSGVKVFNNMQSKSGFKYGLVHQYGSRKKNIPA
RSFLPIDNNNVLHQSIRSVIYKDTK
>fig|195.2033.peg.1697 hypothetical protein
MKHNTQIHSLRVEIIIKEFLSSLENANQFVIQLIKDNQEFKNFVMKKQARENKNQPSLFK
DF
>fig|195.2033.peg.2 hypothetical protein
MSLILGASPLIIKENKEYSNMKTINASIGHEIQPINGINFFKIKLTLTQSWSHKNDYISI
FLRNKRNNTNIHTFYGGLSGNAGNVYEFEISSSDILLILSSSKNGYLDNSFKFKITQYFN
>fig|195.2033.peg.301 putative cytochrome C-type haem-binding periplasmic protein
MLSRAKNLFAENCGICHALHPEKEFTANAWLAVFRSMADRTGIDKKDRWLVIQYLQKNAK
DFKAK
>fig|195.2033.peg.2025 prophage MuSo1, F protein, putative
MFFGKPNKAIEYLQSKKPQTSFDYDEIMHETHNKVFTIAKLNDLNLLK
>fig|195.2033.peg.1910 Ferric receptor CfrA
MKKLCLSVCAIGLLASNAISQNVELDSSIISASGFAQDIKEAPATINVISKKELQSKPYR
DVAEAIADIPGVDLYASKGKTGSYNITMRGITGYTLVLIDGRRQGIGGEVGPNGFNEISN
SLLPPISSIERIEVIKGPMSTLYGSEALGGV
>fig|195.2033.peg.1685 Single-stranded DNA-binding protein
MSVIVSKFYWLGKKDKDDNGAQNPQIPPKEPNIDYENTNIDEETQVF
>fig|195.2033.peg.1752 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MEKTTIDNSWLDALQGTMQDALKPLFENIFNGIQGTLYNGVAYTIIGIWVMFWCLNLLKN
GYPSREELFNAGKWILTLCFIFGIFYSYDGYTTFLGWLMIPAQWLKSATAGLIGGNADSF
GNQVTNAFNSLNDIMVSLWNEGWKRWSGLFSPDTFAALAVFAGMFCFWCFYIVTFFVLAG
VACIIVSSTFFAMIILSLAPATIPLLFSKKTAPYFYSWLKIFISYSLYVPASFIILSICM
IPIQKVQELGNIKQVYDNQFDNFFVPTLISLICIYLVAKIPNWISQVMGVQGLDGGGSGG
ALDMAKSVGMATTSFGAGTLAKRMAGGSIGESLKHGIANAIPGSQSLRKMAGDLKGQNSQ
TNLIDTMQGLTDTITGATAKAG
>fig|195.2033.peg.713 hypothetical protein
MSETYEIYTPDGLTLDVEKDTNKILFKENIKPTGNYTEEYSKAVFKSYYIMKNSPYKDYQ
PKYLDPNFYTGKASTLLEFTEWQSIYLKDPIKGSIAPWTKAEKAYYKSLKTKRERYKYLI
IRSGIRSTVIDIPYDAYANVDEKGYLINEEYAYIYDEVNNNKETLKSSLFRQEWGIAAGI
LGKPEYFVRSKNHGFNARMIQCFILYIQLTGGGYEELGIKRGIYNYADNLLEIGIGMAGI
HKKNPLRAKLVKELAKTIQPNEFGMLPFIDEIMGADWVIDLNKYDFAYDEEGRIIWALYN
DIEKGKLKDPRDVDSTPESRNEFDDAMDGYRNGMKTNFDVDIRNERDERSAKLTMDTLIL
SAKLAALTPPQGYPNAPYYFTPERLEWIYKRGYLDKLLDPRIPAIYRYNFPKELRAKILK
FGEENGIKD
>fig|195.2033.peg.2042 Protein containing aminopeptidase domain
MYELACELFPIPRSITGQGFRASLKILNKTLGGGDTQISLYKKWYKGF
>fig|195.2033.peg.1721 hypothetical protein
MSSILNAYNETRILQEKNPNNAVVISYLNYKGYYPKIQNTDLLIIQGALKAIQQNNTKFE
DNVKLKYEK
>fig|195.2033.peg.1768 FIG00470829: hypothetical protein
MKNIFQKILTLILVSPMFLFGADGGNIASKLANSVNQQVTDVGSSLSSIVNTIAIVMGLI
WIVIMLLMAFFNMEGIKNHAKLLFGALVIIGVVYGLSAAGMN
>fig|195.2033.peg.1733 IncQ plasmid conjugative transfer protein TraQ (RP4 TrbM homolog)
MKKISLGAIVAFSLMNVSVSAIDLSEFTGDTKLSCEAVLCLASPYKPSECAPALARYFGF
SAKYWSDVIRMRTNFLNLCPLGANNAIKSDDKELEAWRNSLVNLTGTCYIPDLNKKQQRT
ILWVEEIKRCTHGDGCTTVKINHYGFRIDPNLDNNCKILSSNKYSDYNLKYTCPTKFYPE
EDWNNGYEKKEVNQSEFNSLKEEDRFTADKLTEVSYSEYKNLPNNKRKISTSGFKTTYYR
IDLGYYKKEWINKNCWINQGKQ
>fig|195.2033.peg.1892 hypothetical protein
MILEIHSYDAEFFLTLGIEKHSQIAFAAKRTSLEIMHNGITHQIKTDKDFGILLNVVCNI
REKLDESFNEEDKSLVIDIDELIEKTCEELE
>fig|195.2033.peg.184 hypothetical protein
MKILLLIGDITIGGGAERVVINLANALFELKYNVKIFSFYKQGQDIAYELNENIKIDYLY
HKSKTDVKKEKPLYKLYYKHYESYILKQKYKDIDVMIFNNCPHFPFFKNKNTKYINFIHM
SFKKYRKRNNYFDALVILSNKQIEQWKKYHKNIWVIPNFLSCKSLQNANLCNKNILNVGR
MALEDQKGFLRLIDIWKMVQKKEIYKDWTLTIVGDGELKKTIEQKIKAYELENSVILKPF
TKEIEKEYLQASIYAMTSLYEGFPMVLVEVSSYGVPLVSFDINTGPSDIIENKKSGFLIE
DGNFQEFADKICLLMDNENLRKQMGQNAKEKIQNEFSKEIIMQKWIKLINS
>fig|195.2033.peg.2020 Phage tail length tape-measure protein GpT
LPVTANELAAIAAAGGQIGLGSKDVREFTNLVTKMKVAFDMSAEDVGDSVAKIKNILGIS
LKDMEDLGDSINNLSDNSASKARE
>fig|195.2033.peg.2026 phage uncharacterized protein
QKHENTPNELKGAMQRKDFLEWMDELKNELKTQFLHESHLDPTLKEERIKRASVDFDYFA
RTYFPHYFTIKGECGLHLHLNEVF
>fig|195.2033.peg.10 hypothetical protein
MQAQTETEKAKPALIARQTAQIDDNLRIEAAKVTQSVQFGYCTGGLDIPQEIMKLVKEKI
ENIEKSS
>fig|195.2033.peg.2040 tail fiber protein H, putative
EKRIITANYDRKYKKMVSLSNIPSEVNMSTYLSKCANSGFPEIAPNYSIYQLKGEHLIYY
LNDQYVASYAYQAISYAPSGSTNN
>fig|195.2033.peg.1740 hypothetical protein
MKKNFKKFLKFFFIINIIGISFNGILFYFNIPNGISFFIKSNYYIQGISIIMYITFSFWL
YKIIVLKQMISEQEKIS
>fig|195.2033.peg.144 Oxidoreductase, short-chain dehydrogenase/reductase family
MDKVVFITGGSTGIGNACVHKFHNEGYKVAFMDINQEEGQKIANNLKDVLFIAGDTKNKE
DIKNAVARAVEKFGNFDVISLNAGIHRCNTILDISDEELDLIIQTNIYGYVNTMRIAIPH
MKKEGGSIVINASDQCFVGKPNSFAYGLTKGALGQITKSLSLDLAPKIRVNAVCAGTIKT
PMAERLFQDFANITHGGNTDFYWQNEAEKYPLKKVGQANEVAELIYFLASPKASFITGGL
YLIDGGLTAGIPH
>fig|195.2033.peg.864 hypothetical protein
MKKSQKQKTPNTIKQENQNKENPSQTFNTQLNFLMENELNAIGKLPKDLADRIVTMLEKS
LEYKKDNDNKILDLENKNIEIRKKDIKSYHFWNGFGMVSFLLITITSICVGLYLILNGHN
EGAYFAFILGALTLLPKIIDSIKNKPKN
>fig|195.2033.peg.850 hypothetical protein
MLERLIEIIGLFIFTLMMLHFRLFLVAGISAGILISCIYHYLKRIFYHGSKDK
>fig|195.2033.peg.1719 hypothetical protein
MKEFINRETNAGRIKKVFILPNGEKQFLINGEYYNEKAVGAKNLFLVREYARKIKPNLFE
LWAMSRVYSDFKNQRISFKEEFEFNNKFMRKKHRNLQGLPYNFANLIQDVEFKLKEFKIL
N
>fig|195.2033.peg.705 SMF family protein, DNA processing chain A (DprA)
MQSELPSAYLELFKELKNPPKKLYYKGNLKLLEQRKIAIIGSRRMSTYTKNCVFELSNLL
KNSKISVVSGGALGVDISASMAAMPSTIG
>fig|195.2033.peg.1034 Transmembrane protein YfcA
MGFEHLDTIYYFVLFFVALFAGFIDSIVGGGGLITLPALIACGIPAHLSLATNKLQSVFG
SFTATLTYFKSTTLPHLAYGIFFTALGAAIGSYSVLFVKDEHLKLIILIFLTLTFYTLLC
VLVWVNTRVKQR
>fig|195.2033.peg.2044 tail fiber protein H, putative
APNYSIYQLKGEHLIYYLNDQYVASYAYQAISYAPSGSTNNNNY
>fig|195.2033.peg.113 hypothetical protein
MNKKFSYPIPNFTDRRKSIIFWRYLRFQARKILYFPQVRLLEKTLNEEKNKHLKDFFSQR
PDACYNVTRRFCDKSFSANERVKTLIYDVNKGLESFKFLPQDQIIFKFDEDFELYLGSNR
HVSEEGFWALSLRYQNAPLNNAVFVLP
>fig|195.2033.peg.2045 hypothetical protein
MFYNLSQEDFLKLEESIAKIIKKLEVLQGL
>fig|195.2033.peg.1749 Single-stranded DNA-binding protein
MNQVNLCGYLGKDFDMKTTPSGSAFAKTTLAVSENRRNEKGEYETYTSWIPIILFGRKAE
VANQYIKKGDRFLGTGKIVTSSYTDQYGNMRYGWQVVISSFEFIEKKAEQNQDYKGKPQP
NQITPPKEAETMQSIDENQAEIYMQDDENLPF
>fig|195.2033.peg.1665 hypothetical protein
MRKELEDDLLKLQEYYDGINVLEYKTFALLKCNSYYEKGRINEELIDKIKKYYINLFKKK
IAKELEEMQKEKERRNILKTNQELILKKIGE
>fig|195.2033.peg.1764 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB8
MAFIDDKKDPNFIFQLERNIKAYMLYIIIALTTIVVSLAIAIAFLAPFKEVKPYLVFFSD
GETNFVKVEQAGMDMRADENLLKSILAGYVKKRETINRVDDSERYEEIRLQSQKNVWQTF
SNLVKAPNSIYTTQGVFRSIEIINVSIFNKNVATIDFIAKITNRDGSENHLKKYRATLFF
DFIPMELTYNSVPKNPTGFIVKQYSITDIIDKDTFNTTQQTQGAK
>fig|195.2033.peg.2003 Phage protein Mup32, I
MLFINKDSLVEANNDKPIKVAIKGEWKGHNNGRFKVDDKDLNSIIENFNQKKIDLVIDYE
HQSLKNEKAPAAGWIKELYLENDALMAK
>fig|195.2033.peg.1869 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIKASNNWYGGGYIKLWFEI
GKLKREFRKKDNHA
>fig|195.2033.peg.1750 Hypothetical protein pVir0012
MRIEFKNKDNSYYINGIKIDDEALQSENLNYYLTHRKKHLDFLICLYADFSKSENPHYLN
KLPLILKDIVKLSRINDKYVFVSNSSFNLITKSLNANKYEAMLKKILSENRIFKAKKTKT
ILKGE
>fig|195.2033.peg.235 Putative C4-dicarboxylate transport protein
MANIMQPGHGMNLNPKQLDTTSVQKYISQTTEVSASSEIMHILQDAMPRDIITPFTEGKT
MQVLVIAIITALIISLMRIEDRQAIQRVLEVIQNFVFKILQVIMYFSPVAAFSAMAVLIA
QYGLGSLINLAYLLLVMLVSCLIFIFGILGLICYFAKVNIFKFMRFISREVLIVFATSSS
ESALAPLMRKLEKAGLSKATVGLVLPTGYSFNLDCTNIYLAMSLIFLAQAFNVNLSLAHE
ISILIVLMIASKGAVGVTGSGFIVLGSTLAALGNMEISEANATLAQVLPVAAIGVLLGVD
KFMSEMRAVGNLCGNSVAALIVAIWDKQIDWEKFRYALDNPEKFHNAGMH
>fig|195.2033.peg.196 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQRQNQKLFEKNPNLKNKLEFIFFKAVDAKNKEYLEFKQHFPW
WASWVLGRELSDGEKACFASHYKLWQECVKIDEPIIILEDDVEFSDEFLNNGGGAEYIDE
LLKSKYEYIRLCYLTQGKMLKLNDNFLFTLDSIGGTQGYLIKPISALKFIDNLKFWIKPV
DNVMDMYYYSKVFTITYTPLLLKTTDINSTIEERKKDKRPIFKRIIKEICRLYFIYLKFT
YKQKAIKFLRREV
>fig|195.2033.peg.866 hypothetical protein
MKNEIVKDNKEIETFEKVGKVMAEIEVSKQKATLAQIEATREDNQRQYDFAINKLTKENK
KWHKSMNIACTAVFILLIASLYLILFTEKIEIGLGLLSTTLASVFGYLAGVGSSKT
>fig|195.2033.peg.1704 FIG00471323: hypothetical protein
MGSRGERMCKIIKYLDYARLNTLEKLYFDLTIMLIVTFLSFLFLVFEFFIYENIAVFFRD
CFLMSVIFIIGMIGLFHTCKGLRKYKEILKSNKREEFI
>fig|195.2033.peg.2038 Methyl-accepting chemotaxis signal transduction protein
NDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKR
F
>fig|195.2033.peg.1720 hypothetical protein
MKNEILKDNKEIETFEKVGKVMAEIEVSKQKATLAQIEATREDNQRQYDFAVNKLTILMK
D
>fig|195.2033.peg.185 Glycosyl transferase family 8 family
MYHIIFSADENYIKYTSVLITSIIKNTNPKNHFQNRPYSFHILSNFVSEETREKLERLKK
ELSKIYPCEISIHIMSDDRFENFPSSGAAQNSKLPYYRLKFISLLDDNVDKCLYLDSDML
CMCDIREIFAIDLQGKIIGVVGDPGSKRLKIKFIENNTKKVLKFDENYFNSGFLLINAKE
YKKANVEKKCEELAKKCIYIKAADQDLLNAVIPKDEILKLSFAYNFNIITLLYVICKDEK
KNRLNYTREEFTQSAKNPKILHYGEKPWKFLKSYVDLQNRNISDYWWDIAKEVPIFKEEL
LRQKENIKDYLLYAGLGFTLYNLCKKYQLFTIKQLLQTEHDAKLIEFAKGLNDDKYGLYC
MLGEMVLYARKHKKGVINIILKSYKMIKMYEKYAHKSRDIKNL
>fig|195.2033.peg.1900 MobC-like protein
MRLAQNEWEQIESKLKESELSFSSFALASMLGQKSLKRKQTPINRDFIAELSKWGNNLNQ
VAKHLNSNKGGLDRVGLEMLSRIENHLKELRKVIE
>fig|195.2033.peg.1717 hypothetical protein
MFDYSKYENASEKQLIHALTLAEKRAEKLNSQLKENNEFFKFLQKKLKKSFNAKKTKKAE
QRRPELDEAIEDYKNGNVVVCHSMEEFKAKMAEED
>fig|195.2033.peg.1829 Bacteriocin resistance protein; peptidase C39
QSCGASSLATLLNILDDQKKFDELELLKIMSGQELYTDMVSFTDLNDAVKKLGFQSNSYQ
INRENLDKLVNIPMLVKIEDDPRFPHFAVIINHKGNYLQVLDPSHGEYISSKSQFFSIWD
RYNKGGYALIVAPKKELKPFKLNTPKSLHFDFSPFSLF
>fig|195.2033.peg.1753 Hypothetical protein pVir0009
MLGVLAEFIKFLGLNNETNFTKTRTEEKEDELKELIEYENDMPKYYEESEIIDLGNQKIE
VIKSIKINPLGKGKAMKTSQIKEQRIIKF
>fig|195.2033.peg.275 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISPYKNVPQNENIQNTLKSKQSPL
DIKMDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGINEVWL
RESIIALKRSDLNVETLQEIVNIVSYYFQYHGYPSATAYIPQQEITDSIQINIMLGKLG
>fig|195.2033.peg.298 Zinc transporter ZupT
MQFTFEQIFIAMLLTLFAGFSTAIGSTIAFFSRKDDLRVLSLGLGFSAGVMIYISFMEIL
PTALKDFKNHYDSHWAELLGLACFFWWNFNIFID
>fig|195.2033.peg.116 Inner membrane protein YihN
MGSGAGGLKAAILFYSACVIIAGILAYFLLEDDKISTKDDEGHEISKNKAAWNGVIKAVK
TPEIWVVSLTIFTIYSVYCGLTYFIPFLKDIYGMPVALVGACGIINQYTLKLVGGPIGGC
LTDKTFRSSTRYLRFALILAAVAILIFIFMPHEKLNIYFGMSLTLGFAAIVFTMRATFFA
PVDEIEMPREISGAAMSIACIFGYSPQLFCFALYGFIIDQFKGLLGYQIVFALMGFFAIC
GVIITTILLRMIAKKKTLQEVA
>fig|195.2033.peg.208 Cobalt/zinc/cadmium resistance protein CzcD
MYKFLSHEPLANKSCHHNHEEHSHEHHHSHADARSVDKKILKISLLMTFSMMLVQFIYSL
LSNSLALLSDTLHMFSDVFALTLSFLAIIAIEKWQDHQKTFGYFRLEILVAFINALTIIL
SAIFIIYEAIEKLINPSSIDAKTMIIVAVLGFLVNAINAFMMFRGANLENVNMKSAFLHM
MSDLLGSLVVIIGGIAVYFSGIVYIDTILAIILSLLLLRWAITLLKQSVNILLETSPVDI
EEVKQALLLNSKVEEVIDLHITQITNKMLVASMHLRVNIDDLKEFEQLSYDLSHDLLHRF
EIGHITIQPLRSKNEI
>fig|195.2033.peg.1116 Type I restriction-modification system, specificity subunit S
MKIKIWKINKLEKICEILDNKRVPISQKDRISGIYPYYGASGIVDYIDKYIFDEELVLIG
EDGAKWDAFENSAFIASGKYWVNNHAHILKPNNEILINKFLVYFLNYSNLEKYITGATVK
KLNQQKLKQIEIPLPPLKEQERIVGILDESFAKIDESIKILEQDLLNLDELMQSALQKAF
NPLKDNVKENYKLPQGWEWKSLGEIANTSSGGTPSRNKKEYWENGNIKWLKSGELNDGYI
DFIEENITEEAIKNSSAKIFQKGTLLIAMYGATAGKLGILNLDSTTNQAICAFLHKDKNI
KFLEKFLFYFLFFLRDKIIKDSFGGAQPNINQTYIKNLQIPLPPIKEQEQIASHLDELSS
HVKNLKQNYQAQIKDLQELKKSLLDKAFKGNL
>fig|195.2033.peg.415 Peptidyl-tRNA hydrolase (EC 3.1.1.29)
MILVVGLGNIGVEYENTRHNVGFMLIDLLLKESNFTNLTNSKFKGELFKIGSSLLLLKPS
TYMNNSGLSVKAVNDFYKCERMIVIHDDIDINLGALRFKKGGSSGGHNGLKSIDTLCGND
YERVRIGVGKGENLISHVLGKFKPEEEITLSKVLEHTKKALLELIENDDLSAISSKYSLK
A
>fig|195.2033.peg.1699 Site-specific recombinase, resolvase family
MILAYARVSTDKQDNISQEKLIKDYCKAQNIKLDNYISVEVSSRKNFEKRRINDLYKLLK
DGDTLITAELSRLGRDMFETISLVNDLLNKGVKVLFIRQPELSLISKSATKLLLSFYAYI
AEYEREMISERTKTGLKAAREKGKVLGRPKGSCSKSVYDGDIDLIKELTSKELTLKSIWK
YIGKKSSYESFYYFCKSRGLINAKNEFKSHLDTIKQYRESGMPFNVIFRTLENKLNCDKQ
TFYKFCEEKGIQ
>fig|195.2033.peg.1970 Phage tail formation protein GpI
MNTLILNHHPKQSKAIDLSAKARFEDLKIESITNLAMRCDE
>fig|195.2033.peg.1687 hypothetical protein
MSDKELEIFELCERLVDLLGDKEAVADLQTLLERHPEMFQNKEQVANLIKKVIHDPEIII
NNPTPKSEKDYIAGKKLNEKKMGEVGIRKDENISKIFHANEKRIKNLELMAKKDVVVDGR
NAHTSYTQAQSLDGRLVQKNISSATNKIIPQQNKSTNDFKAKLEEFSTKKTNAVKSINKE
FKR
>fig|195.2033.peg.2027 hypothetical protein
MNYQDTLEEELITGTKTHLFMIDEKDLIKELSVHAIAELSDLNADGVC
>fig|195.2033.peg.1766 ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MGTSIFTYLKELKNKPKKENLGKKEKKNFKEYINKINRGTDNILMLAEPKIFTMAKENNI
AFKLDENILVTKDGNLCAGMEIKGISYSGTSLEEELSYLQNRVQFFGKISTDVEINLIIK
KDKIELTKQVSQSKNIFANQIIDKWENHKDAFQITYYLLISTIDKKISGALETFKNKTTK
EKEQNKEEKESFSIEAKKNIINETLNEAKRALSIFNPTQITADDILNFYATYSNAQETKF
KYTNELITDSYISSNVEFKKDYILFERNDGKQMFSRFISIKAYETDIISSNITTKILRSS
SDFIIFINMQAYEKEKAIKKVKDTGAFAPQIIKDELSGLIEIIKANRENLMLMSFSVYIL
AENLEDLETKTNELKGILANQNLNIVRETINQKALYFSFFPSRANLNARKRTLKVSNLAS
IANFEKDVLGFVKNDWGDQPVTIFRHLSGTPYLFNFHWTDQGDKPSGHTMIIGGTGTGKT
TLAQFLMCNLYKYDIDIFSMDKLRGMYNFATYTDGEYHDADFSDFKLNPFALPYTSENKS
FLQNFIQKMANIEDNQYNAVNEISKTIERLYNNKLEEDIFTLSDFIDSLQHEENDIKGRL
RPFQNSIFDNKQDALSFSKQLSILNMDSILKNPTLASLTASYIFHRLKNSAKNSKKRGFF
CFIDELKDFLMDENMRESILESILEVRKIGGVMCMGFQNLSFFDDIPNGASFLENIANYI
IFPTTNAQTLDNMRNKLNLTPTELKFLQEAGTNSRQVLLKMNLSNQSAILNVDLSRLGKH
LRVFSSSSDNVMLMKELKELYPNDWRNMYLENQKPNLNQGAK
>fig|195.2033.peg.1955 hypothetical protein
NAFSILARVSNALKKAGVSKEEISQFQKEAMSSDYNHLLNVVQDWVNTN
>fig|195.2033.peg.1736 RepE replication protein, putative
MTKDKKISDSLVYHNDLNCFTFKNFKAVDYNLFFTICYYASQNIKTSKSIVPISLSFEQL
RDFLPQEKNKKRFYENVVEFALKLNNLKTSNLTLDNEGYRIYSVSSFFDEITVNEKEEKI
VFKIKEKWLDLIVNVVREYTILDLRNFCKISNKYTKNLYRYLSQWQSTGEFIIPFEKFNI
LLDIPASYDIDKIEQRIIFPSIKLFKENNYFKNLEYIKEKDKTKQGQGGQVTTFTFTFDI
PEERKDKTLALNKKWGRRRKTENIIPPPPTKRGKIEVSF
>fig|195.2033.peg.1744 Hypothetical protein pVir0015
MNYKKFQTMSKEEYFKKYNVGIRFLFGCDLNQKNETEMISLRVFLPKKHFQEYKNIDIFK
TMDLFKETLLFKGLTEQSIKIDFEKREFVMPDFFIINDIEIIPYFTQGGEKEEELSKEKF
FELLKQNKIKELNYLCFLFFGLFCEEEYKYFCKAKE
>fig|195.2033.peg.190 hypothetical protein
MIHKLADVQSDNIGNNTNIWQFCVVLPNAVIGKNCNICSHCFIENNVKIGNNVTIKCGVQ
IWDGITIEDNVFIGPNVTFCNDKYPRSKQYPEEFSKTIIKKGASIGANATILPGITIGEN
AMIGAGAIVTKDIADNTVFYLKIGNNLN
>fig|195.2033.peg.830 hypothetical protein
MEKENIVKKTCKELGLTYRQLGELIEYNRLFLKN
>fig|195.2033.peg.1727 hypothetical protein
MQKNIKIDFNSKIIALEIDYSKDYGNFFKNIVNELYLENKDYIKLKGYIRKINFQFGVDQ
EKQKRFLLLSYEQIDKIKSINLLMLSEAYRLINFIAEKILIK
>fig|195.2033.peg.189 UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14)
MKNLLFILGTRPEAIKLAPLILEFKKYPNLYNVIVCNTEQQKELSNQALNFFGIKADIFL
DVMKPNQRLSELQARLLMQLEKIIDQIKIDATIIQGDTMSVFAGALVSFFHKIPIVYVEA
GLRSYDLNEPFPEESIRQMTSRIATLHFTPTNEATEALKKEQITSQKIYLTGNTGIDALR
LLSENQDTAYGKFWLKLGIDIEKDEVVLVTIHRRENHGDRLVSILKAIEKLSRAFPTHRF
VLPVHPNPNIRENVYKHLNKYENIFLIEPIEYPHLVHILKNAKLILTDSGGIQEEAPTFG
CPILVLRYETERKEGIKLGFSQLVGTETELIYKKASDILLLDKKETRIYKENPYGDGIAS
QRIEKIIRRFLYE
>fig|195.2033.peg.640 Arginine/ornithine antiporter ArcD
MDSIIIAFFVGFAVFLGTFLELDRSYWVAVSTTVILQGTNLNSVWIKQLQRILGTTVGIL
FAWWLLRIKFTPLEFIFLMMFLAFIIEFLVVRNYALAVIFLTPYVTYLAEAASFGNLSVD
MLIHARLQDIIIGSLLGLLGGFVIHRAYLRKYFEYIAKYIFRVKLTSK
>fig|195.2033.peg.1754 Hypothetical protein pVir0008
MARKKEVNAEIKEVANEQVKDNSYKAWDERTNEEKKASINEYSKAIIAKAIKEKATFWGK
DMSKQDIDNSMPYNASKGIAYTGLTSALLRAVSELNGYEKPSFLTMKQANFLGGTLKKQV
DEKGKPILTKNGKEAYEQGVKIALLKTESYIPKVDENGQVMTRAIKDQNGNQKIGKDGKP
MFETVMEKIYHKTPILETVTLYHTSQFENLKMDKLKERDLESLEKLRDSIKRSNYDTRPN
VNNLGLGERVTRDINNFLNAELKGLEYSKIQDKEITQTQTKKKEQKKSQGRGM
>fig|195.2033.peg.1724 hypothetical protein
MKINKIIWNCINCQKTNDTSLGSLKSLEKAEQILTSFNEEVILLAKCKKCKKNNELLMKF
KIIGLSQFQDENKSKRTLNMVKINKERAKNKKEKIFSLLSGLFSDSYKDEKGNFDIEKIA
LHAKVNIKTAKKYILEYEKENKK
>fig|195.2033.peg.107 Acetyltransferase
MREINLKEDLEKIYPLIKQLRNNLSLEDFLEKFQLAKKLNIINFLHMKTRGLSKQLVELC
PLMCFIIIIVFIFVILL
>fig|195.2033.peg.878 hypothetical protein
MKNTVFVFEDNIIFEINIFEKSNKEDFRYFLDENSNLTKSTKNDYCGSKTKYP
>fig|195.2033.peg.922 hypothetical protein
MSILVNAVDTFYSTKNEAVFSASKSENIKRNVADFNTDNNTKNSVYFFSDDKEISLNLSN
ESMELLTNHFSANDFLKLSNGNIGLSGKAAAFVEGWYKDIMINRNFLNADRDKNGRIENN
EHLSLKNSVEDVAKNQDLSKNFGAVVLRMTQSTTGYVENTISDKSLSIEALIDESIKSDR
NFDGIITRLEYSAKGGTDMQGYTNWAIDALNDILDDSDKAKIHLVVDPTSKIWHSYAGKT
LNEVKAYYDNPFRATSGTSASGFLNIVIEEPRILPSNDLENEKEQLLNEFPEFRALIQNN
PNITKEKLLKLKNQQRITHNYQDHQKQDLQKEFTQNFFKTDLKA
>fig|195.2033.peg.1942 hypothetical protein
KAIDKLKLDLKPKETLKEVLKVDKVFIKDKSCESELKAYKELFNILGAKK
>fig|195.2033.peg.112 Intramembrane protease RasP/YluC, implicated in cell division based on FtsL cleavage
MKSLLFLALILILGFKFYSIEFLATILVISFLIFFHELGHFLAAKSLGVKVEIFSIGFGQ
SLFEREFKGTKYRLSALPLGGYVKLKGQDDMQPGLENQDQDSYSILSPMKKIYILFTGPF
FNLFLAFLLYIAIGNLGIQKLSPQIGNIAPNSAAALAGLENNDTILAINGIKIQSFDEIS
NHLSLEPLKILIDRKGENLEFLITPKLGQAYNDFGQVVSKAQLGVSPSGSTTIIYHQGMQ
SINYALDESIKASTLIVKGIVKLISGEVEAKNLGGIITMTEITSKAAQNSFTLLLFITAL
ISINLGILNLLPIPMLDGGHILFNLYEMIFRRKVPQRAFEYLSYAGMAILLSLMLFATYN
DISRIAGE
>fig|195.2033.peg.1755 Hypothetical protein pVir0007
MASIEDSLREKELQRAKNILAFCELEDGEYPLSKEEAKELEYLKTNEMEQSSLENE
>fig|195.2033.peg.1686 hypothetical protein
MQKILLQLQSDGKMKEAMKKVARLGYLLFYLAKVQKVHQRTLKKVRSLHAVVNYLLVNIK
MNQEIQKQH
>fig|195.2033.peg.1851 Flagellin
MGFRINTNVAALNAKANADLNSKSLDASLSRLSSGLRINSAADDASGMAIADSLRSQANT
LGQAISNGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM
EELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRI
SSSGEVQFTLKNYNGIDDFQFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVETRG
MAAVRAGTTSDDFAINGVKIGKVEYKDGDSNGALVAAINSVKDTTGVEASIDANGQLLLS
SREGRGIKIEGSIGGGAFINKDMMENYGRLSLVKNDGKDISISGTGLSFTGFGASNFISQ
VSVSLRESKGQLDANTADAMGFGSVNKGVMLGGVSSVSAYMSAAGSGFSAGSGYSAGSGK
NYSAVIAANAVVISNASAISKIYNVSAGSGFSSGSTLSQFATMKTSAGNSLGAKDETAGV
TTLKGAMAVMDIAETAITNLDQIRADIGSVQNQVTSTINNITVTQVNVKAAESQIRDVDF
AAESANYSKANILAQSGSYAMAQANSVQQNVLRLLQ
>fig|195.2033.peg.1741 hypothetical protein
MISVTLLFSLSIKDYMVYFIKEILNLKKIGK
>fig|195.2033.peg.1696 conserved hypothetical protein
MANKSFLIKVNQEDKIMLERIKKATNIPFSKILRYLLNLYFQDENISDSIVIQKYKFYSN
EKHTISIKLTREEYENLKTLCKENGFSSITKQAKYLLLNSIHKEKFFKNNEIEHFIKIRS
EMAKDYSNLYQLLKALRGKNLIKINDEVLINMINNINTNTQIILESFGKIVEKNKERI
>fig|195.2033.peg.1728 hypothetical protein
MKIEVIKNKFFDLESVLKGERKNIYNKDAYAFLECKDDKDNIARFFDLGEIALNYNQENN
QIEVYFLKYEFFQESYEILKYLIVNSIKFAFVSAEDTFKRLSNLKINVKDFIKE
>fig|195.2033.peg.1765 VirB7
MKILKISILTITIIFFSACATTNKEIPKKSPCACNYDVIKIS
>fig|195.2033.peg.828 hypothetical protein
MAEEKESKGSYNLQIKIPNELKDKLEKKAEKAGVSLNQYIMYLFIDDIKNERI
>fig|195.2033.peg.1959 Phage tail length tape-measure protein GpT
MENAGSIGIGVILGLAIKNASAVGKVVKDFSNLEKIAAKTKLGISGLQKELNTLKLNANL
RAELKAQRKGLQDELLSLGNVIRGGIIGKGLGEAISFESAMADVRKVVNFDEGDDIKKMS
ADILKMSQTLPVTANELAAIAAAGGQIGLGSKDVREFTNLVTKMKVAFDM
>fig|195.2033.peg.862 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANEFQQEQDLRKQQMEFNQ
AMQNNQLLQNERNFDYQKERANIADQQWQMNYNQRARQYAMQNALRQQAINARKQQMEFN
QAMQNNQLLQNERNFDYQKERANIADQQWQMNYNQRARQYAMQNALRQQAINTNKDLNYQ
KGLLELQKLQNEINAKQKEQDLLNKVFSNAQGFDGQSNTNLPNNTRYKADAQFLDLASNQ
GKTYDTTHGFWNGAIERAFGGWGSQSTDLNDASDLFLKRMLSDLLRGGKNAKWNLENIQA
NFPINGYTMEANNQRVAQALAGEWLAEAPNSYKMELAERLGNAKTNMEKQSAIEDYQKNM
NFYNNYAPKVKAFYWDEKYSKPSKNAVIIDNSTANQNIQNDLAKNTLEVQNQNTPKLHSV
SFNGINAQISEPDANGNVILVNQAGRKMQVSVEELKKQGLIQ
>fig|195.2033.peg.1731 hypothetical protein
MPKPKVFNEEILTLPFDMILMQNGYFHKKDKCSRNFITMSNDSDLIVITRQTNGQYLYFN
PNEENDRGNIYSFCKNRGIKINDLLNDKVDKIELKHNIEPSNSMNKATVEALNNYKSFTT
IKQKNFFNDDRLISQEILETFNTLKQDKHYNVCVPTYVLDNFEGKEFINSSGYVAYLRRP
IAQDKQGNTYNKPIKQLCYGNKGLEIIRNKDNKQKIEDIKTIIITESMVDSLSLFELKDY
DPNSTLLCATNGQITKSHKEIFAYFEKNAKNAKIVLGYDNDEKGLDFTLKTKQCFKQREI
IEENPKLKDFNDDLLISKVFGLKKDFSLEDIQKEINSLQKKTEYLLDRKSVLIESKKTEL
IKEISNNDIPLVSYLKPKLENFVNLKALGKRFDEFNAYLGRITENKKIKE
>fig|195.2033.peg.2005 Phage tail sheath monomer GpFI
MAVNYGVNFNISNGAASPIKVQSDTPIGIAGAIKGASKEMIYTKA
>fig|195.2033.peg.1991 hypothetical protein
ESKKQLFICIANDNDFTSWVDLLGDGSNDIAPKEKIIITFDNTTTGGQYGGCMSDLRLGF
ENGFATPNKVQDEYENAKFTMTKDGNGLNRSDFTIDSNPIAGENQILGTIKTSGIYQETY
HKIAHVFKKYNGGSDECCLWSSSGTREVSIELENTPMPNKLFARGNGYYGQTEITNVRVK
KSIFIGEQEIQSEDFNVEKLEASSDTYGDY
>fig|195.2033.peg.1948 bacteriophage DNA transposition protein A, putative
KDKTKLSTWMQEYALREYRTFGAGGFNFTELWWQIHKEAAIKENYDFIGFDLGEVKPLFS
VKTLQNFIKNYYKDKPLEHCIITQGLDKAKSKFLPAQGNQRELYDMKNMCWQIDSSPADI
IVRDDETLEPFRPHILSVVDVFSGMGVATLVGKSNSLSLTRLLWKAIDKFGKPDMIKGDN
GKDYLSKDFQSLLDSLNISYDAAIAYAGEQKALVERRFGTLQRARLSQMHGHIGNSLAKR
EMIEQKTPKKERKAKDEYGFAKKTNQKLLHTFSEACELLEAEVIKWNMSKVRRKKGVKTP
LELWNSCDRAIVKISYEEFLFNAGNKELRVVGKKGINFESRVYKSALMPSVGTRVKCVQN
IDNIKELFIYDLNGTFLCLALDESIAKLSKESFKMLKKGYESEVKAIKEVLKKDEIAAFT
KLNIKQDLQDLQSAFENSLVEAKEVHQKSLAKEALKTQRELEEIKNNANADELILNAKKE
INNDESEFDMEAFVEKKYFAG
>fig|195.2033.peg.832 hypothetical protein
MLELLKNIGLGLFVNGNYALLSGNITLNNTYIVFGSVALMALSIYADRKEKK
>fig|195.2033.peg.1758 hypothetical protein
MGTIRVYLNEYEQKQLKKLSIKRNESQSAVIRKLISIEKYAKTLEILEKNNEINVEYLYH
IAQCGNNLNQIAYHLNIGIESPSQTQNRLPKLIEELAQILNEHKEQIKNKAIKTSINKKI
KRLSPNENFIGEENQ
>fig|195.2033.peg.823 FIG00472493: hypothetical protein
MKLKDFDFRIWDNTEKRYLNEIELHKYDKSPVEAGTTFTETDRINEVEFVKNKNDLEIEL
FTGYYDYKGNKIYIGDIIECLVFTNEKNSEIFYEIICFDMELGLCSKLSNGDGGYLFDLR
RHKNNKTIEDVYVVGNIHENKELLKG
>fig|195.2033.peg.188 hypothetical protein
MSKNKPLVSVVMPTFNGSTSGYIKESIESVLRQTYKNFEFIIVNDCSIDDTLNIIQDYAS
QDDRIRIVNNQTNQKLPQSLNNGFNLANGIYYTWTSDDNYYHENALEEMVKYLEKNPNKI
LVCSDYEILGLKSYSRIFKVSAAKEDLISYDSVGACFMYRADAAKQIGDYNKEEFKVEDY
EYWLRLGLIGDFGVIHQILYTYRFQPNSLSMTAKKGEIDNKTNELLYKFLPRYIEKYPNL
NLDVISRMRMALVSGLNLKDEVKKIWKTSDRRTKRMIYVFLRDRFANSGKNIYKESIKVL
SVKYIIKFYIFCIKHRIKF
>fig|195.2033.peg.818 hypothetical protein
MEIILGIGAVTLVIVSIALVYTFYKEKHKTQH
>fig|195.2033.peg.279 hypothetical protein
MEQRHLPAFETGRAGKGQKLCAGYCPLIFFSFFVLLLKFSLLSY
>fig|195.2033.peg.1979 hypothetical protein
YLEKLLNESLELEGYLIYDISSFLKENSRLYSLNHKNFIFFTTKALREYHYEKQAKNAFY
HAQTINLPFLRFEFTWEDKND
>fig|195.2033.peg.371 membrane protein , putative
MLLALAFLPTIGGFYCTTRALILAKSNSVQLIELSEPLFAMFFGSLFLAQSISFLQILGG
VFILFAIFVHEFKLKL
>fig|195.2033.peg.2001 Replication initiation ATPase; bacteriophage DNA transposition B protein
ALILVGTRKLKNNLTGIGRNDYNEYGQLSSRIGAKWELKGLCHQNKEGLKDEDLKTLCNH
FDVEEKKAIDLVFNLARGNFRKSEKLLKRACEFADGKAVELKHIEAAASFLMLG
>fig|195.2033.peg.1956 Phage major tail tube protein GpFII
IKAPLLFRESVHKGGKNYGISAEFLGEFISISESDHESGKEVEAEIKMAVHFYMQRRNNI
PIITYDHKNTILMINGVDMMSDVRSNLTL
>fig|195.2033.peg.1930 phage virion morphogenesis protein, putative
MSEYIEIKGIENFFKACDKLIDMDKHGQSIMAGAGESIRNSIIDSFKNERSIFNGKWKSL
KPATIKQKIKDGKNKGILKRDGDLSNDLNWQSEPTKSGVKVFNNMQSKSG
>fig|195.2033.peg.1794 GTP-binding protein Obg
MFIDSVKITLASGDGGKGAVSFRREKHVPLGGPDGGDGGNGGDIIFVCDNNTHTLVNFKG
KRELRAQNGAGGMGRNKNGKKGENLELIVPE
>fig|195.2033.peg.1738 Plasmid partitioning protein ParA
MKFISICNEKGGCGKTTILSNLAIALYEEGKKNLVIDADPQKSLGTFVSIRNQEGHLKKF
DYVIKQGEAYFDYILNLKQNNKDYEFILSDTGGRDSKEMRFALALSDIVIIPIIPSQYDV
SVFDRMIEVVKMAKVKNPNLQVFILINLASTNPFLSKKIDELRDYIKSVEQDCIKLLDFV
IFQREKYKIFTQMGLGVIEDNKKDDKAYLEMNKLCEFIKKLK
>fig|195.2033.peg.1901 hypothetical protein
MLFSLWYNTLLWARLLFVATLLTKLAIKKKLVRGFSPNTPLTFDF
>fig|195.2033.peg.1742 hypothetical protein
MKNLFSNVLIAREKIERFFMRSSLEKVIKNYNENFSNKRDNDFTQGLIKYLYENDIIGEN
DKIFLEKNFQYIRVINEKEKRLINVYFCEKPIIDFFQNAEYEKELQYYGINEKDFISLQR
SKK
>fig|195.2033.peg.1896 Phage tail formation protein GpD
GSFSVNVVSKNYTSNTTEVRASAINFSGKGSVNIKEKKTRSFENTTLFTIARKIANENNL
KIKTSGEDQNIVSILQNNQSNLEFLYSICFDYGFICCVKENTLIITPKDGKIGDNAANIT
SKNENLPLFEIALKECISLEISESARNEYSAVIAEWQDINEAKIKSIKVGSGENIYKMQI
SQPKNDNEAFKKAQAKLNELQKGGLNGRCELIGREIRAGGKLKIKDINMDNYEFSIKSVS
HSFNDSAYVITLEFES
>fig|195.2033.peg.829 hypothetical protein
MEIFIIWLVFVILSLFFWAIGKRKGITNEDELPFLVKICYTIAQLPFGLIAIIFIVFGYI
FGFIFKIIFELLLFCFSNNKK
>fig|195.2033.peg.835 hypothetical protein
MLNLKSLEITCKQCKTKITLDIGKTVIVCPLCNNAFYNSYDEAPLSKLGNILQSLKEHKK
AEFRFITDEKE
>fig|195.2033.peg.1944 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYD
>fig|195.2033.peg.1617 hypothetical protein
MYHEDTGWSPIHFWASNNDYKFLELAIKGGANVDMEEYEFESIYKYQDTPLFEAVKESGN
YRTVQLLIELGANVNFVPYLTTPLDQAEGARNRKLLKAAGAMTSDQLEKKFNIFYKDYED
RNEYCDLLNEAIRKDKEKENLQKN
>fig|195.2033.peg.1737 hypothetical protein
MQFKKANIDENTIQDIKEFANNASGETSLQKNEKNTTKRKKKEENKRNTISFEVYLEDEL
KNKIQDEVTGTLGSRSEFLKKIILEENIYIQNDKDLIEIYNIVQKEGISPKSFIRKKLGL
DTNIEKFNYDKKNKKKVITAWISNEYREKIYEKANQTHSTMRAYAYAKILFYLETKNLFS
FEEQMQLTKEANNYDLDFKEFLALKIKSN
>fig|195.2033.peg.181 Lipopolysaccharide core heptosyltransferase I
MKIAIIRLSALGDIIQSAVVLQFIKKFKKDIEIHWFVDEKFEGILKNHPLIDKLYALPLK
DKKIIQSLKILLEARKNNYNAVMDLQGLIKSALVSRILSRNNFGFDKNSLKESFAHNFYN
QKLSIDYNENVFVRYLGLTSFIFNKDFDPKDLAFKEDIFSVDDKLKQLLSEKMQLAKNKK
NILIHVGSSEENKIYPKTKLALLCKLIVKEFPKIKIFLGWGNLKEYEFAKEVIELGAINQ
DNIEIAPKFSLEELIVFTKSMDLIIGNDSGPTHLAFALNRPSITIFGATWDTRVCFRTPI
NKTISAGKKFNTSIKFRFDRSDFCINTIEEEDILKLAKELLGDE
>fig|195.2033.peg.1767 hypothetical protein
MIETSCYRDLTRKTKIKGLTSTSWFALIILGFIAWFFLVLYSLIVIAFLYCFFFILEFLD
EDIYQIIFAKLSIPQNKYYA
>fig|195.2033.peg.1760 Hypothetical protein pVir0004
MQEISNYEKIKKDIEEGIQKRKEEDKKNKKIISQIKIINSLENKIKKEKEKLSKLVENEN
SKQMEQNNEQ
>fig|195.2033.peg.1899 hypothetical protein
MICKFFKTQTGGGVSAINYLLDKRVNQGTAKVLQGDEFLTRELIKSMTQKHKTCVGVLSF
EEKNISEELKKEIMESFENALLTPEMKGRYNILWVEHTDKGRLELNFVIPKIDLESKKAF
NPYYHPADKKRIETWGDYINLRYGFTDPKDPAKEQTVQGSKKAKELFKDYESLDKILHQQ
VADEVINSRDELITFLEQNNIEVTRKGKDYLSIKLPESKKAKRFKGSIYNEQFTSFAELR
EIRREKETRAKEYNRRDNEKELGRLEHELKELVSLKSQFYRETIRTINERLRKKAEQSFQ
RDREKSLQSRTDEIQTIKPSDELSSGNAYDDNFVSDCVVSVDQALSNQQRANDNGQQWES
VSLYREKSSGTTGEFLLPTTELKEEEYDNIRTRVNRRNREIANEDNRISKSRNELTQYYQ
NGTRELQERVRNFRERIQGIGEQIRRAGQRIRSNSEERRKQQRQRFANFEEQIRSFGSKF
AEQINGVRFFIKERINELRERILMRSKQVLKTSQKIEQEQPKAKVKESDNIKKGFGLGI
>fig|195.2033.peg.1976 phage uncharacterized protein
MLFSKEELDEFLISNEQKHENTPNELKGAMQRKDFLEWMDELKNELKTQFLHESHLD
>fig|195.2033.peg.1775 Translation elongation factor LepA
MLQIKKIWEKGKLSKTYIVCDYPTNWEKPLITLKIQDLRKLLSKESEVNQNIKKEIRNFL
FSQESLSFKEQEIDISTKETDIVSIYNKLKEKMPKFLLFKTDRTNTDKDNEITQITKAIT
QNAISEIEQKFNDMKKNILDDIKSFANATLERLKSFDKDIVKDLTPDITSKELSSLFSYE
FKSDNGISFNKRGSGVKRLFLLSFFLEDAERKHQSNMIYAIEEPETSQHPNYQRIIIESL
KKLAQNKGRQILLTTHTPEIARMVNKENIIFIQKDNKDKRIVYHGDEIDIEILVDALSII
VPNSKALSKGRELVKAMKEIVPRQLFEVAIQASIGNKIIARENVKSMGKNVTAKCYGGDI
TRKRKLLEKQKEGKKRMKAIGKVHLPQEAFLSVLKID
>fig|195.2033.peg.49 hypothetical protein
MIFTIKEKIRFFGETVASSYTLNEIQRNEIIRATQFRANIIGASAINSSPIPISVSTFDI
PNANALSYDFFSNPIFNRVLQGESIDTIRQELIGVSEDFFTKASVEYLGHINMGKLDWYI
AFSSYYPT
>fig|195.2033.peg.877 Protein of unknown function DUF262 family
MFLYAYVYDDFKQVIDSGSLEVEHILLKQWQNANFNEWDEQSHFEYLENIGNKILLPKKS
NIKCIDNFFAKKQIEYSNSNNANLKEVLDLSKRTKNIWTKEDIDNRAQAIYSKMVEFLQG
>fig|195.2033.peg.1723 hypothetical protein
MSNINAFLFGFTNMFNADILKATSLKDRKTMITDFYKKSEELRKHSNEEYNAKFEKITKQ
K
>fig|195.2033.peg.1745 hypothetical protein
MLFFGVYTLFISILLSILLSIESLIPSKYNYEKQLVNVILKPILLLLYGVGLIFLFFNTE
VANSLAVEIINRINRFRIIESFLSSKEIGLYILAFIILLQVVFIFWAVYKGFIENEL
>fig|195.2033.peg.1698 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MTNIFETLADSIQRIIETIRQVGTSDKMAELSVLFSIIITLVIMYKGYEVLMGRSQSPIR
ELTWDIAGKLLAITFALNLGGWLDLTISAIDGLYEWAGGGMDLYKNLDEFGIYIAKINSV
IWSKLNGLTDTFLAVICMVINYISFLFISVIAFSIITITQFTHTLLVIFAPVAFWLLIFK
STKDVFVQWIGLLLSNTLIILFIGLFIGTLMSEVNAWSSYTEYSVKKGTEALGSSIILLV
NCIVFGILIIVMKFFAEKVARVSMEGAMGGAMGSALNPVSRLAGWTAGKAAGKTVNAGKT
GVKYAGKGIVSGAKTAGTQGYSFAKKMYERMRNEA
>fig|195.2033.peg.1314 FIG00973752: TolA-like membrane protein
MKKFIFILAVLSSCLFASDELNIDSLFKKQIGLRSITSLSLLSTGNPHSYYIYPNIGVNG
DLNVWNDTKQLYLNQTFIYTLTPNFDLLISGGGNYARQEYNNIISGAFTSKNTLNFDSLW
IGFIYTGESIADFVPQIKFQTAIIQREKTVLQTKNFYFQSQNLEASLRGYSDPVVYSIYT
GFGYNAQRKFKIAKIDYGNSIYFGGNLSIILSPKITLDLGAEQRFQTEQKINGVKNSEIR
SIPTISGGSTYSINQDTAVSVSASLGGSSAAPDAIFGINLWKKF
>fig|195.2033.peg.2002 Glycerate kinase (EC 2.7.1.31)
MSFEEIAKELNLSVTRVHQIYTEAIRKLKSPK
>fig|195.2033.peg.312 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MANLGQINGNIAKRSVGSTLKPFLYALSIDEGIIAPDSILLDVPTFFFNFNPQNANKKYY
GIISAKEALQRSLNVPFVSLLQDYGYEKFFYKLKAFLNFEDENYKRYGLSLILGTKELSL
EDLIKLYLGLANYGELANLSFIRDENLSGVARMFSKGSAYLTLEAMKELQRVGLENYNKE
KIISWKTGTSYGRKDAWAMGATPKYTLGVWVGNFSGEANANLYGVSIAGDLLFEILGLLD
EVDLEFAPPDDLMTIKLDSISKYRYDEDLNTSYINVLYPKGANILRTSPFLKKVYEYQGR
ELDSKDIHFKDAKALIKLDFPAYALHFFQQRNFKFSNKKGVKIIYPKDNLKLILAKDLNG
MKGLVAKVANLNNEKLFWYLNQKLIYEGDENTQNLNLKEGKYQLFIISQSGEQDTVWFEI
K
>fig|195.2033.peg.1992 Phage baseplate assembly protein GpJ
YEELFKSFLKDNVELLESDPFKAILEALAYREMIIRARINESIKATYLHYAKGSDLDNVV
ANGYLIQRLKGVKPTAKVEFELNSLLTYDVIIPKGAIFSNEKADIATLKEEVVIKKGENK
ASGVLELDEFIESKERKTEFLQTPLPFVAKIKQLEFFKGGASEESDEALRERAVMSVH
>fig|195.2033.peg.203 Lead, cadmium, zinc and mercury transporting ATPase (EC 3.6.3.3) (EC 3.6.3.5); Copper-translocating P-type ATPase (EC 3.6.3.4)
MIMKCEHCRLDYQKSQMIEAKGKFFCCRGCLSVWEILHESGLDEFYERLGNNALKPVSLE
FSNKNYDEFITKTKEGFSEIYLMIHGIECSACVWLNERVLTKQEGILELDINHLSHKARI
VFDEQSVSLAQILNLIESIGYKASAYDPSKNSKKADLIKREFYSKLIVAIACVMNIMWIA
VAKYAGFFSGMDRDIKDILNFAEFILCSPVLFYTGSNFYKSAFKALKMRSLNMDSLVISG
ASLAYGYSLWAMFFRVGEVYFDSVAMIICFVFIGKYLEMFSKKRALDTVDGLNDFLQNEV
LVFNGKDFEPKDVQKVNIGDRILLKSGDKILIDGICKKGEASIDTSSLSGENEPCFVGVG
GIVNSACIVLDGSIEYEANKLYKDSKLNQIIRLLEFASTKKARLESLVSQISAYFSRTIL
TLALLCFFFWLFYHKESVEISLVHAISVLIIACPCALALATPVSNLIALGQALKRAILFK
DSSVVEKLSKCDIAVFDKTGVLTQTQLKITEVFLDEKLNLDEFYSFVSLSNHPIAKSVAQ
FLQDKKAKLLNLDFKGLNNIQAKGIKAYLDNALFLGGSSKFLEDNGIKCKKEFNNSHFIF
ARDNEILAYFEFSSVLREGAKELISYLKQAKIDTMILSGDNEKAVEKIAKELGITSFYAS
CLPQDKMQAIENLSHKKKVLFVGDGVNDALALKYAAVAISLREGSDLAIENSDILLLKND
LLSLKYAIKLSKDTYKIIKQNLILSLAYNAFTIPLAFLGLINPLIAALSMSFSSIMVILN
ALRIKNE
>fig|195.2033.peg.1048 hypothetical protein
MVSFFLIALLSIYQYFYGGKYSRVYISKLEEKCHYDDESNCKMLQTIYKEKCDDGDGKAC
FAGIFVSGDLIRVKIDGQWSFLDKNGEIIAKPEFDDIWSFWEGLAGVGLNGKYGFIDKSG
KIVIEPKFDDIGY
>fig|195.2034.peg.738 Inositol-1-monophosphatase (EC 3.1.3.25)
MKELEIAKLACYKAGDFLLNLKEKKINFNKGKDIKLQADLESEKIICEILTNAFPYPILS
EESYKISNEEKKGIYWVVDPLDGSLNFSQDIPLCCISIALYENNKPILGVIYDFYRDEIF
SGIVGVGAWLNDKKIIPSDNIKDKSQAILATGFSSYMNYDKDGLMEFISNIQEFKKIRLL
GSAALSLAYVACGRIDAYYEKDIAIWDVAAGIAILESLGNITYSFFQNELKCLIRVENKL
KEKNDIRAN
>fig|195.2034.peg.1533 hypothetical protein
MRSIKQDHNTKLIEKGELTSSSEPMKFSFNTSNYYGQMFIELIDKESGISAGQSFYVSSW
GEPSYADVVSSLKIKSDKNKYKIGQSAKIEFESVAGAKALITLSSNSKIIDRFVMDTQGE
STSIELAMKKEYAPNIYVSVSLFQDYNKIDNDRALRLFGIIPLYVEDENTKLNLELKTPD
KILPNSDFEIEIQSKDKRAFNYTVAIVDEGLLDLTDFKTPDIWEGFYAKTGFTLKTYDTY
SQIIPKFTGGDSVSKIGNLRADKNRDDSAQRFKPVVLFNAPARSDEAGFAKLKFKMPSYM
GLVRVMVVANENDAYGSISKDMQVSAPLVLLETLPRTLKIGDNFTLLTQIFKTENRIKNA
TLSVRSKNSLIKISPDTQAIDFKNATNLEVMIDANVSDNRIGKELLEFELKSENYTYKNE
IEIDIKPINAYTYENNTSLIKAGESKEFIIKDYILGTTNATLKLSPTPILDMDKRINYLL
NYPYGCIEQTTSAVLPQLFLDKFSTEFDKQKAINNINAAIERYANFQTADGGFAYWQGGD
ESNAWGSNYAGMFLILAKQNGYFVPDSMYERWLKYEQNFVQKSIYHDYMMDIKANSLYLL
AMAKKPNISEMNLLYDSLNTLSTEAKWQLAAAYKLAGVEDTAKQIASKISIEPDSKYSSY
TYGSLIRDEAIIANAYKQIYGTNNEELLQKISYTLLSKDYLSTQSTGYALYALAMGANLE
NMNENFMDATLKIGDQVHTIDQNQMQIFSFNNEKAIINANKDIFVSFGVEGVKAGENSAF
SNKISLDRAFYDEKGNKISPSEIGSGQTFYMRISASLNEGANYVSNIALTQILPSGWEVS
NTLLDDNTPSFIKNSSYDFIDVRDDKIMWFFSLNKNRTHHFYIKLNAITPGSYTLSGAYV
EAMYDDTYRALSESEKVVVKR
>fig|195.2034.peg.542 Dicarboxylate carrier protein
MMGYYNIIILFSLIISIALGYVLKANIGVFAILSAFIGAYLYGITPEKVINLWNGSLSLF
FILLSITYFYGFAIANGTLNNLALKAVYSVRNRPWSIPIALYITVMVFVGIGPGHYAGFA
FMSPLVLYIASKIKMNKILAAIIIYSGSCAGGFNPFTLGGRVTFDLIEKLGYSAEASAIM
QLNLGKNMFIAHTLIFIIGYFLLKGYKVKITSQITKPKRLNAAQWKTIFIVCFVFAVIMI
PSFFLALNPHDETLKKVTSIFNPVFVSFLGIVLAVIFGIGSEKEAFKNVPWDLIFMIGSL
SMLIELSKTTGIMENITTFMSAHGSSSSNWLYYLLGILSSCMSAFASSMGVVMPTFFSIV
PSIKALEPSLAFSIIAVFATFTGYSSFSTGGALVLAGAQDESEKRYLFIRLIILPLILVV
FGFVLLFLGILN
>fig|195.2034.peg.1208 hypothetical protein
WGFIDRSGKFVIKPKFDSIWDFSEGLAKVELNRKYGFMDKNGKIVIEPKFDDIGY
>fig|195.2034.peg.837 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MKKIIILCALVNISFGYSCYTEEQNYEDAIKYYESFQSDYNYKNAIEAKRKLERCYREKQ
LEYMKDVKRKLNQNW
>fig|195.2034.peg.1521 hypothetical protein
MQLSIRKKMLMLGAICFISMLATFAIFYYNNLKGSQKIAQTTKNLINKEIDIKVELLTKS
MAIALGDLIKDVDDEKEKIKISLPQLKILDLKRIKADTFLSIKKQPSKPILLEKT
>fig|195.2034.peg.83 L-lactate dehydrogenase (EC 1.1.1.27)
MSKIGIVGLGFVGAASAYNIVVQNICSELYLYDIKQDLALAHARDLEDMSAIHSSYTRII
HATNLEQLASCDIIILAFRKENLKELSSRLVELQNNITELKDIVLNLKHANFKGKYIVAT
NPNDTITYYTQVLSQLPKNHVFGSGTNLDSSRLKKLLAKDLNINSKDIFACMIGEHGDSQ
FAALSNASVLGQNLLDFYKQKLGKNLDIQELEKAVISEGYFIYERKGRTEFGIGTSCANL
AKAILEDRKSLHPVSVVFDDIAFSMPAIIGKDGIEKVFELKFNEKEKTKLENSKQQIKNA
IQSVKDEI
>fig|195.2034.peg.388 hypothetical protein
MIHERIKNGANLFENHVFQFDFLNDEFFDKCDDKGKIIQKSKLPLNLQEILKDENKRKKL
IIFINPPYAEATSATQVTNTGKNKDKVARENKICEKYKDILGKANNELFAQFFIRIYCEL
EDCLMASFSKLKYVNSTNFIKFRENFKAKFLKGFMVPADTFDNVKGKFPIGFLIWDMSKK
EEIKKIKLDTFNKNGSFLGIKTFYNDQKESINKWIKIFDDKKSQEKFGFMGNPSPDFQHN
SQLYLSLNKGIEHFNFYIFSLKNLLNGAVYFSVRHAINATWINDRDQFLYPNDLYKNDDE
FKSDCLAFMLFHGQNRISAKEGINHFIPFSEKELGITKEAFESDFMYKFIKGKIKDENSL
FGDELVKIEFSLEAQELLKAGKELFKYYHTHSEDKGYLVNASFYDIKEFFQGRDEKGRMN
RPSQAKDEHYKILLSDLNIALNALAKKLEPKIYEYGFLKE
>fig|195.2034.peg.1371 FIG00470755: hypothetical protein
MLGFHTNMEIFKRAGIYYFYLLVIHIPLFLVWKKVISKIESLDFINTFYFGIAFSLCVFL
AHLAFRWAFSFSAFAMRVV
>fig|195.2034.peg.1247 AgrC, putative
MFIYFLIWQVLFVLGWNLRFILKLIMGEDVFIENFILDKIISVAYIIIAFFFFKTLVQAT
KEKLFYLVFAFFVCGEIVSKLFFAFIRLLDSIRLQEMIVEIIYFISVFHLRLLISFHF
>fig|195.2034.peg.99 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQKQIQKLFEKNPNLKNKLEFIFFKAVDAKNKEHLEFKQHFPW
WASWVLGRELSDGEKACFASHYKLWQECVKIDEPIIILEDDVEFSDEFLNNGEEYIEELS
KSEYEYVRFCYLFDKKFYPLNENYILSFEKLAGTQGYVLKPSAAKKFIKYAKRWIYPVDD
YMDMFYKHKVLNIVKNLYC
>fig|195.2034.peg.105 GDP-L-fucose synthetase (EC 1.1.1.271)
MSKIAKILLTGSTGMVGRNILEKSHDFSYEILTPDSKTLNLLDKNNIKEFLYLNKPDIVV
HCAGLVGGIQANIQNPLEFLQQNTYMGLNLISECKEAKIKSFLNLASSCMYPRNIENPLK
EEYLLKGELEPTNEGYALAKILSTKMCEYITKTNLDFHYKTIIPCNLYGKYDKFDSVRAH
LVPAVISKIHYAKVNNISKVEIWGDGQARREFMYAEDLAEFIFYAIENFDQMPQNLNVGV
GYDYSIVEYYTNIANVIGFTGTFFFNDKKPSGMNQKIIDNQKLKKFGWNPRINLKEGIQK
TYDYYLKEVINA
>fig|195.2034.peg.660 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYEDLEEEL
NFFYQSILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEE
LCSGKIYLVDVCEPKMELQLSILFDQKDMFEWLNLYEMFISCNFYKMYYQDVILKTDQTC
MDNIFVVIRNFDPNDQLTTICYKQFLQNIPHLLQNIPFQRLLSERKAKFDTAVVVSAGPS
LHKQLALLRQYQENVVIFCADGALNMLENEGIVADYVLNLDIEDLAVKFFNCSKSLDYSK
TIAVLAVNTHPNVIDCLINKFPYCIALRDEYLYKQFHLDDFGYIDTGTHVSHFSYTLALA
LGFKNIIMIGQDLAFDKDGNSHSKGFAFGENSNAEKNFQLLQVPSYYKDGNKVTTHVSWN
DYRIKLEYLIARNSEINFYNATEGGAYINFAKNTSFKECCEKFFTQKKPCFDIPKTFTYN
RSLKFLSKVFLHLKNDLQNAQDILRDAHLLNNVLIGVVNIKNPLPLDFLQNIYKSIGDFN
SVLDDDKFIQDGILKGVLYYRGSFLSEAIKKDLKDEAYYLLNFISAYQKWLEKFIERLEI
KNAIIKDTVLKYGNLI
>fig|195.2034.peg.740 D-3-phosphoglycerate dehydrogenase (EC 1.1.1.95)
MENKKIAVTTVAFSKNKYLREKLSSYFKYTQFNDSLKRLDRDELKCFLKDVDGAIVGLDE
INEDVLKEVKNLKVISKYGVGLNNIDFDAIDKYKISVVYSQGINKRSVSELVLGNILSLM
RNSYITSNKLKMQEWDKNGGVQLSGKSIGVIGVGNIGKDFISLLRPFNCTIYVNDIVQQD
EYYKKNNLIETTKEEIYQKCDVVTIHTPSTNLTRGMIDKNVFSMMKKEAYFINTARGDIV
VQDDLKWALKEKIIAGAAIDVYDQEPPEDYEFVLLPNLICTPHIGGNAKEAVLAMGDSAI
ENLVNYFKEN
>fig|195.2034.peg.106 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MHNDYLLASSTWDEKELQAIQDVIKSDMFTMGKKVAEFEKDFAKFVGSKYAVMTSSGSTA
NLIATAALFYTKNPKLKRGDEVIVPAVSWSTTYYPLYQYGLKLKFVDIDLETLNYDLDAL
SSAISDKTKMIMVVNLLGNPNDFDAINDLIKGKDIILLEDNCESMGAEYKGKQAGTFGIM
GTFSTFFSHHMATMEGGFVVTDDEELYHILLCLRAHGWTRNLPKENLVANKSDDWFSESF
RFVLPGYNVRPVEMSGAIGIEQLKKLPMFLKHRRENAKLFCEYFQNHPDFIMQKEIGSSS
WFGFSLVIRPNSKLQRKDIIKKLEENNIEYRPIATGDFTQNEVMKYFDYEIFGELQNAKI
VHKNGFFVGNHQFDIGEQIDLFSKVMNKL
>fig|195.2034.peg.632 hypothetical protein
MRELGFTQIYIIVYFRDTLGYLNSHCSQDHKNNMEYYSADFAPQDHPRKYIFDYEWICKT
HAEVFGEENLIVRLLREDYVGGTLLKDFVYHLRLEWDESFVLKQTKNESFNLLGMELMSR
LNQKDLKQDNLNSLLFMARRKFEGSKEKRLKFAVQKDIAKAYVDYFASSLEWVKNKYFPH
KNSLFTPVNWEEYEQNYTLTHMLSKDWDDVADFIAQIIVSKNEIISSLKEQLELARKD
>fig|195.2034.peg.81 Putative periplasmic protein
MRKILFASLLPIIALADCASLMAKYEAPEPESKTMKQVERWINKKVSDPADAAVLKECMI
ARAADNPNQVSVAGK
>fig|195.2034.peg.963 hypothetical protein
MSSSYAISRLLFFVIFYLKNLAFEKFYIKISLLKTLEIFNLLYKIYLIFQY
>fig|195.2034.peg.625 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAYKYFQEEDIENIKNLLNQFHFSYGEINND
NAFFLANSLVKYVENLKMQNKLDHNFKLNFTSTFIPPNGDYQNFGIMAAIDHINALKDLV
KRFPEFADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSAVPPLNYIIGRELEFKS
KDTNGDMYMQGDHFFVSCFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNI
IYVSYHSDKDPLTPANFKQQTMQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKA
LFRKELPLMLEKLQGRKSFMQENSISYPCGNKVFIFKDVGDKFELEIKD
>fig|195.2034.peg.652 Glutamine--fructose-6-phosphate transaminase (isomerizing), isomerase subunit (EC 2.6.1.16)
MKVLIIGFGSIGKKHFLALNELRFLVDVLSKSYEFSHFEGKNFRLFKDLEELNLQDYDLF
IIANITTSHFKTLKFLDQNVKEKIILVEKPLFQKDMEFIPSNNNQIYIAYLLRFHPMIQD
LKQLIDEKEVYFAKFICNSYLPNWRKLDYRQNYSAKKELGGGVMLDLSHEIDLAFYFFKE
LSLKFSQNLKISELEITSDDFTFLALSAKNTSIHIELDYFSKLTQRKILFHTKENSFKAD
LVHNKLNIYDKTNNFKSKTYENDTFKTLQNMYKAILEKDQNLCTLGEARRVLRLCDKARN
E
>fig|195.2034.peg.656 Motility accessory factor
MKEYTGKEMNFTSNQQEIFKQNINALVNEILRKKLQKIKNTKFELLLGNDNLDINLRNTK
DNTLLYINTIDELNSMLEIYNDKYLLYPVLYFYGFGNGILFKALLQNKHHQHIVIFENDI
EILWIMFHLLDFSCEIKKNKIIIFDTNEINIKDYEMLTLTKPFISFLRIYFLELSSSYYE
KMNKDIQKVNKNLMEYFKKAMIGYGNDPLDALQGIEQFVHNLPKMLTHSSYKELIKKRKN
LSKTAIIVSTGPSLIKQLPLLKKYQNKATIFCADSAYPILAKHNIKPDYVCMLERASLTA
EFFNHDFKDFDKDIVFICASLIHPNAITYLEKNNREYILISRFLSFALFIACHDYGYFDQ
SPSVAHMSYIIAAKLCHKNIIFIGQDLAYAENGDSHPQEYQNSSTFESNIYQKIECLGYG
GKNSVKTHSIWLLFKQIIEQLILDYPYINTYNCTEGGAWIEGTIEQSFKTTCDKLLLDDL
NKPFIKLKKPNIQKQNELMLKSYAKIYKSIKHCIEFKKQTLATIEDIESSYTTLNYLSLE
ESKEILDILIQIIDNFKTKLENVNMVDFYEILGPLLMQFELNLARIYVLNPKTLEDSFNK
SVLWIKEHLEFIHMVYGHIEAQENALFKNIIPLEEELKKRGFKKYLQRIKNANK
>fig|195.2034.peg.80 Membrane protein
MKTKFSLILSACLLSSSLFAKNADDEITKLQKQLAQIQAELAEIRKEREAQAKQNEAVKA
ELADLNDRADETEFQAALSKVKFGLEFSTAVSNTNYKVSGQDYSANNKWMNELHLNMNAD
INDKTKFYGRLSMAKNWSQMGWSGSPLDLDAGRNTRTSGPVLYVDRAYLDYYITPEWIVT
IGRQPGTDGPGSNLRNNALRQSTYPALMINALGDAAVITYKPESLQDHKIAIRAAYGKTY
QWDEEGKVRDWMGDQKDADANLYYAAVEGELPIEGMGDNLIIFNVAHLQDFALPLPGVSQ
SISTPIGDGSATLPAGVYNLGDITLANLHFENNNAFGTNFNWFASLGYSHGSNGAKQSFT
TNGPLGPIVAGEIQKKLDFNEKDGYAVHVGGRYDFTKALKVGYEFFWGSRYWYTMSRPSI
NDPLNIRMTRGTAHDFYVIYQLDRYQFLRLSYTNIQNIWGNRGLPFGGAKKDKARADNIM
LMYNVKF
>fig|195.2034.peg.18 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISHYKNVPQNENIQNTLKSKQSPL
DIKMDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDEKHSL
>fig|195.2034.peg.787 hypothetical protein
MLICNHCNTKNLDVAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEEEKRKIAQEER
EKSLKQRKEFISKHKSKII
>fig|195.2034.peg.116 hypothetical protein
MKILLLIGDITLGGGAERVVCNLANGFNALGHDVEILSFYKDGEKSLYEIHKNIKISFFY
KTPRKQVFKKPFHRLYYKHYESYILKQKYKDIDVMIYNNCSQFPFFKNKNTKYIKLIHEI
FKCYQSRNNFFDNLVILSFCELELWKKHHKNVSVIPNFIPNFIPNISKKKSDLSQKNILS
IGRMTLEDQKGFLRLIDIWKIVQKKEIYKDWTLTIVGEGKLKKTIEQKIKEDKLENSIIL
KPFTKEIEKEYLKASIYVMTSYFESFGMVLIESANYNIPSISFDIYSGPKEIIENKKSGF
LIKDGNLQEFADKICLLMDNENLRKQMGQNAKKKIQNEFSKEIIMQKWIKLINS
>fig|195.2034.peg.1619 hypothetical protein
MRAARTCGANNNDFSILDYLFDEYGLSLKDPKYNFRFADMKYIKEANDKYIVVRYMEDNP
SIYKEALIYRYILKVRNPNPQIIQYLANHGAKFEVYREDTG
>fig|195.2034.peg.19 hypothetical protein
MQEIVNIVSYYFQYHGYPSATAYIPQQEITDLIQINIMLGKLGEYQVKNYSKHLKESAIS
SKLKESLQGKILRTKALEDAIYKINEMSGIKASGSLVAGSEYETTDAIITIEDSKKANAM
LFFDNYESKGSGVYRAGVSGALNNLLGYGDSLNYFAQLSDEMQKSYGFTYNFS
>fig|195.2034.peg.112 UDP-glucose 4-epimerase (EC 5.1.3.2)
MNIFITGSNGFIGKHLKEYLQQRYLHYTLYCPSSKELDLTNENAVDNFIKNRKIDIIIHL
ANKGEYKIGFQNTVEYNLRIFLNLLKHANKVYKFLSFGSGAEYGKHCNIINIKEEECKNY
ALDSYGFYKQIASRLIKNYNNAIHLRLFGVYGEYEDYRFKFISNAIVKNLLKLPIVIYQN
CFFDYIYIADLVRIIDHILHHDMCYQIYNATSGEEYKIDLLTIANIVNNLSDFKSSIIIL
NKGLNNEYTSSNEKIFTEIKSFNFTPHEKAIANMRLYYQQNFDKIDGKAVIDDFYLKTIQ
KLKED
>fig|195.2034.peg.730 Nucleoside-diphosphate-sugar pyrophosphorylase involved in lipopolysaccharide biosynthesis/translation initiation factor 2B, gamma/epsilon subunits (eIF-2Bgamma/eIF-2Bepsilon) / Nucleoside-diphosphate-sugar pyrophosphorylase involved in lipopolysaccharide biosynthesis/translation initiation factor 2B, gamma/epsilon subunits (eIF-2Bgamma/eIF-2Bepsilon)
MNIIIPATGIGKRFKEAGYKDLKPFIKVMEDKIILDYVIECFDIQNDTFYFIIQESEKNK
FEDFISSRNINARVIVYAGEKLGPAGSLYGVFLQLEDILNEEVIISYCDFGQEWNYKDFL
KFIEENQDAQAVIPCYTGYHPHLIPLENVYAACKVYDNTYKVYEVIEKYNSKNKFEEYYS
SGIYYFKSLKLAMEAIKKQIDAKDMISGEYYISVTNNYLENVLCYPFIEKFYQFGTPKDF
EYVKDKLNSQDVYNEKIKIQNTVILSAGRGERFLNLNFNQPKPFLPLGDSTIVENIINTL
KNVETNIICVGAQDHEKYWENISKEVRFVKPNKIGAAYSYKESCGDLKGDVLILPCDLIA
KHINEEFKSLQKEYEIIIFVTQASRYNMNNPHYFTWVDGKDGKVDAISVKNRPNDTDLVM
IGSFYFKANSLLLEYIDKIFQEDIKTNGEFYIDNVFELLIKKHKIGYMIVDNYFSFGTPD
EYLENKYWYNISKSKKRDL
>fig|195.2034.peg.1639 hypothetical protein
MQKAKQEIQETKEDIRDMEDDIKELEERLNKKRQIDDEQHKLIETHYQEFINFKMQMEND
TKEKENKISDLKFKISKKNTAFSIIISSLALIVSIVAIILQFIK
>fig|195.2034.peg.1119 hypothetical protein
GLFNNWVGFLITQVYFIVFIEVLWLGVVYDEINIAVNTCKGLVLSKKRLFALNLSFLFNK
TLTS
>fig|195.2034.peg.107 hypothetical protein
MKIDFIHKIVNKMKNKQKQFHHKFYGSIYPPWYEQNALICNTKPKIYNKSGSIMDMFFIR
DKHFAHTPYGDSANKIENKYFLWDRFNFALDTHFYTGDSILETMGNPSRKIAWILEPKSI
YKKPYEILVRDKELANDFQYIITHDEKLLEQYPHAKMVYTLGVWCYTNINDPLEHTEDKF
NTKSKNISMVVSGKQSTPLHVVRNTLADKVKDLGIVDMFGAYVDKPICFKSESLDKYRYQ
IVVENEISAYYFTEKILDCFISMCVPIYIGATRIGDFFNLDGIIQIFPKDVDRIELILKQ
CNEQNYKDRLEAIKENYFKALKYLNCENHLYEELFVLNG
>fig|195.2034.peg.742 oxidoreductase family protein
MIKIGIAGFGKIGQLRAQKISEKNYAQVVAIYDVKEPLNFGRDMVFCHSFDELLSQDIDA
VFICTFVDSLAEYTKKALLANKHVFCEKPPAKTSKELQEVIEVEQNTKMILKYGFNHRYH
YSVMEAKKIIDSKSMGKLLWMKGTYGKAGSIDYDKNWRNYKNKSGGGILIDQGIHMLDLM
RYLSGEEFEKINSFVTNAYWNIEVEDNAFAIMKTYSNVIAMLHSSATHWKHKFLLEMYFE
EGYINLDGILSGTRSYAPETLVVGRREFEDITFAMGKPKESITWFENDNSWEIEIKEFLD
AVQGEKSILNGTSIDALQTLLLIERIYNNSGFYNE
>fig|195.2034.peg.839 Helix-turn-helix domain protein
MKDDFSNSSEEEILNFYKKVSSNIRKFREKKGISQLELALDIGIKSVAFYSNCECNRYGK
HFNLEHLYKISKSLEIPLKDLLE
>fig|195.2034.peg.1645 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MKKLALALGGIALGACGEKIYKGIKNTWDKLIFKDLITLRKVIKQYEEIEQIYPSYLNDP
KF
>fig|195.2034.peg.20 hypothetical protein
MNKSNYELGEEYESLGAYGSSLDLGVDLSYPLFINTTNSLYLTGGYVYRKLEDIYGSFGI
DFNKESNAFYLGTEGTIGLIPNNILSYNTQLTYGDIKPKSVFLENSPVMGEFWKFNAALN
NTYYFNNKISHILNISYQKTIGDYQLDSSETATLGGAYGVRACPNGFGEADSMILTTIGL
RFNIFSPNFYITPFYEFAHGWNEDYLDNDINMAGREGKNDIFVDAVGLELLYIKLDLAKA
AYKYEADGKRRDRLYTSMGFYF
>fig|195.2034.peg.741 N-Acetylneuraminate cytidylyltransferase (EC 2.7.7.43)
MSKNKYIAEIPARLGSQRVRQKNLRLIEGEPMIAYAIKACKNASSISDIYVNTESDLIGQ
VALDYGVKYYKRNQELALDYIVSDQFNYDFLKKIECEALVMVNPVSPLIESIDIEEAINF
FETNQLDSMISVKDERLQSFYQGKALNFNKDGLLPMTQNIDPVQICVWTICIWRRESFIK
AYEKNGYAVFNGKYALWPINPLKSIKISYEEDFLLAEQLLRARKFGKKSEIRYYGE
>fig|195.2034.peg.108 hypothetical protein
MLDPKLVIIKVDGGIVSQLYFFAAGKLFEKKGYRVKYDITWFEQEGRGFYSVDKGYNQVY
NVNWDIPKIFPNLHIEIASKLEINRYKKFATDSELFLECKPPLYIVGYNYSVNLNIVEIC
REIRNFFTPLDLLTNDKIKFLGEEIKRNKSCGVHIRRGDLSKEHVAYGKPTDIDYFLRCI
NIVMLMHKNIKLYFFSDDNKWVKENIVPCIKGIDCVVSDISTPEQGYLDLYFLSLCKIII
GSHGSMGFGAKLLSQEETLFITPKYNSMLFSMHNIMMINFEPKSNTDFSISKVKKIKYKI
LVKIYYYIRQILLRKFLITRDGS
>fig|195.2034.peg.1644 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MEAFIEYSDKYLQDDITALKISWRFCAIRLKFDSALLQLQDINKIV
>fig|195.2034.peg.1620 hypothetical protein
MDMEEYEFESIYKYQDTPLFEAVKESGNYRTVQLLIELGANVNFVPYLTTPLDQAEGARN
RKLLKAAGAMTSDQLEKKFNIFYKDYEDRNEYCDLLNEAIRKDKEKENLQKN
>fig|195.2034.peg.1241 hypothetical protein
MKVLFFRLKYFMQLFYKNLIKILFYRLLRIDSIFSYQADF
>fig|195.2034.peg.965 hypothetical protein
MTKFLSICSLIAMLLSGCGSDFPGQPSDVARVQQNKYPNGNLKEEIPYNKDSRIHGLKRA
FYDNGQLRAEENYKNGKKDGISREYSRNGQLLEEVHFKDNRGYGDFASYYENGNMRAKGK
LLGYNEDGMPEFEGNYKEYYENGTLMCDYNFDNKGKFDGVQKRYDENGALEDEENYKNGL
KNGVFREYKKGEIVREEEYKNGILVAKPKN
>fig|195.2034.peg.1281 Type I restriction-modification system, specificity subunit S
MTNLPQGWEWKSLGEICFITDGTHKTPNYIETGIPFLSVKNISKGFFDLSDVKYISLEEH
NKLIKRAKPEFEDILICRIGTLGKAIKISLEFEFSIFVSLGLLKPKVKIISDYLVYFLNS
YFIEGWINDNKVGGGTHTAKLNLNILEKCPIALPPLKEQERIVGILDESFAKIDESIKIL
EQDLLNLDELMQSALQKAFNPLKDNVKENYKLPQSWEWKSLGEIGEIITGTTPSKNNPNF
YGNEYPLFKPSDLNGDIIIKYASDNLSKLGFDNARNLPKDTILIVCIGASIGKVGLSGVN
GSCNQQINAIIPNSAFTSKYLFFVCLSNYFQTILKKNASQTTLPIINKTEFSKLQIPLPP
LKEQEQIASHLDELSSHVKNLKQNYQAQIKNLQELKNSLLDKAFKGNL
>fig|195.2034.peg.744 hypothetical protein
MEKQHLVNIEQWYCLSYTFNSRRKFYKDNKGFLNNQERYSGRLINRETEISLNSHMNTHI
DFPAHCVKSGKFGEEYPLNFFHSQNVSMVFFDLTKEEIPELTCKYFHKNITILNQVEILL
INTNFHTLRDDKRYIWNSPIISRQLPLFLKNQFPKLKIVGFDIISLTSQLNRNEGKMCHF
NFLSRKGGREILVIEDMYFGNLKKDAIINEIFIAPFYYEKMDGALCTVMVKCEGRK
>fig|195.2034.peg.1536 Integral membrane protein
MLSNGFKLAASESSLAFIWNKMAFGFSAGYSLALLGAGYLVGLAGAIALFVGMFLAWGVF
TPYLSSFEFDGVKNASELASSVWAAKVRLISTGAIAIAALWTLIELLKPVISGIKEIIKN
VTISNTKSQESTD
>fig|195.2034.peg.884 membrane protein, putative
MCTILTEFKFMDFTTPFVLPIYLFILLILMRKKSFNV
>fig|195.2034.peg.230 Possible dnaJ-like protein
MRFYGRDEMQIVQTLETINVNTDDINVFQYFKDLITKNFTKVVGRKNKIFSFFEENEIPQ
RRYFLKVLDQKYRKSTNEGIENLQDAHFKTFRLIFEQNNMLKLMLFIKIDFVAGRILMKL
SSNEKLFITYIRNYFQDHNIEYNEMTNILILEYKNENTLELFEAFADESEHLKYCVNFEV
DREEYKKFRQNIHNKENMKWKFNALAKLFSNYFNTLECTPQNDLSEIRQKYLILVKLYHP
DFHQGKSAIEKAYAREQFEKIQIAYDNLKALYKNNT
>fig|195.2034.peg.743 Phosphoheptose isomerase (EC 5.3.1.-)
MKNIKDFTKEYIFKLNQLLDKIDENIVADIVHLFEQVSKNKKTIYIIGNGGSAATASHWA
NDFSAGLKRRNIISIDIKSLADNTPLCTAIANDIGYENIFKLQLQDVLTKDDVLFAISCS
GTSPNIINAVKYAKEVGAMVIGATGFDGGDLLKLSDIKFHVQTQKGEYGLVEDVHMILDH
IIYSYYMQKA
>fig|195.2034.peg.1535 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAVLSLFKTS
NILENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMICLCGGGLGVLFTIPL
RRAMVVESKLAYPEGRAAAEILKVANKDQSDKKGKQGVKEIALGSFIAVFLVC
>fig|195.2034.peg.1111 McrBC restriction endonuclease system, McrB subunit, putative
MIEFLNEDRKKFKEYLIDFFHNAYNSDKLSSKDEIVNFDFLKNYGFCVKLSYGKGTISKI
PWIIFIRTDTQEYKASYGIYVYCGIKRENGEIIVCIGESEDKTINYLAKNKVDDYNTQFN
KKTYDYKNLNNDIDLIIDKIIENMQWFAKLPLNEIQDRNDLSKSNNKEIRNDGSEMSNKK
ENKNLSLNQILYGPPGTGKTYHTIDKALEILG
>fig|195.2034.peg.400 ABC transporter, RND-adapter-like protein
MKNRVVLIVVILALFGVGAYFIFFNDNEKITYLTQKVKKIDISQTIEAVGKVYAKDQVDV
GAQVSGQIIKLYVDVGSHVKQGDLIAQIDKDKQQNDLDITKAQLESAKANLESKKVALEI
ASKQYQREQKLYAAKASSLENLETQKNNFYTLKANVAELNAQVVQLEITLKNAQKDLGYT
TITAPMDGVVINVAVDEGQTVNANQNTPTIVRIANLDQMEVRMEIAEADVGKIKIGTELD
FSLLSDPQKTYQASIASIDPADTQISDSSTSSGFSSSSSSSSSSNNAIYYYAKFYVANKD
DFLRIGMSIQNEIVVASAKDVIAVPTYAIKNDAKGYYVEILQDQKAVKKYVKLGIKDSVN
TQILEGLSEGELLVVSSSGDNAAPKLRLRF
>fig|195.2034.peg.966 FIG00638667: hypothetical protein
MFKKVILFFLMGFALLQANSLDKCDNTAVVSNLKEKIPSEIFKNLYELSGLKAQGIDYED
YAKGLKEIAKHDGMVNYTDMIEINSISNFDLNFDSCMATINAALKGEQRKGLWSVVYKVS
NINQVKITDITYINGDFQ
>fig|195.2034.peg.1610 Ferric siderophore transport system, biopolymer transport protein ExbB
MLKKIFLFCFLLLNLNAEVNVTDTNLSFDSPKIEAEVPKIELSLSSLYQNADEVVKGVIY
ILVLFSVLAWAVFISKLMQFYFMKKNLDFSIHKIKELKNLNELDQTKGFAGVLSLEIQDE
LEKSEYKNDHIKERIELRLQNTISKQITASKNGLSLLASIGASAPFIGLFGTVWGIMNAF
IGIANLGNASLAVVAPGIAEALFATAFGLIAAIPAVLFYNYLTRKNLKLMHHLDELANFV
YILFHRSYFNDKN
>fig|195.2034.peg.836 hypothetical protein
MLDGILVGIFAGLPSVVVYGFCLNLVYMIWYKYYRGLCYIVIYFFK
>fig|195.2034.peg.651 Glucosamine-1-phosphate guanylyltransferase
MDINKLKLTPDSSIEEALKVVGKERVRLGIIVDKKDKFLGVISDSNIRKALIKGKNLQSK
IKDIYTKNPITIKENTSKNELLKLSAKTDIYDFPVLNDKKEIISIKSISSLLNRQVNSNF
VIIMAGGLGTRLKELTKDTPKPMLKVGKKPILESIVQKLKEQNFENFIFCVNYKKQIIED
YFKKGKNFGVKIFYIKERKKLGTAGALSLIKQDFKESFIVMNADILTELNFNELLKAHKD
SKALMSVCVREFEQQIPFGVIEQNKGFITNITEKPVQKFLVSAGIYVCEPEMLELLNKNE
YLDMPELIKLAMQKGRVNTYLIHDYWIDIGRLDEFVKANEDFK
>fig|195.2034.peg.1640 hypothetical protein
MDNKRLVINPKKNLQNLKEIGEIQEASRKIVRAKELAYKAKNIENSFFETLNPFAKSETD
KKLEALSEADIANAEANRGTK
>fig|195.2034.peg.1232 Hypothetical protein Cj1505c
MKIDCRNLSCPQPIVETKNALEKLQENEILEIVLNSIISKNNVVKFLNSLNLTPVVDENA
QEFCIKVQKKNFDSSEVNIHDYNVLFLKADKVGEGELGQNLLVGFLSTLKNLDHAPSKIL
CVNESVLINVDENHKAHLAMKELEKLGVEIISCGACLEFFGKSKELKIGSIGNAYEILNE
LCGKAKIITL
>fig|195.2034.peg.657 Motility accessory factor
MQTSDIFKKNLDSMKGNVYKKLKEELKNFQELRDFSFTIGKDSLNINLICKKNLKKIYQD
PVQELNENLVFYQQNYYNHPFLFFYGLGNGILYKALLKNLNHKRIVIIEKELEIIFIVLN
FIDFSEYLFNGRIAIIYSSDYNNNTAELIFSLTNINLFFKTYQINIHSAFYETYQEDIKK
INNINLQTIKYLTLKKGTDPSDAMLGIEQAIWNLPEMFKHYSYKELLQKRKGLNKNAIIV
STGPSLTKQLLLLKQYANKAIIFCVDSSYSILAKHNIKPDYVLSLERIPLTSEFFNNDFG
EFDKDVLFILPSLTHPNSIKYLNKFKKDYMLIARYLPFMISLNLKDNGYIGGGMSVAHVA
YELAISLECKNIILIGQDLAYNKEGKSHTDDYINLTLHEKDFERDKGRFTTTAYGGKGTV
ESSEIWTLFRKIFENYAINNKKCIKIYNCTEGGARIEGTIEKPFEEICEEILESEIKKPL
IKLKKKTKKEQFEHMLKSYQKIKKNIQLALSFQKECKKTLRKIQKITLKNEYINMDDIVK
DIDNIRNKLSNKRYFFLHEILGPSLYHEESLIAPIYIQSVNNESQRQNKILSWIYANESL
IETIIDLIESQNIRIKKAIIPLQDELEKRNLI
>fig|195.2034.peg.998 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MEEVQAIVKIANEFKIPLFPISTGKNLGYGSSAPQQRGQVVVDLKRMNKIIEVDDKRNFC
IVEPGVSYFDLYKYVEKQSQCFFRYS
>fig|195.2034.peg.848 hypothetical protein
MFPNILIQIREFLLKNKAQLKQYSRDGRINSAFNEDEITNIIYDNFSINLPNARDWFDFS
FEESGKFYPVNIKITTTRTIDNLNCKLGIYYALTGDIPSFNNGINWDQYFCNLKTNLKEN
SKDYYFLIINKNDVQDIFIASLKSLEKISPNGNNLPFQAKWNENRHPVQREFKEAKDFII
KCFADSLKLRADAYFYFKRYFNEYF
>fig|195.2034.peg.1642 hypothetical protein
MENDIIKKFINTDYKLLEKELEELSKKDELRLEVDQGLDQTLRDLEIISAKIPQEETQKL
FDQCANNAMDAVMGHFGFAAVILDAKDGGNVNTTHNVRNGFYASEKEKQRYANRGKYDSD
NYHQDDNYKRINKEQNVLKKQGKLEDYMTGKKINANADTDLDHIVAAKTIHDDPARVLAE
IDGAKLANTESNLKMTDSSLNRSKKDKSAEKFLADRDKRLKFLAEKEKNGALTPSQQKEK
EKLLKQKEIQDEKFKEQYEQNEKEINREVDKTYYTSSKLYKEALITGTQDAAKIAVYSAL
GVVLKDFIKAIIIELKVTFKEFGNESLKEILVRFKDRFCKVWEELKLKWKDILKNSLEGA
LQTFFQI
>fig|195.2034.peg.188 hypothetical protein
MKGNEHLRTFFQIDPMLATTSQEDFAIKALALMSVLKL
>fig|195.2034.peg.189 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKRSI
>fig|195.2034.peg.1532 hypothetical protein
MLKNILISLILSFLLIACGGEKNKNSSELIRAQSQGFLKNHEAIFVEFKEAIVDFDEMSI
DAKINSKNSKILLTKASDSRFLLDLTYLEANQNYKIEFIYKNIPIVLEFQTGWIENFTYK
AQLEQDEEKAYLHLNYSFGSTYNWQFEDKTQEGLKITLDGKDLAFSLGEFSLDTDDIKLL
DRPQELVLTYDEKIMGFKEAKVLQFQIPSKSKNNDFRLISAEEKDQIATLKFSKELAENQ
AFQDFIQISPELNFRAWSIGKELKISANFEPGEKYKVKIAKGLKSNQGLINQGEEANIIL
QKDLDPSLVFANDGVFLPSGAEYQVYIKSRNVKKIHLKVSQIFANNISEYLRYKNLVGKK
DDSTQEAFYSSDGFNYVAKNVIDKKIELKNQKNTWINTALDLSDLKGKTGIFSVSLSVDA
NDLDYKGENVYRIINKASVSKNLIFSNIALSAQNLNKQLVVHARDFSKNEALENVKIELV
SKQNQILQSQNTNSNGDVKFQIQEDDEILYILASKKNQISVLRFSNPLSTDGYDVEGDQN
HEMIKAFIYTDRGVYRAGDSVHLSVVARENTNPLKHPISFTLINPKNQKVIENQILKSQN
DIYYTQIHLDKNAINGLYRAIFNIAGVEFSKDILVQSVVPNRIKVELNADENRSLDDGNL
NYELSSKYLFGALASNLKYQSFVYFSPKNYHNSKYKDYIFINPSSLIIRASADDKGNLDE
KGRVQSSVEIPENILNSQGYNFNARIVSEVFEKGGRSVKAVRDVNLNRYDYFVGMKALTN
SYVSEGETIDFYAIVSDLKENLVSGKTL
>fig|195.2034.peg.745 hypothetical protein
MEKDKIKFHNNISIVFAVDENYLPYTSVALASLIEKSVEYYIYDIYIIHSNINLNILLKL
KKVAQARKNIIINFINIKSYLEDAIKQYDNIFYEKSYFSTAMYYRFFIPKIFCDFERVIY
CDSDMLFKKDISELFFIDLKGKAIAACRDVAVLYSYRKRSEIWQRNIGHNFDKIGILSID
NYFNSGLIIFDINKCVKIQSVSLCLNILKKYDNLYLPDQDVLNIAFQNNVYFLHLRWNFQ
WTIHIECKQKSLYLSQQIIEEIYEARMDPGIIHYISETKPWKDKNSFFLEWWKFGRKSLF
YGQILYKKVVIQNNHINLDQNGFIYVDVLDYLLLLPYFNSIDLYKHIEQMYNIENFVLYR
KYAIAQAEKYYNKKSFLLSNDEIYFFMPKKFMHLKEVEKQLVKQSAYLNLELYEILKFVN
NLGKKIFLICKNIYPKEYIIEILQKNHIDFYEDIYFYEDIRKKNHDVFLYFGNFLFETQK
VNNEKYQFKYINPRDDFVRRNPKICRIYHCESLESSIVLGLYIKKWLLNDKYIDNYWENF
GYLYGGPLCYGLANFVYNEAVKNNLKEFIFIARDGYVIEKIFNFLQEQFKTDIRTEYIYA
SRALKILSNVNLKDNSLPWDDKISSLFYLCTEALIELKRYKYKIISKRNKLDLLKQYLDK
IRHFSEEVKKSFSRYVEKYSFEQNKIGLFDFVTFEFSSLKILRSVLKKNFFYAYYFYIMP
KSKEKNLFDFADIQSYSTIFFNNHLIGEFLVTAPELPVSFIKNSKINRRYNAYEQYKIEI
YKIICKFELEFSKDLISTFGNFKVFFKSKDVVRIVNFFVDNMDCKDKYYFENIYHSENSA
HTKYVKIFDQYTSAIDIVKNSLSYKIGLRIIQSKTISKTFTLPFALIGIIYQDYIEKKIG
SKLESMNVNFKTPNMEDCYDFIEGEKVKQHLAYQLGECFLKHPVMFVFYSLKIYIKWKKN
GKTTFS
>fig|195.2034.peg.1466 Flagellar hook-length control protein FliK
MSNLTPSNDILNLTPSKTNTTHSSSSKTKEQDLKKSDNTTQDDTESFLNSLLNSIEETNE
FLPDHMKISKKEVVNEAMDKLQNGVFSESDKISIFESASFMQILSLLDKLKADTADIKLA
NLSTQLSQLVKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNLDKA
NFFKGAVDNVFKEIINNKLAHISKNLNQNVQNLNHTPHANLSQNSKMTKKDDTSLLSQTL
KNLDAIISSKKEKNEVKNDNVKIQTDGETAELKNTSKNLTHSESLKELEQENLTNNDKKI
PSQEVQNKEQSKEFKNDKNTLLNESLKKDDKELKNANKANVQDLTPSKNNTTQDKLPMQD
KVSARDKALTQEKIIPQEKVSTQEKTLPQDKVLIQEKPLNNKEGLNQETNNIKNTNFNKT
SNKENVRDSQNLSLNLSPKDLNLNKDNTNFTHYTNKENYTQEQGKIQSENTEKNPLDDLN
SLVKDLNKISQNNTKNITPKETLQHFSQDLKAAMEQYKAPITKLSITLNPHNLGEVEVTL
VQRGNNLHINFNSNTNAMNLFIQNQAEFKNSLVNMGFTGLEMNFSDQGKREQNQNQGKNR
SGYGFKDALDGKNESEKVNLELVLAKYF
>fig|195.2034.peg.747 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTVGVVIPIYNVEKYLKECLDSVINQSYANLEIILVNDGSTDENSLSIAKEYILKDK
RITLFDKKNGGLSSARNVGIEYFSGEYKLKNKTQTIKENSLIEFNLEDNNPCEIYTVYKS
YKAFSNEKDLINFTYPNIDYIIFLDSDDYWELNCIEECIPRMEGVDVLWFDFKFLYEAKR
KNNKSQMFYFGYNEEKIITSVEWLERAKERGLFYFWFAWQGMINFTFLKNIKLKFIKGVF
AEDCHFGVLLFALSKNIYVFPKQFYTYRIRELSLMNFTHKKWVIHPNSYLKKIDVFKNSN
MTRSYHETTSWMQIALEFIKFTNSKHRLSNEVKQHFLPVVCNKALILKNFDQDPLCLKKY
TKDLKIYIQNQPLGAVDRVKQYFRFRVIKQISKDKGIKKILLPFKIVCLTFYYYKDNIKY
RNKFGEKILDKKIPLEYYKDYQKAIEIIKRLKQIICRI
>fig|195.2034.peg.389 hypothetical protein
MFETLLKLSEEPLKSKIKDLYFSKFNYVGAKIDFCITQNLGLLGEINLLWAEAKQGKSEL
KKSFVQLVLTIGKYKFYTEQTPNLLCAFDGEKIAFLPFACLQEIFYQSDINFSVTPSNHT
SEQFLKLLKELDSILNTAQIFYYEKNDEELKTFIKENLTSENISKIKIDKNNFVSIYHKW
NKMVKDTISIDWNLAKKSGIIDADFYLADLLSSENETIGQNLFAILKKDYYEFNKTKSDL
GSIVNERTSFKDNQKAHHEFWAIYERPPREEFWDYIIKRRDLLVDQDVRERKGAFFTSRI
WVDKACEYLSKTFGEDYEEGYYIWDLAGGTGNLLANFTNKKISFVLLLIKPI
>fig|195.2034.peg.838 conserved hypothetical protein
MIKKIISNGRKRIFDTINTKEVKIKYLENNEICITLINIENGEFNNFRFNCLENFKDDAY
KFLTEKTQNNLMEIKNSIVQFSYQENLLLGVAQ
>fig|195.2034.peg.746 Glycosyltransferase
MREIEKNKPLVTVIMPAFNRENYISFAIESILNQDYLNFEFIIIDDCSTDATYNIIQEYA
KRDQRIIVLRNKKNKGIVYSLNRCLERSRGKYIARMDDDDISLPERIEKQVNVMEKDISI
VVAGTYFKPMDENLEFFGNWVNVCKHEMIKLKMMFECPICHPTVMIRASFLKENNLKYSY
KYQYAEDYKLWSDIIQKGGKIINIPEVLLFYRISNSSISRNRLTSKLQKHNSEIIAYHYR
QFILGSEIKSMFLLNHVTPLEFCKKQLIYKAVQEIQINNEQIDYDKVQQFVQYFCGSESN
IHICFIYSSIQLQDLINGIFSILNNSTVFDHFYFYILHEGDFVNEKNILNLRKIKDFEFK
SINIRKYENCFNFTTPYFKYLSILKHINIKKCILINSKIIARDSLNQMWNLDSKGRTIVA
VAEQEMAKINFMNREFMLENCFENSVLVINLKHIFKNNILDKISFLEKTIFIDNNLVSKE
SVIMNIVFYGNWKNISSRYNTHSNLYLDKMSLYNVEPVLISCINSTIYDSKIFINYIQEN
YRDYIGKILEYNMDNDQYTSAIDIVKNSLSYKIGLRIIQSKTISKTFTLPFALIGIIYQD
YIEKKIGSKLESMNVNFKTPNMEDCYDFIEGEKVKQHLAYQLGECFLKHPVMFVFYSLKI
YIKWKKNGKR
>fig|195.2034.peg.100 Beta-1,4-galactosyltransferase
MLKHDCKLESEISNLGRTNKKLKIHRKIAREIFRLYRDISRLLYIFYIKKKLNLK
>fig|195.2034.peg.748 Predicted glycosyltransferase involved in capsule biosynthesis
MPLLSVIIPFGLSKERSYIEERVYEKAKKFKSDKNIEFIFVEGYSSENHKLKDFIQENHH
IYLKDMDQKVFSQGRCRNLGASYAHSDVLLFLDVDCYISLDSFEKILKLIQIKNISQNIN
ALMVLPVIYLNKEASEKIKQYNEKFWDILIQDDLLTAKNTWIKFFAPSSTSSIIINKYQF
LRLGGNDENFIGHGYEDFDLFSRILKTCISFEKMPMNLSYDARNWNFFDFKGFRAWFSLL
GYEACFHGIYMYHFHHIEPNQNAYMQNKDKNHQLFYRHLKNIKKHDLKPLQVFKAKNEKV
LILFKDQNYDFKDISVYMGEIIYKNIRDFFIDKKFKYKILLDFIQQEKITKVFLDARIKQ
KINSMNYCDIFYFQKGILPHSWFFTKNLDWDYKQDLILSKQELYQVEEYFLTLSDDEKKI
ILDFLSEKYDDKYDLYKILYYLINELYSFKHEGIFYQIIIDKEKILMTQKYNKIFYPLKS
FIYKPYLYEIRSTKPFLLLMRILGLENLSAIISHTKFYRLVRKLFFNPRDFLKDSKFYKR
YSNAN
>fig|195.2034.peg.640 Similar to imidazole glycerol phosphate synthase amidotransferase subunit (LPS cluster)
MQLFLERGYEGGVCEGLGFIEGEVVKFEEDLNLKIPHMGWNELEILKQEPLYQGIDDKSD
FYFVHSFYVKCKDEFVSAKAQYGHRFVASLQKDHIFATQFHPEKSQNLGLKLLENFIRL
>fig|195.2034.peg.109 Glucose-1-phosphate cytidylyltransferase (EC 2.7.7.33)
MKVLILAGGLGTRLSEETGLKPKPMVEIGGKPILWHIMKIYSHYGFNDFIILTGYKGHII
KDYFINYYTQYSDITVDMLDNSVQIHNTRHEPWKVTMLYTGQDSMTGGRILHAKDYVGNE
TFMLTYGDGVSDVNINELLKFHKQHGKAITMTSVLPEGKFGALDIDDTTNCVKSFTEKPK
GDASLNNAGWINGGFFVCEPKVFDYIKEGDMTVFEQAPLRNLAQNGELYSYQHHGFWKCM
DTLKDKNDLTKMWIENKAPWALWLDKSHGEG
>fig|195.2034.peg.786 DnaJ-related protein
MFSLKFKIQEYLQCKNCLKINPEEDAKFCIFCGKELNHPARQRLDYIYSKNPAIIVALLA
KVAKADDKIITKDLSKFISSLLDKIEMFYSKEYSGFRNTYASIFEYEKNQGRSIHELCTG
ARFYEKEIDFLICLLLDLIYYDAKMSANENALMENIIVGLGLNLIKFREVKLKYEQIYNF
THEKAQQEQPKEDKFTITLEQAYEILNSHPKDDFETIKKNYRKLAKEYHYDNLHSKELPP
ELLKIAQEMMKKINLAYEIIKETRGA
>fig|195.2034.peg.1288 Catalase-like heme-binding protein
MKKYISSCLAICCLSSAIYANDVKYDAQKIADIFYQLNADPKNPKVKVNHAKGFCAMGTF
EPAQSINKEIDVPLLTYKSLPIQVRYSLGGAFKDDKSKTRGMAIRITDPQDSASWTMVML
NTEINFAKNPKEFGQFFEMRLPVNGKVDQEKISKMMQEVDSYRNFAAYTDKIGISKSVAN
TPFFSIHTFYFKQADGENYLPARWKLVPSEGVAYLNEAQMKSASSDFLKEDFKDRVKTNK
PVEYKMYLVYANKNDIINETTALWSGKHKESLVGTFKVNALSDEDCNFDVYFPSDVPQGV
NPPQDPLFDVRNEAYAITFGMRQ
>fig|195.2034.peg.809 probable periplasmic protein Cj0413 , putative
MCLLGREFAANTRLPLDLNKALLLFQKACKLGRLDSCVRINNIKFKLLKKLDEETYQSNL
KYFLDQNSSFALLEHITTLSKQDIKSAIILAKKKLRARHDAICAGLSYMYACGQGVEKDL
IKAKELSSKACEKDTKLCFAQGWVELFNQNDILAQKLFYKSCQAGYYTDCNMAVDKNSKD
QAMQLNLIKITQKNSQNQCQNSSNKQSFACHKASALSKEILKIQLKKISEKLLFTILI
>fig|195.2034.peg.111 Acetolactate synthase large subunit (EC 2.2.1.6)
MKASDFLVNFLILNKIDKVFGYIGGAVAHIYDSISKNPNLEIINGIHEQGSAFAAEGYAR
VTGKSGVVIATSGPGATNLITTIGSCYFDSIPLLCITGQVNTYEFNYNKISRQIGFQETD
IVEIVKPITKYAVMVNKIEDLRYELEKAYYISHFQRKGPVLVDIPMNIQRSEFDFDQAKS
FFKTKEYLNMQNYYITSNNLSIKQIKHIASKISKAKSPIVLVGGGVRNSNACEILDFFLK
KYNLPVVHSLMGKDAIESGFELNLGLIGSYGNRCANLALANSDVILVLGSRLDTRQTGTD
LKLFAKNSEIIQVDIDNNELGKKILTKIQISSDIKLFLDELIKQKIQCKCIQWRNWVKNI
IKTLPNNKDIYGNIKIENFLISIISKKTKAPIFCIDVGQHQMWAAQALSVLKNTRILFSG
GMGAMGFSLPCAIGACIASNQPVVVIVGDGGFQMNIQELEVIKRRNLPIKIFIFNNENLG
MVRQFQEIYFDKNYIGTIKDYSAPNFESVAKAYGIQSRTIENLNIFDQISDEIFSNNQPE
VVNILLNNKLTNVEPKLIVGKPIEDMYPFIEKSKLKELMFLKNKD
>fig|195.2034.peg.1233 Methyl-accepting chemotaxis protein
MFKSLNIGLKLIFSVAAVVVIGLVILISLITKQVSQNITKNTEDILASITKEYATQTQGI
FGEMIALNKSISGTLTEMFRSTSKEDLDIDNITNIITNTFDNSAYSNFTYLYLIDPPEYF
KEESKFFNTQSGKFVMLYADEEKDNKGGIKAIQASDEIANLQVVQDILKKAKYGENKVYI
GRPIKMNLEGQDFNAVNVAMPIFDRKNQVVGVIGMTLDFSDIATYLLDPKGQKYDGELRV
LLNSDGFMAIHPNKNLVLKNLKDVNPNKGAQETYKAISEGKNGVFDYIASDGDDSYAAIN
SFKVQDSSWAVLVTAPKYSVFKPLKKLQLIILGASFIFIFVVLGVVYYCVRKIVASRLPV
ILSSLESFFRFLNHEKIEPKAIEIRANDELGAMGRIINENIEKIQISLEQDQNAVDESVQ
TAREIEKGNLTARITKNPINPQLVELKNVLNRMLDVLQSKIGSNMNEINRVFDSYKALDF
STEVFNAKGEVEITTNILGKEIKKMLVASSNFAKDLANQSEELKNSMQKLADGSNAQASS
LEQSAAAVEEINSSMQNVSGKTVEVASQADDIKNIVNVIKDIAEQTNLLALNAAIEAARA
GEHGRGFAVVADEVRQLAERTGKSLSEIEANINILVQSVNEVAESVKEQTAGITQINDAI
AQLETVTKENVEVANVTNNITNEVNQIAAAILEDVNKKRF
>fig|195.2034.peg.1249 hypothetical protein
MFFILLYDLKIYGGAKNLFKNLFIAAGIGFFGILISTSSLFVILEPRTQLQPDLF
>fig|195.2034.peg.406 Major outer membrane protein
MKLVKLSLVAALAAGAFSVANATPLEEAIKDIDVSGVLRYRYETSNEWSDINGVAQNEGS
GISGKQDHKYRAQLNFSGAIADNFKAFVQLDYNAKDGGYGANNGSTTRSYVADNSSTLNV
RQLYLTYTDENVATSVILGKQQLNTIWTDNAIDGLVGTGIKVVNNSIDGLTLAAFAIDSV
NTDEQGDGVFFKNNSLTDAGDNSPYLDWSQNIYGAAAIGSYEVFNGQLNPQLWLAYMSDN
AFLYALDAAYNTTIFDGINWTIEGAYLGNSLDNKLEDRYKVVNESTAGNGNFFALRGSVE
VNGWDATLGGLYYGKKDKVTVTVLEDQGNIGSLLAGEEIFYTNGSQLHGSLGRNIFGYVK
AGYTFNETVRVGADFVYGGTKTENRSGGDKLEAVARVDYKYSPKLNFSAFYSYVNVDKDT
DSTHHDAVRLQALYKF
>fig|195.2034.peg.739 probable beta-D-galactosidase
MAIITNIHHIHRFLNDSIVLEYLYSVCNEVHKNRLRIFELPLNICKKEYISKDFFSLEQN
YMTKSRNECFWESHKKFIDIQLHLDGIEQMEFIDASYLEILEEYDQEKDLTIYNDSSYSD
KIVMRKNDIAIFFPEDAHLGMAMYNKMPSNVLKTVIKYPIGLWK
>fig|195.2034.peg.648 hypothetical protein
MQNSLQTYTQKYDENNYGLLYPDSHVIRFYERILKYKLGITSGNLLDFGCGNGVHSKYFL
DKGFKPFGIDIVPSLQKNWDAKIKISGGGDCKIIEPNSSIKGLFDEKMDIVFANQSLYYI
PKTELKQNILEFYECLNQGGILFATMMSEKNYYFSHSEKENENGLRKVSIQGRLNETTYI
HFAKSIDELQELFKPFEALFLGDYDPINFYNFEGSAHHFIYIGIKR
>fig|195.2034.peg.1251 C4-dicarboxylate anaerobic carrier, putative
MPVFMICSTLLAVIVVAYYILKKYNPIFVFFLSGIILLIFAFYITGTPIPKAPSREHTSF
>fig|195.2034.peg.1370 FIG00470755: hypothetical protein
MFSFVFVFKFIYFCFKKISYFTWKKLIFIITTLLGICAGLAYIFFCLYYQLYIFDNYDFL
GKFYNIPSYKRPLNFIF
>fig|195.2034.peg.641 Similar to imidazole glycerol phosphate synthase amidotransferase subunit (LPS cluster)
MIALIDYKAGNLNSVAKAFEKIGAKNFITQDPKDLQKADKLLLPGVGSFKEAMKNLKELG
FIEALKEQVLVQKNLF
>fig|195.2034.peg.788 hypothetical protein
MVSFFLIASLSIYQYFYGGKYSRVYINKLEGKCHYDDASSCKMLQTIYKEKCDDGDGKAC
FAGIFVSGDLIRVKIDGQWSFLDKNGEIIAKPEFDDIWGFSEGLAKVELNGKYGFIDRSG
KFAIEPKFDSGEYFSEGLAGVKLNGRWGFIDRSGKFVIKPKFDSIWDFSEGLAKVKLNGK
YGFIDKSGKIIAKPKFDYGEYFSEGLAGVKLNGRWGFIDRSGK
>fig|195.2034.peg.1520 hypothetical protein
MIGTDLHNAKDENGIFYVRELYQRALDKGGFVTFHFTKPQPNGENTIAEKTAYSYLIPNA
DDLWISTGVYKDTLEPYIDRSLEELLSFFSKSFFKTVLFSIIFILIIIPFIFIFYRNLIV
GVQGIDANITSFFNFINHKTKNVSTIEIKTNDEFGQISKT
>fig|195.2034.peg.114 hypothetical protein
MKDYLTQKEQLSIINDIEKRFLKFWEKDFDCSIFLTCRDNFALTKDVYSVHFIKQEIVKK
PKFTIAIPVYKRIEELKRALKSALSQNYNDEYEILIVENPNENDNNGIYKMLKEEFNGKV
NFYKNESNIGVFNNWNRCLYLAQGDWVCLLHSDDELMSDYLAEMNYFLNKHSNSILIGCV
DQIRDVYPPDKCSKYKYRLLYFFEKLFCFRRLIEKKSIRCKNWARYAKYGEAIFLPPNAI
LHNREKCIKFGGYNQDEEPNGDQVFVNRMKQLGEVVLYRKKILQKKYEMDSHGLTPGCIM
QLSFLDPQVFYALISSKKRAKKSAYRQMMHYKRVLQEKKCDILVKYLDDFLKKYGFK
>fig|195.2034.peg.850 Dethiobiotin synthase BioD (EC 6.3.3.3)
MKIYISGIDTGVGKTYLSARICKKLGFDYFKLIQAGTPTDSEFIAKFSPKTKVFKEGVFL
QTPASPHKGRILENLSYKAFDIQIPQSNKLIIELAGGLFSPIDDEKTMIDYISKFKYPTI
LVARTYLGSINHTLLSIEILKQRDIKILALVLKSEDHFSKDFISKYTKIPIIEFDDRVCY
GIKKILKNL
>fig|195.2034.peg.655 Motility accessory factor
MNNELFLKNTQALFEVDQPLAYALRILKNIENYNIDKNSDGLNIINKQMQKIYENPNQEL
LDQLVYFQTHYKKYPVLFFYGFGNGMLYKTLCENKNHKHIIVFENTLELIALAFSLFDFS
QEIKSEKLILFYTPNITTAQLTTLFTHPNIYNCLKIYKLHIHSNFYQQLYNQEIKNLNTK
LSETIKFIALNYGNDPKDSLIGIKHTLENLPKVLNHGIFQDFLKERRGKVKNAIIVSTGP
SLTKQLPLLKKYGHKMTIFCADSSYAILAKAGIKPDYVLSLERVHYTSELFNNDFKDFDK
DILFIISSLTHKNTLHYLEKNNRTYMLVHRPLESAGILKLDNFGYIGVGYSVANMAYELA
SALRHENIILIGQDLAYAEDGSSHPKDYLYLEQADNTDNTTTLAYGKNGLVKTTLTWNLF
RQTFEKDIFWTKEKLNINTYNCTEGGAYIEGSIEKPFLWACENLLDESLNKPFSFPKSLS
KKEANDKIDKIKKILQSAILQANKLIKSTQKELNKLKFELNRDEINLQTLEKIRKKLLIS
FKEYKKLKLFNELSRALYFHNECEIVKYEVMDDENQKKYLSHFLKLQYNWFAQGLGYLDT
QNKIIQEALQNWHFDDIKE
>fig|195.2034.peg.113 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MSIQKLKQEILNKTREYYNLYHKKNSYKFTAGTTKIKYAGRIFNERELEYLIDSSLDFWL
TYGAYSERFEKELADFLGIKWAFLVNSGSSANLLAFYTLTSPLLKERQIQRGDEIITVAA
GFPTTVAPIIQYGAIPVFVDMDLEYANIDTTQLELALSSKTKAVMIAHSLGNPFNIKAVK
DFCNKHNLWLIEDNCDALGSQYDGKYTGTWGDIGTSSFYPPHHITMGEGGAVYTNNPLLK
KIILSMRDWGRDCWCKSGVDNTCGCRFGQQFGTLPKGYDHKYVYSHFGFNLKVTDMQAAI
GCAQLEKLPEFIEKRKYNYQRLYEGLKDIRQLELVQKQPNSEPSWFGFMITVKEDSGFTR
NEITNFLEQCNIQTRTLFAGNITRHPAFTSLKLNVDYKIIGNLKITDKIMTDSFWIGVYP
GMSDEMIDYMILKIREFVKR
>fig|195.2034.peg.212 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNFKQVLENLGFKNKNENYIKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAQHLELEPKWNLGRDKKGGKADILVKDNKNNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYLQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFEQGIFEANANAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIIYSLPLQEMLSKNSKTLRVIDYACGAGHFLNTYANELKRYLKEEELKEHYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKTKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIIL
PSSILNKDSIYKNTREILFQNFDFIAIVELGSQTFGATGTNTIILFLRKKETFKQENHLI
SQDYSLIKERIEAENLKDNENFYQNYLSAYCDFRKFDKELYSNFLNGNLDSNLAELEAFK
DYRNAFRQTSDYKKLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLI
IKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLICKAFLK
TLSDIPKDLQGYASKARLIDMMDFEKVEFNKAISLNVKSRDELNPFKNSKYELVRLGEVC
DLNKIRNQASATEIEKMNLNSGNVKLLPSSKNYEWWTDEKTAGQFINEGEVITLGVARYA
NIKKHKGKFVSANNHILSVKDKSKIIFDFLYILLEICGQKLYKQGQQYPQFDTNIFYSFK
IPLPPLEIQKQIVAECEKIEEQHNTLSLSIKEYQKLIKAMLQKSGIIEDNQEYELNSILE
NLQKLESKLDFNLLLSLIEEQISHSEVLVEETQSKERKQDFNAFKNFSKTIQELLQTLST
LPKDGWKRISLKNEQYIELNPSKKEISKLDENMLVSFIEMASVSDKGYIQSKIDRSLNEV
RKGYTYFIENDILIAKITPCMENGKCAIAKNLTNNIGFGSTEFHIFRAKTGLDSSFLFYN
LNQQNIREKAALAMTGASGHKRVPISFYENLTIPLPPLEIQEKIVQNIELVEQQIDFLNL
KLELLEKEKEKILQKYLFS
>fig|195.2034.peg.643 Pseudaminic acid biosynthesis protein PseA, possible Pse5Ac7Ac acetamidino synthase
MKFCKKCVMPDTKPDLHFDAEGVCDACRSQEAKNKKINWQEREKEFFELIKKYKKHSVYD
CVIGVSGGKDSTFQVVKMLELGLNPLCVF
>fig|195.2034.peg.279 Uncharacterized protein Cj0990c
MKITFQGKSDEYEIEKSYFYNRAFIVKDKIPNRDKIDFITDSVRLLEFSDHSFEFDEILK
CLYDENEENTIIVEEIFTTSQIKQDEEPRNPPLEIKIDEAPKNNIRFTPFNTFSRIFNKD
CFIFTSDNCEQKESVKVEKNQKLNIFELLKIEDLDASNDSVNFDLDAFPSGASYKYGISQ
NTMYIILQGKMPSLLLLDFLKSFVYKNKKELACEKTFVLMLNHKLVYELKAFFT
>fig|195.2034.peg.1459 FIG00469675: hypothetical protein
MREIIAVKKDFIAFNKKSFCQDRLLTSGKAYYLHYKDNNKFCGYAGKECAKQKCNNDLNA
IPDFTKSLISNFKKETKIIQGKKHTHRANLSKSDISMAIEYVVLRQSKMKKFKKANYFIL
NDYYKEYLKTNILSPNSIKHIINIEKKAPLRFKLENLLTCYAYEYKILLALKSIPSNKRT
YLSSILSNLRKYYTLTDRQINGVERWFKKIRNKEVAEAKLKKFLYQKPHEKIP
>fig|195.2034.peg.1383 SSU ribosomal protein S11p (S14e)
NTMVTVTDEMGNAIAWSSAGGLGFKGSKKSTPYAAQQAVEDALNKAKEHGIKEVGIKVQG
PGSGRETAVKSVGAMEGIKVTFLKDITPLAHNGCRPPKRRRV
>fig|195.2034.peg.964 Putative integral membrane protein
MEGASGGSIFVTILLFVLYMLPAIIGLSRKHSNWLIISLLNLFFGWTIIVWLVCLIWSFT
GSFKQTIIIKEKNEK
>fig|195.2034.peg.654 Glutamine--fructose-6-phosphate transaminase (isomerizing), glutaminase subunit (EC 2.6.1.16)
MLENKIIFVAGACGRIGKALCKKILQNKGIAILADINENHLSILKTELENEFKKELLSLR
LDITSKESLNCAIDQAFEKYSKIDGFVNSSYPVGKDWGKIAYYEASYEQICESLNLHLGG
FILASQEFVKFFKKQSYGNIINLSSIMGVFAPKFENYENTTMQSSLEYSVIKAGINHLGA
WLAKELFNTNIRVNTLASGGILDNQANIFLEKYRKCCASKGMLDAEDICGTLVFLLSDES
KFVTGQTLVVDDGWGL
>fig|195.2034.peg.1250 hypothetical protein
MIPKNPQTILAIALKRISFIFFEVKFHVNFALKFLKN
>fig|195.2034.peg.556 hypothetical protein
MKIILLTILSFLSLWGLSFDELIYKNEVRASFDCSKVKNNGKNDDELIICNKIGAINEFE
NKKLALMDNIFISLYQELLKNANENIKEDFKLVVKKMFRERKNCAKVISNDLLQADQDPQ
SPFFVYKTDCIEKTYAKVFLELMQKAKKDTQSKERLKQIFNNQVDRYENLIQMSIQDPID
LEIFIDNLAQEGLIDDNARLKL
>fig|195.2035.peg.668 Uncharacterized membrane anchored protein HP_1479
MARSQALSSTNVKISNIINDALNQKLRLANKEFQALLEDYPEHSILQYNLALTYAQMQNY
ELAYKHFSSSYHLNPKNYLAGAFAMFCGKLSDNDTTKLYHEILDNIAADSNFKANMQKNM
LFLANGDYISMLPYLDENGQKTPLNLIFETIIAKNNNLNNQVDVRIAKLRSELPQDIVAN
ILYFNSLNSNLNIKEYAQNAQIHFKNLQVDYRSVFGGSNIARELYVNLMHIAGLLNLERQ
KFKTLINTSKVKDEGMIQTLAYLDIFAQQYEESYALYNTLIDEYGAKDSRTLFLASVAAV
GANNPNSAIALLQLSKLTDKNNKESKVALGLLYQEVGNYEAAMTQYRTLPNDFKSEFFTF
DIKNQ
>fig|195.2035.peg.1679 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAIDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLSFQCEVKSIHKGNSGIDLALKKDGLTQVIIEAKLPNSREFFSPSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYSFFIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EIYKEFEKILNGDSTLKGLFVDLKPILEQDKLSFSKLKPLFKIFSKDCLLGEFNPNDANS
LNNAFYKELLYILGLCESKQNSKLIIAKSEESKEEQGTFYTAINSKLKEENFETILKLLI
LWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEVLAKEKSTRKKSEFA
YLPYLNSSLFEKQSIENTLEISSLSNDLKLFYYKTPC
>fig|195.2035.peg.1573 hypothetical protein
MNNTINFNELFSQIRLSSYDNNIVKHYDNLKLVGKITPKIATLEIILRNKLDNKLSEQDS
NWIKNSNDENIKKAKDEIEKREKNRILSHHQYLSRISLGTIIYLIKENRMQDSIMNLKNI
NFRNYNQYNRNFFLKNGKKRNFGNIYKVDIVLSLLQNLRNRSYHWENILKTTEKNGKHYP
RLTTKIENVYIGINPQKIELFLDDLIKTFDERILKYCQD
>fig|195.2035.peg.1570 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MNLDLFQTLGESIQQIVDAIRQVGTNDKVANFKSK
>fig|195.2035.peg.371 Citrate lyase beta chain (EC 4.1.3.6)
MSLISTINIIGVVLPKAQSYEDIDMLSQFELPIIPIIESALGVENLDDIARHPNVLALSF
GSLDMTLDLNLQEGEGKNFILNSIRTQIILKSTKYNLLSPINGVYPDIKNIDGLKEDLIF
AKSMGFFLGGGGLCAFIQTKLHQLMKFLAHRPSKLHGQKKFYHLGKIAMILFLTTME
>fig|195.2035.peg.431 Putative aminotransferase
MNFINLQAQYLKYKEEIDSEIASVLSSSSFIGGAKLNEFETNLAQYTHVQHAIGCSSGTS
ALYLALRALDIKQGDEVIVPSFTFIATAEMVALLGAKPVFVDINLDNFNIDFELLKNAIS
PKTKAIIAVSMFGQMSNLQELNTFCESKNISLIEDGAQSFGASFKSEKSCSIAKIHALAF
FLLSP
>fig|195.2035.peg.1680 Putative type IIS restriction /modification enzyme, N-terminal half
MLKDDKCKAKKGQVGLLEYLFEFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGY
KEGSFYTPSFITSYMCKESITKVVLDKFNAQFDLDAKNISELRKSLRKEDKKAQKELLNS
IKICDPAVGSGHFLVSALNVMLSIYDELNLFDEEFYLEVQNDEILITNHKGEFIEYKRPS
TPKDKAHLIQQELFHTKKDIIENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDENY
HDLKTLPNIDINIKCGNSLVSYFETGKSLNHYPNIKERINKYKRIVKDYKEGFYTDKSHI
NQEIKNLKISFKNFCFVDKFKKEMKSFNDKCEKYSKKYGNFLAVDDENLKFFVSANLTLF
DFDEKEATKEFANLKKEYDNIFNLESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIR
QEELKELKPHLAKNYKVYKGTSDIYTYFYELGFNVLKDRGGGIELYHF
>fig|195.2035.peg.1682 Integral membrane protein
MEEKIKQAIENIAKNLEVHKEYIRFDNTEQIYIIEDYLNNKIIEIKKNIKFDNLIDYPLK
FYYCDFLETVIGRNKTFKEKIIFEEVVFCKVVNFSFSIFDKNINFSNVKFEDKLYFDKCQ
FKEKFEFFGINNLKAEFNSSHFKKEVYFGKEITDKNVEKSNSFGSCSFEYANFSNCHFKK
EVYFKNNDFKQVFFRNSKFNNNIHFNNSIFKDYADFHECEFEKTANFYRVRFDKTPNFSQ
AIFKGNLNAVNTNLNFTFDDLQERIKQEYAFYETQRTAKEAGVIPNLYQEKSLDKFANDF
RDSFRTFKNALIKDNNLLDASNFHKDELYCKEIELKESWNKLKKVDIDEDIDQNNKNYSK
LMDFLLLGFYRKLCDHHTDFLKVFNNLILLIALYALFVFGFTWLHDDKLEDTRAILTLFG
FFDKFRLYFDIISTIFVVFGCGFFVCKLDSYEKKNNVSKKQNINFIYIIGDFLNLIKSLL
FASFIPCVFYVLFLLFGFFLNLGKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFS
YIGIIIILIKQPNVIHPLIGKIANESDKFFNYPSLIVLNILYTILLALVLFSLQKTARKN
SIVPS
>fig|195.2035.peg.40 5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2)
MQKTSFRTLQKNRLAQHKKLKFKQDFIVFKECFNLIKKTKAKNILIFIPLGYEPNLLKFR
HIFSKNHKLFVPFMQDKSLKIVKLRLPFVKKRFGVLEPMDSFLKTKIDIAIIPVIGVDRE
LKRIGHGQGFYDRFFENLNYKPLVIFAQSINAISEKKLTQEHDIAGEFYINPYKKYYKKD
NKYDRITYRTYNRYSRSWNRIFSCKKNQ
>fig|195.2035.peg.1681 Putative type IIS restriction /modification enzyme, N-terminal half
MSYITSNKYTRAGYGEALREFLLKNVKFLEYTDLNGIKVFDSATVDTSILCFEKSKSKDN
KFKYLALSNEILKTCAYDIGLYKDFAEFSQNSLSKESFTFSDENTSALKAKIERIGTPLK
EWYGLNINYGIKTGHNEAFIITTEKRNEILANCKDEAEKERTAKLIRKMLRGRDIKRYSY
EWAGLWVIGTFPSLKLDIEQYPALKQYLSQFLPRIEQSGEKGCRKKTSNKWFETQDNIAY
YEEFEKEKIVYPNMNKEFIAFFDNEFFLLNQKCFILSHQSNNKKELLYLTALLNSNVNFY
YFKQIGAKLGASGYEMSKIFVEKLPIPKINSKNQKIADELINLADEILKAKEQDKNANTQ
ELENKINSIVYKFYNLTEEEIKIIEGK
>fig|195.2035.peg.1617 hypothetical protein
MDEWELERQRQINLQNLRIYHFEMDFLFHCVFTY
>fig|195.2035.peg.430 Putative aminotransferase
MTNCQIPKIDENAISAYAQYSVLVEDRARVLKAFEKANIPYAIHYPTPLHKQPCFSEFSH
LKLEKSEFASKHILSLPFSAFLSQSEQESVIKVFKEGL
>fig|195.2036.peg.1713 Flagellin
MGFRINTNIGALNAHANSVVNSNELDKSLSRLSSGLRINSAADDASGMAIADSLRSQAAT
LGQ
>fig|195.2036.peg.1716 Flagellin
KTTGVYAIKEGTTSQDFAINGVTIGQINYKDGDNNGQLVSAINAVKDTTGVQASKDENGK
LVLTSADGRGIK
>fig|195.2036.peg.1557 Hemolysin, putative
EYNQDLVSSLDKNFALLDSDLKKATRGCYCFKG
>fig|195.2036.peg.718 FIG00471048: hypothetical protein
MKITSQITKPKRLNAAQWKTIFIVCFVFAVIMISSLFLALNPHDETLKK
>fig|195.2036.peg.105 hypothetical protein
MGFNVNYEKGMSDKAIVNFYFLGGWNHYFLDSLKNNASFKDASLNKFYTKSKLSNQDSLY
LQGEIDFTHN
>fig|195.2036.peg.807 N-Acetylneuraminate cytidylyltransferase (EC 2.7.7.43)
MKFTAVIPVKADSSRLPRKNIKPFGNENLLTRKIRQVKISNIADRIIVSSDSEEMLQMAR
NMGVEAILRPKDLADESKPFSDFLDYITKLIPEGHLVWACATSPFFDEQLMMQAKQEYLK
ALTEGHDSLIAVYKFKHYMLDENGPLNYKLGLAHQNSQDLPPLDFFTNGIIMAPIISVAK
WHYHYGPNAYRFIVDQKASIDIDTKYDYLTALAWLDEDKLMGGG
>fig|195.2036.peg.717 FIG00471048: hypothetical protein
MAVIFGIGSEKEAFKNVPWDLIFMIGSLSMLIELSKTTGIMENITIFMSAHGSSSSNWLY
YLLGILSSCMSAFASSMGVVMPTFFSIVPSIKALEPSLAFSIIAVFATFTGYSSFSTGGA
LVLAGAQDESEKRYLFIRLIILPLILVVFGFVLLFLGILN
>fig|195.2036.peg.933 aminoglycoside 6-adenylyltransferase
MQNQDKFLKQFKKLALLDKNIRLVTLEGSRVNKRAIQDRYQDYDVSFFIKRKNLRKFLNL
KKNKAIKKAKLPKFIKKFGEILLYQAPEGFEFYEGNLPKNWVSFLVIFKNGIRVDFKFIP
LKALKFYYKFEPLSKVLVDKDRKFKKPQHKSAFCIKKPTKKDFDEVSNEFYWTFANLEKA
LLRKQLILANSLLKSMREILFDMLSFKVGIKFGFEIWLGKKNTDILKFLKQKEVKVILNS
FNTASIKQIKQTRKKLEILFHKNAKFIAKKSDFKLFPYRKNVKRYCKILGKL
>fig|195.2036.peg.385 Putative efflux pump
MENFNRTLWVCWFGVFTTSMGLSQIAPILPLYIKELGHTDTSEIAFYSGLAFGITPLGMA
IFSPLWAYLGAKYGYKNMLLRASLGMSALTLWLSFAHDAMEVVLIRGLTGIVSGFTAAAV
VFIAVIAPKEKVAYALGTLSTASISGSLLGPLFGGVVAGIFSISAVFDLVAFLLACSFVT
IFLFIHERKIQKEAKKILKNLKKIKNLLLLFLSQLLSFSLELLGLCLF
>fig|195.2036.peg.1140 Flagellar motor rotation protein MotA
MGLVGAVFGLILALKLLDNPQAMAAGISGAFTATVTGIFGAYALFAPWGRKMKANGMDLV
KEQIVITEAIKGIAEGANPRDLEAKLFNFLSHDDPRISQFDKG
>fig|195.2036.peg.443 hypothetical protein
MLINQTFEIDSCDDVELNIKRTSKLEYRISYDDEKEMKAIVFIIGGFGANANISFLDFDR
EYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTMFTKDDVSNLSQALLEIGVNINVNLEN
AQQCYELLNQNITTLKSQRKLAQNYQAKFTSTFIPPNGDYQNYGIMAALDHINALKDLVK
RFPKLADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGTVLPLLRYIIGRDLEQFDF
IFNDPNTLIEMFTKTYWTREDENSPYFFANENYMIRSLLNSHLIIQVNVNKNIVLVSYHS
SKDEFNTSKDKQTLFLAYKELGYDATLHLIKDESEIDGRFIKDLNHGMRITDRALFRKEL
PLMLEKLQKRKSFMQENSISYPCGNKVFTFKDVGDKFVLCIK
>fig|195.2036.peg.1467 hypothetical protein
MIVFPLSSFNRYFGNNPLQTLTKIRDESIENGNPELAKKQREELGNDLIDLYKISKKFSD
KIELVEGSIEDKLRNNELPESEVKNLFQWMDKNAKHPRWMHIDGVSYDEAYVKIFHTSKS
IDEFKEKYLKLQKKYFVDFNNIDSSQKKLQETSEEDKEKPFKPIQAQSSSETYKEDNTR
>fig|195.2036.peg.1643 hypothetical protein
MLSALYKAEIEGYKFIKTGKDMALIGHTQDNKWIKPYRCIISIFSKSQFLDESTNEIYIY
KIDLFLLLMIKLLRKVKNKNILELNNQLEIFNINNSRQKQYYKFEFFKNQKDFIENHR
>fig|195.2036.peg.905 hypothetical protein
MAFYFIKRFDLLAHINEDYLDSRGGFRASLFQNKENKEFILAIAGSDLRPLKFDIGDLIS
DFILLNGKIPKKQFDSLLKFYTLIKKEFCFGKIALVGHSLGGHLAQLFVLDFALEVQNIY
TFQAPGIAKKILKDIKNEAYIQKISYHFHTCGDFKKMHGINLILFKICILK
>fig|195.2036.peg.453 Motility accessory factor
MKFNLNQKELFNKNIEALGNILLKESLKEIKSSKFELILGKDNLDINLKNTNDNTFLYEN
VIDELNNMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHRHIVVFEKDIEIIWVMFH
ILDFSNELQKNNLIIINTNILSEFDLSNFYKKANSIFLQFSRIYFLELISNYYERYNEEI
LKLNDTILSTIKISIIQYGNDSIDNLMGIKHFIYNLSKLLTHPYSEIFLKKRYKLSDTAI
IVSTGPSLTKQLPLLKQYANKATIFCADSAYPILAKHNIKPDYVCMLERDDIVSKCFDND
FKEFDKGILFILASVVHKEVIEFLERNNREYMLVPRAYDFFYYLNLAKYFQPIDGMVSVA
HMNYWLAKFLSHKNIIFIGQDLAYSKDQSSHAKDFIHEKLHEGHFQKDENLFTSIAYGGK
GEVESSYFWKLFRELFENWISHDNNFINIYNCTEGGARIKGTIEKPFLWACENLLSKNLN
KPFPKLNPLNINKQNELMLKAYNKIYKSIYHCKDFNKKLLQEYNEIKELYLTLENLQIEE
SKELLNFIIQKIDTIKYQIDDAKNMQDLYEILGPLLVQFELNLARIYVLNPKTPEDSFNK
SLIWIKEHLEWIEMIYGHIQAQENALFENIIPLEQKLKERKLNKWMERVKNANK
>fig|195.2036.peg.808 hypothetical protein
MTKVEKLLSSLKNFEFYLNNKTIYDYKTYKGEIADIREAYINNNIQYFVNFWNLKNQEKY
FELKHPILNYITTRAIFSIQLNSANFIFMIDKENKYPWIIGQCQSLVDSIIVENKLYIIS
SVMQTDLLNQIDKLSQISPSVFSFKDIEFGYILSQNRPFHHFYDQLRYFYSIDKPKKIFN
NSSFFIPNHAEKTSEGLVYVFPTGICVNQIGSRSAYAKISSTIADILDDYLEKQMLKNSL
DSKSYINNKKYELNLWFSICSEKRVWLQQTSGYVNIIKELLKYYSNIRVFFDGITAKEGE
VIDYKQDYRIYDKIKISLKDVSKNKYEFVPLIGVDYKTKIYYANEIDFFIASGGTAPIVP
SRICRKPGIIIGNSNTYNLGMKNENTIVIELDRIQDVVAMRYSAFQNFHISWEYIFSLMC
QYFKLEFNDSIPNNNEVVLQWIFDSIKDLSKYKQSWQSFLLELIEIFEQANLIDIADILL
EKVVVFLDENTKIKYINKKKIYQEYCSKKQFESTIAELKSLLSQKELQLQNKTNELKNLQ
EDIIHKKQLLEVQNLEQDLNLKSLQTKEIQENINLKTLEKTKIQKELDQYNNVVYIERYH
QSAKQRIYNHLSYKLGFCAIKKSKTLWGWISMPIILLSIFISHKQEQKIYQEKIKKDPSL
KLPSLELYTDYQEARKEENSFTYKLGQAIMNANKTWYKGGYVKLWFEIRRIKLEFKNKKE
KK
>fig|195.2036.peg.1714 Flagellin
DINRLMEELDNIANTTSFNGKQLLSGNFTNQEFQIGSQSNQTIKASIGPTQSSKIGVTRF
ETGSQSFTSGVVGLTIKNYNGIEDFKFDN
>fig|195.2036.peg.441 formyl transferase domain protein
MALPNEGYLDLTWDKEKISRFLRAMDCGALIGVPKARLKILGEEKEILFYEINELDLILN
LSDNTILKITKE
>fig|195.2036.peg.1644 Integral membrane protein
MCEITLNKDMQNFLIQQIKEEIPLEIILDTEEDKKRLEEDIYKKVINAIKGYCRFEICKD
TNKDTLKEEIKKAAYEITSKKILSKELEIDERHIFVSNKDIVFIQPRNSYPYDESDENII
KKELAERLIIKKLDIGLFARFPLHFRQCDFQCEIKSVLWIPLEYKGLSFINCNFLGEVFL
KCRKKFELLIMENCHFYKAIHFSGVFKENVFFNNSKFNDYVNFQTCDFEKTVSFYGVRFD
KTPNFSQVIFKDSINLINVKTNFDFENLKTTIESMDKPKNETANDFRDSFRNFKSALIKD
NNLLDASNFHKYELYCKEIELENKKDKTLKDKIDKWQLFFYHKLCDHHTDILQSLNSLIL
VIGIFVLSSVVMVFGFNYSLGYKPILEHWYFSLDFYNHHINSIIQDNYLFVVKVNFAMLF
SYLILVGFALCLKCIRGFFIIISYAITLSVLVVSPKILIPAMGFFTDKRAILDPLSAIGG
IYTIVFGFVVFSFIKTIRKNSIVPS
>fig|195.2036.peg.712 Ferric receptor CfrA
MATPLIEDTLSISARIKYYDKAASDLKWPTPVWSNGTQRPENYQIASHSPGYFTSLGFGS
RLNWTVDDSNNVYLDVERYINEISVNSTSSSAIKSERQLFKDNVVLNHDGNYEFGTTNSY
LQYGSTKDKDLHSQIWVGEGKVVLPWNLDKYGNLVSTFGTRIDYETLKNDQESAGSEIRG
KNLDQTTVALYGEGEYFISDDLIFTTGLRYIYSDLFDSEVTPRVYLVYHLNDNVAFKGGV
AMGYKTPAAKQLTNGYYNYSNNGASFGNPDLKPEESTNYELGVDFRIFDFAHYSITGFIT
DFKNQISSEELTGMYNGIDCANGVTCERSINLGKTQTRGIELAFNTKPYKGFSVNSSYTF
MDNRYKDGQTNWFGGDRIENLPRHIAMLKLNYEQGKFSSYVKARARLDTIARSKGGGSGT
LPWQKYKPFYIVDLGVNYKIDKQSSLSFTVQNLFDKDFFDPQVTRWDGANPGGYANRYQD
YTEGRSFWLSYKYDF
>fig|195.2036.peg.813 GDP-L-fucose synthetase (EC 1.1.1.271)
MEKNSRIYIAGHRGSAGSAIMEKLQNLGFDNLIYATREELDLLDFDAVKNFFDDNQPEYV
FFAAAKMSALGVRAPADILYENLTIQNNIFHNSYLSNVKKLIFFGSSWMYPQYTQNPIKE
DSLLTSELEYNAEPYALAKIAGVRMCEFYNLQYNTNFISVALTNLYGKTADFNLKTARVL
PAMLRKFHLAKLLNEKKYGDILLDLNLQDESKAISYLKTNGIYEEYIELWGAGKTRREFI
HSDDLVDACMYIMKHVNFSDLSKNNIKNTHINIGTGSDLSIAELALLIKEITQYKGEIKF
DISKPDSPMNRLLDCSKIHSLGWKHKIELEEGIKMMYEDYLQNNKRGTGVK
>fig|195.2036.peg.440 formyl transferase domain protein
MQENIWENDKKTGITWHMVEESIDTGAILTQKEIKLDDNFTALSLLDTQHKLAIASFKEA
LKNLENKIFKIQTLGGGVSQKIGFAK
>fig|195.2036.peg.803 4-hydroxy-2-oxovalerate aldolase (EC 4.1.3.39)
MNKIKILDCTLRDGAHVNKGNFGKENILLILQKLAEASIDLIEVGFLQNAIFDKDSSIFD
SIEYIDEVLEEINKVKSSFGVMLRTDRCDFEKIKKTKNIDFIRMALYKEHLQDIKKYTSK
AKDLGYSVYLNPIGVTKYSLGEIKNILQELVVLHPEGISIVDTFGSLTNEEFSKFLLLFD
EIIPSDIEIGIHLHENLSSSLSLALQAIKTLSHRNIIIDSSVLGMGRIPGNLPTELLVSH
LQNSRYHIDSLYSLIDIIREYKKINEWGYNPIYVHSAVINIDRTYPEYFFEQGFSTYDNI
KLQKLVKANGYGEKFNSTYAQEIISKYEI
>fig|195.2036.peg.802 Phosphoglycolate phosphatase (EC 3.1.3.18)
MKYELILFDLDGTLVDSASGVIKSIDYTIDFLSLPQLSEEEKKALVGLPIFNSFKERYKM
DDCSAEHATKIFRDIYRKDFLYDASLYKNVAPTLGRLRDCRYKLAIASYKKDDYCRLLLK
YLQVDKMFDFIQGSNSNNKLTKTDIIRHCIKKFNIALDKILMVGDTAHDALGAENVGIDF
VGVSYGFGNKNELYNYKNIAIIDDIEKIFDVLS
>fig|195.2036.peg.815 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTVGIVIPIYNVEKYLKECLDSVINQSYTNLEIILVNDGSTDENSLSIAKEYTLKDK
RITLFDKKNGGQSSARNVGIEYFSGEYKLKNKTQTIKENSLIEFNLEDNNPYEIYTVYKS
YKAFNNEKDLTKFTYPNIDYIIFLDPDDYWRLDAVEQCVIRCQDVDLIWFDYKMFYDNID
KNHYENVENLTKTQMQIYEYFAPEIINVQQWLERMIKIQSTLPFWCVWAACYSFSYLKRI
QLKFLDGFIHEDVHFGILSFIQAENIYIFPSQLYYYRIRSSSTAAYDKKITKDNITPYIE
NLCYDFNGDIKKAKHYHAKSSNFFNAFYIREFIKNKLDDKKGQMLEEAIFMYLYFWHFDL
RDFEKDPRDTLKFLSNHKPLYQENQDRYPEYDFICKYGFARDRIQKQLTYRLGKLVLEKS
QNFFGLIFLPYFIFKLILKFKNEKKEYQKLIKKNPELSLPKLESYPDFDDIWKVREHLSF
KIGHLILKANKNWHKGSYIYLPYYIYKCYKQHQNSKKNISTSIHSQGILLKRQFIWKDEN
LVNIALNKRVFQSSIDELDYRHNPNMIVSQDYSGVKSYKTCFTNWPWFVVDLCKVCVLEK
IRIINVKNHFKRKYLRGMDISFSIDGIHWTAISREKFYWKYNDYYCELVLSECLSARYVK
ISIERGALELSKIEIFSRNKNGYIISSKPDGLGMRLASILVGMYLAKKCNFNFGFTWSNS
IDLAFMGITDSQNTKEINYLGNAMDEVDAVFNLDFIKEYLIDSACVNENHGMEIRKKNST
FEQIQNKTNFETEWGWYSTDILPSNWLNECVEKECLKEISRIYSTIGFSDGFEKIIQDSR
VVKINKFVALHIRGGDIIFSKIRKAPGWNVVQERYFPYEIALDIVTKELASGYSIIVFGQ
DLNANKALVEYFQKTAFEKIFLVDEFIDKTYNEMERSFFEINLMSRAEKIYSAKESVFSK
VAMMIAGKNNLISYHDIYTQVEQADIIQANLSKITLHNFQDARAYFRLFELFRDRDIEKS
MSFLNKALELDYDNDAYRIYILDCLFRLKDYHTVNMMLEKIITERCEEFFTTLLQYSMGS
FTLEYEYYRNFEQKEYPNILYVAFRIFMFFGDIKKADYVRFHLLEDKLSIFKKKSRSNEK
NIGAVARVKCHLSYSLGVEFIRNKNKIYKIPICIYKVIGKYRKERMVWKNYNYPSLETYS
DYQDALRIKNQLSYKIGDLLIQSYKKWYKGAFLILPWEFYLLVKKYKKGK
>fig|195.2036.peg.1141 Flagellar motor rotation protein MotA
MDLSTILGMVLAVTSISVGDILEGGNPLHVIHLSSFLIVMPTAAFCAMTSTHKKIVKAAY
KELKIVFKGSGVNLPERIAQLIEFAIIARRDGLLALESRTNEIENEFLRNAMMMLVDGKS
FEEIHESMEIQTEQLEEHYKECAEYWIIFGETVLLWDLLERFLG
>fig|195.2036.peg.1556 Hemolysin, putative
MDKNFALLDSDLKKATNSQDLILNSIPDLINSGLFTLENKTNDNITYEYTTNTSIIDESK
YFGFLSILNQFKNKNFNEFIVIGDPFLKISLLTQCMQTHYNPILN
>fig|195.2036.peg.106 hypothetical protein
MLNANNIDIDDTLANTKTTGAYAGIFSKYDLEDFYLLGSFRMGYEHTKLNRNVNIGAFSA
NYNSKFNSYLISEMVGIR
>fig|195.2036.peg.804 hypothetical protein
MFTVIIPIRQKDEQLEIAKCNNFSLLERKINCFKKNSLISEIIVASNSLEIREYVSNFDV
KFYFRKEEEVQDNLEEFIINLIQNIENPYVIWTSCMNPFIDEKIFSEAIDEFLNLDFAIY
DSLITCGKLDKFILDENGALNFKTGHYHIHSSSLPKFYYLVNGCFIISKNLMEKYRYPWG
KVPYKKILEHKFTFEIKDTNDFLFFKQILDK
>fig|195.2036.peg.817 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDDYFK
SIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQASARNLGLK
YMQENDYQIPWVTFTDPDDFLDRNYFYEVDKFLATHKANDICMIGCNVIFYYEKQKLYKD
NHALNFKFKNGIQVKENYNLDSFIQLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEY
LLDNINLKSAFLPTVKYFYRKRVEQNSTLDGKDKIKDYYTMVPNFGYLNLFKDIKITKVP
YFVQNVVLYDIFWQIKTLILNPEKLAILNNEEKKLFKELLFENFKFIDSCNIKNFNLHAF
DFFYKKGILNYFKNEDLSENIAFIESIDDKNDEILIKYYFNDVNHKTKILLDNDVAIVKH
SKIRQYDLLDKVFLYEKRIWFKLKNDTKMLDICINSQKLKLVFNDRCINDLSLVLKVLAK
QKKQRSKNSNLWLFADMSWRADDNAEHLYRYVMHNHPKQKTAFILSKNSTDYPRLKKEGF
RLVDPRSFYFKYLIYKADKIISSHIDKYIFNALGGDTLKTKDFIFLQHGVIKDDLSRWLN
QRKIDIFITSTKAEYNSIIGDCNQYKFSTKEVVLTGLARWDALIKNNILNTKQILIMPTW
REYLSGKVQKYGARARNPEFVKSLYFQKWQEFLCSKELEKLAVQYGYSIVFIPHPQVRMY
LEVFNLPSFIITSYKESMQKLFCESSLIITDYSSVAFDMAVLKKPVLYYQFDKDEFFIKH
SYAKGYFDYEKDGFGLVVKNGEKLLREFEIILQNNCKLFDTYKNNVNSAFIFRNSSYCKK
IYKILNKY
>fig|195.2036.peg.1224 hypothetical protein
MVFLRLQDPIKPLIMSIICGFLSLGWLAIDRFMIKDYALGILRIILSLFPCVLFLIPGIS
YENDSNSDISEIFFGLFGIFLLLGIIWWGVDLFLVYKKIKKQNYNKIIEFIFNYQKI
>fig|195.2036.peg.809 D-glycero-alpha-D-manno-heptose 1-phosphate guanylyltransferase (EC 2.7.7.71)
MQAIVLAGGLGTRLRSVVQDLPKPMAPINGKPFLAFVLEYLKKQGITEIILSVSYKYELI
QEYFKDEFHGMKIHYNIEKELLGTGGAIKDALKFVKNEVYVLNGDTFFDIDLKKPVLNSS
KICIALKQMQNFDRYGTVNVDEQGIVTSFEEKVFKKQGLINGGVYLLKKDIFNNFSLERK
FSFEEFLQENYKTLKIQTQIFDDYFIDIGVPKDYKEFINDKGRKIII
>fig|195.2036.peg.805 Amidophosphoribosyltransferase (EC 2.4.2.14)
MHNYKFLLLSGNDLVGIKFQKYFKRYFPNQLQIFDCDEQFLSIMRNDIFEKTEYIIINSL
ESKKENVKKIVGYFSRFSKIIIIQKSIRNTYRTFKNITLIKISNFIGFNDRVNEIQSFAS
AEVLIDYFIESIVEGVKHGHILVKYDSFNSKIISQRQKFCSLRLLYQGDPNENIFLQNVG
NFRIKLGEILADYLNIGDLNDIDYIVPVPSSGIFYAVGLSKALKIPMLPALKKIQISERA
FEIQDVDTRKRYLYNNMEINSELIKNKNIILVDEAIFTGATLKVVCDILKDCDVSKIHLA
IPSPKCFLQCDYLVQPKRILLLKKINERYLSNYFNVNSVNFLPLEQYAKILNKIDNNICY
ECFLKEKRCLL
>fig|195.2036.peg.446 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase (EC 2.3.1.202)
MIKLKNFTELNSQEIELIFKWRNHPDISQFMKTKYIDFEEHLRFLKNLHQDSSKKYFLVF
QDEQIIGVINFVNITTKSCEFGLYAKPDLKGVGQILMNEIIKYAFENLKVNTLKAYVFKD
NHKALKLYQQNHFTIYNEDKNIFYIKLKNYNYKKQFAKRISKLDKGEGGGKYKY
>fig|195.2036.peg.816 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKNIVLLGGSNSVLTNGLKNGLQCEESIVLKNYALGACTCLQNLYALILNKNDILDADLL
VTESNVNEIHSFCRIKMPLKQLSYIINTYYEELSFLNIKILVLILPICEKHPSNEDIEII
NDLHRKNCVKYGFNCIDMQSYYKKNNVFEFFMDLPENHHPMETIMNKLGRNIAKNIDAFK
YHLQNKNKLHRKYAFFIPEVDTIGNKLETKIKSNSLYRETIVRITDKAKILFPSKFQGYR
VAAIYTWNDFEEECYGTKVFSSLVLENLQTKIVKPSNGWMQFSELHQDFNIDCSTFAYFN
SQNTQITENSILIHGRELMLKHVDLIAFFLIKDEYNNLSINMDFNFAHEKTNKLFFDKFI
PDLCFLKNVIQEYCSKKQFESTIAELKSLLSQKELQLQNKTNELKNLQEDIIHKKQLLEV
QNLEQDLNLKSLQTKEIQENINLKTLEKTKIQKELDQYNNVVYIERYHQSAKQRIYNHLS
YKLGFCAIKKSKTLWGWISMPIILLSIFISHKQEQKIYQEKIKKDPSLKLPSLELYTDYQ
EARKEENSFTYKLGQAIMNANKTWYKGGYVKLWFEIRKLKEKENIF
>fig|195.2036.peg.806 3-deoxy-manno-octulosonate cytidylyltransferase (EC 2.7.7.38)
MKILGIIPARYGSTRFPGKPLADILGKPMIWWVYNQAKKAKKLTDLIVATDDERIMRACD
QFDIPNIMTNIHENGISRVHEVSQKIKADLYVQINGDEPLIESRIIERIIPRVIGRDFVA
NLICKIKSPNELLDLSNIKIIFDKNKKAIYMSRTPIPTPYKSLEFEYYKHIGVLAYTKSM
LDFFALSKPSKYEKIEGLEILRFVEYGKDFYCIEVKNFKSLSVDTPKDLEKIKNNLKNKK
RL
>fig|195.2037.peg.1657 hypothetical protein
MSLREMHEQQKQSSPREQLQELNRQSRTELENSLLKEALAMSSENCEELMKQSNQEQVRA
EQNRQRDAEQNRKLISELKQSVELLKNSNELLQDAISGEIGSLKDEVKENTVQEVRKALQ
ANIEAIQRATKLLEKQSDTLTSVMKQKIRELEESKNSFFRYEGLKLYLFCIGWLYDLEFH
YANTEAGRLEAVCDYIPSPEGNTISGVEAGTPVRAVSWQTIDNHLLIFFAADNEENVHGV
MHLYSVNPVQILFLLCDFHKKYILCVLKLAAVSASHCTLVIKAILTNLFTKTLYISNIEL
YLANF
>fig|195.2037.peg.1661 First ORF in transposon ISC1904
MNKLLSIGQASKALGVTIQTLRNWDKKGLTTKSNSRWQSKKISFNSQRQTFTLWC
>fig|195.2037.peg.1373 Integral membrane protein
MERNIYEIELEIPNSGIFIMGLENENLIISLNIMKFIEINAEKIATLDGKLDVGGLAKPL
HSYIIYEVLEKNNKNNFNDVKIIDKIEDENNIIYHFNFGLILNTFIGENEDNKDKEALKT
LSFMQNFIPACFFSYQIIGDSKAIPKNVLEDLKNRYGYEGKNYKSIFKKEVYINCNCLER
LNFSHCEFESKVSLRFLKDNKYKEFHNGIDFSNCIFKNEVDFSYFVSGAPLPDNKYYNNA
QNTLFKDCIFENKVDFHNSKITNNIYFNNAHFKDYVDFHECEFEKTVNFYGVIFEKAPNF
SACYFKEPKAVNLINVDIDKLDFKSLEQYIKDKYQDESYKNETKGIQDEKEIFKIQNEHQ
LRYAKNLKDSFRVIKDILITQNNTLEAQEWHKLELYAKEKELLFEVESCYKEKNKPFIAA
KSEDKNSINLTFSVLLLWIYRVTSLHHTNLPRIINFASLNIVAFGGLVCLITYLSYHINK
QSNFWLFGVLILFALIIGIVSLLLKKQKLKNITLILCLFLAFLLALFLMQRIAFLSSFGD
IIFALLFYCLLVIVLIYLYPYINLKSFISYCFNWLVYFFLVMIVVIKPQLINPFAGIFSS
DKLYESQFEKSLNDLNVSAIMILTDISQDNFNLPSKDQNISFVELNSAKALIIANKEKLK
EILSKVYNDKYVSDYKKVLNELENNTSNVKNIIEEIDNKNNNSVISVQLNQILNFNFSQE
IDILYMIKSNFFISEKLSPEQMAIFDQKDSQDKLKSVLALLKFKSSFEGILKIINQDEIT
ENTIKSTSVLYSIMLLLCIFSLQKTARKNSIVPS
>fig|195.2037.peg.580 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIISGLGGDIDDNLYIEEY
CARNYNVAVLSVNYHCIGNRPQTGASFYINELDRLILKTSLEAIGIQLPVDMQNLKTYDE
FYCVVDFVNKFIEKLKKEKELSEDYCLYLSVGLEPTKNEYQNYGIMQAMDIINAILYINI
NLPFKVSNMSTVSRMGGV
>fig|195.2037.peg.1689 Phage Rha protein
MSNKVIINKQEVQFGTKDNQIFCTSLDVAKVFGKRHDHVLRDIENILNDLREIGTSQDLL
NFGEVVRISKTTNPKNGKLVNRKMPMYNLTRDGFSLLAMGFTGKKALQFKIAFINAFNEM
EKLLQKEIKSPNKYLTDLMELIYPNLPQNDYKVSVTITNNPYSKEAKNVFSLNYLVDNRT
PKDPKKLQ
>fig|195.2037.peg.1842 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MLEKGVLTQTKRHSYIASLLGIKQFIIAVNKMDLIDYNQEIFNTICKNYQEILPCLKNHE
RIKTHFVPICALDGDNIASKSINMPWYDGKTLSELLDTLPIVTNLSDEFIMSVQYVNRPH
LNFRGFCGNIASGSINVKDEVVILPSLKTSKVKQIITPDIENLKVLDKNEKIQSSKNASF
PSAITLTLEDEIDISRGDVIVSKNHSLKISNSFKAMMIWMSEAKFSLSGNYLIKMANLTT
SITFEKIDFKKDINTFEESQSDELKLNDIAKCTLRLSKKTALAAYKDNKTLGSFIIIDRY
SNETLAAGMVEEILTHEDKARVYTQAEIELNTYIRKNYPEWECKKI
>fig|195.2037.peg.1167 Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)
MIMKGKKGLIVGVANNKSIAYGIAKACYEQGASLAFTFLNDALKKRVEPIAEEFGSNFVY
ELDVNNNEHLDSIAEKIKKDLGEIDFIVHAVLMRQKKL
>fig|195.2037.peg.60 hypothetical protein
MQPKSIILFFYGYILFFRRQIYRTKLLMNPKELISQIKDYANIADASYAMLDLKNKENNH
ARI
>fig|195.2037.peg.1707 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYSIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEFEFNQNIFYALNFKNKEISFTELVFSFKI
NSLDRESFDISNIYNKKHFIIQKDNSLITFKYRKIQSKGFN
>fig|195.2037.peg.1870 Flagellin
QLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLMEELDNIANTTSFNGKQLLSGNFIN
QEFQIGA
>fig|195.2037.peg.1861 Flagellin
ANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGERISSSGEV
QFTLKNYNGIDDFKFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVETRGMAAVRA
GTTSDDFAINGVKIGKVDYKDGDSNGALVSAINSVKDTTGVEASIDANGQLLLTSREGRG
IKIEGNIGGGAFINASMKENYGRLSLVKNDGKDILISGSNLSSAGFGATQF
>fig|195.2037.peg.638 Possible sugar transferase
MEQILKILKQMLSPDQAQILLKALKNSNNENFYNFALENIEIICEWLNSKEFQENYTNHP
YPPLLNPNYIDTDASRHCAELAWDLNLPLPKHYKFIYISPHGVGAAAFLRYLNEACNVFC
LASWMLPYDAKERYCINYMCLNDKNISDQAINISELNIINLEKYLALLDPHSKVICGIRD
PIGILT
>fig|195.2037.peg.1829 FIG00471415: hypothetical protein
MKEINIIDFGLMGKQISALFYLLGYEIGVYNKSKLNIYEFEKQIKLLQRKIDFSNFNAGK
INIYQHIEDLKNSLTIESLNEDLNLKKKSCKFLEIII
>fig|195.2037.peg.1611 hypothetical protein
MQSQNTNSNGDVKFQIQEDDEILYILASKENQISVLRFSNPLSTDGYDVEGDQNHEMIKA
FIYTDRGVYRAGDSVHLSVVARENTNPLKHPISFTLINPKNQKIIENQILKSQNDIYYTQ
IHLDKNAINGLYRAIFNIAGVEFSKDILVQSVVPNRIKVELNADENRSLDDGNLNYELSS
KYLFGALASNLKYQSFVYFSPKNYHNSKYKDYIFINPSSLIIRASTDDKGNLDEKGRVQS
SVEIPENILNSQGYNFNARIVSEVFEKGGRSVKAVRDVNLNRYDYFVGMKALTNSYVSEG
ETIDFYAIVSDLKENLVSGKTLEYRIYQNDYYWWWDYDSYDEFLRSIKQDHNTKLIEKGE
LTSSSEPMKFSFNTSNYYGQMFIELIDKESGISAGQSFYVSSWGEPSYADVVSSLKIKSD
KNKYKIGQSAKIEFESVAGAKALITLSSNSKIIDRFVMDTQGESTSIELAMKKEYAPNIY
VSVSLFQDYNKIDNDRALRLFGIIPLYVEDENTKLNLELKTPDKILPNSDFEIEIQSKDK
RAFNYTVAIVDEGLLDLTDFKTPDIWEGFYAKTGFTLKTYDTYSQIIPKFTGGDSVSKIG
NLRADKNRDDSAQRFKPVVLFNAPARSDEAGFAKLKFKMPSYMGLVRVMVVANENDAYGS
ISKDMQVSAPLVLLETLPRTLKIGDNFTLLTQIFKTENRIKNATLSVRSKNSLIKISPDT
QAIDFKNATNLEVMMDANVSDNRIGKELLEFELKSENYTYKNEIEIDIKPINAYTYENNT
SLIKAGESKEFIIKDYILGTTNATLKLSPTPILDMDKRIKYLLNYPYGCIEQTTSAVLPQ
LFLDKFSTEFDKQKAINNINAAIERYANFQTADGGFAYWQGGDESNAWGSNYAGMFLILA
KQNGYFVPDSMYERWLKYEQNFVQKSIYHDYMMDIKANSLYLLAMAKKPNISEMNLLYDS
LNTLSTEAKWQLAAAYKLAGVEDTAKQIASKISIEPDSKYSSYTYGSLIRDEAIIANAYK
QIYGTNNEELLQKISYTLLSKDYLSTQSTGYALYALAMGANLENMNENFMDATLKIGDQV
HTIDQNQMQIFSFNNEKAIINANKDIFVSFGVEGVKAGENSAFSNKISLDRAFYDEKGNK
ISPSEIGSGQTFYMRISASLNEGANYVSNIALTQILPSGWEVSNTLLDDNTSSFIKNSSY
DFIDVRDDKIMWFFSLNKNRTHHFYIKLNAITPGSYTLSGAYVEAMYDDTYRALSESEKV
VVKR
>fig|195.2037.peg.1166 Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)
MGTSVYSLLSLTRAVLPVLKEKGAILTLSYLGGVKYVPHYNVMGVAKAALESSVRYLARD
LGVKGIRVNAISAGPIKTLAASGIGDFRMILKYNEINAPLKRNVSIEDVGNSAMYLLSDL
ARGVTGEVHYVDAGYNIMGMGDVTKDENGNTVLCWDNQKGQ
>fig|195.2037.peg.1662 Replication protein
MLERGYPEVSPHDFYRELFPAGSLQQEPEDGKGNIIATQIRPSGKGRTRQWVIDDSLKML
DKVIGDRFGLIPPISFYGKSHTKENAHELFAVVVDVDYVGKQQLKNLLKQFGNGVQLRPT
YLVSSGKGVHLYYFLQEPVQLYRNREEVLAELKEAFIRRLWNDTSSIRPDSPDITGIYQG
FRCVGSQSKLGVDFPVKAYKLSENRYTLEDIKASIPSCKVDLAPLYEKPRRKSTVTLEEA
KELYPEWYEKRIVQGEPKQKSKKQGGTWVCNEALYEWWKRKITEEVKAGGRYFSIMALCS
YGLKCGISEQKIRRDAYAFLDHLESLTEDEDNHFSRADVKDGIKKPKMIYFYGILKY
>fig|195.2037.peg.1830 Putative transferase
MIQKASFALGVEQINLRKKILVKLSKKSCNFITFIHPQSFVSKEAKIGQGVIVCPFVTIN
ANSNIGDFVLCNIYSSIAHDCKVGEGSILSPYATLNGNSSIGKNCFLATRVSLLPCVNLE
DNCIVSR
>fig|195.2037.peg.1376 conserved hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHIT
>fig|195.2037.peg.1810 hypothetical protein
MANRHWALVDMVLELVQKEDILQKESILSHITNERLLRAIENFKSESALHKDKKFIFSAE
GIVWDFSTKKHVEILEKIMRELGFTQIYIIVYFRDTLGYLNSHCSQDHKNNMEYYSADFA
PQDHPRKYIFDYEWICKTHAEVFGEENLIVRLLREDYVGGTLLKDFVYHLRLE
>fig|195.2037.peg.1660 First ORF in transposon ISC1904
MLEIITVFSARLYGSRSKKNKKLLDEMQEVVVENVSK
>fig|195.2037.peg.1841 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4)
MKTNVEKYLKEHENKELCRFITCGSVDDGKSTLIGRMLYDSKMLFEDQILSLEKDSKKLG
NAGEKLDFALLVDGLASEREQGITIDVAYRFFTSEKRKFIIADTPGHEQYTRNMATGAST
ADIAIILIDARKRGFNSN
>fig|195.2038.peg.1466 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKINEKDLHFILESGILAPSSHGFEPWKFIILDKKEDNQKLA
KLCFDQASVASASHNIILLARKDL
>fig|195.2038.peg.1336 Putative type IIS restriction /modification enzyme, N-terminal half
MSYITSNKYTRAGYGEALREFLLKNVKVLEYTDLNGIKVFDSATVDTSILCFEKSKSKDN
KFKYLALSNEILKTCAYNIGLYKDFAEFSQNSLSKESFTFSDENTSALKAKIERIGTPLK
EWHGLIIYRGILTGYNEAFIITTEKRNEILANCKDEAEKERTAKLIRKMLRGRDIKRYSY
EWAGLWVIGTFPSLKIDIEQYPALKQYLSQFLPRIEQSGEKGCRKKTSNKWFETQDNIAY
YEEFEKEILVWKAVGRNLAFALTEKNTLVSAPSSFISADANLLKYFCGILLSHVLKWLIL
QISDTTGAGDLMLNNQSLERLSIPKINSKNEKIADELINLVDEILKAKEQDKNASTQELE
NKINSLTYKLYNLTEDEIKIIENKEQKWKI
>fig|195.2038.peg.493 SSU ribosomal protein S11p (S14e)
SKKSTPYAAQQAVEDALNKAKEHGIKEVGIKVQGPGSGRETAVKSVGAMEGIKVTFLKDI
TPLAHNGCRPPKRRRV
>fig|195.2038.peg.1883 Flagellin
GQVAYEDGDANGALVSAINSVKDTTGVEASIDANGQLLLSSREGRGIKIEGSIGGGAFIN
KDMMENYGRLS
>fig|195.2038.peg.1413 Methylisocitrate lyase (EC 4.1.3.30)
CIDVRRICSRVDTPLLVDADTGFGGAFNIARTIKELIRAGAAATHIEDQVAQKRCGHRPN
KELVSTEEMCDRIKAAVDAKIDPDFVIMARTDAHAIEGQQKAIERALAYVEAGAEMVFAE
AITSLEEYEEFVKNVKVPILANITEFGKTPYFTKEELNRAGVSMVLYPLSANRAMNKAAV
QVYESILKNGHQKDVLEIMQTREELYEMLDYYSYEQKLDELFKRGAK
>fig|195.2038.peg.1577 FIG00471540: hypothetical protein
MKIGLETESMHLWFQNGRMDIFSYIDFAEELGCDGIIINIIKDFGLDEEWGCLGSNDESH
LKKIKEKLDTYGMYCEIDSKGFDKDKFEKIAKVSQAFRG
>fig|195.2038.peg.1572 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
DSYLLLDTKKEKSALVIALGYSNDEKIPQKNRFEFDKIVQFL
>fig|195.2038.peg.1286 hypothetical protein
MENKSIAIFIDAENIPAKYAKSIFDIASDYGEIIIKRIYGDWTQKIFKLGKSKLLSIL
>fig|195.2038.peg.1 Pyruvate carboxylase subunit A (EC 6.4.1.1)
FAIEARITAENVWKNFIPSPGKIGEYYPALGPSVRVDSHIYKDYTVPPYYDSMLAKLIIK
ATSYDLAVNKLERALKEFTIDIRTTIPFLIAITKTREFRRGYFDTSFIETHMQELLENTE
DRHQDNKEEVIAAIAATLKKIRESRE
>fig|195.2038.peg.1237 Tgh063
MNDRQALEYLKDELLFIFNVRFKYFDFSMFSLLKDKLRPLLKNTSFEKEIKELLSVLEVH
KKSFLENKVFTKKEQKRIILLNACKATYEALKHKLKT
>fig|195.2038.peg.1234 hypothetical protein
MTNNDFESILKKCNLSKKEFATLCDLPYPTLMNWVKADKTPNWVKSWLENYIKAQKYNKI
KDLIKDDL
>fig|195.2038.peg.1833 Protein translocase subunit SecD
MRNSKITYRLVVFIAVFIFGVVFSLPSFLQSERGVKINLGLDLQGGLYMLLGVDNQEAVK
SKIKSVASSLSYSFNKENILNDGLNIHDDSLDFTLLDNADIVKTENLLKEINGLNVQRED
MHYTISFTSEEVKSIENFALLQAVETIRNRLDQFGLAEPTVAKQGEDKILVELAGIKTKE
DELRAKERITKAAHLQLMEVDDSKMSQASNMSDAEAASYGLVLVPDSRNPNLKYPLKSIP
ILDGSMLTDARVGLSDTSNYPVINFTLNAEGSKKFADYTGANVGKRLAIVLDNKVYSAPS
INERIGGGSGQISGAFTQEEARDVAVALRSGALLAPVKLLEQRSIGPSLGADSIKMSMIA
LIGASIFIVVFMVLYYGMAGIFANIAMLVNVLVVVAVMAMFGATLTLPGMA
>fig|195.2038.peg.1517 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MQNLYSEDDTRVKLIDTKLYASSWKEENIIRNYYFTDGRKLIGNKRAERKFADYLLKFQN
NNLAIIEAKKQNKDALDGLSQGIEYAKTLNVPFVYSTNGDKIYEYDLRVSRGEYIENFPS
PNELFQRVYGNLKEWQYKLLTQRELYIPQKTLRYYQKIAVDKVIEALINGKDRILLTLAT
GTGKTTIAFALCYRLLEARWNKENKDQKPKILFLCDRVSLRDQALGEFNAVESDCKVISA
EEIRKNDGKIITNANVFFGIYQSLAANSKDQENTQEEQESKFYLQYPKDFLTLSSSMSVT
EAEQTKKETGRAY
>fig|195.2038.peg.1516 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MSEFERNIHLPQYNDFLAKEILKLIDPMDKTIIFCANQAHASDIKRAIDKFKSVKRDDYC
VRVTSDEGKIGLEYLKQFQDNDKSYPVILTSSKMLTTGVDARNVRNIVLLANIGSIIEFK
QIIGRGTRVYEGKDFFTIIDFVGATKLFYDPKWDGEQVKDEDKEDKSEIWGKQNKKESDK
TKETESKKAITVHLKGTKLKVLDINTSYLGSNGKPLSTKEFLEFLIGKLAEYYDDEVKLR
EIWSKQETRLNFLKTLEKDGVDENALKDLGEIFDKKDCDIYDVLAHLSFNAEIKTRQERV
LQVEKSEFLKRFQKEKALKFIEFLLGRYQQYGIKDFDRSLAPLIELSSLGNVKEIVSEFG
GVENLKQSVDDLQREIYAR
>fig|195.2038.peg.1242 hypothetical protein
MKKDINYYLNLPYKINLVKLDDGDYLAQFDDKELNKLVLMAGDGKTPNEATEDLKNAFAC
YLEEALAKNEFIPEPMQKDKSKNLAITLKNSLVDEIDFYSKKMGLSRSAFLAVSAKAYIK
TL
>fig|195.2038.peg.1349 hypothetical protein
MIKQKFLILRLDKNLFDKIDDFILSIQKSPSIKEIELEIAKGVDKIEHKSDEIIYHRDVN
EECFDENINYDEGNYCKPIEKNELLFEYIYRILGKEGRNLRGEILHLNPIAFLDNPFIIK
DESIYTEELEDRIKYFSANYGFLNKDHTGYCIANNLKLSQIGLKTTGSFKTNTDENINLE
ITNFDISDDAIKSGIVNVQASNIKVNGNVGATKLYGKNISIKGLTHAKSEIFAQDIFITT
HKGTLQADTVYIKNLENGTIIAKNVFVENCMGGKIEAENIYICNLLTDNTLYPRKNLIIT
NNIKFKNNIVVSPLVSIANNSDTECENLKNLSLKIKSKLDDTISEMQNYYDYLIKNQIKI
IKLQKTKNPSAIEMKFSNLYHDIIKKYNHLSISYKKFIKLKYQIDAKLNFLNEMVYNVKI
YIKAENIGEDNFLKFYPNTNTNLELKHHINLKDYEKVLYLEKGQQVSYIKSSHNYSESDI
EEIKIIFEKLEKDNS
>fig|195.2038.peg.869 Phage virion morphogenesis protein Mup30, F
MIGTKIGFFSEPTKAVDFLKNKKPQVSFDYDELSHSIHKKVFTIAKLMDESLLKDMQDTL
VSAIKNGDKFSTWSKIAEEKLKAKGWWNSKEVINPKTGEVKKTHFNSARLKKIFEENSRK
AKAKAIYENQMKSIKPYLKYCTQKDALVRDKHRAFDGIVLPKDDPFWDSHYPHVTMHDYG
CRCYVLAVGESEVKGLKIPPSNTKESDFNGFNDEELLDELYKQKNTEVIQNFIKLKMLSS
AAQKTKEVKNFAHQKEFYAWQKSLDDMVDEVIIKENQKYPINFIQVGKIDKTTKEFLEKL
NKKDLEDLYFTLSKNNLLHASPKRKASYNQALSADEIKQIVKVLDEAKEVYWDTKEESLV
YFFDDLKNSKKVNKIIIRPDYKLKKFGKTNALITLGKVDKDTKESSKEYEKIK
>fig|195.2038.peg.182 Galactoside O-acetyltransferase( EC:2.3.1.79 )
MGKGCVVANSSVVTKSFDDNSLIAGNPARLIRVIEQK
>fig|195.2038.peg.135 S-adenosylmethionine synthetase (EC 2.5.1.6)
MYLFTSEVVSAGHPDKCADIIADTIVDILLKNDKNSRVASEVFVAGNKVVIGGEVKSNHK
LSKADYDNLVKDVLKNIGYDGAGYFSKEQCLHPDEVDVMVFLNEQSPDINQGVDQEDGET
GAGDQGIMFGFASCEAKEYMPAAISYARALCDKVYAYAKAHPQELGVDIKTQVTIDYGTK
ANFENCKPQSIHTIVVSVPCVESMKIEDLRALVNKLILESDLPKELFNPEKTRILINPTG
KYVNHSSLHDSGLTGRKLIVDSFGGYAPIGGGAQSSKDYTKVDRSGLYAGRW
>fig|195.2038.peg.583 DNA polymerase I (EC 2.7.7.7)
MKTLTIIDTFGFFFRLYYALKGFKNSQGQASGMISGFANFIYSLKNEYKSDYIIFALDSK
GKTFRSDIDPNYKKNRTPPPPELLEQIPICIEMIEKMGFMSASYEGY
>fig|195.2038.peg.1244 hypothetical protein
MAIDRKDYNVPIGKGTHLKRHKDKINSFLFRMQNGGKEKQHAFTIPLRPAWNENEYIRIA
LARAKEYENEFKKLFSVGYALNSSILLKNLFEIFIKTNYNIKDLNEQHKGHIRNLISIFN
NHILEPLGNIHLDELTLYKVQEFYNGMKNKGLEPKTYNRAIKEVLSPMIRYAVKNKWINE
NVTLGLKLDRVQNKKLVTNPKGKYEAILNAILELYKDNLLYKALFLLIHSGRRRDEVLSL
LWQNVDLERKTIFLPNTKNGEAQEHALDDECYNALKALKDEVKQDKGLVFVSSVSGKKIS
NLARQEAKIRELSGVKEWTPHFSRHIKASFLMQNGVNPAVISGALGHRDLSTINIYATND
TLKASQRANEALKKLQEKD
>fig|195.2038.peg.1862 Flagellin
ITVTQVNVKAAESTIRDVDFAAESANFSKYNILAQSGSYAMSQANAVQQNVLKLLQ
>fig|195.2038.peg.1235 Replicative DNA helicase (EC 3.6.1.-)
MKDYSKEINDLKKIKSQDIDKLDFKEFENIKSKINETSCNPSKIISQKNANIKNNSFVDL
TQWAIRSVDLEKIEFTSLIDDFLDKGSISFLTSEANKGKTFLSFAICKHLLEFNKIRKII
YFDGDNSKITIKSRIKKSMQIGGYYFLDYPGFNYIQTSNALECGTDEIEVDFNFIVEKYL
EPLMQSGGLVNVFIVFDSLFNFFNGDMNDNKKVAEFMKIIKKISHKGEATFLFIHHKGKS
AESEFMGGVNFLNATDNLFKIQTSNNDGEILNIELNTKKARNFLPYNLKVDIDLNTLDLK
IERAVNENDTNFLIKAKEIIEQKGEILQGELLELLEKSKTDTHAIKKLESGKGLYFNIIE
KSRATGGKALKYYVPLKENKTIINGIEINAEQTLFSE
>fig|195.2038.peg.624 hypothetical protein
MWDKILNYQQLECDYFNLYNQFISVDFQISLFEKNHKSLIKDFIFFYHQILKQKDLNFLL
GVRNKIALKVHNYMQEYSTSPKDLSLICLREHKHIEFFQRFYKALAYFVAFRKKLDEEQK
IKNLISNINDCFGCHFINSDFNNLQNFQKNDFFTLPEKCLQYFHLAMIHLCFMVLNPLNF
KDSNRHLDKAINYLIDGTFEIYELIFKEYFLLFPKDEELKDELKKIKNLEFKILMQEVSR
VKLLNHYKEFCEEIFYNIELEKII
>fig|195.2038.peg.1467 Acetyltransferase
MPFNVLYHNHCLYICDFVVDEALRGKGVGQSFFKKIQIWAKKQGYEELELSSSFFRTQAH
EFYIQKMDFEKSGFVFKKNIKL
>fig|195.2038.peg.1238 hypothetical protein
MQHTNKDFLTIQEVITLYSLSKDTQNKYRMQKKIPYVKIGKKIFYEKVKLDEWFKNHTIN
>fig|195.2038.peg.1351 hypothetical protein
MLFLSTASGWEHSRALDFSVCRSHLGKGLFHLNLLFISLKYFYFHIEFQDFGKNFLILN
>fig|195.2038.peg.1233 hypothetical protein
MTRLEFDEKIKQLGLTRKIFADIAKVSYSGISTNWKDDKEIPSWVEPFLYYYEKGLALDE
LLKILEKYKNKEKLE
>fig|195.2038.peg.1514 Type I restriction-modification system, specificity subunit S
MTNLPQGWEVKKLGDIAEIQIGKTPSRNNIDFFQGENIWLSIRDLKSKFVSSSSEKISNE
AISKTNMKVVPKGTLLMSFKLTLGKTAFAECDLYTNEAIAAIFIKNKNINKYFLDYVLKF
TDLEKYVDNTVKGKTLNKQKLKQIEILLPKNIKEQERIVGILDESFAKIDESIKILEQNL
LNLDELMQSALQKAFNPLKDNAKENYKLPQSWEWKSLEEISENISAGGDKPKNCTESKTA
KNQIPVYANGVNNNGLVGYTDKATIIKPSLTISARGTIGFVCIRKEPYFPIVRLISLIPC
ENILCLHYLYFCLNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKEQEQIAKHLDFVFEKT
KALKELYTKELKDYEELKQSLLNKAFKGEL
>fig|195.2038.peg.1465 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNEKELYHFAQLQCYLAMMQMSLAAMSLGIDSCMIGGYEKDKVDDFLKLEYPFETAVILS
LGYQAHEPKYPTQRLKFDEVVEFYKEK
>fig|195.2038.peg.1231 hypothetical protein
MKTITIKAKEQEINKLLDILKELNISYELESNNYKKALNDYESGKSWQETKQELHKALND
YESGKAKLTPLGSEWL
>fig|195.2038.peg.947 Anaerobic C4-dicarboxylate transporter DcuC
MAIAGFSAYMDHVGASYALFKVFEKPLKMVKSPYILLLVAYFIVQFLVLFIPSHAGLGLL
LMVTMYPILVRSGVSKLSALSVIAICQYIDHGPGSGNVIMASKVAEVDPAIYFVHYQLPT
TLPIIVAVGIAIYFCNKFFDNKDNFVFNAQEVEKELSENKDKENELKKTSKNLCCLTCYT
FSINTWI
>fig|195.2038.peg.970 LSU ribosomal protein L4p (L1e)
MSKVVVLNDKLEKAGELDLPSKYAEVNPHNLYLYVKSYLASLRANTAHTKGRSDVSGGGK
KPWRQKGRGGARA
>fig|195.2038.peg.916 hypothetical protein
MKRSYTDLEANNVVIVQAKDFNENILKANNNAGALLLKFAGDYISTDVQGKDPLEAATII
DISDEDKYGDGEKGLVDYKLSVQNCGGNKCLVINGGATAAAKDKLVQLQVDIDTIDKLLK
NEFDSSQGEEWEQAKETLKKQQAEIQTMLEEAKKNGGKIDDEKYIDLVNKNLNLNLSAND
KASILALRSITEQLGSIGADLASREGVKLALDIKKDTDNTGKSVSNLNSASSAVNTTMNI
SNDVSIGSRVAMLNNPFGTYASKMNGLKFAALDSDMRPSYVNEYTNSVWANAFGGANIID
GDSGAMYGATVGVDKQANDDVLWGTYFTYANAKIKDNNLEQKSDNFQLGMYSTINVAPQW
ELNLKAYAQVSPTKQDNVQIDGAYNSDYTSKFLGLSANAGRVFDFSDNTLFIKPFAGVNY
YFSYTPSHTENGAIAKDIDSMKNNSVSVEVGAEFRKYMNENSYIFVTPKIEQFVINSGDD
YTANLAVNNAFFTSVEANNKKKTYGQIIVGGNVDFTNQLSMNLGFGAKQILAGKVDNKNE
TYLSGQVGLKYKF
>fig|195.2038.peg.1703 Putative two-component sensor histidine kinase
DEDILDKIFQPYITTKHPSQGIGAGLYISKQIVESFGGKIQVKNIKDGACFEIYLKLQEG
N
>fig|195.2038.peg.389 Predicted L-lactate dehydrogenase, Iron-sulfur cluster-binding subunit YkgF
MSQKIPHEEIVHIKLNDIQMRENLMTAMHTLQKNRLGVIDARFRDWQGLRAKAKQAKNNA
LMSLKDRLLEFEKNATKNGIQVHWASSDKDACEIVYEIMREKNITKLLKGKSMASEEIGL
NHYLEKKGLKAIETDLGELILQLNEEPPLHIVVPAIHRNRHEIGQIFKDKLGAKLENDEP
ESLNAIARDHLRKDFEGLKLGLSGVNFAMSREGAFWLIENEGNGRMCTTAPDIHIALCGV
EKVMESFEDAATMVSLLTPSATGQFIPTYNNIITGPRKNGDLDGPKEVHVILFDHNRTKM
LAH
>fig|195.2038.peg.1241 hypothetical protein
MNLILENPSEKLIKAVKAMVKIAKSKASVLNDYELKAYKEYLESGKKATLASNLYKELGL
>fig|195.2038.peg.190 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28)
MINLVEKEWQEHQKVTKASEILKGQIAKVGELLCECLKKRWKNFNLWKWWECRGFSTFCS
GA
>fig|195.2038.peg.580 ISCco1, transposase orfB
MNTFFKMRYHRDLPNTYKFNQITIIKNHNKYYLAFSIIYDESNVSLISSKDFDIKKAVDI
DLNINEITLSSGELIATNSKLLSRAEY
>fig|195.2038.peg.1106 Major outer membrane protein
MKLVKLSLVAALAAGAFSVANATPLEEAIKDIDVSGVLRYRYETSNEWSDINGVAQNEGS
GISGKQDHKYRAQLNFSGAIADNFKAFVQLDYNAKDGGYGANNSSTTRSYTADNSSTLNV
RQLYLTYTDENVATSVILGKQQLNTIWTDNAIDGLVGTGVKVVNNSIDGLTLAAFAVDSY
NSDEQGGDLGTVLNFNENLYGAAAIGSYEVFNGQLNPQLWLAYMTDNAFFYAVDAAYNTT
IFDGVNWTLEGAYLGNSLDNERKDLGNGNGNFFALNGSIEVNGWDATLGGLYYGKKDKAT
VTVIEDQGNLGSLLAGEEIFYTNGSKLNGDTGRNIFGFVKAGYTFNETVRVGADFVYGGT
KTENHSGGDKLEAVARVDYKYSPKLNFSAFYSYVNVDKDTDSTHHDAVRLQALYKF
>fig|195.2038.peg.1437 Phosphoglycerate transporter protein pgtP
MDYYGSWNAGLIMLLSACILCILCSILCHFGAKKKEDICKK
>fig|195.2038.peg.1239 hypothetical protein
MIDKNILHTRTIMVNISDFNPTAEFNEELKKAKDNKDYLKIFICNGLKNSKSNFYLENKL
IIDEFTEKNSRFWNDLDIFNKLKPEVKVEIKEDLLIKINSLLFYARNLKDINSQHKNKLE
KDLSILETLIKNYEKELNIKKTNIECAFKTLENIFYYIDNDTKEKISFQIGLKEFYKKAY
IEITDMSVYPILILMCDIIYNKSILYCIEKKFNKTKTFNDFMLEMQEKYKLNSKKIKRKE
LLNTIIKAFKDFS
>fig|195.2038.peg.841 Phage tail length tape-measure protein GpT
MENAGSIGIGVILGLAIKNASAVGKVVKDFSNLEKIAAKTKLGISGLQKELNTLKLNANL
RAELKAQRKGLQDELFSLGNIISGGIVGKSIKVGIDFESAMADVKKVTDLSEGHTLEGLK
QDILDLSKKLPMTAEEIANIVAEGGKLGLASKEALEFGKTATAMGVAFEMSANEAGEAIG
GLMANLQTDVKGIKDLGDSINYLADKGSSDAKNIVNIVSRIGGMGNLIGLQRENMAALAA
TLDEVKIPAEVAGTAISSMFTKLSTADTLGAKAEEAFSQLGLSGEFMKKALNRNSQEAIN
ILLSRIKTLDKESQIGVITNIFGNDSGTIRAMATLVNGYDRYQELLKMTNSEEKKGSMDK
ELINKCETTASILKILGNNISALAIKFSDALLPVVKLVASGFSFVIDIVDTLLSKFPVLS
TIVATATTVFLLAKPAVLAYAIAKNYLKDCTILLKSALIKTRIHLLAFRNSCILSNITLK
AKTVTTTIYTTSLKALSFVLGGLNKVFKAVAIGIRVLSVAMMSNPIGLILGGIAIVAGLI
IANWDKVKSWFMSFIEWLRPVWEPIYNVIKAVFNKCSGVIGYFKNNALNIIFPFVGILKF
IWKPIYEVFKWVFDKCALVFASFKDIIMSIASPLAEFLNSIWQGIGDFFYSIFGSLFEWF
ASKLSWVGDMISSISGFIKDTLDFVGLGDDKEVKISQNEQTKEKIFATNTYKDELQAKSI
NHTPSFNNGNINVSVNGTFNIATKDGNFNMQEFANAIQKSVFDALRKQEQNKINTTIYG
>fig|195.2038.peg.572 hypothetical protein
MQALKNEIKQKAIFMSLINIKETIKNIQNSADAEVMVIFCEEDMKRLSKSRNIAAHNSQA
MDLNIVTNLIRYDLARLKQSIVNFKNNPNNLHFIPKEENVKKRILKPLEVLIIFLFVCIL
SCIIFITFFYLTSPPKA
>fig|195.2038.peg.266 Ribbon-helix-helix protein, copG family domain protein
MKQETRNYSLRMPLELKERLDNLSKNLSKPKSSIVREALEAYLNEIEDFSFAVNALEELK
DGDYSKASKKIDKVVENLQKESDDL
>fig|195.2038.peg.1633 hypothetical protein
MIVSKTYEIDSCDDVELDIKRESKLEFKLWYDDEKEIKALVFIIPGLGGDVDENYREHLA
EFVAGEFNVAVVSVNYHCIGNRPQTGSSFFMDDIDKLILKTSCEALNIQVNLDKLNSLEE
LSSTLKEVDHILEEQKNQKLINPNFKLSIHLSLQPTKNEYQNFGVMQAQDLLNAALYLKA
HAPFDTMGGGYARYHDR
>fig|195.2038.peg.1881 Flagellin
DMMENYGRLSLVKNDGKDILISGTGLSSTGFGASNFISQVSVSLRESKGRFDANTADAMG
FGSVNKGLVLAASSIA
>fig|195.2038.peg.1240 RelE/StbE replicon stabilization toxin
MFFYYSDKALRQFSKLDKAIQTALRIGKHSELSLSNDR
>fig|195.2038.peg.1579 Putative membrane protein
MQNAKPIRWFTFIVLVIGGGTVFKRCFLCTYAGIYES
>fig|195.2038.peg.1243 hypothetical protein
MLGLEFIFSKQRLEHYKDINEHFENLKLISKIMPKIAILEIYLRNALDYELNSNCKEWIK
TSDNPFLLAKINEFKDKDSLEPHQILSRLSLGVVAKLIISYKVQNKILDLRAFDFRKYSS
SNRNFFIYENTKQGFDNIDKVNIVLNLLHTLRNRACHFENLLKIRENDNKLYPRISTKEK
GTNIGLMPDKIENFLNDLICLINKDLLDYLNRG
>fig|195.2038.peg.1232 hypothetical protein
MEKVDYCRMSCLDGKINAFKYLLDLFLSDLENENDVKTCNMFENDTSIEYVKDMLMMMLD
KIKEIVIDQDNCHHNIDMYASVYHEIIKDELGKEFTPKELKELHKKQEERLLKELFEESK
KK
>fig|195.2038.peg.582 hypothetical protein
MFIEVYGLGVVYDEINIAVNTCKGLVLSKKRLFALNLSFFIQ
>fig|195.2038.peg.1230 hypothetical protein
MQILESDLFTNELNIILSFIVRKESIKVKNTFKNDLYKALKKLDFMPYKFRKSLAFDDEN
VRDFIFKGYVIPYKIDKEKDLIIILGIYKENLPNF
>fig|195.2038.peg.1603 Protein translocase subunit SecD
MLVNVLVVVAVMAMFGATLTLPGMAGLVLTVGMAVDANVIINERIRELLREGENIKASIE
QGYKNAMSAIIDSNITSLVTSIALYAYGTGAVKGFAVTLGIGIVVSMITAIWGTHGMFDY
SMRRIEKSNNTRFWFGYRRK
>fig|195.2038.peg.897 L-carnitine dehydratase/bile acid-inducible protein F
MLPLEGKLVLSIEQAIAAPFCTRQLADLGARVIKIERPEVGDLARGYDKRVDGIASHFVW
VNRSKESLAIDLKDPDGLEFIKTILPKVDIFVQNLAFGASKRLGLDYENLKKYNPKIIVC
DISGYGEGGNYGHKKAYDLLIQSESGLVSITGTQDECVKVPISIADISAGMYAYSGILQA
LLYLEKTGKGSRVEISMLECMAEWMNYPLYYNL
>fig|195.2038.peg.1880 Motility accessory factor
QHIVVFEKDIEIIWIMFHILDFSHELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSRIY
FLELMSHYYERFHEDILGLNKKLAENFKN
>fig|195.2038.peg.1856 Predicted L-lactate dehydrogenase, Iron-sulfur cluster-binding subunit YkgF
NGDLDGPKEVHVILFDHNRTKMLAHKDYYEALRCIRCGACMNFCPVYDQIGGHAYQTTYP
GPIGEVISPNIFGIDHTGDILNFCSLCGRCSEVCPVQIPLADLIRKLRCDKIGQGENPPM
GAKNIHHNAMEAFAFKQFKKAATKGERWRFALSKAHYFNWFVQNLSGALPVIKKWYAFKE
LPQIKKDLYKEIQAIEGVIYE
>fig|195.2038.peg.1789 hypothetical protein
MQNSLETYTMKYNENGYGLLFPDGHVVRFYERILKYKLNKTNGNLLDFGCGNGVHSAYFQ
SKGFKTFGIDIVPSLKEIWEQNIRGGGDIVKL
>fig|195.2038.peg.1287 hypothetical protein
MQQFNFAANKNSSDMYLITEIMSIFYEKDIDIFVIVSSDSDYTSLIQKLRENKKQVIGMG
LEKSIKSYVNAFSEFFYLDQDENKKEDILSKDYLRALINITEQLIDEKGRAEYAQIRTNM
NRKYSDFNPQNYGFKNFRALIQKFLPKMKKFEEEREKNIYFLVKKDYENYY
>fig|195.2038.peg.465 Hemerythrin domain protein
MKEHFHDEEEFMQEIQYPRLYEHKQMHKNIIHEMFQLIQNIKSTNDLKEKLYSIMSKWLS
RHILSHDVMIIAWVNENLKKDENKALELNDLPPKQTLTQEENFEFIYSCPCKIDHRLSFK
EHESITNEGKVMRCKKCQELLFLKKLIRDKACFQNGIKSIAFIMAE
>fig|195.2038.peg.1168 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAVLSLFKTS
NILENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMICLCGGGLGVLFTIPL
RRAMVVESKLAYPEGRAAAEILKVANKDQSSKKGKQGIKEIALGSFIAAIFSLLSNGFKL
AASESNFAFIWNKMAFGFSMGYSLALLGAGYLVGLAGAIALFVGMFLAWGIFTPYLSNFE
FDSAKNAVDLASSVWSSKVRLIGTGAIAIAALWTLIELLKPVIEGIKEIVKNVKITNQEK
NERTNIDLSLKSIFILFVLMVVGLFITFYSFVEDANLSIYYQMLFSFVGTLVSVLIGFFV
AAACGYMAGLVGSSSSPISGIGLIGVIISSIVFLVLGVELFQDPMLSKFAVALAIFTTSV
ILATAAISNDNLQDLKTGHLVGATPWKQQVALLVGCVFGALAIVPVLNLLYQAYGFVGAM
PREGMDASSALAAPQANLMSTIAQGIFHHNIEWGYMAFGVFVGILMIIIDKILKGTQKMS
LPPLAVGIGIYLPPAVNIPLVIGGILKYIVMQHLTKKYAKNSHKEEKLASCEQRGTLFAS
GLIVGESIFGVIIAGITVFSVSMGGSENPLALNLANFHDSELFALIFFVGVVLYFIKRIV
KKDA
>fig|195.2038.peg.746 tRNA-i(6)A37 methylthiotransferase (EC 2.8.4.3)
MSSKKLFIQTLGCAMNVRDSEHMIAELTQKDNYTLTEDIKEADLILINTCSVREKPVHKL
FSEVGGFEKVKKSGAKIGVCGCTASHLGSEIFRRAPYVDFVLGARNISKITQAVNTPKFM
SVDIDYDESEFAFGDFRNSIYKSYINISIGCDKHCTYCIVPHTRGDEISIPLNIIYKEAQ
KAVDKGAKEIFLLGQNVNNYGKRFRNEHKKMDFSDLLEELSTIEGLERIRFTSPHPLHMD
DKFLEVFAKNP
>fig|195.2038.peg.821 tRNA-i(6)A37 methylthiotransferase (EC 2.8.4.3)
ERIRFTSPHPLHMDDKFLEVFAKNPKVCKSMHMPLQSGSSQILKAMKRGYTKEWYLDRAL
KLRELCPNVSISTDIIVAFPGESDKDFEETMEVLEKVRFEQMFSFKYSKRPLTKAATMPN
QIDEEIASNRLSTLQARHNEILDDIVKKQENKTFKVLFEELRAGNAIVGRTDNNFLVQVE
GSEELLGTFKEVKITNAKRMVLYGEII
>fig|195.2038.peg.1338 Integral membrane protein
MIKETHRKNMREYKIRRQLFNILSKNNPNNIKEYDISIPEYKKIKKIIEEIKEKEDFRQR
DDLFSSDEKWYLICNEGGGKIDISLSYDKIKSIPCNVIFNNCNIDLCVIKPKDLEKDNTE
TIKNHLYFYNCTFENLLIKLKNIIFEKTLTFNQCAFYNDLDIHQNQFLDHLVFINCYDKR
NDKKITSLDLQENEFEGYLFIKNCAIEKINLWKNKFKNRCYFVDSNFGYKDKDNTTKLNF
SNTHFKDNVYFNNSEFYSYADFHECEFDDIACFYGVKFHKIPNFSACYFKEQKAANLINV
DIDKLDFKSVEKYIEDNYQDETCENKQEITEEQRNNNCKLKCAKHLKDSFRVIKDVLITQ
NNTLEAQEWHKLELYAKERELLFEVESCYKEKNKPFIAAKSEDKNSINLTFSVLLLWIYR
VTSLHHTNLPRIINFTSLNIVAFGCLVCLITYLSYHIDKQSNFWFRGVFILSVLVMAIVY
LTLKKHKLKSIRLILFTFLAFLMALFLIQSITLLHLFSDVVFALFLYCLLVIALICLYPY
INSISFVSYCFNWLVYFFFVMVVVIKPQLINPFAGIFSSDKLYESQFEKSLNDLNTSAII
NLASILQNDFNLHLKDQNISFTELNSAKALIIANKEKLKEILKVYDDKYESDYKKVLNEL
ENNTSNIKNIIEEIDNKNNNSVVSAQLNKFLKLNFSQEIDILYAIKSNFSISEKLSPEQM
ALFDQKDSQDKLKSVLALLKFKSSFEGILEVINQDEIIQNTIKSTSVLYSIILLLCIFSL
QKTARKNSIVPS
>fig|195.2038.peg.1840 S-adenosylmethionine synthetase (EC 2.5.1.6)
PIGGGAQSSKDYTKVDRSGLYAGRWLAKNIVAAGLAKKCIVQLSYAIGVAKPTSVSVDCL
GTNTGVNDDVLSDFVMKNFSLTPNWIRDKFGLDKPSKDTFLYADVAARGQVGQKDYPWEK
LDAIDQFKTLIK
>fig|195.2038.peg.1542 hypothetical protein
MENDIIKKFINTDYKLLEKELEELSKKDELRLEVDQGLDQALRDLEIISAKIPQEETQKL
FDQCANNAMDAVMGHFGFAAVILDAKDGGNVNTTHNVRNGFYASEKEKQRYANRGKYDSD
NYHQDDNYKRINKEQNVLKKQGKLEDYMTGKKINANADTDLDHIVAAKTIHDDPARVLAE
IDGAKLANTESNLKMTDSSLNRSKKDKSAEKFLADRDKRLKFLAEKEKNGALTPSQQKEK
EKLLKQKEIQDEKFKEQYEQNEKEINREVDKTYYTSSKPYKEALITGTQDAAKIAVYSAL
GVVLKDFIKAIIIELKVTFKEFGNESLKEILVRFKDRFCKVWEELKLKWKDILKNSLEGA
LQTFFSNLVVFIINIFATTLKKSCKL
>fig|195.2038.peg.1101 Acetylornithine deacetylase type II (EC 3.5.1.16)
MLERVKNLSDKYYEKIVNLRHQIHMHPELEFEEENTARLVCEILDEYGIKYEKNIAKTGI
LASIEGKKPSTKKAQCVLLRADMDALPVQEETNLSYASKINGKMHACGHDGH
>fig|195.2038.peg.1825 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
NNTLNKTIQEKDIIINSNTNQIDQLQNNIQEKSTQLNQLQSKLSFQTQYGTAKSRIQNQL
SYKLGQAMIINSKSLLGYLIMPMILLNIIISHKQAQKAYKLKIKKNPNLALPPLESYPDY
KEALKEKECLTYKLGEALIKANKTWYKGGYVKMLFEVRKLKREFKEK
>fig|195.2038.peg.675 Succinyl-CoA ligase [ADP-forming] beta chain (EC 6.2.1.5)
MNIHEYQAKAIFADNGIPTLKGKVAFSVEEAVENAKELGGSVWAVKAQIHAGGRGLGG
>fig|195.2038.peg.896 L-carnitine dehydratase/bile acid-inducible protein F (EC 2.8.3.16)
MFGLQNPREWESFCKIVLQDESLIEHEDFKNNTLRTKNASKVKEIIEDAFKNLSAKEVVD
RLDEAKIANGNVNELNQVWEHPQLKARNRWREVDSEVGKIPALLPPATNNNYEARMDKIP
ALGEHTESILKEFGFSDKINLFKEKKII
>fig|195.2038.peg.1685 tRNA pseudouridine(13) synthase (EC 5.4.99.27)
LEDVKWRYDEQKAHFCMEFFLQKGSYATVVLEEILHKNLFE
>fig|195.2038.peg.183 Galactoside O-acetyltransferase( EC:2.3.1.79 )
MKIIIKNLQKLRVLYYKKFLSNVSIKSKCKIRSATLFYSINGGKIDIHDTVSFGFFPSPY
FYTCYNHIDIREGGNIIIKENTIINNNFILCAFRNNINIGKNCLIGG
>fig|195.2038.peg.1236 hypothetical protein
MSISLFNDEIKAYIKNYYSIVDFLYLRYGLEFDKQGNEKHNKSLKIKTNTCLITDFNGSF
SGDIIDFIAFKENVGLKEALIIFSDFNRLPTQKVGSFKPQKEPLKDNSYLKNIAYSLQAN
FNLANSDFIECKALEKAFFNDFRLFMHLCKLNFLKDDEFESILKDYFAFSKDDKSLAFIL
KDKNEIKSVAIREKLFKNELVKWFKVKGSSNKFIKLIKAKEKGLLKDYCFIFSGIKEIIV
SELLGLNAVCFQSDSMMKNIHSHEQINELLNLIDNKRIVFIVENDESSFKANLELLKELI
QINPLKKGYCVFNYDEVKNADFIDFLAYLMKELRQDYQRDKKGLNSFFSYMEKYFKNYFN
KKINLFLKVKK
>fig|195.2038.peg.579 hypothetical protein
MQRKQSRRILKTKKEKTKLSHNFKKTQLKLNKIYEKSSNIKKDSYHKITSKLIQEFDLLA
VEDLQIKNMCKRAKLKNIKAKSGLNKSILNTSFYQFSQYLEYKAKHNGKFFIKVNPQYTS
KTCSVCGNIKKNLMFKDRVYLCEKCGNTLHRDINAANNILKRGLKSFGLGISLEDYKLKA
FRIS
>fig|195.2038.peg.388 Acetylornithine deacetylase type II (EC 3.5.1.16)
VQEETNLSYASKINGKMHACGHDGHTAGLLGAVLILNELRDEFSGTIKFMFQPAEEGSGG
AKPMIEAGILENPHVDAVFGCHLWGPLLENTAQIVSGEMMAGVDVFDLEFIGKGGHGAHP
HTTIDPIVMASKFVSDVQCIISRRLRPVDAGVITIGKFHAGTTFNVIPQNAILQGTVRFL
SDENQKLLQSSIENTARAVALEFGGDFKLDYKREYPPLINDENAAKIARKAFGKVLGEQN
IISVAKPDMGAEDFAFLTRERMGAYVFVGISKDLNNPTLHHSSTFCWEDENLKVLMQGDS
MMALEFLNS
>fig|195.2039.peg.1765 Putative transferase
MCPFVTINANSNIGDFVLCNIYSSIAHDCKVGEGSILSPYATLNGNSSIGKNCFLATRVS
LLPCVNLEDNCIVSR
>fig|195.2039.peg.1608 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLVDALRSEL
TKEIKSFIPELRVEKRIITAKYDYDRKKRQTVLVSLSNIPSEVNMSTYLSKCANSGFPEI
VPNYSISQLKGEHLIYYLNDQYAASYAYQAISYAPSGSTNNNNY
>fig|195.2039.peg.196 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MMGGYELNSILENLQKLESKLDFNLLLSLIEEQISHSEVLVEETQSKERRQDFNAFKNFS
KTIKELLQTLPASPQNGWERVKLKDICNINQETYNPSNDLGEMLYIDIDSVEKETGKINF
NDKIPCKNLPTRARRIARADSVIISTVRPYLKGFVYIKDEIKDSIFSTGFAILNGKENIA
KSQFVYYCFMFVDDLMRQIEIKMPKSSYPSINTDDIGSFIIPLPPLEIQEKIVQNIELVE
QQIDFLNLKLEFLEKEKEKILQKYLFS
>fig|195.2039.peg.1718 Conjugative transfer protein TrbI
MLEVNMSPNKFLPKNNKRLSKVPIIIIFAIIAIVLFSIFYVALSRKQNLERQTAQTTPKE
ETQIATNHNNDLNLYIDELQVQKAQENNIISPPMPNAAQQPIQETNSQTTQQPPNNTPIL
VQNNAIDEKEMKIKKDMQLKALLSNTKLDIKTEATDSKKNQAINFNPPNNNEDINLGAIN
PQNTGLGLESGTNKDVQGQQFLSQKKDNGYLKYVKQKPLSTYEIKAGWNIPAILITGVNS
DLPGQILAQVTQNVYDSATGKYLLIPQGTKVVGAYSSNIIYGQSRLLVAWNKLIFPNGDT
LNLDGMQGTSQDGYTGFEDQVDNHYFRIFGSAFLLSSISAGIALSDNSDTNSEKETASDK
AIAQAIQQMGQVASEMIRKNMNISPTLKIRPGYKFNIFVTKDIILEPLELNND
>fig|195.2039.peg.1406 membrane protein, putative
MFDFFINYMIFCAKDLSKLFLGTLALFLFAFFGFMFFICEGVFLYVLLFCEIILFL
>fig|195.2039.peg.890 Predicted D-lactate dehydrogenase, Fe-S protein, FAD/FMN-containing
MANFKAFYNEAKYIFKDRIFNDYARCYAYGIDASCYFYIPKIVIIAKNEDEIKQIIQLAN
TYKTPITFRAAGTSLSGQSSCDGVLVVIKFAFKKIKINKDASEITLGCGVVGIHANESLA
FLKKKIGPDPATINSALIGGIINNNSSGMCCGTKDNSYKTLRSIRVILANGSMLDTSDAL
SVARFKDENKKLINELREIKEEINANKELKDLIIKKFKIKNTTGYSLNAFVDYDDEIDIL
AHLLVGSEGTLGFVSEVKLAVLDDLEFKACALLFFDNINNAANTIKEFAKVDFISSAEIM
DYASLKAASNYDELRDILADIKEGNTCVLIQSEHSNELKVDENINKIKEISKLAYKSYFS
KNKAEYDLWWKIRKALLPIAASLRKAGSTVITEDVCFNIEDLADGIKSIQELFYKYGFSD
NGIIFGHALAGNIHFIITPDLNNKLEFDNFSNLVKEMSNIVASYGGSIKAEHGTGRMVAP
FVEVEWGKQAYLINKKIKSIFDKDNLFNPDVIISDDKDIYKKNIKQASWIDEKLNTCMEC
GFCERFCPSNEYTITPRQRIAILREVKRLESLNDDESKAKLKDIKKYYNHLVDSSCAACG
VCSFSCPLGINFADFSLKYRKNNIGFISKILGNLAYKNHEKTLKIAKFSLSIANKFDNLS
LDNKLEKASNFLSIIPRTRAYLPKVNDYELKSRKRACNVVYFTSCLNKSFKPNEKMHDKR
SLQEVFESLCKKANIGIIYAPNDLCCGKAYENFQDIQDKNIQKINDFLSNIDSPIVLDHS
ACSAKLISDHSKYEIYDLSEYLLKFIAPKLRIDKINEDVGLYIMCAARKLGLNENIIKLT
KLCTNGKVLIDNDTYCCGFAGYKGFFNPKLNINATKGFKKFYAKTNIKRGFSTSSTCEIG
LSDATGISWQHIAYLLDECSEAI
>fig|195.2039.peg.955 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MLKPTDLENIKYNISLVKENVKFVYYIVLEREVSLNSIRLYLEDESICNSFQKIIIEGKS
EYKRDYKNIANENIYFVDSLRVDNICKKICYIRMYLMSGEYFKIKKISFLAHKYLKMIVS
GRTDGFGARMFSLLNAYYLAKESNNGFAFVWPSSLADKNLRALQGEQNIDNSVLAGFAMD
SEDNIFEKKFIEQYSYTGIFKVNKGESFPIHSSYRKIFIKESENNIIYINSTPLNIVFDD
IDEKKYRESMKYIWNALPFIPSIKSIISMANKLASTRKFISVHIRSGDVVFGDGVKELMD
STFRHAMPIELAMAVIEENIHRNYNIVIFGEDLTSLKKIKEYYQYNSNVFLISDFIPENR
IFSTLEQVFFELTFMSFSKEIYTTRSSVYSRFAFYIGMSKKLINIYEYFSPREQYDFLNN
KEKIYQSDLQAAYSKFHLFRLSREMKYDFSLQEKYIQECIKLDPNNFIFKILLLDLYFEL
KKYKDADNFLGSLKIDSKLKFVKLLLNKENKNIIKKYLQIPSIELINHKNILQCTINIVS
ATKNANESDIIHNFNLAQNPFLQATLKDNEAKLIQISNLNNTIKEKDNIINSNINHINQL
QSNIQERSTQLNQIQSKLSFQTKYGTAKIRIQNQLSYKLGQAMIVNSKSFLGYLIMPMAL
LSIMISHKQEQKIYQEKIKKNPSLKLPPLESYPDYKEALKFKNHLSYKLGEALIQANKTW
YKGGYVKMLFEIGKLKQKIKKENNGN
>fig|195.2039.peg.356 ABC transporter, substrate-binding protein (cluster 1, maltose/g3p/polyamine/iron)
MSKKFFLSLGLVALLFSNSQAIDENLIKAAQAEGRVNSLAMPDTWANWKDTWADLKNLYG
IEHSDTDMSSAQEIAKFKAEKKNASGDIGDVGASFGEIAVKQGVAQPFKTSYWDQIPTWA
KDKDGNWLLAYTGT
>fig|195.2039.peg.1698 hypothetical protein
MKKVFLDTNIFIDFFEETRENNQQAKQLIYFLISNDIKIIFSEDMISTVAYILKKENLGK
FTHFIKTISLEKEFEIVSFGVSVINMACDYYDKYQGDFEDYLQYFCAEKEGCCAIYTMDK
NFPNLKIPVKRYGEIDI
>fig|195.2039.peg.1707 hypothetical protein
MNKKELIEEIAKKHHIILDENDPILAVVSANEIIFDDFLKKIDLLFIKHKTDLESYKFNI
LNEIREYSKNNQEALKDILIQAQTNQNTIKASQEKTEDTKEKKNTNINFWIIAIASQIIF
LLVGLIIGIII
>fig|195.2039.peg.1453 hypothetical protein
MEKIIRFINFLELNKDDFILFTGNLMQFLQNIDGDNRKKLNFLLDCMKDNVDTLAIHTFN
WDFCKGLAYDILNSKSQTGALGNIALKRDDFRRTKHPIYSFAVAGKFQKELVVLENKGAF
DNNSPFAFMHKNNAKMIIVNLPLQDSFTFVHYVEECLKVDYRFNKSFEALYTDEKGFTQL
KTYDMFVRKDGVLTDVNGLENLFIKENVMELKKFENLCIKKIDLSKAYDVIVKDIEDNHA
KNLMNYA
>fig|195.2039.peg.1694 Conjugative transfer protein TrbE
MLALKEFRSKAKAFPDILNYASFIDEGILLNKDGSLTAGFYYRAGDISSMTINERNTLSA
RINSVLKTLGNGWAVHIDCSRIKTENYIDGDTFYKSNIAQILENERKHYFDNVEHFENLF
TMIFTYLPPHKSINKITDLMIIDETKNKNQGDKILEYFKNTLQKLEDSLSNYIKIERMLP
RIAIDEYNNEYILDDMLEYINFCICGERQKIILPNAPMFLDCLLGGRHFETGMHPRIDNQ
YIGIIAIEGFPSESYPNILNALTELNFDYRFNTRFIFLDDFEAQNSLNKYRKKWQQKTKG
WLDQLLDRPARKQDDHAVLMVQELDSALSESKSGMIGYGYYTANIVVFDRDYESLEYKLK
DIRKVLENLGFLSRTETINSVEAYLGTLPGFVYPNLRRPILNTLNLTHLIPLASIWAGDK
YNSSERFPPNSPPLMQVVTSGNTPFRLNLHVSDLGHTLIFGPPGSGKSTLLANIFLAWQK
YPNAKIYAFDKGQSLLAPTLATGGIHYDVAGDHSSLAFAPLANIKTDAEIAWAEFWIETC
LKLQNVNITPKQKKLIHEALISHINTNSTSLTEFVSALQDSDLRDALNYYTISGTGGFLF
DSEEDKLSLSSITTFEIEELMNLGDQYIIPALLYIFNRIEKGLDGSPTLLIIDEAWIALK
HPAFKDKIVNWLKVLRKANVAVIMATQSLSDSAKSGILDILQEYCPTKIFLPNPEAYKKG
SENVLAPYDFYKIFGLNDVQISIINNAIQKREYYYTSPLGTRLFNLALGKTNLAFTTISD
KVSVKRVRQLYEKHKENWAYKWLEEKEINYKRFDNSQKEQI
>fig|195.2039.peg.1688 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAIDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHKGNSGIDLALKKDKQIQVIVEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EFYKECEKLLSSEKYLDSITRKDLFDEPSLKGVFIDIKPILEQEKPSFSKLKPLFKIFYK
DFLLSEFNPNDANSLNNAFYKELLYILGLYESK
>fig|195.2039.peg.104 Glycosyl transferase family 8 family
MYNIIFSADENYIKYTAVLITSIIKNTNANNDFLNNIYHFHILSDFLSDSIKEKLDKLQN
GLSKIYPCKISIHIMKDDEFKNFPSSGAAHSLKLPYYRLKFISLFDDSIDKCLYLDSDML
CMCDIRELFCIDLKDNIIAVVGDPGSKKAKIKFIENGKKRVLKFDENYFNSGFLLINVKE
YKKAFIEQKCEELAKNCVYIKAADQDLLNATISKDKILKLDFAYNFNIITLLYTVCKDEK
KNRLNYTRKEFIQSMKNPKILHYGEKPWRFLHSYKDFYGKNINDYWWDIAEVTPVFKEEL
SKQKKEIKDYLLYAGLGYTLYYFCKKYQIFSIKKLLKTDKDKELMEFAKDLNDEKYGLYC
MLGEMVLYARKHQKGVINIILKSYKMIKMYEKYAHKSKF
>fig|195.2039.peg.190 hypothetical protein
MSQTNNNTEIKEQDTQDEIIWEGKKGYTFVFALLDNIYCIFMFFSLFIS
>fig|195.2039.peg.1711 transfer origin protein, TraL
MAKIHFVLNGKGGIGKSFISSLLCQYFLDKGESIVAIDTDPNNTTLLNVKALKAKFLQLI
DDDGKFDVRAFDKIVELAFEKKAENYIIDSGATTFIPLIDYLKENEVLDFLTNNNLEVYM
HVPIVGGQARDDTILGLTQLTEAFNCSFVVWINEYHGSIIKDNLEFEETKEYQAIKEKIK
AIVYLNALSKDTFGKDLLELTSKNLTFGEAMQDKSFSLMSKQRLKIFKDKAFSQISNIL
>fig|195.2039.peg.1721 Conjugative transfer protein TrbF
MNIFRQKQKIEKNEFDTSSNPYLNAKTEWLERYGDYITRAKNWQMVAIISLAMCFVCVLF
IGYIGSQNKLIPYVIEVDKLGNTAKVGMVQNIDLKNPNVIKYSLNTFIYSWRSVWGNAET
QRKFIFDAYAYVEPRSKAFNYLNSEFQKNNPFTRSTKENVRVKIKNIVPQNIDTWQVEWE
ETTTNLNEDILSKETYRGLIRIKQIIPNTEEQILKNPLGIFITDINFAKIL
>fig|195.2039.peg.1714 hypothetical protein
MKDFKELETIPNFSYEVDPLTAEELGAFKENALSEDDAKEGTEDQG
>fig|195.2039.peg.1702 hypothetical protein
MKRGFAKIEFFANLEYLKQEYNKGYVVSKILYEKAKQDKNISMVYSQFNKYFNEVFKNKI
EKKEITQENNQSLALENKEPIKLKINTKSKKVFDAKFGKDIKEDDLL
>fig|195.2039.peg.221 Possible purine/pyrimidine phosphoribosyltransferase
MVDDIVSSGSSLLEAKQFLEKNKISVLFAVVLADAKV
>fig|195.2039.peg.963 hypothetical protein
MKAYIHIGTPKTGTTVIQKFFKLNRSKILNKYILYPKTVGDEHHQTLAGFAYNISRLTTH
RKHLKLYNNYEYINYRKKILKKLKEEICGINEIVFSSEVFQEQLSKREIYRLKKYLIFLG
FTEVKIIVYLRNTPELFKSLCSMFCKNNEKSIINLLPYDNSRIHHICNHKQTLQWWGEIF
GKENLIVRLFDNNEFYQGDLLKDFIHSIGLEWDDEFIIPPKQNESLDLLGIELLRRVNSI
SSRYTGVQPFIKTFCEKHFTSKDSHLKFQPPKEIMQSYINYFEESNEWVRQEFFPHKERL
FPKKDLSNYKENYELKEMKPEYWDKIAEFIADIVKTKNQNIADKTNIIQNKDKIIIDQTT
QIKSLQATLKDNEAKLIQISNLNNTIKEKDNIINSNINHINQLQSNIQERSTQLNQIQSK
LSFQTKYGTAKIRIQNQLSYKLGQAMIVNSKSFLGYLIMPMALLSIMISHKQEQKIYQEK
IKKNPSLKLPPLESYPDYKEALKFKNHLSYKLGEALIKASNNWYGGGISNCGLRLGN
>fig|195.2039.peg.1701 hypothetical protein
MEKSKKERIEKLSEKTKNLNLDNELYIFVNNIKWGKKANILINCVDLGTNIEFYFSVFFS
NKYFSRSGDFNFREYMENFFENSRILAVKFKRSKTGYLNCFNARIAEVSDL
>fig|195.2039.peg.106 Putative two-domain glycosyltransferase
MNLEKISVIIIVKNAQNTLFECLNSLKEFGEIILLNNESTDDTLKIAKEFQKDFTHLYIY
ESKFIGFGALKNLALSHAKNEWILNIDADEILENEAKEELKKLEFKEQNILALTRKNLYK
GEWIKACGWWPDHVLRVFNKKHTKFNENLVHESLILHPNTQKVYLKNGLKHFAFESIDDL
LDKLQKYSKLWALQNLHKESGICKALVRGFWTFFRNYVLKKGIFYGYKGFIISVCNGLGA
FFKYMKLYELKKQKPKTCALIITTYNQPKRLALVLDSVKNLDPLPNEVLIADDGSKEDTA
KLIQEYQKNFPCVLKHIWQEDEGFRLSKSRNEAIKNSLSEYIVVIDGDMILEKDFIKEHL
EFAQRRLFLQGSRVILNKKESEEILNKDDYRIAFNKKDFKSSKNSFLAKMLYSLSKKDEK
IFKKITLIKGIRGCNMSFFKTDFDELDGFNENFIGWGREDSEFVARFLFNKGIFRRLKFK
AIAYHIYHKENSKKMLESNHQIYLDTIKNKKISWKNI
>fig|195.2039.peg.1716 hypothetical protein
MENENLEENKPTQFDDNEPSLFDNLEDEEQDND
>fig|195.2039.peg.18 hypothetical protein
MEKPYFKEYHSSFLSFNKSTFATKQRKCRSFRANDRDFPL
>fig|195.2039.peg.881 hypothetical protein
MGVVLKDFIKAIIIELKVTFKEFGNESLKEILVRFKDRFCKVWEELKLKWKDILKNSLEG
ALQTFFSNLVVFIINIFATTLKKIVQIIRAGFTSLWQAVKIITNPQKIYPKKIFIMKLQK
LWLQG
>fig|195.2039.peg.1713 DNA primase TraC, putative
MKNKDFIQETADKIIESLKNGTAPWIKPWKGIDLANNMPYNPITNKPYNGINSINLMLQN
YNDPRWLTYKQAQSINAQVRKGEKSTLIQYWQFSEMVDKLDEEGNVITNENGEVEQIEVK
LENPKVFFTYVFNAEQIENMPKLEQKQEIDNFQIIKEAQKILDDSKAIIHHKGNRAFYNA
ANDTITLPPKENFLSEGAYYTTALHELGHWSGHESRLNRDLKNPFGSKEYAKEELRAEIA
SFLFNGKIGLDYDPGQHLSYIDSWVQILEDKPNEIFKATSDATKIVNFIESLSLEQKQKI
ELENSNTQNQALKQDKELNLATRKTYLYVPFEEKEFAKKAGAKWDKEAKMWYAPKGADLK
NFTQWLNQSPLTQSYNNTHDEFKAFLEKYELNIEGQPIMDGKLHRVSVIGDKGREKSGAY
VGFLNGHPAGFVQNYKTGIKENWKSANSLENTKNKEINLQNALEHNKALKEQRDKELNQA
YENTAVKLENEYNNARWANSEHPYLKEKGFDKNFYLKQDKNGNLLIPLRDIEGKYWATQR
IFANGDKMIGATRTAEEKEQGIEYPAKKQGNFFLLGAKNLNNVNEVYICEGFATSASVYE
ATKSPTIMGVDAGNLEIIVTNIKEKYPKMNIIIAGDNDVKKELNGNKNVGKETALGIQKK
YPEVKVVLPNFTNQEAQKGLSDFNDLMKSRGLEEIKKQLKEQIAKQLMVEKATTKTLDKN
KGINKEITAKKDIGISL
>fig|195.2039.peg.879 hypothetical protein
MDNKRLVINPKKNLQNLKEIGEIQGQIKNCTPEELQILAKDQVKQIDMKIQEASRKIVRA
KELAYKAKNIENSFFETLNPFAKSETDKKLEALSEADIANAEAIGAQNELIQETIKLICC
DMVFADLMINELSLMIYEKYEINEEAILSLSNDTKKLVKKLQQRFFIKQNNALLKCKRQN
KKYKKPKKILEIWKMI
>fig|195.2039.peg.1704 hypothetical protein
MFLDIISKIFIFVAIHAMIIFIIKSHIAVIKTSLKYFDFRFIITYNSIFIIAECFAFFAY
SKYILN
>fig|195.2039.peg.1715 Single-stranded DNA-binding protein
MINNITIGGRLTADAELRHCNQGSIICTFTLANNRKYKEIENSTYIEVSLFGSFANAMHP
YLKKGISVDVVGELTQDTWEHEGKIYSKHRIKAKEIDFRTPKKEKQTIPNIEEGENYEGF
>fig|195.2039.peg.1452 Protein containing aminopeptidase domain
MPDAIPYVTSYYKRRWGFCLTHNERKKLKKGKYKVYINAKHDENGILDYADFILPSTQNS
KDEILISTYLCHPSMANNELSGPVVAIFLAKWLLSLKERKYNYRFVIIPETIGSIVYLSK
HLEHLKKHVKAGFVLSCLGDDHAYSLIHTPKENTLSDKVALHTLKNKENFKAFSFLDRGS
DERQYNAPLVNLGIVGVCRTRYLEYEQYHTSKDDLNFISEKGLMGGLQSIQEMILNLEIN
AVYENTIVCEPNLGKRGLYHTLSTANDIPLACNFLAYCDGENDIIDIANILNMQAYEFKE
LLEKILEYKLLSIIH
>fig|195.2039.peg.1703 hypothetical protein
MIIKKIPSKKQNKSSFKNLSNYILDKDNNNAKVLVDYMLDKNNEMDKVEGYHFTNCSFDN
DEDNINEIINTQKLNTTTKQDKTLHLVVSFQEDENPTLEILQAIEEEIAKSLGMEDHQRL
SVVHSNTNNLHIHIAINKVNPHTLKVINPYNDVRILQETAMKLEKKYNLKLDNHISQKDK
QSNKYNIHTMNCNFETWVKEKLSKQVDLMLKDEKTTFKDIKQFLAEYDLEFRERRKGFVI
ASKSEKLFCKASSIHRGLSKQALEKRFKELDLKQEKENTQNIKEEKHEIKEQYQRPNKET
SKTLWEKYLRIENEKKAELDKELRMLKLRRNEFKTSISSMKFNKNTFAHVKNQRMIFKNK
QKELYQKYKRVSYRDFLISESLSGNEEATRALRRTKTKINENENTLSSTQEKPKIFENVD
YITKEGYAVYKSGFNKAIDKGEMLKVSLINDKDDKEFLLNSLLMAIDRFGNHLNITGDDN
FKRNILEVANDYNLNVSFSDQRMQKIQEENNNKRQEMKTRKVLKNIIELKIKLTEQDKDI
DENIKEKELKALKFSLKKISNSTPSIFKGELKKLGFSYKEIDSMDTESVCIEIDGFIVNS
ANKEGLIAMNEEIKQTLIDDEEIKRFEKFEHLFLNTNKITDIAKGFYTNRKIDADEYIKR
FSMQESKINKVANAISMLSDKNIDIMEKYAKKLEKDLKYQYLKKVEVIENNDINLNNF
>fig|195.2039.peg.494 Membrane protein
MSKRKILKQQCKEIIQLNPTERVWQMPFFFALAVGFALSIAAYYDRMGLGLIAIIGIMAF
VYTTNTPMYHRMAVTMCCSFGLCLSFLIGLCTHFFPAFSPLVVGLVAMASSILIRYYNIG
APGYFFFVFSCLLASFFPFPPKDYIFLVGLICIGGIIANITAFLYSVSVIYIFKNSPPKP
VLKMEI
>fig|195.2039.peg.1806 Motility accessory factor
PDYVCMLERTEITAEFFNHDFGEFDKDIVFVCAGVVHPKTIEYLKNKTFIITQKVLAFPY
YINLKNFCYAAVGFSVAHTLSYLATYLSHKNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2039.peg.1079 Putative periplasmic protein
MRKSIAIIGGSIAGLSAALFFASAKNEELDFDITVFDEGKADLKAAAIYNVPFFPKGAKA
DEIYTHIKAQIASMLEVKYIDSKVVSISGEKGDFTVNDEQGLGIKADYIIVATGANKSDI
KELEDFVIPHELMPKPNKFCFKHHGRQIIKEGIYAAGLASGVTTMVACAMGSANEAACAI
LSDIKGAVSVYHDTSTTRV
>fig|195.2039.peg.1710 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDLTKEQYEQNKSIICGFAIENMFANEEDIINLIKVDK
QEKTPDEIIAEYKKEWGVND
>fig|195.2039.peg.1313 Type I restriction-modification system, specificity subunit S
MINLLQGWEWKSLGEIFNIERGGSPRPIKEFLTDKEDGINWIKIGDIKNQKYLYKTEEKI
IQEGLKKSKLVIEGDLLVSNSMSFGKPVIVKLQKGAIHDGWLLLKEKINLNKEYFYYLFS
SNFMYSFLSYQASGSTVKNLNIDKLKQIEIPLPPLKEQERIVGILDESFAKIDESIKILE
QDLLNLDELMQSALQKAFNPLKDNAKENYKLPQSWEWKSLEEISENISAGGDKPKNCTES
KTAKNQIPVYANGVNNNGLVGYTDKATIIKPSLTISARGTIGFVCIRKEPYFPIVRLISL
IPCENILCLHYLYFCLNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKEQEQIAEHLDFVF
EKAKALKELYTKELKDYEELKQSLLNKAFKGEL
>fig|195.2039.peg.1346 hypothetical protein
MALIFPFLKAFYYEIARVTKQKYFIYAFNTYYLGLLTLIIGIGLVFLLASLVFWILAWVE
FKEFDKQEISNKEKFTIPTQKVIFDFDLKWIKITMVLSLVLFFVFIGLKFTQIITFQSIR
REFFDFETYGRLIHNLFYIRYVLFYIATFLALLSVFLFCKKLKTYKMFIYFLIWQVLFVL
GWNLRFILKLIMGEDVFIENFILDKIISVAYIIIAFFFFKTLVQATKEKLFYLVFAFFVC
GEIVSKLFFAFIRLLDSIRLQEMIVEIIFYAEIIFYIGIPFTPAYFILFLIVWLSLKGQK
EVKKAI
>fig|195.2039.peg.1575 hypothetical protein
MTSQCDKATFCDKEPCSLDPPEDSTILREKKGLRIVRKRAKHAMLLRYGVVLWDYQIKKF
NLKGE
>fig|195.2039.peg.1795 Motility accessory factor
LEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEINFF
YQSILEKTPRYPFVCIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEELKV
YKVVLFDCVAKDLEIQIAMIFDQQSILEYLSLYEMFISSHYYLKYYETSILSLNELCIKS
ASVAIRNADITCFLPLLTHGQFLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSLAK
QLPLLKAYQEKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENLKQSIIAL
ECATHPNIVRSLNAENCMIVLRNKALYQRFNLNDFGYIDTGTHVSHFSYTL
>fig|195.2039.peg.1687 Putative type IIS restriction /modification enzyme, N-terminal half
MRFNDDKNLKFLNFKKIPDFDKLSELFFEILAKGRSARKKSEFAYLPYLNSSLFEKQSIE
NTLEISNLNNDLKLNYYKNTVLKDDKCKAKKGQVGLLEYLFEFLDSFDFGSDDEQSEILS
QKELISSSVLGNVFEKLNGYKEGSFYTPSFITSYMCKESITKVVLDKFNAQFDLDAKDIS
ELRKSLRKEDKKAQKELLNSIKICDPAVGSGHFLVSALNVMLSIYDELNLFDEEFYLEVQ
NDEILITGRKGEFIEYKRPSTPKDKAHLIQQELFHTKKDIIENNLFGVDINPNSCEITKL
RLWIELLKHSFYQSFDDENYHDLKTLPNIDINIKCGNSLVSYFETGKSLSHYPNIKERMS
KYKRIVKDYKEGFYTDKNLIAKEIKNLQESFKNFCLKDKFNKEIKQLTNGANEYSKKYGD
FLADEHHDEKFKSFFSKNMFEFSFDEKVAIKEFANLKKEYDNIFNLESNHPFEWRFEFPE
ILDDDGNFKGFDLIIGNPPYIKEAENKELFTNTKKLRTYQGKMDIWYHFVGRGFDILKNN
GYLAFIATNNWVTNSGAKKLRNIVLEESQILSLVDFSSFMVFDSASIQTMIMSFQKTKPP
KNYEFHFAKITTQTPIYEDALSLLKNEKTQNNEILSINLTPKKFIDKTLNFTKSDYEELF
NKIQKYGKFYLEEREVAQGIVYPQENINKKSLEILGNNFYLGQGIQKLTNEEVENLNLLK
NEKILLKPIFESDNIQKYFVKRYNYFWVIYTNSSFKNPNSMDDYPNLKKHLDKFQNVITS
DNKPYGLHRARDEKFFTGSPRIVALRKCVGEPKFSYVDFDCYVSATFYVIKTQRINVKYL
TAILNSKLIAFWLKHKGKMQGNNYQIDKEPLLNIPIVDTNSKNKKLADELINLVDEILKA
KEQDKNANTQELENKINSLVYKLYNLTEDEIKIIEGK
>fig|195.2039.peg.1812 Motility accessory factor
PFQRILNERKNKFENAIVVSAGPSLAKQLSLLKAYQDKAVIFCADGALSMLEKEGIVPDY
VTNLDFTD
>fig|195.2039.peg.171 Inner membrane protein YihN
MQNAKPIRWFTFIVLVIGGGTVFKLSSLKDAFYVPMQEFMNLSNTQIGLALSVYGIVQTV
GNFASIYIADRFSKKILIPFSLICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVL
LKAIRLLGDSTQQGRLFGFLEAGRGVVDTIVAFSALGIFLLLGSGAGGLKAAILFYSACV
IIAGILAYFLLEDDKISTKDDEGHEISKNKAAWNGVIKAVKTPEIWVVSLTIFTIYSVYC
GLTYFIPFLKDIYGMPVALVGAYGIINQYTLKLVGGPIGGYLADKTFRSSTRYLRFALIL
AAVAILIFIFMPHEKLNIYFGMSLTLGFAAIVFTMRATFFAPVDEIEMPREISGAAMSIA
CIFGYSPQLFCFALYGFIIDQFKGLLGYQIVFALMGFFAICGVIITTILLRMIAKKKTLQ
EVA
>fig|195.2039.peg.1690 hypothetical protein
MLTKLYLAKELLRRFKNLIIFIFLLLPNLAFGLENSNGVLDLLQNGLESWIPLIKTACLW
VFWTLVVIDLVWTFGLKALSGFEFGDFLATLIKKIMYIGIFLFLFNTDQWLQILFNSFSQ
LATGVSNGIKITPSNIVTSGVEILLSIWEAAGLNLAKTLFLLICGLIILIGFLLMAIDLL
IVYLKFFLMNVIVFFALALGGLNHFKQIGLNPIMTAIKIGIELLMIQGLMALAINITNSA
FKEIAQNLTIDLTLQILVIALIFCMIAKMVPGIIEAVFNGSIGESAGAAAGFRAVATMAA
GAAA
>fig|195.2039.peg.102 hypothetical protein
MNKIDKIYCMSHYVAFRFIKNENINFFEGLKHKTFQQKENLLYEIFNITDIEKVIKKTIE
DFYIPNKTALLLSGGIDSAILASYLPKNTKVFTFKCIANGAIDETSQAKKYADAYCLDHE
IIEMYWEDFEKLTPEILQYNKTPFHSIEVQLVKACKIAKQAGIERIIVGDGADYVFGGMD
KLLSQDWDYDSFIKRYNSIEPSMILKDYIDVSDVYKPYKLDNNKIDFMAFMKDIMDIESY
TSYMHAFEKENIHYLDPYSHMKLAFPLDLQRIRNGEPKYLIRELFSKRYPNLNIPDKIPM
PRATEQWLKNYVPKRKEFKIENINILTGDQKWLIYCLETFLNMHDKGEL
>fig|195.2039.peg.678 Membrane protein
MTQEQKISFFKIKRLSIYIFFCALYNFFYFFSYENVGSLHCEFLCISGRFLCFFSWIYIV
LAFIFMVARIYFLFSSKKILIYFLLAIISLGSSFFLLENKILFLGLLALFFVFYFLFSLT
LASLFKEVKMSFYFVFLCMLLAFLFFEKLSFLFFFLTLHFLTFAYAFDRYEALKKLYRV
>fig|195.2039.peg.1301 Arsenical-resistance protein ACR3
MVVVWSDLAKGDREYTSALVAMNSIFQILFFSTLAYIYLDFLPKLLGQSTLATSLDIDFS
ALSKNVLIYLGIPFLMGFITRTLLLKYKSKRWYENTFT
>fig|195.2039.peg.355 ABC transporter, substrate-binding protein (cluster 1, maltose/g3p/polyamine/iron)
MAFSLYRNIAFIVNKDVVKDIPKTWQDLLKGNYKITVGDVSVAAQAVSAVLAANYALGGD
EKDLSPALAFFNTLAKQGRLVNNDVSIANLEKGEVEVGLVWDFNGLGYRDKVGKDRYEVL
IPADGSVISGYTTIINKYAKHPNAAKLAREFILSDKGQINLAKGYARPIRIDHITLPDDI
KAKLLPSEQYKNARAIKDQKAWEKSAKELPQLWQEKVIVDMK
>fig|195.2039.peg.1384 hypothetical protein
IESKFDSGGHFSEGLAGVKLNGKYGFIDKNGEFVIKPKFNAVWGFSEGLVAVKLNGKWGF
IDKSGKIVIESKFDSGGHFSEGLAGVKLNGKYGLIDKSGKIVIEPIFDDIDY
>fig|195.2039.peg.1708 hypothetical protein
MRKTIAIFAFSFAFLSILSYLIFYFGGFHFNYTRSMPLGLYKEINSSTFNKNDIVLLKIP
QKKEILLKKIIAVNGDFVEVNTQGVFINESLLPNSKIFLFDSEGNLLEFKPFKRKLKENE
LFVMGENIKSYDSRYFGVVNILQNEVKKVKLMISF
>fig|195.2039.peg.1706 Chromosome (plasmid) partitioning protein ParA
MIISIVNEKGGSGKTTLAVNLSARLAEDGDNVLLIDADPQKSTEVFSDMRSQSNLEPLFS
NVSKTGISLGDEIKRMKNAFDSIIVDTGGRDSKEMRKAILSSNIIIIPTIPSQYDVNVLD
HMLEIYNEVIEINPNLLALVLVNRVSPNPFLAKELENLKEYINEAKKEKGLDRVIMLESV
IYERQAYRKAVIEGKSMKEFCDKNDKALNDFENFYQELLKIANEKLGV
>fig|195.2039.peg.953 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYTIISAVYNVEK
YLDDYFNSIINQRLDFKKNIFMVLVDDGSTDNSANIIKKYQKKYPKNIVYIYKENGGQAS
ARNLGLKYMQENNYKAPWVTFTDPDDFLDRNYFYEVDKFLSTHQDDDICMVGCSVIFYHE
KQRIYKDNHPLNFKFKNGEIVYNNFELKNNVHMHAASSVFNIIYLVQEFDEKLKPNFEDA
KFVNEYLLENIDLKSAFLPKAKYFYRKREDGTSTLDNSYTKEYFLTTIDIGTLSLLECFY
FNRNIQNVCLYHIIWQIKDLINSPEKLSFMSENEKQRYLELLDQNFSYIDTETILDFNLA
GCWFFHKVGILNCFKIEKPPFQIAYIEDYDPYKEQILITYYTGDDKDVESIVVDGEEVYI
DYKKIVKYDFLDRVFCYQKRLWVSLSKTFNGKLEIYINNIKARITFKRKQLQDIEVKFIF
MEMLSNIKISDIWLLMDKDYEADDNAEHLYRYIMQNHPKQKIAFALRKESSDWERLEKEG
FNLIEFGSFEFERIIKKASKVISSHCDEYLTKYITNRSQFVFIQHGVILNDLSRWLNFKK
INLFITSTQAEYDSIANDYNCYKFGKKEVVLTGLARHDALLKNNRSNVKQILIMPTWRKN
IVNSVVANSGKRKLNLDFKQTMYFKKYNSLINNNLLKKVCQEYGYTIVFNPHPNIMPYLK
EFNFPSYIKIANQNESLQKLFCNSSLMITDYSSVAFEMAYLEKPVIYYQFDKEEFFISQW
QKGYFDYKKDGFGPVVENEENLLKELESLLQNDCKPFGVYKDNIDSTFVFKDGRCCERIY
AMLENMKAD
>fig|195.2039.peg.1798 hypothetical protein
SCDDVELGIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYRNYIAKNFDVV
TINVFYHCFCQRRSDVEKYSTYKYFQEEDIENIKNLLNQFHFSYGEINNDNALFLANSLV
KHVENLKMQNKLDHNFKLNFTSTFIPPNGDYQNFGIMAALDHINALKDLVKCFPKFADLP
KIYGGGSYGGYLALLIAKIAPWYVDGVIDNSG
>fig|195.2039.peg.1693 IncQ plasmid conjugative transfer protein TraQ (RP4 TrbM homolog)
MKNFIFGVKKITLALSATLLISSNAFADDILTGDTKLACEAILCLSSGTRPSECSSSLAR
YFSIKFKKPWKTINARRAFLNLCPIQNDANIEDLVLNNLVDDVLPVSDPRQCTPNYLNTQ
VETKRSYSTFGIMSYRINPNMPNFCHALINHAYTDYKTPKYKCTGEFYNSLEWKLSAKLQ
LITQQAYESLSDDQRYMISRTCGDRNCYDYYQKIPFTKECWTY
>fig|195.2039.peg.1719 hypothetical protein
MKILFLALIAFFITSCAKMNSDYFNSSFAVEETKINYNKIADDFSQFIISYYAPNKTTFF
INEDKNNQDFSNYFINTLRKKGYAISNDNSKKDLTFLSYQISQIDNENIVAIFNINESKI
NVIYKIIENKLVKPNITSFNFTPKTKG
>fig|195.2039.peg.1696 Conjugative transfer protein TrbC
MKKFLILFLALGLGYALASTTGAGLPWEGPLEQIKASLSGPVAFIMSILAIIGAGAGLIW
GNEFSGFIKTLFYIVIVIALIVGANSFMSLFSTSGALI
>fig|195.2039.peg.349 Phosphoserine phosphatase (EC 3.1.3.3)
MKLVLFDLDDTLIQGDSAKLWLKFCVEKGFLPQEYLEKIVFYQKQYQEKKLDMDEFMTFF
LQSVKGKNEDRISSLVDEFIKIYIKPYEKAKELIIKY
>fig|195.2039.peg.1186 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVTDP
DSDEKGLNFGIYGKADNYDARTRDYFKGAVKQMACM
>fig|195.2039.peg.100 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MPQLSIIIPLFNSCDFILRALQSCINQTLKDIEILIIDDKSKDNSLNIVLEFAKKDERVK
IFQNDENLGTFATRNLGVLKSRADFIMFLDSDDFLALNACEVALTKIKQGFDLLCFDAFV
HRVKTKQFYRFKQDEVFNQKEFLEFLSKQRHFCWSVWAKCFRKDMILKIFEKIKIDERLS
YGEDVLFCYVYFMFCEKIAVFKTCIYHYEFNPNGRYENKNKEILNQNYHDKKKSNEIIKR
LSKEFIHDEFHQKLFEVLKREKEGIIKRLTI
>fig|195.2039.peg.1656 hypothetical protein
MAIGKVIHKYGSFFPDFDEIFYKIKYEIYRGDWEMLFFLQIPNIKKTDILEYFEDHFLGS
TLQDGCEFNDTCFPLFFTEDENLKNSIKPNYNSEYVSIIGQLFLAGYIEFGMCGLQNKEE
NLLSNQGDKYQAWIYFRDNFFYTEAYCRDIMEVKEPYKDMSDDDYVYSSWNTPQYWDRYR
FWVARTEKGTKYLREILEPRIYNKYKDLEVEIDDKGSVLRWIGEINR
>fig|195.2039.peg.825 hypothetical protein
MYLKPVEISYESANLETSKSISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENIT
IENGENKISSSSHSSTSSIAGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELN
GGEIDIKADKVDFIAAQNKTHTESDSIAIGVFANANLELTGNGVAVNYSFVQDKANANTT
NSSNSITQGGVRSDLLGTAEAGLEFSKTEKISDELSHVSNTIKGSNININANNALDIGGA
NFEANKDINLRAGEIVSTKYEDIKTQSSTGFGLYIKERIEATSPIASAINQSAQNAAAKN
ENLGVNYGIVASQALANTANIFSNNLINTTSNQTLGFKFNQDKSQSSSENISKINAGDNL
NLESTKGSIVLNGVEAKANSINIEAKDNVILNAAKSKNSSSSSSLEIAATNKQTAGYHAV
DGGTVGEGIEGFASASYSKSNETQFTNANLNANNININTGKDFTLNGANVKASNDAILNV
GGNLEVNSLADSLNSQKYSALLNASGTGGLSSNHLVTGSVSGTLGIGYAKTDKTTVTTQS
GISAGNEINGHVNGNLNLQGGILNSDNQKGNLLVDGKVTNSEVSVYEKSDVAMIRLSGET
NQSFGGVVDIDDHIDKTGSVNSAANININNNKNHGISTDTQNTTDTQDHSWAGGTINLNS
SISKIKNGISKVTGSDSTSNQPSNQPSKSDGPYINESTQTTRL
>fig|195.2039.peg.1506 FIG00638667: hypothetical protein
MKKLLIIPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPYYEIKNINFHKGFLNSKADFT
IEDKYNLGLISKLDFKFNNNYFSKFIAQGKLSNPFKLLDDKLQNKELAWFKIQSIQNDLN
VSIQFQDINLSNEGGNALWENVLTEILLDKEDLKIKAIYSKIGQVDFSQFYAKFYLKNLD
HQQKFEKPISFSNLIQFNESVEEFKFDFCEINNHTISSFYNKNIIYFDDDDNQTLKMHSQ
GKANNLNIDLTSQIYQSIDFDQINFDLIYSQKKPDISDDKLIFKPSNEELNLQIQNITLK
KDNQDINIKGNIFLSMQSHKAHIQISSLKSPDEIFTWGQFFGGLNQYFIKNEEGMFIMDL
HYDSDTKTQLKINGNEFTDINLN
>fig|195.2039.peg.1397 SAM-dependent methyltransferase
MENSIKDSYNKICKKWSEFRKNTSINQCIVDFANNLSPNSRVLDIGCGTGYPIALYLSKQ
GFQVTGDRYFRRNDKTSTKT
>fig|195.2039.peg.1580 hypothetical protein
MNLDFLNEFKLKNKDLNEKLEFLIPDFLVKKAITIIYANGGSGKSYLSAAISKTLCKDTR
VKSIVYVDMDNPLNVLNERGFGELILNESKFTYIHRSSLKTSAYELLEMIEGKGVAGSYE
GVLFVLDSLRNFADIDNDTKMMSLMSLLMNLRECGATIMALHHSTKDGRAFKGSNHIRNS
SDCMYFLQKVANLEQGFEVLLSVQKERAGIKDQAFFINTKTLNIKNTDLQNAKISDKKEA
FIDKVLKLLNEKSLSTSEILSALDVSRSDNFSRNTLEKFKGVFWESELGGENGRTFVWKS
LKADNKNSNDKELSLFGDDNPPSKEDLIKAIDEFNAKNSCSIPYFIADSFINYYKQDDGR
WLMANKKPLKCWKRALNSTWLPKLANKYKNKDKQKALASWLEEEF
>fig|195.2039.peg.882 hypothetical protein
MENDIIKKFINTDYKLLEKELEELSKKDELRLEVDQGLDQTLRDLEIISAKIPQEETQKL
FDQCANNAMDAVMGHFGFAAVILDAKDGGNVNTTHNVRNGFYASEKEKQRYANRGKYDSD
NYHQDDNYKRINKEQNVLKKQGKLEDYMTGKKINANADTDLDHIVAAKTIHDDPARVLAE
IDGAKLANTESNLKMTDSSLNRSKKDKSAEKFLADRDKRLKFLAEKEKNGALTPSQQKEK
EKLLKQKEIQDEKFKEQYEQNEKEINREVDKTYYTSSKPYKEALITGTQDAAK
>fig|195.2039.peg.1697 Conjugative transfer protein TrbB
MSNIEFQARINEKIKREFGDIFFYLEDKETIELMLNSDGKLWLEKLGQDMICLGDFSEAK
AKSIITAVSTLLDTTTNADNPILECELPLDGSRFEALLPPIVAKPTFTIRKKAVKIFTLD
DYVESKILTPKQKEVLINAIKERQNILVVGGTGSGKTTFSNAIIDGISKITPEHRIVIIE
DTAELQCASENKVILRATDKVDMLRLLKATMRLRPDRIIVGETRGKEALDLLKAWNTGHP
GGIATIHANSANGGLTRMEQLISEATNAKMSKLIAEAVNLIVFISKSKEGRKVKEIIKVI
GYENDKYVTQTI
>fig|195.2039.peg.1764 Putative transferase
MKNVIIIGAGGFARELYSYLKDANYEIIGYIDIQENNFFDLKYLGNEDNFDKKLIQKASF
ALGVGQINLRKKILVKLSKKSCNFITFIHPQSFVSKEAKIGQGV
>fig|195.2039.peg.101 Glycerol-3-phosphate cytidylyltransferase (EC 2.7.7.39)
MATLGYTSGVYDLFHIGHLNLLKNAKGLCDKLIVGVTVDELVQYKNKKSVIPFSERIEIV
RSIKYVDAAIPQENIDKYQMWEKLHFDVLFVGDDWFNTPNWNIMEEKFKKVNVRVIYFPY
TKGTSSTLINETLKNLRQ
>fig|195.2039.peg.880 hypothetical protein
MQFPIPFTGEKNDQGELVNFQTIGDALSLCITSACGAVLSTIAIFYMDKWRNDSKIGSLQ
IQLVAQNGVVMHYKIAQTWFVLGDAYNLFGQVMERGSQNLVILKNKVNQVQNKLKQAEGE
R
>fig|195.2039.peg.12 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGVLVGEGATINANKFGVSTTPMGIDAINTFSVDDSFSPVFNANKGDV
VNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTHLKAEIGSEGFFK
YEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEMINSWKGFAKLVN
EGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSNIQIDVADKTYVG
LFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIALDTIEGFNGENSSS
GGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNGGG
FVGYTTGNTTFDGISLKDIRFIKSGALTGGFAGMTQGNVIFENIVLNDLEEISGSHAGGF
AGWINDGTFNNIILNNIEKISVSATHKYIFTGGFTGYAGAGTYKNIILNNIGEISANGTA
SLDEKSIYAGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIANSNIYF
YGLLNSSSNKNYITHNENILNLSNTTDFQTLINQSKIAGLEYLTNTSTSNSHLHMINGGK
IGNEKSKITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDFEDEILK
TIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFYTEFNKG
GLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTILKPELKSIKNNLNRLEFLK
AEIKRLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNKPFLDV
>fig|195.2039.peg.43 Putative polysaccharide deacetylase
MWIDQFDWVYREMDYAIFPMTIHPDVSARPQVLLMHERIIKHINKHEGVKWVNLNDMADD
FSKRFPRKK
>fig|195.2039.peg.1712 Coupling protein VirD4, ATPase required for T-DNA transfer
MKKQTNQTLVYILAITGILIAFIIISQIATQYLAKSFNYSPSLGETLLYGFYNPFKWISW
SYTYYSFYPDFFKKFFMVMFAGIAFCFIVFILVKLAFLRKAKAIENLHGSAHWATLEEVK
ESGVFDKDKGVYIGGFEHKKTLHYLRHDGPEHVMLFAPTRSGKGVSLLLPTLLSWGESAL
IFDIKGELWALTAGWRQKYAKNKVLKLDPTCLDDSAVKFNILEEIRLETMHEIKDTQNIA
INLIFKGETPPTNPTQGSTSYFKSEAGNFLVSIILYALHLKKCQGKNTPNLTDIYKFIND
PNQSIDELLEEMVECDISTMDKNTQEIIQSISRSMKNKATQELSGVVGTASEALNLYIDP
ILAKNTAKSDFKIKDLMNHESPISLYLIIPPGQKDRLRPFFNLLINQIFRTLTDDSLNFK
NGENIKRYKHKMLVLADELTMFGKLSVLEENLAYMAGYGMKFYGSIQDIQQLYSIYGEKE
TIISNCHIRIAFAPNKIETAKLLSEMGGITTIIKKSLTSSGKRTAVMLGNVSETIQEVQR
PLITADECMRLPSAKKDKDDKIIAPGDMLIFIAGQAPIYGKQILYFKDPAFLARSKVTLD
KQVSDIL
>fig|195.2039.peg.1709 hypothetical protein
MIDKVLKFLDDGIPKNDFDRQLLASNLVGATNLIELNKKERIITLQAAKKLELNPIKGNF
DYQHLKDIHKALFKDVYTWAGKDRMEVGLHGNFGKYAPNGTITNFVPGKDLNVTAQQIFT
WLKEDNYLTNSKDLNDFAKNLAEFARNLNALHPFREGNGRTQRIFLNELAKNAGYKLDLN
LIPKDKMIMASVEASQLKLGKLEAIIKTNLKSFRQNLDLEQNKGISL
>fig|195.2039.peg.105 Alpha-1,4-N-acetylgalactosamine transferase PglH (EC 2.4.1.-)
MKIVLLIGDITIGGGAERVVCNLANAFNELGYSVEILSFYKSKENLAYEVHKNIQISFFH
IISRSKVFKKPFYKLYYKYYESYILKQKYKYADIMIYNNCSQFPFFKNKNTKHIKLIHEI
FKRYQLRNNFFDNLIILSLHELSIWKQYHNNVSYIPNFTPTITNKTPTLNQKIILSIGRI
TKEDQKGFLRLVDIWEIVQKNQSFKEWKLHIVGDGALKEELFCKIKTKKLEHSIVLLPFN
KNIEEEYLKASIYVMTSYFESFGMVLIESANYSIPSISFDVKTGPKEIIDNKRSGFLIED
GNLQEFANKLQILMQDEDLRKKFGKNAKEKVREEFSKEVIMKKWIKLINS
>fig|195.2039.peg.624 Phosphoglycerate transporter protein PgtP
MALGLILCALVNVLLGFSNSFYAYVGFVIALGVFQGMGGVGPSFITLANWYPKKSGEFIQ
LFGISRTI
>fig|195.2039.peg.1799 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDINLKDTSDNTFLYEN
VIDELNSMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFH
ILDFSSELQSARLMILQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDILG
LNKKLAENFKNSIV
>fig|195.2039.peg.1300 Arsenical-resistance protein ACR3
MCSYKANEVFHLPLEALKIAFVLTLYFIFMFFLTWFISKKNHLSYPKTCSLCFSASGNNF
ELAIIICIATFGLHSEQAFASIIGPLVEVPVLILLVKWALGKSLNSKK
>fig|195.2039.peg.1699 hypothetical protein
MNNEIEIKDLNEINKNNKQQVVYRKDNLSTDCITGEVIERNQIIVRKVQTRESFIKLFTE
NIHYIINLEPQEKTLFFTLLSSVDYKNVVRFDKSMKQNIILDKVLSRAGMYRALNGLIEK
KVIFKIDRDFVKSYAGVGSDDCYLFNPNLVGRGSWNDLKNLRHTITREWDFENLEVRENL
EIEEEYLGLDEIKNNQKQYQVKEINQEHDETTKVKNTEIVIEEKNNSANNQYSFDKKEEP
SINKKVLISNDTQPSLFDENQKEQEARLFIEKFGGMFSGAYHPTKSAEELKREKLDQDLK
EGKI
>fig|195.2039.peg.44 Putative polysaccharide deacetylase
MAKEILVAYGVDIDAVAGWLGSYGGEDSPDDISRGLFAGEVGIPRLLKLFKKYNIPATWF
APGHSIETFPEQMKMIVDAGHEIGAHGYSHENPIAMSAKQEEDVLLKSIELIEKISGKKP
SGYVAPWWEFSNITNELLLKHGIKYDHSLMHNDFTPYYVRVGDKWTKIDYSKDAKEWMKP
LVRGQETDLIEIPANWYLDDLPPMMFIKKISQ
>fig|195.2039.peg.954 hypothetical protein
MIWKKQDLINVSNDKQAFQSSVSKWSFYNDASRACSEKLEIKDFAFHTSKEQNPWWMLDL
KGVYLLEYIEIFNRIKCSLELIKNIRMALSVDGCSWIWIDIMQYMSKDLKSIHVPLGEKF
YARFIRLEVFDYCYFHLSRVNVFIRKYKGLFLMAATGGWGDRMIAFLNAMYLSEQNGMKF
GYAWKSLDNSNSLGSNIINPMIIEKEEEIFSSSFIEKFSYTHAEEIIYNQYFTQKKENIL
DFSLKPFKYFYGHYAGHDDLEKVIKNIPKDFRKNYKRLWETIDFTPKINQAINTAYMTFK
ECFDGFTVVAIHMRSGDIVYSNKRPYFFKNYKDKATPFEIILGLVEANIHNRIILFGEDS
EVLSNIVNFIFDKYQIQLYLAKAFIPKNFDSTQKDLFEIIFMSNCEKIFSTSGFARLASL
LGNGMEPLNWYNFFTTEEKYTIFKKYENAIQCHSLQKAFSLFCFFMISRERSENYDFLIP
ILNKAIKLDPENPIYKLFLVDCLLLKKDYITAEKHILEYNLENACDFVKKSWIKNHIFQN
VDTDNIEKFVFIKRMLDNISY
>fig|195.2039.peg.1503 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKNALKIFSFLLLFFLAYVFYVYFSFDKNTLLDDFKSRYSKILYDKNGEILSVFLNDEEQ
WHIKSTDIPKRLKVSVINYEDRKFYSHFGVDFLALMRAFVNNFNSTQRSGASTISMQTIK
LWDKKDRTYFNKFNEIIQSLALENAFSKDEILKLYLSNAPYGGNLIGYEAAILFYFDKNP
KDLTWAQAALLAILPNQPGLINLEKNKTKLLDKRNKLLAKLYERKLINKDIYELSLKEPL
PNFKPRKNIAPHLALRLLSDDNKEIFSSIDKKIQLKIEKKAKEFSYTLQQKGIQNLAIIL
ADTKTRKVLAYVGSTLKPFLYALSIDEGIIAPDSILLDVPTFFSNFNPQNANKKYYGIIS
AKEALQRSLNVPFVSLLQDYGYEKFFYKLKAFLNFEDENYKRYGLSLILGTKELSLEDLI
KLYLGLANYGELANLSFIRDENLSGVARMFSKGSAYLTLEAMKELQRVGLENYNKEKIIS
WKTGTSYGRKDAWAMGATPKYTLGVWVGNFSGEANANLYGVSIAGDLLFEILGLLDEVDL
EFAPPDDLMTIKLDSISKYRYDEDLNTSYINVLYPKGANILRTSPFLKKVYEYQGRELDS
KDIHFKDAKALIKLDFPAYALHFFQQRNFKFSNKKGVKIIYPKDNLKLILAKDLNGMKGL
VAKVANLNNEKLFWYLNQKLIYEGDENTQNLNLKEGKYQLFIISQSGEQDTVWFEIK
>fig|195.2039.peg.970 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MISIFSNNCIAGFLYCDYKIKFLSPTINLQLTPVDFIKMCSHLDYYLSLEIKEIKVDDKV
LSKFKDVGGGNNINFPVGMLGDLMIFFQHYKNINEAIEKWNYRKNRIVKKKYIIMNYINY
EAYPCHKDFQEIIAMFKEVPYEKKIFLHSIENLNINKDFVFIPKVKTSWFKQIAYKPYNI
KTYQIFNFSRWFNLDNITNSNSTQLGQLQSKLSFQTKYGTAKTRIQNQLSYKLGQAMIVN
SKSFLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLPPLESYPDYQEALKEKECFT
YKLGEALIRANNNWYGGGYIKLWFEIGKLKREFRNKKI
>fig|195.2039.peg.1692 Phage Rha protein
MSNTSIININNQEVIFENKDEQVFCTSLDVAKVFGKRHDNVLADIKLILNDLREIGTSND
LLNFQEVVRISKTTNPKNGKLVSRKMPIYNLTRDGFSLLAMGFTGKKALRFKIAFINAFN
EMERIIKNQYTPKLENYNKYKIPNTPYKENIIKAIMQTEQNRNCEFEELIAYEIKEIYKD
NKSHIEQKINFKVKGLI
>fig|195.2039.peg.98 hypothetical protein
MKNIILIDAPGEWVETILGLNINISLIITNQTSNIKKKFGNVIENIFPRDVKNKEFNSVY
FSNYNLSYEELEKYRSTQIKVEHYLRRFLVNDGLIQYYYHMALAYWLDFFSKKSIDMVFL
GTVEHGAFWDSILIDIAKNLNIPIFIISYSAGVSISSDNGNEDIDIKHIVHYNSLNFIDL
SNIENIKRDEDRVSMEKYMHLLKKAHNKNSSSKITFKNPIRYYFNTRIKTLFSTWLYYLS
TSMIKYNIENKKDSFMHLSKREILKQSSFVGSLRRVYCNISRKFSLSNEKYIYYPLHLDP
EASIMARSILTSQIFIIQWISSVLPNGWKLLIKEHPHQFFIYERERFYLKNINLYRDFSF
YSQIKDLPNVEFVDINISSKELIEKSQAIASICGSSLIEGIAYKKPILVFGKSLSFVELL
QDSFVIKDREGLRYAIEKIKNGFTPQYSDLELIINKYTFLKNSRAFDNKDFFSSIFKYLL
SIKF
>fig|195.2040.peg.1814 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MNLDLFQTLGKSIQQIVDAIRQVGTND
>fig|195.2040.peg.40 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNDKKYSDKDLIDAFYQLGIKRGDILCVHTELFKFGIPLLSRNEFLQTILNCFF
EVIGQEGTLIIPTFTYSFCKNEVYDKINSKTKMGALNEYFRKQTGVKRTNDPIFSFAIKG
AKEELFLKDTTSCFGENCVYEVLAKENGKYIIFGLNEGHALVHYAEEKNTTFCRYFKNFK
GILINEKRKEKTITIDYYVRDLQQSYLCDINKINPIIQETQNYKKINFAKNFIEIYNTRE
YVQAICQALTNDKLAIYKKDR
>fig|195.2040.peg.1512 hypothetical protein
MQALKNEIKQKAIFMSLINIKETIKNIQDSADAEVMVIFCEEDMKRLSKSRNIAAHNSSH
GFKYRNKSYSLRSSKT
>fig|195.2040.peg.1787 IncQ plasmid conjugative transfer protein TraQ (RP4 TrbM homolog)
MKKILFPFCVFGVINSVNALDLQLLSGDTRTSCEVILCLASPVKPPECASSLAKYFSIHF
KKPWKTIQARKEFLNLCPIDTTNDPEMYKYKNDILVNLDGECSTTALNQRIEKSKQPLKV
EKICTGGGHNGSRECVEIKTYGFRINPELTNSCKLLASSKYTDYHLKYTCDKKFYEQKDW
ERGYELKEVSQEIYNALPVSQREQGEKLTPISYGEFIKLPANKRKQEGFGKYYRIDIAYY
QKIIIKKDCWINEK
>fig|195.2040.peg.1528 McrBC restriction endonuclease system, McrB subunit, putative
MKSITEFIESDKVIYKFSDSKDWEGETFIKIYENDKQ
>fig|195.2040.peg.1050 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENTGTAASLDAQLRDEL
IALINKKENIGVAKQLVDALKEQIPSLVLLNNIELLSLIGFGVYLDGDPLIKTHDMRSRV
NYTNTTGLTIPVTIYAILLRAIGDVDVFVNNKKITTLAPNSQTPNSQITLILKPNDIYSI
YTIAHPTNVSVKARLLNLNRSHV
>fig|195.2040.peg.1529 McrBC restriction endonuclease system, McrB subunit, putative
MVKYLKTRGGEKEFKVEVKNQKIKVNDNRSYSLDKFLKYIELYKTYETSSYAKPLFEDIL
NNSNLSIIKLRENEKMLSENQNLSLNQILYGPPGTGKTYHTIDKALEILGENLESRDEKK
AKFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPNIDSEEGNFKDIEYKIKPGIFKKVCERA
LENEDNIKDFNFHIDKLKEIVKEDGNDPEKYFKLPNTKYSIQYRGGKTFRIKFDDMSKNH
KDYPVSIENIIKLYKTSSINEIYNSAYVKAILNYLKTQGLKDYQEKDEKINLPYIIIIDE
INRGNISKIFGELITLIEPSKRIGEKEELKVRLPYSGDEFGVPKNVYILGTMNTADRSIT
SLDTALRRRFEFIEMMPDVGKLSNNCEGVDLQKLLEVINARIEYLLDREKTIGHAFFIGV
ENLEDLKKVFQNKIIPLLQEYFYNDYALINAVLNDNGILKNKI
>fig|195.2040.peg.1795 Replication protein
MVVDVDYVGKQQLKNLLKQFGNGVQLRPTYLVSSGKGVHLYYFLQEPVQLYRNREEVLAE
LKEAFIRRLWNDTSSIRPDSPDITGIYQGFRCVGSQSKLGVDFPVKAYKLSENRYTLEDI
KASIPSCKVDLAPLYEKPRRKSTVTLEEAKELYPEWYEKRIVQGEPKQKSKKQGGTWVCN
EALYEWWKRKITEEVKAGGRYFSIMALCSYGLKCGISEQKIRRDAYAFLDHLESLTEDED
NHFSRADVKDGIKKPKMIYFYGILKY
>fig|195.2040.peg.1098 hypothetical protein
MKIDTSASLTHSLTNNVDKKELSVLKKEDQDKIPVQDLSSLNSDGVKVVFENKQGELIAL
NLSDENYSSLQKISVLIRIMLLEMMEV
>fig|195.2040.peg.1796 TolA protein
MKNTMYSYLLNDKIKNHSMILCTEIECKKCGEKIYVEFQPNEKFIFKCPNCSRKNRKVFY
AF
>fig|195.2040.peg.38 hypothetical protein
MLKNTKKLFKLIEEKNALHKKCLDGLQLSDEEYNDLEKLIIYYKDTLNINLEEQAKSYIV
VLNDTLEETKYFIEFGKYRYSTLAEVKNMVYFNENYMKQYMVGLAISSFIWNAHIEVRRY
FAKYIDKKQDRKSTYLEIGPGHGEFFVKALRSQKFIEYYGIDISPISCQMSKDMVENQFG
AINQNNFKCDFICKDFTKCNFNNKADLVVMGEVLEHVEQPLQFMKDVKTLLNDGGEIFAT
IPINAPAIDHIYLFSHPDEVKDLLKNAGLKIKECEYFMANNYSLEKALKTKNAIVMAVVL
EK
>fig|195.2040.peg.1832 Flagellin
VAAINSVKDTTGVEASIDANGQLLLTSREGRGIKIDGNIGGGAFINANMKENYGRLSLVK
NDGKDILVSGTGLTAAGFGANSFISQASVSLRESKGRFDANIADAMGFGSVNKGVAIGGF
STVTAYMSSEGSGFSAGSGYSVGSGKGYSATLTANAIVMSNASAASRVYNVSSGSGFSAG
SNLSQFATMKTTAFGVKDETAGVTTLKGAMAVMDIAETATTNLDQIRADIGSVQNQVTST
INNITVTQVNVKAAESTIRDVDFAAESANFSKYNILAQSGSYAMSQANAVQQNVLKLLQ
>fig|195.2040.peg.1097 hypothetical protein
MQNLGFKSNDEKIPNDASMEKKLNFFIDKDRDKNGKIDDNDVKEPSMGEILNDISKISGR
ANAMQTIDPQKIYKKDDSGVTIKEKDEKDDKDLLEIAKEKGLSALSADEQAKLKASNPQI
FEELQNKSLGNLEQNLKKDLMVQISNNEAIFVNKRV
>fig|195.2041.peg.1733 Methyl-accepting chemotaxis signal transduction protein
QTKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLA
SESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTG
IIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQ
SINDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKK
KRF
>fig|195.2041.peg.1679 Integral membrane protein
MDLVSSFLSKKNINNEEDIKFENYIKGEAKLNSEKQYIIESSCCFDGNKDNFKRHYDENK
ILEIHLNNMLFEQDLVFDNVKKLSLIINDNVKFNKLFINNCNELYLQFNGRVEVIDKISI
NDCKFKQISINNHIDGNIEFQKCEFNDFNLYGFSNATIKGTFTFDFCEIKEKVNFMNFEF
ENKVSFKMSKFKDNVYFNNSHFKDYVDFHECEFEKIACFYGVKFYKTPNFSACYFKEPKA
VNLINVDIDKLDFKSVEKYIEDNYQDESYKNEHKLRYAKNLKDSFRVIKDVLITQNNTLE
AQEWHKLELYAKEKELEIQLGGDNKDSIKNIQKIKKSVIKKPSNNPSNILAKIQSLSDKY
IKICDFVVCFIMLIGRSIFGFLLSIIEIFCNVIKSICKIIQIILSCIFCIASIDRILKLE
YLKFYRKISSLGKTMLDFTLWFDCVLLQVYRNTSNHHTNFLKILNFTILMISSYAIFGLL
FLNNMDFILSFGPMTIAAMNYIVLLMLLIIFISLTRQLYQHGAILLFLIYGLFIISIVSF
LSPIYIPAFYFLIYFVGILISYLLFICKIKLFVFISRLFAYICLIGVVILKPQLINPFVG
IFSSDKLYESQFEKRLNDLNTSAIVNLASILQNDFNLHLKDQNISFTELNSAKALIIANK
EKLKEILSKVYNDKYVSDYKKVLNELENNTSNVKNIIEEIDNKNNNSVVSAQLNKFLKLN
FNQEIDILYAIKSNFSISEKLSPEQMALFDQKDSQDKLKSVLALLKFKSSFEGILKIINQ
DEITENTIKSTGVLYGIILLLCIFSLQKTARKNSIVPS
>fig|195.2041.peg.1603 CAAX amino terminal protease family protein
MILTFILLALALALLSFKKIKLSFVVLVISGFLAYYHNIIEISFIVFVGVFFYCPCIIKI
IKMYF
>fig|195.2041.peg.1604 CAAX amino terminal protease family protein
MAFCLLLFLHFIPGVNNVKILDKVHASEHSSAFTLYFSFDKPLGVFLLFLLMPSLFENLN
RIKPKLFQAALLFASPFLLLSIPWYLGVIKMEIGFPSWIVYFLFSNLFLVALVEEAFFRG
YLQQRLQGLIGGVGALLVASLAFGVAHYKAGILMIIFASLAGLIYGMAWRYSKSLWLSVF
FHYGLNLTHLFFFTYPSYVK
>fig|195.2042.peg.1806 Flagellin
AIAISSASAISRIYNVSQGSGFSSGSTLSQFATMKPSAGNSLGAKDETAGVTTLKGAMAV
MDIAETATTNLDQIRAD
>fig|195.2042.peg.274 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHAETELLKATQISIEDFRSR
NISLLNALEKDILNLPYEALNSQDNIINNAGAILKYYRNSGNLLAVYIGLDNGENIVSDD
LSEKKNTNITINGKANNYNATTREWYKEARNSNQMYITPAYIDVVSNEYAITYSKALYKD
GKFIGVLGIDVLLTSLQDRIARTPGNTFVFDHKDRIFAATNKALLDPSVDHSPVLNAYKA
HDDNNFFSYKLNNEERLGTCTKVFAYTACITESTDVINKPIFKAAYIQVIALIIMISISI
ILLYFIVSKYLSPLASIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILAT
KQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQARVGSD
MNEIQRVFNSYKSLDFTTEVKDANGAVEVTTNALGQEIIKMLKQSSDFANALANESGKLQ
TAVQSLTTSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKN
>fig|195.2042.peg.724 Apolipoprotein N-acyltransferase / Copper homeostasis protein CutE
MKLKLNFLPYFSFIPKKLNTNSTIFKIIKVFFIAFLLSNCIYLSFFENIFTQAISSFLAI
WGLVLLLKSKSPKQYFWIGFFVGILWFWWIGLSSIYFDLNYLVPIVIILIGIVYGILFRI
CYLFKFDFLRLCGIFCLSFIHPLSFDWLNWGVYTVYGFFDPSYRGIICIFLLAYIIHENY
ISRYYKIAILLIIFFIGFQYDEKKSEELNLSYKLISTDISQDQKFLQENVSVNSDNLIKE
IIQAINEKKELVILPETAFAFNLKNTLYEKMLKELSYQIIIITGAFNIQEGKTYNSTYIF
KGGNSYILNKHFLVPFGEEIPFFKKTIQKYFLPNIAEFDQGPLQSKYKLNDQIITNAICY
EATKEQNYKNSKIIIAISNNAWFNYSSEYKLQKLLMQFYASKYGVSVYHATNGKESGVIK
PKEKFVQKIKNYFNKQDKS
>fig|195.2042.peg.1795 hypothetical protein
EPIKLKINTKSKKVFDAKFGKDIKEDDLL
>fig|195.2042.peg.1792 Motility accessory factor
NGKVESSGIWTMFRFSLQNTISRNIISTTYNCTEGGARIEGTIEKPFLWACENLLDKDLN
KPFEKLEPLSLNKQNEFLLKAYYK
>fig|195.2042.peg.1694 Ribbon-helix-helix protein, copG family domain protein
EIEDFSFAVNALEELKDGDYSKASKKIDKVVENLQKESDDLGDFDFAIEALEELKDGDYS
KASKKIDKIVKNLKKPE
>fig|195.2042.peg.1827 hypothetical protein
MSVFRATHSDSPLTPITANHSTLKVRFAKLINSVYSFKKGVKIDFN
>fig|195.2042.peg.1804 putative replication protein B
LYRLLKQFRTTGKARFEWEEFCRVMDIPQDYRQSAIEKWILNPAIKELSKERNLFDQVRV
PFKNLAYEKEKAKGTRGRG
>fig|195.2042.peg.1265 Membrane protein
MHLFINANDFDEIFAVIITHSHFDHLDEKSVKTLKDRAKFFITPLKVGNYLKSYGVSEKK
IIELDWWSGI
>fig|195.2042.peg.1772 hypothetical protein
MIIKKIPSKKQNKSSFKNLSNYILDKDNNNAKVLVDYMLDKNNEMDKVEGYHFTNCSFDN
DEDNINEIINTQKLNTTTKQDKTLHLVVSFQEDENPTLEILQAIEEEIAKSLGMEDHQRL
SVVHSNTNNLHIHIAINKVNPHTLKVINPYNDVRILQETAMKLEKKYNLKLDNHISQKDK
QSNKYNHSMNCNFETWVKEKLSKQVDLMLKDEKTTFKDIKQFLAEYDLEFRERRKGFVIA
SKSEKLFCKASSIHRGLSKQALEKRFKELDLKQEKENTQNIKEEKHEIKEQYQRPNKETS
KTLWEKYLRIENEKKAELDKELRMLKLRRNEFKTSIPSMKFNKNTFAHVKNQRMIFKNKQ
KELYQKYKRVSYRDFLISESLSGNEEATRALRRTKTKINENENTLSSTQEKPKIFENVDY
ITKEGYAVYKSGFNKAIDKNQKIIY
>fig|195.2042.peg.1773 hypothetical protein
MNAKCQKLPPLIAILKNNLHKYFLICNLFFWRPYFRALAIKLCICIANAYPALLLQAIII
KFKLFLQTF
>fig|195.2042.peg.403 Integral membrane protein
MSKISKLLNNPKLFFKDMILNLIRKKYNIEENLPNVLCGYPIVLHTGEQGENALSHISMW
YLYFKKSEVNFIIIVRCPKALKLVQDRYPEVSMVYLKDKKEVDIFFNTFSSIKACFYPSN
TGNNFHLFYQTHIKHIFIGHGDSDKSSSAHKFFRAYDENWVAGEAHIDRMLNAGFNLNGL
KHLKTGRPNLLGILKKSKLDWRDRFEGRINLLYLPTWEGTYKEQDYSSLGMVLQNIKKLQ
DYSSFQKINISVKLHPFSGKKEKRFLKLEYLLSKEKKIRVISKYDSLHKYIINSNMFICD
ISAVVSECLAVNAPIFLYIPKDKNIKIAQSNMPYEEYCYIFSSPEELSELVYRVVSGDDF
LWQNRLKAQKYIINTEDTLKETFIKQLQEISEDNSV
>fig|195.2042.peg.1813 Oligopeptide transporter, OPT family
TIIFTASNVYLGLKVGLTFSSSIPAVVISMAVFSLFKTSNILENNMVQTQASAAGTLSSV
IFVIPGLFMCGYWSE
>fig|195.2042.peg.1785 Translation elongation factor LepA
ETDKFEDLRDALDKLKLNDSSITYEPETSLALGFGFRVGFLGLLHMEVIKERLEREFNLD
LIATAPTVTYEIYQTDGELIKIQNPSELPPVNKIDHIKEPYVKATIITPSEFLGNLITLL
NRKR
>fig|195.2042.peg.1095 Hemerythrin domain protein
MDHHKLIPLWDERYNINHQKIDTQHQRLFEPAAQVENAVFKFVKRDELKEILTELFAYMK
EHFHDEEEFMQEIQYPRLYEHKQMHKNIIHEMFQLIQNIKSTNDLKEKLYSIMSKWLSRH
ILSHDVMIIAWVNENLKKDENKALELNDLPPKQTLTQEENFEFIYSCPCKIDHRLSFKEH
ESITNEGKVMRCKKCQELLFFIRSQEKLIRDKACFQNGIKSIAFIMAE
>fig|195.2042.peg.1822 putative replication protein B
RNLFDQVRVPFKNLAYEKEKAKGTRGRGGKGSGISFTFKTESGLMQKVEKESQKKMSREE
KYLKNLNNMKLNQ
>fig|195.2042.peg.1717 Signal recognition particle receptor FtsY
MFDFFKKGLAKTLESIVGVKGENKKITKDLLEEILLEADVAYEIVEEIIYYLPPSDEVKK
EDLKRVMGSYFLYENKEFLDEKPFVELILGVNGAGKTTSIAKLANLYKSQGQKVILGACD
TFRAGAIEQLRLWSEKVGVDIVLTQQGHDPSAVAFDTISKARAK
>fig|195.2042.peg.406 hypothetical protein
MEIKYDISIIVPVYNRENLIKPCINSINAQTLDKSRWEVIFVDDASTDRSIEVIEELIDK
NINYKIIKREVPSGNASAPRNEGIKASLGKYVFFLDSDDYIDSKLLENGINIALKNDSDI
VYFKMELNARTVTKRPFKHPIVDKADIEKNHLMRTLRIFKMFKTKMLRENNILFDVTVNV
CEDMLFGATALLYAKNISILADRDYYFASLHDEPHLSKKKMTLEKLFHIYFYTIQSLYCS
NRDINFKIKFYNALLIRCVEHLRDICKKDKINNENLIRIFSFASDLFNLHKEMFELKQIY
ENERLLVLLFLSKDFKTFFELSNNSKILQDFCQKIEKEFEKEKGFNKAWIFENKMVVLDF
ILNDNRIAFDIEINEKTQNVKIWMFCRNDSKFFETYNGNILEKKDNKLLIYSEDRVNEVV
LNAIKFNIALIVKNIEGF
>fig|195.2042.peg.1787 Ubiquinol-cytochrome C reductase iron-sulfur subunit (EC 1.10.2.2)
MATSESRRSFMGFAFGTVAAVGGVFSLVAVKKTWDPLPSVKAAGFTTVDLSGMQDGELRT
IEWRKKPIFILKKDPNMEKDTKRDVV
>fig|195.2042.peg.1829 Oligopeptide transporter, OPT family
ENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFSLWQTFMICLCGGGLGVLFTIPLRRA
MVVESK
>fig|195.2042.peg.1771 putative replication protein B
NPQFEYILNQLTANFTAFELSEFIALSGKYTKTLYRLLKQFRTTGKARFEWEEFCRVMDI
PQDYRQSAIDKWILKPAIKELSKERNLFDQVRVPFKNLAYEKEKAKGTRGRGGKVSGISF
TFKPESVLMQKLEKESQKIMSDEQKYLKILNNMKLNQVRFNYNDKLWQFNDFDFDEFKII
AVELIRDEYENLNFGNFMHFNAKNQEQFFKMIDTFRKGIR
>fig|195.2042.peg.407 hypothetical protein
MIFRTKDLINISKGKKAIQSSIHSQWSCLNDAERALDDSADYLNHAFHTSEEENPWWMID
LEEEELIDIIKIVNIKDMKFRHRAKKLCILVSLDNKNWTIIPQNMINWDSEMLECIVILS
NKVKARYIKLFLNEKNFFHLSQVSVYRRKVLGYIVCGKPDGFGIRLCAMIIGKYLADKLN
FGFLFIWPNLLDIPLLNENRGLQETADGKQYISCSMDSSENIFDSVFLENFMCAPEDTGV
SYGYKICQAKTIEELKYGPWEKDWGWYSTSELPYLWNTDISKEECLKETRKIYLDIKFSE
KYSTIQKDVELAVGSIKFVAIHLRGGDMIYSDLKYHPSRFIFGRHFPYEIAIEIINIELD
KGNNVIIFGQDPDSDEQLANYFYEKSNKKGLFVKTISSFIYKNYSDTERAFFDINFMSYA
NIIFTSSESTFSRTANLISGKDILKSYFDIFSDEECYDIISKNIEILNLDKRQKAMSCYR
LYHFGRILNKDIRNLCHWMKLAIQYDEDNYAWKIYLLVLLLEKKEYNKVEKLTKDILKNN
KDVVISGMKYRGSRYFKNEIDFMIKHSSGQTPYLSFFLSEYLLNIQNFEESEKFLTYALE
KLPGKLIFG
>fig|195.2042.peg.1582 SSU ribosomal protein S11p (S14e)
MAKRKIVKKKVVKKNIAKGIVYISATFNNTMVTVTDEMGNAIAWSSAGGLGFKGSKKSTP
YAAQQAVEDALNKAKEHGIKEVGIKVQGPGSGRETA
>fig|195.2042.peg.620 Cytolethal distending toxin subunit B
MDMFFRNRPDINWMILGDFNRESGALVTLLDPDLRARTRVVVPPSSTQTSGRTIDYAIAG
NSNTAALYNPPPIVAILALAGLRTFLASDHFPVNFRRP
>fig|195.2042.peg.1783 Methyl-accepting chemotaxis signal transduction protein
INENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDV
LQTKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHL
ASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKN
>fig|195.2042.peg.1816 putative replication protein B
NPQFEYSLNQLTANFTAFELSEFIALSGKYTKTLYRLLKQFRPTGKARFEWEEFCRVMDI
PQDYRQSAIDKWIL
>fig|195.2042.peg.402 Sugar-phosphate cytidylyltransferase / Short-chain dehydrogenase
MRKNIAVILAGGSGSRFGLNFPKQFAKLAGKTIIEHTIETFEKHPCIDEICIVIKSDFRD
KINELILKNQYYKVKKVINGGEERKDSSFNAVLAYDNENVNLIFHDAVRPFVSNKIVDGV
IEALQQYNAIDVAIPSTDTIIEVCSNNIKSIPPRKFMMQGQTPQAFKLETIKKAYELAIR
DSNFTPTDDCGIVKKYLPDEKIYVVSGELKNIKITHMQDLAMADKIFQFNNISNNDQYSY
EYYNQNLQNKTIVVFGGSYGIGFDIASIARQYGANVESFSRSSTNTNVASISDVERDLKY
VAQKYGKIDFVVNTASILIHQPLEAVEYNKILEIVNINYIGAINVAKLSLPFLEKTSGQL
LNFASSSYTRGRSGYSLYSSSKAAVVNLTQALAEEFMIRNKVKINCINPQRTLTPMRVSN
FGKEDPDTLLKSMDVAYVAINTLLSDFTGQIVDVVLEK
>fig|195.2042.peg.1777 hypothetical protein
MSEIVKYHNDFNKIQLPSFTEIEQDLLCGLMVKLKEEKGKVTFYPWDLRNILKSSYDNNS
LMEFASSLKRKFFKADFTIIEKTTRGEKEVEAHKTINLFTEFAIYVYASSKELESIEIQV
NPQFEYILNQLTANFTAFELSEFIALSGKYTKTLYRLLKQFR
>fig|195.2042.peg.1788 Pyruvate carboxylase subunit A (EC 6.4.1.1)
LLDDYNRFYFMEMNTRIQVEHPVTEEITGVDLIVRQIRIAGGEILDLEQSDIKPRGFAIE
ARITAENVWKNFIPSPGKIGEYYPALGPSVRVDSHIYK
>fig|195.2042.peg.1103 Haemin uptake system outer membrane receptor
MNPSKRVLKLSLLVFLLSTGINAQELNDKAIQMQKVVVSATGFEQDADNNLRNVIVIDGK
DLEKRGFNTLEQALERISGISFVNFGLGRNIDMRGQGSKSNIAVKVMVNGNAINVLDNSH
GVTPLESVNLNNIERIEIIPGGGSVLYGSGTRGGVINIITKKEKSDAFALSLKGSSYDHG
NLGGNLGVYGAKKINDYLTFGFDIQGFNRDGYQEGY
>fig|195.2042.peg.1819 Translation elongation factor LepA
ETDKFEDLRDALDKLKLNDSSITYEPETSLALGFGFRVGFLGFLHMEVIKERLEREFNLD
LIATAPTVTYEIYQ
>fig|195.2042.peg.1102 Haemin uptake system outer membrane receptor
MAIKRVINEKGYFVNTKAYLNTSDNSDLSLNYNYFESKNTSSGYLTKAQIQSDPTQKGSG
DNITQINRPEIALDYHHYFSDLYEIQLGAFWQNQKIRYLKDEIPMMGTIAYQTGSGFEDT
LTGINLKNKINYKDDSYFIFGYEFANHDAKRTSIVHYNVNTPAFQMSHTMTTLMDMDKQS
HSVFALDSHQFNDIFSISGGARYEYSLYDTHRSYTSKMIMGGTQRPSNPELFDADDTSNN
FAFEITPNFKYSDTGNIYAKYERGFISPTPAQLVNKDQATQKYYTANLDPEIFDTFELGI
NDFWWDFYGFNLTLFYTLSKDEISYLGNPHSTGGAFWKYYNIDQTRRLGAELNLHQFLFN
DSLILKESLSYLDAQISKGVNDGLRIPYVSKIKATAGVEYAWNKNLSSYIDLSYFSRAKD
GGVVDENTGKMSRNSWIKDYFLTDIGVNYNYRNLQILAGIRNLFDKQYYTYQDSTNDQYL
AGNGRNYYVEFKYAF
>fig|195.2042.peg.416 capsular polysaccharide biosynthesis protein, putative
MINDRERLDSCIKDYQKLCKIFGNILDAPSKGGNISIKDNEYFIIKASGEDLKKEHRVSI
FKNNVNSFCYYKDYSMDIIKPSMEIKMHRVFKNKYVAHYHPVYILPYLCAKEYNFTNYNV
IDFVLPGNDLYEMLSKNYIYEEKGIVLLRNHGVVIYAEQIQDVLELYNQLKNDFFEENDF
AYTPDDVVDKTNGELWLFRNAIENIASKKQINLAPLKANEIYKLLNLPDEQYRKKIMESE
SLR
>fig|195.2042.peg.1264 Membrane protein
MNLSFKTFDLSSKERQKAKKVQGKKYEIFLNENPQTHNAFKVSFREVLRYYYLYPKNAKA
TFKLPFFKPNLKYFRTPHITWLGHSSLFVSYKNYKILIDPIFNTHASPFSFINKAFKNAP
VY
>fig|195.2042.peg.1775 hypothetical protein
MTPREFRKRQLEKLEQRKIQTHQKISNDFIDNTISKNNLVCLKVMFYLSTVLEKEDLSTF
DDENIICVFVDTKQMLEYIGSNVKDIRNNLKQMQETSISFVDEKENIVEGMNLLPLFKIE
YGKNRTEIHLFKRIANMIVGVSKNYTFLNTKLLMDIKNKNTLRMAPLLYEINGYDKHTGK
RKRMDLDALNDFFGTTYKRIIDIEKNILQPVKKELDLVSKLSFTYQVNFDTLNKVGRPRA
LAVTIDLKDNQGNLFAN
>fig|195.2042.peg.1617 Ubiquinol-cytochrome C reductase iron-sulfur subunit (EC 1.10.2.2)
MATSESRRSFMGFAFGTVAAVGGVFSLVA
>fig|195.2042.peg.408 hypothetical protein
MNSETIEKYLYYWDWEKLKSNFNAFIDKDNYIESLEYLFEFADLDEIFNFLSNYSFVNLG
EHYKGNQKIQFLIKLYRFKYSNKTNVLFENQVINDILKLALNKDYKALSYNVHENIIIND
NKERVVVCYALQKLIKARMFELKHLMLVIKMGNILDIKLAFVLSLVIDYKLEILKDPYWF
MRLYVLISFYKDQGSKIYLDKISKSLELKPNSNIKKPKIALCLWGVCRGNYMKVLQETKK
NIIDPLNADVFLHTWDEWDRWPGLCGTLNWHWRFIRPRDRKFFPSIMNGKNLQMYFPNVF
NKMSTVIKDTLPLTDILNIINPRSYKIENANTVERSIDFSIEKLKYQFESHHYPLAVFRL
RYQMYKVIEILRQYEIKNGTYDYIIMQRFDTSCERKIDIKFLENIDFNEIKMQLGKTGVV
DFLLMGKRNSVLKLVNLYQKMIDQQEIDVYKLHTWTEQQEFLWLIEQGILVTQLPDELKV
ADHYLAYEGMLPYFYNELKADLQQKCIVELKQQKELTDFLDFVYNNKTFFKEYSISTGAV
SRVKQHLSYKLGECILNNKKTFFGKVKLPFFIFIIYKNHLKNYSKKQQNLPKLELYSDFD
EAQKIKKSEIYRLGYSLIQYKKKYPILFWFFFLIKINSK
>fig|195.2042.peg.404 hypothetical protein
MFKNNYLSSITILIHTGENLKVGYGHLLYWLPEFFKSEIKFGILVRNKDLYKTIKNEYRT
ISVFFAQDSLEVESVLNKFANLKAIFYMSNSSNNIHLLRFNEYEHIFIGNENYNRDMQTT
KVLKAYDELWLQSQSIIEKIKCSIKDINNMKIVKIGKPQLKNVLNNEQKKSILCVFSIVD
NVVINSIQLLINYSIKKNMKIKFVFSKLDKKNNKFSNNIELQLKEILLRNKIESFVYTVF
SDELLKESGFIVCDLNSYNEKFIINNIPVCVYRSYNFSTDVFLRNKDLPLEKTFLFSLFE
ELQDCFINNTYEEIPDEYINYYLGKKYIIDEKFQKEILRVGL
>fig|195.2042.peg.1801 Citrate lyase beta chain (EC 4.1.3.6)
ILKSTKYNLLSPINGVYPDIKNIDGLKEDLIFAKSMGFLGGGSLCIHPNQVAPINEVFSP
SAKQIAWAKEILSLRQNSNDI
>fig|195.2042.peg.814 Ubiquinol-cytochrome C reductase iron-sulfur subunit (EC 1.10.2.2)
FTTVDLSGMQDGELRTIEWRKKPIFILKKDPNMEKDTKRDVVVDNAAYTVVIGLCTHLGC
IPAYHASEQLFKCACHGGEFDTSGKNTFGPPPRPLDIPPFKIDGTKLVLGEEGPEYKKMT
EEA
>fig|195.2042.peg.409 GDP-L-fucose synthetase (EC 1.1.1.271)
MDKNSKIYIAGHNGTAGSAILHRLKEMGFVNILTRSSKELDLRRQSDVEVFLRKEKPEYI
FLTAAKMSGMLDQAYQKGELIYDNIMIQSNVIHGAYLNNVRKMIICGSGSMYPRKIFNSL
KEEDLMKGVLEETRESYGLAKIAGAVMCESYNVQYGTEYFTLAFNNLYGNNMDFDFRTSR
VIPAFVRKFYLAKLLYEKKYDYIKKNLKLNNLDEAVTYLNANGIYEDYVDIWGSGRAKRE
FIHSSDLADACIFIMKNVSYKNLNSFCGSELKSLINIGNEVEYTIYELAGIVKNIVGFCG
KIHCDLSKPDTSVNRVMDCSKIHSLGWKYKIGLEEGIRMMYEWYLKEQNIR
>fig|195.2042.peg.299 Transposase
MRNDFLHKLTSILANHYKYFCVESLNVQGMMKNHNLARSISDVSFFEFKRMLAYKSAYRG
NEVIEADRFYPSSKTCHCCGYKKEFLTLSERIFQCENCGITIDRDYNASLNLKRYAINNI
GLVQAEFTPEDLTALQSDLAINRIATSKVDTGIQQKSCL
>fig|195.2042.peg.260 Citrate lyase beta chain (EC 4.1.3.6)
MKAKSFLFVSSIFPERFTKALQSGASQIIIDLEDSVEVAKKEVGRKNIVDFSSQCAKNND
KFLIRINETKSKEFQKDLSLISTIKESNGIIGVVLPKAQSYEDIDMLSQFELPIIPIIES
ALGVENLDDIARHPSVLALSFGSLDMTLDLNLQEGEGKNFILNSIRTQIILKSTKYNLLS
PINGVYPDIKNIDGLKEDLIFAKSMGFLGGGVFVHSSKPSCTN
>fig|195.2043.peg.1675 Cytochrome c family protein
MPITTTENRAGLDTAYSKSPSLKPEYFASPQQNLDPKEYIKVKYGPWKNPNHFPGE
>fig|195.2043.peg.692 Proline dehydrogenase (EC 1.5.5.2) / Delta-1-pyrroline-5-carboxylate dehydrogenase (EC 1.2.1.88)
MIQKSLALAEELQGKIEANISNSEKEFHAKMQKLLNNPENKVMLIELLDRSFRCKDKRAS
FELIEHTLNKYGIADFFSAFEKFLLFSFLNFGKFAPNLSVPFFVKHLREDTKAMVLDANP
SVLEPHMRKRKDQDNITLNVNLIGEEVLGEAESKYRIQKYEEALKSSYITYISIKITTIF
HKLILLTLNTPRMKWLKDLIIFML
>fig|195.2043.peg.1674 Cytochrome c family protein
MKKHILLLGLCLSLSLSAKSVSDYKVGEELSDKEGVEYFKELSKRPVQEWPNKNLSINDV
PKGKQGDLIRYGIELLSKTESTLGPYSKLKKTSNEVNCISCHMDNDGNGLPGTKKYVIPF
LNVLNNYPRLDIETMKIISVEDRIRGMGGTDSHRFPNDSKEMKAILAYFKWLKEAYGIKD
GVKLEGDFFAKMNFPNRPADPVRGKKLFEENCVACHGERGLGVKNDNYEQGSGHLYPSLL
IYPDGGQWL
>fig|195.2043.peg.1733 hypothetical protein
MFYFFAFLLFFFIFLFLFFNFYFYLLNLIFHLINESNLYSL
>fig|195.2044.peg.1596 Putative serine/threonine protein phosphatase (EC 3.1.3.16)
MRILLVLRGNYYAGQEEFIKNNKLQNYTLDLNALRLLSGSVKNIVSEYKILNVKNDEDLS
KILLKLLEMRMQKGEFSIINAYNETLKIYKDLAKQYRYKIYVIVFDSSLKQCQEKNLLEA
KKNGYIIPYALLEKTQDLLKKNPKKYPILDSRDWKKCLYQMPNLSKYKKIHHIGDLQGCY
SVLKEYIKTIKEDEFYIFLGDYINRGIENGKVIKFLLKICEKENVCLLEGNHERHLIKWA
NGELSNSKEFNENTLKDFRKEKLTPRDARKLYPHLKECLYYKFQNKFIFCSHGGVNFIPS
KPEKISFIPSHDFIYGVGGYEDSQKVANQFCNFTSDNLYQIFGHRNKEKLPMKIAKRVFL
CEGKIDDGGYLRVVTLDEKGFECIEIKNQIYKKK
>fig|195.2044.peg.424 Chaperone protein HtpG
MRKKNEFAPLVAKFKELLKDQVEDVRLTSRLKDSPSCIVYDKNKPDFAMQQLLKQMGQEQ
NFKPILEINPKHAIFTGLKNNETFSADIATLVLNMAKLSEGMGVDNPAEFNASLTKIITK
AFS
>fig|195.2044.peg.1371 L-serine dehydratase, beta subunit (EC 4.3.1.17) / L-serine dehydratase, alpha subunit (EC 4.3.1.17)
MTADPMGIIDFISLYAIAIAEENASGAKVVTAPTNGACAVIPAVMLYLKNHTIGFNDEKA
IEFLLVAMLIGSFYKKNASISGAEAGCQAEIGSASSMAAAAMATVLGANAFKACNAAEMA
MEHHLGLTCDPVGGLVQIPCIERNAFGAIKAISAARMAMTRKSIPIVSLDEVIETMYETG
KDMNYKYKETSLGGLATNLKTVC
>fig|195.2044.peg.1261 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNGKKYSDKDLIDAFYQLGIKRGDILCVHTELMKFGKALLTKNDFLKTLLECFF
KVLGKEGTLLMPTFTYSFCKNEVYDKVHSKGKVGVLNEFFRTSGGGGG
>fig|195.2044.peg.559 hypothetical protein
MMKEEDVLLYFSKNKTLALEFKEIFNKELNNVKQSHPNIIASWKYYQEFEKICKKLDEKE
>fig|195.2044.peg.1602 Putative outer membrane siderophore receptor
MKKLSLFCAVGLCFASFAFSEELEFDSLEISGSKIKNDEKPFVTPGATSTREGIGSDTQS
IDSIVRSIPGTYTNTDQAQGTVQVNIRGMSGFGRVNTMIDGVTQTFYGSASDDPARFHSQ
TGTSAFGAVIDTNFLIGVDVTRGTFEGVGGANALMGSANFKTIGINDIVHDGNIFGFLGR
FSYGSNGIGPSYMSAVAGKTELENNGYVGALFGYSAKRITQNYTVGGGGKIGSSMVDTDG
DGIADTNIAPFDPDFLTQKPNSQLFKLEYVPNSFTNTIFSYRRYQNELASRKIHNDNYQL
DFWHNPNEWLNVNTLIAYNQGIQTYGSKSTFAANDAIANTKAKNTATTFDISDTLEGEWH
RFNLNIRFGANILLNDYKNTLNTSIQGVNSIPFQPRGKQNLFTYYLDNSLNYGIFTLDTN
VNLLDWNIKGHRPACDEVNFMCFPKAATDIDKNGLRLNASVMLSAAIHELFTPFVSFART
NRAPNVQEMFFSNNEGNGINSFLKPEQANTWQIGFNSFKHGLLKDDDRFGFKAVYYHTKI
KDYIYNEQFYLEDPSKDPPSSQFYMHLNSADDTIFKGVELELSYDLGFAYAKAMYSRQDT
SSTISQTSGPLLGSFSASKIMELPKDYANVELGFRLNDKISFGGIAKYTGKAKRVNPNTD
DWNKDPNNPYYPKPTTQDLPKIPIIVDLYWNIEWFKNLTMRAEVQNLFDKNYMDALNAYN
SLDNQLQYNGAGDPIYLFSNSARGRTFIVSFEYKY
>fig|195.2044.peg.1604 Putative lipoprotein of ferric iron transporter system
MKKIILFLLCVGFAFACSEHSHTDFKDLNKTEYNSQLKDKI
>fig|195.2044.peg.294 hypothetical protein
MIAISILVFKKESMGSNTPNLFLTKGNLNFTIFKLLSCINGTKSL
>fig|195.2044.peg.224 hypothetical protein
MIDNIKIQNYKLIKELEIDKFKNINIFTGEIIVVNQVF
>fig|195.2044.peg.1262 hypothetical protein
MNFLELAGGGEVRRTSDPIFSFAVKGAKADIFLKENSSCFGKDSVYEILTREGGKFMLLG
LNYGHALTHYAEERNTSFCRYFKEFKGFVIDELGQKREKRINYYVRDLEKAYVCSLDKIN
EIVRQTRYYKSIKFAGDFLESYDAKEYVKAIGNALKQDKFAIYEKLLL
>fig|195.2044.peg.871 hypothetical protein
MQNFKNNKQYFIDMFKKEHVNYKLKDPISNNRKLDFKKAVCIIGVQNNKCQQERLQNLYI
LLKYMNKYYNYSNLIDIMVVEQSIKESSELQKLEAIYPAVFYRHLYNPSDYNRGWGYNTA
VKEFCKSYSVIVFMDTDILPGENFLKEVEICLEGIYDVVSPYRHIYYTNNIERKLIEERL
SISFLDNITFKNPVTVTGGIVIFNKEKFLELCGFEQYIGYGGEDRALDVLIFEYFAKEKI
RISPNIYVHLFHEIDFQQKKVSLKIFQHLKKVYKCSYSREVGKDEFIHSRCIHATKEELD
QAILKKQRSFGDKNLYKNYALTVNGEMIQEESIICDVNVITPPKFENLKSYILKEKNSEA
CCESELSKLYNKYLGRRCFIIGNGPSLNLHDLSLLKDEYSFAVNSFYYKTKETGFRPTFY
VVEDTSVMKENLDEIKKYHAQYRFFPTIYKNLIPKDSNTYFFTMNRGFYEKSSPNYCVPR
FSTDITKEIFCGQSVTYINLQLAYFMGFSEVYLIGMDFSYIIPKSHKRVGDVLFSDGDDM
NHFHKDYFGAGKTWKDPKLDRVAQNYKMAKLVFESTNRKIYNASIGGNLNIFPRVDYSNI
FSSHCKKNFIYNNDEFFAISNHDIEILTYKHIKKMIKDGEIELAKKYLEYVKNTDFTIGK
GFKFERIKQLLEILL
>fig|195.2044.peg.1594 Integral membrane protein TerC
MFEWIFSIDAWITLATLSALEIVLGIDNIIFLAILVSKLPPEHRDKGRILGLAFAMITRI
LLLLSLFWVMKLVTPLFSVLGNEISGRDLVLLLGGLFLIVKSIKEIKEQISHQEESQSHF
KASNKLWIVVAEIAVIDIVFSLDSVITAVGIAQDVTIMIIAVIIAVAVMLFASKPIADFV
EKYPSIKILALAFLVLIGVVLVAESFDIHIDKAYIYTAMAFALVVQILNILDQRKEKNG
>fig|195.2044.peg.1519 L-serine dehydratase, beta subunit (EC 4.3.1.17) / L-serine dehydratase, alpha subunit (EC 4.3.1.17)
MSNLNIFKIGVGPSSSHTLGPMLAGNLFCKKIAKKLEKIERIQIILYGSLSLTGRGHLSD
KAVIWGLNALEAKNLSAAIQDEVNKNAIENAQIDFCGEKKLCFNYEKDLIFSKDFLPLHE
NGMKIKAYDCKGGLVDEETYYSVGGGFVLTAAQLEKKGKNSNQNKKKKLDIELNNAKEAL
ELCDKRDWDLAELSYRYELQFHTKEEIRAYCLEIWEVMQEVYYNGTHPNEDYLPGKLHLK
RRAKGLKERAYNC
>fig|195.2044.peg.1578 hypothetical protein
FIADLFLNLGENNIYALNSIRDIVKKFLYKDYK
>fig|195.2045.peg.1345 hypothetical protein
MKPYLYSLIKFIKEEINVIPKESANTSICQNILHKVVFISISLYNKGYFDDESKIKEIID
NNKEILDKANKEIIIKESIEEQKIISSLHSVFNYLYKKIVLFRRNNNTTLKPTIIEATLK
EKFTKEICG
>fig|195.2045.peg.1795 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWYGGGYIKLLFDIRKIKREI
KEKYANKNR
>fig|195.2045.peg.1669 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MFGLIFASFLCLAPLYFSGILSADFYIPFYKYPLFNMYIFALFFWILVLISSSNAVNLTD
GLDGLATVPSIFSLATLGVFLYLSGNLIYSEYLFLPKINGLGELVVICAALIGALMGFLW
FNCYPAQIFMGDSGSLALGGFIGFLTV
>fig|195.2045.peg.1513 RecD-like DNA helicase YrrC
MRKDGLENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTDTN
QQLDSIYENLQSSLKYIGDKRKYKDIKNFHNLLQISVSHYTPNEEVAERLMLKYLFYLFQ
TRNFCKEFLDIQILNNLQEFPINLDTLSFQYYERVVDKIKQTSMFNDTKTDKFYIQKVKP
FIINEEIYYEITFTIAKDNVSKFDKLIAFSKYYIPSNYSTKLTLYYTNIKLLNLQIPVIL
ILQWNIDIRPCEFTNFCLIFNSIRMSFTRSTKYEHFMQFLTKEELNLLDIVKLKTEEYDE
IKNQFSEDKLKHLFNCLDMAREIILNNKSGSNILSYILYAMNNQIIKKQIPKKKNSYQPN
PKLSNLFLKNESIPFDEMPFCSNPAGHIPKLNVLFECISLNNREYELLARKIQYNSEVNG
SLYTSLEDFKEDNIEVLIEKYNTALYNGHKKNRSIKKLHDKFLFINEYQDTLIEIIQLLN
NFTKSGLDHYKENINEWLKECNQLDCKEKKDYLSNLFCNSKLALIYGAAGTGKTTLIEHI
SSFFMIRINYI
>fig|195.2045.peg.405 hypothetical protein
MLGMRTKDDKFKAIELYEKACNLNEGSSCGVVGAMYANGTYVEKNDFKAVKFLKIACDMD
YANSCVNLGGMYENGYGVRKDISKALKFYGKACDLKYDTGCKNYARLKR
>fig|195.2045.peg.1525 PhoX, Predicted phosphatase
MQRRVFLKGSALGSMVAFFGGSNLSAAVLKDKELLGFKAVSASTKDEVIVPDGYEAKVLI
SWGDPLFSKAKAYDESKNIDMNAVDNARFVFGDNNDGMSFFSLSKNRGILAINNEYINPE
IMFNHQGKNLSKEDVLYEQASVGVSVLEIQKKGNEWAVVLDSKYNRRIDANTKMEVSGAA
KKEVLKDKKFAYGTFANCANGQTPWGTYISCEENFDDYFGSSDENLKFDENFKRYGFKTK
SEYGWEKFDERFDLAKNLDEANRFGWIVEINPFDAKSTPIKRTALGRFKHENAEFINFQA
RKLPLL
>fig|195.2045.peg.404 hypothetical protein
MKKVLIILGFIFLNFACSQEDLIEKGENAYKNKDYTNAIKYFQQACDLNNGNGCNELGTM
YTLVKKTILKQWNHIKKLAI
>fig|195.2045.peg.477 FIG00638667: hypothetical protein
MVLLQAKGASNNTIKIRNNLTVINGTQNPSDRINIITGRTLAGEANFNVIDFKDSQASLP
LFIYATT
>fig|195.2045.peg.1357 hypothetical protein
MNEIGLNIIAGVSVILFAYTCYLFYKQNKSLKDKTKESKH
>fig|195.2045.peg.1656 hypothetical protein
MHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENENIIHHRVF
>fig|195.2045.peg.1683 C4-dicarboxylate transporter
MFLPGIAAMLLMPLVLYFLSPPEIKSTPNAFTFMGWSFGLVFWNFS
>fig|195.2045.peg.420 Phosphoglycerate transporter protein
MFDFFKPKVKAIKFPKEEILPRYYKMRAWSLSGVL
>fig|195.2045.peg.421 Phosphoglycerate transporter protein PgtP
MGYYLVRNNITLSTPFIQNQLELSKSDIGTITGSMLIAYGISKGAMSVLSDKADPKNTWL
>fig|195.2045.peg.1340 hypothetical protein
MKMIELKVKMLDAYFGLLQSVVNDGGFIVSMSLLRIGLLIF
>fig|195.2045.peg.1367 hypothetical protein
MTAQEIKEFCKEQGLTYKQLGELIGMSEGGLQNAIKKDSISDQTTKAIELLKEIEILKEQ
LADYENLKQLLKKALF
>fig|195.2045.peg.787 hypothetical protein
MRKLLSVALVACFIGSFAYGKTENNKSPQVRSSCVDYEIRLKRCNSLPTQYQRQMCRLGL
FAACK
>fig|195.2045.peg.478 FIG00638667: hypothetical protein
MNVENNQVFYHNVEAQASGEGVNRESSVYIRAANLAKNNLFKASNYWATSMLNIYGIREV
EESKNNQVIFNNVGFNTDRISEGSELILIGGVGKRVHHNLLSIQDLEIGAYDKEKDFIYI
AASAIPDTNSNLALSYGNTLYIGGDVSIHERSLLNVLSGSVIRIPNYTNNKADDITLPAP
SLAQLTKDNHLILEQALRARVVNNFEHYSLIYHSNNQDKPFIESLETPINLSEES
>fig|195.2045.peg.1346 hypothetical protein
MKKILFFVFAKHNPKPYQEEDIIDVEVEDEKPKKSLKTFLENWKD
>fig|195.2045.peg.1053 hypothetical protein
MLICNHCNTKNLDVAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEEEKRKIAQEER
EKSLKQRKEFISKHKSKIIISMVSFFLIASLSIYQYFYGGKYSRVYINKLEGKCHYDDAS
SCKMLQTIYKEKCDDGDGKACFAGIFVSGDLIRVKIDGQWSFLDKNGEIIAKPEFDDIWG
FSEGLAKVELNGKYGGFIDRSGKFAIEPKFDSGEYFSEGLAGVKLNGRWGFIDRSGKFAI
EPKFDSGEYFSEGLAGVKLNGRWGFIDRSGKFAIEPKFDSGEYFSEGLAGVKLNGRWGFI
DRSGKFVIKPKFDSIWDFSEGLAKVELNRKYGFMDKNGKIVIEPKFDGVGNFSEGLAAVG
LNGKWGFIDKNGEFAIKPKFDDIWDFREGLASVGLNGKIGLIDKSGKFVIKPKFDSIWSF
REGLAKVGLNGKYGLIDKSGKIVIEPKFDDIRY
>fig|195.2045.peg.1065 Type II secretion cytoplasmic ATP binding protein (PulE, ATPase)
MIRILKHNEEILDLENLNLGEKNLTILKKALYNPYGMILLTGPTGSGKSTSLYACLNELK
SIEKKIISVEDPIEYKMPLIQQILLNPKAGLEFNNALRAILRQDPDIIMVGEIRDEESLD
IAIKASLTGHLLLSTLHTNNAISTIDRLIDMSAKPYLIASALRLVIAQRLVRKLCPKCKQ
KSTKVYEIKGDFFEAKGCEYCHHSGYQGRELISECLYIDEEIAQVIREGGYKNKILELAK
VKGFQSMFEQGLQKAKEGITSIDELLRVLNEAL
>fig|195.2045.peg.1670 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MPKFINWAKKNASQPIYEHAPQNHQIKSHTPTMGGVIFVFCAIFASLLCIKFDNLFALMG
LLCLISFCFIGVIDDLGKILKKK
>fig|195.2045.peg.265 hypothetical protein
MSYENFIGKQEKFTENINEKQVQKIVATLQSKQLKMVMLFHVFGNGAFLMKH
>fig|195.2045.peg.1745 Phage Rha protein
MEKLAVINGVDVELEVVDNAVYTTSLSVAEVFNKNHKNIIRKINEFPKDNFTKLNFELSK
YIDSTGRILPCYKITRDGFSLLVMGFTGEKAYKWKIEFIKAFNEMEKRLRNIEYEKHDKL
AFRQSLGYKSQLKQQKEHYENEIKALKYDLEQSKNNFKDKLNCILAKNGLYAFDFKTFKN
YALKLEKMLKDLKDDENKENKLLLRMQNDFLECLELYKSINI
>fig|195.2045.peg.1419 Zinc transporter ZupT
MIDKLIPEDVNPHEPKEDLSELKICPLPQKGQNPPKFHPGEKLHQINTKALKRTGIFTAL
AIAIHNFPEGFATFISSLDNLTLGIAIAIAVAITISQKVWL
>fig|195.2045.peg.1522 Transcriptional regulator
MLKQTKKKLQNQIKTLKESEKVLSKKIKIYEEMLANEVDGFNPESKDYQPCDKFCKES
>fig|195.2045.peg.208 Selenophosphate-dependent tRNA 2-selenouridine synthase
MLSEVEFTEFQKENFSLLIDARSPREFLHSHLIGALNFYALNDEEYQEIGTIYKKNQALA
KVRGASYICQNMSKHILELAHKFRIGDKIGIYCSRGGLRSKSIAVILSELGYRVVRLKGG
FKAYRSFLAHYFDNEINLDFFCSLW
>fig|195.2045.peg.1343 hypothetical protein
MDNLKLENIKIIDVCDLFVTFKSDVENLFSIIKIDNASPKIERLSIFNIPQEVRQIEPNL
KYQPTHKLTFEGKDTGIFLGDNVIGFDSSKREKEDIDFISTILESLKDEIESINRIGIKR
TFDIDSIDNFLELKIKNNDSNDDLKKLSQIQLKEDNWVFNIISAEKNDIVINNNKKTSGY
MVDVIVFYEKLENFNYNETIEKISQLYSLQEEKYKKITK
>fig|195.2045.peg.1523 Transcriptional regulator
MAYTIKKVEKETKISAHTLRFWAKKGLFPFVQKDENSVKYFSKSDIEWAKWIEWLRISGM
PIEQSNII
>fig|195.2045.peg.1174 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IKKLEEVIIRIQVDINQSFLYILEKIIITTFKYSSFKMEYNQLDIFGYSAKTRIQNQLSY
KLGQAMITNSKSLLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLPPLENYPDYKE
ALKEKECLTYKLGEALIKANKTWYGGGYIKLWFEIGKLKREFRKKDNHA
>fig|195.2045.peg.1796 Motility accessory factor
MNLLEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIFDKTHNVFMYENLEEEI
NFFYQSILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEE
>fig|195.2045.peg.654 UDP-N-acetylmuramate--L-alanine ligase (EC 6.3.2.8)
MMQNIHFIGIGGIGISALARFLKEKGFKISGSDLKESKITKELEKEGVKVSIPHHKDNIL
NKDLVIYSAAIKEENPEFKHAKELGIECLSRKEALPLILEDKRVFAVAGAHGKSTTSSIL
ASLLDDASVIIGAILKEFGSNMIYKESQNLVFEADESDSSFLNSNPYLAIVTNAEAEHLD
HYGNEVSKLHHAYTQFLDVAKIRVINAEDEFLKNYKNESTKLYPSKDIKNCTMCIENFKP
FTSFELKDLGEFKVFGMGYHLALDASLAILAALNFLDIETIRTRLKNYQGIKKRFDILHA
DENLVLIDDYGHHPTEIKATLSAAQEYAKLGRYKKITAIFEPHRYTRLATNLKEFAKAFE
GVDELVILPVYAAGEEPIELDLKAVFPKALFVEDIKREGKFLVASKGQVFEEGLIIGFGA
GDISNKLRQKNE
>fig|195.2045.peg.1328 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANEFQQEQDLRKQQMEFNQ
AMQNNQLLQNERNFDYQKERANIADQQWQMNYNQRARQYAMQNALRQQAINARKQQMEFN
QAMQNNQLLQNERNFDYQKERANIADQQWQMNYN
>fig|195.2045.peg.475 Filamentous haemagglutinin domain protein
MLKSLDRILCIKKKGGGGMNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLA
QSLTASNLPSGGKFINGTGSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGK
NYLNLDYTNKASQILGTLNGGTNNVYIVNPSGVLVGEGATINANKFGVSTIPMGIDAINT
FSVDDSFSPVFNANKGDVVNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDF
GINSTHLKAEIGSEGFFKYEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQS
ASNEEMINSWKGFAKLVNEGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGN
NHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTF
SNIALDTIEGFNSENSSSGGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFS
SIILSNIESIYGKNNGGGFVGYTTGNTTFDGIGLKDIRFIKSGAFTGGFAGMTQGNVIFE
NIVLNDLEEISGSHAGGFVGGVLNNENGIASLSNIVLNNIESIKGIGFIGGFAGWINDGT
FNNIILNNIEKISVSATHKYIFTGGFTGYAGAGTYKNIILNNIGEISANGTASLDEKSIY
AGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIANSNIYFYGLLNSSS
NKSYITHNENILNLSNTTDFQTFINQSKIAGLEYLTNTSTSNSHLHMINGGKIGNEKSKI
TFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDFEDEILKTIIDEILN
EDYVLNIDSIDFNKFNEGDVAILLYLLKNTSNKKLKESLKQSLEFYTEFNKGGLKTEFEK
WYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLKPELESIKNNLNRLEFLKAEIKRLER
VYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNKPFLDDLITKEYSFE
DKYTDIQGTFAIAGSSIDANAIENLADKPILSLPENENSGDSQTTNNTDSTDIVNTFSKQ
VKLTSTESILILPAEETQSHIKEDERERGRVCITSDNAKTNNPCIAITF
>fig|195.2045.peg.653 Phosphoglycerol transferase-like protein
MRKILLQILIFSVLFIVAFTINRILMQNSFIPAGLISDKNEIFLMYLLGVFHDIRFLSAA
FLPFLLCGFLSLIFSNIKINNKLVIYSKNFYFIFSSVYIIVLSCLCIGFSYAKYYYYEIY
KTKFDIFMFTLKDDNTKTILSIIYHDYPILKILALMLIFGVFVVFLNLKILNLKLKPVNL
RLFPLIALNLILIIVYVIALRGPFKHVAINVQNYSFSEYSVVNDTMLNPIMAFSWALKQY
KEEAALKVITPLKAQELKEKLFDYLHQSPINLKAEKNHPSVFVNLMESFGLNLADFANTE
HNFLGSLDKHFKQDFLFKRFLSSSNGTIPSFANLFFVSPLSNISTSKFQKTYLDLTPIAI
YKKAGYKVIFVSAGNGSWQNIKNYLSILGVDEIIDENILMKEYNGAKDSENGYGVADEFL
YKKVYDLLQKNPHNTLIIALTISNHPPYKFPQNDLPKLENIPQTLLNMLPYDKNKQDNII
KAYTYANNEFGKFLDKVKQSPFKDSVIIAATGDHRVREMSMDLNSQKAFAYSVPFYLYIP
KDLQDNIYYDKDRVGSHKDIFPTLYALSLNNVKYLSVGGRNMLARPNDEKLEFGINDAVW
IDKKGIYSGGKGYYFESNDTLKDMNKAFNLDGYTKDFDKFYRELNLYQLAERLGISK
>fig|195.2045.peg.1064 Type II secretion cytoplasmic ATP binding protein (PulE, ATPase)
MIERFLFEDYINGKITLEQIDREHKIDSEIFLKALASDKNISYSTLEELDLSLGEKFPCS
FLFKFKILPILSKENTLHIASSKPCSLELLDEIRIFYEVKNIEVLIASEFKIMKFLYKLQ
VREKLKNLSTNLRLEWKENRSQDEQSCISQIFDFILDEILEFNPSDIHIEARENDTLIRF
RVDGILREFACLEKDIYEALVFHIKFLSQLNVAESRKAQDGNFELKIKENDMILGFHLCL
CKMAKAL
>fig|195.2045.peg.1143 Ankyrin-repeat containing protein
MMTLSLEEEKRFAELCKMAFNFARNNEYENLKIMIEAGLNVNLKTHKGDTLLMLAAYNNS
YESAKMLLEKGAKVDEKNDRGQTPLAGVCFKGYLPMCELLVKYGANIDENNGLGMTPYTF
AIMFGRKDVAEFLLKKSKNNFLKKMSLKILKFIKKF
>fig|195.2045.peg.1512 RecD-like DNA helicase YrrC
MELKHIYRTKSEKLQLLWERVRTLDESMLEAIEKNNSSENIQNFNFSRSVNDEIILCLNY
GGIYGVNNINKFLQENNPHKSFYFNGLSYKVDDPILFNENSSSFGEEFHNNLKGIITNIE
EDEKTINFTIKINKIIQNINNNFKIVAKDDKGTEIKFSVARLNSDEEDDNSNIVPFQVAY
AISIHKAQGLEYDKVSIVVADEIEEQVTHNIFYTAITRAKKELKIYWSAETENKILKSLK
IKDINKDFHLFKNNIQNIKTLKN
>fig|195.2045.peg.160 hypothetical protein
MKQWLSDFKLALIQEDVNKLESLLNALDLKKMLEDLARDFQNDELKDKLNDNLGQIKALL
QEAVVLISAKKNSKACEIQKIQKALKYFKA
>fig|195.2045.peg.1684 C4-dicarboxylate transporter
MFFGISLDATSVALLGLSLVLISGVLTFGEVLAEKAAWNILVWFSALVMMATLLGKLGVT
QFLAEALGEFASAMGLGEISIIIFLSLAFLYTHYFFASTTAHISAMFFVFYSAGLALGAP
PLLYAFIMIASGNVMMALTHYATGTAPVIFGTGYVTLKKWWSIGFVISIVDIVVMIAVGL
FWWKILGFY
>fig|195.2045.peg.1668 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MLVGFVFVLETISVILQVGSFKIWGKRVFKMAPIHHHFEKVGWVENKIIVRFWMIALLSN
LLALASLKLR
>fig|195.2045.peg.264 COGs COG3777
MWAGGRFNFIAPLIIGEDATKITTIKKIQEKQGKSGKLTFVTLEHCYYQKEQLKIEEEQD
IVYKQPAPPKLTSDVVAMNADYSEKMQPDSTLLFRYSALTFNGHKIHYDFPYATQVEGYH
GLVIHGPLLATYMINCFVKNHPDKQIINYSYRGMHALCVPDSFAVESKIIDNNTAEVWIN
KNGFVAHSGTIHFK
>fig|195.2045.peg.100 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
MLKDKLLQDLEECFETLGQVRNLAQNYDEKLFDYLLEESKYKEEFKSRFFLFGKKTLVFK
LNDFLNFLDLRSLGGSFTSYANKIGLANKTKSLLKTNNEVVLNFAFKDGVIKGGQSKDEQ
KTQEIFFNEILARDEIDVLFDKKALQNFELIGENKNLQEYLKDNPNLLIKGNNLLALHSL
KKLYANKVKLIYIDPPYNTGNDSFNYNDKFNHSTWLTFMKNRLEIAREFLRDDGVIFVQC
DDNEQAYLKVLMDEIFGRENYLRTINIKKKQSAGVGQDAFILDVTEYIIVYCKNRNSFTY
NKFYINVDFDEKQMKNYKNYIVIKDKVLLKEENDKTCGMLKIYKLDYEICKATGLTHENF
IENFNSHFTTYNPQSTFAKRMIANLDENFYEVEYKPIRGRNQNQNTSVYFYNKRIVQMLH
SIAYISKNKIIKKQILDNFWNDISWDIIGSQGNVEFKNGKKPEALLQRIIEISTNENDII
MDFFAGSGTTLAVAHKMKRKWIAIEQMDYIETITKERLKKVIEGEQGGISKAINWQGGGS
FVYAELMPLNAVYKEKIQNLNDEKELDNIYQELKTKAFLDYRVDINEILKDKEFENLDLE
NKKEILKLILDSNMDYVLYGDIEDENYVLSKETIKLNKTFYGDENA
>fig|195.2045.peg.1751 hypothetical protein
QYAMQNALRQQAINARKQQMEFNQAMQNNQLLQNERNFDYQKERANIAELQKLQNEINAK
QKEQDLLNKVFSNTQGFDGQNNANLQNNTRYKADAQFLDLASNQGKTYDTTHGFWNGALE
RAFGGWGSQSTDLNDASDLFLKRMLSDLLRGGKNAKWNLENIQANFPINGYTMEANNQRV
AQALAGEWLAEAPNSYKMELVERLGNAKTNMEKQSAIEDYQKNMNFYNNYGPKVKAFYWD
EKYSKPSKNAVIIDNSTANQNIQNDLAKNTLEVQNQNTPKLHSVSFNGINAQISEPDANG
NVILVNQAGKKMQVSVEELKKQGLIQ
>fig|195.2045.peg.1767 Motility accessory factor
LQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDILGLNKKLAENFKNSIVS
HGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKK
YASKATIFCADSSYPILAKHDIKPDYVCMLERDEIVAECFNNDFGEFDKDIVFIVKSVTH
PHTIKYLQKNNRAFILVSTYASFIQYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILI
GQDLAYAKDGQTHSQGFIHANLHNGDYERDLDKFSTTAYGGNGKVQSSEIWTLFRHNFEK
DIVNIKMNYHITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNE
FLLKAYYKVYQSIKHCRDFNDNFIKVYDKIKNSFMSLQNSQKNEIFIQEIIQDIDKTKTQ
IDELYNTQKDLIQILGPLLTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYG
HIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2045.peg.1168 hypothetical protein
MTAYVHIGTEKTGSTSIQFFLYSNRRLLQRQNMIYPISIGNYSSQWNFTFLAYNNLRNDF
YCLSKGIFKKDDFLHHKKDIFLKFKDELLKSKCEKVVISSEHLSSRIQDLSEIKRIRKIL
YLLGFKKIKIIVYIREQTSDMISSFSTTLKSGAIGNIQANSKKYFKGYHKLLLLKWQQIF
GKENLIVRLFDKSEFYQGDLLKDFVHSIGLKWDNEFVIPPKQNESLDLIGVEILRRVNNL
LPLFVNEDRNYLRGDLNYFIQKYFSSKDLFLKFQPPKEIIQSYIDSFEESNEWVRKEFFP
YKERLFPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLIITNKTTQIQNLNQA
IKNKDELITNKTTQIQNLNQAIKNKDELITNKTTQIQNLNQAIKNKDELIQNTNNLLSFQ
TKYGTAKTRIQNQLSYKLGQAMILNSKSILGYLIMPMALLSIIISHKQEQKIYQEKIKKD
PSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWYKGGYVKILFEIGKLKREFRN
RKI
>fig|195.2045.peg.1144 YheO-like PAS domain
MDEGQKQQFIKLTYFLGEVLGEQYEIVFHVITEDGVYIAAIANNHISGRSLDSPLTAFAS
ELMQNKKYLEKDFLCDYKALVGKSKLIRGSTFFIKNHDKLVGILCINHDTSIMRDLICKM
IDLEKIGDMGDILGNISFSQNDSSIETLSHSIEDILVQSVDSSYLNSDYQLSIAQKEEIA
EKLYEKGIFNIKGAVPIVAKFLKISEPSVYRYLKKFKK
>fig|195.2045.peg.1432 Alpha-2-macroglobulin
MAKKPNISEMNLLYDSLNTLSTEAKWQLAAAYKLAGVEDTAKQIASKISIEPDSKYSSYT
YGSLIRDEAIIANAYKQIYGTNNEELLQKISDTLLSKDYLSTQSTGYALYALAMGANLEN
MNENFMDATLKIGDQVHTIDQNQMQIFSFNNEKAIINANKDIFVSFGVEGVKAGENSAFS
NKISLDRAFYDEKGNKISPSEIGSGQTFYMRISASLNEGANYASNIALTQILPSGWEVSN
TLLDDNTPSFIKNSSYDFIDVRDDKIMWFFSLNKNRTHHFYIKLNAITPGSYTLSGAYVE
AMYDDTYRALSESEKVVVKR
>fig|195.2045.peg.1420 Zinc transporter ZupT
MSLPIYHATGDKKKAFIYSALSGFAGPLGAFVGALILLPFIGDLTLAISFAVIAGIMVFI
SLDELLPAAKTYDKAHDSLYGLIAGMAIMALSLNLLGQ
>fig|195.2045.peg.1805 Methyl-accepting chemotaxis signal transduction protein
ALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRG
FAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVAQIDQT
TKDNVEIANESAIISNTVSDIANNILEDVKKKRF
>fig|195.2045.peg.1798 hypothetical protein
MISLNSHYPNINYPNNALSIKKDENNEYAYAKKDEPKSEEDAYWEDFVQKYFGEMLSKEY
ANKYGYNGDPDVKEVENSLLERMRKDKLTEEEWEILNGAYDIDNIEFIPRDKIARIREAN
LLKTLTSASEFARIWVAEKDERKKRFIDALDVKPLTQEEIDKFLNKNKQQSSNSTQESNE
SGQNPDEKPFKAIQAKSKNKETYKDDSKMNELVKKLLENKFGKSEELELLFGMKFSDDSA
GEFNKFLSSNSAPKSIDIKA
>fig|195.2045.peg.207 Selenophosphate-dependent tRNA 2-selenouridine synthase
MELLPHHLNLEKMANHLGSSFGDILGAQPTQKAFEANLFYTLNSLKDFIFIESESRKIGE
IVLPLKLYEKMQKAFKIHCFCSLEKRIDRIQKIYQEKMTPLKFKECLAKISPYISVNFRQ
DLLKSYEQREWQRLIALLLAYYDKSYKKPQKIDFELNTDDIFKAKEELLGYFKTQLLF
>fig|195.2046.peg.520 SrpA-related protein
MQIGLNYNYASNSSYYDKTQKNNAEQENTENTNSQNKDSKQNNEQTQMINGVELTIQQVQ
QVRELQSIDRNVKLTKQHIKPLEVV
>fig|195.2046.peg.1139 Butyryl-CoA dehydrogenase (EC 1.3.8.1)
MQTLQKLVQKIDKEGYYPKNQIKALANDGFFAVLEQRSDIFKAVENISKISNICGTTGFC
MWCQFALIWYVLNSKNLELKARLLPKLYGGEILGGTALSNPMKSFAGIEKNRLKAKKTNG
GYIINGTLPWVSNIEQDSAFGAIALLPDEKPIMGVIFCDESVKLSSHIKYATLEGSATKT
ITLKDYFLKDTEVLGGDDIYEYLIKITPGFILLQVGIATGIINQSLECIQKSQLTHAHIN
EFLPYTYDGLRAEFIELLERLKDACGNIENLNSQNILTLRLDASLLTQKITGAAVLFSGA
MGYLADAKPQRLQREGNFVLIITPSIKHILKELQNIQKGDGCINKWKKEIL
>fig|195.2046.peg.1109 hypothetical protein
MILNTKHFFIVYKLHACLLIMYDLKNLDLDKKYFTHFI
>fig|195.2046.peg.1752 hypothetical protein
ATNIGIINNERDKILDNPQTAQIAIVNTIKRVVIGKNTILSSPTKFAKLPHMKSKLEKIN
FTNSQISFLKMQIKAIIAIKIA
>fig|195.2046.peg.988 7-cyano-7-deazaguanine synthase (EC 6.3.4.20)
MSKKALCIISGGMDSTLCAYLAKKEGYEIIALHFDYEQRTQEKEKECFKQICKALKVEKS
YILDVSFIKDIGGNALTDKSIDIPKNELSVSDTPPITYVPFRNGIFLSIAGSLAEKENCE
SIFIGVVEEDGSGYPDCTDEFIQKAQEFINEGTSKNFKVYIKTPLVRLNKAKIVELALKE
NVPLELTWSCYESEDEACGECDSCLLRLRGFERAGFKDKIKYKLKS
>fig|195.2046.peg.976 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MNAELKGYLTSKNGLPDMDKIQNYALKNKIPYWNIDVSVYGCKEVCYANLEYIKQRFKII
EGVDISIVQEFSLPLNLEQKKQLKHKVTLGIPNMEIFWLSTRGEVLEPSDGHVWFSPIIP
RDGKELLKCQEVYMNLFREFGEESPITPFSHPRSWMYRAFCFMLAF
>fig|195.2046.peg.1136 Taurine transport ATP-binding protein TauB
MIKINNLQKFFNNECILDSINLHIKKDEFVVLLGASGSGKSTLLKILSGYESFEYGDVSV
DNQNFIGKIPSHKSRQIITQQYSLLPWLSAKANIEFALKCYGFKDKKERKERAEQFLALV
HLQNKADLFPHSLSGGQAQRVAIARALSLNPTILFLDEPFSALDPIVRLKLQNEIKELSI
NKSVIFVTHDIDEAINIADTIVILRQGKIISKLKNPRFSPHSSNFFELKSKIFDILNGQD
PIIEYMI
>fig|195.2046.peg.1182 hypothetical protein
MVYLIVIFENFLNFSFKLGMILIPLRVVFIILVPFHLENSFLGKTFYFLENLFCLVFAIL
LIIAIIMPF
>fig|195.2046.peg.1709 FIG00470572: hypothetical protein
MLSKDWDDVADFIAQIIVSKNEIISSLKEQLELARKD
>fig|195.2046.peg.741 Putative periplasmic protein
MLAFFKGLGIGFLCLVLFVAGVIFNVEFLNKNKTTQTLNFSRSIETSMEAKPDIFHANIN
FWANENLSTQTFLSNEDKIQISNTFNQILERSKKENFCSGGSFSLEPNFSYKDGVQTPKG
QRLHANLECEFTADKLENFNKLLNDLNSIIAKSEFIGISTPALEPKFSKQTLKDNKEKLY
SELLKKSLFL
>fig|195.2046.peg.414 VgrG protein
MKGENKLLIEKSLTQTIEKEFFLNVHQNLSAHIQDNTSLKSNSMQTNPPSSR
>fig|195.2046.peg.1796 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRYGDTSRRANKSQSIHSDRTPNLFSFISRNDDERQGTDAARSYNQQSVLETAARND
GYERRSLKSGQKLDFVSDDEIYLGSLKDRFQKNLQAIKLSKTIEQENRYATKQEQEILNK
FSGWGGIPQAFDHQNKEWEKEFKELISTLDYAEYEKAKTSTLDAFYTPKIIIDTIYQGLN
QLGFNNDDHTKEIFEPSAGIGSFLSYAKNYSDKYHFTCVELDTISANILKHLHPNQTIYQ
FPSKKTSASISGR
>fig|195.2046.peg.1801 Motility accessory factor
MGGGYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVV
FEKDIEIIWIMFHILDFSNELQSARLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELM
SHYYERFHEDVLELNKKLVQYFKDSIISHGNDSTDTLQGIEQFVYNLPQMITHPSYKELL
SKRKNLSDTAIIVSTGPSLTKQLPLLKKYANTATIFCADSAYPILAKHDIKPDYVLSLER
IPLTSEFFNNDFGEFD
>fig|195.2046.peg.1572 hypothetical protein
MIDNIKIQNYKLIKELEIDKFKNINIFTGEN
>fig|195.2046.peg.1131 Enterochelin uptake periplasmic binding protein
MKKSLVFAFFAFFLSLILTACNSNSNENNASSTIKTNTATVKVLPISMSDEGDSFLVKDS
LGENKIPKNPSKVVILDLGILDTFDALKLNDKVAGVPAKNLPKYLQQFKNKPSVGGVQQV
DFEAINALKPDLIIISGRQSKFYDKLKEIAPTLFVGLDNANFLSSFENNVLSVAKLYGLE
KEALEKISDIKNEIEKAKSIVDEDKKALIILTNSNKISAFGPQSRFGIIHDVLGINAVDE
NIKVGTHGKSINSEFILEKNPDYLFVVDRNIIVGNKERAQGILDNALVTKTNAATNNKII
YLDPEYWYLASGNGLESLKTMILEVTNAIK
>fig|195.2046.peg.1111 Motility accessory factor
LEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2046.peg.1760 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILSLQDEEFKEEILSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQT
YKIIREIYRDDFEIFDYDLEDKKYFNIPQNIYLNNLESKILIKNINLDSLRLKKSFQIQN
LNQTIETKNKTIQDNLIQIQNLNQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYK
LGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYQEA
IKFKNYLSYRLGQVIIKGFKNPLSIILLPYEIVKLIYKFRKR
>fig|195.2046.peg.1276 hypothetical protein
MTGFSPFLNFFMVKSRLKQYLIALGFSPFLNFFMVKSILI
>fig|195.2046.peg.1639 Outer membrane and periplasm component of type IV secretion of T-DNA complex, has secretin-like domain, VirB9
MKNITLTILSFFFLASTAFALNIPKTSSFDKRIAYAVYNANDVFQINAKNGYVSVLEFGI
DERIINTATGFAEGWDLIEKDNLLFIKPKAYKTQLVQQDNNMGESQVSQEFVLDPNPKDW
KTNLIVITNLNTYVFDLKLVNQNNNTTYKLSFSYPKKDLEATKEFLEAQEQEKIRTDLNK
NTIPRNWDFYMKVNKGSEDIAPNFAYDDGVFTYIGFDNTKTFPAVFMYDNGKESILNTHI
KKDGNYEVLVVQKIAKQILLRSGDKVVGIFNRGYAKNPLNKTRETSNENIQREISESHSL
IEASASQLKPSNLS
>fig|195.2046.peg.1138 ABC transporter, substrate-binding protein (cluster 10, nitrate/sulfonate/bicarbonate)
MNRRNALLFLASFMALYAGKAMAKEGSKFKIPIKIGFLPISDHLLIIAKELFVSQNYELV
GIKFSNWADISEALRAGALDGAFLLAPLGLNLKASGVPIKAVLSAHKNGSALVVNKNINS
VNDLKGKKIAVPSRFSMHYFLLDKLLNDNNISDVNIIDMAPPEMPFALVSGQIDAYIVAE
PFGQIGVRLGAKNLLLSKEIKPNHICCVLNLKDEILKIPQISELLDAFKKTAVFIEQNSA
KSAILGNKIMAQKTQILQNILEKKLVTYDDLSLSEQDLSQLRDFLVAKNLGSAKLASLNI
KDYLL
>fig|195.2046.peg.505 methyl-accepting chemotaxis protein, putative
MADISSKTQQAVSENKNAMTELKNISDNLQAEIAIFKL
>fig|195.2046.peg.1708 hypothetical protein
MANRHWALVDMVLELVQKEDILQKESILSHITNERLLRAIENFKSESALHKDKKFIFSAE
GIVWDFSTKKHVEILEKIMRELGFTQIYIIVYFRDTLGYLNSHCSQDHKNNMGYYSADFA
PQDHPRKYIFDYEWICKTHAEVFGEENLIVRLLREDYVGGTLLKDFVYHLGLEWDESFVL
KQTKNESFNLLGMELMSRLNQKDLKQDNLNSLLFMARRKFEGSKEKRFKFAVQKDIAKAY
VDYFASSLEWVKNKYFPHKNSLFTPVKLGRI
>fig|195.2046.peg.1137 ABC transporter, permease protein (cluster 10, nitrate/sulfonate/bicarbonate)
MKILRILFSIGIFISIWAFFSNELISSPKQSFEAILELGKLGTLQDGLKDSLARYILGLS
IGVIFGVIFGVILGFMPRLNAFINPVLDLLRPISPIAWVPVVVIIFGIGDKPTIFIIAYA
VFFPVVLLSINALKQVPRELVLISKNFGANAWQLFYGVYFPSCIFTLVSALKLGASLAWI
NLVVGEMVGAQTGLGYLIIDARNQLEIPTVLGLIFIIGIIGMTINALFNTIELYFTKRFG
YDKNQ
>fig|195.2046.peg.1117 hypothetical protein
MILWGGGIPVIMIGSSHGGYLAHLAAKIAPWLINGVIDNSSYAKFLWRLIGFGKEIDFTK
YYCFGTGIFFKHIHIYCSDKTFWTSNSSSNNFFSIPRRMIRYILELNHIENQANYPKPYY
VSYHSFYDKEIAPPDEKLELYKYLKQFDFDAELHMIKNPDQIDGKFIKSLDHGMGMSIKT
LISKELPCMLEKVLSESDSKKEWKNKSISYPCDGLVYRFSEKNNKINLDITET
>fig|195.2046.peg.1668 helicase, Snf2 family
MSTTDGKTIIEPENLIYKRDEKTFFKLESYVNFGGFVKRLNNFYNDLEKFTQLNKNKIEN
LEKEIVELKSITGDNTPKYKRKDYLEALREDNRIIMDEIEKMSKQKNYKSGFVPKSAKIL
EDLNKQSKTIKENEIDY
>fig|195.2046.peg.974 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MGKEWVFKTQEDLDLYRDAYSPQWDDDDEPIPSLALAPKNVEEVQAIVKIANEFKIPLFP
ISTGKNLGYGSSAPQQRGQVVVDLKRMNKIIEVDDKRNFCIVEPGVSYFDLYKYVEKTIS
MFF
>fig|195.2046.peg.521 SrpA-related protein
MYATAGEVPIRMQKGRTPEETIANARQVVAAAMAPADPSPQDYKVAANALKMEFEARAEA
IKLKAQEAQEKKEENEEKQENLDINNQDSKDNFEETQANKDFKNFIGKIYQQNSQNNPIN
FSLVS
>fig|195.2046.peg.1669 hypothetical protein
FILDNDEKGNDKYVLGEINCSCVGFTSHLELADEVAQNIINIASKAKN
>fig|195.2046.peg.1281 FIG00470336: hypothetical protein
YRGFNFFIKDWIGLARQLSLKYPKFLFILLNFSTNSIQYNIDQNANLKVFCNNKNIASLV
SISQKLDFLITVDTGNLHLCDILQIPTLAFTSSLAAYRFGGGSYGGRFDKLIVKPAWQKE
YRKIYEIFTKKAENNLENL
>fig|195.2046.peg.1667 hypothetical protein
MLKKVAILVDGDFFIRRHKSYFKKFKKSNHYKPSSEELAKALHNHCLKHIDKNKEELYRI
FFYDCKPLDNKAHNPKSNECIDFATTEIYKERIELHKCLISKPCLALRLGYLDEKSATWI
IKNKKKHKKLLSGKITIKDLSDNDYMYYAKQKGVDMKIGIDIATLALKKLVQKIVLISGD
SDFVPASKLARTEGIIFTLDPMGNPIKENLEEHIDYLKTTLPYFKK
>fig|195.2046.peg.854 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVTDP
DSDEKGLNFGIYGKADNYDARTRDYFKGAVKANGLYVTPSYLDLTTNLPCFTYATPLYKE
GKFIGVLAIDILVKDLQREFENLPGRTFVFDSENSIFVSTDKELLKPGYDVSPVANIAKD
KKDYEPFRYVRPLDGTQRFGVCAKVLGEYTACVGEPIDYIEEPVFKIAYIQIAIVIITSI
ISVLLLYFIVSRYLSPLAAIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENI
LATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQL
>fig|195.2046.peg.1716 hypothetical protein
MQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKALFRKELPLMLEKLQKRKSFMR
ENSISYPCGNKVFTFKDVGDKFELVIKD
>fig|195.2046.peg.1656 hypothetical protein
MIPKFLNSLNSIILNKVNQKLKFLNFYFKKLQTESVANRNRNYDIMF
>fig|195.2046.peg.1737 Inner membrane protein of type IV secretion of T-DNA complex, TonB-like, VirB10
MQDKEQDNLDNDFENHTSDLHEQKNHLKKIQAYAIFAIGGLLLIFLMVYFLKSFSGNNND
IEETPKEENNDIAQSVKTKEFAPPPSSSTQKTFDELMAQEQPTQTTALILEAEPPKPRIV
KGIGVTVVASSNNGFNGGNTGDRGEFGEKPNTVFEFGQNGSGALQNSNNFQSGGEFTGEV
FTPTIAKVSEFDQNLLLPKGTYIGCALKTRLVSSIKGGIACIVSNNVYSANGNTLLIEKG
STITGTFNAGQLDDGMDRLFVIWQEIRTPNNIIIPVYSGATDELGASGMQGWVDHHYMKR
FGSAILLSMIDDSMAILADQLSKNGNNNNYYNYSENTRENVNEIANTALEKMIDIKPTLY
KNHGDLVGVYVNRDIDFSKVYKLTRKKNVNYTR
>fig|195.2046.peg.740 hypothetical protein
MSLFCFDYLQINKAVPLMLCSSSFTIGNESSILSALFILFKALG
>fig|195.2046.peg.1140 Bll5738 protein
MATLNSCTRLDPIDKAGLEALKKAGIENPDVIKTLKCRTVAAGKFRHENYIRNLPAYIVD
EPPVLLGDDTAPNPSEAVLAALGSCVAVGIHANAIDKNIVITKLELELEGDLNITAVWGT
GDLDENKPLGFTDVRIKVDLQTNKDKATNDALIAHAIKYSPVANTLLRKVNVEVK
>fig|195.2046.peg.1579 Cytochrome c family protein
MKKHILLLGLCLSLSLSAKSVSDYKVGEELSDKEGVEYFKELSKRPVQEWPNKNLSINDV
PKGKQGDLIRYGIELLSKTESTLGPYSKLKKTSNEVNCISCHMDNDGNGLPGTKKYVIPF
LNILNNYPRLDIETMKIISVEDRIRGMGGTDSHRFPNDSKEMKAILAYFKWLKEAYGIKD
GVKLEGDFFAKMNFPNRPADPVRGKKLFEENCVACHGERGLGVKNDNYEQGSGHLYPSLL
IYPDGGHMAMIPFLARFLKSAMPFGASADNPILSDEDALDIAAYVNTGFVRMPITTTENR
AGLDTAYSKSPSLKPEYFASPQQNLDPKEYIKVKYGPWKNPNHFPGE
>fig|195.2046.peg.1472 Methyl-accepting chemotaxis signal transduction protein
MIGTDLHNAKDENGIFYVRELYQRALDKGGFVTFHFTKPQPNGENTIAEKTAYSYLIPNA
DDLWISLVCTKTL
>fig|195.2047.peg.1730 FIG00638667: hypothetical protein
AQGKLSNPFKLLDDKLQNKELAWFKIQSIQNDLNVSIQFQDINLSNEGGNALWENVLTEI
LLDKEDLKIKAIYSKIGQVDFSQFYAKFYLKNLDHQQKFEKPISFSNLIQFNESVEEFKF
DFCEINNHTISSFYNKNIIYFDDDNQTLKMHSQGKANNLNIDLTSQIYQSIDFDQINFDL
IYSQKKPDISDDKLIFKPSNEELNLQIQNITLKKDNQDINIKGNIFLSMQSHKARIQISS
LKSPDEIFTWGQFFGGLNQYFIKNEEGMFIMDLHYDSDAKTQLKINGNEFTDINLN
>fig|195.2047.peg.1711 Phage tail formation protein GpD
MVRKPKFKLIAKGEDITEKLSKNLINISYEDKEKAESDEISLSVFGLYSKPLFGDSLELW
LGFEKLYKCGSFSVNVVSKNYTSNTTEVRASAINFSGKGSVNIKEKKTRSFENTTLFTIA
RKIANEN
>fig|195.2047.peg.1837 Phage tail formation protein GpI
MNTLILNHHPKQSKAIDLSAKARFEDLKIESITNLAMRCDERLLPVLANAYDVSIDGLEE
KEARKLISKALLLDRYNGTTW
>fig|195.2047.peg.1871 Phage tail sheath monomer GpFI
ENTLTHIVNAIEAFKKAKHKTGFSPDLIIAPYYSHEAGVKAKLESVASSMNITAIVDLYA
TNVGEAINTMEAFSSKRLIATWPQ
>fig|195.2047.peg.1827 hypothetical protein
SNDEALKLLKELNNEFKSDEEWQKTIKSINGGNK
>fig|195.2047.peg.107 FIG00470965: hypothetical protein
MTLDNDLWRFIGFGREIDYVKYCSVGITYMFKNIKLAAFDKTYWTTNKQSPYYFSNARKI
VREPLNKEHLKIQSLYPKPKYIAYHSKFD
>fig|195.2047.peg.1805 hypothetical protein
MFILVYGHFSYGKMGLEIAKGNFFNAKGNFFNAKNIPKGNFFNATD
>fig|195.2047.peg.1836 Phage baseplate assembly protein GpJ
ANGYLIQRLKGVKPTAKVEFELNTLLTYDVIIPKGAIFSNEKADLATLKEEVIIKKGQNK
AQGILELDEFIQSKESKTEFLQTPLPFVAKIKQLEFFKGGASEESDEALRERAVMSVHRF
STAGSEKGYIYHALSASAKVASIKALNNGAGKVRVIIKSEDELSVDVVKEYLSADERRPL
TDEVSVELAKKREFIVDAKLLLLELSRANEISEKINALQKDFDLSVDLALGFIYKCLHQD
GVYKSEILSIKEKIINEEEQELKDLPLANIIIADDEFATLSFSLSYEKAVL
>fig|195.2047.peg.1853 Phage tail formation protein GpD
ENTTLFTIARKIANENNLKIKTSGEDQNIVSILQNNQSNLEFLYSICFDYGFICCVKENT
LIITLKDGKIGDNAANITSKNENLPLFEIALKECISLEISESARNEYSAVIVEWQDINEA
KIKSIKVGSGENVYKMQISQPKNDNEAFKKAQAKLNELQKGGLNGRCELIGREIRAGGKL
KIKDINMDNYEFSIKSVSHS
>fig|195.2047.peg.1865 hypothetical protein
MPFLRALAGAIVEEIKENAKAIDMTDGGKWSIE
>fig|195.2047.peg.1803 hypothetical protein
MILVTPCGVIDTTNFGKSEVNRQTIDFSLKFQEKKAKVEAKAEKEEETRLKDKDISNSTN
ADNKKDQLLDISA
>fig|195.2047.peg.1810 hypothetical protein
MGVVYDEINIAVNTCKGLVLSKKRLFALNLSFLFNKTLTS
>fig|195.2047.peg.1844 hypothetical protein
MRELSLAAFKLLNSVFKTKTAHFNGFLELDFKNKPKLKKQSFKRKKKMTSKQKIRFKERL
QSKKIRLKRI
>fig|195.2047.peg.1833 FIG048677: hypothetical protein, phage tail fiber-like
MTKTELKRVCVKPYDKDKFEVVENYEFSLPNYKGIVPKGFK
>fig|195.2047.peg.1822 Phage tail sheath monomer GpFI
MAANYGVNFNISNGAASPIKVQSDTPIGIAGAIKGASKEMIYTKAGYESVDNFPIFAFSN
VSKAKEFVNDLIKENNLQDFRLLDTLECINLQNVFNVIIISFFEESEESENTLTHIVNAI
EAFKKAKHKTGFSPDLIIAPYYSHEAGVKA
>fig|195.2047.peg.1802 hypothetical protein
MQTSKKTNKKRIQKAVVTQNNRFVYAKYDMNTNELKMFMWIVAQINSQKDSLFQVCEMPL
SEIFEVLNHQSEENYTYIKNLIDNMGKKTYIEDFKLLDEMTMKEVEIHRVMPLFQFIEYK
KGASSISYRLNDSLMQYLLDQKRDFTQLKFNDIQQMKSAYSIRIYNMLVCELKQNKQSLK
INLAVLQNLLEVPKTLLEYKHFNVKVLKQAEKDINGKSNLVLLEIKTYKTGRKITDLEFI
FDYKNNDKRIAQEKAKQEKFFTRLKEILSNYIGKSIYDERFGEMIVTHYDHNEADNKISI
IAQRKSDDKFVAFGVKNFKDIQSLEKLKDKAEELFYLDKQRVINAKEAQNYKNLFTMD
>fig|195.2047.peg.1800 MobC-like protein
MLKQKSLKRKQTPINRDFIAELSKWGNNLNQVAKHLNTSKGGLDRVGLEMLSRIENHLKE
LRKAIE
>fig|195.2047.peg.1862 hypothetical protein
MDNAKEALKELFGISEVQAVAIERLYFKAKTPKDILGFKKYYDLTMLKKQFVGTSYEKLS
LVCAFA
>fig|195.2047.peg.1851 hypothetical protein
KDYEQNYLEYKKNQNKLYNANIDKFTSKLEQILKAKK
>fig|195.2047.peg.1519 integral membrane protein, putative
MLDESHSIFIDYFAIFALMFVVASIWKLVDIYLVFVGIKKDNFHKILNFFS
>fig|195.2047.peg.1673 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTHRYPFACIYGIGNALLIKNLSKHYKHLFVFESEIELFILALSTIDLSEE
LKIYKIVLFDCVAEDLEIQIAMIFDQQSILEYLSLYEILINASYYLHFYEKQILFLNEIC
LKTIGVAVRNADISCFLPLLVHGQFLQNIPSMLGSIPFQRILSERKNKFDNAIVVSAGPS
LTKQLPLLKAYQDKAVVFCADGALSMLEKEGVVPDYVTNLDCRDLAMKFFQNKGKLKQSI
IALECATHPNVVRSLKAENCMIVLRNKALYQRFNLNDFGYIDTGTHVSHFSYTLALALGF
KNIIMIGQDLAFDEKGNSHSKGFSYGEQFSGEKTVPTLKTQAYGGKGEVLTHITWNDYRV
KLEYLFACNDQKAKFYNATE
>fig|195.2047.peg.1845 host-nuclease inhibitor protein Gam, putative
TYKEELNKDAIAELEDSTLVKLGLKRVVKDNFRIEPKIESLEIEK
>fig|195.2047.peg.1715 Phage protein Mup29, H
MKKETKSKREVILKNNSLIDTLINSHFLNITMIKENDQRMIFKDLSFTQAMQSRKGVILA
KELQIICENEKIKENFEHLFHPDLIGQILETYLYGLNVFEVNYKLKDGFYYPILKQRDFR
NFGFNEEDELIYNGNGCEEIVEDKKAIYGLFGSNFLFKNGDALLAKLYFPVKLKNASLKF
WIEFLERFGSPWAVAKTDSDPDALASEIHQMLNGDSAVIDKEEELDLIQPKTKANYNEII
DYLDNQIRSVVLGANLSSQVSSGSLAAAQSHNDIRKDLAAQDGQIVLFILNRALKFFKEI
NNFKDELYVQFFNESDPKSELCERDLKLFNMGFIFDEEYIKSTYNVEGKLIGEILEKKDF
KDLENEKKVFENKTKLENFEEDFIDKGLKQKEYLKVDENMSKFFKEQFESIVKDCKDFDE
ALNKLKENFSSLKQSEFEKHLFIALNNSSVLGYLED
>fig|195.2047.peg.1789 Phage tail sheath monomer GpFI
LESVASSMNITAIVDLYATNVGEAINTMEAFSSKRLIATWPQVQILNTQGKYAYVPQSPI
IAGLIAHTDGDKEYGFSDSYSNRVMNGVTGTEYFIEFINGFDCDAERLRNAHISTCILGE
GYRSWGGETSHEDTIWQDLARVRTFDRIALAGQKAAFKAIDKKASELYFIKISIEELLRD
LKGAKVLIGYEVSWDEERNTDANVSAGKFYLNIKMMNNPIVKQITLEFIYSDKWASDLIK
TISADS
>fig|195.2047.peg.1794 AgrC, putative
MFIYFLIWQVLFVLGWNLRFILKLIMGEDVFIENFILDKIISVAYIIVRGILKRTCNYP
>fig|195.2047.peg.1824 hypothetical protein
MKFNPPSKEDLIKAIDEFNAKNSCSIPYFIADSFINYYK
>fig|195.2047.peg.1801 hypothetical protein
MICKFFKTQKGGGVSSVDYMLNERVNQGTARILKGDEFLTRELIKSMSQKHKTCVGVLSF
EEKNIDENTKKEIMQSFENALLTPAMQGRYNILWIEHTDKGRLELNFIIPKMDLESKKSF
NPYYHPIDNKRIDFWRDFVNLCYGFTNPKDPSKEQTLQGSKKEKELFKDYEALDKILHKQ
VANKIINSRDELIYFLEQNNIEVTRKGSDYLSIKLPESKKAKRFKGGIYNEQFRSFEKLR
DLRTEKESRAREYQQRDIKSELERTKRELDKFIQSKDEYYRETIRKFNERLQGKTRKFNR
KNGEIQLQDTANEIQNIQPSNEFFSGNAYDDDFKRSCMVSVDKTLSDQQGANNKIEQREN
LYTNAERECDSARQLLLPTTRLEKAENDDFRIRINSRNREITGQDNRISTSRDEITRDNQ
ERTNSIRERFGSYEKQTQQLRAGFQGFETENTRNGAIKRARIETIRDIIQAKYTELRERI
RNSFKKTINKARQIKRDFGYSR
>fig|195.2047.peg.1258 AgrC, putative
MIVEIIFYICIPFTPAYFISFLIVWLSLKGQKEVKKAI
>fig|195.2047.peg.1588 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLMESDFLEKIPFIDEVLIYKD
DFLEKIQSKNPVIFITTRRQGLYFKKLKFLNVQKCIVFPHLISIISKNLTTPLPFFRAKK
HMSEIVLKLVRMIN
>fig|195.2047.peg.1804 hypothetical protein
MKKIILGLALIASLSSVASAYKITVSQQPIVQPHYEGCVLVYQYGRDYSKCNNQGIYTDN
IDYKLCKLRGQCK
>fig|195.2047.peg.1864 Phage baseplate assembly protein GpW
MSYMVSVEESIKDILITSLGSRVMRPEYGSLLYTLIDRKIDDDFKIKLTRYTAEAISKW
>fig|195.2047.peg.1783 Phage DNA adenine methylase (EC 2.1.1.72)
MKINTDKFLKTSPLIKPTQTKLKAPFAWVGGKNYLAKEIIALMPEHKSYIEVFGGALS
>fig|195.2047.peg.1857 Flagellin
AINSVKDTTGVEASIDANGQLLLTSREGRGIKIDGNIGGGAFINANMKENYGRLSLVKND
GKDILVSGTGLTAAGFGANSFISQASISLRESKGQLDANIADAMGFGSVN
>fig|195.2047.peg.1846 hypothetical protein
CDYIYLSKHKDAKYSQGMQEELVLAKKLGIKELVLELPLQ
>fig|195.2047.peg.1832 Phage tail formation protein GpD
QKGGLNGRCELIGREIRAGGKLKIKDINMDHYEFSIKSVSHSFNDQAYIISVEFES
>fig|195.2047.peg.1861 hypothetical protein
IYKESGVFVDVLKGIYPDYIAKKIIRFHLDKKLNKSA
>fig|195.2047.peg.257 Uridine diphosphate glucose pyrophosphatase (EC 3.6.1.45)
MIFKNLKELPFCESNYIKPKRFSYESNGKFCTWDFIESKDSVSILLYHKELKSFIFVRQF
RIPLWYHQKQDKNYHKDENMGYTIELCSGLVDKDLPLEQIAKEECIEELGYAPKEFEKVG
DFYTGFGSGVSKQSFYFAIVDENDKICDGGGVDDEQIEAVFVKINEYEEFSKKIIHTPLL
DFAYMWFLKEKWGKLKII
>fig|195.2047.peg.1806 hypothetical protein
MTKTELKRVCVKPYDKDKFEVVENYEFSLPNYKGIVPKGFKTDGASIPRLFWSLFPPFKS
EYFSACVVHDFLCEKANSRSDYKIADLALKE
>fig|195.2047.peg.1795 FIG00471396: hypothetical protein
MNKIDNIANFLNKKSKKCLAINGPWGIGKTHLWKQVEEKINDKKVVYIDLFGKESYKQIL
EEIVFKIHGNYNKIMNTFSQIATKIAKIKSAGTINITPDAIFSFLKKEDFNNIIVCFDNI
ERRSDNLSLKEILGLVNLLKEEKECNVVMIFHKGELEEQDNNSAINDKEKQAKQDNSKNW
YQKYKEKTIDYEFIINDNSKAAYNIISDEAKCDKEIQNIIFECYQNSCNNNLRLLLHFME
HIIYFNKECFIKIKKEDYGNEIFFSGLKMYYDILLNHIKEYYSYDINEDKPRYSIFKKYF
DDSCYLNQDDLDALKSHFESNLKEKARIYFDKCKDKYFYGNLNDIDFAKHIEDLFPRFQN
YTYENGTYYSISYY
>fig|195.2047.peg.1872 Phage baseplate assembly protein GpJ
DPFKAILEALAYREMIIRARINESIKATYLHYAKGSDLDNVVANGYLIQRLKGVKPTAKV
EFELNTLLTYDVIIPKGAIFSNEK
>fig|195.2047.peg.1863 hypothetical protein
TWLPKLANKYKNKDKQKALASWLEEEF
>fig|195.2047.peg.1867 Phage tail formation protein GpI
ERLLPVLANAYDVSIDGLEEKEARKLISKALLLDRYNGTTWAIKEALSAVFPTAVVKEWF
NYGGKPYFFKVKVSTTNVSFDERTLNTLER
>fig|195.2047.peg.1868 Phage DNA adenine methylase (EC 2.1.1.72)
TQTKLKAPFAWVGGKNYLAKEIIALMPEHKSYIEVFGGALSVFYQKSPSKIEVINDINDE
LINLHLCIRNKPQSLTSILHSMLVSRKIF
>fig|195.2047.peg.1816 Motility accessory factor
MIFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELVLGKDNLDINLKDTSDNTFLYEN
VIDEFNSMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFH
ILDFSNE
>fig|195.2047.peg.256 Putative MCP-type signal transduction protein
MFGSKINHTELQDIKNENQNLTQQLEKIKAENLELKDKISLLEQEALESKLKTDLLNVLL
GGVLKNITIVQSDMLENVNKAEIISNYSKTSLAEMDELNHIANSINASLGDITESANKTR
DVAGTLHRSVDEITNVINLIKDVSDQTNLLALNAAIEAARAGEHGRGFAVVADEVRKLAE
KTQKATTEVEMNINLLKQNANEMYTQSEQVEKISIDSNAHIMSFSEKFTHLVNEAHSTNS
NAVGIASEAFVSLAKLDHIAFKLNGYKEIFSKSGKQLADHTSCRLGKWLASTGKERFGQN
KSFLKINEPHEKVHENMNNAITIANTEDISKDITQHSIINKCEVAENASLDLFNVFKEML
DESDH
>fig|195.2047.peg.106 hypothetical protein
MGFEVDFIKITDEKEIDGKFIKNLEHGCGIPMKLLIKKHLLQILKEPLQDKICKKEVSYK
CDELVYTFKEENHQIILNITN
>fig|195.2048.peg.1839 Flagellin
EEINRNADKTGIRATFDVKSVGAYAIKAGNTSQDFAINGVVIGQINYNDGDNNGQLISAI
NAVKDTTGIEASKDENGKLVLTSRDGRGIKITGSIGVGAGILHTENYGRLSLVKNDGRDI
NISGTG
>fig|195.2048.peg.1556 Capsular polysaccharide export system protein KpsC
MHNINRNRFFMLGFAFWKRYFIKPFFRVENSEFIFLNSIEHLNRFKLKKSDKFFVWGQKI
DYNMLKASLIKKAQDKKLQNFIPLIFLVEDGFLRSVFLGSDLTRPFSLIVDSKGLYVDPN
HPSDLEELLQNHGFDDNLRQRAKKLITTITQNKFSKYNGLKHEKLNFNTNKKIILIPAQV
EDDASMILGGAGFDTLKLLQSVRATNKDAFIVFKPHPDVLSGNRKGLKDKDIILEYCDEI
IENVSIDSAINACDEVHTITSTSGFDALLRAKKVVVYGKPFYAGWGLTQDLHRISRRTRV
LSLEELVAGVLILYPRYIHPKSKNLCEVELALDIMLALQKDYFSKRWLKILIDFRIFMLR
KIRRICEFFIKR
>fig|195.2048.peg.1305 hypothetical protein
MSIFSINDNSNYNSILSQSKANKESKENSKISFANAFLKQNASKLSDIESKNSQTLARSE
VLSNNNALNNSSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQADIST
STNTAYGYSVDKDGYMGSDFNKAAGLPEDFKIHKSTLDEIKKAAENEPYIADMKQYFGVS
EYYTNIDMAETIKQYYNLFSNALGPSFPNDKTSFSEADINSMPKGYAINGIKSMDFNDPS
NRMNITHLRDFSNSLISNVYKTPEQAKEADEIWLDSGCMIKGLSSETLGLSLEEIKNVSK
GEDWQFNPDMSVYPQNEDGSYSKETLFMSFLKSQGGQPVESPKTTLNPTIEAYNRAMAKE
SFSTTSVDIGDIMTGKVDFASLFKYLASKNGKLEGQLYMYENNIPKESAMGNWALDAEIK
QAIANGWKAKPSTINSYADSIMDRLNNLIGQTRV
>fig|195.2048.peg.1657 hypothetical protein
MLECILFIILECIQFIKEFAKDLYNSEFLRILVGCIAFYFTFSQLRYAKRNMLLNIAKNE
IEIFNKLDERQKLFIECQIKFSNIKNNDNDEEMKILLNEEERLKKYYFDLLDTVCFYAIN
NNITAKNFYSQYKNILLAVNELYRDTIKEYENICKVIKIIKEKSSFKY
>fig|195.2048.peg.404 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGVLVGEGATINANKFGVSTIPMGIDAINTFSVDDSFSPVFNANKGDV
VNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTHLKAEIGSEGFFK
YEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEMINSWKGFAKLVN
EGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSNIQIDVADKTYVG
LFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIALDTIEGFNGENSSS
GGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNGGG
FVGYTTGNTTFDGIGLKDIRFIKSGAFTGGFAGMTQGNVIFENIVLNDLEEISGSHAGGF
VGMTQGNVIFENIVLNDLEEISGSHAGGFVGGVLNNENGIASLSNIVLNNIESIKGIGFI
GGFAGWINDGTFNNIILNNIEKISVSATHKYIFTGGFTGYAGAGTYKNIILNNIGEISAN
GTASLDEKSIYAGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIANSN
IYFYGLLNSSSNKNYITHNENILNLSNTTDFQTFINQSKIAGLEYLTNTSTSNSHLHMIN
GGKIGNEKFKITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDFEDE
ILKTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFYTEF
NKGGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTILKPELESIKNNLNRLE
FLKAEIKRLERVYQEAMQNDLLPYDQLEVVYKNTQEKNRCLLC
>fig|195.2048.peg.70 unknown protein encoded by bacteriophage BP-933W
MTEEKLLKSLADGVLKINESSIDVAVLENGVRIITHSGVFRALGREPRGNARLDQIPAFM
DAKNLQPLISSELKTQISRISYLDKNSKVKEGYNADILPLVADLYLKAREEGILTQAQIE
TAKKAEILIRSLARLGITALVDEATGYQYERERDELQKILKAYISEELLKWEKRFPDDFY
KELFRLNGWDFTTKGIQKRPAIIGKWTNTLIYEQLPKGVLEELKEITPKNARYHQSLSKD
IGQPNLTAQIYKVIGIMQTSDNMKQMWENFKKIKLREQDEDIEFDEKGRLKEK
>fig|195.2048.peg.355 Putative C4-dicarboxylate transport protein
METLSQTFVERKPPLYKRMFKSLGFWVIVGIVAGIVLGYVNKEMAIASKPGVDYFISALK
VLIGPIIFVTLVLGIISLESLKKVGSIGAKAVIYFEVVSTLALAIGIFMANVMQPGHGMN
LDPSQLDTKSVQKYISQTTEVSASSEIMHILQDAMPRDIITPFTEGKTMQVLVIAIITAL
IISLMRIEDRQAIQRVSCCFFGYGGTYSPIRFRLFN
>fig|195.2048.peg.261 hypothetical protein
MINGINSYSNYNYTNTFSNTTSNTKSSNAINEASNLVSDKSQAVDKILGYGVDKEGFFTS
DFNEAAGLPKDYKIYADGLNNFVNNFIKRQPFYSQIDIAKTIGDAYNSFSSFVKDKGLGE
SFQEQDLKNLSQKDGVNYWQELQSDNAFIWKLADKNIADLGSNKYQIHDNKISKGGALIA
FFINNLSTIKGQTTLLGKLAGLNSDTDNNEIKEFLSFMNKNPLKYSYEQDGWGNPMGDSL
SIWNYINRAKNLGDDKLIKTIENLGDEYNKLINSNMSLEEFKTKYLDFKQRHDEFVKSLE
ETEKAKGVDYSNPLKNTNNKETSEEDKEKPFKPIQAESKNKETYKDDNVRNELVKKLLEG
KFSTSDELEILFGMKFSDDDTGEFNKILSLNSTPKSIDIKA
>fig|195.2048.peg.622 hypothetical protein
MRKLQVLITLFLALFLGACGTHILNENYSSKSLVIYEEDEWKVFFDNGYFGFKDQNDSVV
IEPKFDLALDFKNGIARIVQDGKYGLIDKNGKFIIEPQFDDINYFSDSVFMIKKNEKLCL
ITLNKKTILDRKFDFVFRFIDSFARVILKDKWVFINKNDKIPIKDKYDSVTSFKEGFAAI
KLNEKWGYIDKKGKMHVKPEFDFVSDFINGFSEVKLNDKWGLIDTKGEFFLKPEFDNVKQ
LGNAILTKKDGKYGIASFNGKFLEPQFDYIQKSYNQKIFLVEKDSKIGLVSKEAQIIVEP
KFDKASYQQNGILQVAIGKKLGLFDIKSKQFILEPKLDDIYNFSDNLLQVSLQGKQGVFD
IKNRRFIIEPKLDTIYYTLVMILEESV
>fig|195.2048.peg.1833 Beta-1,3-glucosyltransferase
MSFKKLQELTRDFKPLLKDTIEWKKSELQNFIPESYSFFKYTIISAVYNVEKYLEDYFKS
IINQRLDFQNNIFLILVDDGSK
>fig|195.2048.peg.134 Cytosol nonspecific dipeptidase (EC 3.4.13.18)
MQNVIENFKNLCKIPHCSYQTEQMKEFLSSYAKDKGFKVSIDKAGNIHAIKGNPKICLQS
HYDMVCMGEAPKVEVYEENGFLRAKNSSLGADNGIGIAIMMSAMAEFENLECLFTNDEEV
GLMGVNSLEHTLSSKMLLNLDHESDDEIMIGCAGGVDIEAELSFSTLKARGKIYELQAQN
FKGGAFRDQYRAQ
>fig|195.2048.peg.1826 CDP-glucose 4,6-dehydratase (EC 4.2.1.45)
MLFDIYKNKKVFISGHTGFKGSWLSLWLNYIGAKVYGYSLQPNTTPNHFEIINLQDKLAQ
NYFADINDLKKLEEAMIESDPEIIFHLAAQPLVRYSYKNPLETFQTNAMGTFNILNCARK
LKNLKAIVIITTDKVYENKEWLWGYREDESLGGYDPYSASKACAEIITNSMRQSFFNIDV
FGKSHGVLVASARAGNVIGGGDWSQDRLIPDIIKAASENSLAIIRNPKSTRPWQHVLEPL
RGYLMLGERLLLEQKEFATSFNFGPNNEGDLSVEDVLKLASLFWDKISYQVQVDLNTSHE
ANLLMLDISKARKMLNWTPILNSSLSVEWTIKWYREFYENKITLTSKQLENYMEKL
>fig|195.2048.peg.1474 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MYKTKEIKKFIERIKDISNAEQRYMYDYQSYDCEVADLFKAQLEQNIDLCLNFYRNQENN
KYFEIAHPIHNEIKTRVVASVGEWQSVTFLIDENNKYPWLFISDRCAIDYIITLDKIYTF
PFAGLASILNLENWIYEAIKDQELFFCDITWGFRFCDRWPWHDFYECKANFLALDTNKNI
KDKDNSFFIPRRYMKKKSTHEVYLRAKGLPVYIYHHKETPWHFIHMGKQMLQEVIEHQDR
LVDNDECNLIIWLSLTSTNWGKRWIEQVEGSASIIIELLKYFPKIKVYFDGLCSYETNKN
IPVDAKSSEIEISLKQKLNIFIDSNKILFHSLDGLNFKEKISFCISSDVAIAEPGSAAII
PSLICQKPCIFYGNFTYLEQVSVANPVAISRCILKEFLLEDHSMPPLNNWSGNYPYHIAW
QHLFNLIVEVLKEIKDVKMYKLEVPPVELVAKQYKLEQELGIKLLIENVALYDKLEQRID
NLISHNDNNLTKILDYNTDNILNFNLQIKNQIILNLENKIKEMEFKLKFGSAKQRIQNHL
SYKLGSALIENSKSILGYIRMPFVLSYIRDKH
>fig|195.2048.peg.1825 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13)
MSRFNFIKTHIEGVFIIEAKPIYDERGYFERYFCAKDFEEINLFKPIMQINHSKTIGKGS
IRGIHYQTFPFCENKIPRCLKGAIFDVAVDLRENSPTFLQYVGVELNEENNRSLFIPEGC
AHAFQNLTQEAEIVYQVTAPFNPEADSGFNPLDPKINIKWPLDIGVMSEKDKNAPFINED
FKGIKIK
>fig|195.2048.peg.1081 hypothetical protein
MKGFSIKKIFALLALTSLLTSSVFAEDFLAKLTKGALSDTSPGVKELSLEEMKEVRGGAF
QSVGNCLSGTNSCLSLAVSQTITGTHYRDFKAILTNEEPHSTNYHIGFVAQKNWSISSLG
KPYSFLTYSAIIFDRASGTMYKQSSQVLNNNGIVRELSYRYKNQFDRQLGGLSR
>fig|195.2048.peg.1745 4-carboxymuconolactone decarboxylase (EC 4.1.1.44)
MDNQVKAHISGNLNMGQSREDLLNIIAALIPYIGYPRALNAIAVLDGLTLKA
>fig|195.2048.peg.1104 Translation elongation factor LepA
MLQIKKIWEKGKLSKTYIVCDYPTNWEKPLITLKIQDLRKLLSKESEVNQNIKKEIRNFL
FSQESLSFKEQEIDISTKETDIVSIYNKLKEKMPKFLLFKTDRTNTDKDNEITQITNITS
KELSSLFSYEFKSDNGVSFNKRGSGVKRLFY
>fig|195.2048.peg.1415 Putative periplasmic protein
MKKILLSFAFFASLASANTINAIAVVVDKEPITTYDIDQTMKALKIDRNKALGVLINEKM
EISQMKQLGIVVNDLELDDAINKMLAQNKTTLNAFKANLKSKNQSYEQFHANFKKDLEKR
KLYEKIASMAKTDFSDDGAKKFFEQNKDKFTFYTQINANIYLSNNPQTLENIKNTKKIIL
KPQNASLNTSNADPRLLGLLSQIPVGGFSPVLNGKNGYELYEVKSKDGAQTPEYEQVKNE
VLNAYVSEQRQNFIQDYFDKLRSKINIEYLR
>fig|195.2048.peg.107 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANKFQQEQDLRKQQMDFNQ
AMQNNQILQNEFNNALALRKFDLERQRQVQDNALNWAKYKEDKDYNQKYLDYLTGKNSNI
VTNKTNNNSGFSIDANGNLSEPQTMRDVFSKESNGGDLYHFAKTTKTQNINLNDIYGFGD
TINQKLRNTPFSNSKNLKQEFADKLKAEINLALVNITSGRMSNEDRHRLEELVKTDSFYF
FDKYAKHDIEKAVEILYRVKNDALKKEYMDIWKTERYLKDRDNIEKYYSNMHKKLENEKA
MIKDFINGGNILASQEQRVPLNKILSQQPQQQLSQDFLQQNNMITFR
>fig|195.2048.peg.1823 hypothetical protein
MKKAIITGATGFIGSALVRSLLKDGVEVLALGRKEREKVDPLRLQDHDRLTYIQIDMADI
SDLESILKEKNLNFENASFFHFAWGGKNTLSDLNVKEQYNNISYTIEAFLTAEKIGCKKF
IHVGTMEEAFVTPYLELDYHKEKHYNRHVIYALAKKSARDFLKSLSSEVDMELIFATKSH
VIGANDTRDSFLLVTLQKILNDEKIEMTSGEQTFDTIALKDCIRAFKLIGAMGKKNSEYW
IGSGEPKTLKEYVQIMAKKYPPKFPIEFGKINYSDVKLSKEIFSTKLLKEDFDFYCEQSY
EESLEDLYQWLKYKIIKEV
>fig|195.2048.peg.1606 hypothetical protein
MKKNASSKILLSLGVATLLYSSAFAQEINLTQSSDVGNYFEENGKDINLKNPDKYKGQDL
NIKMGVWDLPNDDYDSADYRLNIDIGKNNTLSFTHNNDQNPVYVTNLNATAKEVKTTDIV
LQAFAPSVINGNLTMTSSGGGAITEDEKKGSGIILYNGNGAVEGKSANGSLTINGNFTAD
KTLFATYGNFVKVNGTANLTNSNFGLMKRSYTDLEANNVVIVQAKDFNKDILEEKSNNNA
GALLLKFASDYISTDVQGKDPLEAGTIIDISDEDKYGDGKKGLVDYKLSVQNCGGNKCLV
INGGATAAAKNKLVQLQVDIDAIDKLLKSEFDSSQDEEWKQAKEALEKQKTELQTMLEEA
EKNGGKIDDEKYIDLVNKNSNLNLSANDKASILALRSITEQLGSIGADLASREGVKLALD
IKKDTDNTGKSVSNLNSASSAVNTTMNISNDVSIGSRVAMLNNPFGTYASKMNGLKFAAL
DSDMRPSYVNEYTNSVWANAFGGANIIDGDSGAMYGATVGVDKQANDDVLWGAYFTYANA
KIKDNNLEQKSDNFQLGMYSTINVAPQWELNLKAYAQVSPTKQDNVQIDGAYNSDYTSKF
LGLSANAGRVFDFSDNTLFIKPFAGVNYYFSYTPSHTENGAIAKDIDSMKNNSVSVEVGA
EFRKYMNENSYIFVTPKIEQFVINSGDDYTANLAVNNAFFTSVEANNKKKTYGQIIVGGN
VDFTNQLSMNLGFGAKQILAGKVDNKNETYLSGQVGLKYKF
>fig|195.2048.peg.1512 DnaJ-related protein
MAKVAKADDKIITKDLSKFISSLLDKIEMFYSKEYSGFRNTYASIFEYEKNQGRSIHELC
TGARFYEKEIDFLICLLLDLIYYDAKMSANENALMENIIVGLGLNLIKFREVKLKYEQIY
NFTHEKAQQEQPKEDKFTITLEQAYEILNSHPKDDFETIKKNYRKLAKEYHYDNLHSKEL
PPELLKIAQEMMKKINLAYEIIKETRGA
>fig|195.2048.peg.400 Putative periplasmic protein
MLAQKGSKVDIHTASFYRDMVGEFILDERITHLVGGLAYNGKVEKNKLNLNGVEFNIHAP
SGLYSSFAPVHIAGAFVDGNGKKAYDATKNTLVIDNFLLNLRADGKTPIFYNAIF
>fig|195.2048.peg.163 hypothetical protein
MLFKELDFATDAQTIAQGLNELNAKAYLDSAKISLDFQEELNKEALSEYANEWQSFVTPF
GTYQSSRANGDFDAYKGYGGGVKAKAIKGFDSFNLGFNLVLNTNNIDIDDTLANTKTTGA
YAGIFSKYDLEDFYLLGSFRMGYEHTKLNRNVNIGAFSANYNSKFNSYLISEMVGIGKSF
NHYGVSYGPLAYIEHSFLHHFAINEENQNSTALNIDSKNFHALNSFMGFNVNYEKGMSDK
AIVNFYFLGGWNHYFLDSLKNNASFKDASLNKFYTKSKLSNQDSLYLQGEIDFTHNQSFF
TRLMLSSDIKDNIDFSTKLEVGAKF
>fig|195.2048.peg.624 hypothetical protein
MGIIDKKGEIVLEPKFDDIDTNDYPFKFKQDTRYGFLDEKAKILFDIKLKAKEWDIYFSY
NDVKVFMDKYYLVIEHGRYRIFNMKDNRLASSLSFDFVQEYKKFIIASINDKIGIMDKDL
NWLILPKFEEFKEFDKNHYKIILDGKIGLLDNNLHTILEPKYDYIGKEFINGFVKIGLNN
KYGFISESGEIIEPQFDYVWNFSNDIAEVLVDKETKFINTKGEFIE
>fig|195.2048.peg.1475 Beta-1,3-glucosyltransferase
MLKLSDKNKKFIKVILSGFFRIYLAKFFSNFKPKKNKAFDRYTIISAVYNVEKYLEDYFK
SIINQRLDFQNNIFLILVDDGSKDASAQIIKEYQKKYPKNIAYLYKENGGQASARNLGLK
YMRENNYQSRWVTFVDPDDFLDRNYFYEVDKFLEKNKNEDICMVKTYTMADACGDILSKK
NKMSIDLFFDLNIRLNIESLFFAFDTIIDNNISFDENLYSRICEICYVEFFCSRIISSSL
IYFVEVKESTKTGIKSEYKGVIKYRDFYKNLDLGLKFYIDKWQIRYAIVPKFLQLEILYS
ASILIFLLDYKRNARFCPKKIDFLYQIFALISDHNMITDFIFPRQYYNNAILKLFKQDYP
YYQTVYIKQHVDNILEITYYAIEQDDVEVVYRDNKEIFPLKEEIYEIAFLEGKIYEKKIF
ISAFYDSVKIKINNRECIICKDNIPEIKFKKNIYLYENKNKLDFNYVEQKAYSAMKATIL
DLATERYSLLYQNIKSESVILHYAKCLRNIRMPQKGLDIIDSFVDKTGELIIEKIECLIS
LKFYNQALKEIENALNIDDIDRIKILCLRVRILSILNECDKVTNFLNTFNIQKNKLSNND
HISNTKDDLNYHVVFNADQNYIKYIAVIITNIIYKLDKSQTDIAEEKFYFHILTDFIDKT
LLEKLKLLQKELSLIFPCEIFVHKVDPKDFEKCPKWQNHTNHLCYFKIKLADYLPQDIHK
CLFMDADMLVRCDLREIFDIDLENKIAAVTPDCSNSHTDRNIKSINPNKTDFILKNSYFN
VGFMLINLKEWRKNNIKIRSLNFLKSYIPRVPEQDTLNFVIGNNTVKLSPKWNFFIAHFL
DERCGWNSNFKDERMDYIYDYTRENYEKALTDIKVIHFTYGMPKPWESIYKDLSVKFEPK
FYPFYNDWWDIALKTPIFGIELRQNMLNMRQQLELYSIKLSKKLNILENRILYLESMFNL
DRSSAHSILKNDSAYKLSHSFIVGFKNSKKILKPIIQFFKDKKNDKNLYNNIEIYEDYEQ
SQIKIKKHLSSKVAQCIKEHPFTFLFRIKSIVLEFRKERQ
>fig|195.2048.peg.625 hypothetical protein
MSEIDKLKETCDLEEVQACEKLTQIYQKDCDNNNSQSCFELGKLYENPAIRDLNKAKAYF
VKADSLGLEKAKTYISFIDYGFAPATFLHKFGYETHKTFKGGGFIDHTGKWAIEPQFSDI
YPFENGFARVVDRDYNIGLINQEGEVIVKPKFDGMGSFVEGLALVLKLKNDKEKYGFINK
SGKVVIDLEFADAYNFSEGLAAVRKDKKWGFINKKGKWAIEAKFDDVFSFSDKTTAFKLS
DKWGIIDKQGKIIIEPQLEREDVANKLIYKFKVNDKFGIMDENGKVIVEPTMDIIIVNKY
SYCATFCLKDKCGFVNTSDNIFIEPKFDNLFFWDDIASFKLGDKWGLMDNKGNIIAQAKF
DHLNSFSEGLAAIRIGDKWGYINKKGEVIEAQFNKVEEFKGGLAAVKKGEKWDFINKKGD
WVIKPQFFKSKLDFGRIRFINAFARVRLDKNNYLENTWINKKGEVIKGYEPVESEFELTK
VKMLDGSGFGVVDTNGNFVLKPL
>fig|195.2048.peg.306 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MPKISILCPSFNHKKYVGFFIESVLAQSFQDFELIIVDDYSSDESIKEVEKFTDDRIKLI
KHSYNKGINAALNTAFKNSSGDYIVFMASDDIFEFDALEILYKTLSTSDAIVAYPRTLWI
DEDNNIIKTTHKEVFQDRIELLHYLFMKGNGLTSPGMMIKKDFCDFFPLPSSMCNQQDTQ
IHINLLLRGKPIFIERQLIKYRRELEKKSNISSNILATHTRENLEIYALMDTFLQCQDIK
LLKNIFKDEIEALKLKPFDDVLEFFLGRMALLSDNKERQIWGYSKIMNFYNNEKNIKILR
ERYNFNFKDYVDIAKCIKQDKTIEKYRKYKKLCNYSAIVLLTIFVIFLIYILILR
>fig|195.2048.peg.1784 hypothetical protein
MIGRDFLYSIHKDKKSIYLFCENKSIIDCQSIYEELYKLEATTDFTFEELQSYQAYIFLN
STLLTGSTELPNNPFYFGELDQDNLIKQDIPSYYFSPKDEGSGLGRLSIFYKNDELCLLN
YSIIENSLNIKLECLSKQSLEYKDLISNTLKEQTTTQVDKKQSIAKLHALLENQNLECIH
GGKVILKSNKGKSFKSDGIPIMLESDLLNSSIVACPHTIANVSYPCTKVVDIKGSLSQKK
VNGEYAILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEARLR
MYYKEHKYQKDNLFTNLYLNDTLY
>fig|195.2048.peg.1828 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
SAKQRIQNHLSYKLGSALIENSKSILGYIRMPFVLSYIRDKHKKDQLAYEAKMKKNPNLT
LPPLTSYLDYKEALKEKECFTYKLGEAFIKAYKAWYKGGLIMFLFKIQKIKLKGDRI
>fig|195.2048.peg.1752 hypothetical protein
MENTIIENSNALLENFAKWLSKYYGEHYLNDTLKIGVGIHHGRLHRCLSQLQVRLFEGKD
LLKTIVSTSSLIEGVNIPAKNLILWDKKNGAKNINHFTYKNIIGRSGRMFKYFIGEVYLF
ESPNEDDNQEKILDVEIKSESLSINDEINNEIPDNIQVEVENNQLEIIKLIGRDKFNLLK
KETLLKNDLGVIIKIIQILQSKDFNSEIFTYLFNDEPDKWYILSRIASIREFHCKNIGDI
NTVELVKKLSQNWTKSLPELIKDMRIDLDDFFKFENHVAFKIASLFSDINTLQKILYPEK
EIDISSFVTKLSNVFLPSVVYTLEEFGLPRIISKKLHECGFINFENKELTLEQALDKFKE
YTADDIINILKEKNLYDDFEDYILNYFYEGLGQ
>fig|195.2048.peg.626 hypothetical protein
MRPNGFIKMTTEHETCGLVNTERKLFIEPIFDDISVDDFLDDKKLIRFIANGSYGFMDQK
GNIIIKEKFTKAGPFSNF
>fig|195.2048.peg.92 hypothetical protein
MNLNKIIIYIKNPFTLSYIIGIFVLILNVKINNLIITIMGYLLLFIPAFIDLYKITKRIN
IAKIYNLLVSFELYYIAEFFSRDIIYNIVGYTPDSYNYVINIFNIIIIIPVIIICIMLIL
SLLLATSFLLVILKEMFKTLFFLNLDFLVQKIFNFIIKTTHFKNKVHICFFIFFGVTVIL
QCLSFSTLGYFYVFNFTPNIIHMTSYYQNNTICSKVSPNAYIHLLGDNRVSISPFNEKFA
FHLDKNTLYKFMTKDCN
>fig|195.2048.peg.1133 hypothetical protein
MQIVYITKLRNTITDIDEFKKQWLEMKAKSDEMGEIYKAEIAKQNREIALAQKNSNKEKD
KPFEPIQAESKSETYKDDNKMNELLKKLLETKFGTSDELELLFGMKFSDDDIGEFNKFLS
QNTSAKIIDIKA
>fig|195.2048.peg.135 Cytosol nonspecific dipeptidase (EC 3.4.13.18)
MRNEKSSIKEMAQFIKENKGKIISFEGGERINSIPKHAKALVHFENEVKGNGWIKCEFKE
EGEFEICDQNEKLLNTINAFAHGVRAYDEHLSIVQTSINLATLKMENQQIKFTLFARSNI
LDGLKQIEFETMEFFKAFGYKVRSFNFYPPWEGKANALSDKVLKALKKVSPKARVSAIHA
GLECGIIEKKQELLCASIGPNIHNPHSTDEHCEITSVEKISRVVFEVLKDNA
>fig|195.2048.peg.126 hypothetical protein
MSNTNVDYNKRLEVFKEIYPQILEMSLAEKSPFGEFKKLLEQFGNDNIIRNDTQFQSLAQ
ALVSVGQTIVAQSQNTALQMILGGDENIVNQANINLTNAQTETEKANANLVKRQTAQIDD
ELELKEQSVNIDKSLSIEKEKLLQAQTETEKAKPALIARQTAQINDNLRIEAAKVTQSVQ
FGYCTGGLDIPQEIMKLVKEKIENIEKSS
>fig|195.2048.peg.1824 hypothetical protein
MKNAIVFGATGYVGLALVKKLLSENINVLAIGRKDDRYFFEKLNFNSDKVRYLQINQSLE
IFLNDLLRYENFKQDCVLYHLAWSGVDRLTNGGIRDQIRNLYISSEVLSFANEFGCKKFI
NASSQEEAIFKNYLKSNKWKNEKYTSSPLYYAGSKFANVELVKLLSYLKKIDYVNTRFSI
VLDESLDGVSFVASTFKKLQNYEEIPEVKNTQPCEIVLLDELVDAYYKIGLYGKHGIDYY
LGQGCPNTLMNYFLNFKSIINSEDNLRQDSFSEDILDIFNPKSLELDTGFVFNKTYKSLA
KEAK
>fig|195.2048.peg.140 putative membrane protein
MLIMRYEKKLELLNQSIQNIKEEVNELKNTTQNNRSLIEKNRSDIESINK
>fig|195.2048.peg.356 Putative C4-dicarboxylate transport protein
MLVSCLIFIFGILGLICYFAKVNIFKFMRFISREVLIVFATSSSESALAPLMRKLEKAGL
SKATVGLVLPTGYSFNLDCTNIYLAMSLIFLAQAFNVNLSLAHEISILIVLMIASKGAVG
VTGSGFIVLGSTLAALGNMEISEANATLAQVLPVAAIGVLLGVDKFMSEMRAVGNLCGNS
VAALIVAIWDKQIDWEKFRYALDNPEKFHNASMH
>fig|195.2048.peg.1555 hypothetical protein
NQIIIKTVDYFEKIVEIIDFN
>fig|195.2048.peg.623 hypothetical protein
MRETDEDMSTSKEQIFFAVKKEDKFGVIDNHRKWIVQPQNYLIKYFDKDMGFIISDGLYY
GVMNMQGKLIVKP
>fig|195.2048.peg.1656 FIG00471323: hypothetical protein
MCKIIKYLDYTKLNTLEKLYFDLTIMLIVTFLSFLFLVFEFFIYENIAVFFQDCFLMSVI
FIIGITGLFHTCKGLRKYKEILKNKEFYYEQPKIRL
>fig|195.2048.peg.95 hypothetical protein
MKMIELKVKMPDEYFELLQSVANDGGFNSINELITDRIAHFLKFEKYYRELGKKDILSLD
KTLDFS
>fig|195.2048.peg.620 Ferrochelatase, protoheme ferro-lyase (EC 4.99.1.1)
MKLVLFLNMGGATNLQDCETFLKNMFNDPYILGIKNKFIRRFVAWIITKSRVKAMRENYK
QMGGKSPLNELTQSLCEKLNAKTKDFKFDFVNLYVPPFANEVLQKYTLSENDEIILFPLY
PHHSSTTVTSSLEVLQNEILKQKIKAKIKIVDIFYEDELYNETIVSHILAKKSEFDAKTL
IFSAHSLPQSIIDKGDLYEKHVNHHVELLKERLKDHFDEIILAYQSKLGPVKWLEPNTSD
ILANLDNKALIYPISFCIDCSETIFELGMEYKHLAKCDYDLITCPNDSDEFIHFILKYLS
NFKGDSNA
>fig|195.2048.peg.1362 hypothetical protein
MQALKNEIKQKAIFMSLINIKETIKNIQDSADAEVMVIFCEEDMKRLSKSRNIAAHNSQA
MDLNIVTNLIRYDLARLKQSIVNFKNNPNNLHFIPKEKNVKKKNTKTTRSINYFFICMHF
ILYYIYYLFLLNKPSKSIRQENFSYNTFIQIIFIH
>fig|195.2048.peg.590 2-oxoglutarate/2-oxoacid ferredoxin oxidoreductase, delta subunit, ferredoxin-like 4Fe-4S binding protein (EC 1.2.7.-)
MSIAAPKDTPVWVDEHRCKACNICVSYCPAGVLAMRDDVHAVLGQMIEVVHPESCIGCTE
CETHCPDFAIMVAKRDEFKFAKLTPEAKDRAVAVKNNKYKKLAQERQ
>fig|195.2048.peg.1821 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MRKKSVVLLGGSTFFMKNGIQKGMQDYIDQHNQSKNKTYDLELYNFSLSASCAIHSLFAL
KNNYGIIQNSELIVINTNISICGMYYQNFSLDILMRNYEALCKELAILNIKILVITNPIK
GNNKDFDNKINIVNKLIYKKTKEYGFNHIDMQRYYEENYINEFFKTSDPFHQLGTIMQVL
GKNILKNIDHFKQNTIRNISASEYLIKSPLEIFDLKEDLEYKCFQNSAFKKDIYKLNGGV
KLKFKNEYQGYTILGIGVCNCFEQSHCSFMNFILENQKNRIVKKVGGEFYLLHAIEGKFC
IDKQSFMYIDLNNEKPTESSVLIDNNLENTNNILHCGLNIFFLAKLDSDLIEAIDLKVLA
DENIEIAEKYNFSHLIPPVKFYKELIEEYCMRMDPIKYASLPKYAISAKQRIQNHLSYKL
GSALIENSKSILGYIRMPFVLSYIRDKH
>fig|195.2048.peg.621 hypothetical protein
MLELYINFWKQATDFKTRTNRSDYWTVMLIHTLVSLCVVLVFFWTPSVVRIFIIVSCVPM
LAIGARRLYDIGFSG
>fig|195.2048.peg.1233 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRDHFGSHCGMEVVLANGEILRTGMGALPKAKTFADLWKTDECGVKRLSYK
>fig|195.2048.peg.1753 hypothetical protein
MPTNKQIGEKIFDKCTEIYEILNNDKEAEAKEKLFYLLDEIQDKALYPPILNHLIRQFGL
YPYMNQDTSILEDKFLLECFKTDIGEDEPKVLHREQSRVLKRLLSNESLILSAPTSFGKS
FIIDALIAMKKPKNILIIVPTISLLDEARRRLVRKFYNYNITTTTQQTNLENNNIFIFSP
ERAVEYFSFINKENIRLDFFIVDEFYKISKDYENERFAPLQNAILKYTSISDQRYYICPN
IDKIKNENSILCKGMKFECLDFNTVFIHINKCYKNKDFEKEEKILEIVKKDEKTLVYTQS
QSNIKKSL
>fig|195.2048.peg.1143 Cell division coordinator CpoB
MKKIFSVALIGATLLYAESSAFGAGDITSDSSYGLTSNEKLFKEKLDNLNNENIQTNARI
NEINERIEGLQSTLEGINSQYAKSNSRLSQVEENNQNIENNFTSEIQKLKAYVEESRKIQ
EANNKQVKKVLAELSSLVDAINANYVSKNELNDANLSVKTITPSVVVSTTDSNSTIENNN
TQNTQDDKAKQIDESWKKKKNNEILELAIKDVDKNAFEDSKAKLNFLITKQYKPARANFW
LGEIEYKQKNYNNAIVYYKKSSSLSTKGDYFPKLLYHTAISLDKTGDTKTANGFYKALKT
NYPNSPEAKASPNRK
>fig|195.2048.peg.1841 Methyl-accepting chemotaxis signal transduction protein
AKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKI
FEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFAN
>fig|195.2048.peg.1476 Predicted glycosyltransferase involved in capsule biosynthesis
MCSLKYKYSVIIPVDLALRPFDILRKVKNILQRSSEEVEIVFGHNDRGSIFDKYLKKITK
KNNVKLISGKFYTRLICQSLLRNRAVEQCSSEFIYLMDVDCLFDEELSDGCINDIKNNKT
PFIILFCLYLSRKGSREIFKHTREEMFDKYIAFRKDLFISLASPSACIFMKKEDYFTVGG
FDEDFIGRGGEDFEFMIKLALYKNVIKPTKDLMLNKFYKAPLLSEGFRKYLAFNGLPYFF
EKKVVFHIYHSRNRLHGYFKQYHKNLNLLQGKINFDSKLEEGEESLIQFYEQLCKKYDVS
IDKYAVLFDGYKPKFFSLERFLLFLRRL
>fig|195.2048.peg.1134 hypothetical protein
MIGINSTFNNSFVNLNIKNNNNSSLNSNTSNANVKNLQDTQDTTKTSNKVLGYEVDKDGF
FTSEFNKAAGIPKDYKIYAKGAENFVNYITNLNFKSFTNIDIAKSLGNAYKVFSQLIDEP
SGNFTTEDLSKIPLGFSYNKKSFQVTNIYYSEKDFESALSFEDDLKIYQNPKQLTLSFPS
WKEKAPADYIKKNSDIFDPSSHINIGASFYKNDNGTISKGGVLMAFFAGMSGQNPLIEGE
TTIEGKLLGYDKNMSQSQVEDLNEFINQNPIEWSITGDVFADSVYNQT
>fig|195.2048.peg.1103 Translation elongation factor LepA
MLTTHTPEIARMVNKENIIFIQKDNKDKRIVYHGDEIDIEILVDALSIIVPNSKALSKGR
ELVKAMKEIVPRQLFEVAIQASIGNKIIARENVKSMGKNVTAKCYGGDITRKRKLLEKQK
EGKKRMKAIGKVHLPQEAFLSVLKID
>fig|195.2048.peg.90 hypothetical protein
MFIRALRVLFILSFIADLTIIGLFVGIPLFLILWGIQYIIYGEKNPFFVFAKHNPKPYQE
EDIIDVEVEDEKPKNP
>fig|195.2048.peg.1160 hypothetical protein
MIITNLILKLTQSSQNGVHLYKNFVRLNAEIAEFFKGI
>fig|195.2048.peg.1832 Beta-1,3-glucosyltransferase
MRENNYQSRWVTFVDPDDFLDRNYFYEVDKFLEKNKNEDICMIGCNIIFYFEKNKSFRDE
HSLKFKFQQGEKLITNKNLDNFIQLACNSALIKSSKICTLFDENLKPNFEDAKFINEYLL
ENLESKSAFLKNAMYFYRKRQDKSSTLDTKLQNKSYYLVVPKIGYLDLLQNIKGEIPYFI
QNLILYDICWYIKELVETNKNLLILNQKEKDEFRNLLFKILKFIDVDIIRKFNNRTFDFY
IIQGILGYFKNEDLCLNRVLIEDIDEKNNEILLKYYFKKIDTQENIFIDGKEISAKNSKI
KQYNFMDKVFLYEKRFWIKLEKNSKNLEIFINSKQASLQFENEKLNNLQRVQQKLSKWKK
IRNKNNNLWLFSDMKTRADDNAEHLYRYIMQNYPEQNIVFILRKDSIDYPRLKKEKFNLV
DPRSLKFKYLLYKSSKIISSHIDKYIFNAFGGDTLKNKDFVFLQHGVTKDDLSRWLNQRK
IDMFITSTKAEYDSIAGDFNYYKFSTKEVVLTGMARWDALVKNNTLNIKQILITPTWREY
LSGRIQKCGIRDRNSKFLKSLYFQKWQELLCSKELEKLAVQYRYNIVFIPHPQAKMYLED
FNLPSYIITSYKKSMQELFCKSSLMITDYSSVAFDMAVLKKPVLYYQFDKKDFFSNHSYK
KGYFNYKKDGFGVVVEDKKSLFKELENLLKNNCKVTEPYRSNMENTFIFKDGKCCERIYK
KLTNI
>fig|195.2048.peg.1822 Putative O-antigen synthesis protein, WbyH
MKILLTGATGFIGINFVLRLYKKYEIIALVRKTSNIEKIKGYCKIYYYDGSIDSIEDIFK
KEKIDGVVHLASLVPSTVNPINDISKLIEANIVFGSFLLQIVNQYKISFFINTATFGSYC
NSLEYRPATLYASIKKAFEDIMYYYTLISKSVFTNLLLFNIYGPNDEKYLFSFLQKISNT
NQELLMGDGSQIVDYSHVYDIADAFDCLIELIQKDPEFCKNKIFSLKGKERKSLKEVVAL
YEEVLGKKLNIKWGARPKRELEIMQPWEGGENLPNWKQKISLREGFVKMTNEKSENIVVL
GAGIAGISAAYHLKQQNKQVKVFEKNNDHGGLCGGFFVDSIKGKFWFDNAVHLSFAKDES
VRKAFFSSAKHHTHIPKPLNYYNGIWVKHPAQNNLYALPLDIKLKAIKDMLQNTYENIKV
ENFEQWLKAQYGEFFSEEFSMKYTRKYWTLDAKDLNTNPMFVGPRFYKPSVDEILTGAMS
EDTPVTYYAKEMYYPIKGGYKAFLEGMVKEIDIAYQKEVTAIDNEKKIIYFSDETRVKYE
KLISTLPLPLLVKILKNTPQDILKSSKHLHATSVALVSLGFDKEIPEQLWYYVYDEDKFF
ARFYSPSIKSSHNAPKNCSSIQVEIYFSDFKSLEKMSNNCSNLADFFIKHVKEKLFQMDF
CKEEDIICEDFRIIPYANIIFNHGMEEHRDKILKYIKDCGILTCGRFGEWDYLWSDQSFL
SGKNIADGLKTY
>fig|195.2048.peg.1626 Flagellin
MGFRINTNVAALNAKANSDLNSRALDQSLSRLSSGLRINSAADDASGMAIADSLRSQANT
LGQAISNGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM
EELDNIANTTSFNGKQLLSGGFTNQEFQIGSSSNQTIKASIGATQSSKIGVTRFETGSQS
FSSGTVGLTIKNYNGIEDFKFQNVVISTSVGTGLGALAEEINRNADKTGIRATFDVKSVG
AYAIKAGNTSQDFAINGVVIGKVDYSDGDENGSLISAINAVKDTTGVQASKDENGKLVLT
SADGRGIKITGSIGVGAGILHTENYGRLSLVKNDGRDINISGTG
>fig|195.2048.peg.1361 hypothetical protein
MNLSFKTFDLSSKERQKAKKVQGKNMKFFLMKIPKHIMLLKCLLGKF
>fig|195.2049.peg.1842 Flagellin
NGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLMEELDNI
ANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRITSGGEV
QFTLKNYNGIDDFKFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVETRGMAAVRA
GTTSNDFAINGVTIGKVDYTDGDGNGALVSAINSVKDTTGVEASIDANGQLLLTSREGRG
IKIDGNIGGGAFINANMKENYGRLSLVKNDGKDILVSGTGLTAAGFGANSFISQAS
>fig|195.2049.peg.920 Type I restriction-modification system, specificity subunit S
MTNLPQGWKMETLGEILSSDKYSIKRGPFGSALKKSFFVEKGIRIFEQYNPINNDPHWKR
YFISHEKFQELEAFKATEGDLLISCSGTLGKIVELPKDTEMGIINQALLKIRLNNIKILN
SYFIYYFNSPIMQEKILESTLGSAIKNIASVKILKQIEIPLPPLKEQERIVGILDESFAK
IDESIKILEQDLLNLDELMQSALQKAFNPLKDNAKENYKLPQSWEWKSLEEISENISAGG
DKPKNCTESKTAKNQIPVYANGVNNNGLVGYTDKATIIKPSLTISARGTIGFVCIRKEPY
FPIVRLISLIPCENILCLHYLYFCLNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKEQEQ
IAKHLDFVFEKTKALKELYTKELKDYEELKQSLLNKAFKGEL
>fig|195.2049.peg.1038 hypothetical protein
MQIGFYPEIKNKEELVDIISRAVWYLWPLEGFIEKFHLCTNLVFDNRLILSRFPKYLDPS
ILRYIGKISPKKVVLHKKIHNSYFENLQYIFLTSEEYREELLKIKTKLNLKFDIVRIDHN
NLSYADSFYLRFAEKIPALHSTYKKISKSRIFNLLERLKTKKIYLFGTGPNFSYSEKYDY
SDGCVIACNSMVINRDVIERLKPKIFVIADPIFHAGPSSYAGKFRQSLIDIFNLNPCPIV
VPLRDYHIYSTYLPDCMVDFLVPIFFKIPSEDDSPFYFDIFKSLEVKTTNNILTLFQLPL
ATSLGEEIYITGCDGRPIKNDSYFWSHNREVQINDKMQDIQIAHKGFFDIKYNDYYNRHI
GFLSQFINLAEKNNKKIYNLTPSYIQPLQNRIINNIIVNDRASKKEYDLSIIIPVYNAEK
FIEKCIASIENTCYLDYEIFVRGILKRTCNYP
>fig|195.2049.peg.1848 Two-component system sensor histidine kinase/response regulator hybrid
ENLSQINNLSQTIETKNKTIQENLSQINNLNQTIETKNKTIQENLSQINNLSQTIETKNK
TIQENLSQINNLN
>fig|195.2051.peg.1768 hypothetical protein
MGIVTSIRKHKNTLSKNVTILEGKKHFWDIKFKIKARVYPSFKQHLITFFGTKRIFWDIW
DFLHFKLGKIKRHFCKL
>fig|195.2051.peg.1811 FIG00471570: hypothetical protein
MSKVIADIKKGFRKTFINAICNHNNELVLEYLKN
>fig|195.2051.peg.1003 hypothetical protein
MTAYVHIGTEKTGSTSIQFFYTAIEDCYKDRI
>fig|195.2051.peg.1364 Motility accessory factor
MGGGYNENLLYQDPIKELQAMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVV
FEKDIEIIWIMFHILDFSNELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFS
>fig|195.2051.peg.1167 probable p-cresol methylhydroxylase subunit
MNKIIEVDDKRNFCIVEPGVSYFDLYKYVEKTISMFF
>fig|195.2051.peg.1265 hypothetical protein
MKPIQAESKSETYKDDNKMNELLKKLLETKFGTSDELELLFGMKFSDDDIGEFNKFLSQN
TSAKIIDIKA
>fig|195.2051.peg.1699 hypothetical protein
MKIYSKTLKIKELENKINSLVFNSTNLAMMR
>fig|195.2051.peg.1790 hypothetical protein
MKYPNVYVKLVGEDGNAFSILARVSNALKKAGVSKEEISQFQKEAMS
>fig|195.2051.peg.1115 Homolog of BLC protein
MKFSIFMNFFNKTNYEILFIDTNYEVAVVGSPDKEYLWILSRKIIDKKEIDKLLDIAKQK
GFDISDIVFDKY
>fig|195.2051.peg.1776 Phage tail length tape-measure protein GpT
AIGIRVLSVAMMSNPIGLILGGIAIVAGLIIANWDKVKSWFMSFIEWLRPVWEPIYNVIK
AVFNKCSGVIGYFKNNALNIIFPFVGILKFIWKPIYEVFKWVFDKCALVFASFKDIIMSI
ASPLAEFLNSIWQGIGDFFYSIFGSLFEWFASKLSWVGDMISSISGFIKDTLDFVGLGDD
KEVKISQNEQTKEKIFATNTYKDELQAKSINHTPSFNNGNINVSVNGTFNIATKDGNFNM
QEFANAIQKSVFDALRKQEQNKINTTIYG
>fig|195.2051.peg.1814 Phage tail sheath monomer GpFI
NTQGKYAYVPQSPIIAGLIAHTDGDKEYGFSDSYSNRVMNGVAGTEYFIEFINGFDCDAE
RLRNAHISTCILGEGYRSWGGETS
>fig|195.2051.peg.1700 Integral membrane protein
MAIQINNFIMYLNNGNYTNDFEMFLNYLADDEKTSTVVKDKDKDKIIVNDEIFIIFNESL
KNKHFNFSDIVFNKTVTFQGNYKNGLEFNFENTYFEKLNILNCNVDNIIFSGEINYIKEL
NISGCNFTGVTINSNIQGEVKFQKCNFKDFNKYNSGKNIKFTANFVFDFCKVDDIVNLIN
FDFENKISFKMSKFKDNVYFNNSHFKDYADFHECEFEKTACFYGVRFDKAPNFSACYFKE
PKAVNLTNVNIDKLDFKSLEQYIKDNYKDESCKNETKEMQDKKEIFKIQNEHQLRYAKNL
KDSFRVIKDVLITQNNKLEAQEWHKLELYAKEKELLFEVESCYKEKNKPFIATKSEDKNS
INLTFSVLLLWIYRVTSLHHTNLPRIINFASLNIVAFGGLVCLITYLSYRIDKQNILWFF
GVLILSVLVMAIVYLTLKKHKLKSIKLILFTFLAFLMALFLIQSIILLHSFSDVVFALFL
YCLLVIALICLYPYINLKSFISYCFHWLVYFFLVMVVVIKPQLINPFAGIFSSDKLYESQ
FEKSLNDLNASAIINLAKISFKEFNLNQEYKNISFTELNSAKALIVANKENLLKLNDVNS
NIAKEVLGEKYTELLKIINQDKITENTIKSTSVLYSIILLLCIFSLQKTARKNSIVPS
>fig|195.2051.peg.1263 hypothetical protein
MIGINSTFNNSFVNLNIKNNNNSSLNSNTSNANVKNLQDTQDTTKTSNKVLGYEVDKDGF
FTSEFNKAAGIPKDYKIYAKGAENFVNYITNLNFKSFTNIDIAKSLGNAYKVFSQLIDEP
SGNFTTEDLSKIPLGFSYNKKSFQVTNIYYSEKDFESALSFEDDLKIYQNPKQLTLSFPS
WKEKAPADYIKKIAIYLIQALI
>fig|195.2051.peg.83 Campylobacter invasion antigen B (CiaB)
MNNFKELAKLVKNRKENINLFYDLLDSEQWGEYFERLLTLSELKRDKTTLLAILRRLVDL
KEENLIQEWKKNNFKEEKITKLKHKFYEEIRKFYEKEHQELIYEIKERKIVNDFYQVLIQ
GVHNIGLVINAFEVSWTKEIIEKNNKILATQFPNLNDAMEFLRKNQLYQTTPKGDICERS
YGVLVRIGNMWKFVPYARFFEDEILKLEFAFDDMIDKLKQIAKNEDELAYIEYFQKLKLA
FCEKEEEKVIGAWQEAEFAWMKVKSPLQVGHPLEYYEDNYTHAVALEWDIRIEDESDFDA
LKFSKDIKQSFMRVYENIGIQDEQLKNEVLHNIDKTQLYVCAPMIYYGAELKGLFSAQVV
PNDEFVSSIAGKKIFAFLNFVYENAKTKPFMRIASEIFNKDFLDYGRDILFFKEKIWKRV
YEVSTIGHEFGHIFFIAKDSEKLMNQSGFFKNIEEYKATSGGLVNFFYHEQEDLKLPVFH
ELIKRAVSLIAWQRVEEVKPYYTEGLIHLSLLFQSGVLKFENNRLNVNFNLEYYENFKDA
TLKNYHDLAKHYALKLDAKEFLNRFCALENDIFMPLYPECKEFVQFYYDLYEKIGNEIDN
SGEFERYKMQKKILKNMFLLDIVF
>fig|195.2051.peg.288 conserved hypothetical protein
MEIIKFLQDNYDVKFFSICPTSPINNYIPLGKEQNNQEFIILKKPNTAILKKYYQARRQN
>fig|195.2051.peg.1766 phage repressor protein, putative
MQMQEVIEKLKDILASEGKRDLKTKDIAKELGINPDTFNSMKFRNSIPYPQILNFLNQRN
ISINYFFYGSSPKD
>fig|195.2051.peg.1773 Motility accessory factor
STGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNHDFG
EFDNGICFIIKSIVHPNAINYLTKKTDNFTIVSTYASFIQYLKLDYFGYFNMGFSVAHMA
CYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQNSANYESQTYEHILTEAYGGKEKIKTH
HVWLMFKRNLEQDVQKIQKYLDTKVYNCTEGGARIEGTIEKPFLWACENLLHKDLNKPFE
KLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSNKFIKSYDKIKNSFMSLQNSQENETLIK
EIIKDIDKIKTQIDELYNTQKDLMQILGPLLTQFELNLARIYVLNPKTKEDAFNKSILWI
KEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2051.peg.283 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MALISIILPTYNVEKYIARALESCINQTFKDIEIIVVDDCGNDKSIEIAKEYAIKDNRIK
IIHNEENLKLLRARYEGVKVAKAPYILFLDSDDYLELDACEECVKILDENTEMICFNAYI
INNAKIPIENYFTDTYSIEKFFPYLIKKDNFAWNAWGKLFKKDKLLKAFKELNLNNDKIT
MAEDALIFSSYIKDIKNVKTFERYLYNYNCENVNSATSQKNINQIKNHIKDLEYCIQKIS
TYSYDNAYCYLFCQYIINCLQLHKYDLYYKNIAKNFIYKFILRIYRKKLKSKKNILIKKA
KYILEGKQCTI
>fig|195.2051.peg.1780 hypothetical protein
IANMIVGVSKNYTFLNTKLLMDIKNKNTLRMAPLLYEINGYDKHTGKRKRMDLDALNDFF
GTTYKRIIDIEKNILQPVKKELDLVSKLSFTYQVNFDTLNKVGRPRALAVTIDLKDNQGN
LFAN
>fig|195.2051.peg.284 hypothetical protein
MSKYDENFYISQMEESYNSAKEMLNQILPLLPKINSVADVGCGVGTWLKTWQDKNNEIKI
LGIDGNSVDEKLFYIDKKNYKQTNLTSNYKDILKQLDLIDGSRYKPFDLVQSLEVAEHLE
EKYARNFIQLLTSLSDIVLFSAAIPHQGGTDHFNEQPPVYWADIFKEFDYVCFDILREKI
WNNEKIAFWYRQNTMLYAHKSKSYIFENLGFKPTQSPLHLVRPEYMNFLNKLQNELNNEK
SKKSILNMFKFYLRHPKRMFINKRYF
>fig|195.2051.peg.1783 hypothetical protein
MTPREFRKRQLEKLEQRKIQTHQKISNDFIDNTISKNNLVCLKVMFYLSTVLEKEDLSTF
DDENIICVFVDTKQMLEYIGSNVKDIRNNLKQMQETSISFVDEKENIVEGMNLLPLFKIE
YGKNRTEIHLFKRIANMIVGVSKNYTFLNTKLLMDIKNKNTLRMAPLLYEINGYD
>fig|195.2051.peg.1264 FIG00470444: hypothetical protein
MAFFAGMSGQNPLIEGETTIEGKLLGYDKNMSQSQVEDLNEFINQNPIEWSITGDVFADS
VYITKLRNTITDIDEFKKQWLEMKAKSDEMGEIYKAEIAKQNREIALAQKNSNKEKDKPF
ETYTSRK
>fig|195.2051.peg.1698 Integral membrane protein
MNISSNKLKNIGKKIKKNEELTNEEQDLFSYWLNLHFDIMKKMHRHVVDKLKKLGIKNYI
IAKRTKRLESISFKLKRYPNFALDRIQDIAGMRIICDNLKDVNSIKNELKKHYQKNISVF
KYSNMDDYINEPKNDGYRSYHLIFIDIKTKCKVEIQIRTKLQHSWATAVEIIDMDPYCKI
KQGTGKSVYKDFFKLSSALFSRIEGTKIVEPYQNYNIEKIYYFLKILDMRSNILEKLKNS
NINENITQDHKDKFYFVVYLDRNKRTNVASYSKDDLNKARKDYNNLEKNKDINVVLISLD
SQKKIRKAYPNYYLDGNLFIDNIKKYNNIKYFFLKRMIYYISFKICFKNKNHFDRQEIKN
ISILYQDIFNQKMDKIDTELNLNFEDLQEKIKQECINYNKNEKESHKKSLSKTANDFRVF
FKKIKNILLKDNNPLDALDFSKLELYCKEIELKEDWCDKIKNFKTNKNKNNNNNFELINF
LLLGFYRKLCDHHTDFLKVFNNLILLIALYALFIFGFTWLHDDKLEDTRAILTLFGFFDK
FRLYFDIISTIFVVFGCGFFVWKLNSYENKNNISKKQNINFIYIIGDFWNLTKSLFFASF
IPCVFYVLFLLFGFFLNLGKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFSYIGF
IIILIKQPNVIHPLIGKIANESDKFFNYPSLIVLNILYTILLVLVLFSLQKTARKNSIVP
S
>fig|195.2051.peg.1106 Uncharacterized metal ion transporter YcsG, Mn(2+)/Fe(2+) NRAMP family
MINKTALLGAAFLMATSAIGPGFLTQTATFTGSLLASFGFVILVSIILDIGAQLNIWRII
GISGKRGTEVANMVLPNLGYFVAFLIALGGFFFNIGNIAGAGLGLNIVLGISVENAAVIS
AIIAIGIFIFKKAGELMDKFIVLAGFVMIVLTCLCSLCFKTSHWRSSF
>fig|195.2051.peg.841 hypothetical protein
MTINSLNFSTNTMQYDKEIINFKQKANEKHQAKFMDLSGLPNLGYAKNGETTILGKLWGY
DKNISKKRSRGFKKIYRSRS
>fig|195.2051.peg.953 Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase (EC 5.3.1.16)
MIIPALDLIDGQVVRLVKGDYEQKKVYKYDPLEKFREYENAGATWLHLVDLSGAKDPNKR
QLALIEKLTNEVSVNLQVGGGIRTKEEIQALLDCGVKRVVIGSLAITNPTLCVEILQHFG
SEAIVLALDTVLKEDYMIAINAWQDTSDKRLLEVLEFYNIKGLKHILCTDISRDGTMQGS
NAELYALIHKNFPKIHTQASGGVASLEDLKKLKGICSGVIVGKALLDGVFSVEEGIKCLQ
NA
>fig|195.2051.peg.1529 Methyl-accepting chemotaxis signal transduction protein
MDFYRCLDTLEPYIDGNLEELLSFFSKNFFKTIIFFTLFILIIIPFIFIFYRNLITGVQG
IKTNITSFFDFINHKTKNVSTIEVKSNDEFGQISKAINENILATKQGLEQDAKAVKESVE
TVGVVESGNLTARITANPRN
>fig|195.2051.peg.1798 Phage tail length tape-measure protein GpT
MENAGSIGIGVILGLAIKNASAVGKVVKDFSNLEKIAAKTKLGISGLQKELNTLKLNANL
RAELKAQRKGLQDEL
>fig|195.2051.peg.1784 Phage tail length tape-measure protein GpT
KIAAKTKLGISGLQKELNTLKLNANLRAELKAQRKGLQDELFSLGNIISGGIVGKSIKVG
IDFESAMADVKKVTDLSEGHTLEGLKQDILDLSKKLPMTAEEIANIVAEGGKLGLASKEA
LEFGKTATAMGVAFEMSANEAGEAIGGLMANLQTDVKGIKDLGDSINYLADKGSSDAKNI
VNIVSRIGGMGNLIGLQRENMAALAATLDEVKIPAEVAGTAISSMFTKLSTADTLGAKAE
EAFSQLGLSGEFMKKALNRNSQEAINILLSRIKTLDKESQIGVITNIFGNDSGTIRAMAT
LVNGYDRYQELLKMTNSEEKKGSMDKELINKCETTASILKILGNNISALAIKFSDALLPV
VKLVASGFSFVIDIVDTLLSKFPVLSTIVATATTVFLLAKPAVLAYAIAKNYLKDCTILL
KSALIKTRIHLLAFRNSCILSNITLKAKTVTTTIYTTSLKALSFVLGGLNKVFKAVAIGI
RVLSVAMMSNPIGLILGGIAIVAGLIIANWDKVKSWFM
>fig|195.2051.peg.1799 Phage major tail tube protein GpFII
MKRMIGEVIQEGNIYIDGQGYLGVVRNLKLPDIEQEMIETKG
>fig|195.2051.peg.1114 Homolog of BLC protein
MIELIGDVNLEKYMGTWLEMARKPAFFQKSCVQSKADIN
>fig|195.2051.peg.291 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQRQNQKLFEKNPSLKNKLEFIFFKAVDAKNKEYLEFKQHFPW
WASWVLGRELSDGEKACFASHYKLWQECIKLDKPIIILEDDVEFSDEFLNNGEEYIEELS
KSEYEYVRFCYLFDKKFYPLNENYILSFEKLAGTQGYVLKPSAANKFISKAKFIYTPVDD
YMDMFYKHKVLNIVKKPLLLKHNCKLESEISNLGRTNKKLKIHRKIVREIFRLYRDISRL
LYVFYIKKKLNLK
>fig|195.2051.peg.1812 Methyl-accepting chemotaxis signal transduction protein
ALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRG
FAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQT
>fig|195.2051.peg.1800 Phage tail sheath monomer GpFI
GTEYFIEFINGFDCDAERLRNAHISTCILGEGYRSWGGETSHEDTIWQDLARVRTFDRIA
LAGQKAAFKAIDKKASELYFIKISIEELLRDLKGAKVLIGYEVSWDEERNTDANVSAGKF
YLNIKMMNNPIVKQITLEFIYSDKWASDLIKTISADS
>fig|195.2051.peg.287 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MLTGTYAICCAIARGYKEIYLAGMDLFENKEQDAYFYGKGYGIIESIHNKIKIWRLLNFC
KIIMM
>fig|195.2051.peg.4 hypothetical protein
MLNYSIIENSLNIKLECLSKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNLE
CIHGGKVILKSNKGKSFKSDGIPIMLESDLLNSSIVACPHTIANVSYPCTKVVDIKGSLS
QKKVNGEYAILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEA
RLRMYYKEHKYQKDNLFTNLYLNDTLYQNEQGLDKLELSKNDLFNLNDINVLNTLKQDFS
KDYEFKECEIRLGMHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRE
NENIIHHRVFFSSC
>fig|195.2052.peg.1328 lipopolysaccharide core biosynthesis protein LpsA
MLQSRLFMNLKGIGISFTPRYFFQTKLHKIFNEILKYNAKELEEIRTRVKYYNQINDFFT
LTEREKIGKFPFKNTSYAFDAYEISKYFNDDFLWKKEFGDVKYTFKEPAICKSRPLENNT
NNILLKLDKNRYFCFLKDNIKYENKKDIAIFRGAVYQKHRKEFFHSYFGKSFCDIGDTSK
QLSQWKKNFLNKKEQMKYKFIISLEGNDVASNLKWAMNSNSLVLAPKITCETWFMEGTLK
PNYHFALIDNDNLATVIEHFISHPKDALEIINNAHQYVKKFLDKKKEFYIGILVLTKYFY
YSGQLDLNKDECEREILELIK
>fig|195.2052.peg.9 Flagellar biosynthesis protein FlhA
MAKNKLVDLVFPFLGPLIGPVLRAKSLTIVGFIVCILAIIIVPLPSPILDFFLALSIALS
VLIILISIYIPKPTDLTTFPTLILIITLFRLSLNIATTRMILSEGQNGPAAVSEIIAAFG
EFVVGGNMVIGVIVFCILVLINFMVVTKGSTRVSEVQARFTLDAMPGKQMAIDADLNAGL
IDEQTARARRQEIIAEANFYGAMDGSSKFIKGDAVAGIIITIINIIGGFLIGAFQHDMAL
SDAASTYTILTIGDGLVSQIPGLITSTATAIIITRASKDEENFAEGTLTQLLSEYRTLLI
VGFVLFIFALVPGLPHLSLGFMALVFLGLGYLTKQVKEGKIEVNAPKKAKASAANAASGA
GGAGGVTAPAKKSEEEILKEEEHKINDILKVEILELELGYGLIKLAESELTERIRSMRRS
IAESLGFLMPKIRIRDNLRLKPNEYSFKLKGVSIASAEIYPDKYLAMDSGFITEEIEGIA
TKEPAFNSDALWIDANLKDEATLNGYIVIDPASVISTHMSELIKAHASELLTRQEVQNLL
DKVKNDYPIIVEGALGVAPVSLI
>fig|195.2052.peg.1732 Motility accessory factor
FYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSHELQSARLMVLNTNKLEI
QDYNELCSSKPFFQFSRIYFLELMSHYYERFHEDILGLNKKLAETFKNIILRNGNDPLDA
LQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLIKQLPLLKKYANKATIF
CADSSYPILAKHGIKPDYVCMLERTEITAEFFNNDFGEFDKDIIFICAGVVHPKAIEYLK
GRNLVITQKVLAFPYYINLKDFSYAAVGLSVAHTLSYLATYLSHKNIIFIGQDLAYAENG
NSHPDDYQNSANYESQMYEHILTTAYGGNGKVETHSIWLLFKNWFENEMIPNTRKMGITT
YNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEP
>fig|195.2052.peg.505 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MGGANSHMAIRASELGMPAVIGVGEENFEKYLKAKKINIECESEQIFCL
>fig|195.2052.peg.125 DNA gyrase subunit A (EC 5.99.1.3)
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDIAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDNKDASLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKEKQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIHNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARARAHILEGLKIALDNIDEVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSVGVRAINLDENDELVTAIIVQRDED
EIFATGGEENLENQEIENLDDENLENEESVSTQGKMLFAVTKKGMCIKFPLAKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSISAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDLQ
>fig|195.2052.peg.1189 Putative periplasmic protein
MKRIIIFLSFYLLPLFGNSELKNGFGEEYYKLNVEQKRQIFFTKMNTMFDKSFEEIAKER
AFVEAFFTMRIKMDLEIQTKTI
>fig|195.2052.peg.1463 tRNA (uracil(54)-C5)-methyltransferase (EC 2.1.1.35) @ tmRNA (uracil(341)-C5)-methyltransferase
MSLQEFGNFLKLEEKASFIKEFFKDFYQGNFELFSSKDKHYRTRAELSFYHDKDEIYYAM
FENKKKIIIESLEFADEKITAFMPKLLKQIRNNTNLKEKLFGVEFLATKNELSTTLLYHK
NIELIYNDLNNLSLELDANLIARSKGKKLVFKKENLRQELDIQGRKIFYKFNNDCFIQPN
TSINEKMITWVCENLKTQERKDLLELYCGYGNFTLALAIFLTMY
>fig|195.2052.peg.1190 Putative periplasmic protein
MGIAQALVESAMGTSRFAREANNLFGEWTWGEKGLIPDLRYPDKKHKIRIFDSLQDSVDS
YVLNLNRHFAYEEFRNERAKFESEGKEITGLEAIKTLDSYSERKSYYINIVTKIIQRYDL
ERYDTPKSF
>fig|195.2052.peg.906 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQELANQEL
TQIALLESKSFRFIMMGIIIIALIISIVIAYLIVRYIKKSVGGEPRDVNRIITEVANGNL
TQPIHTEYKQSILYSISRMQDHLRNIVQKMITISNELNHKADLVVDRISETEKAVIFQGE
TSRESALKIREISQKTQNVSKMALETEENSKNTTQVCQNNKKYAEDTASQMEYIASNSSR
VSQQIALLSEHAKNIGTSRLQIKLIYLP
>fig|195.2052.peg.10 Flagellar biosynthesis protein FlhA
MLTILESISDIAEVSKSFDMIIEHVRASLARMITNMYLDDKGNLDIFILDSASSAVLMEN
VQFRDGSYHLPLSVAQTGTLVDTLRAEVAAVANGRIKPFILCVEPQLRKFIADICYNFNI
NIVVLSFAEIAENTNFNTEGIIRIEL
>fig|195.2052.peg.1462 tRNA (uracil(54)-C5)-methyltransferase (EC 2.1.1.35) @ tmRNA (uracil(341)-C5)-methyltransferase
MLNCKINNISNIHFTRLSSEELSQALKKEREFFRLKDIDLDNFNFSHILVDPPRAGLDKS
VIDLIKNYENIIYISCNPISLKENLKELALTHKVEKFALFDQFVNTPHLECGVLLKSLHS
KQSSI
>fig|195.2052.peg.905 Putative methyl-accepting chemotaxis protein
MAEKTGEATDQIAIINKQIQEETIATVGVIEESIPLISQGKSLSEEVRDSVDLIYKQAND
SLFKAQEVNQEVAAQVKLMEEIEEKIITVADISSKTQQAVSENKNAMTELKNISDNLQAE
IAIFKL
>fig|195.2052.peg.126 Uncharacterized protein HP_1473
MRCINCGAFALLCFCDLCELELSEFSLNVRKLDNNFKVYSFYKYHEIQHLLHSKHYFYGY
FVYKMLAKLSFAKFKDFFDPRMTINVIALDDKVEDMLYSHSAILARYLKTKFVKPVFNVL
KAQNHIKYSGKSLEFRQKHKRNYKLLKTIQEPVILVDDIVTTGSSLLEAKKVLEENKISV
LFALVLADAKV
>fig|195.2052.peg.127 Outer membrane liproprotein mapA precursor
MFKKFLIFIVPILFLSACATKQDTFAQVNQISKNSQCSSCESPDGFEAKIKGLLYISDVG
IQCCANKRTLDTGIALKKVYLHRFYDLKEGQKVLNAKGKKLFVDVNFNAVFYTYLKQELE
ARGIVVLDNNDQNSPYVSKIDLEFISYGATQDAAGLHSKLVGVLQVSDINKNKKFTIRTK
QDVQGFDDLKETTFYTHLLIKQMANKAASLISEL
>fig|195.2052.peg.1710 Motility accessory factor
MMTFTPTQKELFNKNIEALSNILLKEGLKEIKSSKFELVLGKDNLDINLKDTSDNTFLYE
NVIDELNTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMF
HILDFSNELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDIL
GLNKKLAENFKNSIVSYGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAII
VSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDIKPDYVCMLERDEIVAECFNNDF
GEFDKDIVFIVKSVTHPHTIKYLQKNNRAFILVSTYASFIQYLKLDYFGYFNMGFSVAHM
NFLLTIHLKYKNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDKFST
>fig|195.2053.peg.1389 hypothetical protein
MAEEKLLKSLADGVLKINESSIDVAVLENGVRIITHSGVFRALGREPRGNARLDQIPAFM
DAKNLQPLISSELKTQISRISYLDKKSFGKIKKLKLWRENEPINKFS
>fig|195.2053.peg.81 Acetyltransferase
MKEIKLKEDLEKIYPLIKQLRNNLSLKDFLDKFQLATQTQHYKLFAYENEGSYKAACGVM
PFNVLYHNHCLYICDFVVR
>fig|195.2053.peg.1814 Arsenical-resistance protein ACR3
MLGFIDRFLTLWIFLAIFLGLILGIIFPNIALFWNLFEYKSVNVVLTLCLILMMYPPLAK
VDYAKLSKVFDSKKVILLSMILNWFIGPFAYVYLSFYFLKRRAFIYARSYHHRLGKMHRN
GGDMERFSKRR
>fig|195.2053.peg.1537 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTMFTKDDVSNLSQALLEIGVNINVNLEN
AQQCYELLNQNITTLKSQRKLAQNYQAKFTSTFVPPNGDYQNYGIMAAIDHINALKDLVK
RFPKCADVPKMYERGSYGGYLALLIAKIAPLYVDGVIDNSGSAVPPLIYILGREMEGGCD
YVFNDPNTLIECFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSEKNKNIIYVSYH
SDKDPLTPANFKEQTMQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKALFRKEL
PLMLEKLQKRKSLMQENSISYPCGKKVFTFKDVENQLKLIIN
>fig|195.2053.peg.408 Putative acetyltransferase (EC 2.3.1.-)
MHNEIYTFASLSAKDFFLKNGFELIRENKVIKEGQNLKKFLMKKDVVYKN
>fig|195.2053.peg.1376 RloG protein, putative
MSGEYIISGFLTICLVIASYQAYKVYKKVKKQH
>fig|195.2053.peg.1801 hypothetical protein
MTAYVHIGTEKTGSTSIQFFLYSNRRLLQRQNMIYPISIGNYSSQWNFTFLAYNNLRNDF
YCLSKGIFKKDDFLHHKKDIFLKFKDELLKSKCEKVVISSEHLSSRIQDLSEIKRIRKIL
YLLGFKKIKIIVYIREQTSDMISSFSTTLKSGAIGNIQANSKKYFKGYHKLLLLKWQQIF
GKENLIVRLFDKSEFYQGDLLKDFVHSIGLKWDNEFVIPPKQNESLDLIGVEILRRVNNL
LPLFVNEDRNYLRGDLNYFIQKYFSSKDLFLKFQPPKEIIQSYIDSFEESNEWVRKEFFP
YKERLFPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLITNKTTQIQNLNQAI
KNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSKSILGYLIMPMALLSII
ISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWYGGG
YIKLLFDIRKIKREIKEKYANKNR
>fig|195.2053.peg.1831 Beta-1,3-glucosyltransferase
GILNYFKNEDLSENIAFIESIDDKNDEILIKYYFNDVNHKTKILLDNDVAIAKHSKIRQY
DLLDKVFLYEKRIWLKLKNDTKMLDICINSQKLKLVFNDRCINDLSLVLKVLAKQKKQRS
KNSNLWLFADMSWRADDNAEHLYRYIMQNHPKQKTAFILSKNSTDYPRLKKEGFRLVDPR
SFYFKYLIYKADKIISSHIDKYIFNALGGDTLKTKDFIFLQHGVIKDDLSRWLNQRKIDT
FITSTKAEYESIAGDFNHYKFSTKEVVLTGLARWDALIKNNVLNTKQIVIMPTWREYLSG
KVQKYGVRGRNPEFVKSLYFQKWQEFLCSKELEKLAVRHGYNIIFTPHPQVRIYLEDFNL
PSYIITSYKENMQELFCRSSLMITDYSSVAFEMAVLKKPVLYYQFDKDEFFAKHSYAKGY
FDYEKDGFGKVFVESSDLFCYLGKKINHLQDIAINNTQHQSNNACKNIFIKIKSK
>fig|195.2053.peg.1678 hypothetical protein
MSDKELQKEILALENDVKQLEATINVIKKRITHLKDIAWDRQSKKESSQMYKVLKDTKEH
TRVKSNVGDIKVDKDFMEKEIRKHLDNPNLRGMVTTKEMLSFPKVAKGVRVEFNAEHKDF
TWKVKANDENILRYGSREYIQNNKAVNRLLTSYSQTEKGERINNSGNGQTKSALPPLFKD
SNFRRPTNENIIPQQNQSVNDFKAKLEEFSTKKTNAVKSINKEFKR
>fig|195.2053.peg.1825 Motility accessory factor
MDGKGEKVREENNFNKNLKALSGFEYNNLRKKLEDLKELREFTFTQGKDNLDINIIKKRN
LKKMYQDPIKELEKNLEYFKDFTRYPVLFFYGFGNGILYKILLQNQALKRIIIFEKELEL
IFLALNFIDFSKDLSLGRLIILHHDDINLPKMDKVFRLIGDLFYRSYNLHIANDFYEHYK
EDILKLNKLNMQTIKNHNLMHGNDPKDALQGIEQFVYNLPQMITHPSYKELLSKRKGISD
TAIIVSTGPSLTKQLPLLKKYASKAT
>fig|195.2053.peg.1257 hypothetical protein
MELEKKEEFRSKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKY
>fig|195.2053.peg.1562 Integral membrane protein
MINKNKLFRQIHIYVSLFFLPCAVLFALTGIAYILGADQDTGLKVETYKLVKNIEPGKEK
DALIQYLQENNLKVPSDAEATQGKGKGANMGGMHHNANAAPANVKAGKGKTMN
>fig|195.2053.peg.1387 hypothetical protein
MLELIFNTGRNIGLGIFVNGAFALQFSDVPQSQATYAIAEGILIMFLSGLGEIKSKGVKM
EIILGIGAVTLVIVSIALVYTFYKEKHKTQH
>fig|195.2053.peg.260 Filamentous haemagglutinin domain protein
MGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYK
YLGGLAGHIENGTFNNISLKNLGNIGVAKYAGGFAGMTQGNVIFENIVLNDLEEISGSHA
GGFAGWINDGTFNNIILNNIEKSVLALHINISLQVALQDMQALELIKILF
>fig|195.2053.peg.256 FIG00638667: hypothetical protein
MKVQGIYDFFSGYTLDGEANFNVIDFKDSQASLPLFIYATTQENFEGSIHYPEYAKHNKI
SLNNVFGRKDIRSGVEAMNVENNQVFFTM
>fig|195.2053.peg.1350 Pyridoxal phosphate-containing protein YggS
MTLEQILEKTKNIRLVAASKYVDANIIEKLFTQGITEFGENQVQALVQKKRNS
>fig|195.2053.peg.1618 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIKANKTWYKGGYVKILFEI
GKLKREFRNRKI
>fig|195.2053.peg.1609 hypothetical protein
MGGYLFFFGLIILFALFDSDFWEFFKFFLQIRMILIPLRVVFIILVPFHLENSFLGKTFY
FLENLFCLVFAILLIIAIIMPF
>fig|195.2053.peg.1360 Putative periplasmic protein
MLYFDKNGNLKEVFDVYVEGKKLISPDNPSLKFSDKPDGENEKFNIKRSKGFEAMASSKD
GSKLYLLLEGSIYNNNAYENEKGKEYLRIIEFDVKNKKFTGKTYKYFLEDKSHSIGDFNM
IDDKYGIIIERDQKEGTKDKVCKEGEDTKHCFNNVAQFKRIYKVKLDDKTHEAQKISYID
LLNIKDRNKISKKPLVNDKFVFPFETIEGVDIVDDSHIVVENDNNFPYSSSREPNKTDDN
EFILLEVKDFLKSK
>fig|195.2053.peg.1349 Pyridoxal phosphate-containing protein YggS
MDKRLNYKLDTLLEINSANELSKSGLNPDQAIEEYLQIQEECPNLNLCGVMSIGSHSEDQ
REIEKSFETTYKIYEKLQKHGAKICSMGMSNDFEIAIKCGSNMVRLGSILFKNLK
>fig|195.2053.peg.997 hypothetical protein
MRLFFLHTYKDQNNSPQVQRYRNFFYHQPKFLPVEIGKRGILNSFAILTIA
>fig|195.2053.peg.1391 hypothetical protein
MPEEKENIVKEVCKELNITQKELSEILVIYVL
>fig|195.2053.peg.1390 hypothetical protein
MSLSINSVDDLLVIFEKLSNGENIKVTEVGTIQHTIKLQGGRFENYNIGYIDAEIARVID
SYQDSFYRVADILKKDFGIDGIDKNKLIRFYLGEGSLEIKTDELLTNLLGVIKDMESRDK
LILFIVVALIIGGCWSFGNFLTHNEKIEDIKNRNEGGRIIAEIAKNKELQNACNAPKTTL
VKILKDDEKASFSLGNDVITNQNKEDYNFKEIEDTTQTEDTEGDFKILGFEKTNDRKKFK
IILGGKTHWANADIIDVNARMKLAKSSIQEQEVKLKLRIVKEYNKIKEIVILNVE
>fig|195.2053.peg.1776 Replication protein
MSIVCHETARTGIYQGFRCVGSQSKLGVDFPVKAYKLSENRYTLEDIKASIPSCKVDLAP
LYEKPRRKSTVTLEEAKELYPEWYEKRIVQGEPKQKSKKQGGTWVCNEALYEWWKRKITE
EVKAGGRYFSIMALCSYGLKCGISEQKIRRDAYAFLDHLESLTEDEDNHFSRADVKDGIK
KPKMIYFYGILKY
>fig|195.2053.peg.1370 hypothetical protein
MFKWLISLGGEGAVFDDREVFKNCFFIVRNSKKLIEIINQLN
>fig|195.2053.peg.1563 Integral membrane protein
MLHKDKGAWYFSVLSIGFGIALFLLYISGLIITLFASKKDRQKQLATLGAGVVITILLAY
LSL
>fig|195.2053.peg.1721 Hemerythrin domain protein
MKIQWSRDFSIKNMQLDKQHELIFEITNLANDLALNIQDNNTQHKNDLKQILVKLFQYIK
IHFKDEEKFMESIDFPLIEEHKKSHQILVEKTKELLEHSDNIVKMSQELSILTKDWILDH
FVNEDLWIANFTKKALHLQEIHYNLEQYIKLKSIRQDLKTEKTYDYICNCSLRIHAVPQT
IHQELVSKENTLKCEKCGQILVHLDYFDLNQNFEKFNAIFEDALQNHHFTTQKNDMGGGG
EIDEFSSKNLRNFQSFRKFKSRTSKHRTNS
>fig|195.2053.peg.1483 Membrane protein
MPECKYKHSIIDMKFYDEKNAKFLPFLLPDSINSTGLSFSENDKNKLIREAKEEVKELSL
NLIRNLESKIHKSARDTLEAIAKGFGAKKVEFEFKDNTQKLDIN
>fig|195.2053.peg.1144 hypothetical protein
CQLFFICLVYILLCSLGLFNNWVGFLITQVYFIVFIEVLWLGVVYDEINIAVNTCKGLVL
SKKRLFALNLSFFIQ
>fig|195.2053.peg.1394 hypothetical protein
MVQILLVVLATLVLGLAIKVSRLEKEIKELKK
>fig|195.2053.peg.1826 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAMDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHQGNSGIDLALKKDKQIQVIIEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EFYKECEKLLSSEKYLDSITRKDLFDEPSLKGVFIDIKPILEQEKPSFSKLKPLFKIFHK
DFLLSEFNPNDANSLNNAFYKELLYILGLYESKQNSKLIIAKSQESEEEQGTFYTAINSK
LKEENFETILKLLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEI
LAKERSTRKKSEFAYLPYLNSSLFEKQSIENTLEISNLNNDLKLNYYKNTVLKDDKCKAK
KGQVGLLEYLFEFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSF
ITSYMCKESITKVVLDKFNAKFDLKATDISELRRDLRKEDKNAQKELLNSIKICDPAVGS
GHFLVSALNVMLSIYDELNLFDEEFYLEVQNDEILITNRKGEFVEYKRPHSDKDKAHLIQ
KELFYTKKDIIENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDETYHDLKTLPNID
INIKCGNSLVSYFETGKSLSHYPNIKERMSKYKRIVKDYKEGFYTDKNLIAKEIKNLQES
FKNFCLKDKFNKEIKQLTNGANEYSKKYGDFLADEHHDEKFKSFFSKNMFEFSFDEKVAI
KEFANLKKEYDNIFNLESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIKEAENKDLF
TNTKKLRTYQGKMDIWYHFVGRGFDMLKNNGYLAFIATNNWVTNSGAKKLRNIVLEESQI
LSLVDFSSFMVFDSASIQTMIMSFQKTKPPKNYEFHFAKITTQTPIYEDALSLLKNEKTQ
NNEILKINLTPKKFIDKTLNFTKSDYEELFNKIQKYGKFYLEEREVAQGIVYPQ
>fig|195.2053.peg.1475 Ribosomal RNA adenine dimethylase
MFDFKILFSYIFFTVGKIECFFYEYLKNPKQIGAFCSSSQKLGFVMTQNINLRQANYIVE
IGPGTGVFTENILKYKNKKAQFFAIEINKNMADKLKRKIVNLDIEIGSAENLPYFLRQRN
ITYADVIISGIPWSLLRDHEQEKLLKIIHKSLKPNGYFSTFAYVLPTYSSLKFRQKIFSL
FAEVRISKVVWQNLPPAVVYYCKK
>fig|195.2053.peg.566 FIG00471048: hypothetical protein
MDTINIIILFSLIISIALGYVLKANIGVFAILSAFIGAYLYGITPEKGD
>fig|195.2053.peg.1062 Group-specific protein
MDKKNKNVIFQDIIASKSKVDIFVLLEGDDDIKYYGPIIDNRLGDNKKIRYYTCKGKSEV
LLLLKRIQESTKLDLSKKIMSFIDRDFDFEQNLEHTYITESYSIENYYFSNEAINKTMKY
LLKVDDLELNNKDVKNEVDKIIKERDEKLEDIVFVNAIYCLQKTKSLECGIQPKLNKIKE
YDAIIKIDQDKIKDYIEDYIEVSKDEIDLQIEYMKKNLVYETRGKYIFSLMKKKYRIFCD
KFNKEKKRPSSIDISLLNNIIVSFAACADKPKDLINYIDKYR
>fig|195.2053.peg.516 UPF0053 inner membrane protein YgdQ
MFEWIFSAEMWIALATLIGLEIVLGIDNIIFIAILVGRLPKEKRQRARIFGLSLAMITRL
LLLLSLFWIMKLTTPLFSVFSQEISGRDIILILGGLFLIAKSTLEIHHDIDNAGEKSDEE
VLKEGAKRGFFSILIQIAVLDIVFSLDSVITAVGMVNNIEIMMIAVVVAVFVMMLASKSI
SNFVDDNPTIKILALAFLILVGVTLVAEGLDFHISKTYVYFAMAFSLGVESINIYIKKKR
LAQENLRK
>fig|195.2053.peg.1073 hypothetical protein
MQYFCAEKENCCAVYIIDKNSNDEYIKKIKIKLKREETINIDFSHYQYEFFELSPMLIKK
NKLQNFILSHNKE
>fig|195.2053.peg.1484 Membrane protein
MELILLSLIVILLVFVIIKQFKNSSKIEEKDIHISNDITQLKSIGELSVFQVFSKEIVTK
KDSAFNGIWKSILGWSLSERQIALIFEFEITFLYDLRDKNF
>fig|195.2053.peg.1830 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFIQYAIISAVYNVEK
YLDDYFKSIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQAS
ARNLGLKYMQENDYQIPWVTFTDPDDFLDRNYFYEVDKFLATHQDDDICMISTRLINFFH
SSGRYNEHLLNKIRFKNSDYIIKINKLTNEMPSGTTSLFLFQNLIATKLQFPIDEYSRIN
LEDVIFAYTYQLLFYNANIAFINSAKYFIRKTNESTTAKATKDKKFYLGSPILCIELLDK
TKKMIGKTPLYIQNLVLYHIFWNIHGVINSPEKLSILNKEEKKAYMQLMIDCLDLVESRS
IVSFNLMLDHFNFFYKVGILNCFKNEKPPFQIAYIEGYDPYEEQILITYYTGDDKDIESI
LVDEEEVYVDYKKIVKYDFLDRVFCYQKRLWVHIPKNAKDKLEIWINDKQSMVGKYDKYF
LDVKNIRKEFQKRLPKSNIWLLMDKDYEADDNAEHLYRYIMQNHPEQEIVFALRKESSDW
ERLEKEGFNLIEFGSFKFERIIKKASKVISSHADEYLIRHVTLTQQFVFVQHGVIMNDLS
RWLNSKKINLFITSTRAEYDSIANNYNRYKFGKKEVLLTGLARHDVLLKNNKSDTKQILM
MPTWRAGIVGNVTNSSKRELKENFKQSEYFQKWNSLLNNDSLKKLCELYSYTIVFNPHPN
IMPYLKEFNLPSYIKIANQDESLQVLFCNSSLMITDYSSVAFEMAYLEKPVIYYQFDKED
FFNFHTLQKGYFDYTKDGFGPVVENEENLLKELESLLQNDCKSFGVYKDNIDSAFVFRDG
RCCERIYNILKNSNHGVKYLIT
>fig|195.2053.peg.784 Alpha-ketoglutarate permease
MIIQPLFGYIGDKIGHKRSLIIFCILAFVGIYPIFNLISSNAQSNASLVFILVVLLFIIL
SFYTSVAGIFKAKLFPEHVRALGTGLGYAISNAIFGGSAPWVALQFKNAGMENGFFVYIA
VLTLLMFIATLCLPKKSELN
>fig|195.2053.peg.1377 Phage antirepressor protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYMLGFFIKSPKAKEYRKKVAKLLREQTQARFKSLSDENLRLNSLNHHQKIGYKSQ
LKQQKEHYENKIKALKYDLEKKKELSFKRKLSKEELLELRKILARDYGILCMKEWEMSLV
AEKIGKDTVFEAVLNKLEKELKYWQNYEEYEEKWRKILRR
>fig|195.2053.peg.975 lipopolysaccharide core biosynthesis protein LpsA
MLQSRLFMNLKGIGISFTPRYFFQTKLHKIFNEILKYNAKELEEIRTRVKYYNQINDFFT
LTEREKIGKFPFKNTSYAFDAYEISKYFNDDFLWKKEFGDVKYTFKEPAIFKSRPLENNT
NNILLKLEKIGIFVF
>fig|195.2053.peg.1084 hypothetical protein
MKNKINFQNFIKASLIFDFNLKLGYNLTLFLASRFDDYGI
>fig|195.2053.peg.1712 Motility accessory factor
MMTFTPTQKELFNKNIEALSNLFLKESLKEIKSSKFELILGKDNLDINLKDTSDNTFLYE
NVIDELNSMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWVIF
HILDFSNELQSARLMILQTSSLDIELFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDVL
ELNKKLVQDFKDSILSHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAII
VSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHNIKPDYVCMLERDEIVAECFNNDF
KDFDKDIIFLVASLVHKKTISYLEKNQRKYILIIKGQPFARYLELDNYGYINGGMSVSHM
AYELAENLGHKNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDRFSTTAYGGNGK
VQSSEIWTLFRQIFENFIAFSKSKTYNCTQGGARIESAIEKPFKELCEDLLENKKDKKFK
KLQVLNTKEQVKLGLKIYQKIKKNMNLSLNFKKECKKVQKQIHNLTHGKNKLSLEQINQN
IDKIKEKLSNKKYLFLQEILGPTLHHEQSILTPLYLKDIKDDSDKQNKLFAWIYAHESLI
ENIIELLEAQDKRLKIAILPLQEFLEKKKAL
>fig|195.2053.peg.1381 Adenine-specific methyltransferase (EC 2.1.1.72)
MKLNLYNDHFQNFKRYNIPKAQLVIADIPYNLGINAYASNSAWYIDGKIANGESDKAGKA
FFDTDNDFRVAEFMHFCSKMLIKEPKEVGKAPCMIVFCSFQQMSPLIDLAKRYGFMHYIN
LTFRKKSSASVLKANMKIVENCEYGLILYRDKLPKFNNDGRMIMSCIDWLYDDKSIPKIH
PTQKPVKLLEFLIRIFTDVGDVVIDPCAGSGSTLLAAANLNRKAYGFEIKKDFFKSANEI
MFKHIERSLFAKE
>fig|195.2053.peg.1738 Ethanolamine utilization protein EutG
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGAIDSAKSNALQEIQTISNK
ATNQISQLKNTSLNLVNQAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITEQINGAKTQLNSKIDNKVTKTGDETIAGVKTFSVPPVSATNPTANNQ
VANKSYVDTVGNSKVALSGNQTIAGVKTFSSSIVIPNATANNHATNLGQLNGKVAKTGDE
TIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVAKTGDETIAGVKTFSVPPVSAT
NPTANNQVANKSYVDTVVNTVGNSKVALSGNQTIAGVKTFSSSIVIPNATANNHATNLGQ
LNSKVTKTGDETIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNS
>fig|195.2053.peg.82 Acetyltransferase
MKKIQIWAKNQGYEELELSSSFFRTQAHEFYIQKMGFEKSGFVFKKNIKL
>fig|195.2053.peg.783 Alpha-ketoglutarate permease
MQELTRAKKIRSIVAASSGNLVEWFDFYIYAFTATYFAHTFSTSDNPIVQQINAFGVFAA
GFFMRPIGSWLFGSLADKVGRKKSMVVSVVLMALGSFMIAALPSKDVVGDFAIILLLLAR
LIQGLSVGGEYGIAATYLSELATEGKRGFYSSFQYVTLIGGQLLAVASISIMLFFFSIDE
MKDYAWRILFVVGGILVLGSLLVRKVMNESATQIHKHEDRGTLKALFTSSWKQFLMVLGI
TAGGSLAFYTITTYTKTFMENSGMDKTLV
>fig|195.2054.peg.307 C4-dicarboxylate anaerobic carrier, putative
MSVAGFATYMKHINASAKLAFLANKPLGKIENKYLILSGTFIVGMALKIVISSYAGLLLL
LLACIYPVLISLKIRPITAVCVLSLIALDYGPKDGNSINMADMVGQSDNVVGLFLNYQIY
SVIAYVMVIAILIPFYFAWVDKRDKEKGVLNDEVEIPPIIDPKCPTFYILFPWLPVVFLF
IAYFFTIKLDVVTANFLSISLVFLVEFARHRNARKLGEDMMVILKAMAEIFSQS
>fig|195.2054.peg.1717 ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB11
MSITLDKYTQKYFGEFLKDDSINEICYNGDDKIWIQNSKGLWESVQTELDFESAGHFATA
SASFKKDKIDVSRPILSCILVGGERMQIVIPPATKSEHISITIRKPSKTRFKMEDHVKSG
LFEDLSPDDKNIIKPSDEELIKLYKERDYQAFISKAVSYGKNIIIAGETGSGKTTFMKTL
IDFISLDDRIITIEDVEEIKFYEHKNFVQLFYPSEAKSTDFLNSATLLKSCLRMKPDRIL
LAELRGAETYDFINVLASGHGGSITSCHAGSPEETFTRLALMTLQNPQGQCVPFEIIQKT
LKDLIDIVVHIHAHHGKRRISSIYFKEIENIKQKGALDG
>fig|195.2054.peg.1804 hypothetical protein
MVSYECDRWSFHSSIAIRDEYQSLGIGTFLINKMLEIALKYVPTARLSGTLSAVDEEILE
NHIRRDKLYKNLGFIFNEDNTGFSIEQIGDLKIRKDFDYIQEVHILNMCYQLSNLQHEKE
GCIRQLESHKDDMRKLNKENAALRTRNKFILCFCIALIFLIVCLIK
>fig|195.2054.peg.1718 hypothetical protein
MDKEKRGIYNVSFNKKQSTPIDTKLKQELEAIDNAIINYMKEYVVHYVKGWHNTKRDKGR
GAEHIKIHLEPNSEGQITLEELLNLGNSIREYLKVFKEPFDDGRGGKVYEWENNKGVRFR
IATDKIKGEGLIPPLSPSDEIIITFYSDRNLNKQMEFKNPNVAEYYKDKTQQKIGDIGIR
NISSNRNFKRLAKKEQAVTGEAVHSLHTSRPAELGGNNQELSGANAHSVTANSIIPQQNK
SANDFKAKLKEFDAKGKNHIQTKEKER
>fig|195.2054.peg.1289 hypothetical protein
SDLKALMARKVLILQKFSLIFDEFKKDFRV
>fig|195.2054.peg.1844 Conjugative transfer protein TrbL
IEAVFNGSIGESAGAAAGFRAVATMAAGAAAGAAAGAVGITRALDAAKALHLAEGGKGGM
GLVKGVAKKLAIAG
>fig|195.2054.peg.929 hypothetical protein
VEMISKTFMPMFLISRLYFTLKEEKLDIQIRKILKEKDELAEEKSLWISKVLPF
>fig|195.2054.peg.1091 hypothetical protein
MKNTVFVFEDNIIFEINIFEKSNKEDFRYFLDENSNLTKSTKNDYCGSKTKKFFQRLYAD
GIISYECELYNLDTDSLPALKFLLNKIKNKDDILYKINYERKKLNGTPSACIGWYIKFLE
YKHKNF
>fig|195.2054.peg.1229 hypothetical protein
MSSNIDILKYLLFVEYLTPQNIKKINNCCDTCETSYINQYIREKIEKICNALTLNNKNLD
DYSVEIIIQGAIYNNKTS
>fig|195.2054.peg.630 FIG00638667: hypothetical protein
MNKAFSLFETILVLILIGFLALFLSRTLWEFYYLNNQQLKMKDLILKTHLSVLRLEKLLQ
TCTNITFEPNHISYLLKDDLLYLDDNKEKLLNSSLILENN
>fig|195.2054.peg.1678 hypothetical protein
MFLDFIGKVFIFITIYLMTIFIVKSHIAVIKTGFQSFDFRFIFIYNIAFLVAEYFMFLAY
SKYILN
>fig|195.2054.peg.514 hypothetical protein
VQDIFIASLKSLEKISPNGNNLPFQAKWNENRHPVQREFKEAKDFIIKCFADSLKLRADA
YFYFKRYFNEYF
>fig|195.2054.peg.165 hypothetical protein
MFETLLKLSEEPLKSKIKDLYFSKFNYVGAKIDFCITQNLGLLGEINLLWAEAKQGKSEL
KKSFVQLVLTIGKYKFYTEQTPNLLCAFDGEKIAFLPFACLQEIFYQSDINFSVTPSNHT
SEQFLKLLKELDSILNTAQIFYYEKNDEELKTFIKENLTSENISKIKIDKNNFVSIYHKW
NKMVKDTISIDWNLAKKSGIIDADFYLADLLSSENETIGQNLFAILKKDYYEFNKTKSDL
GSIVNERTSFKDNQKAHHEFWAIYERPPREEFWDYIIKRRDLLVDQDVRERKGAFFTSRI
WVDKACEYLSKTFGEDYEEGYYIWDLAGGTGNLLANFTNKKNIFCSTLDKADIDVIHERI
KNGANLFENHVFQFDFLNDEFFDKCDDKGKIIQKSKLPLNLQEILKDENKRKKLIIFINP
PYAEATSATQVTNTGKNKDKVARENKICEKYKDILGKANNELFAQFFIRIYCELEDCLMA
SFSKLKYVNSTNFIKFRENFKAKFLKGFMVPADTFDNVKGKFPIGFLIWDMSKKEEIKKI
KLDTFNKNGSFLGIKTFYNDQKESINKWIKIFDDKKSQEKFGFMGNPSPDFQHNSQLYLS
LNKGIEHFNFYIFSLKNLLNGAVYFSVRHAINATWINDRDQFLYPNDLYKNDDEFKSDCL
AFMLFHGQNRISAKEGINHFIPFSEKELGITKEAFESDFMYKFIKGKIKDENSLFGDELV
KIEFSLEAQELLKAGKELFKYYHTHSEDKGYLVNASFYDIKEFFQGRDEKGRMNRPSQAK
DEHYKILLSDLNIALNALAKKLEPKIYEYGFLKE
>fig|195.2054.peg.1672 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDVNKEDYEGIKSVISNHAIESIYMNELDIIAMIKQSA
LKLSADEIIAEYKEKGFVEYERKQ
>fig|195.2054.peg.513 putative TYPE II DNA MODIFICATION ENZYME (METHYLTRANSFERASE)
MHIFILKDTLMNTFNVKELGQVFTPQYIVSDMMNLIQNNGRFLEPSCGDGAFFKNLPSNK
VGIEIDKNVINDEQILNIDFFNYPLNEKFDTIVGNPPYVKYQDIKIETKILLKIYNQIFD
ERSNLYLFFIYKCILHLKDKGELIFITPRDFLKSTSSIKLNNFLFSQGSITDFIDLGDKK
IFKSAQPNCAIWRFEKGNFKRNTNCLKEFNCINGQILFTKTHYFIPFSKLFFVKVGAVSG
ADQIFTNEKFGNMEFVCSSTKKTKKTKKMIYGIYGKTCKYLIQNKEILLTRKIKKFNENN
WWQWGRDYYKSDLERIYVNTKTRNKNPFFINDCKAYDGSILAIFPKFKCDKKLLQEICDK
LNEIDWEELGFVCDGRFLFSQRSLENCLLNENFKDFLKFS
>fig|195.2054.peg.1505 UPF0102 protein YraN
MGFASYLSGILGEDKACEFLKKQKFEILKRNFRSKFGEIDIIAKKDGILHFIEVKFTQNN
YEVSERLNVKKYEKFLKTIEFY
>fig|195.2054.peg.1090 Protein of unknown function DUF262 family
MEFKPKKEYVCKLLSDEGVKFVIPEYQRPYRWGIDECETLWNDILEVFGDGENISEYFLG
SIVAYQNDKNELEIIDGQQRITTFTLFFRAFYEHFQSERANVKTSYLEGFGKCIWEYDLD
HGLDYSKSHLSSRVITDCDNIILNELLNKEINLENLQKSNSRYAKNFNFFYDKLLEFKTT
RPLQWEMLCKMFLSKTLFTLIVICDSQESAMTIFNTLNSRGLPLSNADILKGYIYKRVSH
KNEFANEWKELEAKIDESNNIKNLDFLFLQFMHVIRAENKDFDTTTHSVLNFFTKSDKKV
YYGAIDNWLYRDNTMYFIKSLANFWDKPENYLSDLSNKYMKILNLFQNDSWKAFVSFLVW
RNKDNIDNKDEFSKEFDKYLPILIQYVTLAFLNGNASINVIKEIVFKMNVKLKINESFPA
KQNIPSFENFLEVSRNFDSRKTKYILFLYAYVYDDFKQVIDSGSLEVEHILPKQWQNANF
NEWDEQSHFEYLENIGNKILLPKKSNIKCIDNFFAKKQIEYSNSNNANLKEVLDLSKRTK
NIWTKEDIDNRAQAIYSKMVEFLQG
>fig|195.2054.peg.279 Translation-disabling ACNase RloC
MKILKFAKINFGSYENFTWDNGLEEFKTINIFYGRNYSGKTTLSRIARSFELKKHNEDFL
DGNFKIKLEDGSFLTQNDVINSNLDIRVYNSDFVKENLNYLYDKKGNIKGFKSIGVEQKD
IKESIEKRKEILKTRNEKLKDIQANRENISKTQQAKIKTLNEKLIDKAKLVKSEPNLIKQ
GSNYDKRNLENDLIEIKDNINAYILNNEEQNQLIKILEDKEKQNIIFKNTFNKDNFQGIF
TYSLKILEKEVIIKENLTSELRKWLEEGLEFHKEHSFTQQCKFCNNPLTLERIAWIENNI
KDDSGEKEQIEKELKDLLDNFESYKLESKKLLLGIEYENFYSNYKDIFIGLKEQLGVSIA
NYNEELLKIEKKLTKKKKDVFTLMKLENINDFSDEVLQILNKIENLCKENNEYAKNLLSK
QDEARKKLRLNEVAKFAKDSDCFAKQDEIKNLGQKLSNMQSTIETEKNEINNYNLEIEKY
KEKLSNLETSTSNINKYLKSYFGHNMLELKAKKDDKGQLNGEFEILRNGKQAKNLSEGEC
SLVAFCYFVASLEDAKTKDKNPIIWIDDPISSLDNNHIFFIFSLIEAKIAKKIKDNKYSQ
LFISTHNLDFLKYIKRFKKSKPKQNENDKTDYEFPQYYFIEKSIKENTETSEIKKLPKCL
EKYTTEFNYLFEQIYKFKNIDDTYNEDLKISLVYNFGNNLRKFLEIYLFFKYPNNFESLD
KELIERFFNDTYQSDNTDENHQRMIANITNRYQNEYSHLREILSRGMQPIDIEESKKIAD
FILKMIEKNDNNQFKALVRSISNDR
>fig|195.2054.peg.1744 hypothetical protein
MQNSLQTYTQKYDENNYGLLYPDSHVIRFYERILKYKLGITSGNLLDFGCGNGVHSKYFL
DKGFKPFGIDIVPSLQKNWDAKNKISGGGGIVKS
>fig|195.2054.peg.389 Predicted glycosyltransferase involved in capsule biosynthesis
MPLLSVIIPFGLSKERSYIEERVYEKAKKFKSDKNIEFIFVEGYSSENHKLKDFIQENHH
IYLKDMDQKVFSQGRCRNLGASYAHSDVLLFLDVDCYISLDSFEKILKLIQIKNISQNIN
ALMVLPVIYLNKEASEKIKQYNEKFWDILIQDDLLTAKNTWIKFFAPSSTSSIIINKYQF
LRLGGNDENFIGHGYEDFDLFSRILKTCISFEKMPMNLSYDARNWNFFDFKGFRAWFSLL
GYEACFHGIYMYHFHHIEPNQNAYMQNKDKNHQLFYRHLKNIKKHDLKPLQVFKAKNEKV
LILFKDQNYDFKDISVYMGEIIYKNIRDFFI
>fig|195.2054.peg.1174 LSU ribosomal protein L4p (L1e)
MSKVVVLNDKLEKAGELDLPSKYAEVNPHNLYLYVKSYLASLRANTAHTKGRSDVSGGGK
KPWRQKGRGGARAGSTRTNVWVGGAVAFGPTNERNYFQKVNKKQKRLALERALADK
>fig|195.2054.peg.107 Glutamyl-tRNA reductase (EC 1.2.1.70)
MYYCISFTHKNTDLSLRERLSFSDEAKKNEFLRLLSIHENIEECLVISTCNRVEIVAYVK
EACAEYIIKSLALLCNVDKESLVQKADIFEDSGAIHHLFSVASSLDSLVVGETQIAGQLK
DAFAFALKNNFCAVHLSRAIHSAFKCAAKVRNETQISKNPISVASVAVAKAKELLPLDGK
SAIVIGAGEMGELAAKHLITAGARVIVLNRDMEKARILCERLGVLSECDSLNNLKKYLDE
YELFFSATNAPNAIIANSLIDEVSHKRYFFDIAVPRDIDISENEKISVFAVDDLEVVVRK
NLALREQEARMAYAIIGRETSEFFRYLNDLALMPIIKAIRLQAKEYADKQLEIALKKGYL
KKSDKEEARKLIHQVFKAFLHTPTVNLKHLQGKMQSDTVINAMRYIFDLENNLEGLNQYT
CEFNMENNDEIY
>fig|195.2054.peg.1789 hygromycin-B-phosphotransferase
MKSDYSKESITEFLSRKYGEDIRLFPIKEGQESQAYWFSRGGREYVVRINSNMEGFKKDK
YAYEHFRSDRVPIPEVVETGNFDGTHYFCISVKADGITYEDSDEETVVRLLGDITDVTEA
ISRTDISGTSGCGVFDSDTGNAPFYSWREYLAEVFERDWTAVSRSYVNLSLIDELLAAYR
ELISYCPEERALFHGDFGSNNVIVGKKSRISGVIDWDCAAYGDFLYDIATAYFWRTWLMC
MEKTAAYWERKYSHLPRYTERILCYELRIGLTEIYENAVENDTETTEWLQNRCREILREY
RQRKA
>fig|195.2054.peg.1743 Legionaminic acid biosynthesis protein PtmG
MLYCDHCVMPNTRPGIKFFKDEKGKKNICSACINHKNKEKIDYKARFKELENLCDKYRRM
NGKFEYDCAIAVSGGKDSHYQVHIMKEKLGMNPILFSVEDNFTMTEAGRKNLRNLSETFG
CHLISLKPDVKTQKKVMLKTFEKYGKPTWFIDRLIYSFPFGMALKFNTPLLVYGENVSYE
YGGGDDKETPSAKAIFENGVASDLDINEFIDDEIKEENLQLFFNPSADDLNKLDPIYLSY
FIKWNSYSNYIFAKSRGFSDLQNEWDRSHCAENFDQIDTIGYILHAWMKYPKFGHAMASD
YASRFVRYGMMSREEAVKIVKEKDHKLDNKCIEDFCNFTGISKTTFWKIVEKHYNLELFY
KNEFNEFKLKNPLK
>fig|195.2054.peg.1584 Putative periplasmic protein
MHAANPMDKNLHPIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNIKTKNPPK
KEEKDKINYVISGGLAREGNAKNNTLELLDGSYINMGVENIYNLKLNGAPYAVGGLAIFG
DAIGNSLLAQKGSKVDIHTASFYRDMVGEFILDERITHLVGGLAYNGKVEKNKLNLNGVE
FNIHAPSGLYSSFAPVHIAGAFVDGNGKKAYDATKNTLVIDNFLLNLRADGKTPIFYNAI
F
>fig|195.2054.peg.1825 hypothetical protein
MALTISNISFFYLENIVPTPISLQKPTNSHYLTPPKPKQAINYTHFFTNIN
>fig|195.2054.peg.1821 Predicted endonuclease distantly related to archaeal Holliday junction resolvase
LKHGILDDFQMDLICISDDMIQFFENISF
>fig|195.2054.peg.1660 Conjugative transfer protein TrbL
CMIAKMVPGIIEAVFNGSIGESAGAAAGFRAVATMAAGAAAGAAAGAVGITRAMNAAKAL
HLAEGGKGGMDLVKGVAKNLAIAGGEHLRDNLTKGRMPNQMANRLQEKLKDIQGKTSEGG
ISSGSPKEESYQSGINPNITK
>fig|195.2054.peg.818 hypothetical protein
MFQSIDKKIQEQLNLWNFDAVEISYEEKLYLLENEYVDFLFQIGKFEKLYSFLKVFQETP
AWWEMTEISKDYVFFSFRKKLLQAVQFDFKNICFEKRYLACYILNSKISKQELNGKFCHE
LFYASIVCMERNKYKWGAYKEACGVISTAYYIKKSIDYFFYTTNDDFLDRMQDYMFILQD
FMKQNFYGASICYEQIGFLLKKKKLNIIYAMPKPNIAVLVTGAIRGKKWFESLKFLKDQV
VDPLNADIFLFSWNKKMLWPSIRNRSNWVYRRIPEIYNNIPEQIKNFNEFTKCFPNVYNK
LSEDLSIPFSKDELEQLNVFFNDIYLEDEKSFIAYHQKYGELNNLHKMLYGRKIAFELME
KYEKRFQKKYDFVLIVRPDLDYPKIDSAMLEKINIGNVIATHELWPHHKEVLDYFFMGNR
EVIKKICDIWDAIQDTRLDFFRDSFRKDFHAQEALHKWLVFNNIKPIEPHFAYNVNVARS
ISSKSICFPNLQDELQKDILNLKKQDYSSDIIEQNTRFFSDVVQFYGQVNVCENDLLDRS
RFYSAKARVQNHLAYKLGQAMIMCSKSIFGYLKMPYILNEVYKKHQVEVNEYNEKIKTMT
FLKIPSMECCEDYEEALKEKKCFTYKLGQELIKANKNWYGGGYIKLLLEIRKLKREYNKK
RIQDDIFTSSK
>fig|195.2054.peg.1791 Aminoglycoside 9-nucleotidyltransferase (EC 2.7.7.-) => ANT(9)-I
MGNFKIAGEIPPPLLTTAKEAYLGNLSDEWETVEKEAMALVEYMKKQIEELLRTE
>fig|195.2054.peg.1798 hypothetical protein
MNTNKITDLHIQISKEDLKILDLLLKANEYSTAIRRRMAENEQDGGKV
>fig|195.2054.peg.1797 Aminoglycoside 2''-phosphotransferase (EC 2.7.1.190) => APH(2'')
MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQ
QREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDM
AIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYE
HIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDD
FGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLAID
PDAFIL
>fig|195.2054.peg.1788 Pyrrolidone-carboxylate peptidase (EC 3.4.19.3)
MRILFTGFDPFGGEKINPAGEAVKMMKNEIQGAEILKLEVPTVFGKAGEVLKKAVEQYRP
DAVVCVGQAGGRAAITPEMIAVNIMDARIPDNAGNKPCHELIIKEGREAYFSSLPVKDIE
KNLNDNGIPSSVSYGADNE
>fig|195.2054.peg.1812 FIG00471065: hypothetical protein
DFICGNFANFVGEDNIVFFPITTLLIVFTIAICAVWGLSNVLSLSLFIMPIFVAVFYIFN
IDISLKNLYGSYFIFLIIINGLSWSVNQR
>fig|195.2054.peg.1685 hypothetical protein
MTQKLKIVFCIKKMKKINIQMLKMYHILRQKQKIYILSQENEKK
>fig|195.2054.peg.1683 hypothetical protein
MKEIVDLENKPVTRLYSKVEEKVDNITGEVTTIVSSFLQKEKTKDDFIKLFVENINYLTD
NLSNSALRVVLMMFKNLNYQNIFHYNSDFVSYFTNKKILGKSSVYRAIKELEDKNVIFKI
TKEQQEEYDIISPNSYIMNPQIIGKGSFKDLKKLRQTTIKEFDFEKLEMIQKVEVESEYE
GLDEVKENPENYYIEDIKQIAYPNTIENQIIISKKEAEADNQTLIANDTQPALFDENQKE
QEARLFIEKFGGMFSGAYHPTKSAKELKREKLDQDLKEGKI
>fig|195.2054.peg.828 hypothetical protein
FIEGEKVKQHLAYQLGECFLKHPVMFVFYSLKIYIKWKKNGKR
>fig|195.2054.peg.1587 hypothetical protein
MYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEMINSWKGFAKLVNEGIFG
ELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYI
KGGSVQNLTIGGLQFPKYAFSYKYLGGLAGHIENGTFSNIALDTIEGFNGENSSSGGFAG
EINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNGGGFVGYT
TGNTTFDGIG
>fig|195.2054.peg.278 Type I restriction-modification system, specificity subunit S
MTDKISYLMTKLPQGWEWKSLGEIFNIERGGSPRPIKKFLTDKENGINWIKIGDIKNQKY
LYKTEEKIIQEGLKKSKLVIEGDLLVSNSMSFGKPVIVKLQKGAIHDGWLLLKEKINLNK
EYFYYLFSSNFMYNFLSYQASGSTVKNLNIDKLKQIEIPLPPLKEQERIVGILDESFAKI
DESIKILEQDLLNLDELMQSALQKAFNPLKDNAKENYKLPQGWEWKNLGEIANTSSGGTP
SRNKKEYWENGNIKWLKSGELNDGYIDFIEENITEEAIKNSSAKIFQKGTLLIAMYGATA
GKLGILNLDSTTNQAICAFLHKDKNIKFLEKFLFYFLFFLRDKIIKDSFGGAQPNINQTY
IKNLQIPLPPIKEQEQIASHLDELSSHVKNLKQNYQAQIKNLQELKNSLLDKAFKGRL
>fig|195.2054.peg.1793 Uridine phosphorylase (EC 2.4.2.3)
MPLVKHDYPVLEYDTASKAVFQPGNGKKCFPAKAVFAFLGDEVENYAHTHDGIQIDEFES
ATRRYPIYECLYNQEKICLCPAPVGSAAAVQVLEYLIAGGVTKIISVGSCGVLEDIPENR
FLIPVSALRDEGTSYHYLPPSREVEISKAGINAIESALSQKNIPYWEVKTWTTDGFYRET
VEMVQYRKEEGCQVVEMECSALAACAKFRKVTWAMLLFSADTLADPHKYQEREWGKTSIS
IALELALDAVLSVVEE
>fig|195.2054.peg.1794 hypothetical protein
MNRSAVSSSIGASCPICPAIIAVTSSMESGFCFCSASASRMAWNIAAVTASPGCSPLSMS
FLMSRRIARNTFLIFSISASCSPIFWAFKSCKSCFASARCSGCSFIRSDREAVAISISWF
LAVMLLLFVHFSQTHAPYSPFQNPYCSIFPACYP
>fig|195.2054.peg.1783 FIG00472059: hypothetical protein
MKRAIERSKLDRETNIELVEIMWKQFSNLGIYELNVIDTTTHSIKDTVSAVQEKIASKRT
TLVEESELTHVAAPDNPTKEFENRQERFALYRAMQQLDAETREVIHLRLAGDFSFRDIGD
ILGHSEVWARVRFYRGKEKLVKIIGGDNNA
>fig|195.2054.peg.1837 Conjugative transfer protein TrbL
AGFRAVATMAAGAAAGAAAGAVGITRAMNAAKALHLAEGGKGGMDLVKGVAKNLAIAGGE
HLRDNLTKGRMPNQMANRLQE
>fig|195.2054.peg.1396 hypothetical protein
MFPNILIQIREFLLKNKAQLKQYSRDGRINSAFNEDEITNIIYDNFSINLPNARDWFDFS
FEESGKFYPVNIKITTTRTIDNLNCKLGIYYALTGDIPSFNNGINWDQYFCNLKTNLKEN
SKDYY
>fig|195.2054.peg.1329 Oligopeptide transporter, OPT family
MLSNGFKLAASESSLAFIWNKMAFGFSAGYSLALLGAGYLVGLAGAIALFVGMFLAWGVF
TPYLSSFEFDGVKNASELASSVWAAKVRLIGTGAIAIAALWTLIELLKPVISGIKEIIKN
VTISNTKSQESTDQDLSLKSIFILFIIMTIGLFITFYSFVSDANLNNYYQILFAFAGTFI
AVLIGFFVAAACGYMAGLVGSSSSPISGIGLIGIIVSSLVILLLGANLFDDPMLSKFAIA
LAIFTTSVIVATAAISNDNLQDLKTGYLVGATPWKQQVALLIGCVFGALAIVPVLNLLYQ
AYGFVGAMPREGMDLSSALAAPQANLMSTIAQGIFNHNIEWSYIAFGVVVGIFIIIIDKI
LRKNGNLSLPPLAVGIGIYLPPSVNIPLVIGGILKYFVMRYLANKYQNNSHKNEKIATHE
QKGTLFASGLIVGESIFGVIIAAITVFSVSMGGSESPLKLSFLNIHNNELLGLIFFIGVI
LYFIKRIVKIH
>fig|195.2055.peg.1778 Flagellin
LISAINAVKDTTGVQASKDENGKLVLTSADGRGIKITGDIGVGSGILGTQKENYGRLSLV
KNDGRDINISGTNLSAIGMGTTDLISQSSVSLRESKGQIDANIADAMGFNSFKGGGKQIL
VGYSSVSAYMSSEGSGFSAGSGFSEGSGKNMSALLTDSLVTISAMSSASNVYTVSKGSGF
SEGSGNSQFATLKTSAGNMAGTVDKSAGVTTLKGAMAVMDIAETAITNLDQIR
>fig|195.2055.peg.1672 Motility accessory factor
MNKNLFLKNTQALFEVDQILAYKLRSLEKIDFKILQNENGINFIKDDIALYKNPNQELLE
SLTLFKSEYEKYPVLFFYGFGNGMFYKALCENKNHKHIIVFEDELEILALAFHLFDFSKE
LKNEKLILFYTPEVTTAQLTTLFIYENIQKSVKIFNLYIHNNFYEKFYTQKIKILNYKLM
ETIKYIVLNKGNDPYDSIIGIKHTLNNIPKLLSHGIFQDFLKKRKGKVKNAIIVSTGPSL
TKQLPLLKQYANKATIFCADSAYPILAKHNIKPDYVCMLERDDIVSKCFDNDFKEFDKGI
LFILASVVHKEVIEFLERNNREYMLVHRPLHFAASLNLKEFGYIGVGASVANMAYELAAS
LRHENIIFIGQDLAYAKDGSSHPREHIYGNQGEKLRGEVYTLAYGGEKQVRTQLTWNLFR
QAFEKDIFWAKEKLKINTYNCTEGGARIEGAIEKPFQEVCETLLKENLKKPFDKPKILEK
NKIKNKFLQTQKLLIKNVKQSEEFIKKCQNELKKLDFELSKSQFNSQTLIKIKKNLLFFF
NEFKKLKLFNELTQAIYYHNECEIMHYEVLNDLEQNKKIKDFLIGQKTWWLQSFEYLNTQ
NQIIKEALKKYENDDIS
>fig|195.2055.peg.1598 hypothetical protein
MKNLELRIFRFDKQKDYEAYYKPYVYDNYENFATLYDLLLQVQDDD
>fig|195.2055.peg.1765 hypothetical protein
MIISVVNKKGGVGKTPFAFSIAKDLEYFLQSNDNSIIEKIYPEKAKILPTPKKIDNCVYD
FGGFVEKGVLDIIKESNKIIIPCTSNYNSLLRTLETLNEIG
>fig|195.2055.peg.145 Cytolethal distending toxin subunit A
MNPNGASLTIWALNPGNWIWGYSLFASRPFGDARAWQLIEFPNNTVMIKNTKTFTCLNAY
RNGIVHYPCDQTNFAQFWRLYPMTNGAYQIQNFATQQCIQTPVSNVMEEFNLSFYNIYLT
DCLKEKEKNLDRQWYIGAPI
>fig|195.2055.peg.1488 Putative transmembrane transport protein
MRTYFSKIGFILAVAGGAVGLGNAWKFPTLSAENGGFVFVLLYLFFTLSIGFSIFLAEVS
MGRLSRSDLANAYYTLAKSHARRWRYGGIFTLGGIFVLSFYLVIMGWVLKYALTSLYYLP
KNLEQAGSDFSTLISADLSNSILFFSLSFFLTLLIVSKGLIKGIERLNVVIMPSLFIMLI
FMLLYCMSFQNGFKQAFSYLFYPDFSNFKLSSIAEALGLAFFTLCLGIGCIVTYSAALSK
K
>fig|195.2055.peg.1220 hypothetical protein
MVTIFVRYGKHSMPFFRKTEISDKELQYLGEYLGRNYK
>fig|195.2055.peg.1142 hypothetical protein
INYHNFLNNHNFTSLWLKNLGYNFLNTLTLKEKHARKS
>fig|195.2055.peg.1780 Flagellin
ISTSVGTGLGALAEEINKSADKTGVRATYDVKTTGAYAIKAGTTSQDFAINGVVIGQISY
KDGDGNGQLISAINAVKDTTGVQASKDENGKLVLTSADGRGIKITGDIGV
>fig|195.2055.peg.1249 lipopolysaccharide core biosynthesis protein LpsA
YRHFCFLKDNIKYENKKDIAIFRGAVYQKHRKEFFHSYFGKSFCDIGNTSKQLSQWKKTF
>fig|195.2055.peg.1614 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDDYFK
SIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQASARNLGLK
YMQENDYQIPWVTFTDPDDFLDRNYFYEVDKFLATHKANDICMIGCNIIFYHEKQKLYKD
NHALNFKFKNGIQVKENCNLDNFIQLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEY
LLDNINLKSAFLPTVKYFYRKRVEQNSTLDGKDKIKDYY
>fig|195.2055.peg.1677 N-Acetyltransferase PseH involved in the biosynthesis of pseudaminic acid
FGFYANPFSKILGIGRILEQISIYYAFKIINIPILSLEIFSNNTQVINLHRKFGFSIVQE
FFIKKQKILKMSLKQSDCKALPS
>fig|195.2055.peg.1777 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MLNTNDDKELEKNQILLNSLEEKDNQIRVIFCVDKLNEGWDVLNLFDIVRLGNKKASKTI
TTKEAQLIGRGARYYSFKSDLFDFDDEFRFKRKYDSDLENELNALEKLTYHTRNDVEFIK
QLNESMNKEGLLFEEEKTRIDLIVNEKIKEIIKNNKIYYANNKRIKKRDLKNFYITRIEM
EQKIKGLQIPYFSNSIKESEEKFEEIKEEYDLQKPSALNHI
>fig|195.2055.peg.1669 Flagellin
MAGTVDKSAGVTTLKGAMAVMDIAETAITNLDQIRADIGSVQNQLQVTINNITVTQVNVK
AAESTIRDVDFASESANFSKYNILAQSGSYAMSQANAVQQNVLKLLQ
>fig|195.2055.peg.1775 Flagellin
MGFRINTNIGALNAHANSVVNSNELDKSLSRLSSGLRINSAADDASGMAIADSLRSQAAT
LGQAINNGNDAIGILQTADKAMDEQLKILDTIKTKATQAAQDGQSTKTRTMLQADINRLM
EELDNIANTTAFNGKQLLSGNFTNQEFQIGASSNQTIKASIGPTQSSKIGVTRFETGSQS
FTSGVVGLTIKNYNGLEDFKFDSVVISTSVGTGLGALAEEINKSADKTGVRATYDVKT
>fig|195.2055.peg.144 hypothetical protein
MFSYKAFEANSFGDFSLGNGPLTALSPLKVLGVITGGTSGMAGNFLPSTKLGVFCLTGGV
GFEPSFKGSLSLNLP
>fig|195.2055.peg.872 hypothetical protein
MIVSKAYEIDSCDDVELGIKRESKLEFKLWYDDEKTPEALVFVVQGMGDDISSIQYVGDY
MVRQFNTAVVGVNYHCIGNRPQTGSTFYLDDIDKLILKASCEAADIKLPYDVDKIQDYKA
MSEIFHFVNNQIIEGKQKGNFTPNYFLNLHVSLQPTKNEYQNFGIMQAQDLLNVALYLKK
HAPFDTMGGGYTNYHDRGFSRGIFSAFGS
>fig|195.2055.peg.1736 TM2 domain family
LIFLKESLEKASEEQKEKLLFTKLKNPLYGLLFAFLLPGLDRIYNGNIILGILKIISAIL
VSIGLIIAEDKNDESTMLIFINLFFILSVWVILDYFLVWKDICQNNLKKIFEVLQ
>fig|195.2055.peg.1732 hypothetical protein
KISKIMENSMSSGASFTELYNENNLSRLSYTNFFNEYQRLLDFIRKDK
>fig|195.2055.peg.733 hypothetical protein
MSIFSINDNSNYNSILSQSKANKESKENSKISFANAFLKQNASKLSDIESKNSQTLARSE
VLSNNNALNNSSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQADIST
STNTAYGYSVDKDGYMGSDFNKAAGLPEDFKIHKSTLDEIKKAAENEPYIADMKQYFGVS
EYYTNIDMAETIKQYYNLFSNALGQSFPNDKTSFTEADINSMPSGYGVSGTQWMDFNEPS
NRMNITGLKDFSNSLISNVYKTPEQAKEADEI
>fig|195.2055.peg.1583 FIG00469957: hypothetical protein
MMNEEINSNENSLYELVKEDNSTNMVIQNYNELLSKFENLIKTIIAKIDIGKQNSSSNT
>fig|195.2055.peg.1783 Methyl-accepting chemotaxis signal transduction protein
VKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKT
SDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHG
>fig|195.2055.peg.1487 Putative transmembrane transport protein
MGLIVFTFIFEFEANPNIQGPGIVFVSLMSLFNELGILGYVLAFCFFLALFFAGITSAVS
MIEPLTFYVVNNYKISRIKALSFIGFIVFVLGICCILSLNTHFSSLFSIFGKDFFTLLDK
VTSNILLPLGAIVSSIFVGFFVDKKRIYKIFSKFVNRQIFTIWLFFIRFISPIAIICIMC
YQIFVKIS
>fig|195.2055.peg.1759 FIG00471065: hypothetical protein
SNILSLSLFIMPIFVAVFYIFNIDISLKNLYGSYFIFLIIINGLSWSVNQR
>fig|195.2055.peg.211 N-acetylornithine aminotransferase (EC 2.6.1.11) @ N-succinyl-L,L-diaminopimelate aminotransferase (EC 2.6.1.17)
MKMNYKEQSHIIPTYKRFDIVLESGEGVYLLDDKGKKYLDFSSGIGVCALGYNHAEFNAK
IKAQVDKLLHTSNLYYNENIAQAAKHLAKASGLERVFFTNSGAESIEGAMKVARKYAFNK
GIKGGNFIAFKHSFHGRTLGALSLTANEKYQKPFKPLISGVKFAKYNDFSSVERLVNEKT
CAIILESVQGEGGVNPAQKDFYKALRKLCDEKDILLIADEIQCGMGRSGKFFAYEHSGIL
PDVMTSAKALGCGLSVGAFVVSEKVAQKSLEAGDHGSTYGGNPLVCAGVNAVFEIFKKEK
ILENVSKLTPYLEQSLENLIKEFRFCKKRKGLGFMQGLSLDKSVKVAEVIKKCQENSLLL
ISCGENDLRFLPPLIIEKSHIDEMSEKLRKVFKSFE
>fig|195.2055.peg.732 hypothetical protein
MIKGLSSETLGLSLEEIKNVSRGEDWQFNPDMSVYPQNEDGSYSKETLFMSFLKAQGGQP
VESLKTTLNPKLEAYKRAMAKESFSGPAINIDSIMTGKSDFKSFFRYWAERGIEGDLYMY
ENNISKESAMGNWALDAEIKQAIANGWKAKPSTINSYADSIMDRLNNLIGQTRV
>fig|195.2055.peg.684 hypothetical protein
MKITMIILSLFSLVFLSACAFK
>fig|195.2055.peg.1540 hypothetical protein
KKVTITMKFYTILNILFISFMLSACAVLQKPSPLQENKDFYILDTHTQKKISFEDMILEL
LKADVILLGEKHDETKHKISQVMIFNALEGNLSSQNISFDVALEMLASTEQNHLDKAFKN
KKTIKTNELTNALNWDKGWKWKDYDQFVNAVFYSRAKILGANLSRSEITSIYNGVQPLKG
YVSTTNEVKKQIFDIISLSHKLNPQENKELLDKLVEIQQFKDRRMADVLVHHTNKVLLLA
GSYHTSKKIGIPLHIQDFKSDKKIVVVNLNYGERDLKDSDYTFIYY
>fig|195.2055.peg.111 Flagellar motor switch protein FliG
MSTRASEAFLEEMGFLGAVRVKDVEDAQRKVVEVVQKLAEQGLVQTGDADEMIE
>fig|195.2055.peg.1361 conserved hypothetical protein
MIHKLHIKNFKLIRDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRN
LIQDTEKIQNNIKFGVSGEYIGNYFSTNSLKSIDEIFYENPDSNKILNYHVDKWIKEILD
LEISFTTNESIDIILNGFKDKNFSNYFLPSNISTGLNFATKII
>fig|195.2055.peg.1754 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYSIAN
GIFL
>fig|195.2055.peg.1721 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MGFEPDFIFFGKKNKDDDNFLSIQCFIETKGEHLAIAKDAWKEEFLETLKGKIITTKDDK
KLTLQSLPFFINKNFNINDKFLSSFDEFVSFQDER
>fig|195.2055.peg.1670 Motility accessory factor
MQNTIFNKNLKAMNGKEYDELKEKLVKIKELREFSYTFGKDNLDINIIQKRNLKTLYKNP
LKELEEKIEFFKDYKRYPALFFYGLGNGILYKALLLNEIHKRIVIFDKEIEIIFIVLNLL
DFSEDIRKGRLILIHTPEMTYAKADIIFSLSPIERFFKTYNLHLHSDFYKNYKEDTLKIN
TLNLKAIKNISLKKGNDPKDAMQGIEQFVRNIPKMISHPSYQTLLKKRRNAKNENAAIIV
STGPSLEKQLPLLKQYANKATIFCADSAYAILAKHNIKPDYVCMMERDDITAECFNNDFK
DFDQGITFLVTSLVHKNTISYLEKNKRSYILVTRPLPFASSVELNEFGYMSCGLSVAHMN
YELAINLNYKNIILIGQDLAYAKDGSSHSKGFIHEKLHDGHHQRDFNKYTTIAYGGKGTV
QSSEVWTIFREIFESFIASNKDKIKTYNCTEGGARIEGAIEKPFKEMCETLLKKEPKKPF
VKISKLSKIQRNALMLKAYTKIKKQILLADTFLKECKKIKNQLASLKREKSKLTLDQINQ
NLDKFKTRLDSNRYNFLFEILGPTLHHEEGILSPLYVQSIQNESEKQNKLFAWLYAHESL
IESIYDLTNTQNTILKKAIMPLQDELEKRNLI
>fig|195.2055.peg.1143 Transcription-repair coupling factor
MQANFFEYLQDSNIAQLVLCEDDKESFLLSQVALFKDLKTFVLPDFRAEFGDDLRAFSKE
LFELCKVLNAYHKEKDTKILISPLSTILKKLPGQKHLKNYKLSKKNVFNLSEFKNELNKL
GYEFVDMVQDKGEVSIRGEIIDIFCINEELPTRVLLFGDELESIRKFDPMNQKSFPKEYE
ELEICPFLTYFSEENYENFKDKLENFDSDVLIND
>fig|195.2055.peg.683 Transcription-repair coupling factor
VLINDINSLGFWCIDDFCDYLELDFISIKKFNQEEWDKDLSKINAKIIPQASVYKDLKSS
YNKDFFSLQQNKKITILAKNEALFKALELENTQNISFQKSDLILNLISNQELIISLNHKE
KQKYKRKANLIIDELKIGDFIVHEDYGVGKFLGLEMISISGAKKEFVAIEYQNSDKLLLP
VENLYTIDKYLGASGGIPLLDRLGKMTFIRLKERLKTKLLAIASEIVIMAAKRALIKPKE
IKIDYADQAYFVSKAGFSYTQDQNKACEEILNDFENGKVMDRLLSGDVGFGKTEVAMNAI
YPVVKSGFCAFFFAPTTLLSHQHYKSLKKRFEPFGIEVFKLDRFTSTKEKKTLMLNLEQN
KACVVIGTHALLNVECENLALVIIDEEHKFGVKQKEKLKELTQNSHLLSMSATPIPRSLN
QALSSIKSYSVLQTPPEDRLDVRTFVKENDDALLKEAITRELRRGGQIFYIHNHIASIEQ
CKKHLLDLFKNLRILILHSKIDAKIQEEEMLKFENKEYDLLLSTSIVESGIDLPNANTMI
VERSDRFGMADLHQLRGRVGRSDRQGYCYFLVENKEELTQDALKRLVSLESNSYLGAGSV
LAYHDLEIRGGGNLLGIDQSGHIEQIGLSLYLKMLEDELNALTKKESFEEKKIDLKLTIN
AFLNSELINEDRLRLELYRRLSKCKNIDEVYEIEGEIEDRFGKLDLYTKQFLMLIIIKIL
ALGKFKTISNFEQNIQFVKINDEKEFIKARSKDDDDIIEAVLTHLRKDK
>fig|195.2055.peg.1658 hypothetical protein
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIGIKNHWDLAFLGYSLNKKDSY
ILNNSLWNFQAIKQHKKNIFSKIKD
>fig|195.2055.peg.1717 Mobile element protein
MSANNNELISISHKVELKPNNKAKTHFKKAFGCARLAYNWGLAKWQEYYKQGIKVTHLDL
KKEFNAIKKEQFPFVYEVSKYATQQPFLNLNLAFQKFFRDLKQGKVSYPKFKKKKDNFGS
YYIGGDQAIIKDEKYLKVPNLGLVKMRENLRFNSKINSATISQKGDKYFASFSVEIPQDE
FIKTHKIKENKGGILGIDMGLKSFVSLSNGLSINAPKPLNKLTRKLKRVSRQLSKKQHPK
AKGDKTKKSNNYLKQNLKLRKIHTKIANMRNDFLHKLTSILANHYKYFCVESLNVQGMMK
NHNLARSISDVSFFEFKRMLAYKSAYRGNEVIEADRFYPSSKTCHCCGYKKEFLTLSERI
FQCENCGITIDRDYNASLNLKRYAINNIGLVQAEFTPEDLTALQSDLAINRIATSKVDTG
IQQKSCL
>fig|195.2056.peg.932 Protein containing aminopeptidase domain
MNKLDFRSQDFSQTGKAMYELACELFPIPRSITGQGFRDSLEILNKTLGGGILKFHSIKS
GTKVFDWIVPDEWNAKEAYIITPEGEKICDFKKHNLHLLNYSEAIDKEIELEELQNHLYS
IEEMPDAIPYVTSYYKRRWGFCLTHNERKKLKKGKYKVYINAKHDENGVLDYADFILPST
QNSKDEILIST
>fig|195.2056.peg.1800 hypothetical protein
MYHQNFFCFFSRAYAYANFFIFYIFLYIFRGLSKPYMMGASEILRVEMVGIKGRNGRY
>fig|195.2056.peg.463 hypothetical protein
MQVKFFLKNRIFLSFASVALIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTF
KQINGTNYYGVFKQGLVSDITLEVFNPKQSLQGAKLEILTPNHSSEEILEVQSMHAANPM
DKNLHPIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNIKTKNPPKKEEKDKI
NYVISGGLAREGNAKNNTLELLDGSYINMGVENIYNLKLNGAPYAVGGLAIFGDAIGNSL
LAQKGSKVDIHTASFYRDMVGEFILDERITHLVGGLAYNGKVEKNKLNLNGVEFNIHAPS
GLYSSFAPVHIAGAFVDGNGKKAYDATKNTLVIDNFLLNLRADGKTPIFYNAIFLANFFG
GKTNKGDANANSIVLKDVPALKRISKKVKVQGIYDFFSGYTLDGEANFNTLEIELKSPLQ
VSNSYLRHSGFGFYGAFASKGASNNTIKIRNNLTVINDTQNPSDRINIITGRTLAGEANF
NVIDFKDSQASLPLFIYATTQENFEGSIHYPEYAKHNKISLNNVFGRKDIRSGVEAMNVE
NNQVFYHNVEAQASGEGVNRESSVYIRAANLAKNNLFKASNYWATSMLNIYGIREVEESK
NNQVIFNNVGFNTDRISEGSELILIGGVGKRVHHNLLSIQDLEIGAYDKEKDFIYIAASA
IPDANSNLALSYGNTLYIGGDVSIHERSLLNVLSGSVIRIPNYTNNKADDITLPAPSLAQ
LTKDNHLILEQALRARVVNNFEHYSLIYHSNNQDKPFIESLETPINLSEES
>fig|195.2056.peg.984 methyltransferase Atu0936 , putative
MEIDKLLKQNGFDILSSIEDYIEETTDDRELLIIAKKKEL
>fig|195.2056.peg.997 hypothetical protein
MDKAHLITYLVSLAFIVSGLIVCCILYLFKDKINKITPENIDNINSNIKDLVSKNMKNVS
SFNSGSSATDCCSMITDSSYRSLSCNIFHDRD
>fig|195.2056.peg.359 2-hydroxymuconate tautomerase-like protein
MPFVNIRITKENGEPTLKQKQELIEGVTDLLAKVLNKNKASTVVIIDEIEMDNYGLGGKT
ITEVRKEQKKS
>fig|195.2056.peg.1489 FIG00469797: hypothetical protein
MGLKDNLKAVKAEINTEEQFI
>fig|195.2056.peg.1814 DNA/RNA non-specific endonuclease
MKLPVKKLILLPLLSTLAFADYTQYKPSEDFAKYFTKQNCSQVLDKFYYINCYDYNYKGT
KAVAYKLEADNLKGEQIKKRPRFEDDTNIPKKYRTTWSDYKNSGYDRGHTLSNASMRKTT
QAQRSTFLMSNITPQNPQINQRVWNKIEKRERQVASKLGSLEVLNLVNYDNNPQRIRNQI
AIPSSYIKILKGENFKECYQVPNHEVEDESIKKYKVNCDKI
>fig|195.2056.peg.597 Peptidyl-prolyl cis-trans isomerase PpiD (EC 5.2.1.8)
MLTWMQHHKKYLVVTIWISTIAFVGAGFLGWGAYDFNLNRSSSVAVVGDEKINYNEFNVR
YNQIFNYYNQISNGGLNEESAKQLGIENAALSSLVEDKLLLNFAKDLGLGSSENEVIQAL
AETRAFQDPSGDFNKTIYYELLNANNMTPKEYEKTLSNEIIIGKLEQIFNLPQTDEELKM
LGASYFMQDSLNIAKLEQDKENIKVNKEELKKLWNEHKEDYKTKKVYEISTYYLPVDMQK
IDDSKLEEFYNNENNKFKYKDFSGKIMSFEAAKKDVAKDYALAQLKNTANAKFLELKEGK
DKFQKDENITESDVYYPLEALSRAKNGDVLRPSEYQNGYIIVKLNKINPVRTKTFDEARE
EIMPIYISEQVKKNLEEKAKQNLENFSGTNIGFVSRDSTKNDSKIDNILNEAEFSYFLMN
VFNSDQNRSYVILNEDKAVLYKINKQKLDMNPEKFQQYRTMLHQNLQNLKANEMKQELIE
ELKKTYPIKIYYKEGK
>fig|195.2056.peg.1792 Beta-1,3-glucosyltransferase
DKDIESIRIDNEVIYADYEKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEILINGEYVKI
TFQKKHHQSIKIQDIRKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEQEIVF
ALRKESSDWKRLEKEGFNLIEFGSYEFERIIKKASKVISSHLDGCCMQYVRKYDKIFVNL
QHGVTFATDVSRWLNSYPQIKLMTLCCTMEQNNIATNYNRYIFSKKEAKMLGFARHDELL
RKSSLYNEKVIFIMPTWRLNIVGKVIQNTGIREFNDVFLNSQYFLKWKEFLHSEKLKKLS
EKFNYKVVFFPHFQSRLYLDYFETPSYISIDARNNGESLQTVFAQSSIMITDYTTAASEM
AIQGKFTLYYQFDRDEILNGQHHQQEIKFNYDTDSFGPVSLTLNDLLLNLEQILDNKVNL
TRYKKNMDTFVFNDQKCCERIYNAILELENSYIPDFDFNYIYNKASIAQKKLMYSEAFLK
WKYLVQNSKDYSKDVLYQLLYCARKSFNYSYAIDFIESNNFLLDDNFIKKEYIRFLILNG
LYMKALDVICAQFSIKKEHCLDFYLIQLELCYLANREELFFQIYKKLVNNNFITELELNM
RITFFQKNMIELKSTECDTDKVSLFVRIENFMEKN
>fig|195.2056.peg.1797 hypothetical protein
MSKVATAHCNPKKQPALNHNDRTNDNAKTITKELTHLNEYSCTSDEVRKNIERLYKKAYE
NFYKYCENKNGLAKSGKPKGLQNFTKKEKCYHEFIYEIGENTTMEQCQELTQKIAELTGF
TPLQVVIHRDEVSENAKGEKQTHYHAHAVFFTLDNNGLQLARREASLNKANLSKIQTLTA
QSLKMERGANRYENNEKQPQYIQDYKIYAQFKEQEKALLQRIQEQEHKLTQMALELKKKE
KEIQDKAKELKSKENELQAKIEQHEKHIQNLELGHERA
>fig|195.2056.peg.461 Filamentous haemagglutinin domain protein
NIMLKSLDRILCIKKKRGGGMNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLV
LAQSLTASNLPSGGKFINGTGSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTN
GKNYLNLDYTNKASQILGTLNGGTNNVYIVNPSGVLVGEGATINANKFGVSTIPMGIDAI
NTFSVDDSFSPVFNANKGDVVNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLE
DFGINSTHLKAEIGSEGFFKYEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGS
QSASNEEMINSWKGFAKLVNEGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFY
GNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENG
TFSNIALDTIEGFDSENSSSGGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGD
FSSIILSNIESIYGKNNGGGFVGYTTGNTTFDGIGLKDIRFIKSGAFTGGFAGMTQGNVI
FENIVLNDLEEISGSHAGGFVGGVLNNENGIASLSNIVLNNIESIKGIGFIGGFAGWIND
GTFNNIILNNIEKISVSATHKYIFTGGFTGYAGAGTYKNIILNNIGEISANGTASLDEKS
IYAGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIANSNIYFYGLLNS
SSNKNYITHNENILNLSNTTDFQTFINQSKIAGLEYLTNTSTSNSHLHMINGGKIGNEKS
KITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDFEDEILKTIIDEI
LNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFYTEFNKGGLKTEF
EKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLKPELESIKNNLNRLEFLKAEIKRL
ERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNKPFLDV
>fig|195.2056.peg.1611 haloacid dehalogenase-like hydrolase domain/phosphoribulokinase domain protein
MFNFKKIAEKYKLIMVDIDNTLFNYTFAHKNALEVVMKLYSFTLEDYDLAKKMIAKRGLS
ANHHKKELYFKIICENKNIHFSKASEMFELYVSIFTRNLKVDKTMFEFLCFIKSLNKKVI
AITNFYFIEQIHKLNCANLTNMIDYLVCSEEFELEKPNKALVNRALELYGKFIDEEEIVM
IGDSIADNFLGGGYRINYYPYNCSKLLISISGKSGSGKTTLSNAIDDIYKSFIISTDGYH
KYERHSKMWERVTHYNPEANNLIQLAMDIKHIYQDIGNKLHIPIYDHKNGVIVKSDEIKI
KDLDIVIIEGLHTLYQEVIGDFVKIKIYIDSDEADRQKINRDSKERNYSHSKIIDTIQKR
EEDYKKYLEKQKDNANFLILVRDGIFKIYLKDILLNNYLQKEYTGRYEDLIQTVKNIFSL
ILQNRWVKKNDIQ
>fig|195.2056.peg.1350 hypothetical protein
MAIGKVIHKYGSFFPDFDEIFYKIKYEIYRGDWEMLFFLQIPNIKKNRYFRIF
>fig|195.2056.peg.1 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYIYVDDY
LARNYNVAIININYHCIGNRPHLGSSFYLDDIDKIILDTSLKTINLNHINVFDINSYENL
NNAFIRIDQEIQKLKLNQKLNQNYKLRTHVSFLPSKNEYQNFGIMQAMDILNAIFYIKEN
SPFKLMGGGIRTILFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKE
IDFTRYHGTYDDTLFKNIFLYLSDKTYWNNNKFSKKYFSNARKIIREPLNKEHLIIQSLY
PNPKYILYHSMFDER
>fig|195.2056.peg.1833 Methyl-accepting chemotaxis signal transduction protein
VKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKT
SDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQ
KSLSEIEANTNLL
>fig|195.2056.peg.1686 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13)
MAIEFDIQESKILKGVYIITPNKFRDLRGEIWTAFTDEAINKLLPSGLKFIHDKFIHSKH
NVIRGIHGDVKTYKLATCVYGEIHQVVVDCRKDSPTYLKHERFIINQDNQQIILVPAGFG
NAHYVSSESAVYYYKCAYKGDYADAPDQFTYAWNDERIGIDWPTNSPILSERDILAMSKD
K
>fig|195.2056.peg.360 hypothetical protein
MSVPFYKLVDLCNPKFNLEPKITDEFLEEIKHELSYFKEREKYFLQILNKLNDEKSEEYK
KFTQEYEKNSQKYILAYKKVFASENDAWFNEMDKKRLYAFYKSYEYYPFIENAKTLNENK
VFAVSDREFDDFYFDDEFLVKNESEILEKLSQEHIKEYKKFKEKIFKDSKKNQSK
>fig|195.2056.peg.1165 integral membrane protein, putative
MLSLLKNPLVGLVLSITVGLFGVDRFYKGDILLACIKLAFFIIPLFATFAAFIALLDESH
SIFIDYFAIFALMFVVASI
>fig|195.2056.peg.1539 hypothetical protein
MNRKKLKKILLSYYSKDGVGSILSSRIGIKVQIAGELWEKHQIPPNIWGKNNRNKLLKFL
GEKERIENEND
>fig|195.2056.peg.1801 hypothetical protein
KKKEKEIQDKAKELKSKENELQAKIEQHEKHIQNLELGHERALKELTQEFENRLSLWKNI
LTFGKHNAKVREDYQLTKNAFLISTDESRREANKELEYLKFEYHKVKDERDNLKTLFEAH
KTKNVKLETRLKEIGKWCEKNLSVEQLKEIFPLKAERIEKELKYQRAFENSFEQTKTKRN
DRGFGFSR
>fig|195.2056.peg.6 hypothetical protein
METFWKHFLLRNGNKFRLTTNDLVLLKPLKARPPKNLCRFSALK
>fig|195.2056.peg.1633 Catalase (EC 1.11.1.6)
MPARWKLVPSEGVAYLNEAQMKSASSDFLKEDFEDRVKTNKPVEYKMYLVYANKNDIINE
TTALWSGKHKESLVGTFKVNALSDEDCNFDVYFPSDVPQGVNPPQDPLFDVRNEAYAITF
GMRQ
>fig|195.2056.peg.1687 GDP-L-fucose synthetase (EC 1.1.1.271)
MQQNSKIYIAGHSGLVGSAILNELKQQGYKNLVFKTHFELDLTNQKAVADFFEREKPEYV
ILAAAKAGGILANNTYRADFIYQNLMIECNVIHNAYLHKVKKLLFIASTTVYPKNATLPT
SEDQMLSGDLEYTNKPYAIAKISGLMLCESYNLQYNTNFIAITPTNLYGNNDKFDLEKSH
VLPGILRKMHLAKLLNEKRYEDLLNDLKFDSIEEAKNYLKKFGIDEDNVEIWGSGKPTRE
FLHSQDLANACLFIMNNIDFKDLKGDNTEIINTHLNIGPHKNITIKELAELIKNIVGFKG
KLVFNLNRPDGAMQKFTDCSKIHSLGWKHKIDLEKGIQMMYEWYKNNQETQNNNNSSIRW
GGGLNFEYFIFSNIQSFYTNNIYDFANSTKRVCNA
>fig|195.2056.peg.1681 Para-aminobenzoate synthase, aminase component (EC 2.6.1.85) / Aminodeoxychorismate lyase (EC 4.1.3.38)
MQKDGNYTILENHIKTSDNNILLLSDKPLNSQSDSLYHKSSLRQIYDQKAFLWKENQCFD
IAFFNEKNELCEGSRSNIIIKKDKVLYTPTLQSGLLNGIYRQFLLDLGLIKEKKLFKEDL
LNADEIYCINSVRGLQKVSVK
>fig|195.2056.peg.1614 hypothetical protein
MRRLAICLYGHCRTFELTYQNFFKFVVDENKLDGYEIDIFFHTWDVYHESFGSWHKHNSF
FNKVSLGDMEKRTICEIYKPKLFSIEHLNEGQHGVDISLDRVNMMREKYSMEHHVAYDYI
LYTRMDIMFLYPFKINSFLDSYNHIELRSFAPKINEKFLFAANNCFTRFKIADYRYPNEG
DLLWFSNFSSKRPFLENNCNIVLLDYRVHNHFYIARANILTQENIWKRLDEQERYIKEQE
NLLIEEKYMLDLLSFRSKYGTAKSRIQNQLSYKLGQTMIINSKNIFGVLFMPVYIISTLL
SHRQEKKIYQEKIKKDPSLKLPSLENYPDYKEALKEKECLTYKLGEVLIRANNNWYGGGY
IKLLFEIRKLKKEFKKK
>fig|195.2056.peg.358 Nitrite extrusion protein NarK
MILRIMICFLSTFVANGLARFGYVVLIPIMIISGRLNENQSIQLGIAVLVGYIFGSFFIN
FLRKFISLENIAKLSFLIISLSFFACMMESLPFIWAWLWRFFAGVASASLMILAAPLSLP
YVKERFRGRIGGFVFSGIGLGAVVSGFTLPFIANINIDLVWIVLGGVVFCAFILSLFSLR
TLKRSKQTIHKDNKFKIPYGLWLLIISYILNAIGYLPHTLFWVDYLVRDLKFSTLLAGSS
WAFFGIGAVLGSIGSGILADRIGIKNAHIVILFFKALSCFIAAFASDLFWLNFSIFVMGF
TTTGNVTLTNALALKIVSKKHFPTSSSFLTLAFGIFQAIFSFLFAYLLKFLDGYFWMFIF
CGFCLIFSFLVLLPIKISTLRN
>fig|195.2056.peg.1734 hypothetical protein
MAEEKENIVKEVCKELNITQKELSEILGVHLTTIQKWVANDNDLPLQAKKSLNLVLENHH
LKIRLKTLDEFVRLFKELQK
>fig|195.2056.peg.1624 hypothetical protein
MVTLNLIGSNSSSAYRSGSFLAWKLINKFYDFFEFSNELFCPHCQARYRLNFNSPMFWAD
ISSFLV
>fig|195.2056.peg.1359 Putative periplasmic protein
YIGNIIPQFTNTKDSIIINFTGKSVTDDSRFRVEFLNNDKPIGFFFDFDVTLQKIYNSAI
LPQN
>fig|195.2056.peg.736 Bacillosamine/Legionaminic acid biosynthesis aminotransferase PglE; 4-keto-6-deoxy-N-Acetyl-D-hexosaminyl-(Lipid carrier) aminotransferase
MADFTIKKFKKGLKLHSILRAFKGNFTIKKFKKGLKLYNIF
>fig|195.2056.peg.1809 hypothetical protein
VVGERSICVEGIPVRSAGANRSEHAGMSSDN
>fig|195.2056.peg.1839 mobilization protein
QYIQDYKIYAQFKEQEKALLQRIQEQEHKLTQMALELKKKRKRDTRQG
>fig|195.2056.peg.1347 hypothetical protein
MTILTSFDNEAEMDETIFADYLFDFSNLYKLANHYADDYVAIVGQLFFR
>fig|195.2056.peg.1349 hypothetical protein
MFFTEDENLKNSIKPNYNSEYVSTIGQLFLAGYIEFGMCGLQNKEENLLSNQGDKYQAWI
YFRDNFFYTEAYCRDIMEVKEPYKDMSDDDYVYSSWNTPQYWDRYRFWVARTEKGTKYLR
EILEPRIYNKYKDLEVEIDDKGSVLRWIGEINR
>fig|195.2056.peg.1610 hypothetical protein
LIMIFLHRQNNLETSIENHGIEIDLRYNENLVLNHDLLEKNSLYPFFKEKIQFMKNIPII
CNVKESGLEEKIIELLSDDFEYYFLDSQIPDILRLSKNGYQGKFIIRISDVESYNEKLMD
ISKPKYVWVDYSQFSSFNIKDYQEFIYNIKPKLGQVEPILVSPELYDRSYAELIKPIQSI
LPKGFSVCTKKPELWSMYV
>fig|195.2056.peg.1793 FIG00469769: hypothetical protein
DNIFISLYQELLKNANENIKEDFKLVVKKMFRERKNCAKVISNDLLQADQDPQSPFVYKT
DCIEKTYAKVFLELMQKAKKDTQSKERLKQIFNNQADRYENLIQMSIQDPIDLEIFIDNL
AQEGLIDDNARLKL
>fig|195.2056.peg.1164 integral membrane protein, putative
MDFYLLFLLPGLDRIYNGNIILGILKIISAILVSIGLIIAEDKNDESTMLIFINLFFILS
VWVILDYFLVWKDICQNNLKKIFEVLQ
>fig|195.2056.peg.1591 rRNA small subunit 7-methylguanosine (m7G) methyltransferase GidB
MDVKPLIKLCLNISDQKTIFILWKGSEIFDEVEGLKDYDIFENGLRRYCVLKNTQSGMNT
TL
>fig|195.2056.peg.1743 DNA-binding protein Roi
MKKNKIEIGEKRLFAFLRDNGFLMSDNKPYQKCIEQGLFKVSETTISTINGDRLVSTTKI
TGKGQIKIANLLL
>fig|195.2056.peg.985 hypothetical protein
IFYLHIDILSNYTKCLVTLNLIGSNSSSAYRSGSFLAWKLIKKIVNLVYI
>fig|195.2056.peg.1791 hypothetical protein
MSDITFYMDRIDGLGSRIIALMNAFFLAEYTSNSDSVKFIWKDNRPFGGVRTEDTKAGFR
KETDGKVDIVGLCIENAENIFSESFLKKYCIDKISFKTISFDKPYSNIDLFREYLFKNQN
SFFNAPLADLTSRSFLPNLDLSYYKSEMQQCWKKIHFSAEINKIILNAQNMAEKIGDFVV
IHIRSGDGIYDYADFRKFNTQQFYHITSAELAMGIIDLNLDKEVILVGDDLKTLDVIVKY
YNKNNIKTINYFRDPTKLSNLELFFFDVAFMSKALILYGTHSAVVRLANFIGNQKFINNY
RVFTNEEYLSILKKYFPILKLHRCQKAYSLFSMFNISRILLKPQDDLLLYLYQALDCDYD
NDKYRIHIVNCLITKGDLLGAENLLKDIFENQNRGKEYIDTLFLKGWTGVVFKEVFDNYL
KNATEDYPYITFIASKICEFQNDIKQSFFYIQLISRRFDKPFFLEYFNKVKQNYNKEKEI
EHALYHKKVALSYIEKWKWKSAINHYQLALKYSDEYLVEFLNFLASIGQLKLLDQIISKY
SYERIEREVSFCKNYYVLSIYLELYKNDIMEKKSIIYDNLYIKDVLINILKKEKISQKEE
LIATYCISSCDEIFSEKLDISIYLSFYRKIWDKNLIRSQFLITKLVKSYKKYIVKNLDIL
IQVTSDITA
>fig|195.2056.peg.1223 Flagellar hook-length control protein FliK
MSNLTPSNDILNLTPSKTNTTHSSSSKTKEQDLKKSDNTTQDDTESFLNSLLNSIEETNE
FLPDHMKISKKEVVNEAMDKLQNGVFSESDKISIFESASFMQILSLLDKLKADTADIKLA
NLSTQLSQLVKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNLDKA
NFFKGAVDNVFKEIINNKLAHISKNLNQNVQNLNHTPHANLSQNSKITKKDDTSLLSQTL
KNLDAIISSKKEKNEVKNDNVKIQTDGETAELKNTSKNLTHSESLKELEQENLTNNDKKI
PSQEVQNKEQSKESKNDKNTLLNESLKKDDKELKNANKANVQDLTPSKNNTTQDKLPMQD
KVSARDKALTQEKIIPQEKVSTQEKTLPQDKVLIQEKPLNNKEGLNQETNNIKNTKDLNQ
ALDKNNNLSENPKEQVKNENTNFNKTSNKENVRDSQNLSLNLSLKDLNLNKDNTNFTHYT
NKENYTQEQGKIQSENTEKNPLDDLNSLVKDLNKISQNNTKNITPKETLQHFSQDLKAAM
EQYKAPITKLSITLNPHNLGEVEVTLVQRGNNLHINFNSNTNAMNLFIQNQAEFKNSLVN
MGFTGLEMNFSDQGKREQNQNQGKNRSGYGFKDALEGKTENEKVNLELVLAKYF
>fig|195.2056.peg.820 hypothetical protein
MLETLKKYVENQGIEDNYPKKKYITKKKKSPNGTKQCK
>fig|195.2056.peg.1675 Bis-ABC ATPase Uup
MALIDLIDASKKFGEKIVLNEANFSANEGEK
>fig|195.2056.peg.1391 hypothetical protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLFDKIKKLKERSKMAEEKENIVKKVCKELNITQAELGRQLDVPASTINTWASG
KIPKMAEVALTLMLENKQQKEILEAIKKARDFIGRI
>fig|195.2056.peg.1236 DNA primase (EC 2.7.7.-)
LEALFKNLHRFFSAKNLDIKILKNNSENDYNEEPF
>fig|195.2056.peg.1141 FIG00638667: hypothetical protein
MKKLLIIPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPYYEIKNINFHKGFLNSKADFT
IEDKYNLGLISKLDFKFNNNYFSKFIAQGKLSNPFKLLDDKLQNKELAWFKIQSIQNDLN
VSIQFQDINLSNEGGNALWENVLTEILLDKEDLKIKAIYSKIGQVDFSQFYAKFYLKNLD
HQQKFEKPISFSNLIQFNESVEEFKFDFCEINNHTISSF
>fig|195.2056.peg.1684 hypothetical protein
SDITALGNTKNKLQPGAKKYQEKLLSYYKLHHQKNIKPKIAVCLWGIYRGNCEKNLEFLK
KNIIEPLGADVFVHLWNKWDLWNGYGGDVIWTRRYLKPKDRDLFPSEISHYDTLEKFFPN
VLKRLSTPIIKILPLDVIKSILSPLLIQVDNDEDFKNKFSFPLEKLSYIPFANYNPYAVA
RLRYGMYQSYNLAKEYGKRYGEYDYIVLARIDQAYLNEMNIQQFLSLGGNEFMCRILKHG
IDDRIIAGSKKTIGKFVNKYNIMIKKQSTNFYQVEERRSYYIKGEEGVGFLWSVENNIRP
IPINLDIDISLSTQGMIPNFYDELKKDLNSSAIAFKDKIEYKELLNFLQSDDGKFFKNYD
QNLEKEKLKIGAVERIHNHLSYKIGCAILNNMGSMINIVKLPIVLYRIKKNHNLDKRLTN
NSLQSIPIEQYADYMEALKEKESFEYKIGEMVIKSHKNWYKGGYIKMLFDICELKSKMKT
RGEE
>fig|195.2056.peg.1200 FIG00469817: hypothetical protein
MILDKKIKYYISNKTKYSYPILTKDIQCSNCKNFYSIEFASNLKKIEKECPSCKTKMDIK
LKD
>fig|195.2056.peg.1813 hypothetical protein
HIDCFVLFGVTAILQCLSFFMIGYFYVFNFSPNIIHMTSYYQNNTICSKVSPNAYIHLLG
DNKVSISPFNEKFVFHLDKSVEYKFITKDCN
>fig|195.2056.peg.1663 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
MLKDKLLQDLEEHFETLGQVRNLAQNYDERLFNYLLEESKYKEEFKNRFFIFNKKVLIFK
INEFLTFLDLKNLSGSFTSYANKIGLANKTKSLLKTNNEVVLNFAFKDGIIKGGQSKDEQ
KTQEIFFNEILAHDEIDVLFDKKALQNFELIGESKNLQEYLKNNPNLLIKGNNLLVLHSL
KKLYVNKIKLIYIDPPYNTGNDSFGYNDKFKHSTWLTFMKNRLEVAREFLRDDGVIFVQC
DDNEQAYLKVLMDEIFGRDNFVNSIAVKLKNIAGASGGGEDKRFKKNIEYILIYGKSYEK
LEQFKSVYDSRELYSHISFCKENNISWKYTSALLNGGEKKLIATTLDGDGNEIKIFERIN
YDIKSIGQMIKDFKMNEKEIFYHYVNKIFRTTMPQSSIRVRVLEKLKELNLSPYLISIEY
TPKSGRNKGVVYEQFYNGEKLNLFAWLKDVVEIKDKQIFKKELAGTLWDFAFAMTNLTKE
GDTQFSNAKKPEALLQRIIEISTNENDIVMDFFAGSGTTLAVAHKMKRKWIGIEQMDYIE
TITKERLKKVIEGEQGGISKAINWQGGGNFVYAELMPLNAIYKEKIQNLNDEKELDNIYQ
ELKTKAFLDYRVDINEILKDKEFENLDLESKKEILKLVLDSNMDYLLYGDIKDEDYALSK
EIIKLNKIFYGDENV
>fig|195.2056.peg.1352 hypothetical protein
MRKLDDQTIIQYKKASKSGGETIEVISNKPRGNLRTIHIENGVKNEV
>fig|195.2056.peg.599 Membrane protein
MLDDDFLKEKQNIRQKMLKFSRAINQGKPLEDDLKEEISSDDILRRRFKKRSNRFLDEIE
EEQELKYTKKSNIYLKEDLINVKLEEKQSLAKKIFSKIKEKNKNQELKNKKSKKIFSFLK
KKEIQIKQNKTLHHNAQEKILPTDKKIEVKKIQNNKILPTQSAPKPDLKQSLENLQKKIQ
TQEIKTEIKEPEIQSIKTESNEDPQKVKNVLLEGFSNATKEDKNLNFNHLLFAVLFVSFT
LALFAPQIYIRNQIYYLSREIGTLRVEESMLNEENKDLKRRLEIMRFQNQILDYLE
>fig|195.2056.peg.931 Protein containing aminopeptidase domain
MANNELSGPVVAIFLAKWLLSLKERKYNYRFVIIPETIGSIVYLSKHLEHLKKYVKAGFV
LSCLGDDHAYSLIHTPKENTLSDKVALHTLKNKENFKAFSFLDRGSDERQYNAPLVNLGI
VGVCRTRYLEYEQYHTSKDDLNFISEKGLMGGLQSIQEMILNLEINAVYENTIVCEPNLG
KRGLYHTLSTANDIPLACNFLAYCDGENDIIDIANILNMQAYEFKELLEKIKFYGLVK
>fig|195.2056.peg.361 hypothetical protein
MKKIVASLICILFLGGCSNKTAGMVAIGVIHSPQIVALGAVIVVTSPFWILEKIEENSRK
AKGANRKRF
>fig|195.2056.peg.1688 GDP-L-fucose synthetase (EC 1.1.1.271)
MLKDSKIYIAGHGGTLGKTLYNTLIDEGFNNIIVKTRKELDLVDQKAVTDFFAKEKPEYV
FLCAAKLDTLGLFTPADVIYENSVLQANIIHSSYQNNVKKLIFYGSAWAYPQKAINPIKE
ENLLDGKLDLKAVAYGLPKIIGTKMCESYNLQYGTNFITLYLANLYGETTEFDLQKAKVL
PALLRKFHLAKLLDENKIDEVLKDLQMNFLEQAMEYLQKFGVSKDSVEIWGSGSVIREFI
HAKDLVDASIYVMRNIDFKDIVSSNEPHLNVGSGEFLSIKELACLIKNIVGFKGEIMFNN
SKPDSTMDRMLDSSRLQNLGWKAKIKLEDGIKMMYEWYLKEQNIRQ
>fig|195.2056.peg.168 hypothetical protein
EVLWLGGIHFLVGLGVNVGLGWIDYDCLFLLARMNVILEINFYQGMLFNK
>fig|195.2056.peg.468 hypothetical protein
MMKCEWILCPVCGSKTGRLEAVCDYIPSPEGNTISGVEAGTPVRAVSWQTIDNHLLIFFA
ADNEENVHGVMHLYSVNPVQILFLLCDFHKKYILCVLKLAAVSASHCTLVIKAILTNLFT
KTLYISNIELYLANF
>fig|195.2056.peg.1541 hypothetical protein
MNLNKIIIYIKNPFILSYIIGIFVLILNVKINNLIIITMGYLLLIIPAFIDLYKITKRIN
IAKIYNLLVSFGVYLVAEFCSRYIIYTTINYIPDSYGYAINIFNIIIIIPIIIICIMVAL
SLLFMVHFLTPVLLDITKCLFFLNLNFLIQKIFNF
>fig|195.2056.peg.54 Flagellar cap protein FliD
MALGQLASLGFASNVLKQDIMDKMKKAEEKDKVEPYTKKVEENTTKQKDLTEIKTKLLTF
QTAVSSLADATAFAKRKVVGSITENPPASLTANSGVSLQSMKVNVTQIAQKDVYQSKGLI
NDSGYVNANLTKATDLTFFSNGKEYTVSVDKNTTYKDLADKINAASGGEIVAKIVNTGEK
NTPYRLTLTSKETGEDHAISFYAGKKDGNGKYTESNESKEIFKNLGWELDTTGGTIDPAK
DKKGYGIKDNATDPLHIQKAQNAEFTLDGIKMIRSSNTITDLGVGLTLTLNKTGEINFDI
QQDNEAVTKTMQELVDAYNDLVTNLNAATDYNSETGTKGTLQGVTEVNSIRSSITSILFD
SQSIDGTVEDKNGNKVKTKVMLSMQDFGLSLTDSGSLSFDSSKFEKKVKENPDLTESFFS
NITKYEDINHTGDLIKEGSLKQYVGTGTNNGLEFKQGEFTIVYNNQSYDISKARDGSTFK
LTGATEQEMLQNLATHINSLGIEGLSVKVEAYDKNNQKGWELKIKGDGGSDFSIKGNKDF
LKKFGLSETNITAKPVEGKGVFSKLKSTLQGMTGTKGSLTKYDESLTNDTKTLNKAKESA
QKAIDTKYDSMANQWLQYESILNKLNQQLNTVTNMINAANNSNN
>fig|195.2056.peg.1602 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MLDALKYFSTTQAKNHQRESAWNALKDAAAKNSALNQYFSLLFGSDYASKRFVPDQKEWN
LDAKIVFKAKSEAVIASKGKLDLNAKEYNQDLVSSLDKNFALLDSDLKKATNSQDLILNS
IPDLINSGLFTLENKTNDNITYEYTTNTSIIDESKYFGFLSILNQFKNKNFNEFIVIGDP
FLKISLLTQCMQTHYNPILN
>fig|195.2056.peg.1682 Para-aminobenzoate synthase, aminase component (EC 2.6.1.85) / Aminodeoxychorismate lyase (EC 4.1.3.38)
MSAETKFAIFGKYFYYDLKFVLKAYNKKQSKKYFKFVQKHKDKYYFLTLVDYEFYKYLQD
KNFTSKEAYLSFYAYKKRKKFTAMRVDEENFMPIFKNHLDFKNYEKNFLQVKSAIAKGRS
YQVNLTQSFHFDSLLDGFSLFNLLSKRQDTEFKAYIKDEGREILSFSPELFFKIHKRKII
TQPMKGTSARSKDLNQDKKNKLFLQKDVKNLSENVMIVDLLRNDLSKLIVKNSMKTKLFK
IQSYPTLHQMTSIIKGKLKKDIDYFQIFKALFPCGSITGAPKLETIKLIEELEARKRGIY
CGAIGCIHKNKSKFSVAIRTLEKKQDYQYSVGSGLVWDSKLEEEIKELELKTQFLMPKNF
YLFETMYYKKGKILFFKEHLQRILNSALKLNFNTQKLIKDFQEVLSYKSNLKISISKL
>fig|195.2056.peg.70 Succinyl-CoA ligase [ADP-forming] beta chain (EC 6.2.1.5)
MNIHEYQAKAIFADNGIPTLKGKVAFSVEEAVYKGR
>fig|195.2056.peg.818 ISCco1, transposase orfB
MIAVEDLQIKNMSKRAKLKNIKAKSGLNKFILNTSFYQFSQYLEYKAKHNGKFFAKVNPQ
YTSKTCSVCGNIKKNLMFKDRVYLCEKCGNTLHRDINAANNILKRGLKSFGLGISLEDYK
LKAFRVS
>fig|195.2056.peg.655 Beta-1,3-glucosyltransferase
MSILKKTKKLFKDPKLFFKDAIEKKVFWLSKVYKKYLPKKYKGFTQYTIIS
>fig|195.2056.peg.1815 Rossmann fold nucleotide-binding protein Smf possibly involved in DNA uptake
MLSLNAINLYEEMLKYEFIWSSIKNSSLKKFKDLQVIQQDFTSQDAKEKIQDFLLNLDKK
DFSILTEYNYQFPKNLKNTYIKSLYYKGNLDLLSEPKKIAIVGARNATEDGIKRAIKLSK
ELSSKGFVIVSGLAHGIDTAAMRSTIKNNGSLIGVIGTPINEYYPIENKALQDEIANKHL
LVSHVPFYKYSIQPFSTKKFYFPERNAVMAAISDATVIVEASETSGTLTQARACIEIGRK
LFILNSCFENGLKWPYTYEKKGAIRVKKIEDILDNL
>fig|195.2056.peg.1521 hypothetical protein
MNIKKTITSLSIVCSMALMPIKALSSQYVSFNNNVKTIQKTIINRIDFYKKICDSLYSDM
KFNFNSFMYHQHGIIKLDEIKKFKKEIKILNKIISVSKERMEKKGSKLKDFDAKVHYASV
ALKNVIEQKLNPDFVKIFGAYKGEEIDIIEYAKGVLKAEEEIKNGVC
>fig|195.2056.peg.1751 hypothetical protein
TTGGHFKACKNILLEKLDPNINIVGLFLAKTEHYYQ
>fig|195.2057.peg.876 Predicted metal-dependent hydrolase
EYVILHEISHLKFPNHSKEFYDFIEYFMSDFRQREKEFLS
>fig|195.2057.peg.822 hypothetical protein
NNVKQSHPNIIASWKYYQEFEKICKKLDEKE
>fig|195.2057.peg.1240 hypothetical protein
MDYTKTIDELYSKITTSKNIEFEKYNTIDTDNIQLETNRVAVIDNVTCVFVDMENSTEMA
IGQIDKALKIQIPYIRALVEIFQLHNAKYIDIQGDGAFALFDGDNSKSNGIYVAAIANTL
FNEKLDMDIRIGIDCGKVYVKKAGKRGENKEIWLGRPVCLASKLCNIDLGAIPEYIRFSS
EIFSSGVLENLRPKIRYKQVNNLGYVYTSNLVIERYNEN
>fig|195.2057.peg.1673 hypothetical protein
MLHLIKKQMLFFTELEDQFLKGEVGKSSIKLDFEYYILYSQFLQIDRESLISGRNYELVF
CFLLYYRALLNKNNTQKIVAKIINAMRCQERLPEKIHYKEKIICMDNHHRDLSQILSSCV
VEFYNSIDLYNTFRKNIGFENRKKIAIEMLNRASEHYGFFGLNRGGITYKEAKISCAPIP
VLNEFHHAMSHLCEVFLKDDARYTNLERAIPHFKRGMMDIYKTIIRDFLILNQDALESNK
KL
>fig|195.2057.peg.1226 Arsenical-resistance protein ACR3
MGFITRTLLLKYKSKRWYENTFLPKISPITLITLLATIIIMCSYKANEVFHLPLEALKIA
FVLTLYFIFMFFLTWFISKKNHLSYPKTCSLCFSASGNNFELAIIICIATFGLHSEQAFA
SIIGPLVEVPVLILLVKWALGKSLNSKKMNQAS
>fig|195.2057.peg.1546 hypothetical protein
DYMENYMIGLAISNFIWDTHIAIRRYFIDLMQNNNIFGKYLEIGPGHGNFFLQSLKFGQF
SELLGVDISPTSCEMTKKIVSFNDHKAKQKCQFICMDFLEYDFNEQFDFITIGEVLEHVE
NPKNFLNKARKILSDDGNIFITVPINGPAVDHIYLFSHPDEVKNMIKNCELEIVKEEYFM
ANNYSLKKALETRNAIIMVALLKKIIK
>fig|195.2057.peg.789 Paralog of flagellar hook protein FlgE
MMRSLWSGVSGLQAHQVAMDVEGNNISNVNTTGFKYSRADFGTMFSQTVKIATAPTDGRG
GSNPLQIGLGVSVSSTTRIHSQGSVQTTDKNTDVAINGDGFFMVSDDGGLTRYLTRSGDF
KLDAYGNFVNNAGFVVQGWNINWDTQSIDSSRTPQNIFIDPGMHIPAAKSTEVAIKANLN
SGLNIGTASRPLYSLDSVHGFNQKTGETKDENDTGTTQFYTTSKNAVEVTEKGVDAGSLF
NANGQGLNLRDGQGIWVSYADAKYSTNSLGYNAFNPNLQQNQTAAFWGNGNQKTRLDIVI
NGVTIQNDTIGSIDEAITYINTFTAPTDAREGTGVRAVKNADGSGIDFVNDNADGTTDNM
KNINLVVNANNTAGELWNAEWNNNTQTFSFNQGNGAQRPTINKNGSSLWTATGQNLTPAP
PNPGPITQIQFTGPANAQIITAHKYIYSSSPQTLPPMYNPDGGFTYIPGTNAQPPVWNGT
DAATIGSQNYYNAVMNGSLLNTNIRTFHTTEDLRELLQRDARYGVDYDGSGKFAAADVNE
NVKVVVNSSGAFSLTNVNKTSNSPALTAPGGQGPLNFGPHNMNFNITAYTDERGTVSTND
AFTKIFKGLDGSFPAGNQVKQSELLKLSAFSAGLEIYDSLGSKHTLEVQFVKQSTTQDGG
NEWQMIIRVPEPAEINTTGEGPNNIIVGTARFNNDGSLSNYNPRTINFSPNNGAAPNQQI
KLSFGTSGSNDGLVSSNSASTLTGQATDGYTSGNLKPDAIRVDDKGNILGEFTNGKTFAV
AKIAMASVANNSGLEEIGGNLFKVTANSGNIVVGEAGTGGRGEMKTSALEMSNVDLSRSL
TELIIIQRGYQANSKTISTSDQMLQTLIQLKQ
>fig|195.2057.peg.1695 Para-aminobenzoate synthase, aminase component (EC 2.6.1.85) / Aminodeoxychorismate lyase (EC 4.1.3.38)
MSAETKFAIFGKYFYYDLNFVLKAYNKKQSKKYFKFVQKHKD
>fig|195.2057.peg.152 Selenophosphate-dependent tRNA 2-selenouridine synthase
MLNEVDFAEFQKENFSLLIDARSPREFLHSHLIGALNFYALNDEEYQEIGTIYKKNQALA
KARGASYICQNMSKHILELAHKFRIGDKIGIYCSRGGLRSKSIAVILSELGYRVVRLKGG
FKAYRSFLAHYFENEINFDFFALCGNTGCGKTELLELLPHHLNLEKMANHLGSSFGDILG
AQPTQKAFEANLFYTLNSLKDFIFIESESRKIGEIVLPLKLYEKMQKAFKIHCFCSLEKR
IDRIQKIYQEKMTPLKFKECLAKISPYISVNFR
>fig|195.2057.peg.1702 Flagellin
LVSAINAVKDTTGVQASKDENGKLVLTSADGRGIKITGNIGVGSGVLQKENYGRLSLVKN
DGRDINISGTGISAIGMGATDMISQASVSLRESKGQISATNADAMGFNSYNGGGAKQIVI
ASSISAFMSQEGSGFSKGSGFSAGSNKNYSTILSASIRIVSSAASMSNTYVVSAGSGFSS
GSGNSQFAALKTSTVSAHEATAGVTTLKGAMAVMDIAETAITNLDQIRADIGSVQN
>fig|195.2057.peg.517 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYAIISAVYNVEK
YLDDYFNSIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQAS
ARNLGLKYMQENDYQIPWVTFTDPDDFLDRNYFYEVDKFLAIHQDDDICMIGCNVIFYYE
KQKLYKDNHALNFKFKSGVQVKENYNLDSFIQLSAASCFMNIGYLDKLLFDEKLKPNFED
AKFINEYLLDNINLKSAFLPTVKYFYRKREDGNSTLDNSNKYSDLYLLVSRRGCLKLLQE
NKFYDIFIQNVCLYHFFWQIKTLVNSPEKLSFMSESEKQRYLELLDQNFSYIDKNTIMEF
NLAGCWFFHKIGILNCFKNEKPPFQIAYIEDYDPYKEQILLTYYTGDDENIESIFVDGEE
VHVDYEKIVEYDFLDRAFCYQKRLWVHIPKNAKDKLKMFINDEQSMIGKYGEYFLNIKNI
RQEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEQKIVFALRKESLDWERLEKE
GFNLVEFGSLEFERIIKKASKVISSHADGYLTRYITSKQQFIFIQHGVIPNDLSKWLNSK
KIDLFVTSTKAEYKSIANDYNRYKFGKKEVALIGLARHDALLKNNQCNARQIVIMPTWRA
NIVGVALGSSKRGLQSDFTQSEYFKKWNLLLNSNILQKLCEKYDYTVVFNPHRNIIPYLK
EFNIPSYIKIASQNESLQKLFCNSSLMITDYSSVAFEMAYLNKPVIYYQFDHEEFFSSHT
LQKGYFDYEKDGFGPVVENEENLLKQLENLLQNDCNPFGIYKDNIDLTFAFKDGKCCERI
YKILRQII
>fig|195.2057.peg.1701 Flagellin
MGFRINTNIGALNAHANSVVNANELDKSLSRLSSGLRINSAADDASGMAIADSLRSQAAT
LGQAINNGNDAIGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADIN
>fig|195.2057.peg.1538 Cytochrome C553 (soluble cytochrome f)
MLCQLDSVLVSLLRGLKLCVGVCIANDILIKKGENLYKKCIACHGANGDKIAPGSKGNIK
IGGLNKAYLIKQLQGYAAGKADNGGAKVIMYANMKNWKFTTSDIEAVSAYIAQLPKAK
>fig|195.2057.peg.1239 Type I restriction-modification system, specificity subunit S
MKTKTWEINKLEEVCEILDNKRVPISSKNRIRGIYPYYGASGIVDYIDKYIFDEELVLIG
EDGAKWGAFENSAFIAEGKYWVNNHAHILKPNNEILINKFLVYFLNYSNLEKYITGATVK
KLNQQKLKQIEIPLPPLEEQMRIVKILDLAFEKIDTSVELLKANLANLDELAKSVLDRAF
NPLGDSTESTQNPSTHDTQSPYPLPQHWEWKSLGEIASVIQSGFAINKSNEIADGYIHLR
THNIATDGNLNFETLVKVKKELIKEQQSFIEEGDILFNNTNSTELVGKTALVTQNYNYAF
SNHITKIKLFNQYSPKLVVFYFVLLLKNKYFERICHKWIGQSGINTDKLKQIQIPLPKDI
KEQEQIAMHLDSVFEKAKALKELYTKELKDYEELKQSLLDKAFKGEL
>fig|195.2057.peg.1610 hypothetical protein
MQEIKQFFINIERTDINESMENLVSEDFIDSIDIMALVAEIEKFYKKPLKAEFITPENFE
SFQAIKNMIEQALFNT
>fig|195.2057.peg.1665 Membrane protein
FNLMYLKCFYFFFVRIFNFYKEGFKNLTLGKTLWKIIFIKLFIMLIVLKLFVFDVNFNSI
FKNDNEKSNFVIENLIKEK
>fig|195.2057.peg.1677 Methyl-accepting chemotaxis signal transduction protein
MQLSIRKKMLMLGAICFISMLATFAIFYYNNLQGSQKIAQTTKNLINKEINIKVELLTKS
MAIALGDLIKNVHSEEEKVKIIATAIENFRFEEDKSGYFFVYQKTTVKAHPVRKDLIGSD
LYNAKDENGIFYVRELYQRALDKGGFVTFHFTKPQPNGENTIAEKTAYSYLIPNADDLWI
STGVYKDTLEPYIDRSLEELLSFFSKSFFKTVLFSIIFILIIIPFIFIFYRNLIVGVQGI
DANITSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVET
VGVVESGNLTARITANPRN
>fig|195.2057.peg.1460 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGIVIPIYNVEKYLRECLESVINQTYVNLEIILVNDGSTDENSLNIAKEYALKDKRI
TLFDKENGGLSSARNTGIEFFYKEYETHFSNEIDGFYTFTVANENPQNVYKIYKNKNTFI
EKNLEAPDIDYLIFLDSDNSWELNCIEECVKRMQDIDILWFDHLCVYEKGIEDKGQKTRM
QIFSYKEECIINPKDYAKRALEVGSRDISFSWGGMIDFNFLKKIKLKFVNYIINEDIHFG
MILFASANKIYVLPKRLYKCLLRSNSISNHDKKVTKANISHYFKNIYEAFDEDAKSAKEY
LR
>fig|195.2057.peg.586 hypothetical protein
MSIFSINDNSNYNSILSQSKANKESKENSKISFANAFLKQNASKLSDIESKNSQTLARSE
VLSNNNALNNSSNSTNISNSSNTNLSINNATKTSSPNYDISSE
>fig|195.2057.peg.380 hypothetical protein
DMIKFWRLYYNKNKIIININYHNFLNNHNFTSLWLKNLGYNFLNTLTLKEKHARKS
>fig|195.2057.peg.211 hypothetical protein
MFETLLKLSEEPLKSKIKDLYFSKFNYVGAKIDFCITQNLGLLGEINLLWAEAKQGKSEL
KKSFVQLVLTIGKYKFYTEQTPNLLCAFDGEKIAFLPFACLQEIFYQSDINFSVTPSNHT
SEQFLKLLKELDSILNTAQIFYYEKNDEELKTFIKENLTSENISKIKIDKNNFVSIYHKW
NKMVKDTISIDWNLAKKSGIIDADFYLADLLSSENETISQNLFAILKKDYYEFNKTKSDL
GSIINERTSFKDNQKAHHEFWAIYERPPREEFWDYIIKRRDLLVDQDVRERKGAFFTPRI
WVDKACEYLSKTFGEDYEEGYYIWDLAGGTGNLLANFTNKKNIFCSTLDKADIDVIHERI
KNGANLFENHVFQFDFLNDEFFDEVDDKGKIIQKSKLPLNLQEILKDENKRKKLIIFINP
PYAEAATSTQITNTGKNKEKVARENRICEKYKDILGKANNELFTQFFIRIYCEIEGAILA
SFSTLKYVNSTNFIKFRQAFKAKFLKGFMVPADTFDNVKGKFPIGFLIWDTSKKEEIKKI
KLDIFNENGNFLGKKMFYSYDKNKKLNEWYKNFYVKNNEIAIMNTRGNDFQNTNYIRITL
FN
>fig|195.2057.peg.1278 Flagellar hook-length control protein FliK
MSNLTPSNDILNLTPSKTNTTHSSSSKTKEQDLKKSDNTTQDDTESFLNSLLNSIEETNE
FLPDHMKISKKEVVNEAMDKLQNGVFSESDKISIFESASFMQILSLLDKLKADTADIKLA
NLSTQLSQLVKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNLDKA
DFFKGAVDNVFKEIINNKISNVSKNLNHNLENTTHTTSTHSMQKTNSKDSGSLLSQTLKN
LDSILSSKESKHEKNDKVKSKIEEDTTDAKNTLKNIKNDEFAKNLTEELNIKDKKNQDNL
NKENKDLNKDFNKELNKNQEKNNLNQENIQDQNKNLKNNNQNLNLDKNLNKEIVKDTQNL
VSNLTQKDLI
>fig|195.2057.peg.1279 Flagellar hook-length control protein FliK
MQYFSQDLKEAVDQYKAPITKLSITLNPNNLGEVEVTLIQRGNNLHINFNSNTNAMNLFI
QNQAEFKNSLVNMGFTGLEMNFSDQGKREQNQNQGKNRSGYGFKDALDGKNESEKVNLEL
VLAKYF
>fig|195.2057.peg.648 hypothetical protein
MVHEIQKTFLLPDATLLEKLQKDRIVFEIYEIETFYTKITYFYDVKFQNLNGNFYKITRL
NNPILEQNQEEKISKKDYEKARKKLIEKSIKKKRYEFKLCSFKSFIDVYEDLNLYVLKVF
FPTLEIANLFILPKEFRIQRELCGVLDSKNIILYGFNNLEIDIEKCFKIIEKNQNFTLDF
PSSILAFDGYRISLFYLFRKLKLYWNLALENRQREVFCEFFSYARKIYIILMSTEEIFDE
ELNKNLALRFEDLVKQSYCILANNELDENLLLFLGSEDLQNLLSDFDFFIKEDSFYKSEQ
EKYFFKQMIAMQLRKR
>fig|195.2057.peg.1704 Methyl-accepting chemotaxis signal transduction protein
EYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSS
SNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNA
AIEAARAGEHG
>fig|195.2057.peg.151 Selenophosphate-dependent tRNA 2-selenouridine synthase
MLKSYEQREWQRLITLLLAYYDKSYKKPQKIDFELNTDDIFKAKEELLGYFKTQLLF
>fig|195.2057.peg.1698 hypothetical protein
MKSNIQQIFDHIEKSNPIHAKYLKKVNLNEEEKVELENLIRFYLNQGFS
>fig|195.2057.peg.1627 N-Acetyltransferase PseH involved in the biosynthesis of pseudaminic acid
FKDNHKALKLYQQNHFTIYNEDKNIFYIKLKNYNYKKQFAKRISKLDKGEGGGKYKY
>fig|195.2057.peg.1307 hypothetical protein
MCFEENKLFDFSTHYISLSTFWAFGNIMLKPKDALDITHLAHQFHFFSLES
>fig|195.2057.peg.1689 hypothetical protein
LQTSIYFSVRHAINATWINDRDQFLYPNDLYKNDDEFKSDCLAFMLFHGQNRISAKEGIN
HFIPFSEKELGITKEAFESDFMYKFIKGKIKDENSLFGDELVKIEFSLEAQELLKAGKEL
FKYYHTHSEDKGYLVNASFYDIKEFFQGRDEKGRMNRPSQAKDEHYKILLSDLNTALNAL
AKKLVPKIYEYGFLKE
>fig|195.2057.peg.1692 FIG00470336: hypothetical protein
NIASLVSISQKLDFLITVDTGNLHLCDILQIPTLAFTSSLAAYRFGGGSYGGRFDKLIVK
PAWQKEYRKIYEIFTKKAENNLENL
>fig|195.2057.peg.516 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MSNKRLAIHLYGMIRTYKRTYESFLKNVIKANELDGWEIDIFMHIWDVFNLVDNSTWHKK
NNYFPTMNNKKLTNEDIEDIKAIYSPARFQIDSDTREYGRYESIKRAMKLREEYESEYNI
KYDWFLTTRTDIFFMNPLKISHYIDFYSQHVEFKYFGIADKMNFCVSYPFRGGGIQVMDH
RHPNESDILWFSNYCSNQGMDPLISYKDKNIVNVFIKYQLNVDCFQVREITKQLQPNITV
SKMTIDQYEDKVTLLQNQIKDKENQIKKIQSGLKDISHRKQELEILDLEYGISLKKKHIE
AIENNILLKKIQISENKKNINYNSNIIYKENSAKFRIQNQLSYKLGQAMIVNSKSILGYI
RMPFVLSYIHDKHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKEKECLTYKLGEALI
RANNNWYGGGYIKLLLEIRKLKREFYTKKDMR
>fig|195.2057.peg.124 Uncharacterized membrane-anchored protein HP0586
MKKKIVYALLVLIVFISVVFLVLKNGILISHIQFSFLNLEQLYIKLDKKLIVRAKNITFN
EDNNASIQDDKNVNSDFASKELLNITKNLK
>fig|195.2058.peg.1399 hypothetical protein
MFKNKHLSSITILIHTGENLKVGYGHLLYWLPEFFKSEIKFGILVRNKDLYKTIKNEYRT
ISVFFAQDSLEVESVLNKFANLKAIFYMSNSSNNIHLLRFNEYEHIFIGNENYNRDMQTT
KVLKAYDELWLQSQSIIEKIKCSIKDINNMKIVKIGKPQLKNVLNNEQKKSILCVFSIVD
NVVINSIQLLINYSIKKNMKIKFVFSKLDKKNNKFSNNIELQLKEILLRNKIESFVYTVF
SDELLKESGFIVCDLNSYNEKFIINNIPVCVY
>fig|195.2058.peg.1063 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNENNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLHEMLSKSSKVLRVIDYACGAGHFLNTYANELKRYLTEDELKEYYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIIL
TSSILNKDSIYTNTREILFQNFDFIAIVELGNQTFG
>fig|195.2058.peg.1235 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
DIAYLNPSFINFSKKLAIKSYKYLNISLKNKDQLIKNQIVQIKELKNKVLQLQKDFDSIN
LLKNDLLEIQKKQLDVLIKDREQMIVNRFRYGKAKNRIQNQLSYKLGQAMIVNSKSLLGY
IRMPFALSYIKDKHKQEQKIYQEKIKKDPSLKLPPLEDYPDYKEALKEKECLTYKLGEAL
IKASNNWYGGGYIKLLLEIRKLKKEFKKK
>fig|195.2058.peg.1786 Flagellin
MGFRINTNVAALNAKANADLNSKSLDASLSRLSSGLRINSAADDASGMAIADSLRSQANT
LGQAISNGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM
EELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSK
>fig|195.2058.peg.1743 hypothetical protein
MEIKYDISIIVPVYNRENLIKPCINSINAQTLDKSRWEVIFVDDASTDRSIEVIEELIDK
NINYKIIKREVPSGNASAPRNEGIKASLGKYVFFLDSDDYIDSKLLENGINIALKNDSDI
VYFKMELNARTVTKRPFKHPIVDKADIEKNHLMRTLRIFKMFKTKMLRENNILFDVTVNV
CEDMLFGATALLYAKNISILADRDYYFASLHDEPHLSKKKMTLEKLFHIYFYTIQSLYCS
NRDINFKIKFYNALLIRCVEHLRDICKKDKINNENLIRIFSFASDLFNLHKEMFELKQIY
ENEKLLVLLFLSKDFKTFFELSNNSKILQDFCQKIEKEFEKEKGFNKAWIFENKMVVLDF
ILNDNRIAFDIEINEKTQNVKIWMFCRNDKEYLKKLLKIGLEIKENNKILIFSNKDEKLL
ESIKNIKSFLGKITNEDKI
>fig|195.2058.peg.414 Methyl-accepting chemotaxis signal transduction protein
MNSIKIKLSLIANLIAIFALIVLGIVSFYFTKTSLYESTLKNQTDLLKVTQSTVEDFRST
NQSFTRALEKDIANLPYQSLITEENIINNVGPILKYYHHSINALNVYLGLNNGKVLLSQK
SNDAKMPELRDDLDIKTKDWYQEALKTNDIFVTPAYLDTVLKQYVITYSKAIYKDGKIIG
VLGVDIPSEDLQNLVAKTPGNTFLFDQKNKIFAATNKELLNPSIDHSPVLNAYKLNGDNN
FFSYKLNNEERLGACTKVFAYTACITESADIINKPIYKAAFIQAIVVIIVVVFSVILLYF
IVSKYLSPLAAIQTGLTSFFDFINYKTKNVSTIEVKSNDEFGQISNAINENILATKQGLE
QDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIH
KIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQN
LTSSSNSQAASLEETAAALEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDI
ADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDM
AESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2058.peg.1764 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MIKERIEAENLKDNENFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLTELEAFKDYRNA
FRQTSDYKKLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLIIKSPS
DIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLIYKSFLNTLDVI
PQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSTQSEMSNPFINSKFELVRLKDFVLD
IQTAKRPSGGVGKYENGALSLGGEHIDNKSGYIKLDNPKYVPIEFYESFALQDKGIVKQF
DILICKDGALTGKIAMVRNEFIRKSAMINEHIFLLRCDNIAKQKYLFYILHSYSGQQALK
SKITGSAQGGINKTNLESILIPNADFEIQKQIVAECEKVEEQYNTIRMSVEEYQNLIKTI
LQKCGIIDDGGGYELNSILENLQKLESKLDFNLLLSLIEEQISHSEVLVEETQSKERKQD
FNAFKNFSKTIQELLQTLSTPPKDGWKRISLKNEQYIELNPSKKEISKLDENMLVSFIEM
ASVSDKGYIQSKIDRSLNEVRKGYTYFIENDILIAKITPCMENGKCAIAKNLTNNIGFGS
TEFHIFRAKTGLDSSFLFYNLNQQNIREKAALAMTGASGHKRVPISFYENLTIPLPPLEI
QEKIVQNIELVEQQIDFLNLKLELLEKEKEKILQKYLFS
>fig|195.2058.peg.1745 hypothetical protein
VYRSYNFSTDVFLRNKDLPLEKTFLFSLFEELQDCFINNTYEEIPDEYINYYLGKKYIID
EKFQKEILRVGL
>fig|195.2058.peg.1742 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MIFKDEDCIDLAKNKKAIQSSISKWSQVNDACRACRDDLYIENFSFHTGIEDNPWWMLDL
EKEEEIDCIRITNRREEHYKVFNRDNLKVEISLDRQIWIGIDSNMYEWKNNDLLEINLYK
SCNARYIKIFLDKKAHLVLRKVEVFVRKCKGYVVGSRVDALGMRIAALINAMFIAKKLDF
KFMFTWVKGTDVDFIGANASIKSVATAGEILTAEEVFCENFIKQHCVDDKYYTYRSDVTN
LSFEDSESNFYRQKWGIYASPYRLSDDMKDLSKEEYLKGVSLCYQEIMWSKKCKSILKDV
QKAHRLISEGRFFCLHIRGGEIVKGNFKIAPEVWMKERHFPYEIAIEIAKGLFNKNHIVI
FGQDFIANKQLEIYLNEIKPNRQIKIICIDTLMEECNLIYSNKERAFFELNLMSKADKIY
TTGGSMYSNLAEMISGKNIICSFYDMYSPDEIYDVLLKNLYCLELDNLNRAYSYYRIYSL
SRVLGKSIELSLEFIYKALECDYENDFFRICILECLFIKKDFDGIEDRLKNYFLKTSFFE
AICGVHNRYKHVQNYYEKIRKYYIDFKDKKRYPYISFMAAKIALYKKDYRRAREFIFYSL
NNDNNNILFIECAKEIDSKEGYK
>fig|195.2058.peg.472 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYIYVDDY
LARNYNVAIININYHCIGNRPHLGSSFYLDDID
>fig|195.2058.peg.1789 Flagellin
GAFINASMKENYGRLSLVKNDGKDILISGSNLSSAGFGATQFTSQASVSLRESKGQIDAN
IADAMGFGSVNKGVILSGFSTVTAYMSSAGSGFSAGSG
>fig|195.2058.peg.234 Methyl-accepting chemotaxis signal transduction protein
MYKDTLEPYIDRSLEELLSFFSKSFFKTVLFSIIFILIIIPFIFIFYRNLIVGVQGIDAN
ITSFFNFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVETVGV
VESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEYKSLDFRNKL
DNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAASLEET
AAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHG
RGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVAQID
QTTKDNVEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2058.peg.1309 Adenine-specific DNA methyltransferase
AIVYGIFVSYIENDDYDLEKIPIENFISFLPSTFRTLSEFVYFAIPSFSLPQDIKYTLEN
IKKTLSLIDKIALCKILNQDLESVSIYLYEDFLKAYDDLRATQKRKEGGVFYTPKSIVDM
IVSSLDELLKTKLNKNKGFNDQGVKVLDFATGTGSFLASVFEKIISKESEVFKNEAIKNK
FLKDIYGFELSFVPYIVARLKLGQILRKNGFVNFSDADFQIFLNNTLDLEKIANFDMFMP
LENLDTEWKKARDIKHSQDLLVILGNPPYNAKSKNKGEDILELLQAYKQGLNETKINLDD
DYIKFMRFAQWKLLEQNKKDLFEEKKGLLGFITNNSFISGKTHRKMRESLYKSFDEIYIL
NLHGSDKDAKNDENVFDIKVGVCISLFVKYKDEPSNGAKVFYYSTGDNNIFSRKEKFALL
DDVRQKGLNAIKWEELSLDEPYFWFIKKEFENEEYEIFWALASDKALGDKKSIFLNYNSG
IETQKDNIAIQLMKNKMEETLKDFSNLNSVDLVKKYDLKDSRDWKISNSVNAIKNNLGKI
ERIAYRPFDLRWTFYTNKSKSFIAYPRYEVMQHFLDKENLGLCFPKICLNSIFDYSMVIN
TIADRALGGCKTGSETCIAPLYLYVNNEKIPNFTSEFLAHKENHKILKDKSPEEILYFIY
ANLYNPRYREKYLEYLKTGFARINFEVEQKTFDDFATLGKKLVELHLFKRDLKDEIDFIF
LKEDKKANFKIEKYQEKDRFIDNKIILNEDLAISPISAEIWQFTIGGYQVIKQWLKYRND
YKCSKEELEHLLKMCKVIKETINLQKELNDY
>fig|195.2059.peg.1789 hypothetical protein
MSKVATAHCNPKKQPALNHNDRTNDNAKTITKELTHLNEYSCTSNEVRKNIERLYKKAYE
NFYKYCENKNGLAKSGKPKGLQNFTKKEKCYHEFIYEIGENTTMEQCQELTQKIAELTGF
TPLQVVIHRDEVSENAKREKQTHYHAHAVFFTLDNNGLQLARREASLNKANLSKIQTLTA
QSLKMERGANRYENNEKQPQYIQDYKTYAQFKEQEKALLQRIQEQEHKLTQMALELKKKE
KEIQDKAKELKSKENELQAKIEQHQKHIQNLELGHERALKELTQEFEKRLSLWKNILTFG
KYNAKVREDYQLTKNAFLISTDESRREANKELEYLKFEYHKVKDERDNLKTLFEAHKTKN
VKLETRLKEIGKWCEKNLSVEQLKEIFPLKAERIEKELKYQRAFENSFEQTKTKRNDRGF
GFSR
>fig|195.2059.peg.296 FIG053235: Diacylglucosamine hydrolase like
KHFGAYDLSPVIVLEKILPTRYEIVAKSEIYYDVKEVIKRT
>fig|195.2059.peg.348 Arginyl-tRNA--protein transferase (EC 2.3.2.8)
MLEIGFCTLEDECPYLKDRRSRIEYKYIENCSKEINSELIRRGWRRFGRYFSRPICKDCK
ECLSLRILVDEYQFSRSERRVINKNTNTKIILRKPLLSNEHLFLYDKYHRFMEEKKTWKR
YDLNFRQYYNLYVDGFMNFGYELAFYAEDKLVCVDLIDWLEDGISSIYCFYDPDFSHLSL
GKFSLLSEIKIAKKEKLKYWDIL
>fig|195.2059.peg.409 Predicted P-loop ATPase
MPKVSQENLKDIFIKKLKTIHIKHEALDKDEFIKKIKENNFADAFKSIRDMERFLNAFKI
EVNAINQELYLYDFAVITLLKIFEPRLYDYIYDNRMLFIEQYNPYDHISSEIKIPENIEQ
EIKKITKSNKDFAFNLIGSIFPKINNQPQDYSQLIQNNTDNQKKRITYPSSFKYYFLLNF
PK
>fig|195.2059.peg.263 Phosphoglycerate transporter protein PgtP
MAWMDTFVYMVHFGLISWLPIYLLETKGFNKEQMGIAFWLFEWAAIPSTLLAGYISDKIF
KGYRMPPAIGAYELCSRRFTWNKSYRLGCGLLW
>fig|195.2059.peg.1788 conserved hypothetical protein
MQKQYPEVYSLEESLAILKKYKDDLTKEQYENIKSNIGTHAIESIYLNELDIIMLVKKNV
YGLSADEIIAEYQEKGFVEYVKSCHRSLQS
>fig|195.2059.peg.835 hypothetical protein
MSNLNQNEQIKCPNCGSFIDISTALYAQILDKAKQEMLKQKKEFEDEVNAKRAEYTKAFN
DLKAQKLEQEKLISEQVSQKLLLEKQKFEQELLTQKQNFQKEFSEKFNKEHENEMKIMQE
ELEKKSKELSEFLSIKAENEKLKREQKENEERLKFKVKEEAFKEFKEQEGKKLELEREKM
RLEFQKSTQEQDLKYKEGV
>fig|195.2059.peg.1464 Putative amino-acid transport protein
MAYFNVGADGKPLLTAMPLVQEAMREYYGGFGVHFITIAIVLFAITSLIGNYYYAQANVK
YLTNSKLVMNLFRITAVAMIFIGSQMNLKLAWSLADLTMAFMAVTNIVSLLLLGGIVNKV
LKDFNTQQDSKINPKFSASKLGIKNAECWD
>fig|195.2059.peg.1735 hypothetical protein
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIG
>fig|195.2059.peg.1145 hypothetical protein
MANKEEKLVKYLQIFDENIKDVEEINGEILIKSLDFNQKVPLKIFGYGFIKFFNYICALV
SNEANYILIDEIENGLHYKTTKKLIESLIELSRKNNIQMFISTHSLEFLSSVEKVANEKE
FKDLGVFNIYRYKENVYCKHYQSEQLKDLLNNGIELRR
>fig|195.2059.peg.1625 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKKVYEYQGRELDSKDIHFKDAKALIKLDFPAYALHFFQQRNFKFSNKKGVKIIYPKDNL
KLILAKDLNGMKGLVAKVANLNNEKLFWYLNQKLIYEGDENTQNLNLKEGKYQLFIISQS
GEQDTVWFEIK
>fig|195.2059.peg.308 hypothetical protein
MKKLRKFLKLLGVKIIRSYVPLTDKNKKVKNASDGAYDDSKITAKFDKSEFLSTADEIKA
LIPLLEEYDLKLAIENHEYQTSDDLLELLNLIHHPRIGFLYDFGNSMMAYEEPIKACENM
AKHTFSTHCKDHIVFIEDDTKYVCGVPLGEGNLDIKTCVEILKQAGLDRINVEQCYPYCA
TFKREEGAGGVKELGKGAFKIEKPLFNDLKAMQYYYPQEVSKEHLERLLILQKEGCERSV
KYLKSII
>fig|195.2059.peg.1754 IncF plasmid conjugative transfer protein TraG
LASTFYNYTKNKLFNFLKQSMKRFYFLFFSTLFFAPSFLFGATNIANSNLIYTWGYGDVM
NEIMQAVKGITTETDYIVNAALAISLLLFSIKKAMDGQTNPVFEFGKMFMLFAVVWYMFL
RAPNDNNHRFMIHDEVTSKDYVISQIPIGIGKSFALMTQFEKVILEAMEKHFSTPQSTNF
SNAGLGFSLQVMSTLPNVKLSAIDATLQKNIDFYFRNCVSVGILLNQQGRNLFQNSDNLI
QDLFTNIGNGSQLTPLFENNNNIEKQSVVPCSDAGPQIVEMIKNDTDEAMKIHAALLGMA
NDMANYEQKFLGAAQIYNEQAVSARSYLQQSMIMLASQDAIINTAKSVGLNPASVAANTA
YADQQFYASMQAQGHMAQTYLPLAKAYLTAIIIGLSWLVALLSIVFGSYAHIKMFFTLCI
WIVLWTPILCIINFINDFNLMKVAQVITGGKAALSLGDNILIFKEVASRSNFMNYLVMST
PVLAYAIAKASEQGFVTFASGLSQALTGASRAAGSFANQQALSTQTSIAAPRGDEVWAVG
AGYNTLQSSFGAGGRSFMGTRDMQHGGELVKDNMTGSSAVINADGSIGNASIKGLNAGIT
ASNLETRAHALSDAIQNSNLSQRALEVASGKGDSLALSENDRSAITNATQHALANAYSKA
TGVDVKQAYNDIISGKVGISFGVSGELSTNSQESEAWYQNLSKDQKETFDKTFNESLSNE
IGKNRDSSASFNNLLKTGNVTNSASIKSSMDSYNEAKTLNNSVGYDGGASIVQGYINENY
GGVVNKENVASAVNAVENMAARGDMQGLSHYAGVDSNVNSNGLHEQTKHNYYDPKGTMTD
HNKAIDDLNSRQKGFMATRNAPNDVKSEGLAGEIQKAANAAEFKTGTATEERNNKIDYTS
VQKDIKDGKADISKAIDFGNQNRNM
>fig|195.2059.peg.1787 replication initiation protein
MSEIVKYNNDFNLLPMPELKAIQMDMFMAIISLTKDKKENTPFLKKFFNPDKRKIIIPQK
NFIELCRLNDSKMDYKEIFFAIDDCLKKLCNFLVSYQKDERTIYNFVCFEEANIIADEVH
ITLQSRFYDMIINKKFGFTAFELAEFAELSGKYTKTLYRLLKQFRTTGKAYFEWEEFCRI
MKIPENYRQIDIDQRILKPAIKELSKERNLFDQIRVPFKNLAYEKEKTAGRGRGGKVSGI
SFTFKPENIQMQKLENESQKIMSDEQKYLKILNNMKLNQARFNYNDKLWQFNDFDFNEFK
IIAIELVRDEYENLNFGNHMHFNAKNQEQFFKMIDTFRKGIR
>fig|195.2059.peg.1629 FIG00638667: hypothetical protein
MKKLLIIPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPYYEIKNINFHKGFLNSKADFT
IEDKYNLGLISKLDFKFNNNYFSKFIAQGKLSNPFKLLDDKLQNKELAWFK
>fig|195.2059.peg.1794 hypothetical protein
MLDLLLYGSVEIVFIWVIEIYCLLVLYQYFYFIVFIEVYGLGVVYDEINIAVNTCKGLVL
SKKRLFALNLSFFIQ
>fig|195.2059.peg.18 Citrate lyase beta chain (EC 4.1.3.6)
MSLISTIKESNGIIGVVLPKAQSYEDIDMLSQFELPILPIIESALGVENLDDIARHPSVL
ALSFGSLDMTLDLNLQESEGKNFILNSIRTQIVLKSTKYNLLSPINGVYPDIKNIDGLKE
DLIFAKSMGFGGSLCIHPNQVAPINEVFSPSAKQIAWAKEILSLRQNSNDIIFNYNGMMV
DLPVIKKAEQILLDSNSNLS
>fig|195.2059.peg.1008 hypothetical protein
MSIIIANRTDGTGSRLISLMNAMYLAKILNKQVKFTWKNYIPF
>fig|195.2059.peg.349 Arginyl-tRNA--protein transferase (EC 2.3.2.8)
MGYFVKKCQSLSYKADYTPNEILKGTKELFENEVLWEK
>fig|195.2059.peg.1138 hypothetical protein
MKKNASIKILLSLGVATLLYSSAFAQEINLTQSSDVGNYFEENGKDINLKNPDKYKGQDL
SIKMGVWDLPNDDYDSDDYRLNIDIGKNNTLSFTHNNGQNPVYVTNLNATAKEVKTTDIV
LQAFAPSVINGNLTMTSSGAETITEDEKKVQV
>fig|195.2059.peg.836 hypothetical protein
MRLEFQKSTQEQDLKYKELETNFKSVAQKLEDAQRRIEQGSQQLQGEAAELLIEEYIQNE
YIGDEVKEVPKGVNGADCLHIVKDSFGNICGSILYESKRTKEFNKEWIDKLKLDSIAAKS
DIAVLITKTMPKDKQKTHFKEGILICTFAEFKGVLAVLRENIVNACKLKNALQNKDEKNH
ILYEYLNSKEFNTQITFILKTYQNMKEELEAEKRALQNIWKKRERAIENLSFNSTAIVSS
LNAIFSDLQGGNLIGEEGLKSLENLAKDED
>fig|195.2060.peg.18 ABC transporter, permease protein 2 (cluster 5, nickel/peptides/opines)
MFKFLIILAPLIFLFLCALFAPFLTPFDILSTHLENLHQAPNFTYILGTDFLGRDLFSRL
LFALRNSLLIGVGGSLLSIIFALCYLFLARCFFYVFWMRILEFFLALPAFLLMMFFQSMI
TSDVFLMIFLIALIHWCFIARIIESELKRLENLDFYKASIVLGRTKFRAFFKDLLPALKS
LIFVLFIFNIIHAIATEATLSFFGLGLGFNIPTLGTLLNESSKAIFIGAWWMILFPLLAL
MFLFLPLLWLGNYLQKIGGVRS
>fig|195.2060.peg.1147 hypothetical protein
MLDLSQKQIQKELKNLKYRFQNEKDIQEIFLTFARLKNEISLHELFSTAYQKRENTTDAI
LAFLQKIKTLNSYSSYGYDFFFGKIWQNTPTSPLKRYNMYLRWMVRKDELDLGLFTKIHT
KDLLIPLDTHTHKISLTLGLLKRKIYDYKSVLELTHNLKRLDANDPIKYDFALYRLGQNK
ELSKLKE
>fig|195.2060.peg.1212 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYIYVDDY
LARNYNVAIININYHCIGNRPHLGSSFYLDDIDKIILDTSLKTINLNHINVFDINSYENL
NNAFIRIDQEIQKLKLNQQLHQNYKLRTHVSFLPSKNEYQNFGIMQAMDILNAIFYIKEN
SPFKLMGGGIRTILFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFSLIVFEKK
SILLDIMEHMM
>fig|195.2060.peg.1281 Phosphoglycerate transporter protein PgtP
MAWVDTFVYMVRFRLISWLPIYLLETKGFNKEQMGIAFWLFE
>fig|195.2060.peg.1786 Methyl-accepting chemotaxis signal transduction protein
PLAAIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVK
ESVETVGVV
>fig|195.2060.peg.1763 DNA-directed RNA polymerase beta' subunit (EC 2.7.7.6)
EGFIRFYNLKTYKNKQGKNIVANRRNAAVLLVEPKIKTPFKGVINIENIYEDVIVSI
>fig|195.2060.peg.1736 Predicted glycosyltransferase involved in capsule biosynthesis
IKRVRFFSKILEFLGLNFLLSLISQTKFYRLARKLFFNPRDFFKDSKFYKRHNNAN
>fig|195.2060.peg.822 Transcriptional regulator, AraC family
MFFFDNAFLIELIYKYKDLFKLEQASEESEIFWVKNDKILQGILESFTPHFDENAQILDP
IVSLKFEEIFFAFTFK
>fig|195.2060.peg.1752 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IETKNKTIQENLSQINNLNQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQT
MIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDY
>fig|195.2060.peg.1715 hypothetical protein
LLMPVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYQEAIKFKNYLSYRLGQVI
IKGFKNPLSIILLPYEIVKLIYKFRKR
>fig|195.2060.peg.1696 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
MSSMNETIKLNRRSFLKMAALSSLASPLLARSETLREANADELKEAYEGSQKIKSVCTAC
SVGCGIIAEVQNGVWLRQEIAQDHPVSSGGHCCKGSDMIDMVRSHVRLKYPMKKENGEWK
RISYEQALSEIGEKLAAYRKENPESVMFLGSAKLNNEQAYYIRKFAAFFGTNNVDHQARI
UHSATVAGVANTFGYGAMTNHLGDIQRSKCIIIIGANPAVNHPVGFRHFLKAKEKGAKLI
VVDPRFTKSAAKADIYARIRPGTDIAFMYGMLKIIFDEGLEDTKYLDERVFGIDKIREEA
AKWTAEEVENVTGISKELLIQITHEVAKNKPTTLIWAMGLTQHTVGTSNTRLAPIVQMVL
GNIGKFGGGVNILRGHDNVQGASDMACLSENLPGYYPLNEATWRYYAKIWGVDYEWLLGN
FVSKDWMHKTGLSLARWWAAALNGK
>fig|195.2060.peg.1787 Acetyl-CoA synthetase (EC 6.2.1.1)
KKEDPKGEWIKKFNLDSLRSIFVAGERCDSDTPKRIEKLTKKPVVDNWWQTETGWGIAGN
PFGLGAQ
>fig|195.2060.peg.1648 SMF family protein, DNA processing chain A (DprA)
FANGLDEIYPRSNEKIIKQIYENALALSENESYYKPKPYDFLLRNRLIVALSEAVVVAQA
DLQSGSMQSARLALELNKPLYVLPQRKNESDGTNLLLQEKNANLLLDFKEFASCFGVIEE
EKDEFLDFCRQGVSVDEATQIYGEKVYEYELEGKISIEGLFIRVLV
>fig|195.2060.peg.954 hypothetical protein
MINGINSYSSYNYTNTFSNNTPNTKSSNTVNETSNLVSDKSRTVSKMLGYGVDKDGFFTS
DFNEAAGLPKDYKIYAKDIENFVNIQTKSLLSSYINIDIVKSIGNAYKVFSQLLNNELNN
K
>fig|195.2060.peg.1148 FIG00469843: hypothetical protein
MKNFTPLKNKLDSLVEEKNTNKALFESPDPLQVAKFIMMNLSLYFVLYLLMGMLKI
>fig|195.2060.peg.1695 Formate dehydrogenase subunit or accessory protein
MKNRREFLKKSAIALGTASLLGGASVAFGQDQDEERKDLVRGKSKKKEVLYQRSANWEKY
YIRAE
>fig|195.2060.peg.1791 Sodium-dependent transporter, SNF family
LFILLVLMLIYAMTKDGFMMAVEFLFVPDFSKISTSNVLEAFGLAFFSLSLGVGTIITYS
ASLPER
>fig|195.2060.peg.1772 hypothetical protein
STFIPPNGEYQNFGIMAAIDHINALKDLVKRFPKLADLPKIYGGGSYGGYLSLLIAKIAP
WYVDGVIDNSGSAVPP
>fig|195.2060.peg.1466 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
YYAKIWGVDYEWLLGNFVSKDWMHKTGLSLARWWAAALNGKDGNDAIDNAGTPLKALVVM
GNGITSTAQQVKVKEGLEALELLVLADPFVNEAGIIAERKDGIYLLPAATQFETSGSVTA
TNRSGQWRFKIIDPLYESKEDQEILFELAKKLGFYEDFTKTLRDENGKIVWPENATREIA
SAVRSIGLNGWSPERLKKHTLNWDKFDEVTLEGKDELAGEYYGLPWPCWSDKHPGSPVLY
NTDIEVAKGGMGFRNNFGLEYEGENLLAKNAPINSPIDTGYPQITKDNIEKVLGITLSAQ
EKEKMGAIWSYDDSNIIATKCIEKGIVPYGNAKARAVVWTFKDQIPLHREPLHSPRNDLV
QKYPSFEDQKALYRVDTKFVSVQKAKDYSKEFPLNLVTARLVNLNGAGMENRASMYLTRL
TPEMFCEINPELASEQKIKAGDMIWVHSPEGTKIHVRVKLNPGVAKDMIFLPFHFTGVMQ
GVDLTHNFPKGTKPYASGESANTVTNYGYDIMCQIPETKGGLCRISKDGV
>fig|195.2060.peg.1588 SMF family protein, DNA processing chain A (DprA)
MQSELPSAYLELFKELKNPPKKLYYKGNLKLLEQRKIAIIGSRRMSTYTKNCVFELSNLL
KNSKISVVSGGALGVDISASMAAMPSTIGVFANGLDEIYPRSNEKIIKQIYENALALSEN
ESYYKPKPYDFL
>fig|195.2060.peg.1788 Translation elongation factor LepA
KERLEREFNLDLIATAPTVTYEIYQPDGELIKIQNPSELPPVNKIDHIKEPYVKATIITP
SEFLGNL
>fig|195.2060.peg.1487 Signal recognition particle receptor FtsY
MFDFFKKGLAKTLESIVGVKGENKKITKDLLEEILLEADVAYEIVEEIIYYLPPSDEVKK
EDLKRVMGSYFLYENKEFLDEKPFVELILGVNGAGKTTSIAKLANLYKSQGQKVILGACD
TFRAGAIEQLRLWSEKVGVDIVLTQQGHDPSAVAFDTISKARAKGFDKVIIDTAGRLQNQ
KNLANELEKIVRISAKAMPHAPHRKILVLDGTQGNAGI
>fig|195.2060.peg.78 hypothetical protein
MLKIILVLSILSSFAFANSCVYYEQELKKCNSLKNSHERKCVV
>fig|195.2060.peg.1740 Tetracycline resistance, ribosomal protection type => Tet(O)
CGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTAC
SGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREILLGALTEIS
DCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAE
YTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGL
YGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQE
YLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTSFTNGQGVCLTELKG
YQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>fig|195.2060.peg.1121 Putative two-component sensor histidine kinase
FLNLIINSIEAFKTQKVKNIIFSFSKFGKNYIKVKVKDNAGGVDEDILDKIFQPYITTKH
PSQGIGAGLYISKQIVESFGGKIQVKNIKDGACFEIYLKLQEGN
>fig|195.2060.peg.590 hypothetical protein
MSNYQNYSPTSHNIKIMTFFSLDDKSDIFKYSLIDPTPYSNNDKTITKSGIL
>fig|195.2060.peg.1781 LSU ribosomal protein L4p (L1e)
RANTAHTKGRSDVSGGGKKPWRQKGRGGARAGSTRTNVWVGGAGAFGPTNERNYFQKVNK
KQKRLALERALADK
>fig|195.2060.peg.1779 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
NIGKFGGGVNILRGHDNVQGASDMACLSENLPGYYPLNEATWGNYAKIWGVEYEGVLGNF
VSKGWEHKNGLSIAR
>fig|195.2060.peg.1435 hypothetical protein
MIKKIKQVNYKSFNNYNSSGLEFNRINILYGRNGQGKSSLVNFIKDNIENNNLDIFEISS
NGFSLFFYDTDYKNSLFYSNDKFKTFYIADDIENIILEKNKICKKIKKLKEFKNKIEEKI
NTANKNKKDLKSTIAKNTREVLSKIDSNKYNTPQSYQSTHIDDGYLSSEKISLFEVLSYD
EFEKIKSMKKNLNYEIIKEFNFDKFKQIENGVKKIDEMLKQTPENNAIDRFKQDNDLENL
ARLAFDIKNKSEMYKDKCPLCGQNILGVKLWEKLEKHFNEEYKQFIERLGKAKIFFEISI
TELGNYTKWLNEYFIKTKLLIDDDIDKKRQEYLLFIEESVKEINNIINHIELKKQNPNKN
DIDIDCDLNLFQRILNDDIQNLIKQHNRKQQTYLKDIDENIEKIKKHFIAKEKDNVALYN
GLINFYNKIKEKINCVLEKRNKHIVDIDAKLKEMDQSFQNLNKDMEEWFFNDICFEKIGD
TYYKIQRLNFNNKWFDCDKGLSEGEKTIVSIIYFTNHFLSKIKEIKECPLVFLDDPINSL
DNSNRDKIINYISSKLLKQNRGQFFIATHIDEVCDKFNKKNSDTQSIFEIKKYANQSEIE
KLAGFKLNNDFKTTHLRLCEYLKFGKYEDAFDISGDVRFILEKICNIFFKNTENFTDCYD
KLLSKFDIIKKYTANDIQDLNHGKNTINSDEIIEKVRFVVEIIDKIRNFHAGNYSSKKGF
YCF
>fig|195.2060.peg.632 hypothetical protein
MTRSKIAKFFTFWIPIRKIRKKIRQKIENLLYIPYIKKIQQTQFDIQQKIKSKKISKLNI
AFFVMYDSIFPAKTLFENMNKISLFNTHLIVIPDITKGEENMYFQMTKTYNTFRSIYTNV
LLSYNFNTKTFEDLGKEMDLICFSNPYDSATHKFYQIKYCALHSLTFHIPYSYTGFLQYN
LKIFSSIEYSLFWKIFVENNNTLQTIKQHQMHQVKNLKLSGYSKMDSLNNKNQLSKKTQP
IIILAPHHTVQKDFALQLSNFLRFSNFYLKLPTIYPNVHFIFRPHPLLFINLENNKIWSK
EQIKNYIHTLTNYANVSYENGGDYFESFIRSDALIHDCGSFIAEYLYLDKPECFIFQNKQ
QIDHEFTNNGKKVLEHLYMAQTEKDIIDFIDNIVIKNMDFLKEKRIQFAKENIRFNHPYA
TQCIMDFIKMELTK
>fig|195.2060.peg.1717 hypothetical protein
MKIGIFPITTYSQLDDFIPRVVWYLYPFRDWFSICNLYVSFKVKKKNKCLEHFDQIIYRN
FKHMNISYVSNSNIFDFSFLFGLDYIFLTNDLMFRELSIFKKKYNLSIEIIRIDHERLSY
ADSFFLRFGEKIPNLYEKYKQISKNKILSLIKPLKTNKIYLFGTGPNSKYAFDYDYSDGL
VIACNSMVINKDIIVKLKPKIFVIADPIFHAGPSSYAAEFRQNLIEMFIVNPCVIVVPLR
DYHIYSTYLPSFMIDFLVPIFFKIPSIDESPFYIDILKYFEVKTTNNILTLFQLPLAASL
GNEIYIIGCDGRPKSKDSYFWSHNDKVQIINKMDVIKVVHKGFFQIKYNEYYDKHMYFIK
NLVKTIEKHGKQIINLTPSYIPPLQKRISDLILETNRQKNICDLSIILPIYNMQKYIEKY
LNFLLNMQDINYELIVIDDFSEDLSLELLLKQELQNVDRLKVYQNFNKNGLYGAIKTGLK
LAVGKYVLILDLILLYILIN
>fig|195.2060.peg.835 Bacteriocin resistance protein; peptidase C39
MEKILKIALIVALLPLFLKAEFVVKSYQEIKNEKVVRQNYEESCGAASLATLINILDDSN
LTELDLLKTMSGQKLYTDMVSFADLNDAVKKLGYESKSYKVDRKILENIISVPILVKIED
DPRFPHFVVIINHKGNYLQILDPSYGEYISSKREFYSVWDRYNKGGFALIVNPKKQLKDY
KLNLPKPLNFEIEHFGF
>fig|195.2060.peg.1597 [NiFe] hydrogenase nickel incorporation-associated protein HypB
MCKDCGCSINSAHTHEHSHHHDHHHENPSLKESKTIEVISKILSKNDEEAKHNRAHFNEA
NTLCINLMSSPGSGKTTLLESTIKALKNELKIAVIEGDLETNNDALRVKNAGALAYQITT
GQSCHLDAFMVHEALHHLAIDDVDLLFIENVGNLVCPASYDLGEHLNVVLLSVTEGSDKP
QKYPVMFKKADIVLITKVDLAHHFDFDVKEATRLIKELNPRADIITLDAKNGTNMELWYK
VLKLKKELF
>fig|195.2060.peg.1549 RecD-like DNA helicase YrrC
LYLRKDGLENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTD
TNQQLDSIYENLQSSLKYIGDKRKYKDIKNFHNLLQISVSHYTPNEEVAERLMLKYLFYL
FQTRNFCKEFLDIQILNNLQEFPINLDTLSFQYYERVVDKIKQTSMFNDTKTDKFYIQKV
KPFIINEEIYYEITFTIAKDNVSKFDKLIAFSKYYIPSNYSTKLTLYYTNIKLLNLQIPV
ILILQWNIDIRPCEFTNFCLIFNSIRMSFTRSTKYEHFMQFLTKEELNLLDIVKLKTEEY
DEIKNQFSEDKLKHLFNCLDMAREIILNNKSGSNILSYILYAMNNQIIKKQIPKKKNSYQ
PNPKLSNLFLKNESIPFDEMPFCSNPAGHIPKLNVLFECISLNNREYELLARKIQYNSEV
NGSLYTSLEDFKEDNIEVLIEKYNTALYNGHKKNRSIKKLHDKFLFINEYQDTLIEIIQL
LNNFTKSGLDHYKENINEWLKECNQLDCKEKKDYLSNLFCNSKLALIYGAAGTGKTTLIE
HISSFFHDKNKLYLANTNTAVNNLRQRLDIQNSSFSTVASYIANKNNISKKFDIVFIDEC
STISNKDIFSVLDDIKLKCEILICVGDIYQIESIRFGNWFLFAQKFFSDIQLELKHIYRT
KSEKLQLLWERVRTLDESMLEAIEKNNSSENIQNFNFSRSVNDEIILCLNYGGIYGVNNI
NKFLQENNPHKSFYFNGLSYKVDDPILFNENSSSFGEEFHNNLKGIITNIEEDEKTINFT
IKINKIIQNINNNFKIVAKDDKGTEIKFSVARLNSDEEDDNSNIVPFQVAYAISIHKAQG
LEYDKVSIVVADEIEEQVTHNIFYTAITRAKKELKIYWSAETENKILKSLKIKDINKDFH
LFKNNIQNIKTLKN
>fig|195.2060.peg.1747 hypothetical protein
ADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSAVPPLNYIIGRELEFKSKDTNGD
MYMQGDHFFVSCFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYH
SKEDPLTPANFKEQTMQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKALFRKEL
PLMLEK
>fig|195.2060.peg.1611 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAVLSLFKTS
NILENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMI
>fig|195.2060.peg.1547 Uncharacterized NAD(P)H oxidoreductase, YdeQ/YrkL/YwrO family
MKTLIIFAHTFWEDSKANKALFESIKNSKQVQIHNLSEIYKEGKIDVSKEMALLKNADKI
IFQFPLFWFSTPALLKEWQDRVLTAILYGENKETFKR
>fig|195.2060.peg.930 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRQMVQTAAEHGWGDYRAAPTFQDDVMGAYSITIIFYAALMSSLKIVLIQMEFSTWSWR
HLA
>fig|195.2060.peg.1546 NAD(P)H oxidoreductase YRKL (EC 1.6.99.-) @ Putative NADPH-quinone reductase (modulator of drug activity B) @ Flavodoxin 2
MEKIKKLLKDKKFQIVTTLGGAQESYDGHHGATLEELLKPICYAFEYLGCKSLKPFAIFS
ADANKLDLKAYQDAISQNSGCS
>fig|195.2060.peg.1733 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSTLADFTKDDLKLIEKVLRKYNIPCDQLANN
TVVSHCEYLSEIMTELKMLNRLPYDFEERLSATFIPSRGEYQNFGIMAAIDHINALKDLV
KRFPKFADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSAVPP
>fig|195.2060.peg.306 Diaminopimelate decarboxylase (EC 4.1.1.20)
FHIGSQLLDISPIHEAAAIVAKLVRELKALQIELKFFDIGGGLGVRYEKEDVEPDLYDYA
QGILAQLHGLDVTIGMEPGRFLVANSGEFVCSVLYEKHNKTKRFVIVDGAMNDLIRPSLY
EAYHEILLPYNQGEESPCDVVGGICESGDFFAKARSLPSTQSGDIMVIKNTGAYGFSMSS
NYNTRNKVCELALEEGQVRLIRQRENFEDQIVLEEKFLKA
>fig|195.2060.peg.1780 Motility accessory factor
ENFKNSIVSHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSL
TKQLPLLKKYASKA
>fig|195.2060.peg.510 DNA-directed RNA polymerase beta' subunit (EC 2.7.7.6)
VINIENIHEDVIVSIKDKKQEVKYILRKYDLAKPNELAGVSGSIDGKLYLPYQSGMQVEE
NESIVEVIKEGWNVPNRIPFASEILVEDGEPVVQNIKAGEKGTLKFYILKGDGLDRVKNV
KKGDIVKEKGFFVVVADENDREAKRHYIPRESRIEFNDSEEVDFDSIIASVPKQEKSVIA
EWDAYNNTIIAEIDGVVSFEDIEAGYSADEQIDEATGKRSLVINEYLPSGVRPTLIIAGK
GDKAVHYQLEPKTVIFVHDGDKISQADILAKTPKAAAKSKDITGGLPRVSELFEARKPKN
AAVIAEIDGVVRFDKPLRSKERLIIQAEDGTSAEYLIDKSKHIQVREGEFIHAGEKLTDG
VVSSHDVLKILGEKALHYYLISEIQQVYRGQGVVISDKHIEVIVSQMLRQVKIINSGHTK
FIEGDLVSRRKFREENERILRLGGEPAIAEPVLLGVTRAAIGSDSVISAASFQETTKVLT
EASIAGKFDYLEDLKENVILGRMIPVGTGLYGEQNLKLKEQE
>fig|195.2060.peg.1541 hypothetical protein
MDIKYSYFGNTSNRVKNLLYNFETQLILFDDLFKNASKNDVWSNDSELQIRYLELLEQHN
LLKSKNKTTHLGTKDARVKSAPLENYGLIKRKEKLITEQGYELLSLIENQSYKEINDFLQ
IDLISLFFLKSSFLFQKDNVKDLFLKYIKVFRYFNGSLSRDIFYLLPLIDNFKNIESFCE
CAKNGNMINEILDNNQKFKDDLEAFLKDLQEDVIDIKYFITAKGDQSAKNIVEALKVFLD
FRQRKDKAILSNFLKSKDTKYKRFKELYLGYICYKIKIDDKIEQLSHFCEGDILDFGKRF
FRFIATSKIQSNLDDYLDLNKRHLRLTGIFDFSDDCVSVSIIFKIILKHSKSEVILNTIA
QNTISKDMLSNYFNDNEMKLLLKEFDIITLQDLSNYKTNLDNQKLDILLKERFSKDKICE
ILPLFNDRKNDEKIFNLVTTEATIPTIFEYIIAIAWCYIDNFNKNRILEAGLSLDSEMLP
KSHAVGGNADFIYHYKDHSLMIEVTLTEKTNQRRAEMESVSRHLGNLLLSLETKVQAQSY
GIFIAPYLDKNVLNDFRSRLTCYYENNTSFIYGMKILPLSVDDLKIILETNHTYDKLLEY
FYSLLGSKNTWGSKWYNNEIAPFIKGLINV
>fig|195.2060.peg.831 Putative phage protein
LIDIDTKIKIYLDYKDTKSGDKIKGLEKVLFNKFKQSVNIKIFTIQSHESNIVQLVDLLI
GAISYKARNDIEHVSEIKNYIINKIETLANIELDAGTPPWENKFNIFRIQLSKGEQ
>fig|195.2060.peg.1617 Flagellar biosynthesis protein FlhA
MAKNKLVDLVFPFLGPLIGPVLRAKSLTIVGFIVCILAIIIVPLPSPILDFF
>fig|195.2060.peg.1782 Signal recognition particle receptor FtsY
EKVGVDIVLTQQGHDPSAVAFDSISKDRD
>fig|195.2060.peg.1728 Beta-1,3-glucosyltransferase
YYLNVTRNGYLKILSDCVKNKRDIPLFVQNLVLYDLCWQIKPLINSPEKLSILNESEQQE
YLNLLDKIFSFIEIETVVNFSLAGCWFFYKVGILNCFKNEKPAFQIAYIEDYDPYKEQIL
LTYYTGDDKDIESILIDREEVYVDYKKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEVLI
NNEQGMVGKYGEYFLDVKNIRKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPE
REIVFALRKESLDWERLEKEGFNLVEFGSFEFERIIKKASKVISSHADEYLMRYITSRQQ
FIFLQHGVTQNDISKWLNNRKINLFFVSAQMEFDSIVKNYTRYKFGQKEVVLTGFARHDA
LLKNNKTNTKQILIMPTWRHYLSGLMIGNSGIRELKDDFKESEYFQKWNLLLDSNTLQKL
CEKYSYTIVFNPHPNIIPYLKDFNIPSYVKITNQSESLQKLFCNSSLMITDYSSVAFEMA
YLNKPVLYYQFDQEDFFSSHTLQKGYFDYRKNGFGPVVEKEENLLKELENLLQDNCRVFG
VYKDNIDSTFAFKDGKCCERIFKILSKDVYE
>fig|195.2060.peg.1446 Putative C4-dicarboxylate transport protein
MANIMQPGHGMNLDPKQLDTTSVQKYISQTTEVSASSEIMHILKDAMPRDIITPFTEGKT
MQVLVIAIITALIISLMRIEDRQAIQRVSCCFFGYGGTYSPIRFRLFN
>fig|195.2060.peg.1754 Tetracycline resistance, ribosomal protection type => Tet(O)
LLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPE
GQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIK
>fig|195.2060.peg.1540 hypothetical protein
MTYVKGSFECHVYKMDFINPPFNYTGSKFKLLRSILPLFPKTINTIIDLFCGGGSVGINI
NAKKIILNDKQSELIDIFRLFQKQNYENLLDSIFFIIDKFNLSKSDILGYEYYNCNSANG
LSSYNKAGFAKLKESYNKNKNQLELFVLLIFSFNNQMRFNSKGDFNLPCGKRDFNKNMQE
KLKKFINALQNKNIEFSSLDFVDFDISNIKCDDFVYIDPPYLLSCASYNENGLWSESIEL
MLYDFMQKLDSKNIKFAFSNVLFHKGVDHTLLQKWLDSNPHLKVHNLDFHYKNCNYQTKR
TESKEVLITNY
>fig|195.2060.peg.1602 hypothetical protein
ILKELNFKVEFFAISQVDNKFIKNLNHGMGLSTKLFFKKHLLQILKEPLQDKICKKEVSY
KCDELVYTFKEENHQIILNITN
>fig|195.2060.peg.1789 Propionate--CoA ligase (EC 6.2.1.17) / Acetyl-coenzyme A synthetase (EC 6.2.1.1)
KKEDKKEDPKGEWIKKFNLDSLRSIFVAGERCDNDKH
>fig|195.2060.peg.1010 Oligopeptide transporter, OPT family
ENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMICLCGGGLGVLFTIPLRRA
MVVESKLAYPEGRAAAEILKVANKDQSSKKGKQGIKEIALGSFIAAIFSLLSNGFKLAAS
ESNFAFIWNKMAFGFSAGYSLALLGAGYLVGLAGAIALFVGMFLAWGVFTPYLSSFEFDG
VKNASELASSVWAAKVRLISTGAIAIAALWTLIELLKPVISGIKEIIKNVTISNTKSQES
TD
>fig|195.2060.peg.1347 DNA-directed RNA polymerase beta' subunit (EC 2.7.7.6)
MSKFKVIEIKEDVRPRDFEAFQLRLASPEKIKSWSYGEVKKPETINYRTLKPERDGLFCA
KIFGPIRDYECLCGKYKKMRFKGVKCEKCGVEVANSKVRRSRMGHIELVTPVAHIWYVNS
LPSRIGTLLGVKMKDLERVLYYEAYIVENAGDAYYDNESTKKVEYCDVLNEEQYQNLMQR
YENSGFKARMGGEVVRDLLANLDLVALLNQLKEEMAATNSEAKKKTIIKRLKVVENFLNS
NLNANTNNEDAVPNRPEWMMITNLPVLPPDLRPLVALDGGKFAVSDVNDLYRRVINRNTR
LKKLMELDAPEIIIRNEKRMLQEAVDALFDNGRRANAVKGANKRPLKSLSEIIKGKQGRF
RQNLLGKRVDFSGRSVIVVGPKLRMDQCGLPKKMALELFKPHLLAKLEEKGYATTVKQAK
KMIENKTNEVWECLEEVVKGHPVMLNRAPTLHKLSIQAFHPVLVEGKAIQLHPLVCAAFN
ADFDGDQMAVHVPLSQEAIAECKVLMLSSMNILLPASGKSVTVPSQDMVLGIYYLSLEKM
GAKGSHKICTGIDEVMMALESKCLDIHASIQTMVDGRKITTTAGRLIIKSILPDFVTENM
WNKVLKKKDIAALVDHVYKQGGLQTTASFLDKLKNLGFEYATKAGISISIADIIVPNDKQ
KAIDEAKKQVREIQNSYNLGLITSGERYNKIIDIWKTTNNTLSRDMMKLVEKDKEGFNSI
YMMADSGARGSAAQISQLAAMRGLMTKPDGSIIETPIISNFREGLNVLEYFISTHGARKG
LADTALKTANAGYLTRKLIDVAQNVKITIEDCGTHEGVEINEITADSSIIETLEERILGR
VLAEDVIDPITNSVLFAEGTLIDEEKARILGESGIKSVNIRTPITCKAKKGICAKCYGIN
LGEGKLVKPGEAVGIISAQSIGEPGTQLTLRTFHSGGTASTDLQDRQVSAQKEGFIRFYN
LKTYKNKQGKNIVANRRNAAVLLVEPKIKTPFKGVINIENIHEDVIVSIKDKKQEVKYIL
RKYDLAKPNELAGVSG
>fig|195.2060.peg.1542 hypothetical protein
MFNISSRRYTGAKTKLLDSIDYTLKQGFDYTKYNDLSFFDVFGGTGVVGEYFLKNPYFNH
FIINDFLHSNYVIYQGFFKQEAFSKDTLEKLVNAFNAIDSKEQNYYSLNFGDKFFSLKDS
IKIGTIREEIENLKESKKINTKEYYILLSSLLYSLDKVANTVGHYDAYRKNIALKDKFIF
ELIRPITTKSKVEIFKEDSNKLVKDFIKEKRKIDVAFIDPPYNSRQYSRFYHLLETITLN
DKPKLYGITLKREPENMSEYCKVGAESVFRELCEDLSKIARFFVVTYNNTNSANVRSNTK
ISLETIQAILESFGKPISYKIPYKAFNSGKTNFKNHMEYIFVCKIFNF
>fig|195.2061.peg.1369 hypothetical protein
INNQENLAHKIAIGEFRIFIAVYKDMKCLENINNITKIYGYNSKVYRLKDQIWDERYLGG
VCKISQALYFSGKAKIGII
>fig|195.2061.peg.475 Hemerythrin domain protein
MKYHFDDEEKYMQFIRYPDFERHRQIHKEIIQSMIKIIQNIKTTNDLKEKLYIMVKNGF
>fig|195.2061.peg.1670 Motility accessory factor
MKFNQNQIKLFNRNINALNNTVLKESLKQIKSSKFELILGKDNLDINLKNTSDNTFLYKN
AIDELNSMLNIYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKELEIVKIMLH
LMDFSQELKENKLIILDVNSLEFQDYYDLCSSNPFFQFSRTYFLELSSDFYEKDKEEILN
LNNNLMEKFKNAVLLKGNDSKDILQGIEQLIYNLPKIITHTAYQDLLKKRENLSDTAIIV
STGPSLTKQLPILKKYANKATIISADSSYPILAKHDIKPDYVVSLERILLTSEFFNNNFG
DFDKDILFITTHLTHPQTIKNLEKNNRNFMLAYRGSEFIKYLKIKNFGELSEGHSVANVA
YGLAVFLRHKNIIFIGQDLAYSNDGLSHTKDYRNLNKHKGHYERDFGHFRTIAYGGVGFV
ESSFYWSLFRFFLEKRIHEANQLELCNTYNCTEGGARIEGAIEKPFKETCETLLKNNLNK
NFPKIDPLSSHKQNELLLKCYCKIIKSINHCKTFKKELLKSYNHIQESFSNLNLISNLDE
GKEILNYLIQEIDKIKFKLEDEKNMLDLYEILGPILTQFELNIAKIYILNPKTSEDSYKK
SLLWVKEHIEFFKMIYIHIEAQEKALIKNIAPLENELTQRNLEKYKRKINAKYNF
>fig|195.2061.peg.998 hypothetical protein
MINSWKGFAKLVNEGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLS
NIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIAL
DTIEGFNSENSSSGGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILS
NIESIYGKNNGGGFVGYTTGNTTFDGISLKDIRFIKSGAFTGGFAGMTQGNVIFENIVLN
DLEEISGSHAGGFAGWINDGTFNNIILNNIEKSVLALHINISLQVALQDMQALELIKILF
>fig|195.2061.peg.1297 Membrane protein
MISFFIAAFTQFIALLSLNYLIASPVVDKILRIFLYGFSFLCLAIAIFCTFIFFKTLKTL
CENKIYFKLCFIFKSAILIIIYILMFVLIYSEHSLALIIAYFMIFFFAGLLFTIYYALFA
FALSKNQNIKLSQT
>fig|195.2061.peg.348 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEL
NFFYQSILEKTPRYPFVCIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTLDLSEE
LCSGKIYLVDVEEEKVNIQLSILFDQKDMFEYLSLYEMFINSSYYVKVFMDKIEKTDNVI
NNIINLVIRNLNPESTIALICYDNFIQNIPSILTGIPFQRIIQERKNQFQNCIVVGAGPS
LAKQIPLLKRYQENFVIFCADGAFPLLYKNDIIPDYVLNLDLEQHPISFFKDILSDKVKK
TLFLFAQSTHPDVARFLKEKDFQFSMVLSGDPGYKKLNIYDFGYLEIGNHVNHMCYTLAL
ELEFKNIIIIGQDLAYSENGLSHYKDFVLGDAVDISLEFPEYKVLAYGGKGEVITHIGWN
DYRKKLELLFLNNIQANFYNATEGGARIAFTKELSFKECCLKFANCKKKSFPIPKSLTLN
RSDKLFKKILEILSQDLKIFEQTLEDSEALYHVLEKVASSENLPLEFLLNVYKSIENFNF
YLEENSVFYDGILKGVLFYRGFKLSEIILKKIKEEEKYLFLVIKAYKDWLLLFIEKLNIR
KQSLEKLFL
>fig|195.2061.peg.1667 Methyl-accepting chemotaxis signal transduction protein
MYITPAYIDVVSNEYAITYSKALYKDGKFIGVLGIDVLLTSLQDRIARTPGNTFVFDHKD
RIFAATNKALLDPSVDHSPVLNAYKAHDDNNFFSYKLNNEERLGTCTKVFAYTACITEST
DVINKPIFKAAYIQVIALIIMISISIILLYFIVSKYLSPLAAIQTGLTSFFDFINHKTKN
VSTIEVKSND
>fig|195.2061.peg.1722 Flagellin
DINRLMEELDNIANTTSFNGKQLLSGGFTNQEFQIGSSSNQTIKASIGPTQSSKIGVTRF
ETGSQSFTSGVVGLTIKNYNGLEDFKFDSVVISTSVGTGLGALAEEINKSADKTGVRATY
DVKTTGAYAIK
>fig|195.2061.peg.1654 RecD-like DNA helicase YrrC
MENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTDTNQQLDS
IYENLQSSLKYIGDKRKYKDIKNFHNLLQISVSHYTPNEEVAERLMLKYLFYLFQTRNFC
KEFLDIQILNNLQEFPINLDTLSFQYYERVVDKIKQTSMFNDTKTDKFYIQKVKPFIINE
EIYYEITFTIAKDN
>fig|195.2061.peg.266 hypothetical protein
FIVNNSLCKKIVLRDLESYKVNITEAFLPLPKIVNITQIDYKKNNDEIYIGTFGIPREIK
FSLEIAQAIEYLNEFKNINIKLLVVGYGASNFFKKYDFNKSYLEIYENVTDDQFYGLINQ
VDLVVQLRKKPRGESSGPIVSALVLDKKIITSKDFVDKKIEDKVFVLDNHELDYKKIAEK
ILECIQTSSDVVNYSEIKNSYTYSNLAKLLDEL
>fig|195.2061.peg.1203 Probable periplasmic protein Cj0776c
MNFKFFSIIVGILVVVILILSGTYYYLFEYSKPSYTPITQTSTEQNQYSNNTHTTTQNSY
VSDITNTNNENINLIQDKQDEKDANNIINDDNKSDTKSSQITKQNNEEKLAAIEKEISKQ
QKILEQEKIFKPQNTNNNKTNYQAKKLSPAQEYLSLGKNSRLEPQLSTENMKVYVLDGKF
LSDYRIKLLKDMLAIIEDNSKDYFLSVFVKMLPKGEMSLTIYNK
>fig|195.2061.peg.1575 CoA-binding domain protein
MIGQFLQENHYKIYPIYPKCDEILGERVYRSLDDIDEKIDLVLMFRKGEFASSLLPSIIR
KGIQNFWLQLGICNNEVAKECENLKINFIQDKCIMRELPLYQDRISKC
>fig|195.2061.peg.165 hypothetical protein
MISKVILVVLDGLNCKSASINMGYLNALCKENLGKFYSLECELPSMSRPLYECLLTGVKP
VLSGIINNKLSFSKQTSIFDLCKEQGLKAGGAAYHWVFELYNKKEFIPSLHRHIEDENLT
LPYGHFYYEDDYLDSHLFADGEHLRNKYNLDFTLIHSMNIDDAGHKFGSHSIEYANKTKK
VDILISEYLPTWLEQGINVIITSDHGMTEGKSHGGLSEDEILVPFFTFGSAFSYENAKIK
QDEICGSICEILGLKHDKRYNDEILKAKK
>fig|195.2061.peg.1333 putative TYPE II DNA MODIFICATION ENZYME (METHYLTRANSFERASE)
NLYLFFIYKCILHLKDKGELIFITPRDFLKSTSSIKLNNFLFSQGSITDFIDLGDKKIFK
SAQPNCAIWRFEKGNFKRNTNCLKEFNCINGQILFTKTHYFIPFSKLFFVKVGAVSGADQ
IFTNEKFGNMEFVCSSTKKTKKTKKMIYGIYGKTCKYLIQNKEILLTRKIKKFNENNWWQ
WGRDYYKSDLERIYVNTKTRNKNPFFINDCKAYDGSILAIFPKFKCDKKLLQEICDKLNE
IDWEELGFVCDGRFLFSQRSLENCLLNENFKDFLKFS
>fig|195.2061.peg.956 Type I restriction-modification system, specificity subunit S
MKTKTWEINKLEEVCEILDNKRVPISSKNRIRGIYPYYGASGIVDYIDKYIFDEELVLIG
EDGAKWGAFENSAFIAEGKYWVNNHAHILKPNNEILINKFLVYFLNYSNLEKYITGATVK
KLNQQKLKQIEIPLPPLEEQMRIVKILDLAFEKIDTSVELLKANLANLDELAQSVLDRTF
NPLGDSADSTESTQNPSTHDTQSPYPLPQHWEWKTLGEIGDIITGSTPSKNNPKFYGNDY
PLFKPSDLGSGNTIKASDNLSKLGFESARKLPKNTLLVVCIGASIGKIGLSGIIGSCNQQ
INAIIPSPNVLSKYLFFVCHSKYFQSILKKNASQTTLPIINKTEFSKLEIPLPKDIKEQE
QIAMHLDSVFGKIQKLKELYNAQLQDYEELKQSLLNKAFKGEL
>fig|195.2061.peg.1367 hypothetical protein
MLESDLLNSSIVACPHTIANVSYPCTKVVDIKGSLSQKKVNGEYAILQELISACKTDKGF
ALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEARLRMYYKEHKYQKDNLFTNLYLND
TLY
>fig|195.2061.peg.1101 Predicted P-loop ATPase
MIADPVASVAMSRASSIINNFNKLLSAEKKGLDEIKNEINTALLNIDIKIIVVIDDLDRL
ADTDIQEIFQLVR
>fig|195.2061.peg.543 Putative two-domain glycosyltransferase
MNLEKISVIIIVKNAQNTLFECLNSLKEFGEIILLNNESTDDTLKIAKEFQKDFTHLYIY
ESKFIGFGALKNLALSHAKNEWILNIDADEILENEAKEELKKLEFKEQNILALTRKNLYK
GEWIKACGWWPDHVLRVFNKKHTKFNENLVHESLILHPNTQKVYLKNGLKHFAFESIDDL
LDKLQKYSKLWALQNLHKESGICKALVRGFWTFFRNYVLKKGIFYGYKGFIISVCNGLGA
FFKYMKLYELKKQKPKTCALIITTYNQPKRLALVLDSVKNLDPLPNEVLIADDGSKEDTA
KLIQEYQKNFPCVLKHIWQEDKGFRAAASRNKAINASNSEYIILIDGDMILEKSFIADHL
NFARLKTILQGSRTILNENESKE
>fig|195.2061.peg.1712 mannosyltransferase
MFIIYDFTRLDQRRNLPTPSGVDRVDLYYILFLLKTYSKIIFVRGYGGYLKTYPTQSALE
ILRKIAKNWAEIDNISYNIDKNDFINTKIDVERILKNNIQYTYFNLAHSLLIGRYTIAKF
AIKENIKMIYFCHDIIPILYPEYTADGKIAFEQHSCMMKLMLWSADLILTTSQAVKQDIL
NYSKEISVNPPKVIAKEIGAEENFLKARWSKQDSHKHFIYVGTFEPRKNHILLFLAWKKL
YSILQEHTPMLYIIGKKGWLIDWLDRYFEVEANVSRFVKRLENIQDSQLEKLMLESYATL
NPSYTEGWGMPVAESVSMGIPTICSDIPAYHESSQECAIFLSPFNVDIWVDTILDVLKDR
AIFPDYAYKIPTWKEYFAEIDEVLNKNYFLREKKQYIRYFYDNIQDFKKKKISIKNILKF
KFTNFKIRSIE
>fig|195.2061.peg.267 capsular polysaccharide biosynthesis protein, putative
MINYKKKLHLIIFKKIFSSSFLKRKAIVFADMFYDENHELIDNFLLFKHMYDLGYDVYYV
MNKKHIKYKEVKQVYKKNIIGCLPNRTSWRLLSVIAKTKIWVDSCQLLFLSKLYSLVDKS
KICCIQAQHGVNYFKEGYRFHLSEFIYDKVIVSNEIEKSIYCKNYSYCEDNFIKAGLPRW
TLLKNHQEENSILIYFTYRQYISLIKDNFKSSAYYQKIKGFLNSRKLIEMCNKYNTKIYF
AMHHEITRLFGEDCFKAENSNIIFIGEQDIGKIKNKASMLITDFSSMCFDFMYINKPVIF
YNIAKNDTLMQKIQEERDVYNRLEEKYKLLNHVYILEDEVLGQIEYYLDKKFLLRTHEEK
KNKEFFYPCNVLEESIKGILEEKKGRNIFFNNLHNPLEKNYFYTFFEDKDFKFYGFYADE
NQRGRWSVAKESIISFTIPYSDKNIVLNILCKAFLCAKRPQVKLELFLNDRRLIDKKLCL
TSNKINQYFAIDKQLYGKTVFFKFKIENTAQPIFYNKSFDTRPLGVFLEGLCLYEL
>fig|195.2061.peg.268 GDP-L-fucose synthetase (EC 1.1.1.271)
MKKNDKIYIAGHRGLVGSAILRKLKDNGYNNLIYKTHSELDLTDQSAVKNFFGKEKPDFV
FLCAARLGGIEAHRQFRAEFIYDNLQIQNNVIHQSYANSVKKLLFISSTSVYPEHASLPI
KEEYLLSGKLQYLHEPYAIAKIAGMKMCEAYSDRYGVNFISVCPTTLYGPNDNFDIKSAN
VVSALMRKIYLAKLLEEKKYDLVLKDLEIDDIDRAKEYLNMLGVKENFVEIWGSGNPRRE
FLYSGDLADACIHIMQNIDMEHINNIDKDNPHINIGPEGNYSIKELAHLLKTVIQYKGEF
RYNLNKPDGTYEKLTCCDKIKQMNWQAYTKLEDGLRSTFHWYKNSKGLI
>fig|195.2061.peg.1643 3'-to-5' oligoribonuclease B, Bacillus type
MKIYHLSHTDLDGYACQYIVNFYFKNVNFYNSNYGK
>fig|195.2061.peg.1600 dTDP-6-deoxy-3,4-keto-hexulose isomerase (EC 5.3.2.3)
MNYKILNFNAKSDNRGSLIALENLKEIPFEIKRIYYIYDTKPEFPRGAHAHRELEQVLIM
MEGSCELVLNDGKNIKNIILNRPDMGIFIGKNMWREMKNFSYGAKLLVLASDFYNEKEYI
RDYEEFLRNINDT
>fig|195.2061.peg.1713 capsular polysaccharide biosynthesis protein, putative
NFILEDEFKAKNKSFFACRENFRENIYNAISSLEKNTPFANILTPINRILPISTLKNIRS
IGLSKREAHGRWSLGDEVSFYFNFTEYKRITIDFKLHAIADLDATVYLDSKKMFSCNIFK
DVSQNKISIVVSRKKLLKQNGCIMIKFIIRFPISPKMLKLNQDSRMLGIFFHSINIYEVK
KS
>fig|195.2061.peg.1526 Transcriptional regulator, LysR family
MKIKDMEIFLDLLNTQSPTNTANNFSITQPNVSIIIKNLEQDLGGALFERLGKKLLPTPK
ALYLGKIWLKLVQDYYKSLEELNDENTLLGEIKIAATQSIAEHFLAPILFDFKSKFSNVK
IHFQTQNSKECLNLLKNGDIEFAIVEAELNPTLIDHEGLKMEFWQKDELVVASSNKNLSQ
KEFYIDELLKQKWILRETGSGLRDKFLNEIGDVSKKLKFFLELDRMSAIKELVIQKNAIS
IFSKKSIEKELKNSILYEVK
>fig|195.2061.peg.1003 FIG00638667: hypothetical protein
MNVENNQVFYHNVEAQASGEGVNRESSVYIRAANLAKNNLFKASNYWATSMLNIYGIREV
EESKNNQVIFNNVGFNTDRISEGSELILIGGVGKRVHHNLLSIQDLEIGAYDKEKDFIYI
AASAIPDTNSNLALSYGNTLYIGGDVSIHERSLLNVLSGSVIRIPNYTNNKADDITLPAP
SLAQLTKDNHLILEQALRARVVNNFEHYSLIYHSNNQDKPFIESLETPINLSEESQITLL
LKKGEKAPEKGSKIALISSQNGFSGINGNAMNKSQLNQLLGRISKNPKTLNYKKIPQLQQ
ENLRVVPLTLSLDNKGKVIYGEIQSD
>fig|195.2061.peg.1711 hypothetical protein
MKVRKNIFLKVLVFTIVIHDKEKIYHFLGIPFFKVQIFNKSKKYSLFGLPILKKYYNDKI
TDLFINEQKSNNEIENVLQRLFKYDIVKESDIAFLNIKKTINQEKNAVFGVLPPEKTGIA
IFNHNAFVDCEYFDIFSDIRDLSIARGLSKNVFDLKTFIKFDASYLYKKFIYILGNSSHN
NPYLNMAIRSTNKEKSWLYIHEADLNGLLYAHCGYNFLTMRVYLINCYPEFKHELLGLNN
FKDYHLWNSDFKIYGLRVIIELTNIYN
>fig|195.2061.peg.1149 Two-component system sensor histidine kinase
MKTKNIFITFFVLLILCFGVIFYTLTNSYLNFLLLKQYEQKIKSLDDVLKFSLLEDLN
>fig|195.2061.peg.1525 Probable periplasmic protein Cj0776c
YISMDKISPYIKTPEVLNQYVAREEIIERFKLQTKKEGKGSEFSKHINSLKTGLNKAQYF
FPFCEIIEITSVK
>fig|195.2061.peg.1249 integral membrane protein
MDINTVLMMISDKIPSNSLPLVQDKLKNASEEKSTLLLSYLLKVIL
>fig|195.2061.peg.1700 Malonyl-[acyl-carrier protein] O-methyltransferase (EC 2.1.1.197)
MNFLKAKDYQKHAKVQDLMGLKLCEILKNLEISHFKKVFEFGCGRGEFSDKLSKIITFDE
YLKNDILDYPDNLNVEIFDINTLATQNFS
>fig|195.2061.peg.727 Anthranilate synthase, aminase component (EC 4.1.3.27)
IMLEMKANLYYRQILKEFPSSYFAEDSTRVIIGIDCDFYDAKDITLSELKAKFYENASRE
QICKYSGFFGVFSANFISLFENLPSNENKNYDFPNFLFANAKAYLVYEKTSKMFFKYGEN
KYFDFLKEDFVFDKKVCEYKILQDFQEEKRDFIQSVEKAKEYLLSGDIFQVVLSKQLCIE
HNFDSFEFYETLSELNPSAYMFYFPTQYGVVLGSSPEFLLKIKNKEIFLAPIAGTRNLDE
NSDILKLEKDLLSDEKELSEHKMLVDLARNDASKFGTNTRVENLFSITRNKFVMHIVSEV
YATMDKQANIFDIIGAVFPAGTLSGAPKIRALEIINELENLDRGVYGGAVGFLNFNEDVV
LAIIIRSAFFKENKAFIASGAGIVLQSDPQKEYEEICAKRKALLVSFEKMAKRS
>fig|195.2061.peg.984 hypothetical protein
MQNLHEILLQKKIKEIRFKAIASIVCGFLGIIPYLGFLFALASWILFFILLYDLKIYGGA
KNLF
>fig|195.2061.peg.1250 integral membrane protein
MILGLFLGAFGIDRFYKGDIGLGIAKLITWLVGVVTIWIYIGGLILFVLWIWCIVDWFLV
WKGIKKDNLNKILAVL
>fig|195.2061.peg.273 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MLKIEQLRKNLQIYCKSVNSKDSIRFMRTYRNLTSMEKKENYDYLDDYIVKFSEILHNTS
QIKINDEFLNRFEILIPTYNRKEYIIQVIREIKFVNENIHIRVSDNGSNDGTYDALKELA
CKYPRLYISKNEKNMGFGFNLHKLLQECDKDFFCVTSDEDPVIVKYLVKAIRFCIDNKID
ALRPLCIHYNKNECRIEYKTYTIEKQLKDIATFGYLPGCIFNTKMIQQFMKYYNRGDITG
VYEFNIWYLIASIFGRSYFFNYPVQYHKFWAKKTFINPNDDISLKNLKPYSHPSMRWEML
VAFANILREIKKDTNDPMVIKKIEQIMDIFSNRAIGLLYNIAVSEFPSLKLKADGGFVYK
STYQKLSTKLNILEKETIYKIAKYRIHNHLAYKLGQAMIINSKSLLGYIRMPFVLSYIKD
KHKQEQKIYQEKIKKDPSLKLPPLENYPDYKEVLKEKECLTYKLGEVLIRANNNWYGGVC
QIVV
>fig|195.2061.peg.1342 putative lipoprotein
MKIWLYPCLTALFFTACSIKETKLSPALSQTILNFKDQQDSHYAKLEFDQNISILSKMNQ
NINFDSQKYKQLFFSPWHSSFKTLKNQNLFWSFSLYTNPKNTYYFFNKQVIPLSWFEKTI
DNANTKELGKFDKKALVIQNTLIKNIPTQRAILKNPFLENEGIPFDYASDSILNAGTPIL
VSHFSKDKRYAFVLSEAGVGFIESKDLEFFSNNRAQIYEKLNFLTPLKEKLAILDEDGNF
FFESRIGALYPYYKEDKNYFYGKIGPKKYKISKDNASNFPLNFNDENLKNQISEVLNLPY
GWGGYNF
>fig|195.2061.peg.618 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKINEKDLHFILESGVLAPSSHGFEPWKFVVLEQKEHNLKLS
TLCYNQQNVASASHNIIFFSKKRSSKQR
>fig|195.2061.peg.455 hypothetical protein
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYATIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGGIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEIKANNVVNIDSVNDLNIKNSDIS
TSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQKSNTTTSIDGVLSTNIKGANVGI
VSNQDVNIIASNINADSKIDINANNVNIKDAHELSKTKTDGVYLKPVEISYESANLETSK
SISSTLNSKGDININTNGNIAIAGSTLQADKSANLNGENITIENGENKISSSSHSSTSSI
AGYKQSSVNTDTSLVSSSQIQSDILNLNAQKNVSIKGSELNGGEIDIKADKVYFIAAQNK
THTESDSIAIGVFANANLELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTA
EAGLEFSKTEKISDELSHVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTK
YEDIKTQSSTGFGLYIKERIEATSPIASAINQSAQNAAAKNENLGVNYGIVASQALANTA
NIFSNNLINTTSNQTLGFKFNQDKSQSSSENISKINAGDNLNLESTKGSIVLNGVEAKAN
SINIEAKDNVILNAAKSKNSSSSSSLEIAATNKQTAGYHAVDGGTVGEGIEGFASASCSK
SNETQFTNANLNANNININTGKDFTLNGANVKASNDAILMSEIWK
>fig|195.2061.peg.1653 hypothetical protein
LVYILLCSLGLFNNWVGFLITQVYFIVFIEVLWVGGGGVYTSWLG
>fig|195.2061.peg.1296 membrane protein
MSNLNFHQMFEIQRQNDFKSIKKLAWVVFISFLLCVCFQFLPIILDFAYDLKLLKFNSNT
NILAMVFNAIFFNFLFDYDFKTLFCKSK
>fig|195.2061.peg.371 hypothetical protein
MEKFQSPKIIKNTSAILNDLMSKSHYRPLKTLFFCKDFLSSFPLAKQRLIAKIYVKNHIL
NIITLHPAAYQELNHDDSKIYIKFLIKAYGQKYPLSGFVDIKDIKIFSQKYTYAANKNKN
DEKLSKNSYLELSKGKFKNCFKDEKLFKKFEDLRELIKKGSNLD
>fig|195.2061.peg.1666 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHAETELLKATQISIEDFRSR
NISLLNALEKDILNLPYEALNSQDNIINNAGAILKYYRNSGNLLAVYIGLDNGENIVSDD
LSEKKNTNITIKWKSQQL
>fig|195.2061.peg.1368 hypothetical protein
MIGRDFLYSIHKDKKSIYLFCENKSIIDCQSIYEELYKLEATTDFTFEELQSYQAYIFLN
STLLTGSTELPNNPFYFGELDQDNLIKQDIPSYYFSPKDEGSGLGRLSIFYKNDELCLLN
YSIIENSLNIKLECLSKQSLEYKDLISNTLKEQTTTQVDKKQSIAKLHALLEN
>fig|195.2061.peg.456 hypothetical protein
MEVNSLADSLNSQKYSALLNASGTGGLSSNHLVTGSVSGTLGIGYAKTDKTTVTTQSGIS
AGNEINGHVNGNLNLQGGILNSDNQKGNLLVDGKVTNSEVSVYEKSDVATIRLSGGTNQS
FGGVVHIDDHIDKTGSVNSAANININNNKNHGISTDT
>fig|195.2061.peg.1343 putative lipoprotein
MLYAGKISDKNVAVHNIWGLRKDETQRLLISSSVITSLEIGKDEISKENLLLSRLKEVSF
IYLSKEEKEQITNYLEKLKNKAD
>fig|195.2063.peg.1542 Protein of unknown function DUF262 family
IEECMKLIDEKIYAFTIEHIIPQNIINNGLLKNYKFENEDDFNKLKNTFGNLIPLEKILN
SICSDRSLLDKKEYYKKSKLSCNLSFANDENFLNFEKKQIIKRNEDFTKWARKFFVDFLK
ITQK
>fig|195.2063.peg.1927 hypothetical protein
MKIKNFTLIASNHNLEIELKNLTKNANKIIFICSDFDGYKEAKNSLYKTLHTIEDNFKID
NTKTFKIIHLNQANKDEITKEQKFSSDKNLSSIKKIIFNNLKFLNNAINQNENKTLNKII
DENNVENIENFLKEIQKELNILLKNIKESNYFEQEIKPKIQLTLDTLFNTLLKNITQSND
DEYKQIIRAIAKFFINILDSVTNLKKPVSLVKKNPYVFVVNTLFEAYNSSAEYQEYKEQK
YYYDFAYPLLELTTSKLYPIIALCNEEILSDVLIIDDKVLLDFSSYSNV
>fig|195.2063.peg.403 Phosphoglycerate transporter protein PgtP
MGVSMANFNETYWHMNHFYTPAACAVKGNPKNEGLVDITEINEMRGIKTEEIKAIETPNL
SSFEIFYHYVLKNKNA
>fig|195.2063.peg.1771 hypothetical protein
MVISQDLFDVLNEDFTKEYEFIDSPALDDMVKHKQSDEVFKVFYKKDDKIRLLRVSNMQA
LNRFDKLKGAMQK
>fig|195.2063.peg.1926 hypothetical protein
ILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEPIIRLHYKSD
RFQKDNLPIYNLLINNEKKEQNKALNEFNIDLKDLKDIEDINILNQFKQDFSKDYEFKEL
NLSFDTNLIKLYFIIPKNIAKVYKSAYKEFENKDLGVGYFTQLHEYDKIIKNALEDNKEL
NEYHFSFLAPAKMQNLKLQIAQGLDEILEDEDRKQELYVCKFVVVNGVKI
>fig|195.2063.peg.1894 hypothetical protein
MHPILEDNTLVCLHGGRVKLKAKKAKRIKSDNVSIMLDNEIQGASISGCLNPPILGGPCT
KVAMVFAYTYSDHKVNNKHSVLQMGLIGVSNKGYPILAIPKKNKIKFALAKIQASPLAKI
EYDRIRWKGGGDDNKQSSIQTHHIATDKNKKFTKEFRKITKKYNMELDEDWNKVKMPHRG
RHPNEYHEYILEKMSKIDKIARGDKDKFLKEFEKLKEEIKNNPAILHKDYYKGRKQ
>fig|195.2063.peg.948 UDP-N-acetyl-D-mannosamine dehydrogenase (EC 1.1.1.336)
MNQFNKVCVIGLGYIGLPTAAIFASRKIKVIGVDINQNIVDIINKGKIHIVEPGLDILVH
MVVNDGYLKATTLPEEADAFIIAVPTPFKGDNHEPNLDYIEMASKAIAKVLKKGNLVILE
STSPVGTTEQMAKWLAEERSDLSFPHQCGEVSDIKIAHCPERVLPGQVIRELVENDRIIG
GMTQKCAEYAIRLYKIFVQGECIMTNARTAEMTKLTENSFRDLNIAFANELSILCDKLDI
NVWELIKLANRHPRVNILQPGCGVGGHCIAVDPWFIVYQNPNEAKIIKTAREVNDNKPNF
VVQKIKKKIKDILGPKIACLGLAFKPDIDDLRESPALDIVIKLASENASQILVVEPNIKQ
LPLKLQNKRNIKLVCLSQALDEADVVAVLVRHKEFIEVQSDKVVSFC
>fig|195.2063.peg.1723 Phage antirepressor protein
MELSIYFPHTELQGAFPANVKFLFYFLEIDTKFADWIKNRISHYNFIENQDYIIEIVYTK
GRPRKEYYVTLDMAKELCMVENNEKGRQARRYFIECEKRLKNLEQEQMQKLAFRQSLGYK
SQLAQQKQKYENEIKALKYDLEQSKNNFKDKLNCILAKNGLYAFDFKTFKNYALKLEKML
KDLKDDENKENKLLLRMQNDFLECLELYKSVNI
>fig|195.2063.peg.1276 CRISPR-associated endonuclease Cas9
MARILAFDIGISSIGWAFSENDELKDCGVRIFTKAENPKTGESLALPRRLARSARKRLAR
RKARLNHLKHLIANEFKLNYEDYQSFDESLAKAYKGSLISPYELRFRALNELLSKQDFAR
VILHIAKRRGYDDIKNNGDEEKSEILKAIKQNEEKLVNYQSVGEYLYKEYFQKFKENSKE
FINVRNKKESYERCIAQSFLKDELKLIFQKQREFGFSFSKKFEEEVLSVAFYKRALKDFS
HLVGNCSFFTDEKRAPKNSPLAFMFVALTRIINLLNNLKNTEGILYTKDDLNTLLNEVLK
NGTLTYKQTKKLLGLSDDYEFKGEKGTYFIEFKKYKEFIKALGEHNLSQDNLNEIAKDIT
LIKDEIKLKKALAKYDLNQNQIDSLSKLEFKDHLNISFKALKLITPLMLEGKKYDEAYNE
LNLKVAINEDKKDFLPAFNETYYKDEVTNPVVLRAIKEYRKVLNALLKKYGKVHKINIEL
AREVGKNHSQRAKIEKEQNENYKAKKDAELECEKLGLKINSKNILKLRLFKEQKEFCAYS
GEKIKISDLQDEKMLEIDHIYPYSRSFDDSYMNKVLVFTKQNQEKLNQTPFEAFGNDSAK
WQKIEVLAKNLPTKKQKRILDKNYKDKEQKDFKDRNLNDTRYIARLVLNYTKDYLDFLPL
SDDENTKLNDTQKGSKVHVEAKSGMLTSALRHTWGFSAKDRNNHLHHAIDAVIIAYANNS
IVKAFSDFKKEQESNSAELYAKKISELDYKNKRKFFEPFSGFRQKVLDKIDEIFVSKPER
KKPSGALHEETFRKEEEFYQSYGGKEGVLKALELGKIRKVNGKIVKNGDMFRVDIFKHKK
TNKFYAVPIYTMDFALKVLPNKAVARSKKGEIKDWILMDENYEFCFSLYKDSLILIQTKD
MQEPELVYFNAFTSSTVSLIVSKHDNKFETLSKNQKILFKNANEKEVIAKSIGIQNLKVF
EKYIVSALGEVTKAEFRQREDFKNELR
>fig|195.2063.peg.1721 phage repressor protein, putative
MGRNGDIFDFHFDTEKFKFYLKNRDKKVTYQDLMEILYKNGIESSEATIKKWLMSKEDNK
TKPKPQYIKILCNALDIPFNEVILQDVFRNDNQINFRYFPDIYASAGLGTSSQSEEAKIV
SVDENFLKEILDIPIKKSYDIIKINGDSMEPILSNGDFIIIDRSKNSLGAISNADIVIFR
KNDDLFCK
>fig|195.2063.peg.1770 hypothetical protein
MAIKIEISGFDKDFLPVFESLAKSLSKKPILSMFFLIF
>fig|195.2063.peg.1460 hypothetical protein
MIILIFGVAHTIKWTMQIQKLLIYHNTKKENKYETWKYFRDNYIYSYNDNLVNHATKGDF
WGNLDNWDMYNINCFRTQKGTKYFNEILAPKFYNKYKDLEVEIDDKGNIIRWIGKINR
>fig|195.2063.peg.1623 UPF0324 inner membrane protein YeiH
KHMIKKIEHYKNILISNFKGLIFTASIVFFAMYLSSVQSIKDTTHLAAAAFAIIIGALLS
PWFFKYQHHLQAGVHFSAKKLLRLGIILYGFNITLTELLSVGLKGFILSMIVIFFIFILA
LIVGVKVFKLDKETSMLVGAGSAICGAAAVLALESSLKSDPFKGILAVGTVVIFGLVFMF
LYPIVFSLDLFPYFNQHAMGIFMGATLHEVANVVGAAEMAKDMANFDQSASNIAIIIKMM
RVILLVPFLLIITYFFAKNQHSSKEKTEKNISIPYFAFIFLGVIVINTYLASRENFLGIS
TSDIISFGKLLCTLCIVFAMAALGLQIDFKKFLKSGSRVFGLAFVLGLVLVFGGYFLTLF
FRGILW
>fig|195.2063.peg.979 Transformation system protein
MCFCTLLSYEDFEEYFKILNTKQNVELGNLQNPFFNPTFEKIKDIKIIAIMLDRVKIDNK
WYKKGDKIGEAVITDITTKEIILRYDTLDFKIAFKNNDKINIY
>fig|195.2063.peg.1089 hypothetical protein
MRKIENVIVYIINYFQKNYAPADLGKVKLNKILWFADRAFMYKNYMSLTKSDYIRNPQGP
VVKKMEHILNKLEKANFIKSFDVNKGDFQQTSFICLREPNLDDFTAKEISILDETINKFA
SRTAKELSEISHDECWEKTKDGDTMPIESVFLQDIVPATKEDVINGSH
>fig|195.2063.peg.1790 hypothetical protein
MEKVYIAENGNQIKLRAENLPSVKNINEDLFIFLSNLEKGISIMYYDFSNDENNENIYII
NAFELFSCVFWGMDFNQREKLEILRDENKNIFLKFKDNIKQIEKDKKYKWEKVLKELKKC
SKK
>fig|195.2063.peg.1586 hypothetical protein
MKKNFKKFLKFFFIINIIGISFNGILFYFNIPNGISFFIKSNYYI
>fig|195.2063.peg.1913 conserved hypothetical protein
MGDLARYSLNNEDKLYQIFGVNAKLLIDHVWGFESCTMQAIKEYKSKHISKVMAKVLPKP
YSFKKARDMLKEIVDHMVLELIEQNLTCNQIVLDVQYDKESLEKVQSYNDPMSKDSYGRS
TINLDYHSSSLETICNKGLELFDL
>fig|195.2063.peg.1087 hypothetical protein
FYTSLCDQNYFLTLEGKNKIKEKQKIRKIIKQLNKTITTSKKRMNDKNFTRFEDADLKVY
YSSLATKNILETILDEDFIKVTGGFDTSLFKEDFDIVEYGKGIEAVYKNITNEEKQKFAL
IRERAKEYECLFQI
>fig|195.2063.peg.1172 Putative cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79)
MLEKQMIKFILSKWNYGNFRIVFWDQEEFYVGNQ
>fig|195.2063.peg.1921 IncF plasmid conjugative transfer protein TraG
MAENYIAENNLGGTREQQVAAAAKGLENLAARGDLQGLLHYANMNTAKPNADGIHDVSNK
SYYSPSSVGANNAHNNDAVANQNSLNNLGTAGGNNIRNEFSQQSGATISNFKNQGTSTSN
VVNNSAKDAIVEQNANRRMGVNPSSYAIQDASKSGNELAKEAQGLFDAMSKK
>fig|195.2063.peg.1104 transcriptional regulator, Cro/CI family
MAEEKENIVKEVCKELNITQKELSEILGVPQTTISGWATTKIPKMAELALNLLIENKTLK
EKLEIFKKAHKIASEL
>fig|195.2063.peg.939 Holo-[acyl-carrier-protein] synthase (EC 2.7.8.7)
MRVGCDIIAISRIEKIHSRHGKNFLDKFLSPKEQILIKNPATLAGLWAAKEAASKALGVG
ICELCSFFDIEISKDEKNAPKLKYSQKITKDFNITQTSLSISHDNGFAIAIVAVV
>fig|195.2063.peg.1761 hypothetical protein
MFIYSQGILTKPHFWGNWSGLPAVSNKLLTKPIFLSIELFYFLIYIFLAYAKR
>fig|195.2063.peg.239 FIG00472122: hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFFK
>fig|195.2063.peg.1105 hypothetical protein
MLELIKNIGLGLFVNGSFALMNFDFKPQSFIITAFSVGIMAICILMQRRQKDE
>fig|195.2063.peg.1774 hypothetical protein
MAIKIEISGFDKDFLPVFESLAKSLKATYCLLECDTPEEKKQSSMKKALEEMKNGEHETF
KNFDEYKKAMREI
>fig|195.2063.peg.1884 hypothetical protein
MMVFIIQRIYPIIYDNYGIFLKGDEGAGLYFRYMEVLSCKNIDKKFKKDDWQVETLE
>fig|195.2063.peg.1090 hypothetical protein
MAHIENADDLCKHFNISEDCKVKIHQLYNTHKDKFLRPAIAYFKAIKIEHTDILKNQYEH
PMGVFYIKTNYFKITYKKEKFEIINIDWLNQ
>fig|195.2063.peg.1622 hypothetical protein
MISEEVKKSERYLKELEKAKKDNYLIDFLINELVKEYPEIELEIIEAFENGINDKLSIFN
KLSPSERIEIRADLYIKILVLVMNIIDEKHIKKIEEAENRLKTYNKALELSKNEQVEYLY
VTKDNKE
>fig|195.2063.peg.1907 hypothetical protein
MDGYNIAILIGAITLVFGILVLVAHYLNDKYTNESKS
>fig|195.2063.peg.1880 hypothetical protein
MGAFRKFYIVWVVFCISGFVISPAVGHNPNRVYEFFVMLGWIIFPLILLMLYRFFSLCEI
KFLYIALLLLLYYPIALILYYMFYYHNSFYVTLYIFLSLFK
>fig|195.2063.peg.951 Capsular polysaccharide export system periplasmic protein KpsD
MKKILILLFSCILCFGAVDVSQIISAEDQGSTTTSIDQNLSSNYDIANKENNLTKIHQIL
VFGAHLFNGNFKNYNQRVYNPDYKIAVGDQISLKIWGAVEFSQVLVVDSQGNIFIPKVGA
VNLLGVKNSALVSVIKARVNKIYKSNVFVYADMNAYQNVSVFVTGSVNAPGLYQGLSSDS
VIQYLDKAGGINLEYGSFRDIQILRNNSVIKNIDLYDFLLKGQMDLFPFRSGDVILVGNV
QNYAFVNGDVQRPFRFELSNDIKTLADLARVSGAKPIVTNAIVKSYGEDHKLDVSAYNKM
QFSKVLLRTGDEVEFHPEYVSENITISVNGEHNGLKTLVVGKGTTLEDISKLIKANPQSN
MQALQVFRKSVARTQKELINAQLKELETLALTSGSVTAQGAAIRAQQAKTILEFIQRAKQ
VEPKGQIVIDNPKSYNSVILEDGDTINVPSKNNLIIVQGEVSLPGAFVYDKGKDLRYYIN
LAGGYGERADTSKVLVIRSNGKAEKYHSGIDMKPGDSVLVLPKVDSENLQIFSMLTQILY
QIAIATNVVLNL
>fig|195.2063.peg.1809 hypothetical protein
MSKTNTRPSEKNKMHKAIETWFTKIYLNKIIHKEKNDKLFINITSCLAFILSIYGKTDEN
KSKMTPAVIAHINTTKNTFTAKLKRVKNHESIIDLQAKYPKLDIVSAYQFLTLKDKFKIT
KSEIQDFETLIDILSKNAQKSKNNPKTIKTLKKSF
>fig|195.2063.peg.1899 hypothetical protein
MKTIKIPLKDYISNIREDKTIYLGLQSDMSIKGLDEEFLKKEYNLKRNFKFETSIYLGKI
IIKEKNIIFKAFNIGENCFEGLK
>fig|195.2063.peg.1878 FIG00470547: hypothetical protein
LLEKPKNINDKKINFFSIKNEEKNTIPAIYYNMEIFITGSIFYGNINSWKIFKQDFEKCL
NCFLSFNIVDDDQIMLLWCTRNNPDNYKIIRTYEWFGSLLSFIPDDIKSHLTFKRKNSKY
YKTIKEEIKKDIYNKQYFKFLFHSLKYGYYKFINKKNIDL
>fig|195.2063.peg.1874 hypothetical protein
MSEGGYYTYWISNQESVSTLGNAPESMARLSNKAIFLDNFFTGQTLARDEQILEELKKLS
HKEKEFHILHLQGTHMEYAKRYSKVFEKFSIKDLKENCLDNLNGSAKLNDRQAKIKSHYL
NAIYYNDFVVSEICNYFKDEEAIVFYLSDHGDEVYDFRDFFGYTETIGSRYMAEIPFMIF
TSDKLKQNHPDIINKIKKAQNLLFMSDDFLHAFLDLLGLDVEDLENNRSLFSDNYNKDRI
RLFANKNYDEELKLCGSD
>fig|195.2063.peg.794 hypothetical protein
MAFFAGMSGQNPLIEGETTIEGKLLGYDKNMSQSQVEDLNEFINQNPIEWSITGDVFADS
VYITKLRNTITDIDEFKKQWLEMKAKSDEMGEIYKAEIAKQNREIALAQKNSNKEKDKPF
EPMQAESKSETYKDDNKMNELLKKLLETKFGTSDELEILFGMKFGDDNAGEFNKILSLNS
TPKSIDIKA
>fig|195.2063.peg.945 hypothetical protein
MNNVLKIALIADELTYASLKEEDGVVLRNVTPINYKVLFYFWKPDFLFVESAWHGCKNKW
KYQIASYPDYPKRNNKKLQKCVDFAKTLNIPTVFWNKEDHVHFDRFIESAKLFDFIFTVD
ENCISKYKSYVGENSFVGVLPFAVQSKFHNFTGFNFTLNKANFVGSYSRHIHEKRRFYQD
MMFKLSSEINNLDVFDRNSNRKSTNYRYPIFKGMQIYPSVEYKKTAQIYKKYLISLNVNT
IENSPTMFSRRLIEIIACGGIAITNHTSAVEKYFKDYCYSFQTEKELRNMLYKFQKNGLS
EDDKIKLKNGAEFIAKNHTWKQRLEQIVDTIGIKKC
>fig|195.2063.peg.1229 FIG00638667: hypothetical protein
MKVQGIYDFFSGYTLDGEANFNTLDIELKSPLQVSNSYLRHSGFGFYGAFASKDASNNTI
KIRNNLTVINGTQNPSDRINIITGRTLAGEANFNVIDFKDSQASLPLFIYATTQENFEGS
IHYPEYAKHNKISLNNVFGRKDIRSGVEAMNVENNQVFYHNVEAQASGEGVNRESSVYIR
AANLAKNNLFKASNYWATSMLNIYGIREVEESKNNQVIFNNVGFNTDRISEGSELILIGG
VGKRVHHNLLSIQDLEIGAYDKEKDFIYIAASAIPDANSNLALSYGNTLYIGGDVSIHE
>fig|195.2063.peg.682 FIG00470755: hypothetical protein
MLGFHTNMEIFKRAGIYYFYLLVIHIPLFLVWKKVISRIESLDFINTFYFGIAFSLCVFF
LLTLPLDGHLALVPLLCVCLVLSLFLNLFIFVLRKFLILLGKNLFL
>fig|195.2063.peg.1643 hypothetical protein
STYNERYFIYTNEKQEYKLQIEVILNTKEKFLSIIKLKRFKYEEKIL
>fig|195.2063.peg.1914 conserved hypothetical protein
MDNTQKYAAIDLKSFYASVECILRKLDPLNTNLVVADESGTEKTICLAVSPALRSYNISG
RLRLFELIQKAKTINYKRLKIAKYFSAKSYNHLELINNPDLELDYIVAKPRMSTYIDYSS
KIYSIYLKYFDPKDIHIYSIDEVFIDLIPYIKHYKLSADKLIENILFEILKTTQITTTAG
IGTKLYLAKIAMDILAKKQNINKDGLCIGYLDEMLYRRKYRNTRP
>fig|195.2063.peg.240 hypothetical protein
MIYDVNKGLESFKFLPQDQIIFKFDEDFELYLGSNRHVSEEGFWALSLRYQNAPIEQCCF
CFTLDNKLLISCIQGYQYSDFNVLDINKIFTKKCYGLRPIALLIECIKMLCVSLKLDATL
GVHEKNQIRSQKGEDKGYFVDYQKIWLENGGKLVKINNHLYYELSHKRKNLEEIPSSKRS
MYKKRFAILEEIKQALDQSLFI
>fig|195.2063.peg.763 hypothetical protein
MRRVREFKGDIILDCGADER
>fig|195.2063.peg.1900 hypothetical protein
LEESLNIKLKPKEFKKAIAYNNASFNKISKEPLNESSSSAKEPCFITLYLKDEHNKPIAN
AKIIIKGFKHDEALRVVNLKRRSDEKGKIRFDKEKYFSDCYSFKVKLDESKAYFPTPLQN
AKRIFNNYTHHKVGLILKFKAKDHLVYDGFNLYHYKGNELINSYMARSGTAKADNQKRSK
KQIAHYFYQDEKDKSKSGKAYFYYDDESIQDRFGTLPEGEYYLKINEIAKDTNPSFLKDY
PFEIGKTWGRYCVRLYTDKECSKTFKEVKIKESNKKENKKSKKEQSIIKDNLYLYSINEK
GEFGSNGSIGMAQAQLLEDLSKQAKFIQDEKEGIVSLRVEYPKQEKSKVNFIKEIEWELD
EDEDVVSAEKSVRIIIDEKANFAPGTYVECEVDGLEDDVNIVWALAQIQNEAGLQRILEG
KEHLEFKDIKFLKDESKYFHECWEMDDEEKDEEFEKIGFSLPLTRANEEEFDKYYALVFA
YEDKNKFKRLPNLNDAYKIIDMSFKVGSGRDDRVKELFTREELKALNVYNLNRQKSIDSV
EEANWFLRANLKNQEKRDFFTYLRTYPQFAGKIAYIYYRFDLINKEFLTSISEKDKGNYL
QDRDGKYISTIINKILPLEYKNGKSFKQFHTELLNNKNRDLKECKDFLKALTQTLCKEFN
LPLENVVFYSQKPSGSLSFGAYEENKVRLNQYILKAYFKEFAKTVFHECRHFYIEKYYNH
NMDALGRYVFYSEKAYINEKIIFDKFSRICDPSENYLVGCNIGAIQDAYEIQPNERDPRY
VETLIGRSL
>fig|195.2063.peg.1866 hypothetical protein
MQIPIYSKLKTKLESKGIDNISSGQIAWCLGSGYIALICAVFVVIYKLKNLEFELYIVFF
FPILLFYIAIFWFIFLSFYKNFFFIHLFCYCFMYIFNIIFNDFYLNLAIINILLMIIWFF
FVKLHLKFKFLFLMMYFCFEIAIFIGIIPYGLLEGTISK
>fig|195.2063.peg.1683 hypothetical protein
MLINQTFEIDSCDDVELNIKRTSKLEYRISYDDEKDIKAIVFIVGGFGANANISFLDFDR
EYIAKNFDVVVVHVFYHCFCARQSIDQKYNPKLIPNQDDLERINGILKNINLGHLSVNKD
NFEQIIPLIEQKVNEMKQAGLVDESQKIELSCDFIPPNGDYQNYGIMAAIDHINALKDLV
KRFPKLADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGVCLPFLACILGREMNQGE
FYFEGSGYRLYCFVYKYWNRNMNSSYYFGDENYLIRAILNSNHLQIQSNLNKNTIFVSYH
SIQDMGAPVQNKIELYKCYQELGYDATLHLIKDENDIDGRFVKSLEHGLRMTDRALFRKE
LPLMLEKLQGRKSFMQENSISYPCGNKVFVFKDLEDKFELEMIN
>fig|195.2063.peg.678 Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase (EC 5.3.1.16)
MTQIIPALDLIDGEVVRLVKGDYEQKKVYKYNPLKKFKEYEKAGAKELHLVDLTGAKDPS
KRQLALIEKLAKEVSVNLQVGGGIRSKEEVKALLDCGVKRVVIGSMAIKDATLCLEILKE
FGSEAIVLALDTILKEDYVVAVNAWQEASDKKLMEVLDFYSNKGLKHILCTDISKDGTMQ
GVNVRLYKLIHEIFPHICIQASGGVASLKDLENLKGICSGVIVGKALLDGVFSVEEGIRC
LVN
>fig|195.2063.peg.1876 hypothetical protein
MIKNQDIDLLTWNESKDLFYNITIKAFFDPQVKIILSGEKGQYR
>fig|195.2063.peg.1940 Methyl-accepting chemotaxis signal transduction protein
AKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKI
FEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLT
SSSNSQAASLEETAA
>fig|195.2063.peg.1872 hypothetical protein
MYIKWFFIFSIVLFLIPYNGLLFLPNEYHILDISKIIIFLVCLISVVKKPHKYFIDDFLL
YSWFEAIKTIRGNANEYLMQLNDLERELKKQNKTYKVINSKNIPKIVVIMGEST
>fig|195.2063.peg.679 hypothetical protein
MSSKLSYKELALEILKQSDKPLNANEIWQKALEKGLDKKLSSIGQTPIATLGARIYVDIK
ELQHNSLFIKASQKPRTFWLKERENELLKLDDKNEITNEKQEKNKFHERDLHPLLVKFLY
ENLDFNLNCKTIYHEQSKKGKGGEDKWNYPDIVGVYFPYDDYEKETITLLENIKQNSYKL
FSFELKIALNFSNLKECYFQAVSNSSWANEGYLVVLQEIDSEVLSELRRLNQSFGIGVIK
LEKDISNSQILISAKEKELDIQTLNMLINKNPNFKEFIDDINKQIKVGKEAKIQANFDEI
KSDEEMEKYLKEKCILEK
>fig|195.2063.peg.1844 GDP-L-fucose synthetase (EC 1.1.1.271)
MNKQSKIYVAGHTGLIGSTILKKLQQDGFCNIICKTHQELDLMNQEAVKYFFEKEKPDCV
FFCAAKVGGMLAQLNQRAEFLYNNLVMQSNVIHYSYLNGVKKLIYLGSICIYPEEVQLPI
KESSLLTGKLQYNNEPYAIAKIAGLKMCEFYSLQYGVDYISIMPVSIYGSNDNFDIQTAH
VQAAIFRKIYLAKLLNECNYKELIDDLGVKTKEEAFMILKQNNINDKSVKLLGTGNSRRE
FLHCEDLAEASIYIMKNISFNEVVEREGWNQGNAHINIGTGEDISIKELAYMIKDILEYR
GEVLFENKMENDGTARKVIDTNKIRALGWHYKIELRDGLVRMYHDYKKGVKQNEKIYTSF
INLG
>fig|195.2063.peg.1456 hypothetical protein
MKYNYIKWNKEEKCAIFFPDIDYSLWKKTQLKENAYNNPSLIISSCLITKMDILELFEYY
ILFICGKSMGVSRWECNNLILLGTCNIDNLSNPFSLNTPKPTYISEYINILGQLFLAGYI
DFGSYCDEEDRNKIDYPSNLSYYKEDKYQAWIYFRDNFFYQDKFIRDLDDRRGWI
>fig|195.2063.peg.1935 hypothetical protein
MQKILQIDLEKRKALENFKNLALLGLGGTMLLNLKEQALDFSQELTYINTYDKYLNLKLD
SFYIPSTLLSLLQLTQKSKEAFYINVLINSDTHYKNPLLQYAITQKQEQENIVYALKNNE
NINASFANLNALKLALEEKNFYLNFIDLN
>fig|195.2063.peg.1932 hypothetical protein
YCYEYLLSWNKTPKTSNNDFDDFMFKMQEKYKLNKREIKRKELKNAIKKAFDNINYVKIS
EIIQKDKNNF
>fig|195.2063.peg.1773 Domain of unknown function (DUF332) superfamily
MKYEIRVLKEYKKNYKKLTLKEKDLVDEIVYRLSNNETLERKYKDHKLKGEFKELRECHV
KPDLLLIYQKQDDKLILTCINIGSHSELF
>fig|195.2063.peg.944 Capsular polysaccharide export system protein KpsC
MLNGYYFYVNNFIQIFYKKKFYGWGRKRTGRYAFLFHKKFGGSLILFEDGFIRSLNLGVE
NSPSFSIVKDDIGIYYDATMPSKLENLLNTYEFKDEEIKQAKKAIELIKKYKISKYNNNL
DIPDDYFQKDEKRVLIITQTANDASLEFGLAKDFKTVDMIKDAIKENPKSKIYIKIHPDV
LSGKKQSDLDINSLSKECILITENFNPIALLEFFDKVYTKTSGMGFEALMQECECICYGM
PFYAGWGLTKDKLECKRRMQKRSLEEVFYAAYILYAEYFNPYLNQKSNIFDTIQTLAKYK
DIEKANSNRLFFFGFSKWKRKFVKPFFIAKNNEIIFLDFLDCLKNIQLKENDKFFIWGKR
IDYNALKTTLIKKAQDEDLLHFTPKISLVEDGFIRSISLGSDLTRPFSLIIDDKGLYIDP
NKASKLEELLQNEIFDENMLNRAKNIIKILLENRFSKYNGLKHENLKINAKIGQKIILIP
AQVEDDASMILGGFGLSTLDLLKEVRSKNQDAYIIFKPHPDVLSGNRVGLKDETLILEFC
DEIVKDCSIDSAIKIADEIHTITSTSGFDALLRAKKVFTYGMPFYAGWGLTKDKYRCERR
TRKLSLEELVAGALIAYPRYINPKTKTLCEIEVCLDIMLNLQKAYFSKKYIKLAIDFKTF
MLRKIRRFYEFLAKK
>fig|195.2063.peg.1789 toxin-antitoxin protein, putative
MQNEDLKFDEWNEVKKHIEKEKNKIVKKQKIYWIKIGKNIGSEIFGKGRVFARPVLVINV
FYNGLFLGVPLSSKTKNKSGKLYYKFTDEKGNSQVALLGQMKIFDNKRKITFESNVKNED
FILIKEKIKKNIID
>fig|195.2063.peg.954 Capsular polysaccharide ABC transporter, permease protein KpsM
MLNVIHALFFRELKTRFGKNRYLGYIWVVGEPMSVVLLVTIIGTVIREYHHQVMPEGISI
FMFLISGIMPFFMFRSIVTQLMNGIGANLSLFAYKPVKPIHVFIARTLLEFCIYFVIFIT
VLFFAGWFFRLDVFPIHLLGVLFCIFLLICSAFALGICFAIVWHFVEPLRTLLAYFSIVF
YWSSGIIFPTWLTPRPLLDIFYYNPLLHIMELLRFNFFENYPLQDEYSYFYAIFWILLVL
FIGLFIYYYNRQALTAAKKE
>fig|195.2063.peg.947 hypothetical protein
MNSNDIVLLKCGEVSYKIYLPNRNIDYIQKKIYNELIPYEYEMLQDFLKKAKKNTIIVDI
GANIGNHSLYLAAHGFDVCAFEANQTLCDIFKISIKLNGFKNLKLYEFGLSDKKEMAVLD
NLNPENLGGQSLKIEDFGNIFLHPLDDIKFEKDISIIKIDVEGMETKVLNGAINTIKKYR
PLLYIEAINSIEFKRINVILEKLDYVYWNTFNATPTHLYYPKERLEYKDILSNVSYHNAL
ESYRITQSLNYSKKLSVEISKIIEITSKNNIELYTRINDLEVQKAKLNKEKCQFEQDLKV
CKEKLKQKDSELKRIENTLSYRIGNRIVKSKNIKDILILPYNLFKEYRNFKLRQKNKNLL
FQEKNKFKRNIEFRKNQIFECKIENLDLLKIACIMDEFTYESFKYECDLLQLSLENWKNE
IMHFKPSLLFIESAWQGKNSLWKLKISGFSIELQELIGYCKENHIPTIFWNKEDPVHFNT
FLPIACSVDFIFTTDIDCVSKYKFYAGHEDVYCLPFAAQTKMYNPIEEFDRKDEFNFAGS
YYLRYPQRQLDFDNLINAIKPYKNISIYDRNFNNPHSHYTFPNCYKDMIIGNLPFNEIVK
AYKGYKFGITINTVKQSQTMFARRAFELIACNTFVVSNFSRALRNFFGDLVISSDNVNEL
KDKLKLACEDEMYCKKIKLNALRKVMKEHTYTDRLKFIASVVYKKQFEYKYKFYLLVYVN
SQEEYIKALDIFNFQKENKEACLLIYSDKELDFQNNDKYIHISELEELYEYVKNDKQAYF
GMLDIR
>fig|195.2063.peg.1819 hypothetical protein
SIHSSSIISNYLRLLNDFNTLSKIELINILESLSLYNLSTLIQTMQTIQSKNEYNSKDFD
KDSIFLSNMIMNVRLK
>fig|195.2063.peg.162 Citrate lyase beta chain (EC 4.1.3.6)
MKAKSFLFVSSIFPERFTKALQSGASQIIIDLEDSVEVAKKEVGRKNIVDFSSQCAKNND
KFLIRINETKSKEFQKDLSLISTIKESNGIIGVVLPKAQSYEDIDMLSQFELPIIPIIES
ALGVENLDDIARHPSVLALSFGSLDMTLDLNLQEGEGKNFILNSIRTQIILKSTKYNLLS
PINGVYPDIKNIDGLKEDLIFAKSMGFFFGGGSLCIHPNQVAPINEVFSPSAKQIAWAKE
ILSLRQNSNDIIFNYNGMMVDLPVIKKAEQILLDSNSNLS
>fig|195.2063.peg.952 Capsular polysaccharide export system inner membrane protein KpsE
MEENKTLLEKIKDLSIFDSFKIIWFIMIFVVIYYTLIAAPRYVSTMILDVRSTSGESAQT
SGILSLLGSTSTASEDLNYLKGYIESSDMLKILDGKIKLKSLYQEQHVDLPFKIWDSSSI
ESYLKYYQARVKVHTDETTKLLQVEVEGFTPKSAHLIAQTIMQESEKFINEISHKAAREQ
MAFAENEVQKYKERYQKAQNDLIAFQNKYGVFDPLKQAEAKASLVAQIETNLAQKEAKLL
TLQSYMNDAAPEVVALKAEIEAIKKQLLREKSKISANNSSQKLNDLAAKFQDLTIEATFA
QKAYEAALKAYESARIEALRKIKQLVIIQSPDIPESAKYPERIYDILTAFIVLSLIFGIV
KFIKMIIEEHKY
>fig|195.2063.peg.1806 Hypothetical protein pVir0029, glutamine-rich
MEETREETSKTILSEWQEQFQDKETETEKTLEKEKSSEELQKELEELNKLNFQEDLENQE
VLKSQLEKELKLEDLPQEAKQTLEILEEKEKLDNDMRNFIELTTEYETPNEKRAFIENNL
KEVRETPEINESLSILKEQDELQKEIDNTKEEMAREEKELKDQLENANKEKKGLSQEEYD
EKFAEMEKEHAQKLKEMEEKMEKLEQNFENSIENLLNSTSLSAILKSLYEMDKSLHLILK
EKENNFDELNRQREEKLNLAMQTEKTREVVIDFIKELHQKTKGVENGISEMNKERNFYYE
LDKLTKNPEKMDLKETQKLQEYINYIDKETPNFKENYPKKYKQTKKIIENNIKKTMDKAK
VKTANSQGMSL
>fig|195.2063.peg.1759 hypothetical protein
MIVLDIFIIIALLKKNIIFTPSFKAKPKAPNSTQGIVIGESKDIESERNTIYTDEHGRVK
VRINLYANQEELDNDTFIANDIDTNSSNLSSNTYKSYHHTPFLRVASSIASNHSGFFHTP
RIGDEVIISFLDDDIDKPYVSSSLYNGANPSLVNLPFNDHQTSLSSKTIGVNEEGYNELT
LSNIKDKEQIYLKAQKDYDELVQHNFTQRILNDKDSIVDGIYNERIKKVHTQTIDLAKNV
NVGGEYLTNVGLSKDTIVGLSNTLNVGVDNKVRIAKNSHEFVGENKDIEIGANQNTIIHK
DEIRNVKGNKKEVVEGHYDINVSDKMQVLSEKEMDYKSKDNILFTSNESIGFESDKNTSM
VADNITTYAKTIHELKADSEATIQVGETIINAKPDCVIIKAGGVEVIIDSNGLVVKGGEL
KAE
>fig|195.2063.peg.1916 hypothetical protein
MLQYPCKKTKRQIEDEKDYDGRSLFDLIELEFSQGEENELLISK
>fig|195.2063.peg.1566 Inner membrane protein of type IV secretion of T-DNA complex, TonB-like, VirB10
MKKSFLSLSLVTILLSNNLFAEDIFDQTSEENVSKKDNQSQNLLNKEDLDYLFKNSDTKF
PVTDYIYKGGFKEPNEEIKIHSEEKPKKEEDNNITKLAKIEEKKQELIQKNQQIAKEIHQ
DNISSQERKIKKLIRDSILADRGNTQIYFQENSSKYGVDGFSNQKSIDVSTNEHRLYRMI
RAGRLIPALLTSAISSDLQGIVTAQIEQDIYASMGNAVLIPRGSKAIGFYKNDNKIGQNR
LEIQWREIITPQGVNILLTNALASDNMGMAGAVGSVNNKYLERYGMPYALSTISNVLLLS
IASKAGNNNYAQEVYSQSKNDVSTIVDDIIQQQKQIKPTIEIKSGSRIFIVPTNHMWFAK
PKNNEVLIQYFNN
>fig|195.2063.peg.1243 sarcosine oxidase, putative
MYQISGAKEDKMTYDITVIGSGSVGSFAGYYAAKMGLKTCLIDKFQAPHTQGSYHGDTRI
FRIAYGEGEKYIPLLQEAYTLWGEFEKEQNTKLFERCGLLNIGSNSTFMQNVLSSVKNYD
LKAKILNAKELQENYNICVSDDFFGVLETDTGFVYSDLSVKSAINAACKLGAHTLCDEIV
RMCKENGVYKIQTQNSSIQAKQILISAGSYVNEVLSVCEFDLPKVPVGIRRKVVNWFDTD
SYKLSQGFPAFILEFEDDYFYGFPDFADGLKVGRDKVGEIISTREERVEFGSYEQDTLDI
GKHIKEFFPDLKDFNKGSVCTYPLSPDDDFIIDFLDENLFFMGGLSHGFKFAPALGLLGV
KALQTQKLDPSIKQYFSLKRFG
>fig|195.2063.peg.1768 Erythrocyte membrane-associated antigen
MEKNTISNENIQKNEILIPKRVLFDEKTLKMIEMMIPAYKDEISNTNKENEKINQMIKLA
IEKMFKNDFLNKINNF
>fig|195.2063.peg.1841 D-glycero-alpha-D-manno-heptose 7-phosphate kinase (EC 2.7.1.168)
MKTIRTQTPLRLGLAGGGTDINLYCDKYTGYVLNATISLYIHCTLIEREDGKIIFDSPDT
NSYSEYESKEFLENDGKLDIFKSIYNRIVKDFTKKPLSFSLHTYSDVPSGSGLGGSSTLV
VGVIKAFSEWLNLPLGEYEIAKLAYEIEREDLGIVGGAQDQYAATFGGFNFMEFYDNKRV
IVNPLRIKNWIASELEARIVLYFTNITREAKDIEEHKKGKLGDEKSLEAMHAIKQDAIKM
KEALFKADFDTLAKILGKSWQSKKIISEIVSNDELERIYKLAIDNGAYSGKTSGAGAGGF
MFFFVDPTKKYNLIKALSKEQGYVQDFSFTKEGVKSWRI
>fig|195.2063.peg.1941 Motility accessory factor
SAGPSLAKQLPLLKACQDKAVIFCADGALSMLEKEGIVPDYVLNIDFKDCHAMKFFQNKE
NLKQSIIALECATHPNVARSLNAENCMIVLRNKALYQRFNFNDFGYIDTGTHVSHFSYTL
ALAL
>fig|195.2063.peg.1905 hypothetical protein
MQGYAMEKEITLNESFKTLLKSIFSDTDQAKKLIQAFEEFANDRATTQRLNFGNLKQEAI
EQIRNELVSKDLFQSEIKRLEDLFHSEIKRLEAEIKRVESSIKTEIKRVESSIKQVESSL
QSEIKLSVSSLKQQGIYWLIGACVVSIATIISSVWAIMNFMVEHLK
>fig|195.2063.peg.1808 hypothetical protein
MRRMQDREEWEMGIKGVINEGINDENYSMKCSG
>fig|195.2063.peg.1882 hypothetical protein
MKNKLYHYFNNKENSNDLKKQFFKNIKQALFYLFLVILTFYNITYLTLLTFFPFPFFGWI
SLFILSTIWVYLFLKLVFYLVFKIFNIDKKIKKFYLFLPYPLFMLLWFGYSFVPLEWQSS
FKEFESLCEKADSKAVIYDAKNIISLWDNYKKINKDILFNITEQYVDFRIKKIIILWYYK
DGKNTIQEYKIDNTYSWLDIGMFAKYKRKMICYDIQKYKELQEKRGY
>fig|195.2063.peg.1016 hypothetical protein
MELEKKREEFRSKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYRNDYNYKIGESN
FNFKDKPEFAYYEDQF
>fig|195.2063.peg.1807 hypothetical protein
MNVGYKNFLGAILKKRQIAISYAIKSLKIGILYFRLGIKMPLLKLGLFNA
>fig|195.2063.peg.1582 hypothetical protein
MLLENIQENNQYSFYSLQNDIDDIAKKYMDKFFAILTLARNENTKFVNLKHFNNLKNAEM
EIFFDNVFRNKKFNTKGKLELFDKDRKHLKKGSYPVLICFLNELYKNLIINDKQFENLLV
STTEEYFIRIIDKREKGMINIYFQKDKKIEWEDRFKIVTDGFGSNDYDEKMLYYGLEKAN
YIKINKKFIEEELEKLNLLKFI
>fig|195.2063.peg.1891 hypothetical protein
MLPQPIFLNKLIEFLSDENLDIVNMKKGVDKIFSKKDFYAIL
>fig|195.2063.peg.1893 hypothetical protein
MRYYKMMYNYNHNDVDNWCSCNLVDIKNNNEYALLESKPITNWQTPSFEIDKDEGSILTG
LIHNDCGWRIVSPKFVKLMENLIKDCVQYLDVEIKNQEINYYDCKIMHVIKSLEALDYEH
SIYTYMGDNDEYLSITKAVLKKSKLDGSHIFRIKDDEVPVFVSSEFRKIVRENNLLGFSF
SEVMVYEN
>fig|195.2063.peg.1763 Transcriptional regulator, Xre family
MISILNIFAKNVRKRRQALNITQEKLAELSSLHRTYIGSIERCEKNITLINAYKIAKALG
ADLSELLK
>fig|195.2063.peg.1892 conserved hypothetical protein
MEDLKLLQRRWEEAYEAMPKLYETPDGLIINFTLSEDTDTILFKKPWENFELDDEDKETK
WRLSFFSISKDEPLGYLEYKEALEKLQDFSLIQSEERILIRAMSLEELESLELKGW
>fig|195.2063.peg.1153 Putative periplasmic protein
MIKKDNVFKLNTCLPLKCDLNSQDCTFLFKGKQILVSAYPKPIKIFKNTAIKVSNFPFDP
NLKIKIYSLNSYIGNIIPQFTNTKDSIIINFTGKSVTDDSRFRVEFLNNDKPTGFFFDFD
VTLQKIYNSAILPQN
>fig|195.2063.peg.1895 hypothetical protein
MIWYDEALKPLCAGIKHDKQRDKYISFITNAKAEIIEWKSIEFDGDEEFEGKIYNDESKA
LYALINRARMIKQNRISFV
>fig|195.2063.peg.1730 hypothetical protein
MFYDLKNKSLKYDDIFLKDVKIQNEEGEIDAQDTYFLSACDDGLLKELGFAKVKEEEAPS
FNEKTQKLNQVQNYDEKSNLYIISYEIKEKTLEELKELKLEELKAIKEEKLLFMPFKNTI
FQIDTEAKINISGKVSEIMLANLNNTPLENIAWIDKDNKIITFNKDEFLEFGVNIAKYTE
SIIFKNDELRNKVKNATSLEELNLIAWESEK
>fig|195.2063.peg.1122 hypothetical protein
MLDYNSWQEAQAKVEPLRKQVMEAILKDKRFNATIEDRDNLLKVEIKNTIFDLIFDLGNF
HIEASFNLFSLGFLEHSSNVIIFQGDYDLYKGNVKRIVDDLYFELSREIPNTRRALKDLI
KDCKRVLKLKVNDK
>fig|195.2063.peg.436 hypothetical protein
MVHEIQKTFLLPDATLLEKLQKDRIVFEIYEIETFYTKITYFYDVKFQNLNGNFYKITRL
NNPILEQNQEEKISKKDYEKARKKLIEKSIKKKRYEFKLCSFKSLIDVYEDFNLYVLKVF
FPTLEMANLFTPPKEFRIQRELCGVLDSKNIILYGFNNLEIDIEKCFKIIEKNQNFTLDF
PSSILAFDGYRIFLFYLFRKLKLYWNLALENRQRETFCEFFSYARKIYIILM
>fig|195.2063.peg.1812 hypothetical protein
MKLHDIVCNELRINRSELGNILGVSKTTIDAWSDPSRMSKTTEIALKQMLENHRLKEIFE
AQANAYRKFLKYANENSSIEISDTHRTLIDKIRYVLKEYNLNSLTAAKKLKISFEELDRI
MLLVKYPNFDFLSHFIESFFISEKWLLEDFGKPFSRNFIESKNMESFTTEAKKYEQIYII
HCNDNSEYAKIIVKNNKDLFSIFDQDFCIGNFTMENQEQKGLFELYNFYNKNKRNTTCYI
FDKEDYQNIISGDYFIKNCLKKGKISYLLEDLFDLNSNSNFYQNCKFYKECVDILNKFIN
>fig|195.2063.peg.1756 hypothetical protein
KLMYEKFTYNYDFPLAVKKEEYITYPLLINSRFMSFDLSEFIFGSLLCTGGLNYYPSIAC
ATTSSEAREFALKRLLSYIILDEKRSAFKEDKINEGKYILNDKEFFEKNNIELRNCNIYK
LEHFQRKEEYKIQHPVIKQHPILAYNDTIQILYEYANGIYNTTQDEKGKFIEDRQKARRL
MENLEAIGQHNLEVMYKGIGDEKTKDEIKNENDEEESDDINKIQDYSNKFIGRLATTIIM
EDGLYIG
>fig|195.2063.peg.1862 Predicted metal-dependent hydrolase
KWSKKTGLFYTHLSIKNMKTRWGSCNHNKAYINLNLKLIQKSLNAIEYVVLHEISHLKFP
NHSKEFYTFIEHFMSDFRQREKEFLS
>fig|195.2063.peg.1816 Domain of unknown function (DUF332) superfamily
MAKYKIYYHKDFIKAYKKISDEERKITDEVIVKLSNDENLEPKYKDHQLKGVLKDFRECH
IKSNLLLIYQKHNNELELNILKLGSHSKLFKKY
>fig|195.2063.peg.1787 hypothetical protein
AEVKEYENYLKILEKNKEFLKDYAKNRLNNLKLSISKNMNKIPLNAYIIQEYKKGCEYLN
INDDLKLASVNFNKMDYGKFNKSKDNQKTL
>fig|195.2063.peg.1583 hypothetical protein
MNLLNKKIILVYAIYIGIIALIYFFGKDFLLVFDNLKNFFLSVNPAYYMLSSPISMFFVF
IVISFLEKRGINGVLVYLLTVIPLLFLFFYYSNAKLSVDYLKSEAMFIIFLILFSSLIAP
VAIYEMFREKEEVD
>fig|195.2063.peg.1801 hypothetical protein
MEESIERRINEIYQETLKQNFDEDMKYDTFKQYDFVSKNYDNEHKLKKDIIKKNFFDFIE
VIKKQGKKGFLEILLLQFLCLFISIISMILGYFEEDLITYYEFIAGFFGIIGIWGFDSNL
GGLKFYADLYSTEFIRKRIFG
>fig|195.2063.peg.1902 hypothetical protein
MRVFDTKRIKTYIGKINDEYFEMIKNKIVENIISPALRQGNSKNEPNPFISEK
>fig|195.2063.peg.1423 Protein of unknown function DUF262 family
MIKKVKEVLNNSIFFIPNYQRDYAWEEKNLDDLWEDLLEAEQAVSDQMGHFLGTIVVSKN
SKNPEIYDIIDGQQRITTIFMLRYALNFRTQNSQRNIVYFCDDNDNFRLQVQDENKLFFN
EVLKQAENNKINIELENKAQTQGQQKLYKVFKAIWSYVASLESDKALKLFNIIGNMSIMW
LEEQDSGKAIRVFQTVNDRGIPLLILDKLKSLLILYSNKYCKGELDEVINERFGKIFKIS
MNIKKHKTIHSLGDVQFYQELEARIFNYHSLGVKEIAHYRNSANIHYNELKRVLKNKDKT
KEEFKKWLDDYSKDLLQFFETFLKILEKTQDNIEMFKIFMILKINPYFYSSLIRLEMNNI
LDDECLRLFSQAEIIFYSFGQTNDSTAFKLGEVTESKDEFKNRIIDDCNKCIKRAGYYDI
NEFISEISEDNYEWGKYFHYLFLTYNNVGIEECMK
>fig|195.2063.peg.1580 Hypothetical protein pVir0019/pVir0020
MFIGFAEVILFFNVVFILWCFYVFLSYRKNQKNIADIQFKIDKEIERREIERREIERHKE
RNQFIYNDNIRAKFASMKEGKITDCYIEVSTEDLKKLDTLTNMKRPLNVVFFCKNDEQHF
LFAEVDTGRDYYIKEGAEIIHEEYNIMKNIKFKGKENEQFNDGTCNDEQERLL
>fig|195.2063.peg.1868 hypothetical protein
MPFEKVKETIFAYDKEVIDCEVLRAKNVDLTHSKIYFQGILLTGSTELPNNPFYFGELDQ
DNLIKQDTPSYYFSPKDESSGL
>fig|195.2063.peg.1865 hypothetical protein
MNDLFQTLGESIKQIDFTHAFLGLTKGKSPDELDKADETLRQEYLKNKEFKLIKSIK
>fig|195.2063.peg.1120 hypothetical protein
MTAQEIKEFCKEQGLTYKQLGELIGYSESSLKSILTTGKISENLEKSIKLLIENRDLKLK
LKEMDNLKNTLKTLLDLK
>fig|195.2063.peg.235 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MSILFETAVILSLGYQAHEPKYPTQRLKFDEVVEFYKEK
>fig|195.2063.peg.1794 hypothetical protein
MYEKTMKEVLSDIWNRAFAKKIGFNEKSFSFTYNKNKETFLVIMRLEYTISDCDLFINEI
SYEITNEKLGGRIVRYGRISKFKGFSQEKSFYNKTRKEINSTIAIYMDKESFKNYLPYHF
LNAYYKKEPK
>fig|195.2063.peg.949 UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14)
MKKILIVFGTRPEAIKMAPLVKIMENRNDVNFRVCVTGQHRQMLDQILNIFDIKPDYDLN
IMQENQDLYDITLKILCGMKNVLNDFKPNIVLVHGDTTTASVTALAAFYQKIKIAHVEAG
LRTYNICNPWPEEANRQIIGVLANIHFTPTVKSAENLIKEGKNKEGIFITGNTVIDALFY
MTEKIKNDKTFKIKVLSSIGNEYKINDNKKFILVTGHRRENFGEGFLQICEALKIIAINN
PDIDIVYPVHLNPNVQKPVKMLLLNISNIYLINPLKYEEFIYLMSKSYFIITDSGGIQEE
APSLGKPILVMRETTERPEAVEAGVVKLVGACKQNIIRESQKLIDDQDEYEKMSKAYNPY
GDGRACEKIINILIKGKNNESI
>fig|195.2063.peg.1936 hypothetical protein
KYEKLYRIVDDNKHNLRSSLFHNEWGMAAGILGDYKYLANDMFQNGFNARFIQATILYIQ
LSGGSSILDKPHLLGAVYGYADIAVGSGLVGVHKNPLREQEIKTLAKTLKPDEFGMLPFI
DEIMGVDWVIDYNKYRIARDEFGSMYKALRSDIVEGKIKDPRDVDSTYESRREFDRHRGG
YYNGMVNGYGTDTPNDWSEERAQLFNDTLILHAKLAALTPPQGYPNAPYYFTPENLEWYY
KRHKLDRLLDPRIPAIYRYNFPQELRAKILAYAKEHNIKE
>fig|195.2063.peg.1454 hypothetical protein
ILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEARLRMYYKEH
KYQKDNLFTNLYLNDTLYQNEQGLDKLELSKNDLFNLNDINVLNTLKQDFSKDYEFKECE
IRLGMHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENENIIHHRV
FLAPAKMQKIGFEIAKGLDEWLDNENVCRFNVYTKDYFNANDKDMLISDNIKDDTNTTQA
HTNENYNNTQEIIPDNVIRIQTQDG
>fig|195.2063.peg.1520 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MPQLSIIIPLFNSCDFISRALQSCINQTLKDIEILIIDDKSKDNSLNIVLEFAKKDPRIK
IFQNEENLGTFASRNLGVLHSSSDFIMFLDSDDFLTLDACEIAFKEMKKGFDLLCFDAFV
HRVKTKQFYRFKQDEVFNQKEFLEFLSKQRHFCWSVWAKCFKKDIILKSFEKIKIDERLS
YGEDVLFCYIYFMFCEKIAVFKTCIYHYEFNPNGRYENKNKEILWQNYQDKVKSNELIKK
LSLEFENDKFYKQLFDVLNKEELDLKRRIDNL
>fig|195.2063.peg.277 hypothetical protein
MQYIGLDFNELLLNFSEFFKALSLNKFILVRIVTHFL
>fig|195.2063.peg.1584 hypothetical protein
MIFDFIIEQIWIHSIFQSIPFSLASLSLIKRLPNMLQA
>fig|195.2063.peg.55 Transposase
MPTIKDALDIIGKLTVAEQESLKTMLLSTAFVKSLNIEDFVAKERFANGRVCPLCGCIHV
VRNGHRKDGTQRYVCKDCGKSFVIATNSIVSGTRKDLSVWEQYIDCMMNGLSIRKTAVAC
GIHRNTAFLWRHKILDALQNMADDVTLNGIIEADETFFAISYKGNHSKSKTFTMPRKAHK
RGHSTHIRGLSKEKVCVPCAVNRNGLSISKITNTGRVSTKDLHHIYDGRIKTNSTLVTDK
MNSYVRFTNANGIDLVQLKTGKAKKGIYNIQHINSYHSQLKRFMRGFNGVSTKYLNNYLV
WNNLVNYAKESDMEKRNIFLTFVLATLKTAKCRDLSNRPAVPLVA
>fig|195.2063.peg.1908 FIG00469806: hypothetical protein
MNARFDKLEYSVGAKLDKLENKLDSFKREVRTYVIILAALMFILQPTIFDLILSIFKSFL
RQ
>fig|195.2063.peg.1904 FIG00470782: hypothetical protein
MGVGVTESSDIVIDIEACQNNTQENKKKVDFSQNFSQSNATTFSEDERQVLLSLGLEVKN
EDGYYWIVRNTYGLNEKIKQLGYRFHSEKKTWWKQIGNVA
>fig|195.2063.peg.1875 hypothetical protein
MDVHYLAEKNYFDIGHDRREESIFLNLKDLLKLAVIRDEEIRPLQTKLWIDFKNLNEYNM
QKSLQTLLGICKETGFNIKNLIVESPNLSF
>fig|195.2063.peg.220 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNEKNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYASDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLQEMLNKNSKALRVIDYACGAGHFLNTYANELKRYLTEDELKEHYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIIL
PSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLRKKETFKQENHLI
SQDYSLIKERIEAENLKDSENFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLAELEAFK
DYRNAFRQTSDYKKLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLI
IKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLICKAFLK
TLSDIPKDLQGYASKARLIDMMDFEKVEFNKAISLNVKSRDELNPFKNSKYELVRLGEVC
DLFNGYAFKKTDYVEKSNTLLIRMGNIRPNGEFDAEHKIQYLPDNFNNKYKDYLLNDGDV
IIAMTDMGNAMNILGVPTIVKNKNNRNFLLNQRVGKLFNFSEKIIVQYLKYALSSNEVKK
QFKLQGYGGLQINLGKTQILSTKIPLPPLEIQKQIVAECEKVEEQYNTLSLSIKEYQNLI
KAMLQKCGIIEDNQEYELNSILDKINNLCKINLDSEFLSSFNKTIKEYALSNPIFKLSIG
KRVLNNELLENGQIPVYSANVLEVFGFVNKEILQDYDNDSVLWGIDGDWMVGFIPKNKKF
YPTDHCGVLRVDDTKINAKYISFILNEAGKKQGFSRKLRASIDRIKALRVKLPSLEFQDQ
IADITDKIEKKINEYKIELDRLEKEKEKILQKYLFS
>fig|195.2063.peg.1915 hypothetical protein
MEAAELAKRLKDYVWETLRRSEDYLYKVYIYDCEPLDKNVPMPPIEKTDKSKNLSKTTTY
KFRSELLKHLRKQPYFAVRLGEIDVSELSNEDFVIDIKQKGVDMKIGLDIATLANKHQVE
KIILITSDSDFVPAVKHARKEGLIVQLDTMRFPETRIKKGLLEHIDILSSVFINKNKNGN
>fig|195.2063.peg.1903 transcriptional regulator, Cro/CI family
MTEEKENIIKEVCKELNITQTELGRQLDVSASTINTWASGKIPT
>fig|195.2063.peg.1765 Modification methylase
MSYKKYLNNVTLGDCCELMKNIPNNYISGCITDPPYNYEFFGRNWDNVEIKRRKNKANNN
KNILVKNIPYGSGLAGGVKNERWYKKNRDNILEYQSWVEHWGKELYRILKPGAFIMVFNS
NRSVAHIQIALENVGFYTKDMFIWIRNSGIPKGLNAYEKMKKDGYELAENWKGWHSATRN
NYEAVSVLQKPIENNYVNNVKKYGVGLLKTEGYINHNGFLSNIFEGYQRDKKDDFNKHIT
VKPIKLIEKLAEMIVPKQTNNIIIDPFMGSGTTALACKNLGIPYIGFELNEEYIKIANMR
LS
>fig|195.2063.peg.1722 hypothetical protein
IDCDEITPIFIKDLLKQYNWNYKDLANNIGAVDTTIRNWVSTGNIPEWAKKSISYIVTIE
KLKRKEEYLKNDLDEVRNSISFLINFANEKDDYDE
>fig|195.2063.peg.898 Putative secreted serine protease (EC 3.4.21.-)
MKKFFCLTLVCKLFALSEFELHHIDKVHKLGYSGDTIIIGVADDAFNQDHISLKDKILKS
TYPTDTAGKQLIPDLKKSTHGSHVAGIAVGAKIGDSKPYGVAYGAKFYGAGVFPNGSYTQ
IPDIYNFFKDVSIINNSWGINFYPYFNLKASNSGLVDCTQTNQGTSYNICNTPLEYVMKA
DKVANDMMRLSKDKGVLNVFAAGNEGILSPALHAILPSYDESLRAWLAVGALDANEITLE
SDGTLIIKSQGLADFSNGFKGATNFSLVAAGVNINNVDSSTNDKFTKKSGTSMAAPMVSG
TAALVKQNFPFLDGKQIADILLSTANKNYKAPKFTVKQVTDGTNQPKFLIVYISQDPPGI
EDEIKRDLKQLYNGIQVQVNGQWIDYSDYIWDNRDSAQSQKLNTSTISSINGVVRVEKEE
LFGQGILDAQKALKGLSILDANRLSDQDVLKYEQEPNTAYYTINTAGYDAEFSNDISQRK
WDENTHLSSAINKPTHLANLNIGLSKEGEGILIISGQNTYEGATLIKQGELKLKGKVKNN
AYVEQKAILSGNGIVGQNLNNKGIVRPGNEDLNDLTVQGTYTQEGVDSKLQLDFGNYKNS
KLIAKTYDIKSGNLEYIPLPKYYILNKPVKINLGDLEKSLSSFNHVLIQNTYALNFDFVL
SDDLVSINKTLIKPNLKPNVYEIPNTSLGNALRQLRSRADLSQTYQEFFASLDNGIDVKT
KLNRIEGSGYLSTFSNHNQSNLMQNNMLFTLHPLNINNFAQNNNILLASTYLPRIFSNEE
YFWHLTPSYKYYKDKDFSGQKTGANISLGENFSSGFLAYALSLSSAKFNFNNGSDLKSYN
MDLLLNYNHDLDFIKILSGLGIGVGFNTLNRFVVEQPIEGKYKTLQTSAQLGVTKDIILG
QDFIFNPLMYFTHSFFYQEDFKENKSPFAKNYESLKHHSINANLGFNLAKNIEQDDYQAS
FSTFVIFEKRIYGRTLENKASFVDFPIAFIQKYKLKDNILSQGFNSEFLYKNNVFWQFML
MNRFSHNAYELHLMSSVGKRF
>fig|195.2063.peg.1879 hypothetical protein
MQEKINELKDYAELAQASYFYFDLEDCILQENETIITLNELLNLSYNGKIAGKKEKVGQK
YSFISKGELNGEFGELQTKNFIQRYEVQFHQPNTTSGFSATLFYDKQKDEFIVGFRGTEG
FWNIDTMQDITLSLNGNIQSSSLLEFLEQVNKIIKNKHKRIIFVGHSLG
>fig|195.2063.peg.1929 hypothetical protein
MSISLFNDEIKAYIKNYYSIVDFLYLRYGLEFDKQGNEKHNKSLKIKTNTCLITDFNGSF
SGDIIDFIAFKENVGLKEALIIFSDFNRLPTQKVGSFKPQKEPLKDNSYLKNIAYSLQAN
FNLANSDFIECKALEKAFFNDFRLFMHLCKLNFLKDVEFEFILKV
>fig|195.2063.peg.1937 hypothetical protein
LLTGSTELPNNPFYFGELDQDNLIKQDTPSYYFSPKDESSGLGRLSIFYKNDELCLLNYS
IIENSLNIKLECLSKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNLECIHGG
KVILKSNKGKTFKDDGIPIMLESDLLNSSIVACPNTIAGVSVPCTKVVNVRGSLSQKKVN
NEYVILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQ
>fig|195.2063.peg.1810 hypothetical protein
MCLIYSDNMRARAYFRSSCEFSKMLCSFEMGCGFCFVLRFL
>fig|195.2063.peg.1682 hypothetical protein
MTAYLHIGTTNTGNQEKQGFLMQNEEKLLQKAYIYPKSLRVANRHWALVDMVLELVQKED
ILKKESVLSHITNERLLRAIENFKSESALHKDKKFIFSAEGIVWDFSTKKHVEILEKIMR
ELGFTQIYIIVYFRDTLGYLNSHCSQDHKNNMGYYSADFAPQDHPRKYIFDYEWICKTHA
EVFGEENLIVRLLREDYVGGTLLKDFVYHLGLEWDESFVLKQTKNESFNLLGMELMSRLN
QKDLKQDNLNSLLFMARRKFEGSKEKRLKFAVQKDIAKVYVDYFASSLEWVKNKYFPHKN
SLFTPVNWEEYEQNYTLTHMLSKDWDDVADFIAQIIVSKNEIISSLKEQLELARKD
>fig|195.2063.peg.1906 hypothetical protein
MESIGIGLFINSLYGLQTGDSRAFIILIESLLILTVVALS
>fig|195.2063.peg.44 hypothetical protein
MNETQQRDCSNAKWAVEMQTDNRVPYGIGKNENYNKDALKWK
>fig|195.2063.peg.946 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
QYIFNNQWICQRYSEIFGKENLIVRLFDKNEFYQGDLLKDFIHTIGLKWDGRFVIPSKQN
ESLDLIGIEFCKALNIKNNNYNFVELYDKYFTSKCLFLKFKPPKKIMQSYLDYFEKSNEW
VRKEFFPFKERLFQKQDLSNYKENYKLKEMKSEYWDKIAEFILDVVKTKDKIIEGKDIII
QSKIMQFNQIQTKLFFQVKYGTAKSRIQNQLSYKLGQTMIVNSKSFLGYLIMPIALLSTV
VSYRQYQKIYQEKIKKDFSLKLPSLKQYPDYQEAIKLKNHISYKLGEALIKAHKNWYGGG
GYIKFLFEIYKLRKK
>fig|195.2063.peg.1729 hypothetical protein
MNCLLLSNNGIALNLPPSLGGSVTNYNYMLKLDMIYKQAVVLPSNINNKEVVMLGEVWTT
GNMSNKTSANTLHITWNNFNSSVQLHALSKYYTANAKIKVEKRFNFGNINNLQIMLSSYQ
SGSSNSRAGWNLNDGNRLNPRANLTLYWN
>fig|195.2063.peg.1772 hypothetical protein
MKKLSQEEIQKAMRECVVSSYTYDPVNPNGYFSRFIRCFK
>fig|195.2063.peg.1854 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
MLKDKLLQDLEEHFETLGQVGNLAQNYDERLFNYLLEES
>fig|195.2063.peg.1235 Arsenical-resistance protein ACR3
MVHRPFAYVYLDFLPKLLGQSTLATSLDIDFSALSKNVLIYLGIPFLMGFITRTLLLKYK
SKRWYENTFLPKISPITLITLLATIIIMCSYKANEVFHLPLEALKIAFVLTLYFIFMFFL
TWFISKKNHLSYPKTCSLCFSASGNNFELAIIICIATFGLHSEQAFASIIGPLVEVSVLI
LLVKWALGKSLNSKK
>fig|195.2063.peg.1084 Protein containing aminopeptidase domain
MPDAIPYVTSYYKRRWGFCLTHNERKKLKKGKYKVYINAKHDENGVLDYADFILPSTQNS
KDEILIST
>fig|195.2063.peg.161 hypothetical protein
MNKLFVYKYNTFLRYFILLLVFKITYNISKKLCFVQILSFKIVFIIIIKVK
>fig|195.2063.peg.1873 hypothetical protein
MSLYNYKLKTTPKLEALRNSENLFVFTDVIAPHAHTNPAISKIFTFSNYENSSIAWFKQK
YC
>fig|195.2063.peg.1567 hypothetical protein
MKTNYTELERKEGQVNGIPYTILKVEYSNLKRLKDNDLLMPNDKGQWLFAYIGLKEGESV
NFDKLQDKVCVAPTYLEKSSTDLFKDNEKIKNLIFFDQNHSWNISERNTQLDEKLCLEDI
QKIANHIIEYNKTKNKNFTLNELEKQINDDVSLLQKKEAIYTQTALKKLINTTKDKIKTA
KENNIKINDKTLNNFNQIVKKHNFQIEL
>fig|195.2063.peg.1121 hypothetical protein
MSNAPVIINNVEVNLNIKENKVFINSLDLAKVFNKNHRHILQTTKNQPQNDFTESNFILS
TYKDKKGVIKC
>fig|195.2063.peg.1385 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
AMNILGLDFNKINENFTFKSKKDFIENCLKNTVVCFSKRQEFNQINNLEIAKYILENFKS
LKQNIKQEYEVSEFITHEFNIGNKVVFKNKENFKEMNFEWLYHKTFCFDSNLEKEFLNFI
EVKKDEINKVFSKWFVIRNEGFEEFKIYDNRKDEVTHAMGFEPDFIFFGKKNKDDDNFLS
IQCFIETKGEHLAIAKDAWKEEFLETLKGKIITTKDDKKLTLQSLPFFINKNFNIKDKFL
SSFDEFVSFQDER
>fig|195.2063.peg.1896 hypothetical protein
IKLYYIENKNLNKFELISMLDEMVQKNDYEVVDFSDDLFYSYLVWSLRKFIIAYDIGLYQ
DKNNLFFNLATYKIHKNHPFYIEANNHLNFNLIELFFSNTSPLEYAVGYLQKEEIIYNGA
LEYSLGTLQKTLNTTTQFHNKFYFKLKERPFEYAQYFKQK
>fig|195.2063.peg.1925 Death on curing protein, Doc toxin
KFRKSTLFNDENIRDFIFKKYVIPYYIDSKNDKILLITIYKKRNPFQTPKK
>fig|195.2063.peg.1881 hypothetical protein
MYEKQAKYMKLYKYARMCWASYFYFDFLNTRNIFELDFNQEKIQEENSLRGYREIKVNLE
HVVSQKHKDKEVLIDLRQDDAWQSKMLNFFDEKTNFDKLNGEFGELQTKNFIQRYEVQFH
QPNTTSGFSATLFYDKEKDEFIVGFRGTETDNFISSIQDIVQDITLSLNGNIQSSSLLEF
LEQVNKIIKNKHKRIIFVGHSLGGYLAQMALIYCDIKYKDKLSFSPNEVYTFNSPSVYGW
NFPNIAIF
>fig|195.2063.peg.1815 hypothetical protein
MTLIIENVNENFLPAFKGLAKSINAKCKISKPKLSSFESKILNASKELDKEKKVNTALSF
NSHQDFVKAYQNGKI
>fig|195.2063.peg.1817 hypothetical protein
MDKAHLITYLVSLAFIVSGLIVCCILYLFKDKINKITPENIENINSNIKDFIEKNICGSS
STIDRSFTTNFGDYSSISGNASSSTNYFIDPTYSYMPENIYHNNQD
>fig|195.2063.peg.1189 hypothetical protein
MCFEKNKLFDFSTHYISLSTFWAFGNIMLKPKDALDTTHLAHQFHSFSLEKLIFKNCKEK
YIKKSLILENSRINS
>fig|195.2063.peg.1171 Two-component system sensor histidine kinase
MKTKNIFITFFVLLILCFGVIFYTLTNSYLNFLLLKQYEQKIKSLDDVLKFSLLEDLNSN
NIKEFAQDTRADFIILKDDFE
>fig|195.2063.peg.1762 hypothetical protein
MVILTINHSPLEFFENKENREKLIKTLIIHLNSYLKTKNNPERINILVEIYQELQKGSQT
PDLIDIEELEFNKEDIFEELFYALGGLGGMYSVEMIQSRIANFIKILGGEPKLLLERFTA
>fig|195.2063.peg.1839 D-glycero-alpha-D-manno-heptose 1-phosphate guanylyltransferase (EC 2.7.7.71)
MQAIILCGGLGTRLKSVIKDIPKPMAPINNKPFLEFIFEYLKKQGIKEVILAVSYKYEVI
QEYFKDEFLGIKIKYSIEKEPLGTGGAIKEALKFIKNEVYVLNGDTFFDIDLSKLKLNGS
KICLALKQMNDFDRYGTVNVDGQGFVISFEEKIFKTQGLINGGIYLLTKDIFNEFDLEKK
FSFEEFLQENYKKLKARAKIFDDYFIDIGIPQDYILFCDKHEFYNLFFHV
>fig|195.2063.peg.1758 hypothetical protein
MIEKEEIGIAIENYDECISGSKTFVFNTKGGTIGSGDDCTFRIQDKLEQIKNTHAIVSYE
EGSFTIAAFEDSDIYYNKSFSRMPSGYEIIISIGDIFKIGNLEFRFVDAKSIEASIKENK
KYLEDIEKRNHFDEIEIKPRGKTSINFDKNKELKEILENNDYKLIEEEKADDSILKEIIQ
KNPNSLEYENVLKSLVKNLKDIKTKQQNSKLNNDYSPISIKDFESIINNIPLIKSTRLIN
ILALSLIAKELYTPIFEEMEENMFIKYIEAAIQNNIKEDKILFENLTIKALEKYIKDFE
>fig|195.2063.peg.1455 hypothetical protein
MVSGEFIEIIFDEFKEWEKSSSGAIKPLFTPLEGIVEDISNSLENVSIIGDALAMLGAVK
NPKNAKNIIKKKSKYATKQEVIEVLKNKYNLKTSKELGLGRSKNVFWVKDNKQIKEIWEE
ITDGADILKDINQDKLGGTIKMRKLDDQTIIQYKKASKSGGETIEVISNKPRGNLRTIHI
ENGVKNEV
>fig|195.2063.peg.646 Integral membrane protein
MIKLKSPALVFWVGTFLFGAFGVGRFMIGDWVLGLIRLGITIVAMFLVGKKLRKQNFEKI
ANIIQ
>fig|195.2063.peg.1846 hypothetical protein
VYRIGHNHGIMADTALLFFYNRCYKNNIFLLPILYRSYITFCMMWNIFGETKEHSIGYQE
FNLKQTLIYLKELNTFFNKNNNKLYALFGYFFNKKLITSKLLKETSRKFLGFMLTNKKLY
FPIGDSIREPSVEFLSKIFFPNKKIMDINEILYPYSVMNGSYSSESYFIYRNDSFGEYVH
FACTCNWNSDAHKQNDELHFCLQLGDDIIFDDCGYTDFLSINQYNELASEFSHSSITINN
HNYIPKKKTNNKSKILSSRANLFGFKVVMQHSRIKKCDICRIINFNSKSYILEINDEIVV
ENDLIGEIINFSFVLSPDINILYIGDKYILLSTKSNIRYIFRANSAFDIKVHNKYYAKEY
PNLSFTNIIVFSSKISNNKNRYYFKLEKYIYKEENMRYDSFMKLKHVVSSSNIKYYVIKP
HNVGFTDTFLSACVVSSFLDSLGLVFKGIVGVDKIDRSEYYQDLYQKINFKNTYNGSYYS
IVDNNLDIDNIINEVKNLNKSIDTILLEFNYNHVLRLFELFPIFERKFFFSSFYGYFNNL
TKAKITYDNKINITIHFRLGDEYPLFVNQDTVVNPSMLLRSRFDFAYYNIKNKKGYRVIQ
QRFNALGEIELYIKKLRQFYKDSVKINFISDGMDLGFNIVNREDIRNKLKKLGIKVDDEF
LQRSTEQSIFKLNNLKKYCDEFIVGESVDKFIQTKNLLLRSNIIVSSARLFCWGVLSAFK
YDFTFKQVLFMNNSGSYYDIIDNKNVKIEQYKNFNYCINNVFKYINHFLNKDIIDKIENH
FNESAKIRIQNQLSYKLGQAMIVSSKSILGYIRMPFVLSYIYDKYKQEQKIYQEKIKKDP
SLKLPSLENYPDYKEALTFKNHLSYKLGQALIKANKTWYKGGYIKMLFEIRELKQKAKKG
K
>fig|195.2063.peg.1886 hypothetical protein
MRRYYDSETLKSILGQKTSLEYS
>fig|195.2063.peg.1918 hypothetical protein
YNIIQKYKKGFLMIISVINKKGGVGKTPFAFSIAKDLEYFLQSNDNSIIEKIYPEKAKIL
PTPKKIDNCVYDFGGFVEKGVLDIIKESNKIIVPCTSNYNSLLRTLETLNEIGNDGKVCI
LVTDYRDEKEKKQICETLESNFTDLNLFFFKFSKIIENSMSSGASFTELYNENNLSRLSY
TNFFNEYQRLLNFIRKDK
>fig|195.2063.peg.1769 hypothetical protein
MNNVLLHRITEKGNIRYYSIEIIATLFEEYMVERVYGNVRFKSCTGRKNNVFPSFNEAQI
FLERLKKQKMKKGYA
>fig|195.2063.peg.1922 hypothetical protein
MDKVEVKLKKSKMTTTEKLILTLWLSCGVAAIVLLLVYLKIITSFIGILGLLSVSSLVIA
FVLFLAKNIKIVPYDEKKHGKEYEIAGYIESDPRKYDYIFHGIRDN
>fig|195.2063.peg.1119 Phage antirepressor protein
MTNIKDIKKIKITCKECKSEFSMFIGHSLYVCPICGNNFGINQLNDPFFRIKQAFECFTN
PKNCDIELVCEIKE
>fig|195.2063.peg.1764 hypothetical protein
MMNIVIEQIERNVIDILSQYKSNFKSKKFDTIVSDSDILMDFFNITYETKMQNMQYWNRE
LGRVWELITKELFTSNNLFKPPESVDFGTDHPVDYFIGNLAIDAKYRIGSGDSGTLKKFK
LYGKMLKEMGYNPVFLILRNDNLPAAITAAINGGWEIISDKDAFDFIINYGGIDIVQYLA
CLKAKYDF
>fig|195.2063.peg.1867 hypothetical protein
MKEIIKYYVAIYVDELLEDEMLKHVDFSLLFEAKFSQISKQIDFTHAFLGLTKGKSPDEL
DKIDETLRQEYLKNKEWDKIDQKWYEAKEPNEFNDGFWGFGTGIANVAESLIGSPGKVFN
NNQYVLDSNIDKNCYIIKKLRSPQAFKPSNRCTLELSKEQYEILLANIKNDFNTTKEITP
NSKEPINEEFTYKLLENNCVTWVIQKLSDIGIELIDDEYKVPGNLIDIFGLIKSLHSIFL
KFQNIDDNLQSVKGARAFITWTRSMLDNNYICYVNQENLEKKIQTFCKKDIENQRYYESI
KKFYDKASQLKSIYNKLDFCLESITKKFNTSIKGDFELIYFDRKDRQIKLLKADNDYEAI
AIQDLDLSQKYNNFSVSKFYPFIFIPKDEMLSRMLYHKYDYGNISQEYQKDRNEFYFNVL
AGEKSDKYWSLSYHKMTKNLRKIHAF
>fig|195.2063.peg.1933 hypothetical protein
EFQGIFDNFLENNLKFENEKLDNTLLVNSSLNNFDTTLKKAINLNISKLNHFFYAEYPDL
NSSMLVEMILDKKNTDQINTTKMGKNYLLITNPPQLNNAGLCEDLYQKKLGAIIKNRPKA
LTKNEKLALKGDFPSKRDYGSYFIERDVKKEDDYVLQLCPFVKLDGQIYQKYKGYFNFYN
QTYSWMKLYLLEHINERLEYEKVKQDFAYIDNFFKLPKELEEISEKEKEKVKEYIRLFND
YLDNINSRYNQIQSNLNSEPLMFKTYENVDFKKYSPLTVVLLTLTLYVLQKDLAFTQEYS
LGVKNIVIPNPDYGDKEISLNYQRIKIPNYFNEYILFIPDDIYFYDNDKKIYIFLSKELN
KNKKEDEVIYLDELAKAMFENDFEEEDQTYVNFLKTLNESFDEEIEFEENIQTDKTLPSK
KDLDKSIQDIMLDNELAKLSIDITFFNIIKQLFPFTEFFMSQPDFFKKMILFF
>fig|195.2063.peg.1766 hypothetical protein
MATSNAELEIVKQLFSTLSDDDKKSFLKSIKNKEKSEQNLILSKEIKACPHCKSTNFVKN
GKKDGKQRFMCMDCHKTFTVTNNSIFFKTQKDLEIWQKYIHCMIEKYSLRKTAEICGIAL
STAFFWRHKILDTLQKMQDEVKLNGIVEADETFMPISYKGHHKDFNFPRLAKKRGTANTK
RGLSKELVCIPCVVNLNGKSIAKISNLGKPNIASLSKVIQGKVEKESVFVTDSLRSYLKL
SNEMSLNHICIPRNKHSNGSFNIQVVNNYHSRLKSMLVYNFKGVATKYLNNYLVYHNFVN
FAKESRKDKEQILLNHILNTNCISQSISVANRPAVPLLVA
>fig|195.2063.peg.1760 hypothetical protein
MKKPFYKLKRFYIPCGVLIALIIFISLTYHFLQRPLELIFWDRYDISKLSINNKEKNFKT
MKTVNYSYFR
>fig|195.2064.peg.690 hypothetical protein
MINGINSYSNYNYTNTFSNTTSNTKSSNAINEASNLVSDKSQAVDKILGYGVDKEGFFTS
DFNEAAGLPKDYKIYAKDMQSFVEWETGDRYFYATHTSIDIAKTIGNAYKVLSQIMPTTS
NASLSEEELTNIPYAFVLDKNLNVTKTFTKDEYEKIDLTQDRINLTFNTFSNTGFDKISI
DNIFSHSNGDVRLNKNAYINKDGSVDKGGVLMALLNSQLYGATSLLLEGDTRLFGKITTD
KNISNDEREAFQNFMNANKIQSAFSYSSNPDEWNPFEERLSMKLFIRRSNNIGNDKLSRL
AMDLDKEYQEMINSNMSLEEFKTKYLDFKQRHDEFVKSLKEAEKAKGIDYDKYPTGKPID
DTKAIEEAQKKRKPIQAESKSETYKDDNKMNELLKKLLENKFGTSDELEILFGMKFSDDD
TGEFNKILSLNSAPKSIDIKA
>fig|195.2064.peg.1496 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISDT
ATNQISQLKDTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVQAKVTKTGDETIAGVKTFSVPPVCSANPTEDAQLARKWYVDYGGGIKNLGNQTAP
KIDLRQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQNITAFSAPFKFRVAQSGFSG
TETFAYFCIASNNIILVRT
>fig|195.2064.peg.109 capsular polysaccharide biosynthesis protein, putative
MRFYILIFYLYRRLIRLCSSCSLFKRQKWILVDNYFNNSSDLNDNLCLFEFILQNKTKQV
YYVISKEHSLYKDLKQKYPKNLIIINKKFLSFSFMWHLLQTRYILDSFQIFSSKFRLGGI
FCSSKIHYIYTQHGVNFFKKYFLKNTDSLSDENFNAIIFSNSHEKSYYETIYNYSENRQL
LVGLARWDNILPIAQCDEKIVLVYFTFRRYLMQDQKAIEYKIFKEWYYLLNDDIFINYMK
GNNIKIYFALHHEMEKANDGRFDILNPISQSKLSEIKNKASLLITDYSSMAFDFMVKDKP
VLFYRIDQDELCLDEESRENSKYSEELNEQIYNVFYNKKDIIDKCMYYFKNNFILEDEFK
AKNKSFFACRE
>fig|195.2064.peg.1696 hypothetical protein
MKLSIRKKMLMLGGICLVSMLITFGIFYYNNLQGSEKIAQITKNLINKEINNS
>fig|195.2064.peg.1723 Putative type IIS restriction /modification enzyme, N-terminal half
TGLSGKFYSSFTDKYLIYLSNKNYSGNLDDLPNLKQHFQKYKEILKESKIKYKTPNKPYF
YLHREREEKFFKKGEEKIISQVRCIEPIFVYSNENFYGSRALFFIQTCRINLKYLTGVLN
SKLIAFWLKHKGKIQGNLFKIDKEPLLNIPIVNINSKNEKLANKLISLVDEILKAKEQNK
NANTQELENKINSLVYKLYNLTEDEIKIIENKE
>fig|195.2064.peg.255 Mobile element protein
MSANNNELISISHKVELKPNNKAKTHFKKAFGCARLAYNWGLAKWQEYYKQGIKKSHLEL
KKEFNAIKKEQFPFTYEVSKYATQQPFLNLNLAFQKFFRDLKQGKVSYPKFKKKRDNFGS
YYIGGDQAIIKDEKYLKVPNLGLVKMKEKLKFNGKINSFTISQSADKFFVSFSMQISKDE
YLKTHNKAKNNNLALGIDVGLKSFLSLSNGLEIKAPKPLLSLIA
>fig|195.2064.peg.1596 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MLKIEQLRKNLQIYCKSVNSKDSIRFMRTYRNLTSMEKKENYDYLDDYIVKFSEILHNTS
QIKINDEFLNRFEILIPTYNRKEYIIQVIREIKFVNENIHIRVSDNGSNDGTYDALKELA
CKYPRLYISKNEKNMGFGFNLHKLLQECDKDFFCVTSDEDPVIVKYLVKAIRFCIDNKID
ALRPLCIHYNKNECRIEYKTYTIEKQLKDIATFGYLPGCIFNTKMIQQFMKYYNRGDITG
VYEFNIWYLIASIFGRSYFFNYPVQYHKFWAKKTFINPNDDISLKNLKPYSHPSMRWEML
VAFANILREIKKDTNDPMVIKKIEQIMDIFSNRAIGLLYNIAVSEFPSLKLKADGGFVYK
STYQKLSTKLNILEKETIYKIAKYRIHNHLAYKLGQAMIINSKSLLGYIRMPFVLSYIKD
KHKQEQKIYQEKIKKDPSLKLPPLENYPDYKEVLKEKECLTYKLGEVLIRANNNWYGGGY
VKLWFEIRKLKKEFGKKGK
>fig|195.2064.peg.1057 putative lipoprotein
MRKIRLISVLFLALFLSACAKPAFVQSSIQTSNEGIFLKAKQGQSFSITLQNPSKIQSTL
KDELALRLKNLGLKEVSLNADYEILINLVDFKKHSYAQRITSSGRFFYDFDPFENNGEWY
IENYYTMQVNIQIGSKNTLQKTSLFTRTAYLSDKKRCQLSLENKIIDQISSFFIFDLNFT
F
>fig|195.2064.peg.737 Phosphoglycerol transferase-like protein
MRKILLQILIFSVLFIVAFTINRILMQNSFIPAGLISDKNEIFLMYLLGVF
>fig|195.2064.peg.256 First ORF in transposon ISC1904
MPLMNKLLSIGQASKALGVTIQTLRNWDKKGLLKPDDMTKGGERRYKLETLKAINKNLVF
NKDSLKTIAYARVSSHDQKDDLIRQVQVLELYCSKQGFNYEIIQDLGSGMNYYKKGLTKL
LNLILEGQVKRLVLTHKDRLLRFGAELVFSICQAKEVEVIIINKGEESVKFEEELAKDVL
EIITVFSARLYGSRSKKNKKLLDEMQEVVVANVSEQ
>fig|195.2064.peg.1445 hypothetical protein
MHDVSRDKLLNHYKEFCEEIFYNIALEKII
>fig|195.2064.peg.1424 hypothetical protein
MLKKLASSLILGSLLASSAFAGDFLAKVSNGALSDNSQGVKALNLDEMKQVKGGYSVVPI
INGTEMYAIAKYEQGELQYIANYLKGNTNAPQGLCGIDQTSCSNPSKNRLIAFLQVTQNS
FSLLPTYIVKRQVKVSALGKPYVLFTYGVGAYNPNTYQMYKFNSSSMLNNNMIIKEMANK
YKEYMESQLGGWTARARR
>fig|195.2064.peg.64 hypothetical protein
MSIFSINDNSNYGSILSQAKANKESKENSKISFANAFLKQNASKLNEIQNANSQTLARSE
VLNSTNTTNTSNNTSFSISSKASSPNYDISSEFKNSIYTLKYKQVDLNTDTAYGYSVDKD
GYMGSDFNKAAGLPEDFKIHKSTLDEIKKAAENDPVVSSTKEYLGVSEYYTNIDMAETIK
QYYNLFSNALGQSFPNDKTSFSEADINSMPKGYAINGIKSMDFNDPSNRMNITHLRDFSN
SLISNVYKTPEQMKEAESLYIQSGSLIDGINGHSFGLSLEEIKNVSKGEDWQFNPDMSVY
PQNEDGSYSKEALFMSFLKSYGSGQPVESLKTTLNPKVEAYNRAMAKESFNGDSIALNDI
MTGKVDFASLLKGYAQDGWLDAGIYAMEKGVAWQNTSIGYGGAWFDNQFNQAKANGWKAS
SESINSFADSIADRLNNLLEQTRV
>fig|195.2064.peg.123 FIG00638667: hypothetical protein
MKKILTSALALGAMTLIIGCGGDDRFVEFNKKELNSFVEKGFELIKAKNNNANMDFYSPE
TLKNFDEKRYKY
>fig|195.2064.peg.1112 hypothetical protein
MARECLGQTHFQLFIKIQGIPALLEDRTDLSPDLVTIFVRYGKHSMPFFRKTEISDKELQ
YLGEYLGRNYK
>fig|195.2064.peg.273 Channel-forming transporter/cytolysins activator of TpsB family
MYADKFLIGDEYTVRGFKESSAALDYGAYSNNTIYLQFLNAPKYLRALEPFVGLDMGYGR
DYLLSNKDFLAGVAFGFRYNLNHLSLNLTASKALHKSSNMPSETIPIYLRASVFF
>fig|195.2064.peg.1754 FIG00470597: hypothetical protein
MDDLNCDFIHFFNTIYIKLIELCGSNLERFTPLKDLKKLGFHIICSKGNRGALANLLLFN
EISSFFK
>fig|195.2064.peg.1704 hypothetical protein
MKQDKTILLIFKDKIPEERLFILEEELKKSQKDLSALYAISLKNPLVGLVLSITVGLFGV
DRFYKGDILLACIKLAFFIIPLFATFAAFAAFIALLYESHSIFIDYFAIFALMFVVASIW
KLVDIYLVFVGIKKDNFHKILNFFS
>fig|195.2064.peg.278 Hemolysin, putative
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGDIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKERLKQIMLLILIR
>fig|195.2064.peg.967 FIG00469432: hypothetical protein
MVHEIQKTFLLPDATLLEKLQKDGIVFEIYEIETFYTK
>fig|195.2064.peg.1630 Chaperone protein DnaJ
QGDKEAEDKFKLVNEAYEVLSNEEKRAIYDRYGKDALKSGGFWLGGGGVCGFVGFGGVFF
FFFFGGVGGGLPRRQKKKGEKN
>fig|195.2064.peg.254 Mobile element protein
MIKRARQLSKKQHAKTKQEALQGIKKSSNYLKASIKLNKLHRKIANIRSDFLHKLTSSLT
ANVKYFCLEDLNVKGYETGTGHNGTAKGRKRLRMDRMPQ
>fig|195.2064.peg.959 dna methylase-type I restriction-modification system
MNLNQTLQEKYPHLEVSVLKLSEVKKNIDFRIDDSFWTMKLIYNNKLNYKKIGECLLKSQ
YGISINMNEGGDGIPIYRMNDIDNMLCNFEVKKYALIDKNELQTFRLNYGDVLFNRTNSY
EFVGRTGIFYNNRENFVFASYLVRLVCNKEILLPEYLTVFLNTHIGKKEIRRRARPSINQ
TNVNPEELKEIKIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDPKNP
LQSLLDSKTNNPTKSLNISIHTLKESFLKTGRLDSEYYQKKYEINEKIIMNKKYTVLDNL
VSITKSIEPGSNLYKNKGIPFIRVANLTQYGLSEGDVFLDEKDFFPQYLQILYPKKDTIL
FSKDGSVGIAYCVKEDKEVITSGAILHLNIKDKENILPEYLTLFLNSIFVKLQAQRDCGG
SIISHWRIEDIKKVLVAILDIKIQEKIAKYIQESFNLRKKSKQLLDNAKNKVEEQIQGKI
>fig|195.2064.peg.1403 Phage antirepressor protein
MSNAPVIINNVEVNLNIKENKVFINSLDLAKVFNKNHRHILQTTKNQPQNDFTESNFILS
TYKDKKGELRPCYNLTRDGFSLLVMGFTGEKAYKWKIEFIKAFNEMEKRLRNIEYEKHDK
LAFRQSLGYKSQLKQQKEHYENKIKALKYDLEKKKELSFKRKLSKEELLELRKILAKDYD
IVCFKEWEYMLFAESVSGKNYKLEKENDFCIYKSIKDSFNSKLDYYKNYEEYEEKWRKIL
RR
>fig|195.2064.peg.1139 lipopolysaccharide core biosynthesis protein LpsA
AKELEEIRTRVKYYNQINDFFTLTEREKIGKFPFKNTSYAFDAYEISKYFNDDFLWKKEF
GDVKYTFKEPAICKSRPLENNTNNILLKLDKNRHFCFLKDNIKYENKKDIAIFRGAVYQK
HRKEFFHSYFGKSFCDIGDTSKQPSQWKKTF
>fig|195.2064.peg.1788 hypothetical protein
MGLSTKLFFKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2064.peg.1375 hypothetical protein
YMVDVIVFYEKLENFNYNETIEKISQLYSLQEEKYKKITK
>fig|195.2064.peg.650 Capsular polysaccharide synthesis protein
MNLYNKIIYNLTNLIPIKPLRRKLRAHISYKIDHPKVSKYLDENYIQPFFKGKIPSFVFK
KKQDFKDNKIIWQLWFQGEENASYMIRQCFKSVKKHMGSEYKIIILNEKNIENYLEFPDF
VLEKIKKKTFGEKTIVFFSDLLRVCLLATYGGIWCDASIFLSDKIPQDLRNREFFAFERA
RHRPNKKELKKFIKSPYFSYGYFNWNDDFMVRLLNSFLIAKENNKIVSVLRDLLIYFWQK
EENSKYFYYFTQQILFELLKRNGYIKNEIFENKSDIECHLLQFYAKDKFDNKLWEEIKKQ
SFLHKLTHFRSVKKDSYIDKIIMQVN
>fig|195.2064.peg.1240 Putative glutamine transport system permease
MSLFIQKCKNFKFQAPLSKKTIFFNSLVLIFILSLFFYFSFSVSAY
>fig|195.2064.peg.251 Hemerythrin domain protein
MDHHKLIPLWDERYNINHQKIDTQHQRLFEPAAQVENAVFKFVKRDELKEILTELFAYMK
EHFHDEEEFMQEIQYPRLYEHKQIHKNIIHEMFQLIQNIKSTNDLKEKLYSIMSKWLSRH
ILSHDVMIIAWVNENLKKDENKALELNDLPPKQTSFISPFGVFCHSLLHLTPSRLDR
>fig|195.2064.peg.1722 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNENNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKEL
>fig|195.2064.peg.1122 Paralog of flagellar hook protein FlgE
MMRSLWSGVSGLQAHQVAMDVEGNNISNVNTTGFKYSRADFGTMFSQTVKIATAPTDGRG
GSNPLQIGLGVSVSSTTRIHSQGSVQTTDKNTDVAINGDGFFMVSDDGGLTRYLTRSGDF
KLDAYGNFVNNAGFVVQGWNINWDTQSIDSSRTPQNIFIDPGMHIPAAKSTEVAIKANLN
SGLNIGNAARPLYALDSVHGFNKKTGETKDENDNGITQFYTTSKNSMEVTEKGVDAGSLF
NGSGQGLNLREGQGIWMSFADSKFTTNGTNRTGFDANNKTNQNNVVFWGSENQKTRLDIT
LNGVAIQNADITSLDQAIAYINTFTNPQEGREGTGIVASKNANGTGIIFTNRNENGTTDN
MKNINLVVNAQNTAGELWNATWNQGNNNFTFGNGKVNANGSVWTATGGTNNQTTGPTNAV
VITAHKYTYSSSPQNIPPMYNPDGGAQFTDNDNNANTKPTDPASGNYWDALKGSLYNTDV
RVFRTTEDLRELLQRDARYGVDYNGNGAFAAEDINQKVTITVSDDGRFTVSNAKQDSQIP
ANALQNQAVTTTAKDLSFNVTAYTDALGKVSTNDAFTKIFKAFDGVQTAGSQKKESEQLK
LSAFSAGLEIYDSLGSKHTLEVQFVKQSTTQDGGNEWQMIIRVPEPAEINTTGEGPNNIV
VGTARFNNDGSLASYNPKTLNFSPNNGAAPNQQIKLSFGTSGSNDGLVSSNSASTLTGQA
TDGYTSGNLKPDAIRVDDKGNILGEFTNGKTFAVAKIAMASVANNSGLEEIGGNLFKVTA
NSGAIVVGEAGTGGRGEMKTSALEMSNVDLSRSLTELIIIQRGYQANSKTISTSDQMLQT
LIQLKQ
>fig|195.2064.peg.1502 hypothetical protein
MLKKEFDEKIKSLGFTRQDFCNMTGLAYSSVSNWNDNNKPIPIWVDTWLEKYEEEKTFSN
VRGKITINKTTMENTRELLKQKYLMLNLRKPQDCLKLSYQYHQVKVNTYFDYYENTFNLF
LVLNYEKSYYFTPLNIDNLIVKNPYLNDVPKEILGQILDNGSLKDFYDNMREHMIHDDVQ
KSNYEDYEFKNGLKSNKNNDKNPFLSHLRKTPMSENHLNFLNAQFNISKYILQRIRAKGY
TIVTTANFSERKSLTLILNESSIRL
>fig|195.2064.peg.563 Dicarboxylate carrier protein
MVFVGIGPGHYAGFAFMSPLVLYIASKIKMNKILAAIIIYSGSCAGGFNPFTLGGRVTFD
LIEKLGYSAEASAIMQLNLGKNMFIAHTLIFIIGYFLLKGYKVKITSQITKPKRLNAAQW
KTIFIVCFVFAVIMIPSFFLALNPHDETLKKVTSIFNPVFVSFLGIVLAVIFGIGSEKEA
FKNVPWDLIFMIGSLSMLIELSKTTGIMENITTFMSAHGSSSSNWLYYLLGILSSCMSAF
ASSMGVVMPTFFSIVPSIKALEPSLAFSIIAVFATFTGYSSFSTGGALVLAGAQDESEKR
YLFIRLIILPLILVVFGFVLLFLGILN
>fig|195.2064.peg.1514 5-hydroxyisourate hydrolase (EC 3.5.2.17)
LREKNMLSTKKILLALISIPIFLNATEYRLSTHILDINSGQPASNVKVELYNLDQNRQWV
KISEKFTKKNGRIADFLPYEKTENRSFGVYKLKFYTKDYYISHKVDSFYPFVEVSFELLK
DQKHYHIPITLSPFGYSTYRGS
>fig|195.2064.peg.451 hypothetical protein
FSSISRKSAGGGSFHYFTNGKFIKSDEKYTGQSY
>fig|195.2064.peg.562 Dicarboxylate carrier protein
MDTINIIILFSLIISIALGYVLKANIGVFAILSAFIGAYLYGITPEKVINLWNGSLSLFF
ILLSITYFYGFAIANGTLNNLALKAVYSVRNRLGVFLLHFILQLWYL
>fig|195.2064.peg.1275 hypothetical protein
MLNYSILENSLNIKLECLSKQSLEYKDLISNTLKEQKTTQVDKKQAIAKLHALLENQNLE
CIHGGKVILKSNKGKTFKDDGVPIMLESDLLNSSIVACPNTIAGVSVPCTKVVNVKGSLS
QKKVNNEYVILQELFSACKTDKGFALKVSFTPTKFKFDHSFDPKEGLGEQSKNQIELKEA
RLRMYYKEHKYQKDNLFTNLYLNDTLYQNEQGLDKLELSKNDLFNLNDINVLNTLKQDFS
KDYEFKECEIRLGMHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRE
NENIIHHRVFLAPAKMQKIGFEIAKGLDEWLDNENVCRFNVYTKDYFNANDKDMLISDNI
KDDTNTTQAHTNENYNNTQEIIPDNFIRIQTQDG
>fig|195.2064.peg.1794 Translation-disabling ACNase RloC
VYNFGNNLRKFLEIYLFFKYPNNFESLDKELIERFFNDTYQSDNTDENHQRMIANITNRY
QNEYSHLREILSRGMQPIDIEESKKIADFILKMIEKNDNNQFKALVRSISNDR
>fig|195.2064.peg.1799 Single-stranded-DNA-specific exonuclease RecJ
LKLILAKDNKTIEALFFNFDKEPQLYENISLLGSISKNEFRGLATPQFIIKEIL
>fig|195.2064.peg.122 hypothetical protein
MIFSVNKDKSDKREFWALICEDSKVENCKIENATGRGV
>fig|195.2064.peg.891 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYIYVDDY
LARNYNVAIININYHCIGNRPHLGSSFYLDDIDKIILDTSLKTINLNHINVFDINSYE
>fig|195.2064.peg.1314 FIG00469432: hypothetical protein
KRLVLFKKNLLKNFEIETFEENFLGLSVFLEYFHNLYNLKILSKLYNKYFICDLEKKTLL
KLTKKKEKLGKLIHKASKKLKIYKGY
>fig|195.2064.peg.274 Channel-forming transporter/cytolysins activator of TpsB family
MIKELTNFIVAKGYSTSSVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPL
KKGDKFNIYDLDTGIENLNNGARDVKIAVKASENYGYSDIFINLKSKPPDLILDFDNSGY
KAKGEYKASAYLSLSSILNLNDSIRFGFIKGLLKDMSQERENVYVANYTLPIQSYQLSCS
MQYSDNINMIEGYDNSFIKNTDTSLRHKIMLKKILHRTSKDKFSIYANLGIKDDVNEIDN
FRLESSSGRYSSIASGVEYSTLAFGGFLFLNLEYEKGIPFLGSKKDSKDSLYKIEFNKVN
FNLSYQKSFYANDSLAFLYQNSLGASYSNEPLFCMLINF
>fig|195.2064.peg.1711 FIG00973752: TolA-like membrane protein
MKKIFLAFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNITIGG
DPTIWNDTKQVFLTQTFIYTLTPKFDILISGGGSYARQEYTNFFTNEYSSKNRIGFDSLW
LG
>fig|195.2064.peg.1392 hypothetical protein
MAEEKENIVKKVCKELGLTYRQLGELIGLSEGRVKQLAIGEVGEQVEKACQMLIKIHKLE
AELNEQKQLKTLLKNFIS
>fig|195.2064.peg.1113 hypothetical protein
MKKIALFFVLFVCLLNLNAKDKEWLPKGESISVYEYIPNNPRSLQHFQALIVKN
>fig|195.2064.peg.1796 capsular polysaccharide biosynthesis protein, putative
IGLSKREAHGRWSLGDEVSFYFNFTEYKRITIDFKLHAIADLDATVYLDSKKMFSCNIFK
DVSQNKISIVVSRKKLLKQNGCIMIKFIIRFPISPKMLKLNQDSRMLGIFFHSINIYEVK
KS
>fig|195.2064.peg.1003 Cytolethal distending toxin subunit B, DNase I-like
MGVGIPIHEYIWNLGSVSRPSSVYIYYSRVDVGANRVNLAIVSRVQADEVFVLPPPTVAS
RPIIGIRIGNDAFFNIHALASGGNDAGAIVAAVDMFFRNRPDINWMILGDFNRESGALVT
LLDPDLRARTRVVVPPSSTQTSGRTIDYAITGNSNTAALYNPPPIVAILALEGLRTFLAS
DHFPVNFRRP
>fig|195.2064.peg.1116 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MILPKNVSQSDFTAAVAKFEKALGKEWVFKT
>fig|195.2065.peg.291 Transmembrane protein YfcA
MGFYDGFLGPGTGSFWIFACVMLLGFNMKKASINTKILNFTSNVVALFIFLWQYELLWIV
GLLMGVGQILGAYLGSKLVLKTNGKFIKTLFLIVVGATIIKVAWDYFS
>fig|195.2065.peg.1158 Motility accessory factor
MTFTPTQKELFNKNIESLSNILLKESLKEIKSSKFELILGKDNLDINLKDTSDNTFLYEN
VIDELNSMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFH
ILDFSNELQSARLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELMSHYYERFHEDVLE
LNKKLVQYFKDSIISHGNDSTDTLQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIV
STGPSLTKQLPLLKKYANTATIFCADSAYPILAKHDIKPDYVCMLERSEFTAEFFNHDFG
EFDRDIVFICAGVVHPKAIEYLKGRNLVITQKVLAFPYYINLKDFSYAAVGFSVAHMLAY
LATYLNHKNIIFIGQDLAYAENGNSHPDDYQNSANYESQMYEHILTKAYGEKEEVKTHAI
WILFKNYFENEIIPNTIKMGITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKL
EPLSLNKQNEFLLKAYYKVYQSIKHCRDFNKILSNDFENIQSIYLSLNEKEEDINLAIEK
IDEFKNKLEDIKQMQDLYDILQSLFIQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEF
MELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2065.peg.1516 hypothetical protein
MENERKKGEAMKKMSLGDDFW
>fig|195.2065.peg.1276 2-hydroxymuconate tautomerase-like protein
MTDLLAKVLNKNKASTVVIIDEIDTDNYGLGGKSITQVRKEKS
>fig|195.2065.peg.1211 putative lipoprotein
MLRKIFIFFLILFFSACALKNQDYSSQKMKVVFSTPTIKINDFGFLKKENKALNLEVYKL
GQAFFKLKIREDICLNSVCYS
>fig|195.2065.peg.1620 Permease of the drug/metabolite transporter (DMT) superfamily
MLKDKKMPKIFESMALIFIILALFLLASGGDISNLNLNLWGIFWAILGAFGVAFYSLGAR
KIIAKYGIFFVMGWSSLIASFILFGILEFKEGLVHYDFALNLYLAQAGIIFIGTIGAFCL
YLKGVEYIGALRASMIACIEPVAAAFMSFLFLGTRYSFLDLFAFALIILSVILNAKKS
>fig|195.2065.peg.1166 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVF
>fig|195.2065.peg.701 Hemerythrin-like iron-binding protein
MRVEQWRLGSLSSENGADITFEEIKDDEDEAVIYFYACECIGQIHDVPSGIHKKNTK
>fig|195.2065.peg.1729 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDCKYKMKNNNQEKNVLIAGNGPSLKEIDYRRLPDKYDVFRCNQFYFEEKYYLGKNIKSV
FFNPGFFFEQYYTSMQLILKKEYFIENIICSTFDLNFIDNSFFLKSFYNWFPEAYLGHEI
LNKLKDFYNYIK
>fig|195.2065.peg.1725 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MPMALLSIIISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQ
ANKTWYGGGYIKLLFDIRKIKREIKEKYANKNR
>fig|195.2065.peg.1322 Fibronectin/fibrinogen-binding protein
MYKNAKKLEQKARNLNLQRENLKEKLEFAYGLKEMLSKAKNEFELEILLPKKSTKKNQEN
KQDNGIANFYFNEFKICVGKNEKGNENLLKSAKKDDLWLHVRDIPSSHVLIISNKQKISE
EVIEFSARLCVNFSGLKKGSYWVDYTLKNFVKVQQKAFVKYTNFKSINITKD
>fig|195.2065.peg.1747 hypothetical protein
MIHLIKEILKALVDKIDVILGASLTLAGFLITALTIIITIMPNYAENSLKQEFFNDFKIA
IRFSIICALFAFLCLVLKRQESVSYILAFIDGVLFLITLWTTYKSVKSLFFIAENK
>fig|195.2065.peg.955 Putative transcriptional regulator
DLSVRAESLSRILKEFKNSELIETKKGKIEILDKEGLKKGLW
>fig|195.2065.peg.1187 hypothetical protein
ARHKSLNNDNNKSFIPKENQSYNPYGNEVKNNNNEKYIEIGDDDESLPF
>fig|195.2065.peg.1761 Phosphoglycerol transferase-like protein
YVIALRGPFKHVAINVQNYSFSEYSVVNDTMLNPIMAFSWALKQYKEEAALKVITPLKAQ
ELKEKLFDYLHQSPINLKVEKNHPSVFVNLMESFGLNLADFANTEHNFLGSLDKHFKQDF
LFKRFLSSSNGTIPSFANLFFVSPLSNISTSKFQKTYLDLTPIAIYKKAGYKVIFVSAGN
GSWQNIKNYLSILGVDEIIDENILMKEYNGAKDSENGYGVADEFLYKKVYDLLQKNPHNT
LIIALTISNHPPYKFPQNDLPKLENIPQTLLNMLPYDKNKQDNIIKAYTYANNEFGKFLD
KVKQSPFKDSVIIAATGDHRVREMSMDLNSQKAFAYSVPFYLYIPKDLQDNIYYDKDRVG
SHKDIFPTLYALSLNNVKYLSVGGRNMLARPNDEKLEFGINDAVWIDKKGIYSGGKGYYF
ESNDTLKDMNKAFNLDGYTKDFDKFYRELNLYQLAERLGISK
>fig|195.2065.peg.1737 hypothetical protein
MKKEEKIKRKEYNVFFYKLSVKPNLFNQENETVS
>fig|195.2065.peg.328 Hypothetical protein Cj1505c
DIEENNNEFYIRVKKQELDFSKASTDEYNVLFLKTDKVGDGKLGENLLVGFLSTLKNVEN
IPSKILCVNESVFINVDENHRAHLVMKELEKLGVEIISCGACLEFFGKSKELKIGSIGNA
YEILNELCGKAKIITL
>fig|195.2065.peg.1769 Protein hydE
MTLDFDFIYNADNDIFEYLLRFYAKNYNYILSKEENTYHFSIDADEENLKTFCDSLNFMS
HSVFLKKFDVKAGHGFSPCIPEDKEFSKFSYITHLNSNAYQEKKLLNKNEWGVFCECEFS
SNLSEFEKINEENFNTFLNLAFDLLSQEKKIYLKDKNGIYEFSLFKNEFIGDFLLPC
>fig|195.2065.peg.1595 hypothetical protein
KMLILGHYLLTQNSNFCFIDESKKLKKDQISCFLYNEEIIQNAKNENLDFAVLIQDKNEI
FLSNALGAKFLLFDDENLARFASEVAEFYLFDSKILLLVENLHKLEKAYELRLDGVILKS
LIQDYH
>fig|195.2065.peg.1538 hypothetical protein
MLIDEKRLMRNYTLKPAYPSNIGELDTGEVYKQWFTYAMIGVNKYVELLHKQLIRKGRSY
SQNATHPLYPNSYIVKKYNIKSASTAPYDKHSHGNLGLNQFFVGQDPYKPYKGDPSSKNG
IYHDICEIRTKYNLGNMQYYYGFPNNLTLLFEKEKAWKYHGKGFFY
>fig|195.2065.peg.1687 FIG00545237: hypothetical protein
AYYEDILKDILEAKPLWNGKNMQKTQCGFNQNLNSANYEIFYEVCDNKISFVDRISRIKI
VLMNFKDKI
>fig|195.2065.peg.696 Membrane protein
MAFMSFSGFFYARNDLRLFKIEKKSEIKSFFYKDYTLASFKDELNLN
>fig|195.2065.peg.1566 tRNA (uracil(54)-C5)-methyltransferase (EC 2.1.1.35) @ tmRNA (uracil(341)-C5)-methyltransferase
MSLQEFGNFLKLEEKASFIKEFFKDFYQGNFELFSSKDKHYRTRAELSFYHENDTLFYAM
FDPKSKKKYIIEYLDFADEKICAFMPKLLEYLHQDNKLKEKLFGVEFLATKNELSTTLLY
HKNIELIYNDLNNLSLELDANLIARSKGKKLVFKKENLRQELDIQGRKIFYEFNNDCFIQ
PNTSINEKMITWVCENLKTQERKDLLELYCGYGNFTLALAIFFNNVLATEISKSNINFAL
LNCKINNISNIHFTRLSSEELSRALKKEREFFRLKDIDLDNFNFSHILVDPPRAGLDKSV
IDLIKNYENIIYISCNPISLKENLKELALTHKVEKFALFDQFVNTPHLECGVLLKSLHSK
QSSI
>fig|195.2065.peg.1229 Dihydroneopterin aldolase (EC 4.1.2.25)
MQSHINIKMQFKCIIGILKFERKKKQKVCIYLTAKANDFLDYAKVSKKIKKYYKKEQFLT
LEESLE
>fig|195.2065.peg.810 ATP/GTP-binding protein
MKELLQKLWQNELQLLDFNASFKDKNILDVSELAIILSVNKDNYERYFLLKEFSNICKKI
DLRVDIFSIQKAQICVLNMFREGFIPKQDLLKALRILQKISNNAEILEYIQNIQVQSIDK
KALFQSGFNELNHINMELSQLSFDENSKIRLQKTLEKFQKLEFNIAITGVMNSGKSSLLN
ALLKEDFLGVSNIPETANLTLLSYGNTQEAVIYFWDTQEWDNILKSSKFSKELKEFIDEL
ALKIDIKEYVQDKALTQKINLKELKEFSSAKNQISALIKKIEIKSNLEFLKNNISIVDTP
GLDDIVVQREILTNEYLKESDFLIHLMNASQALTQKDAEFLIHCLLNSRLGKFLIVLTKA
DLLSQKDLDEVINYTKESLKARLENFDTHLIEKIDFLCVSAKMASDFYKGLSSEESFKKS
GMKEFEEYLFNELYSGEKSKIILQAYKKELLLELRNILNEYEMQNKLIKEDGQGLSEEND
KLLLEFKAKEEALKEAKEEISNSILNLENFENGVDNLVLLLAKKLKERLIDEIKYLKDKA
QKININRILNMIDITVKDGINDILREVK
>fig|195.2065.peg.736 FIG00710232: hypothetical protein
IRNHAVHAKSPTLEQTLKIRNLILGIENTSILKRVLEYKFKQKG
>fig|195.2065.peg.1736 phage repressor protein, putative
MEKGTFNYKLIKSKMREKNITNQYLADYITLHDEKNKRTTVEAIKSWFRSDDNSRTVPEI
HKLKYISELLELDANSLLNFENKNTKEEVFFRYFPDIYASAGLGTSSQSEEVKIVSVDEN
FLKEILDIPIKKSYDIIKINGDSMEPILSNGDFIIIDRSKNSLGAISNADIVIFRKNDDL
FCKKIKKEPFEDYIFLVSENKKYEDKKVDNSEFEQCEILGAVVSKMAVETFKNFIEVVG
>fig|195.2065.peg.1442 hypothetical protein
YWDNIVLLCKQENKESVEYFLSEIFSLEMNDINLILSQLGQFKNSTNKRLECLDVKLTLN
>fig|195.2065.peg.1547 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIRTISDT
ATNQISQLKNTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITEQINGAKTQLNSKIDNKVTKTGDETIAGVKTFSVPPVSATNPTANNQ
VANKSYVDTVGNSKVALSGNQTIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVA
LSGNQTIAGVKTFSAPPVSATNPTANNQVANKSYVDTVVNTVGNSKVALSGNQTIAGVKT
FNAAPVCSANPTEDAQLARKWYVDYGGGIKNLGNQTAPKIDLRQAQHFILTMTARGAIGI
ANWGGAGKSGTITVNNAQNITAFSAPFKFRVAQSGFSGTETFAYFCIASNNVRLVRT
>fig|195.2065.peg.1780 formyl transferase domain protein
MQEFGTYGKMIKTGITWHMVEESIDTGAILTQKEIKLDDNFTALSLLDTQHKLAIASFKE
ALKNLENKIFKIQTLGAGYHKKLALPNEGYLDLTWDKEKISRFLRAMDCGTLSGVPKARL
KILGEEKEILFYEINELDLILNLSDNTILKITKE
>fig|195.2065.peg.541 Possible sugar transferase
MEQILKILKQMLSPDQAQILLKALKNSNNENFYNFALENIEIICEWLNSKEFQENYTNHP
YPPLLNPNYIDTDASRHCAELAWDLNLPLPKHYKFIYISPHGVGAAAFLRYLNEACNVFC
LASWMLPYDAKERYCINYMCLNDKNISDQAINISELNIINLEKYLALLDPHSKVICGIRD
PIGILKHNWGRDWSKVQRNFQNEFDLTYDYRNYINFLNHKKPEIKINLEELNYSVFIINY
LSKYFNQEYI
>fig|195.2065.peg.1197 hypothetical protein
MESRDKLILFIAIALIIGGCWSFGNFLIHNENIEKIKSQNENAKIIAEIAKNKELQNACN
APKTTLVKILKDDEKASFSLGNDVITNQNKEDYNFKEIEDTTQTEDTEGDFKILGFEKTN
DRKKFKIILGGKTHWANADIIDVNARMKLAKSSIQEQEVKLKLRIVKEYNKIKEIVILNV
E
>fig|195.2065.peg.1763 Membrane protein
MSRFFLYLLIILILALITFALREKLGKKTKPFFGILLVIFIVLAVFFEFENTQKSHLRTD
II
>fig|195.2065.peg.1708 Hypothetical protein Cj1505c
MRIDCRNLECPKPIVETKKALQNLQNNEILEIVLNSVISKNNVLKFLTSLNLHADIEQNN
IEFYI
>fig|195.2065.peg.619 Translation elongation factor LepA
MKLVKCKIENFRSYKNIEFKFSDLSVIIGKNDVGKSTLFDALDIFFENNKALEDDVNINS
SENKFSITCFFQVESEMQINIDASESERTQTSLESEYLLNQEKLLQIKKIWEKGKLSKIY
LVCNYPTNWEKPLIVSKIQELKKLLPEDAKVRLDIKKEIRKFLFSQEKLNFTEQEIDIST
KDTDIVSIYNKLKEKMPKFLLFKADRTNTDKDNEITQITNITSKELSSLFSYEFKSDNGV
SFNKRGSGVKRLFLLSFFLEDAERKRQSNMIYAIEEPETSQHPNYQRIIIESLKKLAQNK
GRQILLTTHTPEIARMVNKENIIFIQKDNKDKRIVYHGDEIDIEILVDALSIIVPNSKAL
SKGRELVKAMKEIVPRQLFEVAIQASIGNKIIARENVKSMGKNVTAKCYGGDITRKRKLL
EKQKEGKKRMKAIGKVHLPQEAFLSVLKID
>fig|195.2065.peg.1667 CAAX amino terminal protease family protein
MILTFILLALALALLSFKKIKLSFVALVISGFLAYYHNIIEISFIVFVGVFFLLSLYYKN
NKNVFLELLIVAFCLLLFLHFIPGVNNVKILDKVHASEHSSAFTLYFSFDKPLGVFTLFA
YAKFV
>fig|195.2065.peg.1778 Beta-1,3-glucosyltransferase
TGDDKDIASIRIDNEVIYADYEKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEVLINNEQ
GMVGKYGEYFLDVKNIRKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEREIV
FALRKESSDWERLEKEGFSLVEFGSFEFERIIKKSSKVISSHADDYLMKYITLRQQFVFL
QHGVTKDDVSRWLNSKKINLFITSTQAEYDSIANNYNRYKFGKKEVLLTGFARHDVLLKN
NKSDTKQILIMPTWRVNIVGASINSGARELKENFKQSEYFQKWNSLLNSDNLKKLCKLYS
YTIVFNPHPNIMPYLKEFNLPSYIKIANQDESLQVLFCNSSLMITDYSSVAFEMAYLNKP
VIYYQFDKEEFFLSHSYTMGYFSYEKNGFGPVVENEENLLKELEILLQNNCKSFSVHKDN
IDSTFVFRDGKCCERIYKNILISTKNRNTVEIILELQEKRHFKEAYIEWKNFINKMQFDN
SNYLYNFLYCARKSGYSDDALNHILLPDFRVLNPKIRIEIIKNLILNQNYEVIFN
>fig|195.2065.peg.1154 hypothetical protein
MSKILLEKLDDHFFCDDFGEDIYFQKEYAKFYGKVFEFVYKENGNFLKIVANKKSIKNTS
FFDLQSPYGYGGIYSNSMDKAFLTRALENLRQRALKENIVAFFIRFHPFDKNLSFYEKKL
DFFLKERKIVIVPIYKNLEQIRANYSPRIKTYVKKARKELEISKAKASDAKDFKRLYDET
MRRNQAGEFYFFDDDYFKELFNFKQSLILKASYRGEILAYASFFLGKKFAYYHLSANKNE
KNANAALLDFSFELCLNKNIDFILLGGGVKDDDNLFYFKQKFSTLESFFYIGGIVFDALN
YKKFCKDYKNNFFLKYRNGGGVVIFTIFIWSKNEIL
>fig|195.2065.peg.262 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYAIISAVYNVEK
YLDDYFKSIINQRLDFKKNIFMVLVDDGSTDNSANIIKKYQKKYPKNIVYLYKENGGQAS
ARNLGLKYMQENNYKTPWVTFTAVSYTHMNLPTN
>fig|195.2065.peg.1480 DNA primase (EC 2.7.7.-)
EKDEEKLETLFKNLHKFFSTKNLNIKNLKSNCENNNDEEPF
>fig|195.2065.peg.190 hypothetical protein
LYYNLTQLILQWTSVRNNEIERDG
>fig|195.2065.peg.1467 FIG00638667: hypothetical protein
MKKLLIIPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPYYEIKNINFHKGFLNSKADFT
IEDKYNLGLISKLDFKFNNNYFSKFI
>fig|195.2065.peg.1441 ATP/GTP-binding protein
NIKKIEELKTSLALKYDFLKDDFDNGFEGFKDEISKKIENIFSDEKFALLRLQIEQIIST
KVDLFELETKLTEVIFSTFESFNIGAILKDLDINGAFFAFLNERMKNYEVLQKEKLASIE
HLINNLKNQNADILFSYEGNLEKIAKLQQLEVELMNAN
>fig|195.2065.peg.1709 hypothetical protein
MQNLLILYNPYYQQDVIKLHLEILLDKGQVAFGKIKSKLKEPLSYERDENKISHNQKLSE
IYKNTSADNPLQLFLSDYANLFVAKVVKISKEVDKNIIPKYYQEKNLEVEDYFLITDLRE
LVRENFTLIRDKFLANFTTENNHTYAIYGNNYSYPLVVKQKEEINYFYDEINKYYLSVYK
NQEYLKMQENFIQFIFGKKFFYMLHPDSINNLILAELELQQNLENPLYDFTSIIVKYSKT
IEYEIYDFAKKIFTKLIKQNSHLSSISYSIQGKEFN
>fig|195.2065.peg.1654 Adenine-specific DNA methyltransferase
MDIFKKYTSEIQAIFEGKNYNEHSFRTCFENLLNELKPKEVKIIHEPKSEKGQGSIRPDF
KTYKLIDKEKELSYNHLVGFIECKNLDVDLNLHLKGKQLSKYLQISPNIIFTNYKRFILF
SFEKVVFDIDLLDDKLDLKEENISIFRNLLKAYFDDNSTTIKSKQELVKVLSTQSFYLSN
ALKI
>fig|195.2065.peg.1155 hypothetical protein
MKKYISNEEISNNLGSNEKIWEQIFSKKEWGKYPSENVIRFIARNFYNVQDRSKINILEL
GFGTGANLWFCAKEGFSVSGIEWSKTGLERFKARMKDENLSDKIKQIELGDYIDKLDSFK
DDSFDAIIDVASLCCNDREKSKNIFTKAVRKLKKGGKFYSSALSKQVFGYEADKGDFFEP
NHGIYIKMGSLRFDDEKSLKELYKELKCINFYTQTLKDKQSIKEEILIFEGEKSSTEAMG
GGIIKNKALENE
>fig|195.2065.peg.1715 Membrane protein
IKFMEKIKNYKLIILLLAFDLLALLYGISTLSISVDEAKIYFEEKGSFLFFNHSLLYYLT
HFGTFVFGQNDFGLRIPILFFHFLSCILLYILALKYTKTHFDSFLSLLLFVLLPGTVASA
LLVNEASIVIFLTLAIICAYEYEKKWIFYPLLILALFVDKSFNILFLTFFFFGIYKRNSF
LLTLALVLFGLSISFYGFDTGGRPRGYFLDTLGIFAACFSPLVFIYFFYVVYRLTFKEQK
SLLWFLMSVTFIFCSLLSLRQKLYLEDFLPFCVICTPLLIKTLMASYRVRLPQFRLRYKI
FIECSIIFLLFCYFVIIGNQILYYFVSDPKYNFANNYHLAKELSKELKKQEIFKLRVGTS
LQPRLKFYGIEDSNTFYLKSIKNKDQLDKNKKNITIKLGKFEKIYQIQRY
>fig|195.2065.peg.1249 putative membrane protein
SRKEKFIPYSFFCFVLMVISAIANLLEGIEQKESIFWYYKAFLDVGVCLIYLLFLDKFFQ
SHLFKIFFVCACLCTILTKFKFMDFTTPFVLPIYLFILLILMRKKSFNV
>fig|195.2065.peg.1515 Dihydroneopterin aldolase (EC 4.1.2.25)
LEESLEFVCAKLHRKFPQIYYIKIKTYKPEIIKNARVGVKLKKFY
>fig|195.2065.peg.1764 Membrane protein
KNILCKDINISKAYFNYEFGTGSFISKDNNQSFNSLIIDIRDCRLNDE
>fig|195.2065.peg.1311 Motility accessory factor
MDGKGEKVRKKEINFEKNIKALSGSEYDNLRKKLQDLKELKHFSFTQGKDNLDINIIKKR
NLKKMYQDPIKELEKNLEYFKDFTRYPVLFFYGFGNGILYKILLQNQALKRIIIFEKELE
LIFLALNFIDFSKDLSLGRLIILHHDDINLPKMDKVFRLIGDLFYRSYNLHIANDFYEHY
KEDILKLNKLNMQIIKNHNLMRGNDPKDAMQGIEQFVYNLPQMITHPSYKELLSKRKGIS
DTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVCMLERDEIVAEC
FNNDFGELDKDIIFLIASLVHKKTISYLEKNQRKYILIIKGQPFARYLELDDYGYINAGM
SVSHMAYELAENLGHKNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDRFSTTAY
GGNGKVQSSEIWTLFRQIFENFIAFSKSKTYNCTEGGARIESAIEKPFKELCEDLLENKK
DKKFKKLQVLNTKEQVKLGLKIYQKIKKNMNLSLNFKKECKKVQKQIHNLTHGKNKLSLE
QINQNIDKIKEKLSNKKYLFLQEILGPTLHHEQSILTPLYLKNIKDESDKQNKLFAWVYA
HEALMENIIELLEAQDKRLKIAILPLQDFLEKKKAL
>fig|195.2065.peg.1454 FIG00470160: hypothetical protein
IEIEKIKETKLFNENKDKFEIFKKSKKAFKKIS
>fig|195.2065.peg.1624 hypothetical protein
TKSSEKLINDISEYVGKFNTELSTHNEKINTQLIEGLNSASASINSQIKTLDQELENVLK
NLGSNLASISTKFVDDYNTILSNLSSLNQKMSNLR
>fig|195.2065.peg.1295 Protein hydE
FRKNHNLDFNDFKIRLARDLFCFALGLKLFENEYKFLSVKKIEEYQKDFYISALDEQVVV
LEGFEFINAKARELIFSKEDKNMARISYLVSRYKEKAFILELSKDDEDILLINKELNLLK
LCLPKHSKELYEEIQKDEIGARLLENFAKEFPLLNESFELKNNFYSLLCLVGRVLNLDEN
LHKAGEKLLKIADESKMPRGVKIDYRLKEDKSFDYTRTLRSTMSFMLAGVDSANIAYGAV
ESLAYFLRDTYDDLREKKQSEMALISGSLFEHKALLRNTLKHLKNCQLSDAPLRI
>fig|195.2065.peg.1337 Glycerate kinase (EC 2.7.1.31)
MADFNIFKNKYKQYEDTLKNTSYDKTNNEYLCLKENTVINFENLSL
>fig|195.2065.peg.1733 FIG00472875: hypothetical protein
MDDKDLNLLKNIPYLMEKIKELENRIKQLEQAVQPKHTLPTQNPNYLGEI
>fig|195.2065.peg.1787 hypothetical protein
MFKKLLSVVALGTLLSSSAFAEDILAKVSNGAISDNSAGVKVLSLNEMKDVKGGVYFYRD
PSYDFHGAIPSYAYVATENGSESGSYLTAQKMGIDSGRIVLGKIRYVNNQKDYYLQSYEK
STGTLRDIWAWNGSYALQVLNDFKSRY
>fig|195.2065.peg.1668 CAAX amino terminal protease family protein
MPSLFENLNRIKPKLFQAALLFASPFLLLSIPWYLGVIKMEIGFPSWIVYFLFSNLFLVA
LVEEAFFRGYLQQRLQGLIGGVGALLVASLAFGAAHYKAGSLMIIFASLAGLIYGMAWRY
SKSLWLSVFFHYGLNLTHLFFFTYPSYVK
>fig|195.2065.peg.1379 hypothetical protein
MEKFQSPKIIKNTSAILNDLMSKSHYRPLKTLFFCKDFLNSFPPAKQRLIARIYIKNHIL
NIVTLNSAAYQELNHDNSKIYIKVLIKKYGKMYPLSGFSDIKDLKIFTQKYN
>fig|195.2065.peg.869 Uncharacterized membrane-anchored protein HP0586
MKKKIVYALLVLIVFISVVFLVLKNGILISHIQFSFLNLEQLYIKLDKKLIVRAKNITFN
EDNNASIQDDKNVNSDFASKELLNITKNLKYLYTFVEEIDIQNFNIKDNHMRI
>fig|195.2065.peg.290 Transmembrane protein YfcA
MGFEHLDTIYYFVLFFVALFAGFIDSIVGGGGLITLPALIACGIPAHLSLATNKLQSVFG
SFTATLTYFKSTTLPHLAYGIFFTALGAAIGSYSVLFVKDEHLKLIILIFLTLTFLYTAL
RPSLGKHESEAKIKNIKFFI
>fig|195.2065.peg.1718 Cytosol aminopeptidase PepA (EC 3.4.11.1)
MIFELSDKKIHGIKADFELVFIQDKNLKPFTNEKDFFKLNNYTYEVIILDLYNKRLF
>fig|195.2065.peg.772 Putative transcriptional regulator
MQEYLDFLKGIGKIRKFEKNNILFFEGEKALKFFILLKGRVRVYKSTAGEKEITLHYFTP
PNFIAEMPTFKRLRYPANAICEEYCEILEIDFEDFETLCSQNKEFNFLLIS
>fig|195.2065.peg.1783 Motility accessory factor
IVSHGNDPLDTLQGIEQFVYNLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSLTKQLPL
LKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNHDFGEFDNGICFIIKS
IVHPNAINYLTKKTDNFTIVSTYASFIQYLKLDYFGYFNMGFSVAHMACYLSLHLNHKNI
IFIGQDLAYAENGNSHPDDYQNSANYESQTYEHILTEAYGGKEKIKTHHVWLMFKRNLEQ
DVQKIQKYLDTKVYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNE
FLLKAYYKVCKSIKHCRDFNDNFIKVYDKIKNSFTSLQNSQKNEIFIQEIIQDIDKT
>fig|195.2065.peg.1619 Permease of the drug/metabolite transporter (DMT) superfamily
MVLLGGIFWAISGVLAEYLFKNNYGVDWVSFYRLFCTGIVLILYSLKKIKIFQFKKDELL
SFLIFAFFGLLMTQYGYFKAIFYTDAGTATMIQYCAPLLIMIYVC
>fig|195.2065.peg.1693 Putative periplasmic protein
YRISFYEDYYTKNYQFKGDKILYVKIDSKGKMKILAEQ
>fig|195.2065.peg.842 hypothetical protein
ILSTFNLKKLLLNHQNFLYYLARILFYCFGLAPNFYFNAIKFEL
>fig|195.2065.peg.1676 membrane protein
MSNLNFHQMFEIQRQNDFKSIKKLAWVVFISFLLCVCFQFLPIILDFAYDLKLLKFNSNT
NILAMVFNAIFLISYLIMILKLYFVSQSKVLLISFFIAAFLSLNYLIASPVVDKILRIFL
YGFSFLCLAIAIFC
>fig|195.2065.peg.1779 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
NNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKEEGKYHEFAKILRK
HNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQDRLMWLYKEAMKE
FLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAFLEVHNKELFLKNA
LVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPIQICEFIMYSLPLQ
EMLSKSSKVLRVIDYACGAGHFLNTYANELKRYLTEDELKEYYKNIYGIEKEYRLSKVSK
VSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLLIANPPYSVKGFLE
TLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILND
>fig|195.2065.peg.1101 Phosphoglycerol transferase-like protein
MRKILLQILIFSVLFIVAFTINRILMQNSFIPTGLISDKNEIFLMYLLGVFHDIRFLSAA
FLPFLLCGFLSLIFSNIKINNKLLIYSKNFYFIFSSVYIIVLSCLCIGFSYAKYYYYEIY
KTKFDIFMFTLKDDNAKTILR
>fig|195.2065.peg.1000 hypothetical protein
MPTNKQIGEKIFDKCTEIYEILNNDKEAEAKEKLFYLLDEIQDKALYPPILNHLIRQFGL
YPYMNQDTSILEDKFLLECFKTDIGEDEPKVLHREQSRVLKRLLSNESLILSAPTSFGKS
FIIDALIAMKKPKNILIIVPTISLLDEARRRLVRKFYNYNITTTTQQTNLENNNIFIFSP
ERAVEYFSFINKENIRLDFFIVDEFYKISKDYENERFAPLQNAILKYTSISDQRYYICPN
IDKIKNENSILCKGMKFECLDFNTVFIHINKCYKNKDFEKEEKILEIVKKDEKTLVYTQS
QSNIKKVCEILVENTIIENSNALLENFAKWLSKYYGEHYLNDTLKIGVGIHHGRLHRCLS
QLQVRLFEGKDLLKTIVSTSSLIEGVNIPAKNLILWDKKNGAKNINHFTYKNIIGRSGRM
FKYFIGEVYLFESPNEDDNQEKILDVEIKSESLSINDEINNEIPDNIQVEVEN
>fig|195.2065.peg.1655 Putative periplasmic protein
IEGVDIVDDSHIVVENDNNFPYSSSREPNKTDDNEFILLEVKDFLKSK
>fig|195.2065.peg.1585 hypothetical protein
ILSRIASIREFHCKNIGDINTVELVKKLSQNWTKSLPELIKDMRIDLDDFFKFENHVAFK
IASLFSDINTLQKILYPEKEIDISSFVTKLSNVFLPSVVYTLEEFGLPRIISKKLHECGF
INFENKELTLEQALDKFKEYTADDIINILKEKNLYDDFEDYILNYFYEGLGQ
>fig|195.2065.peg.1294 Glycerate kinase (EC 2.7.1.31)
SLENNKGVKKVDALFCQADKIFLVEFKNQKQSNIEKQEIVQKFEDSVTLLKRLFQENNIA
FKNYIINLYLVIKDGNNYQTYKNRQKGSEIEHAIKARDSLKNFEIKCAPRKSFLPIYEKI
FSARCEI
>fig|195.2065.peg.610 Flagellar hook-length control protein FliK
MSNLTPSNDILNLTPSKTNTTHSSSSKTKEQDLKKSDNTTQDDTESFLNSLLNSIEETNE
FLPDHMKISKKEVVNEAMDKLQNGVFSESDKISIFESASFMQILSLLDKLKADTADIKLA
NLSTQLSQLVKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNLDKA
NFFKGAVDNVFKEIINNKLAHISKNLNQNVQNLNHTPHANLSQNSKMTKKDDTSLLSQTL
KNLDAIISSKKEKNEVKNDNVKIQTDGETAELKNTSKNLTHSESLKELEQENLTNNDKKI
PSQEVQNKEQSKESKNDKNTLLNESLKKDDKELKNANKANVQDLTPSKNNTTQDKLPMQD
KVLIQEKPLNNKEGLNQETNNIKNTNFNKTSNKENVRDSQNLSLNLSPKDLNLNKDNTNF
THYTNKENYTQEQGKIQSENTEKNPLDDLNSLVKDLNKISQNNTKNITPKETLQHFSQDL
KAAMEQYKAPITKLSITLNPHNLGEVEVTLIQRGNNLHINFNSNTNAMNLFIQNQAEFKN
SLVNMGFTGLEMNFSDQGKREQNQNQGKNRSGYGFKDALDGKNESEKVNLELVLAKYF
>fig|195.2065.peg.1746 hypothetical protein
LKEFGLSKESRFILAKEQVSKIKFEISLEETQKFTKSKKEKINKLISNNTDCIKKLIMEV
CSKNEKPEKIDLFKDIFKDKIKVNINKNNAINLESIGEKLIETLQKNKNNLDNILKK
>fig|195.2065.peg.1735 hypothetical protein
MDFLNLTNKLKKHYSYETIKKIRINKMVPSFKKQIEFKKLYGIPHEFWVDVRSNLINIPK
RGRKRKDRE
>fig|195.2065.peg.1616 hypothetical protein
DIDFGFSISCSRPAHYFRDYLPFLFALPYTKKIDDFDSFFILNEHKCLLSKDKKVFINPF
DIKLQQDGYQEIFRNQLQEKIYNETPKATLDRKYDLVLWFCIGSEHRVWLNQTIGIVNIL
TEFAKYYNSILVYFDGMTAYSNGQYEQLLSKKDQKIYFDIVEEITKMKLNNKINMVFLGG
QTYFQKIALCKNVNICYVPHGTATVVPEICKIPGIAYWNGGLNNDRTPPNRKQLISASCS
EQYFLSVGCNDDIYKRNYHIPWEYLFNLSLDLLHNESIKKINIPEMIEVKFEWFFRNIDL
INKQCSTIEKIYRLALLFEDIKEIEAYNILINKIMSKLDKELQEINKIKQVKYKEKIKTK
SSEIDKQIFYLEKKSQDKTTQIKSLQANIKDNEAKLVQIQNLNNTLNNTIKEKDQLINSK
STQLNQIQSKLSFQTKYGTAKARIQNQLSYKLGQAMIVNSKSILGYLIMPMVLLSIMISH
KQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKFKNHLSYKLGEALIKASNNWYGGGVYQ
TVV
>fig|195.2065.peg.1577 hypothetical protein
MYELPILIFKNLSGHILEGTIIIIFFFLLFLFLLYKRKSLHKSSTSLLITIGICFTFYGI
SKGLANFDANNIEENLPQLIDGIKTAFLVSVEAVFFAILLKVIALFMEKPFSNQDEIEED
VGIEDIIILQKENIKISQETLETFNQSLKATKEINDNIKLLRADNEQGFVNIKNSFEGFA
KTMTENNSKAFIQALEEVIKDFNNKITEQFGDNFKQLNLA
>fig|195.2065.peg.1610 hypothetical protein
MTAYVHIGTEKTGSTSIQFFLYSNRRLLQRQNMIYPISIGNYSSQWNFTFLAYNNLR
>fig|195.2065.peg.620 Putative type IIS restriction /modification enzyme, N-terminal half
MKYLTGVLNSKLIAFWLKHKGKIQGNLFKIDKEPLLNIPVVNINSKNEKLANKLISLVDE
ILKAKEQDKNANTQELENKINSIVYKLYNLTEEEIKIIENKE
>fig|195.2065.peg.1526 FIG00469585: hypothetical protein
QKYNNTIKNNENFTAKKPYIELSLGKFENKFENKILAKKFEEIRQMIRNG
>fig|195.2065.peg.1752 hypothetical protein
MLPAFKASFEVANYSPSVEYLSEGGLYSGVFRKAFLYEKIASDGGNNTFICFEFLTRKEQ
KLAIFNLFVAKNNDFSYMGKNGEKENYLGFRQLNAIMKFFGIDELDFSEKGNENVFGVQT
EVIYLNSLVNKLLVLGFGTEEYLSKNGELANKIFLDRIFNEKMQSMD
>fig|195.2066.peg.1294 Putative periplasmic protein
MKKGILIASALLTGSMLLADSVKLQGTIAEVYDNNKTLLIDSIYGGQMAVRILPNTEIDM
DNCGIFGMDKHGKFKDLKVGDFL
>fig|195.2066.peg.1795 Motility accessory factor
FFYQSILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSVLDLSEEL
CSGKIYLVDIEEERVDIQLLILFDMKDMFEYLSLYEMFVNNVYYKKFYEDIWHKADELCE
KNIEVIVRNLNSSLHIAFECYSHLLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSL
AKQLSLLKAYQDKAVIFCADGALSMLEKEGIIPDYVTNLDCRDLAMKFFQNKENKTSLNV
LSCATHPSLVHFLDNKSVVLRDDPLYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNII
MIGQDLAFDEEGNSHSKGFSYGEQFSGEKTVPTLKAQAYAGKGEVLTHITWNDYRIKLEY
LFACNEQKAKFYNATEGGA
>fig|195.2066.peg.1517 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLMESDFLEKIPFIDEVLIYKD
DFLEKIQSKNPVIFITTRRQGLYFKKLKFLNVQKCIVFPHLI
>fig|195.2066.peg.1 Transcriptional regulator
IMQEYLDFLKGIGKIRKFEKNNILFFEGEKALKFFILLKGRVRVYKSTAGEKEITLHYFT
PPNFIAEMPTFKRLRYPANAICEEYCEILEIDFEDFETLCSQNKEFNFLLISSLFEKIKI
LEKKLLENSLDLKSKLARYLLENEKNLAQISQRQIAVDLSVRAESLSRILKEFKNSELIE
TKKGKIEILDKEGLKKGLW
>fig|195.2066.peg.1295 FIG00638667: hypothetical protein
MKKLLIMPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPY
>fig|195.2066.peg.1615 FIG00470019: hypothetical protein
MKNLELRIFRFDKQKDYEAYYK
>fig|195.2066.peg.238 Fe2+ ABC transporter, substrate binding protein
MSIYFVHFLSSILPLSILMAFITPDKRYIFKSFLALFLGFLFGYFAFFIAAQFLKTENLI
FNFNFIFIACLLLSFVFYFWQKIEILSFILLGNLSFCIALHYYNLTQDFPIFNGVLIDSE
AISSLGFIALALLICILIFFFLKWQKNIN
>fig|195.2066.peg.1788 Motility accessory factor
ITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVY
QSIKHCRDFNDNFIKVYDKIKNSFTSLQNSQKNEIFIQEIIQDIDKTKTQIDELYNTQKD
LIQILGPLLTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHIKAQENALI
KNILPLEEKLKERKLDKWMERVRK
>fig|195.2066.peg.1729 Probable integral membrane protein Cj0851c
MENKKAFFIILCLIHVLFYCILVIFKWINLNIILSYEFAFFSILLIVFTSYSNYKKFILA
QAKNHQKDFIYPSLFYIKKIEK
>fig|195.2066.peg.637 putative membrane protein
LKSSLFKKIIYSIIGENKGEQVQYFFVFLIIIFLFIVFMLIMRYEKKLELLNQSIQNIKE
EVNELKNTTQNNRSLIEKNRSDIESINK
>fig|195.2066.peg.947 hypothetical protein
DLNFLLGVRNKIALKVHNYMQEYSTSPKDLSLICLREHKHIEFFQRFYKALAYFVAFRKK
LNEEQKIKNLISNINDCFGCHFINSDFNNLQNFQKNDFFTLPEKCLQYFHLAMIHLCFMV
LNPLNFKDSNQHLDKAINYLVDGTFEIYELIFKEYFLLFPKDEELKDELKKIKNLEFKIL
MQEVSRVKLLNHYKEFCEEIFYNIELEKII
>fig|195.2066.peg.1724 Cytosol nonspecific dipeptidase (EC 3.4.13.18)
MRHHRKKQELLCASIGPNIHNPHSTDEHCEITSVEKISRVVFEVLKDNA
>fig|195.2066.peg.1688 formyl transferase domain protein
MHIFGVYGKTIKKTGITWHMVKESIDTGDILVQKEIKLDNNCTALSLLNAQHKLALTLFR
EALEILKNKAFKMQISGGGYHKKLSLPNNGYLDLT
>fig|195.2066.peg.1671 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLY
>fig|195.2066.peg.1739 hypothetical protein
MQNQDKFLKQFKKLALLDKNIRLV
>fig|195.2066.peg.1560 hypothetical protein
MGNYDLPLIWTADFILDNDEKGNDKYVLGEINCSCVG
>fig|195.2066.peg.329 hypothetical protein
MQGGILNSDNQKGNLLVDGKVTNSEVSVYEKSDVATIRLSGGTNQSFGGVVHIDDHIDKT
GSVNSAANININNNKNHGISTDTQNTTDTQDHSWAGGTINLNSSISKIKNGISKVTGSDS
TSNQPSNQPSKSDGPYINESTQTTRL
>fig|195.2066.peg.1800 Motility accessory factor
ALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLIKQLPLLKKYANKATI
FCADSSYPILAKHGIKPDYVCMLERTEITAEFFNNDFGEFDKDIIFICAGVVHPKAIEYL
KGRNLVITQKVLAFPYYINLKDFSYAAVGLSVAHTLSYLATYLSHKNIIFIGQDLAYAEN
GNSHPDDYQNSANYESQMYEHILTTAYGGNGKVETHSIWLLFKNWFENEMIPNTRKMGIT
TYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEP
>fig|195.2066.peg.553 FIG00438569: hypothetical protein
ITCFKEYSKCLKDKGTILNEKELNKNLIYAYNQACGSGTKEICLDHYDLDHEYIKPLIDF
LKA
>fig|195.2066.peg.1155 hypothetical protein
MNYQQLECDYFNLYNQFISVDFQ
>fig|195.2067.peg.1445 hypothetical protein
MLFEKTILKELKVLYKLDNYHGIFAVLWDYLQIILTIAISCFMHNIFMYLFAVLFIGTRQ
RALATILHESAHRILAKNRKLNDFLGKYPSGYLIFQTFEKYRQSHVIKHHGFLGIENKDP
DYDFYIQSKLFASRSLKEFIFRHLILPLFLGKTFDFISYLIRNRLGDFKDKEIKYLILFW
IAIFGICFYVNVLDILLMYWFVPLLTSFPMVGHFIEMAEHFPIIKNKREIEKSWNRFGNK
IELFFTGLHKENYHLIHHLFANIPFWNLDKAHIWNLDKAHNILCKNEEYRLLNSNMGGIF
SSSNKASSLWKKIIKKELKIC
>fig|195.2067.peg.1775 Motility accessory factor
LNTNKLEIQDYNELCSSKPFFQFSRIYFLELMSHYYERFHEDILGLNKKLAENFKNSIVS
HGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLLKK
YANKATIFCADSSYPILAKHGIKPDYVCMLERTEITSEFFNNDFGEFDNGICFIIKSIVH
PNAINYLTKKTDNFTIVSTYASFIQYLKLDYFGYFNMGFSVAHMACYLSLHLNHKNIIFI
GQDLAYAENGNSHPDDYQNSANYESQTYEHILTEAYGGKEKIKTHHVWLMFKRNLEQDVQ
KIQKYLDTKVYNCTEGGARIEGTIEKPFLWACENLLDKNLNKPFEKLEPLSLNKQNEFLL
KAYYKVCKSIKHCRDFSKILSNDFNNIQNIYLNLNKKENDLNLAIRKIDEFKNKLENIKQ
MQDLYEILSPLRTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHIKAQEN
ALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2067.peg.1400 hypothetical protein
MIGRDFLYSIHKDKKSIYLFCENKSIIDCQSIYEELYKLEATTDFTFEELQSYQAYIFLN
STLLTGSTELPNNPFYFGELDQDNLIKQDTPSYYFSPKDESSGLGRLSIFYKNDELCLLN
YSIIENSLNIKLECLSKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNLECIH
GGKVILKSNKGKTFKDDGIPIMLESDLLNSSIVACPNTIAGVSVPCTKVVNVKGSLSQKK
VNNEYVILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEARLR
MYYKEHKYQKDNLFTNLYLNDTLYQNEQGLDKLELSKNDLFNLNDINVLNTLKQDFSKDY
EFKECEIRLGMHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENEN
IIHHRVFLAPAKMQKIGFEIAKGLDEWLDNENVCRFNVYTKDYFNANDKDMLISDNIKDD
TNTTQAHTNENYNNTQEIIPDNVIRIQTQDG
>fig|195.2067.peg.1756 hypothetical protein
NDEKIKKSKEEIEHREKNRILSHHQYLSRISLGTIIHLIKENKLQNSIMDLKNINFRNYN
QYNRNFFFENGIKLRFRNTHKVDIVLSLLQNLRNRSYHWENILKTTEKNGKHYPRLTTKI
KNTHIGVDPQKIDFFLSDLIKTFNEKILEYC
>fig|195.2067.peg.1214 Motility accessory factor
LNTNKLEIQDYNELCSSKPFFQFSRIYFLELMSHYYERFHEDVLELNKKLAENFKNSIVS
HGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKK
YASKATIFCADSSYPILAKHGIKPDYVCMLERDEIVAECFNNDFKDFDKDIIFLVASLVH
KKTISYLEKNQRKYMLIIKGQPFARYLGLDDYGYINAGMSVSHMAYELAENLGHKNIILI
GQDLAYAKDGQTHSQGFIHANLHNGDYERDLDKFSTTAYGGNGKVQSSEIWTLFRQIFEN
FIAFSKSKTYNCTEGGARIESAIEKPFKELCEDLLKNKKDKKFKKLQVLNTKEQVKLGLK
IYQKIKKNMNLSLNFKKECKKVQKQIYNLTHGKNKLSLEQINQNVDKIKEKLSNKKYLFL
QEILGPTLHHEQSILTPLYLKDIKDESDKQNKLFAWVYAHEALIENIIELLEVQDKRLKI
AILPLQDFLEKKKVL
>fig|195.2067.peg.1743 Methyl-accepting chemotaxis sensor/transducer protein
MKLSIRKKMLMLGGICLVSMLITFGIFYYNNLQGSEKIAQITKNLINKEINVKVELLTKS
MAIALGDLIKNVHSEEEKVKIIATAIENFRFEEDKSGYFFVYQKTT
>fig|195.2067.peg.1715 predicted ATP-dependent endonuclease, OLD family
MKLVKCKIENFRSYKNIEFKFSDLSVIIGKNDVGKSTLFDALDIFFENNKALEDDVNINS
SENKFSITCFFQVESEMQINIDASESERTQTSLESEYLLNQEKLLQIKKIWEKGKLSKIY
LVCNYPTNWEKPLIVSKIQELKKLLPEDAKVRLDIKKEIRKFLFSQEKLNFTEQEIDIST
KDTDIVSIYNKLKEKMPKFLLFKADRTNTDKDNEITQITKAITQNAISEIEQKFNDMKKN
ILDDIKSFANATLERLKSFDKDIVKDLTPDITSKELSSLFSYEFKSDNGISFNKRGSGVK
RLFLLSFFLEDAERKRQSNMIYAIEEPETSQHPNYQKIVIESLQKLAQNQGRQILITTHT
PEIVRMVNKENIIFIQKDDEDRRIVYHGDEIYTKVLADTLGILPYLLYQRVLFVEGETDV
KFLNNLNNKFECLRNIFDLKTITLIPLRGGGNVKNWIREDYLKQSNVKCLYFLDRDEDRR
DVDEQNLIRTKKREIENYYPVDILEEYFKNKLGADFVFSDNFKNNWDNEDIAEYIYNCKP
KKYKKECIKLMFANKEIWDKINENNMQNFDEIKEWFERMKEFFK
>fig|195.2067.peg.1594 hypothetical protein
MNEEINSNENNLYELAKEDNSTNMVIQNYNELLSKFENLIKTIIAKIDIGKQNSSSNTED
GIFKDLEKNIIELDNTFLALISYFKNPPSDEEKEFINKTASIKKTMEDFAEFANEIQKLS
LDDKLKKYNEQINKFCEIVEYKLSHNAENYNSFLDHFVENGKLKLN
>fig|195.2067.peg.1711 hypothetical protein
MLKIFDFFNILQFKNINRNYRGNLGNSKTKIKNKTRL
>fig|195.2067.peg.1628 hypothetical protein
MEKYYKIKVTDVSELNEQYKEAIQEGTYEGEDVNKFFNTIKTFDVAESLLKKDFSNQYIK
FDIITDKEKIPLNIRLGDKNFEKGIEHLINIGSSKISKENINPEIKKDLNNQLGTYKPK
>fig|195.2067.peg.1714 hypothetical protein
MKETPKILEKCCEETHQNHKSESDGKETADIKEELSKVLSIDKRYIFILDAKDTEQEAIK
KIITKDELFSGNEKWYLVCGKEDSKIDILLLCDKIKDIPCNVIFNNCNICLHINKPENTE
KDYKGIIKNYLYFCNCTFDKLFKKSLNLKNIIFKKTLTFNQCVFYSDLEIYQNQFLDHLV
FINCYDKRNDKKITSLDLQENEFEGCLFIKNCAIEKINLWKNKFKNRCYFVDSNFGYKDK
DNTTK
>fig|195.2067.peg.615 hypothetical protein
MELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTAEAGLEFSKTEKISDELS
HVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTKYEDIKTQSSTGFGLYIK
ERIEATSPIASAINQSAQNAAAKNENLGVNYGIVASQALANTANIFSNNLINTTSNQTLG
FKFNQDKSQSSSENISKINAGDNLNLESTKGSIVLNGVEAKANSINIEAKDNVILNAAKS
KNSSSSSSLEIAATNKQTAGYHAVDGGTVGEGIEGFASASYSKSNETQFTNANLNANNIN
INTGKDFTLNGANVKASNDAILNVGGNLEVNSLADSLNSQKYSALLNASGTGGLSSNHLV
AGSVSGTLGIGYAKTDKTTVTTQSGISAGNEINGHVNGNLNLQGGILNSDNQKGNLLVDG
KVTNSEVSVYEKSDVAMIRLSGGTNQSFGGVVDIDDHIDKTGSVNSAANININNNKNHGI
STDTQNTTDTQDHSWAGGTINLNSSISKIKNGISKVTGSDSTSNQPSNQPSKSDGPYINE
STQTTRL
>fig|195.2067.peg.1767 hypothetical protein
MDGVIDNSGTVLPLLRYIIGRDLEQFDFIFNNPNALIEMFTKTYWTREDENSPYFFANEN
YMIRSLLNSSHLIIQVNVNKNIVLVSYHSSKDEFNTSKDKQTLFLAYKELGYDATLHLIK
DESEIDGRFIKDLNHGMRITDRALFRKELPLMLEKLQKRKSFMQENSISYPCGNKVFTFK
DVGDKFVLCIK
>fig|195.2067.peg.1068 lipopolysaccharide core biosynthesis protein LpsA
AKELEEIRTRVKYYNQINDFFTLTEREKIGKFPFKNTSYAFDAYEISKYFNDDFLWKKEF
GDVKYTFKEPAICKSRPLK
>fig|195.2067.peg.304 FIG022708: hypothetical protein
MGDIFDLLIGEISATHEFAKPYIKLLEELALKMEIIYLEGNHDFNLARFFQRVKIFNLQE
QPLKLNLHTSKGKNTDFKNSFITLAHGDIFLSPPLQFALKSLRNHYLLVFLNFLNQISFN
SISNKILKNQNKKNLFYKIENFKNLAKERYNK
>fig|195.2067.peg.1627 Tungstate ABC transporter, ATP-binding protein
MIELCNFKFNYGQKNILNIKHLCLDTDKISILMGSNGSGKSTLLRILKFLEGEFDNITYF
GNKHLNSDEKRQIYLLFPEPVFLNRSVEKNFYFLLKTYKLDSKEIKKRLNEVLNLLEIDR
SLLKKYPSELSSGQGQKIAFALALSVRAKYYLLDEPSAFLDKDTMILFKKAILYMQKTYK
SGFLIASHDKNFLDFLAQKKYYLHAGEILEFENTNIFELENKGVNFSNFIDFS
>fig|195.2067.peg.1774 hypothetical protein
KWYLIFFSFTSIGLGIALGILILLTYIKYSEYNNLKERVSTITQGLATISIDENSKGSFT
LSFAKNKKTIFNENKNSIQITLQGGK
>fig|195.2067.peg.672 hypothetical protein
MIKIIKISLSKIFNNFSKKTTQAVIRILYTFFEIKIKEKKCKPEL
>fig|195.2067.peg.1323 Transcriptional regulator, AraC family
PIVSLKFEEIFLHLLLNKNTYFIGFLAGILKEFRLDLSQLFEYCGREFVSVSEMADFAKL
DFATFSREFKKCFGQSPKKWLDEKRLQKAKVLLEFSKKNVNEIANECAFSSVAWFIERFK
EKYNQTPKQYQKSKNLYFLSKN
>fig|195.2067.peg.1229 Enterochelin uptake permease CeuC
MRKKILILAFLTLIMALVFVFAGLKDFDEYALKNRFLQIAAIVIVAICIAISFV
>fig|195.2067.peg.987 hypothetical protein
MQQVFEYYLKNDSYLKGAIDGLKKHEARAFIGNVLSYEYKNLVENGNLKVDEQYKVTLPP
NLITVLEYDKKDFEGATLKNFIDDVECELSDWEIELYDDPHFMDMMKMRRDMKMMKMMKK
>fig|195.2067.peg.305 hypothetical protein
NFGIMQAMDILNAIFYIKENSPFKLMGGGY
>fig|195.2067.peg.1612 hypothetical protein
MDIKYSYFGNTSNRVKNLLYNFETQLILFDDLFKNASKNDVWSNDSELQIRYLELLEQHN
LLKSKNKTTHLGTKDARVKSAPLENYGLIKRKEKLITEQGYELLSLIENQSYKEINDFLQ
IDLISLFFLKSSFLFQKDNVKDLFLKYIKVFRYFNGSLSRDIFYLLPLIDNFKNIESFCE
CAKNGNMINEILDNNQKFKDDLEAFLKDLQEDVIDIKYFITAKGDQSAKNIVEALK
>fig|195.2067.peg.1735 Transcriptional regulator, AraC family
MEQILSLPQDLKQLKGVDYKNFKSCTFAKYTQVSASHSSFVNVGSHLLTFVRKGYKILHT
ASKDYKIDSYETLFLKAGNYTLSNVGLSSGVYEAYLFFFDNAFLIELIYKYKDLFKLEQA
SEESEIFWVKNDKILQGILESFTPHFDENTQILDPIVSLK
>fig|195.2067.peg.1713 hypothetical protein
LKVFLDFRQRKDKAILSNFLKSKDTKYKRFKELYLGYICYKIKIDDKIEQLSHFCEGDIL
DFGKRFFRFIATSKIQSNLDDYLDLNKRHLRLTGIFDFSDDCVSVSIIFKIILKHSKSEV
ILNTIAQNTISKDMLSNYFNDNEMKLLLKEFDIITLQDLSNYKTNLDNQKLDILLKERFS
KDKICEILPLFNDRKNDEKIFNLVTTEATIPTIFEYIIAIAWCYIDNFNKNRILEAGLSL
DSEMLPKSHAVGGNADFIYHYKDHSLMIEVTLTEKTNQRRAEMESVSRHLGNLLLSLETK
VQAQSYGIFIAPYLDKNVLNDFRSRLTCYYENNTSFIYGMKILPLSVDDLKIILETNHTY
DKLLEYFYSLLGSKNTWGSKWYNNEIAPFIKGLINV
>fig|195.2067.peg.1364 FIG00470547: hypothetical protein
MKNALNAFLSFGMVDDDQIMYLWCTRNHSNNYKIIRSYEWFDALFNFIPIKIKQKLSFKR
KNSKYYKIIKEEIKNSKNKNLIYKIQLYIKYIYYKFINKK
>fig|195.2067.peg.1632 hypothetical protein
MKQEIYTSKFYISKRNGKEVCFKLDFEIKAFEENQKFYYVEIYAIIDYQYLKNEIAVIPN
TNKNRNHWILRYDFNSWNFHSSIMLHSDYRSLGIGTFVINKMLEIALNYIPTARLSGKLS
AVDEVKLENHIRRDKLYKNLGFVFNENNIGFSINSISNLKIRKDFDYIQEVRIFDMCNQL
AELQYLKAGNDKLLKIYKEDFDKEKSKNDTLRARIKLMSFVLIALAVWIVYLLK
>fig|195.2067.peg.1010 Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) in lipid-linked oligosaccharide synthesis cluster
HNEEKKILFTSSDFATKTEIIYQNYNYIHSYASFIFKREFINRYMQSCNISFKEEILLKF
PSLIIKNQNSIIKHILYSDQFIRHGNYFFKIKEYYLAYLCYNRVDEKIKKYIQINFELCK
KFKENM
>fig|195.2067.peg.1748 FIG00638667: hypothetical protein
IGQVDFSQFYAKFYLKNLDHQQKFEKPISFSNLIQFNESVEEFKFDFCEINNHTISSFYN
KNIIYFDDDNQTLKMHSQGKANNLNIDLTSQIYQSIDFDQINFDLIYSQKKPDISDDKLI
FKPSNEELNLQIQNITLKKDNQDINIKGNIFLSMQSHKARIQISSLKSPDEIFTWGQFFG
GLNQYFIKNEEGMFIMDLHYDSDAKTQLKINGNEFTDINLN
>fig|195.2067.peg.1115 Acetyltransferase, GNAT family
MNSFEKAFYEGFKLSNCYDNFNLIREKILKQELILEKHENNNFFFFNRTDGLLYYFINDL
QDYDLKACYIKILSKAPKHALHDEFLKLNHFKKILNHKQMVLNKEIKLFSYTHLTLPTIL
PFFFSFLFFFFSLFL
>fig|195.2067.peg.721 Major antigenic peptide PEB2
MKKYLFLSLVAASFLNAEVLVYGPGGPAPVMKELALKFEEKTKEKVVVTAGPTPSWFKKA
RKDADLIFSGNTSMMDGFIKRIPSLNLKDLVVLNARPSGIIVRPNNPKISKVLRIF
>fig|195.2067.peg.1396 hypothetical protein
MERLIDESKNFRIKNKNSQFERFKMKYKVLNKEHMNFYFYELGKKISKYYEMHLFLQIPN
LKKQIF
>fig|195.2067.peg.943 Methyl-accepting chemotaxis signal transduction protein
MYVTPSYLDLTTNLPCFTYATPLYKEGKFIGVLAIDILVKDLQREFENLPGRTFVFDSEN
SVFVSTDKELLKPGYDVSPVANIAKDKKDYEPFRYARPLDGTQRFGVCAKVLGEYTACVG
ESIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSKYLSPLAAIQTGLTSFFDFINHK
TKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVETVGVVESGNLTARIT
ANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTT
NALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSM
QNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVR
KLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVAQIDQTTKDNVEIAN
ESAIISSTVSDIANNILEDVKKKRF
>fig|195.2067.peg.1685 Membrane protein
MFLLDFLISLSFIFVISALVLSFYFKNSKI
>fig|195.2067.peg.1522 hypothetical protein
MENNQNKQEKLESVNIDKPIEKKEEDLFSRNSVAEQLNTIIKNYKEEDSITFGIIGDWGS
GKTSFVNMTLEDFKDDENFIIVKFNPWNISTRKKLISDFFTTLAKEIRKASFPKFKIKNL
KKYILMQNLNFYLKYLINWKIYHCYLKCHLI
>fig|195.2067.peg.1741 ABC-type tungstate transport system, ATP-binding protein
MECGGKILEFALESERFKQEKLSLYQELCLVFNEEAICFLN
>fig|195.2067.peg.722 Major antigenic peptide PEB2
MVVDGAGQVGLYEDMALKDGKRENLVKLRKNIKVYAKNSKIAIDEWNNNPNIDALIIWSH
WAKVLGDKALFIEDEKAAVYRTAEIIPTKKGLQNKQALEFVKFIQSKEAQKIWKKHAWNE
VE
>fig|195.2067.peg.1668 hypothetical protein
MDGKKILIFGFISDNFLEISSFLEKNKIKKAEIEEKISYMLNTILSSKESTRSACDFKIQ
KMYHCLLQDFNNEASKKRCYIANQNLLYIAEEWLKLDENVLFVLLYENPIEILRQKIFSN
HKFCFKDILMDWLRYNNLMLEFYSKNNNKCILMNYSNYHNSLIKYLSKHNN
>fig|195.2067.peg.1 Phosphate ABC transporter, ATP-binding protein PstB (TC 3.A.1.7.1)
MIAKTTNLNLFYGKKQALFDINMQIEQNKITALIGASGCGKSTFLRCFNRMNDKIAKIDG
LVEIEGKDVKNQDVVALRKNVGMVFQQPNVFVKSIYENISYAPKLHGMIKNKDEEEALVV
DCLQKVGLFEEVKDKLKQNALALSGGQQQRLCIARA
>fig|195.2067.peg.1770 Acetyltransferase, GNAT family
RKYFDPYLFYFSQKNLEEKIPNILVYKENEKIHAALIYTQTLNANFLDFIAVDRNLKHKN
VAFALLNHYFAANTQNKFFKLFVEEKNQKAINFYKRAGFCFNHINLKFYRNF
>fig|195.2069.peg.306 RecD-like DNA helicase YrrC
MKIYWSAETENKILKSLKIKDINKDFHLFKNNIQNIKTLKN
>fig|195.2069.peg.1753 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLRNGGGTLGDEKWAKKNIYKYNSFKEFVLDLKNIEIQNKILNWMHF
IPQYKFLCDNESNILVNFTGKFENLEEDFKKILKILNRKDQLMHINKSNHVDYKNYYN
>fig|195.2069.peg.1780 hypothetical protein
MKKKIIAINIDGFGARFAAIINAIRISKSMDLEFCFTWESRGGNKDLFHTVEDREKIFDQ
DFIKKYCLNNIDGIQVGNFKDYFINKENFDYFRSYSTMPFFNSALKEFKFEFNKELFYQS
NILDFIGFTPKYRQILKDVDDIAKALSGYTAVHIRGGDVIQKDNYNSRISLIFKTLPLAL
LVFLHMQKNSKYLFFIQDECVEVFYKKKYNINTASDFYPKDRVYDRYEKAFFDIILMSKC
REIIAPHSGFSLSASYLSNQDILSYRTLFSGHQITNIIKNYLKNDSNDIY
>fig|195.2069.peg.1421 conserved hypothetical protein
MIHKLHIKNFKLIKDNRYDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEKITKNNSLLY
>fig|195.2069.peg.97 Ammonium transporter
MNAINSSFIVLCTLLVLLMTPALAMFYSGMVRIKILLIP
>fig|195.2069.peg.1231 lipopolysaccharide core biosynthesis protein LpsA
FKEPAICKSRPLENNTNNILLKLDKNRHFCFLKDNIKYENKKDIAIFRGAVYQKHRKEFF
DSYFGRTFCDIGDTSKQPSQWKKTF
>fig|195.2069.peg.1815 hypothetical protein
NYIISSIDSSTASFEVYQGQLPQDVYIDNTPSPSPSKNFLEKLIEFNNTLFAHIKDILRK
EFDFKSFLILLVISFAYGVFHASAPGHAKMLTSSYFLTHKSTPLKILYFVSRIGVIHILS
AFLLVSVGVVLLEHLLKDVNNEAGFVLTKITSLFIIFIALFMISKKILSDKKQCCCAHHK
SNEWGIILSAALVPCPGVVLLIVFAYEFSFWYALSSAIFITLGMCLVLFAFALGANQFYK
SISHTKIRIFLEYFGLIVMFLFGLFLFINIKTNAL
>fig|195.2069.peg.156 FIG00471048: hypothetical protein
MFIAHILIFIIGYFLLKGYKVKITSQITKPKRLNAAQ
>fig|195.2069.peg.418 ATP/GTP-binding protein
MQIDASKNQSFSMDYTTKSGKHLALSMYDNQSLSYSNDEEGKSLNLKRQYGFSFTFEGSK
LTQADLDEIKNAMKEVEPMIKDFLANSKVGELKPKEIIESAMQMANVLPTPNDENHQNAI
INNFTNKLSDLLK
>fig|195.2069.peg.1810 hypothetical protein
MYELPILIFKNLSGHILEGTIIIIFFFLLFLFLLYKRKSLHKSSTSLLITIGICFTFYGI
SKGLANFDANNIEENLPQLIDGIKTAFLVSVEAVFFAILLKVIALFMEKPFSNQDEIEED
VGIEDIIILQKENIKISQETLETFNQSLKATKEINDNIKLLRADNEQGFVNIKNSFEGFA
KTMTENNSKAFIQALEEVIKDFNNKITEQFGDNFKQLNLAVGALLTWQENYKNYIEKSES
IIENLLSSFKKTVEDYSVVVDNSERFVSYAKSFENILKELSEQRIQIQSSIENLDIFLKN
TQLSISSLMQEINNYKEQSLNTVENISKLSANLEESYTKSSEKLINDIS
>fig|195.2069.peg.1735 hypothetical protein
LSTHNEKINTQLIEGLNSASASINSQIKTLDQELENVLKNLGSNLASISTKFVDDYNTIL
SNLSSLNQKMSNLR
>fig|195.2069.peg.1050 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MEQKINIVLLGGSNSVGRYGLQKGLSQDGVKLHNLALGSTTSIQNLYELKREKNIKYLLN
ADLIITESNVNEHIAASHKYEKLSLRIIYKNLYLLYSELSRLEKKVLVLLLPGGNDTIDS
LHKYLIGQFSLNLIDVKSYYKNKNILDLVAMEGAHPFWVFMRELGKNIVHHIPYFHFPKN
HIKAPCLIDFKICSAYEMEIISGNTIKTKYNNSMYNEEILQFNKEVVLTFPEKYHGYHLL
AVHTWNKLDGSIDIKSQNLLKHYTAFKVCNKRYSIIKISNFLNSVVEFQKDFFQIIPDTT
VSISLENEKNIEFHHAAHTWDDENKVYHDTLNLVSFFLIKSNFKIILPRDMDLILDRKYI
FDCIIPPMEIYKQVLDEFCTRFLNLCTYGDKLHEIKNLIQRKMQENNLNRDILVPKEQKN
NQESEFLDVDKLSSFSTFQTKYGTAKQRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSY
IKDKHKQEQKIYQEKIKKDPSLKLPPLENYPDYKEALKEKECLTYKLGEALIRANNNWYG
GGISNYCLKLGS
>fig|195.2069.peg.157 Dicarboxylate carrier protein
MYSVRNRPWSIPIALYITVMVFVGIGPGHYAGFAFMSPLVLYIASKIKMNKILAAIIIYS
GSCAGGFNPFTLGGRVTFDLIEKLGYSAEASAIM
>fig|195.2069.peg.935 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGIVIPIYNVEKYLRECLESVINQTYVNLEIILINDGSTDENSLNIAKEYALKDKRI
TLFDKENGGLSSARNTGIEFFYKEYETHFSNEIDGFYTFTVANENPQNVYKIYKNKNTFI
EKNLEAPDIDYLIFLDSDNSWELNCIEECVKRMQDIDILWFDHLCVYEKGIEDKGQKTRM
QIFSYKEECIINPKDYAKRALEVGSRDISFSWGG
>fig|195.2069.peg.1656 DNA translocase FtsK
MLAPDMGVWLYKANLFLFGEFAYYYPFFLFILNYVYYKRNYKLANFTRRELFGIGFAFFS
SLLLFAVFYPNSGYILELAYAIFSAILGHTGSGIFALLLLFFSFILLFPKTTKELFKIEI
NFNILLKIENALKVLLMRVFGGENEKDDLSKIEPKAPIVTLEKNTAFVQEKIQHENENLN
LNPTEELVKYSNINASKNSIITAKENFEKLKNQILDEKVEIDKESIKEAKSFIYENSQQV
RNFAQKASRMSIKLDEDFNFISEEEVDMIPERFLKPKKLEDIKQIDTSNKNLDEPSYKRK
NIEISIPKQEIKPKIFTKELELRENLMKEAKLEQEYKAYQNEILENKVQEEIKELEKKDS
LEPNLNHIIQGSKYNFGTPLQEVSSAKEEIKTQNAPIPSILEKTNEVEIIDFDESEIEIK
KMESINKSIHDFIPIVEELEHPYIEPTPIIKIEELEPLNNQINNQINKQIPIQEKDEITE
QDNSFSKEQISQEPSQEITRQKAILAKEIELNKALLREIEQGEMEKPKDFELPPLEFLTN
PSHNKQEINESEIDKKIYNLLEKLRRFKIGGDVISTYIGPVVTTFEFRPSADVKVSRILN
LQDDLTMALMAKSIRIQAPIPGKDVVGIEVPNDEIQTIYLREILESEVFKNAKSPLTIAL
GKDIVGNAFVTDLKKLPHLLIAGTTGSGKSVGINSMLLSLLYRNSPKTLRLMMIDPKMLE
FSIYNDIPHLLTPVITDPKKAVNALSNMVAEMERRYRLMAEAKTKNIENYNEKMKELGEE
ELPFIVVIIDELADLMMTAGKDVEFYIGRLAQMARASGIHLIVATQRPSVDVVTGLIKAN
LPSRISYKVGQKIDSKVILDAMGAESLLGRGDCLFTPPGTSSIVRLHAPFASEFEIEKIV
DFLKDQQSVEYDESFLKDQQSMGVTSSESMNNGEYDELYEDAKRVILSDGKTSISYLQRK
LNIGYNRAANIIDQLTESGVLSEPNSKGQREIL
>fig|195.2069.peg.1607 Malonyl-[acyl-carrier protein] O-methyltransferase (EC 2.1.1.197)
MNFLKAKDYQKHAKVQDLMGLKLCEILKNLEISHFKKVFEFGCGRGEFSDKLSKIITFDE
YL
>fig|195.2069.peg.1587 Membrane protein
NLNNEIFFYQSLKENLFKENDEILISNLGKKIILFRNFTQNSDNFAEAKLKQVLLLIFLF
LASVFFASLAAINEFGAVDLVFLMICLLLLVMGIINLGLLFKQIRILKSFSKEEMKEFLT
QRMKKYAKK
>fig|195.2069.peg.625 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISPYKNVPQNENIQNTLKSKQSPL
DIKMDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGINEVWL
RESIIALKRSDLNVETLQEIVNIVSYYFQYHGYPSATAYIPQQEITDSIQINIMLGKLGE
YQVKNYSKHLKESAISSKLKESLQGKILRTKALEDAIYKINEMSGIKASGSLVAGSEYET
TDVIITIEDSKKANAMLFFDNYGSKGSGVYRAGVSGALNNLLGYGDSLNYFAQLSDEMQK
SYGFTYNFFLGNLKVSPRVNKSNYELGEEYESLGAYGSSLDLGVDLSYPLFINTTNSLYL
TGGYVYRKLEDIYGSFGIDFNKESNAFYLGTEGTIGLIPNNILSYNTQLTYGDIKPKSVF
LENSPVMGEFWKFNAASNNAYYFNNKISHILNISYQKTIGDYQLDSSETATLGGAYGVRA
YPNGFGEADSMILTTIGLRFNIFSPNFYITPFYEFAHGWNEDYLDNDINMAGREGKNDIF
VDAVGLELLYIKPNGFYIKLDLAKAAHKYEADGKRRIDSIQVWDFIF
>fig|195.2069.peg.1 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYI
>fig|195.2069.peg.1232 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVASYSEKEAKNAISLSSKRYVNYIQGI
LNEEVTLTKAVATSLNGMFQNNDHVDINLIESLIKNAFDSSHYAVYTFLYLKDTTVLSDM
QNVDKK
>fig|195.2069.peg.1818 FIG00973752: TolA-like membrane protein
TMKKIFLAFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNITNG
KIIGFRVRKFKDINSLQKLKDNAEELFYLDKQRVLKAKEAQSYKNLFI
>fig|195.2069.peg.1042 UDP-N-acetyl-D-glucosamine 6-dehydrogenase (EC 1.1.1.136)
MKNDINIAIIGLGYVGLPLAVEFSQKYNTIGFDISQARIAELQNGIDKTKEISQQEILQC
KNILFTSNVQDIQDANIYIVTVPTPTDSFNNPDLTPIKNATKTIGSVLKKDDIVIYESTV
YPGCTEEVCVPILESLSGLVYNRDFYCGYSPERINPGDKTMKLTDIKKITSGSNESIAKI
IDDLYSSIITAGTYKASSIKVAEAAKIIENTQRDVNIAFMNEISCIFQRIGIDTLEVIEA
ASTKWNFLKFTPGLVGGHCIGVDPYYLIRKSELHDYSPKLLLSAREVNNKMSKEIVFNLV
KKMIQRDVVISRSSIAIFGITFKENCSDIRNSKVVDIIHEIKEYTNNIDIYDPHANSSDV
FYEYGLNLSSLSSFSSDKYQAIIIAVAHDDFKDICFHCDKNMIIYDLKGMIKNKSENILR
P
>fig|195.2069.peg.1782 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDKRI
TLFDKKNGGLSSARNVGIEYFSGEYKLKNKTQIIKENSLIEFNIEGNNPYEIYTIYKSYK
AFNDEQDLTSFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVEVLWFDYRKIYSDMEKP
EPEPMTILQRYNFNQSQKITQKKWLEKTLENNIQSFWFGWHGMINFNFLKNIKLKFFDYI
VHEDNHFGPLLFVCSKNIYVMLNKVYIHRIRPNSIMDYRRLDTVSIPKFIQELFSFLHIE
NIYETKMLHRYISLFLIAFDLLNFIKNIEFSNKSLFCKIFSMRLRQWQMSLLETSYKKEK
IFEIIFKIYKKQINIVSYYEKCVELYQELILQKNARIENLTESIMKNKELILQKNARIEN
LTESIMKNKELAQDAQFQDRIIHNLEKDVAMYKAAIDDKNKEIDSKNIQIQNINTTLNKA
IQEKDLIINTNINQINQLQNNIKAKTKQLNILQNNIQKNSVQLNQLQSKLSFQTKYGTAK
TRIQNQLSYKLGQAMIVNSKSLLGYLRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLPP
LESYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMWFGMRQMKGRQ
>fig|195.2069.peg.1433 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGAIDSAKSNALQEIQTISNK
ATNQISQLKNTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAKVTKTGDETIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVALSGNET
IAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAGVKTFSVPPVSATN
PTANNQVANKSYVDTVGNSKVALSGNQTIAGVKTFNAAPVCSANPTEDAQLARKWYVDYG
GGIKNLGNQTAPKIDLRQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQNITAFSAP
FKFRVAQSGFSGTETFAYFCIASNNVILVRT
>fig|195.2069.peg.1654 [Protein-PII] uridylyltransferase (EC 2.7.7.59) / [Protein-PII]-UMP uridylyl-removing enzyme
LLLDSGILKELCKPFGMVRFLSDEEGDYSFDEQAFLLLKEFEKYEDELESLKNLNTDEKM
ILKLVILLSAINNENEISLASIYRAYCIKFNLKNDVFELGLRIFKNHNALKELAEKEDVY
NPIIICALLSKVENLKTLKLLHTLTWLKAKALNRNPFFYKVIDRILENAKQGFDDENLLD
ETARRVKKELTLKRTKLFLEQNAILQDKITHIKSNLFIIKNTFEDIVEIARFAKENDFKF
WFSNSTNLSLQIVAFKDFKIEIVLTALANLNLVFMNLFELFDDKIYLRFEYDNIITDEQK
NKLYELLNSNLSGFSSRKIKKPIIKPIIKPIIKKDELKLDLNYSKIYAKLSLNTKDQQGL
MAYMMNIFNELGLVLSAAKIQTIRQRTRNTFIFQKNENLEKNEEKLLISLISE
>fig|195.2069.peg.1794 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDCKYKMKNNNQEKNVLIAGNGPSLKEIDYRRLPDKYDVFRCNQF
>fig|195.2069.peg.1677 Motility accessory factor
ILKLNKLNMQIIKNHNLMHGNDPKDAIQGIEQFVYNLPQMITHPSYKELLSKRKGISDTA
IIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVLSLERIPLTSEFFNN
DFGEFDKDIVFVCAGVVHPKTIEYLKNKTFIITQKILAFPYYINLKNFCYAAVGFSVAHM
AYEFATHLSHKNIIFIGQDLAYAEDGFSHTKDYSNLDKHEGHFQRDKGKFQCLAYGGDGK
AESSEVWTMFRFFLQDTISRNIISTTYNCTEGGARIEGTIEKPFLWACENLLYKDLNKPF
EKLEPLSLNKQNEFLLKAYYKVCKSIKHCRDFSKILSNDFEKIQSVYLNLNKKENDLNLA
IRKIDEFKNKLENIKQMQDLYEILSPLLIQFELNLARIYVLNPKTKEDAFNKSILWIKEH
LEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2069.peg.429 Ferric iron ABC transporter, ATP-binding protein
MDKKDIEKRVKKMLKLVELEEYAKTYPHKLSGGQMQRVALARSLVTKPDLLLLDEPLSAL
DAKIRKHLRVQIKEIQKELELTTIFVTHDQEEALELSDRIILMNEGKIIQNSNANNLYLL
PESHFVASFIGNYNILSPKELDSLGLKHDFKKDIALRPETIEISNEGLEAKIKEKSLLGN
IIRYRVRVQEIEFKVDTLNFSTHSTYEAGDKIALKFNLSLAKELK
>fig|195.2069.peg.1443 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANEFQQEQDLRKQQMEFNQ
AMQNNQLLQNERNFDYQKERANIADEQWQMNYNQRARQYAMQNALRQQAINARKQQMEFN
QAMQNNQLLQNERNFDYQKERANIAELQKLQNEINAKQKEQDLLNKVFSNTQGFDGQSNT
NLPNNTRYKADAQFLDLASNQGKTYDTTHGFWNGAIERGFGGWGSQSTDLNDASDLFLKR
MLSDLLRGGKNAKWNLENIQANFPINGYTMEANNQRVAQALAGEWLAQAPNSYKMELVER
LGNAKTNIEKQSAIEDYQKNMNFYNNYAPKVKAFYWDEKYSKPSKNAVIIDNSTTNQNIQ
NDLAKNTLEVQNQNTPKLHSVSFNGINAQISEPDANGNVILVNQAGKKMQVSVEELKKQG
LIQ
>fig|195.2069.peg.1769 formyl transferase domain protein
MTYSHIYIIGTGKVTKECQKIASDFFKQEVIFVKNIENDDFCKNLKNCLIISANNSYIFK
KECVQNNTIINYHNALLPFHKGCNARIWNIWENDKKTGITWHMVEESIDTGAILTQKEIK
LDDNFTALSLLDTQHKLAIASFKEALKNLENKIFKIQTLGGGVSQKIGFAK
>fig|195.2069.peg.1702 hypothetical protein
MKARIMNSIIKFFLAILCIGCVNYLLIYYSDGYFNSSYKETILFIDVIFTWAFCFIFIYA
IFYTIKKIYYGNDKCKNFIFDSAIAIIVITVITKILLISFLRSLNVYGVDVILVMMGIAV
GIYAYVFALTVLLRLTFKGIEVNYPVSNSSVIRLLKVLHIACLVADLTIIGAFFGIPIFL
ALWIFQYIFANEKNPFFVFKKYNPKPYQEEDIIDVEVEDEKPKKSLKTFLENWKD
>fig|195.2069.peg.1790 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWYGGGVYQIAI
>fig|195.2069.peg.738 Ferric uptake regulation protein FUR
MLIENVEYDVLLERFKKILRQGGLKYTKQREILLKTLYHSDTHYTPESLYMEIKQAEPDL
NVGIATVYRTLNLLEEAEMVTSISFGSAGKKYELANKPHHDHMICKNCGKIIEFENPIIE
RQQALIAKEHGFKLTGHLMQLYGVCNNCNQKAKVKFNV
>fig|195.2069.peg.798 Methyl-accepting chemotaxis signal transduction protein
MQSINSGKSVGISAKLTLMVGILVVLIFTITSAVSYFDSRNNTYELLKDNQLKTMQDVGA
FFESYSMSKRHGIQILANELNKRPDMSDEELINLIKAFEKVNGYDLVYVGFDNTGKNYQS
DDQILDLSKGYDTKNRPWYKAAKEAKKLIVTEPYKSYNSGEVGLTYAAPFYDRNGNFRGV
VGGDYDLAKFSTDVLTVGKSYNTFTQVLDLEGTILFNDEVAKILTKTELSINIANAIKAD
PALIDPKNQDTLFTAKDHQGVDYAIMCNSAFNPLFKICTITENKVYTEAVNSILMKQVIV
SIIAIIIALILIRFSISRSLSPLAAIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISK
AINENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLD
VLQTKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANH
LASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNV
TGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLL
VQSINDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISNTVSDIANNILEDV
KKKRF
>fig|195.2069.peg.1783 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
TNKTTQIQNLNQAIKNKDELITNKTTQIQNLNQAIKNKDELITNKTTQIQNLNQAIKNKD
ELIQNTNNLLSLQTKYGTAKQRIQNQLSYKLGQAMILNSKSILGYLIMPMALLSIIISHK
QEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWYKGGYVKI
LFEIGKLKREC
>fig|195.2069.peg.1716 hypothetical protein
MSEQTYELRFEYFNEENATVFFQKITDFLLSIDKLNNSLVSVFGIEIDIN
>fig|195.2069.peg.1817 hypothetical protein
MQNIGGFKALSKELITKLLNEFPNKSILFYDDFIKECEIYK
>fig|195.2069.peg.1713 FIG00472493: hypothetical protein
MARSTSKFDLRRHKNNKTIEDVYVVGNIHENKELLKG
>fig|195.2069.peg.1182 FIG00973752: TolA-like membrane protein
TMKKIFLAFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNITID
GDPTIWNDTKQVFLTQTFIYTLTPKFDILISGGGSYARQEYTNFFTNEYSSKNRIGFDSL
WLGFIYTGDSIADLIPQITFQTAVVQREKAINQTKNFYLKSQSLQASLRGYSDPVVYSIY
TGFGYNQSRKFKTLKIEYGNSIYVGGDLSIILSPKITLDLGAEQRFQMKQKINGYQNSEV
RSIPTLSLGSTYSINSDTAVSVNASFGGSSASPDSIFGISLWKKF
>fig|195.2069.peg.1819 hypothetical protein
KFSDDDAGEFNKILSLNSTPKSIDIKA
>fig|195.2069.peg.1023 Ferrous iron transporter FeoB
MKKIKIALVGQPNVGKSLLINALCKANMKVGNFSGVTIEKAVAKTRYKDYELEFIDLPGT
YSLDGYSEEEKIARQFLESKNYDIIVNVLDATNLERNLILSAELLSLNKKMLLALNMCDE
AKKEGIELDTSILSKEFQINVVEISAKTKFRTFT
>fig|195.2069.peg.216 McrBC restriction endonuclease system, McrB subunit, putative
MYYYFPKDKDEFKEAVVKNGGMSVYVYQEGKLIDEFHTKSRCCKIIFQYYFVKN
>fig|195.2069.peg.1365 hypothetical protein
MVRIATVNDAEQLNILNNEFNGEGASIDNIGNSLVSNKQEVVIVADEDDILVGFVCVQLK
KSFCYDEYMPEITEVYVKPTYRNRGIASEMIIFAENYCSKNYPLHQYELLTGQENLVAQS
VYNKLGYVDDNELHLSKRVKR
>fig|195.2069.peg.1162 hypothetical protein
MKNLNWKKAWNYNEIYVIKSLKLAFIIVKTLAGFDYKF
>fig|195.2069.peg.1331 membrane protein, putative
MRAIFVLIFLALSNLYSCTLCATYTPNVDVNLDFNMSNEKIKQVDISWEFSEEFFNVLLE
NYDFNYNDKFDPDELEIVKYTLLDYIKPKHFLTQFSFNGLEENINIKQFKNPKLQIKSPR
LFFSYQVVLDMPIKDYN
>fig|195.2069.peg.1758 3'(2'),5'-bisphosphate nucleotidase (EC 3.1.3.7)
MLSQIILKDINDIAIKAGKSVLEIYNQDFKISYKDDNSPLSEADIISNEIICNELAKFSL
PILSEENKTLPPVLGVVYAPALDLLYSAKKGEGAFKNGVKLPLQRNDNFLKIVASKSHLN
EQTKDFIDSIQATKQKEFVSMGSSLKLCLVASNEADIYPRLAPTMEWDVAAADAIVREVG
KMTYDFYTKKPLVYNKENLLNPYFIVE
>fig|195.2069.peg.1562 FIG00469432: hypothetical protein
VFLEYFHNLYNLKILSKLYNKYFICDLEKKTLLKLTKKKEKLGKLIHKASKKLKIYKGY
>fig|195.2069.peg.1786 hypothetical protein
MKKFIKSKDTSDAFTLFELVLVVLILGLVISIAQINLKQDRLMQGAKQILNDIRYVRTLA
MTQESFRDLELAVAKREWYKSR
>fig|195.2069.peg.417 ATP/GTP-binding protein
MIYSNKLSDLLKQNQTDDKDINTSMLEDSKKLLDEVLEQMKKQLEKQQEKAKENQNNAEK
GLNLYA
>fig|195.2069.peg.1781 Glycosyltransferase
MINIIEEENQGLKIACRFLEDELNKLYEENNKLYEENNKLYEENNKLYEENNKLQNFLSF
KIARAVVTNLSIKKIYKIPYRIYGLYKQHKQHKQHKQHKHKQHKQHKQMLSKIGFVSWYS
DFLMQLGENKRALLFSKKYLYGNYRKTYYLLNANNQLQNEEEWLKNLNMYLNRINTAPIS
LNNHTNDKIFFKICCKLNYEIKQGPLVTIIMPAYNAEKTIGFAIDSILNQTYKNIELIIV
DDCSNDSTLEFIKQKQKIDTRIKIICNKQNLGPYVSKNKALDISDGEYITGHDADDWAHP
QRIEKQVDFMLNNPNIKAMVAKKIRITEEGKIVNFYISKKVEDDGILSTAFISCIIDATF
MKNKLGYWDSVRFGADSEIMNRIKSLDESIYVEENIFTMFCLESKTSLTNHPKHGISKIT
GMSDIRRKYFNSFKNWHKETSDYYINFPLLKRPFEAPIEMKI
>fig|195.2069.peg.215 McrBC restriction endonuclease system, McrB subunit, putative
MRLKGEFQQCLKQFVEKVEELKKQGITVGSEPGKWKKQIDGLIQDFDYVCSVNFGSGNLS
DYPAINFFRKDILHKGYSNGETPSQQYGMYIWFSYAHKEKTLYLALTASNKYKKTEFDCK
ALRDLEKYTGGIFDNTNYDYTYNIRNFSIEDFDEYKEELYNKFCSLVDLFNRFPQKDFIK
INEEFESNNTQKMLNQNSSLNQILYGPPGTGKTYHTIDKALEILGENLESRDEKKAKFDE
YVKNGQIVFTTFHQSYGYEEFVEGIKPHIDSEENSKEIKYEIKDGIFKELCEKALENRDS
IKNFNFYIDKLKEKVKIDDNNPEKYFELPNTKYSIQYRNGKTFRIKFDDMSKNHKDYPVS
IDNIEKLYKTSNIDEIYNSAYVRAILNYLKLQGLEDYKEKDEKVNLPYIIIIDEINRGNV
SKIFGELITLIEASKRIGEKEELKVTLPYSGKKFGVPKNVYIIGTMNTADRSITSLDTAL
RRRFEFVEMMPNSDLLNNVFICKDVENPNEDEDYLGDDAKTEGYAEILQNILISINKRIE
FLLDREKTIGHAFFMSEAVKFNKNNWIKPDEYEEDWYVLSISKLKSIFQNKIIPLLQEYF
YNDYALISAVLNDNGMIEKCEKDDKYLQKIKNLDNVDSEKIIYNIASFDNKIWNDIKTYQ
AIYNDGENQSKNDKQ
>fig|195.2069.peg.1785 Putative periplasmic ATP /GTP-binding protein
MNSGQSGVIDKSDSKTTQRFNIFKKFGIKKVEFKGSCRGSTRIVFDERGRLYSPLRTSQG
VYDKNLAKTNQDCVIRLSSIQANQICIIVNPLSGFAYIPKFQDFNKQMIMINGVLSQCFK
I
>fig|195.2069.peg.1773 hypothetical protein
LEIGVNINVNLENAQQCYELLNQNITTLKSQRKLAQNYQAKFTSTFIPPNGDYQNYGIMA
ALDHINALKDLVKRFPKLADLPKIYGGGLMEDTYLYS
>fig|195.2069.peg.1287 Malonyl-[acyl-carrier protein] O-methyltransferase (EC 2.1.1.197)
ILDYPDNLNVEIFDMNTLATQNLSKQKFDLITSNASLQWLDLKQVLPTLANMLNKKGILL
LSTFGEMNLKEIKQSTSLGLKYFSTKELEQIFKPYFSDIKITEEIVNLEFQNALEVFRHL
KLSGVNSLGFYRLNKQFLKEFEEKFQNKLTYHPIFILCKKDTK
>fig|195.2069.peg.426 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDDYFK
SIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQASARNLGLK
YMQENDYQIPWVTFT
>fig|195.2070.peg.1425 FIG00638667: hypothetical protein
MKKLLIIPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPYYEIKNINFHKGFLNSKADFT
IEDKYNLGLISKLDFKFNNNYFSKFIAQGKLSNPFKLLDDKLQNKELAWFKIQSIQNDLN
VSIQFQDINLSNEGGNALWENVLTEILLD
>fig|195.2070.peg.1745 RecD-like DNA helicase YrrC
MENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTDTNQQLDS
IYENLQSSLKYIGDK
>fig|195.2070.peg.1837 haloacid dehalogenase-like hydrolase domain/phosphoribulokinase domain protein
MFNLKNIAEKYKLVMVDIDNTLFNYTFAHKNALEAVMDQYDFTLQEYNLAKMMIETRNLS
ANHHKKELYFKIICENKNIHFSKASEMFNLY
>fig|195.2070.peg.775 ABC transporter, ATP-binding protein (cluster 5, nickel/peptides/opines)
MLEVKNLGKFYEFKKHWYLKKEKHLIFENINFSLKENENLMILGQSGAGKSTLARILCFL
ENPSFGEIIYKNLNPHSLDKTKQRLLRKEIQYCFQDQKAALNPYKKIKNLIQDGLENFNI
KKEQEKILEFFDRFNLKKQILEQKPYELSGGEATRVGLIRALILEPKVLILDEITSSLDM
KNSKEILKFLYHYQQENLISYIFITHQDGFFFNFKCKKMKLYTIFILIKFQYRKFRVK
>fig|195.2070.peg.1782 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MLNTILSSKESTRSACDFKIQKMYHCLLQDFNNEASKKRCYIANQNLLYIAEEWLKLDEN
VLFVLLYENPIEILRQKIFSNHKFCFKDILMDWLRYNNLMLEFYSKNNNKCILMNYSNYH
NSLIKYLSKHNNPDMVYAENDAYIFKNKELFDFLLESLINKDYQIINDSYEKLEKNSLSP
ICKRKFSSENVEKEIVDLFYFIETNSILKSKNKSLLDFIFDIQ
>fig|195.2070.peg.1850 Motility accessory factor
FTPTQKELFNKNIEALSNILLKEGLKEIKSSKFELVLGKDNLDINLKDTSDNTFLYENVI
DELNTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHIL
DFSNELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDILGLN
KKLAENFKNSIVSYGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVST
GP
>fig|195.2070.peg.1833 hypothetical protein
INPEIKKDLNNRLGIYKPKIYDEMLDGTFKAIKNLSEVANKDVGVMILEFANSYSETREK
FEKKQINKSSFFKEKMNEFFKKKLNKILPDREISNEKTYSRSR
>fig|195.2070.peg.1277 [Protein-PII] uridylyltransferase (EC 2.7.7.59) / [Protein-PII]-UMP uridylyl-removing enzyme
MLNKELELFKKNLNTYAQNYRNFFLKQGSFSLYHSKNMDNFLKKTYDIVLKECFENFLPT
SDNIPFCVLASKGYAKNNLCANESVSLIFVYKDIKAYHLKPMIKAFIEILNDVHLQIDYV
VLELNGLYNASNELKTTIIGARFICGSKILFKSVKEKFDSILHANKNEFAQILLANFKDF
NLPFIKQEFNIKKDFGGLDHLRALESLLTLFKNSPKNYALNFMDEKNVSELRLATDFLLS
LKSAINLQSNKDQDEFLFSNIHEIAELMYRKGKKNLDAEKILVQKALQSMHTIGFYTHFL
AYKIQNELQNIAQKQYRFKNLAEALTFLLGLKDQDIAFDLDLVFALKNLSYEKKDLEKAL
ALFEKIFYKRHSFCILKLLLDSGILKELCKPFGMVRFLSDEEGDYSFDEQAFLLLKEFEK
YEDELESLKNLNTDEKMILKLVILLSAINNENEISLASIYRAY
>fig|195.2070.peg.1713 FIG00638667: hypothetical protein
NNHTISSFYNKNIIYFDDDNQTLKMHSQGKANNLNIDLTSQIYQSIDFDQINFDLIYSQK
KPDISDDKLIFKPSNEELNLQIQNITLKKDNQDINIKGNIFLSMQSHKARIQISSLKSPD
EIFTWGQFFGGLNQYFIKNEEGMFIMDLHYDSDAKTQLKINGNEFTDINLN
>fig|195.2070.peg.624 hypothetical protein
MINGINSYSSYNYTNTFSNNTPNTKSSNTVNETSNLVSDKSRTVSKMLGYGVDKDGFFTS
DFNEAADLPKDYKIYAKDIEIKDAFIKQTPPNAVNSAIFLTIVNNTDKDISLIDAKTDIN
QVSELHTHEHKHGMKAMIQIPEIPVKAHSSTELKPGSYHIMLFKLNQAIDENTKANLTLT
FDNNQSLEVRDIGSKKL
>fig|195.2070.peg.1597 Fibronectin/fibrinogen-binding protein
MKYTELMQLQNFFSQFKKIDFIKRVNDNILELSFNRERFIFDLTRGMSAIYTAKLMSKNY
NAPFDFMLKKYFNNAFIKEVKLLQDNRILCFSVKVDKAYKSYESKIYFEFTGKNTNVIIT
DEKDLIIEALRHIDKSYRVVKPNVILEALKPYKMDEKFEEIKNFKDYFTQKFEILHANKI
KQIQTLKLAQIDKKIENLKELYLALD
>fig|195.2070.peg.1306 Ferrous iron transporter FeoB
MISTMGVLYSLGKDVDETNNDLKGIIAKNIPLPSAVAYILFVMIYNPCFAATIVFSKESG
KIKYTFFLFLFTCISAYIVAFIGLNITKFVIN
>fig|195.2070.peg.1682 Ribbon-helix-helix protein, copG family domain protein
NKTMDNIRDKIDILSDQLGAIIEKNNERI
>fig|195.2070.peg.265 Selenophosphate-dependent tRNA 2-selenouridine synthase
MLNEVDFAEFQKENFSLLIDARSPREFLHSHLIGALNFYALNDEEYQEIGTIL
>fig|195.2070.peg.1013 lipopolysaccharide core biosynthesis protein LpsA
MNLKGIGISFTPRYFFQTKLHKIFNEILKYNAKE
>fig|195.2070.peg.1326 haloacid dehalogenase-like hydrolase domain/phosphoribulokinase domain protein
LYTSAFIKNLKVDKTMSDFLFYVKKLNKKVIAITNFYFIEQIYKLNCANLINMIDYLVCS
EEFELEKPNKALVNRALELYGKFIDEEEIVMIGDSIADNFLGGGV
>fig|195.2070.peg.1845 FIG00470336: hypothetical protein
LLNFSTNSIQYNIDQNANLKVFCNNKNIASLVSISQKLDFLITVDTGNLHLCDILQIPTL
AFTSSLAAYRFGGGSYGGRFDKLIVKPAWQKEYRKIYEIFTKKAENNLENL
>fig|195.2070.peg.1172 16S rRNA (guanine(966)-N(2))-methyltransferase (EC 2.1.1.171)
PDNIENFTKIKEKKFGSTSLSFYQKNILEE
>fig|195.2070.peg.1840 hydrolase, haloacid dehalogenase-like family
KLCNPKYIIKETFEFIKKNQTHYNMHIASGADEQDLIEICKMLDLTQYFLSIHGSPTKKE
ILVKNLLINNNYKNKETILIGDSVNDYEAALKNNIYFYGLFRLGREE
>fig|195.2070.peg.1580 [Protein-PII] uridylyltransferase (EC 2.7.7.59) / [Protein-PII]-UMP uridylyl-removing enzyme
SIYRAYCIKFNLKNDVFELGLRIFKNHNALKELAEKEDVYNPIIICALLSKVENLKTLKL
LHTLTWLKAKALNRNPFFYKVIDRILENAKQGFDDENLLDETARRVKKELTLKRTKLFLE
QNAILQDKITHIKSNLFIIKNTFEDIVEIARFAKENDFKFWFSNSTNLSLQIVAFKDFKI
EIVLTALANLNLVFMNLFELFDDKIYLRFEYDNIITDEQKNKLCELLNSNLSGFSSRKIK
KPIIKKDELKLDLNYSKIYAKLSLNTKDQQGLMAYMMNIFNELGLVLSAAKIQTIRQRTR
NTFIFQKNENLEKNEEKLLISLISE
>fig|195.2070.peg.1579 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLM
>fig|195.2070.peg.1822 hypothetical protein
NEIQKLSLDDKLKKYNEQINKFCEIVEYKLSHNAENYNSFLDHFVENGKLKLNIFSEIFT
KMTKNTKWYLIFFSFTSIGLGIALGILILLTYIKYSEYNNLKERVSTITQGLATISIDEN
SKGSFTLSFAKNKKTIFNENKNSIQITLQGGE
>fig|195.2070.peg.1735 hydrolase, haloacid dehalogenase-like family
MINIENIKNIIFDFDGVILDSVELKTQAFAELFKEFPKNKVQELVKYHIQNGGISRYHKI
QYFFENILCEEISDKEILN
>fig|195.2070.peg.1836 Motility accessory factor
IKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2071.peg.1375 Possible sugar transferase
LDMEKIKTKNAFQTMEDLAFRFGFTPPCLKESENLFKIQEFRGYIRYLFPITLYANQKDL
SNIFSIKSPNNNPNASIDTSTSIAIILDRPHKNSQKINIINEILNNDLSNDMSVYIDKSD
LEKLEKNTLFFKQIKNYLYEFLQAIHKTIEHTEDSMMKEEDVLLYFSKNKTLALEFKEIF
NKELNNVKQSHPNIIASWKYYQEFEKICKKLDEKE
>fig|195.2071.peg.1847 Putative periplasmic protein
MDFFFVEYRDPLVGLIILTVLIFVVAVANYIWKVFASKDEEQKLEKFIKKFEMDNIHKDL
LRNEGLSFGNLSFLAEIFTKSGEFEKATQIYLIALEKSKDKQEREFIFFALAKVYFKAGF
LERAKEVLLQALKLRPRNIQALKLLKIVYLKLRKYKENLELLGCLFELGENVKEEKEFLK
ALDFLASSLSDEEKKEHILKLQTDNNPMLGRFVFEKYHIFLNQDFSSICDLLYKENKAFN
LQNKEYFEFFYALGLIEDE
>fig|195.2071.peg.1709 hypothetical protein
MMNEEINSNENSLYELVKEDNSTNMVIQNYNELLSKFENLIKTIIAKIDIGKQNSSSNTE
DGIFKDLEKNIIELDNTFLALISYFKNPPSDEEKEFINKTASIKKTMEDFAEFANEIQKL
SLDD
>fig|195.2071.peg.1708 hypothetical protein
MEKDYKIKVTDVSELNEQYKEAIQEGTYEGEDVNKFFNTIKTFDVAESLLKKDFSNQYIK
FDIITDKEKIPLNIRLGDKNFQKGIEHLINIGSSKLIKENINPEIKKDLNNRLGIYKPKI
YDEMLDGTFKAIKNLSEVANKDVGVMILEFANSYSE
>fig|195.2071.peg.1778 hypothetical protein
LNEFFKTNGNNKNTNDKYFYNKIFEVS
>fig|195.2071.peg.697 formyl transferase domain protein
MVKESIDTGDILVQKEIKLDNNCTALSLLNAQHKLALTLFREALEILKNKAFKMQISGGG
ITKNYLYQIMVI
>fig|195.2071.peg.1839 Beta-1,3-glucosyltransferase
FTDPDDFLDRNYFYKVDKFLSAHQDDDICMIGCNVIFYHEKQKLYKDNHALNFKFKNGIQ
VKENCNLDNFIQLFTNSSFINTNYLAKHIRFDKKLKPNFEDAKFINEYLLKNINLKSVFL
PNVKYFYRKREDGSSTLDLKLKSKNYYLNVTRNGYLKILSDCVKNKRDIPLFVQNLVLYD
LCWQIKPLINSPEKLSILNESEQQEYLNLLDKIFSFIEIETVVNFSLAGCWFFYKVGILN
CFKNEKPAFQIAYIEDYDPYKEQILLTYYTGDDKDIESILIDREEVYVDYKKIVKYDFLD
RVFCYQKRLWVHIPKNAKDRLEVLINNEQGMVGKYGEYFLDVKNIRKEFQKRLPKSNIWL
LMDRDYEADDNAEHLYRYIMQNHPEREIVFALRKESLDWERLEKEGFNLVEFGSFEFERI
IKKASKVISSHADEYLMRYITSRQQFIFLQHGVTQNDISKWLNNRKINLFFVSAQMEFDS
IVKNYTRYKFGQKEVVLTGFARHDALLKNNKTNTKQILIMPTWRHYLSGLMIGNSGIREL
KDDFKESEYFQKWNLLLDSNTLQKLCEKYSYTIVFNPHPNIIPYLKDFNIPSYVKIANQS
ESLQKLFCNSSLMITDYSSVAFEMAYLNKPVLYYQFDQEDFFSSHTLQKGYFDYRKNGFG
PVVEKEENLLKELENLLQDNCRVFGVYKDNIDSTFAFKDGKCCERIFKILSKDVYE
>fig|195.2071.peg.1034 haloacid dehalogenase-like hydrolase domain/phosphoribulokinase domain protein
KNKKVIAITNFYFIEQIYKLNCANLINMIDYLVCSEEFELEKPNKALVNRALELYGKFID
EEEIVMIGDSIADNFLGGGV
>fig|195.2071.peg.1830 hypothetical protein
LKKGGGVMEAKGIAIFPANVAFNKKTNAFFTELEDQFLKGEVGKSSIKLDFEYYILYSQF
LQIDRESLISGRNYELVFCFLLYYRALLNKNNTQKIVAKIINAIRCQERLPEKIHYKEKI
ICMDNHHRDLSQILSSCVVEFYNSIDLYNTFRKNIGFENRKKIAIEMLNRASEHYGFFEL
NRGGITYKEAKISCAPIPVLNEFHHAMSHLCEVFLKDDARYTNLERAIPHFKRGMMDIYK
TIIRDFLILNQDALGVKQEALKIRELEYQTIGKPKKVTKNSTLNLISKKEEKVIPGYKEL
CERIVRQSKNTN
>fig|195.2071.peg.938 hypothetical protein
MIDNIKIQNYKLIKELEIDKFK
>fig|195.2071.peg.1733 Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) in lipid-linked oligosaccharide synthesis cluster
LIVIDDFSEDLSLELLLKQELQNVDRLKVYQNFNKNGLYGAIKTGLKLAVGKYVLILDSD
IVIYPDKLKSNLKLLKHNEEKKILFTSSDFATKTEIIYQNYNYIHSYASFIFKREFINRY
MQSCNISFKEEILLKFPSLIIKNQNSIIKHILYSDQFLKHGNYFFKIKEYYLAYLCYNRV
DEKIKKYIQINFELCKKFKENM
>fig|195.2071.peg.230 Predicted metal-dependent hydrolase
MARQSSSLKSFIYKDECYFYSKKRIKTLRLRINERGEFVLSIPYFCTFKSVYEFLDKSSS
WMNEAKKRFEKKVLKDDELIFLAKKYKIIFDENVKKTYFDKDKIICQNKAKLDLFLRQNA
KKIFTFYLKKWSQKTGLFYTHLSIKNMKTRWGSCNHNKAYI
>fig|195.2071.peg.1831 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYGIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEFEFNQNIFYALNFENKEISFTELVFSFKI
NSLDRESFDISNIYNKKHFIIQKDNSLITFKYRKIQSKGFNLVFLLENNILKNYYFNYLE
KINPYIAKDFKNIKENHSFEIYKLLRIDFNVLI
>fig|195.2071.peg.1860 RecD-like DNA helicase YrrC
SYKVDDPILFNENSSSFGEEFHNNLKGIITNIEEDEKTINFTIKINKIIQNINNNFKIVA
KDDKGTEIKFSVARLNSDEEDDNSNIVPFQVAYAISIHKAQGLEYDKVSIVVADEIEEQV
THNIFYTAITRAKKELKIYWSAETENKILKSLKIKGINK
>fig|195.2071.peg.1206 Predicted glycosyltransferase involved in capsule biosynthesis
MPLLSVIIPFGLSKERSYIQERVYEKAQCFKTDEKIEFIFVEGYSSQEHNLKTCILKNNH
IYLKDESQEEYFSQGKCRNFGASYANASVLLFLDLDCFISFDSLEKILKLIKIKNILNNP
SALLVLPVVYLTQEASEILREYPMDLWDVLIQEDLISGKNFLVKFFAPSSTSGLIINRHK
FLEIGGNDENFIGHGYEDFDLFARVLNSCLKFEKIPLNLNYDSRNWNFYNFKGFRSWFSL
LGYELCFYGIYMYHLWHIEPNQNGYMDKKHKNHKLFYKHLKKIKDYSIDPLQISSVKNTK
ILVIANKKYNFRALSVYLGKFVYKSLD
>fig|195.2072.peg.1093 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
QIVAECEKVEEQYNTIRMSVEEYQNLIKTILQKCGIIDDGGGV
>fig|195.2074.peg.1874 Succinyl-CoA ligase [ADP-forming] beta chain (EC 6.2.1.5)
SVEEAVENAKELGGSVWAVKAQIHAGGRGLGGGVKIAKNLDEGKDYASKILGMNLVTHQT
GPEGKLVQKLYIESGANIVKEYYLA
>fig|195.2074.peg.836 UPF0234 protein Yitk
MASEHSFDISAALDKQELKNAFEQAKKELDSRYDLKGIKCEIEFSEKDGVFKLHSSSEAK
LDVLKDIVISKLIKRGINSSAIKELSRESGAMFRLRLLKIVS
>fig|195.2074.peg.1842 Putative integral membrane protein
MEEKIKQAIENIAKNLEVHKEYIRFDNTEQIYIIEDYLNNKIIEIKKNIKFDNLIDYPLK
FYYCDFLETVIGRNKTFKEKIIFEEVVFCKVVNFSFSIFDKNINFSNVKFE
>fig|195.2074.peg.1845 conserved hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRN
LIQDTEKIQNNIKFGVSGEYIG
>fig|195.2074.peg.1787 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAV
>fig|195.2074.peg.891 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENVSAEK
>fig|195.2074.peg.1667 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDSSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGTAASLDAQLRDELKALINTKEDKGVAANLDKALKTEL
TKLINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLVDALRSELTKEIESFIPELR
VEKRIITANYDRKYKKMVSLSNIPSEVNMSTYLSKCANSGFPEFAPNYSIYQLKGEHLIY
YLNDQYVASYAYQAISYAPSGSTNNNNY
>fig|195.2074.peg.1836 McrBC restriction endonuclease system, McrB subunit, putative
MPYSGDEFGVPKNVYILGTMNTADRSITSLDTALRRRFEFIEMMPDVGKLSNNCEGVDLQ
KLLEVINARIEYLLDREKTIGHAFFIGVENLEDLKKVFQNKIIPLLQEYFYNDYALINAV
LNDNGILEKQDINSNYLKSITEFIESDKVIYKFSDSKDWEGETFIKIYENDKQ
>fig|195.2074.peg.505 hypothetical protein
IMIDNIKIQNYKLIKELEIDKFKNINIFTGENNCGKSSILEAIYLLLSQDYIKNFIYSYD
VFRNFPLNKKNIQFVFNNFDLNKKINIFTRLNKDILLSLKISLMQSSIVSISDNLNENKD
ITIHFNHKCQKNEQENILTIREIKNIEEKTGVVERQYQAKEYVNKSNAIYFPVNIFSFES
IYFLRNIRMANKEEKLVKYLQIFDENIKDVEEINGEILIKSLDFNQKVPLKIFGYGFIKF
FNYICALVSNEANYILIDEIENGLHYKTTKKLIESLIELSRKNNIQMFISTHSLEFLSSV
EKVANEKEFKDLGVFNIYRYKENVYCKHYQSEQLKDLLNNGIELRR
>fig|195.2074.peg.1031 McrBC restriction endonuclease system, McrB subunit, putative
MVKYLKTRGGEKEFKVEVKNQKIKVNDNRSYSLDKFLKYIELYKTYETSSYAKPLFEDIL
NNSNLSIIKLRENEKMLSENQNLSLNQILYGPPGTGKTYHTIDKALEILGENLESRDEKK
AKFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPNIDSEEGNFKDIEYKIKPGIFKKVCERA
LENEDNIKDFNFHIDKLKEIVKEDGNDPEKYFKLPNTKYSIQYRGGKTFRIKFDDMSKNH
KDYPVSIENIIKLYKTSSINEIYNSAYVKAILNYLKTQGLKDYQEKDEKINLPYIICRRK
NKMSQKKNKMSYFCDKLSFFQP
>fig|195.2074.peg.841 Membrane protein
MRTKYFKFLAYFAFLASLIYGFYHILKAFDFVKEAYIYTGVFALFFFKFKPFVFFMQI
>fig|195.2074.peg.840 Membrane protein
MFSLCKFKKTKSYPKLLGIFAAFWAFLHFLNYFIFDRNANFLRLFDDISHRLLEASGFFA
FIIIFFMFLSSFRFFKRIEKIRKLGYVCLVLASYHYFLSPKVPMFWEWSALMLSLVYFMI
RYLKFFKFKKA
>fig|195.2074.peg.1877 FIG00469667: hypothetical protein
MRIARGGGYCKIIEPNSSIKGLFDENMDIIFANQSLYYIPLKELKQN
>fig|195.2080.peg.1872 FIG00470222: hypothetical protein
DELELKEQSVNIDKSLSIEKEKLLQAQTETEKANANLVKRQTAQIDDELELKEQSVNIDK
SLSKKKKE
>fig|195.2080.peg.1844 hypothetical protein
MKRTKKIKFTPLYFNFKVMLKSVLEKKISQKRAPCCYNYF
>fig|195.2080.peg.1409 hypothetical protein
MKLKDFDFRIWDGKKYINNVKGGVYIHKINDYIKCLKRNQDCYDYEFELDDLDNSNLEIE
LFTGFYDKNGKKIFEGDILEYTRWCEQYMEDAEHSETIYKVVCFDTNGGLYSKLLNGEFG
WFFEHFMNDKNNTIEEMSIIGNIHENKELLNVRL
>fig|195.2080.peg.1114 Translation elongation factor LepA
MEDAERKHQSNMIYAIEEPETSQHPNYQRIIIESLKKLAQNKGRQILLTTHTPEIARMVN
KENIIFIQKDNKDKRIVYHGDEIDIEILVDALSIIVPNSKALSKGRELVKAMKEIVPRQL
FEVAIQASIGNKIIARENVKSMGKNVTAKCYGGDITRKRKLLEKQKEGKKRMKAIGKVHL
PQEAFLSVLKID
>fig|195.2080.peg.1413 hypothetical protein
MFLSGLGEIKSKGVKMEIILGIGAVTLVIVSIALVYTFYKEKHKTQH
>fig|195.2080.peg.544 Signal transduction protein CetA, mediates an energy taxis response
MKNGLLSTIFLSVIGVLGVIFFHIFVGVIIFVLIAVLMIYLLRQHKDEQIMIDKLLVLCR
ELKEGNFDNRIIYVKTKSKKLAEIADNLNYY
>fig|195.2080.peg.1851 IS605 transposase (tnpA)
GYFACSVGEATPETIKKYIENQG
>fig|195.2080.peg.1018 Channel-forming transporter/cytolysins activator of TpsB family
MLKKILHRTSKDKFSIYANLGIKDDVNEIDNFRLESSSGRYSSIASGVEYSTLAFGGFLF
LNLEYEKGIPFLGSKKDSKDSLYKIEFNKVNFNLSYQKSFYANDGLAFLYQNSLGASYSN
EPLLYADKFLIGDEYTVRGFKESSAALDYGAYSNNTIYLQFLNAPKYLRALEPFVGLDMG
YGRDYLLPNKDFLAGVAFGFRYNLNHLSLNLTASKALHKSSNMPSETIPIYLRASVFF
>fig|195.2080.peg.1825 hypothetical protein
MRQAFYTSKFYISKKSEKEVCFKLNFEIEISGGGEKIYKVEIRAFVDYQYLKNGNNITPN
IHKNQNDWWLSYECDRWSFHSSIAIRDEYQSLGIGTFLINKMLEMDNNKEFKILRLNKQE
ILKIGGYGICDSCNRRLSNDGYMICVLYSCYCEKCYKEWYKVAINHKEDREIEKDVYENI
KSKITNIYF
>fig|195.2080.peg.1640 Protein containing aminopeptidase domain
MLSCLGDDHAYSLIHTPKENTLSNKVALHTLKNKKISKLLVF
>fig|195.2080.peg.1842 hypothetical protein
MSNTNVDYNKRLEVFKEIYPQILEMSLAEKSPFGEFKKLLEQFGNDNIIRNDTQFQSLAQ
ALVSVGQTIVAQSQNTALQMILGGDENIVNQANINLTNAQTETEKANANLVKRQTAQIDD
ELELKEQSVNIDKSLSIEKEKLLQAQTETEKANANLV
>fig|195.2080.peg.409 Phosphoglycerol transferase-like protein
MRKILLQIFSFSFIFMGIFALVRSLMVKNLTNESENSLMVYMHGLGHDMRTFSAIFLPLF
LCGLFSYIGLAFKNRKYNIMGGGVISKFYFYLSSLYIAFISFIVLISTFIHYYYFQLYAS
KIDIFIFGLKDDDTKAILSIVFSDYPIIRMLLLAVIFSIFCIWINIKILNLKLKEIQIKP
IFFIFLNILLIYAYVVALRGHFTYNALRVSSYEFSTIKAFNEISTNPLMAFSWAYKEYKN
QQEFKSVDTKQLNQLEEKLFPMFDTTLPHQNHAKNHIYVNIMESFGLNLAEFSTKKIDLF
GNLKKHFEQDIVFTRFLSSANNTIESLNRLIFLSPNTISNGLYQKEELAFTPLQIYKNAG
YRIIFVYSGNASWYNLGNYFKNQGADQIIDENTLMQDFPQAKETKHKYGIADEFMYKKIY
SIFENAKSPTLVISLSISTHRPYIHKSKKQLIDTENLDEKILNQFIIDNSTEALNTYAYA
NDEFGMFLDRIKESKFKENIIIAATGDHRFRDIKMDINSQKAFAYSVPFYLYLPKYLKND
IYYDKNRVGSHKDIFPTLYNLTLNNTKYLSLGGRNMLAPIKNQKLEFGFNEVVWIDQDGV
YDGNKGYYFENNASIKDTNKAFELDLYHKNFSKIYKELFQKQLSYRLVNLKTKNNE
>fig|195.2080.peg.1454 Phage Rha protein
MGFTGQKAYKWKIEFIKAFNEMEKRLRNIEYEKHDKLAFRQSLGYKSQLAQQKQKYENEI
KALKYDLEQSKNNFKDKLNCILAKNGLYAFDFKTFKNYALKLEKMLKDLKDDENKENKLL
SRMQNDFLECLELYKSINI
>fig|195.2080.peg.1308 hypothetical protein
MSIFSINDNSNYNSILSQAKANKESKENSKISFANAFLKQNASKLNEIQNANSTNSSKK
>fig|195.2080.peg.173 McrBC restriction endonuclease system, McrB subunit, putative
MIEFLNEDRKKFKEYLIDFFHNAYNSDKLSSKDEIVNFDFLKNYGFCVKLSYGKGTISKI
PWIIFIRTDTQEYKASYGIYVYCGIKRENGEIIVCIGESEDKTINYLAKNKVDDYNTQFN
KKTYDYKNLNNDIDLIIDKIIENMQWFAKLPLNEIQDRNDLSKSNNKEIRNDGSEMSNKK
ENKNLSLNQILYGPPGTGKTYHTIDKALEILGENLESRDRDEKKAKFDEYVKDGQIVFTT
FHQSYGYEEFVEGIKPMMNNEANSQEIQYEIKDGIFKDICNRALENYENSNLNTEELREK
IKLREKVEKFLNRLLETNEPISKTKGGNFFINSFNNNTIEIYSEDVERFDGIFKLSLSTF
ITLLKSNIEFNSAVEMFKKVFDRDYADRTHTYYFNLVNKFKEYEKQAVLKTEDNKISSNS
LNSYIIIIDEINRGNVSKIFGELITLIEPSKRIGESEELKVTLPYSGKKFGVPKNVYIIG
TMNTADRSITSLDTALRRRFEFVEMMPNSDLLNNVFICKDVENPNEDEDYLGDDAKTEGY
AEILQNILISINKRIEFLLDREKTIGHAFFMSEAVKFNKNNWIKPDEYEEDWYVLSISKL
KSIFQNKIIPLLQEYFYNDYALISAVLNDNGMIEKCEKDDKYLQKIKNLDNVDSEKIIYN
IASFDNKIWNDIKTYQAIYNDGENQSKNDKQ
>fig|195.2080.peg.1869 hypothetical protein
QNLNQAIKNKDELITNKTTQIQNLNQAIKNKDELITNKTTQIQNLNQAIKNKDELITNKT
TQIQNLNQAIKNKDELITNKTTQI
>fig|195.2080.peg.1777 hypothetical protein
MKKHYTIHDPEIIINNPTPKSEKDYIAGKKLNEKKMGEVGIRKDENISKIFHANEKRIKN
LELMAKKDVVVDGRNAHTSYTQAQSLDGRLVQKNISSATNKIIPQQNKSTNDFKAKLEEF
STKKTNAVKSINKEFKR
>fig|195.2080.peg.1845 hypothetical protein
MYHQNFFCFFSRARTRTRIFLFFIYFFIFLGGFLSPIKWGF
>fig|195.2080.peg.393 hypothetical protein
MNLNQTLQEKYPHLEVSVLKLSEAQKDNESKRIDSEYFKKEYLENEAIIKIKDNYAFLEN
FIVKMTGGATPLGADYPDKGIPFLRVQNIMQNYFNVEDIVYISQQDDEYLKRSRLKFNDV
LLTITGISYGKSAVVERDLVGANINQHSVKIEVKNINPYFLSTFLNSKFGKLQSDKKITG
VTRPALDYQSIKKFLIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDP
KNPLQSLLDSKTNNPTNSPNISIHTLKESFLKTGRLDSEYYQKKYEINEKIIMNKKYTVL
DNLVSITKSIEPGSNLYKNKGIPFIRVTNLTQYGLSEGDVFLDEKDFFPQYLQILYPKKD
TILFSKDGSVGIAYCVKEDKEVITSGAILHLNIKDKENILPEYLTLFLNSIFVKLQAQRD
CGGSIISHWRIEDIKKVLVAILDIKIQEKIAKYIQESFNLRKKSKQLLDNAKNKVEEQIQ
GKI
>fig|195.2080.peg.917 Type I restriction-modification system, specificity subunit S
MTNLPQGWEVKKLGDIAEIQIGKTPSRNNIDFFQGENIWLSIRDLKSKFVSSSSEKISNE
AISKTNMKVVPKGTLLMSFKLTLGKTAFAECDLYTNEAIAAIFIKNKNINKYFLDYVLKF
TDLEKYVDNAVKGKTLNKQKLKQIEILLPKNIKEQERIVGILDENFAKIDENIKILEQDL
LNLDELMQSALQKAFNPLKDNAKENYKLPQGWEWKNLGEIANTSSGGTPSRNKKEYWENG
NIKWLKSGELNDGYIDFIEENITEEAIKNSSAKIFQKGTLLIAMYGATAGKLGILNLDST
TNQAICAFLHKDKNIKFLEKFLFYFLFFLRDKIIKDSFGGAQPNINQTYIKNLQIPLPPI
KEQEQIASHLDELSSHVKNLKQNYQAQIKDLQELKNSLLDKAFKGNL
>fig|195.2080.peg.1853 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSTLADFTKDDLKLIEKVLRKYNIPCDQLANN
TVVSHCEYLSEIMTELKMLNRLPYDFEERLSATFIPSRGEYQNFGIMAAIDHINALKDLV
KRFPKLADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSAVPPLNYIIGRELEFKS
KDTNGDMYMQGDHFFVSCFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNI
IYVSY
>fig|195.2080.peg.1862 Motility accessory factor
FYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSSELQSARLMVLNTNKLEI
QDYNELCSSKPFFQFSRIYFLELMSHYYERFHEDVLELNKKLVQYFKDSIISHGNDSTDT
LQGIEQFVYNLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLLKKYANTATIF
CADSAYPILAKHG
>fig|195.2080.peg.1462 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
KENSLIEFNIEGNNPYEIYTIYKSYKAFNDEQDLTSFTYPIIDYIIFLDSDDYWELNCIE
ECVPRMDGVDVVWFDFEMFIDKEHKDINNPNWNRMRHFSLDGKISREEFEIEMIKKKLRV
FAFVCDGLIDFIFFKKNKLKFFNYGYAEDHYFGLSCFLSLNNIYILRKKFYNYRVRSDSS
CDFSQTYIINPNNKILFYIYKNMNYNAKEAMEYFRTYCYIETTLNIISFFETRSIKSVEL
FKNIIQFYYHRCRAIEQYNLDPMKIKKRLNKIFYYYSLFYEYKQLFNDKMGVIKNKDELI
TNKTTQIQNLNQAIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSKSI
LGYLIMPMALLSIIISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLG
EALIQANKTWYKGGYVKILFEIGKLKREFRNRKI
>fig|195.2080.peg.596 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGVLVGEGATINANKFGVSTTPMGIDAINTFSVDGSFSPVFNANKGDV
VNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTHLKAEIGSEGFFK
YEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEMINSWKGFAKLVN
EGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSNIQIDVADKTYVG
LFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIALDTIEGFNGENSSS
GGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGWINDGTFNNIILNNIEKSVLALHINI
SLQVALQDMQALELIKILF
>fig|195.2080.peg.1683 Putative efflux pump
MENFNRTLWVCWFGVFTTSMGLSQIAPILPLYIKELGHTDTTKSHFTQD
>fig|195.2080.peg.1834 hypothetical protein
PVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAGVKTFSSSIVIPNATANNHATNLG
QLNSKVAKTGDETIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAG
VKTFSSSIVIPNATANNHATNLGQLNSKVAKTGDETIAGVKTFSVPPVSATNPTANNQVA
NKSYVDYGGGIKNLGNQTAPKIDLRQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQ
NITAFSAPFKFRVAQSGFSGTETFAYFCIASNNVILVRT
>fig|195.2080.peg.1492 Predicted hydrolase of the alpha/beta superfamily
MEFQNGGGSFEFRQFIKTELLPYINTHYETSEDFQILFGHSFGGLFALDTLFNDTKLFSH
YFIISPSLWWGGSEFIPKRISLSNCPQIYMALGSAESNSSIKKAKAKISVKELGMQILNH
SACEVEFKLFENETHGSVIEKAMIWAIENIKSEPID
>fig|195.2080.peg.1856 Acetyltransferase, GNAT family
LLYYFINDLQNFNLKANYIKILTKTDKQLLQHNDFLKLNHFKEILNYKQMILKKDEIKLK
KFTFISKASHEDSKEIYSFFRKYFDPYLFYFSQKNLEEKIPNILVYKENQKIRAALIYTQ
TLNANFLDFIAVDRNLKHKNVAFALLNHYFAANTQNKFFKLFVEEKNQKAINFYKRAGFC
FNHINLKFYRNF
>fig|195.2080.peg.1 Diaminopimelate decarboxylase (EC 4.1.1.20)
MDYKKLKDEFQTPFYIYDFDFIKERFLKLKNAFKARKSQIFYAVKANSNLSLLQMLVKLD
SGFDCVSIGEVKRALKAGAKSYKIIFSGVGKTQEELRLALEYDILYINLESEAEMMLLES
VAKELNLKARISIRVNPNVNAKTHPYISTGLNENKFGVEIDLARKMYLYAKNSPHLEPIG
VHFHIGSQLLDISPIHEAAAIVAKLVRELKALQIELKFFDIGGGLGVRYEKEDVEPDLYD
YAQGILAQLHGLDVTIGMEPGRFLVANSGE
>fig|195.2080.peg.1408 hypothetical protein
MLDYNSWQEAQAKVEPLRKQVMEAILKDKRFNATIEDRDNLLKVEIKIPFLI
>fig|195.2080.peg.1022 hypothetical protein
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGDIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEIKANNVVNIDSVNDLNIKNSDIS
TSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQKSNTTTSIDGVLSTNIKGANVGI
VSNQDVNIIASNINADSKIDINANNVNIKDAHELSKTKTDGVYLKPVEISYESANLETSK
SISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENITIENGENKISSSSHSSTSSI
AGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELNGGEIDIKADKVDFIAAQNK
THTESDSIAIGVFANANLELTGNGVAVNYSFVQDKANARLL
>fig|195.2080.peg.1533 hypothetical protein
MSFIIDXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXYLNFHLY
>fig|195.2080.peg.1843 hypothetical protein
MRPRSKKDQKKKALPLNKSLNLAFSQKLNSFRLSHYNKRALRFFAPKKAKKPYNAM
>fig|195.2080.peg.1868 FIG00470627: hypothetical protein
GVKTFSSSIVIPNATANNHATNLGQLNSKVAKTGDETIAGVKTFSVPPVSATNPTANNQV
ANKSYVDTVGNSKVALSGNQTIAG
>fig|195.2080.peg.1410 Phage Rha protein
MSNAPVIINEIKINLEIMKNQVFINSLDLAKVFKKRHDNIIQTIENLPQDEFKTLNFEIS
SSIRKNGLFEKDTKFYKLTRDAFSLLVMGKNGKKY
>fig|195.2080.peg.595 hypothetical protein
MINGGKIGNEKSKITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDF
EDEILKTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFY
TEFNKGGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLKPELESIKNNFN
RLEFLKAEIKRLERVYQEAMQNDLLPYDQLEVVYKNTQEKNRCLLC
>fig|195.2080.peg.991 Peptide chain release factor 1
MLASKLDPFLKRFEELNSLLSSSDIISDISKMTALSKEQKNLEPIVLKAKEYLKTLDSIE
ENKTLLNDAELGELAKEELKNLEELKPKLEEELKILLLPKDPNDERNIFLEIRAGTGGDE
ASLFVGDLVKAYARYAENRGYKLEIVSSSEGSVGGFKEIIMLVKGAGAFSRLKYEGGTHR
VQRVPQTESQGRIHTSAITIAVMPEVDDIEIEINPNDLKIDVMRSSGHGGQSVNTTDSAV
RITHLPTGIVVVNQDGKSQHKNKESAMKVLKARLYEMQESERLAQESEARKSQVGSGDRS
ERIRTYNFPQNRISDHRINLTLYRLDAILQDGLFDEVIEPLIAHYQAESLQEQNYSFISL
ENKTND
>fig|195.2080.peg.1639 Protein containing aminopeptidase domain
MGGLQSIQEMILNLEINAVYKNTIVCEPNLGKRGLYHTLSTANDIPLACNFLAYCDGEND
IIDIANILNMQAYEFKELLEKIKFYGLVK
>fig|195.2082.peg.1212 Motility accessory factor
MTFTPTQKELFNKNIESLSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGG
IMKIYFIKIPLKNCKLC
>fig|195.2082.peg.1406 hypothetical protein
MNIVLSILAVIFIFLLCNYLYRKIKGIPNKPVKEIWNEYKQEMQKIDEVHKQRMQKIDEV
HKQRMQKIDEVHKQRMQKINENFEKEKERKKDLKFNKFQTTSHEIFTIKTPENEDVEVEL
ACTAGLIQTSQIDYGEFVRKEFLYKCFPVTWNDFLKLNKYEKILAYTVKDCNDIGLLKEV
YEQMFKYLKWQSELPEYLKKDIRSRKRYLHEFSNPVQIKSKLSLKAYRYYINFFLNEIPE
GSYFPMQIMHRGDELSEALYNTYFLKDDESIDMYYPPNFYGDTSSFDIVEPRFFNSREYY
KNYKPFNRFDLKPHSDYDFNIPKYIVKHYLDMKTIVKEDEHHKRIFC
>fig|195.2082.peg.224 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYIYVDDY
LARNYNVAIININYHCIGNRPHLGSSFYLDDIDKIILDTSLKTINLNHINVFDINSYENL
NNAFIRIDQEIQKLKLNQKLNQNYKLRTHVSFLPSKNEYQNFGIMQAMDILNAIFYIKEN
SPFKLMGGGIRTILFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKE
IDFTRYHGTYD
>fig|195.2082.peg.1803 hypothetical protein
MAIQINNFIMYLNNGNYTNDFEMFLNYLADDEKTSTVVKDKDKD
>fig|195.2082.peg.1111 DNA recombination and repair protein RecF
MIDNIKIQNYKLIKELEIDKFKNINIFTGENNCGKSSILEAIYLLLSQDYIKNFIYSYDV
FRNFPLNKKNIQFVFNNFDLNKKINIFTRLNKDILLSLKISLMQSSIVSISDNLNENKDI
TIHFNHKCQKNEQENILTIREIKNIEEKTGVVERQYQAKEYVNKSNAIYFPVNIFSFESI
YFLRNIRMANKEEKLVKYLQIFDENIKDVEEINGEILIKSLDFNQKVPLKIFGYGFIKFF
NYICALVSNEANYILID
>fig|195.2082.peg.1763 hypothetical protein
IYYNKCFNWEKLILNEFFKTNGNNKNTNDKYFYNKIFEVS
>fig|195.2082.peg.1734 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDKRI
TLFDKKNGGLSSARNVGIEYFSGEYKLKNKTQIIKENSLIEFNIEGNNPYEIYTIYKSYK
AFNDEQDLTSFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVEVVWMNHVFLYEYYDPN
AFRVTLIDKLKFTSSNKYSIDFLISKMQNLNQNSFWFGWHGMINFKYLYSIKLKFIDRLL
HEDHYFGKLLFFQAKQIYVYTKKKIHYRIRKGSIMNYSKENSYIPSYALSEYSALNNDYF
LYKKYHRISSLFLTAMMVFKFMKEDNKIKSIESFKQIFYKKLKSWRNDLVDFDEFFLEKV
LFLSFQEFFRLSSDYRVNLELISEFIADIVKTKNQLMNKQNNSNSKSKSSNKKQRRTYNK
QNNSNSKSKSSNKKQRRTYNKQNNSNSKSKSSNKKQRRTYTKYKQSTILPN
>fig|195.2082.peg.1661 hypothetical protein
MIGKDFLYSIHKDKKSIYFVKIKASLIVKAFMKNFIN
>fig|195.2082.peg.1004 hypothetical protein
YDDTLFKNIFLYLSDKTYWNNNKFSKKYFSNARKIIREPLNKEHLIIQSLYPNPKYILYH
SIFDERSPFENKENFVHILKELNFKVEFFAISQVDNKFIKNLNHGMGLSTKLFFKKHLLQ
ILKEPLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2082.peg.1822 hypothetical protein
MKKIFALLALTSLLTSSVFAEDFLAKLTKGALSDTSPGVKELSLEEMKQVKGGYVFGDYK
IFKDRRNLTSEVYAIVDFTQYELENLNKGLCGAGEDKCQNPSRDRLFAWLQVSANSPADY
RPVYKVKRQIKYSNLGQPYVLFTYGVAVYNVNNG
>fig|195.2082.peg.1800 conserved hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRN
LIQDTEKIQNNIKFGVSGEYIGNYFSTNSLKSIDEIFYENPDSNKILNYHVVKCLFLIII
>fig|195.2082.peg.1000 Arsenical-resistance protein ACR3
MGFITRTLLLKYKSKRWYENTFLPKISPITLITLLATIIIMCSYKANEVFHLPLEALK
>fig|195.2082.peg.1719 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MQLILKKEYFIENIICSTFDLNFIDNSFFLKSFYNWFPEAYLGHEILNKLKDFYNYIKY
>fig|195.2082.peg.1 Two-component system sensor histidine kinase
MKTKNIFITFFVLLILCFGVIFYTLTNSYLNFLLLKQYEQKIKSLDDVLKFSLLEDLNSN
NIKEFAQDTRADFIILKDDFEISSVLNADLFLNLEENKIYDLNSKR
>fig|195.2082.peg.314 Septum formation protein Maf
MLILASSSVSRSNLLKEAKIEFQQISFDYDENLDKNLKPSIYVQKIVLEKERQFCTTYEE
KFKDETLLFADSIVCIGDKILTKANTKEEACEMLDLQDGKCASILSAFLLKNLKKEFSLF
QKQRFIFQNLILVI
>fig|195.2082.peg.1793 McrBC restriction endonuclease system, McrB subunit, putative
ANYINQDFLNKGNEFPLENKVSIKKILLNFKDEYRSFSLGGSIKSPQSLTIDIIKRDYLN
FKNKKILSFKDIKPKYDSQSDYHGNAIYYFMFYNKLKEFENIQNEKFKIKKEILKSYIII
IDEINRGNVSKIFGELITLIEPSKRIGEKEELKVTLPYSGKEFGVPKNVYIIGTMNTADR
SITSLDTALRRRFEFIEMMPDVSKLSMDCEGINLQELLKAINTRIEYLLDREKTIGHAFF
ISVENLEDLKKVFKNKIIPLLQEYFYNDYALIYAVLNKNGMLEISVENKDYLKNMTEFIE
SDKIVYKFSDSNNWSKDTFIKIYE
>fig|195.2082.peg.151 Inner membrane protein YihN
MICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVLLKAIRLLGDSTQQGRLFGFLE
AGRGVVDTIVAFSALGIFLLLGSGAGGLKAAILFYSACVIIAGILAYFLLEDDKISTKDD
EGHEISKNKAAWNGVIKAVKTPEIWVVSLTIFTIYSVYCGLTYFIPFLKDIYGMPVALVG
AYGIINQYTLKLVGGPIGGCLTDKTFRSSTRYLRFALILAAVAILIFIFTPHEKLNIYFG
MSLTLGFAAIVFTMRATFFAPVDEIEMPREISGAAMSIACIFGYSPQLFCFALYGFIIDQ
FKGLLGYQIVFALMGFFAICGVIITTILLRMIAKKKNITRGSVMKIGLETESMHLWFQNG
RMDIFSYIDFAEELGCDGIIINIIKDFGLDEEWGCLGSNDESRLKKIKEKLDTYGMYCEI
DSKGFDKDKFEKIAKVSQLLGVKIIRSYVPLTDKNKKVKNASDGAYDDSKITAKFDKSEF
LSTADEIKALIQLLEEYDLKLAIENHEYQTSDDLLELLNLIHHPRIGFLYDFGNSMMAYE
EPIKACENMAKHTFSTHCKDHIVFIEDDTKYVCGVPLGEGNLDIKTCVEILKQAGLDRIN
VEQCYPYCATFKREEGAGGVKELGKGAFKIEKPLFNDLKAMQYYYPQEVSKEHLERLLIL
QKEGCERSVKYLKSII
>fig|195.2082.peg.1814 Mob
MSKVATAHCNPKKQPALNHNDRTNDNAKTITKELTHLNEYSCTSDEVRKNIERLYKKAYE
NFYKYCENKNGLAKSGKPKGLQNFTKKEKCYHEFIYEIGENTTMEQCQELTQK
>fig|195.2082.peg.1794 ABC transporter, permease protein (cluster 3, basic aa/glutamine/opines)
AKISTIKGENLSLFIQKCKNFKFQAPLSKKTIFFNSLVLIFILSLFFYFSFSVSAYHFNF
VSLLEYKNKIIYGFFQTLSVSFFALICSIFLGIVICFFSLSKIIILRFFATLYVELIRGT
PLLVQVLLVFYIIANSLGFDDRYIVGIFILSMFSAAYLSEIFRAGILSVPIIQIESARAL
GLSERQIFLYIIFPQAIKNILAPISGQLANLIKDSSLLSVIALNELTQSIQEVNSYIFAT
LEGYIVLAFAYLILTLPIGVFSRYLERKYQK
>fig|195.2082.peg.128 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MMGGYELNSILENLQKLEFKLDFNLLFSFIDDFTNARQEDLKKFKEFVKNIKAILGTFST
PPKQGWNKEKLNEIVSIQSGGTPDRKIKEYWNGNINWVKSEVCQNCYVYDYQVKEKITEL
GLQKSSAKLLKKETTLIALVGATIGKIGFLTFESATNQNITGLYPKNLKILNTKYLYYAC
MGLYGQFRKLGDFAMANSNFIKNLTISLPPLEIQEKIVQNIELVEQQIDFLNLKLEFLEK
EKEKILQKYLFS
>fig|195.2082.peg.313 Septum formation protein Maf
MCEGFHKNYIIKQEGNLNTALGLDTQNLKAYL
>fig|195.2082.peg.735 McrBC restriction endonuclease system, McrB subunit, putative
MWNLDEKKLQEMLDGFLNFQEVWTLEKVKNMTLEEYTNIKKDNPNRDDFTFWIESKLDNL
GSIWGGSAFKFGIYRRNDESQKESSSGRLYSQNYAWIAKYGNNENEAFNNIKEKIIQIIQ
ASQDNNLKTIEKIDFGDAIKWKIAFHYQDVKNIKIVNIFSKNVLDLISLNEFKEKLKIYQ
IHKKLLENKNLSLVKMIENIAIPLWNKYGMDSQNYIDKMKNLFSEYLNKKKLDKNTINKY
IQVIENISKEFLKENLYSCDLFSFDQNINKLNKNEEFKLKNSNGHNMYSSALNYYRAFLI
DYYEQDIFITERVQSEESNMKIIPLNQILYGSPGTGKTYHTIDKALEIISKEEKIQIPSE
DDRINRKKIFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPIIDNDENSQEVK
>fig|195.2082.peg.1208 hypothetical protein
MINGGKIGNEKSKITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDF
EDEILKTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFY
TEFNKGGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTILKPELKSIKNNLN
RLEFLKAEIKRLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNK
PFLDDLITKEYSFEDKYTDIQGTFAIAGSSIDANAIENLADKPILSLPENENSGDSQTTN
NTDSTDIVNTFSKQVKLTSTESILILPAEETQSHIKEDERERGRVCITSDNAKTNNPCIA
ITF
>fig|195.2082.peg.1001 Arsenical-resistance protein ACR3
MFFLTWFISKKNHLSYPKTCSLCFSASGNNFELAIIICIATFGLHSEQAFASIIGPLVEV
PVLILLVKWALGKSLNSKK
>fig|195.2083.peg.1478 Uncharacterized MFS-type transporter
MGHLKLTKLELVCKKISWRILPLIVLMFCLSMLDRTNISFVKSHIEMDAGL
>fig|195.2083.peg.1782 Propionate--CoA ligase (EC 6.2.1.17) / Acetyl-coenzyme A synthetase (EC 6.2.1.1)
VHWYNEWDRVLDDSDGHYRWFVGGGMNTCYNALDLHVHNGRGGQLALIYDSPVTDTKKKY
TYKQLR
>fig|195.2083.peg.1439 Citrate lyase beta chain (EC 4.1.3.6)
MSLISTINIIGVVLPKAQSYEDIDMLSQFELPIIPIIESALGVENLDDIARHPSVLALSF
GSLDMTLDLNLQEGEGKNFILNSIRTQIVLKSTKYNLLSPINGVYPDIKNIDGLKEDLIF
AKSMGFGGGVFVHSSKPSCTN
>fig|195.2083.peg.1779 Methyl-accepting chemotaxis signal transduction protein
DFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVETVGVVESGN
LTARITANPRNPQL
>fig|195.2083.peg.279 Signal transduction protein CetB, mediates an energy taxis response
MEEIFLAKDALITSKTDLKGNIIYANNDFLKYAGYKVDELLYKSHNIVRHEDMPRTVFKC
LWDYIQKGDEIFAFVKNKAKDGNFYWVFANVSASFDTNGNIINYYSVRRAPNRKSLSIIE
EVYKILLEKEKKSGINAGVSALMDIVSSYKMTYNELIFNLQENNEIRYI
>fig|195.2083.peg.1689 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYSIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEFEFNQNIFYALNFKNKEISFTELVFSFKI
NSLDR
>fig|195.2083.peg.1040 hypothetical protein
MSDITFYMDRIDGLGSRIIALMNAFFLAEYTSNSDSVKFIWKDNRPFGGVRTEDTKAGFR
KETDGKVDIVGLCIENAENIFSESFLKKYCIDKISFKTISFDKPYSNIDLFREYLFKNQN
SFFNAPLADLTSRSFLPNLDLSYYKSEMQQCWKKIHFSAEINKIILNAQNMAEKIGDFVV
IHIRSGDGIYDYADFRKFNTQQFYHITSAELAMGIIDLNLDKEVILVGDDLKTLDVIVKY
YNKNNIKTINYFRDPTKLSNLELFFFDVAFMSKALILYGTHSAVVRLANFIGNQKFINNY
RVFTNEEYLSILKKYFPILKLHRCQKAYSLFSMFNISRILLKPQDDLLLYLYQALDCDYD
NDKYRIHIVNCLITKGDLLGAENLLKDIFENQNRGKEYIDTLFLKGWTGVVFKEVFDNYL
KNATEDYPYITFIASKICEFQNDIKQSFFYIQLISRRFDKPFFLEYFNKVKQNYNKEKEI
EHALYHKKVALSYIEKWKWKSAINHYQLALKYSDEYLVEFLNFLASIGQLKLLDQIISKY
SYERIEREVSFCKNYYVLSIYLELYKNDIMEKKSIIYDNLYIKDVLINILKKEKISQKEE
LIATYCISSCDEIFSEKLDISIYLSFYRKIWDKNLIRSQFLITKLVKSYKKYIVKNLDIL
IQVTSDITALGNTKNKLQPGAKKYQEKLLSYYKLHHQKNIKPKIAVCLWGIYRGNCEKNL
EFLKKNIIEPLGADVFVHLWNKWDLWNGYGGDVIWTRRYLKPKDRDLFPSEISHYDTLEK
FFPNVLKRLSTPIIKILPLDVIKSILSPLLIQVDNDEDFKNKFSFPLEKLSYIPFANYNP
YAVARLRYGMYQSYNLAKEYGKRYGEYDYIVLARIDQAYLNEMNIQQFLSLGGNEFMCRI
LKHGIDDRIIAGSKKTIGKFVNKYNIMIKKQSTNFYQVEERRSYYIKGEEGVGFLWSVEN
NIRPIPINLDIDISLSTQGMIPNFYDELKKDLNSSAIAFKDKIEYKELLNFLQSDDGKFF
KNYDQNLEKEKLKIGAVERIHNHLSYKIGCAILNNMGSMINIVKLPIVLYRIKKNHNLDK
RLTNNSLQSIPIEQYADYMEALKEKESFEYKIGEMVIKSHKNWYKGGYIKMLFDICELKS
KMKTRGEE
>fig|195.2083.peg.1741 Site-specific recombinase, resolvase family
MGTLNSIYDKDIDKIQTLLDKDLSIRSIWKLFYKDSGKTYDGLLWFIKKRKLKQK
>fig|195.2083.peg.556 Putative acetyltransferase (EC 2.3.1.-)
MLRKTDIKDLNACLSLFEQSVKTLCAKDYTKDQICAWIKIDRQQWEEKFKYDEIFVYEKR
GKIASFISVKQEQKLLDLLFTHPDFVRQGLSTKFT
>fig|195.2083.peg.1665 Site-specific recombinase, resolvase family
MNIAYIRVSTNKQELDSQKLEIMEYCHKNNIILDEILEVKISSTKSQEKRKIKDLKQRLQ
SGDLLIATELSRLGRSMLEIINLVLEFNANNINFLFLRQRELSNFNNPSSKLILSIYAYL
AENERDLISQRTKAGLENAKASGKKLGLITAK
>fig|195.2083.peg.1751 hypothetical protein
FLLYHKLKPQKESYQNEFLEIYILINDYIKLSYETNNLINLNINSINRITNEHNVLTIEL
EKKQIPKNKKLKIKEDFINLKLPEEFKLIETHKELYLHGMEQKNCVYTRRREIEDGLSAI
YSLNYEGGVYTLEIFKRKNKFAIKEIKAKYNEFANKEVINFVEKSLKAV
>fig|195.2083.peg.1748 IncQ plasmid conjugative transfer protein TraG
MKNTIKLALLGAVITGVFSACSSEPKTVQYYEDPKNATELEAKIKECDKNANSAKTDTEC
ANAYEARYSKSLQNFHNEAISDEEAAKFFKKK
>fig|195.2083.peg.96 hypothetical protein
MGGGYELNSILDKINNLCKINLDSEFLSSFNKTIKEYALSNPIFKLSIGKRVLNNELLEN
GQIPVYSANVLEVFGFVNKEILQDYDNDSVLWGIDGDWMVGFIPKNKKFYPTDHCGVLRV
DDTKINAKYISFILNEAGKKQGFSRKLRASIDRIKALRVKLPSLEFQDQIADITDKIEKK
INEYKIELDRLEKEKEKILQKYLFS
>fig|195.2083.peg.1731 hypothetical protein
MINVYFCEKPIIDFFQNAEYEKELQYYGINEKDFIKTDI
>fig|195.2083.peg.1780 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
VHWYNEWDRVLDDSDGHYRWFVGGCMNTCYNALDFHVHNGRGG
>fig|195.2083.peg.229 hypothetical protein
MIKIYVEGKSDKIFLDLLCKNLKIDEFETIPIGGNN
>fig|195.2083.peg.1 hypothetical protein
IKEDISDMRIEKICIIFDADDDYQKTKENLQQQLKNLQNEKIKIFLFPNNKDNKEIEILL
TKIAKYPHFITCFKEYSKCLKDKGTILNEKELNKNLIYAYNQACGSGTKEICLDHYDLDH
EYIKPLIDFLKA
>fig|195.2084.peg.1824 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDLTKEQYEQNKSIICGFAIENMFANEEDIINLIKV
>fig|195.2084.peg.1742 Enterochelin uptake permease CeuC
MRKKILILAFLTLIMALVFVFAGLKDFDEYALKNRFLQIAAIVIVAICIAISTVIFQTLC
NNKILTPAIIGLDSLYMLLQSALVFSLGSANLSVYRNDINFLITLACMVVFSLGLYKILF
SSDKSIYLIMLLGLIFGTLFSTLSSFFEILIDPDEFMIIQGRMFASFDNVAFDVLALAYI
VTLLSFIWIFRYMKFLDP
>fig|195.2084.peg.1741 Enterochelin uptake permease CeuC
MGKDLSINLGINYQKISKHLMIIIAILTSISTALVGPITFLGLLVVNITYELFKTAKHSI
LLLACILISILALLGGVFFVSRIFDYNTTISVIINFLGGIYFIYLVLKGNKL
>fig|195.2084.peg.824 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTIGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTD
>fig|195.2084.peg.1813 conserved hypothetical protein
QNKSIICGFAIENMFANEEDIINLIKVDKQEKTPDEIIAEYKREWGV
>fig|195.2084.peg.1789 hypothetical protein
GGGWMLHYFRFKKDGNCTKILLRKKKTIFDKPKETYISKKSDILITGINASGKSKRLNSF
LQNAKDLWKKEHVIFFHATDSLSEIFHRNLDNDDETKRLIYGNENANLNLENLDTSKNYL
KIIALVEKSKNSTLIIDDLDKLTGKKLEMAKELLRNCKRFIATAKDENSINKTIGGILKG
RRKRLEVIALSSKASLDATNALFVIFVLALFATGLHELALLVTAGRIAMRGMQK
>fig|195.2084.peg.1841 Motility accessory factor
LQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSLAKQLSLLKAYQDKAVIFCADGALS
MLEKEGIIPDYVTNLDCRDLAMKFFQNKENKTSLNVLSCATHPSLVHFLDNKSVVLRDDP
LYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGN
>fig|195.2084.peg.1459 Phage tail length tape-measure protein GpT
MENAGSIGIGVILGLAIKNASAVGKVVKDFSNLEKIAAKTKLGISGLQKELNTLKLNANL
RAELKAQRKGLQDELLSLGNVIRGGIIGKGLGEAISFESAMADVRKVVNFDEGDDIKKMS
ADILKMSQTLPVTANELAAIAAAGGQIGLGSKDVREFTNLVTKMKVAFDMSAEDVGDSVA
KIKNILGISLKDMEDLGDSINNLSDNSASKAREIIDVMKRTAAAGKQIGFTKEQIAALSS
SFISLGKGPEVAGTAINSLYRVLATADNMGTKTESAFAKLGISGAFLKQASFDDPQKALD
MFLQRISKLDQKEQMGVLVDIFGREFADDMATLVGGLDTYKEALKNAGDEAKKGSLQREF
DTRAATTENSIILMKNAFNSLAINLGSVFLPAISWVSAGISYLVNSITYITGLVPGLNGV
LGGLIATFLLAKPAVLAYAIAKNYLKDCTILLKSALIKTRIHLLAFRNSCILSNITLKVK
TITTNIYTASLKVLSFVLIGLNKVFKLVAIGIRVLSVAMMSNPIGLILGGIAIVAGLIIA
NWDRVKSWFMSFIEWLRPVWEPIYNAIKAVFNKCSGVIGYFKNNALNIIFPFVGILKFIW
KPIYEVFKWVFDKCSGVIGYFKNNALNIIFPFVGILKFIWKPIYEVFKWVFDKCALVFAS
FKDIIMSVASPLAEFLNSIWQGIGDFFYSIFGSLFEWFASKLSWVGDMISSISGFIKDAL
DFVGLGDDKEVKISQNEQTKEKIFATNTYKDELQAKSINHTPSFNNGNINVSVNGTFNIA
TKDGNFNMQEFANAIQKSVFDALRKQEQNKINTTIYG
>fig|195.2084.peg.1844 Motility accessory factor
DFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFSYGEQFSGEKTVP
TLKAQAYAGKGEVLTHITWNDYRIKLEYLFACNEQKAKFYNATEGGARINFTEELSFKEC
CEKLLTKEKPKFELPKSLTK
>fig|195.2084.peg.1457 phage virion morphogenesis protein, putative
MQSKSGFKYGLVHQYGSRKKNIPARSFLPIDNNNVLHQSIRSVIYKDTKDFIVKIAKK
>fig|195.2084.peg.1794 hypothetical protein
MIKIFLFFLHGVSAKKSCKKPTFASFFATLGAEKNPFCEILRKRQAL
>fig|195.2084.peg.1458 phage virion morphogenesis protein, putative
MSEYIEIKGIENFFKACDKLIDMDKHGQSIMAGAGESIRNSIIDSFKNERSIFNGKWKSL
KPATIKQKIKKGKNKGILKRDGI
>fig|195.2084.peg.1447 hypothetical protein
MVDKNINLEDLAKKTISEVSSIMEEQRRQSEILKEQEELRKTQIQEDMPTVKLKEEPILE
QELEDKISMAKFEEEQKIQEEIKNLDELNQENKEPVKEEAVLQSEILNPSIIAEVQTLNE
DIFLKHLRERILVLFEGLNSVKEENLEHRLQLTINFLEFLLANIEDKLKK
>fig|195.2084.peg.811 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGVLVGEGATINANKFGVSTTPMGIDAINTFSVDGSFSPVFNANKGDV
VNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTHLKAEIGSEGFFK
YEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEMINS
>fig|195.2085.peg.1402 hypothetical protein
MFNSFLSEMLKTATLENLVYFLIGVLFGLSIRPLFLYLTKKQKLKRVCIKDMKLENDLTK
RLYPNLGYKLVTKKLLLKWFLKKINLNTLFVLTTVIKNAF
>fig|195.2085.peg.1406 hypothetical protein
MKVKTLVFFLGDNVIGFDSSKREKEDIDFISTILESLKDEIESINRIGIKRTFDIDSIDN
FLELKIKNNDSNDDLKKLSQIQLKEDNWVFNIISAEKNDIVINNNKKTSGYMVDVIVFYE
KLENFNYNETIEKISQLYSLQEEKYKKITK
>fig|195.2085.peg.267 hypothetical protein
MGILGRKLPIIAKIKQENNYNLTHLYQILKEFQMEFKDLLS
>fig|195.2085.peg.663 filamentous hemagglutinin/adhesin
MEFSKKKIVRLSLNLTLLGALFPCVLFSADLRQRNGNVIVSRTTDLTQSSNKTDVINIKN
PNQNGVSHNQFDEFSVQDGVIFNNSLKDGNSQIGG
>fig|195.2085.peg.1237 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MCYANLEYIKQRFKIIEGVDISIVQEFSLPLNLEQKKQLKHKVTLGIPNMEIFWLSTRGE
VLEPSDGHVWFSPIIPRDGKELLKCQEVYMNLFREFGEESPITPFSHPRSWMYRAFCFML
AF
>fig|195.2085.peg.1389 hypothetical protein
MGENAGLSLIGDAAFAGVAKGARALKNTYNMAKTGAQAGKDMIDGMAVKGGNLGNRVIDK
ITQKDIPMIGKFTDGGLQNAETIFNNLTKNVENKKQIDELIVKENPTYLENGKPTIEILK
NIVEQGLNKNNPQFIQDSAKRTSAILKNISNALQGVPTTQRREILLKSAQAYPEIGSFLD
DVLKADKDASISFLNIIKEQDEVFKNKTGLNGEFDVKAWQKDNSSYKKRINNEYAQAIKS
IDELNNGSIRLSKEDLAKIEEFKNNNFLEQDIKTNISSFLEDTIDKDLSAEQIFNLRSAI
NKQLATGNKTYNTKEAYRLVKDTLDETMIKNASDKELAKKILEDANKNYALKENFNNSYL
GKIKDQETPEALAQRIANGARNINEDKDLKRAFEGMNEAERKANEKHAFNALLAKHRIED
IGYDFKNLAKDMDNVEFVSKDLKYAKEVVNVYAKIYQNNKDLIMTALASSGKKTNSSIAT
TIQGVFDRILISGVFARIHALVPFMKSAKEQALRNQILDALKLAKTHKEVISNLKNIKIA
DKEQSRIFKDALDNYIKVDKEQNKILKDALIKEGVIKGDNFFMDKADPSKAKSDLNVKIS
VSPNVRNLAKLTNDEIIADLEYLANKHKEMFKKPSDVFKLIKEIKENPTFFYKNNRMDIA
LIAKRLNDNKLGKLGVNKDTGEVRHVTKVKEKDLTRLEKVSKKNTKENVGIIQTFIQPGS
KNDNSLNGLPNNPNSTQTKPKKNLMEDIKENIKAKEVKKKNKKSVKQSLDEKIQNDKKAS
EERIEKIKQVIARKQKIDKVTDKKNNREIAGKIGTYTLKNLIKLKERSEDK
>fig|195.2085.peg.1869 conserved hypothetical protein TIGR01671
MKLQDFDFRIWNTACKKYIDDVGLISNIMCDLIHSATDIIED
>fig|195.2085.peg.1140 hypothetical protein
MIVFPLSSFNRYFGNNPLQTLTKIRDESIENGNPELAKKQREELGNDLIDLYKISKKFSD
KIELVEGSIEDKLRNNELPESEVKNLFQWMDKNAKHPRWMHIDGVSYDEAYVKIFHTSKS
IDEFKEKYLELQKKYFVDFNNIDSSQKILQENLEENKEKPFKPIQAESKSETYKDDNKMN
ELLRKLLETKFGTSDELEILFGMKFSDDDAGEFNKILSLNSAPKSVDIVRGILKRTCNYP
>fig|195.2085.peg.399 Oligosaccharyltransferase PglB (EC 2.4.1.119)
MDKTMFNSAYVQMFFLGNYDKNLYDLVINARDAKVFKLKI
>fig|195.2085.peg.1879 bacteriophage DNA transposition protein A, putative
ITTDNLKTINNSLKTSNLNLAEPKMNNDLAVLNLKFENLSDELKEDAKSKVKLLKQVEKY
IEGGLSIARTLKIEKINRRFYERIRKAYKENGILGLIDTRGLHRKDKTKLSAWMQEYALR
EYRT
>fig|195.2085.peg.1493 hypothetical protein
MKKMSLGDDFWDQLKVIEKNSPKSFL
>fig|195.2085.peg.1061 Putative polysaccharide deacetylase
MKMIVDAGHEIGAHGYSHENPIAMSAKQEEDVLLKSIELIEKISGKKPSGYVAPWWEFSN
ITNELLLKHGIKYDHSLMHNDFTPYYVRVGDKWTKIDYSKDAKEWMKPLVRGQETDLIEI
PANWYLDDLPPMMFIKKSPNSFGFVSPRDIGQMWIDQFDWVYREMDYAIFPMTIHPDVSA
RPQVLLMHERIIEHINKHEGVKWVNLNDMADDFSKRFPRKK
>fig|195.2085.peg.1403 hypothetical protein
MKKAMKRVRIEIDISDETYEIMLKLMKKRKYEKVEDLLFAYMGTMYKMELAGALLENDKN
LSLIKT
>fig|195.2085.peg.1894 Putative fibronectin domain-containing lipoprotein
LEWVDNDSRAVEYEVRRYGGDQNAIF
>fig|195.2085.peg.1374 hypothetical protein
MINLLFGNAKLYIALVSMAILAGYFYLRLDSTKAKLEKSQSDLALALKVNENNQEKLKEL
NQIHKTELKALNEANNQKNEVQKKVQYVKEYIYKSNENNITKLFNDVVDRLWDANRASSN
QNRNSKSENTTRATNSKPP
>fig|195.2085.peg.1889 Hemerythrin domain protein
GQILVHLDYFDLNQNFEKFNAIFEDALQNHHFTTQKNDMGGGDR
>fig|195.2085.peg.731 FIG00973752: TolA-like membrane protein
MFLTQTFIYTLTPKFDILISGGGSYARQEYTNFFTNEYSSKNRIGFDSLWLGFIYTGDSI
ADLIPQITFQTAVVQREKAINQTKNFYLKSQSLQASLRGYSDPVVYSIYTGFGYNQSRKF
KTLKIEYGNSIYVGGNLSIILSPKITLDLGAEQRFQMKQKINGYQNSEVRSIPTLSLGST
YSINSDTAVSVNASFGGSSASPDSIFGISLWKKF
>fig|195.2085.peg.1287 Probable periplasmic protein Cj0776c
MNLKIFSIIVGILIAVIVILGGTYYYLFEYSKPKNYTLNTNTYTEQKSYTNNYDNSYSPS
IQTNNSSSDININNNTIQKQETNLLDENQSLNNNTFNTSISENNQSLNNNTNTSNNINTN
ENKQILDTDKEKLKQENKQAKIEALKKEISKQQKILERERAVKKELQSNKSNKNKYLNTA
REYLSIGKNSRLEPELSTENMKVYILDGKFLSQYRINLLKDMLSVIQDNAKDYYLSIFVK
MLPKGEMKLTIYNKEIIFSDMKKAYKYISLDRLSPYLNNPKELNEHVAREEILERLKLQI
KKDGKGSDFSKHIKSLKTGLNTAQYFFPFCEIIEISSIK
>fig|195.2085.peg.1424 RloG protein, putative
MAEEKENIVNFKIKIIHEENIELGIMANSLLSFQKLMDSFISKEHGITQSKIFLEKVETG
SDIYSLVFEIAGEVLPIIAPIQALNEFIELIISFKNIKSKSIEEIEENPHFTKYNANNLK
NIFAPVTINQNTFFINHKGEELLRINSDEAELIYENANYICEKKEIEYQKIHENALITMY
KTTNKIDNKTKHKAKCDALSPYAVDVSFSDEKIAEEVLKNPYGFNFLVDLEYYKNDKNKI
ILYRIFNIKDKISLE
>fig|195.2085.peg.1896 Mob
ATAHCNPKKQPALNHNDRTNDNAKTITKELTHLNEYSCTSDEERKNIERLYKKAYENFYK
YCENKN
>fig|195.2085.peg.1426 Phage antirepressor protein
MNLLQCEICQITRSFLNTEVAYNYAVDNTTIMSHKNLHSDELIENIHYFYDYEQTKGGRQ
RVIKWTLEGVYMLGFFIKSPKAKEYRKKVAKLLREQTQARFKTLSDENLRLNSLNHHQKI
GYKSQLAQQKEKYENKIKALKYDLENKNELSFKRKLSQKELLELRKILARDYGMICIKEW
EFEFLAEKIALESTRMTTWDAVVKKLKQSLDYWQNYEEYEEKWRKILRR
>fig|195.2085.peg.266 hypothetical protein
MFIIAIIKISKCGLKQDISIFLIRMLKILKKIKTQNS
>fig|195.2085.peg.1327 hypothetical protein
MSIFSINDNSNYNSILSQSKANKESKENSKISFANAFLKQNASKLSDIESKNSQTLARSE
ILSNNNALSNNSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQVDLST
DTAYGYSVDKDGYMGSDFNKAAGLPEDFKIHKSTLDEIERFNQHGMADETSGNYYDSFDM
ASIVKSYYNSFNQVISAFPNDKTSFSEADLEQLPKGLNDGCNQNKEYIVTHIFNAEQFHE
AQAIKYSTMNLGMNLMKLDFSPQSMEQGPSNEGGFNPDMSVYPKNEDGNYSKEALFMSFL
KSYSPIPSSNQVVLSPEAKVLEAKFEQEMKANPSFSVSLDDIMTGKVDFASLLKGYAQDG
WLDAGIYAMEKGVAWQNTSIGYGGAWFERELNQAKANGWKASNQSIDSYVNSIMDRLNNL
LGQTRV
>fig|195.2085.peg.458 Inner membrane protein YihN
MICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVLLKAIRLLGDSTQQGRLFGFLE
AGRGVIDTIVAFSALGIFLLLGSGAGGFKAAILFYSACVIIAGILAYFLLEDDKISTKDD
EGHEISKNKAAWNGVIKAVKTPEIWVVSLTIFTIYSVYCGLTYFIPFLKDIYGMPVALVG
AYGNYQSIYFKIGWRTNWRLFGR
>fig|195.2085.peg.1675 Undecaprenyl-diphosphatase (EC 3.6.1.27)
MDNLYALILGIIEGLTEFLPISSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVLILIELAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLSNANSLIPLGIGFITAFIVAVLVIKFFLKFISKFDFIPFG
IYRIILGFLFFYLYYSGILNAGSEFKLLNKY
>fig|195.2085.peg.1408 hypothetical protein
MKPYLYSLIKFIKEEINVIPKESANTSICQNILHKVVFISISLYNKGYFDDESKIKEIID
NNKEILDKANKEIIIKESIEEQKIISSLHSVFNYLYKKNSFI
>fig|195.2085.peg.77 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDKIFLAARSDGLGSRLVAILNAFYIASRFGNKENVRFSWVNKETFCQDDGFNKNFRGLN
TKIIGMSVEEEDRIFSRNFIEKYHIVESEINTRDFFYCKKKVNTLEEFLNIFRQDVTSVC
RTDIGFLPQYLKDVELNDYRGICKQAWENIEFSDNLKKIIKDAQQKSQKLGDYVCIHVRS
GDVIYDYLDIRKYHKSHVYHAVNAALALELIYKELGKNKIVIIGDDIDTTEKLVELVNHP
EVYHINTQRSVDHFSNLELFMFDIIFMSNSKKLYGTYSAMIKIARMISETEFFSSYYQFK
SGEYYEILKKNYNYLFPYISSSQNAFILFHLFLTGMELNEDVEILCSYLDKALEYDFEND
KYRIYKIYCLLKYNKIDKAELFLSQYLSFREKDFISLLFYKNYAGSFSEVFPYFFSNAKS
LYPYISYIAAQIYMYHRDYFMAYKIIKDIAYLNPSFINFSKKLAIKSYKYLNISLKNKDQ
LIKNQIVQIKELKNKVLQLQKDFDSINLLKNDLLEIQKKQLDVLIKDREQMIVNRFRYGK
AKNRIQNQLSYKLGQAMIVNSKSLLGYIRMPFALSYIKDKHKQEQKIYQEKIKKDPSLKL
PPLEDYPDYKEALKEKECLTYKLGEALIKASNNWYGGGYIKLLLEIRKLKKEFKKK
>fig|195.2085.peg.655 Channel-forming transporter/cytolysins activator of TpsB family
MIKELTNFIVANGYSTSSVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPL
KKGDKFNIYDLDTGIENLNNGARDVKIAVKASENYGYSDIFINLKSKPPDLILDFDNSGY
KAKGEYKASAYLSLSNILNLNDSIRFGFIKGLLKDMS
>fig|195.2085.peg.1885 Ferric receptor CfrA
DIPGVDLYASKGKTGSYNITMRGITGYTLVLIDGRRQGIGGGGGPNGFNEISNSLLPPIS
SIERIEVIKGPMSTLYGSEALGGVV
>fig|195.2085.peg.660 large supernatant protein 2
MGTNSFDNQGEISANKDISLMLNDDAFINNGKILSQNDIQIQANKDLTLNHGNLYAQNLL
HIKSLNDLNINSKLENTSSIELDAKNIYVKNLVASGKELNLHADENLVNDAYLFSNGDLR
AQATTLTNNSTFNSLNNLYLNAHTIHNNALIFADKVSISRQIF
>fig|195.2085.peg.1370 hypothetical protein
MVEFISLIKKIREEILENERKKGEAMKKMSLGDDFWDQLKVIEKNSPKSFL
>fig|195.2085.peg.1420 hypothetical protein
MAMLELIKNIGLGLFVNGSFALMNFDFKPQSFIINFF
>fig|195.2085.peg.1236 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRDHFGSHCGMEVVLANGEILRTGMGALPKAKTFAENKYGYGPYVDGLFSQSNFGIVTK
MGFWMMPKPEHYMLLSIKMKKREDLIPVVEILNYLEDSFIVGWPQYFSPLNPPYGKPMNA
ELKGYLTSKNGLPDMDKIQNYALKNKIPYWNIDFSLWL
>fig|195.2085.peg.662 hypothetical protein
MATLPLLVTSVKSPLNLPVLSVTPLVFKKAAPFTLKPFSLAKIKLALFPNTSTAPLILEA
CLLEISFIIVLAFCFKFGFFPTYPPI
>fig|195.2085.peg.459 Inner membrane protein YihN
MPHEKLNIYFGMSLTLGFAAIVFTMRATFFAPVDEIEMPREISGAAMSIACIFGYSPQLF
CFALYGFIIDQFKGLLGYQIVFALMGFFAICGVIITTILLRMIAKKKTLQEVA
>fig|195.2085.peg.1890 Hemerythrin domain protein
GQILVHLDYFDLNQNFEKFNAIFEDALQNHHFTTQKNDMGGGIDEFSSKNPRNFQSF
>fig|195.2085.peg.661 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MVDRDYFNVISRGIDLAGSIAHYQSGKNLSDINFIAGLNKVDLSTPNAPKIIASKQKDEK
IDYGIDGKYLGSMYANTVTLISTEEGVGVRHSGVIRGIEDVIVKVKDKAEFQAIGVNTNG
SVKIDAKDIKTSLINADTIDLKASGKVTNEGLYKGKQIQINANNFENAKQTNLSQETKDI
FKINQ
>fig|195.2085.peg.1854 hypothetical protein
MRELSLAAFKLLNSVFKTKTAHFNGFLELDFKNKPKLKKQSFKRKKKMTSKQKI
>fig|195.2085.peg.1880 bacteriophage DNA transposition protein A, putative
DVFSGMGVATLVGKSNSLSLTRLLWKAIDKFGKPDMIKGDNGKDYLSKDFQSLLDSLNIS
YDAAIAYAGEQKALVERRFGTLQR
>fig|195.2085.peg.1897 Mob
RKNIERLYKKAYENFYKYCENKNGLAKSGKPKGLQNFTKKEKCYHEFIYEIGENTTMEQC
QELTQK
>fig|195.2085.peg.889 Putative fibronectin domain-containing lipoprotein
VEYSYEVIAIDSVGLRSEPSKKVKAKQ
>fig|195.2085.peg.566 hypothetical protein
MVTFYFSADIFEKEKAWKYNGKRFFYIDEKINFKDILNKALENINYEMLINDIEVVIFCQ
TIQKNNEWIYPSIDDIKIPNIKVENIEFKPLFGKPYKKPCVDVEKFYNDFKELNKNIFRI
EKVEITYKIYEKAQKTRESDSGKTYYALTSKKVSFFEVFNSIKEIYKCKYATPLCFYNSF
NFVCYEEPYVAFSSLNNASWGKKDTSVTPSIYPLYRKSSNLPYGRRDRWFALWDSFYYLY
VYEKSSKGVLSFLAPIVTIVLAVATWWIGGQGAWLGTLIGVSETIASGITLGISLGLAIG
SLTGNKTFSILNAVWGLVNFLGAWGANNWNLAADFTKNTAQIAQEMTTFESTLNIAGNLL
SGASKIFDVVQSITANTPDMINEQKGSDLDNNEGGNGNEALELAKDMINPTIWYNFETTD
ILNEKIEKNRNLIFAF
>fig|195.2085.peg.1373 hypothetical protein
MKIPQELLTLSPLEKPYAENELDILNAYSMLFYKYKQCEIQIKKIKELNNE
>fig|195.2085.peg.1881 bacteriophage DNA transposition protein A, putative
QEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDFIGFDLGKVKPLFSVKTLQNFIKN
YYKDKPLEHCIITQGLDRAKSKFL
>fig|195.2085.peg.1895 Acetyl-CoA synthetase (EC 6.2.1.1)
MNTCYNALDLHVHNGRGDQLALIYDSPVTGTKKKYTYKQLRDRVAKVAGILANKGGGKGD
RVVIYIP
>fig|195.2086.peg.283 hypothetical protein
MKKILFVIMLSSMLAFADLSNKGDLMQIKLLFNGKELLVNLEQNEASRQFYNTLPLELEF
SDFIGKEKIAHLPKALNAKGSSAYKPQIGDLFYYVPWGNIGIFYELQNANEDLVFLGKIQ
GNLEFLKMQKGDFKVRIEKGD
>fig|195.2086.peg.1552 Methyl-accepting chemotaxis signal transduction protein
MYKDTLEPYIDRSLEELLSFFSKSFFKTVLFSIIFILIIIPFIFIFYRNLIVGVQGIDAN
ITSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAK
>fig|195.2086.peg.407 hypothetical protein
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIGIKNHWDLAFLGYSLNKKDSY
ILNNSLWNFQAIKQHKKNIFSKIKDEVKFNHKIIFSSELLQSRLTRKREIVKLYTFFKKI
GFTNIKVICYIRDANEMLRSLLSEAIKWEEIDSFELKEEKEEYKLGYKKNLFHFHHICNH
KQTLQWWGEVFGKENLIVRLFDKNEFYQGDLLKDFIHSIGLEWDDEFIIPPKQNESLDLL
GIDLLRRINKFLPLFCNNARNIFRGDLHHFAVKHFTSKDSHLKFQPPKEVVQSYIDYFEE
SNEWVRKEFFPHKERLFSKKDLTDYKENYELKEMKPEYWDKIAEFIADIVSTKNQNIADK
TIIIQNKDKVIVNQTNQIKSLQTTLKDNKAHLIQAQNLNNTLNKTIQEKDIIINSNTNQI
DQLQNNIKEKIKQLHILQNSIQEKSTQLNQLQSKLSFQTQYGTAKSRIQNQLSYKLGQTM
IINSKNIFGILFMPICIISTILSHRQEQKIYQEKIKKDPSLKLPSLESYPDYKEALKFKN
HLSYKLGQALIKANKTWYKGGYVKIWFEVRRLKINREKI
>fig|195.2086.peg.1223 putative
MFNLREHCFTDNELGDNFVGIRSKNNNLQKGFVDEDGKSQFDIFIDDIKDMLYV
>fig|195.2086.peg.484 Flagellin
MGFRINTNVAALNAKANSDLNAKSLDSSLARLSSGLRINSAADDASGMAIADSLRSQANT
LGQAISNGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINKLM
EELDNIANTTSFNGKQLLSGGFTNQEFQIGSSSNQTVKATIGATQSSKIGVTRFETGSQS
FTSGVVGLTIKNYNGIEDFKFDNVVISTSVGTGLGALAEEINKNADKTGVRATYDVKTTG
AYAIKAGTTSQDFAINGVIIGKVDYKDGDNNGSLISAINAVKDTTGVQASKDENGKLVLT
SADGRGIKITGDIGVGSGILSTQKENYGRLSLVKNDGRDINVSGTGLSAIGMGAADMISQ
ASVSLRESKGQISAANADAMGFNSYNGGGAKQILQASSISAFMSQAGSGFSAGSGFSAGS
GKGYSTILSGSVQIVSSTASMSSTYVISEGSGFSAGSGNSQFAALKTSTVSAHEATAGVT
TLKGAMAVMDIAETAITNLDQIRADIGSIQNQVTSTINNITVTQVNVKSAESQIRDVDFA
SESANYSKANILAQSGSYAMAQANSSQQNVLRLLQ
>fig|195.2086.peg.1784 hypothetical protein
MLQNNKTNARVVSPCISVSQTAIIYFLGLKKIFLISSLKSVITTAITAMKRLK
>fig|195.2086.peg.402 hypothetical protein
MIGDTIYDKKGAEGLNIKFIGVSWGYGFDNNSSDVSSPHEIISKLP
>fig|195.2086.peg.711 hypothetical protein
MIFENIVLNDLEEISGSHAGGFTGYAGAGTYKNIILNNIGEISANGTASLDEKSIYAGGF
VGNIENGSNIANSNIYFYGLLNSSSNKNYITHNENILNLSNTTDFQTFINQSKIAGLEYL
TNTSTSNSHLHMINGGKIGNEKSKIIFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGE
LSSITLEQSDFEDEILKTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKL
KESLKQSLEFYTEFNKGGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLK
PELESIKNNLNRLEFLKAEIKRLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQ
GLLDILKNKNKPFLDV
>fig|195.2086.peg.463 hypothetical protein
MTTSPYFAHLPKLKSKAKTLFHLNACQTQGYTIKDDQNSS
>fig|195.2086.peg.821 hypothetical protein
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGDIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEIKANNVVNIDSVNDLNIKNSDIS
TSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQKSNTTTSIDGVLSTNIKGANVGI
VSNQDVNIIASNINADSKIDINANNVNIKDAHELSKTKTDGVYLKPVEISYESANLETSK
SISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENITIENGENKISSSSHSSTSSI
AGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELNGGEIDIKADKVDFIAAQNK
THTESDSIAIGVFAKANLELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTA
EAGLEFSKTEKISDELSHVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTK
YEDIKTQSSTGFGLYIKERIEATSPIASAINQSAQNAAAKNENLGVNYGIVASQALANTA
NIFSNNLINTTSNQTLGFKFNQDKSQSSSENISKINAGDNLNLESTKGSIVLNGVEAKAN
SINIEAKDNVILNAAKSKNSSSSSSLEIAATNKQTAGYHAVDGGTVGEGIEGFASASYSK
SNETQFTNANLNANNININTGKDFTLNGANVKASNDAILNVGGNLEVNSLADSLNSQKYS
ALLNASGTGGLSSNHLVAGSVSGTLGIGYAKTDKTTVTTQSGISAGNEINGHVNGNLNLQ
GGILNSDNQKGNLLVDGKVTNSEVSVYEKSDVAMIRLSGGTNQSFGGVVDIDDHIDKTGS
VNSAANININNNKNHGISTDTQNTTDTQDHSWAGGTINLNSSISKIKNGISKVTGSDSTS
NQPSNQPSKSDGPYINESTQTTRL
>fig|195.2086.peg.1749 hypothetical protein
MGLGWKHFILQESIMELFNLFIAVIAVVITLFREEIRKIFFKPKK
>fig|195.2086.peg.483 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIFDKTHNVFMYENLEEEL
NFFYQSILEKTPRYPFVCIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSMIDLSKE
LCSGKIYLVDIKEERVNLQLRILFDQNDMFLWLNVYEMFINHNFYKKYYYEEILNADKII
HENINLVIRNLDPDSKISLSCYENFYKNIPLMLKNIPFKRIIDERKGLFESCIVVCAGPS
LQKQIPLLKKYQENFVIFCVDGAYPLLVKHDITPDYVLNLDFEEYPLEFFKEVNPENKTL
FILAASTHPSVVDYLYKKQIPLSVTLSDNLPYQNLHINDFGYLEFGTHVGHACYTLAIAL
KFKNIILIGQDLSFDKQGNSHFDSFDLGSDIDTTLNIPTLKTVAYGGLGEVLTHLAWDDY
RKKLEDLFARNSQVNFLNATEGGARIEFSKEINFELCCKKFKNLNSKLNKSLPKTLTANR
SIKIFNKILETFKEEKQNALFCLEDAMRLNDALKMILTSDRKLPLDFLKNTYESVSNFES
FLEINSLLNDGVLKGVIFHKGKLLSEVVISKIEDEKEYLLMYLKSYKQWLEIFIFRLQLK
YDIYNFLV
>fig|195.2086.peg.677 Aliphatic amidase AmiE (EC 3.5.1.4)
MQKLLKVALIQFAPKSYEVQNNLDKALKLVHLALEQGAC
>fig|195.2086.peg.1771 hypothetical protein
MSVSEICCKKFFVFKSRLRRKRLKKNAFKYRYNSALIRFLIFPPVGQIFPPVGKKLLVVG
KLFLEKIMFPNKLGKNCFFYLNMFHFLGKLEIVFEFVRIDIEEIA
>fig|195.2086.peg.399 3-deoxy-manno-octulosonate cytidylyltransferase (EC 2.7.7.38)
MKIIGVIPARYGSTRFPGKPLVDIFGKPMIWWVYQQAIRSKKLTDVIVATDNKKIVEICE
KYKFPYMITSEDHLTAANRIFEVSRYVKGDYYIQINGDEPLVDANLIDLVIPKDIPQDIE
FGTNIIARMMNPVEVVDPSNIKVVCDTHDNIVYMSRTPIPYPYKYLQFDYYKHIGIIGFN
EKMLSFYNNSKPLILESIEGIDMLRFTEYNKIFKAILVKKNIHTLSVDTKNDLEKVLKII
EKKFKINKLDYIRRVL
>fig|195.2086.peg.1619 major facilitator family transporter, putative
MLSRLESDNIQKNIAIYVGTTTFGGFVGRVFGSFLSDLFSWHFALNFFSILMMVCGFLFL
FFKEHPISLNTQTSLRDFLPFVKELRFMVILFCVFTIFFSFQSIVSFLPFHLKESIKDIT
QTQIGLVYLGFLTGVISSLLIGKTIEILGSKIRTAIFGFLVFIAGCFCMIVGNFYFAFFA
MFVFCSGMFISHCIFSGILNSIADKKGLANGIYLTFYYSGGALGSVLPSFYYESFGWEFL
CIFTAFLLFIALIIFSKFRYFYK
>fig|195.2086.peg.401 Phosphoglycolate phosphatase (EC 3.1.3.18)
MLVIFDLDGTLIDPASGIIKSVEYVINVLGLPKIEQDTIKNFIGPPIYDSLKSTFDLNHD
VALKATEIFRETYKKYFLYDAYVYKDIPLLLYRLKKTKKKKN
>fig|195.2086.peg.1779 Phage Rha protein
MSNTSIININNQEVIFENKDEQVFCTSLDVAKVFGKEHKNILRDIKNILNDLREIGDVQC
KSNFELSFKVRKIQGFKGRERKYPYYNLTRDGFSLLAMGFTGKEALQWKILFIDAFNEME
RIIKNQYTPKLENYNKYKIPNTFYKEIA
>fig|195.2086.peg.1697 Replication protein
MSIVCHETARTGIYQGFRCVGSQSKLGVDFPVKAYKLSENRYTLEDIKASIPSCKVDLAP
LYEKPRRKSTVTLEEAKELYPEWYEKRIVQGEPKQKSREPYRGRGQPFQPGRCERRYKEA
KDDLFLWYFEILEKNEIKIYPKKMTYNQMMEECKKNDIYIIKPLYSLGYTYNNNREDFKN
YN
>fig|195.2086.peg.1499 Transamidase GatB domain protein
MNLKEQILNDIKEAMRQKDDFKRDTLRTLNAAFKQVEVDERIELSDERILKIIASEIKKR
KDAIELYSKGGREDLAQKEQKEIALFESYLPQ
>fig|195.2086.peg.1541 FIG00470841: hypothetical protein
MRLTHQVIKNGASIFNYLWTLKFFHKMILAFFFLIFLCACGYKGNPQYTSYEQNGSIKSI
KKYEQLNRW
>fig|195.2086.peg.1780 putative antirepressor
MSKVILFENEELGQVRTIRDKNNEPLFCLNDICKILNIKKTNSVRDSINKEFDKGGVFEW
HPFKTLGGIQKFIVINEPELYFVLMRSDKPKAKPFRQWVIKEVLPSIRKQGYYASNNAPK
LENYNKYKIPNTPYKENIIKAIMQTEQNRNCEFEELIAYEIKEIYKDNKSHIEQKINFKV
KGLI
>fig|195.2086.peg.1633 integral membrane protein
MLIFINLFFILSVWVILDYFLVWKDICQNNLKKIFEVLQ
>fig|195.2086.peg.482 hypothetical protein
MIVSKTYEIDSCDDVELDIKRESKLDFKLCFDDEKEIKALVFIIPGLGGDVDENYREHLA
EFVAGEFNVAVASVNYHCIGNRPQTGSTFYLDDIDKLILKVSCEAIDIKLPYDVDKIQDY
KQMSEIFHFVNNQITKGKQKGNFAPNYFLNLHVSLQPAKNEYQNFGVMQAQDLLNVALYL
KKYAPFDAMGGGIPVIMIGSSHGGYLAHLAAKIAPWLIDGVIDNSSYAKFLWRLVGFGKE
VDFMEYSEFGTFNFYQNIRVCCSSKTFWTSNSSSNNFFSVSRRMIRYILESKHLEIQANY
PKPCYTSYHSFYDKEIAPPDEKLELYKYLEQFGFNAELYMIKNTNQIDGKFIKNLEHGMG
MSIKTLISKELPLMLEKIKQNPKKDCKEKCISYPCEDLLYQFSEKDDKISLKIDKI
>fig|195.2086.peg.1804 SSU ribosomal protein S11p (S14e)
MEGIKVTFLKDITPLAHNGCRPPKR
>fig|195.2086.peg.712 hypothetical protein
MGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYK
YLGGLAGHIENGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNG
GGFVGYTTGNTTFDGIG
>fig|195.2086.peg.1657 Coupling protein VirD4, ATPase required for T-DNA transfer
MQNNKSIQIIFLAISSVFLTYLLTPLVFFFLNKVKIMKAIEIYNINFTLQAIANGYPKIW
LSLSITFGICFVVFSVLVLSLKAKKSQFGEARFANFNEIKKMNLFGDKGIIIGKYKGKLL
RFGGQQFVALGAPTRSGKGVGIVIPNLLEWQESAVVQDIKQECFDYTSKYRKEILKQEVY
LFNPFSRQTHRYNPLTYIDMSDKEHCDSQLMDLANILYPLDGDSTSKFFNGLAQNLFIGL
CYLWRDLQLTDMGKEFQKSFNVDVGNFNFYNILQLSKGFSLKNEEKTLRGFDDTYNFLVY
CEILDEATIRRLETYFNINSDATKSGVMSSFNAPLVPFESETLRLSTETSDFDLRDLRKK
KMTIYIGITPDQLANAQFILNIFWSQLILLNTKELPQSNKELKYTCLMVMDEFTAPGRIP
IYQSAISFMAGYWLRSLMIYQSNSQLE
>fig|195.2086.peg.1634 integral membrane protein, putative
MSHDTNFFLLYFKDKIPKDSLIFLKESLEKASEEQKEKLLFTKLKNPLYGLLFAFFASWF
R
>fig|195.2086.peg.1751 Conjugative transfer protein TrbG
MKKIILLSSLIASSLIANNLNERDFSNLTPKEKKDLAIAQKWINSKTTTIQGNNGEVIFL
FGESMPSIVTAPLRLTDIALEPGEVIKDVQIGDSIRWAVSLSVSGEEPYLISHIIIKPTD
KNLQTTMNIMTNKRVYRLNLISEAKKFMPAVSFNYPNSIIKTLEDYKNQMKAKSESKNFY
KTKDDEIPSNIENLDFGYSVEGNAPFKPLRIYNDGIKTYIQMPKNLKFYEAPALMILDSS
NEKQIVNYRLKYDTFIVDRLFNKAILLSNVGSKQEKIKITKHSNKANQDIVNNVLYDLSL
QNKKENK
>fig|195.2086.peg.501 hypothetical protein
MLIAKIAPWYVDGVIDNSGSAVPPLNYILGREMEHSYGEYYEDFPHNRIIFFLKTHWTRK
ENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYHSKEDPLTPANFKEQTMQILKI
LGYDVSL
>fig|195.2086.peg.1222 Pyruvate carboxylase subunit A (EC 6.4.1.1)
LLDDYNRFYFMEMNTRIQVEHPVTEEITGVDLIVRQIRIAGGEILDLEQSDIKPRGFAIE
ARITAENVWKNFIPSPGKIGEYYPALGPSVRVDSHIYKDYTVPPYYDSMLAKLIIKATSY
DLAVNKLERALKEFTIDIRTTIPFLIAITKTREFRRGYFDTSFIETHMQELLENTEDRHQ
DNKEEVIAAIAATLKKIRESRE
>fig|195.2086.peg.1709 Coupling protein VirD4, ATPase required for T-DNA transfer
CLMVMDEFTAPGRIPIYQSAISFMAGYWLRSLMIYQSNSQLETQPPLGYGKEGAKTLLTN
HACQIFYAPREQEDAEAISRILGNTTFKTSSRSINTGNNGGGSHSISEASRALMLPQELR
EMPFENELITIDSGKPILCNKAFYYSDSYFMDKFKAVSKSLSGIKKIPSRKQLEDAILKG
ECKIKIQIIGENNEKNVA
>fig|195.2086.peg.1778 Minor pilin of type IV secretion complex, VirB5
MKNFIFGVNKAIGKSHPHKNGARLKSLDYNYTKEYNYNYEICVTQFNHLFSEVKFSHRVA
ALWLTPKNYTQKLKKLSLIASLLLFIGSNAFADDVLTGDTKLACEAILCLSSGTRPAECG
PSLARYFAIHFKKPWKTINARRAFLNLCPIQNDANIEDLVLNNLVDDVLPVSDPRQCTPN
YLNTQVETKRSYSTFGIMSYRINPNMPNFCHALINHAYTDYKTPKYKCTGEFYNSLEWKL
SAKLQLITQQAYESLSDDQRYMISRTCGDRNCYDYYQKIPFTKECWTY
>fig|195.2086.peg.1762 cell filamentation-like protein
MWDSQENLSEFDKFLIKTNKIGAKSLDELFRKERMITNKKALELGKNPIKGNFDYQHLKD
IHKALFEDVYTWAGQDRMQMGLKEKFAKYAPNGAIINFVPGKELDKYSKIIFDELAKNNY
LKNSKDLNHFAKNLAKFMGEINALHPFREGNGRTQRIFLNELAKNAGYKLDLNLISKHKM
IHACVEASQLKPGRLEALIKDNLKNFRQNLDLEQNKGMSL
>fig|195.2086.peg.1761 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDLTKEQYEAIRSNIGNFAIEDMFLNEKDIIDNVKIIK
GEATANECIVALKKEWGVS
>fig|195.2086.peg.400 4-hydroxy-2-oxovalerate aldolase (EC 4.1.3.39)
MRIGVLDCTLRDGGYLNNWKFGKGVIANIVERLGLSKVDYIELGFLKNDSYLDLDSSHIT
DIRNITLKPNNSLFVAMIEIGEYDISNIPQRDNNILIFGFRLMFRKKQLMEAGGIAEKLQ
RLGYNVFLQPVNIMDYNLQELTTLIQLTNKINPYAVYIVDTYGFMNKYDLMEKFFILDSN
LNKNIKLGYHSHNNLQLAYSNCVELIEHNTQREIILDSSVFGMGKGAGNANTELILSYLN
EKFEANYDIDQILEIIDIYISKEKELNPWGYSLLYYLAAITKTHHSYVRFLLNKKTLSIK
SVKEILISLAEDKRMGYDEEYISQKYFQYQSKNINSEEDLKKLKKEIEGFEILLLGLGLS
AQEEKSKIVKLKKQNCKFKIIAINYIPEDIKVDCVFISNAKRYGQIISPVSDIKIILTSN
INPGVLKPDFVLNYSSIVDEASLSDFGGIMMLKLLVQMGVKKCFIVGFDGFKGRNLYIDK
AYDFNNHDNNIESKFETSFKEIANQLNIINIAELNKDSLCL
>fig|195.2086.peg.1782 hypothetical protein
MKHFIFSGLIGLGALAFLAGCGDEAKTSDYYKAHLDEAKARVAECKKMEKMNETQQRDCS
NANEAVLFQRDKNNKFYQSSPEAFEWK
>fig|195.2086.peg.730 Integral membrane protein
MHKGRDDLISPEEAEKGVEIVSQICGIDKEKINYPTVECNGVSINEQEFDLFPRELLDTD
FKYEIKFTNCKFGCLEYFCLYKTNNSFLIFENCEFDYICLNNDLVTDNVFELNNKLYFFS
CKFNGGVDIGQANINSEIRFNGCTFKDVFYFDIKEYLANIKIKNCIFYKSFFMLGSFKNE
ARFDNSIFKDYVDFHECEFEKTACFYGVRFEKAPNFSACYFKEPKAVNLTNVNIDQLDFR
SAEDYIKDNYQDGNYKNAIKNNEKIQKDEKELYRIENEHKLRCAKNLKDSFRVIKDVLIN
QNNTLEAQEWHKLELYAKEKELEIQLSKNKNDNLKKESKNQVYNPKDYEKFNYSKIIPLI
IFLLKIIGHLSVNILIFVELVLVAPFFTIMFYCVYVVFFIYKILTFILKSFYPLDINKFI
IFWRIKFNKIKRKLIVSGRKMLDFTLWSDCVLLQVYRNTSNHHTNFLKILNFTILMISLY
AFMGFVFSKTINFILSFNSVSIIIASYIILLVFALMLVNVKKQLYQYGVILIFMLCGAFT
ISMILFLSSEYISIFCFLIYFLGVLIFYLFFICKIKLFIFLVRFFAYMIFIATIITKPQF
INPFTGVFSSDKLYESQFEKSLNDLNASAIVNLASILQNDFNLHLKDQNISFTELNSAKA
LIVANKENLLKLNDANLNRAKEVLGEKYTELLKTINQDEITENTIKSTSVLYSIILLLCI
FSLQKTARKNSIVPS
>fig|195.2086.peg.408 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKKLAIQLFGHMRTYEKTYKKFKENIIDVNVQNNWEIDLFIHTWDKFNSSSKSWHKDLNL
FSNNDYLKESDKNKIRKLYNPKILSIESLKEGEHGGLLSKRAGNKIREEYEKQNNIKYNY
ILYTRPDILFLNPLRLDRYLEEYNKYAFLKLPSKHAFCGNNFFRRMCIADPRYINEGDIV
YFSSSSQECFRCEENKDFLVIPIDYTLHKDFFIQRENFIHGWRSHPLDQYEDKITLLQNQ
IKDKEFQVKKIQSELKDISYKKQQLEISNLEQDLINKKLQTKQLERQLGLVSNDAAVSHD
NKITIIHPNSAKSRIQNQLSYKLGQAMIVNSKSLLGYIRMPFVLSYIKDKHKQEQKIYQE
KIKKDPSLKLLPLESYPDYKEALKEKECFTYKLGEALIRANNNWYGGGYIKLLLEIRKLK
REFYTKKDMR
>fig|195.2086.peg.1776 Conjugative transfer protein TrbD
MEEELQRIDIYSALNKPNLIFGADRELILMVGVISFALIFTGATLLTSIIGIFLFFFCNM
LLRLMAKSDPLMRQIFLRQIKYKKFYYAQSTPFSKD
>fig|195.2087.peg.108 hypothetical protein
MFSAAIPHQGGTDHFNEQPPVYWADIFKEFDYVCFDILREKIWNNEKIAFWYRQNTMLYA
HKSKSYIFENLGFKPTQSPLHLVRPEYMNFLNKLQNELNNEKSKKSILNMFKFYLRHPKR
MFINKRYF
>fig|195.2087.peg.681 hypothetical protein
MAKNLTSTTKPKMAKVGCGLQVGAESETPARKDKFTSSAKSQNNLKDLAKELYIAGFDIF
KIAKILNRNEKTIRNYKAKDGDWDKQKANLLTSKIKDKESASLYESFTEQMFCAIENINA
DEKMNAEKKTEAIARIGDSFSKMRKVARLEDPSSYRLNVAKKVVEIIISHLKNDKDCVAK
LVSLLESGVIEKEILAMDI
>fig|195.2087.peg.1836 Motility accessory factor
VSAGPSLAKQLSLLKAYQDKAVIFCADGALSMLEKEGIIPDYILNIDFEDLPLVFFKNKN
LQDSILAFGCSTNPKLIHFLKNFHCVIVLRNKLLYQRFNLNDFGYIDTGTHVSHFSYTLA
LALGFKNIIMIGQDL
>fig|195.2087.peg.1021 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MGKEWVFKTQEDLDLYRDAYSPQWDDDDEPIPSLALAPKNVEEVQAIVKIANEFKIPLFP
ISTGKNLGYGSYVDGLFSQSNFGIVTKMGFWMMPKPEHYMLLSIKMKKREDLIPAVEILN
YLEDSFIVGWPQYFSPLNPPYGKPMNAELKGYLTSKNGLPDMDKIQNYALKNKIPYWNID
VSVYGCKEVCYANLEYIKQRFKIIEGVDISIVQEFSSPLNLEQKKQLKHKVTLGIPNMEI
FWLSTRGEVLEPSDGHVWFSPIIPRDGKELLKCQEVYMNLFREFGEESPITPFSHPRSWM
YRAFCFMLAFNNSRTDKAHN
>fig|195.2087.peg.1389 hypothetical protein
MKIGIFPITTYSQLDDFVPRVVWYLYPFRDWFSICNLYVSFKVKKKEKNKCLEHFDQIVY
RNFKHMNISYVSNSNIFDFSFLFGLDYIFLTNDLMFRELSIFKKKYNLSIEIIRIDHERL
SYADSFFLRFGEKIPNLYEKYKQISKNKILSLIKPLKTNKIYLFGTGPNSKYAFDYDYSD
GLVIACNSMVINKDIIVKLKPKIFVIADPIFHAGPSSYAAEFRQNLIEMFIVNPCVIVVP
LRDYHIYSTYLPSFMIDFLVPIFFKIPSIDESPFYIDILKYFEVKTTNNILTLFQLPLAA
SLGNEIYIIGCDGRPKSKDSYFWSHNDKVQIINKMDVIKVVHKGFFKIKYNEYYDKHMYF
IKNLVKTIEKHGKQIINLTPSYIPPLQKRISDLILETNRQKNICDLSIILPIYNMQKYIE
KYLNFLLNMQDINYELIVIDDFSEDLSLELLLKQELQNVDRLKVYQNFNKNGLYGAIKTG
LKLAVGKYVLILDSDIVIYPDKLKSNLKLLKHNEEKKILFTSSDFATKTEIIYQNYNYIH
SYASFIFKREFINRYMQSCNISFKEEILLKFPSLIIKNQNSIIKHILYSDQFLKHGNYFF
KIKEYYLAYLCYNRVDEKIKKYIQINFELCKKFKENM
>fig|195.2087.peg.180 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWCHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFSNRP
DACYNVTRRFCDKSFSANERVKTLIYDVNRKQSSCIRRGFLGTFFKISKRTIEQCCFCFT
LDNKLLISCIQGYQYSDFNVLDINKIFTKKCYGLRPIALLIECIKMLCVSLKLDATLGVH
EKNQIRSQKGEDKGYFVDYQKIWLENGGKLVKINNHLYYELSHKRKNLEEILSSKRSMYK
KRFAILEEIKQALDQSLFI
>fig|195.2087.peg.1729 helicase, Snf2 family
MIHSKTQYIHEQNKKLYFLTGTPISNSITELYTLQRYIQPNILKEKGIQAFDSWASTFGE
VTNAWELDSSGINYKIVARFNKFKNVPELSTMYKSVADIVTNNDIMKYQKDFVPKLYNDK
PINIVAPRSKEIAEFIGIQDENGRWNEGSIVWRMEHQQDDITRNNLLACTTDARKAGLDF
RLINPHCDDYANSKINKLIENVFNEYNAWNDDKGTQLIFCDLSTPKQHSQKVALNGNIAT
PNLNKEEFVNINETIEQTEEENSKSLDELLAEQAKFDVYTDILKKLVAKGIPQNEIRFIH
DAKTDLQKGQLFADMNSGKARILIGSTQKMGAGTNVQKRIVALHHLDCPWRPSDLEQRSG
RVIRQGNELFMRDPQNFRVKEFRYATERTYDARMWQVIESKARSIEQFRKAGADVRTLED
VTSGAADAAEMKAEATGNPLILLQVQLNSDLRQEEMLYSGYKRQIHNNEESLITNLSKIE
LLKKDIAKMEILNSIIKENNSEHFQGKYYINDDEKDFIVFKNDTSDLNKSRQAELERNFE
KIVKTIADDYQKEYKVLEFKGLLISGERTDLNTLNFYVSTTDGKTIIEPENLIYKRDEKT
FFKLESYVNFGGFVKRLNNFYNDLEKFTQLNKNKIENLEKEIVELKSITGDNTPKYKRKD
YLEALREDNRIIMDEIEKMSKQKNYKSDFVPKSAKILEDLNKHNKILKDRELLI
>fig|195.2087.peg.1834 Holo-[acyl-carrier-protein] synthase (EC 2.7.8.7)
MRIGTDIVEIARITKAIINGEMAFYERVYTSHERLLINPAEPDYERASGFW
>fig|195.2087.peg.14 hypothetical protein
MTQGNVIFENIVLNDLEEISGSHAGGFVGGVLNNENGIASLSNIVLNNIESIKGIGFIGG
FAGWINNGTFENIALNNIKNISDNNYAGGFTGYAGAGTYKNIILNNIGEISANGTASLDE
KSIYAGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIANSNIYFYGLL
NSSSNKNYITHNENILNLSNTTDFQTFINQSKIAGLEYLTNTSTSNSHLHMINGGKIGNE
KSKIIFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDFEDEILKTIID
EILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFYTEFNKGGLKT
EFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTILKPELKSIKNNLNRLEFLKAEIK
RLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNKPFLDDLITKE
YSFEDKYTDIQGTFAIAGSSIDANAIENLADKPILSLPENENSGDSQTTNNTDSTDIVNT
FSKQVKLTSTESILILPAEETQSHIKEDERERGRVCITSDNAKTNNPCIAITF
>fig|195.2087.peg.850 Integral membrane protein
MHKGRDDLISPEEAEKGVEIVSQICGIDKEKINYPTVECNGVSINEQEFDLFPRELLDTD
FKYEIKFTNCKFGCLEYFCLYKTNNSFLIFENCEFDYICLNNDLVTDNVFELNNKLYFFS
CKFNGGVDIGQANINSEIRFNGCTFKDVFYFDIKEYLANIKIKNCIFYKSFFMLGSFKNE
ARFDNSIFKDYVDFHECEFEKTACFYGVTFDKTPNFSACYFKESKAVNLINVNIDKLDFK
SVENYIKDNYQDKSYKNETKGMQNEKEKIKIQNEYKLRCAKNLKDSFRVLKDVLITQNNT
LEAQEWHKLELYAKEKELEIQLGGDNKDSIKNIQKIKKSVIKKPSNNPSNILAKIQSLSD
KYIKIYDFVVCFVMVIGKSIFNFLSSIIGILYNITKAICKIIQIILSCMLHITSISRILK
FEYLKFYRKISSLGKTMLDFTLWFDCVLLQVYRNTSNHHTNFLKILNFTILMISLYAFMG
FVFSKTINFISSFNSVSIIIANYFILFALIMVFFNVKRQLHQQGSILFFGIFGIFIILMM
LLLSPVYIPTFCFLIYFASILFFYLLFLCEIKLFVFILRLVAYGCLIVVIILKPQLINPF
AGIFSSDKLYESQFEKSLNDLNTSAIINLASILQNDFNLHLKDQNISFTELNSAKALIVA
NKENLLKLNVANLNIAKEVLGEKYTELLKTINQDEITENTIKSTSVLYSIILLLCIFSLQ
KTARKNSIVPS
>fig|195.2087.peg.1782 FIG00469622: hypothetical protein
MFSKILSALSLANSFKAMIFKRLSSPVQSAYLGSLVWDIINILNGDQ
>fig|195.2087.peg.107 hypothetical protein
MSKYDENFYISQMEESYNSAKEMLNQILPLLPKINSVADVGCGVGTWLKTWQDKNNEIKI
LGIDGNSVDEKLFYIDKKKL
>fig|195.2087.peg.196 hypothetical protein
MSQTNNNTEIKEQDTQDEIIWEGKKDIPSFLLYWITYIVFLCFFLYLFPRLFNKEIDYYK
WFIVFFTFLLGIYAFARAIYKMANIKRIYITKEKLVIEYYIKNDLVFPLGTFFVYYRKIS
YSPSPGHIVIYTFGDKAKEYLEPGLFSDGDDPTKGCFERINAIIKPYVMPYLLGLSDEEF
EKIFFHVNATSEIDTTFLKEAMELRKEKKDE
>fig|195.2087.peg.674 hypothetical protein
MKIVRNLKWMNFLQTQSFKNIFVEYIKYLEIDLANSLINKTKFARNVVFLNNIKNIFLNL
LNPLYIKSEEYQKRFDNLKQQINKFQLKATNKIQINDELLVKLELIEKYIVSNSKFKIIC
KEFYNSSKYFSDAFMNYIDKKEFKDFLPQQDDSENGNIEEKVFVQSLLEFNNALSHLIIS
ISSDSEAIQQKNIHSAINHLYRATLDNYKIIIRFTIGKISNEDIVTSFLSIRKQEFLLLG
QDLKDKNINFYSPNNKKYEEKNIIQAYQELYKAIDEILEHQS
>fig|195.2087.peg.80 Membrane protein
MKTKFSLILSACLLSSSLFAKNTDDEITKLQKQLAQIQAELAQIRKER
>fig|195.2087.peg.1826 hypothetical protein
GSALIAALTLDLPSDDGYMPRQILISWYVFWASLICGVLSMFFGRKNKKINRTSAKDIVQ
QMRLIEKRYEQGSMD
>fig|195.2087.peg.1829 hypothetical protein
MLSQTTKLDIIKQLFDSLSDKEKENFLNSLTEPKANNKIIDKYKATHCPYCNSDKFVKNG
KAKTHQRYICKTCNKTFTDTNKTILFNTKKDIGIWYKYIDCLVNKYPLRKTAKICGISLP
TAFVWRHKILDTLQTMMNETTLNGVVEADETFLTLSYKGNHKNFKLPRKAKKRGTSATLR
GLSKEQVCISCAINHNGLSISKVSNLGKPKLVNLLNVLANKIAKNSIFVTDSFRAYLKVA
SDLDLNHIRIPRNKYTCGSFNIQTINNYHSKLKAMIVYNFKGVSTKYLNNYLVYHNFVNY
AKNTLDNKISILFNYIQKTECFTRSFNMSNRPSVPLLVS
>fig|195.2087.peg.1267 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDDYFK
SIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQASARNLGLK
YMQENDYQIPWVTFTDPDDFLDRNYFYEVDKFLATHQDDDICMIGCNVIFYYEKQKLYKD
NHALNFKFKSGVQVKENYNLDSFIQLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEY
LLDNINLKSAFLPTVKYFYRKRVEQNSTLDGKDKIKDYYTMVPNFGYLNLFKDIKITKVP
YFVQNVVLYDIFWQIKTLILNPEKLAILNNEEKKLFKELLFENFKFIDSCNIKNFNLHAF
DFFYKKGILNYFKNEDLSENIAFIESIDDKNDEILIKYYFNDVNHKTKILLDNDVAIVKH
SKIRQYDLLDKVFLYEKRIWLKLKNDTKTLDICINSQKLKLVFNDRCINDLSLVLKVLAK
QKKQRSKNSNLWLFADMSWRADDNAEHLYRYIMQNHPKQKTAFILSKNSTDYPRLKKEGF
RLVDPRSFYFKYLIYKADKIISSHIDRYIFNALGGDTLKTKDFIFLQHGVIKDDLSRWLN
QRKIDTFITSTKAEYESIAGDFNHYKFSTKEVVLTGLARWDALIKNNVLNTKQIVIMPTW
REYLSGKVQKYGVRARNPEFVKSLYFQKWQEFLCSKELEKLSVRYGYNIIFTPHPQVRIY
LEDFNLPSFIFTSYKESMQKLFCESSIMITDYSSVAFEMAVLKKPVLYYQFDKDEFFAKH
SYAKGYFDYEKDGFGKVFVESSDLFCYLGKKINHLQDIAINNTQYQSNNACKNIFIKIKS
K
>fig|195.2087.peg.1745 hypothetical protein
MSETYEIYTPDGLTLDVEKDTNKILFKENIKPTGNYTEEYSKAVFKSYYIMKNSPYKDYQ
PKYLDPNFYTGKASTLLEFTEWQSIYLKDPIKGSIAPWTKAEKAYYKSLKTKRERYKYLI
IRSGIRSTVIDIPYDAYANVDEKGYLINEEYAYIYDEVNNNKETLKSSLFRQEWGIAAGI
LGKPEYFVRSKNHGFNARMIQCFILYIQLTGGGYEELGIKRGIYNYADNLLEIGIGMAGI
HKKIL
>fig|195.2087.peg.1548 formyl transferase domain protein
MTYSYIYIIGTGKVAKECQKIANDFFRQEVNFVKNIENLDDFFKNLKNCLIISANNFYIF
KKECIQKNTIINYHNALLPFHRGCNAHIWSIWENDKKTGITWHMVKESIDTGDILVQKEI
KLDNNCTALSLLNAQHKLALTLFREALEILKNKAFKMQISGGGYHKKLSLPNNGYLDLTW
NKEKISRFLRAMDCGALSGVPKARLEILGEEREILFYEINELDLILNLSDNVILKITKEK
KCKKSNNFLSI
>fig|195.2087.peg.204 putative transcriptional regulator
MTEQDFLELIAIDENTNRLKHRENSQLEFKANFNKADFALYAKTLAAFSNNQGGIIVFGV
KDKPREAIGMTNNNLENLDNKDFSNFLNESFAPEIFFNIEIFYVNGKAFGIIEVKESANK
PLVCIKNNGKKQEILEGEIYYRYSGRSEKIRYSELKNILDKNLEIERQKWREHIENIARI
GPKNVKMLDLLRGEIDDGNGKKIVVDRELLKELHLVTEGKFVEKDGAPTLMLVGTIQNGE
IVVPNLNLEKDYFTTKELLERLGLSLSHHYFRGVLAEYPIIQQDTKYFQQKKKQKYYSSF
CLDFLKQQNLSEDKIKTLCRKHNIWKKNIK
>fig|195.2087.peg.1780 ATP/GTP-binding protein
MQNLLILYNPYYQQDVIKLHLEILLDKGQVAFGKIKSKLKEPLSYERDENKISHNQKLSE
IYKNTSADNPLQLFLSDYANLFVAKVVKISKEVDKNIIPKALLK
>fig|195.2087.peg.1825 hypothetical protein
MSDVKSDQIIKYLSEKWGGSKCPLCKKGRWNVSDKIFELREFHEGNVVIGAGPIVPIIPV
TCDNCGNVVLVNAIISGCLSADNKQDGGSK
>fig|195.2087.peg.1687 hypothetical protein
MPEKGKTFAGEVREETVAWSKDTYQLLKQAEQGKVKSYVQDIALAVLDCKETATSRETFI
RLMNERGYGVDWQDSHKYITYTDLAREQAGEKACKIRDNKLEKYYNMDFGKESMEHEFER
NARTAEAEQSKRAASRVKPTEPDRAGKQSAQRSVGDVERELRGIDEAVKSRTIQPNEKFI
FKCPNCSRKNRKVFYAF
>fig|195.2087.peg.947 hypothetical protein
MLKIILVLSILSSFAFANSCVYYEQELKKCNSLKNSHERKMCRLGLFAKCKKDKR
>fig|195.2087.peg.1827 Methyl-directed repair DNA adenine methylase (EC 2.1.1.72)
MSSFISSPILYMGNKNRLIRRGLINLFPKNINHFIDAFAGSATVSMNTQAKKYIINDIDE
TLHLYYQMFAKNNEKTIIKHIEKRIEEFGLPTKTTIRCFSDKNEVEIYKKAYHKFRDFYN
KNKNSLDLYTLMFFAFSQQFRVSKKGDFNMPFGNNCFSLKNKKAINFGCEFFSKNNISIY
KRDFQDLIFNETLNKDDFVYLDSPYSITTATYNESYKWGFNDDNRLFMVCKELDKSNIKF
GMSNVIINKGLENKNLIDFCSKNDFKVYSPNNFQYHACGKENNKQQEVYICNYEVKNNNH
SFNLLN
>fig|195.2087.peg.1485 Ribosomal RNA adenine dimethylase
MDIEIESAENLPYFLRQRNITYADVIISGIPWSLLRDHEQEKLLKIIHKSLKPNGYFSTF
AYVLPTYSSLKFRQKIFSLFAEVRISKVVWQNLPPAVVYYCKK
>fig|195.2087.peg.1397 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKRLAVQLYGHLRTYEYTYISFIKNIIKPNLEDGWVIDIFMHTWDTLSSSEKSWHQNKFI
FNERKLLNSEIKIIKEIYNPKEILIEHLDKDEYGLHKTVNRVNKLREEYEKKHNIKYDFI
IYTRPDVFFYKELKLSFFLQLYAKHIHLSRLGLPDNFIFCASGILEKVPLFDPRWTPAND
LLWITKQSNGCVPNLCKNSFIIYLKYRLGIEFDIARPCDMISQYLLQGVAKQHVNNGYSA
KTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLP
PLENYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMWFEIGKLRKRYREREKNDI
FTPSK
>fig|195.2087.peg.1824 hypothetical protein
MSGGNNFKMSQDYEIAQPKKKMAYPILVEEWDFLIGKIESISDDENIYHTIGSIFLGVAG
SALIAALTLDLPSDDGYMPRQILISWYVFWASLICGVLSMF
>fig|195.2087.peg.1486 Ribosomal RNA adenine dimethylase
MFFYEYLKNPKQIGAFCSSSQKLGFVMTQNINLRQANYIVEIGPGTGVFTENILKYKNKK
AQFFAIEINKNMADKLKRKIVNFGYRNREC
>fig|195.2087.peg.1268 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYAIISAVYNVEK
YLDDYFKSIINQRLDFKKNIF
>fig|195.2087.peg.1709 Phage Rha protein
MNNVNLIGYLGKDFEIGTTNSGRVYAKNSLAITKRWKNEIGTSNDLLNFEFSFKVHKIQG
FKGRERKYPYYQLTKDGFFLLAMGFTGKKALQFKIAFINAFNEMEKLLQKEIKSPNKYLT
DLMELIYPNLPQNDYKVSVTITDNPYSKEAKNVFSLNYLVDNRTPKDPKKLQ
>fig|195.2087.peg.1710 hypothetical protein
MSDKELEIFELCERLSELLGDKEAIADLKKLYTNHPEMFKDMQEVKEVINKVVSEPEIIV
DANRDKRNYEIIKAAKIINDKKMADVVIKNESGTNEIFHANKKRIKEFNRLNNKDNLLQV
ETPTLSTHQLNGLELMDKNPSGANALSATINQTIPQKDKSANDFKAKLEEFSTKKTNAIK
SINKEFKR
>fig|195.2087.peg.1781 FIG00469622: hypothetical protein
MLSDFKNKHPEDFDKIVDILKEILDEYEKNPSEVKKNLKELF
>fig|195.2087.peg.1828 hypothetical protein
MQNSKPIGKSDDSSKEFIIRCLGGDKTYGFDIDSVYVYQNSINSKYYIFEYLKCDSIYVT
PHTSDPNKYPYNWKKFHSLFQLTKKLGGTLILVNYSNGYDSQMKELPNKEIYENQVKMLF
VEDIDYNAIKQYELSYPKPKYLNYLKYSDVKFLTLDEFSNILRQINSNCGNIKINLDRLI
NE
>fig|195.2089.peg.620 membrane protein
MPFFFALAVRFALSIAAYYDRMDLGLIAIIGIMAFVYTTNTPMYHRMAVTMCCSFDLCLS
FLIGLCTHFFSCILSACSWLSSYG
>fig|195.2089.peg.444 hypothetical protein
MGGAYGVRAYPNGFGEADSMILTTIGLRFSIFSPNFYITPFL
>fig|195.2089.peg.1798 Methyl-accepting chemotaxis signal transduction protein
DMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSYVG
>fig|195.2089.peg.740 Methyl-accepting chemotaxis signal transduction protein
MISISIILLYFIVSKYLSPLAAIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISKAIN
ENILATKQGLEQDAKAVKES
>fig|195.2089.peg.766 DNA primase TraC, putative
MSNFDTEAVLAQFENSLREQGFIIDKNIIADGKIHRLRVAGDLGSKTSGAYALHLDGHPA
GYIQNFKSGEGGIKWKYDGKVKYDTDYKAVYKKQIEENRQKILAREQELELKYLQTADRL
CAEYQAAKQVENHPYLTKKEIGAGQDIKLDKNGNLLIPLQDENGKLWSVQRITQKGDKFI
GAIRTTEEKEQNLEFPAKKKGCFYTSKPLDDQDEFIICEGFATAKTLEDELKKATIMAVD
AGNLLFVAEKIHNLYPDKPISIYADNDIAKNINVGLNKALEVKEKLPAVKVFSPALNKDD
VEQKLSDFNDIKIKYGTLKNKIRAVSFSKKLEGNKEPERER
>fig|195.2089.peg.1022 hypothetical protein
MLHALFLLVWPLVIYVSYKFIMLNINQLEKDNKLS
>fig|195.2089.peg.780 Type I restriction-modification system, specificity subunit S
MTNLPQGWKWKSLGEICFITDGTHKTPNYIETGIPFLSVKNISKGFFDLSDVKYISLEEH
NKLIKRAKPEFGDILICRIGTLGKAIKISLEFEFSIFVSLGLLKPKVKIISDYLVYFLNS
CFIEEWINDNKVGGGTHTAKLNLNILEKCPIALPPLKEQERIVGILDESFAKIDESIKIL
EQNLLNLDELMQSALQKAFNPLKDNAKENYKLPQGWEWKNLGEIANTSSGGTPSRNKKEY
WENGNIKWLKSGELNDGYIDFIEENITEEAIKNSSAKIFQKGTLLIAMYGATAGKLGILN
LDSTTNQAICAFLHKDKNIKFLEKFLFYFLFFLRDKIIKDSFGGAQPNINQTYIKNLQIP
LPPIKEQEQIASHLDELSSHVKNLKQNYQAQIKDLQELKNSLLDKAFKGNL
>fig|195.2089.peg.765 hypothetical protein
MIKEYYSGWEALNLAKESGAIADWHPLSYWSSKPQKYIFNKDLGDWGISERFISFIGKKD
YVANYPRAIADLVLKNDIKGLKNCIYYYLDDDETKELYEILKKYKTLDNIKNFLKYELTK
YYFLDKDNQDV
>fig|195.2089.peg.980 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MAPIHHHFEKVGWVENKIIVRFWMIALLSNLLALASLKLR
>fig|195.2089.peg.754 MloA protein, putative
MKQEYNKNPIYRVLYLFIGFYRFVGTVLECIKIGRNHYYINIELLRLFKKGIF
>fig|195.2089.peg.168 hypothetical protein
MYISKKFLSDIGSLNKNAISWAISSNTSISLVNRSLSVNEQGNFIDDITPEEIQAGTQAV
KEYCLENNELELLKQYLPLVLSGAELLTEMKAVKLIEINKDYESAILKVQKDYIPQSEML
SFETQEKESLAYKNSNYKDTSLCPFMQAIATARGIDLRTLCDKALEKATLYRQASGALIG
KRQCLQDRIELVQSLEDLNLIAWESEK
>fig|195.2089.peg.764 hypothetical protein
MYENYQKERIDIIKKVLQALNDNFVLKGGTALSLYYGLNRYSEDIDLDAKSNNMDITKLL
KSNKNFRDCNITIKKDTDTVFRAMLDYGGQSHLGNYPLKIEVSNRNKIFLQQGSLTYTNI
DGVNVYNISELIDMKIAAFNGRDKVRDLYDLNFLLNKYPEYFDHKQLWQINERIAYCGTD
ELNILLADEVKKHKLISNENIDLNNFVQNFQARIENTLNDKRIEKQKEFIKNLSIKDKQI
QNREPQRER
>fig|195.2089.peg.1466 Putative amino acid activating enzyme (EC 6.3.2.-)
MPNKQLNIWRKHLSDTLFANLYGPTEITDVCSFYIINRTFKDEELLPIGKACKNTELLVF
DENMNFISPKQIGVKGELFVRGTSLSLGYYNDKEKTKQAFIQNPLHDNYLDLLYKTGDIV
SYNEFGELLCYGRADNQIKYMGHRIELGEIESVINSHVNIKNSACIFKEDIICFYESEEE
INFKDFLKDKLPSYMIPKNFIKLDKFKLNQNGKIDRKVLKELV
>fig|195.2089.peg.767 hypothetical protein
MQDENGYSSIDNEPELAELFLHKLVNLDAFCHEINMQNGGGIDTSKKLDFSLTLKDDKNG
IHIVSFKDFQMGIKDMGQGFEHLLQQADQIDNNKNKSVVKTKAKLDRICRIPSEITEKKL
ASKAHQFTKALQNAIPKDLSPEASAFMAHFIDNFLSKDKEQDRQSFIKAWNDQRAKEVTR
GEETPKKNSEVFDEKAETKTTIYNDKNEPDYVKKFREDSVAFQAYGRDYEKIQTTFAENK
NEAQKIEAEKKLEQKYKISIPEYLGCVKKQTQMQELALENIKKNNLAKTAKTKEQSRSNQ
PTDRGQNI
>fig|195.2089.peg.1810 hypothetical protein
MKKYISNEEISNNLGSNEKIWEQIFSKKEWGKYPSENVIRFIARNFYNVQDRSKINILEL
GFGTGANLWFCAKEGFSVSGIEWSKTGLERFKARMKDENLSDKIKQIELGDYIDKLDSFK
DDSFDAWMDNYSLAYNDFDKTKKIIDKAMKKLKKGGKFLSVTPSLYNDGFEKDESLGYHL
VKPTSGSDACTGIIRYCDEKDLRKLYESATYSISDIKIHIQKNLTKQLNELFIVEGYKI
>fig|195.2089.peg.1089 Hemerythrin domain protein
MHKNIIHEMSQLIQNIKSTNDLKEKLYSIMSKWLSRHILSHDVMIIAWVNENLKKDENKA
LELNDLPPKQTLTQEENFEFIYSCPCKIDHRLSFKEYESITNEGKVMRCKKCQELLFFIR
SQEKTYKG
>fig|195.2089.peg.1197 Phosphoglycerate transporter protein PgtP
MALGLILCALVNVLLGFSNSFYAYVGFVISLGVFQGMGVGPSFITLANWYPKKERGIYTA
IWNISHNLGGGIIAPIVSLSGFALAAFLGVSLADFNETH
>fig|195.2089.peg.438 FIG00470545: hypothetical protein
MPIAALIRLGMGYGISYANAPGVGEQTYIGRPPFGGCH
>fig|195.2089.peg.781 hypothetical protein
MPTNEQIGEKIFDKCVEIYEILNNDKEAEAKEKLFYLLDEIQDKALYPPILNHLIRQFGL
YPYMNQDTSILEDKFLLECFKANIGEDEPKVLHREQSRVLKRLLSNESLILSAPTSFGKS
FIIDALIAMKKPKNILIIVPTISLLDEARRRLVRKFTPDYNIITTSGAAPKENNIFILTQ
ERVLEYLDFIKANRTDLFIVDEFYKIVGDNRSNILQNAIRQVSPYSKQSYYLCPNVKQFN
ENSLKYQFLKNIEKVSIDFNTVILNIHDLSHKQEDKKDKLKNILNETKKQKTMIYVKSKP
ESREVCKYIKEYVTTNNDQLNNFSNWLKKHYWQDWDFANYLANGIGQHNSAIHRFIQQLQ
VKLFSENEHMNIMVTTTSLIEGVNTATKNIIIWNDSIYNNENKLTSMQYKNITGRCGRMF
KYFVGNVYLLESNNEILKNEQETMEIIPQEEFLYRNDLETFDVKTEMEKNLKKLLNNANK
FHQIMTKMKNYTILMDLESIVTIVENAELLQKSIRYLNSDNPNTWGFIISENIQKVVFRI
LNDKSKDAYFKIIDYYKYNYCGVKQTIDNINKKEGQEWYKIDINKYFDIERIISFDIASF
FNDLNQIMQILYPEKKIDISSFVTKLSNVFLPSVVYTLEEFGLPRIISKKLHECGFINFE
NKELTLEQALDKFKEHTADDIINILKEKNLYDDFEDYILNYFYEGLGQ
>fig|195.2089.peg.762 hypothetical protein
MMTEEQKLFFCELNHIKNQLRDIAEQWRGYNNISLAEMLEQRADALDELGNHITSGGERR
DIADYKIFLDDARIFMYRSIIDFENFERKTQG
>fig|195.2089.peg.365 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQKQIQKLFEKNPNLKNKLEFIFFKAVDAKNKEHLEFKQHFPW
WGFLGFR
>fig|195.2089.peg.763 hypothetical protein
MSQNDKLELFSKLFDFEKRGNNYMAKSDGAVITIYQNGNHQIQGKNVDYAKKMIDFLLRK
SDCESFGGHIFSTLELSIEINPNLKEKALNAIIKALDEIDPENVVFVKN
>fig|195.2089.peg.777 Aminoglycoside 6-nucleotidyltransferase (EC 2.7.7.-) => ANT(6)-I
MRSEKEVYDIVLNFAKTDKRIRMVTLEGSRTNTNIPPDDFQDFDITFFVTDMDSFTSDDK
WLDIFGERLILQKPEDMELFPAVEKGFSYLMLFTDDVKIDLTLLPLELIDEYFTWDKLVK
LLLDKDNRIVKPPIPTDIDYHLQKPTQRMFDDCCNEFWNTTTYVVKGLCRKEILFAIDHM
NDIVRKELLRMISWLIGIKQGFHFSLGKNYKFMKQYVPEELWERLMSTYNMDSYPHMWES
FEQCMALFREVSSEVACQLDYQYPLYDEKISNYVIRQKKKYGIEDDNK
>fig|195.2089.peg.278 hypothetical protein
MLCVSLKLDATLGVHEKNQIRSQKGEDKGYFVDYQKIWLENGGKLVKINNHIYIMNFLTS
EKILKKFQAASVQCIKNALPYLKKSNKL
>fig|195.2089.peg.1743 Methyl-accepting chemotaxis signal transduction protein
NVEIANESAIISNTVSDIANNILEDVKKKRF
>fig|195.2089.peg.1521 Membrane protein
MGWSLSERQIALIFEFEITFLYDLRDKNFEIIVLDNDHYKIIMPECKYKHSIIDMKFYDE
KNAKFLPFLLPDSINSTGLSFSENDKNKLIREAKEEVKELSLNLIRNLESKIHKSARDTL
EAIAKGFGAKKVEFEFKDNTQKLDIN
>fig|195.2089.peg.159 hypothetical protein
MEDIKENIEAKEVEKKNKKSVKQSLDKVSKKNTKENVGIIQTFIQPGSKNDNSLNGLPNN
PNSTQTKPKKNLMEDIKENIEAKEVEKKNKKSVKQRLDEKIQDDKKAREERIKKIKQVIA
RKQKIDKVTDKKNNREIAGKIGTYTLKNLIKLKERSEDK
>fig|195.2089.peg.1833 Motility accessory factor
DQQSILEYLSLYEMFISSHYYLKYYETSILSLNELCIKSASVAIRNVDITCFLPLLTHGQ
FLQNIPSMLESIPFQRILSQRKNKFDNAI
>fig|195.2089.peg.757 TolA protein
MAVIKAVSSKAGIGHAIDYVTKKEKTEEKLVSGLHCEPETVKEEMQATKELWGKTDGRTY
KHYVQSYHEDEEITPEQAHKNAVELAEHTKAWKGHEVLIATHIDKGHIHTHFIVNSVNYE
NGHKLQWM
>fig|195.2089.peg.123 hypothetical protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLFDKIKKLKERSNMAEEKESKGSYNLQIKIPNELKDKLEKKAEKAGVSLNQYI
MYLFIDDIKNERI
>fig|195.2089.peg.446 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISPYKNVPQNENIQNTLKSKQSPL
DIKMDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGTNEVWL
RESIIALKRSDLNVETL
>fig|195.2089.peg.77 Putative periplasmic protein
MVSAYPKPIKIFKNTAIKVSNFPFDPNLKIKIYSLNSYIGNIIPQFTNTKDSIIINFYRK
KCYR
>fig|195.2089.peg.167 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISDT
ATSQISQLKNTSLNLVNEAKNTAIEEVNNAVSGIDTSKEEALLAIEQAKAAQEEKITDLE
QAKENIITELSEKAKLLTQSLEWTVGVGGKFTTLKSALIEASKYITISDFFITIKLVSDI
TENKINIDGLNLKHTSIDFNNFKITGAIYITNSIVRNIAKLNLKKGTTGSQGVYISSAMV
RFTDIVTIEGFNDGLNINENSFVTFFNNTSNTTTMASGRFIAAEKGAYINISGLNINMAT
GFLFSLSRGAVLSNSYQVNFTGGATECNIPKNTVTANGIYFKN
>fig|195.2089.peg.243 Putative periplasmic ATP/GTP-binding protein
MEVVNTLYVVDIDVVRGFNLKSKKEVFNLPIKGAIFLNAIEKLNDDTLLVSDTGTGLVLK
VDLKAKKYDELLKLDIAKFGGPNGLYLDRKNDKLFIAGYHPDGASGGVVMSYDLNDKKLS
VIKNEKEAYDGIVPYENALLVSSWGENLNGVIYRLEDDKALKLDLPSIKGPADIFIEGDT
LWIPKMVEGKILKVELKN
>fig|195.2089.peg.1458 hypothetical protein
MDISLPNIKIKFMIFLKKSEIFLYNDLFKWLISLGEKGATNNRKRL
>fig|195.2089.peg.1090 Hemerythrin-like iron-binding protein
MDHHKLIPLWDERYNINHQKIDTQHQRLFEPAAQVENAVFKFVKRDELKEILTELFAYMK
EHFHDEEEFMQEI
>fig|195.2089.peg.1667 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MGKEWVFKTQEDLDLYRDAYSPQWDDDDEPIPSLALAPKNVEEVQAIVKIANEFKIPLFP
ISTGKNLG
>fig|195.2089.peg.137 hypothetical protein
MDEIQSLKAQLNNLLLRVSELESKVATLEKRLNDKDFQVLNETPNLLEK
>fig|195.2089.peg.1467 Putative amino acid activating enzyme (EC 6.3.2.-)
MITHIYDFLEKSLIKFSEKTAFVEPFAKERKEITYKDFDLFSKKLAGEILKTLGNDNPTQ
APVLIILPKGIDCLISFFGVALSGNFYTLLDEKSPKERVEKVIEVLKPKLFITSKDLNFN
LDLPTLYTEDFESFNIDESLLKNAKEKHIDTNLLYVFFTSGSTGIPKGVSIAHKSVIDYT
FWVCETFKFDENEILANQAPFYFDNSILDIFSSVKSGATLHLLPNHLFAFPNKILECLEK
EKVSAIFWVPSVLIYFANTNAVNASTLKNLKKSIILRRNHA
>fig|195.2090.peg.1788 Flagellin
MGFRINTNIGALNAHANSVVNARELDKSLSRLSSGLRINSAADDASGMAIADSLRSQAAT
LGQAINNGNDAIGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM
EELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRI
TSGGEVQFTLKNYNGIDDFKFQKVVISTSVGTGLGALAEEINKSADKTGVRATFTVETRG
MAAVRAGTTSNDFAINGVTIGQVAYEDGDGNGALVAAINSVKDTTGVEASIDANGQLLLT
SREGRGIKIDGNIGG
>fig|195.2090.peg.1806 Phosphoglycerate transporter protein PgtP
KIFKGYRMPPAIGAMVIIFFMIIGYFTSNNLYMVTFFAAMAGGLVYIPQFLASVQTMEVV
PAFAVGSCVGLR
>fig|195.2090.peg.298 Signal recognition particle receptor FtsY
AGAIEQLRLWSEKVGVDIVLTQQGHDPSAVAFDTISKARAKGFDKVIIDTAGRLQNQKNL
ANELEKIVRISAKAMPHAPHRKILVLDGTQGNAGILQAKAFNELVQLDGVIITKLDGTAK
GGALFSIARELELPILYIGVGEKMQDLIEFNAQNFLDTLLEGVFD
>fig|195.2090.peg.1791 Motility accessory factor
KTQAYGGKGEVLTHITWNDYRVKLEYLFACNDQKAKFYNATEGGARINFTEELSFKECCE
KLLTKEKPKFELPKSLTKNRSDKLLAKFKEKIQKDQENAKRFLDDALALKQILENILSKD
FLLPLEFLEKVYQNIENFNHSLDTDEFIQDGISKVLIYERGFKINLVYKENILDNASFIT
AYIKAYHEWLLYFIEKLEQKINIIINSLKETQ
>fig|195.2092.peg.1769 hypothetical protein
MAIQINNFIMYLNNGNYTNDFEMFLNYLADDEKTSTVVKDKDKDKIIVNDEIFIIFNESL
KNKHFNFSDIVFNKTVTFQGNYKNGLEFNFENTYFEKLNILNCNVDNIIFSGEINYIK
>fig|195.2092.peg.1200 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRQMVQTAAEHGWGDYRAAPTFQDDVMGAYSYNNHILRRFNEQLKDCIDPNGI
>fig|195.2092.peg.1315 hypothetical protein
MWNLDEKKLQEMLDGFLNFQEVWTLEKVKNMTLEEYTNIKKDNPNRDDFTFWIESKLDNL
GSIWGGSAFKFGIYRRNDESQKESSSGRLYSQNYAWIAKYGNNENEAFNNIKEKIIQIIQ
ASQDNNLKTIEKIDFGDAIKWKIAFHYQDVKNIKIVNIFSKNVLDLISLNEFKEKLKIYQ
IHKKLLENKNLSLVKMIENIAIPLWNKYGMDSQNYIDKM
>fig|195.2092.peg.1298 hypothetical protein
MAFFAGMSGQNPLIEGETTIEGKLLGYDKNMSQSQVEDLNEFIKQNPIKYGITGDIGTDF
TNILKLKNNISDIEEFKKQWLEMKAKSDKMGEVYQTEIANKKEVVSSQETSEEGKEKPFK
PIQAESKSETYKDDNKMNELVKKLLETKFGTSDELELLFGMKFSDDDIGEFNKFLSQNTS
AKIIDIKA
>fig|195.2092.peg.252 COGs COG3777
MSYENFIGKQEKFTENINEKQVQKIVATLQSKQLKNGDALPYLWQWCFFNEALTPDKLGR
DGHPKLGLDKNSFFPSFGEVNRMWAGGRFNFIAPLIIGEDAIKITTIKKIQEKQGKSGKL
TFVTLEHCYYQKEQLKIEEEQDIVYKQPAPPKLTSDVVAMNADYSEKMQPDSTLLFRYSA
LTFNGHKIHYDFPYATQVEGYHGLVIHGPLLATYMINCFVKKPS
>fig|195.2092.peg.473 hypothetical protein
MYGATVGVDKQANDDVLWGAYFTYANAKIKDNNLEQKSDNFQLGMYSTINVAPQWELNLK
AYAQVSPTKQDNVQTDGAYNSDYTSKFLGLSANAGRVFDFSDNTLFIKPFAGVNYYFSYT
PSHTENGAIAKDIDSMKNNSVSVEVGAEFRKYMNENSYIFVTPKIEQFVINSGDDYTANL
AVNNAFFTSVEANNKKKTYGQIIVGGNVDFTNQLSMNLGFGAKQILAGKVDNKNETYLSG
QVGLKYKF
>fig|195.2092.peg.1051 hypothetical protein
MSHLCEVFLKDDARYTNLERAIPHFKRGMMDIYKTIIRDFLILNQDALGVKQEALKIREL
EYQTIGKPKKVTKNPTSNLISKKEEKVIPGYKELCERIVRQSKNTN
>fig|195.2092.peg.1546 hypothetical protein
MQKSKFQGGGDCKIIEPNSSIKGLFDEKMDIVFANQSLYYIPKTELKQNILEFYECLNQG
GILFATMMSEKNYYFSHSEKENENGLRKVSIQGRLNETTYIHFAKSIDELQELFKPFEAL
FLGDYDPINFYNFEGSAHHFIYIGIKR
>fig|195.2092.peg.163 Putative integral memnbrane protein
MNYKLSLSPLFVLEIIASVLFIVFFGFGNFLFFILLSMIFGAVLLGIFWKNMLEFQMGGL
KDMLTQFSFVIAGFLLIFPGIITSVFGIFVFFFGIALKLITKSKYQYTKQEYQNSNEEII
DVEIIEDRK
>fig|195.2092.peg.406 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILSLQDEEFKEEILSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQT
YKIIREIYRDDFEIFDYDLEDKKYFNIPQNIYLNNLESKILIKNINLDSLRLKKSFQIQN
LNQTIETKNKTIQDNLIQIQNLNQTIETKNKTIQDNLIQIQNLNQTIETKNKTIQENLSQ
INNLNQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLM
PVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYQEAIKFKNYLSYRLGQVIIKG
FKNPLSIILLPYEIVKLIYKFRKR
>fig|195.2092.peg.1188 ATP/GTP-binding protein
MNEINKTKNFYTLMCLAGFLIILLPVGIANLIFGYMLGDSPCTLCWGQREAMIFIGVMAL
FIVRYGMKGKYLAALLIMTAVGLYQSFAHYGNHAHRDLDQGFGLAVFGIHTYFWAEVVFW
AVVLLLGVIFAFAPKFNAFEAELNGEKFRKYTKFSFAAVLISAIIVASNVFQAFVSTGIP
PYVGQGDPVRFSLNPKYIIWSKEGWNGLWQNISFLGKRDVKAPDYAFAPASEKLGIKFDN
DINNAPFAKINDELKITNEQTINFDKAINTLDYINNEFVASSKWDVAFLDNNFSVKEGFE
LDPYFSATIDPIIGIIPYMNDKFILMGSNKSFLRFAKNPNASEEDIAKQYADFVKGNDKF
KGQGEGLGRGRLDTVRAKFNHVASMSTDGNYLYLATVPNNKDAKTFVISKVSLKDRVLSG
EFTPKANLKEGKTLGDLYVTSMTFKDGEIYALSKNHNVIAVIDPVKEEVVKTIAFPSSIT
NARSIFFKDGKINILSYQDGANKLYTLN
>fig|195.2092.peg.1365 Hypothetical protein Cj0797c
MVILKNNKFEAVLLSMKEFERLQNAMQLLENIYKNQKV
>fig|195.2092.peg.1571 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNDKKYSDKDLIDAFYQLGIKRGDILCVHTELFKFGIPLLSRNEFLQTILNCFF
EVIGQEGTLIMPTFTYSFCKNETYDKVHSKGKVGVLNEFFRTSGGGVRRTSDPIFSFAVK
GAKADIFLKENSSCFGENCVYGVLTKENGKYMTFGGQGHTLTHYAEEQFNVFYRYHKIFS
GILIDENNISYNKTISYYVRKLDISSEPNLINIINIVNNTKNFKKNNFAGDHINIYNAKE
YIEILWKKLDINQTILIENYDTIY
>fig|195.2092.peg.1250 Putative efflux protein
MSISALCYGIFSLSYKYIMRFLSIKMIYIATLFIVGCSFLILFLIDDFIAVLFALALLGM
GGGIMLVNNTAYLFSICPENARARAYGILASCIFLGQFLSPIISQPIVRQLGLVDAFLIW
AILNFIVCIVFLFLKQR
>fig|195.2092.peg.1177 hypothetical protein
MSNTNVDYNKRLEVFKEIYPQILEMSLAEKSPFGEFKKLLEQFGNDNIIRNDTQFQSLAQ
ALVSVGQTIVAQSQNTALQMILGGDENIVNQANINLTNARIETEKANANLVKRQTAQIDD
ELELKEQSVNIDKSLSIEKEKLLQAQTETEKANANLVKRQTAQIDDELELKEQSVNIDKS
LSIEKEKLLQAQTETEKANANLVKRQTAQIDDELELKEQSVNIDKSLSIEKEKLLQAQTE
TEKANANLVKRQTAQIDDELELKEQSVNIDKSLSIEKEKLLQAQT
>fig|195.2092.peg.266 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHAETELLKATQISIEDFRSR
NISLLNALE
>fig|195.2092.peg.1169 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISDT
ATSQISQLKNTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITEQINGAKTELNSKIDNKVTKTGNETIAGVKTFSVPPVSATNPTANNQ
VANKSYVDTVGNSKVALSGNQTIAGVKTFNAAPVCSANPTEDAQLARKWYVDYGGGIKNL
GNQTAPKIDLRQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQNITAFSAPFKFRVA
QSGFSGTETFAYFCIASNNVRLVRT
>fig|195.2092.peg.827 hypothetical protein
MAVDKNSKDQAMQLYLIKITQKNSQNQCQNSSNKQSFACHKASALSKEILKIQLKKISEK
LLFTILI
>fig|195.2092.peg.1251 Putative efflux protein
MFISIEGFVSSYSWRYPFLVYGLGILITLIAMIYLFEPRKFKFYNHTKIEEKTNYWKFFP
IYFIGFFIMVVYYTTSLLYRRASRLRS
>fig|195.2092.peg.279 hypothetical protein
MQIKLLFNGKELLVNLEQNEASRQFYNTLPLELEFSDFIGKEKIAHLPKALNAKGSSAYK
PQIGDFFIMCLGEISEFFMNCKMQMKIWYFWEKYKEI
>fig|195.2092.peg.1549 Legionaminic acid biosynthesis protein PtmG
MIYCDHCVMPNTRPGINFTKDKEGKNICSACINHKNKENIDYKARFKELEVLCDKYRRMN
GKFEYDCAIAVSGGKDSHFQVHIMKEKLGMNPILFSVEDNFTMTEAGKKNLKNLSETFGC
HIISLKPDIKTQKKVMLKTFEKYGKPTWFIDRLIYSYPFAMALKFNTPLLVYGENVSYEY
GGGTLKKPIVLKKYF
>fig|195.2092.peg.823 hypothetical protein
MQNHLNREIMINLGSYYTPIFLVNNVYKLLEKWVDNLNDYIFLDSSCGYGDFFIKDLDYI
GCDIDKIALSQVKNARIIHTNSLVNVDRKKFNLSNDDKLIIIGNPPYNDKTSIIRSNIKK
ELFYCDKTLIYRDLGISFLRSYEILKPEFICILHPLSYLIKKTNFNALAKFKNTYKLIDG
LIVSSEIFTPKSNTFFPIIIAFYKRDSQGMNYEYIKNYTFKTIEGNEFILKNYDSIANYV
PKYPNQKDTRKAIAYFHTLRDINALKRNQTFMLYQNSNSIKVFEDNLKYYVYIHFFKKYS
YLLPYYFGNLDIFINHHNFLKIEDEFLNYFYEKSYNENKIKDYFYNLFNHKEGIK
>fig|195.2092.peg.1544 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing) (EC 3.2.1.184)
MSKRKICIVSATRAEWYLLRNLCLEIQNDKDLELQIIATGAHLSPEFGLTYKEIEKEFKI
AKKIPILLASDDKISLCKAMALANIGFSEAFKSLKPDIVVILGDRYEMLSVASVCLMMNL
PIAHLCGGELTLGAIDDSIRHSISKMAHLHFVSTQTYKNRLLQLGEEKNRVFNVGSLAST
IMKNINFLDKNELAKVLEFDLGQNIYLITYHPVTLNLKNSKKEIDILLKTLDELNNASLI
FTKANADENGLLINEILKDYCEKNPKKAKLFDNLGSQKYLSIMKIAKAMIGNSSSGISES
PFFKTPCINIGSRQKGRLRTQNIIDCEFENLDQAFEKLESKDFKQALHHFKNPYENDKNP
NIIIKTCLKNANLDTILQKNFIDLRQNLGYK
>fig|195.2092.peg.582 Inosine-5'-monophosphate dehydrogenase (EC 1.1.1.205) / CBS domain
MKIVKRALTFEDVLLRPGYSEVLPKEVKIHTKLTKNITLNMPLISAAMDTVTEHRAAIMM
ARLGGLGVIHKNMDIASQVREVKRVKKSESGVIIDPIFVSPKASVAEALEIMAEYRISGV
PVVDEDKKLIGILTNRDLRFESDFSNLVENVMTKMPLITAPKGCTLDDAEKIFSTNKVEK
LPIVDEQERLEGLITIKDLKKRKEYPDANKDNFGRLRVGAAIGVGQMDRVDALVEAGVDV
VVLDSAHGHSKGIIDTVKAIKTKYPNLDLIAGNIATAAAAKALCEAGVDAVKVGIGPGSI
CTTRIVSGVGVPQISAIDECVEEANKFGVPVIADGGIKYSGDIAKALAVGASSVMIGSLL
AGTDESPGELFTYQGRQYKSYRGMGSLGAMQKGSSDRYFQQGTAQDKLVPEGIEGRVPYV
GSIRSVVHQLLGGLRSSMGYVGAKDIEDFQKRAEFVEITTAGLKESHVHDVTITHEAPNY
KVNHQ
>fig|195.2092.peg.1141 hypothetical protein
MKPIKVDLDIHSIPYLNSDDACYYFLDYKPNSGFEANSLVFNFKKDLLFKNHPSWYYRNE
AIKEFAKMINNAFLNINKNIFNIIPMPTSKPKNSIEFNNRLMQTMEELLKLDNSYKIFDC
FDVQNNLVPAHYNGYRNPNDLKQEILFYPPNFFDKNIVLIDDVLTTGGHFKACKNILLEK
LDPNINIVGLFLAKTEHYYQ
>fig|195.2092.peg.455 FIG00545237: hypothetical protein
MRKIRLISVLFLALFLSACAKPAFVQSSIQTSNEGIFLKAKQGQSFSITLQNPSKIQSTL
KDELAFKT
>fig|195.2092.peg.164 Prolyl-tRNA synthetase (EC 6.1.1.15), bacterial type
MRFTKFYAPSLKEAPKDASLPSHIFLTRAGFVEQIGSGLYNFLPLGKRVLDKIKNIVKEE
MDKAGAQEVNLSFITPASLWQESGRYNVFGKELLRFKDRKENEFVLGPTHEEAMLSLVKN
KITSYKQLPLHLYQIGLKFRDEARPRFGLLRCREFLMKDGYSFHANEEDLGREFELMYKT
YSQILQRMGLDFRAVEADSGAIGGSGSKEFMVLAKNGEDDILICENCDYAANVEAAKRAK
KTCQDERPEANYASKFHTPNIKTIDSLAQFFKINAFYTIKAVVKKAIYENESKLVVFFIR
GSDDLQEVKAQNTCSALELVDASEEELEKAGLVAGFIGFVGLKDIDFYIDFELENEKQMI
MGANEKDYHLIGIDVVNLNKDRFKDLIEVKEGDCCVKCGAKLKQSKGIEVGHIFKLGQKY
SKAMNANFLDENGKSQPFYMGCYGIGVSRLLAVAIEANHDEKGCIWNKTLAPFVLEIIVS
NLKDEKALEFANKLYRDLTNLGLEVLLDDRNERFGVKMNDFELMGFPYALVIGKGLENNE
IELIQREGLVKELIKTDELMEILKKKVL
>fig|195.2092.peg.1548 Legionaminic acid biosynthesis protein PtmG
MQLFFNPNKDKLDKLNPIYLSYFVKWNSYSNYIFAKSRGFSDLQNEWDRSHCAENFDQID
TIGYILHAWMKYPKFGHAMASDYASRFVRYGMMSREEAVKIVKEKDHKLDNKCIEDFCNF
TGISKTTFWKIVEKHYNLELFYKNEFNEFKLKNPLK
>fig|195.2092.peg.584 Small hydrophobic protein
MLENPIPNSIIITTIAVVLAFSALAVFLIKKTKENK
>fig|195.2092.peg.826 probable periplasmic protein Cj0413 , putative
MRLLGREFAANTRLPLDLNKALLLFQKACKLGRLDSCTRINNIKFKLLKKLDEETYQSNL
KYFLDQNSSFALLEHIATLSKKDTKLYFAQGWVELFNQNDILAQKLFYKSCQAGYYTD
>fig|195.2092.peg.456 putative lipoprotein
MNADYEILINLVDFKKHSYAQRITSSGRFFYDFDPFENNGERYIENYYTMQVNIQIGSKN
TLQKTSLFTRTAYLSDKKRCQLSLENKIIDQISSFFYF
>fig|195.2092.peg.1332 Thymidylate kinase (EC 2.7.4.9)
MYVVFEGIDCVGKSTQISLLKEIYKDAIFTLEPGGTELGKHLREILLNKTHPINKKAELL
LFLADRAQHFEEILKTNQNKLIISDRSFISGMAYAKDFENDLLFALNSFALENFFPQKII
FLKGDANLIQERLSQKELDSIEKRGIEYFLSVQDKLEKVLHFLKEKISVEILTLDAKESK
EKLHQQIKEFLQ
>fig|195.2092.peg.1052 hypothetical protein
MFCFLLYYRALLNKNNTQKIVAKIINAIRCQERLPEKIHYKEKIICMDNHHRDLSQILSS
CVVEFYNSIDLYNTFRKNIGFENRKNSDRNAKSRIRALWFFWIK
>fig|195.2092.peg.822 hypothetical protein
MNFKIDYELPLTSVAGKIRIKQRSTFNDYGLPVAPTKININVKHYVEWQIGYDMVAGKND
GNFIGVNGKDKKLYELSDIIFQFFKHNIILKENLFGIKNFLENNEELIEDKMKINRTNFT
QKQVAGINFLESYVSYPLLVYQFNNNEFLSEIIIKEKQRAIGVQGMLYFCFPVHLLKNIN
GERNFLNRCIESKEKGYLEISRNNINIFLEMLKIFGILSNNHRYDVLQIIEFILNSK
>fig|195.2092.peg.1124 hypothetical protein
MENLEKYRKEIFKDETSAGDEGVIAESIDIVNDKFGLNQEQMLQALNFLYSIKDSFLGRT
KKEPSDNIVNELSSKIIKYLRPLLIVSEKKFKEEIDELLLYYGLKIDMQETNSYEQMHSI
YKEWQLEKSDNLFFNRKSVGMWIEWFKDSYKYIFDLHFSTIEKKSKGSYNIQIKIPNELK
DKLERKAEKAGVSLNQYIMYLFIDNIKNERI
>fig|195.2092.peg.1226 SSU rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (EC 2.1.1.182)
MMKAKKHYGQNFLNDKSILSKIIQAIPKDTENIVEIGPGLGDLTQELLKVSHVKAYEIDD
DLIPILRKKFQKELDCGKLNLLHQDASKLACFDEKKYFLVANLPYYVASHLILQALEDKN
CSGLIVMVQKEMALKFCAHSGESDFSALGVLSAMICEREILFDVEPECFNPPPKVVSAVM
KMIKFRAYQDLCEIHAFKAFLKDCFKAPRKQLLGNLKIHKAKLTELFQELKLNLNLRPHE
LCVDSYLKIYEKVKEEYERKQQRKQ
>fig|195.2092.peg.251 hypothetical protein
MHALCVPDSFAVESKIIDNNTAEVWINKNGFVAHSGTIHFK
>fig|195.2092.peg.184 Membrane protein
MIGLYLLIAALSFLLLYFALKKLTLNIDEKALLEPIKSDIYPKFCDIIDERIREFKDGVQ
NNSFTLKDQDKKDELLEKLGDLNRELTFIQTMNLSNKSDSVWQSELFDFLKELEKLLLEY
LENGEEEAENLRENLMNEFEKLKRLRCKNAKTF
>fig|195.2092.peg.1252 Putative efflux protein
MKKKSYKFHPNDTKLDKKIVEITEKSGFKIAVFSMAAMTMLGSVVISSALPAINRHFEDI
LIQSGANMQTNFTLAHLDILVRLVLTLPAIFVVILSPFAGILMDKLGKLKFVFPAMIVWT
LAGVSGFFLNNIYAILTSRAIFGMATAFIMTGASALLGDYYSRGGFNRRENALSL
>fig|195.2092.peg.1573 Protein containing aminopeptidase domain
MDKLDFRSQDFSQTGKAMYKLACELFPIPRSITGQGFRDSLEILNKTLGGGGDTQISLYK
KWHKGF
>fig|195.2093.peg.1589 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
LVLVIMIISAKLYAEKVANVSMEGAMGGAIGSALNPVSRLAGWTAGKAAGKTVNAGKTGA
KLAAKGAWAGAKGGYSFAKKMYERARNAG
>fig|195.2093.peg.430 Methionine synthase II (cobalamin-independent)
MKLDQVGSFLRPKILKEARENFALGKIDEEQLRSIEDSCIRDLLEECDKAGIYYLSDGEL
RRSWWHLDFYWGFGGIKKIKKEKGYIFKGIETRAEGIEIESKIECNNHPFLKDFERLMQI
AKGLKIDTNRLKLTIPSPSMLLYMLFIRGGKNTEFNYYGKDFTKLKNDILNAYENFYKEF
AALGGVYLQLDDTSFGSLCDYEFCALNEINTDDICEEYVDFLNESLKTMPKNIMSAIHIC
RGNYRSRYVASGGYMKVAKKLFGELRVDKFFLEFDDERAGNFEPLKYINDQIAVLGILTS
KTNESPSVEELKARVKIAAQFLNPKQIEISTQCGFSSTEEGNEIFTHSQWEKIKLLKQVL
SELENEGFSLESRNCRPWKNGAKPFKRA
>fig|195.2093.peg.954 FIG00469817: hypothetical protein
MDKKIKYYISNKTKYSYPILTKDVQCSNCKNFYSIEFASNLKK
>fig|195.2093.peg.1639 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MNDLFQTLGESIQQIIDAIRQVGTSDKVAELSVLLSIIITLVIMYKGYEVLMGTSQSPIR
ELTWDIAGKLLAITFALNIGGWLTLVINAMDGIYEWAGGGTQMYKTLDEMYANTAQLANI
IWAKSSGVGGAILAIVAMLLCYVGFVIAVAPTFAILVVTTFTQTLLVITAPIVFWLLIFK
STKNVFTQWIGLLLSNTLVILLVGLFLSVFMGEINGWIISLSQHVQSGSEVLGTSIFFVI
ASLVLVIMIISAKLYAEKVANVSMEGA
>fig|195.2093.peg.1054 Type II secretion outermembrane pore forming protein (PulD)
MGGLISHNRSQNDNSVNFLSKIPILGSLFRSEDENSNITEIVFIITPSIVDNTHIPSLRE
LGFKYNE
>fig|195.2094.peg.639 hypothetical protein
INCSCVGFTSHLELADEVAQNIINIASKAKN
>fig|195.2094.peg.1762 hypothetical protein
MLINQTFEIDSCDDVELGIKRTSKLEYRISYDDEKDIKAIVFIVGGFGANANISFLDFDR
EYIAKNFDVVVIHVFYHCFCARQSIDQKYNPKLIPNQDDLERINGILKNINLGHLSVNKD
NFEQIIPLIEQKVNEMKQAGLVDESQKIELSCDFIPPNGDYQNYGIMAAIDHINALKDLV
KRFPKLADLPKIYGGGGVLWRISIFTHSKNSSLVCGWRD
>fig|195.2094.peg.1451 hypothetical protein
MKKITIVAYAICFLSGLWFLFSSVKDDFGILSFILGIALIYQFPSKKTSASISGR
>fig|195.2094.peg.356 Ferric iron ABC transporter, ATP-binding protein
MGLKHDFKKDIALRPETIEISNEGLEAKIKEKSLLGNIIRYRVRVQEIEFKVDTLNFSTH
STYEAGDKIALKFNLSLAKELK
>fig|195.2094.peg.1662 Nicotinate phosphoribosyltransferase (EC 2.4.2.11)
GKILNKQKNVEEIALYAKSQISKLDEKFLNFNNKEKYKIKLSKDLTKLRQNFTNTTL
>fig|195.2094.peg.1424 Major pilus subunit of type IV secretion complex, VirB2
GGSKIMFQGQTLREVAPIFIGGVIFGSASAIAGYIIT
>fig|195.2094.peg.1312 ATP synthase F0 sector subunit c (EC 3.6.3.14)
NTAAATIAGTARNPGLGPKLMTTMFIALAMIEAQVIYALVIALIALYANPFIVFA
>fig|195.2094.peg.903 Flagellar cap protein FliD
MAFGSLSSLGFGSGVLTQDTIDKLKEAEQKARIDPYTKKIEENTTKQKDLTEIKTKLLSF
QTAVSSLADATVFAKRKVVGSISDNPPASLTVNSGVALQSMNINVTQLAQKDVYQSKGLA
NDSGFINANLTG
>fig|195.2094.peg.1749 Methylisocitrate lyase (EC 4.1.3.30)
MSAGKKFKELVKTSKPLIIVGAVNTYSALQATKIGHKALYLSGSGVASASYGLPDLGIIA
LEEVCIDVRRICSRVDTPLLVDA
>fig|195.2094.peg.1680 hypothetical protein
MMNILKNKDKIKKRRNYNIDFSHYQYEFFELSPMLIKKNKLQNFILSHNKE
>fig|195.2094.peg.1371 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALIVLGIVSFYFTKTSLYESTLKNQTDLLKVTQSTVEDFRST
NQSFTRALEKDIANLPYQSLITEENIINNVGPILKYYRHSINALNVYLGLNNGKVLLSQK
SNDAKMPELRDDLDIKTKDWYQEALKTNDIFVTPAYLDTILKQYVITYSKAIYKDGKIIG
VLGVDIPSEDLQNLVAKTPGNTFLFDQKNKIFAATNKELLNPSIDHSPVLNAYKLNGDNN
FFSYKLNNEERLGACTKVFAYTACITESADIINKPIYKAAFIQAIVVIIVVVFSVILLYF
IVSKYLSPLAAIQTGLTSFFDFINYKTKNVSTIEVKSNDEFGQISNAINENILATKRGLE
QDNQAVKESVQTVSVVEGGNLTARITANPRNPQLIELKNVLNKLLDVLQVRVGSDMNAIH
KIFEEYKSLDFRNKLENASGSVELTTNALGDEIVKMLKQSSDFANALANESGKLQTAVQS
LTTSSNSQAQSLEETAAALEEITSSMQNVSVKTSDVITQSEE
>fig|195.2094.peg.1423 Molybdopterin synthase catalytic subunit MoaE (EC 2.8.1.12)
KRVDFDGISLLFAHSIGDVAVHESSYFAGILSKQRKLGLKLLNEFVEDFKASAPIWKYDV
INKERIYAKERSTKLCGAGLLKG
>fig|195.2094.peg.1800 Motility accessory factor
HKNIIFIGQDLAYAENGNSHPDDYQNSANYESQMYEHILTEAYGGKKEIKTHEVWIFFKQ
ILEAMIIKYHITTYNCTEGGARIEGTIEKPFLWACENLLHKDLNKPFEKLEPLSLNKQNE
FLLKA
>fig|195.2094.peg.1718 Methyl-accepting chemotaxis signal transduction protein
NESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2094.peg.1416 C4-dicarboxylate anaerobic carrier, putative
MMKLKFHQSLILNALLFYILFPWLPVVFLFIAYFFTIKLDVVTANFVSISLVFLVEFARH
RNARKLGEDMMVILKAMAEIFISVVSIIIAAGVFAEGIKALGGVNILANAVSNLGTGNFA
WFGILLSIAILSFLVYFATVIMGSGIAAFNAFGKLAPDIATKLGVAPITLVLPIEIASCL
GRAASPIAGGIIALAGFAKVAPMDIIKRTTPLLLIAMLVNVLVAFYLAQTNPLPKEQNTT
KIAVSLNNKYLLFYKNYKFSKLFSAFLVKIS
>fig|195.2094.peg.1797 Flagellin
GILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLMEELDNIANTTSF
NGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRITSGGEVQFTLKN
YNGIDDFKFQKVVISTSVGTGLGALA
>fig|195.2094.peg.499 Putative fibronectin domain-containing lipoprotein
WVDNDSRAVEYEVRRYGGDQNAIFKGVKEKRLKDIKALPGVEYSYEVIAIDSVGLRSEPS
KKVKAKQ
>fig|195.2095.peg.978 hypothetical protein
MEAKANSINIEAKDNVILNAAKSKNSSSSSSLEIAATNKQTAGYHAVDGGTVGEGIEGFA
SASYSKSNETQFTNANLNANNININTGKDFTLNGANVKASNDAILNVGGNLEVNSLADSL
NSQKYSALLNASGTGGLSSNHLVAGSVSGTLGIGYAKTDKTTVTTQSGISAGNEINGHVN
GNLNLQGGILNSDNQKGNLLVDGKVTNSEVSVYEKSDVAMIRLSGGTNQSFGGVVDIDDH
IDKTGSVNSAANININNNKNHGISTDTQNTTDTQDHSWAGGTINLNSSISKIKNGISKVT
GSDSTSNQPSNQPSKSDGPYINESTQTTRL
>fig|195.2095.peg.306 FIG00471048: hypothetical protein
MLKGYKVKITSQITKPKRLNAAQWKTIFIVCFVFAVIMIPSFFLALNPHDETLKKVTSIF
NPVFVSFLGIVLAVIFGIGSEKEAFKNVPWDLIFMIGSLSMLIELSKTTGIMENITIFMS
AHGSSSSNWLYYLLGILLLV
>fig|195.2095.peg.1745 Putative transferase
MIFLLLLLGEVREKCHHHRSGWLSRELYSYLKDANYEIIGYIDIQENNFLT
>fig|195.2095.peg.1524 FIG00973752: TolA-like membrane protein
MKKIFLAFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNITIGG
DPTIWNDTKQVFLTQTFIYTLTPKFDILISGGGSYARQEYTNFFTNEYSSKNRIGFDSLW
LGFIYTGDSIADLIPQITFQTAVVQREKAINQTKNFYLKSQSLQASLRGYSDCSL
>fig|195.2095.peg.1804 hypothetical protein
MLAVGLVADTGGTENVLTPAIVSSPVFATLLFTTVSTYDLFAT
>fig|195.2095.peg.1426 hypothetical protein
ELPLMLEKLQKRKSLMQENSISYPCGNKVFIFKDVGDKFELTIKD
>fig|195.2095.peg.1308 hypothetical protein
MQNVISRGFLPLYDLNQFLELSHKKLKFSRVKFKEKFIF
>fig|195.2095.peg.1328 hypothetical protein
MQDKDNIKTYYECLKELSKEELYEGLLGYGMFADRIPNFLTSEYFFEFCKSNKPSFEQKE
YRYIKYESMRNINVPRVLSIPNPFAYYKQCKILKEYWKKLQRYFYKKTKSNKYKISRIHI
RKLYEKKTY
>fig|195.2095.peg.1823 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
ARNVGIEYFSGEYKLKNKTQIIKENSLIEFNIEGNNPYEIYTIYKSYKAFNDEQDLTSFT
YPIIDYIIFLDSDDYWELNCIEEC
>fig|195.2095.peg.20 FIG00638667: hypothetical protein
MVLLQAKGASNNTIKIRNNLTVINGTQNPSDRINIITGRTLAGEANFNVIDFKDSQASLP
LFIYATTQENFEGSIHYPEYAKHNKISLNNVFGRKDIRSGVEAMNVENNQVFYHNVEAQA
SGEGVNRESSVYIRAANLAKNNLFKASNYWATSMLNIYGIREVEESKNNQVIFNNVGFNT
DRISEGSELILIGGVGKRVHHNLLSIQDLEIGAYDKEKDFIYIAASAIPDANSNLALSYG
NTLYIGGDVSIHERSLLNVLSGSVIRIPNYTNNKADDITLPAPSLAQLTKDNHLILEQAL
RARVVNNFEHYSLIYHSNNQDKPFIESLETPINLSEES
>fig|195.2095.peg.880 hypothetical protein
MKKYFQKRYTLAFFIGILAGIFGAIVKWGWEVPFPPRNPNVFWPADALERVTPPKIFLEQ
LGLPTDWTYMFSGMQMPLSIFIVHVGFSIIFGVAYCMIAEKWHRITMWQGAVFGFFVYLF
AHVIIMPLIAEVPPLSEIPFDEHLSEIFGHIVWLWGMEIVRRDIRNRITKEIEE
>fig|195.2095.peg.121 Lipid A biosynthesis lauroyl acyltransferase (EC 2.3.1.241)
MKNNDRLYLSLYYILKFFVIFMPDCILHFLALIVARITFHLNKKHRKIIDTNLQICFPQY
TQKERDKLSLKIYENFAQFGIDCLQNQNTSKEKILAKVVFDNEEILTQALKEQKGVIFAT
AHYGNWELLSLAYAAKFGAISIVGKQLKSQRMTELLAKNRTQFDIELIDKKGGLRKMLSA
IKNKRALGILTDQNCTDNEGVRLDFFGKRVNYQAGASILAKKTGALIIPAYIYQGEDEKF
HIKFFKTLDPLNSSLEELTKYQAKTCEEMIQFKPDEYFFFHRRFASYDEKLYKGIK
>fig|195.2095.peg.1821 hypothetical protein
PKFDSIWDFSEGLAKVKLNGKYGFIDKSGKFAIEPKFDSIWDFSEGLAKVKLNGKYGFID
KSGKIIAKPKFDYGEYFSEGLAGVKLNGRWGFIDRSGKFVIKPKFDSIWDF
>fig|195.2095.peg.1329 hypothetical protein
MKKKLIDNKYYDVEIEKIFIMNFKNYKLDGTPEQEIFIGKGYKVNADISNCFPSIYTHSI
PWVLIGKIGAKKNKGFTKLYYNKIDNATQWLNYGETHGILIGPHSSNLISEIILVAVDYK
LSKKYKYIRNIDDYTCYVKSHEEAEQFLLDLSIELKKYGLSLNHKKTEIIKLPSSFEKPW
KNKLKLFKLDSYSGGIKYTGIMPFLDMALNLMKDNKNNAAILNYAFKILIKKKMTPSAKK
YFINIIHHLVLLYPYLIFLLDKIFNEKELITQENIEKISSDIFNLGKEKRNYEAMSYALY
FALKYNFKLKEKINLLEEAKRKEDCILMLLCYLYDKKNNKDTEEYKIIANNFIINTTSKN
TNFKILDDEYWLFAYEVLSREDPSALNKCKDWKQIKNSNISFIRQEFQ
>fig|195.2095.peg.1822 hypothetical protein
CFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYHSKEDPLTPANF
KEQTMQILKILGYDVSLNLIDENKIDGKFIK
>fig|195.2095.peg.979 hypothetical protein
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGDIASEGQININAGNEINLQ
SSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEIKANNVVNIDSVNDLNIKNSDIS
TSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQKSNTTTSIDGVLSTNIKGANVGI
VSNQDVNIIASNINADSKIDINANNVNIKDAHELSKTKTDGVYLKPVEISYESANLETSK
SISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENITIENGENKISSSSHSSTSSI
AGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELNGGEIDIKADKVDFIAAQNK
THTESDSIAIGVFANANLELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTA
EAGLEFSKTEKISDELSHVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTK
LKILKHKAVQALVCILKKELKLLVLSLLLSINRLKMQLLRMKI
>fig|195.2095.peg.1666 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKIIGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTARNVGIEYFSGEYKLKNKTQIIKEN
>fig|195.2095.peg.1610 CAAX amino terminal protease family protein
MILTFILLALALALLSFKKIKLSFVVLVISGFLAYYHNIIEISFIVFAGVFFLLSLYYKN
NKNVFLELLIVAFCLLLFLHFIQVLIM
>fig|195.2095.peg.796 hypothetical protein
MTQSTTGYVENTISDKSLSIEALIDESIKSDRNFDGIITRLEYSAKGGTDMQGYTNWAID
ALNDILDDSDKAKNSFSCRSYKQNLAFVCRQNIK
>fig|195.2095.peg.1260 hypothetical protein
NGRWGFIDRSGKFVIKPKFDSIWDFREGLASVGLNGKIGLIDKSGKFVIKPKFDSIWSFR
EGLASVGLNGKYGFIDKSGKIVIEPKFDDIRY
>fig|195.2095.peg.1810 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
TYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDFEMFIDKEHKDINNPNWNRMRH
FSLDGKISREEFEIEMIKKKLRVFAFVCDGLIDFIFFKKNKLKFFNYGYAEDHYFGLSCF
LSLNNIYILRKKFYNYRVRSDSSCDFSQTYIINPNNKILFYIYKNMNYNAKEAMEYFRTY
CYIETTLNIISFFETRSIKSVELFKNIIQFYYHRCRAIEQYNLDPMKIKKRLNKIFYYYS
LFYEYKQLFNDKMGVIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSK
SILGYLIMPMALLSIIISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYK
LGEALIQANKTWYKGGYVKILFEIGKLKREC
>fig|195.2095.peg.1301 ATP/GTP-binding protein
MINRSGLKSIVIQGLFEKYDYKINFENGVKILLSENGYGKTTVLNIINSILERNVNYLAD
LDFKSVDLAINDKTYHISKILNKDDASMIEEYLKYLDGMYDVGFFLKEIKQRKINIKKLK
YLIYNRTEQNRRIYPRRLIDYVDKINDIVADYLYKQIEKIEKINFKVLFYPTYRRVEAAL
EEVVDSDFFDEEHRFLTRRNLRYRNSYRRIEFGMDDVKHIIQNKLNEIKNEANELYVNMS
SEIINDLIDDKVKCDKKDIDIDKVKIVIKRIGESRIKHYDKLENIINTQDKKNEFLTYYL
DKLSGIYDKQKALDLRLSNFEKVCNKYLIKKQIQYDDTLLSMKVLDDEREIDFDSLSSGE
KQIISIFAKVYLDMDAKCIFIIDEPELSLSVEWQRTFLQDIYESNNIELLLATTHSPFIY
DNIFEDYIVDLEKYRVNNG
>fig|195.2095.peg.1487 Ribosomal RNA adenine dimethylase
MEFRGVCFRDHEQEKLLKIIHKSLKPNGYFSTFAYVLPTYSSLKFRQKIFSLFAEVRISK
VVWQNLPPAVVYYCKK
>fig|195.2095.peg.218 hypothetical protein
MNLNQTLQEKYPHLEVSVLKLSEAQKDNESKRIDSEYFKKEYLENEAIIKIKDNYAFLEN
FIVKMTGGATPLGADYPDKGIPFLRVQNIMQNYFNVEDIVYISQQDDEYLKRSRLKFNDV
LLTITGISYGKSAVVERDLVGANINQHSVKIEVKNINPYFLSTFLNSKFGKLQSDKKITG
VTRPALDYQSIKKFLIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDP
KNPLQSLLDSKTNNPTNSPNISIRTLKESFLKTGRLDSEYYQSKYEDIEKFIKSYPNGYD
SFSNIINNKDTNFTPKNNENYSYIELANIGNNGNISEPISDLGKNLPTRARRIVSKGDVI
ISSIEGSLSSCALITQEFDKHLVSTGFFVLNSKLLNGETLLVMFKSQIFQEYLKKFPSGT
ILCAINKEELSKILIPKIDPTTQEKIAKYIQESFNLRKKSKQLLDNAKIKVEEQIQGKI
>fig|195.2095.peg.797 hypothetical protein
MSILVNAVDTFYSTKNEAVFSASKSENIKRNVADFNTDNNTKNSVYFFSDDKEISLNLSN
ESMELLTNHFSANDFLKLSNGNIGLSGKAAAFVEGWYKDIMINRNF
>fig|195.2095.peg.1774 formyl transferase domain protein
MTYSYIYIIGTGKVAKECQKIANDFFRQEVNFVKNIENLDDFFKNLKNCLIISANNFYIF
KKECVQNNTIINYHNALLPFHKGCNARIWNIWENDKNRHYLAHG
>fig|195.2095.peg.1182 Phage antirepressor protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLFDKIKKLKERSKMTNIKDIKKIKITCKECKSEFSMFIGHSLYVCPICGNNFG
INQLNDPFFRIKQAFECFTNPKNCDIELVCEIKE
>fig|195.2095.peg.1525 FIG00973752: TolA-like membrane protein
MTVVYSIYTGFGYNQSRKFKTLKIEYGNSIYVGGDLSIILSPKITLDLGAEQRFQMKQKI
NGYQNSEVRSIPTLSLGSTYSINSDTAVSVNASFGGSSASPDSIFGISLWKKF
>fig|195.2095.peg.1805 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDCKYKMKNNNQEKNVLIAGNGPSLKEIDYRRLPDKYDVFRCNQFYFEEKYYLGKNIKSV
FFNPGFFFEQYYTSMQLILKKEYFIENIICSTFDLNFIDNSFFLKSFYNWFPEAYLGHEI
LNKLKDFYNYIKYNEIYYNQRITSSIYMCAIAIIFGYENIFLTGVDFYDKSKNYYAFNSK
KNNLIKLNPSFSLNHNRGDFHSKDVDLKALDFLMKNYSINIYSVSPNSILSRYIKLPDCV
NKNRFKIIKKHDYINDICIPADSAVYDYYKKVFSKSDKILYDTNNNKLHNIEQKINIQIQ
NLNQAIKNKDELITNKTTQIQNLNQAIKNKDELITNKTTQIQNLNQAIKNKDELITNKTT
QIQNLNQAIKNKDELITNKTTQIQNLNQAIKNKDELI
>fig|195.2096.peg.539 Phosphate ABC transporter, permease protein PstC (TC 3.A.1.7.1)
MLKEKIIKFALFLCAFVSVIVSFAIMLTILIEALKFFQKESVVTFLFSSQWAADAAFMNA
DGTSKQGVFGALSLFWGTFYISLIAMLTALPLGVMCAIYLGVFAGKKSKNYLKPILEIIA
GIPTVVFGFFAAIVVAPFIVWFFSLFGIQASFQSALGAGFIMGIMIVPIVASLSQDCIEA
VSEKRINGAYALGMTKKRSGFCRDFT
>fig|195.2096.peg.1344 hypothetical protein
KEKVLIRNWCVKFRLICKYQSKDFDSLILLTYYLLTLLIAYSLISLIRYLLSSRLGIGLF
L
>fig|195.2096.peg.1739 hypothetical protein
MLINQSFEIDSCDDVELGIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFL
>fig|195.2096.peg.538 Phosphate ABC transporter, permease protein PstC (TC 3.A.1.7.1)
MVFAVILPEAISGIVAACLLGLSRALGETMIVVMAASLRPNLTLNFLEDMTTVTVKIVEA
LSGDQAFDSSLALSAFSLGLVLFVITLIINMFSVYLINRFHKRKNL
>fig|195.2096.peg.1256 hypothetical protein
MLNRASEHYGFFGLNRGGITYKEAKISCAPIPVLNEFHHAMSHLCEVFLKDDARYTNLER
TIPHFKRGMMDIYIYIYIKQSSEIFLY
>fig|195.2096.peg.1263 hypothetical protein
MLRSLLSEAIKWEEIDSFELKEEKEEYKLGYKKNLFHFHHICNHKQTLQWWGEVFGKENL
IVRLFDKNEFYQGDLLKDFIHSIGLEWDDEFIIPPKQNESLDLLGIDLLRRINKFLPLFC
NNARNIFRGDLHHFAVKHFTSKDSHLKFQPPREVVQSYIDYFEESNEWVRKEFFPHKERL
FSKKDLTDYKENYELKEMKPEYWDKIAEFIADIVSTKNQNIADKTIIIQNKDKVIVNQTN
QINSLQTTLKDNKAHLIQAQNLNNTLNKTIQEKDIIINSNTNQIDQLQNNIKEKIKQLHI
LQNSIQEKSTQLNQLQSKLSFQTQYGTAKSRIQNQLSYKLGQTMIINSKNIFGILFMPIC
IISTILSHRQEQKIYQEKIKKDPSLKLPSLESYPDYKEALKFKNHLSYKLGQALIKANKT
WYKGGYVKIWFEVRRLKINREKI
>fig|195.2096.peg.1260 Sulfate permease, Trk-type
AYGASCAFLMPHGYQTHLMVGSICGYKTTDFVKIGWIVSLTYSAMVLIMTPIFFKF
>fig|195.2096.peg.1741 hypothetical protein
AGEFNKILSLNSTPKSIDIKA
>fig|195.2096.peg.1262 hypothetical protein
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIGLKNHWDLAFLAYSMDKKDSY
ILNNSLWNFQAIKQHKKNIFSKIKDEVKFNHKIIFSSELLQSRLTRKREIVKLYTFLKK
>fig|195.2096.peg.1656 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MPKFINWAKKKNASQPIYEHAPQNHQIKSHTPTMGGVIFVFCAIFASLLCIKFDNLFALM
GLLCLISFCFIGVIDDLGKILKKNNHSGLSPKAKMFGLIFASFLCLAPLYFSGILSADFY
IPFYKYPLFNMYIFALFFWILVLISSSNAVNLTDGLDGLATVPSIFSLATLGVFLYLSGN
LIYSEYLFLPKINGLGELVVICAALIGALMGFLWFNCYPAQIFMGDSGSLALGGFIGFLT
V
>fig|195.2096.peg.1062 transporter, putative
MFVNDFWLHLILRAIPAFFHPIYLALAFSTAANLADDKSKVPHIVAKIFMAISAGLVLGV
PLSSYFGGNFSFEMAMAFYVVINSLAFFITLFFMPEFKKTSRIKVGKQLLSLRYALLWIS
MLAVFCISTGYLGFYSYYSEFLFSVSKMSFTNISLALFIYGFASIIGNNIAGKTLVNHSN
QTLIFASMAMILIYALIFVNAAQFAIMLTLSLILGIVNGAMNNAMHYIITFPFPRAKDFT
NGLFISVSNISISVGATLCGLVISIKETKYIAISSIIMVGLGLILVLVRMRLEDKKLKI
>fig|195.2096.peg.398 Putative integral membrane protein HP_0181
MEFYWFDAFILGFTLLLGLKGIVSGLIKEVFGLLGIIGGVFIASKYASQAAEFIQNTFYK
IENQSLANFAGFLAILIIFWIICLVLGNFISKLVKLSGLGFLDRLGGFIFGGAKVFLIFA
ILVFCVARIDFLNDKLNQFAQNSFTLTPLKNIGSFIMNQSLTTSSLGQIDQNLQDIEMI
>fig|195.2096.peg.1502 ISCco1, transposase orfB
MQRKQSRRILKTKKEKTKLSHNFKKTQLKLNKIYEKSSNIKKDSYHKITSKLIQEFDLLA
VEDLQIKNMSKRAKLKNIKAKSIYS
>fig|195.2096.peg.1733 hypothetical protein
MKKIFALLALTSLLTSSVFAEDFLAKLTKGALSDTSPGVKELSLDEMKEVKGGY
>fig|195.2096.peg.1742 hypothetical protein
IGLKWDNEFVIPPKQNESLDLIGVELLKRINQYLPWRIDNKINHLRGDLTKFITKYFQNS
NNYHLKFQPPKEIIQSYIDSFEESNEWVRK
>fig|195.2096.peg.1061 Putative transporter
MQQSSITINNTYQIKILITLCLGVFGLISMELGVMGIIPLISEKFGVSVSDAGWSVSIFA
LIVMCCAPIAPMLCANFNPKKLMLFCLAIFSLSSWQACL
>fig|195.2096.peg.1435 hypothetical protein
MSIFSINDNSNYNSILSQAKANKESKENSKISFAN
>fig|195.2096.peg.885 FIG00470547: hypothetical protein
MQKEITIVTAFYNVGRTTRSNEQYLSYFDFWAGLKNKVIIYTTDDMKEAILEIRKKHNLE
DKTIIITKDLKEFDKENFEKIQETFNNYDQSLNRKHPKNIECNNAMYCYLMYLKPFFVVD
AIEKKLSSENIIWLDFGFNHRDEFFTNKAEFNFLLEKPKNINDKKINFFSIKNEEKNTIP
AIYYNMEIFITGSIFYGNINSWKIFKQDFEKCLNCFLSFNIVDDDQIMLLWCTRNNPDNY
KIIRTYEWFGSLLSFIPDDIKSHLTFKRKNSKYYKTIKEEIKKDIYNKQYFKFLFHSLKY
GYYKFINKKNIDL
>fig|195.2096.peg.928 Oxidoreductase, short-chain dehydrogenase/reductase family
MDKVVFITGGSTGIGNACVHKFHNEGYKVAFMDINQEEGQKIANNLKDVLFIAGDTKNKE
DIKNAVARALEKFGNFDVISLNAGIHRCNTILDISDEELDLIIQTNIYGYVNTMRIAIPH
MKKEGGSIVINASDQCFVGKPNSFAYGLTKGALGQITKSLSLDLAPKI
>fig|195.2097.peg.700 Probable lipoprotein nlpC precursor
MRFVIFFLVVIAFYIGGCSLAQNASHTPTNYNVDKETRLRMIANEWKKTPYVLGGTTKKG
ADCSGFAQSTLAQFNTRIPRTTTKQLRSGIKVSKSKLKTGDLVFLKQVEDQMVCMWEFI
>fig|195.2097.peg.1800 Flagellin
DVKSVGAYAIKAGNTSQDFAINGVVIGKVDYSDGDENGSLISAINAVKDTTGVQASKDEN
GKLVLTSADGRGIKITGSIGVGAGILHTENYGR
>fig|195.2097.peg.1692 Pyrrolidone-carboxylate peptidase (EC 3.4.19.3)
FGKAGEVLKKAVEQYRPDAVVCVGQGERE
>fig|195.2097.peg.1798 hypothetical protein
IDKSGKIVIKPKFNAVWGFSEGLAAVGLNGKWGFIDKNGEFVIEPKFDEAWSFWEGLAAV
GLNGKWGFMDKNGEFVIKPKFDDIWDFREGLAGVKLNGKWGFIDKS
>fig|195.2097.peg.1127 hypothetical protein
MLICNHCNTKNLDVAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEEEKRKIAQEER
EKSLKQRKEFISKHKSKIIISMVSFFLIASLSIYQYFYGGKYSRVYINKLEGKCHYDDAS
SCKMLQTIYKEKCDDGDGKACFAGIFVSGDLIRVKIDGQWSFLDKNGEIIAKPKFDNLGV
FSEGLAGVKLNGKYGFIDKNGEFVIKPKFDDIWDFREGLAGVGLNGKRGFIDKNGEFVIE
PKFDDTRSFWEGLAGVKLNGKWGFIDKSGKIVIKPKF
>fig|195.2097.peg.1490 hypothetical protein
DDIWDFREGLAGVKLNGKWGFIDKSGKIVIEPIFDDIDY
>fig|195.2097.peg.1796 Flagellin
GILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLMEELDNIANTTSF
NGKQLLSGGFTNQEFQIGSSSNQTIKASIGATQSSKIGVTRFETGSQSFSSGTVGLTIKN
YNGIEDFKFQNVVISTSVGTGLGALAEEINRNADKTGIRATFDVKSVGAYAIKAGNTSQD
FAINGVV
>fig|195.2097.peg.1639 hypothetical protein
MHVPEKGKTFAGEVREETVAWSKDTYQLLKQAEQGKVKSYVQDIALAVLDCKETATSRET
FIRLMNERGYGVDWQDSHKYITYTDLAREQAGEKACKIRDNKLEKYYNMDFGKESMEHEF
ERNARTAEA
>fig|195.2097.peg.1795 Methyl-accepting chemotaxis signal transduction protein
KQSSDFANHLASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVI
TQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLS
EIEANTNLLVQSINDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSD
IANNILEDVKKKRF
>fig|195.2097.peg.1633 Pyrrolidone-carboxylate peptidase (EC 3.4.19.3)
MRILFTGFDPFGGEKINPAGEAVKMMKNEIQGAEILKLEVPTVFGKAGEVLKKA
>fig|195.2097.peg.701 Probable lipoprotein nlpC precursor
MHVGIYMSKGKFIHLSTKGGVREVDLNSSYWKNRYIGARRY
>fig|195.2097.peg.1075 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKKYNVVLLGGSNSVMVNGLQKGLRQENVNLTNLALGACSSIQNLYELKRERNREFLDSA
DLIITESNINEIEQNWFELEKLPLSLIYRNLTWMYRELSYLNKKILVIILPYQKLNYKII
NSLHRRNCVKYGFNLIDMQSYYEENNLEEFGNRIDPGHQQSTIMKNLGENIIKKIDSFKL
PNFIAKVKNPEILIVSPSELQYSDSLVKIHNKNSMYDELVYRITSIDKLKFPKKFLGYFL
IGMHTWNTGKIKQKAATVYSSLAFRNNDKVLIKEASMLNSVQEIRDRSFIIDDNSYVGIN
MDNLPCNEKFGAAQSYIDGSKNIDYCDVVNFILAKYNYFDNKKFAIDKMVFSLDEYNFNH
LIPPIEFYKEIIDEYCAVMDSKKLSSMQKQFAILNNEKQEVIAKNFKLQTRINQFQEAIE
SMPVKKQQLEISSLEQDLINKKLQAKQLSKKLGIKMNDFMPKITMIYPNSAKVRIQNQLS
YKLGQAMIVNSKSILGYIRMPFVLSYIYDKHKQEQKIYQEKIKKDSSLILPQLESYPDYK
EALKEKECFTYKLGQALIQANKTWYGGGYIRLLFEIRKLKREFYIKKEAYE
>fig|195.2097.peg.1797 Methyl-accepting chemotaxis protein
LATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDALQAKV
GSDMNEIQRVFNSYKSLDFTTEVKDANGAVEVTTNALGQEIIKMLKQSSDFANHLASESS
KLQSAVQNLT
>fig|195.2098.peg.1601 hypothetical protein
MRVVNLSKKIVDKILFLRINRVVNILMLIFALFSTIAIALFLSVNLTTL
>fig|195.2098.peg.1596 FIG00471065: hypothetical protein
MIYEKKITKKEIFSYAIFIAIIALICIFKNEIWEFVKFIFSNLDFICGNFANFVGEDNIV
FFPITTLLKESRLKSQPSLVVGLKAYP
>fig|195.2098.peg.1860 Motility accessory factor
LKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTELTAEFFNHDFGEFDKDIVFICAG
VVHPKAIEYLKGRNLVITQK
>fig|195.2098.peg.381 Possible sugar transferase
MEQILKILKQMLSPDQAQILLKALKNSNNENFYNFALENIEIICEWLNSKEFQENYTNHP
YPPLLNPNYIDTDASRHCAELA
>fig|195.2098.peg.382 Possible sugar transferase
MLPYDAKERYCINYMCLNDKNISDQAINISELNIINLEKYLALLDPHSKVICGIRDPIGI
LKHNWGRDWSKVQRNFQNEFDLTYDYRNYINFLNHKKPEIKINLEELNYSVFIINYLSKY
FNQEYIYYLDMEKIKTKNAFQTMEDLAFRFGFTPPCLKESENLFKIQEFRGYIRYLFPIT
LYANQKDLSNIFSIKSPNNNPNASIDTSTSIAIILDRPHKNSQKINIINEILNNDLSNDM
SVYIDKSDLEKLEKNTLFFKQIKNYLYEFLQAIHKTIEHTEDSMMKEEDVLLYFSKNKTL
ALEFKEIFNKELNNVKQSHPNIIASWKYYQEFEKICKKLDEKE
>fig|195.2098.peg.1199 Lysophospholipid transporter LplT / 2-acylglycerophosphoethanolamine acyltransferase (EC 2.3.1.40) / Acyl-[acyl-carrier-protein] synthetase (EC 6.2.1.20)
MGNHISFIDWAIVQMAIPRKIYFVMERSIYSKWYIKIFLDKFGVIPVSSAASKASLELIA
ERIKQGDLVCLFPEGVLSRHGQLNEFKGGFEHVCSNLEEDDGVILPFYIRGLWGSTFSRS
DEEFSARNRTLSKRNIAIAFGAPMSLHSKKEEVKAKVLELSFMAWKSQCEAMHTIARAFI
TSAKRNLSNIAIIDSLAGAISYRKLLSLSFILSTLIKENSKKINSNFERGSYAPKEECVG
ILLPASFASSLLNLSVLLAQKVVVNLNFTAGEKALQAAVKSAQISQIYTSKKFLEKLESK
GVSLNFGEEVNLIYMEDVVEIFKKQKSKILAMMMAVSILPSFILKAIFAPSKNNLAIAAI
LFSSGSEGTPKGVMLNNRNILSNIAQISDVLCTRNNDVILSSLPPFHAFGLTVTTFLPLL
ESIKSITFADPTDALGIAKAVAKNNVTIMCGTSTFLGIYARNKKLDAIMFESLRVVVSGA
EKLKSEVRSAFEMKFKKSIFEGYGATETTPVASVNLPNRFDADYWIVHRASKEGSVGMPL
PGTAVRIVDPNTYETLKTNEDGLILIGGHQVMVGYLNNKEKTDEVIKEIDGIRWYNTGDK
GHLDEDGFLYIVDRYSRFAKIGGEMISLGALEEEIAKFIDTNIVKFCTVALEDEKKGEQV
ALLIECDEEFFEGVCEAIKSSSMPAIFKPSRYLKVEKIPLLGSGKVDLKGAKELAKSLV
>fig|195.2098.peg.1841 Motility accessory factor
MMTFTPTQKELFNKNIEALSNILLKEGLKEIKSSKFELVLGKDNLDINLKDTSDNTFLYE
NVIDELNTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMF
HILDFSNELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDIL
GLNKKLAENFKNSIVSYGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAII
VSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDIKPDYVCMLERDEIVAECFNNDF
GEFDKDIVFIVKSVTHPHTIKYLQKNNRAFILVSTYASFIQYLKLDYFGYFNMGFSVAHM
NFLLTIHLKYKNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDKFSTTAYGGNGK
VQSSEIWTLFRHNFEKDIVNIKMNYHITTYNCTEGGARIEGTIEKPFLWACENLLDKDLN
KPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSN
>fig|195.2098.peg.1463 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLVDALKEQI
PSLVLLNNIELLSLIGFGVYLDGDPLIKTHDMRSRVNYTNTTGLTIPVTIYAILLRAIGD
VDVFVNNKKITTLAPNSQTPNSQITLILKPNDIYSIYTIAHPTNVSVKARLLNLNRSHV
>fig|195.2098.peg.1592 putative nucleotidyltransferase
MGRKEITTKEDLMKVIELFENTGITYWLDGGWGVDILAGKQTRIHRDIDINFDAQHTEKL
LNVLLNLGYKIDTDWKPVRIELYSDELGYLDIHPFVLNEDGTSKQADLEGGWYEFEKDYF
GSVFFEGKTIPCISLKGQKVFHSGYELRDKDKHDISILESLSK
>fig|195.2098.peg.590 Citrate lyase beta chain (EC 4.1.3.6)
MSLISTINIIGVVLPKAQSYEDIDMLSQFELPIIPIIESALGVENLDDIARHPNVLALSF
GSLDMTLDLNLQEGEGKNFILNSIRTQIILKSTKYNLLSPINGVYPDIKNIDGLKRI
>fig|195.2098.peg.1200 Lysophospholipid transporter LplT / 2-acylglycerophosphoethanolamine acyltransferase (EC 2.3.1.40) / Acyl-[acyl-carrier-protein] synthetase (EC 6.2.1.20)
MQKNSFLKIYGLIPFLLVAFINAFVDLGHKIIIQNTIYKVYEGSTQLLLTAIVNALILLP
FILMLSPSGFLADKYPKNLIMKLSAVFSVILTIIICISYYNGAFWTAFTLTFIMGIQAAL
YSPSKYGFIKELVGKDLLAMGNGAVNAVSIVAILAGMSLFSLSFESLYDINHNSSEEVLK
QVAPLGFLLILFSLIELYLAWRLPKLKDEIKELKFDSKRYLSGKLLMSNLKLIFENKVIW
LCIVGISIFWAISQLYLVSFPVFSKNELFIENTFFVQVSLGFSGIGVVLGSLIAGRFSKN
YIELGLIPFGALGVFLMALIMPYFTSLITYSFIFFIFGFCGALFIIPLNSLIQFHAKENE
LGKILAGNNFIQNIAMLTFLVLATLFANLEINVIYLFYFITLVAFLGAIYVVFKLPFSLV
RMLLSIAFLGRYRLLVEGFKNIPEKGGALLFWAIIFLLSIGL
>fig|195.2098.peg.1856 Motility accessory factor
LKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNNDFGEFDKDIIFICAG
VVHPKAIEYLKGRNLVITQKVLAFPYYINLKDFSYAAVGLSVAHTLSYLATYLSHKNIIF
IGQDLAYAENGNSHPDDYQNSANYESQMYEHILTTAYGGNGKVETHSIWLLFKNWFENEM
IPNTRKMGITTYNCTEGGARIEGTIEKPFLWAC
>fig|195.2098.peg.889 Transcriptional repressor of CmeABC operon, CmeR
MNSNRIPSQKVLARQEKIKAVALELFLTKGYQETSLSDIIKLSGGSYSNIYDGFKSKEGL
FFEILDDICKKHFHLIYSKTQEIENGTLKEILTSFGLAFIEIFNQPEAVAFGKIIYSQVY
DKDRHLANWIENNQQNFSYNILMGFFKQQNNSYMKKNAKKLAVLFCTMLKEPYHHLNVLI
NAPLKNKKEQKEHVEFVVNVFLNGINSSKA
>fig|195.2098.peg.893 hypothetical protein
MDKAKIVQNLNALFKQRAEFYSYFDENIAKINNTEVFDFKNAKNLNSEEVYKQFYHFDYA
IRKLLPAIYKAYEITDADLDKDF
>fig|195.2099.peg.61 Signal transduction protein CetA, mediates an energy taxis response
MIPKTREINTSISCSQKGEFYRKALPEGLKGIFAHNIEFINKALANIEVTARSTFKNALS
RTLMDLSLGNQNKDMSQISSSLNQDISMMKNVYDTVDAISHTATENGSEVDSLQSAMGSL
MDVVNSSKETVQTFVANSQNITSVVEVIRDIADQTNLLALNAAIEAARAGEHGRGFAVVA
DEVRKLAERTQRSTSEISIAIQTMQQDFVNIQSGSEQVFNIVSESEERINKFSQAFKRLE
ENSSALGVNFGSFAKRLILSVVKIDHILYKSNIYLNLNGAQNFNLESVDPISNLCQDERA
QGVINELSSETELNLAKEFIKDNAKKAIEESSQDYIDQKAYDAIVNDIKSLEQRSAEILA
KLKI
>fig|195.2099.peg.1239 hypothetical protein
MKITMIILSLFSLVFLSACAFKEKKASEIETLASNYGGIYIFDKKIREEILENERKKGEA
MKKMSLGDDFWDQLKVIEKNSPKSFLMVVNIIVMIIIIK
>fig|195.2100.peg.1618 Crossover junction endodeoxyribonuclease RuvC (EC 3.1.22.4)
MKILGIDPGSRNCGYAIIEANKGKNTLIEAGLIKIKPSTLQYQITELCEGLDLIFKNHSF
DEVAIEDIFFAYNPKTVLKLAQFRGALSLKILQIHGDFAE
>fig|195.2100.peg.1818 Motility accessory factor
FLELMSHYYERFHEDILGLNKKLAETFKNIILRNGNDPLDALQGIEQFVYNLPQMITHPS
YKELLSKRKGISDTAIIVSTGPSLIKQLPLLKKYANKAT
>fig|195.2100.peg.529 High-affinity Fe2+/Pb2+ permease precursor
MKFFKILFFFSMLFLANSVFARVDDYVAEANTIKNILEESIKSYEKGDNLKAKKLSEDAY
FQHFENMEGSIGRNIGKKAITMERKFTNLRRLYKDKAPIEQIDALIESLYYDLDEVAPIL
QNGYRLQAEASDINYDKAAAEKSSIQANAKREAEAEALIAQMMGIDKNDLAKTNSSSSTQ
NETINDSINNDLQAAAAMDARLQFVLDNISTKFSQAANAFKNKDYQTSKDFLNDALFNDY
RNTKVEVLINKFTKAGNDQKIQQAIRTLIRQINNANIDEKNLRNDLDSIEEQLFDIFLQI
PNSELSNLKIEGFDDETKGKDYTKVSNDIKLALDEILKNYDGFSASIVDDLQGIYLDIFE
ASGMENKIGAVDSGLKLKIESLFSKSVALIKASTDKKELEATFNDLEQLIASSVDKIQDS
TPYSLFIWALGIILREGLEALIIVVAIVSYLVQSGNKNRLNIAYSALFTGVILSFITAFG
VSWLFKENAGQSRELIEGI
>fig|195.2100.peg.1807 Motility accessory factor
HPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKP
DYVCMLERTEITAEFFNHDFGEFDKDIVFVCAGVVHPKAIEYLKGRNRKYLIIPRYLYFP
IYIKLKYFDFLYNTPSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2100.peg.1463 hypothetical protein
MPKRNTIETITLGLFSDEDVSIICEDTIKLERGSVAVLSGNSEVGKSFLALKVCANAIND
GLKPFFWSVEDKNKAILERIKNIESFYSF
>fig|195.2100.peg.1750 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
MGIVYEQTYRESLQNPEAFWAEAAKKVHWYNEWDRVLDDSDGHYRWFVGGCMNTCYNALD
LHVHNGRGDQLALIYD
>fig|195.2100.peg.269 Motility accessory factor
MTILEKNIQALLSGVNEPLGN
>fig|195.2100.peg.920 Hot dog fold protein HP0420
MAKKDTFEEYAQLEEYASAEDISRVRAELLTCPELNTSLAGTIIELDKNFAKSILITTSD
MVVDEQGLVFDAFIFAAANYVAQASINKEFSVVIGSKCFFYAPLKLGDVLELEAHALFDE
TSKKRDVKVVGHVKEIK
>fig|195.2100.peg.200 Putative aminotransferase
MNFINLQAQYLKYKEEIDSEIASVLSSSSFIGGAKLNEFETNLAQYTHVQHAIGCSSGTS
ALYLALRALDIKQGDEVIVPSFIL
>fig|195.2100.peg.1304 Hot dog fold protein HP0420
EAHALFDETSKKRDVKVVGHVKEIKMFEATIQVVSIDEHIFKLKRPPLNTAKAAENPDSP
TSTVNPEAIGSALSASLRK
>fig|195.2100.peg.1782 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
MKRVVVTGIGMINALGLDKESSFKAICEGKSGVKKITLFDTTDFPVQIAAEIENFDPLEV
VDGKEVKKIDRFIQLGIKAAREAMQDANFDQNLDKEEFGVVSAAGIGGLPNIEKNSVICS
ERGPRKISPFFIPSALVNMLGGLISIEHGLKGPNISCVTACAAGTHAIG
>fig|195.2100.peg.1250 Translation elongation factor LepA
LPPVNKIDHIKEPYVKATIITPSEFLGNLITLLNRKRGVQVKMDYITPERVLLEYDVPLN
EIVMDFYDKLKSLTKGYASFDYEPIEFRVGDLVKLDIKVAGENVDALSIIVPNEKAQSKG
RELVSAMKEIVPRQLFEVAIQASIGNKIIARETVKSMGKNVTAKCYGGDITRKRKLLEKQ
KEGKKRMKAIGKVNLPQEAFLSVLKID
>fig|195.2100.peg.1773 High-affinity Fe2+/Pb2+ permease precursor
FITAFGVSWLFKENAGQSRELIEGITMLVAVLLLFYVGFWLLSNAQNKKWTSFIKQGAID
AISNNSAKTLWITVFLAVYREGAETVLFYQALLFDAKTSTDFGAVFGGLGLGILILIVLY
FLLKAGAIRIPVKQFFYITSYIIFYMVFVFTGKGIAELIEGKVIIPSLIPMNFEPILWLG
IYPYYETLIPQFIVLIMLIIGILITKQISKKGVKS
>fig|195.2100.peg.1653 Signal recognition particle receptor FtsY
FDKVIIDTAGRLQNQKNLANELEKIVRISAKAMPHAPHRKILVLDGTQGNAGILQAKAFN
ELVQLDGVIITKLDGTAKGGALFSIARELELPILYIGVGEKMQDLIEFNAQNFLDTLLEG
VFD
>fig|195.2100.peg.1796 Adenosine deaminase (EC 3.5.4.4), alternative form
KGVRTLFTHCVYLKEMDLLDKNLHSITHCAFSNRLLSQKTFDLKKALKSGLNIHLGTDGL
SSNISLSILDEMRANLLVHTDFDLLKLAPKLLQMATLYPAKALNLNLGEIKQGKMADFSV
FELGECNKEQAPLQFILNAKEVQKIFIKGKECKF
>fig|195.2100.peg.1735 Crossover junction endodeoxyribonuclease RuvC (EC 3.1.22.4)
TVLKLAQFRGALSLKILQIHGDFAEYTPLQVKKAVTGKAKATKEQVAFMVKRLLGLSKDI
KPLDITDAIAVALTHAANLRVRV
>fig|195.2100.peg.201 Putative aminotransferase
MVALLGAKPVFVDINLDNFNIDFELLKNAISPKTKAIIAVSMFGQMSNLQELNTFCESKN
ISLIEDGAQSFGASFKSEKSCSIAKISCTSFFPSKPLGAYGDGGAIFCNDESIAKKLRIL
LNHGQTDRYKHEFIGINARLDTLQAAILNVKLKHLDEEINKRQEIAKFYNENLTNCQIPK
IDENAISAYAQYSVLVEDRARVLKAFEKANIPYAIHYPTPLHKQPCFSEFSHLKLEKSEF
ASKHILSLPFSAFLSQSEQESVIKVFKEGL
>fig|195.2100.peg.1587 Adenosine deaminase (EC 3.5.4.4), alternative form
MYIISAKYIFLCDEQFSILENKAFVFENEILELGELEELKKRYPKAKLIKTSPHCVILPA
FINPHTHLEFSANSTTLHFGEFLIWLKSVINSRSMLNEQAKEELILKNIQKMQKSGIGTI
GEISSFGSDLNPCVRASQNGMRVVFFNEILGINEAQIQDKKQEFLTRFEKSLKFKDEFFI
PAISVHSAYSTHPELAKFAINLAKKQKLLISTHFLESKAENAWLKEVKGGFKEWFKNFTP
DPKPLYKASEFIQLFKGVRTLFTHCVYLKEMDLLDKNLHS
>fig|195.2100.peg.1441 hypothetical protein
MDWQDSHKYITYTDLAREQAGEKACKIRDNKLEKYYNMDFGKESMEHEFERNARTAEAEQ
SKRAASRVKPTEPDRAGKQSAQRSVGDVERELRGIDEAVKSRTSEGRAEQAERRRAEQEA
HQRAEAERRAAEEQQRIASRRYIGRDWEPER
>fig|195.2101.peg.1613 Excinuclease ABC subunit A
MNDTIKIIGAKENNLKNIHLEIPKNKLIVFTGLSGSGKSTLAFGTLYAEGQRRYIESLSA
YARQFLDKVGKPDVDKIEGLTPAIAIDQKTTSKNPRSTVGTITEIYDYLRLLYARVGIQH
CHQCGQKISSMSASDIVGEILKFPKGAKIIIYAPLVREKKGTYADLLENLRNKGYIRAQI
DGVLVRLDEDIELSKTKKHTIKLVIDRLEIQEDLLSRLASDIEKGLEESFGEIEIEVLNP
DEVGLNKHYHFSEHSACFACKISFVPLEPLSFSFNSPKGACEACDGLGIRYTLDMKKIID
ESLSLENGAVKIMYGFNKSYYYKFLIAFCEQNEIPIKLPFAELSEEQKRLVLYGNAKTID
FFWKRNRLKRTFEGVVKMAYEMLKDEKDLAEYMSEKICKDCAGHRLKPESLAVKIASKGL
GEILDMSIEDSTSFFANKKNFSYLSEQERLISEPILKEINERLFFLYDVGLGYLSLGRDA
RTISGGEAQRIRIASQIGSGLSGVMYVLDE
>fig|195.2101.peg.998 Flagellar biosynthesis protein FlhA
ANLKDEATLNGYIVIDPASVISTHMSELIKAHASELLTRQEVQNLLDKVKNDYPIIVEGA
LGVAPVSLIQKILKDLLKHNIPIKDMLTILESISDIAEVSKSFDMIIEHVRASLARMITN
MYLDDKGNLDIFILDSASSAVLMENVQFRDGSYHLPLSVAQTGTLVDTLRAEVAAVANGR
IKPFILCVEPQLRKFIADICYNFNINIVVLSFAEIAENTNFNTEGIIRIEL
>fig|195.2101.peg.1112 Ferrous iron transporter FeoB
MKKIKIALVGQPNVGKSLLINALCKANMKVGNFSGVTIEKASAKTFYKNYEFEVIDLPGT
YSLDGYSEEEKITRHFLNQNDYDVIVNVLDATNLERNLILSAELLSLNKKMLLALNMCDE
AKKEGIELDTSVLSQEFQSQVVEISAKTKENLELLLQKIIILFESKFIPRSQFYTPLCEK
SPEKEDLLYFINELSKKIITHKKEERNLTKKIDALLIH
>fig|195.2101.peg.908 Peptidoglycan D,D-transpeptidase MrdA (EC 3.4.16.4)
ISKLTNFTGKSGIERYYNDVLQGEKGTKIYKVNALNQEVEQLSYTSALSNDIELTIDIEL
QSFLTQLFEGNAGAAIIMDISDGSILAAGSFPEYDLNPFVTGISYKEWDELSNNLDHPFT
NKLINGYYPPGSVVKMGVGLSFLNSKSINPSTQFFCNGSIELGGRFFRCWNRAGHGAVDL
KHAIKASCDVYFYDGSLQVGIDQISRTLSRIGFGAKTGVDLPNEFVGILPSREWKMQRYK
QAWFQGDTLNTSIGQGNFLATPMQIARYTAQIAKGAEVVPHFLKSVENNNTITEDKAQDS
NEIFTLFEKSQLPYIRDAMYAVANEQGGTSYHYLRNLEVKVAAKTGTAQVVGFSQADKNR
VDEKQLRYYTRSHAWVTSYAPYSKPRYVVTVLVEHGGRTISSGVATAKIYQKMIELGYFK
PENKANSLKKN
>fig|195.2101.peg.1659 GTP-binding protein Obg
MFIDSVKITLASGDGGKGAVSFRREKHVPLGGPDGGDGGNGG
>fig|195.2101.peg.1428 Putative periplasmic protein
IVATGASKSEIKGLEDFVIPHELMPKPNKFCFKHHGRQIIKEGIYAAGLASGVTTMVACA
MGSANEAACAILSDIKGAVSVYHDTPTTRN
>fig|195.2101.peg.909 LSU ribosomal protein L4p (L1e)
TAHTKGRSDVSGGGKKPWRQKGRGGARAGSTRTNVWVGGAVAFGPTNERNYFQKVNKKQK
RLALERALADKAAKGVLFTADSLAIESGKTKDANAVIKKLGVKDALIVKDLLDEKTLLAY
RNLANCYVVDISEVNAYLISVFNAVIIEKSALESITKEG
>fig|195.2101.peg.1700 Putative pre-16S rRNA nuclease YqgF
KEIRFVDESGTSKEALGYGVANTRKKDAKLDSLAALIMIKDYFGI
>fig|195.2101.peg.446 AzlC family protein
MKQRELFLLTIPVLMGYIPLGAAFGILAASKDFSLFEILLSSIFIYAGAGQFLLVALVAQ
NVSFLMIFLLCFY
>fig|195.2101.peg.1779 Aminoglycoside 2''-phosphotransferase (EC 2.7.1.190) => APH(2'')
MKQNKLHYTTMIMTQFPDISIQSVESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEI
QLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAVFPDDAKDRLALQL
AEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYL
THPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLEDCGE
LFTRQVMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGLRARDQDWISEGLELLEEDKANN
FGANSA
>fig|195.2101.peg.1784 Mobile element protein
MSANNNELISISHKIELKPNNKAKTHFKKAFGCARLAYNWGLAKWQEYYKQGIKKSHLEL
KKEFNAIKKEQFPFVYEVSKYATQQPFLNLNLAFQKFFRDLKQGKVSYPKFKKKKDNFGS
YYIGGDQAIIKDEKYLKVPNLGLVKM
>fig|195.2101.peg.693 Type I restriction-modification system, specificity subunit S
MQNKMTNLPQGWEVKKFEEIANIKGGKRLPKGENLLDNNTKFTYIRVADFQDNGTINLQN
IKFINENTYNVLKNYKIYDDNLYISIAGTIGKSGIIPKELNGAILTENAVKLEYIQNNIS
NKFMYFFTLSNIFKTQIQTSTKIVAQPKLAITRLKQIQIPLPPLKEQERIVGILDESFAK
IDESIKILEQNLLNLDELMQSALQKAFNPLKDNAKENYKLPQSWEWKSLEEISENISAGG
DKPKNCTESKTAKNQIPVYANGVNNNGLVGYTDKATIIKPSLTISARGTIGFVCIRKEPY
FPIVRLISLIPCENILCLHYLYFCLNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKEQEQ
IAKHLDFVFEKTKALKELYTKELKDYEELKQSLLNKAFKGEL
>fig|195.2101.peg.674 Excinuclease ABC subunit A
GEAQRIRIASQIGSGLSGVMYVLDEPSIGLHERDTAKLIKTLRNLQQKGNTLIVVEHDKM
TIEEADFIVDIGPKAGKFGGEVVFAGTYKELLKSKSETALYMNGKKQISQLQNREQKEWL
ELKNVNINNIKDLSVSFPLQNLVAITGVSGSGKSSLILQTLLPFAQEELNRAKKVKKLGG
VQIEGLEKLDKVIYLDQSPIGRTPRSNPATYTGAMDEIRNLFAATKEAKMRGYKAGRFSF
NVKGGRCEKCSGDGEIKIEMHFLPDVMVVCDTCHGKRYNDATLEIKYKGKNISEILNMSV
LEASEFFAAVPKIKQKLDTLVKVGLDYLTLGQNATTLSGGEAQRIKLAKELSRSDTGKTL
YILDEPTTGLHFEDVNKLILVLQHLVDLKNSVFVIEHNLDVIKNADYIIDMGPEGGVKGG
KIISTGSVEKVAKDHKKTKSYTGYYLDLELKNAKS
>fig|195.2101.peg.1773 DNA translocase FtsK
FLKDQQSMGVTSSESMNNGEYDELYEDAKRVILSDGKTSISYLQRKLNIGYNRAANIIDQ
LTESGVLSEPNSKGQREIL
>fig|195.2101.peg.1771 Transcriptional repressor of CmeABC operon, CmeR
SSYISNNAQKLAMLFCAMLREPYHSLNVLADTPLMNKQEQKEHVEFIVNIFLKGIENKTS
I
>fig|195.2101.peg.1660 Putative periplasmic protein
MRKSIAIIGGSIAGLSAALFFASAKNEELDFDITVFDEGKADLKAAAIYNVPFFPKGAKA
DEIYTHIKEQIASMLEVKYIDSKVVSISGEKGDFTVNDEQGLGIKADYIIVATGASKSEI
KGLEDFVIPHELMP
>fig|195.2101.peg.1717 Peptidoglycan D,D-transpeptidase MrdA (EC 3.4.16.4)
MRMRLVVGFILLFFIFLLSRVYYLSIKSNVYYEELAKQNAIKTEFIVPTRGQILDRNGTP
LAINDLGFSISIKPYLTLKRANRGVLEKELNQLQGFFPDLNTTKLAEFYKRNDSYYNQDF
IKIIDFIPSQEMMKHYSELNLNQNIRIDPAVQRKYPFGKLASHIIGYVGKADLQDIKENE
ISKLTNFTGKSGIERYYNDVLQGEK
>fig|195.2101.peg.1681 hypothetical protein
FADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSALPSPMFILERESGQYDYFEEY
PHNKIGFFIKTYWNADVSSKYFFHTENYLIRIIPNLAHLTIQANINKNIILVSYHSLKDP
FNTAKDKQTLFLAYKELGYDATLHLIKDESEIDGRFIKDLNHGMRISDKALFRKELPLML
EKLQKRKSLMQENSISYPCGNKVFIFKDVGDKFELTIKD
>fig|195.2101.peg.1612 UPF0126 inner membrane protein YicG
CALVATKIPRIVSRLESLFLTLDAIGLVVFSILGAQIAIEQNHGFIIAISAAVITGVFGG
ILRDILCMRIPLVFQKEIYAGIAIIAGAIYYTLMVYLQLHALICTLVTLFVGVTARLLAI
KYQWSLPIFSYNEEK
>fig|195.2101.peg.1796 Flagellin
MKENYGRLSLVKNDGKDILVSGTGLTAAGFGANSFISQASISLRESKGQLNANIADAMGF
GSVNKGVAIGGFSTVTAYMSSEGSGFSAGSGYSVGSGKGYSATLTANAIVMSNASAASRV
YNVSSGSGFSAGSNLSQFATMK
>fig|195.2101.peg.445 AzlC family protein
MFLLNFRHFFYTLSLLKELKSINFLRHYIIFALTDESFALLSSIKEKIKNLSRAQRSLIM
FEVCLLNQIYWVIGSVLGYYFKQGLNIDYSGVEFSLNALFIVLAYELYKQNPNLKILLYS
SFVALFALFCIDKPYMLAFCIFIALMILIFGKKYVR
>fig|195.2101.peg.1530 UPF0126 inner membrane protein YicG
MEISALTITILYIIGISAEGMTGALAAGRHKMDLFGVIFIALVTAIGGGSIRDVLLGHYP
LTWVKHPEYIVLICLCALVATKIPRIVSRLESLFLTLDAI
>fig|195.2102.peg.1855 FIG00973752: TolA-like membrane protein
MKKIILILAVLSSCLFASDELNIDSLFKKQIG
>fig|195.2102.peg.1760 hypothetical protein
MKAENVAKHIINYCLSIDNPISNLQLQKILYFIDIYHLIRTNKRLIEDENFKAWDYGPVI
ENIYKKYSFFASNPINIYQDFTEEFDGNIRGELYGYIDKLSKMYPSVLVEKSHESDSPWD
KTKKYETILPELLEEYASQYRK
>fig|195.2102.peg.99 Beta-1,4-galactosyltransferase
MLKLNDNFLFTLDSIGGTQGYLIKPISALKFIDNLKFWIKPVDNVMDMYYYSKVFTITYT
PLLLKTTDINSTIEERKKDKRPIFKRIIKEICRLYFIYLKFTYKQKAIKFLRREV
>fig|195.2102.peg.570 Propionate--CoA ligase (EC 6.2.1.17) / Acetyl-coenzyme A synthetase (EC 6.2.1.1)
MGFIVLKEGIERDHRGIVEGVVALVRQEIGAVASFKIATVVSALPKTRSGKILRKNLREI
ADGSTLNVPATIEDSNVLKACEKAINALGYPKNKGEK
>fig|195.2102.peg.1646 Leader peptidase (Prepilin peptidase) (EC 3.4.23.43)
MENNPIAFLILAILGASLGSFCMSLTMRFCENKPLLSLRSYCFSCYQKLKPLELIPIFSY
IFLRFKCKTCHIKIPFSVFLAEVLGMIFAWIAYLLSQNIGEFIHLLIFLFVLFALSCIDL
KFQAVPQKLLWLIFFIAFSFAFNSNEFAYFFIFENFQNGFMVQAFIFAGFLFLLKNFIAF
LKNFRTKDIQENLGDADIIILASMAGVFGFKSAFIILFLASLLSLPFFIHNKNTKLAFLP
FINAAFVIYLIYLIYLIVQELI
>fig|195.2102.peg.1759 Integral membrane protein
MLPALGSFLDKDSNATYPLLLSLSVVYFMLVVLILFSLQKTARKNSIVPS
>fig|195.2102.peg.1844 hypothetical protein
MKKIFALLALTSLLTSSVFA
>fig|195.2102.peg.1570 FIG00471065: hypothetical protein
MIYEKKITKKEIFSYAIFIAIIALICIFKNEIWEFVKFIFSNLDFICGNFANFVGEDNIV
FFPITTLLIVFTIAYLCCLGII
>fig|195.2102.peg.1406 FIG00973752: TolA-like membrane protein
KFQTAIIQREKTVLQTKNFYFQSQNLEASLRGYSDPVVYSIYTGFGYNAQRKFKIAKIDY
GNSIYFGGNLSIILSPKITLDLGAEQRFQTEQKINGVKNSEIRSIPTISGGSTYSINQDT
AVSVSASLGGSSAAPDAIFGINLWKKF
>fig|195.2102.peg.964 CRISPR-associated protein Cas1
MSYDEAFKTLLISSNAKLNLELNHLVIKQDENIAKLFLKDINIIVLESLQVSISSALFNA
FARHKIILLTCDETHSINGVFTPFLGHFQSAKIAKEQMNVSAQKKAILWQKIIKNKILNQ
AFVLKKHNKIEQSNELINLAKKVSLNDSKNIEAVAAALYFKTLFGVSFSRDELCFENSAL
NYGYAIIRACIIRAVCISGLLA
>fig|195.2102.peg.1758 Integral membrane protein
MEKTTQEEKEIIAKALKVNIDDVTYDRSSNFKPEKNKFIIKGKVINKFDIHCLKDYELSF
LKCQIKTKISIRKYIEDIKIKSLLFNDCSINSIVFIDDFSCDNMHFLNCSIDKISCSKIS
IKGDVKFKKCSFVKEFLLDNCKFLNAIYFNNSFFKSYADFHECEFDDIACFYGVTFEKTP
NFSQAIFEGNLNMVNTNLNFTFDDLQERIKQEYKDFNKTKEDQDKKPLDKFANDFRDSFR
NFKSALIKDNNLLDASNFHKYELYCKELELKNKKDKTLKDRIDKWQLVFYRRLCDHHTDL
LKAFHNLLIVIMLFSMFSFVLDKFKQPSHIENDIKYNIIKVDSNENYIFKEHNKTTYNLL
SLNIEQESDKIIKNDFVYMIVFLILVLLLLSFNIFASIYIFGSILYLIFSFLDLLALYTH
IAVIVFLYCLL
>fig|195.2102.peg.963 CRISPR-associated protein Cas1
MYKWALGIKHDNIYNSFALCDDLIEVFRASVDDCVLKLKGESEFLSKDDKRALIGNLQSK
INFDGQNYPLNRAINHYVANFKNALLYEDELKIVKFDD
>fig|195.2102.peg.1857 Bacteriocin resistance protein; peptidase C39
KAEFVVKSYAEIKNEKVVRQNYEESCGAASLATLINTLDDNNLTELDLLKTMSGQKLYTD
MVSFADLNDAVKK
>fig|195.2102.peg.495 Ammonium transporter
MNAINSSFIVLCTLLVLLMTPALAMFYSGMVRSKNTLNTIMNCFIVFGVITLQWVVLGFS
LSFGKDEGLGLVGNFENFLLEGISGYNASGVPNILFVIFQMMFALIASAIITGSLVGRIK
LGVLVIFLLFWSTLVYDVLAHMIWSSEGFLLKRGSLDFAGGGVVHISSGVAGLVGALMVG
ARKSDDEDKNAHSIPYAFLGAILLFIGWLGFNAGSAGEMNELLSMLL
>fig|195.2102.peg.12 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGVLVGEGATINANKFGVSITPMGIDAINTFSVDGSFSPVFNVNKGDV
VNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTHLKAEIGSEGFFK
YEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYNGSQSASNEEMINSWKGFAKLVN
EGIFRELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSNIQIDVADKTYVG
LFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIALDTIEGFNGENSSS
GGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNGGG
FVGYTTGNTTFDGISLKDIRFIKSGAFTGGFAGMTQGNVIFENIVLNDLEEISGSHAGGF
AGWINDGTFNNIILNNIEKSVLALHINISLQVALQDMQALELIKILF
>fig|195.2102.peg.1843 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
WQQIFGKENLIVRLFDKSEFYQGDLLKDFVHSIGLKWDNEFVIPPKQNESLDLIGVEILR
RVNNLLPLFVNEDRNYLRGDLNYFIQKYFSSKDLFLKFQPPKEIIQSYIDSFEESNEWVR
KEFFPYKERLFPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLITNKTTQIQN
LNQAIKNKDELI
>fig|195.2102.peg.1850 Motility accessory factor
NILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGYNENLLYQDPIKELQTMLNT
YNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSHELQSA
RLMVL
>fig|195.2102.peg.98 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQRQNQKLFEKNPNLKNKLEFIFFKAVDAKNKEYLEFKQHFPW
WASWVLGRELSDGEKACFASHYKLWQECVKIDEPIIILEDDVEFSDEFLNNGGGQNI
>fig|195.2102.peg.1578 hypothetical protein
MKQEVYTSKFYICKKNEKEACFKLDFEIKAFEENQKFYYVEIYAIIDYQYLKNELGVFKN
DDKKRNSWKLKYSNYWSFSSCVEIDHNYKSLGIGTFVINKILEIALSYVPEAEFHDILSK
GNDENEESCKNRIRRDKLYKNLGFIFNESNTGFSIDSISNLKIRKDFDYIQEVRIFDMCN
QLANLKYLKEGDDKLLKIYKEDCYKEKSKNNILRAIVKLVSFVSIALAVWIVYLLK
>fig|195.2102.peg.1141 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANEFQQEQDLRKQQMEFNQ
AMQNNQLLQNEFNNALALQKFDLERQRQVQDNALNWAKYKEDKDYNQKYLDYLTGKNSNI
VTNKTNNNSGFSIDANGNLSEPQTMRDVFSKESNGGGLYHFSKNAKKQKINLNDIY
>fig|195.2102.peg.866 Ribonuclease HII (EC 3.1.26.4)
MGDFSPFLRENLKTLFEENELLTPFDINLIGIDEAGRGALAGPMMMAACKLHKDLEGLCD
SKKLSEKRREELYEIIIKNSNYLILAFSSEKIDEIGLSACLKMGLTLIKNTLKQKIISYT
MAIQI
>fig|195.2102.peg.1811 hypothetical protein
MTAYVHIGTEKTGSTSIQFFLYSNRRLLQRQNMIYPISIGNYSSQWNFTFLAYNNLRNDF
YCLSKGIFKKDDFLHHKKDIFLKFKDELLKSKCEKVVISSEHLSSRIQDLSEIKRIRKIL
YLLGFKKIKIIVYIREQTSDMISSFSTTLKSGAIGNIQANSKKYFKGYHKLLLLKWQQIF
GKENLIVRLFDKSEFYQGDL
>fig|195.2102.peg.1849 Motility accessory factor
KPFFQFSRIYFLELMSHYYERFHEDVLELNKKLAENFKNSIVSHGNDPLDALQGIEQFVY
NLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPIL
AKHGIKP
>fig|195.2102.peg.1102 hypothetical protein
MQENLKEIYKEFEFLNTQFSSYFNDEEFVNFKKGFEAKNALNYRDFKEFRLEETDKERLK
DIQICKILKEKDELAEEKSLWISKVLPF
>fig|195.2102.peg.1837 hypothetical protein
LEKLQGRKSFMQENSISYPCGNKVFTFKDVENQLKLIIN
>fig|195.2102.peg.1813 Beta-1,3-glucosyltransferase
QLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKYFYRKRED
GSSTLDLKLKSKNYYLNVTRNGYLKILSDCVKNKRDIPLFVQNLVLYDLCWQIKPLINSP
EKLSILNESEQQEYLNLLDKIFSFIEIETVVNFSLAGCWFFYKVGILNCFKNEKPAFQIA
YIEDYDPYKEQILLTYYTGDDKDIESILIDREEVYVDYKKIVKYDFLDRVFCYQKRLWVH
IPKNAKDRLEVLINNEQGMVGKYGEYFLDVKNIRKEFQKRLPKSNIWLLMDRDYEADDNA
EHLYRYIMQNHPEREIVFALRKESLDWERLEKEGFNLVEFGSFEFERIIKKASKVISSHA
DEYLMRYITSRQQFIFLQHGVTQNDISKWLNNRKINLFFVSAQMEFDSIVKNYTRYKFGQ
KEVVLTGFARHDALLKNNKTNTKQILIMPTWRHYLSGLMIGNSGIRELKDDFKESEYFQK
WNLLLDSNTLQKLCEKYSYTIVFNPHPNIIPYLKDFNIPSYVKIANQSESLQKLFCNSSL
MITDYSSVAFEMAYLNKPVLYYQFDQEDFFSSHTLQKGYFDYRKNGFGPVVEKEENLLKE
LENLLQDNCRVFGVYKDNIDSTFVFRDGKCCERIYKNILISTKNRNTVEIILELQEKRHF
KEAYIEWKNFINKMQFDNSNYLYNFLYCARKSGYSDDALNHILLPDFRVLNPKIRIEIIK
NLILNQNYEVIFNELLKFNLSDNDKECLFLAKLRLYLYEKNKIKFDLLSTYLKQYNIIDD
FKLKEEILLSQAFLVNIKHLKLKHLGVDLRKYKRYLCVK
>fig|195.2102.peg.1396 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNGKKYSDKDLIDAFYQLGIKRGDILCVHTELFNFGIPLLSRNEFLQTILNCFF
EVIGKEGTLIMPTFTYSFCKNEVYDKINSKTKMGALNEYFRKQTGVKRTNDPIFSFAIKG
AKEELFLKDTTSCFGENCVYEVLTKENGKLLNFGDTLSFTYFHYPEEYFGIYYRYNKIFQ
GLIIDENKQIHKKQINFYVRKENLYPNEIKIKDFLISTQNYKNIIFGGDNIFISNVKQIF
NSVLESFKKNQYIYL
>fig|195.2102.peg.1557 hypothetical protein
MNRGIIYKKNAKNKKQITNLLKKEKKWHLEN
>fig|195.2102.peg.1856 FIG00973752: TolA-like membrane protein
AQRKFKIAKIDYGNSIYFGGNLSIILSPKITLDLGAEQRFQTEQKINGIKNSEIRSIPTI
SGGSTYSINQDTAV
>fig|195.2102.peg.199 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNEKNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLQEMLSKNSKALRVIDYACGAGHFLNTYANELKRYLTEDELKEHYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIIL
PSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLRKKETFKQENHLI
SQDYSLIKERIEAENLKDNENFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLTELEAFK
DYRNAFRQTSDYKKLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLI
IKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLIYKSFLN
TLDVIPQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSTQSEMSNPFANSKYELVRLV
EIENIKIQKGQNITQKLAKIGNIKVVAGGKDYAYFHNDFNRNENTITISASGANAGYVNF
WKEKIFASDCTTINLPNLKVIQFIYYVLKCNQKYIMSLARGAAQPHVYPKDIENIKIPLP
PLEIQKQIVAECEKVEEQYNTIRMSVEEYQNLIKTILQKCGIIDDGGGYELNSILENLQK
LESKLDFNLLLSLIEEQISHSEVLVEETQSKERRQDFNAFKNFSKTIKELLQTLPASPQN
GWERVKLKDICNINQETYNPSNDLGEMLYIDIDSVEKETGKINFNDKIPCKNLPTRARRI
ARADSVIISTVRPYLKGFVYIKDEIKDSIFSTGFAILNGKENIAKSQFVYYCFMFVDDLM
RQIEIKMPKSSYPSINTDDIGSFIIPLPPLEIQEKIVQNIELVEQQIDFLNLKLEFLEKE
KEKILQKYLFS
>fig|195.2102.peg.1825 hypothetical protein
MLKKLLSVAALGALLSSSAFAEDILAKVSNGAISDNSAGVKVLSLDEMKEVKGGYEFSRA
SSYDYTAGIRSYAYFVYNNGNSVNSELQVENYKKVLATFRFVNNQKEYYLQTYNPLTGSY
GTIFPNYSTSWGKNAMKIMRQFQSRY
>fig|195.2102.peg.494 Ammonium transporter
MVLEWLIHKKPTILGGLSGLVAGLVGITPACGYVDIYASLVIGTLSSVFCYFGLSFIKYK
LKWDDSLDAFSLHGIGGIWGGIATGLFASAKVNPNVIAQNALGEGFFISGSLELLKEQIF
AIVICVVLSALISFVIFKIISCFTDLRVKEEVEQKGLDVSLHGEKAYTLA
>fig|195.2102.peg.1140 FIG00470112: hypothetical protein
MSNEDRHRLEELVKTDSFYFFDKYAKHDIEKAVEVLYRVKNDALKKEYMDIWKTERYLKD
RDNIENYYNNMYKKLENEKAMIKDFINAGNILASQGQRVPLNKILSQQPQQQLNQNFLQQ
NNMITFR
>fig|195.2102.peg.1827 Bacteriocin resistance protein; peptidase C39
KREFYSVWDRYNKGGFALIVNPKKQLKDYKLNLPKSLNFEIEHFGF
>fig|195.2102.peg.1858 Bacteriocin resistance protein; peptidase C39
FADLNDAVKKLGYESKSYKVDRKILENIISVPILVKIEDDPRFPHFVVIINHKGNYLQIL
DPSYGEYISSKR
>fig|195.2102.peg.1398 hypothetical protein
MEKVKFLNAIEEILSITQNSLLENDVLENFQDWDSIAFFELSVLIDKEFNLRVKPEDIKK
FVYVKDILNSVGF
>fig|195.2102.peg.1722 Anaerobic C4-dicarboxylate transporter DcuA
MDTIMIILQVIVLLGAIFIGIRLGGIAIGYAGGLGVVVLGLVLGMKPGNIPWDVILIIAA
AIAAISAMQQAGGLDYMVRVTEKILRSSPKFINYLAPACGWLLTILAGTGNAVFSLMPVV
VDVAKSQNIKPSVPLSLMVVSSQIGITASPVSAAVVYMSGVLEPLGWNYPTLIGIWISTT
FIACMLTAFIVSLITPMDLSKDSVYQERLKAGLVKDAGAILHGEDKPGAKLSVGIFLITV
LAVVLYATAISSNIKWIDPVVVPRDAAIMSFLLTAATLITWLCKVEPGKILDTSVFKSGM
TACVCVFGVAWLGNTFVAGHEASIKEVAGDWVKQTPAMLAVAFFFASMLLYSQAATAKAI
VPVIITALGISAANPHDSYMLVACFAAVSALFVLPTYPTLLGAVQMDDTGTTRIGKFIFN
HSFFVPGVLAIAIAVALGFVIAPMLM
>fig|195.2102.peg.865 Ribonuclease HII (EC 3.1.26.4)
MNFLAKDFPCYEFEKNKAYGTKAHKELIAKFGICKLHRKSFKLL
>fig|195.2102.peg.1397 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
MVITNAKISYICGILPSNKINNCDNELFECRIKNRIIQSSGVKNRYVLNRKNNESILNLF
IKAGQHVIDELSWDKNSIKGIIVVSQTHEYRFPVTAALLQDKLGINNNCFAYDVVMGCSG
YTYGLFCAMSHINVANDKILLFVGDTINDFVYPKNKSVAFLFSDGASCTALEYSKDESFK
NTFMFETFGDKSHLIIARDGGNKNPINPSSFQEFIDDDGNVNIAACMQMKGVELFDFMCN
TVPNSILNFMKNNNFEVVNTEKLFLHQANVFALKEIARKLDIIDKMEELMPINIHKYGNA
SCASIPILMSEQGKINSKNVLLSGFGVGISICSLYIAKLECSTKLLFY
>fig|195.2102.peg.1582 PhoX, Predicted phosphatase
MVIVYMGDDEIDEFIYKFVSKHKYVKGGDTSKILDEGTLYVGQFNGNVGDFRGSGKWIAL
EYGKNGLDESKGFKSQADILINTRLAASVVGTTPMDRCEWIASHKESGSREVFATLTNNK
NRTQANAANPRTKNLYGQILKWIPKNSHKDDEFTWEIFTLVGNPDNQKGLNKGSNNITSE
NKFNSPDGLKFDRDGRLWIQTDGSYSNKGEYAGMGNNCMLAANPKTGEIKRFLTGPIACE
ITGIAFDEDYTTMFVGIQHPGEGLKGSTFPYGKTPRSSIVMIRKLDGGVIGA
>fig|195.2104.peg.1804 hypothetical protein
MDPIVNNHLINAYKDLESSLSQAYTDLYFCFENGKLKLVLSTLHNNIIECFKKMNSRLPS
TENSNNHYWADDSRKLKFNIELALYLQKEFKDSELSFWIDEYYYNVFKQCLNFLKSSEGS
EIPLGMQKITIYEAIPIFVKLNSISNPEVNKNYSLDLIGDGSYAKVYKYYDEFYKHYFAL
KKLNKKVNDKEIQRFIKEFNIMKQINNPYILKVYSLDENKKEYIMEYVDFTLKEYIHKNN
SKLSSDERISLGIQIIKGIKTLWNKNILHRDISLKNILIKQYDDIVVIKISDFGLVKELN
SELTSENTEIKGSLNEISRLQKKGFNNYDKSDEIYALSRVLYFIATGRTNLINTKCDFLE
KGINDNVKNRYNNLDDLMRDFKHYIKKIYN
>fig|195.2104.peg.94 D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7-phosphatase (EC 3.1.3.82)
MKRKALFLDRDGIINIDKKYVYKIQDFEFCDGIFELCRYFLAQKYLLFVATNQSGIARGY
YTQEDFFKLCDFMLNEFLKENIKIDKIYHCPHLEGCECRKPKAGMLLKAREEFDIDMGNS
IFIGDNLSDMQAGKNAQIGTLCLVNEEEKEGDFFRQFKNLNELLDFFKKKRKIDENSNHR
RRRFYRFTTCLKFTR
>fig|195.2104.peg.1858 Motility accessory factor
FDKDIIFICAGVVHPKAIEYLKGRNLVITQKVLAFPYYINLKDFSYAAVGLSVAHTLSYL
ATYLSHKNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2104.peg.1803 hypothetical protein
MARDKSKDDNLFNCSQDYEHDHVVRQYPKEYQDKIRDFLKKACQNKKIYHSKHKEVYDLI
EKELGYFTD
>fig|195.2104.peg.1695 Integral membrane protein
MKYKWIVKNAYIDFKLNNLYMLINPSDKIYLEEDVCYYLEIYIKYRIFNNCILVCDMLDN
WWKLISSTLHLDKSHIKYNYLSNTFIVSDFELGIKLESNLLTKFNFEFYNGLILNQLSIT
NGLSFKRENYNKSLKFSNCKFNKEFCIARININKQIVFENIYFLDNAFIEWVNFNENSCL
RFFKCNFKKQCNFKYNIFYNEIDFLDIYAKELILEQNIFNKFLYIQNSTIDNINLWKNKF
KNRCYFVDSKFGYKDKDNTTKLNFSNTHFEDNAYFNNSEFYSYADFHECEFEKTASFYGV
RFEKTPNFSQAIFKGNLNAVNTNLNFTFDNLQERIKQEYKDFNKTKEEKPLDKIANDFRD
SFRIFKNALIKDNNALDASNFHKYELYCKEIELKESWNKLKKVDIDEDIDQNNKNYSKLM
DFLLLGFYRKLCDHHTDFLKVFNNLILLIALYALFVFGFTWLHDDKLEDTRAILTLFGFF
DKFRLYFDIISAIFVVFGCGFFVCKLNSYEKKNNVSKKQNINFIYIIGDFWNLTKSLFFA
SFISCVFYVLFLLFGFFLNLDKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFSYI
GFIIMLIKQPSVIHPLIGKIANESDKFFNYPSLIVLNILYTILLALVLFSLQKTARKNSI
VPS
>fig|195.2105.peg.724 Possible RNA methyltransferase aq_898
MCAKNLPLTKPEREGWVDREKLEGISGRSRKRQLELAVKFGLEDFESPGGGCLLTLDSFA
KKIRDFIEFDKDMQVNDAQLLKYGRHLRLPNGAKMIIGRNELENTLLKGLKTPKYEVIEL
GDLIGAYSLLSANADEKDLELALKIALTYTKHEANKSYELRFKDKSYKSIAFEDKKEINP
FFIS
>fig|195.2105.peg.1842 Flagellin
QIRADIGSVQNQVTSTINNITVTQVNVKAAESQIRDVDFAAESANYSKANILAQSGSYAM
AQANSVQQNVLRLLQ
>fig|195.2105.peg.1805 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
TLGKSIQQIVDAIRQVGTNDKVAEL
>fig|195.2105.peg.725 Possible RNA methyltransferase aq_898
MKALALFSGGLDSMLAMKLITAQGIEVKALNINIGFGSTSDKSEIMKKRAAMVGADFEMI
DVRNSYLQEVLFNPQYGLCAQKTYL
>fig|195.2105.peg.1854 Motility accessory factor
TLALALGFKNIIMIGQDLAFDEKGNSHSKGFDFGEKFEEEHKKYKLKTQAYGGKGEVLTH
ITWNDYRVKLE
>fig|195.2105.peg.1014 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MKTNVEKYLKEHENKELCRFITCGSVDDGKSTLIGRMLYDSKMLFEDQILSLEKDSKKLG
NAGEKLDFALLVDGLASERESKV
>fig|195.2105.peg.1010 hypothetical protein
MTAYVHIGIAKTGTTSIQDFLTQNYDLLINQGFLYPKSLHGIEEQYSREWSQHRELAFII
KATKARGFLEKESEKLNLFRKEICGFEKVIISSEMLHDSLIDKEHILHCKNILQDLGFKK
IKIIIYLREPAELFQSVCSQSIKNCYNQDVCFKLPEQSNILNHRCSHSKTLINWGQVFGK
ENLIIRLFDKSEFVEQNLLKDFVSCLNINWNEQFIIPNKANESLDVIGSEILLRVNKKLP
LVLSGKINFLRGNLLFYVEKYFSNPKLKITPPKDMYQFYIDYFEESNEWVRKEFFPHKER
LFPKKDLTDYKENYELKEMKPEYWDQIADFVVDVVETKNKTIQENLSQINNLNQTIETKN
>fig|195.2106.peg.77 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28)
MINLVEKEWQEHQKVTKASEILKGQIAKVGELLCECLKKGGKMNELCDHNLVVPSDDTAR
IQEMHILIIHTLCQIVDENF
>fig|195.2106.peg.184 hypothetical protein
MSQTNNNTEIKEQDTQDEIIWEGKKDILSFLLYWINIYCIFMFFSLFIS
>fig|195.2106.peg.721 Channel-forming transporter/cytolysins activator of TpsB family
MIKELTNFIVAKGYSTSSVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPL
KKGDKFNIYDLDTGIENLNNGARDVKIAVKASENYGYSDIFINLKSKPPDLILDFDNSGY
KAKGEYKASAYLSLSNILNLNDSIRFGFIKGLLKDMSQERENVYVANYTLPIQSYQLSYS
MQYSDNINMIEGYDNSFIKNTDTSLRHKIMLKKILHCTSKDKFSIYANLGIKDDVNEIDN
FRLESSSGRYSSIASGVEYSTLAFGGFLFLNLEYEKGIPFLGSKKDSKDSLYKIEFNKVN
FNLSYQKSFYANDGLAFLYQNSLGASYSNEPLLYADKFLIGDEYTVLDYGAYSNNTIYLQ
FLNAPKYLRALEPFVGLDMGYGRDYLLPNKDFLAGVAFGFRYNLNHLSLNLTASKALHKS
SNMPSETIPIYLRASVFF
>fig|195.2106.peg.1758 FIG00470597: hypothetical protein
MDDLNCDFIHFFNTIYIKLIELCGSNLERFTPLKDLKKLGFHIICSKGNRGALANLLLFN
EISSFFKIIEKYDYNFKECQTVYDLLYEKEIC
>fig|195.2106.peg.1745 Ribbon-helix-helix protein, copG family domain protein
DFDFAIEALEELKDGDYSKASKKIDKIVKNLKKPE
>fig|195.2106.peg.1798 Methyl-accepting chemotaxis signal transduction protein
ITANPRNPQLIELKNVLNRLLDVLQARVGSDMNEIQRVFNSYKSLDFTTEVKDANGAVEV
TTNALGQEIIKMLKQSSDFANALANESGKLQTAVQSLTTSSNSQAASLEETAAALEEITS
SMQN
>fig|195.2106.peg.717 Hemolysin, putative
MSSSQIQSDILNLNAQKNVSIKGSELNGGEIDIKADKVGFIAAQNKTHTESDSIAIGVFA
NANLELTGNGVAVNYSFVQDKANARLL
>fig|195.2106.peg.1757 FIG00470597: hypothetical protein
MLNIIDTIGIELCNKICKNLKEDDENFYHPKIFKKAL
>fig|195.2106.peg.1799 hypothetical protein
KKFPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFAYYEDQFKAYMGEENYKKLRPYLGM
TTYYVCEGKKYPVVF
>fig|195.2106.peg.619 hypothetical protein
MFTCIGLFIQSIFMCQLFFICLVYILLCSLGLFNNWVGFLITQVYFIVFIEVLWLGGIHF
LVGLGVNVGLGWIDYDCLFLLARMNVILEINFIIDSLAI
>fig|195.2107.peg.171 Probable periplasmic protein Cj1079
MKRAYILLSLVFLISALGIWLSLNITTSSYIPRFVKDAYYYLQAQILADEIYFIKLN
>fig|195.2107.peg.838 hypothetical protein
KKENTGTAASLDAQLRDELIALINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLV
DALKEQIPSLVLLNNIELLSLIGFGVYLDGDPLIKTHDMRSRVNYTNTTGLTIPVTIYAI
LLRAIGDVDVFVNNKKITTLAPNSQTPNSQITLILKPNDIYSIYTIAHPTNVSVKARLLN
LNRSHV
>fig|195.2107.peg.1758 Coupling protein VirD4, ATPase required for T-DNA transfer
MQNNKSIQMIFLAIASFILTYLITPIVFFFLNKVKIMKAIEIYNINFTLQAISNGYPKIW
LSLGITFGICFVVFSVLVLSLKAKKSQFGEARFANFNEIKKMNFIFR
>fig|195.2107.peg.341 hypothetical protein
MKNLSVQEKKDLDNCVFKTLGKKEPSALVLLFKKYF
>fig|195.2107.peg.639 Iron compound ABC uptake transporter permease protein
MLFKHLFSLNILLILLVVFGIISLFIGVIRINLDDIFSLSTTQLEIILLTRIPRLIAILL
TGMSLSICGLIMQQLTQNKFVSPTTAGTMDCAKFGILISLIFFTGASFFTQALIASIFAL
LGSFIFIQILRKIKLKDVIFVPLIGLMFGGIINAITTFFCLCFKLYTKYPRLATGQYGKC
YAGKL
>fig|195.2107.peg.1757 Coupling protein VirD4, ATPase required for T-DNA transfer
MLEWRESAVVQDIKQECFDYTSKYRKEILGQEVYLFNPFSRQTHRYNPLTYIDMSDKEHC
DSQLMDLGNILYPQDGDSTSKFFNGLAQNLFIGLCYLWRDLQLTDYGKEFQSAFDINVGE
FNFYNILQLSKGFSLKNEGKTLKGFDDTYNFLSYCEVLDEATIRRLETYFNINSDATKSG
VMSSFNAPLVPFESETLRLSTETSDFDLRDLRKKKMTIYIGITPDQLANAQFILNIFWSQ
LILLNTKELPQSNKDLKYTCLMVMDEFTAPGRIPIYQSAISFMAGYWLRSLMIYQSNSQL
ETQPPLGYGKEGAKTLLTNHACQIFYAPREQEDAEAISRILGNTTFKTKSRSINTGNNGG
GSHSISEASRALMLPQELREMPFENELITIDSGKPILCNKAFYYSDSYFMDKFKAVSKSL
STIRKIPSRKQLEDAILKGECKVKIQIIGENNDKKIA
>fig|195.2107.peg.1687 RecD-like DNA helicase YrrC
MENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTDTNQQLDS
IYENLQSSLKYIGDKRKYKDIKNFHNLLQISVSHYTPNEEVAERLMLKYLFYLFQTRNFC
KEFLDIQILNNLQEFPINLDTLSFQYYERVVDKIKQTSMFNDTKTDKFYIQKVKPFIINE
EIYYEITFTIAKDNVSKFDKLIAFSKYYIPSNYSTKLTLYYTNIKLLNLQIPVILILQWN
IDIRPCEFTNFCLIFNSIRMSFTRSTKYEHFMQFLTKEELNLLDIVKLKTEEYDEIKNQF
SEDKLKHLFNCLDMAREIILNNKSGSNILSYILYAMNNQIIKKQIPKKKNSYQPNPKLSN
LFLKNESIPFDEMPFCSNPAGHIPKLNVLFECISLNNREYELLARKIQYNSEVNGSLYTS
LEDFKEDNIEVLIEKYNTALYNGHKKNRSIKKLHDKFLFINEYQDTLIEIIQLLNNFTKS
GLDHYKENINEWLKECNQLDCKEKKDYLSNLFCNSKLALIYGAAGTGKTTLIEHISSFFH
DKNKLYLANTNTAVNNLRQRLDIQNSSFSTVASYIANKNNISKKFDIVFIDECSTISNKD
IFSVLDDIKLKCEILICVGDIYQIESIRFGNWFLFAQKFFSDIQLELKHIYRTKSEKLQL
LWERVRTLDESMLEAIEKNNSSENIQNFNFSRSVNDEIILCLNYCRRKNKM
>fig|195.2107.peg.1751 hypothetical protein
METFRVVVNLNKVAKPFILITKAHQTLKQNKQATILLINVRNAIKDFYKE
>fig|195.2107.peg.640 Enterochelin uptake permease CeuB
MANVMQGNYELLYISLPLFILAYFLAHKITIAGMGEDLALNLGVSYNTILFLGLIIVSII
TSVVIVSIGVIPFLGLIIPNLVAIYRGDNLKKNLIYIALCGALFLLICDIISRLVIFPFE
MPLSITTGVLGSLIFIFLLLKRKTYA
>fig|195.2107.peg.1795 hypothetical protein
MNNNNIDNLKLYICNESYDYERVMKAFKGEQDLINKIQINQQNPRSINKIQIIQNKNNL
>fig|195.2108.peg.1748 Motility accessory factor
ATIFCADSSYPILAKHDIKPDYVCMLERDEIVAECFNNDFGEFDKDIVFIVKSVTHPHTI
KYLQKNNRAFILVSTYASFIQYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILIGQDL
AYAKDGQTHSQGFIH
>fig|195.2108.peg.987 16S rRNA (guanine(527)-N(7))-methyltransferase (EC 2.1.1.170)
MNLDFLNLILSDFNEEDFRAKLKIYKEILNKFNRIHNLTQLKNIDENILDSIEILKYFDF
SKAKNIVDIGSGAGFPAIFLAFILPSNFHLFEPNPKKAAFLRSIKIECNLTNLTVYKEKV
ENYKSSFKADIITSRALMDVKPLIKLCLNISDQKTIFILWKGSEIFDEVEGLKDYDIFEN
GLRRYCVLKNTQVV
>fig|195.2108.peg.1745 Flagellin
GVRATFTVETRGMAAVRAGTTSDDFAINGVKIGKVEYKNGDSNGALVAAINSVKDTTGVE
ASIDANGQLLLSSREGRGIKIEGSIGGGAFINKDMMENYGRLSLVKNDGKDILVSGTNLS
SAGFGAGNFISQASVSLRESKGQLNANIADAMGFGSVNKGVIL
>fig|195.2109.peg.30 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNGKKYSDKDLIDAFYQLGIKRGDILCVHTELMKFGKALLTKNDFLKTLLECFF
KVLGKEGTLLMPTFTYSFCKNEVYDKVHSKGKVGVLNEFFRTSGGGRLGELATLFFPLL
>fig|195.2109.peg.1515 Metal-dependent hydrolase
MHEKYRKEIFMKNNFIYLSYFLDQMTPTYGNKEKIKLIKKSSIEYGDIANHTIVTTSVHN
GTHLDMPLHFFSSGQSIEDFCCSDFIFNQVLFIEIDSSDLIINHNLIQKMSEVENKIKFE
AIIVKTGLCYKRDREVYWKENFGFHPNIADYIRQFFPNVRLFGFDSISVSSFSNRELGRV
AHKSFLDPKKPILLLEDMKLNNLSEKTNIKKLIVAPLRIKNSDGLPCTVIAEVG
>fig|195.2109.peg.855 FIG00470474: hypothetical protein
MIQKSLALAEELQGKIEANISNSVGGKIKCRKRKIKCRIFATNYLSFNLKLKL
>fig|195.2110.peg.1771 Flagellin
SGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRISSSGEVQFTLKNYNGIDD
FQFQKVVISTS
>fig|195.2110.peg.1712 Minor pilin of type IV secretion complex, VirB5
MKKNIFGVNKAIGKSHPHENGERLISLDYNYTKEYNYNYEICVTQFNYLFSEVKSSHRVA
ALWLTPQNYIQKFKKSILIFTSILILPCFSLGAGIPVVDVTANQQMATQNAKQVAEWAKD
ASRWTETVSHYQKQIQAYKDELLSKTGVRDSVSFVKDIKQIYQFPSKKTSASISGR
>fig|195.2110.peg.1763 hypothetical protein
GIRDVAPSRGLSCSCLLYTSDAQISGGETRQDYKDPRRFPLVAPSWALLFLPFGLPVSLR
CYGRVYLIPRLTLSSGKAVRSKLDCMHEPPVQSDCCACSGNYRLESNPERHDKTPLAAAI
GIWFTERRGVYKHTQSS
>fig|195.2110.peg.1723 hypothetical protein
MLLKDELDVLLVYSFSPDFLAPALSSLIHKNLGLSEKTLCFDNIAFCPGFLQGLMQAFSL
LDNENIKKIAFICVSVKSKKIPKKDKITYLSNSDSASVILLEKSNTKEKAFFSQKIFSKL
ATEETFPLKCFKEANDFIDMDKNLTFSHLNENFPRFFDDFFDNFKLDKSKIGEFFFGSAN
NFIKTKLLKLLNFKEIKNDETLKNYGDVTINKLAFDLANYEWRKKKGGGIKQVFMASFGT
GITFNAMSLKIDFSKIKNFIEIIDFNT
>fig|195.2110.peg.1508 hypothetical protein
THWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYHSKEDPLTPANFKEQT
KPCKY
>fig|195.2110.peg.203 sarcosine oxidase, putative
MTYDIAVIGSGSVGSFAGYYAAKMGLKTCLIDKFQAPHTQGSYHGDTRIFRIAYGEGEKY
IPLLQEAYTLWGEFEKEQNIKLFERCGLLNIGSNSTFMQNVLSSVKNYDLKAKILNAKEL
QENYNICVSDDFFGVLETDTGFVYSDLSVKSAINAACKLGAHTLCDEIVRICKENGVYKI
QTQNSSIQAKQILISAGSYVNEVLSVCEFDLPKVPVGIRRKVVNWFDTDSYKLSQGFPAF
ILEFEDDYFYGFPDFADGLKVGRDKVGEDH
>fig|195.2110.peg.141 Putative two-component sensor histidine kinase
MANSVAEQVLKVIEKKTIFFKINLQGIIIDASEKFCKISGYSKKELIGKHHFILKHPDVK
ESYINQLLGKLWQKEAYWVVFKNVDKLGKTFYLDAFLIPIVDNKGDLNEIIALSYDKQFF
>fig|195.2110.peg.1647 Multimodular transpeptidase-transglycosylase (EC 2.4.1.129) (EC 3.4.-.-)
MKNYNKVLKTKKTENFSNSKNYEEQVVNWQQYFPTYHFDYKKIEILL
>fig|195.2110.peg.202 sarcosine oxidase, putative
MEFGSYEQDTLDIGKHIKEFFPDLKDFSKGSVCTYPLSPDDDFIIDFLDENLFFMGGLSH
GFKFAPALGLLGVKALQTQKLDPSIKQYFSLKRFG
>fig|195.2110.peg.140 Two-component system sensor histidine kinase
MKLLLYLMISNSFKLNEELVLNHAKLREISVNLEKTAKERKEEFAKLSKDFEYKLKVALE
KNEKDTKKIYKEILNSSIEQMISDIAHQWRQPLNELGIAMFQMKQNVQDEKGFTEIYLQS
KSTIKNMSETIDIFRTLFKNNENEKNHVSLREILNKVIGIAFETIEKHQVNTRIISKTDY
RVIAHENGLMRVFLNLIINSIEAFKTQKVKNIIFSFSKFGKNYIKVKVKDNAGGVDEDIL
DKIFQPYITTKHPSQGIGAGLYISKQIVESFGGKIQVKNIKDGACFEIYLKLQEGN
>fig|195.2111.peg.1958 Glycerate kinase (EC 2.7.1.31)
MSFEEIAKELNLSVTRVHQIYTEA
>fig|195.2111.peg.1942 hypothetical protein
MKFNPPSKEDLIKAIDEFNAKNSC
>fig|195.2111.peg.1968 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IGLKWDNEFVIPPKQNESLDLIGVEILRRVNNLLPLFVNEDRNYLRGDLNYFIQKYFSSK
DLFLKFQPPKEIIQSYIDSFEESNEWVRK
>fig|195.2111.peg.1955 hypothetical protein
MAISQDSLVYKMEEHLQVQGYLRVEDEDDGRGYR
>fig|195.2111.peg.341 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MLQRLKIYVKLKNLDERNLRQSAIVSLYRQKFQDESLKIKILELPKIEGAGIDDPVQFLI
LGDDLNTLKEAASQAKEILGTNARIVDISDNANATKDEVALHINKEKAKLLDVNPQYIAG
VLGYSFSQLSVGSMDRGNSKDDIILSFAPEFKKDIEALKRISIKNNQGINLELSSVVDFI
YSKDLKTINRYNKNRSVKITAGVNDLSLGAVQKLLLDNMDKILNNNPSLSYAFSGFINLL
GETVQGFAMAVALAFVLIYLVLAALYESFILPLIIVITMPLAFGGASIGLFITGHNFSLF
VLIAIILLFGMVGKNAILLVDVANKKCHEGLDPDKALLIAGKSRLRAILMTTFAMIFAML
PLALSRGAGYEANSPMAIAIIFGLISSTLLTLLVVPALFKFCFKLDSKLRKIYEREKLN
>fig|195.2111.peg.685 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHTETELLKAAQISIEDFRSR
NISLLNAVGGKIKCRKRKIKCRIFATNYLSFNLKLKL
>fig|195.2111.peg.1938 bacteriophage DNA transposition protein A, putative
KWNMSKVRRKKGVKTPLELWNSCDRAIVKISYEEFLFNAGNKELRVVGKKGINFESRVYK
SALMPSVGTRVKCVQNIDNIKELFIYDLNGTFLCLALDESIAKLSKESFKMLKKGYESEV
KAIKEVLKKDEIAAFTKLNIKQDLQDLQSAFENSLVEAKEVHQKSLAKEALKTQRELEEI
KNNANADELILNAKKEINNNESEFDMEAFVEKKYFAG
>fig|195.2111.peg.1969 hypothetical protein
QAMQNNQILQNERNFDYQKERANIADQQWQMNYNQRARQYAMQNALRQQAINARKQQMEF
NQAMQNNQILQNERNFDY
>fig|195.2111.peg.1888 hypothetical protein
PTANNQVANKSYVDTVVNSKVAKTGDETIAGVKTFSAPPVSATNPTANNQVANKSYVDTV
VNSKVAKTGNETIAGVKTFSVPPVCSANPTEDAQLARKWYVDYGGGIKNLGNQTAPKIDL
RQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQNITAFSAPFKFRVAQSGFSGTETF
AYFCIASNNVLITRT
>fig|195.2111.peg.1939 Methyl-accepting chemotaxis signal transduction protein
MLAVYIGLDNGENIVSDDLSEKKNTNITINGKANNYNATTREWYKEARNSNQTYITPAYI
DVVSNEYAITYSKALYKDGKFIGVLGFDVLLIDLQDKIARTPGNTFVFDHQDRIFAATNK
ALLDPSVDHSPVLNAYKAHGDNNFFSYKLNNEERLGVCTKVFAYTACITESTDVINKPIF
KAAYIQVIALIIMISISIILLYFIVSKYLSPLAAIQTGLTSFFDFINHKTKNVS
>fig|195.2111.peg.1956 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
LITNKTTQIQNLNQAIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSK
SILGYLIMPMALLSIIISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYK
LGEALI
>fig|195.2111.peg.924 phage repressor protein, putative
MEKNKTFYKLDKEYLSQILKEKKISRAKFAQMLSENGYEITLDGITYWYRGENNQPEDYK
NIITMAKVLEVPVSKLAPVNDSIKSFLQDDNQINFRYFPDIYASAGLGTSSQSEEAKIVS
VDENFLKEILDIPIKKSYDIIKINGDSMEPILSNGDFIIIDRSKNSLGAISNADIVIFRK
NDDLFCKKIKKEPFADYIFLVSENKKYEDKKVDNSEFEQCEILGAVVSKMAVETFKNFIE
VVGW
>fig|195.2111.peg.1974 hypothetical protein
FINYYKQDDGRWLMANKKPLKCWKRALNSTWLPKLANKYKNKDKQKALASWLEEEF
>fig|195.2111.peg.923 hypothetical protein
MVNIKELLSIEKHPKVQQTYILPSFENSKSLKIELQCDDL
>fig|195.2111.peg.891 hypothetical protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLFDKIKKLKERSKMAEEKENIVKKVCKELGLTYRQLGELIGLSEGRVKQLAIG
EVGEQVEKACQMLIKIHKLEAELNEQKQLKTLLKNFIS
>fig|195.2111.peg.942 hypothetical protein
MAEEKESKGSNLIQLRISDKMREELQKLADEVGLPLTTYIYVLIANKIENNKP
>fig|195.2111.peg.1973 Baseplate assembly protein V
GFGGKGVVTTECICAFTGSPHPHGSSNTRSKI
>fig|195.2111.peg.1927 hypothetical protein
YVDMDNPLNVLNERGFGELILNESKFTYIHRSSLKTSAYELLEMIEGKGVAGSYEGVLFV
LDSLRNFADIDNDTKMMSLMSLLMNLRECGATIMALHHSTKDGRAFKGSNHIRNSSDCMY
FLQKVANLEQGFEVLLSVQKERAGIKDQAFFINTKTLNIKNTDLQNAKISDKEEAFIDKV
LKLLNEKSLSTSEILSALDVSRSDNFSRNTLEKFKGVFWESELGGENGRTFVWKSLKADN
KNSNDKELSLFGDEL
>fig|195.2111.peg.1945 bacteriophage DNA transposition protein A, putative
AQGNQRELYDMKNMCWQIDSSPADFIVRDDETLEPFRPHILSVVDVFSGMGVATLVGKSN
SLSLTRLLWKAIDKFGKPDMIKGDNGKDYLSKDFQSLLDSLNISYDAAIAYAGEQKALVE
RRFGTLQRARLSQMHGHIGNSLAKREMIEQKTPKKERKAKDEYGFAKKTNQKLLHTFSEA
CELLEAEVIKWNMSKVRRKKGVKTPLELWNSCDR
>fig|195.2111.peg.1975 bacteriophage DNA transposition protein A, putative
LDESIAKLSKESFKMLKKGYESEVKAIKEVLKKDEIAAFTKLNIKQDLQDLQSAFENSLV
EAKEVH
>fig|195.2111.peg.356 hypothetical protein
MNLNQTLQEKYPHLEVGVLKLSEVKKNIDFRIDDSFWTMKLIYNNKLNYKKIGECLLKSQ
YGISINMNEEGDGIPIYRMNDIDNMLCNFEVKKYALIDKNELQTFRLNYGDVLFNRTNSY
EFVGRTGIFYNNRENFVFASYLVRLVCNKEILLPEYLTVFLNTHIGKKEIRRRARPSINQ
ANVNPEELKEIKIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDPKNP
LQSLLDSKTNNPTKSLNISIHTLKESFLKTGRLDSEYYQSKYEDIEKFIKSYPNGYDSFS
NIINNKDTNFTPKNNENYSYIELANIGNNGNISEPISDLGKNLPTRARRIVSKGDVIISS
IEGSLSSCALITQEFDKHLVSTGFFVLNSKLLNGETLLVMFKSQIFQEYLKKFPSGTILC
AINKEELSKILIPKIDPTTQEKIAKYIQESFNLRKKSKQLLDNAKNKVEEQIQGKT
>fig|195.2111.peg.1907 Glycerate kinase (EC 2.7.1.31)
KMSFEEIAKELNLSVTRVHQIYTEAIRKLKSPKNKDKWIAIFETINLIKKEKAKRENLIQ
GEKK
>fig|195.2111.peg.1673 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MEKNPLFKGLTRPPMIFGVPMTPFVIAMGSIILVAFYSQNIFLVGFSIPVFFIMKAMTKK
DDFIFRLMFLKMRFFSNPASKNYYKAKTYSTNSYRQMPPNSNFPKISVFGLNAEPNFEKL
IPFSSLINDSVVITKDYLLMTTWEIGGISFEAEDDDELDIKNDLLNMLFKSFANEPVSFY
FHNCRYSIEDKLTSKFNNAFLEEIDRKYYESFKQGTLRKNSLYLTLIFNPLKVKIEKTTF
MKSSFENKRKTISVFLAKFSEFADRLEANIKDFNPKRLKTYSKDDKTYSKQLEFYNYLLG
GKFNPIRVLPSPIDQYLNGNLQNIQFGHDTIQFNQNDSTKRFARCIEIKDYTNETFAGIL
DILMYLDVEYTITQSFSPIPRVDAKSAISKQKKQLIATEDDGFSQVEQIDEALDQLTNGE
ISFGKYHFSILVYGNTIKECKDNTNEVVTKMNELGFGVTLATIALPATFFSQLPSNFDAL
ISYHPSIFHR
>fig|195.2111.peg.889 Phage Rha protein
MSALIPINNVNVAFEVVGDEIFANSLQIAEVFKKDHSNVLKAIDKLPNDEFKSSNFKYDS
YFDKKSEQRRMINLTRDAFSLLVMGFTGEKAYKWKVEFIKAFNEMKKKTKKY
>fig|195.2111.peg.1896 hypothetical protein
MSNTNVDYNKRLEVFKEIYPQILEMSLAEKSPFGEFKKLLEQFGNDNIIRNDTQFQSLAQ
ALVSVGQTIVAQSQNTALQMILGGDENIVNQANINLTNARTETEKANANLVKRQTAQIDD
ELELK
>fig|195.2111.peg.1944 Motility accessory factor
HEDILGLNKKLAENFKNSIVSHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKNLS
DTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEF
FNHDFGEFDNGICFIIKSIVHPNAINYLTKKTDNFTIVSTYASFIQYLKLDYFGYFNMGF
SVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2111.peg.916 hypothetical protein
MKRQTKPLSIRIPLELKEELQKIADKEYRPLATQIVKILSDYVKITSKKERYDK
>fig|195.2111.peg.1936 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
KNKTQTIKENSLIEFNIEGNNPYEIYTIYKSYKAFNDEQDLTSFTYPIIDYIIFLDSDDY
WELNCIEECVPRMDGVDVVWFDFEMFIDKEHKDINNPNWNRMRHFSLDGKISREEFEIEM
IKKKLRVFAFVCDGLIDFIFFKKNKLKFFNYGYAEDHYFGLSCFLSLNNIYILRKKFYNY
RVRSDSSCDFSQTYIINPNNKILFYIYKNMNYNAKEAMEYFRTYCYIETTLNIISFFETR
SIKSVELFKNIIQFYYHRCRAIEQYNLDPMKIKKRLNKIFYYYSLFYEYKQLFNDKMGVI
KNKDELITNKTTQIQNLNQAIKNK
>fig|195.2111.peg.1967 hypothetical protein
GEQEIQSEDFNVEKLEASSDTYGDYAFLFEISKQDQIVMKKELNLNPKKIKNTKNVKK
>fig|195.2111.peg.1878 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
ESYPDYKEALKLKNHLSYKLGEALIKASNNWYGGGYIKLWFEIGKLKREFRKKDNHA
>fig|195.2111.peg.1407 Membrane protein
MELILLSLIVILLVFVIIKQFKNSSKIEEKDIHISNDITQLKSIGELSVFQVFSKEIVTK
KDSAFNGIWKSILGWSLSERQIALIFEFEITFLYDLRDKNFEIIVLDNDHYKIIMPECKY
KHSIIDMKFYDEKNAKFLPFLLPDSINSTGLSFSENDKNKLIREAKEEVKELSLILLEI
>fig|195.2111.peg.948 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISDT
ATSQISQLKNTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITQQINGAKTELNSKIDNKVTKTGNETIAGVKTFSAPPVSATNPTANNQ
V
>fig|195.2111.peg.1937 Replication initiation ATPase; bacteriophage DNA transposition B protein
MQLVELTKKFLSTQNISQNNLSDRLGINKSYMVGYMK
>fig|195.2111.peg.915 hypothetical protein
MTSEELKQFCKERNLTYKELAELIGFGEGAVKNAISTEKISFQMAHAINMLKKIFELEAK
LEKAEAIKKDFKAWINEN
>fig|195.2111.peg.1961 bacteriophage DNA transposition protein A, putative
QDLQSAFENSLVEAKEVHQKSLAKEVLKTQRELEEIKNNANADELILNAKKEITNDESEF
DMEAFVEKKYFAG
>fig|195.2111.peg.1672 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MGKRDKNCWGDAVTILKTPNKQPYYFNFHQSSGVNKNDFGKFFLANTLILGQSSGGKTVF
MNFIVDQMMKYASKDTFPDDIPEDKRKFTAIYLDKDKGALGNILCAGGRYISIENGKPTG
FNPFMVESTQENIRQLQSLMKLLVTRNNEILTTREEEMLNNAVNSLMKGFEKEERKYPIS
LLLENLTENVDDDNSLKSRLALFKKGKQFGWVFDNEYDSLDFPDDINLFGIDGTEFLDDK
DVSGILSYYILWRVMSLADGRRLCIDIDEAWKWLENEIVQEEVKNKFKTIRKQNGFLRLA
TQSLEDFLKLKNAATLIEQSSTMVFLSNPKAKEEEYVKGVGLSYDEYMIIKGFNPVKRQF
LIKRQDEKVICTLDLSPLGNENLKILSTETAYIDVIEKIFSQENKSLDEKVLELKEFYKN
S
>fig|195.2111.peg.1954 Phage baseplate assembly protein GpV
HRAKNTDENTFNIDFEDGTHLEYNSKSSTLKLDVTKDINIVCINANIKADKVLVDSPSID
LGFGGKGVVTTECICAFTGSPHPHGSNNTRSKI
>fig|195.2111.peg.1916 hypothetical protein
MNLDFLNEFKLKNKDLNEKLEFLIPDFLVKKAITIIYANGGSGKSYLSAAISKTLCKDTR
VKSIVYVDMDNPLNVLNERGFGELILNESK
>fig|195.2111.peg.1953 hypothetical protein
FQTKKGDFSYSFVLKYYDGSIVYDELGKPVLKHVDCEDNLYFINANKELCDEQRKPLNVG
EFYNKLVEYMFKNQDKIIFDNKIEISPVIKTQIPSQTKINKDYEQNYLEYKKNQNKLYNA
NIDKFTSK
>fig|195.2111.peg.340 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MFKLAINRPITVLMFFLALMIFGLISAFSMSVNLFPNVSIPLIKITSKINGDLNFVESKV
TKEIENALSEIDGVKTITSTAYDNFSVSVVEFKLGKNLEVAANDVRDKIGTLSLPSKPEI
EKISSDSGSAISLFLYSKDKLQLMREINDKIKPFLQRIDGVGKIEAKGFLEPQIRIELKP
NELRKYNLNALDVANIIKSQNFKQALGELNNNQDNYIIKGYFEATNLEELSNLRIKTGVF
LSDIANISSLYEDEKQSALYEGKEGVLLELGKITNYNTLEMIKNVKNALPILEKQIPKDI
SINMLYDKSLNIHKHLSQVIFDMVLGIFLTLVIVFLFLRNLSATLIACIAIPTSIISTFF
IIDLLGYDLNRLTFIALTLSIGIFIDDAIVVIENIAKKLKTYPPLQAAFLGINEIGFSVL
SISIVLLCVFIPISYMNSISGLFFNALGISVASGIVISFLVSVFLIPSIGARFLNPKENK
FYEKTEAFFEKIEQKYENLLYKILQNKVKFILATLVFIGFSFALATRIGLDFLPMEDDSE
IQVLLESKKDLSLEAMKEKSLNLLEKIKNDSNVKYAFLLVGYDDAKDATKAKNLC
>fig|195.2111.peg.1064 hypothetical protein
MIVFPLSSFNRYFGNNPLQTLTKIRDESIENGNPELAKKQREELGNDLIDLYKISKKFSD
KIELVEGSIEDKLRNNELPESEVKNLFQWMDKNAKHPRWMHIDGVSYDEAYVKICKGYFK
KNM
>fig|195.2111.peg.928 hypothetical protein
MIPSFIASFDVAIGRKRLRERKGYLKLSNTIAYGGLSVDALALYIQLAKLSEKTIVSEIY
LREFIKVKNNQRMSLNRLRIAKKELIELRLLEIKKVRNGSLNFYEWILKDENYQVKKHFN
KSLSLLKNSDEKLSKTLKNNASSIDRKLTTENEKNQNSLYIETRTHAIINL
>fig|195.2111.peg.1840 hypothetical protein
DFAITLGYDEKFLKKQNTKKTRYFKKENTKSGRATKKQLNMIQAIWSKNAKNPTQWALRE
FINNIVKKRPLHLWYLSIEDANKVILGLKNLENNSTH
>fig|195.2112.peg.1432 alpha-2,3-sialyltransferase
MKKIVLLGGSNSILSDGIPKAMKANKDINFINLALGGSASLQNVYEIIRKKDEIEHADLL
ICESNLNDKREDFHQRNLKQIIRDIVILYEQLNMLNVKRILILLLPYDHVQCKNSKIIDN
VHRKLCQDYNFNVVDMASFFHVIGVHDFYMNLKDSAHQLPSILYQLGVSILNNLQLLSIH
KYNNATTGNVFTFYTPKEISDSKIEI
>fig|195.2112.peg.1445 Motility accessory factor
MLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVVFEKDIEIIW
>fig|195.2112.peg.1834 Motility accessory factor
DKAVVFCADGALSMLEKEGVVPDYVLNIDFEDLPLRFFKNKQNKLSLNILSCATHPSLVH
FLDNKSVILRDDPLYQSFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEK
GNSHSKGFDFGEKFEEEHKKYKLKTQAYGGKGEVLTHITWNDYRVKLE
>fig|195.2112.peg.1779 hypothetical protein
MIRFLIFPPVGKKLLVVGKLFLEKIIFPNKLGKNCFFYLNMFHFLGKLEIVFEFVRIDIE
EIA
>fig|195.2112.peg.811 Sulfate adenylyltransferase subunit 2 (EC 2.7.7.4)
MLSANRSYKFKSSNVLEIIEELLLSKTSERQGRLIDTDEEASMEKKKKEGYF
>fig|195.2112.peg.1634 hypothetical protein
MQLSIRKKMLMLGAICFISMLATFAIFYYNNLQGSQKIAQTTKNLINKEINIKVELLTKS
MAIALGDLIKNVHSEEEKVKIIATAIENFRFEEDKSGYFFVYQKTTVKAHPVRKDLIGSD
LYNAKDENGIFYVRELYQRALDKGGFVTFHFTKPQPNGENTIAEKTAYSYLIPNADDLWI
STGVYKDTLEPYIDL
>fig|195.2112.peg.1807 hypothetical protein
ENFLRKNKLNFCLTARERERERERERAE
>fig|195.2112.peg.1431 alpha-2,3-sialyltransferase
MRYNSLVQETAYKVSIKDIKENFSNQEDRYLIGAHYLHVTASTKLSIYKSLKEIFLHSES
DFSELSKWLDRFRYLTSLLFCDKSYLYGITEKVNKLLSEDLMLDKSIYFRKFDCLIPDVL
LFKSIIEDYNKVNLSQNPSDEIFYNVNNQIIFGAVNRVKHHLAYKLGQVMVYYSKTIKGR
LLMPIILSCVMVNHKFTRKFNDKLPPLSEYIDYEQGMKIKQHLTYQLGEALIYAHKNWYK
GGYVRLFFHIRKIKSRKGKLQ
>fig|195.2112.peg.1625 hypothetical protein
MQNLNQNEQIKCPSCGSFIDISTALYAQILDKAVGGKIKCNHRKIK
>fig|195.2112.peg.1552 hypothetical protein
MAFFASMSGQNPLIEGKTTIAGKLNGYDKNMSQSQIEDLNEFTYSNNRVFILKNNANSID
DLFKHLLDYVNLQYQHTDINDYQQAVQEWIKNNTQETQTTQIQNDNTNNSKEDKEKPFKP
IQAQSSSETYKEDNTRNELLRKLLETKFGKSDELEILFGMKFKGDIGEFNKILSQIGLNS
SESKSIDIKA
>fig|195.2112.peg.1776 hypothetical protein
MRKNKLNFCLTARERERERERE
>fig|195.2112.peg.1800 hypothetical protein
MKKLGVNQTQTLLNGNKLAIIFLIFLAPNLAFGAESAEGVLSIIRNGLLSWTPLIKTACL
WVFWTLVIIDLVWTFGLKALSGFEFGDFIATLIKKVMYIGIFLLLFNIDQWLQIIFNSFS
QLATSVNNGTAVSPNNIIIQALSIVRKIIQSMDFWSPGDSILKVIAGVIILIAFVLMAID
LLIVYLKFFLMNVIVFFALALGGLSHFKQIGLNPITTAIKVGVELFMIQGLMALCINMID
TINNEITQNSSVEIILTILTTALIFCMITKMVPGIIEAVFNGSIGESAGASAGFRAVATM
AAGAATGAAVGAVGVTRAMNAAKALHLAEGGAGGMDLVKGVAKNLASAGGEHLRDNLTRG
RMPNQMANRLQEKLRDIQGKASEGGISAGTPKEESYQSGINPNITK
>fig|195.2112.peg.1475 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNGKKYSDKDLIDAFYQLGIKRGDILCVHTELMKFGKALLTKNDFLKTLLECFF
KVLGKEGTLLMPTFTYSFCKNETYDKVHSKSKVGVLNEFFRTSGGGVRRTSDPIFSFAVK
GAKADIFLKENSSCFGKDSVYEILTREGGKFMLLGLNYGHALTHYAEERNTSFCRYFKEF
KGFVIDELGQKREKRINYYVRDLEKAYVCSLDKINEIVRQTRYYKSIKFAGDFLESYDAK
EYVKAIGNALKQDKFAIYEKLLL
>fig|195.2112.peg.1804 Conjugative transfer protein TrbD
MEELHRVDIYSALNKPNLMLGADRELIMMTGLISVSLIFTGATIVTTIVGVVLFFICSLL
LRLMAKSDPLMRQIFIRQNKYKKFYYPQSTPFSKD
>fig|195.2113.peg.354 hypothetical protein
MYKMENRLYDQLCKLRDEYGLHGVKAEFEAEGSSFRDLMRLRRLTSKAGVKLFLKIAGVE
ANRDIKDALEIDVDGIIAPMVESRFGAKKFFDSIQKIYDSVDDNNLPHTTLNLETKNAIE
NIDEILDFSKSKFDNITIGRSDLSASYFDCSIKPDSEFIFYLLENLAYKVKNAKMTFTVG
GSVSSKTIELINTKYPNLKDSIYKLETRKVILPTKVFLERSNAIKEALKFEELYILSKKD
FSDLYIDSEINRLPELKRRMQ
>fig|195.2113.peg.369 hypothetical protein
MQTLKISILIPSFNSAKYIKECLESVIHQTLKDIEIICIDANSNDGTLDILESYAKKDNR
IKIILSNSASLGYQLNLGIASANAKYISIVESDDYADLSMCEKLWNLALLYDCDMIKADI
IGFKSNKTIYLPMITHKKFFSVYGQVLNPSVDIIKHSWTMNQSGIYKLDFIKNNKIKVNE
TLGASYQDFSFWFLMISMAKSIYFHREALYYYRQDNQSSSVKDKNKVYCVNDECKYVEDF
LIKNSKNDLIQVFYYKKFKLYIWNLNRIDKKYALEFLKHFSFEFGKYILSDDMFSKNELK
DINEIVNTPEKYFKNQYSLLWKFKKALARLKKKMF
>fig|195.2113.peg.364 hypothetical protein
MNKKLYYGYYLGFSILVVPYIISIILDKNWWFEHISYIYLGFIAILISAIFDTARIFKIL
YLRFSNSKFIKVLLWFFGPLLSYGTFQIVAERFAREHVYHIVGFMPDNFILSIRALNLFY
SFFIIVICIICLIYLLFIAFIIVDYFKSLKNKLVEYFQFTSKLHLALYIIMGFSSIILTI
SLTMGKLTQISVYAPYLIYYLDYYLNNTPNNEKICNKIDNNFQIKLLGDNKVSVALKSKE
QVIFITKDCN
>fig|195.2113.peg.477 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MIGKFGEYYDDEAKLREIWSDQKNRERFLKALANDGVDEDALKDLREIFQKDCDIYDVLA
HLSFNAEIKTRQERVLQVENGEFLKRFQKEKAIKFIEFLLNRYQEYGIKDFDDGLKPLIE
LSSLGNARELASEFGSLENLKQSFDDLQREIYLN
>fig|195.2113.peg.1915 Motility accessory factor
ENGNSHPDDYQNSANYESQMYEHILTEAYGGKKEIKTHEVWIFFKQILEAMIIKYHITTY
NCTEGGARIEGTIEKPFLWAC
>fig|195.2113.peg.1890 Flagellin
KDILVSGTGLTAAGFGANSFISQASVSLRESKGRFDANIADAMGFGSVNKGVAIGGFSTV
TAYMSSAGSGFSSGSGYSVGSGKGYSATLVANAIVMSNASAASRVYNVSSGSGFSAGSNL
SQFATMKTTAFGVKDETAGVTTLKGAMAVMDIAETATTNLDQIRADIGSVQNQLQVTINN
ITVTQVNVKAAESTIRDVDFAAESANFSKYNILAQSGSYAMSQANAVQQNVLKLLQ
>fig|195.2113.peg.476 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MQNLYSEDDTRVKLIDTKLYASSWKEENIIRNYYFTDGRKLIGNKRAERKFADYLLKFQN
NNLAIIEAKKQNKDALDGLSQGIEYAKTLNVPFVYSTNGDKIYEYDLRVSRGEYIENFPS
PNELFQRVYGNLKEWQYKLLTQRELYIPQKTLRYYQKIAVDKVIEALINGKDRILLTLAT
GTGKTTIAFALCYRLLEARWNKENKDQKPKILFLCDRVSLRDQALGEFNAVESDCKVISA
EEIRKNDGKIITNANVFFGIYQSLAANSKDQENTQEEQESKFYLQYPKDFFDLIIIDECH
RGGANEEGNWACVLEHFSSATHLGLTATPKKSDNVDTYRYFGESAYEYSLKEGIEDGFLT
PYKVKRITTTLSEGYVYNPDDLIEGELEKGFYKMSEFERNIHLPQYNDFLAKEILKLIDP
MDKTIIFCANQAHASDIKRAINKFKSVKRDDYCVRVTSDEGKIGLEYLKQFQDNDKSYPV
ILTSSKMLTTGVDARNVRNIVLLANIGSIIEFKQIIGRGTRVYEGKDFFTILDFVGATKL
FYDPKWDGEKIEELKEQDEKEKITKEHIKQTKEESKEKKERNHTLKRHKT
>fig|195.2113.peg.358 hypothetical protein
MPNSSQAHISNETNYRFLVSSLKPNLDKCIFLDVDLVVVGDIAKLWEIDIDERYMAAVGD
QAPLHPSSWTLKLPLPYDYLYVNTGVTLFNLKKWREDNIQDLLFQNSAKYASVLQFPDQD
TLNITLYKKIRYLSHIYNAMPVQTYYNEEQKQEAFSNPQVIHWAGAHKPWKYPDVPYAEM
FWYYAHQTPFYEEILFKNITQNTLNITRHTSNMIQNNINSTSQGAVEKVKSHLSFKLGKE
ILSVKENKLKALGLPFTLIFVTIKHKMSNLIYKLVLNSNPNLKSLPLSHYSDYHEALKIQ
NYLSYKLGKLLVKHPFTFIFRVSRVYREWKAK
>fig|195.2113.peg.1006 Rubrerythrin
MRQYESYKCPKCGNEVEVQNVGGGKLSCCGVEMECITQDLTAINLMKAFAGESMARNKYD
LFADVAEEEGWHAVARHFREAAENEKWHARAEFKAYHEIVDGKPLEVTTKNLVTAAEGEN
YEHTTMYPNFAKIAEDEGKKAIARLFTAIGKVEIEHEREYLALKKMLEEEEEFFNSEVEE
LWVCEVCGHIHRGKKAPAACPLCKAPKEYFKREFLG
>fig|195.2113.peg.360 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MYHIVLNSDENYIKYSAVLILSIIKNTNKSFINNKEIFNHQEEYYHFHILSADISTKSEL
KLGNLEKEINKEYPCKITIYKLDDSIFKEDNLCKLNGNYNTYFRLLIPSILPNDIKLCLY
LDVDLLCVGDIRELYSLDIKDVPIAAFAYNKQYPPLEPIYTQDKQFHFLPFRFNSGVMLI
NLELYRKLNIEKKCFDMMKKYIIPRAPDELILNAVIGNNFKLLSAKWNATLLYLITDKLG
QKISFNDYQEKHSFCSLNFSKKDFEADIQDVKIIHFTGWGKQTVKPWQSYYTAINFEFKP
VHYLWWDKWWDMALKTPFFSDELKKIYSNLKNNELKHYSEAISYKIKNLEKLILENSKKL
SDQNTKITNLENSKKLSDQNTKITNINTSFKTAKARVKNHLSYKLGQAMIINSKSLLGYI
RIPFVLSYIKDKHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKEKECLTYKLGEALI
RANNNWYEGGYIKLWFEIRKLKKEFKKDKKYHETN
>fig|195.2113.peg.363 N-acylneuraminate cytidylyltransferase (EC 2.7.7.43)
MTLAIIPARAGSKGIKNKNLVLLHNKPLLYYTINAAKKSKYIDKIVLSSDGDEILKYGKT
QDIDILKRPQELALDDTTSDKVVLHALEFYKDYENVILLQPTSPLRTSEHIDKAFEIFKN
TNANSLISVCEYDNKILKAFMCDEKGNLKGICNNHYPFMPRQKLPKTYISNGAIYILKTK
DFLQNPSFLQENTKYFLMDEISSFDIDNLEDLEKAKRILK
>fig|195.2113.peg.355 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKKQKIEELRNSFLNYDKNCFFVDYINIEGNEISNIKKLQDNCQNSQLIRLWKEKCKSEC
FELEHPLYNNVITRAVYNFNDKFLFNFVFMVDEEEQHPWAFIQFRNFINGIVMPGNRYYI
ITKGWDGALENAMLRNLRKIKFSEIFYKQIKFGFTLENSRPAHFFFELLANYIQIDNTEK
HIFSENIFFKPNKLKKLYTSRKDEFVFLFPTVTVSDNKTQKEMLKKIFQESLSSYDILIN
KDSLKQEYDLTMWLGLPGERRAWFEQVEGVANILKHLNKYFNKIKVYIDGMTAYDGERKD
FPENKVLFDKIANFARKLFVEEYNKNIIFIFEELQESICDSIANEERFIVFKSLAGYDYR
TKICYCRECDVAICDAGTTALIPFELCVKPGVVMFGHTLEKQAERYRLLHQVKLISKDYL
ITKDINGWSMNYHIPPQYIYNLVADVLEELSVAGKLKIKNLKMHRLDVPPVELVVKQYEL
EQTLKIKFSIESVVLYSELEKQINALVLCNNTTLNQALENINTNNALNSTLQHSLQTKDQ
IIQNLENKIKDIEFQLYFKTAKARIQNHLAYKLGSALIENSKSMLGYIRMPYVLSYIRDK
HRLEQKMYEENIKKYPECTLPPLEDYSDYEKALKEKECFTYKLGEALIRANKEWYKGRYI
KLWFEIRKLKKEFGKK
>fig|195.2113.peg.1906 Motility accessory factor
ELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCM
LERTEITAEFFNHDFGEFDKDIVFVCAGVVHPKAIEYLKGRNRKYLIIPRYLYFPIYIKL
KYFDFLYNTPSVA
>fig|195.2113.peg.488 hypothetical protein
MIFSQLAYTIIEVERKTGIPSRTLRFWADKGVFPYVEKDKNGVRYFSEKDLQWVIWVDCY
RQIEKALREV
>fig|195.2113.peg.347 Na+/H+ antiporter
MTTSTIQDLFLWILLNVAINATISDTFSIENNLWTAFVTIVLFVLVKVLANIVSKIHFCC
ESIDFFTLSFILLFLAIALLNVVHINPMYTSFLVGFLIKNTLQNNQELKEKISSISDFSL
SCFIPIYFALIGIQLNVIHEFSFIMFAMFCLLACVFEFLGCYVSLLTLRISNLSRINFAV
TMNARGGPGIVLSSVAFYYQIINISFFTTLILTTLFSSMLAGYWLRYQKNKNDEVFHRF
>fig|195.2113.peg.368 UDP-glucuronate decarboxylase (EC 4.1.1.35)
MKTILITGGSGFLGSNLCARLLNEENKVICVDNNYTGRMENIDHLLSHPNFTFIKHDICE
PLKITQKLDQIYNFACPASPPAYQGRHAIKTTQTSVYGAINMLELAKEHKATILQASTSE
VYGDPLVHPQSEDYRGNVNPIGIRACYDEGKRCAESLFFDYHRHENVDIKVIRIFNTYGP
NMDPNDGRVVSNFICQALSGKDITIYGDGSQTRSFCYVDDLIEIIIRVMNSSKDFQGPIN
TGNPGEFTIKELAQKVIEKIGSKSKIIYKDLPLDDPTQRRPDITLAKSKFGWEPKINLDE
GLEKTIEYFKKNINQFKG
>fig|195.2113.peg.487 Oxidoreductase, aldo/keto reductase family
MGGLLPSNRKSIEGSLKRLNIDCIDLYYQHRVDTKVSVEEVASLMSELYKEGKIKAWGMS
EAGIQSIKKAHAVFPLTAAQSEYSLWWREPENELLGVLEDLNIGFVLFSPLEKGFLAGRF
DANSIFANDDFRSQVPRFESENLKANLVLLDALKDLANSKMPP
>fig|195.2113.peg.925 Oligoendopeptidase F-like protein
MSTWDLGALFKNEDELENTTQNYIQQSKEFKKNYSTTLDKLNPDDFLNALKEYEHLHLIL
SKIMTYAYLCFAKDSSKGSFYAKYEQECKKIEENLLFFELEFCELSEEKTKELIKFCKGY
DFYLQNLLQNKRYNLSQKEERIMLYLSNTGANAFSRLFDESMAALKIPFEGNKLSEEEIL
SKLYNNDRKIRKKAAKKFTKALDKNLNLLTFIFNMIKTELNNICKLRGYESAETPRHLQN
QITQQSVDSLIQTTQKHFYLVSNFYKRKKQILGFNKLKDYDRYAPIGKEAKFSFEESKKI
ILNAFYDFSPVFGDIAKEAFEKGWIDVYPQDKKQSGAFSHSATPDTHPFILLNYTDGRRD
LFTLAHELGHAIHQKLSYNVSFLNQNTPLTTAETASVFAEMLVFDYVKNKLKKEELLALY
AAKIEDIFATLYRQINFTCFERRIHANENELKSEEISQIWMEESQKMFGESVELSKNYAL
WWSYIPHFIHSPFYCYAYAYAQLLVLALYGLYKSNACSNFKELYIKMLSLGGSVSPKELV
GMFGFDIEDKSFWEIGIVEIKKLIDEFMRLKQ
>fig|195.2113.peg.1528 hypothetical protein
MKKVYLDTNIFLDYFNTERTYHNEAKQLMYYLLTNNIQIVFSEDMISTIAYLIKKENLNN
FTHFLKDISLEKNFNITSFGVSVINMACDCYEKYRGDFEDYLQYFCAEKEGCCAIYTMDK
KFPNLKIPIKRYGEIDI
>fig|195.2113.peg.367 UDP-glucose 6-dehydrogenase (EC 1.1.1.22)
MNIAIIGTGYVGLPTGVGLAELGNKVICIDREVSKIEALKNGKLTIYEDGLEELFLKNTK
NGNLQFSISMQEGIENADIVIIAVGTPPHPVTKEADMKYIHAAATELADYLKDYTVVATK
STVPVGTGDDIESLISKKNPNAKFDVVSLPEFLREGFAVYDFFNPDRIVVGTNSEQAREL
IEKLYEPFKDKSKLLFVSRRSSETIKYASNAFLAIKIHYINEMANFCEKAGADILEVAKG
MGLDERIGNRFLNPGPGYGGSCFPKDTQAMAFMGKQNDVDLSLINAAIYGNEKRKETIAH
RILNLVEDVKKSKIAILGLAFKDGTDDCRESPAIDIIFKLLERHACIQAYDPKAMELAKS
ILQDKIIFCSDVYEACKDADLLVILTEWSEFKDIDLERLASIMKDRKIFDCRNLLDKQKA
LSLGYKYEGIGR
>fig|195.2113.peg.348 Pyruvate kinase (EC 2.7.1.40)
MQRYILTVGPSLGNKIQINEIHQDDFIYRINGAHGSLEDIKNTIINIRNQNNTAKILIDL
PGNKIRTASIDNPIQVFKEQDFILKTTQFNFKEFYKLIQPGMKVYANDSVFLFIVKSVDN
EKIVFTSKSDGLLLNNKGMHVRNLHQNIPFLFEKDKELIKLCNEFEIDYILLWVIFLLII
LRIVLLVKKEIIYLSV
>fig|195.2113.peg.1914 hypothetical protein
MILQSQKNKNIIYVSYHSKEDPLTPANFKELTMQILKILGYDVSLNLIDENKIDGK
>fig|195.2113.peg.268 Putative periplasmic protein
MISDNGLGKKYNSYDAMLYAHEFKFDFKNSKYELLKTVFLKIVIKDTPIL
>fig|195.2113.peg.508 Transcriptional regulator, GntR family
MSKTSQKNSSYKIYEFIIDSIKEGNLKPNDRIKEQDIVQKTGFSRTPIREALGLLQNDGI
LVQDSKKGLVVARLDLISITKLYEIRELLEGEAAKLAAQYASSSEIEILENIVQAQKNIT
ELNELKSNNVLFHQTLYRCSGNHYLYKIMENLDRSLLLLGDSTLAKENRAKEAYKEHLAV
VEAIRNRDIAKAEEMAKFHIRQAYKVRLSNILNQS
>fig|195.2113.peg.1920 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSK
>fig|195.2113.peg.1489 hypothetical protein
MSIGSNFRIFSNKIDLNVMIFDLNVMIFDLNVMIFDIFTKITYGK
>fig|195.2113.peg.1529 hypothetical protein
MSYETIINKKNKMNGLKLLKLIDKESIKVVFFDPQYRGVLDKLSYGNEGKSRGKERSALP
QMTKENILTFINYIEQILQPNGYLFLWVDKFHLFECKEWINNFHSIDIVDMITWDKQKIG
MGYRSRRRSEYLIIIQKNPKKAKSTWNIHNIPDVWIEKINNKIHTHSKPIELQKQLILAT
TQEEDIIVDPASGGYSVLKACKETNRKFLGCDLKFGDTHE
>fig|195.2113.peg.352 hypothetical protein
MNVTGGLTAIIPVRAGSKRLRNKNILPFGESNLLIHKINQLKKVDAVNEIVVSSDSDEML
DMAKKEGVLVHKRELIYADEITKSFSEVIMNVVSHCGTREHVMWAPCVCPLCDENDFKNA
IESYNKKVLETKCFDSIISSKSFKEYLWDEYKPINYSLGEGHVPSQQLPNFQTIVNGFYL
ASRENMLTWKYFFGLKPYRLEISQVHAIDIDTEFDYQCALVAWSLR
>fig|195.2113.peg.1471 hypothetical protein
MFLDIISKIFIFVAIHAMIIFMIKSHIAVIKTSLKYFDFRFINFQARKLPLL
>fig|195.2113.peg.1524 hypothetical protein
MFFSFWRPYFRALAIKLCICIANAYPALLLQAIIAKYKLFSQKL
>fig|195.2113.peg.498 Arsenical-resistance protein ACR3
MVHRPFAYVYLDFLPKLLGQSTLATSLDIDFSALSKNVLIYLEFLF
>fig|195.2113.peg.974 ADP-heptose--lipooligosaccharide heptosyltransferase II
MKIFIHLPTWLGDAVMASPALYGVYHHFKNAEFILYGSFVSTALFKEFPNAKIIVENKKS
RYKQALSLRKKLGKIDLALSFRSALSSKIILHILKTKKRYFFNKYNFKEEHQVLKYLYFI
ENSLDIKAHAKDLKLPFRLKFQNPIVLKNGKKILGLNPGASFGSAKRWDASYFAQVALNF
SKTHEILIFGAGKAEQELCDEIFHILKEKNVKVKNLCNKTTIKMLCQNIAICDIFITNDS
GPMHIAAAYKTKTIAIFGPTKFTQTSPWQNQNAKLVHLNLACMPCMQKTCPLKHHRCMKD
LKPELVIEKAKAFIKSSHLLSDKACV
>fig|195.2113.peg.351 hypothetical protein
MIKNILWDFDGVIIDSLAVRDYGFREIFKEFDKVLVEKLIKYHSINGGLSRFHKIRYFFN
EILKKDIEDKEVKAYADKFSLIMREELAKSKYLILDSVNFIEENYKKYNFHIVSGSEHNE
LNFLCQKLQINHYFHSINGSPTPKIELVKNLLIKESYKKSETILIGDSINDYEAAKESNM
AFYGYNNQQLKDFSKKYIERFDCMSVL
>fig|195.2113.peg.1273 hypothetical protein
MKNILKLLNKREQKILLENKNLTSKLWKIIPESNKRPMGANDIINILKNENLPLNINSIS
KKFNIILKKNMRLKKYNSKSKFDGNQIIIEYKDEKEIPEQIGHIFQNFLSGIYFQYPPKY
NLKTIDFYEEKAKNFAIRLNLLIVQYELISSFKKHFEIINSFKKHFEIINSFKKHFEIMN
SLRKHTRQKNNLTEKQYLKNNKIQIENVKYDNNFYQAA
>fig|195.2113.peg.1917 Motility accessory factor
NHQHIVVFEKDIEIIWIMFHILDFSNELQNSRLMVLENDKLQAQDYNELCSSKPFFQFSR
IYFLELMSHYYERFHED
>fig|195.2113.peg.1457 hypothetical protein
MDKLLKERRIIIFGNLLCVFILVFYTCIHWSNLSMLIPGWIVISILEIILNFTRI
>fig|195.2113.peg.1530 Type II restriction enzyme HhaII (Endonuclease HhaII) (R.HhaII)
MSKISNQQGRDVQKNGISGYTRVIGNNELGQLLSRVQACVISNGNELEKLLISRCSIIED
IDIFIKNVEKNNIQQGTFLCTKRILKQTQKYKEVIKGIEPDMIIFIVSNFRICKIIELKD
GDMFDTKKVKGEKANLITFTEKFGAKIPFSTDYYICCFNQNNKEVIKEGMKNEFELEHIM
TGKELCEILNIEYQEILNIRKKDMEDNFNYFIEELLKIPEVLEKIKQISYPLCKNE
>fig|195.2113.peg.1272 hypothetical protein
MDTKIKKMDEWEEIGIKDFNDVLYAEELKYNKINEIYELPNHEICTKKKNSKSRFKLEID
QIVIESDKIKIKEVDMEKIGYEVFILYKPILEQKERLIYVYKENNDTMYIPIKNRNYFIE
EEIKKQ
>fig|195.2113.peg.349 Sulfate adenylyltransferase (EC 2.7.7.4)
MISISHESLLDLKYLASKIFDPLEGFMNYEDFKNVVYNMRLSNGVIWTLPITLEVKELNS
YIIGSIRDLYYQNELIGNIHIEDKFQVEDRDIFEIYQTKDLNHPGIKKEKSKSPFKIAGK
IQLKQEIYQNSLYKGVLQDIFSKKNKEVKTIVGFQTRNAIHKAHEHLQKIALEVCDALFI
NPLIGWKKQGDFTQEAVLRAYEVMFEEFYPKNRVYIQGLETNMRYAGPKEAIFHAIVRKN
AGCSHFIIGRDHAGVGDYYGVYDAHKLAKELSSSKDLGIELLLLKEPYFCTKCQEIVSEK
VCSHQDSHKISISGTKIRKALISGEIPDERFMRKEVAQALINLGINNIFIKE
>fig|195.2113.peg.356 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MNVFDSIYRDSKNNLIYGDLNIQRNINIDFGDGENNIVFIARVATSVKISFKGNNSLVFL
ADWCHLGGKGIVIYSNSVCYLGKCTYIGEATIWVSECKNFIIGDNCLFSSNIWFRTTDQH
MIYNMSTNTRINTGKSIYIGDHVWGGYGTSYLKGCFIASGSIIGNGSIVSGKIFRSNTIN
AGVPCKEIKRNIFWIADTPDRSDFDRNTLEGYKFYNNEEFKYCYDRNNFLSPYTLEEKIN
SFLLASEKLDFLYNTIYMNTNKNRFSYNKRNMKNHFIRARLYTTAKARIRNHLAYKLGYI
MIKNSKSFFGYIRMPYILLIVTLLHKIQVKKRRTFKDKFPPLESYPDYKEALKEKECFAY
KLGEALIQAHKDWYKGGYIRFLLKDIFKLKSEI
>fig|195.2113.peg.328 MmgE/PrpD family protein, putative
MQDGRTIQKDVFINKGNFDNPLSFEELKAKFLANAQIYLDNAKANKILDQIINLENLNHF
SF
>fig|195.2113.peg.505 Tricarballylate utilization protein, TcuB
MKITKIYEDANKSCIICNSCRYCEGLCAVFPAMEKKREFSLTDMDYLANLCHQCSECFYD
CQYAPPHEFNVSIPKQFAALRQYSYEKYSFPNFLGSAFRKNTVLTTIVLILCLFFGFWSA
SSYDGENTNGNFFAVVSYEYMVSVFSIVSLLVCIALFGGIIKFYRAIEIKNVNFKVFVQS
IKDAMTLKYLGGHKNEGCTYPNEKRSNIRKTFHHFTAYGFLFCFIATCLGAIYHHFLNLV
APYDITQLPKIFGILGGIMLCIGSLGLFVLKCIADKNIIDEQSVSMDYTFIFMLFLVSFT
GILLMFLKHSFFLSYALWFHLSCVLAFFIMMPYSKFIHMFYRFIALLKYNSEEEI
>fig|195.2113.peg.769 hypothetical protein
MYLKPVEISYESANLETSKSISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENIT
IENGENKISSSSHSSTSSIAGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELN
GGEIDIKADKVDFIAA
>fig|195.2113.peg.506 Tricarballylate dehydrogenase, TcuA
MEFDIVVIGGGNAALCAAISAASKGNVKIALLESSPKEWRGGNSQHTRNLRSMHDAPTDV
LVESYSEDEFFEDVFKVTKGQTNEEYARFVISHTPQAVEFAKKYGVRFQPSMRGTLHLGR
TNAFFLGGGKSLVNAYFNTAQNLGVEIFYEFEALDLVIDGGWCKEILVLDKKQNKELKFK
AKAVIVASGGFESNLEWLEEAWGEKARNFIIRGTRFNQGKMLRALQKNHAQIIGDPTQGH
MVAIDARTPKYDGGIASRVDCVSLGIVVNKKAQRFYDEGEDFWPKRYAIWGRLVANEEDQ
IAYSITDSKVQKCYMPSLFEPIVANSIEDLAIKINLDPKALKATLDEYNQSVVEGEFNHT
IQDNCYTQGLKIEKTHWALKINTPPFYCYPLRPGVTFTYMGVKVDKNARVYQDDGELFKN
VFAAGEIMAGNILTQGYVAGFGMSIGSVFGRLAGENAYDLIKEVK
>fig|195.2113.peg.773 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MVDGDYFNVISRGIDLAGSIAHYQSGKNLSDINFIAGLNKVDLSTPNAPKIIASKQKDEK
NDYGIDGKYLGSMYANTVTLISTEEGVGVRHSGVIRGIEDVIVKVKNKAEFQAIDVNTNG
SVKIDAKDIKTSLINADTIDLKASGKVTNEGLYKGKQIQINANNFENAKQTNLSQETKDI
FKINQENSSIFADSLTLNTLDKTSNFGFINALNDIKVGTNSFDNQGEISANKDIA
>fig|195.2113.peg.1274 hypothetical protein
MNKIKQGAFQISSIEIKKFNFEQNPEIKEGDIDKFEFSRTIGAIAQKKDNKEKDKFLAQL
DLNIKANNNNKKNIYNISTSIVSLIEFEVKDEQNKILLNNAVAIMFSYLRPMIAQITMLS
GFPPYHLQPVSFEEFEVKIINEK
>fig|195.2113.peg.1891 Motility accessory factor
MIFTPTQKELFNKNIEALSNILLKESLKEIKSSKFEL
>fig|195.2113.peg.1543 Conjugative transfer protein TrbI
MLEINTSPNKFLPKNNKRLSKVPIIILFSIAVIVLFSIFYVAVSRKQNLEKQATQTTPKE
QIQTTTNPNNTNLDTYINDLMQNQKLQANNT
>fig|195.2113.peg.1532 hypothetical protein
MQRFLFLFLVLGLGYALASTTGAGLPWEDPLETIKASLSGPVAGVVSILAIIGAGAGLIW
GGELGGFIKTLIYIVLVIAIVVGAGNFMGIFNTSGALI
>fig|195.2113.peg.353 hypothetical protein
MKRDFAVIIPAQESNQYHEKGDLAPFGSTTLLEWKIAQCKEFVKEEQIYICANSFNIKQI
SIDCKVNFIQRIADENYTSVIFNALNQISSEDIILTHCTSPFINKNIYSQMHSTFIEKEL
NFLVATRKIKEYAYYHNYLLEYPAKCFTREQLEPIYIITNGCFIFNKSQALKEKNFIPSK
ARIFEIGQFASLEIKDMNDYVLARELISIYFEKDIS
>fig|195.2113.peg.1526 hypothetical protein
MIRFLIFPPVGQIFPPVGKKLLVVGKLFLEKIMFPNKLGKNCFFYLNMFHFLGKNDIIL
>fig|195.2113.peg.1271 hypothetical protein
MYYIAEFFSRDIIYNIVGYTPDSYGYAINIFNIIIIIPIIIICIMVALSLLFIVHFLTPV
LLDITKCLFFLNLNFLIQKIFNFIMKTTHFKNKFHIDCFVFFGVTAILQCLSFFMLGYFY
VFNFSPNIIHIASYYQNNTICSKVSPNAYIHLLGDNKVSVSPFNEKFVFYLDKNRDKFIT
RDCN
>fig|195.2113.peg.1372 hypothetical protein
MIEFILKDMFFAAMAGFGFA
>fig|195.2113.peg.267 Putative periplasmic protein
MKKVILTSAMLCSVLFGVQEYEANLAGHIIIDSKSTVKPPKDAPDFFKTYGKFANITREE
KIGTFKSKGNRETDFYLPFKNQPIQGHSGIKYIPKKRCFLGD
>fig|195.2113.peg.1856 Formyl transferase domain protein
MLKIGYFADGKWARICLLKILQNPQIQINFIVLRKTKDIKLEKLALRYQIPCYTHIDINS
KEFLNELKKYSNDLLVSMSFDQIFKEELLKLYPRKIINCHAGKLPFYRGRNILNWALIND
EKEFGISVHFIDKGIDTGDIILQKTYEIKDSDDYTTLLNLCHKECANLLYESLILFLEDN
VKAYKQKEGGFYCPKRKKGDEIINWTQSTREIFNFIRALNTKDLGASAFIDEKEIKIYKS
EIYKDKIFNAPIGKIVKKEKNFFIVSTKDGALKITKFKGEVKIGYNFKIYTKNEGGGVIF
RNLDFSFKKSA
>fig|195.2113.peg.1573 Oxygen-independent coproporphyrinogen-III oxidase-like protein YggW
MKFFIQELQNLGFLQYEISNFAKNNAQICKHNLAYWKGLDYLGCGLSAVSCYKNERFYTA
KNLKSYLQNPIFRDVEKLNQEDLNLEHLFLGLRSIVGIKECKLSKIQKEKANLLAREKKL
KFEKGRYYNLNFLISDELALYLSS
>fig|195.2113.peg.1254 hypothetical protein
MNIREFLLEKPQENNIISFLQDGASQSENQNTSEYLSNLKNEAINDFYKNKDKYAKEYEK
YNFKDQNLTNPMGNISEYKRDLYDYNKNPSMNADDLSDYILDKQSKFNASKPIFTDDNEV
ARKNNQFMRDLGDELQKSGRGKLLQDDDGSYWVQDNNGNYSKVQGSTMGNLYRGIRDNGA
SVALGTAGAIGGSMLGGGVGMVAGGALGASLGAGYDYYGNTKDTNQDANLKEALMLMGEN
AGLSLIGDAAFAGVAKGARVLKNTYNMTKTGARAGKDMIDGMAVKGGNLGNRVIDKITQK
DIPMIGKFTDGGLQNAETIFNNLTKNVENKKQIDELIAKENPTYLENGKPTIEILKNIVE
QGLNKNNPQFIQDSAKRTSAILKNISNALQGVPTTQRREILLKSAQAYPEIGSFLDDVLK
ADKDASISFLNIIKGQDEVFKNKTGLNGEFDVKAWQKDNSSYKKRINNEYAQAIKSIDEL
NNGSIRLSKEGLAKIEEFKNNNFLEQDIKTNISSFLEDAIDKDLSAEQIFNLRSAINKQL
ATGNKTYNTKEAYRLVKDTLDETMIKNASDKELAKKILEDANKNYALKENFNNSYLGKIK
DQETPEALAQRIANGARNINEDKDLKRAFEGMNEAERKANEKHAFNALLAKHRIEDIGYD
FKNLAKDMDNVEFVSKDLKYAKEVVNVYAKIYQNNKDLIMTALASSGKKTNSSIATTISG
VFDRILISGVFARIHALVPFMKSAKEQALRNQILDALKLAKTNKEVISNLKNIKIADKEQ
SRIFKDALDNYIKVDKEQNKILKDALIKEGVIKGDNFFMDKADPSKAKSDYTAKFNVEKW
INNVSGILKDEWVVNLKAMAKKHPEMFKNEADVFKVIKEIKDNPTHFFKNYDDEVALIAK
PLKDDKVGNIAIKKDSGKIIHINKTKGKDLERLNRRNKAMLTGTPTPATTKGSTTNVEGD
LLQHSFKNSTQTKPKKNLMEDIKENIEAKEVEKKNKKSVKQRLDEKIQNDKKAREDILKR
YDDFLKENKDYNLDFLGNLDVVTREFILNAKKKTYKGKKADIPDLMRFRIEKELNIQALK
EFGKNYAEYYHDGKGALQKLLIEKQGQVAGAFHRKDLGDIDLVWGEVIDKIKHKGYGLAH
IIDKHPELDLKLVSDIIDKGKLNNQNNIRYRIEYKNYIIGLSSEYKGNKRTFIITAFERY
KG
>fig|195.2113.peg.991 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MGISRRNFLKGLAATSAVASVNPLMAAGETKFYDIKKVPHATHFGAFWADVNSEGKIVKV
TPQQSDKHPSVITDAIIDRTYSDTRVKYPCVRKSFLEGKKKPNLRGKEPFVRVSWEKAYE
LILQKFEETPIENLFNASYGGWGHVGLLHNCNSVAGRFFNTALGGHIGTDGEYSNGAAGK
VNASIMGDLEVYSLQTAHEQILKNTQVYVLWGTDLYKCNQVDFKVANRGNDEYYKKYRKS
NIKFISIDPQYTQTAEILDAEWIKIRPNTDVALMLGMMNYLYKSGKYDKKFIEKYTDGFD
KFLPYLLGKSDGIDKTPAWAAKITGVDEKVITSLADTFVKNRTFLAGNWAMQRAHHGEQA
DWTLMVLAAMIGQIGLAGGGFGFSMHYAGGGQAFSGVRLPVGLPQGKNNLDFNIPASRIS
EAILNPGKTIKFKGKEITYPKIKMMYVVGASILGHHPNTNELIRAIRTLDTVIVHEPWWT
PMAKMADIVLPSTTTLERDDISFGGSYSQDYVYAMKKVIEPVFESKNDYDIFEEMAKRIG
EREHKKFTGGKTKEQWLEGFYGRSDCPYYMEFADFWKQGFIHFEPPKEAYNYVRHSEFRA
DPVANKLATESGKIQIYSPKFEAYNLEDFKAHPTWFEPAEWLGNEKLVKKYPFHLLSPHP
RYRIHSQLDNTWVRDLYKIQGREPVVINNEDAKKLGISHGEVVEVYNDRGSLLAGAFVTD
RIMPGVVSIQEGAWYDPEDVDDSKPRCNAGHVNVLTSSRPTSTMAQATSVNTCLVAIRKV
KGAVKPYKSTTPPEIIGA
>fig|195.2113.peg.1911 Motility accessory factor
KPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFENIQNIYLSLTEKEEDI
NWAIKKIDEFKNKLEDIKQMQDLYEILQPLRTQFELN
>fig|195.2113.peg.489 hypothetical protein
MEFKTLLNIKEKRLQECQELIKQLEKERNKRNIASSENIKEISLKLQTLIEKEILFFENL
EYQKFKNNPQEFDDLEDEIYFYFDLYMINISKPELKKTEFKTKVEFKKYEERYEIRKDKK
DFIKLSKSILQISKDLFQVAILAGFSIIIFILILHSLQTKTIPFLDSQKAVALAITGVLF
GGIFSFFYIGIFSFSRELYKQYFKIPKIIPLIIYFASSIITFITLQKPNILLLISIAIVF
IVANGALYFFGKKYRISSNNFEIFATQTMLIFMIYIAIAIVSIFIIIKSQEINYYYLIFG
CFIIFIFFSLQLCFKDFKSFKFFALINTIILFLSIIFLNKNITSYLKIGNFKAEEMILSK
NKIVKNKLLDNNISFIENEEGLKVEDLYILSDAKDAYYIQSKKEENKRLKKPFLIDKKYV
LDKDF
>fig|195.2113.peg.359 hypothetical protein
MNTEKNNKNLLENTHFQDKEKKLSHSPLVSIIVPIYNVEKYLRQCLDSIITQTLKDIEII
LVNDGSTDNCGVICDEYALKDKRIQVIHKTNAGLGAAYNTGLEMASGEYIGFVESDDWIE
PNMYEELYAKAKETDVDVCLSGYFLNNNQSTKKELQLLESIDDSIFNILNYPQLLMKHSS
IWCKLYNRNFIIKNGIFFNEFDKKNNGYYCDIPFWTKVCCCAKSMTKIDICYYHYRLDNP
NASSVNSRSDKVLLNIINALEDMYDITVKYKKISFLRKEIIYNIILTAFRYFTNIDIKYK
KNFFNSFRKLLLKTNFNIENDFVNFGNDYLDLLRKEFAKAVKNNNYNVALRAAENHGLNA
EKIIKNHLSYRYGNVLLNNHKSFFSILKIPYLFLIEYKRYKKFPKSFIPLKKYKDYTNAI
NIKNFFSYKLGQEIVKLKNPLYIFFIPFNILKIYNENKNKKNNIELYRRLSNIEKMIYEI
RSDNLASILHPKIFHPYKNFYKNKELVIVGNGPTAKNYLPIENAIHIGTNRSFMLPNIKF
DHIFVQHSLYPEGNDILENYIQLNPNINFFLGILPVTFMNNQTHYRHPCKSYYYDNVFPY
IIRKYGNIWGFDLSYEPISDFESVIFAALQFACFTNPSRIYLVGCDCSIGHFYDNDFYSD
FSCNNQIKTWKNIKNILNRFYPHIEIVSINPVGLKNLFEDIELK
>fig|195.2113.peg.357 hypothetical protein
MNVFDRLKTRDKTVGVVIPFYNTKLHYLKECLNSVIGQSYEKLEIILISDGNTEQQNFDL
IKQYIKNDSRIVLIDMDKTSIGNARNVGIDFLQNKIPIQIIKKSNFYYYEAKYSKINSII
SSIERKNIFYNIDYIIFLDSDDYWELDLIEECLKKADCVDIVWLNNQTIDEQSQKIKSEW
TWIEQHNFKQDQIIDTLTFFNTPSKTNFFSLSWQALIDFTFLVKSKVRFLDLNYLEDSAF
GISLFASSNSIYIFASKKLYNYRYTLGSASGHSGSQVVHFHLHDLNEIFHDIAIAQKYYQ
TYCWILNTLKLIDFMRSCSREKKQLIEKKYIYYYISQCYEIFNFNKDPYNCSSKIDIISN
FLNKYKVEYKNRVKPEISIIVPSFNSKNYISECMESILDQKFKNIEVICVDAISYDGTLE
ILKGFSDKDSRVAIVLSPKKSLGYQINLGIEKASGRYLGIVDSDDYIHQDMYKVLYDAIK
KYKCDMVKSDILEFYNDKFNRVFAYKPTLYNEEWYNIILSDNKKILETTWCMNQPALYNL
EFIKLNKIRANETLGASYQDLGFWFQISALVKSCFFIKQAFYYYRQDNPNSSINSQNKVY
CINEEYNFIYDFLKQRTLYNHCMPYIFTKLKFYSYKWNLNRINFIYKYDFLQQFSKEFLQ
HFLFNEIENSFLIKEKELLLILYSFELYYQNYIVQSRSPVGAVEKVKSHLSFKLGKEILS
VKENKLKALGLPFTLIFVTIKHKMSNLIYKLVLNSNPNLKSLPLSHYSDYHEALKIQNYL
SYKLGKLLVKHPFTFIFRVSRVYREWKAK
>fig|195.2113.peg.1823 hypothetical protein
MLKNNATNKNSSFGFNKNHPEKINHFEYSLSLIATIMQETNGILEELGDSYYTSYKVPII
S
>fig|195.2113.peg.1253 Alpha-ketoglutarate permease
MISVGLFGGSVNYVALQFKALGIEWGFFVYFGVIACISLICTALIPKQRELD
>fig|195.2113.peg.1415 Putative metal chaperone, involved in Zn homeostasis, GTPase of COG0523 family
MAKIPVHVVTGFLGSGKTTFLKEILTNQALNDIALVINELGEVSLDHKLVQTDFIEEQTL
FLNAGCACCNKREDLQKKFKELLDNFENKGKKPQRVILETSGLANPAPIIFTFQSDVFLA
NHFELANIITCIDAFEGLNHLQNEEACNQILSSDFLILTKKDLNPHTQSLEEKINTLYPN
IQIISKENFNFDMLSSHHKIQREIKNYRNKKP
>fig|195.2113.peg.1549 hypothetical protein
MEKQFYEILENILETKVDKNTNLSMKNCKNWTSLAHIDIIMSLEEEFEIKFSKDELSQLK
SQNELLKAIKEKLC
>fig|195.2113.peg.1648 hypothetical protein
MQGESIDTIRQELIGVSEDFFTKASVEYLGHINMGKLDWYIASHPTTLPKNGNQFDTFST
FTHELFHALGVLSLAGSCGGNLGQCFNGFLNSFSDHLYDLNGVKAQIGMRIVKTQAEVEE
AKLKGETVFLVKDDGVYINGSFSNASGNVYFKGENVAEVIKNAKLGYDGVNGIPINAWEG
IILDMSHIELDNSLMSHQSWRNYNFYMEAELALLQDIGYNFDRKLYYGDSIYESNLLNWQ
SDHGYYARKDGKWLIGEYNPTEYGVGLHIYGKNNIATQSHDILSSGVAASGIRIDGSNNQ
LIIANDTKVYTLGDYSNALLIAYGKDHVIEHNGELKATGKEGIAINIDFGDNTLGNAEEY
RGSYIHQMSGNNQDDLAEYNLDGALVKSLNLNAASSTIGSLASIYIADNAYVNTINIAQW
AKVEGDIISNWDPNNEKLANQYKDSFYTDLNFGSDSSLSRAAFNALDNTWSVKANVLGYD
NFKMNVNENLNLQGSAFVYDLNNKAHFSLLGADGINPSLLYIKNNFTQDSNAILTAGINA
NGQSLVYVGGNANLVGAFNFYMLKDFYKDKVVLDPDLISANQIQGAFNSIVYDSSLDFSP
TLNFIYDANTKELGVVRDYTPYIKNSSDISLAYALNSLAQNGKYEDIALLFKELDFATDA
QTIAQGLNELNAKAYLDSAKISLDFQEELNKEALSEYANEWQSFVTPFGTYQSSRANGDF
DAYKGYGGGVKAKLLRDLIVSI
>fig|195.2113.peg.507 L-Proline/Glycine betaine transporter ProP
MATRSKSDAKTIFSVASGNFLEMYDFAVYGFYAAFIAKVFFPAENEFISLMQSFMAFGVG
FLMRPIGAIVLGSYMDKYGRKKGLVLTLGIMALGTLSIACCPSYESIGILAPIIVVIGRL
LQGFSAGAEVGGASIYLAEIAPKHLRGFYVSWQSGSQQVATVFAGALGVLLHYLVGDALM
QAWGWRIPFIIGCLVVPYIFYIRRTLDETPEFKAKIHQAPKTLGAIFQSIRQNIPIVFFG
IMFVMMTTVTFYFITAYTPTFANKELHFSKLESFAITTIIGVSNTFWLPFSGYIGDRIGR
KPILLTVTFLGVISAYPMLNFLTNNISFTNLVIVELWFSFIFGAYNGAMVVSLSEIMPKN
VKALGFSFSYSIAVAIFGGFTPAISTYLIEKTDNPASPAFWLTFAALCSLIASLVIFKKG
GIYERQQKGE
>fig|195.2113.peg.1574 Oxygen-independent coproporphyrinogen-III oxidase-like protein YggW
MHLYIHIPFCESKCHYCAFTSLKKHDYENRYFEALYEDISFHLQKLNIKKNSIKTLFIGG
GTPSAVSAKNFEMILTLLEPFLSKNIEFSSEANPNSADIEWLKTMKNLGLNRISFGAQSF
HPKKLEFLGRIHDQKMIFKALENVNKLGFKKINLDLIYDTKLDDKKMLEFELEQLKQIKN
LITHLSAYNLTIEPLSAFAKKEHFKKTHPI
>fig|195.2113.peg.1416 Putative metal chaperone, involved in Zn homeostasis, GTPase of COG0523 family
MLLHEHGSKILRVKGLINTEESYLTNINGVGHLIYHPTHTKISRLNHPSQLVFIAKNLKL
DKIKESLENFLRLEQLN
>fig|195.2113.peg.990 putative cytochrome C-type haem-binding periplasmic protein
MKKILVLLACLCGISFAQDAYIFNEKAEIFDAQSKKAIGEIYEGTKVEVLKKEGDMSLIK
VGGLVVENDPKILAFGKDGIYVLVKLKSQNASPVMEFWIKNKDLTDKEVEAWDEVELAYY
DTCTSCHAAHKPKEHLMEEWDAYLSAMQGFAKITDEEKARILRFLQSHASNGPVDLN
>fig|195.2113.peg.350 Cytidine diphosphoramidate kinase Cj1415
MKNFIITLTGLAGSGKSTIGKALYNAIKQECDNVIYLDGDEFRDILGSYDYDKQSRIDLA
IKRSKFAKFLNDQGVIVIITTISMFDEIYAFNRQNFKNYFEVYIKCDMQELIKRDQKNLY
TKALNKELQNVVGVDIDFDAPRSDLVIDNSSQDKIKEKVQMIMSKLKHL
>fig|195.2113.peg.1901 Motility accessory factor
FIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEINFFYQSILEKTHRYPFACIYGIGNA
LLIKNLSKHYKHLFVFESEIELFILALSTIDLSEELKIYKIVLFDCVAEDLEIQIAMIFD
QQSILEYLSLYEILINASYYLHFYEKQILFLNEICLKTIGVAVRNADISCFLPLLVHGQF
LQNIPSMLGSIPFQRILSERKNKFD
>fig|195.2113.peg.361 N-acetylneuraminate synthase (EC 2.5.1.56)
MKQIKIQNITISQENPPLVVPEIGINHNGSLEIAKLMVDAAKRAGASIIKHQTHIVEDEM
SQEAKKVIPGNADISIYEIMKKCALSSQDELALKEYVEKQGLVYISTPFSRAAANRLEDM
GVSAYKIGSGECNNYPLIKHIAQFKKPMIISTGMNSIESIKPTVKILRDFEIPFVLLHTT
NLYPTPSHLVRLQAMLELYKEFNCLYGLSDHTTDNLACLGAVALGACVLERHFTDTMDRK
GPDIICSMDEQALKELIIQSEQMAIMRGDSASKKAATEEQVTIDFAFASVVSIKDIKKDE
ILSMENIWVKRPGLGGISAKEFENILGKKASKDIKNDTQLTWEDFK
>fig|195.2113.peg.1442 FIG00638667: hypothetical protein
MQVKFFLKNRIFLSFASVALIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTF
KQINGTNYYGVFKQGLVSDITLEVFNPKQSLQGAKLEILTPNHSSEEILEVQSMHAANPM
DKNLHPIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNIKTKNPPKKRRER
>fig|195.2113.peg.365 UDP-galactopyranose mutase (EC 5.4.99.9)
MEKIQNLIVGCGLSGAILARKIAEEKNEKVVIIDRRDHIGGNVYDYKDKNITIHKYGPHV
FHTSIKEVWGFLSRFTKWHIFFYKVKAYIDGKEVNIPFNLDSLYKVFPKEMALLLERKLI
EKYGFDTKTTILELKNSNDKDLQFLADYIYKKVFLGYTVKQWGVKPEEIDPSVSARVPIY
ISKDDRYFQDAYQALPRDGYTKMIENILDHPLIEVKLKTDFKDIKEGVSYNKLFYTGAID
EFFGYKFGKLPYRSLDIKFETYDKEYMQSCAQMNYPNNFDFTRSVEYKYYLDEKSDKTIL
SYEYPCDFKDGKNERYYPIPNDENQKLYEKYLQEASKLKNVYFLGRLGDYKYYDMDKTVD
RALKFDLG
>fig|195.2113.peg.370 Beta-1,3-glucosyltransferase
MLKLSDENKKFIKVVLDGFFRIYLSEFFSKFKPKKYKAFSKYSIVCPIYNVEKYLDDFFK
SIIKQRLDFKNNIFIICVDDGSTDNSAQIIKKYQNKYPKNITYLYKTNGGLSSARNYGLK
FVKTHWLCFTDPDDFLNRDYFYEVDRNIRKYNNENISMLATNYIFYFEKYKIYKDNHPLN
YKFKKDSVFTNEKLDDFIQPNCASVVFNKEKIKDITFSEELKPVLEDVRFVAEFLVQNIN
SKSVFLKNAKYFYRKRAEQNSIMDTFWKDKGFFLISPKIGTLYLLQNYKIHSFIQKVCMY
HIFWQIKSLINSPEKLTILNNEEKELFKELLFENFKFIDSCNIKNFNLNAFDFFYKKGIL
NYFKNEDLNENIAFIEDIDDKNNEILVKYYFNEIDHKVKILLDDEVVIIKHSKIRQYNLL
DKVFLYEKRIWLKLKNNAKNLDIFVNSQKLKLIFNNNFINDLNEVLKVLNKQKKQRSKNS
NLWLFADMSWRADDNAEHLYRYVMHNHPKQKIAFILSKNSIDYPRLKKEGFRLIDPKGFY
FKYLIYKADKIISSHIDRYIFNALGGDTLKTKDFIFLQHGVTKDDLSRWLNQRKIDIFIT
GAKAEYDSIAGDFNQYKFSTKEVVLTGLARWDALIKNNVLNTKQILIMPTWREYLSGKMQ
KYGVRARNPEFVKSLYFQKWQEFLCSKELEKLAVRYGYSVVFIPHPQVRMCLGDFSLPSY
IVTSYKDSIQELFCESSLMITDYSSVAFEMAVLKKPVIYYQFDKDEFFAKHSYAQGYFDY
ERDGFGEVCFDYDQLLFCLKNILNNGDKKNDSCISINQNICKDIFKKCKL
>fig|195.2113.peg.989 membrane protein
ILSALLAAIAHGLRFTLIEYFHFETLFGILQ
>fig|195.2113.peg.1441 Putative periplasmic protein
MGVENIYNLKLNGAPYAVGGLAIFGDAIGNSLLAQKGSKVDIHTASFYRDMVGEFILDER
ITHLVGGLAYNGKVEKNKLNLNGVEFNIHAPSGLYSSFAPVHIAGAFVDGNGKKAYDATK
NTLVIDNFLLNLRADGKTPIFYNAIFLANFFGGKTNKGDANANSIVLKDVPALKRISKKV
KVQGIYDFFSGYTLDGEANFNTLDIELKSPLQVSNSYLRHSGFGFYGAFASKGASNNTIK
IRNNLTVINGTQNPSDRINIITGRTLAGEANFNVIDFKDSQASLPLFIYATTQENFEGSI
HYPEYAKHNKISLNNVFGRKDIRSGVEAMNVESNQVFYHNVEAQASGEGVNRESSVYIRA
ANLAKNNLFKASNYWATSMLNIYGIREVEESKNNQVIFNNVGFNTDRISEGSELILIGGV
GKRVHHNLLNIQDLEIGAYDKEKDFIYIAASAIPDANSNLALSYGNTLYIGGDVSIHERS
LLNVLSGSVIRIPSYTNNKADDITLPAPSLAQLTKDNHLILEQALRARVVNNFEHYSLIY
HSNNQDKPFIESLETPINLSEES
>fig|195.2113.peg.965 CDP-glucose 4,6-dehydratase (EC 4.2.1.45)
MVLFDIYKNKKVFITGHSGFKGSWLSLWLHYIGAKIYGYSLKPNTTPNHFDILSMQKIFE
KSYFEDINDYIKLENALLECQPEIIFHLAAQPLVRYGYRNPLETFQTNAMGTLNILNIAR
NLKNLKAIVIITTDKVYENKEWYRGYKELDPLGGYDPYSASKACAEIITNSMRQSFFNVD
KFKKSHNVLIASARAGNVIGGGDWNEDRLMPDIVKAANDNFSAIIRNPKSTRPWQHVLEP
LRGYLMLGERLLLEQKEFATSFNFGPEANGHLKVEEVLQIAKGFWHKISYEYKIDLDAFH
EANLLMLDTSKAKKMLSWRPILTSEEGIKMTIEWYKSFYNEKNVISIPQLDSFIKNII
>fig|195.2113.peg.366 UDP-glucose 4-epimerase (EC 5.1.3.2)
MRNVLVVGGAGYIGSCTTKHLLDHGYDCIVMDNLIYGHKEAIDKRAKFIHADLLDLYSLK
EVFSSEKIDAVIHFAAFAYVGESVAKPQKYYQNNLIGTLNLLSAMLEHNVKDIVFSSTCA
TYGEPQYTPIDEKHPQNPINAYGRTKLMVEQIFKDYELAYGLRHISLRYFNAAGAMEDIG
ESHDPETHLIPLVLKAIKGEIECINVFGDDYDTKDGTCIRDYIHIEDLASAHRLALENLD
KFRGCINLGTGMGSSVKEIIKTAEELSGKKCPIKYAPRRAGDPAKLFADNKKAKEILGWE
IKHKDIKDIIQSAWKWELNRKF
>fig|195.2113.peg.1 hypothetical protein
LGLFNNWVGFLITQVYFIVFIEVLWLGGIHFLVGLGVNVGLGWIDYDCLFLLARMNVILE
INFYQGMLFNK
>fig|195.2114.peg.1910 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
ENSFNIAKEYTLKDKRITLFDKKNGGQSSARNVGIEYFSGEYKLKNKTQTIKENSLIEFN
IEGNNPYEIYTVY
>fig|195.2114.peg.1896 Flagellin
SKIGLTRFETGGRISSSGEVQFTLKNYNGIDDFKFQKVVISTSVGTGLGALAEEINKSAD
QTGVRATFTVETRGMAAVRAGTTSDDFAINGVKIGQVDYKDGDANGALVAAINSVKDTTG
VEASIDANGQLLLSSREGRGIKIDGNIGGGAFINTDMKENYGRLS
>fig|195.2114.peg.821 FIG00469595: hypothetical protein
MQENHNFISFVLLDEAKFDFLKLKKILEDDFDIWIADENFTQDGVIFSFKNMIVTLNLIK
ILYPTTKQNIMLILILCGKML
>fig|195.2114.peg.1238 hypothetical protein
MQENTQRHIQNIKISALSGVGIIFMLVYFLSSFFIIVVFKMKKDKMSF
>fig|195.2114.peg.606 Quinone-reactive Ni/Fe-hydrogenase small chain (EC 1.12.5.1)
MAAAGWQAEENLESAIEKYKNKYILMVEGGIPMGDTENFLTIGPHGKSGYELSKVASENA
LAIFAIGTCSSFGGIQAARPNPSNAQPLSKVTSKTVINVPGCPPSEKNIVGNVLHYLLFG
ELPALDVYNRPKWAYGLRIHDLCERRGHFDAGEFVQNFGDEGAKNGYCLYKVGCKGPYTF
NNCSRERFNQHTSWPIQAGHGCIGCSEPNFWDTMGPFEEPMASRKFDTVFGLGADNVSDK
IGIGVLTLTGVAIAAHAVIASMKKNEE
>fig|195.2114.peg.944 hypothetical protein
MDLNIVTNLIRYDLARLKQSIVNFKNNPNNLHFIPKEENVKKKNTKTTRSINYFFICMHF
ILYYIYYLFLLNKPSKSIRQGNFSYNFHTSYFYSLDPFILNLPQAGRQKYIHCTIDLELI
KEISLEDFTKISPVIRDTIIQTILAKEIQEIEFSNFKLELQRELVKKINEKLGNKLIKEL
YFRDFIIS
>fig|195.2114.peg.1657 hypothetical protein
MELEKKREEFRSKYLGSEIKVGNETHFVNFSY
>fig|195.2114.peg.1876 conserved hypothetical protein TIGR01671
MKLQDFDFRVWDNIEKKYIKTPHGLYIENTEHNDASNCNRIIANYEQRAFYIDYPFNDRN
NEYYDNEESLSIELFTGLYDKKDKKVYENDIVKVKSLYDYFLAKISIHKEGTFYFEGKNG
DYIGSLIYLVEDEGYTIETIGNIHENPELLKC
>fig|195.2114.peg.1768 Endonuclease I precursor (EC 3.1.21.1)
MSKTYNIRLSDQERKLMEAWDKQYPIDEKEKRIRELL
>fig|195.2114.peg.1903 hypothetical protein
KHVDCGDNLYFINANKELCDEQRKPLNAGEFYNKLVEYMFKNQEKIIFDNKIEIIPVIKT
QIANQATINKDYEQNYLEYKKNQNKLYNANIDKFTSKLEQILKAKK
>fig|195.2114.peg.627 hypothetical protein
MTQGNVIFENIVLNDLEEISGSHAGGFVGGVLNNENGIASLSNIVLNNIESIKGIGFIGG
FAGWINDGTFNNIILNNIEKISVSATHKYIFTGGFTGYAGAGTYKNIILNNIGEISANGT
ASLDEKSIYAGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIANSNIY
FYGLLNSSSNKNYITHNENILNLSNTTDFQTFINQSKIAGLEYLTNTSTSNSHLHMINGG
KIGNEKSKITFDKDNFTYNTPKISEVDPDGSGSSSSPTVPNEGELSSITLEQSDFEDEIL
KTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSDKKLKESLKQSLEFYTEFNK
GGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLKPELESIKNNLNRLEFL
KAEIKRLERVYQEAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNKPFLDV
>fig|195.2114.peg.970 hypothetical protein
MCDLFVTFKSDVENLFSIIKIDNASPKIERLSIFNIPQEVRQIDIVINNNKKTSGYMVDV
IVFYEKLENFNYNETIEKISQLYSLQEEKYKKITK
>fig|195.2114.peg.1894 Flagellin
IKIDGNIGGGAFINTDMKENYGRLSLVKNDGKDILISGNSLSSAGFGTTQFISQASVSLR
ESKGRFDANIADAMGFGSVNKGVVLAYSSVSAYMSAAGSGFSAGSGYSVGSTKNYSAILT
ANATTISAASQLSKVYNVSAGSGFSSGSNLSQFATMKTTAFGVKDETAGVTTLKGAMAVM
DIAETATTNLDQIRADIG
>fig|195.2114.peg.980 DNA-binding protein Roi
MNLEIFKKDNLAVRVIKDENNEPLFCLSDVCKILDIQNTTDVKNAILREFELSRLNLHSF
DTGFGVKEFTMIDEAQLYYVMNNSRSKNAKPFRMWVNKEVLPSIRKNGNYGFKPLTHKEA
LLLGLELLEKNEKLELENKSLKEKELENAPLIHFANRIKDTNDAILIRDFAKILYEKNKI
EIGEKRLFAFLRDNGFLMSDNKPYQKCIEQGLFKVSETTISTINGDRLVSTTKITGKGQI
KIANLLLEGINHAV
>fig|195.2114.peg.1362 hypothetical protein
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGDEIPFGVLIYKYKLKINTINKVNTLPNNSKDSILIHAGTDM
KFWSSFISYISFQEWHVNNKVWSNNYDKMININFRQHNLPIKDQSDLYQFLFSYNLFYSI
YPMLNVLINYKLKEYKLYIDFLISNSRRSFNIFSSFLGSKNFYYQIEFEYGYGEWGTKIY
FNLVLKDFYKEKLKFILLEMADFKPSTIKKLEEVIIRIQVDINQSFLYILEKIIITTFKY
SSFKMEYNQLDIFGYSAKTRIQNQLSYKLGQAMIVNSKSFLGYLIMPMALLSIMISHKQE
QKIYQEKIKKNPSLKLPPLESYPDYKEALKFKNHLSYKLGEALIKASNNWYGGVYQTVV
>fig|195.2114.peg.886 FIG00973752: TolA-like membrane protein
MNQTFIYTLTPNFDLLISGGGNYARQEYNNIISGAFTSKNTLNFDSLWIGFIYTGESIAD
FVPQIKFQTAIIQREKTVLQTKNFYFQSQNLEASLRGYSDPVVYSIYTGFGYNAQRKFKI
AKIDYGNSIYFGGNLSIILSPKITLDLGAEQRFQTEQKINGVKNSEIRSIPTISGGSTYS
INQDTAVSVSASLGGSSAAPDAIFGINLWKKF
>fig|195.2114.peg.1771 hypothetical protein
NQNKLYNANIDKFTSKLEQILKAKK
>fig|195.2114.peg.1867 hypothetical protein
AGDFLAKLTKGALSDTSPGVKELSLDEMKEVKGGYAVTTIRISQNELAALAVPDFENELG
WEIKNGQIDLEQTMKNDRGLCQMGSTQCYSNSATKKHLWQSQKRLQEFTNALDGSNPLYL
A
>fig|195.2114.peg.1743 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLD
>fig|195.2114.peg.1883 hypothetical protein
MDNAKEALKELFGISEVQAVVIEKLYFKAKTPKDILGFKKYYDLTMLKKQFVGTSYEKLS
LVCAFAELDLNLRYKNIESFLEWLFISFSNRFIFQTKKGDFSYSFVLRYYDGNIVYDELG
KPVLKHVDCGDNLYFINANKELCDEQRKP
>fig|195.2114.peg.1815 Phage tail sheath monomer GpFI
MNNPIVKQITLEFIYSDKWASDLIKTISADS
>fig|195.2114.peg.1816 bacteriophage DNA transposition protein A, putative
MSYFLETKEAAQAFNVSTGALRLAASRNSN
>fig|195.2114.peg.971 hypothetical protein
MSVATNGNLSFNNSQINNLSFGNLEINNLSFGNLEINNLSFGNLEINNLYGSTELSQRTK
EYIIGKAKDISQILIEIYLESYKTYTLYNSIDSIYQTVCDKKQEKTITYEQKIKTIYDFY
LDKFKKNTKISEVESKLLSSYRDKIDWIKYNIPRAKQDSLSFFYSVYALNELLNFYFDDY
LGLTEFLEPSSNISKLGEELYIENEKLNVI
>fig|195.2114.peg.885 FIG00973752: TolA-like membrane protein
MKKFIFILAVLSSCLFASDELNIDSLFKKQIGLRSITSLSLLSTGNPHSYYIYPNIGVNG
DLNVWNDTKPTLFESNFYLYAYT
>fig|195.2114.peg.626 Filamentous haemagglutinin domain protein
MGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYK
YLGGLAGL
>fig|195.2114.peg.1904 hypothetical protein
VSANSPADYRPVYKVKRQIKYSNLGQPYVLFTYGVAVYDRKNGQIYQYNSSPMLNNNRII
REITHQYKSVIEDAMGGWNPRLF
>fig|195.2114.peg.1891 host-nuclease inhibitor protein Gam, putative
ELEDSTLVKLGLKRVVKDNFRIEPKIESLEIEK
>fig|195.2114.peg.1535 hypothetical protein
MSQLNSKVLKISDYMTTRINIFRALEQALNKG
>fig|195.2114.peg.822 hypothetical protein
MWKDALEQTQKHKAHLLVSVLSQSESKLDQAKLFTQISSACLQDEHTLGFYTGGVVLEPK
FYIENAKMLKENRLPIYNWIYVSVYPGDNGNNAYTYGLRNFDKLELEVCDANIEEKELFF
TLYDIILHILTYDLSLKDGDTLKFEDGRILSFKKSQGIGVENESLKIIF
>fig|195.2114.peg.1359 Beta-1,3-glucosyltransferase
MSGVYNKYLPKKHKGFTQYTIISAVYNVEKYLDDYFNSIINQRLDFKKNIFMVLVDDGST
DNSANIIKKYQKKYPKNIVYLYKENGGQASARNLGLKYMQENDYQIPWVTFTDPDDFLDR
NYFYEVDKFLATHQDDDICMIGCNVIFYYEKQKLYKDNHALNFKFKNGIQVKENYNLDSF
IQLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKYFYRKRV
EQNSTLDGKDKIKDYYTMVPNFGYLNLFKDIKITKVPYFVQNVVLYDIFWQIKTLILNPE
KLAILNNEEKKLFKELLFENFKFIDSCNIKNFNLHAFDFFYKKGILSYFKNEDLSENIAF
IESIDDKNDEILVKYYFNDIDHKIKILLDDKVAAIKHSKIRQYDLLDKVFLYEKRIWLKL
KNDTKMLDICINSQKLKLVFMIDV
>fig|195.2114.peg.1608 C4-dicarboxylate transporter
MEKKKIPMLILCVLIALAFWIIPTPIGLEENSWHFLGLFIAVIMAVILQVMPLGAVCMIA
IAIVALSGITTTQSSVRATHIKTLEAIVLKDNSNIYKVTMEQKSQASILENLIKANVAKN
LEPKVNEILKSNSNIEYQIDSLNKLYAKATSKVAAQKLIDESKIAALSSLALEFMSQKDI
DEKVNTAISSLKSKTGIKDALSGFSNSLIWLIVVSIIVARGVIKTGLGERLAYYFISIFG
KKTLGIAYSIAFCETILAPVTPSNTARAGAIINPIVQAISRSFKSTPEDGTQNKIGTYLS
LVNFQANPISSAMFITATAPNPLVVDLVAQATNLEVHLPGGNGL
>fig|195.2114.peg.1767 Endonuclease I precursor (EC 3.1.21.1)
MKKIISVLILALSLLNAKSFGESKKELVKLYNDLGSSYWYDFYCQAPFKVNKKGKYISFK
VIKSDLYTPRNEYTKKGKINQRAKHIEWEHIMPAQNFGKHLPYWKEGGRKACQNDPLFTK
MEADKQNLVPAIGEINGDRSNFRYAEAPTNLKYTQYGNCKVYTDFKAKRFYPANYSKG
>fig|195.2114.peg.1885 hypothetical protein
NGRTFVWKSLKADNKNSNDKELSLFGDEL
>fig|195.2114.peg.1902 Phage tail fiber protein GpH
GSAKELMIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINT
KEDKGVAANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINTKEDKGVAANLDK
ALKTE
>fig|195.2114.peg.1866 FIG00470423: hypothetical protein
MGFNRAGKFVYFSYGVVAVNRFDGSIRNVTNSATLNNNVIINELKRNYKDRLESALGGLR
>fig|195.2114.peg.1360 Beta-1,3-glucosyltransferase
MQNHPKQKTAFILSKNSTDYPRLKKEGFRLVDPRSFYFKYLIYKADKIISSHIDKYIFNA
LGGDTLKTKDFIFLQHGVIKDDLSRWLNQRKIDIFITSTKAEYNSIIGDFNQYKFSTKEV
VLTGLARWDALIKNNILNTKQILIMPTWREYLSGKVQKYGARARNPEFVKSLYFQKWQEF
LCSKELEKLAVRHGYNIIFTPHPQVRIYLEDFNLPSYIITSYKENMQELFCRSSLMITDY
SSVAFEMAVLKKPVLYYQFDKDEFFAKHSYAKGYFDYEKDGFGKVFVESSDLFCYLGKKI
NHLQDIAINNTQHQSNNACKNIFIKIKSK
>fig|195.2115.peg.1589 Protein containing aminopeptidase domain
MPCIRLKIKKNFKAFSFLDRGSDERQYNAPLVNLGIVGVCRTRYLEYEQYHTSKDDLNFI
SEKGLMGGLQSIQEMILNLEINAVYKNTIVCEPNLGKRGLYHTLSTANDIPLACNFLAYC
DGENDIIDIANILNMQAYEFKELLEKIKFYGLVK
>fig|195.2115.peg.794 Arginyl-tRNA--protein transferase (EC 2.3.2.8)
MNFGYELAFYVEDKLVCVDLIDWLEDGISSIYCFYDPDFSHLSLGKFSLLSEIKIAKKEK
LKYIYLGYFVKKCQSLSYKADYTPNEILKGTKELFENEILWER
>fig|195.2115.peg.758 Putative periplasmic protein
FVNDTLFSIFFFQAEDGIRDTDRSRGLGDVYKRQFLSTFLNADIIISPDELPSISKEFLK
NNFQAPIGIVQRDKHAYEVYLSDGTELEFESDGSWKEIESKVFPFDLNFLPPNLTNIIQN
KFPNTKAREIERKINYYKIKLTNNIEVHIDFNGTILYTEYDD
>fig|195.2115.peg.1756 Flagellar hook-length control protein FliK
MSNLTPSNDILNLTPSKTNTTHSSSSKTKEQDLKKSDNTTQDDTESFLNSLLNSIEETNE
FLPDHMKISKKEVVNEAMDKLQNGVFSESDKISIFESASFMQILSLLDKLKADTADIKLA
NLSTQLSQLVKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNLDKA
DFFKGAVDNVFKEIINNKISNVSKNLNHNLENTTHTTSTHSMQKTNSKDSGSLLSQTLKN
LDSILSSKESKHEKNDKVKSKIEEDTTDAKNTLKNIKNDEFAKNLTEELNIKDKKNQDNL
NKESKDLNKDFNKELNKNQEKNNLNQENIQDQNKNLKNNDQNLNLDKNLNKEIVKDTQKL
VSNLTQKDFNLNKEPKNNNKENKDIKQNFFDQKLNFENLNKTQVVQNK
>fig|195.2115.peg.795 Arginyl-tRNA--protein transferase (EC 2.3.2.8)
MLEIGFCTLEDECPYLKDRRSRIEYKYIENCSKEINSELIRRGWRRFGRYFSRPICKDCK
ECLSLRILVDEYQFSRSERRVINKNTNTKIILRKPLLSNEHLFLYDKYHRFMEEKKLGKD
MI
>fig|195.2115.peg.1485 Two-component system sensor histidine kinase
MKTKNIFITFFVLLILCFGVIFYTLTNSYLNFLLLKQYEQKIKSLDDVLKFSLLEDLNSN
NIKEFAQDTRADFIILKDDFEISSVLNADLFLNLEENKIYDLNSKRVLVKKFTYKDYKYM
IIVYPRFLNLQNFWLKISIS
>fig|195.2116.peg.1747 hypothetical protein
KKASEIETLASNYGGIYIFDKKIREEILENERKKGEAMKKMSLGDDFWDQLKVIEKNSPK
SFLMVVNIIVMIIIIK
>fig|195.2116.peg.424 Membrane protein
MSRFFLYLLIILILALITFALREKLGKKTKPFLVFYL
>fig|195.2116.peg.1074 hypothetical protein
MEFLELLLVLIALILIIKKPEKENLAFGLVMVA
>fig|195.2116.peg.762 Diaminopimelate epimerase (EC 5.1.1.7)
MKFYKYCASGNDFVITNADRKEDRSALAKELCNRYEGIGADGFIVILPHEKYDFEWEFYN
NDGSRAAMCGNGSRAAAHFVHHINKINPNMSFLTGAGVIKAKVNQDKVEVSLGKIKSVQN
TFEELGKTWQLCNTGVPHLVHFCQNLDEFDTMLCQKMRQKYNANVNFVKILDENHLKVRT
YERGVEDETLACGTGMGACFYLAFLNKKVQNKVKITPKSGEEVGFAYKNEELFFEGKVKY
CFEANYNFF
>fig|195.2116.peg.184 Sodium-dependent phosphate transporter
MWLASLSTNVEGKKLAFANCIFNFTIAIIIILIFPYFIDFLNGMAKILNIENLALKMALF
HTLFNLLGIFIFVLFIPQLVNFLNKIVKAPKDKNKDRPLYLEPSLLKFSDTAIEALRKES
EHLYDNAYAIIAHAIGLSRKDIQSNKSFEEILQNKKWFSKNVDLDYLYQTRIKVLFEAII
DFSTKAQIHIDDELKNHRIFTFKIAAKNLTEATKNLKLVQENIKKYSNCGNKDLALEYNK
IRSNLGELLRSIQELRSVDDEKVYLIIKNFQKGKEILKEIDGLTLNNVEHLILVRKITTA
EGISIINDTSFIAKIAKDLIDAVEIIFAREKVLWDDIN
>fig|195.2116.peg.423 Membrane protein
MIFIVLAVFFEFENTQKSHLRTDIIVAFNQNKNILCKDINVSKAYFNYEFGTGSFISKDN
NQSFNSLIIDIKDCRLNDE
>fig|195.2116.peg.758 hypothetical protein
MPIFMICSTLLAVIVVAYYILKKYNPIFVFFLSGIILLIFAFYITGAPIPKAPSREHASF
LNVLLDSYAFITATFKSQLSGVGLIIMSVAGFAAYMKHINASAKLAFLANKPLGKIKNKY
LILSGTFIVGMALKIVISSYAGLLLLLLACIYPVLISLKIRPITAVCVLSLIALDYGPKD
GNSINMADMVGQSDNVVGLFLNYQIYSVIAYVMVIAILIPFYFAWVDKRDKEKGVLNDEV
EIPPIIDPKCPTFLHTLSLVTCCIFIYSVFFYYQARCCNSKFCKHFFSFSC
>fig|195.2116.peg.185 Sodium-dependent phosphate transporter
MNLKSLEAKVQERKNFLKYLKMTFWGIFTLVLIFALIRFSELANLLAGVAVLLIGMTNLS
LGFKSFSGGLLEKILTHSTNTKLKSILFGAISTLIMQSSTLVSIISLSFLSAGLISLVAG
VGIIFGANLGNTASSWLIVWLTRVNISILAIPLLVIGVLFFFQKDNMIKSFGNIFIGIGF
FFLGVDYIKNGFNEFQDVIDLSYFDFTGFKGVLIFVGLGALLTGIIQSSTATIAIIVTAL
LTGQISFENSLAATLGTSVGGVASFFKY
>fig|195.2116.peg.445 hypothetical protein
MRPVALLIECSKMLCEILKLQATLGVHEKNQIRSQKGKEKGYFVDYQKIWLENGGKLVKI
NNHLYYELSHKRKNLEEIPSSKRSMYKKRFAILEEIKQALDQSLFI
>fig|195.2116.peg.444 hypothetical protein
MYLYPCMQESRRLFSKVKQKLHCEIVYFLNFKEKAQKPSS
>fig|195.2117.peg.1119 hypothetical protein
INVLLVENENTLPFNICFAFQFYKYLKFYDIKNKEEKIIN
>fig|195.2117.peg.715 Methyl-accepting chemotaxis signal transduction protein
MKLSIRKKMLMLGGICLVSMLITFGIFYYNNLQGSEKIAQITKNLINKEINVKVELLTKS
MAIALGDLIKNVHSEEEKVKIIATAIENFRFEEDKSGYFFVYQKTTVKAHPVRKDLIGTD
LYNAKDENGVFYVRELYQRALEKGGFVTFYFTKPQPDGKNIIAEKTAYSYLIPDTNDLWI
STGVYKDTLEPYIDGNLEELLSFFSKNFFKTIIFFTLFILIIIPFIFIFYRNLITGVQGI
KTNITSFFDFINHKTKNVSTIEVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVET
VGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEYKSLDFR
NKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAASL
EETAAALEEITSSMQNVSVKTSDVITQSEEI
>fig|195.2117.peg.874 hypothetical protein
MAEEKENIVKEVCKELNITQKELSEILGVHLRIQNNSVMFF
>fig|195.2117.peg.1804 Motility accessory factor
PRYPFICIYGIGNALLIKNLSKHYKHLFIFESEIELFILALSTIDLSEELCSGKIYLVDI
EEERVDIQLLILFDMKDMFEYLSLYEMFVNNVYYKKFYEDIWHKADELCEKNIKVVIRNL
NSSLCIGFECYSHLLQNIPSMLESIPFQRILSERKNKFENAIVVSAGPSLAKQLPLLK
>fig|195.2117.peg.976 Membrane protein
MENNKNEFDDIILEKSNKSEKMKKILLRVIALIILFLVIMIVMKLINSGEENTENQSILP
SEPLNITQDNNTDSFESMPITENTSAEDQFEALRRQIQGEQNDNSLAPAPNANDNINLTM
PDQEVPAEPNTTNSEKVAPLNTTPPKQEVKQESKPKEEEAKQTVVKKEPAKQTPKQESKA
NANDLFKNIDAKPVHPNGLASGIYVQIFSVSNLDQKSRELAAVKQKGYEYKLYKTTVGGK
EITKVLIGPFEKANVAAELAKIRKEVAKDAFSFTLK
>fig|195.2117.peg.440 hypothetical protein
MFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKEIDFTRYHGTYDDT
LFKNIFLYLSDKTYWNNNKFSKNYFSNARKIIREPLNKEHLIIQSLYPNPKYI
>fig|195.2117.peg.1748 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTIFTKDDVSNLSQVLLEIGVNINVNLEN
AQQCYELLNQNITTLKSQGKLAQNYQAKFTSTFVPPNGDYQNYGIMAAIDHINALKDLVK
RFPKFADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSAVPPLIYILGREMEGGCD
YVFND
>fig|195.2117.peg.1811 hypothetical protein
YIAKNFDVVAVHVFYHCFCQRRSDVLKYDASAKFLEEDLENFSKMLISFNIDSRNLNSNN
ALEYYHHLDHCITTLKSQGKLAQNYQAKFTSTFIPPNGDYQNYGIMAAIDHINALKDLVK
RFPKFADLPKIYGG
>fig|195.2117.peg.1369 FIG00470755: hypothetical protein
IITTLLGICAGLAYIFFCLYYQLYIFDNYDFLGKFYNIPSYKRPLNFIF
>fig|195.2117.peg.1680 hypothetical protein
MTIQIPQGAKTMQLFDMNIDIPEGKTYIDIDDNFLQNKYNQFMQNNQQQNNFNSQEELAL
DGKPMSMYQAPQVSQNEPQEQGVWSKINKGLEDFNNLIDPKRMISEGLDYLSPKVTSGEE
GVRQKIEDATNQISGGLLARNFTSPSNEEQKQIFQIAYDEIKKLGYEPFLEINNGDYKYI
GVDKNGKEVDFTPSFRNTLASTKNELAFSVAGGYAGSLAKTAGQTIAKKALNYFAPSAIG
AGSGAMADLHSQSNNTGIEASYMDYAKRFGSAAAEDALAGAVVGSAIKGIGKTYKSVGDL
ISSVKTGARAGKDMIDGMAVKGGNLGNRVIDKITQKDIPMIGKFTDGGLQNAETIFNNLT
KNVENKKQIDELIAKENPTYLENGKPTIEILKNIVEQGLNKNNPQFIQDSAKRTSVILKN
ISNTLQGVPTTQRREILLKSAQAYPEIGSFLDDVLKSDKDASISFLNMIKGQDEVFKNKT
GLNGEFDVKAWQKDNSSYKKRINNEYAQAIKSIDELNNGSIRLSKEGLAKIEEFKNNNFL
EQDIKTNISSFLEDTIDKDLSAEQIFNLRSAINKQLATGNKTYNTKEAYRLVKDTLDETM
IKNASDKELAKKILEDANKNYALKENFNNSYLGKIKDQETPEALAQRIANGARNINEDKD
LKRAFEGMNEAERKANEKHAFNALLAKHRIEDIGYDFKNLAKDMDNVEFVSKDLKYAKEV
VNVYAKIYQNNKDLIMTALASSGKKTNSSIATTTQGVFDRILISGVFARIHALVPFMKSA
KEQALRNQILDALKLAKTNKEVISNLKNIKIADKEQSRIFKDALDNYIKADKEQNKILKD
ALIKEGVIKGDNFFMDKADPSKAKSDYTAKFNVEKWINNVSGILKDEWVVNLKAMAKKHP
EMFKNEADVFKVIKEIKDNPINKTKGKDLERLNRRNKAMLTGTPTPATTKGSTTNVEGDL
LQHSFKNSTQTKPKKNLMEDIKENIEAKEVEKKNKKSVKQRLDEKIQNDKKASEDILKRY
DDFLKENKDYNLDFLGNLDVVTREFILNAKKKTYKGKKADIPDLMRFRIEKELNIQALKE
FGKNYAEYYHDGKGALQKLLIEKQGQVAGAFHRKDLGDIDLVWGEVIDKIKHKGYGLAHI
IDKHPELDLKLISDIVDKGKLNNQNNIRYRIEYKNYIIGLSSEYKGNKRTFIITAFERYK
G
>fig|195.2117.peg.1798 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDI
EIIWIMFHILDFSHELQSARLMVLNTNKLEIQDYNELCSSK
>fig|195.2117.peg.1581 hypothetical protein
MIGKDFLYSIHKDKKSIYLFCENKSIIDCQSIYEELYKLEATTDFTFEELQSYQAYIFLN
STLLTGSAELPNNPFYFGELDQDNTIKQDTPSYYFSPKDESSGLGKLSIFYKNDELCLLN
YSIIENSLNIKLECLSKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNLECIH
GGKVILKSNKGKSFKSDGIPIMLESDLLNSSIVACPHTIANVSYPCTKVVDIKGSLSQKK
VNGEYAILQELISACKTDKGFALKVSFTPTKFKFDHSFDPKEGLGEQSKNQIELKEARLR
MYYKEHKYQKDNLFTNLYLNDTLYQNEQGLDKLELSKNDLFNLNDINVLNTLKQDFSKDY
EFKECEIRLGMHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENEN
IIHHRVFLAPAKMQKIGFEIAKGLDEWLDNENVCCFNVYTKDYFNANDKDMLISDNIKDD
TNTTQAHTNENYNNTQEIIPDNVIRIQTQDGSGEFIEIIFDEFKEWEKSSSGAIKPLFTP
LEGIVEDISNSLENVSIIGDALAMLGAVKNPKNAKNIIKKKSKYATKQEVIEVLKNKYNL
KTSKELGLGRSKNVFWVKDNKQIKEIWEEITDGADILKDINQDKLGGTIKMRKLDDQTTI
QYKKASKSGGETIEVISNKPRGNLRTIHIENGVKNEV
>fig|195.2117.peg.254 hypothetical protein
MNPLKVFSNVNLGWLIRHYIFGIIILSFFYFALPTHDFYLFFTLIINLIFFPFACFVWEE
LKNMLLGDNVFIVNAIFLLLSKIIIKLILFMLAIPIGIIGFLILWFIINKKQEL
>fig|195.2117.peg.785 hypothetical protein
MFKKLLSVVALGTLLSSSAFAEDILAKVSNGAISDNSAGVKVLSLDEMKEVKGGFNFVRD
SRYDNIAGIRSYAYVVTDADKSQLQISSNSKVLAQYRYVNNQKDYYLQSYNNGTLGTIFP
NYSTSWGQYAMKIMNEFRSKY
>fig|195.2117.peg.548 hypothetical protein
NKTFIFVNLFLENLQKDLNYL
>fig|195.2117.peg.1345 glcG protein
MKKLLILCVFLGVSLMAKSFELVKEPVLTTQMVEGNLELAKKEARKNGFYVSITIVDKSG
QILAVLRDDKAGRAYT
>fig|195.2117.peg.1271 hypothetical protein
TLTLEFKEIFNKELKYIKQSHPNIAASWKYYQEFEKICEELDKKE
>fig|195.2117.peg.1720 hypothetical protein
MSKILLEKLDDHFFCDDFGEDIYFQKEYAKFYGKVFEFVYKENGNFLKIVANKKSIKNTS
FFDLQSPYGYGGIYSNSMDKAFLTRALENLRQRALKENIVAFFIRFHPFDKNLSFYEKKL
DFFLKERKIVIVPIYKNLEQIRANYSPRIKTYVKKARKELEISKAKASDAKDFKRLYDET
MRRNQAGEFYFFDDDYFKELFNFKQSLILKASYRGEILAYASFFLGKKFAYYHLSANKNE
KNANAALLDFSFELCLNKNIDFILLGGGVKDDDNLFYFKQKFSTLESFFYIGGIVFDALN
YKKFCKDYKNNFFLKYRNGGGSYFYNLYME
>fig|195.2117.peg.784 hypothetical protein
MSIFSINDNSNYGSILSQAKANKESKENSKISFANAFLKQNASK
>fig|195.2117.peg.1813 Motility accessory factor
HFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFDFGEKFSGEENIDKLKVTAYAGKGE
VLTHITWNDYRIKLEYLFACNEQKAKFYNATEGGARINFTEELSFKECCEK
>fig|195.2117.peg.1718 FIG00470265: hypothetical protein
MDNYSLAYNDFDKTKKIIDKAMKKLKKGGKFLSVTPSLYNDGFEKDESLGYHLVKPTSGS
DACTGIIRYCDEKDLRKLYESATYSISDIKIHIQKNLTKQLNELFIVEGYKI
>fig|195.2117.peg.234 Putative transmembrane transport protein
MAAFFVPRKKESKKINLLKNPTTWKITLFMGFQSFLAYSLFFWYVQIIVEKGYDKDFATN
MVLFSQLVAAPISLFGPLLLGKLKKSLHTPYIAILCAMYAVSFGILFAFDTRFMIMLAAF
IVGFPWGGVFGIALLFIAQKSSNAKIAARLSAFAQGFGYLIAAQGQWIIGFFHDMFGNFT
SSICILFIVGILVNIFGYLAYKSKVI
>fig|195.2117.peg.1188 Type I restriction-modification system, specificity subunit S
MKIKIWKINKLEKICEILDNKRVPISQKDRISGIYPYYGASGIVDYIDKYIFDEELVLIG
EDGAKWDAFENSAFIASGKYWVNNHAHILKPNNEILINKFLVYFLNYSNLEKYITGATVK
KLNQQKLKQIEIPLPPLKEQERIVGILDESFAKIDESIKILEQDLLNLDELMQSALQKAF
NPLKDNVKENYKLPQSWEWKSLGEIGEIITGTTPSKNNPNFYGNEYPLFKPSDLNGDIII
KYASDNLSKLGFDNARNLPKDTILVVCIGASIGKVGLSGVNGSCNQQINAIIPNSAFTSK
YLFFVCLSNYFQTILKKNASQTTLPIINKTEFSKLQIPLPPIKEQEQITSHLDELSSHVK
NLKQNYQAQIKDLQELKNSLLDKAFKGKL
>fig|195.2117.peg.1223 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MLVCVGSILLSMILVFPLVFVLNYYFLKLKAFVNILIIMPFAVPPIVSCVGLLQLYADNI
GGTAWILIFTYFTIALPFIYRALDNAMSNVNLNELIASNAMLGGSLMGAIFKLVLPNLRN
GILVAVFLSFSFLIGEFLYANILVGSAYETLQVYLYNIKNQSGHYSSALVIVYFVLIFIT
TFIASLIKE
>fig|195.2117.peg.463 Hydrogenase maturation protease
MKFLVLGIGNIMFADEGIGVHLCKLLEKNYKFTHSNHSLDFVDGGTLALQLSYIIAEYDK
MIVLDCIDADDSKIGDVFFFPYDAMPKKINWSGSAHEVEMLQTLQYMELMGDLPHTQILA
CVPKRIKPMSFTLSQEIVSAGEIMEKTLLEYLTKEGFSYEKIANHSLQELADISYKN
>fig|195.2117.peg.1224 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MNENLSLKAKIYHYAVLFLVFLFLALPLMATFLYSISTSWGVSVLPDDLTLKWYQELFHD
ERFLLAL
>fig|195.2117.peg.1320 FIG00470755: hypothetical protein
MMFFILMHRKYISEVPMLGFHTNMEIFKRAGIYYFYLLVIHIPLFLVWKKVISRIESLDF
INTFYFGIAFSLCVFFLLTLPLDGHLALVPLLCVLFSFVFVFKFIYFCFKKISYFTWKKL
IFIITTLL
>fig|195.2117.peg.1346 glcG protein
MHTLNASYKKAYTATSQKRETAVIFKGVKDGKIPEDIRYLDDKFSIMPGGVPIFIDGVVV
GGIGVGGAHLDEDVKIAKAGIAFLK
>fig|195.2117.peg.558 hypothetical protein
MSSKISFKFQFAHVLGGYLFFFGLIILFGLFDSDFWEFFKFFLQIRMILIPLRVVFIILV
PFHLENSFLGKTFYFLENLFCLAFAILLIVAIIMPFLERISKIFF
>fig|195.2117.peg.877 hypothetical protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLFDKIKKLKERNKMAEEKENIVNFKIKIIHEENIELGIMANSLLSFQKLMDSF
ISKEHGITQSKIFLEKVETGSDIYSLVFEIAGEVLPIIAPIQALNEFIELIISFKNIKSK
SIEEIEENPHFTKYNANNLKNIFAPVTINQNTFFINHKGEELLRINSDEAKLIYENANYI
CEKKEIEYQKIHENALITMYKTTNKIDNKTKHKAKCDALSPYAVDVSFSDEKIAEEVLKN
PYGFNFLVDLEYYKNDKNKIILYRIFNIKDKISLE
>fig|195.2117.peg.262 Acetyltransferase
MPFNVLYHNHCLYICDFVVDEALRGKGVGQSFLKKFKFGQKNKDMKNWN
>fig|195.2117.peg.1667 FIG00472875: hypothetical protein
MDDKDLNLLKNIPYLMEKIEELENRIKQLEQAAQPKSYPTHPKSKLLRRNLSLIKA
>fig|195.2117.peg.1807 Motility accessory factor
SSKPFFQFSRIYFLELMSHYYERFHEDILGLNKKLAETFKNIILRNGNDPLDALQGIEQF
VYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYP
ILAKHGIKPDYVCMLERTEITAEFFNNDFGEFDKDIIFICAGVVHPKAI
>fig|195.2117.peg.1740 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDIN
>fig|195.2117.peg.1810 hypothetical protein
GSAVPPLIYILGREMEGGCDYVFNDPNTLIECFLKTHWTRKENSPYFFNNENYFIRTLLN
KDHLILQSQKNKNIIYVSYHSDKDPLTPANFKEQTMQILKILGYDVSLNLIDENKIDGKF
IKNLDHGCGIPDKALFRKELPLMLEK
>fig|195.2117.peg.253 hypothetical protein
MGLNNEKYPFYRLGGIRISAFEKLVGLSNTLNVGVDNKVRIAKNSHEFVGENKDIEIGAN
QNTIIHKDEIRNVKGENKLLIEKSLTQTIEKEFFLNVHQNLSAHIQDNTSLKSNSMQTKI
EEQYSLESDNSTFDFQTDCEVKAGNQILHQVGDTQIVTKKDCVIIKAGGVEVIIDSNDLW
LKVESLRQSKG
>fig|195.2117.peg.1785 hypothetical protein
MKKYISNEEISNNLGSNEKIWEQIFSKKEWGKYPSENVIRFIARN
>fig|195.2118.peg.1493 Methyl-accepting chemotaxis signal transduction protein
MNSIKIKLSLIANLIAIFALIVLGIVSFYFTKTSLYESTLKNQTDLLKVTQSTVEDFRST
NQSFTRALEKDIANLPYQSLITEENIINNVGPILKYYRHSINALNVYLGLNNGKVLLSQE
SNDAKMPELRDDLDIKTKGWYQEALKTNDIFVTPAYLDTILKQYVITYSKAIYKDGKIIG
VLGVDIPSEDLQNLVANTPGNTFLFDQKNKIFAATNKELLNPSIDHSPVLNAYKTHGDHN
FFNYGLDGKERLGACTKVLAYTACITESADIINKPIYKAAFIQAIVVIIVVVFSVILLYF
IISKYLSPLAAIQTGLTSFFDFINHKTKNVSTIEVKSNDEFGQISNAINENILATKRGLE
QDNQAVKESVETVHVVEGGNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDM
>fig|195.2118.peg.609 L-carnitine dehydratase/bile acid-inducible protein F
MLPLEGKLVLSIEQAIAAPFCTRQLADLGARVIKIERPEVGDLARGYDKRVDGIASHFVW
VNRSKESLAIDLKDPDGLEFIKTILPKVDIFVQNLAFGASKRLGLDYENLKKYNPKIIVC
DISGYGEGGNYGHKKAYDLLIQSESGLVSITGAR
>fig|195.2118.peg.1717 Motility accessory factor
CIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTLDLSEELKVYKVVLFDCVAKDLE
IQIAMIFDQQSILEYLSLYEMFISSHYYLKYYETSILSLNELCIKSASVAIRNADITCFL
PLLTHGQFLQNIPSMLESIPFQRILSERKNKFENAIVVS
>fig|195.2118.peg.1674 hypothetical protein
MKKNIVFFEVRGGSDKGEDGYRKDTMPMVNALKAKGWNAEVIFFEVGKKNEIYNYVKENF
DGYVSRINPGNLKEENEYFDMLRKLCQEGLVGMPHPDAMIGYGAKDALTKLADTDLVPSD
TYAYYDIKTFKENFPKSLAKGERVLKQNRGSTGEGIWRVSVEGEVKGDILPLDTKIKCTE
AKDNHVEHRELGEFMDFCEQYIIGDNGMLVDMTFLPRIKEGEIRLLMLYNTPVNVVHKKP
AEDADAFSATLFSGAQYRYDKPEDWQ
>fig|195.2118.peg.1205 hypothetical protein
MKITMIILSLFSLVFLSTCAFKEKKASEIETLASNYGGIYIFDKKIREEILENERKKGEA
MKKMSLGDD
>fig|195.2118.peg.1349 Ferrous iron transporter FeoB
MKKIKIALVGQPNVGKSLLINALCKANMKVGNFSGVTIEKASAKTFYKNYEFEVIDLPGT
YSLDGYSEEEKITRHFLNQNDYDVIVNVLDATNLERNLILSAELLSLNKKMLLALNMCDE
AKKEGIELDTSVLSQEFQSQVVEISAKTKENLELLLQKIIILFESKFIPRSQFYTPLCEK
SPEKEDLLYFINELSKKIITHKKEERNLTKKIDALLIHKFFGLPIFLFLMWLLFQLTFSL
GQIPMDYIESGFNALGELVKNNISNTFIASALADGIIAGVGAVILFFT
>fig|195.2118.peg.1011 Hemerythrin-like iron-binding protein
MRVEQWRLGSLSSENGADITFEEIKDDEDEAVIYFYACECIGQIHDVPSGIHKKIQNEGA
KFKCKKCKFPLEFFKKGINFYIYFVKII
>fig|195.2118.peg.1212 Beta-1,3-glucosyltransferase
MKIKISVIIPIYNTCEYIEECLQSVCSQTLKEIEIICVDDGSTDGSATIVSLLQEKDSRI
RLFEQNKCGSGPARNLGIIKSVGEFIAFMDSDDFYPNTKTLENMYIFAKQNNVQICGGSV
SFCKNKQILPQTHKIYEQGYIFKENSIMDYINYQFDHGYWRFIYKSDLIKRNSILFPSFL
RMQDPPFFIQAMSYSKNFYAMKEATYVYRVSHKKVQWDQHKAYDVVCGYIECLKISENNG
YDDLHFLLVKRLHNIGIIKIINSFIVNSDKKFILLELFNAINFRLVFQKDRQFKMHNFFR
FLFENEFASCKIGAVDRVKDHLAYKLGSYLFDGNRNFILSFFQLLKIYKVHMFKKELKKI
ILKNKLEYDPIETYLDCKEALRLKNQPPYKLGEALIKANKTWYKGGYVKLIFEIRKLKKE
FKKKANHA
>fig|195.2118.peg.608 L-carnitine dehydratase/bile acid-inducible protein F (EC 2.8.3.16)
MQDECVKVPISIADISAGMYAYSGILQALLYLEKTGKGSRVEISMLECMAEWMNYPLYYT
YKNATPPERKGAFHASITPYGPYKAKDGVVMFGLQNPREWESFCKIVLQDESLIEHEDFK
NNTLRTKNVSKVKEIIEDAFKNLSAKEVVDRLDEAKIANGNVNELNQVWEHPQLKARNRW
REVDSEVGKIPALLPPATNNNYEARMDKIPALGEHTESILKEFGFSDKINLFKEKKII
>fig|195.2118.peg.334 hypothetical protein
MGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYK
YLGGLAGHIENGTFSNIALDTIEGFNGENSSSGGFAGEINSGTFNNISLKNLGNIGVAKY
AGGFAGQINGGDFSSIILSNIESIYGKNNGGGFVGYTTGNTTFDGISLKDIRFIKSGAFT
GGFAGMTQGNVIFENIVLNDLEEISGSHAGGFAGWINDGTFNNIILNNIEKISVSATHKY
IFTGGFTGYAGAGTYKNIILNNIGEISANGTASLDEKSIYAGGFAGRIKSDGINFSNIVL
NDIDKISASIAAGGFVGNIENGSNIANSNIYFYGLLNSSSNKNYITHNENILNLSNTTDF
QTLINQSKIAGLEYLTNTSTSNSHLHMINGGKIGNEKSKITFDKDNFTYNTPKISEVDPD
GSGSSSSPTAPNEGELSSITLEQSDFEDEILKTIIDEILNEDYVLNIDSIDFNKFNEGDV
AILLYLLKNTSDKKLKESLKQSLEFYTEFNKGGLKTEFEKWYGSDESTYKTSMGKYNYII
ESLANLKEYVNTTLKPELESIKNNLNRLEFLKAEIKRLERVYQKAMQNDLLPYDQLEVVY
KNTQEKIDAYYAEAQGLLDILKNKNKPFLDV
>fig|195.2118.peg.1213 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MTLYLHIGIMKTGTTFIQDNLYYNRDEMAKFGYIYPNFMKNKGNLHDHNPLVHKLYTCFW
HKDEKWIEDECVHQFKEKGYKNVVISAENFSWQFTSKQSIAFLKEKFMSMGFTKIYILIY
LRDASFFITSIYSQLVKRNSIVGYNNVYIDTKEKIIEKSLDSKKIIKNYIDVFGKENLIV
RLFDKNEFYQGDLFKDFVHAIGLQWSDNFTISKKKTNESLDLIGIELQRRFNKKGLGGYE
AQNKKTLLNFIEKHFTSNYDPYLKFQPPKEIIQSYIDYFKESNEWVRKEFFPHKESLFPK
KDLTDYKENYELKEMKPEYWDKITEFVVDIIKIKNQTIQNNLTQIQNLTQNINFKEQIIQ
DKDNLLSFQTQYGTAKQRIQNQLSYKLGQTMIINSKNIFGILFMPVYIISTLLSHRQEKK
IYQEKIKKNPNLKLPPLESYPDYKEALKEKECLTYKLGEALIRASKTWYKGGYVKLVFEV
RKLKKEFKIASYADLNIYFAKKNRKIFGSKHFGFFNLDSESKNPKSPLNPWAFIRVKNEA
ETLRASLESILPAIQRGVIGYNDCTDGSEEIILEFCKQYPSFIPIKYPYHIDIFSPKCED
NKLFSYYNYVFKHIPNDEWFIKLDADQIFDPKRLYRSFYLVKEDIEAVKIPRIDILVNGS
NFFIVQAPNGRYLRDPGDQMLLKKTMNTKYVEVVVDGNKYGWNVLKSASESNNPKFLEKL
VAGKRNLLKTELLNYHFRYIKNWRTIESEKSKPQVIPFEEFKKNCSSEELKQIHPSWFKS
NNLFKAYNSLFNPSWVDKYQEDLQKYKQELKEFIKSCEKINKIQISQIFLNTFEKDFFYQ
TKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVNDGSTDENSLNIAKEYTLKDKRI
TLFDKKNGGLSSARNVGIEYFSGEYKLKNKTQSIKENSLVEFNIEGNNPYEIYTVYKSYK
AFNDEKDLTKFTYPNIDYIIFLDSDDYWELNCIEECIPRMDGVEIVWFDSRRFLSELKHS
NHLKKTLLESYNIPHECKINKKEWLVHTIENKIQSFWFSVNGLICFSFLKKIHLKFLNGI
MHEDNLFGTILFLKANNIYLFTEKKYNHRIRPNSIMNHDNIVTEKNIPEYMYDKYNHLIL
NPVAIKSYHRAYSWYRIVYCLLEIYPNLTNEVEKIFIERSILIYYNAIFHSIGKEDYIFL
YLCDKFYMLENNIKSIFNSRDIRKVNFVGAVEKIQNHLSYKIGLYLINVNKMNIIKDFYN
IYKIFYFHKKQIAVSKIIQCDQNHPLSYYSDYNDGFKLKRTKCYKVGKSFVDISKKWYIG
IGFIFYYVKFYYLRGKK
>fig|195.2118.peg.1350 Ferrous iron transporter FeoB
MSRVAFLLDGILHKFGLHGKSFIPLITGFGCSVPAFMATRTLKNKRDRLLTLFVINFMSC
GARLPVYVLFIGAFFPSEEAGNYLFGIYLLGAILGLIAAKFLRSTAFRGIDEPFVMEMPK
YRMPNWHLVWFMVYNKAKMYLKKAGTFILLASLLIWFASNFPKNEENLNDFNAQERAIEQ
SYLGQFGKGIEPIFKPLELDWKLSVSLISGLAAKEVMISTMGVLYSLGKDVDETNNDLKG
IIAKNIPLPSAVAYILFVMIYNPCFAATIVFSKESGKIKYTFFLFLFTCISAYIVAFIGL
NITKFVIN
>fig|195.2118.peg.1030 hypothetical protein
MELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTAEAGLEFSKTEKISDELS
HVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTKYEDIKTQSSTGFGLYIK
ERIEATSPIASAINQSAQNAAAKNENLGVNYGIVASQALANTANIFSNNLINTTSNQTLG
FKFNQDKSQSSSENISKINAGDNLNLESTKGSIVLNGVEAKANSINIEAKDNVILNAAKS
KNSSSSSSLEIAATNKQTAGYHAVDGGTVGEGIEGFASASCSKSNETQFTNANLNANNIN
INTGKDFTLNGANVKASNDAILMSEIWK
>fig|195.2118.peg.1206 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILRLQDEYFREKILSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQT
YKIIREIYRDDFEIFDYDLEDKKYFNISQHNYLKNLENKIAIKNTNLEFLRLDKLSKIQN
LNQTIKTKNQAILDKNNLIQDQRANIKNLNQTIQNNLTQIQNLNQAIKNKDELITNKTTQ
IQNLNQAIKNKDELITNKTTQIQ
>fig|195.2118.peg.1091 hypothetical protein
LSLMSIFVLQDGHSFSIFFKFEANSIEDADAFSATLFSGAQYRYDKPEDWQNLVDMFLGE
LPKVRAKLGNYDLPLIWTADFILDNDEKGNDKYVLGEINCSCVGFTSHLELADEVAQNII
NIVSKAKN
>fig|195.2118.peg.1710 Motility accessory factor
FPMTFTPTQKELFNKNIEALGNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGG
GYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVVFEK
DIEIIWIMFHILDFSNELQNSRLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELMSHY
YERFHEDVLELNKKLVQYFKDSIISHGNDSTDTLQGIEQFVYNLPQMITHPSYKELLSKR
KNL
>fig|195.2119.peg.1855 hypothetical protein
MICKFFKTQKGGGVSSVDYMLNERVNQGTARILKGDEFLTRELIKSMSQKHKTCVGVLSF
EEKNIDENTKKEIMQSFENALLTPAMQGRYNILWIEHTDKGRLELNFIIPKMDLESKKSF
NPYYHPIDNKRIDFWRDFVNLCYGFTNPKDPSKEQTLQGSKKEKELFKDYEALDKILHKQ
VANKIINSRDELIYFLEQNNIEVTRKGSDYLSIKLPESKKAKRFKGGIYNEQFRSFEKLR
DLRTEKESRAREYQQRDIKSELERTKRELDKFIQSKDEYYRETIRKFNERLQGKTRKFNR
KNGEIQLQDTANEIQNIQPSNEFFSGNAYDDDFKRSCMVSVDKTLSDQQGANNKIEQREN
LYTNAERE
>fig|195.2119.peg.1771 hypothetical protein
MEKFIERLLEEDIKFEKDVNNGLSDINIFDALNIETKENYHSKFIAYLIDINKDHYQKNF
AKVFLEKLGKSLVNTKFENLNIEDIKSVETEAYIKDNRRIDILITLSDKRYIIIENKIYA
KDQKNQLKDYINFVRKNIKNIKDCYKNILTIYLHQDECASPSDYSLGNFTIKTNLIKDKN
ENNVSYYLKMDYIWIKEWIDECIKIYEEKSTKDQKFILDIQNIIFTLNQYKSILQWYMTD
EYTQRDDVLEFIFQNNIKMQNLKNAMILYRYNKNKSELKNLNEENYKKVKDIIQHKWSNI
CEYIIEEFFDSFEHKEIKIGDITFIGNKIEENRVNHGVFIFYPIDYKNESIYPCIYIYFK
KKYYDIIGLTFEISNDDEEDIENEKYKECLKLFKDVKEENVRKYQNHYYCDKLINNEKLE
GEYAFIYWLIENQNSKKDFIQILNDFFIKKPIQEAYKGINDILNS
>fig|195.2119.peg.1812 Phage Rha protein
MSNTSIININNQEVIFENKDEQVFCTSLDVAKVFGKQHKHILELIGEKFNNNEIKNFCEP
NFRLSFKTRKIEGFRGRERKYPYYQLTKDGFSFIAMGLTGRKADKFKIAFINAFNEMERI
IKNQYTPKLKNYNKYKIPNTPYKENIIKAIMQTEQNRNCEFEELIAYEIKEIYKDNKSHI
EQKINFKVKGLI
>fig|195.2119.peg.1872 Motility accessory factor
ITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVY
QSIKHCRDFSKILSNDFEKIQSIYLSLNEKEEDINLAIEKIDKFKNKLEDIKQMQDLYEI
LQPLRTQFELNLARIYVLNPKTKEDAFNK
>fig|195.2119.peg.473 gamma-Glutamyl-CDP-amidate hydrolase involved in O-methyl phosphoramidate capsule modification
MFIGITQRLICNESYYEERECLAKDWGELFNKDLFKNFIPLPLSYEIDFSRYKDLVKAVI
LSGGNDLNFLNPNAMSKKRDSYEIQVIEACLKEKIPLLGICRGAQIIAHYFNSCISPYVN
HVSKHEIFF
>fig|195.2119.peg.1861 hypothetical protein
TLSDQQGANNKIEQRENLYTNAERECDSARQLLLPTTRLEKAENDDFRIRINSRNREITG
QDNRISTSRDEITRDNQERTNSIRERFGSYEKQTQQLRAGFQGFETENTRNGAIKRARIE
TIRDIIQAKYTELRERIRNSFKKTINKARQIKRDFGYSR
>fig|195.2120.peg.468 hypothetical protein
MFFSKSKYTRGTQCAKSLWLQTYKKDVLSMPDENTLARFSAGDKVGELACELFPNGVKIE
FEGSTFDEKCEQTKQLLENNQEVIYEATFCYDGILIMVDILQNTKEGFIINEVKSSTSLK
DVYIDDCSLQYYVLSNLGYKIKQVNLIHLNSEYYRDDFLDINQLFKLNDITDEIIQKQEQ
VKENLKYFEDILNQKEEEPDIDIGTHCFDPYECDGYEYCWIKQRNLCEKDSIFNISRLNS
NKKFEFYYKNIISFKDIKDLSVFNKNQQIQIQASLNKEIYINKEKIKEFLNTLSHPIYHL
DFETFMQAVPEFKGVKPYMQIPFQYSLHIDHKDKLEHKEFLSECGVDPRYELAKNLINDI
PKDACVLAYNASFEKGVIRNLALAFPEFSEHLLNIEKNIEDLMVPFQNKDYYHYKMQGSY
SIKKVLPALIPDMEQAYKDLNLIHNGSEAMQSFEAMQNMSEDDKKAYRQALLEYCKLDTL
AMVKILKHLEEIAS
>fig|195.2120.peg.462 NAD-dependent protein deacetylase of SIR2 family
MQIKTHIKEALDKAEVIIITAGAGMGVDSGLPDFRGKDGFWRAYPYLQKLGIDFERMANP
TNFYANPQLAWAFYGHRFKLYKDTKPHKGYEILLKLAKSKQDYYVVTTNVDGHFKKAGFD
ESKIYEFHGSINYLQCFNYACGDLIWQMQEELPIDMEEFKALSLPKCPRCQGLARPNILM
FNDGTFNDSRYFLQKQSYKNWLKPLEDKNILIIELGAGKAIPSMRMFGEDFCKKSKTRTL
LRINPNECDFPKFFRNGIGLKMKALEALEMIDSLI
>fig|195.2120.peg.1050 probable periplasmic protein Cj0413 , putative
MKKIKILVFLIFFCQFSVLANNLSQNIKENLGINQFLDESLKEILNQPLKENFALTPKGE
YFFEGDLSLFQKQCLENNATACAYLGREFAANTRLPLNLNKALLLFQKACKLGRLDSCTR
INNIKFKLLKKLDEETYQSNLKYFLDQNSSFALLEHIATLSKKDTKLYFAQGWVELFNQN
DILAQKLFYKSCQAGYYTDCNMAVDKNSKDQAMQLYLIKITQKNSQNQCQNSSNKQSFAC
HKASALSKEILKIQLKKISEKLLFTILI
>fig|195.2120.peg.1787 hypothetical protein
MQEKCISLMEKQTDHIINIERKLIEDDIYPSDFEEFSVEDVV
>fig|195.2120.peg.472 Putative inner membrane protein
MYKINKPENSITKLPEKTFKELEFTERGHLQEWIAKNPSCLGEDLLIIQKEFCDFDGTKE
RFDLLALDKEGNLVIIENKLDDSGRDVTWQAVKYASYCSTFSKSDIERIYIEYIKDENYK
EKLCDFFGVENYDDVKIENQQQRIILVAANFRKEVTSAVLWLINQGLCIQCFKVTPYEFN
QECFLNIEQIIPIKEAQDYIIKMAKKEQEQNLINNSEKQRHVIRLNFWNKLLHKIKEEHF
ELFSNISPSKDNWIAAGSGFGFCQYSFVFNKDCVRIELYIDSKDKDKNKIIFDRLKENEQ
EIGAAFEGLIWERLDDKRACRIKFEKEYDSYDETNWDEIVDFMIKNMKKFETVTKPYIQK
VKI
>fig|195.2120.peg.2011 hypothetical protein
IGLGLLSTTLASVFGYLAGVGSSKT
>fig|195.2120.peg.503 hypothetical protein
MKQELEIIKQLFNSLSDTDKKTLIKSLKSGNKSKTAPKFSIIKEIKECPHCKSSKFVKNG
TSRGTRRFLCRECGKSFTTTNNTIFANGKKDLSVWQKYIHCMIEKYPLRKTAEICGVSLP
TAFAWRHKILDTLQEMQEQVKLDGVVEADETFVPLSFKGHHKSFNLPRLAKHRGEPATRR
GLSKEQVCVTCCVNLDGLSISKISNLGKPKLKDLEKVLSGKINQDSVFVTDSFRAYLKLS
NDMELNHIRIPRNKYSNGAFNIQVINSYHSRLKAMLTYNFKGVSTKYLNNYLVYHNFVNF
AKDSRSDKERILLNHIISTDCISKSIDIANRPAIPVAA
>fig|195.2120.peg.1214 hypothetical protein
MDIETFEKKLNELELTKKEFANMVGAVYNGVINWNAKGETPKWVDSWLINYEKSLALDEL
LNIIEKYKKNT
>fig|195.2120.peg.1937 hypothetical protein
MVGKLFLEKIMFPNKLGKNCFFCLNMFHFLGKNDIIL
>fig|195.2120.peg.1353 Putative amino acid activating enzyme (EC 6.3.2.-)
MTTHIYDFLEKSLIKFSEKTAFVEPFAKERKEITYKDFDLFSKKLASEILKTLKNDEPIQ
APVLIILPKGIDCLISFFGVALSGNFYTLLDEKSPKERVEKVIEVLKPKLFITSKDLNFN
LDLSTLYTQDFESFNIDENLIKNAKEKHIDTNLLYVFFTSGSTGIPKGVSIAYKSVIDYT
F
>fig|195.2120.peg.466 hypothetical protein
MDIKSPFYYCIILQKPKRDKMILAVGTIQEYREKIRNEIQKN
>fig|195.2120.peg.1996 hypothetical protein
MEIDKFNILNEIREYSKNNQEALKDILIQAQTNQNTIKASQEKTEDTKEKKNTNINFWII
AIASQIIFLLVGLIIGIII
>fig|195.2120.peg.1247 Phage antirepressor protein
MSNAPVIINEIKINLEIMKNQVFINSLDLAKVFKKRHDNIIQTIENLPQDEFKTLNFEIS
SSIRKNGLFEKDTKFYKLTRDAFSLLVMGFTGEKAYKWKVEFIKAFNEMEKRLKNLEQEK
MQKLAFHQSLGYKSQLKQQKEHYENKIKALKYDLENKKELSFKRKLSQKELLELRKILAR
DYGILCIKEWEFEFLAEKIALESTRMTTWDAVVKKLKQSLDYWQNYEEYEEKWKKILRR
>fig|195.2120.peg.863 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MKKLALALGGIALGACGEKIYKGIKILGIN
>fig|195.2120.peg.1352 Putative amino acid activating enzyme (EC 6.3.2.-)
MCETFKFDENEILANQAPFYFDNSILDIFSSVKSGATLHLLPNHLFAFPNKILECLEKEK
VSTIFWVPSVLIYFANTEALNNFSLNALKKILFCGEIMPNKQLNIWRKHLPNALFANLYG
PTEITDVCSFYIINRTFKDEELLPIGKACKNTELLVFDENMNFISPKQIGIKGELFVRGT
SLSLGYYNDKEKSKQAFIQNPLHDNYLDLLYKTGDIVSYNEFGELLCYGRVDNQIKYMGH
RIELGEIESVINSHANIKNSACIFKEDIICFYESEEEINFKDFLKDKLPSYMIPKNFIKL
DKFKLNQNGKIDRKVLKELV
>fig|195.2120.peg.1964 Probable lipoprotein Cj0818-related protein
MKKVAFFLLFLFLSCTVLNAA
>fig|195.2120.peg.1750 hypothetical protein
MRIDYEKLTIKPKVFGTIFGLCSLAMFFLIVSFLWIPIGIYIKNFLPSFLSLFYAVATLF
AFGVLVKIFSLFVTMFFVKDKMNKLRSMNETLSYLLLSSLAGAAFTASQSFFSLELFLNN
KPYNPDNMISVALFSLGNYFVENSYFYYLLGASLIAFLFFRFYLLRNKIVLELETKETTE
TTFSEKEKFYLSLLACVILIFVTIGAFFMLFWFLVLLINK
>fig|195.2120.peg.1506 Efflux ABC transporter, permease/ATP-binding protein
MHKDMTLKDVLIRFKPFYKKYKKEFAIAIFGMILTSIGTAGSFASLKPILDYIFVEKNEA
LLYTLLRKIKILPKQIRSEKTCSSLVLLCK
>fig|195.2120.peg.341 hydrogenase, (NiFe)/(NiFeSe) small subunit family
MAKLSNEELKNILEDRIKKLENSTLKEDKVINEESVKILARHLSLGNEIPALAQRFFQIA
PKTKLVWLHLCECTGCSESLLRSELPSFDELIFDFFSLEYHETLMAANGTKAEELLEHVL
EEDFILAVEGGVAAIDTFFLTIGAQGESGYEILEKLAAKAKAIFAVGTCSSYGGIQAAYP
NPSKTCGISEVLSQKVVNIPGCPPSDINIIATLSFFALFGVLPELDEQNRPVWAYGKCLH
DMCERKAKFESGIFAEHFDDEAAKNGACLFKIGCKGPYTYNNCPKVKFNAKTSWPVAAGH
GCIACSEKNFWDEFGNYEKPMANIFSYAKLCNEELKQEFFLEEQIKILEQIDFEFESNIK
LILQNIAKNKLGALLVENYKKSFEKNYTFIEQNFDENPMPSKDFWKYLEISFILVKGEFL
KDKNDFLIAAKNYAFKHASPYDFKLNMNAEKPKLDVSKSFRMTLIYLCGGLDFEALAYSV
LKAFEKNIKSVIDFNKQKAG
>fig|195.2120.peg.469 hypothetical protein
MNECSQTASKSKKDFQKKFKDTLDKDSKIIPIYSIKFLYNFRKILKGK
>fig|195.2120.peg.470 conserved hypothetical protein
MQKLKELAIQHYENSQGKLKLWGDILQYDIIYDDELLVLSMQKSDE
>fig|195.2120.peg.1965 Probable lipoprotein Cj0818-related protein
MKKVAFFLLFLFLSCTVLNAAREYCKYAYQEDRAIPLILNYGIRLGVVGAGKDLR
>fig|195.2120.peg.463 Protein of unknown function DUF262 family
MSEKSSKVKSCVVGLKELVYGKISDQNDQKLEIFSKDSFSLNIPDYQRPYTWEEKHVKTL
LKDVSEQANKNNQKYLLGSLILHKNNENKFNIVDGQQRLTHLGFDFKSFMRKQSRKMQ
>fig|195.2120.peg.1729 Phage tail length tape-measure protein GpT
MENAGSIGIGVILGLAIKNASAVGKVVKDFSNLEKIAAKTKLGISGLQKELNTLKLNANL
RAELKAQRKGLQDELLSLGNVIRGGIIGKGLGEAISFESAMADVRKVVNFDEGDDIKKMS
ADILKMSQTLPVTANELAAIAAAGGQIGLGSKDVREFTNLVTKMKVAFDMSAEDVGDSVA
KIKNILGISLKDMEDLGDSINNLSDNSASKAREIIDVMKRTAAAGKQIGFTKEQIAALSS
SFISLGKGPEVAGTAINSLYRVLATADNMGTKTESAFAKLGISGAFLKQASFDDPQKALD
MFLQRISKLDQKEQMGVLVDIFGREFADDMATLVGGLDTYKEALKNAGDEAKKGSLQREF
DTRAATTENSIILMKNAFNSLAINLGSVFLPAISWVSAGISYLVNSITYITGLVPGLNGV
LGGLIATFLLAKPAVLAYAIAKNYLKDCTILLKSALIKTRIHLLAFRNSCILSNITLKVK
TITTNIYTASLKVLSFVLIGLNKVFKLVAIGIRVLSVAMMSNPIGLILGGIAIVAGLIIA
NWDRVKSWFMSFIEWLRPVWEPIYNAIKAVFNKCSGVIGYFKNNALNIIFPFVGILKFIW
KPIYEVFKWVFDKCSGVIGYFKNNALNIIFPFVGILK
>fig|195.2120.peg.335 Anaerobic C4-dicarboxylate transporter DcuC
MLGLTFSLFSVFLLVFMLYKKINAHMALLLSGLLLLSLAAIFGLSPHIVAKGSLNLGFFD
IFQVFNQTMSNTLAGLGLTLMAIAGFSAYMDHVGASYALFKVFEKPLKMVKSPYVLLLVA
YFIVQFLVLFIPSHAGLGLLLMVTMYPILVRSGVSKLSALSVIGICQYIDHGPGSGNVIM
ASKVAEIDPAIYFVHYQLPTTLPIIVAVGIAIYFCNKFFDKKDNFVFNAQEVEKELSENK
DKENELKKPPKIYAILPVIPLVLILGFSSVLDSILVLMGISSEEEEVKAAASSAIKMNVP
VAMVISTFVAIVFEMIRYKSVVETLNSIMIFFKGMGHLFVITVSLIVCGQVFASGLLSVG
FVDTLIEFCKNAGFGVLAIIIAVSILLAVCAFLMGSGNAAFFSFAPLIPNIAKHFGIETI
TMIAPIQIMTGFGRCVSPIAPAILAISAIAKVSPFAVVKRTAIPMLVAAIVNIIMTYIYL
>fig|195.2120.peg.2015 FIG00470627: hypothetical protein
VANKSYVDTVGNSKVALSGNQTIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVA
LSGNQTIAGVKT
>fig|195.2120.peg.502 DNA-cytosine methyltransferase (EC 2.1.1.37)
MREFKFIDLFAGIGGFRLALESLGAKCVFSAEIDPHAIQTYKENFNDDPTCDITKLDPKR
IPDFDILCAGFPCQAFSISGKQKGFSDTTRGTLFFDICRILKEKQPTAFILENVQNLEKH
DKGNTLFVMINSLNDLGYSVTYKVLNAKDFGVPQNRERIIIIGNKEHKVFSFKKLYKTPV
ISMYDMLDKDGDFEYLQAHEYTLLEPKFIKTQAKSGLIFTGYRNKTIRTNGTKDGTNHLS
RVHKQPNRIYSSLGIHPTIASQEQSGRYFILVDGRVRKLTINECYRFMGFPDNFKKVGSK
SKQYERIGNSICVPMIKEVASEMIKQFFIDDITENPETEFLEKTYKQAIALDFNNISLID
YQLDNVKIVVEKEESSKAVFTVLVSSLTYKCLHSEQDVRMHKTELKNGYSGRGFDTKFVT
PFLKQKQFLGAMKESGWLTRSLEQAHPFTLDFPGKIQSSRLKDAFLQILNDVEVNGANPL
EYLLALFNLSIKAKKDRAVEIINPITSENKLDIKDVMAILEKHFYYKYNSRGASILPVVA
LYSVYECMIMELKRFENKKLLEISSHYSSDKNSGNAGDIVVLNSDNSLYEVVEVKFDIEP
SLIMLLDAYSKIKPTSIQRYYILSTKIANDAAVKQINDKIKEIRKEHGCQVIVNGLMQSL
KYYLRLLSNTDLFIERYAKNLQKHPEINSEHKVSWNNIVNNMF
>fig|195.2120.peg.1112 Acetyltransferase
MQNTIIQKAVNKDLNSILEITKDALNAMKTMNFHQWDENYPNEIVFQEDIQAQELYVFKE
NDEILGFICINEKFEPEFYKQVIFNKNYDDKAFYLHRLAVKQNAKGKGVVQKLLNFCENF
ALENHKASLRADTHSKNFPMNSLFKKLDFNFCGNFDIPNYQDPFLAYEKILNQKAF
>fig|195.2120.peg.710 Alanyl-tRNA synthetase (EC 6.1.1.7)
MNFNKAAGVKNCPLKAGNLVKNIAQILGGNGGGRDDFATAGGKDISKIDEALKQALDLIQ
KGL
>fig|195.2120.peg.1343 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
MIFFDNFKLDKSKIGEFFFGSANNFIKTKLLELLNFKEIKNDETLKNYGDVTINKLAFDL
ANYEWRKKKGGGGIKQVFMASFGTGITFNAMSLKIDFGKIKNFIEIIDFNT
>fig|195.2120.peg.1733 hypothetical protein
MDLIYFFLDITWVEAVVTSLFLSFILIAPIYTRLIGVICFMFWIIFCFFGLVIDQGGDRE
VNLFPPSPYYVEKVVKKYELQEFLYSYPSGLKFEEALKSSTLGFGICLLNKYEGSICSGY
LKYFENKLIGYKNEVLEKRSEEKKEDKKAYDGAIERQRNIDNHFN
>fig|195.2120.peg.1953 Formyl transferase domain protein
MNLCHKECASLLYESLILFLEDNVKAYKQKEGGFYCPKRKKGDEIINWTQSTREIFNFIR
ALNTKDLGASAFIDEKEIKIYKSEIYKDKIFNAPIGKIVKKEKNFFIVSTKDGTLKITKF
KGEVKIGYNFKIYTKNERGGVIFRNLDFSFRKSV
>fig|195.2120.peg.461 hypothetical protein
MALAVDTIQEYTIKKGKKSFWMCFNTPNNDFHVNKIKHKNIFDEKKTDQKARDEFLTFMK
ENFPKTKLIKVFDTAPVGYLLYPYLGSIAVDCEEGDEAYKAISEKYEDENHLPKSMNAVF
WEMSLEVAQELHETRKFDYDNF
>fig|195.2120.peg.2010 Hypothetical protein pVir0042
MTKTQAFVDGFVGKPIKNECFNLWDLNAIIREKQAKL
>fig|195.2120.peg.2012 hypothetical protein
TLASNYGGIYIFDKKIREEILENERKRTELENDDKFRTKIGQLKSGELIYKIDSAAVDKL
LPQILSNGCKYYRNDYNYKIGESNFN
>fig|195.2120.peg.464 hypothetical protein
MILKVLCENNQEKCNECKIGNFLGESKYSHNESKYHIKENYEHIKTYFESYNEKYKFLTY
LLDNIEFICVLAPSEDDAFLFFDSANSKGKTLKPYDRIKAFHLHSLEKKQGNMLDYYARK
FENLAKDEKKITILFDELLAPARAWLRHRSVNANKIEVDEEFCKEFFSDKFLYSKENLGI
LSNFANGVDFFEYLFKYDEFFNKLSNNALYQELDEIYQTGFIYNKYIYVIAVMIYFSKFP
NGNSDYFLLLLARAAFSLRVYSSSIYRATQRDYALEFLEKVYFVSFEEDLEQNLLDFIAI
KNKEERKTKNEEEKHGDEKKWYKEWYLDIVQKRFYENQHIPKHIF
>fig|195.2120.peg.467 hypothetical protein
MKTYDIILEKWMDFHKNQCKEFIHYEIFNDHIIEEALKENKNYHCEIKAIDEEIKLNSEA
KIHILSFKISDDRKLKFIEQILDDVDIYDGVICFDIFYTNEKNTYEVLKIEF
>fig|195.2120.peg.2008 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLE
>fig|195.2120.peg.2004 Motility accessory factor
PDYVLSLERIPLTSEFFNNDFGEFDKDIVFVCAGVVHPKAIEYLKGRNRKYLIIPRYLYF
PIYIKLKYFDFLYNTPSVAHMSYFLSVLLNHKNIIFIGQDLAYAENGNSHPDDYQNSANY
ESQMYEHILTEAYGGKKEIKTHEVWIFFKQILEAMIIKYHITTYNCTEGGARIEGTIEKP
FLW
>fig|195.2120.peg.1908 hypothetical protein
MNKKELIEEIAKKHHIILDENDPILAVVSANEIIFDDFLKKIDLLFIKHKTDLESCESHS
LIEASASQLKPSNLS
>fig|195.2120.peg.1911 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDLTKEQYENIKSNIGTHAIESIYLNELDIIMLVKKNV
YGLSADEIIAEYQEKGFVEYERKQ
>fig|195.2120.peg.465 hypothetical protein
MENNSTNNQNQASVISIESIVNIDDKEQSIFFEIPPYQRLYEWNKEQIQTLLNDIKTKFE
ENKNEEYFIGNVVVSKKNNKNNQQDVKYLLIDGQQRLTTLFLIGFYLSYKIKNPNNDSNW
KEFIMQGDKLRISMPIREKEEKALKEFAKFCDEANKDNKSENNLFLQKIKKFPQGICQNI
PQALETIVNWFEENIKEENIKKFSNFIYNNVKFVFVELAQNTDLNRFFIRMNNRGKQLEK
HEILKARLLKNISDEERILYAHIWDICSQMDNYIFQKTSNRKISKLNESNENTIDTIDTI
INRSFDKPNQDEEKQEKFKSIVDFPTFLLHVYKICNKQDITIDKNKLLEIIKIEDSGKAK
AFIENLLKYRILFDYFIVKGKDDKENSYKIRRLDKEGEKLDKDFDDLAMVQNYLRVARSG
MSNNHHHWLTPFLKFINNDKLKISYERDNNEDKPEELQIKIGDYNITTNFQNFLNTLNPE
ELIEFLENLDTALAKEQASTEEIKKDLLDISNDIMDQLKIENDQIDAESIFFIEDENGIS
VLDRGTATPHYWFYRLEYYLWKYSKIKYYLDGKNLKEIKLKDKNFIDITNNFYFRNLNSI
EHVQAQSKANEKDWDDENIDNFGNLALISSSFNSSLSNQDTQDKYLDLQKYINKDNNVIS
LKLWLIYALSEKNQLNWTFDKAQEHRRQMLEILKKSFNNVQR
>fig|195.2120.peg.471 hypothetical protein
MFSTMKHILTHTADDLLAKKFAYNNVDNFLKTKVLFLECKNIQEWFLKGYYDGVNSSLEF
VQKFDFILDKDILNSFLKQNLLLKDKYIKLQEAKAMIKTNFKRKSEPLHVLIFISFVCA
>fig|195.2120.peg.1949 Motility accessory factor
MDGKGEKVREELFLKNTQALFEVDEFLACTLRSLKYLTFALIQDENGINFKKDDIFLYEN
PNKELLENLTLFKTEYNKYPVLFFYGFGNGMFYKTLCKNKQHKHIIIFEDNLEILTLAFH
LFDFSEELKKEQLILFYTPNINTAQLTTLFTYEIIQKSVKIFNLFIHNDFYQQFYSTQIQ
NINTQLIEMIRFIVLNKGNDPHDSLVGIKHTLDNLPKMLNHGIFQEFLKERRAKVKNAII
VSTGPSLIKQLPLLKKYANKATIFCADSAYVILGKYGIKPDYVCMLERDNIVSKCFDNDF
GDFNKGILFILASVVHKEVLDFLEKDQRAYMLVHRPLNFAASLKLDEYGYLGVGHSVSNM
IYELAGALRFENIIFIGQDLAYGEDGSSHPKEHIHGSQGEEIRGEKYTLAYGGKGKVRTQ
LTWNLFRQAFEKDIFWAKEKLNITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFD
FPKFLDKKLAKEKLEKTKKYLQKSILESKEFIKKTQTQLQKLRYTLEKNDKNFQTLEKIK
NDLLNLFKEFKKLKLFNELCQAIYFHNECEILKFEVLNTNKQKENLIDFLKIQHNWFIQG
LGYLDTQNKTIEKSLENWNFDDRKKFRKLEF
>fig|195.2120.peg.1044 Signal transduction histidine kinase CheA
MEDMQEILEDFLVEAFELVEQIDHDLVELESNPEDLELLNRIFRVAHTVKGSSSFLNFDV
LTKLTHHMEDVLNKARHGELKITPDIMDVVLESIDRMKTLLNSIRDNGNDTAIGMDIEPI
CARLTAISEGESPVAATDSNEKSTPQTEPEAPKQEIATPEPEVDVNQLSDSEVEAEIERL
LKVRKAEDQARRAQKKQTTNAAPKPTNNTANKPAESGEKKVPASGSNASSMDQTIRVEVK
RLDHLMNLIGELVLGKNRLLKIYDDVEERYEGEKFLEELNQVVSQLSIITTDVQLAVMKT
RMQPIAKVFNKFPRVVRDLSRELGKQIELEITGEETELDKSIVEEIGDPIMHMIRNSCDH
GVEDPATRAANGKPEKGIVQLKAYNEGNHIVVEITDDGKGLDANSLKAKAIEKNLITERE
ADQMTDKEAFALIFKPGFSTAAKVTNVSGRGVGMDVVKTNIEKLNGVIEIDSELGKGSSF
KLKIPLTLAIIQSLLVGTQEEFYAIPLASVLETVRVPIDDIYTIEGKNVLRLRDEVLSLV
RLSDVFGVKQVLESGDQTYVVVIGVAESKLGIIVDTLVGQEEIVIKSMGDYLQNIQGIAG
ATIRGDGRVTLIIDVGAMMDMAKEIKVDIKAQIESSAKKPKEKPSDYKVLIVDDSKMDRT
LMQKALEPLGVSLIEATNGVEALNIIKSGDHDIDAILIDIEMPRMDGYTLAGEIRKYSKY
RNLPLIAVTSRTSKTDRLRGVEVGMTEYITKPYSPEYLENVVRKNLKLG
>fig|195.2120.peg.510 Arsenical-resistance protein ACR3
MVVVWSDLAKGDREYTSALVAMNSIFQILFFPLWLIFIWIFYQNY
>fig|195.2120.peg.1764 hypothetical protein
MVYFLCAFIALPLKIFLGGKIKPKVLIFMSLSGDTSQRPKSFKEYKC
>fig|195.2120.peg.473 hypothetical protein
MKDFKKYIANSKLTRLEILYDRLVKSENGITIKELAQELNVSTKTIKRDMQEVLEPMGLV
KNGKKWYIDTSKDTQKQDDKIILEVLDTMAKSAGSSFYAKAHPLLSRFSQNISNPIHASL
DAEKLEEKDLNHFQILEQAISTKTQIVFKYENKLFQVKPLKLAFFSGFWYLLAFDMKKRD
IFKKFYLKNIQNITLTQESFQTDEILEARLRKVNSIWFSLDKPFVVRLLVEEPVRKYFER
KPLNSQIITGKDKDGSIEIELEINHEMEVLPLVYYYIPYVKVLEPDFIADKVKEVVKDYL
EQISK
>fig|195.2120.peg.2002 hypothetical protein
MNIACTAVFILLIASLYLILFTEKIEIGLGLLSTTLASVFGYLAGVGSSKT
>fig|195.2120.peg.504 hypothetical protein
MKYFNRAFYIFTLKSHFYISKILNYHLYFISHKTYIFHKHKKMNPQSLILRQALAKQYKF
LKDFNP
>fig|195.2120.peg.1231 hypothetical protein
MKGIISGVCAIALLVSANTLNADYNEKLSIETKNTQFALKTIKTEDYISLCSEVVKLNRW
AFYTSLCDQNYFLTLEGKNKIKEKQKIRKIIKQLNKTITTSKKRMNDKNFTRFEDADLKV
YYSSLATKNILETILDEDFIKVTGGFDTSLFKEDFDIIEYGKGIEAVYKNITNEEKQKFA
LIRERAKEYECLFQI
>fig|195.2120.peg.2007 Motility accessory factor
KPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFENIQSIYLSLTEKEEDI
NWAIKKIDEFKNKLEDIKQMQDLYEILQPLRTQFELNLARIYVLNPKTKEDAFNKSILWI
KE
>fig|195.2120.peg.1232 hypothetical protein
MPIPDLNSKIIRFLKDTYKNETYIYGVFGIYLKKHLSSLDENSSIEDICDIVGSIDKNKL
NELYAVVKPQEDSTKFPKSIKSRIFKLICQEVNITENEMKAFLKYHKTNYNRN
>fig|195.2120.peg.1780 hypothetical protein
MFKIFFLSKKATIKTPQNVGIIFFFIFSKKYKKINIEYFIFSLFLKLFYSKNIFLIKNHF
LKFIIKSLIDFFFLLCRLIFFLVRNIFSYYRFFF
>fig|195.2120.peg.1255 hypothetical protein
MDIILGIGAVTLAIVLIALAYGFYKEKHKKE
>fig|195.2120.peg.1788 Hypothetical protein pVir0042
KPIKNECFNLWDLNAIIREKQAKLYKENIEFREKQFEKITKQK
>fig|195.2120.peg.1830 Probable lipoprotein Cj0818-related protein
YAYQEDRAIPLILNYGIRLGVVGAGVANVPAPGGSTYNSKIDMMAARCHQA
>fig|195.2120.peg.45 hypothetical protein
MQGESIDTIRQELIGVSEDFFTKASVEYLGHINMGKLDWYIASHPTTLPKNGNQFDTFST
FTHELFHALGVLSLAGSCGGNLGQCFNGFLNSFSDHLYDLNGVKAQIGMRIVKTQAEVEE
AKLKGETVFLVKDDGVYINGSFSNASGNVYFKGENVAEVIKNAKLGYDGVNGIPINAWEG
IILDMSHIELDNSLMSHQSWHNYNFYMEAELALLQDIGYNFDRKLYYGDSIYESNLLNWQ
SDHGYYARKDGKWLIGEYNPTEYGVGLHIYGKNNIATQSHDILSSGVAASGIRIDGSNNQ
LIIANDTKVHTLGDYSNALLIAYGKDHVIEHNGELKATGKEGIAINIDFGDNTLGNAEEY
RGSYIHQMSGNNQDDLAEYNLDGALVKSLNLNAASSTIGSLASIYIADNAYVNTINIAQW
AKVEGDIISNWDPNNEKLANQYKDSFYTDLNFGSDSSLSRAAFNALDNTWSVKANVLGYD
NFKMNVNENLNLQGSAFVYDLNNKAHFSLLGADGINPSLLYIKNNFTQDSNAILTAGINA
NGQSLVYVGGNANLAGAFNFYMLKDFYKDKVVLDPDLISANQIQGAFNSIVYDNSLDFSP
TLNFIYDANTKELGVVRDYTPYIKNSSDISLAYALNSLAQNGKYEDIALLFKELDFATDA
QTIAQGLNELNAKAYLDSAKISLDFQEELNKEALSDVRKGYANEWQSFVTPFGTYQSSRA
NGDFDAYKGYGGGVKAKAIKGFDSFNLGFNLVLNTNNIDIDDTLANTKTTGAYAGIFSKY
DLEDFYLLGSFRMGYEHTKLNRNVNIGAFSANYNSKFNSYLISEMVGIGKSFNHYGVSYG
PLAYIEHSFLHHFAINEENQNSIALNIDSKNFHALNSFMGFNVNYEKGMSDKAIVNFYFL
GGWSHYFLDSLKNNASFKDASLNKFYTKSKLSNQDSLYLQGEIDFTHNQSFFTRLMLSSD
IKDNIDFSTKLEVGAKF
>fig|195.2120.peg.366 Histidinol-phosphatase [alternative form] (EC 3.1.3.15)
MKELEIAKLACYKAGDFLLNLKEKKINFNKGKDIKLQADLESEKIICEILTNAFPYPILS
EESYKISNEEKKGIYWVVDPLDGSLNFSQDIPLCCISIALYENNKPILGVIYDFYRDEIF
SGIVGVGAWLNDNEIIVSSVKKDKSQAILATGFSSYMNYDKSELDKFILYVQNFKKVRLF
GSAALSLAYLACGRIDAYYEKDIAFWDIAAGVSLIASLETITYSICENNSKYSVRVEI
>fig|195.2120.peg.862 Phosphonate ABC transporter phosphate-binding periplasmic component (TC 3.A.1.9.1)
MIFKDLITLRKVIKQYEEIEQIYPSYLNDPKFLEFRKTHKYDAEAIHNIKDHLFSDLKKE
KLIQIGTTMEAFMEYSDKYLQDDITALKISWRFCAIRLKFDSALLQLQDINKIV
>fig|195.2120.peg.1735 hypothetical protein
MNKVLAKRLAKKAREKELFLLFKEFMREVEELEFFVFRKIKNSKEFKEYILKLEDKNLQN
FLVMKV
>fig|195.2121.peg.339 Cytochrome C553 (soluble cytochrome f)
MKKILVGLKLCVGVCIANDILIKKGENLYKKCIACHGVNGEK
>fig|195.2121.peg.679 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
MANTFGYGAMTNHLGDIQRSKCIIIIGANPAVNHPVGFRHFLKAKEKGAKLIVVDPRFTK
SAAKADIYARIRPGTDIAFMYGMLKIIFDEGLEDTKYLDERVFGIDKIREEAAKWTAEEV
ENVTGISKELLVQITHEVAKNKPTTLIWAMGLTQHTVGTSNTRLAPIVQMVLGNIGKFGG
GVNILRGHDNVQGASDMACLSENLPGYYPLNEATWRYYAKIWGVDYEWLLGNFVSKDWMH
KTGLSLARWWAAALNGKDGNDAIDNAGTPLKALVVMGNGITSTAQQVKVKEGLEALELLV
LADPFVNEAGIIAERKDGIYLLPAATQFETSGSVTATNRSGQWRFKVVDPLYESMEDQEI
LFELAKKLGFYEDFTKTLRDEKGEIVWPENATREIAKAVRSIGLNGWSPERLKKHTLYWD
KFDEVTLEGKDEVAGEYYGLPWPCWSDKHPGSPVLYNTDIEVAKGGMGFRNNFGLEYEGE
SLLAKNAPLNSPIDTGYPQITKDNIEKVLGITLSAQEKEKMGSTWSYDDSNIIATKCIEK
GIVPYGNAKARAVVWTFKDKIPLHREPLHSPRNDLVQKYPSFEDQKALYRVDTKFVSVQQ
AKDYSKEFPLNLVTARLVNLNGAGMENRASMYLTRLTPEMFCEINPELAKEQDIKAGDMI
WVHSPEGTKIHVRVKVNPGVAKDMIFLPFHFTGVMQGVDLTHNFPEGTKPYANGESANTV
TNYGYDIMCQIPETKGGLCRISKDGK
>fig|195.2121.peg.841 Integral membrane protein
MNQKNGNGLNSIKKIISKCCNTDNFDISEQKNDKDVLIFKICSNEVLNIDLDKLCAQDFY
ICFEKCTIKILRLSEKKIKINLNLFFNSCSFEEIEIYNVYFLGQFKISELVDTLEKIKDI
KFNHCAFNNLILEKNKFENNICFEEKTKIKKIYLYENEFKKHFFIKKCFIGSINLWKNEF
KNRCYFMDSKFGYDEDENKKAKLNFSNARFQDNVYFNNSHFYDYVDFHECEFEKITCFYG
VKFYKTPNFSACYFKEPKAVNLINVDIDKLDFKSVEKYIEDNYKDESYKNETKGMQDKKE
FFKIKNKHKLRYAKNLKDSFRVIKDVLITQNNTLEAQEWHKLELYAKEKENHINLSVKDR
EKNADIFKNILIWFNCVLLNVYRNTSDHHNDFLKILNFTVGMIVLYGVFIFFCQACIEPY
SKFFNELKSSVIFIIIGILVFLCWIMFYFNRKKSIFAKSIFFIIAMVFIVLYLVTYFYKT
NEYKTILYLVMCYILSIYICYFFFNIKNIIFNIVFKFMLYLVFLFFLINSSQLINPFTGV
FSSGKLYESKFEKSLNDLNASAIINLAKISFKEFNLNQEYKNISFTELNSAKALIVANKE
NLLKLNDANLNRAKEVLGEKYTELLKTINQDKITENTIKSTSVLYSIILLLCIFSLQKTA
RKNSIVPS
>fig|195.2121.peg.753 hypothetical protein
MAVILSKRIDGTGSRLICLMNAFFLSKKANLDIPVKFTWGEFKPYTKTADCNGFRKISDD
NNIQILGLCTDEKENIFTESFISSFFINQINGNIVELNSYFNLEDFNTFLSENTGSDIYI
NTPLGDLCPRWFKNISYEEYRHEMSLIWKKLEFNVKIEQIMENAKKQANERIGNNFIAIH
IRSGDAIYDYGDFRKFNLQSVYHATPCEIPLAIIEKNLNRKILLSGDDLETIQKIAEVSG
HPEIYTMDDFRDVKTMSNLELFFFDIAFMSKALRLYGTHSAVVRLANFIGDQQFVNNYEE
IDASQYLDIHNKYYPILNVSPSQKAFSLFHAFLYSKVLGKPIEYSISVLEDALKYDPDND
KYHIHIVDSLLSNNKKKEAEEYLCKVFFELNRKEQYIKTLLLRGWIGIVYKKEFQNYLKF
AEKDFPCICYVASMITEFEGNIIRSHGFAILASNSKYKTFFYDSCLRIEEKVRLYYEKQN
LERKKENALLFRNKALIFKSEWKWNKAVFSYQSSLEYTDDYLLEFLAFLVDIGKINLLND
IIEKYSYERLKSISELDKFSSVKDYLIFYDKYILNNSKMYYFLRDHNNSQSAILDFLSNH
KDIDSIDENNELVITYLLMILIKKYKLKNIEFDIVKFYRKIWNKNLVRAQYIISKVHFIQ
WNNVDIIIGILSDLTALGDMNNRKILNIRKKIFNQLLIYTRKSNAKIAVCLWGIFRGNSD
KTLKLIKENIIKPLNADVFLHLWDHWDVWNGYGGDLHWVRRYIERRNRKFFPKEICNYDT
LKKYFPNVFRKISTPIKDDLPLDNIYSLLNPRKILIESQDDFINSVTIPMRYLEYSPFPN
YAPYSRARLRYGMYKSFSLTKEVEQKYDYIILARVDQAYLDKFDQEQLFSLKDNDLLCRF
LRHGLDDRIIAAKNSVIEKFVDKYSFMIERKKVDFYDSIKNSFHLKGEEGVGVLWCLENN
ISPININMNIDIYLPSKGMIPDFYNELITDLKTSGLCFSNKEEYINFVKFVKQNQQNLFK
KYLNVGAVDRVKKHLSYRLGEIVLNNYNSFGKCIFIPFLLYIESNKFKKQNSKKLNRNKP
LKYYDDYEQALVEQNSIAYKIGNIIVNANKRGKMGYFRVFCEIINIIKNKG
>fig|195.2121.peg.666 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLMESDFLEKIPFIDEVLIYKD
DFLEKIQSKNPVIFITTRRQGLYFKKLKFLNVQKCIVFPHLISIISKNLTTPLPFFRAKK
HMSEIVLKLVRMINTRHFDKNFNQIDFSKIKNLLPYDARLSDNFFKQIDTKYEKIIGINA
FSNNSEYRGFNFFIKDWIGLARQLSLKYPKFLFILLNFSTNSIQYNIDQNANLKVFCNNK
ILLLW
>fig|195.2121.peg.1712 hypothetical protein
SMEQGPSNEGEFNPDMSVYPQNEDGSYSKEALFMSFLKSYGSGQPVESPKTTLNPKVEAY
NRAMAKESFNGDSVALNDIMTGKVDFASLLKGYAQDGWLDADIYAMEKGVAWQNTSIGYG
GAWFDNQFNQAKANGWKASSESINSYVGSIMDRLNNLIGQTRV
>fig|195.2121.peg.660 hypothetical protein
MISDFILLNGKIPKKQFDSLLKFYTLIKKEFCFGKITLVGHSLGGHLAQLFVLDFALEVQ
NIYTFQAPGIAKKILKDIKNEAYIQKISYHFHTCGDFKKMHGINLILFKICILK
>fig|195.2121.peg.376 Methyl-accepting chemotaxis signal transduction protein
MNINLLKQNANEMYTQSEQVEKISINSNAHIMSFSEKFTHLVNEAHSTNSNAVGIASEAF
VSLAKLDHIAFKLNGYKEIFAKSGQELADHTSCRLGKWVASTGKERFGDSKSFIKINEPH
QKVHENMNSAIRIANTEDVSLSNTQDAIIKKCENAENASLHLFDVFKEMLNEAN
>fig|195.2121.peg.150 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLLIANPPYSVKGFLETLSD
KSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIILPSSILNKDSIYKNTREI
LFQNFDFIAIVELGNQTFGATGTNTIILFLRKKETFKQENHLISQDYSLIKERIEAENLK
DNENFYQNYLSAYCDFRKFDKELYSNFLNGNLDFNLAELEAFKDYRNAFRQTSDYKKLKE
SKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLIIKSPSDIKEQKKFLGYE
WSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLIYKSFLNTLDVIPQELQTYATKAR
LVDMIDFEKVEFNKAISLNPKTQREEIKSQYPLVKLKICGDFFMGGTPSRKNINYWNGDI
KWLTISDYSNHQVIMDTKEKITREGFKNSNAKMIQKGAVVVSIYATIGRVGILGEDMTTN
QAIVAIIPNEEFINKYLMYAIDYFKFQLYNEVITTSQQNINLGILQNMVIPKPPLEIQKQ
IVAECEKIEEQYNTLSLSIEEYQKLIKAILQKCGIIEDDQEYKLNSILENLQKLESKLDF
NLLFSFIDDFTNARQEDLKKFKEFVKNIKAILGTFSTPPKQGWNKEKLNEIVSIQSGGTP
DRKVKEYWNGNINWVKSEVCQNCYIYDYQVKEKITELGLQKSSAKLLKKETTLIALVGAT
IGKIGFLTFESATNQNITGLYPKNLKILNTKYLYYACMGLYGQFRKLGDFAMANSNFIKN
LTISLPPLEIQEKIVQNIELVEQQIDFLNLKLEFLEKEKEKILQKYLFS
>fig|195.2121.peg.1719 Motility accessory factor
VSHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLL
KKYASKATIFCADSSYPILAKHGIKPDYVC
>fig|195.2121.peg.106 hypothetical protein
MNVNENLNLQGSAFVYDLNNKAHFSLLGADGINPSLLYIKNNFTQDSNTILTAGINANGQ
SLVYVGGNANLAGAFNFYMLKDFYKDKVVLDPDLISANQIQDAFNSIVYDSSLDFSPTLN
FIYDANTKELGVVRDYTPYIKNSSDISLAYALNSLAQNGKYEDIALLFKELDFATDAQTI
AQGLNELNAKAYLDSAKISLDFQEELNKEALSEYANEWQSFVTPFGTYQSSRANGDFDAY
KGYGGGVKAKLLRDLIVSI
>fig|195.2121.peg.639 4-carboxymuconolactone decarboxylase (EC 4.1.1.44)
MQLRQKAREIFEKLLGAKKDQLFASDKEYFINHINFTFDESFIKANLDTQKYFLITLAST
LAVGGKIEFKALLQGAIKNDISPIVIKEVIYQATPYVGFARVCDFLSLCNKVFKKLNIAL
VLTPQGTTTQENRKIKGREIQNAIFGEANITKMIESTPEDKAFINDFLSANCFGDYYTRM
GLDLKTRELLTLVYLISLGGLDNQVKAHIQGNLNMGQSRKDLLNVIAALIPYIGYPKALN
AIAVLDSLTL
>fig|195.2121.peg.929 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MLETSTEYSQGFGQVGYGDTAFKRWNMEVGVTGIVKYNNLLDSKQASIQAGKDININTQS
QDNARQINNSGKILAQGNIVSFGNIDNKSLSKEISVGEILEQIRVNGFFAKEYLGSWNTN
STYYFVDHESLLDALKYFSTTQAKNHQRESAWNALKDAAAKNSALNQYFSLLFGSDYASK
RFVPD
>fig|195.2121.peg.638 hypothetical protein
MFYNTKKGGKIQELEKAGIHGSFKGDSKFFSKNVKVSMMFKSNEWRNFSGALVEFEASAR
SAWHTHPQGQTLIVTEGEIITKVPGQKAFIAKKGDVISCPIGVKHFHGATNTSSGAHIAL
TGEKEGKNVEWLELVSDEEYENALKEARE
>fig|195.2121.peg.840 hypothetical protein
MENLTEEQKKLFYKFIENIKDENSLKQLEQFLDLIENNAIQNSLKDIAEFNSVYKGNGNN
EEMSIKEMVEDIKISQKDIDEIYWKIFDVRSEGENEKNKSSALIEIEKAKEYANKMQNDY
MKFYDKKDSQGNITEEGIISKLKQACNDIETNKDKIEEFEEFYNKIFIGVEADENGKGGR
LSLEKYLDEKQTEIKKLISSKKQDLESCLSDYKDKFENLYKEKNDKIDKLLPGATSVGLS
KSYKNQKEEIDKSLMKWNWVFWISISIFIGGAIFYFYHSFDEKFDYVSIFRYFPFWIFSG
FFIFYSTKQIAEYKRLRNEYAYKEALNDTYVGYERAVEKSDNKILKDKLLEIMLKAAEFN
PSSTLGKSKGEHPFKSMMEKTKQKANIDESEEW
>fig|195.2121.peg.635 Transcriptional regulator
MYVRRQGTWAYYGINNKLLKLHLDLFENIKNLELKNAIKKNENIITQICP
>fig|195.2121.peg.1604 putative TonB-dependent receptor
MKSGMIFGLVSSLILHALVLMFFLFSFYTQEKSSGVDFKQGLEFTSIMMVSELPIGELKE
VSIDQKKSNSQDKNKKQDEKMSLNSQDKNKKQDEKMSLNSQDKNAVLKAQKKIEKQDENQ
AQKEIANASENSKFKNESLSAPLQSNEDKTQTIISGNAKEQIKSYQALLMAHLAKFKKYP
QEAIMQKQEGVVRIRVSIDESGNVLSKELKKSCPYAVLNDEVLSLFKRASPLPKPPKEML
KDGEKISFVMPIDYNIKDYLGKK
>fig|195.2121.peg.1711 hypothetical protein
MSIFSINDNSNYNSILSQAKASKESKENSKISFANAFLKQNASKLNEIQNANSQTLARSE
VLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQVDLSTDTAYGYSVDKD
GYMGSDFNKAAGLPEDFKIHKSTLDEIERFNQHNMASETSGNYYDSFDMASIVKSHYNSF
NQVISTFPNDKTSFSEADLEQLPKGLNDGCNQNKEYIVTHIF
>fig|195.2121.peg.637 Putative transporter
MKNLNKASNAQIILVFCLGVFGILSTELGMMGIIPIVSQNFSVSISDAGWCVSIFALVIT
FCAPIVPLLCANFNPKKLMLICLAVFILSSLTSAFVGEFWQLLILRYSLLWIRVLCVICI
NAGIWGFYSYFSDFLHSAGKMNFTLISIVLAIYGFSNIIGNYIAGKTLVKNANFTLILTP
LIMIGFYILLFSFYSEIILIIFAFILGILAGVMNNGTHFMISYPFPKAANFSNGLFISVA
NIGLSTGTAICGLVISLSDTRYIIVNTIVLLILGIIMIFVRSRIEKMKLRF
>fig|195.2121.peg.1724 Motility accessory factor
QDKTHFITAYIKAYHEWLLYFMEKLEQRINIIINSFKES
>fig|195.2121.peg.659 hypothetical protein
MFKVLTHNIFQKECVIIGKFEPLMAFYFIKRFDLLAHINKIILIQGVGLEQVYFKTRKIK
NLF
>fig|195.2121.peg.176 Inner membrane protein YihN
MNLSNTQIGLALSVYGIVQTVGNFASIYIADRFSKKILIPFSLICVGLVGIYISTFPSFY
GILIAWGLLSLFGEVVYWPVLLKAIRLLGDLLNKEDFLDF
>fig|195.2121.peg.752 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKRNPKLFFKDAIEKRFLSLNNTYKKYLPKKNKAFTQYTIISAVYNVEK
YLDDYFKSIINQRLDFKKNIFIILVDDGSTDNSAQIIKTYQKKYPKNIIYLYKENGGQAS
ARNLGLKYMQENDYQTPWVTFTDPDDFLDRNYFYEVDQFLATHKDNNICMISTKTVFYNH
EKQASYEHPMKDLKWHSNCIVNNKNFLYQMPAAPTTLFLYKEIQKYNIRFKEGEHSRYGF
EDVEFSLLYFLYSFYNSTLFLKSSIYFYRKNHGANTTFKALQHKEYYIGTQSRIMQLYRL
FSRIEKSLDYYKNIILYYSFFPIKSLINSPEKLSFMGENEKQRYLELLDQNFSYIDKNTI
VNFYRIPGFNFFYQVGILNCFKNEKPPFQIVYIEDYDPYKEQILLTYYTGDNEDIESILV
DREEVYADYEKIVKYDFLDRVFCYQKRLWVHIPKSAKDKLENFIDGKQSRISFNGKHYQS
IKIQDIRKEFQKRLPKSNIWILIDRDYEADDNAEHLCRYIMQNHPEQEVVFALRKESSDW
ERLEKEGFNLVKFGSLEFERIIKKASKIISSHSDEYLMRYITSRQQFIFLQHGITIFSDV
SAFFNRFKSRLIVMCSPIEHLNIISDYTRYNLTEKEGLLTGFARHDALLKNNRFNIKQIL
VMPTWRKYIVGDVISGKGVREHNDEFLLTEYFKQWNDFLCNKEFEQLAKAYSYKVIFCPH
FLIRDYIEYYNLPDYIQIYSREDGETLQKILQDTSLLITDYSTISCELAVAQKPTIYFQF
DEQDNLVGRHHKRAQGISYHTHGFGPVAYTIDELIKQIKHYFISEKVDKKFYLNIENSFY
RSKNSCMNIYKAILDTSSDYISIVNWKKLMKKARLAQDKQLYLIAYFRWQYIIENYSQNE
KDIFNYIYCARKSNRDLEIINFFEKNHHLMISKKNMLELLKSGIKTNNKQFITSILSKID
LNTNLETMILKLKLQYFIEDCSYLVTRQTLINELGISKCYIDYQIQMFNVGLIKYMCFKD
ESIWEHFRIFGEL
>fig|195.2121.peg.151 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNENNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYEILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADAYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLHEMLSKNSKALRVIDYACGETPMPMSLSVI
>fig|195.2121.peg.107 hypothetical protein
MGQCFNGFLNSFSDHLYDLNGVKAQIGMRIVKTQAEVEEAKLKGETVFLVKDDGVYINGS
FSNASGNVYFKGENVAEVIKNAKLGYDGVNGIPINAWEGIILDMSHIELDNSLMSHQSWR
NYNFYMEAELALLQDIGYNFDRKLYYGDSIYESNLLNWQSDHGYYARKDGKWLIGEYNPT
EYGVGLHIYGKNNIATQSHDILSSGVAASGIRIDGSNNQLIIANDTKVHTLGDYSNALLI
AYGKDHVIEHNGELKATGKEGIAINIDFGDNTLGNAEEYRGSYIHQMSGNNQDDLAEYNL
DGALVKSLNLNASSSTIGSLASIYI
>fig|195.2121.peg.1454 hypothetical protein
MSIFSINDNSNYNSILSQAKAS
>fig|195.2121.peg.1721 Motility accessory factor
DFTDLAMKFFQNKENKTSLNVLSCATHPNVVHSLKAENCVIILRNKALYQRFNLNDFGYI
GTGTHVSHFSYTLA
>fig|195.2121.peg.636 Arsenical resistance operon repressor
MQKFLTIISAINDESRILILHHLLRYKELCVCDLQELLNMGQSRLSRHLKILKDAGFCM
>fig|195.2121.peg.167 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKISEEDLHFILESGILAPSSHGFEPWKFIILDKKEDNQKLA
KLCFDQASVASASHNIILLARKDLQSKDEFAQKQIRVLQAPRKKIFKEF
>fig|195.2121.peg.338 Cytochrome C553 (soluble cytochrome f)
MSWRKWRKIAPGSKGNIKIGGLNKAYLIKQLQGYAAGKADNGGAKVIMYANMKNWKFTTS
DIEAVSAYIAQLPKAK
>fig|195.2121.peg.377 Putative MCP-type signal transduction protein
MFGSKINHTELQDIKNENQNLTQQLEKIKAENLELKDKISLLEQEALESKLKTDLLNVLL
GGVLKNITIVQSDMLENVNKAEIISNYSKTSLAEMDELNHIANSINASLGDITESANKHA
MLQELYIVALMRLQM
>fig|195.2121.peg.641 aminoglycoside 6-adenylyltransferase
MQSEKRILEKIKNIAFIYKQIRLITLEGSRVNKKAKKDKYQDYDISFFLKSKNLRKLLNL
NKSKDIKKAKLPKFIKNFGKILFYQAPESFEFYKADLPKNWVSFLVIFKNGMRVDFKFIP
LKSLKHYYKFEPLSKALIDKDQRFKKTQNENVFCIKKPTEKDFDEICNEFYFTFTKLEKA
LLRKQFIMSNYLLNSMRETLFDMLSFKVGLKFGFEIWLGKQNTDILNFLKQKEIKIILNS
FNTTSLEQIEKTRKKLENLFHKNTKFVAKKNDFKLFSYRKNVKKYCKILRKL
>fig|195.2121.peg.105 hypothetical protein
MLNTNNIDIDDTLANTKTTGAYAGIFSKYDLEDFYLLGSFRMGYEQHQA
>fig|195.2121.peg.932 Channel-forming transporter/cytolysins activator of TpsB family
MKFLKIIFLLMSFICLLQADDSAKTLNLLDKRQQQLHIQIKKNDTLTMQANNILKNTLIS
L
>fig|195.2121.peg.890 hypothetical protein
MKKIFLFLTILSFMWAQDDVIIYDYVPLEDVNLSSLDPVQSLKTLPHQRNKFQKVVQGNG
TGESKEEALNNALIDALSQFKGVSNVNLRQELQSIDLSFSHLGQISQKSKSVLQNVSKGY
IDTYKVDKIDQNGTLWQVEISAFKSLYQNDNKPKLVILNDKNKEESYLKRALYDAFSQDE
NFTLLEREHDFKDENKIIKSEDGSREESYKLGNVLGADYILEFEILDITQAKQSKLSK
>fig|195.2121.peg.987 FIG00471746: hypothetical protein
MAYKVDNDLEFLRELNDESLDNLVSILIKDENGKTRTTESLTNKDLYKKH
>fig|195.2122.peg.1747 Phosphoglycerate transporter protein PgtP
MPPAIGAMVIIFFMIIGYFTSNNLYMVTFFAAMAG
>fig|195.2122.peg.666 Integral membrane protein
MKRNTCEIELEIPNSGIFTISLENENLIISLDLAKFEYKKKLNAGGLAKPLHPYIIYEVL
EKNNKNTFNDVKIIDKIEDENNIIYHFNFGLILNTFIGENKDNKDKEALKALSFMQNFIP
ACFFSYQIIGDSKAIPKNVLEDLKNRYGYEGKNYKSIFKKEVYINCNCLERLNFSHCEFE
SKVSLRFLKDNKYKEFHNGVNFSNCIFKNEVDFSYFVSGAPLPNNKYYNNAQNTLFKDCI
FENKVDFHNSKITNNIYFNNAHFKDYVDFHECEFEKTASFYGVRFDKAPNFSACYFKEPK
AVNLINVDIDKLDFKSLEQYIKDKYQDETYENKQELTEEQRNNNCKLKCAKHLKDSFRVI
KDVLITQNNTLEAQEWHKLELYAKEKENHINLNVKEREKNTDIFKNILIWFNCVLLNVYR
NTSDHHNDFLKILNFTIGMIALYGVFFYLLLEVYMYLDIIFIESFFRFKIIDYIYLCLFV
FLTIIMFLYKNKKSIFTKSILFLTIYITFYIVYIKILNFINITYFREWFFYLLCYIIGIY
IFYLAFIFISKFKFINFILKLCIYLAFLSIWILSSNFINPFTGVFSSDKLYESQFEKSLN
DLNTSAIINLASILQNDFNLHLKDQNISFTELNSAKASIIANKENLLKLNDVNSNIAKEV
LGEKYTELLKTINQDKIIENIIKSTSVLYGIILLLCIFSLQKTARKNSIVPS
>fig|195.2122.peg.1638 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
NPGVAKDMIFLPFHFTGVMQGVDLTHNFPEGTKPYASGESANTVTNYGYDIMCQIPETKG
GLCRISKDGV
>fig|195.2122.peg.710 Uncharacterized protein YgeA of aspartate/glutamate/hydantoin racemase family
MKTIGIIGGMSFESTITYYKTINETINNQLGNLNSAKILLYSVNFEEIANLQKKWRVGKS
CANFRRMC
>fig|195.2122.peg.756 Hemolysin, putative
MLGDIASEGQININAGNEINLQSSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKGEI
KANNVVNIDSVNDLNIKNSDISTSANDSKIVLISQKGDVNIKNDYSKSSSFEQINTDSQK
SNTTTSIDGVLSTNIKGANVGIVSNQDVNIIASNINADSKIDINANNVNIKDAHELSKTK
TDGVY
>fig|195.2122.peg.287 Beta-1,4-galactosyltransferase
MEFSDEFLNNGEEYIEELSKSEYEYVRFCYLFDKKFYPLNENYILSFEKLAGTQGYVLKP
SAAKKFIKYAKRWIYPVDDYMDMFYKHKVLNIVKKPLLLKHDCKLESEISNLGRTNKKLK
IHRKIAREIFRLYRDISRLLYIFYIKKKLNLK
>fig|195.2122.peg.1557 hypothetical protein
AWLGTLIGVSETIASGITLGISLGLAIGSLTGNKTFSILNAVWGLVNFLGAWGANNWNLA
ADFTKNTAQIAQEMTTFESTLNIAGNLLSGASKIFDVVQSITANTPDMINEQKGSDLDNN
EGGNGSEALELAKDMINPTIWYNFETTDILNEKIEKNRNLIFAF
>fig|195.2122.peg.906 hypothetical protein
MSKLISFALSFFSGDKKLYIALGLSLILLGYFYLRLDSTKAKLEKSQSDLALALEINRNN
EAKLKELTQIHKAELKAINEANNQKNEVQKKVQYVKEYIYKSNENNLTKLFNNVVDRLWD
DNSTSSNQNRNSKS
>fig|195.2122.peg.440 hypothetical protein
MSNIDINIQQCLENWNFYMLEKIYDLNIENDTLAKEYVLYLSYTGQYRKILQNYKLKKYF
ENLFSDLYRSEVDKLIKTNDGLINIEEYSSVSRESIGCYLLLNAINNFKHTPEQVLDIFK
NYLVVDDIKISSYKIPKQSYEALLSKKFFIAKSIDYFEIFKDNIFFMKATVILSIIQWLF
PKENGSKKYYLRFSNRMKNGISKSEISTSKNVKVAVCISGAMRGDYLKPIDQIVDNIVKP
LNADVFVFSWSEHLKWPGICGGSNWVHRLLSQDFNLIAPNEIRNNHLFKQLFQHTYNKLD
REISDVLEIQDLKKIYNCKKVVLENQKAFVEQTGLKEHSYTATKLYYGCFRVFELMEEYE
KENNIKYDYVIRIRPDCNFAEVINIEDLLRLEVNEIYIAHHLHMNGRVSDSFSCGKREAM
EKLLLMWKRAEFNKQMQEFVSYPKKFDIETHMLLLRWLIVNNLVANTAFPYPLLGGSSTI
IKDFPDITEELKKDILTIRESNMYKEEKLQSFISFFTKVQKKYNIIKSKSHYNFVYPNSA
KIRIQNQLSYKLGQAMIVNSKSILGYIRMPFVLSYIYDKHKQEQKIYQEKIKKDSSLILP
PLESYPDYKEALKEKECFTYKLGQELIKANKNWYGGGYIKLLLEIRKLKREYNKKRIQDD
IFTSSK
>fig|195.2122.peg.1027 Flagellar hook-associated protein FlgL
GNSYDVTINLQTSTVSYPDPNNPGQTISFPIMHTNPATGNSGVVTGSNDITYGQINDIIG
MFAADKIPTTTIQANNGQINNADYTQIQQLMKDSQATVDVSMDYKGRISVTDKLSSGTNI
EISLSDSQSGQFPAPPFTTTSTVQNGPNFSFSANNSLTIDEPNVDIIKDLDSMIDAVLKG
NMRADSESENPRNTGMQGALERLDHLADHVSKLNTTMGAYHNTIEGVNTRTSFLSVNVQS
IKSNVIDVDYGEAMMNLMQTQLAYQASLKASTTISQLSLLNYM
>fig|195.2122.peg.1452 hypothetical protein
MLNYHLYFISHKTYIFHKHKKMNPQSLILRQALAKQYKFLKDFNP
>fig|195.2122.peg.918 hypothetical protein
MILGTSELKKISKSITSLNESNIRGASIDLSIGDKAKIKKDDRVIDLFKLDCDDNLCDDI
YQEIDLAKGYELKPKEYLYSSSVEKITIPKNMCGIILPRSSFARIGLILPMSSYANPGYT
GNLPIVIFNASNSIVKIPPYIRIMQLLFCEIKGEAIEYKLQEDSKYYNESSLKNPQFNDS
DIKAILEKVRRK
>fig|195.2122.peg.1694 hypothetical protein
MLTKLYLAKELLRRFKNLIIFIFLLLPNLAFGLENSNGVLDLLQNGLESWIPLIKTACLW
VFWTLVVIDLVWTFGLKALSGFEFGDFLATLIKKIMYIGIFLFLFNTDQWLQILFNSFSQ
LATGVSNGIKITPSNIVTSGVEILLSIWEAAGLNLAKTLFLLICGLIILIGFLLMAIDLL
IVYLKFFLMNVIVFFALALGGLNHFKQIGLNPIMTAIKIGIELLMIQGLMALAINITNSA
FKEIAQNLTIDLTLQILVIALIFCMIAKMVPGIIEAVFNGSIGESAGAAAGFRAVATMAA
GAAAGAAAGAVGITRAMNAAKALHLAEGGKGGMDLVKGVAKNLAIAGGEHLRDNLTKGRM
PNQMANRLQEKLKDIQGKTSEGGISSGSPKEESYQSGINPNITK
>fig|195.2122.peg.1558 Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase (EC 5.3.1.16)
MIIPALDLIDGQVVRLVKGDYEQKKVYKYDPLEKFREYENAGATWLHLVDLSGAKDPNKR
QLALIEKLTNEVSVNLQVGGGIRTKEEIQALLDCGVKRVVIGSLAITNPTLCVEILQHFG
SEAIVLALDTILKEDYMIAINAWQDTSDKRLLEVLEFYNIKGLKHILCTDISRDGTMQGS
NAELYALIHK
>fig|195.2122.peg.917 hypothetical protein
MKKSEENEVILLLNGILQDIQKKNEHLTPTINDVYDFCNNILKPNIIERNNENSEIITKN
LKSLTSKEIDRNGFLINIIKTMIIPNLK
>fig|195.2122.peg.1158 Probable lipoprotein Cj0818-related protein
MKKVAFFLLFLFLSCTVLNAAREYCKYAYQEDRAMPLILNYGIRLGVVGAGVANVPAPGG
STYNSKIDMMAARCPPSLVFGCILQC
>fig|195.2122.peg.665 Putative type IIS restriction /modification enzyme, N-terminal half
MSYITSNKYTRAGYGEALREFLLKNVKFLEYTDLNGIKVFDSATVDTSILCFEKSKSKDN
KFKYLALSNEILKTCAYNIGLYKDFAEFSQNSLSKESFTFSDENTSALKAKIERIGTPLK
EWQGLNIYRGILTGYNEAFIITTEKRNEILANCKDEAEKERTAKLIRKMLRGRDIKRYSY
EWAGLWVIFIPWHFPNVEKPKTMLENEQDLKEQYPSLYKHLLSHKERLSKRNKEETGIRY
EWYCLQRWGANYYQEFEREKIVWASVGYIEHSFIPKDMLLQDTNYFFSTSNRYLLGILNS
KPITYYLADIQTPLGNTGAFRNYKYNIEKLPIPKINSKNQNIVDELINLVDEILKAKEQD
KNANTQELENKINSLVYKLYNLNEEEIKIIEGK
>fig|195.2122.peg.960 Pentapeptide repeat family protein
MGILKRLDETIIIEDDRQSEKELVEYCILEGISLNNANLENINLSELDFNNAFINGASFK
NANLNDISSKNASFIDCDFSGASFHFCNFLRTEFENCIFENVSLRDCIGDMKNIFSIVVD
TYVVTFTKTMMNLGCNTKTIKEWRNLSVDDLEDEEQKWLWNYYKDTIFEIIDKRLGVEND
>fig|195.2122.peg.1805 Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase (EC 5.3.1.16)
ILCTDISRDGTMQGSNAELYALIHKNFPKIHTQASGGVASLKDLKKLKGICSGVIVGKAL
LDGVFSVEEGIKCLQNA
>fig|195.2122.peg.1512 Branched-chain amino acid ABC transporter, permease protein LivH (TC 3.A.1.4.1)
FPAPPIFETLVSIGGVSTTLGSLLVPLVTLVVMLGVLFILYKSKYGIAIRALAFDIQTVN
LMGINANRIIAIVFALGSALAALAGIFWSSNYYSAYPTMGTLVGLKAFAAAVLGGIGSVV
GAVLGGLIIGLTEVMAVAFFPELSGFKDAFAFIFLVFILLFRPTGILGINFEKSRF
>fig|195.2122.peg.958 hypothetical phage protein, putative
MKLKDFDFRIWNNNSKTYEAGSIIESLGFITSVFNQSTYEKPTIDYEIELWTGFYDKNGK
KIYEGDILYYFKDCSEGEVFKYQVLFKEGAFYLFESYDGFVDDEDLIAEFDLKELQVMGN
IHENKELLNVRL
>fig|195.2122.peg.709 Aspartate racemase (EC 5.1.1.13)
MHKIFDQIQKNIKIPLIHIAQSTAKILKQQNIHTIGLLGTQYTMMEDFYKNALKKENINT
ITPNQSDMQELSDIIFNELCKGQMKENSKEKYLKIIQKLKDEGAQGIVLGCTEIGLLISQ
EDTNIPIFDTALIHALDAVNLALKD
>fig|195.2122.peg.755 Hemolysin, putative
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGGRY
>fig|195.2122.peg.1825 Arsenical-resistance protein ACR3
IFLKDEPLYMQGVIIIGLARCIAMVVVWSDLAKGDREYTSALVAMNSIFQILFFSTLAYI
YLDFLPKLLGQSTLATSLDIDFSALSKNVLIYLGIPFLMGFITRTLLLKYKSKRWYENTF
LPKISPITLITLLATIIIMCSYKANEVFHLPLEALKIAFVLTLYFIFMFFLTWFISKKNH
LSYPKTCSLCFSASGNNFELAIIICIATFGLHSEQAFASIIGPLVEVPVLILLVKWALGK
SLNSKK
>fig|195.2122.peg.907 hypothetical protein
MKIKIIRRYVGKTCVIGKFKVFNDDDKLLFECFSLEEDKEGVERNKDLRIPEGIYNLERH
TGSSFNISGRKTVAGVKVLKDDDFVINVYNEEVPLDRRILIHWGNSHENTEGCILLGLTK
ANNNEYITSSRQACKEFYDLMYKKDLSEIKLEIVNELV
>fig|195.2122.peg.1157 Small hydrophobic protein
MPTKLSFWVYFTMLEFIFTLILDFTFYSIKTLEKVFLGRTALVILFVVFIALFCVKGLFL
YILLALELFLLLYLFLGILFLRFYKS
>fig|195.2122.peg.288 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQKQIQKLFEKNPNLKKQARIYFL
>fig|195.2122.peg.941 hypothetical protein
MRIILALFIYIYAFGIDVCKEKEIEMSIYINKYTNAYENKNLGYSEEKLYKKSFSDCYDK
KNKEACLYIYNNFAIDGNFKIESNIFNLITIMTYVGLTLDIDKDKKYKEINRLIALDSWK
KASELIDFVLSETNDTKTIEGLKLLKEMSDFEINRAYACPLYYNDKLQSDAIDMPCACKK
NTAFLLEPDTIRRAFLNLKLLCDKYKDSASCWGVGGLYENGKGVRINFKQAKKYYGLACD
GGYQLGCDGYKRLMGY
>fig|195.2122.peg.933 hypothetical protein
MHQIKKGLIKMDDKDLNLLKKHPLSYGKNQRVRKQDKTARTSCTT
>fig|195.2122.peg.1292 Branched-chain amino acid ABC transporter, permease protein LivH (TC 3.A.1.4.1)
MDSTLFLQQLVNGLSLGSMYALIAVGYTMVYGVLRLINFAHGDIMMVGAYIALLLINFFS
PIINHLNQTFFGSDELGKYLVVIFAAALVASMIFSSIVGILIDKIAYKPLRKAPRISLLI
TAIGISFFLQNLFNVIFTSTEQQFPAPPIFETLVSIGGVSTTLGSLLV
>fig|195.2122.peg.1814 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
MKRVVVTGIGMINALGLDKESSFKAICEGKSGVKKITLFDTTDFPVQIAAEIENFDPLEV
VDGKEVKKIDRFIQLGIKAAREAMQDANFDQNLDKEEFGVVSAAGIGGLPNIEKNSVICS
ERGPRKISPFFIPSALVNMLGGLISIEHGLKGPNISCVTACAAGTHAIGEAYKSIALGNA
NKMLVIGAEAAICPVGIGGFASMKALSTRNDDPAHASRPFDKERDGFVMGEGA
>fig|195.2122.peg.904 hypothetical protein
MLIDEKRLMKNYTLKPAYPSNIGKLDTGEVYKQWFTYAMIGVNKYVELLHKQLIRKGRSY
SQNATHPLYPNSYIVKKYNIKSASTAPYDKHSHGNLGLNQFFVGQDPYKPYKGDPSSKNG
IYHDICEIRTKYNLGNMQYYYGFPNNLTLLFEKEKAWKYHGKGFFYIDEKINFKDILNKA
LENINYEMLINDIEVVIFCQTIQKNNEWIYPSIDDIKIPNIKVENIEFKPLFGKPYKKPC
VDVEKFYNDFKELNKNIFRIEKVEITYKIYEKAQKTRESDSGKTYYALTSKKVSFFEVFN
SIKEIYKCKYALPLCFYNSFNFVCYEEPYVAFSSLNNASWGKKDTSVTPSIYPLYRKSSN
LPYGRRDRWFALWDSFYYLYVYEKSSKGILSFLAPIVTIVLAVATWWIGGQ
>fig|195.2122.peg.1818 Flagellar hook-associated protein FlgL
MRITNKLNFTNSISTSMGAQSSLYQISQQLSSGIKIQNSYEDASVYIDNTRLEYELKTLE
QVKQATNSAKEMTQNSMKALQDMVKLLEDFKVKVTQAASDSNSQTSREAIAKELERIKES
IVQLANTSVNGQYLFAGSQVANKPFDSNGNYYGDKNNINVVTGAGTESPYNIPGWDLFFK
ADGDYKKQISTNVSFTDNRWDLNKDPDKTKYLTGDSKWQQLIGQSYVKDNSLDADKDFEY
DDSKLDFPPTTLYVQGTRPDGTSFKSAVLVKPEDTLEDVMENIGALYGNTPNNKVVEVSM
NDSGQIQITDLKQGNNKLDFHVVAFTPQADDKTELNNIIQAAQDEGITMEDVTNRVMTAA
LGNPNNGDITNLNNPVTIQINGQNFEIDLKQTDFIKSKMTDTDGNAANGADYDNVYFEKN
GNTVYGNVSQVIKGSNAYATDSTKLSEVMAGDSLNGTTLNLKVNSKGGNSYDVTINLQTS
TVSYPDPNNPGQ
>fig|195.2123.peg.1683 Integral membrane protein
MGEFDKEQAIADIAENLGISKEYVNFDENKKIYIIKDNNNLKKIHIKNFNYKLYERYNLS
FTKCIFECEIKDTRGLSSDIENGIFFLKCEFENKILFFNLYFKNISFILCNFKNNTTFQA
CTFKTFCNFESSVFENFVSFDKSMFLDKVSFYNTHFHKVPNFSQAIFNENLNIVNTKLNF
TFSNLEEKIEQECEEFNKNKKEEDQKSLDKFANDFRDSFRIFKNALIKDNNLLDASNFHK
YELYCKEIELKNKKGKTFKDVVDRWQLIFYCKLCDHHTDILQSLNSLILVIGIFVISSVA
MVFGFNYSLGYKPILEHWYFSLDFYNHHINSIIQDDYLLMIFVNLMILFIYLGLVGFALC
LKYMREFFIIISYVITLLVLAVSPKILIPAMGIFTDKRAMLDPLSVFGGIYTIIFGFVAF
SFIKTIRKNSIVPS
>fig|195.2123.peg.1682 Putative integral membrane protein
MEEFDKKLEQYGILTKNAQKSIEKDRVKIFNNAIIETINFKTLQEKGIKELHIKKSEIYN
IVFSKKKKMI
>fig|195.2123.peg.825 Type I restriction-modification system, specificity subunit S
MKIKIWKINKLEKICEILDNKRVPISQKDRISGIYPYYGASGIVDYIDKYIFDEELVLIG
EDGAKWDAFENSAFIASGKYWVNNHAHILKPNNEILINKFLVYFLNYSNLEKYITGATVK
KLNQQKLKQIEIPLPPLKE
>fig|195.2123.peg.1681 Integral membrane protein
MKQINAEKLLFKNKFNFIKCIFHEKIDFSYSFFSTTCIEENVSFKECTFKFNVFFNETRF
ETHVNFEESTFEKQVIFNNAFFLNQETEINYIEVSFLGAIFKDRAYFYNITFKSMIDFSY
AIFENEVRFCNTYFESVVHFSFTKFKGVCDFSNTKFLATQKKEERNRICFDDTEFEDIVH
FYSAKFESKVLFCKSVFKSKVNFNGAEFSTSHYDDAEINNFDNVTFESDAWFDDIIFNSS
VLFSKCEYKGNIYMRNITSKQQLYFYESLFLSNVYFNNSHFKDYVSFCECEFEKTACFYG
VKFDKTPNFSQAIFKGNLNVVNTNLNFTFDDLQERIKQEYEDFNKNIENKKPLDKFANDF
RDSFRIFKSALIKDNNLLDASNFHKYELYCKEIELKNKKGKTFKDVVDRWQLLFYRKLCD
HHTNLILNLKWFIVIVGFFTSILFGLRYGDGNLMQFFNKDSDLLKMLKNILNIKALNDSN
ATYLILLYSFIGLFFVRTFFIFYYLVIFILMLAISPYNLFTMINFAIRHETNSFLENIII
IIYTLSIVLIIFSLQKTARKNSIVPS
>fig|195.2123.peg.1684 Putative type IIS restriction /modification enzyme, N-terminal half
MHFTLLNEKDFFNPYYRKKQIMQNEFDIFNKALMQYLERLESSQSENEDYLVANALSPFL
TMLNFKTHIKTKQKGKSEIDLSISKDEFSKDLEVLIEAKKPNSKEFITHTKVNSKALHET
ILYYFRNREYSFSLKFIIITDFYKFYIFKISEFEELFYKNPSFKKLFEEFCNPNSLFKGN
TEEFYKEVAKLIENSKENLKGFLIDLTFLKDKQKSNFKNLASIYKTFHRDFLLNEFNPND
ANSLNNAFYKELLYILGLCESKQNSKLIIAKSEESKEEQGTFYTAINSKLKEENFETILK
LLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEVLAKEKSTRKKS
EFAYLPYLNSSLFEKQSIENTLEISSLSNDLKLFYYKNTVLKDDKCKAKKGQVGLLEYLF
EFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSFITSYMCKESIT
KVVLDKFNAQFDLDAKDISELRRSLRKEDKKAQKELLNSIKICDPAVGSGHFLVSALNVM
LSIYDELNLFDEEFYLEVQNDEILITGRKGEFIEYKRPKTPKDKAHLIQQELFHTKKDII
ENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDETYHDLKTLPNIDINIKCGNSLVS
YFETGKSLNHYPNIKERMGKYKRIVKDYKEGFYTDKSRINQEIKNLKISFKNFCFADKFK
KEMKGFNDKCEKYSKKYGNFLAVDDENLKFFVSANLTLFDFDEKEATKEFANLKKEYDNI
FNLESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIRQEELKELKPHLAKNYKVYKGT
SDIYTYFYELGFNVLKDRGGVLSYITSNKYTRAGYGEALREFLLKNVKFLEYTDLNGIKV
FDSATVDTSILCFEKSKSKDNKFKYLALSNEILKTCAYDIGLYKDFAEFSQNSLSKESFT
FSDENTSALKAKIERIGTPLKEWYGLNINYGIKTGYNEAFIITTEKRNEILANCKDEAEK
ERTAKLIRKMLRGRDIKRYSYEWAGLWVIGTFPSLKLDIEQYPALKQYLSQFLPRIEQSG
EKGCRKKTSNKWFETQDNIAYYEEFEKEKIVYPNMNKEFIAFFDNEFFLLNQKCFILSHQ
SNNKKELLYLTALLNSNVNFYYFKQIGAKLGASGYEMSKIFVEKLPIPKINSKNQKIADE
LINLADEILKAKEQDKNANTQELENKINSLVYKLYNLTEEEIKIIEGK
>fig|195.2123.peg.824 Type I restriction-modification system, specificity subunit S
MGILDESIKILEQNLLNLDELMQSALRKAFNPLNDDTKENYQLPQSWEWKSLEEISENIS
AGGDKPKNCTESKTAKNQIPVYANGVNNNGLVGYTDKATIIKPSLTISARGTIGFVCIRK
EPYFPIVRLISLIPCENILCLHYLYFCLNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKE
QEQIAKHLDFVFEKTKALKELYTKELKDYEELKQSLLNKAFKGEL
>fig|195.2124.peg.1831 Phage holin/antiholin component S
MKLEDVFVYIVLMIVSFIAGLVGIVTKNKLSQALNLKGKFA
>fig|195.2124.peg.1771 Phage tail sheath monomer GpFI
MAANYGVNFNISNGAASPIKVQSDTPIGIAGAIKGVSKEMIYTKAGYESVDSFPIFAFSN
VSKAKEFVNDLIKENNLQDFRLLDTLECINLQNVSNVIIISFFEESEESENTLTHIVNAI
EAFKKAKHKTGFSPDLIIAPYYSHEAGVKAKLESVASSMNITAIVDLYATNVGEAINTME
AFSSKRLIATWPQVQILNTQGKYAYVPQSPIIAGLIAHTDGDK
>fig|195.2124.peg.1797 FIG00469719: hypothetical protein
MTKTELKRVCVKPYDKDKFEVVEN
>fig|195.2124.peg.1463 Fucose permease
MLGRIVSTPLMKVIKGEKILGLYSLINVLICFGLYFTSGFLSTILLIALFFFMSISFPTI
FAVATKNLPLNQVKLGGSLLVMSIVGGAIMPLIIGFINDHYGTGMGYLAMAPLFLYVAWY
GFVGSKIKA
>fig|195.2124.peg.1825 hypothetical protein
MALVYVASPYKALVVRESQRKAQAISIAQQECLKIMRECEGFVPVSPILQFSYLDENKHR
DKALQMGLELLKAC
>fig|195.2124.peg.1462 Fucose permease
MTDSKNIKIAIVLVTSLFFLWGVSYGLIDVMNKNFQNHLHISQHESGFLQFAYFGAYFII
ALPAGYIANKYSYKMGIIFGLALYAVGALLIIPATNLASFHLFLFAFFVLACGIGSLETS
ANPYMVKLGDEKNASFRINAAQSFNGLGQFVGPIIGGALFLSITKQEEGASAEQIEAALL
ANMGNVQLVYVGIAAIVILILIAFVLNKLPEGSA
>fig|195.2124.peg.554 Predicted dehydrogenases and related proteins
MKVGIVGLGKMGQNHLNELSKNKNFKINALFDMVENKNLNAPFFINLDEFLNQDNDIIII
ATPTNSHLEIARKVFCKCKCVLIEKPLALNLNEIDEISNLAKSYGVKVGVGFCERFNPAV
LALKKELQNEEIISINIQRFSTYPQRISDVGILQDLAVHDLDLLHFLSAEKITNANILKS
FNKDNQREDESIITCKLEKTIACVHQSWNSTQRLRKITLVSKNHFYEANLADFSLSKDGQ
NLELMTQTPLFGEHMALYDLLLNKENYLANIQNAYAVVGGKIKCNHRKIK
>fig|195.2124.peg.1820 bacteriophage DNA transposition protein A, putative
QELISKNTLIYDEKMQKVKLSEIITTDNLKTINNSLKTSNLNLAEPKMNNDLAVLNLKFE
NLSDELKEDAKSKVKLLKQVEKYIEGGLSIARTLKIEKINRRFYERIRKAYKENGILGLI
DTRGLHRKDKTKLSAWMQEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDF
>fig|195.2124.peg.1786 Phage head, major capsid protein E
MDLEQLLELFSSTKVTEVINQTKASPHFVSDTFFKDRVPSLESTARVEIIKGAGIVLNSV
SENGEHSLEETRNSYILNIPLPRFALVKRISASEINSLRSLALREAQIKSLSGAMGVLIK
EMKESFTTTLEYMANGALFGKILDGKGNVLFDFGSASKKAISVKKDGSVTLASV
>fig|195.2124.peg.1821 Phage tail sheath monomer GpFI
NDLIKENNLQDFRLLDTLECINLQNVFNVIIISFFEESEESENTLTHIVNAIEAFKKAKH
KTGFSPDLIIAPYYSHEAGVKAKLESVASSMNITAIVDLYATNVGEAINTMEAFSSKRLI
ATWPQVQILNTQGKYAYVPQSPIIAGLIAHTDGDK
>fig|195.2124.peg.1721 Phage head, major capsid protein E
KDNSNRIYYTRANHTDALGKAPSLMFVSKPEILPRGAGIEIVGEMRAMPVCTRPNGLIKL
VLE
>fig|195.2124.peg.1259 formyl transferase domain protein
MTYSYIYIIGTGKVAKECQKIANDFFRQEVNFVKNIENLDDFFKNLKNCLIISANNFYIF
KKECIQKNTIINYHNALLPFHRGCNAHIWSIWENDKKKQVLLGIWLKKV
>fig|195.2124.peg.1829 FIG00471516: hypothetical protein
MALVYVASPYKALAVRESQRKAQAISIAQQECLKIMRECEGFVPVSP
>fig|195.2124.peg.1814 Phage baseplate assembly protein GpJ
MSELLSANDSYFKQSFLKDIPYPQIIEEQDYEKLLKAYEELFKSFLKDNVELLESDPFKA
ILEALAYREMIIRARINESIKATYLHYAKGSDLDNV
>fig|195.2124.peg.1830 hypothetical protein
QERKMKENNKMINQKSIAKDLFIALLFSSFALALLYVFEIFIRN
>fig|195.2124.peg.1153 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MECLIQKKILVSGFVLDNFLEISSFLEKNQIKRAKIEKKILHMLNTIVPSGELIHLAQGY
KIQKMYHCLLQDFDKEAKEKECFISDRNLIYIAEDWIQLDQNILFILFYESPVEVLKQKA
CLNDKFYINDILNSWLKYNTFLLDFYKKNRERSILINYKDFDVALCKYLNEKYYFNMVKI
YKENSSIKSKNLFDFLLEYMLNSNEKCLNCYKGLEGYSLNPNFNSNDLPFKNLESEIINL
FQILKISEILSIKNKSLLDFIFEMQEYIEKLYYQHGNCLKEITFKKSQTIETKNKTIQEN
LSQINNLNQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGC
LLMPVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYREAIKLKNHLSYKLGQSA
IKFCKNPLKLWSLPYEIFKIIKNK
>fig|195.2124.peg.1118 hypothetical protein
MRMMIFYSFSPFLNFFMVKFDGKEFIWINCFSPFLNFFMVKSIKSCNFNTLGFSPFLNFF
MVK
>fig|195.2124.peg.1698 bacteriophage DNA transposition protein A, putative
MSYFLETKEAAQAFNVSTGALRLAASRNSNKYEWLKVDNEKGGRGGKKLLFKISKDKLLT
AFNQELISKNTLIYDEKMQKVK
>fig|195.2125.peg.1640 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing) (EC 3.2.1.184)
MSKRKICIVSATRAEWYLLRNLCHEIQNDKDLSLQIIATGAHLSPEFGLTYKEIEKEFKI
TKKIPILLANDDKISLCKSMSLAFSAFSDAFEDLKPDMVVILGDRYEMLSVASVCLLMHI
PLVHLCGG
>fig|195.2125.peg.1458 C4-dicarboxylate anaerobic carrier, putative
MLVAFYLAQTNPLPKEQNTTKIAVSLNNKYLLFYKNYKFSKLFSAFLVKIS
>fig|195.2125.peg.1803 Phage protein Mup29, H
MKKEIKPKREVILKNNSLINTLINSSYLNVLK
>fig|195.2125.peg.1367 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISPYKNVP
>fig|195.2125.peg.1794 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MIAYIHIGVEKTGSTSIQEFLYHNKDNIFKQNYFFPQSIGLKNHWDLAFLAYSMDKKDSY
ILINSLKNLQDIREHKKNILSKLKAEIKHAENIVFTSELLQSRLDHKKEIIRLKKILYML
NVKKIFVIFYIRDPLDMFKSLCSEAIKWGEIDSFKLLKKGLQYESGFKKNLSHFNYICNY
KQIIQWWQQIFGKENLIVRLFDKSEFYQGDLLKDFVHS
>fig|195.2125.peg.1729 Signal transduction protein CetA, mediates an energy taxis response
GGGAQNFNLESVDPISNLCQDERAQGVINELSSETELNLAKEFIKDNAKKAIEESSQDYI
DQKAYDAIVNDIKSLEQRSAEILAKLKI
>fig|195.2125.peg.1762 host-nuclease inhibitor protein Gam, putative
MQINNLEDVNLALKKVAELSVKIEKINGEVTLACNEIKEARAGEIKVLSDELKYIEQCIT
TFCENNKHEFAEKRSKEFTFGKIGYRLSKSVSLPRVKEKLENLIKALKSYGLNDCITYKE
>fig|195.2125.peg.1356 DnaJ-class molecular chaperone CbpA
MNSLYETLGVSKNASADEIKKAYRRLARQYHPDINKEKGAEEKFKEINAAYEILSDEKKR
AQYDQYGDSMFGGQSFHDFSKNT
>fig|195.2125.peg.1790 hypothetical protein
IWSKNAKNPTQWALREFINNIIKKRPLHLWYLSVEDANKVILGLKNLENNSTH
>fig|195.2125.peg.1684 hypothetical protein
TKLINKKENTGTAASLDAQLRDELIALINKKENTGTAASLDAQLRDELIALINKKENIGV
AKQLVDALRSELTKEIESFIPELRVEKRIITANYDRKYKKMVSLSNIPSEVNMSTYLSKC
ANSGFPEFAPNYSIYQLKGEHLIYYLNDQYVASYAYQAISYAPSGSTNNNNY
>fig|195.2125.peg.1819 Phage virion morphogenesis protein Mup30, F
LADKNFNYNKNLGVEKLEKLYKEKISQISQNFIKLGALSLATKTKENAQSFQREKELYIW
QKSLDDMVDEVIIKENQKYPINFIQVGKIDKTTKEFLEKLNKKDLEDLYFTLSKNNLLHA
SPKR
>fig|195.2125.peg.1822 Flagellin
KNYNGIDDFQFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVETRGMAAVRAGATS
DDFAINGVKIGKVDYKDGDANGALVSAINSVKDTTGVEASI
>fig|195.2125.peg.1773 hypothetical protein
ILFYIILYYFILFYIIIIYYYILLYIIQMYDKTREWMMTAEDIKRIFENKLNERTKNQKV
IFTKNENERPHNGSSKEIAKFLASLKDDAIMKEVVENTSNQAISLVREYKNV
>fig|195.2125.peg.1301 Molybdopterin synthase catalytic subunit MoaE (EC 2.8.1.12)
MKHFTLYQGSLDIPKIYSQWYEFAKDKNCGALLTFCGIVREEGGIEALSFDIYKPLLKKW
FNEWQKRVDFDGITLLFAHSIGDVAVHESSYF
>fig|195.2125.peg.1834 phage uncharacterized protein
GSGKRLRGVRYGVKRPDLVILDDLENDTNVRSKDQRDKLEDWVDEAVLNLGSADGSLDVL
YIGTILHN
>fig|195.2125.peg.1792 hypothetical protein
MFSYIFTDFYRVKIEIKLSKISKNILR
>fig|195.2125.peg.430 FIG00973752: TolA-like membrane protein
MGGDLSIILSPKITLDLGAEQRFQMKQKINGYQNSEARSIPTLSLGSTYSINSDTAVSVN
ASFGGSSASPDSIFGISLWKKF
>fig|195.2125.peg.1761 Phage head, major capsid protein E
MDLEQLLELFSSTKITEVINQTKASPRFVSDTFFKDKIPSLESTVRVEIIKGAGIVLNSI
SDNGEHSLENTKDAYILNIPLPRFALAKRISASEINSLRSLALQEAQAKSLSGALGVLVK
EMKESF
>fig|195.2125.peg.1814 bacteriophage DNA transposition protein A, putative
AIAYAGEQKALVERRFGTLQRARLSQMHGHIGNSLAKREMIEQKTPKKERKAKDEYGFAK
KTNQKLLHTFSEACELLEAEVIKWNMSKVRRKKGVKTPLELWNSCDRSIVKISYEEFLFN
AGNKELRVVGKKGINFESRVYKSALMP
>fig|195.2125.peg.1368 hypothetical protein
MDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGINEVWLRES
IIALKRSDLNVETLQEIVNIVSYYFQYHGYPSATAYIPQQEITDSIQINIMLGKLGEYQV
KNYSKHLKESAISSKLKESLQGKILRTKALEDAIYKINEMSGIKASGSLVAGSEYETTDV
IITIEDSKKANAMLFFDNYGSKGSGVYRAGVSGALNNLLGYGDSLNYFAQLSDEMQKSYG
FTYNFFLGNLKVSPRVNKSNYELGEEYESLGAYGSSLDLGVDLSYPLFINTTNSLYLTGG
YVYRKLEDIYGSFGIDFNKESNAFYLGTKGTIGLIPNNILSYNTQLTYGDIKPKSVFLEN
SPVMGEFWKFNAALNNTYYFNNKISHILNISYQKTIGDYQLDSSETATLGGAYGVRAYPN
GFGEADSMILTTIGLRFNIFSPNFYITPFL
>fig|195.2125.peg.523 Alpha-ketoglutarate permease
MQELTRAKKIRSIVAASSGNLVEWFDFYIYAFTATYFAHTFSTSDNPIVQQINAFGVFAA
GFFMRPIGSWLFGSLADKVGRKKSMVVSVVLMALGSFMIAALPK
>fig|195.2125.peg.1754 hypothetical protein
FPFSEKDLRSLNYSLKLTKVKLRFYKPYVSSFKLIFNPS
>fig|195.2125.peg.1817 hypothetical protein
NTKTLNIKNTDLQNAKISDKEEAFIEKVLKLLKEKNLSTSEILLALDVSRSDNFSRNTLE
KFKGIFWESELGGENGRTFVWKSLKADNKDSNDKELSLFGDEL
>fig|195.2125.peg.1808 Phage virion morphogenesis protein Mup30, F
LNKKDLEDLYFTLSKNNLLHASPKRKASYNQALSADEIKQIVKVLDEAKEVYWDTKEESL
VYFFDDLKNSKKVNKIIIRPDYKLKKFGKTNALITLGKVDKDTKESSKEYEKIK
>fig|195.2125.peg.522 Alpha-ketoglutarate permease
MVGDFAIILLLLARLIQGLSVGEEYGIAATYLSELATEGKRGFYSSFQYVTLIGGQLLAV
ASISIMLFFFSIDEMKDYAWRILFVVGGILALGSLLVRKVMNESATQIHKHEDRGTLKAL
FTSSWKQFLMVLGITAGGSLAFYTITTYTKTFMENSGMDKTLVNNLFLGALFILMIIQPL
FGYIGDKIGHKRSLIIFCILAFVGIYPIFNLISSNAQSNTSLVFILVVLLFIILSFYTSV
AGIFKAKLFPEHVRALGTGLGYAISNAIFGGSAPWVALQFKNAGMENGFFVYIAVLTLLM
FIATLCLPKKSELN
>fig|195.2125.peg.1797 Phage tail formation protein GpD
MVRKPKFKLIAKGKDITEKLSKNLISISYEDKEKAESDEISLSIFGLYSKPLFGDSLELY
LGFEKL
>fig|195.2125.peg.1810 phage repressor protein, putative
MQMQEVIEKLKDILASEGKRDLKTK
>fig|195.2125.peg.1769 Phage head, major capsid protein E
TTLEYMANGALFGKILDGKGNVLFDFGSASKKAVSVKKDGSVTLASICDAIDSAIIDEFG
TSADYEVLCGNELFAAISNLALSEDLYKNHLASRDEKDKSLILYGTKYRRYSAKYKNTNG
KSVEFLKGTEGMVVPKDNSNRIYYTRANHTDALGKAPSLMFVSKPEILPRGAGIEIVGEM
RAMPVCTRPNGLIKLVLE
>fig|195.2125.peg.1802 phage uncharacterized protein
FSLDGINFYDDLPAINQYYMYIDPAGEKAKSDFTAITIIGKGAKGFYVAESIVKILKAQS
IIKTIFNLQKIYKCRLIEIETNGGQFFLKKWLQEKSLESGVFLPLRGKNNSVSKFERIES
LSLAFENEELFLHKSQTMLINQLLEFPEGKNDDAPDSLAGAFLLARTKSSIKRRKHHFNS
VSRIRRF
>fig|195.2125.peg.1361 hypothetical protein
MGFGNGFVGNFYGNNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYK
YLGGLAGHIENGTFSNIALDTIEGFNGENSSSGGFAGEINSGTFNNISLKNLGNIGVAKY
AGGFAGQINGGDFSSIILSNIESIYGKNNGGGFVGYTTGNTTFDGISLKDIRFIKSGAFT
GGFAGMTQGNVIFENIVLNDLEEISGSHAGGFVGGVLNNENGIASLSNIVLNNIESIKGI
GFIGGFAGWINDGTFNNIILNNIEKISVSATHKYIFTGGFTGYAGAGTYKNIILNNIGEI
SANGTASLDEKSIYAGGFAGRIKSDGINFSNIVLNDIDKISASIAAGGFVGNIENGSNIA
NSNIYFYGLLNSSSNKNYITHNENILNLSNTTDFQTFINQSKIAGLEYLTNTSTSNSHLH
MINGGKIGNEKSKITFDKDNFTYNTPKISEVDPDGSGSSSSPTAPNEGELSSITLEQSDF
EDEILKTIIDEILNEDYVLNIDSIDFNKFNEGDVAILLYLLKNTSNKKLKESLKQSLEFY
TEFNKGGLKTEFEKWYGSDESTYKTSMGKYNYIIESLANLKEYVNTTLKPELESIKNNLN
RLEFLKAEIKRLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNK
PFLDDLITKEYSFEDKYTDIQGTFAIAGSSIDANAIENLADKPILSLPENENSGDSQTTN
NTDSTDIVNTFSKQVKLTSTESILILPAEEIQSHIKEDERERGRVCITSDNAKTNNPCIA
ITF
>fig|195.2125.peg.1238 bacteriophage DNA transposition protein A, putative
MYFLETKEAAQAFSVSTGALRLAVSRNSNKYEWLKVDNEKGGRGGKKLLFKISKDGLLTA
FNKQLISKNTLIYDEKMQKVKLNEIITTDNLKTANNSLKTSNLNLTESKMNDDLAVLNLK
FENLSDEIKNNAREKLKALKQVEKYIEGGLKQKRALEICGISKIEIFRIRKAYKENGILG
LIDTRGLHRKDKTKLSTWMQEYALREYRTFGAGGFNFTELWWQIHKEAAIKENYDFIGFD
LGKVKPLFSVKTLQN
>fig|195.2125.peg.1700 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing) (EC 3.2.1.184)
DRYEMLSVASVCLLMHIPLVHLCGGELTLGAIDDSIRHSISKMSHLHFVSHEIYKKRLLQ
LGEEEKRVFNIGSLASTIIKNMNFLNKKDLEKALEMKLDKELYLITYHPLTLNVKNTQKE
IKTLLKKLDTLKNASLIFTKANADENGLLINEILQNYCQKNSHKAKLFDNLGSQKYLSLM
KIAKAMIGNSSSGISESPFFKTPCINIGDRQKGRLRTQNIIDCEINDLDQAFEKLESKEF
KQILKNFKNPYDNDKNPNKFIKTCLKNVNLDTILHKNFIDL
>fig|195.2125.peg.1778 hypothetical protein
VMKFNPPSKEDLIKAIDEFNAKNSCSIPYFIADSFINYYKQDDGRWLMANKKPLKCWKRA
LNSTWLPKLANKYKNKDKQKALASWLEEEF
>fig|195.2125.peg.1801 hypothetical protein
MRECEGFVPVSPILQFSYLDENKHRDKALQMGLELLKACDYIYMSAHKDAKNSTGMQEEL
ALAKKLGIKELVLELPLQ
>fig|195.2125.peg.1728 hypothetical protein
NEINVFKDKLAQQNKAIDKLKLDLKPKETLKEVLKVDKVFIKDKSCQSELKAYKELFNIL
GAKK
>fig|195.2125.peg.1674 Methylisocitrate lyase (EC 4.1.3.30)
MSAGKKFKELVKTSKPLTIVGAVNAYSALQATKIGHKALYLSGSGVASA
>fig|195.2125.peg.1806 hypothetical protein
KLSSLSCVQVVGERSICVEGIPVRSAGANRSEHAGMSSDN
>fig|195.2125.peg.1827 bacteriophage DNA transposition protein A, putative
NKELRVVGKKGINFESRVYKSALMPSVGTRVKCVQNIDNIKELFIYDLNGTFLCLALDES
IAKLSKESYKMLKKGYESEV
>fig|195.2125.peg.1088 bacteriophage DNA transposition protein A, putative
MSYFLETKEAAQAFNVSTGALRLAASRNSNKYEWLKVDNEKGGRGGKKLLFKISKDKLLT
AFNQELISKNTLIYDEKMQKVKLSEIITTDNLKTINNSLKTSNLNLAEPKMNNDLAVLNL
KFENLSDELKEDAKSKVKLLKQVEKYIEGGLSIARTLKIEKINRRFYERIRKAYKENGIL
GLIDTRGLHRKDKTKLSAWMQEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDFIGF
DLGKVKPLFSVKTLQNFIKNYYKDKPLEHCIITQGLDRAKSKFLPAQGNQRELYDMKNMC
WQIDSSPADFIVRDDETLEPFRPHILSVVDVFSGMGVATLVGKSNSLSLTRLLWKAIDKF
GKPDMIKGDNGKDYLSKDFQSLLDSLNISYDAAIAYAGEQKALVERRFGTLQRARLS
>fig|195.2125.peg.1303 Zinc transporter ZupT
MQFTFEQIFIAILLTLFAGFSTAIGSTIAFFSRKDDLRVLSLGLGFSAGVMIYISFMEIL
PTALKDFKNHYDSHWAELLGLACFFGGILISLLIDKLIPEDVNPHEPKEDLSELKICPLP
QKGQNPPKFHPGEKLHQINTKALKRTGIFTALAIAIHNFPEGFATFISSLDNLTLGIAIA
IAVAITISQKVWL
>fig|195.2125.peg.1756 hypothetical protein
MFSFILSRFLSPSKIAFFVLITLCGFLYLKNNALALENENLKLKALHF
>fig|195.2125.peg.1362 FIG00638667: hypothetical protein
MQVKFFLKNRILLSFASVALIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTF
K
>fig|195.2125.peg.1784 host-nuclease inhibitor protein Gam, putative
VKEKLENLIKALKSYGLNDCITYKEELNKDAIAELEDSTLVKLGLKRVVKDNFRIEPKIE
SLEIEK
>fig|195.2125.peg.1807 Phage tail protein GpU
MVLALGEFEFKALNFDNLERSLE
>fig|195.2125.peg.1746 Phage tail length tape-measure protein GpT
SGVIGYFKNNALNIIFPFVGILKFIWKPIYEVFKWVFDKCALVFASFKDIIMSVASPLAE
FLNSIWQGIGDFFYSIFGSLFEWFASKLSWVGDMISSISGFIKDALDFVGLGDDKEVKIS
QNEQTKEKIFATNTYKDELQAKSINHTPSFNNGNINVSVNGTFNIATKDGNFNMQEFANA
IQKSVFDALRKQEQNKINTTIYG
>fig|195.2125.peg.1835 Flagellin
TMLQADINRLMEELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKI
GLTRFET
>fig|195.2126.peg.48 Campylobacter invasion antigen B (CiaB)
MNYNSIKLKKENKSMNNFKELAKLVKNRKENINFFMIF
>fig|195.2126.peg.172 hypothetical protein
MGFSLKFKKYTISQCNFCFTLENNLLLSCIQGYKYKDFNILEINKILTKKCHGLRPVALL
IECSKMLCEILKLQATLGVHEKNQIRSQKGKEKGYFVDYQKIWLENGGKLVKINNHLYYE
LSHKRKNLEEIPSSKRSMYKKRFAILEEIKQALDQSLFI
>fig|195.2126.peg.171 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFSNRP
DACYNAIRRFCDKSFKANERVKTLIYDVDKGLTCFKFLPEEQMIFSFDEDFELFLGYNHN
VYEEGFWAFL
>fig|195.2127.peg.658 Inner membrane protein YihN
MICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVLLKDIRLLGDSTQQGRLFGFLE
AGRGVVDTIVAFSALGIFLLLGSGAGGLKAAILFYSACVIIAGILAYFLLEDDKISTKDD
EGHEISKNKAAWNGVIKAVKTPEIWVVSLTIFTIYSDNNYFNKSIKIYKII
>fig|195.2127.peg.1567 hypothetical protein
ISQVKSIKYLYNFIDFYRFIKVVVIPVPSSARCTVPLSL
>fig|195.2127.peg.1658 hypothetical protein
MKNTVTEASIYEAQGLKDEALEIYKNILKEDPNNQNAIDAVRRLSGITTTLINL
>fig|195.2127.peg.412 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDKIFLAARSDGLGSRLVAILNAFYIASRFGNKENVRFSWVNKETFCQDDGFNKNFRGLN
TKIIGMSVEEEDRIFSRNFIEKYHIVESEINTRDFFYCKKKVNTLEEFLNIFRQDVTSVC
RTDIGFLPQYLKDVELNDYRGICKQAWENIEFSDNLKKIIKDAQQKSQKLGDYVCIHVRS
GDVIYDYLDIRKYHKSHVYHAVNAALALELIYKELGKNKIVIIGDDIDTTEKLVELVNHP
EVYHINTQRSVDHFSNLELFMFDIIFMSNSKKLYGTYSAMIKIARMISETEFFSSYYQFK
SGEYYEILKKNYNYLFPYISSSQNAFILFHLFLTGMELNEDVEILCSYLDKALEYVLKTI
NTEYIKYIAY
>fig|195.2128.peg.1458 UPF0317 protein YcsI
MYKTNIACKSVGVFSGEMVVSMRPFTPDNAKKAKEITANFPLVHGAPVQIGNAKEIGINN
ILKADFGDDPIIKEGEIPVFWACGVTPQNVIMKAKLPFVITHAPGHMFISDILNSSLKS
>fig|195.2128.peg.664 Aldehyde dehydrogenase A (EC 1.2.1.22) @ Glycolaldehyde dehydrogenase (EC 1.2.1.21)
MTTYLNYIDGKFIPHNGEFIEVLNPATKEVISRVASASLEDTKRAIEAAKKAQKVWEAKP
AIERANHLKEIASLIRKNANFLTEVLMQEQENQSFG
>fig|195.2128.peg.1865 Motility accessory factor
ITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVY
QSIKHCRDFSKILSNDFENIQSIYLSLNEKEEDINLAIEKIDEFKNKLEDIKQMQDLYDI
LQSLFIQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHIKAQENALIKNIL
PLEEKLKERKLDKWMERVR
>fig|195.2128.peg.1180 hypothetical protein
MSDYANLFVAKVVKISKEVDKNIIPKYYQEKNLEVEDYFLITDLRELVRENFTLIRDKFL
ANFTTENNHTYAIYGNNYSYPLVVKQKEEINYFYDEINKYYLSVYKNQEYLKMQENFIQF
IFGKKFFYMLHPDSINNLILAELELQQNLENPLYDFTSIIVKYSKTIEYEIYDFAKKIFT
KLIKQNSHLSSISYSIQGKEFNFKQFFINKPNLGTIKFLLKNREIQELLDRDVKGFINYE
FNKTLDEFQTIRNHAVHAKSPTLEQTLKIRNLILGIENTSILKRVLEYKFKQKG
>fig|195.2128.peg.1802 hypothetical protein
MQEIKQFFINIDRADIDESMKNLVNEDLIDSIDIMALVAEIEKFYKKPLKAEFITPENFE
SFESIKKMIKDAIQ
>fig|195.2128.peg.741 hypothetical protein
MLKNPKFQAFFFAFLAAIFNAFVGIFSVFLFKKGFMSSEVAFYKCFVASVILFAILIYMR
KLGALLVFIKQKIFTLLLLAFFGFFMLYHFESAAYTSMGVANVVFVLLGLWMIFLAEGGT
LENFTHLKGLVNAILAGIGYALFLFFTRKLKLGFGLIPLCALLFIGSLYLSIPLFGANLN
LNFSLESLILILALAFLPTIGGFYCTTRALSLAKSNSVQLIELSEPLFAMLFGFLFLAQS
VSFLQILGGVFILFAIFVHEFKLKL
>fig|195.2128.peg.1839 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEI
>fig|195.2128.peg.1807 hypothetical protein
MDGVIDNSGPALPPLQFILGREIDSPEFVFNSKDLNLYCFLKTHWTRKENSSYFFNDANY
IIRVLLNLKHLQILSDISKNIIFVTYHSVKDFQAPVKDKIIFYDIFNTLGFDATLNLIKY
ESQVDGRFIKDLNHGMRISDKALFRKELPLMLEKLQKRKSLMQENSISYPCGNKAFTFKD
VGDKFVLKLN
>fig|195.2128.peg.1861 hypothetical protein
FLDSYRNYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTMFTKDDVSNLSQALLEIGVNI
NVNLENAQQCYELLNQNITTLKSQRKLAQNYQAKFTSTFIPPNGDYQNYGIMAALDHINA
LKDLVKRFPKLADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSAVPPLIYILGRE
MEGGCDYVFNDPNTLIECFLKTHWTRKENSPYFFNNENYFIR
>fig|195.2128.peg.1181 FIG00710232: hypothetical protein
MQNLLILYNPYYQQDVIKLHLEILLDKGQVAFGKIKSKLKEPLSYERDENKISHNQKLSE
IYKNTSADILCNFF
>fig|195.2128.peg.1806 hypothetical protein
MDVEKQIAILKQDNNFNRIEFANSCIVCIDARKYLKANLKALKKDKFALVKD
>fig|195.2128.peg.427 Ribosomal RNA adenine dimethylase
MFFYEYLKNPKQIGAFCSSSQKLGFVMTQNINLRQANYIVEIGPGTGVFTENILKYKNKK
AQFFAIEINKNMADKLKRKIVNLDIEIGSAENLPYFLRQRNITYADVIISGIPWSLLRDL
SAEK
>fig|195.2128.peg.1457 UPF0317 protein YcsI
MNPKELREKIAKGEIKEQTSGMALGYAQANLVILPKEYAKDFQTFCMLNPKPCPLLEIVH
GKFTQKIAKNANIYTDIPKYFIYENGIKTKEAYDISEYYNDDLIGFYWVVAFLLKKLYLK
KA
>fig|195.2128.peg.663 Aldehyde dehydrogenase A (EC 1.2.1.22) @ Glycolaldehyde dehydrogenase (EC 1.2.1.21)
MDYTAEWARRYEGEIIQSDRANEHIYLYKSAIGVIGGILPWNFPFFLIARKMAPALLTGN
TIVIKPSSETPNNAFEFAKLVSQSSLPKGVFNLVAGKGSVVGYELSSNENIGMVSLTGSV
EAGTRVMEAAAKNIIKVSLELGGKAPAIVCKDADIDLAVEAIKASRICNNGQVCNCAERA
YVHTSIYDEFVDKFVKAMSKVSVGNTLKGDFDMGPLVNQAGVDNALAMLQRATAKGAIVE
CGGKITDTSGYYFPASVLTNVKHEDEIMQKEIFAPILPIAKFDTLDEAIDMANDCEYGLT
SSIYTQNLDIAMRASREIKFGETYINRENFEAMQGFHAGFRKSGIGGADGKHGLEEYLAT
HVVYLQYNTNKQ
>fig|195.2128.peg.1804 hypothetical protein
MSHEIRFCALEEYKLLIDFIKKHWKKDHIFVKSKQALDFQHLDKKNKRYNFIVAYNTTNK
EFDAILGFILISQYSHLKDENLWLSIWKSKKNYAGLGLRLVKSLEQKLKPKHIGALGLST
YSRKFYKLFNYDRIAILDHFYIKNQKIACFKIANFSQTQEKSNSSSVYEIKTLTLFEFQK
SDLKFHFLPKKDLCYFIERYYKNPFYSYKNYGIYKNKTLVASFFARIVEQNNSKGMFITD
WLGKFPKKLYNAFEVLLEVNQCEFISFMCYVKNPKPIYAMGFKLLNKDENLIPVYFEPFV
KENIDIYFAFKSKNKNYAIFKGDSDQDRINKL
>fig|195.2128.peg.1500 hypothetical protein
MTAYVHIGTMKTGTSSIQNFLYLNRSLLQKQNYYYPISIKNIGRLNDHNPFAHKFNTLLN
KTDDLKIFSREFKNLNNEIKMCNCDKIIISMENVQWLLNSQQKIKYFYDFLIYIFDNIKI
IVYLRDVAELFISMCSQAIKDDSHLDYHFLYPYQNKKSKILSDYKQTLQWWGEIFGKENL
IVRLFNKNEFYRGDLLKDFIYSVDLKWDEKFQIPIKENETLDLIGFELLSRVNRLKPFMF
KSRYFDIVEYFDRNCTNVKQYSHLKFQPPKEIMQSYINYFEESNEWVRQEFFPHKERLFP
KKDLSNYKENYELKEMKPEYWDKIAEFIADIVSTKNQNIADKTIIIQNKDKVIVNQTNQI
NSLQTTLKDNKAHLIQAQNLNNTLNKTIQEKDIIINSNTNQIDQLQNNIKEKIKQLHILQ
NSIQEKSTQLNQLQSKLSFQTQYGTAKSRIQNQLSYKLGQAMIVNSKSFLGYIRMPFVLS
YIKDKHKQEQKNYQEKIKKDPSLKLPPLESYPDYQEALKEKECFTYKLGEALIRANNNWY
GGGYIKLWFEIGKLKREFRNKKI
>fig|195.2128.peg.1022 hypothetical protein
MHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENENIIHHRVFLAP
AKMQKIGFEIAKGLDEWLDNENVCCFNVYTKDYFNANDKDMLISDNIKDDTNITQAHTNE
NYNNTQEIIPDNVIRIQTQDGSGEFIEIIFDEFKEWEKSSSGAIKPLFTPLEGIVEDISN
SLENVSIIGDALAMLGAVKNPKNAKNIIKKKSKYATKQEVIEVLKNKYNLKTSKELGLGR
SKNVFWVKDNKQIKEIWEEITDGADILKDINQDKLGGTIKMRKLDDQTTIQYKKASKSGG
ETIEVISNKPRGNLRTIHIENGVKNEV
>fig|195.2128.peg.490 Cell division protein FtsZ
MSEFLVEEMQHNKGAKIKVIGCGGGGGNMINHMVKMGLNDLDLIAANTDAQAISNSLAKT
KI
>fig|195.2128.peg.1803 Polysaccharide deacetylase family
MSIEFIIFWVNGGGGLTKFTLNLIDSNALEKDKKQLFEGYYKELDDDLETKNFKLLFNFY
IKYDLREKILDELVKHFCSDEEIYANLYLNPNELKDMYEANMLIGSHSKTHPNFLKISKE
QEEIELFDSFKELENFSQKIKIFSYPYGDFSPYSKELLSKNNCDFAFTSIVNSKDINKKD
LKENYYTLPRYDCNIFPFGKASKG
>fig|195.2128.peg.971 FIG00973752: TolA-like membrane protein
MKKFIFILAVLSSCLFASDELNIDSLFKKQIGLRSITSLSLLSTGNPHSYYIYPNIGVNG
DLNVWNDTKQLYLNQTFIYTLTPNFDLLISGGGNYARQEYNNIISGAFTSKNTLNFDSLW
IGFIYTGESIADFVPQIKFQTAIIQREKQFCKLKTFIFNPKT
>fig|195.2128.peg.1875 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
QAMIVNSKSFLGYIRMPFVLSYIKDKHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALK
FKNHLSYKLGQALIKANKTWYK
>fig|195.2129.peg.789 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTARNVGIEYFSGEYKLKNKTQILKENSLIEFNIEGNNPYEIYTVYKS
YKAFNDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDYNKIYESGF
LDQKNDWTWFLGYNRNSGSKKISSKLWLERYKHIGHFAFVWQGVINFRFLKNIDLKFIDG
IFHQDVHFGFLLFAQSSYIYLLSKKLLVYRIRNGATTVRNFKNNLKDEIPFYIQELLSYF
EIKTAKEYYSIYSWIQIILNVMHSHNIKNNLHSDLYYLFIGNLSEQILKLKFSYKQDPMH
LSGFINFIKTFVGLHRILQNNMQEKITQFSTKTQELTSKTTQINSLQTTLKNKDSLLSFQ
SQHGTAKQRIQNQLSYKLGQTMIINSKNIFGILFMPICIISTILSYRQEQKLYQEKIKKD
PSLKLPPLENYPDYKEALKFKNHLSYKLGQALIKANKTWYKGGYVRFLFELRKIYKQKTM
KNSLILYKNRDSNKKDTTRSIKGGG
>fig|195.2129.peg.618 Uncharacterized membrane anchored protein HP_1479
MADKEDIVLEKPEDTLNEPRLDESLGEFKGQEGQAPEDEEFASLPEELPRENSDGGFKFT
RESAPEESSTFEEVKEDEPTPWYKDRKFMSLVGLSLGIICILVFTLFYLTFNEGKVKPDI
IASKPIEQPVVMPDESYNYNDMTRVDGMIQKANALYLKGEVEQALKVYEQIAVYNESLSN
YNLGVSQMNEGKFDEAFDSFKKAIANGENQSVAAINAAVCALKLNDKEKFKYYIDLAQVY
LPKEGKSKLYDYYLALINYYKGYYPEALQMLQRVNSEPYTDVAKYLSAKIYAKMDFDAKS
VQQLNTQGSFEPSLSLGLLYARMGEYDKANSLKYCNEDRKRFQSKSFSFNFS
>fig|195.2129.peg.15 COGs COG3777
MNADYSEKMQPDSTLLFRYSALTFNGHKIHYDFPYATQVEGYHGLVIHGPLLATYMINCF
VKNHPDKQIINYSYRGMHALCVPDSFAVESKIIDNNTAEVWINKNGFVAHSGTIHFK
>fig|195.2129.peg.1666 hypothetical protein
MENLTEEQKKLFYKFIKNIKDENSLKQLEQFLDLIENNAIQNSLKDIAEFNSVYKGNGNN
EEMSIKDMIEDIKIRQKDIDEIYWKIFDIRSEGENEKNKSSALIEIEKAKEYANKMQNDY
MKFYDKKDSQGNITEEGIISKLKQACNDIETNKDKIEEFEEFYNKIFIGVEADENGKGGR
LSLEKYLDEKQTEIKKLISSKKQDLESCLSDYKDKFENLYKEKNDKIDELLPGATSKGLA
EAYKDEKEDMQENIKKWNGIFIGSIVLFITLFVIYFIISLNKDFTFASFFRAFPFLFFSG
FFTYYSTKQIAEYKRIASEYAYKQRLNQTYKGYETQIKEANNEELKNQLLRIMLDSAENN
PSKILDKKGEIPSLSVIEKMLDILPFDTLKRIQDKIKAKIEK
>fig|195.2129.peg.14 hypothetical protein
MSYENFIGKQEKFTENINEKQVQKIVAMLQSKQLKNGDALPYLWQWCFFNEALTPDKLGR
DGHPKLGLDKNSFFPSFGEVNRMWAGGRFNFIAPLIIGEDATKITTIKKIQEKQGKSGKL
TFVTLEHCYYQKEQLKIEKE
>fig|195.2129.peg.1733 Motility accessory factor
ENAKRFLDDALALKQILENILSKDFILPLEFLEKVYQNIENFNHSLDEDEFIQDGILKAV
MYERGLKISLVYKENIVDNASFITAYIKAYHEWLLYFIEKLEQRINIIINSFKETQ
>fig|195.2129.peg.1444 hypothetical protein
MKITIAIIFTLFTLIFLSACAFKEKKASEIETLASNYGGI
>fig|195.2129.peg.1736 hypothetical protein
FLSACAFKEKKASEIETLASNYGGIYIFDKKIREEILENERKRTELENDDKFRTKIGQLK
SGELIYKIDSAAVDKLLPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFAYYEDQFKAYM
>fig|195.2129.peg.1730 Motility accessory factor
SLAKQLPLLKAYQDKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENKTSL
NILSCATHPNVARSLNAENCMIVLRNKALYQRFNFNDFGYIDTGTHVSHFSYTLALALGF
KNIIMIGQDLAFDEEGNSHSKGFDFGEKFSGEENIDKFKIPAYAGKGEVLTHTTWNDYRI
KLEYLF
>fig|195.2129.peg.1727 Flagellin
EYKDGDSNGALVSAINSVKDTTGVEASIDENGKLLLTSRDGRGIKIEGDIGRGAFINPNM
KENYGRLSLVKNDGKDILISGTNLSAIGFGTGNMISQASVSLRESKGQIDANVADAMGFN
SANKGNILGGYSSISGYMSSAGSGFSSGSGYSIGSNKNYSTGFANVVAMSTASSLSNVYN
VSAGSGFSSQSGLSQFATMKTSAGNTLGVKDETAGVTTLKGAM
>fig|195.2129.peg.619 Uncharacterized membrane anchored protein HP_1479
MLLRLQDTYRNDEDKYKILDRYKIKVRLNKELFNIAIAQRNFSNDILKKQKDQFDLLFYF
APYQVFDSKQASLYIKKANITNFVDDSSDGQSYLARSQALSSTNVKISNIINDALNQKLR
LANKEFQALLEDYPEHSILQYNLALTYAQMQNYELAYKHFSSSYHLNPKNYLAGAFAMFC
GKLSDNDTTKLYHEILDNIAADSNFKANMQKNMLFLANGDYISMLPYLDENGQKTPLNLI
FETIIAKNNNLNNQVDVRIAKLRSELPQDIVANILYFNSLNSNLNIKEYAQNAQIHFKNL
QVDYRSVFGGSNIARELYVNLMHIAGLLNLERQKFKTLINTSKVKDEGMIQTLAYLDIFA
QQYEESYALYNTLIDEYGAKDSRTLFLASVAAVGANNPNSAIALLQLSKLTDKNNKESKV
ALGLLYQEVGNYEAAMTQYRTLPNDFKSEFFTFDIKNQ
>fig|195.2129.peg.1734 Flagellin
KASIGATQSSKIGLTRFETGSRISVGGEVQFTLKNYNGIDDFKFQKVVISTSVGTGLGAL
AEEINKSADKTGVRATFTVETRGMGAVRAGSTSEDFAINGVKIGQIEYKDGDSNGALVSA
INSVKDTTGVE
>fig|195.2129.peg.1036 Type cbb3 cytochrome oxidase biogenesis protein CcoS, involved in heme b insertion
MNSVIMMMMIGVSILGFFIILATLLWGIRTKQFDDDYKFTTLNDDEDALRDAIELEKRKK
EALKKRK
>fig|195.2129.peg.1178 Putative periplasmic protein
MKAVLIFLGAILNLFASDFITLKEYSKMLYENPRGISCKKCHGNDGSEQTLGFYMKNGVK
TAYKVPSIQNLSFEEFQNSLNQDKDAKSIMPNYSLTNDEIITLYNYIKQSKRSKNDKQKS
F
>fig|195.2130.peg.10 hypothetical protein
MHVENNLSPEDRQGIENYLIILNTISFLGDLNIKYNNHNAKIKKLF
>fig|195.2130.peg.1800 hypothetical protein
ITFVGHSLGGYLAVVAMQFCDTIDRTLCTDFNQIKFSASKVYTFNSPTIDGIDNMLMRFL
ANLLGNNIVEQILNPEKIVCVFDNGKIEIIASAQYGASNALGIYTGKNDRSIKPLVNTLY
FYSYLLELDANYNKVKDKSFSECIEYLNHFMKNIQIYTETFVLKNNAINNKNFALKNGPL
GLFRSSPEKINHFEYFLSLIATIMQETNDILEELGDGYYTSYKAPTISQTKIIDFILKAQ
EKEKYILILDKNDFNKYRKDCSFINNQENLAHKIAIGEFRIFIVVYKDMKCLENINNITK
IYGYNSKSYKIKDQIWDEQYLGGVCKISQALYFNGKAKIGII
>fig|195.2130.peg.1722 hypothetical protein
MDLSHSLGQYIILAFAIAVAIFVTFYDFDKKDHQHNIKK
>fig|195.2130.peg.55 hypothetical protein
MNLNQTLQEKYPHLEISVLKLSEVQKDNESKRIDSEFFKKEYFDAMETMQLNQVEYLGDN
MKFNSRYSQPKYDETSKIKVINSQYIRNEYIDYENAKSGYGKIVPKESVLINATGVGTLG
RVFINILDFDFSIDSHINVIVVKNKTYLNPYFLAIFLQSYYGQIQIIRYYSGTSGQIEIY
PRDFNYFKIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDPKNPLQSL
LDSKTNNPTNSPNISIHTLKESFLKTGRLDSEYYQSKYEDIEKMIRSYKDGFCNLKDLVN
DISSGFAFSSDDYQDVGELVLIRINNIKNATLDLSNVIYLKNEAYNLSPKDKIKKGDILI
SMSGSIGLSCVVRDDISAMVNQRILKISIKNFNSDVLVLLLNSFICKMQFERIGTGGVQT
NLSSIDMQNILIPKIDSTTQEKIAKYIQESFNLRKKSKQLLDNAKIKVEEQIQGKV
>fig|195.2130.peg.1286 hypothetical protein
MSIFSINDNSNYGSILSQAKANKESKENSKISFANSFLKQNASKLNEIQNANSQTLARSE
VLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQADLNTNTAYGYSVDKD
GYMGEDFNEAAGLPKDFKIHKSTLDEIKKAAENDPVASSIKEYLGVSEYYTNIDMAETIK
QYYNLFSNALGQSFPNDKTSFSEADINSMPSGYAIDGFYNGYGAFKHPDAIRNDDIAIKS
IADYSNVLISNIYRSQEQLNEANSIYSDSAGLISGIKPETLGLSLEEIKNVSKGEDWQFN
PDMSVYPQNEDGSYSKEALFMSLIKSQEGRILYSPKTTLNPTIEAYNRAMAKESFSGPAI
HLDSIMTGKSDFKSFFRYWAERGIAEGDLYMYENNIPKESAMGNWALDAEIKQALANGWK
AKPSTINSYADSIMDRLNNLLGQTRV
>fig|195.2130.peg.3 FIG00469988: hypothetical protein
MVIFKNILLFLFFSTYLLAQEDFTPLEQCTYENEKFWIKILNLCPEGNITCDKVVYVGVN
KNNGKYIVLNGKSISDVNMNFKGYVFKNGIYEYNIFNNFLYISKNKQIIQEYRLKLCEK
>fig|195.2130.peg.1723 hypothetical protein
MVKHKQSDEVFKVFYKKDDKIRLLRVSNMQALNRFDKLKGAMTKIILDSGFKPDK
>fig|195.2130.peg.13 hypothetical protein
MNKTLIFHENSHIDLNASFAPGTYIELQLEKESDKTLNRSYVECNSEKKMRSLLDVDCRS
IEAKDLKFIASFKGNICGFHLPISRDNEPIKDIKDYKYYIIVFAYDEKKAIPSLEDFHIV
IDMSFRVGVGRDEDVKESKLRNDFNSDIIQTNCIFSVLEAVEFLKACQSFKEKAKETNNY
EFFKNYPQLAGKIAYIYYRFDLANEKFIKSVSDGDKYLKEREKFVKKFIDVYSDEKFFII
PSYKAKFSEFSNKSDEEKIMFFQEFLEDLVKAFDIEPPIPTIYKEFKQYNNGSYNSVGKK
ALYLNLKNKKEQILSTFFTNLDIFILIKIILKK
>fig|195.2130.peg.1015 Probable integral membrane protein Cj1452
MKILRLAIKDFFTLQFLKFALIPLTFSFILMIFLAIFGFSFLLDYFNSLFSVGEDSFWAW
FYALHFVQILITLISVLFSGFVIIFASVFLALFITSFLTPLIVKQINNKYYHHEVQNISN
MYIIFEIFKIFLKFIGIFLLCTLALFLPFINIFVYYLAFYYLFHKLLMIDVTSTILDKES
FKNFHSDFSPLEFKFSTLCFYLLSSVPLLGLFLQVFFVIFLTHLAYQKILKLKAKA
>fig|195.2130.peg.1724 hypothetical protein
MCKDREYIEQRKVLWEKSFEAFKDDKVYQKEQLELAEAGINDGLEED
>fig|195.2130.peg.803 hypothetical protein
MQADTVYIKNLENGTIIAKNVFVENCMGGKIEAENIYICNLLTDNTLYPRKNLIITNNIK
FKNNIVVSPLVSIENNSDTECENLKNLSLKIKSKLDDTISKMQNYYDYLIKNQIKIIKLQ
KTKNPSTIEMKFSNLYHDIIKKYNHLSISYKKFIKLKYQIDAKLNFLNEMVYNVKIYIKA
ENIGEDNFLKFYPNTNTNLELKHHINLKDYEKVLYLEKGQQVSYIKSSHNYSESDIEEIK
IIFEKLEKDNS
>fig|195.2130.peg.9 hypothetical protein
MINSYEKMDLLYKTKLKTEIQEMIYPAIYATKKLNHFIDIAKGRLNACGK
>fig|195.2130.peg.1834 Death on curing protein, Doc toxin
MKIVESDKFKKELNNILAFIAKDSVSAKNYFSKSLKDAILCIDNMPYKFRKSTLFNDENI
RDFI
>fig|195.2130.peg.1780 hypothetical protein
MSKDHRDYFIYDDSLVFYPKLNGEFREIQTQNFAKRYIIKFHQPNTFSGFSATLFYDIQK
DEYIASFRGTEGIVSMDAFADIGLTFGKGDFQANALKQFLLDIAPILNNIDSSKITFVGH
SLGGYLAVVAMQFCDTIDR
>fig|195.2130.peg.1810 IncF plasmid conjugative transfer protein TraG
AGSFANQQALSTQTSIAAPRGDEVWAMNAGVVSLQSAMSAGGGRFSMSAITGGGTTVKDV
NTNTNFALGSNGEITNMSIAGLDAKHAQSETQTRQDSLANSIADTHKTGINQGITSNYLR
NHGAGVEDTKAIEKAEAQALRETMSEVLGDKSSFSEADKKALEGSIGAYASGSAGLEIFG
SGGKIGGEVRGTASMGTSSNETQEYSRSLSKEGQAAFDKMYAEKLGNIIKSSDSVASAYS
NALSTSTGSEFADAKQKAHSYSEASQYSEAIQTSNLPNMAENYIAENNLGGTREQQVAAA
AK
>fig|195.2130.peg.1809 IncF plasmid conjugative transfer protein TraG
AGSFANQQALSTQTSIAAPRGDEVWAVGAGYNTLQSSFGAGGRSFMGTRDMQHGGELVKD
NMTGSSAVINADGFIGNASIKGLNAGVTASNLETRAHALSDAIQNSNLSQRALEVASGKG
DSLALSENDRSAIANATQHALANAYSKATGVDVKQAYDDVMRGNIGFGVGGVSTSSTETE
AWYQNLSKDQRETFNKTFNESISNEIGKNRDASASFSNLLKTGNVTNSASIKSSMDSYNE
AKTLNNSVGYDGGASIVQGYINENYGGVVNKENVASAVNAVENMAARGDMQGLSHYAGVD
SNVN
>fig|195.2130.peg.440 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MFNKKLHELLQEEFGKRGIEQIEIPFYVKENLSKELRIYQEKALKYYYANSDSIKQRHLM
FNMATGSGKTLIMAALILDCYNKGYR
>fig|195.2130.peg.1115 hypothetical protein
MIIVNDKQLKNLIVKKEHILKMHTQKISTSKQKIR
>fig|195.2130.peg.1719 hypothetical protein
MQGYAMEKEITLNESFKALLESIFSDTDQAKKLIQAFEEFANDRATTQRLNFGNLKQEAI
EQIRNELVSKDLFQSEIKRLEAEIKLSVSLLKQQGIYWLIGACVVSIATIISSVWAIMNF
MVEHLK
>fig|195.2130.peg.1081 hypothetical protein
MKNFTIKKFKKGLKLKHYKGKLFFNFTIKKIKKGLTLVD
>fig|195.2130.peg.1172 Campylobacter invasion antigen B (CiaB)
MNNFKELAKLVKNRKENINLFYDLLDSEQWASILRDF
>fig|195.2130.peg.1801 hypothetical protein
MLKFLEKINILENYERIYTSK
>fig|195.2130.peg.1753 IncF plasmid conjugative transfer protein TraG
MKRFYFLFFSTLFFAPSFLFGATNIANSNLIYTWGYGDVMNEIMQAVKGITTETDYIVNA
ALTISLLLFSIKKAMDGQTNPVFEFGKMFMLFAVVWYMFLRAPNDNNHRFMIHDEVTSKD
YVISQIPIGIGKSFALMTQFEKVILEAMEKHFTTPQSTNFSNAGLGFSLQVMSTLPSVKL
SAIDATLQKNIDFYFRNCVSVGILLNQQGRNLFQNSDNLIQDLFTNIGNGSQLTPLFENN
NNIEKQSVVPCSDAGPQIVEMIKNDTDEAMKIHA
>fig|195.2130.peg.1811 hypothetical protein
MHTITITSDNIDFIKSLECLSKNAGAIFKISKNDL
>fig|195.2130.peg.242 hypothetical protein
MIRIPNYTNNKADDITLPAPSLAQLTKDNHLILEQALRARVVNNFEHYSLIYHSNNQDKP
FIESLETPINLSEESQITLLLKKGEKAPEKGSKIALISSQNGFSGINGNAMNKSQLNQLL
GRISKNPKTLNYKKIPQLQQENLRVVPLTLSLDNKGKVIYGEIQSD
>fig|195.2130.peg.1797 hypothetical protein
SSLVIAFVLFLAKNIKIVPYDEKKHRRKSKIAEYIRSGHCKYEHIFGAIRDN
>fig|195.2130.peg.1755 hypothetical protein
MSGNKDIYEIYTSNGLILEVDKNTNQIIFDKREDGREVGKYTQEYSKALFEAHNIKQNSP
YKDYQPQYLDPEFHTGEKSTLLEFKDWQSIYLKDPIKGSIAPWTKAEKAYYKSLKTKKER
YKYLVIRSGIRSVVIDIPYEAIGAVDEKGNVDPKYEKLYRIVDDNKHNLRSSLFHNEWGM
AAGILGDYKYLANDMFQNGFNARFIQATILYIQLSGGSSILDKPNLLGAIYGYADIAVGS
GLVGVHKNPLREQEIKTLAKTLKPDEFGMLPFIDEIMGVDWVIDYNKYRIARDEFGSMYK
ALRSDIVEGKIKDPRDIDSTYESRREFDRYRGGYYNGMVNAYGYDIPNDRSEESAQLRID
SMILTAKLAALTPPQGYPNAPYYFTPENLEWYYKRHKLDRLLDPRIPAIYRYNFPQELRA
KILAYAKEHNIKE
>fig|195.2130.peg.1784 hypothetical protein
MEKNIEKLILEAYEDSKTKFDHVITTGHISQYLKRKYDLKINCSKALIEAGFDLEKDENE
PSLVYVKKATTRNKTSNRDQIQNKVEEKPLLFQFAYFPNFLNTLQELSNIAQKEFWGNGN
NILFSYLFKYFEFIYENKSYPDIITYNKDKTKACFNTGLYSTGVFPIFAYFEIQENGGYV
FRKFCSNGDRVLDDLEIPKSLSDYDTFKNEIIFDSKLDFRVNHLHLFERKERLPEIVKKL
NDRFIGHIINGELKIIKDNYNLQKMIIPAAYKQRVVLYIPLKLQEESVDTIVVVEKEEVK
NEQYYAVRTILNPHDNIYKTARVLSIVESEWVKNTI
>fig|195.2130.peg.239 hypothetical protein
MLGKLGEYQVKNYSKHLKESAISSKLKESLQGKILRTKALEDAIYKINEMSGIKASGSLV
AGSEYETTDVIITIEDSKKANAMLFFDNYGSKGSGVYRAGVSGALNNLLGYGDSLNYFAQ
LSDEMQKSYGFTYNFFLGNLKVSPRVNKSNYELGEEYESLGAYGSSLDLGVDLSYPLFIN
TTNSLYLTGGYVYRKLEDIYGSFGIDFNKESNAFYLGTEGTIGLIPNNILSYNTQLTYGD
IKPKSVFLENSPVMGEFWKFNAALNNTYYFNNKISHILNISYQKTIGDYQLDSSETATLG
GAYGVRAYPNGFGETDSMILTTIGLRFSIFSPNFYITPFL
>fig|195.2130.peg.1085 CRISPR-associated endonuclease Cas9
MARILAFDIGISSIGWAFSENDELKDCGVRIFTKAENPKTGESLALPRRLARSARKRLAR
RKARLNHLKHLIANEFKLNYEDYQSFDESLAKAYKGSLISPYELRFRALNELLSKQDFAR
VILHIAKRRGYDDIKNNGDEEKSEILKAIKQNEEKLVNYQSVGEYLYKEYFQKFKENSKE
FINVRNKKESYERCIAQSFLKDELKLIFQKQREFGFSFSKKFEEEVLSVAFYKRALKDFS
HLVGNCSFFTDEKRAPKNSPLAFMFVALTRIINLLNNLKNTEGILYTKDDLNTLLNEVLK
NGTLTYKQTKKLLGLSDDYEFKGEKGTYFIEFKKYKEFIKALGEHNLSQDNLNEIAKDIT
LIKDEIKLKKALAKYDLNQNQIDSLSKLEFKDHLNISFKALKLITPLMLEGKKYDEAYNE
LNLKVAINEDKKDFLPAFNETYYKDEVTNPVVLRAIKEYRKVLNALLKKYGKVHKINIEL
AREVGKNHSQRAKIEKEQNENYKAKKDAELECEKLGLKINSKNILKLRLFKEQKEFCAYS
GEKIKISDLQDEKMLEIDHIYPYSRSFDDSYMNKVLVFTKQNQEKLNQTPFEAFGNDSAK
WQKIEVLAKNLPTKKQKRILDKNYKDKEQKDFKDRNLNDTRYIARLVLNYTKDYLDFLPL
SDDENTKLNDTQKGSKVHVEAKSGMLTSALRHTWGFSAKDRNNHLHHAIDAVIIAYANNS
IVKAFSDFKKEQESNSAELYAKKLVN
>fig|195.2130.peg.233 FIG00470545: hypothetical protein
MKKSLIYLIALCLSYTAMQAVCKYAEEQREDRGGGAVPIAALIRLGMGYGISYANAPGVG
EQTYIGRPPFGGCH
>fig|195.2130.peg.245 Putative periplasmic protein
MHAANPMDKNLHPIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNIKTKNPPK
KEEKDKINYVISGGLAREGNAKNNTLELLDGSYINMGVENIYNLKLNGAPYAVGGLAIFG
DAIGNSLLAQKGSKVDIHTASFYRNMVGEFILDERITHLVGGLAYNGKVEKNKLNLNGVE
FNIHAPSGLYSSFAPVHIAGAFVDGNGKKAYDVTKNTLVIDNFLLNLRADGKTPIFYNAI
FLANFFGGKTNKGDANANSIVLKDVPALKRISKKVKVQGIYDFFSGYTLDGEANFNTLDI
ELKSPLQVSNSYLRHSGFGFYGAFASKGCKQ
>fig|195.2130.peg.1805 hypothetical protein
IKICEDMEKSQNLYAFFGKDIDEESKKNILNTRFS
>fig|195.2130.peg.1734 hypothetical protein
LIIHLNSYLEAENNLQKIKILVKIYQNLQKCSRTPDLIDIEELEFNKEDIFEELFYALGG
LGGMYSVEMIQSRIANFIKILGGEPKLLLERFTA
>fig|195.2130.peg.8 hypothetical protein
MKKPFYKLKRFYIPCGVLIALIIFISLTYHFLQRPLELIFWDRYYHEKEYQNAKDIYKLF
KSNEEEFKKVFVEQNLNQELKTNQKELLNYMHHFKRDTNFMQILSLDNAYLKALRDKTSI
FGRKSENNLNYFYLASNSTTNLDEMNNFISIIDKYIIFINKIDTLPDTYALMKIAFNADY
FLFNLVPFAST
>fig|195.2130.peg.1607 hypothetical protein
NKALNEFNIDLKDLKDIEDINILNQLSF
>fig|195.2130.peg.1779 hypothetical protein
MNNKEQIKKLRDNAELAWASYGYFDFIDKQYSFDEKDKDKFKTLYAKINDLKKSNEKVQN
AKATYTDILNMEIIPYLMANSPHSKPNNSLKDMIY
>fig|195.2130.peg.12 hypothetical protein
MASLNLKGDYGVEILSYYLWGQSTPPSDLAGKDNRVLIGKDYQARDEKEIIIQASALDYM
KYVDRYTNATNFGIFKNFFKSVFSEKELGKFKDKIENETYILELDDIIKTKVYGGVNPFL
DEDNKNKDKSTKDKENNEENKCEKYDENKMAVRIIHYYLDTNSGNYAKRAFAFGSTSIAF
NKDVKFHISAKTYKPVCISNLKLYPLKDNFDFESDSSLAEFVNFFLEKELDPLKIGRTVN
IHFIDQEKITPMVIYKRVFQILQNQSFNSLTPSITSLREYYKTRILPSGVLYLQDDNTNS
QTNLEQTILYNNTSFNKISKEPLNESSSSAKKPCFITLYLKDEHNKPIANAKIIIKSFKH
DEALRVVNLKRRSDEKGKIRFDKEKYFSDCYSFKVKLDESEAYFPTPLQNAKKIFNNYTH
HKVELILKFKAKDHLVYDGFNLYHYKGNELINSYMARSGTAKADNEKRSKKQIANYFYQD
EKDTSKGKKAYFYYDDESIKDRFGTLPEGEYYLKINEIAKDTNPSFLKDYPFEIGKTWGK
CCVRLYTNKECSKTFKELKIKESNEKENKKSKKEQSIIKDNLYLYSINEKGEFGSNGSIG
MAQAQLLEDLSKQVKFVRSEGENIKWLTLKK
>fig|195.2130.peg.1814 IncF plasmid conjugative transfer protein TraG
PCSDAGPQIVEMIKNDTDEAMKIHAALLGMANDMANYEQKFLGAAQIYNEQAVSARSYLQ
QSMIMLASQDAIINTAKSVGLNPASVAANTAYADQQFYASMQAQGHMAQTYLPLAKAYLT
AIIIGLSWLVALLSIVFGSYAHIKMFFTLCIWIVLWTPILCIINFINDFNLMKVAQVITG
GKAALSLGDNILIFKEVASRSNFMNYLVMSTPVLAYAIAKASEQGFVTFASGLSQALTGA
SRAAGSFANQQALSTQTSIAAPRGDEVW
>fig|195.2130.peg.1318 hypothetical protein
MINTQLTSQIANAQKNDIKTDSGISKDKLNSKDNPKEALSQALKQNLGLSKNASDEEVLT
RFVQNETSAKLKELVNKLLDQINAQKNPDSPMLKQGKNLNLAPNFANELKVLSTELAKSD
TFTQVLDKLNQILKPASEIKNSNLAPLLKNSGIFFEAKLKDALNEELLPKSFHSLISMIK
SLSSEKIGAQIAQLANANLSPKDTLKELRNIIYSNKNENKQILNQSSFKALLNLSSKLEN
FKNYIAKNPSHTQEKILPIASKIAKELNAIKNDFFKALNRPENLMIKDTELLKQSAKAFE
KLENTLKNILGDHFPKTPQKESILESLLNHKENIKNENIKNELIKNENIKEDIKAQNEDI
NKNDEYTKDESPDSSIKQEESEEKSPQVPKKENSLDDNDADIKQDIKKEENLESQEDFHP
KEDQNLDSKTENRKDNTQDSKNKTEENQAENNTKNSTSNQDKIKDEKQEKIKENITKENP
KFYETKTENKTSANTHNPNNNPSNTQNTQQLNNQTAQNIIKNQEFIKQNIVKNLAFSVEN
LDLEQVRDLSKSLSNLSRKVNESLKELEPHTQNAKLNQAELKTLEHKLNLSIKDLAQIKP
KTEQDIAESLHHDVKSTLLQISNLAKNEGNEAVYNQANRLLAQIELNQLMSLANDSINTY
LPFSWEDLDDSKIMFRRGKKDKFFAQIKLKFAKLGDLEILISLNNDKYIDINIMAENVEF
RKTIYENAHELKRNINKAGLLSANFFVGDIIRSKFDTRNAKNLDLEMGMDKKV
>fig|195.2130.peg.1798 hypothetical protein
MLNYSIIENSLNIKLECLSKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNLE
CIHGGKVILKSNKGKTFKDDGIPIMLESDLLNSSIVACPNTIAGVSVPCTKVVNVKGSLS
QKKVNNEYVILQELISACKTDKGFALKVSFTPTKFKFDHSFDPEEGLGEQSKNQIELKEP
IIRLHYKSDRFQKDNLPIYNLLINNEKKEQNKALNEFNIDLKDLKDIEDINILNQ
>fig|195.2130.peg.1112 hypothetical protein
MAKNVVELHNKQLEKYSDSLNEFVQKLGIPIDVFQNCDDRIAVISNLESIVYKIEKHKLQ
HANYISKFIASISVGLFDSALNYLWNETILNIRNKIIQYDINYFLEQSSLSENSKLQIKS
DEDLSKLNDYELLKGARDIDLLSEVGYKQLEHIRYMRNEMSAAHPNNNGLKPFQMLSFLE
TCISEVICSQESEIALKVKKLLGNIKKQAMSKSEIENISAFIQAQPSRKVISLALGLFGI
YTDKNTPKFVVII
>fig|195.2130.peg.4 hypothetical protein
MFISSKTELIQTIKNLTINNKEVKQIDFIYPNFSILHAILKNIDFHQRKMLSKNQILTME
ILEILKQTCDNHNNIEINIHTLNELDAGQNVNLKDLSSSEICTKVYLEDLEEEIQDKKQG
KDFNLFYHTDKNNLCIEFINTLKELAKDSEDITTLDELIENIDPDDISSEKFDDFKKKVL
EKIGNVIESDFFKNSISPTLKNTYEKFINELLEHIKKLAEEKEYEKIKIILSAIAGVAIA
TVVAVLTGGAGLAILAAGLFSLMGSASEYYEFAQRDYGTLLTPLAAFLATRCAMFIHYIN
SRLLSCVLIIDKKEIIDLSGFGLYLGSDESNIASNLAYKITLSEEIKSIENIFSEIFLNS
EQKDKGYKNTPNDSKSSNLPAFISTQKLSNLYLKNNAILKNLQEDIKQFIYFSYIESPNF
NSSKLAEFFAQKNQNAQIDLNTTKMSKNYLIISNIPNKYNAGLSESLTQEIANYNIQDKY
RRIKKNIDTSKKTYDSTRDYSEYSIEMPQDENEPYILQLSPFVKISKEAYENSKKAYEDM
QKVYKYLTNFVATPQKLPEFAKTAKEKLAISENEPMIEIVKKTENLRHCERINILAYIDY
NKKINDKKWLPYFYIKKFFKQNEAKESIIEKEKKIAHQYLTFLKKEFFEKSDKSSFGNYS
LMECLFISFVLYQAKLIFPNINLDLKKYGGSNFVYIKYLEETYVLWTDECPIYVNNEPTN
ITAYEVVSQLLQILDKKDYSFVENDSSITIDDFFNELSKDLDTTNTLDKKIIKLKQMYHL
DEQKCIKEFMNLDEETQRAFVAWMDIEKQISDLSKLLEQMYGKEYLNKAKEQKTSEIFTY
AMLKILLSASPFISFTAQMLWDFNFLKTIEYVIQACIKINKEGFKEFFKEQLGIFAPPKK
NSIYHIHIKSNLIIKARLQQIEKELIHTKIQMILAQEIKSNLIIQKNTSGLNLFITKIKE
YFNEKQIKIYWSDKYMKQLFIYSNQESNISKIALMHSIDIQTQKYTIYTYAKLNKLDLAS
IVTGEFVGIFLNYLFPTNFKALQEQYESIVYQLYTFKDDSPLAVIRDHFVTYPFAINSKF
ISFDLKKIFYGIDLCTGVFDTHFSFHYEIDQKLEENKEFLLKRLLSYLIIDEKRNATALE
DIKEQKYIIDDYTFYFKELKSLELKKCTIYQLPCNHPLFKEFRNKEKQISAFKKDEDSPI
HAYNEALQILQDFANGIYNTSKDKTGRYIEDKNKARRLLEKLNIIGQNNLKAMYMGINKK
QDNLQEKEGDEEEKNEEYTESATKNKQSQKLPPNFIGRLATTIIIEDGLYMG
>fig|195.2130.peg.1113 hypothetical protein
MWNNLKDSAKYKIGIKIGEYTAHADSYRSSKGKELLEHVNNGMSYLCEENKIVEFKRGLE
ELIVTHNSFNNFYTEPTYVNKIKQLVGDKFFIPKDIETEYVFTIINVFLGNGCGISWEAN
EIYLFLIENFTENQIKLAIQSILEDEINRKLEFSQIAREQFLKMIGIFKKKLKNSNLIKI
C
>fig|195.2130.peg.1756 hypothetical protein
MKIKNFTLIASNHNLEIELKNLTKNANKIIFICSDFDGYKEAKNSLYKTLHTIEDNFKID
NTKTFKIIHLNQANKDEITKEQKFSSDKNLSSIKKIIFNNLKFLNNAINQNENKTLNKII
DENNVENIENFLKEIQKELNILLKNIKESNYFEQEIKPKIQLTLDTLFNTLLKNITQSND
DEYKQIIRAIAKFFINILDSVTNLKKPVSLVKKNPYVFVVNTLFEAYNSSAEYQEYKEQK
YYYDFAYPLLELITSKLYPIIALCNEEILSDVLIIDDKVLLDFSSYSNVPSISLYKNSFY
KVILDEEFQGIFDNFLENNLKFENEKLDNTLLVNSSLNNFDTTLKKAINLNISKLNHFFY
AEYPDLNSSMLVEMILDKKNTDQINTTKMGKNYLLITNPPQLNNAGLCEDLYQKKLGAII
KNRPKALTKNEKLALKGDFPSKRDYGSYFIERDVKKEDDYVLQLCPFVKLDGQIYQKYKG
YFNFYNQTYSWMKLYLLEHINERLEYEKVKQDFAYIDNFFKLPKELEEISEKEKEKVKEY
IRLFNDYLDNINSRYNQIQSNLNSEPLMFKIYENVDFKKYSPLTVVLLTLTLYVLQKDLA
FTQEYSLGVKNIVIPNLDYSDKEISLNYQRIKIPNYFNEYILFIPDDIYFYDNDKKIYIF
LSKELNKNKKEDEVIYLDELAKAMFENDFEEEDQTYVNFLKTLNESFDEEIEFEENIQTD
KTLPSKKDLDKSIQDIMLDKELAKLSIDITFFNIIKQLFPFTEFFMSQPDFFKKMILFFI
DSSLDKKYYGNKLFSSFKAHFFKELGIFYALSPKGRFIKINPKSKKSLNKLFLYQIGTNY
YYFNQLEYASELKKSKSFSRLDKAKQIHLISKVKKQLAIDFSIKMSKDLSVDILKNLAGS
FIDTLLPTNYERLKILYEKLMYEKFTYNYDFPLAVKKEEYITYPLLINSRFMSFDLSEFI
FGSLLCTGGLNYYPSIACATTSSEAREFALKRLLSYIILDEKRSAFMEDKINEGKYILND
KEFFEKNNIELRNCNIYKLEHFQRKEEYKIQHPVIKQHPILAYNDTIQILYEYANGIYNT
TQDEKGKFIEDRQKARRLMENLEAIGQHNLEVMYKGINEEYVDNERNRRKEKEDFNDINK
IQDYSNKFIGRLATTIIMEDGLYIG
>fig|195.2130.peg.247 Filamentous haemagglutinin domain protein
MEFLKAEIKRLERVYQKAMQNDLLPYDQLEVVYKNTQEKIDAYYAEAQGLLDILKNKNKP
FLDDLITKEYSFEDKYTDIQGTFAIAGSSIDANAIENLADKPILSLPENENSGDSQTTNN
TDSTDIVNTFSKQVKLTSTESILILPAEETQSHIKEDERERGRVCITSDNAKTNNPCIAI
TF
>fig|195.2130.peg.1818 hypothetical protein
MDKVEVKLKKSKMTTTEKLILTLWLSCGVAAIVLLLVYLKIITSFIGILGLLSVSSLVIA
FVLFLAKNIKIVPYDEKKH
>fig|195.2130.peg.1790 hypothetical protein
MYAISFDMNVSSLQLTYNSNYNNAYYEIQNILKEFGFIRIQGSVYTNDQSNSLSFVYRAI
EALKQIDWFKQSVVDIRVFKIEDWSNFTDIIKN
>fig|195.2130.peg.1792 IncF plasmid conjugative transfer protein TraG
HYAGVDSNVNSNGLHEQTKHNYYDPKGTMTDHNKAIDDLNSRQKGFMATRAVENMAARGD
MQGLSHYAGVDSNVNSNGLHEQTKHNYYDPRGVMTDHNKAIDDLNSRQKGFMATRNAPND
VKSEGLAGGIQRAVNAAEYKAGTAIEERNNKIDYAGIQKDIKDGKADISKAIDFGNQNRN
M
>fig|195.2130.peg.14 hypothetical protein
MFWAYDKKCIISNNYTDYVGVKPYKYSIFSDKPAIYWFSPSERDARISIFYFEKYRG
>fig|195.2130.peg.1778 hypothetical protein
MIRLKKILKISSFILFPLIIIWSMIFGWGRFMPYSLQPSYHEFKEMYKLEPKIYQSNGGK
IDKEYYNKLLAYFNTNFEEVLQGNKGIANVSNSQYIQRENIELYSFNEDRDKGRLSFSLG
LDIEKNKTTNEILPLKKFFSM
>fig|195.2130.peg.1 hypothetical protein
MDNKQQINILRDMAELAQASYGYFQFDIKDEDKIVTFENVLDITYKNSKIIDERGFKIGK
LDGDFSPLQAKQFFSRYDLLIHQPNTESSFSATLFYDKQKDEFIIGFRGTEVSFKDLKAT
WETALDTTQDLVLSLNGNLQSSFLLEFLEQVNKIIKNKHKRITFVGHSLGGYLAVVAMQF
CDTIDR
>fig|195.2130.peg.708 hypothetical protein
MGLNFSTQKYLNNQNYKKYAKTMAKLIRKTRGVKGKVEICYEGTPQKRVHKCNKF
>fig|195.2130.peg.1822 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
LNKTIQEKDIIINSNTNQIDQLQNNIQEKSTQLNQLQSKLSFQTQYGTAKSRIQNQLSYK
LGQAMIINSKSLLGYLIMPMILLNIIISHKQAQKAYKLKIKKNPNLALPPLESYPDYKEA
LKEKECLTYKLGE
>fig|195.2130.peg.1826 hypothetical protein
SSLVIAFVLFLAKNIKIVPYDEKKHGKEYEIAGYIESDPRKYDYIFHGIRDN
>fig|195.2130.peg.1084 CRISPR-associated endonuclease Cas9
MFRVDIFKHKKTNKFYAVPIYTMDFALKVLPNKAVARSKKGEIKDWILMDENYEFCFSLY
KDSLILIQTKDMQEPELVYFNAFTSSTVSLIVSKHDNKFETLSKNQKILFKNANEKEVIA
KSIGIQNLKVFEKYIVSALGEVTKAEFRQREDFKK
>fig|195.2130.peg.1777 hypothetical protein
MDNDISRVGLNDALSKRTIDFVNRFKLLKHRPNTTSGFSATLFGEKRKQIDSKTKEESHT
SEYGYINYILAIRGTEMSSFKDLFVADASLAIGSIPKAQYDDMLNFYETCIKDYPQIKEK
DSLTITGHSLGGCLAQLFALSICDDKNRNNIKALYTYNAPGARKIAPPYDYIVKLFVFHS
KEQQERFIKEEIENIANRARDLGKDNIFLESKIRKILHKIIQEKQSQYYGITMSLSTHTT
MMTLDINAIPILADIAPYYRQLAYNNIESKESV
>fig|195.2130.peg.1787 hypothetical protein
MSEIVKYHNDFNKIQLPSFTEIEQDLLCGLMVKLKEEKGKVTFYPWDLRNILKSSYDNNS
LMEFASSLKRKFFKADFTIIEKTTRGEKEVEAHKTINLFTEFAIYVYASSKELESIEIQV
NPQFEYILNQLTANFTAFELSEFIALSGKYTKTLYRLLKQFRTTGKARFEWEEFCRVMDI
PQDYRQSAIDKWILKPAIKELSKERNLFDQVRVPFKNLAYEKEKAKGTRGRGGKVSGISF
TFKPESVLMQKLEKESQKIMSDEQKYLKILNNMKLNQAKFEYDYKLWQFNDFDFNEFKII
AIELVRDEYENLNFGNFMHFNAKNQEQFFKMIDTFRKGIR
>fig|195.2130.peg.1788 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDVNKEDYEGIKSVISNHAIESIYMNELDIIAMIKQSA
LKLSADEIIAEYKKKRFVEYAKSCHRSLQS
>fig|195.2130.peg.1505 hypothetical protein
MPSLSSKISFKFQFGHVLGRYLFFFGLIILFGLFDSDFWEFFKFFLQIRMILIPLRVVYH
PCALSFRKFFFRQNFLFFRKSFLFGICNFTNRCNYYAIFRTNLQNIFLNILCVFQGLDVW
QKYHQRLLGKMYTQFCLSFLS
>fig|195.2130.peg.1828 IncF plasmid conjugative transfer protein TraG
GIHDVSNKSYYSPSSVGANNAHNNDTVANQNSLNNLGTAGGNNIRNEFSQQSGAAISNFK
NQGTSTSNVVNNSAKDAIVEQNANRRMGVNPSSYAIQDASK
>fig|195.2130.peg.5 hypothetical protein
MSETYKIYTPNGIAVKVDKETNKIYFVESLDSHPPAKGNYTEEYSKALFEAHNIKRNSPY
KDYKPQYLDPNFYTGQKSTLVEFKEWQSIYLKDPIKGAIAPWTKAEKAYYKSLKTKRERY
KYLAIRSGLRSVVIDIPYDAYANVDEKGNLINEEYAYIYDEVSSHRGTLKSYSFFNEWEL
SALLLGNIKASPTAAVGFKARQQQALFLQAQLGDKNAFKSLGLAVLCSNSFLTGQHWNKL
RAKMIYDLHDYHYESLLDEFGMIPFLDEIIGVDWVIDLNRYKFALDEEGRIIWALYDDIE
KGKLKDPRDVDSTSESRKEFDHYMDGYVNGMETRFDADIPNDWGDRQATLFKDTLVLSAK
LAALTPPQGYPNAPRYYSPERLEIIYKRHKLDKLLDPRIPAIYRYNFPEDLRAKIRTYAK
EYNIKE
>fig|195.2130.peg.1757 hypothetical protein
NKALNEFNIDLKDLKDIEDINILNQFKQDFSKDYEFKELNLSFDTNLIKLYFIIPKNIAK
VYKSAYKEFENKDLGVGYFTQLHEYDKIIKNALEDNKELNEYHFSFLAPAKMQNLKLQIA
QGLDEILEDEDRKQELYVCKFVVVNGVKI
>fig|195.2130.peg.1773 hypothetical protein
MKKHIIFIIFVVYLIACFLFALLAGAIGHGATPYKIATFFITLVVAPLVPYVIVSLVIDT
YKQFQWWKILNLIFLIIPIYIFLLDYGGKQMDNKILIQKLRDNAELAWASYGYFHLLKDS
KGISRKRYALDEQGNKITDNSYLRGYKEIEVTFADILNLQLNRQEVLINQTTSNEFLSSI
LNKLDDTFNFDALKGEFSPLQAKQFFSRYDLLKHCPNTGSGFSATLSYEKTERIKRN
>fig|195.2130.peg.1799 hypothetical protein
MIGKDFLYSIHKDKKSIYLFCENKRIIDCQSIYDELYKLEATTDFTFEELQNYQAYIFLN
STLLTGSVELPNNPFYFGELDQDNAIKQDTPSYYFLLKMKIVAKEDLASFIKMMNFACLI
ILL
>fig|195.2130.peg.1791 hypothetical protein
MYIIKTFFVFSLVRDFFIFYIFLYIFMGLSKPYVMGAIEILRVEI
>fig|195.2130.peg.832 Integral membrane protein
MDFNSVLFSIGDKLPKDATSTVMLKEKFDRLNEDKQKEVVAQLPMIKLKSPALVFWVGTF
LFGAFGVGRFMIGDWVLGLIRLGITIVAMFCGILMITYSALGIIYGLLWLVNWI
>fig|195.2130.peg.1783 hypothetical protein
MLKKYTKKCNKKIKYQYSGLIMLKPLFLGSFAFLKKCKKLSQWT
>fig|195.2130.peg.1821 Motility accessory factor
TWNDYRIKLEYLFACNDQKAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFELPKS
LTKNRSDKLLVKFKEKIQKDQDNAKRFLDDALALKQILENILSKDFILPLEFLEKVYQNI
ENFNHNLDTDEFIQD
>fig|195.2130.peg.243 FIG00638667: hypothetical protein
MNVENNQVFYHNVEAQASGEGVNRESSVYIRAANLAKNNLFKASNYWATSMLNIYGIREV
EESKNNQVIFNNVGFNTDRISEGSELILIGGVGKRVHHNLLSIQDLEIGAYDKEKDFIYI
AASAIPDTNSNLALSYGNTLYIGGDVSIHERSLLNVLSGV
>fig|195.2130.peg.1413 hypothetical protein
MLLKDELDVLLVYSFSPDFLAPALSSLIHKNLGLSEKTLCFDNIAFCPGFLQGLMQAFSL
LDNENIKKIAFICASVKSKKIPKKDKITYLSNSDSASVILLEKSNTKEKAFFSQKIFSKL
ATEETFPLKCFKEANDFIDMDKNLTFSHLN
>fig|195.2131.peg.381 hypothetical protein
MRFYKMLLALILSTNLANAYDTTTIIYNEDKPIFKLDFYNKGENTVFLVKLLPLPIL
>fig|195.2131.peg.81 Beta-1,3-glucosyltransferase
MSILKKTKKLFKDPKLFFKDAIEKKVFWLSKVYKKYLPKKYKGFTQYTIISAVYNVEKYL
DDYFNSIINQRLDFKKNIFMILVDDGSTDNSANIIKKYQKKYPKNIVYLYKENGGQASAR
NLGLKYMQENHYKTPWVTFTDPDDFLDRNYFYEVDKFLLTHQDDDICIISTNVFIYNNIT
QNIQVHPSSFKFQNGNILKKIKDLKKEVQSSTPAFFLYDKLKNMQLFFNEDKILLSNFED
GLFCYEYLMDNLKLTIGYVATAHYYYRKGLENSTTSKSTLNKDLYLEIPRVVFNNLYYKW
VEKSKNSIFVQNIILYYYIFQIKDIINSPEKLSFMSENEKQQYLELLDQNFSHIDKNTII
DFNLAGCWFFHKVGILNCFKNEKLPFQIAYIEDYDPYKEQILITYYTGDDKDIESIRIDN
EVIYADYEKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEILINGEYVKITFQKKHHQSIK
IQDIRKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEQEIVFALRKESSDWKR
LEKEGFNLIEFGSYEFERIIKKASKVISSHLDGCCMQYVRKYDKIFVNLQHGVTFATDVS
RWLNSYPQIKLMTLCCTMEQNNIATNYNRYIFSKKEAKMLGFARHDELLRKSSLYNEKVI
FIMPTWRLNIVGKVIQNTGIREFNDVFLNSQYFLKWKEFLHSEKLKKLSEKFNYKVVFFP
HFQSRLYLDYFETPSYISIDARNNGESLQTVFAQSSIMITDYTTAASEMAIQGKFTLYYQ
FDRDEILNGQHHQQEIKFNYDTDSFGPVSLTLNDLLLNLEQILDNKVNLTRYKKNMDTFV
FNDQKCCERIYNAILELENSYIPDFDFNYIYNKASIAQKKLMYSEAFLKWKYLVQNSKDY
SKDVLYQLLYCARKSFNYSYAIDFIESNNFLLDDNFIKKEYIRFLILNGLYMKALDVICA
QFSIKKEHCLDFYLIQLELCYLANREELFFQIYKKLVNNNFITELELNMRITFFQKNMIE
LKSTECDTDKVSLFVRIENFMEKN
>fig|195.2131.peg.1172 putative anion permease
MLASVIFIITLILLFWRPWNLPLWLIAIFGALFAFIFKLVNLEDASFVFNLVWDSSLTLV
GLIILSFSLEVLGFFSFIAIRILRLSKLKNSHAIHTKKLMLFMLAFVFCLSALFGNDGAI
LIITPIVLALFSTLKNYKESAILSAFLLSVSFLCDASSNALIISNLTNIITANYFNLDFL
EFAKTMFLPNLFVLLSTIIMVFLIFAKILPKGLEINISSNDCISVKLFIFCVIYLIFFVS
SFFIGEIYNLNASFFAVSGALLFWFFVCFLKKREALKIIKNVPWGIFAFSFGLYMVVFAL
HKVGISDILIFIYDILAQNAITAIFGTGFISAFLSSVFNNLPMALIGDLALKNFPQSMVY
AHLLGVNIGPKLTPIGSLATLLWLGLLAKKGIEISFWKYCKFGFLITLPVLTCSLFALVL
QYQNKT
>fig|195.2131.peg.165 hypothetical protein
MPNFFGGLLGLVKKLILWNIQSLVLLIFIKILEFVVLAKLFGQVIQV
>fig|195.2131.peg.1130 FIG00471788: hypothetical protein
MPKISILTPCFNHEKYISAYLQSVLNQTFNDFELIIVDDCSSDQSIKEIEKFHDPRIKLI
KHEFNQGINAALNTAFENSNGDYIVFMASDDMFEFDALEILYKTLSTSDAIVAYPRTLWI
DEDNNIIKSTHKEISQDRIELLHYLFMKGNGLTSNGMMIKKDFCDFLPLANSMCNQQDTQ
NKTIEKYRKYKKLFNYSLIFSSIIIMVFISILLLG
>fig|195.2131.peg.164 hypothetical protein
MLVSKAYEIDSCDDVELGIKRESKLEFKLCFDDGKEVKALVFIIPGLGGDADENYREHLA
EFVAGEFNVAVVSANYHCIGNRPQTGSTFYLDDIDKLILKASCEAIDIKLPYDVDKIQNY
KQMSEIFHFVNNQIVEGKQKGDFAPNYFLNLHVSLQPIKNEYQNFGVMQAQDLLNVALYL
KKHAPFDTMGGGYTSYHDR
>fig|195.2131.peg.1216 hypothetical protein
MDLSYPLFINTTNSLYLTGGYVYRKLEDIYGSFGIDFNKESNAFYLGTEGTIGLIPNNIL
SYNTQLTYGDIKPKSVFLENSPVMGEFWKFNAASNNAYYFNNKISHILNISYQKTIGDYQ
LDSSETATLGGAYGVRAYPNGFGEADSMILTTIGLRFNIFNPNFYITPFL
>fig|195.2131.peg.1217 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISHYKNVPQNENIENTLKSKQSPL
DIKMDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGINEVWL
RESIIALKRSDLNVETLQEIVNIVSYYFQYHGYPSATAYIPQQEITDSIQINIMLGKLGE
YQVKNYSKHLKESAISSKLKESLQGKILRTKALEDAIYKINEMSGIKASGSLVAGSEYET
TDVIITIEDSKKANAMLFFDNYGSKGSGVYRAGVSGALNNLLGYGDSLNYFAQLSDEMQK
SYGFTYNFFLGNLKVSPRVNKSNYELGEEYES
>fig|195.2131.peg.1761 hypothetical protein
INPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTKINFNLNKFDIHL
ALSFAISLNFIAKNEQNKLYKFVLENNKLIYDYI
>fig|195.2131.peg.166 hypothetical protein
MIRYILEPKHLEIQANYPKPCYISYHSFYDKNIAPPDEKIELYKLLKQLDFNAELYMIKN
PDQVDGKFIKNLEHGMGMSIKTLISKELPLMLEKIKQNSKKDCKEKYISYPCEDLLYQFS
EKDDKMSLKIDKI
>fig|195.2132.peg.1869 Motility accessory factor
IQLLILFDMKDMFEYLSLYEMFVNNSFYKQFCEKTWCETDEFCKKNIEIVIRDSGLNSNL
SFQSYFHFLQNIPSMLKSIPFQRILNERKNKFENAIVVSAGPSLAKQLPLLKAYQDK
>fig|195.2132.peg.320 ABC transporter, permease protein 1 (cluster 1, maltose/g3p/polyamine/iron)
MIWIVFNAFYVEEDEIYSLANFIHIFESKFYLQSIINSLQISFISSIFGLLIGLLASYSL
FVLAPSKICKFLFSLNTMISNFSGVPLAFAFIIVLGSNGVVNVFLKNLGIEPFISVYANF
GVNIVYVYFQIPLAILLLLPAFKSLENSHLNACKMLGGGNFLYWLKIALPLLAPALFGVF
VILFANAFGAYATIYALSSGNFNVTPVRIAV
>fig|195.2132.peg.1820 Motility accessory factor
VMYERGLKISLVYKENIVDNASFITAYIKAYHEWLLYFIEKLEQRINIIIDSFKELP
>fig|195.2132.peg.1081 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKIIGVVIPIYNVEKYLKECLDSVINQTY
>fig|195.2132.peg.1669 McrBC restriction endonuclease system, McrB subunit, putative
MKFVEFNFSNGEKIQTEIKESNEENFRAFLEKRLKNFDQYIKATKGIIEECKRLNIVNRD
DFDTFQINSIELLKKLLFELKKGLLQEYNNKSGNGCPHACINSHYLEFVKYVNAYKEYTS
KDMVKYLKTRGGDKEFKVEIKNQKIEVIASVDNIIRTYSLERFLRYSVLGKIEEDSSYAK
PLFEDILNNSNLSIIKLSENEKIYKEQHFENEKILSENQNLSLNQILYGPPGTGKTYHTI
DKALEILGENLESRDEKKAKFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPSLNSDENSQI
NYKVKDGIFKELCKKALENRDDIESFNFYINDLKEKTKEDANNPEKYFQLPNTKYSIQYR
GGKTFRIKFDDMSKNHKDYPVSIDNIEKLYKTSNIDEIYNSAYVKAILNYLKSQGLKDYK
EKDEKINLPYIIIIDEINRGNVSKIFGELITLIEPSKRIGESEELKVTLPYSGKKFGVPK
NVYILGTMNTADRSITSLDTALRRRFEFVEMMPDPDLLKNVFICKDVENPNKDEDYLGDD
AKTEGFAEILQNILISINKRIEFLLDREKTIGHAFFMSEAVKFNKDNWCKPDKYEEDWYV
LSISKLKSIFQNKIIPLLQEYFYNDYALISAVLNDNGMIEKCEKDDKYLQKIKNLDNVDS
EKIIYNIASFDNKIWNDIKTYQAIYNDGENQSKNDKQ
>fig|195.2132.peg.967 4-carboxymuconolactone decarboxylase (EC 4.1.1.44)
MGQSREDLLNIIAALIPYIGYPRALNAIAVLDGLTLKA
>fig|195.2132.peg.1873 Motility accessory factor
ALALKQILENILSKDFILPLEFLEKVYQNIENFNHSLDEDEFIQDGILKAVMYERGLKIS
LVYKENIVDNASFIT
>fig|195.2132.peg.1253 Chemotaxis protein methyltransferase CheR (EC 2.1.1.80)
MEEKINPSELELNEFIKIINEISGIDLNEKRNILVLKLSKFVSSTGVKTFAEFLSKLQIN
RQLRQDTLDFVTIGETYFLRELSQLKEIIFYAKSLEKTVNILSAPCSSGEEVYSMAILGA
QNFLKDMMILGIDINSNVIEKAKVGKYQGRTLQRLSESEKRRFFTDIGEQTFSINKSELC
TCRFELCNVFEDKFLRLGKFDIIVSRNMMIYFDYDSRIKLMERFYQILADNGRLYVGNAD
LIPETTFFKKVFSPRGVYYEKNLIIFS
>fig|195.2132.peg.1343 Small hydrophobic protein
MFFAPLKGASLALQAYLGSLVILGLGLNCLQFIANSLLLG
>fig|195.2132.peg.620 Putative methyl-accepting chemotaxis protein
MQILNKGENNESIRNFTRLYFSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISR
QAIDFRGSIHDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDS
NVRSMMEDIAKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLID
YQELANQELTQIALLESKSFRFIMMGIIIIALIISIVIAYLIVRYIKKSVGGEPRDVNRI
ITEVANGNLTQPIHTEYKQSILYSISRMQDHLRNIVQKMITISNELNHKADLVVDRISET
EKAVIFQGETSRESALKIREISQKTQNVSKMALETEENSKNTTQVCQNNKKYAEDTASQM
EYIASNSSRVSQQIALLSEHAKNIGTSTELISEITDQTNLLALNAAIEAARAGDVGRGFA
VVADEIRKLAEKTGGATDQIAIINKQIQEETIATVGVIEESIPLISQGKSLSEEVRDSVD
LIYKQANDSLFKAQEVNQEVAAQVKLMEEIEEKIITVADISSKTQQAVSENKNAMTELKN
ISDNLQAEIAIFKL
>fig|195.2132.peg.1863 hypothetical protein
LDSYRNYIAKNFDVVTINVFYHCFCQRRSDVEKYSTYKYFQEEDIENIKNLLNQFHFSYG
EINNDNALFLANSLVKHVENLKMQNKLDHNFKLNFTSTFIPPNGDYQNFGIMAALDHINA
LKDLVKCFPKFADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSG
>fig|195.2132.peg.995 hypothetical protein
MHLYHYALLSHAAYLNLNTTNIFLNIDRKTLFKVLTHNIFQKECVTIGKFEPLMAFYFIK
RFDLLAHINEDYLDSRGGFRASLFQNKENKEFILAIAGSDLRPLKFDIGDLISDFILLNG
KIPKKQFDSLLKFYTLIKKEFCFGKITLVGHSLGGHLAQLFVLDFALEVQNIYTFQAPGI
AKKILKDIKNEAYIQKISYHFHTCGDFKKMHGINLILFKICILK
>fig|195.2132.peg.1617 hypothetical protein
MTKEKFNQLLKQANLNKKQLADISGIPYPTINAWGSTTSYPPYIAFLLENYIKAQKYDKI
KDLIKDDL
>fig|195.2132.peg.1866 hypothetical protein
MKKIFALLALTSLLTSSVFAEDFLAKLTKG
>fig|195.2132.peg.1065 hypothetical protein
MFDLGNQEIMKKYPNHKLYDYTSVRTISDINNPEGKIKEMKRDLEIDKTPYSNYVFLLNP
NDKKTIKL
>fig|195.2132.peg.247 FIG138056: a glutathione-dependent thiol reductase
MKVYGIKNCNSVKKALEFLDKKALEFDFIDIKKIDLGVLENWLKYKRFSEIINTAGTTSK
KLGLNKDKIESLSELELKNIILENPSCIKRPVIEKDNQIYIGKEYEQIFVILSLER
>fig|195.2132.peg.261 ABC transporter, permease protein 1 (cluster 1, maltose/g3p/polyamine/iron)
MKEKFLAFLSILPFFIVFTFFMIAPVRGILKRTCNYP
>fig|195.2132.peg.1846 FIG00973752: TolA-like membrane protein
FASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLS
>fig|195.2133.peg.1934 hypothetical protein
LGYGVDKEGFFTSDFNEAAGLPKDYKIYAKDMQSFVEWETGDRYFYATHTSIDIAKTIGN
AYKVLSQIMPTTSNASLSEEELTNIPYAFVLDKNLNVTKTFTKDEYEKIDLTQDRINLTF
NTFSNTGFDKISIDNIFSHSNGDVRLNKNAYINKDGSVDKGGVLMALLNSQLYGATSLLL
EGDTRLFGKITTDKNISNDEREAFQNFMNANKIQSAFSYS
>fig|195.2133.peg.1917 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYAIISAVYNVEK
YLDDYFKSIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYKENGGQAS
ARNLGLKYMQENDYQIPWVTFTDPDDFLDRNYFYKVDKFLATHQDDDICMIGCNVIFYYE
>fig|195.2133.peg.1940 hypothetical protein
ISNDEREAFQNFMNANKIQSAFSYSSNSNEWNPFEERLSMKLFIRRSDNIGNTELSRLAM
DLDKEYQEMINSNMSLEEFKTKYLDFKQRHDEFVKSLEEAEKAKGIDYDIYPTGKPIDDT
KAIEEAQ
>fig|195.2133.peg.1518 hypothetical protein
MKLPLKMRYHKDLPQNYKLNQITISKSHNKYFVSFSITYENPSVSLISSQNLDIKKAVGI
DLNINEIALSSGRLIKTNSKLISKAKYDNAFKRLQRKQSRRVLRAKKEKVKLGANFFKTQ
IELNRIYEKASNIKKDLQHKITSQIVNDFDLIAVEALQTKNMTKRAKLKNVKVKSGLNKS
ILDTSFYQFLSFLEYKTSHNGKIFTKIPPQYTSKTCSKCGSIKADLRLSDRIYICKECGN
EMHRDINASINILNRALESFELGINSLDYKQQALCVS
>fig|195.2133.peg.747 hypothetical protein
ISNDEREAFQNFMNANKIQSAFSYSSNPDEWNPFEERLSMKLFIRRSNNIGNDKLSRLAM
DLDKEYQEMINSNMSLEEFKTKYLDFKQRHDEFVKSLKEAEKAKGIDYDIYPTGKPIDDT
KAIEEAQKKRKPIQAESKSETYKDDNKMNELLKKLLENKFGTSDELEILFGMKFSDDDTG
EFNKILSLNSAPKSIDIKA
>fig|195.2133.peg.4 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MLGGSLMGAIFKLVLPNLRNGILVAVFLSFSFLIGEFLYANILVGSAYETLQVYLYNIKN
QSGHYSSALVIVYFVLIFITTFIASLIKE
>fig|195.2133.peg.1930 Flagellin
VYNVSAGSGFSSGSTLSQFATMKTSAGNTLGVKDETAGVTTLKGAMAVMDIAETAITNLD
QIRADIGSVQNQVTSTINNITVTQVNVKAAESQIRDVDFAAESANYSKANILAQSGSYAM
AQANSVQQNVLRLLQ
>fig|195.2133.peg.888 hypothetical protein
MINGINSYSSYNYTNTFSNNTPNTKSSNTVNETSNLVSDKSGAVDKILGYGVDKEGFFTS
DFNEAAGLPKDY
>fig|195.2133.peg.758 hypothetical protein
MENNQNKQEKLESVNIDKPIEKKEEDLFGRNSVAEQLNTIIKNYKEEDSITFGIIGDWGS
GKTSFVNMTLEDFKDDENFIIVKFNPWNISTRKKLISDFFTTLAKEIRKASFPKFKIKNL
KKIYSHAKFKFLSEVPNKLEDLSLLFKMSSYMIADPVASVAMSRASSIINNFNKLLSAEK
KGLDEIKNEINTALLNIDIKIIVVIDDLDRLADTDIQEIFQLVRSIADFKNTIYILSYDE
EIVSKALDKIQKDKGGKYIEKIVQVPIKLPKVSQENLKDIFIKKLKTIHIKHEALDKDEF
IKKIKENNFADAFKSIRDMERFLNAFKIEVNAINQELYLYDFAVITLLKIFEPRLYDYIY
DNRMLFIEQYNPYDHISSEIKIPENIEQEIKKITKSNKDFAFNLIGSIFPKINNQPQDYN
QLIQNNTDNQKKRITYPSSFKYYFLLNFPK
>fig|195.2133.peg.1674 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDD
>fig|195.2133.peg.1513 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRYGDTSRRANKSQSIHSDRTPNLFSFISRNDDERQGTDAARSYNQQSVLETAARND
GYERRSLKSGQKLDFVSDDEIYLGSLKDRFQKNLQAIKLSKTIEQENRYATKQEQEILNK
FSGWGGIPQAFDHQNKEWEKEFKELISTLDYAEYEKAKTSTLDAFYTPKIIIDTIYQGLN
QLGFNNDDHTKEIFEPSAGIGSFLSYAKNYSDKYHFTCVELDTISANILKHLHPNQTIYN
KAFQHHLFDKPYDAFIGNPPFGQKKILDLNDPTLNKTSVHNYFIGNAIKNLKEDGIAAFV
VSSYFLDSKNSTIRNFIAEQATFLGAVRLPNNAFKKRANTEVTTDIIFFKKGKDLNIDKS
WLESVEYYDDRFDEAEKRGMHPDVFNDFRINEYFKNNPQNILGKMNIKSSQYGYSLECLD
DGRDLKIALENFTKTLPKNIYKYQETKIKLSYYRIDRESPEYEKYSKTLSKLKDGNYFEY
NNEIYMKIGSDDELVFSKPVLNEHDTRRIKKLIALRDQFNTLIEYEKNESNDLLVENQRK
SLNKLYDEFVAKEGYLNRDANKKAFREDVEANKILALEKNYSSGISKSVALKEGIDPIAP
SATKADIFFKRTINAQKEIKISTPKEALIASINEYGRIDLKFLETNLNQPLEETLKSLEQ
DRLIFKDHKNPANYVLAEKYLSGNVKAKHKEVKKLVEDGFNEFVNNLESLEQVLPKDLKA
VDISISLGTTWIPIKYYKQFIEETLQITPKDYDLFLMEKTGEWSLKGFGYSLSSYIRSEY
ATERIGCFDLLEHGLLRKPIRIYDKKLDPSGKEIRELNPKETAIANSKLENLKNEFIEWI
YKDYDRRTDLENIYNERFNTNIEPRYNGEHLELPNFNANIKLKKHQKNAIYRAIQENSII
FDHQVGAGKTLVAICSVMEQKRMGLLNKPLIVVPNHLARQWNDEFYHAYTNANILVATND
DLKKDNREKFFSKITTNNFDAIIMTHSQFKLIPAPYEVIKKQYEEDINILEQTLEKKQND
DNVMRYSVKDLEKRIENFKVKLSDLQTTHKKSKAIDFSELGIDALIIDEAHEFKNLLITT
SMGDISGLGNLKGSQKAYDLYSKTQYIHEQNKKLYFLTGTPISNSITELYTLQRYIQPNI
LKEKGIQAFDSWASTFGEVTNAWELDSSGINYKIVARFNKFKNVPELSTMYKSVADIVTN
NDIMKYQKDFVPKLYNDKPINIVA
>fig|195.2133.peg.1121 putative lipoprotein
MKLVFLIYIASILDDINRVFFTAGILTLACGIFSIILYYGSKFEHNEEFANIAIKGMKIF
IPISIITGSIAILTPSKQTAYLMAGAYIGNQVATSEFVNNRLEKIIEIIDLNLDKQIKEL
QGFKK
>fig|195.2133.peg.1581 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAVLSLFKTS
NILENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMICLCGGGLGVLFTIPL
RRAMVVESKLAYPEGRVAAEILKVANKDQSDKKGKQGVKEIALGSFIAVFFSLLSNGFKL
AASESSLAFIWNKMAFGFSAGYSLALLGAGYLVGLAGAIALFVGMFLAWGVFTPYLSSFE
FDGVKNASELASSVWAAKVRLISTGAIAIAALWTLIELLKPVISGIKEIIKNVTISNTKS
QESTD
>fig|195.2133.peg.1859 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKALLKSHESLIYPKDLNYTLEKLGLKQGDTLCIHSELFRLGEVLVSKQEFLQSIIDSFF
QVIGNKGTLIMPTFSYSFNRYKNYDKIHTKSTMGILSEYFRTMARGGGFVLMILYFLFLL
KDIDKTTLLASF
>fig|195.2133.peg.288 probable periplasmic protein Cj0413 , putative
MCLLGREFAANTRLPLDLNKALLLFQKACKLGRLDSCVRINNIKFKLLKKLDEETYQSNL
KYFLDQNSSFALLEHITTLSKQDIKSAIILAKKKLRARHDAICAGLSYMYACGQGVEKDL
IKAKELSSKACEKDTKLCFAQGWVELFNQNDILAQKLFYKSCQAGYYTD
>fig|195.2133.peg.1142 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
TTQIKELNQVVANQTTQIQNLNNTLSTKTQELTSKTTQIKELNQVVANQTTQIQNLNNTL
NKTIKEKDLVINSGINQINQLQNNMQEKITQLNQLQFRLSFQSQHGTAKQRIQNQLSYKL
GQAMIVNSKSLLGYIRMPFVLSYIKDKHKQEQKIYQEKIKKDPSLKLPSLESYPDYKEAL
KFKNHLSYKLGQALIKANKTWYKGGYVKLAFKIRKLKKVKI
>fig|195.2133.peg.1579 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKNALKIFSFLLLFFLAYVFYVYFSFDKNTLLDDFKSRYSKILYDKNGEILSVFLNDEEQ
WHIKSTDIPKRLKVAVINYEDRKFYSHFGVDFLALMRAFVNNFNSTQRSGASTISMQTIK
LWDKKDRTYFNKFNEIIQSLALENAFSKDEILKLYLSNAPYGGNLIGYEAAILFYFDKNP
KDLTWAQAALLAILPNQPGLINLEKNKTKLLDKRNKLLAKLYERKLINKDIYELSLKEPL
PNFKPRKNIAPHLALRLLSDDNKEIFSSIDKKIQLKIEKKAKEFSYTLQQKGIQNLAIIL
ADTKTRKVLAYVGSQDFYDMANLGQINGNIAKRSVGSTLKPFLYALSIDEGIIAPDSILL
DVPTFFF
>fig|195.2133.peg.1102 hypothetical protein
MLSQIQNNTSIQVASFYEVTKNSIAKHFLRNADELIENIHYFYDYEQTKGGRQRVIKWTL
EGVYKLFDKIKKLKERSNMAEEKENIVKKVCKELGLTYRQLGELIEYNRLFLKN
>fig|195.2133.peg.5 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MNENLSLKAKIYHYAVLFLVFLFLALPLMATFLYSISTSWGVSVLPDDLTLKWYQELFHD
ERFLLALWHSLLVCVGSILLSVILVFPLVFVLNYYFLKLKAFVNILIIMPFAVPPIVSCV
GLLQLYADNIGGTAWILIFTYFTIALPCYI
>fig|195.2133.peg.1949 Motility accessory factor
NLVITQKVLAFPYYINLKDFSYAAVEFSVAHMSYFLSVLLNHKNIIFIGQDLAYAENGNS
HPDDYQ
>fig|195.2133.peg.1519 Mobile element protein
MQITKGFKYRIYPNLEQQKLLNHQFFIYNQAYNIILDLQKKQMQINKNLDKSQRTYLTAV
QLDNKVKEILRQREFSV
>fig|195.2133.peg.1948 Flagellin
ILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLMEELDNIANTTSFN
GKQLLSGNFINQEFQIGASSNQTVKAS
>fig|195.2133.peg.769 Uncharacterized protein Cj0990c
MKITFQGKSDEYEIEKSYFYNRAFIVKDKIPNRDKIDFITDSVRLLEFSDHSFEFDEILK
CLYDENEENTIIVEEIFTTSQIKQDEEPRNPPLEIKIDEAPKNNTRFTPFNTFSRIFNKD
CFIFTSDNCEQKESVKVEKNQKLNIFELLKIEDLDASFVKIEILDYDASFVKIEILDYDA
SNDSVNFDLDAFPSGASYKYGISQNTMYIILQGKMPSLLLLDFLKSFVYKNKKELACEKT
FVLMLNHKLVYELKAFFT
>fig|195.2133.peg.1716 hypothetical protein
MKLQDFDFRVWDKDEKCFLDPYTKSRAVVKNLPNEKLLNLEIELFTGLCDKNGNKIYEGD
ILYSFEDCSEDEAFKYKVVFKEEAFYLVECGDNGEEYDEDLISEFRLTELEIMGNIHENA
ELLRI
>fig|195.2133.peg.260 Ferric receptor CfrA
MNAKKLKLSILCFCLMGLGEIKAEEQYQLDDVVVSASGFEQDLVDAPASISVITKEELSK
KPIKDIGEAISDIPGVDVTMNKTGTYDFSIRGFGSSYTLVLIDGKRQSVANGFYDNGFGG
SESGYLPPASMIERIEVIRGPASTLYGSDAVGGVINIITKKIPIKPKRI
>fig|195.2133.peg.1861 Polysaccharide deacetylase family
MKIVMYHYVRNNANNLPYFRYLSFENFCKQIFFFKNHFDFVQYEDFVNLKQDLNIFEKIK
GKILLSFDDGLKDHYDFVFPKLLEHKIFGLFFIPTQILSRKKALDVHRIHYLLGKWGGGL
TKFTLNLIDSNALEKDKKQLFEGYYKELDDDLETKNFKLLFNFYIKYDLREKILDELVKH
FCSDEEIYANLYLNPNELKDMYEANMLIGSHSKTHPNFLKISKEQEEIELFDSFKELENF
SQKIKIFSYPYGDFSPYSKELLSKNNCDFAFTSIVNSKDINKKDLKENYYTLPRYDCNIF
PFGKASKG
>fig|195.2133.peg.1120 hypothetical protein
MKVIKINSSFIRPHTIKSFSVYAEQEFIVLKIFNGINYIQHFKIFQNKELDYHYIFGAKQ
NSKTVMILDEIDNLMQKLAANTSLEVKRLLSKRKGSIFKNETMFLDCELFNFLAKSEEKN
NIELLVKEYRKEQRKIGFFKRFFL
>fig|195.2133.peg.1899 Beta-1,3-glucosyltransferase
FMNIGYLDKLLFDEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKYFYRKREDGNSTLDN
SNKYSDLYLLVSRRGCLKLLQENKFYDIFIQNVCLYHFFWQIKTLVNSPEKLSFMSESEK
QRYLELLDQNFSYIDKNTIMEFNLAGCWFFHKIGILNCFKNEKPPFQIAYIEDYDPYKEQ
ILLTYYTGDDENIESIFVDGEEVYADYKKIVKYDFLDRVFCYQKRLWAHIPKNAKDKLEN
FIDGEQSKISFNGKHYQSINIKDIRQEFQKRLPKSNIWLFADRDYEADDNAEHLYRYIMQ
NHPEQKIVFALRKESLDWERLEKEGFNLVEFGSLEFERIIKKASKVISSHSDEYLIRYIT
PRQQFIFLQHGVIKDDLSKWLNSKKIDLFITSTKAEYDSIANDYNHYKFGKKEVVLTGLV
RHDALLKNNQCNARQIIIMPTWRANIVGVALGSSKRGLQSDFTQSEYFQKWNLLLNSNIL
QKLCEKYDYTIVFNPHPNIIPYLKDFNIPSYVKIANHNESLQELFCNSSLMITDYSSVAF
EMAYLNKPVIYYQFDHEEFFNSHTYQKGYFDYKKDGFGPVVEDEESLLKELENLLQNDCN
PFGIYKDNIDSTFAFKDGKCCERIYKVIKYDK
>fig|195.2134.peg.1783 Flagellin
VEYKDGDSNGALVAAINSVKDTTGVEASIDANGQLLLSSREGRGIKIEGSIGGGAFINKD
MMENYGRLSLVKNDGKDILVSGTNLSSAGFGAGNFISQASVSLRESKGQLNANIADAMGF
GSVNKGVILAGASSVSAYMSAAGSGFSAGSGYSAGSGKNYSAVITANAVVISNTSAVSKI
YNVSAGSGFSSGSTLSQFATMKTSAGNSLGAKDETAGVTTLKGAMAVMDIAETAITNLDQ
IRADIGSVQNQVTSTINNITVTQVNVKA
>fig|195.2134.peg.1796 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
GYSAKTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPS
LKLPPLENYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMWFEIGK
>fig|195.2135.peg.495 Enterochelin uptake periplasmic binding protein
MFVGLDNANFLSSFENNVLSVAKLYGLEKEASEKIADIKNEIEQAKSIVDEDKKALIVLT
NSNKISAFGPQSRFGIIHDVLGINAVDENVKVGTHGKSINSEFILEKNPDYLFVVDRNII
VGNKERAQGILDNALVTKTNAATNNKIIYLDPEYWYLASGNGLESLKTMILEVTNAIK
>fig|195.2135.peg.1793 Enterochelin uptake periplasmic binding protein
MKKSLVFAFFAFFLSLILTACDSKSNENNASTAIKTSTTVKVIPISMSDEGDSFLVKDSL
GENKIPKNPSKVVILDLGILDTFHALRLNDKVAGVPAKNLPKYLQQFKDKPSIGGVQQVD
FEAINALKPDLIIICRRKNKM
>fig|195.2135.peg.251 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
MRFDYGFISKALNECGFGILLNRRICTIEFAQCCIESPRYKLDVLKELLGIKNAHHRALN
DALAAAEIFKHCLGKLPYHIKTTEELINFTKTSRIKQK
>fig|195.2135.peg.1833 Phage tail fiber protein GpH
GSAKELMIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINT
KEDKGVAANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLVD
ALKEQIPSLVLLNNIELLSLIGFGVYLDGDPLIKTHDMRSRVNYTNTTGLTIPVTIYAIL
LRAIGDVDVFVNNKKITTLAPNSQTPNSQITLILKPNDIYSIYTIAHPTNVSVKARLLNL
NRSHV
>fig|195.2135.peg.686 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQELANSRI
NSNSTFRK
>fig|195.2135.peg.1423 hypothetical protein
MRSSLEKVIKNYNENFSNKRDNDFAQGLIKYLYENAIIGENDKFF
>fig|195.2135.peg.1844 Motility accessory factor
ILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSVLDLSEELCSGKI
YLVDIEEERVDIQLLILFDMKDMFEYLSLYEMFVNNVYYKKFYEDIWHKADELCEKNIEV
IVRNLNSSLHIAFECYSHLLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSLAKQLS
LLKAYQDKAVIFCADGALSMLEKEGIIPDYVTNLDCRDLAMKFFQNKENKTSLNVLSCAT
HPSLVHFLDNKSVVLRDDPLYQRFNLNDFGYIDTGTHVSHFSYTLALALG
>fig|195.2135.peg.1825 Phage tail length tape-measure protein GpT
MENAGSIGIGVILGLAIKNASAVGKVVKDFSNLEKIAAKTKLGISGLQKELNTLKLNANL
RAELKAQRKGLQDELLSLGNVIRGGIIGKGLGEAISFESAMADVRKVVNFDEGDDIKKMS
ADILKMSQTLPVTANELAAIAAAGGQIGLGSKDVREFTNLVTKMKVAFDMSAEDVGDSVA
KIKNILGISLKDMEDLGDSINNLSDNSASKAREIIDVMKRTAAAGKQIGFTKEQIAALSS
SFISLGKGPEVAGTAINSLYRVLATADNMGTKTESAFAKLGISGAFLKQASFDDPQKALD
MFLQRISKLDQKEQMGVLVDIFGREFADDMATLVGGLDTYKEALKNAGDEAKKGSLQREF
DTRAATTENSIILMKNAFNSLAINLGSVFLPAISWVSAGISYLVNSITYITGL
>fig|195.2136.peg.1774 hypothetical protein
MDNTQKYAAIDLKSFYASVECILRKLDPLNTNLVVADESRTEKTICLAVSPALRSYNISG
RLRLFELIQKVKTINYERLKIAKYFSAKSYNHLELINNPNLELDYIVAKPRMSAYIDYSS
KIYSIYLKYFDPKDIHIYSIDEVFIDLTPYIKHYKLSADKLIENILFEILKTTQITATAG
IGTNLYLAKIAMDILAKKQNINKDGLCIGYLDEMLYRRKLWQHTPINDFWRIGKGYATKL
KSIGINNMGDLARYSLNNEDKLYQIFGVNAELLIDHAWGFESCTMQAIKEYKSKHISKVM
AKVLPKPYSFKKARNMLKEIVDHMVLELIEQNLTCNQIVLDVQYDKESLEKVQSYKGPMS
KDSYGRSIPKNAHSTINLDYHSSSLETICNKGLELFDLIVNADFLIRKISLTLNNVVKND
TIKKIKEPSLFADIEQKENKNFIKEEKLQKARLAIVHKYGKKSIFKASSLENGLKINSQI
GGHNA
>fig|195.2136.peg.1503 hypothetical protein
MKNLVKIKEYKGIYFIDKDKKLEDIKEISLVELQRRLTIPYELAIRYYEGKKSNYEIFPI
LNNTQTLKKNCELIALQRINGKFAKKFKIKEPKLNEVFEEWISMRKNTISKKHYEVTIFS
YNAHIKDIIGNIKIKQVKLKDMQNIVNKMIDQGKSPRTTKTIKDILSPVFEFAIKNDYIE
KNIAREIEIQKFDNKRYFTIDDEDRNALYKAIINYENLMIRAMFIFLLHGRRKSEVLTLK
WDNIDFANKIYFLPSSQNKSRKNLQFPLSSLQIEALKSIGVKNKGYIFIKEDGNPYKDIR
WHWDKINQKLKTPIRLHDLRHLIGYIGINMGISLEAIGETLGHSSIGVTKRYANIKNETI
NSTLNAIFSNFKTEKH
>fig|195.2136.peg.1769 hypothetical protein
MQKNIQDYIIDVHSCDPHSSNAYKQDLFDVLNEDFTKEYEFIDSPTLDDMVKHKQSDEVF
KVFYKKDDKIRLLRVSNMQALNRFDKLKGAMTKIILDSGFKPDK
>fig|195.2136.peg.1766 hypothetical protein
EENKKQYFLEHKESILEVFQLLDKTIKDFEFKKYKKDEKNIYEIFFIRNGKKFNYQIESE
GIKKIVYFADKITQIIKEGKIIFIDELDSSISTLALILIFNNLINTEENHNGQLIVSSHN
VLLFDVSFLNSQQIFLIQKDQHLESKIRTYYDYDIRSEKKKAYIDYLKGLYDE
>fig|195.2136.peg.1603 Putative type IIS restriction /modification enzyme, N-terminal half
MHFTLLNEKDFFNPYYRKKQIMQNEFDIFNKALMQYLERLESSQSENEDYLVANALSPFL
TMLNFKTHIKTKQKGKSEIDLSMSKDEFSKDLEVLIEAKKPNSKEFITHTKVNSKALHET
ILYYFRNREYSFSLKFIIITDFYKFYIFKISEFEELFYKNPSFKKLFEEFCNPNSLFKGN
TEEFYKEVAKLIENSKENLKGFLIDLTFLKDKQKSNFKNLASIYKTFHRDFLLSEFNPND
ANSLNNAFYKELLYILGLYESKQNSKLIITKSQESEEEQGTFYTAINSKFQKEDFETILK
LLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEVLAKEKSKRKKS
VFAYLPYLNSSLFEKQSIENTLEISSLSNDLKLFYYKNTVLKDDKCKAKKGQVGLLEYLF
EFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSFITSYMCKESIT
KVVLDKFNTQFDLDAKDISELRRSLRKEDKKAQKELLNSIKICDPAVGSGHFLVSALNVM
LSIYDELNLFDEEFYLEVQNDEILITGRKGEFIEYKRPSTPKDKAHLIQQELFHTKKDII
ENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDENYHDLKTLPNIDINIKCGNSLVS
YFETGKSLNHYPNIKERINKYKRIVKDYKEGFYTDKSHINQEIKNLKISFKNFCFADKFK
KEMKSFNDKCEKYSKKYGNFLAVDDENLKFFVSANLTLFDFDEKEATKEFANLKKEYDSI
FNLESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIRIQGLDKNSSQYYKKHFKVASK
NYDIYILFIEQCFKLIKKQGVISFIMPHKWFNADFGVKLREFAKDKISKIISFEEFQIFD
ASTYTALQWFENNSLHLKFIQADKNIKTKEEMSNFIFNLKEENFKMINNKKLSSSFWSFE
ENSNQEIFSKINQHISVKDLFRVFVGLQTSKDSVYFLKDCQENKNSVKGYSKELDKEVEI
EKEILKPLLMGDSFHRYEKPISNSMVLFPYYRQDNTDVKKMCLYDENELKSKFPKAWEYL
KECESILRARENGRLSSDDLWWRYIYPKNQTLFNKEKLLCPDICNNTHFVLDNLGEFYFT
TTIYGYVRNEEYKNLDYKYLMAVLNSSLTWWFLQKTSVVMRGGFYRIKPAYIEKFCIPKI
NSKNEKLADELINLVDEILKAKEQDKNANTQELENKINSLVYKLYNLTDDEIKIIKNKE
>fig|195.2136.peg.1480 hypothetical protein
MEISLFKAGFEASLECCDIENNHFLQEYLKLGAISQLSKWKKLALRVDFDEGEKIIFDLL
LSLKEDILRLEDSLDKNKDLLVLKQKGVVESLNFESLNFEYLNFLDEILEEGKEYYIRFD
LNNQKMAIFAKAQNKKLAQIIKIKPEDRIAFDAFVVQLQRDMIRNKKDKNE
>fig|195.2136.peg.1767 hypothetical protein
MMNKKTKPSIQIWCEGKTEEDYFNSLFKYLNYDNVKIDVKNLKNNNSYKNILYKIEKAPY
VDKLIIVMDLDRAKSDTSELKILEKLIKHIKNSKDKHLFLTLGDFEDWLRFHFVDNSKNS
KTNFYKKLGYSDSKNFKSSTNDLYSQILSKGGCIENAEKYFCNIAVFCNKRCEINKNSLN
NQTQSNLYYFRRLLEQYNGA
>fig|195.2136.peg.1781 FIG00471674: hypothetical protein
MHLFERKERLPEIVKKLNDRFIGHIINGELKIIKDNYNLQKMIIPAAYKQRVVLYIPLKL
QEESVDTIVVVEKEEVKNEQYYAVRTILNPHDNIYKTARVLSIVESEWVKNTI
>fig|195.2136.peg.1775 conserved hypothetical protein
MPNNHDDIINIKYKKSTKYPLMPLEKRAAQFAPFSVLKGFDEAIEKKKKEMERKLEKSIY
INE
>fig|195.2136.peg.1501 hypothetical protein
MENIKKFSLKLENFHSCQESWLLKNLIPKESLGLLYGSSASGKTSVCLYFCKEILKKDNE
IRVFYINADMGISSLKKYGFANLLENFVNRFFLIDLTCYDKKFMLFENICDEIIKIQSKF
NVFMIVDSLNCVTKKIGRFIDPNYLFSKEKIIRKRGGTVLFIHHLNKSGVFSDSHQIVDY
ADFSYKCEYNEEMNSILLKPEKIGRFLLEKIAFKVLNFSNLEKMEFDSVEMSSYEIEFIK
TVLEILKMGRFKQNELINLVLRNCKRYVGREKARKLLQEYAKKGKWCMLKNRFDNNSIFY
YLKNEEK
>fig|195.2136.peg.1771 FIG00469806: hypothetical protein
MKNYYISEGVKALFSVYFKDQTEENFIKALNEFAKESQINSQEIKDKSFREFKEAISKLP
TIDLLNTRFDKPEDSVCAKLDKLEYSIGAKLDKLENKLDSFKREVRTYVIILAALMFILQ
PTIFDLILSIFKSFLRQ
>fig|195.2136.peg.1699 Major antigenic peptide PEB2
MKELALKFEEKTKEKVVVTAGPTPSWFKKARKDADLIFSGNTSMMDGFIKRIPSLNLEDL
VVLNARPSGIIVRPNNRSYKPIKSYKKI
>fig|195.2136.peg.1729 Methyl-accepting chemotaxis signal transduction protein
MNSIKIKLSLIANLIAIFALIVLGIVSFYFTKTSLYESTLKNQTDLLKVTQSTVEDFRST
NQSFTRALEKDIANLPYQSLITEENIINNVGPILKYYHHSINALNVYLGLNNGKVLLSQK
SNDAKMPELRDDLDIKTKDWYQEALKTNDIFVTPAYLDTVLKQYVITYSKAIYKDGKIIG
VLGVDIPSEDLQNLVAKTPGNTFLFDQKNKIFAATNKELLNPSIDHSPVLNAYKLNGDNN
FFSYKLNNEERLGACTKVFAYTACITESADIINKPIYKAAFIQAIVVIIVVVFSVILLYF
IVSKYLSPLAAIQTGLTSFFDFINYKTKNVS
>fig|195.2136.peg.1147 hypothetical protein
MLKNITNFKELIEEYQIKIPIIQRDYAQGRIEASIIRDKFLDNILVHLNNNKEMCLDFIY
GSVKNDVFLPLDGQQRLTTIFLLYWYSGKKEDKEIDFLKKFTYETRASSREFCQKLIQEE
FNTFEDSDKLSEKIKNSSWFLYFWDNDPTIKSMLAMIDDIHKKFNNEEFFDKLELLKFHF
IKLENFNLDDDLYIKMNARGKKLTDFEIFKAEFEKFLISNKKNLFKEYFIKNIDGEWTDL
FWRLGFKNKHYLIDDAFMNFFYFISEMLHVKNKEKTTVIDFENMKKNISKLIENVYLNDE
NIDFFFKAIKYLENIANFNKENLSDNFEKNKLALFDKYPDLLIKVINNDKGNLINLQQKI
LLFIIISNFVENEGNINVVNLLDKLRIVRNLTQRIRALKQGKIDYTATLSYEKLYYILNL
SLVNAKENIYTYLINNEVKLTNTDISKDSLDQEVYKAKYIQNDNNLKCTIQQLEDYKYIC
GDLSFFLFEDKELLKFASDNITKIFTSKTHLIIRSLLTIEDYAKYIGFAGSGSKYYFGVD
NKWEILLTKNNQNDMEDYTDYLGLFYQFFKKYKSIKDEFLDYDSNEILEQLILDYLNNKG
NINYTSWVYYFIKHGDKIFNNTEKREKNYFVWYDEENFNIDKMYGETMGSKYVNTYVKIL
SEISNIHLIEDEQRSEYIKITDKIEITSCNKNGWLLKLNDKFIVENINSDFVLEKEDEDG
VYILKHNKSQDVIEMAQELINTVQDN
>fig|195.2136.peg.619 hypothetical protein
MLGIDTSTSIAIILDRPHKNSQKINIINEILNNDLSNDMSVYIDKSDLEKLEKNTLFFKQ
IKNYLYEFLQAIHKTIEHTEDSMMKEEDVLLYFSKNKTLALEFKEIFNKELNNVKQSHPN
IIASWKYYQEFEKICKKLDEKE
>fig|195.2136.peg.1782 Alpha-ketoglutarate permease
MQTTKLSKKAQIHSVIAASSGNLVEWFDFYIYGFAAVYFAHNFSNATSTLFAQIEIFGVF
AAGFLMLPVGSIIFGKMADIKGRKKAMIVSIIFMAFGSFGIAFLPDKQAIGDMAVVFLLL
LRLIQGIAVGGEFGIVAAYLTEIAPQGKRGFVSSFQYVTIIGGQLLAVASISLLFLFIDE
KQMQEFGWRILFFVGGVLAVLSLFFRSFIQDNSHKALENYADRGSFKALFKSYKALLIVI
GVTAGCTIGFYAITVYPKVFMINNGVDTILANNIMLGSLFVLCVAIPFIGAISDKIGFKI
SLFIYLGFCLVGTYPLFMALKSVALSGPNEFLLFVIVCFMCFMLSFYTAVAAISKTSLFP
PQIRALGAGLGCMISVGLFGGSVNYVALQFKALGIEWGFFVYFGVIACISLICTALIPKQ
RELD
>fig|195.2136.peg.1150 hypothetical protein
MSANETTFEIILEKLKKANLNTRSKGSMFEKLSKHLLKEKDTANIYKNIYLWDEWDKKNG
QDCGIDLIIQTKDDDYIAVQCKFYESSKVDLKDLSTYFTKLQSGVGEIKFSKGIIISTSD
LTQNAKKEIEQISKNIPIELITLEDFLNSNISWDKFDPNNSLELPIIAKKKPREHQIQAI
NNTKEYFANKNNTRGKLIMACGTGKTFTSLKIIEEITPKNSIVLFLAPSIALVGQTFREY
CKEKTDDFVASIVCSDSKSGKSVEDDIDILELPIPASTDTQSIKKAYDIAKKDNKRFIIF
STYQSVEKIMQAQKQNDLDEIDLIICDEAHRSVGNLYSGKEKDKLNTFTLCHSNENINAK
KRIYMSATPKIYSSSQKSKALENDNEVFSMDDEEIFGNEIYSINFREAVEKDLLTDYKVI
ILAIKQEGIANIANTAIAKLKDEKNVDEKYVDIDFVSKIIGTHKGLARNDLVALDENNQI
DNDFLEEMDSNLSRRVINFCKSIRDSKNISNSFKIIMQCYDEALKKDSFKNLNISIDHVD
GTMNSNVRLNKLNNLNSPKENTCNILSNARCLSEGVDVPALDSVVFFDGRNSMVDIIQSV
GRVMRKAPNKKTGYIILPLALSENELSNLDEAIKNTNFLNIWNILKALRSHDDTLVDEAV
FKEKIKIAVADYVGDDNSSNNTDKSYEPSLFDSFTLSELANTLYNAIPTKLGDKGYWQSF
SAKTAKIVEKLNIRLNAIFKEHPEILEEFLTSLKENIHPNIKEDEAIDMICSHIITKPIF
DILFDKNMDDNPIGKALDEVNQKLNTFGLEMEETKSLKALYKSVEESVKLAKSQKSKQEL
IKNLYDTFFRSAFKKQAEKLGIVYTPMQVVDFILHSVNELLKRHFNTDFNDENVKIFDPF
TGTGSFITRLLSKENNLISDENFKNKYENGIFAQDIILLAYYIALINITQTGNERINALD
KFKHIALADSLDYLDKKIQDNGLFALEFKDLEENKKIKDLIANEKIKVIIGNPPYSAGAS
SANDNNANISHPNLEKRVKDTYGKEASAKFGNSTRDTLIQALRMASDKIEDNGIIGFVVN
GGFIDATSADGFRKCVAKEFSDIYILNLRGNQRTSGETSRKEGGKIFDSGSRASVAIVFF
IKDTSVKTNKIHYYDIGDYLDRQTKLDKLENFKSVLNVPFINIIPNEKGDWINQRGEDFD
NLMPLKSDKNEYGIFVINSTGVVTGRDSWVYNFSKEKLANSMQKCIATYNEDLAKFDHQA
FLEKNKNVKNSELYKELSDKDISIDNTKIAWTRALKKDFINNEKIKEFNQENIREISHRP
FTKEYLYWEKTWNEEQSQLTKFFPKNTDENLLILTSLMVTKEFSSFIVNSIADYQTLANT
QIFSLYFYQEDGSKEYAISDFALDEFKKQLQDETINKEDIFYYIYAIFHHKSYLEKYKFE
LSKEAPRIPISKDFKNLSVLGKKLATLHLNYENNEMFKEVEFKDGVLADISNDEFYKVTK
MKKLGNDIFYNQNITIKNIPSKAFEYKINGKSAIDWIIDRYQISIDKKSLIENNPNDYQG
GKYIYELLLKIIDLSIKSVDLINEISKMECE
>fig|195.2136.peg.848 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MQNLYSEDDTRVKLIDAKLYASSWSEENIIRNYYFTDGRKLIGNKRAERKFADYLLKFQN
NNLAIIEAKKQNKDALDGLSQGIEYAKTLNVPFVYSTNGDKIYEYDLRVSRGL
>fig|195.2136.peg.1776 hypothetical protein
MGVFFKKRQIAISYVIKSLKIGILCFRVGIKMPLLKARLFNA
>fig|195.2136.peg.1820 Putative periplasmic protein
MKKWIFIVFCFILGFIIHIFYIGYTNELLFNKFIKNSNPDYTITDIYFKKGFLTSKGSFT
LNHSHTQLSTKINLKFNNYFFLNKIIKGNFTNPFDFLDEVLKNNKLGTFTLKLHDNNSKI
FLNIKDINLSNEGGDTIINGGYIEALMNKNLEIKNIKIHFDMINFSQFYTKFVLQNLNYE
QFFNNPVQFYELNLFSDSQQEINFDYLVLDNNKINSFYSKNQVNFNEENSTINLNIQGKS
NEIDIDLKSLLGQNLNFDKTKFNITLSLIHI
>fig|195.2136.peg.1792 hypothetical protein
MIKENIKFLRKQHKLTQQELGEILNVGQKTVSMWEKGYNNITLPIILKICEHFQISPNEL
LANNLADVEFHRNLRNYNRLTHELQIKNGLNDFLKSNIVNMQLQKISKHIRSLKGVGFIE
KLSESWNGNGEKMLLILLLFIKHLNKIELSHTTMSKKDFISMLKKFKISLKNIKLYSLVL
SEKDKRNIIEWAEKNLDEIDVNALFVDLRKDVEKIIINELNSFNYLIFKD
>fig|195.2136.peg.1148 hypothetical protein
MSDIKSINDLFGLNFVIPSYQRGYRWDKTQVEDLLEDIWNFCEKEDDKKDSFYCLQPIIV
KKYEQDEKKYKLVDGQQRLTTIHMILSHFKVYMDDSRYESFKIEYEIRKDSKDFLENIQE
KHKTNEKESNIDFYYMSEAYEYIEEWFSKNNNRRQEFFRILTSQNNIAKNVRIIWHEIED
NEDEREVFSRINSGKIPLTNAELIKALFLNSNNFKKEEVDLRQIEISKEWDEMEYALQNN
EFWRFLTSDEDYPARIELLFKTYYNNAYNNPTDKDPCTIYRFFANELKSDNKLKILDEIW
LEVKKIFLTFKYWYENHKLYHLIGYLNVLENKESEKSLVSLYKESSKKSKEDFMLFIEEQ
ISKHIKVKNINEIKEMSYEDDKNEIKKILLLFNIATYLESDIRFSFDKYISEKWSLEHIN
PQSGFTIKNEDERKQWVKDIINILKLLNNSNEQTNLLLNKIKKVINNPNEKIGDKKFADI
TNNIFEYFGSEDKHSIANLTLLSLDTNSKLSNHIFAIKRNRLKDDEKTGKFIPLCTKNVF
MKYYSENFDDAKNIYFWTSSDQDSYLKAIEEKIKVFIKNGE
>fig|195.2136.peg.1146 hypothetical protein
MDRILENNLANAFNELQQTLSNSYLELYSCTTNKRLQLVFSSLHNNIIECFKKMNERLPS
TEKSNKHYLANYSRKLKTNIELALHLQKEFKNSELSFEIDKYYYNIFKQCLDFLENSGGS
EIPLGMKKITIYEKISIFVLSNKINIPNILRSCTLTLIGSGSYANVYKYYDDFYQCHFAL
KRLNKAANDKEFIRFVKEYEIMRSVNNPYILKVYSMDEQKKEYIMEYADFTLEKYIKNYN
QKLSNGERISLGCQVLKGIEILWNNNILHRDISFNNILLKLYDYIYPVIKISDFGLAKEI
NSDLTSIDTEIKGSLNDFSTLKIKGFNEYNIEDELYALTQVLYFIATGKENVKKANCDFL
KKGIGEDKENRYKKLEDLKVDFISFLKAR
>fig|195.2136.peg.1442 Putative periplasmic protein
FNITINKFLNSNFNISHFIQKNLDLKIQNLILEKNKQNISLQGNLNINNSYQAKLQVISS
DEPDEIFPWTKDYGGLNQYFLKENNNFFLNLSYDSLANPQLKINGSEFSNMDLN
>fig|195.2136.peg.1149 hypothetical protein
MGIDKETLKNKVVNLLRQYSLSNESAIAIAIDGEWGVGKSYMYHKIIEEEIKEVLKITPI
YTSVFGKKDENEIIKDLISQFLTIENKNVDGIRNLIQGTFKLFGKNIDMDLLFKFFRKEH
MGNTIICIDDFERLSDKIPVQDILGLISELKENKGCHVILLYNSSKINTNSQEQFNNYIE
KIVDVTYNYTPYPFDQLELLKGLLKYPLYTENFPQEEVEKYLSNIKIKNKIDELKLINLR
EIKKIIYCFNEYFEGLDNEYLKDEYTRVLFVNIIFYCMVNAKLVIKLEDELSTISQKDTD
SISKIKNELRLCGMKEDPKNGILNFKPIDGNFIRSFVNVIKKYQKNNFFDFRFSNRYEDK
SFVKSEEELISKLFELAQEYKNNKNKISGEDNE
>fig|195.2136.peg.1780 FIG00471674: hypothetical protein
MEKNIEKLILEAYEDSKTKFNHVTTGHISQYLKRKYDLKINCSKALIEAGFDLEKDENEP
SLVYVKKATTRNKTSNRDQIQNKVEEKPLLFQFAYFPNFLNTLQELSNIAQKEFWGNGNN
ILFFYLFNILSSFTKIKAILILLLIIKTKQKHALIQDCIVQVFFQYLHTLKSRKMEDMFL
ENFVLMEIEF
>fig|195.2136.peg.1441 Major antigenic peptide PEB2
ISQVKSIKYLYNFIDFFIIYLAVISPKNIKSFEDILKDNVNVMVVDGAGQVGLYEDMALK
DGKRENLVKLRKNIKVYAKNSKIAIDEWNNNPNIDALIIWSHWAKVLGDKALFIEDEKAA
VYCTAEIIPTKKGLQNKQALEFVKFIQSKEAQKIWKKHAWNEVE
>fig|195.2137.peg.1860 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KTIQENLSQINNLNQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQTMIVNS
KSFLGCLLMPVILLGIVISYKQEQKIYK
>fig|195.2137.peg.1813 hypothetical protein
MDNAKEALKELFGISEVQAVAIERLYFKAKTPKDILGFKKYYDLTMLKKQFIGTSYEKLS
LVCAFAELDLNLRYKNIESFLEWLFISFSNRFIFQTKKGDFSYSFVLKYYDGSIVYD
>fig|195.2137.peg.1844 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KLPSLEQYPDYREAIKLKNHLSYKLGKELVKANKIWYKGGYFYFLYFIKKIKI
>fig|195.2137.peg.1833 Phage tail protein GpU
VILSLNENRSAFVDGSGFVAQSFSMDLERDFDE
>fig|195.2137.peg.1104 Hemerythrin domain protein
MDKLIPAWDEKYSINDEKIDAQHQKLFELAAKIENAVYKFVQRDELKEILTELFNYMKDH
FSNEEDYMQEISYPYLNEHKIMHKNIIHDMSHLIQNIKTTNDLKEKLYTIMSDWLLEHIL
HHDVMIGNWLSEQLLAKQEEELEKLQQEDLQQEDLQQEKQYENNPNPSPPQIKKEYDFIY
SCPCRTNHFLSYIEHLDIICHKKQLRCKKCQKNLFYVRSEIKTEKRNNDVSKVG
>fig|195.2137.peg.922 hypothetical protein
MTAYVHIGIAKTGTTSIQDFLTQNYDLLIMSAEK
>fig|195.2137.peg.1499 hypothetical protein
MIDQISLYKIFKFLKSDIYVKNNTIGKINANMLVELAQHFPGGKEAFIKHYKKN
>fig|195.2137.peg.1845 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MQKKILVSGFVLDNFLEISSFLEKNQIKRAKIEKKILHMLNTIVPSGELIHLAQGYKIQK
MYHCLLQDFDKEAKEKECFISDRNLIYIAEDWIQLDQNILFILFYESPVEVLKQKACLND
KFYINDILNSWLKYNTFLLDFYKKNRERSILINYKDFDVALCKYLNEKYYFNMVKIYKEN
SSIKSKNLFDFLLEYMLNSNEKCLNCYKGLEGYSLNPNFNSNDLPFKNLESEIINLFQIL
KISEILSIKNKSLLDFIFEMQEYIEKLYYQHGNCLKEITFKKSQTIETKNKTIQENLSQI
NNLNQTIETKN
>fig|195.2137.peg.1507 hypothetical protein
MNDIIAYDLMQCDGEYFLQTHSTNPLLKTSTIDLAIEKFFDNLDVYDSLFSVTKVQARFY
DKNAKAINHNPEELLRTQDLESMYEENSNFYIFSKNSFNLAGKKRIGLKPQIFSMNKLEA
IDIDNPEDFILAELLYKNRDLI
>fig|195.2138.peg.1262 hypothetical protein
MSEKSSKVKSCVVGLKELVYGKISDQNDQKLEIFSKDSFSLNIPDYQRPYTWEEKHVKTL
LKDVSEQANKNNQKYLLGSLILHKNNENKFNIVDGQQRLTTLALILKVLCENNQEKCNEC
KIGNFLGESKYSHNESKYHIKENYEHIKTYFESYNEKYKFLTYLLDNIEFICVLAPSEDD
AFLFFDSANSKGKTLKPYDRIKAFHLHSLEKKQGNMLDYYARKFENLAKDEKKITILFDE
LLAPARAWLRHRSVNANKIEVDEEFCKEFFSDKFLYSKENLGILSNFANGVDFFEYLFKY
DEFFNKLSNNALYQELDEIYQTGFIYNKYIYVIAVMIYFSKFPNGNSDYFLLLLARAAFS
LRVYSSSIYRATQRDYALEFLEKVYFVSFEEDLEQNLLDFIAIKNKEERKTKNEEEKHGD
EKKWYKEWYLDIVQKRFYENQHIPKHIF
>fig|195.2138.peg.470 hypothetical protein
EDIKENIEAKEVEKKNKKSVKQRLDKVSKKNTKENVGIIQTFIQPGSKNDNSLNGLPKNP
LVESPYSTQPVLSKDAEPTANGANALSKGNNPNSTQTKPKKNLMEDIKENIEAKEVEKKN
KKSVKQRLDEKIQDDKKAREERIKKIKQVIARKQKIDKVTDKKNNREIAGKIGTYTLKNL
IKLKERSEDK
>fig|195.2138.peg.452 Predicted P-loop ATPase
MSSYMIADPVASVAMSRASSIINNFNKLLSAEKKGLDEIKNEINTALLNIDIKIIVVIDD
LDRLADTDIQEIFQLVRSIADFKNTIYILSYDEEIVSKALDKIQKDKGGKYIEKIVQVPI
KLSKVSQENLKDIFIKKLKTIHIKHEALDKDEFIKKIKENNFADAFKSIRDMERFLNAFK
IEVNAINQELYLYDFAVITLLKIFKPRLYDYIYDNRMLFIEQYNPYDHISSEIKIPENIE
QEIKKNY
>fig|195.2138.peg.1821 hypothetical protein
NFDVVAVHVFYHCFCQRRSDVEKYSAFTMFTKDDVSNLSQALLEIGVNINVNLENAQQCY
ELLNQNITTLKSQRKLAQNYQAKFTSTFIPPNGDYQNFGIMAALDHINALKDLVKRFPK
>fig|195.2138.peg.1148 Membrane protein
MIEFILKDMFFAAMAGFGFAYACNPPLKTLILSALLAAIAHGLRFTLIEYFHFETLAIAT
FVASFCVGCLGIALAKIIKTVLTNL
>fig|195.2138.peg.1801 Motility accessory factor
QNSQKNEIFIQEIIQDIDKTKTQIDELYNTQKDLIQILGPLLTQFELNLARIYVLNPKTK
EDAFNKSILWIKEHLEFMELVYGHIKAQESALIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2138.peg.1362 Hypothetical protein Cj0261c
MYLAQNAKEITALDNAKAMLEILKEDANKLQLTNIKYENCTFTEWINKNQNAQFDIAFLS
MSPALQDKKDYLNFMRLAKIRIYLGWADYRKSDFLDPIFKHFNTEFKGIYKQDLESYLLE
NNVKFHKFIFDETRIVERKKDEAIENTLWHLNMNGVKASKQDLETFVKGDIKETIQSKIK
LLVF
>fig|195.2138.peg.1660 Putative outer membrane siderophore receptor
MKKLSLFCVMGLCFANFAFSEELEFDSLEISGSKIKNDEKPFVTPGATSTRDNLNSNTQS
IDSIVRSVPGAYTQVDQAQGGVSVNIRGMTGLGRVNTQIDGVTQTFFGSASDDSFHGQIG
TSSFTAPIDKNFLVALDINRGTFSGANGVNALMGSANFRTIGVDDIVQEGRVFGFLGKYS
YGSNAIGPNFMGAIAGKTMLENNANLGILFAYSGQNVSQNYKIGGGGYIGDQKPVLTNL
>fig|195.2138.peg.1019 hypothetical protein
MKHDILIISGRKDGFGARLNAMFNAWYIAQKLNCVFGFVWPKPNGPMSFFNKNNKNLDVL
FDIFNEDELFSQEFCSKYSYTSKLEPFECHLIVEKKIYFKDLLSLNKKIIYAPLCNLKEQ
FYDFDEEDFFVQINKFWNLIKINEKLQDLVIELKKQIQTIGNYSAVHIRGGEIVHCDNIR
RAGNYAYKALPIELAVAKIEEELQTNNNVVLFQDDTKTCEDIKRFFNNQNFKAKVYTFSD
FTFTKHLNGNERTFLEIILMSESSRIYSSGNSNFSRVAVSIKGVHQISLYNIFSINQQYK
ILNQYIETIPNIHPLQVAFSYYHLYLMAVKFEDKEQKTIRYLKKARKFDPENELYDIFLV
NSYLLNNEFDKAEELLKMNFNKRYDSFKKWLLNKFYNSYTSGRVFDNYKKYASEKYPNLS
HAVALIYQSEGSVKYAERYSYMSLKESPFFALYVEYLNHNLDTTNKQILKLDSEYQKINH
DIKKIQEKPLLLGAPSRIKNHLAYRLGQIAIANSKTIGGYFRLPFNLIKEYKQYNQEQKN
YQMMIKINPILALPKLQDYDDYQEAVKIKKYFSYRLGEAIIQANNTWYGGGGVYQAVV
>fig|195.2138.peg.490 membrane protein , putative
MLKNPKFQAFFFAFLAAIFNAFVGIFSVFLFKKGFMSSEVAFYKCFVASVILFAILIYMR
KLGALLVFIKQKIFTLLLLAFLDFLCFIILRVLLTQVWVWLM
>fig|195.2138.peg.1022 Nucleotide sugar dehydratase, putative
MNEILERRLKLLEDNFGLNINKMTNKKILITGANGYIGSILTLILHHNAKLYCLVRDKDK
MIKRFQEICGDIDKISIYEDLHKIKDKIDIVIHCAAPTQSDFFIENPIDTVDIIYTNTKN
ILDFSKKNNVEKVIFLSTMEIYGDVIGDNIVEDDIGKFSITNIRNSYPLAKQISEFMVHS
YSKKYSLSASIARLTQTIGPTAQINDNRVYMDFIRSAVKKSKITLFTKGETKREYIDVFD
VAMAIIFIACEKKLFEIYNISNPNIFISIYDLAKIISNKLNAELVFDLQRDTSRYLPPFI
RKLNSDKIYQLGWKPLFGLNQSLDDMINYIKDVNE
>fig|195.2138.peg.1830 Mobile element protein
MSANNNELISISHKVELKLNNKAKTHFKKAFGCARLAYNWGLAKWQEYYKQGIKKSHLEL
KKEFNAIK
>fig|195.2138.peg.1021 hypothetical protein
MNKIKKYLFKIFRFLPLSKNKIVFIAHSASRFDCNPKAIFEELLKNKAKVKYVWILNKKF
HKEYKDKYPMVSFVSPSSFKAFFHLSTCRVFINNQIHVYYKKMGFSKKPGQLYLQTWHGS
FGMKHIPISDDLNIVRNACMDMDYWVTNSVFESIVYKNTFDKNARFLEIGHARSDFLFSG
RVEKIHDYYNLQKDFKIILYAPTKRDNIFDNYNLDFVKLKSICECKFKHKFVILVRMHRN
LHFELKNDDIIDAFDYPDVMGLVKECDVLISDYSSIICDFALTYKPIFIYANDYDSFILT
SKLYHDYSKLPFGLAKNFDELEKCIINFDHDVYKHELKVWLESVGCIEDGKAGKKISSVI
RQFIEKDRDLNLYTTNQVTPYIAKIMGFKNIYFTFRNIGDQIIMMRSLELLHQKTKQTFL
IGTTLPDLWKEVKFVKVINLKEVKLHIYQKEQFDLMASYGIKPIFLTQESFNKEKGRYIR
TYGPSHIVANVCSKLGLEGDIAVDLNFPLSEKEKAFGRFAPENRKQIAIISGGLQRYKTY
PFEKLQEIVNLLQEKYDFIQIGTKKDLPLRGALDLREKLTLREVASTLYNSDLFVGGIGG
LMHMANAVGCPSVVLYSEAEPEYIVNYNNNINVFPVDNTCVKCTEGKHCPWTSPCKAEDQ
KYSCIDNIQIEDVIQAINKRIELPRNLNKPTIYHIKQKKVYGLEEQKKVGFSFQPSNKCG
VYIDKKKDKDKKVLQFNFFGIKPISFLWKNKYYKLRVLNMHLSLDKATVKFRIGKKKIIT
NQKPDLFCNVGDFEWIKGFENYCSRFLSFQKYFDRDSLGLLHYIFQVKLMSKKINKSYIQ
TNYYIKKEDIAIRNELIGLSHSVGKVFFEGQPMDMYIYNGYITLMKVQNSYVLSHNCFIR
ENYNDYIKNNDIIDIGTGNGLSSLYLSEYTDKFVYSFEASSKVYELFQECVKLNNKQDKI
VSCNVAIGSKKQSVYVDNNINNGNTTSLSVKSSSILMDRLDDIINELNIQPKMINIWVNG
DEYECLLGMYTTIEKFRPIIHINISKSSKILFSVIDFAVKNFSAYNFEIKKTIEPHIVQE
LFLIATPKELR
>fig|195.2138.peg.1507 hypothetical protein
MKITMIILSLFSLVFLSACAFKEKKASEIETLASNYGGIYIFDKKIREEILELEK
>fig|195.2138.peg.1826 Motility accessory factor
LDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMNYHITTYNCTEGGARIEGTIEKP
FLWACENLLDKDLNKPFEKLEPLSLNK
>fig|195.2138.peg.760 FIG00469624: hypothetical protein
MFKIILLISIIFGLNACKGEDMNNNEDTN
>fig|195.2138.peg.788 Imidazole glycerol phosphate synthase amidotransferase subunit HisH
MKIIIIDTACANLASLKFCLDRLGFNATISRDLKELESADKLFLPGVGTAKEAMKNLEQF
NLIDFIQNTKKPLLGICLGMQILGNFSEELNQETLKLIDFTTQKFKAKEGFTFPHMGWNE
VYSSHALFKGLEGAYFYFVHSYCVGLGKYTIADCEYSQKFSASVMKDNFYGVQFHPERSS
EAGEILISNFIKDIG
>fig|195.2138.peg.1776 Integral membrane protein
MKETPKILEKCCEETHQNHKSESDGKETADIKEELSKVLSIDKRYIFILDAKDTEQEAIK
KIITKDELFSGNEKWYLVCGKEDSKIDILLLCDKIKDIPCNVIFNNCNICLHINKPENTE
KDYKGIIKNYLYFCNCTFDKLFKKSLNLKNIIFKKTLTFNQCVFYSDLEIYQNQFLDHLV
FINCYDKRNDKKITSLDLQENEFEGCLFIKNCAIEKINLWKNKFKNRCYFVDSNFGYKDK
DNTTKLNFSNTHFKDNVYFNNSEFYSYADFHECEFDDIACFYGVKFHKIPNFSACYFKEQ
KAVNLINVDIDKLDFKSVEKYIEDNYQDETCENKQEITEEQRNNNCKLKCAKHLKDSFRV
IKDVLITQNNTLEAQEWHKLELYAKEKENHINLSVKDREKNADIFKNILIWFNCVLLNVY
RNTSDHHNDFLKILNFTVGMIVLYGVFIFFCQACIEPYSKFFNELKSSVIFIIIGILVFL
CCIMFYFNRKKSIFAKSIFFIIAMVFIVLYLVTYFYKTNEYKTILYLVMCYILSIYICYF
FFNIKNIIFNIVFKFMLYLVFLFFLINSSQLINPFTGVFSSGKLYESQFEKSLNDLNASA
IVNLASILQNDFNLHLKDQNISFTELNSAKALIIANKENLLKLNDVNSNITKEVLGEKYT
ELLKIINQDKITENTIKSTSVLYSIILLLCIFSLQKTARKNSIVPS
>fig|195.2138.peg.1018 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13)
MAIEFDIQESKILRGVYIITPNKFRDLRGEIWSAFSKDCLKYLLPNNLNFVLDKFTLSKS
NVLRGIHGDHKSWKLVTCVYGEVHQVVVDCRKDSPTYLKWEKFIINQNNQKLILIPPYFG
NAQYVSSKSEALYYYKWAYEGEYVDAKDQFTYAWNDSRIAIDWPTNNPILSDRDIDATIN
DHTKGF
>fig|195.2138.peg.1062 hypothetical protein
MKSSKKQGMYNAYLQSLQYKNLDVAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEE
EKRKIAQEEREKSLKQRKEFIAKHKSKIIISMVSFFLIALLSIYQYFYGGKYSRVYISKL
EEKCHYDDESNCKMLQTIYKEKCDDGDGKACFAGIFVSGDLIRVKIDGQWSFLDKNGEII
AKPEFDDIWGFSEGLAKVELNGKYGFIDRSGKFAIEPKFDSGEYFSEGLAKVKLNGRWGF
IDRSGKFVIKPKFDSI
>fig|195.2138.peg.1011 hypothetical protein
MLNILTIYNFCKTNNDLDFIIKLLKLTLKQYELETLLSFCEILNSRHIKEQDIFENYYIS
YKLPHIEKEFDLLKVGEDTIINIELKSKYIEENKILLQLKRNYYYLSMLNKKIICCVYIK
EGNLIYILENNKLVNYTVDLLISNLSEIKDHTEHLNALFSPLNFLISPFNNTSSFLNSKY
YLTQQQEEIKNDLLKKIVSNKIFSIEGVAGTGKTLLIYDIAKNLQNNCIVHCAQANDGIQ
KLKENKWNITTIKEFNQKFIEDCDIIIVDESQRISLSQVDKFISTGKIIIFSHDENQKLN
SYNDAKETVKKIKDISNIQYKLSKKIRHNEELAAFIYQMFDLNKVNKYKNKNYNYNNTTI
HYEKNLDSAKNYIHYLKNTKNYNHIYLTSSVRQKETLDDIVFDSNISAHKSIGQEYDNVL
VVIDQHFCYNNNKLVYKINTYYNPIETLFQAMSRVRKKLFILIINNEEVFMSCMKIMNNI
K
>fig|195.2138.peg.1023 Sugar-phosphate cytidylyltransferase
MNTIALIFAGGTGQRMNISSGLPKQFLLIEDKPVIIHTLEVFSNHKEIDGIVVVCLKDYI
DELYQNIKKYSIKKIIEITNGGLSGQQSIFNGLTLIKKIVKTNPYVLIHDGVRPLVTNKE
ISQSLSCAYANGNSISCSKMIETVLYKAKNIEILNRDKCFHIKAPQIFKLNDIYDLHIKS
QKEDLEFIDSASMAFHYGLKLYFTECSNNNIKLTTPKDFYMIQALMQVKKVESIFGV
>fig|195.2138.peg.491 hypothetical protein
MGVANVVFVLFGVGMIITFICEALDAKRFFHLNELLAMVFALLGLWMIFLAEGGTLENFT
HLKGLVNAILAGIGYALFLFFTRKLKLGFGLIPLCALLFIGSLYLSIPLFGANLNLNFSL
ESLILILALAFLPTIGGFYCTTRALILAKSNSVQLIELSEPLFAMLFGFLFLAQSVSFLQ
ILGGVFILFAIFVHEFKLKL
>fig|195.2138.peg.1020 alpha-2,3-sialyltransferase
MGKIIAARQDGLCSRLGAILNAMYLAKKTQKDFYYFWPDSEEQMKKWEEIKTQNNFRSLE
CDSERNIFSKDFIENFSMGTSFQNLGIPYGLKQHHSVFKTTLEELIAKDEDVYISHIPCF
NYIDGIDKKDYYENMKKLWQQIDFHLEIKNITNKAKEIAKQLGGFTAIHIRIADVALNEL
YKNTGFFVYKFSPLELVFEIIKQKAKDDKIILFSDDLDGAKVLQRYCFSKKIENIFVVDE
FIDSGIQNENDRAFFEIALMSFAEKVYTGDSNFSKFASRVGLGEEATYISQVFSNQQRYD
LIIANGDNNLILKPLQEAYKYLYLYTRGRLIKKPWNELENIAFKALELDPANSLYKICIL
ECFLRQKHYEKAEAFLADIFRNDFSNFIKDLLNPMMIFKESFFEILSQIYTEYDKIHLLY
LFAFKNDKNLLGAPSRIKNHLAYRLGQIALANSKTISDYFKLPFILMKECKQYNQEQKNY
QMMIKINPTLALPKLQDYDDYQEAIKIKKYFSYRLGEAIMQANNTWYRGGYIKLWFEIKR
LRKGCNET
>fig|195.2138.peg.256 Membrane protein
MIPGIYAYKAILYLISFIRSDDLKAKSEFLVQFFDYFFTTLSVTLALAIGVSVTLLIFFE
QSFMMTRHAKKH
>fig|195.2138.peg.1740 formyl transferase domain protein
MDCGALSGVPKARLEILGEEREILFYEINELDLILNLSDNVILKITKERKCKKSNNFLSI
>fig|195.2138.peg.1817 hypothetical protein
PKFDSIWDFSEGLAKVKLNGKYGFIDRSGKFVIKPKFDDIWDFREGLASVGLNGKIGLID
RSGKFVIEPKFDSIWDFSEGLAKVKLNGKYGFIDKSGKIIAKPKFDYGEYFSEGLAGVKL
NGRWGFIDRSGKFVIKPKFDSIWDF
>fig|195.2138.peg.1774 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAMDEKEFLNPYYRKKPILEAELNEFTKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHKGNSGIDLALKKDKQIQVIIEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKVDLFEELFNKNKYFKEAFENFERKDSHFKGNTD
EFYKECEKLLSSEKYLDSITRKDLFDEPSLKGVFIDLKPILEQEKPSFSKLKPLFKIFHK
DFLLSEFNPNDANSLNNAFYKELLYILGLCESKQNSKLIIAKSQESKEEQGTFYTAINSK
LEEENFETILKLLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEI
LAKERSARKKSEFAYLPYLNSSLFEKQSIENTLEISSLSNDLKLFYYKNTVLKDDKCKAK
KGQVGLLEYLFEFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSF
ITSYMCKESITKVVLDKFNAQFDLDAKDISELRKSLRKEDKKAQKELLNSIKICDPAVGS
GHFLVSALNVMLSIYDELNLFDEEFYLEVQNDEILITNRKGEFVEYKRPHSDKDKAHLIQ
KELFYTKKDIIENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFEDEAYHDLKTLPNID
INIKCGNSLISRFKPNDKFSNNNIKSQVEKYKNFVKDYKNPNQTAYRRNKEELRVKIKDI
KAVFALELKNPSETKELQKNIDEHMNKFGDFMLDNETLFEGLKGLSKEGILFKKELSLDE
QKKAIESFYKIKAQRAKIDYEMSGEEFENSFEWRFEFPEILDDDGNFQGFDLIIGNPPYI
KEAENKELFTNTKKLRTYQGKMDIWYHFVGRGFDILKNNGYLAFIATNNWVTNSGAKKLR
NIVLEESQILSLVDFSSFMVFDSASIQTMIMQFQKIKPPKNYEFHFAKITTQTPIYEDVI
NLLKNEKTQNNEILSINLTPKKFIDKTLNFTKSDYEELFNKIQKYGKFYLEESEVAQGIV
PNPDIITKRNISDEMVSKGIKVGDGVFVIEKDFLNVCEYEKKYLKPLYEVEHFGKYYFNK
NNSKQLIYTTKNNSKKENIPTIIKHLQKFRSIMNNRRENLNKRLDFYHLHWARDERFFES
GEKIVSVRKCIEPIFSYLNNEAYVMLSLNVIKTQRINVKYLTAILNSKLVAFWLKHKGKM
QGNNYQIDKEPLLNIPIVDTNSKNKKLADELINLADEILKAKEQDKNANTQELENKINSL
VYKLYNLTEDEIKIIENKE
>fig|195.2138.peg.1735 Putative outer membrane siderophore receptor
MDLKFLFAYNDGKQKYNQDKTWGYHNMSGIKTKNRAVTFDLSNTMNKEFSQDSNLYFTYG
VNILNNHYSNDFPQDRVLLPYILTSFYPKGKQDIKTFYLDTSFTKGIFTLNSNVNWINAQ
LSGYKGVCSMANPYCQPKNATNLEKDYNNFNYSLMLSADIHPLFNPFISYSKSHRIPNVQ
EYFFTHDASGEHNMNTFLRAESANTYQIGFNSFAHEILNNNDTLGFKVLYYDTKVKNYIY
NRRYWQKADNAIFIMQLNDDEKAKFHGVELEFKYDTGFFYSILSYTYQKSKHKFSDTESL
ETGGAQSGQSQFAQLPEHYANLDMGVRLFEEKLTLGALAKYTGKAKRVAPVGSLEDDPSN
PDAIAPLKTTDELPKIPTIVDLYANYKILKNFTIKAEIQNLFDKNYMDALYTYNTGDSQN
AGGLFNPIYIYNNSARGRTFIVSFEYKY
>fig|195.2138.peg.934 McrBC restriction endonuclease system, McrB subunit, putative
MIEFLNEDRKKFKEYLIDFFHNAYNSDKLSSKDEIVNFDFLKNYGFCVKLSYGKGTISKI
PWIIFIRTDTQEYKASYGIYVYCGIKRENGEIIVCIGESEDKTINYLAKNKVDDYNTQFN
KKTYDYKNLNNDIDLIIDKIIENMQWFAKLPLNEIQDRNDLSKSNNKEIRNDGSEMSNKK
ENKNLSLNQILYGSPGTGKTYHTIDKALEILGENLESRDEKKAKFDEYVKNGQIVFTTFH
QSYGYEEFVEGIKPHIDSEENSKEIKYEIKDGIFKELCEKALENRDSIKNFNFYIDKLKE
KVKIDDNNPEKYFELPNTKYSIQYRNGKTFRIKFDDMSKNHKDYPVSIDNIEKLYKTSNI
DEIYNSAYVRAILNYLKLQGLEDYKEKDEKVNLPYIIIIDEINRGNVSKIFGELITLIEA
SKRIGEKEELKVTLPYSGEKFGVPKNVYIIGTMNTADRSITSLDTALRRRFEFVEMMPNS
DLLNNVFICKDVENPNEDEDYLGDDAKTEGYAEILQNILISINKRIEFLLDREKTIGHAF
FMSEAVKFNKNNWIKPDEYEEDWYVLSISKLKKVFQNKIIPLLQEYFYNDYALISAVLND
NGMIEKCEKDDKYLQKIKNLDNVDSEKIIYNIASFDNKIWNDIKTYQAIYNDGENQSKND
KQ
>fig|195.2138.peg.1692 PhoX, Predicted phosphatase
MQRRVFLKGSALGSMVAFFGGSNLSAAILKDKELLGFKAVSASTKDEVIVPEGYEAKVLI
SWGDPLFSKAKAYDESKNIDMNAVNNTRFVFGDNNDGMSFFSLSKNRGILAINNEYINPE
IMFNHQGKNLSKEDVLYEQASVGVSVLEIQKKGNEWAVVLDSKYNRRIDANTKMEVSGAA
KKEVLKDKKFTYGTFANCANGQTPWGTYISCEENFDDYFGSSDENLKFDENFKRYGFKTK
SEYGWEKFDERFDLAKNLDEANRFGWIVEINPFDAKSTPIKRTALGRFKHENAEFIVEKD
GLVIVYMGDDEIDEFIYKFVSKHKYVKGGDTSKILDEGTLYVGQFNGNVGDFRGSGKWIA
LEYGKNGLDESKGFKSQADILINTRLAASVVGATPMDRCEWIASHKESGSREVFATLTNN
KNRTQANAANPRTKNLYGQILK
>fig|195.2138.peg.1149 Mobile element protein
KWQEYYKQGIKKSHLELKKEFNAIKKEQFPFTYEVSKYATQQPFLNLNLAFQKFFRDLKQ
GKVSYPKFKKKRDNFGSYYIGGDQAIIKDEKYLKVPNLGLVKMKEKLRFNGKINSFTISL
GLVKMKEKLRFNGKINSFTISQSADKFFVSFSMQISKDEYLKTHNKAKNNNLALGIDVGL
KSFLSLSNGLEIKAPKPLAKFNRLMIKRARQLSKKQHAKTKQEALQGIKKSSNYLKASIK
LNKLHRKIANIRSDFLHKLTSSLVANAKYFCLEDLNVKGMMSNHRLAKSISDVSFYEFKR
QLEYKSSYNDKEIYQVDRFYPSSKLCSNCGTIKENLALKDRVYICDECEISIDRDYNASL
NLLSQLKQKIGKVLAEFTPADLTALLDDLAINQIATSKVETGIQQKSYL
>fig|195.2138.peg.1024 hypothetical protein
MFLKWCIFAKQMLFQSIYYFYYYLFSTKKILLIIYSNSSMLYSNLKELEKSLEKYNVKYQ
VIFNNKSVSNIKYIANSSIIIIDQSNYFLSYIKLFPSTKVLQLWHGGGLYKKVAFDKIIS
LESNKNITRIYRNISFLNISDEKLVDDYSRMYNIYKENIIHYGLPRTDRLFSRDTLKDKK
EFLLMHPEIGNKKICLYAPTFREDAKQQRKLLNVDMEDMVKQLQDYVIIYRAHPTIEVFG
NIKGVIDVSNIELDFVLSIADILISDYSSIIFDYSFFKRPIVLYVPDLKEYFVKKKQLYF
HPSELVGCSNVCYNSTELANVVKRATYEIDLWDLFMSNCKGNSCQQLVGFIKDLQIKGDT
>fig|195.2138.peg.1820 Motility accessory factor
LSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGV
>fig|195.2138.peg.358 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKINEKDLHFILESGILAPSSHGFEPWKFIILDKKEDNQKLA
KLCFDQASVASASHNIILLARKDLQSKDEFAQKQIRRFAGSKEENFQRILKIYTHDTDAM
NEKELYHFAQLQCYLANDANVASCDEFGD
>fig|195.2139.peg.1500 hypothetical protein
MNSISQKNLELFSKLSGDFNPLHLDQEFAKNSYYGDQVIYGIYQVFLTLENFFKKNQKNI
KIQKIKASFINPLFKNEDFKLKSIKSK
>fig|195.2139.peg.1635 hypothetical protein
MINGINSYSSYNYTNTFSNNATNIKSSNAINETSNLVSDKSQAVNKVLGYGVDKDGFFTS
DFNEKAGIPKDYKIYVDDVENLVKHIINSNSKFFTSIDIAKSVGNAYKVFSQLVDEPNGN
FTTEDLSKIPLGFSYDKKSFQVTNIFQTQKEFESALSANNNLQIYQNSEQLALSFPSSHI
DIKEIYKNDNGSINKGGCFNGILCKYVRSKPSYRR
>fig|195.2139.peg.1726 hypothetical protein
NKILSKIDFEFQEELKLHNPYESNFFNKYDAISNPLSKEKNAKEELKYNTILFKQLFPLC
ANYLNPQNIAILLASTRIVGMKIPGLHSIYSSLNLNFSNDNIENKQLIYNYEKHHSIECY
LIDFISPCKGSIKAFIRPQLVKNLNYKSLVLKYPNISENKNFKEQKALVIGASSGLGNTC
AKILALGGAKILATYHTKNIQEDIPNCDFLQYNVLKPSKISIEKIKKFNPTHIYYFATPK
ISTQNNKLDRKMLFDFLDYYIFGLEKILSFTSPISSSSSSSSSIEDLPLDMKEYSIAKAA
MEIYMKYLKKTKNIEIKIPRFPRAKTNQTLSFIPQDLKETDELIVSMLLNKELK
>fig|195.2139.peg.1751 Motility accessory factor
MTFTPTQKELFNKNIEALNNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVVFEKDI
EIIWIMFHILDFSNELQSARLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELMSHYYE
RFHEDVLELNKKLVQYFKDSIISHGNDSTDTLQGIEQFVYNLPQMITHPSYKELLSKRKN
LSDTAIIVSTGPSLTKQLPLLKKYANTATIFCADSAYPILAKHDIKPDYVLSLERIPLTS
EFFNNDFGEFDRDVLFVCVSWVYPQTIKYLQKNNRNFMLISRPSDFIKNINFHQYGYVGY
GPSVAHMAYEFATHLNYKNIIFIGQDLAYAKDGFSHTKDYSNLDKHEGHFQRDKGKFQCL
AYGGNGKVESSGIWTMFRFSLQNTISRNIISTTYNCTEGGARIEGTIEKPFLWACENLLD
KDLNKPFEKLEPLSLNKQNEFLLKA
>fig|195.2140.peg.382 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVASYSEKEAKNAILLSSKRYVNYIQGI
LNEEVTLTKVVATSLNEMFQNNDHVDINLIESLIKNAFDSSHYAAYTFLYLKDTTVLSDM
QNVDKKYISPDGKTFSMIFFDQIAEKSGGITTISTPNNFSQLNLIQNIEQNAKYGDKDSV
FVGSPRKLNMEIKTLFL
>fig|195.2140.peg.1783 Motility accessory factor
FSRIYFLELMSHYYERFHEDILGLNKKLAENFKNSIVSYGNDPLDALQGIEQFVYNLPQM
ITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDI
KPDYVCMLERDEIVAECFNNDFGEFDKDIVFIVKSVTHPHTIKYLQKNNRAFILVSTYAS
FIQYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILIGQDLAYAKDGQTHSQGFIH
>fig|195.2140.peg.732 DNA recombination and repair protein RecF
MIDNIKIQNYKLIKELEIDKFKNINIFTGENNCGKSSILEAIYL
>fig|195.2140.peg.862 Type II secretion cytoplasmic ATP binding protein (PulE, ATPase)
MIERFLFEDYINGKITLEQIDREHKIDSEIFLKALASDKNISYSTLEELDLSLGEKFPCS
FLFKFKILPILSKENTLHIASSKPCSLELLDEIRIFYEVKNIEVLIASEFKIMKFLYKLQ
VREKLKNLSTNLRLEWKENRSQDEQSCISQIFDFILDEILEFNPSDIHIEARENDTLIRF
RVDGILREFACLEKDIYEALVFHIKFLSQLNVAESRKAQDGNFELKIKENRYDFRISSLP
LQNGESIVIRILKHNEEILDLENLNLGEKNLTILKKALYNPYGMILLTGPTGSGKSTSLY
ACLNELKSIEKKIISVEDPIEYKMPLIQQILLNPKAGLEFNNALRAILRQDPDIIMVGEI
RDEESLDIAIKASLTGHLLLSTLHTNNAISTIDRLID
>fig|195.2140.peg.861 Type II secretion cytoplasmic ATP binding protein (PulE, ATPase)
MIASALRLVIAQRLVRKLCPKCKQKSTKVYEIKGDFFEAKGCEYCHHSGYQGRELISECL
YIDEEIAQVIREGGYKNKILELAKVKGFQSMFEQGLQKAKEGITSIDELLRVLNEAL
>fig|195.2140.peg.383 Methyl-accepting chemotaxis signal transduction protein
MPIFNNKGKFIGVIGYTLDLLEISEIILDPKFDFFEGDLRILMNDQGIIAVHKIKNGILK
TLFDINKDQSAQLIVEAVKNHKDEILDNYIASTGDPSYASISSFSTLGNSSHWSVIVTAP
KKSVLAPLYKLQYTIISVAIIALIAILTVVYFFIRKIIGSRIPLILKSLENFFRFLNHEK
IEIQTIEIKANDELGKMGKIINENILATKQGLEQDAKAVKESVETVGVVESGNLTARITA
NPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTN
AL
>fig|195.2140.peg.347 Cytolethal distending toxin subunit B, DNase I-like
MKKIVFLILSFNVLFAALENYNTGTWNLQGSSAATESKWNVSIRQLITGANPMDVLAVQE
AGVLPSTAMMTPRQVQPVGVGIPIHEYIWNLGSVSRPSSVYIYYSRVDVGANRVNLAIVS
RVQADEVFVLPPPTVASRPIIGIRIGNDAFFNIHTLASGGNDAGAIVAAVDMFLEIDLIL
IG
>fig|195.2140.peg.1277 FIG00471674: hypothetical protein
MEKNIEKLILEAYEDSKTKFDHVTTGHISQYLKRKYDLKINCSKALIEAGFDLEKDENEP
SLVYVKKSYHKKQDFKS
>fig|195.2140.peg.1735 Putative helicase
KNIKLTQPKRTHNLEFYGNLSLIRQGFLDDKILNFFENLCINTKELEELDDDYTLLCSIN
KKVNAVNDDRLSKLESPLVCFKAEICKESKDIDEHKIQTWIKSLNILDELKLKIGARVIF
CVNNWDKGYYNGEQGIIESITYEEDKTYIGIMKNNGIKIMLEPYVFFMEELEQNNNEMFI
NVLASVSQFPIKLAYAITIHKSQGMSIEKLVCDIDHIFENGQLYVALSRAINPATLKIYF
TKRINFKAYFASILKFDISVREFYQNNDFLDLELENNII
>fig|195.2140.peg.1757 Putative integral membrane protein
MKYKWIVKNAYIDFKLNNLYMLINPSDKIYLEEDVCYYLEIYIKYRIFNNCILVCDMLDN
WWKLISSTLHLDKSHIKYNYLSNTFIVSDFELGIKLESNLLTKFNFEFYNGLILNQLSIT
NGLSFKRENYNKSLKFSNCKFNKEFCIARININKQIVFENIYFLDNAFIEWVNFNENSCL
RFFKCNFKKQCNFKYNIFYNEIDFLDIYAKELILEQNIFNKFLYIQN
>fig|195.2140.peg.1287 hypothetical protein
MDKVEVKLKKSKMTTTEKLILTLWLSCGVAAIVLLLVYLKIITSFIGILGLLSVSSLVIA
FVLFLAKNIKIVPYDEKKHGGYRSDNNTHFSEFLDGYATGYSMSIHGIDGEALHSDK
>fig|195.2140.peg.526 hypothetical protein
MLRKIEISGLYSFGIETQIVDFTAKPKSKLKNTKYEYNFNLSQVGKPMKSAVFFGKNTSG
KTNFFIGVKILLNIIKYGFSHTLREHLVDNAFNKNSNSVKLNIELSDNSKNIFAYSIEFN
KEYVLKETFLKNNKIIYKFENERATFDIYSKKENEQLGMFFSRKLSENIFYFLKDFEIEQ
KEIFINLINNIEVYMNSNYSKKYNFEFEENKKQYFLEHKESILEVFQLLDKTIKDFEFKK
YKKDEKNIYEIFFIRNGKKFNYQIESEGIKKIVYFADKITQIIKEGKIIFIDELDSSIST
LALILIFNNLINTEENHNGQLIVSSHNVLLFDVSFLNSQQIFLIQKDQHLESKIRTYYDY
DIRSEKKKAYIDYLKGLYDE
>fig|195.2141.peg.615 hypothetical protein
MIINSNTQAHQNDFTLGFSECLNIFIFIFIFIFIFILKSK
>fig|195.2141.peg.60 Signal transduction protein CetA, mediates an energy taxis response
MNSKIFNKGINYDEKWIIINYFSKHYWYFRCYFFHIYVGVIIFILIAVLMIYLFRQHKDE
QIMIDKLLVLCRELKEGNFDNRIIYVKTKSKKLAEIADNLNNTIDGLEAYLREINTSISC
SQKGEFYRKALPEGLKGIFTHNIEFINKALANIEVTARSTFKNALSRTLMDLSLGNQNKD
MSQISSSLNQDISMMKNVYDTVDAISHTATENGSEVDSLQSAMGSLMDVVNSSKETVQTF
VANSQNITSVVEVIRDIADQTNLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQRST
SEISIAIQTMQQDFVNIQSGSEQVFNIVSESEERINKFSQAFKRLEENSSTLGVNFGSFA
KRLILSVVKIDHILYKSNIYLNLNGAQNFNLESVDPISNLCQDERAQGVINELSSETELN
LAKEFIKDNAKKAIEESSQDYIDQKAYDAIVNDIKSLEQRSAEILAKLKI
>fig|195.2141.peg.1760 hypothetical protein
MSETYEIYTPDGLTLDVEKDTNKILFKENIKPTGNYTEEYSKAVFKSYYIMKNSPYKDY
>fig|195.2141.peg.293 FIG00471048: hypothetical protein
MMDTINIIILFSLIISIALGYVLKANIGVFAILSAFIGAYLYGITPEKVINL
>fig|195.2141.peg.1396 hypothetical protein
MAEEKESKGSNIVQIRLSDKQKDELQKKADEVGLPLTQYIIFLITKDLKAL
>fig|195.2141.peg.199 hypothetical protein
MPYLLGLSDEEFEKIFFHVNATSEIDTTFLKEAMELRKEKKDE
>fig|195.2141.peg.222 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MVSVFLIPSIGARFLNPKENKFYEKTEAFFEKIEQKYENLLYKILQNKVKFILATLVFIG
FSFALATRIGLDFLPMEDDSEIQVLLESKKDLSLEAMKEKSLNLLEKIKNDSNVKYAFLL
VGYDDAKDATKAKIYVKLKNLDERNLRQSAIVSLYRQKFQDESLKIKILELPKIEGAGID
DPVQFLILGDDLNTLKEAASQAKEILGTNARIVDISDNANTTKDEVALHINKEKAKLLDV
NPQYIAGVLGYSFSQLSVGSMDRGNSKDDIILSFAPEFKKDIEALKRISIKNNQGINLEL
SSVVDFIYSKDLKTINRYNKNRSVKITAGVNDLSLGAVQKLLLDNMDKILNNNPSLSYAF
SGFINLLGETVQGFAMAVALAFVLIYLVLAALYESFILPLIIMITMPLAFGGASIGLFIT
GHNFSLFVLIAIILLFGMVGKNAILLVDVANKKCHEGLDPDKALLIAGKSRLRAILMTTF
AMIFAMLPLALSRGAGYEANSPMAIAIIFGLISSTLLTLLVVPALFKFCFKLDSKLRKIY
EREKLN
>fig|195.2141.peg.1846 Motility accessory factor
IKNLAKHYKHLFVFESEIELFILALSTIDLSEELKTYQVILFDAAVKDVEIHIAMIFDQQ
SILEHLSLYEMFISSHYYLKYYETSILSLNELCIKSASVAIRNADITCFLPLLTHGQFLQ
NIPSMLESIPFQRILSERKNKFENAIVVSAGPSLAKQLPLLKAYQDKAVIFCADGALSML
EKEGIVPDYVTNLDCRDLAMKFFQNKENLKQSIIALECATHPNVVHSLKAENCMIVLRNK
ALYQRFNLNDFGYIDTGTHVSHFSYTL
>fig|195.2141.peg.1373 hypothetical protein
MHFFIFIISIVIMYYIIMFILENKKEKKKKIEDINKEISLIKANLNELNESFKIHFIENI
YKIRKDFDETREKTEKDIILLEECCSLLLQEREEKDRSEDNDALKQLIEAISDDEYSVDE
SYKIAEDKREDIIDAMYKENENLKEKLSEYEKKFGKL
>fig|195.2141.peg.1382 DNA-binding protein Roi
MNLEIFRKKDENKEISLTSLEIAELTGKEHRNVTRDIETYLEKVVEGGVFKFEHTYQNPQ
NKQFYKCYRLPKREVLILVSGYSVELRAKIIDRLEYLENELKKQSYKPLSLKESLQMQLE
LLERNEKLQIENVNLKNEAKENAPLIHFANRIKDTNDAILIRDFAKILYEKNKIEIGEKR
LFAFLRDNGFLMSDNKPYQKCIEQGLFKVSETTISTINGDRLVSTTKITGKGQIKIANLL
LEGINHAV
>fig|195.2141.peg.198 hypothetical protein
MANIKRIYITKEKLVIEYYIKNDLVFPLGTFFVYYRKISYSPSPGHIVIHTFGDKAKEYL
EPGLFSDGDDPTKGFLKELMPL
>fig|195.2141.peg.1860 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
ENSFNIAKEYTLKDKRITLFDKKNGGQSSARNVGIEYFSGEYKLKNKTQTIKENSLIEFN
IEGNNPYEIYTVYKSYKAFNDEQDLTNFTYPIIDYIIFLDSDDYWELNCIEE
>fig|195.2141.peg.745 FIG00638667: hypothetical protein
MRHFIFPPTNFKFRYNYINLIFKIGVKMKKILTSALALGAMTLIIGCGGDDRFVENLIKT
N
>fig|195.2141.peg.789 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENTGTAASLDTQLRDEL
IALINKKENIGVAKQLVDALRSELTKEIKSFIPELRVEKRIITANYDRKNRQTVLVSLSN
IPSEVNMSTYLSKCANSGFPEIAPHYSIRQLKGEHLIYYLNDQYAASYAYQAISYAPSGS
TTNNNNY
>fig|195.2141.peg.1548 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
FTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVEVVWFDFEMFIDKEHKDINNPNWNRMR
HFSLDRKISREEFEIEMIKKKLRVFAFVCDGLIDFIFFKKNKLKFFNYGYAEDHYFGLSC
FLSLNNIYILRKKFYNYRVRSDSSCDFSQTYIINPNNKILFYIYKNMNYNAKEAMEYFRT
YCYIETTLNIISFFETRSIKSVELFKNIIQFYYHRCRAIEQYNLDPMKIKKRLNKIFYYY
SLFYEYKQLFNDKMGVIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNS
KSILGYLIMPMALLSIIISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSY
KLGEALIQANKTWYKGGYVKILFEVRRLKINREKI
>fig|195.2141.peg.1859 FIG00470627: hypothetical protein
VKTFSVPPVSATNPTANNQVANKSYVDTVVNTVGNSKVALSGNQTIAGVKTFSSSIVIPN
ATANNHATNLGQLNGKVAKTGDETIAGVKTFSVPPVSATNPTANNQVANKSYVDTVVNTV
GNSKVALSGNQTIAGVKTF
>fig|195.2141.peg.1371 hypothetical protein
MNGENLKKLLKKHNLTQNELAEKLTAYGYRNGHGIKTAAISKYALGQRKMTAEFIEAVLK
VLGETDANVLISDEPIEVQRIRITGSVSCGLSINDVYECQDEFTYIPLSQNKSNLKAARA
NGDSMFPIIEDGDIIIYDTDSSKPRHGDLVVYTYNNEIACKIFVEKKDVGVIEFKPVNQS
DSFKTTTFRIDIDDIDDLKIYKVVKIQKTPNNPKSNLKLVNEN
>fig|195.2141.peg.223 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MFKLAINRPITVLMFFLALMIFGLISAFSMSVNLFPNVSIPLIKITSKINGDLNFVESKV
TKEIENALSEIDGVKTITSTAYDNFSVSVVEFKLGKNLEVAANDVRDKIGTLSLPSKPEI
EKIGSDSGSAISLFLYSKDKLQLMREINDKIKPFLQRVEGVGKIEAKGFLEPQIRIELKP
NELRKYNLNALDVANIIKSQNFKQALGELNNNQDNYIIKGYFEATNLEELSNLRIKTGVF
LSDIANISSLYEDEKQSALYEGKEGVLLELGKITNYNTLEMIKNVKNALPILEKQIPKDI
SINMLYDKSLNIHKHLSQVIFDMVLGIFLTLVIVFLFLRNLSATLIACIAIPTSIISTFF
IIDLLGYDLNRLTFIALTLSIGIFIDDAIVVIENIAKKLKTYPPLQAAFLGINEIGFSVL
SISIVLLCVFIPISYMNSIPGLFFNALGIKRCKWDSYKLFGFCIFNT
>fig|195.2141.peg.1767 hypothetical protein
MTAYVHIGTEKTGSTSIQFFLYSNRRLLQRQNMIYPISIGNYSSQWNFTFLAYNNLRNDF
YCLSKGIFKKDDFLHHKKDIFLKFKDELLKSKCEKVVISSEHLSSRIQDLSEIKRIRKIL
YLLGFKKIKIIVYIREQTSDMISSFSTTLKSGAIGNIQANSKKYFKGYHKLLLLKWQQIF
GKENLIVRLFDKSEFYQGDLLKDFVHSIGLKWDNEFVIPPKQNESLDLIGVEILRRVNNL
LPLFVNEDRNYLRGDLNYFIQKYFSSKDLFLKFQPPKEIIQSYIDSFEESNEWVRKEFFP
YKERLFPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLITNKTTQIQNLNQAI
KNKDELITNKTTQIQNLNQAIKNKDELI
>fig|195.2141.peg.1370 hypothetical protein
MKKIDLIKKITLKFGGANSSWYAKLNGNRKVDIKTALKLKDEFNIPLEAWGNSEIFSKTM
KGVTNIPKRGRKRKDRE
>fig|195.2141.peg.1847 hypothetical protein
MDGVIDNSGSALPPLNYILGREMEHSYGDYYEDFPHNRIIFFLKTHWTRKENSPYFFNNE
NYFIRTLLNKDHLILQSQKNKNIIYVSYHSDKDPLTPANF
>fig|195.2142.peg.1576 Phage protein Mup29, H
DSAVIDKEEELDLIQPKAKANYNEIIDYLDNQIRSVVLGANLSSQVSGGSLAAAESHNQI
RKDLAAQDGQIVLFILNRAIKFFKEINHFKDELYVQFFSEAEPKSELCERDLKLFNMGFC
FDEEYIKSTYNVEGELIRETLEKKDFKDLENDKKVFENKVKFIQKKPMDKIDAALESKEF
KVIDEQIKEKLEQAFNQLLNDSNSYEELFENLQKEFSDISINILEEFMFQALANSSILGY
GD
>fig|195.2142.peg.1459 GDP-mannose 4,6-dehydratase (EC 4.2.1.47)
MKKVALITGVTGQDGAYLSEFLLSKGYEVHGIKRRASLFNTDRIDHLFEGHHGKNNDFYL
HYGDMTDSMNLTRIIAEIKPDEIYNLAAMSHVHVSFETPEYTANADGIGTLRILDAVRFL
NLIQKTKIY
>fig|195.2142.peg.1709 hypothetical protein
MREHAAKKIVVAHDLITKDNKVENIVFDYNGFNAERFYHRAQLILREEGFINFTAYKTKT
PGHLHLYIHKGHTALNEGYSLASKLSMMFASKMPVEWKVFPSMDIPREFNILILPYEVYQ
KERGSSWSKHM
>fig|195.2142.peg.1866 Motility accessory factor
KHLFVFESEIELFILALSTIDLSEELKIYKIVLFDCVAEDLEIQIAMIFDQQSILEYLSL
YEILINASYYLHFYEKQILFLNEICLKTIGVAVRNADISCFLPLLVHGQFLQNIPSMLGS
IPFQRILSERKNKFDNAIVVSAGPSLTKQLPLLKAYQDKAVVFCADGALSMLEKEGVVPD
YVTNLDCRDLAMKFFQNKGKLKQSIIALECATHPNVVRSLKAENCMIVLRNKALYQRFNL
NDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEKGNSHSKGFSYGEQFSGEKTV
PTLKTQAYGGKGEVLTHITWNDYRVKLE
>fig|195.2142.peg.1865 tail fiber protein H, putative
LRDELIALINKKENIGVAKQLVDALKEQIPSLVLLNNIELLSLIGFGVYLDGDPLIKTHD
MRSRVNYTNTTGLTIPVTIYAILLRAIGDVDVFVNNKKITTLAPNSQTPNSQITLILKPN
DIYSIYTIAHPTNVSVKARLLNLNRSHV
>fig|195.2142.peg.1870 hypothetical protein
YAFLFEISKQDQIVMKKELNLNPKKTKNTKNVKK
>fig|195.2142.peg.1879 hypothetical protein
KMTKTELKRVCVKPYDKDKFEVVENYEFSLPNYKGIVPKGFKTDGASIPRFFWSLFPPFK
SEYFSACVVHDFLCEKANSRSDYKIADLALKEAMAFLGCSKFKIFVFYHSCNLYHVIKCI
FKSIKKELK
>fig|195.2142.peg.1769 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MKVGVIGAGISGMSIARLIDSDFEVEILEKESVVGGIARTKDVNGIAYHIVGGHCFNSIY
PEVLNFIFDKVLSKDNWNLIERQARALFRDQWISYPVEFAISEIDKIDSFLGMKIVQEML
NASYEKGSNLEEWFINHFGPTLSREYFLPYNEKIWGINPKEMDNSWIRDEKQMKLPVPTK
MSFYKSLLNNSKNVFDNMPHAFYYYPKTNNQNTFIDALSVGLKIIYNYQVKPVSLYTSPS
PRDYAASRMPSSA
>fig|195.2142.peg.1877 hypothetical protein
NGLNRSDFTIDSNPIAGENQILGTIKTSGIYQETYHKIAHVFKKYNGGSDECCLWSSSGT
REVSIELENTPMPNKLFARGNGYYGQTEITNVRVKKSIFIGEQEIQSEDFNVEKLEASSD
TYGDYAFLFEISKQDQIVMKKELNLNPKK
>fig|195.2142.peg.1781 Phage protein Mup29, H
MKKEIKSKREVILKNNSLINTLINSSYLNVLKISENDQKMIFKDLSFTQAHQSRRSVILA
KELQIVCENEKIKESFEYLFNPDLLSQILETYLYGLNVFEVNYKLKDGFYYPILKQRDFR
NFGFNENDELVYNGNGCEEIVEDKKAIYGLFGSNFLFKNGDALLTKLYFPVKLKNASLKF
WMEFLERFGSPW
>fig|195.2142.peg.1461 putative nucleotidyl-sugar pyranose mutase
LSVGLKIIYNYQVKHIEYFNKKWCINGEKQYDILINTSPLDLIPNILQNIPSDIINSFKK
LKYNKISNMLWETDGSFDSTWAYVPKKDIGFHRLLNIGTYFRPIKNYCITESVGEKTYEH
FVNEGKKINFLKRPVDFHVSDRAYICFDLNYVLSKTTTLKYLESIGLISHGRFAEWEYYN
MDVCIKRSIDLAKKIKSEYLL
>fig|195.2142.peg.1458 GDP-mannose 4,6-dehydratase (EC 4.2.1.47)
MQEIPQSEKTPFYPRSPYAVAKMYAYWITVNYREAYNMFACNGILFNHESPVRGETFVTR
KITRAVAKIALNLDDIFYLGNLDAKRDWGHAKDYVKMMWMILQYDKAEDWVIATGKTTTV
RDFVKLAFEYCGIKLNFKGDGVDEEGFIEDFDQQRANELSLNLNHLRKGQVVVKVNPRYF
RPTEVDLLLGDPSKAEKELGWNREYDLKNLVNDMMESDLKLMNKDVYLKKGGYKTMRYYE
>fig|195.2143.peg.1463 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MEEVQAIVKIANEFKIPLFPISTGKNLGYGPYVDGLFSQSNFGIVTKMGFWMMPKPEHYM
LLSIKMKKREDLIPAVEILNYLEDSFIVGWPQYFSPLNPPYGKPMNAELKGYLTSKNGLP
DMDKIQNYALKNKIPYMDKIQNYALKNKIPYMDKIQNYALKNKIPYWNIDVSVYGCKEVC
YANLEYIKQRFKIIEGVDISIVQEFSLPLNLEQKKQLKHKVTLGIPNMEIFWLSTRGEVL
EPSDGHVWFSPIIPRDGKELLKCQEVYMNLFREFGEESPITPFSHPRSWMYRAFCFMLAF
NNSRTDKAHN
>fig|195.2143.peg.122 Putative C4-dicarboxylate transport protein
METLSQTFAERKPPLYKRMFKSLGFWVIVGIVAGIVLGYVNKEMAIASKPGVDYFISALK
VLIGPIIFVTLVLGIISLESLKKVGSIGAKAVIYFEVVSTLALALGIFMANVMQPGHGMN
LDPKQLDTTSVQKYISQTTEVSASSEIMHILQDAMPRDIITPFTEGKTMQVLVIAIITAL
IISLMRIEDRQAIQRVLEVIQNFVFKILQVIMYFSPVAAFSAMAVLIAQYGLGSLINLAY
LLLVMLVSCLIFIFGILGLICYFAKVNIFKFMRFISREVLIVFATSSSESALAPLMRKLE
KAGLSKATVGLVLPTGYSFNLDCTNIYLAMSLIFLAQAFNVNLSLAHEISILIVLMIAVR
GILKRTCNYP
>fig|195.2143.peg.1089 Hemolysin, putative
MQSSNLNAQNINLSANNVNIDTVLGIDEKGSYNSIKKERLKQIMLLILIR
>fig|195.2143.peg.60 Putative C4-dicarboxylate transport protein
MRHFIFPPTIASKGAVGVTGSGFIVLGSTLAALGNMEISEANATLAQVLPVAAIGVLLGV
DKFMSEMRAVGNLCGNSVAALIVAIWDKQIDWEKFRYALDNPEKFHNAGMH
>fig|195.2143.peg.1665 Aminoglycoside N3'-acetyltransferase (EC 2.3.1.81)
MNFLELAGGGVRRTSDPIFSFAVKGAKADIFLKENSSCFGENCVYGVLTKENGKYMTFGG
QGHTLTHYAEEQFNVFYRYHKIFSGILIDENNISYNKTISYYVRKLDISSEPNLINIINI
VNNTKNFKKNNFAGDHINIYNAKEYIEILWKKLDINQTILIENYDTIY
>fig|195.2143.peg.700 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MIWMSEAKFSLNGNYLIKIANLTTSITFERIDFKKDINTFEESQSDELKLNDIAKCTLRL
SKKTALAAYKDNKTLGSFIIIDKYSNETLAAGMVEEILASEEKSRIYTQAEIELNAYIRK
NYPEWECKKI
>fig|195.2143.peg.1090 Hemolysin, putative
MYANALQSNTKLSEEEIKKLLENGAKYANENGLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYLSKETIGNNEIKSNLTGKTGVDINTQSFNSLLGDIASEGQINISMLATRLIC
KVLI
>fig|195.2143.peg.1177 Integral membrane protein
YISFKICFKNKNHFDRQEIKNISILYQDIFNQKMDKIDTELNLNFEDLQEKIKQECINYN
KNEKESHKKSLSKTANDFRVFFKKIKNILLKDNNPLDALDFSKLELYCKEIELKEDWCDK
IKNFKTNKNKNNNNNFELINFLLLGFYRKLCDHHTDFLKVFNNLILLIALYALFIFGFTW
LHDDKLEDTRAILTLFGFFDKFRLYFDIISTIFVVFGCGFFVWKLNSYENKNNISKKQNI
NFIYIIGDFWNLTKSLFFASFIPCVFYVLFLLFGFFLNLGKDFGYSLLINTLFVSLYICL
VYTKSLFFGRYVVLIFSYIGFIIILIKQPNVIHPLIGKIANESDKFFNYPSLIVLNILYT
ILLVLVLFSLQKTARKNSIVPS
>fig|195.2143.peg.1845 Flagellin
SIGATQSSKIGVTRFETGSQSFSSGTVGLTIKNYNGIEDFKFDSVVISTSVGTGLGALAE
EINRNADKTGIRATFDVKSVGAYAIKAGNTSQ
>fig|195.2143.peg.701 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4)
MQTNIEKYLQEHENKELCRFITCGSVDDGKSTLIGRMLYDSKMLFEDQILSLEKDSKKLG
NAGEKLDFALLVDGLASEREQGITIDVAYRFFTSEKRKFIIADTPGHEQYTRNMATGAST
ADIAIILIDARKGVLTQTKRHSYIVSLLGIKQFIIAINKMDLVDFRQDIFDDICKSYKEI
LPYLKNYENIQTHFVPISALDGDNIASKSIHTPWYNGKTLSELLDTLPIAADFNDEFIMS
VQYVNRPHLNFRGFCGSIASGKVSVGDEIMILPSLKTSKIKEIITPDIKNLKVLDKNENI
QSAKNASFPSAITLTLEDEIDIQGVML
>fig|195.2143.peg.775 hypothetical protein
MQYFCAEKENCCAVYIMDKNSNDEYIKKIKIKLKREETIILIFLIINTSFLSYRLCLLKR
INCKILY
>fig|195.2143.peg.1803 Methyl-accepting chemotaxis signal transduction protein
MLLNKDILNLPYEALNSQDNIINNAGAILKYYRNSGNLLAVYIGLDNGENIVSDDLSEKK
NTNITINGKANNYNATTREWYKEARNSNQMYITPAYIDVVSNEYAITYSKALYKDGKFIG
VLGFDVLLTSLQDRIARTPGNSFVFDHKDRIFAATNKALLDPSVDHSPVLNAYKAHGDNN
FFSYKLNNEERLGTCTKVFAYTACITESTDVINKPIFKAAYIQVIALIIMISISIILLYF
IVSKYLSPLASIQVGLNSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLE
QDAK
>fig|195.2144.peg.1675 hypothetical protein
MIVLIFKILGFFAFCISVIALFFNPPLGVFFCLLASLLAVVGIIIGEGSTINLSYPIMEW
IWNVGKYVLVIFAIIVVVGVMSDLIRKFKSNKRVNKGMDIKNKGEQNPKILIIDNTMEDL
LALKKESLYEK
>fig|195.2144.peg.1827 hypothetical protein
MGSTVKDKHVEMRDFLFNKYKKMTFSRKECAEILGVSLQTLDRLTKNKKIESMNITRFVI
FSIEEIAKILSGSKQMK
>fig|195.2144.peg.1919 hypothetical protein
MKQQIKNLRDYAELAWASYFNLIYIDGQKTNDFTIGTERILKDKENIEKFEYYKALSKDH
RDYFIYDDSLVFYPKLNGEFREIQTQNFAKRYIIKFHQPNTFSGFSATLFYDIQKDEYIA
SFRGTEGIVSMDAFADIGLTFGKGDFQANALKQFLLDIAPILNNIDSSKITFVGHSLGGY
LAVVAMQFCDTIDRTLCTDFNQIKFSASKVCTFNSPTIDGIIIC
>fig|195.2144.peg.1794 hypothetical protein
MTTKKQRKLCIEELASRGIYAYEHDGLVVVSIDEIDQSFILHDGEVIARAKKCED
>fig|195.2144.peg.1843 hypothetical protein
MRKYLFLIFVVCNFLQAANNAAAEGNSFGSQLNNYFKSNADAAINSLTNGGEIRTVDGKQ
KANVQMACDESKSGEFLNIDYTGTSDINIKIKFDKNVDGKVDKIWSFDNVSGICTNGVVK
CDKNSWNNCEYFQYNYGDNINLVKTTIDNLNGCYCINSSCGSAAAKNRDKILSDIAGPIY
SALSAKTQLVLSKTTKVGSALSYRGQDYSVCDNYGQAVNIDSSSNLEGLGQELAASQSNN
ENSVYSVFHKGTDNTVPKDENFNNKVSNSSVSIDQSAKYSKGSSKIDFSYIDTTSGKNVA
GDMQATPDVDAKFCEVNVAKEDTSAFNDGTNRENSTNNTTVYQSEIRECTNNWTKCPVNG
KNETLKHDCGKINDMGEALAQLSALDEASKDMVCSK
>fig|195.2144.peg.1669 hypothetical protein
MNIVDLVKTIESIENPQNLKITREGACFYMCLGENKKYFYFFKTNSKNKESLPYTLTLDD
LKSDEWKILKD
>fig|195.2144.peg.1817 hypothetical protein
MNCFKKLKEKIILIKIEKEKASEEKFLKECEIKEAEIRMEILEKRKDDLFKQREELIHSI
LGEASFNALTEERYLELIDNYHILTEDNKANLYGILRRAYNLSSMVGNLKRLDKSINELE
EEEDKQVEILKRKKTNSHIKKEEKMEKNAVEILNNIKTDEFSNTINIIKVIEIENILEFK
DLVDIFVNDKYKIEAKAAKYLEVVLNKTEFFRTYLESKISKEFSEYHAKEQEKDYFGKFL
KTLEKGLDNLTGETEEDRAKFKKHVKEIFEKIFNKKENNENK
>fig|195.2144.peg.273 IncF plasmid conjugative transfer protein TraN
MKNYNLLRFFSKNTSVEQITPKTLRLAILLSASLSFSQAAIQCTDYNDFKQFNGHYYTAT
VQKMTFEDAKKLAEDSGGYLAIPDSKAENDFLSSLFRGGQYAWIGVYDPSYISNYCVEGN
SGCIYDDSRFKTVKGNPLTYKNWAQTQPDNLLKKYDIVDGKERVSPLGEHWVAMASPSGQ
WSDQGNHFGDTNNPVRNYALLEFGKIPDCAGGGSDGGDNGHTATDAMQCNTNFSDDPNFK
PANGQGQSIACLQNSQQKYFCPAQLTQCVNSDD
>fig|195.2144.peg.1676 hypothetical protein
MKLYMNSDKLNSIENNKLRAIYKDIKEKLIDIIVYMDTINLGNISKGYIEKELNSIILIL
NQNCKEYFLIKNKLHTSDLERNEERLVQQAQKLFDKLKNLDFKKEINIEKDIKLDHIENS
LDNSIKNRVQ
>fig|195.2144.peg.1661 Phage Rha protein
MNNVVFINNQEVVFENKDEQVFCTSLDVAKVFGKQHKHILELIGEKFNNNEIKNFCEPNF
RLSFKTRKIEGFRGKERKYPYYQLTKDGFSFIAMGLTGRKADKFKIEFINAFNEMKNIIR
SNNQTTNYSDYEFIKKQNEILNQITCTQSSTIYVLQDSIRFLNNTISSMKEINKELKKIA
GIDRFL
>fig|195.2144.peg.1836 Thiol:disulfide involved in conjugative transfer
MKIFSKIILGSLALASLLHAQTLIEQQEESLVKGVIPSTKIAKVERSQIDGFYKAYLDNG
NILYVNPFKRVIFIGELYTNTGVSLTANDRDAWQSEVSAKQAKDLNLKEVTQYAKKVDFG
KGSKKYEFVLFTDPECPFCARVEELFIKKDVSVYVNFFPLSIHPHAEQWSKEILSAPDFK
EALIKLRETQKDLEVKITPQAEQTLKNMRELGEKLNIMGTPKLLVVDKKKKKIIDVIDGA
NMQKINSYLDKDKQ
>fig|195.2144.peg.1957 IncF plasmid conjugative transfer protein TraN
NFSDDPNFKPANGQGQSIACLQNSQQKYFCPAQLTQCVNSDDAVDGSSKKIEGGVLKTGK
TKVRLTFSKSIGYNAWQVVTNDIYITDIDAIDSFKLVYAGADDWVVPFAPNSTVAVVGNK
PNNTKDALDYIPYRPNNDNYGELSKFSGKNLNIELKQYLHTGINKSVAFFATVGSGGWQL
TYEATGKDISCSNFGRNLNCTEESETIPFSAYKYTCPSGYQPKEQGGVCSPQSVDDLIDT
NGDGIGDSCNSSIAPAKNCLGVTRTCPFNSSRECVLIDNKYQCSPFPCFKGVSDVENTDT
PVGVNDANNNGWNDDGTCSGQIIIFNGQDNRCKNWDMFGGLLGGGCCDKDNVFLGLVACK
EDEKKLAKLNDAGKCHEVGTYCSKKVSLGFTKICVEKKKSFCCFNSKLGRIFNEQGRPQL
GKGWGSAEGPQCKGFTPEEFQKLDFSEIDLSEFIADIVGSFDTGKIQADSVKIQEKIQNN
IENATKKPTN
>fig|195.2144.peg.1667 Conjugative transfer transglycosylase
MKAIFFLTSLLFANLLFAQKNYFIQAGEKFGINPQLLWTIAYKESRLTPNIISKPNKNGT
YDIGIMQINSIHLPRLKKQYGINENDLLRPKINIFVGAEILKMCLDKHGLNEEGITCYNG
RIINNPYGKEVIKLLKKARITNGKIN
>fig|195.2144.peg.1962 IncF plasmid conjugative transfer protein TraG
PSSVGANNAHNNDAVANQNSLNNLGTAGGNNIRNEFSQQSGATISNFKNQGTSTSNVVNN
SAKDAIVEQNANRRMGVNPSSYAIQDASKSGNELAKEAQGLFEAIGANNAHNNDTVANQN
SLNNLGTAGGNNIRNEFSQQSGAAISNFKNQGTSTSNVVNNSA
>fig|195.2144.peg.1952 Domain of unknown function (DUF332) superfamily
ECHIFGDLVIIYKRDDKILSLYRIGRHQDLFKKY
>fig|195.2144.peg.1945 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRYGDTSRRANKSQSIHSDRTVPTNL
>fig|195.2144.peg.1685 hypothetical protein
MGFGICLLNKYEGFLCSGYLKYFENKLIGYKNEILEKRSEGKREDKKAHDEAIERQRNID
NHFN
>fig|195.2144.peg.1818 IncF plasmid conjugative transfer surface exclusion protein TraT
MKINKTIFKTGMCSVLAASLLTGCLTTTLQTNATMSQSIFLDPVAKEKRIVFLNIKNTSG
HDVNLEPKLRSALEAKGYKVIDDPDKANYILSTNILYCDKKQENNAVGGAVAGGATGVAV
SGYNGGGAGGMVAAGAAGALVGGLLGKLTEDTIWQMQVDINIKQKADGKVLTSSGNVSGQ
ASVRDSQSSGFLNSFGGNVRSDKVGHLNSNQINNTQQTYEGKYIEKNTIIFAEAVKTGLK
LPEATPILEDKIANQIAGLF
>fig|195.2144.peg.1673 hypothetical protein
MNKISKEELQKATEESLANVYSYDPNSPSGYRKDLFDISNEDFVEKYEFIDSPTSDDMVK
CKQSDEVFQVFYKKDGKIRLLRVSNVQALNHFDKLKGVMTKIILDSGFKPDEQ
>fig|195.2144.peg.1805 hypothetical protein
MNQEIKNVEVPMNENAYKKWQRVPKDMQEKAIEAALTMLWRDEVFFYTFFNGHIEEGEIR
IEAKREEKVEFPY
>fig|195.2144.peg.1766 hypothetical protein
MKDFFKKLSIFTKISTKAILRFMESIGVGLFVNSLYGLQMGDSRAFIILIESLLILAIVA
LSSIFLKD
>fig|195.2144.peg.1679 hypothetical protein
MEILLTIIPRVFYEEMITSSLILYFTAAIYLATLSILFMYYKEKNNIPHQAVMLGTFIFC
IIFNGSIIYVICSFIFQYYTTEMPCLFLWKIFIFIMVISYVLIFLLFPQSCFGGLIIVIF
TAFGNLIFIPLS
>fig|195.2144.peg.1968 IncF plasmid conjugative transfer protein TraG
ALAISLLLFSIKKAMDGQTNPVFEFGKMFMLFAVVWYMFLRAPNDNNHRFMIHDEVTSKD
YVISQIPIGIGKSFALMTQFEKVILEAMEKHFTTPQSTNF
>fig|195.2144.peg.1845 hypothetical protein
MKTFNCNIEINKNKTKQPKFSFNDKGLFDSQKYDITDVGNLIFASSINKIFGFTTKSFKE
MIIKCNTNNLLKNESAFESIELKKEEEEKFTLDFLIESNKTSVLSVFKGKII
>fig|195.2144.peg.175 Inner membrane protein YihN
MICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVLLKAIRLLGDSTQQGRLFGFLE
AGRGVVDTIVAFSALGIFLLLGSGAGGLKAAILFYSACVIIAGILAYFLLEDDKISTKDD
EGHEISKNKATWNGVIKAVKTPEIWVVSLTIFTIYSVYCGLTYFIPFLKDIYGMPVALVG
AYGIINQYTLKLVGGPIGGYLADKTFRSSTRYLRFALILAAVAILIFIFMPHEKLNIYFG
MSLTLGFAAIVFTMRATFFAPVDEIEMPREISGAAMSIACIFGYSPQLFCFALYYRSV
>fig|195.2144.peg.1823 hypothetical protein
MFCKDGSNARNKIAHARFSQDAFDGYYRLADYMWIFLMVFFIKNHNKK
>fig|195.2144.peg.1778 hypothetical protein
MKITVDIWKEIPELKNLKKHFSDDEILSLDSYGKYVFSSQEYANKLVEENKKYYLNTDLE
NRNSILKQALKLEKNEIKSFLHSDNFIAFIKDMILFSKKYFDKTGAGHYKFFEGLRMPFL
DYDFNDTQDRVKIFLTALERGSIAYVCFYEDYLKLEPICNKDMILFVSKNENFSRNCKLP
TESIQKLKKELLEYIETNNLSMN
>fig|195.2144.peg.1762 hypothetical protein
MAKNKNQNENTTQTNEKSNVTTQTNQNSERISRAEFLRRRIEGKKRTIDLNSNAQVFVSD
SIAGTEIFSDLRMLDAMDSTIRKLWGNGVDSQDAETWVKEINSIKESINELQNKGREILV
KVGNVRHISNNVLRRTILREIQAQNVKAE
>fig|195.2144.peg.1779 hypothetical protein
MKKINILASSKNSKKLEEGFWFTKDKTIALGNDDSNLDEVYEHLKECIDKSKDLSKFDGE
CIRVIISANGNYFDEGSESVRFRFNGCGSLGVFHNWECDKHKAFSPLVWKLWSFLHEQIG
AAKVA
>fig|195.2144.peg.379 DnaJ-related protein
MFSLKFKVQEYLQCKNCLKINPEEDAKFCIFCGKGLNHPARQRLDYIYSKNPAIIVALLA
KVAKADDEIITKDLSKFISSLLDKIEMFYSKEYSGFRNTYASIFEYEKNHGRSVNELCTS
TRFYEKEIDFLICLLLDLIYYDAKMSANENALMENIIIGLGLNLIKFREVKLKQEKL
>fig|195.2144.peg.1815 hypothetical protein
MFIKELRERLNLTQSEFAKNLNINQAIVSRYENKKLRPTSEFIIRLIKTFNANPNFIFFG
KEPCLNENTYKNEISQELNQLIDELSLYENEKNIISELENSALEKIISLVSDKEIWEKLF
SLLFKIDRKLYTITLFICRVSKRLEEKSEAHKAYLASIINSFDDKDFSKLNECMKMDLIT
LFNEKFTEEEANIIIEDCLVVFKHIEKTAPIHKMIELGKN
>fig|195.2144.peg.1783 Thymidine kinase (EC 2.7.1.21)
MLKMILGTMKAGKSAKIIEEASNILFQDEVIIIRPSCDIREFFTRKHKNSDLQNFTFGNE
NTSLDSYSFIFVDEIQFFKKDFLEKIINLSRKKEIFITVAGLINDVEGNSWGNVETLKSY
ADEILHLKADCDCCGRKESAAFHVGDGGINNNYFVFCEECYKM
>fig|195.2144.peg.1785 hypothetical protein
MVSSKIVKYGELWIADFEPQVGEEITKKRPALILSNNLLNSNQKLVFVVPLTTWQEEFKK
RIWLIKVDKNNINNLNVDSAINCSQIKSFSKDRLIKKIGEVDERIMENTRNMINVFLSPQ
FNS
>fig|195.2144.peg.1793 DNA primase (EC 2.7.7.-)
MKYDLERLNNIPIMDVLESLGAISDRNKKIIHCFNITAHKNNDHNASLGVYENTNTCHCF
ACGVGGNPVNVVKIMFNGNFKEACEYLHTQFNIPFLDGVQATYKKAFEKPKPKAKDYVFF
DPNKEYVEVEKLLPYVQSYSKLTKAQRLKLIYTTIYRFSLSTEQKAKNLYYIKRGIREIS
LVKKIGFLSFDNIKDLENLLKKYFPMEDLIEFKIFSREKQVWKYAFNVAFVPNFDLYTDM
IVGFSLRVIDSTYNGAKEVNISCGNIVFATPFGLENKPLKECEKVVITEGHIDCLSAKSY
YKQDSKTLFISFAGTFSFREEILTVFKGKRIMLCFDKDEAGLNGEKSLSEKLNLLNIENH
SLTWDIVDGKDLNDLLLADKMGSIKLIA
>fig|195.2144.peg.1970 IncF plasmid conjugative transfer protein TraG
MFFAPSFLFGATNIANSNLIYTWGYGDVMNEIMQAVKGITTETDYIVNAALAISLLLFSI
KKAMDGQTNPVF
>fig|195.2144.peg.1844 hypothetical protein
MFKIKTTPKVVSLWSRALQKAVSYFLDLKNIFLISSLKSVINTAVTAMNVFRKSIVDSFL
GVISSRIPNLIAKKKARPFLRIELLSHLQGSVKPLLSIYLMDKNIITQNSKKGNDENI
>fig|195.2144.peg.1776 hypothetical protein
MTLRELLNFLSDPKNEAFYLNRIKIPMYLVVNPLMLEDEFFVYDDSFKKIWVGKIFKFLS
NKSITPSYFIRKDNYDASIDIDLIESTQWQVLKKQISFEATFEEKGKIIGSIDFDRFNDE
AKFRIIEKYEDLKAKHKMLCIDFRAKLRSSGHPREVEKEFLEEIHLTTACYDNILLEIEH
AFQHYAEHKTLHMKTQTWTYR
>fig|195.2144.peg.1806 hypothetical protein
MLSLILNMDVRYFLFILIFIAVICFLLWKSLEEELNFTSRMILICLSLIFIFASYKFYDA
FYYKENSAKKEAVQNYIQTIENKIDPRFKDKIKEQFSSIPNTFGFNLCYENNYTGKTCLN
YLFYFENKIKDEVKKAREEFFKSRDINNNINDNFNKGEKNESRN
>fig|195.2144.peg.1840 IncF plasmid conjugative transfer pilus assembly protein TraC
MSLSDFINEKLGINQSVKKITSLQTNVWNACMQRYKFSDFLPYMSYDSQKEYYINNDNSF
GTVFLCSPRIRMGESTAVAVEEMLGKLPENMFIQFTLFGSKNIKDIVEYWKYMHLERADR
ENNELLFKAIKNMEEFYYSKTKEGISSSMTTRLKNYYLLVSIKSNSEEDVISYKHILKNI
LTSNNFSPVVAEPEVLKPMLYELFNGNHDINNIPNYDRTCYLNRQVIMPTTEILIKDDEL
KIDGRSFISLTPQSFPQEAHIGDFGEKLGDYISRALDNNQFKDTFLITASVCALSKKKTA
RVKDNHSMLLTQKWSENIFRQFAAARKESVSILERIDNQKEKLYAFDLNVIVSGDNYNEA
SLNASTIISYWNKGGSKAIVLDEALGIHQLNLIASLPMGINKEYMFDITVKYRSMFPDQI
SQFIPLEADFKLNIPNLILFSRRAQIAGLDLFVSNSNYNAYLVATSGAGKSVLLNMLAFN
SYARNDRIFIIDQDNSFINICDAVGGQYLALDPLQPISFNPFSGLKNNDRESFMDDLNYL
SDLIYMLGSSKNQDRALEDEKLIKAKTQAIMEELFLSKGNTMEVTDIRDELAKVDDQRFR
DFADQLRPFCKEGIYGKYFNGPCEFNIEKEFIVTEFKGLEGHNDLRDPLIMLLIYHINQL
MYMSSDRKSRIQIIIDEAHRFLGKNPKMDDFIEQAYRRARKYDASVIIATQGFDDIYNAK
DGGLSRAGTVIVNNSAYKIFMKQTETSVNMLIKSEVFSLSETDKEILRSIMTLKGEYSEL
FLMTPDDVKLPYRLVMDKYFYYLTTTDPKDKAKIKELTDQGIPLGEAIELLANTKTKSNE
AK
>fig|195.2144.peg.1660 hypothetical protein
MNFKRASELLQIANNYNIEVSEVFSALKQALEVVLKCGKLHADFSNEKISFYEIIYNRFG
EKRKKFVQIKRNNYKAVQDRFISIVISYSLEKKREQVKSLKSMIFKGKIEKVLKSGFEVS
SSIGFGFLPKVEILRKDLARMQLGTELYLAIKKFKGSKKAPNGALVFTRKNMNILEHEII
DNMSDCGVYYIEKISARKISIFCTKMPTKDQIKNTMRAANTFLDIQVRN
>fig|195.2144.peg.1816 hypothetical protein
MKKQIIGSILLCSSLFAIDDNLTKEQIFHNKYLKDKAAMQNKISVDELYKNTKDFNLSSM
RQDMNLTKDEIKKRYDIKFNQSAEANKSAKIVSDMRRSDAFEKKIVDNQNYILYDKSMNF
NEYLGEYSQNTKDMINQMENSKHLISTNKYLNPNEKIFIVISSSMDKSSIQNYFKLLENV
KTDITFVLRGLVGNDARYINPTFSYLQDLLVKDPNNKNKEDKNNFYYYNIEINPKVTRRF
NITKVPAVIFIKNYDPIVEDYQKMTNTPADTNEEYFVAYGEASINYALSEINKQAKSDGL
ARFIQNMNSNFYTK
>fig|195.2144.peg.1915 hypothetical protein
MHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENENIIHHRVFLAP
AKMQKIGFEIAKGLDEWLDNENVCCFNVYTKDYFNANDKDMLISDNIKDDTNTTQAHTNE
NYNNTQEIIPDNVIRIQTQDGSGEFIEIIFDEFKEWEKSSSGAIKPLFTPLEGIVEDISN
SLENVSIIGDALAMLGAVKNPKNAKNIIKKKSKYATKQEVIEVLKNKYNLKTSKELGLGR
SKNVFWAYNC
>fig|195.2144.peg.1830 hypothetical protein
MDNLENKIEHLELGYKKQNSTCSIQEIRLPVFAPIKRYTPSSAIYKDFLKNKRTRTINTQ
WGNVTIRGSLLTQIHKDILDLIILNNTKIQILKDQRISVDFCISNVLKSYGDAGFNYKWF
KNILEDIMGAVIKIKLENQTEFYFHIISAMGYNEKGDFGGIILSKEYLDFYQKTIAINYN
KEIQSIVLIENSLVKSIIRFFLSHNQINITLENLLIALGLEINTKDRYFRKIKQEIKVSK
NIFSNFKIEFNENKNTFEYKGNNSVNFLFTN
>fig|195.2144.peg.1678 hypothetical protein
MSSTQQYKVMNEKVMVLLKKDSEKSSAVSASPLIKISMDQLKNTDNGEVYKKLDELQVLI
DNVSPYRNKSVFGKAGVIPKILSKAFKINHLSRYIDKFENSSKLIDNIILYLNKSKEELE
NDNKALKLEIEGMAIKRNELKNLIEELSQTQQECDEYLSINKKDEFEINRFKSDTYFPLL
QKMTDVKQRVMVMEQSVIAFTTLIANNRELIVSLDRAKEVTVEALGVAILMAQSLSEQER
ILNSVNGLNRVTSDLIKQTSTQLKNQGASIQMQASSAMLDMQALETSFKECLESFEKIKD
FRIKATDDIKKHLQNFDKLMDEINSKNMLINHVK
>fig|195.2144.peg.1789 hypothetical protein
MKNDELVHYINQNFQKDWLKIKNEELVLIYTGELKKNLDNKNIQSELDLHSNHNEKSFQK
FLKSEITYVSNNEKLYPNSFGLTNAPLFIFNRINNKKKQIAVFAYMDYAVFDWVDYLKRY
GEVKFSGFLNLLESV
>fig|195.2144.peg.1799 hypothetical protein
MKLKDFDFRIWDNIENKYIETPHGLYIENTEHNDASNCNRIIANYEQRAFYIDYPFNDRN
NEYYDNEESISIELFTGLYDKKGNKIYEGDILYSFEDCSEGEAFKYKAVLKEGAFYLVEC
GDDGEEYDEDLISEFRLEELEIVGNIHENADLLKVKDDEAEENDIFFKGNMIVWLFGNYY
SVYEVVKAYEESYIISDLMGRQIEIDPRVAMKGGYKDAKDDLFLWYFEVMENEEIKIYPK
KLTYNQMLEECKKNDIYIIKPLYSLGYTYNNNREDFKNYN
>fig|195.2144.peg.1822 hypothetical protein
MKEKEYSIVNNLLNLDFNKCENIFSLHELIKRIATIVL
>fig|195.2144.peg.1974 Ribbon-helix-helix protein, copG family domain protein
IDKVVENLQKESDDLGDFDFAIEALEELKDGDYSKASKKIDKVVENLQKESDDLGDFDFA
IEALEELKD
>fig|195.2144.peg.1846 IncF plasmid conjugative transfer protein TraN
MKNYNLLRFFSKNTSVEQITPKTLRLAILLSASLSFSQAAIQCTDYNDFKQFNGHYYTST
VQKM
>fig|195.2144.peg.800 Mobile element protein
KVSYPKFKKKKDNFGSYYIGGDQAIIKDEKYLKVPNLGLVKMKEKLRFNGKINSFTISQS
ADKFFVSFSMQISKDEYLKTHNKAKNNNLALGIDVGLKSFLSLSNGLEIKAPKPLAKFNR
LMIKRARQLSKKQHAKTKQEALQGIKKSSNYLKASIKLNKLHRKIANIRSDFLHKLTSSL
VANAKYFCLEDLNVKGMMSNHRLAKSISDVSFYEFKRQLEYKSSYNDKEIYQVDRFYPSS
KLCSNCGTIKENLALKDRVYICDECEISIDRDYNASLNLLSQLKQKIGKVLAEFTPADLT
ALLNDLAINQIATSKVETGIQQKSYL
>fig|195.2144.peg.1125 FIG00973752: TolA-like membrane protein
MKQEYNKNPIYRVLYLFIGFYRFVGTGYSDPVVYSIYTGFGYNQSRKFKTLKIEYGNSIY
VGGDLSIILSPKITLDLGAEQRFQTEQKINGYQNSEVRSIPTLSLGSTYSINSDTAVSVN
ASFGGSSASPDSIFGISLWKKF
>fig|195.2144.peg.1832 IncF plasmid conjugative transfer pilus assembly protein TraL
MAKTENGYVEINKFIDTKPMFGNWEVDTLAIFCIFIATAIMFAKGLVAYGIIITFGVVAA
KYYEKLKKSRVKGFFFHIIYMLGLRQPKTLPPSYMRYFLGA
>fig|195.2144.peg.1664 hypothetical protein
MFLKKSEEEKTFIGIGFDLEDKKQEKLLEIYQIDDNSKNHTFVFGSTGVGKTRLIEGLIE
QDIPKGKNVVIIDPKGDIGLFSKMVEIAKKSNREKELMFLSPIYPEYSIKINPLANYYME
EEIIAHIVSGVPAKDEFFYNVANETTTAVVKALLIIRRYEKLEKPLNFEEIAEKVYYEGL
KELQSELKEIQSNGFEDDEIARLLALYDRVLSSPQDYFAKVSSTLRTTLTQMTMGNVGKI
IGTAQENTFIKRLQENQGVLLYIMTGSMLTRQVSSIISKVTISMIQSCVGRVYASGKKFD
KTLKIYIDEAASSVYRGIETLYAQARGAGVAIMGLTQSAADLAAEIGQDGANRLLELTNT
KIIMRLNDTKSSKMISDLGGKKRAYSYFLTVEGGITSREVEELNIEVDDVTNLQKREFFY
FGFEGRFKGKTLKVNDGKLVVDMPNVTQKNEDFNV
>fig|195.2144.peg.1790 hypothetical protein
MSANMLKIIKEANQDFEWYPTTEEMINSLINGLNVKYLTSVLDIGAGDGRVLDMLNNKIS
IDNLYSIEKSELLIQAMSKNILNIGRDFWETSLVEKQVDLIFCNPPYSEYENWMTRIIKE
ANFDTLAFIVPERWKENIFIQQAIQQRGLDYKIIDSFDFLNAERKARAKVDLIVFKPKPD
DKDSFEFFLEERFGFTMPNDRFDKIEKEKKAVDELHSQCNIIKSEDLVDFLLNKYNEELK
LYIDSIENLSKVNNSVLEYLDIDKSKVLKGLEARLKRIKAIYWDELFKKLSPISSKVISR
IRSSLSSSVITKAHIEFNRGNIESVLCWFAKNINEHIELSYLNFFDRLSKENNAFLYKSN
QRFDYGNWRYRKSEYDDTDEFKNIKLKLDYRIVVPYLAQVDHWRHNEQTNEFMQDLKVIA
NNLGFSFSCEFYFKFNAGESGSIYLDNGAKFFEYKAYKNGNVHFKFSQDFMAKFNLAVGR
LRNWLTKEEAKEEFKDVSEDIIDEIFDKPLLLDFKNMKLLSF
>fig|195.2144.peg.1800 hypothetical protein
MKDNENKSTRVTFFINDEKVASILEQLPKGVRSMFIEQAILEYSSKKPKVEFFFHGITKT
RRINKVKQQDKNSEENNLQSKISKENNVQTNINEPKNDNKAQKKSGGMMFNFSRKE
>fig|195.2144.peg.1763 hypothetical protein
MDKGSLNKNANFISSFGEAYSLCFYLRISYS
>fig|195.2144.peg.1807 hypothetical protein
MSTQKIAIDIGYGDTKVFFNGKTLKFPSAVSEVRQAQVDLSETKTDIYTYNGTQYRVGEK
AITNAIATRGFNFLNKYSPLLVFHALNQAGVDLSQPIEIATGLSILNYHSANDFKEVIEN
FTINKIHLEPSVFLFAQGQGIFLEYPNHEDSLVGVIDIGYNTLDFLVFEDKEPRSDLCFA
NQGGANRIIVDLQKILTREFRVDFSEQEAKKVFLNKEVKIAGKVIDFKDEIKSMTERYID
FVLDEFANKCGDLMMRSDGVIIGGGGAYFLDQEYIKETHPNIILAPSPHEFSNVRGYYKG
AFEN
>fig|195.2144.peg.799 Putative periplasmic protein
MKKVILTSAMLCSVLFGVQEYEANLAGHIIIDSKSTVKPPKDAPDFFKTYGKFANITREE
KIGTFKSKGNRETDFYLPFKNQPIQGHSGIKYIPKKDVFWVISDNGLGKKYNSYDAMLYA
HEFKFDFKNSKYELLKTVFFKDSDKKYRSYKPIKSYKKI
>fig|195.2144.peg.1771 hypothetical protein
MNKNKEKLEKEFWDFVALITLFFICTIIFSFAKLAVLAALCWIMFLLFAFIYPVKWIVQF
FLSFFKKKEGR
>fig|195.2144.peg.1967 IncF plasmid conjugative transfer protein TraN
ERVSPLGEHWVAMASPSGQWSDQGNHFGDTNNPVRNYALLEFDKIPDCAGGGSDGGDNGH
TATDAMQCNTNFSDDPNFKPANGQGQSIACLQNSQQKYFCPAQLTQCVNSDD
>fig|195.2144.peg.1792 hypothetical protein
MAKFTPEELEELECNFTIIKSNSEVPAIGKNPLEERIIEIFHEMDFQVLKAKDLNDNTIY
FLWDEQREKYYLSNSIEKNYLASELKKSGLNFKVQNGYCLINDLKVIDCLNSTSLEVLID
FLPYDYYEDHEINIDEIFKGENMDKFIEISKDLIKHYGLDNVANETEINALAYALQDCCA
MHNEKSELSFTDKQIDDFKSYIVEYHIKGDNEPNNEQSVEDIAYSLHYSMLLSSAPEEIV
DDVDRDLFINKVEMGIDGRYQVSFLCDDADSLLKRLKNCIMLGIELNKYIKFCIKNTDNF
YELESLEDVFITEEIFNVKKHIENAPSNEVQDKELALKICSDLDAYYSFYEDAFSKICFD
DIKTIKTLQNNDEREEFLKDLLSLSDNEFRIFEEAIEAYKKLSNKKSSNLLLNEILLNLS
SLRQSNDSKEIGFIDSFFNDNNTVYSGKVMLNNSNVNVYIQSWKNKDGDLDDEDITEVLD
KDFDFLEYAVAEIKGKVIDKILAVKIYEELNVIKNQLLN
>fig|195.2144.peg.1775 hypothetical protein
MNKNKFDEFVAKNLPQALKKDTEQSLGDRSKYVGSSDIGGCLRKAYLDKTTSYEHDLATL
IRFQRGHVAEGIIEKMLDGLNPTLQKEVKLTIEGFDLKAHIDFCLESKNEIVVVEAKSVN
TAVDKPYDSWVMQVNFQLALLATQTQKKLRAYVVAINLNTGWFKSFEINHNQTFEKLAIE
NAQLLANSLLNKEEPAPSEQLYCSTCPHKKTCPLMMKKSEGSELSGDLLEVGKKIIELNA
RKKELEKELEEKKALIEEYMRTCGAKKIKVDDSFFSLSNDTTSTSFDTKALKDNEPELYE
SLFEKYQKTSQRKGYLAIK
>fig|195.2144.peg.1802 FIG00470684: hypothetical protein
MTEMQFNEIKERLADWRSERGLTYENQREEFLGNVFEKVSEYFRAKDDLERVEALCDIAV
FFFNAFEIKFGEISNIKRASMIHLIDHFTSYFIEDNNKTVYNNNKDEDFEYLLIVEIEIL
VKNLGFDFYKCMLEKIKEIESRTGFYDERLNRFVEKIGAYCEREAFDLAINDFKLTNVPN
KYFLDKEGSDFWCIRIEDNNGDYEDYYIRKWYKADYESCRL
>fig|195.2144.peg.1791 hypothetical protein
MDLKTNEEVKEIVIFLENFLNKYGCDSNREYFCYLKNTFLKHISIINEIGFDMLEILLDD
LITSDRIYYNNDAEIIQDIASKFFSVVLFEAHKEIFGNFLVDFCIKRIYLKDERFVIDIY
HSQSKEQLESKIDQFGIVPNQYDLFILSNLIQ
>fig|195.2144.peg.1801 hypothetical protein
MKVAGYKMLNIILVLLFILFFILMFFNYKYQKAQVELLEQNKKNIRIKY
>fig|195.2144.peg.1829 F-box DNA helicase 1
MSISCSQTKNSLTEEQQAVVDFNIDDILIVNAYAGTGKTSTLVQFCEARKDFKILYLSYN
SSMRKEAETKFKHLKNVEVKTMHSLAYVELEVQKKYKDRLGSLRAIDLFDFIGDLKEDVR
SFYATAILKAVRYFCNSNLEPKEFLKEIAKEPSKYEISPKMDLSYISKKTEKLWNDLQSQ
DCALVYEHDFYLKSYQLSKPKLEYDFILVDEAQDINACVIDIVLNQKQAKKVFIGDTFQS
IYKFRGAVNSLEVLASMPKSHILYLTQSFRCPQSIATIANSYLGILNAPRDFKGTLKSRK
GNNENEAKAIICRTNAKLFDIAVENLNKKLFFVGGVNSYSFDELLDIQNLLFKKHKYIKN
QFIAKFADLKEFLEYINETKEVDLKQKIFVLFKYVHSDIIKLIKDIEKSCVKKQEQADLI
LSTGHKSKGLEWNNVEIIDDFLNIKQELEEREQITIAKEELNLLYVAVTRAKNSLNINKD
YLLEKDFIEKNLERITIE
>fig|195.2144.peg.1672 hypothetical protein
MNNDVQISQIANIPYFTIRDWKQKKDNWRGKIYLFLKNTNQEELKEIFSNSINSSNTGLS
DSKIAKITTIPLPTLNTWKKDKSTYRKKIYDFLKSCDESRLRNIFL
>fig|195.2144.peg.1828 hypothetical protein
MKIIKKLQEDGSFKEQTYYSVDEVAKMHSVTHTTVRIWISRGVLKSLKLGKGYYISKETI
LNFQKTDSLS
>fig|195.2144.peg.1694 FIG00471065: hypothetical protein
MTEEKLIKKEIFSYAIFIAIIALICIFKNEILGSL
>fig|195.2144.peg.11 conserved hypothetical protein
MAGREGKNDIFVDAVGLELLYIKPNGFYIKLDLAKAAHKYEADGKRRDRLYTSMGFYFLR
LLNQFYSQETLSHCDKVSIKVFIQVF
>fig|195.2144.peg.1690 DNA/RNA non-specific endonuclease
MKKLMILPLLATLALADYTQYKPSEDFAKYFTKQSCSQVLDKFYYLNCYDYNYKGTKAVA
YKLEAENLKGEQIKKRPRFEDDTNIPKKYRTTWSDYKNSGYDRGHTLSNASMRKTTQAQR
STFLMSNITPQNPQINQRVWNKIEKRERQVALKLGSLEVLNLVNYDNNPQRIRNQIAIPS
SYTKILKGENFKECYQVPNHEVENESIRSYQIKCQF
>fig|195.2144.peg.1960 hypothetical protein
MKKLSVKGNKGRNKRSYVQIMDILLTQLEENLPSKVVASRYDITLQTVYKWKKIYAKHLE
NYKKLKEEAKIKNADKENKDLQEEKIHNAACGKRLKLLRTSLNLSQDRIAEILGITVAIY
MRMEKGYTVLNSYIITKLYKFLGINPVYLITGEGDSFLIKDPDLFKKINTEQKKYSNRNN
TKENEEDLF
>fig|195.2144.peg.1680 hypothetical protein
MIKNMDILINILTNLSFLLLVNIIFIFIYDAIDKEI
>fig|195.2144.peg.1842 IncF plasmid conjugative transfer pilus assembly protein TraH
MGILKKRVIISAIACAFLLPSALNANLSSFIQNNLGSSITSENSGYYKSQVSGFISGGSS
RIRWGGGETIRPYSVTAPSFNVGCSGIDMIFGGFSYLNFEYLVEKLKKIASAAPAYAFQM
ALSTLCKDCQTIMDELEKIANAINSMNFDTCQMTTNWTNKFGKMLSSNTESGQNDSWLTS
FAKGMEGTAQTVQNFAKEANAFVNGTTPDKSGETNAAKILKQGSIIQKIIEKGKASFFAD
AFGENQYEDILRGVFGDLVAYTEKSTSITNKKMSDPEKVMLIGPTLNTDKFIEALWNKNG
ENKSITLEFTAYTINKDENGLYQEPVGKETKVTIDKDIRSLLIEKFKAIVAKIKAKTSLD
DADKNLINAAPLPVADILNIEASTGLNGDAVYEFVALLMVDAFVNELFNEFITNINTVQG
LDPKFSSDHKDDLAKFNAAVAKVQETTRALLSENAQAIIRDNQQVDSIRKIISNFYGVSD
IFNYGTGR
>fig|195.2144.peg.1803 hypothetical protein
MKLKDFDFRIWDNIENKYIETPHGLYIENTEHNDASNCNRIIANYEQRAFYIDYPFNDRN
NEYYDNEESISIELFTGLYDKKGNKIYEGDILYSFEDCSEGEAFKYKAVLKEGAFYLVEC
GDDGEEYDEDLISEFRLEELEIVGNIHENADLLVVKE
>fig|195.2144.peg.1796 hypothetical protein
MKNNEIFTKAFRFTDEGDLVITLTPDFECFLAENQIKNSQDFADKFSDTLDENRYFDIPR
ILCYKEDLKSTPFEDFDNEYFVFVPNDTNIDLDSLSYAVSALNPSNQKDFLIEAMKTKIK
KGEINKENLKENLENKIKYISEQIPIVFEGKVGEDTIEKLLKEKETIVLPNVTKYAKNSI
NEYFENEKDEILEELNAICKKNMI
>fig|195.2144.peg.1692 hypothetical protein
MKILDLLKVKVYYFCSYKANKEDKIITGSCLVDYSRYFWKKTDFEVVYHLISNQIKKDLK
ATGIYFTQFHKL
>fig|195.2144.peg.1971 IncF plasmid conjugative transfer protein TraN
ILLSASLSFSQAAIQCTDYNDFKQFNGHYYTATVQKMTFEDAKKLAEDSGGYLAIPDSKA
ENDFLSSLFRGGQYAWIGVYDPSYI
>fig|195.2144.peg.1701 IncQ plasmid conjugative transfer protein TraG
YEDPKNATELEAKIKECDKNANSAKTDTECANAYKASYSKSLQNFHNEAISDEEAAKFFK
KK
>fig|195.2144.peg.1686 hypothetical protein
MDLIYFFLDITWVEAVVTSLFLSFILIVPIYTRLIGVICFMFCIIFLFFGLVIDRGVDRQ
VKSFSTKSLLC
>fig|195.2144.peg.657 hypothetical protein
MVIVNDKQLKNLIVEKRTYIKDAYTKNLYIEAKDSLKGTIIFFYFRYRLNKKIQSIKIGK
YPTTTLSSAREKANIFNDMLAQKIDPKEQIQDKGVKKSKTVKEIFHEWSQVFYKNNTSYN
LSKRLETHIISKYEDKHINELAKNDILLVLDKLYVEGKLETIKRVFLGLKKMLMYAINKE
YIENSNILTLDLKALYGSPKKQNLRAITKEERFKELLLAIENYNGSIFTKVALQISPYLF
LRSTNIRNLEWSEIDFKNLKIIIPANKMKGGEDFIIPLSESVIKLFEFIKPFSFHNSKYV
FPSDISKSKTMSENTLNQAIKRLGFGDEMVFHGFRTTASTLLYEFKNLHGQDSEVIELCL
DHRERNNVKATYNRSLRLNDRKLLMQWWSDYVDNLKGII
>fig|195.2144.peg.1769 hypothetical protein
MNLQRKIKTIEKEKTKLLKSHKSLLEASNEIDLYNLVIEKEFSKFYKAVNSKYPCRSREW
DERMDFAQDYSDILKKIANVERLQSLINKKSKENEDGYKVGDFLYSSWGYEQTNIDFYQV
IATTEKTIFLAEVKADVKVTGWERGLKSPCKNALKLDKAAFKTLSNSPKDSRGGGYAKSL
YKYKGKALEFTSDY
>fig|195.2144.peg.1788 hypothetical protein
MKKYKYTPKTKEELKALVKDESIYLGDIDTSNITDMSCLFTNSTRKDFSGIEKWNTSKVI
TMAHMFSLCRFFNQDISRWDVGEVENMSYMFHGCHYFNQPLDDWDVRNVETMAGMFWGCE
SFNQNISKWNVGRVVNMDSMFARCYDFNQPLGDWDVRKVENMNSMFSSCKSFNQPLGDWD
VRKVENMNSMFSSCKSFNQPLGDWDVKSVKSMRFMFHKCYVFNQDISKWDVRKDQYTENT
FLDCPIDNSNKPEALQELSI
>fig|195.2144.peg.1964 IncF plasmid conjugative transfer protein TraN
ADSVKIQEKIQNNIENATKKPTN
>fig|195.2144.peg.1689 hypothetical protein
MKLEINISANDIKEIHIEDVVYLYEKLNQEQQDLFLGLINATKNMGENKTIEILKTHFSG
LVKDFIQEINKK
>fig|195.2144.peg.469 Methyl-accepting chemotaxis signal transduction protein
MISISIILLYFIVSKYLSPLAAIQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISKAIN
ENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRN
>fig|195.2144.peg.1852 Flagellar biosynthesis protein FlhA
MDGSSKFIKGDAVAGIIITIINIIGGFLIGAFQHDMALSDAASTYTILTIGDGLVSQIPG
LITSTATAIIITRASKDEENFAEGTLTQLLSEYRTLLIVGFVLFIFALVPGLPHLSLGFM
ALVFLGLGYLTKQVKEGKIEVNAPKKAKASAANAASGAGGAGGVTAPAKKSEEEILKEEE
HKINDILKVEILELELGYGLIKLAESELTERIRSMRRSIAESLGFLMPKIRIRDNLRLKP
NEYSFKLKGVSIASAEIYPDKYLAMDSGFITEEIEGIATKEPAFNSDALWIDANLKDEAT
LNGYIVIDPASVISTHMSELIKAHASELLTRQEVQNLLDKVKNDYPIIVEGALGVAPVSL
IQKILKDLLKHNIPIKDMLTILESISDIAEVSKSFDMIIEHVRASLARMITNMYLDDKGN
LDIFILDSASSAVLMENVQFRDGSYHLPLSVAQTGTLVDTLRAEVAAVANGRIKPFILCV
EPQLRKFIADICYNFNINIVVLSFAEIAENTNFNTEGIIRIEL
>fig|195.2144.peg.1666 M protein, putative
MKKRRADLLKKHNSKIVLADTLESEAMVDLAMKANDIFLKLKKTAGVGLDFKDADEMLML
WNLVLVKSSQTLEQISQKIDMKYDEPFTITLAREKLEK
>fig|195.2144.peg.1824 putative transposase OrfB
MFTQTIKRNARKVFHNAVQTLVDSGTAFVPIKINLAF
>fig|195.2144.peg.1773 hypothetical protein
MSSRSVTNIISVSIDENCNKNIRGSSFSSLYGQIGYNILIGIKTLAEDDFWGKYPHYKDF
VEEIFVNQSNLLNQVDYEGTADVVFYKKNNKIFACVRCRVEDNNSAFFSDQVVFDEKFIR
ETSFIHPISYFMDEYISREAIISIDKYIEYRYAEKPNETNSLIKEIVDNFVDFYKVEPLK
PNFDFSKFDETLNKIIMSKHFPKTKDEF
>fig|195.2144.peg.1821 hypothetical protein
MLEKIKLYLENYRIQKVLFELLNLDLKELNYSWNDNINCFSFSGGIIKLLKLNEYYIKSS
LVYIKDGQWLQKQDDFIGLLSNLFKQDEYKEIDDFDLGVVKSISCSRSNNETNYFANINL
YESNIDPRDIIYLFGFDTFRALNKKGGWDLQSCIKHFQEDKILEFTYYEWADWYEWNNHN
GSHHFAVALYHLRNNQDKYKVKARIKIEKLNQYNLKKLLEEYEIFITHEDNIYKINSLFN
QIFTAQDYKNYKLNNDKTYAIVFKKNKINNFILNILNKLDSKYFFYWNRELKKHSNPK
>fig|195.2144.peg.176 Putative membrane protein
MGYQIVFALMGFFAICGVIITTILLRMIAKKKTLQEVA
>fig|195.2144.peg.1684 hypothetical protein
MNLLNFILSISGVGDFIIILFASMIIYAIVYLIIFLLINVFFYLFKFSEKVTDIINNKLI
FLFYLSYPCLGILFFLFFDTLIGEANKSYVEKSIKNIISI
>fig|195.2144.peg.1765 Single-stranded DNA-binding protein
MFNQITVIGNICQDIKLSYSQSGVAFLNNAIASSYKYVANDGTTKEEVCYLNFSVFGRLA
ENMNQYLHKGSKIFLQGRMVQENYTDKEGKNRTNYKIAVETMKFLDSKPTDNNQSGNPYG
NVQEPAMPEANQKVQQQVPNNQPRAEGENFPF
>fig|195.2144.peg.1831 FIG00471953: hypothetical protein
MKKNFFLLALLLGFFITSAFAGNTDSIGAKGLWDIVSGWLNDTYVSRIIALLLFCVGVWR
AFAGSILQFFLMLGFAVLVTQGSTIIETINSATF
>fig|195.2144.peg.1764 hypothetical protein
MFSFKKFYLRHLSYKNKREHALNRDILFAFIKQERNP
>fig|195.2144.peg.311 MmgE/PrpD family protein, putative
MFYSEILADFIFNLKYENIPNTVVQRAKELMLDSLGTAIAASKEECVLNAFKAFENLSTE
KNTPIWVNDQKLDPIYAAMLDGIASHALDFDDTHTEAILHASAILTPLCLSYGFHVSKDA
KKIIKAFIIGWEIAARVGIASKGTFHKRGFHTTAIAGIFGSVSASAILLDLNKEQIINAL
GLTGSFASGINEFLSNGSNSKVLHIANAIKNGIIVAHFAKNHMSGPLSIFEGRDNIFKCF
GIEEECDKTELNKALGEIWQTMQVSIKPYPSCHFTHGLIDCAIALKNDGLKANEIQSIHC
FVDEVPISFICDPLEAKYTPNSAYEAKFSMPFLMALGFFNGKITLESYENLKREEVLEFA
KKISYEKRKSQGFPKIFQGI
>fig|195.2144.peg.1681 hypothetical protein
MKLLGKLKKEQIYFLGLFSLVLMLISNIFNIDILWGISLCFLIIISLALIKKDKNYKE
>fig|195.2144.peg.1235 hypothetical protein
MSCKKYLGFLKLGFAFFSLILISKKSIKYSYDSLCRFFEKLLKILLKLIFMIFIIKMS
>fig|195.2144.peg.1597 hypothetical protein
MKQEYNKNPIYRVLYLFIGFYRFVGTVKDNKQIKEIWEEITDGADILKDINQDKLGGTIK
MRKLDDQTIIQYKKLLKVEVGP
>fig|195.2144.peg.1683 hypothetical protein
MRSIGFGVCNNSDYASQICKNYLKYFENSLEQSIARSKKEEELKKKKQEEIEKNIMEIK
>fig|195.2144.peg.1786 hypothetical protein
MLTYTNELVVARLARALAYKEAKKDKSKVDFLINLFKKQIQNCIKATEHFTDRVSQRFEE
VENDTLSVAISRAIRNTSPLQHGADYHIATAQKYLDKDSNIVVVLERQGEFGAVLVTTYK
RGQENLLSDEELADLKKRGVL
>fig|195.2144.peg.1795 conserved hypothetical protein
MKLLVCGGRDYTDIEHFNKEMDNVFSLYQNQIDTIIEGGARGADNMAKNYALKNKINLVE
VKADWQHFGKAAGPIRNQRMLSMLDSNDCVLAFWNGVSKGTKNMIEIARNKNIKVIIINI
K
>fig|195.2144.peg.1774 hypothetical protein
MEKIIIIAKESDIRVYKNPNDAKEYLKKYFDEFSDKTYTDHDHASIDSFVDKLDTNENTI
GFFVEDNYDLSPVVFTGKIHLL
>fig|195.2144.peg.338 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MSIIIANRTDGTGSRLISLMNAMYLAKILNKQVKFTWKNYIPFTKDSDTNNFRKVENDNV
SILGLCVESHTEIFSKNFIDKYFLESINGSIFGIDGKVYTNFDLFLKELKVNKYDYISVP
LSDLSTRVFKDIDDLEYRKHMQNIWKDIEFSESVKKIVNMAKQTCMKFKDFICIHIRSGD
AIYDYAEFRKFNLQSIYHATPCEIAIGIIQKNKNKNIVLVGDDLLSIRQIAKFCNFKNVF
VMEDFRNSNQLSNMELFFYDVIFMSYAKILYGTNSAVVRLANYIGNQKFINNYSVFNEKE
LYDIIKENIEKFNTSNSQKAFSYFHLFIVSKKINISKENLIEFLEKALEYDYENDKYRIH
LIDVLLNHNEFSKANEMLKTILLTRESEYLKTLFLKGWIGVVYSNLFDIYLKSSCLQYPY
IAYVAMHILKFRTSLQIQNLNNTLNKTIQEKDIIINSNTNQIDQLQNNIQEKSTQLNQLQ
SKLSFQTQYGTAKSRIQNQLSYKLGQAMIINSKSLLGYLIMPMILLNIIISHKQAQKAYK
LKIKKNPNLALPPLESYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMLFEVRKL
KREFKEK
>fig|195.2144.peg.1819 Putative thioredoxin
MIKKIRILFLAIFLAFSPMVLEAKIYDDVYVAQKQALKEAKLMIFFVVSNTCEYCHKLMN
DVLNNRDLMEYLNKNFIVAISDLNANGLIPKDLLFNGVTPTTYILTPTGKVIGTPIEGAV
DSDILFGLLKGLEDYKKGQLGF
>fig|195.2144.peg.1682 hypothetical protein
MENKEINKECLEFIAFLKDENTKEFSGNIRVKKRTYENNFNLDFLDGTLKANKDFKYSDE
KAEELYNYIRFLHCL
>fig|195.2144.peg.1838 hypothetical protein
MYIKASLQKISLVSLALAFSLTNLSAKEAQTSEYDNNLLLKKAVLKLYRENQELEKRVAV
LEEKLGIPKPEQNASVINPKPLDQNAFVFLSRVKDEFKKGRKIVLGQAIKDAKYYSKPSI
SSRVVGNVAKGKRIIIKGVTEQNGNAWYKIEDWMYIDASAVSFRSKK
>fig|195.2144.peg.1662 hypothetical protein
MENGSGNIGNKGDINSYGSGRFAHPNLDFGELKERQGGSGRHIFHALSEIQRYHVIEDRS
EEIPKEYFTIEQILDYLKIGFKSGMFESFIFTGLLCFLQVIYPSYKYYFLDSPLSKNEEL
FFDLLSYTPILVSTLFMAYISKYYKGLLTRRAIFALMNGRSFSFLLKGFAIFWLFSWLKE
ISINNPRTVYSWADWTLWLIQYFKPNVSTEQLYVFYYKYAIPALHDASYELLYSMCIFAI
LPYLTIFYKGYKERVKRFENKDAYENY
>fig|195.2144.peg.1833 IncF plasmid conjugative transfer pilus assembly protein TraE
MLFDKYKNQMDKYIFENITFRIVTLILSFVILVLIWVILARTDSQKVVFMPPKIVNQEFW
IAGNQVSKGYLHEMGQFISFNLLNITKENARNNIDNLLTLVDPKFYQEVKTKLLEQMNYI
IDNAISRTFFVSAIDADTKGQIKVFGVVKDIISDKVVRSSQSVLKINYIIEQGRFILNDL
SIEEEKNNKEKN
>fig|195.2144.peg.1688 hypothetical protein
MKLKIDSTGLILLFMILMSVFLINAEYSIKPTYNELYRIFFTILASLLSAILVETQNKKF
IKDCYNFSGIISSITG
>fig|195.2144.peg.1768 Phage recombination protein Bet
MDTKTTKNTKITNTQNQAVSTSFTQEKIELIRKHFFPVNAKTVEMEYCLNIANKYNLDPF
LKQIFFVPRRSQVEVNGKKEWVDKIDPLVGRDGFLAIAHKTGKFGGIRSYSEIKQFPRLN
NKGKWEYIQDLVAVCEVYRTDSDKPFVVEVAYNEYVQKKASGEATSFWTTKPDTMLKKVA
ESQALRKAFNLSGLYSAEEMGVGMTESSDIVIDIEAEQNNTQENKKKVDFSQNFSQSNAT
TFSEDERQVLLSLGLEVKNEDGYYWIVGNTYGLNEKIKQLGYRFHSEKKTWWKQIGNVA
>fig|195.2144.peg.1871 hypothetical protein
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIGIKNHWDLAFLGYSLNKKDSY
ILNNSLWNFQAIKQHKKNIFSKIKDEVKFNHKIIFSSELLQSRLTRKREIVKLYTFFKKI
GFTNIKVICYIRDANEMLRSLLSEAIKWEEIDSFELKEEKEEYKLGYKKNLFHFHHICNH
KQTLQWWGEVFGKENLIARLFDKNEFYQGDLLKDFIHSIGLEWDDEFIIPPKQNESLDLL
GIDLLRRINKFLPLFCNNARNIFRGDLHHFAVKHFTSKDSHLKFQPPKEVVQSYIDYFEE
SNEWVRKEFFPHKERLFSKKDLTDYKENYELKEMKPEYWDKIAEFIADIVSTKNQNIADK
TIIIQNKDKVIVNQTNQINSLQTTLKDNKAHLIQAQNLNNTLNKTIQEKDIIINSNTNQI
DQLQNNIQEKSTQLNQLQS
>fig|195.2144.peg.1811 hypothetical protein
MCFSRAKIQRENYSKTIFILIYFFVFLSIIFHFHFYFFTYLYSKIFVNFSIKKYSKSKPT
KRQKIVLN
>fig|195.2144.peg.1841 hypothetical protein
MNYLPILRQKVMKLNKNQIRTLINKALFVLIAFIVGNIVVLALSQFYGIGVIHTKSIDKD
VFIYQKKFQGDLKDSLIYFSLPVQTRYFDKNSNFGKYVRCEEGQTLSVKDLKYYCDNVFL
GIAQKTDKDGNKVEQFIFNGVIPKDKFFVMGTHPRSFDSRYWGFVDRKDIKGVSIWAF
>fig|195.2144.peg.1670 hypothetical protein
MNTIQKLRRELKIYAAGIIVLPILSIISYMFNNQKLDYNFLIFFALYFGLFFGFCVIGFF
STKKAIKTYSQLIEKSQKEFGEKNENHRI
>fig|195.2144.peg.1851 Flagellar biosynthesis protein FlhA
MAKNKLVDLVFPFLGPLIGPVLRAKSLTIVGFIVCILAIIIVPLPSPILDFFLALSIALS
VLIILISIYIPKPTDLTTFPTLILIITLFRLSLNIATTRMILSEGQNGPAAVSEIIAAFG
EFVVGGNMVIGVIVFCILVLINFMVVTKGSTRVSEVQARFTLDAMPGKQMAIDADLKCRT
Y
>fig|195.2144.peg.1798 hypothetical protein
MKDDKILLPQKSQFGDKFWLIRDNLAVCENGRIFNYDELGKLIETQYECILDNVSKASSK
KILANIIDLKNIIIDDYFINLIEHTIDGNKFEFSHDMNLIKYKGYVANLNTLEIAGLAQE
MEKVGDELILPDFPKRLDENLIREFQALIKLVFRKDCNKIKL
>fig|195.2144.peg.1804 hypothetical protein
MKTFNTDDYIAIVKIIPFSERRTCFCDFAKQNEIKIEKINWKNYINKEDLKKVYAIYKNK
PHERNFFHEKKLIVKAFEDVEKFLRSENEIKRF
>fig|195.2144.peg.1665 hypothetical protein
MFDLIENVMSFIYRHQLIRKVVWQIIITFVSIFLFLTFLFWVNLEKMGYSSFNFSLLLNL
QAYIFLLWEYSREIACFLIIEQAFFILLLWYMNNKLKNPSNDKEVAHIHIKELAKIWLED
DNTPMIDTSRQATEKANIIMVNKQVRDSIISLANLKQDISQIFLNDIIKPNLEKIHPKHL
EMIIKLLQLLEENIACPSVVQLFEGDPNSAYGKISARRKDGERIDTVTLDGKTRFDIYEK
ISLLRHSLNVAYKIIELLNESKEYKSFKKTLFGKAIIVALGHDIGKINNFTLRESYIKEQ
RLKGDSKQAFMNLKRMQEHQKISYIIFYELFKNYPDLKELATVVQGHHLGSIDKDDKLLK
LLIDADKQTRDYELDAYLQNSEEFEKIRNKELESIITTVPQKNNLAHENTQKTISKTPEK
KTQTIQNKTQNESTENEISILDLKELQDRFVLNFNEFKKQFFLFVAEDNSKEFQELVYTF
AFKNTEKEFYKNKKDLFILVECGVINGNRTDTMNYFYDLSDEINKKLNKKIKIGFAMFRD
CKDINEAIDGCKKALEYAKNNNQVVYYDYKDLKISNSDKILISDNAEVKITESVKIQEKT
DTITTNNQVNTLEEIDTLKQKTIDTQIIENMFEMIESKVQEVEYSLSQEENFDIPLIEAK
FIEILKSKINTFKRKGFAKIPQAISFKRFVLFSHECLLESLAKALNVKNENLNAKLNFLI
RYYRNHPDENKRLIWFVNVEKGFYYSTYILKFDERQDEVFFCVPFDGKRAFGMSISELSI
HKDNSGLRNCIVKPYVKKEEK
>fig|195.2144.peg.1777 hypothetical protein
MKYKKKVFSAINTSFKIAYCYVVEAKCNDHLSEHLRLGIFTSFEEALTFIAKNFYKTTKS
KISYSRETNNTWIIDNCEIKNQSIRHRVTDCCIENIAVDAREIRIRVDTNNFIILDNGKL
IEISKPFFHDQVAYLNS
>fig|195.2144.peg.1668 Predicted signal transduction protein
MNNLLEKNINEVNEMLIKSLDDLPPLPETIQKLQEYIATHGSNIVIDEIANIISTDPLIT
ANLLHLTNSAYYGFSKEIKTVNQALVLLGVSNVKNMIIADYAKSSFVINLSPYGIETDRF
LALIHEQTNFISTWLMEEDKMLCHNLIPCVMMLRLGIMVFSNFLIQNNIDKKFLLHLSKN
NFNNILRLEREFLGVDHISFLSNLFKVWNLDEDLIEIISSLDYLGSTSTKVKKETYALAA
IEALFSPEKNTYNEFCVQKAYQILKDAKANGVDFNLENFLNKLPEKFIEILSKSKEQL
>fig|195.2144.peg.1770 hypothetical protein
MKKYKYTPKTKEELQALVEDESIYLGDIDTSEITDMSYLFANSTRKDFSGIEKWNTSKVI
TMAHMFSLCRFFNQDISRWDVGEVENMSYMFHGCHYFNQPLGDWDVSMVRYMNSMFSGCH
AFNQDISGWNVNRVKNMEEMFYGCYNFNQNISSWDVYEVESMSWMFYDCYNFNQDISKWN
VFNVAYMENMFWGCKNFNQPLGRWNVSNVESMAGMFWGCENFNQPLEKWNTSKVKNMSWM
FKNTISFNQSLNDWNVSRVEDTDDMFLNCPIDNSNKPEALQELSI
>fig|195.2144.peg.1898 helicase, Snf2 family
MAEKYLSGNVKAKHKEVKKLVEDGFNEFVNNLESLEQVLPKDLKAVDISISLGTTWIPIK
YYKQFIEETLQITPKDYDLFLMEKTGEWSLKGFGYSLSSYIRSEYATERIGCFDLLEHGL
LRKPIRIYDKKLDPSGKEIRELNPKETAIANSKLENLKNEFIEWIYKDYDRRTDLENIYN
ERFNTNIEPRYNGEHLELPNFNANIKLKKHQKNAIYRAIQENSIIFDHQVGAGKTLVAIC
SVMEQKRMGLLNKPLIVVPNHLARQWNDEFYHAYTNANILVATNDDLKKDNREKFFSKIT
TNNFDAIIMTHSQFKLIPAPYEVIKKQYEEDINILEQTLEKKRNDDNVMRYSVKDLEKRI
ENFKVKLSDLQTTHKKSKAIDFSELGIDALIIDEAHEFKNLLITTSMGDISGLGNLKGSQ
KAYDLYSKTQYIHEQNKKLYFLTGTPISNSITELYTLQRYIQPNILKEKGIQAFDSWAST
FGEVTNAWELDSSGINYKIVARFNKFKNVPELSTMYKSVADIVTNNDIMKYQKDFVPKLY
NDKPINIVAPRSKEIAEFIGIQDENGRWNEGSIVWRMEHQQDDITRNNLLACTTDARKAG
LDFRLINPHCDDYANSKINKLIENVFNEYNAWNDDKGTQLIFCDLSTPKQHSQKVALNGN
IATPNLNKEEFVNINETIEQTEEENSKSLDELLAEQAKFDVYTDILKKLVAKGIPQNEIR
FIHDAKTDLQKGQLFADMNSGKARILIGSTQKMGAGTNVQKRIVALHHLDCPWRPSDLEQ
RSGRVIRQGNELFMRDPQNFRVKEFRYATERTYDARMWQVIESKARSIEQFRKAGADVRT
LEDVTSGAADAAEMKAEATGNPLILLQVQLNSDLRQEEMLYSGYKRQIHNNEESLITNLS
KIELLKKDIAKMEILNSIIKENNSEHFQGKYYINDDEKDFIVFKNDTSDLNKSRQAELER
NFEKIVKTIADDYQKEYKVLEFKGLLISGERTDLNTLNFYVSTTDGKTIIEPENLIYKRD
EKTFFKLESYVNFGGFVKRLNNFYNDLEKFTQLNKNKIENLEKEIVELKSITGDNTPKYK
RKDYLEALREDNRIIMDEIEKMSKQKNYKSDFVPKSAKILEDLNKNNNIQKEYDIEI
>fig|195.2144.peg.1814 IncF plasmid conjugative transfer pilus assembly protein TraU
MKFKAHLISAVAAAYLFFHPSETKAVCAPNPSQILISLTELCWECIFPISIAGIQVIQGP
MPDPQGSVGSPICICPAPPPLFFRIGIPIGYFEPSRMLDSVKDPYCFVGLGFGMPEMLTA
SKGTKGDGHDRARVFYQSHYYIYPIIGMVGILIDAACMNITSGVDIAYMTEVDPLWQDDE
LTALINPEALLFGNPISNLACMADSVSAQANVALDPLFWCKGSWGNAYPLSGNTGSKDYV
EDAASVAGSMIYKLHRELILWESAGQLGLCGEYPMPIWRKSSYRLQILAPVPHPMGMGIG
QSGILWSFAKNYPVAGDNFTFMVFKKKECCAF
>fig|195.2144.peg.1674 hypothetical protein
MRNKELKIIEAYGAFMSILFSFLIVYEDVWTNILKIFLYTEIQAFFIFFVRIFMILHMIL
FMGFLLDAKIKAEHNQLIKLLADKKKKLTVIFLIPLQISFLCSVVLVFFCNIFPNIHSLD
FSFYTIFICVILLYNLILLYNFTKIIRS
>fig|195.2144.peg.1780 hypothetical protein
MGYRCHIAKHYEVEYENGSYFNNSENKLLSLLEKVGLLEDAWMNEGHEDLEVSRQDTLSL
DLEEYVLDEEERGFLEDLIEVAKTAPYAKKSGFIRLSWF
>fig|195.2144.peg.656 hypothetical protein
MNLSNKSLGSPPSILMKFAILDCIISTEYIPPKPPKA
>fig|195.2144.peg.1316 Putative amino-acid transport protein
MAFFGGASAFAESTLAQIYKSKDNTGGFKGGPAYYIKKALGSHFFGAFFAFILIITYAYG
FNGLQSQTMTSAFKVYYDMFNPNATTDFASSSWPMIIGIILTLFGIWMFFSHHTKIGKVS
SLIVPFMALAYILLAFIAVLINFEKIPSVIVLIFESAFDFKAILGGFAGSALVIGIKRGL
FSNEAGMGSAPNAAAAALTSHPAKQGIIQAFSVLIDVIVCTSSGFLVLFSMAYFNVGADG
KPLLTAMPLVQEAMREYYGGFGVHFITIAIVLFAITSLIGNYYYAQANVKYLTNSKLVMN
LFRITAVAMIFIGSQMNLKLAWSLADLTMAFMAVTNIVSLLLLGGIVNKVLKDFNTQQDS
KINPKFSASKLGIKNAECWD
>fig|195.2144.peg.1784 hypothetical protein
MQRINLTLNSEASLMLDKLVKDLKMSKTQILTDALKQMYEKQEIEKIKRLLIMGFKDAEN
DEEYQKEQLELAEAGVGDGII
>fig|195.2144.peg.1859 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
NLALPPLESYPDYKEALKEKECLTYKLGEALIKASNNWYGGGISNCGLRLGS
>fig|195.2144.peg.1388 hypothetical protein
MNSISQKNLELFSKLSGDFNPLHLDQEFAKNSYYGDQVIYGIYQVFLTLENFFKKNQKNI
KIQKIKASFINPLFKNEDFKLKSIKSKNNFLKKYEITNKNKILSKIDFEFQEELKLHNPY
E
>fig|195.2144.peg.1839 IncF plasmid conjugative transfer pilus assembly protein TraV
MNKKSILILCATLLFTACASKQQITKEPSVDAQLKLLVDGGMKYTDLDKQDEDELIRGLL
KNSPSFAQSNQQSAVKENMVKLPNNMPLFRQPLFAQMVVFPYVSDDGIYHGYSESWLKIK
EGEFVLSDPRSKQDPSERIFDMNDVGTK
>fig|195.2144.peg.1813 IncF plasmid conjugative transfer pilus assembly protein TraW
MKKIFFSTIILASVLYAGGSKEMILGKTKDFAERDMIELIQEFIEKNKAQIEQKAFKTRE
QARENVKNYQPKGLIPLKPALEDKIFYPDLTYTLDQDIKNANGDILYPKGFKFNPADYVK
LSYAMVVINGNNKKEVEWFKKSGFSNQVSYRLLLSEGSYYDLNQELKQEVFYLNPQIREK
FKIEKTPSIIKQIDNKIQIHEICIPCMENNKTKIVDNNLSIKEI
>fig|195.2144.peg.1972 Domain of unknown function (DUF332) superfamily
MNLDVLPTRLKDHALKGEFKDFRECHIFGDLVIIYKRDD
>fig|195.2144.peg.1700 Mobile element protein
KVSYPKFKKKKDNFGSYYIGGDQAIIKDEKYLKVPNLGLVKMRENLRFNSKINSATISQK
GDKYFASFSVEIPQDEFIKTHKIKENKGGILGIDMGLKSFVSLSNGLSINAPKPLNKLTR
KLKRVSRQLSKKQHPKAKGDKTKKSNNYLKQNLKLRKIHTKIANMRNDFLHKLTSILANH
YKYFCVESLNVQGMMKNHNLARSISDVSFFEFKRMLAYKSAYRGNEVIEADRFYPSSKTC
HCCGYKKEFLTLSERIFQCENCGITIDRDYNASLNLKRYAINNIGLVQAEFTPEDLTALQ
SDLAINRIATSKVDTGIQQKSCL
>fig|195.2144.peg.1772 hypothetical protein
MGTRSWIAMETNSGFYVDRIYCHFDGYVKGVGYTLLQYYNDPKSVKDLIKHGDIRALRQD
LSQCEKLQINKSSKMLFTDFVKATEGNRTNDIEYFYLYTQNRWHYCKACEGNILTQELQF
NYNKEKLLEETKQYALEKFENNQAFSLDTNSAKFLNYVWELAYINKDEAYELFEKEMINL
KLSSEEIEEALQSLDVEIDEDLSGEYLTRIITQEIFRLYLEGERSSCLIGTFDKKIDNLV
QKYFFSYTENLNFDEETTLDEFVKEKQIDLLEAYFEK
>fig|195.2144.peg.1834 IncF plasmid conjugative transfer pilus assembly protein TraK
MKKVILSALTLSTSLFAINVIDNPSSDIININVSNSSVNRIVLPTQILDVAYSKEKGIDI
KISGNQAFIKFLPIQKEQVRSVGKDRYEPVGEPEIVYDKAKGSEVFFVTANRTYSFALNP
KNMDAETVIINDFSAQKDEILKYESDDPYMSTMAKITESILKGGVPQGYKIKKINKVASS
DKTLTTRELTNYDGLLYKATLLEVENKTDKAIRLNPKDYISIAKEAPKAISIYYNNEVNH
LLPYSKAQIIIITKGGRNTNGGVFDGGMSK
>fig|195.2145.peg.1728 hypothetical protein
MNKQVETIRILFVDDNQETLDSYEESIKVENDSLQEESMQYKAYKALTYEKALDILDENR
IDIAVIDLDLGSEFTGEDITKYILKRYSIPIFIATGKPADFDSKLIGPMVKVLNRDDMSL
LNEIKKQMQSKLVRFFSKNNGFLEQQIVEFFWDHMSKNLPYWDQYTIDEIDLVLLRHTTA
CLNEKLYVSNSSGKYFNEYHPGEMYIYPTIKDRHHTGDIVKKNDDFFIILTPSCDIVNNK
NDYYVLARIINYDKNNNSNRIPERFYFIKNFAKIFEVDNKDKEILEPSICFQGLISVKKE
EISDYARVASISYPFLKDIIAKFSRYYARQGSPEIIEELK
>fig|195.2145.peg.405 Glycerol-3-phosphate cytidylyltransferase (EC 2.7.7.39)
MKNVITFGTFDLFHYGHLRILERASELGDRLIVGVSSDMLNFSKKGRKPICSENERMKII
SALKCVNEVFLEESLELKEKYINRYQADILVMGDDWKGKFDCFNKICKVVYLERTPSIST
TEIIEMIKT
>fig|195.2145.peg.1838 Methyl-accepting chemotaxis signal transduction protein
ADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVAQIDQTTKDN
VEIANESAIISSTVSDIANNILEDVKKKRF
>fig|195.2145.peg.1817 hypothetical protein
MICEIGVRGREVSLELTNGQAPFLMYIIKTKKVLFLSRAYAYAFFIFFIFFIYFYIFLGG
FLSPI
>fig|195.2145.peg.1846 hypothetical protein
MLCKARQLNFIKIVVIFNYFAHLHIQSKTINARGFSAPAVLLEKYFNFKLKKPKI
>fig|195.2145.peg.1837 Motility accessory factor
TWCETDEFCKKNIEIVIRDSGLNSNLSFQSYFHFLQNIPSMLESIPFQRILSQRKNKFEN
AIVVSAGPSLAKQLPLLKACQDKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQ
NK
>fig|195.2145.peg.1702 DNA topoisomerase III, TraE-type (EC 5.99.1.2)
MIQIEKKQTKPRPYYTMTTLLKDLNSVAKYVSDERIKKLLIEKDKDKKGESGGIGTPATR
SNHIKTLIEREYIEVSKDKKQIIKSTKKGRDLIKLSPKSLITPDMTALWFEQQKMIEISE
LRREQFLEEITKEVISEIQRIDKNQEFKILDNENKPKIQCPQCNKGFLQRIKSKNGNSWW
WGCSEFKQGCKAMYYDDNGKPKIINV
>fig|195.2145.peg.1823 hypothetical protein
EGIPVRSAGANRSEHAGMSSDN
>fig|195.2145.peg.537 3-isopropylmalate dehydrogenase (EC 1.1.1.85)
MTKTLYEKVFDAHVVYENENELPILYIDRHLIHEVTSPQAFSGLKMANRKMARSDLTFMQ
IIKNPSTFDVMLCSNLFGDILSDELAAISGSLGLLCSASLNDKGFGLYEPAGGSAPDIAH
LNIANPIAQILSAALMLKYSFKEEKAARDIENTIAIALERGKMTKDLNAKSYLNTDEMGD
CILEILKENNND
>fig|195.2145.peg.407 hypothetical protein
MMFWMYYFFGIWYYHKKKDYKKAQSYFLKALKRQEEHSKCNFKLGMSYFKLKQWKEANEF
IFKALTIDPSKKSWGVQLKQTENHLNNTYTATKLWWKEVEDLKKQIQNKGKNFFICRDLA
IALENMKRYHEAADYYKQAIELNDKKDSMLYYKLGYCYESKGHDSEPNIELSKKYYDKAI
KYDEELDAQKFGIGIFHEKQGLWQEANKAYLEYYQKTQNLENDDLLYKIAFSFEKLYDWP
HAEIYYKEILKYNYQNSYIHYRLGYVLERQNKLEESLVYYKECSNRANELPQKIFFKIGE
ILTKLNRPEEAVKFFLYTQDYKDASNYKDVNFSKSAYFYQKCIYTEFYESEKVIDTFILY
QSHTARNMSCNPYAIFKYLLQHSDFKNYIHIWAVNDIESVPKKYKKLKNVVLVKPGSVLY
LKYLACAKYLINSGSFFRFFIRKKEQKYLATWHGTPLKFLGKDIKRGFLDYEVTQKDFLQ
STHIIAPNKHTASVLIDRYDIEGIYSGMVYESGYPRIDTTINITDAEKKLIKKQLGIKED
KKIILYAPTYRNSFEKADLNFEQVRKDIEILQESTDYTVLYRGHYTTEQNTNILSVSREI
DTNELLSIVDVLITDYSSIFFDFMVLERPIIFYAYDYEQYKNEHGLYFDYIKLECQNCTN
ITEVVGKLNNPVKLKQCIIRSDIAQNFISYEDGNATKRVVDMFFFDTYNNDRIYKKNTTE
KKQILISSGLFAKNGITSSFLNFINAIDLNFYSIYLAVDTWQLKGKKDVVEKLRRLNEKI
HILGNPNIISQTMEENYLLNHPVYKISRTNEAQEKIFSNIFSRDFRCLYGESKFDGLISF
DGYTELWIYRFAYAETNAKKIIYLHSDMLNEYNIRYPYLERIFNVYKYFDYIFSVSQELS
DLNRDNLSSLYGIPKHKFDYINNIISDDDILFKSNFRLECQSDERLYEKDYKIFITIGRL
SPEKNHIGLIQAFCKFHQNYSKTRLIILGDGPLKEELQEYIRKNDLGDCIFMLGIKSNPY
PYLKKADCFVLSSLHEGQPIVLLESLVLSKPIVATNILGNKSVLKNFGGILVEKDIEDIV
SGLNSFMEGHADVIEFDSKKYNKETLNKFNRLFKIKTTVVLKEKNKVNAPCIIMAKPDGF
GMRLFSLMAGMIIAEKIGFSFYFKWVDIEDVIGNIEEMFSSKNHIPFALGKVEEIFDEKF
IHKYYIENQEIKSNHGFGMHQKCKNFDDIQNGYYEQPWGWYSPGIGGGALSQWISDYEEE
QCYKDFRQVYKKIQFSEKYLNIIEDAKSIAKNLGHFVSIHIRGADIVFSSSYKQASLYGF
VGDKYFPYEIAIEIIKSELNKNNTIIVFSQDVKSSEKLIDYFKNSKIILADVFAKKYTDT
TQRAFFEINLMSHSELIYTPGISLQKSAFSQCASFISGNKKDVSFHEVFSLNEQFEILNR
NIQILDLNPLYRSMAYFRLYQLSLSLKKNLKYAFEYIEKAIENDNDNMAWKIHKCYLLIL
NKDYNSVEEYLKKEMNNRFFHTLFMYRGNVFREIMKDILKCTIMPNLPYMCYLQYNIYKH
EGKLKSFQKFFQKVIKENNTFKVLIERGVKL
>fig|195.2145.peg.63 Signal transduction protein CetB, mediates an energy taxis response
MGEVLNKPHNIVRHEEMPKTVFKYLWDYMREGKEIFAYVKNKTKDNNYYWVFANVTPSID
INNNIIGYYSVRRMPNKSAISTIESLYSDLLRAEQQQDLNKGVEMLKNFCKDADKTYNEL
IFSLQETR
>fig|195.2145.peg.1665 Integral membrane protein
MLIKQPNVIHPLIGKIANESDKFFNYPSLIVLNILYTILLALVLFSLQKTARKNSIVPS
>fig|195.2145.peg.1729 DNA-cytosine methyltransferase (EC 2.1.1.37)
MVVLDLFSGAGGLSEGFFRANSTFVAHIESDKYACETLKTRTSYWKLKKNNNLNIYYDYL
LKKITKEQLWELTNTSDSEEVICKEISEHNFDSLVSKIKNNLKKTLSKNIDVIIGGPPCQ
AYSIIGRARMKNSIENDHRNYLYKYYVKFLNIFKPKIFVFENVPGIKSAGNGKYFDDLKK
SIEDIGYSIQIKELIASDFGVLQNRKRIIIVGFKIKKNKKYSYPIFEKIENKNYFVKDVL
SDLPKINPGEKIEGLNKYTKKTNSYLKMANIRDANFNILTQHETRPHNDRDREIYKEAIL
AWNTKRERLCYKKLALTRPELISHKNTNSFTNRFNVIKENTNASHTILAHMAMDGHYYIH
PDITQLRSLSIREAARLQSFPDDFYFEGPRTSIFRQIGNAVPPKMAEQIAKKIKELII
>fig|195.2145.peg.1824 Motility accessory factor
EDIKQMQDLYEILSPLLIQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHI
KAQENALIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2145.peg.1664 Integral membrane protein
VIAYCRFNKNFYFEANTFCNSSNFERNFYNYASFKKSHFEKNVTFYNSTFKGLDFSQAIF
NENLNIVNTKLNFTFSNLEEKIEQEYEEFNKNKKEEDQKSLDKFANDFRDSFRTFKSALI
KDNNALDASNFHKYELYCKEIELKESWNKKGKNVSNMTDLETNVSRIRDFMDFLLLGFYR
KLCDHHTDFLKVFNNLILLIALYALFVFGFTWLHNDKLEDTRAILTLFGFFDKFRLYFDI
ISAIFAVFGCGFFVWKLNSYEKKNNVSKKQNINFYIYHW
>fig|195.2145.peg.1814 DNA primase TraC, putative
MPQKRIYLYVPFKDKEKVKSLGAMWDDKEKKWFAPKSLDKNIFSQWLYPHQNKEFSFDEN
EVLTTFKSALENQGLIVDGLPIMDGKIHRVKTATDKGREMSGAYSGFLDKYPAGFIQNFK
TGIKENWKMPLENAKQNIVSYQTPSQKRLHNSTSNNTKQDILELQQKTALKIEEEYNQAN
WAHSNHPYLKKKGFSENFYLKQDNKGSLLIPLKDENGKLWSVQRIFPNGDKIIGVIKTKE
EKEQGIEYSAKKSGCFHLIGAKNLEYCKEFIIAEGFATAATIYKALNKPVIMGIDAGNLS
KIVETLKNKFQNTPITLIADNDKKRELKGLSNVGVETAKEIQQKFSDIKVIIPKISNQEA
KQGISDFNDIFLNKGLDEVKKQLNFIDFHNKLKAFKSMEKTQPEKEITRQ
>fig|195.2145.peg.1383 hypothetical protein
MLKREFDEKIKSLGLTRQDFCNITGLAYSSVSNWNDNNKPIPIWVDTWLLNYEKSLALDE
LLNIIEKYKKIHN
>fig|195.2145.peg.1830 replication protein A
DCLTLDMQMSEIVKYHNDFNKIQLPSFTEQEQNLLFLIFARIKEKGIDNVINLYANDFKI
NEKLSNSREYLTENINSLKYKFFKANFKQIIETKTEVIHKYVNLFETMEIHYVKRNPDDG
YDESTLFNRITLKINPDFAYLVNQLTTNFTAFELEEFIALSGKYAKTLYRLLKQFRTTGK
AYFEWDEFCKVMDIPQDYRQSEVDKWILKPAIKELSKERNLFDQIRVPFKNLAYEKEKTA
GRGRGGK
>fig|195.2145.peg.1816 hypothetical protein
MENKQYIYNLPNESNEKQKLETNTNSIIIVGANGSGKSKLGAWMGKNNNHTHIIASKRLT
YISENLSIWLETDVQKQDDYTDIKNTQDDYDDTISILFRQQIKELCSRDKNKPFKTRIDY
LFEIFNKVTQKELNINKNRFCINSKDKSYDLTNFSRGEELILYLISKILTIPNNEQQIII
IDEPELHLHPSLTNRLWDILEKHRQDCLFIYITHDLNFASSRTNSDKFWIKSYNGEKWEF
EQISTNEIMPQELFLKLLGTRRNVLFIEGKNNSLDFKIYSVLYPQYQIITCGSCEKVIQY
TKAFNDQSALHGFKAYGIIDRDYRSQNEINALMNKDINVLKVAEVENLFLLECIVLAVLK
QSGRENKFEEIKNYLFEEKFKNCLEKQILENLKSEIKHKLN
>fig|195.2145.peg.409 GDP-L-fucose synthetase (EC 1.1.1.271)
MLQKESKIYIAGSSGMVGSSIVKYLKRNNYNNLIFKSHSELNLLNMSDVNSFFKNNQPEY
VFLCAAKVGGILDNKNHKADFIFQNLQIQNNIIHQSYLHGVKKLIFIASTSIYPKDLNEV
RESDLMKGELDYSNESYAIAKIAGLKMCEAYNIQYNTNFISLVPTNLYGENDRFDLEKAH
VVPALIRKFHLARLLMEKRYEEILRDLKIKNLEEAENYLNQFGINNNSLIIWGSGNAKRE
FLHVDDLTEACIFTMNNINFKDLYKPSDLEIKNTHINISPSCNTSIGELAFIVKDVVGYS
GNVFFDKTKPEGALNRFTDCSKMHSLGWHHKISLADGIKKLYNWYLKKNKEEK
>fig|195.2145.peg.1795 Predicted P-loop ATPase
MPKVSQENLKDIFIKKLKTIHIKHEALDKDEFIKKIKENNFADAFKSIRDMERFLNAFKI
EVNAINQELYLYDFAVITLLKIFEPRLYDYIYDNRMLFIEQYNPYD
>fig|195.2145.peg.1760 Integral membrane protein
MTNAQINDKILELANYLKIDNKCVAHNARLQSTQINGAVIKNFSFKLFNEYKLSFFNCKF
LCEINEAPGFFEIENPVYIYDCTFEENVISYNIK
>fig|195.2145.peg.1727 hypothetical protein
MKKELKIRPEARLIKTIGEDLIKNPYAAVVELIKNSYDADSEIVIVSIELTNEYVYDKKQ
KFLKFTIEDDGEGMSLETIKNTWMVPATSYKVNKQYSSKKKRVVQGKKGIGRYASAILGD
FLRITTTDLNGMTSIIEIDWKQFDDGKFLDEINIPYECNRTNLKSGTKIEIYSSIEVYYD
EIKQQYQDKINWNKDQNKLLFKELRKLLVPTNKSNETFEIIFLNNGLDKLDIDDKNEKIE
PFPLLDFYEYRIKGKISSNGKGLLFYENKNFENSNEKIELDLRNTCGNIEVDLMVFDLDP
DVIQNLVNKQKDKEEKQLGKSEFKALIKQYSGVGIYRNLFRIRPYGDYDFDWLGLNARRV
NSPTMSISTNQIAGFVSIESENKSNLIEKSDREGLKENENYDNLKKILLEVLSEVEKRRY
EFRKNTKRGRVVANNIKDTIRDVFSFDDVNNKISVILHKANIDAHIIEKVQFELKQEEIK
KNNGLKNIEEDLAMNEAHAALGKLVLYVLHEGRKPMQIIGLKLNNLKKSLQRFIKTKDES
IEQDIKKYNEDSLSQLEKLSNLFKRLDPLMITRSSRRKEVNLYQNALNNYELFKEILKRE
NIDFEIQCENKELFIYGRDEDLYIIYSNLIENSLYWFQATKQMQKKITISIYRDSNYFYI
DYKDNGIGVKKEHANLIFDPGFSTKPEGGTGIGLTIVGQAVSRNDGEIKYIRADEGVYFK
ICFKDTQNEQTS
>fig|195.2145.peg.408 hypothetical protein
MKKIYLKYVDNWYNGKMNEGDFYNNFIIRLLINRLSHKYEILFSDKPDYLIYGPFGYRNN
YEHLNYECIRISLTSEYIQTDWSIADYGIDFDFIDFQDRHLRFPFYFLYHADDIKKAMVK
HINPDFQRDKFCAYMVTDPSRIEFTPRDLFFKKLSLYKKVDSGGRHLNNIGGPIGNRYGN
FSDSKNRWLKNYKFNICFENGSSPGYITEKLFQAYAGGCIPIYWGDISLRSGENELANKG
GIKEVEGGGISNEIVEQGMRYKTREINQYIPRISESLIDYKINLKSFINAHDFSSWDELI
DYIKYIDNDYNAYSSMLKEPVFLNDFNPVDFYEKKLVAFFDNIFSQDYKSAFRRKCGIHV
FRKFEFMKTGIEVPILKKQLEAKNNTDYKIENLSQEIDNMRQTVVNYKINNFLSYKLGFA
MYKLKNNIFYMLVMLFIIKKNHLFFQENRINKRLYRHLGKMAIFAYKNWYNNQGVRALKK
IIKMLKSV
>fig|195.2145.peg.1811 Ribbon-helix-helix protein, copG family domain protein
IKLKLTENEVNILKEISKNTGFSSITKQAKFLLLNSIKNEKLFTNIEIDKFIKTRTEINA
IGKNIYQLLKILRSGNSVKINENNLNKTMDNIRDKIDILSDQLGAIIEKNNERI
>fig|195.2145.peg.1522 FIG00545237: hypothetical protein
MNKAILLTLICLFFTACEQTKSVEYYKAHPEEAKKKVMNVV
>fig|195.2145.peg.406 hypothetical protein
MTLKTSFRKALRDSKNLSFIQKCLAFYMVNLMQKKAKHSKLLKVFKICAFFRQKIVYFYQ
AEFNYYHSKYDISIDCIDYFLKFYPKHIEGKYLKAQLLLSLNKKRESWDILIECLNSTKR
LKTWLFLSKIAQNQDDNVRLERLCLQYMQNYSQQEQMIIRGYLISAFKKNHDYTRAKEYI
KKNIMDYPLETVSKKNKMIKQDAIDALRDIKKILDNIGINFFLVSGTFLGCIRDSDFIGY
DYDIDIGIWSEDYSDKVKNEILEYGVFIQYDLNWIGGLKLKHANGVKIDVFLHFKEYDKI
YHQGEVVKWYNTTFKLQKYNFIGDEYYGFKDFDKYLSENYGDWKIRKMDFDNILDTPNAV
IINKDAFVVHLYQLLMSRYARKNKNKILTHLKELEEKI
>fig|195.2145.peg.1719 hypothetical protein
MDKNPSGANALSATINQTIPQKDKSANDFKAKLEEFSTKKTNAVKSINKEFKR
>fig|195.2145.peg.1720 hypothetical protein
MSDKELEIFELCERLSELLGDKEAIADLKKLYTNHPEMFKDMQEVKEVINKVVSEPEIIV
DANRDKRNYEIIKAAKIINDKKMADVVIKNESGTNEIFHANKKKNKRV
>fig|195.2146.peg.1832 Putative fibronectin domain-containing lipoprotein
SSPSIILAQSTSDGIDLEWVDNDSRAVEYEVRRYGGDQNAIF
>fig|195.2146.peg.1859 Pyruvate carboxylase subunit A (EC 6.4.1.1)
DLEQSDIKPRGFAIEARITAENVWENFIPSPGKIGEDYPALGPSVRVDSHIYKDYTVPPY
YDSMLA
>fig|195.2146.peg.1840 Translation elongation factor LepA
GFRVGFLGLLHMEEIKESLEREFNLD
>fig|195.2146.peg.1818 Propionate--CoA ligase (EC 6.2.1.17)
EYKVNVLFSAPTAFRAIKKEDPKGEWIKKFNLDSLRSIFVAGERCDSDTLKWIEKLTKKP
VIDNWWQTETGWAIAANPLGLEAQVVKAGSPTKPMPGFNLKVLDEKGQELGAG
>fig|195.2146.peg.1544 Putative fibronectin domain-containing lipoprotein
VKEKRLKDIKALPGVEYSYEVIAIDSVGLRSEPSKKVKAKQ
>fig|195.2146.peg.1748 Propionate--CoA ligase (EC 6.2.1.17)
WAIAANPLGLEAQVVKAGSPTKPMPGFNLKVLDEKGQELGAGKKGILCLKLPLPPACLMG
IWENDERYRRGYLDQFPGYYLTGDTGYIDKDGYVYVLGRMDGIINVAGHRLSTGEMEEII
AKHPDVAECAVIGVNDELKGEIPMGFIVLKEGIERDHRGIVEGVVALVRQEIGAVASFKI
ATVVSALPKTRSGKILRKNLREIADGSTLNVPATIEDSNVLKACEKAINALGYPKNKGEK
>fig|195.2146.peg.1851 Rod shape-determining protein MreB
GSRAKILAVGKEAKDMVGKTPGNIEAIRPMKDGGIADFDMTEKMIRYFIEKTHRRKSFLR
PRIIISVPYGLTQ
>fig|195.2146.peg.1816 UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (EC 6.3.2.9)
LKNNEVALLSPACASLDQFSSYAQRGEKFKECVGKI
>fig|195.2146.peg.1807 Propionate--CoA ligase (EC 6.2.1.17)
QLALIYDSPVTDTKKKYTYKQLRDRVAKVAGILANKGVVKGDRVVIYMPMIPEALIAMLA
CARLGAIHSVVFGGFAAHELATRIEDAKPRMIISASCGIEVSSIIEYKPILDEAIKKCTH
KPTTCLIWQRPQYRANMLPWRDIDWELEEEKTRGVDPVPVLATDPLYILYTSGTTGSPKG
VIRSNGGHSVAMKWSMDNIYNAKAGDVFFTASDVGWVVGHSYIVYAPLMNGCTTIVYEGK
PVRTPNPSAFWRIIEEYKVNVLFSAPTAFRAIKKEDPKGEWIKKFNLDSLRSIFVA
>fig|195.2146.peg.1837 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
TSNTRLAPIVQMVLGNIGKFGGGVNILRGHDNVQGASDMACLGENLPGYYPLNEVTWRYY
AKIWGVDYEWLLGNFVSKDWMHKT
>fig|195.2146.peg.1761 Signal transduction histidine kinase CheA
KRLDHLMNLIGELVLGKNRLLKIYDDVEERYEGEKFLEELNQVVSQLSIITTDVQLAVMK
TRMQPIAKVFNKFPRVVRDLSRELGKQIELEITGEETELDKSIVEEIGDPIMHMIRNSCD
HGVEDPATRAANGKPEKGIVQLKAYNEGNHIVVEITDDGKGLDANSLKAKAIEKNLITER
EADQMTDKEAFALIFKPGFSTAAKVTNVSGRGVGMDVVKTNIEKLNGVIEIDSELGKGSS
FKLKIPLTLAIIQSLLVGTQEEFYAIPLASVLETVRVPIDDIYTIEGKNVLRLRDEVLSL
VRLSDVFGVKQVLESGDQTYVVVIGVAESKLGIIVDTLVGQEEIVIKSMGDYLQNIQGIA
GATIRGDGRVTLIIDVGAMMDMAKEIKVDIKAQIESSAKKPKEKPSDYKVLIVDDSKMDR
TLMQKALEPLGVSLIEATNGVEALNIIKSGDHDIDAILIDIEMPRMDGYTLAGEIRKYSK
YRNLPLIAVTSRTSKTDRLRGVEVGMTEYITKPYSPEYLENVVRKNLKLG
>fig|195.2146.peg.1825 Putative fibronectin domain-containing lipoprotein
SSPSIILAQSTSDGIDLEWVDNDSRAVEYEVRRYGGDQNAIFKGVKEKRLKDIKALPGVE
YSYEVIAIDSVGLRSEPSKKVKAKQ
>fig|195.2146.peg.1797 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
MGIVYEQTYRESLQNPEAFWAEAAKKVHWYNEWDRVLDDSDGHYRWFVGG
>fig|195.2146.peg.1829 Translation elongation factor LepA
GFRVGFLGLLHMEVIKERLEREFNLDLTATAPTVTYEIYQPEGKLKKIQNPSDLPPVNKI
DHIKEPYVKATIITPSEFLGNLIT
>fig|195.2146.peg.1775 Rod shape-determining protein MreB
MILDQLIGFFSSDMGIDLGTANTLVLVKDKGIVINEPSVVAVERERYGSRAKILAVGKEA
KDMVGKTPGNIEAIRPMKDGVIADFDMT
>fig|195.2146.peg.1712 Signal transduction histidine kinase CheA
MEDMQEILEDFLVEAFELVEQIDHDLVELETNPEDLELLNRIFRVAHTVKGSSSFLNFDV
LTKLTHHMEDVLNKARHGELKITPDIMDVVLESIDRMKTLLNSIRDNGNDTAIGMDIEPI
CARLTAISEGESPNGVENETPVEAPQKEEPAPTPEPEVDVNQLSDSEVEAEIERLLKARK
AEDQARRAQKKQNTAASTTSKPAASTPKAENMEKKVPASGGGGGGMDQTIR
>fig|195.2146.peg.1822 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
VIGAEAAICPVGIGGFASMKALSTRNDDPAHASRPFDKERDGFVMGEGAGALVFEEYEEA
KKRGAKIYAELVGFGESADAHHITSPTLDG
>fig|195.2146.peg.1852 Propionate--CoA ligase (EC 6.2.1.17)
EYKVNVLFSAPTAFRAIKKEDPKGEWIKKFNLDSLRSIFVAGERCDSDTLKWIEKLTKKT
GSDNWWQTET
>fig|195.2146.peg.1836 Pyruvate carboxylase subunit A (EC 6.4.1.1)
TGVDLIVRQIRIAGGEILDLEQSDIKPRGFAIEARITAENVWKNFIPSPGKIGEYYPALG
PSVRVDSHIYKDYTVPPYYDSMLA
>fig|195.2147.peg.501 hydrolase, haloacid dehalogenase-like family
MHIASGADEQDLIEICKMLDLTQYFLSIHGSPTKKEILVKNLLINNNYKNKETILIGDSV
NDYEAALKNNIYFYGLFRLGREE
>fig|195.2147.peg.500 hydrolase, haloacid dehalogenase-like family
MINIENIKNIIFDFDGVILDSVELKTQAFAELFKEFPKNKVQELVKYHIQNGGISR
>fig|195.2148.peg.16 FIG00638667: hypothetical protein
MKVQGIYDFFSGYTLDGEANFNTLDIELKSPLQVSNSYLRHSGFGFYGAFASKGASNNTI
KIRNNLTVINGTQNPSDRINIITGRTLAGEANFNVIDFKDSQASLPLFIYATTQENFEGS
IHYPEYAKHNKISLNNVFGRKDIRSGVEAMNVENNQVFYHNVEAQASGEGVNRESSVYIR
AANLAKNNLFKASNYWATSMLNIYGIREVEESKNNQVIFNNVGFNTDRISEGSELILIGG
VGKRVHHNLLSIQDLEIGAYDKEKDFIYIAASAIPDANSNLALSYGNTLYIGGDVSIHER
SLLNVLSGSVIRIPNYTNNKADDITLPAPSLAQLTKDNHLILEQALRARVVNNFEHYSLI
YHSNNRDKPFIESLETPINLSEESQITLLLKKGEKAPEKGSKIALISSQNGFSGINGNAM
NKSQLNQLLGRISKNPKTLNYKKIPQLQQENLRVVPLTLSLDNKGKVIYGEIQSD
>fig|195.2148.peg.1420 Phage Rha protein
MNNVVFINNQEVVFENKDEQVFCTSLDVAKVFGKNHFHVLRDIENILNNLRKIGTSQDLS
NFGLVKYKDKKGELRPVYQISRDGFSLLAMSFTGKKALQWKMLFINAFNEMENIIRSNNQ
TTNYSDYEFIKKQNEILNQITCTQSSTIYVLQDSIRFLNNTISSMKEINKELKKIAGIDR
FL
>fig|195.2148.peg.1830 hypothetical protein
MENKQYIYNLPNESNEKQKLETNTNSIIIVGANGSGKSKLGAWMGKNNNHTHIIASKRLT
YISENLSIWLETDVQKQDDYTDIKNTQDDYDDTISILFRQQIKELCSRDKNKPFKTRIDY
LFEIFNKVTQKELNINKNRFCINSKDKSYDLTNFSRGEELILYLISKILTIPNNEQQIII
IDEPELHLHPSLTNRLWDILEKHRQDCLFIYITHDLNFASSRTNSDKFWIKSYNGEKWEF
EQISTNEIMPQELFLKLLGTRRNVLFIEGKNNSLDFKIYSVLYPQYQIITCGSCEKVIQY
TKAFNDQSALHGFKAYGIIDRDYRSQNEINALMNKDINVLKVAEVENLFLLECIVLAVLK
QSGRENKFEEIKNYLFEEKFKNCLEKQILENLKSEIKHKLNTIDINLKTSDKIKEKINSI
EEFINFDDLHKNISNKFNSVYKEKNYNELLKVFNKKEIYKDNGFLNKVGRTEESYIKEVL
KLLKENKKLRKEVLKYINLPEI
>fig|195.2148.peg.1660 hypothetical protein
MQANTENNLFATVYKQKEFDITKAKEQSSCIQAILEKLTYDSLKDVNGLIEEIKKFYTDN
ERHKYSDITLHLFNLQHAEQNGKIDNIEKNIKLLIENLGDDKKLKDKLFKLQDHVLLEIV
RLNELSLIKKDIEKTSKEVQESKKDIEKTSKEVQESKKDIEKTSKEVQESKKSYIAILGI
FSSIILSFVAGLNFSNSILSNMDKASIYRLVFVMAFIALFVGNVLYFLFAFLVRISLNTS
FKANWLLIAFNAIILAIILIDFMCYLFNVKTIDDILAMIDFFKQKPHEKIP
>fig|195.2148.peg.1063 hypothetical protein
AAKARSLESSIKINDNDIVTKSKEDEALKEQTDAFEAFFLKHGKFKARRCN
>fig|195.2148.peg.1906 hypothetical protein
MAKKYSKTPAQIILNFLYKLGILLIPKSSNLQRMKQNLQIFDFELEDEDTQKLIYLDQNK
SFFGWYD
>fig|195.2148.peg.569 alpha-2,3-sialyltransferase
MIMCSKSIFGYLKMPYILNEVYKKHQVEVNEYNEKIKTMTFLKIPSMECCEDYEEALKEK
ECLTYRLGEELIKANKSKYKLEYINFFINTYKSVKKFNSYQNKSNSK
>fig|195.2148.peg.1955 LSU ribosomal protein L4p (L1e)
LYVKSYLASLRANTAHTKGRSDVSGGGKKPWRQKGRGGARAGSTRTNVWVGGAVAFGPTN
ERNYFQKVNKKQKRLALERALADKAAKGVLFTADSL
>fig|195.2148.peg.1440 hypothetical protein
MKLKIDSTGLILLFMILISVFLINAEYLIKPTYNELYRIFFTILATMLSAILVETQNKKF
IKDCYNFSGIISSIIGSLVISIILSCFMEFNDSFGSTSYTVFIAVVDFLTILIAIIGFDR
ILIFCEKDSYVIKRSNDINIESYTQKQNNKMLIIDNTQDDLFRISISDWRNKEKH
>fig|195.2148.peg.1732 hypothetical protein
MKESNEELFKRLITDNKLGIKDEKLFDKESRKYTSQRIDELITSPIKGNFDYQHLKNIHK
HIFQDVFHWAGKDRMEVGLHGNFGKYAPNGTITNFVPGKDLNATAQQIFTWLKEDNYLKN
SKDLNDFAKNLAEFARNLNALHPFREGNGRTQRIFLNELAKNAGYKLDLNSLPKDKMIMA
SVEASQLKLGKLEAIIKTNLKSFRQNLDLEQNKGISL
>fig|195.2148.peg.1462 Mobile element protein
MQIEYDINLHSVFLLQYHLILVVKYRREVIDDKICARLKEIFEYIAKNDN
>fig|195.2148.peg.214 Putative periplasmic ATP/GTP-binding protein
MKKYVLSLALVGASLLGASELKYQEFDGFKSPESIFVDKTSVYVSNVGEKLEPLAKDNDG
FISKLDKNGKVLEHKFISNLNAPKGMMEVANTLYVVDIDVVRGFDLKSKKEVFNLPIKGA
IFLNAIEKLNDDTLLVSDTGTGLVLKVDLKAKKYDELLKLDIAKFGGPNGLYLDRKNDKL
FIAGYHPDGASGGVVMSYDLNDKKLSVIKNEKEAYDGIVPYENALLVSSWGENLNGVIYR
LEDDKALKLDLPSIKGPADIFIEGDTLWIPNDGRR
>fig|195.2148.peg.1934 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase (EC 2.3.1.202)
MIKLKNFTELNSQEIELIFKWRNHPDISQFMKTKYIDFEEHLRFLKNLHQDSSKKYFLVF
QDEQIIGVINFVNITTKSCEFGLYAKPDLKGVGQILMNEIIKYAFENLKVNTLKAYVFKD
NHKALKLYQQNHFTIY
>fig|195.2148.peg.567 hypothetical protein
MTLKQISELIKSESVKIISFDIFDTLLVRPCINPSDMFKIIATRAGLDESFIKIRQLAEQ
YARENKPFYEDDITIDDIYRHLHLNFELSIEECERLKIIEMEVEFDYLYPKNSIQDLFFE
ALENRKKVIIVSDMYLPKNFLEKVLEKNNYKNYDGLFVSGDLKISKGSGRLFDFIIAKFE
KMGFDKSSILHIGDNQRADVNMPNSKGIKGVRIVNSSTRFSMLHLLDSIQYSKMVFTDNR
FILGFMINKVFDHISRPYDKEHSMFNGEIENFTNLLLTPIFYAFARWLLEDCKKNNIDTL
LLVYRDGYLIEKILNIFLKDRESQISIKPLRLSRKALYAFDGLSKKECKKKLVAIPASAT
MTVENFLKLRFLMDDFQIAEASEKYNFVLDAYVGDVKNQLTIADQVYEYFFNNAKKKTEV
IKDYCRHVIADGENIAVFDVGYSGRICKFLKDVLNVETTAYHMFKHFGFKGDSSIRTYFD
FSSTFFQHIHIIHNQIFEDILSEPVGTLQEIIKKNDKFDFILDNKYQAQDEILKVQDRIL
NNIEEFYNLFKKDIDTLNIHGFDFYHILTRFLWQPKAKDMNVFKNLTFKDDFIIGDNNIG
YDKWFASKKNFQKPNDEYCTVRKIVKRYYKKFKNFSFFQNFKDKLELKKQKQSLQKNIQD
LFELPSKCFDDALEKKDFLFVGHFASFDKGVCRYISNAAQGKSALVVSTTPWLKKEFVQN
KLKMPSIIVPKATFNRGYDGNVDLNLTESEKYILERNPRLKEISLRMKLQYKDMGKNYPD
KMVVFLFQYFDILLKKTSPKKVFIWNKFNATHEIFYLVCLKSNIQCIFMEFGVIPGTFNF
DLQGQMGESWIANHTSDFNKLEIDLGELENAKKVLEYICKEKLCRNLQPRNNLIDDIKRK
IKKDRPTIVYFGQNDFEAGMIPYNQHVVKYHSPWSVDSNDAYRALSEICIKNNWNFIYKP
HPNLEWLEEKKSEIIDARGVDIHELIDLADVAVTILSQSSYEALMRGKPVVMLGYTHLKY
KNCTYEAFAKDDVEQILDKAIKDGFTEEMRKNFHSHIARLLKYYLYDDYVIRKFKYGKKI
EDFQNEFLN
>fig|195.2148.peg.1422 hypothetical protein
MILENSLQAEVVNNSNIVLFENEELGQVRVALDENNEPLFCLSDICKILELTNPSMVKDA
ILREFEIPKLNLGVIESTNNRRLEVSFIDEPQLYFVLMRSDKPNAKTFRMWVTKEVLPSI
RKKGFYGSINKNNTTIDSNIYYKELCDRLLIENKELKSENINLKRHINGELYLEFLNKLN
TFSKIHFKNSKSKALDYIYKTIAIEFMCPTYSNFDISDLESDPRYLRYAIDLCNDAISNN
FLSRKLI
>fig|195.2148.peg.1721 Minor pilin of type IV secretion complex, VirB5
MKKFIFNTNTATREIHHTPTSGARLKSLDYNYTKEYNYNYDEFYGIHLSSFRGLDFRHKG
DDLVANTPKNYTQKLKKLSLIASLLLFIGSSAYANNLNERDFSNLTPKEKKDLAIAQKWI
NSKTTTIQGNNGEVIFLFGESMPSIVTAPLRLTDIALEPGEVIKDVQIGDSIRWAVSLSV
SGEEPYLISHIIIKPTDKNLQTTMNIMTNKRVYRLNLISEAKKFMPAVSFNYPNSIIKTL
EDYKNQMKAKSESKNFYKTKDDEIPSNIENLDFGYSVEGNAPFKPLRIYNDGIKTYIQMP
KNLKFYEAPALMILDSSNEKQIVNYRLKYDTFIVDRLFNKAILLSNVGSKQEKITITKHS
NKANQDIVNNVLYDLSLQNKNKKENK
>fig|195.2148.peg.1000 hypothetical protein
DKALFRKELPLMLEKLQGRKSFMQENSISYPCGNKVFTFKDVENQLKLIIN
>fig|195.2148.peg.536 hypothetical protein
MKVDNFLNTYSMNSALLDRAAKAR
>fig|195.2148.peg.1831 hypothetical protein
FGLMMKFNNFIKYLNYKKLRNIEKLYFDLIVMIILSSVSFLFLAFKFLICKDILIFLQDY
FLLFIIFVIALIGLFDTFKGIRRYKSFKPIQA
>fig|195.2148.peg.1905 oxidoreductase of aldo/keto reductase family, subgroup 1
MKYQILNNGLKIPIMGFGTARLQERECFNVLNNALECGYRLIDTAQMYKNHKDIAKVLKE
SQIPRKELFIESKISQNLSYLQAKDMIYKILDELGLEYLDLLLIHEPYENSLQIYDAMQE
AFENKLIKSLGVSNFNENLLFDFIQKVTIKPVINQCETHLLYQQKSLHKALQKHDIFLQS
WGPFIANKNKILIILFYCVWLKNIQKLLRKLF
>fig|195.2148.peg.1675 hypothetical protein
MSIVGDDPYRNFLGYTVKRNIGISNLGKRFVYFSYGVAVINEQSGSWYRVKSSPVLNNYR
VVKEISSNYKDFLERYLGGYSIK
>fig|195.2148.peg.1957 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
ELLGLGLTLDKNNIFTLQTRTKKIKEEIFCIVDIESTGGIKNGQILEIGAVKIKNLQEID
RFSSLVQVKEIPENITELTGINLDMVKDAPS
>fig|195.2148.peg.1408 hypothetical protein
MNAKSRNIIQHKAANTANLAKENMIVHIKNSVIRATKSQNSFSNFSLFLFIIFPFYFLTI
KRIEVSLVG
>fig|195.2148.peg.104 Glycosyl transferase, group 2 family protein
MLKISIIMACYNCTAYLSRSVMSVLNQTYKNWELICVDDGSTDGTYDKLLGFSRQDNRIK
AFTKKHSGMAAPNRNYALEFISGDFIFVLDSDDEINPECLSECVKRYEELKAKDIDVDII
IPKLVFLYPNQAKKRTICGIVNQCGSESKILDGKKAFSYSLDWRISGLGMYKTILVKKLK
WYEEGMNGDEYSTREFFINSRYIAFAKNGVYIYYQNEDSVTKKLSIKLFDTFKGLYKLET
LAKSFNMSKDIIKKINQDRYKMFYSLQELYCKNKHNFNNEEKNQIERYLDENQKLLKPYR
IIRDYFFRKERDKMGKSIVLFHKIKFYYKRLENA
>fig|195.2148.peg.1987 Acetyl-CoA synthetase (EC 6.2.1.1)
QLALIYDSPVTDTKKKYTYKQLRDRVAKVAGILANKGVGKGDRVVIYMPMIPEALIAMLA
CARLGAIHS
>fig|195.2148.peg.1676 hypothetical protein
LLALTSLLTSSVFAEDFLAKLTKGALSDTSPGVKELSLEEMKQVKGGYITYLKRLSDNEV
IAFAKPDWNLELTLFQDSNGDQYYWNREGLVRFGGMCGIDTTNCLVNGKHTYTNQQRL
>fig|195.2148.peg.1967 hypothetical protein
LSYPQVGQCLVGSLTGAVASQIITEAYKGWLRTVGNRSESIKV
>fig|195.2148.peg.535 Oligopeptide transport ATP-binding protein OppF (TC 3.A.1.5.1)
MLEVKNLGKFYEFKKHWYLKKEKH
>fig|195.2148.peg.1434 hypothetical protein
MIVLIFKILGFIGLWISVIVLFFNPPLGAIFMLLASLLTVVGMIIEEGNTINLSYPIMEW
IWNVGKYVLVIFAIMMVFAVVLELIKKIKSNKRVNKKIDIKNKEEQDYKILIIDNTMEDL
LVLKKESLYEK
>fig|195.2148.peg.1412 hypothetical protein
MGYYPNIVSKYAIEYNYDLKIPQYDYQEFIIALNDLNINYCQSEFNLERVEVDVEQIEQL
PLDNFEGDLLILAQTLKTASKFDYARKSGFVIIDFF
>fig|195.2148.peg.1948 hypothetical protein
MKKIFALLALTSLLTSSVFAEDFLAKLTKGALSDTSPGV
>fig|195.2148.peg.1945 Motility accessory factor
DFGEFDKDILFVLKSYVHPHTTKYLQKNNRNFMLVSTYASFIQYLKLDYFGYFNMGKSVA
NMSYLLTEYLNYKNIILIGQDLAYAKDGFSHTKDYKNLDKHEGHFQRDKGKFQCLAYGGN
GKVESSEIWTMFRLIFENDINYFQKFFNITTYNCTEGGARIEGTIEKPFLWACENLLHKD
LNKPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFENIQSIYLSLNEKEE
>fig|195.2148.peg.1618 RecD-like DNA helicase YrrC
MYKKHPSNYSTKLTLYYTNIKLLNLQIPVILILQWNIDIRPCEFTNFCLIFNSIRMSFTR
STKYEHFMQFLTKEELNLLDIVKLKTEEYDEIKNQFSEDKLKHLFNCLDMAREIILNNKS
GSNILSYILYAMNNQIIKKQIPKKKNSYQPNPKLSNLFLKNESIPFDEMPFCSNPAGHIP
KLNVLFECISLNNREYELLARKIQYNSEVNGSLYTSLEDFKEDNIEVLIEKYNTALYNGH
KKNRSIKKLHDKFLFINEYQDTLIEIIQLLNNFTKSGLDHYKENINEWLKECNQLDCKEK
KDYLSNLFCNSKLALIYGAAGTGKTTLIEHISSFFHDKNKLYLANTNTAVNNLRQRLDIQ
NSSFSTVASYIANKNNISKKFDIVFIDECSTISNKDIFSVLDDIKLKCEILICVGDIYQI
ESIRFGNWFLFAQKFFSDIQLELKHIYRTKSEKLQLLWERVRTLDESMLEAIEKNNSSEN
IQNFNFSRSVNDEIILCLNYGGIYGVNNINKFLQENNPHKSFYFNGLSYKVDDPILFNEN
SSRFGEEFHNNLKGTITNIEEDEKTINFTIKINKIIQSINNNFTIITKNDKDTEIKFSVT
RLNSDEEDDNSNIVPFQVAYAISIHKAQGLEYDKVSIIVADEIEEQITHNIFYTAITRAK
KELKIYWSAETENKILKSLKIKDINKDFHLFKNNIQNIKTLKN
>fig|195.2148.peg.1890 IncF plasmid conjugative transfer protein TraG
GAAISNFKNQGTSTSNVVNNSAKDAIVEQNANRRMGVNPSSYTIQDASKSGNELAKEAQG
LFEAMSKK
>fig|195.2148.peg.1232 FIG00638667: hypothetical protein
MKTKIIPAILACSAILASANMVPASTQTPAVAPAPLHPYPAYPQQAMPPQDYFNGLPKKY
QQPNSKSTSRCFYC
>fig|195.2150.peg.642 hypothetical protein
MSASEGFNEDITNSNKASANISKNFESIVGMSNKDLGLDYEVVRAMDIKDFIEYKLSTKD
NKLLISGGANKNVDNNKMILENDKKYLELIKTDLEGAKNEEGTNKEKIDEAIAKIDEQIK
QIQDMISNAGDQIISNDDYIKNDSSVSASNKDFVSKILDGLTLGKDFNAIGSIKFDKAGE
QIANDIKDSAKSISNINQASSGINSTINISNDVSIGSRVAMLNNPYGNYATKLSQMRFAV
NDYRGNYVDNYENSIWGNVIGGTNIIDGDSSALYGATIGMDRKINDDAIIGAYFTYVNAE
IKDNLLTQKSDNFQFGAYSNIYISPKVEVNVKAYAQISTTDQDITNRGFNTTNSADFNRK
FLGLSANMGYVFDFSDNTLFVKPFAGANYYYAYTPSYKENGIAGKNVDSTSNNSLSLELG
TEIRKYMSEESYLFITPKIEQYVMNNGDDFVASLNGVALPSVKSDDKKKTYGQIIIGGNI
DISEQFSLNAGIGAKQILAGKTDGKNETYVSGQLGFKYKF
>fig|195.2150.peg.1830 Lipoprotein signal peptidase (EC 3.4.23.36)
ILALVIYLLWQKQFLREHLVAFGMMLGAGCSNLLDRFIHGGVGDMFFWHKWFHFAIFNVA
DVMINISVALILIKEIFIKKEKNDR
>fig|195.2150.peg.1212 DNA-directed RNA polymerase beta subunit (EC 2.7.7.6)
GSNMQRQAVPLLTASAPIVGTGMEQIIARDAWEAVKAKRGGVVEKVDNKSIFILGEDDKG
PFIDHYTMEKNLRTNQNTNYIQHPIVKKGDIVKAGQIIADGPSMDQGELAIGKNALIAFM
PWNGYNYEDAIVVSERIIREDTFTSVHIYEKEIEARELKDGIEEITKDIPNVKEEDVAHL
DESGIAKIGTHIKPGMILVGKVSPKGEVKPTPEERLLRAIFGEKAGHVVNKSLYATASLE
GVVVDVKIFTKKGYEKDDRAIKSYDKEKMALEKEHHDRLLMMDREEMLRVCALLSKAPLN
SDQKIGDKNYKKGQTADISELEKINRFTLTTLIKAYSKEIQKEYDDLKNHFQNEKKKLKA
EHDEKLEILEKDDILPSGVIKLVKVYIATKRKLKVGDKMAGRHGNKGIVSTIVPEVDMPY
LPNGKSVDIALNPLGVPSRMNIGQILESHLGLVGLRLGDQIQEIFDRKQKDFVKELRAKM
LEICSIPRLVNEKEFIKNLSDEELLNYARDWSKGVKFATPVFEGVNIEEFAKLFEIAKID
MDGKTELYDGRTGEKIAERVHVGCMYMLKLHHLVDEKVHARSTGPYSLVTQQPVGGKALF
GGQRFGEMEVWALEAYGAAHTLREMLTIKSDDVEGRFSAYKALTKGENVPATGIPETFFV
LTNELKSLALDVEIFDKDEDNE
>fig|195.2150.peg.1773 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
MGIVYEQTYRESLQNPEAFWAEAAKKVHWYNEWDRVLDDSDGHYRWFVGGCMNTCYNALD
LHVHNGRGDQLALIYDSPVTDTKKKYTYKQLRDRVAKVAGILANKGVVKGD
>fig|195.2150.peg.1849 Fructose-1,6-bisphosphatase, type I (EC 3.1.3.11)
NEFVFVKDLQMQEKGKINATGGTQKFWEEKHAKFIKKLFDEGYRLRYSGAMVSDINQILL
KGGGLFSYPATS
>fig|195.2150.peg.1847 Signal recognition particle receptor FtsY
SEKVGVDIVLTQQGHDPSAVAFDTISKARAKGFDKVIIDTAGRLQNQKNLANELEKIVRI
SAKAMPHAPHRKIL
>fig|195.2150.peg.1821 Methylisocitrate lyase (EC 4.1.3.30)
ELVKTSKPLIIVGAVNAYSALQATKIGHKALYLSGSGVASASYGLPDLGIIALEEVCIDV
RRICSRVDTPLLVDADTGFGGAFNIARTIKELIRAGAAATHIEDQVAQKRCGHRPNKELV
STE
>fig|195.2150.peg.1707 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
MSLQQVDQIISILSKQSKPYEWVIKEFKKIEELKDYELDLETFELLGLGLTLDKNNIFTL
QTRTKKIKEEIFCIVDIESTGGIKNGQILEIGAVKIKNLQEIDRFSSLVQVKEIPENITE
LTGINLDMVKDAPSLTKVLNDFRLFLKDSIF
>fig|195.2150.peg.1840 3-isopropylmalate dehydrogenase (EC 1.1.1.85)
YESLRHASPLKDEIIQKGVDILCVRELTGGIYFGKQELGKERAYDTEIYTKAEIERITSP
AFESARKRKKKGHLI
>fig|195.2150.peg.1862 Putative amino-acid transport protein
GGFAGSALVIGIKRGLFSNEAGMGSAPNAAAAALTSHPAKQGIIQAFSVLIDVIVCTSSG
FLVLFS
>fig|195.2150.peg.1801 hypothetical protein
MQIGFYPEIKNKEELVDIISRAVWYLWPLEGFIEKFHLCTNLVFDNRLILSRFPKYLDPS
ILRYIGKISPKKVVLHKKIHNSYFENLQYIFLTSEEYREELLKIKTKLNLKFDIVRIDHN
NLSYADSFYLRFAEKIPALHSTYKKISKSRIFNLLERLKTKKIYLFGTGPNFSYSEKYDY
SDGCVIACNSMVINRDVIERLKPKIFVIADPIFHAGPSSYAGKFRQSLIDIFNLNPCPIV
VPLRDYHIYSTYLPDCMVDFLVPIFFKIPSEDDSPFYFDIFKSLEVKTTNNILTLFQLPL
ATSLGEEIYITGCDGRPIKNDSYFWSHNREVQINDKMQDIQIAHKGFFDIKYNDYYNRHI
GFLSQFINLAEKNNKKIYNLTPSYIQPLQNRIINNIIVNDRASKKEYDLSIIIPVYNAEK
FIEKCIASIENTCYLDYEILAVDDFSDDSSLKLLMKMAQLNKRIKIYQNFGKKGASGARN
TGIALSSGKAICFLDSDDTVLENSLNIRYNILMSDEGKKIVHGIIQFIDENDNFLGVEYG
KKSTVTIKDCIHGNPISFNTMMLKREIINLLYFDEQVTNGEDWLANFNLFKNNLSSNFVY
DSISTYRIHSESTVLKNFELHENNLLAIIDKIFSDDTVKHI
>fig|195.2150.peg.643 hypothetical protein
MKLSYHTSKVLMSVSISALLSSAALAQEITIADGDGSMENHFETNDGQHFTLKNDYTNGN
LTININNTDIPNSIAKEGYEDLATVNINLGSNDLAIKNISHGDISTYVTNYTINAKKPKL
>fig|195.2150.peg.1858 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
IKEEIFCIVDIESTGGIKNGQILEIGAVKIKNLQEIDRFSSLGQVKEIPENITELTGINL
DMVKDAPS
>fig|195.2150.peg.808 Putative cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79)
VGVTISEEQCKKAQERVRELKLEDRVEIRLQNYQDLEFEDYFDKVVSVGMFEHVGKENLG
LYFMKAKQVLKPGGSMLLHSILAMFEGKTNAWIDKYIFPGGYLPSLREVVSAMSEWDFHL
LLAESLRIHYAKTLDIWSENFNQVLPQVREKYDEEFVRMWDLYLRSCASAFRVGSVDLFQ
FLITKEINNNLSLTKEYIYK
>fig|195.2150.peg.1854 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
NIGKFGGGVNILRGHDNVQGASDMACLSENLPGFYPLNEVTWGYYTKILGVDY
>fig|195.2150.peg.1831 FIG00638667: hypothetical protein
DINIKGNIFLSMQSHKARIQISSLKSPDEIFTWGQFFGGLNQLSFSNLIQFNESVEEFKF
DFCEINNHTISSFYNKNIIYFDDD
>fig|195.2150.peg.1635 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
QVKEIPENITELTGINLDMVKDAPSLTKVLNDFRLFLKDSIFVAHNVRFDYGFISKALNE
CGFGILLNRRICTIEFAQCCIESPRYKLDVLKELLGIKNAHHRALNDALAAAEIFKHCLG
KLPYHIKTTEELINFTKTSRIKQK
>fig|195.2150.peg.1833 Serine/threonine:Na+ symporter SstT
MQAFLLSIIATFAACGASGVAGGSLLLIPLACSLFNIDYDIAMKVVAIGFIIGVVQDSV
>fig|195.2150.peg.1068 LSU ribosomal protein L22p (L17e)
QGMNAELAMASLKFMPNKGAKYIANAISSAVANGGFEANEVVVKSCRVDAGAVLKRFRPR
ARGSASRIRKPTSHILVEVAKAEVKTEAKKAVAKKTPVKKTSTKKVTAEKES
>fig|195.2150.peg.451 hypothetical protein
HITNQYKKQDLKSKIIRMRSISNFFMLFFKSDFDVWKDFLDKTDFADIFYDNTINFIEKM
RVSFIRTFKIHILKVSNILSEDNLFLDKFALLKQKYPDSKIVLDINSIIGFYSSSMQEIK
KGNLCFSQKDYIGALKYYEKVDISLRKYIDINIALCQILKERR
>fig|195.2150.peg.1613 Putative amino-acid transport protein
PSVIVLIFESAFDFKAILGGFAGSALVIGIKRGLFSNEAGMGSAPNAAAAALTSHPAKQG
IIQAFSVLIDVIVCTSSGFLVLFSMAYFNVGADGKPLLTAMPLVQEAMREYYGGFGVHFI
TIAIVLFAITSLIGNYYYAQANVKYLTNSKLVMNLFRITAVAMIFIGSQMNLKLAWSLAD
LTMAFMAVTNIVSLLLLGGIVNKVLKDFNTQQDSKINPKFSASKLGIKNAECWD
>fig|195.2150.peg.1805 Putative cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79)
MLEKQMIKFILSKWNYGNFRIVFWDQEEFYVGNQPAKFSLIFKEKIPLLKLFSDASLVFA
KHYMESKLEIEGDYDEIAKVLYYFSNKRFLKNKEDILSKIAQKEESKNIKSHYDIGNDFY
RLWLDDTMSYSCAYFKTSSDTLYEAQINKIEHTLKKLDLKPNEKLLDIGCGWGWLSIMAA
QKYG
>fig|195.2150.peg.888 Serine/threonine:Na+ symporter SstT
LIPLACSLFNIDYDIAMKVVAIGFIIGVVQDSVETALNSSTDVLFSAICSKDELNYDIR
>fig|195.2150.peg.1799 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKQKIEKDPSLKLPSLEQYPDYREAIKLK
NHLSYKLGKELVKANKIWYKGGYFYFLYFIKKIKI
>fig|195.2150.peg.1825 Serine/threonine:Na+ symporter SstT
TIAILSLSAAHSVGIQVSFLQAFLLSIIATFAACGASGVAGGSLLLIPLACSLFNIDYDI
AMKVVAIGFIIGVVQDSVETALNSSTD
>fig|195.2150.peg.1517 hypothetical protein
MKKNIVFFEVRGGSDKGEDGYRKDTMPMVNALKAKGWNAEVIFFEVGKKNEIYNYVKENF
DGYVSRINPGNLKEENEYFDMLR
>fig|195.2150.peg.1826 Putative cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79)
YEAQINKIEHTLKKLDLKPNEKLLDIGCGWGWLSIMAAQKYGVKVVGVTISEEQCKKAQE
RVRELKLEDRVEIRLQNYQDLEFEDYF
>fig|195.2150.peg.1823 Protein translocase subunit SecD
VYSAPSINERIGGGSGQISGAFTQEEARDVAVALRSGALLAPVKLLEQRSIGPSLGADSI
KMSMIALIGASIFIVVFMVLYYGMAGIFANIAMLVNVL
>fig|195.2150.peg.719 probable periplasmic protein Cj0093 , putative
NWENIALFMQREMEKSLFFDTLEEDNKQEGKENTYKLHENGGVNLGF
>fig|195.2150.peg.920 hypothetical protein
MRHFIFPPTNYNKVKDKSLSECIEYLNHFMKNIQIYTETFVLKNNATNKNSSFGFNKNHP
EKINHFEYSLSLIATIMQETNGILEELGDSYYTSYKVPIIS
>fig|195.2150.peg.1806 LSU ribosomal protein L22p (L17e)
MSKALIKFIRLSPTKARLIAREVQGMNAELAMASLKFMPNKGAKYIANAISSAVANGGFE
ANEVV
>fig|195.2150.peg.1069 Lipoprotein signal peptidase (EC 3.4.23.36)
MAFGMMLGAGCSNLLDRFIHGGVVDMFFWHKWFHFAIFNVADVMINISVALILIKEIFIK
KEKNDRMD
>fig|195.2150.peg.1211 Lipoprotein signal peptidase (EC 3.4.23.36)
MVKRYKTILIFILVFIAVFAFDQWVKSLTLSGLRWQSEYLDLTYALNTGVAFSMFSFLEH
YLKYLHLALILALVIYLLWQKQFLREHLVAFGMMLGAGCSNLLDRFIHG
>fig|195.2150.peg.1419 3-isopropylmalate dehydrogenase (EC 1.1.1.85)
MNTYKIAVLPGDGIGPSVMKEALKILNFVAQKHGFKLETKEAKIGGASIDAYGVALSDET
LKLCEQSDAILFGSVGGPKWDNLPIDQRPERASLLPLRKHFNLFANLRPCKIYESLRHAS
PLKDEIIQKGVDILCVRELTGGIYFGKQELGKESAYDTEIYTKAEIERITRLAFESARIR
NKKVHLIDKANVLASS
>fig|195.2150.peg.174 Protein translocase subunit SecD
ADSIKMSMIALIGASIFIVVFMVLYYGMAGIFANIAMLVNVLVVVAVMAMFGATLTLPGM
AGLVLTVGMAVDANVIINERIRELLREGANIKASIEQGYKNAMSAIIDSNITSLVTSIAL
YAYGTGAVKGFAVTLGIGIVVSMITAIWGTHGMFDYFMRRIEKSNNTRFWFGYRRK
>fig|195.2151.peg.1375 Fructose-1,6-bisphosphatase, type I (EC 3.1.3.11)
MQELISYIQKAVIEISNALKFPDTSYSQNQNSTGDTQLKFDVLSDEIITNTLSQCPSIKA
IISEEKDEILNINENAKFIVAYDPLDGSSLMDVNFAIGSIFAIYEEKASAKNLKAALYSM
YGARLELVICEDKPKLYRLDKNNEFVFVKDLQMQEKGKINATGGTQK
>fig|195.2151.peg.1797 Methyl-accepting chemotaxis signal transduction protein
FRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSNSQAA
SLEETAAALEEITSSMQNVS
>fig|195.2151.peg.685 Protein containing aminopeptidase domain
MPDAIPYVTSYYKRRWGFCLTHNERKKLKKSKYKVYINAKHDENGVLDYADFILPSTQNS
KDEILISTYLCHPSMANNELSGPVVAIFLAKWLSSLKERKYNYRFVIIPETIGSIVYLSK
HLEHLKKHVKAGFVLSCLGDDHAYSLIHTPKKNTLSDKVALHTLKNKKISKLLVF
>fig|195.2151.peg.1583 Conjugative transfer protein TrbL
VAKNLAIAGGEHLRDNLTKGRMPNQMANRLQEKLKDIQGKTSEGGISSGSPKEESYQSGI
NPNITK
>fig|195.2151.peg.939 hypothetical protein
MQALKNEIKQKAIFMSLINIKETIKNIQDSADAEVMVIFCEEDMKRLSKSRNIAAHNSQA
MDLNIVTNLIRYDLARLKQSIVNFKNNPNNLHFIPKEKNVKKKNTKTTRSINYFFICMHF
ILYYIYYLFLLNKPSKSIRQGNFSYNFHTNYFYSLDPFILNLPQAGRQKYIHCTIDLELI
KEISLEDFTKISPVIRDTIIQTILAKEIQEIEFSNFKLELQRELVKKN
>fig|195.2151.peg.479 hypothetical protein
MLKFIISLILQIKNIKIHRICMNVILMYILIFIGILF
>fig|195.2151.peg.1816 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
SINVSELTQSKNEARDKKEKKVMIIGGGPNRIGQGIEFDYGCGHASFALKGLGGKTIMDN
CNPENGSTDYDT
>fig|195.2151.peg.1024 short-chain dehydrogenase/reductase SDR
MDINQEEGQKIANNLKDVLFIVGDTKNKEDIKNAVARAVEKFGNFDVISLNAGIHRCNTI
LDISDEELDLIIQTNIYGYVNTMRIAIPHMKKEGGSIVINASD
>fig|195.2151.peg.1603 DNA transfer system protein TraJ
MKKTKQVNIRLTLEEYNLLTEKAQSHGLTLSRYLRDLSMNYPITCIVDQKVAHDVLNIAG
DIGRLGGLFKHWLVRNEDNKVNFSNKRTYNDIDEIVDQILDLQILLKEQAKRIIQNDNQK
DSKKKAE
>fig|195.2151.peg.1622 probable periplasmic protein Cj0413 , putative
MDLNKALLLFQKACKLGRLDSCVRINNIKFKLLKKLDEETYQSNLNYFLDQNSSFALLEH
ITTLSKQDIKSAIILAKKAASKA
>fig|195.2151.peg.1320 Methyl-accepting chemotaxis signal transduction protein
MIGTDLHNAKDENGIFYVRELYQRALDKGGFVTFHFTKPQPNGENTIAEKTAYSYLIPNA
DDLWISTGVYKDTLEPYIDRSLEELLSFFSKSFFKTVLFSIIFILIIIPFIFIFYRNLIV
GVQGIDANITSFFNFINHKTKNVSTIEIKSNDEFGQISKAINENILATKQGLEQDAKAVK
ESVETVGVVESGNLTARITANPRN
>fig|195.2151.peg.1815 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
SINVSELTQSKNEARDKKEKKVMIIGGGPKRIGQGIEFA
>fig|195.2151.peg.1624 hypothetical protein
MSSKVAFYKCFVASVILFVMLIYMRKLTTLLAFIKQKIFTLLLLAFFGFFMLYHFESTAY
TSMGVANVVFVLFGVEMIITFICEALDAKRFFHLNELLAMVFALLGLWMIFLAEGGTLEN
FTHLKGLVNAILAGIGYALFLFFTRKLKLGFGLIPLCALLFIGSLYLSIPLFGANLNLNF
SLESLILILALAFLPTIGGFYCTTRALSLAKSNSVQLIELSEPLFGMFFGSLFLA
>fig|195.2151.peg.1823 Transcription-repair coupling factor
MQANFFEYLQDSNIAQLVLC
>fig|195.2151.peg.1615 Phage Rha protein
MSNTSIININNQEVIFENKDEQVFCTSLDVAKVFGKRHDNVLADIKLILNDLREIGTSND
LLNFQEVVRISKTTNPKNGKLVSRKMPIYNLTRDGFSLLAMGFTGKKALRFKIAFINAFN
EMERIIKNQYTPKLENYNKYKIPNTFYKEIA
>fig|195.2151.peg.1754 Protein translocase subunit SecA
GLYIIGTERHESRRIDNQLRGRAGRQGDPGISRFYLSLEDNLLRIFGGDRIKNIMERLGI
QEGEHIESRIVTRAVENAQKKVESLHFESRKHLLEYDDVANEQRKTIYRYRNELLDEEYD
IKTKISQNIAEYSAYVMNDFMIEESGVDLNFENLKAKILDECSIELKQSDFENLSLIEMQ
EKLSEILEKSYDEKMSKLDSKQLHHIERILYLQVLDNAWREHLYQMDILKTGIGLRGYNQ
KDPLVEYKKESYNLFLELVNRIKFDSIKLLFSVKFNQEEAQNLEEKANQENEALFEKSVE
MGASEDNLGEAEFKKVPRNAPCPCGSGKKFKECHGKSGPKQGILA
>fig|195.2151.peg.1826 Polymer-forming bactofilin
ADSLEILAGGVVSGNISIKDLAIENGGRFNGTSKIKQEEPVRLLENSSE
>fig|195.2151.peg.304 Chorismate synthase (EC 4.2.3.5)
MNTFGTRLKFTSFGESHGVAVGCVIDGMPAGVKFDEEFLQSELDKRKGGSKFATPRKEGD
RAQVLSGVFEGYTTGHPIAMVVFNENTHSKDYDNLKDLFRPAHADFTYFHKYGIRDHRGG
GRASARESVARVAAGAVAAMLLREFGICVRSGVFGVGNFISNLKEEELDFEFAKQSEIFC
LDPNLEDEFKKEILSARNSKDSVGASVYTRAKGMLVGLGEVLYDKLDSKLAHALMGINAV
KAVEIGEGINASKMRGSQNNDALKGGEFLSNHSGGILGGISNGQDLILKTYFKPTPSIFL
KQSSMDKFGNDLEFELKGRHDPCVGVRGSVVVSAMVRLVLADCLLLHASANLNNLKNAYG
IKKR
>fig|195.2151.peg.1771 Motility accessory factor
AENCMIVLRNKALYQRFNFNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEG
NSHSKGFDFGEKFSGEENIDKLKIPAYAGKGEVLTHTTWNDYRIKLEYLFACNDQKAKFY
NATEGGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQEN
AKRFLDDALALKQILENILSKDFILPLEFLEKVYQNIENFNHSLDEDEFIQD
>fig|195.2151.peg.1430 Protein translocase subunit SecA
MFLNTLKAVFGTKNDREVKKYLKRVAQINTLESKYQNLSDDELKAEFGKFKEQILSGEKK
ESDILNDVFAIVREVGKRTLNMRHFDVQLIGGMVLHDGKIAEMKTGEGKTLVATLPVVLN
AMSGKGVHVVTVNDYLAKRDAEQMSAIYNFLGFSVGVILSSQNSDLEHKKAYDCDITYGT
NNEFGFDYLRDNMKFSKAEKVQREHHFVIVDEVDSILIDEARTPLIISGPTNRTLDGYIK
ANEVAKQMQRGEAVLPPAKPEGDFIVDEKNRNILITEAGIAKAEKLFGVENLYSLDNAIL
AHQLDQALKAHNLFEKDVHYVLRNNEVIIVDEFTGRLSEGRRFSEGLHQALEAKENVKIQ
EESQTLADITFQNYFRMYEKLAGMTGTAQTEATEFSQIYSLDVVSIPTNIPIKRQDKDDL
IYKTQNEKFKAVIEEIKKANAKGQPVLVGTASIERSEVFHNMLVKEKIPHHVLNAKNHEQ
EALIIQDAGKKGAVTIATNMAGRGVDIKIDDEIRALGGLYIIGTERHESRRIDNQLRGRA
GRQGDPGISRFYLSLEDNL
>fig|195.2151.peg.215 Putative type IIS restriction /modification enzyme, N-terminal half
MGKYKRIVKDYKEGFYTDKNLIAKEIKNLQESFKNFCLKDKFNKEIKQLTNGANEYSKKY
GDFLADEHHDEKFKSFFSKNMFEFSFDEKEATKEFANLKKEYDNIFNLESNHPFEWRFEF
PEILDDDGNFKGFDLIIGNPPYIRQEELKELKPHLAKNYKVYKGTSDIYTYFYELGFNVL
KENGILSFITSNKYTRAGYGEALREFLLKNVKVLEYTDLNGIKVFDSATVDTSILCFEKS
KSKDNKFKYLALSNEILKTCAYDIGLYKDFAEFSQNSLSKESFTFSDENTSALKAKIERI
GTPLKEWQGLNIYRGILTGYNEAFIITTEKRNEILANCKDEAEKERTAKLIRKMLRGRDI
KRYSYEWAGLWVINTHNGYKNQNGEKVEVINIEYYPSLKKHFDEFYPQLEKRTDKGLTPY
NLRNCAYLDEFEKEKIVWNPVSGEYLFSYIKEHIFFNNSLFMMTLDVFSLKYILAFMNSN
CYKWLITLKTNLIQTGSYAYGAKDKIERLPIPKINSKNEKLANELINLVDEILKAKEQDK
NVNTQELENKINSLVYKLYNLTEEEIKIIENKE
>fig|195.2151.peg.1782 Methyl-accepting chemotaxis signal transduction protein
VGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASES
SKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTS
>fig|195.2151.peg.1134 hypothetical protein
MIFTIKEKIRFFGETVASSYTLNEIQRNEIIRATQFWANIIGASAINSSPIPISVSTFDI
PNANALSYDFFSNPIFNRVLQGESIDTIRQELIGVSEDFFTKASVEYLGHINMGKLDWYI
ASHPTTLPKNGNQFDTFSTFTHELFHALGVLSLAGSCGGNLGQCFNGFLNSFSDHLYDLN
GVKAQIGMRIVKTQAEVEEAKLKGETVFLVKDDGVYINGSFSNASGNVYFKGENVAEVIK
NAKLGYDGVNGISINAWEGIILDMSHIELDNSLMSHQSWRNYNFYMEAELALLQDIIGYN
FDRKLYYGDSIYESNLLNWQSDHGYYARKDGKWLIGEYNPTEYGVGLHIYGKNNIATQSH
DILSSGVAASGIRIDGSNNQLIIANDTKVHTLGDYSNALLIAYGKDHIIEHNGELKATGK
EDIAINIDFGDNTLGNAEEYRGSYIHQMSGNNQDDLAEYNLDGALVKSLNLNAASSTIGS
LASIYIADNAYVNTINIAQWAKVEGDIICNWDPNNEKLANQYKDSFYTDLNFGSDSSLSR
AAFNALDNTWSVKANVLVMIILK
>fig|195.2151.peg.1837 Diaminopimelate decarboxylase (EC 4.1.1.20)
IGGGLGVAYEKDECEPDLYNYAQGILAQLHGLDLTIGMEPGRDLVAKSGEFVCSVLYEKH
NKTKRF
>fig|195.2151.peg.1783 Fructose-1,6-bisphosphatase, type I (EC 3.1.3.11)
ELVICEDKPKLYRLDKNNEFVFVKDLQMQEKGKINATGGTQKFWEEKHAKFIKKLFDEGY
RLRYSGAMVSDINQILLKGGGLFSYPATSDAPKGKLRAFFE
>fig|195.2151.peg.198 Type I restriction-modification system, specificity subunit S
MTDKISYLMTKLPQGWEWKSLGEIFNIERGGSPRPIKKFLTDKENGINWIKIGDIKNQKY
LYKTEEKIIQEGLKKSKLVIEGDLLVSNSMSFGKPVIVKLQKGAIHDGWLLLKEKINLNK
EYFYYLFSSNFMYNFLSYQASGSTVKNLNIDKLKQIEIPLPPLKEQERIVGILDESFAKI
DESIKILEQDLLNLDELMQSALQKAFNPLKDNVKENYKLPQSWEWKSLGEIGEIITGTTP
SKNNPNFYGNEYPLFKPSDLNGDIIIKYASDNLSKLGFDNARNLPKDTILVVCIGASIGK
VGLSGVNGSCNQQINAIIPNSAFTSKYLFFVCLSNYFQTILKKNASQTTLPIINKTEFSK
LQIPLPPIKEQEQIASHLDELSSHVKNLKQNYQAQIKNLQELKNSLLDKAFKGRL
>fig|195.2151.peg.1068 FIG00470547: hypothetical protein
MEELTIVTAFYNVGRTTRSNEQYLSYFDFWAGVKNKVIIYTTDDMKEAILEIRKKHKLED
KTIIITKNLKEFDKENLEKIEETFSKYDQTLNRKYPKNIECNNPLYCYLVFLKPFFVVDA
IEKKLTNENIIWLDFGFNHGNEFFTNKAEFNFLLEKQEIINEEKINFFSVKEEEYRNIAH
VYFNMEPFIMGGLIFAKSKNWHIFKEHMKNALNAFLSFGIVDDEQTMYLWCIRNYLNNYK
IIRSYEWFDALFNFIPIEIKSHLSFKRKNSKYYKIIKEKIKNSKNKNLIYKIQLYIKYIY
YKFINKKIIKL
>fig|195.2151.peg.1529 DNA-directed RNA polymerase beta subunit (EC 2.7.7.6)
MLDNKLRNRLRVDFSNISKQIEIPNLLQLQKASFDYFLNLENGESGIEKVFKSIFPIHDP
QNRLSLEYVSSEIGKPKYTIRECMERGLTYSVNLKMKIRLTLHEKDEKTGEKVGIKDIKE
QEIYIREIPLMTDRVSFIINGVERVVVNQLHRSPGVIFKEEESSTVVNKLVYTAQIIPDR
GSWLYFEYDAKDVLYVRINKRRKVPVTMLFRALGYKKQDIIKLFYPIQTIHVKKDKFLTE
FNPSDFMDRIEYDIKDEKGNIIHQAGKRLTKKKAEQLIKDGLKWIEYPVEILLNRYLANP
IIDKESGEVLFDSLTLLDESKLAKIKEQKSFEIANDLANGVDAAIINSFAQDNETLKLLK
QSENIDDENDLAAIRIYKVMRPGEPVVKDAAKAFVNDLFFNPERYDLTKVGRMKMNHKLG
LEVPEYVTVLTNEDIIKTAKYLIKVKNGKGHIDDRDHLGNRRIRSIGELLANELHLGLAK
MQKAIRDKFTSLNADLDKVMPYDLINPKMITTTIIEFFTGGQLSQFMDQTNPLSEVTHKR
RLSALGEGGLVKERAGFEVRDVHSTHYGRICPVETPEGQNIGLINTLSTYAKVNELGFVE
APYRKVANGKVTNEVVYLTATQEEGLFIAPASTKVDAKGNIVEEFVEARQDGETILARRE
EVQLIDLCSGMVVGVAASLIPFLEHDDANRALMGSNMQRQAVPLLTASAPIVGTGMEQII
ARDAWEAVKAKRGGVVEKVDNKSIFILGEDDKGPFIDHYTMEKNLRTNQNTNYIQHPIVK
KGDIVKAGQIIADGP
>fig|195.2151.peg.1787 Signal transduction histidine kinase CheA
QARRAQKKQNTAASTTSKPAASTPKAENMEKKVPASGGGGGGMDQTIRVEVKRLDHLMNL
IGELVLGKNRLLKIYDDVEERYEGEKFLEELNQ
>fig|195.2151.peg.1798 DNA-directed RNA polymerase beta subunit (EC 2.7.7.6)
VGTGMEQIIARDAWEAVKAKRGGVGEKVDNKSIFILGEDDKGPFIDHYTMEKNLRTNQNT
NYIQHPIVKKGDIVKAGQI
>fig|195.2151.peg.1021 Protein translocase subunit SecD
MRNSKITYRLVVFIAVFIFGVVFSLPSFLQSERGVKINLGLDLQGGLYMLLGVDNQEAVK
SKIKSVASSLSYSFNKENILNDGLNIHDDSLDFTLLDNADIVKTENLLKEINGLNVQREG
MHYTISFTSEEVKSIENFALLQAVETIRNRLDQFGLAEPTVAKQGEDKILVELAGIKTKE
DELRAKERITKAAHLQLMEVDDSKMSQTSNMSDAEAASYGLVLVPDSRNPNLKYPLKSIP
ILDGSMLTDARVGLSDTSNYPVINFTLNAEGSKKFADYTGANVGKRLAIVLDNKVYSAPS
INERIGGGSGQISGAFTQEEARD
>fig|195.2151.peg.1836 Diaminopimelate decarboxylase (EC 4.1.1.20)
AKLVRELKALQIDLKFFDIGGGLGVAYEKDECEPDLYNYAQGILAQLHGLDLTIGMEPGR
DLVAKS
>fig|195.2151.peg.214 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAIDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHKGNSGMDLALKKDKQIQVIVEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EFYKECEKLLSSEKYLDSITRKDLFDEPSLKGVFIDIKPILEQEKPSFSKLKPLFKIFHK
DFLLSEFNPNDANSLNNAFYKELLYILGLYESKQNSKLIITKSEESKEEQGTFYTAINSK
LKEENFETILKLLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEV
LAKEKSTRKKSEFAYLPYLNSSLFEKQNIENTLEISSLSNDLKLFYYKNTVLKDDKCKAK
KGQVRLLEYLFEFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSF
ITSYMCKESITKVVLDKFNAQFDLDAKDISELRKSLRKEDKKAQKELLNSIKICDPAVGS
GHFLVSALNCLLSIYDELNLFDEEFYLEVQNDEILITGRKGEFIEYKRPSTPKDKAHLIQ
QELFHTKKDIIENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDENYHDLKTLPNID
INIKCGNSLVSYFETGKSLNH
>fig|195.2151.peg.1829 Protein translocase subunit SecA
KNHEQEALIIQDAGKKGAVTIATNMAGRGVGIKNDDEIRALGGAYIIGTERQESRRIDNQ
LRGRAGRQ
>fig|195.2151.peg.656 hypothetical protein
MKKIALFFVLFVCLLNLNAKDKELQYLGEYLGRNYK
>fig|195.2151.peg.1669 hypothetical protein
MSLSGFALAAFLGVSLADFNETTLAYQSFLCSCFLCCAY
>fig|195.2151.peg.1672 Phosphoglycerate transporter protein PgtP
MPPAIGAMVIIFFMIIGYFTSNNLYMVTFFAAMAGCLVYIPQFLASVQTMEVVPAFAVGS
CVGLRGFMSYVVGTSLGTKAIGWAVD
>fig|195.2151.peg.1404 hypothetical protein
MGNLDNWDVYNINCFRTQKGTKYFNEILAPKFLQQIQRFRSRD
>fig|195.2151.peg.1335 Oligopeptide transporter, OPT family
MTIGLFITFYSFVSDANLNNYYQILFAFVGTLVSVLIGFFVAAACGYMAGLVGSSSSPIS
GIGLIGIIVSSLVILLLGANLFDDPMLSKFAIALAIFTTSVIVATAAISNDNLQDLKTGY
LVGATPWKQQVALLIGCVFGALAIVPVLNLLYQAYGFVGAMPREGMDASSALAAPQANLM
STIAQGIFHHNIEWGYMAFGVFVGILMIIIDKILKGTQKMSLPPLAVGIGIYLPPAVNIP
LVIGGILKYIVMQHLTKKYAKNSHKEEKLASCEQRGTLFASGLIVGESIFGVIIAGITVF
SVSMGGSENPLALNLANFHDSELFALIFFVGVVLYFIKRIVKKDA
>fig|195.2151.peg.1623 hypothetical protein
MYACGQGVEKDLIKAKELSSKACEKDTKLCFAQGWVELFNQNDILAQKLFYKSCQAGYYT
DCNMAVDKNSKDQAMQLNLIKITQKIVKINVKTQAINNLLLAIKHLLFLKKF
>fig|195.2151.peg.1084 D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7-phosphatase (EC 3.1.3.82)
MFIFFNLNYIIIYSMKRKALFLDRDGIINIDKKYVYKIQDFEFCDGIFELCRYFLAQKYL
LFVATNQSGIARGYYTQEDFFKLCDFMLNEFLKENIKIDKIYHCPHLEGCECRKPKAGML
LKAREEFDIDMGNSIFIGDNLSDMQAGLNADIGTLILVNEEKKEGDFFRQFKNLKEILSF
FKEKDI
>fig|195.2151.peg.1832 Protein translocase subunit SecA
GLYIIGTERHESRRIDNQLRGRAGRQGDPGISRFYLSLEDNLLRIFGGDRIKNIMERLGI
QEGEHIES
>fig|195.2151.peg.1730 Translation elongation factor LepA
MSVKNIRNFSIIAHIDHGKSTLADRIISECGAISDRQMSSQVMDTMDIEKERGITIKAQS
VRLNYKFNNENFVLNLIDTPGHVDFSYEVSRSLASCEGALLVVDASQGVEAQTIANVYIA
LENNLEIIPVINKIDLPNADVEKVKHEIEHIIGIDCKDAICVSAKTGVGIKELIETIITK
IPAPKTDDEAPTKALIYDSWFDNYLGALALVRIYEGSIAKNDEVLVMSTEKKHIVQDLFY
PHPLSPIKTQSLQSGEVGVVVLGLKTVGDVQVGDTITLVKNKAKEAIGGFEKAKAFVFAG
LYPIETDKFEDLRDALDKLKLNDSSITYEPETSLALGFGFRVGFLGLLHMEVIKERLERE
FNLDLIATAPTVTYEIYQTDGELIKIQNPSELPPVNKIDHIKEPYVKATIITPSEFLGNL
ITLLNRKRGV
>fig|195.2151.peg.1020 Fructose-1,6-bisphosphatase, type I (EC 3.1.3.11)
MQEKGKINATGGTQKFWEEKHAKFIKKLFDEGYRLRYSGAMVSDINQILLKGGGLFSYPA
TSDAPKGKLRAFFEVFPLAFIIEKAGGKTTNGKNHSLLELDFDEIHATTPCFFGSKYEIS
ELLKAYNE
>fig|195.2151.peg.1834 Putative amino-acid transport protein
MGSAPNAAAAALTSHPAKQGIIQAFSVLIDVIVCTSSGFLVLFS
>fig|195.2151.peg.1773 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEL
NFFYQSILEKTPRYPFVCIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEE
LKVYKVVLFDCVAKDLEIQIAMIFDQQSILEYLSLYEMFISSHYYLKYYETSILSLNELC
IKSASV
>fig|195.2151.peg.177 hypothetical protein
MPLYDLNQFLELSYKKNLNSQELDLRKNLYFDFKQNKNALMHLYHYALLSHAAYLNLNTT
NIFLNIDRKTLFKVLTHNIFQKECVTIGKFEPLMAFNFIKRFDLLAHINEECLDSKGGFR
ASLFQNKENQEFILAIAGSDLRPLKFDIGDLISDFILLNGKIPKKQFDSLLKFYTLIKKE
FCFDKITLVGHSLGGHLAQLFVLDFASEVQNLYTFQAPGIAKKILKDVKNKAYIQKISYH
FHTCDDFKKNTWYKFNFVQNLHSKIGYPIWLNIGNKFHHPRLCPKILYKVLNML
>fig|195.2151.peg.1748 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
HASFALKDLGVKTIMYNCNPETVSTDYDTSDILYFEPIDFEHLRGVIEREKPDGVIVHFG
GQTPLKFAKRLSAFGAKIIGTSARVIDMAEDRKKFAEFITKLGINQPKNSTATSVEEAVL
KASEIGYPVLVRPSYVLGGRAMRVVTDESELRLYMQEAVDVSDKSPVLIDQYLDNATEID
VDAISDGKDVYVAGIMEHIEEAGIHSGDSACSLPPCNIDEKMQEQIVQKTADIALNLGVV
GLLNIQFAIYNNELYMIEVNPRASRTVPFVSKATGIPLAKVATRVMWQGNLKEALKFYDA
FGVVNFDNAILRPKPSKYISVKEAVFPFAKLSGSDLELGPEMRSTGEVMGISKDFANSYA
KSQISSFNHLPESGVVFISLKEKDKKYAKKLASEYSKLGFKLMATSGTCKEIVENGFECE
LVHKISEGRPNVEDKLKNGEIQLVINTSDSHTFAGDTKKIRENIIRFKIPYFTNLRSALA
GAKSIKAIQNQSYLEVKSLQEWLK
>fig|195.2151.peg.1406 hypothetical protein
MAGIHKNPLRPKLVKELAKTIQPDEFGMLPFIDEIMGADWVIDLNKYDFAYDEEGRIIWA
LYNDIEKGKLKDPRDVDSTPESRNEFDDAMDGYRNGMKTNFDVDIRNERDERSAKLTMDT
LILSAKLAALTPPQGYPNAPYYFTPERLEWIYKRGYLDKLLDPRIPAIYRYNFPKELRAK
ILKFGEENGIKD
>fig|195.2151.peg.1828 Motility accessory factor
VLRGAFAYRGKLISDVLKLHIKDETHFITAYIKAYHEWLLYFIEKLEQRINIIINSFKET
Q
>fig|195.2151.peg.1610 Conjugative transfer protein TrbB
MLRLLKATMRLRPDRIIVGETRGKEALDLLKAWNTGHPGGIATIHANSANGGLTRMEQLI
SEATSAKMSKLIAEAVNLIVFISKTKEGRKIKEIIKVIDYENDKYITQAI
>fig|195.2151.peg.1256 Adenine-specific DNA methyltransferase
MDIFKKYTSEIQAIFEGKNYNEHSFRTCFENLLNELKPKEVKIIHEPKSEKGQGSIRPDF
KTYKLIDKEKELSYNHLVGFIECKNLDVDLNLHLKGKQLSKYLQISPNIIFTNYKRFILF
SFEKVVFDIDLLDDKLDLKEENISIFGNLLKAYFDDNSTTIKSKQELVKVLSTQSFYLSN
ALKISFDESDANSSFKRFFRKTKDTFKNIEKIDLKDEEFCDILAQAIVYGIFVSYIENDD
YDLEKIPIENFISFLPSTFRTLSEFVYFAIPSFSLPQDIKYTLENIKKTLSLIDKIALCK
ILNQDLESVSIYLYEDFLKAYDDLRATQKRKEGGVFYTPKSIVDMIVSSLDELLKTKLNK
NKGFNDQGVKVLDFATGTGSFLASVFEKIISKESEVFKNEAIKNKFLKDIYGFELSFVPY
IVARLKLGQILRKNGFVNFSDADFQIFLNNTLDLEKIANFDMFMPLENLDTEWKKARDIK
HSQDLLVILGNPPYNAKSKNKGEDILELLQAYKQGLNETKINLDDDYIKFMRFAQWKLLE
QNKKDLFEEKKGLLGFITNNSFINGKTHRKMRESLYKSFDEIYILNLHGSDKDAKNDENV
FDIKVGVCISLFVKYKDEPSNGAKVFYYSTGDNNIFSRKEKFALLDDLRQKGLNAIKWEE
LSLDEPYFWFIKKEFENEEYEIFWALASDKALGDKKSIFLNYNSGIETQKDNIAIQLMKN
KMEETLKDFSNLNSVDLVKKYDLKDSRDWKISNSVNAIKNNLGKIERIAYRPFDLRWTFY
TNKSKSFIAYPRYEVMQHFLDKENLGLCFPKICLNSIFDYSMVINTIADRALGGCKTGSE
TCIAPLYLYVNNEKIPNFTSEFLAHKENHKILKDKSPEEILYFIYANLYNPRYREKYLEY
LKTGFARINFEVEQKTFDDFATLGKKLVELHLFKRDLKDEIDFIFLKEDKKANFKIEKYQ
EKDRFIDNKIILNEDLAISPISAEIWQFTIGGYQVIKQWLKYRNDYECSKEELEHLLKMC
KVIKETINLQKELNDYQRRKI
>fig|195.2151.peg.1772 Motility accessory factor
DQQSILEYLSLYEMFISSHYYLKYYETSILSLNELCIKSASVAIRNVDITCFLPLLTHGQ
FLQNIPSMLESIPFQRILSQRKNKFDNAIVVSAGPSLAKQLPLLKACQDKAVIFCADGAL
SMLEKEGIVPDYVTNLDFTDLAMKFFQNKENKTSLNILSCATHPNVAHSLKAENCMIVLR
NKALYQRFNFNDFGYIDTGTHVSHFSYTLALAL
>fig|195.2151.peg.1609 Conjugative transfer protein TrbB
MSNIEFQARINEKIKREFGDILFYLEDKETIELMLNSDGKLWLEKLGQDMICLGEFSEAK
AKSIITAVSTLLDTTTNAENPILECELPLDGSRFEALLPPIVAKPTFTIRKKAVKIFT
>fig|195.2151.peg.1793 LSU ribosomal protein L22p (L17e)
QGMNAELAMASLKFMPNKGAKYIANAISSAVANGGFEANEVVGKRCRVDAGAVLKRFRPR
ARGSASRIRKPTSHILVEVAKAEVK
>fig|195.2151.peg.1606 hypothetical protein
MGCGVCSRLERQTNLTPPYCCKKSKRRLVSSNLQMSVSEICCKKFFVFKSRLRRKRLKKN
AFKYRYNSALIRFLIFPPVGQIFPPVGKKLLVVGKLFLEKIMFPNKLGKNCFFYLNMFHF
LGKLEIVFEFVRIDIEEIA
>fig|195.2152.peg.1633 hypothetical protein
MGTRSWIAMETDSGYYVDHIYCHYDGCVEGVGYTLLQYYNDPESVKKLMKHGDIRSLKKD
LNQCEKLEVDESGKMLLTEFLNFAESNELGDIEYFYLYSKNRWHYCKASEGYILAQELSF
NYNKEKLLEEAKEYALKQFENNKELCLDTNLAKFLNYDWELAYINQDKAYELFEKEIVDL
KLSYKEIKDNLELLDVEFEEKLSDEYLSKIIAQKIFELYLEEERSVNLVGIFDEKIDNLI
RKYFFSYTENLSFGEEATLDKFVKEKQIDLLKAYFGE
>fig|195.2152.peg.1623 hypothetical protein
MNLLLRNDIDDLNLKEFKKFRECEEAFRLRGMKNKNQEIFVKRMAKGEKIIARISCVMDV
KEKIKIEILKISRKEKGIKEEILFEESFFTNYHEKTQFHDFHGFRIYKIIKLFLRDYLKL
>fig|195.2152.peg.1617 hypothetical protein
MALSYELCCKLFDKNFENLNYTKEELFFIREYYSECSKVMNMLDEDLAIKLYRDYNDFIC
DNCSSNISDFFTNELLVAIRTIVAECIFQAAYTINIKIHKWRNGK
>fig|195.2152.peg.1335 hypothetical protein
MVKISTTILVLACFLQASTFFGDSKRGWFYYELADNNNTQEKNETKIQKRMNADDLFIAS
IPLNNLDLLTAEEFTETFEKVRKIAIMNPTKTNVMTMQIMNKWQVDQSEKFAKVWALNLL
ENPNLEYPEIRDDKFGRSEMFRQKQEKINNFYKAHQDDFSYVVFVSDLNKEINEKQKGIY
RSLQSDYGVNVEYVNVDERKDLISKFKLATTPENFFVYRNSKGEAIWQRVKSGLTNKDDI
INNTLFLFDNAILEKDK
>fig|195.2152.peg.1649 hypothetical protein
MNLENSLQAEVVNNSNIVLFENEELGQVRVALDENNEPLFCLSDICKILEIQNATDTKNA
ILREFELPRLNLYSFDTGFGIKEFTMITEPQLYFILMRSDKPNAKHFRHWVTKEVLPSIR
KKGYYSINKDFHPDYDIVKKQNDILNEMVCTQNNTIYNLKEAIKVLNTSVQTLKEVNKFK
SNENVKKEYGTNNNPSELYSDLRKLVNTLASKANGNHRNIWKDVYFELANNFNIKKRIQA
DDIKKDKAYLLYLIDYLKRKIECEVI
>fig|195.2152.peg.1614 hypothetical protein
MQGNIVRNYYISEGVKALFSVYFKDQTEENFIKALNEFNKENQINSQEIKDEALREIKEE
LSKLATTDLLNAKIDKVEAKIDKVEASLNAKIDKVDTRIDKVEASLNAKIDKVEASLNAK
IDKVENKLDSFKTEVKTYVIILAALMFILQPTIFDLIKSIFK
>fig|195.2152.peg.1676 hypothetical protein
MTEEKENKGSYSLQIKIPNELKDKLEKKAEKAGVSLNQYIMYLFIDDIKEKCNYFYFSQK
>fig|195.2152.peg.1948 Translation elongation factor LepA
GFRVGFLGFLHMEVIKERLEREFNLDLIATAPTVT
>fig|195.2152.peg.916 Integrase-recombinase protein XERCD family
DINKMKLKNTTISEDLERWIEAYLKHIQALSYSNNTFLLYRRILLEFVEYSLDYQDEMQI
NDIKTTFLVNFLNYLENNSKNGNKLSKKTKITYLRVLTSFFSFISDNNDDLFVFSFDMKK
IRFRTEKSEEKLNYLNENEIIRLNNVLEKEKAKKEVYNSFRNSLLIKLMLYGGLRISEAL
NVKLCDFEEVDDEILKISIIGKGGKEQFAFIKKEEVDDELEYFKENIQDSDYIMQTSTGK
HLNRSNAFLIVNNIYAKALISKKGLHLLRHTLAMRLTAKGTNLVVIQKILRHANLNTTTI
YAKATNDTVKAALLNN
>fig|195.2152.peg.185 Methyl-accepting chemotaxis signal transduction protein
GDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSI
NDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSDIANNILEDVKKKR
F
>fig|195.2152.peg.1949 Methyl-accepting chemotaxis signal transduction protein
MVTFYFSADRTQKSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVA
>fig|195.2152.peg.1616 hypothetical protein
MTYENLIEKIENEETGIAKGYNISFLQDVCCYRNNSEEIFDNLIAKDLKMFASIETALLA
IKEPKEGDFVEYADGKFARISVDHRNGTFQLSNNIGVFVSEYGSQASGCIWDPNLDHIKR
ERLIFDNLKPTSKTMKGRCWMFSEGNAGGHGGVWYDIQFKVWLLG
>fig|195.2152.peg.1634 hypothetical protein
MNKRKLEQEFWDFVTMITLFFVCTVIFAFTKLAPLAAVCWIMFLFFASVYPVKWIIQFIL
FLLKRKKGE
>fig|195.2152.peg.1680 hypothetical protein
MKMLNIILVLLFVLFFILMFFNYKYQKTQVELLEKNKKILELNIKILELNIKKIELLEKR
IKEKQ
>fig|195.2152.peg.1398 Translation elongation factor LepA
GFGFRVGFLGLLHMEVIKERLEREFNLDLIATAPTVTYEIYQTDGELIKIQNPSELPPVN
KIDHIKEPYVKATIITPSEFLGNLITLLNRKRGVQVKMDYITPERVLLEYDVPLNEIVMD
FYDKLKSLTKGYASFDYEPIEFRVGDLVKLDIKVAGENVDALSIIVPNEKAQSKGRELVS
AMKEIVPRQLFEVAIQASIGNKIIARETVKSMGKNVTAKCYGGDITRKRKLLEKQKEGKK
RMKAIGKVNLPQEAFLSVLKID
>fig|195.2152.peg.1931 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTHRYPFACIYGIGNALLIKNLSKHYKHLFVFESEIELFILALSTIDLSEE
LKIYKIVLFDCVAEDLEIQIAMIFDQQSILEYLSLYEILINASYYLHFYEKQILFLNEIC
LKTIGVAVRNADISCFLPLLVHGQFLQNIPSMLGSIPFQRILSERKNKFDNAIVVSAGPS
LTKQLPLLKAYQDKAVVFCADGALSMLEKEGVVPDYV
>fig|195.2152.peg.1683 conserved hypothetical protein TIGR01671
MKLSDFDFRIWDKNYTGCDNKNCKCQSNFIYGEEAKIRLSEFNNDAEIELWTGYFDKNGT
KIYENDILEYEPLEELYHITRDNTYKMFKIEIFSKNFNNKIYKRKAEPNISFLKVFKSEK
NMEVIGNIHENAELLK
>fig|195.2152.peg.1366 IncF plasmid conjugative transfer pilus assembly protein TraB
MKNPFIKFFSNDKSPIDAQKTQNKNKVLIFTGIFVIAGALLFLVGGGDKKESKEKVGNFN
LVQDDPMAKTRWVGEASNDLTLAKKRVDNLDTRNKELSKQVSDLKKIITDMKKENDANKR
NYELNLKNIQEAQKKATENTPATVLEDTPNNKEEDLYKNFPQPNKNTANANTQKPSDYGL
THFGDVPELNEVTQTRYTPIQDSLSFTNIAKPEEKEKVEKKSTRHVIPTGSIVKAVLLSG
MDAPTMTQAKTEPLPVLMKVTDLSILPNRWGYDINECFLMGEGYGDLTSERAYIRVNNIS
CVTNKGQKIDMAMKGAATGEDGKLGLRGEVVTKQGALLARTLIAGFLQGVGEGFANQNQI
VTQNGFGGTTTTNSDMSASATLQAGAFKGLSKSAEKLADFYLKMADQVSPVIEIAAGREI
NIITTATLELKTLEEQQQDSAKKNNNKK
>fig|195.2152.peg.1624 hypothetical protein
MGIICMFGIFSLAYVLICLFCMLIMMCFGKLKPMSLLRFLMFFLTVPLVCLELIFEGKKK
>fig|195.2152.peg.1639 hypothetical protein
MKKTQRDVIVLASYRREISLNTRMSKDKTKYSRKQKHKKAYYA
>fig|195.2152.peg.1686 hypothetical protein
MLSLILNINIDYFIIILSLMALVSLVIFMTKRYSENINFKTTLVLIYLVFVWFFVSYKLY
NFFSYETNSAKKEAVQNYIQTIESKIEPRFKDKIKEQFSSIPNTFGFNLCYENNYTGETC
LNYLFYFENKVKDEVKKAREEFVKARDINNNINDKFNKGEENESRN
>fig|195.2152.peg.1364 IncF plasmid conjugative transfer pilus assembly protein TraV
MIKNGVITLSLAASIFLGACSMLPYKENFSCEKGKDNGMCGSVTEVYDLSSDMDELRKKT
DREYEQKHPEVKAEAKTKAKQEARDSFRTLKLQEMVESVEIRKIQNETPTIFRYYLSEEE
ASNKADVALISENDKESKAIRKDLKNQTEKANSQTNKNTKNGKNTHLKHSNKSASKNDSK
IKNNANKETNINKLYDGIKIYDNNESGIKDANLTNKEGNASSVNILDINFTKSNAEQNLS
TANTNTNGIDKNSQVTNEPAIDCSASSDSKITQINGKVKVCVYHANIREMPSCKALVLRV
ANQGEELEALYEQGGWIKLKDGTYVHKSIVTKD
>fig|195.2152.peg.1621 hypothetical protein
MGITVNIWKEIPELKNLKKYLSEKEILGLDSYEKCAFGSQEYVDRLVRDEKIYYLNTNLE
NRNFILKQALKLEKNEIKTFLHSDNFITFAKDMILFSIRKYFDKTGAGHYKFYEKLGMYY
RDYGFDSTQDRVKLFLTALERGSVPYVCFYKDYLELQSIRNKDMILFVSKNENFSRNSKL
PTESIQKLKKELLEYIKANNLTIE
>fig|195.2152.peg.1921 Motility accessory factor
TGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDIKPDYVCMLERDEIVAECFNNDFGE
FDKDIVFIVKSVTHPHTIKYLQKNNRAFILVSTYASFIQYLKLDYFGYFNMGFSVAHMNF
LLTIHLKYKNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDKFSTTAYGGNGKVQ
SSEIWTLFRHNFEKDIVNIKMNYHITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKP
FEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFNDNFIKVYDKIKNSFTSLQNSQKNEIF
IQEIIQDIDKTKTQIDELYNTQKDLIQILGPLLTQFELNLARIYVLNPKTKEDAFNKSIL
WIKEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2152.peg.1613 hypothetical protein
MIETQYECILDNVSKASSKKILANIIDLKNIIIDDYFINLIEHTIDGNKFEFSHDMNLIK
YKGYVANLNTLEIAGLPQEMEKVGDELILPDFPKRLDENLIREFQALIKLVFRKDCNKIK
L
>fig|195.2152.peg.1681 FIG00470684: hypothetical protein
MTEIQFNEIKERLADWRSERGLTYENQREEFLGNVFEKVSEYFRAKDDLERVEALCDIAV
FFFNAFELKFGAFSNIKRAGMIHLIDHFTSYFLEHNNKTVYNNSKDEDFEYLLIVEIEIL
VKNLGFDFYKCMLEKIKEIESRTGFYDERLKKFVDTICAFSKDEALSNVSKDFGFLGNSI
IYKLTQEDKNFWFITCKEIETNLQIDYKVKKIYKADYKSCRL
>fig|195.2152.peg.1675 hypothetical protein
MKKLTLVAYLVIFLSGLWFLFSSFEENFNILFFAFGIVLVYIGYANIKRISSKAHGNKTE
LENLINTAKDIFALLASVTLLAFIIFLTFQNEIKIKFFSDQGLVLEDNAKISIYFKEKKV
ESFDKNKYDFAGATFDDKYIGVFLGNKEGNTSIALRCDENGCKETKIGELK
>fig|195.2152.peg.1682 hypothetical protein
MKLVDKLKKAYDYKKELYKAEKGSSSKEYHIENAEIFQDFIELELLQCEDIERRYFLMQI
YRYGYQNIRSLNSKLAFKAKLDNDDINFIKILKEANILHALNEIYTTKEVKKIAKD
>fig|195.2152.peg.1636 hypothetical protein
MTLRELLKFLSEPRNKAFYLNKQGLPMYLVVNPLMKRNEFFVYDKSYKKIWLGMLSHFIV
NHEIIPSYMLDKKRYDATIDIDLIESTHWQVFKKQISFEAVFEEKGGFLSRIKFDRFNDE
AKRQIIEKYEALKIKHQKLSIVFTAFLKSSGHPQEPEKVYVEEIFLTAISTITYANYDNI
LLDLERTFQVYAEHKILHVKSQTWTYQ
>fig|195.2152.peg.821 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IYPMLNVLINYKLKEYKLYIDFLISNSRRSFNIFSSFLGSKNFYYQIEFEYGYGEWGTKI
YFNLVLKDFYKEKLKFILLEMVDFKPSTIKKLEEVIIRIQVDINQSFLYILEKIIITTFK
YSSFKMEYNQLDIFGYSAKTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSYIKDKHKQ
EQKNYQEKIKKDPSLKLPPLENYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMW
FEIGKLKREFKEKVNHA
>fig|195.2152.peg.1627 hypothetical protein
MQRINLTLNNETSLMLDKLAKDLKMSKTQILTDALKQMHESKRIEQRKALWIKSFEAFKN
DEEYQKEQLELAEAGVGDGII
>fig|195.2152.peg.1631 hypothetical protein
MGYRCHIATHYEVKYTGGYFNNSENELLELLEKVELLDDTWMNEGHEEIEVSTETVLYLN
LEDYDLNEDEKDFLKDLIKVAKTAPYAKNSGYIRLSWF
>fig|195.2152.peg.1637 hypothetical protein
MSKTLAKTLAKKAREKELFLLFKEFMREVEEIEFFIFKKIKNSKEFKNYISKLEDRKLPK
LFSDEELKVQCVYERI
>fig|195.2152.peg.1677 hypothetical protein
MNLLNKKIILVYAIYIGIIALIYFFGKDFLLVFDNLKNFFLSVNPAYYMLSSPISMFFVF
IVISFLEKRGINGVLVYLLTVIPLLFLFFYYSNAKLSVDYLKSEAMFIIFLILFSSLIAP
VAIYEMFREKEEELEKDFY
>fig|195.2152.peg.1640 hypothetical protein
MNLLGKIKKIEQEKKKLLKAHKGLFEASNEIDLYNLIVKKEFSKFYKAVNEKYLCKTKEW
DERMVFAQDYSDFLEKIANIEKLQSLINKKSKDNVDGYKVGDFLYSSWGYEQTNIDLYQV
VATTEKTIYLADIKADVKITGWERGLKSPCKNAFNFNKVAFKTFSKYPQDSRGGYTKSLC
KYKGKALEFTSYY
>fig|195.2152.peg.1635 hypothetical protein
MKYKKKDFSVCKKSFDIAYVYVVEALCNDYLSERYRIGVFASFDEALDFVAKNFYKSKKS
KISYSRESNDTWVIDNNEIKNQSIRHRITDSYIENVNIDAREIRIRVDTSNFILLNDGRL
IQIIEPFFHDEIVCLN
>fig|195.2152.peg.1944 Motility accessory factor
PKAIEYLKGRNRKYLIIPRYLYFPIYIKLKYFDFLYNTPSVAHMSYFLSVLLNHKNIIFI
GQDLAYAENGNSHPDDYQNSANYESQMYEHILTE
>fig|195.2152.peg.1619 hypothetical protein
MKKFTEMSKDLIKHYGLDNVANETEINALAYALQDCCAMYNEKNELSFTDEQINDFKHLI
VDNYVKGDNEPNNEQSVEDIVYSLHYSMLLNSVPEEIVDNIGRDLFIDKVEMGIDDRYQV
SFLCNDAESFLKRIKEHIMLDNELNEYTKFCIKNTDNFCGCEEVF
>fig|195.2152.peg.999 Two-component system sensor histidine kinase
MLKDENLKDEKLKNELLEKISRQSLKLNALTHKLNFVFNLNHEALQMQEFDLFTLCEKIV
KNPGFERVILRGKSTRVKADEFLIEQVIINLLSNALKYSQKEVILIAQDQKISVLDFGKG
IEKNQLKFITKKFYKIDTKSNNSFGLGLFLVKKILSIHKSYLEISSTVSQGSKFSFKLH
>fig|195.2152.peg.1622 hypothetical protein
MEKNYEDFKEALLKGNLALVLTGVSKSGMTRTFKVFYKNKKEQYLPIPDEIAKAVSERKV
GEKGIVIRGCGMDMSLALWINIASYLKCYDEAYRNYFSYRLNSGNFNPFYPNMETFINEM
TKNQSID
>fig|195.2152.peg.1746 Methyl-accepting chemotaxis signal transduction protein
GDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTCKGYFKKNM
>fig|195.2152.peg.1629 hypothetical protein
MSGFKIIPSKHFAERLQQRKVDLSLVALIYQEIAKNPFQKSYKLINNNSAIVFAVDRDNG
VITIITGYPVK
>fig|195.2152.peg.1668 hypothetical protein
MLGTFIFCIIFNGSIIYVICSFIFQYYTTEMPCLFLWKIFIFIMVISYVLIFLLFPQAFL
RGLIVVTITLFSFFVQTPA
>fig|195.2152.peg.1690 hypothetical protein
MRERMSIKAIRICVKDSVKMRFECVECKIGRNGRWGIKGVINEGINEGINDENYSMKCSG
>fig|195.2152.peg.1678 hypothetical protein
MKLKDFDFRIWDKKYKEYIFTNRTISKYYKDASTVTSLAGRIRKEKYSGNLVFDDLGCDC
EECEIELFTGLYDKNRRKIYENDIVSYETLQGKTLFYFITTNKNINTFQIFVISDLENFK
LCNEIEIDRFLYSDFSKIEDMKNIEVIGNIHNKAELLEVKELK
>fig|195.2152.peg.1747 FIG00471396: hypothetical protein
MNKIDNIANFLNKKSKKCLAINGPWGIGKTHLWKQVEEKINDKKVVYIDLFGKESYKQIL
EEIVFKIHGNYNKIMNTFSQIATKIAKIKSAGTINITPDAIFSFLKKEDFNNIIVCFDNI
ERRSDNLSLKEILGLVNLLKEEKECNVVMIFHKGELEEQDNNSAINDKEKQAKQDNSKNW
YQKYKEKTIDYEFIINDNSKAAYNIISDEAKCDKEIQNIIFECYQNSCNNNLRLLLHFME
HIIYFNKECFIKIKKEDYGNEIFFSGLKMYYDILLNHIKEYYSYDINEDKPRYSIFKKYF
DDSCYLNQDDLDALKSHFESNLKEKARIYFDKCKDKYFYGNLNDIDFAKHIEDLFPRFQN
YTYENGTYYSISYYQAFFELYEKIMSKELVYKKDIEKKIIKELVEYEFNISIWRDLPYKN
FYKEIKDMIDKNEEYKNYYQDLQSEKRKKININSFLNGLSSDKIRQTFSTNNIWQYNHFE
IESIVKSFQTNNDFYHEFFIFFSSAMDAQMQEKYDLKNSLFQAYLNFLDLNENKIKKEEI
LKTLEHQEYNCFLLQILKLNILK
>fig|195.2152.peg.1600 hypothetical protein
MFKVLTHNIFQKECVIIGKFEPLMAFYFIKRFDLLAHINEDYLDSRGGFRASLFQNKENK
EFILAIAGSDLRPLKFDIGDLISDFILLNGKIPKKQFDSLLKFYTLIKKRILLW
>fig|195.2152.peg.1670 hypothetical protein
MNLLNFILGISGYGDFVFILFISMIIYAIAFLIIILLFNVIFELFKFSEKNTNIINNKLI
FLFFLSYSCLGIAFALIFIVLFGEANKSYIEKINKKYNINLEAIQSIGFGVCNNSDYKSQ
TCKNYLRYFENSLERSIAQIKKEEIEKISHGKSKK
>fig|195.2152.peg.1669 hypothetical protein
MENKKFILVYAIYIGIIAFIIFFGKDFLNLTFLVFENLWNFFSAIEGVYYGIGFVLFLSI
AFVCLALIHVENKIVFILIFLLIATPLLFLFFYYSNANFSLNYFRKLYDLQFPIILILFI
VVFSCFVTLTIDEKLQ
>fig|195.2152.peg.1620 hypothetical protein
MEKNVLENMFKKLMHKGISVFTLDGKEIRIEQDEFYNPFDNCRNPSFFNLLKRYDIGEKE
IDGLDCTDFENIQEIEDYLNSKGYIWIRVGAYIHSGIALHSEGNKPRSYSYGWDCGCAGY
AYYTKEQVREIFDVKRISAKFKDKLYKNIEIFIKELEAYLEGNIYMLYVDDIPEDTFIGY
DKKQMLQTLERFAA
>fig|195.2152.peg.1658 hypothetical protein
MNIVDLVKTIESIENPQNLKIIREGACFYMCLGENKKYFYFF
>fig|195.2152.peg.1399 Methyl-accepting chemotaxis signal transduction protein
MAIALGDLIKNVHSEEEKVKIIATAIENFRFEEDKSGYFFVYQKTTVKAHPVRKDLIGSD
LYNAKDENGIFYVRELYQRALDKGGFVTFHFTKPQPNGENTIAEKTAYSYLIPNADDLWI
STGVYKDTLEPYIDRSLEELLSFFSKSFFKTVLFSIIFILIIIPFIFIFYRNLIVGVQGI
DANITSFFDFINHKTKNVSTIDVKTNDEFGQISKIINENILATKQGLEQDAKAVKESVET
VGVVESGNLTARITA
>fig|195.2152.peg.1615 hypothetical protein
MDMLGEDTIEKLLKEKETIVLPNVTKYAKNSINEYFENEKDEILEELNAICKKNMI
>fig|195.2152.peg.1345 hypothetical protein
MFVGFSKNLGNGFRIGIGYNLNNNKPSKRDNDREEFVSKVLSEIKNLFQEICNKLNISQE
TFKFAIEQNCQIEITDILTENNSKKMSEISDIFSNISELIEKVSFSKSLSTETKEKITDL
IFKSKKIIFTLESENDLEQRLISLLSEKLQKEEKKIRKMIKKMNGKKKKIGCLTYIVLFF
IFMLIISFITHEDKTNNLEHSKVEHSNVDKKTK
>fig|195.2152.peg.1356 hypothetical protein
MKTFNCNIEINKNKIKQPKFSFNEKDLCDIDLNNNTCIFSTSGAGYSYIINFLYQYIRAK
DENTKIVFVSNQSSGLILDYWFAKDKNVEYCDFEYEKLLSLYKTKSIVICVFLDDKGLFD
SRKYDITDVGNLIFASSINKIFGFTTKSFKEMIIKCNTNNLLKNESAFESIELKKKEEEG
KFTLDFLIESNKTSVLSVFKGKII
>fig|195.2153.peg.1226 GTP cyclohydrolase II (EC 3.5.4.25)
MVIYLRQEGRGIGLFNKVNAYALQDKGFDTIKANHQLGFKADERTYEIVEFILKHYKISK
VNLLTNNPQKIHSIQDKIMARVPILINPNRFNANYLEVKQNQMGHLL
>fig|195.2153.peg.452 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAN
>fig|195.2153.peg.1794 Predicted P-loop ATPase
IYDYIDDNRMLFIEQYNPYDHISSEIKIPENIEQEIKKITKSNKDFAFNLIGSIFPKINN
QPQDYSQLIQNNTDNQKKRITYPSSFKYYFLLNFPK
>fig|195.2153.peg.1717 Phage Rha protein
MSNKVIINKQEVQFGTQDNQIFCTSLDVAKVFGKEHKNILRDIENILNDLREIGTSNCLL
NFELSFKVHKIQGFKGRERKYPYYNLTRDGFSLLAMGFTGKEALQWKILFIDAFNEMQKL
LQKEIKSPNKYLTDLMELIYPNLPQNDYKVSVTITANEKRIKNLELMAKKDVVVDGRNAH
TSYTQAQSLDGRLVQKNISSATNKIIPQQNKSTNDFKAKLEEFSTKKTNAVKSINKEFKR
>fig|195.2153.peg.223 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAELNFKTKAQNLKNLQTKLKKAKILPLVLTSLEELILNEEKILSDIQALKANKLIIRSS
SLSEDSMKNSNAGAFLSLANIDANSKDELLKALYKVANSMPSKSDEILIQPMLENITLCG
VGFSVDKDNFSPYFCLQYDENGSNNSITDGSSKSAKTYYHYREHLDFKDIKLQKIIELIK
ELESLYDCCFLDVEFAFAFKDNKEELFCLQVRPLVMQEKENLFNALPKEALQRFYKRFIS
LQNLRPRVLGEKALFGVMPDWNPAEIIGLRPKRLAFSLYKEIITDNIWAYQRDNYGYKDL
RSHPLIHSFLGIPYVDVRLSFNSFIPKKLDENIAQKLVNFYLDKLNKNHELHDKIEFDIV
YSCYDFNSSKKLQELLNHGFNENELKRLEFSLLELTNKIINPQSGLYLKDIKKAYRLKER
YDGIIDSNFSLIDKIYWLIEECKRYGTLPFAGVARAAFVAMQLLNSLVEINFISKEEKND
FLNSLNTVSKNLSKQTNNLNSCTKNQFLIEFGHLRAGTYNILSPRYDENFELYFEINQKD
NNVYLEDKAFILPEEKMKALNTLLKEHGLEISACEFFDFLKQSIEGRELLKFEFTRLLSK
AIVYIEELGKYYDIKKEDLAHLDIKSILNLYSSLYSINPREQFLEEIARNKKEYKLTQAI
KLPYFAILRKFFLFIIIVLFQILSHKKV
>fig|195.2153.peg.1843 Legionaminic acid biosynthesis protein PtmG
MIYCDHCVMPNTRPGINFTKDKEGKNICSACINHKNKENIDYKARFKELEALCDKYRRMN
GKFEYDCAIAVSGGKDSHFQVHIMKEKLGMNPILFSVEDNFTMTEAGKKNLKNLSETFGC
HIISLKPDIKTQKKVMLKTFEKYGKPTWFIDRLIYSYPFAMALKFNTPLLVYGENVSYEY
GGSDAKETPSAKEIFLNGVASDLNINEFIDDEIKEENLQLFFNPNANDINKLNPIYLSYF
IKWNSYSNYIFAKSRGFTDLEGEWYRTMCAENFDQVDSIGYILHAWMKYRSYKPIKSYKK
I
>fig|195.2153.peg.74 Methionine synthase II (cobalamin-independent)
MQIAKGLKIDTNRLKLTIPSPSMLLYMLFIRGGKNTEFNYYGKDFTKLKNDILNAYENFY
KEFAALGGVYLQLDDTSFGSLCDYEFCALNEINTDDICEEYVDFLNESLKTMPKNIMSAI
HICRGNYRSRYVASGGYMKVAKKLFGELRVDKFFLEFDDERAGNFEPLKYINDQIAVLGI
LTSKTNESPSVEELKARVKIAAQFLNPKQIEISTQCGFSSTEEGNEIFTHSQWEKIKLLK
QVLSELENEGFFS
>fig|195.2153.peg.168 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIISGLGGDIDDIRVRWRY
R
>fig|195.2153.peg.1771 Legionaminic acid biosynthesis protein PtmG
MRYGLLSRKEAIELVQKRDHKLDNRCVEDFCNFIGISKTTFWKIVEKHYNMDLFYKNDFG
EFKLKNPLK
>fig|195.2153.peg.1757 FIG00471323: hypothetical protein
MCKIIKYLDYARLNTLEKLYFDLTIMAIVTFLSFLFLVFEFFIYENIAVFFQDCFLMSVI
FIIGMIGLFHT
>fig|195.2153.peg.1681 Integral membrane protein
TNNIYFNNAHFKDYVDFHECEFEKTVNFYGVIFEKAPNFSACYFKEPKAVNLINVDIDKL
DFKSLEQYIKDKYQDESYKNETKGIQDEKEIFKIQNEHQLRYAKNLKDSFRVIKDILITQ
NNTLEAQEWHKLELYAKEKELLFEVESCYKEKNKPFIAAKSEDKNSINLTFSVLLLWIYR
VTSLHHTNLPRIINFASLNIVAFGGLVCLITYLSYHINKQSNFWLFGVLILFALIIGIVS
LLLKKQKLKNITLILCLFLAFLLALFLMQRIAFLSSFGDIIFALLFYCLLVIVLIYLYPY
INLKSFISYCFNWLVYFFLVMIVVIKPQLINPFAGIFSSDKLYESQFEKSLNDLNVSAIM
ILTDISQDNFNLPSKDQNISFVELNSAKALIIANKEKLKEILSKVYNDKYVSDYKKVLNE
LENNTSNVKNIIEEIDNKNNNSVISVQLNQILNFNFSQEIDILYMIKSNFFISEKLSPEQ
MAIFDQKDSQDKLKSVLALLKFKSSFEGILKIINQDEITENTIKSTSVLYSIMLLLCIFS
LQKTARKNSIVPS
>fig|195.2153.peg.1875 Motility accessory factor
ADSSYPILAKHGIKPDYVCMLERTEITSEFFNNDFGEFDKDIMFIVKSVTHPHTIKYLQK
NNRAFILVSTYASFIQYLKLDYFGYFNMGKSVANMSYLLTEYLNYKNIILIGQDLAYAKD
GFSHTKDYKNLDKHEGHFQRDKGKFQCLAYGGNGKVESSEIWTMFRLIFENDINYFQKLF
NITTYNCTEGGARIEGTIEKPFLWACENLLHKDLNKPFEKLEP
>fig|195.2153.peg.1069 hypothetical protein
IFGYGFIKFFNYICALVSNEANYILIDEIENGLHYKTTKILIESLIELSRKNNIQMFIST
HSLEFLSSVEKVANEKEFKDLGVFNIYRYKENVYCKHYQSEQLKDLLNNGIELRR
>fig|195.2153.peg.1767 helicase, Snf2 family
MRDPQNFRVKEFRYATERTYDARMWQVIESKARSIEQFRKAGADVRTLEDVTSGAADAAE
MKAEATGNPLILLQVQLNSDLRQEEMLYSGYKRQIHNNEESLITNLSKIELLKKDIAKME
ILNSIIKENNSEHFQGKYYINDDEKDFIVFKNDTSDLNKSRQAELERNFEKIVKTIADDY
QKEYKVLEFKGLLISGERTDLNTLNFYVSTTDGKTIIEPENLIYKRDEKTFFKLESYVNF
GGFVKRLNNFYNDLEKFTQLNKNKIENLEKEIVELKSITGDNTPKYKRKDYLEALREDNR
IIMDEIEKMSKQKNYKSDFVPKSAKILEDLNKHNKILKDRELLI
>fig|195.2153.peg.75 Methionine synthase II (cobalamin-independent)
MKLDQVGSFLRPKILKEARENFALGKIDEEQLRSIEDSCIRDLLEECDKAGIYYLSDGEL
RRSWWHLDFYWGFGGIKKIKKEKGYIFKGIETRAEGIEY
>fig|195.2153.peg.1831 Putative integral membrane protein
MERNIYEIELEIPNSGIFIMGLENENLIISLNIMKFIEINAEKIATLDGKLDVGGLAKPL
HSYIIYEVLEKNNKNNFNDVKIIDKIEDENNIIYHFNFGLILNTFIGENEDNKDKEALKT
LSFMQNFIPACFFSYQIIGDSKAIPKNVLEDLKNRYGYEGKNYKSIFKKEVYINCNCLER
LNFSHCEFESKVSLRFLKDNKYKEFHNGIDFSNCIFKNEVDFSYFVSGAPLPDNKYYNNA
QNT
>fig|195.2153.peg.1735 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLK
>fig|195.2153.peg.1680 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLMESDFLEKIPFIDEVLIYKD
DFLEKIQSKNPVIFITTRRQGLYFKKLKFLNVQKCIVFPHLISIISKNLTTPLPFFRAKK
HMSEIVLKLVRMINTRHFDKNFNQIDFSKIKNLLPYDARLSDNFFKQIDTKYEKIIGINA
FSNNSEYR
>fig|195.2153.peg.1227 GTP cyclohydrolase II (EC 3.5.4.25)
MDIKISEIANLPSKWGSFQIQSFKEGEKEHLCIFKNTPQDILNLRIHSECLTGDALGSLK
CDCGEQLEFS
>fig|195.2153.peg.1804 RecD-like DNA helicase YrrC
MENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTDTNQQLDS
IYENLQSSLKYIGDKRKYKDIKNFHNLLQISVSHYT
>fig|195.2153.peg.454 hypothetical protein
NYGLFGDEGRGFSFSSISRKSAGGGSFHYFTNGKFIKSDEKYCKGYFKKNM
>fig|195.2154.peg.393 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAELNFKTKAQNLKNLQTKLKKAKILPLVLTSLEELILNEEKILSDIQALKANKLIIRSS
SLSEDSMKNSNAGAFLSLANIDANSKDELLKALYKVANSMPSKSDEILIQPMLENITLCG
VGFSVDKDNFSPYFCLQYDENGSNNSITDGSSKSAKTYYHYREHLDFKDIKLQKIIELIK
ELESLYDCCFLDVEFAFAFKDNKEELFCLQVRPLVMQEKENLFNALPKEALQRFYKRFIS
LQNLRPRVLGEKALFGVMPDWNPAEIIGLRPKRLAFSLYKEIITDNIWAYQRDNYGYKDL
RSHPLIHSFLGIPYVDVRLSFNSFIPKKLDENIAQKLVNFYLDKLNKNHELHDKIEFDIV
YSCYDFNSSKKLQELLNHGFNENELKRLEFSLLELTNKIINPQSGLYLKDIKKAYRLKER
YDGIIDSNFSLIDKIYWLIEECKRYGTLPFAGVARAAFVAMQLLNSLVEINFISKEEKND
FLNSLNTVSKNLSKQTNNLNSCTKNQFLIEFGHLRAGTYNILSPRYDENFELYFEINQKD
NNVYLLVLVNFLIF
>fig|195.2154.peg.1176 Cell division coordinator CpoB
MSTKGDYFPKLLYHTAISLDKIGDPKTANGFYKALKTNYPNSPEAKASPNRK
>fig|195.2154.peg.1678 Putative type IIS restriction /modification enzyme, N-terminal half
MCLYKDFAEFSQNSLSKESFTFSDENTSALKAKTERIGTPLKEWQGLNIYRGILTGYNEA
FIITTEKRNEILANCKDEAEKERTAKLIRKMLRGRDIKRYSYEWAGLWVINTHNGYKNQN
GEKVEAINIKHYPSLKKHFDEFYPQLEKRADKGLTPYNLRNCAYIEEFEKEKIVYPCIMA
KEPYFSYETSFAFAMAPANIITSNSDILKYILAFLNSDFIYLMLRKFYMGGGIEGELKTN
NLEKLPIPKINSKNQKLADELINLVDEILKAKEQDKNANTQELENKINSLVYKLYNLTEE
EIKIIEGR
>fig|195.2154.peg.1455 Motility accessory factor
MTFTPTQKELFNKNIEALNNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
N
>fig|195.2154.peg.1534 haloacid dehalogenase-like hydrolase domain/phosphoribulokinase domain protein
MFNLKNIAEKYKLVMVDIDNTLFNYTFAHKNALEAVMDQYDFTLQEYNLAKMMIETRNLS
ANHHKKELYFKIICENKNIHFSKASEMFNLYTSAFIKNLKVDKTMSDFLFYVKKLNKKVI
AITNFYFIEQIYKLNCANLINMIDYLVCSEEFELEKPNKALVNRALELYGKFIDEEEIVM
IGDSIADNFLGGGIG
>fig|195.2154.peg.803 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILSLQDEEFKEEILSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQT
YKIIREIYRDDFEIFDYDLEDKKYFNIPQNIYLNNLESKILIKNINLDSLRLKKSFQIQN
LNQTIETKNKTIQDNLIQIQNLNQTIETKNKTIQDNLIQIQNLNQTIETKNKTIQNKDDL
LNFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRK
IEKDPSLKLPSLEQYPDYQEAIKFKNYLSYRLGQVIIKGFKNPLSIILLPYEIVKLIYKF
RKR
>fig|195.2154.peg.1449 Glucosamine-1-phosphate guanylyltransferase
MNADILTELDFNDLLKAHKKSKALMSVCVREFEQQIPYGVITQKQGFIENIEEKPTQKFL
VSAGIYVLENEILNLIAKNEYLDMPELIKLALQKGKVNTYIINDYWIDIGRPDEFLKANE
DFK
>fig|195.2154.peg.1448 Glucosamine-1-phosphate guanylyltransferase
MDINKLKLTPDSSIKEALKIVGQERVRLGIIVDKKDKFLGVISDSNIRKALISGKTLKDS
IKDIYTKNPITIKENTSKEQLLRISAKTDIYDFPVLDEKGQILSIKSISSLLKANPNSIV
IMAGGLGSRLKELTKDTPKPMLKVGKKPILESIIQRLKNQNFENFIFCVNYKKQIIEDYF
QKGQKFGVKISYIKERKKLGTAGALSLIKQEFKEVLSL
>fig|195.2154.peg.1504 hypothetical protein
MLTSFLNHNTMKKIKNEAKKRKIPLVCAKRSVSCVYCEYCKIFNLDKEFSCSKVE
>fig|195.2154.peg.394 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MLKFEFTRLLSKAIVYIEELGKYYDIKKEDLAHLDIKSILNLYSSLYSINPREQFLEEIA
RNKKEYKLTQAIKLPSLLCNTEEIFSFYNHSIIPNFITQKSITAFTAKENDKDLEGKIVL
IYAADPGYDYLFTKNIAGLITCYGGANSHMAIRASELGMPAVIGVGEENFEKYLKAKKIN
IECESEQIFCL
>fig|195.2155.peg.1795 hypothetical protein
TLASNYGGIYIFDKKIREEILELEKKREEFRSKYLGSEIKVGNETHFVNFSYLKKKFPQI
LSNGCKYYRNDYNYKIGESNFNFKDKPEFAYYEDQFKAYMGEENYKKLRPYLGMTTYYVC
EGKKYPVVF
>fig|195.2155.peg.48 LSU ribosomal protein L7p/L12p (P1/P2)
MAISKEDVLEFISNLSVLELSELVKEFEEKFGVSAAPVMVAGGAAAGGAAAGGAAAAAEE
KTEFDIVLVDGGAKKIEVIKIVRALTGLGLKEAKDAVEQTPSTLKEGVAKADAEEAKKQL
EEAGAKVELK
>fig|195.2155.peg.969 Filamentous haemagglutinin domain protein
MLKSPDRILCIKKKGGGMNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQ
SLTASNLPSGGKFINGTGSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKN
YLNLDYTNKASQILGTLNGGTNNVYIVNPSGVLVGEGATINANKFGVSITPMGIDAINTF
SVDGSFSPVFNANKGDVVNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFG
INSTHLKAEIGSEGFFKYEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSA
SNEEMINSWKGFAKLVNEGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNN
HTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFN
NISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNGGGFVGYTTGNTTFDG
ISLKDIRFIKSGAFTGGFAGMTQGNVIFENIVLNDLEEISGSHAGGFAGWINDGTFNNII
LNNIEKSVLALHINISLQVALQDMQALELIKILF
>fig|195.2155.peg.1548 hypothetical protein
MTMIFDFEPWQLDIDIDLTKQLYRSCKGDFVWVEKK
>fig|195.2155.peg.1697 hypothetical protein
MEAKGIAIFPANVAFNKKTNAFFTELEDQFLKGEVGKSSIKLDFEYYILYSQFLQIDRES
LISGRNYELVFCFLLYYRALLNKNNTQKIVAKIINAIRCQERLPEKIHYKEKIICMDNHH
RDLSQILSSCVVEFYNSIDLYNTFRKNIGFENRKKIAIEMLNRASEHYGFFELNRGGITY
KEAKISCAPYQF
>fig|195.2155.peg.1541 FIG00472706: hypothetical protein
MMQEEGTSGLIEKDLKEIKKDKSYFFDKMSSFAKNQTIEKSRTKEDYSINN
>fig|195.2155.peg.120 membrane protein
MSKRKILKQQCKEIIQLNPTERVWQMPFFFALAVGFVLSIAAYYDRMDLGLIAGFCLYNQ
YTYVS
>fig|195.2155.peg.1799 Motility accessory factor
KEIKSSKFELILGKDNLDINLKDTSIKNNGGGV
>fig|195.2155.peg.1540 FIG00472706: hypothetical protein
MKVNYIELEKKEGQIGNIPYIIIKVEYPNLKKLQENDLLMANDKGQWLCGFIGLKENQKV
DFKELDNGYIAPQYLYLNSKDQKEIDLFSNNLEITKVLQFDLNHSWNKTEKILN
>fig|195.2155.peg.1785 hypothetical protein
FGVSGEYIGNYFSTNSLKSIDEIFYENPDSNKILNYHVDKWIKEILDLEISFTTNESIDI
ILNGFKDKNFSNYFLPSNISTGLNFATKIIIIGLSLKKGDIFIIENPEIHLHPKAISKFA
DFFAFLVSKGIQVIIETHSNYLLSKLRYINFKKEFKDEDCIIYYKDQQTDFVPIFIHSGK
FTNINREKINFPTGFFDTDLDKLMEIR
>fig|195.2155.peg.1171 hypothetical protein
MDGKKILIFGFISDNFLEISSFLEKNKIKKAEIEEKISYMLNTILSSKESTRSACDFKIQ
KMYHCLLQDFNNEASKKRCYIANQNLLYIAEEWLKLDENVLFVLLYENPIEILRQKIFSN
HKFCFKDILMDWLRYNNLMLEFYSKNNNKCILMNYSNYHNSLIKYLSKHNNPDMVYAEND
AYIFKNKELFDFLLESLINKDYQIINDSYEKLEKNSLSPICKRKFSSENVEKEIVDLFYF
IETNSILKSKNKSLLDFIFDIQEDLEKLHQENLSQINNLNQTIETKNKTIQENLSQINNL
NQTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVIL
LGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYQEAIKFKNYLSYRLGQVIIKGFKNP
LSIILLPYEIVKLIYKFRKR
>fig|195.2155.peg.1801 Methyl-accepting chemotaxis signal transduction protein
KSLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISS
TVSDIANNILE
>fig|195.2155.peg.1773 hypothetical protein
MLINQSFEIDSCDDVELGIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVTINVFYHCFCARQSIDQKYNPKLIPNKDDLERINNILKNINLGHLLANED
NFEQIIPFIEQRAGEIKQAGLVDESQKIGLSCDFIPPNGDYQNFGIMAAIDHINALKDLV
KRFPKFADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSAVPPLIYILGREMEGGC
DYVLNSSHILIQCFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSY
H
>fig|195.2155.peg.239 hypothetical protein
MHHIVFLQGIILKKPKVSLNRLKSSNIHLFTQEIRVFFLGIWVKNILKINSKNFKKARLK
>fig|195.2155.peg.119 Membrane protein
MCCSFGLCLSFLIGLCTHFFPAFSPLVVGLVAMASSILIRYYNIGAPGYFFFVFSCLLAS
FFPFPPKDYIFLVGLICIGGIIANITAFLYSVSVIYIFKNSPPKPVLKNGNLGFDVIFVD
SIIIAFFVGFAVFLGTFLELDRSYWVAVSTTVILQGTNLNSVWIKQLQRILGTTVGILFA
WWLLRIKFTPLEFIFLMMFLAFIIEFLVVRNYALAVIFLTPYVTYLAEAASFGNLSVDML
IHARLQDIIIGSLLGLLGGFVIHRAYLRKYFKYIAKYIFRVKLTSK
>fig|195.2156.peg.602 Pseudaminic acid biosynthesis protein PseA, possible Pse5Ac7Ac acetamidino synthase
MPTKIGRKNLENLNHLGVDLIHIKRDPKVYQKLAREAFIRTGDNEWQNHLGIFTSVPRIA
VNFGVPLIIWGGGKSADRVWRSCEE
>fig|195.2156.peg.430 ATP/GTP-binding protein
MIDWDKTYAAIYRSRKDYLKPIIDLDNIGLNDLLGMEEQKNVLYQNTLNFIHNKGANHAL
LWGAKGTGKSSLIKAIFNEFKDK
>fig|195.2156.peg.1338 Putative periplasmic protein
MFLFFPKGAKADEIYTHIKAQIASMLEVKYIDSKVVSISGEKGDFTVNDEQGLGIKADYI
IVATGANKSDIKELEDFVIPHELMPKPNKFCFKHHGRQIIKEGIYAAGLASGVTTMVACA
MGSANEAACAILSDIKGAVSVYHDTPTTRV
>fig|195.2156.peg.1704 McrBC restriction endonuclease system, McrB subunit, putative
LLENKNLSLVKMIENIAIPLWNKYGMDSQNYIDKMKNLFSEYLNKKKLDKNTINKYIQVI
ENISKEFLKENLYSCDLFSFDQNINKLNKNEEFKLKNSNGHNMYSSALNYYRAFLIDYYE
QDIFITERVQSEESNMKIIPLNQILYGSPGTGKTYHTIDKALEIISKEEKIQIPSEDDRI
NRKKIFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPIIDNDENSQEVKYDVKDGIFKELCD
KSLKNYILSMQNENEIDLDKLIFEFANYINQDFLNKGNEFPLENKVSIKKILLNFKDEYR
SFSLGGSIKSPQSLTIDIIKRDYLNFKNKKILSFKDIKPKYDSQSDYHGNAIYYFMFYNK
LKEFENIQNEKFKIKKEILKSYIIIIDEINRGNVSKIFGELITLIEPSKRIGEKEELKVT
LPYSGKEFGVPKNVYIIGTMNTADRSITSLDTALRRRFEFIEMMPDVSKLSMDCEGINLQ
ELLKAINTRIEYLLDREKTIGHAFFISVENLEDLKKVFKNKIIPLLQEYFYNDYALIYAV
LNKNGMLEISVENKDYLKNMTEFIESDKIVYKFSDSNNWSKDTFIKIYE
>fig|195.2156.peg.1350 lipopolysaccharide core biosynthesis protein LpsA
MEKNFLSKKEQMKYKFIISLEGNDVASNLKWEMNSNSLVLAPKITCETWFMEGT
>fig|195.2156.peg.1339 Putative periplasmic protein
MRKSIAIIGGSIAGLSAALFFASAKNDELDFDITIFDEGKADLKAAAIYNVPFFPKRCKS
R
>fig|195.2156.peg.431 ATP/GTP-binding protein
MNLKTNEKNDDSYKFLKPLLEGSIEAPPQNIIIYASSNRRHLLSESMSDNQGVQVAHTEL
HASDAAEERLSLSDRFGLWLSFYQGNLNEYLKLVDFYFKDIKCDKELLHKKAKEFANLRA
SRSGRTAKQFYLAFKESIE
>fig|195.2156.peg.1722 hypothetical protein
MFQALISILFGAEFEERNLLNSPA
>fig|195.2156.peg.446 Inner membrane protein YihN
MQNAKPIRWFTFIVLVIGGGTVFKLSSLKDAFYVPMQEFMNLSNTQIGLALSVYGIVQTV
GNFASIYIADRFSKKFLFLFH
>fig|195.2156.peg.156 Phosphate ABC transporter, permease protein PstC (TC 3.A.1.7.1)
MVFSLFGIQASFQSALGAGFIMGIMIVPIVASLSQDCIEAVSEKRINGAYALGMTKKEVV
FAVILPEAIPGIVAACLLGLSRALGETMIVVMAASLRPNLTLNFLEDMTTVTVKIVEALS
GDQAFDSSLALSAFSLGLVLFVITLIINMFSVYLINRFHKRKNL
>fig|195.2156.peg.1349 lipopolysaccharide core biosynthesis protein LpsA
MVHGRNLKPNYHFALIDNDNLATVIEHFISHPKDALEIINNAHQYVKKFLDKKKEFYIGI
LVLTKYFYYSGQLDLNKDECKREILELIK
>fig|195.2156.peg.324 Putative periplasmic protein
MRGIFYIIALFSLLNADELTEALAKNNNQNSWEHFDYKNTKEAPKIQEENVDFKSTFDSL
LSKTLENNNGIDKTDGNLDFQNENAQVKNLSSLYEGENNSLLFQKELFVAQDNYNYSGGL
INRYEKDDFLFGVNGFIDKQKEQKDTKSFGTEFGYSKFIKAYSNYYIPNEAEKNLQLGMS
FVIPTYTAFAFDISKDNDKTNYQVSYSPYSVFSLNLLRRDYSARETVDDTVVQVGFSFNF
NESFLKQFRKKDNTLEEVNRYDFLQRTH
>fig|195.2156.peg.155 Phosphate ABC transporter, permease protein PstC (TC 3.A.1.7.1)
MLKEKIIKFALFLCAFVSVIVSFAIMLTILIEALKFFQKESVVTFLFSSQWAADAAFMNA
DGTSKQGVFGVLSLFWGTFYISLIAMLTALPLGVMCAIYLGVFAGKKSKNYLKPILEIIA
GIPTVVFGFFAAIVVAPFIVWFFLYLAYKQAFKVL
>fig|195.2156.peg.468 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MIKERIEAENLKDNESFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLAELEAFKDYRNA
FRQTSDYKRLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLIIKSPS
DIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLIYKSFLNTLDVI
PQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSTQSEMSNPFINSKFELVRLKDFVLD
IQTAKRPSGGVGKYENGALSLGGEHIDNKSGYIKLDNPKYVPIEFYESFALQDKGIVKQF
DILICKDGALTGKIAMVRNEFIRKSAMINEHIFLLRCDNIAKQKYLFYILHSYSGQQALK
SKITGSAQGGINKTNLESILIPNADFEIQKQIVAECEKVEEQYNTIRMSVEEYQNLIKVI
LQKCGIIDDGGGYELNSILENLQKLESKLDFNLLFSFIDDFTNARQEDLKKFKEFVKNIK
AILGTFSTPPKQGWNKEKLNEIVSIQSGGTPDRKIKEYWNGNINWVKSEVCQNCYVYDYQ
VKEKITELGLQKSSAKLLKKETTLIALVGATIGKIGFLTFESATNQNITGLYPKNLKILN
TKYLYYACMDLYGQFRKLGDFAMANSNFIKNLTISLPPLEIQEKIVQNIELVEQQIDFLN
LKLEFLEKEKEKILQKYLFS
>fig|195.2156.peg.526 Ferrous iron transport protein A, putative
MTLNELKDGQSAIIKEVKAYKELHSRLLSFGFMKNKTLKKYTLL
>fig|195.2157.peg.1561 Membrane protein
MFGRSKNLYYEYFLSLPFEKKELENILQRKLDKICALKFQTPYQNNVLLFKQNEFDATLF
FNIIEKQCSQNMRVNSFSELKKELKKEAYRLILLDYELIKFDLEQMRSILSAYKKQHPQS
HIIFFSRGRG
>fig|195.2157.peg.1368 hypothetical protein
MKRQTKPLSIRIPLELKEELQKIADKEYRPLATQIVKIFKRLC
>fig|195.2157.peg.1114 Phospholipase A1 (EC 3.1.1.32) (EC 3.1.1.4) @ Outer membrane phospholipase A
MGNFDINIGSLGNDYFINLMLRNNLDFHDNKGAVQVDIGYDIFDNGIYWYLQYFNGYGES
LIDYNKRLQRLSTGFLISY
>fig|195.2157.peg.939 DNA primase DnaG
MITKESIENLSQRLNIVDIIENYIEVKKQGSSFVCVCPFHADKNPSMHINPTKGFYHCFA
CKAGGDAFKFVMDYEKLSFTDAVEKIANLCNFTLSYTKEKNENKKELRTILPSLNAYFKS
NLKHHKEALDYLYKRTLNDQDIAKFELGFAGSSEDSIRLFHNEKIPLEDAMSVGALKKDE
NNEFYASFIWRITFPIYDHKDLLVGFGGRTLNPNVAAKYVNSPQNILFDKSRIFYAFNIA
KENIAKKKEMIVCEGYMDAIAFHKAGFNNAVAVLGTALTENHLPLIRRYEAKVILCFDND
EAGLNAATRSAFLLSTHKIDGKVALLEGGKDPAELVANNQSAKLHTLLEKGMDLGEFYIR
RILSSFSLNSALDKQKALENIQKYTFSLEPLVASSYVGLVSKLLGVDEKLIVLTSNRKPS
KTINFNTSFQQTQNHNPKSHITELELLNYLKNNPNMHELFIKITDIRCFKHKVLLEKILE
HKSYEDSDIREFESKNFSKDLSQIEFLWGICKVNLAFLNHINITNSYLALKKQIFTFLVK
I
>fig|195.2157.peg.1867 hypothetical protein
MLIAKIAPWYVDGVIDNSGSALPPLNYILGREMEHSYGEYYEDFPHNRIIFFLKTHWTRK
ENSPYFFNNENYFIRTLLNKD
>fig|195.2157.peg.513 Phosphoglycerate transporter protein PgtP
MLISLYVLYAVKGSPKNEGLVDITEINEMRGIKTEEIKAIETPNLSSFEIFYHYVLKNKN
AWYVAWMDTFVYMVRFGLISWLPIYLLETKGFNKEQMGIAFWLFEWAAIPSTLLAGYISD
KIFKGYRMPPAIGAMVIIFFMIIGYFTSNNLYMVTFFAAMAGCLVYIPQFLASVQTMEVV
PAFAVGSCVGLRGFMSYVVGTSLGTKAIGWAVDYYGSWNAGLIMLLSACILCILCSILCH
FGAKKKEDICKK
>fig|195.2157.peg.1664 Pseudoazurin
MKILIKTAILGLLMMSLEAKNYEVKMLDLDSKNQTMIFEPAVLHIEVGDSVTFVPTHKSH
WAKSVIVPKGASKFESKLDEKATFTFEKEGVYLYECPPHRIMNMLGFIQVGKAKNLEQIK
NAVPKLEKRAIMNQGRLEAYVKELK
>fig|195.2157.peg.871 Putative periplasmic protein
MNLSKTKQARLAIIIDDMANISQVRALQALKLKLIPSFFPPDKNHIDTPKLALKFDFYMV
HLPLAAMNYTKPELDTLNPSDSEKRIFKKIQQVKKDFKDLKFINNHTGSLFTSDEKAMKK
LYKAFEKEELIFVDSKTIASSKAPKVAKALGQIYIQRDVFLDNRDDVAYIKNQLIEAVRL
AKQKGFAIAIGHPRKNTFKALEQSKDLLKSVELVYLSEIYAK
>fig|195.2157.peg.1877 FIG00470627: hypothetical protein
ATNPTANNQVANKSYVDTVGNSKVALSGNQTIAGVKTFSSSIVIPNATANNHATNLGQLN
SKVAKTGDETIAGVKTFSAPPVSA
>fig|195.2157.peg.1662 ABC transporter, permease protein (cluster 8, B12/iron complex)
MQNKIVATLKAHRKRELKRFYIIISFLMIAFISLVFDIATGPSLLAPKEVLSALLSPFTS
KEIDSTTLSIVYDLRLPIALMALVVGAALGIGGAEIQTLLNNPMASPYTLGLAAASGFGA
SLVIAFGSFGLPLIIAVPVGAFLMTMLAASVLFGFASFKRFDSAMLVLVGISLLFLFQSF
LSLVQYLSAPEISQQILFWLFGSLLKSNWTNLPIVSIVTFVCVLLLLRDSWALTALKLGE
ARAKSMGIDLNFLRFKTLVLVSIMTATAISFVGVIGFIGLVSPHIARMLVGEDQRFFLPS
AMFVGAAFLSLASVLSKVIIPGALFPVGIITSLIGVPFFFWIIFSRKNYAKA
>fig|195.2157.peg.1663 ABC transporter, ATP-binding protein (cluster 8, B12/iron complex)
MLKLENFSVHRKNLCVVDQINLKLEKGKIYAILGANGAGKSSLLGAIFGEFASSGQLKFD
DKDLSKKLIGYMPQDNYIEASLTALEVVLLGLIDQLGMYLSNMQIKKAAKLMEELGILHL
AERDISTLSGGQRQMVNFASVLLKKPQILLLDEPVSALDLHHQCVLLENVKKHTKEQNLL
TLVILHDLSLASQFADELIILHQAKIKAKDKPENVLNKDLLKEVYRIDADIFYCERGLPC
VLAKSAAKELKGKENENFN
>fig|195.2157.peg.1409 Fic family protein MloA
MKEFIPQKLPLNIELNANIYSLIIKASRKLAELNGLSKSIPNPNILINALILQEAKDSSE
IENIITTHDELFLSQIDESKLTRAAKEVKDYENALKKGYELLKKERLLRNAHILEIQKRL
ERNNAGFRKQSGTMLKNPITGEIKHIPSLNLSNFQSFFNIIFYLASLLGKSISLPLLQLH
KLKFTSL
>fig|195.2157.peg.1661 ABC transporter, substrate-binding protein (cluster 8, B12/iron complex)
MRILFYIITLIVCLNAKEVVIKDILDREVKVDLPAKRIVLGFYYTDFLAVGGIEAFDKVV
GFVKDGWAVYAKNSYEFYAQFIPRIKNLADVGDPQFGTFSAEKVLSLKPDLLILAAWQYE
AIREDLAIFEKHNIPVVVIDYNQESVARHSLSTEILGQILGQEEKALELVDFYKSRISVI
QERIKSASLPKPKIYIEFGNKGPQENSFTFGNEMWGALIELAGGENIAKNLVKKWGVINP
ELVLKANPDVIIITGRESDLEKNKEAMVMGFNIEENEALKRLERFKFRKGYENLNAIIHN
KLFGAYHRASTTLADVAMVEFIAKTLYPSLFKDIDPLKTYLDFHQKFLLAKPQGTFMIKA
KNAK
>fig|195.2157.peg.1862 Methyl-accepting chemotaxis signal transduction protein
MFDSENSIFVSTDKELLKPGYDVSPVANIAKDKKDYEPFRYVRPLDGTQRFGVCAKVLGE
YTACVGEPIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSRYLSPLAAIQTGLTSFF
DFINHKTKNVS
>fig|195.2157.peg.1187 Replication initiation ATPase; bacteriophage DNA transposition B protein
MKELQTPFIATKDAKAINVTIESAMSNREMGVIIGEAGTGKSRAIKEYATKNGTRVVLFE
ATTETSKRMLLVGLENKLNVCFKGSLDDKIRGIASELARTSKVLIIDESEHLPFRALECL
RRIYDFSNTALILVGTRKLKNNLTGIGRNDYNEYGQLSSRIGAKWELKGLCYQNKEGLKD
EDLKTLCKHFDVEDKKAIDLVFNLARGNFRKSEKLLKRACEFADGKAVELKHIEAAASFL
MLG
>fig|195.2157.peg.1628 hypothetical protein
MQENLKEIYKEFEFLNTQFSSYFNDEE
>fig|195.2157.peg.1531 hypothetical protein
NEDKMIKVYEDSYLKEKFPNVMVDKFLK
>fig|195.2157.peg.1856 hypothetical protein
MQEIKQFFINIDRADIDENMQDLVSEDLIDSIDIMALVAEIEKFYKKP
>fig|195.2157.peg.1560 hypothetical protein
MLLVWIIFIFNIILAFLSIDFTRIHESLEQIKLTFFASIFILSLTLIFFLFRKKRALARK
DQKILLIKNEFIHAEEIDIETSLDLIREKIAHLNQDLFKISHEKETYAKLLEDSLYQIGN
IEGVVRCLDEEEASKEIKSLVLNALKHQKEQIRLGLNQALEYHKSIGVAQGNVLQFEASA
AIVSDDGLEAFLLANLLSYFGIENTIFKSLSFDINDFHVVFIKDKILE
>fig|195.2157.peg.1549 G:T/U mismatch-specific uracil/thymine DNA-glycosylase (EC 3.2.2.27)
MSEFLTHPFKPFFDKDSKILILGSFPSVKSREDGFYYQHPRNRFWPILETLFDTRLENIT
KL
>fig|195.2157.peg.1186 Replication initiation ATPase; bacteriophage DNA transposition B protein
MQLVELTKKFLNTQNISQNNLSDRLGINKSYMVGYMKEGSNYKYASKVEPLLEKYIKSFV
EEKA
>fig|195.2157.peg.1416 Modulator of drug activity B
MKNILLLNGAKSFGHSGGKLNDTLHEVAKESLLNLGLKVDETYIDKGYDIENEVAKILNA
DAIIYQMLGWWMGEPWIVKKYIDEVFTAGHGKFYANDGRSREDASKKYGSGGLVNNKKYM
FSLTWSTT
>fig|195.2157.peg.1115 Phospholipase A1 (EC 3.1.1.32) (EC 3.1.1.4) @ Outer membrane phospholipase A
MKKILFLIFFYSLVFCDDFEQALEFEKKGQYKKAMQIYKKLALQNSPKQDLKENNASLLS
SIKHETQNTQKTPSTKEDFSRIALANYLGENSSFNPLGISSYKMNYFLPFAYSFGSLGGE
NRKTEMKFQLSIKKRLFEDLLGLGEKYYVGYTQTSWWQNYKHSSPFRETNYQPEFFVDIP
LHFEDYKFLNNLRVGILHESNGKGDENLESRSWNRIYASSVFLYQRFFLFLEFGIEFLKT
AKMMIILKSHIIWEILISI
>fig|195.2157.peg.1365 DNA-binding protein Roi
MNLELFKKDENKEINLTSLEIAELTGKEHFHVIRDIETYLEKVVEGGISKFRDTYQNPQN
KQFYRCYHLPKREVLILVSGYSVELRAKIIDRLEYLENELKKQSYKPLSLKESLQMQLEL
LERNEKLQIENVNLKNEAKENAPLIHFANRIKDTNDAILIRDFAKILYEKNKIEIEEKRL
FAFLRDNGFFNE
>fig|195.2157.peg.1568 Putative phosphatase
MLGIDLGSNTLRAVFINEKFEKLDEYEFIIGSAKNLDKTGKISDEAIEKLRNALQEIAKK
YDLSQARAVATAAFRKASNTNEIFTRLKQEFQIDFKVIDAKIEAKISVLGMKRGLLNLGL
NLDCGYCDLGGASCEFSFRDNFQSFDFGIISFYEKCKIKKIANSFSFKKILQKYPNFPY
>fig|195.2157.peg.1417 Modulator of drug activity B
MHLHKANQFLGMKPLPTFICNDVMKNPQVEKYIEDYKAHLQKVFS
>fig|195.2157.peg.1710 hypothetical protein
MSKPLNEEIFIEFKSDLAERKNEVLLQVLELLETFRSDKNEKMARISSELTEILENEENL
EKILNAKN
>fig|195.2157.peg.1851 Motility accessory factor
MNLLEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFSIDENLNIYDKTHNVFMYENLEEEL
NFFYQSILEKTPRYPFICIYGIGNALLIKNL
>fig|195.2157.peg.1364 DNA-binding protein Roi
MAFLMSDNKPYQKCIEQGLFKVSETTISTINGDRLVSTTKITGKGQIKIANLLLEGINHA
V
>fig|195.2157.peg.373 Acylphosphate phosphohydrolase (EC 3.6.1.7) / [NiFe] hydrogenase metallocenter assembly protein HypF
MCHLGYKIKISGLVQGVGFRPLVYELALKSKLFGEVRNDGFGVEIILACTQKECQNFIEN
LKNHLPPLARIDQLIITQISISNYENFSITPSLENTKSTPMLSDFALCKECKKEFFDEKN
PRFLYPFITCTHCGPRFSIIKSLPYDRTHTSMQELLMCEFCKSEYEDPKNRRFHAQPISC
PKCKINVFLKNPKGEILAKDQEAFIQSAKFLKEGKILAIKGMGGFHLMCDAFNEEALKTL
RLRKNRPKKPFALMCKDLQSAKELAFIDEKEEALLGGVLAPIVILKAKKAFSLIAPDVDK
IGIMLAYTPLHLLLFEYFKGNLVATSANLSGESIIKDEFNLCKKLDKVFDFYLDYDREII
NASDDSIAQVVNGETMFLRTSRGLNPFYLERNFNKKGTFLALGAELKNEFVIFYENKLLI
SPYIGDLKSLDVHERFFKLLEFFKQNYDLKFDAILCDKHPHFSYAKEFEERIKISHHYAH
FCAAYFEYEENFAKDEKALAFICDGTGYGEDGKIWGGEVFVGNLKEYERIAHFENFTLIN
SDIKNIQN
>fig|195.2157.peg.1665 hypothetical protein
MLIIATCKAYKEGNEVLKKLKAKLENLHYQCELKAWQEIRVRHLAQNTLILPLAVWDYSL
EYANFLHFLNELERAKISILNPSEILKMNADKSYLKILEEANLPIIDSIIFKQNEEFDLS
LIPFQKAVIKPLVGQSGYKVRFLEQKIPTKEEFLHGALIQPFIESVEELGEFCFIFFGGK
FNYAIHRQTQKDWRANSNYGVKIAPLKNPSKAHIDLALKALKALKSSNLLYARVDLLPQK
NGNVLINEVELIEPSLYFDFHENALEIFIKNLLHFYLKANC
>fig|195.2157.peg.202 Auxin efflux carrier family protein
RRGYGMFIFSPLFTIFILLAGGYFAKRVGILKQKQARTFLDFAIVFALPCLIFDKAYHLN
FDFSLVVLIFIGFFSCALAAFIVVFLGFIFNFSKATLVSMFLLSCFGNTIFVGMPIVEGI
FANAQFGAEVILYDALATTLPISLLGPFILSLGSGEKVSLVANIKKILSFPPFLALLLGF
LCKLISLPEFIFSPIRLFGGAATPVALFAIGLGLGFMAIKTAYKPTILVILAKMVLAPLI
FVLLLKLFGFEMKASIIVAIIESATPTMTLAGAMVMKAKLDSNLAVSTVAFGVLFAFISM
PILVWALA
>fig|195.2157.peg.872 FIG00638667: hypothetical protein
MSKKLIQIKRYLIIAILFLICVILFLGILIQYQDSQNALKFAQNSSKNITIEPKQENISN
ENHLGIFKEIPYKDENDNFQEKN
>fig|195.2157.peg.876 hypothetical protein
FKKGFEAKNALNYRDFKEFRLEETDKERLKDIQICLLAYINFCSSKDIKEKRVEMISKTF
MPMFLISRLYFTLKEEKLDIQIRKILKEKDELAEEKSLWISKVLPF
>fig|195.2157.peg.1660 ABC transporter, substrate-binding protein (cluster 8, B12/iron complex)
MFKKYLKLFFIILGIFGANLTLAKEIVVKDVLDREVKLNLPAKRIALGFYYTDFLAVGGV
KALDKIVGFSKAVWTDWTPASWELYNKTLPQLNSIADFGEVEVGTFSVEKVLSLKPDLLI
LAAWQYQVLEFDLEPIIEANIPIIVLDYNKEKVELHAKSTELLGVITGEEKRAKELIDFY
KNTANEVANRIEKAQLPKPKIYIEFGNKGPNETGFTYGKDMWGALIDLAGGENIAAPFVK
QWAPINPEQVIVSKPDVIMIAGRETELKKNQEAMVMGFNIDEKEALKRLEAYKNRPGWSA
LPAIKDNRLYGLYMGASRTLADAAMIQYIAKALYPSLFEDIDPIQTYINFHKNYLPVIPK
GTFGVQAK
>fig|195.2157.peg.1181 G:T/U mismatch-specific uracil/thymine DNA-glycosylase (EC 3.2.2.27)
MQPKSIILFFYGYILFFRRQKQQAFLKEKNIAIWDVLQSCKIKNSDDKTISYAKANDLNL
ILSQAQIQAIFTTGKSAYRFFTKFHPHLKAIALPSSSPANLNFSFEQLLQSYKIIKNFIK
>fig|195.2157.peg.758 hypothetical protein
MNLNQTLQEKYPHLEVSVLKLSEAQKDNESKRIDSEFFKKEYFDAMETMQLNQVEYLGDN
MKFNSRYSQPKYDETSKIKVINSQYIRNEYIDYENAKSGYGKIVPKESVLINATGVGTLG
RVFINILDFDFSIDSHINVIVVKNKTYLNPYFLAIFLQSYYGQIQIIRYYSGTSGQIEIY
PRDFNYFKIPIFPMEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDPKNPLQSL
LDSKTNIPTNSPNISIHTLKESFLKTGRLDSEYYQSKYEDIEKFIKSYPNGYDSFSNIIN
NKDTNFTPKNNENYSYIELANIGNNGNISEPISDLGKNLPTRARRIVSKGDVIISSIEGS
LSSCALITQEFDKHLVSTGFFVLNSKLLNGETLLVMFKSQIFQEYLKKFPSGTILCAINK
EELSKILIPKIDPTTQEKIAKYIQESFNLRKKSKQLLDNAKIKVEEQIQGKV
>fig|195.2157.peg.1659 Major outer membrane protein
MSKLKNLTLRFIPLCLGLSVSWGGVAGAVTLEEAIQDIDISGILRYRYDTGRYKNENKIG
FQNGSGLISSNQNHRWLGNLNFKANIDDNFKAFIQLRYGPTKEGGYGNSSSNITDTSKSL
NVRQLYVEYNNPDYQTSVKAGKQQMDSIWTENYYDGLVATGLKITNTSLDGIMFQAYAYD
SYNSDEQGGVGGDMGVYKDYSNPKSSYTQLPIYEKNLYGIAILGNHEILQGNLNSQLWLS
YLSENVFFYALNLAYSYEFSENFSINLEGAYLGNTIQSDFEKKVDATNGNFFGAKAILYT
YGFDINLGGVHYGDKNKYSITVLEDTGNLNVLGGQQIFYTDGSHLSGDRGENSFIYGGLG
YTFDKVRIGADVAYGETKTGISGLGGEKLEFVGKVSYKYSPKLNFLAWYSHINIDTNDLS
SASLDSKKNTVRFQTLYKF
>fig|195.2158.peg.1790 Flagellin
VSAINSVKDTTGVEASIDANGQLLLTSREGRGIKIEGSIGGGAFINKDMMENYGRLSLVK
NDGKDILISGTGL
>fig|195.2158.peg.1516 Arsenical-resistance protein ACR3
MVVVWSDLAKGDREYTSALVAMNSIFQILFFSTLAYIYLDFLPKLLGQSTLATSLDIDFF
SSK
>fig|195.2158.peg.1786 Motility accessory factor
ANKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNHDFGEFDNGICFIIKSIVHP
NAINYLTKKTDNFTIVSTYASFIQYLKLDYFGYFNMGFSVAHMACYLSLHLNHKNIIFIG
QDLAYAENGNSHPDDY
>fig|195.2158.peg.1337 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KTIQENLSQINNLNQTIETKNKTIQENLSQINNLNQTIETKNKTIQNKDDLLNFQAQYGT
AKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISHKQEQKIYKQKIEKDPSLKL
PSLEQYPDYREAIKLKNHLSYKLGKELVKANKIWYKGGYFQFLYFIKKLKV
>fig|195.2158.peg.1137 Methyl-accepting chemotaxis signal transduction protein
MSNFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKARNTAALESLAKNILKLPYE
QISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVADPDSDEKGLNFGILW
>fig|195.2158.peg.1761 hypothetical protein
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGDEIPFGVLIYKYKLKINTINKVNTLPNNSKDSILIHAGTDM
KFWSSFISYISFQEWHVNNKVWSNNYDKMIRLC
>fig|195.2158.peg.1766 Flagellin
KNYNGIDDFQFQKVVISTSVGTGLGALAEEINKNADQTGVRATFTVETRGMAAVRAGTTS
DTFAINGVKIGQVAYEDGDANGALVSAINSVKDTTGVEASIDANGQLLLSSREGRGIKIE
GSIGGGAFINKDMMENYGRLSLVKNDGKDILISGTGLSSTGFGASNFISQVSVSLRESKG
RFDANTADAMGFGSVNKGLVLAASSIADYMSAEGSGFSAGSGYSVGSGKGYSATLTANAI
AISSASAISRIYDVSAGSGFSSGSTLSQFATMKTSAGNSLGAKDETAGVTTLKGAMAVMD
IAETATTNLDQIRADIGSVQNQLQVTINNITVTQVNVKAAESTIRDVDFAAESANFSKYN
ILAQSGSYAMSQANAVQQNVLKLLQ
>fig|195.2158.peg.353 Dicarboxylate carrier protein
MMDTINIIILFSLIISIALGYVLKANIGVFAILSAFIGAYLYGITPEKVINLWNGSLSLF
FILLSITYFYGFAIANGTLNNLALKAVYSVRNRPWSIPIALYITVMVFVGIGPGHYAGFA
FMSPLVLYIASKIKMNKILAAIIIYSGSCAGGFNPFTLGGRVTFDLIEKLGYSAEASAIM
QLNLGKNMFIAHTLIFIIGYFLLKGYKVKITSQITKPKRLNAAQWKTIFIVCFVFAVIMI
PSFFLALNPHDETLKKSNFHF
>fig|195.2158.peg.1131 McrBC restriction endonuclease system, McrB subunit, putative
MLEDKYDWKISKADQNGNVYYYFPKDSDEFKEAVVKNGGMSVYVYQDDKLIDEFHTKSRG
YKWKIPIFGYLKNMHKDGEYFHRYYKNCKFFAIVD
>fig|195.2158.peg.861 hypothetical protein
MNFQVKTLETFNPFESLNHEQANTEQILDFRVIDFKLLCSSVKPAKTKTYERKDFDLFYA
DDFFVKNYNTIVQKFLIEIYPKTQSFPFTVKLRSNSNLTHLKASINLTENFKYYPNLKFD
ILQNIYKIMIKQKFLILRLDKNLFDKIDDFILSIQKSPSIKEIELEIAKGVDKIEHKSDE
IIYHRDVNEECFDENINYDEGIYCKPVEKNELLFEYIYRFLGKEGRNLRGEILHLNPIAF
LDNPFIIKDESIYTEELEDRIKYFSANYGFLNKDHSGYSVINNLKLSQIGLKTTGSIKTN
TDENINLEITNFDISDDAIKSGIVNVQASNIKVNGSIGATKLYGKNISIKGLTHAKSEIF
AQDIFITTHKGTLQADTVYIKNLENGTIIAKNVFVENCMGGKIEAENIYICNLLTDNTLY
PRKNLIITNNIKFKNNIVVSPLVSIENNSDTECENLKNLSLKIKSKLDDTISKMQNYYDY
LIKNQIKIIKLQKTKILAP
>fig|195.2159.peg.789 hypothetical protein
MLFEKTILKELKVLYKLDNYHGIFAVLWDYLQIILTIAISCFMHNIFMYLFAVLFIGTRQ
RALATILHESAHRILAKNRKLNDFLGKYPSGYLIFQTFEKYRQSHVIKHHGFLGIENKDP
DYDFYIQSKLFASRSLKEFIFRHLILPLFLGKTFDFISYLIRNRLGDFKDKEIKYLILFW
IAIFGICFYVNVLDILLMYWFVPLLTSFPMVGHFIEMAEHFPIIKNKREIEKSWNRFGNK
IELFFTGLHKENYHLIHHLFANIPFWNLDKAHNILCKNEEYRLLNSNMGGIFSSSNKASS
LWKKIIKKELNMLKNPKFQAFFFAFLAAIFNAFVGIFSVFLFKKGFMSSEVAFYKCFVAS
VILFAILIYMRKLGALLVFIKQKIFTLLLLAFFGFFMLYHFESAAYTSMGVANVVFVLFG
VGMIITFICEALDAKRFFHLNELLAMVFALLGLWMIFLAEGGTLENFTHLKGLVNAILAG
IGYALFLFFTRKLKLGFGLIPLCALLFIGSLYLSIPLFGANLNLNFSLESLILILALAFL
PTIGGFYCTTRALSLAKSNSVQLIELSEPLFAMLFGFLFLAQSVSFLQILGGVFILFAIF
VHEFKLKL
>fig|195.2159.peg.1774 hypothetical protein
LKVQEKEKYILILDKNDFNKYRKDCSFINNQENLAHKIAIGEFRIFIAVYKDMKCLENIN
NITKIYGYNSKVYRLKDQIWDERYLGRVCKISQALYFSGKAKIGII
>fig|195.2159.peg.1378 hypothetical protein
MLINQTFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTMFTKDDVSNLSQALLEIGVNINVNLEN
AQQCYELLNQNITTLKSQRKLAQNYQAKFTSTFIPPNGDYQNYGIMAALDHINALKDLVK
RFPKLADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSAVPPLIYILGREMEGGCD
YVFNDPNTLIECFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYH
SKEDPLTPANFKEQTKPCKY
>fig|195.2159.peg.1203 ISCco1, transposase orfB
MNTFFKMRYHRDLPNTYKFNQITIIKNHNKYYLAFSIIYDESNISLISSKDFDIKKAVDI
DLNINEITLSSGELIATNSKLLSRAEYDLAFKRLQRKQSRRILKTKKEKTKLSHNFKKTQ
LKLNKIYEKKFKYQKG
>fig|195.2159.peg.1799 Flagellin
KQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRISSSGEVQFTLKNYN
GIDDFQFQKVVISTSVGTGLGALAEEINKSADQTGVRATFTVETRGMAAVRAGTTSDTFA
INGVKIGQVAYEDGDANGALVSAINSVKDTTGVEASIDANGQLLLSS
>fig|195.2159.peg.1780 Capsular polysaccharide biosynthesis/export periplasmic protein WcbA; Capsular polysaccharide export system protein KpsC
NHPSDLEELLQNHEFDDNLRQRAKKIIKNIIKNKF
>fig|195.2159.peg.1794 Motility accessory factor
SSYPILAKHGIKPDYVCMLERTEITAEFFNHDFGEFDNGICFIIKSIVHPNAINYLTKKT
DNFTIVSTYASFIQYLKLDYFGYFNMGFSVAHMACYLSLHLNHKNIIFIGQDLAYAENGN
SHPDDYQNSANYESQTYEHILTEAYGGKEKIKTHHVWLMFKRNLEQDVQKIQKYLDTKVY
NCTEGGARIEGTIEKPFLWACENLLHKDLNKPFEKLEPLSLNKQNEFLLKA
>fig|195.2160.peg.944 Sulfate permease, Trk-type
MKIIVALSILGLLVLLVSNKIKPFILFGSVAVLYYLLGYLNLNSWLGSYTSESLIVLILL
LLVSLAIEKVWLSLGVLNLS
>fig|195.2160.peg.1825 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MDKIYFVAKQESTGIILDFESFAIDRIIFSFKKNIYLDKIRLLCLTNDKKWKEILNYNLL
ISSNNKIVIDFEKTIFNYLSAEK
>fig|195.2161.peg.396 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MDQLYLGNIFYLNNEKIWGINPKEMDNSWIIDEKQMKLPVPTKINFYKSLISNSENIFDN
MPHAFYYYPKTNNQNTFIEALSVGLNIIYSYEVECIEYCNQKWYINGEKQYDILINTSPL
DLIPNILQNIPNDIINSFKKLKFNKISNMLWETDGSFDSTWAYVPNKDIGFHRLLNIGTY
FRPIKNYCITESVGEKTYEHFVEEGKKVDFLKKPIDFHVSERAYIRFDLNYVLSKTTTLK
YLESIGLISHGRFAEWEYYNMDVCIKRSIDLAKKIKSEYLL
>fig|195.2161.peg.358 MSHA biogenesis protein MshL
MIRLIFIKILFFTNLVYAMECQKRLFDININEDLSIRRKPKRTC
>fig|195.2161.peg.1121 FIG00471942: hypothetical protein
MSTENIIKEGAILGSLSGSALLGLMVFVLAGIAWHLYKTLHKEAGKKQRNL
>fig|195.2161.peg.1089 Beta-1,4-galactosyltransferase
MEFSDEFLNNGEEYIEELSKSEYEYVRLCYLTQGKMLKLNDNFLFTLDSIGGTQGYLIKP
ISALKFIDNLKFWIKPVDNVMDMYYYSKVFTITYTPLLLKTTDINSTIEERKKRQKTYF
>fig|195.2161.peg.1445 hypothetical protein
MSIFSINDNSNYNSILSQAKANKESKENSKISFANAFLKQNASKLNEIQNANSQTLARSE
VLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQVDLNTDTAYGYSVDKD
GYMGSDFNKAAGLPEDFKIHKSTLDEIYNFNEAQYQDIKEQLGISRYFTNIDMADTIKQY
YNQFNQIVNHTFNDTNKTSFTEADINSMPKGYISVGYKGLDFSDQSNPYNALGLVNHSNT
KVTNVFKTDDEFHEAQAIQMGMMGIDFYPQKLNISTQSLSQGALMEGGFNPDMSVYPQNE
DGSYSKEALFMSFLKSEGGYMVAGKNTTIAPQAMNYNLNVAKQSIPKYSNVDFDDIMTGK
VDFASLLKGYAQDGWLDADIYAMEKGVEWQNTSIGYGGAWFDNQFNQAKANGWKASSESI
NSYVGSIMDRLNNLIGQTRV
>fig|195.2161.peg.1860 Motility accessory factor
CIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSVLDLSEELCSGKIYLVDIEEERVD
IQLLILFDMKDMFEYLSLYEMFVNNVYYKKFYEDIWHKADELCEKNIKVVIRNLNSSLCI
GFECYSHLLQNIPSMLESIPFQRILSQRKNKFDNAIVVSAGPSLAKQLSLLKAYQDKAVI
FCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENKTS
>fig|195.2161.peg.395 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase (EC 4.2.1.-)
MKIGIIGAGISGMSVARLLKDCFEVEILEKETFVGGIARTKDVNGVAYHVVGGHCFNSIY
PDVLDFVFNEVLQKDYWNLIERKAKALFRNQWISYPVEFAIPEIDKIDSFLGMKIVQEML
NASYEKGSNLEEWFINHFGPTLSREYFLP
>fig|195.2161.peg.311 Bacillosamine/Legionaminic acid biosynthesis aminotransferase PglE; 4-keto-6-deoxy-N-Acetyl-D-hexosaminyl-(Lipid carrier) aminotransferase
MKKPRNFHYLVNIYFTIKKFKKGLKPLDYRYTLKVHFTIKKFKKGLKPKSLSMLSTCYFT
IKKFKKGLKHILLLGLENTHFTIKKFKKGLKQFKYFYARNFHFTIKKFKKGLKHSIKEFV
VGVILP
>fig|195.2161.peg.1088 Beta-1,4-galactosyltransferase
MKAFIINLERSLDRKEYMQKQIQKLFEKNPNLKNKLEFIFFKAVDAKNKEHLEFKQHFPW
WASWVLGRELSDGEKACFASHYKLW
>fig|195.2161.peg.1567 hypothetical protein
MIGINSTFNNSFVNLNIKNNNNSSLNSNTSNANVKNLQDTQDTTKTSNKVLGYEVDKDGF
FTSEFNKAAGIPKDYKIYAKGAENFVNYITNLNFKSFTNIDIAKSLGNAYKVFSQLIDEP
SGNFTTEDLSKIPLGFSYNKKSFQVTNIYYSEKDFESALSFEDDLKIYQNPKQLTLSFPS
WKEKAPADYIKKK
>fig|195.2161.peg.844 Oligosaccharyltransferase PglB (EC 2.4.1.119)
MAQFYIFYLKDSTIPYAQFILMDKTMFNSAYVQMFFLGNYDKNLYDLVINARDAKVFKLK
I
>fig|195.2161.peg.850 hypothetical protein
MILLKFFMKFWIKKLKNNHFYKKKLNKNIVKNAIIHF
>fig|195.2161.peg.1862 Motility accessory factor
DFTDLAMKFFQNKENKTSLNVLSCATHPNLVHFLDNKSVILREDPLYQRFNLNDFGYIDT
GTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFDFGEKFSGEENIDKLKVPAY
GGKGEVLTHITWNDYRIKLEYLFACNDQKAKFYNATEGGARINFTEELSFKECC
>fig|195.2162.peg.784 Membrane protein
GIQSKNTHNTQEKHLHTDKQIEIKKIQNNKIQPTQTDPKPDIKQSLENLQKKIQTQEVKI
EIEKSEIQPIKTEHDEDTQKVKNVLLEGFSNATKEDKNLNFNHLLFAVLFVSFALVLFVP
QIYIRNQIYYLSREIATLRVEESVLDEENKDLKRRLEIMRFQNQILDYLE
>fig|195.2162.peg.591 hypothetical protein
MKSSKKQGVYNAYLQSLQYKNLDVAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEE
EKRKIAQEEREKSLKQRKEFIAKHKSKIIISMVSFFLIASLSIYQYFYGGKYSRVYISKL
EEKCHYDDESSCKMLQTIYKEKCDDGDGKACFAGIFVSGDLIRVKIDGQWSFLDKNGEII
AKPKFDNLGVFSEGLAGVGLNGKYGFIDRSGKFAIEPKFDSGEYFSEGLAGVKLNGRWGF
IDRSGKFVIKPKFDSIWDFSKGLAKVKLNGKYGFIDRSGKFVIKPKFDSIWDFSEGLAAV
GLNGKWGFIDKNGEFAIKPKFDDIWDFREGLASVGLNGKIGLIDKSGKFVIKPKFDSIWS
FREGLAKVGLNGKYGLIDKSGKIVIEPKFDDIRY
>fig|195.2162.peg.90 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MFKLAINRPITVLMFFLALMIFGLISAFSMSVNLFPNVSIPLIKITSKINGDLNFVESKV
TKEIENALSEIDGVKTITSTAYDNFSVSVVEFKLGKNLEVAANDVRDKIGTLSLPSKPEI
EKISSDSGSAISLFLYSKDKLQLMREINDKIKPFLQRIDGVGKIEAKGFLEPQIRIELKP
NELRKYNLNALDVANIIKSQNFKQALGELNNNQDNYIIKGYFEATNLEELSNLRIKTGVF
LSDIANISSLYEDEKQSALYEGKEGVLLELGKITNYNTLEMIKNVKNALPILEKQIPKDI
SINMLYDKSLNIHKHLSQVIFDMVLGIFLTLVIVFLFLRNLSATLIACIAIPTSIISTFF
IIDLLGYDLNRLTFIALTLSIGIFIDDAIVVIENIAKKLKTYPPLQAAFLGINEIGFSVL
SISIVLLCVFIPISYMNSISGLFFNALGISVASGIVISFLVSVFLIPSIGARFLNPKENK
FYEKTEAFFEKIEQKYENLLYKILQNKVKFILATLVFIGFSFALATRIGLDFLPMEDDSE
IQVLLESKKDLSLEAMKEKSLNLLEKIKNDSNVKYAFLLVGYDDAKDATKAKIYVKLKNL
DERNLR
>fig|195.2162.peg.1847 bacteriophage DNA transposition protein A, putative
SDELKEDAKSKVKLLKQVEKYIEGGLSIARTLKIEKINRRFYERIRKAYKENGILGLIDT
RGLHRKDKTKLSAWMQEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDFIGFDLGKV
KPLFSVKTLQNFIKNYYKDKPLEH
>fig|195.2162.peg.1070 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISNK
ATNQISQLKDTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITEQINGAKTELNSKIDNKVTKTGDETIAGVKTFSVPPVSATNPTANNQ
VANKSYVDTVGNSKVALSGNQTIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVA
LSGNQTIAGVKTFSVPPMCGANPTEDAQLARKWYVDYGGGIKNLGNQTAPKIDLRQAQHF
ILTMTARGAIGIANWGGAGKSGTITVNNAQNITAFSAPFKFRVAQSGFSGTETFAYFCIA
SNNVLITRT
>fig|195.2162.peg.1579 Membrane protein
MLDDDFLKEKQNIRQKMLKFSRAVNQGKPLDDDLKEEISSDDILRRRFKKRSNHFLDEIE
EDYELEYTKKSNIYLKEDLINVKLEEKQSLAKKIFSKIKEKNKNQESKKKKTKKLFSFLK
KKEIQGIQNKNTHNT
>fig|195.2162.peg.1850 bacteriophage DNA transposition protein A, putative
TLQNFIKNYYKDKPLEHCIITQGLDRAKSKFLPAQGNQRELYDMKNMCWQIDSSPADFIV
RDDETLEPFRPHILSVVDVFSGMGVATLVGKSNSLS
>fig|195.2162.peg.1846 Beta-1,3-glucosyltransferase
DNSAQIIKKYQKKYPKNIVYLYKENGGQASARNLGLKYMQENDYQIPWVTFTDPDDFLDR
NYFYEVDKFLATHKANDICMIGCNIIFYHEKQKLYKDNHALNFKFKSGVQVKENYNLDSF
IQLSAASCFMNIGYLDKLLFDEKL
>fig|195.2162.peg.892 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKKKLAIQLFGHMRTYEQTYEKFKENIINVNLQDGWEIDLFIHTWNKFNSSSKSWHESLN
LFSNNDYLKEEDKIKIQKLYNPKVLSIEFLNEGEHGGLLSKIRGNELRKQYSQEHNNKYD
YILYTRPDLLFISPFRIDIFLSIYLQGTYKNIGLPKKHTFCCNNFFRGRKVADPRVLNEA
DLIYFSSFEQNFFRPEENRDFLNISLDYTLHKDFFIQREKFIHGWRSHPLDQYEDKVTLL
QNQIKDKENQIKKIQSGLKDISHRKQELEILDLEYGISLKKKHIEAIENNILLKKIQISE
NKKNINYNSNIIYKENSAKFRIQNQLSYKLGQAMIVNSKSILGYIRMPFVLSYIHDKHKQ
EQKIYQEKIKKDPSLKLPPLESYPDYKEALKEKECLTYKLGEALIRANNNWYGGGYIKLL
LEIRKLKREFYTKKDMR
>fig|195.2162.peg.1334 probable periplasmic protein Cj0413 , putative
MKKIKILVFLIFFCQFSVLANNLSQNIKENLGINQFLDESLKEILNQPLKENFALTPKGE
YFFEGDLSLFQKQCLENNATACAYLGREFAANTRLPLNLNKALLLFQKACKLGRLDSCTR
INNIKFKLLKKLDEETYQSNLKYFLDQNSSFALLEHIATLSKKDTKLCFAQGWVELFNQN
DILAQKLFYKSCQAGYYTD
>fig|195.2162.peg.1051 hypothetical protein
MYLKPVEISYESANLETSKSISSTLNSKGDININTNGNIAITGSTLQADKSANLNGENIT
IENGENKISSSSHSSTSSIAGYKQSSVNTDASLVSSSQIQSDILNLNAQKNVSIKGSELN
GGEIDIKADKVDFIAAQNKTHTESDSIAIGVFANANLELTGNGVAVNYSFVQDKANANTT
NSSNSITQGGARSDLLGTAEAGLEFSKTEKISDELSHVSNTIKGSNININANNALDIGGA
NFEANKDINLRAGEIVSTKYEDIKTQSSTGFGLYIKERIEATSPIASAINQSAQNAAAKN
ENLGVNYGIVASQALANTANIFSNNLINTTSNQTLGFKFNQDKSQSSSENISKINAGDNL
NLESTKGSIVLNGVEAKANSINIEAKDNVILNAAKSKNSSSSSSLEIAATNKQTAGYHAV
DGGTVGEGIEGFASASYSKSNETQFTNANLNANNININTGKDFTLNGANVKASNDAILMS
EIWK
>fig|195.2162.peg.1761 Putative transferase
MQNLIQSIKKFNKKKYENSGGGDLIFLLLLLGEVREKCHHHRSGWLSRELYSYLKDANYE
IIGYIDIQENNFFDLKYLGNEDNFDKKFIQKASFALGVGQINLRKKILVKLSKKSCNFIT
FIHPQSFVSKEAKIGQGVIVCPFVTINANSNIGDFVLCNIYSSIAHDCKVGEGSILSPYA
TLNGNSSIGKNCFLATRVSLLPCVNLEDNCIVSR
>fig|195.2162.peg.1078 hypothetical protein
MNEKIINICQVLNAKEKDISQLKNEILDGFLEYWKKDLDSGFISKKESATILKNLKTLNS
LKIDIKDFNKELIRGILNGEYEFSGSDIIKKANIKDFFSFFSELNFSDKKKVYIDCDEIT
PIFIKDLLKQYNWNYKDLANNIGAVDTTIRNWVSTGNIPEWAKKSISYIVTIEKLKRKEE
YLKNDLDEVRNSISFLINFANEKDDYDE
>fig|195.2163.peg.1828 Diaminopimelate decarboxylase (EC 4.1.1.20)
FHIGSQLLDISPIHEAAAIVAKLVRELKALQIELKFFDIGGGLGVRYEKEDVEPDLYDYA
QGILAQLHGLDVTIGMEPGRFLVANSGE
>fig|195.2163.peg.1518 Putative outer membrane siderophore receptor
MKKLSLFCVMGLCFANFAFSEELEFDSLEISGSKIKNDEKPFLQTYKIL
>fig|195.2163.peg.471 hypothetical protein
MKIDTSASLTHSLTNNVDKKELSVLKKEDQDKIPVQDLSSLNSDGVKVVFENKQGELIAL
NLSDENYSSLQKNFSSYTNYVTRNDGSIRLNGEANEFIANWFENIEDNFNSLSSNLSSNT
QDKNIKLNFHTNTITQSMQNLGFKSNDEKIPNDASMEKKLNFFIDKDRDKNGKIDDNDVK
EPSMGEILNDISKISGRANAMQTIDPQKIYKKDDSGVTIKEKDEKDDKDLLEIAKEKGLS
ALSADEQAKLKASNPQIFEELQNKSLGNLEQNLKKDLMVQISNNEAIFVVGGKIKCRKRK
IKCRIFATNYLSFNLKLKL
>fig|195.2163.peg.1790 Tripartite tricarboxylate transporter TctA family
MAAPEAANNASACGSFIPMLTLGLPGSGTTAVMMGALTLYNITPGPTMFTDQVNIVWGLI
ASLLFANVILLLMNLPLVGIFVKILSIPMWSLAPIIAIVSIIGVYSINSTDFDIILILII
GILGYFLRKLEFPMAPLILGFVLGEQLETNLRRALSISNGDFSILWSGIIAQSLLIGAVL
IILIPLLIKKIRKSKF
>fig|195.2163.peg.1843 1-deoxy-D-xylulose 5-phosphate synthase (EC 2.2.1.7)
FKPFIAIYSTFLQRAYDQVIHDCAIMNLNVVFAMDRAGIVGEDGETHQGAFDVSFLAPLP
NLTLIAPRDELMMKNIMEYA
>fig|195.2163.peg.905 Beta-1,3-glucosyltransferase
MVLNFKKLRKLRTNPKLFFKDAIEKKVFWLSGVYNKYLPKKHKGFTQYTIISAVYNVEKY
LDDYFNSIINQRLDFKKNIFMVLVDDGSTDNSANIIKKYQKKYPKNIVYIYKENGGQASA
RNLGLKYMQENNYKAPWVTFTDPDDFLDRNYFYKVDKFLSAHQDDDICMIGCNVIFYHEK
QKLYKDNHALNFKFKNGIQVKENCNLDNFIQLFTNSSFINTNYLAKHIRFDKKLKPNFED
AKFINEYLLKNI
>fig|195.2163.peg.1489 DNA primase (EC 2.7.7.-)
MNLFLLKNEKDEEKLEALFKNLHRFFSAKNLDIKILKNNSENDYNEEPF
>fig|195.2163.peg.1741 Propionate--CoA ligase (EC 6.2.1.17)
EYKVNVLFSAPTAFRAIKKEDPKGEWIKKFNLDSLRSIFVAGERCDSDTLKWIEKLTKKP
VIDNWWQTETGWAIAANPLGLEAQVVKAGSPTKPMPGFNLKVLDEKGQELGAGKKGILCL
KLPLPPACLMGIWENDERYRRGYLDQFPGYYLTGDTGYIDKDGYVYVLGRMDGIINVAGH
RLSTGEMEEIIAKHPDVAECAVIGVNDELKGEIPMGFIVLKEGIERDHRGIVEGVVALVR
QEIGAVASFKIATVVSALPKTRSGKILRKNLREIADGSTLNVPATIEDSNVLKACEKAIN
ALGYPKNKGEK
>fig|195.2163.peg.1831 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase II (EC 2.5.1.54)
QMAIVLTFAGGCPVVKIGRMAGQFAKPRSSDYEEINGVKLPRYRGDIINGFEFNEKARIP
DPNRMLEAYYQSATTLNLLRGFAK
>fig|195.2163.peg.1791 hypothetical protein
MKYNYIKWNKEEKCAIFFPDIDYSLWKKTQLKENAYNNPSLIISSCLITKMDILELFEYY
ILFICGKSMGVSRWECNNLILLGTCNIDNLSNPFSLNTPKPTYISEYINILGQLFLAGYI
DFGSYCDEEDRNKIDYPSNLSYYKEDKYQAWIYFRDNFFYQDKFIRDLDDPETLDEGGYS
LILNDVSWDTPQYWSQYNIWVATTPKGTKYFNEILAPKFYNKYKDLEVEIDDKGL
>fig|195.2163.peg.1062 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase II (EC 2.5.1.54)
MTWTKNSWKNFSIKQQPIYSNQEELNKVLNKLEKLPPLVFAGEVRELQSALARVCRKEAF
LLQGGDCAESFANFGAVNIRDMFKILLQMAIVLTFAGGCPVVKIGRMAGQFAKPRSSDYE
EINGVKLP
>fig|195.2163.peg.1842 Hemerythrin domain protein
MNQNFEKFNAIFEDALQNHHFTTQKNDMGGGGIDEFSSKNLRNFQSFRKFKSRTSKHRTN
S
>fig|195.2163.peg.1851 Signal transduction histidine kinase CheA
QNTAASTTSKPAASTPKAENMEKKVPASGGGGGGMDQTIRVAGKRLDHLMNTIGEPVFGK
NRLLKI
>fig|195.2163.peg.1862 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
NEARDKKEKKVMIIGGGPNRIGQGIEIDYACVHASFALKDLGVKTIMYNCNPETVSTDYD
TSDILYFE
>fig|195.2163.peg.1131 DNA recombination and repair protein RecF
MIDNIKIQNYKLIKELEIDKFKNINIFTGENNCGKSSILEAIYLLLSQDYIKNFIYSYDV
FRNFPLNKKNIQFVFNNFDLNKKINIFTRLNKDILLSLKISLMQSSIVSISDNLNENKDI
TIHFNHKCQKNEQENILTIREIKNIEEKTGVVERQYQAKEYVNKSNAIY
>fig|195.2163.peg.1732 hypothetical protein
MKKIFLFLTILSFMWAQDDVIIYDYVPLEDVNLSSLDPVQSLKTLPHQRNKFQKVVQGNG
TGESKEEALNNALIDALSQFKGVSNVNLRQELQSIDLSFSHLGQISQKSKSVLQNVSKGL
>fig|195.2163.peg.1819 Cytochrome d ubiquinol oxidase subunit I (EC 1.10.3.-)
MNELSSVDWSRAQFALTALYHFLFVPLTLGLSFIIAIMETIYVKTGNERWKKITKFWLSL
FAINFAIGVATGIIMEFEFGTNWANYSWFVGDIFGAPLAVE
>fig|195.2163.peg.1733 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
MPKRTDIKNILLIGSGPIVIGQACEFDYSGTQAAKTLKEQGYRVVLINSNPATIMTDPEF
ADATYIEPVTKESILSIIKKEKIDAILPTMGGQVALNVAMEVYESGLLGDVKFLGANPEA
IKKGEDRQVFKECMKKIGMDLSKSMYAYNYDEALKAVDEIGFPLMIRASYTLGGAGSGVV
YNMDEFKELANTALALSPIHEILIEESLLGWKEYEMEVIRDKNDNCIIVCSIENLDPMGV
HTGDSITVAPALTLTDKEYQVMRNASFAILREIGVDTGGSNVQFAVNPTNGRMIVIEMNP
RVSRSSALASKATGYPIAKVATLLAIGFSLDEIKNDITGTPASFEPVIDYIVTKIPRFTF
EKFPGANTTLGTAMKSVGEVMAIGRTFKESIQKALCSLERNLSGFDRVKFEDKNDLIFKI
RNANEKRLLYVAQAFREGFDVKELYELCKIDPWFLSQIKEIVDFEEQIDMDILHNKTLLR
KAKTMGFSDKMIALLVNLKDNLELSQNDIYYARMKQKIIAEFSEVDTCAGEFEALTPYLY
SSINVSELTQSKNEARDKKEKKVMIIGGGPNRIGQGIEFDYACVHASFALKDLGVKTIMY
NCNPETVSTDYDTSDILYFEPIDFEHLRGVIEREKPD
>fig|195.2163.peg.1458 probable periplasmic protein Cj0093 , putative
MYQNDNKPKLVILNDKNKEESYLKRALYDAFSQDENFTLLEREHDFKDENKIIKSEDGSR
EESYKLGNVLGADYILEFEILDITQAKQSKISYQNNTKVSINIAYKLIFYPTRELVFSKT
FNTTFTLSGDSKKEQKNWENIALFMQREMEKSLFFDTLEEDNKQEGKENTYKLHENGGVN
LGF
>fig|195.2163.peg.1753 1-deoxy-D-xylulose 5-phosphate synthase (EC 2.2.1.7)
MNEIIKKDYQFAYTKEELEKLNLTQLEDLAARIREKIIDVVSKNGGHLSSNLGAVELTIA
MHTVFDNGIDPLIFDVSHQSYTHKLLSGKENVFESLRQFGGLSGYTKPNDGDYFVAGHSS
TSISLAVGACKAIALKGEKRTPVALIGDGALSAGMAYEALNELGDSKFPCVVILNDNEMS
ISKPIGAISKYLSQAMATQFYQNFKKRVAKMLDALPDSATYMAKRFEESFKLITPGLLFE
ELGLEYIGPIDGHNLSEVISALKQAKAMQKPCIVHAQTLKGKGYSLAEGKNAKWHGVSAF
DVDSGESIKKPDAKNSATEIFSKALFDLATKYKNIVGITAAMPSGTGLEKLIEHYPNRFW
DVGIAEQHAVTSMAAMAKE
>fig|195.2163.peg.304 hypothetical protein
MDKNAKHPRWMHIDGVSYDEAYVKIFHTSKSIDEFKEKYLKLQKKYFVDFNNIDSSQKKL
QETSEEDKEKPFKPIQAESKSETYKDDNKMNELLRKLLETKFGTSDELEILFGMKFSDDD
AGEFNKILSLNSAPKSVDIKA
>fig|195.2163.peg.1694 Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) in lipid-linked oligosaccharide synthesis cluster
MKIGIFPITTYSQLDDFIPRVVWYLYPFRDWFSICNLYVSFKVKKKNKCLEHFDQIIYRN
FKHMNISYVSNSNIFDFSFLFGLDYIFLTNDLMFRELSIFKKKYNLSIEIIRIDHERLS
>fig|195.2163.peg.1786 1-deoxy-D-xylulose 5-phosphate synthase (EC 2.2.1.7)
TAAMPSGTGLEKLIEHYPNRFWDVGIAEQHAVTSMAAMAKEGFKPFIAIYSTFLQRAYDQ
VIHDCAIMNLNVVFAMDRAGIVGEDGETHQGAFDVSFLAPLPNLTLIAPRDELMMKNIME
YAYTHEGCLAFRYPRGSFILDEEFNPTKIELGKAQWLVKNQSNIAFLGYGQGVGKAWKVL
RKLQDEGQNANLIDLIFAKPLDKLLLKELAKQSQIWFVFSENARIGGVASLLESFVQEND
LKIKIVSFEYEDSFIEHGKTNEVEKALKLDIDGLVQRVKINWVDNIL
>fig|195.2163.peg.303 hypothetical protein
MIVFPLSSFNRYFGNNPLQTLTKIRDESIENGNPELAKKQREELGNDLIDLYKISKKFSD
KIELVEGSIGR
>fig|195.2164.peg.1815 ATP-dependent zinc metalloprotease HP0286
EFGVKMPKGVLMVGPPGVGKTLIAKAVAGEAGGPFFYQSGSRFVEIYVGMGAKRVRELFS
RAKMMAPSIIFIDEI
>fig|195.2164.peg.327 TrkA domain protein HP0282
MNHILIIIDGILAKHFLERLCFEKGLGYFFTIVCQNEENINLGANSEYIEFHHFDPTSTA
RLETLMNKSFKQAFIYMQDEFETKKTYEALRSLDANLEIEIMDFWGLNINDVHTNLADAR
MTLSRRFMDFLPDIALTAYCVGLGVGEVMEVKIPAGSIFAYRHISSIQQKRWRIVLIYRN
SKIYFVKPSFVLQPNDSILIVGDPAVLQSIFHNIRGKAGQFPLPFGSNIFTLIDMKKMSE
DTQERLLDTTLQLVKKSNAKKFFIRVLNPKLGALYDKMKQLSDEQESIFFDFFNTDFANL
NSFLENNDIGII
>fig|195.2164.peg.1810 Protein translocase subunit SecD
ERIGGGSGQISGAFTQEEARDVAVALRSGALLAPGKLLEQRSIGPSLGADSIKMSMIALI
GASIFIVGFMVLYYGMA
>fig|195.2164.peg.1769 RloF
SIYSKKATSGNDEKIVKFLLFNIERHLSGGICDEQIATIEHILPSSLNDEKVHKLGNYIL
LEAKYNQQLKNKNFKEKIDIYSKSNFKLAQYVAENFKTWDTKSIDQYQNFLAKQALALWK
F
>fig|195.2164.peg.1770 McrBC restriction endonuclease system, McrB subunit, putative
INRDDFDTFQINSIELLKNLLFELKKGLLQEYNNKSGNGCPHACINSHYLEFVKYVNAYK
EYTSKDMVKYLKTRGGEKEFKVEVKNQKIKVNDNRSYSLDKFLKYIELYKTYETSSYAKP
LFEDILNNSNLSIIKLRENEKMLSENQNLSLNQILYGPPGTGKTYHTIDKALEILGENLE
SRDEKKAKFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPNIDSEEGNFKDIEYKIKPGIFK
KVCERALENEDNIKDFNFHIDKLKEIVKEDGNDPEKYFKLPNTKYSIQYRGGKTFRIKFD
DMSKNHKDYPVSIENIIKLYKTSSINEIYNSAYVKAILNYLKTQGLKDYQEKDEKINLPY
IIIIDEINRGNISKIFGELITLIEPSKRIGEKEELKVRLPYSGDEFGVPKNVYILGTMNT
ADRSITSLDTALRRRFEFIEMMPDVGKLSNNCEGVDLQKLLEVINARIEYLLDREKTIGH
AFFIGVENLEDLKKVFQNKIIPLLQEYFYNDYALINAVLNDNGILEKQDINSNYLKSITE
FIESDKVIYKFSDSKDWEGETFIKIYENDKQ
>fig|195.2164.peg.1669 hypothetical protein
MGNSFLNTETLTLNDLFSKDRTYSVPKYQRNYSWDEDQWEDLWSDIEDLEKSNYPHFMGS
IVLQETKDVKNIDIIDGQQRLSTLSIFIAAVIVYIDDLVKKDKDKINNEKRKEIFNKKYL
GYESSTTLKIVPKLTLNKTNNNFFTTYIINQNIPDKPTLADADKSNLLLHKAFDFFQKKI
KEKFQEEDGKKIAEYVEMIGEQLKFIVIIVQNELDAYVLFQTLNARGAELTAADLLKNYF
LSLLKNDSEALEQANSIWEDINNKISTEKIPDFLRSVVNFQTDLVTKNRLFKEVRKNIKT
SEEAFSFISKLHNLSSLYLALQNSNHNSWNEFSQKDAKYYINILELLRFKSSLPLLLIAK
EKIINDQEFTKILKACAVLSIRYSISKTRTNKLESNYNKIACNIFYDKYKNANEIIKALK
LIDIDDND
>fig|195.2164.peg.1701 TrkA domain protein HP0282
DIGIILTDFKHFEQEKKTFFELKIPILKIGEGKFENIQNAVILSTNETELENNANVITDL
SKQLDFDITLYYYNPNLQNTTDMEEYFGSLSKLYDKNIQIISKNDENPILSLSYRADLLQ
FVSFEKELLEGEFSKSLSTNLNRHYSKMRQNYQLFIPVE
>fig|195.2164.peg.1459 ATP/GTP-binding protein
MTFKDGEIYALSKNHNVIAVIDPVKEEVVKTIAFPSSITNARSIFFKDGKINILSYQDGA
NKLYTLN
>fig|195.2164.peg.1722 Pyruvate-flavodoxin oxidoreductase
MGKIMKTMDGNEAAAYAAYAFTEVAGIYPITPSSPMADYTDMWAAAGKKNLFGVPVKIVE
MQSEAGAA
>fig|195.2164.peg.1796 Motility accessory factor
FYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSNELQSARLMVLQTSSLDI
EFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDILGLNKKLAENFKNSIVSYGNDPLDA
LQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIF
CADSSYPILAKHDIKPDYVCMLERDEIVAECFNNDFGEFDKDIVFIVKSVTHPHTIKYLQ
KNNRAFILVSTYASFIQYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILIGQDLAYAK
DGQTHSQGFIHANLHNGDYERDLDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMN
YHITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEP
>fig|195.2164.peg.1776 hypothetical protein
NKLYKFVLENNKLIYDYIDFINNNFANEHFIKIKYKRKKYKIINIASFLLYHKLKPQKES
YQNEFLEIYILINDYIKLSYETNNLINLNINSINRITNEHNVLTIELEKKQIPKNKKLKI
KEDFINLKLPEEFKLIETHKELYLHGMEQKNCVYTRRREIEDGLSAIYSLNYEGGVYTLE
IFKRKNKFAIKEIKAKYNEFANKEVINFVEKSLKAV
>fig|195.2164.peg.1740 Putative two-component sensor histidine kinase
IGAGLYISKQIVESFGGKIQVKNIKDGACFEIYLKLQEGN
>fig|195.2165.peg.1746 Signal recognition particle receptor FtsY
AGAIEQLRLWSEKVGVDIVLTQQGHDPSAVAFDTISKARAKGFDKVIIDTAGRLQNQKNL
ANELEKIVRISAKAMPHAPHRKILVLDGTQGNAG
>fig|195.2165.peg.67 Aminotransferase
MINFLDLRKINTRFENEIKDKINEVINSGWYILGEQNKIFEENFSAYCGVKGCVGVANGL
DALRLIIKAYGFSNEDEIIVPANT
>fig|195.2165.peg.1515 Hemerythrin domain protein
MLPKWDSSFSVHNAKIDDQHKKLFELAAKVEIVSDRSVSKNEVKELLAEFFNYMKDHFND
EEKYMQLIAYPAFEEHKKFIKKSYKL
>fig|195.2165.peg.1756 Methylisocitrate lyase (EC 4.1.3.30)
PLIIVGAVNAYSALQATKIGHKALYLSGSGVASASYGLPGLGVIALEEGCIDVRRICSRV
GTPFFVDADTGFGGAFN
>fig|195.2165.peg.763 hypothetical protein
MFKKLLSVVALGTLLSSSAFAEDILAKVSNGAISDNSAGVKVLSLDEMKEVKGGYYFKRD
SAFDYGAGSLSSYGYVVMNDSFHQDSNAVTQSLGYSSGYIVAKYRYVNNQKDYYL
>fig|195.2165.peg.68 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase (EC 2.6.1.90)
MVVHLYGLATDMSKIQKIAKKYNLKIIEDCAQAHGAVYDKKRVGNLGDAAAFSFYPGKNL
GALGDGGCVVSNDEKLILKIRALANYGSHKKYENLYTGLNSRLDEIQAGILDIKLKYLDE
DNRKRRKIAKYYLENIKHKDIILPFYEEEENHVWHLFVIRTKNRNDLQEYLMKNGVQTLI
HYPIPPHKQECYKEYNHLNFPITEQIHVEVLSLPISPVMTQDEISETAKIINSWKKL
>fig|195.2165.peg.1191 hypothetical protein
MNISVLLPMKGHSERVKNKNMKDFNGFPLYHAIVRTLLKSSYVNKIFINTDSDIIASDAK
KSFGDGIVIIKRPLEIQGDFVSMNDIIAYDLTQCDGEYFLQTHSTNPLLKTSTIDLAIKK
FFDNLDLYDSLFCYKSAD
>fig|195.2165.peg.1752 hypothetical protein
MHKDPPQKNPIDFANIKSSLIHQYFLYQDKLHLLAIKDCILCFLE
>fig|195.2165.peg.1735 Motility accessory factor
MDGKGEKVREENNFNKNLKALSGFEYNNLRKKLKDLKELREFTFTQGKDNLDINIIKKSN
LKKMYQDPIKELEKDLEYFKDFTRYPVLFFMVLEMEFYIKFYFKIKYLKE
>fig|195.2165.peg.1758 Flagellin
RLSLVKNDGKNNLVSGTGLTAAGFGANSFISQASISLRESKGQLDANIADAMGFGSVNKG
VAIGGFSTVTAYMSSE
>fig|195.2165.peg.917 methyl-accepting chemotaxis protein, putative
MEDIAKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIIKN
>fig|195.2165.peg.1598 Phosphoglycerate transporter protein PgtP
KIFKGYRMPPAIGAMVIIFFMIIGYFTSNNLYMVTFFAAMAGCLVYIPQFLASVQTMEVV
PAFAVGSCVGLRGFMSYVVGTSLGTKAIGWAVDYYGSWNAGLIMLLSACILCILCSILCH
FGAKKKEDICKK
>fig|195.2165.peg.1754 1-deoxy-D-xylulose 5-phosphate synthase (EC 2.2.1.7)
TAAMPSGTGLEKLIEHYPNRFWDVGIAEQHAVTSMAAMAKEGFKPFFALYSTFLQRAYDQ
VIHDCAIMNLNVVFAMDRA
>fig|195.2165.peg.167 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MMGGGYELNSILENLQKLESKLDFNLLLSLIEEQISHSEVLVEETQSKERKQDFNAFKNF
SKTIQELLQTLSTPPKDGWKRISLKNEQYIELNPSKKEISKLDENMLVSFIEMASVSDKG
YIQSKIDRSLNEVRKGYTYFIENDILIAKITPCMENGKCAIAKNLTNNIGFGSTEFHIFR
AKTGLDSSFLFYNLNQQNIREKAALAMTGASGHKRVPISFYENLTIPLPPLEIQEKIVQN
IELVEQQIDFLNLKLELLEKEKEKILQKYLFS
>fig|195.2165.peg.1182 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MYYLIKDKHKQEQKNYQEKIKKDPSLKLPPLENYPDYKEALKEKECLTYKLGEALIKANK
TWYKGGYVKMWFEIGKLRKRYREREKK
>fig|195.2165.peg.1747 Flagellin
FSAGSNLSQFATMKTTAFGVKDETAGVTTLKGAMAVMDIAETAITNLDQIRADIGSVQNQ
LQVTINNITVTQVNVKAAESTIRDVD
>fig|195.2165.peg.1745 Methylisocitrate lyase (EC 4.1.3.30)
ELVKTSKPLIIVGAVNAYSALQATKIGHKALYLSGSGVASASYGLPDLGIIALEEVCIDV
RRICSRVDTPLLVDADTGFGGAFNIARTIKELIRAGAA
>fig|195.2165.peg.916 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILMIL
>fig|195.2165.peg.1738 Motility accessory factor
LDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYANKA
TIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNHDFGEFDKDIVFVCAGVVHPKAIE
YLKGRNRKYLIIPRYLYFPIYIKLKYFDFLYNTPSVAHMACYLSLHLNHKNIIFIGQDLA
YAENGNSHPDDYQNSANYESQMYEHILTEAYGGKKEIKTHEVWIFFKQILEAMIIKYHIT
TYNCTEGGARIEGTIEKPFLWACENLLHKDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKS
IKHCRDFSKILSNDFNNIQNIYLNLNKKENDLNLAIRKIDEFKNKLENIKQMQDLYEILQ
PLRTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGH
>fig|195.2165.peg.1514 Hemerythrin domain protein
MINLIKDIKSTNDLKEKLYIIAKKWLLEHILYEDMKVEKWRSSSLATDEGKDVSFEAADD
SDDDKPQFYLYKCNCPGKVHDVPYGIHQKIELQGHKFTCKICKQAITFFQKHS
>fig|195.2165.peg.1190 hypothetical protein
MIAYFVTKVQTRFYDKNAKAINHNPQKLLRTQDLEPMYEENSNFYIFSKKSFELAGKKRI
GLKPQIFSMNKLEAVDIDNPEDFILAELLYKNRSII
>fig|195.2166.peg.1833 Cysteine desulfurase (EC 2.8.1.7)
PGWLRISLHYTHEKEDIDYFFEALQKSIAKLKF
>fig|195.2166.peg.1761 3-isopropylmalate dehydrogenase (EC 1.1.1.85)
YESLRHASPLKDEIIQKGVDILCVRELTGGIYFGKQELGKESAYDTEIYTKAEIERITRL
AFESARIRNKKVHLVDKANVLASSILWRDVVGQIAKEYEDIKLEYMYVDNAAMQIIKNPS
TFDVMLCSNLFGDILSDELAAISGSLGLLCSASLNDKGFGLYEPAGGSAPDIAHLNIANP
IAQILSAALMLKYSFKEEKAARDIENTIAIALERGKMTKDLNAKSYLNTDEMGDCILEIL
KENNND
>fig|195.2166.peg.1781 hypothetical protein
LLSDQKHKEIIEALGLVDNFILLSAKQIAPVKVL
>fig|195.2166.peg.1817 hypothetical protein
LKELLEIKKEMEPVIHEANVKLNVLAREVIVRRKEYEIYGPMGDRVYLDNAIYVKVMASG
RDVKTDNVPIKTGFYMVFVAPEKES
>fig|195.2166.peg.1788 hypothetical protein
MKEATMTQVFKNSNSIQVKEQKNKENHFNLMLQLSLTLN
>fig|195.2166.peg.1815 mobilization protein
QTHYHAHAVFFTLDNNGLQLARREASLNKANLSKIQTLTAQSLKMERGANRYENNEKQPQ
YIQDYKTYAQFKEQEKALLQRIQE
>fig|195.2166.peg.691 hypothetical protein
MKKNASSKILLSLGVATLLYSGAFAAEITFNSDSDLNTHFDINEKDNVATFKNENYKNQD
LTFKINTLAFDDAHEDAKINIDLGNNSLTLENTRNSGGETAALVRNFNVDAKDFKTTDIG
LSYFNAGIINANFTMVGSGEDFDLDNIDKNKASSLLIFNGSRENTNDTVNGSLTVNGDFS
ATNSAIVSMKSDTFKVNGTATIEKSGLGFLSQSYSNLDANDFIVLRAKDIKTDKLNDETN
AGALILKSGSSYIDESLLNGDDSIASLDVTAEDNKYGGVFVDYKLSLKNCGGDKCLVING
GATAAAKKLTNQIAVDLEAITRIIDDLDNEQAKEALQEQKTELEKLQQEAMQNGGKIDDE
KYIDLVNKNLNLNLSANDKASILALRSITEQLGSIGADLASREGVKLALDIKKDTDNTGK
SVSNLNSASSAVNTTMNISNDVSIGSRVAMLNNPFGTYASKMNGLKFAALDSDMRPSYVN
EYTNSVWANAFGGANIIDGDSGAMYGATVGVDKQANDDVL
>fig|195.2166.peg.1809 hypothetical protein
LKMERGANRYENNEKQPQYIQDYKTYAQFKEQEKALLQRIQEQEHKLTQMALELKKKEKE
IQDKAKELKSKENELQAKIEQHEKHIQNLELGHERALKELTQEFENRLSLWKNILTFGKY
NAKVREDYQLTKNAFLISTNESKREANKELEYLKFEYHKVKDERDNLKTLFEAHKTKNDK
LENRLKEIGKWCEQNLSLEQLKEIFPKKAESIEKELKYKRAFESAFERSETQRNNRGFGL
SR
>fig|195.2166.peg.1387 MmgE/PrpD family protein, putative
MCYCFKNDGLKANEIQSIHCFVDEVPISFICDPLEAKYTPNSAYEAKFSMPFLMALGFFN
GKITLESYENLKREEVLEFAKKISYEKRKSQGFPKYFPGHLEASLQDGRTIQKDVFINKG
NFDNPLSFEELKAKFLANAQIYLDNAKANKILDQIINLENLNHFSF
>fig|195.2166.peg.1600 hypothetical protein
IYNTRKDKIIYLDLQSDVEKYKRE
>fig|195.2166.peg.1588 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKNALKIFSFLLLFFLAYVFYVYFSFDKNTLLDDFKSRYSKILYDKNGEILSVFLNDEEQ
WHIKSTDIPKRLKVAVINYEDRKFYSHFGVDFLALMRAFVNNFNSTQRSGASTISMQTIK
LWDKKDRTYFNKFNEIIQSLALENAFSKDEILKLYLSNAPYGGNLIGYEAAILFYFDGSV
TTNG
>fig|195.2166.peg.1821 hypothetical protein
NNEKQPQYIQDYKTYAQFKEQEKALLQRIQEQEQKLTQMALEMKKKEKEIQDKAKEQKSK
ENELQAKIEQHEKHIQN
>fig|195.2166.peg.1835 mobilization protein
LKMERGANRYENNEKQPQYIQDYKTYAQFKEQEKALLQRIQEQEHKLTQMALELKKKEKE
IQDKAKE
>fig|195.2166.peg.1162 hypothetical protein
MLRVGIIGFGPRGLSILERLVSKKLGQIINDKLEIYIFDPNSLGSGCHSPKQSSRLLVNT
VASQMTIFADETICPNEFFIKGPNFYEFLLSKGYKADKNGYYSRVLLGKYLEHSFQCILK
LCSQDISIHIVKEYAQCIIQQEKYFIISGENTKIEVDSAFITTGHNQNQNNFPMYSAYPL
EISTQNISANDAIGIKGLGLSAIDVITMLTSGNGGFFEKLNNELIYNPSGKEPKIFVFSR
SNLPLMARAITQKETREQYQAIFFNSTTIKKLKKEFKKLNFEKQILPLIIKEMEYVYSYT
YINLKSQEDSFLFRNEYLTSIDTQSVLDKYIPKCDQFNFYSLVNPLQKIIDKQDFYSQLI
TYLENDIKEARLGNLKSPIKSACDVLRDVRDNLRLCVDFGGLDEESYKFFIHSFVPINNR
LCVGPPLVKIEELLALIKANVVNVLHDVTIKHIENTQFQLVDSFNNSYCVNRLIDARINE
IKINDNALFQSLIANNLATKFNYGNLELECLKIDENFCSINKDNKTIDRLFILGLPTEGI
KFYTFILPRPHIASTFLCDSNKAVDSLIKRTQA
>fig|195.2166.peg.1828 hypothetical protein
EQNLSLEQLKEIFPKKAESIEKELKYKRAFERAFERSETQRNNRGFGLSR
>fig|195.2166.peg.1778 hypothetical protein
MQINSSYNNAYYTQKNFSADQSIKKTENVKEDEKISTYKDVRDRVWEDYLNGKIDQDTFI
TANAAFFTASLVEASKDGFQGNPFGEMKRIQQERLKADTSSKVKAEIYKDIYIIDNYFDV
LAPGVTQEENQRINNKTKDFLFEILQDIKV
>fig|195.2166.peg.381 hypothetical protein
MSIFSINDNSNYNSILSQAKANKESKENSKISFANAFLKQNASKLNEIQNANSQTLARSE
VLSNNNALNNSSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQADIST
STNTAYGYSVDKDGYMGSDFNKAAGLPEDFKIHKSTLDEIERKAENNSYTSDIKKYLGID
KYYTNIDMAETIKQYYNQFNQIVNHTFNDTNKTSFTETDINSMPKGISELSSDKTIGIMP
KNYDKLTITNYYNTQERYNEAEQLGMFGHINIGLQPLNFTPQSMQTQNLDKDTAIDTFNP
DMSVYPQNEDGSYSKEALFMSFLKSTGVLPREGSATLNPIAKSYAEAMAKESFDGSLTSL
DDIMTGKVDFASLLKGYAQDGWLDADIYAMDKGVAWQNTSIGYGGAWFDNQFNQAKANGW
KASNQSIDSYVNSIMDRLNNLLGQTRV
>fig|195.2166.peg.1803 Motility accessory factor
LENDKLQTQDYNELCSFKPFFQFSRIYFLELMSHYYERFHEDVLELNKKLVQYFKDSIIS
HGNDSTDTLQGIEQFVYNLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLLKK
YASKATIFCADSAYPILAKHDIKPDYVLSLERIPLTSEFFNNDFGEFDRDVLFVCVSWVY
PQTIKYLQKNNRNFMLISRPSDFIKNINFHQYGYVGYGPSVAHMAYEFATHLNYKNIIFI
GQDLAYAKDGFSHTKDYSNLDKHEGHFQRDKGKFQCLAYGGNGKVESSGIWTMFRFSLQN
TISRNIISTTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLL
KAYYKVYQSIKHCRDFNKILSNDFENIQSIYLSLNEKEEDINLAIEKIDEFKNKLEDIKQ
MQDLYDILQSLFIQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHI
>fig|195.2166.peg.724 Formerly called adenylosuccinate lyase (similar to archaeal version), but most likely something else
MRAVFCEENRVQKWLDVEAALAKVQAKLNIIPQEAADEIAKKAYYKFMDMDFIFNEFKKT
KHPLVPTVRGLEKACDNNLGEYVHFGVTTQDIIDTGLVLQFKEAMTLVKSELKAIAKALA
KLAKTHKNTAMMGRTLALQALPITFGHKVAIWLSELDRHFERILELEKRLYVGSIVGAVG
TKASLGDECNEVEKLTLENLGLDVPNISWQSARDRFIELGFVLGNINATFNKIAHEILIL
SHNEIDEVAEPFGKGQVGSSTMPHKRNPAVSENAVTVSNAFKANLAILSDIERHEHERDG
QVWKMEWKLLPEMFLMLSVVLANMKFALSDLEVKKDKMLKNLALSQQMVDF
>fig|195.2166.peg.540 hypothetical protein
MMKKSVKILLSVATFAYDPYTCSLQNLINPGSCNPNLVSNDEYAC
>fig|195.2166.peg.1779 Initiator RepB protein family
MAKNTDIVELKEGFTRNQSNVSNAIANARTKMTALELKTFYQVSTLIQMDDTEFKEYEIS
VSDFLKALNISDSNREQVVKLCRRLIRQVFEINQENGDYIGYTIFSRMHYKHKEQKISMK
FNEEFRPFLLELKQFTKIQQVKYIKSFDSKYSIRFYALLKDYRKMSQRDFNLENIFNIFE
LPKTYNYTRFYQKVLKPAIDEINAKSDLWVSEPEIIGKKGKKITDIRLYFGNKNEKMSDD
FTKELIKQYNKFKSFNVFANCRYLANGLNTINDLMKITRISTEKNTYFRAYHSNGFGEES
CIIGTPNKDDFLQELANGIYRAINLIYEKEKKEQLPTMQWQDEKDKINRFKSILAEWREN
SPYAR
>fig|195.2166.peg.1660 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
LNQLQSKLSFQTQYGTAKSRIQNQLSYKLGQAMIINSKSLLGYLIMPMILLNIIISHKQA
QKAYKLKIKKNPNLALPPLESYPDYKEALKEKECLTYKLGEALIKASNNWYGGGYIKLWF
EIRKLKREGRKVRK
>fig|195.2166.peg.1287 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MLAILPNQPGLINLEKNKTKLLDKRNKLLAKLYERKLINKDIYELSLKEPLPNFKPRKNI
APHLALRLLSDDNKEIFSSIDKKIQLKIEKKAKEFSYTLQQKGIQNLAIILADTKTRKVL
AYVGSQDFYDMANLGQINGNIAKRSVGSTLKPFLYALSIDEGIIAPDSILLDVPTFFSNF
NPQNANKKYYGIISAKEALQRSLNVPFVSLLQDYGYEKFFYKLKAFLNFEDENYKRYGLS
LILGTKELSLEDLIKLYLGLANYGELANLSFIRDENLSGVARMFSKGSAYLTLEAMKELQ
RVGLENYNKEKIISWKTGTSYGRKDAWAMGATPKYTLGVWVGNFSGEANANLYGVSIAGD
LLFEILGLLDEVDLEFAPPDDLMTIKLDSISKYRYDEDLNTSYINVLYPKGANILRTSPF
LKKVYEYQGRELDSKDIHFKDAKALIKLDFPAYALHFFQQRNFKFSNKKGVKIIYPKDNL
KLILAKDLNGMKGLVAKVANLNNEKLFWYLNQKLIYEGDENTQNLNLKEGKYQLFIISQS
GEQDTVWFEIK
>fig|195.2166.peg.1385 Formerly called adenylosuccinate lyase (similar to archaeal version), but most likely something else
MFALSDHYGKQHAHEIVYENAMLGIEKQKTFKEVLLADKRVSKVLKEKEIDALLDATTYV
GYAPKLVDEFLAKIKNSAILK
>fig|195.2166.peg.175 FIG015287: Zinc protease
MEEIRVKRGLAYSAYAMLDMNASFTRVFGYLQTKNESAKEAKKIVKEVFRDFVKEGVSQN
ELVQAKNFLIGSTPLRYESLSRRLSISFNEYYQGLPKGYYKEELKLIEKVELQELNAYIQ
KHNEILDLNFASIANEN
>fig|195.2166.peg.1551 Putative periplasmic protein
NKEYFEFFYALGLIEDEESKDVNFKNSNFKMLKILKENSFKARLEFSYRCTECKSVMPLF
FYHCPVCYEFNTCQIIYEVKNNETY
>fig|195.2166.peg.1834 hypothetical protein
QTHYHAHAVFFTLDNNGLQLARREASLNKANLSKIQTLTAQSLKMERGANRYENNEKQPQ
YIQDYK
>fig|195.2166.peg.1789 hypothetical protein
MLKELLEIKKEMEPVIHEANVKLNVLAREVIVRRKEYEIYGPM
>fig|195.2166.peg.1820 Pyruvate carboxylase subunit A (EC 6.4.1.1)
TRIQVEHPVTEEITGVDLIVRQIRIAGGEILDLEKRDIKARGFAIEARITAGKGWKNFIP
SPGKIGEYYPALGPSVRV
>fig|195.2166.peg.1786 3-isopropylmalate dehydrogenase (EC 1.1.1.85)
MNTYKIAVLPGDGIGPSVMKEALKILNFVAQKHGFKLETKEAKIGGASIDAYGVALSDET
LKLCEQSDAILFGSVGGPKWDNLPIDQRPERASLLPLRKHFNLFANLRPCKIYESLRHAS
PLKDEIIQKGVDILCVRELTGGIYFGKQELGKE
>fig|195.2166.peg.176 FIG015287: Zinc protease
MQNLEVSGVKIPFIFEENNDFPIVILKLVFRNCGRSYDEIAGLAKMFARILNEGVDDSFF
KELEFKAVNLEASSGFESLEINLSCLKENFEFALKHLENLLLNPRFEEKILEKLKINALG
ELASKNSDFDYLAKNLLNSEIFECKEFQSPNDGDEKSIKQISLSDLESFYKKNINLSNLV
VILGGNLAQEKAKG
>fig|195.2166.peg.1511 Possible purine/pyrimidine phosphoribosyltransferase
INVIPLDDRVENLLYSHSAILAKYLKTEFIKPIFGALHAQNHLKYSGKSLKFRQDNKRKF
KLLKKINNPVILVDDIVSSGSSLLEAKQFLEKNKISVLFAVVLADAKV
>fig|195.2166.peg.1386 MmgE/PrpD family protein, putative
MFYSEILADFIFNLKYENIPNTVVQRAKELMLDSLGTAIAASKEECVLNAFKAFENLSTE
KNTPIWVNDQKLDPIYAAMLDGIASHALDFDDTHTEAILHASAILTPLCLSYGFHVSKDA
KKIIKAFIIGWEIAARVGIASKGTFHKRGFHTTAIAGIFGSVSASAILLDLNKEQIINAL
GLTGSFASGINEFLSNGSNSKVLHIANAIKNGIIVAHFAKNHMSGPLSIFEGRDNIFKCF
GIEEECDKTELNKALGEIWQTMQVSIKPYPSCHFTHGLIDCAIALKMMV
>fig|195.2166.peg.1775 mobilization protein
MSKVATAHCNPKKQPALNHNDRTNDNAKTITKELTHLNEYSCTSDEVRKNIERLYKKAYE
NFYKYCENKNGLAKSGKPKGLQNFTKKEKCYHEFIYEIGENTTMEQCQELTQKIAELTGF
TPLQVVIHRDEVSENAKGEKQTHYHAHAVFFTLDNNGLQLARREASLNKANLSKIQTLTA
Q
>fig|195.2166.peg.405 Fructose-1,6-bisphosphatase, type I (EC 3.1.3.11)
YRLRYSGAMVSDINQILLKGGGLFSYPATSDAPKGKLRAFFEVFPLAFIIEKAGGKTTNG
KNHSLLELDFDEIHATTPCFFGSKYEISELLKAYNE
>fig|195.2166.peg.1777 hypothetical protein
MVKNLISVAVASVLSCSIAFAADNASIEGKEKITRNGVSIYLEPNSPEKQSILNGDFDKA
IERMKKAYEANKNNKAMRAPAPPVTYADVVQVYSQQGGYEDLAEGQMVTRNDHGGDPFGA
VTGVLGYGGSTTDSATFAGNQARYIKDQPVDVNGDNIIDGWWLWWDISKPANSSGQFVYT
ARSMNAPGNTMTATIQIK
>fig|195.2166.peg.1811 Transposase
MPTIKDALDIIGKLTVAEQESLKTMLLSPAFVKSLNIEDFVAKERFANGRVCPLCGCIHV
VRNGHRKDGTQRYVCKDCGKSFVIATNSIVSGTRKDLSVWEQYIDCMMNGLSIRKTAVAC
GIHRNTAFLWRHKILDALQNMADDVTLDGIIEADETFFAISYKGNHSKSKTFAMPRKAHK
RGHSTHIRGLSQEK
>fig|195.2166.peg.1780 hypothetical protein
MAKIDELKEELGILKFWLGITVATLLALIGWSATNYQKADWFLLVGAVICIFIAIGFLIV
INKKIKAKIKEIGKA
>fig|195.2166.peg.1806 hypothetical protein
STRDLHHIYDGRIKTNSTLVTDKMNSYVRFTNANGIDLVQLKTGKAKKGIYNIQHINSYH
SQLKRFMRGFNGVSTKYLNNYLVWNNLVNYAKESDMEKRNIFLTFVLATLKTAKCRDLSN
RPAVPLVA
>fig|195.2166.peg.109 Succinyl-CoA ligase [ADP-forming] beta chain (EC 6.2.1.5)
MNIHEYQAKAIFADNGIPTLKGKVAFSVEEAVENAKELGGSVWAVKAQIHAGGRGLGGGV
KIAKNLDEVKDYASKILGMNLVTHQTGPEGKLVQKLYIESG
>fig|195.2166.peg.864 Uncharacterized protein HP_1473
MKCLNCGVFTLLCFCHHCAEELSEFSLGVRELEKDFKVYSFYKYHEIKHLLHAKHKFYGY
FVFHFLAKLSFFKFKNFFSVNEQIN
>fig|195.2166.peg.1827 mobilization protein
LEYLKFEYHKVKDERDNLKTLFEAHKTKNDKLENRLKEIGKWSEQNLSLEQLKEIFPKKA
ESIEKELKYKRAFE
>fig|195.2166.peg.1818 hypothetical protein
SYIDESLLNGDDSIASLDVTAEDNKYGGVFVDYKLSLKNCGGDKCLVINGGATAAAKKLT
NQIAVDLEAITRIIDDLDNEQAK
>fig|195.2166.peg.1288 Transcription-repair coupling factor
MQANFFEYLQDSNIAQLVLCEDDKESFLLSQVALF
>fig|195.2166.peg.1512 hypothetical protein
FLSSVKKVANEKEVKDLGVFNIYRYKENVYCKHYQSEQLKDLLNNGIELRR
>fig|195.2166.peg.1796 FIG00470336: hypothetical protein
NNSEYRGFNFFIKDWIGLARQLSLKYPKFLFILLNFSTNSIQYNIDQNANLKVFCNNKIL
LLW
>fig|195.2166.peg.1616 rRNA small subunit 7-methylguanosine (m7G) methyltransferase GidB
MNLDFLNLILSDFNEEDFRAKLKIYKEILNKFNRIHNL
>fig|195.2166.peg.1192 hypothetical protein
MYACGQGVEKDLIKAKELSSKACEKDTKLCFAQGWVELFNQNDILAQKLFYKSCQAGYYT
DCNMAVDKNSKDQESY
>fig|195.2169.peg.1828 bacteriophage DNA transposition protein A, putative
DFIGFDLGKVKPLFSVKTLQNFIKNYYKDKPLEHCIITQGLDKAKSKFLPAQGNQRELYD
MKNMCWQIDSSPADFIVRDDETLEPFRP
>fig|195.2169.peg.1829 Flagellin
TGVEASIDANGQLLLTSREGRGIKIDGNIGGGAFINAKMKEKYGRLSLVKNDGKDILVSG
KGLTAAGFGGKRFIFQASFFLRETKG
>fig|195.2169.peg.1648 Integral membrane protein
NIHFNNSIFKDYADFHECEFEKTANFYRVRFDKTPNFSQAIFKGNLNAVNTNLNFTFDDL
QERIKQEYAFYETQRTAKEAGVIPNLYQEKSLDKFANDFRDSFRTFKNALIKDNNLLDAS
NFHKDELYCKEIELKESWNKLKKVDIDEDIDQNNKNYSKLMDFLLLGFYRKLCDHHTDFL
KVFNNLILLIALYALFVFGFTWLHDDKLEDTRAILTLFGFFDKFRLYFDIISTIFVVFGC
GFFVCKLDSYEKKNNVSKKQNINFIYIIGDFLNLIKSLLFASFIPCVFYVLFLLFGFFLN
LGKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFSYIGIIIILIKQPNVIHPLIGK
IANESDKFFNYPSLIVLNILYTILLALVLFSLQKTARKNSIVPS
>fig|195.2169.peg.221 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAELNFKTKAQNLKNLQTKLKKAKILPLVLTSLEELILNEEKILSDIQALKANKLIIRSS
SLSEDSMKNSNAGAFLSLANIDANSKDELLKALYKVANSMPSKSDEILIQPMLENITLCG
VGFR
>fig|195.2169.peg.1826 Motility accessory factor
GGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIKHCRD
FSKILSNDFEKIQSIYLSLNEKEEYLNLAIEKID
>fig|195.2169.peg.1835 tail fiber protein H, putative
LDSSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGVAANLDKALKTELTKLIN
KKENTGTAASL
>fig|195.2169.peg.1756 phage uncharacterized protein
MLFSKEELDEFLISNEQKHENTPNELKGAMQRKDFLEWMDELKNELKTQFLHESHLDPTL
KEERIKRASVDFDYFARTYFPHYFTIKGECGLHLHLNEIFTKIALKKESKGEKHAIAAPR
AHGKSTYTSQLFPLWCLVFNYKSFIVEISDAVELMEGMLEAIKAELEDNPHLKLDFPEVV
GIGKTWRVGEFVSNNGVKIKAFGSGKRLRGVRYGVKRPDLVILDDLENDTNVRSKDQRDK
LEDWVDEAVLNLGSADGSLDVLYIGTILHNDS
>fig|195.2169.peg.403 bacteriophage DNA transposition protein A, putative
MSYFLETKEAAQAFNVSTGALRLAASRNSNKYEWLKVDNEKGGRGGKKLLFKISKDKLLT
AFNQELISKNTLIYDEKMQKVKLSEIITTDNLKTINNSLKTSNLNLAEPKMNNDLAVLNL
KFENLSDELKEDAKSKVKLLKQVEKYIEGGLSIARTLKIEKINRRFYERIRKAYKENGIL
GLIDTRGLHRKDKTKLSAWMQEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDFIGF
DLGKVKPLFSVKTLQNFIKNYYKDKPLEHCIITQGLDRAKSKFLPAQGNQRELYDMKNMC
WQIDSSPADFIVRDDETLEPFRP
>fig|195.2169.peg.1122 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
QLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYP
DYREAIKLKNHLSYKLGQSAIKFCKNPLKLWSLPYEIFKIIKNK
>fig|195.2169.peg.1802 FIG00732228: membrane protein
MEEKIKQAIENIAKNLEVHKEYIRFDNTEQIYIIEDYLNNKIIEIKKNIKFDNLIDYPLK
FYYCDFLETVIGRNKTFKEKIIFEEVVFCKVVNFSFSIFDKNINFSNVKFEDKLYFDKCQ
FKEKFEFFGINNLKAEFNSSHFKKEVYFGKEITDKNVEKSNSFGSCSFEYANFSNCHFKK
EVYFKNNDFK
>fig|195.2169.peg.922 Pyruvate carboxylase subunit A (EC 6.4.1.1)
MVQIHKILIANRAEIAVRVIRACRDLHIKSVAVFTEPDRECLHVKIADEAYRIGTDAIRG
YLDVGRIIEIAKACGADAIHPGYGFLSENYDFAKACEEAGIIFIGPKSEVIHKMGNKNIA
RKLMAQNGIPIVPGTEKLNAYSMDEIKVFAEKIGYPVILKASGGGGGRGIRVVHKEEELE
NAFDSCKREALTYFNNDEVFMEKYVVNPRHIEFQILGDNYGNIIHLCERDCSIQRRHQKV
IEIAPCPGISDNLRKTMGVTAVAAAKAVGYTNAGTIEFLLDDYNRFYFMEMNTRIQVEHP
VTEEITGVDLIVRQIRIAGGEILDLEQSDIKPRGFAIEARITAENVWKNFIPSPGKIGEY
YPALGPSVRVDSHIYK
>fig|195.2169.peg.1830 FIG00471516: hypothetical protein
MALVYVASPYKALAVRESQRKAQAISI
>fig|195.2169.peg.1533 hypothetical protein
MFEEISFSPFLNFFMVKFETHNIETALSFSPFLNFFMVK
>fig|195.2170.peg.1658 hypothetical protein
MKIPGLHSIYSSLNLNFSNDNIENKQLIYNYEKHHSIECYLIDFISPCKGSIKAFIRPQL
VKNLNYKSLVLKYPNISENKNFKEQKALVIGASSGLGNTCAKILALGGAKILATYHTKNI
QEDIPNCDFLQYNVLKPSKISIEKIKKFNPTHIYYFATPKISTQNNKLDRKMLFDFLDYY
IFGLEKILSFTSPISSSSSSSSSIEDLPLDMKEYSIAKAAMEIYMKYLKKTKNIEIKIPR
FPRAKTNQTLSFIPQDLKETDELIVSMLLNKELK
>fig|195.2170.peg.1574 hypothetical protein
MEKQFYEILKNILEIEVNEHTNLSMNNCPEWNSLAHIDIIM
>fig|195.2170.peg.912 Paralog of flagellar hook protein FlgE
NEWQMIIRVPEPAEINTTGEGPTNIIVGTARFNNDGSLANYTPKTINFSPNNGAAPNQQI
KLSFGTSGSNDGLVSSNSASTLTGQATDGYTSGNLKPDAIRVDDKGNILGEFTNGKTFAV
AKIAMASVANNSGLEEIGGNLFKVTANSGAIVVGEAGTGGRGEMKTSALEMSNVDLSRSL
TELIIIQRGYQANSKTISTSDQMLQTLIQLKQ
>fig|195.2170.peg.1721 Motility accessory factor
VSKCFDNDFKEFDKGILFILASVVHKEVIEFLERNNREYMLVPRAYDFFYYLNLAKYFQP
IDGMVSVAHMNYWLAKFLSHKNIIFIGQDLAYSKDQSSHAKDFIHEKLHEGHFQKDENLF
TSIAYGGKGEVESSYFWKLFRELFENWISHDNNFINIYNCTEGGARIKGTIEKPFLWACE
NLLSKNLNKPFPKLNPLNINKQNELMLKAYNKIYKSIYHCKDFNKKLLQEYNEIKELYLT
LENLQIEESKELLNFIIQKIDTIKYQIDDAKNMQDLYEILGPLLVQFELNLARIYVLNPK
TPEDSFNKSLIWIKEHLEWIEMIYGHIQAQENALFENIIPLEQKLKERKLNKWMERVKNA
NK
>fig|195.2170.peg.1099 Septum-associated rare lipoprotein A
ILKVTNLNNNRQVTVRVNDRGPFVNNRIIDLSKGAASQIDMIAAGTAPVRLEVIGFGSAN
SGNNVVHSNINYGASGGIANNGQIYEGGNFMVQIGAFKNPSGAQTIASRYKTYRTYSSTI
RKSSVDGLSRVFLTGFRSEEEARDFAASGAFAGAFVVRE
>fig|195.2170.peg.1739 Paralog of flagellar hook protein FlgE
IKESEQLKLSAFSAGLEIYDSLGSKHTLEVQFVKQSTTQDGGNEWQMIIRVPEPAEINTT
GEGPTNIIVGTA
>fig|195.2170.peg.1420 RecD-like DNA helicase YrrC
MENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIALCIYNTDTNQQLDS
IYENLQSSLKYIGDKRKYKDIKNFHNLLQISVSHYTPNEEVAERLMLKYLFYLFQTRNFC
KEFLDIQILNNLQEFPINLDTLSFQ
>fig|195.2170.peg.592 FIG00469585: hypothetical protein
AKKPYIELSLGKFENKFENKILAKKFEEIRQMIRNG
>fig|195.2170.peg.1100 Two-component system sensor histidine kinase
SFSKFGKNYIKVKVKDNAGGGDEDILDKIFQPYITTKHPSQGIGAGLYISKQIVESFGGK
IQVKNIKDGACFEIYLKLQEGN
>fig|195.2170.peg.819 FIG00469432: hypothetical protein
KKEKLGKLIHKASKKLKIYKGY
>fig|195.2170.peg.1631 Amidophosphoribosyltransferase (EC 2.4.2.14)
MHNYKFLLLSGNDLVGIKFQKYFKRYFPNQLQIFDCDEQFLS
>fig|195.2170.peg.1347 Paralog of flagellar hook protein FlgE
MMRSLWSGVSGLQAHQVAMDVEGNNISNVNTKGFKYSRADFGTMFSQTVKIATAPTDGRG
GSNPLQIGLGVSVSSTTRIHSQGSVQTTDKNTDVAINGDGFFMVSDDGGLTRYLTRDGDF
KLDAYGNFVNNAGFVVQGWNINWDTQSIDSSRTPQNIFIDPGMHIPAAKSTEVAIKANLN
SGLNIGTSSRNLYALDSVHGWNTKTQRAEDENDTGTTQFYTTSKNSVEVTEKGVDAGSLF
NAKGQGLNLRDGQGIWVSYADAKYTINKTGNAFDENNKTNQNNVIFWGNKDVAVTLDITL
NGVKIQNANIRSLDEAIAYINTFTAPTDTRDGTGVKAVKKADGTGFELVNDNADGTTDNM
KNIDLTVNQTNTAGELHNVNYNQNTDKFTANSLKNNGNSNWIDANGAVVGTTERAQVITA
HKYIYSSNPVTLPPMYNPDGGPAFKPNANNPTQRPTDPASANYWDAIQGGLKNTTARTFR
TTEDLRELLQRDARYGVDYDGDGLKTHDVDDINQNVKVVVTENGNFAISNAKENSTIPPN
AGAGNTAATTTPKDMSFNITAYSNKQGTVSTNDAFTKIFKAFDGVLTVGGQIKESEQLKL
SAFSAGLEIYDSLGSKHTLEVQFVKQSTTQDGGNEWQMIIRVPEPAEINTTGEGPTNIIV
GTARFNNDGSLANYT
>fig|195.2170.peg.1695 hypothetical protein
MQACLIQLTHLLLYSCNSPFFDSENEFFESSLEFNLNVSK
>fig|195.2170.peg.1619 tRNA-dihydrouridine synthase DusB
MIDFSKKPLFLAPMAGFSDLPFRNVVKKFGADITISEMISSNALVYESSKTLHMLERAEL
ENPYIVQI
>fig|195.2170.peg.1731 Septum-associated rare lipoprotein A
VVSVGETADGIASWYGPGFHGKKTSNGETYNQNGLTAAHKTLPMNTILKVTNLNNNRQVT
VRVNDRGPFVNNRIIDLSKGAASQIDM
>fig|195.2170.peg.1722 Motility accessory factor
MQTNEIFKKNLEAMQGSAYKKLKHKLKNFQELRNFSFHIGKDPIDINIIDKKHLKKIYQN
PIKELEENLKLYQEQYTNYPFLFFYGLGNGILYKALLKNTYHKRIIIIEKELDI
>fig|195.2170.peg.1719 Motility accessory factor
YQENIKKINNINLQTIKYLTLKKGTDPLDAMIGIEQAIWNLPQMFKHYSYKELLNKRKNL
SKNAIIVSTGPSLTKQLPLLKQYANKAIIFCADSSYPILAKHSIKPDYVLSLERIPLTSE
FFNNDFGDFDKNILFILPGLTHPNSIKYLNKFKKDYMLVARYLPFTISLELKENGYIGGG
MSVAHSAYELAILLKCENIILIGQDLAYSKEGKSHTDDYVNLSLHEKDFEQNKGRFTTTA
YGGKGMVESSEVWTLFRKIFENYAINNQTKINTYNCTEGGARIEGTIEKPFKEVCEELLK
NNIKKPLRKLKKKTKKEQFDSMLKSYQKIKKNMQLALNFQKECKKTLRKIQKITQKNKYI
NPENIIKDIDIIREKLSHKKYFFLHEILGPTLHHEESLIAPIYTQSVHNESQRQNKILSW
IYANESLIETIIDLIESQNTRLKKAIIPLQDELEKRSLI
>fig|195.2170.peg.971 Rod shape-determining protein MreB
MILDQLIGFFSSDMGIDLGTANTLVLVKDKGIVINEPSVVAVERERYGSRAKILAVGKEA
KDMVGKTPGNIEAIRPMKDGVIADFDMTEKMIRYFIEKTHRRKSFLRPRIIISVPYGLTQ
VER
>fig|195.2170.peg.1380 hypothetical protein
MQENLKEIYKEFEFLNTQFSSYFNDEEFVNFKKGFEAKNALNYRDFKEFRLEETDKE
>fig|195.2170.peg.1253 Rod shape-determining protein MreB
IADFDMTEKMIRYFIEKTHRRKSFLRPRIIISVPYGLTQVERKAVRESALSAGAREVFLI
EEPMAAAIGANLPIQEPKGNLVVDIGGGTTEIGVISLGGLVISKSIRTAGDKLDTSIVNY
VKEKYNLIIGERTGEEIKIAIGSAIQLPKELSMVVKGRDQVSGLLSRIELTSEDVREAMR
EYLKEIADALKMVLEMMPPDLASDIVENGVVLTGGGALIRGLDKYLSEIVRLPVYIADEP
LLAVAKGTGKALEEISLLQQLTNEE
>fig|195.2170.peg.1477 hypothetical protein
MEHKEIYSRILDIHKHIFEQLKFVETKNNILLVFIVAFIAMIVRFLQSSNNDNIGIKVVM
ICILIILSCAAWELILSFKPILNNKEKKYNFLVRICNKYFNKTRNNSKICNIFFFKDLAK
INSKELME
>fig|195.2171.peg.1697 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
MGIVYEQTYRESLQNPEAFWAEAAKKVHWYNEWDRVLDDSDGHYRWFVGGCMNTCYNALD
LHVHNGRGDQLALIYDSPVTDTKKKYTYKQLRDRVAKVAGILANKGVVKGDRVVIYMPMI
PEALIAMLACARLGAIHSVVFGGFAAHELATRIEDAKPRMIISASCGIEVSSIIEYKPIL
DEAIKKCTHKPTTCLIWQRPQYRANMLPWRDIDWELEEEKTRGVDPVPVLATDPLYILYT
SGTTGSPKGVIRSNGGHSVAMKWSMDNIYNAKAGDVFFTASDVGWVVGHSYIVYAPLMNG
CTTIVYEGKPVRTPNPSAFWRIIEEYKVNVLFSAPTAFRAIKKEDPKGEWIKKFNLDSLR
SIFVAGERCDSDTLKWIEKLTKKPVIDNWWQTETGWAIAANPLGLEAQ
>fig|195.2171.peg.1624 Fe2+ ABC transporter, substrate binding protein
MSIYFVHFLSSILPLSILMAFITPDKRYIFKSFLALFLGFLFGYFAFFIAAQFLKTENLI
FNFNFIFIACLLLSFVFYFWQKIEILSFILLGILSFCIALH
>fig|195.2171.peg.1421 hypothetical protein
MVKLELIEKYIVSNSKFKIICKEFYNSSKYFSDAFMNYIDKKEFKDFLPQQDDSENGNIE
EKVFVQSLLEFNNALSHLIISISSDSEAIQQKNIHSAINHLYRATLDNYKIIIRFTIGKI
SNEDIVTSFLSIRKQEFLLLGQDLKDKNINFYSPNNKKYEEKNIIQAYQELYKAIDEILE
HQS
>fig|195.2171.peg.1747 hypothetical protein
MIKKIKQVNYKSFNNYNSSGLEFNRINILYGRNGQGKSSLVNFIKDNIENNNLDIFEISS
NGFSLFFYDTDYKNSLFYSNDKFKTFYIADDIENIILEKNKICKKIKKLKEFKNKIEEKI
NTANKNKKDLKSTIAKNTREVLSKIDSNKYNTPQSYQSTHIDDGYLSSEKISLFEVLSYD
EFEKIKSMKKNLNYEIIKEFNFDKFKQIENGVKKIDEMLKQTPENNAIDRFKQDNDLENL
ARLAFDIKNKSEMYKDKCPLCGQNILGVKLWEKLEKHFNEEYKQFIERLGKAKIFFEISI
TELGNYTKWLNEYFIKTKLLIDDDIDKKRQEYLLFIEESVKEINNIINHIELKKQNPNKN
DIDIDCDLNLFQRILNDDIQNLIKQHNRKQQTYLKDIDENIEKIKKHFIAKEKDNVALYN
GLINFYNKIKEKINCVLEKRNKHIVDIDAKLKEMDQSFQNLNKDMEEWFFNDIC
>fig|195.2171.peg.1736 hypothetical protein
MVVLDFILNDNRIAFDIEINEKTQNVKIWMFCRNDKEYLKKLLKIGLEIKENNKILIFSN
KDEKLLESIKNIKSFLGKITNEDKI
>fig|195.2171.peg.978 hypothetical protein
MKKNASSKILLSLGVATLLYSGAFAQEIDLTQSSDIGKYFEENGKDINLKNPDQYKGQDL
SIKMGIGDLPSDGYDSADYRFNIDIGKNNTLSFTHNNKGEPAYVTNLNATAKEVKTTDIV
LQAFAPSVINGDLTMTSSGAGAITEDEKKGSGIILYNGAGETQSANGSLTINGNFTVDKT
LFATYGNFVKVNGTANLTNSNFGLIKRSYTDLEANNVVMVQAKDFNKDILEEKSNNNAGA
LLVKFLNDYVSTDLHGKDVIETGAVIDISDEDEYGDGKKGLVDYKLSVQNCGGNKCLVVN
GGATAAAKDKLTQLKVDINAIDKLLKNEFDSSQDEEWKQAKEALEKQKTELEKLQQEAMQ
NGGKIDDEKYIDLVNKNLNLNLSANDKASILALRSITEQLGSIGADLASREGVKLALDIK
KDTDNTGKSVSNLNSASSAVNTTMNISNDVSIGSRVAMLNNPFGTYASKMNGLKFAALDS
DMRPSYVNEYTNSVWANAFGGANIIDGDSGAMYGATVGVDKQANDDVLWGAYFTYANAKI
KDNNLE
>fig|195.2171.peg.1361 hypothetical protein
MKYFIFGLLAIILLSGCGKREVSKDTTLGNLRKQAFEEFVAFPYKEKSELKDSIKNIVLE
YIKTNNIQADLFKLNNFTNCVMYNIWEKNPNQTLVLPLQVCTNEINNGELDKINYEDPSW
ILGQFDTVSGEHYLASKYIKDNLNDPKSYDFVDASYNILQNGSQVLITTEYIAKNLLGGN
TRNKTAILFSNRGEILAVY
>fig|195.2171.peg.1712 Translation-disabling ACNase RloC
TTEFNYLFEQIYKFKNIDDTYNEDLKISLVYNFGNNLRKFLEIYLFFKYPNNFESLDKEL
IERFFNDTYQSDNTDENHQRMIANITNRYQNEYSHLREILSRGMQPIDIEESKKIADFIL
KMIEKNDNNQFKALVRSISNDR
>fig|195.2171.peg.632 Flagellar motor rotation protein MotA
MALESRTNEIENEFLRNAMMMLVDGKSFEEIHESMEIQTEQLEEHYKECAEYWIIFGETC
PTMGLVGAVFGLILALKLLDNPQAMAAGISGAFTATVTGIFGAYALFAPWGRKMKANGMD
LVKEQIVITEAIKGIAEGANPRDLEAKLFNFLSHDDPRISQFDKG
>fig|195.2171.peg.631 Flagellar motor rotation protein MotA
MDLSTILGMVLAVTSISVGDILEGGNPLHVIHLSSFLIVMPTAAFCAMTSTHKKNCKSSL
>fig|195.2171.peg.1363 hypothetical protein
MLKQYFKNHSINIRAFAKQHNLHYITLFKVINGELTGERNTKGNTKAVFEKLLELGIINE
LPQGLK
>fig|195.2171.peg.1767 hypothetical protein
MEKLVKSVQGRVGFINIPCFNVGNTCDTTQTTSNNELDKMLENLERDLIEDRKKFKMDEF
FANAKF
>fig|195.2171.peg.1031 Putative periplasmic protein
MLGRFVFEKYHIFLNQDFSSICDLLYKENKAFNLQNKEYFEFFYALGLIEDEESKDVNFK
NSNFKMLKILKENSFKARLEFSYRCTECKSVMPLFFYHCPVCYEFNTCQIIYEVKNNETY
>fig|195.2171.peg.1798 Motility accessory factor
FNFNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEKGNSHSKGFDFGEKFEEE
HKKYKLKIPAYAGKGEVLTHTTWNDYRIKLEYLFACNDQKAKFYN
>fig|195.2171.peg.1768 hypothetical protein
MFFLIIIVKSHKQVLIKTILQDLLKDKTQLSFLWFYLYLLTIFIFYNKENIRSKILN
>fig|195.2171.peg.1821 FIG00973752: TolA-like membrane protein
MKKIFLTFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTG
>fig|195.2171.peg.1728 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDKIFLAARSDGLGSRLVAILNAFYIASRFGNKENVRFSWVNKETFCQDDGFNKNFRGLN
TKIIGMSVEEEDRIFSRNFIEKYHIVESEINTRDFFYCKKKVNTLEEFLNIFRQDVTSVC
RTDIGFLPQYLKDVELNDYRGICKQAWENIEFSDNLKKIIKDAQQKSQKLGDYVCIHVRS
GDVIYDYLDIRKYHKSHVYHAVNAALALELIYKELGKNKIVIIGDDIDTTEKLVELVNHP
EVYHINTQRSVDHFSNLELFMFDIIFMSNSKKLYGTYSAMIKIARMISETEFFSSYYQFK
SGEYYEILKKNYNYLFPYISSSQNAFILFHLFLTGMELNEDVEILCSYLDKALEYDFEND
KYRIYKIYCLLKYNKIDKAELFLSQYLSFREKDFISLLFYKNYAGSFSEVFPYFFSNAKS
LYPYISYIAAQIYMYHRDYFMAYKIIKDIAYLNPSFINFSKKLAIKSYKYLN
>fig|195.2171.peg.1030 hypothetical protein
RMCCLFEVGDNVKEANESLKAMDFLD
>fig|195.2171.peg.195 Paralog of flagellar hook protein FlgE
MMRSLWSGVSGLQAHQVAMDVEGNNISNVNTKGFKYSRADFGTMFSQTVKIATAPTDGRG
GSNPLQIGLGVSVSSTTRIHSQGPVQTTNKNTDVAINGDGFFMVSDDGGLTRYLTRDGDF
KLDAYGNFVNNAGFVVQGWNINWDTQSIDSSRTPQNIFIDPGMHIPAAKSTEVAIKANLN
SGLNIGTSSRNLYALDSVHGWNNKTQRPEDENDTGTTQFYTTSKNAVEVTEKGVDAGSLF
NANGQGLNLREGQGIWVSYADAKFTTDRANGANVFDPNLTVAQQANVIFWGNKDISVTLD
INLNGVRIQNDNIRSLDEAIAYINTFTAPTDTRDGTGVKAVKKADGSGIEFVNDNADGTT
DNMKNIDLTVNVGNSAGERNTINYDANTGVFSPQGGNLTTAQNDTDWIAGAAQAGQPQNV
KVVTAHKYIYSSNPVTIPPMINPDGGPAFQPNANPNTRPTDPASANYWDAIQGSLKNTTE
RTFRTTEDLRELLQRDARYGVDYNGSGIIDNATPTFDANDINQAVKVVVTENGNFAISNA
NETSTIPAGAGAGANAATTNPKNMSFNITAYSNKQGTVSTNDAFTKIFKAFDGPLVIGNQ
IKESEQLKLSAFSAGLEIYDSLGSKHTLEVQFVKQSTTQDGGNEWQMIIRVPEPAEINTT
GEGPTNIIVGTARFNNDGSLASYTPRTINFSPNNGAAPNQQIKLSFGTSGSNDGLVSSNS
ASTLTGQATDGYTSGNLKPDAIRVDDKGNILGEFTNGKTFAVAKIAMASVANNSGLEEIG
GNLFKVTANSGNIVVGEAGTGGRGEMKTSALEMSNVDLSRSLTELIIIQRGYQANSKTIS
TSDQMLQTLIQLKQ
>fig|195.2171.peg.1818 Motility accessory factor
IKAYHEWLLYFIEKLEQRINIIINSFKETQ
>fig|195.2171.peg.1738 Integral membrane protein
SKSGFMRAIYLDNKIKGAINQLINYFIEGVFDCNNTKVIFKYYKESFLYYKRQLKKYKIN
HEYFFSVNKLDMSSYKVVFYLFNAQSNCRILTYRNAKHIFITHGESNKLASIKPIIRIYD
YVVCAGDAGVSRYLENGIFSRYDVENHRIIKMGDTFIGKSVFKKISDKKNAYILYAPTWE
GGIKSEQYSSLSEDLYAFKTIQKYAQKSDIKKIIIQAHPNTGHRDKKYRKYLNQGIKFLK
SYNLEVENMGIYNHKTSFLNKFFLKRSSKDIYPIYQAFVDISAMEIQLLNEYIPTFIFIN
KTKNAIVDKQILKDYYAKIAIQSDAVKVENFEGLEQIKNFYIGYSFDELKIMPKNKRVDW
LVDFVSKESYGNKI
>fig|195.2171.peg.1737 Beta-1,3-glucosyltransferase
MEIKYDVSIIVPVYNRENLIKPCIDSINAQTLDKSRWEVIFVDDASTDGSVEVIEKLINE
NINYRIIKREIPSGNASAPRNEGIKASLGKYVFFLDSDDYIDSKLLENGINIALKNDSDI
VYFKMELNARTVTKRPFKHPIVDKADIEKNHLMRTLRIFKMFKTKMLRENNILFDVTVNV
CEDMLFGATALLYAKNISILADRDYYFASLHDEPHLSKKKMTLEKLFHIYFYTIQSLYCS
NRDINFKIKFYNALLIRCVEHLRDICKKDKINNENLIRIFSFASDLFNLHKEMFELKQIY
ENEKLLVLLFLSKDFKTFFELSNNSKILQDFCQKIEKEF
>fig|195.2171.peg.309 Methyl-accepting chemotaxis signal transduction protein
MYVTPSYLDLTTNLPCFTYATPLYKEGKFIGVLAIDILVKDLQREFENLPGRTFVFDSEN
SIFVSTNKELLKPGYDVSPVANIAKDKKDYEPFRYVRPLDGTQRFGVCAKVLGEYTACVG
EPIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSRYLSPLAAIQTGLTSFFDFINHK
TKNVSTIEIKSNDEFGQISKAINENILATKQGLEQDAKAVKESVETVGVVESGNLTARIT
ANPRNPQLIELKNVLNRLLDALQARVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTT
NALGDEI
>fig|195.2171.peg.1806 ATP synthase F0 sector subunit c (EC 3.6.3.14)
MKKIFFLFLALAATAFAAEANAPVEQEAINVWIKAFSVLAAGLGVGVDALGGAIGMGNTA
AATIAGTARNPGLGPKLMTTMFIA
>fig|195.2171.peg.1362 hypothetical protein
MKENDKKIIKEMKEYFNVESISQIAEKLGYKPSTANNWHNKGLTQSVIDKFQSIKYTNSK
NSLKNSNMVNFRYFPDVYAAAGYGNSNESEHYEIISLDAKFVVDFLGLSAQTDYDIIKIF
GNSMEPYLLDGQSAIVDFKKNNLSLVKNADVVIISVDNELFCKRIKKQPLLNKFILTSDN
KDYDDIVVAEDDFNRCKIIGVVVCKIDIQMFLNKIELKNISI
>fig|195.2171.peg.1373 hypothetical protein
MKLQDFDFRIWNKTKEEFLKKEPTLIKLDNERVIAGRISRFYANTADIADMFIGNGNDLE
IELWTGYFDKNGNKIYENDIIKNEPLEEIYHITRDDTYK
>fig|195.2171.peg.1567 Translation-disabling ACNase RloC
IVSIIYFTNHFLSKIKEIKECPLVFLDDPINSLDNSNRDKIINYISSKLLKQNRGQFFIA
THIDEVCDKFNKKNSDTQSIFEIKKYANQSEIEKLAGFKLNNDFKTTHLRLCEYLKFGKY
EDAFDISGDVRFILEKICNIFFKNTENFTDCYDKLLSKFDIIKKYTANDIQDLNHGKNTI
NSDEIIEKVRFVVEIIDKIRNYSCGKL
>fig|195.2171.peg.1775 Putative periplasmic protein
MDFFFVEYRDPLVGLIILTVLIFVVAVANYIWKVFASKDEEQKLEKFIKKFEMDNIHKDL
LRNEGLSFGNLSFLAEIFTKSGEFEKATQIYLIALEKSKDKQEREFIFFALAKVYFKAGF
LERAKEVLLQALKLRPRNIQALKLLKIVYLKLRKYKENLELLGCLFELGENVKEEKEFLK
ALDFLASSLSDEEKKEHILKLQTDNN
>fig|195.2172.peg.1578 CDP-diacylglycerol--serine O-phosphatidyltransferase (EC 2.7.8.8)
MNNNKSQFIYILPNLFTAASAFLGVISIIASIQGNYYMALLYIIFSLICDGLDGRVARLT
KTTSKFGIEFDSLADLIAFGAAPAIFFYMVIGSEFGRYGSLITAFFVVFGAIRLARFNVT
TGTYEPSVFIGLPIPTAAVVSAIWTYAFISYDFLKPYGVVFLVLQAILGLLMVSNIRYPS
FKKLDFNRSSVLKVLIILIIIFSFLYLYPLESLVILASLYVLYGIIRVLYTIIVSKFKIR
NQE
>fig|195.2172.peg.731 Transcriptional regulator, LysR family
KDRIMRIVFVFKQKTAYDIGSGLVGSEMCIKDMIERTSMKIKDMEIFLDLLNTQSPTNTA
NNFSITQPNVSIIIKNLEQDLGGALFERLGKKLLPTPKALYLGKIWLKLVQDYYKSLEEL
NDENTLLGEIKIAATQSIAEHFLAPILFDFKSKFSNVKIHFQTQNSKECLNLLKNGDIEF
AIVEAELNPTLIDHEGLKMEFWQKDELVVASSNKNLSQKEFYIDELLKQKWILRETGSGL
RDKFLNEIGDVSKKLKFFLELDRMSAIKELVIQKNAISIFSKKSIEKELKNSILYEVKLK
NINLWRNFYILKRKNYNFNRALEKFEKIFKQ
>fig|195.2172.peg.1868 hypothetical protein
MGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYRNDYNYKIGESNFNFKDKPEFAYYED
QFKAYMGEENYKRLRPYLGMTTYYVCEGKKYPVVFSTMIDYKVKNYGLFGDEGRGFSFS
>fig|195.2172.peg.1635 Uncharacterized membrane protein, YraQ family
MLPYIVIAVLIGALIHDFIPQEILQKYLSGNEILSIILAAFFGVLLYLRVETIIPIGLIL
LQMGISQGVIMSFLIAGAGCSLPELVLLKQMFKMKFLLLFIAIILSVAISFGMLINFI
>fig|195.2172.peg.875 hypothetical protein
MEENKEYWHNVALLEKLWEKIPQCNTNTLNANEVFNIIKKEKIKIDIHSICKFFKITLIK
TNGKKFVIFNENNKLIIHYHNESDIFYFLGHVFHNFLDGAYFKYPFKKRTWDLEHREKLA
KKFAIRLKLLIAGYELASGLGKYFEAISNFGKHFEIISNFGKHFEAISNFGKHFEIISNF
GKHFEIISNFGKHFEIINYTNKRNRLNKIEDVKYNNKFYQAA
>fig|195.2172.peg.1851 hypothetical protein
YYTNIDMAETIKQYYNLFSNALGQSFPNDKTSFSEADINSMPSGYGVSGTQWMDFNDPSN
RMNITGLKDFSNSLISNIYKTPEQAKEANDLWADSGYMIDGLLPKTLGLSLEEIKNVSKG
EDWQFNPDMSVYPQNEDGSYSKEALFMSFLKSQGGQPVESPKTTLNPKVEAYNRAMAKES
FSTTSVDIGDIMTGKVDFASLFKYLASKNGKLEGQLYMYENNIPKESAMGNWALDAEIKQ
ALANGWKAKPSTINSYADSIMDRLNNLIGQTRV
>fig|195.2172.peg.14 Ferric receptor CfrA
MNAKKLKLSILCFCLMGLGEIKAEEQYQLDDVVVSASGFEQDLVDAPASISVITKEELSK
NPLRI
>fig|195.2172.peg.1899 Motility accessory factor
TMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSH
ELQNSRLM
>fig|195.2172.peg.1877 Flagellin
DINRLMEELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRF
ETGGRISSSGEVQFTLKNYNGIDD
>fig|195.2172.peg.622 hypothetical protein
MHFILYYIYYLFLLNKPSKSIRQENFSYNFHTNYFYSLDPFILNLPQAGRQKYIHCTIDL
ELIKEISLEDFTKISPVIRDTIIQTILAKEIQEIEFSNFKLELQRELVKKINEKLGNKLI
KELYFRDFIIS
>fig|195.2172.peg.1691 hypothetical protein
MNFQVKTLETFNPFESLNHEQANTEQILDFRVIDFKLLCSSVKPAKTKTYERKDFDLFYA
DNFFVKNYNTIVQKFLIEIYPKKQSFPFTVKLRSNSNLTHLKASINLTENFKYYPNLKFD
ILQNIYKIMIKQKFLILRLDKNLFDKIDDFILSIQKSPSIKEIELEIAKGVDKIEHKSDE
IIYHRDINEECFDENNSYDEGIYCKPVEKNELLFEYIYRVLGKEGRNLRGEILHLNPIAF
LDNPFIIKDESIYTEELEDRIKYFSANYGFLNKDHSQDIAL
>fig|195.2172.peg.1634 Uncharacterized membrane protein, YraQ family
MLFIGISFLISIINQKYEGMFRKQLSGDKISSYFKAIFLGALTPFCSCSTIPLLKAFLEA
RVKLSVCLAYLFTSPLINPIIFTMLFVTFGLKLSLMYVLF
>fig|195.2172.peg.1885 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase II (EC 2.5.1.54)
QMAIVLTFAGGCPVVKIGRMAGQFAKPRRSDYGKVNGVKLPRYRGDIINGFEFNEKTRIS
DPKKML
>fig|195.2172.peg.1752 Polymer-forming bactofilin
MLHVDGELNGIVHSESIVVIGKNGNLKGELKADKIVVNGCFEGDLEADSLEILAGGVVSG
NISIKDLAIENGG
>fig|195.2172.peg.1783 Motility accessory factor
MTFTPTQKELFNKNIEALSNLFLKESLKEIQSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVF
>fig|195.2172.peg.340 hypothetical protein
MLYHFESAAYTSMSVANVVFVLFGVGMIITFICEALDVKRFFHLNELLAMVFALLGLWMI
FLAEGGTLENFTHLKGLVNAILAGIGYALFLFFTRKLKLGFGLIPLCALLFIGSLYLSIP
LFGANLNLNFSLESLFCF
>fig|195.2172.peg.1287 FIG00973752: TolA-like membrane protein
MKKIFLTFMVLVNCVFASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNITIGG
DPTIWNDTKQCF
>fig|195.2172.peg.1307 McrBC restriction endonuclease system, McrB subunit, putative
MIEFLNEDRKKFKEYLIDFFHNAYNSDKLSSKDEIVNFDFLKNYGFCVKLSYGKGTISKI
PWIIFIRTDTQEYKASYGIYVYCGIKRENGEIIVCIGESEDKTINYLAKNKVDDYNTQFN
KKTYDYKNLNNDIDLIIDKIIENMQWFAKLPLNEIQDRNDLSKSNNKEIRNDGSEMSNKK
ENKNLSLNQILYGPPGTEKLTIL
>fig|195.2172.peg.1058 N-terminal HTH domain of molybdenum-binding protein family
MDKNQEKEIISYMRELLNSNEKLDCGTAFKIAKKFNINIEKIGQLADENHMRIDNCELGQ
FGHLDFEKAKIEVLKKIEPSLDEKRRIFCKDARDIAKEGCGLKSMRSALKTYKVDVKYCQ
LGCFKEKKGKQFIVRTKTWIENADGDLLFGRGKTELLELIGQTGSLLHASKLMGINYKKA
WMHLQTLQKNSQEILVSTRQGRSKESGTKLTPRAMELMENYSILQKDIEEYANKRFKELF
LKGKNKSSIKKY
>fig|195.2172.peg.1505 Dihydroorotase (EC 3.5.2.3)
MTLKNPLDMHLHLRDKNMLSLVAPFSAKDFRAGVIMPNLVPPLCDLESLKSYKTRIINAC
ENENFTPLMTLFFKNYDEKFLKSAKDEIFGIKLYPAGITTNSKGGVSSFDIENLKPTLEA
MSDLQIPLLVHGETNDFVMDRESNFAKIYENLAKNFPRLKIVMEHITTQTLCELLKDYEN
LYATITLHHLIITLDDVIGGKMQPHLFCKPIAKHYKDKEALCELAFGGYEKVMFGSDSAP
HPKHEKECCGCAAGVFSASVALCVLADLFSKNSNEANLQRFISDNACKMHNLTFEKEKII
VLENQEWQVPNEYKNENEKVVPFMAGERLKIRVKKKIVLKLVFI
>fig|195.2172.peg.444 hypothetical protein
MYLENQDSEDKIYIFKQIQFKKNDTLTMQANNIFKKIH
>fig|195.2172.peg.1836 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KAKKKMNKNLNFTKKSVLIAGNGPSLKEIDYSLLPKEYDIFRCNHFYAEDKYYTGKKIKA
AFFVIPYFFNEYYTMQKMLQNGDYECENIVCKMYNFQDRKEKIFRENFKYFFPAAINGYD
AFFYKLKELSNMIDFDFCYEYNTTEMLTGTYVICCAVACGYKEIYLAGMDFGDEKYNYFS
EKIEKIKESKKRTTKMHHKSIDLKILDFLQQQYNVKIFSICPNSSINAFIPLHPIQNNEN
IFKPIERPKDAIKTQLTPPIKAVRRYKRLYLESNIIIKFFHELVQVPRRIRHYYSKTRYT
R
>fig|195.2172.peg.1869 hypothetical protein
FLSTCAFKEKKASEIKTLASNYGGIYIFDKKIREEILELEKRRIS
>fig|195.2172.peg.1600 hypothetical protein
MKNIVFHSDGFGDLLVCFKALYAIKQLYPEYKLFLLTNGLMESDFLEKIPFIDEVLIYKD
DFLEKIPKIQ
>fig|195.2172.peg.1599 hypothetical protein
PYSNNDKTITKSGIFMTFFTGFQAKNYFIEGQTSILGKMQGFDKTMSQSEIDNLNKFISE
NSMNFKGDIFKLFDLLNSDMSIDDFKQKILEQKENLNNPTKNTNNKETSEEDKKSHLNLY
KRKVQAKPIKMIIK
>fig|195.2172.peg.1140 hypothetical protein
MKLQDFDFRIWNKTKEEFLKKEPTLIKLDNERVIAGRISRFYANTADIADMFIGNGNDLE
IELWTGYFDKNGNKIYENDIIKNEPLEEIYHITRDDTYKMFKIEIFSKNFNNKIYKRKAE
PDISFLKSFKSEKNMEVIGNIHENKELLRI
>fig|195.2172.peg.1756 Putative transferase
MKNVIIIGAGGFARELYSYLKDANYEIIGYIDIQENNFFDLKYLGNEDNFDKKLI
>fig|195.2172.peg.762 Highly acidic protein
MKILLLNENPVVSRLISLSAKKMSYDFEEINAYDENLGHYDVIIVDSDTPAPLKILKEKC
DKLIFLAPRNQSADIDALILHKPFLPTDFLNLLNQENLKIADDAILPIEEAENPYANISL
DLDGLNLDDLPDENTEDTQENKLSMEENLESLALDDMEEETNQKEIASENTDKELNLDDL
SLDEDQEENEASEQTTANHIEEKNEDEQALEVAFQDDILDDKTSEENKEEFEIQEQDTQE
QDANQDEQDKIEDTQELEDQVDNLNDDLVQDNENSEAQEAIVNNNLDTKEEAEFEVSGKE
EKLEKTQSQDFITDDFPIVEEQERKIDFDDIPEDAEFLGQRKEEDEAVEDFLPVVEDQEN
LNEHDEFEEMSSLSTQDQIKEELAQLDELEYDIDSDDSIKVLEDFKEEPILDDKDLPNND
EEIVVPKLEINDFDSLKESDIQEALGEEISTLEDNKSEKLKIKEDQLASEAGEEIVNELS
QSIAGAITSSIKDDTLKAALKGMNMNINISISFNEDKN
>fig|195.2172.peg.1863 Predicted glycosyltransferase involved in capsule biosynthesis
DKEYYSLKSFVYKPYLYEIKRVRFFSKILEFLGLNFLLSLISQTKFYRLARKLFFNPRDF
FKDSKFYKRHNNAN
>fig|195.2172.peg.879 hypothetical protein
MACIENAYDLCKHFNISEDCEIKIHNFFNTHKDNFLKPCTGIFYGIKQQNKIILERENEY
PPGIFCVKTNYLKIVYKKENLEIINIDWINS
>fig|195.2172.peg.1033 hypothetical protein
MTAYIHIGTPKTGTTSIQKFITLNLDLFLQQGMVYPKTFCVNNQHAKIAYIIKNMKSDFN
FWLNQEVVFLRNEISENKKYTFLFSSEMISLYINESYTLIRLKELFNWLGFKNIKCILYL
RSNDEYMISHSSQNIKCGLGVYYKRKAEFCTSMGMHMYKTICKNYINVFGKENIIVRLFD
KNEFYQGDLLKDFIHSIGLEWDNKFRIPERENETLDLIGFELQGRLNKLGCGWNNKINST
MEFSEKYFTSKDPHLKFQPAKEVTQSYMDYFEESNEWVRKEFFPHKERLFPKKDLTNYKE
NYELKEMKPEYWDRIAEFIADIVKTKNQAIQNKDNQIATINNEKQKLIDEKLNLQIQINQ
LQNTLNTLPIKKQQLEISNLEQELNINQAFSYIPKEQSAKQRIQNQLSYKLGQAMIINSK
SILGYIRMPFVLSYIKDKHKQEQKIYQEKIKKDPSLKLPPLENYPDYKEALKEKECLTYK
LGEALIRANNNWYGGGDISNCGLRLGS
>fig|195.2172.peg.1308 McrBC restriction endonuclease system, McrB subunit, putative
MEILGENLESRDRDEKKAKFDEYVKDGQIVFTTFHQSYGYEEFVEGIKPMMNNEANSQEI
QYEIKDGIFKDICNRALENYENSNLNTEELREKIKLREKVEKFLNRLLETNEPISKTKGG
NFFINSFNNNTIEIYSEDVERFDGIFKLSLSTFITLLKSNIEFNSAVEMFKKVFDRDYAD
RTHTYYFNLVNKFKEYEKQAVLKTEDNKISSNSLNSYIIIIDEINRGNVSKIFGELITLI
EPSKRIGESEELKVTLPYSGKKFGVPKNVYILGTMNTADRSITSLDTALRRRFEFVEMMP
DPDLLKNVFICKDVENPNKDEDYLGDDAKTEGFAEILQNILISINKRIEFLLDREKTIGH
AFFMSEAVKFNKDNWCKPDEYEEDWYVLSISKLKSIFQNKIIPLLQEYFYNDYALISAVL
NDNGMIEKCEKDDKYLQKIKNLDNVDSEKIIYNIASFDNKIWNDIKTYQAIYNDGENQSK
NDKQ
>fig|195.2172.peg.1640 Arsenical-resistance protein ACR3
MAYIYLDFLPKLLGQSTLATSLDIDFSALSKNVLIYLGIPFLMGFITRTLLLKYKSKRWY
ENTFLPKISPITLITPC
>fig|195.2172.peg.1871 hypothetical protein
FLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYHSKEDPLTPANFK
EQTMQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKALFRKELPLMLEKLQKRKS
FMQENSISYPCGNKVFTFKDVENQLKLIIN
>fig|195.2172.peg.898 FIG00470684: hypothetical protein
MTEIQFNEIKERLTQWRQERHLTYENQQAEFLGNVFEKVSEYFRAKDDLERVKALCDIAV
FCFNVNDVKFSNYECYMKSDKVDFEIFDIASQINSIAIYKANFEIDSVKVILDTLIALLH
KKCEILKFDFYKCMLEKIKEIESRTGFYDERLKKFVDTICAFSKDEALSNVSKDFGFLGN
SIIYKLTQEDKNFWFITCKEIETNLQIDYKVKKNL
>fig|195.2172.peg.1380 Protein containing aminopeptidase domain
MDKLDFRSQDFSQTGKAMYELACELFPIPRSITGQGFRDSLEILNKTLGGGILKFHSIKS
GTKVFDWIVPDEWNVKEAYIITPEGEKICDFKKHNLHLLNYSEAIDQEIELEELQDHLYS
IEEMPDAIPYVTSYYKRRWGFCLTHNERKKLKKGKYKVYINAKHDENGVLDYADFILPST
QNSKDEILISTYLCHPSMANNELSGPVVAIFLAKWLLSLKERKYNYRFVIIPETIGSIVY
LSKHLEHLKKYVKAGFVLSCLGDDHAYSLIHTPKENTLSDKVALHTLKNKENFKAFSFLD
RGSDERQYNAPLVNLGIVGVCRTRYLEYEQYHTSKDDLNFISEKGLMGGLQSIQEMILNL
EINAVYENTIVCEPNLGKRGLYHTLSTANDIPLACNFLAYCDGENDIIDIANILNMQAYE
FKELLEKILEYKLLSIIH
>fig|195.2172.peg.1835 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
NSKNIFGILFMPVYIISTLLSHKQEQKIYQEKIKKDPSLKLPSLESYPDYKEALKFKNHL
SYKLGQALIKANKTWYKGGYVRFLFELRKIYKQKTMKNSLILYKNRDSNKKDTTRSIRGG
GIG
>fig|195.2172.peg.1579 FIG00005326: uncharacterized protein
MQKEFFQELQDILYEKNITIKFHSFQNFYEDFKSHKFIFNHEHQSIFKKNTSQQITLLHP
TRIRRPKFVNSTHALAKIIHSVAHIEFNAINLALDASYRFKNLPLQFYYDWLEVADEEIK
HFKLLNSALKELGYKYGNFPVHDNLESALEATKDSLSFRMGVVHRGLEAKGLDANPFVVQ
KLQSSNHSIKNLLMEYLEIILNDEIKHVKKGDTWWKFANQNRYDFIELCKTFKQFSLAGK
KLNIQARIKAGFTQEECEVIEKFYS
>fig|195.2172.peg.1881 Polymer-forming bactofilin
DKIVVNGCFEGDLEADSLEILAGGVVSGNISIKDLAIENGGRFNGTSKIKQEEPVRLLEN
SSE
>fig|195.2172.peg.1580 Peptide-methionine (R)-S-oxide reductase MsrB (EC 1.8.4.12)
MKELNEEEKKVILNKGTEAPFSGKYNDFYEKGIYQCKQCGASLYKSEDKFKSGCGWPSFD
DEIKGAVKRIPDKDGIRTEIVCANCNGHLGHVFEGEGFSAKNVRHCVNSISLEFVKTKD
>fig|195.2172.peg.1872 Motility accessory factor
KAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENLKQSIIALECATHPNIVR
SLNAENCMIVLRNKALYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFD
EEGNSHSKGFDF
>fig|195.2172.peg.1883 Cinnamyl alcohol dehydrogenase/reductase (EC 1.1.1.195) @ Alcohol dehydrogenase (EC 1.1.1.1)
AGITTYSPLKFSNIKAGSSVAVAGFGGLGMMAVKYAVKMGAKGSVFARNENKKADALAMG
VSSFYTSTDKNAVKERFDLIISTIP
>fig|195.2172.peg.732 hypothetical protein
MKSFVYVLSVNIILFSLIYLSKQVYFNFKLFSKRMFQIIRRNFSVLYILFFVISFFLIFF
KTIFEFVLVALFFIVGIVNLFLFFKFNSFLNTTFLEAILFTTISETKEFISSYFD
>fig|195.2172.peg.874 hypothetical protein
MKRKNIQNINNELIKEQKNLKEIFCENEYNNLSLLHYSINMIENETIKAQKVDKIDKENY
LTKFCIDGDFSFVIVNILAEKIPKSQIKIALQRLEKCVIIYQSIDSLVIERNEIEKTQRF
SKIKYGKSIEWQEEN
>fig|195.2172.peg.1128 hypothetical protein
MIQDKIIFANHFTRFFFYFLKPNEKLILQNRYEEVLGLIKEKFELYQSFCFEQLSRELLE
KKFQVSGVQSYWDKNLELDLYYKDDEISFIGEVKFKNKKICRNILNLLESKAKSLKLEPN
NYIIISKNGFSKEFYKICKQDLLLLDLNDFKILLEEDK
>fig|195.2172.peg.1286 hypothetical protein
MIGINSTFNNSFVNLNIKNNNNSSLNSNTSNANVKNLQDIKQYSKTSNKVLGYGVDKDGF
FTSDFNEAAGLPILHNFRPLK
>fig|195.2172.peg.442 Channel-forming transporter/cytolysins activator of TpsB family
MSQERENVYVANYTLPIQSYQLSYSMQYSDNINMIEGYDNSFIKNTDTSLRHKIMLKKIL
HCTSKDKFSIYANLGIKDDVNEIDNFRLESSSGRYSSIASGVEYSTLAFGGFLFLNLEYE
KGIPFLGSKKDSKDSLYKIEFNKVNFNLSYQKSFYANDGLAFLYQNSLGASYSNEPLLYA
DKFLIGDEYTVRGFKESSAALDYGAYSNNTIYLQFLNAPKYLRALEPFVGLDMGYGRDYL
LPNKDF
>fig|195.2173.peg.611 hypothetical protein
MLEIITLGSIIAFANICYLINKDCIKYCEDEIKEISKLIKEAFEKTIEYKETKEDERNRL
RLTAIISHIEALQYTRLIKENDLQKTIRIFATSINDYFDGGINDEDFIGFYKNTLKETYN
MKASFKKYIKHIFIKKMHL
>fig|195.2173.peg.1877 Cytochrome d ubiquinol oxidase subunit I (EC 1.10.3.-)
IGVATGIIMEFEFGTNWANYSWFVGDIFGAPLAVEGIMAFFLEATFFAVMFFGWDKVSKG
FHLLSTWCVAIGSNLSAF
>fig|195.2173.peg.1445 hypothetical protein
QRELCGVLDSKNIILYGFNNLEIDIEKCFKIIEKNQNFTLDFPSSILAFDGYRIFLFYLF
RKLKLYWNLALENRQREVFCEFFSYARKIYIILMSTEKIFDEELNKNLALRFEDLVKQSY
CILANNELDENLLLFLGSEDLQNLLSDFDFFIKEDSFYKSEQEKYFFKQMIAMQLRKRLV
LFKKNLLKNFEIETFEENFLGLSVFLEYFHNLYNLKILSKLYNKYFICDLEKKTLLKLTK
KKEKLGKLIHKASKKLKIYKGY
>fig|195.2173.peg.1875 tail fiber protein H, putative
LKTELTKLINKKENTGTAASLDAQLRDELIALINKKENIGVAANLDKALKTELTKLINKK
ENTGTAASLDAQLRDELIALIN
>fig|195.2173.peg.1861 hypothetical protein
MNLRIKLNLFISLLFSLFSFFFCFSLFFSYLLSLISFYIEYLKNNVKSKF
>fig|195.2173.peg.1448 Hypothetical protein Cj0261c
MRLAKIRIYLGWADYRKSDFLDPIFKHFNTEFKGIYKQDLESYLLENNVKFHKFIFDETR
IVERKKDEAIENTLWHLNMNGVKASKQDLETFVKGDIKETIQSKIKLLVF
>fig|195.2173.peg.713 Ankyrin repeat-containing possible periplasmic protein
MLNQRNKDILNLLIRLGARIDEGYENALFYALENYDNTKFLLELGLNVNSANTFGKTPLF
YAIEFKRKDIVSLLLEYGTDVNKKYINDNEKLALSANIGGNTPYFITFCALEHTSKNVLM
HAAAYGDVEILKMLVAKGADINEIDDLGFNALDFALAANQKDNANYLQSLGLKPNENLIY
GGSLE
>fig|195.2173.peg.610 hypothetical protein
MKGKLEYNFAKEFTEEPGPRFRYLGKKSGEEFREDVLKPMLKEYDFIDIDGTDITSSFNP
SFLSEAFGVLAEELGGSEELLKRIRLYSRKNLGLEEKFKEYIDI
>fig|195.2173.peg.1889 LSU ribosomal protein L4p (L1e)
STRTNVWVGGAVAFGPTNERNYFQKGNKKQKRLALERALADKAAKGVLFTADSLAIESGK
TKDANAVI
>fig|195.2173.peg.260 Channel-forming transporter/cytolysins activator of TpsB family
MIKELTNFIVAKGYSTSSVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPL
KKGDKFNIYDLDTGIENLNNGARDVKIAVKASKIMVILIYLSILNQSHLI
>fig|195.2173.peg.387 Oxidoreductase, short-chain dehydrogenase/reductase family
MRTYKRCFRQITKSLSLDLAPKIRVNAVCAGTIKTPMAERLFQDFANITHGGNTDFYWQN
EAKKYPLKKVGQANEVAELIYFLASPKASFITGGLYLIDGGLTAGIPH
>fig|195.2173.peg.1831 RecD-like DNA helicase YrrC
MENNILIQILDIDRNINKNIVRNKEDRGFLSQNILNELRNLLEHIAL
>fig|195.2173.peg.1126 Membrane protein
MIAAASDLKYSDRDLKELVKLFVQTHKLGSKTSKELDEKTKNKLEFVSALAANPKASPQT
VSFLNQELKKISASYKKEIDAYEQMGLAKRKIKEEK
>fig|195.2173.peg.1885 Methylisocitrate lyase (EC 4.1.3.30)
KIGHKALYLSGSGVASASYGLPDLGIIALEEVCIDVRRICSRGDTPLLVDADTGFGGAFN
IARTIKELIRAGAA
>fig|195.2173.peg.1819 Putative periplasmic protein
AIELARHNSRMAMKVYGMENLDKECKLFIQAPSFKNISFTKNDFKWYYLE
>fig|195.2173.peg.69 Ammonium transporter
MNAINSSFIVLCTLLVLLMTPALAMFYSGMVRSKNTLNTIMNCFIVFGVITLQWVVLGFS
LSFGKDEGLGLVGNFENFLLEGISGTLQAFQIFFL
>fig|195.2173.peg.368 FIG00638667: hypothetical protein
LYLDDNKEKLLNSSLILENNTSLYSPNSNFKLQLQNRKELYNDEQNIIYALVNKEIKKIF
IHSENNITASFKGKFIPIQARIKLFLKEDKIHYELYPYFDNQLEQYSIFMDNVSLFEIQK
QKLKVCLKEQEQEYCLTKRLFI
>fig|195.2173.peg.633 hypothetical protein
MAEEKEQAQRVMLTMSAKLKETLDKKAEELGINTTQYIINLIINDIKEK
>fig|195.2173.peg.609 hypothetical protein
MKKYKKITSRGKRFLRHYDRRSTNEKYKKFSRCNIIKKRYISKLPPKNPFTVPKHNIDIR
GNIVFPRNINKINQKIKDMQMHAGLYKICVNHRHLDEIDNTSILILTVLINEAMCNIKKF
QKNKKLSPKKEIDERLSAIGYWEALCVNHISNNSNLDYLKIASHCGKEIDNGLHIKIVNF
VLEKTELSMKYKDIFMDAVFEAMANAKEHAYDDSRDKKIWLMGAYNEKTKETEIIFYDIG
IGIFQSLEYSETKFAKYLNKFANMFGKKKALERLCTTNLSKYKKNKRRGLGMMVYKKLID
SLSAERNAILELYSDSLRYSTNKGTHAIQGNIKGTLVRWIIGEKK
>fig|195.2173.peg.797 hypothetical protein
MCRILPVIRDTIIQTILAKEIQEIEFSNFKLELQRELVKKINEKLGNKLIKELYFRDFII
S
>fig|195.2173.peg.1757 FIG00469432: hypothetical protein
MVHEIQKTFLLPDATLLEKLQKDGIVFEIYEIETFYTKITYFYDVKFQNLNGNFYKITRL
NNPILEQNQEEKISKKDYEKARKKLIEKSIKKKRYEFKLCSFKSLIDVYEDFNLYVLKVF
FPTLEMANLFTPPK
>fig|195.2173.peg.261 Channel-forming transporter/cytolysins activator of TpsB family
MILDFDNSGYKAKGEYKASAYLSLSNILNLNDSIRFGFIKGLLKDMSQERENVYVANYTL
PIQSYQLSYSMQYSDNINMIEGYDNSFIKNTDTSLRHKIMLKKILHRTSKDKFSIYANLG
IKDDVNEIDNFRLESSSGRYSSIASGVEYSTLAFGGFLFLNLEYEKGIPFLGSKKDSKDS
LYKIEFNKVNFNLSYQKSFYANDGLAFLYQNSLGASYSNEPLLYADKFLIGDEYTVKGFK
ESSAALDYGAYSNNTIYLQFLNAPKYLRALEPFVGLDMGYGRDYLLPNKDFLAGVAFGFR
YNLNHLSLNLTASKALHKSSNMPSETIPIYLRASVFF
>fig|195.2173.peg.601 hypothetical protein
MQEKIQILMDLLEINKAQATDIVGRYLKSVKDIHAFLDFYFETLERENIVGTTYEKLRRV
CKRAEIEFKKRFEDKEIFLEWLKNKYKNSPFFRLLESDFKYSYVCYDGQGNLFKRLAKSI
NMLVCLNNFGELTYEDGEMLKNNEFKHALIDFIFKNQERIGKDIYINTSYKIKGYTSLSH
EEEYNNFKKVQKKILRRIKKNFKRKQKSKWLLKI
>fig|195.2173.peg.808 hypothetical protein
IIQSLYPNPKYILYHSIFDERSPFENKENFVHILKELNFKVEFFAVSQVDNKFIKNLNHG
MGLSTKLFFKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2173.peg.1871 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
SPFFIPSALVNMLGGLISIEHGLKGPNISCVTACPARNHAIGGANKSIALGNAKKKVGIG
AEAAFCPVGIGGFASMKALSTRNDD
>fig|195.2173.peg.687 hypothetical protein
MKITMIILSLFSLVFLSACAFKEKKASEIETLASNYGGIYIFDKKIREEILELEKKEEFR
SKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYR
>fig|195.2173.peg.70 Ammonium transporter
MMFALIASAIITGSLVGRIKLGVLVIFLLFWSTLVYDVLAHMIWSSEGFLLKRGSLDFAG
GGVVHISSGVAGLVGALMVGARKSDDEDKNAHSIPYAFLGAILLFIGWLGFNAGSAGEMN
DIAINAFIVSIISAACGFLSWVVLEWLIHKKPTILGGLSGLVAGLVGITPACGYVDIYAS
LVIGTLSSVFCYFGLSFIKYKLKWDDSLDAFSLHGIGGIWGGIATGLFASAKVNPNVIAQ
NALGEGFFISGSLELLKEQIFAIVICVVLSALISFVIFKIISCFTDLRVKEEVEQKGLDV
SLHGEKAYTLA
>fig|195.2173.peg.1870 Chaperone protein DnaJ
IYDRYGKDALKGGGFGSGGAGFGGFEDLGDIFSSFFGGGFSGASQRRKKSSDEKFQAELV
VKLKLSFKEAGFGCKKNIDFTYKS
>fig|195.2173.peg.1189 Inner membrane protein YihN
MQNAKPIRWFTFIVLVIGGGTVFKLSSLKDAFYVPMQEFMNLSNTQIGLALSVYGIVQTV
GNFASIYIADRFSKKILIPFSLICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVL
LKAIRLLGDSTQQGRLFGFLEAGRGVIDTIVAFSALGIFLLLGSGAGGFKAAILFYSACV
IIAGILAYFLLEDDKISTKDDEGHEISKNKAAWNGVIKAVKTPEIWVVSLTIFTIYSVYC
GLTYFIPFLKDIYGMPVALVGAYGIINQYTLKLVGGPIGGYLADKTFRSSTRYLRFALIL
AAVAILIFYFYAA
>fig|195.2173.peg.1789 Motility accessory factor
MGGGYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNG
>fig|195.2173.peg.1326 Protein containing aminopeptidase domain
MPDAIPYVTSYYKRRWGFCLTHNERKKLKKGKYKVYIDAKHDENGVLDYADFILPSTQNS
KDEILISTYLCHPSMANNELSGPVVAIFLAKWLLSLKKRRYNYRFVIISETIGSIVYLSK
TFRAFKKTC
>fig|195.2173.peg.1096 FIG00470444: hypothetical protein
MAFFAGMSGQNPLIEGETTIEGKLLGYDKNMSQSQVEDLNEFINQNPIEWSITGDVFADS
VYNQT
>fig|195.2173.peg.1888 LSU ribosomal protein L4p (L1e)
LYVKSYLASLRANTAHTKGRSDVSGGGKKPWRQKGRGGARAGSTRTNVWVGGAVAFGPTN
ERNYFQK
>fig|195.2173.peg.1771 Motility accessory factor
SLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFEKIQSVYLNLNKKENDLNLAIRKIDE
FKNKLENIKQMQVLYEILQPLRTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMEL
VYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2173.peg.608 hypothetical protein
MKKEEKIKQKEYNVFFYKLSVKPNLFNQENEIYNSMLKFLKINLRDRQLCDINGCKAYVN
FIKEKNGIYLFYYKKYKQTYEKYSESCKVID
>fig|195.2173.peg.331 Membrane protein
MSFSGFFYARNDLRLFKIEKKSEIKSFFYKDYTLASFKDELNLNNEIFFYQSLKENLFKE
NDEILISNLGKKIILFRNFTQNSDNFAEAKLKQVLLLIFLFLASVFFASLAAINEFGAVD
LVFLMICLLLLVMGIINLGLLFKQIRILKSFSKEEMKEFLTQRMKKYCKGYFKKNM
>fig|195.2173.peg.737 hypothetical protein
MXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXCESIEP
>fig|195.2173.peg.439 hypothetical protein
MKKPLLLKHDCGLESMISQAGRSFVKPRLYKKLLEKFLDFIEIFQDCSIFFILRKN
>fig|195.2173.peg.712 Ankyrin repeat-containing possible periplasmic protein
MRLLFILFCCFLGLKAENLITCDYIKNNKAQVFQDSPKQDYLDIASTCDFSLKNQAFTKR
LYQLANEIRGGNAACSGIEYFPKLQEFDFLLLKISIDPIEYQKGLDAPENLEKNTLF
>fig|195.2173.peg.1887 FIG00470222: hypothetical protein
ETEKANANLVKRQTAQIDDELELKEQSVNIDKSLSIEKEKLLQAQTETEKANANLVKRQT
AQIDDELEL
>fig|195.2173.peg.1790 Putative periplasmic protein
MKKVFPILISLCSLSLANVYEKLNDFAYEKKPNKDFKIQEVKLVQFLQDDKNCLELLIEA
GRVRILKSYNECQKLSKDADFQKFLNEDFLRLYKNNGYSINENLQDLKKAMQDIMIYYKL
RFAFSKNIQDMSKNKNLSILNIDEKEGGTLLYKINNQACVAIEL
>fig|195.2173.peg.1447 Hypothetical protein Cj0261c
MNLWDKKAKSYARYNQKLNSIQEQSFKELEKLNINFKDKKIIDIGCGTGVWTLHLAQNAK
EITALDNAKAMLEILKEDANKLQLTNIKYENCTFTEWINKNQNAQFDIAFLSMSPAL
>fig|195.2173.peg.1849 Methylisocitrate lyase (EC 4.1.3.30)
MSAGKKFKELVKTSKPLTIVGAVNAYSALQATKIGHKALYLSGSGVASASYGLPDLGIIA
LEE
>fig|195.2174.peg.1252 hypothetical protein
MIVSKTYEIDSCDDVELGIKRESKLEFKLWYDDEKTPEALVFVVQGVGADCNDIYLKFIV
EYLLKNFNLAFVGVNYHCIGNRPQTGSTFYLDDIDKLILKASCEAVDIKLPYDVDKIQDY
KQMSEIFHFVNNQIVEGKQKGNFMPNYFLNLHVSLQPAKNEYQNFGIMQAQDLLNVALYL
KKNTPFDTMGGGIPVIMIGGSHGGYLAHLTAKIAPWLVDGVIDNSSGAKFLWRVVGFGKE
IDFMQYSEFATFDFFHHIKTHCSTKTFWTSNSSSPRFFSPARRKIRNLLEEDHLLEQSKC
LKTCFISYHSLYDEYVSLKEKTMLYEELEKLGFDVTLHSITKESQVDGKFIKNLNHGMGI
PVKLLIKKELPLMLEKIKQNSKKDCKEKCISYPCEDLLYQFSEKDDKISLKIDKI
>fig|195.2174.peg.371 Major antigenic peptide PEB2
MKELALKFEEKTKEKVVVTAGPTPSWFKKARKDADLIFSGNTSMMDGFIKRIPSLNLEDL
VVLMPVLQVSSCVLITQKISKVLRIF
>fig|195.2174.peg.615 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
NLESLHIEDFYKNINKESDLLNKSLEFFKKEYQNTYAKTIVNFLKNNFKTLYMLNTNDDK
ELEKNQILLNSLEEKDNQIRVIFCVDKLNEGWDVLNLFDIVRLGNKKASKTITTKEAQLI
GRGARYYSFKSDLFDFDDEFRFKRKYDSDLENELNALEKLTYHTRNDVEFIKQLNESMNK
EGLLFEEEKTRIDLIVNEKIKEIIKNNKIYYANNKRIKKRDLKNFYITRIEMEQKIKGLQ
IPYFSNSIKESEEKFEEIKEEYDLQKPSALNHIDNIYFLKAMNILGLDFNKINENFTFKS
KKDFIENCLKNTVVCFSKRQEFNQINNLEIAKYILENFKSLKQNIKQEYEVSEFITHEFN
IGNKVVFKNKENFKEMNFEWLYHKTFCFDSNLEKEFLNFIEVKKDEINKVFSKWFVIRNE
GFEEFKIYDNRKDEVTYAMGFEPDFIFFGKKNKDDDNFLSIQCFIETKGEHLAIAKDAWK
EEFLETLKGKIITTKDDKKLTLQSLPFFINKNFNINDKFLSSFDEFVSFQDER
>fig|195.2174.peg.1616 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISNT
ATNQISQLKNTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITEQINGAKTELNSKINNKVTKTGDETIAGVKTFSVPPVSATNPTANNQ
VANKSYVDTVGNSKVALSGNQTIAGVKTFSSSIVIPNATANNHATNLGQLNSKVAKTGDE
TIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAGIKTF
>fig|195.2174.peg.1868 hypothetical protein
MLGSTAPDWIEWILKFFGISVKHRGATHFLIIPLSLILFSFALDFNGFLFWFGMGYLSHW
IADSLTISGVPISPL
>fig|195.2174.peg.1834 hypothetical protein
NIVNQANINLTNARTETEKANANLVKRQTAQIDDELELKEQSVNIDKSLSIEKEKLLQAQ
TETEKANANLVKRQTAQIDDELELKEQSVNIDKSLSIEKEKLLQAQTETEKAKPALIARQ
TAQINDNLRIEAAKVTQSVQFGYCTGGLDIPQEIMKLVKEKIENIEKSS
>fig|195.2174.peg.945 McrBC restriction endonuclease system, McrB subunit, putative
MLEDKYDWKISKADQNGNVYYYFPKDEDEFKEAVVKNGGMSVYVYQGGL
>fig|195.2174.peg.1831 hypothetical protein
MTYLMSWIWSGKGMNKTRPKQLSFRVSEEEYQQLQEKISESGKNQQEYILSCVLEKQIVN
TDGIKELIPELKRIGNNLNQIAKRCNEGGMLPSEAEVRKHGEELNKVWQSLRRYLQRRA
>fig|195.2174.peg.507 hypothetical protein
ICDECEISIDRDYNASLNLLSQLKQKIGKVLAEFTPADLTALLNDLAINQIATSKVETGI
QQKSYL
>fig|195.2174.peg.1851 Tetracycline resistance, ribosomal protection type => Tet(O)
VFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNGELYPSDTACSGD
IVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKPEQREILLGALTEISDGD
P
>fig|195.2174.peg.1771 First ORF in transposon ISC1904
MLLMNKLLSIGQASKALGVTIQTLRNWDKKGLLKPDDMTKGGER
>fig|195.2174.peg.1086 Phage antirepressor protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLLWIKL
>fig|195.2174.peg.221 Multidrug efflux system, outer membrane factor lipoprotein => CmeD
MLEKYLKSAIFLALYPLAMLASNLHEFIALSQNNESYLIKQMQSEQANLDKEQAFRNYLP
SLSLNSAYVANNKDRFIIDPQESLFAKVSLNFLLFDGGAREANLRALKAKKN
>fig|195.2174.peg.1846 Beta-1,3-glucosyltransferase
VDDGSTDNSAQIIKKYQKKYPKNIVYLYKENDGQASARNLGLKYIQENNYKTPWVTFTDP
DDFLDRNYFYEVDKFLATHQDDDICMIGCNIIFYYEKQKIHKDNHPLNFKFKSGVQVKEN
YNLDSFIQLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKY
FYRKRED
>fig|195.2174.peg.506 Zinc transporter ZupT
MLFMEFTLEQILVAMALTILAGLSTAIGSVIAFFSRNDNLRILSFGLGFSAGVMIYISFM
EILPFLQTYKIL
>fig|195.2174.peg.1858 Tetracycline resistance, ribosomal protection type => Tet(O)
TEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPL
RKAEYTIHIEVPPNPFWASVGLSI
>fig|195.2174.peg.1345 3'-to-5' oligoribonuclease B, Bacillus type
MKIYHLSHTDLDGYACQFIVNFYFINVNFYNSNYGNDINDNFIAILADIKKYNS
>fig|195.2174.peg.1843 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGAYNC
>fig|195.2174.peg.222 Multidrug efflux system, outer membrane factor lipoprotein => CmeD
MQKFYDAGLSPKDELESIKAKYHLSLLELSQNELKLANIQKEIKILSDTDFKVQGNAFLE
NPQQEKSQNYEVMIAKEQINLAKESVNLAKAEYFPKFYIQDNFNFYKNNYNPKVPAPFVN
LADQFLEKYSQGNQFILGMEWKIFDFNARAKEVEKERLNVQIANANARFSERKNKEELNY
LDKSLKVLQEQILALNLSLNAANLAFESVDKKYQAGLVSYVEYLQALEAKFKAQSDLELA
KNEFEITKANYYFNAGIDLNSKVKE
>fig|195.2174.peg.1826 Beta-1,3-glucosyltransferase
MDRDYEADDNAEHLYRYIMQNHPEREIVFALRKESLDWERLEKEGFNLVEFGSFEFERII
KKASKVISSHADEYLMRYITSRQQFIFLQHGVTQNDISKWLNNRKINLFFVSAQMEFDSI
VKNYTRYKFGQKEVVLTGFARHDALLKNNKTNTKQILIMPTWRHYLSGLMIGNSGIRELK
DDFKESEYFQKWNLLLDSNTLQKLCEKYSYTIVFNPHPNIIPYLKDFNIPSYVKIANQSE
SLQKLFCNSSLMITDYSSVAFEMAYLNKPVLYYQFDQEDFFSSHTLQKGYFDYRKNGFGP
VVEKEENLLKELENLLQDNCRVFGVYKDNIDSTFVFRDGRCCERIYNILKNSNHGVKY
>fig|195.2174.peg.1855 Mobile element protein
KEQFPFVYEVSKYATQQPFLNLNLAFQKFFRDLKQGKVSYPKFKKKKDNFGSYYIGGDQA
IIKDEKYLKVPNLGLVKMKEKLRFNGKISSFTISQ
>fig|195.2174.peg.1668 FIG00470597: hypothetical protein
MSMDDLNCDFIHFFNTIYIKLIELCGSNLERFTPLKDLKKLGFHIICSKGNRGALANLLL
FNEISSFFKIIEKYDYNFKECQTVYDLLYEKRNLLNIIDTIGIELCNKICKNLKEDDENF
YHPKIFKKAL
>fig|195.2174.peg.793 GDP-4-amino-4,6-dideoxy-alpha-D-acetylglucosamine N-acetyltransferase
MKYFLEHNDKKYSDKDLIDAFYQLGIKRGDILCVHTELFNFGIPLLSGNEFLQTILDCFF
EVIGKEGTLIMPTFTYSFCKNEVYDKINSKTKMGALNEYFRKQTGVKRTNDPIFSFAIKG
AKEELFLKDTTSCFGENCVYEVLTKENGKYMTFGGQGHTLTHYAEEQFNVFYRYHKIFSG
ILIDENNISYNKTISYY
>fig|195.2174.peg.1298 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MALISIILPTYNVEKYIARALESCINQTFKDIEIIVVDDCGNDKSIEIAKEYAIKDNRIK
IIHNEENLKLLRARYEGVKVAKAPYILFLDSDDYLELDACEECVKILDENTEMICFNAYI
INNAKIPIENYFTDTYTIEKFIQY
>fig|195.2174.peg.873 Oligopeptide transport ATP-binding protein OppF (TC 3.A.1.5.1)
MLEVKNLGKFYEFKKHWYLKKEKHLIFENINFSLKENENLMILGQSGAGKSTLARI
>fig|195.2174.peg.1819 hypothetical protein
MPEKGKTFAGEVREETVAWSKDTYQLLKQAEQGKVKSYVQDIALFCIGWLYDLEFHYANT
EAGRLEAVCDYIPSPEGNTISGVEAGTPVRAVSWQTIDNHLLIFFAADNEENVHGVMHLY
SVNPVQILFLLCDFHKKYILCVLKLAAVSASHCTLVIKAILTNLFTKTLYISNIELYLAN
F
>fig|195.2174.peg.1210 hypothetical protein
MLPNINEIAKETLITLKDRKLRPTPENYTEIFEELSKKYGLISSNKAKLEKYKALLLPNY
QQELNSKSIRTLEELISFLISALNRQNGKQFSEFFDFLATLSKSLQVSKDKKIRDLAKIT
SIRISKTMDSESIYLLSKKWKEFEKNYNENDLEGGLRRYGIAKYDDFDTVVKKLLNKLEE
RSLEVFAELLASCLNPSLVEDLKIHGFAQNLLQKPFLLSESGFKNELLEFVNRRVMVDNM
Y
>fig|195.2174.peg.285 hypothetical protein
IQLNERINSLNAQIEFTQNLEERESWSVLKELERLDENYNKYKVNYSLALFSIKNYRFIM
ERYGVGSLNEIFVRFKKILKDNCSEFDELWMIDEKSYLIISPGRNKEKVAQLVRENLKTI
ENFRFIYKQDIITPKIITAYLDKQSKPHTNILEELMNQISNLDERNNAKDQ
>fig|195.2174.peg.1692 hypothetical protein
MTAYIHIGTPKTGTTSIQKFITLNLDLFLQQGMSIQKLFV
>fig|195.2174.peg.1745 Filamentous haemagglutinin domain protein
MKQEYNKNPIYRVLYLFIGFYRFVGTVLVGEGATINANKFGVSITPMGIDAINTFSVDGS
FSPVFNANKGDVVNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTH
LKAEIGSEGFFKYEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEM
INSWKGFAKLVNEGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSN
IQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIALD
TIEGFNGENSSSGGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSN
IESIYGKNNGGGFVGYTTGNTTFDGIGLKDIRFIKSGAFTGGFAGMT
>fig|195.2174.peg.1812 hypothetical protein
VEITYKIYEKDQKTRESDPSKIYYTLTSKKVSFFEVFNSIKEIYKCKYATPLCFYNSFNF
VCYEEPYVAFSSLNNASWGKKDTSVTPSIYPLYRKSSNLPYGRRDRWFALWDSFYYLYVY
EKSSKGILSFLAPIVTIVLAVATWWMGGQGAWLGTLIGVSESVAAGITLGISLGLAIGSL
TGNKTFSILNAVWGLVNFLGAWGANNWNLAADFTKNTAQIAQEMTTFESALNIAGNLLSG
ASKIFDVVQSITANTPDMINEQKGSDLDNNEGGNGSEALELAKDMINPTIWYNFETTDIL
NEKIEKNRNLIFAF
>fig|195.2174.peg.1833 hypothetical protein
MLIDEKRLMRNYTLKPAYPSNIGELDTGEVYKQWFTYAMIGVNKYVELLHKQLIRKGRSY
SQNATHPLYPNSYIVKKYNIKSASTAPYDKHSHGNLGLNQFFVGQDPYKPYKGDPSSKNG
IYHDICEIRTKYNLGNMQYYYGFPNNLTLLFEKEKAWKYNGKRFFYIDEKINFKDILNKA
LENINYEMLINDIEVVIFSQTIQKNNEWIYPSIDDIKIPNIKVENIEFKPTFGKPYKKPC
VDVEKFYNDFKELNKNIFRI
>fig|195.2174.peg.1847 Motility accessory factor
NAIVVSAGPSLAKQLPLLKAYQDKAVIFCADGALSMLEKEGIIPDYVLNIDFEDLPLRFF
QNKENKTSLNMLSCATHPSLVRVLDNKSVILRDDPLYQRFNLNDFGYIDTGTHVSHFSYT
LALALGFKNIIMIGQDLAFDEKGNSHSKGFALGERIDHTLNLPTLQVPAYAGKGEVLTHI
AWN
>fig|195.2174.peg.1211 hypothetical protein
NKIAVLPLCKEVDLQNLNIDNEIQKISKFIYQNQFEQIYIVCPRNKKFTHFIQIKHFLCD
LNKTMLKLVPYSITNKLIRRK
>fig|195.2174.peg.1861 hypothetical protein
QTTQSQNLNNTLSTKTQELTSKTTQIKELNQVVANQTTQIQNLNNTLSTKTQELTSKTTQ
IKELNQVVANQTTQIQNLNNTLSTK
>fig|195.2174.peg.1615 hypothetical protein
MLFGFDDKREFIPRVYSSLCKQELVKTFLIQYNASIDSALRIPLSYAKSAKDLKMPFQNF
LQDVIHTPFGKIKNIDKNLTLNISYFQKRKSLIFKTKIFQNVDILRLLRAYFRGICFDAQ
VLFDFYVYDKISHQNQNRSIVQNDNLIIIDNK
>fig|195.2174.peg.1380 Protein export cytoplasm protein SecA ATPase RNA helicase (TC 3.A.5.1.1)
MPKFEITTLKREELDILLEMIIEFAQYE
>fig|195.2174.peg.1844 First ORF in transposon ISC1904
ILDGKVKRLVLTHKDRLLRFGAELVFAICEAKEVEVIIINKGEESVKFEEELAKDVLEII
TVFSARLYGSRSKKNKKLLDEMQEVVVENVSK
>fig|195.2174.peg.1251 Type II secretion envelope pseudopilin protein (PulG,guides folded protein to PulD in outer membrane)
MRKAFTILELVFVIVILGILAAIALPKMSSSKDEAEVSKSLNNLKTLINDISIYTLKNDH
LSSIKTMSNVIGVENVDLGNFNGTKEVNFGVGNDKECLKLVFINKADFILMGISSNEASK
NAIINAANQSHEDLENIDFTSSSSNKACVILSKNENFKNLASKTYLLIGGM
>fig|195.2174.peg.1842 Motility accessory factor
LLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRFLNDALALKQILENILSKDF
ILPLEFLEKVYQNIENFNHSLDTDEFIQDGILKAVIYERGLKISLVYKENILDHASFISA
YIKAYDEWLLYFMEKLEQRINIIINFLKELP
>fig|195.2174.peg.1514 Arsenical-resistance protein ACR3
MLGFIDRFLTLWIFLAIFLGLILGIIFPNIALFWNLFEYKSVNVVLTLCLILMMYPPLAK
VDYAKLSKVFDSKKVILLSMILNWFIGPFAYVYLDFLPKLPGQSTLATSLDIDFSALSKN
VLIYLEFLF
>fig|195.2174.peg.1324 putative integral membrane protein (dedA homolog)
MQEIIHFIIETASDWGYLGIIILMTLESCFIPFPSEVVMIPAGYLAHKGELDIVFCILSG
VLGSVLGALINYYICFFLG
>fig|195.2174.peg.1839 Tetracycline resistance, ribosomal protection type => Tet(O)
LLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPE
GQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNGELYP
SDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKPEQREILLGA
LTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERP
LRKAEYTIHIEVPPNPFWASVGLSI
>fig|195.2174.peg.1845 Mobile element protein
MSANNNELISISHKIELKPNNKAKTHFKKAFGCARLAYNWGLAKWQEYYKQGIKVTHLDL
KKEFNAIKKEQFPFVYEVSKYATQQPFLNLNLAFQKFFRDLKQGKVSYP
>fig|195.2174.peg.1825 Beta-1,3-glucosyltransferase
DEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKYFYRKREDGSSTLDLKLKSKNYYLNVT
RNGYLKILSDCVKNKRDIPLFVQNLVLYDLCWQIKPLINSPEKLSILNESEQQEYLNLLD
KIFSFIEIETVVNFSLAGCWFFYKVGILNCFKNEKPAFQIAYIEDYDPYKEQILLTYYTG
DDKDIESILIDREEVYVDYKKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEVLINNEQGM
VGKYGEYFLDVKNIRKEFQKRLPKSNI
>fig|195.2174.peg.1699 hypothetical protein
MTAYVHIGTMKTGTSSIQNFLYLNRSLLQKQNYYYPISIKNIGRLNDHNPFAHKFNTLLN
KTDDLKIFSREFKNLNNEIKMCNCDKIIISMENVQWLLNSQQKIKYFYDFLIYIFD
>fig|195.2174.peg.1796 Translation-disabling ACNase RloC
YKDIFIGLKEQLGVSIANYNEELLKIEKKLTKKKKDVFTPMKLENINDFSDEILQILNKI
ENLCKENNEYAKNLLSKQDEARKKLRLNEVAKFAKDSDCFAKQDEIKNLGQKLSNMQSTI
ETEKNEINNYNLEIEKYKEKLSNLETSTSNINKYLKSYFGHNMLELKAKKDDKGQLNGEF
EILRNGKQAKNLSEGECSLVAFCYFVASLEDANTKDKNPIIWIDDPISSLDNNHIFFIFS
LIEAKIAKKIKDNKYSQLFISTHNLDFLKYLKSLTGYDKNDKKSFMYLIEKTNNSDIKIL
PDYIRKYVTEFNYLFEQIFKNYNNTNITIDSYYSLANNIRKFLDTYMYFKYPNNDSLMTK
YYIFFGEENAILINRVINEFSHLENIERAKMPLDLLEIHKVINIIIENIKNKDKEQFEAL
LKSLDIEENDNAK
>fig|195.2174.peg.1686 First ORF in transposon ISC1904
ILDGKVKRLVLTHKDRLLRFGAELVFAICEAKEVEVIIINKG
>fig|195.2174.peg.1755 Aminoglycoside N3'-acetyltransferase (EC 2.3.1.81)
HINIYNAKEYIEILWKKLDINQTILIENYDTIY
>fig|195.2174.peg.1509 Putative transporter
MSISKINFDLISIILALYGFANIIGNNLAPKLLIKNVNLNLIFTLLLMIGIYVLIFNFYY
QNMILMILAFILGILGGVMNNGTHFLISHPFPRAKDFTNGLFISVANIGLSVGTAICGLV
ISLSNTRFIAISSVILLSFGIVMILLRDKIQSMKLRF
>fig|195.2174.peg.1709 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MFNKKLHELLQEEFGKRGIEQIEIPFYVKENLSKELRIYQEKALKYYYANSDSIKQRHLM
FNMATGSGKTLIMAALILDCYNKGYRNFIFFVNSTSILEKTKANFANKYSSKYLFKENIN
IDSKNIEINIINNLFESKNECINIYFTTIQALFSLFKNER
>fig|195.2174.peg.1810 Predicted P-loop ATPase
MSSYMIADPVASVAMSRASSIINNFNKLLSAEKKGLDEIKNEINTALLNIDIKIIVVIDD
LDRLADTDIQEIFQLVRSIADFKNTIYILSYDEEIVSKALDKIQKDKGGKYIEKIVQVPI
KLSKVSQENLKDIF
>fig|195.2174.peg.1734 Motility accessory factor
LLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRFLDDALALKQILENILSKDF
ILPLEFLEKVYQNIENFNHSLDEDEFIQDEVLRGAFAYRGKMIADVLKLHIKDKIHFITA
YIKAYHEWLLYFIEKLGQKYKSLSKV
>fig|195.2174.peg.1836 Tetracycline resistance, ribosomal protection type => Tet(O)
HVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLG
YLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQA
LKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQ
EYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>fig|195.2174.peg.1764 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
NDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDYNKIYESGFLDQK
NDWTWFLGYNRNSGSKKISSKLWLERYKHIGHFAFVWQGVINFRFLKNIDLKFIDGIFHQ
DVHFGFLLFAQSSYIYLLSKKLLVYRIRNGATTVRNFKNNLKDEIPFYIQELLSYFEIKT
AKEYYSIYSWIQIILNVMHSHNIKNNLHSDLYYLFIGNLSEQILKLKFSYKQDPMHLSGF
INFIKTFVGLHRILQNNMQEKITQLSTKTQELTSKTTQIKELNQVVANQTTQIQNLNNTL
STKTQELTSKTTQINSLQTTLKNKDSLLSFQSQHGTAKQRIQNQLSYKLGQAMIINSKNI
FGILFMPICIISTILSYRQEQKLYQEKIKKDPSLKLPSLESYPDYKEALKFKNHLSYKLG
QALIKANKTWYKGGYVRFLFELRKIYKQKTMKNSLILYKNRDSNKKDTTRSIKKKGGGDR
LALGLDEQYFIKRHESFFHYKPDFRNPKTFNEKIIHRILFDRRDIYTFLADKIKVRLYIQ
FILEYDISNGQIYKLLSKNIDELSEELKNTNKCSYLPEIYGIYKHTDEIDFDFLPNSFVI
KTNHDWGGVVVVNNKAEFLADSSKKIESLTKLQKHLDRNYYDVSKEWHYKNITPRIFIEE
NLSQKNNDLKDYRFHVFNHKTQFIQVANSAHTCNNLYYPDWKIFPIMYLNKRDSKEIQKP
YKLKKMLKLASLLSIDFDYIRVDMYLVDSKIYIGELTFTPNCGKAKIEPAEWDLKLGQMW
RSDVFKL
>fig|195.2174.peg.1727 McrBC restriction endonuclease system, McrB subunit, putative
MIDEFHTKSQGYRWTSPVFNYLKTMNKNGKDFYRYYKNCKLFAIVD
>fig|195.2174.peg.1581 Phosphoglycerate transporter protein PgtP
MLISLYVLYAVKGSPKNEGLVDITEINEMRGIKTEEIKAIETPNLSSFEIFYHYVLKNKN
AWYVAWMDTFVYMVRFGLISWLPIYLLETKGFNKEQMGIAFWLFE
>fig|195.2174.peg.1852 First ORF in transposon ISC1904
LETLKAINKNLVFNKDSLKTIAYARVSSHDQKDDLIRQVQVLELYCSKQGFNYEVIQDLG
SGMNYYKKGLTKLLNQILDGKVKRLVLTHKDRLLRFGAELVFAICEAKEVEVIIINK
>fig|195.2174.peg.874 Translation-disabling ACNase RloC
MKILKFDKINFGSYENFTWDNGLEEFKTINIFYGRNYSGKTTLSRIARSFELKKHNEDFL
DGNFKIKLEDGSFLTQNDVINSNLDIRVYNSDFVKENLNYLYDKKGNIKGFKSIGVEQKD
IKESIEKRKEILKTRNEKLKDIQANRENISKTQQAKIKTLNEKLIDKAKLVKSEPNLIKQ
GSNYDKRNLENDLIEIKDNINAYILNNEEQNQLIKILEDKEKQNIIFKNTFNKDNFQGIF
TYSLKILEKEVIIKENLTSELRKWLEEGLEFHKEHSFTQQCKFCNNPLTLERIAWIENNI
KDDSGEKEQIEKELKDLLDNFESYKLESKKLLLGIE
>fig|195.2174.peg.1837 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
NDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVEVVWFANKHLYDNVNIPET
RQPTLFEYYNFDKECQISSEEWASKTLQMGRKSFWFTVMGMIDFNFLKNIKLKHYDYAIL
EDNLFGILLFMQVSKIYILPKQMYRNRVRPNSTMNHDKKVTASNIPLFLQTVYYSFDKDP
ERTKEYFRVASWVLLNNQMKLFLQNSYLSYYRCLLMREFVKYYFSLAKPIFKYKNDPLNV
SSICLEVSNYIKVLTMQTKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEI
>fig|195.2174.peg.1770 N-Acetyltransferase PseH involved in the biosynthesis of pseudaminic acid
MGGINTNIKNTLMTNFFKITQYNIKNKNIVFLMQDYRCNILLKNYINLNYIEKEKIRKYR
NHPEVKKYLYQTHFISKLEHKNFIKKLKYNTKKSYFCVILDNQIIGNINFCIRENEIDFG
FYANPFSKILGIGRILEQISIYYAFKIINIPILSLEIFSNNTQVINLHRKFNFSIVQEFF
IKKQKILKMSLKQSDCKALLS
>fig|195.2174.peg.1587 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
EFFPHKERLFPKKDLSNYKENYELKEMKPEYWDKIAEFIADIVKTKNQNIADKTNIIQNK
DKIITDQTTQIKSLQVNIKDSEVKLVQIQTSNNTLSNIIKEKDNIINSNINHINQLQSNI
QEKSTQLNQIQSKLSFQTKYGTAKTRIQNQLSYKLGQAMIVNSKSFLGYIRMPFALSYIK
DKHKQEQKNYQEKIKKDPSLKLPPLESYPDYKEALKEKECFTYKLGEALIRANNNWYGGG
YIKLWFEIGKLKREFRNKKI
>fig|195.2174.peg.1642 ABC transporter, ATP-binding protein (cluster 5, nickel/peptides/opines)
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGAGRGGGVGKGGGGEMRYGNVGPHSLD
KTKQRLLRKEIQYCFQDQKAALNPYKKIKNLIQDGLENFNIKKEQEKILEFFDRFNLKKQ
ILEQKPYELSGGEATRVGLIRALILEPKVLILDEITSSLDMKNSKEILKFLYHYQQENLI
SYIFITHQDGFFVNFKCKKMKL
>fig|195.2174.peg.1586 Zinc transporter ZupT
MCFFGGIFLSAIIDKFIPEDVNPHDPKEDLSELKICPLPQKNEKAPAFHAGEPLKKINVK
ALKRTGIFTALAIAIHNFPEGFATFISSLDNLSFGVAIAVAVAIHNIPEGMAVSLPIYHA
TKDKKKAFIYSALSGVAEPMGAIVGAFLILPIMNELTLAITFAVVAGIMVFISFDELLPA
AKTYDKAHDSLYGLVLGMAVMAVSLILLNP
>fig|195.2174.peg.1111 hypothetical protein
RLSELMEKYTEFRFRNENHIHIFTEGYADKWAFPLSEFNIKTNDDFLNQSYDFCQFCNII
NIKFAKGDLFC
>fig|195.2174.peg.614 FIG00469432: hypothetical protein
MDNDLVYLMFFFLSGEELQNLLSDFDFFIKEDSFYKSEQEKYFFKQMIAMQLRKRLVLFK
KNLLKNFEIETFEENFLGLSVFLEYFHNLYNLKILSKLYNKYFICDLEKKTLLKLTKKKE
KLGKLIHKASKKLKIYKGY
>fig|195.2174.peg.1108 FIG00471554: hypothetical protein
MNLFIRALRVLFILSFIADLTIIGLFVGIPLFLILWGI
>fig|195.2174.peg.1870 hypothetical protein
MTWKSHLAIGTAISLPFSPFGTPLAMLGSAAPDWIEWILKFFGISVKHRGATHFLII
>fig|195.2174.peg.153 L-carnitine dehydratase/bile acid-inducible protein F
MLPLEGKLVLSIEQAIAAPFCTRQLADLGARVIKIERPEVGDLARGYDKRVDGIASHFVW
VNRSKESLAIDLKDPDGLEFIKTILPKVDIFVQNLAFGASKRLGLDYENLKKYNPKIIVC
DISGYGEGGNYGHKKAYDLLIQSESGLVSITGTQDECVKVPISIADISAGMYAYSGILQA
LLYLEKTGKGSRVEISMLECMAEWMNYPLYYTYKNATPPERKGAFHASITPYGPYKAKDG
VVMFGLQNPREWESFCKIVLQDESLIEHEDFKNNTLRTKNASKVKEIIEDAFKNLSAKEV
VDRLDEAKIANGNVNELNQVWEHPQLKARNRWREVDSEVGKIPALLPPATNNNYEARMDK
IPALGEHTESILKEFGFSDKINLFKEKRLSKDFI
>fig|195.2174.peg.1159 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
TDTYSIEKFFPYLIKKDNFARNAWGKLFKKDKLLKAFKELNLNNDKITMAEDALIFSSYI
KDIKNVKTFERYLYNYNCENVNSATSQKNINQIKNHIKDLEYCIQKISTYSYDNAYCYLF
CQYIINCLQLHKYDLYYKNIAKNFIYKFILRIYRKKLKSKKNILIKKAKYILEGKQCTI
>fig|195.2174.peg.1510 Putative transporter
MQALNQEKFNSLSDIKIILVLCLGVFGILSTELGMMGIIPIVSQNFSVSISDAGWSVSIF
ALVITFCAPIVPLLCANFNPKKLMLVCLAVFILSSLIAAFVSEFWQLLVFRAIPAFFHPI
YIALALSMAANLASDKKDIPKNVGKIFAAVSAGMVLGVPLTSYLGGNFGFEISMLLFVFL
NLLSFVATLFFVPNFKKENKVKIGKQLLILRYPLLWISILCVVCINAGI
>fig|195.2174.peg.1290 FIG00470545: hypothetical protein
MNHEKSLIYLIALCLSYTAMQAVCKYAEEQREDRGGVCLLLL
>fig|195.2174.peg.1857 First ORF in transposon ISC1904
LMNKLLSIGQASKALGVTIQTLRNWDKKGLLKPDDMTKGGERRYKLETLKAINKNLVFNK
DSLKTIAYARVSSHDQKDDLIRQVQVL
>fig|195.2174.peg.1641 hypothetical protein
MINIKELLSIEKHPKVQQTYILPSFENSKSLKIELQCDDDKYHKENFILDISRSSVQFQR
KTNQYRYNAINII
>fig|195.2174.peg.1323 putative integral membrane protein (dedA homolog)
MPGIRQYISMPAGLVKMKLVNFVLFTALGSAIWVSILAFLGYYIGENEELIKAYLTQILI
VIIIFIVLASLIYIKIKKPFAKKA
>fig|195.2174.peg.1710 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MEKYQDKIIYEYTLREFCKEGHSKRIFLVKYDNDSLEHRFLGAVLCSLYRELLAQKYNIV
LKPVVLLKSESIKESMQN
>fig|195.2174.peg.1700 Predicted metal-dependent hydrolase
NKAYVNLNLKLIQKSLNVIEYVVLHEICHLKFPNHSKEFYDFIEYFMSDFRQREKEFLS
>fig|195.2174.peg.1089 Phage antirepressor protein
MQNITSNLIFTNEQIAINYGLTTGLTIAKHLRIHNDEFIENTHYFLVENSFKNKTIKWTL
EGVYKLFDKIKKLKERNKMTNIKDIKKIKITCKECKTKITLDIGKTVIVCPLCNNAFYNS
YDEAPLSKLGNILQSLKEHKKAEFRFITDEKE
>fig|195.2174.peg.1461 DNA primase (EC 2.7.7.-)
EKNFVLLSKNLNDHELVEFLKENLFLLKNEKDEEKLEALFKNLHRFFSAKNLDIKILKNN
SENDYNEEPF
>fig|195.2174.peg.1418 Membrane protein
LFIMLIVLKLFVFDVNFNSIFKNDNEKSNFVIENLIKEK
>fig|195.2175.peg.1673 Oligopeptide transporter, OPT family
MTIGLFITFYSFVSDANLNNYYQILFAFVGTLVSVLIGFFVAAACGYMAGLVGSSSSPIS
GIGLIGIIVSSLVILLLGANLFDDPMLSKFAIALAIFTTSVIVATAAISNDNLQDLKTGY
LVGATPWKQQVALLIGCVFGALAIVPVLNLLYQAYGFVGAMPREGMDLSSALAAPQANLM
STIAQGIFNHNIEWSYIAFGVVVGIFIIIIDKILRNLPPLAVGIGIYLPPSVNISLVIGG
ILKYFVMRYLANKYQNNSHKNEKIATHEQKGTLFASGLIVGESIFGVIIAAITVFSVSMG
GSESPLKLSFLNIHNNELLGLIFFIGVILYFIKRIVKI
>fig|195.2175.peg.211 Motility accessory factor
MQTSDIFKKNLDSMKGNVYKKLKEELKNFQELRDFSFTIGKDSLNINLICKKNLKKIYQD
PVQE
>fig|195.2175.peg.1776 hypothetical protein
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGDEIPFGVLIYKYKLKINTINKVNTLPNNSKDSILIHAGTDM
KFWSSFISYISFQEWHVNNKVWSNNYDKMININFRQHNLPIKDQSDLYQFLFSYNLFYSI
YPM
>fig|195.2175.peg.595 hypothetical protein
MIDGLLPKTLGLSLEEIKNVSKGEDWQFNPDMSVYPQNEDGSYSKEALFMSFLKSQGGQP
VESPKTTLNPKVEAYNTAMAKESFSTTSVDIGDIMTGKVDFASLFKYLASKNGKLEGQLY
MYENNIPKESAMGNWALDAEIKQALANGWKASSESINSYVGSIMDRLNNLIGQTRV
>fig|195.2175.peg.1498 membrane protein
MFKFKLSWFGFVLFNSILITLLNFNLHSFVYEKLSQNLLLTLVFIVAYFGLVHMIFSLIF
VKYLTTILSI
>fig|195.2175.peg.704 hypothetical protein
LYIIQMYDKTREWMMTAEDIKRIFENKLNERTKNQKVIFTKNENERPHNGSSKEIAKFLA
SLKDDAIMKEVVENTSNQAISLVREYKNV
>fig|195.2175.peg.1277 Two-component transcriptional response regulator, LuxR family
MYNMSKSKILIIEDDIDLNDLLSLRLKACDYQIFSLLDFKGVEDLLDSEQIDLLIVDRNL
PSGDSLDRIKELRKQGYKEAVIFLTAKTLHQDLLEGFESGCDDYMCKPFDFNELLLRIKA
ILKRHKREEEKLVFKDFSLDLINYEFFYKNEKLDVSNLEYELLKCFFENPNTLLTRQFLS
ENVWKDDTTSDPTPPTPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
>fig|195.2175.peg.1574 Oligopeptide transport ATP-binding protein OppF (TC 3.A.1.5.1)
MGLIRALILEPKVLILDEITSSLDMKNSKEILKFLYHYQQENLISYIFITHQDGFFVNFK
CKKMKL
>fig|195.2175.peg.1356 DNA primase (EC 2.7.7.-)
INITNSYLALKKQIFTLIEKNFVLLSKNLNDHELVEFLKENLFLLKNEKDEEKLEALFKN
LHRFFSAKNLDIKILKNNSENDYNEEPF
>fig|195.2175.peg.998 ABC transporter, ATP-binding protein (cluster 5, nickel/peptides/opines)
MLEVKNLGKFYEFKKHWYLKKEKHLIFENINFSLKENENLMILGQSGAGKSTLARILCFL
ENPSFGEIIYKNLNPHSLDKT
>fig|195.2175.peg.89 hypothetical protein
MDTKEDGKTLTLEDLGINEVWLRESIIALKRSDLNVETLQEIVNIVSYYFQYHGYPSATA
YIPQQEITDSIQINIMLGKLG
>fig|195.2175.peg.1788 hypothetical protein
MDGKKILIFGFISDNFLEISSFLEKNKIKKAEIEEKISYMLNTILSSKESTRSACDFKIQ
KMYHCLLQDFNNEASKKRCYIANQNLLYIAEEWLKLDENVLFVLLYENPIEILRQKIFSN
HKFCFKDILMDWLRYNNLMLEFYSKNNNKCILMNYSNYHNSLIKYLSKHNNPDMVYAEND
AYIFKNKELFDFLLESLINKDYQIINDSYEKLEKNSLSPICKRKFSSENVEKEIVDLFYF
IETNSILKSKNKSLLDFIFDIQEDLEKLHQENLSQINNLNQTIETKNKTIQENLSQINNL
NQTIETKNKTIQNKDDLLNFQAQYGTAKSRI
>fig|195.2175.peg.626 AzlC family protein
MKQRELFLLTIPVLMGYIPLGAAFGILAASKDFSLFEILLSSIFIYAGAGQFLLVALVAQ
NVSFLMIFFYFVFIEFSPFFLYFITFKRAKIH
>fig|195.2175.peg.1317 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYAIISAVYNVEK
YLDDYFKSIINQRLDFKKNIFMILVDDGSTDNSAQIIKKYQKKYPKNIVYLYK
>fig|195.2175.peg.1707 hypothetical protein
MKTIKQFFENIGRSDIEETMDNLVENGIIDSIEIMNLIQEIEAHYGVFIDFDYISPECLR
NFQTIKNMVEEILKKSN
>fig|195.2175.peg.1153 hypothetical protein
MYFTNYKKGEKMKKLFFIIANLFISYRYKNQFDSHLGGLSR
>fig|195.2175.peg.1470 NAD(P)H oxidoreductase YRKL (EC 1.6.99.-) @ Putative NADPH-quinone reductase (modulator of drug activity B) @ Flavodoxin 2
MKTLIIFAHTFWEDSKVNKALFESIKNSKQVQIHNLSEIYKEGKIDVSKEMALLKKCR
>fig|195.2175.peg.1767 conserved protein
VFIVSFGIKISFIYIGFLYAIILFISFLLSKFDTSKFLNNDFLENEFNEKSSCCSTKKCC
SSKTHINLKQICIDSLKEYKKILPYALAGTFIGALIHGVFPSNFFEIYLKDYGILGVFIA
AFIGVLLYMNCTAMIPVALVLTQTGIPLGIMMSFLIAGSGCSLPELILLKRNFKTSFLIL
FALLIILIAILFGILMFFI
>fig|195.2175.peg.373 hypothetical protein
MDYNVFLLNIQDKINQEDFFNLKLKFEQLQNKKEALSNLVFLRLQDPIKPLIMSIICGFL
SLGWLAIDRFMIKDYALGILRIILSLFPCVLFLILGISYENDSNSDISEIFFGLFGIFLL
LGIIWWGVDLLFLIYI
>fig|195.2175.peg.1754 hypothetical protein
LLAISLLIAKPSIDFFIREPNFFNVYYMNYKELNEKKIIDNKEYLEKRFKFF
>fig|195.2175.peg.1717 Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) in lipid-linked oligosaccharide synthesis cluster
FINRYMQSCNISFKEEILLKFPSLIIKNQNSIIKHILYSDQFLKHGNYFFKIKEYYLAYL
CYNRVDEKIKKYIQINFELCKKFKENM
>fig|195.2175.peg.1131 hypothetical protein
MAIQINNFIMYLNNGNYTNDFEMFLNYLADDEKTSTVVKDKDKDKIIVNDEILFYLMSH
>fig|195.2175.peg.1761 Uncharacterized membrane protein, YraQ family
MQVFFNTFKEFLYLFVELSVLFIGINILVAFLNAKYSNFFEKHLKQDNFQTRLKAIFFGS
LTPFCSCSSIPLLNAFLKAKVPLSVCMAYLITSPLINPIIIVV
>fig|195.2175.peg.1708 formyl transferase domain protein
MKFLFDRLIVIGRGNVARECLKIAEHFFQVKGELLFLFGNNVEKNNLNHFFQQCKKALII
SANNFYIFKEECVKNNTIINYHNALLPKHRGSNAHIWAIWENDKQTGITWHKVDYSVDTG
DIIVQKEINIGEMTAMELLQKQHLLAIASLKECLANLLENEITQQKGEETEYHLASKLPN
DGFLDLSWRDDKIIRFMRSMDCGFTRAKVKISNNILRVLKFYFDETKLEFVLENYMKISI
LRKEKNEDN
>fig|195.2175.peg.1797 Phage tail length tape-measure protein
KCSGVIGYFKNNALNIIFPFVGILKFIWKPIYEVFKWVFDKCSGVIGYFKNNALNIIFPF
VGILKFIWKPIYEVFKWVFDK
>fig|195.2175.peg.596 hypothetical protein
MSIFSINDNSNYGSILSQAKANKESKENSKISFANAFLKQNASKLNEIQNANSQTLARSE
VLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQVDTSNIVSLAYGYGVD
VNGYMGSDFNKAAGLPEDFKIHKSTLDEIKKAAENDPVVSSTKEYLGVSEYYTNIDMAET
IKQYYNLFSNALGQSFPNDKTSFSEADINSMPSGYGVSGTQWMDFNDPSNRXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXEYYRFKRFFKFFNFKYL
>fig|195.2175.peg.625 AzlC family protein
MFEVCLLNQIYWVIGSVLGYYFKQGLNIDYLGVEFSLNALFIVLAYELYKQNPNLKILLY
SSFVALFALFCIDKPYMLAFCIFIALMILIFGKKYVR
>fig|195.2176.peg.1772 FIG00469432: hypothetical protein
LYNKYFICDLEKKTLLKLTKKKEKLGKLIHKASKKLKIYKGY
>fig|195.2176.peg.1793 hypothetical protein
MKNLFSNVLIAREKIERFFMRSSLEKVIKNYNENFSNKRDNDFAQGLIKYLYENAIIGEN
DKFFLEKNFQYIRII
>fig|195.2176.peg.1821 Integral membrane protein
MFTFSLDTDILYMIKSNFFISEKLSPEQMAIFDQKDSQDKLKSVLALLKFKSSFEGILKI
INQDEITENTIKSTSVLYSIMLLLCIFSLQKTARKNSIVPS
>fig|195.2176.peg.862 hypothetical protein
MVSHIEWIALDNTITNFSVDEFKIFASSMAYFVQETIFKASALKEKARNAQSKEELDLIV
WESEK
>fig|195.2176.peg.1722 Ribbon-helix-helix protein, copG family domain protein
MNKNNNCVIKVSKDDKIILEYIKSETNASYSKIISILLKKFNSCDTDEKNKINDEISKNK
FYTSDENKIIKLKLTENEVNILKEISKNTGFSSITKQAKFLLLNSIKMKNFLLI
>fig|195.2176.peg.1556 FIG022708: hypothetical protein
FNYISNKILKNQNKKNLFYKIENFKNLAKERYKKYENLGFWVCEGHYHQNLILDEKDVKY
FNLASFAYERSFFVVECCQEIKFREQKLRGQNV
>fig|195.2176.peg.1871 Motility accessory factor
LAMNFFQNKENKTSLNILSCATHPNLVHFLDNKSVILRDDPLYQRFNLNDFGYIGTGTHV
SHFSYTLALALGFKNIIMIG
>fig|195.2176.peg.1723 Ribbon-helix-helix protein, copG family domain protein
MKILRSGNSVKINENNLNKTMDNIRDKIDILSDQLGAIIEKNNERI
>fig|195.2176.peg.1641 hypothetical protein
TREKFEKKQINKKSFFKEKMNEFFKKKLNKILPDREISNEKTYSRSR
>fig|195.2176.peg.26 FIG00005326: uncharacterized protein
MHPTRIRRPKFVNSTHSLAKIVHSIAHIEFSAINLALDASYRFKNLPQQFYIDWLEVADE
EIKHFKLLNAALDELGYKYGDFAIHDNLEAALEATKDCLSLRMGVVHRGLEAKGLDANPF
VVAKLESSNHPIKSLLKDVLHIILNDEIKHVSKGDNWWKFSNQNNYDFIELCKMFNQFSL
AGKKLNIEARIKAGFSKAECEAIAQFYA
>fig|195.2176.peg.1734 hypothetical protein
IRIINEKEKRLINVYFCEKPIIDFFQNAEYEKELQYYGINEKDFIKTDI
>fig|195.2176.peg.299 tRNA (guanine(46)-N(7))-methyltransferase (EC 2.1.1.33)
EFDFSDIHLSKNDLMLLEKNFENFTLKKEDFFLHFENIYKQGESLLLKIAFGAFNKPEHC
YLHIGEAISFVFKEPFKIQENLKAIKELKKSVKFHFNMKHFLEN
>fig|195.2176.peg.300 tRNA (guanine(46)-N(7))-methyltransferase (EC 2.1.1.33)
MPNFKTRKLKEIILPFEKDGIEFVWMAHNDNVNLIYTRVEEESFFLQIKKGENEFVVKVD
KHTKPSKIAYLHKALYIFKQYFCEDVISEAFGIKNNALAEKTPLIANDFEEVLERLEGKI
YIEIGFGSGRHLLYQAKNNPQILILGIEIYNPAITQVAKLARAQGIDNILLVQSDARLLL
SVLRSDSIEKIFLHFPVPWDKKPHRRVVSKAFCKECARVLTTQGVFELRTDSYEYFDFTF
KEFLEFSSPQFSIRKNENLEISSKYEDRWKRQEKDIYDLWVWNLDKEEKNVLSEEFD
>fig|195.2176.peg.1782 Transcriptional regulator
ENMAYTIKKVEKETKISAHTLRFWAKKGLFPFVQKDENSVKYFSKSDIEWVKWIEWLRIS
GMPIEQIKHYIKLCSLGIKTAKERQEMLKQTKKKLQNQIKTLKESEKVLSKKIKIYEEML
ANEVDGFNPESKDYQPCDKFCKES
>fig|195.2178.peg.439 hypothetical protein
NKIDDFKIYFMDENFNISEFGSSARAFIIVSNQNTFDFWQENFKNIKGFRTALHNSLFCD
FSYDKLLDLKNLKNFKYCLLLEDYEAFEREFKNKENQSPSLFLN
>fig|195.2178.peg.1752 hypothetical protein
NGKYGFIDKNGEFAIEPKFDYVWSFGEGLAAVKLNGKWGFIDKSGKIVIESKFDSGGHFS
EGLAGVKLNGKYGFIDKNGEFAIEPKFDYVWSFWEGLAGVKLNGKWGFID
>fig|195.2178.peg.978 lipopolysaccharide core biosynthesis protein LpsA
FRGAVYQKHRKEFFHSYFGKSFCDIGDTSKQPSQWKKTF
>fig|195.2178.peg.49 hypothetical protein
MVKIRILFLLTANFYKKILKLINNKNYDFMLLKVKNMLKFIKIKQG
>fig|195.2178.peg.1704 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
MNLKLNSHNIKAISIVLPKNPHTLEKELQECNLNQKKYELLKQNTGINHHFISPNNIYAS
DLASKALEKLFRENLLLKDELDVLLVYSFSPDFLAPALSSLIHKNLGLSEKTLCFDNIAF
CPGFLQGLMQAFSLLDNENIKKIAFICVSVKSKKIPKKDKITYLSNSDSASVILLEKSNT
KEKAFFSQKIFSKLATEETFPLKCFKEANDFIDMDKNLTFSHLNENFPRFFDDFFDNFKL
DKSKIG
>fig|195.2178.peg.695 hypothetical protein
MISIIPYITNKKDTWNNFNKDAKNGLFMFDRNYMDYHSDRFMDNSLMFYEDEKLIALLPC
NVVENILYSHQGLTFGGFIVDENMKQGKMLECFEVLKEYMKENNFKKLIYKSTPYIYHKI
PAQEDLYALFRSKAELFRVDCSTAIDLQNICKMPKGRKAQISRAKREGVEIASSEDFNIF
LILLNSVLQKQHGVNAVHSVEELKLLYSRFPQNIKLFVAKFNGEIIAATLVFIYENLVHT
QYLAANEKAREIGALDLLIKTLMDEFAKSKKYFDFGISTENGGEFLNHGLISQKEGFGGR
SVAHQFFSINGGGSLLVTIIFIDCLRLKYKRLYNE
>fig|195.2178.peg.1592 hypothetical protein
PQNIKENLGINQFLDESLKEILNQPLKEQFALTPKGEYFFEGNLSLFQKQCLENNATAYA
Y
>fig|195.2178.peg.1593 16S rRNA (guanine(966)-N(2))-methyltransferase (EC 2.1.1.171)
LKLDALFCIILEHNSKIKTPDNIANFTKIKEKKFGSTSLSFYQKNILEE
>fig|195.2178.peg.1703 Uracil-DNA glycosylase, family 1 (EC 3.2.2.27)
VKINIFFLACLIKYTFNLFLEVFMKEITINIEDIKINNDWKEFLKEEFSKSYFLEIKKRY
IQALNNKAIIYPPSNLTFNAFNLTPLSELKIVLLGQDPYHQPNQAMGLSFSVPCGVKIPP
SLLNIYKELKADLNIEPSKSGDLSSWAKQGVLLLNSILSVEAGKPASHSSWGWQEFSDAV
ISKLSLEKSGLIFILWGNYAKSKKALIDTKKHFILEAAHPSPLARTGFLGCKHFSKANEI
LKNLGKKPINWQLT
>fig|195.2178.peg.616 sodium/pantothenate symporter , putative
MVLSFIVSWQIFNAYFNFLVFLILFFVSYKIWQFKKK
>fig|195.2178.peg.1235 hypothetical protein
FDYVWSFWEGLAGVKLNGKWGFIDKSGKIVIESKFDYVWSFWEGLAGVKLNGKWGFIDKN
GEFAIKPNFDDAWYFREGLAKVGLNGKYGLIDKSGKIVIEPIFDDIDY
>fig|195.2178.peg.327 hypothetical protein
MKKNASSKILLSLGVATLLYSGAFAQEIDLTQSSDIGKYFEENGKDINLKNPDQYKGQDL
SIKMGIGDLPSDGYDSADYRFNIDIGKNNTLSFTHNNKGEPAYVTNLNATAKEVKTTDIV
LQAFAPSVINGDLTMTSSGAGAITEDEKKRFGYNSL
>fig|195.2178.peg.286 Ribosomal silencing factor RsfA
MQERVDLIVKILDEKKAEDIKTFDMSEQDYFVKYVIIAATLGEKHALSLIDELKTKLKAK
GEEFLNIESSEEWSVIDLGDILIHLLTPEHRGIYNIEELLESLKKTRHKLKMQKIH
>fig|195.2178.peg.615 Heat shock protein 60 kDa family chaperone GroEL
MLLTTEATISEIKEDKPAMPDMSG
>fig|195.2178.peg.1503 sodium/pantothenate symporter , putative
MTHNDLSNLCILISLLFLEYILINAKTFRQMTRFANFYGVIMVLSFIVSWQIFNAYFNF
>fig|195.2178.peg.1673 FIG000605: protein co-occurring with transport systems (COG1739)
NYSIFLKILLIHYILPYLIIIPNKKAKMQTIDQNFQAQIEIKKSTFLSYLCPFKDFKNLL
VNLKKEHPKAVHFVYAYRTLNEYNQIIEDKSDDGEPKGTSGIPSLNVLRGYDLVNTAVIT
VRYFGGTKLGTGGLVRAYSDAANAAINNASLLTFEFKKNIKIAIDFKNLNRFEHFLRTHS
LEFERDFKNEKVILSLNLNEEEEQKFEIFCAQFTPFEIEKL
>fig|195.2178.peg.1634 hypothetical protein
NYNEIYVIKSLKLAFIIVKTLAGFDYKF
>fig|195.2178.peg.1570 hypothetical protein
MELEKKREEFRSKYLGSEIKVGNETHFVNFSYLKKKFPQILSNGCKYYRNDYNYKIGES
>fig|195.2178.peg.438 ATP/GTP-binding protein
MQINILNHFIKAYEDAYNIDFDKSFEGQIKMLCKKLNEPFMHPSYNLIQELEELSFSLDK
NINIAIIGQFSSGKSTLLNLILKKECLPTGVVPVTFKPTFLRYADEYFLRVEFQDGSDEI
THIEELAKYTDQRNNVKETKSLHIFAPIPLLKKITLVDTPGLNANEDDTLTTLKELQNIH
AAIWLSLIDNAGKKSEEDVIKANLELLGENSICVLNQKDKLSAQELENVLNYAKTVFSKY
FKELIAISCKEAKDKTKYEESNFNLLLDFLDNLDEKALKQKFTKRKMLHLCQVLEDENRL
FVDIFDKLANQFQIYQEKLNSSFDDFIKEVQILNHQILNKLKSIGERIASEIFNCIKEKE
AHFYKEAKGFLKKDLYVKYDYKAPFISSDDAFLAMFYNSDIMNKEFKKIKNEIYESFEKI
KQKLKDFIDNLEKDILLFKAEFSNIQK
>fig|195.2178.peg.1613 hypothetical protein
MLICNHCNTKNLDIAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEEEKRKIAQEER
EKSLKQRKEFISKHKSKIIISMVSFFLIASLSIYQYFYGGKYSRVYINKLEGKCHYDDAS
SCKMLQTIYKEKCDDGDGKACFAGIFVSGDLIRVKIDGQWSFLDKNGEFAIEPKFDYVWS
FGEGLVAVKLNGKYGFIDKNGEFAIEPKFDYV
>fig|195.2178.peg.264 hypothetical protein
LIYSEDRVNEVVLNAIKFNIALIVKNIEGF
>fig|195.2178.peg.1743 hypothetical protein
DDEKEIKAIVFIIGGYGANANIYFLDSYRNYIAKNFDVVAVHVFYHCFCQRRSDVEKYST
LADFTKDDLKLIEKVLRKYNIPCDQLANNTVVSHCEYLSEIMTELKMLNRLPYDFEERLS
ATFIPSRGEYQNFGIMAAIDHINALKDLVKRFPKLADLPKIYGGGSYGGYLALLIAKIAP
>fig|195.2179.peg.1784 Chitinase (EC 3.2.1.14)
VRKVENMNSMFSSCKSFNQPLGDWDVKSVKSMRFMFHKCYVFNQDISKWDVRKDQYTENT
FLDCPIDNSNKPEALQELSI
>fig|195.2179.peg.235 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKISEEDLHFILESGILAPSSHGFEP
>fig|195.2179.peg.330 conserved hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIPVSYTHLRAHETGRNLVCRLLLEKKKKMPSLKCAFTLLF
YIISLEKTAILFF
>fig|195.2179.peg.1020 Predicted metal-dependent hydrolase
MARQSSSLKSFIYKDECYFYSKKRIKTLRLRLNERGEFVLSIPYFCTFKNVYEFLDKSSS
WMNEAKKRFEKKALKDDELIFLAKKYKIIFDENVKKAYFDKDKIICQNK
>fig|195.2179.peg.1808 lipopolysaccharide core biosynthesis protein LpsA
FDAYEISKYFNDDFLWKKEFGDVKYTFKEPTICKSRPLENNTNNILLKLDKNRHFCFLKD
NIKYENKKDIAIFRGAVYQKHRKEFFHSYFGKSFCDIGDTSKQPSQWKKTF
>fig|195.2179.peg.820 Putative efflux protein
MKKKSYKFHPNDTKLDKKIVEITEKSGFKIAVFSMAAMTMLGSVVISSALPAINRHFEDI
LIQSGANMQTNFTLAHLDILVRLVLTLPAIFVVILSPFAGILMDKLGKLKFVFPAMIVWT
LAGVSGFFLNNIYAILTSRAIFGMATAFIMTGASALLGDYYSRGGFNRRENALSLQGFFC
AVGGAVFISIAGFVSSYSWRYPFLVYGLGILITLIAMIYLFEPRKFKFYNHTKIEEKTNY
WKFFPIYFIGFFIMVVYYISPTQLPYYMA
>fig|195.2179.peg.1210 Membrane protein
MAFMSFSGFFYARNDLRLFKIEKKSEIKSFFYKDYTLASFKDELNLNNEIFFYQSLKENL
FKENDEILISNLGKKIILFRNFTQNS
>fig|195.2179.peg.1269 FIG00470684: hypothetical protein
MTEIQFNEIKERLADWRSERGLTYENQREEFLGNVFEKVSEYFRAKDDLERVEALCDIAV
FFFNAFELKFGEISNIKRAGMIHLIDHFTSYFIEHNNKTVYNNSKDEDFEYLLIVEIEIL
VKNLGFDFYKCMLQTIKKIKSRTGHYDENLNKFIKDTSDEAKAKWYKADYKSYRL
>fig|195.2179.peg.341 Flagellar hook-length control protein FliK
MSNLAPQNDVLNLTPSKTSTTSSSFSKTSKNKEHESSDSKISTQDDTESFLNSLLNSIDE
TNEFLPDHMKISQKEVVSEAMNRLQKGAFDESDKISIFESASFMQILSLLDKLKTDTADV
KLANLSTQLSSLIKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNL
DKANFFKGAVDNVFKEIINNKLAHISKNLNQNVQNLNHTPHANLSQNSKMTKKDDTSLLS
QTLKNLDSILSSKESKHEKKDKVKSKIEEDAADAKNTLKNIKNDEFAKNLTEELNIKDKE
NKDLNKDFNKELNKNQGDMQGQNKNLKNNNQNLNLDKNLNKEIVKDTQNLVSNLTQKDFN
LNKEPKNNKENKDIKQNFFDQKLNFENLNKTQVVQNKENNANFNNNTNKETFTQEQTKTH
SENIDKNSLDELNSLVKDLNKVTQNNARNITPKETLQYFSQDLKEAVDQYKAPITKLSIN
LNPNNLGEVEVTLIQRGNNLHINFNSNTNAMNLFIQNQAEFKNSLVNMGFTGLEMNFSDQ
GKREQNQNQGKNRSGYGFKDVLDGKNESEKVNLELVLAKYF
>fig|195.2179.peg.1418 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTIGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTARNVGIEYFSGEYKLKNKTQILKENSLIEFNIEGNNPYEIYTVYKS
YKAFNNEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVEVVWFANKHLYDNVN
IPETRQPTLFEYYNFDKECQISSEEWASKTLQMGRKSFWFTVMGMIDFNFLKNIKLKHYD
YAILEDNLFGILLFMQVSKIYILPKQMYRNRVRPNSTMNHDKKVTASNIPLFLQTVYYSF
DKDPERTKEYFRVASWVLLNNQMKLFLQNSHLSYYRCLLMREFVKYYFSLAKPIFKYKND
PLNVSSICLEVSNYIKVLTMQTKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVND
GSTDENSLNIAKEYTLKDKRITLFDKKNGGQSTARNVGIEY
>fig|195.2179.peg.334 Bipolar DNA helicase HerA
MIVGKIVSIQFNQFRVRIFSNVKGGGLNIKGEIYYFGNIGSYLKTSNALGEDIVCEVIAI
FDSDRQDDGQDFNLNSNRELLLKPIGIYKDDNFTLGISVYPSLYSDVSLLTNEDLKNILM
SKEYKTENQGVCLGVSKSQINHPIYIQEDKFFGMHSAVLGNSGSGKSNTIAHLFQEIYKK
EHPAIGSKVIIFDVNGEYSQAFSKLDHPDVKVKLFKPNIKENENGDESDTKGAKNNTKPF
YMPHFLLSLDEWCAFLMATDATQKPFWDQVLQEAYRFYKILSLNEAEEQKKFINYLRYKL
YSFANNILVQTETDTAKITTLQSVISKVRKIIMDIFENNKEAESLIKDAKSLYQKCSLNY
GEKNKEISTTLEDIKKRINFDDVNKISEYKYKDGEFFEHEFLKIAAEMILVDEETRGIKT
TRGYVGTMLTRLDYFISNPECSFMREINHKNIKEVKQYLDYLWGKTQLIIIDASELGKDT
LETLTSVISRLIFEYRKKQKGENRQKNPVHLVLDEAHRYIKKDQKYLLKDNVFERIAREG
RKFSLYLFISSQRPSELSETVLSQCINFIIHRIQNENDMRHINAVLPYFSEDFVSKIKQS
VPGEALIFGDFVPMPMHVKIQKADPEPHSSNCKISQEWYCKLK
>fig|195.2179.peg.1838 Motility accessory factor
KELLNFIIHTPDTIKYQIDDAKNMQDLYEILGPLLVQFELNLARIYVLNPKTPEDSFNKS
LIWIKEHLEWIEMIYGHIQAQENALFENIIPLEQKLKERKLNKWMERVKNANK
>fig|195.2179.peg.1861 hypothetical protein
DSIWDFSEGLAKVKLNGKYGFIDKSGKIIAKPKFDYGEYFSEGLAGVKLNGRWGFIDRSG
KFVIKPKFDSIWDFSEG
>fig|195.2179.peg.1065 Integrase-recombinase protein XERCD family
MFVFSFDMKKIRFRTEKSEEKLNYLNENEIIRLNNVLEKEKAKKEVYNSFRNSLLIKLML
YGGLRISEALNVKLCDFEEVDDEILKISIIGKGGKEQFAFIKKEEVDDELEYFKENIQDS
DYIMQTSTGKHLNRSNAFLIVNNIYAKALISKKGLHLLRHTLAMRLTAKGTNLVVIQKIL
RHANLNTTTIYAKATNDTVKAALLNN
>fig|195.2179.peg.1584 3-deoxy-D-manno-octulosonic acid transferase (EC 2.4.99.12)(EC 2.4.99.13)
IDEVFAQSEVDKIRLEDLGAKNVKIFSNIKSKLQIFPTQKYLKPKQKLIIFASTHKGEEE
LLLKHYKMDKQEKLIIAPRHPERFLEVEQLLHDKGLKFDKFSLLQNEDKKFNQDILLLDC
LGELVNFYAISDVVVLGGSFFEGIGGHNPIEVAHFNNVLISGIYIHNQKSLFQEVDNVYF
CEDLKELDGIIHNYNLKAKIAQNNDLSTIIQAIQEGIDARKSI
>fig|195.2179.peg.1557 3-deoxy-D-manno-octulosonic acid transferase (EC 2.4.99.12)(EC 2.4.99.13)
MIFLYYILVWIAFLLCAIPLFLLSLFKPKYKYSLKARFFLFRNISQKRSDVHFHVCSYGE
ARSVKELVLRFDSRITTITQTGYDYAKEICNKVNYLAFENWIPFWLKPSKVLVIFEAEYW
LMLVFIAKLQKSKVILLNARISDNSYASYKK
>fig|195.2179.peg.1317 hypothetical protein
MSSRSVTNIISVSIDENCNKNIRGSSFSSLYGQIGYNILIGIKTLAEDDFWGKYPHYKDF
VEEIFVNQSNLLNQVDYEGTADVVFYKKNNKIFACVRCRVEDNNSAFFLIKLFLMKNLSE
KQALFILSVILWMSISLGRQLFQ
>fig|195.2179.peg.332 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAMDEKEFLNPYYRKKPILEAELNEFTKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHKGNSGMDLALKKDKQIQVIIEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EFYKECEKLLSSEKYLDSITRKDLFDEPSLKGVFIDIKPILEQEKPSFSKLKPLFKIFHK
DFLLSEFNPNDANSLNNAFYKELLYILGLCESKQNSKLIIAKSQESKEEQGTFYTAINSK
LEEENFETILKLLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEV
LAKEKSTRKKSEFAYLPYLNSSLFEKQSIENTLEISNLNNDLKLNYYKNTVLKDDKCKTK
KGQVGLLEYLFEFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSF
ITSYMCKESITKVVLDKFNAQFDLDAKDISELRKSLRKEDKKAQKELLNSIKICDPAVGS
GHFLVSALNVMLSIYDELNLFDEEFYLEVQNDEILITNHKGEFIEYKRPSTPKDKAHLIQ
QELFHTKKDIIENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDENYHDLKTLPNID
INIKCGNSLVSYFETGKSLSHYPNIKERINKYKRIVKDYKEGFYTDKNLIAKEIKNLQES
FKNFCLKDKFNKEIKQLTNGANEYSKKYGDFLADEHHDEKFKSFFSKNMFEFSFDEKVAI
KEFANLKKEYDNIFNLESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIRQEELKELK
PHLAKNYKVYKGTSDIYTYFYELGFNVLKDRGGVLSYITSNKYTRAGYGEALREFLLKNV
KVLEYTDLNGIKVFDSATVDTSILCFEKSKSKDNKFKYLALSNEILKTCAYNIGLYKDFA
EFSQNSLSKESFTFSDENTSALKAKIERIGTPLKEWHGLIIYRGILTGYNEAFIITTEKR
NEILANCKDEAEKERTAKLIRKMLRGRDIKRYSYEWAGLWVIFIPWHFPNVEKPKTMLEN
EQDLKEQYPSLYKHLLSHKERLSKRNKEETGIRYEWYCLQRWGANYYQEFEREKIGWQRI
TQEPSFILEKEYILLDSMAFMVANSKNELKYLLGFLNSNLIFYYFKNIGHLYSDKGFLLS
NQYVEKFPIPKINSKNQKLADELINLADDILKAKEQDKNANTQELENKINSLVYKLYNLN
EEEIKIIKNKE
>fig|195.2179.peg.1258 hypothetical protein
MENNQNKQEKLESVNIDKPIEKKEEDLFSRNSVAEQLNTIIKNYKEEDSITFGIIGDWGS
GKTSFVNMTLEDFKDDENFIIVKFNPWNISTRKKTYQRFFYNACQRNS
>fig|195.2179.peg.234 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MQSKDEFAQKQIRRFAGSKEENFQRILKIYTHDTDAMNEKELYHFAQLQCYLAMMQMSLA
AMSLGIDSCMIGGYEKDKVDDFLKLEYPFETAVILSLGYQAHEPKYPTQRLKFDEVVEFY
KEK
>fig|195.2179.peg.1530 gamma-Glutamyl-CDP-amidate hydrolase involved in O-methyl phosphoramidate capsule modification
MILSGGNDLNFLNPNAMSKKRDSYEIQVIEACLKEKIPLLGICRGAQIIAHYFNSCISPY
VNHVSKHEIFFLEEKFISNSFHNFAIARLGDELEPLCFAKDKTIEAFKHKYENIFGIMWH
IEREDGLNNVQILKEWLDLIKEEK
>fig|195.2179.peg.1859 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
TTQIKELNQVVANQTTQIQNLNNTLNKTIKEKDLVINSGINQINQLQNNMQEKITQLNQL
QFRLSFQSQHGTAKQRIQNQLSYKLGQTMIINSKNIFGILFMPICIISTILSYRQEQKLY
QEKIKKDPSLKLPSLESYPDYKEA
>fig|195.2179.peg.1417 hypothetical protein
MAFYFIKRFDLLAHINEDYLDSRGGFRASLFQNKENKEFILAIAGSDLRPLKFDIGDLI
>fig|195.2179.peg.1459 hypothetical protein
WGFIDRSGKFVIKPKFDSIWDFSEGLAKVELNRKYGFMDKNGKIVIEPKFDGVGNFSEGL
AAVGLNGKWGFIDKNGEFAIKPKFDDIWDFREGLASVGLNGKIGLIDKSGKIVIEPKFDD
IRY
>fig|195.2179.peg.889 [Protein-PII] uridylyltransferase (EC 2.7.7.59) / [Protein-PII]-UMP uridylyl-removing enzyme
MCQTLINEILKDSKDLLNKELELFEKNLNTYAQNYRKFFLKQGSFSLYHSKNMDNFLKKT
YDIVLKECFENFLPTSDNIPFCVLASKGYAKNNLCANESVSLIFVYKDIKAYHLKPMIKA
FIEILNDVHLQIDYVVLELNGLYNASNELKTTIIGARFICGSKILFKSVKEKFDSILQTN
KNEFAQILLANFKDFNLPFIKQEFNIKKDFGGLDHLRALESLLTLFKNSPKNYALNFMDE
KNVSELRLAADFLLSLKSAINLQSNKDQDEFLFSNIHEIAELMYRKGKKNLDAEKILVQK
ALQSMHTIGFYTHFLAYKIQNELQNIAQKQYRFKNLAEALTFLLGFKDQDIAFDLDLVFA
LKNLSYGKKDLEKALALFEKIFYKRHSFCILKLLLDSGILKELCKPFGMVRFLSDEEGDY
SFDEQAFLLLKEFEKYEDELESLKNLNTDEKMILKLVILLSAINNENEISLASIYRAYCI
KFNLKNDVFELGLRIFKNHNALKELAEKEDVYNPIIICALLSKVENLKTLKLLHTLTWLK
AKALNRNPFFYKVIDRILENAKQGFDDENLLDETARRVKKELTLKRTKLFLEQNAILQDK
ITHIKSNLFIIKNTFEDIVEIARFAKENDFKFWFSNSTNLSLQIVAFKDFKIEIVLTALA
NLNLVFMNLFELFDDKIYLRFEYDNIITDEQKNKLCELLNSNLSGFSSRKIKKPIIKKDE
LKLDLNYSKIYAKLSLNTKDQQGLMAYMMNIFNELGLVLSAAKIQTIRQRTRNTFIFQKN
ENLEKNEEKLLISLISE
>fig|195.2179.peg.1290 hypothetical protein
MRNKELKIIEAYGAFMSILFSFLIVYENVWTNILKIFLYTEIQAFFIFFC
>fig|195.2179.peg.664 Flagellar cap protein FliD
MAFGSLSSLGFGSGVLKQDTIDKLKEAEQKARIDPYTKKIEENTTKQKDLTEIKTKLLSF
QTAVSSLADATVFAKRKVVGSITENPPASLTANSGVSLQSMKVNVTQIAQKDVYQSKGLA
NDSGFINANLTGTTDLTFFSNGKEYTVTVDKNTTYRDLADKINEASGGEIVAKIVNTGEK
STPYRLTLTSKETGEDSAISFYAGKKDSNGQYQSDSEAEKIFSNLGWELDTTTQTIDPAK
DKKGYGIKDTSLHIQTAQNAEFTLDGIKMFRSSNTVTDLGVGMTLTLNKTGEINFDVQQD
FEGVTKAMQDLVDAYNDLVTNLNAATDYNSETGTKGTLQGISEVNSIRSSILADLFDSQV
VDGTTEDANGNKVNTKVMLSMQDFGLSLNDAGTLSFNSSKFEQKVKEDPDSTESFFSNIT
KYEDINHTGEVIKTGSLSKYLNSNGGNTNGLDFKPGDFTIVFNNQTYDLSKNSDGTNFKL
TGKTEEELLQNLANHINSKGIEGLKVKVESYNQNNVTGFRLNFSGDGSSDFSIKGDANIL
KELGLSDVNITSKPIEGKGIFSKLKATLQEMTGKDGSITKYDESLTNDIKSLNTSKDSTQ
AMIDTRYDTMANQWLQYESILNKLNQQLNTVTNMINAANNSNN
>fig|195.2179.peg.1815 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKIVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTAR
>fig|195.2179.peg.1775 IncF plasmid conjugative transfer protein TraG
SSYTIQDASKSGNELAKEAQGLFEAMSKK
>fig|195.2179.peg.1860 hypothetical protein
GEYFSEGLAGVKLNGRWGFIDRSGKFVIKPKFDSIWDFSEGLAKVKLNGKYGFIDKSGKF
VIKPKFDSIWDFSEGLAKVKL
>fig|195.2179.peg.1160 L-Proline/Glycine betaine transporter ProP
MKKSKLGTKEFKILGLSSLGGTLEFYDFIIFVFFAEYIAKVFFPKDMSEFWTLLNTYGAF
AAGYLARPLGGIVMAILVINLGVKICLC
>fig|195.2179.peg.1332 hypothetical protein
MKKYKYTPKTKEELKALVKDESIYLGDIDTSNITDMSCLFTNSTRKDFSGIEKWNTSKVI
TMAHMFSLCRFFNQDISRWDVGEVENMSYMFHGCHYFNQPLDDWDVRNVETMAGMFWGCE
SFNQNISKWNVGRVVNMDSMFARCYDFNQPLGDWDVRKVENMNSMFSSCKSFNQPLGDWD
VRKVENMNSMFSSCKS
>fig|195.2180.peg.1648 tRNA(Ile)-lysidine synthetase (EC 6.3.4.19)
SNENVKYFRNYIRKNFSNAFVSKFHQGLKRSFFYLDEDRKKLYDLESIKEIQGLMICPKN
ESLIAKAVKMKGLLLSAAQRKEFLKGDCVLGGKIGIVYKDEKAIVFKYETCQKLPKEFKE
ACRIAKIPRLLRAYLYNHKIDISSLNF
>fig|195.2180.peg.1561 hypothetical protein
EILMKKIKILVFLIFFCQFSVLANNLPQNIKENLGINQFLDESLKEILNQPLKEKFALTP
KGGIFFRG
>fig|195.2180.peg.1721 ATP/GTP-binding protein
FIDNLEKDILLFKAEFSNIQKDNILQSDKNFSELRAFCNASDEYFLKDFKELLFKSLLEL
DLFFEKLNLKAFANYANATKLSLAFFSRKINESRVLYELDSSEFTLFYPKKSEIYERVLT
ELNAYEFEALLINKPILVKISNHFLEQNTNIIQEKNKILDLKKVELQKRKEQILEVRSVL
KENL
>fig|195.2180.peg.583 Zinc ABC transporter, substrate-binding protein ZnuA
YKIDYLSYDWENELLKTANAFYENL
>fig|195.2180.peg.187 2-Oxobutyrate oxidase, putative
MNLPVLDLKIYEKDKSAFLKNLREVTSNVGFFILSITVSIKI
>fig|195.2180.peg.755 tRNA(Ile)-lysidine synthetase (EC 6.3.4.19)
MQIKDEILSFLKKGQNLLAFSYGSDSSALFHFLVQKKINFDLVMINYKTRKNSDLEEQKA
KELALEFHKKIFIKIAPVIKGNFEKEARDFRYDFFEKICLEQNYSNLILAHHLNDQLEWF
LMQLSRGAGLAEILGMQECEKRSNYTLLRPLLFMSKDEILSYLKENDIFYFQDESNE
>fig|195.2180.peg.1658 Predicted glycosyltransferase involved in capsule biosynthesis
MPLLSVIIPFGLSKERSYIQERVYEKAQCFKTDEKIEFIFVEGYSSQEHNLKTCILKNNH
IYLKDESQEEYFSQGKCRNFGASYANASVLLFLDLDCFISFDSLEKILKLIKIKNILNNP
SALLVLPVVYLTQEASEILREYPMDLWDVLIQEDLISGKNFLVKFFAPSSTSGLIINRHK
FLEIGGNDENFIGHGYEDFDLFARVLNSCLKFEKIPLNLNYDSRNWNFYNFKGFRSWFSL
LGYELCFYGIYMYHLWHIEPNQNGYMDKKHKNHKLFYKHLKKIKDYSIDPLQISSVKNTK
ILVIANKKYNFRALSVYLGKFVYKSLDELAYQSKKEIEIYLQEEKFDKILLDKNIYNEDL
HKIFKDYLCVYFESGILPDSWLFYKDANGLYDRKHWDIDLDKLQIKEMQAYIISLKFEEK
KKILTFIQKLGFDKDD
>fig|195.2180.peg.382 Protein hydE
MTLDFDFIYNADNDIFEYLLRFYAKNYNYTLSKEENTYHFSIDADEENLKTFCDSLNLMS
HSVFLKKFDVKAGQDFNPCIPEDKEFSKFSYIT
>fig|195.2180.peg.1720 Predicted glycosyltransferase involved in capsule biosynthesis
YKIVFYLKNELYSFAKNDDFYQIIFNKKKMLMLGNYDKEYYSLKSFVYKPYLYEIKRVRF
FSKILEFLGLNFLLSLISQTKFYRLARKLFFNPRDFFKDSKFYKRHNNAN
>fig|195.2180.peg.1319 lipopolysaccharide core biosynthesis protein LpsA
FKAIESMEKNFLSKKEQMKYKFIISLEGNDVASNLKWEMNSNSLVLAPKITCETWFMEGT
LKPNYHFALIDNDNLATVIEHFISHPKDALEIINNAHQYVKKFLDKKKEFYIGILVLTKY
FYYSGQLDLNKDECKREILELIK
>fig|195.2180.peg.1539 hypothetical protein
FMCLMMRRPPGSTRVRSSAASDVYKRPDIELSDICGLKCDFCPSKKALRGVMSVENFSKL
ARQIWDKSEIFTFHLLGDPLLLNNLEEYLQIAKNHQMKLEITTSGFYFSPKNSKLLLKYD
NIHQINISLMAFLSQSKLSLEQYFKPILEFCKEHLEYKKSSFINLRLWNLDTNFKAPSEN
LPIYEFLSKEFGVRILTHLAKNRLQRHILLHQNKLFKWPSLKDKPLYTQGKCHALKEQIG
ILSDGTLVPCCLDTKGDISLGNVFNAEFKSLLESKRIQEIKKAFEENKRIEKLCQSCEFF
KTRLSD
>fig|195.2180.peg.1628 Two-component system sensor histidine kinase
MLKTKNIFITFFVLLILCFGVIFYTLTNSYLNFLLLKQYEQKIKSLDDVLKFSLLEDLNS
NNIKEFAQDTRADFIILKDDFEISSVLNADLFLNLEENKIYDLNSKRVLVKKFTYKDYKY
MIIVYPRFLNLQNFWLKISISFGIYFMLVFILVFFMGRKLAKSFKKILEFLNFINDSKPI
I
>fig|195.2180.peg.359 Two-component system response regulator RacR
MINVLMIEDDPDFAQLLSEYLTQFNIKITNFENPKEALNVGIQGYDCLILDLTLPGIDGL
EVCREIRQKYNIPIIISSARGDLSDKVVGLQIGADDYLPKPYDPKEMHARIMSLIRRTKR
AENTNNENINSAFKIREQLVSRCKNLKDKDSKSLDVIIGRLRTKINDSSKAPKHIFSVRG
IGYKLIG
>fig|195.2182.peg.1453 FIG00638667: hypothetical protein
VFNKNHETYIKNLQNLSLENNLWISNIEWLQSEENSYRKISLNIFGDFSPILSFMKQLEN
SDLHYQIHKFEIDNTTSLNLHLKLTLSFISLAKLK
>fig|195.2182.peg.1068 Haemin uptake system ATP-binding protein
MILKIQNLSFSYHKKELLKNINLELQNKAFIGILGPNGSGKSTLLKLILKNLNISKGEIS
LFNTNIKNFALKEFAQLCGFVPQNSGLNTPLKVIDVLLMSKFTNLKHAFCDYSKEDILEV
EKFAKTLKLENFLERNILSLSGGEFQRVLLARALLKKTQNSFFR
>fig|195.2182.peg.1106 hypothetical protein
MQTLTQKTIFLNTEVAISYKTSKQNINSTKNYHADELIENIHYFYDYEQTKGGRQRVIKW
TLEGVYKLFDKIKKLKEREKMEKENIVKKVCKELNITQRQLSEMLEIPESTIARWKSGDL
PRLTELFLKTMLENIELKRKLETIKKAHKIISEL
>fig|195.2182.peg.1884 Integral membrane protein
LTFNQCAFYNDLDIHQNQFLDHLVFINCYDKRNDKKITSLDLQENEFEGYLFIKNCAIEK
INLWKNKYKNRCYFVDSNFGYKDKDNTTKLNFSNTHFKDNVYFNNSEFYSYADFHECEFD
DIACFYGVKFHKIPNFSACYFKEQKAANLINVDIDKLDFKSVEKYIEDNYQDETCENKQE
ITEEQRNNNCKLKCAKHLKDSFRVIKDVLITQNNTLEAQEWHKLELYAKEKENHINLSVK
DREKNADIFKNILIWFNCVLLNVYRNTSDHHNDFLKILNFTVGMIVLYGVFIFFCQACIE
PYSKFFNELKSSVIFIIIGILVFLCWIMFYFNRKKSIFAKSIFFIIAMVFIVLYLVTYFY
KTNEYKTILYLVMCYILSIY
>fig|195.2182.peg.574 FIG00638667: hypothetical protein
MNQIEQFLENLSPREKILIYLTTILLAILLSFHFYHSYLKSFFNHEFFIQSNDMDKIITT
NQDLNQQIKQLEKELVFIQDKIKSHE
>fig|195.2182.peg.1703 Integral membrane protein
LVFLFFLINSSQLINPFTGVFSSGKLYESKFEKSLNDLNASAIINLAKISFKEFNLNQEY
KNISFTELNSAKALIVANKENLLKLNDANLNRAKEVLGEKYTELLKTINQDKITENTIKS
TSVLYSIILLLCIFSLQKTARKNSIVPS
>fig|195.2182.peg.573 Possible dnaJ-like protein
MRFYGRDEMQIVQTLETINVNTDDINVFQYFKDLITKNFTKVVGRKNKIFSFFEENEIPQ
RRYFLKVLDQKYRKSTNEGIENLQDAHFKTFRLIFEQNNMLKPMLFIKIDFVAGRILMKL
SSNEKLFITYIRNYFQDHNIE
>fig|195.2182.peg.1556 FIG00470336: hypothetical protein
CIVFPHLISIISKNLTTPLPFFRAKKHMSEIVLKLVRMINTRHFDKNFNQIDFSKIKNLL
PYDARLSDNFFKQIDTKYEKIIGINAFSNNSEYRGFNFFIKDWIGLARQLSLKYPKFLFI
LLNFSTNSIQYNIDQNANLKVFCNNKNIASLVSISQKLDFLITVDTGNLHLCDILQIPTL
AFTSSLAAYRFGGGSYGGRFDKLIVKPAWQKEYRKIYEIFTKKAENNLENL
>fig|195.2182.peg.1758 hypothetical protein
MDGVIDNSGSAVPPLIYILGREMEGGCDYVFNDPNTLIECFLKTHWTRKENSPYFFNNEN
YFIRTLLNKD
>fig|195.2182.peg.773 Possible dnaJ-like protein
HNIEYNEMTNILILEYKNENTLELFEAFANESEHLKYCVNFEVDREEYKKFRQNIHNKEN
MKWKFNALAKLFSNYFNTLECTPQNDLSEIRQKYLILVKLYHPDFHQGKSAIEKAYAREQ
FEKIQIAYDNLKALYKNNT
>fig|195.2182.peg.1197 hypothetical protein
LGLFNNWVGFLITQVYFIVFIEVLWLGVVYDEINIAVNTCKGLVLSKKSVGGKIKFPFGK
IKLP
>fig|195.2182.peg.1184 hypothetical protein
MKLKDFDFRIWDNIENKYIETPHGLYIENTEHNDASNCNRIIANYEQRAFYIDYPFNDRN
NEYYDNEESISIELFTGLYDKKGNKIYEGDIAKIITFSYDFVGHVAYDKEEARFKLIDNK
YMEDFANYEDWDSIEVIGNIHENKELLRI
>fig|195.2182.peg.1892 Motility accessory factor
PLLKKYASKATIFCADSSYPILAKHNIKPDYVLSLERIPLTSEFFNNDFGEFDKDILFVL
KSYVHPHTTKYLQKNNRNFMLVSTYASFINYLKLDDFGYFNMGFSVANMNFLLAIHLKHK
NIVLIGQDLAYAKDGLSHTKDYSNLDKHEGHFQRDKNKYTTQAYGDNGKVESSFVWTLFR
HNFEQDVANAKKNYYITTYNCTEGGARIEGTIEKPFLWACENLLDK
>fig|195.2182.peg.1306 hypothetical protein
DMKCLENINNITKIYGYNSKVYRLKDQIWDERYLGRVCKISQALYFSGKAKIGII
>fig|195.2182.peg.562 hypothetical protein
MNKVELGSNTAKNGFKNENFVVNTFNNWQNDTLAQSWLKAMNYNINDIQNVKAQKIKGSF
KADVQVVILVQIKLQNLQDVQNIQVKLVSNPQGFNQVDKRWLKNYNELWNFPSELLEILQ
YFTGEKSPKIKNPKDKRRMFLTEFTKEEQEQVINFFIKNQALIVNDILKGRGQFASEWFL
VILKIEKQDLKWLLKPINEVINFYSGEVLITDRGSLKIGKITMQRKGGDNGRISANMLQF
KINPCELFTEIIKRD
>fig|195.2182.peg.1838 hypothetical protein
NKYKISRIHIRKLYEKKLIDNKYYDVEIEKIFIMNFKNYKLDGTPEQEIFIGKGYKVNAD
ISNCFPSIYTHSIPWVLIGKIGAKKK
>fig|195.2182.peg.263 Zinc ABC transporter, periplasmic-binding protein ZnuA
YELVQNHIEFLGKKLKNKDIKNLGALIKEKNIKVIFVQTRFPEKTAKTLEKEYNVKIYKI
DYLSYNWENELLKTANAFYENL
>fig|195.2182.peg.1863 hypothetical protein
MSKTSQKFMNSFKSYKRNKMGCYK
>fig|195.2182.peg.1891 hypothetical protein
YRNYIAKNFDVVAVHVFYHCFCQRRSDVEKYSTLADFTKDDLKLIEKVLRKYNIPCDQLA
NNTVVSHCEYLSEIMTELKMLNRLPYDFEERLSATFIPSRGEYQNFGIMAAIDHINALKD
LVKRFPKLADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSAVPPLNYIIGRELEF
KSKDTNGDMYMQGDHFFVSCFLKTHWTRKENSPYFFNNENYFIRTLLNKD
>fig|195.2182.peg.561 cytosine specific DNA methyltransferase (BSP6IM)
MKFIDFCSGIGGGRLGLEKTGFSCIAFCEIDKAAIKTYKKLFDTKNELELGDLTKINPEI
LPDFDLLISGFPCQSFSIVGKREGLDNKEKGQVIFYLADILKIKQPNFFILENVKGLLNH
DKGQTFQKILELLKSLDYEVSTKLLNSLDFSLAQSRERVYFIGIKKSLNKIFKFDFKEKK
KPNIKDFLNPNDENILNRNKYETFLRYLQNKYNKNRFCLEELLENDFLILDTRQSDLRCY
QDKIPTLRRDRQGILYVYNKNFYILSKIEALKLQGFGKINNLEDKIKNIKQSDILRQCGN
AMSVNVIESIAKSLKEQIDE
>fig|195.2182.peg.180 hypothetical protein
MINGINSYSSYNYTNTFSNNTPNTKSSNTVNETSNLVSDKSRTVSKMLGYGVDKDGFFTS
DFNEAAGLPKDYKIYAKDIENFVNIQTKSLLSSYINIDIVKSIGNAYKVFSQLLNDELNN
KINFTKEDLVKIPQGFEFNQNTLEINKKYNLNDKEYKDFMSNYQNYSPTSHNIKIMTFFS
LDDKSDIFKYSLIDPTPYSNNDKTITKSGIFMTFFTGFQAKNYFIEGQTSILGKMQGFDK
TMSQSEIDNLNKFISENSMNFKGDIFKLFDLLNSDMSIDDFKQKILEQK
>fig|195.2182.peg.1701 Multidrug resistance transporter, Bcr/CflA family
MQKHTKIHGFSKLKLVIILALMSSIAPLSTDMYLPALSHVEQSFHTSKALTQLSLASFFV
AFALGQLIYGPLSDIFGRKIPALVGIFFFIVSSLFCVIIDNIYAFIALRFFEALGGCAGV
VIARAIVNDLFEIKEAAGIFALMMVFSSLAPMLSPTFGSFLLEYFSWHSIFTTLFALGIL
LFVMMLFGLKESAPHLKNKKFSHHEAMKSYKFVLSDKRFLVYILCASFALAAMFAYITGS
SFVFTEFFDLSEQQFGMLFGANALGFVICANINARLVRKFESEKILSKALMIMFVSTLIL
LINAFLYPNLFLFEASIFTSIAMLGFIAPNTTTLAMARFKEHSGTASAVLGFIQFALAGL
ISSVVSALDANTPIILACVMCACVLVANMIYFLGKKIPKEKYENKLPFYIGGGGFGKCDP
SLWL
>fig|195.2182.peg.1889 Beta-1,3-glucosyltransferase
SEVIMSFYIPNYNFFHKVGILNCFKNEKPPFQIAYIEDYDPYKEQILITYYTGDDKDIAS
IRIDNEVIYADYEKIVKYDFLDRVFCYQKRLWVHIPKNAKDRLEVLINNEQGMVGKYGEY
FLDVKNIRKEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNHPEREIVFALRKESSD
WERLEKEGFSLVEFGSFEFERIIKKSSKVISSHADDYLMKYITLRQQFVFLQHGVTKDDV
SRWLNSKKINLFITSTQAEYDSIANNYTRYKFEKKEGLL
>fig|195.2182.peg.1574 SopA protein
MAKSICFFNHKGGVSKTTTTYNIGWALSKLGKKVLMVDLDPQCNLTGLVLSSKALDDDFM
ASFYQNRQFITFEPIIEKIISGANSYGSAKQTSKEKIQDFHNTFMKLGRTIINITS
>fig|195.2182.peg.830 L-fuconolactone hydrolase
MQKIFDAHLHLWDLDKMPISWLKGNEKLEQNYDFFRAKEEYEGFEFLGAMYVETNSDDLE
KEALFALEQKKLHNLLLCLADLKYKEELSSFREVMHTSKKEAKRLFEADFEEKIEILKTF
NIPFEACMKNEELSFLEKFLNKNPNLKVVLNHLGSPKIDRLN
>fig|195.2182.peg.1637 Beta-1,3-glucosyltransferase
EYDSIANNYNRYKFGKKEVLLTGFARHDVLLKNNKSDTKQILIMPTWRVNIVGASINSGA
RELKENFKQSEYFQKWNSLLNSDNLKKLCKLYSYTIVFNPHPNIMPYLKEFNLPSYIKIA
NQDESLQVLFCNSSLMITDYSSVAFEMAYLNKPVIYYQFDKEEFFLSHSYTMGYFSYEKN
GFGPVVENEENLLKELEILLQNNCKSFSVHKDNIDSTFVFRDGKCCERIYKNILISTKNR
NTVEIILELQEKRHFKEAYIEWKNFINKMQFDNSNYLYNFLYCARKSGYSDDALNHILLP
DFRVLNPKIRIEIIKNLILNQNYEVIFNELLKFNLSDNDKECLFLAKLRLYLYEKNKIKF
DLLSTYLKQYNIIDDFKLKEEILLSQAFLVNIKHLKLKHLGVDLRKYKRYLCVK
>fig|195.2182.peg.1849 methyl-accepting chemotaxis protein, putative
MNRLGISARLYFSFALIIFIMLFIAVFSIAKVNFLNKTLTIATGENALISR
>fig|195.2182.peg.1332 Putative helicase
MLDKLEKFLVYDNVFLSGGAGVGKSFLTNELIRSYKRQGKVVIALGSSALSAFNIAGATL
HSFFCLGYCQDMDTLSVFDRNQKQREKILKLKENLKKIDLIIIDEISMVSADIFEMIGFR
LKNSQFDGKILVVGDFFQLPPVIKEKKENLFLNSTYAFSSFFLERIKI
>fig|195.2182.peg.1901 Flagellin
IANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRISSSGE
VQFTLKNYNGIDDFKFQKVVISTSVGTGLGALADEINKNAD
>fig|195.2182.peg.467 hypothetical protein
MAYFVAFRKKLNEEQKIKNLISNINDCFGCHFINSDFNNLQNFQKNDFFTLPEKCLQYFH
LAMIHLCFMVLNPLNFKDSNRHLDKAINYLIDGTFEIYELIFKEYFLLFPKDEELKDELK
KIKNLEFKILMQEVSRVKLLNHYKEFCEEIFYNIELEKII
>fig|195.2182.peg.1636 L-fuconolactone hydrolase
YKKDLNLLKKFPNLYIKLSVPDDFSEQTSKEFIYELFAFFKENFSEDKFIFGSNYPVAKI
APAKWAKLIIESKIFKNLNKIFYQNALSIYKEDRCKDMAKS
>fig|195.2182.peg.1569 hypothetical protein
MQSVANDGGFNNINELIIITDRIAHFLKFEKYYRELGKKDILSLDKT
>fig|195.2182.peg.1069 Haemin uptake system ATP-binding protein
MIKQNNIAVVAILHDLNLASMFCDKVLFLKEGEIKYFGSTKELFTKEILKEIYNLNCEIV
YKDLKPYILALKEKI
>fig|195.2182.peg.1684 hypothetical protein
IRYEIMYELPILIFKNLSGHILEGTIIIIFFFLLFLFLLYKRKSLHKSSTSLLITIGICF
TFYGISKGLANFDANNIEENLPQLIDGIKTAFLVSVEAVFFAILLKVIALFMEKPFSNQD
EIEEDVGIEDIIILQKENIKISQETLETFNQSLKATKEINDNIKLLRADNEQGFVNIKNS
FEGFAKTMTENNSKAFIQALEEVIKDFNNKITEQFGDNFKQLNLAVGALLTWQENYKNYI
EKSESIIENLLSSFKKTVEDYSVVVDNSERFVSYAKSFENILKELSEQRIQIQSSIENLD
IFLKNTQLSISSLMQEINNYKEQSLNTVENISKLSANLEESYTKSSEKLINDISEYVGKF
NTELSTHNEKINTQLIEGLNSASASINSQIKTLDQELENVLKNLGSNLASISTKFVDDYN
TILSNLSSLNQKMSNLR
>fig|195.2182.peg.1813 Phage antirepressor protein
MNDLVYSLNGGLVTDQNKISTISKVDINSIQRLIRNYKQDLECFGELGFELQKIAKTNKK
IYYLNEQQATLLLTYMKNSESVRNAKKVLVFAFYQMKEKLRSLEQEQEKARFKSLSDENL
RLNSLNHHQKIGYKSQLKQQK
>fig|195.2182.peg.1799 hypothetical protein
MICDNGVRGREVSLELTNGQATALMYHQNFFCFFSRARTRTRIFLFFIYFFIFLGGFLSP
IKWGF
>fig|195.2182.peg.1903 Methyl-accepting chemotaxis signal transduction protein
TGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLL
VQSINDMAESIKEQTAGITQINESV
>fig|195.2182.peg.1868 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDCKYKMKNNNQEKNVLIAGNGPSLKEIDYRRLPDKYDVFRCNQFYFEEKYYLGKNIKSV
FFNPGFFFEQYYTSMQLIL
>fig|195.2182.peg.1773 Epoxyqueuosine reductase (EC 1.17.99.6) QueH / hypothetical domain
ALIKLDKKAVKSHILFYSHFKNHYTRFSLDEKNLNENLKNGIYKSTKDEISFIEFWRFNS
DFKNKWKSFEDFLKHPLKIEEEIKWRNKHFGAYDLSPVIVLEKILPTRYEIVAKSEIYYD
VKEVIKRT
>fig|195.2182.peg.1120 Phage antirepressor protein
RKILARDYGILCIKEWEMSLVAEKIGKDTVFEAVLNKLEKELKYWQNYEEYEEKWRKILR
R
>fig|195.2182.peg.1858 integral membrane protein
VDLFLVYKKIKKQNYNKIIEFIFNYQKI
>fig|195.2182.peg.1787 Cinnamyl alcohol dehydrogenase/reductase (EC 1.1.1.195) @ Alcohol dehydrogenase (EC 1.1.1.1)
GYAMLSKDAKFTPFEFTRHTVGDNDILLKFLYAGICYSDIHTRRNEWGEAVYPCASILCA
GMTI
>fig|195.2182.peg.1103 hypothetical protein
MLNDTKIKALKAKDKKYYIADFDNLLLCIYPSGKKTFIFNYKCPKTLRYKRITLGEYPTL
NLANARKQRDNLKVNLAENDSIREKYEITFKELALEKMDLKKLELSEKTYKSYMSYLQRF
AFGIYGEIILDKLQIKDILKSFEKFRKENIREGADKFFTLLNEIFRHGVIKEYIKSNPMA
NLNRKELLINKASKNHATLLETKEIKALVDNIIDYKGYISVKIAAMFSLLTAQRSFSIRS
AKWEDIDLENGIWYIPQEDMKMKRAHTIPLNSQCVYMLKKYKEMSINTGYLFYSLRSKSE
IISDNTIRSMFRRMGYSNDDFTPHGFRAMFSTLAHENRNKHQMSSDIIELCLAHVEKNKI
KSAYNHALNLKEKAILMQWWGDYLDEIADLNQQVRNIFYKIFNILFRIQSRTISMLFKLS
KFALFGVFVNYRLFYF
>fig|195.2182.peg.1730 Putative integral membrane protein
MIKETHRKNMREYKIRRQLFNILSKNNPNNIKEYDISIPEYKKIKKIIEEIKEKEDFRQR
DDLFSSDEKWYLICNEGGGKIDISLSYDKIKSIPCNVIFNNCNIDLCVIKPKDLEKDNTE
>fig|195.2182.peg.1882 Zinc ABC transporter, substrate-binding protein ZnuA
MKKIFLLFIFLGLFNSFLCAKTLQPSENLNLPLISVSIAPQAFFVKKIAGDTLNINILST
NTHKPKSKSNPMKKLEKSELYFTIGLEFEKKLTDKLEQKFPKVKIIDMQENISLAKASSS
DSEEILDPFTWLDPILVQNIALNTYNALVQKYPQNKSLYKHNLDKFLTELDVLNLQISSK
LQKVKNKEFITYHPAWSYFAKRYDLVQ
>fig|195.2184.peg.1129 hypothetical protein
MAEEKENIVKKTCKELGLTYRQLGELIGFGEEAISKAARTENISTQMQKALDLYLENIDL
KEKLKVLDTLSDIIKQLSK
>fig|195.2184.peg.1127 Phage antirepressor protein
MSALTPYKTKECEIIDCEIIENLEVIDNIIFTNSLFVAKVFNKNHAHILRAIENLPQDEF
NALNFNAVSYKASNGKINPCYNLTRDAFSLLVMGFTGEKAYKWKILFIKAFNEMEKRLRN
IEYEKHDKLAFRQSLGYKSQLKQQKEHYENKIKALKYDLENKNELSFKRKLSQKELLELR
KILARDYGILCMKEWEMSLVAEKIGKDTVFEAVLNKLEKELNYWQNYEEYEEKWRKILRR
>fig|195.2184.peg.1753 hypothetical protein
MYTPFLPPLTTPCFFRYATKTKKVWLFLSQGGKTGGF
>fig|195.2184.peg.1655 FIG00469432: hypothetical protein
LYWNLALENRQRETFCEFFSYARKIYIILMSTEEIFDEELNKNLALRFKDLVKKSHCILA
NNELGENLLLFLSGEELQNLLSDFDFFIKEDSFYKSEQEKYFFKQMIAMQLRKRLVLFKK
NLLKNFEIETFEENFLGLSVFLEYFHNLYNLKILSKLYNKYFICDLEKKTLLKLTKKKEK
LGKLIHKASKKLKIYKGY
>fig|195.2184.peg.1791 hypothetical protein
NSYENLNNAFIRIDQEIQKLKLNQKLNQNYKLRTHVSFLPSKNEYQNFGIMQAMDILNAI
FYIKENSPFKLMGGGIRTILFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRL
IGFGKEIDFTRYHGTYDDTLFKNIFLYLSDKTYWNNNKFSKKYFSNARKIIREPLNKEHL
IIQSLYPNPKYILYHSIFDERSPFENKENFVHILKELNFKVEFFAVSQVDNKFIKNLNHG
MGLSTKLFFKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2184.peg.1128 hypothetical protein
MLEIIVLVIATLVCVLSVKVYRLEKEIKELKK
>fig|195.2184.peg.1523 FIG022708: hypothetical protein
MGDIFDLLIGEISATHEFAKPYIKLLEELALKMEIIYLEGNHDFNLARFFQRVKIFNLQE
QPLKLNLHTSKGKNTDFKNSFITLAHGDIFLSPPLQFALKSLRNHYLLVFLNFLNQISFN
>fig|195.2184.peg.1824 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
DCINIYFTTIQALFSLFKNERENSLSFEDLKDEKLVFLADEAHHLNSDTKSKNENEIKEG
WEAIIKRAYESNNENLLFEFSATIPQEFNVLEKYQDKIIYEYTLREFCKEGYSKRIFLVK
YDNDSLEHRFLGAVLCSLYRELLAQKYNIVLKPVVLFKSESIKESMQNQEKFIDFIDNLE
SLHIEDFYKNINKESDLLNKSLEFFKKEYQNTYAKTIVNFLKNNFKTLYMLNTNDDKELE
KNQILLNSLEEKDNQIRVIFCVDKLNEGWDVLNLFDIVRLGNKKASKTITTKEAQLIGRG
ARYYSFKSDLFDFDDEFRFKRKYDSDLENELNALEKLTYHTRNDVEFIKQLNESMNKEGL
LFEEEKTRIDLI
>fig|195.2184.peg.1754 hypothetical protein
MLFLLGFCEATARNFSCVREAKRTKGKSTPINQRHEIAKIFSAMSAKPKEKKDKTKLKFK
MKFNRWGTLLLEKDCNAGA
>fig|195.2184.peg.849 hypothetical protein
SDMSIDDFKQKILEQKENLNNPTKNTNNKETSEEDKKKPFKPIQAQSSSETYKDDNKMNE
LLKKLLENKFGTSDELEILFGMKFSDDDTGEFNKILSLNSAPKSIDIKA
>fig|195.2184.peg.1695 Uncharacterized membrane-anchored protein HP0586
MKKKIVYALLVLIVFISVVFLVLKNGILISHIQFSFLNLEQLYIKLDKKLIVRAKNITFN
EDNNASIQDDKNVNSDFASKELLNITKNLKYLYTFVEEIDIQNFNIKDNHMRILFKNDEF
FVDNDLLFLKLALHREGKEINADIKN
>fig|195.2184.peg.1442 hypothetical protein
MNISNLSELIHANMLNEGSVLSVTGFALSLHELKNGFAFFSNNKKEIIQAVQKGAFAIIS
EHELCIDDKEIYYLQVDNLESALIKLLRFLCEEKECEFIALQAYELGICKAFSLNILKGN
IFVDFNSLIKAKKGEIFCFSDENYLLQLCASLTILKEANFTLLSRSSFFFTTLVCDNLYF
KNLNLPFIYAKIFAKIMFYLKEKNTKMSFDFNKIDDFKIYFMDENFNISEFLTLIHI
>fig|195.2184.peg.1828 Beta-1,3-glucosyltransferase
QIIKKYQKKYPKNIVYLYKENGGQASARNLGLKYMQENDYQIPWVTFTDPDDFLDRNYFY
EVDKFLATHQDDDICMIGCNVIFYYEKQKLYKDNHALNFKFKSGVQVKENYNLDSFIQLS
AASCFMNIGYLDKLLFDEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKYFYRKREDGNS
TLDNSNKYSDLYLLVSRRGCLKLLQENKFYDIFIQNVCLYHFFWQIKTLILNPEKLAILN
NEEKKLFKELLFENFKFIDSCNIKNFNLHAFDFFYKKGILNYFK
>fig|195.2184.peg.96 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
QAIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMIVNSKSFLGYIRMPFALS
YIKDKHKQEQKNYQEKIKKDPSLKLPPLESYPDYKEALKEKECFTYKLGEALIRANNNWY
GGGYIKLWFEIGKLKREFRNKKI
>fig|195.2184.peg.1758 hypothetical protein
MTWQSHIAIGTAISLPFSPFATPLAILGSTAPDWIEMILRFFGIQIKHRGETHFLIIPLS
LILFSFALDFNGFLFWFGVGYLSHWIADSLTISGVPISPLDKNKFTLFGGKIKTGEPLEF
ILAF
>fig|195.2184.peg.1730 Protein hydE
NTFLNLAFDLLSQEKKIYLKDKNGIYEFSLFKNEFIGDFLLPCDIKAINSVFVCSNENLK
LLASLEKPLMKLRLNAMFRKNHNLDFNDFKIRLARDLFCFALGLKLFENEYKFLSVKKIE
EYQKDFYISALDEQVVVLEGFEFINAKARELIFSKEDKNMARISYLVSRYKEKAFILELS
KDDEDILLINKELNLLKLCLPKHSKELYEEIKKDEIGARLLENFSKEFPLLDENFELQNN
FYSLFGLVGRVLNLGKNLQESASELLKIADESKMPRGVKIDYRLKEDKSFDYTRTLRSAM
SFMLAGVDSANIAYGAVESLAYFLRDTYDELREKKQSDLALISGSLFEHKSLLKNTLKHL
KNCQLSDVPLRI
>fig|195.2184.peg.1133 hypothetical protein
MSLSINSVDDLLVIFEKLSNGENIKVTEVGTIQHTIKLQGGRFENYNIGYIDAEIARVID
SYQDSFYRVADILKKDFGIDGIDKNKLIRFYLGEGSLEIKTDELLTNLLGVIKDMESRDK
LILFIVVALIIGGCWSFGNFLTHNEKIEKIKSQNENAKIIAEIAKNKELQNACNAPKTTL
VKILKDDEKASFSLGNDVITNHLL
>fig|195.2184.peg.1 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
NKRIKKRDLKNFYITRIEMEQKIKGLQIPYFSNSIKESEEKFEEIKEEYDLQKPSALNHI
DNIYFLKAMNILGLDFNKINENFTFKSKKDFIENCLKNTVVCFSKRQEFNQINNLEIAKY
ILENFKSLKQNIKQEYEVSEFITHEFNIGNKVVFKNKENFKEMNFEWLYHKTFCFDSNLE
KEFLNFIEVKKDEINKVFSKWFVIRNEGFEEFKIYDNRKDEVTYAMGFEPDFIFFGKKNK
DDDNFLSIQCFIETKGEHLAIAKDAWKEEFLETLKGKIITTKDDKKLTLQSLPFFINKNF
NINDKFLSSFDEFVSFQDER
>fig|195.2184.peg.746 hypothetical protein
MENGNLKVDEQYKVTLPPNLITVLEYDKKDFEGATLKNFIDDVECELSDWEIELYDDPHF
MDMMKMRRDMKMRRDMKMMKMMKK
>fig|195.2184.peg.92 Putative periplasmic protein
MKKVILTSAMLCSVLFGVQEYEANLAGHIIIDSKSTVKPPKDAPDFFKTYGKFANITREE
KIGTFKSKGNRETDFYLPFKNQPIQGHSGIKYIPKKDVFWVISDNGLGKKYNSYDAMLYA
HEFKFDFKNSKYELLKTVFFKDSDKKYPYPITTETTKERYLSGVDFDTESI
>fig|195.2184.peg.1336 Putative amino-acid transport protein
MGEQNLTLNPSVPFDEKILKILEYVLPYTDTIMVVLLIICGIYYSFLTRFVQFRMLKSVF
KILTERNENHTKEHISPFQALMISTASRVGIGNIAGISIAIAAGGAGALFWMWFMAFFGG
ASAFAESTLAQIYKSKDNTGGFKGGPAYYIKKALGSHFFGAFFAFILIITYAYGFNGLQS
QTMTSAFKVYYDMFNPNATTDFASSSWPMIIGIILTLFGIWMFFSHHTKIGKVSSLIVPF
MALAYILLAFIAVLINFEKIPSVIVLIFESAFDFKAILGGFAGSALVIGIKRGLFSNEAG
MGSAPNAAAAALTSHPAKQGIIQAFSVLIDVIVCTSSGFLVLFSMAYFNVGADGKPLLTA
MPLVQEAMREYYGGF
>fig|195.2184.peg.1639 hypothetical protein
MRVKLNIFEISNIIRVTDYGASCPLEVSIKDNSKFILKTKYNEKLMILPLLATLALADYT
YYKRRLKAYTIIQNL
>fig|195.2184.peg.316 Multidrug efflux system, outer membrane factor lipoprotein => CmeD
YNPKVPAPFVILADQFLEKYSQGNQFILGMEWKIFDFNARAKEVEKERLNVQIANANARF
SERKNKEELNYLDKSLKVLQEQILALNLSLNAANLAFESVDKKYQAGLVSYVEYLQALEA
KFKAQSDLELAKNEFEITKANYYFNAGIDLNSKVKE
>fig|195.2184.peg.1155 ATP synthase delta chain (EC 3.6.3.14)
ASPSFNNFLKLLAENSRLSCIPQIAKELERQKSFKENIFLGTVYSKEVLSEDNIKELENR
LSTKFGVKIKLQNKVGLNEGVKISLEELGYEISFSMKALQNKMSEYILKII
>fig|195.2184.peg.1752 Plasmid replication initiation protein
MKGRFIVKHSDKLTKGRSKLTAVQMKVFLQTITLVNMSDVEFKETRLPIKNFCSEVGLFL
DKKFVIDLCDKLSSQVYSVFNEFKKSKFRYDNFPIYKRFSVDLEREEIIFCFNDYMREFL
LELRSKFTKYDIRYILNLKSKYSIRIYQILKNLRDLTRQKEFDLTEFQDMLNVPQTKRAW
ANFKNDILKKSIDEINEFTDLQILNFYEEKKIRKKVISFSLKFCTKDEFKEIEYFTDMGL
NDREIWFLKIKNLIGSKFLINGKIEILEFVNLPESDGKVQIFFTQNGNLNQYFFNSFDDL
KKSIENARNILDDSPILDFD
>fig|195.2184.peg.1557 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase (EC 2.6.1.62)
FCQNIFKKEVIMQNQILKNLDLKHIWHPCTQMKDHETLPLIPIKKAKGVWLYDFDDKAYM
DCVSSWWVNLFGHCNEKIANAIKKQVDELEHVILAGFTHEPIIKLSARLCEKVGRNFNKC
FYADNGSSAIEVALKMSFHYHLNKGMKKSKFLSLSNSYHGETLGALSVGDVALYKDTYKA
LLLECLSTPVPQGKDYTKELEILKDILEKNASEICAFILEPLVQCAGNMHMYQAGFIDEA
IKLCHKFGVQVIFDEIAVGFGRTGTLFALHQCKQSPDFICLSKGITGGFMPLSVVLTRDE
IYNAFYDTYESQKAFLHSHSYTGNTLACAAANAVLDIFEDENILVKNQILSEFIKKEFSR
LEKFDFLGNFRTCGMISAFDILSTKYKRVGLFVFQKALEKGLLLRPLANTIYFMPPYIIT
KEQIVYVLESLEQIFKEF
>fig|195.2184.peg.1675 Integrase-recombinase protein XERCD family
GGVSCRGEYCFFFFKQKTAYEISLGLVGSEMCIRDRFWLAKYVKFKLNSLSNKELKNPKA
LAEVNFALTRGVKNIEELDALAKKARNAGLNGVNTYFNPLKKVFEYLNFYKLHSLKQIDE
ELIVEVLASITGALSDASKKNYRIAVINFFDFLDKQNEEDEKAHIFNIVLKNWGGITGSK
GAKLPEFMNEDELKKFLEAIENSDFKNNTIRNKLIIKIIIFTGIRVSEAINIKLKDISEE
NELYIIRIRAKGNKYRVVMIKKELIEHLLKDVRVNYLSEGGLLFVNRNGKALTQAYVSRI
VEQILFRAGIRKQKNGAHMLRHTFATLLYKKQKDLVLVQEALGHASLNTSRIYTHFDNDK
LKLAAQVAKELSER
>fig|195.2184.peg.1479 FIG00470336: hypothetical protein
QIDFSKIKNLLPYDARLSDNFFKQIDTKYEKIIGINAFSNNSEYRGFNFFIKDWIGLARQ
LSLKYPKFLFILLNFSTNSIQYNIDQNANLKVFCNNKNIASLVSISQKLDFLITVDTGNL
HLCDILQIPTLAFTSSLAAYRFGGGSYGGRFDKLIVKPAWQKEYRKIYEIFTKKAENNLE
NL
>fig|195.2184.peg.1751 hypothetical protein
LDKNKFTLFGGKIKTGEPLEFILAFGLLAISLLIAKPIDFFIRDQPSYFNVFYMDYKDLN
EKKIIDNKEYLEKRFKFF
>fig|195.2184.peg.1541 hypothetical protein
MVHEIQKTFLLPDATLLEKLQKDRIVFEIYEIETFYTKITYFYDVKFQNLNGNFYKITRL
NNPILEQNQEEKISKKDYEKARKKLIEKSIKKKRYEFKLCSFKSLIDVYEDFNLYVLKVF
FPTLEMANLFTPPKEFRIQRELCGVLDSKNIILYGFNNLEIDIEKCFKIIEKNQNFTLDF
PSSI
>fig|195.2184.peg.95 ABC transporter, permease protein 1 (cluster 1, maltose/g3p/polyamine/iron)
MKEKFLAFLSILPFFIVFTFFMIAPLIWIVFNAFYV
>fig|195.2184.peg.1403 Putative type IIS restriction /modification enzyme, N-terminal half
IHPHYDFINNRINSNHNFAFKIGQGIFGLSEEEKEKLKLTKLENNLVKPYYDTQNFLKFF
FKKNNHQWLIYTNSSFKNPNSMDDYPNLKKHLDKFQNVITSDNKPYGLHRARDEKFFTGS
PRIVALRKCVGEPKFSYVDFDCYVSATFYVIKTQRINVKYLTAILNSKLVAFWLKHKGKM
QGNNYQIDKEPLLNIPIVDTNSKNKKLADELINLVDEILKAKEQNKNANTQELENKINSL
VYKLYNLTEDEIKIIENKE
>fig|195.2184.peg.928 membrane protein
MKNNIQLFVLLSIFAFLFFWQKFAWVSLFLIPIFLAF
>fig|195.2184.peg.1585 Leader peptidase (Prepilin peptidase) (EC 3.4.23.43)
FQNGFMVQAFIFAGFLFLLKNFIAFLKNFRTKDIQENLGDADIIILASMAGVFGFKSAFI
ILFLASLLSLPFFIHNKNTKLAFLPFINAAFVIYLIYLIVQELI
>fig|195.2184.peg.1834 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
SFQTKYGTAKTRIQNQLSYKLGQAMILNSKSILGYLIMPMALLSIIISHKQEQKIYQEKI
KKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWY
>fig|195.2184.peg.1831 hypothetical protein
WEDFVQKYFGEMLSKEYANKYGYNGSPDVKEVENSLYKRYMEDKLSKDEIKILNEFGTDY
LVEGVDLTALIRRKVDLLKTLTSMNEFEKIWGAERAQREKQFFNELGKPLTQEDIDRFLA
NKNNQKEDKKTFKPIQAESKNKETYKDDNTRNELLRKLLETKFGT
>fig|195.2184.peg.1759 hypothetical protein
MLNKKDLVNFFLSFSSNKNFKRYDFENYDCEISNYISEFKNGKHPDHFFNFWNKHSDKKF
FELKHPIYNHIKTRAITNVSFREGVFGNYIFFIDSTNKYYWILGIHFYLNILICDDGIYY
>fig|195.2184.peg.1809 hypothetical protein
LYKICKQDLLLLDLNDFKILLEEDK
>fig|195.2184.peg.1832 Motility accessory factor
LKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGYNENLLYQDPIKELQTMLNTYND
KYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSNELQSARLM
ILQTSSLDIELFSNFCSSKPFFQFSRIYFLELMSHYYERFH
>fig|195.2184.peg.1842 Methyl-accepting chemotaxis signal transduction protein
IHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAV
QNLTSSSNSQAASLE
>fig|195.2184.peg.1337 Putative amino-acid transport protein
MNLFRITAVAMIFIGSQMNLKLAWSLADLTMAFMAVTNIVSLLLLGGIVNKVLKDFNTQQ
DSKINPKFSASKLGIKNAECWD
>fig|195.2184.peg.757 Multidrug efflux system, outer membrane factor lipoprotein => CmeD
MFEKYLKSAMFLALYPLAMLASNLHEFIALSQNNESYLIKQMQSEQANLDKEQAFRNYLP
SLSLNSAYVANNKDRFIIDPQESLFAKVSLNFLLFDGGTREANLRALESKEKLSLLDKEQ
SKNYLALNAITLYFNTLSLKKILLANQQKVAFLKSTFERLQKFYDAGLSPKDELESIKAK
YHLSLLELSQNELKLANIQKEIKILSDTDFKVQGNAFLENPQQEKSQNYEVMIAKEQINL
AKESVNLAKAEYFPK
>fig|195.2185.peg.96 FIG00638667: hypothetical protein
MWEFYYLNNQQLKMKDLILKTHLSVLRLEKLLQTCTNITFEPNHISYLLKDDLLYLDDNK
EKLLNSSLILENKIQVYILPIVILNFNFKIEKNCIMMSKISFML
>fig|195.2185.peg.1443 hypothetical protein
KEFMKGFSIKKIFALLALTSLLTSSAFAGDFLAKLTKGALSDTIPGVKELSLEEMKQVKG
GYITYLKRLSDNEVIAFAKPDWNLELTLFQDSNGDQYYWNREGLVRFGGMCGIDTTNCLV
NGKHTYTNQQRLWETMSIVGDDPYRNFLGYTVKRNIGISNLGKRFVYFSYGVAVINEQSG
SWYRVKSSPVLNNYRVVKEISSNYKDFLERYLGGYSIK
>fig|195.2185.peg.1442 hypothetical protein
WGFIDRSGKFVIKPKFDSIWDFSEGLAKVKLNGKYGFIDKSGKIIAKPKFDYGEYFSEGL
AGVKLNGRWGFIDRSGKFVIKPKFDSIWDFSEGLAKVELNRKYGFMDKNGKIVIEPKFDD
IGY
>fig|195.2185.peg.1511 Fe2+ ABC transporter, substrate binding protein
MSIYFVHFLISVLPLSILMAFIASDKKYIFKSFLVVFLGFLFGYFAFFIAAQFLKTENLI
FNFDFVFIGLLLVSFI
>fig|195.2185.peg.1510 Membrane protein
KEGFKNLTLGKTLWKIIFIKLFIMLIVLKLFVFDVNFNSIFKNDNEKSNFVIENLIKEK
>fig|195.2185.peg.408 Uncharacterized MFS-type transporter
MLINGFFSMASLFILLQGFGAQEVSYFMFCGVLGGFLAQIVVGSISDKMGRKFAIITCSS
IGFFTMLIFAFFKLHLYMQYFLGILLGIGVFCLYALALARANDMLTNKNQGVELGRGVLF
CYSLGSLFGPLILGFLIQYFNTDGFVWFYIASLGFLILFAVNKPNILNKKFKKKPGNMVM
LDD
>fig|195.2185.peg.1415 Sulfur carrier protein FdhD
IKEKMMEPLFTTQILKYKGKDLFTCDDTLVREIKLEIFINDEKVGALMATPVDEQALAVG
YLMSENIIAKVSDIESIETKDDGMSVHIKAKIDKENLAKLNAEGVVISGCGRAHTANIDP
EAIEASKISSDAKFSKDEILKQMSTFYTQCELYEKTGCVHTAKLFVDEKTFFIGEDIAQH
NTIDKALGKARLAGVDLSQCFLMVSGRLSSEMVAKAVMHKIPVLVSRTAPTCLGVMIARK
FDLTLCGFARENKINIYSGEFRIHG
>fig|195.2185.peg.1488 Fe2+ ABC transporter, substrate binding protein
MCIFDSYYNLTQDFPIFNGVLIDSEAISSLGFIALALLICILIFFFLKWQKNINKKASFI
LFLILIFIEGDKVLANILLTLMRNSFIETHTFLVSFVGKSNYFGVFGIYVYLFFIIFLAF
LSLQIRKKNIVKKQILDIVYRKNEAKNTLINRYFSSVFISCILSFCIILYFFMVSSKPLS
IDEPTELLPDKNGKFIFDVALLRDNKLHRFAYISEQGKVIRFFLINKREDRDSPVAVFDA
CAICGDMGYIKKEGELICISCNVRIFLPSVGKTGGCNPIPLKYDYDGEKITIDVKDVVAG
SNYFSQIKDIQVQDPVSKDKIINTQAPFSYSYKGITYYFSNEKNYEEFKKDPMKYVEDTE
ALFLIQRRNNAS
>fig|195.2185.peg.1 Transcriptional regulator, LysR family
IKELVIQKNAISIFSKKSIEKELKNSILYEVKLKNINLWRNFYILKRKNYNFNRALEKFE
KIFKQ
>fig|195.2185.peg.1298 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHAETDLLKATQISIENFRSR
NISLLNALEKDILNLPYEALNSQDNIVIM
>fig|195.2185.peg.1703 FIG00469634: hypothetical protein
TNIYKTNNPFQFNLTHFDDKNHKNQLKQNF
>fig|195.2185.peg.171 Beta-1,4-galactosyltransferase
MDMFYKHKVLNIVKKPLLLKHDCKLESEISNLGRTNKKLKIHRKIAREIFRLYRDISRLL
YIFYIKKKLNLK
>fig|195.2185.peg.806 Membrane protein
FNSNTTILAMVFNAIFLISYLIMILKLYFVSQSKVLLISFFIAAFTQFIALLSLNYLIAS
PVVDKILRIFLYGFSFLCLAIAIFCTFIFFKTLKTLCENKIYFKLCFIFKSAILIIIYIL
MFVLIYSEHSLALIIAYFMIFFFAGLLFTIYYALFAFALSKNQNIKLSQT
>fig|195.2185.peg.1684 Fibronectin/fibrinogen-binding protein
MKYTELMQLQNFFSQFKKIDFIKRVNDNILELSFNRERFIFDLTRGMSAIYTAKLMSKNH
NAPFDFMLKKYFNNAFIKEVKLLQDNRILCFSVKVDKAYKSYESKIYFEFTGKNTNVIIT
DEKDLIIEALRHIDKSYRVVKPNVVLEALKPYKMDEKFEEIKNFKDYFTQKFEILHANKI
KQIQTLKLAQIDKKIENLKELYLALGKEEVLLDQALNLRKQADILFANLSILKEYEREFE
LDDFEGKKVKFKLDLSPKESANLFYKNAKKLEQKARNLNLQRENLK
>fig|195.2185.peg.952 membrane protein
MSNLNFHQMFEIQRQNDFKSIKKLAWVVFISFLLCVCFQFLPIILDFAYDLKLLKFNSNT
N
>fig|195.2185.peg.1723 hypothetical protein
KEFMKGFSIKKIFALLALTSLLTSSVFAGDFLAKLTKGALSDTSPGVKELSLEEMKEVKG
GYAVTTIRISQNELAALAVPDFENELGWEIKNGQIDLEQTMKNDRGLCQMGSTQCYSNSA
TKKHLWQSQKRLQEFTNALDGSNPLYTALGFSVKRNVGFNRAGKFVYFSYGVVAVNRFDG
SIRNVTNSATLNNNVIINELKRNYKDRLESALGGLR
>fig|195.2185.peg.1730 hypothetical protein
MVFLSLGWLAIDRFMIKDYALGILRIILSLFPCVLFLILGISYENDSNSDISEIFFGLFG
IFLLLGIIWWGVDLFLVYKKIKQQNYN
>fig|195.2185.peg.407 Uncharacterized MFS-type transporter
MTALFASMTFLFAGNALIVSSIGVILKENKESSLAVGVLSSCFFIGALIGTIGAHKIISR
IGHIRSFGLFGAVFGISAMLHTLSENLVFWAILRFFIGICYYGLLMVIESWLNEKSKNAV
RSRILGFYEIVFYLAFGIGILIIALDLNKHNIFILSAALILLSSLPLNLIKIKEPVLPAP
SPISIPKIFDIAPLELLLQVL
>fig|195.2185.peg.97 FIG00638667: hypothetical protein
MYNDEQNIIYALVNKEIKKIFIHSENNITASFKGKFIPIQARIKLFLKEDKIHYELYPYF
NNQLEQYSIFMDNVSLFEIEKQKLKICLKEQEQEYCLTKRLFI
>fig|195.2185.peg.788 Tripartite tricarboxylate transporter TctA family
MDTWMYLMQGFSIALDPYNILIALIGCFIGTIVGMLPGLGPINGVAILLPLAFAMNLPAE
SAIILLATVYMGCEYGGRISSILLGIPGDAAAIMTTLDGHPLAKKGQAGKALSISALSSF
IGSFIAICGIILFAPLIAQWSLKFGPAEYFALIVFGLATLGSMLAQKPIRSFLSALIGLF
LTTIGIDGNTGVYRFTFDSPHLYDGISFVVLVMGLFSVSEIFLMLEHTQTSQNIINKTGK
ILVNIKEFFFCFWTIIRSSIIGFFVGVLPGAGATIASAITYMSEKKIAGEKGKFGQGDLK
GGQPLKQLIMLQPVVLLSQC
>fig|195.2185.peg.406 Probable integral membrane protein Cj0851c
MFFALFKLIAYGVLVAGFLFLHRQDKLDILSYICGISSLLVCVFIFMLYIRRYESKKNH
>fig|195.2186.peg.1078 UDP-N-acetylmuramate--L-alanine ligase (EC 6.3.2.8)
MMQNIHFIGIGGIGISALARFLKEKGFKISGSDLKESKITNELEKEGVKVSIPHHKDNIL
NKDLVIYSAAIKEENPEFKHAKELGIKCLSRKEALPLILEDKRVFAVAGTHGKSTTSSIL
ASLLDDASVIIGAILKEFGSNMIYKESQNLVFEADESDSSFLNSNPYLAIVTNAEAEHLD
HYGNEVSKLHHAYTEFLDTAKIRVINAEDEFLKNYKNESIKLYPSKDIKNCTMCIENFKP
FTSFELKDLGEFKVFGMGYHLALDASLAILAALNFLDIETIRTRLKNYQGIKKRFDILHA
DENLVLIDDYGHHPTEIKATLSAAQEYARLGGYKKITAIFEPHRYTRLAANLKEFAKAFE
GVDELIILPVYAAGEEPIELDLKAVFPKALFVEDIKREGKFLVASKGQVFEEGLIIGFGA
GDISLPITHI
>fig|195.2186.peg.1142 COG2833: uncharacterized protein
MQKEFFNELEKILYEQNLDNKFENFAIFY
>fig|195.2186.peg.511 bacteriophage DNA transposition protein A, putative
MSYFLETKEAAQAFNVSTGALRLAASRNSNKYEWLKVDNEKGGRGGKKLL
>fig|195.2186.peg.1794 hypothetical protein
NKLEDLSLLFKMSSYMIADPVASVAMSRASSIINNFNKLLSAEKKGLDEIKNEINTALLN
IDIKIIVVIDDLDRLADTDIQEIFQLVRSIADFKNTIYILSYDEEIVSKALDKIQKDKGG
KYIEKIVQVPIKLPKVSQENLKDIFIKKLKTIHIKHEALDKDEFIKKIKENNFADAFKSI
RDMERFLNAFKIEVNAINQELYLYDFAVITLLKIFEPRLYDYIYDNRMLFIEQYNPYDHI
SSEIKIPENIEQEIKKITKSNKDFAFNLIGSIFPKINNQPQDYSQLIQNNTDNQKKRITY
PSSFKYYFLLNFPK
>fig|195.2186.peg.278 hypothetical protein
MLKKQQHSSLYPRNKSFLSRNMGKKYFKINSKNFKKARLK
>fig|195.2186.peg.1362 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAVLSLFKTS
NILENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMICLCGGGLGVLFTIPL
RRTMVVESKLAYPEGRAAAEILKVANKDQSNKKGKQGIKEIALGSFIAAIFSLLSNGFKL
AASESSLAFIWNKMAFGFSAGYSLALLGAGYLVGLAGAIALFVGMFLAWGIFTPYLSNFE
FDSTKNAVDLASSVWSSKVRLIGTGAIAIAALWTLIELLKPVIEGIKEIVKNVKITNQEK
NERTNIDLSLKSIFILFVLMVVGLFITFYSFVEDANLSIYYQMLFSFVGTLVSVLIGFFV
AAACGYMAGLVGSSSSPISGIGLIGVIISSIVFLVLGVELFQDPMLSKFAVALAIFTTSV
ILATAAISNDNLQDLKTGHLVGATPWKQQVALSSLWFCRSNAKRRYGCFIGFSSTASEFN
EYYRSRNFSSQYRVGLYGFWCICRNFNDYYR
>fig|195.2186.peg.1772 UPF0246 protein YaaA
MKILFSPSESKNDTCKEKPIDKSSFIFENLFDFRMQAVKKYEEYINNADLKALQELFGIK
NENEISNFQRDLKNSPTQQAITLYSGVSYEYLNFDILDKESQKYILENTLIFSNLFGVVK
ASDHLPFYKFKQGAKINNFAL
>fig|195.2186.peg.1196 FIG00713008: hypothetical protein
MGQCFNGFLNSFSDHLYDLNGVKAQIGMRIVKTQAEVEEAKLKGETVFLVNVGGKIKCNH
RKIK
>fig|195.2186.peg.681 McrBC restriction endonuclease system, McrB subunit, putative
MKFVEFNFSNGEKIQTQIKESNEENFRAFLEKRLKNFDQYIKATKGIIEECKRLNIVNRD
DFDTFQINSIELLKKLLFELKKGLLQEYNNKSGNGCPHACINSHYLEFVKYVNAYKEYTS
KDMVKYLKTRGGDKEFKVEIKNQKIEVIASVDNIIRTYSLERFLRYSVLGKIEEDSSYAK
PLFEDILNNSNLSIIKLSENEKIYKEQHFENEKILSENQNLSLNQILYGPPGTGKTYHTI
DKALEILGENLESRDRDEKKAKFDEYVKDGQIVFTTFHQSYGYEEFVEGIKPMMNNEANS
QEIQYEIKDGIFKDICNRALENYENSNLNTEELREKIKLREKVEKFLNRLLETNEPISKT
KGGNFFINSFNNNTIEIYSEDVERFDGIFKLSLSTFITLLKSNIEFNSAVEMFKKVFDRD
YADRTHTYYFNLVNKFKEYEKQAVLKTEDNKISSNSLNSYIIIIDEINRGNVSKIFGELI
TLIEPSKRIGESEELKVTLPYSGKKFGVPKNVYIIGTMNTADRSITSLDTALRRRFEFVE
MMPNSDLLNNVFICKDVENPNEDEDYLGDDAKTEGYAEILQNILISINKRIEFLLDREKT
IGHAFFMSEAVKFNKNNWIKPDEYEEDWYVLSISKLKSIFQNKIIPLLQEYFYNDYALIS
AVLNDNGMIEKCEKDDKYLQKIKNLDNVDSEKIIYNIASFDNKIWNDIKTYQAIYNDGEN
QSKNDKQ
>fig|195.2186.peg.1538 FIG00470545: hypothetical protein
MNHEKSLIYLIALCLSYTAMQAVCKYAEEQREDRGGGCAYCCFNKAWYGLWHFVC
>fig|195.2186.peg.1023 Transamidase GatB domain protein
MQAALKEMIANLGVSSLKDQGLVMKEAKAKFGARVDGKRLNVTLRELLN
>fig|195.2186.peg.1730 Putative integral membrane protein
MNISSNKLKNIGKKIKKNEELTNEEQDLFSYWLNLHFDIMKKMHRHVVDKLKKLGIKNYI
IAKRTKRLESISFKLKRYPNFALDRIQDIAGMRIICDNLKDVNSIKNELKKHYQKNISVF
KYSNMDDYINEPKNDGYRSYHLIFIDIKTKCKVEIQIRTKLQHSWATAVEIIDMDPYCKI
KQGTGKSVYKDFFKLSSALFSRIEGTKIVEPYQNYNIEKIYYFLKILDMRSNILEKLKNS
NINENITQDHKDKFYFVVYLDRNKRTNVASYSKDDLNKARKDYNNLEKNKDINVVLISLD
SQKKIRKAYPNYYLDGNLFIDNIKKYNNIKYFFLKRMIYYISFKICFKNKNHFDRQEIKN
ISILYQDIFNQKMDKIDTELNLNFEDLQEKIKQECI
>fig|195.2186.peg.1061 Putative transferase
MKNVIIIGAGGFARELYSYLKDANYEIIGYIDIQENNFF
>fig|195.2186.peg.1652 Predicted D-lactate dehydrogenase, Fe-S protein, FAD/FMN-containing
FKIIFKLLNYIIDNKLKRGTMANFKAFYNEAKYIFKDRIFNDYARCYAYGIDASCYFYIP
KIVIIAKNEDEIKQIIQLANTYKTPITFRAAGTSLSGQSSCDGVLVVIKFAFKKIKINKD
ASEITLGCGVVGIHANESLAFLKKKIGPDPATINSALIGGIINNNSSGMCCGTKDNSYKT
LRSIRVILANGSMLDTSDALSVARFKDENKKLINELREIKEEINANKELKDLIIKKFKIK
NTTGYSLNAFVDYDDEIDILAHLLVGSEGTLGFVSEVKLAVLDDLEFKACALLFFDNINN
AANTIKEFAKVDFISSAEIMDYASLKAASNYDELRDILADIKEGNTCVLIQSEHSNELKL
DENINKIKEISKLAYKSYFSKNKAEYDLWWKIRKALLPIAASLRKAGSTVITEDVCFNIE
DLADGIKSIQELFYKYGFSDNGIIFGHALAGNIHFIITPDLNNKLEFDNFSNLVKEMSNI
VASYGGSIKAEHGTGRMVAPFVEVEWGKQAYLINKKIKSIFDKDNLFNPDVIISDDKDIY
KKNIKQASWIDEKLNTCMECGFCERFCPSNEYTITPRQRIAILREIKRLESLNDDESKAK
LKDIKKYYNHLVDSSCAACGVCSFSCPLGINFADFSLKYRKNNIGFISKILGNLAYKNHE
KTLKIAKFSLSIANKFDNLSLDNKLEKASNFLSIIPRTRAYLPKVNDYELKSRKRAYNVV
YFTSCLNKSFKPNEKMHDKRSLQEVFESLCKKANIGIIYAPNDLCCGKAYENFQDIQDKN
IQKINDFLSNIDSPIVLDHSACSAKLISDHLKYEIYDLSEYLLKFIAPKLRIDKINENVG
LYIMCAARKLGLNENIIKLAKLCTNGKVLIDNDTYCCGFAGYKGFFKPQLNINATKGFKK
FYAKTNIKRGFSTSSTCEIGLSDATGISWQHIAYLLDECSEKQFN
>fig|195.2186.peg.1363 Oligopeptide transporter, OPT family
MAFGVFVGILMIIIDKILRRTQKMSLPPLAVGIGIYLPPAVNIPLVIGGILKYIVMQYLT
KKYAKNSHKEEKLASCEQRGTLFASGLIVGESIFGVIIAGITVFSVSMGGSENPLALNLA
NFHDSELFALIFFVGVVLYFIKRIVKKDA
>fig|195.2186.peg.1752 Integral membrane protein
MFFKKIKNILLKDNNPLDALDFSKLELYCKEIELKEDWCDKIKNFKTNKNKNNNNNFELI
NFLLLGFYRKLCDHHTDFLKVFNNLILLIALYALFIFGFTWLHDDKLEDTRAILTLFGFF
DKFRLYFDIISTIFVVFGCGFFVWKLNSYENKNNISKKQNINFIYIIGDFWNLTKSLFFA
SFIPCVFYVLFLLFGFFLNLGKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFSYI
GFIIILIKQPNVIHPLIGKIANESDKFFNYPSLIVLNILYTILLVLVLFSLQKTARKNSI
VPS
>fig|195.2186.peg.207 hypothetical protein
MFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKEIDFTRYHGTYDDT
LFKNIFLYLSDKTYWNNNKFSKKYFSNARKIIREPLNKEHLIIQSLYPNPKYILYHSIFD
ERSPFENKENFVHILKELNFKVEFF
>fig|195.2186.peg.1564 UPF0246 protein YaaA
FGKALDEYLKNEELLDLRAGFYDKFYTPKRKFSTYKFIKKGKVVSHFAKAYRGILLALCA
RIKAKNNAEILNHLPSNLSLKEIQNKGLKEEIVLKILD
>fig|195.2186.peg.516 hypothetical protein
MKKNASSKILLSLGVATLLYSSAFAQEINLSAEK
>fig|195.2186.peg.1062 Putative transferase
MIYKKIIFFDLKYLGNEDNFDKKLIQKASFALGVGQINLRKKILVKLSKKSCNFITFIHP
QSFVSKEAKIGQGV
>fig|195.2187.peg.213 IncF plasmid conjugative transfer protein TraG
MKRFYFLFFSTLFFAPSFLFGATNIANSNLIYTWGYGDVMNEIMQAVKGITTETDYIVNA
ALAISLLLFSIKKAMDGQTNPVFEFGKMFMLFAVVWYMFLRAPNDNNHRFMIHDEVTSKD
YVISQIPIGIGKSFALMTQFEKVILEAMEKHFTTPQSTNFSNAGLGFSLQVMSTLPNVKL
SAIDATLQKNIDFYFRNCVSVGILLNQQGRNLFQNSDNLIQDLFTNIGNGSQLTPLFENN
NNIEKQSVVPCSDAGPQIVEMIKNDTDEAMKIHAALLGMANDMANYEQKFLGAAQIYNEQ
AVSARSYLQQSMIMLASQDAIINTAKSVGLNPASVAANTAYADQQFYASMQAQGHMAQTY
LPLAKAYLTAIIIGLSWLVALLSIVFGSYAHIKMFFTLCIWIVLWTPILCIINFINDFNL
MKVAQVITGGKAALSLGDNILIFKEVASRSNFMNYLVMSTPVLAYAIAKASEQGFVTFAS
GLSQALTGASRAAGSFANQQALSTQTSIAAPRGDEVWAMNAGVVSLQSAMSAGGGRFSMS
SITGGGTTVKDVNTNTNFALGSNGEITNMSIAGLDAKHAQSETQTRQDSLANSIADTHKT
GINQGITSNYLRNHGAGVEDTKAIEKAEAQALRETMSEVLGDKSSFNEADKKALEGSVGA
YASGSAGLEIFGSGGKIGGEIKGIASIGTGSTETQEYSRSLSKEGQAAFDKMYAEKLGNI
IKSSDSVASAYSNALSTSTGSEFADAKQKAHSYSEASQYSEAIQTSNLPNMAENYIAENN
LGGTREQQVAAAAKGLENLAARGDLQGLLHYANMNTAKPNADGIHDVSNKSYYSPSSVGA
NNAHNNDTVANQNSLNNLGTAGGNNIRNEFSQQSGATISNFKNQGTSTSNVVNNSAKDAI
VEQNANRRMGVNPSSYAIQDASKSGNELAKEAQGLFEAIGANNAHNNDTVANQNSLNNLG
TAGGNNIRNEFSQQSGAAISN
>fig|195.2187.peg.1804 Erythrocyte membrane-associated antigen
DEISNTNKENEKINQMIKLAIEKMFKNDFLNKINNF
>fig|195.2187.peg.47 Cobalt/zinc/cadmium resistance protein CzcD
MDIEEVKQALLLNSKVEEVIDLHITQITNKMLVASMHLRVNIDDLKEFEQLSYDLSHDLL
HRFEIGHITIQPLRSKNEI
>fig|195.2187.peg.868 Beta-1,3-glucosyltransferase
MSILKKTKKLFKDPKLFFKDAIEKKVFWLSKVYKKYLPKKYKGFTQYTIISAVYNVEKYL
DDYFN
>fig|195.2187.peg.1925 Legionaminic acid biosynthesis protein PtmG
MIYCDHCVMPNTRPGINFTKDKEGKNICSACINHKNKENIDYKARFKELEALCDKYRRMN
GKFEYDCAIAVSGGKDSHFQVHIM
>fig|195.2187.peg.1140 Protein hydE
MTLDFDFIYNADNDIFEYLLRFYAK
>fig|195.2187.peg.1095 Phage antirepressor protein
KYENKIKALKYDLENKNELSLKRKLSKEELLELRKILARDYGILCIKEWEMSLVAEKIGK
DTVFEAVLNKLEKELKYWQNYEEYEEKWRKILRR
>fig|195.2187.peg.1736 hypothetical protein
MLLCYLYDKKNNKDTEEYKIIANNFIINTTSKNTNFKILDDEYWLFAYEVLSREDPSALN
KCKDWKQIKNSNISFIRQEFQ
>fig|195.2187.peg.1558 hypothetical protein
MNDLIVKYNGALVTTQNKISKLTNNNEIAIQKLIRTYKADLEEFG
>fig|195.2187.peg.670 hypothetical protein
MSIFSINDNSNYNSILSQAKANKESKENSKISFANAFLKQNASKLNEIQSANSQTLARSE
VLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQADISNTSTNTAYGYSV
DKDGYMGSDFNKAAGLPEDFKIHKSTLDEIERYNTDLNAHTANYLGVSSYYSNIDMANTI
KQYYNKFDEILNHTFNNASKTSFTEVDLNSLPKGVSMSVGDFDFASPLNLESKTITNYYN
TQEQYNEIEQLGILGHINTGLQPLNFTPQSMQTQNTSNKYTFNPDMSVYPQNEDGSYSKE
ALFMSFLKSTGADVLKGGNTTMNPIVKSFKEAMAKESFDGSLASLDDIMTGKVDFASLLK
YELDRGYMAGELYMYEKGISPKQALGNWALDAEIKQALANGWKASSESINSYVDSIMDRL
NNLMGQTKV
>fig|195.2187.peg.909 RidA/YER057c/UK114 superfamily protein
MSNYPKAIGPYSAYREANGLLFISGQIPINPASGEIESSDIKEQTKQSLKNIGAILEENG
ISYDQVIKTTCLLADISDFAAFNEVYAQFFKSPYPARSAFAVKDIPKGAKVEIEVIAQKD
KTC
>fig|195.2187.peg.1379 hypothetical protein
MNLLNFILSISGVGDFIIILFASMIIYAIVYLIIFLLINVFFYLFKFSEKVTDIINNKLI
FLFYLSYPCLGILFFLFFDTLIGEANKSYVEKINKKYNINLETMRSIGFGVCNNSDYASQ
ICKNYLKYFENSLEQSIARSKKEEELKKKKQEEIEKNIMEIK
>fig|195.2187.peg.121 Tetracycline resistance, ribosomal protection type => Tet(O)
MVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMS
ELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEY
SEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPN
DVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYY
VDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPP
NPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCK
ICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDA
PRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFI
CQPRRPNSRIDKVRHMFHKLA
>fig|195.2187.peg.1921 SrpA-related protein
DNFEETQANKDFKNFIGKIYQQNSQNNPINFSLVS
>fig|195.2187.peg.1561 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MQNLYSEDDTRVKLIDAKLYASSWSEENIIRNYYFTDGRKLIGNKRAERKFADYLLKFQN
NNLAIIEAKKQNKDALDGLSQGIEYAKTLNVPFVYSTNGDKIYEYDLRVSRGEYIENFPS
PNELFQRVYGNLKEWQYKLLTQRELYIPQKTLRYYQKTLRYYQKIAVDKVIEALINGKDR
ILLTLATGTGKTTIAFALCYRLLEARWNKENKDQKPKILFLCDRVSLRDQALGEFNAVES
DCKVISAEEIRKNDGKIITNANVFFGIYQSLAANSKDQENTQEEQESKFYLQYPKDFFDL
IIIDECHRGGANEEGNWACVLEHFSSATHLGLTATPKKSDNVDTYRYFGESAYEYSLKEG
IEDGFLTPYKVKRITTTLSEGYVYNPDDLIEGELEKGFYKMSEFERNIHLPQYNDFLAKE
ILKLIDPMDKTIIFCANQAHASDIKRAIDKFKSVKRDDYCVRVTSDEGKIGLEYLKQFQD
NDKSYPVILTSSKMLTTGVDARNVRNIVLLANIGSIIEFKQIIGRGTRVYEGKDFFTIID
FVGATKLFYDPKWDGEQVKDEDKEDKSEIWGKQNKKESDKTKETESKKAITVHLKGTKLK
VLDINTSYLGSNGKPLSTKEFLEFLIGKLAEYYDDEVKLREIWSKQETRLNFLKTLEKDG
VDENALKDLGEIFDKKDCDIYDVLAHLSFNAEIKTRQERVLQVEKSEFLKRFQKEKALKF
IEFLLGRYQQYGIKDFDRSLAPLIELSSLGNVKEIVSEFGGVENLKQSVDDLQREIYAR
>fig|195.2187.peg.1766 Flagellar hook-length control protein FliK
LNIKDKESKDLNKDFNKELNKNQGDMQGQNKNLKNNNQNLNLDKNLNKEIVKDTQNLVSN
LTQKDFNLNKEPKNNKENKDIKQNFFDQKLNFENLNKTQVVQNKENNANFNNNTNKETFT
QEQTKTHSENIDKNSLDELNSLVKDLNKVTQNNARNITPKETLQYFSQDLKEAVDQYKAP
ITKLSINLNPNNLGEVEVTLIQRGNNLHINFNSNTNAMNLFIQNQAEFKNSLVNMGFTGL
EMNFSDQGKREQNQNQGKNRSGYGFKDALDGKNESEKVNLELVLAKYF
>fig|195.2187.peg.1388 hypothetical protein
MRNKELKIIEAYGAFMSILFSFLIVYEDVWTNILKIFLYTEIQAFFIFFVRIFMILHMIL
FMGFLLDAKIKAEHNQLIKLLADKKKVDCYFSHTFANFFSLFCCAGFFL
>fig|195.2187.peg.1923 Motility accessory factor
EQFVYNLPQMITHPSYKELLSKRKGVSDTAIIVSTGPSLTKQLPLLKKYANKATIFCADS
SYPILAKHGIKPDYVCMLERTEITAEFFNHDFGEFDNGICFIIKSIVHPNAINYLTKKTD
NFTIVSTYASFIQYLKLDYFGYFNMGFSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNS
HPDDYQNSANYESQMYEHILTEAYGGKEKIKTHHVWLMFKRNLEQDVQKIQKYLDTKVYN
CTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNK
>fig|195.2187.peg.1559 hypothetical protein
MNFKNYKLDGTPEQEIFIGKGYKVNADISNCFPSIYTHSIPWVLIGKIGAKKNKGFTKLY
YNKIDNATQWLNYGETHGILIGPHSSNLISEIILVAVDYKLSKKYKYIRNIDDYTCYVKS
HEEAEQFLLDLSIELKKYGLSLNHKKTEIIKLPSSFEKPWKNKLKLFKLDSYSGGIKYTG
IMPFLDMALNLMKDNKNNAAILNYAFKILIKKKMTPSAKKYFINIIHHLVLLYPY
>fig|195.2187.peg.48 Cobalt/zinc/cadmium resistance protein CzcD
MYKFLSHEPLANKSCHHNHEEHSHEHHHSHADARSVDKKILKISLLMTFSMMLVQFIYSL
LSNSLALLSDTLHMFSDVFALTLSFLAIIAIEKWQDHQKTFGYFRLEILVAFINALTIIL
SAIFIIYEAIEKLINPSSIDAKTMIIVAVLGFLVNAINAFMMFRGANLENVNMKSAFLHM
MSDLLGSLVVIIGGIAVYFSGIVYIDTI
>fig|195.2187.peg.869 Fibronectin/fibrinogen-binding protein
MKYTELMQLQNFFSQFKKIDFIKRVNDNILELSFNRERFIFDLTRGMSAIYTAKLMSKNY
NAPFDFMLKKYFNNAFIKEVKLLQDNRILCFSVKVDKAYKSYESKIYFEFTGKNTNVIIT
DEKDLIIEALRHIDKSYRVVKPNVVLEALKPYK
>fig|195.2187.peg.1822 Integral membrane protein
NLGKDFGYSLLINTLFVSLYICLVYTKSLFFGRYVVLIFSYIGFIIILIKQPNVIHPLIG
KIANESDKFFNYPSLIVLNILYTILLVLVLFSLQKTARKNSIVPS
>fig|195.2187.peg.1864 death-on-curing family protein
MKYIELSEAIAIHEKIIEKTGGLSGYNETQIGYLASALEHIKNDDYYPTIIDKITHLIFS
CVKFHPFADGNKRTSIFLGMHFLDLDGKYNDKFAEVMEDIVVGVADDSIAKDDLNQILQN
FIDKNIEVEG
>fig|195.2187.peg.1863 DNA repair protein RAD50, putative
MSDTIILDILLEKYNNAKYKKVGDCIKLRYQYNNANVNLYFDGYDKNYPSTSIFLSIKFC
KI
>fig|195.2187.peg.1940 FIG00469432: hypothetical protein
YWNLALENRQREVFCEFFSYARKIYIILMSTEEIFDEELNKNLALRFEDLVKQSYCILAN
NELDENLLLFLGSEDLQNLLSDFDFFIKEDSFYKSEQEKYFFKQMIAMQLRKRLVLFKKN
LLKNFE
>fig|195.2187.peg.1494 Two-component system sensor histidine kinase
NKIYDLNSKRVLVKKFTYKDYKYMIIVYPRFLNLQNFWLKISISFGIYFMLVFILVFFMG
RKLAKSFKKILEFLNFINDSKPIILEKSIFKELNLLNKKLLKTKEKILKYPQKHKQQSDK
ISLKNTQLASVISAISHELKNPLSVIDLSLEMLKDENLKDEKLKNELLEKISRQSLKLNA
LTHKLNFVFNLNHEALQMQEFDLFTLCEKIVKNPGFERVILRGKSTRVKADEFLIEQVII
NLLSNALKYSQKEVILIAQDQKISVLDFGKGIEKNQLKFITKKFYKIDTKSNNSFGLGLF
LVKKILSIHKSYLEISSTVSQGSKFSFKLH
>fig|195.2187.peg.1636 lipopolysaccharide core biosynthesis protein LpsA
GLHNATIEIIYEFKRHRNIFCTKIFFQTKLHKIFNEILKYNAKELEEIRTRVKYYNQIND
FFTLTEREKIGKFPFKNTSYAFDAYEISKYFNDDFLWKKEFGDVKYTFKEPAICKSRPLE
NNTNNILLKLDKNRHFCFLKDNIKYENKKDIAIFRGAVYQKHRKEFFHSYFGKSFCDIGD
TSKQPSQWKKTF
>fig|195.2187.peg.1813 Legionaminic acid biosynthesis protein PtmG
MKEKLGMNPILFSVEDNFTMTEAGKKNLKNLSETFGCHIISLKPDIKTQKKVMLKTFEKY
GKPTWFIDRLIYSYPFAMALKFNTPLLVYGENVSYEYGGSDTEETPSAKEIFLNGVASDL
NINEFIDDEIKEENLQLFFNPSKDKLDKLDPIYLSYFIKWNSYSNYIFAKSRGFTDLEGE
WDRTMCAENFDQVDSIGYILHAWMKYPKFGHACASDYAARFVRYGLLSRKEAIELVQKRD
HKLDNKCVEDFCNFIGISKTTFWKIVEKHYNMDLFYKNDFGEFKLKNKLQ
>fig|195.2187.peg.1859 hypothetical protein
IENILEFKDLVDIFVNDKYKIERKAMKYLEVVLNKTEFFRTYLESKISKEFSEYHAKEQE
KDYFGKFLKTLEKGLDNLTGETEEDRAKFKKHVKEIFEKIFNKKENNENK
>fig|195.2187.peg.1423 hypothetical protein
MNFKCYIVEKYEIVYGKGHFQNETQKLEDLFEKLQIDYSEPSDFIIEIPTEQLFSLKLSN
YQLDSDELIFMTNLIKTAKTAKTAKYCKDFGFIRIDWRGQ
>fig|195.2187.peg.1814 Legionaminic acid biosynthesis protein PtmG
VHIMKEKLGMNPILFSVEDNFTMTEEWKI
>fig|195.2187.peg.1085 Phage antirepressor protein
MHNDEFIENTHYFLVENSFKNKTIKWTLEGVYKLFDKIKKLKERSKMTNIKDIKKIKITC
KECKSEFSMFIGHSLYVCPICGNNFGINQLNDPFFRIKQAFECFTNPKNCDIELVCEIKE
>fig|195.2187.peg.1719 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHTETELLKAAQISIEDFRSR
NISLLNALEKDILNLPYEALNSQDNIINNVGAILKYYRNSGNLLAVYIGLDNGENIVSDD
LSEKKNTNITINGKANNYNATTREWYKEARNSNQTYITPAYIDVVSNEYAILTLKLFIRM
VNLLVF
>fig|195.2187.peg.1949 hypothetical protein
INQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYRNY
IAKNFDVVA
>fig|195.2187.peg.120 Tetracycline resistance, ribosomal protection type => Tet(O)
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFHQ
>fig|195.2187.peg.1882 hypothetical protein
MNCFKKLKEKIILIKIEKEKANKEKFLKECEIKEAEIRMEILEKRKDDLFKQREELIHSI
LGEASFNALTEERYLELIDNYHILTEDNKANLYGILRRAYNLSSMVGNLKCLDKSINELE
EEEEKQVEIIKTRKTNSQIKKERVMEKNAVEILN
>fig|195.2188.peg.1799 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MVESTQENIRQLQSLMKLLVTRNNEILTTREEEMLNNAVNSLMKGFEKEERKYPISLLLE
NLTENVDDDNSLKSRLALFKKGKQFGWVFDNEYDNLDFPDDINLFGIDGTEFLDDKDVSG
ILSYYILWRVMSLADGRRLCIDIDEAWKWLENEIVQEEVKNKFKTIRKQNGFLRLATQSL
EDFLKLKNAATLIEQSSTMVFLSNPKAKEEEYVKGVGLSYDEYMIIKGFNPVKRQFLIKR
QDEKVICTLDLSPLGNENLKILSTETAYIDVIEKIFSQENKSLDEKVLELKEIYKNS
>fig|195.2188.peg.1792 IncQ plasmid conjugative transfer protein TraG
MKNTIKLALLGAVITGVFSACSSEPKTVQYYEDPKNANSAQTDTECANAYKANYSKSFQK
PRESAMEFFKNNK
>fig|195.2188.peg.1797 hypothetical protein
MSDKELQKEILALENDVKQLEATIDVIKQRITHLKDIAWDR
>fig|195.2188.peg.1796 hypothetical protein
MYKVLKEDKTHTRVKSNVGDIKVDKDFMDKEIKKHLDNPNLRGMVTTQEMLSFPKVAKGV
EANNEARGYTWQVKANDGNTLVYGSRKYETNNEKIHRLATSHSKTEKNERQAEVGGRSHP
HHPIFNDFNFRKSAENIISQQNKSTNDFKAKLEEFSTKKTNAIESINKEFKR
>fig|195.2188.peg.342 hypothetical protein
MNPKELISQIKDYANIADASYAMLDLKNKENNCRRKNKM
>fig|195.2188.peg.1402 GDP-L-fucose synthetase (EC 1.1.1.271)
MNKEAKIYVAGHTGTAGSAIVELLYKRGYCNLVFKGSSELDLRNQKSVEKFFQQEKPEYV
FMCAATPCGVANMQYRADFIYNNIMMQINVIHASFKHRVKKLICFGSGYMYPKEAQNPLK
EEYILSGKLDFQLSLMRFQKL
>fig|195.2188.peg.1401 GDP-L-fucose synthetase (EC 1.1.1.271)
MPALLQKFYLGKLLQKQEYVQLANELKVTGVKNIEEKLKEIGIFKDQIFLWGNGRTRREF
IHCEDLADACIYLMNYNFKTCDLHFNIGTNVDYSIADVASIVSNIVGFNGEIKFDITKPS
SDMNRLMDCSKIHSLGWKHKIELEQGIKMMYKWYLENKGAIE
>fig|195.2189.peg.784 hypothetical protein
MKKFIKSKDTSDAFTLFELVLVVLILGLVISIAQINLKQDRLMQGAKQILNDIRYARTLA
MTQESFRDLELAVAKREWYKSRWQFVGGKIKCRKRKIKCRIFATNYLSFNLKLKL
>fig|195.2189.peg.1761 Putative helicase
MLDKLEKFLVYDNVFLSGGAGVGKSFLTNELIRSYKRQGKVVIALGSSALSAFNIAGVTL
HSFFLFGLLSRYGYA
>fig|195.2189.peg.845 Putative periplasmic ATP /GTP-binding protein
MRTSQGVYDKNLAKTNQDCVIRLSSIQANQICIIVNPLSGFAYIPKFQDFNKQMIMINGV
LSQCSKI
>fig|195.2190.peg.714 Two-component system sensor histidine kinase/response regulator hybrid
MTAYVHIGIAKTGTTSIQDFLTQNYDLLINQGFLYPKSLHGIEEQYSREWSQHRELAFII
KATKARGFLEKESEKLNLFRKEICGFEKVIISSEMLHDSLIDKEHILHCKNILQDLGFKK
IKIIIYLREPAELFQSVCSQSIKNCYNQDVCFKLPEQSNILNHRCSHSKTLINWGQVFGK
ENLIIRLFDKSEFVEQNLLKDFVSCLNINWNEQFIIPNKANESLDVIGSEILLRVNKKLP
LVLSGKINFLRGNLLFYVEKYFSNPKLKITPPKDMYQFYIDYFEESNEWVRKEFFPHKER
LFPKKDLTDYKENYELKEMKPEYWDQIADFVVDVVETKNKTIQENLSQINNLNQTIETKN
KTIQENLSQINNLNQTIETKNKTIQENLSQINNLNQTIETKNKTIQENLSQINNLNQTIE
TKNKTIQENLSQINNLNQTIETKNKTIQENLSQINNLNQTIE
>fig|195.2190.peg.1468 Diacylglycerol kinase (EC 2.7.1.107)
MKPKYHLLNNARYALEGILALLKNEMAFRLELCVIIPAIVFSFFLDVSFL
>fig|195.2190.peg.723 Glycosyl transferase family 8 family
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGMKYHLVF
>fig|195.2190.peg.1859 Motility accessory factor
TKEDAFNKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2190.peg.722 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MGDEIPFGVLIYKYKLKINTINKVNTLPNNSKDSILIHAGTDMKFWSSFISYISFQEWHV
NNKVWSNNYDKMININFRQHNLPIKDQSDLYQFLFSYNLFYSIYPMLNVLINYKLKEYKL
YIDFLISNSRRSFNIFSSFLGSKNFYYQIEFEYGYGEWGTKIYFNLVLKDFYKEKLKFIL
LEMVDFKPSTIKKLEEVIIRIQVDINQSFLYILEKIIITTFKYSSFKMEYNQLDIFGYSA
KTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLP
PLENYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMWFEIGKLKREFKEKVNHA
>fig|195.2190.peg.1467 Diacylglycerol kinase (EC 2.7.1.107)
MFLITVLILILITEALNSAIEACVDLITNEWHEKAKVAKDCASAAVFFSVCLALFIWGFI
LGKLWL
>fig|195.2190.peg.1201 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDQNILFILFYESPVEVLKQKACLNDKFYINDILNSWLKYNTFLLDFYKKNRERSILINY
KDFDVALCKYLNEKYYFNMVKIYKENSSIKSKNLFDFLLEYMLNSNEKCLNCYKGLEGYS
LNPNFNSNDLPFKNLESEIINLFQILKISEILSIKNKSLLDFIFEMQEYIEKLYYQHGNC
LKEITFKKSQTIETKNKTIQENLSQINNLNQTIETKNKTIQNKDDLLNFQAQYGTAKSRI
QNQLSYKLGQTMIVNSKSFLGCLLMPVILLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQ
YPDYREAIKLKNHLSYKLGQSAIKFCKNPLKLWSLPYEIFKIIKNK
>fig|195.2190.peg.1884 Methyl-accepting chemotaxis signal transduction protein
AVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITCC
>fig|195.2190.peg.1850 hypothetical protein
MAISQDSLVYKMEEHLQVQGYLRVEDEDDGRGYRRYSMPFLRALAGAIVEEIK
>fig|195.2190.peg.1839 Phage baseplate assembly protein GpW
MSYMVSVEESIKDILITSLGSRVMRPEYGSLLYTLIDRKIDDD
>fig|195.2191.peg.1211 alpha-2,3-sialyltransferase
MTSLLFCDKSYLYGITEKVNKLLSEDLMLDKSIYFRKFDCLIPDVLLFKSIIEDYNKVNL
SQNPSDEIFYNVNNQIIFGAVNRVKHHLAYKLGQVMVYYSKTIKGRLLMPIILSCVMVNH
KFTRKFNDKLPPLSEYIDYEQGMKIKQHLTYQLGEALIYAHKNWYKGGYVRLFFHIRKIK
SRKGKLQ
>fig|195.2191.peg.1721 N,N'-diacetyllegionaminic acid synthase (EC 2.5.1.101)
MKKTLIIAEAGVNHNGDLNLAKKLIEIAADSGADFVKFQSFKAKNCISTKAKKAPYQLKT
TANDESQLQMVQKLELDLKAHKELILHAKKCNIAFLSTPFDLESVDLLNELGLKIFKIPS
GEITNLPYLKKMVI
>fig|195.2191.peg.1212 alpha-2,3-sialyltransferase
MKKIVLLGGSNSILSDGIPKAMKANKDINFINLALGGSASLQNVYEIIRKKDEIEHADLL
ICESNLNDKREDFHQRNLKQIIRDIVILYEQLNMLNVKRILILLLPYDHVQCKNSKIIDN
VHRKLCQDYNFNVVDMASFFHVIGVHDFYMNLKDSAHQLPSILYQLGVSILNNLQLLSIH
KYNNATTGNVFTFYTPKEISDSKIEINNSLVQETAYKVSIKDIKENFSNQEDRYLIGAHY
LHVTASTKLSIYKSLKEIFYILNLILASYLNGSIDFDI
>fig|195.2191.peg.1720 N,N'-diacetyllegionaminic acid synthase (EC 2.5.1.101)
MANLGEIEEALNALCKNGTKRQNITLLHCTTEYPAPFDEVNLKAMQSLKDAFKLDVGYSD
HTRGIHISLAAVALGACVIEKHFTLDKNMSGPDHKASLEPHELKTLCTQIRQIQKAMGDG
IKKASKSERKNINIVRKSLVAKKDIQKGEIFNEENLTTKRPANGISAMRYEEFLGKIATK
NYKEDELICE
>fig|195.2192.peg.1977 hypothetical protein
MYIPGIKAYNLGDYIQTIATRSLIELIDKNAKFHFYNRDSFSLYNKKESICIMQGWFADD
YNFLPNERIFPVYIGTHFTKKMQEYFDVLNVDFKDFEIGCRDLSTLDYFNKKGANAYFSR
CLTLTLPKREVSAKQNSIFLVNLNHEMSSLLPDFIKKEAIEINQKAIKIKNRNLKNEWQE
CYKEAQDILEKYASEAKLVITTALHCAAPCIALGIPVILLQEDKVYEDRFSALKGILKPY
TFNDLKDNRIDFEPKILDIEFLKEMMIKNLKLTLKKHMF
>fig|195.2192.peg.1144 Putative metal chaperone, involved in Zn homeostasis, GTPase of COG0523 family
MAKIPVHVVTGFLGSGKTTFLKEILTNQALNDIALVINELGEVSLDHKLVQTDFIEEQTL
FLNAGCACCNKREDLQKKFKELLDNFENKGKKPQRVILETSGLANPAPIIFTFKVMCF
>fig|195.2192.peg.752 hypothetical protein
MLIKGLACFKFLPEEQIIFSFDEDFELFLGYNYNVCEEGFWAFSLKFKKYTILQCNFCFT
LENNLLLSCIQGHKYKDFNILEINKILTKKCHGLRPVALLIECSKMLCEILKLQTTLGVH
EKNQIRSQKGKEKGYFVDYQKIWLENGGKLVKINNHLYYELSHKRKNLEEIPSSKRSMYK
KRFAILEEIKQALDQSLFI
>fig|195.2192.peg.1466 Phage antirepressor protein
KHDKLAFRQSLGYKSQLKQQKEHYENKIKALKYDLEKKKELSFKRKLSKEELLELRKILA
KDYDIVCFKEWEYMLFAESVSGKNYKLEKENDFCIYKSIKDSFNSKLDYYKNYEEYEEKW
RKILRR
>fig|195.2192.peg.1632 Leader peptidase (Prepilin peptidase) (EC 3.4.23.43)
FLKNFRTKDIQENLGDADIIILASMAGVFGFKSAFIILFLASLLSLPFFIHNKNTKLAFL
PFINAAFVIYLIYLIVQELI
>fig|195.2192.peg.1987 Flagellin
DANIADAMGFGSVNKGVMLGGFSTVTAYMSSAGSGFSAGSGYSVGSGKNYSTSISGIAVA
FSSGSGLSAVYNVSAGSGFSSQSGLSQFATMKTSAGNSLGAKDETAGVTTLKGAMAVMDI
AETATTNLDQIRADIGSVQNQ
>fig|195.2192.peg.1818 Coupling protein VirD4, ATPase required for T-DNA transfer
MNDKKITPAKWVLMFITSIILGIILYLLMVKIIFKPDLLVTHQVGLQILHNLGNPALKLK
AYVAVFALILPFIVCLIWFFMPQMNLKENYGNARFAKEKDFEEMNICNDRGLILGCNIKK
GIKGDEIEYIRAKMPLSALVVAPPGTGKTSGIILPNLFTVPNSTLALDIKGELYAKSAGY
RKKYFNNEILLFEPFSDNNTLFFNPFDNSIVKDMNFIQMMKLADQIAGTIFVAEKGKEGD
HWVTSAKTLFTFFALYNMQKHKHTSLGDLTQAPKKDYFNELNEEFGKECLVEDEDTGEVS
RDYNVDTFKVFLKQVANDENLDEIVRNQARAYQTAAEQEFASIKSTYDTYMKVFTNPQVA
NATSKMNFRFEDLREKRITMYVVIQTEDMDILAPLVRIFIESLFKKLMSGQENSNPDKFI
YCLLDEFVRFGKMPFLLEAPALCRSYGLIPVFVTQSYEQIRKYYGEDDLGIIRANAGYQT
IFRMNTEKDAKEISDLIGDFTREKTSSSKGTFDFFKSNNTVSKEGYKLITSQDIKNQSSE
DILILVTGFLSRPIKAKVPYWFKNPKLKGADKISLEDNNTNTEGESKNTEGESKNDEINN
DDSQNVNQEQNFTQENSSSKQIFELEELGIKVKKE
>fig|195.2192.peg.1985 Methyl-accepting chemotaxis signal transduction protein
ESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGI
IGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQS
INDMAESIKEQTAGITQINESVAQIDQTT
>fig|195.2192.peg.976 capsular polysaccharide biosynthesis protein, putative
MINYKKKLHLIIFKKIFSSSFLKRKAIVFADMFYDENHELIDNFLLFKHMYDLGYDVYYV
MNKKHIKYKEVKQVYKKNIIGCLPNRTSWRLLSVIAKTKIWVDSCQLLFLSKLYSLVDKS
KICCIQAQHGVNYFKEGYRFHLSEFIYDKVIVSNEIEKSIYCKNYSYCEDNFIKAGLPRW
TLLKNHQEENSILIYFTYRQYIS
>fig|195.2192.peg.1161 FIG00470545: hypothetical protein
MPKNKEKIGGGAVPIAALIRLGMGYGISYANAPGVGEQTYIGRPPFGGCH
>fig|195.2192.peg.1984 Motility accessory factor
KDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIKHCRDFNDNFIKVYNKIKNSFMSLQNS
QKNEIFIQEIIQDIDKTKTQIDELYNTQKDLMQILGPLLTQFELNLARIYVLNPKTKEDA
FNKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEK
>fig|195.2192.peg.1187 capsular polysaccharide biosynthesis protein, putative
LIKDNFKSSAYYQKIKGFLNSRKLIEMCNKYNTKIYFAMHHEITRLFGEDCFKAENSNII
FIGEQDIGKIKNKASMLITDFSSMCFDFMYINKPVIFYNIAKNDTLMQKIQEERDVYNRL
EEKYKLLNHVYILEDEVLGQIEYYLDKKFLLRTHEEKKNKEFFYPCNVLEESIKGILEEK
KGRNIFFNNLHNPLEKNYFYTFFEDKDFKFYGFYADENQRGRWSVAKESIISFTIPYSDK
NIVLNILCKAFLCAKRPQVKLELFLNDRRLIDKKLCLTSNKINQYFAIDKQLYGKTVFFK
FKIENTAQPIFYNKSFDTRPLGVFLEGLCLYEL
>fig|195.2192.peg.977 Ferric siderophore transport system, biopolymer transport protein ExbB
IMELNMEFLKDYIDLIIFIILGVMAFIAFWCVIERVLFFRKIDFKNYENQEQFDDAISEN
LTTIYIIYSNAPYIGLLGTVVGIMITFYEMGIAGNIDVKSIVVGLSLALKATALGLLVAI
PALMAYNALLRKVSLLSNAYKVSKNA
>fig|195.2192.peg.1701 Phage Rha protein
MSNAPVIINNVEVNLNIKENKVFINSLDLAKVFNKNHRHILQTTKNQPQNDFTESNFILS
TYKDKKGELRPCYNLTRDGFSLLVMGFTGEKAYKWKIEFIKAFNEMEKRLRNIEYEKHDK
LAFRQSL
>fig|195.2192.peg.1847 hypothetical protein
MFELSNELALSFEKIGLYFFIFIISIQTLFIFWSFITSFDFCKKYWKESITFGLKTLMVE
KFKKDKVITVVSQNPKILIKE
>fig|195.2192.peg.1275 hypothetical protein
MKIILLTILSFLSLWGLSFDELIYKNEVRASFDCSKVENNGKNDDELIICNKIGAINEFE
NKKLALMDNIFISLYQELLKNANENIKEDFKLVVKKMFRERKNCAKVISNDLLQADQDPQ
SPFVYKTDCIKKLMLKYF
>fig|195.2192.peg.973 capsular polysaccharide biosynthesis protein, putative
MRFYILIFYLYRRLIRLCSSCSLFKRQKWILVDNYFNNSSDLNDNLCLFEFILQNKTKQV
YYVISKEHSLYKDLKQKYPKNLIIINKKFLSFSFMWHLLQTRYILDSFQIFSSKFRLGGI
FCSSKIHYIYTQHGVNFFKKYFLKNTDSLSDENFNAIIFSNSHEKSYYETIYNYSENRQL
LVGLARWDNILPIAQCDEKIVLVYFTFRRYLMQDQKAIEYKIFKEWYYLLNDDIFINYMK
GNNIKIYFALHHEMEKANDGRFDILNPISQSKLSEIKNKASLLITDYSSMAFDFMVKDKP
VLFYRIDQDELCLDEESRENSKYSEELNEQIYNVFYNKKDIIDKCMYYFKNNFILEDEFK
AKNKSFFACRENFRENIYNAISSLEKNTPFANILTPINRILPISTLKNIRSIGLSKREAH
GRWSLGDEVSFYFNFTEYKRITIDFKLHAIADLDATVYLDSKKMFSCNILKDVSQNKISI
VVSRKKLLKQNGCIMIKFIIRFPISPKMLKLNQDSRMLGIFFHSINIYEVKKS
>fig|195.2192.peg.36 hypothetical protein
MQGNIVRNYYISEGVKALFSVYFKDQTEENFIKALNEFNKENQINSQEIKDEALREIKEE
LSKLATTDLLNAKIDKVEAKIDKVEASLNAKIDKVEAKIDKVENKLDSFKTEVKTYVIIL
AALMFFCSLQFLI
>fig|195.2192.peg.975 hypothetical protein
MKVRKNIFLKVLVFTIVIHDKEKIYHFLGIPFFKVQIFNKSKKYSLFGLPILKKYYNDKI
TDLFINEQKSNNEIENVLQRLFKYDIVKESDIAFLNIKKTINQEKNAVFGVLPPEKTGIA
IFNHNAFVDCEYFDIFSDIRDLSIARGLSKNVFDLKTFIKFDASYLYKKFIYILGNSSHN
NPYLNMAIRSTNKEKSWLYIHEADLNGLLYAHCGYNFLTMRVYLINCYPEFKHELLGLNN
FKDYHLWNSDFKIYGLRVIIELTNIYNFIVNNSLCKKIVLRDLESYKVNITEAFLPLPKI
VNITQIDYKKNNDEIYIGTFGIPREIKFSLEIAQAIEYLNEFKNINIKLLVVGYGASNFF
KKYDFNKSYLEIYENVTDDQFYGLINQVDLVVQLRKKPRGESSGPIVSALVLDKKIITSK
DFVDKKIEDKVFVLDNHELDYKKIAEKILECIQTSSDVVNYSEIKNSYTYSNLAKLLDEL
>fig|195.2192.peg.1930 hypothetical protein
MKLQDFDFRIWDKHHKGCGNKDCKCQTKFVYGEEAKTRLSEFKEDCEIELFTGLYDKNGN
KIYEGDILEYTRWCEQYMEDAEHSETIYEVVCFDTNGGLYSKLLNGEFGWFFEHFMNDKN
NTIEEMSIIGNIHENKELLNVRL
>fig|195.2192.peg.9 hypothetical protein
MKKYKYTPKTKEELKALVKNESIHLGDIDTSKITDMSCLFFKSTREDFSGIETWNTSNVE
DMSYMFYGCHAFNQDISGWNVSMVRYMNSMFSGCHAFNQDISGWNVNRVKNMEEMFYGCY
NFNQNISSWDVYEVESMSWMFYDCYNFNQDISKWNVFNVAYMENMFWGCKNFNQPLGRWN
VSNVESMAGMFWGCENFNQPLEKWNTSKVKNMSWMFKNTISFNQSLNDWNVSRVEDTDDM
FLNCPIDNSNKPEALQELSI
>fig|195.2192.peg.1680 hypothetical protein
MDKAHLITYLVSLAFIVSGLIVCCILYLFKDKINKITPENIDNINSNVKDFIEKNIGILN
SNESTTDYITDPTYSHMPGNIYYNNQD
>fig|195.2192.peg.373 hypothetical protein
MFLDFIGKVFIFIYNIAFLVAEYFMFLSYSKYILN
>fig|195.2192.peg.1274 FIG00469769: hypothetical protein
MYKKTYAKVFLELMQKAKKDTQSKERLKQIFNNQVDRYENLIQMSIQNPIDLEIFIDNLA
QEGLIDDNARLKL
>fig|195.2192.peg.1673 hypothetical protein
MEKNAVEILNNIKTDEFSNTINIIKVIEIENILEFKDLVDIFVNDKYKIEAKAAKYLEVV
LNKTEFFRTYLESKISKEFSEYHAKEQEKDYFGKFLKTLEKGLDNLTGETEEDRAKFKKH
VKEIFEKIFNKKENNENK
>fig|195.2192.peg.1749 Phage Rha protein
MEKLAVINGVDVELEVANDQVTTTSLDIAAVFNKRHDNIIAKIETFPKDSFTDLNFKASK
YIDSTGRILPCYKITRDGFSLLVMGFTGEKAYKWKVEFIKVFNEMEKRLRNIEYEKHDKL
AFRQSL
>fig|195.2192.peg.1172 hypothetical protein
MQVKFFLKNRIFLSFASVALIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTF
KQINGTNYYGVFKQGLVSDITLEVFNPKQSLQGAKLEILTLNHSSEEILEVQSMHAANPM
DKNLHPIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNIKTKNPPKKEEKDKI
NYVISGGLAREGNAKNNTLELLDGSYINMGVENIYNLKLNGAPYAVGGLAIFGDAI
>fig|195.2192.peg.1273 4-hydroxythreonine-4-phosphate dehydrogenase (EC 1.1.1.262)
MKKLAISIGDINGIGLEILAHSHEKLSQICTPYYFIHESLLQKALKLLNLELLNAKIVAF
KGAKNYEFTLLKKHNSLEIYSFGLPPLNLKVDENFDIKAGEIDAKSGLYSFLSFKAASYF
VYKNHAHALLTLPIHKKAWEDAGLKFKGHTDALRFFFKKNAIMMLGCKELFVGLFSEHIP
LAKVSKKITFQNLSIFLKDFYQETRFKKIGLLGFNPHAGDYGVIGGKEEELMQKAIAFVN
AFLNSKKDEKFFKKALKDEKLQKELLLNFNTKGVYLPYPLVADTAFTKSNLKACNRLIAM
YHDLGLAPLKALYFEKSINVSLNLPIIRVSVDHGTAFDKAYKNAKISTKSYFEAAKFALE
LPSKASI
>fig|195.2192.peg.1915 Leader peptidase (Prepilin peptidase) (EC 3.4.23.43)
MENNPIAFLILAILGASLGSFCMSLTMRFCENKPLLSLRSYCFSCYQKLKPLELIPIFSY
IFLRFKCKTCHIKIPFSVFLAEVLGMIFAWIAYLLSQNIGEFIHLLIFLFVLFALSCIDL
KFQAVPQKLLWLIFFIAFSFAFNSNEFAYFFIFENFQNGFMVQAF
>fig|195.2192.peg.753 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFSNRP
DACYNATRRFCDKSFKANERVKTLIYDVDKGTRLF
>fig|195.2192.peg.379 conserved hypothetical protein
MQKQYPEVHSLEESLAILKKYKDDVSKKDYEEIKSTICGHAIEDMFANEEDIIMLVKMSA
YNLSSDEIIAEYKEKGFVEYERKQ
>fig|195.2193.peg.1232 ATP synthase F0 sector subunit c (EC 3.6.3.14)
MKKIFFLFLALAATAFAAEANAPVEQEAINVWIKAFSVLAAGLGLGVAALGGAIGMGNTA
AATIAGT
>fig|195.2193.peg.503 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVTSYSEKEAKNAILLSSKRYVNYIQGI
LNEEVTLTKVVATSLNEMFQNNDHVDINLIESLIKNAFDSSHYAAYTFLYLKDTTVLSDM
QNVDKKYISPDGKTFSMIFFDQIAEKSGGITTISTPNNFSQLNLIQNIEQNAKYGDKDSV
FVGSPRKLNYDNNEFLGINFGMPIFNNKGKFIGVIGYTLDLLEISEIILDPKFDFFEGDL
RILMNDQGIIAVHKIKNGILKTLFDINKDQSAQLIVEAVKNHKDEILDNYIASTGDPSYA
SISSFSTLGNSSHWSVIVTAPKKSVLAPLYKLQYTIISVAIIALIAILTVVYFFIRKIIG
SRIPLILKSLENFFRFLNHEKIEIQTIEIKANDELGKMGKIINENILATKQGLEQDAKAV
KESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTRVGSDMNAIHKIFEEY
KSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESSKLQSAVQNLTSSSN
SQAASLEETAAALE
>fig|195.2193.peg.1601 ATP synthase F0 sector subunit c (EC 3.6.3.14)
LGLGVAALGGAIGMGNTAAATIAGTARNPGLGPKLMTTMFIALAMIEAQVIYALVIALIA
LYANPFIVFA
>fig|195.2193.peg.1135 hypothetical protein
MAEKNNKKIYNLTPSYIQPLQNRIINNIIVNDRASKKEYDLSIIIPVYNAEKFIEKCIAS
IENTCYLDYEILAVDDFSDDSSLKLLMKMAQLNKRIKIYQNFGKKGASGARNTGIALSSG
KAICFLDSDDTVLENSLNIRYNILMSDEGKKIVHGIIQFIDENDNFLGVEYGKKSTVTIK
DCIHGNPISFNTMMLKREIINLLYFDEQVTNGEDWLANFNLFKNNLSSNFVYDSISTYRI
HSESTVLKNFELHENNLLAIIDKIFSDDTVKHITNQYKKQDLKSKIIRMRSISNFFMLFF
KSDFDVWKDFLDKTDFADIFYDNTINFIEKMRVSFIRTFKIHILKVSNILSEDNLFLDKF
ALLKQKYPDSKIVLDINSIIGFYSSSMQEIKKGNLCFSQKDYIGALKYYEKVDISLRKYI
DINIALCQILKERR
>fig|195.2193.peg.1136 hypothetical protein
MQIGFYPEIKNKEELVDIISRAVWYLWPLEGFIEKFHLCTNLVFDNRLILSRFPKYLDPS
ILRYIGKISPKKVVLHKKIHNSYFENLQYIFLTSEEYREELLKIKTKLNLKFDIVRIDHN
NLSYADSFYLRFAEKIPALHSTYKKISKSRIFNLLERLKTKKIYLFGTGPNFSYSEKYDY
SDGCVIACNSMVINRDVIERLKPKIFVIADPIFHAGPSSYAGKFRQSLIDIFNLNPCPIV
VPLRDYHIYSTYLPDCMVDFLVPIFFKIPSEDDSPFYFDIFKSLEVKTTNNILTLFQLPL
ATSLGEEIYITGCDGRPIKNDSYFWSHNREVQINDKMQDIQISS
>fig|195.2193.peg.1838 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MQKKILVSGFVLDNFLEISSFLEKNQIKRAKIEKKILHMLNTIVPSGELIHLAQGYKIQK
MYHCLLQDFDKEAKEKECFISDRNLIYIAEDWIQLDQNILFILFYESPVEVLKQKACLND
KFYINDILNSWLKYNTFLLDFYKKNRERSILINYKDFDVALCKYLNEKYYFNMVKIYKEN
S
>fig|195.2194.peg.1115 MdaB protein homolog
MKNILLLNGTKEFGNSKGQLNLTLHNHALEILKTLGCEVDQTHIDQGYDPKEEIQKFIKA
DAVIYQMPAWWMGEPWIVKKYIDEVFGLGAGVLFKNDGRTHENPSKNYGKGGLDHGKKYM
FSLTWNAPLEAFNDKNEFFEGKGVDMVYWHLHKAHEFIGMKALPTFMCNDVVKNPQVEKY
LNEYELHLKKIF
>fig|195.2194.peg.106 Glycosyl transferase, group 2 family protein
MFYSLQELYCKNKHNFNNEEKNQIERYLDENQKLLKPYRIIRDYFFRKERDKMGKSIVLF
HKIKFYYKRLENA
>fig|195.2194.peg.1109 hypothetical protein
MNNNILTYKIDTEQPIDIKELAESLIAIQNMYRKSIISNEASIKISEVRKGSYEFDIVVL
GLGLSLPYIENFNSAIEFIKNLKDCYKFFKENKFDNNVDKINIDDAKNTNKIIQPIISIG
GNSTVIIQNGYSDPSECFSVVSKEAVEVQKNIYSYIENKERKTKEELQTYKYFQNILVEF
TQTRTDDKRGNKLLCKNIYSKELNVEFSSDYLKKQILEEHNPHLHLYNVDLQVVYENNVP
KIYKIISIKDIKNKNI
>fig|195.2194.peg.1106 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72)
MQNKIDKITDILRRDDGISGAMHYTEQISWILFLKFLDDYEEELKLEAILNNQEYKSILE
EKFSWKVWAAPKTSEEKIDFNKALSGQDLLNFVNKELFVYLKNFKNNEDFKSIEYKIGGI
FEFIDNRIANGHTLREVINIIDELSFSKESDVFALGEVYEKLLKDMGSDGGNSGEFYTPR
PLIKAMVEVINPKPKERIYDPSCGSCGFLVESFLHILYKDESRKTKASLSVEELEFLHND
ALFGKEKTPLSYAMGVMNMILHGVKSPNIIKTNTLSKKITDITESDKYEVILANPPFGGK
EKEQIQNNFTVASNATELLFLQHILKSLKNNARCAVVVPEGVLFQNSNAFVSVKADLVQN
YNLECVLSLPSGVFLPYSAVKTNVLFFSKGLNSILKANDDKVYYYELTPPYKLTKNKPLE
YAHFKEFLKCYKERKITANSWLLSKKELEERNYDLSAKNPNVKEEKILRTSEEILNSLEE
NLKTQQKYLNELKSILK
>fig|195.2194.peg.1121 Lactam utilization protein LamB
MFKVDLNSDLGESFGAYKMGMDEEILKFVSSVNVACGFHAGDPCVMDKTLNLAKQNGVCI
GAHPSYPDLLGFGRRNMQISFEEAKNYALYQLGAIWLCQSKR
>fig|195.2194.peg.1117 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54)
MAIYAESSESIEHKNSADIISDSAVFGSIQVPKSGIPIILMAARQSTGGYTKIATVIEND
LSLLAQAKLGSSFKFQSISMQEALELYKQREMKFKIMDQKINLDFENLI
>fig|195.2194.peg.1108 Type I restriction-modification system, specificity subunit S
MTNLPQGWEVKTLGSIGFFIRGVSYKKEQLLSIKDEKSVYLLRANNIQNELILDDLQIIP
KELAVDKIIQNNDILFAMSSGSKHIVGKNILLNDLNDFTFGAFCGLFRINNLNISYKFLA
FYLKSSFYKNYILNISKGSNINNLRFADLENLQIPLPPLKEQERIVGILDFAFSKIDENI
KKAKENLANIDELMQSALQKAFNPLNDNTKENYQLPQSWEWKSLGEISNLIQNGFAASKN
NEIPSGYVHLRTHNISMDGSLKFDTLIRIKEEFIKEKQSFIERNDILFNNTNSTELVGKT
ALVTQNYNYAFSNHLTKIKLKNQYNSKLVVFYFVLLLKNKYFEKICHQWIGQSGINIDKL
KKIQIPLPPLQEQEQIAKHLDFVFEKAKALKELYTKELKDYEELKQFLLDKAFKGEL
>fig|195.2194.peg.1102 Putative transporter
MTPYIQKPASFKIFTRYIIVNTIVLLILGIIMIFVRTRIEKMKLRF
>fig|195.2194.peg.1731 Motility accessory factor
KHLFVFESEIELFILALSTIDLSEELKIYKIVLFDCVAEDLEIQIAMIFDQQSILEYLSL
YEILINASYYLHFYEKQILFLNEICLKTIGVAVRNADISCFLPLLVHGQFLQNIPSMLGS
IPFQRILSERKNKFENAIVVSAGPSLTKQLPLLKAYQDKA
>fig|195.2194.peg.1305 hypothetical protein
MSMINSTLPIQMKVLAKSGYGHYTLLLNHKKIQTKSMIELEIGAEYLAELYMQNGGVIQF
KHLSKRPNFKPFEEGLALIIAILQDKISYKKFIIQNLLDCKDIERYQILKEMLFASFENI
YHIPFIFENKSCLFQMRKRAKYLEIYLYFSVFGALKILIDSQGISVFTPFAKVQKFLNEH
LDFNVSQENKIEPLFVFKRLFDFKG
>fig|195.2194.peg.1740 Motility accessory factor
MITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHG
IKPDYVCMLERTEITAEFFNHDFGEFDKDIVF
>fig|195.2194.peg.1118 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54)
MSIKIIEASINSSLQDFGRKKFAKFGIARSGAMDEDALRMANILLGNKQDEAGVELCLKG
GKYEFLDENYFVLSGAEFEAKFNNQKIKTYKVYKANKGDILELGLAKIGFRGYLCVAGGF
EIKSFLNSKSSDAKMGVGFFEGRALQKDDILNTHNTFIPFNLEARECENPFFKSPKEPII
RVILGTNEDAFTQKGIETFLNTTYKVG
>fig|195.2194.peg.1110 RloE
MIQMTNLKNLYKDIKNKQMTYCIFNYTHNRIELEIMFDINPEPFKLLIIKKHSNKTLLLD
ILNGFKLDIFLSKEKYQILLDILDIKGGGTIPFSTKKFFEELNNAIPHQVMQYNLSNNLR
YIISQVNNLDEANLVYIKCLIDWSKKENNKHVTEKNRKKTKYLYPDVFEIIKDKNISVVY
TNNKDYSKHTNIEDIEVING
>fig|195.2194.peg.1114 Transcriptional regulator, HxlR family
MTKENSPCNFEECGFNYTLALINGKYKMSILYCLFRYEIVRYNELKRFLSSISFKTLTNT
LRELENDGLIIRKEYAQIPPKVEYSLSKRGQSLIPILQAMSKWGKKDKKGKKCLN
>fig|195.2194.peg.1111 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MNFSEQDTRVKIIDEKLKLALWNEENIIREYYFNAGKKFIGGKRGQRKFVDYLLKFQNKH
LAIIEAKKLSKDPLDGLSQAQEYAKNLDVRFVYCTNGEKIYEYDMQNARGEYVQNFASPQ
VLFERVFGNLKEWQHKLLTQKDLFIPQKELRYYQKIAVERVIKALIEQKDRILLTLATGT
GKTTIAFALCYRLLEARWNKNNKDKKPRILFLSDRVSLRDQALGEFNYIEQDCKKIDTKE
LKKSFTLPSANVYFGIYQSLSAESDINDEENKFYLLFPKDFFDLVIIDECHRGGANEEGS
WKEVLEHFSCATHLGLTATPKQKDNVDTYKYFGESVYEYSLKDGIEDGFLTPYKVKLVTT
SLSGGYTYNPDDIIEGKLEKGHFDIKEFERNISIPQYNEFIAKELLKLINLMDKTIIFCV
NQAHASEIKRAIDKHKSIKHNDYCVRVTSDEGIIGLNYLKSFQDNDKAFPVILTSSKMLT
TGVDARNVRNIVLLANIGSMIEFKQIIGRGTRVYEGKDFFTIIDFVGATKLFYDPKWDGQ
RILEDNEDNKEQKGEESKKENNKNENESKIKKKEKITVHIKGTKLAIYDIKTSYIGENDK
PLDAKEFLEFLFGKLAKYYQNEAKLREIWSDLNTRKEFLKKLENDGISKDSLQDLALMFE
KDCDLYDVLAHLSFNTELKTRKERVQNVKNSSFLKSFHNEKALRLMNFLLDKYENVGIEE
FEKGLKPLIELSSLGNIKELSIEFGGINELMQSFATLQRELYAG
>fig|195.2194.peg.1651 Integral membrane protein
MTNTQINDKILELANYLKIDNKCVAHNARLQSIQINGAVIKNFSFKLFNEYKLSFFNCKF
LCEINEAPGFFEIENPVYIYGCTFEENVISYNIKFKSNVVIAYCRFNKNFYFEANTFCNS
SNFERNFYNYASFKKSHFEKNVTFYNSTFKGLDFSQAIFNENLNIVNTKLNFTFSNLEEK
IEQEYEEFNKNKKEEDQKSLDKFANDFRDSFRTFKSALIKDNNALDASNFHKYELYCKEI
ELKQNWDKKGENVKNTTDLEKNVSRIRDFMDFLLLGFYRKLCDHHTDFLKVFNNLILLIA
LYALFVFGFTWLHDDKLEDTRAILTLFGFFDKFRLYFDIISTIFVVFGCGFFVCKLDSYE
KKNNVSKKQNINFYIYHW
>fig|195.2194.peg.1104 4-carboxymuconolactone decarboxylase (EC 4.1.1.44)
MQLRQKAREIFEKLLGGAKKDQLFASDERHYYARKSQNKRQGNTKCYF
>fig|195.2194.peg.1113 Homolog of BLC protein
MLELIGELSLQNYMGEWLEMARKPAFFQKSCLNSKAKYELKYKNGIPYVEIENFCSKKNE
ISSIKGKAKIVSNRQLAVRFNIFMNLFNKVNYEIIFVDSEYKVAIVGSPDKKYLWILARN
IIDEKNIKEFLNIAKQRGFDISDVVFDKY
>fig|195.2194.peg.105 Glycosyl transferase, group 2 family protein
MLKISIIMACYNCTAYLSRSVMSVLNQTYKNWELICVDDGSTDGTYDKLLGFSRQDNRIK
AFTKKHSGMAAPNRNYALEFISGDFIFVLDSDDEINPECLGECVKRYEELKAKDIDVDII
IPKLVFLYPNQAKKRTICGIVNQCGSESKILDGKKAFSYSLDWRISGLGMYKTILVKKLK
WYEEGMNGDEYSTREFLLILDILLLLKMVCIYIIKMKIVSLKN
>fig|195.2194.peg.1105 4-carboxymuconolactone decarboxylase (EC 4.1.1.44)
MIETTPEDKAFINDFLSANCFGDYYTRMGLDLKTRELLTLVYLISLGGLDNQVKAHIQGN
LNMGQSRKDLLNIIAALIPYIGYPKALNALNLLDDIKK
>fig|195.2194.peg.1307 Putative processing peptidase
MIFFIIILGACLGSFCTSLASRIIEKKPFFISRSFCFSCDTKLKYYEIIPIFSYIFLKAK
CQTCKCHLPISLLINEILGIILLILAYSLSQNFYDFLFLSLFLFNLFLLSLIDIKLKAVP
QILLWSAFLFAFFYAFRESEILHFLIFKEFSGGFLLNAFSFGGFVFLLKSLVFFLMNFRK
KDEILENLGDADIIIMSCIGGILGFEYGFLVLLIASILTLPFFIFFKIKAIKEQELAMIP
FLNIAFVAVLFYKNLGLF
>fig|195.2195.peg.1126 PhoX, Predicted phosphatase
MFNHQGKNLSKEDVLYEQASVGVSVLEIQKKGNEWAVVLDSKYNRRIDANTKMEVSGAAK
KEVLKDKKFAYGTFANCANGQTPWGTYISCEENFDDYFGSSDENLKFDENFKRYGFKTKS
EYGWEKFDERFDLAKNLDEANRFGWIVEINPFDAKSTPIKRTALGRFKHENAEFIVEKDG
LVIVYMGDDEIDEFIYKFVSKHKYVKGGDTSKILDEGTLYVGQFNGNVGDFRGSGKWIAL
EYGKNGLDESKGFKSQADILINTRLAASVVGATPMDRCEWIASHKESGSREVFATLTNNK
NRTQA
>fig|195.2195.peg.1377 Chorismate dehydratase (EC 4.2.1.151)
MCTKWHEKTGLPFVFARFSCVQKKALYKQILKKFPKTKIKIPYYILQNYAKTRDLDIKDI
RYYLDEIIYHKISTKEKAALKRFIKACKALNLT
>fig|195.2195.peg.1374 KtrAB potassium uptake system, peripheral membrane component KtrA
MRVISYKKLNTDWEILPDLETTTVYGGDVVILLGTVKELREFEH
>fig|195.2195.peg.1502 hypothetical protein
KSDIFKYSLIDPTPYSNNDKTITKSGIL
>fig|195.2195.peg.918 hypothetical protein
MIKIYVEGKSDKIFLDLLCKNLKIDEFETIPIGGNNLSSSDLKSIKEDISDMRIEKICII
FDADDDY
>fig|195.2195.peg.1376 Chorismate dehydratase (EC 4.2.1.151)
MIFGKIDYINLLPLHIYLKKYPLPNGFKASMEHKKGVPSKLNKDLFYRRIDAAIVSSIES
ARKKYKNLDLGICANKRVLSVLVEKNTPNAKDPS
>fig|195.2195.peg.1375 Uracil phosphoribosyltransferase (EC 2.4.2.9)
MFATGGTAIEACNFLKSQGVKKIKFISILAALQGLQKFSQMHDDVEVFVACIDEDLNEKG
YIIPGLGDAGDRVFNTL
>fig|195.2196.peg.977 Branched-chain amino acid transport protein, putative
MDFYSYPYGLDFIVSCILVFLIHLLFKNALLSIILGTIFYMFVLRLF
>fig|195.2196.peg.1109 Amidophosphoribosyltransferase (EC 2.4.2.14)
MHNYKFILLSSNNLVGIKFQKYFKRYFPNQLQIFHCDEQFLSIMQNGIFEKTEYIIINSL
ELKKENIKKIVGYFSQFSKIIIIQKSIKNIYRTFKNITLIRISNFIGFNDRMNEIQSFAS
AEVLIDYFIESIVEGIKHGHILVKYDSFNSKIISQRQKFCSLRLLYQGDPNENIFLQNVG
NFRIKLGEILADYLNIGDLNDIDYIVPVPSSGIFYAVGLSKALKIPMLPALKKIQISERA
FEIQDVDTRKRYLYNNMEINSELIKNKNIILVDEAIFTGATLKVVCDILKDCDVSKIHLA
IPSPKCFLQCDYLVQPKRTLLLKKINERYLSNYFNVNSVNFLPLEQYAKILNKIDNNICY
ECFSKEKRCLPQ
>fig|195.2196.peg.1107 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
IQKELDQYNNVVYIERYHQSAKQRIYNHLSYKLGFCAIKKSKTLSGWISMPITLLSIFIS
HKQEQKIYQEKIKKDPSLKLPSLELYTDYQEARKEENSFTYKLGQAIMNANKTWYKGGYV
KLWFEIRKLKEKI
>fig|195.2196.peg.1723 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MVWKNYNYPSLDSYSDYQEALKIKNQLSYKIGNLFIQSYKKWHKGAFLILPWEFYLLVKK
YKKGK
>fig|195.2196.peg.1788 Motility accessory factor
HEDILGLNKKLAENFKNSIVSHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGIS
DTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVLSLERIPLTSEF
FNNDFGEFDQDVLFVCISWVYPQTIKYLQKNNRAFILTSRPSSFIENINLCPYGYVGYGP
SVAHMAYEFATHLSHKNIIFIGQDLAYAKDGFSHTKDYKNLDKHEGHFQRDKGKFQCLAY
GGDGKAESSEVWTMFRFFLQDTISRNIISTTYNCTEGGARIEGTIEKPFLWACENLLDK
>fig|195.2196.peg.1790 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MNANKTWYKGGYVKLWFEIRKLKEKESQNDK
>fig|195.2196.peg.1712 hypothetical protein
MTSAVDIFIKNLKNEALLIENKEQYDYKFYKGDISDIRQAFLNNDIQYFVNFWNCKNKNK
YFETQHPLLNHIMTRAVFSVQFGTANFVLMIDENNQYPWIIGQCQSLVDSIIVNDKLYVI
STVMQVDLFKEIHRLSEINTSSLKYKDIEFGYLLSQNRPFHHFYDQLRYFYYMDKPKKIF
DNKSFFIPNHASKTSEDLVYLFPSGICVSQVSSRISYAKKTFLSDILDDNLEKNLLLDSL
TSRQYVDDIYYDLNLWFTICSEKRFWLDQIYGYANIIKEFLKYYSNIRVFLDGITSKEGL
VMDYFQDRYICDKIRLLIGSTQKDKCVIESLVGVDYKTKIYYANKVDCFVAVSGTASIVP
FRICKKPGLIISNSILRNLDNAEEKFLPKADMIIDQVEPKDAFLKSFHISWEYIFNMMAD
ILNNKNIQKIKQPSNDEVILRWVINSIKELDKNSNWENLLLELVVIFEKANYFDIAYLLS
NEIYSKINHKQKKLFLSKIELYRENSFYVKRISDLELQLQNKTKELKNLQEDIIHKKQLL
EVQNLEQDLNLKSLQTKEIQENINLKTLEKTKIQKELDQYNNVVYIERYHQSAKQRI
>fig|195.2196.peg.1350 Zinc ABC transporter, substrate-binding protein ZnuA
VQTRFPEKTAKTLEKEYNVKIYKIDYLSYDWENELLKTANAFYENL
>fig|195.2196.peg.526 Dienelactone hydrolase and related enzymes
MIHGENAHSRYFSEDAFKNLKGDNKELFIVKNANHVDLYDNADKIPFSKIAEFFKANLK
>fig|195.2196.peg.840 Signal transduction protein CetA, mediates an energy taxis response
MDAISHTATENGSEVDSLQNAMGSLMDVVNLSKETVQTFVANSQNITSVVEVIRDIADQT
NLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQRSTSEISIAIQTMQQDFVNIQSGS
EQVFNIVSESEERINKFSQAFKRLEENSSALGVNFGSFAKRLILSVVKIDHILYKSNIYL
NLNGAQNFNLESVDPISNLCQDERAQGVINELSSETELNLAKEFIKDNAKKAIEESSQDY
IDQKAYDAIVNDIKSLEQRSAEILAKLKI
>fig|195.2196.peg.642 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKNIVLLGGSNSVLTNGLKNGLQCEESIELKNYALGACTCLQNLYALILNKNDILDADLL
VTESNVNEIHSFCRIKMPLKQLSYIINTYYEELSFLNIKILVLILPICEKHPSNEDIEII
NDLHRKNCVKYGFNCIDMQSYYKKNNVFEFFMDLPENHHPMETIMNKLGRNIAKNIDAFK
HHLQNKNKLHRKYAFFIPEVDTIGNKLETKIKSNSLYRETIVRITDKAKILFPSKFQGYR
VAAIYTWNDFKEECYGTKVFSSLVLENLQTKIVKPSNGWMQFSELHQDFNIDCSTFAYFN
SQNTQITENSILVHGRELMLKHVDLIAFFLIKDEYNNLSINMDFNFAHEKTNKLFFDKFI
PDLYFLKNVIQEYCSKKQFESTIAELKSILSQKELQLQNKTKELKNLQEDIIHKKQLL
>fig|195.2196.peg.841 Signal transduction protein CetA, mediates an energy taxis response
MMKNGLLSTIFLSVIGVLGVIFIHIFVGVIIFVLIAVLMIYLLRQHKDEQIMIDKLLVLC
RELKEGNFDNRIIYVKTKSKKLAEIADNLNNTIDGLEAYLREINTSISCSQKGEFYRKAL
PEGLKGIFAHNIEFINKALANIEVTARSTFKNALSRTLMDLSLGNQNKDMSQISSSLNQD
ISMMKNVYDTCGCHFSYSYRKWF
>fig|195.2196.peg.1644 hypothetical protein
MANRHWALVDMVLELVQKEDILQKESILSHITNERLLRAIENFKSESALHKDKNLFFQLR
V
>fig|195.2196.peg.1731 hypothetical protein
MIAVEALQTKNMTKRAKLKNVKVKSGLNKSILDTSFYQFLSFLEYKTSHNGKIFTKIPPQ
YTSKTCSKCGSIKADLRLSDRIYICKECGNEMHRDINASINILNRALESFELGINSLDYK
QQALCVS
>fig|195.2196.peg.1810 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
SAKQRIYNHLSYKLGFCAIKKSKTLWGWISMPIILLSIFISHKQEQKIYQEKIKKDPSLK
LPSLELYTDYQEARKEENSFTYKLGQAIM
>fig|195.2196.peg.1729 Mobile element protein
MLQYHLILVVKYRREVIDDKICARLKEIFEYIAKNDNYSLELIEFNHDKDHLHILFKAKP
KSELLKFINAYKSASSRLIKKEFPHLKQYLWKQYFWSGSYFLATTGGVTLDILKQYVENQ
GIEDNRVKKQYKNTKRKKLLNANN
>fig|195.2196.peg.1724 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTVGIVIPIYNVEKYLKECLDSVINQSYTNLEIILVNDGSTDENSLSIAKEYTLKDK
RITLFDKKNGGQSSARNVGIEYFSGEYKLKNKTQTIKENSLIEFNLEDNNPYEIYTVYKS
YKAFNNEKDLTKFTYPNIDYIIFLDPDDYWRLDAVEQCVIRCQDVDLIWFDYKMFYDNID
KNHYENVENLTKTQMQIYEYFAPEIINVQQWLERMIKIQSTLPFWCVCAACYSFSYLKRI
QLKFLDGFIHEDVHFGILSFIQAENIYIFPSQLYYYRIRSSSTAAYDKKITKDNITPYIE
NLCYDFNGDIKKAKHYHAKSSNFFNAFYIREFIKNKLDDKKGQMLEEAIFMYLYFWHFDL
RDFEKDPRDTLKFLSNHKPLYQENQDRYPEYDFICKYGFARDRIQKQLTYRLGKLVLEKS
QNFFGLIFLPYFIFKLILKFKNEKKEYQKLIKKNPELSLPKLESYPDFDDIWKVREHLSF
KIGHLILKANKNWHKGSYIYLPYYIYKCYKQHQNSKKNISTSIHSQGILLKRQFIWKDEN
LVNIALNKRVFQSSIDELDYRHNPNMIVSQDYSGVKSYKTCFTNWPWFVVDLCKVCVLEK
IRIINVKNHFKRKYLRGMDISFSIDGIHWTAISREKFYWKYNDYYCELVLSECLSARYVK
ISIERGALELSKIEIFSRNKNGYIISSKPDGLGMRLASILVGMYLAKKCNFNFGFTWSNS
IDLAFMGITDSQNTKEINYLGNAMDEVDAVFNLDFIKEYLIDSACVNENHGMEIRKKNST
FEQIQNKTNFETEWGWYSTDILPSNWLNECVEKECLKEISRIYSTIGFSDGFEKIIQDSR
VVKINKFVALHIRGGDIIFSKIRKAPGWNVVQERYFPYEIALDIVTKELASGYSIIVFGQ
DLNANKALVEYFQKTAFEKIFLVDEFIDKTYNEMERSFFEINLMSRAEKIYSAKESVFSK
VAMMIAGKNNLISYHDIYTQKDQADIIQANLSKIRLHNFQDARAYFRLFELFRDRDIEKS
MSFLNKALELDYDNDAYRIYILDCLFRLKDYHTADTMLEKIIAERYEEFFSTLLQYSMGS
FTMEYELYKDFKQKEYPNILYVAFKIFMFFGDAKKADYVRFHLLEDKLSILKKKVAQMKK
I
>fig|195.2196.peg.978 Branched-chain amino acid transport protein, putative
MLDKNILYAILAASLATYLTRVLAFILFKNKKENYHLLFVQYNMPLVIIIILFFLYFL
>fig|195.2196.peg.1182 hypothetical protein
MIGSSHGGYLAHLAAKIAPWLIDGVIDNSSYAKFLWRLIGFGKEMDFVQYSEFSTFDFFH
HIKTHCSTKTFWTSNSSSNNFFSIPRRMIRYILEPKHLEIQTNYPKPCYTSYHSFYDKEI
APPDEKLELYKYLEQFGFDAELYMIKNPDQVDGRFIKSLEHGMGMSIKTLISKELPLMLE
KIKQNPKKDCKEKYISYPCEDLLYKFSEKDDKISLKIDKI
>fig|195.2196.peg.1647 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
MIFFDNFKLDKSKIGEFFFGSANNFIKTKLLELLNFKEIKNDETLKNYGDVTINKLAFDL
ANYEWRKKKGGGYKTSFYG
>fig|195.2196.peg.1730 hypothetical protein
MQITKGFKYRIYPNLEQQKLLNHQFFIYNQAYNIILDLQKKQMQINKNLDKSQRTYLTAV
QLDNKVKEILRQRELAFKSVVTQQARINLLRALKDKTKGFPKFKNSKFAKQSFNWNNQGY
QIKDSNNPKFKIFHLMKLPLKMRYHKDLPQNYKLNQITISKSHNKYFVSFSITYENPSVS
LISSQNLDIKKAVGIDLNINEIALSSGRLIKTNSKLISKAK
>fig|195.2196.peg.1555 C4-dicarboxylate transporter
MVNFQANPISSAMFITATAPNPLVVDLVAQATNLEVHLTWGQWALGMFLPGIAAMLLMPL
VIYFLSPPEIKSTPNAKIFAKGKLEELGAMKGGEKITLGVFVLLLLLWAGALGFLFGISL
DATSVALLGLSLVLVSGVLTFGEVLAEKAAWNTLVWFSALVMMATLLGKLGVTQFLAEAL
GEFASAMGLGEISIMIFLSLAFLYTHYFFASTTAHISAMFFVFYSAGLALGAPPLLYAFI
MIASGNVMMALTHYATGTAPVIFGTGYVSLKKWWSVGFVISVIDITVMILVGLVWWKFLG
FY
>fig|195.2196.peg.1725 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
ARKEENSFTYKLGQAIMNANKTWYKDGYVKLWFEIRKLKEKENIF
>fig|195.2196.peg.1789 hypothetical protein
MINKKKLAIQLFGHIRTFEQTFPYFKDNIISANMVDYDIDIFIHTWDEFSAMGKPNTERF
RLNEPLCGKKLTKDDIDKINKLYQPKKILIEKLTVPYGGDASIEKVNRLREEYEFEIGVK
YHQILYIRPDILALHPLKIDIFLEFHRKIIDNNVSNNRYIYCATSVLDRLPIITCNNGLG
VGECDLVWFCNFSSKSPIRHNNAILVPIRYSLHYNFLIWRYLNVESDKDFFVRLKNSDYK
KLYRENSFYVKRISDLELQLQNKTKE
>fig|195.2197.peg.1790 Motility accessory factor
SSYPILAKHGIKPDYVCMLERDEIVAECFNNDFGEFDKDIVFIVKSVTHPHTIKYLQKNN
RAFILVSTYASFIQYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILIGQDLAYAKDGQ
THSQGFIHANLHNGDYERDLDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMNYHI
TTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEP
>fig|195.2197.peg.1414 Predicted D-lactate dehydrogenase, Fe-S protein, FAD/FMN-containing
MANFKAFYNEAKYIFKDRIFNDYARCYAYGIDASCYFYIPKIVIIAKNEDEIKQIIQLAN
TYKTPITFRAAGTSLSGQSSCDGVLVVIKFAFKKIKINKDASEITLGCGVVGIHANESLA
FLKKKIGPDPATINSALIGGIINNNSSGMCCGTKDNSYKTLRSIRVILANGSMLDTSDAL
SVARFKDENKKLINELREIKEEINANKELKDLIIKKFKIKNTTGYSLNAFVDYDDEIDIL
AHLLVGSEGTLGFVSEVKLAVLDDLEFKACALLFFDNINNAANTIKEFAKVDFISSAEIM
DYASLKAASNYDELRDILADIKEGNTCVLIQSEHSNELKLDENINKIKEISKLAYKSYFS
KNKAEYDLWWKIRKALLPIAASLRKAGSTVITEDVCFNIEDLADGIKSIQELFYKYGFSD
NGIIFGHALAGNIHFIITPDLNNKLEFDNFSNLVKEMSK
>fig|195.2197.peg.1448 Hypothetical protein Cj0135
MHRFKHFQGELYKNFAFGRSVYLCETCILSEGKVLQKAFFKSCKNLNTKITQQNLKEIVL
NGKN
>fig|195.2197.peg.514 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAELNFKTKAQNLKNLQTKLKKSKNSTFGLDFA
>fig|195.2197.peg.1415 Predicted D-lactate dehydrogenase, Fe-S protein, FAD/FMN-containing
MAPFVEVEWGKQAYLINKKIKSIFDKDNLFNPDVIISDDKDIYKKNIKQASWIDEKLNTC
MECGFCERFCPSNEYTITPRQRIAILREIKRLESLNDDESKAKLKDIKKYYNHLVDSSCA
ACGVCSFSCPLGINFADFSLKYRKNNIGFISKILGNLAYKNHEKTLKIAKFSLSIANKFD
NLSLDNKLEKASNFLSIIPRTRAYLPKVNDYELKSRKRAYNVVYFTSCLNKSFKPNEKMH
DKRSLQEVFESLCKKANIGIIYAPNDLCCGKAYENFQDIQDKNIQKINDFLSNIDSPIVL
DHSACSAKLISDHLKYEIYDLSEYLLKFIAPKLRIDKINENVGLYIMCAARKLGLNENII
KLAKLCTNGKVLIDNDTYCCGFAGYKGFFKPQLNINATKGFKKFYAKTNIKRGFSTSSTC
EIGLSDATGISWQHIAYLLDECSEKQFN
>fig|195.2197.peg.21 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
MNLKLNSHNIKAISIVLPKNPHTLEKELQECNLNQKKYELLKQNTGINHHFISPNNIYAS
DLASKALEKLFRENLLLKDELDVLLVYSFSPDFLAPALSSLIHKNLGLSEKTLCFDNIAF
CPGFLQGLMQAFSLLDNENIKKIAFICVSVKSKKIPKKDKITYLSNSDSASVILLEKSNT
KEKAFFSQKIFSKLATEETFPLKCFKEANDFIDMDKNLTFSHLNENFPRFFDDFFDNFKL
DKSKIGEFFFGSANNFIKTKLLELLNFKEIKNDETLKNYGDVTINKLAFDLANYEWRKGG
GGIKQVFMASFGTGITFNAMSLKIDFSKIKNFIEIIDFNT
>fig|195.2198.peg.518 hypothetical protein
EQSVNIDKSLSIEKEKLLQAQTETEKANANLVKRQTAQIDDELELKEQSVNIDKSLSIEK
EKLLQAQTETEKAKPALIARQTAQINDNLRIEAAKVTQSVQFGYCTGGLDIPQEIMKLVK
EKIENIEKSS
>fig|195.2198.peg.1708 hypothetical protein
MKKNKKNKIFFLFFFASSLFSAGIPVIDAASIAQAVTNYQQMLKQYEQMIKDTTNFEKQM
KELGVDMSSISEILGDTKSLINQTQSLYDGIKAVPNDFYGEVEDITKACNFMEQQSTFFQ
TKIQNVGTKYTDKVNSCISAISDTTEVDKSINQLNQKLLIISKNDTKTYNETLVQIQNLE
NAKQYLASKANQDRVNKMLAFYDNYQKNESTNPYTKTKMDKDLQELSKQLLKANNQKQAQ
ALTNSILIKILEMTQRQYELNVYFSQAMTSLGLNGNGGQMNKSPSFELIYQEPQDPKEYN
PYLKDIKQQPKDENGFPIFTF
>fig|195.2198.peg.1223 Capsular polysaccharide export system protein KpsS
MKFSDKIKKEFSGKTVLLLQGPVGTFFHRLAIKMEKNKTKVLKLNFNGGDFFFYPNGKRC
KCDEKDLENFYESFFKEKKIDAIVMYNDCRLIHAKAIKVAKELGIGIWIFEEGYLRPYCI
TFEKDGVNANSSLPRDKNFYLSCNISTKESIKEIPGGFKFMAFSAFLYWLFSFLLAPFFN
NKLHHRTLYPFEFLFWFRSLYRKYLYKLTEKNLIKKFIALKKSTFWLFCKFIMIRKLSTI
IKKA
>fig|195.2198.peg.1867 Motility accessory factor
QDLAYAENGNSHPDDYQNSANYESQMYEHILTTAYGGNGKVETHSIWLLFKNWFENEMIP
NTRKMGITTYNCTEGGARIEGTIEKPFLWACENLLDKNLNKPFEKLEPLSLNKQNEFLLK
AYY
>fig|195.2198.peg.242 Broad-specificity multidrug efflux pump YkkC
MNEKFNINIAWFLIILGGIIECFWVSGLKYSTEIWQYILTAIGVCISLYLLFKSL
>fig|195.2198.peg.361 methyl-accepting chemotaxis protein, putative
MNRLGISARLYFSFALIIFIMLFIAVFSIAKVNFLNKTLTIATGENALISRQAINFRGSI
HDRSILIRDVVLAQD
>fig|195.2198.peg.1866 hypothetical protein
GEYFSEGLAGVKLNGRWGFIDRSGKFVIKPKFDSIWDFSEGLAKVKLNGKYGFIDKSGKF
AIEPKFDSIWDFSEGLAKVKLNGKYGFIDKSGKFAIEPKFDSIWDFSEGLAKVKLNGKYG
FIDKS
>fig|195.2198.peg.1798 Motility accessory factor
MDGKGEKVREELFLKNTQALFEVDEFLACTLRSLKYLTFALIRDENGINFKKDDIFLYEN
PNKELLENLTLFKTEYNKYPVLFFYGFGNGMFYKTLCKNKQHKHIIIFEDNLEILTLAFH
LFDFSEELKKEQLILFYTPNINTAQLTTLFTYEIIQKSVKIFNLFIHNDFYQQFYSTQIQ
NINTQLIEMIRFIVLNKGNDPHDSLVGIKHTLDNLPKMLNHGIFQEFLKERRAKVKNAII
VSTGPSLIKQLPLLKKYANKATIFCADSAYVILGKYGIKPDYVCMLERDNIVSKCFDNDF
GDFNKGILFILASVVHKEVLDFLEKDQRTYMLVHRPLNFAASLKLDKYGYLGVGHSVSNM
IYELAGALRFENIIFIGQDLAYGEDGSSHPKEHIHGSQGEEIRGEKYTLAYGGKGKVRTQ
LTWNLFRQAFEKDIFWAKEKLNITTYNCTEGGARIEGTIEKPFLWACENLLDKNLNKPFE
KLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFEKIQSVYLNLNKKENDLNLAI
RKIDEFKNKLENIKQMQDLYEILQPLLTQFELNLARIYVLNPKTKEDAFNKSILWIKEHL
KFMELVYGHIKAQESALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2198.peg.241 Broad-specificity multidrug efflux pump YkkC
MGFVFLCTCFLKACERLEVSITYSVFVGIGTIGVVLNEMFIFNEAVSIIKLVLIAILLLS
IIALKWVSKEA
>fig|195.2198.peg.1133 putative lipoprotein
MKIFIPISIITGSTAILIPSKETAYLMAGAYIGEKAVKSEFVNNRLEKIIEIIDLNLDKQ
IKELQGFKK
>fig|195.2198.peg.61 Arginine/ornithine antiporter ArcD
MGLICIGSIIANITAFLYSVSVIYIFKNSPPKPVLKNGNLGFDVIFVDSIIIAFFVGFAV
FLGTFLELDRSYWVAVSTTVILQGTNLNSVWIKQLQRILGTTVGILFAWWLLRIKFTPLE
FIFLMMFLAFIIEFLVVRNYALAVIFLTPYVTYLAEAASFGNLSVDMLIHARLQDIIIGS
LLGLLGGFVIHRAYLRKYFKYIAKYIFRVKLTSK
>fig|195.2198.peg.1293 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIFDKTHNVFMYENLEEEI
NFFYQSILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEE
LCSGKIYLVDIEEERVDIQLLILFDMKDMFEYLSLYEMFVNNVYYKKFYEDIWHKADELC
EKNIEVIVRNLNSSLHIAFECYSHLLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPS
LAKQLSLLKAYQDKAVIFCADGALSMLEKEGIIPDYVTNLDCRDLAMKFFQNKENKTSLN
VLSCATHPSLVHFLDNKSVVLRDDPLYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNI
IMIGQDLAFDEEGNSHSKGFSYGEQFSGEKTVPTLKAQAYAGKGEVLTHITWNDYRIKLE
YLFACNEQKAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKN
>fig|195.2198.peg.1134 putative lipoprotein
MKLVFLIYIASILDDINRAFFTAGVLSLACGIFAIILYYICKFESNEKFVNIAKKE
>fig|195.2198.peg.170 Dicarboxylate carrier protein
MEWKFKFIFYTSFYYLFLWFCDCKWYAKQSPLKAVYSVRNRPWSIPIALYITVMVFVGIG
PGHYTGFAFMSPLVLYIASKIKMNKILAAIIIYSGSCAGGFNPFTLGGRVTFDLIEKLGY
SAEASAIMQLNLGKNMFIAHTLIFIIGYFLLKGYKVKITSQITKPKRLNAAQ
>fig|195.2198.peg.1031 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
HEFNIGNKVVFKNKENFKEMNFEWLYHKTFCFDSNLEKEFLNFIEVKKDEINKVFSKWFV
IRNEGFEEFKIYDNRKDEVTYAMGFEPDFIFFGKKNKDDDNFLSIQCFIETKGEHLAIAK
DAWKEEFLETLKGKIITTKDDKKLTLQSLPFFINKNFNINDKFLSSFDEFVSFQDER
>fig|195.2198.peg.1224 Capsular polysaccharide export system protein KpsS
MDRGYRNYSKLIDELSQKYHVEGRIFYVHDTYLPTLLKNALGCITINSTVGLSAILEGCP
TKVCGNAFYNFEGLAYPKKLQFFWREAHAYKPNPSLVINFKNYLLNTNQFNGNFYKNSFL
G
>fig|195.2198.peg.1724 DNA topoisomerase I (EC 5.99.1.2)
IAFAEKLAKENNLELPKDYKENIKVCMNFLEKAKENVKPLPASAKQIAFAEKLAKENNLE
LPKDYKENIKVCSSFIDEAIKKNKK
>fig|195.2198.peg.1 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MFNKKLHELLQEEFGKRGIEQIEIPFYVKENLSKELRIYQEKALKYYYANSDSIKQRHLM
FNMATGSGKTLIMAALMLDCYKKGYKDFIFFVNSTSILEKTKANFANKYSSKYLFKENIN
IDSKNIEINIINNLFESKDDCINIYFTTIQALFSLFKNERENSLSFEDLKDKKLVFLADE
AHHLNSDTKSKNENEIKEGWEAIIKRAYESNNENLLFEFSATIPQEFNVLEKYQDKIIYE
YTLREFCKEGYSKRIFLVKYDNDSLEHRFLGAVLCSLYRELLAQKYNIVLKPVVLFKSES
IKESMQNQEKFIDFIDNLESLHIEDFYKNINKESDLLNKSLEFFKKEYQNTYAKTIVNFL
KNNFKTLYMLNTNDDKELEKNQILLNSLEEKDNQIRVIFCVDKLNEGWDVLNLFDIVRLG
NKKASKTITTKEAQLIGRGARYYSFKSDLFDFDDEFRFKRKYDSDLENELNALEKLTYHT
RNDVEFIKQLNESMNKEGLLFEEEKTRIDLIVNEKIKEIIKNNKIYYANNKRIKKRDLKN
FYITRIEMEQKIKGLQIPYFSNSIKESEEKFEEIKEEYDLQKPSALNHIDNIYFLKAMNI
LGLDFNKINENFTFKSKKDFIENCLKNTVVCFSKRQEFNQINNLEIAKYILENFKSLKQN
IKQEYEVSEFITHEFNIG
>fig|195.2198.peg.1703 hypothetical protein
MLFILFLYVFLNSFCTKPKTFSPFFAYRKPFLVLKRSLKEFIMFVKN
>fig|195.2198.peg.1859 Motility accessory factor
QLPLLKKYASKATIFCADSSYPILAKHGIKPDYVLSLERIPLTSEFFNNDFGEFDKDIVF
VCAGVVHPKTIEYLKNKTFIITQKILAFPYYINLKNFCYAAVGFSVAHMAYEFATHLSHK
NIIFIGQDLAYAEDGFSHTKDYSNLDKHEGHFQRDKGKFQCLAYGGDGKAESSEVWTMFR
FFLQDTISRNIISTTYNCTEGGARIEGTIEKPFLWACE
>fig|195.2199.peg.1040 hypothetical protein
MQKIIIKNLGPIQEATISLKPFMVFIGKSSSGKSVLLRTISLLKWLYKQEQIKSFHEAKL
FNNINQKEFMNYLKESMLDIYINHNTEIALVDDKPLIEIKGKNITLYQEHIKTEQLIGKI
VFINDVRNFLPELLAIPRQREIKASYHTNDMIANFIESINEVKYFKLKTMENTTLTAENE
AGFIKYYLIHNDIKIPFEQSSSGEKSTSIMETISSYFAHLYDIKKKSLDKIAIENIIFDL
KKSISTKGRFTENNVIKRIKLIETLLSEKNKPTLDIFIEEPESNLFPINQMNMAYYLASL
RNAKNKPNIMFSTHSPYILTSLNNILYASMVEQKLQDNKKDDIYKIIDKKNIIDYKDLVA
YKLENGKAKSIIDKETKLIDAEYIDTISGEIMDDFYKIAELDND
>fig|195.2199.peg.1858 Motility accessory factor
GNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEELKTYQVILFDAAVKDVEIHIAM
VFDQQSILEYLSLYEMFISSHYYLKYYETSILSLNELCIKSASVAIRNADISCFLPLLTH
GQFLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSLAKQLPLLKAYQDKAVIFCADG
ALSMLEKEGIIPDYVTNLDFTDLAMKFFQNKEN
>fig|195.2199.peg.1869 Motility accessory factor
NLPQMITHPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPIL
AKHGIKPDYVC
>fig|195.2199.peg.1 hypothetical protein
EIGIPLFSYCVIKNLHHQLKQSNNFLKDKNFY
>fig|195.2199.peg.1041 hypothetical protein
MIDKFIESNQQEYDKILTCEQNVKLELRCNGEKFYKILIDTKDTNKIENKATRCDYLATT
TDLKKIIIYIELKGEDIKQAIEQILTTRDFLNEKFEKRYAAITHTGNPEVKTILQKNISR
FRKKNFKLPLFTSSGALRLKYDPNTQTISK
>fig|195.2199.peg.1038 hypothetical protein
MIEQLNRLFIDDIKKLASILNINIENKNRTIILELISQELNKKNDTDQYEILKDVFSQGK
FELIIYKVKGLFELDQINSFIFPNNKHNLFTDAIEYYFNYKECYYVCCIKKHLNNSSLSP
TQALKQIKKNGIDGSICITHNDIKEIFSVFIGNKNLKKNFNLNQYKSMIFYSSHSTSNQY
LSTNCKLSSNNEKISKNNKIDNNNTIDDLTIHSIIRKEKFNKMELIDYFVVGFPKNFIDA
LKDVGINLCFKKDKIFIRYNFILKINGSVFIKNYDTDLDDIIEISKSIIDLKNEISRK
>fig|195.2199.peg.1850 hypothetical protein
IVLLNELNVYKNTSQKTHLKYLFYLYLLILNKSFGQQVLFLINLINLKL
>fig|195.2199.peg.796 Zinc ABC transporter, substrate-binding protein ZnuA
YKIMKKIFLLFIFLGLFNSFLCAKTLQPSENLNLPLISVSIAPQAFFVKKIAGDTLNINI
LSTNTHKPKSKSNPMKKLEKSELYFTIGLEFEKKLTDKLEQKFPKVKIIDMQENISLAKA
SSSDSEEILDPFTWLDPILVQNIALNTYNALVQKYPQNKSLYKHNLDKFLTELDVLNLQI
SSKLQKVKNKEFITYHPAWSYFAKRYDLVQNHIEFLGKKLKNKDIKNLGALIKEKNIKVI
FVQTRFPEKTAKTLEKEYNVKIYKIDYLSYDWENELLKTANAFYENL
>fig|195.2199.peg.1042 hypothetical protein
MIVKSAIKDKMKRTLNALINKFNPFNYFLLKNYTKKYF
>fig|195.2199.peg.1391 FIG053235: Diacylglucosamine hydrolase like
KYPLKIEEEIKWRNKHFGAYDLSPVIVLEKILPTRYEIIAKSEIYYDVKEVIKRT
>fig|195.2199.peg.1794 hypothetical protein
MLINQTFEIDSCDDVELNIKRTSKLEYRISYDDEKDIKATVFIVGGFGANANISFLDFDR
EYIAKNFDVVVVHVFYHCFCARQSIDQKYNPKLIPNQDDLERVNGILKNINLGHLSVNKD
NFEQIIPLIEQKVNKMKQAGLVDESQKIELSCDFIPPNGDYQNYGVMAAIDHINALKDLV
KRFPEFADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVI
>fig|195.2199.peg.349 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKIIGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGLSSARNVGIEYFSGEYKLKNKTQIIKENSLIEFNIEGNNPYEIYTIYKS
YKAFNDEQDL
>fig|195.2199.peg.1039 hypothetical protein
MKLVENKLLELIKQNGNIVSESDFIMLEQRLDIDDKDLKFAFKELIKQNKIMSVWVNPST
HLCVNKKDFEHYEIGYSVIYPKYDLDELWL
>fig|195.2199.peg.1855 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
DLTSFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVEVVWMNHVFLYEYYDPNAFRVTL
IDKLKFTSSNKYSIDFLISKMQNLNQNSFWFGWHGMINFKYLYSIKLKFIDRLLHEDHYF
GKLLFFQAKQIYVYTKKKIHYRIRKGSIMNYSKENSYIPSYALSEYSALNNDYFLYKKYH
RISSLFLTAMMVFKFMKEDNKIKSIESFKQIFYKKLKSWRNDLVDFDEFFLEKVLFLSFQ
EFFRLSSDYRVNLELISEFIADIVKTKNQLITNKTTQIQN
>fig|195.2199.peg.1263 hypothetical protein
MNISNDVSIGSRVAMLNNPFGTYASKMNGLKFAALDSDMRPSYVNEYTNSVWANAFGGAN
IIDGDSGAMYGATVGVDKQANDDVLWGAYFTYANAKIKDNNLEQKSDNFQLGMYSTINVA
PQWELNLKAYAQVSPTKQDNVQIDGAYNSDYTSKFLGLSANAGRVFDFSDNTLFIKPFAG
VNYYFSYTPSHTENGAIAKDIDSMKNNSVSVEVGAEFRKYMNENSYIFVTPKIEQFVINS
GDDYTANLAVNNAFFTSVEANNKKKTYGQIIVGGNVDFTNQLSMNLGFGAKQILAGKVDN
KNETYLSGQVGLKYKF
>fig|195.2199.peg.1864 hypothetical protein
WTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVSYHSKEDPLTPANFKEQTMQ
ILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKALFRKELPLMLEKLQKRKSLMQE
>fig|195.2199.peg.1783 hypothetical protein
MNYDEFENKLKSISLSKKDFSEMVKMSYTGVTNWRQTNSIPGWVNSWLLNYEKSLALDEL
LNIIEKYKKNT
>fig|195.2199.peg.1863 DNA topoisomerase III, TraE-type (EC 5.99.1.2)
TPNFETKQASNDTTHKCPQCNKGFLQRIKSKNGNSWWWGCSEFKQGCKAMYYDDNGKPKI
INV
>fig|195.2199.peg.1816 Epoxyqueuosine reductase (EC 1.17.99.6) QueH / hypothetical domain
MLVHICCSVDSHYFIEELRKEYPKEKIIGYFYDPNIHPLSEYELRFLDVKRSCDKLGIKL
YKGEYEYEKWLKAVKGYEDEPEKGARCEICFDLRMGSSVEFAAKIGEKKLTTTLLTSPKK
DLEQLKNALQKECEPYGVEFLAPDFRKDGGTQRQFALAKKEMLYHQNYCGCIYGLKKQKQ
DKNFIDELMSPINAQILPASIEARIALYKKVNLLEKKGIKFEIIRQKFLNYRLLSALIKL
DKKAVKSHILFYSHFKNHYTRFSLDEKNLNENLKNGIYKSTKDEISFIEFCRFNSY
>fig|195.2199.peg.459 Type I restriction-modification system, specificity subunit S
MQNKMTNLPQGWEVKKLEEIANIKGGKRLPKGENLLDNNTKFTYIRVADFQDNGTINLQN
IKFINENTYNVLKNYKIYDDNLYISIAGTIGKSGIIPKELNGAILTENAVKLEYIQNNIS
NKFMYFFTLSNIFKTQIQTSTKIVAQPKLAITRLKQIQIPLPPLKEQERIVGILDESFAK
IDESIKILEQDLLNLDELMQSALQKAFNPLKDNVKENYKLPQSWEWKSLGEIGEIITGTT
PSKNNPNFYGNEYPLFKPSDLNGDIIIKYASDNLSKLGFDNARNLPKDTILVVCIGASIG
KVGLSGVNGSCNQQINAIIPNSAFTSKYLFFVCLSNYFQTILKKNASQTTLPIINKTEFS
KLQIPLPPIKEQEQIASHLDELSSHVKNLKQNYQAQIKDLQELKNSLLDKAFKGNL
>fig|195.2199.peg.1264 hypothetical protein
MKKNASSKILLSLGVATLLYSSAFAQEINLTQSSDVGNYFEENGKDINLKNPDKYKGQDL
NIKMGVWDLPNDDYDSADYRLNIDIGKNNTLSFTHNNDQNPVYVTNLNATAKEVKTTDIV
LQAFAPSAINGNLTMTSSGGGAITEDEKKGSGIILYNGAVEGKSANGSLTINGNFTADKT
LFATYGNFVKVNGTANLTNSNFGLMKRSYTDLEANNVVIVQAKDFNENILKANNNAGALL
LKFAGDYISTDVQGKDPLEAGTIIDISDEDKYGDGEKGLVDYKLSVQNCGGNKCLVINGG
ATAAAKDKLVQLQVDIDTIDKLLKNEFDSSQGEEWEQAKETLKKQQAEIQTMLEEAKKNG
GKIDDEKYIDLVNKNLNLNLSANDKASILALRSITEQ
>fig|195.2199.peg.1784 hypothetical protein
EDIKENIEAKEVEKKNKKSVKQRLDEKIQNDKKASEERIEKIKQVIARKQKIDKVTDKKN
NREIAGKIGTYTLKNLIKLKERSEDK
>fig|195.2200.peg.170 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFSNRP
DACYNAIRRFCDKSFKANERVKTLIYDVDKGLTCFKFLPEEQMIFSFDEDFELFLGYNHN
VYEEGFWAFSLKFKKYTISQCNFCFTLENNLLLSCIQGYKYKDFNILEINKILTKKCHGL
RPVALLIECSKMLCEILKLQATLGVHEKNQIRSQKGKEKGYFVDYQKIWLENGGKLVKIN
NHLYYELSHKRKNLEEIPSSKRSMNFLTSEKILKKFQAASVQCIKNALLYLKKSNKL
>fig|195.2200.peg.213 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (EC 2.7.1.148)
MKAYAKANIFLKLVGFDKRRYHLLESRFILLKNLFDEIHIVEKSSNSPKGFEIISNFNCE
DNIITKAYHLLCQNGYQNKLEEFFKTKSLKLIKNIPTCAGLGGGSSDCASFLMLINEELN
LKLSTQKLIELSTQLGSDIAFFLSGFESANVSGCGEIIEEFNDTIPSLEWVFPEVSCQTK
KVYDEFDKGEIHIVEKSSNSPKGFEIISNFNCEDNIITKAYHLLCQNGYQNKLEEFFKTK
SLKLIKNIPTCAGLGGGSSDCASFLMLINEELNLKLSTQKLIELSTQLGSDIAFFLSGFE
SANVSGCGEIIEEFNDTIPSLEWVFPEVSCQTKKVYDEFDKGEIDFEKNILEAKIYKDLN
TKELLETFKNTQLNDLFTPCVTLYPKMFLFLEQGFFLSGSGSSVFKVHQ
>fig|195.2200.peg.1628 hypothetical protein
MNFQVKTLETFNPFESLNHEQANTEQILDFRVIDFKLLCSSVKPAKTKTYERKDFDLFYA
DDFFVKNYNTIVQKFLIEIYPKTQSFPFTVKLRSNSNLTHLKASINLTENFKYYPNLKFD
ILQNIYKIMIKQKFLILRLDKNLFDKIDDFILSIQKSPSIKEIELEIAKGVDKIEHKSDE
IIYHRDVNEECFDENINYDEGNYCKPIEKNELLFEYIYRILGKEGRNLRGEILHLNPIAF
LDNPFIIKDESIYTEELEDRIKYFSANYGFLNKDHTGYCIANNLKLSQIGLKTTGSIKTN
TDENINLEITNFDISDDAIKSGIVNVQASNIKVNGNVGATKLYGKNISIKGLTHAKSEIF
AQDIFITTHKGTLQADTVYIKNLENGTIIAKNVFVENCGWKNRSRKYLYLQFTNG
>fig|195.2200.peg.662 Phosphoglycerate transporter protein PgtP
MPPAIGALASVQTMEVVPAFAVGSCVGLRGFMSYVVGTSLGTKAIGWAVDYYGSWNAGLI
MLLSACILCILCSILCHFGAKKKEDICKK
>fig|195.2200.peg.1627 hypothetical protein
MQNYYDYLIKNQIKIIKLQKTKNPSAIEMKFSNLYHDIIKKYNHLSISYKKLVKLKYQID
AKLNFLNEMVYNVKIYIKAENIGEDNFLKFYPNTNTNLELKHHINLKDYEKVLYLEKGQQ
VSYIKSSHNYSESDIEEIKIIFEKLEKDNS
>fig|195.2200.peg.1631 C4-dicarboxylate transporter
MARGVIKTGLGEHLAYHFISILGKKTLGIAYSIAFCETILAPVTPSNTARAGAIINPIVQ
AISRSFKSTPEDGTQNKIGTYLSLVNFQANPISSAMFITATAPNPLVVDLVAQATNLEVH
LTWGQWALGMFLPGIAAMLLMPLVIYFLSPPEIKSTPNAKIFAKGKLEELGAMKGGEKIT
LGVFVLLLLLWAGALGFLFGISLDATSVALLGLSLVLVSGVLTFGEVLAEKAAWNTLVWF
SALVMMATLLGKLGVTQFLAEALGEFASAMGLGEISIMIFLSLAFLYTHYFFASTTAHIS
AMFFVFYSAGLALGAPPLLYAFIMIASGNVMMALTHYATGTAPVIFGTGYVSLKKWWSVG
FVISVIDITVMILVGLVWWKFLGFY
>fig|195.2200.peg.52 ABC transporter, permease protein PebF (cluster 3, basic aa/glutamine/opines)
MENVFNAQNIEFLMQGLVLTLKIALATCIISIIFGTFLAITKNYGDRFSRLLATCYIDIF
RNTPLLLWMLAACFVLPSFFPQMPQAFWGTIGFSLYTSSVMAEIIRGGLNSIPKGQFEAA
YSQGFSKFFTLFYIILPQTFRKVVPSLLSQIVTTVKDTAYLAGLQIAELTYNSKNILARL
TSFDEILATIGFVAVIYFAICFSLSMLVRYYAKKPLMFLRKYVF
>fig|195.2200.peg.1630 C4-dicarboxylate transporter
MAFSWAFYCCDYGSDFTSNAFWAVCMITIAIVALSGITTTQSSVRATHIKTLEGIVLRDN
SNIYKTTMDEAVEAATLQALINANISRNLKAKVDEILKSSTDVNYQIENLSKIYTKATSK
TSTQQLIDEIKISALNTSALDFLSQKSIDEKVDTAISNLKSKTGIKDALSGFSNFLI
>fig|195.2201.peg.1744 Phage tail sheath monomer GpFI
MAANYGVNFNISNGAASPIKVQSDTPIGIAGAIKGVSKEMIYTKAGYESVDSFPIFAFSN
VSKAKEFVNDLIKENNLQDFRLLDTLECINLQNVSNVIIISFFEESEESENTLTHIVNAI
EAFKKAKHKTGFSPDLIIAPYYSHEAGVKAKLESVASSMNITAIVDLYATNVGEAINTME
AFSSKRLIATWPQVQILNTQGKYAYVPQSPIIAGLIAHTDGDKEYGFSDSYSNRVMNGVT
GTEYFIEFINGFDCDAERLRNAHISTCILGEGYRSWGGETSHEDTIWQDLARVRTFDRIA
LAGQ
>fig|195.2201.peg.1800 Phage tail formation protein GpI
MNTLILNHHPKQSKAIDLSAKARFEDLKIESITNLAMRCDERLLPVLANAYDVSIDGLEE
KEARKLISKALLLDRYNGTTWAIKEALSAVFPTAVVKEWFNYGGKPYFFKVKV
>fig|195.2201.peg.1310 hypothetical protein
MIAYVHIGTPKTGTTTIQNFLFNQDKIKKYGFYYPKNFISKQQHWPLMTAVKTQKINLKL
LLAEIKGSKCEKVIFSSEGFSWVFNGKQNLVSLKKILKELGFKKIFIICYLRSVEDLLAS
LSMQDIKEARMPSYKMPPFSHYKNYIFNYKWLLQLWGEIFGKENLIVRLFDKNEFYQGDL
LKDFIHSIGLEWDDEFIIPPKQNESLDLISLELMTRIHNRVKQPYFFEIFCIKHFTSKDP
HLKFQPPKEIMQSYIDYFEESNEWVRKEFFPRKERLFPGKDLSNYKENYELKEMKPEYWD
RIAEFIADIVKTKNQTIIDKTNIIQNKDKTIAAQTTQINSLQIILKDSEAKFVQMRNLNN
TLNKTIQEKTTQLDQLQSKLSFQTQYGTAKQRIQNQLSYKLGQAMIVNSKSLLGYIAIPI
ALLSITISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKEKECLTYKLGEALIKASN
NWYGGGYIKLLLEIRKLKREFRKKANHA
>fig|195.2201.peg.1777 Replication initiation ATPase; bacteriophage DNA transposition B protein
MQLVELTKKFLSTQNISQNNL
>fig|195.2201.peg.1716 prophage MuSo1, F protein, putative
MFFGKPNKAIEYLQSKKPQTSFDYDEIMHETHNKVFTIAKLNDLNLLKDIQNSLIEALKN
GDKFETWKKQITPKLKAKGWFGDKVEVVNPKTGEVKNIKIGTSRLKKVFETNMRIAKAQA
VWENILQSNKEYVRWISLLHGNRRKEHLALHGMILRRDDPFWINNRPPCGYGCKC
>fig|195.2201.peg.1093 Uncharacterized metal ion transporter YcsG, Mn(2+)/Fe(2+) NRAMP family
MINKTALLGAAFLMATSAIGPGFLTQTATFTGSLLASFGFVILVSIILDIGAQLNIWRII
GISGKRGTEVANMVLPNLGYFVAFLIALGGFFFNIGNIAGAGLGLNIVLGISVENAAVIS
AIIAIGIFIFKKAGELMDKFIVLAGFVMIVLTAYVAFASKPPIGEALFRTFIPTQIDVIS
IVTLVGGTVGGYIVFSGAHRLIDAKLYGKENLNYINKAAVSGIIITGIMRVILFLAVLGS
>fig|195.2201.peg.1815 Phage DNA adenine methylase (EC 2.1.1.72)
FMLSYNDCELIRELYKDFNIKELKVRYSLNNNVLKRKESKELLIMNF
>fig|195.2201.peg.181 hypothetical protein
MIFKKIRVLKWQILSLIYKKDHYRYKIYMYNHQNKNFILKKYSHLINKKFSSFGMKKYPR
REEIGGDYCLFKYLYIPGIKAYNLGDYIQTIATRSLIELIDKNAKFHFYNRDSFSLYNKK
ESICIMQGWFADDYNFLPNERIFPVYIGTHFTKKMQEYFDVLNVDFKDFEIGCRDLSTLD
YFNKKGANAYFSRCLTLTLPKREVSAKQNSIFLVNLNHEMSSLLPDFIKKEAIEINQKAI
KIKNRNLKNEWQECYKEAQDILEKYASEAKLVITTALHCAAPCIALGIPVILLQEDKVYE
DRFSALKGILKPYTFNDLKDNRIDFEPKILDIEFLKEMMIKNLKLTLKKHMFTLNKDEEK
ELNSIRNKIAHFEII
>fig|195.2201.peg.1020 Alternative cytochrome c oxidase polypeptide CoxO (EC 1.9.3.1)
MTALDIFQIIFIFVVVLIGFVGMIWVISKDKSNC
>fig|195.2201.peg.1840 Phage tail sheath monomer GpFI
NDLIKENNLQDFRLLDTLECINLQNVFNVIIISFFEESEESENTLTHIVNAIEAFKKAKH
KTGFSPDLIIAPYYSHEAGVKAKLESVASSM
>fig|195.2201.peg.1309 CDP-abequose synthase
MKILVTGATGFIGTNFILQMHDRYEIIALVRKSSNIDKIKDYCKICYYEDFAVLKENLQE
EQIDGVLHLATLYLKHHRPEDLKDLIDSNILFGIKLLEILYLIGFSGWFINIGTFWQFYQ
NLSNNPLNLYAATKTAFLNIANYYTQIAKYKFVTILLNDTYGLNDWRPKIINLWKKSLET
KEAIRMSGGEQIIDMLYIDDVINAFEKCIHNFENKKNTNNVIYALHSKERITLKQLSNIF
EECAQEKLNIIWGVLPYSNRENFIPFEGGEKLPNWEQKIYFREGILKILDL
>fig|195.2201.peg.1757 putative lipoprotein
ISKYYLEVENIAKLCTGEKDERK
>fig|195.2201.peg.1798 Phage tail formation protein GpI
TTNVSFDERTLNTLERLIKDFKNVRSVLEAIEIEIESKNDSFNASAELSGEAIEILPFQT
TFLENEIKSTKNAFGVFICEISKTNIDFKGVY
>fig|195.2201.peg.1836 bacteriophage DNA transposition protein A, putative
SLSLTRLLWKAIDKFGKPDMIKGDNGKDYLSKDFQSLLDGLNITYDAAIAYAGEQKALVE
RRFGTLQHAGISKMHGHIGNSLAKREMIEQKTPKKERKAKDE
>fig|195.2201.peg.1829 Endonuclease I precursor (EC 3.1.21.1)
GEINGDRSNFRYAEAPTNLKYTQYGNCKVYTDFKAKRFYPANYSKGWIARSYLYMSKTYN
IRLSDQERKLMEAWDKQYPIDEKEKRIRELL
>fig|195.2201.peg.1850 Phage tail length tape-measure protein GpT
YEVFKWVFDKCALVFASFKDIIMSVASPLAEFLNSIWQGIGDFFYSIFGSLFEWFASKLS
WVGDMISSISGFIK
>fig|195.2201.peg.1853 hypothetical protein
FDAIEAVDKVLLNAEPSNGFRIELKELKKVYEGISDHGYLSIYARTLQSSFLPKDDFLRI
>fig|195.2201.peg.1845 tail fiber protein H, putative
INKKENIGVAKQLVDALRSELTKEIKSFIPELRVEKRIITAKYDYDRKKRQTVLVSLSNI
PSEVNMSTYLSKCANSGFP
>fig|195.2201.peg.1726 Phage major tail tube protein GpFII
GANYSSGVLKPLEISFKLAVVDPVLYAAFFHTTFSEIKAPLLFRESVHKGGKNYGISAEF
LGEFISISESDHESGKEVEAEIKMAVHFYMQRRNNIPIITYDHKNTILMINGVDMMSDVR
SNLTL
>fig|195.2201.peg.1822 hypothetical protein
MNLDFLNEFKLKNKDLNEKLEFLIPDFLVKKAITIIYANGGSGKSYLSAAISKTLCKDAR
VKSIVYVDMDNPLNVLNERGFGELILNESKFTYIHRSSLKTSAYELLEMIEGKGVAGSYE
GVLFVLDSLRNFADIDNDTK
>fig|195.2201.peg.1833 Phage baseplate assembly protein GpJ
VIKKGENKASGVLELDEFIESKERKTEFLQTPLPFVAKIKQLEFFKGGASEESDEALRER
AVMSVHRFSTAGSEKGYIYHALSASAKVASIKALNNGAGKVRVIIKSE
>fig|195.2201.peg.1821 Phage tail length tape-measure protein GpT
MMSNPIGLILGGIAIVAGLIIANWDRVKSWFMSFIEWLRPVWEPIYNAIKAVFNKCSGVI
GYFKNNALNIIFPFVGILKFIWKPIYEVFKWVFDKCALVFASFKDIIMSVVSPLAEFLNS
IWQGIGDFFYSIFSSLFEWFASKLSWVGDMISSISGFIK
>fig|195.2201.peg.837 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MLETSTEYSQGFGQVGYGDTAFKRWNMEVGVTGIVKYNNLLDSKQASIQAGKDININTQS
QDNARQINNSGKILSQGNIVSFGNIDNKSLSKEISVGEILEQIRVNGFFAKEYLGSWNTN
STYYFVDHESLLDALKYFSTTQAKNHQRESAWNALKDAAAKNSALNQCFSLLFGSDYASK
RFVPDQKEWNLDAKIVFKAKSEAVIASKGKLDLNAKEYNQDLVSSLDKNFALLDSDLKKA
TNSQDLILNSIPDLINSGLFTLENKTNDNITYEYTTNTSIIDESFKYFKSI
>fig|195.2201.peg.1710 hypothetical protein
KSLSNDPLIAMPKSLESFINKDLFSINAKIDLETNESLALGTLLISEDFGESFKKCPNED
ISAKENVKLAMLKDHALSSGVYGVLLAGEINLKGVHVSAVKKAFMQNLIINTKE
>fig|195.2201.peg.1720 Endonuclease I precursor (EC 3.1.21.1)
MKKIISVLILALSLLNAKSF
>fig|195.2201.peg.1813 Phage tail sheath monomer GpFI
TSHEDTIWQDLARVRTFDRIALAGQKAAFKAIDKKASELYFIKISIEELLRDLKGAKVLI
GYEVSWDEERNTDANVSAGKFYLNIKMMNNPIVKQITLEFIYSDKWASDLIKTISADS
>fig|195.2201.peg.750 Oligopeptide transporter, OPT family
MLSKFAVALAIFTTSVILATAAISNDNLQDLKTGYLVGATPWKQQVALLIGCVFGALAIV
PVLNLLYQAYGFVGAMPREGMDASSALAAPQANLMSTIAQGIFHHNIEWGYMAFGVFVGI
LMIIIDKILKGTQKMSLPPLAVGIGIYLPPAVNIPLVIGGILKYIVMQHLTKKYAKNSHK
EEKLASCEQRGTLFASGLIVGESIFGVIIAAITVFSVSMGGSESPLKLSFLNIHNNELLG
LIFFIGVILYFIKRIVKIH
>fig|195.2201.peg.1844 Phage baseplate assembly protein GpV
NKAKVAIGDMVTDFLSVFQSLANSYAVSFSPLRIGEQVLVIPVRGDLNSGVILRGLYQEK
HRAKNTDENTFNIDFEDGTH
>fig|195.2201.peg.1832 hypothetical protein
KLLNLEIELFTGLCDKNGNKIYEGDILYSFEDCSEDEAFKYKVVFKEEAFYLVECGDNGE
EYDEDLISEFRLTELEIMGNIHENAELLRI
>fig|195.2201.peg.1811 Phage DNA adenine methylase (EC 2.1.1.72)
MKINTDKFLKTSPLIKPTQTKLKAPFAWVGGKNYLAKEIIALMPEHKSYIEVFGGALSVF
YQKSASKIEVINDINDELINLHLCIRNKPQSLTSILHSMLVSRKIFHMLKNKEIKPRNNI
ERAAFYFYLISTSFGSSMGQFAMS
>fig|195.2201.peg.1743 putative lipoprotein
MNDKMRIFLLIIPFVFLSACASKDILIKTEIKEVKVPIKCPLKLPLKPLDKKDLESAK
>fig|195.2201.peg.751 oligopeptide transporter
MTIGLFITFYSFVSDANLNNYYQILFAFAGTFIAVLIGFFVAAACGYMAGLVGSSSSPIS
GIGLIGIIVSSLVIFFWVQIYLMILCFLNLQ
>fig|195.2201.peg.1787 Phage DNA adenine methylase (EC 2.1.1.72)
IERAAFYFYLISTSFGSSMGQFAMSKQRTPKRLCRDFSLYTKRLKNASIENKSFEYILKE
YDYNEALFYLDPPYVGTENYYKNTGGFGLKEHELLCNLLKNIKGKFMLSYNDCELIRELY
KDFNIKELKVRYSLNNNVLKRKESKELLIMNF
>fig|195.2201.peg.1751 Phage baseplate assembly protein GpJ
MSELLSANDSYFKQSFLKDIPYPKIIEELDFEKILKDLEELFKSFLKEDVELLESDPFKA
VLEALAYREMIIRARINESIKATYLHYASGSDLDNVVVNGYLIERLKGVKPSAKVEFKLN
SLLTYDVIIPKGAIFSNEKADIATLKEEVVIKKGENKASGVLELDEFIESKERKTEFLQT
PLPFVAKIKQLEFFKGGASEESDEALRERAIMSVHRFSTAGSEKGYIYHALSASAKVASI
KALNNGAGKVRVIIKSEDELSVDVVKEYLSADERRPLTDEVSVELAKKREFIVDAK
>fig|195.2201.peg.1725 Phage virion morphogenesis protein Mup30, F
HGMILRRDDPFWINNRPPCGYGCKCSIQGVSESELKLYGWKLSKQTPADLADKNFNYNKN
LGVEKLEKLYKEKISQISQNFIKLEALSLATKTKENAQSFQREKELYIWQKSLDDMVDEV
IIKENQKYPINFIQVGKIDKTTKEFLEKLNKKDLEDLYFTLSKNNLLHASPTRKASYNQA
LSADEIKQIVKVLDEAKEVYWDTKEESLVYFFDDLKNSKKVNKIIIRPDYKLKKFGKTNA
LITLGKVDKDTKESSKEYEKIK
>fig|195.2201.peg.1092 Uncharacterized metal ion transporter YcsG, Mn(2+)/Fe(2+) NRAMP family
MGLKIFGVVLFLAAISSVIGAAYTSVSFIRSFHPWIEKYNRFVVIFFIIVSTLVFYILGK
SPASILIIVGTINGWILPITLFIMIIAAHKKSVVGDYKHPKWMSAFGLLIVALMSYLSVL
SMIKLM
>fig|195.2201.peg.1788 Phage tail length tape-measure protein GpT
SLFEWFASKLSWVGDMISSISGFIKDALDFVGLGDDKEVKISQNEQTKEKIFATNTYKDE
LQAKSINHTPSFNNGNINVSVNGTFNIATKDGNFNMQEFANAIQKSVFDALRKQEQNKIN
TTIYG
>fig|195.2201.peg.1828 hypothetical protein
LNVVCNIREKLDESFNEEDKSLVIDIDEIVAKVCKELE
>fig|195.2201.peg.632 Tricarboxylate transport protein TctB
MFFFSEDTKVKWGNFILWKKLIVLTLAFLIYALFFEFLGFIICTIFLIFTITLLFGATLI
KAIVFSISSSIILYYLFNTLLQITLPFGFIFDNF
>fig|195.2201.peg.1847 Phage tail sheath monomer GpFI
VKAKLESVASSMNITAIVDLYATNVGEAINTMEAFSSKRLIATWPQVQILNTQGKYAYVP
QSPIIAGLIAHTDGDK
>fig|195.2201.peg.1824 Glycerate kinase (EC 2.7.1.31)
MSFEEIAKELNLSVTRVHQIYTEALRKLKSPKNKDKWIAIFETINLIKKE
>fig|195.2201.peg.1801 Phage baseplate assembly protein GpJ
DERRPLTDEVSVELAKKREFIVDAKLLLLELSRANEISEKINALQKDFDLSVDLALGFIY
KCLHQDGVYKSEILSIKEKIINEEEQELKDLPLANIIIADDEFATLSFSLSYEKAVL
>fig|195.2201.peg.752 Integral membrane protein
MFLAWGVFTPYLSSFEFDGVKNASELASSVWVAKVRLISTGAIAIAALWTLIELLKPVIS
GIKEIIKNVTISNTKSQESTD
>fig|195.2201.peg.1793 hypothetical protein
AFKGSNHIRNSSDCMYFLQKVANLEQGFEVLLSVQKERAGIKDQAFFINIKTLNIKNTDL
QNAKISDKEEAFIEKVLKLLKEKNLSTSEILLALDVSRSDNFSRNTLEKFKGIFWESELG
GENGRTFVWKSLKADNKDSNDKELSLFGDEL
>fig|195.2201.peg.1666 FIG00471415: hypothetical protein
MKEINIIDFGLMGKQISALFYLLGYEIGVYNKSKLNIYEFEKQIKLL
>fig|195.2201.peg.1837 hypothetical protein
MKNNPYFKESEFKCKCGKCELPQNVPSDELIDILCEIREYYNAPIIINSGYRCKEHNAKV
GGAPKSQHTIGSAADFVVKGVKTEEVHQYVLNTY
>fig|195.2201.peg.1665 Putative transferase
MCPFVTINANSNIGDFVLCNIYSSIAHDCKVGEGSILSPYATLNGNSSIGKNCF
>fig|195.2201.peg.1791 hypothetical protein
MDNAKEALKELFGISEVQAV
>fig|195.2201.peg.1719 Motility accessory factor
LAYAENGNSHPDDYQNSANYESQMYEHILTIAYGGNGKVETHSIWLLFKNWFENEMIPNT
RKMGITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAY
YKVYQSIKHCRDFSKILSNDFENIQSVYLSLNEKEEDINLAIKKIDEFKNKLENIKQMQD
LYEILSPLLIQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHIKAQENALI
KNILPLEEKLKERKLDKWMERVRK
>fig|195.2201.peg.1776 bacteriophage DNA transposition protein A, putative
SLSLTRLLWKAIDKFGKPDMIKGDNGKDYLSKDFQSLLDSLNISYDAAIAYAGEQKALVE
RRFGTLQRARLSQMHGHIGNSLAKREMIEQKTPKKERKAKDEYGFAKKTNQKLLHTFSEA
CELLEAEVIKWNMSKVRRKKGVKTPLELWNSCDRSIVKISYEEFLFNAGNKELRVVGKKG
INFESRVYKSALMPSVGTRVKCVQNIDNIKELFIYDLSGNFLCLALDESIAKLSKESYKM
LKKGYESEVKAIKEVLKKDEIAAFTKLNIKQDLQDLQSAFENSLVEAKEVHQKSLAKEAL
KTQRELEEIKNNANADELILNAKKEINNNESEFDMEAFVEKKYFAG
>fig|195.2201.peg.1686 hypothetical protein
MLHIAFSCSIEYIKYCAVVITSILMHGDHKEEYCFYIITSSSITKSMVDRIKAFEKKLNE
NYTVNISLFFINEDEYKNHPIYAGSTASFWRLKVAEALPVDVDKCIFLGVDVLVLGNIKK
LIEMDLQNKTVGMAPDCFNFKGFLRSMKSRDVEKLDFIFPYPEYYSNVDVMLIDLKQWRQ
KNISQQCELLFQQYIPKWVEQDLINAVLGDDIYELSPRWNFWIGGHYVISRLGKKITFKG
ESLKPYWKYTRSEFEQSERNIQIAHFTHCCRKPWVTPYSHLDQDFKFIKYPYYDTWWHIA
MQTPVFKKELIEIYRRIENNKVDVYQNTVVPQIKSLQTTIKNNEAKLVQMQTSNNTLNKT
IQEKDIIINSNTNQIDQLQNN
>fig|195.2201.peg.1771 Glycerate kinase (EC 2.7.1.31)
IFETINLIKKEKAKRENLIQGEKK
>fig|195.2201.peg.538 Integral membrane protein
MDFNSVLFSIGDKLPKDATSTVMLKEKFDRLNEDKQKEVVAQLPMIKLKSPALVFWVGTF
LFGAFGVGRFMIGDWVLGLIRLGITIVAMFCGILMITYSALGIIYGLLWLVNWIWWIVDM
FLVGKKLRKQNFEKIANIIVGGKIKCRKRKIKCRIFATNYLSFNLKLKL
>fig|195.2201.peg.753 Oligopeptide transporter, OPT family
MQKTYSLPELTLRGLLLGSILTIIFTASNVYLGLKVGLTFSSSIPAVVISMAVLSLFKTS
NILENNMVQTQASAAGTLSSVIFVIPGLFMCGYWSEFPLWQTFMICLCGGGLGVLFTIPL
RRAMVVESKLAYPEGRAAAEILKVANKDQSNKKGKQGIKEIALGSFIAAIFSLLSNGFKL
AASESSLAFIWNKMAFGFSAGDSLALLGAGYLVGLAGL
>fig|195.2201.peg.1838 tail fiber protein H, putative
SVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGVAANLDKALKTELTKLINKKE
NTGTAASLDAQLRDELKALINTKEDKGVAANLDKALKTE
>fig|195.2201.peg.1848 bacteriophage DNA transposition protein A, putative
AEVIKWNMSKVRRKKGVKTPLELWNSCDRAIVKISYEEFLFNAGNKELRVVGKKGINFES
RVYKSALMPSVGTRV
>fig|195.2201.peg.1113 Tgh102
MALIFPFLKAFYYEIARVTKQKYFIYAFNTYYLGLLTLIIGIGLVFLLASLVFWILAWVE
FKEFDKQEISNKEKFTIPTQKVIFDFDLKWIKITMVFLSLVLFFCFYWFKIYSNNYISIH
TERIF
>fig|195.2201.peg.1839 Phage tail protein GpU
MVLALGEFEFKALNFDNLERSLEYNIQSQNRLNNHNALFASSKESEKIKIQGKTLPLKGD
RNTYLDKLENMAKEQRSFILTGANGKYYGKFV
>fig|195.2202.peg.709 Uncharacterized membrane anchored protein HP_1479
MADKEDIVLEKPEDTLNEPRLDESLGEFKGQEGQAPEDEEFASLPEELPRENSDGGFKFT
RESAPEESSTFEEVKEDEPTPWYKDRKFMSLVGLSLGIICILVFTLFYLTFNEGKVKPDI
IASKPIEQPVVMPDESYNYNDMTRVDGMIQKANALYLKGEVEQALKVYEQIAVYNESLSN
YNLGVSQMNEGKFDEAFDSFKKAIANGENQSVAAINAAVCALKLNDKEKFKYYIDLAQVY
LPKEGKSKLYDYYLALINYYKGYYPEALQMLQRVNSEPYTDVAKYLSAKIYAKMDFDAKS
VQQLNTQGSFEPSLSLGLLYARMGEYDKAKIALNTAMKIERDFNQSLSALTLVDIKTGDF
QDMLLRLQDTYRNDEDKYKILDRYKIKVRLNKELFNIAIAQRNFSNDILKKQKDQFDLLF
YFAPYQVFDSKQASLYIKKANITNFVDDSSDGQSYLARSQALSSTNVKISNIINDALNQK
LRLANKEFQALLEDYPEHSILQYNLALTYCKGYFKKNM
>fig|195.2202.peg.1198 Uncharacterized metal ion transporter YcsG, Mn(2+)/Fe(2+) NRAMP family
MIVLTAYVAFASKPPIGEALFRTFIPTQIDVISIVTLVGGTVGGYIVFSGAHRLIDAKLY
GKENLNYINKAAVSGIIITGIMRVILFLAVLGVVSSGFILDKENPAGSVFHHALGDLGLK
IFGVVLFLAAISSVIGAAYTSVSFIRSFHPWIEKYNRFVVIFFIIVSTLVFYTLGKSPAS
ILIIVGTINGWILPITLFIMIIAAHKKSVVGDYKHPKWMSAFGLLIVALMSYLSVLSMIK
LM
>fig|195.2202.peg.99 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
MLKDKLLQDLEEHFETLGQVRNLAQNYDERLFNYLLEESKYKEEFKNRFFIFNKKVLIFK
INEFLTFLDLKNLSGSFTSYANKIGLANKTKSLLKTNNEVVLNFAFKDGIIKGGQSKDEQ
KTQEIFFNEILAHDEIDVLFDKKALQNFELIGEIKNLQEYLKNNPNLLIKGNNLLVLHSL
KKLYVNKIKLIYIDPPYNTGNDSFGYNDKFKHSTWLTFMKNRLEVAREFLRDDGVIFVQC
DDNEQAYLKVLMDEIFGRENFESCITHIVKPEGRMYGNVAKTHEYILVYAKQAAFLELNE
IEKKGHSFDFQDEFGGFNLKNLENGNFRAFNSKNRQNLRYPLYIDLSSKDKFDLLKVYVE
NKDNKYIKVLPRFVNNFECVWRWSKDKCKNEIYDLCARKSNNGEYLIFQKVRKTTTKVKS
IFYETEMITQKGTQEIKALFLGQQSAWDFRDKRGDKGDALQVEHLIPLDKEKDNLKENPK
VELFSTPKPEALLQRIIEISTNENDIVMDFFAGSGTTLAVAHKMKRKWIGIEQMDYIESI
TKERLKKVIEGEQGGISKAVNWQGGGSFIYAELMPLNAVYKEKIQNLNDEKELDNIYQEL
KTKAFLDYRVDINEILKDKEFENLDLENKKEILKLVLDSNMDYVSYGDIKDEDYALSKEI
IKLNKIFYGDENV
>fig|195.2202.peg.478 Membrane protein
MSRFFLYLLIILILALITFVLREKLGKKTKPFFWYFACDFYCFSSIF
>fig|195.2202.peg.627 Broad-specificity multidrug efflux pump YkkC
MVLNEMFIFNEAVSIIKLVLIAILLLSIIALKWVSKET
>fig|195.2202.peg.628 Quaternary ammonium compound-resistance protein SugE
MVVFYLLCFGYNCRAKNIKERIMNTNIAWFMVIFGGLIECF
>fig|195.2202.peg.1863 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
KTVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVNDGSTDENSLNIAKEYTLKDKRIT
LFDKKNGGQSTARNVGIEYFSGEYKLKNKTQTIKENSLIEFNIEGNNPYEIYTVYKSYKA
FNDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGV
>fig|195.2202.peg.834 probable integral membrane protein Cj0564 - related protein
MFWGVILAFMLLDLSGSYGMVALYILFIVLNLVLIYKIIRRKK
>fig|195.2202.peg.1360 hypothetical protein
MKLSDFDFRIWDGRKYVNNIKGGVYIHKKDTDVKCLNRNQACYDYEFQLDDLDNSNLEIE
LFTGYYDYKGNKIYIGDIIECLVFTNEKNSEIFYEIICFDMELGLCSKSSNGDGGYLFDL
RRHKNNKTIEDVYVVGNIHENKELLKG
>fig|195.2202.peg.1369 Phage antirepressor protein
MSALIPINNVNVVFEVVGDEIFANSLQIAEVFEKDHSNVLKAIDKLPNDEFKSSNFKYDS
YFDKKSEQRRMINLTRDAFSLLVMGFTGEKAYKWKIEFIKAFNEMEKRLRNIEYEKHDKL
AFRQSLGYKSQLKQQKEKYENKIKALKYDLEHKKELSFKRKLSKEELLELRKILARDYGI
LCIKEWEMSLVAEKIGKDTVFKAVLNKLEKELKYWQNYEEYEEKWKKILRSENETKRF
>fig|195.2202.peg.4 Ferric iron ABC transporter, ATP-binding protein
MAYLKIKNFKKAYGDKIIFEDINFSAKKGEFITLLGPSGCGKSTLLRCIAGLSQINGGKI
SLNDKDLTKLSPQKRNIGMVFQNYALFPNLNVFENVAFGLKIKKMDKKDIEKRVKKMLKL
VELEEYAKTYPHKLSGGQMQRVALARSLVTKPDLLLLDEPLSALDAKIRKHLRVQIKEIQ
KELELTTIFVTHDQEEALELSDRIILMNEGKIIQNSNANNLYLLPESHFVASFIGNYNIL
SPKELDSLGLKHDFKTRF
>fig|195.2202.peg.1371 Pentapeptide repeat family protein
MLDYNSWQEAQVELLEKKIKEMKMGILKRLDETIIIEDDRKSEKELVEYCILEGISLNDA
NLENLNLSGLDFDNVFINGASFKNTNLSNISSKNASFIDCDFSGVRLYGCNLLDTEFENC
IFENVDFRDCIGDMKNIFTVAIDTYVMNFSKTHLSLGCQIKTIREWKTTHIDDIEDEEQK
WLWGYYKDTIFEIIDKRLGVEND
>fig|195.2202.peg.1867 FIG00470627: hypothetical protein
KTGDETIAGIKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAGVKTFSVP
PVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAG
>fig|195.2203.peg.1809 Phage baseplate assembly protein GpJ
MSELLSANDSYFKQSFLKDIPYPQIIEEQDYEKLLKAYEELFKSFLKDNVELLESDPFKA
ILEALAYREMIIRARINESIKATYLHYAKGSDLDNVVANGYLIQRLKGVKPTAKVEFELN
TLLTYDVIIPKGAIFSNEKADLATLKEEVIIKKGQNKAQGILELDEFIQ
>fig|195.2203.peg.1802 Replication initiation ATPase; bacteriophage DNA transposition B protein
MQLVELTKKFLSTQNISQNNLSDRLGINKSYMVGYMKEGSGYKYASKVEPLLEKYIKSFV
EEKSVKELQTPFIATKDAKAINVTIESAMSNREMGVIIGEAGTGKSRAIKEYAAKNGTRV
VLFEATTETSKRMLLVGLENKLNICFKGSLDDKIRGIASELARTSKVLIIDESEHLPFRA
LECLRRIYDFSNTALILVGTRKLKNNLTGIGRNDYNEYGQLSSRIGAKWELKGLCYQ
>fig|195.2203.peg.1747 hypothetical protein
MANFDERLKNLETLHTKTAKLDLAELELSELKFNLLDFVKDDFKPNLERLLK
>fig|195.2203.peg.1798 hypothetical protein
MLKIFENELLELLKDFKAKMYLGEFEDTQNIASCINNLDASLLLDFEGESYKD
>fig|195.2203.peg.1833 Phage protein Mup29, H
QPKAKANYNEIIDYLDNQIRSVVLGANLSSQVSGGSLAAAESHNQIRKDLAAQDGQIVLF
ILNRAIKFFKEINHFKDELYVQFFSEAEPKSELCERDLKLFNMGFCFDEEYIKSTYNVEG
ELIRETLEKKDFKDLENDKKVFENKVKFIQKKP
>fig|195.2203.peg.1684 hypothetical protein
TAASLDAQLRDELIALINKKENIGVAKQLVDALRSELTKEIKSFIPELRVEKRIITANYD
RKYKKMVSLSNIPSEVNMSTYLSKCANSGFPEFAPNYSIYQLKGEHLIYYLNDQYVASYA
YQAISYAPSGSTNNNNY
>fig|195.2203.peg.1233 Ferrous iron transporter FeoB
MLQKIIILFESKFIPRSQFYTPLCEKSPEKEDLLYFINELSKKIITHKKEERNLTKKIDA
LLIHKFFGLPIFLFLMWLLFQLTFSLGQIPMDYIESGFNALGELVKNNISNTFIASALAD
GIIAGVGAVILFLPYNNFIFRHSSFRNHRLYVKSSFLTRWNFT
>fig|195.2203.peg.1739 Phage virion morphogenesis protein Mup30, F
SLATKTKENAQSFQREKELYIWQKSLDDMVDEVIIKENQKYPINFIQVGKIDKTTKEFLE
KLNKKDLEDLYFTLSKNNLLHASPKRKASYNQALSADEIKQIVKVLDEAKEVYWDTKEES
LVYFFDDLKNSKKVNKIIIRPDYKLKKFGKTNALITLGKVDKDTKESSKEYEKIK
>fig|195.2203.peg.737 hypothetical protein
MLNKKDLVNFFLSFSSNKNFKRYDFENYDCEISNYISEFKNGKHPDHFFNFWNKHSDKKF
FELKHPIYNHIKTRAITNVSFREGVFGNYIFFIDSTNKYYWILGIHFYLNILICDDGIYY
NPFSPKIIQDISKGKLKSISDIFICRVDELFFKDIDFGFSISCSRPAHYFRDYLPFLFAL
PYTKKIDDFDSFFILNEHKCLLSKDKKVFINPFDIKLQQDGYQEIFRNQLQEKIYNETPK
ATLDRKYDLVLWFCIGSEHRVWLNQTIGIVNILTEFAKYYNSILVYFDGMTAYSNGQYEQ
LLSKKDQKIYFDIVEEITKMKLNNKINMVFLGGQTYFQKIALCKNVNICYVPHGTATVVP
EICKIPGIAYWNGGLNNDRTPPNRKQLISASCSEQYFLSVGCNDDIYKRNYHIPWEYLFN
LSLDLLHNESIKKINIPEMIEVKFEWFFRNIDLINKQCSTIEKIYRLALLFEDIKEIEAY
NILINKIMSKLDKELQEINKIKQVKYKEKIKTKSSEIDKQIFYLEKKSQDKTTQIKSLQA
NIKDNEAKLVQIQNLNNTLNNTIKEKDQLINSKSTQLNQIQSKLSFQTKYGTAKARIQNQ
LSYKLGQAMIVNSKSILGYLIMPMVLLSIMISHKQEQKIYQEKIKKNPSLKLPPLESYPD
YKEALKFKNHLSYKLGEALIKASNNWYGGGYIKLWFEIGKLKREFRKKDNHA
>fig|195.2203.peg.1275 Enterochelin uptake ATP-binding protein
MIRLQNITKCYDQKAIISDLSIDFHKGKITSIIGANGAGKSTLLALASRLIKPDSGRIYI
DGMNLTLYKEQDLAQKISILKQQNHINLRLKVEELVAFGRFPHSQGRINLNDKMKIDEAL
EYMGLNTLRNEFLDSLKWGTKTKSFYSNDYRSRY
>fig|195.2203.peg.1817 hypothetical protein
PVIKTQIPSQTKINKDYEQNYLEYKKNQNKLYNANIDKFTSKLEQILKAKK
>fig|195.2203.peg.1792 Phage baseplate assembly protein GpV
MNELGIICDIKDNKAKVAIGEMVTDFLSVFQSLANSYAVSFSPLRIGEQVLVIPVRGDLN
SGVILRGLYQEKHKAKNTDENTFNIDFEDGTHLEYNSKTSTLKLDVTKD
>fig|195.2203.peg.1494 Selenophosphate-dependent tRNA 2-selenouridine synthase
MLNEVDFAEFQKENFSLLIDARSPREFLHSHLIGALNFYALNDEEYQEIGTIYKKNQALA
KARGASYICQNMSKHILELAHKFRIGDKIGIYCSRGGLRSKSIAVILSELGYRVVRLKGG
FKAYRSFLAHYFDNEINLDFFALCGNTGCGKTELLELLPHHLNLEKMANHLGSSFGDILG
AQPTQKAFEANLFYTLNSLKDFIFIESESRKIGEIVLPLKLYEKMQKAFKIHCFCSLEKR
IDRIQKIYQEKMTPLKFKECLAKISPYISVNLRQDLLKSYEQREWQRLIALLLAYYDKSY
KKPQKIDFELNTDDIVGGKIKCRKRKIKCRIFATNYLSFNLKLKL
>fig|195.2203.peg.1839 bacteriophage DNA transposition protein A, putative
AKDEYGFAKKTNQKLLHTFSEACELLEVEVIKWNMSKVRRKKGVKTPLELWNSCDRAIVK
ISYEEFLFNAGNKELRVVGKKGINFESRVYKSALMP
>fig|195.2203.peg.1842 hypothetical protein
MLINQSFEIDSCDDVELGIKRTSKLEYRISY
>fig|195.2203.peg.1816 Phage tail formation protein GpI
ISKALLLDRYNGTTWAIKEALSAVFPTAVVKEWFNYGGKPYFFKVKVSTTNVSFDERTLN
TLERLIKDFKNVRSVLEAIEIEIESKNDSFNASAELSGEAIEILPFQTTFLENEIKSTKN
AFGVFICEISKTNIDFKGVY
>fig|195.2203.peg.863 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MYRDHFGSHCGMEVVLANGEILRTGMGALPKAKTFAENKYGYGPYVDGLFSQSNFGIVTK
MGFWMMPKPEHYMLLSIKMKKREDLIPVVEILNYLEDSFIVGWPQYFSPLIHLMENR
>fig|195.2203.peg.1807 phage uncharacterized protein
MLFSKEELDEFLISNEQKHENTPNELKGAMQRKDFLEWMDELKNELKTQFLHESHLDPTL
KEERIKRASVDFDYFARTYFPHYFTIKGECGLHLHLNEVFTKIALKKESKGEKHAIAAPR
AHGKSTYTSQLFPLWCLVFNYKSFIVEISDAVELMEGMLEAIKAELEDNPHLKLDFPEVV
GIGKTWRVGEFVSNNGVKIKAFGSGKRLRGVRYGVKRPDLVILDDLENDTNVRSKDQRDK
LEDWVDEAVLNLGSADGSLDVLYIGTILHNDSVLSRKLKLGFWNPKVFRSIEEFPQRLDL
WDEYATLYRNTDFNTAHQFYLKNKVLMDKGAKVLWKEAKSLEDLMKLRAENLKAFNKEQL
NNPRSENQ
>fig|195.2203.peg.1785 hypothetical protein
MYVNVSIDASDLEDIDAHDLAELFEDLSTKEQEEFFGIIHKDNKPLERIRAILSNLSNDE
ALKLLKEL
>fig|195.2203.peg.1364 Hemolysin, putative
MYANALQSNTKLSEEEIKKLLENGAKYANENDLNLGQGLAKNQAVDQDMILYVTIKQNGK
NIMAPMLYL
>fig|195.2203.peg.1127 hypothetical protein
MYFLETKEAAQVFSVSTGALRLAVSRNSNKYEWLKVDNEKGGRGGKKLLFKISKDGLLTA
FNKQLISKNTLIYDEKMQKVKLSEIITTDNLKTANNSLKISNLNLTESKMNDDLAVLNLK
FENLSDEIKNNAREKLKALKQVEKYIEGGLKQKRALEICGISKIEIFRIRKAYKENGILG
LIDTRGLHRKDK
>fig|195.2203.peg.1608 FIG00469983: hypothetical protein
MEDNYDVNLFENQCIKYYEEAQKLKTIKSKQKRIDYINDLIKEAEINPKIDEKFVNFWKN
KVKEIL
>fig|195.2203.peg.1309 Uracil phosphoribosyltransferase (EC 2.4.2.9)
MKNIHHICHPLIEHKLGFLRDKETKPFHFRMLIDEISTFLLFEATKDLCLKETQIQTPVA
NAKVKRLDEKIMICPILRAALGMLDSIFRLIPDASVGFLWLVLMKI
>fig|195.2203.peg.1822 Phage tail formation protein GpI
MNTLILNHHPKQSKAIDLSAKARFEDLKIESITNLAMRCDERLLPVLANAYD
>fig|195.2203.peg.1274 Enterochelin uptake ATP-binding protein
MIIAQDTEFIMFDEPLNNLDMKHSVQIMQLMKNLVKDFNKSIAVVLHDINFASIYSDEII
ALKNGKLLKQGLKDEIIQEDVLRQIYDMDIPVSQIDGKKICIYF
>fig|195.2203.peg.1749 hypothetical protein
MIKIFLFFLHGVSAKKIMQKNYLRVFFRDARSRKKPFCEISLKSEAL
>fig|195.2203.peg.1776 Mu-like prophage I protein, putative
MLFINKENLVEVSNDKPIKVAIKGEWKGHNNGRFKVDDKDL
>fig|195.2203.peg.1748 hypothetical protein
MRPRSKKDQKKKALPLNKSLNLAFSQKLNLGFHITIKGLCVFSHRKKQRSPTMQCKARNR
>fig|195.2203.peg.1746 hypothetical protein
MTWKSHLAIGTAISLPFSPFGTPLAMLGSTAPDWIEWILKFFGIHVKHRGETHFLIIPLS
IIIISFVIDFNNFLFWFGMGYLSHWIADSLTISGVPISPLDKNKFTLFGGKIKTGEPFEF
ILAFGLLAISLLIAKPSVDFFIRDQPNFFNVYYMNYKELNEKKIIDNKEYLEKRFKFF
>fig|195.2203.peg.1768 hypothetical protein
KPLERIRAILSNLSNDEALKLLKELNNEFKSDEEWQKTIKSINGGNK
>fig|195.2203.peg.1813 prophage MuSo1, F protein, putative
MFFGKPNKAIEYLQSKKPQTSFDYDEIMHETHNKVFTIAKLNDLNLLKDIQNSLIEALKN
GDKFETWKKQITPKLKAKGWFGDKVEVVNPKTGEVKNIKIGTSRLKKVFETNMRIAKAQA
VWENILQSNKEYVRWISLLHGNRRKEHLALHGMILRRDDPFWINNRPPCGYGCKCSIQGV
SESELKLYGWKLSKQTPADLADKNFNYNKNLGVEKLEKLYKEKISQISQNFIKLEALSLA
TKTKENAQSFQREKELYIWQKS
>fig|195.2203.peg.1823 Phage baseplate assembly protein GpJ
KESKTEFLQTPLPFVAKIKQLEFFKGGASEESDEALRERAVMSVHRFSTAGSEKGYIYHA
LSASAKVASIKALNNGAGKVRVIIKSEDELSVDVVKEYLSADERRPLTDEVSVELAKKRE
FIVDAKLLLLELSRANEISEKINALQKDFDLSVDLALGFIYKCLHQDGVYKSEILSIKEK
IINEEEQELKDLPLANIIIADDEFATLSFSLSYEKAVL
>fig|195.2203.peg.1801 bacteriophage DNA transposition protein A, putative
GTRVKCVQNIDNIKELFIYDLSGNFLCLALDESIAKLSKESYKMLKKGYESEVKAIKEVL
KKDEIAAFTKLNIKQDLQDLQSAFENSLVEAKEVHQKSLAKEALKTQRELEEIKNNANAD
ELILNAKKEINNNESEFDMEAFVEKKYFAG
>fig|195.2203.peg.1609 hypothetical protein
MLYFIIAILIIIIALFIYSGFKTESKLKKIADGALTKQDLKEIEVISKYYEISLIEAAKI
HYGKAIITEEMIERLERPYRELYEQYKKLSINEQGKFLHNLLLNNQDEYAEAIRFIQIAE
ESVNIALKSKNKDIAESRRKLALEIEQKYRKDILKPMA
>fig|195.2203.peg.1814 FIG00471796: hypothetical protein
MDKIDAALESKEFKVIDEQIKEKLEQAFNQLLNDSNSYEELFENLQKEFSDISINILEEF
MFQALANSSILGYGD
>fig|195.2203.peg.1751 hypothetical protein
MANNELKDLAKELYIAGFDIFKIAKILNRNEKTIRNYKAKDGDWDKQKANLLTSKIKDKE
SASLYESFTEQMFCAIENINADEKMNAEKKTEAIARIGDSFSKMRKVARLEDPSSYRLNV
AKKVVEIIISHLKND
>fig|195.2203.peg.1610 hypothetical protein
MYKTTDILNRVYAILNITDDKEFCGIYEIKPNTLSTWRTRNTIPYELLLKISKEQNISLD
SIFFGKMRINDDNLQLRYYTDVAAAAGYGAINSKLEYTEIVISKKFACEALGLPPLTRLD
IIKVIGDSMEPFIHNGDVIAVDVSKNKLELVKNGDIVVINLDGEIYCKKLLKQPFVNEIV
LSSMNSFYKDIVVNIDQISCAEIIGVVCKAISIKTFENAIIKYE
>fig|195.2203.peg.472 Phosphoglycerate transporter protein PgtP
MDTFVYMVHFGLISWLPIYLLETKGFNKEQMGIAFWLFEWAAIPSTLLAGYISDKIFKGY
RMPPAIGAMVIIFFMIIGYFTSNNLYMVIFFAAMAGCLVYIPQFLASVQTMEVVPAFAVG
SCVGFRGFMSYVVGASLGTKAIGWAVDYYGSWNTGLIMLLSACILCILCSILCHFGAKKK
EDICKK
>fig|195.2203.peg.1554 FIG00471707: hypothetical protein
MNLWDKKAKSYARYNQKLNSIQEQSFKELEKLNINFKDKKIIDIGCGTGVWTLYLAKCKR
NHCS
>fig|195.2203.peg.1511 hypothetical protein
MLKNILISLILSFLLIACGGEKNKNSSELIRAQSQGLLKNHEAIFVEFKEAIVDFDEMSI
DAKINSKNSKILLTKASDSRFLLDLTYLEANQNYKIEFIYKNIPIVLEFQTGWIENFTYK
AQLEQDEEKAYLHLNYSFGSTYNWQFEDKTQEGLKITLDGKDLAFSLGEFSLDTDDIKLL
DRPQELVLTYDEKIMGFKEAKVLQFQIPSKSKNNDFRLISAEEKDQIATLKFSKELAENQ
AFQDFIQISPELNFRAWSIGKELKISANFEPGEKYKVKIAKGLKSNQGLINQGEEANITL
QKDLDPSLVFANDGVFLPSGAEYQVYIKSRNVKKIHLKVSQIFANNISEYLRYKNLVGKK
DDSTQEAFYSSDGFNYVAKNVIDKKIELKNQKNTWINTALDLSDLKGKTGIFSVSLSVDA
NDLDYKGENVYRIINKASVSKNLIFSNIALSAQNLNKQLVVHARDFSKNEALENVKIELV
SKQNQILQSQNTNSNGDVKFQIQEDDEILYILASKENQISVLRFSNPLSTDGYDVEGIKI
MR
>fig|195.2203.peg.1808 hypothetical protein
EDPSSYRLNVAKKVVEIIISHLKNDKDCVAKLVSLLESGVIEKEILAMDI
>fig|195.2203.peg.1803 Phage protein Mup29, H
MKKEIKPKREVILKNNSLINTLINSSYLNVLKISENDQKMIFKDLSFTQAHQSRRSVILA
KELQIVCENEKIKESFEYLFNPDLLSQILETYLYGLNVFEVNYKLKDGFYYPILKQRDFR
NFGFNENDELVYNGNGCEEIVEDKKAIYGLFGSNFLFKNGDALLTKLYFPVKLKNASLKF
WMEFLERFGSPWAVAKTDSDPDALASEIHQMLNGDSAVIDKEEELDLIQPKAKANYNEII
DYLDNQIRSVVLG
>fig|195.2204.peg.1767 Methyl-accepting chemotaxis signal transduction protein
DVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQK
SLSEIEANTNLLVQSINDM
>fig|195.2204.peg.15 Uncharacterized protein YgeA of aspartate/glutamate/hydantoin racemase family
MKTIGIIGGMSFESTITYYKTINETINNQLGNLNSAKILLYSVNFEEIANLQKNGEWEKA
AQILGECAKKLELGGADFILIATNTMHKIFDQIQKNIKIPLIHIAQSTAKILKQQNIHTI
GLLGTQYTMMEDFYKNALKKENINTITPNQSDMQELSDIIFNELCKGQMKENSKEKYLKI
IQKLKDEGAQGISFRLHRNWIVDFPRRYKYPNFRYSLNSRP
>fig|195.2204.peg.284 hypothetical protein
MFQSTDKKIQEQLNLWNFDAVEISYEEKLYLLENEYVDFLFQIGKFEKLYSFLKVFQETP
AWWEMTEISKDYVFFSFRKKLLQAVQFDFKNICFEKRYLACYILNSKISKQELNGKFCHE
LFYASIVCMENNKYKWGAYKEACGVISTAYYIKKSIDYFFYTTNDDFLDRMQDYMFILQD
FMKQNFYGASICYEQIGFLLKKKKLNIIYAMPKPNIAVLVTGAIRGKKWFESLKFLKDQV
VDPLNADIFLFSWNKKMLWPSIRNRSNWVYRRIPEIYNNIPEQIKNFNEFTKCFPNVYNK
LSEDLSIPFSKDELEQLNVFFNDIYLEDEKSFIAYHQKYGELNNLHKMLYGRKIAFELME
KYEKKFQKKYDFVLIVRPDLDYPRIDSAILEKINIGNVIATHELWPHHKEVLDYFFMGNR
EVIKKICDIWDAIQDSRLDFFRDSFRKDFHAQEALHKWLVFNNIKPIEPHFAYNVNVARS
ISSKSICFPNLQDELQKDILNLKKQDYSSDIIEQNIRFFSDVVQFYGQVNVCENDL
>fig|195.2204.peg.285 alpha-2,3-sialyltransferase
MNVCENDLLDRSRFYSAKARVKNHLAYKLGQAMIMCSKSIFGYLKMPYILNEVYKKHQVE
VNEYNEKIKTMTFLKIPSMECCEDYKEALKEKECLTYRLGEELIKANKSKYKLRYINFFI
SIYKSVKKFNSYQSKSNSK
>fig|195.2204.peg.287 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MSNININIQQCLENWNFYMLEKIYDLNIENDTLAKEYVLYLSYTGQYRKILQNYKLRKYF
ENLFSDSYRSEVDKLLKTNDGLINTEEYSNVSRESIGCYLLLNTIDNFKHTPEQVLDIFK
NYLVVDDIKISSYKIPKQSYEALLSKKFFIAKSIDYFEIFKDNIFFMKATVILSIIQWLF
PKENGSKKYYFRFSSRMKMVLVKAKLAQVKMLKLLFVFLVQ
>fig|195.2204.peg.421 Uncharacterized MFS-type transporter
MFLIEGGITVLVGVFCLFYLDSHPKDAKWLDVKEKTVLLKNIEICNSKAKDYSIKDIFKN
ILVWKFVFVYFCIQLSVYGVLFYLPSKIAQILQINVGFEVGLLNAIPWIFVFIALPIFTS
LADKKRSWNLYAILFLLLASLSMIASTFVANLAPFLFFISLAVIGFIVIQPIFWNLPTQV
LKGKGGAAAIALIGSLGNLGGFVAPTLKTYIENHFGVEFGLITLALIAVLGVLILVHLKM
TLN
>fig|195.2204.peg.420 Uncharacterized MFS-type transporter
MGHLKLTKLELVCKKISWRILPLIVLMFCLSMLDRTNISFVKSHIEMDAGISETAYALGA
GIFFVGYALFEVPSNLLLHKLGAKIWLSRIMITWGLVTMAMIFIQGETSFYILRFFLGLT
EAGFSPGIILYLSYFFPAIYRSKAYGIYQMGVPIAFVFGSLISGFILDYASNMYLKIGSG
CF
>fig|195.2204.peg.1766 hypothetical protein
SYGGYLSLLIAKIAPWYVDGVIDNSGSAVPPLIYILGREMEGGCDYVFNDPNTLIECFLK
THWTRKENSPYFFNNENYFIRTLLNKDHLIL
>fig|195.2204.peg.1768 Flagellin
KSADKTGVRATYDVKTTGAYAIKAGTTSQDFAINGVVIGQISYKDGDGNGQLISAINAVK
DTTGVQASKDENGKLV
>fig|195.2204.peg.1712 Two-component system sensor histidine kinase
EFLNFINDSKPIILEKSIFKELNLLNKKLLKTKEKILKNTQKNKKQSDKISLKNTQLASV
ISAISHELKNPLSVIDLSLEMLKDENLKDEKLKNELLEKISRQSLKLNALTHKLNFVFNL
NHEALQMQEFDLFTLCEKIVKNPGFERVILRGKSTRVKADEFLIEQVIINLLSNALKYSQ
KEVILIAQDQKISVLDFGKGIEKNQLKFITKKFYKIDTKSNNSFGLGLFLVKKILSIHKS
YLEISSTVSQGSKFSFKLH
>fig|195.2205.peg.1796 hypothetical protein
RTLLNKDHLILQSQKNKNIIYVSYHSDKDPLTPANFKQQTMQILKILGYDVSLNLIDENK
IDGKFIKNLDHGCG
>fig|195.2205.peg.1753 hypothetical protein
MLINQTFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAYKYFQEEDIENIKNLLNQFHFSYGEINND
NALFLANSLVKHVENLKMQNKLDHNFKLNFTSTFIPPNGDYQNYGIMAAIDHINALKDLV
KRFPKFADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSALPPLNYILGREMEHSY
GDYYEDFPHNRIIFFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVS
YH
>fig|195.2205.peg.1693 hypothetical protein
MNNNNIDNLKLYICNESYDYERVMKAFKGEQDLINKIQINQQNPNQSTKSKSINKIQDQS
TKSKSYRTKIIYDIRYNY
>fig|195.2205.peg.1738 hypothetical protein
LMMKFKNFIKYLNYKKLRNIEKLYFDLIVMIILSSVSFLFLAFKFLICKDILIFLQNYLE
K
>fig|195.2205.peg.417 RNA polymerase sigma-54 factor RpoN
MLRQKTTQAPKTKISQTLRSWLPILQANIEDLKENLDKFAEENPFLSVQEPIQTHEHNKN
YFDSFYKRNANSAFVDNKGLATKSVYELLNEQIIPPLFPTSKSQELAGKIVECLNHEGYF
EYDEEILKDYDINELERIRARFKFLDPVGVGAKDYKEAFYLR
>fig|195.2205.peg.1101 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVTNP
DSDEKGLNFGIYGKADNYDARTRDYFKGAVKANGLYVTPSYLDLTTNLPCFTYATPLYKE
GKFIGVLAIDILVKDLQREFENLPGRTFVFDSENSIFVSTDKELLKPGYDVSPVANIAKD
KKDYEPFRYVRPLDGTQRFGVCAKVLGEYTACVGESIDYIEEPVFKIAYIQIAIVIITSI
ISVLLLYFIVSRYLSPLASIQVGLNSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENI
LATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQTRV
GSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLASESS
KLQSAVQNLTSSSNSQAASLEETAA
>fig|195.2205.peg.416 RNA polymerase sigma-54 factor RpoN
MLIQDFENIQNYTKEPLYKEALAIFKRFSIPPFLEYFEDSRVIIPDIFVYRENNEIKVKI
NDDYYPEISIETDGLTHEYLNHYIKEAKNLVDALMMRKATLYKIGLMIVEYQYDFFMGKD
IKPMTFKDLALDLERNASTISRAVANKYLSCDRGLIPLRDFFAFALDEEGETSNVGVKDF
VANLVKNENRSKPLSDSKILELIKKEFKVDIGRRTITKYRKHLNIPSSTDRKKLYELEG
>fig|195.2205.peg.11 hypothetical protein
MPQTHNKNLKNELEDLRYELSIVLEAMLLYAGVKREKLESAIEAYIDNIEFKQRRG
>fig|195.2205.peg.1781 Motility accessory factor
QDLAFDEEGNSHSKGFSYGEQFSGEKTVPTLKAQAYAGKGEVLTHITWNDYRIKLEYLFA
CNEQKAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFK
EKIQKDQENAKRFLDDALALKQILENILSKDFLLPLEFLEKVYQNIENFNHSLDEDEFIQ
D
>fig|195.2206.peg.338 putative anion permease
MLASVIFIITLILLFWRPWNLPLWLIAIFGALFAFIFKLVNLEDASFVFDLVWDSSLTLV
GLIIFSFSLEVLGFFSFIAIRILRLSKLKNSHAIHTKKLMLFMLAFVFCLSALFGNDGTI
LIITPIVLALFSTLKNYKESAILSAFLLSVSFLCDASSNALIISNLTNIITANYFNLDFL
EFAKTMFLPNLFVLLSTIIMVFLIFAKILPKGLEINILSNDCISVKLFIFCVIYLIFFVS
SFFIGEIYNLNASFFAVSGALLFWFFVCFLKKKRGIENYQKCTLGYFCF
>fig|195.2206.peg.1278 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTHRYPFICIYGIGNALLIKNLSKHYKHLFVFESEIELFILALSTIDLSEE
LCSGKIYLVDIEEERVDIQLLILFDMKDMFEYLSLYEMFVNNVYCKKFYEDIWHKADELC
EKNIKVVIRNLNSSLCIGFECYSHLLQNIPSMLESIPFQRILSQRKNKFDNAIVVSAGPS
LTKQLPLLKAYQDKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKF
>fig|195.2206.peg.1131 hypothetical protein
QEYNKNPIYRVLYLFIGFYRFVGTVLECKEQ
>fig|195.2206.peg.1898 hypothetical protein
IMAALDHINALKDLVKCFPKFADLPKIYGGGVIWRILSLAHSKNSSLVCGWRD
>fig|195.2206.peg.1841 hypothetical protein
MWGINLLKTDIFNVKTDIFNVKNMVKTDIFNVKIKVVLLFKKLKLKQTKRAEIKM
>fig|195.2206.peg.1738 Minor pilin of type IV secretion complex, VirB5
MKNFIFGVNKAIGKSHPHKNGARLKSLDYNYTKEYNYNYEI
>fig|195.2206.peg.1905 hypothetical protein
GYLSLLIAKIAPWYVDGVIDNSGSAVPPLNYIIGRELEFKSKDTNGDMYMQGDHFFVSCF
LKTHWTRKENSPYFFNNENYFIRTLLNKD
>fig|195.2206.peg.1208 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
ESYPDYKEALKLKNHLSYKLGEALIQANKTWYKGGYVKILFEIGKLKREFRNRKI
>fig|195.2206.peg.1682 hypothetical protein
MADLEQVVNDLNLASQSLQELREKYDGALDLLDNKNTQITGALDSAKSNALQEIQTISDT
ATSQISQLKNTSLNLVNEAKNTATTEISNKKEEHKQELETKKNEYINKIVAKANEYDIAN
INAQVKAMDTKITQQINSAKTELNSKIDNKVTKTGDETIAGVKTFSAPPVSATNPTANNQ
VANKSYVDTVGNSKVALSGNQTIAGVKTFSSSIVIPNATANNHATNL
>fig|195.2206.peg.1771 Phage Rha protein
MSNTSIININNQEVIFENKDEQVFCTSLDVAKVFGKQHKDILEIIRSKIRNKEIQNFNGR
NFSPVKYRDAKGEMRPAYQLTKDGFSFIAMGLTGRKADKFKIEFINAFNEMERIIKNQYT
PKLENYNKYKIPNTFYKEIA
>fig|195.2206.peg.1684 hypothetical protein
MKNIQIYTETFVLKNIDNLSNPFSLNTPKPTYISEYINILGQLFLAGYIDFGSYCDEEDR
NKIDYPSNLSYYKEDKYQAWIYFRDNFFYQDKFIRDLDDPETLDEGGYSLILNDVSWDTP
QYWSQYNIWVATTPKGTKYFNEILAPKFYNKYKDLEVEIDDKGNIIRWIGKINR
>fig|195.2206.peg.919 Cytochrome d ubiquinol oxidase subunit I (EC 1.10.3.-)
MNELSSVDWSRAQFALTALYHFLFVPLTLGLSFIIAIMETIYVKTGNERWKKNH
>fig|195.2206.peg.1901 Motility accessory factor
LSNILLKESLKEIKSSKFELILGKDNLDINLKDTSDNTFLYENVIDELNTMLNTYNDKYL
LYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIW
>fig|195.2206.peg.1584 FIG00471065: hypothetical protein
MIYEKKKKITKKEIFSYAIFIAIIALICIFKNEIWEFVKFIFSNLDFICGNFANFVGEDN
IVFFPITTLLIVFTIAICAVWGLSNVLSLSLFIMPIFVAVFYIFNIDISLKNLYGSYFIF
LIIINGLSWSVNQR
>fig|195.2206.peg.899 hypothetical protein
MDIIIIKAITCIYAALNIGLFITSVLSVIQAV
>fig|195.2206.peg.1715 hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRN
LIQDTEKIQNNIKFGVSGEYIGNYFSTNSLKSIDEIFYENPDSNKILNYHVDKWIKEILD
LEISFTTNESIDIILNGFKDKNFSNYFLPSNISTGLNFATKIIIIGLSLKKGDIFIIENP
EIHLHPKAISKFADFFAFLVSKGIQVIIETHSNYLLSKLRYINFKKEFKDEDCIIYYKDQ
QTDFVPIFIHSGKFTNINREKN
>fig|195.2206.peg.339 putative anion permease
MKIIKNVPWGIFAFSFGLYMVVFALHKVGISDILIFIYDILAQNAITAIFGTGFISAFLS
SVFNNLPMALIGDLALKNFPQSMVYAHLLGVNIGPKLTPIGSLATLLWLGLLAKKGIEIS
FWKYCKFGFLITLPVLTCSLFALVLQY
>fig|195.2206.peg.1799 FIG00470597: hypothetical protein
MKDLKKLGFHIICSKGNRGALANLLLFNEISSFFKIIEKYDYNFKECQTVYDLLYEKRNL
LNIIDTIGIELCNKICKNLKEDDENFYHPKIFKKAL
>fig|195.2206.peg.1869 hypothetical protein
QEYNKNPIYRVLYLFIGFYRFVGTVNRSKLEPQSSINLI
>fig|195.2206.peg.969 Hemolysin, putative
MEVGVTGIVKYNNLLDSKQASIQAGKDININTQSQDNARQINNSGKILLKAISYLLEI
>fig|195.2206.peg.1835 hypothetical protein
MRTEYKHNPPIPYSLHDMRVKKIIIQDKTIVLEFEDGYEKLTEPFEQVEGNITIEGVDFD
CTCVMLQSKWGNYGKFNGEKLELERFIKRYKNYSFEIVDELYGLITAK
>fig|195.2206.peg.632 hypothetical protein
VDEDGKSQFDIFIDDIKDMLYV
>fig|195.2206.peg.1885 Motility accessory factor
NHQHIVVFEKDIEIIWIMFHILDFSSELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSR
IYFLELMSHYYERFHEDILGLNKKLAENFKNSIVSHGNDPLDALQGIEQFVYNLPQMITH
PSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPD
YVCMLERTEITAEFFNHDFGEFDNGICFIIKSIVHPNAINYLTKKTDNFTIVSTYASFIQ
YLKLDYFGYFNMGFSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQNSANYES
QTYEHILTEAYGGKEKIKTHHVWLMFKRNLEQDVQKIQKYLDTKVYNCTEGGARI
>fig|195.2206.peg.1627 hypothetical protein
MAEEKLLKSLADGVLKINESSIDVAVLENGVRIITVPTNL
>fig|195.2207.peg.1694 C4-dicarboxylate transporter
EISIMIFLSLAFLYTHYFFASTTAHISAMFFVFYSAGLALGAPPLLYAFIMIASGNVMMA
LTHYATGTAPVIFGTGYVSLKKWWSVGFVISVIDITVMILVGLVWWKFLGFY
>fig|195.2207.peg.919 Formate dehydrogenase-O, major subunit (EC 1.2.1.2) @ selenocysteine-containing
MANTFGYGAMTNHLGDIQRSKCIIIIGANPAVNHPVGFRHFLKAKEKGAKLIVVDPRFTK
SAAKADIYARIRPGTDIAFMYGMLKIIFDEGLEDTKYLDERVFGIDKIREEAAKWTAEEV
ENVTGISKELLVQITHEVAKNKPTTLIWAMGLTQHTVGTSNTRLAPIVQMVLGNIGKFGG
GVNILRGHDNVQGASDMACLSENLPGYYPLNEATWRYYAKIWGVDYEWLLGNFVSKDWMH
KTGLSLARWWAAALNGKDGNDAIDNAGTPLKALVVMGNGITSTAQQVKVKEGLEALELLV
LADPFVNEAGIIAERKDGIYLLPAATQFETSGSVTATNRSGQWRFKVVDPLYESMEDQEI
LFELAKKLGFYEDFTKTLRDEKGEIVWPENATREIAKAVRSIGLNGWSPERLKKHTLYWD
KFDEVTLEGKDEVVGEYYGLPWPCWSDKHPGSPVLYNTDIEVAKGGMGFRNNFGLEYEGE
NLLAKNAPINSPIDTGYPQITKDNIEKVLGITLSAQEKEKMGSTWSYDDSNIIATKCIEK
GIVPYGNAKARAVVWTFKDKIPLHREPLHSPRNDLVQKYPSFEDQKALYRVDTKFVSVQQ
AKDYSKEFPLNLVTARLVNLNGAGMENRASMYLTRLTPEMFCEINPELAKEQDIKAGDMI
WVHSPRNDLVQKYPSFEDQKALYRVDTKFVSVQQAKDYSKEFPLNLVTARLVNLNGAGME
NRASMYLTRLTPEMFCEINPELAKEQDIKAGDMIWVHSPEGTKIHVRVKFNPGVAKDMIF
LPFHFTGVMQGVDLTHNFPKGTKPYASGESANTVTNYGYDIMCQIPETKGGLCRISKDGV
>fig|195.2207.peg.1695 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
MSLQQVDQIISILSKQSKPYEWVIKEFKKIEELKDYELDLETFELLGLGLTLDKNNIFTL
QTRTKKIKEEIFCIVDIESTGGIKNGQILEI
>fig|195.2207.peg.175 Succinyl-CoA ligase [ADP-forming] beta chain (EC 6.2.1.5)
MNIHEYQAKAIFADNGIPTLKGKVAFSVEEAVENAKELGGSVWAVKAQIHAGGRGLGGGV
KIAKNLDEVKDYASKILGMNLVTHQTGPEGKLVQKLYIESGANIVKEYYLAILFNRMAEQ
ITIIASSEGGMDIEKVAKESPEKIAKVGIDPQIGFKMFHGLEVAKVLGLDKDESKKLISM
IAKLYKLYMDKDMNMLEINPLIKTAEGDFYALDAKCSFDDSALYRHPEIAELRDITEENP
AEREAAEFGLSYVKLDGDVACMVNGAGLAMATMDIINYSGAKPANFLDVGGGASAETVAK
AFEIILRDKNVKVIFINIFGGIVRCDRIANGILEATKNVEVNIPIVVRLDGTNAAEAKAI
LDSSNLKNIKAATNLKNGAELVKSLVGSRIKNEYIG
>fig|195.2207.peg.1569 TrkA domain protein HP0282
MNHILIIIDGILAKHFLERLCFEKGLGYFFTIVCQNEENINLGANSEYIEFHHFDPTSTA
RLETLMNKSFKQAFIYMQDEFETKKTYEALRSLDANLEIEIMDFWGLNINDVHTNLADAR
MTLSRRFMDFLPDIALTAYCVGLGVGEVMEVKIPAGSIFAYRHISSIQQKRWRIVLIYRN
SKIYFVKPSFVLQPNDSILIVGDPAVLQSIFHNIRGKAGQFPLPFGSNIFT
>fig|195.2207.peg.1678 2-methylcitrate synthase (EC 2.3.3.5)
MSISEATKKTGGLAGVIAGQSAICTCGLGNGLNYYGYSIEELAQNAEFEEIAYLLQFGEL
PNAKELENYKEKIIAQRALSENLKNVLKAIPKEVHPMNLMQTAVAALGALEGENEDFSDQ
DEKIIRLLGILPSMLCYWHHYVNFGKEIDFDSNQTSIAGYFLEKLKLEAPKEDFIKAMQC
SLILYAEHEFNASTFTARICASTKSDIFSAVAAAIGALRGPLHGGANEAAMHLIESFK
>fig|195.2207.peg.1592 Hydroxymethylpyrimidine kinase (EC 2.7.1.49) @ Hydroxymethylpyrimidine phosphate kinase ThiD (EC 2.7.4.7)
MGKDLYNAVSEAKEYVRNAIYYSLNLGKGCGPTNHFFRFLNEK
>fig|195.2207.peg.1748 Flagellar hook protein FlgE
AEGFFEQYNISDDGSIVAQFSNGKNAIVGKLALYNFINEQGLVAMGDNIFAATANSGDAS
FIMKDGQVINTAKFKGGFLEQSNVDLSAELSNLIVTQKAFDASSKSITTSDQMIQKAINM
KR
>fig|195.2207.peg.1054 Domain of unknown function (DUF332) superfamily
MNLDVLPTRLKDHALKGEFKDFRECHIFGDLVIIYKRDDKILSLYRIGRHQDLFKKY
>fig|195.2207.peg.1622 Uncharacterized amidohydrolase HP_1481
MSKIAALQFPTLALSESRLDYYLKASKDSGANLVVLGEYVLNSFFTELLHMPKNMIKEQS
EAKKESLIKLAKKYELEIIAPYVSVEAKSYKKLCLKVTPNGVKSYEQQILMPYEHWNEEK
FFSNKTPSELKIFTFNYEKLKCALLFGFETHFDIFWQQIMAKKIDLVIVPSACTFESKQR
WEEL
>fig|195.2207.peg.981 GDP-L-fucose synthetase (EC 1.1.1.271)
MQQNSKIYIAGHSGLVGSAILNELKQQGYKNLVFKTHFELDLTNQKAVADFFEREKPEYV
ILAAAKAGGILANNTYRADFIYQNLMIECNVIHNAYLHKVKKLLFIASTTVYPKNATLPT
SEDQMLSGDLEYTNKPYAIAKISGLMLCESYNLQYNTNFIAITPTNLYGNNDKFDLEKSH
VLPGILRKMHLAKLLNEKRYEDLLNDLKFDSIEEAKNYLKKFGIDEDNVEIWGSGKPTRE
FLHSQDLANACLFIMNNIDFKDLKGDNTEIINTHLNIGPHKNITIKELAELIKNIVGFKG
KLVFNLNRPDGAMQKFTDCSKIHSLGWKHKIDLEKGIQMMYEWYKNNQETQNNNNSSIRW
GGGD
>fig|195.2207.peg.1763 Flagellin
VGTGLGALADEINKNADKTGVRATFTVETRGMAAVRAGTTSDTFAINGVTIGKTAYEDGD
ANGALVSAINSVKDTTGVEASIDANGQLLLSSREGRGIKIEG
>fig|195.2207.peg.1750 Beta-1,3-glucosyltransferase
MSILKKTKKLFKDPKLFFKDAIEKKVFWLSKVYKKYLP
>fig|195.2207.peg.1193 TrkA domain protein HP0282
LQSIFHNIRGKAGQFPLPFGSNIFTLIDMKKMSEDTQERLLDTTLQLVKKSNAKKFFIRV
LNPKLGALYDKMKQLSDEQESIFFDFFNTDFANLNSFLENNDIGIILTDFKHFEQEKKTF
FELKIPILKIGEGKFENIQNAVILSTNETELENNANVITDLSKQLDFDITLYYYNPNLQN
TTDMEEYFGSLSKLYDKNIQIISKNDENPILSLSYRADLLQFVSFEKELLEGEFSKSLST
NLNRHYSKMRQNYQLFIPVE
>fig|195.2207.peg.1746 Hemerythrin domain protein
MKIQWSRDFSIKNMQLDKQHELIFEIAEIANDLALKIQDNDVQHKNDLKQILTKLFQYVK
IHFKDEEKFMESIDFPLIEEHRKSHQILLKKTKELLEHSNDIIKMSFELSTLTKDWILDH
FANEDLWIANFTKKALHLQEIHYNLEQYIKLKSIRQDLKTEKNL
>fig|195.2207.peg.1646 2-methylcitrate synthase (EC 2.3.3.5)
AIGALRGPLHGGANEAAMHLIESFKSVEDAIEGVNKKLENKELLMGFGHRVYGLGGDPRN
TLIKVWSKHLGGDDLLFKISEAIEALMKEKRPSLPPNADFYSASAYHFMGIPTEYFTPIF
IMSRVSGWCAHIKEQRANNKLIRPSSEYIGVEPRKFVKIQDR
>fig|195.2207.peg.973 Arsenical-resistance protein ACR3
MDIFSYFLGLVLGIIFPNIALFWNLFEYKSVNVVLTLCLILMMYPPLAKVDYTKLLKVFD
SKKVILLSMILNWFIGPLLMFILAFIFLKDEPLYMQGVIIIGLARCIAMVVIWSDLAKGD
REYTSALVAMNSIFQILFFSTLAYIYLDFLPKLPGQSTLATSLDIDFSALSKNVLIYLEF
LF
>fig|195.2207.peg.1570 Uncharacterized amidohydrolase HP_1481
RAFLNSTNILRVNRIGTTKDEWSFYGDSMLINAFGEIESRLGSEEEMLIIEPKKSDEARK
LWGFDKILKNF
>fig|195.2207.peg.944 Lactam utilization protein LamB
MAVLDENLALALCEAVASFDENIIFLGLSNSAMNEAAKKKGLRYANEVFADRAYNDDGTL
VSRKLEGALIHDENLAIKRVIKMIKESKVTSINGKEIDLKADSICVHGDNVKALKFVKKI
KENLTKEQIQIKALNDFIN
>fig|195.2207.peg.849 Beta-1,3-glucosyltransferase
MILNFKKLRKLRTNPKLFFKDAIEKKVFWLSKVYKKYLP
>fig|195.2207.peg.1605 Inner membrane protein YihN
MQNAKPIRWFTFIVLVIGGGGTVFKLSSLKDAFYVPM
>fig|195.2207.peg.1762 Beta-1,3-glucosyltransferase
YKGFTQYTIISAVYNVEKYLDDYFNSIINQRLDFKKNIFMVLVDDGSTDNSANIIKKYQK
KYPKNIVYIYKENGGQASARNLGLKYMQENNYKAPWVTFTDPDDFLDRNYFYEVDKFLL
>fig|195.2207.peg.1753 Motility accessory factor
PDYVCMLERTEITAEFFNHDFGEFDKDIVFICAGVVHPKAIEYLKGGNRKYLIMPRYLYF
PIYIKLNKYFYFLYNTPSVAHMSYFLSVLLNHKNIILIGQDLAYAENGNSHPDDYQNSAT
YESQAYEHILTEAYGGKKEIKTHEFWIFFKQILEAMIIKYHITTYNCTEGGARIEGTIEK
PFLWACENLLDKNLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIEHCRDFSKILSNDFEK
IQNIYLNLNKKENDLNLAIRKIDEFKNKLENIKQMQDLYEILQPLRTQFELNLARIYVLN
PKTKEDAFNKS
>fig|195.2207.peg.1378 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDI
EIIWIMFHILDFSSELQSARLMVLNTNKLEIQDYNELCSSKPFFQFSRIYFLELMSHYYE
RFHEDILGLNKKLAENFKNSIVSHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKN
LSDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVCMLERTEITA
EFFNHDFGEFDNGICFIIKSIVHPNAINYLTKKTDNFTIVSTYASFIQYLKLDYFGYFNM
GFSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQNSANYESQMYEHILTEAYG
GKEKIKTHHVWLMFKRNLEQDVQKIQKYLDTKVYNCTEGGARIEGTIEKPFLWACENLLD
KDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIEHCRDFNDNFIKVYDKIKNSFTSLQNS
QKNEIFIQEIIQDIDKTKTQIDELYNTQKDLIQILGPLLTQFELNLARIYVLNPKTKEDA
FNKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRK
>fig|195.2208.peg.1565 hypothetical protein
MIVSKAYEIDSCDDVELGIKRESKLEFKLWYDDEKTPEALVFVVQGMGDDISSIQYVGDY
MVRQFNTAVVGVNYHCIGNRPQTGSTFYLDDIDKLILKVSCEAADIKLPYDVDKIQDYK
>fig|195.2208.peg.1566 hypothetical protein
MSEIFHFVNNQIIEGKQKGNFTPNYFLNLHVSLQPAKNEYQNFGIMQAQDLLNVTLYLKK
YAPFDTMGGIPVIMIGSSHGGYLAHLAAKIAPWLIDGVLDNSAYAKFLWRVVGFGKEIDF
MQYSEFATFDFFHHIKTHCSTKTFWTSNSSSPCFFSPARRKIRNLLEEDHLLEQSKYLKT
CFISYHSLYDEYVSLKEKTMFYEELEKLGFDVTLCSVTKESQVDGKFIKNLNHGMGIPVK
LLIKKELPLMLEKIKQNSKKDYKEKCISYPCEDLLYQFSEKDDKMSLKIDKI
>fig|195.2208.peg.1415 formyl transferase domain protein
MTYSYIYIIGTGKVAKECQKIANDFFRQEVNFVKNIENLDDFFKNLKNCLIISANNFYIF
KKECIQKNTIINYHNALLPFHRGCNAHIWSIWENDKKTGITWHMVKESIDTGDILVQKEI
KLDNNCTALSLLNAQHKLALTLFREALEILKNKAFKMQISGGGYHKKLSLPNNGYLDLT
>fig|195.2209.peg.1423 hypothetical protein
MNLGFCTKNFDYLARDNILELMTIYNMGINSYSIAKNLEMNEDKSLIQVPLFERYIIGRK
FVVKYNNEKQRYELKSTFCEF
>fig|195.2209.peg.1956 conserved hypothetical protein
IIYYKDQQTDFVPIFIHSGKFTNINREKINFPTGFFDTDLDKLMEIR
>fig|195.2209.peg.899 hypothetical protein
MRERMSIKAIRICVKDSVKMRFECVECKIGRNGRWGIKGVINEGINEGINEGIKGEKKTF
LFKGVKRFRLGIKMAILLTKLMYGRYKIF
>fig|195.2209.peg.1777 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYI
>fig|195.2209.peg.1495 alpha-2,3-sialyltransferase
MKKIVLLGGSNSILSDGIPKAMKANKDINFINLALGGSASLQNVYEIIRKKR
>fig|195.2209.peg.1932 hypothetical protein
MDKAVNMKSPKMKLINKIAIGLGVAVMFALILLSCLLINIYNIGIKHIILSFIISLVCLF
LVLLLINATNKPFKKTYPKKDNCYDTHFKQSGISKYSTLSLSNPFYNNLYSNED
>fig|195.2209.peg.875 hypothetical protein
MKIIGFNLGIANIGWALRENDKIIDCGVRVFDIPENPKNGNSLALERRENKARMKIVKRK
KARMLATKTFLKKELNVDLSKLFLIGSTQSIYELRAKALSSLISKEELSAIILHIAKHRG
YDDSALKNENGTIIEALNKNKEAMLKFKSVGEYFYKNFVQNKEVKKIRNTTEDYSNSVPR
SLLKQELDLILDKQKELGLIKNADFKEKLFEIIFFKRPLKDFSNKIGNCIFFENEKRAAK
NTISACEFVALGKVVNLLKSIEKDIGIVYEKDSINEIMSIILDKTSISYKKIRDILNLPQ
EINFKGLDYSKNNVENSKLVDLKKLNEFKKALGDGFANLDKDILDSIATDITLTKDTVTL
KEKLKNYNVLNAEQIEKLSELVFNDHINLSLKALKQIIPLMYEGKRYDEACELCNFTIAK
NQEKSEYLPLFEKTRFAKDISSPVVIRAICEFRKLLNDIIRRYGSVHKIHLELTRDFGIS
FSDRKKIIKEIEQNEQSRIKALETIKELKLEETSKNIQIVRLFEDQKGICPYSGLKMDLN
RLDELVIDYIRPYNRSLDDSYSNKVLTFKKLSDLKQGKTPFEAFGEDEKLWAEINERIKE
YNGKKRFKIFDKFFKDKKPFDFTEQTLQDTRWLTKLVASYLNEYLSFLPISEDENTALGY
GEKGSKQHVILSSGMITQMLRNFWYLGFKNHKDYKNNAMDAIIVAFTTNSIIFAFNNFKK
ELDLAKAEFYANKISESDYLLKRKFLPPFSGFKEQALEKVKNIFVSHSLKIKNKGTLHDL
TPLKIKELKNTYGDLDLAVKLGKIRKYNDKYYANANGSLVRADLFVDKKNKFHAVSIYKA
DFSTKKLPNKTPATTSNGETKEGIEMNENYNFCMSLYKNTPISVKIKGMKEPIICYYHGF
NTSGSKITYKKHDNNYHNLSEDEMVVFRKNDKESIAVGKILEIKKYSISPSGELSLIENE
ERKWFRYFCSKNKKKHW
>fig|195.2209.peg.1933 IncF plasmid conjugative transfer protein TraG
LKQSMKRFYFLFFSTLFFAPSFLFGATNIANSNLIYTWGYGDVMNEIMQAVKGITTETDY
IVNAALAISLLLFSIKKAMDGQTNPVFEFGKMFMLFAVVWYMFLRAPNDNNHRFMIHDEV
TSKDYVISQIPIGIGKSFALMTQFEKVILEAMEKHFSTPQSTNFSNAGLGFSLQVMSTLP
SVKLSAIDATLQKNIDFYFRNCVSVGILLNQQGRNLFQNSDNLIQDLFTNIGNGSQLTPL
FENNNNIEKQSVVPCSDAGPQIVEMIKNDTDEAMKIHAALLGMANDMANYEQKFLGAAQI
YNEQAVSARSYLQQSMIMLASQDAIINTAKSVGLNPASVAANTAYADQQFYASMQAQGHL
AQTYLPLAKAYLTAIIIGLSWLVALLSIVFGSYAHIKMFFTLCIWIVLWTPILCIINFLN
DFNLMKVAQVITGGKAALSLGDNILIFKEVANRSNFMNYLVMSTPVLAYAIAKASEQGFV
TFASGLSQALTGASRAAGSFANQQALSTQTSIAAPRGDEVWAVGAGVASLQYARSIDGAV
TKFNTQSVMGDNIKNSEISNANMTGTNVDGMMSGAKLSAGAMTTVNSVSQANSDAWNKNF
NDQYSHMSQSGRASALNEAKGFMEKGDEAFKKAFGNNFGQEVEKRTDLSETEKANIKAYA
RVQAGGSLFGTEAVGGVEGSVSNDHARNRTLSDKEKVAYNETMERASLKTLSTTKGMDSS
WSNTLSGGDSTAYSKMVGYAQSYTQTEQGIQSVSTNNIDNTLNVVARDLAAGDNKDFSSL
NTAQQNEYFAKAGNYVSDMIKNDPAQLAQYNSQYGAQSIVSPNNTTMPHAAGMNFKTIDG
SERSVLNQSNLNQDQVNQSSKRTSNTTTMPDSQEVKGVAVKSNLNNEVGEKIKKANHLID
GKTGDPAIH
>fig|195.2209.peg.1422 hypothetical protein
MKDIKNYTDKELKEKIMQDLEDEFRILYKKL
>fig|195.2210.peg.964 conserved hypothetical protein
MIKKIISNGRKRIFDTTNTK
>fig|195.2210.peg.409 Alpha-L-Rha alpha-1,3-L-rhamnosyltransferase (EC 2.4.1.-)
MNNVVAVLLATYNGEKYLKEQIDSILNQTYKDIKIYIGDDCSKDSTIDIIKTYKDLYPDK
IIYYQNNTNMGFIKNFEKLLQCCSENYMAFSDQDDIWLSNKLEEQMKEIAKMEKKCNLPI
MCHSDLIMIDEDKKILYKSFFKFKKYKINLKKDLGHILGPCGVMGNTMMINKVLKEKILP
FPKNINFHDYYIAIMCELFGKRITLSESFVLYRIHQNNTSNSKLNIKKKKNTTLPYLERD
LDWLDNIKQDLNKNDLLIVNKFQCYIQNPKKIYHYLELLRYNLVKRNDIYRLKLFFRFLY
NIYWKING
>fig|195.2210.peg.410 hypothetical protein
MDEFFKIINFNAIGNQNDGFLVALESNKNIPFEIKRVYYIWGNQQDKIRGKHAHKDLEQV
VVCVKGSCDFILDNGIIQKHIHLNQPSQGLYIGNNIWREFTNFSKDCVVMVIASKYYDID
DYDTDYLEFKSRVNCR
>fig|195.2210.peg.407 dTDP-4-dehydrorhamnose reductase (EC 1.1.1.133)
MNRSIAILGSNGQLGKTFQELSSLYKKKYSMFFFDKTQINIQDKNLLEYFIDKYKFDYII
NCAAYTDVNLAEVKQKEAYMLNYNSVENIADLTKKYNLTFIHISTDYVFDGKSCTPYKEN
DKTKPLNVYGKSKLRGEQVIVDINPKNTIVIRTSWLYSNYKGNFVHTVRNLGKKKGEINV
VYDQIGTPTYARDLAEVILNILPYIQNDKPEIYHYSNEGIASWYDFAKEIMKLSQLGCNI
KPIESKDFLALAPRPSYSVLNKQKIKEKFHIEIPYWRDSLEKCISMLQKDDIL
>fig|195.2210.peg.419 Beta-1,3-glucosyltransferase
MSSSLPLISVLIPAYNHQNYIQECIESVICQDYGNLELIILDDGSSDLTWLKIIELEKKC
RVRFSNFSSMTRQNKGIYETLNELIELSNGEYIYLLASDDRIQNEKAISTLYQIISHDDK
IVLAVGDSEIIDCNSNRIAWDIKQNIVKFNEGYNTFWEYFCYRHPRVKKISKDMKNFGSY
RTLVKGNYIPNGYLIRAEKLKKIEKFTAKAPMEDWFMHLQLSKLGRYKFTKEILFSYRWH
DENTIKNKKQNKIKNKITKRYFGILCFLYKFFKKEGLKL
>fig|195.2210.peg.1709 Motility accessory factor
MDGKGEKVREELFLKNTQALFEVDEFLACTLRSLKYLTFALIQDENGINFKKDDIFLYEN
PNKELLENLTLFKTEYNKYPVLFFYGFGNGMFYKTLCKNKQHKHIIIFEDNLEILTLAFH
LFDFSEELKKEQLILFYTPNINTAQLTTLFTYEIIQKSVKIFNLFIHNDFYQQFYSTQIQ
NINTQLIEMIRFIVLNKGNDPHDSLVGIKHTLDNLPKMLNHGIFQEFLKERRAKVKNAII
VSTGPSLIKQLPLLKKYANKATIFCADSAYVILGKYGIKPDYVCMLERDDIVSKCFDNDF
GEFNKNILFILASVVHKEVLDFLEKDQRTYMLVHRPLNFAASLKLDEYGYLGVGHSVSNM
IYELAGALRFENIIFIGQDLAYDEDGSSHPKEHIHGSQGEEIRGEKYTLAYGGKGKVRTQ
LTWNLFRQAFEKDIFWAKEKLNITSYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFD
KLEPLSLNKQNEFLLKA
>fig|195.2210.peg.413 hypothetical protein
MEIINYKLMEEILKQGYRNICFMLPAKNIGGGTKKFCELAILLSQCSQLKIYYMDYKNGY
PSYLLKDSDVEIIEYKDTDIFFPLKECIVVTNSTRMILLKQMDKNNKVFFWHYETTPCGW
NTLMLNNETDKFMKLVDDNNAMSFLDWASKDSLNRYFPFKIFKKLNYWYVTVDPKKTHSN
FKIINKDEINICWLSRLNIDKITALLNLIEIFAHYSTDKKKRLHIIGDGVSRKAVEEFCS
KYKKYIEFVFTGSLTLDDANFYMVKNADIVFGMGVSILESAALKIPSVILFASHNRYTDN
EALWLKDSREKCIALTIEQKKDFNANYTSIIDIINSVYNEPSGKLKYGLLCYRYYKENHC
DVNKLANNVLLFLKNSTLTFDKISKCLKFIPYCLIEIERKKIFNKTFFLKIKHLNGIRYR
LLGMTFFRVKTSGSQITYFLFGINIFSKEVKKCFRFPVALRDESHIYKKEKK
>fig|195.2210.peg.1723 Motility accessory factor
HKNIIFIGQDLAYAENGNSHPDDYQNSANYESQMYEHILTEAYGGKEKIKTHHVWLMFKR
NLEQDVQKIQKYLDTKVYNCTEGGARIEGTIEKPFLWACENL
>fig|195.2210.peg.415 Sugar-phosphate cytidylyltransferase
MNIALIIAGGIGARMNQSIPKQFMSINDKPIIIYTLEKFEKHPAIDEIVVVSLNGWENLL
LSYAKQFKITKLRYITKGGASGQESIKNGILKLKEFYSDDDIVLIHDAIRPNVSEEIISD
AIRVINEKGSAVSVIPCNEAMLVSNDDGINSRQTYDRQKLKRTQTPQGATLKALKDLHDK
AEKMGIKDSVATCTLMIETGGEIYFSIGSEKNIKITTMDDIDIFKALLK
>fig|195.2210.peg.277 Transcriptional regulator
MAYTIKKVEKETKISAHTLRFWAKKGLFPFVQKDENSVKYFSKSDIEWAKWIEWLRISGM
PIEQVKHYIKLCSLGIKTAKERQEMLKQTKKKLQN
>fig|195.2210.peg.420 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKKNIVLLGGSNSVMINGLQRGLRKYSKEVNRDFYNFSLGACTAVQNFYELHRKKNLDVL
ENAELIITESNVNEIYQNYEEHEKLPLNVINDNLFLLYRKLASYQSKILVLILPYLLGNF
KIINDMHKFWIRYFKLNYIDVHEYYEKNNLHEFGKRIDMAHQLPRVMYELGKNIIKNIDQ
MKNNNKESNIEDNLIIVNMGDMETFKKVNPRNSLYNEIAYRLDNKKVFIFPKKYSGYKIL
AVHTWNYNKCFCRDENLINYSKIIFKNKTKTLSKDINFLNLVCEFHHDFFIDDNTTVFVS
KMIADIEEHHQAVRFWNKKSKWHEYVDVVSFILIKNHNTNLSFFEQSNIGTIGYDFNHII
PDILTYKEIIDEYCQMMDPIKSQSLQNQVNILNSRIILLEQNKIKLSQEKDKIQQDNTSL
IQALNSLPIKKQQLEISNLEQDLINKKLQTKQLSKKFGIKMNDFMPKITIINPSSAKARI
QNQLSYKLGQAMIVNSKSFLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLPPLES
YPDYQEALKEKECFTYKLGEALIRANNNWYGGGVYQTVV
>fig|195.2210.peg.1667 Formyl transferase domain protein
MLYESLILFLEDNVKAYKQKEKKRGGGVIFRNLDFSFKKSA
>fig|195.2210.peg.418 Aminotransferase
MIKFLDLHKINSRFQEKINCEIKEVLDSGWYIHGKKNEEFVKNYSNYCGVKYCLGVANGL
DGLRIMLKASGLKQDDEVIVPANTYIATILAISDNGYRPILVEPDIETYNIDPKLIEDKI
TPKTRAIMVVHLYGQAAPMEEIYTIAKKYNLIVFEDAAQAHGATLNGKKVGSLSKAAAFS
FYPGKNLGCLGDGGCITTNDEELYYKMQALSNYGSHKKYHNIYKGFNSRLDEIQAAILNV
KLAFLDQDNQERRKIARWYLNGIKNPMVVLPRMQDEMSHVWHLFVVRVKNRDAFQAYLSK
NKIESIIHYPIPPHKQEAYKEWNHLSFPITEQIHNEVLSLPISPVMEEWEVSKVIEVVNQ
YDE
>fig|195.2210.peg.412 hypothetical protein
MQNIAFDLDGTLLKSFIRHRYVLELALQKNSISLKLSDLIEAKRNGMSNEKYLLSKNLDI
KLIRNICDYWCYHIEDIRFLELDRLYVNSYNILIRNRLKNNKLFLITARNNSKNCNIQID
KLGIRGYFNEIFIIPSNSSSYQSKAQILMQNKVDYFIGDTEVDKKAALISGVKFIPCYHG
FRSKLFLDKVSV
>fig|195.2210.peg.293 Type I restriction-modification system, specificity subunit S (EC 3.1.21.3)
MTNLPQGWEWKSLGEICFITDGTHKTPNYIETGIPFLSVKNISKGFFDLSDVKYISLEEH
NKLIKRAKPEFGDILICRIGTLGKAIKISLEFEFSIFVSLGLLKPKVKIISDYLVYFLNS
CFIEE
>fig|195.2210.peg.417 L-ribulose-5-phosphate 4-epimerase (EC 5.1.3.4)
MLGDLREEVLEANIALVKENLVVLTWGNVSAINDQEVVAIKPSGVEYSKMSSNDIVLLDL
DGKILKGQLKPSSDTPTHLALYKQHPEIKCIIHTHSPYATAFAQAGKSIQALGTTHADYF
FGDIPVSRSLTKEEVEVDYEVNTGKVILETIAGRNALDIPGILVKQHGVFVWGGTIKKAL
ENAVVIEQIAYMNYLTLNLNPSIESIPKFILNKHFYRKHGNNAYYGQSN
>fig|195.2210.peg.1333 FIG00470572: hypothetical protein
MTAYLHIGTTNTGNQEKQGFLMQNEERLLKKKAIFIQKALEWQIGIGLW
>fig|195.2210.peg.280 Arsenical-resistance protein ACR3
MLGFIDRFLTLWIFLAIFLGLILGIIFPNIALFWNLFEYKSVNVVLTLCLILMMYPPLAK
VDYAKLSKVFDSKKVILLSMILNWFIGPFCLCLS
>fig|195.2210.peg.507 Uridine diphosphate glucose pyrophosphatase (EC 3.6.1.45)
MIFKNLKELPFCESNYIKPKRFSYESNGKFCTWDFIESKDSVSILLYHKELKSFIFVRQF
RIPLWYHQKQDKNYHKDENMGYTIELCSGLVDKDLPLEQIAKEECIEELGYAPKEFEKVG
DFYTGFGSGVSKQSFYFAIVDENDKIWMVAGLMTSK
>fig|195.2210.peg.414 hypothetical protein
MKICFFKIPILDIVKIPNSSNYNIYLFKIPFLSIRSKNNCINVNFLLLQRIWAKIKLKIT
GFRKSYANYKYKRSLKLKYYKGKIRILLVAVPRPSMWIFDYIYKALEKNGKFEIFIVIPP
DPAYEYTMMCKYAKEVYDELSSKGYNPIMGYDFATKKNIDLRKAINPDIIFYSDFHKMHF
HKDFYITNFLDKVTVLNDYGFSVMQEEKTVNFELNNTVDMYFRPTTIHMKMAAELMENKG
RNTVLVNGSPKLDAIFDKNHIFKDVWKTQPKIKKRIIWAPHYSDGHPKDMYQYNAFYELY
DFMFELALKFKDEIQIAFRPHPVLESRLVLKWGKEKQQAYYDKWEKLENGQYYPGDFLDL
FISSDAMIMDSCSFMGEYTVVNKPLFHTVGSTTRIKLNDFGNEIYKFCYKTEHNLKQDIE
KFIKEVVLEGKDVYKTLREDFIQRYYISKDGKNASESIVEKIVNYIEKGGL
>fig|195.2210.peg.411 hypothetical protein
MVNLLILSAGTNAAFHFIRTIKNNFQDKIRVIGVDINEKHTIASSIFLDSFYMAPLSSDE
KYYGFILNICKKERIDYLMPILDIDQIMFYKENLDLNEINVKVLGLSKKVACLYADKEKM
NVFLAKNHFLVPKSFSLENIKDNEIYFIKPKKGYGSIGADIKLGADIKKINDICNFLIQE
ICSGPEYTVECFRYQKFISCITRERIQAKSGVCVKAKVCHMDEIEKMVKKIAQIIPECPM
FFNVQFMKNRENRFVITDINLRLAGGMSISKTAGWDEASAIAHVLLGSDLDKIESCFGFS
HKECFVMRAYCDYITECN
>fig|195.2210.peg.405 Glucose-1-phosphate thymidylyltransferase (EC 2.7.7.24)
MKGIILAGGSGTRLYPITKGTSKQLLPIYDKPMIYYPLSVLMLSGIKEILIISTPKDLPR
FQELLGDGRELGITLCYKEQPSPDGLAQAFLLGEEFIGNDDVCLILGDNIFYGQGLSYLL
VDSVERAKNNSRATVFGYYVNDPERYGVVEFDQQGRVISIEEKPEKPKSNYAVTGLYFYP
NDVIAKAKLVKPSDRGELEITTLNQIYLEEERLNVEIMGRGYAWFDTGTHDSLSDANIYV
QTLEKRQALKIACLEEIAYNKGYITKKQLLKLAEPLLKNQYGQYLAKISENIYFK
>fig|195.2210.peg.291 Type I restriction-modification system, specificity subunit S
MNFFIAKGEGSSIPQLTIPKFKSLQIPLPPLKEQEQIAKHLDFVFEKTKALKELYTKELK
DYEELKQSLLNKAFKGEL
>fig|195.2210.peg.292 Type I restriction-modification system, specificity subunit S (EC 3.1.21.3)
MGILDESFAKIDESIKILEQDLLNLDELMQSALQKAFNPLKDNAKENYKLPQSWEWKSLE
EISENISAGGDKPKNCTESKTAKNQIPVYANGVNNNGLVGLQIKLPL
>fig|195.2210.peg.1553 conserved hypothetical protein
IKYLENNEICITLINIENGEFNNFRFNCLENFKDDTYKFLTEKTQNNLMEIKNSIVQFSY
QENLLLGVAQ
>fig|195.2210.peg.508 Uridine diphosphate glucose pyrophosphatase (EC 3.6.1.45)
MDGGGVDDEQIEAVFVKINEYEEFSKKIIHTPLLDFAYLWFLKEKKELCLK
>fig|195.2210.peg.408 dTDP-glucose 4,6-dehydratase (EC 4.2.1.46)
MKNLLLTGTAGFIGSNFVSYFLEKYKDYILINLDLLTYAGKLENLKECQNNPRFKFIRGD
ICNQELVQFLFEEYNIQGVIHFAAESHVDNSIKNPEIFIQTNINGTFNLLNIAYKHWMEK
PFVYKDKYQNCRFHHISTDEVYGTLGECGFFTENTPYAPNSPYSASKASSDMLVRSYHET
YGLNTIITNCSNNYGPKQHDEKLIPTIIRNALAGNKIPIYGDGKNIRDWLYVLDHCKGID
LAFHGGRSGHTYNIGGRNERTNLQIAYKVCELLDQYRPKDISYKTQITFVEDRAGHDRRY
AIDASKIENKLGWKADENFDTGIIKTVEWYLKKYE
>fig|195.2210.peg.416 dTDP-glucose 4,6-dehydratase (EC 4.2.1.46)
MYFQDKIYINNFQTIKKEYFDSLQSSNILITGATGLVGSCIVDFLMYLNEYFKYDINIYA
VTRFSSKAFERFSSYANYCNLHIVECDLSKEIPNIDVNIDYILHAASNTHPELYAKNPVE
TMCINFIGTLNILKFMQQNYRKSKMIFLSTLEVYGEMQKNKKYFCESDIGKVDFNLSRSC
YPESKRTCETLCQSFIKEYDLNITIARLGYIYGPTVDLSSSKADVQFLKCALEQKNITMK
SKGIQARSYCYVVDVVSALMFLIINGKNGEAYNIANKESNITLKDYAVALANQADVKIEF
CEPSDIEKEGYSTVQNSTLNSDKIEQLGWRPQFSLREGVGFTLAIKKNIKGN
>fig|195.2210.peg.279 Arsenical-resistance protein ACR3
MFILAFIFLKDEPLYMQGVIIIGLARCIAMVVVWSDLAKGDREYTSALVAMNSIFQILFF
STFGLYLSGFFTKITRSKHFSYKFRYRFFSSK
>fig|195.2210.peg.1331 hypothetical protein
MLLKDELDVLLVYSFSPDFLAPALSSLIHKNLGLSEKTLCFDNIAFCPGFLQGLMQAFSL
LDNENIKKIAFICASVKSKKIPKKDKITYLSNSDSASVILLEKSNTKEKAFFSQKIFSKL
ATEETFPLKCFKEANDFIDMDKNLTFSHLNENFPRFFDDFFDNFKLDKSKIGEFFFGSAN
NFIKTKLLKLLN
>fig|195.2210.peg.406 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13)
MQIIDTNFNDVKLIKKELFFDNRGYFTEVFHQKKIIEKICKNIDFVQENESCSKKNTIRG
LHYQMHPFAQTKLINVIRGRILDVIVDLRKDSPTFLEHIKITVRAEDNILLFVPRGFAHG
FIALEDFTKVSYMVDNFYNPKSERGILYNDPQLKIDWGVNDSEVLISDKDLYLPTLEQIQ
DFFDYNVDYYE
>fig|195.2210.peg.1725 Motility accessory factor
QDKAVIFCADGALSMLEKEGIIPDYVTNLDCRDLAMKFFQNKENKTSLNVLSCATHPSLV
HFLDNKSVVLRDDPLYQRFNLNDFGYIDTGTHVSHFSYT
>fig|195.2210.peg.92 Acetyltransferase
MIAREINLKEDLEKIYPLIKQLRNNLSLEDFLEKFQLAKKTQHYKLFAYEEKGAFKAACG
VMPFNVLYHNHCLYICDFVVDEALRGKGVGQSFFKKIQIWAKNKDMKNWN
>fig|195.2210.peg.1694 3-oxoacyl-[acyl-carrier-protein] synthase, KASIII (EC 2.3.1.41)
LNFKEIKNDETLKNYGDVTINKLAFDLANYEWRKGGGIKQVFMASFGTGITFNAMSLKID
FSKIKNFIEIIDFNT
>fig|195.2211.peg.1710 Motility accessory factor
MTFTPTQKELFNKNIEALSNLFLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDI
EIIWIMFHILDFSNELQNSRLMILETNSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYE
RFHEDVLELNKKLAETFKYSIISHGNDPLDALQGIEQFVYNLPSMITHPSYKELLSKRKN
LSDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVCMLERSEFTA
EFFNHDFGEFDKDIVFVCAGVVHPKAIEYLKGRNRKYLIIPRYLYFPIYIKLKYFDFLYN
TPSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2211.peg.5 ABC transporter, permease protein 1 (cluster 1, maltose/g3p/polyamine/iron)
MISNFSGVPLAFAFIIVLGSNGVVNVFLKNLGIEPFVSVYANFGVNIVYVYFQIPLAILL
LLPAFKSLENSHLNACKMLGGGNFLYWLKIALPLLAPALFGVFVILFANAFGAYATIYAL
SSGNFNVAPVRIAALIAGDINLDPYMASALSIIITIIMLVVTFIANFLSKKYHFKVL
>fig|195.2211.peg.6 ABC transporter, permease protein 1 (cluster 1, maltose/g3p/polyamine/iron)
MKEKFLAFLSILPFFIVFTFFMIAPLIWIVFNAFYVEEDEIYSLANFIHIFESKFYLQSI
INSLQISFISSIFGLLIGLLASYSLFVLAPSKICKFLFFFKYHDK
>fig|195.2211.peg.50 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MQRFYKRFISLQNLRPRVLGEKALFGVMPDWNPAEIIGLRPKRLAFSLYKEIITDNIWAY
QRDNYGYKDLRSHPLIHSFLGIPYVDVRLSFNSFIPKKLDENIAQKLVNFYLDKLNKNHE
LHDKIEFDIVYSCYDFNSSKKLQELLNHGFNENELKRLEFSLLELTNKIINPQSGLYLKD
IKKAYRLKERYDGIIDSNFSLIDKIYWLIEECKRYGTLPFAGVARAAFVAMQLLNSLVEI
NFISKEEKNDFLNSLNTVSKNLSKQTNNLNSCTKNQFLIEFGHLRAGTYNILSPRYDENF
ELYFEINQKDNNVYLEDKAFILPEEKMKALNTLLKEHGLEISACEFFDFLKQSIEGRELL
KFEFTRLLSKAIVYIEELGKYYDIKKEDLAHLDIKSILNLYSSLYSINPREQFLEEIARN
KKEYKLTQAIKLPSLLCNTEEIFSFYNHSIIPNFITQKSITAFTAKENDKDLEGKIVLIY
AADPGYDYLFTKNIAGLITCYGGANSHMAIRASELGMPAVIGVGEENFEKYLKAKKINIE
CESEQIFCL
>fig|195.2212.peg.1372 ATP-dependent DNA helicase UvrD/PcrA/Rep, epsilon proteobacterial type 1
MPLSRLNEEQYLAAFFYNSCFLRKKMPLSRLNEEQYLAATANFGHNLIIASAGTGKTSTI
VARISYLLSQGVSPQKIMLLTFTNKASKEMISRLGKYFDKNITGKILAGTFHSTAYTLLK
SANKDVVLKQASELKTLLKSVYEKRTFRHLSDIKPYQSSYLYDIYSLFQNKAYDQDFYHW
FCVNYEDQSIYAEIYEDILKEYSEEKKRFNYVDFNDLLLNLKTLLNEKKYEFDEILVDEY
QDTNALQSSLIEAFESKSLFCVGDYDQSIYAFNGADINIIGGFKQRFKDAQIFSLNKNYR
SSRSILALANKVILNNERLYPKELIVTRKDEFKAPSLLTFEELFDQYQNIAKMILTSGVS
LEEIAVIFRNNSSADGIEVALREQGIASVRKGSGSFFESLEVKAFSAMLALVVNPKDIMA
FIHLVQYTKGVGGVLAKEIFDALLKLGHGSLIRGFLEPDKSVNLQNHQKRNYQLGLFADL
EELASENRFKFESEFNAHPILKLSKINDLCAKNLEKIYFFLKKAMETKHSLVLVNLICEN
SFYKEICEELAIKRATNKAGQVDLLRKKENLEKIETKFNVLKELTKNYSDIYKYYNFLTL
GASEMSNGKGVNLLSVHASKGLEFDLVFVIDLAQGRFPNQKLMSMGGSLEEERRLFYVAV
TRAKNILYLSYAKYDKNKKTAFTPSRFLIEAGLCKGELTID
>fig|195.2212.peg.1209 hypothetical protein
MSHLCEVFLKDDARYTNLERAIPHFKRGMMDIYIKQSSEIFLY
>fig|195.2212.peg.1454 Coupling protein VirD4, ATPase required for T-DNA transfer
APLVPFESETLRLSTETSDFDLRDLRKKKMTIYIGITPDQLANAQFILNIFWSQLILLNT
KELPQSNKELKYTCLMVMDEFTAPSRIPIYQSAISFMAGYWLRSLMIYQSNSQLETQPPL
GYGKEGAKTLLTNHACQIFYAPREQEDAEAISRILGNTTFKTSSRSINSGGNGGGSRSIS
EASRALMLPQELREMPFENELITIDSGKPILCNKAFYYSDSYFMDKFKAVSKSLSGIKKI
PSRKQLEDAILKGECKIKIQIIGENNEKNVA
>fig|195.2212.peg.1806 Flagellin
GSQSFSSGTVGLTIKNYNGIEDFKFQNVVISTSVGTGLGALAEEINRNADKTGIRATFDV
KSVGAYAIKAGNTSQDFAINGVVIGKVDYSDGDENGSLISAINAVKDTTGVQASKDENGK
LVLTSADGRGIKITGSIGVGAGILHTENYGR
>fig|195.2212.peg.1774 Flagellar biosynthesis protein FliP
MKKILTLLFISGFFSVIFAAEATIPTVNLSLSA
>fig|195.2212.peg.1401 Coupling protein VirD4, ATPase required for T-DNA transfer
MQDNKSIQIIFLAVASFILTYLITPIVFFFLNKVKIMKAIEIYNINFTLQAIANGYPKIW
LSLSITFGICFVVFSVLVLSLKAKKSQFGEARFANFNEIKKMNLFGDKGIIIGKYKGKLL
RFGGQQFVALGAPTRSGKGVGIVIPNLLEWQESAVVQDIKQECFDYTSKYRKEILKQEVY
LFNPFSRQTHRYNPLTYIDMSDKEHCDSQLMDLANILYPLDGDSTSKFFNGLAQNLFIGL
CYLWRDLQLTDMGKEFQKSFNVDVGNFNFYNILQLSKGFSLKNEEKTLRGFDDTYNFLVY
CEILDEATIRRLETYFNINSDATKSGVMSSFNAPLVPFESETLRLSTETSDFDLRDL
>fig|195.2212.peg.1143 Excinuclease ABC subunit A
MNDTIKIIGAKENNLKNIHLEIPKNKLIVFTGLSGSGKSTLAFGTLYAEGQRRYIESLSA
YARQFLDKVGKPDVDKIEGLTPAIAIDQKTTSKNPRSTVGTITEI
>fig|195.2212.peg.1508 Na+-driven multidrug efflux pump
LRASGDAKFPFFSGLVFMMGVSLPVGYVLCFHFNLGILGVWIGFCADEFLRGMVNSYRWK
SKKWQGKALV
>fig|195.2212.peg.1279 Argininosuccinate synthase (EC 6.3.4.5)
MKNEVKKVVLAYSGGLDTSIILKWLQDEYKCEVVTFTADIGQGEELEPARKKALSLGIKE
ENVFIKDLREEFVKDYVFPMFRANTIYEGEYLLGTSIARPLIAKTQAQIALQTRADAVSH
GATGKGNDQVRFELGYLAFNPDLKIIAPWREWDLNSREKLLAYAQKHGIDISKKKGKSPY
SMDANLLHISYEGLVLEDPAHAPEEDMWRWSKSPKEAPNESEIIELDFQKGDLVAINGEH
LSPAGLLSKLNELGAKHGIGRLDIVENRYVGMKS
>fig|195.2212.peg.1751 4-hydroxy-tetrahydrodipicolinate synthase (EC 4.3.3.7)
PRMILISGEDAINYPILSNGGKGVISVTSNLLPDMISKLTHLALEENYKEAKKINDELYN
INKILFCESNPIPIKTAMYIAGLIESLEFRLPLCSPSKENFAKIEEVMKKYKIKGF
>fig|195.2212.peg.1796 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
YYDSALKQTQSFGEAFATPMPNFEEFWAKNEPITFEATAESLEWTRFSEFIEDPILNALG
TESGLIEIYSQTIKNYNYDDCKAHPTWFEPIEWLGNATKEAPFHLLTNHPKDRLHSQLCH
TSLRDTYAIKDREPILINTKDAKKLGVKNGDVVRVFNKRGEVLAGVIISDDIMQGVVRLC
EGAWYDPDENGLCKCGNANVLTIDIPSSKLANGNIAHTGLVNIEKFTGTLPALNAFSAPK
GAI
>fig|195.2212.peg.1733 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
TLVIALGYSNDEKIPQKNRFEFDKIVQFL
>fig|195.2212.peg.1408 Minor pilin of type IV secretion complex, VirB5
MKKIIFGVNNNKAIGKSHPHENGARLISLDYNYTKEYNYNYEICVTQFNHLFSEVKFSHR
VAALWLTPQNYIQKFKKSILIFTSILILPCFSLGAGIPVVDVTANQQMATQNAKQIAEWT
KEASRWTETVSHYQKQIQAYKDELLSKTGVRDSVSFVKDIKQIYSDFAESGQNIQSFYND
VLRDPQDFLSDKGSEIFGKYTSFDRCNFDFLSQSEKNICKMNLITYAAQVETYNQASKQM
DTISQTLQKLQDKLVNSKDIKESTDVGNAIQLEVAKIQMVKNQVDLANSSYENQRRIQED
MAIQEYSKSFDYKPQVSTKELMQKAREQNKQ
>fig|195.2212.peg.1342 4-hydroxy-tetrahydrodipicolinate synthase (EC 4.3.3.7)
MDKNIIIGAMTALITPFKNGKLDEQSYARLIQRQIDNGIDAVVPVGTTGESATLTHEEHR
TCIEIAVDICKGTKVKVLAGAGSNATHEAVDLAQFAKEHGADGILSVAPYYNKPTQQGLY
EHYKAIANSVDIPVLLYNVPGRTGCEICTETIIKLFRDCENIYGVKEASGNIDKCVDLLA
HEPRMILISGEDAINYPILSNGGKGVI
>fig|195.2212.peg.875 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MHHQDTNTNVKAWRKPRTVVVNEIYWTPTAKMADIVMPATSSYERDDITMSGDYSNMHIV
PMKQAVEPVGESKDDYIIFADICKVYGQNVYNAYTEKGKKAKDFIKEYYDSALKQTQSFG
EAFATPMPNFEE
>fig|195.2212.peg.1547 Argininosuccinate synthase (EC 6.3.4.5)
LNELGAKHGIGRLDIVENRYVGMKSRGCYETPGGTILLKAHRAIESITLDREAAHLKDEL
MPKYASLIYNGYWFSPERMMLQALIDESQKHANGRVKLELYKGNVMVIGRESANDSLFNA
AYCTFEEDEVYNQKDAAGFIKLNALRFIIAGKNGRKF
>fig|195.2213.peg.1832 Putative integral membrane protein
MEEKIKQAIENIAKNLEVHKEYIRFDNTEQIYIIEDYLNNKIIEIKKNIKFDNLIDYPLK
FYYCDFLETVIGRNKTFKEKIIFEEVVFCKVVNFSFSIFDKNINFSNVKFEDKLYFDKCQ
FKEKFEFFGINNLKAEFNSSHFKKEVYFG
>fig|195.2214.peg.1025 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MDKIYFVAKQESTGIILDFESFAIDRIIFSFKKKHIFG
>fig|195.2214.peg.1026 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MIGLFSLLKKNIYLDKIRLLCLTNDKKWKEILNYNLLISSNNKIVIDFEKTIFNYLKIEL
SEQTYFQVEIDLFLRNRIIVAGLNSYIGDRFFIDTEFNVYSRYFKL
>fig|195.2214.peg.1029 alpha-2,3-sialyltransferase
MPIILSCVMVNHKFTRKFNDKLPPLSEYIDYEQGMKIKQHLTYQLGEALIYAHKNWYKGG
YVRLFFHIRKIKSRKGKLQ
>fig|195.2214.peg.1775 Glutamate synthase [NADPH] large chain (EC 1.4.1.13)
ANAKPYKQWLKNLVELEKQHSGVYKHKFLKEDEVLKLQKAFGWSYDELKMSVASMAQNGK
EALAAMGVDTPLAILSKTYQPLYNYFKQLFAQVTNPPLDAIREEIVTSTRIYLGSEGNLL
KPDENNAKRVKISLPIISNEELFEVKALNNFQVKEFSILYDYSKKTLEKALDELCVKIED
EVKKGVSIIILSDKGVDEKNAYIPALLAVSGVHNHLVRKNLRTHTSLIIESGEPREIHHF
ACLLGYGATVINPYLVYESIQKLIANKDLNLSYEKAVENFIKASSSGIVKIASKMGVSTL
QSYNGSALFECLGLSSKVIDKYFTSTTSRIEGMDLEDFEKELIALHKHAFNDTHKALDSK
GIHGFRSAKEEHLIDPLVIFNLQQACRNKDYKSFKKYSALVDEKQVNLRSLMEFDFSEAI
SIDKVESVESIVKRFRTGAMSYGSISKEAHECLAQAMNKIGAKSNSGEGGEDEERYEIKD
GVNKNSAIKQVASGRFGVDLNYLSHAKELQIKVAQGAKPGEGGQLMGFKVYPWIAKARHS
TAGVTLISPPPHHDIYSIEDLAQLIYDLKNANKDAKISVKLVSENGIGTVAAGVAKAGAN
LILVSGYDGGTGASPRTSIPHAGIPWELGLAETHQTLILNKLRDRVRLETDGKLMNGRDL
AIAALLGAEEFGFATAPLIVMGCTMMRVCHLNTCPFGIATQDKELRDRFKGKVDDVVNFM
YFIAEELREYMARLGFERLDDMIGRVDKLRQKPMQGKAGKVNLDKILKSLPTYNRTAVHF
KDYKDNKLEKTIDYRILLPLCKNAVEKKEPIKLSLEVGNQSRTFATMLSSEILKTYGKDA
LSEDSIQIKAIGNAGNSFGAFLLKGIKLEIIGDSNDYLGKGLSGGKIIAKISNEATFSPE
ENIIAGNACLYGATEGEVYLDGIAGERFCVRNSGAKAVVLGTGVHGCEYMTGGLVVVLGD
VGANFAAGMSGGVVYIFGRHNEAHVNTELVDIKDLSTKDEKELKTMIENHIAYTNSKKAK
DILEKFDKKDFFKVMPRDYEKMLEMIELCKDEEDPSLAAFLKITQK
>fig|195.2214.peg.1273 ABC transporter, ATP-binding protein (cluster 9, phospholipid)
MIIKAQNIITRFGNKVVHDGVSFEINKNEIFGILGGSGNGKSVLLKQMLMLEHFDEGEYE
ILGFKLKNISEEDALELRKKWGVVFQFSALFSFFSVYENIAIPLKEYTNLDSIAIKELVL
MKLKMVGLNEAVLKQL
>fig|195.2214.peg.1027 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MYIADILNFNFAMVWNSRKVDTKDMKKYQNDKKLVSYIIDDEKEIFDDLFLQKNSYTSAL
PIRQTKWMSKMSFHDLKYGPFVEKQWGWYVGHSPLEHFIEGEIDKSYSIKLKEYFKKIIF
SKKVQEIIAKIDLLAKNFIKKNGNFHAIHVRTGDLVYCDENPFFAAVHWRKAMPPEIALE
LALKNLENNMNIVLFGDSLSVVEEIQMHCNTYYQGKARIYKAQELIDDLSCPTPFLQAFA
EIIFMSNADEIYSGDSSFARLASIIGHGKEPKYYFKFFSFVQQQDILMDNIGILNTDNIM
KAYTMCYYYLISRLYLKKNFNHLVKIVFKILSYNSNNEFYHVLFIDSLLNLEKYDTAERH
LDDFIFKLQREDRFLSCLKQSSFYNLFKNVYMSDKINEKYQKLMLIKSSII
>fig|195.2214.peg.1387 LSU ribosomal protein L4p (L1e)
GGAVAFGPTNERNYFQKVNKKQKRLALERALADKAAKGVLFTADSLAIESGKTKDANAVI
KKLGVKDALIVKDLLDEKTLLAYRNLANCYVVDISEVNAYLISVFNAVIIEKSALESITK
EG
>fig|195.2214.peg.1865 Glutamate synthase [NADPH] large chain (EC 1.4.1.13)
AFYEYHSLLMEPWDGPAAIVFTDGVIMGASLDRNGFRPSRYYLTKDDMLILSSETGALKL
DENNIKAKKRLEPGKLLLVDTARGRVIADNEIKEHYANAKPYKQWLKNLVELEKQHSGVY
K
>fig|195.2214.peg.1632 ABC transporter, ATP-binding protein (cluster 9, phospholipid)
SIAIKELVLMKLKMVGLNEAVLKQLPSELSGGMQKRVAIARALALDSKLLFLDEPTSGLD
PHSSREFDDLILELKQSFDLNIVLVTHDKESMKNLLERFIILEDKKVAFCGNYEELRAQN
ERLFKRFME
>fig|195.2214.peg.1740 Ferredoxin-type protein NapG (periplasmic nitrate reductase)
MKDRREFFASAFKGLCLCTAGGFLANLSLKADDDYALRPPGAEDEARFLSKCIRC
>fig|195.2214.peg.1591 Glutamate synthase [NADPH] large chain (EC 1.4.1.13)
MDLENILENNQSVGLYHPKNEHDACGIAAVANIRGIASYKVICDALEILMNLEHRGGAGA
EENSGDGAGILIQIPHDFFMTQELGFELPQKGDYAVAQMFLSPNADAKEEAKAIFLQGLK
DKNLEFLGFREVPFNPSDIGASALKAMPYFLQAFVKKPSTVNAGLEFERVLYACRRLIEK
RALHVPKFYFSSFSSRTIVYKGMLLSTQLSDFYLDFKDVNMKSAIALVHSRFSTNTFPSW
ERAHPNRYMVHNGEINTIRGNVDSIRAREGLMESEYFENLDEIFPIIAKPSSDSAMFDNT
LEFLALNGRTLEEAFMMMVPEPWHKNENMGSKKRAFYEYHSLLMEPWDGPAAIVFTDGV
>fig|195.2214.peg.1793 tRNA-dihydrouridine synthase DusB
MIDFSKKPLFLAPMAGFSDLPFRNVVKKFGADITISEMISSNA
>fig|195.2214.peg.1867 Motility accessory factor
QTHSQGFIHANLHNGDYERDLDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMNYH
ITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKA
>fig|195.2214.peg.1855 Motility accessory factor
NCTEGGARIEGTIEKPFLWACENLLDKDLNKPFDFPKFLDKKLAKEKLEKTKKYLQKSIL
ESKEFIKKTQTQLQKLRYTLEKNDKNFQTLEKIKNDLLNLFKEFKKLKLFNELCQATYFH
NECEILKFEVLNTNKQKENLIDFLKIQHNWFIQGLGYLDAQNQTIEKSLENWNFDDIIKK
>fig|195.2216.peg.1254 Auxin efflux carrier family protein
MFIFSPLFTIFILLAGGYFAKRVGILKQKQARTFLDFAIVFALPCLIFDKAYHLNFDFSL
IVLIFIGFFSCALAAFIVVFLGFIFNFSKATLVSMFLLSCFGNTIFVGMPIVEGIFANAQ
FGAEVILYDALATTLPISLLGPFILSLGSGEKVSLVANIKKILSFPPFLALLLGFCVN
>fig|195.2216.peg.1621 hypothetical protein
MNFQVKTLETFNPFESLNHEQANTEQILDFRVIDFKLLCSSVKPAKRKTYERKDFDLFYA
DDFFVKNYNTIVQKFLIEIYPKTQSFPFTVKLRSNSNLTHLKASINLTENFKYYPNLKFD
ILQNIYKIMIKQKFLILRLDKNLFDKIDDFILSIQKSPSIKEIELEIAKGVDKIEHKSDE
IIYHRDVNEECFDENINYDEGNYCKPIEKYDEGNYCKPIEKNELLFEYIYRILGKEGRNL
RGEILHLNPIAFLDNPFIIKDESIYTEELEDRIKYFSANYGFLNKDHSGYSVINNLKLSQ
IGLKTTGSIKTNTDENINLEITNFDISDDAIKSGIVNVQASNIKVNGNVGATKLYGKNIS
IKGLTHAKSEIFAQDIFITTHKGTLQADTVYIKNLENGTIIAKNVFVENCMGGKIEAENI
YICNLLTDNTLYPRKNLIITNNIKFKNNIVVSPLVSIENNSDTECENLKNLSLKIKSKLD
DTISKMQNYYDYLIKNQIKIIKLQKTKNPSAIEMKFSNLYHDIIKKYNHLSISYKKFIKL
KYQIDAKLNFLNEMVYNVKIYIKAENIGEDNFLKFYPNTNTNLELKHHINLKDYEKVLYL
EKGQQVSYIKSSHNYSESDIEEIKIIFEKLEKDNS
>fig|195.2216.peg.1255 Auxin efflux carrier family protein
MPEFIFSPIRLFGGAATPVALFAIGLGLGFMAIKTAYKPTILVILAKMVLAPLIFVLLLK
LFGFEMKASIIVAIIESATPTMTLAGAMVMKAKLDSNLAVSTVAFGVLFAFISMPILVWA
LA
>fig|195.2217.peg.1033 Serine acetyltransferase (EC 2.3.1.30)
MNFWGIIKEDFSQPKAQDPAFNSCIELFFNYPGVWAVVNYRFAHFFYIRNFKHIARMISG
ISQFLTGVDLHPGAELGRRVFIDHANGVVIGQTAIIEDDVLIYQGVTLGGTSLEKGTKRH
PTIKKGVIIGSGAKVLGNITIGENAKIGSNAVVVKDVGANLTAVGIPAYIIEERKNKNIR
AIDANCDDKLEKLEKKILELENLILKQPESQK
>fig|195.2217.peg.1039 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MTNYKEKDLENFIESYLLENNAYIKRTNENYDKNLCIDTEIFENFLQATQSVALEELKKR
CGQNYKKELFDRIFSQIKTKGIVKALQGYVEIKGIKIYLAFAKPNTNANEESVKKYEQNT
LSIIRQLYYSTQNKNSLDMVIFLNGLPLITIELKNHFTGQNVFHAIEQYKKDRNPKEAIF
NYTIVHFALDHDLCYMSTKLDQDATTFLPFNLGLNNGSGKIGLANGAGNPPSDGIKTAYL
WEKIFKKDTLLNLFFNFVQVVKKKNEEIIIFPRYHQFDVVEKLLAHAKENGTGQRYLIQH
SAGSGKSNSISWLAHNLVSLHRLEKNIFDSIIVVTDRKVLDSQIRENVKSFSQTKNLVEA
ITHGSKQLKNALEEGKKIIITTIQKFPFILDEIKTLKSKTFAIIIDEAHSSQSGSNAQKM
AEAIRDKSGDESQNLDDEILEIIKNKKLQSNASYFAFTATPKPKTLEMFGMPCDVNGEQR
FIPFHLYSMKQAIEEGFILDVLKGYATYKSYYKIISCTNDNPKYDKKRASTKLKAYVQNN
IKTIEQKSQIMCEHFFQNSFKKINGKAKAMIVTSSRENAVKYYLVFREYLRKNYPHFKAI
VAFSGEVNLEGEIYSESGLNGFAENVLKDEFKKDEYRFLIVAEKYQTGFDEPLLHTMYVD
KALSGVSAVQTLSRLNRTCKNKENTFVLDFVNTHEDIAKSFSVFYEQTYLSEATDDNRIF
DLKANLNEYEIYTQEEIDDFANAILRKEKENIIHAKLDIMLDRFNQKSDDEKLDFYNKAK
TYLKEYSFLAQILPYEDIELEKLYILLKKLASKIILPKSEDLAKGILDNVDFDSYRLQLD
KTQDIVLQGNGELKPSFADGSSKSVEAELEELSNIIKDFNNKYANIDFNESDKIAKILYD
IKDDIAKNERIRETFSKSDMQNSRIEFDALLKDKIQDILELNLELFKQFNQNIEFKDKIA
NTMFNMVCNDF
>fig|195.2217.peg.1088 NAD-dependent glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12)
MAVKVAINGFGRIGRCVARIISKRDDIELVAINDTTDIELTKYLFKYDTVHGEFEGSVDS
EGDDLVVNGKKIKVFKSRNVKDLDFAKHGAQIVLECTGAHLTMAKCQEFIDMGVQKVIMS
APAKDDTPTYVLGVNSELYKGESIISNASCTTNCLGPVCRVLQDNFGIEKGLMTTIHAYT
NGQSIIDAKAKDKRRSRAAAQNIIPTSTGAAKAMKLVMPELNGKLHGQSMRVPVIDVSSV
DLTAQLSRKVSKDEINEAFRKAATTNLKGILMVDDDERVSSDFITCSYGAIVASDLTQVI
ADDFIKVIAWYDNEWGYSSRLVDMAVYMQIRLNHE
>fig|195.2217.peg.1037 Membrane protein
MIITHSHFDHLDAKSVKVLKDKAKFFYHSFKSGKLSKKLWGE
>fig|195.2217.peg.1058 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MPWYDGKTLSELLDTLPIVTNLSDEFIMSVQYVNRPHLNFRGFCGNIASGSINVKDEVVI
LPSLKTSKVKQIITPDIENLKVLDKNEKIQSSKNASFPSAITLTLEDEIDISRGDVIVSK
NHSLKISNSFKAMMIWMSEAKFSLSGNYLIKMANLTTSITFEKIDFKKDINTFEESQSDE
LKLNDIAKCTLRLSKKTALAAYKDNKTLGSFIIIDRYSNETLAAGMVEEILTHEDKARVY
TQAEIELNTYIRKNYPEWECKKI
>fig|195.2217.peg.1040 hypothetical protein
MKGKDRNKLCWCGSGKKFKKCHIDRENQSPIRQSDFIEINKKVKNKKICMAPEEIKCDCS
KKIIKAHTISKNCNLKSIADEKNNLATLKLSNLNIEKAENPICELSIIGINKASTYQIFC
SKHDVELFSVLENKNFEFENIQIFMLAYRNLCYELYLKESILDTSKERRCFDRGKPIVEQ
LSIQAHFKFYDDALNVGIRDLKLLKEKFDSFLTNREFDCIRYYSIEISSISQFIGSCTWF
PIVDFDNTKLADLENIEEIFNPISASIINIDNKSLIIFSWLKDFYNEQYCMKFISSLNKI
PNDEKSGAILHWFFSSVENLYFQLSWWNNLKSEEKNILINFYKQPMLDRFKLDKSFYKKC
SHMLNWNILNIKHNLNFINY
>fig|195.2217.peg.1042 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72)
MKQSQFQPIVNFIWSVADDLLRDVYVKGKYRDVILPMTIIRRIDAVLEPTKDKVLETYDT
YKDKFENLDFILGGKQGNNLGFSNYSKFNLQTLLNDPKNIRINFENYLDCFSENIKDIIL
KFKFKNQLDTLEESNILFGVIERFCSPKVNFGIEDILDEKGNVIHKGLSNLGMGYVFEEL
IRKFNEENNEEAGEHFTPREIIELMTHLVFLPVKEQIKQGTWLIYDNACGSGGMLTESKE
FITDPEGLIQSKANIYLYGQEINPETYAICKADMLIKGEDPDHIKFGSTLSNDQQNLQFD
FMLSNPPYGKSWENDQKILGVEKKGSNSTCNDPRFSVGITSKSDGQMMFLLNMLSKMKTD
TPLGSRIASVHNGSSLFNSDSGMVAIRKHIIEKDYLEAIVALPTNMFYNTGIPTFIWIIT
NKKPEHKKGKVQLINATSEEYFSKMKKSLGSKQNEMTKEHIEKITKLFLENASNKDCKIL
DNEDFGYTKIIIEKPKSIEALKDDEKFAKLKDKDKILEKLQELEQNPQDFEDRNEFISFL
GVKLKKSEENLIIDSDKTNNTEKIPLKTDIQSYYDTEVKPYVANSWIAWDSASVGYEILF
NKYFYTYTPPRELEEINSELEKLEKEVQDLLREIIQ
>fig|195.2217.peg.1038 Membrane protein
MSVDFFKTFDISNAQRSKAKKVQGKKYEIFLNENEQSLITPKVSFKEILRYYYLYPKNAI
PSFKLPFFKPDLSGFSAPHITWLGHSSLFISFKEYKILIDPVFNTHASPISFINKAFKML
LFIM
>fig|195.2217.peg.1041 Type I restriction-modification system, specificity subunit S
MKNFKNSGIEWLGEIPKHWEVSKFKYFYRSSMGETILAQDLKDDGIPIYSATEDDKFFGR
IKNAINILNINDFVIPARGNSIGAVKIVKEKSTCTQTTIFSKQFKEMNSYYVYYFLLGYR
KFLFEFTQTAIPQITISQVNDNPILYPPLKEQEQIANFLDEKCEQIANFIEKKEKLINLL
KEQKQVLINETITKGLDKNVNFKDSGIEWLGEIPQHWEIKKLKMLFILGNGLNITKADFV
SYGIPCVSYGEIHSKYPCRLNTTIHTLPFVSKTYLADKPQSLLQKGDFVFADTSEDIEGS
GNFTSIQSDTPIFAGYHTIILKYKGKINSLYFSFLFDSIFTRNQIRKEVCGVKVFSITKS
ILKEVQCLIPSLKEQEQIANFLDEKCGKIDLLIEKTEKQIKLIKEYKTTLINQAVCGRIN
N
>fig|195.2217.peg.1036 Membrane protein
MGNYLKSYGVSEKKIIELDWWNGIEFDDLKIIATPAQHSSSRGDGKNKTLWASFVMEFLS
VDKRVFFSADGGYFTHFKKIGEYFGGFDLACLESGQFNIAWPYSHSFPDQILKEAKDLNA
KAVMPIHWGRFLAGTHAWNEVVKFLYENLDLPLITPKMGEAYEIGVKFKQDFWWKEG
>fig|195.2218.peg.1786 hypothetical protein
MLNKFFSVKLFVKLFEFNIKKEIIKAIIIFLGGINIIVFIAIFISQARIPNQAYIYKLKK
ENIVIKPYDFLYSNYNTLGFGICENDNYTGETCLNYLKYFEEIEKRKALKTEKQKKSYDE
KQKIIEENINKLEKQ
>fig|195.2218.peg.1791 hypothetical protein
MKLKDFDFRIWNGKKYLKQKIYNDNINNNEYIAVTGNIDDENYVFTIEHGCERDYYGGDY
DEYCKVKDFTSCNYEIELFTGFYDKKGNKIYEGDILYSFEGCSEGEAFKYKAVLKEGAFY
LVECGDDGEEYDEDLISEFRLEELEIVGNIHENADLLVVKE
>fig|195.2218.peg.1895 Methyl-accepting chemotaxis signal transduction protein
AVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQ
INLLALNAA
>fig|195.2218.peg.40 Putative periplasmic protein
MFYYHEKFFIAAIFLIIFSLTFYILYDKKKDNVFKLNTCLPLKCDLNSQDCTFLFKGK
>fig|195.2218.peg.1835 hypothetical protein
EELIAYEIKEIYKDNKSHIEQKINFKVKGLI
>fig|195.2218.peg.1086 hypothetical protein
VRKVENMNSMFSSCKSFNQPLGDWDVRKVENMNSMFSSCKSFNQPLGDWDVKSVKSMRFM
FHKCYVFNQDISKWDVRKDQYTENTFLDCPIDNSNKPEALQELSI
>fig|195.2218.peg.1785 hypothetical protein
MILGFGISITRVVAIRIANAKQNLFMLKKPKQGCPSLIRIKGKNYE
>fig|195.2218.peg.1783 Hypothetical protein pVir0015
MLDYEKFQTMSKEEYFKKYNVGIRFLFGCDLNQKNETEMISLRVFLPKKHFQEYKNIDIF
KTMDLFKKTPLFKELIEQSIKIDFEKREFVMPDFFIKHDIETIPYFTQGGEKEEELSKEK
FFELLKQNNIKELNYLCFLFFGSFCKEEYEYFYNQELLK
>fig|195.2218.peg.1784 hypothetical protein
MNDKRKVREFLSYAEKYLSYVLFICIGSCFVALILSASIDSDFYSLFIILALGTTISPLI
CIGLVKLIEKLIKIIKK
>fig|195.2218.peg.1787 hypothetical protein
MKLQDFDFRIWDNIEKKYIKTPHGLYIENTEHNDASSYSRIIGNYEQRSFYIDYPFNDRN
NEYYDNEESLLIELFTGLYDKNGKKIYEGDILSYKTSQGTTLFYFVTINKDINIFEIFRI
ANLEKFELYNTTESDRFSLYLFSKINDMKDIEVIGNIHNKAELLEVKELK
>fig|195.2218.peg.1837 hypothetical protein
MKHFIFGGLLSLGALAFLAGCGDEAKTSDYYKTHIDEAKARVAECKKMEKMNETQQRDCS
NAKWAIETNGLENAGSSWGKSNPDALKWK
>fig|195.2218.peg.1769 hypothetical protein
MFELSNELALSFEKIGLYFFIFIISIQTLFIFWSFITSFDFCKKYWKESITFGLKTLMVE
KFKKDKVITVVSQNPKILIIDNTMEDLLALKRESFIVEEVKIIKKYKYTPKTKEELQALV
KDESIYLGDIDTSEITDMSYLFTGSTRTNFSGIEKWNTGKVKTMRSMFECNKFFNEDIGA
WDVGDVRDMAWMFLNCPNFNQNISEWDVKKVETMSGMFWNCESFNQNIRKWNIKKVWDMS
YMFKYCKLFNQDLSSWNTKRIRTYNMFSRCPIDDSNKPKYINTKE
>fig|195.2219.peg.1796 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGVVIPIYNVEKYLKECLDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTL
>fig|195.2219.peg.431 Transcriptional regulator, LysR family
MEFWQKDELVVASSNKNLSQKEFYIDELLKQKWILRETGSGLRDKFLNEIGDVSKKLKFF
LELDRMSAIKELVIQKNAISIFSKKSIEKELKNSILYEVKLKNINLWRNFYILKRKNYNF
NRALEKFEKIFKQ
>fig|195.2219.peg.1788 Motility accessory factor
WACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIKHCRDFSKILSNDFEKIQS
VYLSLNEKEEYLNLAIEKIDEFKNKLEDIKQMQDLYEILSPLLIQFELNLARIYVLNPKT
KEDAFNKSILWIKEHLEFMELVYGHIKAQENAL
>fig|195.2219.peg.1800 hypothetical protein
KMNELVKKLLENKFGKSEELELLFGMKFSDDDAGEFNKFLSSNSAPKSIDIKA
>fig|195.2219.peg.1233 Putative C4-dicarboxylate transport protein
METLSQTFVERKPPLYKRMFKSLGFWVIVGIVAGIVLGYVNKEMAIASKPGVDYFISALK
VLIGPIIFVTLVLGIISLESLKKLEV
>fig|195.2219.peg.1790 hypothetical protein
DDEKEIKAIVFIIGGYGANANIYFLDSYRNYIAKNFDVVTINVFYHCFCARQSIDQKYNP
KLIPNKDDLERINNILKNINLGHLLANEDNFEQIIPFIEQRAGEIKQAGLVDESQKIGLS
CDFIPPNGDYQNFGIMAALDHINALKD
>fig|195.2219.peg.1488 hypothetical protein
ISQVKSIKYLYNFIDFFIIYLAVISPLNAFKNTDLNNYNKEYNFEN
>fig|195.2219.peg.1757 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
EALKLKNHLSYKLGEALIQANKTWYGGVYQIAI
>fig|195.2219.peg.394 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MFKLAINRPITVLMFFLALMIFGLISAFSMSVNLFPNVSIPLIKITSKVNGDLNFVESKV
TKEIENALSEIDGVKTITSTAYDNFSVSVVEFKLGKNLEVAANDVRDKIGTLSLPSKPEI
EKIGSDSGSAISLFLYSKDKLQLMREINDKIKPFLQRVEGVGKIEAKGFLEPQIRIELKP
NELRKYNLNALDVANIIKSQNFKQALGELNNNQDNYIIKGYFEATNLEELSNLRIKTGVF
LSDIANISSLYEDEKQSALYEGKEGVLLELGKITNYNTLEMIKNVKNALPIIRKTNSKRY
KH
>fig|195.2219.peg.1784 Flagellin
RLSLVKNDGKDILISGTNLSAIGFGTGNMISQASVSLRESKGQIDANVADAMGFNSANKG
NILGGYSSISGYMSSAGSGFSSGSGYSIGSGKEYSTGFANVVAMSTASSLSNVYNVSAGS
GFSSGSTLSQFATMKTSAGNTLGVKDETAGVTTLKGAMAVM
>fig|195.2219.peg.432 Transcriptional regulator, LysR family
MKIKDMEIFLDLLNTQSPTNTANNFSITQPNVSIIIKNLEQDLGGALFERLGKKLLPTPK
ALYLGKIWLKLVQDYYKSLEELNDENTLRRNQDRCYSKHS
>fig|195.2219.peg.393 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeF
MPCLLLEKQIPKDISINMLYDKSLNIHKHLSQVIFDMVLGIFLTLVIVFLFLRNLSATLI
ACIAIPTSIISTFFIIDLLGYDLNRLTFIALTLSIGIFIDDAIVVIENIAKKLKTYPPLQ
AAFLGINEIGFSVLSISIVLLCVFIPISYMNSISGLFFNALGISVASGIVISFLVSVFLI
PSIGARFLNPKENKFYEKTEAFFEKIEQKYENLLYKILQNKVKFILATLVFIGFSFALAT
RIGLDFLPMEDDSEIQVLLESKKDLSLEAMKEKSLNLLEKIKNDSNVKYAFLLVGYDDAK
DATKAKIYVKLKNLDERNLRQSAIVSLYRQKFQDESLKIKILELPKIEGAGIDDPVQFLI
LGDDLNTLKEAASQAKEILGTNARIVDISDNANATKDEVALHINKEKAKLLDVNPQYIAG
VLGYSFSQLSVGSMDRGNSKDDIILSFAPEFKKDIEALKRISIKNNQGINLELSSVVDFI
YSKDLKTINRYNKNRSVKITAGVNDLSLGAVQKLLLDNMDKILNNNPSLSYAFSGFINLL
GETVQGFAMAVALAFVLIYLVLAALYESFILPLIIMITMPLAFGGASIGLFITGHNFSLF
VLIAIILLFGMVGKNAILLVDVANKKCHEGLDPDKALLIAGKSRLRAILMTTFAMIFAML
PLALSRGAGYEANSPMAIAIIFGLISSTLLTLLVVPALFKFCFKLDSKLRKIYEREKLN
>fig|195.2220.peg.1695 possible prophage ps3 protein01-like protein
MKALYVAKYFLFLARSKEAGDTLSNLKIQKMLYYAQGYMLAIFEKPLFDDRIEAWKHGPV
IRTVYEQFKKYGSNSISFDELEDFDTDCIADNKDAHELLVLIFDKYGSMGAWELREKTHE
EYPWKSSYVASLGNEITQDAIATFFKEENKKEALRLKELQKNDMEINELWP
>fig|195.2220.peg.1696 hypothetical protein
MPIPNLAINIIRFLVSTYKLKNETYAYSEFGKYIRVTFSKLNEKSDVKEILDLIRNFDEK
KLVEFYDLLVCATKNFKDFLAEFKAKLFCFICEEMRIEIKSLINK
>fig|195.2220.peg.1362 Protein of unknown function DUF262 family
MIKKVKEVLNNSIFFIPNYQRDYAWEEKNLDDLWEDLLEAEQAVSDQMGHFLGTIVVSKN
SKNPEIYDIIDGQQRITTIFMLRYALNFRTQNSQRNIVYFCDDNDNFRLQVQDENKLFFN
EVLKQAENNKINIELENKAQTQGQQKLYKVFKAIWSYVASLESDKALKLFNIIGNMSIMW
LEEQDSGKAIRVFQTVNDRGIPLLILDKLKSLLILYSNKYCKGELDEVINERFGKIFKIS
MNIKKHKTIHSLGDVQFYQELEARIFNYHSLGVKEIAHYRNSANIHYNELKRVLKNKDKT
KEEFKKWLDDYSKDLLQFFETFLKILEKTQDNIEMFKIFMILKINPYFYSSLIRLEMNNI
LDDECLRLFSQAEIIFYSFGQTNDSTAFKLGEVTESKDEFKNRIIDDCNKCIKRAGYYDI
NEFISEISEDNYEWGKYFHYLFLTYNNVGIEECMKLIDEKIYAFTIEHIIPQNIINNGLL
KNYKFENEDDFNKLKNTFGNLIPLEKILNSICSDRSLLDKKEYYKKSKLSCNLSFANDEN
FLNFEKKQIIKRNEDFTKWARKFFVDFLKITQK
>fig|195.2220.peg.1872 Beta-1,3-glucosyltransferase
MLGLNQRKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYAIISAVYNVEK
YLDD
>fig|195.2220.peg.1871 Beta-1,3-glucosyltransferase
EKQKLYKDNHALNFKFKNGIQVKENYNLDSFIQLSAASCFMNIGYLDKLLFDEKLKPNFE
DAKFINEYLLDNINLKSAFLPTVKYFYRKRVEQNSTLDGKDKIKDYYTMVPNFGYLNLFK
DIKITKVPYFVQNVVLYDIFWQIKTLILNPEKLAILNNEEKKLFKELLFENFKFIDSCNI
KNFNLHAFDFFYKKGILNYFKNEDLSENIAFIESIDDKNDEILIKYYFNDVNHKTKILLD
NDVAIVKHSKIRQYDLLDKVFLYEKRIWLKLKNDTKTLDICINSQKLKLVFNDRCINDLS
LVLKVLAKQKKQRSKNSNLWLFADMSWRADDNAEHLYRYIMQNHPKQKTAFILSKNSTDY
PRLKKEGFRLVDPRSFYFKYLIYKADKIISSHIDKYIFNALGGDTLKTKDFIFLQHGVIK
DDLSRWLNQRKIDTFITSTKAEYESIAGDFNHYKFSTKEVVLTGLARWDALIKNNVLNTK
QIVIMPTWREYLSGKVQKYGVRGRNPEFVKSLYFQKWQEFLCSKELEKLAVRYGYNIIFT
PHPQVRIYLEDFNLPSYITTSYKENMQELFCRSSLMITDYSSVAFEMAVLKKPVLYYQFD
KDEFFAKHLYAKGYFDYEKDGFGKVFVESSDLFFYLGKKINHLQDIAINNTQHQSNNVRK
NIFIKIKSK
>fig|195.2220.peg.1901 Motility accessory factor
NEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEINFFYQSILEKTPRYP
FVCIYGIGNA
>fig|195.2220.peg.930 hypothetical protein
MSQTNNNTEIKEQDTQDEIIWEGKKDILSFLLYWITYIVFLCFFFIYFLDYLIKK
>fig|195.2220.peg.1903 Flagellin
NIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRISSSG
EVQFTL
>fig|195.2220.peg.1520 hypothetical protein
MNNGDDFVASLNGVALPSVKSDDKKKTYGQIIIGGNIDISEQFSLNAGIGAKQILAGKTD
GKNETYVSGQLGFKYKF
>fig|195.2220.peg.1129 Membrane protein
MSLNLIRNLESKIHKSARDTLEAIAKGFGAKKVEFEFKDNTQKLDIN
>fig|195.2220.peg.1033 Enterochelin uptake permease CeuC
MLACILISILALLGGVFFVSRIFDYNTTISVIINFLGGIYFIYLVLKGNKL
>fig|195.2220.peg.1697 hypothetical protein
MRKMDAASEKRLIEAVSYLKKISKDALMARLYQKILFLLELKYYQQHSRPFIGINFKSYK
FGPFSLDVAKALDDPKPNSECSNEVKEKIDEILKEYNLNRFDQKTMGKSFKKMIDYIHSL
VFYNLTPFDCDFNFDNYSFEDLFERINSKLDGKKLEDEKYKFALINQKAKEYECLFQI
>fig|195.2220.peg.1898 Motility accessory factor
TMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSS
ELQSARLMVLNTNKLEIQDYNELCSSKPFFQFSRIYFLELMSHYYERFHED
>fig|195.2220.peg.1714 hypothetical protein
MNIREFLLEKPQENNIISFLQDGASQSENQNTNEYLASLKNEAINDFYKNKDKYAKEYEK
YNFKDQNLTNPMGNVSEYKRDLYDYNKNPSMNADDLSDYILDKQSKFNASKPIFTDDNEV
ARKNNQFMRDLGDELQKSGRGKLLQDDDGSYWVQDNNGNYSKVQGSTMGNLYRGIRDNGA
SVALGTAGAIGGSMLGGGVGMVAGGALGASLGAGYDYYGNTKDTNQDANLKEALMLMGEN
AGLSLIGDAAFAGVAKGARVLKNTYNMTKTGARAGKDMIDGMAVK
>fig|195.2220.peg.1588 hypothetical protein
MKNIQIYTETFVLKNNAINNKNFALKNGPLGLFRSSPEKINHFEYFLSLIATIMQETNGI
LEELGDSYYASYKAPTISQTKIIDFILKAQKKEKYILILDKNDFNKYRKDCSFINNQENL
AHKIAIGEFRIFIVVYKDMKCLENINNITKIYGYNSKSYKIKDQIWDEQYLGGVCKISQA
LYFSGKAKIGII
>fig|195.2220.peg.1694 hypothetical protein
MALINFRYFLILLSNMTSIDIEILLEHKNELLKYLSHLGDSSVFEKDKCFKALNNIEQDY
FICIGLTDNEKQKDFCKSVFIILRDHWRKFNSTFY
>fig|195.2220.peg.4 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MQVYLYNIKNQSGHYSSALVIVYFVLIFITTFIASLIKE
>fig|195.2220.peg.326 hypothetical protein
MWDKILNYQQLECDYFNLYNQFISVDFQISLFEKNHKSLIKDFIFFYHQILKQKDLNFLL
GVRNKIALKVHNYMQEYSTSPKDLSLICLREHKHIEFFQRFYKALAYL
>fig|195.2220.peg.1667 unknown protein encoded by bacteriophage BP-933W
MQNITSNLIFTNEQIAINYGLTTGLTIAKHLRTHNDEFIENTHYFLVENSFKNKTIKWTL
EGVYKLFDKIKKLKERSNMTEEKLLKSLADGVLKINESSIDVAVLENGVRIITHSGVFRA
LGREPRGNARLDQIPAFMDAKNLQPLISSELKTQISRISYLDKNSKVKEGYNADILPLVA
DLYLKAREEGILTQAQIETAKKAEILIRSLARLGITALVDEATGYQYERERDELQKILKA
YISEELLKWEKRFPDDFYKELFRLNGWDFTTKGIQKRPAIIGKWTNTLNYEQLPKGVLEE
LKEITPKNARYHQSLSKDIGQPNLTAQIYKVIGIMQTSDNMKQMWENFKKIKLREQDEDI
EFDEKGRLKEK
>fig|195.2220.peg.1828 Motility accessory factor
MMTFTPTQKELFNKNIEALSNILLKESLKQIQSSKFELILGKDNLDINLKDTSDNTFLYE
NVIDELNTMLNTYNDKYLLYPVLYFYGFGNGI
>fig|195.2220.peg.1772 hypothetical protein
MSSNIDILKYLLFVEYLTPQNIKKINNCCDTCETSYINQYIREKIEKICNALTLNNKNLD
DYSVEIIIQGAIYNNKTLFENIINKFNINKDLENFYDNLN
>fig|195.2220.peg.1508 Bacillosamine/Legionaminic acid biosynthesis aminotransferase PglE; 4-keto-6-deoxy-N-Acetyl-D-hexosaminyl-(Lipid carrier) aminotransferase
MFHFTIKKFKKGLKPLVANTPKLLNFTIKKFKKGLKHCLSFQN
>fig|195.2220.peg.1675 hypothetical protein
MKLKDFDFRIWDNIEKRYLESPHGLYIENTEHNDASNCNRIIANYEQRAFYIDYPFNDRN
NEYYDNEESISIELFTGLYDKKGNKIYEGDILYSFEDCSEGEAFKYKAVLKEGAFYLVEC
GDDGEEYDEDLISEFRLEELEIVGNIHENMV
>fig|195.2220.peg.1747 hypothetical protein
MENKQYIYNLPNESNEKQKLETNTNSIIIVGANGSGKSKLGAWMGKNNNHTHIIASKRLT
YISENLSIWLETDVQKQDDDTDIKNTQDDYDDTISILFRQQIKELCSRDKNKPFKTRIDY
LFEIFNKVTQKELNINKNRFCINSKDKSYDLTNFSRGEELILYLISKILTIPNNEQQIII
IDEPELHLHPSLTNRLWDILEKHRQDCLFIYITHDLNFASSRTNSDKFWIKSYNGEKWEF
EQISTNEIMPQELFLKLLGTRRNVLFMKVKTIA
>fig|195.2220.peg.519 hypothetical protein
MDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGTNEVWLRES
IIALKRSDLNVETL
>fig|195.2220.peg.683 FIG00471540: hypothetical protein
MKIGLETESMHLWFQNGRMDIFSYIDFAEELGCDGIIINIIKDFGLDEEWGCLGSNDESH
LKKIKEKLDTYGMYCEIDSKGFDKDKFEKIAKVSQLLGVKIIRSYVPLTDKNKKVKNASD
GAYDDSKITAKFDKSEFLSTADEIKALIPLLEEYD
>fig|195.2220.peg.5 ABC transporter, permease protein 2 (cluster 1, maltose/g3p/polyamine/iron)
MNENLSLKAKIYHYAVLFLVFLFLALPLMATFLYSISTSWGVSVLPDDLTLKWYQELFHD
ERFLLALWHSLLVCVGSILLSMILVFPLVFVLNYYFLKLKAFVNILIIMPFAVPPIVSCV
GLLQLYADNIGGTAWILIFTYFTIALPFIYRALDNAMSNVNLNELIASNAMLGGSLMGAI
FKLVLPNLRNGILVAVF
>fig|195.2220.peg.1839 hypothetical protein
LKNTYNMTKTGARAGKDMIDGMAVKGGNLGNRVIDKITQKDIPMIGKFTDGGLQNAETIF
NNLTKNVENKKQIDELIAKENPTYLENGKPTIEILKNIVEQGLNKNNPQFIQDSAKRTSA
ILKNISNTLQGVPTTQRREILLKSAQAYPEIGSFLDDVLKADKDASISFLNIIKGQDEVF
KNKTGLNGEFDYKAWQKDNSSYKKRINNEYAQAIKSIDELNNGSIRLSKEGLAKIEEFKN
NNFLEQDIKTNISSFLEDTIDKDLSAEQIFNLRSAINKQLATGNKTYNTKEAYRLVKDTL
DETMIKNASDKELAKKILEDANKNYALKENFNNSYLGKIKDQETPEALAQRIANGARNIN
EDKDLKRAFEGMNEAERKANEKHAFNALLAKHRIEDIGYDFKNLAKDMDNVEFVSKDLKY
AKEVVNVYAKIYQNNKDLIMTALASSGKKTNSSIATTTQGVFDRILISGVFARLHALVPF
MKSAKEQALRNQILDALKLAKTNKEVISNLKNIKIADKEQSRIFKDALDNYIKADKEQNK
ILKDALIKEGVIKGDNFFMDKADPSKAKSDYTAKFNVEKWINNVSGILKDEWVVNLKAMA
KKHPEMFKNEADVFKVIKEIKDNPTHFFKNYDDEVALIAKPLKDDKVGNIAIKKDSGKII
HINKTKGKDLERLNRRNKAMLTGTPTPATTKGSTTNVEGDLLQHSFKNSTQTKPKKNLME
DIKENIEAKEVEKKNKKSVKQRLDEKIQNDKKAREDILKRYDDFLKENKDYNLDFLGNLD
VVTREFILNAKKKTYKGKKADIPDLMRFRIEKELNIQALKEFGKNYAEYYHDGKGALQKL
LIEKQGQVAGAFHRKDLGDIDLVWGEVIDKIKHKGYGLAHIIDKHPELDLKLVSDIIDKG
KLNNQNNIRYRIEYKNYIIGLSSEYKGNKRTFIITAFERYKG
>fig|195.2220.peg.249 putative lipoprotein
MQSVWFYMGKSFKIAFIARLVFILQWLIFLTCKKIYKGDKVDQISNVILFWHGRLALMPF
AFRHFGKKGKKAYVMISHHRDGEQIARIIKLFGLDTVRGSTSKGASTALRSAFKILDENH
DVVITPDGPRGPYHSISDGAVLLAQKKNVKIRILNYEARNFWEFKSWDKMILPKPFTHLV
YRLSEPLDISSLDKDQAKFFLLEHFKKIEQMDKF
>fig|195.2220.peg.1698 hypothetical protein
MKLSNYGKFLISLKMHKPQKEKLFQKKDKKNLVVLANKLVS
>fig|195.2220.peg.1786 Flagellar hook-length control protein FliK
MSNLVPQNDVLNLTPNKTSTTSSSFSKTSKNKEHESSDSKNSTQDDTESFLNSLLKSIDE
TNEFLPDHMKIGQKEVVNEVMSRLQKGAFDESDKISIFESASFMQILSLLDKLKTDTADV
KLANLSTQLSSLIKTEANFNALKGASNLSELLDIAKDLGLNVKNIKVDRLLDLKATFPNL
DKADFFKGAVDNVFKEIINNKISNVSKNLNHNLQNTTHTTSTHSTQKTNSKDSGSLLSQT
LKNLDSILSSKESKHEKNDKVKSKIEEDVTDAKNTLKNIKNDEFAKNLTEELNIKDKKNQ
DNLNKDNNLKDLIKDSTKQDKNSNKELKDNASTQELTNLKDLNKENKDLNKDFNKELNKN
QGDMQGQNKNLKNNNQNLNLDKNLNKEIVKDTQNLVSNLTQKDFNLNKELKNNNKEN
>fig|195.2220.peg.1746 hypothetical protein
MNKDINVLKVAEVENLFLLECIVLAVLKQSGRENKFEEIKNY
>fig|195.2220.peg.1762 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRYGDTSRRANKSQSIHSDRTPNLFSFISRNDDERQGTDAARSYNQQSVLETAARND
GYERRSLKSGQKLDFVSDDEIYLGSLKDRFQKNLQAIKLSKTIEQENRYATKQEQEILNK
FSGWGGIPQAFDHQNKEWEKEFKELISTLDYAEYEKAKTSTLDAFYTPKIIIDTIYQGLN
QLGFNNDDHTKEIFEPSAGIGSFLSYAKNYSDKYHFTCVELDTISANILKHLHPNQTIYN
KAFQHHLFDKPYDAFIGNPPFGQKKILDLNDPTLNKTSVHNYFIGNAIKNLKEDGIAAFV
VSSYFLDSKNSTIRNFIAEQATFLGAVKLPNNAFKKRANTEVTTDIIFFKKGKDLNIDKS
WLESVEYYDDRFDEAEKRGMHPDVFNDFRINEYFKNNPQNILGKMNIKSSQYGYSLECLD
DGRDLKIALENFTKTLPKNIYKYQETKIKLSYYRIDRESPEYEKYSKTLSKLKDGNYFEY
NNEIYMKIRSDDELVFSKPVLNEHDTRRIKKLIALRDQFNTLIEYEKNESSDLLVENQRK
YLNKLYDEFVAKEGYLNRDANKKAFREDVEANKILALEKNYSSGISKSVALKEGIDPIAP
SATKADIFSKEL
>fig|195.2220.peg.1900 Motility accessory factor
KDLNKPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFNKILSNDFENIQSIYLSLNEK
EEDINLAIEKIDEFKNK
>fig|195.2221.peg.355 Hypothetical protein Cj1162c
MKFKVKNVNCMNCVNLIKNSLEDEFGNIEVDLEQKILSLNLEENQVSNFTKEFQDLGFEI
VERL
>fig|195.2221.peg.1771 Motility accessory factor
ITTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVY
QSIKHCRDF
>fig|195.2221.peg.635 Putative methyl-accepting chemotaxis protein
MVDRISETEKAVIFQGETSRESALKIREISQKTQNVSKMALETEENSKNTTQVCQNNKKY
AEDTASQMEYIASNSSRVSQQIALLSEHAKNIGTSTELISEITDQTNLLALNAAIEAARA
GDVGRGFAVVADEIRKLAEKTGEATDQIAIINKQIQEETIATVGVIEESIPLISQGKSLS
EEVRDSVDLIYKQANDSLFKAQEVNQEVAAQVKLMEEIEEKIITVADISSKTQQAVSENK
NAMTELKNISDNLQAEIAIFKL
>fig|195.2221.peg.634 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQELANQEL
TQIALLESKSFRFIMMGIIIIALIISIVIAYLIVRYIKKSVGGEPRDVNRIITEVANGNL
TQPIHTEYKQSILYSISRMQDHLRNIVQKMITISK
>fig|195.2221.peg.1671 DNA primase (EC 2.7.7.-)
HRFFSAKNLDIKILKNNSENDYNEEPF
>fig|195.2221.peg.350 L-lactate dehydrogenase (EC 1.1.1.27)
MAKIGIVGLGYVGSASAYSIATQGICSELYLYDIKQDLALAHARDLEDMSAIHFSYTKIF
HVPNLENLASCDIIILAFRKESLKELPSRLVELQNNILELKDIVLTLKNANFKGKYIVAT
NPNDTITYYTQVLSQLPKNHVFGSGTNLDSSRLKKFLAKDLNINSKDIFACMIGEHGDSQ
FAALSNASVLGQNLLDFYKQKLGKDLDIQELEKAVISEGYFIYERKGRTEFGIGTSCANL
AKAILEDRKSLHPVSVVFDDIAFSMPAIIGKDGIEKVFELKFNEKEKTKLENSKQQIKNA
IQSVKDKNLSLFKRLFDFDIN
>fig|195.2221.peg.1554 Flagellar hook-length control protein FliK
MSNLTPSKTNTTHSSSSKTKEQDLKKSDNTTQDDTESFLNSLLNSIEETNEFLPDHMKIS
KKEVVNEAMDKLQNGVFSESDKISIFESASFMQILSLLDKLKADTADIKLANLSTQLSQL
VKTEANFNALKSASNLSELLNIAKDLGLNVKNIKVDRLLDLKATFPNLDKADFFKGAVDN
VFKEIINNKISNVSKNLNHNLENTTHTTSTHSMQKTNSKDSGSLLSQTLKNLDSILSSKE
SKHEKNDKVKSKIEEDTTDAKNTLKNIKNDEFAKNLTEELNIKDKKNQDNLNKESKDLNK
DFNKELNKNQEKNNLNQENIQDQIKI
>fig|195.2221.peg.356 Lead, cadmium, zinc and mercury transporting ATPase (EC 3.6.3.3) (EC 3.6.3.5); Copper-translocating P-type ATPase (EC 3.6.3.4)
MEELRIKIGKMTCVNCSNAIERACKKIDGVKDASVSYVNSSGVFLLEDQKKRKDIIAKIK
NLGFEILEDEQSLNAYKAKKHLELRKNLLLSIVLSVIIMYFEMFVKSSFSQNIQMALSFF
GIFYCGRDFFSHAFLGFKSKNLDMNTLVALGTLSAFVYSFLVYLQIFKEEDLYFSGAMMI
ISFVLLGKYLESKAKFKAQDYQRILENIDTKKTKILLEDESIKEISSSFVKSGDVLLVKE
GESIVADGVVLLGSAELDMSFLNGEFLPVLKKEGDEVQAGAVVLNGALRIKANKKAMDST
LEQIKNLVFEAGSIKSPLANLADQISKYFVGGIIFFAFLVFVFWVLKADLNTAFLHSCAV
LLISCPCALGLATPIALVVASANAAKNFILIKNPAALEKLALVKYAFFDKTGTLTKENLS
IFKHNLSKDDFDKLCQIESLSSHPIAKALHKDHFFDLKGEGRVIVGSGIKYKEDNDIYLA
GSAKFLHENEIDTKESDIFFDTFKEYIRVYFAKNKKCLGGVLLSNALKDGAKELVLNLKK
QNLKTFILSGDHVKNVEKIAKELQIDEFHAQLKSEEKLQIIQKFEKTLFVGDGINDAAAL
SAASVSISFSKANELAKKTGDFILIKDDLSAIFKCFKLAKKTRSIIKLNLFWAFIYNVLC
IPIAAGFVPFIALSPHIAALAMCFSSVTVVFNSLRLRKSKP
>fig|195.2221.peg.357 hypothetical protein
MQRRDFLNGMALAVVAGMTPLQLLYGKDSKIEDFTKEYYPPNLLGLRGSNNKSYKYAHML
RDGDKFGFSSIKPKENYDLVIVGAGISGLAAACFYQQKFGENKKILILDNHDDFGGHARR
NEIQLDEGTILSYGGSESFQSPKALYSKEVIELLKSLGVSIDELAKRFDVNFYPDLKLSR
GVYFSKENFGVDKVVNGNPRKVICDDIPDSKNNGKSIENFIKDFPMTSKDKRELISLFKS
NKDYLKGLSKEEKEEYMAKTSYKKFLEEKVKLSQKAITFFEGMTDDFLALGIDAISCEDA
RISFLPGFDKLGLDPIEGEALAEMEEPYIYHCADGNATVARLMVRKLIPTVSQKGKDMDD
ITLAHFDYSKLDDSNNKVRLRLNSTVIHVENTKNGTLISYINQGKKYRIKAKNVVMANYN
NMIPYIIPSLPKEQKEALSKNVKTSLLHTKVIISNWEPFIKLGVHEIYSPKMPYARTKLD
YPVDMGGYHHPRDPKKPICIHMVCSPLALANIQGIDLEGLDARDRARVGRNLLFTMSFEE
HEKIIRGQLQGMLGTAGFNHEKDILAIVVNRWGHCYSYTENSLYDDPKIAEQTRLIARKP
FGNIVIANSDSDWSAYMHSAIDQAYRAINEIKA
>fig|195.2222.peg.1769 Putative amino acid activating enzyme (EC 6.3.2.-)
IQNPLHDNYLDLLYKTGDIVSYNEFGELLCYGRADNQIKYMGHRIELGEIESVINSHVNI
KNSACIFKEDIICFYESEEEINFKDFL
>fig|195.2222.peg.1771 hypothetical protein
VISTFPNDKTSFSEADLEQLPKGLNYGRNENKEKIVKNIFNAEQFHEAQAIKYSTMNLGM
NLMKLDF
>fig|195.2222.peg.1155 Putative amino acid activating enzyme (EC 6.3.2.-)
MTTHIYNFLEKSLIKFSEKTAFVEPFAKERKEITYKDFDLFSKKLASEILKTLKNDNPTQ
VPVLIILPKGIDCLISFFGVALSGNFYTLLDEKSPKERVEKVIEVLKPKLFITSKDLNFN
LDLPTLYTQDFESFNIDESLIKHAKEKHIDTNLLYVFFTSGSTGIPKGVSIAHKSVIDYT
FWVCETFKFDENEILANQAPFYFDNSILDIFSSVKSGATLHLLPNHLFAFPNKILECLEK
EKVSTIFWVPSVLIYFANTEALNNFSLNALKKILFCGEIMPNKQLNIWRKHLPNALFANL
YGPTEITDVCSFYIINRTFKDEELLPIGKACKNTELLVFDENMNFISPKQISVKGELFVR
GTSLSLGYYNDKEKTKQAFIQNPLHDNYLDLLYKTG
>fig|195.2222.peg.1572 Membrane protein
FRNFTQNSDNFAEAKLKQVLLLIFLFLASVFFASLAAINEFGAVDLVFLMICLLLLVMGI
INLGLLFKQIRILKSFSKEEMKEFLTQRMKKYAKK
>fig|195.2222.peg.768 FIG00470336: hypothetical protein
PHLISIISKNLTTPLPFFRAKKHMSEIVLKLVRMINTRHFDKNFNQIDFSKIKNLLPYDA
RLSDNFFKQIDTKYEKIIGINAFSNNSEYRGFNFFIKDWIGLARQLSLKYPKFLFILLNF
STNSIQYNIDQNANLKVFCNNKILLLW
>fig|195.2222.peg.471 hypothetical protein
MFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKEIDFTRYHGTYDDT
LFKNIFLYLSDK
>fig|195.2222.peg.1737 Putative amino acid activating enzyme (EC 6.3.2.-)
LPSYMIPKNFIKLDKFKLNQNGKIDRKVLKELV
>fig|195.2222.peg.941 Adenine-specific DNA methyltransferase
MDIFKKYTSEIQAIFEGKNYNEHSFRTCFENLLNELKPKEVKIIHEPKSEKGQGSIRPDF
KTYKLIDKEKELSYNHLVGFIECKNLDVDLNLHLKGKQLSKYLQISPNIIFTNYKRFILF
SFEKVVFDIDLLDDKLDLKEENISIFRNLLKAYFDDNSTTIKSKQELVKVLSTQSFYLSN
ALKISFDESDANSSFKRFFRKTKDTFKNIEKIDLKDEEFCDILAQAIVYGIFVSYIENDD
YD
>fig|195.2222.peg.1687 hypothetical protein
VISTFPNDKTSFSEADLEQLPKGLNDGCNQNKEYIVTHIFNAEQFHEAQAIKYSTMNLGM
NLMKLDFSPQSMEQGPSNEGEFNPDMSVYPQNEDGNYSKEALFMSFLKSYPPFPSPNQVV
LSPEAKVREAKLELEMKANPSFDISLDDIMTGKVDFASLLKGYAQDGWLDAGIYAMEKGV
AWQNTSIGYGGAWFERELNQAKANGWKASNQSIDSYVNSIMDRLNNLLGQTRV
>fig|195.2222.peg.1087 Membrane protein
MAFMSFSGFFYARNDLRLFKIEKKSEIKSFFYKDYTLASFKDELNLNNEIFFYQSLKENL
FKENDE
>fig|195.2222.peg.1088 hypothetical protein
MSIFSINDNSNYNSILSQAKASKESKENSKISFANAFLKQNASKLNEIQSANSQTLIRSE
VLNSTNTTNTSNNTNFSISSKT
>fig|195.2222.peg.937 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNEKNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLHEMLSKNSKALRVIDYACGAGHFLNTYANELKRYLTEDELKEHYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIIL
PSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLRKKETFKQENHLI
SQDYSLIKERIEAENLKDNESFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLTELEAFK
DYRNAFRQTSDYKKLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLI
IKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNETKLNTLIYKSFLN
TLDVIPQELQTYAIKARLVDMIDFEKVEFNKAISLNPKTQREEIKSQYPLVKLKICGDFF
MGGTPSRKNINYWNGDIKWLTISDYSNHQVIMDTKEKITREGFKNSNAKMIQKGAVVVSI
YATIGRVGILGEDMTTNQAIVAIIPNEEFINKYLMYAIDYFKFQLYNEVITTSQQNINLG
ILQNMVIPKPPLEIQKQIVAECEKIEEQYNTLSLSIEEYQKLIKAILQKCGIIEDDQEYK
LNSILENLQKLESKLDFNLLFSFIDDFTNARQEDLKKFKEFVKNIKAILGTFSTPPKQGW
NKEKLNEIVSIQSGGTPDRKVKEYWNGNINWVKSEVCQNCYIYDYQVKEKITELGLQKSS
AKLLKKETTLIALVGATIGKIGFLTFESATNQNITGLYPKNLKILNTKYLYYACMGLYGQ
FRKLGDFAMANSNFIKNLTISLPPLEIQEKIVQNIELVEQQIDFLNLKLEFLEKEKEKIL
QKYLFS
>fig|195.2222.peg.1765 hypothetical protein
RSEVLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQVDLSTDTAYGYSV
DKDGYMGSDFNKAAGLPEDFKIHKSTLDEIERFNQHNMASETSGNYYDSFDMASIVKSHY
NSFNQVISTFPNDKTSFSEADLEQLPKGLN
>fig|195.2222.peg.690 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MHKINVVCFGSCDMYPTYGFVGGIKDIGSKVISFGESFNGVHSVLYHLLRKENKNIVNNA
DLFVVGITETTKETACSDMEMYKIFYKKLSDIGKKVVIIIMPHATTDSDFYGNFHQNQCE
FFGFNLIDIKHFCIENEIYEFYTKYYDSRHPFYSFMSGISKRVVENYEKLQYPKKTTKMD
NFNFEIYPIKEFVSEDMFRCKKARTFTTYENIIEIPLGSKIKFPISCIGKKLVGIHMFNG
FIGVKDISKFSIENKDQKFLLQTPPYNRIVQISENFVIDDQSYICAYSNDSAKIIHPLYR
YAQTKETNLGIVAFFLSENKKISFEVANTQNFRLSQEYDFAYLLNFLIEGKNFIEDYNKK
QDIIRINPLQNQITTLINEKLILKDRIDQLQNTINSLSVKRQQLEISNLKQDLTNRKLQT
KQLSKKSSIKMSDFMSRIAMVNSTSAKTRIQNQLSYKLGQAMITNSKSLLGYIRMPFVLS
YIKDKHKQEQKNYQEKIKKDPSLKLPPLENYPDYKEALKEKECLTYKLGEALIKANKTWY
KGGYVKMWFEIGKLKKGFKKK
>fig|195.2223.peg.1200 Membrane protein
MTQEQKISFFKIKRLSIYIFFCALYNFFYFFSYENVGSLHCEFLCISGRFLCFFSWIYIV
LAFIFMVARIY
>fig|195.2223.peg.462 UPF0394 inner membrane protein YeeE
MPLQDNLNTFKISDGTFYQSLGISPWILVLALSLVVGFFVIRELRKPRLKVARLKPRKQG
ISHILFEKSWHPFVTAVLVALIAILAWPLSSLSGRNYGLGITTPSANLVQYLSTGDVQFV
DWGVFLVLGIALGSFLGAKLSGEFRFRLPDKKTLAYASIGGILMGVGASLAGGCTIGNGL
VETSLFSYKGWVATVFFLIGAYIATFYTIILPTRKATQKI
>fig|195.2223.peg.1771 hypothetical protein
SITKVKTKIFEFLQEKDNTSAEISKIKLNDIKKSNKNILNP
>fig|195.2223.peg.461 UPF0394 inner membrane protein YeeE
MLSGIIVGLLLGFVLQRGRFCVVGAYRDVFLSKKFTIFIALFIVVALQSIGVWALHSLGY
ISIKPQEFYWLSTIIGGIIFGFGMVIAGGCATGTWYRAGEGLIGSSQLYCFMLLVQVL
>fig|195.2223.peg.7 Thiaminase II (EC 3.5.99.2) involved in salvage of thiamin pyrimidine moiety, TenA subgroup with Cys in active site
MKFQNYIIEGEIELHKSILKLGINADKLNVKDESLTNIAYTRYMLSVGESGDFLDMLVAL
SACAIGYGYIGAEIYKRLGKEKLQNHPYKEWILTYSSDEFQSEIKEFEDFLNSYTQQISQ
EKFENLSEIFYNVVRLENAFWEHALQMKMDI
>fig|195.2223.peg.703 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MLEARWNKENKDQKPKILFLCDRVSLRDQALGEFNAVESDCKVISAEEIRKNDGKIITNA
NVFFGIYQSLAANSKDQENTQEEQESKFYLQYPKDFFDLIIIDECHRGGANEEGNWACVL
EHFSSATHLGLTATPKKSDNVDTYRYFGESAYEYSLKEGIEDGFLTPYKVKRITTTLSEG
YVYNPDDLIEGELEKGFYKMSEFERNIHLPQYNDFLAKEILKLIDPMDKTIIFCANQAHA
SDIKRAIDKFKSVKRDDYCVRVTSDEGKIGLEYLKQFQDNDKSYPVILTSSKMLTTGVDA
RNVRNIVLLANIGSIIEFKQIIGRGTRVYEGKDFFTIIDFVGATKLFYDPKWDGEQVKDE
DKEDKSEIWGKQNKKESDKTKETESKKAITVHLKGTKLKVLDINTSYLGSNSKPLSTKEF
LEFLIGKLAEYYDDEVKLREIWSKQETRLNFLKTLEKDGVDENALKDLGEIFDKKDCDIY
DVLAHLSFNAEIKTRQERVLQVEKSEFLKRFQKEKALKFIEFLLGRYQQYGIKDFDRSLA
PLIELSSLGNVKEIVSEFGGVENLKQSVDDLQREIYAR
>fig|195.2223.peg.1802 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MIAYIHIGVEKTGSTSIQEFLYHNKDNIFKQNYFFPQSIGLKNHWDLAFLAYSMDKKDSY
ILINSLKNLQDIQEHKKNILSKLKAEIKHAENIVFTSELLQSRLDHKKEIIRLKKILYML
NVKKIFVIFYIRDPLDMFKSLCSEAIKWGEIDSFKLLKKGLQYESGFKKNLSHFNYICNY
KQIIQWWQQIFGKENLIVRLFDKSEFYQGDLLKDFVHSIGLKWDNEFVIPPKQNESLDLI
GVEILRRVNNLLPLFVNEDRNYLRGDLNYFIQKYFSSKDLFLKFQPPKEIIQSYIDSFEE
SNEWVRKEFFPYKERLFPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLITNK
TTQIQNLNQAIKNKDELIQN
>fig|195.2223.peg.1626 Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13)
MFGLIFASFLCLAPLYFSGILSADFYIPFYKYPLFNMYIFALFFWILVLISSSNAVNLTD
GLDGLATVPSIFSLATLGVFLYLSGNLIYSEYLFLPKINGLGELVVICAALIGALMGFLW
FNCYPAQIFMGDSGSLALGGFIGFLTVVSKNEILLLLVGFVFVLETISVILQVGSFKIWG
KRVFKMAPIHHHFEKVGWVENKIIVRFWMIALLSNLLALASLKLR
>fig|195.2223.peg.713 Mobile element protein
MTISHKIALIPNNKQKTYFHKAFGCSRLAYNWGLAKWQEYYKQGIKVTHLDLKKEFNAIK
KEQFPFVYEVSKYATQQPFLNLNLAFKKFFRDLKGGKLSYPKFKRKKEFAGSFYLGGDIV
KILQKDNKAYLKVPNLGLVKMRENLRFNSKINSATISQKGDKYFASFSVEIPQDEFIKTH
KIKENKGGILGIDMGLKSFVSLSNGLSINAPKPLNKLTRKLKRVSRQLSKKQHPKAKGDK
TKKSNNYLKQNLKLRKIHTKNSKYAQ
>fig|195.2223.peg.1629 Translation elongation factor LepA
MPKFLLFKTDRTNTDKDNEITQITNITSKELSSLFSYEFKSDNGVSFNKRGSGVKRLFY
>fig|195.2223.peg.747 hypothetical protein
MDKNSNDEYIKKIKIKLKREETINIDFSHYQYEFFELSPMLIKKNKLQNFILSHNKE
>fig|195.2223.peg.1804 Motility accessory factor
VSTGPSLTKQLPLLKKYANKATIFCADSAYPILAKHDIKPDYVLSLERIPLTSEFFNNDF
GEFDRDVLFVCVSWVYPQTIKYLQKNNRNFMLISRPSDFIKNINFHQYGYVGYGPSVAHM
AYEFATHLNYKNIIFIGQDLAYAKDGFSHTKDYSNLDKHEGHFQRDKGKFQCLAYGGNGK
VESSGIWTMFRFSLQNTISRNIISTTYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPF
EKLEPLSLNKQNEFLLKA
>fig|195.2223.peg.1815 Motility accessory factor
MNLLEKNIQALLSGVNEPLGNKLLNFIQN
>fig|195.2223.peg.704 Type I restriction-modification system, restriction subunit R (EC 3.1.21.3)
MQNLYSEDDTRVKLIDAKLYASSWSEENIIRNYYFTDGRKLIGNKRAERKFADYLLKFQN
NNLAIIEAKKQNKDALDGLSQGIEYAKTLNVPFVYSTNGDKIYEYDLRVSRGEYIENFPS
PNELFQRVYGNLKEWQYKLLTQRELYIPQKTLRYYQKNSRR
>fig|195.2223.peg.1613 C4-dicarboxylate transporter
MEKKKIPMLILCVLIALAFWIIPTPIGLEENSWHFLGLFIAVIMAVILQVMPFIAIAIVA
LSGITTTQLKI
>fig|195.2223.peg.934 hypothetical protein
LLESKAKSLKLEPNNYIIISKNGFSKEFYKICKQDLLLLDLNDFKILLEEDK
>fig|195.2223.peg.1805 Motility accessory factor
MGGGYNENLLYQDPIKELQAMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVV
FEKDIEIIWIMFHILDFSNELQNSRLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELM
SHYYERFHEDVLELNKKLVQYFKDSIISHGNDSTDTLQGIEQFVYNLPQMITHPSYKELL
S
>fig|195.2223.peg.1635 ABC transporter, permease protein (cluster 9, phospholipid)
ILSFDLLKILQKFINFTGAFFTSLFLCIKNPKNFRFISFLYHIENSAFKALPIVILTALL
VGVVLAYQAAYQLAQFGANIFIVDLVGISATRELAPLIAAIVIAGRSASSYTAQIGVMKI
TDEINAMNTMGFRSFEFIIIPRVMALVIAMPLIVALSDAISILGGMVVAKINLDISFGEF
LRRFREAVEMKHIIIGLAKAPIFGFLIGLIACFRGFEVKNTTQSIGIYTTKSVVNAIFWV
IAFDALFSVVLTIMEV
>fig|195.2223.peg.1182 Ferrous iron transporter FeoB
MKVGNFSGVTIEKASAKTFYKNYEFEVIDLPGTYSLDGYSEEEKITRHFLNQNDYDVIVN
VLDATNLERNLILSAELLSLNKKMLLALNMCDEAKKEGIELDTSVLSQEFQSQVVEISAK
TKENLELLLQKIIILFESKFIPRSQFYTPLCEKSPEKEDLLYFINELSKKIITHKKEERN
LTKKIDALLIHKFFGLPIFLFLMWLLFQLTFSLGQIPMDYIESGFNALGELVKNNISNTF
IASALADGIIAGVGAVILFLPNIIILFLGIALLETTGYMSRVAFLLDGILHKFGLHGKSF
IPLITGFGCSVPAFMATRTLKNKRDRLLTLFVINFMSCGARLPVYVLFIGAFFPSEEAGN
YLFGIYILGAILGLFAAKFLRMTAFRGLDEPFVMETPKYRMPNWHLVWFMVFNKAKMYLK
KAGTFILVASLLIWFASNFPNNESNLDDFSAQERAVEQSYLGQFGKTIEPIFSPLELD
>fig|195.2224.peg.1789 Phosphomethylpyrimidine synthase ThiC (EC 4.1.99.17)
MKTQMLYAKEGIFTKEMEIVAQKEEVSKDFLLANIACGKIIIPANINHKSLDPNGIGLGL
RTKVNVNLGVSNDCVDYSEEMKKVELAHKFGIEAIMDLSNYGKTSRFR
>fig|195.2224.peg.1156 Acyl-phosphate:glycerol-3-phosphate O-acyltransferase PlsY (EC 2.3.1.n3)
MENLIIYAIAYLLGSIPFGLILAKQFAQINIQ
>fig|195.2224.peg.1822 hypothetical protein
MLINQSFEIDSCDDVELNIKRTSKLEYRISYDDEKEIKAIVFIIGGYGANANIYFLDSYR
NYIAKNFDVVAVHVFYHCFCQRRSDVEKYSAFTIFTKDDVSNLSQVLLEIGVNINVNLEN
AQQCYELLNQNITTLKSQGKLAQNYQAKFTSTFVPPNGDYQNYGIMAAIDHINALKDLVK
RFPKFADLPKIYGGG
>fig|195.2224.peg.1567 LSU ribosomal protein L22p (L17e)
MSKALIKFIRLSPTKARLIAREVQGMNAELAMASLKFMPNKGAKYIANAISSAVANGGFE
ANEVVVKSCRVDAGAVLKRFRPRARGSASRIRKPTSHILVEVVKAEVKAEEKKTVAKKTT
TTKAPAKKTTSTKKVTAEKES
>fig|195.2224.peg.1419 Minor pilin of type IV secretion complex, VirB5
MKKNIFGVNKAIGKSHPHENGERLISLDYNYTKEYNYNYEICVTQFNYLFSEVKSSHRVA
ALWLTPQNYIQKFKKSILIFTSINFALLFTWCWYSCS
>fig|195.2224.peg.561 hypothetical protein
MFIRALRVLFILSFIADLTIIGLFVGIPLFLILWGIQYIIYGEKNPFFVFAKHNPKPYQE
EDIIDVEVEDEKPKKILKNIFRKLEGLMRWI
>fig|195.2224.peg.1437 Tetracycline resistance, ribosomal protection type => Tet(O)
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYPSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKPEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQN
>fig|195.2224.peg.562 hypothetical protein
MRNIGYIDEFFRKILKDEDRNTVKCLQKALCNVILARYDDFAKDYKCFRNFKEYQTFEEC
LAFIFQIELNRIEKTLSLLEEFKNIQNDITRCMNVKIDNL
>fig|195.2224.peg.300 Phosphoserine phosphatase (EC 3.1.3.3)
MKLVLFDLDDTLIQGDSAKLWLKFCVEKGFLPQEYLEKIVFYQKQYQEKKLDMDEFMTFF
LQSVKGKNEDRISSLVDEFIKIYIKPYEKAKELIIKYQDQRCIIISATAEFLVRKIASFF
GGERKHSHKMRACG
>fig|195.2224.peg.1405 FIG00471323: hypothetical protein
MLIVTFLSFLFLVFEFFIYENIAVFFQDCFLMSVIFIIGMIGLFHTCKGLRKYKEILKSN
KREEFI
>fig|195.2224.peg.563 hypothetical protein
MKGIISGVCAIALLVSANTLNADYNEKLSIETKNTQFALKTIKTEDYISLCSEVVKLNRW
AFYTSLCDQNYFLTLEGKNKIKEKQKIRKIIKQLNKTITTSKKRMSDKNFERFGNADLRV
YYSSLATKNILETILDEDFIKITGGFDTSFFEEDFDIIEYGKGVEEAKEHIKAIV
>fig|195.2224.peg.534 hypothetical protein
MEVFICVVDLTTAIVKLISIYLLYKIVKR
>fig|195.2224.peg.1425 Outer membrane and periplasm component of type IV secretion of T-DNA complex, has secretin-like domain, VirB9
MKVNKGSEDIAPNFAYDDGVFTYLGFDNTKTFPAVFMYDNGKESILNTHIKKDGNYDVLV
VQKIAKQILLRSGDKVVGIFNRGYAKNPLNKTRETSNENIQREINKK
>fig|195.2224.peg.925 Methionine ABC transporter substrate-binding protein
MELLEKAGLIELNQNTLKTPLDIKKNPKNLKFIELKAAQLPRALDDVDIAVINSNFALGA
GLNPIKDTVFREDKNSPYVNYVVVRFEDKDNEKTKIMDEILRSDKFRNIIDEHYKDVLIP
AF
>fig|195.2224.peg.1815 Pseudaminic acid biosynthesis protein PseA, possible Pse5Ac7Ac acetamidino synthase
GGGGSPQIEYGGPASSKNKNILGREWLEEFGGLLGNRASDMLGVNGITEKDLFLYTYPSD
EELQRVGVTGLFLGYYFKWDYKKILEISKKYGFLTLDHPVETTYENFENLDCYSNHVHDY
LKYCKYGFGRATDNACLDIRLGYISREEGVRLVQKYDGKPPKKAIKKYLEFSGFSEEEFQ
KIVDSFTNKKIFKRDENGKFIRDYDGSLVRKDECVLK
>fig|195.2224.peg.1254 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MEEVQAIVKIANEFKIPLFPISTGKNLGYGSSAPQQRGQVVVDLKRMNKIIEVDDKRNFC
IVEPGVSYFDLYEYVEKNNLNVFLDIPDPGWGSPLGNALDHGWGYSYGMYRDHFGSHCGM
EVVLANGEILRTGMGALPKAKTFAENKYGYGPYVDGLFSQSNFGIVTKMGFWMMPKPEHY
MLLSIKMKKREDLIPVVEILNYLEDSFIVGWPQYFSPLNPPYGKPMNAELKGYLTSKNGL
PDMDKIQNYALKNKIPYWNIDVSVYGCKEVCYANLEYIKQRFKIIEGVDISIVQEFSLPL
NLEQKKQLKHKVTLGIPNMEIFWLSTRGEVLEPSDGHVWFSPIIPRDGKELLKCQEVYMN
LFREFGEESPITPFSHPRSWMYRAFCFMLAFNNSRTDKAHN
>fig|195.2224.peg.1383 Tetracycline resistance, ribosomal protection type => Tet(O)
SGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPAD
FRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEV
ILKGEIPARCIQEYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMF
HKLA
>fig|195.2224.peg.948 hypothetical protein
HINALKDLVKRFPKFADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSAVPPLIYI
LGREMEGGCDYVFNDPNTLIECFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQK
NKNIIYVSYHSDKDPLTPANFKEQTMQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGI
PDKALFRKELPLMLEKLQKRKSLMQENSISYPCGNKVFIFKDVENQLKLIIN
>fig|195.2224.peg.1424 Outer membrane and periplasm component of type IV secretion of T-DNA complex, has secretin-like domain, VirB9
MKNITLAILSFLFLAPAFALNIPKTSSFDKRIAYAVYNANDVFQINAKNGYVSVLEFGID
ERIINTATGFAEGWDLIEKDNLLFIKPKAYKTQLVQQDNNMGESQVSQEFVLDPNPKDWK
TNLIVITNLNTYVFDLKLVNQNNNTTYKLSFSYPKKRLRSN
>fig|195.2224.peg.1420 Minor pilin of type IV secretion complex, VirB5
MPCFSLGAGIPVVDVTANQQMATQNAKQVAEWAKDASRWTETVSHYQKQIQAYKDELLSK
TGVRDSVSFVKDIKQIYSDFAESGQNIQSFYNDVLRDPQKFLSDKGNEIFGKYTSFDRCN
FDFLSQSEKNICKMNLITYAAQVETYNQASKQMDTISQTLQKLQDKLVNSKDIKESTDVG
NAIQLEVAKIQMVKNQVDLANSSYENQRRIQEDMAIQEYSKSFDYKPQVSTKELMQKARE
QNKQ
>fig|195.2224.peg.1798 L-carnitine dehydratase/bile acid-inducible protein F (EC 2.8.3.16)
EVVDRLDEAKIANGNVNELNQVWEHPQLKARNRWREVDSEVGKIPALLPPATNNNYEARM
DKIPALGEHTESILKEFGFSDKINLFKEKKII
>fig|195.2224.peg.1611 ATP synthase beta chain (EC 3.6.3.14)
MQGFISQVLGPVVDVDFNDYLPQINEAIVVNFESEGKKQKLVLEVAAHLGDNRVRTIAMD
MTDGLV
>fig|195.2225.peg.1817 oxidoreductase of aldo/keto reductase family, subgroup 1
MKYQILNNGLKIPIMGFGTARLQERECFNVLNNALECGYRLIDTAQMYKNHKDIAKVLKE
SQIPRKELFIESKISQNLSYLQAKDMIYKILDELV
>fig|195.2225.peg.1856 hypothetical protein
VEKFDCKNTKNILDKINNLYDFNHRNDKIDTAKKQ
>fig|195.2225.peg.618 hypothetical protein
MKKIIFLLCLCISFVFAKQIYIVHGYGSDENYGFLPSVAKNLKAKNHEVLLLSFPNAFSP
KLDEWMQTMSQNFTKLDENTFFITHSLGGVAVLDFLNSLDERTKIGGVIMVHPLMNLWQN
CLF
>fig|195.2225.peg.1731 hypothetical protein
MKHFIFGGLLGLGALAFLAGCGDEAKTNDYYKTHLDEAKARVAECKKMEKMNETQQRDCS
NAKW
>fig|195.2225.peg.1865 Motility accessory factor
NFKNSIVSYGNDPLDALQGIEQFVYNLPQMITHPSYTKLLSKRKNLSDTAIIVSTGPSLT
KQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNNNFGEFDKDIV
FVCAGVVHPKTIEYLKNKTFIITQKVLAFPYYINLKNFCYAAVGFSVAHTLSYLATHLSH
KNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2225.peg.1818 hypothetical protein
MIHEPYENSLQIYDAMQEAFENKLIKSLGVSNFNENLLFDFIQKVTIKPVINQCETHLLY
QQKSLHKALQKHDIFLQSWSPFIANKNKIFNHPLLLCMAKKYSKTPAQIILNFLYKLGIL
LIPKSSNLQIFDFELEDEDTQKLIYLDQNKSFFGWYD
>fig|195.2225.peg.1834 Legionaminic acid biosynthesis protein PtmG
MIYCDHCVMPNTRPGINFTKDKEGKNICSACINHKNKENIDYKARFKELEVLCDKYRRMN
GKFEYDCAIAVSGGKDSHFQVHIMKEKLGMNPILFSVEDNFTMTEAGKKNLKNLSETFGC
HIISLKPDIKTQKKVMLKTFEKYGKPTCLLID
>fig|195.2225.peg.1739 hypothetical protein
MYHILGQKQKIYILSQENETKWKIFYKKCIFYLKKMRKINIQLLKMYHFIRKKP
>fig|195.2225.peg.1808 hypothetical protein
MFKESKLIEELKREYDEKLKKLRQKEKENKERIYKKFSSALFKDFEINEDFK
>fig|195.2225.peg.1871 Motility accessory factor
KVLAFPYYINLKNFCYAAVGFSVAHMAYEFATHLSHKNIIFIGQDLAYAKDGFSHTKDYK
NLDKHEGHFQRDKGKFQCLAYGGDGKAESSEVWTMFRFFLQDTISRNIISTTYNCTEGGA
RIEGTIEKPFLWACE
>fig|195.2225.peg.752 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIGIKNHWDLAFLGYSLNKKDSY
ILNNSLWNFQAIKQHKKNIFSKIKDEVKFNHKIIFSSELLQSRLTRKREIVKLYTFFKKI
GFTNIKVICYIRDANEMLRSLLSEAIKWEEIDSFELKEEKEEYKLGYKKNLFHFHHICNH
KQTLQWWGEVFGKENLIVRLFDKNEFYQGDLLKDFIHSIGLEWDDEFIIPPKQNESLDLL
GIDLLRRINKFLPLFCNNARNIFRGDLHHFAVKHFTSKDSHLKFQPPKEVVQSYIDYFEE
SNEWVRKEFFPHKERLFSKKDLTDYKENYELKEMKPEYRDKIAEFIADIVSTKNQNIADK
TIIIQNKDKVIVNQTNQINSLQTTLKDNKAHLIQAQNLNNTLNKTIQEKDIIINSNTNQI
DQLQNNIKEKIKQLHILQNSIQEKSTQLGQLQSKLSFQTKYGTAKIRIQNQLSYKLGQAM
IVNSKSFLGYIRMPFVLSYIKDKHKQEQKNYQEKIKKDPSLKLPPLESYPDYQEALKEKE
CFTYKLGEALIRANNNWYGGGYIKLLLEIRKLKKEFKKK
>fig|195.2225.peg.1876 hypothetical protein
FSTSKELELLFGMKFSDDSAGEFNKFLSSNSAPKSIDIKA
>fig|195.2225.peg.1874 Motility accessory factor
KNIIMIGQDLAFDKEGNSHSKGFDFGEKFSGEENIDKLKIPAYAGKGEVLTHTTWNDYRI
KLEYLFACNDQKAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKNRSD
KLLVKFKEKIQ
>fig|195.2225.peg.699 MSHA biogenesis protein MshL
MIRLIFIKILFFTNLIYAMECQKRLFDININEDLSIEESLKELASYCSFSVVIKDTIAKE
KLKAI
>fig|195.2225.peg.1338 hypothetical protein
MLINQTFEIDSCDDVELNIKRTSKLEYRISYDDEKDIKAIVFIVGGFGANANISFLDFDR
EYIAKNFNVVVIHVFYHCFCARQSIDQKYNPKLIPNQDDLERINGILKNINLGHLSVNKD
NFESIIPLIEQKVNKMKQAGLVDESQKIELSCDFIPPNGDYQNYY
>fig|195.2225.peg.1337 hypothetical protein
MEIIKTIIDHINVLKDLVKKFPNFKNLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSG
VCLPFLACILGREMNQGEFYFEGSGYRLYCFVYKYWNRNMNSSYYFGDENYLIRAILNSN
HLKIQANIDSDIVFSSYHSLQDTRASAQNKIELYKCYQELGYDATLHLIKDENDVDGRFI
KSLEHGLRMTDKALFRKELPLMLEKLQGRKSFMRENSISYPCGNKVFAFKDVGDKFKLEI
KD
>fig|195.2225.peg.841 hypothetical protein
MLKNPKFQAFFFAFLAAIFNAFVGIFSVFLFKKGFMSSEVAFYKCFVASVILFVMLIYMR
KLTTLLAFIKQKIFTLLLLAFFGFFMLYHFESAAYTSMGVANVVFVLLGLWMIFLAEGGT
LENFTHLKGLVNAILAGIGYALFLFFTRKLKLGFGLIPLCALLFIGSLYLSIPLFGANLN
LNFSLESLFCF
>fig|195.2225.peg.1732 Conjugative transfer protein TrbJ
MKHFIFGVNQKSKKLSLALISSLIIGNNAFAGGIPVIDVSAIANQVKDYAMQLQQYEQMY
SQLQQQIQMVQMQKQNLERLTKEDWDNLGTVLYQTRNVMNKVNGISYDIGNVSRKFEDTY
KNFEGYSNDLENATNESERNKIYSDRYKQIAETNQNTFNGTLQQLELRYQDLESEDVLIA
KLKQNSQNSNGNLQAVQATNDLLAYQIDEIRKLRSVIMDQSNMLTNYLASQNNQRIMQQA
KIDKFIEDTGYIEKTWGKSNPDALKWK
>fig|195.2225.peg.1788 hypothetical protein
MILDTITKIITIVGFCLAFFQLRNVIKNTKVNVLKTEFDIFGKISEKEKIFVDCYEQSML
SSEESKTQEYYSLYKKSKEQYLSELNLVCLYILEGYFTRKHFFQEYGSKIFSMYDEIKDK
DYTSINKLCKKYRCELSKYKK
>fig|195.2225.peg.1833 Legionaminic acid biosynthesis protein PtmG
MFIDRLIYSYPFAMALKFNTPLLVYGENVSYEYGGSDTEETPSAKEIFLNGVASDLNINE
FIDDEIKEENLQLFFNPNKDKLDKLNPIYLSYFVKWNSYSNYIFAKSRGFTDLEGEWDRT
MCAENFDQVDSIGYILHAWMKYPKFGHACASDYAARFVRYGLLSRKEAIELVQKRDHKLD
NKCVEDFCNFIGISKTTFWKIVEKHYNMDLFYKNDFGEFKLKNKLQ
>fig|195.2225.peg.1430 Channel-forming transporter/cytolysins activator of TpsB family
MIKELTNFIVANGYSTSSVTIDELDQERDILFLDLKYGFVGEVYLNGDNNTTRLDFGMPL
KKGDKFNIYDLDTGIENLNNGARDVKIAVKASENYGYSDIFINLKSKPPDLILDFDNSGY
KAKGEYKASAYLSLSNILNLNDSIRFGFIKGLLKDMSQERENVYVANYTLPIQSYQLSYS
MQYSDNINMIEGYDNSFIKNTDTSLRHKIMLKKILHCTSKDNVRGILKRTCNYP
>fig|195.2225.peg.617 hypothetical protein
MPILNDFIKPKLDYKKLDNMIIHKIIISAKDDKVVPIWVSENLAKKLNAKFIQTPNGGHF
MESKGFKDLPLVIEELERIK
>fig|195.2226.peg.1749 Proline dehydrogenase (EC 1.5.5.2) / Delta-1-pyrroline-5-carboxylate dehydrogenase (EC 1.2.1.88)
GKTFLEIDPEVSEAIDFTEFYPHSLKVLREQNKNTQFSPKGIGVTIAPWNFPIGISVGTI
AAPLAAGNVVIYKPSSLSTLTGYMLCKCFWDAGISKDALIFLPSKGSDISKYLLVDEAVK
FSILTGGEDTAYAMLKANPTLLLSAETGGKNATIVSKFADRDSAIKNIIHSAFSNSGQKC
SATSLLVLEEEVYEDEEFKKTLVDAAASMAVGNPFEFKNKLGTLADKPSAKVEKALNELA
PYEEWALKPQFLENNPYLMTPGIKYGTKKGDFTHMNELFVPILSVMKAKDLKEAIEIVNS
TGYGLTAGFESLDEREWEYFHTHIEAGNIYINKPTTGAIVLRQPFGGVKKSAIGFGRKVG
IYNYITQFLDISTSEADENLLNNEFVKTLEKIDLGTNEENKKALNNAILMAKSYAYHYRN
EFSVSKDYVNIRGEDNLFSYTKIKNLAFRVCENDNLQDILGVIIAANILNIPLSVSYEEN
DKISLVKELCKAINLNLEITNESKAQFVSRLKNFERIRYHGKVSVEDEIYQEAAKEAKII
IREKPLLNGRFELLFYHNEKALSVSFHRYGNLGIRALNH
>fig|195.2226.peg.1682 Propionate--CoA ligase (EC 6.2.1.17)
ATDPLYILYTSGTTGSPKGVIRSNGGHSVAMKWSMDNIYNAKAGDVFFTASDVGWVVGHS
YIVYAPLMNGCTTIVYEGKPVRTPNPSAFWRIIEEYKVNVLFSAPTAFRAIKKEDPKGEW
IKKFNLDSLRSIFVAGERCDSDTLKWIEKLTKKPVIDNWWQTETGWAIAANPLGLEAQVV
KAGSPTKPMPGFNLKVLDEKGQELGAGKKGILCLKLPLPPACLMGIWENDERYRRGYLDQ
FPGYYLTGDTGYIDKDGYVYVLGRMDGIINVAGHRLSTGEMEEIIAKHPDVAECAVIGVN
DELKGEIPMGFIVLKEGIERDHRGIVEGVVALVRQEIGAVASFKIATVVSALPKTRSGKI
LRKNLREIADGSTLNVPATIEDSNVLKACEKAINALGYPKNKGEK
>fig|195.2226.peg.1129 Proline dehydrogenase (EC 1.5.5.2) / Delta-1-pyrroline-5-carboxylate dehydrogenase (EC 1.2.1.88)
MIQKSLALAEELQGKIEANISNSEKEFHAKMQKLLNNPENKVMLIELLDRSFRCKDKRAS
FELIEHTLNKYGIADFFSAFEKFLLFSFLNFGKFAPNLSVPFFVKHLREDTKAMVLDANP
SVLEPHMRKRKDQDNITLNVNLIGEEVLGEAESKYRIQKYEEALKSSYITYISIKITTIF
SQINIIDFEYSKDEVVKRLDHLYALALEEEKKQGVSKFINLDMEEFRDLELTVAAFMESV
SKFDIKAGIVLQAYIPDSYEYLKKLFAFSKERVLKGMKPIKIRFVKGANMESEETIASQR
GWELPTFYKKIDTDSNYNKMLDFVLEGDNYKYINVGIASHNIFEIAYAYTRISEAGALDS
FTFEMLEGMSLQCSYELSKMHDLILYAPVCDEAHFNNAIAYLVRRLDENTSEDNFMRYFF
NLKVGDNNWNVQKELFLKSLEGIKTLDNSTHRTQDRNKAPNIVSAYESGMFNNESDTDFI
LPQNRAWAKVIRAKYENLENYDVMPVIGDLEFDKNTLNILEVKDKIKDRMIGKAYLAGEN
EIKKALEVAKNSNFKNTSFDEIHAILAKAANLMRERRGDLIGLAALEVGKTFLEIDPEVS
EAIDFTEFYPHSL
>fig|195.2226.peg.1789 Pseudaminic acid biosynthesis protein PseA, possible Pse5Ac7Ac acetamidino synthase
MRFCKKCVMPDTKPDLHFDEEGVCDACRSQEAKNQNINWQEREKEFFELIKKYKKHPVYD
CVIGVSGGKDSTFQVVKMLELGLNPLCVCFEPSVPTKIGRKNLDNLNHLGVDLIHIKRDP
KVYQKLAREAFIRTGDNEWQNHLGIFTSVPRIAVNFGVPLIIWGESPQIEYGGPASSKNK
NILGREWLEEFGGLLGNRASDMLGVN
>fig|195.2226.peg.1793 Motility accessory factor
KNIILIGQDLAYAKDGQTHSQGFIHANLHNGDYERDLDRFSTTAYGGNGKVQSSEIWTLF
RQIFENFIAFSKSKTYNCTQGGARIESAIEKPFKELCEDLLKNKKDKKFKKLQVLNTKEQ
VKLGLKIYQKIKKNMNLSLNFKKECKKVQKQIHNLTHGKNKLSLEQINQNIDKIKEKLSN
KKYLFLQEILGPTLHHEQSILTPLYLKDIKDDSDKQNKLFAWIYAHESLMENIIELLEAQ
DKRLKIAILPLQDFLEKKKAL
>fig|195.2226.peg.1424 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKNALKIFSFLLLFFLAYVFYVYFSFDKNTLLDDFKSRYSKILYDKNGEILSVFLNDEEQ
WHIKSTDIPKRLKVSVINYEDRKFYSHFGVDFLALMRAFVNNFNSTQRSGASTISMQTIK
LWDKKDRTYFNKFNEIIQSLALENAFSKDEILKLYLSNAPYGGNLIGYEAAILFYFDKNP
KDLTWAQAALLAILPNQPGLINLEKNKTKLLDKRNKLLAKLYERKLINKDIYELSLKEPL
PNFKPRKNIAPHLALRLLSDDNKEIFSSIDKKIQLKIEKRLKNFLILCNKKAYKI
>fig|195.2227.peg.1202 hypothetical protein
MISKDFCINGETYWYYHHKAHLLDNLYYDKMQDEADILFSMAAAKARSKDLFHITNGVFS
TRSLKYFESMLSVDVKKRNIIEYYGNYIFSKQDSCFLICADSKYFKNYSFAFLNSFRNSI
NKNSGFNIIPHIHIINPDQECKELILDKYKDEFTFNYSFEYIDLDNISDHSKRAYYTTPR
YTLVPDLLELYGVDIIVSEIDAVIGKNLYEFVRFCRNYELALSQGVSSMNFYYHYGRISA
ILSYFGNNFLSKTFAKLNKKYIDLYFDFSKTSTNWLIDQISLYKIFKFLKSDIYVKNNTI
GKINANMLVELAQHFPGGKEAFIKHYKKN
>fig|195.2227.peg.1766 GDP-N-acetylglucosamine 4,6-dehydratase [NAD+]
MDGKGEKVRNILVTGADGFIGSHLCESLVKKGFKVRALSQYNSFNFWGHLEKSPFLKDME
VISGDLRDSFFCEKITKNIDAIFHLGALIAIPYSYAAPQSYVDTNVNGTLNMLEAAKKTR
FHILSTLQQAKFMARPFMCLSMKNTLYNLKALILQAKSLQI
>fig|195.2227.peg.1201 hypothetical protein
MNMEDRINLAVDKRDILELNNIISLYEKEGKIIELSNIMQGSKNAILPFDYGNQEEQYGK
MIERYFLLLARNLKKKTTVLL
>fig|195.2227.peg.1191 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
QTIETKNKTIQNKDDLLNFQAQYGTAKSRIQNQLSYKLGQTMIVNSKSFLGCLLMPVILL
GIVISYKQEQKIYKQKIEKDPSLKLPSLEQYPDYREAIKLKNHLSYKLGKELVKANKIWY
KGGYFYFLYFIKKIKI
>fig|195.2227.peg.1664 Ferric siderophore transport system, biopolymer transport protein ExbB
MLFYNYLTRKNLKLMHHLDELANFVYILFHRSYFNDKN
>fig|195.2227.peg.1765 GDP-N-acetylglucosamine 4,6-dehydratase [NAD+]
MMALSYYNSFNLNVNIARPFNTYGPRQSARAIIPTIITQILSGAKEIKLGDLSPKRDLNF
VLDTCEGFISLLNLKHFGEVYNIGSGVEYSMQEVLDLIQKILDSKVKIIQDEQRFRPKNS
EVFRLCCDANKLKKATNWQSKISLEEGLRQSIEYFKENLENYKSELYNV
>fig|195.2227.peg.1498 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MIFSGDITHLETLKKFDGLQMGAQEIKLETLNLVDVVINSESSLIGKSVKEANFRAKFDA
GIVALKRGSQNISKIGKSVLQAGDRLILSVGKDFHSRDNINKNFYIISNIIQNQKLSNVQ
SFIVVFVFLAIIALSALEIVSLLKALLVFLAFLFVFKIISFDEIKRRFPLEIFIIVGSSL
AITKVLVDSGLAKDFADLIIGTFGAYGLYGSFVGIYLLTLLLTEIITNNAAAALAFPIAY
STALALEVNPVPFILAVAYGASCGFMMPHGYQTHLMVGSICGYKTTDFVKIGWIVSLTYS
AMVLIMTPIFFKF
>fig|195.2228.peg.1749 Motility accessory factor
MGGGYNENLLYQDPIKELQTMLNTYND
>fig|195.2228.peg.1690 Cytochrome c family protein
MKKHILFLGLCLSLSLSAKSVSDYKVGEELSDKEGVKYFKELSKRPVQEWPNKI
>fig|195.2228.peg.1689 Cytochrome c family protein
MDNDGNGLPGTKKYVIPFLNILNNYPRLDIETMKIISVEDRIRGMGGTDSHRFPNDSKEM
KAILAYFKWLKEAYGIKDGVKLEGDFFAKMNFPNRPADPVRGKKLFEENCVACHGERGLG
VKNDNYEQGSGHLYPSLLIYPDGGHMAMIPFLARFLKSAMPFGASADNPILSDEDALDIA
AYVNTGFVRMPITTTENRAGLDTAYSKSPSLKPEYFASPQQNLDPKEYIKVKYGPWKNPN
HFPGE
>fig|195.2229.peg.1791 hypothetical protein
MKKNIVFFEVRGGSDKGEDGYRKDTMPMVNALKAKGWNAEVI
>fig|195.2229.peg.1320 Type II secretion system protein
MKLYELEIKGKTKQTKHLRAKNLNEAQAKAIAKKWEILNIKEIQKASFKRLDDARFILFF
QELSLLCEVGISIKDALKELDKIYSHKMIAKLCDNLNLGQNLSLAFENANFGLTHAELAL
IKTSQNTGKLSEIFMQISRLRQNNVENEQRVKKALRYPLIVFLSVCAAFVLLMLFVVPNL
KIYLRI
>fig|195.2229.peg.1321 Type II secretion system protein
MLVFCLIALILFLTLFLYRKYYFFSYFCDSLLLKLPLLSKFIIYQQNYSFFMIFSLLLKS
GISLLEAFKLATLALNNKKVLLYYQEIRTFMDSGLEISHAFKKVDLFDPLVFSMLSIAMK
SSKLEFLSEEIAKYYKNKSENLMDKFLSFLEPIMTLWVAILVLFLALGIFLPIWELSSGV
NF
>fig|195.2229.peg.743 putative TonB-dependent receptor
MKTFISNHKNQSSFITLFVFTPLFFVFLYSKDFLHIQPNETIKENKFNMAIKHFVQNSSD
MKPTQPTQTIQEPSNVQPKEPVQEIKKIKPRKEKPIAKPKKIIPPANAKAISQPKKDTNM
QQPIMQQQTPQASSYQSVSLTSNSEFLKEIKSAIDEALIYPRQARKMRMS
>fig|195.2230.peg.892 hypothetical protein
MKKIIPANSEFMTPQMLENELGISISKQSKLRMKRAQNQPNPLPFIKQGKLIVYPRSSVY
SWFNSLARGL
>fig|195.2230.peg.886 hypothetical protein
MLCNITQVQSKSTPSDCDVSLDLFKRFCKFFISVLEFKDYCFILNYNLFDPHIMQTIWNG
RIVFIFCPHETSPSNSNLSISFYLLIIPYNSIRNTKILQTIPPQNRYNFKPSYLKKLFLL
SSSSRIFCFITLVSVSDCFSRSFVALCIASIFACNAFLTSWTVFSLTSSFRLPISPDIAS
>fig|195.2230.peg.963 hypothetical protein
MIEEPRILPSNDLENEKEQLLNEFPEFRALIQNNPNITKEKLLKLKNQQRITHNY
>fig|195.2230.peg.890 hypothetical protein
MKKILEDDFEFRTKTIYLSKQKATQIKQNLEPNFIYNSTPKFSRANISYPKNFTERVNKN
RGSSANIRKAKSNSQKHNERNEEKEPKYFLPLEYRQENETWDCGISEQELFEQELQKYNE
IKKGYNGKRPAFENCKWEMIINLNNTHDMADCQKVANYVANKFNFHSTRIAIHRDEGRLI
DLDNADDKTNTLILTGKRKNCYKDENSKKYYWDKELSKEINVGVVYNYHAHLNFLTIKDA
KQNMRRAYIKREDLSELQTKLAIMLDMPRGEIIKESERSSDKKHRSGREYAKEQHEQQET
LLNLKEQKEILEIERKASVGNNYTKEYFRELKRLATKELKSKDELEKEIKELKIKHDKFY
SSKDYTKALENKIIELNNDKNDLLGIIKQTSDNFIELAEETKKDAREKLEKAELENWLMK
EVVKNDYFVKNRINEKFEIHGIEPIENEADKQRRERRNFIQSYNQEVKTMPEYVEMSKNR
DIEKTSKKVVLTQIQKDRALVQFAEVLKENNIIVKEPLVADGALHKLPCVGDRWGENSGA
YRLDLDSSPAGFIQIIKRGVMIEWDYNDNKTISEEQIQAYKALGQAELNAKNTTEQISQE
KSKTHQKNDYGR
>fig|195.2230.peg.884 site-specific recombinase, phage integrase family
MPNISKANLMDKDIKALSVKEKKYIKACGNPKELYIWIYPSKKKTFSLLYDGHYYMIKEF
REGIFSVADARKEAIKMLKDLENGKDPKEQKENEKYTFGALFERYAELKRKKGLVSVDKT
IVNRCKKYLLPSLAKRDIKSIKYSELLDILSPIFNPNEPNESKLDTIGKLIGYINEIFQI
ALKDGYLETMSLISALRKEFPSKTIFYAKNDIEANQKAITDLNELKEFIYDLKCYNGELS
TKRALYLQLLVPNRAGNTAEAKWADIDLENGVWHIRSSEMKMKDKHEIALSKQVIELLRQ
QKLLTCDKEFVFASSESKSGHLQRDTISKNIRTTLGGKVDGKKGKWYGRATPHGFRATFK
TICKNNIAQLLPLGISSDTIKACLAHKVTDKVEQAYLRQLATTEQKKILMQWYADFLESI
EPLGIL
>fig|195.2230.peg.1811 hypothetical protein
GGYGANANIYFLDSYRNYIAKNFDVVTINVFYHCFCARQSIDQKYNPKLIPNKDDLERIN
NILKNINLGHLLANEDNFEQIIPFIEQRAGEIKQAGLVDESQKIGLSCDFIPPNGDYQNF
GIMAAIDHINALKDLVKRFPKFADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSA
VPPLIYILGREMEGGCDYVLNSSHILIQCFLKTHWTRKENSPYFFNNENYFIR
>fig|195.2230.peg.1815 hypothetical protein
MQTLTQKTIFLNTEVAISYK
>fig|195.2230.peg.889 hypothetical protein
MSLDIYGKHSLGEQIEFELVLSAMYEEELLNVTKLLSKDQKLSFINTVQEVLLMDVVSDE
YAKKVMSEFDIKIYDNIAQSYLSTTSSNDIIIANTNNKTINAGKGNDIIYANGGSINTGD
GADVIISSEENESFYGREGADIYGFYAGFGRDEINNYHIDNSKDIIKFADISADDIAFSK
NGSDLIITAFDDKLTIKNALNNIHYAFSKIIFEDEVR
>fig|195.2230.peg.1813 hypothetical protein
ISNAGDQIISNDDYIKNDSSVSASNKDFVSKILDGLALGKDFNAIGSIKFDKAGEQIAND
IKDSAKSISNINQASSGINSTINISNDVSIGSRVAMLNNPYGNYATKLSQMRFAANDYRG
NYVDNYENSIWGNVIGGTNIIDGDSSALYGATIGMDRKINDDAIIG
>fig|195.2230.peg.1412 hypothetical protein
MAFYNPQRVVFNPDTGVIQNAGKVGGVLYDIMSKSFDDKVKANEFQQEQDLRKQQMEFNQ
AMQNNQILQNERNFDY
>fig|195.2230.peg.891 hypothetical protein
MNSVLDYLDSFAIPESEWEKELEWIDIFDNEKFLAKASITLISADTSSFKTFFTTEFSMP
LLKNGVFKKVYDIDFDGDTRVYKERNQNDILKPLRDNKQWIYIRENEIIAKNTSIDVILD
DISRKNENLNGVLFIIDVLSNFTNPNDVKEVNRFFGILRRLTNLNATIIVLHHNKKERTQ
DGLGQYSGVSYLTGKADVAYQLSANDNKEIPVLTFKIIKSKYNYLNGKKHIIFSLDTTKR
AGERLSIDTRKSYEEIQNSQSPKRKEIVEKIREVLSTVDQIYQGQLLEKIGTNKNDKTAI
NVIDTCAKYSEPLWHIKTIAKGNITSKLISLKVFENDV
>fig|195.2230.peg.1440 Phage antirepressor protein
MLSQIQNNTSIQVASFYEVTKNSIAKHFLRNADELIENIHYFYDYEQTKGGRQRVIKWTL
EGVYMLGFFIKSPKAKEYRKKVAKLLREQTQARFKTLSDENLRLNSLNHHQKIGYKSQLA
QQKEKYENKIKALQYDLEKKKELSFKRKLSKEELLELRKILAKDYNMLCFKEWEYMLFAE
SVSGKNYKLEKENDFCIYKSIKDSFNSKLDYYKNYEEYEEKWRKILRR
>fig|195.2230.peg.1823 FIG00470627: hypothetical protein
KSYVDTVGNSKVALSGNQTIAGIKTFSSSIVIPNATANNHATNLGQLNSKVALSGNQTIA
GVKTFSVPPVSATNPTANNQVANKSY
>fig|195.2230.peg.1099 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MGTNSFDNQGEISANKDISLMLNDDAFINNGKILSQNDIQIQANKDLTLNHGNLYAQNLL
HIKSLNDLNINSKLENTSSIELDAKNIYVKNLVASGKELNLHADENLVNDAYLFSNGDLR
AQATTLTNNSTFNSLNNLYLNAHTIHNNALIFADKDINIEANILNNNANLTGMLETSTEY
SQGFGQVGYGDTAFKRWNMEVGVTGIVKYNNLLDSKQASIQAGKDININTQSQDNARQIN
NSGKILAQGNIVSFGNIDNKSLSKEISVGEILEQIRVNGFFAKEYLGSWNTNSTYYFVDH
ESLLDALKYFSTTQAKNHQRESAWNALKDAAAKNSALNQYFSLLFGSDYASKRFVPDQKE
WNLDAKIVFKAKSEAVIASKGKLDLNAKEYNQDLVSSLDKNFALLDSDLKKATNSQDLIL
NSIPDLINSGLFTLENKTNDDITYEYTTNTSIIDESKYFGFLSILNQFKNKNFNEFIVIG
DPFLKISLLTQCMQTHYNPILN
>fig|195.2230.peg.883 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MVGPLGNALDHGWGYSYGMYRDHFGSHCGMEVVLANGEILRTGMGALPKAKTFADLWKTD
ECGVKRLSYK
>fig|195.2230.peg.288 hypothetical protein
MQIEVSFFDFVVVQILYPYFTFQIKSFSLLFIFLYLNFLKLKSKDLTCKCKK
>fig|195.2230.peg.535 SrpA-related protein
MAPADPSPQDYKVAANALKMEFEARAEATKLKAQEAQEKKEENEEKQENLDINNQDSKDN
FEETQANKDFKNFIGKIYQQNSQNNPINFSLVS
>fig|195.2230.peg.12 Filamentous haemagglutinin domain protein
MNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVLAQSLTASNLPSGGKFINGT
GSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNGKNYLNLDYTNKASQILGTL
NGGTNNVYIVNPSGVLVGEGATINANKFGVSITPMGIDAINTFSVDGSFSPVFNANKGDV
VNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFGINSTHLKAEIGSEGFFK
YEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSASNEEMINSWKGFAKLVN
EGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYGNNHTLSNIQIDVADKTYVG
LFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGHIENGTFSNIALDTIEGFNGENSSS
GGFAGEINSGTFNNISLKNLGNIGVAKYAGGFAGQINGGDFSSIILSNIESIYGKNNGGG
FVGYTTGNTTFDGISLKDIRFIKSGAFTGGFAGMTQGNVIFENIVLNDLEEISGSHAGGF
VGGVLNNENGIASLSNIVLNNIESIKGIGFIGGFAGWINDGTFNNIILNNIEKISVSATH
KYIFTGGFTGYAGAGTYKNIILNNIGEISANGTASLDEKSIYAGGFAGRIKSDGINFSNI
VLNDIDKISASIAAGGFVGNIENGSNIANSNIYFYGLLNSSSNKSYITHNENILNLSNTT
DFQTFINQSKIAGLEYLTNTSTSNSHLHMINGGKIGNEKSKITFDKDNFTYNTPKISEVD
PDGSGSSSSPTAPNEGELSSITLEQSDFEDEILKTIIDEILNEDYVLNIDSIDFNKFNEG
DVAILLYLLKNTSNKKLKESLKQSLEFYTEFNKGGLKTEFEKWYGSDESTYKTSMGKYNY
IIESLANLKEYVNTTLKPELESIKNNLNRLEFLKAEIKRLERVYQEAMQNDLLPYDQLEV
VYKNTQEKNRCLLC
>fig|195.2230.peg.885 Replication protein
MAKYTKRRDKRGYEWKSAYREKEALMLERGYPEVSPHDFYRELFPAGSLQQEPEDGKGNI
IATQIRPSGKGRTRQWVIDDSLKMLDKVIGDRFGLIPPISFYGKSHTKENAHELFAVVVD
VDYVGKQQLKNLLKQFGNGVQLRPTYLVSSGKGVHLYYFLQEPVQLYRNREEVLAELKEA
FIRRLWNDTSSIRPDSPDITGIYQGFRCVGSQSKLGVDFPVKAYKLSENRYTLEDIKASI
PSCKVDLAPLYEKPRRKSTVTLEEAKELYPEWYEKRIVQGEPKQKSKKQGGTWVCNEALY
EWWKRKITEEVKAGGRYFSIMALCSYGLKCGISEQKIRRDAYAFLDHLESLTEDEDNHFS
RADVKDALRALKGDRKRLSTIASREWIEDNTKVTIPANKRNYRKQKDHVKVMNTMKALKK
QLGEEVKEGRPKDYKPKMTILV
>fig|195.2230.peg.183 Inner membrane protein YihN
MTDKTFRSSTRYLRFALILAAVAILIFIFMPHEKLNIYFGMSLTLGFAAIVFTMRATFFA
PVDEIEMPREISGAAMSIACIFGYSPQLFCFALYGFIIDQFKGLLGYQIVFALMGFFAIC
GVIITTILLRMIAKKKTLQEVA
>fig|195.2230.peg.534 SrpA-related protein
MQIGLNYNYASNSSYYDKTQKNNAEQENTENTNSQNKDSKQNNEQTQMINGVELTIQQVQ
QVRELQSIDRNVKAHEAAHQAAGGGLAGAASFSYTRGPDNQMYATAGEVPIRMQKRKDT
>fig|195.2230.peg.1790 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
DKLSIFKKKSRSNEKNIGAVARVKCHLSYSLGVEFIRNKNKIYKIPICIYKVIGKYRKER
MVWKNYNYPSLETYSDYQDALRIKNQLSYKIGDLLIQSYKKWYKGAFLILPWEFYLLVKK
YKKGK
>fig|195.2230.peg.292 hypothetical protein
DELELKEQSVNIDKSLSIEKEKLLQAQTETEKTKPALIARQTAQIDDNLRIEAAKVTQSV
QFGYCTGGLDIPQEIMKLVKEKIENIEKF
>fig|195.2230.peg.893 hypothetical protein
MDLGKRLQSLRKALKLSQTELGECLGISKSAIASYENGYNPLPDYVINSISDKFNISNEF
FSDESIDIKNLSKSLIERNIVNIEFFNDISNFIDKKNAKKIALPYDFFTFLFPFAPNKKY
YMARWRGDSILVFDDEQKMLNGDDCQVLVANHDLVFTGVYDYKKGVVKIKDQAFFDNIKI
DKWDFWAVYKYKIKSDILKLSDLKR
>fig|195.2230.peg.386 hypothetical protein
MKNIKDFTKEYIFKLNQLLDKIDENIVADIVHLFEQVSKNKKTIYIKEMVAVQLLLRIFP
KLKIVGFDIISLTSQLNRNEGKMCHFNFLSRKGGREILVIEDMYFGNLKKDAIINEIFIA
PFYYEKMDGALCTVMVKCEGRK
>fig|195.2230.peg.1295 Major outer membrane protein
MKLVKLSLVAALAAGAFSVANATPLEEAIKDIDV
>fig|195.2231.peg.1934 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
LDSVINQTYTNLEIILVNDGSTDENSLNIAKEYTLKDKRITLFDKKNGGQSSARNVGIEY
FSGEYKLKNKTQTIKENSLIEFNIEGNNPYEIYTIYKS
>fig|195.2231.peg.1896 Type III restriction-modification system methylation subunit (EC 2.1.1.72)
LKDKEFENLDLESKKEILKFVLDSNMDYVLYGDIKDEDYALSKEIIKLNKIFYGDENV
>fig|195.2231.peg.481 UPF0234 protein Yitk
MASEHSFDISAALDKQELKNAFEQAKKELDSRYDLKGIKCEIEFSEKDGVFKLHSSSEAK
LDVLKDIVISKLIKRGINSSAIKELSREVERCFV
>fig|195.2231.peg.1150 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
IEVKKDEINKVFSKWFVIRNEGFEEFKIYDNRKDEVTYAMGFEPDFIFFGKKNKDDDNFL
SIQCFIETKGEHLAIAKDAWKEEFLETLKGKIITTKDDKKLTLQSLPFFINKNFNINDKF
LSSFDEFVSFQDER
>fig|195.2231.peg.1132 Type I restriction-modification system, specificity subunit S
MTNLPQGWKMETLGEILSSDKYSIKRGPFGSALKKSFFVEKGIRIFEQYNPINNDPHWKR
YFISHEKFQELEAFKATEGDLLISCSGTLGKIVELPKDTEMGIINQALLKIRLNNIKILN
SYFIYYFNSPIMQGKILESTLGSAIKNIASVKILKQIKIPLPPLKEQERIVGILDESFAK
IDESIKILEQNLLNLDELMQSALQKAFNPLKDNAKENYKLPQGWEWKSLGEIANTSSGGT
PSRNKKEYWENGNIKWLKSGELNDGYIDFIEENITEEAIKNSSAKIFQKGTLLIAMYGAT
AGKLGILNLDSTTNQAICAFLHKDKNIKFLEKFLFYFLFFLRDKIIKDSFGGAQPNINQT
YIKNLQIPLPPIKEQEQIASHLDELSSHVKNLKQNYQAQIKDLQELKKSLLDKAFKGNL
>fig|195.2231.peg.860 hypothetical protein
MLRRKALSDLLKEYDESTKKKSFYAHLIKMVFWAFLVIIGAIYFGNMLFGQYSLDTLLSL
EATKEELNKKISFLKEQNAKAQKDYFELQGLYPNEN
>fig|195.2231.peg.1910 Motility accessory factor
NLPQMITHPSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPIL
AKHNIKPDYVLSLERIPLTSEFFNNDFGEFDKDILFVLKSYVHPHTTKYLQKNNRNFMLV
STYASFINYLKLDDFGYFNMGFSVANMNFLLAIHLKHKNIVLIGQDLAYAKDGLSHTKDY
SNLDKHEGHFQRDKNKYTTQAYGDNGKVESSFVWTLFRHNFEQDVANAKKNYYITTYNCT
EGGARIEGTIEKPFLWACENLLHKDLNKPFEKLEPLSLNKQNEFLLKA
>fig|195.2231.peg.266 Predicted metal-dependent hydrolase
MARQSSSLKSFIYKDECYFYSKKRIKTLRLRLNERGEFVLSIPYFCTFKSVYEFLDKSSS
WMNEAKKRFEKKALKDDELIFLAKKYQ
>fig|195.2231.peg.1813 Predicted metal-dependent hydrolase
DKILCQNKAKLDLFLRQNAKKIFTFYLKKWSQKTGLFYTHLSIKNMKTRWGSCNHNKAYV
NLNLKLIQKSLKAIEYVILHEISHLKFPNHSKEFYTFIEYFMSDFRQREKEFLS
>fig|195.2231.peg.1918 hypothetical protein
SDEQKYLKILNNMKLNQARFNYNDKLWQFNDFDFDEFKIIAIELVRDEYENLNFGNHMHF
NAKNQEQFFKMIETFRKGIR
>fig|195.2231.peg.1802 hypothetical protein
KTGDETIAGVKTFSVPPVSATNPTANNQVANKSYVDTVVNTVGNSKVALSGNQTIAGVKT
FSSSIVIPNATANNHATNLGQLNSKVAKTGDETIAGVKTFSVPPVSATNPTANNQVANKS
YVDTVGNSKVAKTGDETIAGVKTFNAAPVCSANPTEDAQLARKWYVDYGGGIKNLGNQTA
PKIDLRQAQHFILTMTARGAIGIANWGGAGKSGTITVNNAQNITAFSAPFKFRVAQSGFS
GTETFAYFCIASNNVILVRT
>fig|195.2231.peg.513 Membrane protein
MENKILFLGLLALFFVFYFLFSLTLASLFKEVKMSFYFVFLCMLLAFLFFEKLSFLFFFL
ALHFLTFAYAFDRYETLKKLY
>fig|195.2231.peg.1879 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
EFNIEGNNPYEIYTIYKSYKAFNDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRM
DGVEVVWFDYRAVYDKVKRKHLSQMTHFDYKNEVIITSKEWLDRAKERRLFYFWFAWQGM
VNFTFLKNIKLKFIKGIFAEDCHFGVLLFALSKNIYILPKQIYIYRLRESSSMNFTRKKW
AIHPDSHLKKIDIFENLNKARLYYETTSWMQIALEFIKFIHSKHHLSDEVKQHFLPVVCN
KALTLQKFDKDPLYLKKYAKNLKIYIQNQPLGAVSRVKEYLSYKIAKEISRKKGIMKLTL
AFSVVKVSVQHQKEVRRYKKDIKRDVLNKRLPLEFYKDYQRALSLRNQRLIQMLYNASLK
LKG
>fig|195.2231.peg.916 Bacteriocin resistance protein; peptidase C39
LDKLVNIPMLVKIEDDPRFPHFVIIINHKGNYLQVLDPSHGEYISSKNQFFSIWDRYNKG
GYALIVAPKKELKPFKLNTPKSLHFDFSPFSLF
>fig|195.2231.peg.1822 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELEFKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENTGTAASLDAQLRDEL
IALINKKENTGTAASLDAQLRDELIALINK
>fig|195.2231.peg.1926 hypothetical protein
YIAKNFDVVAVHVFYHCFCQRRSDVEKYSTLADFTKDDLKLIEKVLRKYNIPCDQLANNT
VVSHCEYLSEIMTELKMLNRLPYDFEERLSATFIPSRGEYQNFGIMAAIDHINALKDLVK
RFPKLADLP
>fig|195.2231.peg.1915 hypothetical protein
NQGTAKVLQGDEFLTRELIKSMTQKHKTCVGVLSFEEKNISEELKKEIMESFENALLTPE
MKGRYNILWVEHTDKGRLELNFVIPKIDLESKKAFNPYYHPADKKRIETWGDYINLRYGF
TDPKDPAKEQTVQGSKKAKELFKDYESLDKILHQQVADEVINSRDELITFLEQNNIEVTR
KGKDYLSIKLPESKKAKRFKGSIYNEQFTSFAELREIRREKETRAKE
>fig|195.2231.peg.1944 Phage head, major capsid protein E
GALFGKILDGKGNVLFDFGSASKKAVSVKKDGSVTLASICDAIDSAIIDEFGTSADYEVL
CGNELFAA
>fig|195.2231.peg.311 Putative periplasmic protein
MKKTLFSFALASLFVSQASSIEFQSGLSGNLSLGVGVRDVKSNISPLANSDYLSGYNADN
SDTAAIPFIGLELYYGNLIDNDRVFLKNYNDRVFLKNYNGRDLSGIALGYERAYLERFST
SFSFISSLREKAYANPYFIGNREETDVSKYGFRISQLYESDFGKFNASYVFAKNKLDKES
IEFASLKREGNYHELELSYNYSLLNLGLNYDYNDADGKAQSYSRYGFKIGTHLVFARNYI
LTPSLSLNQYKADGTDPIFNQKQDGSITKFNLKLVKNQFLGYNSLYGFTNYGLEKRNSDI
DFYDETYHILLTGVGYKF
>fig|195.2231.peg.216 Putative polysaccharide deacetylase
MAKEILVAYGVDIDAVAGWLGSYGGEDSPDDISRGLFAGEVGIPRLLKLFKKYNIPATWF
APGHSIETFPE
>fig|195.2231.peg.1938 Phage head, major capsid protein E
MDLEQLLELFSSTKITEVINQTKASPRFVSDTFFKDKTPSLESTVRVEIIKGAGIVLNSI
SDN
>fig|195.2231.peg.1928 Phage head, major capsid protein E
PSLESTVRVEIIKGAGIVLNSISDNGEHSLENTKDAYILNIPLPRFALAKRISASEINSL
RSLALQEAQAKSLSGALGVLVKEMKESFNTTLEYMANGALFGKILDGKGNVLFDFGSASK
KA
>fig|195.2231.peg.1462 Membrane protein
MLDDDFLKEKQNIRQKMLKFSRAVNQGKPLDDDLKEEISSDDILRRRFKKRSNHFLDETE
EDYKLEYTKKSNIYLK
>fig|195.2231.peg.1909 putative replication protein B
MSEIVKYNNDFNLLPMPELKAIQMDMFMAIISLTKDKKENTPFLKKFFNPDKRKIIIPQK
KFIELCRLNDSKMDYKEIFFAIDDCLKKLCNFLISYQKDERTIYNFVCFEEANIIADEVH
ITLQSRFYDMIINKKFGFTAFELAEFAELSGKYTKTLYRLLKQFRTTGKAYFEWEEFCRI
MKIPENYRQIDIDQRILKPAIKELSKERNLFDQIRVPFKNLAYEKEKTAGRGRGGK
>fig|195.2231.peg.1645 Putative periplasmic protein
MKKVFPILIISLCSLSLANVYEKLNDFAYEKKPNKDFKIQEVKLVQFLQDDKNCLELLIE
AGQVRILKSYNECQKLSKDADFQKFLNEDFLRLYKNNGYSINENLQDLKKAMQDIMIYYK
LRFAFSKNIQDMSKNKNLSILNIDEKEGGTLLYKINNQACVAIELARHNSRMAMKVYGME
NLDKECKLFIQAPSFKNISFTKNDFKWYYLE
>fig|195.2231.peg.1940 replication initiation protein
DQIRVPFKNLAYEKEKTAGRGRGGKVSGISFTFKPENIQMQKLENESQKIMSDEQKYLKI
LNNMKLNQARFNYNDK
>fig|195.2231.peg.480 UPF0234 protein Yitk
MFRLNLKANDSIDSENAKKINKAIKDSKLKVSSSIRGDEIRVVAKQIDDLQAVMKMVKEL
NLELNLSFKNLK
>fig|195.2231.peg.1684 Phage head, major capsid protein E
ILPRGAGIEIVGEMRAMPVCTRPNGLIKLVLE
>fig|195.2231.peg.1869 hypothetical protein
IYNEQFTSFAELREIRREKETRAKEYNRRDNEKELGRLEHELKELVSLKSQFYRETIRTI
NERLRKKAEQSFQRDREKSLQSRTDEIQTIKPSDELSSGNAYDDNFVSDCVVSVDQALSN
QQRANDNGQQWESVSLYREKSSGTTGEFLLPTTELKEEEYDNIRTRVNRRNREIANEDNR
ISKSRNELTQYYQNGTRELQERVRNFRERIQGIGEQIRRAGQRIRSNSEERRKQQRQRFA
NFEEQIRSFGSKFAEQINGVRFFIKERINELRERILMRSKQVLKTSQKIEQEQPKAKVKE
SDNIKKGFGLGI
>fig|195.2232.peg.1835 hypothetical protein
MVFISIVETFLVLWLIKSKNEVKPVWIAASGERYFDTMK
>fig|195.2232.peg.1060 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
LPPLESYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKMLFEVRKLKREFKEK
>fig|195.2232.peg.1647 hypothetical protein
MDRESFDISNIYNKKHFIIQKDNSLITFKYRKIQSKGFNLVFLLENNILKNYYFNYLEKI
NPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTKINFNLNKFDIHLA
LSFAISLNFIAKNEQNKLYKFVLENNKLIYDYIDFINNNFANEHFIKIKYKRKK
>fig|195.2232.peg.1761 hypothetical protein
MNISNLSELIHANMLNEGSVLSVTGFALSLHELKNGFAFFSNNKKEIIQAVQKGAFAIIS
EHELCIDDKEIYYLQVDNLESALIKLLRFLCEEKECEFIALQAYELGICKAFSLNILKGN
IFVDFNSLIKAKKGEIFCFSDENYLLQLCASLTILKEANFTLLSRSSFFFTTLVCDNLYF
KNLNLPFIYAKIFAKIMFYLKEKNTKMSFDFNKIDDFKIYFMDENFNISEFGSSARAFII
VSNQNTFDFWQENFKNIKGFKTALHNSLFCDFSYDKLLDLKNLKNFKYCLLLEDYEAFER
EFKNEENQSPSLFLNCLKPTPSHSNKNLFIARPPLYPPKPLLAIT
>fig|195.2232.peg.253 Ferric iron ABC transporter, ATP-binding protein
MAYLKIKNFKKAYGDKIIFEDINFSAKKGEFITLLGPSGCGKSTLLRCIAGLSQINGGKI
SLNDKDLTKLSPQKRNIGMVFQNYALFPNLNVFENVAFGLKIKKMDKKDIEKRVKKC
>fig|195.2232.peg.513 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSVIANSIAIFALSILSIISFYFTKDSLYQSTLHAETDLLKATQISIEDFRSR
NISLLNTLEKDILNLPYEALNSQDNIINNVGAILKYYRNSGNLLAVYIGLDNGENIVSDD
LSEKKNTNITINGKANNYNATTREWYKEARNSNQTYITPAYIDVVSNEYAITYSKALYKD
GKFIGVLGFDVLLISLQDEITRTPGNTFVFDHQDRIFAATNKALLDPSVDHSPVLNAYKA
HGDNNFFSYKLNNEERLGVCTKVFAYTACITESTDVINKPIFKAAYIQ
>fig|195.2232.peg.1722 Putative type IIS restriction /modification enzyme, N-terminal half
DNIQKYFVKRYNYFWVIYTNSSFKNPNSMDDYPNLKKHLDKFQNVITSDNKPYGLHRARD
EKFFTGSPRIVALRKCVGEPKFSYVDFDCYVSATFYVIKTQRINVKYLTAILNSKLIAFW
LKHKGKMQGNNYQIDKEPLLNIPIVTINSKNQKIADELINLVDEILKAKEQDKNANTQEL
ENKINSLVYKLYNLNEEEIKIIEGK
>fig|195.2232.peg.1825 Flagellar motor switch protein FliM
EADDKAIVSIDKKDVFLAQIGLHRFRKSIKILELIRTDKDEIKEILEKYEEERKAKASVY
DEPEEEEEEI
>fig|195.2232.peg.703 hypothetical protein
MSIIIANRTDGTGSRLISLMNAMYLAKILNKQVKFTWKNYIPFTKDSDTNNFRKVENDNV
SILGLCVESHTEIFSKNFIDKYFLESINGSIFGIDGKVYTNFDLFLKELKVNKYDYISVP
LSDLSTRVFKDIDDLEYRKYMQNIWKDIEFSESVKKIVNMAKQTCMKFKDFICIHIRSGD
AIYDYAEFRKFNLQSIYHATPCEIAIGIIQKNKNKNIVLVGDDLLSIRQIAKFCNFKNVF
VMEDFRNSNQLSNMELFFYDVIFMSYAKILYGTNSAVVRLANYIGNQKFINNYSVFNEKE
LYDIIKENIEKFNTSNSQKAFSYFHLFIVSKKINISKENLIEFLEKALEYDYENDKYRIH
LIDVLLNHNEFSKANEMLKTILLTRESEYLKTLFLKGWIGVVYSNLFDIYLKSSCLQYPY
IAYVAMHILKFRTSLQIQNLNNALNKTIQEKDIIINSNTNQIDQLQNNIQEKSTQLNQLQ
SK
>fig|195.2232.peg.1841 hypothetical protein
MKKNIVFFEVRGGSDKGEDGYRKDTMPMVNALKAKGWNAEVIFFEVGKKNEIYNYVKENF
D
>fig|195.2232.peg.1435 Serine transporter
MNTPKWTRYDTRWVLSLFGTAVGAGILFLPIKA
>fig|195.2232.peg.1836 Motility accessory factor
NFKNSIVSYGNDPLDALQGIEQFVYNLPQMITHPSYTKLLSKRKNLSDTAIIVSTGPSLT
KQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNNNFGEFDKDIV
FVCAGVVHPKTIEYLK
>fig|195.2233.peg.1650 Biotin carboxylase of acetyl-CoA carboxylase (EC 6.3.4.14)
GAEAAKKLAKEIGYPVILKAAAGGGGRGMRVVEHEKDLEKAYWSAESEAMTAFGDGTMYM
EKYIQNPRHIEVQVIGDSFGNVIHVGERDCSMQRRHQKLIEESPAILLDEKTRTRLHETA
IKAAKAIGYEGAGTFEFLVDKNLDFYFIEMNTRLQVEHCVSEMVSGIDIIEQMIKVAEGY
ALPSQESIKLNGHSIECRITAEDPKTFLPSPGKIIKYVPPAGRNVRMESHCYQDYSVPPY
YDSMIGKLVVWAEDRNKAISKMKVALDELIIGGIKTTKDFHLAMMDNPDFISNNYDTNYL
ARH
>fig|195.2233.peg.1331 C4-dicarboxylate anaerobic carrier, putative
MPIFMICSTLLAVIVVAYYILK
>fig|195.2233.peg.1835 hypothetical protein
MFENIEYLLLKNYLHIKDYFKLDETASYALSLLAKNNRKRFSINRKIQHFKALSTLKYLL
RAGIIKLEHSKEAKRIKDKRQKLKKELRSYVIQDKIIFANHFTRFFFYFLKPNEKLILQN
HYEEVLGLIKEKFELYQSFCFEQLSRELLEKKFQVSGVQSYWDKNLELDLYYKDDEISFI
GEVKFKNKKNQPPTLF
>fig|195.2233.peg.1799 Translation elongation factor G
VDKGVQEALQNGVLAGYPVEDVKVTVYDGSYHEVDSSEMAFKLAASMGFKEGARKAGAVI
LEPMMKVEVETPEDYMGDVIGDLNKRRGQVNSMDERGGNKIITAFCPLAEMFGYSTDLRS
QTQGRATYSMEFDHYDEVPKNVADEIIKKRNG
>fig|195.2233.peg.1628 Flagellin
SAINAVKDTTGVQASKDENGKLVLTSADGRGIKITGDIGVGSGILANQKENYGRLSLVKN
DGRDINISGTNLSAIGMGTTDMISQSSVSLRESKGQISATNADAMGFNSYKGGGKLVLSS
AVSSISAFMSAQGSGFSRGSGFSVGSGKNLSVGLSQGIQIISSAASMSNTYVVSAGSGFS
SGSGNSQFAALKTTAANTTDETAGVTTLKGAMAVMDIAETAITNLDQIRADIGSIQNQLQ
VTINNITVTQVNVKAAESTIRDVDFASESANFSKYNILAQSGSYAMSQANAVQQNVLKLL
Q
>fig|195.2233.peg.1845 Motility accessory factor
FILASVVHKEVIEFLERNNREYMLVHRPLHFAASLNLKEFGYIGVGASVANMAYELAASL
RHENIIFIGQDLAYAKDGSSHPREHIYGNQGEKLRGEVYTLAYGGEKQVRTQLTWNLFRQ
AFEKDIFWAKEKLKINTYNCTEGGARIEGAIEKPFQEVCETLLKENLKKPFDKPKILEKN
KIKNKFLQTQKLLIKNVKQSEEFIKKCQNELKKLDFELSKSQFNSQTLIKIKKNLLFFFN
EFKKLKLFNELTQAIYYHNECEIMHYEVLNDLEQDKKNEDFLTNQKKWWLQSFEYLNTQN
QIIKETLKKYKNDDI
>fig|195.2233.peg.1834 dTDP-glucose 4,6-dehydratase (EC 4.2.1.46)
MKSYSCLENPIVIEDLEYIYNSLTKVEKQKFNNSTILFTGCAGFLGFYFINFFIKYSKDL
NIKKIIALDNFM
>fig|195.2233.peg.1693 hypothetical protein
MTAYVHIGTMKTGTSSIQNFLYLNRSLLQKQNYYYPISIKNIGRLNDHNPFAHKFNTLLN
KTDDLKIFSREFKNLNNEIKMCNCDKIIISMENVQWLLNSQQKIKYFYDFLIYIFDNIKI
IVYLRDVAELFISMCSQAIKDDSHLDYHFLYPYQNKKSKILSDYKQTLQWWGEIFGKENL
IVRLFNKNEFYRGDLLKDFIYSVDLKWDEKFQIPIKENETLDLIGFELLSRVNRLKPFMF
KSRYFDIVEYFDRNCTNVKQYSHLKFQPPKEIMQSYINYFEESNEWVRQEFFPHKERLFP
KKDLSNYKENYELKEMKPEYWDKIAEFIADIVSTKNQNIADKTIIIQNKDKVIVNQTNQI
NSLQTTLKDNKAHLIQAQNLNNTLNKTIQEKDIIINSNTNQIDQLQNNIQEKSTQLNQLQ
SKLSFQTQYGTAKSRIQNQL
>fig|195.2233.peg.1869 Adenylosuccinate synthetase (EC 6.3.4.4)
TPFITDTTRMLWKALDEDKKVLLEGAQGSMLDIDHGTYPYVTSSSTISAGALTGLGLNPK
EVGSIIGIVKAYTTRVGNGAFPTEDKGESGEKIAQIGKEIGVSTGRKRRCGWFDAIAVKY
TARLNGLDALSLMKLDVLDGFEKVKICRAYEYKGMEIDYIPSDLENVKPIYEEMDGWDKV
FGIKDYDLLPENAKKYIARLEELCGVKIKYISTSPERDDTIIL
>fig|195.2233.peg.1825 hypothetical protein
KNQIRSQKGKEKGYFVDYQKIWLENGGKLVKINNHLYYELSHKRKNLEEIPSSKRSMYKK
RFAILEEIKQALDQSLFI
>fig|195.2233.peg.973 Indole-3-glycerol phosphate synthase (EC 4.1.1.48)
DFSMDMNLCEKLIPQIPNSKIIIAESGLEDKDFLRHLQNLGVDAFLIGEYFMRQNDEGEA
LKALL
>fig|195.2233.peg.1859 Predicted glycosyltransferase involved in capsule biosynthesis
MKYKYSVIIPIDLDLRPFDILKKVKSILKRSSDEVEIVFGHNDRGSIFDKYLKRITKKNN
VKLVSGKFYTRLICQSLLRNRAVEQCSSEFIYLMDVDCLFDEELSDGCINDIKSDKNPLI
ILFCLYLSKKGSREVFKHTREEMFDKYIAFRKDLYLHLASPSASIFMKKTDYFAVGGFDE
EFMGHGGEDFEFMIKLALYKNVIKPTKDLMLNKFYKAPLLSEGFRKYLA
>fig|195.2233.peg.1829 membrane protein
MSLLKNNIQLFVLFGIFTFLFFWQKFAWVSLFLIPIFLAFFLEFFYFLRLRKNIIKEATM
IKNSLIYRVSAGDFYIYSLSFFMALFALASLFLNLISYEKQDGFFLFVLLPLFLFFFKQK
LQLQFLDNAYNDFRIIILSSLILALLYAIFNGVVNPIQSFNLEDFNQSIIHYKNSKFFVF
DLISQILTLINALKEYFLYSLG
>fig|195.2233.peg.1 hypothetical protein
KNQIRSQKGKEKGYFVDYQKIWLENGGELIKIDKHKYYKLHHSQKNLEEIPSQKRSMYKK
RFAMLEEIKVNLDKTLDIQD
>fig|195.2233.peg.1744 Imidazole glycerol phosphate synthase amidotransferase subunit HisH
MKLIIIDTACANLASLKFCLDRLGFNAKISRDLKDLENADKLFLPGVGTAAKAMSNLESF
NLTNFIKNTKKPLLGICLGMQIL
>fig|195.2233.peg.1867 Threonyl-tRNA synthetase (EC 6.1.1.3)
KLFDFSYEMEISTKPEKAIGDDEIWEIATKALKEALDEQGLKYGIDEGGGAFYGPKIDIK
ITDALKRKWQCGTIQVDFNLPSRFKLEYTDSDNEKKQPVMLHRAILGSFERFIGILTEHC
AGEFPFFIAPTAVGIVPIGEAHIAYAKEIQKELLELNIDSEVYEKNESLSKKIRIAEKQK
LPMILVLGDDEVAKRSVALRDRRAKEQKNLSLEEFINLVKEKMSEVHF
>fig|195.2233.peg.1837 Glutamine--fructose-6-phosphate transaminase (isomerizing), isomerase subunit (EC 2.6.1.16)
KFNKREITIHTLEKSFKADLINNKIEIYHKDQSQKILNFENDTIKTLQNLHQAIFEKDKE
LCDLKQALKVLEICDEVRKKNG
>fig|195.2233.peg.1873 GDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hexos-4-ulose aminotransferase [PLP]
MFEKEISFIKSLFNKENIALHEPCFIGNEKKYLLECIDSGFVSSVGEFVTRFEEALKEKT
KARFVIATNTGTAALHIALLANGIDENCEVITQSISFVATANAIAYTGAKPVFLDIDENT
LSLSPKALEHFLENQTYQKDNLSYNKTTHKPIKACVIMHTFGLSAHIKAIKELCEKYHIL
LIEDAAEALGSTYENKALGTFGKCGILSFNGNKIITGGCGGAILSDDENLAKLARHLSTT
AKIPHPYEYDHDRIAYNYRLCNINAAILFAGLENLELFLENKRELAKIYKDFFKNHDKCK
F
>fig|195.2233.peg.1842 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing) (EC 3.2.1.184)
MSKRKICIVSATRAEWYLLRNLCHEIQNDKDLNLQIIATGAHLSPEFGLTYKEIEKEFKI
TKKIPILLANDDKISLCKSMSLAFSAFSDAFEDLKPDMVVILGDRYEMLSVASICLLMHI
PLVHLCGGELTLGAIDDSIRHSISKMSHLHFVSHEIYKKRLLQLGEEEKRVFNIGSLAST
IIKNMNFLNKKDLEKALEMKLDKELYLITYHPLTLN
>fig|195.2233.peg.1858 D-arabinose-5-phosphate isomerase (EC 5.3.1.13)
ATLVMGDALAAALMKARNFRPDDFALFHPGGSLGRKLLTRVSDLMVSKNLPIVHPDTEFN
NLVDVMTSGKLGLCLVLENEKLVGIITDGDLRRALKANDKPRFDFKAKEIMSINPKVVDA
DAMASEAEEIMLKYKIKEIVVSKEDKVVGIIQLYAIGNV
>fig|195.2233.peg.1774 hypothetical protein
MENKKFKFISAYAIYIGVITFIIFFGKDFLNLTFLIFENLWNFFSAIEGVYYDTGIVLFC
SLAFVCVTLIFLENKIVGILIFLLIATPLFFLFFYYSDANFSLNYLRKLCDLQFFPIKFI
ILIVIFSCFVTAAIVHFIGLNTDENQ
>fig|195.2233.peg.1626 Motility accessory factor
MNKNLFLKNTQALFEVDQILAYKLRSLEKIDFKILQNENGINFIKDDIALYKNPNQELLE
SLTLFKSEYEKYPVLFFYGFGNGMFYKALCENKNHKHIIVFEDELEILALAFHLFDFSKE
LKNEKLILFYTPEVTTAQLTTLFIYENIQKSVKIFNLYIHNNFYEKFYTQKIKILNYKLM
ETIKYIVLNKGNDPYDSIIGIKHTLNNIPKLLSHGIFQDFLKKRKGKVKNAIIVSTGPSL
TKQLPLLKQYANKATIFCADSAYPILAKHNIKPDYVCMLERDDIVSKCFDNDFKEFDKGI
LFILASVVHKEVIEFLERNNREYMLVPRAYDFFYYLNLAKYFQPIDGMVSVAHMNYWLAK
FLSHKNIIFIGQDLAYSKDQSSHAKDFIHEKLHEGHFQKDENLFTSIAYGGKGEVESSYF
WKLFRELFENWISHDNNFINIYNCTEGGARIKGTIEKPFLWACENLLSKNLNKPFPKLNP
LNINKQNELMLKAYNKIYKSIYHCKDFNKKLLQEYNEIKELYLTLENLQIEESKELLNFI
IQKIDTIKYQIDDAKNMQDLYEILGPLLVQFELNLARIYVLNPKTPEDSFNKSLIWIKEH
LEWIEMIYGHIQAQENALFENIIPLEQKLKERKLNKWMERVKNANK
>fig|195.2233.peg.1841 Paralog of flagellar hook protein FlgE
IGLGVSVSSTTRIHSQGSVQTTDKNTDVAINGDGFFMVSDDGGLTRYLTRSGDFKLDAYG
NFVNNAGFVVQGWNINWDTQSIDSSRSPQNIFIDPGMHIPAAKSTEVAIKANLNSGLNIG
NAARPLYALDSVHGFNKKTGETKDENDNGITQFYTTSKNSMEVTEKGVDAGSLFNGSGQG
LNLREGQGIWMSFADSKFTTNGTNRTGFDANNKTNQNNVVFWGSENQKTRLDITLNGVAI
QNADITSLDQAIAYINTFTNPQEGREGTGIVASKNANGTGIIFTNRNENGTTDNMKNINL
VVNAQNTAGELWNATWNQGNNNFTFGNGKVNANGSVWTATGGTNNQTTGPTNAVVITAHK
YTYSSSPQNIPPMYNPDGGAQFTDNDNNANTKPTDPASGNYWDALKGSLYNTDVRVFRTT
EDLRELLQRDARYGVDYNGNGAFATEDINQKVTITVSDDGRFTVSNAKQDSQIPANALQN
QAVTTTAKDLSFNVTAYTDALGKVSTNDAFTKIFKAFDGVQTAGSQKKESEQLKLSAFSA
GLEIYDSLGSKHTLEVQFVKQSTTQDGGNEWQMIIRVPEPAEINTTGEGPNNIVVGTARF
NNDGSLASYNPKTLNFSPNNGAAPNQQIKLSFGTSGSNDGLVS
>fig|195.2233.peg.1486 hypothetical protein
MKKLKYILGLGLLLLTGCENGEYNTNTNVLDIQNDIHKAFYNKTYSDKAKFYEKMQKTIN
ENISTGNAIIQASNIEPKFKIDPIQFKECVFYEIWTIKNPQNTSYTLSAERCQTAFLNNK
ELIKYADPSFVMGNFIKDNQENILGIKAVKEELSKPSYVTDVKSYKFISDKYKILENGNY
IYILQNFKAKSEILGEYTQNAHIIFNNKGNVIKIELNQNKEFGSY
>fig|195.2233.peg.388 Imidazole glycerol phosphate synthase amidotransferase subunit HisH
SFNLTNFIKNTKKPLLGICLGMQILGDFSEELDQETLGIIPFKTQKFELPKEYSLPHMGW
NEVASSHPLFKGLNGAYFYFVHSYHVALNDYTIATSDYGVKFSASLAKDNFYGVQFHPER
SGEAGEILISNFIKDIA
>fig|195.2233.peg.1857 hypothetical protein
YRNLSENKIVEIWKSLFFIIPSISSTYASFGSCFKDIGHNQFGYLISDESGQSTITSAIG
AIYRTKKAIIIGDPLQLEPIVNIPNNINNFFTQYFNIDKAFDVKNTSLQSRCDFLQSYGR
YIYQDSQKIWLGSPLRVHNRCDRPIFELSNKIAYGGMMIYGKKNENTLQLQNTWYNIKEE
QWNGNCNEREIEYLHILLDEITQYDLEIGIITPFVDVKQKLKDIANKYNNLKDDKIGTIH
TMQGKEADIIILILGGNNENARNWVASRPNLINVALTRAKNTIFIIGNKEKYIKLSYFNH
LESMHTITPSFSNL
>fig|195.2233.peg.1850 hypothetical protein
MSSKLSYKELALEILKQSDKPLNANEIWQKALEKGLDKKLSSIGQTPIATLGARIYVDIK
ELQHNSLFIKASQKPRTFWLKERENELLKLDDKNEITNEKQEKNK
>fig|195.2233.peg.1847 GTP-binding protein TypA/BipA
MENIRNIAVIAHVDHGKTTMVDELLKQSGTFSEREQISERVMDSNDIEKERGITILSKNT
AINYKGTKINIIDTPGHADFGGEVERVLKMIDGVLLLVDAQEGVMPQTKFVVKKALSLGL
KPIVVINKIDKPAADPERVINEIFDLFVALDANDEQLDFAIVYAAAKNGYAKLDLNDESD
NMEPLFKTILERVPAPSGTNDNPLQLQVFTLGYDNFVGKIGIARIFNGVVKKNQSVMLAK
ADGTKVNGRISKLIGFMGLEKMDIEEAGSGDIVAIAGFEALDVGDSVVDPNNPMPLDPLH
IEEPTLSIVFSVNDGPLAGTEGRHVTSNKIAERLEAEMKTNIAMKYESTGEGKFKVSGRG
ELQITILAENMRREGFEFCMGRPEVIVKVEDGVKTEPFEHLVIDVPEEFSGAVIEKLGKR
KAEMKTMAPTGDGQTRLEFEIPARGLIGFRSQFLTD
>fig|195.2233.peg.1709 Acylphosphate phosphohydrolase (EC 3.6.1.7) / [NiFe] hydrogenase metallocenter assembly protein HypF
MCHLGYKLQISGLVQGVGFRPLVFELASELGLHGEVKNDGFGVEIILACTKEECENFIYK
LKEKLPPLARIDSIDITEQTTTNYTHFSIGTSLQNAKTTPMLSDFALCKECKKEFFDEKN
PRFLYPF
>fig|195.2233.peg.1672 Ferric siderophore transport system, biopolymer transport protein ExbB
IKERIELRLQNTISKQITASKNGLSLLASIGASAPFIGLFGTVWGIMNAFIGIANLGNAS
LAVVAPGIAEALFATAFGLIAAIPAVLFYNYLTRKNLKLMHHLDELANFVYILFHRSYFN
DKN
>fig|195.2233.peg.1862 Galactoside O-acetyltransferase( EC:2.3.1.79 )
MKIIIKNLQKLRVLYYKKFLSNVSIKSKCKIRSATLFYSINGGKIDIHDTVSFGFFPSPY
FYTCYNHIDIREGGNIIIKENTIIN
>fig|195.2233.peg.1602 Biotin carboxylase of acetyl-CoA carboxylase (EC 6.3.4.14)
MEIKSILIANRGEIALRALRTIKEMGKKAICVYSEADKDALYLKYADASICIGKARSSES
YLNIPAIITAAEIAEADAIFPGYGFLSENQNFVEICAKHNIKFIGPSVEAMNLMSDKSKA
KQVMQRAGVPVIPGSDGALAGAEAAKKLAKEIGYPVILKAAAGGG
>fig|195.2233.peg.210 Putative integral membrane protein HP_0181
MEFYWFDAFILGFTLLLGLKGIVSGLIKEVFGLLGIIGGVFIASKYASQAAEFIQNTFYK
IENQSLANFAGFLVILIIFWIICLVLGNFISKLVKLSGLGFLDRLGGFIFGGAKVFLIFA
ILVFCVARIDFLNDKLNQFAQNSFTLTPLKNIGSFIMNQSLTTSSLGQIDQNLQDIRDDL
SILLKENKIC
>fig|195.2233.peg.134 Omega amidase (Nit2 homolog)
MAANRSGSEISKINNETLTFAGKSKIINPKGEIIKEILEEEGFIIAELDLEEVQIQRKNL
PYLKDLNLKLNQEILTNIHLNTKE
>fig|195.2233.peg.1866 Translation initiation factor 3
MSKEKEVLLNEEIRADEIRCVGDDGKVYGIISSDEALEIANRLGLDLVMIAADAKPPVCK
IMDYGKFRYQQEKKQKEAKKKQKVIDIKEIKLSVKIAQN
>fig|195.2233.peg.1098 Carbon starvation protein A
MARFGTKILWLFVAALGAICFAHLALQNGESVSAIYLVVAAVCIYMIGYRFYGRFVAYKV
LELDKNRATPAVLENDGRDFVPTNRTVLFGHHFAAIAGAGPLVGPILAAQMGYLPSMLWI
LVGGVLAGAVHDFVVLFISTRRRGRSLGEIIKDEMGKFTGGVAMVAIFGIMLIIIAILAM
VVVKALAE
>fig|195.2233.peg.1520 Ferric siderophore transport system, biopolymer transport protein ExbB
MLKKIFLFCFLLLNLNAEVNVTDTNLSFDSPKIEAEVPKIELSLSSLYQNADEVVKGVIY
ILVLFSVLAWAVFISKLMQFYFMKKNLDFSIHKIKELKNLNELDQTKGFAGVLSLEIQDE
LEKSEYKNDHIKERIELRLQNTISKQITASKNGLS
>fig|195.2233.peg.1864 Translation elongation factor G
DELMEKYLGGEELSLEEIKTGIKAGCLSLSIVPMLCGTAFKNKGVQPLLDAVVAYLPAPD
EVANIKGEYEDGTEVSVKSTDDGEFAGLAFKIMTDPFVGQLTFVRVYRGCLESGSYAYNS
TKDKKERIGRLLKMHSNKREEIKVLYAGEIGAVVGLKDTLTGDTLASEKDKVILERMDFP
DPVISVAVEPKTKADQEKMSIALNKLAQEDPSFRVSTDEESGQTIISGMGELHLEIIVDR
MLREFKVEAEVGQPQVAYRETIRKTVEQEYKYAKQSGGRGQYGHVFLRLEPLEPGSGYEF
VNDIKGGVIPKEYIPAVDKGVQEALQNGVLAGYPVEDVKVT
>fig|195.2233.peg.1809 Translation initiation factor 2
EKNGRKITFIDTPGHEAFTAMRARGASITDIVIIVVAADDGVKPQTKEAINHAKAAGVPI
IIAINKMDKEAANPDMVKTQLAEMEIMPVEWGGSYEFVGVSAKTGMGIEDLLEIVLLQAD
ILELKANPKSFAKASIIESSVQKGRGAVATIIVQNGTLTVGSTVVAGEAYGKVRAMSDDQ
GKALKEIKPGECGVIVGLSEVADAGEILIAVKTDKEAREYANKRHEYNRQKELSKSTKVS
IDELGAKIKEGNLKALPVILKADVQGSLEALKASLEKLRNDEIKVNIIHSGVGGITQSDI
ELASASENSIVLGFNIRPTGEVKERAKDKGVEIKTYNVIYNLLDDVKALLGGMMSPIISE
EQLGQAEIRQVINVPKIGQIAGCMVTEGVINRGAKIRLIRDGVVVYEGNVSSLKRFKDDA
KEVAKGYECGVGIEGCDDMRVGDYIESYKEVQEQASL
>fig|195.2233.peg.1725 ABC-type siderophore export system, fused ATPase and permease components
MPFILELLKQNKFKFISFLIFSFITSAVGVLTLVFINDYLLKNTQNIPILYFIALLIVFF
LSSTIVELGLSVFGQN
>fig|195.2233.peg.590 Paralog of flagellar hook protein FlgE
NNGAAPNQQIKLSFGTSGSNDGLVSSNSASTLTGQATDGYTSGNLKPDAIRVDDKGNILG
EFTNGKTFAVAKIAMASVANNSGLEEIGGNLFKVTANSGNIVVGEAGTGGRGEMKTAALE
MSNVDLSRSLTELIIIQRGYQANSKTISTSDQMLQTLIQLKQ
>fig|195.2233.peg.1509 hypothetical protein
MALYINVFYKSKIQNGGNMNNQIDNKAQENESQATTIHCFQGAEDLLSNKDNKDKIKAVL
FDLFNIKNVNFLFGAGTSNGAIPTMKELQKCVVEKLNEGEKKIFEKIKERNLEEILEILY
SGKTYLKNNPQDKDNKEFNTLKSLIEKIEEIIFQKINIEIGINCGSDVQKEVFENYMKFY
KKVTYRNKDLNRVNIFTTNNDLFNEYVLDYLNIDYNNGFGGGLKRSFNPARFEYIYAKKM
DEGIEKYEPLNHMIYLYKLHGSINWVETKNHNSFFDIEEIYLKSGEQELKETCLIYPTPL
KEGKSLTSPYTDLIREFQKKLSLPNSVLFIIGYSFSDEHINTIIYRALASNNSLSVVVFA
DKDKLARRIPLFSINDKRIYVIYGKDEGKTIHYFNYFVDELIPEQKQNEEDEIYKKFASI
VKNVTGDKNDCG
>fig|195.2233.peg.1099 Carbon starvation protein A
MTIPIAIFMGVYMRFIRPGRVGEASVIGFILLILAIHYGSVIAADPYWAKIFTLEAPTLA
IIMMAYGFIAAVLPVWFLLAPRDYLSTFLKIGVIVVMAVAIIIVAPDLQMPKANTQYFDG
TGPVFAGAIFPFLFITIACGAISGFHALISSGTTPKMLENETHALPVGYGSMLAESAVAI
MALICACILHPGLYFAINSSSALIGSDVASAAQAISSWGFSITPEEISTLTANIGEYTIL
SRTGGAPTFAIGVALILHELFGGIDLMAFWYHFAILFEALFILTAVDAGTRACRFMVQDI
LGNVYKPLGNIHNYPAGLLATALSVAGWGYFLYQGAIDPKGGIYTLWPLFGVSNQMLAGM
ALLLATAILVKMGKAKYTWVTLIPATFVLVATLYGGIQKVMPYEEGNKVGNAVSHVAAVT
IQSQKIQDLELKLNNAKDENEIAAIEKEISVATQSKIGNLINAILCVFFMLATLLVILSC
IGICLGKIKIPLKETKYIKLDEFQKV
>fig|195.2233.peg.1169 Flagellar cap protein FliD
MANQWLQYESILNKLNQQLNTVTNMINAANNSNN
>fig|195.2233.peg.1848 Imidazole glycerol phosphate synthase amidotransferase subunit HisH
SFNLTNFIKNTKKPLLGICLGMQILGNFSEELNQETLKLIDFTTQKFKAKEGFTFPHMGW
NQVHSSHALFKGLEGAYFYFVHSYCVGLGEYTIADCEYSQKFSASVMKDNFYGVQFHPER
SSEAGEILISNFIKDIG
>fig|195.2233.peg.1881 UDP-glucuronate decarboxylase (EC 4.1.1.35)
DNFMLRKPKWLEHLSNDYFDILELHKFDIINDKIDLLKDAHSADLIIHAASIASPMFYRT
YPIETLDANIWGLRSLLDFYKNKNIKGFLFFSSSEIYGDPDISQIPTDEEYRGNVACIGP
RACYDESKRFGETMCSLFAQKFNMPITIARPFNNYGPGMSIGDKRVPADFAKAVIEGKNI
EILSDGSPKRTFCYIADAIVGYLKVLVHGKFDYFNIGIDKPEISVKELSYIYA
>fig|195.2233.peg.486 Translation initiation factor 2
MAKIRIHEIAKELGYDSKEIIEKANELGLNIKTASNAVEPEVAAGIYEYIQTKIIPEAFK
KNLKQDPVKKAKAAPKEEKKEEKSPKEVETKAPAKVVEEVKPEPKTPEEPKENIQESLAS
ATLAKRRGLVIVKKKKDEEEAAKKEEPKASTPSNEERLSLKTMFSNADENLKKKKKEKKP
FVATKKESAEKMDFLEGHDFADISLEDEDVVVLPDFSVKEQEKPQNTMKKPPNFLRQAVG
NSANLGLEGGIQRRSRKKPPKKVEKKENEAVSSVEISKEIRVYEFADKIGKSVSEVISKL
FMLGMMTTKNDFLDEDAIEILAAEFGIEINIINEADEFDYVKDYEEEVDEKDLVSRAPVI
TIMGHVDHGKTSLLDYIRKSRVASGEAGGITQHVGAYMVEKNGRKITFIDTPGHEAFTAM
RARG
>fig|195.2233.peg.1798 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
IIFLDSDDYWELNCIEECVPRMDGVDVVWFDYNKIYESGFLDQKNDWTWFLGYNRNSGSK
KISSKLWLERYKHIGHFAFVWQGVINFRFLKNIDLKFIDGIFHQDVHFGFLLFAQSSYIY
LLSKKLLVYRIRNGATTVRNFKNNLKDEIPFYIQELLSYFEIKTAKEYYSIYSWIQIILN
VMHSHNIKNNLHSDLYYLFIGNLSEQILKLKFSYKQDPMHLSGFINFIKTFVGLHRILQN
NMQEKITQLSTKTQELTSKTTQINSLQTTLKNKDSLLSFQSQHGTAKQRIQNQLSYKLGQ
TMIVNSKNIFGILFMPVYIISTLLSHKQEQKIYQEKIKKDPSLKLPSLESYPDYKEALKF
KNHLSYKLGQALIKANKTWYKGGYVRFLFELRKIYKQKTMKNSLILYKNRDSNKKDTTRS
IRGGG
>fig|195.2233.peg.133 Aliphatic amidase AmiE (EC 3.5.1.4)
MQKLLKVALIQFAPKSYEVQNNLDKALKLAHLALEQGARLIVLPELYDSAYCVEDQDEKF
SLNLHQAHPNLDALQKLAKNYQAYIVACSIEKDTQLYDSAYIISHKGLLGVYRKIYLWGN
EKERFARGDKYPIFELEFENFKLKLGL
>fig|195.2233.peg.1889 hypothetical protein
IFSFDEDFELFLGYNHNVYEEGFWAFSLKFKKYTISQCNFCFTLENNLLLSCIQGYKYKD
FNILEINKILTKKCHGLRPVALLIECSKMLCEILKLQATLGVHEKNQIRSQKGKEKGYFV
DYQKIWLEN
>fig|195.2233.peg.1170 hypothetical protein
SIYTLKYKQADISNNTAYGYSVDKDGYMGSDFNKAAGLPEDFKIHKSTLDEIKKAAENDP
VVSSTKEYLGVSEYYTNIDMAETIKQYYNLFSNALGQSFPNDKTSFSEADINSMPSGYGV
SGTQWMDFNDPSNRMNITGLKDFSNSLISNIYKTPEQAKEANDLWADSGYMIDGLLPKTL
GLSLEEIKNVSKGEDWQFNPDMSVYPQNEDGSYSKETLFMSFLKSQGGQPVESLKTTLNP
KVEAYNTAMAKESFSTTSVDIGDIMTGKVDFASLFKYLASKNGKLEGQLYMYENNIPKES
AIGNWALDAEIKQAIANGWKAKPSTINSYADSIMDRLNNLIGQTRV
>fig|195.2233.peg.1127 Efflux transport system, outer membrane factor (OMF) lipoprotein
MKNLLSILLAFFLSACGVKLSLPKEPIMSEESFKDLNITYDWYKAYDNAKLNEFLNFVLL
NNSD
>fig|195.2233.peg.1258 [NiFe] hydrogenase metallocenter assembly protein HypE
LKALEILKKYNVNASIIGEVLEEKKARVILENAYGAKRFLEAPKGELLPRIC
>fig|195.2233.peg.1870 Motility accessory factor
IQKSVKIFNLFIHSDFYQNFQNTQIQNTNAQLIEMIRFIVLNKGNDPHDSLVGIKHTLDN
LPKMLNHGIFQEFLKERRAKVKNAIIVSTGPSLIKQLPLLKKYANKATIFCADSAYVILG
KYGIKPDYVCMLERDDIVSKCFDNDFGDFNKGILFILASVVHKEVLDFLEKDQRTYMLVH
RPLNFAASLKLDEYGYLGVGHSVSNMIYELAGALRFKNIIFIGQDLAYGEDGSSHPKEHI
HGSQGEEIRGEKYTLAYGGKGKVRTQLTWNLFRQAFEKDIFWAKEKLNITTYNCTEGGAR
IEGTIEKPFLWACENLLDKDLN
>fig|195.2233.peg.304 hypothetical protein
MGLNNEKYPLIEEQYSLESDNSTFDFQTDCEVKAGNQILHQVGDTQIVTKKDCVIIKAGG
VEVIIDSNGLVVKGGELKAE
>fig|195.2233.peg.1868 hypothetical protein
MKSKYNSVAKVRKQQLDKAQSNLNAAKQRQIENERLYELSRKECESLSVLPSSGSIAELR
SNLTMAQVGRDALARAKERVELSKKEMNHYQFLYQKAHLDYE
>fig|195.2233.peg.1831 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
ECLTYKLGEALIKASNNWYGGGYIKLWFEIRKLKREGRKVRK
>fig|195.2233.peg.1882 hypothetical protein
MISLNSHYPNINYPNNALSIKKDENNEYAYAKKDEPKSEEDAYWEDFVQKYFGEMLSKEY
ANKYGYNGSPDVKEVENSLYKRYMEDKLSKDEIKILNEFGTDYLVEGVDLTALIRRKVDL
LKTLTSMNEFEKIWGAERAQREKQFFNELGKPLTQEEIDRFLNKQQSSNSTQESN
>fig|195.2233.peg.1487 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAMDEKEFLNPYYRKKPILEAELNEFTKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHKGNSGMDLALKKDKQIQVIIEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKADLFEELFNKNKYFKEAFENFESKNSVGGKIKC
RKRKIKCRIFATNYLSFNLKLKL
>fig|195.2234.peg.1020 ABC transporter, permease protein (cluster 9, phospholipid)
MEANFKFQKEENKVFIFGIWDKTSVSKIKIKDLLSQISQTNCIFDFSQLNEIDMTGVRFF
LALEHDLKKNDILILKQGLNTRFKSLFELCEKNYQRINEKQEKKFNFTDFFISLGILSFD
LLKILQKF
>fig|195.2235.peg.1277 Cell-division-associated, ABC-transporter-like signaling protein FtsE
QRVAMARALAHNPKLLLCDEPTGNLDEYSSDIIWTLLKSARELLGTCVVVVTHRIPSNLR
LNYRRFNIENGNMNEIF
>fig|195.2235.peg.1735 hypothetical protein
NFDVVAVHVFYHCFCQRRSDVEKYSAYKYFQEEDIENIKNLLNQFHFSYGEINNDNALFL
ANSLVKHVENLKMQNKLDHNFKLNFTSTFISPNGDYQNFGIMAALDHINALKDLVKCFPK
FADLPKIYGG
>fig|195.2235.peg.713 Acylphosphate phosphohydrolase (EC 3.6.1.7) / [NiFe] hydrogenase metallocenter assembly protein HypF
IKNIQNLALSLIFHYDLEDKAKDFLAKIPKIKLKNLKKIYSHSNLQTSSLGRIIDAFGSI
VFNLEKSSYEAQVGLMCEAFYDKNLDFSYKLFVEKGQVNFKNLILGALQDEKTKAITGMF
NALANFIIDFSKDYDLKVLLSGGVFQNKTLLEILKAKNFDFFIPLKYPCNDSSIALGQMV
HFLNLEK
>fig|195.2235.peg.259 Cell-division-associated, ABC-transporter-like signaling protein FtsE
MSNLIQAHKLSLGYDELVIKEASFTFKDDDFVFITGKSGSGKSTLLKSFYGDLELLSGQL
EVCGSFMRKIGNSELLKLRQQIGIIFQDYRLIQEYSVEKNVMLPLMIKGYSKKVCHDQAS
KLLKHVNLTFKADKLPNQLSGGEQQRVAMARALAHNPKLLLCDEPTGNL
>fig|195.2235.peg.714 hypothetical protein
MTLYLHIGIMKTGTTFIQDNLYYNRDEMAKFGYIYPNFMKNKGNLHDHNPLVHKLYTCFW
HKDEKWIEDECVHQFKEKGYKNVVISAENFSWQFTSKQSIAFLKEKFMSMGFTKIYILIY
LRDASFFITSIYSQLVKRNSIVGYNNVY
>fig|195.2235.peg.1602 Hydrolase, HAD superfamily
MINIKLIEHIFKAASISRWNDYPRMANLVELDKQAHKFIIAYFIAKMEKDVDIRVIIEGG
IFEFLSRVVVTDIRPDVYHEI
>fig|195.2236.peg.1749 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
FNIFSSFLGSKNFYYQIEFEYGYGEWGTKIYFNLVLKDFYKEKLKFILLEMVDFKPSTIK
KLEEVIIRIQVDINQSFLYILEKIIITTFKYSSFKMEYNQLDIFGYSAKTRIQNQLSYKL
GQAMITNSK
>fig|195.2236.peg.1493 Putative periplasmic protein
MFKLNPCLPLKCDLNSQDCTFLLKEKKILVSAYPKPIKIFKNTAIKVSNFPFDPNLKIKI
YSLNS
>fig|195.2236.peg.1642 DNA ligase (NAD(+)) (EC 6.5.1.2)
LEKTTRLIGVNLQVGRSGVITPVAVLEPVNLDGVIVKSATLHNFYEIARLDAKINDFVSV
IRSGDVIPKITKVFKERRDGLELDIARPRFCPTCKSELLDEGTLIKCQNIDCEDRLVNSI
IHFVSKKCLNIDGLGESIVELLFKEKKINTLESIFHLKFSDFEGLEGFKEKKINNILNAI
EQARDCELFRFITALGIEHIGEVAAKKLALSFGKEWHKQSLEAYANLEGFGEQMALSLCE
FSRVNSARIDEFYKLLNLKEQKVQIQEDSVIFGKTFVITGALSRPRDEFKNLIESLGGKV
SGSVSKKTDYVLFGQEAGSKLDKAQELGVKCIDENEFNELIEK
>fig|195.2236.peg.1397 DNA ligase (NAD(+)) (EC 6.5.1.2)
MTKKEYLEKVALAASWMRAYYEKDEPLASDEEYDALIRELRVFEEQNKDEISKDSPTQKI
APTIQSEFKKIAHLKRMWSMEDVFDESELRAWAKRAKCEKNFFIEPKFDGASLNLLYENG
KLVSGATRGDGEVGEDITLNVLEIDNIPKTINYKEKIEIRGEVVILKDDFEKINEKRTRL
NQSLFANPRNAASGSLRQLDTSITKERNLKFYPWGVGENTLNFTKHSEVMQFIRELGFLK
DDFVKLCTNLDEVLKAYNELLSLRDQKPMMMDGMVVRVDDLALCKELGHTVKFPKFMAAF
KFPALEKTTRLIGVNLQVGRSGVITPVAVLEPVNLDGVIVKSATLHNFDEIARLDAKIND
FVS
>fig|195.2236.peg.718 methyl-accepting chemotaxis protein, putative
MISQGKSLSEEVRDSVDLIYKQANDSLFKAQEVNQEVAAQVKLMEEIEEKIITVADISSK
TQQAVSENKNAMTELKNISDNLQAEIAIFKL
>fig|195.2237.peg.1913 Replication initiation ATPase; bacteriophage DNA transposition B protein
MEEKKAIDLVFNLARGNFRKSEKLLKRACEFADGKAVELKHIEAAASFLMLG
>fig|195.2237.peg.1508 Motility accessory factor
MNLLEKNIQALLSGVNEPLGNKLLNFIQNKTCFRFSIDENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTP
>fig|195.2237.peg.1839 hypothetical protein
MTQQIDFAKYQKMNERQKFNALLKEKKDIENLKEKIKFKKSVIGYLQGELNFFLEQEFND
ELKEAIEEIKNGGGTLCKSMEEFKAKMAED
>fig|195.2237.peg.724 hypothetical protein
MAVDKNSKDQAMQLNLIKITQKIVKINVKTQAINNLLLAIKHLLFLKKF
>fig|195.2237.peg.1891 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
ENSLNIAKEYTLKDKRITLFDKKNGGLSSARNVGIEYFSGEYKLKNKTQIIKENSLIEFN
IEGNNPYEIYTIYKSYKAFNDEQDLTSFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGV
EVVWMNHVFLYEYYDPNAFRVTLIDKLKFTSSNKYSIDFLISKMQNLNQNSFWFGWHGMI
NFKYLYSIKLKFIDRLLHEDHYFGKLLFFQAKQIYVYTKKKIHYRIRKGSIMNYSKENSY
IPSYALSEYSALNNDYFLYKKYHRISSLFLTAMMVFKFMKEDNKIKSIESFKQIFYKKLK
SWRNDLVDFDEFFLEKVLFLSFQEFFRLSSDYRVNLELISEFIADIVKTKNQLITNKTTQ
IQN
>fig|195.2237.peg.1621 Dienelactone hydrolase and related enzymes
MKNNFFKLLLMVLLIGGANMLYATTWDKVFTRSDKVKIQKVTFKNRYGITLVGDLYIPKN
AKSKKLSAIAISGLFGAVKEQASGFYAQTLAELGFVVLAFDPSFTGESGGSPRNVASPDI
NTEDFSAAVDFLSNLANVDPSKIGILGICGFGGFALNAGSMDTRIKAIVTSTMYDMSRVN
AYGYNDSLDKQARYELKKKLNEARTKDFKNGTFELAPTLPQKLSGNEP
>fig|195.2237.peg.1859 phage virion morphogenesis protein, putative
NERSIFNGKWKSLKPATIKQKIKDGKNKGILKRDGDLSNDLNWQSEPTKSGVKVFNNMQS
KSGFKYGLVHQYGSRKKNIPARSFLPIDNNNVLHQSIRSVIYKDTKDFIVKIAKK
>fig|195.2237.peg.403 Flagellar protein FlaG
MEISKANGQMDTALANISQRTSETQASLNIQTDRSQGQEGDDGQQRGVSEKLADITKKLN
EQMDSLDTNVRFGYSDKIGSMYISVTEKSTGREIRQIPSEEAIRLAEYFKDVIGIIFDKE
S
>fig|195.2237.peg.1871 phage virion morphogenesis protein, putative
MSEYIEIKGIENFFKACDKLIDMDKHGQSIMAGAGESIRNSIIDSF
>fig|195.2237.peg.1836 hypothetical protein
MYIIKTKKVLFFSRAYAYAIFFIFYIFFLFLGGFLKTI
>fig|195.2237.peg.1713 conserved hypothetical protein
MHPKAISKFADFFAFLVSKGIQVIIETHSNYLLSKLRYINFKKEFKDEDCIIYYKDQQTD
FVPIFIHSGKFTNINREKINFPTGFFDTDLDKLMEIR
>fig|195.2237.peg.1698 Flagellar basal-body rod modification protein FlgD
MISSSDWNLNTAATTSGATSSGSTSGTTRTDSSSSSGIVSNPNATLDKDAFLKLLLIELQ
HQDPTDPMDSDKMLTQTSQLSALEMQQNTNTTMQKMVETMQKLSDSFSTSMSTSALGAIG
KMATVSDNKIKLTGADELIALKMYLPEDSDENGVTLEIYDSNNKLVFSEKSDAKSISQGL
FTMEWPGRNNDGVYAGDGEYTVKMVYNNKNGKKITANYGTYPIEGVVFKDGVAYAKMAGK
EVPFGAIQEITDYKLGSSSSTGSTGGSGSSGDSSGGSSDGDSSGSTEDSDEEEKA
>fig|195.2237.peg.1915 FIG00470627: hypothetical protein
TIAGVKTFSVPPVSATNPTANNQVANKSYVDTVGNSKVALSGNQTIAGVKTFSVPPVSAT
NPTANNQVANKSYVDT
>fig|195.2237.peg.1866 hypothetical protein
MGIVTSIRKHKNTLSKNVTILEGKKHFWDIKFKIKARVYPSFKQHLITFLGQNGYFGIFG
IFYTLN
>fig|195.2237.peg.1899 hypothetical protein
KGLCGAGEDKCQNPSRDRLFAWLQASANSPADYRPVYKVKRQIKYSNLGQPYVLFTYGVA
VYNVNNGQIYQYNSSPMLNNNRIIREIAHQYKSVIEDAMGGWNPRLF
>fig|195.2237.peg.1838 mRNA interferase YafQ
MKYEIKYSTKFKKHYKKLNTKERQNADIIINRIANNETLEAKHRDHALKGNYIGFRECHI
QQDLLLVYQKQDDKLILYLLRIGSHSELF
>fig|195.2237.peg.1840 hypothetical protein
MILLEKVLDERKRQKQEKENDNANNTRTNSTGIVRENDKTEPREISQSSSLSDPERDGGY
STMATLGLSDNLQTIRFKRELSESLSRNTDEPRNTAQSRLSRAESRESGAIISANKEFQN
INDEKIPSKLNKEESKEFNIPAL
>fig|195.2237.peg.1822 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
LITNKTTQIQNLNQAIKNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSK
SILGYLIMPMALLSIIISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYK
LGEALIKASNNWYGGGYIKLWFEIGKLKREFRKKDNHA
>fig|195.2237.peg.1837 Mobilization protein
MGAISSINFKKSNAIQTMHNDRELPPNYLIGGSCECNKSSIQALKLKEKIIQEAKEAYNN
NKSAKAPSFKAKSYEWSAVVNIKLDTTMQDLERLALFLNEKYGFQCYQIAIHRDEGHINE
QGQKEINHHAHLEFITLNKENGRNMWRRELITPKVLRQMQSEVAEILGMERGEDKRISGA
KRIEPRAYAVLKEKEKREKKKNINLEQEQEKEQFLNKSEYKKIIEDFRKSQINQGLDKDF
FKELSELKKNFQEIKEDNLSELLNDILREHLERIEKLKKENSILKAENELLKQKEQKNDK
SQGLFEFIENLAIFRLNEALNKIYSKPLKKILEAETEVKKKERVKILTEAMEKTKTHIPE
TFEKWIENNKDFDLKEILMTYQNSPSKELKQSIYKGR
>fig|195.2237.peg.1789 COGs COG3777
MSYENFIGKQEKFTENINEKQVQKIVATLQSKQLKNGDALSCLWQWCFFNEALTPDKLGR
DGHPKLGLDKNSFFPSFGEVNRMWAGGRFNFIAPLIIGEDATKITTIKKIQEKQGKSGKL
TFVTLEHCYYQKEQLKIEEEQDIVYKQPAPPKLTSDVVAMNADYSEKMQPDSTLLFRYSA
LTFNGHKIHYDFPYATQVEGYHSLVIHGPLLATYMINCFVKNHPDKQIINYSYRGMHALC
VPDSFAVESKIIDNNTAEIWINKNGFVAHSGTICKGYFKKNM
>fig|195.2237.peg.1651 Putative periplasmic protein
MQDSVDSYVLNLNRHFAYEEFRNERAKFESEGKEITGLEAIKTLDSYSERKGYYINIVTK
IIQRYDLERYDTPKSF
>fig|195.2237.peg.227 Putative transmembrane transport protein
MLSFRKIFWLNVAIVIIVAFNLRAPITAIGPMIDIIQDEYNLNSTLAGVLTSLPLIAFGS
ISFIVGYFSPICAIIVGIFLIFIAELIRSYLGVYGLFLGMLGIGCGIAIAKFY
>fig|195.2237.peg.306 Ferric receptor CfrA
MDKYGNLVSTFGTRIDYETLKNDQESAGSEIRGKNLDQTTVALYGEGEYFISDDLIFTTG
LRYIYSDLFDSEVTPRVYLVYHLNDNVAFKGGVAMGYKTPAAKQLTNGYYNYSNNGASFG
NPDLKPEESTNYELGVDFRIFDFAHYSITGFITDFKNQISSEELTGMYNGIDCANGVTCE
RSINLGKTQTRGIELAFNTKPYKGFSVNSSYTFMDNRYKDGQTNWFGGDRIENLPRHIAM
LKLNYEQGKFSSYVKARARLDTIARSKGGGSGTLPWQKYKPFYIVDLGVNYKIDKQSSLS
FTVQNLFDKDFFDPQVTRWDGANPGGYANRYQDYTEGRSFWLSYKYDF
>fig|195.2237.peg.1133 Phage Rha protein
MEKLAVINGVDVELEVANDFKTFKNYALKLEKMLKDLKDDENKENKLLLRMQNDFLECLE
LYKSVNI
>fig|195.2237.peg.1898 hypothetical protein
MISLNSHYPNINYPNNALSIKKDENNEYAYAKKDEPKSEEDAYWEDFVQKYFGEMLSKEY
ANKYGYNGSPDVKE
>fig|195.2237.peg.1911 hypothetical protein
GALSDTSPGVKELSLDEMKEVKGGYLVRFKFFKDRPNLISEVYAIAEITLEERKNLDKGL
CGAGEDKCQNPSRDRLFAWLQA
>fig|195.2237.peg.228 hypothetical protein
MASMMGIYSLVLSISSIAGIALSMPLLNIFDLAGAMVFWSVFSFIALMIYYPQAKNGRFF
RTKKKESKKINLLKNPTTWKITLFMGFQSFLAYSLFFWYVQIIVEKGYDKDFATNMVLFS
QLVAAPISLFGPLLLGKLKKSLHTPYIAILCAMYAVSFGILFAFDTRFMIMLAAFIVGFP
WGGVFGIALLFIAQKSSNAKIAARLSAFAQGFGYLIAAQGQWIIGFFHDMFGNFTSSICI
LFIVGILVNIFGYLAYKSKVI
>fig|195.2237.peg.1908 hypothetical protein
GRGGKKLLFKISKDKLLTAFNQELITKNTLIYDEKMQKVKLSEIITTDNLKTINNSLKTS
NLNLTESKINDDLAVLNLKFENLSDELKEDAKSKVK
>fig|195.2237.peg.1897 hypothetical protein
ESQNKETYKDDNTRNELLRKLLETKFGTSDELEILFGMNFSNDNAGEFNKILSLNSTPKS
IDIKA
>fig|195.2237.peg.1890 Bacteriocin resistance protein; peptidase C39
MEKILKILLFLPILTLSVKAEWVVKSYQEIKNERVIRQTYEQSCGASSLATLLNILDDQK
KFDELELLKIMSGQELYTDMVSFADLSDAFKKLGFQSNSYQINRENLDKLVNIPMLVKIE
DDPRFPHFVIIINHK
>fig|195.2237.peg.190 FIG00471540: hypothetical protein
MMAYEEPIKACENMAKHTFSTHCKDHIVFIEDDTKYVCGVPLGEGNLDIKTCVEILKQAG
LDRINVEQCYPYCATFKREEGAGGIKELGKGAFKIEKPLFNDLKAMQYYYPQEVSKEHLE
RLLILQKEGCERSVKYLKSII
>fig|195.2237.peg.1757 conserved hypothetical protein TIGR01671
MKLQDFDFRIWDKTKEEFLKKEPTLIKIDNERVIAGRISRFYANTADITDMFIGNGNDLE
IELWTGIYDKNGKKIYEGDIVKTKSPYDCFLAKVGIHKEGTFYLESKSRDYIGSLIYLVK
DEGYDTEIIGNIHENPELLKC
>fig|195.2237.peg.1343 Putative periplasmic protein
MKRIIIFLSFYLLPLFGNSELKNGFGEEYYKLNVEQKRQIFFTKMNTMFDKSFEEIAKER
AFVEAFFYDAYKNGLRNSNQNNLEKLINLKNKYRVENLYDFTEYKKRIQKIPKSMGIAQA
LVESAMGTSRFAREANNLFGEWTWGEKGLIPDLSVRGILKRTCNYP
>fig|195.2237.peg.238 Multidrug efflux system, outer membrane factor lipoprotein => CmeD
MLEKYLKSAIFLALYPLAMLASNLHEFIALSQNNESYLIKQMQSEQANLDKEQAFRNYLP
SLSLNSAYVANNKDRFIIDPQESLFAKVSLNFLLFDGGAREANLRALESKEKLSLLDKEQ
SKNYLALNAITLYFNTLSLKKNFTSKSTKSSFFKINF
>fig|195.2237.peg.1861 hypothetical protein
MSATKECMGEEPMFYAITHNNFGAILLLLKYGAILDKEYLEESNKDFSKEALKFLSSLLK
>fig|195.2238.peg.1442 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase (EC 2.3.1.202)
MIKLKNFTELNSQEIELIFKWRNHPDISQFMKTKYIDFEEHLRFLKNLHQDSSKKYFLVF
QDEQIIGVINFVNITTKSCEFGLYAKPDLKGVGQILMNEIIKYAFENLKVNTLKAYVFKD
NHKALKLYQQNHFTIYNEDKNIFYIKLKNYNYKKQFAKRISKLDKGEGGVNTNIKNTLMT
NFFKITQYNIKNKNIVFLMQDYRCNILLKNYINLNYIEKEKIRKYRNHPEVKKYLYQTHF
ISKLEHKNFIKKLKYNTKKSYFCVILDNQIIGNINFYIRENEIDFGFYANPFSKILGIGR
ILEQISIYYAFKIINIPILSLEIFSNNTQVINLHRKFGFSIVQEFFIKKQKILKMSLKQS
DCKALLS
>fig|195.2238.peg.1439 hypothetical protein
MLINQTFEIDSCDDVELGIKRTSKLEYRISYDDEKDIKAIVFIVGGFGANANISFLDFDR
EYIAKNFDVVVIHVFYHCFCARQSIDQKYNPKLIPNQDDLERINGILKNINLGHLSVNKD
NFEQIIPLIEQKVNEMKQAGLVDESQKIELSCDFIPPNGDYQNYGIMAAIDHINALKDLV
KRFPKFADLPKIYGGGSYGGYLSLLIAKIAPWYVDGVIDNSGSAVPPLNYILGREMEHSY
GDYYEDFPHNRIIFFLKTHWTRKENSPYFFNNENYFIRTLLNKDHLILQSQKNKNIIYVS
YHSKEDPLTPANFKEQTMQILKILGYDVSLNLIDENKIDGKFIKNLDHGCGIPDKALFRK
ELPLMLEKLQKRKSLMQENSISYPCGNKVFIFKDVGDKFELTIKD
>fig|195.2238.peg.1767 Motility accessory factor
IQNIYLNLNKKENDLNLAIRKIDEFKNKLENIKQMQDLYEILSPLLIQFELNLARIYVLN
PKTKEDAFNKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVR
>fig|195.2238.peg.1746 FIG00470597: hypothetical protein
MYKSHVYDLLYEKRNLLNIIDTIGIELCNKICKNLKEDDENFYHPKIFKKAL
>fig|195.2238.peg.366 Selenophosphate-dependent tRNA 2-selenouridine synthase
MQKAFKIHCFCSLEKRIDRIQKIYQEKMTPLKFKECLAKISPYISVNFRQDLLKSYEQRE
WQRLIALLLAYYDKSYKKPQKIDFELNTDDIFKAKEELLGYFKTQLLF
>fig|195.2238.peg.1761 Motility accessory factor
RKGVSDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVLSLERIP
LTSEFFNNDFGEFDKDIMFIVKSVTHPHTIKYLQKNNRAFILVSTYASFIQYLKLDYFGY
FNMGKSVANMSYLLTEYLNYKNIILIGQDLAYAKDGFSHTKDYKNLDKHEGHFQRDKGKF
QCLAYGGNGKVESSEIWTMFRLIFENDINYFQKLFNITTYNCTEGGARIEGTIEKPFLWA
CENLLHKDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIKHCRDFSKILSNDFNNIQNIY
LNLNKKENDLNLAIRKIDEF
>fig|195.2238.peg.791 Phage antirepressor protein
MQNITSNLIFTNEQIAINYGLTTGLTIAKHLRMHNDEFIENTHYFLVENSFKNKTIKWTL
EGVYKLLWIKLRN
>fig|195.2238.peg.182 Single-stranded DNA-binding protein
MFNKVVLVGNLTRDIEMRYAQSGSAIGASAIAVTRRFTTNGEKREETCFIDISFYGRTAE
VANQYLTKGSKVLIEGRLRFEQWNDQNGQNRSKHSIQVENMEMLGGNSNAPQQGGNFGNN
SFSNNNYSGNYENQSYDPYMSENNFKKAPQQAQTKTQNPNQNQEKIKEIDVDAYDSDDTD
LPF
>fig|195.2238.peg.764 hypothetical protein
MKKEEKIKRKEYNVFFYKLSVKPNLFNQENEIYNSMLKFLKINLRDRQLCDINGCKAYVN
FIKEKNGIYLFYFEKYRQEELPQIENIINGNIRNIYLEENEAITEKTCFALCFNETKGAF
YIAYVKLQHSYEPSSLLKYISQTIGIKEDELNLSIILHKDTLEKLYKYEKIKGYSYTIAT
PNETLLKEFGLSKESRFILAKEQVSKIKFEISLEETQKFTKSKKEKINKLISNNTDCIKK
LIMEVCSKNEKPEKIDLFKDIFKDKIKVNINKNNAINLESIGEKLIETLQKNKNNLDNIL
KK
>fig|195.2239.peg.829 transcriptional regulator, Crp/Fnr family
MDKEKILKEYFKNYNLENKDFEAMVEKSYFKEFDKNTILDDCLGFVIVLKGGFRAFILGQ
NAKEITVFKLKQNEECVICSHLSLKLYLTISP
>fig|195.2239.peg.772 Cytolethal distending toxin subunit C
MHAKDLPFGYVQFISPRGDDICLAVLSEKSFGTKSCKQDLQDGTMQTIFSIIPMTNGSIQ
IRSLTNGGNQCMSTFPDSSIAIENRFGLGEYLLDRSIVTVLSKLFFFSPAIIEASAIY
>fig|195.2239.peg.207 hypothetical protein
MESWTIYKEQKSFLKDLLRDMETMDKGNNNSFYNKYAQSMKSKFVIMLYTMLESVIMQSL
QDIFDHIKQNKISFYDLHDNMKKIYFQAKIKNKERHFNAIVADNLIEVIEQLNNGVVEIN
LKKDFNSENPFNAGSLNYKNVKDNILAILMSSDSIDSNINKFNKYFKINIQEVIGVNTKD
RNKLAHGEKSFQDFGSNITVDDLKKRYISIIIFLHKYLKNIEYYIINKGYKNA
>fig|195.2239.peg.828 transcriptional regulator, Crp/Fnr family
MFSFIFETISYNLTLESFEDTQILIVPVKIYSQLKDKYPLIANYTLNLIAKRFNSLINIL
EQALFTPLHHRVKMFLKENAKEGKITFTHEEIALHLGSTREVISRILKTMQKEGFIQQNR
KEITLLKDL
>fig|195.2239.peg.1099 hypothetical protein
MKAYIHIGIPKTGTTVIQKFFKLNRSKILNKYILYPKTVGDEHHQTLAGFAYNISRLTTH
RKHLKLYNNYEYINYRKKILKKLKEEICGINEIVFSSEVFQEQLSKREIYRLKKYLIFLG
FTEVKIIVYLRNTPELFKSLCSMFCKNNEKSIINLLPYDNSRIHHICNHKQTLQWWGEIF
GKENLIVRLFDNNEFYQGDLLKDFIHSIGLEWDDEFIIPPKQNESLDLLGIELLRRVNSI
SSRYTGVQPFIKTFCEKHFTSKDSHLKFQPPKEIIQSYIDSFEESNEWVRKEFFPYKERL
FPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLITNKTTQIQNLNQAIKNKDE
LITNKTTQIQNLNQAIKNKDELITN
>fig|195.2239.peg.38 DNA transfer protein
MSFWNSLYLNLKEFRYLFLFGFIVFVFNIFLEYNHFLNLKEKKHYLVENALLLQYYPKHN
KNNKKYWVLKLKTKDFILYTTSFKDLNLSKNQLLNLKIITNNISFKDYLGKSFYAPSYGF
EVLGYLKNNTLISYFLNQHTNEKIQEFYGALFFALPISSELRNDVNHYGVAHLIAISGYH
IGLLFTLVFFILAPLYSFFQKRYFPYRSLRFDLSIFIFILLFAYAYLIGFVPSYVRSLIM
AFGVFICFVKISKF
>fig|195.2239.peg.205 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72)
MIEEILKDSDYKLDLFSKKAIAELETKIIAKTNKNNQIIYYTNCLIRDKEIKLTPEEIVR
QLYIDKLLNEYNYPKDMIKIEFGVHFGREVKRADIVIMDKIQITTPYIIIEVKKPKLKDG
KEQLKSYCNATGATMAVWCNGKEISYYHRKDPNYFESIPNIPASNQTLPDLLKVKFTFDD
LIKEDILKSQKRSLKNLVTEMEDEVLANAGVDVFEECFKLIFIKLFDELESARDRTKSLE
FRNYGESDSELKQKIEKLFDKAKKKWEGVFNNDEKIKLSPSHLSVCVSSLQNVKLFNSNL
EVIDDAFEYLVNKSSKGEKGQYFTPRYVIDMCVKMLNPKKDESMIDTASGSCGFPIHTCF
YVWRSIYKERGIEASHLFTAQEKISECQDYVKEKVFGIDFDEKSVRVSKMLNLIAGDGHT
NVLYLNSIDFDRWDEWVKDDEDWQDVYFEGFKRLKNLRATRNQNRDFNFDILMANPPFAG
DIKESRILARYELGKKENGKPQSKVGRDILFIERNLDMLKPGGRMAIVLPQGRFNNSSDK
YIREFIAQKARILAVVGLHGNVFKPHTGTKTSVLFLQKWDDKLCPKCEDYNIFFATMSEP
SKDNSGEKIYYPLLDSHDHLVVKHDLFNPHLEGDEPIKQKDESQEEFDKRIQEYRLNVEK
YKDLQKDGIAEAFIEFAKAENLSFWRL
>fig|195.2239.peg.19 hypothetical protein
MEKPFLKSIILASCLLTRALSQQNKENAEALEQMIEISHYKNVPQNENIQNTLKSKQSPL
DIKMDKQDSLQEDTKKVLDKEGLVAPSSEEFRFKYKFFVDTKEDGKTLTLEDLGINEVWL
RESIIALKRSDLNVETLQEIVNIVSYYFQYHGYPSATAYLPQQEITDSIQINIMLGKLGE
YQVKNYSKHLKESAISSKLKESLQGKILRTKALEDAIYKINEMSGV
>fig|195.2239.peg.1775 Motility accessory factor
LGLNKKLAENFKNSIVSHGNDPKDALQGIEQFVYNLPQMITHPSYKELLSKRKGVSDTAI
IVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVLSLERIPLTSEFFNND
FGEFDKDILFVLKSYVHPHTTKYLQKNNRNFMLVSTYASFIQYLKLDYFGYF
>fig|195.2239.peg.206 hypothetical protein
MASNKSMLSSDEITNILKEKQKNIKYDTKDWSIELVLSKFHKQTEKNQTEINIPFYQREF
VWTSDQISKLIETILLGLPLPLIFLEQTDDGLLEVIDGSQRIRALDKFFNNEHKLNKLEI
LGDFNGMKFEDFPPSIQRKMKDSSLRIIVLESNEEENAKDIANKIFERINTGGTNATAME
ARKGSNYGKFVEFVYSECSTEEFENIAKLGKTASLRGYQQELIIKFFAYYDLYIKNNKIE
FNETINAVLENYMKEKNKSFDDDDKNKDELLTLFKNVINIIERCKITENDSYKLRKKDKL
LPIMLAIAIYIKDNPNYTNKTFDVWSQDFISKSNNSSLQTLNNNIMLILDSLKQ
>fig|195.2239.peg.1779 Motility accessory factor
NRNFMLVSTYASFIQYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILIGQDLAYAKDG
QTHSQGFIHANLHNGDYERDLDKFS
>fig|195.2239.peg.1778 Flagellin
DANIADAMGFGSVNKGVVIGGFSSVSAYMSSAGSGFSAGSGYSIGSSKGYSAILTANATV
ISTASAASRVYNVSSGSGFSVGSNLSQFATMKTSVLGVKDETAGVTTLKGAMAVMDIAET
A
>fig|195.2239.peg.20 hypothetical protein
MLFFDNYGSKGSGVYRAGVSGALNNLLGYGDSLNYFAQLSDEMQKSYGFTYNFFLGNLKV
SPRVNKSNYELGEEYESLGAYGSSLDLGVDLSYPLFINTTNSLYLTGGYVYRKLEDIYGS
FGIDFNKESNAFYLGTEGTIGLIPNNILGYNTQLTYGDIKPKSVFLENSPVMGEFWKFNA
ALNNTYYFNNKISHILNISYQKTIGDYQLDSSETATLGGAYGVRAYPNGFGEADSMILTT
IGLRFNIFSPNFYITPFL
>fig|195.2240.peg.935 Putative efflux protein
MFISIAGFVSSYSWRYPFLVYGLGILITLIAMIYLFEPRKFKFYNHTKIEEKTNYWKFFP
IYFIGFFIMVVYYISPTQLPYYIEEHLGLDPKFIGISMSISALCYGIFSLSYKYIMRFLS
IKMIYIATLFIVGCSFLILFLIDDFIAVLFALALLGMGGGIMLVNNTAYLFSICPENARA
RAYGILASCIFLGQFLSPIISQPIVRQLGLVDAFLIWAILNFIVCIVFLFLKQR
>fig|195.2240.peg.1474 Major antigenic peptide PEB2
MKKYLFLSLVAASFLNAEVLVYGPGGPAPVMK
>fig|195.2240.peg.1827 Bacteriocin resistance protein; peptidase C39
MVALLPLFLKAEFVVKSYQEIKNEKVVRQNYEESCGAASLATLINTLDDNNLTELDLLKT
MSGQKLYTDMVSFADLNDAVKKLGYESKSYKVDRKIL
>fig|195.2240.peg.1688 FIG00471323: hypothetical protein
MCKIIKYLDYARLNTLEKLYIFNNFLLLFFEKESELKFICCS
>fig|195.2240.peg.1653 helicase, Snf2 family
MHPDVFNDFRINEYFKNNPQNILGKMNIKSSQYGYSLECLDDGRDLKIALENFTKTLPKN
IYKYQETKIKLSYYRIDRESPEYEKYSKTLSKLKDGNYFEYNNEIYMKIGSDDELVFSKP
VLNEHDTRRIKKLIALRDQFNTLIEYEKNESNDLLVENQRKSLNKLYDEFVAKEGYLNRD
ANKKAFREDVEANKILALEKNYSSGISKSVALKEGIDPIAPSATKADIFFKRTINAQKEI
KISTPKEALIASINEYGRIDLKFLETNLNQPLEETLKSLEQDRLIFKDHKNPANYVLAEK
YLSGNVKAKHKEVKKLVEDGFNEFANNLESLEQVLPKDLKAVDISISLGTTWIPIKYYKQ
FIEETLQITPKDYDLFLMERTGEWSLKGFGYSLSSYIRSEYATERIGCFDLLEHGLLRKP
IRIYDKKLDPSGKEIRELNPKETAIANSKLENLKNEFIEWIYKDYDRRTDLENIYNERFN
TNIEPRYNGEHLELPNFNANIKLKKHQKNAIYRAIQENSIIFDHQVGAGKTLVAICSVME
QKRMGLLNKPLIVVPNHLARQWNDEFYHAYTNANILVATNDDLKKDNREKFFSKITTNNF
DAIIMTHSQFKLIPAPYEVIKKQYEEDINILEQTLEKKQNDDNVMRYSVKDLEKRIENFK
VKLSDLQTTHKKSKAIDFSELGIDALIIDEAHEFKNLLITTSMGDISGLGNLKGSQKAYD
LYSKTQYIHEQNKKLYFLTGTPISNSITELYTLQRYIQPNILKEKGIQAFDSWASTFGEV
TNAWELDSSGINYKIVARFNKFKNVPELSTMYKSVADIVTNNDIMKYQKDFVPKLYNDKP
INIVAPRSKEIAEFIGIQDENGRWNEGSIVWRMEHQQDDITRNNLLACTTDARKAGLDFR
LINPHCDDYANSKINKLIENVFNEYNAWNDDKGTQLIFCDLSTPKQHSQKVALNGNIATP
NLNKEEFVNINETIEQTEEENSKSLDELLAEQAKFDVYTDILKKLVAKGIPQNEIRFIHD
AKTDLQKGQLFADMNSGKARILIGSTQKMGAGTNVQKRIVALHHLDCPWRPSDLEQRSGR
VIRQGNELFMRDPQNFRVKEFRYATERTYDARMWQVIESKARSIEQFRKAGADVRTLEDV
TSGAADAAEMKAEATGNPLILLQVQLNSDLRQEEMLYSGYKRQIHNNEESLITNLSKIEL
LKKDIAKMEILNSIIKENNSEHFQGKYYINDDEKDFIVFKNDTSDLNKSRQAELERNFEK
IVKTIADDYQKEYKVLEFKGLLISGERTDLNTLNFYVSTTDGKTIIEPENLIYKRDEKTF
FKLESYVNFGGFVKRLNNFYNDLEKFTQLNKNKIENLEKEIVELKSITGDNTPKYKRKDY
LEALREDNRIIMDEIEKMSKQKNYKSDFLPKSAKILEDLNKNNNIQKEYDIEI
>fig|195.2240.peg.1772 hypothetical protein
MFENIEYLLLKNYLHIKDYFKLDETASYALSLLAKNNRKRFSINRKIQHFKALSTLKYLL
RAGIIKLEHSKEAKRIKDKRQKLKKELRSYVIQDKIIFANHFTRFFFYFLKPNEKLILQN
RYEEVLGLIKEKFELYQSFCFEQLSRELLEKKFQVSGVQSYWDKNLELDLYYKDDEISFI
GEVKFKNKKICRNILNL
>fig|195.2240.peg.1847 Motility accessory factor
LEYLFACNDQKAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKNRSDK
LLVKFKEKIQ
>fig|195.2240.peg.1654 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRHGDTSRRANKSQSIHSDRTPNLFSFISRNDDERQGADARRNNQQSVLETATRNDG
YERRSLKSGQKLDFISDDEIYLGSLKDRFQKNLQAIKLSKTIEQENRYATKQEQEILNKF
SGWGGIPQAFDHQNKEWEKEFKELISTLDYAEYEKAKTSTLDAFYTPKIIIDTIYQGLNQ
LGFNNDGHTKEIFEPSAGIGSFLSYAKNYSDKYHFTCVELDTISANILKHLHPNQTIYNK
AFQHHLFDKPYDAFIGNPPFGQKKILDLNDTTLNKTSVHNYFIGNAIKNLKEDGIAAFVV
SSYFLDSKNSTIRNYIAEQATFLGAVRLPNNAFKKRANTEVTTDIIFFKKGKDLNIDKS
>fig|195.2240.peg.1845 Bacteriocin resistance protein; peptidase C39
YLQILDPSYGEYISSKREFYSVWDRYNKGGFALVVNPKKQLKDYKLNLPKPLNFEIEHFG
F
>fig|195.2240.peg.1810 FIG00005326: uncharacterized protein
QKNILERLKMQKEFFNELEKILYEQNLDNKFENFAIFYDDFKSQKFIFNHEQGSIFKTNI
NPALKLLHPTRIRRPKFVNSTHSLAKIVHSIAHIEFSAINLALDASYRFKNLPQQFYIDW
LEVADEEIKHFKLLNAALDELGYKYGDFAIHDNLEAALEATKDCLSLRMGVVHRGLEAKG
LDANPFVVAKLESSNHPIKSLLKDVLHIILNDEIKHVSKGDNWWKFSNQNNYDFIELCKI
FNQFSLAGKKLNIEARIKAGFSKAECEAIAQFYA
>fig|195.2240.peg.1815 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
EALKLKNHLSYKLGEALIQANKTWYGGGISNCYLILEKLREK
>fig|195.2240.peg.1658 hypothetical protein
MGAKPVIKLERTLFWRIIPFISKLNNSLRKELEDDLLKLQEYYDGINVLEYKTFALLKCN
SYYEKGRINEELIDKIKKYYINLFKKKIAKELEEMQKEKERRNILKTNQELILKKIGE
>fig|195.2240.peg.1435 Bacteriocin resistance protein; peptidase C39
FADLNDAVKKLGYESKSYKVDRKILENIISVPILVKIEDDPRFPHFVVIINHKGNYLQIL
DPSYGEYISSKREFYSVWDRYNKGGFALIVNPKKQLKDYKLNLPKSLNFEIEHFGF
>fig|195.2240.peg.489 hypothetical protein
MEVLFFQMEILFFRRQNLLESKAKSLKLEPNNYIIISKNGFSKEFYKICKQDLLLLDLND
FKILLEEDK
>fig|195.2241.peg.1404 YheO-like PAS domain
KTLYQKGIFNIKGSVPIVARLLKISEPSVYRYLKNFKS
>fig|195.2241.peg.1736 Flagellar basal-body rod modification protein FlgD
TDYKLSSSSSTGSGSSGSGSSGDSSGSTEDSDEEEKA
>fig|195.2241.peg.1765 Sodium-dependent transporter, SNF family
MNSKFSKIGFILAVAGSAVGLGNAWKFPTLVGQSGGSAFILLYIILTL
>fig|195.2241.peg.416 Two-component system histidine kinase RacS
MYFSVLKSLEPLKKLRKQVAEVANGGKADFENYQEDEVGKIALEFQKAFKKNQELIQSRQ
LFLRTIMHELKTPIGKGRIISEMLQEEKQKERLIDIFLRMDSLINEFAKIENLFSKNYNL
QFKPVHFSTILNEAKDYLMRDDFNRVVKLNLKHDALINVDMEIFPLILKNLIDNALKYSS
NGTCELYCCKECFVIKNPGNPLREPIEHYFEAFTREPYQKVKGMGLGLYIVFEVCKLHNF
DIIYFYEEGKHCFKIFFGVKTNNDA
>fig|195.2241.peg.1358 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTHRYPFICIYGIGNALLIKNLSKHYKHLFVFESEIELFILALSTIDLSEE
LCSGKIYLVDIEEERVDIQLLILFDMKDMFEYLSLYEMFVNNVYCKKFYEDIWHKADELC
EKNIKVVIRNLNSSLCIGFECYSHLLQNIPSMLESIPFQRILSERKNKFE
>fig|195.2241.peg.1755 Flagellin
MGFRINTNIGALNAHANSVVNARELDKSLSRLSSGLRINSAADDASGMAIADSLRSQAAT
LGQAINNGNDAIGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM
EELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRI
STSGEVQFTLKNYNGIDDFQFQKVVISTSVGTGLGALAEEINKSADQTGVRATFTVETRG
MAAVRAGTTSDDFAINGVKIGQVEYKDGDSNGALVAAINSVKDTTGVEASIDANGQLLLS
SREGRGIKIEGSIGGGAFINKDMMENYGRLSLVKNDGKDILVSGTGLESAGFGAGNFISQ
ASVSLRESKGRFDANIADAMGFGSVNKGVILAGASSVS
>fig|195.2241.peg.1754 Malonyl CoA-acyl carrier protein transacylase (EC 2.3.1.39)
ARDEDKKIFAANYNCDGQIVVAGLKPDLASYEGTFKEAGAKRAMLLNMSVASHCPLLENA
SNKLCIELEKILEPTFKAVISNATAKAYTSKQEALELLKTQLVAPVLYKQSIKACENEAD
CFIEFGASVLKGLNKKITSKETYALTNMNDIEEFLKVI
>fig|195.2241.peg.281 3-oxoacyl-[acyl-carrier-protein] synthase, KASII (EC 2.3.1.179)
LGGLISIEHGLKGPNISCVTACAAGTHAIGEAYKSIALGNANKMLVIGAEAAICPVGIGG
FASMKALSTRNDDPAHASRPFDKERDGFVMGEGAGALVFEEYEEAKKRGAKIYAELVGFG
ESADAHHITSPTLDGPLRAMKKALKMAGNPKVDYINAHGTSTPVNDKNETAAIKELFGSE
IPAVSSTKGQTGHCLGAAGAIEAVISIMALDNGIMPPTINQFVSDEECDLDYIPNEARKA
DLRVVMSNSFGFGGTNGCVVFKKVD
>fig|195.2241.peg.1465 hypothetical protein
MKFCYNFKKIGKKEILMKKIKILVFLIFFCQFSVLANNLPQNIKENLGINQFLDESLKEI
LNQPLKEKFALTPKGEYFFEGNLSLFQKQCLENNATACAY
>fig|195.2241.peg.1609 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine transaminase (EC 2.6.1.92)
MLTYSHQNIDQSDIDALTKALKDEILTGGKKVDEFEEALCEYVGVKHACVLNSATSALHL
AYTALDIKEKIVLTTPLTFAATANAALIAGAKVEFIDIKNDGNIDEKKLEARLLKDSKNI
GAISVVDFGGNSVEIDEISSLAKKYNIPLIDDASHALGALYK
>fig|195.2241.peg.417 Two-component system histidine kinase RacS
MTRNYSIYTKLVILFVVTFFLVCVLFIVLLKIESNTYSEEEGFKQESFIKNIINSYGNAS
GVDIGAHLNNSGFVAIQNDYFVKIARLEGQSLFRAGNGENACTLTSLKYQNKLYLDVQCK
DFSALFEEDTNNRVYNLLLIGFFLFFFFGCFYVFFSIKIP
>fig|195.2241.peg.1757 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFNIDENLNIYDKTHNVFMYENLEEEL
NFFYQSILEKTPRYPFVCIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEE
LKVYKVVLFDCVAKDLEIQIAMIFDQQSILEYLSLYEMFISSHYYLKYYETSILSLNELC
IKSASVAIRNADITCFLPLLTHGQFLQNIPSMLESIPFQRILSERKNKFENAIVVSAGPS
LAKQLPLLKAYQDKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENLKQSI
IALECATHPNIVHSLKAENCMIVLRNKALYQRFNLNDFGYIDTGTHVSHFSYTLALALAL
GFKNIIMIGQDLAFDKEGNSHSKGFDFGEKFSGEENIDKLKVPAYAGKGEVLTHTTWNDY
RIKLEYLFACNSKEAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKNR
SDKLLVKFKEKIQKDQENAKRFLDDALALKQILENILSKDFILPLEFLEKVYQNIENFNH
SLDEDEFIQDETLRGAFAYRGKMIADVLKLHIQDKTHFITAYIKAYHEWLLYFIEKLEQK
YKSLSKV
>fig|195.2241.peg.1660 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine transaminase (EC 2.6.1.92)
ISSLAKKYNIPLIDDASHALGALYKSEKVGKKADLSIFSFHPVKPITTFEGGAVVSDNEE
LITKIKLLRSHGIIKKRLWDSDMIELGYNYRLSDVACALGINQLKKLDHNLEKREEIASF
YDKEFEKNPYFSTIKIKNYKKSSRHLYPILLFPEFYCQKEELFESLLHTGIGVQVHYKPT
YEFSFYKKLLGEIRLQNADNFYKAELSIPCHQEMNLKDAKFVKDTLFSILEKVKKGYCE
>fig|195.2241.peg.887 Peptidyl-tRNA hydrolase (EC 3.1.1.29)
KCERIIVVHDDIDINLGALRFKRGGSSGGHNGLKSIDNLCGSDYERVRIGVGKGENVISH
VLGKFRAEEELILSKVLEHSKKALLELIRNDDLSAISSKYSLKA
>fig|195.2243.peg.1335 Putative transmembrane transport protein
MLSFRKIFWLNVAIVIIVAFNLRAPITAIGPMIDIIQDEYNLNSTLAGVLTSLPLIAFGS
ISFIVGYFSPIRAIIVGIFLIFIAELIRSYLGVYGLFLGMLGIGCGIAIANVLLPSFIKE
KFPKKMASMMGIYSLVLSISSIAGIALSMPLLNIFDLAGAMVFWSVFSFIALMIYYPQAK
NGRFFRTKKKESKKINLLKNPTTWKITLFMGFQSFLAYSLFFWYV
>fig|195.2243.peg.1856 Motility accessory factor
NHQHIVVFEKDIEIIWIMFHILDFSNELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSR
IYFLELMSHYYERFHEDILGLNKKLAENFKNSIVSYGNDPLDALQGIEQFVYNLPQMITH
PSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDIKPD
YVCMLERDEIVAECFNNDFGEFDKDIVF
>fig|195.2243.peg.1830 hypothetical protein
MSDKELQKEILALENDVKQLEATIDVIKQRITHLKDIAWDRQSKKESSQMYKVLKED
>fig|195.2243.peg.1336 Putative transmembrane transport protein
MVLFSQLVAAPISLFGPLLLGKLKKSLHTPYIAILCAMYAVSFGILFAFDTRFMIMLAAF
IVGFPWGGVFGIALLFIAQKSSNAKIAARLSAFAQGFGYLIAAQGQWIIGFFHDMFGNFT
SSICILFIVGILVNIFGYLAYKSKVI
>fig|195.2243.peg.1829 hypothetical protein
MVTTQEMLSFPKVAKGVEANNEARGYTWQVKANDGNTLVYGSRKYETNNEKIHRLATSHS
KTEKNERQAEVGGRSHPHHPIFNDFNFRKSAENIISQQNKSTNDFKAKLEEFSTKKTNAI
ESINKEFKR
>fig|195.2243.peg.316 FIG00470129: hypothetical protein
MLKQYFEDNGINIKKFAQKHNLDYLSTIRVIKGEYLGKYKAKKNTRAVYEKLLELKIIDE
MPKACS
>fig|195.2243.peg.1859 Flagellin
VEYKDGDSNGALVAAINSVKDTTGVEASIDANGQLLLSSREGRGIKIEGSIGGGAFINKD
MMENYGRLSLVKNDGKDILVSGTNLSSAGFGAGNFISQASVSLRESKGQLNANIADAMGF
GSVNKGVILAGASSVSAYMSAAGSGFSAGSGYSAGSGKNYSA
>fig|195.2243.peg.1825 DNA gyrase subunit A (EC 5.99.1.3)
MENIFNKDSDIELIDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMNDLGV
GSRSAYKKSARIVGDVIGKYHPHGDTAVYDALVRMAQDFSMRYPSIDGQGNFGSIDGDGA
AAMRYTEARMTILAEELLRDIDKDTVDFVPNYDDSMSEPDVLPARVPNLLLNGSSGIAVG
>fig|195.2243.peg.319 FIG00469983: hypothetical protein
MLYFIIIILIATIGLFVYSGFRIKSKLIKIATSGTLTKQDLKEIEAISKYYEISLMEAAK
IHYGKAMITEEMILRLERPYRELYEQCKNFSTNKHEKISHYLSSNNQDNYLEAINFILIA
EESVSIALKSKNKDTAESRRKLALEMEQKIQERHPKAYGLIIDTIQLLEDNYDVSLFENQ
CIKYYEEAGKLKTIKSKQKRIDCINDLIKEAEANPKIDRKFVDFWKNKVKEII
>fig|195.2243.peg.478 methyl-accepting chemotaxis protein, putative
MEEIEEKIITVADISSKTQQAVSENKNAMTELKNISDNLQAEIAIFKL
>fig|195.2243.peg.1845 Flagellin
YMSAAGSGFSAGSGYSAGSGKNYSAVIAANAVVISNTSAVSKIYNVSAGSGFSSGSTLSQ
FATMKTSAGNSLGAKDETAGVTTLKGAMAVMDIAETATTNLDQIRADIGSVQNQLQVTIN
NITVTQVNVKAAESTIRDVDFAAESANFSKYNILAQSGSYAMSQANAVQQNVLKLLQ
>fig|195.2243.peg.79 Chaperone protein ClpB (ATP-dependent unfoldase)
MANIQEFLTDNMLSNLESAASLAIHSKNNEVVPLHLLWALIVDSSSILNQICNKFNISKE
ALELEIKSRISNLATSSNVNRENVRFSNEFINSLESAKGLMSANGDNYLSIDTWLISESE
KNPIREILAKFIDIKEFQKELQNLRAGRKIESKTSDETLDSLNKFGIDLTAKASEGKLDP
VIGREEEIERLMQILIRKTKNNPILLGEPGVGKTAIVEALAQRIIKKDVPKSLQNKKVIA
LDMSALIAGAKYRGEFEDRLKAVVNEVIKSENIILFIDEIHTIVGAGASEGSMDAANILK
PALARGELHTIGATTLKEYRKYFEKDAALQRRFQPVNVGEPSVNEALAMLRGIKEKLEIH
HNVTINDSALVAAAKLSKRYIADRFLPDKAIDLIDEAAAELKMQIESEPSSLRKARKDIE
TLEVENEALKMENDEKNQKRLDEIAKELANLKEKQSALNSQFENEKAVFDSISAKKKEID
SLKNEAVFAKNKGEFQKAAELEYGKIPECEKEVANLEEKWKKMSENGVLLKNQVDEDLVA
GILSKWTGISVQKMLTSEKQKFLEVEKHLKESVIGQDKALSALARAIKRNKAGLNADNKP
IGSFLFLGPTGVGKTQSAKALAKFLFDDEKAMIRFDMSEFMEKHSVSRLLGAPPGYVGHE
EGGELTEAVRRKPYSVLLFDEVEKAHKDVFNVLLGILDDGRATDSKGVTVDFKNTIIILT
SNIASSAIMNLSGKEQEDAVKNELKNFFKPEFLNRLDDIITFNPLGKDEAYEIVKLLFKD
LQKSLENKGIKASLSENAALLIAKDGFDPDFGARPLRRAIYDLIEDKLSDMILADKLNEN
DEIVIDAKNDEIVIDAKNDEIVIEKA
>fig|195.2243.peg.317 hypothetical protein
MSYFKIQFAIKISNYKTKCELSQDILSHFVNFLIKEGL
>fig|195.2244.peg.618 Membrane protein
MTQEQKISFFKIKRLSIYIFFCALYNFFYFFSYENVGSLHCEFLCISGRFLCFFSWIYIV
LAFIFMVARIYFLFSSKKILIYFLLAIISLGSSFFFWKIKFYF
>fig|195.2244.peg.1385 hypothetical protein
MGDLARYSLNNKDKLYQIFGVNAELLIDHAWGFESCTMQAIKEYKSKHISKVMAKVLPEP
YSFKKARDMLKEIVDHMVLELIEQNLTCNQIVLDVQYDKESLEKVQSYNGPMSKDSYGRS
IPKNAHSTINLDYHTSSLEAICNKGLELFDLIVNADFLIRKISLTLNNVVKNDTIKKIKE
PSLFTDLE
>fig|195.2244.peg.1909 hypothetical protein
GKLKDPRDIDSTPESRNKFDDAMDGYVNGMVTRFDVDTPNEWSEQQAALDRDTLVLSAKL
AALTPPQGYPNAPYYFTPERLEWIYKRGYLDKLLDPRIPAIY
>fig|195.2244.peg.1417 hypothetical protein
MLEVAIKNIFKHKDFLQTRKEPYAIYLAINTNIKSYNNICPSEQYFWKFNDMNELECYNP
KFGIYLGKIVFDKKGNKLIPKYIPAKFENLEEEVKKIKNPLWLANKNPNYIKPKFYDGMG
GGYYFESPNNLEYQCKIEKDTQILSQEQIISYVKELYSKNTMIIKNYIDTINKNHGIKPF
VFSDEIYDQLGEVGILTKEQANNFKDKSYIKKNPILLAMLDYLAKQNKKDEDYLITFDDE
YFYAYLVWSLKDFLLELSYGLFQDETKLLFNPAAYMDDTKIDYKNLNEEINKRYEKILLD
MGFEGENGYFNDYYDYGFGNNGIFKFNIYDYFAYDEIGVRPYVSPRSPFDSPNFVYSDGN
YHGDAKLIPSALGKYYFELSYQKGVYIELLHPYYPSIKDLPEGWDNKMLEKANLK
>fig|195.2244.peg.1858 hypothetical protein
MSKNIKTQEAKLDLITKFLDYANCADASYALLDPVFTGVIIDKQEKELEKDLDTQRLGDK
HNNQNSIYARAIQARFEQNKIVKIEPKYCISLINTCFDSKEITLDNDISRVGLNDALSKR
TIDFVNRFKLLKH
>fig|195.2244.peg.1900 mobilization protein
LELGHERALKELTQEFEKRLSLWKNILTFGKYNAKVREDYQLTKNAFLISTDESRREANK
ELEYLKFEYHKVKDERDNLKTLFEAHKTKNVKLETRLKEIGKWCEKNLSVEQLKEIFPLK
AERIEKELKYQRAFENSFEQTKTKRNDRG
>fig|195.2244.peg.1366 hypothetical protein
NKLRAKMIYDLHDYHYESLLDEFGMIPFLDEIIGVDWVIDLNRYKFALDEEGRIIWALYD
DIEKGKLKDPRDIDSTPESRKEFDHYMDGYVNGMATRFDVDIRNERDERSAKLTMDTLVL
SAKLAALTPPQGYPNAPRYYSPERLEIIYKRHKLDKLLDPRIPAIYRYNFPEDLRVKILA
YAKEHNIKE
>fig|195.2244.peg.1863 predicted secreted protein
MTREQAELIIKEEKLIDTTWYPSYKHSGEYHLTMWFDSDNNKYEAVYIGERGSVELEYSF
DSEKEAIDKMLQMNYEQKKYNGKDIKEYLTKEVALRIIQEEKLEVIWYDEALKPMRAGIK
HDKQRDKYISFITNAKAEIIEWKSIEFDGDRYSETFKEMLNDEFLALYALINRARMIKQN
RISFV
>fig|195.2244.peg.1467 hypothetical protein
MRAARTCGANNNDFSILDYLFDEYGLSLKDPKYNFRFADMKYIKEANDKYIVVRYMEDNP
SIYKEALIYRYILKVRNPNPQIIQYLANHGAKFEVYREDTSWSPIHFWASNNDYKFLELA
IKGGANVDMEEYEFESIYKYQDTPLFEAVKESGNYRTVQLLIELGANVNFVPYLTTPLDQ
AEGARNRKLLKAAGAMTSDQLEKKFNIFYF
>fig|195.2244.peg.1880 hypothetical protein
MENQKLEQCFYLEHLINIQELEKKIIEYFSKEQKLLLDHFRHANIVSRKADECGYFANIK
TDPARPKIQVNGFTNSLNLCLNGVVIGGAMIYIENGLLSMIECYSWDDNDIFIKLLSDTN
KKVYL
>fig|195.2244.peg.1775 hypothetical protein
MPKRNTINTITLGIFSDENASVICEDTIKLERGSVAVLSGNSEVGKSFLALKVCANAIND
GLKPFFWSIEDKNKAILERIKNIENFYPFNSLEFEFSNELPKIDKEPIDSLKEELNELAD
CDLIVLDTFSAFFSISGFKDQNNQNDVQNFFNILTDVAKSNNQAILLLHHLDKKGESLMG
SSVIINAPRLVYKLSFQKGEDKNSTTYRLLEVLKDNNNINAGEFQKTIKVLQNSSIDEPL
VKDIKVENIDNHTLEIINKKDISAVSVNDLAEGYVTMNENRGVFYLSSRKLTDSNFYKAF
KENDNKIEFGMLGANGSSYAITLKNSLLTQTHRSILDALFLYIKKNVDTSVIKKYQENFW
DMEVRLEPYKFLKQYLNKAPSNYSWLKQKFTEISRFAYDLAFTQNIEDKDKDKKTITQRD
KGILMFDSVERITKENGVIVSVFVLTVRREYIKRLETESTLSYDDDLSKILIDLNSLVAQ
DLIRFLTSFPDKKILSYSEFCEIKAYRLYKESSIISKQKKEIAKLKDKLIEFGINVYGKG
IEFANYDDEFFYNKYKNENDLFFIYQSNNRVKRYIKRGDPMNRLNTKSNKFILQKSLFE
>fig|195.2244.peg.1388 hypothetical protein
MEKAKTLEQLRAEKERAETQLAQEQHKLNRLENRKKYLEKGERQKRTHRLCNLGGTIESL
APEVKGLTRTEMTELMEHIFSLSEVQRAVRHMAITNISQANREKELKADGTISSKRHAD
>fig|195.2244.peg.1744 Motility accessory factor
VLSLERIPLTSEFFNNDFGEFDKDIVFVCAGVVHPKTIEYLKNKTFIITQKILAFPYYIN
LKNFCYAAVGFSVAHMAYEFATHLSHKNIIFIGQDLAYAEDGFSHTKDYSNLDKHEGHFQ
RDKGKFQCLAYGGNGKAESSEVWTMFRFFLQDTISRNIISTTYNCTEGGARIEGTIEKPF
LWACEKLLYKDLNKPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFEKIQ
SVYLNLNKKENDLNLAIRKIDEFKNKLENIKQMQDLYEILSTLLIQFELNLARIYVLNPK
TKEDAFNKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2244.peg.4 hypothetical protein
MRLKVSGLIPNSLPIASIISCICMLNPLILILRNLNIKSSEKLLI
>fig|195.2244.peg.1903 hypothetical protein
WRIVSPKFINLMQDLIKDCVQYLDVEIKSQEINYYDCKIMHVIKSLEALDYEHSVYTYMG
DNDEYLSITKAVLKKSKLDGSHIFRIKDDEVPVFVSSEFRKIVRENNLLGFSFSEVMVYE
N
>fig|195.2244.peg.1705 hypothetical protein
MFCKKSLFFLLPLFFCACSSVVSVKINNVENSNLNNRHDDVPVTAIVYQLKDIKKFEEAS
DIDLATREEGVLGKDKLDSIKTQIAPKDNIIAVKVDEEEVPYVGILVLFANNTKKTTKIW
AKTEDANGFGKNKYLKFEISKEGIKRIK
>fig|195.2244.peg.1395 TrsK-like protein
MRKNEKITALYERLSRDDFGKDDDQQRESNSISNQKAMLEEFAARQGFTNIVHFTDDGIS
GTCFDRPGFLAMMKEVEAGNVEYLCIKDMSRMGRDYLKVGQIMEILRQRGVRLIAINDGV
DSARGDDDFTPFRNIMNEYYARDTSRKIRSTFQSKGKSGKHLTGTVIYGYLWNEARDQWL
VDPEAAEVVKRIFSMTIDGYGPYQIASKLKSEKVLIPSAYLAQHGEGVNKNKTFKDVYGW
GSSTICNILEKREYLGHTINFKTRKHFKDKKSHYVPEDEWTIFENTHEPIIDQQTFDLVQ
KIRGNVRRYPDGWGEAAPLTGLLYCADCGGKMYVHRTNNGKRISQYTCSQYTKVPCGTLC
KTQHRINEDVVLSLVSEMLKAIAEYAKHDRAEFVRVVQEAQSSQQTTEVRKQRTRLATAK
QRVSELEVLLCKIYEDNILGKLSDSRYATLDAQYEKEQSELTAEISVLEEAVKSYEKHEK
DADRFIALIDKYENFDKLTIAMLNEFIEKILVHERDRKGSIQTTQEVEIYFNFVGRFVPP
AFGEVELTPEELEEIRKREERKDRLHQNYLKRKASGAQKRYEDKIKKRKKAEIEAKKAAI
RAEDIAKGVFVPVSSLPQREPMKGVQTA
>fig|195.2244.peg.1184 hypothetical protein
LNGKYGFIDKSGKIVIEPIFDDIDY
>fig|195.2244.peg.1874 hypothetical protein
MVGFNINDLWYEIGNGDFLHAFFSNVAYHLEKGNWGSRFPILMNEVYQGELNFSQASLAL
NELENIQKEFKNFTPKQIIWDIENLSLMPPWGDNISSDITNLSNYFITSDGNDFIELFKK
VLQLAENEKVNLTIKSF
>fig|195.2244.peg.1791 hypothetical protein
MKQTLSSNRVSFYLFSTKTFSDEKYLNAWSLKGERLNAKDWFEFKQANKDKFYNKHLENT
LKAMQEFKAYFSVDQFEGINLHGDDEWLDFLPSNYTQFYNRLCRDKSKYILHRYYQKNDL
TEIGMLKNLSPNFPFWDEKGENFSQNQIDIFIEKDNLAPYFNKYDIYFNSSLELSFNFSD
ESLEYLINNYNHRINHTFTPKSQDEIQKELNLSKEDKIILELENMFLNLCKGISADYAFM
DFSYFFVGYDHTLDSKNNTLKSYPINQDKLIHKRSFKEYIEEYANTYFLNYYSKEFLNEL
DNQELNKDRLNYYLINYNKIPKNTEEENIQGILSKQKDIDINFVNFIDYKDYVYKNKDDF
WEFSAKENSILWEKFLSKNTLKPFPLNFDCSLEEKLLYAKDEQLENILKTHKTFHG
>fig|195.2244.peg.266 Filamentous haemagglutinin domain protein
MLKSLDRILCIKKNGGGMNITNLSNIKHFLNTSLYFTNHLSKSLRVIVNISVIISLVLAQ
SLTASNLPSGGKFINGTGSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNSKN
YLNLDYINKASQILGTLNGGTNNVYIVNPSGVLVGEGATINANKFGVSTTPMGIDAINTF
SVDGSFSPVFNANKGDVVNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLEDFG
INSTHLKAEIGSEGFFKYEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQSA
SNEEMINSWKGFAKLVNEGIFGELKFKDVYLSKDIDFAGAGVIDPVGFSNGFVGNFTVVI
IRFLIYKLMLLIKLM
>fig|195.2244.peg.1593 methyl-accepting chemotaxis protein (tlpB), putative
MQNENNLALKIENMVKYAQNIQKATQMMGEIADKTNLLSLNAGIESARAGSYGKGFSVIA
EDIRALANNSEEFLHNVELIIKELLESIQEVAKELKENSHSIFSLNENTHLLASSANEVK
LCNQDSKNLVTQCTQRIKISQENIQNLLMHMRENVEASGKNEEISKILLQVADELKIVCH
NLESELSQFQI
>fig|195.2244.peg.1113 hypothetical protein
MGTDDLRKKRKTKIRDRKTRKNEYEAILIVCEGEKTEINYLKQLKNFFRLNNITIDIIPS
ENSSPLQVVKFAKKKNDLFDYNEVYCVFDKDTHANFIKAQKECEKYIKEYIKEDKNFKFE
AIISNPCFEFWILLHFTCTTKPFGTNSPCNELINKDLKIYIKDYKKDYNFTNIIKQNLST
AITNARKANKEAEKNNYESSYTFMDKLAIKFQELNNAK
>fig|195.2244.peg.1420 hypothetical protein
MRDKFLKRVLKLCFFTFFICNAAYALCTDELSDEDLKFIQNANLNQVNFKCNINNQTYYY
NNLTRKEYLQNLEELKAIYFNLNKEELKTLSYIIYINEALFYLKLDLNFFKNFFSVQKND
ISNLESLRNSHYKQIENSLTLNQKEKLQNSFVLADQILQKNAIAKDYTNISSKLIEQSKQ
ENKEILKYIESSNKDIFSLKNINQLTFLYNANLLINEAKNYPQRSALAYDKNEALKLLEI
LLKTMNKISNKEDKLVLLQGALITYNKAISSLDIDLPLNEQKYKKIIKRKEYIILMGRFF
QSDAFAYFNTNIKRKFDFKDDFIQIFPKRTSEILKLIAIYNQTKKTLILTKEALKYKE
>fig|195.2244.peg.1899 hypothetical protein
MSETYEIYTPNGLIMDVYKDTNKIIFSGSAKPTGDYTEEYSKALFEADRILRNSPYKDYK
PQYLDPEFHTGEKS
>fig|195.2244.peg.1792 hypothetical protein
MKNKKLLDDEYIQEVFKYYLKNDNYLKDALYGLKKYERRAFISSILSYEYKNLVENGNLK
VDAKYKVTLPPNLIAVLEYDKSEFNGVNLRNFINDLEFELEHIEMELYDDPADFEGGDYY
NEDSDCDEDYTVEDWVEDQVSDIKDFLYALKDFK
>fig|195.2244.peg.278 hypothetical protein
EGKKYPVVFSTMIDYKVKNYGLFGDEGRGFSFSSISRKSAGGGSFHYFTNGKFIKSDEKY
TGQSY
>fig|195.2244.peg.1772 hypothetical protein
MKIKNILLKCLKPNKLNTLEKLYFGSMFMMVLSFAIFLILLLNFFMKIF
>fig|195.2244.peg.1825 hypothetical protein
MSETYKIYTPNGIAVKVDKETNKIYFVESLDSHPPAKGNYTEEYSKALFEAHDIKRNSPY
KDYKPQYLDPNFYTGQKSTLVEFKEWQSIYLKDPIKGAIAPWTKAEKAYYKSLKTKRERY
KYLAIRSGLRSVVIDIPYDA
>fig|195.2244.peg.1904 hypothetical protein
MSETYEIYTPNGLTLDVEKDTNKILFKENVK
>fig|195.2244.peg.1711 Uncharacterized protein ImpH/VasB
MNNLTSYSFFKLIKKLEKDYGRKNIFLRTNKSLKHPNKDIEKIIFSEHEQSVIELFINFM
GLHGVSSQLPSFMLDKLSRNEDGDQGWTLFFDFFNHYLLWIFFDVISLKNYPRSFNENFK
DSISKILFSMLGIKEYDIAKKYLPFAPLLLSLRRPKTHIERVLQVNFKLKDKLSIIENLP
HQILISNSQKNNLGIKNNILGNNFILGDKFISYQNKIAIYIKDISYQEAVKFMPNGTKHD
DLKNSIMFLTNNEFCVDLYLKINYSSEMKFVLGEENTAKLGWAKILGNTQKKYTIVYMKL
CE
>fig|195.2244.peg.1422 hypothetical protein
MHAENNLSPEDRQGIENAVLAKKDIIPDWIANFNRQDIEDLQDKTQYLRDTVDRLKNTVN
SYSKQYPTLEPIARKIRIITKPTENTLKIMDYSLEYVLNGERSVVIKAIAEGVETIVYTV
GISATAIAAGIVSLVGILCPDSAPLVAFGAFVIFTQGEELSYYISQKAKKIIINFLNPKI
QYFPQTIHLGNGQYYKNDKNIDEIFNNIYEVLGLSLFTPHPYPRYSKEYEFALAKKKELI
TKTSIASNSYNFMDEEYLKNIQDLQEQDQIIDQEEQKYQLALKLYKEDSKIKNEIFNSLF
KSLNKNLSFQLKQERNTFLNPNQSLNIIATKKYSLKTLNLQDIDNININSEFAYLRTLFL
CEAFLVLDNNDEALLNEKIAKEILEYDEDEYILFIFHKTKLNDTYLKARKELYKSIDEFK
KLGFKDLENAYQTYMNSLIVNKEINSKDETINKNKNKEINKNLNQDENSNQESDTKENTN
SIKEQDFYLLSSHSKNLNHFILENKDKNKKIIFLNNASSMSNLIHIYDSHCDIFIKNESL
LDIKKIEKEYDIKFKEFNTRVFFYEKLLLGAKENNEFSFEEKEENLLYYFKYDKEDLNSL
GDLNIKYNNHNAKIKNYSLLEDTINKIQKTLDECK
>fig|195.2244.peg.1836 hypothetical protein
MNDLFQTLGESIKQIDFTHAFLGLTKGKSPDELDKADETLRQEYLKNKEFKLIKILSRLV
IIKQFIYIRSKFANSYLF
>fig|195.2244.peg.1114 hypothetical protein
MLIEFRVENFLSIQDEQILSMMASKDNTFFDSHTNGDKKLALLKSSVIYGANASGKSNIV
KALQTMKTIVISSAKKQRGDKLPITPFLLGNEDNKPTKFEIIFIQNDTKYQYGFILNSEK
ILEEWLLIFGESNRAQKWFERIYNEKEEKYNYSFGTKFLGSKQLWAENTRDNALFLSVAI
QLNNEQLKPVFDFFLKYIRVNYIDNWNDVSKATMNILQQDKQKIIDYLKQADLDIEDIIV
EEKELDKTSLMQENIPQEIKQMIQADLEKGMKLTKTDIKTMHTNQQGKQVLFDMLALESQ
GTRKFFGLIGPWIEALSQGYTIVVDELNTHLHPLMTKFLVNLFHNEDLNKSNAQLIFTTH
DTSILNQDVFRRDQIWFCEKQNKATKLYPLSDFKVRKDKTNLENDYLLGRFGALPYFKEI
LSSWSDNGN
>fig|195.2244.peg.1767 IncQ plasmid conjugative transfer protein TraG
MKNTIKLALLSVVTACVFSACSSEPKNATELESKIKECDKNANSAQTDTECANAYKANYS
KSFQKPLSSAKDFFKNNK
>fig|195.2244.peg.1849 hypothetical protein
MKIKNFTLIASNHNLEIELKNLTKNANKIIFICSDFDGYKEAKNSLYKTLHTIEDNFKID
NTKTFKIIHLNQANKDEITKEQKFSSDKNLSSIKKIIFNNLKFLNNAINQNENKTLNKII
DENNVENIENFLKEIQKELNILLKNIKESNYFEQEIKPKIQLTLDTLFNTLLKNITQSND
DEYKQIIRAIAKFFINILDSVTNLKKPVSLVKKNPYVFVVNTLFEAYNSSAEYQEYKEQK
YYYDFAYPLLELITSKLYPIIALCNEEILSDVLIIDDKVLLDFSSYSNVPSISLYKNSFY
KVILDEEFQGIFDNFLENNLKFENEKLDNTLLVNSSLNNFDTTLKKAINLNISKLNHFFY
AEYPDLNSSMLVEMILDKKNTDQINTTKMGKNYLLITNPPQLNNAGLCEDLYQKKLGAII
KNRPKALTKNEKLGLKEQFPSKRDYGSYFIERDVKKEDDYVLQLCPFVKLDGQIYQKYKG
YFNFYNQTYSWMKLYLLEYINERLEYEKVKQDFAYIDSFFKLPKELEEISEKEKVKVKEY
VELFNDYLDNINSCYDQIQFFLELDSSISKTYENVDFKKYSPLTVVLLTLTLYVLQKDLA
FTQEYSLGYKLFQAYTGRDKKNISLNYQRIKIPNYFNEYILFIPDDIYFYDNDKKIYIFL
SKELSEPHLLIEVGASLLKPTNVS
>fig|195.2244.peg.1859 hypothetical protein
MFILSTIWVYLFLKLVFYLVFKIFNIDKKIKKFYLFLPYPLFMLLWFGYSFVPLEWQSSF
KEFESLCEKADSKAVIYDAKNIISLWDNYKKINKDILFNITEQYVDFRIKKIIILWYYKD
GKNTIQEYKIDNTYSWLDIGMFAKYKRKMICYDIQKYKELQEKRGY
>fig|195.2244.peg.1277 Membrane protein
MKKIIILFLLGISCLWGDEFRLIDTNASAQDKSVYSLVQKYIDLNHQIKEFKKNNDENSS
SYDGILSEFEKDKKSILSKMPDMIVKQQINEKAVESFLKTRQNLLDLQKKSINKPYVYVD
TTLNIMYLDVVKSFYSSLFELERLFKNAANSESIISTVDKAMENLQNSTNIDLSIYKAKI
NNPSELEKISNKEEMIFNAVDAYVEILKYLRANADLLESNYIFSLLELQVWIDRINEIAN
IDFINTGKIVISILVLVFFMSLRRFFSNIVYFILVRLVYRNKSDADDIKVIFIDNIKKPV
GFLLICYAISLCLTIATYPAPLSINLSNLFHIVYVVLIAWLILRILDGYGVVLVSKLAQK
SGKKEVVNLIIKILYFVIIIIALLYILAQLGFNISAIIASLGIGGLAVALAAKDIIANFF
ASILLLFDNSFNQGDWVEVSGIEGTVVETGLRKTTIRTFDNCLVFLPNSTIMGANIKNWS
KRRMGRHVRMYLGVGYDATPEKLEQCVKDLREFLHTSDLVAHDEDSALKYGDHTTKYRQN
LVSINDLEGYKNACYVALSEFADSSINIELYFYTKEIGGKDFREARQSLMLEFMRIIEKN
GLTFAFPSRSIYIENLPPLDLKPKIG
>fig|195.2244.peg.910 Beta-1,3-glucosyltransferase
FMNIGYLDKLLFDEKLKPNFEDAKFINEYLLDNINLKSAFLPTVKYFYRKREDGNSTLDN
SNKYSDLYLLVSRRGCLKLLQENKFYDIFIQNVCLYHFFWQIKTLVNSPEKLSFMSESEK
QRYLELLDQNFSYIDKNTIMEFNLAGCWFFHKVGILNCFKNEKPPFQIAYIEDYDPYKEQ
ILLTYYTGDDENIESIFVDGEEVHVDYEKIVEYDFLDRAFCYQKRLWVHIPKNAKDKLEM
FINDEQSMIGKYDEYFLNIKNIRQEFQKRLPKSNIWLLMDRDYEADDNAEHLYRYIMQNH
PEQKIVFALRKESLDWERLEKEGFNLVEFGSLEFERIIKKASKVISSHADGYLTRYITSK
QQFIFLQHGVIKNDLSKWLNSKKIDLFVTSTKAEYKSIANDYNRYKFGKKEVALIGLARH
DALLKNNQCNTRQIVIMPTWRANIVGVALGSSKRGLQSDFTQSEYFQKWNLLLNSNILQK
LCEKYDYTVVFNPHRNIIPYLKEFNIPSYIKIASQNESLQKLFCNSSLMITDYSSVAFEM
AYLNKPVIYYQFDHEEFFSSHTLQKGYFDYEKDGFGPVVENEENLLKQLENLLQNDCNPF
GIYKDNIDLTFAFKDGKCCERIYKILRQII
>fig|195.2244.peg.1881 hypothetical protein
SEFRKIVRENNLLGFSFSEVMVYEN
>fig|195.2244.peg.1766 hypothetical protein
MFFDFMLPTHLEDYLEYKTKLSLKNQRNKNKYYLFLLFINK
>fig|195.2244.peg.1855 hypothetical protein
MQITKGFKYRLYPNKEQSLKLSHQCFIYNQAYNICLNLQQEQWLKNKELDKKERTYLSAT
QIDNQVKLALKARNLEFKSVVAQQARINANRALEQAIKDKNKGFPKFKNSKLAKQSFNWN
NQGYQILEFNDKFKIFRLMSMPIKMRYHRALPNNYKLNQITISKTHNKYFVSFSITYDEP
SVVLMSSNKIDINRAVGIDMNINEIALSNGALLLTCSKSINKAKYSTTFKRLMRKQSKRV
LKAKKDKIKLGSNFRKTQIRLNKIYERASNIKKDLAHKISNQIVKNFDLIVVENLKVKNM
TKRAKLKNVKAKSGLNKSILDTSFYQFLSFVEYKAMHNGKVFTKIEPQYTSKACCKCGTI
KENLTLKDRVFTCDNCGYVEHRDINASKNILDRGLKSFGLGTSLLDYKQEALRVS
>fig|195.2244.peg.1888 hypothetical protein
MTREQAELIIKEEKLIDTDWYPSYKHSGEYHLTMWFDSDNNKYE
>fig|195.2244.peg.1921 hypothetical protein
MLEFFVNLLIFILIFFFFVFIFSIILYFIFK
>fig|195.2244.peg.1760 DNA primase TraC, putative
MPQKRIYLYVPFKDKEKVKSLGAMWDDKEKKWFAPKSLDKNIFSQWFYPHQNKEFSFDEN
EVLTTFKSALENQGLIIDGSPIMDGKIHRVKTTTDKGREMSGAYSGFLDEYPAGFIQNFK
TGIKENWKMPLENAKQNIVSYQTPSQKRLHNSTSNNTKQDILELQQKTALKIEEEYNQAN
WAHSNHPYLKKKGFSENFYLKQDNKGSLLIPLKDENGKLWSVQRIFPNGDKIIGVIKTKE
EKEQGIEYSAKKSGCFHLIGAKNLEYCKEFIIAEGFATAATIYKALNKPVIMGIDAGNLS
KIVETLKNKFQNTPITLIADNDKKRELKGLSNVGVETAKEIQQKFSDIKVIIPKISNQEA
EQGISDFNDIFLNKGLDEVKKQLNFIDFHNKLNTFENPTKTI
>fig|195.2244.peg.264 Putative periplasmic protein
MQVKFFLKNRIFLALIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTFKQING
TNYYGVFKQGLVSDITLEVFNPKQSLQGAKLEILTPNHSSEEILEVQSMHAANPMDKNLH
PIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNTKTKNPPKKEEKDKINYVIS
GGLAREGNVKNNTLELLDGSYINMGVENIYNLKLNGAAYAIGGLAIFGDAIGNSLLAQKG
SKVDIHTASFYRDMVGEIILDERITHLVGGLAYNGKVEKNKLNLNGVEFNIHAPSGLYSS
FAPVHIAGAFVDGNGKKAYDATKNTLVIDNFLLNLKADGKTPIFYNAIFLANFFGGKTNK
GDANANSIVLKDVPALKRISKKVKVQGIYDFFSGYTLDGEANFNTLDIELKSPLQVSNSY
LRHSGFGFYGAFASKGASNNTIKIRNNLTVINGTQNPSDRINIIAGRTLAGEANFNVIDF
KDSQASLPLFIYATTQENFEGSIHYPEYAKHNKISLNNVFGRKDIRSGVRL
>fig|195.2244.peg.1291 N-linked glycan phosphoethanolamine transferase EptC [Campylobacter]
MFKFKLSWFGFVLFNSILITLLNFNLHSFVYEKLSQNLLLTLVFIVAYFGLVHMIFSLIF
VKYLTKILSIFFILSSCTSLYFITFYGVLIDSDMIQMLCKLT
>fig|195.2244.peg.1912 hypothetical protein
LAKLTKGALSDTIPGVKELSLEEMKQVKGGYVFGDYKIFKDRRNLTSEVYAIVDFTQYEL
ENLNKGLCGAGEDKCQNPSRDRLFAWLQVSANS
>fig|195.2244.peg.1890 hypothetical protein
PKGLQNFTKKEKCYHEFIYEIGENTTMEQCQELTQKIAELTGFTPLQVVIHRDEVSENAK
GEKQTHYHAHAVFFTLDNNGLQLARREASLNKANLSKIQTLTAQSLKMERGANRYENNEK
QPQYIQDYKTYAQFKEQEKALLQRIQEQEHKLTQMALELKKKEKEIQDKAKELKSKENEL
QAKIEQHQKHIQNLELGHERALKELTQEFEKRLSLWKN
>fig|195.2244.peg.1889 hypothetical protein
HLYKHNGIWPKDTPKPRSPGYIGENGKIKYPDDDGYKIPPKPREITLKKGMKLDRYGDNL
GSFVCPFKEKKGVMPYEKRSLPYENNEAMQKTYKRYEALEDINMESVERKIKMSGNDKLI
EKIKELKEKNKFHSPKIGKISPHFDQEGKGTQIKLPISVENLMQLDFIKQIP
>fig|195.2244.peg.1837 hypothetical protein
MEIDKNKKEDEVIYLDELAKAMFENDFEEEDQTYVNFLKTLNESFDEEIEFEENIQTDKT
FPSKKDLDKSIQDIMLDKELAKLSIDITFFNIIKQLFPFTEFFMSQPDFFKKMILFFIDS
SLDKKYYGNKLFSSFKAHFFKELGIFYALSPKGRFIKINPKSKKSLNKLFLYQIGTNYYY
FNQLEYASELKKSKSFSRLDKAKQIHLISKVRKQLAIDFSIKMSKDLSVDILKNLAGSFI
DTLLPTNYERLKILYEKLMYEKFTYNYDFPLAVKKEEYITYPLLINSRFMSFDLSEFIFG
SLLCTGGLNYYPSIACATTSNEAREFALKRLLSYIILDEKRSAFKEDKINEGKYILNDKE
FFEKNNIELRNCNIYKLEHFQRKEEYKTQHPVIKQHPILAYNDAIQILYEYANGIYNTTQ
DERGKFIEDRQKARRLMENLEAIGQHNLEVMYKGINEEGDEIIYQNKRYYKNIENLTTNN
KAQDYSNKFIGRLATTIIMEDGLYIG
>fig|195.2244.peg.1142 C4-dicarboxylate anaerobic carrier, putative
MALKIVISSYAELLLLLLACIYPVLISLKIRPITTVYALSLIALDYDSKDGNSINMADMV
GQSDNVVGLFLNYQIYSVIAYVMVIAILIPFYFAWIDKRDKEKGVLNDEVEIPQIIDPKC
PTFYILFPWLPVIFLFIAYFFTIKLDVVIANFVRISLVFLVEFARHRNARKLGEDMMVIL
KGYG
>fig|195.2244.peg.1840 hypothetical protein
MSKNIKTQEAKLDLITKFLDYANVADASYAMLHWIDYVKKENDKKHENGDTQRLGDKHNN
QNSTYARAIQARFEQNKIVKIEPKYCISLINTCFDSKEITLDNDISRVGLNDALSKRTID
FVNRFKLLKHQPNTTSGFSATLFEDTKDNNQKIIVIRGTEPTSNFGIDILDADVDLALGK
VPYNQYLDMIKFYSECVKEFPNIIKDKGLVIVGHSLGGALAQLLTLSLASVNSSANVKEI
YTFNSPGAKELKALNLNQIYRIDGKIINSDNKEQALFYQIRSYKYQKSIEINLIGYDSNL
FQNIKSYFHNKTNLKEHYIFIKTNIIYSKSTNYFYDIFEVDEVFINCVNQLLTNLNIKNI
LATSDNTYHIETDTDSDASNTKGVIQDLGVDIDGKHYIVNLGDRFWDSHFLEPTIIELNY
ILNLMKNKEIDNLLEYNINKDEELWTFIKYHNNVLATARTRYDDRILSYFSIPKLSNDFS
NSLEYLQIHYLPKEPKKPLFAANIQGFSSTQLQALEEYKIKKAKYDEKLKWYELYKVKYE
REQQIFNQKFKEYFSEIIFYQNRLYSHKKTQEKIILNAIIQQINQKDITYFNLYSVIEFL
KENKAYYKYIDLNEIQDLILNDLDNKLGYFYCLYVCINLIVLREDKNTYFTQATAINNLG
YNSTFTKIFILDKEKLNDTYLDVRKRLYKSINTLKEKRNEKIKDIQDYLNKEISLQDNLN
NQSFNTKENDVNLILNEVFNIEQFYDKNTNTIVLKTNNIKIIFLDKVNLQDLQDNSNNTS
FISMSNLIHIYDNHCDIFAKDRSVLDIKDIEEKYQIDFKSLDIKIFLNSTLLTGSNELPN
NPFYFGELD
>fig|195.2244.peg.1868 Replication protein Rep
MSEIVKYHNDFNKIQLPSFTEQEQNLLFLIFARIKEKGIDNVINLYANDFKINEKLSNSR
EYLTENINSLKYKFFKANFKQIIETKTEVIHKYVNLFETMEIHYVKRNPDDGYDESTLFN
RITLKINPDFAYLVNQLTTNFT
>fig|195.2244.peg.1920 hypothetical protein
EFIALSGKYTKSLYRLLKQYRTTGKVYFEWEEFKRIMDIPENYEIHNIDKWILKPAIKEL
SKERNLFD
>fig|195.2244.peg.1386 TnpY-like protein
MQYTQAQIDRANAVSLEDFLRTQGETLIKSGREYRWKEHDSLTVRGNKWFRHSQSKGGYP
IDFVMEFYGKSFPEAVQLLTGESGEGQSEASTAPPTAFHLPLHNRTADRAIQYLTESRGL
NKTLVEAFLLSGDIYEDAKRHNVVFVGRDRSGTPRYAHVRGTADPFRQDIAGSDKSYPFR
HEGNGNQLFVFEAPIDLLSFICLYPQDWQTRNYLALGGVSGKALDRFLSERKDTRKVFLC
LDSDTAGSEACTRLAQSIPGKIAVMRLVPARKDWNDVLRQQKDIPSHKFIAETITLRELP
TAQPVPMLRMADVELTSVEWLWFPYIPFGKLTIIQGNPGEGKTYFAMRLAAACTNRKPLP
GMETLEPFNIIYQTAEDGLGDTVKPRLMEADADLEKVLVIDDRDTPLTLADERIARAIRE
NNARLVIIDPVQAFLGADVDMNRANEVRPIFRSLGDIAQATGCAIVLIGHLNKAAGTQST
YRGLGSIDITAAVRSLLFIGKLKDSPTTRVLIHEKSSLAFSLGDEKGFEWIGAYDITADE
LLAGTDTAKTESKTAQAQMLILELLADGKRMPSAELEKTVNERGISSRTMRTAKSRIGDR
LVTEKDGTAWVCYLRD
>fig|195.2244.peg.1770 hypothetical protein
MEIKYYPPVFRQDSFHCPHCNVYSHIKWEDTCLDFYHVEYLCSIAFCNHCKKYSIWLNET
KEMLYPKTINVPLPNEDLKENIKQIYNEAAIILNDSPRAACALMRLALQELMKELGEKGK
DLASDILNLKNKGLDEQIIKACEIVRIVGNNAVHPGIIDINDNPEIAYCLFEMINLIAEK
LITQKIKTEKLFNKIQNLKNKKPKINP
>fig|195.2244.peg.1866 hypothetical protein
MRRYYDSETLKSILGQKTSLEYSDDLECLSKNTIYKIILSEKQYNFPYVNIFEDKIENNF
TASFIKNEDRKKAKEHLKAIFLNANHLFVYDKFINKNQKQFIKFAEECFPRKKLNIFYPI
ENIMKFPKNLCSNLKNIYKEWLVVENKDAEINEKYDYLHDRYIIVDKKIQIILTSGIDNL
MNIEKDFTYIIREL
>fig|195.2244.peg.1917 hypothetical protein
RIRWEGGGDDNKQSSIQTHHIATDKSKKYTPKFQEILNSYDLKLNGDWNKVKMPHRGRHP
NEYHEYILEKMS
>fig|195.2244.peg.1860 Glycerate kinase (EC 2.7.1.31)
MYEKQAKYMKLYKYARMCWASYFYFDFLNTRNIFELDFNQEKI
>fig|195.2244.peg.1850 hypothetical protein
LDEILEDEDRKQELYVCKFVVVNGVKI
>fig|195.2244.peg.1769 hypothetical protein
MNKSYIPYGSDVSGGEFECVDCKRKITISSSDSLPPCPNFRKEPDKHKLKGWKNLTGRGD
AKEDPYP
>fig|195.2244.peg.1877 hypothetical protein
YKNVKNKEIEYNPNINNILNQACISSIYKEQSLRTNSFTHSSINANTPLNLLSLHSSKVP
YEQELNNKACYNEHFYESEYSFTKSIDLKTKPSLKEKRALVLNESLLAKSNIYHLSLGDF
ITLNYKEFNHQEEIKNQDEEKQDKASLLKDFIIIANTQILIDDAILANSINTNDHLNLKD
LNLNKSYSNTLTLLKKNIIFTPSFKAKPKAPNSTQGIVIGESKDIESERNTIYTDEHGRV
KVRINLYANQEELDNDTFIANDIDTNSSNLSSNTYKSYHHTPFLRVASHIASNHSGFFHT
PRIGDEVIISFLDDDIDKPYVSGSLYNGA
>fig|195.2244.peg.1830 hypothetical protein
MKQQIKNLRDYAELAWASYFNLIYIDGQKTNDFTIGTERILKDGENIEKFEYYKALSKDY
KDYFIYDDSLAFYPKLNGEFREIQTQNFAKRYTIKFHQPNTFSGFSATLFYDIQKDEYIV
SFRGTEGIVSMDAFADIGLTFGKGDFQANALKQFLLDIAPILNNIDSSKITFVGHSLGGY
LAVVAMQLCDTIDRTLCTDFNQIKFSASKVYTFNSPTIDGIDNMLMRFLANLLGNNIVEQ
ILNPEKIVCVFDNGKIEIIASAQYGASNALGIYTGKNDHSIKPLVNTLYFYSYLLELDAN
YNKVKDKSLSECIEYLNHFMKNIQIYTETFVLKNNAINNKNFALKNGPLGLFRSSPEKIN
HFEYFLSLIATIMQETNGILEELGDNYYASYKAPTISQTKIIDFILKAQKKEKYILILDK
NDFNKYRKDCSFINNQENLAHKIAIGEFRIFIVVYKDMKCLENINNITKIYGYNSKSYKI
KDQIWDEQYLGGVCKISQALYFNGKAKIGII
>fig|195.2244.peg.1633 Integral membrane protein
CKLKEKMIFLGINNLKAKFRNTIFEEVYFGKEIDDRNLEKSNSFGSCSFEYTDFSNCHFK
NEVYFKNNEFKQVFFRNSKFNDNVYFNNSIFKDYTDFNECEFEKTTSFYGVTFEKTPNFS
QVIFKGNLNAINAKLNFTFDDLQQRIKQECTSYESQRTTKKAGVIPNLYQEKSLDKFAND
FRDSFRTFKNALIKDNNLLDASNFHKYELYCKEIELKQNWDKKGENVKNTTDLEKNVSRI
RDFVDFLLLGFYRKLCDHHTDFLKVFNNLILLISLYILFIFVGSFEFDLEKKSIQNLNKT
SDMFSYLTKVKEVIINFSFMQQYYNHILISFVAVCFICLIVIFYKIFKNIKLDFIIIKNI
IFKDIIKSILILCVYLLFLLIILIYINIYIPKNQNNLNILSNIGIFFTFCIFYLWMVCLN
TLFLRYIFICISYIIVIISMGANITILNPFIGKLINDKIFSNDPLFIYLTFAYTILIFLV
LFSLQKTARKNSIVPS
>fig|195.2244.peg.1919 replication protein A
EFIALSGKYAKTLYRLLKQFRTTGKAYFEWDEFCKVMDIPQDYRQSEVDKWILKPAIKEL
SKERNLFD
>fig|195.2244.peg.1501 23S rRNA (guanosine(2251)-2'-O)-methyltransferase (EC 2.1.1.185)
MHTLKKGEFIAILYGISDVGNIGAIVRTAYALGVDGLIFIGERLAMEGVIRTSSGAALDL
EIALNNDIFTVLNELKQVGFKLFASASGGKQIHHYKVDKGKKALILGSEGLGLSAKIIKK
CDECVGIEMKNNFDSLNVSVAFAILCDRMINA
>fig|195.2244.peg.1394 TnpV
MNITYTQNGDYLIPNIIIRKTKPLGHYGRLRKAYLEMHRPILFNELVLSDKLFEHCAEID
EAARNRMELIVPELVKRNGVTEQLKAENQMEWVRQMNACKAQAEEVVKAELIYD
>fig|195.2244.peg.1835 hypothetical protein
MQIPIYSKLKTKLESKGIDNISSGQIAWFVCSVGIFIIPMVYFYISNNYDQFTILFIMLF
IFILNMLYIKNFFALLLLVILIFIYMKYHEFIYNFKILFFIFAPVIFIFLRAWRILITFL
CGYIFLVAMVYIFELLGGFYK
>fig|195.2244.peg.1834 hypothetical protein
MKYYVTIYIDPLVECFLDFKNQCYWQREDFTHAFLGLTKGKSPDELDKADETLRQEYLKN
KEWDKIDQKWYEAKEPNEFNDGFWGILGNYFFV
>fig|195.2244.peg.1390 Aminoglycoside 3'-phosphotransferase (EC 2.7.1.95) => APH(3')-III/APH(3')-IV/APH(3')-VI/APH(3')-VII
MRYIDEIQILGKCSEGMSPAEVYKCQLKNTVCYLKKIDDIFSKTTYSVKREAEMMMWLSD
KLKVPDVIEYGVREHSEYLIMSELRGKHIDCFIDHPIKYIECLVNALHQLQAIDIRNCPF
SSKIDVRLKELKYLLDNRIADIDVSNWEDTTEFDDPMTLYQWLCENQPQEELCLSHGDMS
ANFFVSHDGIYFYDLARCGVADKWLDIAFCVREIREYYPDSDYEKFFFNMLGLEPDYKKI
NYYILLDEMF
>fig|195.2244.peg.1708 T6SS component TssC (ImpC/VipB)
MANTKAVDMPIIEQIMEKSKYSKTDESYSIAKRGVAEFISEIVKSDNAEEKINKFALDEM
IAHIDYLLSKQMDEVLHNEEFQKLESTWRGLRFLVERTDFNENIKIDLFDIRKEEALEDF
ENNPDITQSVVYKNIYSSEYGQFGGEPIGAIIGDYQLGSASPDMTFLNKMASIAAMSHSP
FLTSFGPKFFGLDDYSELANIQDLQGLLEGPQYTRWRTFRENEDSKYTGLLVTRFLARSP
YDPEENPIKSFNYKENVHASHNHLLWANSSYTFCTRLTESFAKYRWCGNIIGPKSGGTVK
DLPTYLYENFGTIQSKIPTEVLITDRREYELAEAGFITLTLRRDSNNAAFFSANSPLKPK
LFQNTPEGKEAETNYRLGTQLPYIFLISRLAHYLKVLQREEIGSWKERSDIENGLNEWIR
QYISDQENPPSEVRSRRPFRAAQVKVNDIPGEPGWYKIGLSVRPHFKYMGGNFELSLVGK
LDKE
>fig|195.2244.peg.1879 hypothetical protein
MGEIVKYHNDFNKIKLPSFTEQEQNLLCFLFTKIKEKKENEIFSIYPKDLIGFSEKNLSN
KEITEILTSFEEKFFKADFTIIVKDEVKNLIGKMRVNLFNHFVIWKEFRGEYNMEIGMYD
AWEEFTRIDIEVNKHFEYLINQLTANFTAFELAEFIALSGK
>fig|195.2244.peg.1748 FIG00471415: hypothetical protein
MKEINIIDFGLMGKQISALFYLLGYEIGVYNKSKLNIYEFEKQIKLLQRKIDFSNFNAGK
INIYQHIEDLKNSLTIESLNEDLNLKKEIMQILRDNNIVFSNSSSLSMDDLNCDFIHFLI
LFISN
>fig|195.2244.peg.827 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVVFEKDI
EIIWIMFHILDFSSELQSARLMVLENDKLQAQDYTELCSSKPFFQFSRIYFLELMSHYYE
RFHEDILGLNKKLAETFKYSIVSHGNDPKDALQGIEQFVYNLPQMITHPSYKELLSKRKG
VSDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVLSLERIPLTS
EFFNNDFGEFDKDILFVLKSYVHPHTTKYLQKNNRNFMLVSTYASFIQYLKLDYFGYFNM
GKSVANMSYLLTEYLNYKNIILIGQDLAYAKDGFSHTKDYKNLDKHEGHFQRDKGKFQCL
AYGGNGKVESSEIWTMFRLIFENDINYFQKLFNITTYNCTEGGARIEGTIEKPFLWACEN
LLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVCKSIEHCRDFSKILSNDFEKIQSVYLSL
NEKEEYLNLAIEKIDEFKNKLEDIKQMQDLYEILSPLLIQFELNLARIYVLNPKTKEDAF
NKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2244.peg.1706 Uncharacterized protein ImpA
MYFCDQLKNNLDELQEFQLLEDEMSKYKTLNHENISWDKVYQYSQFILLNHSLDFKICNY
FLLSCFNLNNEECFEKLLLLFQHLKKLIDENNAYILAQKRKIQNFIQNFIQEYNKTKVLI
SSEIVNQFITLFSEFENLLSCNFAKIEIAQVAPQLPKSPVTQVSVNIRSDNINSLNEREY
KNFYQKLAFELLEEDENNLNIYALFTQAMWGKIRCLPECNNEKITKIRKPDADIIRILLS
DKENDIEHIKCFMHELILNPFWIEGVQLFCDFLEKKKKNKQLDILIILTSDFISKFDTIE
LLRFQNGDFICKEEVYKYFVKSKENKKSFFSSKKTDKEHTLQDFEQMLMNIDKENFNNSI
MNNINSLLDMVKIFESKGMKKNSKILNIYLVELMEKTLLKDYLAEEYENAKSKIK
>fig|195.2244.peg.1701 hypothetical protein
MFKKIFDFVKSRLFITAFLLCCIFLLSILFWFWGSLVAFNDIYIFSSSFLRFSIILIIWL
IVFLFFLLKPIINFISSLKSEKRLKFKVLKKEADEFIYKSKRNFFLSLKDAKETWKNDLK
TKNLPLIIIIGNEGAGKSTFINYSDIEYPLSDSLESYKKFHKSTRNFALYVSKKGALLDT
EGNYFSQEEFFKPTSSDEIPEDDIDKNRDFLIKKNIWKKFLTFLNKNFFHSKLNGIILVV
DTVIFLNNPKEYSKNLIRYLTKRVNECEKTLNLKLPIYIVFSKLDLIEGMKEYFDIFDKK
ISDKILGLSFDKILSEEFLNNEFKELSDSLLCSLMSKNSHIYNIENKNKSYLFLKQLDNL
FALAKTFILEVQEENKLKNNSYLRGVYFVSAYQENIPRNFLLDAICEKYNCKKVLSKSNI
IHNKQSYFVKSLLEDLIFTDYSLSTMKSYSKKLSFLMIILIISFGTYVISSYFISKNNKE
FEKSQNTLRSLQLLLKDQDYQNLNIKQKADFLIELRNILNTYPELWQDNNIFQYLNLNLS
YKGFKEAKQLYYKLNEDVLKNTLLKEMEYTLLTDTNKENLIKTLYMYRSLFEQKYFNKEI
LKIWINENWNTLSKYSISKDDFLEGVDELKQFNLKSFTEDENSIHTGKRKLESISRTQRI
YILLNFLNSDKPKEKYLIKEDLGFAANSVFSNNSQITSIDKIYTKVGMMDFLNDLNQQVD
TAINIESWMLDNNFKENKNTLTMGILKLYLSEYQNAWQNLLASLQPVRYNTKEAMLNELN
ILSKKENPLYSLLKIVSSNTNLNDAVLLTQAYNLGLNAGEIRSNFIGVSNAFTQYHKLVN
KNTLLSVGNIEVGKGTDDEKILDILNTSITNMSNKIIDFSSNNNQSAEEKISYALGGNKD
ANDPFAVFQMNIKKLPNDLERYYSQLSNYSWNFIENHGISLFNTAWINEVYNPFVNDIAP
YYPFNDESVADLSMDSFKTFFGRNGTLNSFYKKYLNNVLVKRKNNYSINSQFASKLNFSK
EFLDFITNAGNLSSLILNGNDNIKVNFTIQSLDLSADFSFIKLGYDNKNIQYDHTLNQTL
QIVAEKFNNGTSLNFTAYNYSNPNLNYTKSYKGEWAWYKFIKDNKSNSIYSIIFNNNKNL
YFDFEIINGASELNNIVYILNNLKIVENITGVNKQ
>fig|195.2244.peg.1869 hypothetical protein
MKILLNKQKLKETIEGLGLADSFLFWCFSKSHLLRCYDLRKGGAGAV
>fig|195.2244.peg.1915 hypothetical protein
PRDIDSTPESRKEFDHYMDGYVNGMETRFDADIPNDWGDRQATLFKDTLVLSAKLAALTP
PQGYPNAPRYYSPERLEIIYKRH
>fig|195.2244.peg.1856 Mobile element protein
MKIEYERNLHSVFLLQYHLILVVKYRKKVITDEICCRLKEIFEYIAKSSNYQLEIIEFNH
DIDHLHILFKAKPKSELLKFINAYKSASSRLIKKEFSEIKKYLWKEYFWSGSYFLATTGG
VSLDVLKAYVQNQGIEDNRVKKQYNSKHKRLKEQELCK
>fig|195.2244.peg.1704 T6SS component TssK (ImpJ/VasE)
MANKLKVAWFDGLNIGQTHFEQQERFFNRNIDLKTINIYSNLYGIIDLEFSQEMLLQGKI
ALSKISGIAQDGSIFNAPEQDLLPEPIEINYESLIDSVVVLKIPIGVTDIADLSLRNTFP
NSKFICLRNSIALRNYDDSKSNVMDKIEDEYELENLTFTQEKKDLLLASLRLKLGILGNS
TPDELELPIAKIKNIDINKKIELESDFIPTCLNISKISTIRSFLEEIIFSINQHKKVLSN
VFKGIDQTKNTLDFSTFLSLNLLKKWYLIFSHLSKKDKIHPEFLYEKFLEFQGELAAFSN
EESFLDFIPYKHDNLYNTFLNMMNNLRLLFSKITSPKYFIAKTSINGNGFYDFIFDNSGI
LEESEIYFAIRADVTTEYLLNNFKIQSKIHTQSKIKNIVATQLEGLNVDQVPNVPSSIPY
LNGYVYYKLDKRDQLFKDFKNESIISMYLTNNIKNPDIIMWAVFQ
>fig|195.2244.peg.529 Ferric iron ABC transporter, ATP-binding protein
MNEGKIIQNSNANNLYLLPESHFVASFIGNYNILSPKELDSLGLKHDFKKDIALRPETIE
ISNEGLEAKIKEKSLLGNIIRYRVRVQEIEFKVDTLNFSTHSTYEAGDKIALKFNLSLAK
ELK
>fig|195.2244.peg.621 membrane protein, putative
MKKKIFKFSILFTIFISLSQSTLVFIFNHYLIIDYSAYETLPQSFAMLNLADQKLYHLTQ
NLRFLHSILAFLLIISFFFVHLFFFYISRKEKFIPYSFFLFCAYGNKCYC
>fig|195.2244.peg.1387 mobilization/transfer protein
MALFHLSVTQTKRSAGQSAIASAAYRAGERLYSEYYGEYSDYTRKGGVICSDILLPSYAP
PEYADRQTLWNAVEKAERGKNAQLAYSFDIALQNEFSLEENIALARQFLLENFVSRGMVV
DFAVHQPDREDGGIPNPHFHVLCPIRPIEQNGKWGLKQRRVYELDEDGNRIRDQNGEYVF
NAVPTTDWGSPETLEYWRQTWAELCNGKFAEKGLDVRIDHRSYERQGVELLPTVHEGATV
RAMEKKGIRTEKGEFNRWIKATNAVIRDIKKKIALLFDWIAEAKAELAKPQAPDLVSLLN
AYYTQRRAGAYSQKGKVSNLKEMNETFNYLRANGIYSLEDLESRVSEHSAATESLKKTLD
EQTARMKAIKQLYDSSAAFQSLKPVYDGLQKIKFEKPRAKYKAEREAELKQFYAARRKLT
GEFPDGKVDMKKLTEEYDELEQAHNTTYGEFKTVRDDLHRLWKVKSCVDTAARFNERTEE
QMLQNRPQTRHKKEDMTR
>fig|195.2244.peg.1703 Outer membrane protein ImpK/VasF, OmpA/MotB domain
MKEINEEKKALSLLLDSDFDGLKNNKIIDYSLELLLLSYRLSKISSMDTSSINQLRETLI
NKILDITAKLSICKEYDEKEIIKFKYCLCVFIDESLMKNELFINFWAHNTLTVRLFDETL
GGNNFYDIASSWINNPFKFKDFLEFIYACLILGYKGKYNETKDRDEKIIHFCNNIATSLK
PVYKIEEELAFNKAYKTGLKENIWQKFIRLYFKKLIIVVPVLIILGVLSYSIFNLETNNL
KVDNNISVLIKNLTHIE
>fig|195.2244.peg.1709 Uncharacterized protein similar to VCA0109
MSLLDKLIHNLDEQNIHIPFYQNDFEDVKNNIKVLLNAKINDCYAVKNLGMPNMADINLN
SNELCVSMAKEIRKLIDNYEKRICVVSITYDNNLSPWQLSFIVKCFFQDDRFKEFNIEII
FKNNRYCEVK
>fig|195.2244.peg.1851 hypothetical protein
MSLNSYMSLNISNSTSNPLPFKITKALIKESLEELFSIECEGFFESLEQDLFSLNTLTNA
SSHLSTPTTFNFHPNVLIDQEAILSIHNPYENNTLNFDNNKVINYKGIITYIKYLGINHE
SALNINDSASNTKQIQYKHFFSFKLQSVLIRLSLNKANRIYTHTNIIEVIKQTLGFYQDI
LHKEIDYSNIHFNYEEQELISQYNESDLDFITRLSHNNGIFFYEDENTIYFCDVYKNVKN
KEIEYNPNINNILNQACIS
>fig|195.2244.peg.1547 Putative amino-acid transport protein
MGEQNLTLNPSVPFDEKILKILEYVLPYTDTIMVVLLIICGIYYSFLTRFVQFRMLKSVF
KILTERNENHTKEHISPFQALMISTASRVGIGNIAGISIAIAAGGAGALFWMWFMAFFGG
ASAFAESTLAQIYKSKDNTGGFKGGPAYYIKKALGSHFFGAFFAFILIITYAYGFNGLQS
QTMTSAFKVYYDMFNPNATTDFASSSWPMIIGIILTLFGIWMFFSHHTKIGKVSSLIVPF
MALAYILLAFIAVLINFEKIPSVIVLIFESAFDFKAILGGFAGSALVIGIKRGLFSNEA
>fig|195.2244.peg.1857 hypothetical protein
LLLFLVGGCSYKYMDPQYYEFKSLCKDIDNKVIIYNKAYWELYSDFTKKKPSIEKRVKDD
GYEYFYYEKLNETFAYYDIEDMIKSKKRNGNIITIVYDKKYKKMPKPFASYIRYNYKNDG
VFLRGDEGAGLYFTYEEVFTCSYFDNFK
>fig|195.2244.peg.1594 methyl-accepting chemotaxis protein (tlpB), putative
MFRTIGFKVSAAIFVVLVLSFIAMQLILNLDFKNTADKMSKSNLNTVSSSVFQTMRMAMN
LGDPEKIQEAIEDAKTIEGISDIKIYPSKETIELFEIKDPKISQEKLIIDQFTQPNLISL
EQKLDNINHLRLIRPLIADESCIACHANANLGSVLGVMDVYHSLENIEKDIAKTSRSYIV
IFTIALIFTLVVVLFVLKMVVGNPIMELLSHAKELAQGSGNLRARIRVKGRDEIAKACEY
INQFIEKTQKTVSSASLNSKNVEKQSILLNSNAIELNEISTSSHQKIDSSFKLGVDIGAD
LDEISNLSSDANKANDKSYQLLDRMIHSLLEIDKKSK
>fig|195.2244.peg.1918 Motility accessory factor
RKGISDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVLSLERIP
LTSEFFNNDF
>fig|195.2244.peg.1418 hypothetical protein
MNKTLIFHENSHIDLNASFAPGTYISLQLEKESDEKLKWAFVECESKEKLNLLLHDCNGY
IDEKNLKVLFENDDLIYNESYKDNILSFCLPINRSNEPKEDIQDYKYYIVLFAYSSEKTM
PNLEDHYIIIDMSFRVGVGDDEDVEESKLRNDFNSDIIQTNCIFSVFEAVEFLKACQSFK
EKAKETNNYEFFKNYPQLAGKIAYIYYRFDLANEKFIKSVSDGDKYLKEREKFVKKFIDV
YSDEKFFIIPSYKAKFSEFSNKSDEEKIMFFQEFLEDLVKAFDIEPPIPTIYKEFKQYNN
GSYNSVGKKALYLNLKNKEEQILSTFFHEFRHFYIDKNNSKEIKNQHTESIFKLIYSNEY
FKFENVVMFWAYDKKCIISNNYTDCVGVKPYKYSIFSDKPAIYWFSPSERDARISTFYFE
KYRG
>fig|195.2244.peg.82 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MKQDEGQFFTPIQICEFIMYSLPLQEMLSKNSKALRVIDYACGAGHFLNTYANELKRYLT
EDELKEHYKNIYGIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKA
KPQIESNSFDLLIANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFL
>fig|195.2244.peg.1396 hypothetical protein
MDNTQKYAVIDLKSFYASVECILRKLDPLNTNLVVADESRTEKTICLAVSPALRSYNISG
RLRLFELIQKVKTINYERLKIAKYFSAKSYNHLELINNPNLELDYIVAKPRMSTYIDYSS
KISVFI
>fig|195.2244.peg.176 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MMYKLIQNGDYKCENIAFKKYNFQDRKEKIFCDNFRYFFPTAINAYDEYFSKLKKNLVII
>fig|195.2244.peg.1500 23S rRNA (guanosine(2251)-2'-O)-methyltransferase (EC 2.1.1.185)
MIVYGKQIFFYILERHKELINELYLAKECDKETFKKLLVQALRSKNLILKQPKLMLKVEI
IKVFY
>fig|195.2244.peg.1146 hypothetical protein
MPYIILSPHFTIKKFKKGLKLPFFPHIQALYFTIKKFKKGLKRFHLRY
>fig|195.2244.peg.1794 hypothetical protein
MNEGIEIHFAKVNFHIKEFQKVYILENCKLYFYKPFHLQTEDKNNGKEFEDKNRTIHKEQ
EIKKINSQDQLNEKEDITKDYAQKIDKEINKFDENNFILQTKKQRQIDPDNYDIFYDVYT
SKDNKDNSVNKKLGCGDGFEVKNGIAKVRAEFFDKCFEKGIYVLIPRLVSLDKNEELHFD
PVPLEDKGFVVTDFRKGKKGEKNIDLSFQRNIAKIKNPNLTLQSPKEFLQALNENKEFTE
DDKIQQAQAIKKACGKKADEITKILLKDDESLKDIITDEKELKKKISDLQNNQNKSPKEL
NLLGRLEFLQRNQDKAKDYKKTIKDLQNPQQASNANKNNTDDNKKKKLTKKNQNQEEQKN
KNINSKDIGDAGEYAASMLFTKRSTRYLSNRRKIDANFNTHSFNHTIPDFLVTLNDYPTL
VEVKNVQDQALTEQISFELKLAREYELDYLFLCNHYTKLIDNITNLEIFNKDNKNHKGSR
SGFIYHRHAHRSIKTIFKEMYLHHIKGAAPNKIIIKRLNLNNSANIEEELNKNKQIQKN
>fig|195.2244.peg.1423 hypothetical protein
MNKPFYKLKRFYIPCGVLIALIIFTSLTYHFLQRPLELIFWDRYYHEKEYQNAKDIYKLF
KSNEEEFKKVFVEQNLNQELKLNQKELLNYMHNFKKDFKFMQILGLDNAYLVALKNKDVL
FGLQMQNNLNYFYLASNSTTNLKEINNYLNVADELLVFMSEIEKLPSKYNLGKIMFEINF
MTYNILFFGFTLDTNLMCSIPQKEQLLKNMINSYKKINLFHDADLKFQDQELYEAIYVTK
KLNYFINFAKGRLNACGK
>fig|195.2244.peg.1809 hypothetical protein
MKELIVIADIAENLGISKENVSFDNINKTYVIAKKADGKPCDILEIKKNNKLEILFIYPL
KFVSCNFLEPIFINDKTFQEKIIFRDVIFSKN
>fig|195.2244.peg.1403 hypothetical protein
MNIINNFYKGVFCFFVFILLFKSYITTLYTLSFLKVLK
>fig|195.2244.peg.1852 hypothetical protein
MLPQPIFLNKLIEFLSDENLDIVNMKKGVDKIFSKKDFYAILELNIKIMNIAKLIFKSDE
QLNILLPQASDYKNTNYFPQELELKKEMDVNLNDLKNCDNKKIIEIIKQEYQNNLIKELD
INSQKEKIKILFIINEVPKFLKSIYKECEFKEYGLANYLEFDEIWGFYENNTRYFTILTP
MGANKIKLRLENTQNSEKELNIIEVNLDKK
>fig|195.2244.peg.1768 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MNLDLFQTLGESIQQIVDAIKTNKIYKITLIF
>fig|195.2244.peg.299 hypothetical protein
MKYETINQESIAKLMELFYDKIRKDKDLGPIFNNAIGTSDEAWKEHKAKIGNFWAGMLLG
EGDYIGQPLKNILICLLFRKNFLEFG
>fig|195.2244.peg.1908 predicted secreted protein
SGEYHLTMWFDSDNNKYEAVYIGERGGVEFEYSFDSEKEAIDKMLQMNYKQKYFSVNEDY
SMQNRKEVALRIIKEENLEVIWYDEALKPMRAGIKHDKQRDKY
>fig|195.2244.peg.1910 IncQ plasmid conjugative transfer protein TraG
MQYYEDPKNATELESKIKECANASSYSKSFNYKPQVSTKELME
>fig|195.2244.peg.1793 hypothetical protein
MKTLEDIKAMSYQEKDELEDLVLEIIDNNDLVKLKDILKDYPVKISCYELHFKNKDNEYP
LFEPMNLILRAAFACEDNNNDFSILDYLFDEYGLSLKDPKYNFYHSDMKYIKEANDKYIL
MEEVEDDPCIYQNALIYDYILSADNPNSQIIKYLVNRGAKFEVHDEGYSGRTPMHFWARR
NNYQLLELAIKGGANVDMQTLLDPKSEYNETLLFEAVEEAETYRVTQLLIELGANVNFAT
PTTPLDDAKGSRNKKLLKDAGAMTSEQIRKKFNLPAYDSSHCEIDGKTDFDLLGKYRDEC
SKLLNDAIKKAKESE
>fig|195.2244.peg.1905 hypothetical protein
KTRRLLEKLNIIGQNNLKAMYMGINGNKESLKAIGKRENNTSKASANTDITSETKTPPNF
IGRLATTIIIEDGLYMG
>fig|195.2244.peg.1377 hypothetical protein
MKTTEYNTQQKNNKEYLAEREAVKKTMAKMEKELEKPAINAVFQRLKNKS
>fig|195.2244.peg.1771 possible DNA primase, putative
MNIKLNIPYSNKDKLKKYKIKWNNDYKIWYLEDYRNLIYLIDYLENRNFTIYVTEKLYIV
EGFITCWKCSKMILVYAFGALKSSFLDCEKKYWKFNSKFKMIWNILSYSQELESILKKII
>fig|195.2244.peg.1141 C4-dicarboxylate anaerobic carrier, putative
MSIAILSFLVYFATVIMGSGIAAFNAFGKLAPDIATKLGVAPITLVLPIEIASCLGRAAS
PIAGGIIALAGFAKVAPMDIIKRTTPLLLIAMLVNVLVAFYLAQTNPLPKEQNTTKIAVS
LNNKYLLFYKNYKFSKLFSAFLVKIS
>fig|195.2244.peg.1421 hypothetical protein
MSLYKECEVCKTKINKLQNIWNIFSGKLEIKCKNCKSKYGVFSKIIDWIYDTFGYLLLIP
DSMIVIIIFFGGYFFVKYGLLVTLYLLAIILLARKLIGIILLILCKLKRIENER
>fig|195.2244.peg.1808 Ferric receptor CfrA
MNAKKLKLSILCFCLMGLGEIKAEEQYQLDDVVVSASGFEQDLVDAPASISVITKEELSK
KPIKDIGEAISDIPGVDVTMNKTGTYDFSIRGFGSSYTLVLIDGKRQSVANGFYDNGFGG
SESGYLPPASMIERIEVIRGPASTLYGSDAVGGVINIITKKNPNKTEANIEFSTLLQQHS
SKYGNAGGFNAYVATPLIEDTLSISARIKYYDKAASDLKWPTPVWSNGTQRPENYQIASH
SPGYFTSLGFGSRLNWTVDDSNNVYLDVERYINEISVNSTSSSAIKSERQLFKDNVVLNH
DGNYEFGTTNSYLQYGSTKDKDLHSQIWVGEGKVVLPWNLDKYGNLVSTFGTRIDYETLK
NDQESAGSEIRGKNLDQTTVALYGEGEYFISDDLIFTTGLRYIYSDLFDSEVTPRVY
>fig|195.2244.peg.1893 putative replication protein B
DKWILKPAIKELSKERNLFDQIRVPFKNLAYEKEKAKGTRGRGGKVSGITFTFKPENIQM
QKLENESQKIMSDEQKYLKILNNMKLNQVRFDYNDKLWQFNDFDFDEFKIIAIELVRDEY
ENLNFGNHMHFNAKNQEQFFKMIETFRKGIR
>fig|195.2244.peg.980 hypothetical protein
MSIFSINDNSNYGSILSQSKANKESKENSKISFANAFLKQNASKLSDIESKNSQTLARSE
ILSNNNALSNNSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQADTSN
IVSLAYGYGVDANGYMGSDFNKAAGLPNDFKIHKSTLDEIKKAAENDPVVSSTKEYLGVS
EYYTNIDMAETIKQYYNLFSNALGQSFPNDKTSFSEADINSMPSGYAVGGDKCMNFNDPN
NRMNITHLKDFSGALVSNVYQTPEQVKEADDLWADSGNMINGLKPQTLGLSLEEIKNVSQ
AKYECDFKPDMSFYPKNEDGTYTKEDLFMSFLKAQNGQPVESLNTTLNPKVEAYNRAMAK
ESFNGDSIALNDIMTGKVDFASLLKYELDRGYMAGELYMYEKGISPKQALGNWALDAEIK
QALANGWKASSESINSYVDSIMDRLNNLMGQTKV
>fig|195.2244.peg.1702 T6SS component Hcp
MAEPAFIKIEGSTQGLISSGASTEASIGNRYKSGHEDEIMAQEVSHIVTVPVDQQSGQPS
GQRVHKPFSFTCSLNKSVPLLYNALTKGERLPTVEVHWFRTATSGGSEHFFTTKLEDAII
TNIELIMPNAQESSNHDKTELLKVSMSYRKVVWEHTAAGTSGSDDWREGKA
>fig|195.2244.peg.1862 hypothetical protein
MKFENLKHGSLFKREFYLKDVKIDLKNDFFVYSIITNEKTLEIFFKSEKKDIQDLQIIFY
DYKLLHSKSYCKNFNQLEASFIDLIRNNWDDITGYIEKEEEMLISIYFDNDLEYITLTCK
YFNIDFID
>fig|195.2244.peg.1867 hypothetical protein
IFLNSTLLTGSNELPNNPFYFGELDQDNTIKQDTPSYYFSPKDESSGLGRLSIFYKNDEL
CLLNYSIIENSLNIKLECLRKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNL
ECIHGGKVILKSNKGKTFKDDGVPIMLESDLLNSSIVACPNTIAGVSVPCTKVVNVKGSL
SQKKVNHEYVILQELISACKTDKGFALKVSFTPTKFKFDHSFDPKEGLGEQSKNQIELKE
PIIRLHYKSDRFQKDNLPIYNLLINNEKKEQDKALNEFNIDLKDLKDIEDINILNQFKQD
FSKDYEFKELNLSFDTNLIKLYFIIPKNIAKVYKSAYKEFENKDLGVGYFTQLHEYDKII
KNALEDNKELNEYHFSFLAPAKMQNLKLQIAQGLDEILEDEDRKQELYVCKFVVVNGV
>fig|195.2244.peg.1914 DNA primase TraC, putative
EVKKQLNFIDFHNKLNTFENPTKTISQKDITR
>fig|195.2244.peg.1832 hypothetical protein
MIILKNLYIIWIIIWGFGAILGYYMGYDATFTKMFFFLVILYLFPLLPYFYYLIYKKARN
TKNIFVATID
>fig|195.2244.peg.83 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAQHLELEPKWNLGRDKKGGKADILVKDNENNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFCKKV
>fig|195.2244.peg.1079 hypothetical protein
MQSQKNKNIIYVSYHSDKDPLTPANFKQQTMQILKILGYDVSLNLIDENKIDGKFIKNLD
HGCGIPDKALFRKELPLMLEKLQGRKSFMQENSISYPCGNKVFIFKDVGDKFELVIKD
>fig|195.2244.peg.1397 hypothetical protein
MNEVQFDSWNERKKSLNKVKLIRKVSVKKDLLA
>fig|195.2244.peg.1796 hypothetical protein
MNEGIKIDFAKVNFHIKEFQKVYILENCKLCFYSPFHLQTQNGKEVKKIEKKGKSKIYLI
DEDGKTVDIDKTSEQNKIKAREETRKKEEKSKNVLFSNDEKGNDAINAYFGEKNIDTLNK
AYEEREAKPLSRNTESFKDYDVFYDVYTSKDNKDNSVNKKLGCGDGFEVNNGIAEVGAEF
FDKCFEKGIYVLIPRLISLDKNEELHFDPVPLEDKGFVVTDFRKGKKGEKNIDLSFQRNI
AKIKNPNLTLQSPKEFLQALNENKEFTEDDKIQQAQAIKKACGKKADEITKILLKDDKSL
KDVIRDEEKLEKKIKELQSKPKTNEKLNLLGRLEFLQRNQKKVKEYKDIIDNLQNPQQVS
DSKQNNSTKGRAKGGLKNKQKQTTTPNQEEQKNKNINSKDIGDAGEYAASMLFTKRSTRY
LSNRRKIDANFNTHSFNHTIPDFLVTLNDYPTLVEVKNVQDQALTEQISFELKLAREYEL
DYLFLCNHYTKLVENIAGGNVTVKNEKEIKLKEIQNHDDKKKKGYETNTKNLTKFDERYD
WGSRRGFIYHRHAHRSIKTIFKEMYLHHIKGAAPNKIIIKRLNLNNSANIEEELNKNKQI
QKN
>fig|195.2244.peg.528 Ferric iron ABC transporter, ATP-binding protein
MAYLKIKNFKKAYGDKIIFEDINFSAKKGEFITLFGPSGCGKSTLLRCIAGLSQINGGKI
SLNDKDLTKLSPQKRNIGMVFQNYALFPNLNVFENVAFGLKIKKMDKKDIEKRVKKMLKL
VELEEYAKTYPHKLSGGQMQRVALARSLVTKPDLLLLDEPLSALDAKIRKHLRVQIKET
>fig|195.2244.peg.1707 T6SS component TssB (ImpB/VipA)
MSDGSYAPKERINITYKAKTNGQNEDVELPLKLMVMANLKGKNETPLEEREILQINKINF
DQVMRKLDITTSFSVKNTLGTGAEELDVKLNIASMKDFSPDSLAKQIPELNKLLQLREAL
MALKGPMGNIPDFRKAVLEALKNEKTKEKLLLEIKQEEQGN
>fig|195.2244.peg.1424 hypothetical protein
DEVIISFLDDDIDKPYVSGSLYNGANPSLVNLPFNDHQTSLSSKTIGVNEEGYNELTLSN
IKDKEQIYLKAQKDYDELVQHNFTQRILNDKDSIVDGIYNERIKKVHTQTIDLAKNVNVG
GEYLTNVGLSKDTIVGLSNTLNVGVDNKVRVSKNSSEYVGENKDIEIGANQNTIIHKDEI
RNVKGNKKEVVEGHYDINISDKMQVLSEKEMDYKSKDNILFTSNESIGFESDKNTSMVAD
NITTYAKTIHELKADSEATIQVGETIINAKPDCVIIKAGGVEVTIDSNGLVVRGGEIKAE
>fig|195.2244.peg.388 Conjugative transfer protein TrbL
MNGSKLALVLFLCFLIPNLAFGAESPEGALTLIKNGLLSWTPLIKTACLWVFWTLVAIDL
IWTFDFVLFLNFFMAN
>fig|195.2244.peg.1876 Fic domain protein, MA2133 type
MNIKDELKEIDILKDFLKEHKLAFETKKSLEEDFKLRYTNDSNAIEGNTLTLFETKAVLE
GMTIDGKSVREHLETINHSQAIDFMIKLAKTNTALNALDIKSLHQIVLQSIDSRNAGVYR
NVDVIISGAKHIPPNHLNVVFEMERFLNWYKNEARELHPVIRASRVHIDFVGIHPFVDGN
GRMSRLLLNYELVKNGYPPINIKYSAKVQYFEALEEACYSKNFEKFDLLVINEVKKELEK
RKHFALENEKNEEQENCNHKNFRR
>fig|195.2244.peg.1712 hypothetical protein
MSLNSYMSLNISNSTSNPLPFKITKALIKES
>fig|195.2244.peg.1865 hypothetical protein
MFLLPAYLLLFLVGGCSYKYMDPQYYEFKSLCYFNLGKVLIENESIKNKTNIIVTPKSKQ
IKDRIVETRFERKNENQVVYYRINTYFYDNYGIFLKGDEGAGLYFRYMEVLSCKNIDKKF
KKDDWQVETLE
>fig|195.2244.peg.1710 Protein ImpG/VasA
MKDNIFYYQKELEYLYEKREYFIKNYPKLTPFLAYDSKDPDIERIIENLAILSSKIHQEL
DENIPHIAESLINIVSPNYTNPLPSLCMQEFKFEQNSKENNLIIPKGTLIKSKPIDKCVC
EFKTVYDVYLYSISISEVFISSKNQDYTFNLTLQVNKAETKICDLGLEKINLYLGNDTYM
SSTLLLYMHSYLKELKIQSLDTDEEFFLNTYNIEKIGLNPDESSLSYNDLGFEAFSLLRE
YFFMPHKFNFLRINGLDILNNCQGKTINIEFKFSKPFPANCIFRKELLSLSMTPIINIFT
KSAEPLINNHKKDSYRIFVDRSQPKAYEIIQTLQVKAHNSEGGKRLLKNYKSFERFEFLK
DNQKDFYSVNTKKNSKGEVFSEISFFSSYIMDETISIDLLCSNGDLPSKLKIGDINTCDL
KGVDTKNVEIPSETRRCSVDGNLLWKLVSVLSFSYQTILSKKAFFGVLESYSFLDNQSNW
KIYKLLQESIIDIQSKSTYLIDENITKKGTLAIFSIKDSKFYTLGEVYLLGLIISKFLAS
FASINSFCELKIRCLDSKEILHYPASFGKKALI
>fig|195.2244.peg.1898 hypothetical protein
LEWIYKRGYLDKLLDPRIPAIYRYNFPEDLRVKILAYAKEHNIKE
>fig|195.2244.peg.1425 hypothetical protein
MLICNHCNTKNLDIAKFCKECGNSDLYDPQAEEKLEQERRKQEELRRLEEEKRKIAQEER
EKSLKQRKEFISKHKSKIIISMVSFFLIASLSIYQYFYGGKYSRVYINKLEGKCHYDDAS
SCKMLQTIYKEKCDDGDGKACFAGIFVSGDLIRVKIDGQWSFLDKNGEFAIEPKFDYVWS
FGEGLVAVKLNGKWGFIDKSGKIVIESKFDSGGHFSEGLAGVKLNGKRGFIDKNGEFVIE
PKFDDTRSFWEGLAGVKLNGKWGFIDKSGKIVIKPKFDDTRSFWEGLAGVKLNGKWGFMD
KNGKIVIEPKFDGVGNFSEGLARVELNGKYGFIDKSGKIVIEPIFDDIDY
>fig|195.2244.peg.131 Short-chain dehydrogenase/reductase SDR
MDKVVFITGGSTGIGNACVHKFHNEGYKVAFMDINQEEG
>fig|195.2244.peg.1896 hypothetical protein
KPTRLFMAKKRTILIPRIKDINITPDTSCMHPILEDNTLVCLHGGRVKLKAKKAKRIKSD
NVPIMLNNEIQGASISGCLNPPILGGPCTKVAMVFAYTYSDHKVNNKHSVLQMGLIGMSI
KGYPIFAIPKKNKIKFALAKIQASPLAKIKYDRIRWEGGG
>fig|195.2244.peg.1419 hypothetical protein
MSDKDDLIIPEEIRQAWDEIEPILDYGNTILETFNSCGLICKKIPITGDVINFILVWDEE
KSVSKAIANLGIDRIADLTIIISSIMDLGMTLDNIKDIENSREEAKKFTFNLIDSFTSNK
TYKFNTHSLYPYYKNIQNSFTPLCSIDNKNSNLLKEFNFDSFSCNFYNNNIFNQSLKHLN
NIQNEKEYINKYKIFLENLNYFNQEYNNYKLVSIQVINNLKIAYIQKLSLQDIDNININS
ELYLLKALYFCEDYVLFDKDKQALFDKNTIKELEFDSSFYTIFVSHKTKLNDTYLKARKE
LYKSIDEFKKLGFKDLENAYQTYMNSLIVNKEINSKDETINKNKNKEINKNLNQDENSNQ
ESDTKENTNSIKEQDFYLLSSHSKNLNHFILENKDKNKKIIFLNNASSMSNLIHIYDSHC
DIFIKNESLLDIKKIEKEYDIKFKEFNTRVFFYEKLLLGAKENNEFSFEEKEENLLYYFK
YDKEDLNSLGDLNIKYNNHNAKIKNYSLLEESLNIKLKPKEFKKAIAYNNASFNKISKEP
LNESSSSAKEPCFITLYLKDEHNKPIANAKIIIKGFKHDEALRVVNLKRRSDEKGKIRFD
KEKYFSDCYSFKVKLDESKAYFPTPLQNAKRIFNNYTHHKVGLILKFKAKDHLVYDGFNL
YHYKGNELINSYMARSGTAKADNQKRSKKQIAHYFYQDEKDKSKSGKAYFYYDDESIQDR
FGTLPEGEYYLKINEIAKDTKPNFLKDYPFEIGKTWGRYCVRLYTDKECSKTFKEVKIKE
SNEKENKTSKKDKKEQSIIKDNLYLYSINEKGEFGSSGSIGMAQAQLLEDLNKQAKFVRS
EGENIISLKVAYPEKIDNKIIFVGKVYE
>fig|195.2244.peg.298 hypothetical protein
MPPFPQEFFGIWLGLFEESLDKIYNNEEMKNVILQRAQMIASHFQNMLYRFGGH
>fig|195.2244.peg.1833 hypothetical protein
MMVFGVFWGIIFLFSSLYAYFSDIEFFGDMLKIAFFIYSYPLLPYISYLTLQETIKSKNI
FLYYFVFFYTFFCIFLFFKINNLENYAKLV
>fig|195.2244.peg.1672 Zinc ABC transporter, substrate-binding protein ZnuA
MLRILLLSVLCVFAFGKPIISVSIPPQAFFVKKIAKDSVEINILIPPNSDEHTMEFKPQA
LKKLEQSEIYFLADLELEKILEKKFKSVLKNVKIVNINEGIHLLEGGHDHEHEHDHDHDH
DHDRHHAEEHDEHNDPHVWLDPILVKKLAQNITQALVQSFPNNKEFYEANLANFLKELDQ
MDAQIAEKLKNIKRNEFIVYHPSWAYLAKRYNLVQIPVEIDGKEPKSKDLQNLIKLAKEK
DIRVIFVQPGFPENSAKVLAKELNAQIVSINHLARNWDEELLKSIQALSSALQ
>fig|195.2244.peg.1221 hypothetical protein
MPKGESISVYEYIPNNPRSPAAFSSVDSKKLNANQRKGQQVYSKWCIACHGEGMPGTNAL
SALYKDQGIPALLEDRTDLSPDLVTIFFALW
>fig|195.2244.peg.787 hypothetical protein
MELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTAEAGLEFSKTEKISDELS
HVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTKYEDIKTQKQYRLWFVY
>fig|195.2245.peg.1312 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MRGDYLKPINQIVDNIVKPLNADVFIFSWSEHLKWPGICGGSNWVHRLLSQDFNLVAPNE
IRNNHLFKQLFQHTYKKLDREISDILEIQDLKKIYNCKKVVLENQKAFIEQTGLKEHSYT
ATKLYYGCFRVFELMEEYEKENNIKYDYVIRIRPDCNFAEVISIDDLLRLEVNEIYIAHH
LHMNGRVGDSFSCGKREAMEKLLLMWKRAEFNKQMQEFASYPKKFDIETHMLLLRWLIVN
NLAANTAFPYPLLGGSSTIIRDFPDITEELKKDILTIRESNMYKEEKLQSFISFFTKVQK
KYNIIKSKSHYNFVYPNSAKIRIQNQLSYKLGQAMIVNSKSMLGYIRMPFVLSYIYDKHK
QEQKIYQEKIKKDSSLILPPLESYPDYKEALKEKKCFTYKLGQELIKANKNWYGGGISSC
CLRLGS
>fig|195.2246.peg.1458 PhoX, Predicted phosphatase
MVIVYMGDDEIDEFIYKFVSKHKYVKGGDTSKILDEGTLYVGQFNGNVGDFRGSGKWIAL
EYGKNGLDESKGFKSQADILINTRLAASVVGATPMDRCEWIASHKESGSREVFATLTNNK
NRTQA
>fig|195.2246.peg.1826 Malonyl CoA-acyl carrier protein transacylase (EC 2.3.1.39)
AVAADVVATKMNAVFIFPGQGSQSLGMGKDFYENSKTAKELLENASDFCKIDFKNLLFNE
NDDLNKSEFTQPAILLNSLMAYSALSELKPDIKAKFALGHSLGEFSALAINGAFSFLEAT
MLVHKRGLFMQEDCAKVEAGMMVILGLDDKKVEELCQKARDEDKKIFAANYNCDGQIVVA
GLKPDLASYEGTFKEAGAKRAMLLNMSVASHCPLLENASNKLCIELEKILEPTFKAVISN
ATAKAYTSKQEALELLKTQLVAPVLYKQSIKACENEADCFIEFGASVLKGLNKKITSKET
YALTNMNDIEEFLKVI
>fig|195.2246.peg.1535 ATP synthase epsilon chain (EC 3.6.3.14)
MDNLISFEIVTPMGVIYQGEVKSVTLPGSEGEFGVLKGHAALVSSLKSGVIDIEKADLNH
ELIAIDAGHAKVDEDKISVLA
>fig|195.2246.peg.1115 L-fuconolactone hydrolase
MQKIFDAHLHLWDLDKMPISWLKGNEKLEQNYDFF
>fig|195.2246.peg.1843 ATP synthase epsilon chain (EC 3.6.3.14)
DLNHELIAIDAGHAKVDEDKISVLAKGAVWISGSSESEIEKNLESAKELIKSMSSDNTAL
AATFSKLDNAKVR
>fig|195.2246.peg.1459 PhoX, Predicted phosphatase
MQRRVFLKGSALGSMVAFFGGSNLSAAVLKDKELLGFKAVSASTKDEVIVPEGYEAKVLI
SWGDPLFSKAKAYDESKNIDMNAVDNARFVFGDNNDGMSFFSLSKNRGILAINNEYINPE
IMFNHQGKNLSKEDVLYEQASVGVSVLEIQKKGNEWAVVLDSKYNRRIDANTKMEVSGAA
KKEVLKDKKFAYGTFANCANGQTPWGTYISCEENFDDFLEVLMKI
>fig|195.2246.peg.649 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54)
MSIKVIEASINSTIQDLGRKNYAKLGIARSGVMDELSLRIANILLGNKQDEAGLELCLKG
GKYEFLDESYFVLSGAEFEAKLNNKKNSNLQSLSSKKG
>fig|195.2246.peg.1687 hypothetical protein
GVMISEFANSYSETREKFEKKQINKKSFFKEKMNEFFKKKLNKILPDREISNEKTYSRSR
>fig|195.2246.peg.1619 hypothetical protein
MDGVIDNSGSALPSPMFILERESGQYDYFEEYPHNKIGFFIKTYWNADVSSKYFFHTENY
LIRIIPNLAHLTIQANINKNIILVSYHSLKDPFNTAKDKQTLFLAYKELGYDATLHLIKD
ESEIDGRFIKDLNHGMRISDKALFRKELPLMLEKLQKRKSLMQE
>fig|195.2246.peg.648 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54)
MGVGVFNGRALQKDDVLELNNSFIPFNLSKRECENPVFQFAKEPTIRVILGTNDDAFTQN
GLNTFLNTSYKIGLKSDRMAIYAEAKTTIEHKNSADIISDPAVFGSIQVPKNGLPIILMA
GRQSTGGYTKIASVIENDLPLLAQAKLGTNFKFENISMQNALELYKQREEKFKTLDKKIN
LDFENLI
>fig|195.2246.peg.62 FIG00638667: hypothetical protein
MGMVKKAYDATKNTLVIDNFLLNLRADGKTPIFYNAIF
>fig|195.2246.peg.1502 Transcriptional regulator, LysR family
ELKNSILYEVKLKNINLWRNFYILKRKNYNFNRALEKFEKIFKQ
>fig|195.2246.peg.1349 membrane protein, putative
MFDFFINYMIFCAKDLSKLFLGTLALFLFAFFGFMFFICEGVFL
>fig|195.2246.peg.1862 Peptidyl-tRNA hydrolase (EC 3.1.1.29)
GHNGLKSIDNLCGSNYERVRIGVGKGENVISHVLGKFRAEEELILSKVLEHSKKALLELI
RNDDLSAISSKYSLKA
>fig|195.2247.peg.1610 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MLDRRRFLKIGAALSTLPLIPTLGAGKSAEATKVSLGLVKNGEVITAAHWGILKLTIKDG
KIIKSEPWEKITKMDNPLQHYTADMVYKSRVKYPYVRKSYLENPDNPKPELRGKDEFVRV
SYDEAIKLIAKELKKTREAKGTSAIFGGSYGWKSSGNMQNARILLHRFLNVTGGFVGATG
DYSTGASQIIMPYVVGSIEVYEQQTSWENILEHSKYVVIWGADPISTLRIAWTASEQRGL
AYFEKLKEKKIKVICIDPVKTDTAQFLNAKWVAPRPNTDVALMMGMASHLIAQNKVNYEF
LENYTTGFDKFKDYLDGKEDGIKKDVKWASKICGIDEKMIKNLAEIFYDNPTMIMSGWGM
QRAHYGEQPHWMLVTLASMIGQIGTKGGGFGLSYHYSNGGVPTCKGGVIGGINAESLGIW
KNGKFQGLAKSNQASGGAEWLQNAASYSFPVARIADALLNPGKTIDHNGSKITYPDIDFI
YWVGGNPLVHHQDTNTNVKAWRKPRTVVVNEIYWTPTAKMADIVMPATSSYERDDITMSG
DYSNMHIVPMKQAVEPVGESKDDYIIFADICKVYGQNVYNAYTEKGKKAKDFIKEYYDSA
LKQTQSFGEAFATPMPNFEDFGQKTNLLLLKPLQKA
>fig|195.2247.peg.1814 hypothetical protein
GFIDRSGKFAIEPKFDSGEYFSEGLAGVKLNGRWGFIDRSGKFAIEPKFDSGEYFSEGLA
GVKLNGRWGFIDRS
>fig|195.2247.peg.1808 hypothetical protein
GIMAAIDHINALKDLVKRFPKFADLPKIYGGGSYGGYLALLIAKIAPWYVDGVIDNSGSA
VPPLIYILGREMEGGCDYVFNDPNTLIECFLKTHWTRKENSPYFFNNENYFIRTLLNKDH
LILQSQKNKNIIYVSYHSDKDPLTPANF
>fig|195.2247.peg.1615 hypothetical protein
MIVKINTTKIPTISVSLAEIPTDLPEFIDCIITPIFILKMK
>fig|195.2247.peg.1611 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MIEIYSQTIKNYNYDDCKAHPTWFEPIEWLGNATKEAPFHLLTNHPKDRLHSQLCHTSLR
DTYAIKDREPILINTKDAKKLGVKNGDVVRVFNKRGEVLAGAVVSDEIMQGVVRLCEGAW
YDPNENGLCKCGNANVLTMDIPTSKLANGNISHTGLVNIEKFKGELPKLTAFSAPKGAN
>fig|195.2247.peg.1408 sarcosine oxidase, putative
MKISFFMGGLSHGFKFAPALGLLGVKALQTQKLDPSIKQYFSLKRFG
>fig|195.2247.peg.807 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MTAYVHIGTEKTGSTSIQFFLYSNRRLLQRQNMIYPISIGNYSSQWNFTFLAYNNLRNDF
YCLSKGIFKKDDFLHHKKDIFLKFKDELLKSKCEKVVISSEHLSSRIQDLSEIKRIRKIL
YLLGFKKIKIIVYIREQTSDMISSFSTTLKSGAIGNIQANSKKYFKGYHKLLLLKWQQIF
GKENLIVRLFDKSEFYQGDLLKDFVHSIGLKWDNEFVIPPKQNESLDLIGVEILRRVNNL
LPLFVNEDRNYLRGDLNYFIQKYFSSKDLFLKFQPPKEIIQSYIDSFEESNEWVRKEFFP
YKERLFPKQDLANYKENYELKEMKPEYWNKISEFIADIVKTKNQLITNKTTQIQNLNQAI
KNKDELIQNTNNLLSFQTKYGTAKTRIQNQLSYKLGQAMILNSKSILGYLIMPMALLSII
ISHKQEQKIYQEKIKKDPSLKLPPLESYPDYKEALKLKNHLSYKLGEALIQANKTWYKGG
YVKILFEVRRLKINREKI
>fig|195.2247.peg.835 Anaerobic C4-dicarboxylate transporter DcuC
MVRSGVSKLSALSVIGICQYIDHGPGSGNVIMASKVAEIDPAIYFVHYQLPTTLPIIVAV
GIAIYFCNKFFDKKDNFVFNAQEVEKELSENKDKENELKKPPKIYAILPVIPLVLILGFS
SVLDSILVLMGISSEEEVKAAASSAIKMNVPVAMVISTFVAIVFEMIRYKSVVETLNSIM
IFFKGMGHLFVITVSLIVCGQVFASGLLSVGFVDTLIEFCKNAGFGVLAIIIAISILLAV
CAFLMGSGNAAFFSFAPLIPNIAKHFGIETITMIAPIQIMTGFGRCVSPIAPAILAISAI
AKVSPFAVVKRTAIPMLVAAIVNIIMTYIYL
>fig|195.2247.peg.211 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAELNFKTKAQNLKNLQTKLKKAKILPLVLTSLEELILNEEKILSDIQALKANKLIIRSS
SLSEDSMKNSNAGAFLSLANIDANSKDELLKALYKVANSMPSKSDEILIQPMLENITLCG
VGFSVDKDNFSPYFCLQYDENGSNNSITDGSSKSAKTYYHYREHLDFKDIKLQKIIELIK
ELESLYDCCFLDVEFAFAFKDNKEELFCLQVRPLVMQEKENLFNALPKEALQRFYKRFIS
LQNLRPRVLGEKALFGVMPDWNPAEIIGLRPKRLAFSLYKEIITDNIWAYQRDNYGYKDL
RSHPLIHSFLGIPYVDVRLSFNSFIPKKLDENIAQKLVNFYLDKLNKNHELHDKIEFDIV
YSCYDFNSSKKLQELLNHGFNENELKRLEFSLLELTNKIINPQSGLYLKDIKKAYRLKER
YDGIIDSNFSLIDKI
>fig|195.2247.peg.1812 Putative periplasmic protein
AEELFYLDKQRVLKAKEAQSYKNLFT
>fig|195.2247.peg.836 Anaerobic C4-dicarboxylate transporter DcuC
MLGLTFSLFSVFLLVFMLYKKINAHMALLLSGLLLLSLAAIFGLSPHIVAKGSLNLGFFD
IFQVFNQTMSNTLAGLGLTLMAIAGFSAYMDHVGASYALFKVFEKPLKMVKSPYVLLLVA
YFIVQFLVLFIPSHAGLGLLLMVTMFLYWFALEFLNFQL
>fig|195.2248.peg.1773 Flagellar biosynthesis protein FliP
MKKILTLLFISGFFSVIFAAEATIPTVNLSLSAPDTPNQLVTTLNIVIVLTILALAPSII
FVMTSFLRLIVVFSFLRQAMGTQSMPPNTILVTLALILTFFIMEPVATKSYN
>fig|195.2248.peg.1048 Flagellar biosynthesis protein FliP
NTILVTLALILTFFIMEPVATKSYNEGIKPYLAEQIGYEEAFARGVKPFKDFMLKNTREK
DLALFYRIRNLPNPKTIDDVPLTVLVPAFMISELKTAFEIGFLIYLPFLVIDMVVSSVLM
AMGMMMLPPVMISLPFKLLIFVLVDGWNLLVQRLVESFVT
>fig|195.2248.peg.1652 Protein translocase subunit SecD
MRNSKITYRLVVFIAVFIFGVVFSLPSFLQSERGVKINLGLDLQGGLYMLLGVDNQEAVK
SKIKSVASSLSYSFNKENILNDGLNIHDDSLDFTLLDNADIVKTENLLKEINGLNVQRED
MHYTISFTSEEVKSIENFALLQAVETIRNRLDQFGLAEPTVAKQGEDKILVELAGIKTKE
DELRAKERITKAAHLQLMEVDDSKMSQASNMSDAEAASYGLVLVPDSRNPNLKYPLKSIP
ILDGSMLTDA
>fig|195.2248.peg.699 hypothetical protein
MKKILFVIMLSSMLAFADLSNKGDLMQIKLLFNGKELLVNLEQNEASRQFYNTLPLELEF
SDFIGKEKIAHLPKALNAKGSSAYKPQIGDFFLLCALGKYRNFL
>fig|195.2248.peg.1842 NADH-ubiquinone oxidoreductase chain L (EC 1.6.5.3)
NDYFIPKFYHEFIVSKYESLCAVLKHCDTYIFDAIVDKIAYYCNLISQKIIMSNSLNLML
RFLVAGFVILLILVWVV
>fig|195.2248.peg.1 Chaperone protein DnaJ
MELSYYEILEITQSADKDTIKKAYRKMALKYHPDRNQGDKEAEDKFKLVNEAYEVLSNEE
KRAIYDRYGKDALKSGGF
>fig|195.2248.peg.1554 Putative transmembrane transport protein
MDFFKLKENGTNIRTEVVAGLTTFLAMVYIIPVNSSIVSNTGMPIEALITATALITIVAT
AFNAFFANTPVAMSVGMGLNAYFTFAVCLGQKIPWQSALGAVFISSIIFLILSFTPFRLW
VIRNIPKDLRLAICAGIGCFIAFLGLSQMGIITPNKDTLVSIGNFKNPHVLFGIFTLILI
VFFWAIKLRGAFILGVLISSIIAWIFGIDNASFPKQILSLPNFSSDNGLGAIFLELDIKS
ALNITMIPIILTFFITQLFDSIGTITGIGERGKIFDDAKDGEKKLG
>fig|195.2248.peg.978 Putative transmembrane transport protein
IGTITGIGERGKIFDDAKDGEKKLGKTLMADATGSALGALGGTSTVTAFVESTTGVESGG
RTGLTALVVAICFAFTLFLLPLFKAIPANAIYPVLVMVGILMFMEVKNIDFKDSAIAVAS
FFTIIMMPFTYSITTGFAFGFLSYLLVRIFKREWDKINLGIIVLSLISLGNFLLIALQ
>fig|195.2248.peg.1797 hypothetical protein
MQNLNQNEQIKCPSCGSFIDISTA
>fig|195.2248.peg.1653 Protein translocase subunit SecD
DSRNPNLKYPLKSIPILDGSMLTDARVGLSDTSNYPVINFTLNAEGSKKFADYTGANVGK
RLAIVLDNKVYSAPSINERIGGGSGQISGAFTQEEARDVAVALRSGALLAPVKLLEQRSI
GPSLGADSIKMSMIALIGASIFIVVFMVLYYGMAGIFANIAMLVNVLVVVAVMAMFGATL
TLPGMAGLVLTVGMAVDANVIINERIRELLREGANIKASIEQGYKNAMSAIIDSNITSLV
TSIALYAYGTGAVKGFAVTLGIGIVVSMITAIWGTHGMFDYFMRRIEKSNNTRFWFGYRR
K
>fig|195.2248.peg.1291 FIG00470547: hypothetical protein
MEELTIVTAFYNVGRTTRSNEQYLSYFDFWAGLKNKVIIYTTDDMKESILEIRKKHNLED
KTIIITKDLKEFDEQSLEKIKDTFNKYDQTLNRKNPRNIECNNPLYCYLMYLKPFFVVDA
IERNLTGENVMWLDFGFNHGDEFFTNRTQFNFLLEKQEIINEEKINFFSVKEEEYKNIAN
VYFNMEPFIMGGADFY
>fig|195.2248.peg.1817 LSU ribosomal protein L15p (L27Ae)
MNLTKAAGSTHKTKRIGRGQGSGMGKTATKGGKGQTARKGYNEKRGFE
>fig|195.2248.peg.1684 hypothetical protein
FMQNLNQNEQIKCPSCGSFIDISTALYAQILDKAKQEMLKQKKEFDDEVNAKRAEYTKAL
NDLKTQKIEQEKLINEQVSQKLLLEKQKFEQELLIQKQNFQKEFSEKFNKEHENEMKIMQ
EELEKKSKELSEFLSIKAENERLKREQKENEERLKFQAKEEAFKEFKEQESKNLEFEREK
MRLEFQKSTQEQDLKYKELETNFKSVAQKLEDAQRRIEQGSQQLQGEAAELLIEEYIQSE
YLSDEVKEVPKGVNGADCLHIVKDNFGNICGSILYESKRTKEFNKEWLDKLKLDSIAAKS
DIAVLITKTMPKDKEKTHFKEGILICTFNEFKGVLAVLRESIINAYKLKNALQNKDEKNH
ILYEYLNSKEFNTQITFILKTYQNMKEELEAEKRALQNIWKKRERAIENLSFNSTAIVSS
LNAIFSDLQGGNLIGEEGLKSLENLAKDED
>fig|195.2248.peg.1617 Oligosaccharyltransferase PglB (EC 2.4.1.119)
VYIYMPARMSLIFSTVASFSFVDLETGEINKPFTFSAAYPLDVKNGEIYLSNGIALSDDF
RSFKINNSTISVNSIIEINSIKQGEYKITPIDDMAQFYIFYLKDSTIPYAQFILMDKTMF
NSAYVQMFFLGNYDKNLYDLVINARDAKVFKLKI
>fig|195.2249.peg.1067 Tgh102
MALIFPFLKAFYYEIARVTKQKYFIYAFNTYYLGLLTLIIGIGLVFLLASLVFWILAWVE
FKEFDKQEISNKEKFTIPTQKVIFDFDLKWIKITMVLSLVLFFVFIGLKFTQIITFQSIR
REFFDFETYGRLIHNLFYIRYVLFYIATFLALLSVFLFCKKLKTYKMFIYFLIWQV
>fig|195.2249.peg.1589 Phage antirepressor protein
MAEEKENIVKEVCKELNITQRQLSEMLEIPESTIARWKSGDLPRLTELFLKTMLENIELK
RKLETIKKAHKIISEL
>fig|195.2249.peg.882 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase (EC 2.3.1.202)
MIGLKDFTHLNGNEILLIWQWRNDEKISQFMKTKYIDFQEHLNFITSLKKDQSKKYFLVF
KDDGAIGVIDFINIMQDSCEFGLYAKPDLKGIGQILIQEIKKYAFENLKVNTLKAYVFKD
NRKALKLYQQNHFTIYDEDKDFYHICLKQSDCKALPS
>fig|195.2249.peg.1842 Motility accessory factor
AIVVSAGPSLAKQLPLLKAYQDKAVIFCADGALSMLEKKGIVPDYVTNLDFTDLAMKFFQ
NKENKTSLNILSCATHPNLVCLLDNKSVILRDDPLYQRFNLNDFGYIDTGTHVSHFSYTL
ALALG
>fig|195.2249.peg.1129 Molybdopterin molybdenumtransferase (EC 2.10.1.1)
SSNHIAIANLAKNLNCDTRVFPLLKDDEKATFSTLESALQSCDILVTTGGVSMGDFDFLK
KAIKEYEIIIDKADIKPGRHIKIAKANEKFIIALPGFPYSAMVMFNLYAREILNSWLLQP
KDYICKAFLQGSYKKKTPYLEFVACNIKFENGRILANLEGKKEGSSAIINNLNNKAALMI
APKECEILENESLVDIIFMP
>fig|195.2249.peg.754 Transcriptional regulator, YafY family
MTHDKLAVRLAQILMRFNNGGRFSLEELASEFNVDIRTIQRDLNQRLSFMPIKKENGKYF
LESFALGKLSVKDIQNFAMLSGIQELYPKLDEDFITDLLNSKVNSIFMIKNNGFEKVDYE
NFKIISVAILKHNILNFNYKEKSREVKPYKLLNYQGIWYLIADEDEKDKLKHFTFSKIKN
IRKNDEIFTPKEEFLDQILNDKNIWLDDSKEAIVKLDKKAKEHFFRKNILNNFELIDEDE
QSYTLKVYFSYDDELLNVVKQWIPYMKIEKPFELKEKLDSILKDYLEN
>fig|195.2249.peg.1833 Motility accessory factor
YGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEELCSGKIYLVDIEEERVDIQ
LLILFDMKDMFEYLSLYEMFVNNSFYKQFCEKTWCETDEFCKKNIEIVIRDSGLNSNLSF
QSYFHFLQNIPSMLESIPFQRILSERKNKFANAIVVSAGPSLAKQLPLLKAYQDKAVIFC
ADGALSILEKEGIVPDYVLNIDFEDLPLRFFKNKENKISLNMLSCTTHPNVVHSLKAENC
MIVLRNKALYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHS
KGFALGERIDHTLNLPTLQVPAYAGKGEVLTHIAWNDYRIKLEYLFACNDQKAKFYNATE
GGARINF
>fig|195.2249.peg.1535 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKAAIVTSNGPSMREIDYSLLPKDYDVFRCNEFYHEREYFIGKNKSCIFSH
>fig|195.2249.peg.1788 hypothetical protein
MQNSLEAYTMKYNENGYGLLFPDGHVVRFYERILKYKLNKINGNLLDFGCGNGVHSAYFQ
SKGFKTFGIDIVPSLKEIWEQNISGGGGYCKIIEPNSSIKGLFDENMDIIFANQSLYYIP
LKELKQNILEFYELLNTGGILFATMMSKKNYYFSHSQKEEKNGLSKVEINGRLNETSFIH
FIDKAQDLENLFQPFETLFLGDYDPINFYNFEGSAHHYIYIGIKK
>fig|195.2249.peg.1678 Molybdopterin molybdenumtransferase (EC 2.10.1.1)
MLMSYEESLKILHSHIKPFARVEKIALTECLGRILAQDIKASKNQPEFPTSAMDGYAIKF
EDQDKPLKILGLTPAGTMPEFKVENNTCVKTFTGSLMSEGSDTLVPVENVRVEKDTLFIE
KKVSKGFAVREIGENYKKDEILLKKGTKLSYSEIALLAELGFFHISVFIKPIVGVLSSGS
EIKDLGEALENPAQIRSSNHIAIANLAKNLNCDTRVFPLLK
>fig|195.2249.peg.1585 Peptidyl-tRNA hydrolase (EC 3.1.1.29)
MILVVGLGNIGKEYEDTRHNVGFMLIDLLLKEGNFTNLTNSKFKGELFKMGSSLLLKPHT
YMNNSGLSVKAVNDFYKCERIIVVHDDIDINLGALRFKRGGSS
>fig|195.2249.peg.1491 3-oxoacyl-[acyl-carrier protein] reductase (EC 1.1.1.100)
LASPKASFITGGLYLIDGGLTAGIPH
>fig|195.2249.peg.1821 Methyl-accepting chemotaxis signal transduction protein
MLSGLNPSTSFASISSKEQTAGITQINESVAQIDQTTKDNV
>fig|195.2249.peg.238 5-hydroxyisourate hydrolase (EC 3.5.2.17)
MLSTKKILLALINIPIFLNATEYQLSTHILDINSGQPASNVKVELYNLDQNRQWVKISEK
FTKKNGRIADFLPYEKQKIVLLEFINSNFIPKIIIYHIKLIVFTPL
>fig|195.2249.peg.1710 McrBC restriction endonuclease system, McrB subunit, putative
MLEDKYDWKISKADQNGNVYYYFPKDEDEFKEAVVKNGGMSVYIYQEGELIDEFHTKSRC
CKIIFQYYFVKN
>fig|195.2249.peg.1844 Motility accessory factor
NLKDTSIKNNGGGYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQ
NKNHQHIVVFEKDIEIIWIMFHILDFSSELQSARLM
>fig|195.2249.peg.1169 hypothetical protein
MQDASRKYLVVLHTMINYSVESYVDYLEMKERWVALQA
>fig|195.2249.peg.1849 Motility accessory factor
KDIEIIWIMFHILDFSSELQSARLMILQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSH
YYERFHED
>fig|195.2249.peg.1827 hypothetical protein
MDFKTLLNIKEKRLQECQELIKKLEKERSNYEIANCKNIKEINIKLEKLIKKEILFFENL
EYEKFKNNPQEFDDLEDEIYFYFDLYMINISKLELKELEFNSKVEFKKYEEHYEIRKDKK
DFIKLSKSILQTSKDLFQVAILAGFSIIIFILILHSLQTKTIPFLDSQKATALAITGVLF
GGIFSFFYMGIFSFSRELYKQYFKIPIRIPFIIYITSSIITFITLQKPNILLLISIAIVF
IVANGALYFFGKKYRISSNNFEIFATQTMLIFIIYIAIAIISVFIIIKSQEINYCYLGFG
CFIIFIFFSLQLCFKDFKSFKFFALINTIIL
>fig|195.2249.peg.1779 hypothetical protein
FSEGLAGVGLNGKYGFIDKNGEFVIKPKFDEAWDFSEGLAKVELNRKYGFMDKNGKIVIE
PKFDGVGNFSEGLAAVGLNGKWGFIDKNGEFAIKPKFDDIWDFREGLARVELNGKYGFMD
KNGKIVIEPKFDSIWDFSEGLAKVKLNGKYGFIDKSGKIIAKPKFDYGEYFSEGLAGVKL
NGRWGFIDRSGKFVIKPKFDSIWDFREGLASVGLNGKIGLIDKSGKFVIKPKFDSIWSFR
EGLASVGLNGKYGFIDKSGKIVIEPKFDDIRY
>fig|195.2249.peg.1128 AgrC, putative
MQPKSIILFFYGYILFFRRQQVLFVLGWNLRFILKLIMGEDVFIENFILDKIISVAYIII
AFFFFKTLVQATKEKLFYLVFAFFVCGEIVSKLFFAFIRLLDSIRLQEMIVEIIFYAEII
FYIGISFTPAYFISFLIVWLSLKGQKEVKKAI
>fig|195.2249.peg.664 FIG00973752: TolA-like membrane protein
MFLTQTFIYTLTPKFDILISGGGSYARAEYTNFFTNEYSSKNRIGFDSLWLGFIYTGDSI
ADLIPQITFQTAVVQREKAINQTKNFYLKSQSLQASLRGYSDCSL
>fig|195.2249.peg.1039 hypothetical protein
IIFLNENITSYLKIGNFKAEEMTLSKNKIVKNKLLDNNISFIENEEGLKVKDLYILSDAK
DVYYVQSKKEENKKLKKSFLIDKKYVLDKDF
>fig|195.2249.peg.1840 Methyl-accepting chemotaxis signal transduction protein
FFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVETVGVVES
GNLTARITANPRNPQLIELKNVLNRLLDVLQTKVGSDMNAIHKIFEEYKSLDFRNKLDNA
NGSVEVTTNALGDEIVKMLKQSSDFAN
>fig|195.2250.peg.1796 Motility accessory factor
KLEPLSLNKQNEFLLKAYYKVCKSIKHCRDFNDNFIKVYDKIKNSFTSLQNSQKNEIFIQ
EIIQDIDKTKTQIDELYNTQKDLIQILGPLLTQFELKLARIYVLNPKTKEDAFNKSILWI
KE
>fig|195.2250.peg.1041 FIG00387915: hypothetical protein
LEDYEAFEREFKNEENQSPSLFLN
>fig|195.2250.peg.1665 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYGIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEF
>fig|195.2250.peg.803 L-lactate permease
MISPQSIAIACAAVGLVGKESDLFKFTLKYSIAFIILIGIWTCIIAFFLQGIIPEVVAK
>fig|195.2250.peg.1555 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase II (EC 2.5.1.54)
HQQYTDISEKISQALDFMEACGINTYNTPSLKEVDIYTSHEALLLPYEEALTRVDSLSGE
IYDCSAHMLWIGERTRGLDEAHVHFLSGVRNPLGVKIGPNASADDVIALANALNPNNEEG
RLNIIIRMGAEKIATQLPKIFSKLKKEGLNLVYSIDPMHGNTVKAGDFKTREFDKIMQEV
RYFFEIAMSEGVYAGGVHLEMTGQDVTECTGGASNVTAQSLEKRYETQCDPRLNADQALE
LAFLIADLVKKARK
>fig|195.2250.peg.1600 RloF
HYIINQNIPDKPTLADEDNSNYLLYKAFNFFQKKIKEKFQEEDGKIIAEYVEMIGEQLKF
IVIIVQNELDAYVLFQTLNARGVELTAADLLKNYFLNLLKNEPEILNQANLMWENINNKI
STEKIPDFLRSVINSQIDLVTKNRLFKEVKKNIKTSEEAFNFISKLHKLSSLYLALQNSN
HSSWNDFTAQDAKYYIDILELLRFKSSLPLLLIAKEKIVDDQDFIKILKACAILSIRYSI
SKTRTNKLESSYNKIACNIFHSKYKNTKEIIDALKSIDIDDNDFKKSFSIYSKKATSGND
AKIVKFLLVNIERHLSGGICDEQIATIEHILPSSLNNEKVHKLGNYILLEKKYNQELKDK
KFEEKISIYNKSSFKLPRYIADNFKTWDTKSIDQYQNFLAKQALALWKIQ
>fig|195.2250.peg.443 RloF
MSNSFLNTETLTLNDLFGKDRTYSVPKYQRNYSWSEDQWEDLWCDIEDLEKSNYPHFMGS
IVLQETKDAKNIDIIDGQQRLTTLSIFMSAIIFYIDNLVKKDKDKTDNEKRKEIFNKKYL
GYESSTTLKIVPKLTLNNTNNNFFTHYI
>fig|195.2250.peg.248 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase II (EC 2.5.1.54)
MTWTKNSWKNFSIKQQPIYSNQEELNKVLNKLEKLPPLVFAGEVRELQSALARVCRKEAF
LLQGGDCAESFANFGAVNIRDMFKILLQMAIVLTFAGGCPVVKIGRMAGQFAKPRSSDYE
EINGVKLPSYRGDIINGFEFNEKARIPDPNRMLEAYYQSATTLNLLRGFAKGGLANLHEV
HRWNLGFLKKSELHQQYTDISEKISQALDFMEACGINT
>fig|195.2250.peg.1771 hypothetical protein
NPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTKINFNLNKFDIHLA
LSFAISLNFIAKNEQNKLYKFVLENNKLIYDYIDFINNNFANEHFIKIKYKRKKYKIINI
ASFLLYHKLKPQKESYQNEFLEIYILINDYIKLSYETNNLINLNINSINRITNEHNVLTI
ELEKKQIPKNKKLKIKEDFINLKLPEEFKLIETHKELYLHGMEQKNCVYTRRREIEDGLS
AIYSLNYEGGVYTLEIFKRKNKFAIKEIKAKYNEFANKEVINFVEKSLKAV
>fig|195.2250.peg.1798 Motility accessory factor
HHVWLMFKRNLEQDVQKIQKYLDTKVYNCTEGGARIEGTIEKPFLWACENLLHKDLNKPF
EKLEPLSLNKQNEFLLKA
>fig|195.2251.peg.1792 Motility accessory factor
NHQHIVVFEKDIEIIWIMFHILDFSSELQSARLMVLQTSSLDIEFFSNFCSSKPFFQFSR
IYFLELMSHYYERFHEDILGLNKKLAENFKNSIVSHGNDPLDALQGIEQFVYNLPQMITH
PSYKELLSKRKNLSDTAIIVSTGPSLTKQLPLL
>fig|195.2251.peg.1799 Motility accessory factor
FNIDENLNIYDKTHNVFMYENLEEELNFFYQSILEKTPRYPFVCIYGIGNALLIKNLAKH
YKHLFVFESEIELFILALSTIDL
>fig|195.2251.peg.1759 Putative amino acid activating enzyme (EC 6.3.2.-)
DIICFYESEEEINFKDFLKDKLPSYMIPKNFIKLDKFKLNQNGKIDRKVLKELV
>fig|195.2252.peg.1763 hypothetical protein
VYILEGYFTRKHFFQEYGSKIFSMYDEIKDKDYTSINKLCKKYRCELSKYKK
>fig|195.2252.peg.1746 hypothetical protein
MNEEINSNENNLFEIVNEDNSKNIAMQNYNELLEKFENLIKIIIAKINVGKQNAQNNTED
GIFKDLESNIIELDNTY
>fig|195.2252.peg.1205 membrane protein
MSFYFVFLCMLLAFLFFEKLSFLFFFLALHFLTFAYAFDRYETLKKLY
>fig|195.2252.peg.1725 Transcriptional regulator of rhamnose utilization, DeoR family
MILDTITKIITLDRITKIITLDRITKIITLDRITKIITIVGFCLAFFQLRNVIKNTKVNV
LKTEFDIFGKISEKEKIFVDCYEQSMLSSEESKTQEYYSLYKKSKEQYLSELNLVCLYI
>fig|195.2252.peg.1774 hypothetical protein
MEQKNCVYTRRREIEDGLSAIYSLNYEGGVYTLEIFKRKNKFAIKEIKAKYNEFANKEVI
NFVEKSLKAV
>fig|195.2252.peg.943 Integral membrane protein
MERNIYEIELEIPNSGIFIMGLENENLIISLDLAKFECKKKLNAGELAKPLHPYIIYEVL
EKNNKNNFNGVKIIDKRENENNIIYYFNFRLILKENEDNKNKEALKTLSFMQNFIPAYFF
SYQIIGDSKAIPKNVLEDLKNRYGYEGKNYKSIFKKEVYINCNCLERLNFSHCEFESKVS
LRFLKDNKYKEFHNGVNFSNCIFKNEVDFSYFVSGTPLPDNKYYNNAQNTLFKDCIFENK
VDFHNSKITNNIYFNNSHFKDYVDFHECEFEKTASFYGVRFEKAPNFSACYFKEPKAVNL
INVDIDKLDFRSAEDYIQDNYQDGNYKNAIKNNEKIQKDEKELYRIENEHKLRYAKNLKD
SFRVIKDVLINQNNTLEAQEWHKLELYAKEKENHIDLSVKDIEKNPDISKNILIWFNCVL
LNVYRNTSDHHNDFLKILNFTVGMIVLYGVFIFFCQACIEPYSKFFNELKSSVIFIIIGI
LVFLCCIMFYFNRKKSIFAKSIFFIIAMVFIVLYLVTYFYKTNEYKTILYLVMCYILSIY
ICYFFFNIKNIIFNIVFKFMLYLVFLFFLINSSQLINPFTGVFSSGKLYESQFEKSLNDL
NASAIINLAKISFKEFNLNQEYKNISFTELNSAKALIVANKENLLKLNDANLNRAKEVLG
EKYTELLKTINQDKITENTIKSTSVLYSIILLLCIFSLQKTARKNSIVPS
>fig|195.2252.peg.1118 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQELANQEL
TQIALLESKSFRFIMMGIIIIALIISYSYCLFDSEIY
>fig|195.2252.peg.1117 Putative methyl-accepting chemotaxis protein
MRYIKKSVGGEPRDVNRIITEVANGNLTQPIHTEYKQSILYSISRMQDHLRNIVQKMITI
SNELNHKADLVVDRISETEKAVIFQGETSRESALKIREISQKTQNVSKMALETEENSKNT
TQVCQNNKKYAEDTASQMEYIASNSSRVSQQIALLSEHAKNIGTSTELISEITDQTNLLA
LNAAIEAARAGDVGRGFAVVADEIRKLAEKTGEATDQIAIINKQIQEETIATVGVIEESI
PLISQGKSLSEEVRDSVDLIYKQANDSLFKAQEVNQEVAAQVKLMEEIEEKIITVADISS
KTQQAVSENKNAMTELKNISDNLQAEIAIFKL
>fig|195.2252.peg.538 FIG00472472: hypothetical protein
MDGVIDNSGVCLPFLAHILGRDMNQGEFVFEGDNNRIYCFVQKYWTRNINSSYYFGDENY
LIRAVLNSNHLKIQASMNNNTNLYKLSQHARYGRSSAK
>fig|195.2252.peg.539 hypothetical protein
MQDMGAPVQNKIELYKCYQELGYDATLYLVKDENDIDGRFIKSLEHGLRMTDKALFRKEL
PLMLEKLQGRKFDMSKNSITYPCKDKQFIFKDKDDKFELEIV
>fig|195.2254.peg.2016 hypothetical protein
MNFQVKTLETFNPFESLNHEQANTEQILDFRVIDFKLL
>fig|195.2254.peg.1719 FIG00469806: hypothetical protein
MKNYYISEGVKALFSIYFKDQTEENFIKALNEFAKESQINSQEIKDKSFREFKEAISKLP
TIDLLNTRFDKLEYSVCAKLDKLEYSVCAKLDKPEDSVCAKLDKPEDSVCAKLDKLENKL
DSFKREVRTYVIILAALMFILQPTIFDLILSIFKSFLRQ
>fig|195.2254.peg.1453 Protein containing aminopeptidase domain
MDKLDFRSQDFSQTGKAMYELACELFPIPRSITGQGFRDSLEILNKTLGGGGILKFHSIK
SGTKVFDWIVPDEWNAKEAYIITPEGEKICD
>fig|195.2254.peg.622 probable periplasmic protein Cj0413 , putative
MKKIKILVFLIFFCQFSVLANNLPQNIKENLGINQFLDESLKEILNQPLKEKFALTPKGE
YFFESNLSLFQKQYLENNATACAYLGREFAANTRLPLDLNKALLLFQKACKLGRLDSCVR
INNIKFKLLKKLDEETYQSNLKYFLDQNSSFALLEHIATLSKKDIKSAIILAKKSCEQGH
DAICTGLSYMYACGQGVEKDLIKAKELSSKACEKDTKLCFAQGWVELFNQNDILAQKLFY
KSCQAGYYTDCNMAVDKNSKDQAMQLYLIKITQKNSQNQCQNSSNKQSFACHKASALSKE
ILKIQLKKISEKLLFTILI
>fig|195.2254.peg.1996 hypothetical protein
LYNTSKDKTGRYIEDKNKTRRLLEKLNIIGQNNLKAMYMGINENKESLKNKDNEEGNEED
IESVTKNKQSQKLPPNFIGRLATTIIIEDGLYMG
>fig|195.2254.peg.356 FIG00470547: hypothetical protein
MYCYLMYLKPFFVVDAIEKKLSSENIIWLDFGFNHRDEFFTNKAEFNFLLEKPKNINDKK
INFFSIKNEEKNTIPAIYYNMEIFITGSIFYGNINSWKIFKQDFEKCLNCFLSFNIVDDD
QIMLLWCTRNNPDNYKIIRTYEWFGSLLSFIPDDIKSHLTFKRKNSKYYKTIKEEIKKDI
YNKQYFKFLFHSLKYGYYKFINKKNIDL
>fig|195.2254.peg.730 hypothetical protein
MELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTAEAGLEFSKTEKISDELS
HVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTKYEDIKTQSSTGFGLYIK
ERIEATSPIASAINSLLLSINRLKMQLLRMKI
>fig|195.2254.peg.1957 hypothetical protein
MSKNIKTQEAKLDLITKFLDYADIADASYAMLQYVWENIEQDEKNNIYKADKLTFGDKLK
QDIVMKNSKGEDIVKPKNTNTAYACAIQARFEQNKIVKIEPKYCISLINTCFDSKEITLD
NDISRVG
>fig|195.2254.peg.1565 hypothetical protein
MISVTLLFFLFGLNKLMCGFLFNAKNTIYKLLSYVKIHAIFINLRTLLFLILVLLAFNAD
LSYMGIVLFLVDLMTAISIFFAYAQLAYGFSIKDCMVYLIYGKIDKKWLKEIQK
>fig|195.2254.peg.1972 Glycerate kinase (EC 2.7.1.31)
MYEKQAKYMKLYKYARMCWASYFYFDFLNTRNIFELDFNQEKIQEENSLRGYREIKVNLE
>fig|195.2254.peg.761 Fe2+ ABC transporter, substrate binding protein
MSIYFVHFLSSILPLSILMAFITPDKRYIFKSFLALFLGFLFGYFAFFIAAQFLKTENLI
FNFNFIFIACLLLSFVFYFWQKIEILSFILLGNLSFCIALHYYNLTQDFPIFNGVLIDSE
AISSLGFIALALLICILIFFFLKWQKNINKKASFILFLILIFIEGDKVLANILLTLMRNS
FIETHTFLVSFV
>fig|195.2254.peg.1993 hypothetical protein
AIQARFEQNKIVKIEPKYCISLINTCFDSKEITLDNDISRVGLNDALSKRTIDFVNRFKL
LKHQPNTTNCLMKKTEKIKRS
>fig|195.2254.peg.1740 Single-stranded DNA-binding protein
MINNIIIGGRLTEDAEIKRTNQGVAICNFTLANNRKYKETEFSTYIEVSLFGAFAEVMQP
HLKKGIAIDVIGELMQDVWDHEGKTYYKHKIKAKEIDFRTPKKEKQAIQNIEEGENYEGF
>fig|195.2254.peg.1960 IncQ plasmid conjugative transfer protein TraG
CANASSYSKSFNYKPQVSTKELMEQVEKI
>fig|195.2254.peg.1773 Integral membrane protein
VIISMGANITILNPFIGKLINDKIFSNDPLFIYLTFAYTILIFLVLFSLQKTARKNSIVP
S
>fig|195.2254.peg.183 Putative periplasmic protein
MSKKKLVQIQRYLIIAILFLICVILFLGILIQYQDSQNALKFAQNSSKNITIEPKQENIS
NENHLGIFKEIPYKDENDNFQENNQSILEEQIKDLNLSSIIDGNLSKIDENLSLVVEQNL
SKEENLTKDMNLSKTKQARLAIIIDDMANISQVRALQALKLKLIPSFFPPDKNHIDTPKL
ALKFDFYMVHLPLAAMNYTKPELDTLNPSDSEKRIFKKIQQVKKDFKDLKFINNHTGSLF
TSDEKAMKKLYKAFEKEELIFVDSKTIASSKAPKVAKALGQIYIQRDVFLDNRDDVAYIK
NQLIEAVRLAKQKGFAIAIGHPRKNTFKALEQSKDLLKSVELVYLSEIYAK
>fig|195.2254.peg.2005 hypothetical protein
ERYKYLAIRSGLRSVVIDIPYDAYANVDEKGRLVNEDYAYIYDEVSSHRGTLKSYSFFNE
WELSALLLGNIKASPTAAVGFKARQQQALFLQAQLGDKNAFKSLGLAVLCSNSFLTGQHW
>fig|195.2254.peg.1854 hypothetical protein
IIVLIGLFNALKSVRKYKEILKKKNYEY
>fig|195.2254.peg.1998 hypothetical protein
GDKNKFLKEFEKLKEEVKNNPAILHKDYYKERK
>fig|195.2254.peg.1598 hypothetical protein
MRLDTEFNGNIEDDIYPSDFEEFSVEDVVWFYEALSEKEQNEFLHRIKKSKSTDPEEKIR
ELFDELNNDETVMLLKELNEKFKSFEEWQEIVKSINNIEA
>fig|195.2254.peg.1936 hypothetical protein
KEVEDTIIYQNALIYDYILSADNPNSQIIKYLVNRGAKFEVHKDDFGWTPMHFWVMQNNY
ELLELAIKGGANVDMQTLLDPKSEYNETLLFEAVKEAETYRVTQLLIELGANVNFATPRT
PLDDAKGSRNKKLLKDAGAMTSEQIRKKFNLPAYDSSHCEIDGKTDFDLLGKYHDECSKL
LNDAIKKAKESE
>fig|195.2254.peg.1216 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MLHIAFSCSIEYIKYCAVVITSILMHGDHKEEYCFYIITSSSITKSMVDRIKAFEKKLNE
NYTVNISLFFINEDEYKNHPIYAGSTASFWRLKVAEALPVDVDKCIFLGVDVLVLGNIKK
LIEMDLQNKTVGMAPDCFNFKGFLRSMKSRDVEKLDFIFPYPEYYSNVDVMLIDLKQWRQ
KNISQQCELLFQQYIPKWVEQDLINAVLGDDIYELSPRWNFWIGGHYVISRLGKKITFKG
ESLKPYWKYTRSEFEQSERNIQIAHFTHCCRKPWVTPYSHLDQDFKFIKYPYYDTWWHIA
MQTPVFKKELIEIYRRIENNKVDVYQNTVVPQIKSLQTTIKNNEAKLVQMQTSLSFQTQY
GTAKSRIQNQLSYKLGQAMIINSKSLLGYLIMPMILLNIIISHKQAQKAYKLKIKKNPNL
ALPPLESYPDYKEALKEKECLTYKLGEALIKASNNWYGGGYIKLLLEIRKLKREGRKVRK
>fig|195.2254.peg.2010 VgrG protein
KDIESERNTIYTDEHGRVKVRINLYANQEELDNDTFIANDIDTNSSNLSSNTYKSYHHTP
FLRVASHIASNHSGFFHTPRIGDEVIISFLDDDID
>fig|195.2254.peg.903 Glutamate 5-kinase (EC 2.7.2.11)
MQRIVVKVGSHVISDENLLNLKRFENLVAFLTKLMQKYEVILVTSAAISAGCTKLHIDRK
NLINKQVLAAIGQPFLISVYNEFLAKFGKMGGQILLTGKDFDSRKATKHAKNAIDAMIDL
GILPIINENDATAIEEIVFGDNDSLSAYATHFFEADLLVILSDIDGFYDKNPSEFSDAKR
LERVEFIKEEWLNVSVKTGSEHGTGGIVTKLKAAKFLLENHKKMFLASGFDLSVAKAFLL
ENKQIGGTLFERL
>fig|195.2254.peg.1571 hypothetical protein
MLFFGVYTLFISILLSILLSIESLIPSKYNYEKQLVNVILKPILLLLYVVGLKITNIKNS
MMNFSNIKNFMIM
>fig|195.2254.peg.1573 hypothetical protein
MTINQKTAIRINQDFKEKYNQLWRKNCLLRENEKRLEKLKPLEEIFIKVCNTVHNLSWFF
YNDLKKQDAYYSYCLKIACKVYSDGFKSEYQLKKMIKQEIKKDIEIRKQSI
>fig|195.2254.peg.1992 hypothetical protein
MLEFFVNLLIFILIFFFFVFIFSIILYFIFKVFFKIKNKTKTINFKTIFKKFTLFLLPVY
LLLFLVGGCSYKYMDPQYYEFK
>fig|195.2254.peg.1948 hypothetical protein
MGEIVKYHNDFNKIKLPSFTEQEQNLLCFLFTKIKEKKENEIFSIYPKDLIGFSEKNLSN
KEITEILTSFEEKFFKADFTIIVKDEVKNLIGKMRVNLFNHFVIWKEFRGEYNMEIGMYD
AWEEFTRIDIEVNKHFEYLINQLTANFTAFELAEFIALSGKYTKSLYRLLKQYRTTGKVY
FEWEEFKRIMDIPENYEIHNIDKWILKPAIKELSKERNLFDQIRVPFKNLAYEKEK
>fig|195.2254.peg.1905 hypothetical protein
MSIIIANRTDGTGSRLISLMNAMYLAKILNKQVKFTWKNYIPFTKDSDTNNFRKVENDNV
SILGLC
>fig|195.2254.peg.1835 FIG00470597: hypothetical protein
MKEINIIDFGLMGKQISALFYLLGYEIGVYNKSKLNIYEFEKQIKLLQRKIDFSNFNAGK
INIYQHIEDLKNSLTIESLNEDLNLKKEIMQILRDNNIVFSNSSSLSMDDLNCDFIHFFN
TIYIKLIELCGSNLERFTPLKDLKKLGFHIICSKGNRGALANLLLFNEISSFFKIIEKYD
YNFKECQTVYDLLYEKRNLLNIIDTIGIELCNKICKNLKEDDENFYHPKIFKKAL
>fig|195.2254.peg.1899 Integral membrane protein
MEEKIKQAIENIAKNLEVHKEYIRFDNTEQIYIIEDYLDNKIIEIKKDIKFDNLMDYPLK
FSYCNFLETVIGWNKTFKEKIIFKEVVFCKVVNFSFSIFDKNINFSNVKFEDKLYFEKCQ
FKEKFEFFGINNLKVEFNNSLFEKEVYFGKEINDKNIEKSNSFGSCSFEYANFSNCYFKN
EVYFKNNEFKQVFFRNSKFNDNVYFNNSIFKDYTDFNECEFEKTTSFYGVTFEKTPNFSQ
VIFKGNLNAINAKLNFTFDDLQQRIKQECTSYESQRTTKKAGVIPNLYQEKSLDKFANDF
RDSFRTFKNALIKDNNLLDASNFHKYELYCKEIELKQNWDKKGENVKNTTDLEKNVSRIR
DFVDFLLLGFYRKLCDHHTDFLKVFNNLILLISLYILFIFVGSFEFDLEKKSIQNLNKTS
DMFSYLTKVKEVIINFSFMQQYYNHILISFVAVCFICLIVIFYKIFKNIKLDFIIIKNII
FKDIIKSILIL
>fig|195.2254.peg.1970 hypothetical protein
IKYDRIRWEGGGGKLGAAQRRRREKSKEKAKMLLYLENENKKDSKIKQISISNIPKKPHW
RESEEDISKLYHDYEKQKSFLNSKEVPYGTKHSVRPDLYKNGSSIEIKNYNLDKTYSANN
LINIITKQYQQRLQHLPPKTEQIFIIDSRGQNISKEIQEKIKQKIRIKLNCDILIQFKTK
>fig|195.2254.peg.1913 hypothetical protein
FLAPAKMQNLKLQIAQGLDEILEDEDRKQELYVCKFVVVNGVKI
>fig|195.2254.peg.1974 hypothetical protein
LINTCFDSKEITLDNDISRVGLNDALSKRTIDFVNRFKLLKH
>fig|195.2254.peg.1924 hypothetical protein
MSRVIKINFTDVNFHIKEFQKVYILENCKLYFYKPFHLQTEDKNNGKEFEDKNRTIHKEQ
EIKKINSQDQLNEKEDITKDYAQKIDKEINKFDENNFILQTKKQRQIDPDNYDIFYDVYT
SKDNKDNSVNKKLGCGDGFEVNNGIAEVGAEFFDKCFE
>fig|195.2254.peg.355 FIG00470547: hypothetical protein
MQKEITIVTAFYNVGRTTRSNEQYLSYFDFWAGLKNKVIIYTTDDMKEAILEIRKNII
>fig|195.2254.peg.1979 hypothetical protein
MSKNIKTQEAKLDLITKFLDYANVADASYAMLHWIDYVKKENDKKHENGDTQRLGDKHNN
QNSTYARAIQARFEQNKIVKIEPKYCISLINTCFDSKEITLDNDIS
>fig|195.2254.peg.1725 hypothetical protein
MVISQDLFDVLNEDFTKEYEFIDSPTLDDIVKHKQSDEVFKVFYKK
>fig|195.2254.peg.1754 hypothetical protein
MKEIIDINNSNIVSTVYGIEKTNIDYTTGEIKEKDNILIKKVKKKDEFIKMMALNLQFLA
TELENSEKTVLFLLMSNMNYKNIVNVNLDLRSEIIHKSKLHRNTVSRAINSLQEKKIVLK
LDTDDLKKAYDVFAKNAFLINPNVIGKGSFRDLRNLRQTIVQNFNADRFEMTKEVFTEVE
YKGLQEIKNNKEDYEIKAIQQTQNNNEKNTEIFLAKKGNVNVLENKQPTLFDNEENNKEV
LGDFWSMCGILTGAYHPTKSAKELKREKLDQDLKEGRI
>fig|195.2254.peg.1788 hypothetical protein
MNQGEFYFEGSGYRLYCFVYKYWNRNMNSSYYFGDENYLIRAILNSNHLKIQANIDSDIV
FSSYHSLQDTRASAQNKIELYKCYQELGYDATLHLIKDENDVDGRFIKSLEHGLRMTDKA
LFRKELPLMLEKLQGRKSFMRENSISYPCGNKVFAFKDVGDKFKLEIKD
>fig|195.2254.peg.1606 hypothetical protein
MQEKEEKYIQLYKTQDKILDLVAKENLDFYLTGGTALQRFHYNQFRFSDDLDFFLINNGI
KNHTPKEFNDFTSMLQDNNIDFEIKVSNQYFTQLYIKENNLKIDLVNDYVFHEKNDYVKL
ENGLLIDSIQNIFVNKLETSISRDEPRDLFDIYTILTNNKMDIEKSFDILIKKTNIDPKD
IINKLKNIKIEQIQYNKINTKSDFILKDFLQNFHKTVDENFNSYNKKQAIDKDISNFKKN
LQYYIEKADILIPNTKKDLEEKIKTSFSKLNNFENANIIPKGTLKEALNQKELDLCQKIS
NQSKTKER
>fig|195.2254.peg.958 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDEYFK
PIINQRLEFKKNIFMIFLDDG
>fig|195.2254.peg.1919 hypothetical protein
MHAENNLSPEDRQGIENAVLAKKDIIPDWIANFNRQDIEDLQDKTQYLRDTVDRLKNTVN
SYSKQYPTLEPIARKIRIITKPTENTLKIMDYSLEYVLNGERSVVIKAIAEGVETIVYTV
GISATAIAAGIVSLVGILCPDSAPLVAFGAFVIFTQGEELSYYISQKAKKIIINFLNPKI
QYFPQTIHLGNGQYYKNDKNIDEIFNNIYEVLGLSLFTPHPYPRYSKEYEFALAKKKELI
TKTSIASNSYNFMDEEYLKNIQDLQEQDQIIDQEEQKYQLALKLYKEDSKIKNEIFNSLF
KSLNKNLSFQLKQERNTFLNPNQSLNIIATKKYSLKTLNLQDIDNININSEFAYLRTLFL
CEAFLVLDNNDEALLNEKIAKEILEYDEDEYILFIFHKTKLNDTYLKARKELYKSIDEFK
KLGFKDLENAYQTYMNSL
>fig|195.2254.peg.1953 hypothetical protein
SIKGYPIFAIPKKNKIKFALAKIQASPLAKIKYDRIRWEGGGGKLGAAQRRRREKSKEKA
KMLLYLENENKKGKVSDKEVHLYKHNGIWPKDTPKPRSPGYIGENGEIILNIKQRAMEIK
NTLNGGYNSVSIKTKDKLTRYDLDGKPHYEKTSKKIIDTPHKIEYTKHINPQDPTKYRMS
QGLVEPISHKDLDIVENYLKRQNNEI
>fig|195.2254.peg.1933 hypothetical protein
MAKKRTILIPRIKDINITPDTSCMHPILEDNTLVCL
>fig|195.2254.peg.1999 hypothetical protein
NVDMQTLLDPKSEYNETLLFEAVSEPETYRVTQLLIELGANVNFATPRTPLDDAKGSRNK
KLLKDAGAMTSNEIRKKYNLPAYDDSHCEIDGKDDMDLLGKYRDECSKLLNDAIKKAKEN
E
>fig|195.2254.peg.1709 hygromycin-B-phosphotransferase
MKSDYSKESITEFLSRKYGEDIRLFPIKEGQESQAYWFSRGGREYVVRINSNMEGFKKDK
YAYEHFRSDRVPIPEVVETGNFDGTHYFCISVKADGITYEDSDEETVVRLLGDITDVTEA
ISRTDISGTSGCGVLGEKILSPAEIYRANFML
>fig|195.2254.peg.1980 hypothetical protein
KTINFKTIFKKFTLFLLPVYLLLFLVGGCSYKYMDPQYYEFKKLCKDNSNKMIVFNKDYL
DLKKQFIQAMMNNSNIRIKNNGIKYFYNEKLNLEIQPSNWKEIETKSREIKLGIGKVKEK
EIEAWYIDDKNNIKYQEFKRYLYYNYNIFLRGDEGAGFHFEYEEILDCEDVR
>fig|195.2254.peg.169 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNNYIYVDDY
LARNYNVAVININYHCIGNRPHLGSSFYLDDIDKIILDTSLKTINLNHINVFDINSYENL
NNAFIRIDQEIQKLKLNQQLHQNYKLRTHVSFLPSKNEYQNFGIMQAMDILNAIFYIKEN
SPFKLMGGGIRTILFGNSYGGYLANLCAKIAPWSIDFILDNSSFVNLFGNIFRLIGFGKE
IDFTRYHGTYDDTLFKNIFLYLSDKTYWNNNKFSKKYFSNARKIIREPLNKEHLKIQSLY
PKPKYIAYHSKFDQYVLLEKRENYFNILRELGFEVDFIKITDEKEIDGKFIKNLEHGCGI
PMKLLIKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENHQIILNITN
>fig|195.2254.peg.762 Fe2+ ABC transporter, substrate binding protein
MQIRKKNIVKKQILDIVYRKNEAKNTLINRYFSSVFISCILSFCIILYFFMVSSKPLSID
EPTELLPDKNGKFIFDVALLRDNKLHRFAYISEQGKVIRFFLINKREDRDSPVAVFDACA
ICGDMGYIKKEGELICISCNVRIFLPSVGKTGGCNPIPLKYDYDGEKITIDVKDVVAGSN
YFSQIKDIQVQDPVSKDKIINTQAPFSYSYKGITYYFSNEKNYEEFKKDPMKYVEDTEAL
FLIQRRNNAS
>fig|195.2254.peg.2000 hypothetical protein
ARQQQALFLQAQLGDKNAFKSLGLAVLCSNSFLTGQHWNKLRAKMIYDLHDYHYESLLDE
FGMLPFLDEIIGVDWVIDLNRYKFALDEEGRIIWALYDDIEKGKLKDPRDIDSTPESRKE
FDHYMDGYKNGMATRFDVD
>fig|195.2254.peg.1932 hypothetical protein
SIKGYPIFAIPKKNKIKFALAKIQASPLAKIKYDRIRWEGGGDDNKQSSIQTHHIATDKN
KRFTKEFRKITKKYNMELDEDWNKVKMPHRGRHPNEYHEYILEKMSKIDKITRGDKNKFL
KEFEKLKEEVKNNPAILHKDYYKERK
>fig|195.2254.peg.1884 hypothetical protein
HKTKLNDTYLKARKELYKSIDEFKKLGFKDLENAYQTYMNSLIVNKEINSKDETINKNKN
KEINKNLNQDENSNQESDTKENTNSIKEQDFYLLSSHSKNLNHFILENKDKNKKIIFLNN
ASSMSNLIHIYDSHCDIFIKNESLLDIKKIEKEYDIKFKEFNTRVFFYEKLLLGAKENNE
FSFEEKEENLLYYFKYDKEDLNSLGDLNIKYNNHNAKIKNYSLLEDTINKIQKTLDECK
>fig|195.2254.peg.1922 hypothetical protein
KDIESERNTIYTDEHGRVKVRINLYANQEELDNDTFIANDIDINSSNLSSNTYKSYHHTP
FLRVASHIASNHSGFFHTPRIGDEVIISFLDDDIDKPYVSGSLYNGATTMPQYNYPRYKR
EIATNALSYLSVVPAMIDKGLDTLKLQENTDYELSSINNHYLTLANSTVGVDNTNARARN
EITLKNDKDKEEIYILAQKDYKEEIGNNYEQTIKNNKTSEVGALYTEFITLGHMQNIIGF
KNVNVGAEYLENTLLSKDTNVGLSNTLNVGISNEVNIGQNHEEKIGNDKRVIINNNLEQD
IKNDFIQRIGHNKNETIKGSYVLQTNQSIKFHSKKDLSIETNEYFKAEADDSISFKAKNN
CSFTADEINTLANKESTLIAQEQIISQVGENTTITQTKDKIILQVGTTQVIIDSKGLRVK
GGDLRAD
>fig|195.2254.peg.1872 hypothetical protein
MIGKDFLYSIHKDKKSIYLFCENKSIIDCQSIYEELYKLEATTDFTFEELQNYQAYIFLN
STLLTGSNELPNNPFYFGELDQDNTIKQDTPSYYFSPK
>fig|195.2254.peg.1730 IncP-type conjugative transfer protein TrbM
MKHFIFGVKKITLALGATLLISNNAFADDVLTGDTRLACEAILCLSSGTRPGECSSSLAR
YFSIKFKKPWETVNARRAFLNLCPVQNDANIEDLVLNNLVDDVLPASDPRQCTPEYLNTQ
VEQSNNTYLDELLGNRSYRIKTTMPNFCYSLINHEYTDYKTPKYKCSGEFYSALEWRLSA
RLELVNWQEYQSLNDSQRYAISRSCGDNTCYTYFKKTPFSKICWTY
>fig|195.2254.peg.1951 hypothetical protein
DVYTSKDNKDNSVNKKLGCGDGFEVNNGIAEVGAEFFDKCFEKGIYVLIPRLVSSDKNEE
LHFDPVPLEDKGFVVTDFRKGKKGEKNIDLSFQRNIAKIKNPNLTLQSPKEFLQALNENK
EFTEDDKIQQAQAIKKACGKKADEITKILLKDDKSLKDVITDEKELKKKIGKLQDKQNKS
TKELSLLGRLEFLQRNQDKAKDYKKTIKDLQNPQQASNANKNNTDDNKKKKLTKKNQNQE
EQKNKNINSKDIGDAGEYAASMLFTKRSTRYLSNRRKLDANFNTKGFNHTIPDFLVTLND
YPTLVEVKNVQDQALTEQISFELKLAREYELDYLFLCNHYTKLIDNITNLEIFNKDNKNH
KGSRSGFIYHRHAHRSIKTIFKEMYLHHIKGAAPNKIIIKRLNLNNSANIEEELNKNKQI
QKN
>fig|195.2254.peg.1944 Motility accessory factor
LYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDKEGNSHSKGFDFGEK
FSGEENIDKLKVPAYAGKGEVLTHITWNDYRIKLEYLFACNSKEAKFYNATEGGARINFT
EELSFKECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRFLDDALALK
QILENILSKDFILPLEFLEKVYQNIENFNHSLDEDEFIQDGILKAVMYERGLKISLVYKE
NIVDNASFITAYIKAYHEWLLYFMEKLGQRINIIINSFKEI
>fig|195.2254.peg.1863 hypothetical protein
MDLSNKDTEFSIIQPKKTAVLVDLSFLLKDTIHAKALKQWKPQN
>fig|195.2254.peg.1977 hypothetical protein
MNEGIEIHFAKVNFHIKEFQKVYILENCKLCFYSPFHLQTQNGKEVKKIEKKGKSKIYLI
DEDGKTVDIDKTSEQNKIKAREETRKKEEKSKNVLFSNDEKGNDAINAYFGEKNIDTLNK
AYEEREAKPLSRNTENFKDYDVFYDVYTSKDNKDNSVNKKLGCGDGFEVNNGIAEVGAEF
FDKCFE
>fig|195.2254.peg.1918 hypothetical protein
LKKLMVLDLASEYGTYIRKLILKEARTLNINN
>fig|195.2254.peg.2018 mobilization protein
RIEKELKYQRAFENSFEQTKTKRNDRGFGFSR
>fig|195.2254.peg.1906 hypothetical protein
MYNFAFCAYNSSCYIFVKEFIEDQQSIEKYCIKTKIEILKNLVEIKDVKNVFILAEQLLE
GEAIIQFKLRYSLYIDNEELFYENYKILINDFAKSKESIFEKLLLFQSSLISRAFEQNNS
KKYNCFENFFKEII
>fig|195.2254.peg.1755 hypothetical protein
MKKVYLDTNILLDYFNSERAYHNEARQLVYYLLTNNIQIVFSEDMISTLVYILKKTNIDM
MQFYNYLSKITLDPKILICSFSGSVIRSACQMCQSYNDDFEDYLQYFCAEKENCCAIYSM
DKKFPNLKIPVKRYGEIDI
>fig|195.2254.peg.359 hypothetical protein
MDVHYLAEKNYFDIGHDRREESIFLNLKDLLKLAVIRDEEIRPLQTKLWIDFKNLNEYNM
QKSLQTLLGICKETGFNIKI
>fig|195.2254.peg.1683 hypothetical protein
DDIEKGKLKDPRDIDSTPESRKEFDHYMDGYKNGMATRFDVDIRNERDERSAKLTMDTLV
LSAKLAALTPPQGYPNAPRYYSPERLEIIYKRHKLDRLLDPRIPAIYRYNFPEDLRVKIL
AYAKEHNIKE
>fig|195.2254.peg.1592 hypothetical protein
MFKTFFLLKKATITFPQNVGIIFFYFFKKYQKINIKYLFFYCSEVFYSKNIFHIKNHFLI
F
>fig|195.2254.peg.1040 hypothetical protein
MGSYFFEYIIKISIGSLEFTINWILSKFLNKKYFLFKNYLFFVL
>fig|195.2254.peg.2008 hypothetical protein
FALAKIQASPLAKIKYDRIRWEGGGDDNKQSSIQTHHIATDKSKKYTPKFQEILNSYDLK
LNGDWNKVKMPHRGRHPNEYHEYILEKMSKIDKITRGDKNKFLKEF
>fig|195.2254.peg.1988 hypothetical protein
MSKNIKTQEAKLDLITKFLDYANCADASYAMLQYVFKGIIKYKNDNGNELEKKVDTQRLG
DKHNNQNSIYARAIQARFEQNKIVKIEPKYCISLI
>fig|195.2254.peg.1036 hypothetical protein
MVKSLCNFYNQSISFSPFLNFFMVKLVYKNKQDVECFSPFLNFFMVK
>fig|195.2254.peg.1564 hypothetical protein
MRIDYEKLTIKPKVFGTIFGLCSLAMFFLMVSFLWIPIGIFVF
>fig|195.2254.peg.1909 Protein PhnA
MPKDANGTELNAGDSVSVIKDLKVKGASTTLKRGTTIKNIKLTSKENEIEAKVGEPHLLI
EVGASLLKPTNVS
>fig|195.2254.peg.1987 hypothetical protein
VGGCSYKYMDPQYYEFKSLCKDIDNKVIIYNKAYWEIFSNREKGNTMHDEKGEFFFNQKI
NKKIYFDFKKSESINVLQKNKFTLTEVTFEDYYDGIHYSTHLSYIYNDYGIFLGGDEGAG
FYFRYHKRLYCEDTR
>fig|195.2254.peg.1997 hypothetical protein
MKYYKMMYNGQHNDVDNWINCIKPDIKNNDKYALLESKPITNWQTPSFEIDKDDGKILTD
LISNVYNWRIVSPKFINLMQDLIKDCVQYLDVEIKSQEINYYDCKIMHV
>fig|195.2254.peg.2007 hypothetical protein
KEVEDTIIYQNALIYDYILSADNPNSQIIKYLVNRGAKFEVHDEGYSGRTPMHFWARRNN
YQLLELAIKGGANVDMQTLLDPKSEYNETLLFEAVSEPETYRVTQLLIELGAN
>fig|195.2254.peg.1943 Replication protein Rep
RGGKVSGITFTFKPENIQMQKLENESQKIMSDEQKYLKILNNMKLNQVRFDYNDKLWQFN
DFDFDEFKIIAIELVRDEYENLNFGNHMHFNAKNQEQFFKMIETFRKGIR
>fig|195.2254.peg.2011 hypothetical protein
NYEIHNIDKWILKPAIKELSKERNLFDQIRVPFKNLAYEKEKAKGTRGRGGKVSGITFTF
KPENIQMQKLENESQKIMSDEQKYLKILNN
>fig|195.2254.peg.1643 hypothetical protein
FLAPAKMQNLKLQIAQGLDEILEDEDRKQELYVCKFVVVNGVSENNAQEKITHLSNDGQN
LLKNIEKLRLKPYNDQNGKEITSYVKGATIGYGHLIGQNEWDLYKNGITLQEADKLFKSD
LLPFENAVKNSINSSLAQNEFDALVILCFNIGIDNFKNSSVAKIINGEKTGYKTLKEAWM
AWNKSQNKVMQGLINRRNAE
>fig|195.2254.peg.1952 hypothetical protein
MKTLEDIKAMSYQEKDELEDLVLEIIDNNDLVKLKDILKDYPVKISCYELNIKDEDGDFP
LFDPFNLIIRAAHACEDNNNDFSILDYLFDEYGLSLKDPKYNFAFHDMKHIKEANDKYIL
MKEVEDTIIYQNALIYDYILSADNPNSQIIKYLVNRGAKFEVH
>fig|195.2254.peg.1983 hypothetical protein
GSHIFRIKDDEVPVFVSSEFRKIVRENNLLGFSFSEVMVYEN
>fig|195.2255.peg.893 MmgE/PrpD family protein, putative
MFYSEILADFIFNLKYENIPNTVVQRAKELMLDSLGTAIAASKEECVLNAFKAFENLSTE
KNTLIWANDQKLDPIYAAMLDGALLLMR
>fig|195.2255.peg.946 Motility accessory factor
MSILEKNIQALLSGVNEPLGNKLLNFIQNKTCSCFNIDENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEVELFILALSTIDLSKE
LCSGKIYLVDIEEERVDIQLLILFDMKDISEYLSLYEMFVNNVYYKKFYEDIWHKANELC
EKNIKIVIRNLGSNSDLSFECYSHLLQNIPSMLESIPFQRILSQRKNQFENAIVVSAGPS
LAKQLPLLKAYQDKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENKTSLN
VLSCATHPNLVHFLDNKSVILREDPLYQRFNLNDFGYIGTGTHVSHFSYTLALALGFKNI
IMIGQDLAF
>fig|195.2255.peg.135 Phosphoglycerol transferase-like protein
MRKILLQILIFSVLFIVAFTINRILMQNSFIPAGLISDKNEIFLMYLLGVFHDIRFLSAA
FLPFLLCGFLSLIFSNIKINNKLVIYSKNFYFIFSSVYIIVLSCLCIGFSYAKYYYYEIY
KTKFDIFMFTLKDDNTKTILSIIYHDYPILKILALMLIFGVFVVFLNLKILNLKLKPVNL
RLFPLIALNLILIIVYVIALRGPLSMWL
>fig|195.2255.peg.602 Conjugative transfer protein TrbL
MKLNKGIVLMQNGQLKCKPTIVFLTELEKMKITTKTLLNGNKLAIIFLIFLAPNLAFGVE
STKGVLSIIYNGLLS
>fig|195.2255.peg.365 Phage tail length tape-measure protein GpT
MLVMKQKKGSLQREFDTRAATTENSIILMKNAFNSLAINLGSVFLPAISWVSAGISYLVN
SITYITGLVPGLNGVLGGLIATFLLAKPAVLAYAIAKNYLKDCTILLKSALIKTRIHLLA
FRNSCILSNITLKAKTVTTNIYTASLKVLSFVLIGLNKVFKLVAIGIRVLSVAMMSNPIG
LILGGIAIVAGLIIANWDKVKSWFMSFIEWLRPVWEPIYNVIKAVFNKCSGVIGYFKNNA
LNIIFPFVGILKFIWKPIYEVFKWVFDKCALVFASFKDIIMSVASPLAEFLNSIWQGIGD
FFYSIFGSLFEWFASKLSWVGDMISSISGFIKDALDFVGLGDDKEVKISQNEQTKEKIFA
TNTYKDKLQAKSINHTPSFNNGNINVSVNGTFNIATKDGNFNMQEFANAIQKSVFDALRK
QEQNKINTTIYG
>fig|195.2255.peg.1775 tail fiber protein H, putative
INTKEDKGVAANLDKALKTELTKLINKKENTGTAASLDAQLRNELKALINTKEDKGVAAN
LDKALKTELTKLINKKENTGTAASL
>fig|195.2255.peg.1555 hypothetical protein
GYSVDKDGYMGSDFNKAAGLPEDFKIHKSTLDEIERFNQHGMADETSGNYYDSFDMASIV
KSYYNSFNQVISTFPNDKTSFSEADLEQLPKGLNYGRNENKEKIVKNIFNAEQFHEAQAI
KYSTMNLGMNLMKLDFSPQSMEQGPSNEGEFNPDMSVYPQNEDGSYSKEALFMSFLKSYG
SGQPVESPKTTLNPKVEAYNRAMAKESFNGDSVALNDIMTGKVDFASLLKGYAQDGWLDA
DIYAMEKGVAWQNTSIGYGGAWFDNQFNQAKANGWKASSESINSYVGSIMDRLNNLIGQT
RV
>fig|195.2255.peg.892 hypothetical protein
MKTTLMKSAFACNAYSSCNFSAYYKSFDDFFRIFANMKTIT
>fig|195.2255.peg.290 Metal chaperone, involved in Zn homeostasis
MQKKFKELLDNFENKGKKPQRVILETSGLANPAPIIFTFQSDVFLANHFELANIITCIDA
FEGLNHLQNEEACNQILSSDFLILTKKDLNPHTQSLEEKINTLYPNIQIISKENFNFDML
SSHHKIQREIKNIEIKSHKDDISSITLIFDKAINWNIFSIWLSMLLHEHGSKILRVKGLI
NTEESYLTNINGVGHLIYHPTHTKISSLNHPSQLVFIAKNLKLDKIKESLENFLRLEQLN
>fig|195.2255.peg.1752 Transcriptional regulator
MGKMIEWLRISGMPIEQIKHYIKLCSLGIKTAKERQEMLKQTKKKLQNQIKTLKESEKVL
SKKIKIYEEMLVNEVDGFNPESKDYQPCDKLHKFKG
>fig|195.2255.peg.419 membrane protein, putative
MFDFFINYMIFCAKDLSKLFLGTLALFLFAFFGFMFFICEGVFLYVLLFCEIILFLYMLL
GIFYIRNQKLFYKIFDYFIAFVGGKIKCNHRKIK
>fig|195.2255.peg.350 methyltransferase Atu0936 , putative
MVTLNLIGSNSSSAYRSGSFLAWKLIKLHDKLLKQNGFDILSSIEDYIEETTDDRELLII
AKKKEL
>fig|195.2255.peg.855 Capsular polysaccharide export system inner membrane protein KpsE
MTKINKSINTFFSKIKDLSIFDSFKIVWILMIFVIIYYILIAADRYVSTITMSVKSTTGS
TQASGVLSLLTATSNTSEDIKFLQGYIESLDMLKILDEKIHLKKLYNEQYIDLFFSLSSS
SSIESYLKYYQNRVKVHVDDKTGLLNVEVEGFTPESAHLIAKTIMQESDKFINEISHKAA
REQMAFAEEELVKYKERYQKAQNDLIAFQNKYGVFDPLKQAEAKASLVTQLESDIAQREA
KLLTMQSYMNDHAPEVVTLKAEIAALKKQLIKERSKISADNSSQKLNDLAAKFQDLTIEA
GFAQSAYEAALKAYESARIEALRKIKQLVIVQTPDVPQSAKYPEKIYNILTAFIVLSLIF
GVIKFVKMIIEEHKY
>fig|195.2255.peg.491 Citrate lyase beta chain (EC 4.1.3.6)
MKAKSFLFVPSIFPERFTKALQSGASQIIIDLEDSVEVAKKEVGRKNIVDFSSQCAKNND
KFLIRINETKSKEFQKDLSLISTIKESNGIIGVVLPKRKVMRI
>fig|195.2255.peg.1766 Motility accessory factor
FAYRGKLISDVLKLHIQDKTHFITAYIKAYHEWLLYFMEKLEQKYKSLSKV
>fig|195.2255.peg.1750 N-Acetyltransferase PseH involved in the biosynthesis of pseudaminic acid
YINLNYIEKEKIRKYRNHPEVKKYLYQTHFISKLEHKNFIKKLKYNTKKSYFCVILDNQI
IGNINFYIRENEIDFGFYANPFSKILGIGRILEQISIYYAFKIINIPILSLEIFSNNTQV
INLHRKFGFSIVQEFFIKKQKILKMSLKQSDCKALLS
>fig|195.2255.peg.897 Anaerobic C4-dicarboxylate transporter DcuC
MAIAGFSAYMDHVGASYALFKVFEKPLKMVKSPYILLLVAYFIVQFLVLFIPSHAGLGLL
LMVTMYPILVRSGVSKLSALSVIGICQYIDHGPGSGNVIMASEKAEVDPAIYFVHYQLLQ
PYLSL
>fig|195.2255.peg.644 hypothetical protein
MVINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIIPGGAEDMNSYIYIDDY
LTRNYKVAVININYHCIGNRPHLGSSFYLDDIDKFILDTSLKAINLKCINVYGINSYENL
NNAFIRIDQEIQKLKLNQQLHQNYKLKTHVSFLPFKNEYQNFGIMQAMDILNAIFYIKEN
SPFKLMRGGGY
>fig|195.2255.peg.1003 Haemin uptake system outer membrane receptor
MNPSKRVLKLSLLVFLLSTGINAQELNDKAIQMQKVVVSATGFEQDADNNLRNVIVIDGK
DLEKRGFNTLEQALERISGISFVNFGLGRNIDMRGQGSKSNIAVKVMVNGNAINVLDNSH
GVTPLESVNLNNIERIEIIPGGGSVLYGSGTRGGVINIITKKEKSDAFALSLKGSSYDHG
NLGGNLGVYGAKKINDYLTFGFDIQGFNRDGYQEGYNEKGYFVNTKAYLNTSDNSDLSLN
YNYFESKNTSSGYLTKAQIQSDPTQKGSGDNITQINRPEIALDYHHYFSDLYEIQLGAFW
QNQKIRYLKDEIPMMGTIAYQTGSGFEDTLTGINLKNKINYKDDSYFIFGYEFANHDAKR
TSIVHYNVNTPAFQMSHTMTTLMDMNKQSHSVFALDSHQFNDIFSISGGARYEYSLYDTH
RSYTSKMIMGGTQRPSNPELFDADDTSNNFAFEITPNFKYSDTGNIYAKYERGFISPTPA
QLVNKDQATQKYYTANLDPEIFDTFELGINDFWWDFYGFNLTLFYTLSKDEISYLGNPHS
TGGAFWKYYNIDQTRRLGAELNLHQFLFNDSLILKESLSYLDAQISKGVNDGLRIPYVSK
IKATAGVEYAWNKNLSSYIDLSYFSRAKDGGVVDDENTGKMSRNSWIKDYFLTDIGVNYN
YRNLQILAGIRNLFDKQYYTYQDSTNDQYLAGNGRNYYVEFKYAF
>fig|195.2255.peg.891 MmgE/PrpD family protein, putative
MLDLNKEQIINALGLAGSFASGINEFLSNGSNSKVLHIANAIKNGIIVAHFAKNHMSGPL
SIFEGRNNIFKCFGIEEECDKTELGKALGEIWQTMQVSIKPYPSCHFAHGLIDCAIALKN
DGLKADEIKSIHCFVDEVPISFICDPLEAKYTPNSTYEAKFSMPFLMALGFFDGKITLES
YENLKREEVLEFAKKISYEKRKSQGFPKYFPGHLEASLQDGRTIQKDVFINKGNFDNPLS
FEELKAKFLANAHIYLDNAKANKILDQIINLENLNHFSF
>fig|195.2255.peg.1742 Putative transferase
MKNVIIIGAGGFTRELYSYLKDANYEIIGYIDIQENNFFDLKYLGNEDNFDKKLIQKASF
ALGVGQINLRKKILVKLSKKIM
>fig|195.2256.peg.1072 Haemin uptake system outer membrane receptor
MIGLILKESLSYLDAQISKGVNDGLRIPYVSKIKATAGVEYAWNKNLSSYIDLSYFSRAK
DGGVVDENTGKMSRNSWIKDYFLTDIGVNYNYRNLQILAGIRNLFDKQYYTYQDSTNDQY
LAGNGRNYYVEFKYAF
>fig|195.2256.peg.834 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQELANQEL
TQIALLESKSFRFIMMGIIIIALIISIVIAYLIVRYIKKSVGGEPRDVNRIITEVANGNL
TQPIHTEYKQSILYSISRMQDHLRNIVQKMITISNELNHKADLVVDRISETEKAVIFQGE
TSRESALKIREISQKTQNVSKMALETEENSKNTTQVCQNNKKYAEDTASQMEYIASNSSR
VSQQIALLSEHAKNIGTSTELISEITDQTNLLALNAAIEAARAGDVGRGFAVVADEIRKL
AEKTGEATDQIAIINKQIQEETIATVGVIEESIPLISQGKSLSEEVRDSVDLIYKQANDS
LFKAQEVNQEVAAQSKINGRN
>fig|195.2256.peg.1586 Ferric siderophore transport system, biopolymer transport protein ExbD
MAINDDKLSLENLSSALDIKTKGNKEEIIYFHIDKSVKYEDIMQVMQKLKENGYGKIALS
SKKVD
>fig|195.2256.peg.1585 Ferric siderophore transport system, biopolymer transport protein ExbD
MIKTEMAHKEEELSEINITPFIDIMLVLLIVFMAVTPLITSSIKIELPKSSQQAEDKLKN
PIILYLNTDNTFGY
>fig|195.2257.peg.1688 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAIDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLSFQCEVKSIHKGNSGIDLALKKRWSYPSHHRSKIA
>fig|195.2258.peg.1726 Flagellar hook-length control protein FliK
NLTQKDFNLNKEPKNNNKENKDIKQNFFDQKLNFENLNKTQVVQNKENNANFNNNTTNKE
TFTQEQTKTHSENVDKNSLDELNSLVKDLNKVTQNNARNITPKETLQYFSQDLKEAVDQY
KAPITKLSITLNPNNLGEVEVTLIQRGNNLHINFNSNANAMNLFIQNQAEFKNSLVNMGF
TGLEMNFSDQGKREQNQNQGKNRSGYGFKDALDGKNESEKVNLELVLAKYF
>fig|195.2258.peg.1651 TM2 domain family
NFICRIFCFIRMMRINKQMSHDTNFFLLYFKDKIPKDSLIFLKESLEKASEEQKEKLLFT
KLKNPLYGLLFAFLLPGLDRIYNGNIILGILKIISAILVSIGLIIAEDKNDESTMLIFIN
LFFILSVWVILDYFLVWKDICQNNLKKIFEVLQ
>fig|195.2259.peg.369 hypothetical protein
MSQTNNNTEIKEQDTQDEIIWEGKKDILSFLLYWITYIVFLCFFLYLFPRLFNKEIDYKW
FIVFYISFRHICICTSDL
>fig|195.2259.peg.278 hypothetical protein
VFNNFDLNKKINIFTRLNKDILLSLKISLMQSSIVSISDNLNENKDITIHFNHKCQKNEQ
ENILTIREIKNIEEKTGVVERQYQAKEYVNKSNAIYFPVNIFSFESIYFLRNIRMANKEE
KLVKYLQIFDENIKDVEEINGEILIKSLDFNQKVPLKIFGYGFIKFFNYICALVSNEANY
ILIDEIENGLHYKTTKKLIESLIELSRKNNIQMFISTHSLEFLSSVEKVANEKEFKDLGV
FNIYRYKENVYCKHYQSEQLKDLLNNGIELRR
>fig|195.2260.peg.641 hypothetical protein
MDENLTQDQQNASNENDLKNKENEDQNPPVTENEDEGQTQDQNPPVTENEEGEKMAKEA
>fig|195.2260.peg.1477 hypothetical protein
MNMEDRINLAVDKRDILELNNIISLYEKEGKIIELSNIMQGSKNAILPFDYGNQEEQYGK
MIERYFLLLARNLKKENYCSLIEDLISKDFCINGETYWYYHHKAHLLDNLYYDKMQDEAD
ILFSMAAAKARSKDLFHITNGVFSTRSLKYFESMLSVDVKKEILLNIMVIIYLASKIPVF
>fig|195.2260.peg.1001 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4)
MKTNVEKYLKEHENKELCRFITCGSVDDGKSTLIGRMLYDSKMLFEDQILSLEKDSKKLG
NAGEKLDFALLVDGLASEREQGITIDVAYRFFTSEKRKFIIADTPGHEQYTRNMATGAST
ADIAIILIDAEKGVLTQTKRHSYIASLLGIKQFIIAVNKMDLIDYNQEIFNTICKNYQEI
LPCLKNHERIKTHFVPICALDGDNIASKSINMP
>fig|195.2260.peg.1799 Flagellin
MGFRINTNVAALNAKANADLNSKSLDASLSRLSSGLRINSAADDASGMAIADSLRSQANT
LGQAISNGNDALGILQTADKAMDEQLKILDT
>fig|195.2260.peg.1475 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MDKIYFVAKQESTGIILDFESFAIDRIIFSFKKNIYLDKIRLLCLTNDKKWKEILNYNLL
ISSNNKIVIDFEKTIFNYLKIELSEQTYFQVEIDLFLRNRIIVAGLNSYIGDRFLSILNS
MYIADILNFNFAMVWNSRKVDTKDMKKYQNDKKLVSYIIDDEKEIFDDLFLQKNSYTSAL
PIRQTKWMSKMSFHDLKYGPFVEKQWGWYVGHSPLEHFIEGEIDKSYSIKLKEYFKKIIF
SKKVQEIIAKIDLLAKNFIKKMVIFMLSMLEQVILFIVMKILFLLLCIGERLCLQKSH
>fig|195.2260.peg.642 FIG00469991: hypothetical protein
MLLISEDFGETFKKCPDDLAGKSNFKLGLLKDDVFANGNYGVLLMGEVNLLNVNASIKQA
AFLQNLIINTKE
>fig|195.2260.peg.1134 Methyl-accepting chemotaxis signal transduction protein
MLGEYTACVGESIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSRYLSPLASIQVGL
NSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENILATKQGLEQDAKAVKESVE
>fig|195.2260.peg.1476 hypothetical protein
MNSFRNSINKNSGFNIIPHIHIINPDQECKELILDKYKDEFTFNYSFEYIDLDNISDHSK
RAYYTTPRYTLVPDLLELYGVDIIVSEIDAVIGKNLYEFVRFCRNYELALSQGVSSMNFY
YHYGRISAILSYFGNNFLSKTFAKLNKKYIDLYFDFSKTSTNWLIDQISLYKIFKFLKSD
IYVKNNTIGKINANMLVELAQHFPGGKEAFIKHYKKN
>fig|195.2260.peg.1135 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVTNP
DSDEKGLNFGIYGKADNYDARTRDYFKGAVKANGLYVTPSYLDLTTNLPCFTYATPLYKE
GKFIGVLAIDILVKDLQREFENLPGRTFVFDSENSIFVSTDKELLKPGYDVSPVANIAIR
>fig|195.2260.peg.1474 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MPPEIALELALKNLENNMNIVLFGDSLSVVEEIQMHCNTYYQGKARIYKAQELIDDLSCP
TPFLQAFAEIIFMSNADEIYSGDSSFARLASIIGHGKEPKYYFKFFSFVQQQDILMDNIG
ILNTDNIMKAYTMCYYYLISRLYLKKNFNHLVKIVFKILSYNSNNEFYHVLFIDSLLNLE
KYDTAERHLDDFIFKLQREDRFLSCLKQSSFYNLFKNVYMSDKINEKYQKLMLIKSSII
>fig|195.2261.peg.1725 2-oxoglutarate/malate translocator
MALLGLSLVLISGVLTFGEVLAEKAAWNTLVWFSALVMMATLFGKLGVTQFLAEA
>fig|195.2261.peg.1723 C4-dicarboxylate transporter
MFFIVQLALGAPPLFYAFIMIASGNVMMALTHYAIGTAPVIFGTGCVTLKKWWSIGFVIS
IVDIVVMIAVGLFWWKILGFY
>fig|195.2261.peg.824 hypothetical protein
MLALVSLDFTIKKFKKGLKHTKRHLFQGLHFTIKKFKKGLKPCLKDILP
>fig|195.2261.peg.825 Bacillosamine/Legionaminic acid biosynthesis aminotransferase PglE; 4-keto-6-deoxy-N-Acetyl-D-hexosaminyl-(Lipid carrier) aminotransferase
MSKISYFTIKKFKKGLKQLNSTNETLENFTIKKFKKGLKQTLVD
>fig|195.2261.peg.1728 C4-dicarboxylate transporter
MDRKKIPLLVLCILIAAVFWLVPTPVGLEDNSWHFLGLFIAVIMAVILQVMPFIAIAIVA
LSGYYHYPIENLSKIYTKATSKTSTQQLIDETKISFKYFST
>fig|195.2261.peg.1356 putative integral membrane protein (dedA homolog)
MQEIIHFIIETASDWGYLGIIILMTLESCFIPFPSEVVMIPAGYLAHKGELDIVFCILSG
VLGSVLGALINYYICFFWGKKFVLRWGKYFGINEAKFAKFEEFFNKHGEFSTFTCRLLPG
IRQYISMPAGLVKMKLVNFVLFTALGSAIWVSILAFLGYYIGENEELIKAYLTQILIVII
IFIVLASLIYIKIVGGKIKCNHRKIK
>fig|195.2261.peg.1175 4-cresol dehydrogenase [hydroxylating] flavoprotein subunit (EC 1.17.99.1)
MNAELKGYLTSKNGLPDMDKIQNYALKNKIPYWNIDVSVYGCKEVCYANLEYIKQRFKII
EGVDISIVQEFSLPLNLEQKKQLKHKVTLGIPNMEIFWLSTRGEVLEPSDGHVWFSPIIP
RDGKELLKCQEVYMNLFREFGEESPITPFSHPRSWMYRQMVQTAAEHGWGDYRAAPTFQD
DVMGAYSYNNHILRRFNEQLKDCIDPNGILAPSRGGIWPKNLRDERFVNNKRDALRMKEG
KEK
>fig|195.2261.peg.1726 C4-dicarboxylate transporter
MFLPGIAAMLLMPLMLYFLSPLEIKSTPNASTFAKDKLKELVKMKNSEKIILSVFVSLLL
LWAGALGLFFWNFS
>fig|195.2261.peg.1724 FIG00471393: hypothetical protein
MGLGEISIMIFLSLAFFIYTLFLCFHYSSYISNVFCFL
>fig|195.2261.peg.1727 C4-dicarboxylate transporter
MISIIVARGVIKTGLGEHLAYHFISILGKKTLGIAYSIAFCETILAPVTPSNTARAGAII
NPIVQVIARSFKSTPEDGTQNKIGTYLSLVNYQEPILFHQLCLLQLQLQILWWLIL
>fig|195.2262.peg.1054 Mannose-1-phosphate guanylyltransferase (EC 2.7.7.13) / Mannose-6-phosphate isomerase (EC 5.3.1.8)
MTNILLCGGSGTRLWPLSRILMPKQFLKLFDNISLFELALRRNSKICTNTLIVCNEEQYF
LALDQILSTNKTKFILEPLARNTAAAITLACLFLHKEEVVLITPSDHLIKNEKAYQEAIT
KALEFANDDHLVTFGIKPDNPHTGYGYIKSKNIYDVESFIEKPDLKKAKEFLEDGNYLWN
SGMFMFKVEFFLEEMQKHAKEIYDFCFKAYKNALKQDNFIKIKSLDMEKIPELSIDYALM
EKSSRVKVISSDISWSDVGSFESLAKEFNNNKNYTNTNAKFLDSNNIFCYASDKNKFIAT
IDLDDIFIIDTQDALLVSKKSSS
>fig|195.2262.peg.1039 Probable integral membrane protein Cj0851c
AFFSILLIVFTSYSNFKKFILAQAKNHQKDFIYPSLFYIKKIEKLPRIVKFISIKDDLSL
NFKDRLRFFTLFFALFKLIAYGVLVAGFLFLHRQDKLDILSYICGISSLLVCVFIFMLYI
RRYESKKNH
>fig|195.2262.peg.1825 Motility accessory factor
TQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHIKAQENALIKNILPLEEK
LKERKLDKWMERV
>fig|195.2262.peg.1273 Cytosol aminopeptidase PepA (EC 3.4.11.1)
MIFELSDKKIHGIKADFELVFIQDKNLKPFTNEKDFFKLNNYTG
>fig|195.2262.peg.1055 Mannose-1-phosphate guanylyltransferase (EC 2.7.7.13) / Mannose-6-phosphate isomerase (EC 5.3.1.8)
MQKHFHRNEHWIVLSGTASVEIDGIESLVRPNESIYIRMGQKHRLSNYGKIPVVIIEVQV
GEYTGEDDIVRLEDDYKRI
>fig|195.2262.peg.1799 hypothetical protein
MRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRNLIQDTEKIQN
NIKFGVSGEYIGNYFSTNSLKSIDEIFYENPDSNKILNYHVDKWIKEILDLEISFTTNES
IDIILNGFKDKNFSNYFLPSNISTGLNFATKIIIIGLSLKKGDIFIIENPEIHLHPKAIS
KFADFFAFLVSKGIQVIIETHSNYLLSKLRYINFKKEFKDEDCIIYYKDQQTDFVPIFIH
SGKFTNINREKINFPTGFFDTDLDKLMEIR
>fig|195.2262.peg.1731 conserved hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLY
>fig|195.2262.peg.1803 Motility accessory factor
HPSYKELLSKRKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHDIKP
DYVCMLERDEIVAECFNNDFGEFDKDIVFIVKSVTHPHTIKYLQKNNRAFILVSTYASFI
QYLKLDYFGYFNMGFSVAHMNFLLTIHLKYKNIILIGQDLAYAKDGQTHSQGFIHANLHN
GDYERDLDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMNYHITTYNCTEGGARIE
GTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDF
>fig|195.2263.peg.1247 Putative efflux protein
MEFLASCIFLGQFLSPIISQPIVRQLGLVDAFLIWAILNFIVCIVFLFLKQR
>fig|195.2263.peg.1039 Anaerobic C4-dicarboxylate transporter DcuA
MDIMIILQVIVLLGAIFIGIRLGGIAIGYAGGLGVVVLGLVLGMKPGNIPWDVILIIAAA
IAAISAMQQAGGLDYMVRVTEKILRSKPKFINYLAPACGWLLTILAGTGTGNAVFSLMPV
VVDVAKSQNIKPSVPLSLMVVSSQIGITASPVSAAVVI
>fig|195.2263.peg.1040 Anaerobic C4-dicarboxylate transporter DcuA
MSGVLEPLGWNYPTLIGIWISTTFIACMLTAFIVSLITPMDLSKDSVYQERLKAGLVKDA
GAILHGEDKPGAKLSVAIFLITVLAVVLYATAISSNIKWIDPVVVPRDAAIMSFLLTAAT
LITWLCKVEPGKILDTSVFKSGMTACVCVFGVAWLGNTFVAGHEASIKEVAGDWVKQTPA
MLAVAFFFASMLLYSQAATAKAIVPVIVTALGISATNPQDSYMLVACFAAVSALFVLPTY
PTLLGAVQMDDTGTTRIGKFIFNHSFFIPGVLAIAIAVALGFVIAPMLM
>fig|195.2263.peg.1797 Flagellin
DANTADAMGFGSVNKGLVLAASSIADYMSAEGSGFSAGSGYSVGSGKGYSATLTANAIAI
SSASTISKIYNVSQGSGFSSQSGLSQFATMKTSVGNSLGAKDETAGVTTLKGAMAVMDIA
ET
>fig|195.2263.peg.1800 Flagellin
ATFTVETRGMAAVRAGTTSDTFAINGVKIGKVEYKDGDSNGALVAAINSVKDTTGVEASI
DANGQLLLSSREGRGIKIEG
>fig|195.2263.peg.1798 Methyl-accepting chemotaxis signal transduction protein
DVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQK
SLSEIEANTNLLVQSINDMAESIKEQTAGITQINESVAQIDQTTKDNVEI
>fig|195.2264.peg.1722 Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63)
VIASNGLGGYNGGLAIKRFLFECEGVDFSQF
>fig|195.2264.peg.1784 FIG00638667: hypothetical protein
MKKIYLVFMVLVNCVFASDELNIDSLFKKQIG
>fig|195.2264.peg.1380 hypothetical protein
FIKNLDHGCGIPDKALFRKELPLMLKKLQGRKSFMQENSISYPCGNKVFIFKDVGDKFEL
TIKD
>fig|195.2264.peg.1657 Multidrug resistance transporter, Bcr/CflA family
MILLINAFLYPNLFLFEASIFTSIAMLGFIAPNTTTLAMARFKEHSGTASAVLGFIQFAL
AGLISSVVSALDANTPIILACVMCACVLVANMIYFLGKKNPKGKI
>fig|195.2264.peg.1658 Multidrug resistance transporter, Bcr/CflA family
MQKHTKIHGFSKLKLVIILALMSSIAPLSTDMYLPALSHVEQSFHTSKALTQLSLASFFV
AFALGQLIYGPLSDIFGRKIPALVGIFFFIVSSLFCVIIDNIYAFIALRFFEALGGCAGV
VIARAIVNDLFEIKEAAGIFALMMVFSSLAPMLSPTFGSFLLEYFSWHSIFTTLFALGIL
LFLMILFGLKESAPHLKNKKFSHKEAMKSYKFVLKDKRFLTYVFCAALALAAMFAYITGS
SFVFTEFFDLSEQQFGMLFGANALGFVICANINARLVRKFESEKILSKALMIMFVST
>fig|195.2264.peg.1785 hypothetical protein
MLKKLASSLILGSLLASSAFAGDFLAKVSNGALSDNSQGVKALNFDEMKQVKGGYVFGDY
KIFKDRRNLTSEVYAIVDFTQYELENLNKGLCGAGEDKCQNPSRDRLFAWLQVSANS
>fig|195.2264.peg.1190 hypothetical protein
MAKVAKADDKIITKDLSKFISSLFDKIEMFYSKEYSGFRNTYASIFEYEKNQGRSIHELC
TSARFYEKEIDFLICLLLDLIYYDAKMSANENALMENIIVGLGLNLIKFREVKLKYEQIY
NFTHEKAQQEQSKEDKFTITLEQAYEILNSHPKDDFETIKKNYKN
>fig|195.2264.peg.270 Membrane protein
MQKPDIQSLTNFLIDYTKTLLSAGTYTARVAKCVGRIAQVYGYEININFFFHHITLNIVD
IEDNSIQRTYVIPNHHAHINFKLIFELSALSWAIYDHKYELEKAKSAFNAISIQKNILMY
>fig|195.2264.peg.269 Membrane protein
MVFFATFLGLLLRFALTKIKIDLRIQYILCSFVSSWFVFFGLDMGYTNTSDVALGSSILY
LIPGVFFINSVIDILKDHILMGLSRIISVAILICCIALGIYMTLSISDFGILR
>fig|195.2264.peg.1568 hypothetical protein
MSQKYDILFFFCDILFFRRQISPVIRDTIIQTILAKEIQEIEFSNFKLELQRELVKKINE
KLGNKLIKELYFRDFIIS
>fig|195.2265.peg.1508 methyltransferase Atu0936 , putative
MLDIGCGTGYPIALYLSKQGFQVTGIDISEEMIKQAQKLNLHNATFLVEDILNFKTDKKY
DAIIAFDSIWHIRYDKQECIYQIISSLLTSGGLFLFTHGKNDGEIISTMWKESFYHSALD
LEKVHKLLKQNGFDILSSIEDYIEETTGDRELLIIAKKKEL
>fig|195.2265.peg.783 hypothetical protein
MSFFQRIKSPHLTLVSSEKKTRNIEQRAIKIKVPTEKDAVLRAHN
>fig|195.2265.peg.1697 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MNLDLFQTLGKSIQQIVDAIRQVGASDKVAELSVLLSIIITLVIMYKGYEVLMGTSQSPI
RELTWDIAGKLLAITFALNIGGWLTLVINAMDGIYEWAGGGTQMYKTLDEMYANTAQLAN
IIWAKSSGVGGAILAIVAMLLCYVGFVIAVVPTLAIFVITTFTQTLLVITAPIVFWLLIF
KSTKNVFTQWIGLLLSNTLVILLVGLFLSVFMEQVSTWIKYFAKVTQAGDEVLGTSIFFV
IASLVLVIMIISAKLYAEKVANVSMEGAMGGAMGSALNPVSRLAGWTAGKAAGKTVNAGK
TGAKLAAKGAKLAAKGGYSFAKKCMKGLEMQAKLIFILFCGVLFFSACSTKNQGKYDEFF
NNQTGWIPINQNKDLNKGTMNEK
>fig|195.2266.peg.818 hypothetical protein
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGDEIPFGVLIYKYKLKINTINLGQTMIVNSKSFLGCLLMPVI
LLGIVISYKQEQKIYKRKIEKDPSLKLPSLEQYPDYREAIKLKNHLSYKLGKELVKANKI
WYKGGYFQFLYFIKKLKV
>fig|195.2266.peg.1083 Putative methyl-accepting chemotaxis protein
MNRLGISARLYLSFALIIFIMLFIAVFSIAKVNFLDKTLTAATGENALISRQAINFRGSI
HDRSILIRDVVLAQDQEDLRKTLAQIQKLEKDYEEAELILNDIVAKGGGDSNVRSMMEDI
AKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQELANQEL
TQIALLESKSFRFIMMGIIIIALIISIVIAYLIVRYIKKSVGGEPRDVNRIITEVANGNL
TQPIHTEYKQSILYSISRMQDHLRNIVQKMITISNELNHKADLVVDRISETEKAVIFQGE
TSRESALKIREISQKTQNVSKMALETEENSKNTTQVCQNNKKYAEDTASQMEYIASNSSR
VSQQIALLRNMLRI
>fig|195.2267.peg.1703 hypothetical protein
MSDKELQKEILALENDVKQLEATINVIKKRITHLKDIAWDKQSKKESSQMYKVLKEDKTH
TRVKSNVGDIKVDKDFMEKEIKKHLDNPNLRGMVTTQEMLSFPKVAKNIKPDIDKRTQNF
TWKVKANDKSVIRYGSREYNNTNRLLTAYTETEYNQRQRQDRGERGQLRQEFNDRDFLRP
VENIIPQQNKSVNDFKAKLKEFSTKKTNAVKSINKEFKR
>fig|195.2267.peg.1750 hypothetical protein
VTLNLIGSNSSSAYRSGSFLAWKLIKNYVKELSDKVKIQTKSDMN
>fig|195.2267.peg.1743 helicase, Snf2 family
MSYAKNYSDKYHFTCVELDTISANILKHLHPNQTIYNKAFQHHLFDKPYDAFIGNPPFGQ
KKILDLNDPTLNKTSVHNYFIGNAIKNLKEDGIAAFVVSSYFLDSKNSTIRNFIAEQATF
LGAVRLPNNAFKKRANTEVTTDIIFFKKGKDLNIDKSWLESVEYYDDRFDEAEKRGMHPD
VFNDFRINEYFKNNPQNILGKMNIKSSQYGYSLECLDDGRDLKIALENFTKTLPKNIYKY
QETKIKLSYYRIDRESTEYEKYSKTLSKLKDGNYFEYNNEIYMKIGSDDELVFSKPVLNE
HDTRRIKKLIALRDQFNTLIEYEKNESNDLLVENQRKSLNKLYDEFVAKEGYLNRDANKK
AFREDVEANKILALEKNYSSGISKSVALKEGIDPIAPSATKADIFFKRTINAQKEIKIST
PKEALIASINEYGRIDLKFLETNLNQPLEETLKSLEQDRLIFKDHKNPANYVLAEKYLSG
NVKAKHKEVKKLVEDGFNEFVNNLESLEQVLPKDLKAVDISISLGTTWIPIKYYKQFIEE
TLQITPKDYDLFLMEKTGEWSLKGFGYSLSSYIRSEYATERIGCFDLLEHGLLRKPIRIY
DKKLDPSGKEIRELNPKETAIANSKLENLKNEFIEWIYKDYDRRTDLENIYNERFNTNIE
PRYNGEHLELPNFNANIKLKKHQKNAIYRAIQENSIIFDHQVGAGKTLVAICSVMEQKRM
GLLNKPLIVVPNHLARQWNDEFYHAYTNANILVATNDDLKKDNREKFFSKITTNNFDAII
MTHSQFKLIPAPYEVIKKQYEEDINILEQTLEKKRNDDNVMRYSVKDLEKRIENFKVKLS
DLQTTHKKSKAIDFSELGIDALIIDEAHEFKNLLITTSMGDISGLGNLKGSQKAYDLYSK
TQYIHEQNKKLYFLTGTPISNSITELYTLQRYIQPNILKEKGIQAFDSWASTFGEVTNAW
ELDSSGINYKIVARFNKFKNVPELSTMYKSVADIVTNNDIMKYQKDFVPKLYNDKPINIV
APRSKEIAEFINFQARKLPLL
>fig|195.2267.peg.422 Xaa-Pro aminopeptidase (EC 3.4.11.9)
MLFIDREKIDFELEKKLNLDGICLKEYNKIQDELKKLQNTNLLIEPSKTTTLLIEILDKS
VEILEEINPSTHLKAIKTDKEIAHIQNAMIEDGVALCKFFTWLEENIKNNTQISELDIDT
KITEFRSQSPYYISNSFSTIAGFNANAALPHYKAEKESFSYIQKNGLLLIDSGGQYKNGT
TDITRVVAIGELNEEQIHDYTLVLKAHIAIASTIFPKDIAMPLLDAITRAPLWQEQLDYT
HGTGHGVGYFLNVHEGPQTLSYFSPVLEKTKAKEGMLTSIEPGIYRTGKWGIRLENLVVN
AKIENPKNKDFGEFLYFKPLTLCPFEISCIDKTLLDAKEKAWINTYHKEVYEKLSPKLHD
NLKALKWLKERTKAV
>fig|195.2267.peg.1129 Acetyl-CoA synthetase (EC 6.2.1.1)
MMIMTITGRTDDVVNVAGHRIGTAEIESAIAKHPSVAESAVVSVLDAIKGESLFAFVVLN
PTSSCDLGGAIETLKELNDILRAEIGPIAKIEKILYTTGLPKTRSGKIMRRILRTIARGE
ELKQDISTLEDSGVVQSIIDAAKTGIQ
>fig|195.2267.peg.421 Xaa-Pro aminopeptidase (EC 3.4.11.9)
MNIHKIRVEKIRQFMIKEKLDAYLILSADPHLNEYLPSFYQSRAFVSGFKGSAGSLIITS
QDAFLWTDGRYWIQAQKELEGSGILLQKQDANNTFLKWLKENLNEEQNLGIDFSVLSLSL
QKEIQKNCKAELKNIDLISLIWEDRPALPKNKVYEHELEYCSYSRKEKLLLVREKMNKLQ
AKNHLISSLDDIAWITNLRGNDVCYNPIF
>fig|195.2267.peg.1686 DNA topoisomerase III, TraE-type (EC 5.99.1.2)
MKLFIAEKPELGRAIAEGLDGNYKSGEGYIQKGDNIVTWAFGHILELAKPEEYDEKYKLW
KLEDLPLPIKEFKYLPKKESKKQLKIICDLIHSDKITSIVNCGDADDEGQILVDEIIQYS
KTSKPVFRVLINDLTPKAVKEEIAKIKPNADFKGMSERGFARSQADWIVGINLTRAYTIM
ARKNGYEGILSVGRVQTPILALIVNRDKEFENFKSINYYSLLGDFNINNNTIKARLKTED
KILDENLAKEIKESCENQNAKINLKIENKKEYPPLPYNLLVLQAECAKLFGFSPDKTLEI
TQILREKHKAITYNRSDCQYLPETMFEQAPNILNIIKENLNSNDEIQALIASSDLTIKSK
AFNDANISAHYGIIPTQNKISSQLTQDELVVYNLIAKRFINFQARKLPLL
>fig|195.2267.peg.1128 Acetyl-CoA synthetase (EC 6.2.1.1)
MRYQNTQGLFKPNKQLSRNARIKNLCEYYDLCDEVREDFEGFWKRQALEKIDWFSPFSRV
LNDDKAPFYKWFEGGTLNVSYQCLDRHMKTRRNKAAIVFEGEMGDYEVYTYRRLLHEVCK
AANLLKRFGVKKGDRVIIYMPMIPETAIVMLACARIGAIHSVVFGGFSPEALRDRIIDAG
AKLVVTADGAFRRGKPYMLKPAVDKALSEGCESVEKVLIVIRNNEPIEYVKGRDYIYNEL
VKNESYKCEPEIMDSEDLLFLLYTSGSTGKPKGVMHASAGYILWAQMTMEWVFDIKDYDN
YWCSADVGWITGHTYVVYGPLACGATTIMHEGTPTYPNSGRWWRMIEEYQVSKFYTSPTA
IRMLHADAPDEPKKYDLNTLEVLGTVGEPINPSAWQWFYENIGNSKCSIVDTWWQTETGG
HMITPLPGATPLKPGCATLPLPGIFAEVIDEEGNVKDVAEDGLLCITKPWPSMIRGIWGD
ENRYIESYFSQAKKEGKPVYFSGDGAFYDDNDYHGKN
>fig|195.2267.peg.1747 DNA topoisomerase III, TraE-type (EC 5.99.1.2)
MIQIEKKQTKPRPYYTMTTLLKDLNSVAKYVSDERIKKLLIEKDKDKKGESGGIGTPATR
SNHIKTLIEREYIEVSKDKKQIIKSTKKGRDLIKLSPKSLITPDMTALWFEQQKMIEISE
LRREQFLEEITKEVISEIQRIDKNQEFKILDNENKPKIQCPQCNKGFLTKRKGKYGNFWG
CSEFKQGCKAIYPDNKGTPNFETKQASNDTTHKCPQCNKGFLQRIKSKNGNSWWWGCSEF
KQGCKAMYYDDNGKPKIINV
>fig|195.2267.peg.1722 FIG00469644: hypothetical protein
MRQAFYTSKFYISKKSEKEVCFKLNFEIEISGGGEKIYQFPSKKTSASISGR
>fig|195.2267.peg.1756 helicase, Snf2 family
MWRMEHQQDDITRNNLLACTTDARKAGLDFRLINPHCDDYANSKINKLIENVFNEYNAWN
DDKGTQLIFCDLSTPKQHSQKVALNGNIATPNLNKEEFVNINETIEQTEEENSKSLDELL
AEQAKFDVYTDILKKLVAKGIPQNEIRFIHDAKTDLQKGQLFADMNSGKARILIGSTQKM
GAGTNVQKRIVALHHLDCPWRPSDLEQRSGRVIRQGNELFMRDPQNFRVKEFRYATERTY
DARMWQVIESKARSIEQFRKAGADVRTLEDVTSGAADAAEMKAEATGNPLILLQVQLNSD
LRQEEMLYSGYKRQIHNNEESLITNLSKIELLKKDIAKMEILNSIIKENNSKHFQGKYYI
NDDEKDFIVFKNDTSDLNKSRQAELERNFEKIVKTIADDYQKEYKVLEFKGLLISGERTD
LNTLNFYVSTTDGKTIIEPENLIYKRDEKTFFKLESYVNFGGFVKRLNNFYNDLEKFTQL
NKNKIENLEKEIVELKSITGDNTPKYKRKDYLEALREDNRIIMDEIEKMSKQKNYKSDFV
PKSAKILEDLNKHNKILKDRELLI
>fig|195.2268.peg.128 Chemotaxis regulator - transmits chemoreceptor signals to flagellar motor components CheY
MKLLVVDDSSTMRRIIKNTLTRLGHNDVLEAEHGVEAWDLLEKNEDIKILITDWNMPEMN
GLELVKKVRAEKNMKICLLLWLLPKGARLR
>fig|195.2268.peg.129 Chemotaxis regulator - transmits chemoreceptor signals to flagellar motor components CheY
MPIIMVTTEGGKAEVITALKAGVNNYIVKPFTPQVLKEKLEDVLGTGNGDSEAE
>fig|195.2268.peg.1055 Hemerythrin domain protein
MDKLIPAWDEKYSINDEKIDAQHQKLFELAAKIENAVYKFVQRDELKEILTELFNYMKDH
FSNEEDYMQEISYPYLNEHKIMHKNIIHDMSHLIQNIKTTNDLKEKLYTIMSD
>fig|195.2268.peg.1054 Hemerythrin-like iron-binding protein
MIGNWLSEQLLAKQEEELEKLQQEDLQQEKQYENNPNPSPPQIKKEYDFIYSCPCRTNHF
LSYIEHLDIICHKKQLRCKKCQKNLFYVRSEIKTEKRNNDVSKVG
>fig|195.2268.peg.1666 helicase, Snf2 family
MSKKTKRQIEDEKDYGGRSLFDLIELEFSQGEENEQQNRELSEHREVTDNIERTSISSNT
PSVDRQENSTIQLDNTREMGRVLSEHNQESRNVRSNDTSIATNTNGISNLGEQRSRQEER
TGANRYGDTSRRANKSQSIHSDRTPNLFSFISRNDDERQGTDAARSYNQQSVLETAARND
GYERRSLKSGQKLDFVSDDEIYLGSLKDRF
>fig|195.2268.peg.532 Quinone-reactive Ni/Fe-hydrogenase small chain (EC 1.12.5.1)
MIDYNQIESRLSALEKLPSLNPENSIPKALERSGFTRRDFMKWAGAMTAFLALPASFTPM
VAKAAELADRLPVIWLHMAECTGCSESLLRSDTPTIDSLIFDYISLEYHETVMLQRVGRL
KKI
>fig|195.2269.peg.528 Selenophosphate-dependent tRNA 2-selenouridine synthase
MLNEVDFAEFQKENFSLLIDARSPREFLHSHLIGALNFYALNDEEYQEIGTIYKKNQALA
KARGASYICQNMSKHILELAHKFRIGDKIGIYCSRGGLRSKSIAVILSELGYRVVRLKGG
FKAYRSFLAHYFDNEINLDFFALCGNTGCGKTELLELLPHHLNLEKMANHLGSSFGDILG
AQPTQKAFEANLFYTLNSLKDFIFIERKS
>fig|195.2269.peg.1398 Protein containing aminopeptidase domain
MDKLDFRSQDFNQTGKAMYELACELFPIPRSITGQGFRASLEILNKTLGGGDILKFHSIK
SGTKVFDWIVPDEWNAKEAYIITPEGEKICDFKKHNLHLLNYSEAIDKEIGLEELQNHLY
SIEEMPDAIPYVTSYYKRRWGFCLTHNERKKLKKSKYKVYINAKHDENGVLDYADFILPS
TQNSKDEILISTYLCHPSMANNELSGPVVAIFLAKWLSSLKERKYNYRFVIIPETIGSIV
YLSKHLEHLKKHVKAGFVLSCLGDDHAYSLIHTPKKNTLSDKVALHTLKNKKISKLLVF
>fig|195.2269.peg.1739 Motility accessory factor
IKNLAKHYKHLFVFESEIELFILALSTIDLSEELCSGKIYLVDIEEERVDIQLLILFDMK
DMFEYLSLYEMFVNNSFYKQFCEKTWCETDEFCKKNIEIVIRDSGLNSNLSFQSYFHFLQ
NIPSMLESIPFQRILSQRKNKF
>fig|195.2269.peg.1750 hypothetical protein
FAIEPKFDYVWSFGEGLVAVKLNGKWGFIDKSGKIVIESKFDSGGHFSEGLAGVKLNGKY
GFIDKNGEFAIEPKFDYV
>fig|195.2269.peg.676 4Fe-4S ferredoxin, iron-sulfur binding
MLKCVGHNDQPACASACPTDGCIVWSEIASGQPSRDNIGSDMRDGTTPVFA
>fig|195.2269.peg.1732 Motility accessory factor
ESIPFQRILSQRKNKFDNAIVVSAGPSLAKQLPLLKACQDKAVIFCADGALSMLEKEGIV
PDYVTNLDFTDLAMKFFQNKENKTSLNILSCATHPNVAHSLKAENCMIVLRNKALYQRFN
FNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFDFGEKFSGEEN
IDKLKIPAYAGKGEVLTHTTWNDYRIKLEYLFACNDQKAKFYNATEGGARINFTEELSFK
ECCEK
>fig|195.2269.peg.1725 hypothetical protein
IMQAQDLLNVTLYLKKHAPFDTMGGGYTSYYDR
>fig|195.2269.peg.1751 Motility accessory factor
GGARINFTEELSFKECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRF
LDDALALKQ
>fig|195.2269.peg.677 4Fe-4S ferredoxin, iron-sulfur binding
MAVKITDSCIACGSCIDECPVSAIVDDANNPEGEDRYYVYADKCVEVCRTQ
>fig|195.2270.peg.1031 dna methylase-type I restriction-modification system
MEFQLEIQNLVKDSHKALEESKELYKKAEETLYLELGLDPKNPLQSLLDSKTNNPTKSLN
ISIHTLKESFLKTGRLDSEYYQKKYEINEKIIMNKKYTVLDNLVSITKSIEPGSNLYKNK
GIPFIRVANLTQYGLSEGDVFLDEKDFFPQYLQILYPKKDTILFSKDGSVGIAYCVKEDK
EVITSGAILHLNIKDKENILPEYLTLFLNSIFVKLQAQRDCGGSIISHWRIEDIKKVLVA
ILDIKIQEKIAKYIQESFNLRKKSKQLLDNAKNKVEEQIQGKI
>fig|195.2270.peg.1263 hypothetical protein
LGLFNNWVGFLITQVYFIVFIEVLWVGGCL
>fig|195.2270.peg.1030 dna methylase-type I restriction-modification system
MNLNQTLQEKYPHLEVSVLKLSEVKKNIDFRIDDSFWTMKLIYNNKLNYKKIGECLLKSQ
YGISINMNEGGDGIPIYRMNDIDNMLCNFEVKKYALIDKNELQTFRLNYGDVLFNRTNSY
EFVGRTGIFYNNRENFVFASYLVRLVCNKEILLPEYLTVF
>fig|195.2270.peg.1115 hypothetical protein
MTSVLLSQSLHAISIGGKYEFFANKDLSIPVINTNKALNASKKYYLIFECEFVKSFSYNP
ISYKSAIQGRGIFVDDKLFTTVVATKSGTKGQKITYQGWVKGSKIKHVNFDASWTHSPAS
QAHIKTTKFELYYN
>fig|195.2270.peg.619 Methyltransferase (EC 2.1.1.-), possibly involved in O-methyl phosphoramidate capsule modification
MECDYKELWDKDRYLGAWHSVNDIQAQAGKKKMERNFRYD
>fig|195.2270.peg.1832 Translation-disabling ACNase RloC
MKKNLNYEIIKEFNFDKFKQIENGVKKIDEMLKQTPENNAIDRFKQDNDLENLARLAFDI
KNKSEMYKDKCPLCGQNILGVKLWEKLEKHFNEEYKQFIERLGKAKIFFEISITELGNYT
KWLNEYFIKTKLLIDDDIDKKRQEYLLFIEESVKEINNIINHIELKKQNPNKNDIDIDCD
LNLFQRILNDDIQNLIKQHNRKQQTYLKDIDENIEKIKKHFIAKEKDNVALYNGLINFYN
KIKEKINCVLEKRNKHIVDIDAKLKEMDQSFQNLNKDMEEWFFNDICFEKIGDTYYKIQR
LNFNNKWFDCDKGLSEGEKTIVSIIYFTNHFLSKIKEIKECPLVFLDDPINSLDNSNRDK
IINYISSKLLKQNRGQFFIATHIDEVCDKFNKKNSDTQSIFEIKKYANQSEIEKLAGFKL
NNDFKTTHLRLCEYLKFGKYEDAFDISGDVRFILEKICNIFFKNTENFTDCYDKLLSKFD
IIKKYTANDIQDLNHGKNTINSDEIIEKVRFVVEIIDKIRNFHAGNYSSKKGFYCF
>fig|195.2270.peg.1835 Putative type IIS restriction /modification enzyme, N-terminal half
MKFEAIDEKEFLNPYYRKKPILEAELNEFIKALKDYKTSLENNLKNNEDSLVANALSKFF
ENLHFECEIKSIHKGNSGIDLALKKDKQIQVIVEAKLPHSKEFFSQSKPNCKALHECILY
YLRERKALNSSLKHIIITDFYRFYIFKADLFEELFNKNKYFKEAFENFESKNSLFKGNTD
EFYKECEKLLSSEKYLDSITRKDLFDEPSLKGVFIDIKPILEQEKPSFSKLKPLFKIFHK
DFLLSEFNPNDANSLNNAFYKELLYILGLYESKQNSKLIITKSEESKEEQGTFYTAINSK
LKEENFETILKLLILWLNRILFLKLIESNLVRFNDDKNLKFLNFKKIPDFDKLSELFFEV
LAKEKSTRKKSEFAYLPYLNSSLFEKQSIENTLEISSLSNDLKLFYYKNTVLKDDKCKAK
KGQVGLLEYLFEFLDSFDFGSDDEQSEILSQKELISSSVLGNVFEKLNGYKEGSFYTPSF
ITSYMCKESITKVVLDKFNAQFDLDAKDISELRKSLRKEDKKAQKELLNSIKICDPAVGS
GHFLVSALNVMLSIYDELNLFDEEFYLEVQNDEILITGRKGEFIEYKRPSTPKDKAHLIQ
QELFHTKKDIIENNLFGVDINPNSCEITKLRLWIELLKHSFYQSFDDENYHDLKTLPNID
INIKCGNSLVSYFETGKSLSHYPNIKERMSKYKRIVKDYKEGFYTDKNLIAKEIKNLQES
FKNFCLKDKFNKEIKQLTNGANEYSKKYGDFLADEHHDEKFKSFFSKNMFEFSFDEKVAT
KEFANLKKEYDNIFNLESNHPFEWRFEFPEILDDDGNFKGFDLIIGNPPYIRQEELKELK
PHLAKNYKVYKGTSDIYTYFYELGFNVLKENGILSFITSNKYTRAGYGEALREFLLKNVK
VLEYTDLNGIKVFDSATVDTSILCFEKSKSKDNKFKYLALSNEILKTCAYDIGLYKDYAE
FSQNSLSKESFTFSDENTSALKAKIERIGTPLKEWQGLNIYRGILTGYNEAFIITTEKRN
EILANCKDEAKKNAPLNSYAKCYADAI
>fig|195.2270.peg.1833 hypothetical protein
MIKKIKQVNYKSFNNYNSSGLEFNRINILYGRNGQGKSSLVNFIKDNIENNNLDIFEISS
NGFSLFFYDTDYKNSLFYSNDKFKTFYIADDIENIILEKNKICKKIKKLKEFKNKIEEKI
NTANKNKKDLKSTIAKNTREVLSKIDSNKYNTPQSYQSTHIDDGYLSSEKISLFEVLSYD
EFEKIKSMKKKLNQ
>fig|195.2270.peg.1107 hypothetical protein
MLIDEKRLMRNYTLKPAYPSNIGELDTGEVYKQWFTYAMIGVNKYVELLHKQLIRKGRSY
SQNATHPLYPNSYIVKKYNIKSASTAPYDKHSHGNLGLNQFFVGQDPYKPYKGDPSSKNG
IYHDICEIRTKYNLGNMQYYYGFPNNLTLLFEKEKAWKYNGKGFFYIDEKINFKDILNKA
LENINYEMLINDIEVVIFCQTIQKNNEWIYPSIDDIKIPNIKVENIEFKPTFGKPYKKPC
VDVEKFYNDFKELNKNIFRIEKVEITYKIYEKAQKTRESDSSKIIYYTLTSKKVSFFEVF
NSIKENYKCKYATPLCFYNSFRFVCYEEPYVAFYSLNNASWGKKDTSVRPSIYPLYRKSS
NLPYGRRDRWFALWDSFYYLYVYEKSSKGFLSFLAPIVTIVLAVATWWIGGQGAWLGTLI
GVSETIASGITLGISLGLAIGSLTGNKTFSILNAVWGLVNFLGAWGANNWNLAADFTKNT
AQIAQEMTTFESTLNIAGNLLSGASKIFDVVQSITANTPDMINEQKGSDLDNNEGGNGSE
ALELAKDMINPTIWYNFETTDILNEKIEKNRNLIFAF
>fig|195.2270.peg.1834 Putative type IIS restriction /modification enzyme, N-terminal half
MLRGRDIKRYSYEWAGLWVINTHNGYKNQNGEKVEAINIKHYPSLKKHFDEFYPQLEKRA
DKGLTPYNLRNCAYIEEFEKEKIVYPCIMAKEPCFSYETSFAFAMAPANIITSNSDILKY
ILAFLNSDFIYLMLRKFYMGGGIEGELKTNNLEKLPIPKINSKNQKLADELINLVDEILK
AKEQDKNANTQELENKINSLVYKLYNLTEEEIKIIENKE
>fig|195.2270.peg.817 hypothetical protein
MNTEKNNKNLLENTHFQDKNIIHIFFTINDAYSGYLATCIVSILDNLDQDYTPCFYVIDG
GISEKNKKKFKLLNTDREFYIEFIPINQDLFINLPNSSQAHISNETNYRFLVSSLKPNLD
KCIFLDVDLVVVGDIAKLWEIDIDERYMAAVGDQAPLHPSSWTLKLPLPYDYLYVNTGVT
LFNLKKWREDNIQDLLFQNSAKYASVLQFPDQDTLNITLYKKIRYLSHIYNAMPVQTYYN
EEQKQEAFSNPQVIHWAGAHKPWKYPDVPYAEMFWYYAHQTPFYEEILFKNITQNTLNIT
RHTSNMIQNNINSTSQGAVEKVKSHLSFKLGKEILSVKENKLKALGLPFTLIFVTIKHKM
SNLIYKLVLNSNPNLKSLPLSHYSDYHEALKIQNYLSYKLGKLLVKHPFTFIFRVSRVYR
EWKAK
>fig|195.2271.peg.1756 hypothetical protein
SFTELVFSFKINSLDRESFDISNIYNKKHFIIQKDNSLITFKYRKIQSKGFNLVFLLENN
ILKNYYFNYLEKINPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTK
INFNLNKFDIHLALSFAISLNFIAKNEQNKLYKFVLENNKLIYDYIDFINNNFANEHFIK
IKYKRKKYKIINIASFLLYHKLKPQKESYQNEFLEIYILINDYIKLSYETNNLINLNINS
INRITNEHNVLTIELEKKQIPKNKKLKIKEDFINLKLPEEFKLIETHKELYLHGMEQKNC
VYTRRREIEDGLSAIYSLNYEGGVYTLEIFKRKNKFAIKEIKAKYNEFANKEVINFVEKS
LKAV
>fig|195.2271.peg.1791 Motility accessory factor
LKEIKSSKFELILGKDNLDINLKDTSIKNNGGGYNENLLYQDPIKELQTMLNTYNDKYLL
YPVLYFYGFGNGILFKALLQNKNH
>fig|195.2272.peg.1746 hypothetical protein
FIPPNGDYQNFGIMAAIDHINALKDLVKRFPEFADLPKIYGGGSYGGYLSLLIAKIAPWY
VDGVIDNSGSAVPPLNYIIGRELEFKSKDTNGDMYMQGDHFFVSCFLKTHWTRKENSPYF
FNNENYFIRTLL
>fig|195.2272.peg.498 Putative acetyltransferase (EC 2.3.1.-)
MLRKTDIKDLNACLSLFEQSVKTLVLRIIQKIKFVLGLKLIDNNGKKNLNMMRSLSMKKE
EKSQVL
>fig|195.2272.peg.1730 Methyl-accepting chemotaxis signal transduction protein
MYVTPSYLDLTTNLPCFTYATPLYKEGKFIGVLAIDILVKDLQREFENLPGRTFVFDSEN
SVFVSTDKELLKPGYDVSPVANIAKDKKDYEPFCYARPLDGTQRFGVCAKVLGEYTACVG
EPIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSRYLSPLAAIQTGLTSFFDFINHK
TKNVST
>fig|195.2272.peg.1751 hypothetical protein
EIKTLASNYGGIYIFDKKIREEILELEKKKRRIS
>fig|195.2272.peg.1141 Putative periplasmic protein
MFGGFEGFFKISHSQPKHKQKGEKMKLKLGLAALLGATVLFARDIIVPASELPRNAQDFI
SKNFKTAQIALVKKDIDSYDVTLNDGTEIDFIITGEWKDVDGKYKALPNSILPNIMPKIS
ASSNAQIIEVSREINGYKFELSNQLKIYTDAQGNILGQKFDY
>fig|195.2272.peg.1030 Mn2+/Fe2+ transporter, NRAMP family
MIIAAHKKSVVGDYKHPKWMSAFGLLIVALMSYLSVLSMIKLM
>fig|195.2272.peg.499 Putative acetyltransferase (EC 2.3.1.-)
MLDLLFTHPDFVRQGLAQNLLDFILKTYLHNEIYTFASLSAKDFFLKNGFELIRENKVIK
EGQNLKKFLMKKDVVYKN
>fig|195.2273.peg.1748 Motility accessory factor
VCMLERTEITAEFFNNDFGEFDKDIVFVCAGVVHPKAIEYLKGRNRKYLIIPRYLYFPIY
IKLKYFDFLYNTPSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQ
>fig|195.2273.peg.819 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MKIIVALSILGLLVLLVSNKIKPFILFGSVAVLYYLLGYLNLNSWLGSYTSESLIVLILL
LLVSLAIEKSVVIAWCSKFIIGKNYHLSLLKLGVITASISAFLNNTAVVASFMSLIKNNK
FQAPSKLLIPLSYFSIVGGTMTLIGTSTNLIVNSFVVQNGLESLKIFDFFAVGFCISVSV
LIVLLIFSFLLPNYKEKDNEINEYLINAKVLKNSSLIGKTIQENGLRNLEFLFLFEIQRQ
DEIISPVSHDEIIKEGDVLIFSGDITHLETLKKFDGLQMGA
>fig|195.2273.peg.1738 Motility accessory factor
QDKAVIFCADGALSMLEKEGIIPDYVTNLDFTDLAMKFFQNKENKTSLNMLSCATHPSLV
HFLDNKSVVLRDDPLYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDE
EGNSHSKGFDFGEKFSGEENIDKLKVTAYAGKGEVLTHITWNDYRIKLEYLFACNEQKAK
FYNATEGGARINFTEELSFKECCEKLLTKEKPQFELPKSLTKNRSDKLLVKFKEKIQKDQ
DNAKRFLDDALALKQILENILSKDFILPLEFLEKVYQNIENFNHSLDEDEFI
>fig|195.2273.peg.1737 Motility accessory factor
MDGKGEKVREENNFNKNLKALSGFEYNNLRKKLEDLKELREFTFTQGKDNLDINIIKKRN
LKKMYQDPIKELEKNLEYFKDFARYPVLFFYGFGNGILYKILLQNQALKRIIIFEKELEL
IFLALNFIDFSKDLSLGRLIILHHDDINLPKMDKVFRLIGDLFYRSYNLHIANDFYEHYK
EDILKLNKLNMQTIKNHNLMHGNDPKDALQGIEQFVYNLPQMITHPSYKELLSKRKGISD
TAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCMLERDEIVAECF
NNDFKDFDKDIIFLVASLVHKKTISYLEKNQRKYILIIKGQPFARYLELDDYGYINGGMS
VSHMAYELAENLGNKNIILIGQDLAYAKDGQTHSQGFIHAN
>fig|195.2276.peg.196 hypothetical protein
MGLNNEKYPFYRLGGIRISAFEKLVGLSNTLNVGVDNKVRIAKNSHEFVGENKDIEIGAN
QNTIIHKDEIRNVKGENKLLIEKSLTQTIEKEFFLNVHQNLSAHIQDNTSLKSNSMQTKI
EEQYSLESDNSTFDFQTDCEVKAGN
>fig|195.2276.peg.1731 hypothetical protein
MIWKEEDLIDILKSDGSVYKNYENNSYFFDLQKEIKLEYIVLKLNNKTNIVNIKYSKDNL
NFYSFDSELCEIKDNAMIFILSEKISVRYLRICIKKEELNQINLYVRKFPLLFIAARTD
>fig|195.2276.peg.1610 hypothetical protein
MDLEISFTTNESIDIILNGFKDKNFSNYFLPSNISTGLNFATKIIIIGLSLKKGDIFIIE
NPEIHLHPKAISKFADFFAFLVSKGIQVIIETHSNYLLSKLRYINFKKEFKDEDCIIYYK
DQQTDFVPIFIHSGKFTNINREKINFPTGFFDTDLDKLMEIR
>fig|195.2276.peg.1725 Capsular polysaccharide biosynthesis heptosyltransferase HddD
KKEELNQINLYVRKFPLLFIAARTDALGERLCSLLNAMYLADRLNCKFGFVWEYPDWWKN
RDIKQDQEKQEIISPSICHAKDIFSEKFIYNYSYTGKIKATMESYFWDKKLERKTDNFLK
VNYDNDWGFYTSQMYLCNIFTDVDKEEYLNKLSLIFKNIQFSSKYIGIVSMAEKIKKQID
KDFISLHIRGADIIYKDKNWGIFAFMYKAAVLELMVDISLKSKNTSIVIFGDDLNAVKNI
KNFLLTKSVDAYSVDDFISRETFLSSTEQAFFEIMLMSKSLKIYGSGKSGFSRAACYIGG
VKDNISIYEYYSKEEQYEIIQHHMQNIQSSRMQKVFSTFHLFCLSKELKHPLDIQRKHIL
KCISLDNDNFIYKVFYVDILLHLKQYKEADEYISTFSKYIQFYLEVVCRKWGNDFLYTSI
LEMYFKIQGISAFPYLSTITVEIIQKIYLYGLQDRYQAIVASFVTDYLKELTSKTIQLQE
SKQLITNQTTQIQNLNNTLNKTIKEKDNI
>fig|195.2276.peg.1458 Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) / Sulfate permease, Trk-type
MTLIGTSTNLIVNSFVVQNGLESLKIFDFFAVGFCISVSVLIVLLIFSFLLPNYKEKDNE
VNEYLINAKVLKNSSLIGKTIQENGLRNLEFLFLFEIQRQDEIISPVSHDEIIKEGDVLI
FSGDITHLETLKKFDGLQMGAQEIKLETLNLVDVVINSESSLIGKSVKEANFRAKFDAGI
VALKRGSQNISKIGQSILQAGDRLILSVGKDFHSRDNINKNFYIISNIIQNQKLSNAQSF
IVVFAFLAIIALSALEIVSLLKALLVFLAFLFVFKFISFDEIKRRFPLEIFIIVGSSLAI
TKVLVDSGLAKDFADLIIGTFGAYGLYGSFVGIYLLTLLLTEIITNNAAAALAFPIAYST
ALALEVNPVPFILAVAYGASCGFMMPHGYQTHLMVGSICGYKTTDFVKIGWIVSLTYSAM
VLIMTPIFFKF
>fig|195.2276.peg.575 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MAMQLLNSLVEINFISKEEKNDFLNSLNTVSKNLSKQTNNLNSCTKNQFLIEFGHLRAGT
YNILSPRYDENFELYFEINQKDNNVYLEDKAFILPEEKMKALNTLLKEHGLEISACEFFD
FLKQSIEGRELLKFEFTRLLSKAIVYIEELGKYYDIKKEDLAHLDIKSILNLYSSLYSIN
PREQFLEEIARNKKEYKLTQAIKLPSLLCNTEEIFSFYNHSIIPNFITQKSITAFTAKEN
DKDLEGKIVLIYAADPGYDYLFTKNIAGLITCYGGANSHMAIRASELGMPAVIGVGEENF
EKYLKAKKINIECESEQIFCL
>fig|195.2276.peg.1459 Sulfate permease, Trk-type
MKIIVALSILGLLVLLISNKIKPFILFGSVAVLYYLLGYLNLNSWLGSYTSESLIVLILL
LLVSLAIEKSVVIAWCSKFIIGKNYHLSLLKLGVITASISAFLNNTAVVASFKPYKKQ
>fig|195.2276.peg.1438 Ferrous iron transporter FeoB
MLLALNMCDEAKKEGIELDTSILSQEFQSQVVEISAKTKENLELLLQKIIILFESKFIPR
SQFYTPLCEKSPEKEDLLYFINELSKKIITHKKEERNLTKKIDALLIHKFFDLPIFLFLM
WLLFQLTFSLGQIPMDYIESGFNALGEFVKNNISNTFITSALADGIIAGVGAVVLFLPNI
IILFLGIALLETTGYMSRVAFLLDGILHKFGTWKKLHSAHHWFWLLCACFYGYAHA
>fig|195.2276.peg.1456 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDRWLVGHRKANDYMMFNKDRFESYFSFGF
VRNPYDRVVSAYHYLRNGGGTLGDEKWAKKNIYKYNSFKEFVLDLKNIEIQNKILNWMHF
IPQYKFLCDNESNILVNFTGKFENLEEDFKKILKILNRKDQLMHINKSNHVDYKNYYNDV
MYKIVREIYRDDFEIFDYDLEDKKYFNISQCSYLKNLEAKIAIKNTKLEFLRLGKFFKIQ
NLNQIIVEKTNTIQNKESKLIQIQNINTTLNKAIQEKDIIINSNTDQINQLQNIIQENST
QINQLQSKLSLQTKYGTAKTRIQNQLSYKLGQAMIVNSKSFLGYIRMPFALSYIKDKHKQ
EQKNYQEKIKKDPSLKLPPLENYPDYKEALKLKNHLSYKLGQALIKANKAWYKGGYVKMW
FEVGKLKREFRNRKI
>fig|195.2276.peg.1741 Methyl-accepting chemotaxis signal transduction protein
LEEITSSMQNVSVKTSDVITQSEEIKNVTGIIGDIADQINLLALNAAIEAARAGEHGRGF
AVVADEVRKLAERTQKSL
>fig|195.2276.peg.502 Major outer membrane protein
MKLVKLSLVAALAAGAFSVANATPLEEAIKDIDVSGVLRYRYDTGRFGDRGYGFQDQRSS
INDRQNHNYRAQVNLSTAIADNFKAFVQFNYSAKDGGYGADSVSNTSNTFSVRQLYLTYT
NEDVATSVILGKQQLNTIWTDNGIDGLVGTGVKVVNNSIDGLTLAAFAVDSFNTDTEGDI
LASSKLFNSATTNPAGAPQDGTLLNVNPYAGNLYGAAAIGSYEVLGGQLNPQLWLSYLND
TGFFYALDVAYSTTIFDGINWTLKGTYLGNSLDSKMKSKDTIIATEYVGGVGTDVITGEE
AMANGNLFALKGAIEVNGWDASLGGIYYGKKDKLTFNTLEDVGNLDLAGAEIFYTDGSNL
NGDIGRNIFGYVTAGYTFNETVRVGADLVYGGTKTMDNSGGEKLEAVARVSYKYSPKLNF
SAFYSYVNVSNDNQGQEDGRKNTVRLQALYKF
>fig|195.2276.peg.669 major facilitator family transporter, putative
MKMLKILIIFCATLTLSIVYAPQPIAPLLSNYFHVNLHQISWIISVTLIPLAVAPLVYGY
LLEIFSLKKILVVSLFLCSIFGIIGNLNDNFYFFLFLRFLQALCIPAILQHFLPCLAA
>fig|195.2276.peg.1471 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
KKEELNQINLYVRKFPLLFIAARTDGFGARITALLNAMYLADRLNCKFGFVWPIRSFPKM
INDNVVHTPFIEDEKYIFNGKFLENHSYTNSFKNNHQTPLFEYMDVGNFSIPNRSVDRLL
MKPYANSWGWTTPFGFCFKFFYNLSEEEYFDGLRKAWKKICFSDSILVALNRADFEASKI
GKFVNIHIRSGDMVYTVHRFNIPEHFFVKHVVSIEMAILVIELELKKHNKILICGDDIET
LEAIKNHYISKLDSVLFLHDFSLKYNFGKLEQLLFELQFRSKAQSIYTTKSAFGILPYAI
GNSKELINIYDFLFNKNNLYKELVNYDGLIKANKLQISLSNWIFFQTGIISNMKVNILIE
HVKKSLRIDKDNFSYKISFLYCLLKKKEIIKAEKYCQLLLRNYNQDIERIIRNGLFGAWN
FIFNAVLEAYKIYQYSASLRYLAALIFQKKQDIHSSLKILRELYDGGELNSIQHDKYIEL
LNVYITNQTTQIQNLNNTLNKTIKEKDNIINSNINHINQLQSNMQENLTQLNQTQSKLSF
QTKYGTAKSRIQNQLSYKLGQAMIVNSKSLLGYIRMPFVLSYIKDKHKQEQKIYQEKIKK
DPSLKLPPLESYPDYKEALKEKECLTYKLGEALIKANKTWYKGGYVKLLFKIRKLKIKKR
KLNE
>fig|195.2276.peg.675 hypothetical protein
MQQVFEYYLKNDSYLKGAIDGLKKHEARAFIGNVLSYEYKNLVENGNLKVDEQYKVTLPP
NLITVLEYDKKDFEGATLKNFIDDVECELSDWEIELYDDPHFYGYDEDEEGYEDEEGYED
DEDDEKMSVDEWATDQVSDIRDFLYALKNFKSKYR
>fig|195.2276.peg.1011 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVNDGSTDENSLNIAKEYTLKDKRI
TLFDKKNGGLSTARNVGIEYFSGEYKLKNKTQTIKENSLIEFNIEGNNPYEIYTVYKSYK
AFNDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDFEMFIDETKNK
KEWSRLRSFQFLKEITITPKEWLEQSIATKQNEFAFAWGGMINFSFLENIKLKFTNGIIF
EDVAFGTILFAQTKNIYILPRVVYNYRIRQNSIMQSLKNSNLSEYLSYMREYFISDSEVK
SYHVVISKIITIEKLCAFITSFHNIEVSYLMRIAFFNYLRQWSLEIFNLSKDPMDFFDQV
VILTHDLFVHKNKKILYKEANSKDIFIWLSQIITLKNTLLQTKDKTIANQTTQIQNLNNT
LSTKTQELTSKTTQIKELNQVVANQTTQIQNLNNTLSTKTQELTSKT
>fig|195.2276.peg.1013 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
MQTKTVGVVIPIYNVEKYLRECLDSVINQSYTNLEIILVNDGSTDENSLNIAKEYTLKDK
RITLFDKKNGGQSTARNVGIEYFSGEYKLKNKTQTIKENSLIEFNIEGNNPYEIYTVYKS
YKAFNDEKDLTKFTYPIIDYIIFLDSDDYWELNCIEECVPRMDGVDVVWFDYNKIYESGF
LDQKNDWTWFLGYNRNSGSKKISSKLWLERYKHIGHFAFVWQGVINFRFLKNIDLKFIDG
IFHQDVHFGFLLFAQSSYIYLLSKKLLVYRIRNGATTVRNFKNNLKDEIPFYIQELLSYF
EIKTAKEYYSIYSWIQIILNVMHSHNIKNNLHSDLYYLFIGNLSEQILKLKFSYKQDPMH
LSGFINFIKTFVGLHRILQNNMQEKITQLSTKTQELTSKTTQINSFQTTLKNKDSLLSFQ
SQHGTAKQRIQNQLSYKLGQTMIINSKNIFGILFMPICIISTILSYRQEQKLYQEKIKKD
PSLKLPPLENYPDYKEALKFKNHLSYKLGQALIKANKTWYKGGYVRFLFELRKIYKQKTM
KNSLILYKNRDSNKKDTTRSIRGGDRLALGLDEQYFIKRHESFFHYKPDFRNPKTFNEKI
IHRILFDRRDIYTFLADKIKVRLYIQFILEYDISNGQIYKLLSKNIDELSEELKNTNKCS
YLPEIYGIYKHTDEIDFDFLPNSFVIKTNHDWGGVVVVNNKAEFLADSSKKIESLTKLQK
HLDRNYYDVSKEWHYKNITPRIFIEENLSQKNNDLKDYRFHVFNHKTQFIQVANSAHTCN
NLYYPDWKIFPIMYLNKRDSKEIQKPYKLKKMLKLASLLSIDFDYIRVDMYLVDSKIYIG
ELTFTPNCGKAKIEPAEWDLKLGQMWRSDVFKL
>fig|195.2276.peg.1744 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
TTQIQNLNNTLSTKTQELTSKTTQINSLQTTLKNKDSLLSFQSQHGTAKQRIQNQLSYKL
GQAMIVNSKS
>fig|195.2276.peg.1738 Motility accessory factor
QTMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFS
NELQSAKLMVLENDKLQAQDYTELCSSK
>fig|195.2276.peg.1611 conserved hypothetical protein
MIHKLHIKNFKLIKDNSFDFKPLTIITGTNSCGKSSILQTLCFFINTNILNIEKSMYIQN
FTRNLYIFDQMRNKDLHEDSIHITLNEKNIINITKEEITKNTEYLFDFEENFYYLKSNRN
LIKIPKKYKIISNLEFLVNI
>fig|195.2276.peg.1437 Ferrous iron transporter FeoB
MKKIKIALVGQPNVGKSLLINALCKANMKVGNFSGVTIEKASAKTFYKNYEFEVIDLPGT
YSLDGYSEEEKITRHFLNQNDYDVIVNVLDATNLERNLILSAELLSLNKKCF
>fig|195.2278.peg.1531 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGFLAVYIAQPDGELVVTNP
DSDEKGLNFGIYGKADNYDARTRDYFKGAVKANGLYVTPSYLDLTTNLPCFTYATPLYKE
GKFIGVLAIDILVKDLQREFENLPGRTFVFDSENSIFVSTDKELLKPGYDVSPVANIAKD
KKDYEPFRYVRPLDGTQRFGVCAKVLGEYTACVGESIDYIEEPVFKIAYIQIAIVIITSI
ISVLFFILLYHAIYPHLLLSK
>fig|195.2278.peg.263 Putative aminotransferase
MNFINLQAQYLKYKEEIDSEIASVLSSSSFIGAYNC
>fig|195.2278.peg.1462 Putative efflux protein
MKKKSYKFHPNDTKLDKKMVEITEKSGFKIAVFSMAAMTMLGSVVISSALPAINRHFEDI
LIQSGANMQTNFTVPTNL
>fig|195.2278.peg.1606 Flagellar hook-length control protein FliK
MSNLAPQNDVLNLTPSKTSNTSSSFSKTSKNKEHESSDSKNSTQDDTESFLNSLLNSIDE
TNEFLPDHMKISQKEVVNEAMNRLQKGAFDESDKISIFESASFMQILSLLDKLKTDTADV
KLANLSTQLSSLIKTEANFNALKGASNLSELLDIAKDLGLNVKNIKVDRLLDLKATFPNL
DKADFFKGAVDNVFKEIINNKISNVSKNLNHNLENTTHTTSTHSTQKTNSKDSGSLLSQT
LKNLDSILSSKESKHEKNDKVKSKIEEDTTDAKNTLKNLKNDEFAKNLTEELNIKDKKNQ
DNLNKDNNLKDLNKESKDLNKDFNKELNKELNKNQEKNNLNQENIQDQNKNLKNNDQNLN
LDKNLNKEIVKDTQNLVSNLTQKDFNLNKEPKNNNKENKDIKQNFFDQKLNFENLNKTQV
VQNKENNANFNNNATNKETFTQEQTKTHSENVDKNSLDELNSLVKDLNKVTQNNARNITP
KETLQYFSQDLKEAVDQYKAPITKLSITLNPNNLGEVEVTLIQRGNNLHINFNSNTNAMN
LFIQNQAEFKNSLVNMGFTGLEMNFSDQGKREQNQNQGKNRSGYGFKDALDGKNESEKVN
LELVLAKYF
>fig|195.2279.peg.836 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKNIVLLGGSNSVLTNGLKNGLQCEESIVLKNYALGACTCLQNLYALILNKNDILDADLL
VTESNVNEIHSFCRIKMPLKQLSYIINTYYEELSFLNIKILVLILPICEKHPSNEDIEII
NDLHRKNCVKYGFNCIDMQSYYKKNNVFEFFMDLPENHHPMETIMNKLGRNIAKNIDAFK
YHLQNKNKLHRKYAFFIPEVDTIGNKLETKIKSNSLYRETIVRITDKAKILFPSKFQGYR
VAAIYTWNDFEEECYGTKVFSSLVLENLQTKIVKPSNGWMQFSELHQDFNIDCSTFAYFN
SQNTQITENSILIHGRELMLKHVDLIAFF
>fig|195.2279.peg.1053 hypothetical protein
MKKIALFFVLFVCLLNFNAKDKEWLPKGESISVYEYIPNNPRSPAAFSSVDSKKLNANQR
KGQQVYSKWCIACHG
>fig|195.2279.peg.1821 Motility accessory factor
FELILGKDNLDINLKDTSIKNNGGGV
>fig|195.2279.peg.1405 Motility accessory factor
MTFTPTQKELFNKNIEALGNILLKESLKEIKSSKFELILGKDNLDINLKDTSIKNNGGGY
NENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDI
EIIWIMFHILDFSHELQSARLMVLNTNKLEIQDYNELCSSKPFFQFSRIYFLELMSHYYE
RFHEDILGLNKKLAENFKNSIVSYGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKG
ISDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHDIKPDYVCMLERTEITA
EFFNHDFGEFDKDIMFICAGVVHPKAIEYLKGRNLVITQKVLGLPYYINLKDFSYAAVGF
SVAHMLAYLATYLNHKNIIFIGQDLAYAENGNSHPDDYQNSANYESQMYEHILTKAYGEK
EEVKTHAIWILFKNYFENEIIPNTIKMGITTYNCTEGGARIEGTIEKPFLWACENLLDKD
LNKPFEKLEPLSLNKQNEFLLKAYY
>fig|195.2279.peg.837 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MDFNFAHEKTNKLFFDKFIPDLCFLKNVIQEYCSKKQFESTIAELKSLLSQKELQLQNKT
NELKNLQEDIIHKKQLLEVQNLEQDLNLKSLQIKEIQENINLKILEKTKIQKELDQYNNV
VYIERYHQSAKQRIYNHLSYKLGFCAIKKSKTLWGWISMPIILLSIFISHKQEQKIYQEK
IKKDPSLKLPSLELYTDYQEARKEENSFTYKLGQAIMNANKTWYKDGYVKLWFEIRKLKE
KENIF
>fig|195.2279.peg.726 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MVDGDYFNVISRGIDLAGSIAHYQSGKNLSDINFIAGLNKVDLSTPNAPKIIASKQKDEK
NDYGIDGKYLGSMYANTVTLISTEEGVGVRHSGVIRGIEDVIVKVKDKAEFQAIDVNTNG
SVKIDAKDIKTSLINADTIDLKASGKVTNEGLYKGKQIQINANNFENAKQTNLSQETKDI
FKINQENSSIFADSLTLNTLDKTSNFGFINALNDIKVGTNSFDNQGEISANKDISLMLND
DAFINNGKILSQNDIQIQANKDLTLNHGNLYAQNLLHIKSLNDLNINSKLENTSSIELDA
KNIYVKNLVASGKELNLHADENLVNDAYLFSNGDLRAQATTLTNNSTFNSLNNLYLNAHT
IHNNALIFADKDINIEANILNNNANLTGMLETSTEYSQGFGQVGYGDTAFKRWNMEVGVT
GIVKYNNLLDSKQASIQAGKDININTQSQDNARQINNSGKILAQGNIVSFGNIDNKSLSK
EISVGEILEQIRVNGFFAKEYLGSWNTNSTYYFVDHESLLDALKYFSTTQAKNHQRESAW
NALKDAAAKNSALNQYFSLLFGSDYASKRFVPD
>fig|195.2279.peg.256 Putative metal chaperone, involved in Zn homeostasis, GTPase of COG0523 family
MAKIPVHVVTGFLGSGKTTFLKEILTNQALNDIALVINELGEVSLDHKLVQTDFIEEQTL
FLNAGCACCNKREDLQKKFKELLDNFENKGKKPQRVILETSGLANPAPIIFTFQSDVFLA
NHFELANIITCIDAFEGLNHLQNEEACNQILSSDFLILTKKRS
>fig|195.2279.peg.1182 hypothetical protein
NAILYININLPFKVSNMSTVSRMGGGIKTILIGVSHGGYLANLCAKISPWNIDVVLDNSS
NVTLDNDLWRFIGFGREIDYVKYCSVGITYMFKNIKLAAFDKTYWTTNKQSPYYFSNARK
IVREPLNKEHLKIQSLYPKPKYIAYHSKFDQYVLLEKRENYFNILRELGFEVDFIKITDE
KEIDGKFIKNLEHGCGIPMKLLIKKHLLQILKEPLQDKICKKEVSYKCDELVYTFKEENH
QIILNITN
>fig|195.2279.peg.1054 hypothetical protein
MPGTNALSALYKDQGIPALLEDRTDLSPDLVTIFFALW
>fig|195.2279.peg.257 Putative metal chaperone, involved in Zn homeostasis, GTPase of COG0523 family
MLSSHHKIQREIKNIEIKSHKDDISSITLIFDKAINWNIFSIWLSMLLHEHGSKILRVKG
LINTEESYLTNINGVGHLIYHPTHTKISSLNHPSQLVFIAKNLKLDKIKESLENFLRLEQ
LN
>fig|195.2279.peg.1258 Phage antirepressor protein
MQNITSNLIFTNEQIAINYGLTTGLTIAKHLRMHNDEFIENTHYF
>fig|195.2279.peg.1819 FIG00470039: hypothetical protein
MISLNSHYPNINYPNNALSIKKDENNEYTYTKKDEPKSEEDAYWEDFVQKYFGEMLS
>fig|195.2280.peg.1845 Putative DNA-binding protein
MLSNNEYFEYFIDFVKNNDKREILKEFGGANIYIPSYKTLLRDEELKQ
>fig|195.2280.peg.667 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MKQDEGQFFTPIQICEFIMYSLPLQEMLSKSSKALRVIDYACGAGHFLNTYANELKRYLT
EDELKEHYKNIYGIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKA
KPQIESNSFDLLIANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQ
ILNDNAKAAIILPSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLR
KKETFKQENHLISQDYSLIKERIEAENLKDNESFYQNYLSAYCDFRKFDKELYSNFLNGN
LDSKLAELEAFKDYRNAFRQTSDYKRLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLL
YFSLSLNQEVLIIKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNET
KLNTLIYKSFLNTLDVIPQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSTQSEMSNP
FINSKFELVRLKDFVLDIQTAKRPSGGVGKYENGALSLGGEHIDNKSGYIKLDNPKYVPI
EFYESFALQDKGIVKQFDILICKDGALTGKIAMVRNEFIRKSAMINEHIFLLRCDNIAKQ
KYLFYILHSYSGQQALKSKITGSAQGGINKTNLESILIPNADFEIQKQIVAECEKVEEQY
NTIRMSVEEYQNLIKTILQKCGIIDDGGGV
>fig|195.2280.peg.1728 hypothetical protein
MDPIVNNHLINAYKDLESSLSQAYTDLYFCFENGKLKLVLSTLHNNIIECFKKMNSRLPS
TENSNNHYWADDSRKLKFNIELALYLQKEFKDSELSFWIDEYYYNVFKQCLNFLKSSEGS
EIPLGMQKITIYEAIPIFVKLNSISNPEVNKNYSLDLIGDGSYAKVYKYYDEFY
>fig|195.2280.peg.1700 hypothetical protein
MNTQNTLKKHLIKIIHTLRKDANLSDDESYRWVLNQRYGKASSKDLSIDELRDFAITLGY
DEKFLKKQNTKKTRYFKKEN
>fig|195.2280.peg.1701 DNA topoisomerase III, TraE-type (EC 5.99.1.2)
MRLFIAEKPELGKAIAEGLDGNYKSGEGYIQKGDNIVTWAFGHILELAKPEEYDEKYKLW
KLEDLPLPIKEFKYLPKKESKKQLKIICDLIHSDKITSIVNCGDADDEGQILVDEIIQYS
KTSKPVFRVLINDLTPKAVKEEIAKIKPNADFKGMSERGFARSQADWIVGINLTRAYTIM
ARKNGYEGILSVGRVQTPILALIVNRDKEFENFKSINYYSLLGDFNINNNTIKARLKTED
KILDENLAKEIKESCENQNAKINLKIENKKEYPPLPYNLLVLQAECAKLFGFSPDKTLEI
TQNLREKHKAITYNRSDCQYLPETMFEQAPNILNIIKENLNSNDEIQALIASSDLTIKSK
AFNDANISAHYGIIPTQNKISSQLTQDELVVYNLIAKRFIIQFFHPREYQTTTINLEVNQ
RIFTATQNKTTKSGFRSLWQNIDSEEEQENNENDINDLSILKNGDIAKCSLIQIEKKQTK
PRPYYTMTTLLKDLNSVAKYVSDERIKKLLIEKDKDKKGESGGIGTPATRSNHIKTLIER
EL
>fig|195.2280.peg.609 Putative DNA-binding protein
LKEFGGANIYIPSYKTLLRDEELKQDFKTLIKQGISTKNASVECAKKYDLSLNAVYLITK
ELRENLEPSLF
>fig|195.2280.peg.1764 putative serine/threonine protein kinase
QINNPYILKVYSLDENKKEYIMEYVDFTLKEYIHKNNSKLSSDERISLGIQIIKGIKTLW
NKNILHRDISLKNILIKQYDDIVVIKISDFGLVKELNSELTSENTEIKGSLNEISRLQKK
GFNNYDKSDEIYALSRVLYFIATGRTNLINTKCDFLEKGINDNVKNRYNNLDDLMRDFKH
YIKKIYN
>fig|195.2281.peg.205 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MKQDEGQFFTPIQICEFIMYSLPLHEMLSKSSKVLRVIDYACGAGHFLNTYANELKRYLT
EDELKEYYKNIYGIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKA
KPQIESNSFDLLIANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQ
ILNDNAKAAIILPSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLR
KKETFKQENHLISQDYSLIKERIEAENLKDNENFYQNYLSAYCDFRKFDKELYSNFLNGN
LDSKLTELEAFKDYRNAFRQTSDYKKLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLL
YFSLSLNQEVLIIKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQNET
KLNTLIYKSFLNTLDVIPQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSTQSEMSNP
FINSKFELVRLKDFVLDIQTAKRPSGGVGKYENGALSLGGEHIDNKSGYIKLDNPKYVPI
EFYESFALQDKGIVKQFDILICKDGALTGKIAMVRNEFIRKSAMINEHIFLLRCDNIAKQ
KYLFYILHSYSGQQALKSKITGSAQGGINKTNLESILIPNADFEIQKQIVAECEKVEEQY
NTIRMSVEEYQNLIKTILQKCGIIDDGGGYELNSILENLQKLESKLDFNLLLSLIEEQIS
HSEVLVEETQSKERKQDFNAFKNFSKTIQELLQTLSTPPKDGWKRISLKNEQYIELNPSK
KEISKLDENMLVSFIEMASVSDKGYIQSKIDRSLNEVRKGYTYFIENDILIAKITPCMEN
GKCAIAKNLTNNIGFGSTEFHIFRAKTGLDSSFLFYNLNQQNIREKAALAMTGASGHKRV
PISFYENLTIPLPPLEIQEKIVQNIELVEQQIDFLNLKLELLEKEKEKILQKYLFS
>fig|195.2282.peg.1776 Motility accessory factor
ENAKRFLDDALALKQILENILSKDFLLPLEFLEKVYQNIENFNHSLDEDEFIQDEVLRGA
FAYRGKLISDVLKLHIQDKTHFITAYIKAYDEWLLYFIEKLEQKYKSLSKV
>fig|195.2282.peg.1789 Motility accessory factor
AYAGKGEVLTHTTWNDYRIKLEYLFACNDQKAKFYNATEGGARINFTEELSFKECCEKLL
TKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRFLDDALALKQILENILSKDF
>fig|195.2282.peg.1570 ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB11
MSITLDKYTQKYFGEFLKDDSINEICYNGDDKIWIQNSKGLWESVKTELDFESAGHFATA
SASFKKDKIDVSRPILSCILVGGERMQIVIPPATKSEHISITIRKPSKTRFKMEDHVKSG
LFEDLNPDDKNIIKPSDEELIKLYKERDYQAFYIKSC
>fig|195.2282.peg.1793 Methyl-accepting chemotaxis signal transduction protein
AIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNLLVQSINDMAESIKEQTAGI
TQINESVAQIDQTTKDNVEI
>fig|195.2282.peg.1569 ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB11
MKTLIDFISLDDRIITIEDVEEIKFYEHKNFVQLFYPSEAKSTDFLNSATLLKSCLRMKP
DRILLAELRGAETYDFINVLASGHGGSITSCHAGSPEETFTRLALMTLQNPQGQCVPFEI
IQKTLKDLIDIVVHIHAHHGKRRISGIYFKEIENIKLER
>fig|195.2282.peg.946 DNA-directed RNA polymerase beta subunit (EC 2.7.7.6)
MLDNKLRNRLRVDFSNISKQIEIPNLLQLQKASFDYFLNLENGESGIEKVFKSIFPIHDP
QNRLSLEYVSSEIGKPKYTIRECMERGLTYSVNLKMKIRLTLHEKDEKTGEKVGIKDIKE
QEIYIREIPLMTDRVSFIINGVERVVVNQLHRSPGVIFKEEESSTVVNKLVYTAQIIPDR
GSWLYFEYDAKDVLYVRINKRRKVPVTMLFRALGYKKQDIIKLFYPIQTIHVKKDKFLTE
FNPSDFMDRIEYDIKDEKGNIIHQAGKRLTKKKAEQLIKDGLKWIEYPVEILLNRYLANP
IIDKESGEVLFDSLTLLDESKLAKIKEQKSFEIANDLANGVDAAIINSFAQDNETLKLLK
QSENIDDENDLAAIRIYKVMRPGEPVVKDAAKAFVNDLFFNPERYDLTKVGRMKMNHKLG
LEVPEYVTVLTNEDIIKTAKYLIKVKNGKGHIDDRDHLGNRRIRSIGELLANELHLGLAK
MQKAIRDKFTSLNADLDKVMPYDLINPKMITTTIIEFFTGGQLSQFMDQTNPLSEVTHKR
RLSALGEGGLVKERAGFEVRDVHSTHYGRICPVETPEGQNIGLINTLSTYAKVNELGFVE
APYRKVANGKVTNEVVYLTATQEEGLFIAPASTKVDAKGNIVEEFVEARQDGETILARRE
EVQLIDLCSGMVVGVAASLIPFLEHDDANRALMGSNMQRQAVPLLTASAPIVGTGMEQII
ARDAWEAVKAKRGGVVEKVDNKSIFILGEDDKGPFIDHYTMEKNLRTNQNTNYIQHPIVK
KGDIVKAGQIIADGPSMDQGELAIGKNALIAFMPWNGYNYEDAIVVSERIIREDTFTSVH
IYEKEIEARELKDGIEEITKDIPNVKEEDVAHLDESGIAKIGTHIKPGMILVGKVSPKGE
VKPTPEERLLRAIFGEKAGHVVNKSLYATASLEGVVVDVKIFTKKGYEKDDRAIKSYDKE
KMALEKEHHDRLLMMDREEMLRVCALLSKAPLNSDQKIGDKNYKKGQTADISELEKINRF
TLTTLIKAYSKEIQKEYDDLKNHFQNEKKKLKAEHDEKLEILEKDDILPSGVIKLVKVYI
ATKRKLKVGDKMAGRHGNKGIVSTIVPEVDMPYLPNGKSVDIALNPLGVPSRMNIGQILE
SHLGLVGLRLGDQIQEIFDRKQKDFVKELRAKMLEICSIPRLVNEKEFIKNLSDEELLNY
ARDWSKGVKFATPVFEGVNIEEFAKLFEIAKIDMDGKTELYDGRTGEKIAERVHVGCMYM
LKLHHLVDEKVHARSTGPYSLVTQQPVGGKALFGGQRFGEMEVWALEAYGAAHTLREMLT
IKSDDVEGRFSAYKALTKGENVPATGIPETFFVLTNELKSLALDVEIFDKDEDNEQI
>fig|195.2282.peg.296 Channel-forming transporter/cytolysins activator of TpsB family
MGSKKDSKDSLYKIEFNKVNFNLSYQKSFYANDGLAFLYQNSLGASYSNEPLLYADKFLI
GDEYTVRGFKESSAALDYGAYSNNTIYLQFLNAPKYLRALEPFVGLDMGYGRDYLLPNKD
F
>fig|195.2283.peg.1816 Motility accessory factor
QSVYLSLNEKEEYLNLAIEKIDEFKNKLEDIKQMQDLYDILQSLFIQFELNLARIYVLNP
KTKEDAFNKSI
>fig|195.2283.peg.1803 Motility accessory factor
VSTGPSLTKQLPLLKKYANTATIFCADSSYPILAKHGIKPDYVCMLERTEITSEFFNNDF
GEFDKDIVFICAGVVHPKAIEYLKGGNRKYLIMPRYLYFPIYIKLNKYFYFLYNTPSVAH
MSYFLSVLLNHKNIILIGQDLAYAENGNSHPDDYQNSATYESQAYEHILTEAYGGKKEIK
THEFWIFFKQILEAMIIKYHITTYNCTEGGARIEGTIEKPFLWACENLLDK
>fig|195.2283.peg.1755 Mobile element protein
MQITKGFKYRIYPNLEQQKLLNHQFFIYNQAYNIILDLQKKQMQINKNLDKSQRTYLKES
RLKSQPSLVVGLKAYP
>fig|195.2283.peg.705 Pyruvate-flavodoxin oxidoreductase
SHWIFGGDGWAYDIGYGGLDHVLASGENVNILVLDTEVYSNTGGQSSKSSRTGAVAQFAA
AGKPIQKKDLGQIAMTYGYIFVAQVNSTANYSHLIKAIMAAEAYDGPSLIICYSPCIAHG
IKGGLGYSGEQGELATKCGYWPLYTFDPRLEEQGKNPLTMVGKEPDWDLYESFLMNEVRY
NSLKKSNPEHAKELFERNKKDAQRRYRQLKRIAMADFSDEVES
>fig|195.2283.peg.1761 hypothetical protein
MKQEAHLSFSRWVIHKENSKRIRRNAEREREKKYFKNKSRANLEKDRRVIKC
>fig|195.2283.peg.1749 hypothetical protein
FKDFEINENFKNEFNLLVEKFDCKNTKNILDKINNLYDFNHRNDKIDTAKKQ
>fig|195.2283.peg.1735 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MEKNPLFKGLTRPPMIFGVPMTPFVIAMGSIILVAFYSQNIFLVGFSIPVFFIMKAMTKK
DDFIFRLMFLKMRFFSNPASKNYYKAKTYSTNSYRQMPPNSNFPKISVFGLNAEPNFEKL
IPFSSLINDSVVITKDYLLMTTWEIGGISFEAEDDDELDIKNDLLNMLFKSFANEPVSFY
FHNCRYSIEDKLTSKFNNAFLEEIDRKYYESFKQGTLKKNSLYLTLIFNPLKVKIEKTTF
MKSSFENKRKTISVFLAKFSEFADRLEANIKDFNPKRLKTYSKDDKTYSKQLEFYNYLLG
GKFNPIRVLPSPIDQYLNGNLQNIQFGHDTIQFNQNDSTKRFARCIEIKDYTNETFAGIL
DILMYLDVEYTITQSFSPIPRVDAKSAISKQKKQLIATEDDGFSQVEQIDEALDQLTNGE
ISFGKYHFSILVYGNTIKECKDNTNEVVTKMNELGFAVTLATIALPATFFSQLPSNFTIR
PRINLISSINYSSLIALHNFSMGKRDKNCWGDAVSILKTPNKQPYYFNFHQSSGVNKNDF
GKFFLANTLILGQSSGGKTVFMNFIVDQMMKYASKDTFPDDIPEDKRKFTAIYLDKDKGA
LGNILCAGGRYISIENGKPTGFKRI
>fig|195.2283.peg.1491 hypothetical protein
MIFTIKGKIRFFGETVASSYTLNEIQRNEIIRATQFWANIIGASAINSSPIPISVSTFDI
PNANALSYDFFSNPILIGYCKEKV
>fig|195.2283.peg.1572 NAD-dependent protein deacetylase of SIR2 family
MKNIMILSGAGLSAPSGLKTFRDNDGLWEEYDVMEVCSATGFRKNPKKVLDFYDARRAQL
QNVKPNHAHEKIAQLKEKWGKNLMILSGAGLSAPSGLKTFRDNDGLWEEYDVMEVCSATG
FRKNPKKVLDFYDARRAQLQNVKPNHAHEKIAQLKEKWGKNLFVITQNVDDLLERAGCKD
VVHLHGFLPELRCLKCEGIFNIGYEKFTDKQCPKCKSKDLRHNIVMFEEQAPAYATLYSL
LNQTSLFISVGTSGAVLPVGRYASMCEKSILNIYEKDANLEWYFDKIYIEDIISAIDKIA
LDIENFMKDGNV
>fig|195.2283.peg.1776 Thiamin-phosphate pyrophosphorylase (EC 2.5.1.3)
VCMREVLMREKDVKKYLVECKRNLL
>fig|195.2284.peg.554 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MLEIKKEYKLTQAIKLPSLLCNTEEIFSFYNHSIIPNFITQKSITAFTAKENDKDLEGKI
VLIYAADPGYDYLFTKNIAGLITCYGGANSHMAIRASELGMPAVIGVGEENFEKYLKAKK
INIECESEQIFCL
>fig|195.2285.peg.1204 Endonuclease I precursor (EC 3.1.21.1)
MKKIISVLILAFSLLNAKSFEESKKELVKFL
>fig|195.2285.peg.1875 Motility accessory factor
FSRIYFLELMSHYYERFHEDILGLNKKLAENFKNIILRNGNDPKDALQGIEQFVYNLPQM
ITHPSYKELLSKRK
>fig|195.2285.peg.1834 Putative integral membrane protein
MNQKNGNGLNSIKKIISKCCNTDNFDISEQKNDKDVLIFKICSNEVLNIDLDKLCAQDFY
ICFEKCTIKILRLSEKKIKINLNLFFNSCSFEEIEIYNVYFLGQFKISELVDTLEKIKDI
KFNHCAFNNLILEKNKFENNICF
>fig|195.2285.peg.1203 Endonuclease I precursor (EC 3.1.21.1)
MIKSDLYAPRNEYTKKGKINQRIKRIEWEHIMPAQNFGKHLPCWKEGGRKACKNDPTFAK
MEADKQNLVPAIGEINGDRSNFRYAEAPTNLKYTQYGNCKVYTDFKAKRFYPANYSKGWI
ARSYLYMSKTYNIRLSDQERKLMEAWDKQYPIDEKEKRIRELL
>fig|195.2285.peg.1871 Motility accessory factor
YQSIKHCRDFSKILSNDFEKIQSVYLSLNEKEEYLNLAIEKIDEFKNKLEDIKQMQDLYE
ILQPLRTQFELNLARIYVLNPKTKEDAFNKS
>fig|195.2285.peg.1097 FIG00469622: hypothetical protein
MGSLVWDIINILNGDQQDSEKICQILDLLSDFKNKHPEDFDKIVDILKEILDEYEKNPSE
VKKNLKELF
>fig|195.2285.peg.1797 hypothetical protein
MYKKVLVIAVHPDDETLGAGGTLLKHKAKGDEIHCIFCTDIFEDEGFSKEQIDTREQELQ
EISKSYAFTSIHRLGLKTTKIDQYSQAHLVSLFSQIFEKIKPNILYLPFAYDVHSDHRIV
FQTAFSCTKSFRYPSIEKILMMETLSESEFAPALTHQSFIPNVFVDISDFFEKKCQIMKI
YKSELGKAPFPRSIENIKALATFRGCTMGGGGILANAKYAESFMLLKERC
>fig|195.2285.peg.1880 hypothetical protein
MQENSISYPCGNKVFTFKDVENQLKLIIN
>fig|195.2285.peg.1228 Phage tail fiber protein GpH
MAKSEYYTILTKIGIAKFIAARASGNGVNLKSFKLSSKVILPSEEMQSLEEIVYEANINS
KSVDENNPNYINLMCYVPSDIGGFEINAIGIYDEVGDLLAVGNLPRTYKPILKEGSAKEL
MIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINTKEDKGV
AANLDKALKTELTKLINKKENTGT
>fig|195.2285.peg.1874 Motility accessory factor
IHANLHNGDYERDLDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMNYHITTYNCT
EGGARIEGTIEKPFLWAC
>fig|195.2285.peg.1754 Integral membrane protein
FEEKTKIKKIYLYENEFKKHFFIKKCFIGSINLWKNEFKNRCYFMDSKFGYDEDENKKAK
LNFSNARFQDNVYFNNSHFYDYVDFHECEFEKITCFYGVKFYKTPNFSACYFKEPKAVNL
INVDIDKLDFKSVEKYIEDNYKDESYKNETKGMQDKKEFFKIKNKHKLRYAKNLKDSFRV
IKDVLITQNNTLEAQEWHKLELYAKEKENHINLSVKDREKNADIFKNILIWFNCVLLNVY
RNTSDHHNDFLKILNFTVGMIVLYGVFIFFCQACIEPYSKFFNELKSSVIFIIIGILVFL
CWIMFYFNRKKSIFAKSIFFIIAMVFIVLYLVTYFYKTNEYKTILYLVMCYILSIYICYF
FFNIKNIIFNIVFKFMLYLVFLFFLINSSQLINPFTGVFSSGKLYESKFEKSLNDLNASV
IINLASILQNDFNLHLKDQNISFTELNSAKALIVANKENLLKLNDANLNRAKEVLGEKYT
ELLKTINQDEITENTIKSTSVLYSIILLLCIFSLQKTARKNSIVPS
>fig|195.2286.peg.1079 hypothetical protein
MFQNLDSQTITNFYNTQERYNEAEQLGMFGHINIGLQPLNFTPQSMQTQNLDENSAKYTF
NPDMSVYPQNEDGSYSKEALFMSFLKSSGGEALEGGNTTLNPLVKAHIEAMTKESFDGSL
ASLDDIMTGKVDFASLLKGYAQDGWLDADIYAMEKGVKWQNTSIGYGGAWFDNQFNQAKA
NGWKAKPSTINSYADSIMDRLNNLLGQTRV
>fig|195.2286.peg.1339 phage uncharacterized protein
MLFSKEELDEFLISNEQKHENTPNELKGAMQRKDFLEWMDELKNELKTQFLHESHLDPTL
KEKRIKRASVDFDYFARTYFPHYFTIKGECGLHLHLNEVFTKIALKKESKGEKHAIAAPR
AHGKSTYTSQLFPLWCLVFNYKSFIVEISDAVELMEGMLEAIKAELEDNPHLKLDFPEVV
GIGKTWP
>fig|195.2286.peg.1882 hypothetical protein
FAIPKKNKIKFALAKIQASPLAKIKYDRIRWEGIGGKRNKKNKNDKARQIQALKNNRQKG
NYTEMQMDKYYKAKGYKRISLNKVQGLDDKIHHGIDGIYYNPNKNPKYIIAEAKFGTSKL
DRKTKQMSDEWITEKSRNRLGIVDEKHRKEIKELLKKNSNEVRKDLFHVDKKGNVSIKEL
DKNAKTKNLIERIENGKRY
>fig|195.2286.peg.1423 hypothetical protein
PYDAYANVDEKGYLINEEYAYIYDEVNNNKETLKSSLFRQEWGIAAGILGKPEYFVRSKN
HGFNARMIQCFILYIQLTGGGYEELGIKRGIYNYADNLLEIGIGMAEIHKNPLRAKLVKE
LAKTIQPDEFGMLPFIDEIMGADWVIDLNKYDFAYDKEGRIIWALYNDIEKGKLKDPRDV
DSTPESRNEFDDAMDGYRNGMKTNFDVDIRNERDERSAKLTMDTLILSAKLAALTPPQGY
PNAPYYFTPERLEWIYKRGYLDKLLDPRIPAIYRYNFPKELRAKILKFDEKNGIKD
>fig|195.2286.peg.1077 hypothetical protein
MFKKLLGVTALGALLASSAFAGDFLAKVTNGALSDNSPGVKALSLDEMKEVKGGVYFYRD
SSYDFTAGLRSYAYVATENGTEKGSHLTAQKMGIDSTKIILAKYRYVNNRKEHYLQSYDK
SSGRLNDIWAWNGSYALQVLNDFKKRY
>fig|195.2286.peg.1817 hypothetical protein
MQKILQIDLEKRKALENLKNLALLELGGTILLNLKEQALDFSQELTYINTYDKYLNLKLD
SFYIPSTLLSLLQLTKKSKEAFYINVLINSNTHYKNPLLQYAITQKQEQENIVYALKNDA
NLNASFANLNALKLALEEKNFYLNFIDLNSKESLLSFYNQIISNNHLKDYFYIKNNQFFI
KEDIKNKIVFHNINSSSSIISNYLRLLNDFNTLSKIELINILESLSLYNLSTLMQTMQNI
QSKNEYNSKDFDKDSIFLSNMIMNVRLK
>fig|195.2286.peg.1809 FIG00471674: hypothetical protein
MEKNIEKLILEAYEDSKTKFDHVITTGHISQYLKRKYDLKINCSKALYRSRL
>fig|195.2286.peg.1381 hypothetical protein
MLKKLASSLILGSLLASSAFAGDFLAKVSNGALSDNSQGVKALNFDEMKEVKGGYAAQNR
MAPFLVGGGYWLARQGAMWGVRYAAWGVFSERHPLNSGVGSKGWRY
>fig|195.2286.peg.1911 hypothetical protein
MKIKNFTLIASNHNLEIELKNLTKNVNKIIFICSDFDGYKEAKNSLYKTLHTIEDKFKIN
KKKTFKLYI
>fig|195.2286.peg.1880 hypothetical protein
MVKEIDYDLLIAIEESDVRKFQIALEKGANINGIVNKEYKEYGDFKSSCGFTFLAVAAEI
ALYETINAHHDKKGFNKEEYEKEYSDAFEIFNTLKALKPNENQEGCTSAKICIENIAQTR
EMELYDDPYCYGYDEFDEEMSEDEWISEDPAIEYLKSFKFE
>fig|195.2286.peg.1814 hypothetical protein
VENIENFLKEIQKELNILLKNIKESNYFEQEIKPKIQLTLDTLFNTLLKNITQSNDDEYK
QIIRAIAKFFINILDSVTNLKKPVSLVKKILMFLL
>fig|195.2286.peg.1922 hypothetical protein
QVDKKQAIAKLHALLENQNLECIHGGKVILQSNKGKAFKDDGVPIMLESDLLNF
>fig|195.2286.peg.1703 hypothetical protein
MKISKEAYENSKKAYEDMQKVYKYLTNFVASYQNSQKQLKKN
>fig|195.2286.peg.710 Ferrous iron transporter FeoB
LIAAKFLRSTAFRGIDEPFVMEMPKYRMPNWHLVWFMVFNKAKMYLKKAGTFILVASLLI
WFASNFPNNESNLDDFSAQERAVEQSYLGQFGKTIEPIFSPLELDWKLSVSLVSGLAAKE
VMISTMGVLYSLGKEVDETSSDLKGIIAKNIPLPSAVAYILFVMIYNPCFAATIVFSKES
GKIKYTFFLFLFTCISAYIVAFIGLNITKFVIN
>fig|195.2286.peg.1942 Motility accessory factor
DKAVIFCADGALSMLEKEGIVPDYVLNIDFKDCHAMKFFQNKENLKQSIIALECATHPNV
ARSLNAENCMIVLRNKALYQRFNFNDFGYI
>fig|195.2286.peg.1699 hypothetical protein
MSALLLGNIKASPTAAVGFKARQQQALFLQAQLGDKNAFKSLGLAVLCSNSFLTGQHWNK
LRAKMIYDLHDYHYESLLDEFGILPFLDEIIGVDWVIDLNRYKFALDEEGRIIWALYDDI
EKGKLKDPRDIDSTSESRKEFDHYMDGYKNGMATRFDVDIRNKRDERSAKLTMDTLVLSA
KLAALTPPQGYPNAPRCYSPERLEIIYKRHKLDKLLDPRIPAIYRYNFPEDLRAKIRTYA
KEYNIKE
>fig|195.2286.peg.1917 hypothetical protein
CIEYLNHFMKNIQIYTETFVLKNNATNKNSSFGFNKNHPEKINHFEYSLSLIATIMQETN
GILEELGDSYYTSYKVPIIS
>fig|195.2286.peg.1750 hypothetical protein
MRKNKLNFCLTAREREREREREQNNLKLFLIFKLLQLHNPYKKNPDKFLTLVIESKGLLN
E
>fig|195.2286.peg.1808 hypothetical protein
MPTTISFKRLYLGYIIALCPLAQLFTFFSKKQKSLKIRVLA
>fig|195.2286.peg.1379 hypothetical protein
MINTLVDCKLLAKENNLMKKSFLPIYFVNEILFTRWQR
>fig|195.2286.peg.1541 hypothetical protein
MLNHEKITPFVCFGWGCDFASDEKTVLAKLNVLNEFYYLNKTYIFKADGNSDHNYFSPVS
MYFREEKWEVNEMFEIMKEIAETSLRYYIF
>fig|195.2286.peg.1805 hypothetical protein
MYFSRAKIQRENYSKTIFILIYFFCFFTYLYSKIFINFSIKKYSKSKPTKRQKIVLIKH
>fig|195.2286.peg.1540 hypothetical protein
MFEIKKQIEISFMIENIKLSKIRAEFDSSFLKIKLSLMVEFYF
>fig|195.2286.peg.718 hypothetical protein
MIFFEFSNELFCPHCQARYRSNFNSAMFWADISSFLV
>fig|195.2286.peg.524 hypothetical protein
MLIALIIFISLTYHFLQRPLELIFWDRYYHEKEYQNAKDMYKLFKSNEEEFKKVFKEQNL
NEELKTNQKELLNYMHHFKRDTNFMQILSLDNAYLKALRDKTSIFGRKSENNLNYFYLAS
NSTTNLDEMNNFISIIDKYIIFINKIDTLPDTYALMKIAFNADYFLFNLIPFASSLDKNF
ICSMPQKEQLLENMINSYEKMDLLYKTKLKTEIQEMIYPAIYATKKLNHFIDIAKGRLNA
CGK
>fig|195.2286.peg.266 FIG00469380: hypothetical protein
MFFKKKITQKQNTRAKISINDAVLDDRLYKFKNKIQK
>fig|195.2286.peg.1704 hypothetical protein
MFISSKTELIQTIKNLTINNKEVKQIDFIYPNFSILHAILKNIDFHQRKMLSKNQILAME
ILEILKQTCDNHNNIEVNIHTLNELDAGQNVNLKDLSSSEICTKVYLEDLEEEIQDKKQG
KDLNLFYHTDKNNLCIEFINTLKELAKDSEDITTLDELIENIDPDNISSEKFDDFKKKVL
EKIGNVIESDFFKNSISPTLKNTYEKFINELLEHIKKLAEEKEYEKIKIILSAIAGVAIA
TVVAVLTGGAGLAILAAGLFSLMGSASEYYEFAQRDYGTLLTPLAAFLATRCAMFIHYIN
SRLLSCVLIIDKKEIIDLSGFGLYLGSDESNIASNLAYKITLSEEIKSIENIFSEIFLNP
EQKDKGYKNTPNDSKSSNLPAFISTQKLSNLYLKNNAILKNLQEDIKQFIYFSYIESPNF
NSSKLAEFFAQKNQNVQIDLNTTKMSKNYLIISNIPNKYNAGLSESLTQEIANYNIQDKY
RRIKKNIDTSKKTYDSTRDYSEYSIEMPQDENEPYILQL
>fig|195.2286.peg.1926 Flagellin
YNGIDDFKFQKVVISTSVGTGLGALAEEINKSADKTGVRATFTVETRGMGAVRAGSTSED
FAINGVKIGQIEYKDGDSNGALVSAINSVKDTTGVEASIDENGKLLLTSRDGRGIKIEGN
IGRGAFINPNMLENYGRLSLVKNDGKDILISGTNLSAIGFGTSNM
>fig|195.2286.peg.1921 hypothetical protein
MIYLISSIVACPNTIAGVSVPCAKVVNVKGSLSQKKVNNEYVILQELISACISD
>fig|195.2286.peg.1924 Motility accessory factor
KLHIKDETHFITAYIKAYHEWLLYFVEKLEQKYKSLSKV
>fig|195.2286.peg.1702 hypothetical protein
MTTIKKINDKKWLPYFYIKKFFKQNEAKESTIEKEKKIAHQYLTFLKKEFFEKSDKSSFG
NYSLMECLFISFVLYQAKLIFPNINLDLKKYGGSNFVYIKYLEETHVLWTDECPIYVNNE
PTNITAYEVVSQLLKILDKKDYSFVENDNSITIDDFFNELSKDLDTTNTLDKKIIKLKQM
YHLDEQKCIKEFMNLDEETQRAFVAWMDIEKQISDLSKLLEQMYGKEYLNKAKEQKTSEI
FTYAMLKILLSASPFISFTAQMLWDFNFLKTIEYVIQACIKINKEGFKEFFKEQLGIFAP
PKKNSIYHIHIKSNLIIKARLQQIEKELIHTKIQMILAQEIKSNLIIQKNTSGLNLFITK
IKEYFNEKQIKIYWSDKYMKQLFIYSNQESNISKIALMHSIDIQTQKYTIYTYAKLNKLD
LASIVTGEFVGIF
>fig|195.2286.peg.233 Membrane protein
MKKFKDFSCNFLFKISDQPVLLRDLLEANALFNDGMLVDPSKLNFNFKILNSYIYFGIFC
ALVLLPLLLITHYLFTRLDFHISIISAVAVTACVFISYDIFKVYARKMISKKLIQKAWAL
HFPYFSYEKYSIMAGNFYKEALKEEIPKANLEQYVLEKIILLNNLKFDFESA
>fig|195.2286.peg.1878 hypothetical protein
MTKEKIISYEEVQANPMLKWFFDREIKHSIKDKYYKEWQEFIHKEGINVVCIIEDPKGKD
IYELDLWYRSTILDPLFHLAWCYDYEFFEFILQFVKDQTWLNFLLGCNAIGWSEDELDLE
HTKKIIKLLVDKGANINAYFYDSDGQYKPIIFHTIPLGLASKTERANKLELLHFLLELGA
DPNLKNSEGENLLHSFLLSEEQKFANALIDSDKIKDINEIIEYNKGAINYGESALILAVE
ECYSSTVKKLIEAEANVNVFDHFGESALDLIENKSETIKKYLLKAGAKSSLELLGSEEKL
REFKDEMRDKNEMQEKIRKERKKQLKENYRAIVEKTPLVFHRDIEVIKA
>fig|195.2286.peg.1816 hypothetical protein
MYQKKLGAIIKNRPKALTKNEKLGLKEQFPSKRDYGSYFIERDVKKEDDFVLQLCPFVKL
DGQIYQKYKEYFNFYNQTYSWVKLYLLEYINERLEYEKVKQDFAYIDSFFKLPKELEEIS
EKEKEKVEEYVELFNNYLDNINSRYDQIQFFLELDSSISKTYENVDFKKYSPLTVVLLTL
TLYVLQKDLAFTQEYSLGVKNIVIPNLDYSDKEISLNYQKIKIPNYFNEYILFIPDDIYF
NEWGMAAGILGDYKYLANDMFQNGFNARFIQATILYIQLSGGSSILDKPNLLGAIYGYAD
IAVGSGLVGVHKNPLREQEIKTLAKTLKPDEFGMLPFRDEIMGVDWVIDYNKYRIARDEF
GSMYKALRSDIVEGKIKDPRDVDSTYESRREFDRHRGGYYNGMVNGYGADTPNDWSEERA
QLFNDTLILHAKLAALTPPQGYPNAPYYFTPENLEWYYKRHKLDKLLDPRIPAIL
>fig|195.2286.peg.1868 hypothetical protein
MSETYEIYTPDGLTLDVEKDTNKILFKENIKPTGNYTEEYSKAVFKSYYIMKNSPYKDYQ
PKYLDPNFYTGKASTLLEFTEWQSIYLKDPIKGSIAPWTKAEKAYYKSLKTKRERYKYL
>fig|195.2286.peg.1378 hypothetical protein
MINGINSYSSYNYTNTFSKNTSNIKSSNVANDNSSLVSDKSGAVSKMLGYGVDKDGFFTS
DFNEAAGLPKDYKIYAKGAENLASYITNLNFKSFTNIDIAKSLGNAYKVFSQLVDEPSGN
FTTEDLSKIPLGFSYDKKSFQVTNIYQTQKEFDSALSANNDLQIYQSSKQLALSFPSWNE
NSPNDYTKKNSDIFAPSSHIDIGASFYKNDNGTISKGGVLMAFFAGMSGQNPLMEGETTI
SGKLNGYDKNMSQNQVEDLNEFIKQNPIKYGITGDIGTDFTNILKLKNNISDIEEFKKQW
LEMKAKSDKMGEVYQTEIANKKEVVSSQETSEEGKEKPFKPIQAESSSETYKDDNKMNEL
VKKLLETKFGTSDELELLFGVKFSDDDAGEFNKFLSSNSTPKSIDIKA
>fig|195.2286.peg.1936 hypothetical protein
CIEYLNHFMKNIQIYTETFVLKNNAINNKNFALKNGPLGLFRSSPEKINHFEYFLSLIAT
IMQETNDILEELGDGYYTSYKAPTISQTKIIDFILKAQEKEKYILILDKNDFNKYRKDCS
FI
>fig|195.2286.peg.1810 hypothetical protein
MFQFAYFPNFLNTLQELSNIAQKEFWGNGNNILFSYLFKYFEFIYENKSYPDIITYNKDK
TKACFNTGLYSTGIFPIFAYFEKQENGGYVFRKFCSNGDRVLDDLEIPKSLSDYDTFKNE
IIFDSKLDFRVNHLHLFERKERLPEIVKKLNDRFIGHIINGELKIIKDNYNLQKMIIPAA
YKQRVVLYIPLKLQEESVDTIVVVEKEEVKNEQYYAVRTILNPHDNIYKTARVLSIVESE
WVKNTI
>fig|195.2286.peg.1701 hypothetical protein
MIIDEKRNATALEDIKEQKYIIDDYTFYFKELKSLELKKCTIYQLPCNHPLFKEFRNKEK
QISAFKKDEDSPIHAYNEALQILQDFANGIYNTSKDKTGRYIEDKNKTRRLLEKLNIIGQ
NNLKAMYMGINGNEESLKNKDNEEGNEEDIESVTKNKQSQKLPPNFIGRLATTIIIEDGL
YMG
>fig|195.2286.peg.1102 hypothetical protein
MLTEKIDPKEQIQKEDIQKSKTLKEVFKEWVENFYKEKSNYNTPHRVDIHIISKLGDKDI
TTLTRQDIIAIYDKLKAEGKLETIKRISQAFKRIILYAINKEYIENSNILTLDMKALYGS
PKKQNLRAITKEERFKELLLAIENYNGSIFTKVALQISPYLFLRSTNIRNLEWSEIDFKN
LKIIIPANKMKKKRGGVKILLYH
>fig|195.2286.peg.380 FIG00438569: hypothetical protein
MIKIYVEGKSDKIFLDLLYKNLKIDEFETIPIGGNNLSSSDLKSIKEDISDMRIEKICII
FDADDDYQKTKENLQQQLKNLQNEKIKIFLFPNNKDNKEIEILLTKIAKYPHFITCFKEY
SKCLKDKRDNLE
>fig|195.2286.peg.526 hypothetical protein
MIISFLDDDIDKPYVSGSLYNGANPSLVNLPFNDHQTSLSSKTIGVNEEGYNKLTLSNIK
DKEQIYLKAQKDYDELVQHNFTQRILNDKDSIVDGIYNERIKKVHTQTIDLAKMSM
>fig|195.2286.peg.1891 hypothetical protein
MSLNSYMSLNISNSTSNPLPFKITKALIKESLEELFSIECEGFFESLEQDLFSLNTLTNA
SSHPSTPTTFNFHPNVLIDQEAILSIHNPYENNTLNFDNNEVKNYKGIITYIKYLGINHE
SALNINDSTSNTKQIQYKHFFSFKLQSVLIRLSLNKANRIYTHTNIIEVIKQTLGFYQDI
LHKEIDYSNIHFNYEEQELISQYNESDLDFITRLSHNNGIFFYEDENTIYFCDVYKNVKN
KEIEYNPNINNILNQACISSIYKEQSLRTNSFTHSSINADTPLNLLSLHSSKVPYEQELN
NKACYNEHFYESEYSFTKSIDLKTKPSLKEKRALVLNESLLAKSNIYHLSLGDFITLNYK
EFNHQEEIKNQDEEKQDKASLLKDFIIIANTQILIDDAILANSINTNDHLNLKDLNLSKS
YSNTLTLLKKNIIFTPSFKAKPKAPNSTQGIVIGESKDIESERNTIYTDEHGRVKVRINL
YANQEELDNDTFIANDIDTNSSNLSSNTYKSYHHTPFLRVASHIASNHSGFFHTPRIGDE
VIISFLDDDIDKPYVSGSLYNGA
>fig|195.2286.peg.282 Putative periplasmic protein
MIFNSVSYAASQAISIGDKRFQTPRHSFSNEEVWDFDDKTFKQINGTNYYGVFKQGLVSD
ITLEVFNPKQSLQGAKLEILTPNHSSEEILEVQSMHAANPMDKNLHPIKILPFLVAGSSL
KGDSINNKLLIKEAELSSAVFLEPSNIKTKNPPKKEEKDKINYVISGGLAREGNAKNNTL
ELLDGSYINMGVENIYNLKLNGAPYAVGGLAIFGDAIGNSLLAQKGSKVDIHTASFYRDM
VGEFILDERITHLVGGLAYNGKVEKNKLNLNGVEFNIHAPSGLYSSFAPVHIAGAFVDGN
GKKAYDATKNTLVIDNFLLNLRADGKTPIFYNAIFLANFFGGKTNKGDANANSIVLKDVP
ALTKNK
>fig|195.2286.peg.1895 hypothetical protein
MTREQAELIIEEEKLIDTDWYPSYKHSGEYHLTMWFDSDNNKYEAVYIGERGSVELEYSF
DSEKEAIDKMLQMNYEQKKYNGKDIKEYLTKEVALRIIKEEKLEVIWYDEALKPLCAGIK
HDKQRDKYIYLLSLMLKQSL
>fig|195.2286.peg.951 McrBC restriction endonuclease system, McrB subunit, putative
MWNLDEKKIQEMHDGFLNFQKVWTLEKVKNMTLEEYTNIKKDNPNRDDFTFWIESKLDNL
GSIWGGSAFKFGIYRRNDESQKESSSGRLYSQNYAWIAKYGNNENEAFNNIKEKIIQIIQ
ASQDNNLKTIEKIDFGDAIKWKIAFHYQDVKNIKIVNIFSKNVLDLISLNEFKEKLKIYQ
IHKKLLENKNLSLVKMIENIAIPLWNKYGMDSQNYIDKMKNLFSEYLNKKKLDKNTINKY
IQVIENISKEFLKENLYSCDLFSFDQNINKLNKNEEFKLKNSNGHNMYSSALNYYRAFLI
DYYEQDIFITERVQSEESNMKIIPLNQILYGSPGTGKTYHTIDKALEILGENLESRDEKK
AKFDEYVKNGQIVFTTFHQSYGYEEFVEGIKPHIDSEENSKEIKYEIKDGIFKELCEKAL
ENRDSIKNFNFYIDKLKEKVKIDDNNPEKYFELPNTKYSIQYRNGKTFRIKFDDMSKNHK
DYPVSIDNIEKLYKTSNIDEIYNSAYVRAILNYLKLQGLEDYKEKDEKVNLPYIIIIDEI
NRGNVSKIFGELITLIEASKRIGEKEELKVTLPYSGEKFGVPKNVYIIGTMNTADRSITS
LDTALRRRFEFIEMMPDVSKLSMDCEGINLQELLKAINTRIEYLLDREKTIGHAFFISVE
NLEDLKKVFKNKIIPLLQEYFYNDYALIDAVLNKNGMLEISVENKDYLKNMTEFIESDKI
VYKFSDSNNWSKDTFIKIYE
>fig|195.2286.peg.1947 hypothetical protein
LGIYTGKNDRSIKPLVNTLYFYSYLLELDANYNKVKDKSFSECIEYLNHFMKNIQIYTET
FVLKNNA
>fig|195.2286.peg.1732 DNA primase (EC 2.7.7.-)
MKNKDFIQETADKIIESLKNGTAPWIKPWKGIDLANNMPYNPITNKPYNGINSINLKESR
LKSQPSLVVGLKAYP
>fig|195.2286.peg.1700 hypothetical protein
MSETYEIYTPNGLALDVEKDTNKILFKENVKPTGNYTEEYSKALFEAHDIKRNSLQRL
>fig|195.2286.peg.1879 hypothetical protein
MITIHTGEIELILCEEAHFHEDYENKIKNIPIIGAKVKIYDKDKKTLLYDNTANDQGKIE
ISNSEIKDEELSFYIELEHPDFDEKPIGGHVFLRKGLEKQENPIYFRRTKLRLKHAPFEK
LQTPKEFKEALEVSDEERKHYQEKDGELDQDLNSLKAKAEEILARNEAIIEKTYEEERKK
AEGQLQRATTKEEKDEIGEKIDKIKNDREAKVKRHNKQTVDLKDIVNNKNTKKLKNFINK
RAGADYAEWVVSFALLRHAPHLYHQRINADGVFKEDGIHSGKGSDPDFIITLEDKKRMIV
EVKNYAYSSALNLTDQISYQLKCVRLYGMDYAIACNKSTEITDHGKNYKSVFKEPNNQAK
AKTKEEKEYSINFNKKRFKGPENQTKEEAENLLKDEEKGLRSALIRMYKEALNGGPSWVF
IKRLNFRSNLGKINGEDFNLDKHFVNFYANLHSQDRKEISADFQVILEP
>fig|195.2286.peg.1804 hypothetical protein
MKIHRKKDKILILILINFYFKSKIYRDKSGIKNTLLKKYLFFYLFLIDFYI
>fig|195.2286.peg.1797 FIG00470782: hypothetical protein
MTETSDIVIDIEACQNNTHENKKKVDFSQNFSQSNATTFSEDERQVLLSLGLEVKNEDDY
YWIVGNTYGLNEKIKQLGYRFHSEKKNMVEANWKCSLRTHMKIYYNLGVSMQGYDIKKEI
TLNESFKALLESIFSDTDQAKKLIQAFEEFANDRATTQRLNFGNLKQEAIEQIRNELVSK
DLFQSEIKRLEAEIKLSVSLLKQQGIYWLIGACVVSIATIISSVWAIMDFMVEHLK
>fig|195.2286.peg.1078 hypothetical protein
MSIFSINDNSNYGSILSQSKANKESKENSKISFANAFLKQNASKLNEIQNANSQTLARSE
VLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQADISTSTNTAYGYSVD
KNGYMGSDFNKAAGLPEDFKIHKSTLDEIYSFNTSFKEHTANDLGVSNYYTNIDMADTIR
QYYSKFNQIINHSFGNSNKTSFSVEDLNSLPKGV
>fig|195.2286.peg.1539 hypothetical protein
MPRQALMQNKNQHLAKNQYSKSDDLNIDLAMQQTKEYLENRFANGGGVSNFIEGNYYFV
>fig|195.2286.peg.1101 Mobile element protein
MFEFIKPFSFHNSKYVFPSDISKSKTMSENTLNQAIKRLGFGDEMVFHGFRTTASTLLYE
FKNLHGQDSEVIELCLDHRERNNVKATYNRSLRLNDRKLLMQYWSDYIDKLKGII
>fig|195.2286.peg.522 hypothetical protein
MTLRPIVTLNQEGYCIKEGRRLSQNELFERATKDWLEKLYNQAHDPLVMNADGDWLDITN
CYYSSKEKAKKGLNCQFYSNGKQFGIDDIAKQIDLNKSQEENMQKIMQGFSIVRPFEEEK
ILTDDLELKYSLLLQDRLSDFTFMPYDIRFIVVGGDTGYYSKFGYSVFALMIQKYFIGND
HDFKFKKGTVEYWKNKDNKNNHEYIYYPITNCGEVEMRYDFVLLDYIINYFMICNGGMNG
IVKFKRRLWSRNFILLSLGAKHTAK
>fig|195.2286.peg.1338 phage uncharacterized protein
MAVGEFVSNNGVKIKAFGSGKRLRGVRYGVKRPDLVILDDLENDTNVRSKDQRDKLEDWV
DEAVLNLGSADGSLDVLYIGTILHNDSVLSRKLKLGFWNPKVFRSIEEFPQRLDLWDEYA
TLYRNTDFNTAHQFYLKNKVLMDKGAKVLWKEAKSLEDLMKLRAENLKAFNKEQLNNPRS
ENQIFSLDGINFYDDLPAINQYYMYIDPAGEKAKSDFTAITIIGKGAKGFYVAESIVKIL
KAQSIIKTIFNLQKIYKCRLIEIETNGGQFFLKKWLQEKSLESGVFLPLRGKNNSVSKFE
RIESLSLAFENEELFLHKSQTMLINQLLEFPEGKNDDAPDSLAGAFLLARTKSSIKRRKH
HFNSVSRIRRF
>fig|195.2286.peg.525 hypothetical protein
MKGNKKEVVEGHYGINVSDKMQVLSEKEMDYKSKDNILFTSNESIGFESDKNTSMVADNI
TTYAKTIHELKADSEATIQVGETIINAKPDCVIIKAGGVEVTIDSNGLVVRGGELKAE
>fig|195.2286.peg.1856 hypothetical protein
MKTLEDIKAMSFEEKMQIQKQLFDFIKNNDLENVKNILKDYPVKESFYEAHFTYHHNNED
YELSLFDPAASLLRAAHACEDNNNDFSILDYLFDEYGLSLKDPKYNFAFPDMKHIKEANE
KYILIKKAKESNIICRNALIYAYILNTKNPNSQIIQYLVNRGAKFEVHDEGAYGWTPMHF
WVMQNNYELLELAIKGGANVDMQTRLIQESEYNETLLFEAVKEAETYRVTQLLIELGANV
NFATPRTPLDDAKGSRNKKLLKDAGAMTSNEIRKKYNLPAYDSSHCKIDGKTDMDLLGKY
LNECSKLLNDAIKKAKESE
>fig|195.2286.peg.719 hypothetical protein
MIKNLNKIACTFFLKAFDGIFATHPSLEKRIGYLEKYFGDSF
>fig|195.2286.peg.1898 Erythrocyte membrane-associated antigen
VLFDEKTLKMIEMMIPTYKDEISNTNKENEKINQMIKLAIEKMFKNDFLNKINNF
>fig|195.2286.peg.1881 hypothetical protein
MKTQNISANQISFHLFSTKTFSDEKYLNAWSLKGNRLNLQEWFEFKKANENNFYNKHLEN
TLKAMQEFKAYFSVDQFE
>fig|195.2286.peg.1438 methyl-accepting chemotaxis protein (tlpB), putative
MFRTIGFKVSAAIFVVLVLSFIAMQLILNLDFKNTADKMSKI
>fig|195.2286.peg.1883 hypothetical protein
MARDTSKDEAYFTKHIIEWEEEIKEDEKKLLELPLGDARRENYFFSITDGKKCIAIDKYS
RGDDINLVKKDLEAYILLKQKNRLEFAIDIGYYRGNALELCIRVLLDMDTACVLELIEED
ERKRRDILNRDWFLHFIGSKGKNLNLERKCIRKEHELIKEFVATKDIEFLHQYMKKHTRL
RDPLDTWDLEGAAIVKLMNLDKEEFKQYKYFPYDLI
>fig|195.2286.peg.1815 hypothetical protein
MCNEEILSDVLIIDDKVLLDFSSYSNVPSISLYKNSFYKVILDEEFQGIFDNFLENNLKF
ENEKLDNTLLVNSSLNNFDTTLKKAINLNISKLNHFFYAEYPDLNSSMLVEMILDKKILI
KSIQPKWVKIICLLLIHHSLTMQDFVRTCIKKN
>fig|195.2286.peg.1877 hypothetical protein
GAEYLENTLLSKDTNVGLSNTLNVGTDQEVKIHKNSYEKVGENKKVEIGTNYEERITGEH
TSSVSSNRKTFIRGYHHTQSQGKYSVYTDSELVTEAKGNIQEHTEKSIFMVAKKDHCVNA
ENVSSLAQKDNTIVAHNRIINQVKSTSITTTAKEVIIQVGGVQVIIDNKGLRVKGGDLRA
D
>fig|195.2286.peg.1613 Membrane protein
NSKFFIFDLISQILPLINALKEYFLYSLGLFWFRVLNFIFDFINFFIFCSFVAYLYNFAF
KAKKKTYVFVFSFFITLASFFIIEDKNQNPKAYQKELVLMMNNLSFLKEQNLSMLQNDKD
RLVKNLKQVQELLDKNAFEIGIWWFSKEKEELQKALNESLQ
>fig|195.2286.peg.1707 hypothetical protein
MDNKQQINKLRDMAELAQASYGYFHYVDNKFDIKDEDKIVTFENVLDITYKNSKIIDERG
FKIGKLDGDFSPLQAKQFFSRYDLLIHQPNTESSFSATLFYDKQKDEFIIGFRGTEVSFK
DLKATWETALDTTQDLVLSLNGNLQSSFLLEFLEQVNKIIKNKHKRITFVGHSLGGYLAV
VAMQFCDTIDRTLCTDFNQIKFSASKVYTFNSPTIDGIDNMLMRFLANLLGNNIVEQILN
PEKIVCVFDNGKIEIIASAQYGASNALGIYTGKNDRSIKPLVNTLYFYSYL
>fig|195.2286.peg.1844 hypothetical protein
MFLDIISKIFIFVAIHAMIIFIIKSHIAV
>fig|195.2286.peg.1899 hypothetical protein
MAIKIEISGFDKDFLPVFESLAKSLKATYCLLECDTPEEKKQSSMKKALEEMKNGEYETF
KNFGKIDLSQKPILSMFFLFFEQKLTHTLFSFFVSLTSQKKFVPH
>fig|195.2286.peg.381 hypothetical protein
MNEKELNKNLIYAYNQACGSGTKEICLDHYDLDHEYIKPLIDFLKA
>fig|195.2286.peg.1934 Motility accessory factor
EFLEKVYQNIENFNHSLDEDEFIQDEVLRGAFAYRGKLISDVLKLHIKDETHFITAYIKA
YHEWLLYFIEKLEQRINIIINSFKETQ
>fig|195.2287.peg.1585 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MEKNPLFKGLTRPPMIFGVPMTPFVIAMGSIILVAFYSQNIFLVGFSIPVFFIMKAMTKK
DDFIFRLMFLKMRFFSNPASKNYYKAKTYSTNSYRQMPPNSNFPKISVFGLNAEPNFEKL
IPFSSLINDSVVITKDYLLMTTWEIGGISFEAEDDDELDIKNDLLNMLLNHLQMNL
>fig|195.2287.peg.218 Fucose permease
MQPKSIILFFYGYILFFRRQFFFMSISFPTIFAVATKNLPLNQVKLGGSLLVMSIVGGAI
MPLIIGFINDHYGTGMGYLAMAPLFLYVAWYGFVGSKIKA
>fig|195.2287.peg.1651 hypothetical protein
MVNKSFSFCSSLAFSKLYLRKIKESFGILSLKYNKKKLVSWLICLLILIILIKQKILQIK
FL
>fig|195.2287.peg.425 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S (EC 3.1.21.3)
MSVEEYQNLIKTILQKCGIIDDGGGV
>fig|195.2287.peg.84 Two-component system response regulator protein
MSYLNDNSDVKLIIADANMPVISGSELLSEVRARFSDDELGVIILGDKDDALEASLLVSG
ANEYLVKPLSKESLNCRLDKCLHYMANMQFLSIYNNLDPISGIKNSNALLSCVEDYLNEI
VSKEEEFAFAFLDIDNLRNLNEEYGYEVGDKIIKICADEIVNETKGRDIVGRYSAEKICI
VLKNISQERAIKILSRIRVNIKKVGILVNLDEVFFTASIGVVFAKSGDKFEILVDKASKA
LSQAKANGKDRVEVCS
>fig|195.2287.peg.302 Mannose-1-phosphate guanylyltransferase (EC 2.7.7.13) / Mannose-6-phosphate isomerase (EC 5.3.1.8)
MVSKKSSSQKVKQIYEFIKENENLSKNHLCTHRPWGSFTILEDEKGYKIKRIEVKPGKRL
SLQKHFHRNEHWIVLSGTASVEIDGIESLVRPNESIYIRMGQKHRLSNYGKIPVVIIEVQ
VGEYTGEDDIVRLEDDYKRI
>fig|195.2287.peg.1584 Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB3 / ATPase required for both assembly of type IV secretion complex and secretion of T-DNA complex, VirB4
MKIEKTTFMKSSFENKRKTISVFLAKFSEFADRLEANIKDFNPKRLKTYSKDDKTYSKQL
EFYNYLLGGKFNPIRVLPSPIDQYLNGNLQNIQFGHDTIQFNQNDSTKRFARCIEIKDYT
NETFAGILDILMYLDVEYTITQSFSPIPRVDAKSAISKQKKQLIATEDDGFSQVEQIDEA
LDQLTNGEISFGKYHFSILVYGNTIKECKDNTNEVVTKMNELGFGVTLATIALPATFFSQ
LPSNFAIRPRINLISSINFSSLIALHNFSMGKRDKNCWGDAVTILKTPNKQPYYFNFHQS
SGVNKNDFGKFFLANTLILGQSSGGKTVFMNFIVDQMMKYASKDTFPDDIPEDKRKFTAI
YLDKDKGALGNILCAGGRYISIENGKPTGFNPFMVESTQENIRQLQSLMKLLVTRNNEIL
TTREEEMLNNAVNSLMKGFEKEERKYPISLLLENLTENVDDDNSLKSRLALFKKGKQFGW
VFDNEYDSLDFPDDINLFGIDGTEFLDDKDVSGILSYYILWRVMSLADGRRLCIDIDEAW
KWLENEIVQEEVKNKFKTIRKQNGFLRLATQSLEDFLKLKNAATLIEQSSTMVFLSNPKA
KEEEYVKGVGLSYDEYMIIKGFNPVKRQFLIKRQDEKVICTLDLSPLGNENLKILSTETA
YIDVIEKIFSQENKSLDEKVLELKEFYKNS
>fig|195.2287.peg.1858 Motility accessory factor
LNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNSHSKGFDFGEKFSGEEN
IDKLKVTAYAGKGEVLTHTTWNDYRIKLEYLFACNDQKAKFYNATEGGARINFTEELSFK
ECCEKLLTKEKPKFELPKSLTKNRSDKLLVKFKEKIQKDQENAKRFLDDALALKQILENI
LSKDF
>fig|195.2287.peg.85 Two-component system response regulator protein
MNKKILLIDDNKMLGKLLAKKIQTTLNHEVDIVFSLAEVKALPNDEYFLTFADLCLPDAP
NGEVVDYVLAKNWPVIVLTASNDKATRDKFMDKDILDYIFKESDTCIDQIIDSIVKLECY
AKTKVILALSKLPERNEIKKFSHKENLMFWPLLMVRKR
>fig|195.2288.peg.1787 hypothetical protein
MKDYGISYIPNANQSSKEPSEPIVSDKLNAQKVNELIDKKLNLFKEGLANQEELKSLIRE
ILKDQNFQNTNIKISKTPPNYNTQAKVGEIWAV
>fig|195.2288.peg.172 Inner membrane protein YihN
MTIFTIYSVYCGLTYFIPFLKDIYGMPVALVGAYGIINQYTLKLVGGPIGGYLADKTFRS
STRYLRFALILAAVAILIFIFMPHEKLNIYFGMSLTLGFAAIVFTMRATFFAPVDEIEMP
REISGAAMSIACIFGYSPQLFCFALYGFIIDQFKGLLGYQIVFALMGFFAICGVIITTIL
LRMIAKKKTLQEVA
>fig|195.2288.peg.1835 hypothetical protein
MNTQNTLKKHLIKIIHTLRKDANLSDDESYRWVLNERYGKASSKDLSIEELRDFAITLGY
DEKFFKKQNTKKARYFKKENAKSGRATKKQLNMIQAIWSKNAKNPTQWALR
>fig|195.2288.peg.1797 Phage protein Mup29, H
EEIVEDKKAIYGLFGSNFLFKNGDALLTKLYFPVKLKNASLKFWMEFLERFGSPWAVAKT
DSDPDALASEIHQMLNGDSAVIDKEEELDLIQPKAKANYNEIIDYLDNQIRSVVLGANLS
SQVSGGSLAAAESHNQIRKDLAAQDGQIVLFILNRAIKFFKEINHFKDELYVQFFSEAEP
KSELCERDLKLFNMGFCFDEEYIKSTYNVEGELIRETLEKKDFKDLENDKKVFENKVKFI
QKKPMDKIDAALESKEFKVIDEQIKEKLEQAFNQLLNDSNSYEELFENLQKEFSDISINI
LEEFMFQALANSSILGYGD
>fig|195.2288.peg.1801 Phage virion morphogenesis protein Mup30, F
DEIKQIVKVLDEAKEVYWDNANNSLLYFFEDKKDASRINKIVITPDYKLKKFGKTNAIVT
LGKVEAINKDNKTYIKIR
>fig|195.2288.peg.1811 Motility accessory factor
MTFTPTQKELFNKNIEALSNILLKESLKEIKSSKFELILGKDNLDINLKDTSDNTFLYEN
VIDELNSMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFH
ILDFSSELQSARLMILQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSHYYERFHEDILG
LNKKLAENFKNSIVFHGNDPLDALQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIV
STGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNHDFG
EFD
>fig|195.2288.peg.1622 Conjugative transfer protein TrbL
MKKLGVNQTQTLLNGNKLAIIFLIFLAPNLAFGAESAEGVLSIIRNGLLSWTPLIKTACL
WVFWTLVIID
>fig|195.2288.peg.606 Ferrous iron transporter-associated protein FeoA
MKKIHSSLKNATIMVELDTSCVILRSDEAKTIEVNLI
>fig|195.2288.peg.1791 Phage tail formation protein GpD
YGFICCVKENTLIITPKDGKIGDNAANITSKNENLPLFEIALKECISLEISESARNEYSA
VIAEWQDINEAKIKSIKVGSGENIYKMQISQPKNDNEAFKKAQAKLNELQKGGLNGRCEL
IGREIRAGGKLKIKDINMDHYEFSIKSVSHSFNDQAYIISVEFES
>fig|195.2288.peg.1798 Phage tail formation protein GpD
MVRKPKFKLIAKGEDITEKLSKNLINISYEDKEKAESDEISLSVFGLYSKPLFGDSLELW
LGFEKLYKCGSFSVNVVSKNYTSNTTEVRASAINFSGKDSVNIKEKKTRSFENTTLFTIA
RKIANENNLKIKTSGEDQNIVSILQNNQSNLEFLYSICFDYGFICCVKENTLIITPKDGK
IGDNA
>fig|195.2288.peg.935 Tripartite tricarboxylate transporter TctA family
MDTWMYLMQGFSIALDPYNILIALIGCFIGTIVGMLPGLGPINGVAILLPLAFAMNLPAE
SAIILLATVYMGCEYGGRISSILLGIPGDAAAIMTTLDGHPLAKKGQAGKALSISALSSF
IGSFIAICGIILFAPLIAQWSLKNLVLLNILLLLSLV
>fig|195.2288.peg.1834 host-nuclease inhibitor protein Gam, putative
KVLSDELKYVEQCITTFCENNKHEFAEKRSKEFTFGKIGYRLSKSVSLPRVKEKFDNLIK
ALKSYGLNDCITYKEELNKDAIAELEDSTLVKLGLKRVVKDNFRIEPKIESLEIEK
>fig|195.2288.peg.1843 Phage tail formation protein GpD
YGFICCVKENTLIITPKDGKIGDNAANITSKNENLPLFEIALKECISLEISESARNEYSA
VIAEWQDI
>fig|195.2288.peg.936 Tripartite tricarboxylate transporter TctA family
MLAQKPIRSFLSALIGLFLTTIGIDGNTGVYRFTFDSPHLYDGISFVVLVMGLFSVSEIF
LMLEHTQTSQNIINKTGKILVNIKEFFFCFWTIIRSSIIGFFVGVLPGAGSTIASAITYM
SEKKIAGEKGKFGQGDLKGVAAPEAANNASACGSFIPMLTLGLPGSGTTAVMMGALTLYN
ITPGPTMFTDQVNIVWGLIASLLFANVILLLMNLPLVGIFVKILSIPMWSLAPIIAIVSI
IGVYSINSTDFDIILILIIGILGYFLRKLEFPMAPLILGFVLGEQLETNLRRALSISNGD
FSILWSGIIAQSLLIGAVLIILIPLLIKKLRKSKF
>fig|195.2288.peg.1773 hypothetical protein
MAKAKKETQNLENEDLETGDLPKALSLEDENLANEEAVSENETAKEFINEEGEEMPSKVT
SKSLSNDPLIAMPKSLESFINKDLFSINAKIDLETNESLALG
>fig|195.2288.peg.1655 Putative acetyltransferase (EC 2.3.1.-)
MLRKADIKDLNACLSLFEQSVKTLCAKDYTKDQICAWIKIDRQQWEEKFKYDEIFVYEKR
GKIASFISVKQEQKLLDLLFTHPDFVRQGLAQNLLDFILKTYLHNEIYTFASLSAKDFFL
KNGFELIRENKVIKEGQNLKKFLMKKDVRGILKRTCNYP
>fig|195.2288.peg.1808 conserved hypothetical protein TIGR01671
MKLQDFDFRVWDKHHKGCGNKDCKC
>fig|195.2288.peg.1744 Putative type IIS restriction /modification enzyme, N-terminal half
MRFNDDKNLKFLNFKKIPDFDKLSELFFEILAKGRSARKKSEFAYLPYLNSSLFEKQSIE
NTLEISNLNNDLKLNYYKNTVLKDDKCKAKKGQVGLLEYLFEFLDSFDFGSDDEQSEILS
QKELISSSVLGNVFEKLNGYKEGSFYTPSFITSYMCKESITKVVLDKFNAQFDLDAKDIS
ELRKSLRKEDKKAQKELLNSIKICDPAVGSGHFLVSALNVMLSIYDELNLFDEEFYLEVQ
NDEILITGRKGEFIEYKRPSTPKDKAHLIQQELFHTKKDIIENNLFGVDINPNSCEITKL
RLWIELLKHSFYQSFDDENYHDLKTLPNIDINIKCGNSLVSYFETGKSLSHYPNIKERMS
KYKRIVKDYKEGFYTDKNLIAKEIKNLQESFKNFCLKDKFNKEIKQLTNGANEYSKKYGD
FLADEHHDEKFKSFFSKNMFEFSFDEKVAIKEFANLKKEYDNIFNLESNHPFEWRFEFPE
ILDDDGNFKGFDLIIGNPPYIKEAENKELFTNTKKLRTYQGKMDIWYHFVGRGFDILKNN
GYLAFIATNNWVTNSGAKKLRNIVLEESQILSLVDFSSFMVFDSASIQTMIMSFQKTKPP
KNYEFHFAKITTQTPIYEDALSLLKNEKTQNNEILSINLTPKKFIDKTLNFTKSDYEELF
NKIQKYGKFYLEEREVAQGIVYPQENINKKSLEILGNNFYLGQGIQKLTNEEVENLNLLK
NEKILLKPIFESDN
>fig|195.2288.peg.1805 hypothetical protein
MNLDFLNEFKLKNKDLNEKLEFLIPDFLVKKAITIIYANGGSGKSYLSAAISKTLCKDTR
VKSIVYVDMDNPLNVLNERGFGELILNESKFTYIHRSSLKTSAYELLEMIEGKGVAGSYE
GVLFVLDSLRNFADIDNDTKMMSLMSLLMNLRECGATIMALHHSTKDGRAFKGSNHIRNS
SDCMYFLQKVANLEQGFEVLLSVQKERAGIKDQAFFINTKTLNIKNTDLQNAKISDK
>fig|195.2288.peg.1831 hypothetical protein
QAFFINTKTLNIKNTDLQNAKISDKKEAFIDKVLKLLNEKSLSTSEILSALDVSRSDNFS
RNTLEKFKGVFWESELGGENGRTFVWKSLKADNKNSNDKELSLFGDDNPPSKEDLIKAID
EFNAKNSCSIPY
>fig|195.2288.peg.1627 Conjugative transfer protein TrbD
MEELQRIDIYSALNKPNLIFGADRELILMVGVISFALIFTGATLLTSIIGIFLFFSATCF
>fig|195.2288.peg.1626 Conjugative transfer protein TrbD
MLLRLMAKSDPLMRQIFLRQIKYKKFYYAQSTPFSKD
>fig|195.2288.peg.1659 Sugar phosphate permease of the Major Facilitator Superfamily
MALGLILCALVNVLLGFSNSFYAYVGFVIALGVFQGMGGGRSFFYHSCKLVS
>fig|195.2288.peg.1824 hypothetical protein
LDSYRNYIAKNFDVVTINVFYHCFCARQSIDQKYNPKLIPNKDDLERINNILKNINLGHL
LANEDNFEQIIPFIEQRAGEIKQAGLVDESQKIGLSCDFIPPNGDYQNFGIMAALDHINA
LKDLVKRFPKLADLPKIYGGGSYGGYLALLIAKIAPWYVDGVID
>fig|195.2288.peg.1283 hypothetical protein
LYKYIFKLKSIFKRNKIMIKFLKFLYKVTTMDENLIIDKILNNTKTIAIVGLSPDESKPS
FMIGQFLQENHYKIYPIYPKCDEILGERVYRSLDDIDEKIDLVLMFRKGEFASSLLPSII
RKGIQNFWLQLGICNNEVAKECENLKINFIQDKCIMRELPLYQDRISKC
>fig|195.2288.peg.1758 Phage protein Mup29, H
MKKEIKPKREVILKNNSLINTLINSSYLNVLKISENDQKMIFKDLSFTQAHQSRRSVILA
KELQIVCENEKIKESFEYLFNPDLLSQILETYLYGLNVFEVNYKLKDGFYYPILKQRDFR
NFGFNENDELVYNGN
>fig|195.2288.peg.171 Inner membrane protein YihN
MQNAKPIRWFTFIVLVIGGGTVFKLSSLKDAFYVPMQEFMNLSNTQIGLALSVYGIVQTV
GNFASIYIADRFSKKILIPFSLICVGLVGIYISTFPSFYGILIAWGLLSLFGEVVYWPVL
LKAIRLLGDSTQQGRLFGFLEAGRGVVDTIVAFSALGIFLLLGSGAGGLKAAILFYSACV
IIAGILAYFLLEDDKISTKDDEGHEISKNKAAWNGVIKAVKTPEI
>fig|195.2288.peg.557 Putative periplasmic protein
MAGKIYRVEFYELRGANLQQFLENSVESKLIKNAKMLDLATLRTARAKDKFIGSILVEFE
>fig|195.2288.peg.1832 Phage baseplate assembly protein GpJ
MSELLSANDSYFKQSFLKDIPYP
>fig|195.2289.peg.1765 Putative integral membrane protein
MERNIYEIELEIPNSGIFIMGLENENLIISLNIMKFIEINAEKIATLDGKLDVGGLAKPL
HSYIIYEVLEKNNKNNFNDVKIIDKIEDENNIIYHFNFGLILNTFIGENEDNKDKEALKT
LSFMQNFIPACFFLIKL
>fig|195.2289.peg.970 hypothetical protein
MPLELEFSDFIGKEKIAHLPKALNAKGSSAYKPQIGDFFYYVPWGNIGIFYELQNANEDL
VFLGKIQGNLELLKMQKGDFKVKIIKK
>fig|195.2289.peg.971 hypothetical protein
MKKILFVIMLSSMLAFADLSNKGDLMQIKFTF
>fig|195.2289.peg.1859 Motility accessory factor
MYENLEEEINFFYQSILEKTPRYPFACIYGIGNALLIKNLAKHYKHLFIFESEIELFILA
LSVIDLSEELKVYKVVLFDCVAKDLEIQIAMIFDQQSILEYLSLYEMFISSHYYLKYYET
SILSLNELCIKSASVAIRNADITCFLPLLTHGQFLQNIPSMLESIPFQRILSQRKNKFDN
TIVVSAGPSLAKQLPLLKAYQDKAVI
>fig|195.2290.peg.1694 cag pathogenicity island protein (cag12)
MKKMSLSLALITSLMVGCSAPKAKRLDDSSALSINNSILEHKYSFVPKDPYLSGFNWTYH
IVVEKKTVDDDFIKNDLVTKTFFTRPQFNKNYFSR
>fig|195.2290.peg.946 conserved hypothetical protein, with TPR repeat
MGVIRGIEDVIVKVKDKAEFQAIGVNTNGSVKIDAKDIKTSLINADTIDLKASGKVTNEG
LYKGKQIQINANNFENAKQTNLSQETKDIFKINQENSSIFADSLTLNTLDKTSNFGFINA
LNDIKVGTNSFDNQGEISANKDISLMLNDDAFINNGKILSQNDIQIQANKDLTLNHGNLY
AQNLLHIKSLNDLNINSKLENTSSIELDAKNIYVKNLVASGKELNLHADENLVNDAYLFS
NGDLRAQATTLTNNSTFNSLNNLYLNAHTIHNNALIFADKVSISRQIF
>fig|195.2290.peg.534 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MFNKKLHELLQDEFGKRGIEQIEIPFYVKENLSKELRIYQEKALKYYYANSDSIKQRHLM
FNMATGSGKTLIMAALMLDCYKKGYKDFIFFVNSTSILEKTKANFANKYSSKYLFKENIN
IDSKNIEINIINNLFESKDDCINIYFTTIQALFSLFKNERENSLSFEDLKDKKLVFLADE
AHHLNSDTKSKNENEIKEGWEAIIKRAYESNNENLLFEFSATIPQEFNVLEKYQDKIIYE
YTLREFCKEGYSKRIFLVKYDNDSLEHRFLGAVLCSLYRELLAQKYNIVLKPVVLFKSES
IKESMQNQEKFIDFIDNLESLHIEDFYKNINKESDLLNKSLEFFKKEYQNTYAKTIVNFL
KNNFKTLYMLNTNDDKELEKNQIFLIA
>fig|195.2290.peg.1674 virulence associated protein D (vapD)
MYAVTFDIDTNCLSDNNINHSKAYSDIRKFMEANGFKWQQGSVYFGNETINAVTCVTTIQ
ALAKTLPCFSICVKDVRMLKIEENNDLMPAVKAVL
>fig|195.2290.peg.1673 FIG01061029: hypothetical protein
MSGVTRHIFEKDIRDIFRMWNSQLKTIIPILPKRYTKENVIDLLKKYYPHEWESVKIKYD
YYTIKDRHINKHKKRTRYNMQNPTSLIKNASLFKKITNKDYQEQHYKKYDEIYKQKMENQ
LWNKRFPKIDRINKKINKALLKTQQMYPSFLDKLIGFYERKNTSQNDRMYILIELKKYYS
NKTIQFFFKLNDTELNRQLRENAFYHLQSFNYQPRLRRQKYMQIHTKNKKRKEFLKNYAN
ECCQIEGTPQELEYRINNAKEQKIKEYDFFISHSYLDSEEIQKLITYENENNKNVFCDWI
CDNDYLKRKLLCEETLKVLEKRMEQSKEMIFVESDNSKKSRWCKYELNYFYNLKKPIYTI
PKYFIQSGNFKIKKMDDLWFIEENFNLLNYRKSLLLNSCNCQVKTFTQ
>fig|195.2290.peg.151 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MLYFSLSLNQEVLIIKSPSDIKEQKKFLGYEWSNRKGDEGLKELHEPYLSPLFERGNPQN
ETKLNTLIYKSFLNTLDVIPQELQIYATKARLVDMMDFEKVEFNKAISLNPSNSTQSEMS
NPFINSKFELVRLKDFVLDIQTAKRPSGGVGKYENGALSLGGEHIDNKSGYIKLDNPKYV
PIEFYESFALQDKGIVKQFDILICKDGALTGKIAMVRNEFIRKSAMINEHIFLLRCDNIA
KQKYLFYILHSYSGQQALKSKITGSAQGGINKTNLESILIPNADFEIQKQIVAECEKVEE
QYNTIRMSVEEYQNLIKTILQKCGIIDDGGGMS
>fig|195.2290.peg.1672 hypothetical protein
MKIEDRLKILTEEVKNLQGIIKRMASNSLEIKKWTIALVVSALILKFEHKYIAFIPLIAF
WILDSYYLRQEKLFRKKYDEIIVTRVFNDNNFFDVNPKRYNKEVDSVFKICFSVSTLPFY
GSICIILIFILIYDYFFS
>fig|195.2290.peg.1643 Methyl-accepting chemotaxis signal transduction protein
MFLLIDVKTNDEFGQISKAINENILATKQ
>fig|195.2290.peg.535 Type III restriction-modification system DNA endonuclease res (EC 3.1.21.5)
MFDFDDEFRFKRKYDSDLENELNALEKLTYHTRNDVEFIKQLNESMNKEGLLFEEEKTRI
DLIVNEKIKEIIKNNKIYYANNKRIKKRDLKNFYITRIEMEQKIKGLQIPYFSNSIKESE
EKFEEIKEEYDLQKPSALNHIDNIYFLKAMNILGLDFNKINENFTFKSKKDFIENCLKNT
VVCFSKRQEFNQINNLEIAKYILENFKSLKQNIKQEYEVSEFITHEFNIGNKVVFKNKEN
FKEMNFEWLYHKTFCFDSNLEKEFLNFIEVKKDEINKVFSKWFVIRNEGFEEFKIYDNRK
DEVTYAMGFEPDFIFFGKKNKDDDNFLSIQCFIETKGEHLAIAKDAWKEEFLETLKGKII
TTKDDKKLTLQSLPFFINKNFNINDKFLSSFDEFVSFQDER
>fig|195.2290.peg.945 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MVDRDYFNVISRGIDLAGSIAHYQSGKNLSDINFIAGLNKVDLSTPNAPKIIASKQKDEK
IDYGIDGKYLGSMYANTVTLISTEEGVGVRHSGSNTRN
>fig|195.2290.peg.1675 plasmid replication protein, putative
MKMFYENFINVLEVYFSGSSFKVSVLKFLFLNADKENCIFATSAEIAEALETTRPAVSKE
LKILQDCNFIKKVRNSVYQINVDCIFKGSHTQRMSAKEKFTKPLKKP
>fig|195.2290.peg.1211 Methyl-accepting chemotaxis signal transduction protein
MRFLIKWLSNYVRTAKNSMEAFKARNTAALESLAKNILKLPYEQISNQEALMRYVGKDLK
VFRDAGGFLAVYIAQPDGELVVTDPDSDEKGLNFGIYGKADNYDARTRDYFKGAVKANGL
YVTPSYLDLTTNLPCFTYATPLYKEGKFIGVLAIDILVKDLQREFENLPGRTFVFDSENS
VFVSTDKELLKPGYDVSPVANIAKDKKDYEPFRYARPLDGTQRFGVCAKVLGEYTACVGE
SIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSKYLSPLAAIQTGLTSFFDF
>fig|195.2291.peg.1086 Methyl-accepting chemotaxis signal transduction protein
MKSVKIKVSLIANLIAIVCLIFLGIITFIFVKDEVFNQVVKSESNYVRTAKNSMEAFKAR
NTAALESLAKNILKLPYEQISNQEALMRYVGKDLKVFRDAGGLITAK
>fig|195.2291.peg.603 hypothetical protein
MKEKITFFNTIMIAIIKEMRLERNIHQAVLADICGKTISAWSKIEKGKSPMSLELFCKIC
NTLRVQPSLVMITLERYADVLAQNGYIILTEIQNEQPDTLLEQLDKYYSSEEFKNRQLNF
THYNWNISILNTPYYDINGNLILNNAFRYIIQNAHTQYIEK
>fig|195.2291.peg.602 hypothetical protein
MKKFHEKITEPENTHLEQSMPQQETQEPTKKEDLQEKHKDLESKDENVAKISQNESIDIQ
EIAKNKIEIKDFKDKDNINNRMRILEQNMTSIQKKQHSKRMMGER
>fig|195.2291.peg.604 hypothetical protein
MYNIEVCINKNDKNQKKRGDLLEKIAKEFLGRLDYSVETEVKKTGMELDLLCKANANPSK
QIYIECKAYREDNKIQADVIKNIVGIRDIENYNEVWLIALSELGKDAKGLKEKIQADENK
SKHYTFYTPKEFLEALQNNKLICNPDIPQQEIKKRIESENTIGNHCLLITEYGYFWAFEH
KQGGKPKNIFVAYANNGELVKEKDLLENLQNLDSSFSNLNFNFILDSTNAYNSSSVITDF
KLGSNYFKSINDIGIKLTHPNKNELTLSDIFCYQDLQNLQNINDDKVSVISSERILTLGD
YKKCIIFGEEVSGKTALLRMYQIKLNENGLIPICINAKDIKTSEYDKFENLLIKCFKNQY
GEYNELNTLMKDKKDSIVLLIDDLEDLGIKKREYKPPFFKMLSSHFENILIFSDDSVEME
ILTKREIKDELDNFKL
>fig|195.2291.peg.923 hypothetical protein
MIKIIKISLSKIFNNFSKKTTQAVIRILYTFFEIKIKEKNANPSFKNPKYFLQDKKLYFY
L
>fig|195.2291.peg.1288 Ferrous iron transporter FeoB
MLLKFQLKQNLELLLEKIIILFENKFTPKSRFSTPLCEKSLEKEDILTLVNGLSRKIITY
KKEERNLTKKIDALLIHKFFGLPIFLFLMWLLFQLTFTLGQIPMDYIESGFNTLGEWVKG
NIQNTFIASALADGIIAGVGAVILFLPNIIILFLGIALLETTGYMSRVAFLLDGILHKFG
LHGKSFIPLITGFGCSVPAFMATRTLKNKRDRLLTLFVINFMSCGARLPVYVLFIGAFFP
SEEAGNYLFGIYLLGAILGLIAAKFLRSTAFRGIDEPFVMEMPKYRMPNWHLVWFMVYNK
AKMYLKKAGTFILLASLLIWFASNFPKNEENLNDFNAQERAIEQSYLGQFGKGIEPIFKP
LELDWKLSVSLISGLAAKEVMISTMGVLYSLGKEVDETSSDLKGIIAKNIPLPSAVAYIL
FVMIYNPCFAATIVFSKESGKIKYTFFLFLFTCISAYIVAFIGLNITKFVIN
>fig|195.2291.peg.1733 hypothetical protein
GLPEDFKIHKSTLDEIKKAAENDPVVSSTKEYLGVSEYYTNIDMAETIKQYYNLFSNALG
QSFPNDKTSFSEADINSMPSGYGVSGTQWMDFNDPSNRMNITGLKDFSNSLISNIYKTPE
QAKEADDLWADSGYMIDGLLPKTLGLSLEEIKNVSKGEDWQFNPDMSVYPQNEDGSYSKE
A
>fig|195.2291.peg.1747 Mobile element protein
DEKYLKVPNLGLVKMKEKLRFNGKISSFTISQSADKFFVSFSMQISKDEYLKTHNKAKNN
NLALGIDVGLKSFLSLSNGLEIKAPKPLAK
>fig|195.2291.peg.601 hypothetical protein
MSKHARKRRKNYIDNEGYLQWEAEEDDRIKRAKEIWQKVKHIDQTKQLATAF
>fig|195.2291.peg.1405 hypothetical protein
MSIFSINDNSNYNSILSQAKANKESKENSKISFANAFLKQNASKLNEIQSANSQTLARSE
ILSNNNALSNNSNSTNISNSSNTNLSINNATKTSSPNYDISSEFKNSIYTLKYKQADISN
IVSLAYGYGVDANGYMGSDFNKAAGLPEDFKIHKSTLDEIKKAAENDPV
>fig|195.2291.peg.599 hypothetical protein
MYIADLRHIDNMVRLGGDEALKEIKDYLDTYLYKSDFPRLKGKVNQCFDEIYERQVLQKK
LEEITEKYHVNEDCIFFDKCN
>fig|195.2291.peg.1734 Mobile element protein
IDVGLKSFLSLSNGLEIKAPKPLAKFNRLMIKRARQLSKKQHAKTKQEALQGIKKSSNYL
KASIKLNKLHRKIANIRSDFLHKLTSSLAANVKYFCLEDLNVKGMMSNHRLAKSISDVSF
YEFKRQLEYKSSYNDKEIYQVDRFYPSSKLCSNCGTIKENLALKDRVYICDEC
>fig|195.2291.peg.1740 hypothetical protein
SKENSKISFANAFLKQNASKLNEIQNANSQTLARSEVLNSTNTTNTSNNTNFSISSKTSS
PNYDISSEFKNSIYTLKYKQVDTSNIVSLAYGYGVDVNGYMGSDFNKAAGLPEDFKIHKS
TLDEIKKAAENDPV
>fig|195.2291.peg.600 hypothetical protein
MTNAIEILQTRIFLMLKTSHTITSENLNKGNITKDFKIPYCKIQDCEEFGRWEK
>fig|195.2291.peg.607 hypothetical protein
KLCSNCGTIKENLALKDRVYICDECEISIDRDYNASLNLLSQLKQKIGKVLAEFTPADLT
ALLNDLAINQIATSKVETGIQQKSYL
>fig|195.2291.peg.1751 Mobile element protein
MSANNNELISISHKVELKPNNKAKTHFKKAFGCARLAYNWGLAKWQE
>fig|195.2292.peg.1471 hypothetical protein
FTSLWLKNLGYNFLNTLTLKEKHARKS
>fig|195.2292.peg.2 hypothetical protein
MTAYVHIGIAKTGTTSIQDFLTQNYDLLINQGFLYPKSLHGIEE
>fig|195.2292.peg.713 DEDDh 3'-5' exonuclease domain of the epsilon subunit of DNA polymerase III
KIKEEIFCIVDIESTGGIKNGQILEIGAVKIKNLQEIDRFSSLVQVKEIPENITELTGIN
LDMVKDAPSLTKVLNDFRLFLKDSIFVAHNVRFDYGFISKALNECGFGILLNRRICTIEF
AQCCIESPRYKLDVLKELLGIKNAHHRALNDALAAAEIFKHCLGKLPYHIKTTEELINFT
KTSRIKQK
>fig|195.2292.peg.1801 Motility accessory factor
LYPVLYFYGFGNGILFKALLQNKNHQHIVVFEKDIEIIWIMFHILDFSNELQSARLMVLN
TNKLEIQDYNELCSSKPFFQFSRIYFLELMSHYYERFHEDILGLNKKLAENFKNSIVSYG
NDPLDALQGIE
>fig|195.2292.peg.1565 Peptidyl-tRNA hydrolase (EC 3.1.1.29)
MILVVGLGNIGKEYEDTRHNVGFMLIDLLLKEGNFTNLTNSKFKGELFKMGSSLLLKPHT
YMNNSGLSVKAVNDFYKCERIIVVHDDIDINLGALRFKRGGSSGGHNGLKSIDNLCGSNY
ERVRIGVGKGENVISHVLGKFRA
>fig|195.2292.peg.544 ISCco1, transposase orfB
MFKDRVYLCEKCGNTLHRDINAANNILKRGLKSFGLGISLEDYKLKAFRIS
>fig|195.2293.peg.1716 putative serine/threonine protein kinase
MRSVNNPYILKAYSMDEQKKEYIMEYADFTLEKYIKNYNQKLSNGERISLGCQVLKGIEI
LWNNNILHRDISFNNILLKLYDYIYPVIKISDFGLAKEINSDLTSIDTEIKGSLNDFSTL
KIKGFNEYNIEDELYALTQVLYFIATGKENVKKANCDFLKKGIGEDKENRYKKLEDLKVD
FISFLKAR
>fig|195.2293.peg.1717 hypothetical protein
MDRILENNLANAFNELQQTLSNSYLELYSCTTNKRLQLVFSSLHNNIIECFKKMNERLPS
TEKSNKHYLANYSRKLKTNIELALHLQKEFKNSELSFEIDKYYYNIFKQCLDFLENSRGS
EIPLGMKKITIYEKISIFVLSNKINIPNILRSCTLTLIGSGSYANVYKYYDDFINVILH
>fig|195.2293.peg.1574 hypothetical protein
MLQIKKIWEKGKLSKIYLVCNYPTNWEKPLIVSKIQELKKLLPEDAKVRLDIKKEIRKFL
FSQEKLNFTEQEIDISTKDTDIVSIYNKLKEKMPKFLLFKADRTNTDKDNEITQITKAIT
QNAISEIEQKFNDMKKIF
>fig|195.2293.peg.1924 bacteriophage DNA transposition protein A, putative
SDELKEDAKSKVKLLKQVEKYIEGGLTLKRALFLCNVEWRNYSNWRSDYKKYGILGLVDT
RGLHRKDKTKLSAWMQEYALREYRTFGAG
>fig|195.2293.peg.1926 phage uncharacterized protein
WMDELKNELKTQFLHESHLDPTLKEKRIKRASVDFDYFARTYFPHYFTIKGECGLHLHLN
EVFTKIALK
>fig|195.2293.peg.1899 Replication initiation ATPase; bacteriophage DNA transposition B protein
MQLVELTKKFLSTQNISQNNLSDRLGINKSYMVGYMKEGSSYKYASKVEPLLEKYIKSFV
EEKSVKELQTPFIATKDAKAINVTIESAMSNREMGVIIGEAGTGKSRAIKEYAAKNGTRV
VLFEATTETSKRMLLVGLENKLNVCFKGSLDDKIR
>fig|195.2293.peg.1920 Phage head, major capsid protein E
YGTKYRRYSAKYKNTNGKSVEFLKGTEGMVVPKDNSNRIYYTRANHTDALGKAPSLMFVS
KPEILPRGAGIEIVGEMRAMPVCTRPNGLIKLVLE
>fig|195.2293.peg.1919 Phage head, major capsid protein E
GALFGKILDGKGNVLFDFGSASKKAISVKKDGSVTLASVCDAIDSAIIDEFGTSADYEVL
CGNELFAAISNLALSEDLYKNHLASRDEKDKSLILYGTKYRRYSAKYKNTNGKSVEFLKG
>fig|195.2293.peg.1862 hypothetical protein
MKKEQYKAFLNTSIENIKKAHDENYLSIFAGAGISANSGLPTWSELIDNISKELYGNEKA
KENTEDNLVLAEKFYNQFGKNYYYQKLNEFIPSNKQPHELHKKIIKLNLKNLITTNWDNL
FEKAIGDEGCFYNIIKKDEDIGFATGFSKLIKIHGSLEEQNIVFKEDDYLKYSDNFPLIE
NYIKGIFSTDLVVLMGYSLSDSNVKQIISWVNSKASNIKPVYLFKINKKFDKLEFDFYKN
KNIYILYLDEIYKKDNYEQFLYSFFCENEINNPTNNLLDLFLNGLNDLKYYALNLLKNRE
INEKIEEFLQKYQNCKFVILEFFMQDFKRYFTLDAKDISFDISYISIYNKKLIDFVDEKN
YKTIANLTKTLIYINGKYIKPDYKDEKDIENILYFNYDNIEKEIKELSLKDLSDEEELNL
AFWLYQNEHCIQSYNTLKKVSKNAFKNKNYTAWFISEINRKNFIFKDVTEENEEQIRAYL
KEMNEVDIDELYLKLPKKNRLEVKFLKELHNYIDKNLIKINELKEKILRDYNNYKNGGFN
INNNIYLISDIFKKIFSIEIDLKLIGSLGSIYDNIVKSSLIYSAHEGLQKEKNKEDISID
IDIYLFSFAIRYVKNQDLKNIFRKYFKQSYVLKLDNNEDINKIYKNICKNFTTQGFIETT
YS
>fig|195.2293.peg.1923 phage uncharacterized protein
FPEVVGIGKTWRVGEFVSNNGVKIKAFGSGKRLRGVRYGVKRPDLVILDDLENDTNVRSK
DQRDKLEDWVDEAVLNLGSADGSLDVLYIGTILHN
>fig|195.2293.peg.1713 hypothetical protein
SKLFDNFLVFSSWTNLTQKNFDLIIDGFNKKLENNLLGISQYDSMNYFLSNQYQKNKNLD
FSNITNIIKKYINAFLSGRFGGYNTLALQHSNMFYNVFNILINKKIKLEDSFNPKISEFI
TNLKNKNINDKYYYVRYFLGQLAHIVAKDMQKEIDDFNLEIYNQVKNENKDLYTLELGFC
LYGDKKISKEEYEKVFFEIKKRAKEEYEKVFFEIKKRAKEEYDKRISKMKFNSLDETMLI
LDFIEKNEKKIFGENNE
>fig|195.2293.peg.1821 Replication initiation ATPase; bacteriophage DNA transposition B protein
KRMLLVGLENKLNVCFKGSLDDKIRGIASELARTSKVLIIDESEHLPFRALECLRRIYDF
SNTALILVGTRKLKNNLTGIGRNDYNEYGQLSSRIGAKWELKGLCYQNKEGLKDEDLKTL
CNHFDVEEKKAIDLVFNLARGNFRKSEKLLKRACEFADGKAVELKHIEAAASFLMLG
>fig|195.2293.peg.1914 hypothetical protein
MNYQDTLEEELITGTKTHLFMIDEKDLIKELSVHAIAELSDLNADGVCDKEVIDDAISDA
QSYIASFIKIPKNPTPLLKDICVKLTIMELKRRNDFPKESLEEIKEWANDLL
>fig|195.2293.peg.1694 hypothetical protein
MNMDNILICKASDLEDIFKKILKENELIKNKTDENLNVQQASNYLKISTSKLYKDCNLGK
VPFCKIGKKLVFKKNDLDEYLKFNSSKNSLKF
>fig|195.2293.peg.1910 phage uncharacterized protein
DEAVLNLGSADGSLDVLYIGTILHNDSVLSRKLKLGFWNPKVFRSIEEFPQRLDLWDEYA
TLYRNTDFNTAHQFYLKNKVLMDKGAKVLWKEAKSLEDLMKLRAENLKAFNKEQLNNPRS
ENQIFSLDGINFYDDLPAINQYYMYIDPAGEKAKSDFTAITIIGKGAKGFYVAESIVKIL
KAQSIIK
>fig|195.2293.peg.1852 DNA/RNA non-specific endonuclease
MRKTTQAQRSTFLMSNITPQNPQINQRVWNKIEKRERQVALKLGSLEVLNLVNYDNNPQR
IRNQIAIPSSYIKILKGENFKECYQVPNHEVENENIRSYQVKCQN
>fig|195.2293.peg.1781 hypothetical protein
MDDPETLDEGGYSLILNDVSWDTPQYWSQYNIWVATTPKGTKYFNEILAPKFYNKYKDLE
VEIDDKGNIIRWIGKINR
>fig|195.2293.peg.1032 Uncharacterized MFS-type transporter
MTALFASMTFLFAGNALIVSSIGVILKENKESSLAVGVLSSCFFIGALIGTIGAHKIISR
IGHIRSFGLFGAVFGISAMLHTLSENLVFWAILRFFIGICYYGLLMVIESWLNEKSKNAV
RSRILGFYEIVFYLAFGIGILIIALDLNKHNIFILSAALILLSSLPLNLIKIKEPVLPAP
SPISIPKIFDIAPLAIVTSFIAGMLINGFFSMASLFILLQGFGAQEVSYFMFCGVLGGFL
AQIVEEVFLIKWDENSQSSLAQA
>fig|195.2293.peg.794 Predicted P-loop ATPase
MSSYMIADPVASVAMSRASSIINNFNKLLSAEKKGLDEIKNEINTALLNIDIKIIVVIDD
LDRLADTDIQEIFQLVRSIADFKNTIYIFFLMMKRLFLKL
>fig|195.2293.peg.271 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase (ED 2.4.1.290)
MRVGFLTHAGASIYHFRLPIIKALIARGDEVFVIVPQDEYTEKLKALNLNIVLMIWLNFI
FFILKIAPYLMLSLF
>fig|195.2293.peg.1868 hypothetical protein
MKYNYIKWNKEEKCAIFFPDIDYSLWKKTQLKENAYNNPSLIISSCLITKMDILELFEYY
ILFICGKSMGASRWECNNLILLGTCNIDNLSNPFSLNTPKPTYISEYINILGQLFLAGYI
DFGSYCDEEDRNKIDYPSNLSYYKEDNVGGKIKFPFGKIKLP
>fig|195.2293.peg.1918 bacteriophage DNA transposition protein A, putative
FLETKEAAQAFNVSTGALRLAASRNSNKYEWLKVDNEKGGRGGKKLLFKISKDKLLTAFN
QELISKNTLIYDEKMQKVKLSEIITTDNLKTINNSLKTSNLNLTESKINDDLAVLNLKFE
NLSDELKEDAKSKVKLLKQVEKYIEGG
>fig|195.2293.peg.1841 phage uncharacterized protein
IFNLQKIYKCRLIEIETNGGQFFLKKWLQEKSLESGVFLPLRGKNNSVSKFERIESLSLA
FENEELFLHKSQTMLINQLLEFPEGKNDDAPDSLAGAFLLARTKSSIKRRKHHFNSVSRI
RRF
>fig|195.2293.peg.1851 DNA/RNA non-specific endonuclease
MKKLIILPLLATLALADYTQYKPSEDFAKYFTKQSCSQVLDKFYYLNCYDYNLKGTKAVA
YRLEAENLKGEQIKKRPRFEDDTNIPKNIVLHGVIIETVVMIEDTLFLMLL
>fig|195.2293.peg.1031 Uncharacterized MFS-type transporter
MLIFAFFKLHLYMQYFLGILLGIGVFCLYALALARANDMLTNKNQGVEVGRGVLFCYSLG
SLFGPLILGFLIQYFNTDGFVWFYIASLGFLILFAVNKPNILNKKFKKKPGNMVMLDD
>fig|195.2293.peg.1708 hypothetical protein
MPTTIRFKRLYLGYIIALCPLAQLFTFFFKKAKEPKNKGFSIISPEY
>fig|195.2294.peg.1761 Tripartite tricarboxylate transporter TctA family
FFCFWTIIRSSIIGFFVGVLPGAGATIASAITYMSEKKIAGEKGKFGQGDLKGVAAPEAA
NNASACGSFIPMLTLGLPGSGTTAVMMGALTLYNITPGPTMFTDQVNIVWGLIASLLFAN
VILLLMNLPLVGIFVKILSIPMWSLAPIIAIVSIIGVYSINSTDFDIILILIIGILGYFL
RKLEFPMAPLILGFVLGEQLETNLRRALSISNGDFSILWSGIIAQSLLIGAVLIILIPLL
IKKLRKSKF
>fig|195.2294.peg.511 hypothetical protein
MTEIKTKRLAIHLYGHMRTYEKTYQSFYQNIIEINEKDGWNIDIFIHTWDVFNRTDPNIW
HAKDNLFPTITGKKLSSDDKINIIKIYQPKKYIIEVDPNKPAGRYESVRKAMNLRKEYEE
EMNIAYDIYLTTRPDLLFLNPLRIDEYLDLYKTQQNLKNIGFPEKINFCSCWYFRYPRYL
PILDPRFPNESDLLWFSNYCSNNGFDPLIAFQENSNIINVFIKYRFNMDFIQYREVTKNI
DFFVFTTYLKNKAYMGQKDQIKTLNNILCVRKQVIDFQLSQIEQQDKIIKDKIITIKNIN
SQLIQIQKKNHELTFYSKYGTAKTRIKNQLSYKLGQAMIANSKTLFGYLTMPMILLSIMI
SHRNEKRIYCKKIKKDPSLKQPPLESYPDYQEALKLKNHLSYKLGQVLIQANKTWYKGGY
VKMLFEIGKFKRD
>fig|195.2294.peg.468 N-succinyl-L,L-diaminopimelate desuccinylase (EC 3.5.1.18)
MNAKEFLIELLKFKSVTPNDDGALNFIAMELSDFEAFFIEKKGIKNLLLTKKFKDEGEHL
AFGGHVDVVPAGEGWKNDPFEPLEEEGFIYARGAQDMKSGVAAFVDAVKNADFKGARLSL
ILTSDEEGEAIYGTKAVLEWMQERDMLPDYAVVAEPTCVKKIGDSIKIGRRGSINGKLLI
RGKQGHAAYPEKCINPVHDF
>fig|195.2294.peg.509 Beta-1,3-glucosyltransferase
MLGLNQKKLQKLKTNPKLFFKDAIEKKLLHLNSTYNKYLPKKHKGFTQYTIISAVYNVEK
YLDDYFNSIINQRLDFKKNIFMILVDDGSNDNSANIIKKYQKKYPKNIVYLYKENGGQAS
ARNLGLRYMQENNYKTPWVTFTDPDDFLDRNYFYEVDKFLSTHQDDDICMIGTNNQMFFE
ENSFIQNHPLYKFKFENGTKIVSVDQLKMEIQTSTVSLFKAKIIENFKIYFDERINVYED
IKFLLSYISNLFKKNKVAFLVDARYYSRKRVNMDSTMNKSYLDERFYLDTLYYGIYDSFS
FNDTLFSKNCALSLLLYQIRYIVNNSNRIGFMSIEKQKKYLLILDNIFSKITQDDYLSFN
AIGNTLFYKVGILNCFKKEKPPFQITYIEDYDPYKEQILITYYTGDDKDIESIVVDGEEV
YADYEKIVKYDFLGRVFCYQKRLWISIPKNAEGKLEIFINNKQAMIGWQIYTVDIKNIRK
EFQKRLPKSNIWLFADRDIEADDNAEHLYRYIMQNHPEQEIVFALRKESSDWERLEKEGF
NLVDFGSYEFERIIKRIALFISSHTPGSFGIQLVPGQKFIFLGHGVDAVNISNYFNKLKI
NLRLSSCSREYQSLVEDYNQYELSTKEVIITGQPRHDALSKGNKLNTKRILIMPTWRLYL
VEDKSNTFDRNLKDMFFESEYYKKWFSFLNNSYLKKLINCYGYKIVFVPHFNMKDILNKC
NFPDFINVHYRKDNESFQKNFQNCDLMITDYTSAAFEMAYLEKPVVYYQFDQEYFFNNHS
YKKGWFDYEIDGFGPVVKNEDDLLRELENLLKSDCVLNEIKYTNNIKNTFKFKDQNNCIR
VYNEICKLSYMDKCHSLKYLAKKAFEAQNNFYYELALKRWKFILNSFQDVPMEFYGNFLY
CLRRNSNDEQNIMQGLIFIEKLIKNIRNVKMKTIQIELLKNYAIVKKYDKVLKILDLFKY
DQKNMRKLTYLKLQISVISNDIVGFERNYSSLLQEYKIPESTIKNRLYIFQTTLNFNPCL
LKKEIFQFIEEAIYEKQ
>fig|195.2294.peg.521 Nucleoside-diphosphate-sugar pyrophosphorylase involved in lipopolysaccharide biosynthesis/translation initiation factor 2B, gamma/epsilon subunits (eIF-2Bgamma/eIF-2Bepsilon)
MTIVFPMAGLSSRFSNAGYKIPKYMLEIQNQTVFYNAVLSFKCYFEDCNFLFIYRDIYNT
EKFIIEECKKLKIKNKFLVKLDNETQGQAHTVMLGLEKSHIDDNENILIFNIDTFRYNYI
LPNFNYEKLDGYLEVFQADGDQWSFVLPGENKKVLKTTEKDKISNLCSSGLYYFKKSKDF
KDVFHYIKINNLLVKNEFYIAPMYNYLINQNKDIRYHEIDINDIIFCGTPQEYERLIL
>fig|195.2294.peg.1861 Motility accessory factor
GGYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGILFKALLQNKNHQHIVVFE
KDIEIIWIMFHIL
>fig|195.2294.peg.1401 Replication protein
MYEKPRRKSTVTLEEAKELYPEWYEKRIVQGEPKQKSKKQGGTWVCNEALYEWWKRKITE
EVKAGGRYFSIMALCSYGLKCGISEQKIRRDAYAFLDHLESLTEDEDNHFSRADVKDGIK
KPKMIYFYGILKY
>fig|195.2294.peg.1253 hypothetical protein
MNVLFLQWLGLSRDLKKNTIKPLSNIKNQKTCIFYQKTSTLFLSKSI
>fig|195.2294.peg.1619 Phage antirepressor protein
MQNITSNLIFTNEQIAINYGLTTGLTIAKHLRMHNDEFIENIHYFLVENSFKNKTIKWTL
EGVYKLLQISRISYLDKKSFGKIKKLKLWRENEPINKFS
>fig|195.2294.peg.1441 hypothetical protein
MNKGIIYKKNAKNKKQITNLSKKGAKNGIWKIS
>fig|195.2294.peg.513 GDP-L-fucose synthetase (EC 1.1.1.271)
MNKDSKIYIAGHKGTAGVALVENLKKRGYENLILKTRQELDLLNQQAVIEFFKNEQPEYV
FLAAVLPCGAANVSQRADFIYENTTIQNNIIHQSFKFGVKKLIFFGSGYMYPEKTLNPIK
EESMLTDILEYNATSFGVAKISGTLMCESYNIQYGTNFITLALNNLYGTRANFDFGKSRV
LPALLRKFHLAKLLEGEREDEILKDLKMKSFIEAKKYLTDFGISKDCVEIWGTGKVRREF
IHSDDLADAAIYVMENVNFSDLYKKDEKIKNTHINIGTGIDYSIAEVAQMVKQIVGFKGK
LIFNANRPDSTMDRLMDCSKIHSLGWKHKIELEEGIRMMYDWYLNNYGGGGYTKK
>fig|195.2294.peg.1129 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54)
MSIKVIEASINSTIQDLGRKNYAKLGIARSGVMDELSLRIANILLGNKQDEAGLELCLKG
GKYEFLDESYFVLSGVKE
>fig|195.2294.peg.519 Capsular polysaccharide biosynthesis protein
MKQLVIDLDGTLTLDVDSSYKDKPINTDVLEQLCYYKDLGFKITIFTSRNMRTYQGDVRN
IRQNTLPIIIEWLDKHKVPYDDIVIGKPWCGFDGFYVDDKAIRPSEFIKYSYNEIIELLQ
RENPYKDGGNK
>fig|195.2294.peg.1496 Cytosol nonspecific dipeptidase (EC 3.4.13.18)
MQNVIENFKNLCKIPHCSYQTEQMKEFLSSYAKDKGFKVSIDKAGNIHAIKGNPKICLQS
HYDMVCMGEAPKVEVYEENGFLRAKNSSLGADNGIGIAIMMNAMAEFENLECLFTNDEEV
GLMGVNSLEHTLSSKMLLNLDHESDDEIMIGCAGGVDIEAELSFSTLKARGKIYELQAQN
FKGGGHSGINIVRNEKSSIKEMAQFIKENKGKIISFEGGERINSIPKHAKALVHFENEVK
GNGWIKCEFKEEGEFEICDQNEKLLNTINAFAHGVRAYDEHLSIVQTSINLATLKMENQQ
IKFTLFARSNILDGLKQIEFETMEFFKAFGYKVRSFNFYPPWEGKANALSDKVLKALKKV
SPKARVSAIHAGLECGIIEKKQELLCASIGPNIHNPHSTDEHCEITSVEKISRVVFEVLK
DNA
>fig|195.2294.peg.827 hypothetical protein
MKIINLGILAHVDAGKTTLTESL
>fig|195.2294.peg.520 Capsular polysaccharide biosynthesis protein
MIIIMSSAYCSTDFELEFGKIPPSFLPLGNKRLYEYQIGLFRGLNESIILTLPRSFQISK
YDFLKLKSLSVEILYIPDNMKLAEALIYTINMISPINDSIYILHGDTYFSSIQSLKNYLV
VSKVKENYKWAYLFEKEVLKYNIKNDIAEDHELVLSGFMNIEYPYFLVKCLLDNNYSFVD
GLREYSKTYTFSVVQDDSWLDFGLITNYFHSKKNFSTQRAFNHLLIDENFVIKSSSWRSK
IGAEINWFRNFPQEYSIYLPRFYCENTDSYQLEYLYHNTLLELFVFGKLPHYIWRSIFES
VKVFLNAIHKFKSDKEIVFDYKTKTLKRLKQVNHPEISFTKKYSFNNYESISVCEILDLL
NENISQKQDIVLIHGDFCFSNIMYDFRSKNIKTFDPRGMDFDENITVYGDIRYDYAKLVH
SVLGLYDFIISGFSRCEIQKDKIFLSIDISDEIVKIQEEFFAMFEIDKQVCSIAIHLFAS
MLPLHADDDDRQKALFVNIFRLYFYFKDKGLL
>fig|195.2294.peg.1787 hypothetical protein
MNIREFLLEKPQENNIISFLQDEVSQSENQNTNEYLANLKNEAINDFYKNKDKYAKEYEK
YNFKDQNLTNPMGNISEYKRDLYDYNKNPSMNADDLSNYILDKQSKFNASKPIFTDNNEV
ARKNNQFMRDLGDELQKSGRGKLLQDDDGSYWVQDNNGNYSKVQGSTMGNLYRGIRDNGA
SVALGTAGAIGGSMLGGGVGMVAGGALGASLGAGYDYYGNTKDTNQDANLKEALMLMGEN
AGLSLIGDAAFAGVAKGARALKNTYNMTKTGASAGKDMIDGMVVKGGNLGNRIIDKITQK
DIPMIGKFTDGGLQNAETIFNNLTKNVENKKQIDELIAKENPTYLENGKPTIEILKNIVE
QGLNKNNPQFIQDSAKRTSVILKNISNALQGVPTTQRREILLKSAQAYPEIGSFLDDVLK
SDKDASISFLNIIKGQDEVFKNKTGLNGEFDVKAWQKDNSSYKKRINNEYAQAIKSIDEL
NNGSIRLSKEGLAKIEEFKNNNFLEQDIKTNISSFLEDTIDKDLSAEQIFNLRSAINKQL
ATGNKTYNTKEAYRLVKDTLDETMIKNASDKELAKKILEDANKNYALKENFNNSYLGKIK
DQETPEALAQRIANGARNINEDKDLKRAFEGMNEAERKANEKHAFNALLAKHRIEDIGYD
FKNLAKDMDNVEFVSKDLKYAKEVVNVYAKIYQNNKDLIMTALASSGKKTNSSIATTTQG
VFDRILISGVFARIHALVPFMKSAKEQALRNQILDALKLAKTNKEVISNLKNIKIADKEQ
SRIFKDALDNYIKADKEQNKILKDALIKEGVIKGDNFFMDKADPKDNSLRFIGKNGKEYT
INKDVRNEWMKTFNLKNIDDEYIPNIPKEAKIALKDREIKLTKGSLLKLIEKDRIKYIPH
IKETLESPQAILKDKDDFIFIKNIDNQTYFTSIGKDYETHLTIISNSPKKQNNIRNKIKN
AEVVYYNNARALPTSRASSETNQVSFSDKNSTQAKPKKNLMEDIKENIEAKEVEKKNKKS
VKQRLDEKIQNDKKASEDILKRYDDFLKENKDYNLDFLGNLDVVTREFILNAKKKTYKGK
KADIPDLMRFRIEKELNIQALKEFGKNYAEYYYDGKGALQKLLIEKQGQVAGAFHRKDLG
DIDLVWGEVIDKIKHKGYGLAHIIDKHPELDLKLISDIVDKGKLNNQNNIRYRIEYKNYI
IGLSSEYKGNKRTFIITAFERYKG
>fig|195.2294.peg.1845 Tetracycline resistance, ribosomal protection type => Tet(O)
NHMKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQT
AVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQI
MKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAV
IMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLG
>fig|195.2294.peg.1519 Uncharacterized integral membrane protein HP0284
RISMRKILLLLCFSLFAFGDINRTIINNINEKISNLDTVIGASIWDVRYENFIKYQDIND
ELIILNLELKKIEDVHLQDELKRKIATLEEQLNVLKEYKELNFAHSLSAPEDIETLSKLT
NPFAIIGAFSHIKKLRGEKEEYAFKFNDFKNLVEKIREKNLELKELVNLELNIENIEALK
ASDKKLEEFDQALKFASVSYSVYEKKIDDEIARVSAEIKAQGLRAINIVIAIVIVVAIAF
MLKLVAKKYIKDNERYYTATKIINFINLNIIFLILLFAYIENITYLVTILGFASAGLAIA
MKDMFMSMLGWCVIVFGGSFRVGDRVKVFQNDTTYVGDIIDISFLRITLYEDITLETYSK
NRRAGRIVFIPNNYVFTNLISNYTHHGMKTILDGIDISVTFDSNIEKAQAIVEEVVNRLA
KGYTELAKKTMKRLQNEYSIRNPKVEPRFFVFFEHWGMRISAWYMTNSYAALILRSAISK
EIIKEFNKHEDIKIAYPSQNLYLGNLNQAPFETHYNSMHFHTKDNN
>fig|195.2294.peg.522 Methyltransferase
MKKAFIYGSAQLGIQIAWHVSKDYEILGFIDTDSRKYTSNSGVYIEIDDKNYMIYSPDIL
CNTQIDKVFIGTEVDIYIKQIKNTLLKYGIGDDKIDLSLTFIPYYARLNFIKIISLEFQN
KNIMGSVAELGVFRGKTAKEINRIFKNDIFYLFDTFEGFNEKDINEEIGLAKQANINDFS
NTSLNFVKKQMPYLDKCCFVEGYFPETIVKIPQDEKFKFVNIDMDLYQPILEGLVYFYSK
LVKDGVILIHDYFHPYYTGAKRAVDEFCKNNNIEIVPIGDAFSVAIFK
>fig|195.2294.peg.595 Motility accessory factor
MTILEKNIQALLSGVNEPLGNKLLNFIQNKTCSRFSINENLNIYDKTHNVFMYENLEEEI
NFFYQSILEKTPRYPFICIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSVLDLSEE
LCSGKIYLVDIEEERVDIQLLILFDMKDMFEYLSLYEMFVNNSFYKQFCEKTWCETDEFC
KKNIEIVIRDSGLNSNLSFQSYFHFLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPS
LAKQLSLLKAYQDKAVIFCADGALSMLEKEGIIPDYILNIDFEDLPLRFFQNKENLKQSI
IALECATHPNVVRSLKAENCMIVLRNKALYRRFNLNDFGYIDTGTHVSHFSYTLALALGF
KNIIMIGQDLAFDEEGNSHSKGFDLGERIDHTLNLPVLQVPAYAGKGEVLTHIAWNDYRI
KLEYLFACNEQKAKFYNATEGGARINFTEELSFKECCEKLLTKEKPKFEFPKSLTKNRSD
KLLVKFKEKIQKDQENAKRFLDDALALKQILENILSKDFLLPLEFLEKVYQNIENFNHSL
DTDEFIQDGILKAVVYERGLRISLVYKENIVDNASFITAYIKAYDEWLLYFIEKLDQRIN
IIINSFKES
>fig|195.2294.peg.510 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKNNKGRLAICFFGHLRTYEITHKFFISNIINVNILDGWHIDIFMHTWDKFQTQYSRHSE
SVYLSLTEKEVTSKDILDIKNIYSLKQVKVETYNPKNGHGMFLSVKAVSELRRSYENTNS
IKYDYILYTRPDILFLNPFRISDYIDNYITFHSNRLGIPQKITFSVINIFVHLNFLDPRF
INEGDLCWINNFDCDEIPSRKADEYFVVPIKYRLYYDFFICRESTDLSTLDPFVDSIKKG
FILKKDHLISEQSSQIDHSKEIINNKDMLINSQLIQIQKKNHELTFYSKYGTAKTRIKNQ
LSYKLGQAMIANSKTLFGYLTMPMILLSIMISHRNEKRIYCKKIKKDPSLKQPPLESYPD
YQEALKLKNHLSYKLGQALIKANKTWYGGGYVKMLFEINKIKSTYKKSV
>fig|195.2294.peg.1648 hypothetical protein
MQEKIQILMDLLEINKAQATDIVGRYLKSVKDIHSFLDFYFETLERENIVGTTYEKLRRV
CKRAEIEFKKRFEDKEIFLEWLKNKYKNSPFFRLLESDFKYSYVCYDGQGNLFKRLAKSI
NMLVCLNNFGELTYEDGEMLKNNEFKHALIDFIFKNQERIGKDIYINTSYKIKGYTSLST
SLSHEEEYNNFKKVQKKIFKENQEEFQKKAKVKMAFKDIS
>fig|195.2294.peg.512 dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13)
MDIEFDIQESKILKGVYIITPNKFRDLRGEIWTAFTEENLGNIIPKDLRFKHDKFINSHF
NVLRGIHGDVKTWKLVTCVYGEVHQVVVDCRKDSPTYLKWEKFIINQSNQQLILLPPNMG
NSHYVSSKDAVYYYKLAYEGEYLDAPDQFTYAWNDERIEIDWPTNSPILSERDILAPKKG
K
>fig|195.2294.peg.324 Signal transduction protein CetB, mediates an energy taxis response
MSREIFLQEDSLITSKTDLKGRIVYANDDF
>fig|195.2294.peg.1422 hypothetical protein
MIYLQKVLKNILKTLAKKFTWFGECVKEFDITEIGEQYSLKDTIQNLCIKEINKQAGYNK
DFHGKFKEFTQKTPKNQKLKDLER
>fig|195.2294.peg.1785 hypothetical protein
DSGEYFSEGLAGVKLNGRWGFIDRSGKFAIEPKFDSGEYFSEGLAGVKLNGRWGFIDRSG
KFVIKPKFDSIWDFSEGLAKVELNRKYGFMDKNGKIVIEPKFDGVGNFSEGLAAVGLNGK
WGFIDKNGEFAIKPKFDDIWDFREGLASVGLNGKIGLIDKSGKFVIKPKFDSIWSFREGL
AKVGLNGKYGLIDKSGKIVIEPKFDDIRY
>fig|195.2294.peg.547 Anaerobic C4-dicarboxylate transporter DcuC
MLGLTFSLFSVFLLVFMLYKKINAHMALLLSGLLLLSLAAIFGLSPHIVAKGSLNLGFFD
IFQVFNQTMSNTLAGLGLTLMAIAGFSAYMDHVGASYALFKVFEKPLKMVKSPYILLLVA
YFIVQFLVLFIPSHAGLGLLLMVTMYPILVRSGVSKLSALSVIGICQYIDHGPGSGNVIM
ASEKAEVDPAIYFVHYQLLQPYLSL
>fig|195.2294.peg.1292 MscS family mechanosensitive ion channel
MRKILLLLCFSLFAFGDINRTI
>fig|195.2294.peg.514 GDP-L-fucose synthetase (EC 1.1.1.271)
MNKDSKIYIAGHNGLTGSAILTKLQEKGYKNFILKSHKELDLTNQQAVEYFFEKEKPEYV
FLCAAKVGGILANNTYRADFIYQNLQIQNNVIHSAYLNNVKKLLFLGTACIYPKNCSQPM
KEEYLLTSILEYTNEPYAIAKIAGLKMCESYNLQYNTNFISVMPCSLYGLNDNFNLEKSH
VLPALIRKFYLAKLLNEKRYDLVLKDVQMDDISRAKEYLQKFGITENEVEIWGTGNARRE
FLHADDMADACIYVMQNINFNDLYNPQCDEIRNTHINIGSGKDIAIKDLVSLVNEIIGFT
GNVFYNSAKPEGTFQKLGSCDKIHSLGWKHKIELKDGVKLMYEWYLKQENIRN
>fig|195.2294.peg.1151 hypothetical protein
MWDINFTIKKFKKGLKLEDCSEDEAFNFTIKKFKKGLKQFSV
>fig|195.2294.peg.1243 N-succinyl-L,L-diaminopimelate desuccinylase (EC 3.5.1.18)
GKLLIRGKQGHAAYPEKCINPVHDFAPVLKLLAGFDLDPGSAEFSPSKIVITDIRGGMGV
CNVTPNDLRLMFNVRNSPDTNLEDVRAYVEKICHGLNYELELTQSSEPFLTSIDNKIVQK
MNESVQKITHEVPELNTKGGTSDARYFAKYGVKVVEFGVCNDRIHAIDERVSVEEFEKLC
LVFKDLVENFN
>fig|195.2294.peg.1666 Translation-disabling ACNase RloC
MKILKFDKINFGSYENFTWDNGLEEFKTINIFYGRNYSGKTTLSRIARSFELKKHNEDFL
DGNFKIKLEDGSFLTQNDVINSNLDIRVYNSDFVKENLNYLYDKKGNIKGFKSIGEEQKN
IKEIIEKREKILKTRNEKLQKLENDKKEFLNDDRETKLEEKFTEKASLIATNPNYLKGYR
YNKTALKKDLNIIKNNEDAYILNNEEQNQFIKILEDKEKHNTNFNNTFNKDNFQGILKHS
LGILEKEVIIKENLTSELRQWLEEGLKFHKEHLSTQQCKFCNNPLTLERIVWIENNIKDD
SGEKEKIEEELKDLLDNFENYKLELKKILQDIEYENFYSNYKDSFIALKEQLGANIANYN
KELLKIEEKIKEKQKDVFTPIKLENTNDFSDEIFLILNKIENLCKENDEYTNKLSTNQDE
AREKLRLNEVAKFAKDSDCFAIQDEIQNLKQNINTLEKSIATQNNKIDLLESRIEKYKEK
LSNLETSTSNINKYLKSYFGHNMLELKVKKDDKGQLNGEFEILRNGKQAKNLSEGECSLI
AFCYFVASLKDANTKDKNPIIWIDDPISSLDNNHIFFIFSLIENEIIKKDSFEQFFISTH
NLDFLKYIKRLKKSKSKQSKNDEKEYDFPQYYFIEKSVKESMETSEVKKLPKCLEKYTTE
FNYLFEQIYKFKNIDGINDEDLKTSLVYNFGNNLRKFLEIYLFFKYPNNFESLDKELIKR
FFNDTYQSDDIDENQKIIAGVINRYQNEYSHLREVLSRGMQPIDIEESKKIAKFILETIK
QNDKQQYKALVKSIGK
>fig|195.2295.peg.1112 membrane protein
MLLVWIIFIFNIILAFLSIDFTRIHESLEQIKLTFFASIFILSLTLIFFLFRKKRALARK
DQKILLI
>fig|195.2295.peg.1748 Methyl-accepting chemotaxis signal transduction protein
MQSINSGKSVGISAKLTLMVGILVVLIFTITSAVSYFDSRNNTYELLKDNQLKTMQDVGA
FFESYSMSKRHGIQILANELNKRPDMSDEELINLIKAFEKVNGYDLVYVGFDNTGKNYQS
DDQILDLSKGYDTKNRPWYKAAKEAKKLIVTEPYKSYNSGEVGLTYAAPFYDRNGNFRGV
VGGDYDLAKFSTDVLTVGKSYNTFTQVLDLEGTILFNDEVAKILTKTELSINIANAIKAD
PALIDPKNKILYLPLKITKA
>fig|195.2295.peg.1343 Protein hydE
MTLDFDFIYNADNDIFEYLLRFYAKNYNYILSKEENTYHFSIDADEENLKTFCDSLNLMS
HSVFLKKFDVKAGQGFNPCMPEDKEFSRFSYITHLNSNAYQEKKLLNKNEWGVFCECEFS
SNLSEFEKINEENFNTFLNLAFDLLSQEKKIYLKDKNSIYEFSLFKNEFIGDFLLPCDIK
AINSVFVCSNENLKLLASLEKPLMKLRFNAMFRKNHNLDFNDFKIRLARDLFCFALGLKL
FENEYKFLSVKKIEEYQKDFYISALDEQVVVLEGFEFINAKARELIFSKEDKNMARISYL
VSRYKEKAFILELSKDDEDILLINKELNLLKLCLPKHSKELYEEIKKD
>fig|195.2295.peg.871 Cell division protein FtsZ
MSEFLVEEMQHNKGAKIKVIGCGG
>fig|195.2295.peg.611 hypothetical protein
MLLQEREEKDRSEDNDALKQLIEAISDDEYSVDESYKIAEDKREDIIDAMYKENENLKEK
LSEYEKKFGKL
>fig|195.2295.peg.1854 putative lipoprotein
MKYKTIVFSILAIIFSACSTHQEQNVFYQQNLFSQTCNKQFFQEQQEKISQNKDVIFTGL
NTGYIARDCKDFNLSNSIFDKVEDSYKYDVDLQSLSKKSTRALASTLINEGVNDYQGAWY
ERTMLNVYKGLNFMSLGDFVNARVEFNRALMRQEKAKEYFASEIKKAYQEASKEEKLRQN
IDNNIKIVSKQYENLFKDFNAQKDYTNPYVTYISSIFFFMDYDYKKAADLLKEVYVLNLN
KEIEKEFKIFDQYSSSLNPKKLKKYIF
>fig|195.2295.peg.1881 hypothetical protein
MKFNRWGTPLLKKIATRGALLLGTLGASVFWLCYPGIYIAKFRLKLKLRLNLKL
>fig|195.2295.peg.1687 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MNINKDFVFIPKVKTSWFKQIAYKPYNIKTYQIFNFSRWFNLDNITNSNSTQLGQLQSKL
SFQTKYGTAKTRIQNQLSYKLGQAMIVNSKSFLGYIRMPFVLSYIKDKHKQEQKNYQEKI
KKDPSLKLPPLESYPDYQEALKEKECFTYKLGEALIRANNNWYGGGVYQTVV
>fig|195.2295.peg.1568 Cell division protein FtsZ
FMSEFLVEEMQHNKGAKIKVIGCGGGGGNMINHMVKMGLNDLDLIAANTDAQAISNSLAK
TKIQLGEKKTKGLGAGMLPEVGAESARESFEEIKASLSQSDIVFIASGFGGGTGTGATPV
IAQAAKEIGALTVSVVTMPFAFEGKQRKKLAENGLLELKKESDSILVIQNEKLLSIIDKK
AGIKDAFKLVDDILARAVKGMVSILLDNGDINVDFADVRTIMSHRGLALMGVGSASGENA
IEEALSNAIESPLLDGMDIKGAKGVILHFKTSSNCSLIEISAAANNIEEIVDENAKIIFG
STTDDSMEDRVEVTIIATGFEDRDSIAKKAAEEAETPKKNPYLNLRKVSGGFDEEIMAQI
ETPTFLRRQMD
>fig|195.2295.peg.1258 hypothetical protein
MVNFDTQYTNINHLSNNMNNKKVVSKNEDTYFNSVIKKFNFSEKTKEEQGYNGSPDVKEV
ENSLYKRYMEDKLSKDEIKILNEFGTDYLVEGVDLTALHRRKVDLLKTLTSMNEFEKIWG
AERAQREKQFFNELGKPLTQEDIDRFLANKNNQKEDKKTFKPIQAESQNKETYKDDSKMN
ELVKKLLENKFGKSEELELLFGVKFSDDDAGEFNKFLSSNSAPKSIDIKA
>fig|195.2295.peg.1879 hypothetical protein
MLHYFRFKKDGNCTKILLRKKKTIFDKPKETYISKKSDILITGINASGKSKRLNSFLQN
>fig|195.2295.peg.610 hypothetical protein
MHFFIFIISIVIMYYIIMFILENKKEKKKKNRRYKQRNIFNQS
>fig|195.2295.peg.1052 Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)
AKAALESSVRYLARDLGIKGIRVNAISAGPIKTLAASGIGDFRMILKYNEINAPLKRNVS
IEDVGNSAMYLLSDLARGVTGEVHYVDAGYNIMGMGDVTKDENGNTVLCWDNQKGQ
>fig|195.2295.peg.1858 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MSEQILKLKFSYKQDPMHLSGFINFIKTFVGLHRILQNNMQEKITQLSTKTQELTSKTTQ
IKELNQVVANQTTQIQNLNNTLNTKTQELTSKTTQINSLQTTLKNKDSLLSFQSQHGTAK
QRIQNQLSYKLGQTMIINSKNIFGILFMPICIISTILSYRQEQKLYQEKIKKDPSLKLPP
LENYPDYKEALKFKNHLSYKLGQALIKANKTWYKGGYVRFLFELRKIYKQKTMKNSLILY
KNRDSNKKDTTRSIRGGG
>fig|195.2295.peg.936 Protein hydE
NKELNLLKLCLPKHSKELYEEIKKDEIGARLLENFAKEFPLLNESFELKNNFYSLLCLVG
RVLNLDENLHKAGEKLLKIADESKMPRGVKIDYRLKEDKSFDYTRTLRSAMSFMLAGVDS
ANIAYGAVESLAYFLRDTYDELREKKQSDLALISGSLFEHKSLLKNTLKHLKNCQLSDVP
LRV
>fig|195.2295.peg.1526 Penicillin-insensitive transglycosylase (EC 2.4.2.-) & transpeptidase PBP-1C
MKNALKIFSFLLLFFLAYVFYVYFSFDKNTLLDDFKSRYSKILYDKNGEILSVFLNDEEQ
WHIKSTDIPKRLKVAVINYEDRKFYSHFGVDFLALMRAFVNNFNSTQRSGASTISMQTIK
LWDKKDRTYFNKFNEIIQSLALENAFSKDEILKLYLSNAPYGGNLIGYEAAILFYFDKNP
KDLTWAQAALLAILPNQPGLINLEKNKTKLLDKRNKLLAKLYERKLINKDIYELSLKEPL
PNFKPRKNIAPHLALRLLSDDNKEIFSSIDKKIQLKIEKKAKEFSYTLQQKGIQNLAIIL
ADTKTRKVLAYVGSQDFYDMANLGQINGNIAKRSVGSTLKPFLYALSIDEGIIAPDSILL
DVPTFFSNFNPQNANKKYYGIISAKEALQRSLNVPFVSLLQDYGYEKFFYKLKAFLNFED
ENYKRYGLSLILGTKELSLEDLIKLYLGLANYGELANLSFIRDENLSGVARMFSKGSAYL
TLEAMKELQRVGLENYNKEKIISWKTGTSYGRKDAWAMGATPKYTLGVWVGNFSGEANAN
LYGVSIAGDLLFEILGLLDEVDLEFAPPDDLMTIKLDSISKYRYDEDLNTSYINVLYPKG
ANILRTSPFLKKVYEYQGRELDSKDIHFKDAKALIKLDFPAYALHFFQQRNFKFSNKKGV
KIIYPKDNLKLILAKDLNGMKGLVAKVANLNNEKLFWYLNQKLIYEGDENTQNLNLKEGK
YQLFIISQIF
>fig|195.2295.peg.1747 Methyl-accepting chemotaxis signal transduction protein
MCNSAFNPLFKICTITENKVYTEAVNSILMKQVIVSIIAIIIALILIRFSISRSLSPLAA
IQTGLTSFFDFINHKTKNVSTIDVKTNDEFGQISKAINENI
>fig|195.2295.peg.1887 Replication protein Rep
DCLTLDMQMSEIVKYHNDFNKIQLPSFTEQEQNLLFLIFARIKEKGIDNVINLYANDFKI
NEKLSNSREYLTENINSLKYKFFKANFKQIIETKTEVIHKYVNLFETMEIHYVKRNPDDG
YDESTLFNRITLKINPDFAYLVNQLTTNFTAFELSEFIALSGKYTKTLYRLLKQFRTTGK
AYFEWEEFCRIMDIPQDYRQSEVDKWILKPTIKELSKERNLFDQIRVPFKNLAYEKEKTA
GRGRGGKVSGITFTFKPENIKMQKLENESQKIMSDEQKYLKILNNMKLNQVRFDYNDKLW
QFNDFDFNEFKIIAVELQRDEYENLNFGNHMHFNAKNQEQFFNMVDTFRKRIR
>fig|195.2295.peg.1883 hypothetical protein
MFLEANSIFIYDQYLTQENLNDFIEICSINKNIYLPKYIYSRINPHNEMIKIDKQNNRYL
GCHDRYILIYYPTYKIELILTSGIDYLLDTEKDFTYIVRVITSSTS
>fig|195.2295.peg.1605 hypothetical protein
GKYGFIDRSGKFVIKPKFDSIWDFSKGLAKVKLNGKYGFIDRSGKFVIKPKFDSIWDFSE
GLAAVGLNGKWGFIDKNGEFAIKPKFDDIWDFREGLASVGLNGKIGLIDKSGKFVIKPKF
DSIWSFREGLAKVGLNGKYGLIDKSGKIVIEPKFDDIRY
>fig|195.2295.peg.1672 Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)
MIMKGKKGLIVGVANNKSIAYGIAKACYEQGASLAFTFLNDALKKRVEPIAEEFGSNFVY
ELDVNNNDHLDSIAEKIKKDLGEIDFIVHAVAYAPKEALENSFLETSKEAFDIAMGTSVY
SLLSLTRAVLPVLKEKGAILTLSYLGGVKYVPHYNVMGVAKAALESSVRYLARDLGIKGI
RVNA
>fig|195.2295.peg.1762 Alpha-2-macroglobulin
MLKNILISLILSFLLIACGGEKNKNSSELIRAQSQGLLKNHEAIFVEFKEAIVDFDEMSI
DAKINSKNSKILLTKASDSRFLLDLTYLEANQNYKIEFINFQARKLPLL
>fig|195.2295.peg.1688 hypothetical protein
MISIFSNNCIAGFLYCDYKIKFLSPTINLQLTPVDFIKMCSHLDYYLSLEIKEIKVDDKV
LSKFKDVGGGNNINFPVGMLGDLMIFFQHYKNINEAIEKWNYRKNRIVKKKYIIMNYINY
EAYPCHKDFQEIIAMFKEVPYEKKFFYILLKI
>fig|195.2295.peg.1695 hypothetical protein
MTAYIHIGTPKTGTTSIQKFITLNLDLFLQQGMVYPKTFCVNNQHAKIAYIIKNMKSDFN
FWLNQEVVFLRNEISENKKYTFLFSSEMISLYINESYTLIRLKELFNWLGFKNIKCILYL
RSNDEYMISHSSQNIKCGLGVYYKRKAEFCTSMGMHMYKTICKNYINVFGKENIIVRLFD
KNEFYQGDLLKDFIHSIGLEWDNKFRIPERENETLDLIGFELQGRLNKLGCGWNNKINST
MEFSEKYFTSKDPHLKFQPAKEVTQSYMDYFEESNEWVRQEFFPHKERLFPKKDLSNYKE
NYELKEMKPEYWDKIAEFIADIVKTKNQNIADKTNIIQNKDKIITDQTTQIKSLQVNIKD
SEVKLVQIQTSNNTLSNIIKEKDNIINSNINHINQLQSNIQEKSTQLNQIQSKLSFQTKY
GTAKTRIQNQLSYKLGQAMIVNSKSFLGYIRMPFALSYIKDKHKQEQKNYQEKIKKDPSL
KLPPLESYPDYQEALKEKECLTYKLGEALIKASNNWYGGGYIKLLLEIRKLKKEFKKKAN
HA
>fig|195.2295.peg.1437 Flagellum-specific ATP synthase FliI
MNLEKLRSKLGKENLSAVFGEITKISATSIEIRGLKTGVGDIIKLVSNENENLNTLAMVV
EIKEQFSYLSPFSFIEGFKIGDRAFISDAGMQIGVSDELLGRVVDPFMRPKDGKGAIEAT
KYMPIMRAPIDAMKRGLIEEVFPVGVKTIDALLTCGVGQKLGIFAGSGVGKSTLMGMIVK
NSKAPIKVVALIGERGREIPEFIQKNLGGKLDDTVIIVATSDDSALMRKYGAFCAMSVAE
YFKEQGKDVLFIMDSVTRFAMAQREIGLALGEPPTTKGYPPSVLSLLPQLMERTGKEEGK
GTITAFFTVLVDGDDMSDPIADQSRSILDGHIVLSRELTDFGIYPPINIQNSASRVMGDI
ISPEHKLWARKFKRLNSLLKENEVLLRIGAYQKGSDKELDEAIAKKEFMQKFLGQNPEES
FEFEETIRLLSQIDANVAPSAVQQNINMGSSNATLPNPNPNLK
>fig|195.2296.peg.1838 Bores hole in peptidoglycan layer allowing type IV secretion complex assembly to occur (VirB1)
MIDIALIEQCKNPNVETQIIQKIIQVESNNQQFAININKVGSFILKNKKEAENLANNFIK
GGYSVDIGLMQFNSNNLKSSTFSHYSVEDLLDTCKNIKAGSDIFYLAYEMTNKNLAKEDR
INQALSIYNTGDLKKGFSNGYVAKYDSTAKTIDDLEEKARKSDTRIKITYNLFNLQTQKR
SKNGK
>fig|195.2296.peg.1188 DNA recombination and repair protein RecF
MIDNIKIQNYKLIKELEIDKFKNINIFTGENNCGKSSILEAIYLLLSQDYIKNFIYSYDV
FRNFPLNKKNIQFVFNNFDLNKKIN
>fig|195.2296.peg.1919 hypothetical protein
MAIQINNFIMYLNNGNYTNDFEMFLNYLADDEKTSTVVKDKDKDKIIVNDEIFIIFNESL
KNKHFNFSDIVFNKTVTFQGNYKNGLEFN
>fig|195.2296.peg.1974 IncF plasmid conjugative transfer protein TraG
GTREQQVAAAAKGLENLAARGDLQGLLHYANMNTAKPNADGIHDVSNKSYYSPSSVGANN
AHNNDAVANQNSLNNLGTAGGNNIRNEFSQQSGATISNFKNQGTSTSNVVNNSAKDAIVE
QNANRRMGVNPSSY
>fig|195.2296.peg.1926 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
SYKLGEALIQANKTWYKGGYVKILFEIGKLKREFRKKDNHA
>fig|195.2296.peg.745 Hemolysin, putative
MILKLFLYLKKGDVNIKNDYSKSSSFEQINTDSQKSNTTTSIDGVLSTNIKGANVGIVSN
QDVNIIASNINADSKIDINANNVNIKDAHELSKTKTDGVY
>fig|195.2296.peg.363 hypothetical protein
MAKFTPEELEELECNFTIIKSNSEVPAIGKNPLEERIIEIFHEMDFQVLKAKDLNDNTIY
FLWDEQREKYYLSNSIEKKLFS
>fig|195.2296.peg.1969 hypothetical protein
SSLVIAFVLFLAKNIKIVPYDEKKHGGYRSDNNTHFSEFLDGYATGYSMSIHGIDGEALH
SDK
>fig|195.2296.peg.1973 Motility accessory factor
SLNAENCMIVLRNKALYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFD
EKGNSHSKGFALGERIDHTLNLPTLQVPAYAGKGEVLTHIAWNDYRIKLEYLFACNDQKA
KFYNATEGGARINF
>fig|195.2296.peg.1371 hypothetical protein
MIVSKTYEIDSCDDVELDIKRESKLEFKLCFDDEKEIKALVFIIPGLGGDVDENYREHLA
EFVAGEFNVAVVSVNYHCIGNRPQTGSSFFMDDIDKLILKTSCEALNIQVNLDKLNSLEE
LSSTLKEVDHILEEQKNQKLINPNFKLSIHLSLQPTKNEYQNFGVMQAQDLLNAALYLKA
HAPFDTMGGGIPVIMIGSSHGGYLAHLAAKIAPWLVDGVLDNSAYAKFLWKVVGFGKEID
FMQYSEFSTFDFFHHIKTHCSTKTFWTSNSSSPCFFSPARRKIRNLLEEDHLLEQSKYLK
TCFISYHSLYDEYVSLKEKTMFYEELEKLGFDVTLCSVTKESQVDGKFIKNLNHGMGIPV
KLLIKKELPLMLEKIKQNSKKDYKEKCISYPCEDLLYQFSEKDDKMSLKIDKI
>fig|195.2296.peg.1680 Chitinase (EC 3.2.1.14)
MFELSNELALSFEKIGLYFFIFIISIQTLFIFWSFITSFDFCKKYWKESITFGLKTLMVE
KFKKDKVITVVSQNPKILIIDNTMEDLLALKRESFIVEEVKIIKKYKYTPETKEELQALV
DNEAIHLGDIDTSKITDMSYLFKRTKRKNFSGIETWNTINVKNMEGMFWGCENFNQDISA
WNTSSVENMSCMFLGCENFNQPLNGWDVRNVEYRYGMFYESGMERDDSKKPRFEKE
>fig|195.2296.peg.1815 Phage Rha protein
MSNLTVININNQEVVFENKDEQVFCTSLDVAKVFGKRHDDVLKAIRNILNDLREIGDLQC
IRNFTESFQYRKIEGFRGRGKKYPYYQLTKDGFSLLAMGLTGKKALRFKIAFINAFNEME
RIIKNQYTPKLENYNKYKIP
>fig|195.2296.peg.896 UPF0033 protein YedF
MKITYTLNLEGEACPYPAIATLDALPQLKSGEILEVLCDCP
>fig|195.2296.peg.546 TraG-like protein
MLFLSTLFFAPSFLFGANIENIKKYRNSIERKIGLVKSLFDTAGNPLQLPQKWGLVNMP
>fig|195.2296.peg.1968 IncF plasmid conjugative transfer protein TraG
VNNSAKDAIVEQNANRRMGVNPSSYTIQDASKSGNELAKEAQGLFEAMSKK
>fig|195.2296.peg.1849 Phage Rha protein
FNEMERIIKNQYTPKLENYNKYKIPNTPYRENIIKAIMQTEQNRNCEFEELIAYEIKEIY
KDNKSHIEQKINFRAKGLI
>fig|195.2296.peg.1988 IncF plasmid conjugative transfer protein TraG
IVEQNANRRMGVNPSSYAIQDASKSGNELAKEAQGLFEAIGANNAHNNDTVANQNSLNNL
GTAGGNNIRNEFSQQSGAAISN
>fig|195.2296.peg.1992 Motility accessory factor
SLAKQLPLLKAYQDKAVIFCADGALSMLEKEGIVPDYVTNLDFTDLAMKFFQNKENLKQS
IIALECATHPN
>fig|195.2296.peg.897 hypothetical protein
MKFFAPAFKIKTRAKVYQLFKFGAKFKAFGLRTEVWDHFDRFQEF
>fig|195.2296.peg.1826 hypothetical protein
MGFKKLSSEAPKKENDFVNSARGETGNAKTGNAKTGNAKRNKKLMINFTEEEYQILNQES
NSMGLSLNSYVRFKIFRKD
>fig|195.2296.peg.374 hypothetical protein
MVEIYQELQKGSQTPDLIDIEELEFNKEDIFEELFYALGGLGGMYSVEMIQSRIANFIKI
LGGEPKLLLERFTA
>fig|195.2297.peg.1800 Flagellin
SLRESKGQLDANIADAMGFGSVNKGVAIGGFSTVTAYMSSEGSGFSAGSGYSVGSGKGYS
ATLTANAIVMSNASAASRVYNVSSGSGFSAGSNLSQFATMKTTAFGVKDETAGVTTLKGA
MAVMDIAETAITNLDQIRADIGSVQNQVTSTINNITVTQV
>fig|195.2297.peg.352 hypothetical protein
MQYFCAEKENCCAVYIMDKNSNDEYIKKIKIKLKREKL
>fig|195.2297.peg.814 putative anion permease
MLASVIFIITLILLFWRPWNLPLWLIAIFGALFAFIFQLVDFKDVCFVFSLVWDSSLTLV
GLIILSFSLEALGFFDFIASKILHFSREKNQEKIYISTKKLMLFLLIFVFFLSAFFANDG
AILIITPIIIALFSTLKDCKNHAFILSSFLLSLSFLCDASSNALVISNLTNIITANYFKI
EFLEFAKNMFLPNFFVLLSTIVTVFVLYVRVLPKRLEFKLIKKEQISLKLFFLCIVFLFL
FVISFFIGEIFNIKISFFALLWAGIFWLIILKIQGKKSIKILFEAPYGVLLFSFGLYMVV
FALHKIGVSEILVKSYAFLMQDKSGIFGVALISAFGSSVFNNLPMVLIGDLALKEYFENF
SFDSLMIYAHLLGVNIGPKLTPIGSLATLLWLGVLARKGINISFWQYCKFGFLITLPVLV
FSLFALIV
>fig|195.2298.peg.1842 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILSLQDEEFKEEILSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQ
>fig|195.2298.peg.1620 FIG00638667: hypothetical protein
MKKLLIIPIIIFLCFIAQIFYMGHINESFFYNLTQTQNPYYEIKNINFHKGFLNSKADFT
IEDKYNLG
>fig|195.2299.peg.1903 hypothetical protein
MKFKILILMIFGVPLFADYNASKITKTDLENLQNMEISIYEKSTKNHEFNIMELVDLIWE
NRAIKIQPILERFNLSISGFAGEKSKISYYDASSRYENLRPYAYIGLQAEFKIIDPKEAR
QKKDEIRKQRMLISQMVRDFKAKKLQIFHLKNQISILHEKENRLKIRVNEAVSNFDERLK
NLENLQETNEKLDIAILDLSQLQNNLIDLVSDDFKPTLKRLLK
>fig|195.2299.peg.1955 hypothetical protein
MICKFFKTQTGGGVSAINYLLDKRVNQGTAKVLQGDEFL
>fig|195.2299.peg.1960 Motility accessory factor
CIYGIGNALLIKNLAKHYKHLFVFESEIELFILALSTIDLSEELKVYKVVLFDCVAKDLE
IQIAMIFDQQSILEHLSLYEILINASYYLRFYEKQILFLNEMCLKTIGVAVRNANISCSL
PLLTYGQFLQNIPSMLESIPFQRILNERKNKFENAIVVSAGPSLAKQLSLLKAYQDKAVI
FCADGALSMLEKEGIIPDYILNIDFEDLPLVFFKNKNLQDSILAFGCSTNPKLIHFLKNF
HCVIVLRNKLLYQRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEEGNS
HSKGFVLGEKIDHTLNIP
>fig|195.2299.peg.194 Filamentous haemagglutinin domain protein
MLKSPDRILCILKKKKGGGMNITNLLNIKHFLNTSSYFTNHLSKSLRVIVNISVITSLVL
AQSLTASNLPSGGKFINGTGSIATNGNIMNITGDKTHNVIAWGGGFNIGKDNTVNFTTNG
KNYLNLDYTNKASQILGTLNGGTNNVYIVNPSGVLVGEGATINANKFGVSITPMGIDAIN
TFSVDGSFSPVFNANKGDVVNMGTIKANEIVLVGNKVENIKGTLQADKVDIKGDKVYLED
FGINSTHLKAEIGSEGFFKYEVKDVYDAYKDDSNLVDNYEFTGTATTNGNFKEYLYIGSQ
SASNEEMINSWKGFAKLVNEGIFGELKFKDVYLGKDIDFAGASTINPVGFGNGFVGNFYG
NNHTLSNIQIDVADKTYVGLFGYIKGGSVQNLTIDGLQFPKYAFSYKYLGGLAGL
>fig|195.2299.peg.1812 hypothetical protein
MKFSLVLDDEVLIEFEKFKNSLECDKNIIENLFKYYKPTHLINLKQIQKLEESNLVIDSD
IKSAFLQSGYANLTLEKLSQKTTLKIILTNDKNKSFPYLYIKDEKIENNLCATFKQKESR
EKAFEYFKNLFLEANSIFIYDQYL
>fig|195.2299.peg.1859 Hypothetical protein pVir0016
MELAMMSKKDYYKEFIENDVIRVIFGYKNEKEYDSDDYFEMSLRVWVGKEYFDEFLNNPK
VENNMEVVKLFMETPFFKELAEQTIKIDFENWDFIIPDFFKKHNIKIIPYFQLGNNENLS
PKQFFMFLKELKVKELKYITTILCSKSIEDEYKFLHKKF
>fig|195.2299.peg.1964 hypothetical protein
LKRKNINFNHFAKFCNTSALAKIFDFYSVFEGFESLDSLNFEEDVFENIEYLLLKNYLHI
KDYFKLDETASYALSLLAKNNRKRFSINRKIQHFKALSTLKYLLRAGIIKLEHSKEAKRI
KDKRQKLKKELRSYVIQDKIIFANHFTRFFFYFLKPNEKLILQNRYEEVLGLIKEKFELY
QSFCFEQLSRELLEKKFQVSGVQSYWDKNLELDLYYKDDEISFIGEVKFKNKKICRNILN
LLESKAKSLKLE
>fig|195.2299.peg.1939 hypothetical protein
YSSSLNPKKLKKYIFIIYENGLSPALDEFNLTLPFIFDDYITTASVALPILKKRNASYEN
LNIANNHQKFITSNAFDFDQIVASEFKANLTSIIIKSLISSTLKTSLNMAVAKNDESGIL
SLATNIFSIATTRSDLRFWNFLPKNIQIMMIENDGSVQIYDDKNQKIYSSEVDIDKNVLI
VVRSFASQFPARVYKIEN
>fig|195.2299.peg.1243 Biotin sulfoxide reductase (EC 1.-.-.-) / Free methionine-(S)-sulfoxide reductase
MHHQDTNTNVKAWRKPRTVVVNEIYWTPTAKMADIVMPATSSYERDDITMSGDYSNMHIV
PMKQAVEPVGESKDDYIIFADICKVYGQNVYNAYTEKGKKAKDFIKEYYDSALKQTQSFG
EAFATPMPNFEEFWAKNEPITFEATAESLEWTRFSEFIEDPILNALGTESGLIEIYSETI
KNYNYDDCKAHPTWFEPIEWLGNATKEAPFHLLTNHPKDRLHSQLCHTSLRDTYAIKDRE
PILINTKDAKKLGVKNGDVVRVFNKRGEVLAGAVVSDEIMQGVVRLCEGAWYDPNENGLC
KCGNANVLTMDIPTSKLANGNISHTGLVNIEKFKGELPKLTAFSAPKGAN
>fig|195.2299.peg.1878 Translation-disabling ACNase RloC
LRKFLEIYLFFKYPNEIKSLDKELIKRFFNDTYQSDNIDENQKIIAGVINRYQNEYSHLR
EVLSRGMQPIDIEEAKKIAEFILKTIEQNDKQQYKALVESIGK
>fig|195.2299.peg.415 Phosphoglycerate transporter protein PgtP
MALGLILCALVNVLLGFSNSFYAYVGFVISLGFFKVWEWILLLSLLQTGILKKELGIYTA
VWNISHNIGGEIVAPIVSLSGFALAALLGVSMADFNETYWHMNHFYVPAVCAVIISLYVL
YAVKGSLKMKVWLILLKSMKCEGLKQKKSKL
>fig|195.2299.peg.1976 hypothetical protein
GALSDTSPGVKELSLEKMKEVKGGYVFGDYKIFKDRRNLTSEVYAIVDFTQYELENLNKG
LCGAGE
>fig|195.2299.peg.1 Putative phage protein
MDNMKEFKIFCDESNHLFYKDNPTLCSRVMVLGALKVPSSEIIKINKTIKYLKHKYKYNK
EIKWTKLNLSQKGFYDELLEFFFSSVYMWFKAVLIPNKTILQHDIYNQGDHDLFYYKMYY
QALHNLIDIDTKIKIYL
>fig|195.2299.peg.1892 Sulfate adenylyltransferase subunit 2 (EC 2.7.7.4)
MFNSHLKYLESESIHIIREVVAEFEKPAMLYSVGKDSSVMLHLLQKAFYPAVPPLPLVHV
DTTWKFKEMIEFRDKRAKELGMELIVYQNPKIKELNLSPFTHGSSMHTDISKTQGLKQML
DLYQFDAVFGGARRDEEKSRAKERIYSFRDENHSWDPKNQRPELWNIYNGRHKKGESIRV
FPLSNWTELDIWQYIYKENIPIPSLYFAKKRPVIEYMGAKILVDDERMPKELAKNAKEEL
VRFRTLGCYPLTGAINSNASNVLEIIEELLLSKTSERQGRLIDTDEEASMEKKKKEGYF
>fig|195.2299.peg.1559 hypothetical protein
SSFKALLNLSSKLENFKNYIAKNPSHTQEKILPIASKIAKELNAIKNDFFKALNRPENLM
IKDTELLKQSAKAFEKLENTLKNILGDHFPKTPQKESILESLLNHKENIKNENIKNENIK
EDIKAQNEDINKNDEYTKDESPDSSIKQEESEEKSPQVPKKENSLDDNDADIKQDIKKEN
LESQEDFHPKEDQNLDSKTENRKDNTQDSKNKTEENQAENNTKNSTSNQDKIKDEKQEKI
KENITKENPKFYETKTENKTSANTHNPNNTQNTQQLNNQTAQNIIKNQEFIKQNIVKNLA
FSVENLDLEQVQDLSKSLSNLSRKVNESLKELEPHTQNAKLNQAELKTLEHKLNLSIKDL
AQIKPKTEQDIAESLHHDVKSTLLQISNLAKNEGNEAVYNQANRLLAQIELNQLMSLAND
SINTYLPFSWEDLDDSKIMFRRGKKDKFFAQIKLEFAKLGDLEILISLNNDKYIDINIMA
ENVEFRKTIYENAHELKRNINKAGLLSANFFVGDIIRSKFDTRNVKNLDLEMGMDKKV
>fig|195.2299.peg.1248 hypothetical protein
LMQENSISYPCGNKVFIFKDVGDKFVLCIK
>fig|195.2299.peg.222 Ferric receptor CfrA
MNAKKLKLSILCFCLMGLGEIKAEEQYQLDDVVVSASGFEQDLVDAPASISVITKEELSK
KPIKDIGEAISDIPGVDVTMNKTGTYDFSIRGFGSSYTLVLIDGKRQSVANGFYDNGFGG
SESGYLPPASMIERIEVIRGPASTLYGSDAVGGVINIITKKNPNKTEANIEFSTLLQQHS
SKYGNAGGFNAYVATPLIEDTLSISARIKYL
>fig|195.2299.peg.1819 Para-aminobenzoate synthase, aminase component (EC 2.6.1.85) / Aminodeoxychorismate lyase (EC 4.1.3.38)
MSAETKFAIFGKYFYYDLKFVLKAYNKKQSKKYFKFVQKHKDKYYFLTLVDYEFYKYLQD
KNFTSKEAYLSFYAYKKRKNFTSKEAYLSFYAYKKRKKFTAMRVDEENFMPIFKNHLDFK
NYEKNFLQVKSAIAKGRSYQVNLTQSFHFDSLLDGFSLFNLLSKRQDTEFKAYIKDEGRE
ILSFSPELFFKIHKRKIITQPMKGTSARSKDLNQDKKNKLFLQKDVKNLSENVMIVDLLR
NDLSKLIVKNSMKTKLFKIQSYPTLHQMTSIIKGKLKKDIDYFQIFKALFPCGSITGAPK
LETIKLIEELEARKRGIYCGAIGCIHKNKSKFSVAIRTLEKKQDYQYSVGSGLVWDSKLE
EEIKELELKTQFLMPKNFYLFETMYYKKGKILFFKEHLQRILNSALKLNFNTQKLIKDFQ
EVLSYKSNLKEFKNFNIQALNEKLFHKNHSFFYPSIIKSHHKQAIFKLILQKDGNYTILE
NHIKTSDNNILLLSDKPLNSQSDSLYHKSSLRQIYDQKAFLWKENQCFDIAFFNEKNELC
EGSRSNIIIKKDKVLYTPTLQSGLLNGIYRQFLLDLGLIKEKKLFKEDLLNADEIYCINS
VRGLQKVSVK
>fig|195.2299.peg.1972 FIG00470222: hypothetical protein
ANANLVKRQTAQIDDELELKEQSVNIDKSLSIEKEKLLQAQTETEKANANLVKRQTAQID
DELELKEQSVNIDKSLSIEKEKLLQAQTETE
>fig|195.2299.peg.376 Methyl-accepting chemotaxis signal transduction protein
MFQNNDHVDINLIESLIKNAFDSSHYAVYTFLYLKDTTVLSDMQNVDKKYISPDGKTFSM
IFFDQITEKSGGITTISTPNNFSQLNLIQNIEQNVKYGDKDSVFVDSPRKLNYDNNEFLG
INFGMPIFNNKGKFIGVIGYTIDLLEISEIILDPKFDFFEGNTRILMNDQGIIAVHKNKN
GILKTLFDINKDQSTQLIVEAVKNHKDEILDNYITSTGDLSYASISSFSTLGNSSHWSVI
VTTPKKSVLAPLYKLQYTIISVAIIALIAILTVVYFFIRKIIGSRIPLILKSLENFFRFL
NHEKIEIQTIEIKANDELGKMGKIINENILATKQGLEQDAKAVKESVETVG
>fig|195.2299.peg.1802 Integral membrane protein
MTNAQINDKILELANYLKIDNKCVAHNARLQSMQINGAVIKNFSFKLFNEYKLSFFNCKF
LCEINEAPGFFEIENPVYIYDCTFEENVISYNIKFKSNVVIAYCRFNKNFYFEANTFC
>fig|195.2299.peg.1613 hypothetical protein
MHNGITHQIKTDEDFGILLNVICVIRERIDESFEEEDKSLVIDIDELIEKTCEELE
>fig|195.2299.peg.1877 Type I restriction-modification system, specificity subunit S
MTNLPQGWEVKKLGDIAKIQIGKTPSRNNIDFFQGENIWLSIRDLKSKFVSSSSEKISNE
AISKTNIKVVPKGTLLMSFKLTLGKTAFAECDLYTNEAIAAIFIKNKNINKYFLDYVLKF
TDLEKYVDNAVKGKTLNKQKLKQIEMLLPKNIKEQERIVGILDESFAKIDESIKILEQDL
LNLDELMQSALQKAFNPLKDNAKENYKLPQGWEWKSLGEIGEIITGTTPSKNNPNFYGNE
YPLFKPSDLNGDMIIKYASDNLSKLGFDNARNLPKDTILVVCIGASIGKVGLSGVNGSCN
QQINAIIPNSAFTSKYLFFVCLSNYFQTILKKNASQTTLPIINKTEFSKLQIPLPPIKEQ
EQITSHLDELSSHVKNLKQNYQAQIKDLQELKNSLLDKAFKGNL
>fig|195.2299.peg.1965 Methyl-accepting chemotaxis signal transduction protein
ENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDVLQ
TKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFANHLAS
ESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKNVTGI
IGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSL
>fig|195.2299.peg.1032 hypothetical protein
MSFLKLDEKECEKMAKKEFKVPNANELMGQIMAFNEKNNTNFGEELANDFIGYWDAREWK
RNGKRMSSIAGSLYTWLKYAKENELRKNQRFNRKKEANPSVVDSLMEYYGMKDENKNKLL
GCF
>fig|195.2299.peg.1015 hypothetical protein
MGTSLNELKTGREKLEIINQVLARISNVATALDNTRIEEIVGLKEQVNNFYNQILELKNL
VVKNSELTQSNTDFTKNKRNEIEKISN
>fig|195.2299.peg.1907 hypothetical protein
MHSPFLPPLTTPCFFRYATKTKGLAIFIARGKDRGILRGLASHSNAVRLFTLFCLFR
>fig|195.2299.peg.1067 Phage antirepressor protein
MQLQLTFPHTELQGAFPANVKNLFYFLEIDTKFADWINRRINHYDFIENQDYIIELVYTK
GRPRKEYYVTLDMAKELCMVENNEKGRQARRYFIECEKRLKNLEQEQMQKLAFRQSLGYK
SQLAQQKEHYENKIKALKYDLEKKKELSFKRKLSQKELLELRKILARDYGILCIKEWEMS
LVAEKIALESTKMTTWDAVVKKLKQSLDYWQNYEEYEEKWRKILRR
>fig|195.2299.peg.623 3'(2'),5'-bisphosphate nucleotidase (EC 3.1.3.7)
MEIKNSTKSSCIILKNLIESLIIMLNLDKFLEIAINASNQASKAILEERKNFKTWEKEDK
SPLTSADLASNKILNDILGSTDIKILSEEKLLSKEECEELKTFWLIDPLDGTSGFLKGSD
EFCIMISLVHDNRPVLSLIQNPSKGDIFYAHAKTKVYKNDKPLQIDQQEYEKNKYKALLS
VNHLSKEDEDFAKEHQLEAINIGSGLKFCAILEAKAGVYKRFEKLNIWDIVAGDFLVNQK
GGFMGTFSKEMILYSPLNYKCEPFICVSKKSFLNIYT
>fig|195.2299.peg.225 Methyl-accepting chemotaxis signal transduction protein
MSDITESANKTRDVAGTLHRSVDEITNVINLIKDVSDQTNLLALNAAIEAARAGEHGRGF
AVVADEVRKLAEKTQKATTEVEMNINLLKQNANEMYTQSEQVEKISINSNAHIMSFSEKF
THLVNEAHSTNSNAVGIASEAFVSLAKLDHIAFKLNGYKEIFAKSGQELADHTSCRLGKW
VASTGKERFGGSKSFIKINEPHQKVHENMNSAIRIANTEDVSLSNTQDAIIKKCENAENA
SLHLFDVFKEMLNEAN
>fig|195.2299.peg.377 Methyl-accepting chemotaxis signal transduction protein
MFRLSSVSSKLLLSVAISIIVAIALIIAIVSFQVASYSEKEAKNAISLSSKRYVNIYKVS
>fig|195.2300.peg.605 Diaminopimelate decarboxylase (EC 4.1.1.20)
PSTQSGDIMVIKNTGAYGFSMSSNYNTRNKVCELALEEGQVRLIRQRENFEDQIALEEKF
LKA
>fig|195.2300.peg.1805 Motility accessory factor
LDKFSTTAYGGNGKVQSSEIWTLFRHNFEKDIVNIKMNYHITTYNCTEGGARIEGTIEKP
FLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLKAYYKVYQSIKHCRDFSKILSNDFEKI
QSIYLSLNEKEEDINLAIEKIDKFKNKLEDIKQMQDLYEILQPLRTQFELNLARIY
>fig|195.2300.peg.825 Altronate dehydratase (EC 4.2.1.7)
AIASASCDISTGEWVHIHNTAGIRGRGDKE
>fig|195.2300.peg.1459 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
FTQTLLVITAPIVFWLLVFKATKNVFTQWIGLLLSNTLVILLVGLFLGVFMEQISTWIKY
FAKVTQAGDEVLGTSIFFVIAALVLVIMIISAKLYAEKVANVSMEGAMGGVIGSVLNPVG
RLAGWAGGKVAGKTVNTAKAGGKLAAKGTLASAKGGYSFAKKMYERARNAG
>fig|195.2300.peg.490 Macrolide export ATP-binding/permease protein MacB
IGIRMAIGARREDIMMQFLIEAVMICSMGAILGVLLSVFVIFGFNTLSTDFPMILNAYSV
LLGLLSSVLIGVIFGFFPARNAANLNPISALSKE
>fig|195.2300.peg.886 hypothetical protein
MATIRLSGGTNQSFGGVVHIDDHIDKTGSVNSAANININNNKNHGISTDTQNTTDTQDHS
WAGGTINLNSSISKIKNGISKVTGSDSTSNQPSNQPSKSDGPYINESTQTTRL
>fig|195.2300.peg.1507 Inner membrane protein of type IV secretion of T-DNA complex, VirB6
MNLDLFQTLGKSIQQIVDAIRQVGTNDKVAELSVLLSIIITLVIMYKGYEVLMGRSQSPI
RELTWDIVGKLVAITFALNLGGWLDLTISTMDGLYEWAGGGTQMYKTLDEMYANTAQLTN
IIWAKSSGVGGAILAIVAMLLCYVGFAIAVVPALTIFVVTTFTQTLLVITAPIVFWLLVF
KATKNV
>fig|195.2300.peg.1810 Diaminopimelate decarboxylase (EC 4.1.1.20)
EKEDVEPDLYDYAQGILAQLHGLDVTIGMEPGRFLVANSGEFVCSVLYEKHNKTKRFVIV
DGAMNDLIRPSLYEAYHEILLPYNQGEESPCDVVGGICESGDFFAKARSLPSTQSGDIMV
IKNTGAYGFSMSSNY
>fig|195.2300.peg.1822 Thiazole tautomerase TenI (EC 5.3.99.10)
EFLNSLLSFSQIPLYAIGGINVQNIASFKDINVAGVCMREVLMREKDVKKYLVECKRNLL
>fig|195.2300.peg.1780 Citrate lyase beta chain (EC 4.1.3.6)
MSLISTINIIGVVLPKAQSYEDIDMLSQFELPIIPIIESALGVENLDDIARHPNVLALSF
GSLDMTLDLNLQEGEGKNFILNSIRTQIILKSTKYNLLSPINGVYPDIKNIDGLKEDLIF
AKSMGFFWGG
>fig|195.2300.peg.1403 S-ribosylhomocysteine lyase (EC 4.4.1.21) @ Autoinducer-2 production protein LuxS
ELNIYQCGTCAMHSLDEAKEIAQKVLNSTIGVMNNEELKLENI
>fig|195.2300.peg.885 hypothetical protein
MELTGNGVAVNYSFVQDKANANTTNSSNSITQGGVRSDLLGTAEAGLEFSKTEKISDELS
HVSNTIKGSNININANNALDIGGANFEANKDINLRAGEIVSTKYEDIKTQSSTGFGLYIK
ERIEATSPIASAINQSAQNAAAKNENLGVNYGIVASQALANTANIFSNNLINTTSNQTLG
FKFNQDKSQSSSENISKINAGDNLNLESTKGSIVLNGVEAKANSINIEAKDNVILNAAKS
KNSSSSSSLEIAATNKQTAGYHAVDGGTVGEGIEGFASASYSKSNETQFTNANLNANNIN
INTGKDFTLNGANVKASNDAILNVGNLEVNSLADSLNSQKYSALLNASGTGGLSSNHLVT
GSVSGTLGIGYAKTDKTTVTTQSGISAGNEINGHVNGNLNLQGGILILIIKKEIYLLMEK
LQILK
>fig|195.2301.peg.489 Proline dehydrogenase (EC 1.5.5.2) / Delta-1-pyrroline-5-carboxylate dehydrogenase (EC 1.2.1.88)
MIQKSLALAEELQGKIEANISNSEKEFHAKMQKLLNNPENKVMLIELLDRSFRCKDKRAS
FELIEHTLNKYGIADFFSAFEKFLLFSFLNFGKFAPNLSVPFFVKHLREDTKAMVLDANP
SVLEPHMRKRKDPR
>fig|195.2301.peg.1126 Putative large exoprotein involved in heme utilization or adhesion of ShlA/HecA/FhaA family
MYLNAHTIHNNALIFADKDINIEANILNNNANLTGMLETSTEYSQGFGQVGYGDTAFKRW
NMEVGVTGIVKYNNLLDSKQASIQAGKDININTQSQDNARQINNSGKILAQGNIVSFGNI
DNKSLSKEISVGEILEQIRVNGFFAKEYLGSWNTNSTYYFVDHESLLDALKYFSTTQAKN
HQRESAWNALKDAAAKNSALNQYFSLLFGSDYASKRFVPDQKEWNLDAKIVFKAKSEAVI
ASKGKLDLNAKEYNQDLVSSLDKNFALLDSDLKKATNSQDLILNSIPDLINSGLFTLENK
TNDNITYEYTTNTSIIDESKYFGFLSILNQFKNKNFNEFIVIGDPFLKISLLTQCMQTHY
NPILN
>fig|195.2301.peg.1794 hypothetical protein
MQEKEKYILILDKNDFNKYRKDCSFINNQENLAHKIAIGEFRIFIAVYKDIVGGKIKCNH
RKIK
>fig|195.2301.peg.1844 hypothetical protein
DECCLWSSSGTREVSIELENTPMPNKLFARGNGYYGQTEITNVRVKKSIFIGEQEIQSED
FNVEKLEASSDTYGDYAFLFEISKQDQIVMKKELNLNPKKTKNTKNVKK
>fig|195.2301.peg.1861 Phage protein Mup29, H
YFPVKLKNASLKFWMEFLERFGSPWAVAKTDSDPDALASEIHQMLNGDSAVIDKEEELDL
IQPKAKANYNEIIDYLDNQIRSVVLGANLS
>fig|195.2301.peg.1786 Phage tail fiber protein GpH
GSAKELMIKIVMELSNAEEVILKLDPSVIMASRDYVDAIKIELELKIETLKEELKALINT
KEDKGVAANLDKALKTELTKLINKKENTGTAASLDAQLRDELIALINKKENIGVAKQLVD
ALRSELTKEIESFIPELRVEKRIITANYDRKYKKMVSLSNIPSEVNMSTYLSKCANSGFP
EFAPNYSIYQLKGEHLIYYLNDQYVASYAYQAISYAPSGSTNNNNY
>fig|195.2301.peg.1835 bacteriophage DNA transposition protein A, putative
WMQEYALREYRTFGAGGFNFTELWWQIHKEAATKENYDFIGFDLGKVKPLFSVKTLQNFI
KNYYKDKPLEHCIITQGLDRAKSKFLPAQGNQRELYDMKNMCWQIDSSPADFIVRDDETL
EPFRPHILSVVDVFSGMGVATLVGKSNSLSLTRLLWKAIDKFGKPDMIKGDNGKDYLSKD
FQSLLDSLNISYD
>fig|195.2301.peg.599 hypothetical protein
MWDKILNYQQLECDYFNLYNQFISVDFQISLFEKNHKSLIKDFIFFYHQILKQKDLNFLL
GVRNKIALKVHNYMQEYSTSPKDLSLICLREHKHIEFFQRFYKALAYFVAFRKKLDEEQK
IKNLISNINDCFGCHFINSDFNNLQNFQKNDFFTLPEKCLQYFHLAMIHLCFMVLNPLNF
KDSNRHLDKAINYLIDGTFEIYELIFKEYFLLFPKDEELKDELKKIKI
>fig|195.2301.peg.1811 phage uncharacterized protein
AHQFYLKNKALMDKGAKVLWKEAKSLEDLMKLRAENLKAFNKEQLNNPRSENQIFSLDGI
NFYDDLPAINQYYMYIDPAGEKAKSDFTAITIIGKGAKGFYVAESIVKILKAQSIIKTIF
NLQKIYKCRLIEIETNGGQFFLKKWLQEKSLESGVFLPLRGKNNSVSKFERIESLSLAFE
NEELFLHKNQTMLINQLLEFPEGKNDDAPDSLAGAFLLARTKSSIKRRKHHFNSVSRIRR
F
>fig|195.2301.peg.1836 Phage baseplate assembly protein GpJ
LPLANIIIADDEFATLSFSLSYEKAAL
>fig|195.2301.peg.1857 Phage tail formation protein GpI
GLEEKEARKLISKALLLDRYNGTTWAIKEALKAVFPTAVVKEWFEYSGKPYFFKVKVSTT
NVSFDERTLNTLERLTKDFKNVRSVLEAIEIEIESKNDSFN
>fig|195.2301.peg.1822 hypothetical protein
MKDYGISYIPNANQSSKEPSEPIVSDKLNAQKVNELIDKKLNLFKEGLANQEELKSLIRE
ILKDQNFQNTNIKISKTPPNYNTQAKVGEIWAVLESKKQLFICIANDNDFTSWVDLLGDG
SNDIAPKEKIIITFDNTTTGGQYGGCMSDLRLGFENGFATPNKVQDEYENAKFTMTKDGN
GLNRSDFTIDSNPIAGENQILGTIKTSGIYQETYHKIAHVFKKYNGGSDECCLWSSSGTR
EVSIELENTPMPN
>fig|195.2301.peg.1843 Phage tail sheath monomer GpFI
MAANYGVNFNISNGAASPIKVQSDTPIGIAGAIKG
>fig|195.2301.peg.1837 Phage tail formation protein GpI
MNTLILNHHPKQSKAIDLSAKARFEDLKIESITNLAMRCDERLLPVLANAYDVSIDGLEE
KEARKLISKALLLDRYNGTTWAIKEALSAVFPTAVVKEWFNYGGKPYFFKVKVSTTNVSF
DERTLNTLERLIKDFKNVRSVLEAIEIEIESKNDSFN
>fig|195.2302.peg.474 Signal transduction protein CetA, mediates an energy taxis response
MAVSKFLTLLVNLKSESEERINKFSQAFKRLEENSSALGVNFGSFAKRLILSVVKIDHIL
YKSNIYLNLNGAQNFNLESVDPISNLCQDERAQGVINELSSETELNLAKEFIKDNAKKAI
EESSQDYIDQKAYDAIVNDIKSLEQRSAEILAKLKI
>fig|195.2302.peg.1740 Methyl-accepting chemotaxis signal transduction protein
INENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLLDV
LQTKVGSDMNAIHKIFEEYKSLDFRNKLD
>fig|195.2302.peg.746 Fe2+ ABC transporter, substrate binding protein
MSIYFVHFLSSILPLSILMAFITPDKRYILKAF
>fig|195.2302.peg.475 Signal transduction protein CetA, mediates an energy taxis response
MVKNGLLLSIFLSIIGILGAIFFHIYVGVIIFILIAVLMIYLFRQHKDEQIMIDKLLVLC
RELKEGNFDNRIIYVKTKSKKLAEIADNLNNTIDGLEAYLREINTSISCSQKGEFYRKAL
PEGLKGIFAHNIEFINKALANIEVTARSTFKNALSRTLMDLSLGNQNKDMSQISSSLNQD
ISMMKNVYDTVDAISHTATENGSEVDSLQSAMGSLMDVVNSSKETVQTFVANSQNITSVV
EVIRDIADQTNLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQRSTSEISIAIQTMQ
QDFVNIQSGSEQVFNIVSESEE
>fig|195.2302.peg.1624 C4-dicarboxylate transporter
MEDNSWHFLGLFIAVIMAVILQVMPLGPVCMIAIAIVALSGITTTQLKI
>fig|195.2303.peg.1753 FIG022708: hypothetical protein
FKNLAKERYKKYENLGFWVCEGHYHQNLILDEKDVKYFNLASFAYERSFFVVECCQEIKF
REQKLRGQNV
>fig|195.2304.peg.1776 Motility accessory factor
ATIFCADSSYPILAKHGIKPDYVCMLERTEITAEFFNHDFGEFDKDIVFICAGVVHPKAI
EYLKGGNRKYLIMPRYLYFPIYIKLNKYFYFLYNTPSVAHMSYFLSVLLNHKNIILIGQD
LAYAENGNSHPDDYQNSANYESQM
>fig|195.2305.peg.1130 hypothetical protein
MNKTTIIMACDDNLVFAVANMIIGIKRYCYNDVLKIVIMYDNIQKEEIDKVRSIWLEKIE
FKLYSKNDFLKDVGCIGKIKLSDRFGFHLVYAKFYIFNFLKDYESVLWLDIDMLLLDNII
SLLSFDTEGTITKGSPKILNKYLQHINKLENINATKPNGGFIHFNKSVLQCSTSDLTQEC
FSVLKDLYDKEFLEGIAWGDEIPFGVLIYKYKLKINTINKVNTLPNNSKDSILIHAGTDM
KFWSSFISYISFQEWHVNNKVWSNNYDKMININFRQHNLPIKDQSDLYQFLFSYNLFYSI
YPMLNVLINYKLKEYKLYIDFLISNSRRSFNIFSSFLGSKNFYYQIEFEYGYGEWGTKIY
FNLVLKDFYKEKLKFILLEMVDFKPST
>fig|195.2305.peg.230 hypothetical protein
MNLFKFPIPNFNDKSKSTIFWRHMRFYSRKFLYYPQVKFLEKTLNMKGNEHLKNFFSNRP
DACYNAIRRFCDKSFKANERVKTLIYDVDKGLTCFKFLPEEQMIFSFDEDFELFLGYNHN
VYEEGFWAFSLKFKKYTISQCNFCFTLENNLLLSCIQGYKYKDFNILEINKI
>fig|195.2305.peg.1793 hypothetical protein
MFKDFHDKYKCIFIHVPKVAGSSIERVIYQTDKWLVGHVKASDYTKFDKDKFDSYFSFGF
VRNPYDRVVSAYHYLKNDSPDPCDIKWGRLHINNLTFEEFILSLQDEEFKEENLSKNHFS
FQYKYLCDKNMNILVNFIGKFEKLDNDFKKILNILRRKDSLVHINKSKHLNYRDYYNSQT
YKIIREIYRDDFEIFDYDLEDKKYFNIPQNIYLNNLESKILIKNINLDSLRLKKSFQIQN
LNQTIETKNKTIQD
>fig|195.2306.peg.107 hypothetical protein
MIINQIYSIDSCDDVELNIKRGSKLEFRLTYDDSKEIEAIVCIISGLGGDIDDNLYIEEY
CARNYNVAVLSVNYHCIGNRPQTGASFYINELDRLILKTSLEAIGIQLPVDMQNLKTYDE
FYCVVDFVNKFIEKLKKEKELSEDYCLYLSVGLEPTKNEYQNYGIMQAMDIINAILYINI
NLPFKVSNMSTVSRMGGGIKTILIGVSHGGYLANLCAKISPWNIDVVLDNSSNVTLDNDL
WRFIGFGREIDYVKYCSVGITYMFKNIKLAAFDKTYWTTNKQSPYYFSNARKIVREPLNK
EHLKIQSLYPKPKYIAYHSKFD
>fig|195.2306.peg.1791 Motility accessory factor
KHLFVFESEIELFILALSTIDLSEELCSGKIYLIDIKEERVDIQLLILFDMKDMFEYLSL
YEMFVNNVYYKKFYEDIWHKADELCEKNIKIVIRNLGLNLTISFQCYSHLLQNIPSMLGS
IPFQRILSERKNKFDNAIVVSAGPSLTKQLPLLKAYQDKAVVFCADGALSMLEKEGVVPD
YVLNIDFEDLPLRFFKNKQNKLSLNILSCATHPSLVHFLDNKSVILRDDPLYQSFNLNDF
GYIDTGTHVSHFSYTLALALGFKNIIMIGQDLAFDEKGNSHSKGFDFGEKFEEEHKKYKL
KTQAYGGKGEVLTHITWNDYRVKLEYLFACNDQKAKFYNATEGGARINFTEELSFKECCE
KLLTKEKPKFELPKSLTKNRSDKLLAKFKEKIQKDQENAKRFLDDALALKQILENILSKD
FLLPLEFLEKVYQNIENFNHSLDTDEFIQDEVLRGAFAYRGKLISDVLKFHINDKIHFIT
AYIKAYHEWLLYFIEKLEQKYKSLSKV
>fig|195.2307.peg.1675 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYGIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEFEFNQNIFYALNFENKEISFTELVFSFKI
NSLDRESFDISNIYNKKHFIIQKDNSLITFKYRKIQSKGFNLVFLLENNILKNYYFNYLE
KINPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTKINFNLNKFDIH
LALSFAISLNFIAKNEQNKLYKFVLENN
>fig|195.2307.peg.1725 Propionate--CoA ligase (EC 6.2.1.17); Acetyl-CoA synthetase (EC 6.2.1.1)
MGIVYEQTYRESLQNPEAFWAEAAKKVHWYNEWDRVLDDSDGHYRWFVGGCMNTCYNALD
LHVHNGRGDQLALIYDSPVTDTKKKYTYKQLRDRVAKVAGILANKGVVKGDRVVIYMPMI
PEALIAMLACARLGAIHSVVFGGFAAHELATRIEDAKPRMIISASCGIEVSSIIEYKPIL
DEAIKKCTHKPTTCLIWQRPQYRANMLPWRDIDWELEEEKTRGVDPVPVLATDPLYILYT
SGTTGSPKGVIRSNGGHSVAMKWSMDNIYNAKAGDVFFTASDVGWVVGHSYIVYAPLMNG
CTTIV
>fig|195.2307.peg.1811 ATP synthase F0 sector subunit c (EC 3.6.3.14)
AAEANAPVEQEAINVWIKAFSVLAAGLGLGVAALGGAIGMGNTAAATIAGTARNPGLGPK
LMTTMF
>fig|195.2307.peg.1383 ATP-dependent protease La (EC 3.4.21.53) Type I
VFSDKKVRSDVAMTGEIDLAGNVLPIGGLKEKLIAAYKADIKIALIPKKNYERDLKDIPD
EVKDNMKIIGVKDFDEVLKYALV
>fig|195.2307.peg.1710 Oligoendopeptidase F-like protein
ETPRHLQNQITQQSVNSLIQTTQKHFYLVSNFYKRKKQILGFNKLKDYDRYAPIGKEAKF
SFEESKKIILNAFYDFSPVFGDIAKEAFEKGWIDVYPQDKKQSGAFSHSATPDTHPFILL
NYTDGRRDLFTLAHELGHTIHQKLSYNVSFLNQNTPLTTAETASVFAEMLVFDYVKNKLK
KEELLALYAAKIEDIFATLYRQINFTCFERRIHANENELKSEEISQIWMEESQKMFGESV
ELSKNYALWWSYIPHFIHSPFYCYAYAYAQLLVLALYGLYKSNACSNFKELYIKMLSLGG
SVSPKELVGMFGFDIEDKSFWEIGIVEIKKLIDEFMRLK
>fig|195.2307.peg.1331 Putative transmembrane transport protein
SKIGLKMRTYFSKIGFILAVAGGAVGLGNAWKFPTLSAENGGFVFVLLYLFFTLSIGFSI
FLAEVSMGRLSRSDLANAYYTLAKSHARRWRYGGIFTLGGIFVLSFYLVIMGWVLKYALT
SLYYLPKNLEQAGSDFSTLISADLSNSILFFSLSFFLTLLIVSKGLIKGIERLNVVIMPS
LFIMLIFMLLYCMSFQNGFKQAFSYLFYPDFSNFKLSSIAEALGLAFFTLCLGIGCIVTY
SAALSKKINFIKSSIFIVLINLLISFIMGLIVFTFIFEFEANPNIQGPGIVFVSLMSLFN
ELGILGYVLAFCFFLALFFAGITSAVSMIEPLTFYVVNNYKISRIKALSFIGFIVFVLGI
CCILSLNTHFSSLFSIFGKDFFTLLDKVTSNILLPLGAIVSSIFVGFFVDKKRIYKIFSK
FVNRQIFTIWLFFIRFISPIAIICIMCYQIFVKIS
>fig|195.2307.peg.1542 Oligoendopeptidase F-like protein
MLTWDLGVLFKNEDELENTTQNYIQQSKEFKKNYSTTLDKLNPDDFLNALKEYEHLHLIL
SKIMTYAYLCFAKDSSKGSFYAKYEQECKKIEENLLFFELEFCELSEEKTKELIKFCKGY
DFYLQNLLQNKRYNLSQKEERIMLYLSNTGANAFSRLFDESMTALKIPFEGNKLSEEEIL
SKLYNNDRKIRKKAAKKFTKALDKNLNLLTFIFNMIKTELNNICKLRGYESAETPRHLQN
QITQQSVNSLIQTTQKH
>fig|195.2307.peg.1198 Uncharacterized protein Cj0990c
MPSLLLLDFLKSFVYKNKKELACEKTFVLMLNHKLVYELKAFFT
>fig|195.2307.peg.1802 Methyl-accepting chemotaxis signal transduction protein
KNGILKTLFDINKDQSAQLIVEAVKNHKDEILDNYIASTGDPSYASISSFSTLGNSSHWS
VIVTAPKKSVLAPLYKLQYTIISVAIIALIAILTVVYFFIRKIIGSRIPLILKSLENFFR
FLNHEKIEIQTIEIKANDELGKMGKIINENILATKQGLEQDAKAVKESVETVGVVE
>fig|195.2307.peg.493 Translation elongation factor G
FKLAASMGFKEGARKAGAVILEPMMKVEVETPEDYMGDVIGDLNKRRGQVNSMDERGGNK
IITAFCPLAEMFGYSTDLRSQTQGRATYSMEFDHYDEVPKNVADEIIKKRNG
>fig|195.2307.peg.1197 Uncharacterized protein Cj0990c
MKITFQGKSDEYEIEKSYFYNRAFIVKDKIPNRDKIDFITDSVRLLEFSDHSFEFDEILK
CLYDENEENTIIVEEIFITSQIKQDEEPRNPPLEIKIDEAPKNNTRFTPFNTFSRIFNKD
CFIFTSDNCEQKESVKVEKNQKLNIFESLKIEDLDASFVKIEILDYDASNDSVNFDLDAF
PSGASYKYGIS
>fig|195.2308.peg.562 Citrate lyase beta chain (EC 4.1.3.6)
MKAKSFLFVPSIFPERFTKALQSGASQIIIDLEDSVEVAKKEVGRKNIVDFSSQCAKNND
KFLIRINETKSKEFQKDLSLISTIKESNGIIGVVLPKAQSYEDIDMLSQFELPILPIIES
ALGVENLDDIARHPSF
>fig|195.2308.peg.1712 hypothetical protein
DKNGEIIAKPEFDKAGNFSEGLARVALNGKWGFIDKSGKIVIEPIFDDIDY
>fig|195.2308.peg.344 CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase (EC 2.7.8.12)
MNKIKKYLFKIFRFLPLSKNKIVFIAHSAGRFDCNPKAIFEELLKNKVKAKYIWILNKKF
HKEYKDKYPMVSFVSPSSFKAFFHLSTCRVFINNQIHVYYKKMGFNKRPEQLYLQTWHGS
FGMKRINIVDEVEKVFQASQDMDYWITNSFFESEVYKKYLWANRVLEIGHARSDILFNSD
YKGRVKEKYNLSKDCKLVLYAPTKKEQYSQLNCAEVVAKFSDKVLKIFKQKYPKHTWYIL
IRRHAYDKGIVKYQNQNIIDAFDYPDVMELIKECDVLISDYSSIICDFALTYKPIFIYAN
DYDSFILTSKLYHDYSKLPFSLAKNFDELEKCIINFDHDIYKQGLKVWLESVGCIENGEA
SKKISSLITQFIEKDRDLNLYTTNQVTPYIAKIMGFKNIYFTFRNIGDQIIMMRSLELLH
QKTKQIFLIGTTLPDLWKEVKFVKVVNLKEIKLHIYQKEQFDLMASYGIKPIFLTQESFN
KEKGKYIRTYGPSHIVANVCSKLGLEGDIVVDLNFPLSEKEKTFGRFASENKKQIAIISG
GLQRYKTYPFEKLQEVVNSLQEKYDFIQIGTEEDLPLRGALDLREKLTLREVASVLYNSD
LFVGGIGGLMHMANAVGCPSVVLYSEAEPKHVVYYTNNINVYPTDNTCIKCTEGKHCPWN
SPCKAEDQKYSCIDNIQIEDVVQAINKRIELPRNLNKPTIYHIKQKKVYGLEEYKKIGFS
FVKENQYFGIGNVKNKTKKALQVLFFGYSPISFVYSRSYFKIRILNLHINLSRFIVKTNN
KKQAPQNQHSKNDLNDNFMNRIIKIKNHLKTRDWFLINELVQNTNIKNQGKFIELLNKEK
YIDHITKPVGKKEINQKVYEIFLYDGFILPFKIAYKFYVLEKKCYINTKRKKEYIQQGDI
IDIGGGLGLTTCFLSRYTNNTVYSLEPSFRLYMLLNEICLLNQIENIKIFNLACSDSNDS
LYTTNKLDNSNKVGREKHANVTGVKATTLDSFVLKYNVQPKFINIWNNGYEFESLIGMTK
TIQQFRPIIHINISNSIDKLFDIFDFLIFHDYSIDIKRAAISNNKEFFVLCEPR
>fig|195.2308.peg.353 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MKKYNIVLIGESHFVMKDGFQSGLESEFTNIFNLSLGASPAIQSLYEIIRNRKIFKEADL
IIFGSNTVDVIQYNSIQLLPISIQVIEWVYKELFF
>fig|195.2308.peg.1811 hypothetical protein
ISSRLSSFTPGLVSLKAPFVSLAKKSSAKTELVSKEVKAKKAKIFFIENPFVNSFCKFFK
TTIDLF
>fig|195.2308.peg.1805 Motility accessory factor
RKGISDTAIIVSTGPSLTKQLPLLKKYASKATIFCADSSYPILAKHGIKPDYVCMLERTE
ITAEFFNHDFGEFDNGICFIIKSIVHPNAINYLTKKTDNFTIVSTYASFIQYLKLDYFGY
FNMGFSVAHMACYLSLHLNHKNIIFIGQDLAYAENGNSHPDDYQNSANYESQ
>fig|195.2308.peg.1303 Integral membrane protein
MIKLKSPALVFWVGTFLFGAFGVGRFMIGDWVLGLIRLGITIVAMFCGILMITYSALGII
YGLLWLVNWIWWIVDMFLVGKKLRKQNFEKIANIIQ
>fig|195.2308.peg.1645 Transcription termination protein NusB
DDIDKNLNPYLNENEIEKLGHIERAILRLGAYELLFTDTPNAIVINEAIELAKELANDNS
PKFINGVLDTLVKAKQ
>fig|195.2308.peg.960 hypothetical protein
MNIESILKPIIDLRIKIGATLEHIDLSYIKNSISAEEIKLLETQGIDVEINDIKVVSDGT
FAYKNRRVLIYIRDVSPLYKENDINSTLPRYHLCHCNAYQTMLSNNRKHRYVVSSRDDGV
FWLNFFGFQGDTMVKTKSQERKLDVCMYCLRKLNWCNINQYSGKDRSIIRNNFDLKDFLK
NIQKILSILKIILMIK
>fig|195.2308.peg.355 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
MQFLDFYDRKFKIIKDTKIVFNFKSNFIALLLADLNNNSKASERDEYFLQNSKLAQDDYC
FNNLIPPIEWYKEIIDEYCHVVDPRKVLPLQIQLNMLNRNIELVKQDNYRLLQINNDIQS
DNILLKNTLKSLYEKTRQLENSNLGQKLIIDKILQEKKQ
>fig|195.2308.peg.1736 hypothetical protein
MQNITSNLIFTNSGVFRALGREPRGNARLDQIPAFMDAKNLQPLISSELKTQISRISYLD
KKSFGKIKKLKLWRENEPINKFS
>fig|195.2308.peg.1342 Transcription termination protein NusB
MATRHQVRQSVISLLYALEMNEKNENFIDEFLNEKKIRNEQKNFTLSLYEGIIKNLDDID
KNLNPYLNENEIEKLGHIERA
>fig|195.2308.peg.947 hypothetical protein
MQDKDNIKTYYECLKELSKEELYEGLLGYGMFADRIPNFLTSEYFFEFCKSNKPSFEQKE
YRYIKYESMRNINVPRVLSIPNPFAYYKQCKILKEYWKKLQRYFYKKTKSNKYKISRIHI
RKLYEKKLIDNKYYDVEIEKIFIMNFKNYKLDGTPEQEIFIGKGYKVNADISNCFPSIYT
HSIPWVLIGKIGAKKNKGFTKLYYNKIDNATQWLNYGETHGILIGPHSSNLISEIILVAV
DYKLSKKYKYIRNIDDYTCYVKSHEEAEQFLLDLSIELKKYGLSLNHKKQKL
>fig|195.2308.peg.1514 Flagellar biosynthesis protein FlhB
FSLKKLVESVKIVLKVGVVFTVAFIVLLKFMQELPLVERYNIIGQLIWLRDRAIILAAIV
IIAFLVIAVLDIFLVRFQYFKGLRMSKQEIKDEYKQMEGDPQVKGRIRRLQMEAARRRMV
QDVAGADVVITNPTHYAVAIRYDTTKEQAPRVVAKGVDFLALRIKQVAYDNNVVVYENPP
LARELYKACDINDLIPREMFKAVAEVLGFVYNTNNKSRLAGQVKKNN
>fig|195.2308.peg.1237 PhoX, Predicted phosphatase
MQRRVFLKGSALGSMVAFFGGSNLSAAVLKDKELLGFKAVSASTKDEVIVPDGYEAKVLI
SWGDPLFSKAKAYDESKNIDMNAVDNARFVFGDNNDGMSFFHFQKIEEF
>fig|195.2308.peg.1814 Motility accessory factor
AIRKIDEFKNKLENIKQMQDLYEILSTLLIQFELNLARIYVLNPKTKEDAFNKSILWIKE
HLEFME
>fig|195.2308.peg.1558 tRNA-dihydrouridine synthase DusB
MIDFSKKPLFLAPMAGFSDLPFRNVVKKFGADITISEMISSNALVYESSKTLHM
>fig|195.2308.peg.1785 hypothetical protein
KIKKYFSYRLGEAIIQANNTWYGGGGYIKLWFDIKRLKKEIKRGQR
>fig|195.2308.peg.1803 Cytolethal distending toxin subunit A
MQKIKLSLMFLIVTIIFSACSSKEQQINPLGRSYGKFNDNDPLKLGSKPTPPVKQKTPSL
VEGKKFPAIPLVPPVITPNTFKGDNAVK
>fig|195.2308.peg.1788 Motility accessory factor
QDLAYAENGNSHPDDYQNSANYESQTYEHILTEAYGGKEKIKTHHVWLMFKRNLEQDVQK
IQKYLDTKVYNCTEGGARIEGTIEKPFLWACENLLDKDLNKPFEKLEPLSLNKQNEFLLK
AYYKVYQSIKHCRDFNDNFIKVYDKIKNSFMSLQNSQKNEIFIQEIIQDIDKTKTQIDEL
YNTQKDLIQILGPLLTQFELNLARIYVLNPKTKEDAFNKSILWIKEHLEFMELVYGHIKA
QENALIKNILPLEEKLKERKLDKWMERVRR
>fig|195.2308.peg.354 hypothetical protein
MHDYYVQNNLHAFHKIRDGVHDFNFVMRKLGKNIIKNIDSFQFPHCKDDIYNDNPSFSVF
TFNDDIKNEIKKIHYTLRKFFH
>fig|195.2308.peg.352 D-glycero-alpha-D-manno-heptose 1-phosphate guanylyltransferase (EC 2.7.7.71)
MQAIVLAGGLGTRLRSVVQALPKPMAPINGKPFLAFVLEYLKKQGITEIILSVSYKYELI
QEYFKDEFHGMKIHYNIEKELLGTGGAIKDALKLVKNEVYVLNGDTFFDVDLKKLVLNGS
KICIALKQMQNFDRYGTVNVNEQGFLTSFEEKIFKKQGLINGGIYLLKKDIFDEFSLEKK
FSFEEFLQKNYRSLKIQTQIFDDYFIDIGIPQDYYLFHDCNIFHQVSNLK
>fig|195.2308.peg.1662 DNA-binding protein Roi
MNLEIFRKKDENKEISLTSLEIAELTGKEHFNVTRDIETYLEKVVEGGVFKFEDTYQNPQ
NKQSYKCYRLPK
>fig|195.2308.peg.1677 hypothetical protein
MIPNFIASFDVAIGRKRLRERKGYLKLSNTIAYGGLSVDALALYIQLAKLSEKTIVSEIY
LREFIKVKNNQRMSLNRLRIAKKELIELRLLEIKKVRNGSLNFYEWILKDENYQVKKHFN
KSLSLLKNSDEKLSKTLKNNASSIDRKLTTENEKNQKSLYIETRTHARDNKFINNININN
NKFIKKENLENLNNKFIKKENLENLKNNQEKKERVFNQNASFAVSFLKLDEKECEKMAKK
EFKVPNANELMGQIMAFNEKNGTNFGEELANDFIGYWDAREWKRNGKRMSSIAGSLYTWL
KYAKENELRKNQRFNRKKEANPSVVDSLMEYYGMKDENKDKLLGCF
>fig|195.2308.peg.1304 integral membrane protein
MDFNSVLFSIGDKLPKDATSTVMLKEKFDRLNEDKKKK
>fig|195.2308.peg.563 Citrate lyase beta chain (EC 4.1.3.6)
MTLDLNLQEGEGKNFILNSIRTQIVLKSTKYNLLSPINGVYPDIKNIDGLKEDLIFAKSM
GFGGSLCIHPNQVAPINEVFSPSAKQIAWAKEILSLRQNSNDIIFNYNGMMVDLPVIKKA
EQILLDSNSNLS
>fig|195.2308.peg.948 hypothetical protein
MPFLDMALNLMKDNKNNAAILNYAFKILIKKKMTPSAKKYFINIIHHLVLLYPYLIFLLD
KIFNEKELITQENIEKISSDIFNLGKEKRNYEAMSYALYFALKYNFKLKEKINLLEEAKR
KEDCILMLLCYLYDKKNNKDTEEYKIIANNFIINTTSKNTNFKILDDEYWLFAYEVLSRE
DPSALNKCKDWKQIKNSNISFIRQEFQ
>fig|195.2308.peg.345 hypothetical protein
MRTEIKFVSSRRDGLGARLSALFNALALSRYYKGDFLFWWPQSSEQMQRYDQIRENIELD
SKKLTVMNKEDLFSPLFLQKYCKNLPVKDGLPFCYKNNRVNDVLKFKITKDRLEDCNFIS
HTPCVNYIEDMESDKYYLILVELWKSYRNIFSDRICKIIDNARDTAKALGYYESISLRMA
DVVWNPEYKNLGTYVFKYSPLEIMSDVIAKRPEVKFIIFSDDHSSAIQLKCFFKNRDGVL
LADDFLNKDYSEDEKTIFEIALMSYSGNVYMGDSNFAKFPCRVGLGKEPISITDLYTNKD
RYNLIKKNINSFTLSKYQKAYSYLYLYTRAKLLNRSLKELRGIMVNALMLDRDNDLYRIG
ILYSLLKEKKYFRAENYLKYIMFVRYRVFLRVLVDDRMLFKKDILDGLQGIDLRDYPHIL
KLFNDIYFNKKEKPLLLGAPSRIKNHLAYRLGQIAIANSKTIGGYFRLPFNLIKEYKQYN
QEQKNYQMMIKINPILALPKLQDYDDYQEAVKIKKYFSYRLGEAIIQANNTWYGGGVYQA
VV
>fig|195.2308.peg.1238 PhoX, Predicted phosphatase
MFNHQGKNLSKEDVLYEQASVGVSVLEIQKKGNEWAVVLDSKYNRRIDANTKMEVSGAAK
KEVLKDKKFAYGTFANCANGQTPWGTYISCEENFDDYFGSSDENLKFDENFKRYGFKTKS
EYGWEKFDERFDLAKNLDEANRFGWIVEINPFDAKSTPIKRTALGRFKHENAEFINFQAR
KLPLL
>fig|195.2308.peg.1538 Flagellar biosynthesis protein FlhB
MAGEDQEKTEEPTSKKIEDARKEGNVPKSQDAAAIVTLIVGFVITLFMMGFIGERITNLY
RYYQSFIGVEFDLRIIQAIMIKSIFEVLILLAPIVLSIMIAGILGNVMQFGFIFTTKPIM
PNLGKINPLKGLKNLFSLKKLVESVKIVLKVGVVFTVAFI
>fig|195.2308.peg.1484 Multidrug efflux system, inner membrane proton/drug antiporter (RND type) => CmeB
SIFIGLPPIPGLSITGGFEMYVQNKSGKSYDEIQKDVNKLVAAANQREELYGVRTTLDTS
FPQYKLIIDRDKLKHFNLNMQDVFSTMNATIGTYYVNDFTMLGKNFQVNIRAKGDFINTQ
NALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNIFPAAQIQGQPAPGYTSGQAIEA
ISQVAQETLSDDYSIAWSGSAYQEVSSKGTGSYAFALGMVFVFLILAAQYERWLIPLAVV
TAVPFAVFGSFLLVYLRGFTNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKKIFD
AAIEAAKLRFRPIVMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFV
PLFFYLLENFNEWLDKKRGKVHE
>fig|195.2308.peg.1784 hypothetical protein
MISDNISCFKMIDLQRILLKKNALGVFELDQQENIEYIEIDNFHSAVKCFISNNNKIWKE
IEVLNKDDKYQIKYTKFKFLKTNTDSIEFYAYIRQYPGLIIVSRPDGFGCRIGALLNAMY
ISRETGFKFGFIGGKNYDFSRFQPIIDDFENIFSEKFLEEHYYHREITLDSEHDHFVTNI
LNPKDILELPYEKEWGFFYNFHPLTSSLIKDNNYRSNMKKSFNAIGFSKKYCDLIELSKQ
IKQQIKTKFVAIHMRNGDVMVPDKMNKGTAEMFWRLFPVEILIEIIERENSIGNAVVLFS
PDFDILRQVKIFFKSNNMVYTSEELIEGYYSNIYERDFLELMLMSQSFKIYKSPASLYSE
LAFYIGDVKEKIEIHKHFNLEEQYHIMIKNHNMINILNPYYSTCYYIYLYFMVALPLKKE
IQILIDILNKIIRNNQKYVLGHYELVRLLLDNKRLKEADMVIKDYWLPCFDEVISWILLD
NLHHCIYKQKQFLKQSAQNYPYISYVKAFIMENKGDVCGAMKAIMASINNESDNIVFLKM
FYRLYLKYFYKNEKQIEDIFLKFDMVNKQISKLDSESQKISHNIKKIQEKPLLLGAPSRI
KNHLAYRLGQIALANSKTISDYFKLPFILMKEYKQYNQEQKNYQMMIKINPILALPKLQD
YDDYQEAVKIKKYFSYRLGEAIMQANNTWYRGGYIKLWFEIKRLRKGCNET
>fig|195.2310.peg.1805 Flagellin
VEYKDGDSNGALVAAINSVKDTTGVEASIDANGQLLLSSREGRGIKIEGSIGGGAFINKD
MMENYGRLSLVKNDGKDILVSGTNLSSAGFGAGNFISQASVSLRESKGQLNANIADAMGF
GSVNKGVILAGASSVSAYMSAAGSGFSAGSGYSAGSGKNYSAVIAANAVVISNTSAVSKI
YNVSAGSGFSSGSTLSQFATMKTSA
>fig|195.2310.peg.804 Putative methyl-accepting chemotaxis protein
MMEDIAKTKKNTVQIYQKIIDAVVKENDIQSATKMVLDSARPEFILWLAQTNKLIDYQEL
ANQELTQIALLESKSFRFIMMGIIIIALIISIVIAYLIVRYIKKSVGGEPRDVNRIITEV
ANGNLTQPIHTEYKQSILYSISRMQDHLRNIVQKMITISNELNHKADLVVDRISETEKAV
IFQGETSRESALKIREISQKTQNVSKMALETEENSKNTTQVCQNNKKYAEDTASQMEYIA
SNSSRVSQQIALLSEHAKNIGTSTELISEITDQTNLLALNAAIEAARAGDVGRGFAVVAD
EIRKLAEKTGEATDQIAIINKQIQEETIATVGVIEESIPLISQGKSLSEEVRDSVDLIYK
QANDSLFKAQEVNQEVAAQVKLMEEIEEKIITVADISSKTQQAVSENKNAMTELKNISDN
LQAEIAIFKL
>fig|195.2310.peg.1390 hypothetical protein
MVTFYFSADNLIRIIPNLAHLTIQANINKNIILVSYHSLKDPFNTAKDKQTLFLAYKELG
YDATLHLIKDESEIDGRFIKDLNHGMRISDKALFRKELPLMLEKLQKRKSLMQENSISYP
CGNKVFIFKDVGDKFELTIKD
>fig|195.2310.peg.1521 hypothetical protein
MKKNASSKILLSLGVATLLYSSAFAQEINLTQSSDVGNYFEENGKDINLKNPDKYKGQDL
NIKMGVWDLPNDDYDSADYRLNIDIGKNNTLSFTHNNDQNPVYVTNLNATAKEVKTTDIV
LQASAPSVINGNLTMTSSGAGTITEDEKKGSGIILYNGNGAVEGKSANGSLTINGNFTAD
KTLFCCLWKFC
>fig|195.2311.peg.1877 Motility accessory factor
GIVPDYVTNLDFTDLAMKFFQNKENLKQSIIALECATHPNIVRSLNAENCMIVLRNKALY
QRFNLNDFGYIDTGTHVSHFSYTLALALGFKNIIMIGQ
>fig|195.2311.peg.1806 Multidrug efflux system, outer membrane factor lipoprotein => CmeD
IAMFEKYLKSAIFLALYPLAMLASNLHEFIALSQNNESYLIKQMQSEQANLDKEQAFRNY
LPSLSLNSAYVANNKDRFIIDPQESLFAKVSLNFLLFDGGAREANLRALESREKLSLLDK
EQNKNYLALNAITLYFNTLSLEKILLANQQKVAFLKSTFERLQKFYDAGLSPKDELESIK
AKYHLSLLELSQNELKLANIQKEIKILSDTDFKVQGNAFLENPQQEKSQNYEVMIAKEQI
NLAKESVNLAKAEYFPKFYIQDNFNFYKNNYNPKVPAPFANLADQFLEKYSQGNQFILGM
EWKIFDFNARAKEVEKERLNVQIANANARFSERKNKEELNYLDKSLKVLQEQILALNLSL
NAANLAFESVDKKYQAGLVSYVEYLQALEAKFKAQSDLELAKNEFEITKANYYFNAGIDL
NSKVKE
>fig|195.2311.peg.1307 Amidophosphoribosyltransferase (EC 2.4.2.14)
MCAVVGVINSKNASTYAYYALFAMQHRGQEASGISVSNGKTIKTIKAKGEVNQIFNPENL
KTLEGEI
>fig|195.2311.peg.1700 hypothetical protein
HFEIISNFGKHFEIISNFGKHFEIINYTNKRNRLNKIEDVKYNNKFYQAA
>fig|195.2311.peg.1306 Lipoprotein releasing system transmembrane protein LolC/LolE
MRKSVLKYLLFKYLRFDKEQPFINLSMLLAFLGVCVGLCVLLVAMAIMNGFDKEFEKRFF
VMNYPITIVPKFYSPMNDDLVTELKREFPHLLFSPYISTQVVAKADNRFEGGILFGVNFN
DEVKINEVVAKALKDENLSGFDILVGSVLADELNLHKNDKLSLIFSNLSPSGFSLVPQAK
RFDVKARFASGLIFYDKAYMYTDVNALRKVLGISNQQSYDGVHVYS
>fig|195.2311.peg.546 Methyl-accepting chemotaxis signal transduction protein
MNNIKIKLSIIANSIAIFALSILSIISFYFTKDSLYQSTLHAETDLLKATQISIEDFRSR
NISLLNTLEKDILNLPYEALNSQDNIINNVGAILKYYRNSGNLLAVYIGLDNGENIVSDD
LSEKKNTNITINGKANNYNATTREWYKEARNSNQTYITPAYIDVVSNEYAITYSKALYKD
GKFIGVLGFDVLSISLQDEIARTPGNTFVFDHQDRIFAATNKALLDPSVDHSPVLNAYKA
HGDNNFFSYKLNNEERLGVCTKVFAYTACITESTDVINKPIFKAAYIQVIALIIMISISI
ILLYFIVSKYLSPLAAIQTGLTSFFDFINHKTKNVSTIEIKSNDEFGQISKAINENILAT
KQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNR
>fig|195.2311.peg.1549 hypothetical protein
KEFMKGFSIKKIFALLALTSLLTSSVFAEDFLAKVSNGVLSDNSQGVKALNLDEMKQVKG
GYVFGDYKIFKDRRNLTSEVYAIVDFTQYELENLNKGLCGAGEDKCQNPSRDRLFAWLQV
SANSPADYRPVYKVKRQIKYSNLGQPYVLFTYGVAVYDRKNGQIYQYNSSPMLNNNRIIR
EITHQYKYAIEDAMGGWNPRLF
>fig|195.2311.peg.22 L-fuco-beta-pyranose dehydrogenase, type 2 (EC 1.1.1.122)
MDLKIKNKVCIITGGAKGIGYGIAKLWAMEGGIPVVFSRSMPKEHDEELKNLCKSYEFYE
IDLKNYEQIEELIKKVAIKHGGIYALVNNAGANDNLHIENTSTKDLIKSYENNLFHYYAM
AKECLPYIKKEQGSILNIVSKTGITGQGRTSAYASAKAAQIGFTREWLVLLLKIVLE
>fig|195.2311.peg.782 Fe2+ ABC transporter, permease protein 1
MLVKMITHSIFRNKIQKFLAFLTCFLATLLLCTMLNITLSIGDEVTKQLKSYGSNILVLP
KGSSLSIEIGNELYEPLKNKNYLEEKNLYMLKDIYWRNNITAFAPFLEGKIEIKSNNSSK
KILLYGTYFQKAIEIKDDDDFITGIKSLYPYLKVQGKWAKDDSNEI
>fig|195.2311.peg.1878 hypothetical protein
PDMSVYPQNEDGSYSKEALFMSFLKSYPPFPSSNQVVFSPEAKVREAKLELEMKANPSFS
VSLDDIMTGKVDFASLLKGYAQDGWLDADIYAMEKG
>fig|195.2311.peg.1798 hypothetical protein
MDNVEFVSKDLKYAKEVVNVYAKIYQNNKDLIMTALASSGKKTNSSIATTISGVFDRILI
SGVFARIHALVPFMKSAKEQALRNQILDALKLAKTNKEVISNLKNIKIADKEQSRIFKDA
LDNYIKVDKEQNKILKDALIKEGVIKGDNFFMDKADPSKAKSDYTAKFNVEKWINNVSGI
LKDEWVVNLKAMAKKHPEMFKNEADVFKVIKEIKDNPTHFFKNYDDEVALIAKPLKDDKV
GNIAIKKDSGKIIHINKTKGKDLERLNRRNKAMLTGTPTPATTKGSTTNVEGDLLQHSFK
NSTQTKPKKNLMDDIKENIKAKEVKKKNKKSVKQSLDEKIQNDKKAREERIKKIKQVIAR
KQKIDKVRDKKNNREIAGKIGTYTLKNLIKLKESSEDNKN
>fig|195.2311.peg.1884 hypothetical protein
AFLKQNASKLSDIESKNSQTLARSEVLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKN
SIYTLKYKQ
>fig|195.2311.peg.1873 Motility accessory factor
KDIEIIWIMFHILDFSHELQNSRLMILQTSSLDIEFFSNFCSSKPFFQFSRIYFLELMSH
YYERFHEDILGLNKKLAENFKNSIVFHGNDPLDALQGIEQFVYNLPQMITHPSYKEL
>fig|195.2311.peg.1742 hypothetical protein
MTIQIPQGAKTMQLFDMNIDIPEGKTYIDIDDNFLQNKYNQFMQNNQQQNNFNSQEELAL
DGKPMSMYQAPQVSQNEPQEQGVWSKINKGLEDFNNLIDPKRMISEGLDYLSPRVTSGEE
GARQKIEDATNQISGGLLARNFTSLDNEEQKQIFQIAYDEIKKLGYEPFLEINNGDYKYI
GVDKNGKEVDFTPSFRNTLASTKNELAFSVAGGYAGSLAKTAGQTIGKKALNYFAPSAIG
AGGGAVSDLHSQSNNTGIEASYMDYAKRFGSAAAEDALAGAVVGSAIKGIGKTYKSVGDL
ISSVKTGAQAGKDMIDGMAVK
>fig|195.2311.peg.1761 hypothetical protein
MARRKLNQKKRFKIFKKIFMEENKEYWHNVALLEKLWEKIPQCNTNTLNANEVFNIIKKE
KIKIDIHSICKFFKITLIKTNGKKFVIFNENNKLIIHYHNESDIFYFLGHVFHNFLDGAY
FKYPFKKRTWDLEHREKLAKKFAIRLKLLIAGYELASGLGKYFEAISNFGKHFEIISNFG
KHFE
>fig|195.2311.peg.1641 Peptidoglycan lipid II flippase MurJ
MKSLVFKNFIINALGILFSRVLGLARDVLIALFLGAGIYSDIFFVALKMPAFFRRIFAEG
AFGQSFLPNFVKAKKKGAFCVSVMYQFSVIVFLFCLLVSFFSSFFTKLFAFGFSSDTIAL
ASPLVAINFWYLFFIFLVTFLGAILNYRQKFFITSFSAALFNLSIVIAAFFVDKDAPQDT
LYYFSYATVLSGVAQLILHLMVLRKNPVIRAMALSVKFRRAKAKLEGFYSN
>fig|195.2311.peg.1807 Phage tail length tape-measure protein GpT
KMSADILKMSQTLPVTANELAAIAAAGGQIGLGSKDVREFTNLVTKMKVAFDMSAEDVGD
SVAKIKNILGISLKDMEDLGDSINNLSDNSASKAREIIDVMKRTAAAGKQIGFTKEQIAA
LSSSFISLGKGPEVAGTAINSLYRVLATADNMGTKTESAFAKLGISGAFLKQASFDDPQK
ALDMFLQRISKLDQKEQMGVLVDIFGREFADDMATLVGGLDTYKEALKNAGDEAKKGSLQ
REFDTRAATTENSIILMKNAFNSLAINLGSVFLPAISWVSAGISYLVNSITYITGLVPGL
NGVLGGLIATFLLAKPAVLAYAIAKNYLKDCTILLKSALIKTRIHLLAFRNSCILSNITL
KAKTVTTTIYTTSLKALSFVLGGLNKVFKAVANGIRVLSVAMMSNPIGLILGGIAIVAGL
IIANWDRVKSWFMSFIEWLRPVWEPIYNAIKAVFNKCSGVIGYFKNNALNIIFPFVGILK
FIWKPIYEVFKWVFDKCALVFASFKDIIMSVASPLAEFLNSIWQGIGDFFYSIFSSLFEW
FASKLSWVGDMISSISGFIKDALDFVGLGDDKEVKISQNEQTKEKIFATNTYKDELQAKS
INHTPSFNNGNINVSVNGTFNIATKDGNFNMQEFANAIQKSVFDALRKQEQNKINTTIYG
>fig|195.2311.peg.1850 Lipoprotein releasing system transmembrane protein LolC/LolE
TDVNALRKVLGISNQQSYDGVHVYSENAFKDVEKLKSYLKSDYVVVGWWEQNQNFFSALK
LEKRALFIVLMLIILVASLNIVSSLLMIVMNRRTEIALLLALGASKLEVKKSFFALGMLI
GGGGMIIGIILAFFVLWLLGNFDIVTLPADVYGTSKLPLDLSVMDFSLTLVGALIIIALS
SYYPAKKATQINVLDTLRNE
>fig|195.2311.peg.1872 hypothetical protein
FSNALGQSFPNDKTSFSEADINSMPSGYGVSGTQWMDFNDPSNRMNITGLKDFSNSLISN
IYKTPEQAKEANDLWADSGYMIDGLLPKTLGLSLEEIKNVSKGEDWQFNPDMSVYPQNE
>fig|195.2311.peg.1619 Periplasmic nitrate reductase (EC 1.7.99.4)
KPPVGLVYVPWFDENVYINKVTLDATCPLSKQTDFKKCAVKIYKA
>fig|195.2311.peg.1885 GTP-binding protein Obg
GAVSFRREKHVPLGGPDGGDGGNGGDIIFVCDNNTHTLVNFKGKRELRAQNGAGGMGRNK
NGKKGENL
>fig|195.2311.peg.1865 hypothetical protein
MGSDFNKAAGLPEDFKIHKSTLDEIERFNQHGMADETSGNYYDSFDMASIVKSYYNSFNQ
VISAFPNDKTSFSEADLEQLPKGLNYGRNENKEKIVKNIFNAEQFHEAQAIKYSTMGLDM
NLMKLDFSPQSMEQDPSIEGDFNPDMSVYPQNEDGSYSKEALFMSF
>fig|195.2311.peg.1842 Fe2+ ABC transporter, permease protein 1
ITGIKSLYPYLKVQGKWAKDDSNEIMLGEDFAKNNDLKINDTIQLIGENKISKEVKIVGI
LLHANPKMSNKIITPLNLAQELLEKKGLYASAEVRAFTIPESALSEKVRRMGEEKLDQIE
YDKWYCSAYVGSIASQISDGLPGADAKALNAISDAQSLVVKKIQSLMAITCIICLIVASI
AISSLMSSEIHRRKKEIGLLKVLGANTFQIYLLFAGENLIIALVSAVFGFIFGIGLSELI
SLGIFGYFINIAFIALPLSLVFAGLIAILGCLLPIKNIANLSPAGVLYGR
>fig|195.2311.peg.1082 Outer-membrane-phospholipid-binding lipoprotein MlaA
MKLKLISCILLFSTIFAFANELDLNDFEEEYQSYKVNDPLYGYNKAMTSFNVALYDYSLR
PILKGYNAITPEFIRTGVRNFFDNLFAPLRFVGNVLQFKFEEAGEEFKRFSANTIMGFGG
IMSIKAIK
>fig|195.2311.peg.1614 Ankyrin repeat-containing possible periplasmic protein
MHAAAYGDVEILKMLVAKGADINEIDDLGFNALDFALAANQKDNANYLQSLGLKPNENLI
YGGSLE
>fig|195.2311.peg.284 Methyl-accepting chemotaxis sensor/transducer protein
MFGAKKNNTKIIEQLEKKCNGLGDILRSIGNTMAVIEFTTDGVILEANQNFLTTMKYSLS
EIKGKHHSMFCLPEVVNSSAYSDFWKDLRDGKARSGLFRRIAKGGIDVYLEANYLPISDN
NGYVYKIIKFANDITQRHYEMLDLRNTIAAANRSMAIIEFKPDGTIITANENFLRTMDFN
IDEIKGKHHSMFCDSNYRHSKDYVQFWEDLREGKFQSGKYIRYGRNNKKVYLEASYNPVK
NDDGKIYKVIKFATDISEQVKKDQEKLRLISELAEKNDNLTQDGDRVIENTVSNVQNIAD
MMSQSSNLVSSLNQQSDEIKSIIQTISDIADQTNLLALNAAIEAARAGEHGRGFAVVADE
VRSLAERTGHSVNEITTTINSIRNVTSQVVESIKSGLEDVNKSVELAKEARECMEKIRES
SAEVAKAMS
>fig|195.2311.peg.1799 hypothetical protein
VGDLISSVKTGAQAGKDMIDGMAVKGGNLGNRAIDKITQKDIPMIGKFTDGGLQNAETIF
NNLTKNVENKKQIDELIAKENPTYLENGKPTIEILKNIVEQGLNKNNPQFIQDSAKRTSA
ILKNISNTLQGVPTTQRREILLKSAQAYPEIGSFLDDVLKADKDASISFLNIIKEQDEVF
KNKTGLNGEFDVKAWQKDNSSYKKRINNEYAQAIKSIDELNNGSIRLSKEDLAKIEEFKN
NNFLEQDIKTNISSFLEDTIDKDLSAEQIFNLRSAINKQLATGNKTYNTKEAYRLVKDTL
DETMIKNASDKELAKKILEDANKNYALKENFNNSYLGKIKDQETPEALAQRIANGARNIN
EDKDLKRAFEGMNEAERKANEKHAFNALLAKHRMKI
>fig|195.2311.peg.1025 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
TSQIQNLNNTLNTKTQELTSKTTQINSLQTTLKNKDSLLSFQSQHGTAKQRIQNQLSYKL
GQTMIINSKNIFGILFMPVYIISTLLSHKQEQKIYQEKIKKDPSLKLPPLENYPDYKEAL
KFKNHLSYKLGQALIKANKTWYKGGYVKVIFEIRKLKKVKI
>fig|195.2311.peg.23 L-fuco-beta-pyranose dehydrogenase, type 2 (EC 1.1.1.122)
MACAFAKDSVRVNAIAPAEVMTPLYEKWLQNFPNPKEQYEKIAKTIPLGHRFTTIEEIAN
TAVFTLSPLASHTTGQILMPDGGYVHLDRALNWDEI
>fig|195.2311.peg.1686 Peptidoglycan lipid II flippase MurJ
PVIRAMALSVKFRRAKAKLEGFYSNFFHGVLGSSATQISSLLDTTIASFLMTGSISYLYY
ANRVFQLPLALFAIALTQVSFPKILKHLKSDQENLALSFMQRALAVLSILLIVSSIVGSV
FALEISKLLFERGNFTHEDSIITAYVLIAYLIGLLPFGLQKLFSLWLYAKFKQKTAAFIA
FKALLISALCSVLFIFLIKDESLKVIAVALSSSLSAFYLLIANIKEFGFKNFFALISFKF
CFLMITGLVVFTILLYEIKPYLIEALLWIVASVKGVF
>fig|195.2311.peg.1844 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
DDYWELNCIEECVPRMDGVDVVWFDYNKIYESGFLDQKNDWTWFLGYNRNSGSKKISSKL
WLERYKHIGHFAFVWQGVINFRFLKNIDLKFIDGIFHQDVHFGFLLFAQSSYIYLLSKKL
LVYRIRNGATTVRNFKNNLKDEIPFYIQELLSYFEIKTAKEYYSIYSWIQIILNVMHSHN
IKNNLHSDLYYLFIGNLSEQILKLKFSYKQDPMHLSGFINFIKTFVGLHRILQNNMQKNS
VQLNQLQSKLSFQSQHGTAKQRIQNQLSYKLGQTMIVNSKNIFGILFMPVYIISTLLSHK
QEQKIYQEKIKKDPSLKLPSLESYPDYKEALKFKNHLSYKLGQALIKANKTWYKGGYVRF
LFELRKIYKQKTMKNSLILYKNRDSNKKDTTRSIRGGDRLALGLDEQYFIKRHESFFHYK
PDFRNPKTFNEKIIHRILFDRRDIYTFLADKIKVRLYIQFILEYDISNGQIYKLLSKNID
ELSEELKNTNKCSYLPEIYGIYKHTDEIDFDFLPNSFVIKTNHDWGGVVVVNNKAEFLAD
SSKKIESLTKLQKHLDRNYYDVSKEWHYKNITPRIFIEENLSQKNNDLKDYRFHVFNHKT
QFIQVANSAHTCNNLYYPDWKIFPIMYLNKRDSKEIQKPYKLKKMLKLASLLSIDFDYIR
VDMYLVDSKIYIGELTFTPNCGKAKIEPAEWDLKLGQMWRSDVFKL
>fig|195.2311.peg.1859 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase
IIFLDSDDYWELNCIEECVPRMDGVDVVWFDFEMFIDETKIKKEWSRLRSFQFLKEIIIT
PKEWLEQSIATKQNEFAFAWGGMVNFTFLKNIKLKFIDGIIFEDVTFGTILFAQSKNIYI
FPKVVYNYRIRQNSIMQSLKNSNLSEYLSYMREYFISDSEVKSYHVVISKIITIEKLCAF
ITSFHNIEVSYLMRIAFFNYLRQWSLEIFNLSKDPMDFFDQVVILTHDLFVHKNKKILYK
EANSKDIFIWLSQIITLKNTLLQTKDKTIANQTSQIQNLNNTLNTKTQELTSKTTQIKEL
NQVVANQTSQIQNLNNTLNTKTQELTSKT
>fig|195.2311.peg.663 FIG00973752: TolA-like membrane protein
FASDELNIDSLFKKQIGLRSITSFSLLSTGNANSYSLYPNITIGGDPTIWNDTKQCF
>fig|195.2311.peg.1882 hypothetical protein
WLDADIYAMEKGVAWQNTSIGYGGAWFDNQFNQAKANGWKASSESINSFADSIADRLNNL
LEQTRV
>fig|195.2311.peg.1 ATP-dependent DNA helicase RecG (EC 3.6.1.-)
MSGDLLDGFIQHGNEFKYFDFSKDEYILEKAKKDLMEI
>fig|195.2312.peg.1766 Motility accessory factor
QDKAVIFCADGALSMLEKEGIIPDYILNIDFEDLPLVFFKNKNLQDSILAFGCSTNPKLI
HFLKNFHCVIVLRNKLLYQRFNLNDFGYIDTGTHVSHFSYT
>fig|195.2312.peg.1652 hypothetical protein
MEEKNKYNQCLLLNGYEFLDFENTKNTTLKEWLKDENFLLFIKSIPKDYIFIIKKYSIAN
GIFLTHKKTFEFAQKILEKVKDINFDFSYSEFEFNQNIFYALNFKNKEISFTELVFSFKI
NSLDRKSFDISNIYNKKHFIIQKDNSLITFKYRKIQSKGFNLVFLLENNILKNYYFNYLE
KINPYIAKDFKNIKENHSFEIYKLLRIDFNVLINCHSVQEVIEKSLNTKINFNLNKFDIH
LALSFAISLNFIAKNEQNKLYKFVLENNKLIYDYIDFINNNFANEHFIKIKYKRKKYKII
NIASFLLYHKLKPQKESYQNEFLEIYQFPSKKTSASISGR
>fig|195.2312.peg.1770 Motility accessory factor
DDYQNSANYESQMYEHILTEAYGGKEKIKTHHVWLMFKRNLEQDVQKIQKYLDTKVYNCT
EGGARIEGTIEKPFLWACENL
>fig|195.2312.peg.1675 Major pilus subunit of type IV secretion complex, VirB2
MQNLSTALYALGAVLLTIAFMWGGSKIMFQGQTLREVAPIFIGGVIFGSASAIAGYIIT
>fig|195.2312.peg.1751 Motility accessory factor
ANKATIFCADSSYPILAKHGIKPDYVLSLERIPLTSEFFNNDFGEFDKDIVFVCAGVVHP
KTIEYLKNKTFIITQKILAFPYYINLKNFCYAAVGFSVAHMAYEFATHLSHKNIIFIGQD
LAYAEDGFSHTKDYSNLDKHEGHFQRDKGKFQCLAYGGNGKAESSEVWTMFRFFLQDTIS
RNIISTTYNCTEGGARIEGTIEKPFLWACEKLLYKDLNKPFEKLEPLSLNKQNEFLLKAY
YKVCKSIKHCRDFSKILSNDFEKIQSVY
>fig|195.2312.peg.1713 hypothetical protein
MRQAFYTSKFYISKKSEKEVCFKLNFEIEISGGGEKIYKVEIRAFVDYQYLKNGNNITPN
IHKNQNDWWLSYECDRWSFHSSIAIRDEYQSLGIGTFLINKMLEIALKYVPTARLSGTLS
AVDEEILENHIRRDKLYKIKAKINCHFYFY
>fig|195.2312.peg.379 hypothetical protein
MVKNNIATQSHDILSSGVAASGIRIDGSNNQLIIANDTKVYTLGDYSNALLIAYGKDHVI
EHNGELKATGKEGIAINIDFGDNTLGNAEEYRGSYIHQMSGNNQDDLAEYNLDGALVKSL
NLNAASSTIGSLASIYIADNAYVNTINIAQWAKVEGDIISNWDPNNEKLANQYKDSFYTD
LNFGSDSSLSRAAFNALDNTWSVKANVLGYDNFKMNVNENLNLQGSAFVYDLNNKAHFSL
LGADGINPSLLYIKNNFTQDSNAILTAGINANGQSLVYVGGNANLVGAFNFYMLKDFYKD
KVVLDPDLISANQIQGAFNSIVYDSSLDFSPTLNFIYDANTKELGVVRDYTPYIKNSSDI
SLAYALNSLAQNGKYEDIALLFKELDFATDAQTIAQGLNELNAKAYLDSAKISLDFQEEL
NKEALSEYANEWQSFVTPFGTYQSSRANGDFDAYKGYGGGVKAKLLRDLIVSI
>fig|195.2312.peg.736 Hemolysin, putative
MEVGVTGIVKYNNLLDSKQASIQAGKDININTQSQDNARQINNSGKILAQGNIVSFGNID
NKSLSKEISVGEILEQIRVNGFFAKEYLGS
>fig|195.2312.peg.484 hypothetical protein
PNNYIIISKNGFSKEFYKICKQDLLLLDLNDFKILLEEDK
>fig|195.2312.peg.531 Type II secretion system protein
MKLYELEIKGKTKQTKHLRAKNLNEAQAKAIAKKWEILNIKEIQKASFKRLDDARFILFF
QELSLLCEVGISIKDALKELDKIYSHKMIAKLCDNLNLGQNLSLAFENANFGLTHAELAL
IKTSQNTGKLSEIFMQISRLRQNNVENEQRVKKALRYPLIRYPLIVFLSVCAAFVLLMLF
VVPNFKDLFEDLNLALPFITELIIYIYNFLDKYILLVFCLIALILFLTLFLYRKYYFFSY
FCDSLLLKLPLLSKFIIYQQNYSFFMIFSLLLKSGISLLEAFKLATLALNNKKVLLYYQE
IRTFMDSGLEISHAFKKVDLFDPLVFSMLSIAMKSSKLEFLSEEIAKYYKNKSENLMDKF
LSFLEPIMTLWVAILVLFLALGIFLPIWELSSGVNF
>fig|195.2312.peg.1531 major facilitator family transporter, putative
MKMLKILIIFCATLTLSIVYAPQPIAPLLSNYFHVNLHQISWIISVTLIPLAIAPLVYGY
LLEIFSLKKILVVSLFLCSIFGIIGNLNDNFYFFLFLRFLQALCIPAILTALLTLLSRLE
SDNIQKKHSHLCRCYNFWWFCWEGFWKFFERSFFLAFCLKFF
>fig|195.2312.peg.378 hypothetical protein
MGQCFNGFLNSFSDHLYDLNGVKAQIGMRIVKTQAEVEEAKLKGETVFLVKDDGVYINGS
FSNASGNVYFKGENVAEVIKNAKLGYDGVNGIPINAWEGIILDMSHIELDNSLMSHQSWR
NYNFYMEAELALLQDIGYNFDRKLYYGDSIYESNLLNWQSDHGYYARKDGKWLIGEYNPT
EYGVGLHIYGKK
>fig|195.2313.peg.1850 hypothetical protein
NVNFITPTSPLDNAKGSRNKKLLKDAGAMTSAQLDKKYNIYWDSEECEKDESYMEKYCKL
LNDAIKKAKESE
>fig|195.2313.peg.1825 hypothetical protein
MLEFFVNLLIFILIFFFFVFIFSIILYFIFKIFYKLKNKTKTINFKTIFKKFTLFLLPVY
LLLFLVGGCSYKYMDPQYYEFKSLCYFNLGKVLIENESIKNKTNIIVTPKSKQIKDRIVE
TRFERKNENQVVYYRINTYFYDNYGIFLKGDEGAGLYFRYMEVLSCKNIDKKFKKDDWQV
ETLE
>fig|195.2313.peg.834 Phosphoglycerol transferase-like protein
MLARPNDEKLEFGINDAVWIDKKGIYSGGKGYYFESNDTLKDMNKAFNLDGYTKDFDKFY
RELNLYQLAERLGISK
>fig|195.2313.peg.1893 hypothetical protein
RSEVLNSTNTTNTSNNTNFSISSKTNSPNYDISSEFKNSIYTLKYKQVDLSTDTAYGYSV
DKDGYMGSDFNKAAGLPNDFKIHKSTLDEIERFNQHGMADETS
>fig|195.2313.peg.1891 hypothetical protein
YRYNFPEDLRVKILAYAKEHNIKE
>fig|195.2313.peg.1904 hypothetical protein
ALTEQISFELKLAREYELDYLFLCNHYTKLIDNITNLEIFNKDNKNHKGSRSGFIYHRHA
HRSIKTIFKEMYLHHIKG
>fig|195.2313.peg.1748 Selenocysteine-specific translation elongation factor
PVSEPLKKEQKNKFLMLLKNKELKKAFEFLKNTHKYGFGLLSSYQRFKLSHEEALNLAKE
LNGVFIDEKNLNIYNLLALDELKKFIFFILEKNPYAMLSASSLALRLPWASAEFCEFGLQ
NLSNLLEFEKGVYFKKGIDYEKLREKNNDELYNILKKQGIKPQAPYNLYEFLELDRKSGD
EILKKLTKQNRVIRLSHNLFVEKNALDKLMQECLEILKSQSLDIQSMKERFNLSRKYAIA
YLEYLDKDERVQKKDEKRFLKTNI
>fig|195.2313.peg.1911 hypothetical protein
NIDKWILKPAIKELSKERNLFDQIRVPFKNLAYEKEKAKGTRGRGGKVSGITFTFKPENI
QMQKLENESQK
>fig|195.2313.peg.1780 IncQ plasmid conjugative transfer protein TraG
MCFFACSSEPKTVQYYEDPKNATELESKIKECANASSYSKSFNYKPQVSTKELMEQVEKI
>fig|195.2313.peg.1823 hypothetical protein
MLEFFVNLLIFILIFFFFVFIFSIILYFIFKIFYKLKNKTKTINFKTIFKKFTLFLLPVY
LLLFLVGGCSYKYMDPQYYEFKSLCKDIDNKVIIYNKAYWELYSDFTKKKPSIEKRVKDD
GYEYFYYEKLNETFAYYDIEDMIKSKKRNGNIITIVYDKKYKKMPKPFASYIRYNYKNDG
VFLRGDEGAGLYFTYEEVFTCSYFDNFK
>fig|195.2313.peg.1907 hypothetical protein
LARSEVLNSTNTTNTSNNTNFSISSKTSSPNYDISSEFKNSIYTLKYKQVDLNTDTAYGY
SVDKDGYMGSDFNK
>fig|195.2313.peg.1594 Integral membrane protein
LILCVYLLFLLIILIYINIYIPKNQNNLNILSNIGIFFTFCIFYLWMVCLNTLFLRYIFI
CISYIIVIISMGANITILNPFIGKLINDKIFSNDPLFIYLTFAYTILIFLVLFSLQKTAR
KNSIVPS
>fig|195.2313.peg.1906 hypothetical protein
IIRAAHACEDNNNDFSILDYLFDEYGLSLKDPKYNFAFHDMKHIKEANEKYILMEEVEDD
PCIYQNALIYDYILNA
>fig|195.2313.peg.1897 hypothetical protein
FIYHRHAHRSIKTIFKEMYLHHIKGAAPNKIIIKRLNLNNSANIEEELNKNKQIQKN
>fig|195.2313.peg.1890 hypothetical protein
MSETYKIYTPNGIAVKVDKETNKIYFVESLDSHPPAKGNYTEEYSKALFEAHDIKRNSPY
KDYKPQYLDPNFYTGQKSTLV
>fig|195.2313.peg.1266 Selenocysteine-specific translation elongation factor
MNSLLIGTAGHIDHGKTSLIKAINGFEGDSLKEEKERQITINLSFSNLNYKQKHLSFIDV
PGHKDLVKTMISGAFGFSACLFVVDINEGLKEQSIEHLEVLELLGVKDIILVLSKCDLCE
NPKEQEQKILNSLEFIPMKVFHTSIKDQESIERLKNYLLNLECKNANANLVFRYYIDRVF
SLKGIGTIVTGSLNEGKISLNEKIICLDNQKELVVKNIQNHESNFAEISAFNRVALSLNC
DYKELKKGYVLSKKGFFKGFKECDVLIKAKRLKNEKMLFCVGAKSIECKISILKELENNE
FFAHLEFEKNLFLCFNEKFILLQNNRVVGGGEVLNPV
>fig|195.2313.peg.1882 hypothetical protein
DNNNDFSILDYLFDEYGLSLKDPKYNFVLIDMKHIKEANEKYILIKKAKESNIICRNALI
YYYILNADNPNSQIIKYLVNRGAKFEVHDEDTNWTPMHFWARRNNYQLLELAIKGGANVD
MQTFSKLRKCNNETLLFEAVSEPETYRVTQLLIELGANVNFATPTTPLDDAKGSRNKKLL
KDAGAMTSEQI
>fig|195.2313.peg.1719 hypothetical protein
MSLNSYMSLNISNSTSNPLPFKITKALIKESLEELFSIECEGFFESLEQDLFSLNTLTNA
SSHPSTPTTFNFHPNVLIDQEAILSIHNP
>fig|195.2313.peg.810 Possible dnaJ-like protein
MRFYGRDEMQIVQTLETINVNTDDINVFQYFKDLITKNFTKVVGRKNKIFSFFEENEIPQ
RRYFLKVLDQKYRKSTNEGIENLQDAHFKTFRLIFEQNNMLKPMLFIKIDFVAGRILMKL
SSNEKLFITYIRNYFQDHNIEYNEMTNILILEYKNENTLELFEAFANESEHLKYCVNFEV
DREEYKKFRQNIHNKENMKWKFNALAKLF
>fig|195.2313.peg.568 Methyl-accepting chemotaxis signal transduction protein
MYVTPSYLDLTTNLPCFTYATPLYKEGKFIGVLAIDILVKDLQREFENLPGRTFVFDSEN
SIFVSTNKELLKPGYDVSLVANIAKDKKDYEPFRYVRPLDGTQRFGVCAKVLGEYTACVG
EPIDYIEEPVFKIAYIQIAIVIITSIISVLLLYFIVSRYLSPLASIQVGLNSFFDFINHK
TKNVSTIDVKTNDEFGQISKTINENILATKQGLEQDAKAVKESVETVGVVESGNL
>fig|195.2313.peg.1884 hypothetical protein
KGAIAPWTKAEKAYYKSLKTKRERYKYLAIRSGLRSVVIDIPYDAYANVDEKGRLVNEDY
AYIYDEVSSHRGTLKSYSFFNEWELSALLLGNIKASPTAAVGFKARQQQALFLQAQLGDK
NAFKSLGLAVLCSNSFLTGQHWNKLRAKMIYDLHDYHYESLLDEFGM
>fig|195.2313.peg.1898 hypothetical protein
MKKLEDIKAMSYQEKDELEDLVLEIIDNNDLVKLKD
>fig|195.2313.peg.1824 conserved domain protein
MSKNIKTQEAKLDLITKFLDYADIADASYAMLQYVWENIEQDEKNNIYKADKLTFGDKLK
QDIVMKNSKGEDIVKPKNTNTAYACAIQARFEQNKIVKIEPKYCISLINTCFDSKEITLD
NDISRVGLNDALSKRTIDFVNRFKLLKHQPNTTNCLMKKTEKIKRS
>fig|195.2313.peg.1887 hypothetical protein
QALNENKEFTEDDKIQQAQAIKKACEKKADEITKILLKDDESLKDVIRDKQELKKKISDL
QNNQNKSPKELSLLGRLEFLQRNQDKAGKHKDIIKVLQNPQQTSNANKNNTDDNKKKKLT
KKNQNQEEQKNKNINSKDIGDAGEYAASM
>fig|195.2313.peg.1903 hypothetical protein
NALIYDYILSADNPNSQIIKYLVNRGAKFEVHKDGFGWTPMHFWVMQNNYELLELAIKGG
ANVDMQTLLDPKSEYNETLL
>fig|195.2313.peg.1856 hypothetical protein
FALAKIQASPLAKIKYDRIRWEGGGGKLGAAQRRRREKSKEKAKMLLYLENENKKGKVSD
KEVHLYKHNGIWPKDTPKPRSPGYIGENGKIKYPDDDGYKIPPKPREITLKKGMKLDRYG
DNLGSFVCPFKEKKGVMPYEKRSLPYENNEAMQKTYKRYEALEDINMESVERKIKMSGND
KLIEKIKELKEKNKFHSPKIGKISPHFDQEGKGTQIKLPISVENLMQLDFIKQIP
>fig|195.2313.peg.1815 hypothetical protein
IFLNSTLLTGSNELPNNPFYFGELDQDNTIKQDTPSYYFSPKDESSGLGRLSIFYKNDEL
CLLNYSIIENSLNIKLECLRKQSLEYKDLISNTLKEQKTTQVDKKQSIAKLHALLENQNL
ECIHGGKVILKSNKGKTFKDDGVPIMLESDLLNSSIVACPNTIAGVSVPCTKVVNVKGSL
SQKKVNHEYVILQELISACKTDKGFALKVSFTPTKFKFDHSFDPKEGLGEQSKNQIELKE
PIIRLHYKSDRFQKDNLPIYNLLINNEKKEQDKALNEFNIDLKDLKDIEDINILNQFKQD
FSKDYEFKELNLSFDTNLIKLYFIIPKNIAKVYKSAYKEFENKDLGVGYFTQLHEYDKII
KNALEDNKELNEYHFSFLAPAKMQNLKLQIAQGLDEILEDEDRKQELYVCKFVVVNGVSE
NNAQEKITHLSNDGQNLLKNIEKLRLKPYNDQNGKEITSYVKGATIGYGHLIGQNEWDLY
KNGITLQEADKLFKSDLLPFENAVKNSINSSLAQNEFDALVILCFNIGIDNFKNSSVAKI
INGEKTGYKTLKEAWMAWNKSQNKVMQGLINRRNAE
>fig|195.2313.peg.1909 hypothetical protein
MKYYKMMYNGQHNDVDNWINCIKPDIKNNDKYALLESKPITNWQTPSFEIDKDDGN
>fig|195.2313.peg.1774 Glycerate kinase (EC 2.7.1.31)
MKTQINNLKDYAELAWASYFYFDFLNTRNIFELD
>fig|195.2313.peg.1399 Possible dnaJ-like protein
FNTLECTPQNDLSEIRQKYLILVKLYHPDFHQGKSAIEKAYAREQFEKIQIAYDNLKALY
KNNT
>fig|195.2313.peg.1873 Integral membrane protein
VFFRNSKFNDNVYFNNSIFKDYTDFNECEFEKTTSFYGVTFEKTPNFSQVIFKGNLNAIN
AKLNFTFDDLQQRIKQECTSYESQRTTKKAGVIPNLYQEKSLDKFANDFRDSFRTFKNAL
IKDNNLLDASNFHKYELYCKEIELKQNWDKKGENVKNTTDLEKNVSRIRDFVDFLLLGFY
RKLCDHHTDFLKVFNNLILLISLYILFIFVGSFEFDLEKKSIQNLNKTSDMFSYLTKVKE
VIINFSFMQQYYNHILISFVAVCFICLIVIFYKIFK
>fig|195.2313.peg.1880 hypothetical protein
VALGALLSSSAFAEDILAKVSNGAISDNSAGVKVLSLDEMKEVKGGVYTFNRASNYDNVI
GVRSYAYIAGDSDKTPEQFLQAMNISGNKIILAKYRYVNNRKEHYLQSYDKSSGRLNDIW
AWNGSYALQVLNDFKKRY
>fig|195.2313.peg.1869 hypothetical protein
HLYKHNGIWPKDTPKPRSPGYIGENGEIILNIKQRAMEIKNTLNGGYNSVSIKTKDKLTR
YDLDGKPHYEKTSKKIIDTPHKIEYTKHINPQDPTKYRMSQGLVEPISHKDLDIVENYLK
RQNNEI
>fig|195.2313.peg.1877 hypothetical protein
FKKDEDSPIHAYNEALQILQDFANGLYNTSKDKTGRYIEDKNKTRRLLEKLNIIGQNNLK
AMYMGINGNKESLKAIGKRENNTSKASANTDITSETKTPPNFIGRLATTIIIEDGLYMG
>fig|195.2313.peg.1914 hypothetical protein
FEKGIYVLIPRLVSLDKNEELHFDPVPLEDKGFVVTDFRKGKKGEKNIDLSFQRSIAKIK
NPNLTL
>fig|195.2313.peg.1892 hypothetical protein
FSNALGQSFPNDKTSFSEADINSMPKGYAINGIKSMDFNDPSNRMNITHLRDFSNSSITN
IYQTSEQMKEAESLYIQSGSLIDGINGHSFGLSLEEIKNVSKGEDWQFNPDMSVYPQNED
GSYSKEALFMSF
>fig|195.2313.peg.1317 Putative acetyltransferase (EC 2.3.1.-)
IRENKVIKEGQNLKKNFNEKRCGL
>fig|195.2313.peg.1854 hypothetical protein
MFKKLLSVVALGALLSSSAFAEDILAKVSNGAI
>fig|195.2313.peg.615 hypothetical protein
MIKDNYQVKHLKACILSAWSFWYRCSCDIKSKNKQDNI
>fig|195.2314.peg.1924 Motility accessory factor
QDPIKELEKNLEYFKDFARYPVLFFYGFGNGILYKILLQNQALKRIIIFEKELELIFLAL
NFIDFSKDLSLGRLIILHHDDINLPKMDKVFRLIGDLFYRSYSLHIANDFYEHYKEDILK
LNKLNMQTIKNHNLMHGNDPKDAMQGIEQFVYNLPQMITHPSYKELLSKRKGISDTAIIV
STGP
>fig|195.2314.peg.1480 hypothetical protein
MNGSKLALVLFLCFLIPNLAFGAESPEGALTLIKNGLLSWTPLIKTACLWVFWTLVAIDL
IWTFGLKALSGFEFGEFLTTLIKKIIYIGIFLFLFNTDQWLQIIFNSFSQLATNVNNGID
VKPNNIISTAIDVVITILQSASIFSPVQSFFIAISGIIILISFLLMAIDLLIVYLKFFLM
NVIVFFALALGGLNHFKQIGLNPIMTAIKVGVELFMIQGLMGICFTMIGAIANEINQNIT
IENILIALVTPVIFCIITKMIPGIIEAVFNGGIGESAGAAAGFRAVATMAAGAAAGAAAG
AVGITRAMNAAKALHLAEGGKGGMDLVKGVAKNLARAGGEHLRDNLTKGRMPNQMANRLQ
EKLKDIQGKTSEGGISSGSPKEESYQSGINPNITK
>fig|195.2314.peg.1873 ATP/GTP-binding protein
QEKLNSSFDDFIKEVQILNHQILNKLKSIGERIASEIFNCIKEKEAHFYKEAKGFLKKDL
YVKYDYKAPFISSDDAFLAMFYNSDIMNKEFKKIKNEIYESFEKIKQKLKDFIDNLEKDI
LLFKAEFSNIQKDNILQSDKNFSELRAFCNASDEYFLKDFKELLFKSLLELDLFFEKLNL
KAFANYANATKLSLAFFSRKINESRVLYELDSSEFTLFYPKKSEIYERVLTELNAYEFEA
LLINKPILVKISNHFLEQNTNIIQEKNKILDLKKVELQKRKEQILEVRSVLKENL
>fig|195.2314.peg.1929 IncF plasmid conjugative transfer protein TraG
DTDEAMKIHAALLGMANDMANYEQKFLGAAQIYNEQAVSARSYLQQSMIMLASQDAIINT
AKSVGLNPASVAANTAYADQQFYASMQAQGHLAQTYLPLAKAYLTAIIIGLSWLVALLSI
VFGSYAHIKMFFTLCIWI
>fig|195.2314.peg.1380 Phage antirepressor protein
MNLENSLQAEVVNNSNIVLFENEELGQVRVALDENNEPLFCLSDICKILELTNPSMVKDA
ILREFEIPKLNLGVIESTNNRRLEVSFIDEPQLYFILMRSDKPNAKHFRHWVTKEVLPSI
RKI
>fig|195.2314.peg.1885 putative lipoprotein
MLDLKDYVNEVVYTSFESFITKDSKDKKTSFCMASLKFTYPQMPNEMREKYSRGVLKGVL
FDEGEYETQISYSARFSDDKKQVFVELLDYQFILTMKFYFHCLYK
>fig|195.2314.peg.1921 Methyl-accepting chemotaxis signal transduction protein
KAINENILATKQGLEQDAKAVKESVETVGVVESGNLTARITANPRNPQLIELKNVLNRLL
DVLQTKVGSDMNAIHKIFEEYKSLDFRNKLDNANGSVEVTTNALGDEIVKMLKQSSDFAN
HLASESSKLQSAVQNLTSSSNSQAASLEETAAALEEITSSMQNVSVKTSDVITQSEEIKN
VTGIIGDIADQINLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQKSLSEIEANTNL
LVQSINDMAESIKEQTAGITQINESVAQIDQTTKDNVEIANESAIISSTVSDIANNILED
VKKKRF
>fig|195.2314.peg.362 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MHEPYLSPLFERGNPQNETKLNTLICKAFLKTLSDIPKDLQGYASKARLIDMMDFEKVEF
NKAISLNVKSRDELNPFKNSKYELVRLGEVCDLNKIRNQASATQIEKMNLNSGNVKLLPS
SKNYEWWTDEKTAGQFINEGEVITLGVARYANIKKHKGKFVSANNHILSVKDKSKIIFDF
LYILLEICGQKLYKQGQQYPQFDTNIFYSFKIPLPPLEIQKQIVAECEKIEEQHNTLSLS
IKEYQKLIKAMLQKCGIIEDNQEYELNSILDKINNLCKINLDSEFLSSFNKTIKEYALSN
PIFKLSIGKRVLNNELLENGQIPVYSANVLEVFGFVNKEILQDYDNDSVLWGIDGDWMVG
FIPKNKKFYPTDHCGVLRVDDTKINAKYISFILNEAGKKQGFSRKLRASIDRIKALRVKL
PSLEFQDQIADITDKIEKKINEYKIELDRLEKEKEKILQKYLFS
>fig|195.2314.peg.35 Type II secretion outermembrane pore forming protein (PulD)
MQIQNGQGFVKNLGLRANLNFDSIVNFLSQSGKTSVLSNPKLMALNNQQAIISIGDTVNY
QVKESSKGTENGTTVSESYSNYSIFIGILLNILPEISDDGKIMLRINPSLSDFKYPEDNK
RQKEPRTIAPDTIQKKLSSVVQVENNQTLILGGLISHNRSQNDNSVNFLSKIPILGSLFR
SEDENSNITEIVFIITPSIVDNANIPSLRELGFKYNE
>fig|195.2314.peg.122 Catalase-like heme-binding protein
MKKYISSCLAICCLSSAIYANDVKYNAQKIADIFYQLNADPKNPKVKVNHAKGFCAMGTF
EPAQSINKEIDVPLLTYKSLPIQVRYSLGGAFKDDKSKTRGMAIRITDPQDSASWTMVML
NTEINFAKNPKEFGQFFEMRLPVNGKVDQEKISKIMQEVDSYRNFAAYTDKIGISKSVAN
TPFLAYILSILSKQGVKTICQQDGN
>fig|195.2314.peg.1703 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
LKEKECLTYKLGEALIKASNNWYGGGISNCGLRLGS
>fig|195.2314.peg.1814 hypothetical protein
TKTINFKTIFKKFTLFLLPVYLLLFLVGGCSYKYMDPQYYEFRSLCKDIDNKVIIYNKAY
WEIFSNREKGNTMHDEKGEFFFNQKINKKIYFDFKKSKKH
>fig|195.2314.peg.764 ATP synthase delta chain (EC 3.6.3.14)
MNDLIAKRYAKAIALREDISEFYDNLSILSSAFASPKFKNIIESNQIQKEKKLEFVISLI
EKASPSFNNFLKLLA
>fig|195.2314.peg.1346 ATP/GTP-binding protein
MQINILNHFIKAYEDAYNIDFDKSFEGQIKMLCKKLNEPFMHPSYNLIQELEELSFSLDK
NINIAIIGQFSSGKSTLLNLILKKECLPTGVVPVTFKPTFLRYADEYFLRVEFQDGSDEI
THIEELAKYTDQRNNVKETKSLHIFAPIPLLKKITLVDTPGLNANEDDTLTTLKELQNIH
AAIWLSLIDNAGKKSEEDAIKANLELLGENSICVLNQKDKLSAQELENVLNYAKTVFSKY
FKELIAISCKEAKDETKYEESNFNLLLDFLDNLDEKALKQKFTKRKMLHLCQVLEDENRL
FVDIFDKLANQFQ
>fig|195.2314.peg.1459 hypothetical protein
MVDKETMLIKHNEYIKYFDKCEEIKIKNNELQNKVVLTISTALFGIIITSLDKIIPLMLS
IACLKYLFIGLIISNALVIVSIFASIYYANKGIDISIKNAKAYYLNRGEMKEDKYSKLAT
KLRYLYIIFICIVIAIFVIILTIILLSKDYKMDKNKSKELSLCMESLTAPAIPVSFYDSE
IQSQINYIRADSNLNGINIQQEDNQTKNNNTKEDN
>fig|195.2314.peg.1928 Mobile element protein
MQIEYDITLHSVFLLQYHLILVVKYRREVIDDKICARLKEIFEYIAKNDNYSLELIEFNH
DKDHLHILFKAKPKSELLKFINAYKSASSRLIKKEFPHLKQYLWKQYFWSGSYFLATTG
>fig|195.2314.peg.1931 IncF plasmid conjugative transfer protein TraG
KLSAIDATLQKNIDFYFRNCVSVGILLNQQGRNLFQNSDNLMQDLFTNIGNGSQLTPLFE
NNNNIEKQSVVPCSDAGPQIVEMIKNDTDEAMKIHAALLGMANDMANYEQK
>fig|195.2314.peg.1488 hypothetical protein
ILSQENEKNKHSIVKNVSYFETKAKNLYFVSRNEKNKHSIVKNVSFY
>fig|195.2314.peg.36 Type II secretion outermembrane pore forming protein (PulD)
MECQKRLFDININEDLSIEESLKELASYCSFSVVIKDTIAKEKLKAIQSSINIHQMSLDE
IFKLFIEEQDLAYKFDGKILKISALQTRIFKINYITSVREGQSITKASVDSKPRQSEYYS
AFEDNEDNMIKSMEKFDFWQNIEKEIMILLSSSHENYDIKAPIVNPNAGLVIVTGTHSQL
QRVKAYLQKLESRLKKQVIIDVSILAVNLNKNHSSGSIGKISI
>fig|195.2314.peg.1638 Membrane protein
EYTKKSNIYLKEDLINVKLEEKQSLAKKIFSKIKEKNKNQESKKKKTKKLFSFLKKKEIQ
GIQNKNTHNTQEKHLHTDKQIEIKKIQNNKIQPTQTDPKPDIKQSLENLQKKIQTQEVKI
EIEKSEIQPIKTEHDEDTQKVKNVLLEGFSNATKEDKNLNFNHLLFAVLFVSFALVLFVP
QIYIRNQIYYLSREIATLRVEESVLDEENKDLKRRLEIMRFQNQILDYLE
>fig|195.2314.peg.1901 IncF plasmid conjugative transfer protein TraG
LVALLSIVFGSYAHIKMFFTLCIWIVLWTPILCIINFLNDFNLMKVAQVITGGKAALSLG
DNILIFKEVASRSNFMNYLVMSTPVLAYAIAKASEQGFVTFASGLSQALTGASRAAGSFA
NQQALSTQTSIAAPRGDEVWAMNAGVVSLQSAMSAGGGRFSMSSITGGGTTIKDVNTNTN
FALGSNGEITNMSIAGLDAKHAQSETQTRQDSLANSIADTHKTGINQGITSNYLRNHGAG
VEDTKAIEKAEAQALRETMSEVLGDKSSFNEADKKALEGSVGAYANASAGLEIFGSGGKI
GGEIKGTASIDTGSTETQEYSRSLSKEGQAAFDKMYAEKLGNIIKSSDSVASAYSNALST
STGSEFADAKQKAHSYSEASQYSEAIQTSNLPNMAENYIAENNLGGTREQQVAAAAKGLE
NLAARGDLQGLLHYANMNTAKPNADGIHDVSNKSYYSPSSVGANNAHNNDAVANQNSLNN
LGTAGGNNIRNEFSQQSGAAISNFKNQGTSTSNVVNNSAKDAIVEQNANRRMGVNPSSYA
IQDASKSGNELAKEAQGLFDAMSKK
>fig|195.2314.peg.1750 hypothetical protein
MKLSKNQIRTLINKALFVLIAFIIGNIVVSALSQFYGIGVIHTKSIDKDVFIYQKKFQGD
LKDSLIYFSLPVQTRYFDKNSNFGKYVRCEEGQTLSVKDLKYYCDNVFLGIAQKTDKDGS
ESHSLIEASASQLKPSNLS
>fig|195.2314.peg.1934 Motility accessory factor
ALGFKNIIMIGQDLAFDEEGNSHSKGFSYGEQFSGEKTVPTLKTQAYRGKGEVLTHITWN
DYRIKLEYLFACNDQKAKFYNAT
>fig|195.2314.peg.1922 Motility accessory factor
ISDTAIIVSTGPSLTKQLPLLKKYANKATIFCADSSYPILAKHGIKPDYVCMLERTEITS
EFFNNDFGEFDKDIVFICAGVVHPKAIEYLKGGNRKYLIMPRYLYFPIYIKLNKYFYFLY
NTPSVAHMSYFLSVLLNHKNIILIGQDLAYAENGNSHPDDYQNSATYESQAYEHILTEAY
GGKKEIKTHEFWIFFKQILEAMIIKYHITTYNCTEGGARIEGTIEKPFLWACENLLDKNL
NKPFEKLEPLSLNKQNEFLLKAYYKVCKSIEHCRDFSKILSNDFEKIQNIYLN
>fig|195.2314.peg.1010 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
SLGYQAHEPKYPTQRLKFDEVVEFYKEK
>fig|195.2314.peg.347 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MQMSLAAMSLGIDSCMIGGY
>fig|195.2314.peg.129 hypothetical protein
MNSISQKNLELFSKLSGDFNPLHLDQEFAKNSY
>fig|195.2314.peg.1927 Mobile element protein
EFPHLKQYLWKQYFWSGSYFLATTGEATPETIKKYIENQG
>fig|195.2314.peg.1765 Integral membrane protein
MTNAQINDKILELANYLKIDNKCVAHNARLQSMQINGAVIKNFSFKLFNEYKLSFFNCKF
LCEINEAPGFFEIENPVYIYDCTFEENVISYNIKFKSNVVIAYCRFNKNFYFEANTFCNS
SNFERNFYNYASFKKSHFEKNVTFYNSTFKGLDFSQAIFNENLNIVNTKLNFTFSN
>fig|195.2314.peg.1932 IncF plasmid conjugative transfer protein TraG
MKRFYFLFFSTLFFAPSFLFGATNIANSNLIYTWGYGDVMNEIMQAVKGITTETDYIVNA
ALAISLLLFSIKKAMDGQTNPVFEFGKMFMLFAVVWYMFLR
>fig|195.2314.peg.361 Type I restriction-modification system, DNA-methyltransferase subunit M (EC 2.1.1.72) / Type I restriction-modification system, specificity subunit S
MITKDNLKQVLENLGFKNKNENYVKTINNYTLLIDYKNQSINYPKEIKIHDKTTSNFSHP
ENFVVFECVHRLLEKGYKAEHLELEPKWNLGRDKKGGKADILVKDNENNPYLIIECKTTD
SKNSEFIKEWNRMQEDGGQLFSYFQQEKGVKYLCLYTSDFSDKLEYKNYIIQAYDNEEYL
KEKELQNSYKKSNNNIELFKTWKESYELQYFKQGIFEANVNAYKILEITPTFDNLKELKE
EGKYHEFAKILRKHNISGKENAFDKLVNIFLCKIYDETFNKNNLKFGYFGVMADTYANMQ
DRLMWLYKEAMKEFLGEKITFVSNEDIEKDFKQLKIKTLKEVMQNYIKELKFYSNNDFAF
LEVHNKELFLKNALVLKEIVELFANYKLTQNSTNQFLGNLFELFLQKGMKQDEGQFFTPI
QICEFIMYSLPLQEMLSKSSKALRVIDYACGAGHFLNTYANELKRYLTEDELKEHYKNIY
GIEKEYRLSKVSKVSSAMYGQNEINILYADALASFELANTNNLEGEKAKPQIESNSFDLL
IANPPYSVKGFLETLSDKSKNTYKLFNDDINIETNNSIECFFCERANQILNDNAKAAIIL
PSSILNKDSIYKNTREILFQNFDFIAIVELGNQTFGATGTNTIILFLRKKETFKQENHLI
SQDYSLIKERIEAENLKDSENFYQNYLSAYCDFRKFDKELYSNFLNGNLDSKLAELEAFK
DYRNAFRQTSDYKRLKESKIYKESKDKQDLEDKAFLAYAQAIEKDKLLYFSLSLNQEVLI
IKSPSDIKEQKKFLGYEWSNRKGDEG
>fig|195.2314.peg.1345 hypothetical protein
MINTQLTSQIANAQKNDIKTDSGISKDKLNSKDNPKEALSQALKQNLGLSKNASNEEVLT
RFVQNETSAKLKELVNKLLDQINAQKNPDSPMLKQGKNLNLAPNFANELKVLSTELAKSD
TFTQVLDKLNQILKPASEIKNSNLAPLLKNSGIFFEAKLKDALNEELLPKSFHSLISMIK
SLSSEKIGAQIAQLANANLSPKDTLKELRNIIYSNKNENKQILNQSSFKALLNLSSKLEN
FKNYIAKNPSHTQEKILPI
>fig|195.2314.peg.1893 Signal peptidase I (EC 3.4.21.89)
MEIDKVEQFIFNGVIPKDKFFVMGTHPRSFDSRYWGFVDRKDIKGVSIWAF
>fig|195.2314.peg.1912 IncF plasmid conjugative transfer protein TraG
LVALLSIVFGSYAHIKMFFTLCIWIVLWTPILCIINFINDFNLMNVAQVITGGKAALSLG
DNILIFKEVANRSNFMNYLVMSTPVLAYAIAKASEQGFVTFASGLSQALTGASRAAGSFA
NQQALSTQTSIAAPRGDEVWAVGAGYNTLQSSFGAGGRSFMGTRDMQHGGELVKDNMTGS
SAVINADGSIGNASIKGLNAGITASNLETRAHALSDAIQNSNLSQRALEVASGKGDSLAL
SENDRSAITNATQHALANAYSKATGVDVKQAYNDIISGKVGISFGVSGELSTNSQESEAW
YQNLSKDQKETFDKTFNESLSNEIGKNRDSSASFNNLLKTGNVTNSASIKSSMDSYNEAK
TLNNSVGYDGGASIVQGYINENYGGVVNKENVASAVNAVENMAARGDMQGLSHYAGVDSN
VNSNGLHEQTKHNYYDPKGTMTDHNKAIDDLNSRQKGFMATRNAPNDVKSEGLAGEIQKA
ANAAEFKTGTATEERNNKIDYTSVQKDIKDGKADISKAIDFGNQNRNM
>fig|195.2314.peg.247 hypothetical protein
IYYNIIQIKENKHFDIFKKNVKVKNI
>fig|195.2314.peg.1918 Mobile element protein
EFPHLKQYLWKQYFWSGSYFLATTGGVTLDILKQYVENQGIEDNRVKKQYKNTKRKRLLN
ANN
>fig|195.2314.peg.536 Membrane protein
MVTRIYFLFSSKKILIYFLLAIISLGSSFFLLENKILFLLFFVFYFLFSLTLASLFKEVK
MSFYFVFLCMLLAFLFFEKLSFLFFFLALHFLTFAYAFDRYETLKKLY
>fig|195.2314.peg.348 Oxygen-insensitive NAD(P)H nitroreductase (EC 1.-.-.-) / Dihydropteridine reductase (EC 1.5.1.34)
MNFKELISKRRACKLFNDKKISEEDLHFILESGILAPSSHGFEPWKFIILDKKEDNQKLA
KLCFDQASVASASHNIILLARKDLQSKDEFAQKQIRRFAGSKEENFQRILKIYTHDTDAM
NEKELYHFAQLQCYLAMMQMSLAAMSLGIDSCMIGGYEKDKVDDFLKLEYPFETAVILSL
GYQAHEPKYPTQRLKFDEVVEFYNAILQ
>fig|195.2314.peg.1923 IncF plasmid conjugative transfer protein TraG
PNDNNHRFMIHDEVTSKDYVISQIPIGIGKSFALMTQFEKVILEAMEKHFTTPQSTNFSN
AGLGFSLQVMSTLPSVKLSAIDATLQKNIDFYFRNCVSVGILLNQQGRNLFQNSDNLIQE
LFTNIGNGSQLTPLFENNNNIEKQSVVPCSDAGPQIVEMIKKDTDEAMKIHAALLGMAND
MANYEQK
>fig|195.2314.peg.1737 Putative transferase
MKNVIIIGAGGFARELYSYLKDANYEIIGYIDIQENNFFDLKYLGNEDNFDKKLIQKASF
ALGVGQINLRKKILVKLSKKKKKNHVILSLLYILNLLFQKKLK
>fig|195.2315.peg.1108 Type I restriction-modification system, specificity subunit S
MTNLPQGWEWKSLGEICFITDGTHKTPNYIETGIPFLSVKNISKGFFDLSDVKYISLEEH
NKLIKRAKPEFEDILICRIGTLGKAIKISLEFEFSIFVSLGLLKPKVKIISDYLVYFLNS
YFIEGWINDNKVGGGTHTAKLNLNILEKCPIALPPLKEQERIVGILDESFAKIDESIKIL
EQDLLNLDELMQSALQKAFNPLKDNVKENYKLPQSWEWKSLGEIGEIITGTTPSKNNPNF
YGNEYPLFKPSGFKWRYNNKIC
>fig|195.2315.peg.341 FIG00638667: hypothetical protein
MEVQSMHAANPMDKNLHPIKILPFLVAGSSLKGDSINNKLLIKEAELSSAVFLEPSNIKT
KNPPKKEEKDKINYVISGGLAREGNAKNNTLELLDGSYINMGVENIYNLKLNGAPYAVGG
LAIFGDAI
>fig|195.2315.peg.1066 hypothetical protein
MISNAGDQIISNDDYIKNDSSVSASNKDFVSKILDGLALGKDFNAIGSIKFDKAGEQIAN
DIKDSAKSISNINQASSGINSTINISNDVSIGSRVAMLNNPYGNYATKLSQMRFAANDYR
GNYVDNYENSIWGNVIGGTNIIDGDSSALYGATIGMDRKINDDAIIGAYFTYVNAEIKDN
LLTQKSDNFQFGAYSNIYISPKVEVNVKAYAQISTTDQDITNRGFNTTNSADFNRKFLGL
SANMGYVFDFSDNTLFVKPFAGANYYYAYTPSYKENGIAGKNVDSASNNSLSLELGTEIR
KYMSEESYLFITPKIEQYVMNNGDDFVASLNGVALPSVKSDDKKKTYGQIIIGGNIDISE
QFSLNAGIGAKQILAGKTDGKNETYVSGQLGFKYKF
>fig|195.2315.peg.631 L-glutamine kinase involved in O-methyl phosphoramidate capsule modification
MISFIIEFDIVYSCYDFNSSKKLQELLNHGFNENELKRLEFSLLELTNKIINPQSGLYLK
DIKKAYRLKERYDGIIDSNFSLIDKIYWLIEECKRYGTLPFAGVARAAFVAMQLLNSLVE
INFISKEEKNDFLNSLNTVSKNLSKQTNNLNSCTKNQFLIEFGHLRAGTYNILSPRYDEN
FELYFEINQKDNNVYLEDKAFILPEEKMKALNTLLKEHGLEISACEFFDFLKQSIEGREL
LKFEFTRLLSKAIVYIEELGKYYDIKKEDLAHLDIKSILNLYSSLYSINPREQFLEEIAR
NKKEYKLTQAIKLPSLLCNTEEIFSFYNHSIIPNFITQKSITAFTAKENDKDLEGKIVLI
YAADPGYDYLFTKNIAGLITCYGGANSHMAIRASELGMPAVIGVGEENFEKYLKAKKINI
ECESEQIFCL
>fig|195.2315.peg.1007 ATP/GTP-binding protein
MQIDASKNQSFSMDYTTKSGKHLALSMYDNQSISYANNEEGKTLNLKRQYGFSFTFEGSK
LTQNDLDEIKNAMKEVEPMIKDFLANSKVGELKPKEIIESAMQMANVLPTPNDKNHQNAI
MNNFTNKLSDLLKQNQTNDKDINTSMLEDSKKLLDEVLEQMKKQLEKQLEKQQEKAKENQ
DKTDDSLNLYA
>fig|195.2315.peg.333 hypothetical protein
MEDAIYKINEMSGIKASGSLVAGSEYETTDVIITIEDSKKANAMLFFGNYGSKGSGVYRA
GVSGALNNLLGYGDSLNYFAQLSDEMQKSYGFTYNFFLGNLKVSPRVNKSNYELGEEYES
LGAYGSSLDLGVDLSYPLFINTTNSLYLTGGYVYRKLEDIYGSFGIDFNKESNAFYLGTE
GTIGLIPNNILSYNTQLTYGDIKPKSVFLENSPVMGEFWKFNAALNNTYYFNNKISHILN
ISYQKTIGDYQLDSSETATLGGAYGVRACPNGFGEADSMILTTIGLRFNIFSPNFYITPF
YEFAHGWNEDYLDNDINMAGREGKNDIFVDAVGLELLYIKPNGFYIKLDLAKAAHKYEAD
GKRRIDSIQVWDFIFKAFKSILQPRNFIAL
>fig|195.2315.peg.1447 MBL-fold metallo-hydrolase superfamily
MQILKQACGPYETNCYILNTSKGDFIIDPGVNALSFIKQYAKKPLAILNTHGHYDHVWDN
ARVKKEFDIPIYIHKNDEFMLQDPFGKGFEPSKADVLIENNEDELEISNTRFKFHFLPGH
TPGCTMIELMGENLMFSGDFLFYRSIGRWDFPYSDANLMKQSLEKVMTYKEDFRLLPGHG
QETSLRAEQVHLPSWLRYF
>fig|195.2315.peg.1822 Mobile element protein
LMIKRARQLSKKQHAKTKQEALQGIKKSSNYLKASIKLNKLHRKIANIRSDFLHKLTSSL
VANAKYFCLEDLNVKGMMSNHRLAKSISDVSFYEFKRQLEYKSSYNDKEIYQVDRFYPSS
KLCSNCGTIKENLALKDRVYICDECEISIDRDYNASLNLLSQLKQKIGKVLAEFTPADLT
ALLNDLAINQIATSKVETGIQQKSYL
>fig|195.2315.peg.1065 hypothetical protein
MKLSYHTSKVLMSVSISALLSSAALAQEITIADGDGSMENHFETNDRQHFTLKNDYTNGN
LTININNTDIPNSIAKEGYEDLATVNINLGSNDLAIKNISHGDISTYVTNYTINAKKTEA
IDVIFQSTNGRSIVNGDFNIKGSSAPTEGVLDDIKSSAILIGDGHGLQGSLEVNGNFTAD
QSTLFTVGGNKSQNHIQINGKANITNSNFSIGATSFGDLALNNYVFMSASEGFNEDITNS
NKASANISENFESIVGMSNKDLGLDYEVIRAMDIKDFIEYKLSTKDNKLLISGGANKNVD
NNKMILETKKKYLELIKTDLEGAKNEVLIKKKLMKLSQKLMSK
>fig|195.2315.peg.1132 hypothetical protein
MQNQTFAPYKGKNEAFALLFPMEKLFEDYVAHMLKKANPTQNIKTQSSGKYLISKKGEKC
FMLKPDLYIENETILDTKWKIPDSNEDKKHGIAQSDLYQMFAYACKFKIHDIKLIYPLCE
RTMSLQNTIKELEFNANEHLAFLNDNSPLKTNIKVQVIFAPLPF
>fig|195.2315.peg.572 Putative periplasmic protein
MYERGELVRQNLKSALAFYSKSCTLGFAEACYLIGRYYELEKKDLKKAKRYLGMACDKKH
QEACAAYRKLNSQDIEIY
>fig|195.2315.peg.571 FIG00638667: hypothetical protein
MRIFFILSLFFHTLFAVDDLDNALRLYEGNKFVKAYEIFERLCEKDNARACFSLAYMNEN
AQGVARDFDKAYKFYDKSCKLGLAKACSNMALTLQDLGYVNESLLAFNKACNLGESSSCN
HMGLVYEDEKDGQMATHFYKRSCDLKDARACYKLGFCMKEESL
>fig|195.2315.peg.1133 hypothetical protein
MMGKINQKMINNNTFSIIEHQAFSKEDLQGIFKEKAKKFYQELEDFAKNNENFLGFKNKN
TLTAKNYVGIIQTKSGVLEILPKCTNLDGYKDKECKLSTISKEKLLKNYILNQISQAKTS
ENFYGEDFAFNPKTLLINILKTLKNSPFKKSQISSLQISKMPLLEVFIAMFLDELDGVYK
KGLKKDYISIEENRNFLKGKLQFSQHLKQNLVHKERFFTQSDEFMLDIAPNRLIKSTLNL
LKSKTTHHKFKIIKALEMFDEVGFSTNYEKDFTYKISRHFDYYENLLS
>fig|195.2315.peg.1663 Pseudaminic acid biosynthesis protein PseA, possible Pse5Ac7Ac acetamidino synthase
MLELGLNPLCVCFEPSVPTKIGRKNLDNLNHLGVDLIHIKRDPKVYQKLAREAFVRTGDN
EWQNHLGIFTSVPRIAVNFGVPLIIWGESPQIEYGGPASSKNKNILGREWLEEFGGLLGN
RASDMLGVNGITEKDLFLYTYPSDEELQRVGVTGLFLGYYFKWDYKKILEISKKYGFLTL
DHPVETTYENFENLDCYSNHVHDYLKYCKYGFGRATDNACLDIRLGYISREEGVRLVQKY
DGKPPKKAIKKYLEFSGFSEEEFQKIVDSFTNKKIFKRDENGKFIRDYDGSLVRKDECVL
K
>fig|195.2316.peg.1550 hypothetical protein
MHLLKLIFVIPKNIAKVYKSAYKEFKNKDLGVGYFTQLHEYDKDYRENENIIHHRVFLAP
AKMQKIGFEIAKGLDE
>fig|195.2316.peg.1139 Capsular polysaccharide biosynthesis heptosyltransferase HddD
MSIIIANRTDGTGSRLISLMNAMYLAKILNKQVKFTWKNYIPFTKDSDTNNFRKVENDNV
SILGLCVESHTEIFSKNFIDKYFLESINGSIFGIDGKVYTNFDLFLKELKVNKYDYISVP
LSDLSTRVFKDIDDLEYRKHMQNIWKDIEFSESVKKIVNMAKQTCMKFKDFICIHIRSGD
AIYDYAEFRKFNLQSIYHATPCEIAIGIIQKNKNKNIVLVGDDLLSIRQIAKFCNFKNVF
VMEDFRNSNQLSNMELFFYDVIFMSYAKILYGTNSAVVRLANYIGY
>fig|195.2316.peg.1749 Motility accessory factor
KDIEIIWIMFHILDFSHELQSARLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELMSH
YYERFHEDVLELNKKLVQYFKDSIISHGNDSTDTLQGIEQFVYNLPQMITHPSYKELLSK
RKNLSDTAIIVSTGPSLTKQLPLLKKYANTATIFCADSAYPILAKHDIKPDYVLSLERIP
LTSEFFNNDFGEFDRDVLFVCVSWVYPQTIKYLQKNNRNFMLISRPSDFIKNINFHQYGY
VGYGPSVAHMAYEFATHLNYKNIIFIGQDLAYAKDGFSHTKDYSNLDKHEGHFQRDKGKF
QCLAYGGNGKVESSGIWTMFRFSLQNTISRNIISTTYNCTEGGARIEGTIEKPFLWACEN
LLDKDLNKPFEKLEPLSLNKQNEFLLKA
>fig|195.2316.peg.1750 Flagellin
KNYNGIDDFQFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVETRGMAAVRAGTTS
DTFAINGVTIGKTAYEDGDANGALVSAINSVKDTTGVEASIDANGQLLLSSREGRGIKIE
GSIGGGAFINKDMMENYGRLSLVKNDGKDILISGTGLSSTGFGASNFISQVSVSLRESKG
QLDANTADAMGFGSVNKGLVLAASSIA
>fig|195.2316.peg.1690 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-)
CLTYKLGEALIKASNNWYGGGVYQIVV
>fig|195.2316.peg.1704 GDP-L-fucose synthetase (EC 1.1.1.271)
MNKDSKIYIAGHMGLVGSSILKKLQNDGYENLIFKTHSELDLTNQQAVSEFFFKEKPEYI
FFCAAKMGGMMEQLEKRADFLYLNLIMQTFVLHEAYKNNCKKLLYLSSLCIYPQNVSLPI
KETSMLEGKLQFINEPYAIAKITGNKMCEFYNQQFGTNFITLVPTSIYGPGDNFNLATAH
VFPAIFAKIYLGKLLNEQKHQELFNNLRLDNIQDVLKYLSQFDIDENKVTLLGSGNPRRE
FIYVDDVADACIFAMDKIDTSVLKSYDENFHNTHLNLADGRDYSIKEIAFLIKDIIGYKG
DIVFDSSKLDGTMLKTTDTERIRKLGWKAKVKLEEGIKMMYEWYLKEQNIRQIG
>fig|195.2316.peg.1140 hypothetical protein
MSKKINISKENLIEFLEKALEYDYENDKYRIHLIDVLLNHNEFSKANEMLKTILLTRESE
YLKTLFLKGWIGVVYSNLFDIYLKSSCLQYPYIAYVAMHILKFRTSLQIQNLNNTLNKTI
QEKDIIINSNTNQIDQL
>fig|195.2317.peg.1192 Translation-disabling ACNase RloC
MQPIDIEEAKKIAEFILKTIEQNDKQQYKALVESIGK
>fig|195.2317.peg.1614 Domain of unknown function (DUF332) superfamily
MRKINLLRSFKKDYEKVKKQSWDLNTIDDVIQCLMNLDVLPTRLKDHALKGEFKDFRECH
IFGDLVIICESHSLIEASASQLKPSNLS
>fig|195.2317.peg.1739 hypothetical protein
MTAYVHIGTEKTGTTSIQEFLYINKSIIQKQNYFFAQSIGIKNHWDLAFLGYSLNKKDSY
ILNNSLW
>fig|195.2317.peg.1663 Motility accessory factor
MGGGYNENLLYQDPIKELQTMLNTYNDKYLLYPVLYFYGFGNGVLFKALLQNKNHQHIVV
FEKDIEIIWIMFHILDFSNELQSARLMILENDKLQTQDYNELCSFKPFFQFSRIYFLELM
SHYYERFHEDILGLNKKLAENFKN
>fig|195.2317.peg.1801 hypothetical protein
SRLTRKREIVKLYTFFKKIGFTNIKVICYIRDANEMLRSLLSEAIKWEEIDSFELKEEKE
EYKLGYKKNLFHFHHICNHKQTLQWWGEVFGKENLIARLFDKNEFYQGDLLKDFIHSIGL
EWDDEFIIPPKQNESLDLLGIDLLRRINKFLPLFCNNARNIFRGDLHHFAVKHFTSKDSH
LKFQPPKEVVQSYIDYFEESNEWVRKEFFPHKERLFSKKDLTDYKENYELKEMKPEYWDK
IAEFIADIVSTKNQNIADKTIIIQNKDKVIVNQTNQINSLQTTLKDNKAHLIQAQNLNNT
LNKTIQEKDIIINSNTNQIDQL
>fig|195.2317.peg.1349 hypothetical protein
SISSKTSSPNYDISSEFKNSIYTLKYKQVDLSTDTAYGYSVDKDGYMGSDFNKAAGLPED
FKIHKSTLDEIYSFNTSFKEHTANDLGVSNYYTNIDMADTIRQYYSKFNQIINHSFGNSN
KTSFSVEDLNSLPKGYSIHNTDFKFMFQNLDSQTITNFYNTQERYNEAEQLGMFGHINIG
LQPLNFTPQSMQTQNLDENSAKYTFNPDMSVYPQNEDGSYSKEALFMSFLKSSGGEALEG
GNTTLNPLVKAHIEAMTKESFDGSLASLDDIMTGKVDFASLLKGYAQDGWLDADIYAMEK
GVAWQNASIGYGGAWFDNQFNQAKANGWKASSESINSYVGSIMDRLNNLLGQTRV
>fig|195.2317.peg.1689 hypothetical protein
GCVFFFFFQAEDGIRDSVASRGLGDVYKETEIKF
>fig|195.2317.peg.1097 hypothetical protein
RDLTKFIIGFYINSRNIFSFMVDEIEEGGDICIYSLNSNNKISIEYKNKWYND
>fig|195.2317.peg.1191 Translation-disabling ACNase RloC
MKILKFDKINFGSYENFTWDNGLEEFKTINIFYGRNYSGKTTLSRIARSFELKKHNEDFL
DGNFKIKLEDGSFLTQNDVINSNLDIRVYNSDFVKENLNYLYDKKGNIKGFKSIGVEQKD
IKESIEKRKEILKTRNEKLKDIQANRENISKTQQAKIKTLNEKLIDKAKLVKSEPNLIKQ
GSNYDKRNLENDLIEIKDNINAYILNNEEQNQLIKILEDKEKQNIIFKNTFNKDNFQGIF
TYSLKILEKEVIIKENLTSELRKWLEEGLEFHKEHSFTQQYKFCNNPLTLERIAWIENNI
KDDSGEKEQIEKELKDLLDNFESYKLESKKLLLGIEYENFYSNYKDIFIGLKEQLGVSIA
NYNEELLKIEKKLTKKKKDVFTPMKLENINDFSDEILQILNKIENLCKENNEYAKNLLSK
QDEARKKLRLNEVAKFAKDSDCFAKQDEIKNLGQKLSNMQSTIETEKNEINNYNLEIEKY
KEKLSNLETSTSNINKYLKSYFGHNMLELKAKKDDKGQLNGEFEILRNGKQAKNLSEGEC
SLVAFCYFVASLEDANTKDKNPIIWIDDPISSLDNNHIFFIFSLIENEIVEKDSFKQFFI
STHNLDFLKYTKRLKKIKPKQNENSKKSTNSHNTILLKGVLKKV
>fig|195.2317.peg.1816 hypothetical protein
MGEENYKKLRPYLGMTTYYVCEGKKYPVVF
>fig|195.2317.peg.1690 hypothetical protein
FFQAEDGIRDSVASRGLGMCIRDSHRSCHGFL
>fig|195.2317.peg.807 Beta-1,3-glucosyltransferase
MLKLSNENKKFIKVILDGFFRIYLAKLFSNFKPKKHKGFTQYAIISAVYNVEKYLDDYFK
SIINQRLDFKKNIFMILVDDGSIDNSAQIIKKYQKKYPKNIVYLYKENGGQASARNLGLK
YMQENDYQIPWVTFTDPDDFLDRNYFYEVDKFLVTHKANDICMIGCNIIFYHEKQKLYKD
NHALNFKFKNGIQVKENCNLDNFIQLSAASCFMNIGYLDKLLFDEKLKPNFEDAKFINEY
LLDNINLKSAFLPTVKYFYRKRVEQNSTLDGKDKIKDYYTMVPNFGYLNLFKDIKITKVP
YFVQNVVLYDIFWQIKTLILNPEKLAILNNEEKKLFKELLFENFKFIDSCNIKNFNLH
>fig|195.2317.peg.1426 hypothetical protein
NKLKIKIKTKELKNIVFLESGA
>fig|195.2317.peg.1246 ATP synthase gamma chain (EC 3.6.3.14)
FHKKNQIKNVDLIFITADKGLCGGFYIKKPKAVREIFKENEKKKKILLSL
>fig|195.2317.peg.1018 hypothetical protein
MIDKNILHTRTIMVNISDFNPTAEFNEELKKAKDNKDYLKIFICNGLKNSKSNFYLENKL
IIDEFTEKNSRFWNDLDIFNKLKPEVKVEIKEDLLIKINSLLFYARNLK
>fig|195.2317.peg.1780 hypothetical protein
RNLKDINSQHENKLEKDLSILETLIKNYEKELNIKKTNIECAFKTLENIFYYIDNDTKEK
ISFQIGLKEFYKKAYIEITDMSVYPILILMCDIIYNKSILYCIEKKFNKTKTFNDFMLEM
QEKYKLNSKKIKRKELLNTIIKAFKDFS
